id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
27755333|NCT03731364|80932458|FG000|Overall Study|Adverse Event|0|||
27755334|NCT03731364|80932459|FG001|Overall Study|Adverse Event|0|||
27755335|NCT03731364|80932460|FG002|Overall Study|Adverse Event|1|||
27755336|NCT03731364|80932461|FG003|Overall Study|Adverse Event|2|||
27959454|NCT02524145|81686115|FG000|Overall Study|Withdrawal by Subject|2|||
27755337|NCT03731364|80932462|FG004|Overall Study|Adverse Event|1|||
27755338|NCT03580382|80932466|FG000|Overall Study|Early Termination of Study|0|||
27755339|NCT03580382|80932467|FG001|Overall Study|Early Termination of Study|3|||
27755340|NCT01658579|80932472|FG000|Treatment Period A|Other|0|||
27755341|NCT01658579|80932473|FG001|Treatment Period A|Other|0|||
27755342|NCT01658579|80932474|FG002|Treatment Period A|Other|1|||
27755343|NCT01658579|80932475|FG003|Treatment Period A|Other|1|||
27755344|NCT01658579|80932472|FG000|Treatment Period A|Adverse Event|1|||
27755345|NCT01658579|80932473|FG001|Treatment Period A|Adverse Event|0|||
27755346|NCT01658579|80932474|FG002|Treatment Period A|Adverse Event|0|||
27959455|NCT02524145|81686116|FG001|Overall Study|Withdrawal by Subject|2|||
27959456|NCT02524145|81686117|FG002|Overall Study|Withdrawal by Subject|3|||
27959457|NCT01396187|81686118|FG000|Overall Study|Adverse Event|0|||
27959458|NCT01396187|81686119|FG001|Overall Study|Adverse Event|1|||
27959459|NCT01396187|81686120|FG002|Overall Study|Adverse Event|0|||
27959460|NCT01396187|81686121|FG003|Overall Study|Adverse Event|0|||
27959461|NCT01396187|81686122|FG004|Overall Study|Adverse Event|0|||
27959462|NCT01396187|81686118|FG000|Overall Study|Withdrawal by Subject|0|||
27959463|NCT01396187|81686119|FG001|Overall Study|Withdrawal by Subject|1|||
27959464|NCT01396187|81686120|FG002|Overall Study|Withdrawal by Subject|1|||
27959465|NCT01396187|81686121|FG003|Overall Study|Withdrawal by Subject|0|||
27959466|NCT01396187|81686122|FG004|Overall Study|Withdrawal by Subject|0|||
27755347|NCT01658579|80932475|FG003|Treatment Period A|Adverse Event|0|||
27755348|NCT01658579|80932472|FG000|Treatment Period B|Other|0|||
27755349|NCT01658579|80932473|FG001|Treatment Period B|Other|0|||
27755350|NCT01658579|80932474|FG002|Treatment Period B|Other|0|||
27755351|NCT01658579|80932475|FG003|Treatment Period B|Other|1|||
27755352|NCT03806179|80932478|FG000|Overall Study|Progressive disease|0|||
27755353|NCT03806179|80932479|FG001|Overall Study|Progressive disease|2|||
27755354|NCT01364233|80932480|FG000|Overall Study|Lost to Follow-up|1|||
27755355|NCT04570657|80932481|FG000|Overall Study|Adverse Event|0|||
27755356|NCT04570657|80932482|FG001|Overall Study|Adverse Event|0|||
27755357|NCT04570657|80932483|FG002|Overall Study|Adverse Event|1|||
27755358|NCT04570657|80932481|FG000|Overall Study|Lost to Follow-up|0|||
27755359|NCT04570657|80932482|FG001|Overall Study|Lost to Follow-up|0|||
27755360|NCT04570657|80932483|FG002|Overall Study|Lost to Follow-up|1|||
27755361|NCT04570657|80932481|FG000|Overall Study|Physician Decision|0|||
27755362|NCT04570657|80932482|FG001|Overall Study|Physician Decision|1|||
27755363|NCT04570657|80932483|FG002|Overall Study|Physician Decision|0|||
27755364|NCT04570657|80932481|FG000|Overall Study|Withdrawal by Subject|1|||
27755365|NCT04570657|80932482|FG001|Overall Study|Withdrawal by Subject|2|||
27755366|NCT04570657|80932483|FG002|Overall Study|Withdrawal by Subject|2|||
27755367|NCT01533935|80932487|FG000|Overall Study|Adverse Event|5|||
27755368|NCT01533935|80932488|FG001|Overall Study|Adverse Event|7|||
27755369|NCT01533935|80932489|FG002|Overall Study|Adverse Event|1|||
27755370|NCT01533935|80932490|FG003|Overall Study|Adverse Event|5|||
27755371|NCT01533935|80932491|FG004|Overall Study|Adverse Event|3|||
27755372|NCT01533935|80932487|FG000|Overall Study|Protocol Violation|0|||
27755373|NCT01533935|80932488|FG001|Overall Study|Protocol Violation|2|||
27560829|NCT02045797|80241160|FG000|Overall Study|Adverse Event|3|||
27755374|NCT01533935|80932489|FG002|Overall Study|Protocol Violation|0|||
27959467|NCT01396187|81686118|FG000|Overall Study|Other|1|||
27959468|NCT01396187|81686119|FG001|Overall Study|Other|1|||
27959469|NCT01396187|81686120|FG002|Overall Study|Other|0|||
27959470|NCT01396187|81686121|FG003|Overall Study|Other|0|||
27959471|NCT01396187|81686122|FG004|Overall Study|Other|1|||
27959472|NCT01648023|81686129|FG000|Overall Study|Screen Fail Post Randomization|1|||
27959473|NCT01648023|81686130|FG001|Overall Study|Screen Fail Post Randomization|2|||
27959474|NCT00642707|81686131|FG000|Overall Study|Adverse Event|0|||
27560830|NCT02045797|80241161|FG001|Overall Study|Adverse Event|1|||
27560831|NCT02045797|80241162|FG002|Overall Study|Adverse Event|0|||
27560832|NCT02045797|80241160|FG000|Overall Study|Lack of Efficacy|1|||
27560833|NCT02045797|80241161|FG001|Overall Study|Lack of Efficacy|0|||
27560834|NCT02045797|80241162|FG002|Overall Study|Lack of Efficacy|0|||
27560835|NCT02045797|80241160|FG000|Overall Study|Lost to Follow-up|2|||
27755375|NCT01533935|80932490|FG003|Overall Study|Protocol Violation|0|||
27755376|NCT01533935|80932491|FG004|Overall Study|Protocol Violation|0|||
27755377|NCT01533935|80932487|FG000|Overall Study|Lost to Follow-up|0|||
27755378|NCT01533935|80932488|FG001|Overall Study|Lost to Follow-up|0|||
27755379|NCT01533935|80932489|FG002|Overall Study|Lost to Follow-up|1|||
27755380|NCT01533935|80932490|FG003|Overall Study|Lost to Follow-up|0|||
27755381|NCT01533935|80932491|FG004|Overall Study|Lost to Follow-up|0|||
27755382|NCT01533935|80932487|FG000|Overall Study|Withdrawal by Subject|0|||
27755383|NCT01533935|80932488|FG001|Overall Study|Withdrawal by Subject|4|||
27755384|NCT01533935|80932489|FG002|Overall Study|Withdrawal by Subject|5|||
27886595|NCT01435018|81418120|FG000|Overall Study|Site is closing|4|||
27959475|NCT00642707|81686132|FG001|Overall Study|Adverse Event|0|||
27959476|NCT00642707|81686133|FG002|Overall Study|Adverse Event|0|||
27959477|NCT00642707|81686134|FG003|Overall Study|Adverse Event|2|||
27959478|NCT00642707|81686131|FG000|Overall Study|Withdrawal by Subject|1|||
27959479|NCT00642707|81686132|FG001|Overall Study|Withdrawal by Subject|0|||
27959480|NCT00642707|81686133|FG002|Overall Study|Withdrawal by Subject|0|||
27959481|NCT00642707|81686134|FG003|Overall Study|Withdrawal by Subject|0|||
27959482|NCT00690430|81686141|FG000|Core Phase|Abnormal Laboratory value|0|||
27959483|NCT00690430|81686142|FG001|Core Phase|Abnormal Laboratory value|1|||
27959484|NCT00690430|81686143|FG002|Core Phase|Abnormal Laboratory value|0|||
27959485|NCT00690430|81686141|FG000|Core Phase|Adverse Event|5|||
27959486|NCT00690430|81686142|FG001|Core Phase|Adverse Event|1|||
27959487|NCT00690430|81686143|FG002|Core Phase|Adverse Event|0|||
27959488|NCT00690430|81686141|FG000|Core Phase|Death|0|||
27959489|NCT00690430|81686142|FG001|Core Phase|Death|2|||
27959490|NCT00690430|81686143|FG002|Core Phase|Death|0|||
27959491|NCT00690430|81686141|FG000|Core Phase|Protocol Violation|1|||
27959492|NCT00690430|81686142|FG001|Core Phase|Protocol Violation|0|||
27959493|NCT00690430|81686143|FG002|Core Phase|Protocol Violation|0|||
27959494|NCT00690430|81686141|FG000|Core Phase|Withdrawal by Subject|3|||
27959495|NCT00690430|81686142|FG001|Core Phase|Withdrawal by Subject|3|||
27959496|NCT00690430|81686143|FG002|Core Phase|Withdrawal by Subject|0|||
27959497|NCT00690430|81686141|FG000|Core Phase|Subject no longer requires study drug|1|||
27959498|NCT00690430|81686142|FG001|Core Phase|Subject no longer requires study drug|0|||
27959499|NCT00690430|81686143|FG002|Core Phase|Subject no longer requires study drug|0|||
27959500|NCT00690430|81686141|FG000|Core Phase|Lack of Efficacy|8|||
27959501|NCT00690430|81686142|FG001|Core Phase|Lack of Efficacy|10|||
27959502|NCT00690430|81686143|FG002|Core Phase|Lack of Efficacy|0|||
27959503|NCT00690430|81686141|FG000|Core Phase|Administrative Problems|0|||
27959504|NCT00690430|81686142|FG001|Core Phase|Administrative Problems|1|||
27959505|NCT00690430|81686143|FG002|Core Phase|Administrative Problems|0|||
27959506|NCT00690430|81686141|FG000|Core Phase|Early Termination|0|||
27959507|NCT00690430|81686142|FG001|Core Phase|Early Termination|5|||
27857387|NCT01284621|81314241|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27857388|NCT01284621|81314242|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27857389|NCT01284621|81314243|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27857390|NCT01284621|81314244|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27857391|NCT01284621|81314245|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
27857392|NCT01284621|81314246|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
27857393|NCT00724048|81314249|FG000|Overall Study|Adverse Event|1|||
27857394|NCT00724048|81314250|FG001|Overall Study|Adverse Event|1|||
27857395|NCT00724048|81314251|FG002|Overall Study|Adverse Event|1|||
27857396|NCT00724048|81314252|FG003|Overall Study|Adverse Event|0|||
27857397|NCT00724048|81314249|FG000|Overall Study|Lost to Follow-up|0|||
27857398|NCT00724048|81314250|FG001|Overall Study|Lost to Follow-up|1|||
27857399|NCT00724048|81314251|FG002|Overall Study|Lost to Follow-up|0|||
27755385|NCT01533935|80932490|FG003|Overall Study|Withdrawal by Subject|2|||
27755386|NCT01533935|80932491|FG004|Overall Study|Withdrawal by Subject|4|||
27857400|NCT00724048|81314252|FG003|Overall Study|Lost to Follow-up|0|||
27857401|NCT00724048|81314249|FG000|Overall Study|Withdrawal by Subject|1|||
27857402|NCT00724048|81314250|FG001|Overall Study|Withdrawal by Subject|2|||
27857403|NCT00724048|81314251|FG002|Overall Study|Withdrawal by Subject|1|||
27857404|NCT00724048|81314252|FG003|Overall Study|Withdrawal by Subject|2|||
27857405|NCT00724048|81314249|FG000|Overall Study|Investigator decision|0|||
27857406|NCT00724048|81314250|FG001|Overall Study|Investigator decision|0|||
27857407|NCT00724048|81314251|FG002|Overall Study|Investigator decision|1|||
27857408|NCT00724048|81314252|FG003|Overall Study|Investigator decision|0|||
27857409|NCT00724048|81314249|FG000|Overall Study|Did not tolerate study drug|0|||
27857410|NCT00724048|81314250|FG001|Overall Study|Did not tolerate study drug|0|||
27857411|NCT00724048|81314251|FG002|Overall Study|Did not tolerate study drug|0|||
27857412|NCT00724048|81314252|FG003|Overall Study|Did not tolerate study drug|1|||
27857413|NCT00724048|81314249|FG000|Overall Study|Other than specified|1|||
27755387|NCT01533935|80932487|FG000|Overall Study|Other reason not defined above|1|||
27755388|NCT01533935|80932488|FG001|Overall Study|Other reason not defined above|0|||
27755389|NCT01533935|80932489|FG002|Overall Study|Other reason not defined above|1|||
27959508|NCT00690430|81686143|FG002|Core Phase|Early Termination|0|||
27959509|NCT00690430|81686141|FG000|Extension Phase|Lack of Efficacy|3|||
27959510|NCT00690430|81686142|FG001|Extension Phase|Lack of Efficacy|1|||
27959511|NCT00690430|81686143|FG002|Extension Phase|Lack of Efficacy|4|||
27560836|NCT02045797|80241161|FG001|Overall Study|Lost to Follow-up|3|||
27959512|NCT00690430|81686141|FG000|Extension Phase|Abnormal Lab Values|1|||
27959513|NCT00690430|81686142|FG001|Extension Phase|Abnormal Lab Values|0|||
27959514|NCT00690430|81686143|FG002|Extension Phase|Abnormal Lab Values|0|||
27755390|NCT01533935|80932490|FG003|Overall Study|Other reason not defined above|0|||
27857414|NCT00724048|81314250|FG001|Overall Study|Other than specified|1|||
27857415|NCT00724048|81314251|FG002|Overall Study|Other than specified|0|||
27857416|NCT00724048|81314252|FG003|Overall Study|Other than specified|0|||
27857417|NCT02132637|81314253|FG000|Study Period 1|Withdrawal by Subject|0|||
27857418|NCT02132637|81314254|FG001|Study Period 1|Withdrawal by Subject|4|||
27857419|NCT02132637|81314253|FG000|Study Period 1|Physician Decision|1|||
27755391|NCT01533935|80932491|FG004|Overall Study|Other reason not defined above|1|||
27857420|NCT02132637|81314254|FG001|Study Period 1|Physician Decision|0|||
27857421|NCT02132637|81314253|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
27857422|NCT02132637|81314254|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
27857423|NCT02132637|81314253|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
27857424|NCT02132637|81314254|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
27857425|NCT00369655|81314255|FG000|Overall Study|Refusal of further treatment|2|||
27857426|NCT04516759|81314259|FG000|Overall Study|Withdrawal by Subject|1|||
27857427|NCT04516759|81314260|FG001|Overall Study|Withdrawal by Subject|1|||
27857428|NCT04516759|81314259|FG000|Overall Study|Other|0|||
27857429|NCT04516759|81314260|FG001|Overall Study|Other|1|||
27857430|NCT04663295|81314261|FG000|Run-in Period|Withdrawal by Subject|3|||
27857431|NCT04663295|81314261|FG000|Overall Study Period|Pregnancy|1|||
27857432|NCT04663295|81314261|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
27857433|NCT03283319|81314263|FG000|Overall Study|Lost to Follow-up|5|||
27755392|NCT00434512|80932494|FG000|Overall Study|Migrated/moved from study area|0|||
27755393|NCT00434512|80932495|FG001|Overall Study|Migrated/moved from study area|0|||
27755394|NCT00434512|80932496|FG002|Overall Study|Migrated/moved from study area|0|||
27755395|NCT00434512|80932497|FG003|Overall Study|Migrated/moved from study area|1|||
27755396|NCT00434512|80932498|FG004|Overall Study|Migrated/moved from study area|1|||
27755397|NCT00434512|80932499|FG005|Overall Study|Migrated/moved from study area|1|||
27857434|NCT03283319|81314264|FG001|Overall Study|Lost to Follow-up|4|||
27560837|NCT02045797|80241162|FG002|Overall Study|Lost to Follow-up|1|||
27560838|NCT02045797|80241160|FG000|Overall Study|Physician Decision|0|||
27560839|NCT02045797|80241161|FG001|Overall Study|Physician Decision|1|||
27560840|NCT02045797|80241162|FG002|Overall Study|Physician Decision|0|||
27560841|NCT02045797|80241160|FG000|Overall Study|Withdrawal by Subject|1|||
27560842|NCT02045797|80241161|FG001|Overall Study|Withdrawal by Subject|2|||
27560843|NCT02045797|80241162|FG002|Overall Study|Withdrawal by Subject|0|||
27560844|NCT03519347|80241163|FG000|Interventional Crossover Period 1|Death|0|||
27560845|NCT03519347|80241164|FG001|Interventional Crossover Period 1|Death|0|||
27560846|NCT03519347|80241165|FG002|Interventional Crossover Period 1|Death|0|||
27560847|NCT03519347|80241166|FG003|Interventional Crossover Period 1|Death|1|||
27560848|NCT02632552|80241169|FG000|Overall Study|Lost to Follow-up|14|||
27560849|NCT02632552|80241170|FG001|Overall Study|Lost to Follow-up|8|||
27560850|NCT02632552|80241169|FG000|Overall Study|Withdrawal by Subject|2|||
27560851|NCT02632552|80241170|FG001|Overall Study|Withdrawal by Subject|0|||
27560852|NCT02632552|80241169|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
27560853|NCT02632552|80241170|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
27857435|NCT03283319|81314265|FG002|Overall Study|Lost to Follow-up|5|||
27857436|NCT03283319|81314266|FG003|Overall Study|Lost to Follow-up|5|||
27857437|NCT03283319|81314267|FG004|Overall Study|Lost to Follow-up|4|||
27857438|NCT03283319|81314268|FG005|Overall Study|Lost to Follow-up|3|||
27857439|NCT03283319|81314263|FG000|Overall Study|Withdrawal by Subject|2|||
27857440|NCT03283319|81314264|FG001|Overall Study|Withdrawal by Subject|2|||
27857441|NCT03283319|81314265|FG002|Overall Study|Withdrawal by Subject|2|||
27857442|NCT03283319|81314266|FG003|Overall Study|Withdrawal by Subject|1|||
27857443|NCT03283319|81314267|FG004|Overall Study|Withdrawal by Subject|0|||
27857444|NCT03283319|81314268|FG005|Overall Study|Withdrawal by Subject|1|||
27857445|NCT03283319|81314263|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
27857446|NCT03283319|81314264|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
27857447|NCT03283319|81314265|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
27857448|NCT03283319|81314266|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
27857449|NCT03283319|81314267|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
27857450|NCT03283319|81314268|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
27857451|NCT00859586|81314269|FG000|Overall Study|Donors|4|||
27857452|NCT02655666|81314270|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
27857453|NCT02246439|81314276|FG000|Overall Study|Adverse Event|3|||
27560854|NCT00832585|80241176|FG000|Overall Study|Withdrawal by Subject|1|||
27560855|NCT00832585|80241176|FG000|Overall Study|Lost to Follow-up|1|||
27560856|NCT04964128|80241180|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
27560857|NCT04964128|80241180|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
27560858|NCT01106898|80241185|FG000|Overall Study|Adverse Event|6|||
27755398|NCT00434512|80932494|FG000|Overall Study|Other|0|||
27857454|NCT02246439|81314277|FG001|Overall Study|Adverse Event|0|||
27857455|NCT02246439|81314276|FG000|Overall Study|Lost to Follow-up|7|||
27560859|NCT02424383|80241186|FG000|Overall Study|Withdrawal by Subject|32|||
27857456|NCT02246439|81314277|FG001|Overall Study|Lost to Follow-up|5|||
27857457|NCT02246439|81314276|FG000|Overall Study|Protocol Violation|0|||
27857458|NCT02246439|81314277|FG001|Overall Study|Protocol Violation|2|||
27857459|NCT02246439|81314276|FG000|Overall Study|Physician Decision|0|||
27857460|NCT02246439|81314277|FG001|Overall Study|Physician Decision|1|||
27857461|NCT02246439|81314276|FG000|Overall Study|Unkonwn|1|||
27857462|NCT02246439|81314277|FG001|Overall Study|Unkonwn|3|||
27857463|NCT02246439|81314276|FG000|Overall Study|Withdrawal by Subject|1|||
27857464|NCT02246439|81314277|FG001|Overall Study|Withdrawal by Subject|0|||
27857465|NCT02352779|81314278|FG000|Overall Study|Personal Issues|1|||
27857466|NCT02352779|81314279|FG001|Overall Study|Personal Issues|1|||
27857467|NCT02352779|81314280|FG002|Overall Study|Personal Issues|0|||
27857468|NCT02352779|81314278|FG000|Overall Study|Too Many Forms|2|||
27857469|NCT02352779|81314279|FG001|Overall Study|Too Many Forms|0|||
27857470|NCT02352779|81314280|FG002|Overall Study|Too Many Forms|0|||
27857471|NCT02352779|81314278|FG000|Overall Study|Feeling Overwhelmed|1|||
27857472|NCT02352779|81314279|FG001|Overall Study|Feeling Overwhelmed|0|||
27755399|NCT00434512|80932495|FG001|Overall Study|Other|1|||
27755400|NCT00434512|80932496|FG002|Overall Study|Other|0|||
27857473|NCT02352779|81314280|FG002|Overall Study|Feeling Overwhelmed|0|||
27959515|NCT00690430|81686141|FG000|Extension Phase|Abnormal test procedure results|1|||
27755401|NCT00434512|80932497|FG003|Overall Study|Other|0|||
27755402|NCT00434512|80932498|FG004|Overall Study|Other|0|||
27959516|NCT00690430|81686142|FG001|Extension Phase|Abnormal test procedure results|0|||
27959517|NCT00690430|81686143|FG002|Extension Phase|Abnormal test procedure results|0|||
27959518|NCT00690430|81686141|FG000|Extension Phase|Administrative Problems|0|||
27959519|NCT00690430|81686142|FG001|Extension Phase|Administrative Problems|1|||
27959520|NCT00690430|81686143|FG002|Extension Phase|Administrative Problems|1|||
27959521|NCT00690430|81686141|FG000|Extension Phase|Adverse Event|2|||
27959522|NCT00690430|81686142|FG001|Extension Phase|Adverse Event|1|||
27959523|NCT00690430|81686143|FG002|Extension Phase|Adverse Event|2|||
27959524|NCT00690430|81686141|FG000|Extension Phase|Death|1|||
27959525|NCT00690430|81686142|FG001|Extension Phase|Death|1|||
27959526|NCT00690430|81686143|FG002|Extension Phase|Death|1|||
27959527|NCT00690430|81686141|FG000|Extension Phase|Withdrawal by Subject|0|||
27959528|NCT00690430|81686142|FG001|Extension Phase|Withdrawal by Subject|0|||
27959529|NCT00690430|81686143|FG002|Extension Phase|Withdrawal by Subject|2|||
27959530|NCT00690430|81686141|FG000|Extension Phase|Early Termination|10|||
27959531|NCT00690430|81686142|FG001|Extension Phase|Early Termination|1|||
27959532|NCT00690430|81686143|FG002|Extension Phase|Early Termination|3|||
27959533|NCT03783962|81686146|FG000|Overall Study|Lost to Follow-up|3|||
27959534|NCT03783962|81686147|FG001|Overall Study|Lost to Follow-up|6|||
27959535|NCT03783962|81686146|FG000|Overall Study|Protocol Violation|0|||
27959536|NCT03783962|81686147|FG001|Overall Study|Protocol Violation|1|||
27959537|NCT01721486|81686150|FG000|Overall Study|Protocol Violation|1|||
27959538|NCT01721486|81686151|FG001|Overall Study|Protocol Violation|0|||
27959539|NCT01721486|81686150|FG000|Overall Study|Physician Decision|0|||
27959540|NCT01721486|81686151|FG001|Overall Study|Physician Decision|1|||
27959541|NCT03497039|81686152|FG000|Overall Study|Withdrawal by Subject|1|||
27959542|NCT03497039|81686153|FG001|Overall Study|Withdrawal by Subject|0|||
27959543|NCT03497039|81686152|FG000|Overall Study|Protocol Violation|0|||
27959544|NCT03497039|81686153|FG001|Overall Study|Protocol Violation|1|||
27959545|NCT01135459|81686161|FG000|Overall Study|Adverse Event|8|||
27959546|NCT01135459|81686162|FG001|Overall Study|Adverse Event|10|||
27959547|NCT01135459|81686161|FG000|Overall Study|Lack of Efficacy|3|||
27560860|NCT02424383|80241186|FG000|Overall Study|Death|170|||
27560861|NCT02424383|80241186|FG000|Overall Study|Sponsor's decision|3|||
27560862|NCT02424383|80241186|FG000|Overall Study|Investigator's decision|44|||
27857474|NCT02352779|81314278|FG000|Overall Study|Disliked Intervention|1|||
27857475|NCT02352779|81314279|FG001|Overall Study|Disliked Intervention|0|||
27857476|NCT02352779|81314280|FG002|Overall Study|Disliked Intervention|0|||
27857477|NCT02352779|81314278|FG000|Overall Study|Changed Mind|1|||
27857478|NCT02352779|81314279|FG001|Overall Study|Changed Mind|0|||
27857479|NCT02352779|81314280|FG002|Overall Study|Changed Mind|0|||
27857480|NCT02352779|81314278|FG000|Overall Study|Study Related Symptoms|1|||
27560863|NCT02424383|80241186|FG000|Overall Study|Lost to Follow-up|81|||
27560864|NCT02424383|80241186|FG000|Overall Study|Other|7|||
27560865|NCT02424383|80241186|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
27755403|NCT00434512|80932499|FG005|Overall Study|Other|0|||
27857481|NCT02352779|81314279|FG001|Overall Study|Study Related Symptoms|0|||
27857482|NCT02352779|81314280|FG002|Overall Study|Study Related Symptoms|0|||
27857483|NCT02352779|81314278|FG000|Overall Study|Absence of Symptoms|1|||
27857484|NCT02352779|81314279|FG001|Overall Study|Absence of Symptoms|0|||
27857485|NCT02352779|81314280|FG002|Overall Study|Absence of Symptoms|0|||
27857486|NCT02352779|81314278|FG000|Overall Study|Other Medical Reason|0|||
27959548|NCT01135459|81686162|FG001|Overall Study|Lack of Efficacy|1|||
27959549|NCT01135459|81686161|FG000|Overall Study|Withdrawal by Subject|2|||
27560866|NCT00450333|80241192|FG000|Overall Study|Study terminated|47|||
27755404|NCT00492856|80932500|FG000|Induction|Adverse Event|2|||
27857487|NCT02352779|81314279|FG001|Overall Study|Other Medical Reason|0|||
27857488|NCT02352779|81314280|FG002|Overall Study|Other Medical Reason|1|||
27857489|NCT02352779|81314278|FG000|Overall Study|No Reason|0|||
27959550|NCT01135459|81686162|FG001|Overall Study|Withdrawal by Subject|3|||
27560867|NCT00450333|80241193|FG001|Overall Study|Study terminated|54|||
27857490|NCT02352779|81314279|FG001|Overall Study|No Reason|0|||
27857491|NCT02352779|81314280|FG002|Overall Study|No Reason|1|||
27857492|NCT04669691|81314283|FG000|Overall Study|Death|0|||
27857493|NCT04669691|81314284|FG001|Overall Study|Death|1|||
27857494|NCT04669691|81314285|FG002|Overall Study|Death|0|||
27857495|NCT04669691|81314286|FG003|Overall Study|Death|0|||
27560868|NCT00450333|80241194|FG002|Overall Study|Study terminated|16|||
27560869|NCT00450333|80241195|FG003|Overall Study|Study terminated|21|||
27560870|NCT00450333|80241192|FG000|Overall Study|Adverse Event|1|||
27560871|NCT00450333|80241193|FG001|Overall Study|Adverse Event|7|||
27560872|NCT00450333|80241194|FG002|Overall Study|Adverse Event|2|||
27560873|NCT00450333|80241195|FG003|Overall Study|Adverse Event|2|||
27560874|NCT00450333|80241192|FG000|Overall Study|Protocol Violation|1|||
27560875|NCT00450333|80241193|FG001|Overall Study|Protocol Violation|0|||
27560876|NCT00450333|80241194|FG002|Overall Study|Protocol Violation|1|||
27560877|NCT00450333|80241195|FG003|Overall Study|Protocol Violation|0|||
27560878|NCT00450333|80241192|FG000|Overall Study|Withdrawal by Subject|1|||
27560879|NCT00450333|80241193|FG001|Overall Study|Withdrawal by Subject|0|||
27560880|NCT00450333|80241194|FG002|Overall Study|Withdrawal by Subject|3|||
27560881|NCT00450333|80241195|FG003|Overall Study|Withdrawal by Subject|0|||
27560882|NCT00450333|80241192|FG000|Overall Study|Kidney transplant|1|||
27560883|NCT00450333|80241193|FG001|Overall Study|Kidney transplant|0|||
27560884|NCT00450333|80241194|FG002|Overall Study|Kidney transplant|1|||
27560885|NCT00450333|80241195|FG003|Overall Study|Kidney transplant|3|||
27560886|NCT00450333|80241192|FG000|Overall Study|Death|3|||
27560887|NCT00450333|80241193|FG001|Overall Study|Death|2|||
27857496|NCT04669691|81314287|FG004|Overall Study|Death|0|||
27857497|NCT04669691|81314288|FG005|Overall Study|Death|0|||
27857498|NCT01383135|81314289|FG000|Overall Study|Not Scanned / Imaged|1|||
27857499|NCT01383135|81314290|FG001|Overall Study|Not Scanned / Imaged|0|||
27857500|NCT01383135|81314291|FG002|Overall Study|Not Scanned / Imaged|1|||
27857501|NCT01383135|81314292|FG003|Overall Study|Not Scanned / Imaged|0|||
27857502|NCT00213135|81314297|FG000|Overall Study|Adverse Event|9|||
27857503|NCT00213135|81314298|FG001|Overall Study|Adverse Event|5|||
27857504|NCT00213135|81314299|FG002|Overall Study|Adverse Event|5|||
27857505|NCT00213135|81314297|FG000|Overall Study|Lost to Follow-up|11|||
27857506|NCT00213135|81314298|FG001|Overall Study|Lost to Follow-up|8|||
27560888|NCT00450333|80241194|FG002|Overall Study|Death|2|||
27857507|NCT00213135|81314299|FG002|Overall Study|Lost to Follow-up|4|||
27857508|NCT00213135|81314297|FG000|Overall Study|Protocol Violation|4|||
27857509|NCT00213135|81314298|FG001|Overall Study|Protocol Violation|4|||
27857510|NCT00213135|81314299|FG002|Overall Study|Protocol Violation|10|||
27857511|NCT00213135|81314297|FG000|Overall Study|Death|1|||
27857512|NCT00213135|81314298|FG001|Overall Study|Death|1|||
27857513|NCT00213135|81314299|FG002|Overall Study|Death|2|||
27857514|NCT00213135|81314297|FG000|Overall Study|Disease progression|4|||
27857515|NCT00213135|81314298|FG001|Overall Study|Disease progression|5|||
27857516|NCT00213135|81314299|FG002|Overall Study|Disease progression|21|||
27857517|NCT00213135|81314297|FG000|Overall Study|Other|21|||
27857518|NCT00213135|81314298|FG001|Overall Study|Other|12|||
27857519|NCT00213135|81314299|FG002|Overall Study|Other|15|||
27857520|NCT01857271|81314300|FG000|Overall Study|Lost to Follow-up|1|||
27857521|NCT01104792|81314301|FG000|Overall Study|Adverse Event|77|||
27857522|NCT01104792|81314301|FG000|Overall Study|Insufficient Therapeutic Response|22|||
27857523|NCT01104792|81314301|FG000|Overall Study|Protocol Violation|45|||
27857524|NCT01104792|81314301|FG000|Overall Study|Withdrawal of Consent|179|||
27857525|NCT01104792|81314301|FG000|Overall Study|Lost to Follow-up|43|||
27857526|NCT01104792|81314301|FG000|Overall Study|Reasons Not Specified|27|||
27560889|NCT00450333|80241195|FG003|Overall Study|Death|2|||
27560890|NCT01365507|80241200|FG000|Overall Study|Withdrawal Criteria|8|||
27857527|NCT01104792|81314301|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
27857528|NCT00174954|81314309|FG000|Overall Study|Adverse Event|2|||
27857529|NCT00174954|81314309|FG000|Overall Study|No tophi found in MRI|1|||
27857530|NCT00174954|81314309|FG000|Overall Study|Physician Decision|1|||
27857531|NCT03421730|81314310|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857532|NCT03421730|81314311|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
27857533|NCT03421730|81314312|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857534|NCT03421730|81314313|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857535|NCT03421730|81314314|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857536|NCT03421730|81314315|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857537|NCT03421730|81314316|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27560891|NCT01365507|80241201|FG001|Overall Study|Withdrawal Criteria|5|||
27560892|NCT01365507|80241200|FG000|Overall Study|Unclassified|1|||
27560893|NCT01365507|80241201|FG001|Overall Study|Unclassified|4|||
27560894|NCT03164928|80241204|FG000|Overall Study|Lost to Follow-up|1|||
27560895|NCT03164928|80241205|FG001|Overall Study|Lost to Follow-up|0|||
27560896|NCT01275833|80241206|FG000|Overall Study|Study terminated|1|||
27857538|NCT03421730|81314317|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857539|NCT03421730|81314318|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857540|NCT03421730|81314319|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857541|NCT03421730|81314320|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857542|NCT03421730|81314321|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
27857543|NCT03421730|81314310|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857544|NCT03421730|81314311|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857545|NCT03421730|81314312|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857546|NCT03421730|81314313|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857547|NCT03421730|81314314|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
27560897|NCT01275833|80241207|FG001|Overall Study|Study terminated|1|||
27560898|NCT02320149|80241208|FG000|Overall Study|Adverse Event|3|||
27560899|NCT02320149|80241209|FG001|Overall Study|Adverse Event|7|||
27560900|NCT02320149|80241208|FG000|Overall Study|Withdrawal of Consent|28|||
27560901|NCT02320149|80241209|FG001|Overall Study|Withdrawal of Consent|32|||
27560902|NCT02320149|80241208|FG000|Overall Study|Lost to Follow-up|21|||
27560903|NCT02320149|80241209|FG001|Overall Study|Lost to Follow-up|34|||
27560904|NCT02320149|80241208|FG000|Overall Study|Protocol Violation|2|||
27560905|NCT02320149|80241209|FG001|Overall Study|Protocol Violation|1|||
27560906|NCT02320149|80241208|FG000|Overall Study|Noncompliance with Study Treatment|7|||
27560907|NCT02320149|80241209|FG001|Overall Study|Noncompliance with Study Treatment|2|||
27560908|NCT02320149|80241208|FG000|Overall Study|Lack of Efficacy|0|||
27560909|NCT02320149|80241209|FG001|Overall Study|Lack of Efficacy|1|||
27560910|NCT02320149|80241208|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27560911|NCT02320149|80241209|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27560912|NCT02436356|80241210|FG000|Overall Study|Excluded by MRI Screening|0|||
27560913|NCT02436356|80241211|FG001|Overall Study|Excluded by MRI Screening|0|||
27560914|NCT02436356|80241212|FG002|Overall Study|Excluded by MRI Screening|2|||
27560915|NCT02436356|80241210|FG000|Overall Study|Lost to Follow-up|0|||
27560916|NCT02436356|80241211|FG001|Overall Study|Lost to Follow-up|1|||
27560917|NCT02436356|80241212|FG002|Overall Study|Lost to Follow-up|0|||
27560918|NCT02436356|80241210|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
27560919|NCT02436356|80241211|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
27560920|NCT02436356|80241212|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
27560921|NCT02436356|80241210|FG000|Overall Study|Excluded due to other medical conditions|3|||
27560922|NCT02436356|80241211|FG001|Overall Study|Excluded due to other medical conditions|0|||
27560923|NCT02436356|80241212|FG002|Overall Study|Excluded due to other medical conditions|0|||
27560924|NCT02436356|80241210|FG000|Overall Study|Withdrawal by Subject|1|||
27560925|NCT02436356|80241211|FG001|Overall Study|Withdrawal by Subject|0|||
27560926|NCT02436356|80241212|FG002|Overall Study|Withdrawal by Subject|0|||
27560927|NCT00560950|80241213|FG000|Overall Study|Lost to Follow-up|1|||
27560928|NCT00560950|80241214|FG001|Overall Study|Lost to Follow-up|0|||
27560929|NCT00664742|80241216|FG000|Overall Study|Withdrawn due to adverse events|3|||
27560930|NCT00664742|80241216|FG000|Overall Study|Withdrawal by Subject|31|||
27560931|NCT00664742|80241216|FG000|Overall Study|Lost to Follow-up|92|||
27560932|NCT01994629|80241218|FG000|Overall Study|Withdrawal by Subject|1|||
27560933|NCT01994629|80241219|FG001|Overall Study|Withdrawal by Subject|0|||
27560934|NCT01994629|80241218|FG000|Overall Study|Lost to Follow-up|0|||
27560935|NCT01994629|80241219|FG001|Overall Study|Lost to Follow-up|3|||
27560936|NCT00322842|80241220|FG000|Overall Study|Withdrawal by Subject|0|||
27560937|NCT00322842|80241221|FG001|Overall Study|Withdrawal by Subject|1|||
27560938|NCT00322842|80241220|FG000|Overall Study|Lost to Follow-up|0|||
27560939|NCT00322842|80241221|FG001|Overall Study|Lost to Follow-up|1|||
27560940|NCT00322842|80241220|FG000|Overall Study|Refused transplant|1|||
27560941|NCT00322842|80241221|FG001|Overall Study|Refused transplant|0|||
27560942|NCT00322842|80241220|FG000|Overall Study|Death|1|||
27560943|NCT00322842|80241221|FG001|Overall Study|Death|0|||
27560944|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Death|3|||
27560945|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Death|2|||
27560946|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Death|4|||
27560947|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Death|3|||
27560948|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Death|0|||
27560949|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Death|0|||
27560950|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27560951|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
27857548|NCT03421730|81314315|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27560952|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
27560953|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27560954|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27560955|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
27560956|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
27560957|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27560958|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27560959|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27560960|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27560961|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
27560962|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
27560963|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
27560964|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
27560965|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
27560966|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
27560967|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
27560968|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27560969|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27857549|NCT03421730|81314316|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857550|NCT03421730|81314317|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857551|NCT03421730|81314318|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857552|NCT03421730|81314319|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27560970|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
27560971|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
27560972|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27560973|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
27560974|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
27560975|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
27560976|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
27560977|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
27560978|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
27560979|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
27560980|NCT02432846|80241226|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27560981|NCT02432846|80241227|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27755405|NCT00492856|80932501|FG001|Induction|Adverse Event|0|||
27755406|NCT00492856|80932502|FG002|Induction|Adverse Event|0|||
27755407|NCT00492856|80932503|FG003|Induction|Adverse Event|0|||
27755408|NCT00492856|80932500|FG000|Induction|Withdrawal by Subject|1|||
27755409|NCT00492856|80932501|FG001|Induction|Withdrawal by Subject|0|||
27755410|NCT00492856|80932502|FG002|Induction|Withdrawal by Subject|0|||
27755411|NCT00492856|80932503|FG003|Induction|Withdrawal by Subject|0|||
27560982|NCT02432846|80241228|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
27560983|NCT02432846|80241229|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27560984|NCT02432846|80241230|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27560985|NCT02432846|80241231|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
27560986|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
27560987|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
27560988|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
27560989|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
27560990|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
27560991|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
27560992|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27560993|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27560994|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27560995|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
27560996|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
27560997|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
27857553|NCT03421730|81314320|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857554|NCT03421730|81314321|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
27857555|NCT01683838|81314322|FG000|Overall Study|Adverse Event|12|||
27857556|NCT01683838|81314323|FG001|Overall Study|Adverse Event|2|||
27857557|NCT01683838|81314322|FG000|Overall Study|Protocol Violation|3|||
27857558|NCT01683838|81314323|FG001|Overall Study|Protocol Violation|1|||
27857559|NCT01683838|81314322|FG000|Overall Study|Withdrawal by Subject|6|||
27857560|NCT01683838|81314323|FG001|Overall Study|Withdrawal by Subject|5|||
27857561|NCT01683838|81314322|FG000|Overall Study|Lost to Follow-up|1|||
27857562|NCT01683838|81314323|FG001|Overall Study|Lost to Follow-up|1|||
27857563|NCT01683838|81314322|FG000|Overall Study|Other|4|||
27857564|NCT01683838|81314323|FG001|Overall Study|Other|3|||
27857565|NCT01996332|81314324|FG000|Overall Study|Adverse Event|117|||
27560998|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27560999|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27755412|NCT00492856|80932500|FG000|Induction|Death|3|||
27857566|NCT01996332|81314324|FG000|Overall Study|Lack of Efficacy|1245|||
27857567|NCT01996332|81314324|FG000|Overall Study|Death|264|||
27857568|NCT01996332|81314324|FG000|Overall Study|Protocol Violation|9|||
27857569|NCT01996332|81314324|FG000|Overall Study|Withdrawal by Subject|71|||
27857570|NCT01996332|81314324|FG000|Overall Study|Other|20|||
27857571|NCT01996332|81314324|FG000|Overall Study|Clinical Deterioration|28|||
27857572|NCT01996332|81314324|FG000|Overall Study|Physician Decision|17|||
27857573|NCT01996332|81314324|FG000|Overall Study|Lost to Follow-up|34|||
27561000|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27561001|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27561002|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
27561003|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
27561004|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27561005|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27561006|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27561007|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
27561008|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
27561009|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
27561010|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27561011|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27561012|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27561013|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
27561014|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
27561015|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
27561016|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27561017|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27561018|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27561019|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
27561020|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
27561021|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
27561022|NCT02432846|80241226|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27561023|NCT02432846|80241227|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27561024|NCT02432846|80241228|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27561025|NCT02432846|80241229|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27561026|NCT02432846|80241230|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
27561027|NCT02432846|80241231|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
27561028|NCT03325075|80241235|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
27561029|NCT03325075|80241236|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
27857574|NCT00987389|81314327|FG000|Overall Study|Ineligible|0|||
27857575|NCT00987389|81314328|FG001|Overall Study|Ineligible|3|||
27857576|NCT00987389|81314329|FG002|Overall Study|Ineligible|0|||
27857577|NCT00987389|81314330|FG003|Overall Study|Ineligible|0|||
27857578|NCT00987389|81314327|FG000|Overall Study|Lost to Follow-up|4|||
27857579|NCT00987389|81314328|FG001|Overall Study|Lost to Follow-up|1|||
27857580|NCT00987389|81314329|FG002|Overall Study|Lost to Follow-up|3|||
27857581|NCT00987389|81314330|FG003|Overall Study|Lost to Follow-up|1|||
27857582|NCT00987389|81314327|FG000|Overall Study|Withdrawal by Subject|4|||
27857583|NCT00987389|81314328|FG001|Overall Study|Withdrawal by Subject|3|||
27857584|NCT00987389|81314329|FG002|Overall Study|Withdrawal by Subject|2|||
27857585|NCT00987389|81314330|FG003|Overall Study|Withdrawal by Subject|1|||
27857586|NCT00987389|81314327|FG000|Overall Study|Withdrawn from Treatment|0|||
27857587|NCT00987389|81314328|FG001|Overall Study|Withdrawn from Treatment|1|||
27857588|NCT00987389|81314329|FG002|Overall Study|Withdrawn from Treatment|0|||
27857589|NCT00987389|81314330|FG003|Overall Study|Withdrawn from Treatment|0|||
27857590|NCT00987389|81314327|FG000|Overall Study|Multiple different reasons|1|||
27857591|NCT00987389|81314328|FG001|Overall Study|Multiple different reasons|0|||
27857592|NCT00987389|81314329|FG002|Overall Study|Multiple different reasons|3|||
27857593|NCT00987389|81314330|FG003|Overall Study|Multiple different reasons|1|||
27857594|NCT02185053|81314331|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
27857595|NCT02185053|81314332|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
27857596|NCT02185053|81314333|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
27857597|NCT02185053|81314331|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
27857598|NCT02185053|81314332|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27857599|NCT02185053|81314333|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27857600|NCT02185053|81314331|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
27857601|NCT02185053|81314332|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
27857602|NCT02185053|81314333|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
27561030|NCT03325075|80241237|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
27561031|NCT03325075|80241238|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
27561032|NCT03325075|80241235|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
27857603|NCT02185053|81314331|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
27857604|NCT02185053|81314332|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
27561033|NCT03325075|80241236|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
27561034|NCT03325075|80241237|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
27561035|NCT03325075|80241238|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
27561036|NCT03325075|80241235|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
27561037|NCT03325075|80241236|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
27561038|NCT03325075|80241237|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
27561039|NCT03325075|80241238|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
27561040|NCT00350636|80241241|FG000|Overall Study|Adverse Event|19|||
27561041|NCT00350636|80241242|FG001|Overall Study|Adverse Event|13|||
27561042|NCT00350636|80241241|FG000|Overall Study|Protocol Violation|1|||
27561043|NCT00350636|80241242|FG001|Overall Study|Protocol Violation|3|||
27561044|NCT00350636|80241241|FG000|Overall Study|Withdrawal by Subject|13|||
27561045|NCT00350636|80241242|FG001|Overall Study|Withdrawal by Subject|17|||
27561046|NCT00350636|80241241|FG000|Overall Study|Lost to Follow-up|9|||
27561047|NCT00350636|80241242|FG001|Overall Study|Lost to Follow-up|8|||
27561048|NCT00350636|80241241|FG000|Overall Study|Physician Decision|0|||
27857605|NCT02185053|81314333|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
27561049|NCT00350636|80241242|FG001|Overall Study|Physician Decision|2|||
27561050|NCT00350636|80241241|FG000|Overall Study|Other|1|||
27561051|NCT00350636|80241242|FG001|Overall Study|Other|2|||
27561052|NCT00495170|80241243|FG000|Overall Study|Lost to Follow-up|9|||
27561053|NCT00495170|80241243|FG000|Overall Study|Withdrawal by Subject|3|||
27561054|NCT00495170|80241243|FG000|Overall Study|Inappropriate staging|8|||
27561055|NCT01404325|80241244|FG000|Overall Study|Lost to Follow-up|1|||
27561056|NCT01404325|80241245|FG001|Overall Study|Lost to Follow-up|0|||
27561057|NCT01404325|80241244|FG000|Overall Study|Death|2|||
27561058|NCT01404325|80241245|FG001|Overall Study|Death|0|||
27561059|NCT01404325|80241244|FG000|Overall Study|Graft loss/Retransplantation|1|||
27561060|NCT01404325|80241245|FG001|Overall Study|Graft loss/Retransplantation|0|||
27561061|NCT01404325|80241244|FG000|Overall Study|non-specified reason|0|||
27561062|NCT01404325|80241245|FG001|Overall Study|non-specified reason|2|||
27561063|NCT03605303|80241247|FG000|Period 1|Study Terminated|2|||
27561064|NCT03605303|80241248|FG001|Period 1|Study Terminated|1|||
27561065|NCT02085785|80241249|FG000|Overall Study|Withdrawal by Subject|2|||
27561066|NCT02085785|80241250|FG001|Overall Study|Withdrawal by Subject|1|||
27561067|NCT02085785|80241249|FG000|Overall Study|Lost to Follow-up|0|||
27561068|NCT02085785|80241250|FG001|Overall Study|Lost to Follow-up|1|||
27561069|NCT02075658|80241267|FG000|Overall Study|Physician Decision|2|||
27561070|NCT02075658|80241268|FG001|Overall Study|Physician Decision|2|||
27561071|NCT01405963|80241271|FG000|Overall Study|Moved Away|2|||
27561072|NCT01405963|80241272|FG001|Overall Study|Moved Away|0|||
27561073|NCT01405963|80241271|FG000|Overall Study|Adverse Event|0|||
27561074|NCT01405963|80241272|FG001|Overall Study|Adverse Event|1|||
27561075|NCT01405963|80241271|FG000|Overall Study|Lost to Follow-up|0|||
27561076|NCT01405963|80241272|FG001|Overall Study|Lost to Follow-up|1|||
27561077|NCT04256785|80241273|FG000|Overall Study|Adverse Event|8|||
27561078|NCT04256785|80241274|FG001|Overall Study|Adverse Event|6|||
27561079|NCT04256785|80241273|FG000|Overall Study|Lack of Efficacy|3|||
27561080|NCT04256785|80241274|FG001|Overall Study|Lack of Efficacy|4|||
27561081|NCT04256785|80241273|FG000|Overall Study|Lost to Follow-up|7|||
27755413|NCT00492856|80932501|FG001|Induction|Death|0|||
27755414|NCT00492856|80932502|FG002|Induction|Death|0|||
27857606|NCT02185053|81314331|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27857607|NCT02185053|81314332|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
27857608|NCT02185053|81314333|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
27857609|NCT02185053|81314331|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
27857610|NCT02185053|81314332|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
27857611|NCT02185053|81314333|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
27857612|NCT02185053|81314331|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
27857613|NCT02185053|81314332|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
27857614|NCT02185053|81314333|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
27857615|NCT02185053|81314331|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
27755415|NCT00492856|80932503|FG003|Induction|Death|0|||
27561082|NCT04256785|80241274|FG001|Overall Study|Lost to Follow-up|7|||
27561083|NCT04256785|80241273|FG000|Overall Study|Protocol Violation|1|||
27561084|NCT04256785|80241274|FG001|Overall Study|Protocol Violation|0|||
27561085|NCT04256785|80241273|FG000|Overall Study|Withdrawal by Subject|4|||
27561086|NCT04256785|80241274|FG001|Overall Study|Withdrawal by Subject|1|||
27561087|NCT04256785|80241273|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
27561088|NCT04256785|80241274|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
27561089|NCT03686384|80241275|FG000|Overall Study|Lack of Efficacy|4|||
27561090|NCT03686384|80241276|FG001|Overall Study|Lack of Efficacy|13|||
27561091|NCT03686384|80241275|FG000|Overall Study|Lost to Follow-up|3|||
27857616|NCT02185053|81314332|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
27561092|NCT03686384|80241276|FG001|Overall Study|Lost to Follow-up|0|||
27561093|NCT03686384|80241275|FG000|Overall Study|Physician Decision|0|||
27857617|NCT02185053|81314333|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
27857618|NCT01154816|81314334|FG000|Overall Study|Withdrawal by Subject|1|||
27857619|NCT01154816|81314335|FG001|Overall Study|Withdrawal by Subject|0|||
27857620|NCT01154816|81314336|FG002|Overall Study|Withdrawal by Subject|0|||
27857621|NCT01154816|81314337|FG003|Overall Study|Withdrawal by Subject|1|||
27755416|NCT00492856|80932500|FG000|Consolidation|Adverse Event|6|||
27755417|NCT00492856|80932501|FG001|Consolidation|Adverse Event|0|||
27755418|NCT00492856|80932502|FG002|Consolidation|Adverse Event|0|||
27755419|NCT00492856|80932503|FG003|Consolidation|Adverse Event|0|||
27755420|NCT00492856|80932500|FG000|Consolidation|Not protocol specified|2|||
27755421|NCT00492856|80932501|FG001|Consolidation|Not protocol specified|0|||
27755422|NCT00492856|80932502|FG002|Consolidation|Not protocol specified|0|||
27755423|NCT00492856|80932503|FG003|Consolidation|Not protocol specified|0|||
27755424|NCT00492856|80932500|FG000|Consolidation|Lost to Follow-up|1|||
27755425|NCT00492856|80932501|FG001|Consolidation|Lost to Follow-up|0|||
27755426|NCT00492856|80932502|FG002|Consolidation|Lost to Follow-up|0|||
27755427|NCT00492856|80932503|FG003|Consolidation|Lost to Follow-up|0|||
27755428|NCT00492856|80932500|FG000|Post-consolidation|Adverse Event|0|||
27755429|NCT00492856|80932501|FG001|Post-consolidation|Adverse Event|4|||
27755430|NCT00492856|80932502|FG002|Post-consolidation|Adverse Event|0|||
27755431|NCT00492856|80932503|FG003|Post-consolidation|Adverse Event|1|||
27755432|NCT00492856|80932500|FG000|Post-consolidation|Withdrawal by Subject|0|||
27755433|NCT00492856|80932501|FG001|Post-consolidation|Withdrawal by Subject|4|||
27755434|NCT00492856|80932502|FG002|Post-consolidation|Withdrawal by Subject|0|||
27755435|NCT00492856|80932503|FG003|Post-consolidation|Withdrawal by Subject|0|||
27755436|NCT00492856|80932500|FG000|Post-consolidation|Death|0|||
27755437|NCT00492856|80932501|FG001|Post-consolidation|Death|1|||
27755438|NCT00492856|80932502|FG002|Post-consolidation|Death|0|||
27755439|NCT00492856|80932503|FG003|Post-consolidation|Death|0|||
27755440|NCT00492856|80932500|FG000|Post-consolidation|Not protocol specified|0|||
27755441|NCT00492856|80932501|FG001|Post-consolidation|Not protocol specified|1|||
27755442|NCT00492856|80932502|FG002|Post-consolidation|Not protocol specified|0|||
27755443|NCT00492856|80932503|FG003|Post-consolidation|Not protocol specified|0|||
27755444|NCT00492856|80932500|FG000|Post-consolidation|Lost to Follow-up|0|||
27755445|NCT00492856|80932501|FG001|Post-consolidation|Lost to Follow-up|2|||
27755446|NCT00492856|80932502|FG002|Post-consolidation|Lost to Follow-up|0|||
27755447|NCT00492856|80932503|FG003|Post-consolidation|Lost to Follow-up|0|||
27755448|NCT00492856|80932500|FG000|Post-consolidation|Observation Arm|0|||
27755449|NCT00492856|80932501|FG001|Post-consolidation|Observation Arm|0|||
27755450|NCT00492856|80932502|FG002|Post-consolidation|Observation Arm|27|||
27755451|NCT00492856|80932503|FG003|Post-consolidation|Observation Arm|0|||
27755452|NCT01409031|80932504|FG000|Overall Study|transferred to other hosp|1|||
27755453|NCT01409031|80932505|FG001|Overall Study|transferred to other hosp|0|||
27755454|NCT00077610|80932506|FG000|Overall Study|Adverse Event|9|||
27755455|NCT00077610|80932507|FG001|Overall Study|Adverse Event|7|||
27755456|NCT00077610|80932508|FG002|Overall Study|Adverse Event|1|||
27755457|NCT00077610|80932506|FG000|Overall Study|Lost to Follow-up|0|||
27755458|NCT00077610|80932507|FG001|Overall Study|Lost to Follow-up|1|||
27755459|NCT00077610|80932508|FG002|Overall Study|Lost to Follow-up|2|||
27755460|NCT00077610|80932506|FG000|Overall Study|Withdrawal by Subject|4|||
27755461|NCT00077610|80932507|FG001|Overall Study|Withdrawal by Subject|10|||
27857622|NCT01154816|81314338|FG004|Overall Study|Withdrawal by Subject|0|||
27857623|NCT01154816|81314339|FG005|Overall Study|Withdrawal by Subject|0|||
27857624|NCT01154816|81314340|FG006|Overall Study|Withdrawal by Subject|0|||
27857625|NCT01154816|81314341|FG007|Overall Study|Withdrawal by Subject|0|||
27857626|NCT01154816|81314342|FG008|Overall Study|Withdrawal by Subject|1|||
27857627|NCT01154816|81314343|FG009|Overall Study|Withdrawal by Subject|3|||
27857628|NCT01154816|81314344|FG010|Overall Study|Withdrawal by Subject|0|||
27857629|NCT01154816|81314345|FG011|Overall Study|Withdrawal by Subject|0|||
27857630|NCT01154816|81314334|FG000|Overall Study|Progressive Disease|13|||
27857631|NCT01154816|81314335|FG001|Overall Study|Progressive Disease|8|||
27755462|NCT00077610|80932508|FG002|Overall Study|Withdrawal by Subject|6|||
27755463|NCT00077610|80932506|FG000|Overall Study|Death|17|||
27755464|NCT00077610|80932507|FG001|Overall Study|Death|13|||
27755465|NCT00077610|80932508|FG002|Overall Study|Death|13|||
27755466|NCT00077610|80932506|FG000|Overall Study|Renal transplant|12|||
27755467|NCT00077610|80932507|FG001|Overall Study|Renal transplant|15|||
27755468|NCT00077610|80932508|FG002|Overall Study|Renal transplant|11|||
27755469|NCT00077610|80932506|FG000|Overall Study|Withdrew from dialysis care|5|||
27755470|NCT00077610|80932507|FG001|Overall Study|Withdrew from dialysis care|0|||
27755471|NCT00077610|80932508|FG002|Overall Study|Withdrew from dialysis care|3|||
27755472|NCT00077610|80932506|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27755473|NCT00077610|80932507|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27755474|NCT00077610|80932508|FG002|Overall Study|Insufficient Therapeutic Response|0|||
27755475|NCT00077610|80932506|FG000|Overall Study|Multiple blood transfusions|0|||
27857632|NCT01154816|81314336|FG002|Overall Study|Progressive Disease|9|||
27857633|NCT01154816|81314337|FG003|Overall Study|Progressive Disease|9|||
27857634|NCT01154816|81314338|FG004|Overall Study|Progressive Disease|8|||
27755476|NCT00077610|80932507|FG001|Overall Study|Multiple blood transfusions|0|||
27755477|NCT00077610|80932508|FG002|Overall Study|Multiple blood transfusions|1|||
27755478|NCT00077610|80932506|FG000|Overall Study|Principal Investigator's decision|1|||
27755479|NCT00077610|80932507|FG001|Overall Study|Principal Investigator's decision|0|||
27755480|NCT00077610|80932508|FG002|Overall Study|Principal Investigator's decision|1|||
27755481|NCT00077610|80932506|FG000|Overall Study|Worsening of health condition|1|||
27755482|NCT00077610|80932507|FG001|Overall Study|Worsening of health condition|1|||
27755483|NCT00077610|80932508|FG002|Overall Study|Worsening of health condition|0|||
27755484|NCT00077610|80932506|FG000|Overall Study|Given Epogen in hospital|1|||
27755485|NCT00077610|80932507|FG001|Overall Study|Given Epogen in hospital|0|||
27755486|NCT00077610|80932508|FG002|Overall Study|Given Epogen in hospital|0|||
27755487|NCT00077610|80932506|FG000|Overall Study|Transferred to other unit|0|||
27755488|NCT00077610|80932507|FG001|Overall Study|Transferred to other unit|0|||
27755489|NCT00077610|80932508|FG002|Overall Study|Transferred to other unit|1|||
27755490|NCT00077610|80932506|FG000|Overall Study|Transferred to nursing home|0|||
27755491|NCT00077610|80932507|FG001|Overall Study|Transferred to nursing home|0|||
27755492|NCT00077610|80932508|FG002|Overall Study|Transferred to nursing home|1|||
27755493|NCT00077610|80932506|FG000|Overall Study|Transfer to satellite unit|1|||
27755494|NCT00077610|80932507|FG001|Overall Study|Transfer to satellite unit|0|||
27755495|NCT00077610|80932508|FG002|Overall Study|Transfer to satellite unit|0|||
27755496|NCT00077610|80932506|FG000|Overall Study|Transfer to other center for surgery|1|||
27755497|NCT00077610|80932507|FG001|Overall Study|Transfer to other center for surgery|0|||
27755498|NCT00077610|80932508|FG002|Overall Study|Transfer to other center for surgery|0|||
27561094|NCT03686384|80241276|FG001|Overall Study|Physician Decision|1|||
27561095|NCT03686384|80241275|FG000|Overall Study|Took prohibited medication|0|||
27561096|NCT03686384|80241276|FG001|Overall Study|Took prohibited medication|1|||
27561097|NCT00768300|80241277|FG000|Overall Study|Randomized but not treated|1|||
27561098|NCT00768300|80241278|FG001|Overall Study|Randomized but not treated|1|||
27561099|NCT00768300|80241277|FG000|Overall Study|Adverse Event|10|||
27561100|NCT00768300|80241278|FG001|Overall Study|Adverse Event|2|||
27561101|NCT00768300|80241277|FG000|Overall Study|Protocol Violation|6|||
27561102|NCT00768300|80241278|FG001|Overall Study|Protocol Violation|1|||
27561103|NCT00768300|80241277|FG000|Overall Study|Withdrawal by Subject|13|||
27561104|NCT00768300|80241278|FG001|Overall Study|Withdrawal by Subject|7|||
27561105|NCT00768300|80241277|FG000|Overall Study|Physician Decision|2|||
27561106|NCT00768300|80241278|FG001|Overall Study|Physician Decision|3|||
27561107|NCT00768300|80241277|FG000|Overall Study|Study discontinued by Sponsor|271|||
27561108|NCT00768300|80241278|FG001|Overall Study|Study discontinued by Sponsor|140|||
27561109|NCT00768300|80241277|FG000|Overall Study|Death|21|||
27561110|NCT00768300|80241278|FG001|Overall Study|Death|5|||
27561111|NCT00768300|80241277|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
27561112|NCT00768300|80241278|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
27857635|NCT01154816|81314339|FG005|Overall Study|Progressive Disease|8|||
27857636|NCT01154816|81314340|FG006|Overall Study|Progressive Disease|5|||
27857637|NCT01154816|81314341|FG007|Overall Study|Progressive Disease|6|||
27857638|NCT01154816|81314342|FG008|Overall Study|Progressive Disease|8|||
27857639|NCT01154816|81314343|FG009|Overall Study|Progressive Disease|6|||
27857640|NCT01154816|81314344|FG010|Overall Study|Progressive Disease|10|||
27857641|NCT01154816|81314345|FG011|Overall Study|Progressive Disease|3|||
27857642|NCT01154816|81314334|FG000|Overall Study|Physician Decision|1|||
27857643|NCT01154816|81314335|FG001|Overall Study|Physician Decision|0|||
27857644|NCT01154816|81314336|FG002|Overall Study|Physician Decision|1|||
27857645|NCT01154816|81314337|FG003|Overall Study|Physician Decision|0|||
27857646|NCT01154816|81314338|FG004|Overall Study|Physician Decision|2|||
27857647|NCT01154816|81314339|FG005|Overall Study|Physician Decision|0|||
27561113|NCT00768300|80241277|FG000|Overall Study|Screen failure following randomization|1|||
27561114|NCT00768300|80241278|FG001|Overall Study|Screen failure following randomization|0|||
27561115|NCT00768300|80241277|FG000|Overall Study|Received lung transplant|1|||
27857648|NCT01154816|81314340|FG006|Overall Study|Physician Decision|0|||
27959551|NCT01135459|81686161|FG000|Overall Study|Protocol Violation|5|||
27561116|NCT00768300|80241278|FG001|Overall Study|Received lung transplant|1|||
27561117|NCT00768300|80241277|FG000|Overall Study|Lost to Follow-up|0|||
27561118|NCT00768300|80241278|FG001|Overall Study|Lost to Follow-up|1|||
27561119|NCT00768300|80241277|FG000|Overall Study|Began prohibited concomitant medication|0|||
27561120|NCT00768300|80241278|FG001|Overall Study|Began prohibited concomitant medication|1|||
27561121|NCT00768300|80241277|FG000|Overall Study|Treated but never dosed with Study drug|1|||
27561122|NCT00768300|80241278|FG001|Overall Study|Treated but never dosed with Study drug|0|||
27561123|NCT00768300|80241277|FG000|Overall Study|Missing data|1|||
27561124|NCT00768300|80241278|FG001|Overall Study|Missing data|0|||
27755499|NCT00077610|80932506|FG000|Overall Study|Change in dialysis modality|1|||
27755500|NCT00077610|80932507|FG001|Overall Study|Change in dialysis modality|0|||
27755501|NCT00077610|80932508|FG002|Overall Study|Change in dialysis modality|0|||
27857649|NCT01154816|81314341|FG007|Overall Study|Physician Decision|0|||
27857650|NCT01154816|81314342|FG008|Overall Study|Physician Decision|0|||
27857651|NCT01154816|81314343|FG009|Overall Study|Physician Decision|1|||
27561125|NCT04251221|80241279|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
27561126|NCT04251221|80241280|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
27561127|NCT01894581|80241281|FG000|Overall Study|Withdrawal by Subject|2|||
27561128|NCT01894581|80241282|FG001|Overall Study|Withdrawal by Subject|3|||
27561129|NCT01894581|80241281|FG000|Overall Study|Screen Failure|3|||
27561130|NCT01894581|80241282|FG001|Overall Study|Screen Failure|4|||
27561131|NCT02875860|80241283|FG000|Overall Study|Withdrawal by Subject|0|||
27561132|NCT02875860|80241284|FG001|Overall Study|Withdrawal by Subject|1|||
27561133|NCT00399360|80241285|FG000|Overall Study|Lost to Follow-up|2|||
27561134|NCT00399360|80241286|FG001|Overall Study|Lost to Follow-up|1|||
27561135|NCT00399360|80241287|FG002|Overall Study|Lost to Follow-up|2|||
27561136|NCT00399360|80241288|FG003|Overall Study|Lost to Follow-up|4|||
27561137|NCT00399360|80241285|FG000|Overall Study|Adverse Event|0|||
27561138|NCT00399360|80241286|FG001|Overall Study|Adverse Event|0|||
27561139|NCT00399360|80241287|FG002|Overall Study|Adverse Event|1|||
27561140|NCT00399360|80241288|FG003|Overall Study|Adverse Event|0|||
27561141|NCT00399360|80241285|FG000|Overall Study|Withdrawal by Subject|0|||
27561142|NCT00399360|80241286|FG001|Overall Study|Withdrawal by Subject|2|||
27561143|NCT00399360|80241287|FG002|Overall Study|Withdrawal by Subject|0|||
27561144|NCT00399360|80241288|FG003|Overall Study|Withdrawal by Subject|2|||
27561145|NCT03020407|80241302|FG000|Overall Study|Withdrawal by Subject|2|||
27561146|NCT03020407|80241303|FG001|Overall Study|Withdrawal by Subject|1|||
27561147|NCT03020407|80241302|FG000|Overall Study|Lost to Follow-up|2|||
27857652|NCT01154816|81314344|FG010|Overall Study|Physician Decision|1|||
27857653|NCT01154816|81314345|FG011|Overall Study|Physician Decision|1|||
27561148|NCT03020407|80241303|FG001|Overall Study|Lost to Follow-up|3|||
27561149|NCT03020407|80241302|FG000|Overall Study|Protocol Violation|0|||
27561150|NCT03020407|80241303|FG001|Overall Study|Protocol Violation|1|||
27561151|NCT00311623|80241310|FG000|Overall Study|Physician Decision|0|||
27561152|NCT00311623|80241311|FG001|Overall Study|Physician Decision|0|||
27561153|NCT00311623|80241312|FG002|Overall Study|Physician Decision|2|||
27561154|NCT03255382|80241315|FG000|Overall Study|Adverse Event|3|||
27561155|NCT03255382|80241316|FG001|Overall Study|Adverse Event|0|||
27561156|NCT03255382|80241315|FG000|Overall Study|Lost to Follow-up|2|||
27561157|NCT03255382|80241316|FG001|Overall Study|Lost to Follow-up|0|||
27561158|NCT03255382|80241315|FG000|Overall Study|Withdrawal by Subject|2|||
27561159|NCT03255382|80241316|FG001|Overall Study|Withdrawal by Subject|0|||
27561160|NCT03255382|80241315|FG000|Overall Study|Other|6|||
27561161|NCT03255382|80241316|FG001|Overall Study|Other|0|||
27561162|NCT02268786|80241319|FG000|Overall Study|No Euploid Embryos available|42|||
27561163|NCT02268786|80241320|FG001|Overall Study|No Euploid Embryos available|0|||
27857654|NCT01154816|81314334|FG000|Overall Study|Adverse Event|5|||
27561164|NCT02268786|80241319|FG000|Overall Study|Withdrawal by Subject|7|||
27561165|NCT02268786|80241320|FG001|Overall Study|Withdrawal by Subject|14|||
27561166|NCT02268786|80241319|FG000|Overall Study|Thaw Failure|6|||
27561167|NCT02268786|80241320|FG001|Overall Study|Thaw Failure|4|||
27857655|NCT01154816|81314335|FG001|Overall Study|Adverse Event|2|||
27857656|NCT01154816|81314336|FG002|Overall Study|Adverse Event|0|||
27857657|NCT01154816|81314337|FG003|Overall Study|Adverse Event|0|||
27857658|NCT01154816|81314338|FG004|Overall Study|Adverse Event|0|||
27857659|NCT01154816|81314339|FG005|Overall Study|Adverse Event|0|||
27857660|NCT01154816|81314340|FG006|Overall Study|Adverse Event|1|||
27857661|NCT01154816|81314341|FG007|Overall Study|Adverse Event|1|||
27857662|NCT01154816|81314342|FG008|Overall Study|Adverse Event|0|||
27857663|NCT01154816|81314343|FG009|Overall Study|Adverse Event|0|||
27561168|NCT02268786|80241319|FG000|Overall Study|Protocol Violation|1|||
27561169|NCT02268786|80241320|FG001|Overall Study|Protocol Violation|0|||
27561170|NCT03232281|80241325|FG000|Overall Study|Adverse Event|1|||
27561171|NCT03232281|80241326|FG001|Overall Study|Adverse Event|1|||
27561172|NCT03232281|80241325|FG000|Overall Study|Withdrawal by Subject|5|||
27561173|NCT03232281|80241326|FG001|Overall Study|Withdrawal by Subject|4|||
27561174|NCT03232281|80241325|FG000|Overall Study|Protocol Deviation|1|||
27561175|NCT03232281|80241326|FG001|Overall Study|Protocol Deviation|1|||
27561176|NCT01358357|80241327|FG000|Open Label Phase|Adverse Event|0|||
27561177|NCT01358357|80241328|FG001|Open Label Phase|Adverse Event|0|||
27561178|NCT01358357|80241329|FG002|Open Label Phase|Adverse Event|59|||
27561179|NCT01358357|80241327|FG000|Open Label Phase|Lack of Efficacy|0|||
27561180|NCT01358357|80241328|FG001|Open Label Phase|Lack of Efficacy|0|||
27561181|NCT01358357|80241329|FG002|Open Label Phase|Lack of Efficacy|107|||
27561182|NCT01358357|80241327|FG000|Open Label Phase|Lost to Follow-up|0|||
27561183|NCT01358357|80241328|FG001|Open Label Phase|Lost to Follow-up|0|||
27561184|NCT01358357|80241329|FG002|Open Label Phase|Lost to Follow-up|76|||
27561185|NCT01358357|80241327|FG000|Open Label Phase|Protocol Violation|0|||
27561186|NCT01358357|80241328|FG001|Open Label Phase|Protocol Violation|0|||
27561187|NCT01358357|80241329|FG002|Open Label Phase|Protocol Violation|45|||
27857664|NCT01154816|81314344|FG010|Overall Study|Adverse Event|0|||
27857665|NCT01154816|81314345|FG011|Overall Study|Adverse Event|0|||
27857666|NCT00315731|81314346|FG000|Overall Study|Lost to Follow-up|1|||
27857667|NCT00315731|81314346|FG000|Overall Study|Death|5|||
27857668|NCT02040779|81314347|FG000|Overall Study|Adverse Event|1|||
27857669|NCT02040779|81314348|FG001|Overall Study|Adverse Event|0|||
27857670|NCT02040779|81314349|FG002|Overall Study|Adverse Event|0|||
27857671|NCT02040779|81314347|FG000|Overall Study|Withdrawal by Subject|4|||
27857672|NCT02040779|81314348|FG001|Overall Study|Withdrawal by Subject|1|||
27857673|NCT02040779|81314349|FG002|Overall Study|Withdrawal by Subject|3|||
27857674|NCT02040779|81314347|FG000|Overall Study|Non-compliance|0|||
27857675|NCT02040779|81314348|FG001|Overall Study|Non-compliance|1|||
27857676|NCT02040779|81314349|FG002|Overall Study|Non-compliance|0|||
27857677|NCT02040779|81314347|FG000|Overall Study|Protocol Violation|2|||
27857678|NCT02040779|81314348|FG001|Overall Study|Protocol Violation|1|||
27857679|NCT02040779|81314349|FG002|Overall Study|Protocol Violation|0|||
27857680|NCT02040779|81314347|FG000|Overall Study|Lost to Follow-up|1|||
27857681|NCT02040779|81314348|FG001|Overall Study|Lost to Follow-up|2|||
27857682|NCT02040779|81314349|FG002|Overall Study|Lost to Follow-up|1|||
27857683|NCT02040779|81314347|FG000|Overall Study|Lack of Efficacy|4|||
27857684|NCT02040779|81314348|FG001|Overall Study|Lack of Efficacy|2|||
27561188|NCT01358357|80241327|FG000|Open Label Phase|Withdrawal by Subject|0|||
27561189|NCT01358357|80241328|FG001|Open Label Phase|Withdrawal by Subject|0|||
27561190|NCT01358357|80241329|FG002|Open Label Phase|Withdrawal by Subject|112|||
27561191|NCT01358357|80241327|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
27561192|NCT01358357|80241328|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
27561193|NCT01358357|80241329|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
27561194|NCT01358357|80241327|FG000|Open Label Phase|Terminated at study completion|0|||
27561195|NCT01358357|80241328|FG001|Open Label Phase|Terminated at study completion|0|||
27561196|NCT01358357|80241329|FG002|Open Label Phase|Terminated at study completion|5|||
27561197|NCT01358357|80241327|FG000|Open Label Phase|Mood episode|0|||
27561198|NCT01358357|80241328|FG001|Open Label Phase|Mood episode|0|||
27561199|NCT01358357|80241329|FG002|Open Label Phase|Mood episode|42|||
27561200|NCT01358357|80241327|FG000|Double-Blind Phase|Adverse Event|8|||
27561201|NCT01358357|80241328|FG001|Double-Blind Phase|Adverse Event|5|||
27561202|NCT01358357|80241329|FG002|Double-Blind Phase|Adverse Event|0|||
27561203|NCT01358357|80241327|FG000|Double-Blind Phase|Lost to Follow-up|5|||
27561204|NCT01358357|80241328|FG001|Double-Blind Phase|Lost to Follow-up|7|||
27561205|NCT01358357|80241329|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27561206|NCT01358357|80241327|FG000|Double-Blind Phase|Protocol Violation|1|||
27561207|NCT01358357|80241328|FG001|Double-Blind Phase|Protocol Violation|11|||
27561208|NCT01358357|80241329|FG002|Double-Blind Phase|Protocol Violation|0|||
27561209|NCT01358357|80241327|FG000|Double-Blind Phase|Protocol Violation|16|||
27561210|NCT01358357|80241328|FG001|Double-Blind Phase|Protocol Violation|12|||
27561211|NCT01358357|80241329|FG002|Double-Blind Phase|Protocol Violation|0|||
27561212|NCT01358357|80241327|FG000|Double-Blind Phase|Terminated at study completion|2|||
27561213|NCT01358357|80241328|FG001|Double-Blind Phase|Terminated at study completion|0|||
27561214|NCT01358357|80241329|FG002|Double-Blind Phase|Terminated at study completion|0|||
27561215|NCT01358357|80241327|FG000|Double-Blind Phase|Recurrence of mood event|48|||
27561216|NCT01358357|80241328|FG001|Double-Blind Phase|Recurrence of mood event|64|||
27561217|NCT01358357|80241329|FG002|Double-Blind Phase|Recurrence of mood event|0|||
27561218|NCT01358357|80241327|FG000|Double-Blind Phase|Administrative|0|||
27561219|NCT01358357|80241328|FG001|Double-Blind Phase|Administrative|1|||
27561220|NCT01358357|80241329|FG002|Double-Blind Phase|Administrative|0|||
27561221|NCT00708162|80241332|FG000|Randomized Phase|Randomized but Not Treated|7|||
27561222|NCT00708162|80241333|FG001|Randomized Phase|Randomized but Not Treated|5|||
27561223|NCT00708162|80241332|FG000|Randomized Phase|Participant Noncompliance|40|||
27561224|NCT00708162|80241333|FG001|Randomized Phase|Participant Noncompliance|32|||
27561225|NCT00708162|80241332|FG000|Randomized Phase|Lost to Follow-up|34|||
27857685|NCT02040779|81314349|FG002|Overall Study|Lack of Efficacy|0|||
27857686|NCT03375203|81314350|FG000|Overall Study|Protocol Violation|0|||
27857687|NCT03375203|81314351|FG001|Overall Study|Protocol Violation|0|||
27959552|NCT01135459|81686162|FG001|Overall Study|Protocol Violation|3|||
27959553|NCT01135459|81686161|FG000|Overall Study|Lost to Follow-up|2|||
27959554|NCT01135459|81686162|FG001|Overall Study|Lost to Follow-up|1|||
27959555|NCT01135459|81686161|FG000|Overall Study|Non-compliance to study procedures|0|||
27959556|NCT01135459|81686162|FG001|Overall Study|Non-compliance to study procedures|1|||
27959557|NCT01135459|81686161|FG000|Overall Study|Other than specified|1|||
27959558|NCT01135459|81686162|FG001|Overall Study|Other than specified|1|||
27959559|NCT03542266|81686168|FG000|Treatment Phase|Withdrawal by Subject|1|||
27959560|NCT03542266|81686168|FG000|Treatment Phase|Adverse Event|1|||
27959561|NCT03542266|81686168|FG000|Treatment Phase|PD|1|||
27959562|NCT00427011|81686171|FG000|Overall Study|Adverse Event|10|||
27959563|NCT00427011|81686171|FG000|Overall Study|Withdrawal by Subject|1|||
27959564|NCT00427011|81686171|FG000|Overall Study|Lack of Efficacy|2|||
27959565|NCT00427011|81686171|FG000|Overall Study|Other|12|||
27959566|NCT03456700|81686174|FG000|Overall Study|Withdrawal by Subject|1|||
27959567|NCT01244035|81686175|FG000|Part 1: Period 1|Adverse Event|0|||
27959568|NCT01244035|81686176|FG001|Part 1: Period 1|Adverse Event|0|||
27959569|NCT01244035|81686177|FG002|Part 1: Period 1|Adverse Event|0|||
27959570|NCT01244035|81686178|FG003|Part 1: Period 1|Adverse Event|0|||
27959571|NCT01244035|81686179|FG004|Part 1: Period 1|Adverse Event|0|||
27959572|NCT01244035|81686180|FG005|Part 1: Period 1|Adverse Event|1|||
27959573|NCT01244035|81686175|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
27959574|NCT01244035|81686176|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
27959575|NCT01244035|81686177|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
27959576|NCT01244035|81686178|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
27959577|NCT01244035|81686179|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
27959578|NCT01244035|81686180|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
27959579|NCT01244035|81686175|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
27959580|NCT01244035|81686176|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
27959581|NCT01244035|81686177|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
27959582|NCT01244035|81686178|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
27959583|NCT01244035|81686179|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
27959584|NCT01244035|81686180|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
27959585|NCT01244035|81686175|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27959586|NCT01244035|81686176|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27959587|NCT01244035|81686177|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
27959588|NCT01244035|81686178|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27959589|NCT01244035|81686179|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27959590|NCT01244035|81686180|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
27959591|NCT01244035|81686175|FG000|Part 1: Period 3|Adverse Event|0|||
27959592|NCT01244035|81686176|FG001|Part 1: Period 3|Adverse Event|0|||
27959593|NCT01244035|81686177|FG002|Part 1: Period 3|Adverse Event|0|||
27959594|NCT01244035|81686178|FG003|Part 1: Period 3|Adverse Event|0|||
27959595|NCT01244035|81686179|FG004|Part 1: Period 3|Adverse Event|0|||
27959596|NCT01244035|81686180|FG005|Part 1: Period 3|Adverse Event|1|||
27959597|NCT01244035|81686175|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
27959598|NCT01244035|81686176|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
27959599|NCT01244035|81686177|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
27959600|NCT01244035|81686178|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
27959601|NCT01244035|81686179|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
27959602|NCT01244035|81686180|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
27959603|NCT01244035|81686175|FG000|Part 1: Period 3|Protocol Deviation|0|||
27959604|NCT01244035|81686176|FG001|Part 1: Period 3|Protocol Deviation|1|||
27959605|NCT01244035|81686177|FG002|Part 1: Period 3|Protocol Deviation|0|||
27959606|NCT01244035|81686178|FG003|Part 1: Period 3|Protocol Deviation|0|||
27959607|NCT01244035|81686179|FG004|Part 1: Period 3|Protocol Deviation|0|||
27959608|NCT01244035|81686180|FG005|Part 1: Period 3|Protocol Deviation|0|||
27959609|NCT03549338|81686181|FG000|Overall Study|Progressive Disease|1|||
27959610|NCT03549338|81686182|FG001|Overall Study|Progressive Disease|0|||
27959611|NCT03549338|81686183|FG002|Overall Study|Progressive Disease|0|||
27959612|NCT03549338|81686181|FG000|Overall Study|Clinical Progression|0|||
27959613|NCT03549338|81686182|FG001|Overall Study|Clinical Progression|1|||
27959614|NCT03549338|81686183|FG002|Overall Study|Clinical Progression|0|||
27959615|NCT01102491|81686187|FG000|Overall Study|Protocol Violation|11|||
27959616|NCT01102491|81686188|FG001|Overall Study|Protocol Violation|12|||
27959617|NCT01340664|81686189|FG000|Overall Study|Adverse Event|0|||
27959618|NCT01340664|81686190|FG001|Overall Study|Adverse Event|1|||
27959619|NCT01340664|81686191|FG002|Overall Study|Adverse Event|7|||
27959620|NCT01340664|81686189|FG000|Overall Study|Lost to Follow-up|2|||
27959621|NCT01340664|81686190|FG001|Overall Study|Lost to Follow-up|0|||
27959622|NCT01340664|81686191|FG002|Overall Study|Lost to Follow-up|2|||
27959623|NCT01340664|81686189|FG000|Overall Study|Withdrawal by Subject|2|||
27959624|NCT01340664|81686190|FG001|Overall Study|Withdrawal by Subject|4|||
27959625|NCT01340664|81686191|FG002|Overall Study|Withdrawal by Subject|0|||
27959626|NCT01340664|81686189|FG000|Overall Study|Glycemic withdrawal criteria|2|||
27959627|NCT01340664|81686190|FG001|Overall Study|Glycemic withdrawal criteria|0|||
27959628|NCT01340664|81686191|FG002|Overall Study|Glycemic withdrawal criteria|0|||
27959629|NCT01340664|81686189|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
27959630|NCT01340664|81686190|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
27959631|NCT01340664|81686191|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
27959632|NCT01340664|81686189|FG000|Overall Study|Other|1|||
27959633|NCT01340664|81686190|FG001|Overall Study|Other|2|||
27561226|NCT00708162|80241333|FG001|Randomized Phase|Lost to Follow-up|34|||
27561227|NCT00708162|80241332|FG000|Randomized Phase|Withdrew Consent|31|||
27959634|NCT01340664|81686191|FG002|Overall Study|Other|2|||
27959635|NCT00347932|81686192|FG000|Overall Study|Adverse Event|4|||
27959636|NCT00347932|81686193|FG001|Overall Study|Adverse Event|5|||
27959637|NCT00347932|81686192|FG000|Overall Study|Lack of Efficacy|3|||
27959638|NCT00347932|81686193|FG001|Overall Study|Lack of Efficacy|14|||
27959639|NCT00347932|81686192|FG000|Overall Study|Lost to Follow-up|10|||
27959640|NCT00347932|81686193|FG001|Overall Study|Lost to Follow-up|9|||
27755502|NCT00077610|80932506|FG000|Overall Study|Relocation|0|||
27959641|NCT00347932|81686192|FG000|Overall Study|Withdrawal by Subject|10|||
27959642|NCT00347932|81686193|FG001|Overall Study|Withdrawal by Subject|16|||
27755503|NCT00077610|80932507|FG001|Overall Study|Relocation|8|||
27959643|NCT00347932|81686192|FG000|Overall Study|Did not meet inclusion criteria|4|||
27959644|NCT00347932|81686193|FG001|Overall Study|Did not meet inclusion criteria|8|||
27959645|NCT01575808|81686194|FG000|Overall Study|Death|2|||
27561228|NCT00708162|80241333|FG001|Randomized Phase|Withdrew Consent|22|||
27561229|NCT00708162|80241332|FG000|Randomized Phase|Lack of Efficacy|14|||
27561230|NCT00708162|80241333|FG001|Randomized Phase|Lack of Efficacy|19|||
27561231|NCT00708162|80241332|FG000|Randomized Phase|Protocol Violation|10|||
27561232|NCT00708162|80241333|FG001|Randomized Phase|Protocol Violation|11|||
27561233|NCT00708162|80241332|FG000|Randomized Phase|Adverse Event|8|||
27561234|NCT00708162|80241333|FG001|Randomized Phase|Adverse Event|12|||
27561235|NCT00708162|80241332|FG000|Randomized Phase|Investigator's Discretion|7|||
27561236|NCT00708162|80241333|FG001|Randomized Phase|Investigator's Discretion|10|||
27561237|NCT00708162|80241332|FG000|Randomized Phase|Death|2|||
27561238|NCT00708162|80241333|FG001|Randomized Phase|Death|9|||
27561239|NCT00708162|80241332|FG000|Randomized Phase|Pregnancy|3|||
27561240|NCT00708162|80241333|FG001|Randomized Phase|Pregnancy|0|||
27561241|NCT00708162|80241332|FG000|Open-Label Phase|Lost to Follow-up|10|||
27561242|NCT00708162|80241333|FG001|Open-Label Phase|Lost to Follow-up|8|||
27561243|NCT00708162|80241332|FG000|Open-Label Phase|Withdrew Consent|12|||
27561244|NCT00708162|80241333|FG001|Open-Label Phase|Withdrew Consent|6|||
27561245|NCT00708162|80241332|FG000|Open-Label Phase|Participant Noncompliance|7|||
27561246|NCT00708162|80241333|FG001|Open-Label Phase|Participant Noncompliance|7|||
27561247|NCT00708162|80241332|FG000|Open-Label Phase|Lack of Efficacy|7|||
27959646|NCT01575808|81686195|FG001|Overall Study|Death|0|||
27959647|NCT01575808|81686194|FG000|Overall Study|Withdrawal by Subject|1|||
27561248|NCT00708162|80241333|FG001|Open-Label Phase|Lack of Efficacy|4|||
27561249|NCT00708162|80241332|FG000|Open-Label Phase|Investigator's Discretion|3|||
27561250|NCT00708162|80241333|FG001|Open-Label Phase|Investigator's Discretion|2|||
27561251|NCT00708162|80241332|FG000|Open-Label Phase|Death|3|||
27561252|NCT00708162|80241333|FG001|Open-Label Phase|Death|1|||
27561253|NCT00708162|80241332|FG000|Open-Label Phase|Adverse Event|1|||
27561254|NCT00708162|80241333|FG001|Open-Label Phase|Adverse Event|2|||
27959648|NCT01575808|81686195|FG001|Overall Study|Withdrawal by Subject|0|||
27959649|NCT03188263|81686196|FG000|Overall Study|Withdrawal by Subject|3|||
27959650|NCT03188263|81686197|FG001|Overall Study|Withdrawal by Subject|0|||
27959651|NCT03188263|81686196|FG000|Overall Study|Physician Decision|1|||
27959652|NCT03188263|81686197|FG001|Overall Study|Physician Decision|0|||
27959653|NCT02278341|81686204|FG000|Overall Study|Randomized but never received study drug|1|||
27959654|NCT02278341|81686205|FG001|Overall Study|Randomized but never received study drug|1|||
27959655|NCT02278341|81686204|FG000|Overall Study|Adverse Event|3|||
27959656|NCT02278341|81686205|FG001|Overall Study|Adverse Event|0|||
27959657|NCT02278341|81686204|FG000|Overall Study|Death|68|||
27959658|NCT02278341|81686205|FG001|Overall Study|Death|56|||
27959659|NCT02278341|81686204|FG000|Overall Study|Withdrawal by Subject|30|||
27959660|NCT02278341|81686205|FG001|Overall Study|Withdrawal by Subject|19|||
27959661|NCT02278341|81686204|FG000|Overall Study|Lost to Follow-up|0|||
27959662|NCT02278341|81686205|FG001|Overall Study|Lost to Follow-up|1|||
27959663|NCT02278341|81686204|FG000|Overall Study|Physician Decision|1|||
27959664|NCT02278341|81686205|FG001|Overall Study|Physician Decision|1|||
27959665|NCT02278341|81686204|FG000|Overall Study|Miscellaneous|15|||
27959666|NCT02278341|81686205|FG001|Overall Study|Miscellaneous|14|||
27959667|NCT01146613|81686206|FG000|Overall Study|Lost to Follow-up|3|||
27959668|NCT01146613|81686207|FG001|Overall Study|Lost to Follow-up|8|||
27959669|NCT01146613|81686206|FG000|Overall Study|Lack of Efficacy|0|||
27959670|NCT01146613|81686207|FG001|Overall Study|Lack of Efficacy|1|||
27959671|NCT01146613|81686206|FG000|Overall Study|Death|1|||
27959672|NCT01146613|81686207|FG001|Overall Study|Death|0|||
27959673|NCT01146613|81686206|FG000|Overall Study|Physician Decision|1|||
27959674|NCT01146613|81686207|FG001|Overall Study|Physician Decision|0|||
27959675|NCT01146613|81686206|FG000|Overall Study|Withdrawal by Subject|0|||
27561255|NCT00708162|80241332|FG000|Open-Label Phase|Other|1|||
27561256|NCT00708162|80241333|FG001|Open-Label Phase|Other|0|||
27561257|NCT03839212|80241337|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
27959676|NCT01146613|81686207|FG001|Overall Study|Withdrawal by Subject|3|||
27959677|NCT01146613|81686206|FG000|Overall Study|schedule conflict|1|||
27959678|NCT01146613|81686207|FG001|Overall Study|schedule conflict|0|||
27561258|NCT02447081|80241338|FG000|Overall Study|Death|161|||
27561259|NCT02447081|80241338|FG000|Overall Study|Lost to Follow-up|36|||
27561260|NCT02447081|80241338|FG000|Overall Study|Visit not completed|17|||
27561261|NCT02447081|80241338|FG000|Overall Study|unsuccessful implant procedure|10|||
27561262|NCT01356966|80241341|FG000|Overall Study|Withdrawal by Subject|1|||
27959679|NCT01146613|81686206|FG000|Overall Study|Outpatient detox|1|||
27959680|NCT01146613|81686207|FG001|Overall Study|Outpatient detox|0|||
27959681|NCT00881530|81686208|FG000|Overall Study|Adverse Event|5|||
27561263|NCT01356966|80241342|FG001|Overall Study|Withdrawal by Subject|2|||
27561264|NCT01356966|80241341|FG000|Overall Study|Physician Decision|1|||
27561265|NCT01356966|80241342|FG001|Overall Study|Physician Decision|0|||
27959682|NCT00881530|81686209|FG001|Overall Study|Adverse Event|1|||
27959683|NCT00881530|81686210|FG002|Overall Study|Adverse Event|1|||
27959684|NCT00881530|81686211|FG003|Overall Study|Adverse Event|4|||
27959685|NCT00881530|81686212|FG004|Overall Study|Adverse Event|10|||
27959686|NCT00881530|81686213|FG005|Overall Study|Adverse Event|2|||
27959687|NCT00881530|81686208|FG000|Overall Study|Lack of Efficacy|1|||
27959688|NCT00881530|81686209|FG001|Overall Study|Lack of Efficacy|0|||
27959689|NCT00881530|81686210|FG002|Overall Study|Lack of Efficacy|0|||
27959690|NCT00881530|81686211|FG003|Overall Study|Lack of Efficacy|0|||
27959691|NCT00881530|81686212|FG004|Overall Study|Lack of Efficacy|1|||
27959692|NCT00881530|81686213|FG005|Overall Study|Lack of Efficacy|1|||
27959693|NCT00881530|81686208|FG000|Overall Study|Not compliant with the protocol|0|||
27959694|NCT00881530|81686209|FG001|Overall Study|Not compliant with the protocol|0|||
27959695|NCT00881530|81686210|FG002|Overall Study|Not compliant with the protocol|0|||
27959696|NCT00881530|81686211|FG003|Overall Study|Not compliant with the protocol|0|||
27959697|NCT00881530|81686212|FG004|Overall Study|Not compliant with the protocol|2|||
27959698|NCT00881530|81686213|FG005|Overall Study|Not compliant with the protocol|0|||
27959699|NCT00881530|81686208|FG000|Overall Study|Lost to Follow-up|0|||
27959700|NCT00881530|81686209|FG001|Overall Study|Lost to Follow-up|1|||
27959701|NCT00881530|81686210|FG002|Overall Study|Lost to Follow-up|1|||
27959702|NCT00881530|81686211|FG003|Overall Study|Lost to Follow-up|3|||
27959703|NCT00881530|81686212|FG004|Overall Study|Lost to Follow-up|1|||
27959704|NCT00881530|81686213|FG005|Overall Study|Lost to Follow-up|0|||
27959705|NCT00881530|81686208|FG000|Overall Study|Refused to continue medication|7|||
27959706|NCT00881530|81686209|FG001|Overall Study|Refused to continue medication|2|||
27959707|NCT00881530|81686210|FG002|Overall Study|Refused to continue medication|1|||
27959708|NCT00881530|81686211|FG003|Overall Study|Refused to continue medication|2|||
27959709|NCT00881530|81686212|FG004|Overall Study|Refused to continue medication|0|||
27959710|NCT00881530|81686213|FG005|Overall Study|Refused to continue medication|0|||
27561266|NCT02063854|80241343|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
27561267|NCT02063854|80241344|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
27561268|NCT02063854|80241345|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
27561269|NCT02063854|80241346|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
27561270|NCT02063854|80241347|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
27561271|NCT02063854|80241348|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
27561272|NCT02063854|80241349|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
27561273|NCT02063854|80241343|FG000|Overall Study|Major Protocol Deviation|0|||
27561274|NCT02063854|80241344|FG001|Overall Study|Major Protocol Deviation|0|||
27561275|NCT02063854|80241345|FG002|Overall Study|Major Protocol Deviation|3|||
27561276|NCT02063854|80241346|FG003|Overall Study|Major Protocol Deviation|0|||
27561277|NCT02063854|80241347|FG004|Overall Study|Major Protocol Deviation|0|||
27561278|NCT02063854|80241348|FG005|Overall Study|Major Protocol Deviation|0|||
27561279|NCT02063854|80241349|FG006|Overall Study|Major Protocol Deviation|0|||
27561280|NCT02063854|80241343|FG000|Overall Study|Voluntary Withdrawal|2|||
27561281|NCT02063854|80241344|FG001|Overall Study|Voluntary Withdrawal|0|||
27561282|NCT02063854|80241345|FG002|Overall Study|Voluntary Withdrawal|8|||
27561283|NCT02063854|80241346|FG003|Overall Study|Voluntary Withdrawal|1|||
27561284|NCT02063854|80241347|FG004|Overall Study|Voluntary Withdrawal|3|||
27561285|NCT02063854|80241348|FG005|Overall Study|Voluntary Withdrawal|6|||
27561286|NCT02063854|80241349|FG006|Overall Study|Voluntary Withdrawal|1|||
27561287|NCT02063854|80241343|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
27561288|NCT02063854|80241344|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
27561289|NCT02063854|80241345|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
27561290|NCT02063854|80241346|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
27561291|NCT02063854|80241347|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
27561292|NCT02063854|80241348|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
27561293|NCT02063854|80241349|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
27561294|NCT02063854|80241343|FG000|Overall Study|Reason Not Specified|1|||
27561295|NCT02063854|80241344|FG001|Overall Study|Reason Not Specified|0|||
27561296|NCT02063854|80241345|FG002|Overall Study|Reason Not Specified|0|||
27561297|NCT02063854|80241346|FG003|Overall Study|Reason Not Specified|0|||
27561298|NCT02063854|80241347|FG004|Overall Study|Reason Not Specified|0|||
27561299|NCT02063854|80241348|FG005|Overall Study|Reason Not Specified|0|||
27561300|NCT02063854|80241349|FG006|Overall Study|Reason Not Specified|0|||
27959711|NCT00881530|81686208|FG000|Overall Study|Other reason not defined above|1|||
27561301|NCT02063854|80241343|FG000|Overall Study|Did Not Receive Study Drug|0|||
27561302|NCT02063854|80241344|FG001|Overall Study|Did Not Receive Study Drug|0|||
27561303|NCT02063854|80241345|FG002|Overall Study|Did Not Receive Study Drug|0|||
27561304|NCT02063854|80241346|FG003|Overall Study|Did Not Receive Study Drug|0|||
27561305|NCT02063854|80241347|FG004|Overall Study|Did Not Receive Study Drug|0|||
27959712|NCT00881530|81686209|FG001|Overall Study|Other reason not defined above|1|||
27561306|NCT02063854|80241348|FG005|Overall Study|Did Not Receive Study Drug|1|||
27561307|NCT02063854|80241349|FG006|Overall Study|Did Not Receive Study Drug|0|||
27561308|NCT01266460|80241350|FG000|Overall Study|Adverse Event|3|||
27959713|NCT00881530|81686210|FG002|Overall Study|Other reason not defined above|2|||
27959714|NCT00881530|81686211|FG003|Overall Study|Other reason not defined above|0|||
27959715|NCT00881530|81686212|FG004|Overall Study|Other reason not defined above|0|||
27959716|NCT00881530|81686213|FG005|Overall Study|Other reason not defined above|2|||
27959717|NCT00833469|81686216|FG000|Overall Study|Withdrawal by Subject|1|||
27959718|NCT00833469|81686216|FG000|Overall Study|Lost to Follow-up|1|||
27959719|NCT00792740|81686217|FG000|Overall Study|Disease Worsening|3|||
27959720|NCT00792740|81686218|FG001|Overall Study|Disease Worsening|2|||
27959721|NCT00792740|81686217|FG000|Overall Study|Personal Reason|1|||
27959722|NCT00792740|81686218|FG001|Overall Study|Personal Reason|0|||
27959723|NCT00792740|81686217|FG000|Overall Study|Adverse Event|1|||
27959724|NCT00792740|81686218|FG001|Overall Study|Adverse Event|3|||
27561309|NCT01266460|80241350|FG000|Overall Study|Withdrawal by Subject|5|||
27561310|NCT01266460|80241350|FG000|Overall Study|Disease Progression|18|||
27561311|NCT01266460|80241350|FG000|Overall Study|Not otherwise specified|8|||
27561312|NCT01154218|80241351|FG000|Third Intervention Period|Adverse Event|0|||
27959725|NCT00792740|81686217|FG000|Overall Study|Patient's withdrawal of consent|0|||
27959726|NCT00792740|81686218|FG001|Overall Study|Patient's withdrawal of consent|1|||
27959727|NCT00792740|81686217|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
27959728|NCT00792740|81686218|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
27959729|NCT00792740|81686217|FG000|Overall Study|Other reasons|0|||
27561313|NCT01154218|80241352|FG001|Third Intervention Period|Adverse Event|1|||
27561314|NCT01154218|80241353|FG002|Third Intervention Period|Adverse Event|0|||
27561315|NCT01154218|80241354|FG003|Third Intervention Period|Adverse Event|0|||
27561316|NCT01154218|80241351|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27561317|NCT01154218|80241352|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27561318|NCT01154218|80241353|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27561319|NCT01154218|80241354|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
27561320|NCT01154218|80241351|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
27561321|NCT01154218|80241352|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
27561322|NCT01154218|80241353|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
27561323|NCT01154218|80241354|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
27561324|NCT00412854|80241358|FG000|Overall Study|Withdrawn due to adverse events|1|||
27561325|NCT00412854|80241359|FG001|Overall Study|Withdrawn due to adverse events|5|||
27561326|NCT00412854|80241358|FG000|Overall Study|Withdrawn for other reasons|13|||
27561327|NCT00412854|80241359|FG001|Overall Study|Withdrawn for other reasons|11|||
27561328|NCT00422591|80241362|FG000|Overall Study|Physician Decision|4|||
27561329|NCT00422591|80241362|FG000|Overall Study|Withdrawal by Subject|2|||
27561330|NCT02551731|80241363|FG000|Overall Study|Withdrawal by Subject|2|||
27561331|NCT02917031|80241367|FG000|Overall Study|Reason not specified|7|||
27561332|NCT02917031|80241368|FG001|Overall Study|Reason not specified|5|||
27561333|NCT02917031|80241369|FG002|Overall Study|Reason not specified|6|||
27561334|NCT02917031|80241367|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
27561335|NCT02917031|80241368|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
27561336|NCT02917031|80241369|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
27561337|NCT02917031|80241367|FG000|Overall Study|Withdrawal by Subject|3|||
27561338|NCT02917031|80241368|FG001|Overall Study|Withdrawal by Subject|3|||
27561339|NCT02917031|80241369|FG002|Overall Study|Withdrawal by Subject|0|||
27561340|NCT02917031|80241367|FG000|Overall Study|Physician Decision|1|||
27561341|NCT02917031|80241368|FG001|Overall Study|Physician Decision|0|||
27561342|NCT02917031|80241369|FG002|Overall Study|Physician Decision|0|||
27561343|NCT02917031|80241367|FG000|Overall Study|Adverse Event|4|||
27561344|NCT02917031|80241368|FG001|Overall Study|Adverse Event|1|||
27561345|NCT02917031|80241369|FG002|Overall Study|Adverse Event|5|||
27561346|NCT02917031|80241367|FG000|Overall Study|Death|2|||
27561347|NCT02917031|80241368|FG001|Overall Study|Death|3|||
27561348|NCT02917031|80241369|FG002|Overall Study|Death|4|||
27561349|NCT01172847|80241381|FG000|Overall Study|Withdrawal by Subject|3|||
27561350|NCT00518323|80245934|FG000|Overall Study|Lack of Efficacy|14|||
27755504|NCT00077610|80932508|FG002|Overall Study|Relocation|5|||
27959730|NCT00792740|81686218|FG001|Overall Study|Other reasons|1|||
27959731|NCT02517398|81686222|FG000|Overall Study|Death|2|||
27959732|NCT02517398|81686223|FG001|Overall Study|Death|3|||
27959733|NCT02517398|81686224|FG002|Overall Study|Death|4|||
27959734|NCT02517398|81686225|FG003|Overall Study|Death|2|||
27959735|NCT02517398|81686226|FG004|Overall Study|Death|3|||
27561351|NCT00518323|80245935|FG001|Overall Study|Lack of Efficacy|2|||
27561352|NCT00518323|80245936|FG002|Overall Study|Lack of Efficacy|4|||
27561353|NCT00518323|80245937|FG003|Overall Study|Lack of Efficacy|20|||
27561354|NCT00518323|80245934|FG000|Overall Study|Withdrawal by Subject|1|||
27959736|NCT02517398|81686227|FG005|Overall Study|Death|8|||
27561355|NCT00518323|80245935|FG001|Overall Study|Withdrawal by Subject|2|||
27561356|NCT00518323|80245936|FG002|Overall Study|Withdrawal by Subject|4|||
27561357|NCT00518323|80245937|FG003|Overall Study|Withdrawal by Subject|2|||
27561358|NCT00518323|80245934|FG000|Overall Study|Lost to Follow-up|0|||
27561359|NCT00518323|80245935|FG001|Overall Study|Lost to Follow-up|2|||
27959737|NCT02517398|81686228|FG006|Overall Study|Death|3|||
27959738|NCT02517398|81686229|FG007|Overall Study|Death|2|||
27561360|NCT00518323|80245936|FG002|Overall Study|Lost to Follow-up|1|||
27561361|NCT00518323|80245937|FG003|Overall Study|Lost to Follow-up|3|||
27561362|NCT00518323|80245934|FG000|Overall Study|Adverse Event|1|||
27561363|NCT00518323|80245935|FG001|Overall Study|Adverse Event|1|||
27561364|NCT00518323|80245936|FG002|Overall Study|Adverse Event|1|||
27561365|NCT00518323|80245937|FG003|Overall Study|Adverse Event|0|||
27561366|NCT00518323|80245934|FG000|Overall Study|Prohibited medication and others|3|||
27561367|NCT00518323|80245935|FG001|Overall Study|Prohibited medication and others|1|||
27561368|NCT00518323|80245936|FG002|Overall Study|Prohibited medication and others|1|||
27561369|NCT00518323|80245937|FG003|Overall Study|Prohibited medication and others|0|||
27561370|NCT02024867|80245938|FG000|Overall Study|Protocol Violation|3|||
27561371|NCT02024867|80245939|FG001|Overall Study|Protocol Violation|3|||
27561372|NCT02024867|80245938|FG000|Overall Study|Lost to Follow-up|6|||
27561373|NCT02024867|80245939|FG001|Overall Study|Lost to Follow-up|4|||
27561374|NCT00462761|80245940|FG000|Overall Study|Adverse Event|6|||
27561375|NCT00462761|80245940|FG000|Overall Study|Withdrawal by Subject|9|||
27561376|NCT00462761|80245940|FG000|Overall Study|Physician Decision|5|||
27561377|NCT00462761|80245940|FG000|Overall Study|Disease progression|43|||
27561378|NCT00462761|80245940|FG000|Overall Study|Death|12|||
27561379|NCT00462761|80245940|FG000|Overall Study|Other|1|||
27561380|NCT01853046|80245944|FG000|Overall Study|Withdrawal by Subject|1|||
27561381|NCT01853046|80245945|FG001|Overall Study|Withdrawal by Subject|1|||
27561382|NCT01853046|80245944|FG000|Overall Study|Adverse Event|4|||
27561383|NCT01853046|80245945|FG001|Overall Study|Adverse Event|2|||
27561384|NCT01853046|80245944|FG000|Overall Study|Disease progression|13|||
27561385|NCT01853046|80245945|FG001|Overall Study|Disease progression|3|||
27561386|NCT01485640|80245946|FG000|Overall Study|Adverse Event|10|||
27561387|NCT01485640|80245946|FG000|Overall Study|Lack of Efficacy|2|||
27561388|NCT01485640|80245946|FG000|Overall Study|Protocol Violation|1|||
27561389|NCT01485640|80245946|FG000|Overall Study|Withdrawal by Subject|14|||
27561390|NCT01485640|80245946|FG000|Overall Study|Terminated by Sponsor|95|||
27561391|NCT02542631|80245947|FG000|Overall Study|Adverse Event|1|||
27561392|NCT02542631|80245948|FG001|Overall Study|Adverse Event|1|||
27561393|NCT02542631|80245947|FG000|Overall Study|Sponsor Termination|1|||
27561394|NCT02542631|80245948|FG001|Overall Study|Sponsor Termination|0|||
27561395|NCT02542631|80245947|FG000|Overall Study|Withdrawal by Subject|11|||
27561396|NCT02542631|80245948|FG001|Overall Study|Withdrawal by Subject|16|||
27561397|NCT02542631|80245947|FG000|Overall Study|Protocol Violation|1|||
27561398|NCT02542631|80245948|FG001|Overall Study|Protocol Violation|1|||
27561399|NCT02542631|80245947|FG000|Overall Study|Physician Decision|6|||
27561400|NCT02542631|80245948|FG001|Overall Study|Physician Decision|4|||
27561401|NCT02542631|80245947|FG000|Overall Study|Lost to Follow-up|6|||
27561402|NCT02542631|80245948|FG001|Overall Study|Lost to Follow-up|5|||
27561403|NCT02542631|80245947|FG000|Overall Study|Death|1|||
27561404|NCT02542631|80245948|FG001|Overall Study|Death|2|||
27561405|NCT02542631|80245947|FG000|Overall Study|Other|2|||
27561406|NCT02542631|80245948|FG001|Overall Study|Other|1|||
27561407|NCT02542631|80245947|FG000|Overall Study|Used Prohibited Medication|2|||
27561408|NCT02542631|80245948|FG001|Overall Study|Used Prohibited Medication|1|||
27561409|NCT03011307|80245950|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
27561410|NCT03011307|80245951|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
27561411|NCT03011307|80245950|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
27561412|NCT03011307|80245951|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
27561413|NCT03011307|80245950|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
27561414|NCT03011307|80245951|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
27561415|NCT00227903|80245952|FG000|Overall Study|Withdrawal by Subject|2|||
27561416|NCT00227903|80245953|FG001|Overall Study|Withdrawal by Subject|5|||
27561417|NCT00227903|80245952|FG000|Overall Study|Subject moved out of area|1|||
27561418|NCT00227903|80245953|FG001|Overall Study|Subject moved out of area|2|||
27561419|NCT00227903|80245952|FG000|Overall Study|Lost to Follow-up|1|||
27959739|NCT02517398|81686230|FG008|Overall Study|Death|6|||
27561420|NCT00227903|80245953|FG001|Overall Study|Lost to Follow-up|3|||
27561421|NCT00227903|80245952|FG000|Overall Study|Miscarriage|1|||
27561422|NCT00227903|80245953|FG001|Overall Study|Miscarriage|0|||
27561423|NCT02921776|80245958|FG000|Overall Study|patient deterioration, fatigue|2|||
27561424|NCT02921776|80245959|FG001|Overall Study|patient deterioration, fatigue|6|||
27561425|NCT02921776|80245960|FG002|Overall Study|patient deterioration, fatigue|0|||
27561426|NCT02921776|80245961|FG003|Overall Study|patient deterioration, fatigue|0|||
27561427|NCT02921776|80245962|FG004|Overall Study|patient deterioration, fatigue|0|||
27561428|NCT02921776|80245963|FG005|Overall Study|patient deterioration, fatigue|0|||
27561429|NCT02921776|80245964|FG006|Overall Study|patient deterioration, fatigue|0|||
27561430|NCT02921776|80245965|FG007|Overall Study|patient deterioration, fatigue|0|||
27561431|NCT02921776|80245958|FG000|Overall Study|Withdrawal by Subject|0|||
27561432|NCT02921776|80245959|FG001|Overall Study|Withdrawal by Subject|2|||
27561433|NCT02921776|80245960|FG002|Overall Study|Withdrawal by Subject|0|||
27561434|NCT02921776|80245961|FG003|Overall Study|Withdrawal by Subject|1|||
27561435|NCT02921776|80245962|FG004|Overall Study|Withdrawal by Subject|1|||
27561436|NCT02921776|80245963|FG005|Overall Study|Withdrawal by Subject|0|||
27561437|NCT02921776|80245964|FG006|Overall Study|Withdrawal by Subject|8|||
27561438|NCT02921776|80245965|FG007|Overall Study|Withdrawal by Subject|1|||
27561439|NCT02921776|80245958|FG000|Overall Study|Death|0|||
27561440|NCT02921776|80245959|FG001|Overall Study|Death|0|||
27561441|NCT02921776|80245960|FG002|Overall Study|Death|0|||
27561442|NCT02921776|80245961|FG003|Overall Study|Death|2|||
27561443|NCT02921776|80245962|FG004|Overall Study|Death|0|||
27561444|NCT02921776|80245963|FG005|Overall Study|Death|0|||
27561445|NCT02921776|80245964|FG006|Overall Study|Death|0|||
27561446|NCT02921776|80245965|FG007|Overall Study|Death|0|||
27561447|NCT02921776|80245958|FG000|Overall Study|extubation or early discharge|0|||
27561448|NCT02921776|80245959|FG001|Overall Study|extubation or early discharge|0|||
27561449|NCT02921776|80245960|FG002|Overall Study|extubation or early discharge|0|||
27561450|NCT02921776|80245961|FG003|Overall Study|extubation or early discharge|5|||
27959740|NCT02517398|81686231|FG009|Overall Study|Death|24|||
27959741|NCT02517398|81686232|FG010|Overall Study|Death|53|||
27959742|NCT02517398|81686233|FG011|Overall Study|Death|25|||
27959743|NCT02517398|81686234|FG012|Overall Study|Death|73|||
27959744|NCT02517398|81686235|FG013|Overall Study|Death|29|||
27959745|NCT02517398|81686236|FG014|Overall Study|Death|26|||
27561451|NCT02921776|80245962|FG004|Overall Study|extubation or early discharge|5|||
27561452|NCT02921776|80245963|FG005|Overall Study|extubation or early discharge|0|||
27561453|NCT02921776|80245964|FG006|Overall Study|extubation or early discharge|0|||
27561454|NCT02921776|80245965|FG007|Overall Study|extubation or early discharge|0|||
27561455|NCT02921776|80245958|FG000|Overall Study|Lost to Follow-up|0|||
27561456|NCT02921776|80245959|FG001|Overall Study|Lost to Follow-up|0|||
27561457|NCT02921776|80245960|FG002|Overall Study|Lost to Follow-up|0|||
27561458|NCT02921776|80245961|FG003|Overall Study|Lost to Follow-up|0|||
27561459|NCT02921776|80245962|FG004|Overall Study|Lost to Follow-up|0|||
27561460|NCT02921776|80245963|FG005|Overall Study|Lost to Follow-up|2|||
27561461|NCT02921776|80245964|FG006|Overall Study|Lost to Follow-up|3|||
27561462|NCT02921776|80245965|FG007|Overall Study|Lost to Follow-up|6|||
27561463|NCT00507442|80245966|FG000|Overall Study|Adverse Event|8|||
27959746|NCT02517398|81686237|FG015|Overall Study|Death|23|||
27561464|NCT00507442|80245967|FG001|Overall Study|Adverse Event|11|||
27561465|NCT00507442|80245968|FG002|Overall Study|Adverse Event|4|||
27561466|NCT00507442|80245969|FG003|Overall Study|Adverse Event|1|||
27561467|NCT00507442|80245966|FG000|Overall Study|Protocol Violation|0|||
27561468|NCT00507442|80245967|FG001|Overall Study|Protocol Violation|1|||
27561469|NCT00507442|80245968|FG002|Overall Study|Protocol Violation|0|||
27561470|NCT00507442|80245969|FG003|Overall Study|Protocol Violation|0|||
27561471|NCT00507442|80245966|FG000|Overall Study|Lost to Follow-up|0|||
27561472|NCT00507442|80245967|FG001|Overall Study|Lost to Follow-up|0|||
27561473|NCT00507442|80245968|FG002|Overall Study|Lost to Follow-up|1|||
27561474|NCT00507442|80245969|FG003|Overall Study|Lost to Follow-up|0|||
27561475|NCT00507442|80245966|FG000|Overall Study|Physician Decision|0|||
27959747|NCT02517398|81686238|FG016|Overall Study|Death|26|||
27561476|NCT00507442|80245967|FG001|Overall Study|Physician Decision|2|||
27561477|NCT00507442|80245968|FG002|Overall Study|Physician Decision|4|||
27561478|NCT00507442|80245969|FG003|Overall Study|Physician Decision|1|||
27561479|NCT00507442|80245966|FG000|Overall Study|Progressive Disease|2|||
27561480|NCT00507442|80245967|FG001|Overall Study|Progressive Disease|4|||
27561481|NCT00507442|80245968|FG002|Overall Study|Progressive Disease|2|||
27561482|NCT00507442|80245969|FG003|Overall Study|Progressive Disease|0|||
27561483|NCT00507442|80245966|FG000|Overall Study|Withdrawal by Subject|4|||
27561484|NCT00507442|80245967|FG001|Overall Study|Withdrawal by Subject|4|||
27561485|NCT00507442|80245968|FG002|Overall Study|Withdrawal by Subject|2|||
27561486|NCT00507442|80245969|FG003|Overall Study|Withdrawal by Subject|1|||
27561487|NCT00507442|80245966|FG000|Overall Study|Other|2|||
27561488|NCT00507442|80245967|FG001|Overall Study|Other|5|||
27561489|NCT00507442|80245968|FG002|Overall Study|Other|2|||
27561490|NCT00507442|80245969|FG003|Overall Study|Other|2|||
27561491|NCT02968563|80245970|FG000|Overall Study|Adverse Event|0|||
27561492|NCT02968563|80245971|FG001|Overall Study|Adverse Event|6|||
27561493|NCT02968563|80245970|FG000|Overall Study|Death|1|||
27561494|NCT02968563|80245971|FG001|Overall Study|Death|1|||
27561495|NCT02968563|80245970|FG000|Overall Study|Lost to Follow-up|0|||
27561496|NCT02968563|80245971|FG001|Overall Study|Lost to Follow-up|1|||
27561497|NCT02532647|80245972|FG000|Overall Study|Did not receive trial medication|1|||
27561498|NCT02532647|80245973|FG001|Overall Study|Did not receive trial medication|0|||
27959748|NCT02517398|81686239|FG017|Overall Study|Death|25|||
27561499|NCT02532647|80245974|FG002|Overall Study|Did not receive trial medication|1|||
27561500|NCT01139450|80245977|FG000|Overall Study|Withdrawal by Subject|7|||
27561501|NCT01139450|80245978|FG001|Overall Study|Withdrawal by Subject|10|||
27959749|NCT02517398|81686240|FG018|Overall Study|Death|22|||
27561502|NCT01139450|80245979|FG002|Overall Study|Withdrawal by Subject|13|||
27959750|NCT02517398|81686241|FG019|Overall Study|Death|7|||
27959751|NCT02517398|81686242|FG020|Overall Study|Death|26|||
27561503|NCT01139450|80245977|FG000|Overall Study|Lack of Efficacy|3|||
27561504|NCT01139450|80245978|FG001|Overall Study|Lack of Efficacy|1|||
27561505|NCT01139450|80245979|FG002|Overall Study|Lack of Efficacy|8|||
27561506|NCT01139450|80245977|FG000|Overall Study|Protocol Violation|6|||
27561507|NCT01139450|80245978|FG001|Overall Study|Protocol Violation|5|||
27561508|NCT01139450|80245979|FG002|Overall Study|Protocol Violation|2|||
27561509|NCT01139450|80245977|FG000|Overall Study|Lost to Follow-up|9|||
27561510|NCT01139450|80245978|FG001|Overall Study|Lost to Follow-up|7|||
27561511|NCT01139450|80245979|FG002|Overall Study|Lost to Follow-up|11|||
27959752|NCT02517398|81686243|FG021|Overall Study|Death|30|||
27959753|NCT02517398|81686244|FG022|Overall Study|Death|20|||
27959754|NCT02517398|81686222|FG000|Overall Study|Other|0|||
27959755|NCT02517398|81686223|FG001|Overall Study|Other|0|||
27959756|NCT02517398|81686224|FG002|Overall Study|Other|0|||
27959757|NCT02517398|81686225|FG003|Overall Study|Other|1|||
27959758|NCT02517398|81686226|FG004|Overall Study|Other|0|||
27561512|NCT01139450|80245977|FG000|Overall Study|Administrative|0|||
27561513|NCT01139450|80245978|FG001|Overall Study|Administrative|0|||
27561514|NCT01139450|80245979|FG002|Overall Study|Administrative|1|||
27561515|NCT01139450|80245977|FG000|Overall Study|Adverse Event|2|||
27561516|NCT01139450|80245978|FG001|Overall Study|Adverse Event|2|||
27561517|NCT01139450|80245979|FG002|Overall Study|Adverse Event|3|||
27959759|NCT02517398|81686227|FG005|Overall Study|Other|0|||
27561518|NCT02522286|80245980|FG000|Overall Study|Withdrawal by Subject|3|||
27561519|NCT02522286|80245981|FG001|Overall Study|Withdrawal by Subject|0|||
27959760|NCT02517398|81686228|FG006|Overall Study|Other|0|||
27959761|NCT02517398|81686229|FG007|Overall Study|Other|0|||
27959762|NCT02517398|81686230|FG008|Overall Study|Other|0|||
27959763|NCT02517398|81686231|FG009|Overall Study|Other|1|||
27959764|NCT02517398|81686232|FG010|Overall Study|Other|0|||
27959765|NCT02517398|81686233|FG011|Overall Study|Other|0|||
27959766|NCT02517398|81686234|FG012|Overall Study|Other|0|||
27959767|NCT02517398|81686235|FG013|Overall Study|Other|1|||
27959768|NCT02517398|81686236|FG014|Overall Study|Other|0|||
27959769|NCT02517398|81686237|FG015|Overall Study|Other|1|||
27959770|NCT02517398|81686238|FG016|Overall Study|Other|1|||
27959771|NCT02517398|81686239|FG017|Overall Study|Other|0|||
27959772|NCT02517398|81686240|FG018|Overall Study|Other|0|||
27959773|NCT02517398|81686241|FG019|Overall Study|Other|1|||
27959774|NCT02517398|81686242|FG020|Overall Study|Other|0|||
27959775|NCT02517398|81686243|FG021|Overall Study|Other|0|||
27959776|NCT02517398|81686244|FG022|Overall Study|Other|0|||
27959777|NCT02517398|81686222|FG000|Overall Study|Lost to Follow-up|0|||
27959778|NCT02517398|81686223|FG001|Overall Study|Lost to Follow-up|0|||
27959779|NCT02517398|81686224|FG002|Overall Study|Lost to Follow-up|0|||
27959780|NCT02517398|81686225|FG003|Overall Study|Lost to Follow-up|0|||
27959781|NCT02517398|81686226|FG004|Overall Study|Lost to Follow-up|0|||
27959782|NCT02517398|81686227|FG005|Overall Study|Lost to Follow-up|0|||
27959783|NCT02517398|81686228|FG006|Overall Study|Lost to Follow-up|0|||
27959784|NCT02517398|81686229|FG007|Overall Study|Lost to Follow-up|0|||
27959785|NCT02517398|81686230|FG008|Overall Study|Lost to Follow-up|0|||
27959786|NCT02517398|81686231|FG009|Overall Study|Lost to Follow-up|1|||
27959787|NCT02517398|81686232|FG010|Overall Study|Lost to Follow-up|0|||
27959788|NCT02517398|81686233|FG011|Overall Study|Lost to Follow-up|2|||
27959789|NCT02517398|81686234|FG012|Overall Study|Lost to Follow-up|2|||
27959790|NCT02517398|81686235|FG013|Overall Study|Lost to Follow-up|0|||
27959791|NCT02517398|81686236|FG014|Overall Study|Lost to Follow-up|1|||
27959792|NCT02517398|81686237|FG015|Overall Study|Lost to Follow-up|1|||
27959793|NCT02517398|81686238|FG016|Overall Study|Lost to Follow-up|0|||
27959794|NCT02517398|81686239|FG017|Overall Study|Lost to Follow-up|3|||
27959795|NCT02517398|81686240|FG018|Overall Study|Lost to Follow-up|1|||
27959796|NCT02517398|81686241|FG019|Overall Study|Lost to Follow-up|0|||
27959797|NCT02517398|81686242|FG020|Overall Study|Lost to Follow-up|1|||
27959798|NCT02517398|81686243|FG021|Overall Study|Lost to Follow-up|0|||
27959799|NCT02517398|81686244|FG022|Overall Study|Lost to Follow-up|2|||
27959800|NCT02517398|81686222|FG000|Overall Study|Withdrew Consent|0|||
27561520|NCT02522286|80245982|FG002|Overall Study|Withdrawal by Subject|0|||
27755505|NCT00077610|80932506|FG000|Overall Study|Financial issues|0|||
27959801|NCT02517398|81686223|FG001|Overall Study|Withdrew Consent|0|||
27959802|NCT02517398|81686224|FG002|Overall Study|Withdrew Consent|0|||
27959803|NCT02517398|81686225|FG003|Overall Study|Withdrew Consent|0|||
27959804|NCT02517398|81686226|FG004|Overall Study|Withdrew Consent|0|||
27959805|NCT02517398|81686227|FG005|Overall Study|Withdrew Consent|0|||
27959806|NCT02517398|81686228|FG006|Overall Study|Withdrew Consent|1|||
27959807|NCT02517398|81686229|FG007|Overall Study|Withdrew Consent|0|||
27959808|NCT02517398|81686230|FG008|Overall Study|Withdrew Consent|0|||
27959809|NCT02517398|81686231|FG009|Overall Study|Withdrew Consent|2|||
27959810|NCT02517398|81686232|FG010|Overall Study|Withdrew Consent|7|||
27959811|NCT02517398|81686233|FG011|Overall Study|Withdrew Consent|1|||
27959812|NCT02517398|81686234|FG012|Overall Study|Withdrew Consent|5|||
27959813|NCT02517398|81686235|FG013|Overall Study|Withdrew Consent|4|||
27561521|NCT02522286|80245983|FG003|Overall Study|Withdrawal by Subject|3|||
27959814|NCT02517398|81686236|FG014|Overall Study|Withdrew Consent|2|||
27561522|NCT02590939|80245990|FG000|Overall Study|Withdrawal by Subject|3|||
27561523|NCT02590939|80245991|FG001|Overall Study|Withdrawal by Subject|1|||
27561524|NCT02590939|80245990|FG000|Overall Study|Failed the nociceptive test|2|||
27561525|NCT02590939|80245991|FG001|Overall Study|Failed the nociceptive test|1|||
27561526|NCT02005250|80245992|FG000|Overall Study|Lost to Follow-up|15|||
27561527|NCT02005250|80245993|FG001|Overall Study|Lost to Follow-up|5|||
27561528|NCT02092662|80245994|FG000|Overall Study|Lost to Follow-up|13|||
27561529|NCT02092662|80245995|FG001|Overall Study|Lost to Follow-up|0|||
27561530|NCT03717480|80245996|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
27561531|NCT01288911|80245997|FG000|Double-blind Period|Death|11|||
27561532|NCT01288911|80245998|FG001|Double-blind Period|Death|7|||
27561533|NCT01288911|80245997|FG000|Double-blind Period|Lost to Follow-up|0|||
27561534|NCT01288911|80245998|FG001|Double-blind Period|Lost to Follow-up|2|||
27561535|NCT01288911|80245997|FG000|Double-blind Period|Progressive Disease|75|||
27561536|NCT01288911|80245998|FG001|Double-blind Period|Progressive Disease|103|||
27561537|NCT01288911|80245997|FG000|Double-blind Period|Protocol Violation|1|||
27561538|NCT01288911|80245998|FG001|Double-blind Period|Protocol Violation|0|||
27561539|NCT01288911|80245997|FG000|Double-blind Period|Withdrawal by Subject|25|||
27561540|NCT01288911|80245998|FG001|Double-blind Period|Withdrawal by Subject|26|||
27561541|NCT01288911|80245997|FG000|Double-blind Period|Miscellaneous Reason|29|||
27561542|NCT01288911|80245998|FG001|Double-blind Period|Miscellaneous Reason|42|||
27561543|NCT01288911|80245997|FG000|Double-blind Period|Randomized but never received study drug|1|||
27561544|NCT01288911|80245998|FG001|Double-blind Period|Randomized but never received study drug|2|||
27959815|NCT02517398|81686237|FG015|Overall Study|Withdrew Consent|5|||
27959816|NCT02517398|81686238|FG016|Overall Study|Withdrew Consent|4|||
27561545|NCT01288911|80245997|FG000|Open-label Period (All Enzalutamide)|Death|0|||
27561546|NCT01288911|80245998|FG001|Open-label Period (All Enzalutamide)|Death|1|||
27561547|NCT01288911|80245997|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
27561548|NCT01288911|80245998|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
27561549|NCT01288911|80245997|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
27561550|NCT01288911|80245998|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
27561551|NCT01288911|80245997|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
27561552|NCT01288911|80245998|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
27561553|NCT01288911|80245997|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
27561554|NCT01288911|80245998|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
27561555|NCT01288911|80245997|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
27561556|NCT01288911|80245998|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
27561557|NCT00909779|80245999|FG000|Overall Study|Adverse Event|53|||
27561558|NCT00909779|80246000|FG001|Overall Study|Adverse Event|55|||
27561559|NCT00909779|80245999|FG000|Overall Study|Lack of Efficacy|7|||
27561560|NCT00909779|80246000|FG001|Overall Study|Lack of Efficacy|4|||
27561561|NCT00909779|80245999|FG000|Overall Study|Lost to Follow-up|19|||
27561562|NCT00909779|80246000|FG001|Overall Study|Lost to Follow-up|15|||
27561563|NCT00909779|80245999|FG000|Overall Study|Physician Decision|8|||
27561564|NCT00909779|80246000|FG001|Overall Study|Physician Decision|2|||
27561565|NCT00909779|80245999|FG000|Overall Study|Protocol Violation|2|||
27561566|NCT00909779|80246000|FG001|Overall Study|Protocol Violation|5|||
27561567|NCT00909779|80245999|FG000|Overall Study|Withdrawal by Subject|116|||
27561568|NCT00909779|80246000|FG001|Overall Study|Withdrawal by Subject|80|||
27561569|NCT00909779|80245999|FG000|Overall Study|Site Ceasing Operation|2|||
27561570|NCT00909779|80246000|FG001|Overall Study|Site Ceasing Operation|2|||
27561571|NCT00909779|80245999|FG000|Overall Study|Medical Monitor Decision|1|||
27561572|NCT00909779|80246000|FG001|Overall Study|Medical Monitor Decision|0|||
27561573|NCT00909779|80245999|FG000|Overall Study|Noncompliance|1|||
27561574|NCT00909779|80246000|FG001|Overall Study|Noncompliance|1|||
27561575|NCT00909779|80245999|FG000|Overall Study|Randomized in error|1|||
27561576|NCT00909779|80246000|FG001|Overall Study|Randomized in error|1|||
27561577|NCT05024058|80246001|FG000|Treatment|Study terminated by sponsor|5|||
27561578|NCT05024058|80246002|FG001|Treatment|Study terminated by sponsor|6|||
27561579|NCT05024058|80246003|FG002|Treatment|Study terminated by sponsor|4|||
27561580|NCT05024058|80246004|FG003|Treatment|Study terminated by sponsor|2|||
27561581|NCT05024058|80246005|FG004|Treatment|Study terminated by sponsor|3|||
27561582|NCT05024058|80246006|FG005|Treatment|Study terminated by sponsor|3|||
27561583|NCT05024058|80246007|FG006|Treatment|Study terminated by sponsor|1|||
27959817|NCT02517398|81686239|FG017|Overall Study|Withdrew Consent|2|||
27959818|NCT02517398|81686240|FG018|Overall Study|Withdrew Consent|3|||
27959819|NCT02517398|81686241|FG019|Overall Study|Withdrew Consent|2|||
27561584|NCT05024058|80246008|FG007|Treatment|Study terminated by sponsor|3|||
27561585|NCT05024058|80246009|FG008|Treatment|Study terminated by sponsor|6|||
27561586|NCT05024058|80246010|FG009|Treatment|Study terminated by sponsor|6|||
27561587|NCT05024058|80246001|FG000|Follow-up|Withdrawal by Subject|1|||
27561588|NCT05024058|80246002|FG001|Follow-up|Withdrawal by Subject|0|||
27561589|NCT05024058|80246003|FG002|Follow-up|Withdrawal by Subject|1|||
27561590|NCT05024058|80246004|FG003|Follow-up|Withdrawal by Subject|0|||
27959820|NCT02517398|81686242|FG020|Overall Study|Withdrew Consent|9|||
27561591|NCT05024058|80246005|FG004|Follow-up|Withdrawal by Subject|0|||
27561592|NCT05024058|80246006|FG005|Follow-up|Withdrawal by Subject|0|||
27561593|NCT05024058|80246007|FG006|Follow-up|Withdrawal by Subject|0|||
27561594|NCT05024058|80246008|FG007|Follow-up|Withdrawal by Subject|1|||
27561595|NCT05024058|80246009|FG008|Follow-up|Withdrawal by Subject|0|||
27561596|NCT05024058|80246010|FG009|Follow-up|Withdrawal by Subject|1|||
27561597|NCT01412021|80246011|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
27561598|NCT01412021|80246011|FG000|Overall Study|Treatment Prior to Approval|3|||
27561599|NCT01412021|80246011|FG000|Overall Study|Transferred to Other Hospital|9|||
27561600|NCT02009046|80246014|FG000|Overall Study|Lost to Follow-up|256|||
27959821|NCT02517398|81686243|FG021|Overall Study|Withdrew Consent|3|||
27561601|NCT02009046|80246015|FG001|Overall Study|Lost to Follow-up|206|||
27755506|NCT00077610|80932507|FG001|Overall Study|Financial issues|1|||
27755507|NCT00077610|80932508|FG002|Overall Study|Financial issues|0|||
27755508|NCT00077610|80932506|FG000|Overall Study|Sponsors decision to withdraw|0|||
27755509|NCT00077610|80932507|FG001|Overall Study|Sponsors decision to withdraw|0|||
27755510|NCT00077610|80932508|FG002|Overall Study|Sponsors decision to withdraw|1|||
27755511|NCT02723604|80932514|FG000|Overall Study|ineligible|1|||
27755512|NCT02723604|80932514|FG000|Overall Study|never received treatment|1|||
27755513|NCT02431468|80932515|FG000|Overall Study|Adverse Event|2|||
27755514|NCT02431468|80932516|FG001|Overall Study|Adverse Event|4|||
27755515|NCT02431468|80932517|FG002|Overall Study|Adverse Event|5|||
27755516|NCT02431468|80932515|FG000|Overall Study|Withdrawal by Subject|4|||
27755517|NCT02431468|80932516|FG001|Overall Study|Withdrawal by Subject|12|||
27755518|NCT02431468|80932517|FG002|Overall Study|Withdrawal by Subject|2|||
27755519|NCT02431468|80932515|FG000|Overall Study|noncompliance, investigator termination,|2|||
27755520|NCT02431468|80932516|FG001|Overall Study|noncompliance, investigator termination,|2|||
27755521|NCT02431468|80932517|FG002|Overall Study|noncompliance, investigator termination,|2|||
27755522|NCT00377611|80932518|FG000|Overall Study|Adverse Event|2|||
27755523|NCT00377611|80932519|FG001|Overall Study|Adverse Event|9|||
27755524|NCT00377611|80932518|FG000|Overall Study|Protocol Violation|2|||
27755525|NCT00377611|80932519|FG001|Overall Study|Protocol Violation|0|||
27959822|NCT02517398|81686244|FG022|Overall Study|Withdrew Consent|1|||
27959823|NCT02735421|81686245|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
27959824|NCT02735421|81686245|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
27959825|NCT02735421|81686245|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
27959826|NCT02735421|81686245|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
27959827|NCT02735421|81686245|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
27959828|NCT02735421|81686245|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
27959829|NCT02735421|81686245|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
27959830|NCT03159468|81686246|FG000|Overall Study|Withdrawal by Subject|0|||
27959831|NCT03159468|81686247|FG001|Overall Study|Withdrawal by Subject|0|||
27959832|NCT03159468|81686248|FG002|Overall Study|Withdrawal by Subject|3|||
27959833|NCT03159468|81686249|FG003|Overall Study|Withdrawal by Subject|0|||
27959834|NCT03159468|81686250|FG004|Overall Study|Withdrawal by Subject|0|||
27959835|NCT03159468|81686251|FG005|Overall Study|Withdrawal by Subject|0|||
27959836|NCT00590122|81686256|FG000|Overall Study|swallowed oral dissolving dose|1|||
27959837|NCT00590122|81686257|FG001|Overall Study|swallowed oral dissolving dose|0|||
27959838|NCT02454530|81686259|FG000|Overall Study|Other|8|||
27959839|NCT02454530|81686260|FG001|Overall Study|Other|13|||
27959840|NCT02454530|81686259|FG000|Overall Study|Missing information|56|||
27959841|NCT02454530|81686260|FG001|Overall Study|Missing information|69|||
27959842|NCT02454530|81686259|FG000|Overall Study|Death|2|||
27959843|NCT02454530|81686260|FG001|Overall Study|Death|41|||
27959844|NCT02454530|81686259|FG000|Overall Study|Lost to Follow-up|4|||
27959845|NCT02454530|81686260|FG001|Overall Study|Lost to Follow-up|4|||
27959846|NCT00603941|81686261|FG000|Overall Study|Disease progression|6|||
27959847|NCT00603941|81686262|FG001|Overall Study|Disease progression|7|||
27755526|NCT00377611|80932518|FG000|Overall Study|Withdrawal by Subject|0|||
27755527|NCT00377611|80932519|FG001|Overall Study|Withdrawal by Subject|5|||
27755528|NCT00377611|80932518|FG000|Overall Study|Lost to Follow-up|18|||
27755529|NCT00377611|80932519|FG001|Overall Study|Lost to Follow-up|16|||
27755530|NCT00377611|80932518|FG000|Overall Study|Other|0|||
27959848|NCT00603941|81686263|FG002|Overall Study|Disease progression|1|||
27959849|NCT00603941|81686261|FG000|Overall Study|Adverse Event|1|||
27959850|NCT00603941|81686262|FG001|Overall Study|Adverse Event|0|||
27561602|NCT01951157|80246025|FG000|Overall Study|Progressive Disease|12|||
27561603|NCT01951157|80246026|FG001|Overall Study|Progressive Disease|13|||
27755531|NCT00377611|80932519|FG001|Overall Study|Other|3|||
27755532|NCT01115738|80932522|FG000|Overall Study|Death|1|||
27755533|NCT01115738|80932523|FG001|Overall Study|Death|0|||
27755534|NCT01115738|80932524|FG002|Overall Study|Death|0|||
27959851|NCT00603941|81686263|FG002|Overall Study|Adverse Event|1|||
27959852|NCT00603941|81686261|FG000|Overall Study|Physician Decision|0|||
27959853|NCT00603941|81686262|FG001|Overall Study|Physician Decision|1|||
27755535|NCT01115738|80932522|FG000|Overall Study|Lost to Follow-up|0|||
27959854|NCT00603941|81686263|FG002|Overall Study|Physician Decision|0|||
27857688|NCT03375203|81314352|FG002|Overall Study|Protocol Violation|1|||
27755536|NCT01115738|80932523|FG001|Overall Study|Lost to Follow-up|0|||
27755537|NCT01115738|80932524|FG002|Overall Study|Lost to Follow-up|1|||
27755538|NCT01115738|80932522|FG000|Overall Study|Physician Decision|18|||
27755539|NCT01115738|80932523|FG001|Overall Study|Physician Decision|15|||
27755540|NCT01115738|80932524|FG002|Overall Study|Physician Decision|17|||
27755541|NCT01115738|80932522|FG000|Overall Study|Withdrawal by Subject|6|||
27755542|NCT01115738|80932523|FG001|Overall Study|Withdrawal by Subject|6|||
27857689|NCT03375203|81314353|FG003|Overall Study|Protocol Violation|0|||
27857690|NCT03375203|81314354|FG004|Overall Study|Protocol Violation|0|||
27857691|NCT03375203|81314350|FG000|Overall Study|Adverse Event|2|||
27857692|NCT03375203|81314351|FG001|Overall Study|Adverse Event|3|||
27857693|NCT03375203|81314352|FG002|Overall Study|Adverse Event|0|||
27857694|NCT03375203|81314353|FG003|Overall Study|Adverse Event|2|||
27857695|NCT03375203|81314354|FG004|Overall Study|Adverse Event|2|||
27857696|NCT03375203|81314350|FG000|Overall Study|Withdrawal by Subject|3|||
27857697|NCT03375203|81314351|FG001|Overall Study|Withdrawal by Subject|0|||
27857698|NCT03375203|81314352|FG002|Overall Study|Withdrawal by Subject|1|||
27857699|NCT03375203|81314353|FG003|Overall Study|Withdrawal by Subject|0|||
27857700|NCT03375203|81314354|FG004|Overall Study|Withdrawal by Subject|2|||
27857701|NCT03375203|81314350|FG000|Overall Study|Non-compliance with study drug|1|||
27857702|NCT03375203|81314351|FG001|Overall Study|Non-compliance with study drug|0|||
27857703|NCT03375203|81314352|FG002|Overall Study|Non-compliance with study drug|0|||
27857704|NCT03375203|81314353|FG003|Overall Study|Non-compliance with study drug|0|||
27857705|NCT03375203|81314354|FG004|Overall Study|Non-compliance with study drug|0|||
27857706|NCT03375203|81314350|FG000|Overall Study|Randomized, not treated.|0|||
27857707|NCT03375203|81314351|FG001|Overall Study|Randomized, not treated.|1|||
27857708|NCT03375203|81314352|FG002|Overall Study|Randomized, not treated.|0|||
27857709|NCT03375203|81314353|FG003|Overall Study|Randomized, not treated.|0|||
27857710|NCT03375203|81314354|FG004|Overall Study|Randomized, not treated.|0|||
27857711|NCT03151408|81314355|FG000|Overall Study|Adverse Event|24|||
27857712|NCT03151408|81314356|FG001|Overall Study|Adverse Event|23|||
27857713|NCT03151408|81314355|FG000|Overall Study|Death|46|||
27857714|NCT03151408|81314356|FG001|Overall Study|Death|26|||
27857715|NCT03151408|81314355|FG000|Overall Study|Physician Decision|13|||
27857716|NCT03151408|81314356|FG001|Overall Study|Physician Decision|19|||
27857717|NCT03151408|81314355|FG000|Overall Study|Withdrawal by Subject|16|||
27857718|NCT03151408|81314356|FG001|Overall Study|Withdrawal by Subject|20|||
27857719|NCT03151408|81314355|FG000|Overall Study|Progressive disease|45|||
27857720|NCT03151408|81314356|FG001|Overall Study|Progressive disease|61|||
27857721|NCT03151408|81314355|FG000|Overall Study|non-compliance by patient|1|||
27857722|NCT03151408|81314356|FG001|Overall Study|non-compliance by patient|0|||
27857723|NCT03151408|81314355|FG000|Overall Study|other reasons|56|||
27857724|NCT03151408|81314356|FG001|Overall Study|other reasons|52|||
27857725|NCT03151408|81314355|FG000|Overall Study|randomized and not treated|2|||
27857726|NCT03151408|81314356|FG001|Overall Study|randomized and not treated|2|||
27857727|NCT03052127|81314358|FG000|Overall Study|Withdrawal by Subject|0|||
27857728|NCT03052127|81314359|FG001|Overall Study|Withdrawal by Subject|0|||
27857729|NCT03052127|81314360|FG002|Overall Study|Withdrawal by Subject|0|||
27857730|NCT03052127|81314361|FG003|Overall Study|Withdrawal by Subject|0|||
27857731|NCT03052127|81314362|FG004|Overall Study|Withdrawal by Subject|0|||
27857732|NCT03052127|81314363|FG005|Overall Study|Withdrawal by Subject|0|||
27857733|NCT03052127|81314364|FG006|Overall Study|Withdrawal by Subject|0|||
27857734|NCT03052127|81314365|FG007|Overall Study|Withdrawal by Subject|1|||
27857735|NCT03052127|81314366|FG008|Overall Study|Withdrawal by Subject|1|||
27857736|NCT03052127|81314367|FG009|Overall Study|Withdrawal by Subject|1|||
27857737|NCT03052127|81314368|FG010|Overall Study|Withdrawal by Subject|0|||
27857738|NCT03052127|81314369|FG011|Overall Study|Withdrawal by Subject|0|||
27857739|NCT03052127|81314358|FG000|Overall Study|Discontinuation by Sponsor|0|||
27959855|NCT00603941|81686261|FG000|Overall Study|Withdrawal by Subject|0|||
27959856|NCT00603941|81686262|FG001|Overall Study|Withdrawal by Subject|2|||
27959857|NCT00603941|81686263|FG002|Overall Study|Withdrawal by Subject|0|||
27959858|NCT04466384|81686264|FG000|First Phase|Protocol Violation|1|||
27959859|NCT04466384|81686265|FG001|First Phase|Protocol Violation|0|||
27959860|NCT04466384|81686264|FG000|First Phase|Missing data|1|||
27959861|NCT04466384|81686265|FG001|First Phase|Missing data|0|||
27755543|NCT01115738|80932524|FG002|Overall Study|Withdrawal by Subject|9|||
27857740|NCT03052127|81314359|FG001|Overall Study|Discontinuation by Sponsor|0|||
27755544|NCT02554253|80932532|FG000|Overall Study|ineligible after enrollment|1|||
27857741|NCT03052127|81314360|FG002|Overall Study|Discontinuation by Sponsor|0|||
27857742|NCT03052127|81314361|FG003|Overall Study|Discontinuation by Sponsor|0|||
27857743|NCT03052127|81314362|FG004|Overall Study|Discontinuation by Sponsor|0|||
27857744|NCT03052127|81314363|FG005|Overall Study|Discontinuation by Sponsor|0|||
27857745|NCT03052127|81314364|FG006|Overall Study|Discontinuation by Sponsor|0|||
27857746|NCT03052127|81314365|FG007|Overall Study|Discontinuation by Sponsor|0|||
27857747|NCT03052127|81314366|FG008|Overall Study|Discontinuation by Sponsor|4|||
27857748|NCT03052127|81314367|FG009|Overall Study|Discontinuation by Sponsor|2|||
27857749|NCT03052127|81314368|FG010|Overall Study|Discontinuation by Sponsor|5|||
27857750|NCT03052127|81314369|FG011|Overall Study|Discontinuation by Sponsor|13|||
27857751|NCT03052127|81314358|FG000|Overall Study|Inability to comply with trial requirements|0|||
27857752|NCT03052127|81314359|FG001|Overall Study|Inability to comply with trial requirements|0|||
27857753|NCT03052127|81314360|FG002|Overall Study|Inability to comply with trial requirements|1|||
27857754|NCT03052127|81314361|FG003|Overall Study|Inability to comply with trial requirements|0|||
27857755|NCT03052127|81314362|FG004|Overall Study|Inability to comply with trial requirements|0|||
27959862|NCT04466384|81686264|FG000|Cross Over Phase|Physician Decision|1|||
27857756|NCT03052127|81314363|FG005|Overall Study|Inability to comply with trial requirements|0|||
27857757|NCT03052127|81314364|FG006|Overall Study|Inability to comply with trial requirements|0|||
27857758|NCT03052127|81314365|FG007|Overall Study|Inability to comply with trial requirements|0|||
27857759|NCT03052127|81314366|FG008|Overall Study|Inability to comply with trial requirements|0|||
27857760|NCT03052127|81314367|FG009|Overall Study|Inability to comply with trial requirements|0|||
27857761|NCT03052127|81314368|FG010|Overall Study|Inability to comply with trial requirements|0|||
27857762|NCT03052127|81314369|FG011|Overall Study|Inability to comply with trial requirements|0|||
27857763|NCT03052127|81314358|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
27857764|NCT03052127|81314359|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857765|NCT03052127|81314360|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857766|NCT03052127|81314361|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857767|NCT03052127|81314362|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
27959863|NCT04466384|81686265|FG001|Cross Over Phase|Physician Decision|0|||
27959864|NCT04466384|81686264|FG000|Cross Over Phase|Withdrawal by Subject|0|||
27959865|NCT04466384|81686265|FG001|Cross Over Phase|Withdrawal by Subject|1|||
27959866|NCT00041470|81686266|FG000|Overall Study|Loss of Funding|38|||
27857768|NCT03052127|81314363|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
27755545|NCT02554253|80932533|FG001|Overall Study|ineligible after enrollment|0|||
27755546|NCT02554253|80932532|FG000|Overall Study|converted to transcatheter procedure|0|||
27959867|NCT01890265|81686268|FG000|Overall Study|Other (Unspecified reason)|0|||
27959868|NCT01890265|81686269|FG001|Overall Study|Other (Unspecified reason)|1|||
27959869|NCT01890265|81686270|FG002|Overall Study|Other (Unspecified reason)|0|||
27959870|NCT01890265|81686271|FG003|Overall Study|Other (Unspecified reason)|0|||
27959871|NCT01890265|81686272|FG004|Overall Study|Other (Unspecified reason)|0|||
27959872|NCT01890265|81686273|FG005|Overall Study|Other (Unspecified reason)|0|||
27959873|NCT01890265|81686268|FG000|Overall Study|Progressive disease|6|||
27959874|NCT01890265|81686269|FG001|Overall Study|Progressive disease|6|||
27959875|NCT01890265|81686270|FG002|Overall Study|Progressive disease|0|||
27959876|NCT01890265|81686271|FG003|Overall Study|Progressive disease|0|||
27959877|NCT01890265|81686272|FG004|Overall Study|Progressive disease|0|||
27959878|NCT01890265|81686273|FG005|Overall Study|Progressive disease|0|||
27959879|NCT01890265|81686268|FG000|Overall Study|Adverse Event|2|||
27959880|NCT01890265|81686269|FG001|Overall Study|Adverse Event|1|||
27959881|NCT01890265|81686270|FG002|Overall Study|Adverse Event|0|||
27959882|NCT01890265|81686271|FG003|Overall Study|Adverse Event|0|||
27959883|NCT01890265|81686272|FG004|Overall Study|Adverse Event|0|||
27959884|NCT01890265|81686273|FG005|Overall Study|Adverse Event|0|||
27959885|NCT01890265|81686268|FG000|Overall Study|Death|2|||
27959886|NCT01890265|81686269|FG001|Overall Study|Death|3|||
27959887|NCT01890265|81686270|FG002|Overall Study|Death|1|||
27755547|NCT02554253|80932533|FG001|Overall Study|converted to transcatheter procedure|1|||
27755548|NCT02554253|80932532|FG000|Overall Study|received both drugs|0|||
27755549|NCT02554253|80932533|FG001|Overall Study|received both drugs|1|||
27755550|NCT04504032|80932536|FG000|Overall Study|Adverse Event|1|||
27755551|NCT04504032|80932537|FG001|Overall Study|Adverse Event|2|||
27755552|NCT04504032|80932536|FG000|Overall Study|Lost to Follow-up|6|||
27755553|NCT04504032|80932537|FG001|Overall Study|Lost to Follow-up|9|||
27755554|NCT04504032|80932536|FG000|Overall Study|Protocol Violation|2|||
27959888|NCT01890265|81686271|FG003|Overall Study|Death|0|||
27755555|NCT04504032|80932537|FG001|Overall Study|Protocol Violation|0|||
27755556|NCT04504032|80932536|FG000|Overall Study|Study terminated by sponsor|1|||
27857769|NCT03052127|81314364|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
27959889|NCT01890265|81686272|FG004|Overall Study|Death|0|||
27959890|NCT01890265|81686273|FG005|Overall Study|Death|0|||
27886596|NCT01435018|81418121|FG001|Overall Study|Site is closing|9|||
27959891|NCT01890265|81686268|FG000|Overall Study|Withdrawal by Subject|0|||
27959892|NCT01890265|81686269|FG001|Overall Study|Withdrawal by Subject|2|||
27959893|NCT01890265|81686270|FG002|Overall Study|Withdrawal by Subject|3|||
27959894|NCT01890265|81686271|FG003|Overall Study|Withdrawal by Subject|0|||
27755557|NCT04504032|80932537|FG001|Overall Study|Study terminated by sponsor|2|||
27959895|NCT01890265|81686272|FG004|Overall Study|Withdrawal by Subject|2|||
27959896|NCT01890265|81686273|FG005|Overall Study|Withdrawal by Subject|0|||
27959897|NCT00809926|81686274|FG000|Overall Study|Adverse Event|18|||
27755558|NCT04504032|80932536|FG000|Overall Study|Withdrawal by Subject|9|||
27755559|NCT04504032|80932537|FG001|Overall Study|Withdrawal by Subject|11|||
27857770|NCT03052127|81314365|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857771|NCT03052127|81314366|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857772|NCT03052127|81314367|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857773|NCT03052127|81314368|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857774|NCT03052127|81314369|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
27857775|NCT02325518|81314376|FG000|Overall Study|Adverse Event|4|||
27857776|NCT02325518|81314377|FG001|Overall Study|Adverse Event|1|||
27857777|NCT02325518|81314376|FG000|Overall Study|Physician Decision|0|||
27857778|NCT02325518|81314377|FG001|Overall Study|Physician Decision|1|||
27857779|NCT02325518|81314376|FG000|Overall Study|Withdrawal by Subject|0|||
27857780|NCT02325518|81314377|FG001|Overall Study|Withdrawal by Subject|1|||
27857781|NCT00619112|81314383|FG000|Overall Study|Adverse Event|1|||
27857782|NCT00619112|81314384|FG001|Overall Study|Adverse Event|2|||
27959898|NCT00809926|81686275|FG001|Overall Study|Adverse Event|10|||
27857783|NCT00699374|81314387|FG000|Overall Study|Death|93|||
27857784|NCT00699374|81314388|FG001|Overall Study|Death|83|||
27857785|NCT00699374|81314387|FG000|Overall Study|Adverse Event|70|||
27857786|NCT00699374|81314388|FG001|Overall Study|Adverse Event|67|||
27959899|NCT00809926|81686274|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27959900|NCT00809926|81686275|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27959901|NCT00809926|81686274|FG000|Overall Study|Patient withdrew consent|8|||
27959902|NCT00809926|81686275|FG001|Overall Study|Patient withdrew consent|6|||
27959903|NCT00809926|81686274|FG000|Overall Study|Lost to Follow-up|2|||
27959904|NCT00809926|81686275|FG001|Overall Study|Lost to Follow-up|1|||
27959905|NCT00809926|81686274|FG000|Overall Study|Administrative Problems|0|||
27959906|NCT00809926|81686275|FG001|Overall Study|Administrative Problems|1|||
27959907|NCT00809926|81686274|FG000|Overall Study|Protocol deviation|0|||
27959908|NCT00809926|81686275|FG001|Overall Study|Protocol deviation|2|||
27959909|NCT00251693|81686281|FG000|Overall Study|Adverse Event|17|||
27959910|NCT00251693|81686282|FG001|Overall Study|Adverse Event|9|||
27959911|NCT00251693|81686283|FG002|Overall Study|Adverse Event|9|||
27959912|NCT00251693|81686281|FG000|Overall Study|Protocol Violation|2|||
27959913|NCT00251693|81686282|FG001|Overall Study|Protocol Violation|0|||
27959914|NCT00251693|81686283|FG002|Overall Study|Protocol Violation|2|||
27959915|NCT00251693|81686281|FG000|Overall Study|Lost to Follow-up|12|||
27959916|NCT00251693|81686282|FG001|Overall Study|Lost to Follow-up|7|||
27959917|NCT00251693|81686283|FG002|Overall Study|Lost to Follow-up|8|||
27959918|NCT00251693|81686281|FG000|Overall Study|Withdrawal by Subject|11|||
27561604|NCT01951157|80246027|FG002|Overall Study|Progressive Disease|10|||
27561605|NCT01951157|80246025|FG000|Overall Study|Treatment-unrelated AE|1|||
27561606|NCT01951157|80246026|FG001|Overall Study|Treatment-unrelated AE|0|||
27561607|NCT01951157|80246027|FG002|Overall Study|Treatment-unrelated AE|3|||
27561608|NCT01951157|80246025|FG000|Overall Study|Study Termination|0|||
27561609|NCT01951157|80246026|FG001|Overall Study|Study Termination|0|||
27561610|NCT01951157|80246027|FG002|Overall Study|Study Termination|1|||
27561611|NCT01951157|80246025|FG000|Overall Study|Physician Decision|5|||
27561612|NCT01951157|80246026|FG001|Overall Study|Physician Decision|3|||
27561613|NCT01951157|80246027|FG002|Overall Study|Physician Decision|2|||
27561614|NCT01951157|80246025|FG000|Overall Study|Non-treatmentrelated death|2|||
27561615|NCT01951157|80246026|FG001|Overall Study|Non-treatmentrelated death|2|||
27561616|NCT01951157|80246027|FG002|Overall Study|Non-treatmentrelated death|2|||
27561617|NCT01951157|80246025|FG000|Overall Study|No treated|0|||
27561618|NCT01951157|80246026|FG001|Overall Study|No treated|1|||
27561619|NCT01951157|80246027|FG002|Overall Study|No treated|0|||
27561620|NCT01951157|80246025|FG000|Overall Study|Treatment-related AE|2|||
27561621|NCT01951157|80246026|FG001|Overall Study|Treatment-related AE|0|||
27561622|NCT01951157|80246027|FG002|Overall Study|Treatment-related AE|4|||
27561623|NCT01951157|80246025|FG000|Overall Study|Consent withdrawn by subject|0|||
27561624|NCT01951157|80246026|FG001|Overall Study|Consent withdrawn by subject|1|||
27561625|NCT01951157|80246027|FG002|Overall Study|Consent withdrawn by subject|3|||
27561626|NCT01951157|80246025|FG000|Overall Study|Treatment-related death|0|||
27561627|NCT01951157|80246026|FG001|Overall Study|Treatment-related death|2|||
27561628|NCT01951157|80246027|FG002|Overall Study|Treatment-related death|0|||
27561629|NCT00613015|80246028|FG000|Overall Study|Lost to Follow-up|0|||
27561630|NCT00613015|80246029|FG001|Overall Study|Lost to Follow-up|1|||
27755560|NCT04504032|80932536|FG000|Overall Study|Disease progression prior to dosing|15|||
27755561|NCT04504032|80932537|FG001|Overall Study|Disease progression prior to dosing|3|||
27561631|NCT00613015|80246030|FG002|Overall Study|Lost to Follow-up|3|||
27561632|NCT00613015|80246031|FG003|Overall Study|Lost to Follow-up|3|||
27561633|NCT00613015|80246032|FG004|Overall Study|Lost to Follow-up|2|||
27561634|NCT00613015|80246033|FG005|Overall Study|Lost to Follow-up|3|||
27857787|NCT00699374|81314387|FG000|Overall Study|Global deterioration of health status|7|||
27959919|NCT00251693|81686282|FG001|Overall Study|Withdrawal by Subject|17|||
27561635|NCT03082599|80246034|FG000|Overall Study|Lost to Follow-up|1|||
27561636|NCT03082599|80246035|FG001|Overall Study|Lost to Follow-up|0|||
27857788|NCT00699374|81314388|FG001|Overall Study|Global deterioration of health status|8|||
27959920|NCT00251693|81686283|FG002|Overall Study|Withdrawal by Subject|14|||
27561637|NCT02066467|80246036|FG000|Overall Study|Did not undergo implant procedure|24|||
27561638|NCT02066467|80246036|FG000|Overall Study|Attempted to implant withoput success|43|||
27561639|NCT02066467|80246036|FG000|Overall Study|Consent ineligible|1|||
27561640|NCT02066467|80246036|FG000|Overall Study|Death|54|||
27561641|NCT02066467|80246036|FG000|Overall Study|Lost to Follow-up|51|||
27561642|NCT02066467|80246036|FG000|Overall Study|Adverse Event|20|||
27561643|NCT02066467|80246036|FG000|Overall Study|Withdrawal by Subject|16|||
27561644|NCT02066467|80246036|FG000|Overall Study|Physician Decision|2|||
27561645|NCT02066467|80246036|FG000|Overall Study|Not defined|4|||
27561646|NCT00982488|80246037|FG000|Overall Study|Administrative reason by sponsor|81|||
27561647|NCT00982488|80246038|FG001|Overall Study|Administrative reason by sponsor|3|||
27561648|NCT00982488|80246039|FG002|Overall Study|Administrative reason by sponsor|11|||
27561649|NCT00982488|80246040|FG003|Overall Study|Administrative reason by sponsor|0|||
27561650|NCT00982488|80246041|FG004|Overall Study|Administrative reason by sponsor|0|||
27561651|NCT00982488|80246037|FG000|Overall Study|Adverse event unrelated to study drug|5|||
27561652|NCT00982488|80246038|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27561653|NCT00982488|80246039|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27561654|NCT00982488|80246040|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27561655|NCT00982488|80246041|FG004|Overall Study|Adverse event unrelated to study drug|0|||
27857789|NCT00699374|81314387|FG000|Overall Study|Lost to Follow-up|3|||
27857790|NCT00699374|81314388|FG001|Overall Study|Lost to Follow-up|5|||
27959921|NCT00251693|81686281|FG000|Overall Study|Lack of Efficacy|0|||
27959922|NCT00251693|81686282|FG001|Overall Study|Lack of Efficacy|1|||
27959923|NCT00251693|81686283|FG002|Overall Study|Lack of Efficacy|0|||
27959924|NCT00251693|81686281|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
27959925|NCT00251693|81686282|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
27959926|NCT00251693|81686283|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
27959927|NCT00251693|81686281|FG000|Overall Study|Noncompliant|0|||
27959928|NCT00251693|81686282|FG001|Overall Study|Noncompliant|0|||
27959929|NCT00251693|81686283|FG002|Overall Study|Noncompliant|2|||
27959930|NCT00251693|81686281|FG000|Overall Study|Possible Barrett's esophagus|3|||
27959931|NCT00251693|81686282|FG001|Overall Study|Possible Barrett's esophagus|5|||
27959932|NCT00251693|81686283|FG002|Overall Study|Possible Barrett's esophagus|2|||
27959933|NCT00251693|81686281|FG000|Overall Study|Subject request/subject unavailable|1|||
27959934|NCT00251693|81686282|FG001|Overall Study|Subject request/subject unavailable|2|||
27959935|NCT00251693|81686283|FG002|Overall Study|Subject request/subject unavailable|0|||
27959936|NCT00251693|81686281|FG000|Overall Study|Abnormal laboratory findings|0|||
27959937|NCT00251693|81686282|FG001|Overall Study|Abnormal laboratory findings|0|||
27959938|NCT00251693|81686283|FG002|Overall Study|Abnormal laboratory findings|1|||
27959939|NCT02544750|81686285|FG000|Overall Study|Physician Decision|3|||
27959940|NCT02544750|81686286|FG001|Overall Study|Physician Decision|1|||
27959941|NCT02544750|81686285|FG000|Overall Study|Other reasons|69|||
27959942|NCT02544750|81686286|FG001|Overall Study|Other reasons|39|||
27959943|NCT02544750|81686285|FG000|Overall Study|Met withdrawal criteria|2|||
27959944|NCT02544750|81686286|FG001|Overall Study|Met withdrawal criteria|2|||
27959945|NCT02544750|81686285|FG000|Overall Study|Transition To Commercial Product|1|||
27959946|NCT02544750|81686286|FG001|Overall Study|Transition To Commercial Product|0|||
27959947|NCT02544750|81686285|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
27959948|NCT02544750|81686286|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
27959949|NCT02544750|81686285|FG000|Overall Study|Adverse Event|8|||
27959950|NCT02544750|81686286|FG001|Overall Study|Adverse Event|10|||
27959951|NCT02544750|81686285|FG000|Overall Study|Withdrawal by Subject|10|||
27959952|NCT02544750|81686286|FG001|Overall Study|Withdrawal by Subject|4|||
27959953|NCT02544750|81686285|FG000|Overall Study|Lost to Follow-up|1|||
27959954|NCT02544750|81686286|FG001|Overall Study|Lost to Follow-up|0|||
27959955|NCT00383331|81686287|FG000|Overall Study|Protocol Violation|0|||
27561656|NCT00982488|80246037|FG000|Overall Study|Death|11|||
27561657|NCT00982488|80246038|FG001|Overall Study|Death|0|||
27561658|NCT00982488|80246039|FG002|Overall Study|Death|2|||
27561659|NCT00982488|80246040|FG003|Overall Study|Death|0|||
27561660|NCT00982488|80246041|FG004|Overall Study|Death|0|||
27561661|NCT00982488|80246037|FG000|Overall Study|Disease progression|30|||
27959956|NCT00383331|81686288|FG001|Overall Study|Protocol Violation|1|||
27959957|NCT00049257|81686291|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
27959958|NCT00049257|81686291|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
27959959|NCT00049257|81686291|FG000|Carboplatin, Paclitaxel|Death|2|||
27959960|NCT00049257|81686291|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
27959961|NCT00402324|81686292|FG000|Overall Study|Lost to Follow-up|11|||
27959962|NCT00402324|81686293|FG001|Overall Study|Lost to Follow-up|11|||
27959963|NCT00402324|81686292|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
27561662|NCT00982488|80246038|FG001|Overall Study|Disease progression|5|||
27561663|NCT00982488|80246039|FG002|Overall Study|Disease progression|10|||
27561664|NCT00982488|80246040|FG003|Overall Study|Disease progression|1|||
27561665|NCT00982488|80246041|FG004|Overall Study|Disease progression|1|||
27959964|NCT00402324|81686293|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
27959965|NCT00402324|81686292|FG000|Overall Study|Protocol Violation|8|||
27959966|NCT00402324|81686293|FG001|Overall Study|Protocol Violation|7|||
27959967|NCT00402324|81686292|FG000|Overall Study|Withdrawal by Subject|5|||
27959968|NCT00402324|81686293|FG001|Overall Study|Withdrawal by Subject|2|||
27959969|NCT00402324|81686292|FG000|Overall Study|Physician Decision|2|||
27959970|NCT00402324|81686293|FG001|Overall Study|Physician Decision|4|||
27959971|NCT00402324|81686292|FG000|Overall Study|Sponsor Decision|4|||
27959972|NCT00402324|81686293|FG001|Overall Study|Sponsor Decision|5|||
27959973|NCT00402324|81686292|FG000|Overall Study|Lack of Efficacy|1|||
27959974|NCT00402324|81686293|FG001|Overall Study|Lack of Efficacy|4|||
27959975|NCT00402324|81686292|FG000|Overall Study|Adverse Event|6|||
27959976|NCT00402324|81686293|FG001|Overall Study|Adverse Event|4|||
27959977|NCT00402324|81686292|FG000|Overall Study|Death|1|||
27959978|NCT00402324|81686293|FG001|Overall Study|Death|0|||
27857791|NCT00699374|81314387|FG000|Overall Study|Withdrawal by Subject|34|||
27857792|NCT00699374|81314388|FG001|Overall Study|Withdrawal by Subject|44|||
27755562|NCT04504032|80932536|FG000|Overall Study|Drug supply issues|1|||
27755563|NCT04504032|80932537|FG001|Overall Study|Drug supply issues|1|||
27755564|NCT04504032|80932536|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
27755565|NCT04504032|80932537|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
27755566|NCT00772382|80932538|FG000|Overall Study|Adverse Event|19|||
27755567|NCT00772382|80932538|FG000|Overall Study|Death|6|||
27755568|NCT00772382|80932538|FG000|Overall Study|Lack of Efficacy|4|||
27755569|NCT00772382|80932538|FG000|Overall Study|Physician Decision|5|||
27755570|NCT00772382|80932538|FG000|Overall Study|Protocol Violation|1|||
27959979|NCT01881009|81686294|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
27755571|NCT00772382|80932538|FG000|Overall Study|Withdrawal by Subject|10|||
27959980|NCT01881009|81686295|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
27959981|NCT02141672|81686299|FG000|Overall Study|Adverse Event|0|||
27959982|NCT02141672|81686300|FG001|Overall Study|Adverse Event|1|||
27959983|NCT02141672|81686301|FG002|Overall Study|Adverse Event|0|||
27959984|NCT02141672|81686299|FG000|Overall Study|Death|10|||
27959985|NCT02141672|81686300|FG001|Overall Study|Death|2|||
27959986|NCT02141672|81686301|FG002|Overall Study|Death|1|||
27959987|NCT02141672|81686299|FG000|Overall Study|Lack of Efficacy|0|||
27959988|NCT02141672|81686300|FG001|Overall Study|Lack of Efficacy|0|||
27959989|NCT02141672|81686301|FG002|Overall Study|Lack of Efficacy|2|||
27959990|NCT02141672|81686299|FG000|Overall Study|Lost to Follow-up|1|||
27959991|NCT02141672|81686300|FG001|Overall Study|Lost to Follow-up|1|||
27959992|NCT02141672|81686301|FG002|Overall Study|Lost to Follow-up|3|||
27959993|NCT02141672|81686299|FG000|Overall Study|Physician Decision|1|||
27959994|NCT02141672|81686300|FG001|Overall Study|Physician Decision|2|||
27857793|NCT00699374|81314387|FG000|Overall Study|Objective progression or relapse|281|||
27857794|NCT00699374|81314388|FG001|Overall Study|Objective progression or relapse|277|||
27857795|NCT00699374|81314387|FG000|Overall Study|Other|18|||
27857796|NCT00699374|81314388|FG001|Overall Study|Other|15|||
27755572|NCT00772382|80932538|FG000|Overall Study|Other Reasons|10|||
27755573|NCT03198754|80932546|FG000|Overall Study|Withdrawal by Subject|5|||
27755574|NCT03198754|80932547|FG001|Overall Study|Withdrawal by Subject|4|||
27959995|NCT02141672|81686301|FG002|Overall Study|Physician Decision|5|||
27959996|NCT02141672|81686299|FG000|Overall Study|Protocol Violation|0|||
27959997|NCT02141672|81686300|FG001|Overall Study|Protocol Violation|0|||
27959998|NCT02141672|81686301|FG002|Overall Study|Protocol Violation|1|||
27959999|NCT02141672|81686299|FG000|Overall Study|Withdrawal by Subject|3|||
27755575|NCT03198754|80932546|FG000|Overall Study|Lost to Follow-up|4|||
27755576|NCT03198754|80932547|FG001|Overall Study|Lost to Follow-up|3|||
27755577|NCT03198754|80932546|FG000|Overall Study|Ineligible|2|||
27755578|NCT03198754|80932547|FG001|Overall Study|Ineligible|1|||
27755579|NCT01208038|80932548|FG000|Overall Study|Withdrawal by Subject|1|||
27755580|NCT03136367|80932549|FG000|T1 Consultation|discontinued mistakenly included|2|||
27755581|NCT03136367|80932550|FG001|T1 Consultation|discontinued mistakenly included|6|||
27755582|NCT03136367|80932551|FG002|T1 Consultation|discontinued mistakenly included|1|||
27755583|NCT03136367|80932549|FG000|T1 Consultation|Discontinued other|0|||
27960000|NCT02141672|81686300|FG001|Overall Study|Withdrawal by Subject|2|||
27960001|NCT02141672|81686301|FG002|Overall Study|Withdrawal by Subject|5|||
27755584|NCT03136367|80932550|FG001|T1 Consultation|Discontinued other|1|||
27960002|NCT02141672|81686299|FG000|Overall Study|refused to follow-up|1|||
27960003|NCT02141672|81686300|FG001|Overall Study|refused to follow-up|0|||
27960004|NCT02141672|81686301|FG002|Overall Study|refused to follow-up|1|||
27960005|NCT02725476|81686303|FG000|Overall Study|Physician Decision|2|||
27960006|NCT02725476|81686304|FG001|Overall Study|Physician Decision|0|||
27755585|NCT03136367|80932551|FG002|T1 Consultation|Discontinued other|0|||
27960007|NCT02725476|81686303|FG000|Overall Study|Adverse Event|1|||
27857797|NCT00699374|81314387|FG000|Overall Study|Protocol Violation|2|||
27857798|NCT00699374|81314388|FG001|Overall Study|Protocol Violation|6|||
27857799|NCT00699374|81314387|FG000|Overall Study|Study terminated by sponsor|13|||
27960008|NCT02725476|81686304|FG001|Overall Study|Adverse Event|1|||
27960009|NCT02063984|81686305|FG000|Overall Study|Lost to Follow-up|6|||
27960010|NCT02063984|81686306|FG001|Overall Study|Lost to Follow-up|5|||
27960011|NCT01119066|81686309|FG000|Overall Study|Withdrawal by Subject|4|||
27960012|NCT01119066|81686310|FG001|Overall Study|Withdrawal by Subject|6|||
27960013|NCT01119066|81686311|FG002|Overall Study|Withdrawal by Subject|0|||
27960014|NCT01119066|81686312|FG003|Overall Study|Withdrawal by Subject|0|||
27960015|NCT01119066|81686309|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
27960016|NCT01119066|81686310|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
27755586|NCT03136367|80932549|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
27755587|NCT03136367|80932550|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
27755588|NCT03136367|80932551|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
27755589|NCT03136367|80932549|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
27755590|NCT03136367|80932550|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
27857800|NCT00699374|81314388|FG001|Overall Study|Study terminated by sponsor|28|||
27857801|NCT00699374|81314387|FG000|Overall Study|Randomized but not treated|4|||
27960017|NCT01119066|81686311|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
27755591|NCT03136367|80932551|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
27755592|NCT03136367|80932549|FG000|T2 Post-consultation|Discontinued other|0|||
27755593|NCT03136367|80932550|FG001|T2 Post-consultation|Discontinued other|2|||
27755594|NCT03136367|80932551|FG002|T2 Post-consultation|Discontinued other|6|||
27755595|NCT03136367|80932549|FG000|T2 Post-consultation|Discontinued transferred care|0|||
27960018|NCT01119066|81686312|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
27960019|NCT01119066|81686309|FG000|Overall Study|Relapse identified before transplant|1|||
27960020|NCT01119066|81686310|FG001|Overall Study|Relapse identified before transplant|0|||
27960021|NCT01119066|81686311|FG002|Overall Study|Relapse identified before transplant|0|||
27960022|NCT01119066|81686312|FG003|Overall Study|Relapse identified before transplant|0|||
27960023|NCT01119066|81686309|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
27960024|NCT01119066|81686310|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
27960025|NCT01119066|81686311|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
27960026|NCT01119066|81686312|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
27561666|NCT00982488|80246037|FG000|Overall Study|Lost to Follow-up|1|||
27561667|NCT00982488|80246038|FG001|Overall Study|Lost to Follow-up|0|||
27561668|NCT00982488|80246039|FG002|Overall Study|Lost to Follow-up|0|||
27561669|NCT00982488|80246040|FG003|Overall Study|Lost to Follow-up|0|||
27561670|NCT00982488|80246041|FG004|Overall Study|Lost to Follow-up|0|||
27561671|NCT00982488|80246037|FG000|Overall Study|Maximum clinical benefit|1|||
27561672|NCT00982488|80246038|FG001|Overall Study|Maximum clinical benefit|1|||
27561673|NCT00982488|80246039|FG002|Overall Study|Maximum clinical benefit|1|||
27561674|NCT00982488|80246040|FG003|Overall Study|Maximum clinical benefit|0|||
27561675|NCT00982488|80246041|FG004|Overall Study|Maximum clinical benefit|0|||
27561676|NCT00982488|80246037|FG000|Overall Study|Other|15|||
27561677|NCT00982488|80246038|FG001|Overall Study|Other|1|||
27561678|NCT00982488|80246039|FG002|Overall Study|Other|3|||
27561679|NCT00982488|80246040|FG003|Overall Study|Other|1|||
27561680|NCT00982488|80246041|FG004|Overall Study|Other|0|||
27561681|NCT00982488|80246037|FG000|Overall Study|Poor compliance/noncompliance|0|||
27561682|NCT00982488|80246038|FG001|Overall Study|Poor compliance/noncompliance|1|||
27561683|NCT00982488|80246039|FG002|Overall Study|Poor compliance/noncompliance|0|||
27561684|NCT00982488|80246040|FG003|Overall Study|Poor compliance/noncompliance|0|||
27561685|NCT00982488|80246041|FG004|Overall Study|Poor compliance/noncompliance|0|||
27561686|NCT00982488|80246037|FG000|Overall Study|Stem cell transplant|2|||
27561687|NCT00982488|80246038|FG001|Overall Study|Stem cell transplant|0|||
27561688|NCT00982488|80246039|FG002|Overall Study|Stem cell transplant|0|||
27561689|NCT00982488|80246040|FG003|Overall Study|Stem cell transplant|1|||
27960027|NCT01119066|81686309|FG000|Overall Study|Relapse identified before transplant|0|||
27960028|NCT01119066|81686310|FG001|Overall Study|Relapse identified before transplant|4|||
27960029|NCT01119066|81686311|FG002|Overall Study|Relapse identified before transplant|0|||
27755596|NCT03136367|80932550|FG001|T2 Post-consultation|Discontinued transferred care|0|||
27755597|NCT03136367|80932551|FG002|T2 Post-consultation|Discontinued transferred care|3|||
27755598|NCT03136367|80932549|FG000|T2 Post-consultation|Discontinued lost contact|0|||
27755599|NCT03136367|80932550|FG001|T2 Post-consultation|Discontinued lost contact|1|||
27755600|NCT03136367|80932551|FG002|T2 Post-consultation|Discontinued lost contact|0|||
27755601|NCT03136367|80932549|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
27561690|NCT00982488|80246041|FG004|Overall Study|Stem cell transplant|0|||
27755602|NCT03136367|80932550|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
27561691|NCT00982488|80246037|FG000|Overall Study|Study drug toxicity|34|||
27561692|NCT00982488|80246038|FG001|Overall Study|Study drug toxicity|1|||
27561693|NCT00982488|80246039|FG002|Overall Study|Study drug toxicity|6|||
27561694|NCT00982488|80246040|FG003|Overall Study|Study drug toxicity|0|||
27561695|NCT00982488|80246041|FG004|Overall Study|Study drug toxicity|0|||
27561696|NCT00982488|80246037|FG000|Overall Study|Withdrawal by Subject|5|||
27755603|NCT03136367|80932551|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
27755604|NCT03136367|80932549|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
27561697|NCT00982488|80246038|FG001|Overall Study|Withdrawal by Subject|1|||
27561698|NCT00982488|80246039|FG002|Overall Study|Withdrawal by Subject|1|||
27561699|NCT00982488|80246040|FG003|Overall Study|Withdrawal by Subject|0|||
27561700|NCT00982488|80246041|FG004|Overall Study|Withdrawal by Subject|0|||
27561701|NCT02762266|80246042|FG000|Overall Study|Physician Decision|2|||
27561702|NCT02762266|80246043|FG001|Overall Study|Physician Decision|0|||
27561703|NCT00228917|80246044|FG000|Overall Study|Migrated/moved from study area|0|||
27561704|NCT00228917|80246045|FG001|Overall Study|Migrated/moved from study area|0|||
27561705|NCT00228917|80246046|FG002|Overall Study|Migrated/moved from study area|0|||
27561706|NCT00228917|80246047|FG003|Overall Study|Migrated/moved from study area|0|||
27561707|NCT00228917|80246048|FG004|Overall Study|Migrated/moved from study area|0|||
27561708|NCT00228917|80246049|FG005|Overall Study|Migrated/moved from study area|2|||
27561709|NCT00228917|80246050|FG006|Overall Study|Migrated/moved from study area|0|||
27561710|NCT00228917|80246051|FG007|Overall Study|Migrated/moved from study area|0|||
27561711|NCT03683758|80246054|FG000|Overall Study|Non-study commitment conflict|1|||
27561712|NCT03683758|80246055|FG001|Overall Study|Non-study commitment conflict|3|||
27561713|NCT03683758|80246054|FG000|Overall Study|Illness preventing participation|1|||
27561714|NCT03683758|80246055|FG001|Overall Study|Illness preventing participation|0|||
27561715|NCT03683758|80246054|FG000|Overall Study|Adverse Event|1|||
27561716|NCT03683758|80246055|FG001|Overall Study|Adverse Event|0|||
27561717|NCT03060447|80246056|FG000|Overall Study|Withdrawal by Subject|2|||
27561718|NCT03060447|80246057|FG001|Overall Study|Withdrawal by Subject|0|||
27561719|NCT02406651|80246059|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
27561720|NCT03287804|80246060|FG000|Overall Study|Death|1|||
27561721|NCT03287804|80246060|FG000|Overall Study|Physician Decision|2|||
27561722|NCT03287804|80246060|FG000|Overall Study|Progressive disease|8|||
27561723|NCT01077804|80246063|FG000|Overall Study|Unreachable|102|||
27561724|NCT01077804|80246063|FG000|Overall Study|Refused to continue|79|||
27561725|NCT01077804|80246063|FG000|Overall Study|Other|18|||
27561726|NCT01998737|80246070|FG000|Overall Study|Corrupted database|23|||
27561727|NCT01998737|80246071|FG001|Overall Study|Corrupted database|0|||
27561728|NCT00741039|80246072|FG000|Overall Study|Patient non-compliance|2|||
27561729|NCT00741039|80246073|FG001|Overall Study|Patient non-compliance|0|||
27561730|NCT05778786|80246074|FG000|Period 1|COVID-19 Related|3|||
27561731|NCT05778786|80246075|FG001|Period 1|COVID-19 Related|3|||
27561732|NCT05778786|80246074|FG000|Period 1|Withdrew Consent during Study|1|||
27561733|NCT05778786|80246075|FG001|Period 1|Withdrew Consent during Study|0|||
27561734|NCT05778786|80246074|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
27561735|NCT05778786|80246075|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
27561736|NCT05778786|80246074|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
27561737|NCT05778786|80246075|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
27561738|NCT01465022|80246079|FG000|Overall Study|Lost to Follow-up|15|||
27561739|NCT01465022|80246080|FG001|Overall Study|Lost to Follow-up|14|||
27561740|NCT01465022|80246081|FG002|Overall Study|Lost to Follow-up|0|||
27561741|NCT01465022|80246079|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
27561742|NCT01465022|80246080|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
27561743|NCT01465022|80246081|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
27561744|NCT01465022|80246079|FG000|Overall Study|Not Randomized|0|||
27561745|NCT01465022|80246080|FG001|Overall Study|Not Randomized|0|||
27561746|NCT01465022|80246081|FG002|Overall Study|Not Randomized|70|||
27561747|NCT01475331|80246082|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
27561748|NCT01475331|80246083|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
27561749|NCT01475331|80246082|FG000|Overall Study|excessive main duct communication|1|||
27561750|NCT01475331|80246083|FG001|Overall Study|excessive main duct communication|1|||
27561751|NCT01475331|80246082|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
27561752|NCT01475331|80246083|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
27561753|NCT01475331|80246082|FG000|Overall Study|Sign of malignancy during the procedure|2|||
27561754|NCT01475331|80246083|FG001|Overall Study|Sign of malignancy during the procedure|0|||
27561755|NCT01475331|80246082|FG000|Overall Study|cyst found to be prohibitively small|0|||
27561756|NCT01475331|80246083|FG001|Overall Study|cyst found to be prohibitively small|1|||
27561757|NCT00481195|80246084|FG000|Overall Study|Adverse Event|16|||
27561758|NCT00481195|80246085|FG001|Overall Study|Adverse Event|11|||
27561759|NCT00481195|80246084|FG000|Overall Study|Lack of Efficacy|1|||
27561760|NCT00481195|80246085|FG001|Overall Study|Lack of Efficacy|3|||
27561761|NCT00481195|80246084|FG000|Overall Study|Lost to Follow-up|4|||
27561762|NCT00481195|80246085|FG001|Overall Study|Lost to Follow-up|6|||
27561763|NCT00481195|80246084|FG000|Overall Study|Physician Decision|3|||
27561764|NCT00481195|80246085|FG001|Overall Study|Physician Decision|1|||
27561765|NCT00481195|80246084|FG000|Overall Study|Protocol Violation|10|||
27561766|NCT00481195|80246085|FG001|Overall Study|Protocol Violation|7|||
27561767|NCT00481195|80246084|FG000|Overall Study|Withdrawal by Subject|3|||
27561768|NCT00481195|80246085|FG001|Overall Study|Withdrawal by Subject|9|||
27561769|NCT00481195|80246084|FG000|Overall Study|Miscellaneous|2|||
27561770|NCT00481195|80246085|FG001|Overall Study|Miscellaneous|2|||
27561771|NCT00256698|80246086|FG000|Overall Study|Withdrawal by Subject|7|||
27561772|NCT00256698|80246087|FG001|Overall Study|Withdrawal by Subject|7|||
27960030|NCT01119066|81686312|FG003|Overall Study|Relapse identified before transplant|0|||
27960031|NCT01118780|81686313|FG000|Overall Study|Adverse Event|15|||
27960032|NCT01118780|81686314|FG001|Overall Study|Adverse Event|15|||
27960033|NCT01118780|81686313|FG000|Overall Study|Death|1|||
27960034|NCT01118780|81686314|FG001|Overall Study|Death|0|||
27960035|NCT01118780|81686313|FG000|Overall Study|Lack of Efficacy|2|||
27960036|NCT01118780|81686314|FG001|Overall Study|Lack of Efficacy|6|||
27960037|NCT01118780|81686313|FG000|Overall Study|Physician Decision|2|||
27960038|NCT01118780|81686314|FG001|Overall Study|Physician Decision|0|||
27960039|NCT01118780|81686313|FG000|Overall Study|Protocol Violation|3|||
27960040|NCT01118780|81686314|FG001|Overall Study|Protocol Violation|6|||
27960041|NCT01118780|81686313|FG000|Overall Study|Withdrawal by Subject|13|||
27960042|NCT01118780|81686314|FG001|Overall Study|Withdrawal by Subject|8|||
27960043|NCT01747915|81686315|FG000|Overall Study|Other|1|||
27960044|NCT01747915|81686316|FG001|Overall Study|Other|1|||
27960045|NCT01747915|81686317|FG002|Overall Study|Other|1|||
27960046|NCT01747915|81686315|FG000|Overall Study|Adverse Event|8|||
27960047|NCT01747915|81686316|FG001|Overall Study|Adverse Event|5|||
27960048|NCT01747915|81686317|FG002|Overall Study|Adverse Event|2|||
27960049|NCT01747915|81686315|FG000|Overall Study|Death|0|||
27561773|NCT00256698|80246086|FG000|Overall Study|Adverse Event|13|||
27561774|NCT00256698|80246087|FG001|Overall Study|Adverse Event|6|||
27561775|NCT00256698|80246086|FG000|Overall Study|Protocol Violation|6|||
27561776|NCT00256698|80246087|FG001|Overall Study|Protocol Violation|5|||
27561777|NCT00256698|80246086|FG000|Overall Study|Lost to Follow-up|1|||
27561778|NCT00256698|80246087|FG001|Overall Study|Lost to Follow-up|3|||
27561779|NCT00256698|80246086|FG000|Overall Study|disease progression|97|||
27561780|NCT00256698|80246087|FG001|Overall Study|disease progression|105|||
27561781|NCT00256698|80246086|FG000|Overall Study|still ongoing at data cut-off|41|||
27561782|NCT00256698|80246087|FG001|Overall Study|still ongoing at data cut-off|46|||
27561783|NCT00256698|80246086|FG000|Overall Study|withdrawn due to osteoporosis|1|||
27561784|NCT00256698|80246087|FG001|Overall Study|withdrawn due to osteoporosis|0|||
27561785|NCT00256698|80246086|FG000|Overall Study|Prematurely Discontinued|1|||
27561786|NCT00256698|80246087|FG001|Overall Study|Prematurely Discontinued|0|||
27561787|NCT02268812|80246090|FG000|Overall Study|Adverse Event|8|||
27561788|NCT02268812|80246091|FG001|Overall Study|Adverse Event|26|||
27561789|NCT02268812|80246092|FG002|Overall Study|Adverse Event|7|||
27561790|NCT02268812|80246093|FG003|Overall Study|Adverse Event|10|||
27561791|NCT02268812|80246090|FG000|Overall Study|Protocol deviation|0|||
27561792|NCT02268812|80246091|FG001|Overall Study|Protocol deviation|0|||
27561793|NCT02268812|80246092|FG002|Overall Study|Protocol deviation|1|||
27561794|NCT02268812|80246093|FG003|Overall Study|Protocol deviation|0|||
27561795|NCT02268812|80246090|FG000|Overall Study|Withdrawal by Subject|0|||
27561796|NCT02268812|80246091|FG001|Overall Study|Withdrawal by Subject|1|||
27561797|NCT02268812|80246092|FG002|Overall Study|Withdrawal by Subject|0|||
27561798|NCT02268812|80246093|FG003|Overall Study|Withdrawal by Subject|0|||
27561799|NCT02268812|80246090|FG000|Overall Study|Physician Decision|3|||
27561800|NCT02268812|80246091|FG001|Overall Study|Physician Decision|1|||
27561801|NCT02268812|80246092|FG002|Overall Study|Physician Decision|0|||
27561802|NCT02268812|80246093|FG003|Overall Study|Physician Decision|1|||
27561803|NCT02268812|80246090|FG000|Overall Study|Other|5|||
27960050|NCT01747915|81686316|FG001|Overall Study|Death|0|||
27960051|NCT01747915|81686317|FG002|Overall Study|Death|1|||
27960052|NCT01747915|81686315|FG000|Overall Study|Lack of Efficacy|0|||
27960053|NCT01747915|81686316|FG001|Overall Study|Lack of Efficacy|1|||
27960054|NCT01747915|81686317|FG002|Overall Study|Lack of Efficacy|0|||
27960055|NCT01747915|81686315|FG000|Overall Study|Lost to Follow-up|1|||
27960056|NCT01747915|81686316|FG001|Overall Study|Lost to Follow-up|0|||
27960057|NCT01747915|81686317|FG002|Overall Study|Lost to Follow-up|0|||
27960058|NCT01747915|81686315|FG000|Overall Study|Withdrawal by Subject|4|||
27960059|NCT01747915|81686316|FG001|Overall Study|Withdrawal by Subject|4|||
27960060|NCT01747915|81686317|FG002|Overall Study|Withdrawal by Subject|1|||
27960061|NCT01747915|81686315|FG000|Overall Study|Protocol Violation|1|||
27960062|NCT01747915|81686316|FG001|Overall Study|Protocol Violation|0|||
27960063|NCT01747915|81686317|FG002|Overall Study|Protocol Violation|0|||
27960064|NCT01747915|81686315|FG000|Overall Study|Pregnancy|0|||
27960065|NCT01747915|81686316|FG001|Overall Study|Pregnancy|0|||
27960066|NCT01747915|81686317|FG002|Overall Study|Pregnancy|1|||
27960067|NCT02553928|81686318|FG000|Overall Study|Adverse Event|2|||
27561804|NCT02268812|80246091|FG001|Overall Study|Other|4|||
27755605|NCT03136367|80932550|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
27960068|NCT02553928|81686319|FG001|Overall Study|Adverse Event|1|||
27561805|NCT02268812|80246092|FG002|Overall Study|Other|1|||
27561806|NCT02268812|80246093|FG003|Overall Study|Other|3|||
27561807|NCT00768144|80246094|FG000|Overall Study|Adverse Event|13|||
27561808|NCT00768144|80246094|FG000|Overall Study|Progressive Disease|21|||
27960069|NCT02553928|81686318|FG000|Overall Study|Lost to Follow-up|0|||
27960070|NCT02553928|81686319|FG001|Overall Study|Lost to Follow-up|1|||
27960071|NCT02553928|81686318|FG000|Overall Study|Administrative reason(s)|0|||
27960072|NCT02553928|81686319|FG001|Overall Study|Administrative reason(s)|1|||
27960073|NCT02168101|81686320|FG000|Overall Study|Death|2|||
27960074|NCT02168101|81686321|FG001|Overall Study|Death|2|||
27960075|NCT02168101|81686322|FG002|Overall Study|Death|1|||
27960076|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
27960077|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
27960078|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960079|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960080|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960081|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960082|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960083|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960084|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960085|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
27960086|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
27960087|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
27960088|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960089|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960090|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960091|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960092|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960093|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960094|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960095|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
27960096|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
27960097|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960098|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960099|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960100|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27561809|NCT00768144|80246094|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
27561810|NCT00768144|80246094|FG000|Overall Study|Pt Withdrew Consent|1|||
27561811|NCT00600938|80246097|FG000|Core Study|Abnormal test procedure result(s)|3|||
27561812|NCT00600938|80246098|FG001|Core Study|Abnormal test procedure result(s)|2|||
27561813|NCT00600938|80246099|FG002|Core Study|Abnormal test procedure result(s)|0|||
27561814|NCT00600938|80246100|FG003|Core Study|Abnormal test procedure result(s)|0|||
27561815|NCT00600938|80246097|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
27561816|NCT00600938|80246098|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
27561817|NCT00600938|80246099|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
27561818|NCT00600938|80246100|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
27561819|NCT00600938|80246097|FG000|Core Study|Patient withdrew consent|7|||
27561820|NCT00600938|80246098|FG001|Core Study|Patient withdrew consent|12|||
27561821|NCT00600938|80246099|FG002|Core Study|Patient withdrew consent|0|||
27561822|NCT00600938|80246100|FG003|Core Study|Patient withdrew consent|0|||
27561823|NCT00600938|80246097|FG000|Core Study|Lost to Follow-up|3|||
27561824|NCT00600938|80246098|FG001|Core Study|Lost to Follow-up|2|||
27561825|NCT00600938|80246099|FG002|Core Study|Lost to Follow-up|0|||
27561826|NCT00600938|80246100|FG003|Core Study|Lost to Follow-up|0|||
27561827|NCT00600938|80246097|FG000|Core Study|Death|1|||
27561828|NCT00600938|80246098|FG001|Core Study|Death|1|||
27561829|NCT00600938|80246099|FG002|Core Study|Death|0|||
27561830|NCT00600938|80246100|FG003|Core Study|Death|0|||
27561831|NCT00600938|80246097|FG000|Core Study|Protocol Violation|1|||
27561832|NCT00600938|80246098|FG001|Core Study|Protocol Violation|2|||
27561833|NCT00600938|80246099|FG002|Core Study|Protocol Violation|0|||
27561834|NCT00600938|80246100|FG003|Core Study|Protocol Violation|0|||
27561835|NCT00600938|80246097|FG000|Extension Study|Adverse Event|1|||
27561836|NCT00600938|80246098|FG001|Extension Study|Adverse Event|0|||
27561837|NCT00600938|80246099|FG002|Extension Study|Adverse Event|2|||
27561838|NCT00600938|80246100|FG003|Extension Study|Adverse Event|0|||
27561839|NCT00600938|80246097|FG000|Extension Study|Abnormal test procedure results|0|||
27561840|NCT00600938|80246098|FG001|Extension Study|Abnormal test procedure results|1|||
27561841|NCT00600938|80246099|FG002|Extension Study|Abnormal test procedure results|1|||
27561842|NCT00600938|80246100|FG003|Extension Study|Abnormal test procedure results|1|||
27561843|NCT00600938|80246097|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
27561844|NCT00600938|80246098|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
27561845|NCT00600938|80246099|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
27561846|NCT00600938|80246100|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
27561847|NCT00600938|80246097|FG000|Extension Study|Withdrawal by Subject|2|||
27561848|NCT00600938|80246098|FG001|Extension Study|Withdrawal by Subject|2|||
27561849|NCT00600938|80246099|FG002|Extension Study|Withdrawal by Subject|3|||
27561850|NCT00600938|80246100|FG003|Extension Study|Withdrawal by Subject|0|||
27960101|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960102|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960103|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960104|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960105|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
27960106|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
27960107|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
27960108|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960109|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960110|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960111|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960112|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960113|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960114|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960115|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
27960116|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960117|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
27960118|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960119|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960120|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960121|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960122|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960123|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960124|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960125|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
27960126|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
27960127|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
27960128|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960129|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960130|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960131|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960132|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960133|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960134|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960135|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
27960136|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
27960137|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
27960138|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960139|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960140|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960141|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960142|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960143|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960144|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960145|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
27960146|NCT01194219|81686323|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
27960147|NCT01194219|81686324|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
27960148|NCT01194219|81686325|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960149|NCT01194219|81686326|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960150|NCT01194219|81686327|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960151|NCT01194219|81686328|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960152|NCT01194219|81686329|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960153|NCT01194219|81686330|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960154|NCT01194219|81686331|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960155|NCT01194219|81686332|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
27960156|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960157|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960158|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
27960159|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
27960160|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960161|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960162|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960163|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960164|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960165|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
27960166|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960167|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960168|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
27960169|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
27960170|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960171|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960172|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960173|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960174|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960175|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
27960176|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27755606|NCT03136367|80932551|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
27755607|NCT03136367|80932549|FG000|T3 1 Week After Surgery|other discontinued|2|||
27755608|NCT03136367|80932550|FG001|T3 1 Week After Surgery|other discontinued|4|||
27960177|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27960178|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
27960179|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
27960180|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27960181|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27755609|NCT03136367|80932551|FG002|T3 1 Week After Surgery|other discontinued|3|||
27755610|NCT03136367|80932549|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
27755611|NCT03136367|80932550|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
27755612|NCT03136367|80932551|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
27755613|NCT03136367|80932549|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
27755614|NCT03136367|80932550|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
27755615|NCT03136367|80932551|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
27755616|NCT03136367|80932549|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
27755617|NCT03136367|80932550|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
27960182|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27960183|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27960184|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27960185|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
27960186|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960187|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27561851|NCT00600938|80246097|FG000|Extension Study|Lost to Follow-up|1|||
27561852|NCT00600938|80246098|FG001|Extension Study|Lost to Follow-up|1|||
27561853|NCT00600938|80246099|FG002|Extension Study|Lost to Follow-up|2|||
27561854|NCT00600938|80246100|FG003|Extension Study|Lost to Follow-up|0|||
27960188|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
27960189|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
27960190|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960191|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960192|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960193|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960194|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960195|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
27960196|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960197|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960198|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
27960199|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960200|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960201|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960202|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960203|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960204|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960205|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
27960206|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960207|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960208|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960209|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
27960210|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960211|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960212|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960213|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960214|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960215|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
27960216|NCT01194219|81686323|FG000|Maintenance Phase Weeks16-32|Other|0|||
27960217|NCT01194219|81686324|FG001|Maintenance Phase Weeks16-32|Other|0|||
27960218|NCT01194219|81686325|FG002|Maintenance Phase Weeks16-32|Other|2|||
27960219|NCT01194219|81686326|FG003|Maintenance Phase Weeks16-32|Other|1|||
27960220|NCT01194219|81686327|FG004|Maintenance Phase Weeks16-32|Other|0|||
27960221|NCT01194219|81686328|FG005|Maintenance Phase Weeks16-32|Other|0|||
27960222|NCT01194219|81686329|FG006|Maintenance Phase Weeks16-32|Other|0|||
27960223|NCT01194219|81686330|FG007|Maintenance Phase Weeks16-32|Other|0|||
27960224|NCT01194219|81686331|FG008|Maintenance Phase Weeks16-32|Other|0|||
27960225|NCT01194219|81686332|FG009|Maintenance Phase Weeks16-32|Other|0|||
27960226|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960227|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960228|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960229|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960230|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960231|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
27960232|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
27960233|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
27960234|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960235|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
27960236|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27960237|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27960238|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27755618|NCT03136367|80932551|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
27755619|NCT03136367|80932549|FG000|T4 12 Weeks After Surgery|Death|0|||
27755620|NCT03136367|80932550|FG001|T4 12 Weeks After Surgery|Death|1|||
27755621|NCT03136367|80932551|FG002|T4 12 Weeks After Surgery|Death|3|||
27755622|NCT03136367|80932549|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
27755623|NCT03136367|80932550|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
27755624|NCT03136367|80932551|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
27755625|NCT03136367|80932549|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
27755626|NCT03136367|80932550|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
27960239|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27960240|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
27960241|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
27960242|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
27960243|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
27960244|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27960245|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
27960246|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27960247|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27960248|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27561855|NCT00600938|80246097|FG000|Extension Study|Death|1|||
27561856|NCT00600938|80246098|FG001|Extension Study|Death|0|||
27561857|NCT00600938|80246099|FG002|Extension Study|Death|0|||
27561858|NCT00600938|80246100|FG003|Extension Study|Death|0|||
27561859|NCT03204305|80246101|FG000|Overall Study|Lost to Follow-up|6|||
27561860|NCT03204305|80246102|FG001|Overall Study|Lost to Follow-up|4|||
27561861|NCT03204305|80246103|FG002|Overall Study|Lost to Follow-up|0|||
27960249|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27960250|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
27960251|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27960252|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
27960253|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27960254|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27561862|NCT03204305|80246104|FG003|Overall Study|Lost to Follow-up|0|||
27561863|NCT03204305|80246101|FG000|Overall Study|Physician Decision|1|||
27561864|NCT03204305|80246102|FG001|Overall Study|Physician Decision|0|||
27561865|NCT03204305|80246103|FG002|Overall Study|Physician Decision|0|||
27561866|NCT03204305|80246104|FG003|Overall Study|Physician Decision|0|||
27561867|NCT03204305|80246101|FG000|Overall Study|failure to place arterial line|2|||
27561868|NCT03204305|80246102|FG001|Overall Study|failure to place arterial line|1|||
27561869|NCT03204305|80246103|FG002|Overall Study|failure to place arterial line|0|||
27561870|NCT03204305|80246104|FG003|Overall Study|failure to place arterial line|0|||
27561871|NCT03204305|80246101|FG000|Overall Study|Withdrawal by Subject|2|||
27561872|NCT03204305|80246102|FG001|Overall Study|Withdrawal by Subject|0|||
27561873|NCT03204305|80246103|FG002|Overall Study|Withdrawal by Subject|0|||
27561874|NCT03204305|80246104|FG003|Overall Study|Withdrawal by Subject|0|||
27561875|NCT02345811|80246106|FG000|First Intervention|Withdrawal by Subject|1|||
27561876|NCT02345811|80246107|FG001|First Intervention|Withdrawal by Subject|1|||
27960255|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
27960256|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27960257|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27755627|NCT03136367|80932551|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
27886597|NCT01435018|81418122|FG002|Overall Study|Site is closing|7|||
27960258|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27960259|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27960260|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
27960261|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27960262|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
27960263|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
27960264|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27960265|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
27960266|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960267|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960268|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960269|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960270|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
27960271|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
27960272|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
27960273|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960274|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960275|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
27960276|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960277|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960278|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960279|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960280|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960281|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960282|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960283|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
27960284|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27755628|NCT03136367|80932549|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
27960285|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
27960286|NCT01194219|81686323|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960287|NCT01194219|81686324|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960288|NCT01194219|81686325|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960289|NCT01194219|81686326|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960290|NCT01194219|81686327|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960291|NCT01194219|81686328|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960292|NCT01194219|81686329|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
27755629|NCT03136367|80932550|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
27755630|NCT03136367|80932551|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
27755631|NCT03136367|80932549|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
27755632|NCT03136367|80932550|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
27755633|NCT03136367|80932551|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
27755634|NCT03136367|80932549|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
27755635|NCT03136367|80932550|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
27755636|NCT03136367|80932551|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
27755637|NCT03136367|80932549|FG000|T5 1 Year After Surgery|Death|0|||
27755638|NCT03136367|80932550|FG001|T5 1 Year After Surgery|Death|0|||
27755639|NCT03136367|80932551|FG002|T5 1 Year After Surgery|Death|1|||
27755640|NCT03136367|80932549|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
27755641|NCT03136367|80932550|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
27755642|NCT03136367|80932551|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
27755643|NCT03136367|80932549|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
27755644|NCT03136367|80932550|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
27561877|NCT00720057|80246108|FG000|Overall Study|Lost to Follow-up|0|||
27561878|NCT00720057|80246109|FG001|Overall Study|Lost to Follow-up|2|||
27561879|NCT00720057|80246108|FG000|Overall Study|Protocol Violation|1|||
27561880|NCT00720057|80246109|FG001|Overall Study|Protocol Violation|0|||
27561881|NCT00720057|80246108|FG000|Overall Study|Withdrawal by Subject|0|||
27561882|NCT00720057|80246109|FG001|Overall Study|Withdrawal by Subject|1|||
27561883|NCT04127786|80246112|FG000|Primary Series|Adverse Event|1|||
27561884|NCT04127786|80246113|FG001|Primary Series|Adverse Event|0|||
27755645|NCT03136367|80932551|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
27755646|NCT03136367|80932549|FG000|T5 1 Year After Surgery|study ended before due|31|||
27886598|NCT01435018|81418120|FG000|Overall Study|Withdrew consent|0|||
27755647|NCT03136367|80932550|FG001|T5 1 Year After Surgery|study ended before due|103|||
27755648|NCT03136367|80932551|FG002|T5 1 Year After Surgery|study ended before due|110|||
27755649|NCT03136367|80932549|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
27755650|NCT03136367|80932550|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
27755651|NCT03136367|80932551|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
27561885|NCT04127786|80246114|FG002|Primary Series|Adverse Event|0|||
27755652|NCT01755195|80932552|FG000|Overall Study|Participant noncompliance|2|||
27755653|NCT01755195|80932552|FG000|Overall Study|Switched to alternative treatment|4|||
27755654|NCT01755195|80932552|FG000|Overall Study|Withdrawal by Subject|1|||
27755655|NCT01755195|80932552|FG000|Overall Study|Participant refused to start treatment|1|||
27561886|NCT04127786|80246115|FG003|Primary Series|Adverse Event|1|||
27561887|NCT04127786|80246116|FG004|Primary Series|Adverse Event|0|||
27561888|NCT04127786|80246117|FG005|Primary Series|Adverse Event|1|||
27561889|NCT04127786|80246112|FG000|Primary Series|Protocol Violation|5|||
27561890|NCT04127786|80246113|FG001|Primary Series|Protocol Violation|3|||
27561891|NCT04127786|80246114|FG002|Primary Series|Protocol Violation|4|||
27561892|NCT04127786|80246115|FG003|Primary Series|Protocol Violation|3|||
27561893|NCT04127786|80246116|FG004|Primary Series|Protocol Violation|2|||
27561894|NCT04127786|80246117|FG005|Primary Series|Protocol Violation|0|||
27561895|NCT04127786|80246112|FG000|Primary Series|Withdrawal by Subject|0|||
27561896|NCT04127786|80246113|FG001|Primary Series|Withdrawal by Subject|0|||
27561897|NCT04127786|80246114|FG002|Primary Series|Withdrawal by Subject|0|||
27561898|NCT04127786|80246115|FG003|Primary Series|Withdrawal by Subject|1|||
27561899|NCT04127786|80246116|FG004|Primary Series|Withdrawal by Subject|0|||
27561900|NCT04127786|80246117|FG005|Primary Series|Withdrawal by Subject|0|||
27561901|NCT04127786|80246112|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
27561902|NCT04127786|80246113|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
27561903|NCT04127786|80246114|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
27561904|NCT04127786|80246115|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
27561905|NCT04127786|80246116|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
27561906|NCT04127786|80246117|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
27561907|NCT04127786|80246112|FG000|Booster Phase|Withdrawal by Subject|2|||
27561908|NCT04127786|80246113|FG001|Booster Phase|Withdrawal by Subject|0|||
27561909|NCT04127786|80246114|FG002|Booster Phase|Withdrawal by Subject|0|||
27561910|NCT04127786|80246115|FG003|Booster Phase|Withdrawal by Subject|0|||
27561911|NCT04127786|80246116|FG004|Booster Phase|Withdrawal by Subject|0|||
27561912|NCT04127786|80246117|FG005|Booster Phase|Withdrawal by Subject|0|||
27561913|NCT03045887|80246118|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
27561914|NCT03045887|80246119|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561915|NCT03045887|80246120|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561916|NCT03045887|80246121|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561917|NCT03045887|80246122|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561918|NCT03045887|80246123|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561919|NCT03045887|80246124|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561920|NCT03045887|80246125|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561921|NCT03045887|80246126|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561922|NCT03045887|80246127|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
27561923|NCT03045887|80246118|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561924|NCT03045887|80246119|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561925|NCT03045887|80246120|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561926|NCT03045887|80246121|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
27561927|NCT03045887|80246122|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561928|NCT03045887|80246123|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561929|NCT03045887|80246124|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561930|NCT03045887|80246125|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561931|NCT03045887|80246126|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561932|NCT03045887|80246127|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
27561933|NCT03045887|80246118|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
27561934|NCT03045887|80246119|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561935|NCT03045887|80246120|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561936|NCT03045887|80246121|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561937|NCT03045887|80246122|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561938|NCT03045887|80246123|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
27755656|NCT01755195|80932552|FG000|Overall Study|Participant has been consented for another trial|1|||
27755657|NCT01755195|80932552|FG000|Overall Study|Refused further treatment|3|||
27561939|NCT03045887|80246124|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561940|NCT03045887|80246125|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561941|NCT03045887|80246126|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561942|NCT03045887|80246127|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
27561943|NCT03045887|80246118|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27561944|NCT03045887|80246119|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27960293|NCT01194219|81686330|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960294|NCT01194219|81686331|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27960295|NCT01194219|81686332|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
27561945|NCT03045887|80246120|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
27561946|NCT03045887|80246121|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
27561947|NCT03045887|80246122|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27561948|NCT03045887|80246123|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27561949|NCT03045887|80246124|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27561950|NCT03045887|80246125|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27561951|NCT03045887|80246126|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27755658|NCT01755195|80932552|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
27755659|NCT02625324|80932555|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
27755660|NCT02625324|80932555|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
27755661|NCT02625324|80932555|FG000|6-Month Follow-up Subject Accountability|Death|5|||
27755662|NCT02625324|80932555|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
27755663|NCT02625324|80932555|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
27755664|NCT02625324|80932555|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
27755665|NCT02625324|80932555|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
27755666|NCT02625324|80932555|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
27755667|NCT02625324|80932555|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
27755668|NCT02625324|80932555|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
27755669|NCT02625324|80932555|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
27755670|NCT02625324|80932555|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
27755671|NCT02625324|80932555|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
27755672|NCT02625324|80932555|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
27755673|NCT02625324|80932555|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
27755674|NCT02625324|80932555|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
27755675|NCT02625324|80932555|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
27755676|NCT01429792|80932556|FG000|Overall Study|Other Reasons|67|||
27755677|NCT01429792|80932556|FG000|Overall Study|Unknown Disposition|94|||
27755678|NCT01429792|80932556|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
27755679|NCT01429792|80932556|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
27755680|NCT01429792|80932556|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
27755681|NCT01429792|80932556|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
27755682|NCT01429792|80932556|FG000|Overall Study|Withdrawal by Subject|70|||
27755683|NCT01429792|80932556|FG000|Overall Study|Lost to Follow-up|88|||
27755684|NCT00238303|80932557|FG000|Overall Study|Withdrawal by Subject|11|||
27886599|NCT01435018|81418121|FG001|Overall Study|Withdrew consent|3|||
27561952|NCT03045887|80246127|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
27561953|NCT03045887|80246118|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561954|NCT03045887|80246119|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561955|NCT03045887|80246120|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561956|NCT03045887|80246121|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
27561957|NCT03045887|80246122|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561958|NCT03045887|80246123|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561959|NCT03045887|80246124|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561960|NCT03045887|80246125|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561961|NCT03045887|80246126|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561962|NCT03045887|80246127|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27561963|NCT00994240|80246132|FG000|Overall Study|Lost to Follow-up|3|||
27561964|NCT00994240|80246133|FG001|Overall Study|Lost to Follow-up|2|||
27561965|NCT00994240|80246132|FG000|Overall Study|Withdrawal by Subject|1|||
27561966|NCT00994240|80246133|FG001|Overall Study|Withdrawal by Subject|0|||
27561967|NCT00994240|80246132|FG000|Overall Study|study termination|2|||
27561968|NCT00994240|80246133|FG001|Overall Study|study termination|3|||
27561969|NCT02608268|80246134|FG000|Overall Study|Adverse Event|0|||
27561970|NCT02608268|80246135|FG001|Overall Study|Adverse Event|0|||
27561971|NCT02608268|80246136|FG002|Overall Study|Adverse Event|1|||
27561972|NCT02608268|80246137|FG003|Overall Study|Adverse Event|0|||
27561973|NCT02608268|80246138|FG004|Overall Study|Adverse Event|0|||
27561974|NCT02608268|80246139|FG005|Overall Study|Adverse Event|0|||
27561975|NCT02608268|80246140|FG006|Overall Study|Adverse Event|0|||
27561976|NCT02608268|80246141|FG007|Overall Study|Adverse Event|0|||
27561977|NCT02608268|80246142|FG008|Overall Study|Adverse Event|0|||
27561978|NCT02608268|80246143|FG009|Overall Study|Adverse Event|0|||
27561979|NCT02608268|80246144|FG010|Overall Study|Adverse Event|0|||
27561980|NCT02608268|80246145|FG011|Overall Study|Adverse Event|0|||
27561981|NCT02608268|80246146|FG012|Overall Study|Adverse Event|2|||
27561982|NCT02608268|80246147|FG013|Overall Study|Adverse Event|0|||
27561983|NCT02608268|80246148|FG014|Overall Study|Adverse Event|0|||
27755685|NCT00238303|80932558|FG001|Overall Study|Withdrawal by Subject|1|||
27755686|NCT00238303|80932559|FG002|Overall Study|Withdrawal by Subject|2|||
27755687|NCT00238303|80932557|FG000|Overall Study|Death|1|||
27755688|NCT00238303|80932558|FG001|Overall Study|Death|0|||
27755689|NCT00238303|80932559|FG002|Overall Study|Death|1|||
27755690|NCT00238303|80932557|FG000|Overall Study|Other Medical Problems|2|||
27755691|NCT00238303|80932558|FG001|Overall Study|Other Medical Problems|0|||
27755692|NCT00238303|80932559|FG002|Overall Study|Other Medical Problems|2|||
27755693|NCT00238303|80932557|FG000|Overall Study|Poor tolerance of study treatment|1|||
27755694|NCT00238303|80932558|FG001|Overall Study|Poor tolerance of study treatment|0|||
27755695|NCT00238303|80932559|FG002|Overall Study|Poor tolerance of study treatment|1|||
27755696|NCT00238303|80932557|FG000|Overall Study|Adverse Event|0|||
27755697|NCT00238303|80932558|FG001|Overall Study|Adverse Event|1|||
27755698|NCT00238303|80932559|FG002|Overall Study|Adverse Event|3|||
27561984|NCT02608268|80246149|FG015|Overall Study|Adverse Event|0|||
27561985|NCT02608268|80246150|FG016|Overall Study|Adverse Event|0|||
27561986|NCT02608268|80246151|FG017|Overall Study|Adverse Event|0|||
27561987|NCT02608268|80246152|FG018|Overall Study|Adverse Event|0|||
27561988|NCT02608268|80246153|FG019|Overall Study|Adverse Event|0|||
27561989|NCT02608268|80246154|FG020|Overall Study|Adverse Event|1|||
27755699|NCT02176291|80932560|FG000|Overall Study|Death|1|||
27755700|NCT02176291|80932561|FG001|Overall Study|Death|0|||
27755701|NCT02176291|80932560|FG000|Overall Study|non compliance with protocol|2|||
27755702|NCT02176291|80932561|FG001|Overall Study|non compliance with protocol|0|||
27561990|NCT02608268|80246155|FG021|Overall Study|Adverse Event|1|||
27755703|NCT02176291|80932560|FG000|Overall Study|Withdrawal by Subject|2|||
27755704|NCT02176291|80932561|FG001|Overall Study|Withdrawal by Subject|0|||
27561991|NCT02608268|80246156|FG022|Overall Study|Adverse Event|0|||
27561992|NCT02608268|80246157|FG023|Overall Study|Adverse Event|0|||
27561993|NCT02608268|80246158|FG024|Overall Study|Adverse Event|1|||
27561994|NCT02608268|80246159|FG025|Overall Study|Adverse Event|0|||
27561995|NCT02608268|80246160|FG026|Overall Study|Adverse Event|0|||
27561996|NCT02608268|80246161|FG027|Overall Study|Adverse Event|0|||
27561997|NCT02608268|80246162|FG028|Overall Study|Adverse Event|1|||
27561998|NCT02608268|80246163|FG029|Overall Study|Adverse Event|0|||
27561999|NCT02608268|80246134|FG000|Overall Study|Death|1|||
27562000|NCT02608268|80246135|FG001|Overall Study|Death|0|||
27562001|NCT02608268|80246136|FG002|Overall Study|Death|0|||
27562002|NCT02608268|80246137|FG003|Overall Study|Death|0|||
27562003|NCT02608268|80246138|FG004|Overall Study|Death|0|||
27562004|NCT02608268|80246139|FG005|Overall Study|Death|0|||
27562005|NCT02608268|80246140|FG006|Overall Study|Death|0|||
27562006|NCT02608268|80246141|FG007|Overall Study|Death|0|||
27562007|NCT02608268|80246142|FG008|Overall Study|Death|1|||
27562008|NCT02608268|80246143|FG009|Overall Study|Death|1|||
27562009|NCT02608268|80246144|FG010|Overall Study|Death|0|||
27562010|NCT02608268|80246145|FG011|Overall Study|Death|0|||
27562011|NCT02608268|80246146|FG012|Overall Study|Death|0|||
27562012|NCT02608268|80246147|FG013|Overall Study|Death|0|||
27562013|NCT02608268|80246148|FG014|Overall Study|Death|0|||
27562014|NCT02608268|80246149|FG015|Overall Study|Death|1|||
27562015|NCT02608268|80246150|FG016|Overall Study|Death|0|||
27562016|NCT02608268|80246151|FG017|Overall Study|Death|1|||
27562017|NCT02608268|80246152|FG018|Overall Study|Death|0|||
27562018|NCT02608268|80246153|FG019|Overall Study|Death|1|||
27562019|NCT02608268|80246154|FG020|Overall Study|Death|1|||
27562020|NCT02608268|80246155|FG021|Overall Study|Death|0|||
27562021|NCT02608268|80246156|FG022|Overall Study|Death|0|||
27562022|NCT02608268|80246157|FG023|Overall Study|Death|0|||
27562023|NCT02608268|80246158|FG024|Overall Study|Death|1|||
27755705|NCT03448224|80932568|FG000|Overall Study|Provided same answer to every question|1|||
27755706|NCT03448224|80932569|FG001|Overall Study|Provided same answer to every question|0|||
27755707|NCT02815293|80932570|FG000|Overall Study|Study termination by sponsor|10|||
27562024|NCT02608268|80246159|FG025|Overall Study|Death|2|||
27562025|NCT02608268|80246160|FG026|Overall Study|Death|0|||
27562026|NCT02608268|80246161|FG027|Overall Study|Death|1|||
27755708|NCT02815293|80932571|FG001|Overall Study|Study termination by sponsor|7|||
27755709|NCT02815293|80932572|FG002|Overall Study|Study termination by sponsor|0|||
27755710|NCT02815293|80932570|FG000|Overall Study|Participants not randomized|0|||
27562027|NCT02608268|80246162|FG028|Overall Study|Death|4|||
27562028|NCT02608268|80246163|FG029|Overall Study|Death|0|||
27562029|NCT02608268|80246134|FG000|Overall Study|Physician Decision|0|||
27562030|NCT02608268|80246135|FG001|Overall Study|Physician Decision|0|||
27562031|NCT02608268|80246136|FG002|Overall Study|Physician Decision|0|||
27562032|NCT02608268|80246137|FG003|Overall Study|Physician Decision|0|||
27562033|NCT02608268|80246138|FG004|Overall Study|Physician Decision|0|||
27562034|NCT02608268|80246139|FG005|Overall Study|Physician Decision|0|||
27562035|NCT02608268|80246140|FG006|Overall Study|Physician Decision|0|||
27562036|NCT02608268|80246141|FG007|Overall Study|Physician Decision|0|||
27562037|NCT02608268|80246142|FG008|Overall Study|Physician Decision|0|||
27562038|NCT02608268|80246143|FG009|Overall Study|Physician Decision|0|||
27755711|NCT02815293|80932571|FG001|Overall Study|Participants not randomized|0|||
27755712|NCT02815293|80932572|FG002|Overall Study|Participants not randomized|18|||
27755713|NCT02815293|80932570|FG000|Overall Study|Adverse Event|0|||
27755714|NCT02815293|80932571|FG001|Overall Study|Adverse Event|1|||
27755715|NCT02815293|80932572|FG002|Overall Study|Adverse Event|0|||
27755716|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
27755717|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
27755718|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
27755719|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
27755720|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
27755721|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
27755722|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
27755723|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27755724|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
27755725|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
27755726|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
27755727|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
27755728|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
27755729|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
27755730|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
27755731|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
27755732|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Missing|3|||
27755733|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Missing|1|||
27755734|NCT00838916|80932574|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
27755735|NCT00838916|80932575|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
27755736|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
27755737|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
27755738|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
27755739|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
27755740|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
27755741|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
27755742|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
27755743|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
27755744|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
27755745|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
27755746|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
27755747|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
27755748|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
27755749|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
27755750|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
27755751|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
27755752|NCT00838916|80932574|FG000|Follow-up Period (8 Weeks)|Missing|3|||
27755753|NCT00838916|80932575|FG001|Follow-up Period (8 Weeks)|Missing|0|||
27755754|NCT04402008|80932577|FG000|Overall Study|Adverse Event|0|||
27755755|NCT04402008|80932578|FG001|Overall Study|Adverse Event|0|||
27755756|NCT04402008|80932579|FG002|Overall Study|Adverse Event|0|||
27755757|NCT04402008|80932580|FG003|Overall Study|Adverse Event|1|||
27755758|NCT04402008|80932581|FG004|Overall Study|Adverse Event|0|||
27755759|NCT04402008|80932582|FG005|Overall Study|Adverse Event|0|||
27755760|NCT04402008|80932583|FG006|Overall Study|Adverse Event|0|||
27755761|NCT04402008|80932577|FG000|Overall Study|Disease Progression|3|||
27755762|NCT04402008|80932578|FG001|Overall Study|Disease Progression|2|||
27755763|NCT04402008|80932579|FG002|Overall Study|Disease Progression|3|||
27755764|NCT04402008|80932580|FG003|Overall Study|Disease Progression|3|||
27755765|NCT04402008|80932581|FG004|Overall Study|Disease Progression|4|||
27755766|NCT04402008|80932582|FG005|Overall Study|Disease Progression|3|||
27755767|NCT04402008|80932583|FG006|Overall Study|Disease Progression|10|||
27755768|NCT04402008|80932577|FG000|Overall Study|Withdrawal by Subject|0|||
27755769|NCT04402008|80932578|FG001|Overall Study|Withdrawal by Subject|1|||
27755770|NCT04402008|80932579|FG002|Overall Study|Withdrawal by Subject|0|||
27755771|NCT04402008|80932580|FG003|Overall Study|Withdrawal by Subject|0|||
27562039|NCT02608268|80246144|FG010|Overall Study|Physician Decision|1|||
27562040|NCT02608268|80246145|FG011|Overall Study|Physician Decision|0|||
27755772|NCT04402008|80932581|FG004|Overall Study|Withdrawal by Subject|1|||
27755773|NCT04402008|80932582|FG005|Overall Study|Withdrawal by Subject|0|||
27755774|NCT04402008|80932583|FG006|Overall Study|Withdrawal by Subject|0|||
27562041|NCT02608268|80246146|FG012|Overall Study|Physician Decision|0|||
27562042|NCT02608268|80246147|FG013|Overall Study|Physician Decision|1|||
27562043|NCT02608268|80246148|FG014|Overall Study|Physician Decision|0|||
27562044|NCT02608268|80246149|FG015|Overall Study|Physician Decision|0|||
27562045|NCT02608268|80246150|FG016|Overall Study|Physician Decision|0|||
27755775|NCT04402008|80932577|FG000|Overall Study|Sponsor Decision|0|||
27755776|NCT04402008|80932578|FG001|Overall Study|Sponsor Decision|0|||
27755777|NCT04402008|80932579|FG002|Overall Study|Sponsor Decision|0|||
27755778|NCT04402008|80932580|FG003|Overall Study|Sponsor Decision|0|||
27562046|NCT02608268|80246151|FG017|Overall Study|Physician Decision|0|||
27755779|NCT04402008|80932581|FG004|Overall Study|Sponsor Decision|0|||
27755780|NCT04402008|80932582|FG005|Overall Study|Sponsor Decision|0|||
27755781|NCT04402008|80932583|FG006|Overall Study|Sponsor Decision|3|||
27562047|NCT02608268|80246152|FG018|Overall Study|Physician Decision|0|||
27562048|NCT02608268|80246153|FG019|Overall Study|Physician Decision|0|||
27562049|NCT02608268|80246154|FG020|Overall Study|Physician Decision|0|||
27562050|NCT02608268|80246155|FG021|Overall Study|Physician Decision|0|||
27562051|NCT02608268|80246156|FG022|Overall Study|Physician Decision|1|||
27562052|NCT02608268|80246157|FG023|Overall Study|Physician Decision|1|||
27562053|NCT02608268|80246158|FG024|Overall Study|Physician Decision|1|||
27562054|NCT02608268|80246159|FG025|Overall Study|Physician Decision|0|||
27562055|NCT02608268|80246160|FG026|Overall Study|Physician Decision|0|||
27562056|NCT02608268|80246161|FG027|Overall Study|Physician Decision|2|||
27562057|NCT02608268|80246162|FG028|Overall Study|Physician Decision|1|||
27562058|NCT02608268|80246163|FG029|Overall Study|Physician Decision|1|||
27562059|NCT02608268|80246134|FG000|Overall Study|Progressive disease|12|||
27562060|NCT02608268|80246135|FG001|Overall Study|Progressive disease|8|||
27562061|NCT02608268|80246136|FG002|Overall Study|Progressive disease|13|||
27562062|NCT02608268|80246137|FG003|Overall Study|Progressive disease|5|||
27562063|NCT02608268|80246138|FG004|Overall Study|Progressive disease|2|||
27562064|NCT02608268|80246139|FG005|Overall Study|Progressive disease|4|||
27562065|NCT02608268|80246140|FG006|Overall Study|Progressive disease|6|||
27562066|NCT02608268|80246141|FG007|Overall Study|Progressive disease|2|||
27562067|NCT02608268|80246142|FG008|Overall Study|Progressive disease|5|||
27562068|NCT02608268|80246143|FG009|Overall Study|Progressive disease|6|||
27562069|NCT02608268|80246144|FG010|Overall Study|Progressive disease|5|||
27562070|NCT02608268|80246145|FG011|Overall Study|Progressive disease|5|||
27562071|NCT02608268|80246146|FG012|Overall Study|Progressive disease|4|||
27562072|NCT02608268|80246147|FG013|Overall Study|Progressive disease|11|||
27562073|NCT02608268|80246148|FG014|Overall Study|Progressive disease|6|||
27562074|NCT02608268|80246149|FG015|Overall Study|Progressive disease|3|||
27562075|NCT02608268|80246150|FG016|Overall Study|Progressive disease|5|||
27562076|NCT02608268|80246151|FG017|Overall Study|Progressive disease|5|||
27562077|NCT02608268|80246152|FG018|Overall Study|Progressive disease|5|||
27562078|NCT02608268|80246153|FG019|Overall Study|Progressive disease|2|||
27562079|NCT02608268|80246154|FG020|Overall Study|Progressive disease|10|||
27562080|NCT02608268|80246155|FG021|Overall Study|Progressive disease|4|||
27562081|NCT02608268|80246156|FG022|Overall Study|Progressive disease|5|||
27562082|NCT02608268|80246157|FG023|Overall Study|Progressive disease|5|||
27562083|NCT02608268|80246158|FG024|Overall Study|Progressive disease|3|||
27562084|NCT02608268|80246159|FG025|Overall Study|Progressive disease|11|||
27562085|NCT02608268|80246160|FG026|Overall Study|Progressive disease|16|||
27562086|NCT02608268|80246161|FG027|Overall Study|Progressive disease|11|||
27562087|NCT02608268|80246162|FG028|Overall Study|Progressive disease|10|||
27562088|NCT02608268|80246163|FG029|Overall Study|Progressive disease|15|||
27562089|NCT02608268|80246134|FG000|Overall Study|Subject/guardian decision|1|||
27755782|NCT04402008|80932577|FG000|Overall Study|Death|0|||
27562090|NCT02608268|80246135|FG001|Overall Study|Subject/guardian decision|1|||
27562091|NCT02608268|80246136|FG002|Overall Study|Subject/guardian decision|2|||
27562092|NCT02608268|80246137|FG003|Overall Study|Subject/guardian decision|0|||
27562093|NCT02608268|80246138|FG004|Overall Study|Subject/guardian decision|0|||
27562094|NCT02608268|80246139|FG005|Overall Study|Subject/guardian decision|0|||
27562095|NCT02608268|80246140|FG006|Overall Study|Subject/guardian decision|0|||
27562096|NCT02608268|80246141|FG007|Overall Study|Subject/guardian decision|0|||
27562097|NCT02608268|80246142|FG008|Overall Study|Subject/guardian decision|2|||
27562098|NCT02608268|80246143|FG009|Overall Study|Subject/guardian decision|2|||
27562099|NCT02608268|80246144|FG010|Overall Study|Subject/guardian decision|0|||
27562100|NCT02608268|80246145|FG011|Overall Study|Subject/guardian decision|1|||
27562101|NCT02608268|80246146|FG012|Overall Study|Subject/guardian decision|0|||
27562102|NCT02608268|80246147|FG013|Overall Study|Subject/guardian decision|1|||
27755783|NCT04402008|80932578|FG001|Overall Study|Death|0|||
27755784|NCT04402008|80932579|FG002|Overall Study|Death|0|||
27755785|NCT04402008|80932580|FG003|Overall Study|Death|0|||
27562103|NCT02608268|80246148|FG014|Overall Study|Subject/guardian decision|0|||
27562104|NCT02608268|80246149|FG015|Overall Study|Subject/guardian decision|1|||
27562105|NCT02608268|80246150|FG016|Overall Study|Subject/guardian decision|0|||
27562106|NCT02608268|80246151|FG017|Overall Study|Subject/guardian decision|0|||
27562107|NCT02608268|80246152|FG018|Overall Study|Subject/guardian decision|1|||
27562108|NCT02608268|80246153|FG019|Overall Study|Subject/guardian decision|0|||
27562109|NCT02608268|80246154|FG020|Overall Study|Subject/guardian decision|0|||
27562110|NCT02608268|80246155|FG021|Overall Study|Subject/guardian decision|0|||
27562111|NCT02608268|80246156|FG022|Overall Study|Subject/guardian decision|1|||
27562112|NCT02608268|80246157|FG023|Overall Study|Subject/guardian decision|0|||
27562113|NCT02608268|80246158|FG024|Overall Study|Subject/guardian decision|0|||
27562114|NCT02608268|80246159|FG025|Overall Study|Subject/guardian decision|1|||
27562115|NCT02608268|80246160|FG026|Overall Study|Subject/guardian decision|1|||
27562116|NCT02608268|80246161|FG027|Overall Study|Subject/guardian decision|1|||
27562117|NCT02608268|80246162|FG028|Overall Study|Subject/guardian decision|1|||
27562118|NCT02608268|80246163|FG029|Overall Study|Subject/guardian decision|0|||
27562119|NCT02587065|80246164|FG000|Overall Study|Adverse Event|14|||
27562120|NCT02587065|80246164|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
27562121|NCT02587065|80246164|FG000|Overall Study|Non-adherence to the Protocol|3|||
27562122|NCT02587065|80246164|FG000|Overall Study|Discontinuation of Study Medication|2|||
27562123|NCT02587065|80246164|FG000|Overall Study|Reason not Specified|3|||
27562124|NCT00484939|80246165|FG000|Overall Study|Death|9|||
27562125|NCT00484939|80246166|FG001|Overall Study|Death|13|||
27562126|NCT00484939|80246165|FG000|Overall Study|Adverse Event|22|||
27562127|NCT00484939|80246166|FG001|Overall Study|Adverse Event|12|||
27562128|NCT00484939|80246165|FG000|Overall Study|Patient Withdrew Consent|19|||
27562129|NCT00484939|80246166|FG001|Overall Study|Patient Withdrew Consent|10|||
27562130|NCT00484939|80246165|FG000|Overall Study|Protocol Violation|3|||
27562131|NCT00484939|80246166|FG001|Overall Study|Protocol Violation|3|||
27562132|NCT00484939|80246165|FG000|Overall Study|Lost to Follow-up|0|||
27562133|NCT00484939|80246166|FG001|Overall Study|Lost to Follow-up|3|||
27562134|NCT00484939|80246165|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
27562135|NCT00484939|80246166|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
27562136|NCT00484939|80246165|FG000|Overall Study|Disease progression|67|||
27562137|NCT00484939|80246166|FG001|Overall Study|Disease progression|88|||
27562138|NCT00484939|80246165|FG000|Overall Study|Screen Failure|2|||
27562139|NCT00484939|80246166|FG001|Overall Study|Screen Failure|2|||
27562140|NCT00484939|80246165|FG000|Overall Study|Reason Not Specified|11|||
27562141|NCT00484939|80246166|FG001|Overall Study|Reason Not Specified|6|||
27562142|NCT02064166|80246167|FG000|Overall Study|Adverse Event|1|||
27562143|NCT02064166|80246168|FG001|Overall Study|Adverse Event|0|||
27562144|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
27562145|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
27562146|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
27562147|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
27562148|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
27562149|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
27562150|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
27562151|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
27562152|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Other|4|||
27562153|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Other|1|||
27562154|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
27562155|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
27562156|NCT00303498|80246169|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
27562157|NCT00303498|80246170|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
27562158|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
27562159|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
27562160|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Death|1|||
27562161|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Death|0|||
27562162|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
27562163|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
27562164|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
27562165|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
27562166|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
27562167|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
27562168|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
27562169|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
27562170|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Other|1|||
27562171|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Other|0|||
27562172|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
27562173|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
27562174|NCT00303498|80246169|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
27562175|NCT00303498|80246170|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
27562176|NCT01558752|80246171|FG000|Overall Study|Physician Decision|2|||
27562177|NCT01558752|80246172|FG001|Overall Study|Physician Decision|0|||
27562178|NCT03340025|80246173|FG000|Overall Study|Lost to Follow-up|2|||
27562179|NCT03340025|80246174|FG001|Overall Study|Lost to Follow-up|2|||
27562180|NCT01536379|80246176|FG000|Overall Study|Adverse Event|1|||
27562181|NCT01536379|80246177|FG001|Overall Study|Adverse Event|2|||
27562182|NCT01536379|80246176|FG000|Overall Study|Withdrawal by Subject|1|||
27562183|NCT01536379|80246177|FG001|Overall Study|Withdrawal by Subject|1|||
27562184|NCT02710045|80246178|FG000|Overall Study|Death|1|||
27562185|NCT02710045|80246179|FG001|Overall Study|Death|2|||
27562186|NCT02710045|80246180|FG002|Overall Study|Death|0|||
27562187|NCT02710045|80246178|FG000|Overall Study|Withdrawal by Subject|6|||
27562188|NCT02710045|80246179|FG001|Overall Study|Withdrawal by Subject|6|||
27562189|NCT02710045|80246180|FG002|Overall Study|Withdrawal by Subject|2|||
27562190|NCT02710045|80246178|FG000|Overall Study|Protocol Violation|1|||
27562191|NCT02710045|80246179|FG001|Overall Study|Protocol Violation|2|||
27562192|NCT02710045|80246180|FG002|Overall Study|Protocol Violation|3|||
27562193|NCT02710045|80246178|FG000|Overall Study|Lost to Follow-up|3|||
27562194|NCT02710045|80246179|FG001|Overall Study|Lost to Follow-up|6|||
27562195|NCT02710045|80246180|FG002|Overall Study|Lost to Follow-up|7|||
27562196|NCT02710045|80246178|FG000|Overall Study|Physician Decision|0|||
27562197|NCT02710045|80246179|FG001|Overall Study|Physician Decision|0|||
27562198|NCT02710045|80246180|FG002|Overall Study|Physician Decision|1|||
27562199|NCT02710045|80246178|FG000|Overall Study|Poor Attendance|0|||
27562200|NCT02710045|80246179|FG001|Overall Study|Poor Attendance|1|||
27562201|NCT02710045|80246180|FG002|Overall Study|Poor Attendance|0|||
27562202|NCT01782859|80246181|FG000|Overall Study|Protocol Violation|6|||
27562203|NCT01782859|80246182|FG001|Overall Study|Protocol Violation|6|||
27562204|NCT01782859|80246181|FG000|Overall Study|Withdrawal by Subject|0|||
27562205|NCT01782859|80246182|FG001|Overall Study|Withdrawal by Subject|1|||
27562206|NCT00853723|80246183|FG000|Overall Study|Adverse Event|3|||
27562207|NCT00853723|80246184|FG001|Overall Study|Adverse Event|4|||
27562208|NCT00853723|80246185|FG002|Overall Study|Adverse Event|1|||
27562209|NCT00853723|80246183|FG000|Overall Study|Withdrawal by Subject|2|||
27562210|NCT00853723|80246184|FG001|Overall Study|Withdrawal by Subject|1|||
27562211|NCT00853723|80246185|FG002|Overall Study|Withdrawal by Subject|0|||
27562212|NCT00853723|80246183|FG000|Overall Study|Protocol Violation|1|||
27562213|NCT00853723|80246184|FG001|Overall Study|Protocol Violation|2|||
27562214|NCT00853723|80246185|FG002|Overall Study|Protocol Violation|1|||
27755786|NCT04402008|80932581|FG004|Overall Study|Death|1|||
27755787|NCT04402008|80932582|FG005|Overall Study|Death|0|||
27755788|NCT04402008|80932583|FG006|Overall Study|Death|2|||
27755789|NCT04402008|80932577|FG000|Overall Study|Other|0|||
27755790|NCT04402008|80932578|FG001|Overall Study|Other|0|||
27755791|NCT04402008|80932579|FG002|Overall Study|Other|0|||
27755792|NCT04402008|80932580|FG003|Overall Study|Other|0|||
27755793|NCT04402008|80932581|FG004|Overall Study|Other|0|||
27755794|NCT04402008|80932582|FG005|Overall Study|Other|0|||
27755795|NCT04402008|80932583|FG006|Overall Study|Other|5|||
27755796|NCT01934894|80932584|FG000|Overall Study|Adverse Event|1|||
27755797|NCT01934894|80932585|FG001|Overall Study|Adverse Event|2|||
27755798|NCT01934894|80932584|FG000|Overall Study|Death|2|||
27755799|NCT01934894|80932585|FG001|Overall Study|Death|0|||
27755800|NCT01934894|80932584|FG000|Overall Study|Withdrawal by Subject|0|||
27755801|NCT01934894|80932585|FG001|Overall Study|Withdrawal by Subject|1|||
27755802|NCT01934894|80932584|FG000|Overall Study|Progressive Disease|3|||
27755803|NCT01934894|80932585|FG001|Overall Study|Progressive Disease|2|||
27562215|NCT01852942|80246187|FG000|Overall Study|Physician Decision|1|||
27562216|NCT01852942|80246188|FG001|Overall Study|Physician Decision|0|||
27562217|NCT01852942|80246187|FG000|Overall Study|Death|1|||
27562218|NCT01852942|80246188|FG001|Overall Study|Death|1|||
27562219|NCT01852942|80246187|FG000|Overall Study|Withdrawal by Subject|2|||
27562220|NCT01852942|80246188|FG001|Overall Study|Withdrawal by Subject|3|||
27562221|NCT01852942|80246187|FG000|Overall Study|Lost to Follow-up|1|||
27562222|NCT01852942|80246188|FG001|Overall Study|Lost to Follow-up|2|||
27562223|NCT00227305|80246191|FG000|Overall Study|Adverse Event|40|||
27562224|NCT00227305|80246191|FG000|Overall Study|Withdrawal by Subject|42|||
27562225|NCT00227305|80246191|FG000|Overall Study|Lost to Follow-up|33|||
27562226|NCT00227305|80246191|FG000|Overall Study|Study specific discontinuation|13|||
27562227|NCT00227305|80246191|FG000|Overall Study|MOVED OUT OF AREA|3|||
27562228|NCT00227305|80246191|FG000|Overall Study|Lack of Efficacy|7|||
27562229|NCT00227305|80246191|FG000|Overall Study|Physician Decision|3|||
27562230|NCT00227305|80246191|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
27562231|NCT00227305|80246191|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
27755804|NCT03970395|80932586|FG000|Overall Study|Withdrawal by Subject|3|||
27562232|NCT00227305|80246191|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
27562233|NCT01826487|80246193|FG000|Overall Study|Adverse Event|1|||
27562234|NCT01826487|80246194|FG001|Overall Study|Adverse Event|1|||
27562235|NCT01826487|80246193|FG000|Overall Study|Lost to Follow-up|1|||
27562236|NCT01826487|80246194|FG001|Overall Study|Lost to Follow-up|0|||
27562237|NCT01826487|80246193|FG000|Overall Study|Withdrawal by Subject|1|||
27562238|NCT01826487|80246194|FG001|Overall Study|Withdrawal by Subject|3|||
27755805|NCT03970395|80932587|FG001|Overall Study|Withdrawal by Subject|4|||
27755806|NCT03970395|80932586|FG000|Overall Study|Lost to Follow-up|4|||
27562239|NCT01826487|80246193|FG000|Overall Study|Protocol Violation|1|||
27562240|NCT01826487|80246194|FG001|Overall Study|Protocol Violation|1|||
27755807|NCT03970395|80932587|FG001|Overall Study|Lost to Follow-up|8|||
27755808|NCT01098461|80932588|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
27755809|NCT01098461|80932589|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
27755810|NCT01098461|80932590|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
27562241|NCT03316885|80246202|FG000|Overall Study|Adverse Event|1|||
27562242|NCT03316885|80246202|FG000|Overall Study|Death|10|||
27562243|NCT03316885|80246202|FG000|Overall Study|Lost to Follow-up|4|||
27562244|NCT03316885|80246202|FG000|Overall Study|Withdrawal by Subject|9|||
27562245|NCT03316885|80246202|FG000|Overall Study|COVID related|8|||
27562246|NCT00993291|80246203|FG000|Overall Study|Withdrawal by Subject|1|||
27755811|NCT01098461|80932591|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
27562247|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
27562248|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
27562249|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
27562250|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
27562251|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
27562252|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
27562253|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
27562254|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
27562255|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
27562256|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
27562257|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
27562258|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
27562259|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
27562260|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
27562261|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
27562262|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
27562263|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
27562264|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
27562265|NCT00887354|80246207|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
27562266|NCT00887354|80246208|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
27562267|NCT00887354|80246207|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
27562268|NCT00887354|80246208|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
27562269|NCT00887354|80246207|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
27562270|NCT00887354|80246208|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
27562271|NCT00887354|80246207|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
27562272|NCT00887354|80246208|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
27562273|NCT00887354|80246207|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
27562274|NCT00887354|80246208|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
27562275|NCT00887354|80246207|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
27562276|NCT00887354|80246208|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
27562277|NCT01696994|80246209|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
27562278|NCT01696994|80246210|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
27562279|NCT01696994|80246209|FG000|Overall Study|Died Before Randomization|1|||
27562280|NCT01696994|80246210|FG001|Overall Study|Died Before Randomization|2|||
27562281|NCT01696994|80246209|FG000|Overall Study|Died Before ASU (Control)|73|||
27562282|NCT01696994|80246210|FG001|Overall Study|Died Before ASU (Control)|0|||
27562283|NCT01696994|80246209|FG000|Overall Study|No Ovaries at Baseline|4807|||
27562284|NCT01696994|80246210|FG001|Overall Study|No Ovaries at Baseline|4851|||
27562285|NCT01696994|80246209|FG000|Overall Study|Refused ASU (Control)|311|||
27562286|NCT01696994|80246210|FG001|Overall Study|Refused ASU (Control)|0|||
27562287|NCT01696994|80246209|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
27562288|NCT01696994|80246210|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
27562289|NCT00605813|80246212|FG000|Overall Study|Protocol Violation|25|||
27562290|NCT02738333|80246216|FG000|Overall Study|Death|1|||
27562291|NCT02738333|80246217|FG001|Overall Study|Death|0|||
27562292|NCT02738333|80246218|FG002|Overall Study|Death|0|||
27562293|NCT02738333|80246216|FG000|Overall Study|Lost to Follow-up|1|||
27562294|NCT02738333|80246217|FG001|Overall Study|Lost to Follow-up|0|||
27562295|NCT02738333|80246218|FG002|Overall Study|Lost to Follow-up|0|||
27562296|NCT02385084|80246222|FG000|Period 2|Protocol Violation|0|||
27562297|NCT02385084|80246223|FG001|Period 2|Protocol Violation|0|||
27562298|NCT02385084|80246224|FG002|Period 2|Protocol Violation|1|||
27562299|NCT02385084|80246225|FG003|Period 2|Protocol Violation|0|||
27562300|NCT02385084|80246226|FG004|Period 2|Protocol Violation|0|||
27562301|NCT02385084|80246227|FG005|Period 2|Protocol Violation|0|||
27562302|NCT03970733|80246228|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
27562303|NCT03970733|80246229|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
27562304|NCT03970733|80246230|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
27562305|NCT03970733|80246231|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
27562306|NCT03970733|80246232|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
27562307|NCT03970733|80246228|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
27562308|NCT03970733|80246229|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
27562309|NCT03970733|80246230|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
27562310|NCT03970733|80246231|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
27562311|NCT03970733|80246232|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
27562312|NCT03970733|80246228|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
27562313|NCT03970733|80246229|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
27562314|NCT03970733|80246230|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
27562315|NCT03970733|80246231|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
27562316|NCT03970733|80246232|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
27562317|NCT03970733|80246228|FG000|Main Study Phase (18 Months)|Other|1|||
27562318|NCT03970733|80246229|FG001|Main Study Phase (18 Months)|Other|1|||
27562319|NCT03970733|80246230|FG002|Main Study Phase (18 Months)|Other|0|||
27562320|NCT03970733|80246231|FG003|Main Study Phase (18 Months)|Other|0|||
27562321|NCT03970733|80246232|FG004|Main Study Phase (18 Months)|Other|0|||
27562322|NCT03970733|80246228|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27562323|NCT03970733|80246229|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27562324|NCT03970733|80246230|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27562325|NCT03970733|80246231|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
27562326|NCT03970733|80246232|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
27562327|NCT00415909|80246233|FG000|Overall Study|Withdrawal by Subject|2|||
27562328|NCT00415909|80246233|FG000|Overall Study|Death|1|||
27562329|NCT01173718|80246234|FG000|Overall Study|Death|17|||
27562330|NCT01173718|80246234|FG000|Overall Study|Abandonment of study graft|27|||
27562331|NCT02951156|80246235|FG000|Overall Study|Death|3|||
27562332|NCT02951156|80246236|FG001|Overall Study|Death|8|||
27562333|NCT02951156|80246237|FG002|Overall Study|Death|5|||
27562334|NCT02951156|80246235|FG000|Overall Study|Progressive disease|1|||
27562335|NCT02951156|80246236|FG001|Overall Study|Progressive disease|0|||
27562336|NCT02951156|80246237|FG002|Overall Study|Progressive disease|1|||
27562337|NCT02951156|80246235|FG000|Overall Study|Withdrawal by Subject|0|||
27562338|NCT02951156|80246236|FG001|Overall Study|Withdrawal by Subject|0|||
27562339|NCT02951156|80246237|FG002|Overall Study|Withdrawal by Subject|1|||
27562340|NCT02951156|80246235|FG000|Overall Study|Study terminated by sponsor|0|||
27562341|NCT02951156|80246236|FG001|Overall Study|Study terminated by sponsor|0|||
27562342|NCT02951156|80246237|FG002|Overall Study|Study terminated by sponsor|1|||
27562343|NCT02951156|80246235|FG000|Overall Study|Other|5|||
27562344|NCT02951156|80246236|FG001|Overall Study|Other|1|||
27562345|NCT02951156|80246237|FG002|Overall Study|Other|2|||
27562346|NCT02419742|80246238|FG000|Overall Study|Adverse Event|2|||
27562347|NCT02419742|80246239|FG001|Overall Study|Adverse Event|0|||
27562348|NCT02419742|80246238|FG000|Overall Study|Disease Progression|0|||
27562349|NCT02419742|80246239|FG001|Overall Study|Disease Progression|1|||
27562350|NCT02419742|80246238|FG000|Overall Study|Withdrew Consent|2|||
27562351|NCT02419742|80246239|FG001|Overall Study|Withdrew Consent|1|||
27562352|NCT02419742|80246238|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
27562353|NCT02419742|80246239|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
27562354|NCT02802592|80246241|FG000|Overall Study|Study terminated due to loss of funding|4|||
27562355|NCT01857934|80246250|FG000|Overall Study|Relapse or progression|2|||
27562356|NCT01857934|80246250|FG000|Overall Study|Unacceptable toxicity|3|||
27562357|NCT01857934|80246250|FG000|Overall Study|Unwillingness or inability to comply|2|||
27562358|NCT01857934|80246250|FG000|Overall Study|Physician Decision|3|||
27562359|NCT02036502|80246258|FG000|Part 1:Dose Determination/Escalation|Death|3|||
27562360|NCT02036502|80246259|FG001|Part 1:Dose Determination/Escalation|Death|2|||
27562361|NCT02036502|80246260|FG002|Part 1:Dose Determination/Escalation|Death|0|||
27562362|NCT02036502|80246261|FG003|Part 1:Dose Determination/Escalation|Death|0|||
27562363|NCT02036502|80246262|FG004|Part 1:Dose Determination/Escalation|Death|0|||
27562364|NCT02036502|80246263|FG005|Part 1:Dose Determination/Escalation|Death|0|||
27562365|NCT02036502|80246264|FG006|Part 1:Dose Determination/Escalation|Death|0|||
27562366|NCT02036502|80246265|FG007|Part 1:Dose Determination/Escalation|Death|0|||
27562367|NCT02036502|80246258|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
27562368|NCT02036502|80246259|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562369|NCT02036502|80246260|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562370|NCT02036502|80246261|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562371|NCT02036502|80246262|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562372|NCT02036502|80246263|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562373|NCT02036502|80246264|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562374|NCT02036502|80246265|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
27562375|NCT02036502|80246258|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562376|NCT02036502|80246259|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
27562377|NCT02036502|80246260|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562378|NCT02036502|80246261|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562379|NCT02036502|80246262|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562380|NCT02036502|80246263|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562381|NCT02036502|80246264|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562382|NCT02036502|80246265|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
27562383|NCT02036502|80246258|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
27562384|NCT02036502|80246259|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
27562385|NCT02036502|80246260|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
27562386|NCT02036502|80246261|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
27755812|NCT01098461|80932588|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
27562387|NCT02036502|80246262|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
27755813|NCT01098461|80932589|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
27755814|NCT01098461|80932590|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
27755815|NCT01098461|80932591|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
27755816|NCT01098461|80932588|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
27755817|NCT01098461|80932589|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
27755818|NCT01098461|80932590|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
27755819|NCT01098461|80932591|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
27755820|NCT01098461|80932588|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
27755821|NCT01098461|80932589|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
27755822|NCT01098461|80932590|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
27755823|NCT01098461|80932591|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
27755824|NCT01098461|80932588|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
27755825|NCT01098461|80932589|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
27755826|NCT01098461|80932590|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
27755827|NCT01098461|80932591|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
27755828|NCT01098461|80932588|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
27755829|NCT01098461|80932589|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
27755830|NCT01098461|80932590|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
27755831|NCT01098461|80932591|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
27755832|NCT01098461|80932588|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
27755833|NCT01098461|80932589|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
27755834|NCT01098461|80932590|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
27755835|NCT01098461|80932591|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
27755836|NCT01702363|80932607|FG000|Overall Study|Adverse Event|14|||
27755837|NCT01702363|80932607|FG000|Overall Study|Lack of Efficacy|4|||
27755838|NCT01702363|80932607|FG000|Overall Study|Withdrawal by Subject|2|||
27755839|NCT03453151|80932609|FG000|Overall Study|Withdrawal by Subject|1|||
27755840|NCT03453151|80932609|FG000|Overall Study|Physician Decision|3|||
27755841|NCT01293032|80932610|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
27755842|NCT01293032|80932611|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
27755843|NCT01293032|80932612|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
27755844|NCT01293032|80932613|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
27755845|NCT01293032|80932610|FG000|Treatment|Adverse Event|0|||
27755846|NCT01293032|80932611|FG001|Treatment|Adverse Event|0|||
27562388|NCT02036502|80246263|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
27562389|NCT02036502|80246264|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
27562390|NCT02036502|80246265|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
27562391|NCT02036502|80246258|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27562392|NCT02036502|80246259|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27562393|NCT02036502|80246260|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
27562394|NCT02036502|80246261|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
27562395|NCT02036502|80246262|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
27562396|NCT02036502|80246263|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27562397|NCT02036502|80246264|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27562398|NCT02036502|80246265|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
27562399|NCT02036502|80246258|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562400|NCT02036502|80246259|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562401|NCT02036502|80246260|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
27562402|NCT02036502|80246261|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562403|NCT02036502|80246262|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562404|NCT02036502|80246263|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562405|NCT02036502|80246264|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562406|NCT02036502|80246265|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
27562407|NCT02036502|80246258|FG000|Part 2:Dose Confirmation|Death|0|||
27562408|NCT02036502|80246259|FG001|Part 2:Dose Confirmation|Death|0|||
27562409|NCT02036502|80246260|FG002|Part 2:Dose Confirmation|Death|1|||
27562410|NCT02036502|80246261|FG003|Part 2:Dose Confirmation|Death|0|||
27562411|NCT02036502|80246262|FG004|Part 2:Dose Confirmation|Death|0|||
27562412|NCT02036502|80246263|FG005|Part 2:Dose Confirmation|Death|0|||
27562413|NCT02036502|80246264|FG006|Part 2:Dose Confirmation|Death|0|||
27562414|NCT02036502|80246265|FG007|Part 2:Dose Confirmation|Death|0|||
27562415|NCT02036502|80246258|FG000|Part 2:Dose Confirmation|Not treated|0|||
27562416|NCT02036502|80246259|FG001|Part 2:Dose Confirmation|Not treated|0|||
27562417|NCT02036502|80246260|FG002|Part 2:Dose Confirmation|Not treated|0|||
27562418|NCT02036502|80246261|FG003|Part 2:Dose Confirmation|Not treated|1|||
27562419|NCT02036502|80246262|FG004|Part 2:Dose Confirmation|Not treated|0|||
27562420|NCT02036502|80246263|FG005|Part 2:Dose Confirmation|Not treated|0|||
27562421|NCT02036502|80246264|FG006|Part 2:Dose Confirmation|Not treated|0|||
27562422|NCT02036502|80246265|FG007|Part 2:Dose Confirmation|Not treated|0|||
27562423|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Adverse Event|0|||
27562424|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Adverse Event|0|||
27562425|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Adverse Event|0|||
27562426|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Adverse Event|0|||
27562427|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Adverse Event|0|||
27562428|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Adverse Event|4|||
27562429|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Adverse Event|0|||
27562430|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Adverse Event|2|||
27562431|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Death|0|||
27562432|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Death|0|||
27562433|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Death|0|||
27562434|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Death|0|||
27562435|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Death|0|||
27562436|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Death|24|||
27562437|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Death|0|||
27562438|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Death|3|||
27562439|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562440|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562441|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562442|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562443|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562444|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562445|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
27562446|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
27562447|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Physician Decision|0|||
27562448|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Physician Decision|0|||
27562449|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Physician Decision|0|||
27562450|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Physician Decision|0|||
27562451|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Physician Decision|0|||
27562452|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Physician Decision|1|||
27562453|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Physician Decision|0|||
27562454|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Physician Decision|0|||
27562455|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
27562456|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
27562457|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
27562458|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
27562459|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
27562460|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
27562461|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
27562462|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
27562463|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27562464|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27562465|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27562466|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27562467|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27562468|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
27562469|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
27562470|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
27562471|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27562472|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27562473|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27562474|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27562475|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
27562476|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
27562477|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
27562478|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
27755847|NCT01293032|80932612|FG002|Treatment|Adverse Event|1|||
27755848|NCT01293032|80932613|FG003|Treatment|Adverse Event|1|||
27755849|NCT01293032|80932610|FG000|Treatment|Withdrawal by Subject|2|||
27755850|NCT01293032|80932611|FG001|Treatment|Withdrawal by Subject|4|||
27755851|NCT01293032|80932612|FG002|Treatment|Withdrawal by Subject|0|||
27755852|NCT01293032|80932613|FG003|Treatment|Withdrawal by Subject|0|||
27755853|NCT01293032|80932610|FG000|Treatment|Disease Progression, relapse|0|||
27755854|NCT01293032|80932611|FG001|Treatment|Disease Progression, relapse|1|||
27755855|NCT01293032|80932612|FG002|Treatment|Disease Progression, relapse|0|||
27755856|NCT01293032|80932613|FG003|Treatment|Disease Progression, relapse|0|||
27562479|NCT02036502|80246258|FG000|Part 3:Dose Expansion|Not Treated|0|||
27755857|NCT01069523|80932616|FG000|Overall Study|Withdrawal by Subject|4|||
27755858|NCT01069523|80932617|FG001|Overall Study|Withdrawal by Subject|7|||
27755859|NCT01626352|80932619|FG000|Overall Study|Disease Progression|3|||
27755860|NCT01626352|80932619|FG000|Overall Study|Intercurrent Illness|2|||
27562480|NCT02036502|80246259|FG001|Part 3:Dose Expansion|Not Treated|0|||
27562481|NCT02036502|80246260|FG002|Part 3:Dose Expansion|Not Treated|0|||
27755861|NCT01626352|80932619|FG000|Overall Study|Death|2|||
27755862|NCT01626352|80932619|FG000|Overall Study|Withdrawal by Subject|1|||
27755863|NCT01626352|80932619|FG000|Overall Study|Non-Compliance|1|||
27755864|NCT01626352|80932619|FG000|Overall Study|Never Treated|1|||
27755865|NCT01911845|80932620|FG000|Overall Study|Adverse Event|2|||
27755866|NCT01911845|80932620|FG000|Overall Study|Lost to Follow-up|1|||
27755867|NCT01911845|80932620|FG000|Overall Study|Other (not specified)|3|||
27755868|NCT00356863|80932621|FG000|Overall Study|Death|16|||
27755869|NCT00356863|80932622|FG001|Overall Study|Death|32|||
27755870|NCT00356863|80932621|FG000|Overall Study|Lost to Follow-up|76|||
27755871|NCT00356863|80932622|FG001|Overall Study|Lost to Follow-up|43|||
27755872|NCT00976950|80932623|FG000|Overall Study|Adverse Event|3|||
27654831|NCT00321555|80576787|FG000|Overall Study|Developed antibodies|1|||
27654832|NCT00321555|80576787|FG000|Overall Study|Switched to alternative treatment|3|||
27654833|NCT00321555|80576787|FG000|Overall Study|Physician Decision|1|||
27654834|NCT00321555|80576787|FG000|Overall Study|Disease progression on study|1|||
27654835|NCT05072795|80576788|FG000|Overall Study|Lost to Follow-up|5|||
27654836|NCT01180400|80576790|FG000|Overall Study|Withdrawal by Subject|5|||
27654837|NCT01180400|80576791|FG001|Overall Study|Withdrawal by Subject|6|||
27654838|NCT01180400|80576790|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27654839|NCT01180400|80576791|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
27654840|NCT01180400|80576790|FG000|Overall Study|Adverse Event|12|||
27654841|NCT01180400|80576791|FG001|Overall Study|Adverse Event|10|||
27654842|NCT01180400|80576790|FG000|Overall Study|Severe non-compliance to protocol|1|||
27654843|NCT01180400|80576791|FG001|Overall Study|Severe non-compliance to protocol|2|||
27654844|NCT01180400|80576790|FG000|Overall Study|Condition under investigation worsened|2|||
27654845|NCT01180400|80576791|FG001|Overall Study|Condition under investigation worsened|1|||
27654846|NCT01180400|80576790|FG000|Overall Study|Lack of Efficacy|2|||
27654847|NCT01180400|80576791|FG001|Overall Study|Lack of Efficacy|0|||
27654848|NCT01180400|80576790|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27654849|NCT01180400|80576791|FG001|Overall Study|Study-specific withdrawal criteria|2|||
27654850|NCT01180400|80576790|FG000|Overall Study|Lost to Follow-up|2|||
27654851|NCT01180400|80576791|FG001|Overall Study|Lost to Follow-up|3|||
27654852|NCT01180400|80576790|FG000|Overall Study|Other|0|||
27654853|NCT01180400|80576791|FG001|Overall Study|Other|1|||
27654854|NCT02830893|80576793|FG000|Overall Study|Relocation to out of the country|1|||
27654855|NCT02830893|80576794|FG001|Overall Study|Relocation to out of the country|0|||
27654856|NCT02830893|80576793|FG000|Overall Study|Lost to Follow-up|0|||
27654857|NCT02830893|80576794|FG001|Overall Study|Lost to Follow-up|2|||
27654858|NCT02830893|80576793|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
27654859|NCT02830893|80576794|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
27654860|NCT01911819|80576795|FG000|Overall Study|Adverse Event|0|||
27654861|NCT01911819|80576796|FG001|Overall Study|Adverse Event|1|||
27654862|NCT01911819|80576797|FG002|Overall Study|Adverse Event|0|||
27654863|NCT01911819|80576795|FG000|Overall Study|Withdrawal by Subject|1|||
27654864|NCT01911819|80576796|FG001|Overall Study|Withdrawal by Subject|1|||
27654865|NCT01911819|80576797|FG002|Overall Study|Withdrawal by Subject|0|||
27654866|NCT03686176|80576799|FG000|Overall Study|Procedure cancelled|1|||
27654867|NCT03686176|80576800|FG001|Overall Study|Procedure cancelled|0|||
27654868|NCT03686176|80576801|FG002|Overall Study|Procedure cancelled|0|||
27654869|NCT03686176|80576799|FG000|Overall Study|VR Malfunction|1|||
27654870|NCT03686176|80576800|FG001|Overall Study|VR Malfunction|0|||
27654871|NCT03686176|80576801|FG002|Overall Study|VR Malfunction|0|||
27654872|NCT00670449|80576805|FG000|Overall Study|Adverse Event|6|||
27654873|NCT00670449|80576806|FG001|Overall Study|Adverse Event|2|||
27755873|NCT00976950|80932623|FG000|Overall Study|Events with no relationship to Aptivus|3|||
27755874|NCT01669811|80932624|FG000|Overall Study|Investigator decision|0|||
27755875|NCT01669811|80932625|FG001|Overall Study|Investigator decision|1|||
27755876|NCT01669811|80932624|FG000|Overall Study|Withdrawal by Subject|1|||
27755877|NCT01669811|80932625|FG001|Overall Study|Withdrawal by Subject|2|||
27755878|NCT01669811|80932624|FG000|Overall Study|Adverse Event|2|||
27755879|NCT01669811|80932625|FG001|Overall Study|Adverse Event|6|||
27755880|NCT01669811|80932624|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27755881|NCT01669811|80932625|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27755882|NCT04348591|80932626|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
27755883|NCT04348591|80932627|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
27755884|NCT04348591|80932626|FG000|Imaging Session (120 Min)|Physician Decision|0|||
27755885|NCT04348591|80932627|FG001|Imaging Session (120 Min)|Physician Decision|1|||
27755886|NCT04348591|80932626|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
27755887|NCT04348591|80932627|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
27755888|NCT03259490|80932629|FG000|Period 1|Withdrawal by Subject|0|||
27755889|NCT03259490|80932630|FG001|Period 1|Withdrawal by Subject|1|||
27755890|NCT03259490|80932629|FG000|Period 2|Protocol Violation|1|||
27755891|NCT03259490|80932630|FG001|Period 2|Protocol Violation|0|||
27755892|NCT00343291|80932643|FG000|Overall Study|Adverse Event|13|||
27654874|NCT00670449|80576807|FG002|Overall Study|Adverse Event|8|||
27654875|NCT00670449|80576808|FG003|Overall Study|Adverse Event|5|||
27654876|NCT00670449|80576805|FG000|Overall Study|Protocol Deviation|1|||
27755893|NCT00343291|80932644|FG001|Overall Study|Adverse Event|13|||
27654877|NCT00670449|80576806|FG001|Overall Study|Protocol Deviation|2|||
27654878|NCT00670449|80576807|FG002|Overall Study|Protocol Deviation|0|||
27654879|NCT00670449|80576808|FG003|Overall Study|Protocol Deviation|1|||
27654880|NCT00670449|80576805|FG000|Overall Study|Administrative Problems|0|||
27654881|NCT00670449|80576806|FG001|Overall Study|Administrative Problems|2|||
27654882|NCT00670449|80576807|FG002|Overall Study|Administrative Problems|0|||
27654883|NCT00670449|80576808|FG003|Overall Study|Administrative Problems|1|||
27654884|NCT00670449|80576805|FG000|Overall Study|Subject Withdrew Consent|0|||
27654885|NCT00670449|80576806|FG001|Overall Study|Subject Withdrew Consent|2|||
27654886|NCT00670449|80576807|FG002|Overall Study|Subject Withdrew Consent|0|||
27654887|NCT00670449|80576808|FG003|Overall Study|Subject Withdrew Consent|1|||
27654888|NCT00670449|80576805|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
27654889|NCT00670449|80576806|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27654890|NCT00670449|80576807|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
27654891|NCT00670449|80576808|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27654892|NCT00670449|80576805|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
27654893|NCT00670449|80576806|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
27654894|NCT00670449|80576807|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
27654895|NCT00670449|80576808|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
27654896|NCT01074229|80576811|FG000|Overall Study|Lost to Follow-up|1|||
27654897|NCT01074229|80576812|FG001|Overall Study|Lost to Follow-up|0|||
27654898|NCT01074229|80576813|FG002|Overall Study|Lost to Follow-up|0|||
27654899|NCT01074229|80576811|FG000|Overall Study|Change to open surgical procedure|1|||
27654900|NCT01074229|80576812|FG001|Overall Study|Change to open surgical procedure|3|||
27654901|NCT01074229|80576813|FG002|Overall Study|Change to open surgical procedure|4|||
27654902|NCT04085614|80576814|FG000|Overall Study|Protocol Violation|9|||
27654903|NCT04085614|80576815|FG001|Overall Study|Protocol Violation|6|||
27654904|NCT02865083|80576816|FG000|Overall Study|Early Termination|3|||
27654905|NCT02865083|80576817|FG001|Overall Study|Early Termination|1|||
27654906|NCT00535626|80576818|FG000|Overall Study|Death|15|||
27755894|NCT00343291|80932643|FG000|Overall Study|Death|3|||
27755895|NCT00343291|80932644|FG001|Overall Study|Death|2|||
27654907|NCT00535626|80576818|FG000|Overall Study|Lost to Follow-up|29|||
27654908|NCT00535626|80576818|FG000|Overall Study|Withdrawal by Subject|20|||
27654909|NCT00535626|80576818|FG000|Overall Study|Removal/revision of study component|8|||
27654910|NCT00535626|80576818|FG000|Overall Study|Subject terminated|31|||
27654911|NCT00535626|80576818|FG000|Overall Study|Unable to return|2|||
27654912|NCT00821093|80576822|FG000|Overall Study|Adverse Event|20|||
27654913|NCT00821093|80576823|FG001|Overall Study|Adverse Event|12|||
27654914|NCT00821093|80576822|FG000|Overall Study|Withdrawal by Subject|9|||
27654915|NCT00821093|80576823|FG001|Overall Study|Withdrawal by Subject|13|||
27654916|NCT00821093|80576822|FG000|Overall Study|Lost to Follow-up|9|||
27654917|NCT00821093|80576823|FG001|Overall Study|Lost to Follow-up|3|||
27654918|NCT00821093|80576822|FG000|Overall Study|Protocol deviation|3|||
27654919|NCT00821093|80576823|FG001|Overall Study|Protocol deviation|6|||
27654920|NCT00821093|80576822|FG000|Overall Study|Abnormal laboratory value(s)|2|||
27654921|NCT00821093|80576823|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27654922|NCT00821093|80576822|FG000|Overall Study|Lack of Efficacy|2|||
27654923|NCT00821093|80576823|FG001|Overall Study|Lack of Efficacy|2|||
27654924|NCT00821093|80576822|FG000|Overall Study|Death|2|||
27654925|NCT00821093|80576823|FG001|Overall Study|Death|1|||
27654926|NCT00821093|80576822|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27654927|NCT00821093|80576823|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27654928|NCT00821093|80576822|FG000|Overall Study|Administrative problems|1|||
27654929|NCT00821093|80576823|FG001|Overall Study|Administrative problems|2|||
27654930|NCT01377844|80576824|FG000|Overall Study|Withdrawal by Subject|25|||
27654931|NCT01377844|80576825|FG001|Overall Study|Withdrawal by Subject|28|||
27654932|NCT01377844|80576824|FG000|Overall Study|Protocol Violation|2|||
27654933|NCT01377844|80576825|FG001|Overall Study|Protocol Violation|3|||
27654934|NCT01377844|80576824|FG000|Overall Study|Adverse Event|3|||
27755896|NCT00343291|80932643|FG000|Overall Study|Progressive disease|33|||
27755897|NCT00343291|80932644|FG001|Overall Study|Progressive disease|34|||
27755898|NCT00343291|80932643|FG000|Overall Study|Withdrawal by Subject|0|||
27755899|NCT00343291|80932644|FG001|Overall Study|Withdrawal by Subject|2|||
27755900|NCT00343291|80932643|FG000|Overall Study|Other|8|||
27755901|NCT00343291|80932644|FG001|Overall Study|Other|5|||
27755902|NCT02864940|80932647|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
27755903|NCT02864940|80932648|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
27755904|NCT00264849|80932650|FG000|Overall Study|Adverse Event|7|||
27755905|NCT00264849|80932651|FG001|Overall Study|Adverse Event|2|||
27755906|NCT00264849|80932650|FG000|Overall Study|Withdrawal by Subject|7|||
27755907|NCT00264849|80932651|FG001|Overall Study|Withdrawal by Subject|11|||
27755908|NCT00264849|80932650|FG000|Overall Study|Protocol Violation|5|||
27755909|NCT00264849|80932651|FG001|Overall Study|Protocol Violation|3|||
27755910|NCT00264849|80932650|FG000|Overall Study|Lack of Efficacy|1|||
27654935|NCT01377844|80576825|FG001|Overall Study|Adverse Event|0|||
27654936|NCT01377844|80576824|FG000|Overall Study|Physician Decision|6|||
27857802|NCT00699374|81314388|FG001|Overall Study|Randomized but not treated|2|||
27857803|NCT00699374|81314387|FG000|Overall Study|Died 28 days after last dose|5|||
27857804|NCT00699374|81314388|FG001|Overall Study|Died 28 days after last dose|9|||
27654937|NCT01377844|80576825|FG001|Overall Study|Physician Decision|3|||
27654938|NCT01377844|80576824|FG000|Overall Study|Study terminated by Sponsor|0|||
27654939|NCT01377844|80576825|FG001|Overall Study|Study terminated by Sponsor|1|||
27654940|NCT00476151|80576827|FG000|Overall Study|Adverse Event|0|||
27654941|NCT00476151|80576828|FG001|Overall Study|Adverse Event|2|||
27654942|NCT00476151|80576827|FG000|Overall Study|Protocol Violation|1|||
27654943|NCT00476151|80576828|FG001|Overall Study|Protocol Violation|3|||
27654944|NCT00476151|80576827|FG000|Overall Study|Withdrawal by Subject|2|||
27654945|NCT00476151|80576828|FG001|Overall Study|Withdrawal by Subject|0|||
27654946|NCT00476151|80576827|FG000|Overall Study|Physician Decision|0|||
27654947|NCT00476151|80576828|FG001|Overall Study|Physician Decision|2|||
27654948|NCT03769090|80576832|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
27654949|NCT03769090|80576833|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
27654950|NCT03769090|80576834|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
27654951|NCT03769090|80576832|FG000|Overall Study|Withdrawal by Subject|52|||
27654952|NCT03769090|80576833|FG001|Overall Study|Withdrawal by Subject|62|||
27654953|NCT03769090|80576834|FG002|Overall Study|Withdrawal by Subject|74|||
27654954|NCT03769090|80576832|FG000|Overall Study|Death|4|||
27654955|NCT03769090|80576833|FG001|Overall Study|Death|2|||
27654956|NCT03769090|80576834|FG002|Overall Study|Death|2|||
27654957|NCT03769090|80576832|FG000|Overall Study|Adverse Event|7|||
27654958|NCT03769090|80576833|FG001|Overall Study|Adverse Event|7|||
27654959|NCT03769090|80576834|FG002|Overall Study|Adverse Event|8|||
27654960|NCT03769090|80576832|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
27654961|NCT03769090|80576833|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
27654962|NCT03769090|80576834|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
27654963|NCT03769090|80576832|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
27654964|NCT03769090|80576833|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
27654965|NCT03769090|80576834|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
27654966|NCT03769090|80576832|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
27654967|NCT03769090|80576833|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
27654968|NCT03769090|80576834|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
27654969|NCT03769090|80576832|FG000|Overall Study|Protocol Violation|5|||
27654970|NCT03769090|80576833|FG001|Overall Study|Protocol Violation|6|||
27654971|NCT03769090|80576834|FG002|Overall Study|Protocol Violation|8|||
27654972|NCT03769090|80576832|FG000|Overall Study|Pregnancy|1|||
27654973|NCT03769090|80576833|FG001|Overall Study|Pregnancy|0|||
27654974|NCT03769090|80576834|FG002|Overall Study|Pregnancy|3|||
27654975|NCT03769090|80576832|FG000|Overall Study|Lost to Follow-up|19|||
27654976|NCT03769090|80576833|FG001|Overall Study|Lost to Follow-up|25|||
27654977|NCT03769090|80576834|FG002|Overall Study|Lost to Follow-up|21|||
27654978|NCT03769090|80576832|FG000|Overall Study|Condition under investigation worsened|2|||
27654979|NCT03769090|80576833|FG001|Overall Study|Condition under investigation worsened|0|||
27654980|NCT03769090|80576834|FG002|Overall Study|Condition under investigation worsened|1|||
27654981|NCT03769090|80576832|FG000|Overall Study|Lack of Efficacy|1|||
27654982|NCT03769090|80576833|FG001|Overall Study|Lack of Efficacy|2|||
27654983|NCT03769090|80576834|FG002|Overall Study|Lack of Efficacy|2|||
27654984|NCT03769090|80576832|FG000|Overall Study|Other reasons|8|||
27654985|NCT03769090|80576833|FG001|Overall Study|Other reasons|12|||
27654986|NCT03769090|80576834|FG002|Overall Study|Other reasons|15|||
27654987|NCT00529529|80576835|FG000|Overall Study|Adverse Event|12|||
27654988|NCT00529529|80576836|FG001|Overall Study|Adverse Event|17|||
27654989|NCT00529529|80576837|FG002|Overall Study|Adverse Event|8|||
27654990|NCT00529529|80576835|FG000|Overall Study|Subject withdrew consent|12|||
27755911|NCT00264849|80932651|FG001|Overall Study|Lack of Efficacy|6|||
27654991|NCT00529529|80576836|FG001|Overall Study|Subject withdrew consent|9|||
27654992|NCT00529529|80576837|FG002|Overall Study|Subject withdrew consent|12|||
27654993|NCT00529529|80576835|FG000|Overall Study|Protocol deviation|8|||
27654994|NCT00529529|80576836|FG001|Overall Study|Protocol deviation|12|||
27654995|NCT00529529|80576837|FG002|Overall Study|Protocol deviation|5|||
27654996|NCT00529529|80576835|FG000|Overall Study|Lost to Follow-up|5|||
27654997|NCT00529529|80576836|FG001|Overall Study|Lost to Follow-up|3|||
27654998|NCT00529529|80576837|FG002|Overall Study|Lost to Follow-up|1|||
27654999|NCT00529529|80576835|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27655000|NCT00529529|80576836|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27755912|NCT00264849|80932650|FG000|Overall Study|Lost to Follow-up|0|||
27857805|NCT02397408|81314389|FG000|Overall Study|Physician Decision|4|||
27655001|NCT00529529|80576837|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27655002|NCT00529529|80576835|FG000|Overall Study|Death|2|||
27655003|NCT00529529|80576836|FG001|Overall Study|Death|0|||
27755913|NCT00264849|80932651|FG001|Overall Study|Lost to Follow-up|2|||
27755914|NCT00264849|80932650|FG000|Overall Study|Death|0|||
27655004|NCT00529529|80576837|FG002|Overall Study|Death|0|||
27655005|NCT00529529|80576835|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27655006|NCT00529529|80576836|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27655007|NCT00529529|80576837|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27655008|NCT00529529|80576835|FG000|Overall Study|Administrative problems|1|||
27655009|NCT00529529|80576836|FG001|Overall Study|Administrative problems|0|||
27655010|NCT00529529|80576837|FG002|Overall Study|Administrative problems|3|||
27655011|NCT00632736|80576838|FG000|Overall Study|Adverse Event|104|||
27655012|NCT00632736|80576838|FG000|Overall Study|Lost to Follow-up|15|||
27655013|NCT00632736|80576838|FG000|Overall Study|Protocol Violation|14|||
27655014|NCT00632736|80576838|FG000|Overall Study|Withdrawal by Subject|99|||
27655015|NCT00632736|80576838|FG000|Overall Study|Lack of Efficacy|5|||
27655016|NCT00632736|80576838|FG000|Overall Study|Sponsor terminated study|5|||
27655017|NCT00632736|80576838|FG000|Overall Study|Non-compliance|10|||
27655018|NCT00632736|80576838|FG000|Overall Study|Other|16|||
27655019|NCT00621842|80576844|FG000|Overall Study|Adverse Event|6|||
27655020|NCT00621842|80576844|FG000|Overall Study|Withdrawal by Subject|7|||
27655021|NCT00621842|80576844|FG000|Overall Study|Protocol Violation|4|||
27655022|NCT00621842|80576844|FG000|Overall Study|Lack of Efficacy|2|||
27655023|NCT00832650|80576845|FG000|Overall Study|Randomized but not treated|0|||
27655024|NCT00832650|80576846|FG001|Overall Study|Randomized but not treated|0|||
27655025|NCT00832650|80576847|FG002|Overall Study|Randomized but not treated|1|||
27655026|NCT00732498|80576848|FG000|Overall Study|Ineligible|1|||
27655027|NCT00732498|80576848|FG000|Overall Study|Adverse Event|2|||
27655028|NCT00732498|80576848|FG000|Overall Study|Physician Decision|3|||
27655029|NCT00753896|80576849|FG000|Overall Study|Adverse Event|4|||
27655030|NCT00753896|80576849|FG000|Overall Study|Death|1|||
27655031|NCT00753896|80576849|FG000|Overall Study|Lost to Follow-up|2|||
27655032|NCT00753896|80576849|FG000|Overall Study|Protocol Violation|1|||
27755915|NCT00264849|80932651|FG001|Overall Study|Death|1|||
27755916|NCT00264849|80932650|FG000|Overall Study|Administrative Problems|2|||
27755917|NCT00264849|80932651|FG001|Overall Study|Administrative Problems|0|||
27655033|NCT00753896|80576849|FG000|Overall Study|Withdrawal by Subject|4|||
27655034|NCT00753896|80576849|FG000|Overall Study|Entry Criteria Not Met|4|||
27655035|NCT00441168|80576850|FG000|Treatment Period|Death|3|||
27655036|NCT00441168|80576851|FG001|Treatment Period|Death|0|||
27655037|NCT00441168|80576850|FG000|Treatment Period|Adverse Event|1|||
27655038|NCT00441168|80576851|FG001|Treatment Period|Adverse Event|2|||
27655039|NCT00441168|80576850|FG000|Treatment Period|Progressive Disease|0|||
27655040|NCT00441168|80576851|FG001|Treatment Period|Progressive Disease|2|||
27755918|NCT01968954|80932658|FG000|Overall Study|Adverse Event|6|||
27755919|NCT01968954|80932659|FG001|Overall Study|Adverse Event|3|||
27755920|NCT01968954|80932658|FG000|Overall Study|Death|1|||
27755921|NCT01968954|80932659|FG001|Overall Study|Death|2|||
27755922|NCT01968954|80932658|FG000|Overall Study|Lost to Follow-up|6|||
27755923|NCT01968954|80932659|FG001|Overall Study|Lost to Follow-up|4|||
27755924|NCT01968954|80932658|FG000|Overall Study|Withdrawal by Subject|20|||
27755925|NCT01968954|80932659|FG001|Overall Study|Withdrawal by Subject|23|||
27755926|NCT01968954|80932658|FG000|Overall Study|Other|7|||
27755927|NCT01968954|80932659|FG001|Overall Study|Other|8|||
27755928|NCT01968954|80932658|FG000|Overall Study|Protocol Violation|0|||
27755929|NCT01968954|80932659|FG001|Overall Study|Protocol Violation|1|||
27755930|NCT01968954|80932658|FG000|Overall Study|Did not met inclusion criteria|0|||
27755931|NCT01968954|80932659|FG001|Overall Study|Did not met inclusion criteria|2|||
27755932|NCT00980980|80932662|FG000|Overall Study|Withdrawal by Hospital|0|||
27755933|NCT00980980|80932663|FG001|Overall Study|Withdrawal by Hospital|1|||
27755934|NCT00980980|80932664|FG002|Overall Study|Withdrawal by Hospital|0|||
27755935|NCT03521193|80932665|FG000|Overall Study|Withdrawal by Subject|8|||
27755936|NCT03521193|80932666|FG001|Overall Study|Withdrawal by Subject|0|||
27886600|NCT01435018|81418122|FG002|Overall Study|Withdrew consent|1|||
27562482|NCT02036502|80246261|FG003|Part 3:Dose Expansion|Not Treated|0|||
27562483|NCT02036502|80246262|FG004|Part 3:Dose Expansion|Not Treated|0|||
27562484|NCT02036502|80246263|FG005|Part 3:Dose Expansion|Not Treated|2|||
27562485|NCT02036502|80246264|FG006|Part 3:Dose Expansion|Not Treated|0|||
27562486|NCT02036502|80246265|FG007|Part 3:Dose Expansion|Not Treated|0|||
27562487|NCT00537381|80246266|FG000|Overall Study|Adverse Event|13|||
27562488|NCT00537381|80246267|FG001|Overall Study|Adverse Event|9|||
27655041|NCT00441168|80576850|FG000|Treatment Period|Protocol Violation|0|||
27655042|NCT00441168|80576851|FG001|Treatment Period|Protocol Violation|1|||
27655043|NCT00441168|80576850|FG000|Treatment Period|Lost to Follow-up|0|||
27655044|NCT00441168|80576851|FG001|Treatment Period|Lost to Follow-up|1|||
27655045|NCT00441168|80576850|FG000|Treatment Period|Withdrawal by Subject|3|||
27655046|NCT00441168|80576851|FG001|Treatment Period|Withdrawal by Subject|0|||
27655047|NCT00441168|80576850|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
27755937|NCT03521193|80932665|FG000|Overall Study|non compliant to ASA treatment|8|||
27755938|NCT03521193|80932666|FG001|Overall Study|non compliant to ASA treatment|0|||
27755939|NCT00808249|80932668|FG000|Overall Study|Adverse Event|4|||
27755940|NCT00808249|80932669|FG001|Overall Study|Adverse Event|7|||
27562489|NCT00537381|80246266|FG000|Overall Study|Death|3|||
27562490|NCT00537381|80246267|FG001|Overall Study|Death|3|||
27562491|NCT00537381|80246266|FG000|Overall Study|Withdrawal by Subject|5|||
27562492|NCT00537381|80246267|FG001|Overall Study|Withdrawal by Subject|14|||
27562493|NCT00537381|80246266|FG000|Overall Study|Physician Decision|7|||
27562494|NCT00537381|80246267|FG001|Overall Study|Physician Decision|6|||
27562495|NCT00537381|80246266|FG000|Overall Study|Disease Progression|9|||
27562496|NCT00537381|80246267|FG001|Overall Study|Disease Progression|18|||
27562497|NCT00537381|80246266|FG000|Overall Study|Sponsor decision|14|||
27562498|NCT00537381|80246267|FG001|Overall Study|Sponsor decision|9|||
27562499|NCT00537381|80246266|FG000|Overall Study|Other|5|||
27562500|NCT00537381|80246267|FG001|Overall Study|Other|3|||
27562501|NCT05089682|80246277|FG000|Overall Study|Withdrawal by Subject|2|||
27755941|NCT00808249|80932670|FG002|Overall Study|Adverse Event|10|||
27755942|NCT00808249|80932671|FG003|Overall Study|Adverse Event|6|||
27755943|NCT00808249|80932668|FG000|Overall Study|Lost to Follow-up|2|||
27755944|NCT00808249|80932669|FG001|Overall Study|Lost to Follow-up|3|||
27755945|NCT00808249|80932670|FG002|Overall Study|Lost to Follow-up|3|||
27755946|NCT00808249|80932671|FG003|Overall Study|Lost to Follow-up|5|||
27755947|NCT00808249|80932668|FG000|Overall Study|Withdrawal by Subject|4|||
27562502|NCT01316276|80246278|FG000|Overall Study|Death|1|||
27755948|NCT00808249|80932669|FG001|Overall Study|Withdrawal by Subject|0|||
27755949|NCT00808249|80932670|FG002|Overall Study|Withdrawal by Subject|2|||
27562503|NCT01316276|80246278|FG000|Overall Study|Adverse Event|19|||
27562504|NCT01316276|80246278|FG000|Overall Study|Withdrawal of consent|24|||
27562505|NCT01316276|80246278|FG000|Overall Study|Lost to Follow-up|1|||
27562506|NCT01316276|80246278|FG000|Overall Study|Other|22|||
27562507|NCT02503332|80246279|FG000|Overall Study|Adverse Event|17|||
27562508|NCT02503332|80246280|FG001|Overall Study|Adverse Event|5|||
27562509|NCT02503332|80246281|FG002|Overall Study|Adverse Event|3|||
27562510|NCT02503332|80246282|FG003|Overall Study|Adverse Event|1|||
27562511|NCT02503332|80246279|FG000|Overall Study|Investigator's Decision|5|||
27562512|NCT02503332|80246280|FG001|Overall Study|Investigator's Decision|1|||
27562513|NCT02503332|80246281|FG002|Overall Study|Investigator's Decision|0|||
27562514|NCT02503332|80246282|FG003|Overall Study|Investigator's Decision|0|||
27562515|NCT02503332|80246279|FG000|Overall Study|Sponsor's Decision|1|||
27562516|NCT02503332|80246280|FG001|Overall Study|Sponsor's Decision|0|||
27655048|NCT00441168|80576851|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
27655049|NCT00441168|80576850|FG000|Treatment Period|refractory disease|1|||
27655050|NCT00441168|80576851|FG001|Treatment Period|refractory disease|0|||
27655051|NCT00441168|80576850|FG000|Follow-up Period|Death|3|||
27655052|NCT00441168|80576851|FG001|Follow-up Period|Death|0|||
27655053|NCT00441168|80576850|FG000|Follow-up Period|Lost to Follow-up|5|||
27655054|NCT00441168|80576851|FG001|Follow-up Period|Lost to Follow-up|6|||
27655055|NCT00441168|80576850|FG000|Follow-up Period|Withdrawal by Subject|3|||
27655056|NCT00441168|80576851|FG001|Follow-up Period|Withdrawal by Subject|0|||
27655057|NCT00441168|80576850|FG000|Follow-up Period|Other|1|||
27655058|NCT00441168|80576851|FG001|Follow-up Period|Other|3|||
27655059|NCT01528605|80576852|FG000|Overall Study|Lost to Follow-up|1|||
27655060|NCT01528605|80576853|FG001|Overall Study|Lost to Follow-up|0|||
27655061|NCT01528605|80576854|FG002|Overall Study|Lost to Follow-up|1|||
27655062|NCT01528605|80576855|FG003|Overall Study|Lost to Follow-up|1|||
27562517|NCT02503332|80246281|FG002|Overall Study|Sponsor's Decision|0|||
27655063|NCT01528605|80576856|FG004|Overall Study|Lost to Follow-up|0|||
27655064|NCT01528605|80576857|FG005|Overall Study|Lost to Follow-up|0|||
27655065|NCT01528605|80576852|FG000|Overall Study|Death|1|||
27655066|NCT01528605|80576853|FG001|Overall Study|Death|0|||
27655067|NCT01528605|80576854|FG002|Overall Study|Death|0|||
27655068|NCT01528605|80576855|FG003|Overall Study|Death|0|||
27655069|NCT01528605|80576856|FG004|Overall Study|Death|0|||
27562518|NCT02503332|80246282|FG003|Overall Study|Sponsor's Decision|1|||
27655070|NCT01528605|80576857|FG005|Overall Study|Death|0|||
27655071|NCT02964234|80576861|FG000|Overall Study|Lost to Follow-up|22|||
27655072|NCT02964234|80576862|FG001|Overall Study|Lost to Follow-up|13|||
27655073|NCT00307489|80576863|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
27655074|NCT00307489|80576864|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
27655075|NCT00307489|80576863|FG000|Baseline Through Week 48|Physician Decision|1|||
27655076|NCT00307489|80576864|FG001|Baseline Through Week 48|Physician Decision|0|||
27655077|NCT00307489|80576863|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
27655078|NCT00307489|80576864|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
27655079|NCT00307489|80576863|FG000|Week 48 Through Week 168|Adverse Event|1|||
27655080|NCT00307489|80576864|FG001|Week 48 Through Week 168|Adverse Event|0|||
27655081|NCT00307489|80576863|FG000|Week 48 Through Week 168|Physician Decision|1|||
27655082|NCT00307489|80576864|FG001|Week 48 Through Week 168|Physician Decision|0|||
27655083|NCT00307489|80576863|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
27655084|NCT00307489|80576864|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
27655085|NCT00307489|80576863|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
27755950|NCT00808249|80932671|FG003|Overall Study|Withdrawal by Subject|4|||
27755951|NCT00808249|80932668|FG000|Overall Study|Protocol Violation|3|||
27655086|NCT00307489|80576864|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
27655087|NCT00307489|80576863|FG000|Week 48 Through Week 168|Death|0|||
27655088|NCT00307489|80576864|FG001|Week 48 Through Week 168|Death|1|||
27655089|NCT00307489|80576863|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
27655090|NCT00307489|80576864|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
27655091|NCT00307489|80576863|FG000|Week 48 Through Week 168|Seroconversion|1|||
27655092|NCT00307489|80576864|FG001|Week 48 Through Week 168|Seroconversion|0|||
27655093|NCT01714947|80576865|FG000|Part B|Progressive Disease|3|||
27655094|NCT04421456|80576866|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
27655095|NCT04421456|80576867|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
27655096|NCT04421456|80576868|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
27655097|NCT04421456|80576866|FG000|Randomized Treatment Period|Adverse Event|0|||
27655098|NCT04421456|80576867|FG001|Randomized Treatment Period|Adverse Event|1|||
27655099|NCT04421456|80576868|FG002|Randomized Treatment Period|Adverse Event|0|||
27655100|NCT04421456|80576866|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
27655101|NCT04421456|80576867|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
27655102|NCT04421456|80576868|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
27655103|NCT04421456|80576866|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
27655104|NCT04421456|80576867|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
27655105|NCT04421456|80576868|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
27655106|NCT04421456|80576866|FG000|Randomized Treatment Period|Participant non-compliance|1|||
27655107|NCT04421456|80576867|FG001|Randomized Treatment Period|Participant non-compliance|1|||
27655108|NCT04421456|80576868|FG002|Randomized Treatment Period|Participant non-compliance|2|||
27655109|NCT04421456|80576866|FG000|Randomized Treatment Period|Other|0|||
27655110|NCT04421456|80576867|FG001|Randomized Treatment Period|Other|1|||
27655111|NCT04421456|80576868|FG002|Randomized Treatment Period|Other|3|||
27655112|NCT00134056|80576869|FG000|Randomization|Not eligible for assigned treatment|22|||
27655113|NCT00134056|80576870|FG001|Randomization|Not eligible for assigned treatment|20|||
27655114|NCT00134056|80576869|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
27655115|NCT00134056|80576870|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
27655116|NCT00134056|80576869|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
27655117|NCT00134056|80576870|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
27655118|NCT00134056|80576869|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
27655119|NCT00134056|80576870|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
27655120|NCT00134056|80576869|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
27655121|NCT00134056|80576870|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
27655122|NCT01964547|80576877|FG000|Overall Study|Adverse Event|8|||
27655123|NCT01964547|80576878|FG001|Overall Study|Adverse Event|2|||
27655124|NCT01964547|80576877|FG000|Overall Study|Withdrawal by Subject|4|||
27655125|NCT01964547|80576878|FG001|Overall Study|Withdrawal by Subject|7|||
27655126|NCT01964547|80576877|FG000|Overall Study|Lost to Follow-up|0|||
27655127|NCT01964547|80576878|FG001|Overall Study|Lost to Follow-up|1|||
27655128|NCT01964547|80576877|FG000|Overall Study|Withdrawal by Investigator|0|||
27655129|NCT01964547|80576878|FG001|Overall Study|Withdrawal by Investigator|1|||
27655130|NCT03708744|80576879|FG000|Overall Study|Withdrawal by Subject|0|||
27655131|NCT03708744|80576880|FG001|Overall Study|Withdrawal by Subject|0|||
27655132|NCT03708744|80576881|FG002|Overall Study|Withdrawal by Subject|1|||
27655133|NCT03708744|80576882|FG003|Overall Study|Withdrawal by Subject|0|||
27655134|NCT02547974|80576887|FG000|Overall Study|Withdrawal by Subject|1|||
27655135|NCT02547974|80576888|FG001|Overall Study|Withdrawal by Subject|0|||
27655136|NCT02547974|80576889|FG002|Overall Study|Withdrawal by Subject|0|||
27655137|NCT02547974|80576890|FG003|Overall Study|Withdrawal by Subject|0|||
27655138|NCT00316121|80576891|FG000|Overall Study|Death|1|||
27655139|NCT00316121|80576892|FG001|Overall Study|Death|0|||
27655140|NCT00316121|80576891|FG000|Overall Study|Lost to Follow-up|14|||
27655141|NCT00316121|80576892|FG001|Overall Study|Lost to Follow-up|8|||
27655142|NCT00316121|80576891|FG000|Overall Study|Withdrawal by Subject|2|||
27655143|NCT00316121|80576892|FG001|Overall Study|Withdrawal by Subject|0|||
27655144|NCT00316121|80576891|FG000|Overall Study|Reason is missing|1|||
27655145|NCT00316121|80576892|FG001|Overall Study|Reason is missing|0|||
27655146|NCT00316121|80576891|FG000|Overall Study|Subject relocated|1|||
27655147|NCT00316121|80576892|FG001|Overall Study|Subject relocated|1|||
27655148|NCT00316121|80576891|FG000|Overall Study|Subject refused to return|1|||
27655149|NCT00316121|80576892|FG001|Overall Study|Subject refused to return|0|||
27655150|NCT00316121|80576891|FG000|Overall Study|Subject no show for visit x 3|1|||
27655151|NCT00316121|80576892|FG001|Overall Study|Subject no show for visit x 3|0|||
27655152|NCT00316121|80576891|FG000|Overall Study|Subject did not have 24 month visit|1|||
27655153|NCT00316121|80576892|FG001|Overall Study|Subject did not have 24 month visit|0|||
27655154|NCT00668746|80576893|FG000|Overall Study|Lost to Follow-up|2|||
27655155|NCT00668746|80576894|FG001|Overall Study|Lost to Follow-up|1|||
27655156|NCT00383500|80576895|FG000|Overall Study|Withdrawal by Subject|8|||
27655157|NCT00383500|80576896|FG001|Overall Study|Withdrawal by Subject|3|||
27655158|NCT00383500|80576897|FG002|Overall Study|Withdrawal by Subject|0|||
27655159|NCT00383500|80576895|FG000|Overall Study|Lost to Follow-up|0|||
27655160|NCT00383500|80576896|FG001|Overall Study|Lost to Follow-up|0|||
27655161|NCT00383500|80576897|FG002|Overall Study|Lost to Follow-up|2|||
27655162|NCT00901459|80576900|FG000|Overall Study|Withdrawal by Subject|6|||
27655163|NCT01399905|80576903|FG000|Overall Study|Withdrawal by Subject|1|||
27655164|NCT01399905|80576904|FG001|Overall Study|Withdrawal by Subject|1|||
27655165|NCT02825550|80576912|FG000|Overall Study|Physician Decision|1|||
27655166|NCT02784834|80576923|FG000|Overall Study|Lack of Efficacy|1|||
27655167|NCT00476957|80576927|FG000|Overall Study|Lost to Follow-up|176|||
27655168|NCT00476957|80576928|FG001|Overall Study|Lost to Follow-up|193|||
27655169|NCT02710669|80576942|FG000|Overall Study|Physician Decision|2|||
27655170|NCT02710669|80576943|FG001|Overall Study|Physician Decision|1|||
27655171|NCT02710669|80576944|FG002|Overall Study|Physician Decision|0|||
27655172|NCT02710669|80576942|FG000|Overall Study|Institutional delays (including COVID)|2|||
27655173|NCT02710669|80576943|FG001|Overall Study|Institutional delays (including COVID)|2|||
27655174|NCT02710669|80576944|FG002|Overall Study|Institutional delays (including COVID)|0|||
27655175|NCT02710669|80576942|FG000|Overall Study|arrived in afib/aflutter|10|||
27655176|NCT02710669|80576943|FG001|Overall Study|arrived in afib/aflutter|8|||
27655177|NCT02710669|80576944|FG002|Overall Study|arrived in afib/aflutter|2|||
27655178|NCT04930263|80576948|FG000|Overall Study|Withdrawal by Subject|3|||
27655179|NCT04930263|80576949|FG001|Overall Study|Withdrawal by Subject|5|||
27655180|NCT04425252|80576950|FG000|Overall Study|Withdrawal by Subject|2|||
27655181|NCT04425252|80576951|FG001|Overall Study|Withdrawal by Subject|1|||
27655182|NCT04425252|80576950|FG000|Overall Study|Lost to Follow-up|1|||
27655183|NCT04425252|80576951|FG001|Overall Study|Lost to Follow-up|0|||
27655184|NCT04425252|80576950|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
27655185|NCT04425252|80576951|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
27655186|NCT02942771|80576954|FG000|Overall Study|Adverse Event|1|||
27655187|NCT02942771|80576955|FG001|Overall Study|Adverse Event|0|||
27755952|NCT00808249|80932669|FG001|Overall Study|Protocol Violation|3|||
27755953|NCT00808249|80932670|FG002|Overall Study|Protocol Violation|3|||
27755954|NCT00808249|80932671|FG003|Overall Study|Protocol Violation|0|||
27755955|NCT00808249|80932668|FG000|Overall Study|Lack of Efficacy|1|||
27755956|NCT00808249|80932669|FG001|Overall Study|Lack of Efficacy|1|||
27755957|NCT00808249|80932670|FG002|Overall Study|Lack of Efficacy|0|||
27755958|NCT00808249|80932671|FG003|Overall Study|Lack of Efficacy|0|||
27755959|NCT00808249|80932668|FG000|Overall Study|study specific discontinuation criteria|1|||
27755960|NCT00808249|80932669|FG001|Overall Study|study specific discontinuation criteria|0|||
27755961|NCT00808249|80932670|FG002|Overall Study|study specific discontinuation criteria|1|||
27755962|NCT00808249|80932671|FG003|Overall Study|study specific discontinuation criteria|0|||
27755963|NCT00808249|80932668|FG000|Overall Study|All other reasons|2|||
27755964|NCT00808249|80932669|FG001|Overall Study|All other reasons|1|||
27755965|NCT00808249|80932670|FG002|Overall Study|All other reasons|3|||
27755966|NCT00808249|80932671|FG003|Overall Study|All other reasons|1|||
27755967|NCT01363713|80932673|FG000|Overall Study|Adverse Event|1|||
27755968|NCT01363713|80932673|FG000|Overall Study|Protocol Violation|3|||
27755969|NCT01363713|80932673|FG000|Overall Study|Withdrawal by Subject|2|||
27755970|NCT03558555|80932677|FG000|Overall Study|Lost to Follow-up|2|||
27755971|NCT03558555|80932678|FG001|Overall Study|Lost to Follow-up|1|||
27755972|NCT00434122|80932686|FG000|Overall Study|Non-compliance with protocol|0|||
27755973|NCT00434122|80932687|FG001|Overall Study|Non-compliance with protocol|1|||
27755974|NCT00434122|80932686|FG000|Overall Study|loss of subject contact|1|||
27755975|NCT00434122|80932687|FG001|Overall Study|loss of subject contact|1|||
27755976|NCT00434122|80932686|FG000|Overall Study|Personal reasons|1|||
27755977|NCT00434122|80932687|FG001|Overall Study|Personal reasons|1|||
27755978|NCT00434122|80932686|FG000|Overall Study|Large follicle size|2|||
27755979|NCT00434122|80932687|FG001|Overall Study|Large follicle size|2|||
27755980|NCT00434122|80932686|FG000|Overall Study|Low follicular response.|1|||
27755981|NCT00434122|80932687|FG001|Overall Study|Low follicular response.|2|||
27755982|NCT00434122|80932686|FG000|Overall Study|Travelling of subject.|1|||
27755983|NCT00434122|80932687|FG001|Overall Study|Travelling of subject.|0|||
27755984|NCT01617187|80932690|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
27755985|NCT01617187|80932691|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
27755986|NCT01617187|80932692|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
27755987|NCT01617187|80932693|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
27755988|NCT01617187|80932690|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
27755989|NCT01617187|80932691|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
27755990|NCT01617187|80932692|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
27755991|NCT01617187|80932693|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
27755992|NCT01617187|80932690|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
27655188|NCT02942771|80576956|FG002|Overall Study|Adverse Event|0|||
27655189|NCT02942771|80576957|FG003|Overall Study|Adverse Event|0|||
27655190|NCT02942771|80576958|FG004|Overall Study|Adverse Event|2|||
27755993|NCT01617187|80932691|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
27755994|NCT01617187|80932692|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
27755995|NCT01617187|80932693|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
27755996|NCT01617187|80932690|FG000|Treatment Through Study Completion|Adverse Event|1|||
27755997|NCT01617187|80932691|FG001|Treatment Through Study Completion|Adverse Event|1|||
27755998|NCT01617187|80932692|FG002|Treatment Through Study Completion|Adverse Event|0|||
27755999|NCT01617187|80932693|FG003|Treatment Through Study Completion|Adverse Event|1|||
27756000|NCT01617187|80932690|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
27756001|NCT01617187|80932691|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
27756002|NCT01617187|80932692|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
27756003|NCT01617187|80932693|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
27756004|NCT01617187|80932690|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
27756005|NCT01617187|80932691|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
27756006|NCT01617187|80932692|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
27756007|NCT01617187|80932693|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
27756008|NCT01617187|80932690|FG000|Treatment Through Study Completion|Protocol Violation|1|||
27756009|NCT01617187|80932691|FG001|Treatment Through Study Completion|Protocol Violation|0|||
27756010|NCT01617187|80932692|FG002|Treatment Through Study Completion|Protocol Violation|0|||
27756011|NCT01617187|80932693|FG003|Treatment Through Study Completion|Protocol Violation|1|||
27756012|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
27756013|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
27756014|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
27756015|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
27756016|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
27756017|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
27756018|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
27756019|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
27756020|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
27756021|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
27756022|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
27756023|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
27756024|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
27756025|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
27756026|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
27756027|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
27756028|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
27756029|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
27756030|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
27756031|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
27756032|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
27756033|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
27756034|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
27756035|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
27756036|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
27756037|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
27756038|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
27756039|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
27756040|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
27756041|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
27655191|NCT02942771|80576954|FG000|Overall Study|Lost to Follow-up|1|||
27655192|NCT02942771|80576955|FG001|Overall Study|Lost to Follow-up|0|||
27655193|NCT02942771|80576956|FG002|Overall Study|Lost to Follow-up|0|||
27756042|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
27756043|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
27756044|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
27756045|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
27756046|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
27756047|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
27756048|NCT01963208|80932694|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
27756049|NCT01963208|80932695|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
27756050|NCT01963208|80932696|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
27756051|NCT01963208|80932697|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
27756052|NCT01963208|80932698|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
27756053|NCT01963208|80932699|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
27756054|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
27756055|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
27756056|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
27756057|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
27756058|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
27756059|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
27756060|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
27756061|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
27756062|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
27756063|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
27756064|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
27756065|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
27756066|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
27756067|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
27756068|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
27756069|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
27756070|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
27756071|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
27756072|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
27756073|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
27756074|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
27756075|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
27756076|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
27756077|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
27756078|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
27756079|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
27756080|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
27756081|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
27756082|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
27756083|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
27756084|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
27756085|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
27756086|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
27756087|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
27756088|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
27756089|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
27756090|NCT01963208|80932694|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
27756091|NCT01963208|80932695|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
27756092|NCT01963208|80932696|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
27756093|NCT01963208|80932697|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
27756094|NCT01963208|80932698|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
27756095|NCT01963208|80932699|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
27756096|NCT01969799|80932700|FG000|Overall Study|Adverse Event|0|||
27756097|NCT01969799|80932701|FG001|Overall Study|Adverse Event|1|||
27756098|NCT01969799|80932700|FG000|Overall Study|Death|16|||
27756099|NCT01969799|80932701|FG001|Overall Study|Death|11|||
27756100|NCT01969799|80932700|FG000|Overall Study|Lost to Follow-up|0|||
27756101|NCT01969799|80932701|FG001|Overall Study|Lost to Follow-up|2|||
27756102|NCT01969799|80932700|FG000|Overall Study|Physician Decision|1|||
27756103|NCT01969799|80932701|FG001|Overall Study|Physician Decision|0|||
27756104|NCT02159469|80932709|FG000|Overall Study|Missing Completion status|1|||
27756105|NCT02159469|80932709|FG000|Overall Study|Adverse Event|5|||
27756106|NCT02159469|80932709|FG000|Overall Study|Non-compliance|2|||
27756107|NCT02159469|80932709|FG000|Overall Study|Withdrawal by Subject|9|||
27756108|NCT02159469|80932709|FG000|Overall Study|Lost to Follow-up|1|||
27756109|NCT02159469|80932709|FG000|Overall Study|Sponsor's request|2|||
27756110|NCT02159469|80932709|FG000|Overall Study|Met Stopping Criteria|3|||
27756111|NCT02159469|80932709|FG000|Overall Study|Other|1|||
27756112|NCT02159469|80932709|FG000|Overall Study|Multiple|29|||
27756113|NCT02349789|80932712|FG000|Overall Study|Withdrawal by Subject|2|||
27756114|NCT01303380|80932713|FG000|Overall Study|Lack of compliance to study procedures|1|||
27756115|NCT00352755|80932717|FG000|Overall Study|Physician Decision|1|||
27756116|NCT00352755|80932717|FG000|Overall Study|Adverse Event|1|||
27756117|NCT01953328|80932718|FG000|Overall Study|Withdrawal by Subject|0|||
27756118|NCT01953328|80932719|FG001|Overall Study|Withdrawal by Subject|0|||
27756119|NCT01953328|80932720|FG002|Overall Study|Withdrawal by Subject|0|||
27756120|NCT01953328|80932721|FG003|Overall Study|Withdrawal by Subject|0|||
27756121|NCT01953328|80932722|FG004|Overall Study|Withdrawal by Subject|1|||
27756122|NCT01953328|80932723|FG005|Overall Study|Withdrawal by Subject|0|||
27756123|NCT01953328|80932724|FG006|Overall Study|Withdrawal by Subject|0|||
27756124|NCT01953328|80932725|FG007|Overall Study|Withdrawal by Subject|0|||
27756125|NCT01953328|80932718|FG000|Overall Study|Lost to Follow-up|0|||
27756126|NCT01953328|80932719|FG001|Overall Study|Lost to Follow-up|0|||
27756127|NCT01953328|80932720|FG002|Overall Study|Lost to Follow-up|0|||
27756128|NCT01953328|80932721|FG003|Overall Study|Lost to Follow-up|0|||
27756129|NCT01953328|80932722|FG004|Overall Study|Lost to Follow-up|1|||
27756130|NCT01953328|80932723|FG005|Overall Study|Lost to Follow-up|0|||
27756131|NCT01953328|80932724|FG006|Overall Study|Lost to Follow-up|0|||
27756132|NCT01953328|80932725|FG007|Overall Study|Lost to Follow-up|0|||
27756133|NCT01714817|80932728|FG000|Year 1 Period|Lack of Efficacy|11|||
27756134|NCT01714817|80932729|FG001|Year 1 Period|Lack of Efficacy|9|||
27756135|NCT01714817|80932728|FG000|Year 1 Period|Adverse Event|20|||
27756136|NCT01714817|80932729|FG001|Year 1 Period|Adverse Event|17|||
27756137|NCT01714817|80932728|FG000|Year 1 Period|Withdrawal by Subject|6|||
27756138|NCT01714817|80932729|FG001|Year 1 Period|Withdrawal by Subject|7|||
27756139|NCT01714817|80932728|FG000|Year 1 Period|Death|1|||
27756140|NCT01714817|80932729|FG001|Year 1 Period|Death|1|||
27756141|NCT01714817|80932728|FG000|Year 1 Period|Lost to Follow-up|0|||
27756142|NCT01714817|80932729|FG001|Year 1 Period|Lost to Follow-up|2|||
27756143|NCT01714817|80932728|FG000|Year 1 Period|Poor / non-compliance|0|||
27756144|NCT01714817|80932729|FG001|Year 1 Period|Poor / non-compliance|1|||
27655194|NCT02942771|80576957|FG003|Overall Study|Lost to Follow-up|0|||
27655195|NCT02942771|80576958|FG004|Overall Study|Lost to Follow-up|0|||
27655196|NCT02942771|80576954|FG000|Overall Study|Withdrawal by Subject|1|||
27655197|NCT02942771|80576955|FG001|Overall Study|Withdrawal by Subject|0|||
27655198|NCT02942771|80576956|FG002|Overall Study|Withdrawal by Subject|0|||
27655199|NCT02942771|80576957|FG003|Overall Study|Withdrawal by Subject|0|||
27655200|NCT02942771|80576958|FG004|Overall Study|Withdrawal by Subject|2|||
27655201|NCT02991456|80576959|FG000|Overall Study|Adverse Event|2|||
27655202|NCT02991456|80576960|FG001|Overall Study|Adverse Event|0|||
27655203|NCT02991456|80576959|FG000|Overall Study|Lost to Follow-up|0|||
27655204|NCT02991456|80576960|FG001|Overall Study|Lost to Follow-up|2|||
27655205|NCT02991456|80576959|FG000|Overall Study|Withdrawal by Subject|1|||
27655206|NCT02991456|80576960|FG001|Overall Study|Withdrawal by Subject|0|||
27655207|NCT03386344|80576963|FG000|Overall Study|Adverse Event|6|||
27655208|NCT03386344|80576964|FG001|Overall Study|Adverse Event|3|||
27655209|NCT03386344|80576965|FG002|Overall Study|Adverse Event|1|||
27655210|NCT03386344|80576963|FG000|Overall Study|Poor Compliance to Protocol|0|||
27655211|NCT03386344|80576964|FG001|Overall Study|Poor Compliance to Protocol|1|||
27655212|NCT03386344|80576965|FG002|Overall Study|Poor Compliance to Protocol|0|||
27655213|NCT03386344|80576963|FG000|Overall Study|Study Terminated by Sponsor|101|||
27655214|NCT03386344|80576964|FG001|Overall Study|Study Terminated by Sponsor|102|||
27655215|NCT03386344|80576965|FG002|Overall Study|Study Terminated by Sponsor|106|||
27655216|NCT03386344|80576963|FG000|Overall Study|Lost to Follow-up|3|||
27655217|NCT03386344|80576964|FG001|Overall Study|Lost to Follow-up|2|||
27655218|NCT03386344|80576965|FG002|Overall Study|Lost to Follow-up|1|||
27655219|NCT03386344|80576963|FG000|Overall Study|At the Participant's own Request|7|||
27655220|NCT03386344|80576964|FG001|Overall Study|At the Participant's own Request|7|||
27655221|NCT03386344|80576965|FG002|Overall Study|At the Participant's own Request|8|||
27655222|NCT03386344|80576963|FG000|Overall Study|Reason not Specified|0|||
27655223|NCT03386344|80576964|FG001|Overall Study|Reason not Specified|1|||
27655224|NCT03386344|80576965|FG002|Overall Study|Reason not Specified|0|||
27655225|NCT02291861|80576973|FG000|Overall Study|Adverse Event|2|||
27655226|NCT02291861|80576974|FG001|Overall Study|Adverse Event|4|||
27655227|NCT02291861|80576975|FG002|Overall Study|Adverse Event|1|||
27655228|NCT02291861|80576976|FG003|Overall Study|Adverse Event|2|||
27655229|NCT02291861|80576973|FG000|Overall Study|Death|0|||
27655230|NCT02291861|80576974|FG001|Overall Study|Death|0|||
27655231|NCT02291861|80576975|FG002|Overall Study|Death|1|||
27655232|NCT02291861|80576976|FG003|Overall Study|Death|1|||
27655233|NCT02291861|80576973|FG000|Overall Study|Protocol Violation|1|||
27655234|NCT02291861|80576974|FG001|Overall Study|Protocol Violation|0|||
27655235|NCT02291861|80576975|FG002|Overall Study|Protocol Violation|0|||
27655236|NCT02291861|80576976|FG003|Overall Study|Protocol Violation|1|||
27655237|NCT02291861|80576973|FG000|Overall Study|Withdrawal by Subject|1|||
27655238|NCT02291861|80576974|FG001|Overall Study|Withdrawal by Subject|2|||
27655239|NCT02291861|80576975|FG002|Overall Study|Withdrawal by Subject|1|||
27655240|NCT02291861|80576976|FG003|Overall Study|Withdrawal by Subject|4|||
27655241|NCT02291861|80576973|FG000|Overall Study|Noncompliance|1|||
27655242|NCT02291861|80576974|FG001|Overall Study|Noncompliance|1|||
27655243|NCT02291861|80576975|FG002|Overall Study|Noncompliance|2|||
27655244|NCT02291861|80576976|FG003|Overall Study|Noncompliance|1|||
27756145|NCT01714817|80932728|FG000|Year 1 Period|Pregnancy|2|||
27756146|NCT01714817|80932729|FG001|Year 1 Period|Pregnancy|0|||
27756147|NCT01714817|80932728|FG000|Year 1 Period|Participant no longer meets criteria|6|||
27756148|NCT01714817|80932729|FG001|Year 1 Period|Participant no longer meets criteria|2|||
27756149|NCT01714817|80932728|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
27756150|NCT01714817|80932729|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
27756151|NCT01714817|80932728|FG000|Year 1 Period|Change in Concomitant Medication|0|||
27655245|NCT02291861|80576973|FG000|Overall Study|Lost to Follow-up|2|||
27655246|NCT02291861|80576974|FG001|Overall Study|Lost to Follow-up|1|||
27655247|NCT02291861|80576975|FG002|Overall Study|Lost to Follow-up|4|||
27655248|NCT02291861|80576976|FG003|Overall Study|Lost to Follow-up|0|||
27756152|NCT01714817|80932729|FG001|Year 1 Period|Change in Concomitant Medication|1|||
27756153|NCT01714817|80932728|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
27756154|NCT01714817|80932729|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
27756155|NCT01714817|80932728|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
27756156|NCT01714817|80932729|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
27756157|NCT01714817|80932728|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
27756158|NCT01714817|80932729|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
27756159|NCT01714817|80932728|FG000|Year 2 Period|Lack of Efficacy|4|||
27756160|NCT01714817|80932729|FG001|Year 2 Period|Lack of Efficacy|12|||
27756161|NCT01714817|80932728|FG000|Year 2 Period|Adverse Event|7|||
27756162|NCT01714817|80932729|FG001|Year 2 Period|Adverse Event|6|||
27756163|NCT01714817|80932728|FG000|Year 2 Period|Participant request to stop treatment|4|||
27756164|NCT01714817|80932729|FG001|Year 2 Period|Participant request to stop treatment|4|||
27756165|NCT01714817|80932728|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
27756166|NCT01714817|80932729|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
27756167|NCT01714817|80932728|FG000|Year 2 Period|Participant withdrew consent|1|||
27756168|NCT01714817|80932729|FG001|Year 2 Period|Participant withdrew consent|5|||
27756169|NCT01714817|80932728|FG000|Year 2 Period|Participant no longer meets criteria|1|||
27756170|NCT01714817|80932729|FG001|Year 2 Period|Participant no longer meets criteria|4|||
27756171|NCT01714817|80932728|FG000|Year 2 Period|Lost to Follow-up|2|||
27756172|NCT01714817|80932729|FG001|Year 2 Period|Lost to Follow-up|0|||
27756173|NCT01714817|80932728|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
27756174|NCT01714817|80932729|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
27756175|NCT01714817|80932728|FG000|Year 2 Period|Pregnancy|1|||
27756176|NCT01714817|80932729|FG001|Year 2 Period|Pregnancy|1|||
27756177|NCT01714817|80932728|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
27756178|NCT01714817|80932729|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
27756179|NCT01714817|80932728|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
27756180|NCT01714817|80932729|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
27756181|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
27756182|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
27756183|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
27756184|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
27756185|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
27756186|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
27756187|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
27756188|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
27756189|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
27756190|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
27756191|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
27756192|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
27756193|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27756194|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
27756195|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
27756196|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
27756197|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
27756198|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
27756199|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
27756200|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
27756201|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
27756202|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
27756203|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
27756204|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
27756205|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
27756206|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
27756207|NCT01714817|80932728|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
27756208|NCT01714817|80932729|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
27756209|NCT01021852|80932732|FG000|Treatment Period 1|Adverse Event|3|||
27756210|NCT01021852|80932733|FG001|Treatment Period 1|Adverse Event|1|||
27756211|NCT01021852|80932734|FG002|Treatment Period 1|Adverse Event|1|||
27756212|NCT01021852|80932735|FG003|Treatment Period 1|Adverse Event|0|||
27756213|NCT01021852|80932736|FG004|Treatment Period 1|Adverse Event|2|||
27756214|NCT01021852|80932737|FG005|Treatment Period 1|Adverse Event|2|||
27756215|NCT01021852|80932738|FG006|Treatment Period 1|Adverse Event|0|||
27756216|NCT01021852|80932739|FG007|Treatment Period 1|Adverse Event|0|||
27756217|NCT01021852|80932732|FG000|Treatment Period 1|Pregnancy|0|||
27756218|NCT01021852|80932733|FG001|Treatment Period 1|Pregnancy|0|||
27756219|NCT01021852|80932734|FG002|Treatment Period 1|Pregnancy|1|||
27756220|NCT01021852|80932735|FG003|Treatment Period 1|Pregnancy|0|||
27756221|NCT01021852|80932736|FG004|Treatment Period 1|Pregnancy|0|||
27756222|NCT01021852|80932737|FG005|Treatment Period 1|Pregnancy|0|||
27756223|NCT01021852|80932738|FG006|Treatment Period 1|Pregnancy|0|||
27756224|NCT01021852|80932739|FG007|Treatment Period 1|Pregnancy|0|||
27756225|NCT01021852|80932732|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27756226|NCT01021852|80932733|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27756227|NCT01021852|80932734|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27756228|NCT01021852|80932735|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27756229|NCT01021852|80932736|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27756230|NCT01021852|80932737|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27756231|NCT01021852|80932738|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27756232|NCT01021852|80932739|FG007|Treatment Period 1|Withdrawal by Subject|1|||
27756233|NCT01021852|80932732|FG000|Treatment Period 1|Not Treated|0|||
27756234|NCT01021852|80932733|FG001|Treatment Period 1|Not Treated|0|||
27756235|NCT01021852|80932734|FG002|Treatment Period 1|Not Treated|0|||
27756236|NCT01021852|80932735|FG003|Treatment Period 1|Not Treated|2|||
27756237|NCT01021852|80932736|FG004|Treatment Period 1|Not Treated|0|||
27756238|NCT01021852|80932737|FG005|Treatment Period 1|Not Treated|0|||
27655249|NCT02291861|80576973|FG000|Overall Study|Other|0|||
27655250|NCT02291861|80576974|FG001|Overall Study|Other|0|||
27655251|NCT02291861|80576975|FG002|Overall Study|Other|0|||
27655252|NCT02291861|80576976|FG003|Overall Study|Other|1|||
27655253|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
27655254|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
27655255|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
27655256|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
27655257|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Adverse Event|7|||
27655258|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Adverse Event|8|||
27655259|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Adverse Event|8|||
27655260|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Adverse Event|9|||
27655261|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
27655262|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
27655263|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
27655264|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
27655265|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
27655266|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
27655267|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
27655268|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
27655269|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Pregnancy|0|||
27655270|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Pregnancy|2|||
27655271|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Pregnancy|2|||
27655272|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Pregnancy|0|||
27756239|NCT01021852|80932738|FG006|Treatment Period 1|Not Treated|0|||
27756240|NCT01021852|80932739|FG007|Treatment Period 1|Not Treated|0|||
27756241|NCT01021852|80932732|FG000|Washout Period-Placebo|Adverse Event|0|||
27756242|NCT01021852|80932733|FG001|Washout Period-Placebo|Adverse Event|0|||
27756243|NCT01021852|80932734|FG002|Washout Period-Placebo|Adverse Event|0|||
27756244|NCT01021852|80932735|FG003|Washout Period-Placebo|Adverse Event|1|||
27756245|NCT01021852|80932736|FG004|Washout Period-Placebo|Adverse Event|0|||
27756246|NCT01021852|80932737|FG005|Washout Period-Placebo|Adverse Event|1|||
27756247|NCT01021852|80932738|FG006|Washout Period-Placebo|Adverse Event|0|||
27756248|NCT01021852|80932739|FG007|Washout Period-Placebo|Adverse Event|0|||
27756249|NCT01021852|80932732|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
27655273|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Non-compliance|1|||
27655274|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Non-compliance|0|||
27655275|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Non-compliance|0|||
27655276|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Non-compliance|3|||
27655277|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Other|3|||
27655278|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Other|0|||
27655279|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Other|3|||
27655280|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Other|2|||
27655281|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
27655282|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
27655283|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
27655284|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
27655285|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
27655286|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
27655287|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
27655288|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
27756250|NCT01021852|80932733|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
27756251|NCT01021852|80932734|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
27756252|NCT01021852|80932735|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
27756253|NCT01021852|80932736|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
27756254|NCT01021852|80932737|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
27655289|NCT02143713|80576979|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
27655290|NCT02143713|80576980|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
27655291|NCT02143713|80576981|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
27655292|NCT02143713|80576982|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
27655293|NCT02143713|80576979|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
27655294|NCT02143713|80576980|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
27655295|NCT02143713|80576981|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
27655296|NCT02143713|80576982|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
27655297|NCT02143713|80576979|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
27655298|NCT02143713|80576980|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
27655299|NCT02143713|80576981|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
27655300|NCT02143713|80576982|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
27655301|NCT02143713|80576979|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
27655302|NCT02143713|80576980|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
27655303|NCT02143713|80576981|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
27655304|NCT02143713|80576982|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
27655305|NCT02143713|80576979|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
27655306|NCT02143713|80576980|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
27655307|NCT02143713|80576981|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
27655308|NCT02143713|80576982|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
27655309|NCT02143713|80576979|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
27655310|NCT02143713|80576980|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
27655311|NCT02143713|80576981|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
27655312|NCT02143713|80576982|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
27655313|NCT02143713|80576979|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
27655314|NCT02143713|80576980|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
27655315|NCT02143713|80576981|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
27655316|NCT02143713|80576982|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
27655317|NCT02660086|80576985|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
27655318|NCT02660086|80576986|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
27655319|NCT02660086|80576985|FG000|Overall Study- 12-month|Left full-time employment|12|||
27655320|NCT02660086|80576986|FG001|Overall Study- 12-month|Left full-time employment|20|||
27655321|NCT02660086|80576985|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
27655322|NCT02660086|80576986|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
27655323|NCT02660086|80576985|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
27655324|NCT02660086|80576986|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
27655325|NCT02660086|80576985|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
27655326|NCT02660086|80576986|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
27655327|NCT02660086|80576985|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
27655328|NCT02660086|80576986|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
27655329|NCT02449902|80576987|FG000|Overall Study|Adverse Event|0|||
27655330|NCT02449902|80576988|FG001|Overall Study|Adverse Event|1|||
27655331|NCT02449902|80576987|FG000|Overall Study|Withdrawal by Subject|0|||
27655332|NCT02449902|80576988|FG001|Overall Study|Withdrawal by Subject|1|||
27655333|NCT02316171|80576989|FG000|Overall Study|difficulties with urinary catheter|1|||
27655334|NCT02316171|80576990|FG001|Overall Study|difficulties with urinary catheter|0|||
27655335|NCT02316171|80576991|FG002|Overall Study|difficulties with urinary catheter|0|||
27655336|NCT02316171|80576992|FG003|Overall Study|difficulties with urinary catheter|0|||
27655337|NCT02092909|80576994|FG000|Overall Study|Adverse Event|0|||
27655338|NCT02092909|80576995|FG001|Overall Study|Adverse Event|0|||
27655339|NCT02092909|80576996|FG002|Overall Study|Adverse Event|4|||
27655340|NCT02092909|80576997|FG003|Overall Study|Adverse Event|2|||
27655341|NCT02092909|80576994|FG000|Overall Study|Lack of Efficacy|0|||
27655342|NCT02092909|80576995|FG001|Overall Study|Lack of Efficacy|2|||
27756255|NCT01021852|80932738|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
27756256|NCT01021852|80932739|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
27756257|NCT01021852|80932732|FG000|Washout Period-Placebo|Protocol Violation|0|||
27756258|NCT01021852|80932733|FG001|Washout Period-Placebo|Protocol Violation|0|||
27756259|NCT01021852|80932734|FG002|Washout Period-Placebo|Protocol Violation|0|||
27756260|NCT01021852|80932735|FG003|Washout Period-Placebo|Protocol Violation|0|||
27756261|NCT01021852|80932736|FG004|Washout Period-Placebo|Protocol Violation|0|||
27756262|NCT01021852|80932737|FG005|Washout Period-Placebo|Protocol Violation|0|||
27756263|NCT01021852|80932738|FG006|Washout Period-Placebo|Protocol Violation|1|||
27756264|NCT01021852|80932739|FG007|Washout Period-Placebo|Protocol Violation|0|||
27756265|NCT01021852|80932732|FG000|Washout Period-No Drug|Adverse Event|1|||
27655343|NCT02092909|80576996|FG002|Overall Study|Lack of Efficacy|1|||
27655344|NCT02092909|80576997|FG003|Overall Study|Lack of Efficacy|0|||
27655345|NCT02092909|80576994|FG000|Overall Study|Withdrawal by Subject|0|||
27756266|NCT01021852|80932733|FG001|Washout Period-No Drug|Adverse Event|0|||
27756267|NCT01021852|80932734|FG002|Washout Period-No Drug|Adverse Event|0|||
27756268|NCT01021852|80932735|FG003|Washout Period-No Drug|Adverse Event|0|||
27756269|NCT01021852|80932736|FG004|Washout Period-No Drug|Adverse Event|0|||
27756270|NCT01021852|80932737|FG005|Washout Period-No Drug|Adverse Event|1|||
27756271|NCT01021852|80932738|FG006|Washout Period-No Drug|Adverse Event|0|||
27756272|NCT01021852|80932739|FG007|Washout Period-No Drug|Adverse Event|0|||
27756273|NCT01021852|80932732|FG000|Treatment Period 2|Adverse Event|0|||
27756274|NCT01021852|80932733|FG001|Treatment Period 2|Adverse Event|1|||
27756275|NCT01021852|80932734|FG002|Treatment Period 2|Adverse Event|0|||
27756276|NCT01021852|80932735|FG003|Treatment Period 2|Adverse Event|0|||
27756277|NCT01021852|80932736|FG004|Treatment Period 2|Adverse Event|1|||
27756278|NCT01021852|80932737|FG005|Treatment Period 2|Adverse Event|0|||
27756279|NCT01021852|80932738|FG006|Treatment Period 2|Adverse Event|1|||
27756280|NCT01021852|80932739|FG007|Treatment Period 2|Adverse Event|0|||
27756281|NCT01021852|80932732|FG000|Treatment Period 2|Lack of Efficacy|0|||
27756282|NCT01021852|80932733|FG001|Treatment Period 2|Lack of Efficacy|0|||
27756283|NCT01021852|80932734|FG002|Treatment Period 2|Lack of Efficacy|0|||
27756284|NCT01021852|80932735|FG003|Treatment Period 2|Lack of Efficacy|0|||
27756285|NCT01021852|80932736|FG004|Treatment Period 2|Lack of Efficacy|0|||
27756286|NCT01021852|80932737|FG005|Treatment Period 2|Lack of Efficacy|1|||
27756287|NCT01021852|80932738|FG006|Treatment Period 2|Lack of Efficacy|0|||
27756288|NCT01021852|80932739|FG007|Treatment Period 2|Lack of Efficacy|0|||
27756289|NCT01021852|80932732|FG000|Treatment Period 2|Physician Decision|0|||
27756290|NCT01021852|80932733|FG001|Treatment Period 2|Physician Decision|0|||
27756291|NCT01021852|80932734|FG002|Treatment Period 2|Physician Decision|1|||
27756292|NCT01021852|80932735|FG003|Treatment Period 2|Physician Decision|0|||
27756293|NCT01021852|80932736|FG004|Treatment Period 2|Physician Decision|0|||
27756294|NCT01021852|80932737|FG005|Treatment Period 2|Physician Decision|0|||
27756295|NCT01021852|80932738|FG006|Treatment Period 2|Physician Decision|0|||
27756296|NCT01021852|80932739|FG007|Treatment Period 2|Physician Decision|0|||
27756297|NCT01021852|80932732|FG000|Treatment Period 2|Protocol Violation|0|||
27756298|NCT01021852|80932733|FG001|Treatment Period 2|Protocol Violation|0|||
27756299|NCT01021852|80932734|FG002|Treatment Period 2|Protocol Violation|0|||
27756300|NCT01021852|80932735|FG003|Treatment Period 2|Protocol Violation|0|||
27756301|NCT01021852|80932736|FG004|Treatment Period 2|Protocol Violation|1|||
27756302|NCT01021852|80932737|FG005|Treatment Period 2|Protocol Violation|0|||
27756303|NCT01021852|80932738|FG006|Treatment Period 2|Protocol Violation|1|||
27756304|NCT01021852|80932739|FG007|Treatment Period 2|Protocol Violation|0|||
27756305|NCT01021852|80932732|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27756306|NCT01021852|80932733|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27756307|NCT01021852|80932734|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27655346|NCT02092909|80576995|FG001|Overall Study|Withdrawal by Subject|0|||
27655347|NCT02092909|80576996|FG002|Overall Study|Withdrawal by Subject|2|||
27655348|NCT02092909|80576997|FG003|Overall Study|Withdrawal by Subject|1|||
27655349|NCT02092909|80576994|FG000|Overall Study|Study terminated by Sponsor|0|||
27655350|NCT02092909|80576995|FG001|Overall Study|Study terminated by Sponsor|0|||
27756308|NCT01021852|80932735|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27756309|NCT01021852|80932736|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27756310|NCT01021852|80932737|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27756311|NCT01021852|80932738|FG006|Treatment Period 2|Withdrawal by Subject|1|||
27756312|NCT01021852|80932739|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27756313|NCT03103906|80932741|FG000|Overall Study|Adverse Event|2|||
27756314|NCT03103906|80932742|FG001|Overall Study|Adverse Event|3|||
27756315|NCT03103906|80932741|FG000|Overall Study|Other|2|||
27756316|NCT03103906|80932742|FG001|Overall Study|Other|0|||
27756317|NCT01124448|80932745|FG000|Overall Study|Lost to Follow-up|0|||
27756318|NCT01124448|80932746|FG001|Overall Study|Lost to Follow-up|3|||
27756319|NCT01124448|80932745|FG000|Overall Study|Protocol Violation|2|||
27756320|NCT01124448|80932746|FG001|Overall Study|Protocol Violation|0|||
27756321|NCT04105244|80932749|FG000|Overall Study|Withdrawal by Subject|10|||
27756322|NCT04105244|80932750|FG001|Overall Study|Withdrawal by Subject|12|||
27756323|NCT04105244|80932749|FG000|Overall Study|Lost to Follow-up|20|||
27756324|NCT04105244|80932750|FG001|Overall Study|Lost to Follow-up|15|||
27756325|NCT04105244|80932749|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
27756326|NCT04105244|80932750|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
27756327|NCT04105244|80932749|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
27756328|NCT04105244|80932750|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
27756329|NCT02156492|80932754|FG000|Period 1|No Reason Given|0|||
27756330|NCT02156492|80932755|FG001|Period 1|No Reason Given|1|||
27756331|NCT02156492|80932756|FG002|Period 1|No Reason Given|0|||
27756332|NCT02156492|80932754|FG000|Period 3|Adverse Event|0|||
27756333|NCT02156492|80932755|FG001|Period 3|Adverse Event|1|||
27756334|NCT02156492|80932756|FG002|Period 3|Adverse Event|0|||
27832847|NCT00705666|81219375|FG000|Overall Study|Withdrawal by Subject|21|||
27832848|NCT00705666|81219375|FG000|Overall Study|Physician Decision|7|||
27832849|NCT00705666|81219375|FG000|Overall Study|Lost to Follow-up|5|||
27655351|NCT02092909|80576996|FG002|Overall Study|Study terminated by Sponsor|0|||
27756335|NCT00239837|80936455|FG000|Overall Study|Lost to Follow-up|3|||
27756336|NCT00239837|80936456|FG001|Overall Study|Lost to Follow-up|7|||
27756337|NCT03722784|80936458|FG000|Overall Study|Withdrawal by Subject|1|||
27756338|NCT03722784|80936459|FG001|Overall Study|Withdrawal by Subject|0|||
27756339|NCT03722784|80936458|FG000|Overall Study|Physician Decision|1|||
27756340|NCT03722784|80936459|FG001|Overall Study|Physician Decision|1|||
27756341|NCT03722784|80936458|FG000|Overall Study|Protocol Violation|0|||
27756342|NCT03722784|80936459|FG001|Overall Study|Protocol Violation|1|||
27756343|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
27756344|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
27756345|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
27756346|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
27756347|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
27756348|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
27756349|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
27756350|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
27756351|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
27756352|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
27756353|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
27756354|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
27756355|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
27756356|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
27756357|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
27756358|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
27756359|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
27756360|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
27756361|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
27756362|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
27756363|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
27756364|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
27756365|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
27756366|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
27756367|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
27756368|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
27756369|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
27756370|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
27756371|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
27756372|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
27756373|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
27756374|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
27756375|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
27756376|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
27756377|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
27756378|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
27756379|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
27756380|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
27756381|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
27756382|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
27756383|NCT00383721|80936464|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
27756384|NCT00383721|80936465|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
27756385|NCT00383721|80936466|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
27756386|NCT00383721|80936467|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
27756387|NCT00383721|80936468|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
27756388|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
27756389|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
27756390|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
27756391|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
27756392|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
27756393|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
27756394|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
27756395|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
27756396|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
27756397|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
27756398|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
27756399|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
27756400|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
27756401|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
27756402|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
27756403|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
27756404|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
27756405|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
27756406|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
27756407|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
27756408|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
27756409|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
27756410|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
27756411|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
27756412|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
27756413|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
27756414|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
27756415|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
27756416|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
27756417|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
27756418|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
27756419|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
27756420|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
27756421|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
27756422|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
27756423|NCT00383721|80936464|FG000|26-Week Treatment Safety Extension|Administrative|1|||
27756424|NCT00383721|80936465|FG001|26-Week Treatment Safety Extension|Administrative|2|||
27756425|NCT00383721|80936466|FG002|26-Week Treatment Safety Extension|Administrative|3|||
27756426|NCT00383721|80936467|FG003|26-Week Treatment Safety Extension|Administrative|1|||
27756427|NCT00383721|80936468|FG004|26-Week Treatment Safety Extension|Administrative|0|||
27756428|NCT02559713|80936469|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
27756429|NCT00798655|80936470|FG000|Overall Study|Did not receive at least one dose of pan|2|||
27756430|NCT04550221|80936471|FG000|Overall Study|Lost to Follow-up|0|||
27756431|NCT04550221|80936472|FG001|Overall Study|Lost to Follow-up|4|||
27756432|NCT04550221|80936471|FG000|Overall Study|Withdrawn|3|||
27756433|NCT04550221|80936472|FG001|Overall Study|Withdrawn|0|||
27756434|NCT04550221|80936471|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
27756435|NCT04550221|80936472|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
27756436|NCT00302718|80936474|FG000|Overall Study|Participant left the hospital|1|||
27756437|NCT00302718|80936475|FG001|Overall Study|Participant left the hospital|0|||
27756438|NCT00302718|80936476|FG002|Overall Study|Participant left the hospital|0|||
27756439|NCT00302718|80936477|FG003|Overall Study|Participant left the hospital|1|||
27756440|NCT00302718|80936474|FG000|Overall Study|Withdrawal by Subject|0|||
27756441|NCT00302718|80936475|FG001|Overall Study|Withdrawal by Subject|1|||
27756442|NCT00302718|80936476|FG002|Overall Study|Withdrawal by Subject|0|||
27756443|NCT00302718|80936477|FG003|Overall Study|Withdrawal by Subject|0|||
27756444|NCT00302718|80936474|FG000|Overall Study|Participant left primary care setting|0|||
27756445|NCT00302718|80936475|FG001|Overall Study|Participant left primary care setting|0|||
27756446|NCT00302718|80936476|FG002|Overall Study|Participant left primary care setting|2|||
27756447|NCT00302718|80936477|FG003|Overall Study|Participant left primary care setting|1|||
27756448|NCT00448760|80936478|FG000|Overall Study|Death|3|||
27756449|NCT01361919|80936479|FG000|Overall Study|technical issues|10|||
27756450|NCT01361919|80936480|FG001|Overall Study|technical issues|12|||
27756451|NCT01361919|80936481|FG002|Overall Study|technical issues|10|||
27756452|NCT01188564|80936486|FG000|Double-blind Phase|randomized not treated|1|||
27756453|NCT01188564|80936487|FG001|Double-blind Phase|randomized not treated|0|||
27756454|NCT05554471|80936493|FG000|Overall Study|Physician Decision|2|||
27756455|NCT05554471|80936494|FG001|Overall Study|Physician Decision|1|||
27756456|NCT05554471|80936493|FG000|Overall Study|Lost to Follow-up|2|||
27756457|NCT05554471|80936494|FG001|Overall Study|Lost to Follow-up|1|||
27756458|NCT05554471|80936493|FG000|Overall Study|Death|0|||
27756459|NCT05554471|80936494|FG001|Overall Study|Death|1|||
27756460|NCT04397718|80936495|FG000|Overall Study|Death|7|||
27756461|NCT04397718|80936496|FG001|Overall Study|Death|11|||
27756462|NCT04397718|80936495|FG000|Overall Study|Lost to Follow-up|0|||
27756463|NCT04397718|80936496|FG001|Overall Study|Lost to Follow-up|4|||
27756464|NCT01766817|80936500|FG000|Overall Study|Drug-related adverse event|1|||
27756465|NCT01766817|80936501|FG001|Overall Study|Drug-related adverse event|2|||
27756466|NCT01766817|80936502|FG002|Overall Study|Drug-related adverse event|1|||
27756467|NCT01766817|80936500|FG000|Overall Study|Drug-unrelated adverse event|3|||
27756468|NCT01766817|80936501|FG001|Overall Study|Drug-unrelated adverse event|3|||
27756469|NCT01766817|80936502|FG002|Overall Study|Drug-unrelated adverse event|3|||
27756470|NCT01766817|80936500|FG000|Overall Study|Death|1|||
27756471|NCT01766817|80936501|FG001|Overall Study|Death|1|||
27756472|NCT01766817|80936502|FG002|Overall Study|Death|0|||
27756473|NCT01766817|80936500|FG000|Overall Study|Unable to take study drug|0|||
27756474|NCT01766817|80936501|FG001|Overall Study|Unable to take study drug|1|||
27756475|NCT01766817|80936502|FG002|Overall Study|Unable to take study drug|0|||
27756476|NCT01766817|80936500|FG000|Overall Study|Withdrawal by Subject|2|||
27756477|NCT01766817|80936501|FG001|Overall Study|Withdrawal by Subject|0|||
27756478|NCT01766817|80936502|FG002|Overall Study|Withdrawal by Subject|3|||
27756479|NCT01766817|80936500|FG000|Overall Study|Subject non-compliance|0|||
27756480|NCT01766817|80936501|FG001|Overall Study|Subject non-compliance|1|||
27756481|NCT01766817|80936502|FG002|Overall Study|Subject non-compliance|2|||
27756482|NCT01766817|80936500|FG000|Overall Study|Physician Decision|3|||
27756483|NCT01766817|80936501|FG001|Overall Study|Physician Decision|3|||
27756484|NCT01766817|80936502|FG002|Overall Study|Physician Decision|4|||
27756485|NCT01766817|80936500|FG000|Overall Study|Other|1|||
27756486|NCT01766817|80936501|FG001|Overall Study|Other|0|||
27756487|NCT01766817|80936502|FG002|Overall Study|Other|0|||
27756488|NCT02163993|80936503|FG000|Treatment Period|Adverse Event|0|||
27756489|NCT02163993|80936504|FG001|Treatment Period|Adverse Event|1|||
27756490|NCT02163993|80936505|FG002|Treatment Period|Adverse Event|0|||
27756491|NCT02163993|80936506|FG003|Treatment Period|Adverse Event|0|||
27756492|NCT02163993|80936507|FG004|Treatment Period|Adverse Event|1|||
27756493|NCT02163993|80936503|FG000|Treatment Period|Lost to Follow-up|2|||
27756494|NCT02163993|80936504|FG001|Treatment Period|Lost to Follow-up|3|||
27756495|NCT02163993|80936505|FG002|Treatment Period|Lost to Follow-up|1|||
27756496|NCT02163993|80936506|FG003|Treatment Period|Lost to Follow-up|3|||
27756497|NCT02163993|80936507|FG004|Treatment Period|Lost to Follow-up|1|||
27756498|NCT02163993|80936503|FG000|Treatment Period|Physician Decision|1|||
27756499|NCT02163993|80936504|FG001|Treatment Period|Physician Decision|0|||
27756500|NCT02163993|80936505|FG002|Treatment Period|Physician Decision|0|||
27756501|NCT02163993|80936506|FG003|Treatment Period|Physician Decision|0|||
27756502|NCT02163993|80936507|FG004|Treatment Period|Physician Decision|0|||
27756503|NCT02163993|80936503|FG000|Treatment Period|Protocol Violation|2|||
27756504|NCT02163993|80936504|FG001|Treatment Period|Protocol Violation|1|||
27756505|NCT02163993|80936505|FG002|Treatment Period|Protocol Violation|0|||
27756506|NCT02163993|80936506|FG003|Treatment Period|Protocol Violation|1|||
27756507|NCT02163993|80936507|FG004|Treatment Period|Protocol Violation|2|||
27756508|NCT02163993|80936503|FG000|Treatment Period|Withdrawal by Subject|6|||
27756509|NCT02163993|80936504|FG001|Treatment Period|Withdrawal by Subject|4|||
27756510|NCT02163993|80936505|FG002|Treatment Period|Withdrawal by Subject|1|||
27756511|NCT02163993|80936506|FG003|Treatment Period|Withdrawal by Subject|4|||
27756512|NCT02163993|80936507|FG004|Treatment Period|Withdrawal by Subject|1|||
27756513|NCT02163993|80936503|FG000|Treatment Period|Not treated|1|||
27756514|NCT02163993|80936504|FG001|Treatment Period|Not treated|0|||
27756515|NCT02163993|80936505|FG002|Treatment Period|Not treated|0|||
27756516|NCT02163993|80936506|FG003|Treatment Period|Not treated|1|||
27756517|NCT02163993|80936507|FG004|Treatment Period|Not treated|2|||
27756518|NCT02163993|80936503|FG000|Post-treatment Period|Adverse Event|0|||
27756519|NCT02163993|80936504|FG001|Post-treatment Period|Adverse Event|0|||
27756520|NCT02163993|80936505|FG002|Post-treatment Period|Adverse Event|1|||
27756521|NCT02163993|80936506|FG003|Post-treatment Period|Adverse Event|0|||
27756522|NCT02163993|80936507|FG004|Post-treatment Period|Adverse Event|0|||
27756523|NCT02163993|80936503|FG000|Post-treatment Period|Lost to Follow-up|2|||
27756524|NCT02163993|80936504|FG001|Post-treatment Period|Lost to Follow-up|2|||
27756525|NCT02163993|80936505|FG002|Post-treatment Period|Lost to Follow-up|3|||
27756526|NCT02163993|80936506|FG003|Post-treatment Period|Lost to Follow-up|1|||
27756527|NCT02163993|80936507|FG004|Post-treatment Period|Lost to Follow-up|0|||
27756528|NCT02163993|80936503|FG000|Post-treatment Period|Protocol Violation|0|||
27655352|NCT02092909|80576997|FG003|Overall Study|Study terminated by Sponsor|2|||
27655353|NCT02092909|80576994|FG000|Overall Study|Miscellaneous|1|||
27655354|NCT02092909|80576995|FG001|Overall Study|Miscellaneous|1|||
27756529|NCT02163993|80936504|FG001|Post-treatment Period|Protocol Violation|0|||
27756530|NCT02163993|80936505|FG002|Post-treatment Period|Protocol Violation|0|||
27756531|NCT02163993|80936506|FG003|Post-treatment Period|Protocol Violation|0|||
27756532|NCT02163993|80936507|FG004|Post-treatment Period|Protocol Violation|1|||
27756533|NCT02163993|80936503|FG000|Post-treatment Period|Withdrawal by Subject|2|||
27756534|NCT02163993|80936504|FG001|Post-treatment Period|Withdrawal by Subject|4|||
27756535|NCT02163993|80936505|FG002|Post-treatment Period|Withdrawal by Subject|0|||
27756536|NCT02163993|80936506|FG003|Post-treatment Period|Withdrawal by Subject|1|||
27756537|NCT02163993|80936507|FG004|Post-treatment Period|Withdrawal by Subject|2|||
27756538|NCT01623531|80936508|FG000|Overall Study|Death|1|||
27756539|NCT01623531|80936509|FG001|Overall Study|Death|0|||
27756540|NCT01623531|80936508|FG000|Overall Study|Protocol Violation|2|||
27756541|NCT01623531|80936509|FG001|Overall Study|Protocol Violation|1|||
27756542|NCT01623531|80936508|FG000|Overall Study|Missing data at primary outcome time poi|1|||
27756543|NCT01623531|80936509|FG001|Overall Study|Missing data at primary outcome time poi|1|||
27756544|NCT02358369|80936513|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
27756545|NCT02358369|80936514|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27756546|NCT02358369|80936515|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27756547|NCT02358369|80936516|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27832850|NCT00705666|81219375|FG000|Overall Study|Death|1|||
27832851|NCT00705666|81219375|FG000|Overall Study|Adverse Event|4|||
27832852|NCT00705666|81219375|FG000|Overall Study|Other|12|||
27832853|NCT00705666|81219375|FG000|Overall Study|Other|2|||
27832854|NCT00705666|81219375|FG000|Overall Study|Lack of data|3|||
27832855|NCT00705666|81219375|FG000|Overall Study|Untreated|5|||
27832856|NCT01693523|81219377|FG000|Overall Study|Adverse Event|2|||
27832857|NCT01693523|81219378|FG001|Overall Study|Adverse Event|1|||
27832858|NCT01693523|81219379|FG002|Overall Study|Adverse Event|0|||
27832859|NCT01693523|81219377|FG000|Overall Study|Death|0|||
27832860|NCT01693523|81219378|FG001|Overall Study|Death|1|||
27832861|NCT01693523|81219379|FG002|Overall Study|Death|1|||
27832862|NCT01693523|81219377|FG000|Overall Study|Lost to Follow-up|0|||
27832863|NCT01693523|81219378|FG001|Overall Study|Lost to Follow-up|0|||
27832864|NCT01693523|81219379|FG002|Overall Study|Lost to Follow-up|4|||
27832865|NCT01693523|81219377|FG000|Overall Study|Physician Decision|0|||
27832866|NCT01693523|81219378|FG001|Overall Study|Physician Decision|0|||
27832867|NCT01693523|81219379|FG002|Overall Study|Physician Decision|1|||
27832868|NCT01693523|81219377|FG000|Overall Study|Withdrawal by Subject|1|||
27832869|NCT01693523|81219378|FG001|Overall Study|Withdrawal by Subject|2|||
27832870|NCT01693523|81219379|FG002|Overall Study|Withdrawal by Subject|2|||
27832871|NCT01693523|81219377|FG000|Overall Study|Lack of compliance study medication|1|||
27832872|NCT01693523|81219378|FG001|Overall Study|Lack of compliance study medication|2|||
27832873|NCT01693523|81219379|FG002|Overall Study|Lack of compliance study medication|0|||
27832874|NCT01693523|81219377|FG000|Overall Study|Chemotherapy was held|1|||
27832875|NCT01693523|81219378|FG001|Overall Study|Chemotherapy was held|2|||
27832876|NCT01693523|81219379|FG002|Overall Study|Chemotherapy was held|0|||
27832877|NCT00725322|81219380|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
27832878|NCT00725322|81219381|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
27832879|NCT00725322|81219380|FG000|Washout (28 Days)|Protocol Violation|0|||
27832880|NCT00725322|81219381|FG001|Washout (28 Days)|Protocol Violation|1|||
27832881|NCT02011945|81219382|FG000|Overall Study|Participant requested to Discontinue|0|||
27832882|NCT02011945|81219383|FG001|Overall Study|Participant requested to Discontinue|1|||
27832883|NCT02011945|81219384|FG002|Overall Study|Participant requested to Discontinue|1|||
27832884|NCT02011945|81219382|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
27832885|NCT02011945|81219383|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
27832886|NCT02011945|81219384|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
27832887|NCT02011945|81219382|FG000|Overall Study|Study Drug Toxicity|0|||
27832888|NCT02011945|81219383|FG001|Overall Study|Study Drug Toxicity|0|||
27832889|NCT02011945|81219384|FG002|Overall Study|Study Drug Toxicity|1|||
27832890|NCT02011945|81219382|FG000|Overall Study|Treatment Failure|0|||
27832891|NCT02011945|81219383|FG001|Overall Study|Treatment Failure|7|||
27832892|NCT02011945|81219384|FG002|Overall Study|Treatment Failure|6|||
27832893|NCT02011945|81219382|FG000|Overall Study|No Longer Meets Study Criteria|1|||
27832894|NCT02011945|81219383|FG001|Overall Study|No Longer Meets Study Criteria|0|||
27832895|NCT02011945|81219384|FG002|Overall Study|No Longer Meets Study Criteria|0|||
27832896|NCT02011945|81219382|FG000|Overall Study|Proceeded to stem cell transplant|0|||
27832897|NCT02011945|81219383|FG001|Overall Study|Proceeded to stem cell transplant|0|||
27832898|NCT02011945|81219384|FG002|Overall Study|Proceeded to stem cell transplant|1|||
27832899|NCT02011945|81219382|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
27832900|NCT02011945|81219383|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
27832901|NCT02011945|81219384|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
27832902|NCT01741545|81219389|FG000|Treatment Period|Lack of Efficacy|0|||
27832903|NCT01741545|81219390|FG001|Treatment Period|Lack of Efficacy|1|||
27832904|NCT01741545|81219389|FG000|Treatment Period|Adverse event, non-fatal|1|||
27832905|NCT01741545|81219390|FG001|Treatment Period|Adverse event, non-fatal|3|||
27832906|NCT01741545|81219389|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
27832907|NCT01741545|81219390|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
27832908|NCT01741545|81219389|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
27832909|NCT01741545|81219390|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
27832910|NCT05479058|81219393|FG000|Overall Study|Withdrawal by Subject|1|||
27832911|NCT05479058|81219394|FG001|Overall Study|Withdrawal by Subject|1|||
27832912|NCT05479058|81219393|FG000|Overall Study|Study terminated by sponsor|10|||
27832913|NCT05479058|81219394|FG001|Overall Study|Study terminated by sponsor|10|||
27832914|NCT04583423|81219401|FG000|Overall Study|Lost to Follow-up|0|||
27832915|NCT04583423|81219402|FG001|Overall Study|Lost to Follow-up|1|||
27832916|NCT04583423|81219403|FG002|Overall Study|Lost to Follow-up|0|||
27832917|NCT04583423|81219404|FG003|Overall Study|Lost to Follow-up|2|||
27857806|NCT02397408|81314389|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
27857807|NCT03858634|81314390|FG000|Overall Study|Withdrawal by Subject|1|||
27857808|NCT03858634|81314391|FG001|Overall Study|Withdrawal by Subject|0|||
27857809|NCT03858634|81314390|FG000|Overall Study|Adverse Event|1|||
27857810|NCT03858634|81314391|FG001|Overall Study|Adverse Event|0|||
27857811|NCT03858634|81314390|FG000|Overall Study|Lost to Follow-up|0|||
27857812|NCT03858634|81314391|FG001|Overall Study|Lost to Follow-up|1|||
27857813|NCT03858634|81314390|FG000|Overall Study|Other, Not Specified|1|||
27857814|NCT03858634|81314391|FG001|Overall Study|Other, Not Specified|1|||
27857815|NCT00985712|81314392|FG000|Overall Study|Adverse Event|0|||
27857816|NCT00985712|81314393|FG001|Overall Study|Adverse Event|1|||
27857817|NCT00985712|81314392|FG000|Overall Study|Lost to Follow-up|2|||
27857818|NCT00985712|81314393|FG001|Overall Study|Lost to Follow-up|2|||
27857819|NCT00985712|81314392|FG000|Overall Study|Protocol Violation|0|||
27857820|NCT00985712|81314393|FG001|Overall Study|Protocol Violation|1|||
27857821|NCT00985712|81314392|FG000|Overall Study|Withdrawal by Subject|4|||
27857822|NCT00985712|81314393|FG001|Overall Study|Withdrawal by Subject|1|||
27857823|NCT00985712|81314392|FG000|Overall Study|Sponsor decision|0|||
27857824|NCT00985712|81314393|FG001|Overall Study|Sponsor decision|2|||
27857825|NCT02006693|81314394|FG000|Overall Study|No Reason Specified|6|||
27857826|NCT02006693|81314395|FG001|Overall Study|No Reason Specified|8|||
27857827|NCT02006693|81314394|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
27857828|NCT02006693|81314395|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
27857829|NCT02006693|81314394|FG000|Overall Study|XEN Implant Explantation|0|||
27857830|NCT02006693|81314395|FG001|Overall Study|XEN Implant Explantation|1|||
27857831|NCT02006693|81314394|FG000|Overall Study|Death|2|||
27857832|NCT02006693|81314395|FG001|Overall Study|Death|2|||
27857833|NCT02006693|81314394|FG000|Overall Study|Lost to Follow-up|4|||
27857834|NCT02006693|81314395|FG001|Overall Study|Lost to Follow-up|1|||
27857835|NCT02006693|81314394|FG000|Overall Study|Patient Decision|4|||
27857836|NCT02006693|81314395|FG001|Overall Study|Patient Decision|0|||
27857837|NCT01189487|81314396|FG000|Overall Study|Lack of Efficacy|2|||
27857838|NCT01189487|81314396|FG000|Overall Study|Adverse Event|1|||
27857839|NCT02728843|81314397|FG000|Overall Study|Adverse Event|0|||
27857840|NCT02728843|81314398|FG001|Overall Study|Adverse Event|2|||
27857841|NCT02728843|81314399|FG002|Overall Study|Adverse Event|3|||
27857842|NCT02728843|81314400|FG003|Overall Study|Adverse Event|1|||
27857843|NCT02728843|81314401|FG004|Overall Study|Adverse Event|2|||
27857844|NCT02728843|81314397|FG000|Overall Study|Lack of Efficacy|0|||
27857845|NCT02728843|81314398|FG001|Overall Study|Lack of Efficacy|1|||
27857846|NCT02728843|81314399|FG002|Overall Study|Lack of Efficacy|1|||
27857847|NCT02728843|81314400|FG003|Overall Study|Lack of Efficacy|0|||
27857848|NCT02728843|81314401|FG004|Overall Study|Lack of Efficacy|0|||
27857849|NCT02728843|81314397|FG000|Overall Study|Protocol Violation|2|||
27857850|NCT02728843|81314398|FG001|Overall Study|Protocol Violation|0|||
27857851|NCT02728843|81314399|FG002|Overall Study|Protocol Violation|4|||
27857852|NCT02728843|81314400|FG003|Overall Study|Protocol Violation|2|||
27857853|NCT02728843|81314401|FG004|Overall Study|Protocol Violation|2|||
27857854|NCT02728843|81314397|FG000|Overall Study|Withdrawal by Subject|1|||
27857855|NCT02728843|81314398|FG001|Overall Study|Withdrawal by Subject|0|||
27857856|NCT02728843|81314399|FG002|Overall Study|Withdrawal by Subject|0|||
27857857|NCT02728843|81314400|FG003|Overall Study|Withdrawal by Subject|1|||
27857858|NCT02728843|81314401|FG004|Overall Study|Withdrawal by Subject|0|||
27857859|NCT02728843|81314397|FG000|Overall Study|Use of rescue medication|0|||
27857860|NCT02728843|81314398|FG001|Overall Study|Use of rescue medication|2|||
27857861|NCT02728843|81314399|FG002|Overall Study|Use of rescue medication|0|||
27857862|NCT02728843|81314400|FG003|Overall Study|Use of rescue medication|2|||
27857863|NCT02728843|81314401|FG004|Overall Study|Use of rescue medication|1|||
27857864|NCT00289536|81314409|FG000|Period 3|Lost to Follow-up|0|||
27857865|NCT00289536|81314410|FG001|Period 3|Lost to Follow-up|0|||
27857866|NCT00289536|81314411|FG002|Period 3|Lost to Follow-up|1|||
27857867|NCT03709823|81314419|FG000|Overall Study|Adverse Event|0|||
27857868|NCT03709823|81314420|FG001|Overall Study|Adverse Event|0|||
27857869|NCT03709823|81314421|FG002|Overall Study|Adverse Event|1|||
27857870|NCT03709823|81314422|FG003|Overall Study|Adverse Event|0|||
27857871|NCT03709823|81314423|FG004|Overall Study|Adverse Event|0|||
27857872|NCT03709823|81314424|FG005|Overall Study|Adverse Event|0|||
27857873|NCT03709823|81314419|FG000|Overall Study|Lost to Follow-up|2|||
27857874|NCT03709823|81314420|FG001|Overall Study|Lost to Follow-up|2|||
27857875|NCT03709823|81314421|FG002|Overall Study|Lost to Follow-up|2|||
27857876|NCT03709823|81314422|FG003|Overall Study|Lost to Follow-up|1|||
27857877|NCT03709823|81314423|FG004|Overall Study|Lost to Follow-up|1|||
27857878|NCT03709823|81314424|FG005|Overall Study|Lost to Follow-up|0|||
27857879|NCT03709823|81314419|FG000|Overall Study|Withdrawal by Subject|1|||
27857880|NCT03709823|81314420|FG001|Overall Study|Withdrawal by Subject|3|||
27857881|NCT03709823|81314421|FG002|Overall Study|Withdrawal by Subject|0|||
27857882|NCT03709823|81314422|FG003|Overall Study|Withdrawal by Subject|0|||
27857883|NCT03709823|81314423|FG004|Overall Study|Withdrawal by Subject|0|||
27857884|NCT03709823|81314424|FG005|Overall Study|Withdrawal by Subject|0|||
27857885|NCT03709823|81314419|FG000|Overall Study|Other, Not Specified|0|||
27857886|NCT03709823|81314420|FG001|Overall Study|Other, Not Specified|0|||
27857887|NCT03709823|81314421|FG002|Overall Study|Other, Not Specified|0|||
27857888|NCT03709823|81314422|FG003|Overall Study|Other, Not Specified|1|||
27857889|NCT03709823|81314423|FG004|Overall Study|Other, Not Specified|0|||
27857890|NCT03709823|81314424|FG005|Overall Study|Other, Not Specified|0|||
27857891|NCT04729309|81314425|FG000|Period 1|Subject unable to return for Period 2|3|||
27857892|NCT04729309|81314426|FG001|Period 1|Subject unable to return for Period 2|0|||
27857893|NCT04729309|81314425|FG000|Period 1|Lost to Follow-up|1|||
27857894|NCT04729309|81314426|FG001|Period 1|Lost to Follow-up|0|||
27857895|NCT00837473|81314427|FG000|Overall Study|Lost to Follow-up|1|||
27857896|NCT00837473|81314427|FG000|Overall Study|Withdrawal by Subject|2|||
27857897|NCT03084367|81314428|FG000|Overall Study|Lost to Follow-up|32|||
27857898|NCT03084367|81314428|FG000|Overall Study|Withdrawal by Subject|4|||
27857899|NCT03084367|81314428|FG000|Overall Study|Other|1|||
27857900|NCT00510289|81314429|FG000|Overall Study|Withdrawal by Subject|7|||
27857901|NCT00510289|81314429|FG000|Overall Study|Refused bone marrow biopsy|2|||
27857902|NCT00510289|81314429|FG000|Overall Study|Lost to Follow-up|1|||
27562519|NCT02503332|80246279|FG000|Overall Study|Subject Request|6|||
27857903|NCT00510289|81314429|FG000|Overall Study|Progressed prior to starting drug|2|||
27857904|NCT00620555|81314431|FG000|Overall Study|Adverse Event|4|||
27857905|NCT00620555|81314431|FG000|Overall Study|Protocol Violation|2|||
27857906|NCT00620555|81314431|FG000|Overall Study|Lack of Efficacy|12|||
27857907|NCT00620555|81314431|FG000|Overall Study|Withdrawal by Subject|1|||
27857908|NCT00620555|81314431|FG000|Overall Study|Choice of other treatment|1|||
27857909|NCT00620555|81314431|FG000|Overall Study|Visit failure against planned|1|||
27857910|NCT00090363|81314432|FG000|Overall Study|Lost to Follow-up|1|||
27857911|NCT00090363|81314433|FG001|Overall Study|Lost to Follow-up|2|||
27857912|NCT00090363|81314434|FG002|Overall Study|Lost to Follow-up|1|||
27857913|NCT00090363|81314432|FG000|Overall Study|Withdrawal by Subject|7|||
27857914|NCT00090363|81314433|FG001|Overall Study|Withdrawal by Subject|7|||
27857915|NCT00090363|81314434|FG002|Overall Study|Withdrawal by Subject|6|||
27857916|NCT00090363|81314432|FG000|Overall Study|Study-specific discontinuation criteria|75|||
27857917|NCT00090363|81314433|FG001|Overall Study|Study-specific discontinuation criteria|74|||
27857918|NCT00090363|81314434|FG002|Overall Study|Study-specific discontinuation criteria|62|||
27857919|NCT00090363|81314432|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27857920|NCT00090363|81314433|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27857921|NCT00090363|81314434|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27857922|NCT00090363|81314432|FG000|Overall Study|Consent expired|7|||
27756548|NCT02358369|80936517|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
27756549|NCT02358369|80936513|FG000|Treatment Period A/B|Adverse Event|0|||
27756550|NCT02358369|80936514|FG001|Treatment Period A/B|Adverse Event|0|||
27756551|NCT02358369|80936515|FG002|Treatment Period A/B|Adverse Event|1|||
27756552|NCT02358369|80936516|FG003|Treatment Period A/B|Adverse Event|2|||
27756553|NCT02358369|80936517|FG004|Treatment Period A/B|Adverse Event|0|||
27756554|NCT02358369|80936513|FG000|Treatment Period A/B|Death|0|||
27756555|NCT02358369|80936514|FG001|Treatment Period A/B|Death|0|||
27756556|NCT02358369|80936515|FG002|Treatment Period A/B|Death|1|||
27756557|NCT02358369|80936516|FG003|Treatment Period A/B|Death|0|||
27756558|NCT02358369|80936517|FG004|Treatment Period A/B|Death|0|||
27756559|NCT02358369|80936513|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
27756560|NCT02358369|80936514|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
27756561|NCT02358369|80936515|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
27857923|NCT00090363|81314433|FG001|Overall Study|Consent expired|10|||
27857924|NCT00090363|81314434|FG002|Overall Study|Consent expired|9|||
27857925|NCT00090363|81314432|FG000|Overall Study|Reasons not specified|2|||
27857926|NCT00090363|81314433|FG001|Overall Study|Reasons not specified|1|||
27857927|NCT00090363|81314434|FG002|Overall Study|Reasons not specified|1|||
27857928|NCT00090363|81314432|FG000|Overall Study|Continuing on study off treatment|14|||
27857929|NCT00090363|81314433|FG001|Overall Study|Continuing on study off treatment|13|||
27857930|NCT00090363|81314434|FG002|Overall Study|Continuing on study off treatment|16|||
27857931|NCT01400919|81314435|FG000|Overall Study|Withdrawal by Subject|4|||
27857932|NCT01400919|81314435|FG000|Overall Study|Lost to Follow-up|2|||
27857933|NCT01400919|81314435|FG000|Overall Study|Missed visit|2|||
27857934|NCT00922272|81314438|FG000|Open-label Phase|Adverse Event|5|||
27857935|NCT00922272|81314439|FG001|Open-label Phase|Adverse Event|0|||
27857936|NCT00922272|81314438|FG000|Open-label Phase|Protocol Violation|1|||
27857937|NCT00922272|81314439|FG001|Open-label Phase|Protocol Violation|0|||
27857938|NCT00922272|81314438|FG000|Open-label Phase|Withdrawal by Subject|11|||
27857939|NCT00922272|81314439|FG001|Open-label Phase|Withdrawal by Subject|0|||
27857940|NCT00922272|81314438|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
27857941|NCT00922272|81314439|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
27857942|NCT00922272|81314438|FG000|Open-label Phase|Withdrawal criteria met|5|||
27857943|NCT00922272|81314439|FG001|Open-label Phase|Withdrawal criteria met|0|||
27857944|NCT00922272|81314438|FG000|Double-blind Phase|Adverse Event|1|||
27857945|NCT00922272|81314439|FG001|Double-blind Phase|Adverse Event|1|||
27857946|NCT00922272|81314438|FG000|Double-blind Phase|Withdrawal by Subject|1|||
27857947|NCT00922272|81314439|FG001|Double-blind Phase|Withdrawal by Subject|1|||
27857948|NCT00922272|81314438|FG000|Double-blind Phase|Lost to Follow-up|2|||
27756562|NCT02358369|80936516|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
27756563|NCT02358369|80936517|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
27756564|NCT02358369|80936513|FG000|Treatment Period C|Adverse Event|0|||
27756565|NCT02358369|80936514|FG001|Treatment Period C|Adverse Event|0|||
27756566|NCT02358369|80936515|FG002|Treatment Period C|Adverse Event|0|||
27756567|NCT02358369|80936516|FG003|Treatment Period C|Adverse Event|0|||
27756568|NCT02358369|80936517|FG004|Treatment Period C|Adverse Event|7|||
27857949|NCT00922272|81314439|FG001|Double-blind Phase|Lost to Follow-up|1|||
27857950|NCT00922272|81314438|FG000|Double-blind Phase|Withdrawal criteria met|1|||
27857951|NCT00922272|81314439|FG001|Double-blind Phase|Withdrawal criteria met|1|||
27857952|NCT00922272|81314438|FG000|Double-blind Phase|Noncompliance|1|||
27857953|NCT00922272|81314439|FG001|Double-blind Phase|Noncompliance|1|||
27857954|NCT00922272|81314438|FG000|Double-blind Phase|Positive urine drug screen|1|||
27857955|NCT00922272|81314439|FG001|Double-blind Phase|Positive urine drug screen|1|||
27857956|NCT02011113|81314440|FG000|Overall Study|Adverse Event|4|||
27857957|NCT02011113|81314440|FG000|Overall Study|Disease Progression (DP)|16|||
27857958|NCT02011113|81314440|FG000|Overall Study|Death|1|||
27857959|NCT02011113|81314440|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
27857960|NCT02011113|81314440|FG000|Overall Study|Investigator's judgement- DP|3|||
27857961|NCT02011113|81314440|FG000|Overall Study|Study terminated by sponsor|11|||
27857962|NCT03560986|81314450|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
27857963|NCT03560986|81314451|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
27857964|NCT03560986|81314450|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
27756569|NCT01885078|80936519|FG000|Treatment Period|Adverse Event|52|||
27857965|NCT03560986|81314451|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
27857966|NCT03560986|81314450|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
27857967|NCT03560986|81314451|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
27857968|NCT03560986|81314450|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
27857969|NCT03560986|81314451|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
27857970|NCT03560986|81314450|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
27857971|NCT03560986|81314451|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
27857972|NCT03560986|81314450|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
27857973|NCT03560986|81314451|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
27857974|NCT03560986|81314450|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
27857975|NCT03560986|81314451|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
27857976|NCT03665441|81314452|FG000|Overall Study|survival follow up ongoing|23|||
27857977|NCT03665441|81314453|FG001|Overall Study|survival follow up ongoing|0|||
27857978|NCT03665441|81314452|FG000|Overall Study|Patients ongoing on treatment|9|||
27857979|NCT03665441|81314453|FG001|Overall Study|Patients ongoing on treatment|6|||
27857980|NCT03665441|81314452|FG000|Overall Study|Randomized but not treated|7|||
27857981|NCT03665441|81314453|FG001|Overall Study|Randomized but not treated|11|||
27857982|NCT02140411|81314454|FG000|Overall Study|Adverse Event|1|||
27857983|NCT01359969|81314455|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
27857984|NCT01161407|81314458|FG000|Overall Study|Protocol Violation|3|||
27857985|NCT01161407|81314459|FG001|Overall Study|Protocol Violation|1|||
27857986|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
27857987|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
27857988|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
27857989|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
27857990|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
27857991|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
27857992|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
27857993|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
27857994|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
27857995|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
27857996|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
27857997|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
27857998|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
27857999|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
27858000|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
27858001|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
27858002|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
27858003|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
27858004|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
27858005|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
27858006|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
27858007|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
27858008|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
27858009|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
27858010|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
27858011|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
27858012|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
27858013|NCT02552212|81314460|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
27858014|NCT02552212|81314461|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
27858015|NCT02552212|81314462|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
27858016|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
27858017|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
27756570|NCT01885078|80936520|FG001|Treatment Period|Adverse Event|136|||
27756571|NCT01885078|80936521|FG002|Treatment Period|Adverse Event|30|||
27756572|NCT01885078|80936522|FG003|Treatment Period|Adverse Event|73|||
27756573|NCT01885078|80936523|FG004|Treatment Period|Adverse Event|17|||
27756574|NCT01885078|80936524|FG005|Treatment Period|Adverse Event|72|||
27756575|NCT01885078|80936525|FG006|Treatment Period|Adverse Event|24|||
27756576|NCT01885078|80936526|FG007|Treatment Period|Adverse Event|5|||
27756577|NCT01885078|80936527|FG008|Treatment Period|Adverse Event|0|||
27756578|NCT01885078|80936528|FG009|Treatment Period|Adverse Event|0|||
27756579|NCT01885078|80936519|FG000|Treatment Period|Death|13|||
27756580|NCT01885078|80936520|FG001|Treatment Period|Death|33|||
27756581|NCT01885078|80936521|FG002|Treatment Period|Death|5|||
27858018|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
27858019|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
27858020|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
27858021|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
27858022|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
27858023|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
27960296|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27756582|NCT01885078|80936522|FG003|Treatment Period|Death|9|||
27756583|NCT01885078|80936523|FG004|Treatment Period|Death|2|||
27756584|NCT01885078|80936524|FG005|Treatment Period|Death|10|||
27756585|NCT01885078|80936525|FG006|Treatment Period|Death|3|||
27756586|NCT01885078|80936526|FG007|Treatment Period|Death|2|||
27756587|NCT01885078|80936527|FG008|Treatment Period|Death|0|||
27756588|NCT01885078|80936528|FG009|Treatment Period|Death|0|||
27756589|NCT01885078|80936519|FG000|Treatment Period|Lack of Efficacy|12|||
27756590|NCT01885078|80936520|FG001|Treatment Period|Lack of Efficacy|33|||
27756591|NCT01885078|80936521|FG002|Treatment Period|Lack of Efficacy|10|||
27756592|NCT01885078|80936522|FG003|Treatment Period|Lack of Efficacy|23|||
27756593|NCT01885078|80936523|FG004|Treatment Period|Lack of Efficacy|24|||
27756594|NCT01885078|80936524|FG005|Treatment Period|Lack of Efficacy|58|||
27756595|NCT01885078|80936525|FG006|Treatment Period|Lack of Efficacy|9|||
27756596|NCT01885078|80936526|FG007|Treatment Period|Lack of Efficacy|5|||
27756597|NCT01885078|80936527|FG008|Treatment Period|Lack of Efficacy|0|||
27756598|NCT01885078|80936528|FG009|Treatment Period|Lack of Efficacy|0|||
27756599|NCT01885078|80936519|FG000|Treatment Period|Lost to Follow-up|16|||
27756600|NCT01885078|80936520|FG001|Treatment Period|Lost to Follow-up|19|||
27756601|NCT01885078|80936521|FG002|Treatment Period|Lost to Follow-up|7|||
27756602|NCT01885078|80936522|FG003|Treatment Period|Lost to Follow-up|9|||
27756603|NCT01885078|80936523|FG004|Treatment Period|Lost to Follow-up|2|||
27756604|NCT01885078|80936524|FG005|Treatment Period|Lost to Follow-up|8|||
27756605|NCT01885078|80936525|FG006|Treatment Period|Lost to Follow-up|2|||
27756606|NCT01885078|80936526|FG007|Treatment Period|Lost to Follow-up|0|||
27756607|NCT01885078|80936527|FG008|Treatment Period|Lost to Follow-up|0|||
27756608|NCT01885078|80936528|FG009|Treatment Period|Lost to Follow-up|0|||
27756609|NCT01885078|80936519|FG000|Treatment Period|Physician Decision|19|||
27756610|NCT01885078|80936520|FG001|Treatment Period|Physician Decision|21|||
27756611|NCT01885078|80936521|FG002|Treatment Period|Physician Decision|5|||
27756612|NCT01885078|80936522|FG003|Treatment Period|Physician Decision|12|||
27756613|NCT01885078|80936523|FG004|Treatment Period|Physician Decision|9|||
27756614|NCT01885078|80936524|FG005|Treatment Period|Physician Decision|24|||
27756615|NCT01885078|80936525|FG006|Treatment Period|Physician Decision|4|||
27756616|NCT01885078|80936526|FG007|Treatment Period|Physician Decision|3|||
27756617|NCT01885078|80936527|FG008|Treatment Period|Physician Decision|0|||
27756618|NCT01885078|80936528|FG009|Treatment Period|Physician Decision|0|||
27756619|NCT01885078|80936519|FG000|Treatment Period|Protocol Violation|3|||
27756620|NCT01885078|80936520|FG001|Treatment Period|Protocol Violation|5|||
27756621|NCT01885078|80936521|FG002|Treatment Period|Protocol Violation|0|||
27756622|NCT01885078|80936522|FG003|Treatment Period|Protocol Violation|3|||
27756623|NCT01885078|80936523|FG004|Treatment Period|Protocol Violation|1|||
27756624|NCT01885078|80936524|FG005|Treatment Period|Protocol Violation|6|||
27756625|NCT01885078|80936525|FG006|Treatment Period|Protocol Violation|0|||
27756626|NCT01885078|80936526|FG007|Treatment Period|Protocol Violation|0|||
27756627|NCT01885078|80936527|FG008|Treatment Period|Protocol Violation|0|||
27756628|NCT01885078|80936528|FG009|Treatment Period|Protocol Violation|0|||
27756629|NCT01885078|80936519|FG000|Treatment Period|Sponsor Decision|245|||
27756630|NCT01885078|80936520|FG001|Treatment Period|Sponsor Decision|648|||
27756631|NCT01885078|80936521|FG002|Treatment Period|Sponsor Decision|49|||
27756632|NCT01885078|80936522|FG003|Treatment Period|Sponsor Decision|90|||
27756633|NCT01885078|80936523|FG004|Treatment Period|Sponsor Decision|20|||
27756634|NCT01885078|80936524|FG005|Treatment Period|Sponsor Decision|38|||
27858024|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
27858025|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
27858026|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
27858027|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
27858028|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
27858029|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
27858030|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
27858031|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
27858032|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
27858033|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
27858034|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
27858035|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
27858036|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
27858037|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
27858038|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
27858039|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
27858040|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
27858041|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
27756635|NCT01885078|80936525|FG006|Treatment Period|Sponsor Decision|162|||
27756636|NCT01885078|80936526|FG007|Treatment Period|Sponsor Decision|3|||
27756637|NCT01885078|80936527|FG008|Treatment Period|Sponsor Decision|0|||
27756638|NCT01885078|80936528|FG009|Treatment Period|Sponsor Decision|0|||
27756639|NCT01885078|80936519|FG000|Treatment Period|Withdrawal by Subject|72|||
27756640|NCT01885078|80936520|FG001|Treatment Period|Withdrawal by Subject|132|||
27756641|NCT01885078|80936521|FG002|Treatment Period|Withdrawal by Subject|25|||
27756642|NCT01885078|80936522|FG003|Treatment Period|Withdrawal by Subject|63|||
27756643|NCT01885078|80936523|FG004|Treatment Period|Withdrawal by Subject|15|||
27756644|NCT01885078|80936524|FG005|Treatment Period|Withdrawal by Subject|34|||
27756645|NCT01885078|80936525|FG006|Treatment Period|Withdrawal by Subject|17|||
27756646|NCT01885078|80936526|FG007|Treatment Period|Withdrawal by Subject|10|||
27756647|NCT01885078|80936527|FG008|Treatment Period|Withdrawal by Subject|0|||
27756648|NCT01885078|80936528|FG009|Treatment Period|Withdrawal by Subject|0|||
27756649|NCT01885078|80936519|FG000|Treatment Period|Other|0|||
27756650|NCT01885078|80936520|FG001|Treatment Period|Other|0|||
27756651|NCT01885078|80936521|FG002|Treatment Period|Other|0|||
27756652|NCT01885078|80936522|FG003|Treatment Period|Other|1|||
27756653|NCT01885078|80936523|FG004|Treatment Period|Other|0|||
27756654|NCT01885078|80936524|FG005|Treatment Period|Other|0|||
27756655|NCT01885078|80936525|FG006|Treatment Period|Other|0|||
27756656|NCT01885078|80936526|FG007|Treatment Period|Other|0|||
27756657|NCT01885078|80936527|FG008|Treatment Period|Other|0|||
27858042|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
27858043|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
27858044|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
27756658|NCT01885078|80936528|FG009|Treatment Period|Other|0|||
27756659|NCT01885078|80936519|FG000|Step-down Period|Sponsor Decision|0|||
27756660|NCT01885078|80936520|FG001|Step-down Period|Sponsor Decision|0|||
27756661|NCT01885078|80936521|FG002|Step-down Period|Sponsor Decision|0|||
27756662|NCT01885078|80936522|FG003|Step-down Period|Sponsor Decision|0|||
27756663|NCT01885078|80936523|FG004|Step-down Period|Sponsor Decision|0|||
27756664|NCT01885078|80936524|FG005|Step-down Period|Sponsor Decision|0|||
27756665|NCT01885078|80936525|FG006|Step-down Period|Sponsor Decision|0|||
27756666|NCT01885078|80936526|FG007|Step-down Period|Sponsor Decision|0|||
27756667|NCT01885078|80936527|FG008|Step-down Period|Sponsor Decision|1|||
27756668|NCT01885078|80936528|FG009|Step-down Period|Sponsor Decision|1|||
27756669|NCT01885078|80936519|FG000|Step-down Period|Adverse Event|0|||
27756670|NCT01885078|80936520|FG001|Step-down Period|Adverse Event|0|||
27756671|NCT01885078|80936521|FG002|Step-down Period|Adverse Event|0|||
27756672|NCT01885078|80936522|FG003|Step-down Period|Adverse Event|0|||
27756673|NCT01885078|80936523|FG004|Step-down Period|Adverse Event|0|||
27756674|NCT01885078|80936524|FG005|Step-down Period|Adverse Event|0|||
27756675|NCT01885078|80936525|FG006|Step-down Period|Adverse Event|0|||
27756676|NCT01885078|80936526|FG007|Step-down Period|Adverse Event|0|||
27756677|NCT01885078|80936527|FG008|Step-down Period|Adverse Event|29|||
27756678|NCT01885078|80936528|FG009|Step-down Period|Adverse Event|38|||
27756679|NCT01885078|80936519|FG000|Step-down Period|Withdrawal by Subject|0|||
27756680|NCT01885078|80936520|FG001|Step-down Period|Withdrawal by Subject|0|||
27562520|NCT02503332|80246280|FG001|Overall Study|Subject Request|5|||
27756681|NCT01885078|80936521|FG002|Step-down Period|Withdrawal by Subject|0|||
27756682|NCT01885078|80936522|FG003|Step-down Period|Withdrawal by Subject|0|||
27756683|NCT01885078|80936523|FG004|Step-down Period|Withdrawal by Subject|0|||
27756684|NCT01885078|80936524|FG005|Step-down Period|Withdrawal by Subject|0|||
27756685|NCT01885078|80936525|FG006|Step-down Period|Withdrawal by Subject|0|||
27756686|NCT01885078|80936526|FG007|Step-down Period|Withdrawal by Subject|0|||
27756687|NCT01885078|80936527|FG008|Step-down Period|Withdrawal by Subject|25|||
27756688|NCT01885078|80936528|FG009|Step-down Period|Withdrawal by Subject|15|||
27756689|NCT01885078|80936519|FG000|Step-down Period|Physician Decision|0|||
27756690|NCT01885078|80936520|FG001|Step-down Period|Physician Decision|0|||
27756691|NCT01885078|80936521|FG002|Step-down Period|Physician Decision|0|||
27756692|NCT01885078|80936522|FG003|Step-down Period|Physician Decision|0|||
27756693|NCT01885078|80936523|FG004|Step-down Period|Physician Decision|0|||
27756694|NCT01885078|80936524|FG005|Step-down Period|Physician Decision|0|||
27756695|NCT01885078|80936525|FG006|Step-down Period|Physician Decision|0|||
27756696|NCT01885078|80936526|FG007|Step-down Period|Physician Decision|0|||
27756697|NCT01885078|80936527|FG008|Step-down Period|Physician Decision|7|||
27756698|NCT01885078|80936528|FG009|Step-down Period|Physician Decision|2|||
27756699|NCT01885078|80936519|FG000|Step-down Period|Death|0|||
27756700|NCT01885078|80936520|FG001|Step-down Period|Death|0|||
27756701|NCT01885078|80936521|FG002|Step-down Period|Death|0|||
27756702|NCT01885078|80936522|FG003|Step-down Period|Death|0|||
27756703|NCT01885078|80936523|FG004|Step-down Period|Death|0|||
27756704|NCT01885078|80936524|FG005|Step-down Period|Death|0|||
27756705|NCT01885078|80936525|FG006|Step-down Period|Death|0|||
27756706|NCT01885078|80936526|FG007|Step-down Period|Death|0|||
27756707|NCT01885078|80936527|FG008|Step-down Period|Death|4|||
27756708|NCT01885078|80936528|FG009|Step-down Period|Death|3|||
27756709|NCT01885078|80936519|FG000|Step-down Period|Lost to Follow-up|0|||
27756710|NCT01885078|80936520|FG001|Step-down Period|Lost to Follow-up|0|||
27756711|NCT01885078|80936521|FG002|Step-down Period|Lost to Follow-up|0|||
27756712|NCT01885078|80936522|FG003|Step-down Period|Lost to Follow-up|0|||
27756713|NCT01885078|80936523|FG004|Step-down Period|Lost to Follow-up|0|||
27756714|NCT01885078|80936524|FG005|Step-down Period|Lost to Follow-up|0|||
27756715|NCT01885078|80936525|FG006|Step-down Period|Lost to Follow-up|0|||
27756716|NCT01885078|80936526|FG007|Step-down Period|Lost to Follow-up|0|||
27756717|NCT01885078|80936527|FG008|Step-down Period|Lost to Follow-up|1|||
27756718|NCT01885078|80936528|FG009|Step-down Period|Lost to Follow-up|1|||
27756719|NCT01885078|80936519|FG000|Step-down Period|Lack of Efficacy|0|||
27756720|NCT01885078|80936520|FG001|Step-down Period|Lack of Efficacy|0|||
27756721|NCT01885078|80936521|FG002|Step-down Period|Lack of Efficacy|0|||
27756722|NCT01885078|80936522|FG003|Step-down Period|Lack of Efficacy|0|||
27756723|NCT01885078|80936523|FG004|Step-down Period|Lack of Efficacy|0|||
27756724|NCT01885078|80936524|FG005|Step-down Period|Lack of Efficacy|0|||
27756725|NCT01885078|80936525|FG006|Step-down Period|Lack of Efficacy|0|||
27756726|NCT01885078|80936526|FG007|Step-down Period|Lack of Efficacy|0|||
27756727|NCT01885078|80936527|FG008|Step-down Period|Lack of Efficacy|1|||
27756728|NCT01885078|80936528|FG009|Step-down Period|Lack of Efficacy|0|||
27756729|NCT01885078|80936519|FG000|Step-down Period|Protocol Violation|0|||
27756730|NCT01885078|80936520|FG001|Step-down Period|Protocol Violation|0|||
27756731|NCT01885078|80936521|FG002|Step-down Period|Protocol Violation|0|||
27756732|NCT01885078|80936522|FG003|Step-down Period|Protocol Violation|0|||
27756733|NCT01885078|80936523|FG004|Step-down Period|Protocol Violation|0|||
27756734|NCT01885078|80936524|FG005|Step-down Period|Protocol Violation|0|||
27756735|NCT01885078|80936525|FG006|Step-down Period|Protocol Violation|0|||
27756736|NCT01885078|80936526|FG007|Step-down Period|Protocol Violation|0|||
27756737|NCT01885078|80936527|FG008|Step-down Period|Protocol Violation|1|||
27756738|NCT01885078|80936528|FG009|Step-down Period|Protocol Violation|1|||
27756739|NCT02932332|80936529|FG000|Overall Study|Withdrawal by Subject|1|||
27756740|NCT02932332|80936530|FG001|Overall Study|Withdrawal by Subject|1|||
27756741|NCT02932332|80936531|FG002|Overall Study|Withdrawal by Subject|0|||
27756742|NCT02932332|80936532|FG003|Overall Study|Withdrawal by Subject|1|||
27756743|NCT02932332|80936529|FG000|Overall Study|Chest pain|0|||
27756744|NCT02932332|80936530|FG001|Overall Study|Chest pain|0|||
27756745|NCT02932332|80936531|FG002|Overall Study|Chest pain|0|||
27756746|NCT02932332|80936532|FG003|Overall Study|Chest pain|1|||
27756747|NCT02932332|80936529|FG000|Overall Study|Not Dyspneic cough|1|||
27562521|NCT02503332|80246281|FG002|Overall Study|Subject Request|2|||
27756748|NCT02932332|80936530|FG001|Overall Study|Not Dyspneic cough|2|||
27756749|NCT02932332|80936531|FG002|Overall Study|Not Dyspneic cough|1|||
27756750|NCT02932332|80936532|FG003|Overall Study|Not Dyspneic cough|0|||
27756751|NCT00764478|80936533|FG000|Overall Study|Adverse Event|1|||
27756752|NCT00764478|80936534|FG001|Overall Study|Adverse Event|1|||
27756753|NCT00764478|80936535|FG002|Overall Study|Adverse Event|1|||
27756754|NCT00764478|80936533|FG000|Overall Study|Withdrawal by Subject|7|||
27756755|NCT00764478|80936534|FG001|Overall Study|Withdrawal by Subject|12|||
27756756|NCT00764478|80936535|FG002|Overall Study|Withdrawal by Subject|1|||
27756757|NCT00764478|80936533|FG000|Overall Study|Lost to Follow-up|7|||
27756758|NCT00764478|80936534|FG001|Overall Study|Lost to Follow-up|8|||
27756759|NCT00764478|80936535|FG002|Overall Study|Lost to Follow-up|5|||
27756760|NCT00764478|80936533|FG000|Overall Study|Protocol Violation|0|||
27756761|NCT00764478|80936534|FG001|Overall Study|Protocol Violation|1|||
27756762|NCT00764478|80936535|FG002|Overall Study|Protocol Violation|1|||
27756763|NCT01348425|80936536|FG000|Overall Study|Imaging was not taken.|1|||
27756764|NCT01348425|80936537|FG001|Overall Study|Imaging was not taken.|1|||
27756765|NCT02486952|80936538|FG000|Overall Study|Not Started Induction Therapy|3|||
27756766|NCT02486952|80936538|FG000|Overall Study|Adverse Event|1|||
27756767|NCT02486952|80936538|FG000|Overall Study|Death|15|||
27756768|NCT02486952|80936538|FG000|Overall Study|Lack of Efficacy|3|||
27756769|NCT02486952|80936538|FG000|Overall Study|Lost to Follow-up|26|||
27756770|NCT02486952|80936538|FG000|Overall Study|Other|2|||
27756771|NCT00305253|80936539|FG000|Overall Study|Withdrawal by Subject|0|||
27756772|NCT00305253|80936540|FG001|Overall Study|Withdrawal by Subject|1|||
27756773|NCT00574119|80936541|FG000|Overall Study|Adverse Event|1|||
27756774|NCT00574119|80936541|FG000|Overall Study|Protocol Violation|1|||
27756775|NCT00574119|80936541|FG000|Overall Study|Withdrawal by Subject|1|||
27756776|NCT00574119|80936541|FG000|Overall Study|Physician Decision|1|||
27756777|NCT00423085|80936542|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
27756778|NCT00423085|80936543|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
27756779|NCT00423085|80936544|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
27756780|NCT00423085|80936545|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
27756781|NCT00423085|80936542|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
27858045|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
27858046|NCT02552212|81314460|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
27756782|NCT00423085|80936543|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
27858047|NCT02552212|81314461|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
27858048|NCT02552212|81314462|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
27858049|NCT00681590|81314463|FG000|Overall Study|Withdrawal by Subject|2|||
27858050|NCT00681590|81314464|FG001|Overall Study|Withdrawal by Subject|12|||
27858051|NCT04305587|81314465|FG000|Overall Study|Withdrawal by Subject|0|||
27858052|NCT04305587|81314466|FG001|Overall Study|Withdrawal by Subject|0|||
27858053|NCT04305587|81314467|FG002|Overall Study|Withdrawal by Subject|0|||
27858054|NCT04305587|81314468|FG003|Overall Study|Withdrawal by Subject|1|||
27858055|NCT04305587|81314469|FG004|Overall Study|Withdrawal by Subject|0|||
27858056|NCT04305587|81314470|FG005|Overall Study|Withdrawal by Subject|0|||
27858057|NCT04305587|81314471|FG006|Overall Study|Withdrawal by Subject|0|||
27858058|NCT04305587|81314472|FG007|Overall Study|Withdrawal by Subject|0|||
27858059|NCT04305587|81314473|FG008|Overall Study|Withdrawal by Subject|0|||
27858060|NCT03981419|81314474|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
27858061|NCT03981419|81314475|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
27858062|NCT00969540|81314476|FG000|Overall Study|Lost to Follow-up|1|||
27858063|NCT00969540|81314477|FG001|Overall Study|Lost to Follow-up|1|||
27858064|NCT00372411|81314479|FG000|Overall Study|Withdrawal by Subject|3|||
27858065|NCT00372411|81314480|FG001|Overall Study|Withdrawal by Subject|4|||
27858066|NCT00372411|81314481|FG002|Overall Study|Withdrawal by Subject|1|||
27858067|NCT00372411|81314479|FG000|Overall Study|Death|0|||
27858068|NCT00372411|81314480|FG001|Overall Study|Death|2|||
27858069|NCT00372411|81314481|FG002|Overall Study|Death|1|||
27858070|NCT00372411|81314479|FG000|Overall Study|Lost to Follow-up|1|||
27858071|NCT00372411|81314480|FG001|Overall Study|Lost to Follow-up|1|||
27858072|NCT00372411|81314481|FG002|Overall Study|Lost to Follow-up|1|||
27858073|NCT00372411|81314479|FG000|Overall Study|Adverse Event|1|||
27858074|NCT00372411|81314480|FG001|Overall Study|Adverse Event|1|||
27756783|NCT00423085|80936544|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
27858075|NCT00372411|81314481|FG002|Overall Study|Adverse Event|0|||
27858076|NCT00478426|81314483|FG000|Overall Study|Withdrawal by Subject|1|||
27858077|NCT00265395|81314484|FG000|Overall Study|Adverse Event|3|||
27858078|NCT00265395|81314485|FG001|Overall Study|Adverse Event|6|||
27756784|NCT00423085|80936545|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27756785|NCT00423085|80936542|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
27756786|NCT00423085|80936543|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
27756787|NCT00423085|80936544|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
27756788|NCT00423085|80936545|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
27655355|NCT02092909|80576996|FG002|Overall Study|Miscellaneous|2|||
27655356|NCT02092909|80576997|FG003|Overall Study|Miscellaneous|1|||
27858079|NCT00265395|81314484|FG000|Overall Study|Lost to Follow-up|2|||
27858080|NCT00265395|81314485|FG001|Overall Study|Lost to Follow-up|1|||
27858081|NCT00265395|81314484|FG000|Overall Study|Withdrawal by Subject|1|||
27858082|NCT00265395|81314485|FG001|Overall Study|Withdrawal by Subject|6|||
27858083|NCT00265395|81314484|FG000|Overall Study|Protocol Violation|2|||
27858084|NCT00265395|81314485|FG001|Overall Study|Protocol Violation|2|||
27756789|NCT00423085|80936542|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
27858085|NCT00265395|81314484|FG000|Overall Study|Lack of Efficacy|0|||
27858086|NCT00265395|81314485|FG001|Overall Study|Lack of Efficacy|1|||
27858087|NCT00265395|81314484|FG000|Overall Study|Administrative|0|||
27858088|NCT00265395|81314485|FG001|Overall Study|Administrative|1|||
27858089|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
27858090|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
27858091|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
27858092|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
27858093|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
27858094|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
27858095|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
27858096|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
27858097|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
27858098|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
27858099|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
27858100|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
27858101|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
27756790|NCT00423085|80936543|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
27756791|NCT00423085|80936544|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
27756792|NCT00423085|80936545|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
27756793|NCT00423085|80936542|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
27756794|NCT00423085|80936543|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
27756795|NCT00423085|80936544|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
27756796|NCT00423085|80936545|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
27756797|NCT00423085|80936542|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
27756798|NCT00423085|80936543|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
27756799|NCT00423085|80936544|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
27756800|NCT00423085|80936545|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
27655357|NCT04783389|80577004|FG000|Overall Study|Withdrawal by Subject|2|||
27655358|NCT04783389|80577005|FG001|Overall Study|Withdrawal by Subject|0|||
27655359|NCT04783389|80577006|FG002|Overall Study|Withdrawal by Subject|0|||
27655360|NCT04783389|80577004|FG000|Overall Study|Termination of Study by Sponsor|10|||
27655361|NCT04783389|80577005|FG001|Overall Study|Termination of Study by Sponsor|12|||
27655362|NCT04783389|80577006|FG002|Overall Study|Termination of Study by Sponsor|14|||
27655363|NCT02256553|80577008|FG000|Period I|Adverse Event|5|||
27655364|NCT02256553|80577008|FG000|Period I|Protocol Violation|1|||
27655365|NCT02256553|80577008|FG000|Period II|Adverse Event|1|||
27655366|NCT02256553|80577008|FG000|Period II|Subject Moved|1|||
27655367|NCT02256553|80577008|FG000|Period III|Adverse Event|3|||
27655368|NCT03747575|80577009|FG000|Overall Study|Withdrawal by Subject|6|||
27655369|NCT03747575|80577010|FG001|Overall Study|Withdrawal by Subject|3|||
27655370|NCT03747575|80577009|FG000|Overall Study|Lost to Follow-up|3|||
27655371|NCT03747575|80577010|FG001|Overall Study|Lost to Follow-up|3|||
27655372|NCT03747575|80577009|FG000|Overall Study|Adverse Event|0|||
27655373|NCT03747575|80577010|FG001|Overall Study|Adverse Event|1|||
27655374|NCT02935894|80577011|FG000|Overall Study|Subject dismissed|1|||
27655375|NCT00042939|80577013|FG000|Overall Study|Adverse Event|6|||
27655376|NCT00042939|80577014|FG001|Overall Study|Adverse Event|7|||
27655377|NCT00042939|80577013|FG000|Overall Study|Death|3|||
27655378|NCT00042939|80577014|FG001|Overall Study|Death|2|||
27655379|NCT00042939|80577013|FG000|Overall Study|Withdrawal by Subject|3|||
27655380|NCT00042939|80577014|FG001|Overall Study|Withdrawal by Subject|4|||
27655381|NCT00042939|80577013|FG000|Overall Study|Other disease|1|||
27655382|NCT00042939|80577014|FG001|Overall Study|Other disease|0|||
27655383|NCT00042939|80577013|FG000|Overall Study|Ineligible|2|||
27655384|NCT00042939|80577014|FG001|Overall Study|Ineligible|2|||
27655385|NCT00042939|80577013|FG000|Overall Study|Deterioration of health|3|||
27655386|NCT00042939|80577014|FG001|Overall Study|Deterioration of health|4|||
27655387|NCT00042939|80577013|FG000|Overall Study|QOL diminished|1|||
27655388|NCT00042939|80577014|FG001|Overall Study|QOL diminished|0|||
27655389|NCT00042939|80577013|FG000|Overall Study|Rising ca 19-9|1|||
27655390|NCT00042939|80577014|FG001|Overall Study|Rising ca 19-9|0|||
27655391|NCT00042939|80577013|FG000|Overall Study|Patient non-compliance|1|||
27655392|NCT00042939|80577014|FG001|Overall Study|Patient non-compliance|0|||
27655393|NCT00042939|80577013|FG000|Overall Study|Still on treatment|1|||
27655394|NCT00042939|80577014|FG001|Overall Study|Still on treatment|0|||
27655395|NCT00042939|80577013|FG000|Overall Study|Treatment break > 4 weeks|0|||
27655396|NCT00042939|80577014|FG001|Overall Study|Treatment break > 4 weeks|1|||
27655397|NCT00042939|80577013|FG000|Overall Study|Did not start treatment|2|||
27655398|NCT00042939|80577014|FG001|Overall Study|Did not start treatment|1|||
27655399|NCT01365546|80577015|FG000|Overall Study|Withdrawal by Subject|1|||
27756801|NCT00423085|80936542|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
27756802|NCT00423085|80936543|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
27655400|NCT01365546|80577015|FG000|Overall Study|Screen failure|9|||
27756803|NCT00423085|80936544|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
27756804|NCT00423085|80936545|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
27756805|NCT00423085|80936542|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
27756806|NCT00423085|80936543|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
27756807|NCT00423085|80936544|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
27756808|NCT00423085|80936545|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
27756809|NCT00423085|80936542|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
27756810|NCT00423085|80936543|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
27756811|NCT00423085|80936544|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
27756812|NCT00423085|80936545|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
27756813|NCT00423085|80936542|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
27756814|NCT00423085|80936543|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
27756815|NCT00423085|80936544|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
27858102|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
27858103|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
27858104|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
27858105|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27858106|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27858107|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
27858108|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27858109|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27858110|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27858111|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27858112|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
27858113|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
27858114|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27858115|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27858116|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
27858117|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27858118|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
27858119|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
27858120|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
27858121|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
27858122|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
27858123|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
27858124|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
27858125|NCT00773734|81314487|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
27858126|NCT00773734|81314488|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
27858127|NCT00773734|81314489|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
27858128|NCT00773734|81314490|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
27858129|NCT00773734|81314491|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
27858130|NCT00773734|81314492|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
27858131|NCT00773734|81314487|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
27858132|NCT00773734|81314488|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
27858133|NCT00773734|81314489|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
27562522|NCT02503332|80246282|FG003|Overall Study|Subject Request|1|||
27858134|NCT00773734|81314490|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
27858135|NCT00773734|81314491|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
27858136|NCT00773734|81314492|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
27858137|NCT00773734|81314487|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
27756816|NCT00423085|80936545|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
27756817|NCT00423085|80936542|FG000|52-Week Open-Label Extension Phase|Death|0|||
27756818|NCT00423085|80936543|FG001|52-Week Open-Label Extension Phase|Death|0|||
27756819|NCT00423085|80936544|FG002|52-Week Open-Label Extension Phase|Death|0|||
27756820|NCT00423085|80936545|FG003|52-Week Open-Label Extension Phase|Death|2|||
27756821|NCT01056341|80936546|FG000|Overall Study|Treatment Intolerance|0|||
27756822|NCT01056341|80936547|FG001|Overall Study|Treatment Intolerance|2|||
27756823|NCT01056341|80936548|FG002|Overall Study|Treatment Intolerance|0|||
27756824|NCT01056341|80936549|FG003|Overall Study|Treatment Intolerance|2|||
27756825|NCT01056341|80936550|FG004|Overall Study|Treatment Intolerance|0|||
27756826|NCT01056341|80936546|FG000|Overall Study|Lack of Efficacy|32|||
27756827|NCT01056341|80936547|FG001|Overall Study|Lack of Efficacy|30|||
27756828|NCT01056341|80936548|FG002|Overall Study|Lack of Efficacy|7|||
27756829|NCT01056341|80936549|FG003|Overall Study|Lack of Efficacy|25|||
27756830|NCT01056341|80936550|FG004|Overall Study|Lack of Efficacy|9|||
27756831|NCT01056341|80936546|FG000|Overall Study|Other reasons|4|||
27756832|NCT01056341|80936547|FG001|Overall Study|Other reasons|4|||
27756833|NCT01056341|80936548|FG002|Overall Study|Other reasons|8|||
27756834|NCT01056341|80936549|FG003|Overall Study|Other reasons|9|||
27756835|NCT01056341|80936550|FG004|Overall Study|Other reasons|5|||
27756836|NCT00642746|80936551|FG000|Overall Study|Patient unevaluable|1|||
27756837|NCT00642746|80936552|FG001|Overall Study|Patient unevaluable|0|||
27756838|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
27756839|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
27756840|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
27756841|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
27756842|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Death|8|||
27756843|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Death|3|||
27756844|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
27756845|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
27756846|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
27756847|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
27756848|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
27756849|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
27756850|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
27756851|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
27756852|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
27756853|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
27756854|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
27756855|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
27756856|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
27756857|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
27756858|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
27756859|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
27756860|NCT00494871|80936556|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
27756861|NCT00494871|80936557|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
27756862|NCT00494871|80936556|FG000|Follow-up (FU) Period|Adverse Event|1|||
27756863|NCT00494871|80936557|FG001|Follow-up (FU) Period|Adverse Event|1|||
27756864|NCT00494871|80936556|FG000|Follow-up (FU) Period|Death|13|||
27756865|NCT00494871|80936557|FG001|Follow-up (FU) Period|Death|12|||
27756866|NCT00494871|80936556|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
27756867|NCT00494871|80936557|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
27756868|NCT00494871|80936556|FG000|Follow-up (FU) Period|Physician Decision|0|||
27756869|NCT00494871|80936557|FG001|Follow-up (FU) Period|Physician Decision|1|||
27756870|NCT00494871|80936556|FG000|Follow-up (FU) Period|Protocol Violation|1|||
27756871|NCT00494871|80936557|FG001|Follow-up (FU) Period|Protocol Violation|0|||
27756872|NCT00494871|80936556|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
27756873|NCT00494871|80936557|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
27756874|NCT00494871|80936556|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
27756875|NCT00494871|80936557|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
27756876|NCT00006604|80936558|FG000|Overall Study|Met study objective - no further FU|1|||
27756877|NCT00006604|80936559|FG001|Overall Study|Met study objective - no further FU|0|||
27756878|NCT00006604|80936560|FG002|Overall Study|Met study objective - no further FU|0|||
27756879|NCT00006604|80936561|FG003|Overall Study|Met study objective - no further FU|0|||
27756880|NCT00006604|80936562|FG004|Overall Study|Met study objective - no further FU|0|||
27756881|NCT00006604|80936563|FG005|Overall Study|Met study objective - no further FU|0|||
27756882|NCT00006604|80936564|FG006|Overall Study|Met study objective - no further FU|0|||
27756883|NCT00006604|80936565|FG007|Overall Study|Met study objective - no further FU|0|||
27756884|NCT00006604|80936566|FG008|Overall Study|Met study objective - no further FU|0|||
27756885|NCT00006604|80936567|FG009|Overall Study|Met study objective - no further FU|0|||
27756886|NCT00006604|80936568|FG010|Overall Study|Met study objective - no further FU|0|||
27756887|NCT00006604|80936569|FG011|Overall Study|Met study objective - no further FU|0|||
27756888|NCT00006604|80936570|FG012|Overall Study|Met study objective - no further FU|0|||
27756889|NCT00006604|80936571|FG013|Overall Study|Met study objective - no further FU|0|||
27756890|NCT00006604|80936572|FG014|Overall Study|Met study objective - no further FU|1|||
27756891|NCT00006604|80936573|FG015|Overall Study|Met study objective - no further FU|1|||
27756892|NCT00006604|80936574|FG016|Overall Study|Met study objective - no further FU|0|||
27756893|NCT00006604|80936558|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
27756894|NCT00006604|80936559|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
27756895|NCT00006604|80936560|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
27756896|NCT00006604|80936561|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
27756897|NCT00006604|80936562|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
27756898|NCT00006604|80936563|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
27756899|NCT00006604|80936564|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
27756900|NCT00006604|80936565|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
27756901|NCT00006604|80936566|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
27756902|NCT00006604|80936567|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
27756903|NCT00006604|80936568|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
27756904|NCT00006604|80936569|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
27756905|NCT00006604|80936570|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
27756906|NCT00006604|80936571|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
27756907|NCT00006604|80936572|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
27756908|NCT00006604|80936573|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
27756909|NCT00006604|80936574|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
27858138|NCT00773734|81314488|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
27858139|NCT00773734|81314489|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
27858140|NCT00773734|81314490|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
27858141|NCT00773734|81314491|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
27858142|NCT00773734|81314492|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
27858143|NCT00773734|81314487|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
27858144|NCT00773734|81314488|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
27858145|NCT00773734|81314489|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
27858146|NCT00773734|81314490|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
27858147|NCT00773734|81314491|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
27858148|NCT00773734|81314492|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
27858149|NCT00773734|81314487|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27858150|NCT00773734|81314488|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
27858151|NCT00773734|81314489|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
27858152|NCT00773734|81314490|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27858153|NCT00773734|81314491|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27858154|NCT00773734|81314492|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
27858155|NCT00773734|81314487|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
27858156|NCT00773734|81314488|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27858157|NCT00773734|81314489|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27858158|NCT00773734|81314490|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27858159|NCT00773734|81314491|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
27858160|NCT00773734|81314492|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
27858161|NCT00773734|81314487|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
27858162|NCT00773734|81314488|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
27858163|NCT00773734|81314489|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
27858164|NCT00773734|81314490|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
27858165|NCT00773734|81314491|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
27858166|NCT00773734|81314492|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
27858167|NCT00773734|81314487|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27858168|NCT00773734|81314488|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27858169|NCT00773734|81314489|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27858170|NCT00773734|81314490|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
27858171|NCT00773734|81314491|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
27858172|NCT00773734|81314492|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
27858173|NCT00773734|81314487|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
27858174|NCT00773734|81314488|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
27858175|NCT00773734|81314489|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
27858176|NCT00773734|81314490|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
27858177|NCT00773734|81314491|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
27858178|NCT00773734|81314492|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
27858179|NCT00773734|81314487|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
27858180|NCT00773734|81314488|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
27858181|NCT00773734|81314489|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
27858182|NCT00773734|81314490|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
27858183|NCT00773734|81314491|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
27858184|NCT00773734|81314492|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
27858185|NCT00773734|81314487|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
27858186|NCT00773734|81314488|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
27858187|NCT00773734|81314489|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
27858188|NCT00773734|81314490|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
27858189|NCT00773734|81314491|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
27858190|NCT00773734|81314492|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
27858191|NCT00773734|81314487|FG000|Extension: Active Treatment Week 24-52|Other|0|||
27858192|NCT00773734|81314488|FG001|Extension: Active Treatment Week 24-52|Other|0|||
27858193|NCT00773734|81314489|FG002|Extension: Active Treatment Week 24-52|Other|1|||
27858194|NCT00773734|81314490|FG003|Extension: Active Treatment Week 24-52|Other|2|||
27858195|NCT00773734|81314491|FG004|Extension: Active Treatment Week 24-52|Other|0|||
27858196|NCT00773734|81314492|FG005|Extension: Active Treatment Week 24-52|Other|1|||
27858197|NCT00773734|81314487|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27858198|NCT00773734|81314488|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27858199|NCT00773734|81314489|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27858200|NCT00773734|81314490|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
27858201|NCT00773734|81314491|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27858202|NCT00773734|81314492|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
27858203|NCT00773734|81314487|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27858204|NCT00773734|81314488|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27858205|NCT00773734|81314489|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
27858206|NCT00773734|81314490|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
27858207|NCT00773734|81314491|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27858208|NCT00773734|81314492|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
27858209|NCT00773734|81314487|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27858210|NCT00773734|81314488|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27858211|NCT00773734|81314489|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
27858212|NCT00773734|81314490|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
27858213|NCT00773734|81314491|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27858214|NCT00773734|81314492|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
27858215|NCT00773734|81314487|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27858216|NCT00773734|81314488|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27858217|NCT00773734|81314489|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
27858218|NCT00773734|81314490|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
27858219|NCT00773734|81314491|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27858220|NCT00773734|81314492|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
27858221|NCT01212588|81314493|FG000|Overall Study|Physician Decision|0|||
27858222|NCT01212588|81314494|FG001|Overall Study|Physician Decision|1|||
27858223|NCT01212588|81314493|FG000|Overall Study|Protocol Violation|1|||
27858224|NCT01212588|81314494|FG001|Overall Study|Protocol Violation|1|||
27858225|NCT03559400|81314495|FG000|Overall Study|Lost to Follow-up|9|||
27858226|NCT03559400|81314496|FG001|Overall Study|Lost to Follow-up|7|||
27858227|NCT03559400|81314495|FG000|Overall Study|Death|0|||
27858228|NCT03559400|81314496|FG001|Overall Study|Death|2|||
27858229|NCT02912650|81314500|FG000|Overall Study|Withdrawal by Subject|1|||
27858230|NCT02912650|81314501|FG001|Overall Study|Withdrawal by Subject|0|||
27858231|NCT02912650|81314502|FG002|Overall Study|Withdrawal by Subject|1|||
27858232|NCT02912650|81314503|FG003|Overall Study|Withdrawal by Subject|5|||
27858233|NCT02912650|81314500|FG000|Overall Study|Adverse Event|0|||
27858234|NCT02912650|81314501|FG001|Overall Study|Adverse Event|0|||
27858235|NCT02912650|81314502|FG002|Overall Study|Adverse Event|1|||
27858236|NCT02912650|81314503|FG003|Overall Study|Adverse Event|0|||
27858237|NCT01646138|81314506|FG000|Overall Study|Lost to Follow-up|0|||
27858238|NCT01646138|81314507|FG001|Overall Study|Lost to Follow-up|0|||
27858239|NCT01646138|81314508|FG002|Overall Study|Lost to Follow-up|0|||
27858240|NCT01646138|81314509|FG003|Overall Study|Lost to Follow-up|0|||
27858241|NCT01646138|81314510|FG004|Overall Study|Lost to Follow-up|2|||
27858242|NCT00132028|81314516|FG000|Overall Study|Adverse Event|7|||
27858243|NCT00132028|81314516|FG000|Overall Study|Death|2|||
27858244|NCT00132028|81314516|FG000|Overall Study|Lack of Efficacy|11|||
27858245|NCT00132028|81314516|FG000|Overall Study|Withdrawal by Subject|2|||
27858246|NCT00132028|81314516|FG000|Overall Study|not eligible|2|||
27858247|NCT00132028|81314516|FG000|Overall Study|Physician Decision|3|||
27858248|NCT01709838|81314517|FG000|Overall Study|Withdrawal by Subject|21|||
27858249|NCT01709838|81314517|FG000|Overall Study|Lost to Follow-up|16|||
27858250|NCT01709838|81314517|FG000|Overall Study|Pregnancy|10|||
27858251|NCT01709838|81314517|FG000|Overall Study|Subject/guardian decision|8|||
27858252|NCT01709838|81314517|FG000|Overall Study|Adverse Event|4|||
27858253|NCT01709838|81314517|FG000|Overall Study|Physician Decision|4|||
27858254|NCT01709838|81314517|FG000|Overall Study|Death|3|||
27858255|NCT01709838|81314517|FG000|Overall Study|Protocol Violation|1|||
27858256|NCT01119508|81314518|FG000|Overall Study|Adverse Event|56|||
27858257|NCT01119508|81314518|FG000|Overall Study|Withdrawal by Subject|2|||
27858258|NCT01119508|81314518|FG000|Overall Study|Died before tumor response evaluation|1|||
27858259|NCT02517463|81314521|FG000|Overall Study|Lost to Follow-up|5|||
27858260|NCT02517463|81314522|FG001|Overall Study|Lost to Follow-up|2|||
27858261|NCT04485039|81314523|FG000|TPOXX Only|Adverse Event|2|||
27858262|NCT04485039|81314523|FG000|TPOXX Only|Physician Decision|1|||
27858263|NCT04485039|81314523|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
27858264|NCT04485039|81314523|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
27858265|NCT01330459|81314524|FG000|Overall Study|Physician Decision|0|||
27858266|NCT01330459|81314525|FG001|Overall Study|Physician Decision|2|||
27858267|NCT04709835|81314526|FG000|Overall Study|Withdrawal by Subject|0|||
27858268|NCT04709835|81314527|FG001|Overall Study|Withdrawal by Subject|1|||
27858269|NCT04709835|81314528|FG002|Overall Study|Withdrawal by Subject|0|||
27858270|NCT01001988|81314534|FG000|Overall Study|Protocol Violation|84|||
27858271|NCT01001988|81314534|FG000|Overall Study|Withdrawal by Subject|18|||
27858272|NCT01001988|81314534|FG000|Overall Study|Lost to Follow-up|15|||
27858273|NCT01517373|81314535|FG000|Run-in Period|Death|1|||
27858274|NCT01517373|81314536|FG001|Run-in Period|Death|0|||
27858275|NCT01517373|81314537|FG002|Run-in Period|Death|0|||
27858276|NCT01517373|81314538|FG003|Run-in Period|Death|0|||
27858277|NCT01517373|81314539|FG004|Run-in Period|Death|0|||
27858278|NCT01517373|81314540|FG005|Run-in Period|Death|0|||
27858279|NCT01517373|81314535|FG000|Run-in Period|Adverse Event|5|||
27858280|NCT01517373|81314536|FG001|Run-in Period|Adverse Event|0|||
27858281|NCT01517373|81314537|FG002|Run-in Period|Adverse Event|0|||
27858282|NCT01517373|81314538|FG003|Run-in Period|Adverse Event|0|||
27858283|NCT01517373|81314539|FG004|Run-in Period|Adverse Event|0|||
27858284|NCT01517373|81314540|FG005|Run-in Period|Adverse Event|0|||
27858285|NCT01517373|81314535|FG000|Run-in Period|Did not meet eligibility criteria|34|||
27858286|NCT01517373|81314536|FG001|Run-in Period|Did not meet eligibility criteria|0|||
27858287|NCT01517373|81314537|FG002|Run-in Period|Did not meet eligibility criteria|0|||
27858288|NCT01517373|81314538|FG003|Run-in Period|Did not meet eligibility criteria|0|||
27858289|NCT01517373|81314539|FG004|Run-in Period|Did not meet eligibility criteria|0|||
27858290|NCT01517373|81314540|FG005|Run-in Period|Did not meet eligibility criteria|0|||
27858291|NCT01517373|81314535|FG000|Run-in Period|Lost to Follow-up|1|||
27858292|NCT01517373|81314536|FG001|Run-in Period|Lost to Follow-up|0|||
27858293|NCT01517373|81314537|FG002|Run-in Period|Lost to Follow-up|0|||
27858294|NCT01517373|81314538|FG003|Run-in Period|Lost to Follow-up|0|||
27858295|NCT01517373|81314539|FG004|Run-in Period|Lost to Follow-up|0|||
27858296|NCT01517373|81314540|FG005|Run-in Period|Lost to Follow-up|0|||
27858297|NCT01517373|81314535|FG000|Run-in Period|Withdrawal by Subject|12|||
27858298|NCT01517373|81314536|FG001|Run-in Period|Withdrawal by Subject|0|||
27858299|NCT01517373|81314537|FG002|Run-in Period|Withdrawal by Subject|0|||
27858300|NCT01517373|81314538|FG003|Run-in Period|Withdrawal by Subject|0|||
27858301|NCT01517373|81314539|FG004|Run-in Period|Withdrawal by Subject|0|||
27858302|NCT01517373|81314540|FG005|Run-in Period|Withdrawal by Subject|0|||
27858303|NCT01517373|81314535|FG000|Run-in Period|Sponsor Decision|3|||
27858304|NCT01517373|81314536|FG001|Run-in Period|Sponsor Decision|0|||
27858305|NCT01517373|81314537|FG002|Run-in Period|Sponsor Decision|0|||
27858306|NCT01517373|81314538|FG003|Run-in Period|Sponsor Decision|0|||
27858307|NCT01517373|81314539|FG004|Run-in Period|Sponsor Decision|0|||
27858308|NCT01517373|81314540|FG005|Run-in Period|Sponsor Decision|0|||
27858309|NCT01517373|81314535|FG000|Run-in Period|Other|1|||
27858310|NCT01517373|81314536|FG001|Run-in Period|Other|0|||
27858311|NCT01517373|81314537|FG002|Run-in Period|Other|0|||
27858312|NCT01517373|81314538|FG003|Run-in Period|Other|0|||
27858313|NCT01517373|81314539|FG004|Run-in Period|Other|0|||
27858314|NCT01517373|81314540|FG005|Run-in Period|Other|0|||
27858315|NCT01517373|81314535|FG000|Treatment Period|Adverse Event|0|||
27858316|NCT01517373|81314536|FG001|Treatment Period|Adverse Event|0|||
27858317|NCT01517373|81314537|FG002|Treatment Period|Adverse Event|0|||
27858318|NCT01517373|81314538|FG003|Treatment Period|Adverse Event|0|||
27858319|NCT01517373|81314539|FG004|Treatment Period|Adverse Event|0|||
27858320|NCT01517373|81314540|FG005|Treatment Period|Adverse Event|2|||
27858321|NCT01517373|81314535|FG000|Treatment Period|Lost to Follow-up|0|||
27858322|NCT01517373|81314536|FG001|Treatment Period|Lost to Follow-up|0|||
27858323|NCT01517373|81314537|FG002|Treatment Period|Lost to Follow-up|1|||
27858324|NCT01517373|81314538|FG003|Treatment Period|Lost to Follow-up|1|||
27858325|NCT01517373|81314539|FG004|Treatment Period|Lost to Follow-up|0|||
27858326|NCT01517373|81314540|FG005|Treatment Period|Lost to Follow-up|0|||
27858327|NCT01517373|81314535|FG000|Treatment Period|Withdrawal by Subject|0|||
27858328|NCT01517373|81314536|FG001|Treatment Period|Withdrawal by Subject|3|||
27858329|NCT01517373|81314537|FG002|Treatment Period|Withdrawal by Subject|2|||
27858330|NCT01517373|81314538|FG003|Treatment Period|Withdrawal by Subject|2|||
27858331|NCT01517373|81314539|FG004|Treatment Period|Withdrawal by Subject|2|||
27858332|NCT01517373|81314540|FG005|Treatment Period|Withdrawal by Subject|3|||
27858333|NCT01517373|81314535|FG000|Treatment Period|Other|0|||
27858334|NCT01517373|81314536|FG001|Treatment Period|Other|0|||
27858335|NCT01517373|81314537|FG002|Treatment Period|Other|0|||
27858336|NCT01517373|81314538|FG003|Treatment Period|Other|0|||
27858337|NCT01517373|81314539|FG004|Treatment Period|Other|1|||
27858338|NCT01517373|81314540|FG005|Treatment Period|Other|0|||
27858339|NCT01517373|81314535|FG000|Treatment Period|Protocol Violation|0|||
27858340|NCT01517373|81314536|FG001|Treatment Period|Protocol Violation|0|||
27858341|NCT01517373|81314537|FG002|Treatment Period|Protocol Violation|0|||
27858342|NCT01517373|81314538|FG003|Treatment Period|Protocol Violation|0|||
27858343|NCT01517373|81314539|FG004|Treatment Period|Protocol Violation|1|||
27858344|NCT01517373|81314540|FG005|Treatment Period|Protocol Violation|0|||
27858345|NCT01517373|81314535|FG000|Treatment Period|Lack of Efficacy|0|||
27858346|NCT01517373|81314536|FG001|Treatment Period|Lack of Efficacy|1|||
27858347|NCT01517373|81314537|FG002|Treatment Period|Lack of Efficacy|1|||
27858348|NCT01517373|81314538|FG003|Treatment Period|Lack of Efficacy|3|||
27858349|NCT01517373|81314539|FG004|Treatment Period|Lack of Efficacy|2|||
27858350|NCT01517373|81314540|FG005|Treatment Period|Lack of Efficacy|0|||
27858351|NCT01517373|81314535|FG000|Treatment Period|Medication error without AEs|0|||
27858352|NCT01517373|81314536|FG001|Treatment Period|Medication error without AEs|0|||
27858353|NCT01517373|81314537|FG002|Treatment Period|Medication error without AEs|2|||
27858354|NCT01517373|81314538|FG003|Treatment Period|Medication error without AEs|1|||
27858355|NCT01517373|81314539|FG004|Treatment Period|Medication error without AEs|0|||
27858356|NCT01517373|81314540|FG005|Treatment Period|Medication error without AEs|2|||
27858357|NCT00678886|81314546|FG000|Overall Study|Withdrawal by Subject|0|||
27858358|NCT00678886|81314547|FG001|Overall Study|Withdrawal by Subject|0|||
27858359|NCT00678886|81314548|FG002|Overall Study|Withdrawal by Subject|4|||
27858360|NCT00678886|81314549|FG003|Overall Study|Withdrawal by Subject|6|||
27858361|NCT00678886|81314546|FG000|Overall Study|Physician Decision|0|||
27858362|NCT00678886|81314547|FG001|Overall Study|Physician Decision|0|||
27858363|NCT00678886|81314548|FG002|Overall Study|Physician Decision|1|||
27858364|NCT00678886|81314549|FG003|Overall Study|Physician Decision|1|||
27858365|NCT00678886|81314546|FG000|Overall Study|Lost to Follow-up|0|||
27858366|NCT00678886|81314547|FG001|Overall Study|Lost to Follow-up|0|||
27858367|NCT00678886|81314548|FG002|Overall Study|Lost to Follow-up|3|||
27858368|NCT00678886|81314549|FG003|Overall Study|Lost to Follow-up|2|||
27858369|NCT00678886|81314546|FG000|Overall Study|Other|0|||
27858370|NCT00678886|81314547|FG001|Overall Study|Other|0|||
27858371|NCT00678886|81314548|FG002|Overall Study|Other|1|||
27858372|NCT00678886|81314549|FG003|Overall Study|Other|0|||
27858373|NCT02099682|81314550|FG000|Overall Study|Data Not Available|51|||
27858374|NCT02099682|81314550|FG000|Overall Study|Lost to Follow-up|31|||
27858375|NCT02099682|81314550|FG000|Overall Study|Other|29|||
27858376|NCT00416884|81314551|FG000|Overall Study|Study terminated due to low accrual|1|||
27858377|NCT00469144|81314553|FG000|Overall Study|Death|0|||
27858378|NCT00469144|81314554|FG001|Overall Study|Death|1|||
27858379|NCT00469144|81314553|FG000|Overall Study|No Response|5|||
27858380|NCT00469144|81314554|FG001|Overall Study|No Response|5|||
27858381|NCT00469144|81314553|FG000|Overall Study|Progressive Disease|1|||
27858382|NCT00469144|81314554|FG001|Overall Study|Progressive Disease|0|||
27858383|NCT00912912|81314557|FG000|Overall Study|Withdrawal by Subject|1|||
27858384|NCT00912912|81314557|FG000|Overall Study|Disease Progression|3|||
27858385|NCT03822832|81314558|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
27858386|NCT03822832|81314559|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
27858387|NCT03822832|81314558|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
27858388|NCT03822832|81314559|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
27858389|NCT03822832|81314558|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
27858390|NCT03822832|81314559|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
27858391|NCT03822832|81314558|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
27858392|NCT03822832|81314559|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
27858393|NCT03822832|81314558|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
27858394|NCT03822832|81314559|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
27858395|NCT03822832|81314558|FG000|Re-allocation|Not re-allocated to open label period|2|||
27858396|NCT03822832|81314559|FG001|Re-allocation|Not re-allocated to open label period|6|||
27858397|NCT03822832|81314558|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
27858398|NCT03822832|81314559|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
27858399|NCT03822832|81314558|FG000|Period 2 - Open Label Period|Adverse Event|0|||
27858400|NCT03822832|81314559|FG001|Period 2 - Open Label Period|Adverse Event|3|||
27858401|NCT01664130|81314562|FG000|Overall Study|competing secondary disease|2|||
27858402|NCT02952898|81314563|FG000|Overall Study|Withdrawal by Subject|10|||
27858403|NCT02952898|81314564|FG001|Overall Study|Withdrawal by Subject|8|||
27858404|NCT02952898|81314565|FG002|Overall Study|Withdrawal by Subject|8|||
27858405|NCT02952898|81314563|FG000|Overall Study|Adverse Event|8|||
27858406|NCT02952898|81314564|FG001|Overall Study|Adverse Event|8|||
27858407|NCT02952898|81314565|FG002|Overall Study|Adverse Event|3|||
27858408|NCT02952898|81314563|FG000|Overall Study|Lost to Follow-up|3|||
27858409|NCT02952898|81314564|FG001|Overall Study|Lost to Follow-up|2|||
27858410|NCT02952898|81314565|FG002|Overall Study|Lost to Follow-up|2|||
27858411|NCT02952898|81314563|FG000|Overall Study|Non-compliance with study drug|1|||
27858412|NCT02952898|81314564|FG001|Overall Study|Non-compliance with study drug|1|||
27858413|NCT02952898|81314565|FG002|Overall Study|Non-compliance with study drug|2|||
27858414|NCT03151811|81314566|FG000|Overall Study|Randomized But Not Treated|18|||
27858415|NCT03151811|81314567|FG001|Overall Study|Randomized But Not Treated|3|||
27858416|NCT03151811|81314566|FG000|Overall Study|Progressive Disease|130|||
27858417|NCT03151811|81314567|FG001|Overall Study|Progressive Disease|170|||
27858418|NCT03151811|81314566|FG000|Overall Study|Adverse Event|49|||
27858419|NCT03151811|81314567|FG001|Overall Study|Adverse Event|40|||
27858420|NCT03151811|81314566|FG000|Overall Study|Lack of Efficacy|6|||
27858421|NCT03151811|81314567|FG001|Overall Study|Lack of Efficacy|8|||
27858422|NCT03151811|81314566|FG000|Overall Study|Physician Decision|21|||
27858423|NCT03151811|81314567|FG001|Overall Study|Physician Decision|9|||
27858424|NCT03151811|81314566|FG000|Overall Study|Withdrawal by Subject|17|||
27858425|NCT03151811|81314567|FG001|Overall Study|Withdrawal by Subject|7|||
27858426|NCT03151811|81314566|FG000|Overall Study|Lost to Follow-up|0|||
27858427|NCT03151811|81314567|FG001|Overall Study|Lost to Follow-up|1|||
27858428|NCT03151811|81314566|FG000|Overall Study|Study Terminated by Sponsor|5|||
27858429|NCT03151811|81314567|FG001|Overall Study|Study Terminated by Sponsor|11|||
27858430|NCT03753763|81314568|FG000|Overall Study|Adverse Event|2|||
27858431|NCT03753763|81314569|FG001|Overall Study|Adverse Event|0|||
27858432|NCT03753763|81314568|FG000|Overall Study|Withdrawal by Subject|3|||
27858433|NCT03753763|81314569|FG001|Overall Study|Withdrawal by Subject|1|||
27858434|NCT03753763|81314568|FG000|Overall Study|clinical deterioration|1|||
27858435|NCT03753763|81314569|FG001|Overall Study|clinical deterioration|0|||
27858436|NCT01502410|81314576|FG000|Overall Study|Adverse Event|1|||
27858437|NCT01502410|81314577|FG001|Overall Study|Adverse Event|2|||
27858438|NCT01502410|81314578|FG002|Overall Study|Adverse Event|0|||
27858439|NCT01502410|81314579|FG003|Overall Study|Adverse Event|0|||
27858440|NCT01502410|81314576|FG000|Overall Study|Lack of Efficacy|7|||
27858441|NCT01502410|81314577|FG001|Overall Study|Lack of Efficacy|7|||
27858442|NCT01502410|81314578|FG002|Overall Study|Lack of Efficacy|0|||
27858443|NCT01502410|81314579|FG003|Overall Study|Lack of Efficacy|0|||
27858444|NCT01502410|81314576|FG000|Overall Study|Physician Decision|0|||
27858445|NCT01502410|81314577|FG001|Overall Study|Physician Decision|1|||
27858446|NCT01502410|81314578|FG002|Overall Study|Physician Decision|0|||
27858447|NCT01502410|81314579|FG003|Overall Study|Physician Decision|0|||
27858448|NCT01502410|81314576|FG000|Overall Study|Withdrawal by Subject|2|||
27858449|NCT01502410|81314577|FG001|Overall Study|Withdrawal by Subject|0|||
27858450|NCT01502410|81314578|FG002|Overall Study|Withdrawal by Subject|0|||
27858451|NCT01502410|81314579|FG003|Overall Study|Withdrawal by Subject|0|||
27858452|NCT00351533|81319002|FG000|Overall Study|Extubated before first BAL|1|||
27858453|NCT00351533|81319003|FG001|Overall Study|Extubated before first BAL|0|||
27858454|NCT00351533|81319002|FG000|Overall Study|Lost to Follow-up|1|||
27858455|NCT00351533|81319003|FG001|Overall Study|Lost to Follow-up|3|||
27858456|NCT00351533|81319002|FG000|Overall Study|Physician Decision|0|||
27858457|NCT00351533|81319003|FG001|Overall Study|Physician Decision|1|||
27858458|NCT00351533|81319002|FG000|Overall Study|Withdrawal by Subject|0|||
27858459|NCT00351533|81319003|FG001|Overall Study|Withdrawal by Subject|1|||
27858460|NCT00638027|81319008|FG000|Overall Study|Adverse Event|0|||
27858461|NCT00638027|81319009|FG001|Overall Study|Adverse Event|2|||
27858462|NCT04497948|81319010|FG000|Overall Study|Death|2|||
27858463|NCT03371459|81319011|FG000|Washout|Lost to Follow-up|0|||
27858464|NCT03371459|81319012|FG001|Washout|Lost to Follow-up|1|||
27858465|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
27858466|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
27858467|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
27858468|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
27858469|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
27858470|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
27858471|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
27858472|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
27858473|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
27858474|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
27858475|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
27858476|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
27858477|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
27858478|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
27858479|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
27858480|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
27858481|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27858482|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27858483|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27858484|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27858485|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
27858486|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
27858487|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
27858488|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
27858489|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
27858490|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
27858491|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
27858492|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
27858493|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
27858494|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
27858495|NCT03713619|81319013|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
27858496|NCT03713619|81319014|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
27858497|NCT03713619|81319015|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
27858498|NCT03713619|81319016|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
27858499|NCT03713619|81319017|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
27858500|NCT03713619|81319013|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
27858501|NCT03713619|81319014|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
27858502|NCT03713619|81319015|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
27858503|NCT03713619|81319016|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
27858504|NCT03713619|81319017|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
27858505|NCT03713619|81319013|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
27858506|NCT03713619|81319014|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27858507|NCT03713619|81319015|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27858508|NCT03713619|81319016|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
27858509|NCT03713619|81319017|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27858510|NCT03713619|81319013|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
27858511|NCT03713619|81319014|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
27858512|NCT03713619|81319015|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
27858513|NCT03713619|81319016|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
27858514|NCT03713619|81319017|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
27858515|NCT03713619|81319013|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
27858516|NCT03713619|81319014|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
27858517|NCT03713619|81319015|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
27858518|NCT03713619|81319016|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
27858519|NCT03713619|81319017|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
27858520|NCT03713619|81319013|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
27858521|NCT03713619|81319014|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
27858522|NCT03713619|81319015|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
27858523|NCT03713619|81319016|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
27858524|NCT03713619|81319017|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
27858525|NCT03713619|81319013|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
27858526|NCT03713619|81319014|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
27858527|NCT03713619|81319015|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
27858528|NCT03713619|81319016|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
27858529|NCT03713619|81319017|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
27858530|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
27858531|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
27858532|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
27858533|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
27858534|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
27858535|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
27858536|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
27858537|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
27858538|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
27858539|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
27858540|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Death|1|||
27858541|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Death|0|||
27858542|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Death|0|||
27858543|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Death|0|||
27858544|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Death|0|||
27858545|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
27858546|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
27858547|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
27858548|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
27858549|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
27858550|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
27858551|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
27858552|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
27858553|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
27858554|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
27858555|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
27858556|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
27858557|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
27858558|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
27858559|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
27858560|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
27858561|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
27858562|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
27858563|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
27858564|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27858565|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
27858566|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27858567|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27858568|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27858569|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27858570|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Other|4|||
27858571|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Other|4|||
27858572|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Other|3|||
27858573|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Other|1|||
27858574|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Other|0|||
27858575|NCT01081834|81319018|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
27858576|NCT01081834|81319019|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
27858577|NCT01081834|81319020|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27858578|NCT01081834|81319021|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27858579|NCT01081834|81319022|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27858580|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27858581|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27858582|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27858583|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27858584|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27858585|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Death|1|||
27858586|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Death|0|||
27858587|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Death|0|||
27858588|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Death|0|||
27858589|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Death|0|||
27858590|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
27858591|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
27858592|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27858593|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27858594|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27858595|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27858596|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27858597|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27858598|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27858599|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27858600|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27858601|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
27858602|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27858603|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27858604|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27858605|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27858606|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27858607|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27858608|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27858609|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27858610|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
27858611|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
27858612|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
27858613|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
27858614|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
27858615|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Other|4|||
27858616|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Other|5|||
27858617|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Other|4|||
27858618|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Other|0|||
27858619|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Other|0|||
27858620|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
27858621|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
27858622|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
27858623|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
27858624|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
27858625|NCT01081834|81319018|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27858626|NCT01081834|81319019|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
27858627|NCT01081834|81319020|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27858628|NCT01081834|81319021|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27858629|NCT01081834|81319022|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27858630|NCT03190330|81319031|FG000|Overall Study|Adverse Event|2|||
27858631|NCT03190330|81319031|FG000|Overall Study|Death|10|||
27858632|NCT03190330|81319031|FG000|Overall Study|Lost to Follow-up|1|||
27858633|NCT03190330|81319031|FG000|Overall Study|Withdrawal by Subject|6|||
27858634|NCT03190330|81319031|FG000|Overall Study|Progressive Disease|1|||
27858635|NCT01687478|81319034|FG000|Overall Study|Adverse Event|3|||
27858636|NCT01687478|81319035|FG001|Overall Study|Adverse Event|10|||
27858637|NCT01687478|81319034|FG000|Overall Study|Lost to Follow-up|1|||
27858638|NCT01687478|81319035|FG001|Overall Study|Lost to Follow-up|3|||
27858639|NCT01687478|81319034|FG000|Overall Study|Protocol Violation|0|||
27858640|NCT01687478|81319035|FG001|Overall Study|Protocol Violation|2|||
27858641|NCT01687478|81319034|FG000|Overall Study|Withdrawal by Subject|21|||
27858642|NCT01687478|81319035|FG001|Overall Study|Withdrawal by Subject|19|||
27858643|NCT01687478|81319034|FG000|Overall Study|Physician Decision|1|||
27858644|NCT01687478|81319035|FG001|Overall Study|Physician Decision|3|||
27858645|NCT01687478|81319034|FG000|Overall Study|Entry Criteria Not Met|6|||
27858646|NCT01687478|81319035|FG001|Overall Study|Entry Criteria Not Met|2|||
27858647|NCT00858143|81319036|FG000|Overall Study|Adverse Event|16|||
27858648|NCT00858143|81319036|FG000|Overall Study|Lack of Efficacy|4|||
27858649|NCT00858143|81319036|FG000|Overall Study|Death|7|||
27858650|NCT00858143|81319036|FG000|Overall Study|Other|23|||
27858651|NCT00896480|81319038|FG000|Overall Study|Disease progression/recurrence|21|||
27858652|NCT03283761|81319039|FG000|Study Treatment|Patient Non-Compliance|1|||
27858653|NCT03283761|81319039|FG000|Study Treatment|Alternative Cancer Therapy|7|||
27858654|NCT03283761|81319039|FG000|Study Treatment|Disease progression|21|||
27858655|NCT03283761|81319039|FG000|Study Treatment|Adverse Event|3|||
27858656|NCT03283761|81319039|FG000|Study Treatment|Withdrawal by Subject|4|||
27858657|NCT03283761|81319039|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
27858658|NCT03283761|81319039|FG000|Study Treatment|Symptomatic Deterioration|1|||
27858659|NCT03283761|81319039|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
27858660|NCT03283761|81319039|FG000|Follow up|Lost to Follow-up|1|||
27858661|NCT03283761|81319039|FG000|Follow up|Symptomatic Deterioration|1|||
27858662|NCT03283761|81319039|FG000|Follow up|Death|29|||
27858663|NCT03283761|81319039|FG000|Follow up|study terminated|4|||
27858664|NCT03283761|81319039|FG000|Follow up|Primary Investigator Withdrawal|1|||
27858665|NCT03283761|81319039|FG000|Follow up|Switched to alternative therapy|1|||
27858666|NCT03283761|81319039|FG000|Follow up|Subject is now in Hospice|1|||
27858667|NCT00851318|81319040|FG000|Overall Study|Withdrawal by Subject|7|||
27858668|NCT00851318|81319041|FG001|Overall Study|Withdrawal by Subject|1|||
27858669|NCT00851318|81319042|FG002|Overall Study|Withdrawal by Subject|5|||
27858670|NCT00851318|81319043|FG003|Overall Study|Withdrawal by Subject|3|||
27858671|NCT00851318|81319040|FG000|Overall Study|Adverse Event|13|||
27858672|NCT00851318|81319041|FG001|Overall Study|Adverse Event|2|||
27858673|NCT00851318|81319042|FG002|Overall Study|Adverse Event|9|||
27858674|NCT00851318|81319043|FG003|Overall Study|Adverse Event|12|||
27858675|NCT00851318|81319040|FG000|Overall Study|Pregnancy|0|||
27858676|NCT00851318|81319041|FG001|Overall Study|Pregnancy|0|||
27858677|NCT00851318|81319042|FG002|Overall Study|Pregnancy|1|||
27858678|NCT00851318|81319043|FG003|Overall Study|Pregnancy|1|||
27858679|NCT00851318|81319040|FG000|Overall Study|Lack of Efficacy|8|||
27858680|NCT00851318|81319041|FG001|Overall Study|Lack of Efficacy|2|||
27858681|NCT00851318|81319042|FG002|Overall Study|Lack of Efficacy|4|||
27858682|NCT00851318|81319043|FG003|Overall Study|Lack of Efficacy|2|||
27858683|NCT00851318|81319040|FG000|Overall Study|Non-compliance with Study Procedures|2|||
27858684|NCT00851318|81319041|FG001|Overall Study|Non-compliance with Study Procedures|0|||
27858685|NCT00851318|81319042|FG002|Overall Study|Non-compliance with Study Procedures|1|||
27858686|NCT00851318|81319043|FG003|Overall Study|Non-compliance with Study Procedures|0|||
27858687|NCT00851318|81319040|FG000|Overall Study|Physician Decision|0|||
27858688|NCT00851318|81319041|FG001|Overall Study|Physician Decision|0|||
27858689|NCT00851318|81319042|FG002|Overall Study|Physician Decision|1|||
27858690|NCT00851318|81319043|FG003|Overall Study|Physician Decision|1|||
27858691|NCT00106964|81319044|FG000|Overall Study|Lost to Follow-up|8|||
27858692|NCT00106964|81319045|FG001|Overall Study|Lost to Follow-up|6|||
27858693|NCT00106964|81319046|FG002|Overall Study|Lost to Follow-up|2|||
27858694|NCT00106964|81319044|FG000|Overall Study|Pregnancy|2|||
27858695|NCT00106964|81319045|FG001|Overall Study|Pregnancy|3|||
27858696|NCT00106964|81319046|FG002|Overall Study|Pregnancy|2|||
27858697|NCT00106964|81319044|FG000|Overall Study|Death|1|||
27858698|NCT00106964|81319045|FG001|Overall Study|Death|1|||
27858699|NCT00106964|81319046|FG002|Overall Study|Death|0|||
27858700|NCT00106964|81319044|FG000|Overall Study|Incarceration|0|||
27858701|NCT00106964|81319045|FG001|Overall Study|Incarceration|1|||
27858702|NCT00106964|81319046|FG002|Overall Study|Incarceration|0|||
27858703|NCT00106964|81319044|FG000|Overall Study|Site Funding Terminated|0|||
27858704|NCT00106964|81319045|FG001|Overall Study|Site Funding Terminated|1|||
27858705|NCT00106964|81319046|FG002|Overall Study|Site Funding Terminated|1|||
27858706|NCT00106964|81319044|FG000|Overall Study|Failure to adhere|2|||
27858707|NCT00106964|81319045|FG001|Overall Study|Failure to adhere|0|||
27858708|NCT00106964|81319046|FG002|Overall Study|Failure to adhere|0|||
27858709|NCT00106964|81319044|FG000|Overall Study|Did not meet eligibility criteria|0|||
27858710|NCT00106964|81319045|FG001|Overall Study|Did not meet eligibility criteria|2|||
27858711|NCT00106964|81319046|FG002|Overall Study|Did not meet eligibility criteria|2|||
27858712|NCT00106964|81319044|FG000|Overall Study|Required disallowed medication|0|||
27562523|NCT02503332|80246279|FG000|Overall Study|Death|0|||
27858713|NCT00106964|81319045|FG001|Overall Study|Required disallowed medication|1|||
27858714|NCT00106964|81319046|FG002|Overall Study|Required disallowed medication|0|||
27858715|NCT00140426|81319049|FG000|Overall Study|Withdrawal by Subject|0|||
27858716|NCT00140426|81319050|FG001|Overall Study|Withdrawal by Subject|3|||
27858717|NCT02036775|81319051|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27858718|NCT02036775|81319052|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27858719|NCT02036775|81319053|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27858720|NCT02036775|81319054|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27858721|NCT02036775|81319055|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
27858722|NCT02036775|81319056|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
27858723|NCT00509366|81319057|FG000|Overall Study|Not Treated (Screen Failure)|1|||
27858724|NCT00509366|81319058|FG001|Overall Study|Not Treated (Screen Failure)|1|||
27858725|NCT00509366|81319059|FG002|Overall Study|Not Treated (Screen Failure)|1|||
27858726|NCT00509366|81319060|FG003|Overall Study|Not Treated (Screen Failure)|0|||
27858727|NCT00509366|81319061|FG004|Overall Study|Not Treated (Screen Failure)|0|||
27858728|NCT03167723|81319062|FG000|Overall Study|Protocol Violation|4|||
27858729|NCT03167723|81319063|FG001|Overall Study|Protocol Violation|6|||
27858730|NCT02853370|81319064|FG000|Overall Study|Physician Decision|1|||
27858731|NCT02853370|81319064|FG000|Overall Study|Lack of Efficacy|2|||
27858732|NCT02853370|81319064|FG000|Overall Study|Death|1|||
27858733|NCT02853370|81319064|FG000|Overall Study|Adverse Event|4|||
27858734|NCT02853370|81319064|FG000|Overall Study|Withdrawal by Subject|3|||
27858735|NCT00326963|81319065|FG000|Overall Study|Adverse Event|2|||
27858736|NCT00326963|81319065|FG000|Overall Study|Injection site reaction|1|||
27858737|NCT00326963|81319065|FG000|Overall Study|Death|1|||
27858738|NCT00326963|81319065|FG000|Overall Study|Failure to return|10|||
27858739|NCT00326963|81319065|FG000|Overall Study|Withdrawal by Subject|10|||
27858740|NCT00326963|81319065|FG000|Overall Study|Refused treatment / did not cooperate|5|||
27858741|NCT00326963|81319065|FG000|Overall Study|Violation of selection criteria at entry|2|||
27858742|NCT00326963|81319065|FG000|Overall Study|Other protocol violation|1|||
27858743|NCT00326963|81319065|FG000|Overall Study|Administrative / other|1|||
27858744|NCT02628743|81319068|FG000|Overall Study|Other|3|||
27858745|NCT02628743|81319068|FG000|Overall Study|Withdrawal by Subject|50|||
27858746|NCT02628743|81319068|FG000|Overall Study|Study Terminated by Sponsor|76|||
27858747|NCT02628743|81319068|FG000|Overall Study|Physician Decision|2|||
27858748|NCT02933255|81319069|FG000|Overall Study|Discontinued due to study closure.|1|||
27858749|NCT02933255|81319070|FG001|Overall Study|Discontinued due to study closure.|0|||
27858750|NCT00252239|81319071|FG000|Overall Study|Withdrawal by Subject|1|||
27858751|NCT00252239|81319072|FG001|Overall Study|Withdrawal by Subject|0|||
27858752|NCT00252239|81319073|FG002|Overall Study|Withdrawal by Subject|0|||
27858753|NCT00252239|81319074|FG003|Overall Study|Withdrawal by Subject|1|||
27858754|NCT00252239|81319071|FG000|Overall Study|Lost to Follow-up|0|||
27858755|NCT00252239|81319072|FG001|Overall Study|Lost to Follow-up|0|||
27858756|NCT00252239|81319073|FG002|Overall Study|Lost to Follow-up|2|||
27858757|NCT00252239|81319074|FG003|Overall Study|Lost to Follow-up|0|||
27858758|NCT04283500|81319077|FG000|Overall Study|Lost to Follow-up|8|||
27858759|NCT04283500|81319077|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
27858760|NCT04555720|81319080|FG000|Overall Study|Lost to Follow-up|2|||
27858761|NCT04555720|81319081|FG001|Overall Study|Lost to Follow-up|0|||
27858762|NCT04555720|81319082|FG002|Overall Study|Lost to Follow-up|0|||
27858763|NCT04555720|81319083|FG003|Overall Study|Lost to Follow-up|0|||
27858764|NCT04555720|81319080|FG000|Overall Study|Withdrawal by Subject|4|||
27858765|NCT04555720|81319081|FG001|Overall Study|Withdrawal by Subject|6|||
27858766|NCT04555720|81319082|FG002|Overall Study|Withdrawal by Subject|0|||
27858767|NCT04555720|81319083|FG003|Overall Study|Withdrawal by Subject|0|||
27858768|NCT00792935|81319084|FG000|Overall Study|Adverse Event|2|||
27858769|NCT00792935|81319085|FG001|Overall Study|Adverse Event|1|||
27858770|NCT00792935|81319084|FG000|Overall Study|Lost to Follow-up|0|||
27858771|NCT00792935|81319085|FG001|Overall Study|Lost to Follow-up|1|||
27858772|NCT00792935|81319084|FG000|Overall Study|Protocol Violation|2|||
27858773|NCT00792935|81319085|FG001|Overall Study|Protocol Violation|0|||
27858774|NCT00792935|81319084|FG000|Overall Study|Withdrawal by Subject|0|||
27858775|NCT00792935|81319085|FG001|Overall Study|Withdrawal by Subject|1|||
27858776|NCT04159935|81319086|FG000|Overall Study|Study terminated due to COVID-19|1|||
27858777|NCT04159935|81319087|FG001|Overall Study|Study terminated due to COVID-19|3|||
27858778|NCT02679235|81319088|FG000|Overall Study|Withdrawal by Subject|3|||
27858779|NCT02679235|81319088|FG000|Overall Study|Adverse Event|1|||
27858780|NCT01468818|81319093|FG000|Overall Study|Death during treatment|2|||
27858781|NCT00849186|81319094|FG000|Overall Study|Adverse Event|2|||
27858782|NCT00849186|81319094|FG000|Overall Study|Withdrawal by Subject|1|||
27858783|NCT00849186|81319094|FG000|Overall Study|not treated|6|||
27858784|NCT00849186|81319094|FG000|Overall Study|Other|1|||
27858785|NCT02458287|81319095|FG000|Overall Study|Adverse Event|0|||
27858786|NCT02458287|81319096|FG001|Overall Study|Adverse Event|0|||
27858787|NCT02458287|81319097|FG002|Overall Study|Adverse Event|0|||
27858788|NCT02458287|81319098|FG003|Overall Study|Adverse Event|1|||
27960297|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960298|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960299|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960300|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960301|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960302|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960303|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
27960304|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
27858789|NCT02458287|81319095|FG000|Overall Study|Lost to Follow-up|0|||
27858790|NCT02458287|81319096|FG001|Overall Study|Lost to Follow-up|1|||
27858791|NCT02458287|81319097|FG002|Overall Study|Lost to Follow-up|1|||
27858792|NCT02458287|81319098|FG003|Overall Study|Lost to Follow-up|0|||
27858793|NCT02458287|81319095|FG000|Overall Study|Protocol Violation|0|||
27858794|NCT02458287|81319096|FG001|Overall Study|Protocol Violation|1|||
27858795|NCT02458287|81319097|FG002|Overall Study|Protocol Violation|0|||
27858796|NCT02458287|81319098|FG003|Overall Study|Protocol Violation|0|||
27858797|NCT02458287|81319095|FG000|Overall Study|Withdrawal by Subject|0|||
27858798|NCT02458287|81319096|FG001|Overall Study|Withdrawal by Subject|2|||
27858799|NCT02458287|81319097|FG002|Overall Study|Withdrawal by Subject|2|||
27858800|NCT02458287|81319098|FG003|Overall Study|Withdrawal by Subject|1|||
27858801|NCT02458287|81319095|FG000|Overall Study|Relocated Out of State|0|||
27858802|NCT02458287|81319096|FG001|Overall Study|Relocated Out of State|0|||
27858803|NCT02458287|81319097|FG002|Overall Study|Relocated Out of State|0|||
27858804|NCT02458287|81319098|FG003|Overall Study|Relocated Out of State|1|||
27858805|NCT03207867|81319103|FG000|Overall Study|Adverse Event|1|||
27858806|NCT03207867|81319104|FG001|Overall Study|Adverse Event|0|||
27858807|NCT03207867|81319105|FG002|Overall Study|Adverse Event|1|||
27858808|NCT03207867|81319106|FG003|Overall Study|Adverse Event|0|||
27858809|NCT03207867|81319107|FG004|Overall Study|Adverse Event|0|||
27858810|NCT03207867|81319108|FG005|Overall Study|Adverse Event|2|||
27858811|NCT03207867|81319109|FG006|Overall Study|Adverse Event|1|||
27858812|NCT03207867|81319110|FG007|Overall Study|Adverse Event|1|||
27858813|NCT03207867|81319111|FG008|Overall Study|Adverse Event|2|||
27858814|NCT03207867|81319112|FG009|Overall Study|Adverse Event|2|||
27858815|NCT03207867|81319113|FG010|Overall Study|Adverse Event|0|||
27858816|NCT03207867|81319114|FG011|Overall Study|Adverse Event|0|||
27858817|NCT03207867|81319115|FG012|Overall Study|Adverse Event|0|||
27858818|NCT03207867|81319116|FG013|Overall Study|Adverse Event|0|||
27858819|NCT03207867|81319117|FG014|Overall Study|Adverse Event|0|||
27960305|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
27960306|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960307|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960308|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960309|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960310|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960311|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960312|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960313|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
27960314|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
27858820|NCT03207867|81319118|FG015|Overall Study|Adverse Event|0|||
27858821|NCT03207867|81319119|FG016|Overall Study|Adverse Event|3|||
27858822|NCT03207867|81319120|FG017|Overall Study|Adverse Event|1|||
27858823|NCT03207867|81319121|FG018|Overall Study|Adverse Event|2|||
27858824|NCT03207867|81319122|FG019|Overall Study|Adverse Event|1|||
27858825|NCT03207867|81319123|FG020|Overall Study|Adverse Event|0|||
27858826|NCT03207867|81319124|FG021|Overall Study|Adverse Event|0|||
27858827|NCT03207867|81319125|FG022|Overall Study|Adverse Event|0|||
27858828|NCT03207867|81319126|FG023|Overall Study|Adverse Event|0|||
27858829|NCT03207867|81319103|FG000|Overall Study|Death|0|||
27858830|NCT03207867|81319104|FG001|Overall Study|Death|0|||
27858831|NCT03207867|81319105|FG002|Overall Study|Death|0|||
27858832|NCT03207867|81319106|FG003|Overall Study|Death|0|||
27858833|NCT03207867|81319107|FG004|Overall Study|Death|0|||
27858834|NCT03207867|81319108|FG005|Overall Study|Death|1|||
27858835|NCT03207867|81319109|FG006|Overall Study|Death|0|||
27858836|NCT03207867|81319110|FG007|Overall Study|Death|3|||
27858837|NCT03207867|81319111|FG008|Overall Study|Death|1|||
27858838|NCT03207867|81319112|FG009|Overall Study|Death|2|||
27858839|NCT03207867|81319113|FG010|Overall Study|Death|0|||
27858840|NCT03207867|81319114|FG011|Overall Study|Death|1|||
27858841|NCT03207867|81319115|FG012|Overall Study|Death|0|||
27858842|NCT03207867|81319116|FG013|Overall Study|Death|1|||
27858843|NCT03207867|81319117|FG014|Overall Study|Death|0|||
27858844|NCT03207867|81319118|FG015|Overall Study|Death|0|||
27858845|NCT03207867|81319119|FG016|Overall Study|Death|0|||
27858846|NCT03207867|81319120|FG017|Overall Study|Death|2|||
27858847|NCT03207867|81319121|FG018|Overall Study|Death|0|||
27858848|NCT03207867|81319122|FG019|Overall Study|Death|1|||
27858849|NCT03207867|81319123|FG020|Overall Study|Death|0|||
27858850|NCT03207867|81319124|FG021|Overall Study|Death|0|||
27858851|NCT03207867|81319125|FG022|Overall Study|Death|0|||
27858852|NCT03207867|81319126|FG023|Overall Study|Death|0|||
27858853|NCT03207867|81319103|FG000|Overall Study|Physician Decision|3|||
27858854|NCT03207867|81319104|FG001|Overall Study|Physician Decision|5|||
27858855|NCT03207867|81319105|FG002|Overall Study|Physician Decision|0|||
27858856|NCT03207867|81319106|FG003|Overall Study|Physician Decision|3|||
27858857|NCT03207867|81319107|FG004|Overall Study|Physician Decision|2|||
27858858|NCT03207867|81319108|FG005|Overall Study|Physician Decision|0|||
27858859|NCT03207867|81319109|FG006|Overall Study|Physician Decision|0|||
27858860|NCT03207867|81319110|FG007|Overall Study|Physician Decision|0|||
27858861|NCT03207867|81319111|FG008|Overall Study|Physician Decision|4|||
27858862|NCT03207867|81319112|FG009|Overall Study|Physician Decision|2|||
27858863|NCT03207867|81319113|FG010|Overall Study|Physician Decision|0|||
27858864|NCT03207867|81319114|FG011|Overall Study|Physician Decision|4|||
27858865|NCT03207867|81319115|FG012|Overall Study|Physician Decision|0|||
27858866|NCT03207867|81319116|FG013|Overall Study|Physician Decision|0|||
27858867|NCT03207867|81319117|FG014|Overall Study|Physician Decision|2|||
27858868|NCT03207867|81319118|FG015|Overall Study|Physician Decision|1|||
27858869|NCT03207867|81319119|FG016|Overall Study|Physician Decision|1|||
27858870|NCT03207867|81319120|FG017|Overall Study|Physician Decision|2|||
27858871|NCT03207867|81319121|FG018|Overall Study|Physician Decision|1|||
27858872|NCT03207867|81319122|FG019|Overall Study|Physician Decision|3|||
27858873|NCT03207867|81319123|FG020|Overall Study|Physician Decision|0|||
27858874|NCT03207867|81319124|FG021|Overall Study|Physician Decision|0|||
27858875|NCT03207867|81319125|FG022|Overall Study|Physician Decision|0|||
27858876|NCT03207867|81319126|FG023|Overall Study|Physician Decision|0|||
27858877|NCT03207867|81319103|FG000|Overall Study|Progressive Disease|7|||
27858878|NCT03207867|81319104|FG001|Overall Study|Progressive Disease|7|||
27858879|NCT03207867|81319105|FG002|Overall Study|Progressive Disease|9|||
27858880|NCT03207867|81319106|FG003|Overall Study|Progressive Disease|10|||
27858881|NCT03207867|81319107|FG004|Overall Study|Progressive Disease|11|||
27858882|NCT03207867|81319108|FG005|Overall Study|Progressive Disease|10|||
27858883|NCT03207867|81319109|FG006|Overall Study|Progressive Disease|9|||
27858884|NCT03207867|81319110|FG007|Overall Study|Progressive Disease|8|||
27858885|NCT03207867|81319111|FG008|Overall Study|Progressive Disease|19|||
27858886|NCT03207867|81319112|FG009|Overall Study|Progressive Disease|23|||
27858887|NCT03207867|81319113|FG010|Overall Study|Progressive Disease|2|||
27858888|NCT03207867|81319114|FG011|Overall Study|Progressive Disease|24|||
27858889|NCT03207867|81319115|FG012|Overall Study|Progressive Disease|3|||
27858890|NCT03207867|81319116|FG013|Overall Study|Progressive Disease|11|||
27858891|NCT03207867|81319117|FG014|Overall Study|Progressive Disease|9|||
27858892|NCT03207867|81319118|FG015|Overall Study|Progressive Disease|5|||
27858893|NCT03207867|81319119|FG016|Overall Study|Progressive Disease|10|||
27858894|NCT03207867|81319120|FG017|Overall Study|Progressive Disease|14|||
27858895|NCT03207867|81319121|FG018|Overall Study|Progressive Disease|13|||
27858896|NCT03207867|81319122|FG019|Overall Study|Progressive Disease|14|||
27858897|NCT03207867|81319123|FG020|Overall Study|Progressive Disease|6|||
27858898|NCT03207867|81319124|FG021|Overall Study|Progressive Disease|3|||
27858899|NCT03207867|81319125|FG022|Overall Study|Progressive Disease|3|||
27858900|NCT03207867|81319126|FG023|Overall Study|Progressive Disease|3|||
27858901|NCT03207867|81319103|FG000|Overall Study|Patient/guardian Decision|0|||
27562524|NCT02503332|80246280|FG001|Overall Study|Death|2|||
27858902|NCT03207867|81319104|FG001|Overall Study|Patient/guardian Decision|0|||
27858903|NCT03207867|81319105|FG002|Overall Study|Patient/guardian Decision|1|||
27858904|NCT03207867|81319106|FG003|Overall Study|Patient/guardian Decision|1|||
27858905|NCT03207867|81319107|FG004|Overall Study|Patient/guardian Decision|1|||
27858906|NCT03207867|81319108|FG005|Overall Study|Patient/guardian Decision|2|||
27858907|NCT03207867|81319109|FG006|Overall Study|Patient/guardian Decision|1|||
27858908|NCT03207867|81319110|FG007|Overall Study|Patient/guardian Decision|0|||
27858909|NCT03207867|81319111|FG008|Overall Study|Patient/guardian Decision|1|||
27858910|NCT03207867|81319112|FG009|Overall Study|Patient/guardian Decision|0|||
27858911|NCT03207867|81319113|FG010|Overall Study|Patient/guardian Decision|0|||
27858912|NCT03207867|81319114|FG011|Overall Study|Patient/guardian Decision|1|||
27858913|NCT03207867|81319115|FG012|Overall Study|Patient/guardian Decision|0|||
27858914|NCT03207867|81319116|FG013|Overall Study|Patient/guardian Decision|1|||
27858915|NCT03207867|81319117|FG014|Overall Study|Patient/guardian Decision|2|||
27858916|NCT03207867|81319118|FG015|Overall Study|Patient/guardian Decision|0|||
27858917|NCT03207867|81319119|FG016|Overall Study|Patient/guardian Decision|1|||
27858918|NCT03207867|81319120|FG017|Overall Study|Patient/guardian Decision|3|||
27858919|NCT03207867|81319121|FG018|Overall Study|Patient/guardian Decision|4|||
27858920|NCT03207867|81319122|FG019|Overall Study|Patient/guardian Decision|1|||
27858921|NCT03207867|81319123|FG020|Overall Study|Patient/guardian Decision|0|||
27858922|NCT03207867|81319124|FG021|Overall Study|Patient/guardian Decision|0|||
27858923|NCT03207867|81319125|FG022|Overall Study|Patient/guardian Decision|0|||
27858924|NCT03207867|81319126|FG023|Overall Study|Patient/guardian Decision|0|||
27858925|NCT04645966|81319131|FG000|Vaccination Phase|Adverse Event|1|||
27858926|NCT04645966|81319132|FG001|Vaccination Phase|Adverse Event|0|||
27858927|NCT04645966|81319133|FG002|Vaccination Phase|Adverse Event|0|||
27858928|NCT04645966|81319134|FG003|Vaccination Phase|Adverse Event|0|||
27858929|NCT04645966|81319135|FG004|Vaccination Phase|Adverse Event|0|||
27858930|NCT04645966|81319136|FG005|Vaccination Phase|Adverse Event|0|||
27858931|NCT04645966|81319137|FG006|Vaccination Phase|Adverse Event|1|||
27858932|NCT04645966|81319138|FG007|Vaccination Phase|Adverse Event|0|||
27858933|NCT04645966|81319139|FG008|Vaccination Phase|Adverse Event|0|||
27858934|NCT04645966|81319131|FG000|Vaccination Phase|Death|0|||
27858935|NCT04645966|81319132|FG001|Vaccination Phase|Death|0|||
27858936|NCT04645966|81319133|FG002|Vaccination Phase|Death|0|||
27858937|NCT04645966|81319134|FG003|Vaccination Phase|Death|0|||
27858938|NCT04645966|81319135|FG004|Vaccination Phase|Death|0|||
27858939|NCT04645966|81319136|FG005|Vaccination Phase|Death|1|||
27858940|NCT04645966|81319137|FG006|Vaccination Phase|Death|0|||
27858941|NCT04645966|81319138|FG007|Vaccination Phase|Death|0|||
27858942|NCT04645966|81319139|FG008|Vaccination Phase|Death|0|||
27858943|NCT04645966|81319131|FG000|Vaccination Phase|Protocol Violation|0|||
27858944|NCT04645966|81319132|FG001|Vaccination Phase|Protocol Violation|0|||
27858945|NCT04645966|81319133|FG002|Vaccination Phase|Protocol Violation|0|||
27960315|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
27960316|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960317|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960318|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960319|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960320|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960321|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960322|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960323|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
27960324|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
27960325|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
27960326|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960327|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960328|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960329|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27858946|NCT04645966|81319134|FG003|Vaccination Phase|Protocol Violation|0|||
27858947|NCT04645966|81319135|FG004|Vaccination Phase|Protocol Violation|1|||
27858948|NCT04645966|81319136|FG005|Vaccination Phase|Protocol Violation|0|||
27858949|NCT04645966|81319137|FG006|Vaccination Phase|Protocol Violation|0|||
27858950|NCT04645966|81319138|FG007|Vaccination Phase|Protocol Violation|0|||
27858951|NCT04645966|81319139|FG008|Vaccination Phase|Protocol Violation|0|||
27858952|NCT04645966|81319131|FG000|Vaccination Phase|Study terminated by sponsor|0|||
27858953|NCT04645966|81319132|FG001|Vaccination Phase|Study terminated by sponsor|0|||
27858954|NCT04645966|81319133|FG002|Vaccination Phase|Study terminated by sponsor|14|||
27858955|NCT04645966|81319134|FG003|Vaccination Phase|Study terminated by sponsor|15|||
27858956|NCT04645966|81319135|FG004|Vaccination Phase|Study terminated by sponsor|47|||
27858957|NCT04645966|81319136|FG005|Vaccination Phase|Study terminated by sponsor|43|||
27858958|NCT04645966|81319137|FG006|Vaccination Phase|Study terminated by sponsor|29|||
27858959|NCT04645966|81319138|FG007|Vaccination Phase|Study terminated by sponsor|29|||
27858960|NCT04645966|81319139|FG008|Vaccination Phase|Study terminated by sponsor|12|||
27858961|NCT04645966|81319131|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
27858962|NCT04645966|81319132|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
27858963|NCT04645966|81319133|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
27858964|NCT04645966|81319134|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
27858965|NCT04645966|81319135|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
27858966|NCT04645966|81319136|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
27858967|NCT04645966|81319137|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
27858968|NCT04645966|81319138|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
27858969|NCT04645966|81319139|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
27858970|NCT04645966|81319131|FG000|Vaccination Phase|Other|0|||
27858971|NCT04645966|81319132|FG001|Vaccination Phase|Other|0|||
27858972|NCT04645966|81319133|FG002|Vaccination Phase|Other|0|||
27858973|NCT04645966|81319134|FG003|Vaccination Phase|Other|0|||
27858974|NCT04645966|81319135|FG004|Vaccination Phase|Other|0|||
27858975|NCT04645966|81319136|FG005|Vaccination Phase|Other|2|||
27858976|NCT04645966|81319137|FG006|Vaccination Phase|Other|0|||
27858977|NCT04645966|81319138|FG007|Vaccination Phase|Other|0|||
27858978|NCT04645966|81319139|FG008|Vaccination Phase|Other|0|||
27858979|NCT04645966|81319131|FG000|Vaccination Phase|Lost to Follow-up|0|||
27858980|NCT04645966|81319132|FG001|Vaccination Phase|Lost to Follow-up|0|||
27858981|NCT04645966|81319133|FG002|Vaccination Phase|Lost to Follow-up|0|||
27960330|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960331|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960332|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960333|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
27960334|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
27960335|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
27960336|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
27960337|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
27960338|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
27960339|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
27960340|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
27960341|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
27960342|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
27960343|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
27960344|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
27960345|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
27960346|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960347|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960348|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960349|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960350|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27858982|NCT04645966|81319134|FG003|Vaccination Phase|Lost to Follow-up|0|||
27858983|NCT04645966|81319135|FG004|Vaccination Phase|Lost to Follow-up|0|||
27858984|NCT04645966|81319136|FG005|Vaccination Phase|Lost to Follow-up|0|||
27562525|NCT02503332|80246281|FG002|Overall Study|Death|2|||
27562526|NCT02503332|80246282|FG003|Overall Study|Death|0|||
27562527|NCT02503332|80246279|FG000|Overall Study|Other|5|||
27562528|NCT02503332|80246280|FG001|Overall Study|Other|6|||
27562529|NCT02503332|80246281|FG002|Overall Study|Other|1|||
27562530|NCT02503332|80246282|FG003|Overall Study|Other|1|||
27562531|NCT02205333|80246283|FG000|Overall Study|Death|5|||
27562532|NCT02205333|80246284|FG001|Overall Study|Death|6|||
27562533|NCT02205333|80246285|FG002|Overall Study|Death|2|||
27562534|NCT02205333|80246286|FG003|Overall Study|Death|6|||
27562535|NCT02205333|80246287|FG004|Overall Study|Death|5|||
27562536|NCT02205333|80246288|FG005|Overall Study|Death|3|||
27562537|NCT02205333|80246289|FG006|Overall Study|Death|3|||
27858985|NCT04645966|81319137|FG006|Vaccination Phase|Lost to Follow-up|0|||
27858986|NCT04645966|81319138|FG007|Vaccination Phase|Lost to Follow-up|1|||
27858987|NCT04645966|81319139|FG008|Vaccination Phase|Lost to Follow-up|0|||
27858988|NCT04645966|81319131|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
27858989|NCT04645966|81319132|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
27858990|NCT04645966|81319133|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
27858991|NCT04645966|81319134|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
27858992|NCT04645966|81319135|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
27858993|NCT04645966|81319136|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
27858994|NCT04645966|81319137|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
27858995|NCT04645966|81319138|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
27858996|NCT04645966|81319139|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
27858997|NCT04645966|81319131|FG000|Follow-up Phase|Lost to Follow-up|0|||
27858998|NCT04645966|81319132|FG001|Follow-up Phase|Lost to Follow-up|0|||
27858999|NCT04645966|81319133|FG002|Follow-up Phase|Lost to Follow-up|0|||
27859000|NCT04645966|81319134|FG003|Follow-up Phase|Lost to Follow-up|0|||
27859001|NCT04645966|81319135|FG004|Follow-up Phase|Lost to Follow-up|0|||
27859002|NCT04645966|81319136|FG005|Follow-up Phase|Lost to Follow-up|0|||
27859003|NCT04645966|81319137|FG006|Follow-up Phase|Lost to Follow-up|0|||
27859004|NCT04645966|81319138|FG007|Follow-up Phase|Lost to Follow-up|1|||
27859005|NCT04645966|81319139|FG008|Follow-up Phase|Lost to Follow-up|0|||
27859006|NCT01898650|81319140|FG000|Overall Study|the subject would not lie still for imaging|1|||
27859007|NCT00103610|81319142|FG000|Overall Study|Entered Rescue Procedure|10|||
27859008|NCT00103610|81319143|FG001|Overall Study|Entered Rescue Procedure|52|||
27859009|NCT00103610|81319142|FG000|Overall Study|Death|16|||
27562538|NCT02205333|80246290|FG007|Overall Study|Death|2|||
27562539|NCT02205333|80246291|FG008|Overall Study|Death|0|||
27562540|NCT02205333|80246283|FG000|Overall Study|Withdrawal by Subject|1|||
27562541|NCT02205333|80246284|FG001|Overall Study|Withdrawal by Subject|0|||
27562542|NCT02205333|80246285|FG002|Overall Study|Withdrawal by Subject|0|||
27562543|NCT02205333|80246286|FG003|Overall Study|Withdrawal by Subject|1|||
27562544|NCT02205333|80246287|FG004|Overall Study|Withdrawal by Subject|0|||
27859010|NCT00103610|81319143|FG001|Overall Study|Death|12|||
27859011|NCT00103610|81319142|FG000|Overall Study|Elective Withdrawal|4|||
27859012|NCT00103610|81319143|FG001|Overall Study|Elective Withdrawal|0|||
27859013|NCT00103610|81319142|FG000|Overall Study|Lost to Follow-up|3|||
27562545|NCT02205333|80246288|FG005|Overall Study|Withdrawal by Subject|0|||
27859014|NCT00103610|81319143|FG001|Overall Study|Lost to Follow-up|1|||
27859015|NCT00103610|81319142|FG000|Overall Study|Adverse Event|2|||
27859016|NCT00103610|81319143|FG001|Overall Study|Adverse Event|2|||
27562546|NCT02205333|80246289|FG006|Overall Study|Withdrawal by Subject|2|||
27562547|NCT02205333|80246290|FG007|Overall Study|Withdrawal by Subject|0|||
27562548|NCT02205333|80246291|FG008|Overall Study|Withdrawal by Subject|0|||
27562549|NCT02337907|80246296|FG000|Overall Study|Other than listed|1|||
27562550|NCT02337907|80246297|FG001|Overall Study|Other than listed|0|||
27960351|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960352|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960353|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
27960354|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
27960355|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
27859017|NCT00103610|81319142|FG000|Overall Study|Other|2|||
27859018|NCT00103610|81319143|FG001|Overall Study|Other|7|||
27859019|NCT00103610|81319142|FG000|Overall Study|Failed mobilization|1|||
27859020|NCT00103610|81319143|FG001|Overall Study|Failed mobilization|5|||
27960356|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960357|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960358|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960359|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960360|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960361|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27562551|NCT02337907|80246298|FG002|Overall Study|Other than listed|0|||
27562552|NCT02337907|80246299|FG003|Overall Study|Other than listed|1|||
27960362|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960363|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960364|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
27960365|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
27960366|NCT01194219|81686323|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960367|NCT01194219|81686324|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960368|NCT01194219|81686325|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960369|NCT01194219|81686326|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960370|NCT01194219|81686327|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960371|NCT01194219|81686328|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960372|NCT01194219|81686329|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960373|NCT01194219|81686330|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
27960374|NCT01194219|81686331|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
27960375|NCT01194219|81686332|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
27960376|NCT00437268|81686333|FG000|Overall Study|Adverse Event|1|||
27960377|NCT00437268|81686334|FG001|Overall Study|Adverse Event|1|||
27960378|NCT00437268|81686333|FG000|Overall Study|Withdrawal by Subject|2|||
27960379|NCT00437268|81686334|FG001|Overall Study|Withdrawal by Subject|2|||
27960380|NCT00437268|81686333|FG000|Overall Study|Progressive disease|9|||
27960381|NCT00437268|81686334|FG001|Overall Study|Progressive disease|9|||
27960382|NCT00437268|81686333|FG000|Overall Study|Physician Decision|1|||
27960383|NCT00437268|81686334|FG001|Overall Study|Physician Decision|0|||
27960384|NCT00437268|81686333|FG000|Overall Study|Death|0|||
27960385|NCT00437268|81686334|FG001|Overall Study|Death|1|||
27960386|NCT02257242|81686346|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
27960387|NCT02257242|81686347|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960388|NCT02257242|81686348|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960389|NCT02257242|81686349|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960390|NCT02257242|81686350|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960391|NCT02257242|81686351|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960392|NCT02257242|81686352|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960393|NCT02257242|81686353|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960394|NCT02257242|81686354|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
27960395|NCT02100423|81686357|FG000|Overall Study|Death|1|||
27960396|NCT02100423|81686357|FG000|Overall Study|Withdrawal by Subject|3|||
27960397|NCT02100423|81686357|FG000|Overall Study|Adverse Event|1|||
27960398|NCT02100423|81686357|FG000|Overall Study|Physician Decision|1|||
27960399|NCT00407602|81686360|FG000|Overall Study|Death - unrelated to device|1|||
27960400|NCT00407602|81686360|FG000|Overall Study|Device explanted|5|||
27960401|NCT00407602|81686360|FG000|Overall Study|Withdrawal by Subject|1|||
27960402|NCT01295944|81686361|FG000|Overall Study|Switched to alternative treatment|1|||
27960403|NCT01295944|81686361|FG000|Overall Study|Ineligible|9|||
27960404|NCT01295944|81686361|FG000|Overall Study|Withdrawal by Subject|4|||
27960405|NCT01295944|81686361|FG000|Overall Study|Participant chose to be treated in Peru|1|||
27960406|NCT01295944|81686361|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
27960407|NCT01295944|81686361|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
27960408|NCT01295944|81686361|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
27960409|NCT01127633|81686362|FG000|Overall Study|Adverse Event|74|||
27960410|NCT01127633|81686363|FG001|Overall Study|Adverse Event|73|||
27960411|NCT01127633|81686362|FG000|Overall Study|Death|40|||
27960412|NCT01127633|81686363|FG001|Overall Study|Death|43|||
27960413|NCT01127633|81686362|FG000|Overall Study|Lost to Follow-up|4|||
27960414|NCT01127633|81686363|FG001|Overall Study|Lost to Follow-up|0|||
27960415|NCT01127633|81686362|FG000|Overall Study|Parent/Caregiver Decision|246|||
27960416|NCT01127633|81686363|FG001|Overall Study|Parent/Caregiver Decision|228|||
27960417|NCT01127633|81686362|FG000|Overall Study|Physician Decision|60|||
27960418|NCT01127633|81686363|FG001|Overall Study|Physician Decision|45|||
27960419|NCT01127633|81686362|FG000|Overall Study|Withdrawal by Subject|57|||
27960420|NCT01127633|81686363|FG001|Overall Study|Withdrawal by Subject|72|||
27562553|NCT02337907|80246300|FG004|Overall Study|Other than listed|1|||
27562554|NCT02337907|80246301|FG005|Overall Study|Other than listed|0|||
27960421|NCT01127633|81686362|FG000|Overall Study|Sponsor Decision|163|||
27960422|NCT01127633|81686363|FG001|Overall Study|Sponsor Decision|195|||
27960423|NCT01127633|81686362|FG000|Overall Study|Protocol Violation|8|||
27960424|NCT01127633|81686363|FG001|Overall Study|Protocol Violation|16|||
27960425|NCT01127633|81686362|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
27960426|NCT01127633|81686363|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
27960427|NCT01127633|81686362|FG000|Overall Study|Not treated|1|||
27960428|NCT01127633|81686363|FG001|Overall Study|Not treated|0|||
27960429|NCT03896477|81686364|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
27960430|NCT03896477|81686365|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
27960431|NCT03896477|81686366|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
27960432|NCT03896477|81686364|FG000|Overall Study|Parent Requested Withdrawal|8|||
27960433|NCT03896477|81686365|FG001|Overall Study|Parent Requested Withdrawal|12|||
27960434|NCT03896477|81686366|FG002|Overall Study|Parent Requested Withdrawal|9|||
27960435|NCT03896477|81686364|FG000|Overall Study|Adverse Event|0|||
27960436|NCT03896477|81686365|FG001|Overall Study|Adverse Event|0|||
27960437|NCT03896477|81686366|FG002|Overall Study|Adverse Event|1|||
27960438|NCT03896477|81686364|FG000|Overall Study|Death|1|||
27960439|NCT03896477|81686365|FG001|Overall Study|Death|0|||
27960440|NCT03896477|81686366|FG002|Overall Study|Death|0|||
27960441|NCT03896477|81686364|FG000|Overall Study|Other|5|||
27960442|NCT03896477|81686365|FG001|Overall Study|Other|6|||
27960443|NCT03896477|81686366|FG002|Overall Study|Other|7|||
27960444|NCT03896477|81686364|FG000|Overall Study|Lost to Follow-up|2|||
27960445|NCT03896477|81686365|FG001|Overall Study|Lost to Follow-up|1|||
27960446|NCT03896477|81686366|FG002|Overall Study|Lost to Follow-up|1|||
27960447|NCT03276728|81686367|FG000|Overall Study|Lost to Follow-up|0|||
27960448|NCT03276728|81686368|FG001|Overall Study|Lost to Follow-up|0|||
27960449|NCT03276728|81686369|FG002|Overall Study|Lost to Follow-up|2|||
27960450|NCT03276728|81686370|FG003|Overall Study|Lost to Follow-up|2|||
27655401|NCT01365546|80577015|FG000|Overall Study|Study termination|1|||
27960451|NCT03276728|81686371|FG004|Overall Study|Lost to Follow-up|0|||
27960452|NCT03276728|81686372|FG005|Overall Study|Lost to Follow-up|0|||
27960453|NCT03276728|81686373|FG006|Overall Study|Lost to Follow-up|0|||
27960454|NCT03276728|81686374|FG007|Overall Study|Lost to Follow-up|0|||
27960455|NCT03276728|81686367|FG000|Overall Study|Withdrawal by Subject|0|||
27960456|NCT03276728|81686368|FG001|Overall Study|Withdrawal by Subject|0|||
27960457|NCT03276728|81686369|FG002|Overall Study|Withdrawal by Subject|0|||
27960458|NCT03276728|81686370|FG003|Overall Study|Withdrawal by Subject|3|||
27960459|NCT03276728|81686371|FG004|Overall Study|Withdrawal by Subject|0|||
27960460|NCT03276728|81686372|FG005|Overall Study|Withdrawal by Subject|0|||
27960461|NCT03276728|81686373|FG006|Overall Study|Withdrawal by Subject|0|||
27960462|NCT03276728|81686374|FG007|Overall Study|Withdrawal by Subject|0|||
27960463|NCT03276728|81686367|FG000|Overall Study|Decision by sponsor|0|||
27960464|NCT03276728|81686368|FG001|Overall Study|Decision by sponsor|0|||
27960465|NCT03276728|81686369|FG002|Overall Study|Decision by sponsor|0|||
27960466|NCT03276728|81686370|FG003|Overall Study|Decision by sponsor|0|||
27960467|NCT03276728|81686371|FG004|Overall Study|Decision by sponsor|1|||
27960468|NCT03276728|81686372|FG005|Overall Study|Decision by sponsor|0|||
27960469|NCT03276728|81686373|FG006|Overall Study|Decision by sponsor|2|||
27960470|NCT03276728|81686374|FG007|Overall Study|Decision by sponsor|1|||
27960471|NCT01106157|81686375|FG000|Overall Study|Withdrawal by Subject|1|||
27960472|NCT01106157|81686376|FG001|Overall Study|Withdrawal by Subject|0|||
27960473|NCT02688192|81686379|FG000|Overall Study|Lost to Follow-up|11|||
27960474|NCT02688192|81686380|FG001|Overall Study|Lost to Follow-up|5|||
27960475|NCT02688192|81686379|FG000|Overall Study|Physician Decision|1|||
27960476|NCT02688192|81686380|FG001|Overall Study|Physician Decision|0|||
27960477|NCT02685826|81686381|FG000|Overall Study|Adverse Event|2|||
27960478|NCT02685826|81686382|FG001|Overall Study|Adverse Event|0|||
27960479|NCT02685826|81686383|FG002|Overall Study|Adverse Event|1|||
27960480|NCT02685826|81686381|FG000|Overall Study|Progressive Disease|2|||
27960481|NCT02685826|81686382|FG001|Overall Study|Progressive Disease|1|||
27960482|NCT02685826|81686383|FG002|Overall Study|Progressive Disease|0|||
27960483|NCT02685826|81686381|FG000|Overall Study|Withdrawal by Subject|2|||
27960484|NCT02685826|81686382|FG001|Overall Study|Withdrawal by Subject|0|||
27960485|NCT02685826|81686383|FG002|Overall Study|Withdrawal by Subject|0|||
27960486|NCT02685826|81686381|FG000|Overall Study|Full Clinical Hold by FDA|19|||
27859021|NCT00103610|81319142|FG000|Overall Study|Noncompliance|0|||
27859022|NCT00103610|81319143|FG001|Overall Study|Noncompliance|1|||
27859023|NCT02113189|81319148|FG000|Overall Study|Lost to follow up|2|||
27859024|NCT02113189|81319149|FG001|Overall Study|Lost to follow up|1|||
27859025|NCT02113189|81319150|FG002|Overall Study|Lost to follow up|3|||
27859026|NCT00927394|81319151|FG000|Overall Study|Adverse Event|14|||
27859027|NCT00927394|81319152|FG001|Overall Study|Adverse Event|9|||
27960487|NCT02685826|81686382|FG001|Overall Study|Full Clinical Hold by FDA|9|||
27960488|NCT02685826|81686383|FG002|Overall Study|Full Clinical Hold by FDA|20|||
27960489|NCT02980107|81686384|FG000|Overall Study|Withdrawal by Subject|51|||
27960490|NCT02980107|81686385|FG001|Overall Study|Withdrawal by Subject|62|||
27960491|NCT00673231|81686392|FG000|Overall Study|Withdrawal by Subject|14|||
27960492|NCT00673231|81686393|FG001|Overall Study|Withdrawal by Subject|10|||
27960493|NCT00673231|81686394|FG002|Overall Study|Withdrawal by Subject|8|||
27960494|NCT00673231|81686395|FG003|Overall Study|Withdrawal by Subject|6|||
27960495|NCT00673231|81686392|FG000|Overall Study|Adverse Event|6|||
27960496|NCT00673231|81686393|FG001|Overall Study|Adverse Event|5|||
27960497|NCT00673231|81686394|FG002|Overall Study|Adverse Event|9|||
27960498|NCT00673231|81686395|FG003|Overall Study|Adverse Event|6|||
27960499|NCT00673231|81686392|FG000|Overall Study|Lost to Follow-up|1|||
27960500|NCT00673231|81686393|FG001|Overall Study|Lost to Follow-up|2|||
27960501|NCT00673231|81686394|FG002|Overall Study|Lost to Follow-up|1|||
27960502|NCT00673231|81686395|FG003|Overall Study|Lost to Follow-up|2|||
27960503|NCT00673231|81686392|FG000|Overall Study|Death|0|||
27960504|NCT00673231|81686393|FG001|Overall Study|Death|0|||
27960505|NCT00673231|81686394|FG002|Overall Study|Death|1|||
27960506|NCT00673231|81686395|FG003|Overall Study|Death|0|||
27960507|NCT00673231|81686392|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
27960508|NCT00673231|81686393|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
27960509|NCT00673231|81686394|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
27960510|NCT00673231|81686395|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
27960511|NCT03902392|81686396|FG000|Overall Study|Lost to Follow-up|7|||
27960512|NCT03902392|81686397|FG001|Overall Study|Lost to Follow-up|7|||
27960513|NCT03369665|81686398|FG000|Overall Study|Adverse Event|3|||
27960514|NCT03369665|81686398|FG000|Overall Study|Lost to Follow-up|7|||
27960515|NCT03369665|81686398|FG000|Overall Study|Withdrawal by Subject|15|||
27960516|NCT03369665|81686398|FG000|Overall Study|Progression Disease|2|||
27960517|NCT03369665|81686398|FG000|Overall Study|Not classified|3|||
27960518|NCT01871545|81686399|FG000|Overall Study|Death|2|||
27960519|NCT01871545|81686400|FG001|Overall Study|Death|0|||
27960520|NCT01871545|81686399|FG000|Overall Study|Lack of Efficacy|11|||
27960521|NCT01871545|81686400|FG001|Overall Study|Lack of Efficacy|2|||
27960522|NCT01871545|81686399|FG000|Overall Study|Physician Decision|4|||
27960523|NCT01871545|81686400|FG001|Overall Study|Physician Decision|0|||
27960524|NCT01871545|81686399|FG000|Overall Study|Withdrawal by Subject|0|||
27960525|NCT01871545|81686400|FG001|Overall Study|Withdrawal by Subject|1|||
27960526|NCT02709577|81686404|FG000|Overall Study|non-accommodating anatomy|0|||
27960527|NCT02709577|81686405|FG001|Overall Study|non-accommodating anatomy|1|||
27960528|NCT02709577|81686406|FG002|Overall Study|non-accommodating anatomy|0|||
27960529|NCT02709577|81686407|FG003|Overall Study|non-accommodating anatomy|0|||
27960530|NCT02709577|81686404|FG000|Overall Study|procedural complication|0|||
27960531|NCT02709577|81686405|FG001|Overall Study|procedural complication|1|||
27960532|NCT02709577|81686406|FG002|Overall Study|procedural complication|0|||
27562555|NCT02337907|80246296|FG000|Overall Study|Withdrawal by Subject|2|||
27960533|NCT02709577|81686407|FG003|Overall Study|procedural complication|0|||
27960534|NCT02709577|81686404|FG000|Overall Study|Withdrawal by Subject|2|||
27960535|NCT02709577|81686405|FG001|Overall Study|Withdrawal by Subject|3|||
27960536|NCT02709577|81686406|FG002|Overall Study|Withdrawal by Subject|2|||
27960537|NCT02709577|81686407|FG003|Overall Study|Withdrawal by Subject|0|||
27960538|NCT01492426|81686408|FG000|Treatment|Death|0|||
27960539|NCT01492426|81686409|FG001|Treatment|Death|1|||
27960540|NCT01492426|81686408|FG000|Treatment|Other|1|||
27960541|NCT01492426|81686409|FG001|Treatment|Other|0|||
27960542|NCT01492426|81686408|FG000|Treatment|Adverse Event|25|||
27960543|NCT01492426|81686409|FG001|Treatment|Adverse Event|25|||
27960544|NCT01492426|81686408|FG000|Treatment|Lack of Efficacy|38|||
27960545|NCT01492426|81686409|FG001|Treatment|Lack of Efficacy|5|||
27960546|NCT01492426|81686408|FG000|Treatment|Participant withdrew consent|1|||
27960547|NCT01492426|81686409|FG001|Treatment|Participant withdrew consent|2|||
27960548|NCT01492426|81686408|FG000|Treatment|Poor compliance/noncompliance|1|||
27960549|NCT01492426|81686409|FG001|Treatment|Poor compliance/noncompliance|0|||
27960550|NCT01492426|81686408|FG000|Treatment|Subject requested discontinue study drug|7|||
27960551|NCT01492426|81686409|FG001|Treatment|Subject requested discontinue study drug|3|||
27960552|NCT01492426|81686408|FG000|Treatment|Lost to Follow-up|9|||
27960553|NCT01492426|81686409|FG001|Treatment|Lost to Follow-up|4|||
27960554|NCT01492426|81686408|FG000|Treatment|Participant does not meet study criteria|1|||
27960555|NCT01492426|81686409|FG001|Treatment|Participant does not meet study criteria|0|||
27960556|NCT01492426|81686408|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
27960557|NCT01492426|81686409|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
27960558|NCT01492426|81686408|FG000|Follow-Up|Death|1|||
27960559|NCT01492426|81686409|FG001|Follow-Up|Death|0|||
27960560|NCT01492426|81686408|FG000|Follow-Up|Other|4|||
27960561|NCT01492426|81686409|FG001|Follow-Up|Other|2|||
27960562|NCT01492426|81686408|FG000|Follow-Up|Participant Withdrew Consent|6|||
27960563|NCT01492426|81686409|FG001|Follow-Up|Participant Withdrew Consent|1|||
27960564|NCT01492426|81686408|FG000|Follow-Up|Lost to Follow-up|12|||
27960565|NCT01492426|81686409|FG001|Follow-Up|Lost to Follow-up|6|||
27960566|NCT03338400|81686410|FG000|Overall Study|Lost to Follow-up|1|||
27960567|NCT03338400|81686411|FG001|Overall Study|Lost to Follow-up|2|||
27960568|NCT00996658|81686413|FG000|Overall Study|Adverse Event|2|||
27960569|NCT00996658|81686414|FG001|Overall Study|Adverse Event|5|||
27960570|NCT00996658|81686413|FG000|Overall Study|Protocol Violation|0|||
27960571|NCT00996658|81686414|FG001|Overall Study|Protocol Violation|1|||
27960572|NCT00996658|81686413|FG000|Overall Study|Lost to Follow-up|2|||
27960573|NCT00996658|81686414|FG001|Overall Study|Lost to Follow-up|5|||
27960574|NCT00996658|81686413|FG000|Overall Study|Non-compliance issues|3|||
27960575|NCT00996658|81686414|FG001|Overall Study|Non-compliance issues|3|||
27960576|NCT00996658|81686413|FG000|Overall Study|Other|9|||
27960577|NCT00996658|81686414|FG001|Overall Study|Other|7|||
27960578|NCT01926444|81686415|FG000|Overall Study|Colonoscopy not performed|0|||
27960579|NCT01926444|81686416|FG001|Overall Study|Colonoscopy not performed|0|||
27960580|NCT01926444|81686417|FG002|Overall Study|Colonoscopy not performed|4|||
27960581|NCT01926444|81686418|FG003|Overall Study|Colonoscopy not performed|2|||
27960582|NCT01253369|81686425|FG000|Overall Study|Adverse Event|4|||
27960583|NCT01253369|81686425|FG000|Overall Study|Withdrawal by Subject|2|||
27960584|NCT01253369|81686425|FG000|Overall Study|Death|1|||
27960585|NCT01253369|81686425|FG000|Overall Study|Progressive disease|23|||
27960586|NCT01253369|81686425|FG000|Overall Study|Not Evaluable|3|||
27960587|NCT00114127|81686426|FG000|Overall Study|Adverse Event|2|||
27960588|NCT00114127|81686427|FG001|Overall Study|Adverse Event|1|||
27960589|NCT00114127|81686426|FG000|Overall Study|Lost to Follow-up|1|||
27960590|NCT00114127|81686427|FG001|Overall Study|Lost to Follow-up|0|||
27960591|NCT00114127|81686426|FG000|Overall Study|Withdrawal by Subject|1|||
27960592|NCT00114127|81686427|FG001|Overall Study|Withdrawal by Subject|3|||
27960593|NCT03943290|81686428|FG000|Overall Study|Sponsor Terminated Study|6|||
27960594|NCT03943290|81686429|FG001|Overall Study|Sponsor Terminated Study|1|||
27960595|NCT03943290|81686430|FG002|Overall Study|Sponsor Terminated Study|11|||
27960596|NCT03943290|81686431|FG003|Overall Study|Sponsor Terminated Study|6|||
27960597|NCT03943290|81686432|FG004|Overall Study|Sponsor Terminated Study|7|||
27960598|NCT03943290|81686433|FG005|Overall Study|Sponsor Terminated Study|6|||
27960599|NCT03943290|81686434|FG006|Overall Study|Sponsor Terminated Study|6|||
27960600|NCT03943290|81686435|FG007|Overall Study|Sponsor Terminated Study|7|||
27960601|NCT03943290|81686436|FG008|Overall Study|Sponsor Terminated Study|8|||
27960602|NCT03943290|81686428|FG000|Overall Study|Lost to Follow-up|1|||
27960603|NCT03943290|81686429|FG001|Overall Study|Lost to Follow-up|0|||
27960604|NCT03943290|81686430|FG002|Overall Study|Lost to Follow-up|1|||
27960605|NCT03943290|81686431|FG003|Overall Study|Lost to Follow-up|0|||
27960606|NCT03943290|81686432|FG004|Overall Study|Lost to Follow-up|0|||
27960607|NCT03943290|81686433|FG005|Overall Study|Lost to Follow-up|0|||
27960608|NCT03943290|81686434|FG006|Overall Study|Lost to Follow-up|0|||
27960609|NCT03943290|81686435|FG007|Overall Study|Lost to Follow-up|1|||
27960610|NCT03943290|81686436|FG008|Overall Study|Lost to Follow-up|0|||
27960611|NCT03943290|81686428|FG000|Overall Study|Withdrawal by Subject|0|||
27960612|NCT03943290|81686429|FG001|Overall Study|Withdrawal by Subject|0|||
27960613|NCT03943290|81686430|FG002|Overall Study|Withdrawal by Subject|1|||
27960614|NCT03943290|81686431|FG003|Overall Study|Withdrawal by Subject|0|||
27960615|NCT03943290|81686432|FG004|Overall Study|Withdrawal by Subject|0|||
27960616|NCT03943290|81686433|FG005|Overall Study|Withdrawal by Subject|0|||
27960617|NCT03943290|81686434|FG006|Overall Study|Withdrawal by Subject|0|||
27960618|NCT03943290|81686435|FG007|Overall Study|Withdrawal by Subject|0|||
27960619|NCT03943290|81686436|FG008|Overall Study|Withdrawal by Subject|0|||
27960620|NCT03559517|81689076|FG000|Overall Study|Withdrawal by Subject|1|||
27960621|NCT03559517|81689077|FG001|Overall Study|Withdrawal by Subject|0|||
27960622|NCT03559517|81689078|FG002|Overall Study|Withdrawal by Subject|0|||
27960623|NCT00335738|81689082|FG000|Overall Study|Physician Decision|6|||
27960624|NCT00335738|81689083|FG001|Overall Study|Physician Decision|0|||
27960625|NCT00335738|81689082|FG000|Overall Study|Withdrawal by Subject|2|||
27756910|NCT00006604|80936558|FG000|Overall Study|Death|0|||
27960626|NCT00335738|81689083|FG001|Overall Study|Withdrawal by Subject|0|||
27960627|NCT00335738|81689082|FG000|Overall Study|Ineligible|3|||
27960628|NCT00335738|81689083|FG001|Overall Study|Ineligible|4|||
27960629|NCT00532129|81689085|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
27960630|NCT00532129|81689085|FG000|Treatment Period|Physician Decision|15|||
27960631|NCT00532129|81689085|FG000|Treatment Period|Disease progression|3|||
27960632|NCT00532129|81689085|FG000|Treatment Period|Protocol Violation|1|||
27960633|NCT00532129|81689085|FG000|Treatment Period|Other|5|||
27960634|NCT00532129|81689085|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
27960635|NCT00532129|81689085|FG000|Follow-up Period|Disease progression|57|||
27960636|NCT00532129|81689085|FG000|Follow-up Period|Lost to Follow-up|1|||
27960637|NCT00532129|81689085|FG000|Follow-up Period|Other|6|||
27960638|NCT00837161|81689086|FG000|Overall Study|refused hysterectomy|2|||
27960639|NCT00414076|81689087|FG000|Overall Study|Progression|1|||
27960640|NCT00414076|81689088|FG001|Overall Study|Progression|2|||
27960641|NCT00414076|81689087|FG000|Overall Study|Withdrawal by Subject|1|||
27960642|NCT00414076|81689088|FG001|Overall Study|Withdrawal by Subject|3|||
27960643|NCT00414076|81689087|FG000|Overall Study|Adverse Event|1|||
27960644|NCT00414076|81689088|FG001|Overall Study|Adverse Event|0|||
27960645|NCT01162473|81689089|FG000|Overall Study|Adverse Event|2|||
27960646|NCT01162473|81689090|FG001|Overall Study|Adverse Event|1|||
27960647|NCT01162473|81689089|FG000|Overall Study|Withdrawal by Subject|0|||
27960648|NCT01162473|81689090|FG001|Overall Study|Withdrawal by Subject|4|||
27960649|NCT01445613|81689094|FG000|30-day Follow-up|Withdrawal by Subject|6|||
27960650|NCT01445613|81689094|FG000|30-day Follow-up|Physician Decision|3|||
27960651|NCT01445613|81689094|FG000|30-day Follow-up|Missed visit|23|||
27960652|NCT01445613|81689094|FG000|30-day Follow-up|Death|3|||
27960653|NCT01445613|81689094|FG000|1-year Follow-up|Withdrawal by Subject|12|||
27960654|NCT01445613|81689094|FG000|1-year Follow-up|Missed visit|29|||
27960655|NCT01445613|81689094|FG000|1-year Follow-up|Lost to Follow-up|2|||
27960656|NCT01445613|81689094|FG000|1-year Follow-up|Death|30|||
27960657|NCT01445613|81689094|FG000|1-year Follow-up|Physician Decision|2|||
27960658|NCT01445613|81689094|FG000|1-year Follow-up|Received a non-study stent|2|||
27960659|NCT04571060|81689095|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
27960660|NCT04571060|81689096|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
27960661|NCT04571060|81689095|FG000|Overall Study|Never treated migraine|47|||
27960662|NCT04571060|81689096|FG001|Overall Study|Never treated migraine|36|||
27960663|NCT04571060|81689095|FG000|Overall Study|Protocol Violation|4|||
27960664|NCT04571060|81689096|FG001|Overall Study|Protocol Violation|2|||
27859028|NCT00927394|81319151|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
27859029|NCT00927394|81319152|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
27859030|NCT00927394|81319151|FG000|Overall Study|Withdrawal by Subject|20|||
27859031|NCT00927394|81319152|FG001|Overall Study|Withdrawal by Subject|24|||
27859032|NCT00927394|81319151|FG000|Overall Study|Lost to Follow-up|8|||
27859033|NCT00927394|81319152|FG001|Overall Study|Lost to Follow-up|14|||
27859034|NCT00927394|81319151|FG000|Overall Study|Administrative Problem|1|||
27859035|NCT00927394|81319152|FG001|Overall Study|Administrative Problem|0|||
27859036|NCT00927394|81319151|FG000|Overall Study|Death|1|||
27859037|NCT00927394|81319152|FG001|Overall Study|Death|1|||
27859038|NCT00927394|81319151|FG000|Overall Study|Protocol deviation|16|||
27859039|NCT00927394|81319152|FG001|Overall Study|Protocol deviation|13|||
27859040|NCT00927394|81319151|FG000|Overall Study|Randomized in error|0|||
27859041|NCT00927394|81319152|FG001|Overall Study|Randomized in error|1|||
27859042|NCT04431726|81319155|FG000|Overall Study|Ongoing in the Study|55|||
27859043|NCT02564211|81319162|FG000|Overall Study|Adverse Event|4|||
27859044|NCT02549027|81319164|FG000|Washout After Period 4|Withdrawal by Subject|0|||
27859045|NCT02549027|81319165|FG001|Washout After Period 4|Withdrawal by Subject|1|||
27859046|NCT02549027|81319166|FG002|Washout After Period 4|Withdrawal by Subject|1|||
27859047|NCT02549027|81319167|FG003|Washout After Period 4|Withdrawal by Subject|1|||
27859048|NCT02549027|81319168|FG004|Washout After Period 4|Withdrawal by Subject|0|||
27859049|NCT02549027|81319169|FG005|Washout After Period 4|Withdrawal by Subject|0|||
27859050|NCT02549027|81319164|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27859051|NCT02549027|81319165|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27960665|NCT04571060|81689095|FG000|Overall Study|Withdrawal by Subject|6|||
27960666|NCT04571060|81689096|FG001|Overall Study|Withdrawal by Subject|2|||
27960667|NCT04571060|81689095|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
27960668|NCT04571060|81689096|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
27960669|NCT02316353|81689097|FG000|Overall Study|Pregnancy|1|||
27960670|NCT02316353|81689098|FG001|Overall Study|Pregnancy|3|||
27960671|NCT02316353|81689097|FG000|Overall Study|Adverse Event|1|||
27960672|NCT02316353|81689098|FG001|Overall Study|Adverse Event|3|||
27960673|NCT02316353|81689097|FG000|Overall Study|Withdrawal by Subject|6|||
27960674|NCT02316353|81689098|FG001|Overall Study|Withdrawal by Subject|2|||
27960675|NCT01833494|81689106|FG000|Overall Study|Adverse Event|24|||
27960676|NCT01833494|81689106|FG000|Overall Study|Physician Decision|6|||
27960677|NCT01833494|81689106|FG000|Overall Study|Withdrawal by Subject|6|||
27960678|NCT01833494|81689106|FG000|Overall Study|Decrease in serum phosphorus|4|||
27960679|NCT01833494|81689106|FG000|Overall Study|Decrease in serum calcium|4|||
27562556|NCT02337907|80246297|FG001|Overall Study|Withdrawal by Subject|3|||
27960680|NCT01833494|81689106|FG000|Overall Study|Increase in serum ferritin|1|||
27960681|NCT03083665|81689107|FG000|Double-Blind Period|Adverse Event|5|||
27960682|NCT03083665|81689108|FG001|Double-Blind Period|Adverse Event|4|||
27960683|NCT03083665|81689109|FG002|Double-Blind Period|Adverse Event|5|||
27960684|NCT03083665|81689110|FG003|Double-Blind Period|Adverse Event|0|||
27960685|NCT03083665|81689111|FG004|Double-Blind Period|Adverse Event|0|||
27960686|NCT03083665|81689112|FG005|Double-Blind Period|Adverse Event|0|||
27960687|NCT03083665|81689107|FG000|Double-Blind Period|Lack of Efficacy|0|||
27960688|NCT03083665|81689108|FG001|Double-Blind Period|Lack of Efficacy|0|||
27960689|NCT03083665|81689109|FG002|Double-Blind Period|Lack of Efficacy|1|||
27960690|NCT03083665|81689110|FG003|Double-Blind Period|Lack of Efficacy|0|||
27960691|NCT03083665|81689111|FG004|Double-Blind Period|Lack of Efficacy|0|||
27960692|NCT03083665|81689112|FG005|Double-Blind Period|Lack of Efficacy|0|||
27960693|NCT03083665|81689107|FG000|Double-Blind Period|Protocol Violation|1|||
27960694|NCT03083665|81689108|FG001|Double-Blind Period|Protocol Violation|0|||
27960695|NCT03083665|81689109|FG002|Double-Blind Period|Protocol Violation|1|||
27960696|NCT03083665|81689110|FG003|Double-Blind Period|Protocol Violation|0|||
27960697|NCT03083665|81689111|FG004|Double-Blind Period|Protocol Violation|0|||
27960698|NCT03083665|81689112|FG005|Double-Blind Period|Protocol Violation|0|||
27960699|NCT03083665|81689107|FG000|Double-Blind Period|Lost to Follow-up|1|||
27859052|NCT02549027|81319166|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27859053|NCT02549027|81319167|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27859054|NCT02549027|81319168|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
27859055|NCT02549027|81319169|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
27859056|NCT00077857|81319175|FG000|Overall Study|Adverse Event|30|||
27859057|NCT00077857|81319176|FG001|Overall Study|Adverse Event|32|||
27859058|NCT00077857|81319175|FG000|Overall Study|Death|7|||
27859059|NCT00077857|81319176|FG001|Overall Study|Death|3|||
27960700|NCT03083665|81689108|FG001|Double-Blind Period|Lost to Follow-up|0|||
27960701|NCT03083665|81689109|FG002|Double-Blind Period|Lost to Follow-up|1|||
27960702|NCT03083665|81689110|FG003|Double-Blind Period|Lost to Follow-up|0|||
27960703|NCT03083665|81689111|FG004|Double-Blind Period|Lost to Follow-up|0|||
27960704|NCT03083665|81689112|FG005|Double-Blind Period|Lost to Follow-up|0|||
27960705|NCT03083665|81689107|FG000|Double-Blind Period|Withdrawal by Subject|3|||
27960706|NCT03083665|81689108|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27960707|NCT03083665|81689109|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27960708|NCT03083665|81689110|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27960709|NCT03083665|81689111|FG004|Double-Blind Period|Withdrawal by Subject|0|||
27960710|NCT03083665|81689112|FG005|Double-Blind Period|Withdrawal by Subject|0|||
27960711|NCT03083665|81689107|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
27960712|NCT03083665|81689108|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
27960713|NCT03083665|81689109|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
27960714|NCT03083665|81689110|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
27960715|NCT03083665|81689111|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
27960716|NCT03083665|81689112|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
27960717|NCT03083665|81689107|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
27960718|NCT03083665|81689108|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
27960719|NCT03083665|81689109|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
27960720|NCT03083665|81689110|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
27960721|NCT03083665|81689111|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
27960722|NCT03083665|81689112|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
27960723|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
27960724|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
27960725|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
27960726|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
27960727|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
27960728|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
27960729|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
27960730|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
27960731|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
27960732|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
27960733|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
27960734|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
27960735|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
27960736|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
27960737|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
27960738|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
27960739|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
27960740|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
27960741|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
27960742|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
27960743|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
27960744|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
27960745|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
27960746|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
27960747|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
27960748|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
27960749|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
27960750|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
27960751|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
27859060|NCT00077857|81319175|FG000|Overall Study|Insufficient therapeutic response|112|||
27859061|NCT00077857|81319176|FG001|Overall Study|Insufficient therapeutic response|128|||
27859062|NCT00077857|81319175|FG000|Overall Study|Violation of selection criteria at entry|3|||
27859063|NCT00077857|81319176|FG001|Overall Study|Violation of selection criteria at entry|1|||
27859064|NCT00077857|81319175|FG000|Overall Study|Other protocol violation|0|||
27859065|NCT00077857|81319176|FG001|Overall Study|Other protocol violation|1|||
27859066|NCT00077857|81319175|FG000|Overall Study|Refused treatment|29|||
27859067|NCT00077857|81319176|FG001|Overall Study|Refused treatment|21|||
27859068|NCT00077857|81319175|FG000|Overall Study|Failure to return|5|||
27859069|NCT00077857|81319176|FG001|Overall Study|Failure to return|5|||
27859070|NCT00077857|81319175|FG000|Overall Study|Other|15|||
27859071|NCT00077857|81319176|FG001|Overall Study|Other|13|||
27859072|NCT00721630|81319178|FG000|Overall Study|Participant found to be ineligible|1|||
27859073|NCT00936897|81319180|FG000|Overall Study|Withdrawal by Subject|9|||
27859074|NCT00936897|81319181|FG001|Overall Study|Withdrawal by Subject|19|||
27859075|NCT00936897|81319180|FG000|Overall Study|Adverse Event|4|||
27859076|NCT00936897|81319181|FG001|Overall Study|Adverse Event|13|||
27859077|NCT00936897|81319180|FG000|Overall Study|Other|3|||
27960752|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
27960753|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
27960754|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
27960755|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
27960756|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
27960757|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
27960758|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
27960759|NCT03083665|81689107|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
27960760|NCT03083665|81689108|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
27960761|NCT03083665|81689109|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
27960762|NCT03083665|81689110|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
27960763|NCT03083665|81689111|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
27960764|NCT03083665|81689112|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
27960765|NCT00819156|81689113|FG000|Overall Study|Adverse Event|1|||
27960766|NCT00819156|81689114|FG001|Overall Study|Adverse Event|4|||
27960767|NCT00819156|81689115|FG002|Overall Study|Adverse Event|2|||
27960768|NCT00819156|81689116|FG003|Overall Study|Adverse Event|1|||
27960769|NCT00819156|81689117|FG004|Overall Study|Adverse Event|2|||
27960770|NCT00819156|81689118|FG005|Overall Study|Adverse Event|3|||
27960771|NCT00819156|81689113|FG000|Overall Study|Withdrawal by Subject|0|||
27960772|NCT00819156|81689114|FG001|Overall Study|Withdrawal by Subject|3|||
27960773|NCT00819156|81689115|FG002|Overall Study|Withdrawal by Subject|2|||
27960774|NCT00819156|81689116|FG003|Overall Study|Withdrawal by Subject|0|||
27960775|NCT00819156|81689117|FG004|Overall Study|Withdrawal by Subject|1|||
27960776|NCT00819156|81689118|FG005|Overall Study|Withdrawal by Subject|0|||
27960777|NCT00819156|81689113|FG000|Overall Study|Protocol Violation|1|||
27960778|NCT00819156|81689114|FG001|Overall Study|Protocol Violation|0|||
27960779|NCT00819156|81689115|FG002|Overall Study|Protocol Violation|1|||
27960780|NCT00819156|81689116|FG003|Overall Study|Protocol Violation|0|||
27960781|NCT00819156|81689117|FG004|Overall Study|Protocol Violation|0|||
27960782|NCT00819156|81689118|FG005|Overall Study|Protocol Violation|1|||
27960783|NCT00819156|81689113|FG000|Overall Study|Lost to Follow-up|0|||
27960784|NCT00819156|81689114|FG001|Overall Study|Lost to Follow-up|1|||
27960785|NCT00819156|81689115|FG002|Overall Study|Lost to Follow-up|0|||
27960786|NCT00819156|81689116|FG003|Overall Study|Lost to Follow-up|0|||
27960787|NCT00819156|81689117|FG004|Overall Study|Lost to Follow-up|0|||
27960788|NCT00819156|81689118|FG005|Overall Study|Lost to Follow-up|2|||
27960789|NCT00819156|81689113|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
27960790|NCT00819156|81689114|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
27960791|NCT00819156|81689115|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
27960792|NCT00819156|81689116|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
27960793|NCT00819156|81689117|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
27960794|NCT00819156|81689118|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
27960795|NCT00819156|81689113|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
27960796|NCT00819156|81689114|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27960797|NCT00819156|81689115|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27960798|NCT00819156|81689116|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27960799|NCT00819156|81689117|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
27960800|NCT00819156|81689118|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
27960801|NCT00819156|81689113|FG000|Overall Study|Prostate-specific antigen progression|0|||
27960802|NCT00819156|81689114|FG001|Overall Study|Prostate-specific antigen progression|0|||
27960803|NCT00819156|81689115|FG002|Overall Study|Prostate-specific antigen progression|0|||
27960804|NCT00819156|81689116|FG003|Overall Study|Prostate-specific antigen progression|0|||
27960805|NCT00819156|81689117|FG004|Overall Study|Prostate-specific antigen progression|1|||
27960806|NCT00819156|81689118|FG005|Overall Study|Prostate-specific antigen progression|0|||
27960807|NCT00529243|81689120|FG000|Overall Study|Adverse Event|1|||
27960808|NCT00529243|81689120|FG000|Overall Study|Death|1|||
27960809|NCT00529243|81689120|FG000|Overall Study|Relocated|1|||
27960810|NCT03072043|81689121|FG000|Overall Study|Death|0|||
27960811|NCT03072043|81689122|FG001|Overall Study|Death|0|||
27960812|NCT03072043|81689123|FG002|Overall Study|Death|3|||
27960813|NCT03072043|81689121|FG000|Overall Study|Adverse Event|0|||
27960814|NCT03072043|81689122|FG001|Overall Study|Adverse Event|0|||
27960815|NCT03072043|81689123|FG002|Overall Study|Adverse Event|2|||
27960816|NCT03072043|81689121|FG000|Overall Study|Withdrawal by Subject|0|||
27960817|NCT03072043|81689122|FG001|Overall Study|Withdrawal by Subject|0|||
27960818|NCT03072043|81689123|FG002|Overall Study|Withdrawal by Subject|4|||
27960819|NCT04162470|81689124|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
27960820|NCT00194077|81689125|FG000|Overall Study|Lack of Efficacy|22|||
27960821|NCT00194077|81689126|FG001|Overall Study|Lack of Efficacy|29|||
27960822|NCT00194077|81689125|FG000|Overall Study|Study nonadherence|1|||
27960823|NCT00194077|81689126|FG001|Overall Study|Study nonadherence|0|||
27960824|NCT00194077|81689125|FG000|Overall Study|Withdrawal by Subject|1|||
27960825|NCT00194077|81689126|FG001|Overall Study|Withdrawal by Subject|1|||
27960826|NCT02567799|81689127|FG000|Concurrent Chemoradiotherapy|Death|1|||
27960827|NCT02567799|81689128|FG001|Concurrent Chemoradiotherapy|Death|0|||
27859078|NCT00936897|81319181|FG001|Overall Study|Other|9|||
27859079|NCT00936897|81319180|FG000|Overall Study|Lost to Follow-up|1|||
27562557|NCT02337907|80246298|FG002|Overall Study|Withdrawal by Subject|0|||
27562558|NCT02337907|80246299|FG003|Overall Study|Withdrawal by Subject|2|||
27562559|NCT02337907|80246300|FG004|Overall Study|Withdrawal by Subject|5|||
27562560|NCT02337907|80246301|FG005|Overall Study|Withdrawal by Subject|0|||
27562561|NCT02337907|80246296|FG000|Overall Study|Lost to Follow-up|0|||
27562562|NCT02337907|80246297|FG001|Overall Study|Lost to Follow-up|0|||
27562563|NCT02337907|80246298|FG002|Overall Study|Lost to Follow-up|0|||
27562564|NCT02337907|80246299|FG003|Overall Study|Lost to Follow-up|0|||
27562565|NCT02337907|80246300|FG004|Overall Study|Lost to Follow-up|0|||
27562566|NCT02337907|80246301|FG005|Overall Study|Lost to Follow-up|1|||
27562567|NCT02337907|80246296|FG000|Overall Study|Adverse Event|1|||
27562568|NCT02337907|80246297|FG001|Overall Study|Adverse Event|1|||
27562569|NCT02337907|80246298|FG002|Overall Study|Adverse Event|1|||
27562570|NCT02337907|80246299|FG003|Overall Study|Adverse Event|1|||
27562571|NCT02337907|80246300|FG004|Overall Study|Adverse Event|4|||
27562572|NCT02337907|80246301|FG005|Overall Study|Adverse Event|0|||
27562573|NCT02750592|80246302|FG000|Overall Study|Adverse Event|3|||
27859080|NCT00936897|81319181|FG001|Overall Study|Lost to Follow-up|10|||
27859081|NCT00936897|81319180|FG000|Overall Study|Administrative Decision|1|||
27859082|NCT00936897|81319181|FG001|Overall Study|Administrative Decision|2|||
27859083|NCT00936897|81319180|FG000|Overall Study|Protocol Violation|1|||
27859084|NCT00936897|81319181|FG001|Overall Study|Protocol Violation|1|||
27859085|NCT00936897|81319180|FG000|Overall Study|Ineligibility Determined|0|||
27960828|NCT02567799|81689129|FG002|Concurrent Chemoradiotherapy|Death|0|||
27960829|NCT02567799|81689127|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
27960830|NCT02567799|81689128|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
27960831|NCT02567799|81689129|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
27960832|NCT02567799|81689127|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
27960833|NCT02567799|81689128|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
27960834|NCT02567799|81689129|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
27960835|NCT02567799|81689127|FG000|Follow-up|Death|1|||
27960836|NCT02567799|81689128|FG001|Follow-up|Death|0|||
27960837|NCT02567799|81689129|FG002|Follow-up|Death|1|||
27960838|NCT02567799|81689127|FG000|Follow-up|Progressive Disease|1|||
27960839|NCT02567799|81689128|FG001|Follow-up|Progressive Disease|1|||
27562574|NCT02750592|80246302|FG000|Overall Study|Lack of Efficacy|2|||
27562575|NCT02081690|80246303|FG000|Overall Study|Death|3|||
27562576|NCT02081690|80246303|FG000|Overall Study|Physician Decision|3|||
27859086|NCT00936897|81319181|FG001|Overall Study|Ineligibility Determined|3|||
27859087|NCT00936897|81319180|FG000|Overall Study|Noncompliance|0|||
27859088|NCT00936897|81319181|FG001|Overall Study|Noncompliance|2|||
27859089|NCT00936897|81319180|FG000|Overall Study|Death|0|||
27859090|NCT00936897|81319181|FG001|Overall Study|Death|1|||
27859091|NCT00886288|81319187|FG000|Overall Study|no respect of the 12 weeks period|657|||
27859092|NCT00886288|81319188|FG001|Overall Study|no respect of the 12 weeks period|227|||
27859093|NCT00886288|81319187|FG000|Overall Study|Lost to Follow-up|86|||
27859094|NCT00886288|81319188|FG001|Overall Study|Lost to Follow-up|0|||
27859095|NCT01140503|81319189|FG000|Overall Study|Withdrawal by Subject|1|||
27859096|NCT01377987|81319190|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
27859097|NCT01377987|81319191|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
27859098|NCT04345601|81319192|FG000|Overall Study|Death|0|||
27859099|NCT04345601|81319193|FG001|Overall Study|Death|3|||
27859100|NCT04345601|81319194|FG002|Overall Study|Death|2|||
27859101|NCT04345601|81319192|FG000|Overall Study|Lost to Follow-up|0|||
27859102|NCT04345601|81319193|FG001|Overall Study|Lost to Follow-up|0|||
27859103|NCT04345601|81319194|FG002|Overall Study|Lost to Follow-up|2|||
27859104|NCT00090610|81319197|FG000|Overall Study|Withdrawal by Subject|1|||
27859105|NCT00090610|81319198|FG001|Overall Study|Withdrawal by Subject|1|||
27562577|NCT02081690|80246303|FG000|Overall Study|Withdrawal by Subject|1|||
27859106|NCT04428333|81319199|FG000|Overall Study|Physician Decision|5|||
27960840|NCT02567799|81689129|FG002|Follow-up|Progressive Disease|3|||
27960841|NCT00787839|81689130|FG000|Overall Study|Failure to have the OGTT was most common|404|||
27960842|NCT02079909|81689131|FG000|Overall Study|Adverse Event|23|||
27859107|NCT04428333|81319200|FG001|Overall Study|Physician Decision|6|||
27960843|NCT02079909|81689132|FG001|Overall Study|Adverse Event|23|||
27859108|NCT04428333|81319199|FG000|Overall Study|Withdrawal by Subject|1|||
27859109|NCT04428333|81319200|FG001|Overall Study|Withdrawal by Subject|3|||
27859110|NCT04428333|81319199|FG000|Overall Study|Study Terminated By Sponsor|14|||
27859111|NCT04428333|81319200|FG001|Overall Study|Study Terminated By Sponsor|16|||
27859112|NCT03786718|81319233|FG000|Overall Study|Lost to Follow-up|3|||
27859113|NCT03786718|81319233|FG000|Overall Study|Withdrawal by Subject|1|||
27859114|NCT03786718|81319233|FG000|Overall Study|Did not use the intervention|2|||
27859115|NCT03786718|81319233|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
27859116|NCT03825341|81319242|FG000|Overall Study|Withdrawal by Subject|0|||
27859117|NCT03825341|81319243|FG001|Overall Study|Withdrawal by Subject|1|||
27859118|NCT04933968|81319244|FG000|Overall Study|Adverse Event|0|||
27859119|NCT04933968|81319245|FG001|Overall Study|Adverse Event|0|||
27859120|NCT04933968|81319246|FG002|Overall Study|Adverse Event|1|||
27859121|NCT04933968|81319247|FG003|Overall Study|Adverse Event|1|||
27859122|NCT04933968|81319248|FG004|Overall Study|Adverse Event|0|||
27859123|NCT04933968|81319249|FG005|Overall Study|Adverse Event|0|||
27859124|NCT04933968|81319244|FG000|Overall Study|Lost to Follow-up|1|||
27859125|NCT04933968|81319245|FG001|Overall Study|Lost to Follow-up|0|||
27859126|NCT04933968|81319246|FG002|Overall Study|Lost to Follow-up|1|||
27859127|NCT04933968|81319247|FG003|Overall Study|Lost to Follow-up|0|||
27859128|NCT04933968|81319248|FG004|Overall Study|Lost to Follow-up|0|||
27859129|NCT04933968|81319249|FG005|Overall Study|Lost to Follow-up|0|||
27859130|NCT04933968|81319244|FG000|Overall Study|Randomized not treated|1|||
27859131|NCT04933968|81319245|FG001|Overall Study|Randomized not treated|0|||
27859132|NCT04933968|81319246|FG002|Overall Study|Randomized not treated|0|||
27859133|NCT04933968|81319247|FG003|Overall Study|Randomized not treated|0|||
27859134|NCT04933968|81319248|FG004|Overall Study|Randomized not treated|0|||
27859135|NCT04933968|81319249|FG005|Overall Study|Randomized not treated|0|||
27859136|NCT04933968|81319244|FG000|Overall Study|Sponsor terminated study|0|||
27859137|NCT04933968|81319245|FG001|Overall Study|Sponsor terminated study|0|||
27859138|NCT04933968|81319246|FG002|Overall Study|Sponsor terminated study|0|||
27859139|NCT04933968|81319247|FG003|Overall Study|Sponsor terminated study|1|||
27859140|NCT04933968|81319248|FG004|Overall Study|Sponsor terminated study|2|||
27859141|NCT04933968|81319249|FG005|Overall Study|Sponsor terminated study|0|||
27859142|NCT04933968|81319244|FG000|Overall Study|Other|0|||
27859143|NCT04933968|81319245|FG001|Overall Study|Other|0|||
27859144|NCT04933968|81319246|FG002|Overall Study|Other|0|||
27859145|NCT04933968|81319247|FG003|Overall Study|Other|1|||
27859146|NCT04933968|81319248|FG004|Overall Study|Other|0|||
27859147|NCT04933968|81319249|FG005|Overall Study|Other|0|||
27859148|NCT04933968|81319244|FG000|Overall Study|Missing|1|||
27859149|NCT04933968|81319245|FG001|Overall Study|Missing|3|||
27859150|NCT04933968|81319246|FG002|Overall Study|Missing|2|||
27859151|NCT04933968|81319247|FG003|Overall Study|Missing|1|||
27859152|NCT04933968|81319248|FG004|Overall Study|Missing|1|||
27859153|NCT04933968|81319249|FG005|Overall Study|Missing|0|||
27859154|NCT03866902|81319252|FG000|Overall Study|Lost to Follow-up|98|||
27859155|NCT03866902|81319253|FG001|Overall Study|Lost to Follow-up|82|||
27859156|NCT03866902|81319252|FG000|Overall Study|Pregnancy|18|||
27859157|NCT03866902|81319253|FG001|Overall Study|Pregnancy|24|||
27859158|NCT01320150|81319255|FG000|Overall Study|Protocol Violation|15|||
27859159|NCT01320150|81319255|FG000|Overall Study|Withdrawal by Subject|5|||
27859160|NCT01320150|81319255|FG000|Overall Study|Death|2|||
27859161|NCT01320150|81319255|FG000|Overall Study|Lost to Follow-up|44|||
27859162|NCT04594707|81319256|FG000|Overall Study|Adverse Event|0|||
27859163|NCT04594707|81319257|FG001|Overall Study|Adverse Event|0|||
27859164|NCT04594707|81319258|FG002|Overall Study|Adverse Event|1|||
27859165|NCT04594707|81319256|FG000|Overall Study|Death|0|||
27960844|NCT02079909|81689133|FG002|Overall Study|Adverse Event|7|||
27960845|NCT02079909|81689131|FG000|Overall Study|Withdrawal by Subject|9|||
27960846|NCT02079909|81689132|FG001|Overall Study|Withdrawal by Subject|17|||
27960847|NCT02079909|81689133|FG002|Overall Study|Withdrawal by Subject|4|||
27960848|NCT02079909|81689131|FG000|Overall Study|Lost to Follow-up|2|||
27960849|NCT02079909|81689132|FG001|Overall Study|Lost to Follow-up|3|||
27960850|NCT02079909|81689133|FG002|Overall Study|Lost to Follow-up|1|||
27960851|NCT02079909|81689131|FG000|Overall Study|Death|2|||
27960852|NCT02079909|81689132|FG001|Overall Study|Death|2|||
27960853|NCT02079909|81689133|FG002|Overall Study|Death|0|||
27960854|NCT02079909|81689131|FG000|Overall Study|Lack of Efficacy|0|||
27960855|NCT02079909|81689132|FG001|Overall Study|Lack of Efficacy|0|||
27960856|NCT02079909|81689133|FG002|Overall Study|Lack of Efficacy|1|||
27960857|NCT02079909|81689131|FG000|Overall Study|Protocol Violation|0|||
27960858|NCT02079909|81689132|FG001|Overall Study|Protocol Violation|1|||
27960859|NCT02079909|81689133|FG002|Overall Study|Protocol Violation|1|||
27960860|NCT02079909|81689131|FG000|Overall Study|Physician Decision|0|||
27960861|NCT02079909|81689132|FG001|Overall Study|Physician Decision|1|||
27960862|NCT02079909|81689133|FG002|Overall Study|Physician Decision|1|||
27960863|NCT02079909|81689131|FG000|Overall Study|Relocation etc.|2|||
27960864|NCT02079909|81689132|FG001|Overall Study|Relocation etc.|2|||
27859166|NCT04594707|81319257|FG001|Overall Study|Death|2|||
27960865|NCT02079909|81689133|FG002|Overall Study|Relocation etc.|3|||
27960866|NCT00703963|81689134|FG000|Overall Study|Withdrawal by Subject|7|||
27960867|NCT00703963|81689135|FG001|Overall Study|Withdrawal by Subject|13|||
27960868|NCT00703963|81689134|FG000|Overall Study|Physician Decision|0|||
27960869|NCT00703963|81689135|FG001|Overall Study|Physician Decision|1|||
27960870|NCT01063062|81689139|FG000|Overall Study|Patient withdrew consent|0|||
27960871|NCT01063062|81689140|FG001|Overall Study|Patient withdrew consent|1|||
27960872|NCT01063062|81689139|FG000|Overall Study|Adverse Event|2|||
27960873|NCT01063062|81689140|FG001|Overall Study|Adverse Event|4|||
27960874|NCT01063062|81689139|FG000|Overall Study|Protocol Violation|5|||
27960875|NCT01063062|81689140|FG001|Overall Study|Protocol Violation|4|||
27960876|NCT01063062|81689139|FG000|Overall Study|Investigator's request|1|||
27960877|NCT01063062|81689140|FG001|Overall Study|Investigator's request|0|||
27960878|NCT01063062|81689139|FG000|Overall Study|Lost to Follow-up|0|||
27960879|NCT01063062|81689140|FG001|Overall Study|Lost to Follow-up|2|||
27960880|NCT01063062|81689139|FG000|Overall Study|Miscellaneous reason|0|||
27960881|NCT01063062|81689140|FG001|Overall Study|Miscellaneous reason|1|||
27960882|NCT01970241|81689141|FG000|Overall Study|Withdrawal by Subject|2|||
27960883|NCT01970241|81689142|FG001|Overall Study|Withdrawal by Subject|0|||
27960884|NCT01970241|81689141|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
27960885|NCT01970241|81689142|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
27960886|NCT03462641|81689145|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
27960887|NCT03462641|81689146|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
27960888|NCT03462641|81689145|FG000|Visit 2|Withdrawal by Subject|0|||
27960889|NCT03462641|81689146|FG001|Visit 2|Withdrawal by Subject|1|||
27960890|NCT01696773|81689154|FG000|Days 15-27, Washout|Adverse Event|1|||
27960891|NCT01696773|81689155|FG001|Days 15-27, Washout|Adverse Event|0|||
27960892|NCT00075764|81689156|FG000|Overall Study|Adverse Event|5|||
27960893|NCT00075764|81689157|FG001|Overall Study|Adverse Event|12|||
27960894|NCT00075764|81689156|FG000|Overall Study|Death|4|||
27960895|NCT00075764|81689157|FG001|Overall Study|Death|8|||
27960896|NCT00075764|81689156|FG000|Overall Study|Withdrawal by Subject|28|||
27960897|NCT00075764|81689157|FG001|Overall Study|Withdrawal by Subject|18|||
27960898|NCT00075764|81689156|FG000|Overall Study|Progression|269|||
27960899|NCT00075764|81689157|FG001|Overall Study|Progression|274|||
27960900|NCT00075764|81689156|FG000|Overall Study|Still on treatment|8|||
27960901|NCT00075764|81689157|FG001|Overall Study|Still on treatment|15|||
27960902|NCT00075764|81689156|FG000|Overall Study|Delinquent|4|||
27562578|NCT00878709|80246306|FG000|Overall Study|Withdrawal by Subject|197|||
27960903|NCT00075764|81689157|FG001|Overall Study|Delinquent|2|||
27960904|NCT00075764|81689156|FG000|Overall Study|Not protocol specified|27|||
27960905|NCT00075764|81689157|FG001|Overall Study|Not protocol specified|19|||
27960906|NCT00075764|81689156|FG000|Overall Study|Under review|0|||
27960907|NCT00075764|81689157|FG001|Overall Study|Under review|1|||
27960908|NCT03981744|81689161|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
27960909|NCT03981744|81689162|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
27960910|NCT03981744|81689163|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
27960911|NCT03981744|81689164|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
27960912|NCT03981744|81689161|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
27960913|NCT03981744|81689162|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
27960914|NCT03981744|81689163|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
27960915|NCT03981744|81689164|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
27960916|NCT03981744|81689161|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
27960917|NCT03981744|81689162|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
27960918|NCT03981744|81689163|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
27960919|NCT03981744|81689164|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
27562579|NCT00878709|80246307|FG001|Overall Study|Withdrawal by Subject|120|||
27960920|NCT01333722|81689165|FG000|Overall Study|Lack of Efficacy|0|||
27960921|NCT01333722|81689166|FG001|Overall Study|Lack of Efficacy|2|||
27960922|NCT01333722|81689165|FG000|Overall Study|Withdrawal by Subject|0|||
27960923|NCT01333722|81689166|FG001|Overall Study|Withdrawal by Subject|1|||
27960924|NCT00556439|81689167|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
27960925|NCT00556439|81689168|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
27960926|NCT00556439|81689169|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
27960927|NCT00556439|81689170|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
27960928|NCT00556439|81689167|FG000|Study Entry to Week 12|Physician Decision|1|||
27960929|NCT00556439|81689168|FG001|Study Entry to Week 12|Physician Decision|0|||
27960930|NCT00556439|81689169|FG002|Study Entry to Week 12|Physician Decision|0|||
27960931|NCT00556439|81689170|FG003|Study Entry to Week 12|Physician Decision|0|||
27562580|NCT00878709|80246306|FG000|Overall Study|Lost to Follow-up|35|||
27960932|NCT00556439|81689167|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
27960933|NCT00556439|81689168|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
27960934|NCT00556439|81689169|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
27960935|NCT00556439|81689170|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
27960936|NCT00556439|81689167|FG000|Study Entry to Week 12|Recurrent infection|1|||
27960937|NCT00556439|81689168|FG001|Study Entry to Week 12|Recurrent infection|0|||
27960938|NCT00556439|81689169|FG002|Study Entry to Week 12|Recurrent infection|0|||
27960939|NCT00556439|81689170|FG003|Study Entry to Week 12|Recurrent infection|0|||
27960940|NCT00556439|81689167|FG000|Study Entry to Week 12|Malignancy|0|||
27960941|NCT00556439|81689168|FG001|Study Entry to Week 12|Malignancy|0|||
27960942|NCT00556439|81689169|FG002|Study Entry to Week 12|Malignancy|1|||
27960943|NCT00556439|81689170|FG003|Study Entry to Week 12|Malignancy|0|||
27960944|NCT00556439|81689167|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
27960945|NCT00556439|81689168|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
27960946|NCT00556439|81689169|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
27960947|NCT00556439|81689170|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
27960948|NCT00556439|81689167|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
27960949|NCT00556439|81689168|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
27960950|NCT00556439|81689169|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
27960951|NCT00556439|81689170|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
27960952|NCT00556439|81689167|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
27960953|NCT00556439|81689168|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
27960954|NCT00556439|81689169|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
27960955|NCT00556439|81689170|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
27960956|NCT00556439|81689167|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
27960957|NCT00556439|81689168|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
27960958|NCT00556439|81689169|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
27960959|NCT00556439|81689170|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
27960960|NCT02151786|81689174|FG000|Overall Study|Unavailability of Case Report Form|26|||
27960961|NCT02151786|81689174|FG000|Overall Study|Outside the Contract Period|1|||
27960962|NCT02151786|81689174|FG000|Overall Study|Randomized, not Treated|1|||
27960963|NCT02151786|81689174|FG000|Overall Study|Unavailability of Information|8|||
27960964|NCT02819297|81689175|FG000|Overall Study|Withdrawal by Subject|25|||
27960965|NCT02819297|81689176|FG001|Overall Study|Withdrawal by Subject|13|||
27960966|NCT02819297|81689175|FG000|Overall Study|Lost to Follow-up|12|||
27960967|NCT02819297|81689176|FG001|Overall Study|Lost to Follow-up|14|||
27960968|NCT02819297|81689175|FG000|Overall Study|Adverse Event|12|||
27960969|NCT02819297|81689176|FG001|Overall Study|Adverse Event|10|||
27960970|NCT02819297|81689175|FG000|Overall Study|Physician Decision|5|||
27960971|NCT02819297|81689176|FG001|Overall Study|Physician Decision|5|||
27960972|NCT02819297|81689175|FG000|Overall Study|Lack of Efficacy|5|||
27960973|NCT02819297|81689176|FG001|Overall Study|Lack of Efficacy|8|||
27960974|NCT02819297|81689175|FG000|Overall Study|Protocol Violation|1|||
27960975|NCT02819297|81689176|FG001|Overall Study|Protocol Violation|2|||
27960976|NCT00135330|81689177|FG000|Overall Study|Adverse Event|2|||
27960977|NCT00135330|81689178|FG001|Overall Study|Adverse Event|5|||
27960978|NCT00135330|81689179|FG002|Overall Study|Adverse Event|1|||
27960979|NCT00135330|81689177|FG000|Overall Study|Lost to Follow-up|0|||
27960980|NCT00135330|81689178|FG001|Overall Study|Lost to Follow-up|2|||
27960981|NCT00135330|81689179|FG002|Overall Study|Lost to Follow-up|3|||
27960982|NCT00135330|81689177|FG000|Overall Study|Physician Decision|1|||
27960983|NCT00135330|81689178|FG001|Overall Study|Physician Decision|1|||
27960984|NCT00135330|81689179|FG002|Overall Study|Physician Decision|0|||
27960985|NCT00135330|81689177|FG000|Overall Study|Protocol Violation|4|||
27960986|NCT00135330|81689178|FG001|Overall Study|Protocol Violation|3|||
27960987|NCT00135330|81689179|FG002|Overall Study|Protocol Violation|3|||
27960988|NCT00135330|81689177|FG000|Overall Study|Patient Decision|5|||
27960989|NCT00135330|81689178|FG001|Overall Study|Patient Decision|1|||
27960990|NCT00135330|81689179|FG002|Overall Study|Patient Decision|4|||
27960991|NCT00135330|81689177|FG000|Overall Study|Sponsor Decision|0|||
27960992|NCT00135330|81689178|FG001|Overall Study|Sponsor Decision|1|||
27960993|NCT00135330|81689179|FG002|Overall Study|Sponsor Decision|0|||
27960994|NCT00325130|81689182|FG000|Overall Study|Lost to Follow-up|6|||
27960995|NCT00325130|81689183|FG001|Overall Study|Lost to Follow-up|14|||
27960996|NCT00325130|81689182|FG000|Overall Study|Withdrawal by Subject|12|||
27960997|NCT00325130|81689183|FG001|Overall Study|Withdrawal by Subject|14|||
27960998|NCT00325130|81689182|FG000|Overall Study|Protocol Deviation|0|||
27960999|NCT00325130|81689183|FG001|Overall Study|Protocol Deviation|1|||
27961000|NCT00325130|81689182|FG000|Overall Study|Moved|0|||
27961001|NCT00325130|81689183|FG001|Overall Study|Moved|1|||
27961002|NCT00325130|81689182|FG000|Overall Study|Patient Discontinued for Other|1|||
27961003|NCT00325130|81689183|FG001|Overall Study|Patient Discontinued for Other|0|||
27562581|NCT00878709|80246307|FG001|Overall Study|Lost to Follow-up|33|||
27961004|NCT04721158|81689184|FG000|Overall Study|Lost to Follow-up|4|||
27961005|NCT04721158|81689184|FG000|Overall Study|Device did not connect|1|||
27961006|NCT03472495|81689188|FG000|Overall Study|Treatment no longer indicated|1|||
27961007|NCT03472495|81689189|FG001|Overall Study|Treatment no longer indicated|2|||
27961008|NCT03472495|81689188|FG000|Overall Study|Physician Decision|0|||
27961009|NCT03472495|81689189|FG001|Overall Study|Physician Decision|2|||
27961010|NCT01766037|81689195|FG000|Overall Study|Adverse Event|1|||
27961011|NCT01766037|81689196|FG001|Overall Study|Adverse Event|0|||
27961012|NCT01766037|81689195|FG000|Overall Study|Lack of Efficacy|1|||
27961013|NCT01766037|81689196|FG001|Overall Study|Lack of Efficacy|0|||
27961014|NCT01766037|81689195|FG000|Overall Study|Lost to Follow-up|0|||
27961015|NCT01766037|81689196|FG001|Overall Study|Lost to Follow-up|10|||
27961016|NCT01766037|81689195|FG000|Overall Study|Physician Decision|0|||
27961017|NCT01766037|81689196|FG001|Overall Study|Physician Decision|1|||
27961018|NCT01766037|81689195|FG000|Overall Study|Withdrawal by Subject|18|||
27961019|NCT01766037|81689196|FG001|Overall Study|Withdrawal by Subject|16|||
27961020|NCT01766037|81689195|FG000|Overall Study|Moved from area|5|||
27961021|NCT01766037|81689196|FG001|Overall Study|Moved from area|0|||
27961022|NCT01766037|81689195|FG000|Overall Study|medical - unrelated|1|||
27961023|NCT01766037|81689196|FG001|Overall Study|medical - unrelated|2|||
27961024|NCT01766037|81689195|FG000|Overall Study|nausea / discomfort|3|||
27961025|NCT01766037|81689196|FG001|Overall Study|nausea / discomfort|0|||
27961026|NCT01665911|81689199|FG000|Overall Study|Protocol Violation|4|||
27961027|NCT01665911|81689199|FG000|Overall Study|Withdrawal by Subject|1|||
27961028|NCT01665911|81689199|FG000|Overall Study|Adverse Event|1|||
27961029|NCT04396795|81689203|FG000|Month 1|Lost to Follow-up|2|||
27961030|NCT04396795|81689204|FG001|Month 1|Lost to Follow-up|3|||
27961031|NCT04396795|81689203|FG000|Month 3|Lost to Follow-up|1|||
27961032|NCT04396795|81689204|FG001|Month 3|Lost to Follow-up|3|||
27961033|NCT04396795|81689203|FG000|Month 6|Lost to Follow-up|3|||
27961034|NCT04396795|81689204|FG001|Month 6|Lost to Follow-up|3|||
27961035|NCT01664247|81689210|FG000|Overall Study|Adverse Event|5|||
27961036|NCT01664247|81689211|FG001|Overall Study|Adverse Event|3|||
27961037|NCT01664247|81689210|FG000|Overall Study|Protocol Violation|3|||
27961038|NCT01664247|81689211|FG001|Overall Study|Protocol Violation|5|||
27961039|NCT01664247|81689210|FG000|Overall Study|Withdrawal Criteria|1|||
27961040|NCT01664247|81689211|FG001|Overall Study|Withdrawal Criteria|4|||
27961041|NCT01664247|81689210|FG000|Overall Study|Unclassified|5|||
27961042|NCT01664247|81689211|FG001|Overall Study|Unclassified|29|||
27961043|NCT00690794|81689212|FG000|Overall Study|Adverse Event|12|||
27961044|NCT00690794|81689213|FG001|Overall Study|Adverse Event|10|||
27961045|NCT00690794|81689212|FG000|Overall Study|Lost to Follow-up|1|||
27961046|NCT00690794|81689213|FG001|Overall Study|Lost to Follow-up|4|||
27961047|NCT00690794|81689212|FG000|Overall Study|Withdrawal by Subject|0|||
27961048|NCT00690794|81689213|FG001|Overall Study|Withdrawal by Subject|9|||
27961049|NCT00690794|81689212|FG000|Overall Study|Protocol Violation|6|||
27961050|NCT00690794|81689213|FG001|Overall Study|Protocol Violation|7|||
27961051|NCT00690794|81689212|FG000|Overall Study|Noncompliance|1|||
27961052|NCT00690794|81689213|FG001|Overall Study|Noncompliance|2|||
27961053|NCT00690794|81689212|FG000|Overall Study|Other not specified|1|||
27961054|NCT00690794|81689213|FG001|Overall Study|Other not specified|3|||
27961055|NCT00078806|81689215|FG000|Part 1A|Adverse Event|2|||
27961056|NCT00078806|81689216|FG001|Part 1A|Adverse Event|0|||
27961057|NCT00078806|81689217|FG002|Part 1A|Adverse Event|0|||
27961058|NCT00078806|81689218|FG003|Part 1A|Adverse Event|0|||
27961059|NCT00078806|81689215|FG000|Part 1A|Lack of Efficacy|7|||
27961060|NCT00078806|81689216|FG001|Part 1A|Lack of Efficacy|0|||
27961061|NCT00078806|81689217|FG002|Part 1A|Lack of Efficacy|0|||
27961062|NCT00078806|81689218|FG003|Part 1A|Lack of Efficacy|0|||
27961063|NCT00078806|81689215|FG000|Part 1A|Other|1|||
27961064|NCT00078806|81689216|FG001|Part 1A|Other|0|||
27961065|NCT00078806|81689217|FG002|Part 1A|Other|0|||
27961066|NCT00078806|81689218|FG003|Part 1A|Other|0|||
27961067|NCT00078806|81689215|FG000|Part 1B|Adverse Event|1|||
27961068|NCT00078806|81689216|FG001|Part 1B|Adverse Event|0|||
27961069|NCT00078806|81689217|FG002|Part 1B|Adverse Event|0|||
27562582|NCT00878709|80246306|FG000|Overall Study|Other Reasons|93|||
27961070|NCT00078806|81689218|FG003|Part 1B|Adverse Event|0|||
27961071|NCT00078806|81689215|FG000|Part 1B|Lack of Efficacy|7|||
27961072|NCT00078806|81689216|FG001|Part 1B|Lack of Efficacy|0|||
27961073|NCT00078806|81689217|FG002|Part 1B|Lack of Efficacy|0|||
27961074|NCT00078806|81689218|FG003|Part 1B|Lack of Efficacy|0|||
27961075|NCT00078806|81689215|FG000|Part 2|Adverse Event|0|||
27961076|NCT00078806|81689216|FG001|Part 2|Adverse Event|1|||
27961077|NCT00078806|81689217|FG002|Part 2|Adverse Event|0|||
27961078|NCT00078806|81689218|FG003|Part 2|Adverse Event|0|||
27961079|NCT03122145|81689220|FG000|Overall Study|Concurrent respiratory disease|3|||
27961080|NCT03122145|81689221|FG001|Overall Study|Concurrent respiratory disease|0|||
27961081|NCT01973231|81689222|FG000|Overall Study|Protocol Violation|1|||
27961082|NCT01973231|81689223|FG001|Overall Study|Protocol Violation|1|||
27961083|NCT01973231|81689222|FG000|Overall Study|Lost to Follow-up|1|||
27961084|NCT01973231|81689223|FG001|Overall Study|Lost to Follow-up|1|||
27961085|NCT01973231|81689222|FG000|Overall Study|unclassified|2|||
27961086|NCT01973231|81689223|FG001|Overall Study|unclassified|1|||
27961087|NCT01973231|81689222|FG000|Overall Study|Withdrawal by Subject|7|||
27961088|NCT01973231|81689223|FG001|Overall Study|Withdrawal by Subject|9|||
27961089|NCT03036852|81689233|FG000|Overall Study|Death|2|||
27961090|NCT03036852|81689233|FG000|Overall Study|Lack of Efficacy|2|||
27961091|NCT03036852|81689233|FG000|Overall Study|Adverse Event|1|||
27961092|NCT03036852|81689233|FG000|Overall Study|Lost to Follow-up|1|||
27961093|NCT00771927|81689242|FG000|Overall Study|Adverse Event|100|||
27961094|NCT00771927|81689243|FG001|Overall Study|Adverse Event|105|||
27961095|NCT00771927|81689242|FG000|Overall Study|Lack of Efficacy|70|||
27961096|NCT00771927|81689243|FG001|Overall Study|Lack of Efficacy|42|||
27961097|NCT00771927|81689242|FG000|Overall Study|Lost to Follow-up|46|||
27961098|NCT00771927|81689243|FG001|Overall Study|Lost to Follow-up|46|||
27961099|NCT00771927|81689242|FG000|Overall Study|Withdrawal by Subject|16|||
27961100|NCT00771927|81689243|FG001|Overall Study|Withdrawal by Subject|17|||
27961101|NCT00771927|81689242|FG000|Overall Study|Other reason|23|||
27961102|NCT00771927|81689243|FG001|Overall Study|Other reason|27|||
27961103|NCT02676895|81689244|FG000|Overall Study|Administrative reason|1|||
27961104|NCT02676895|81689245|FG001|Overall Study|Administrative reason|0|||
27961105|NCT02676895|81689246|FG002|Overall Study|Administrative reason|0|||
27961106|NCT02676895|81689244|FG000|Overall Study|Protocol Violation|1|||
27961107|NCT02676895|81689245|FG001|Overall Study|Protocol Violation|0|||
27961108|NCT02676895|81689246|FG002|Overall Study|Protocol Violation|0|||
27961109|NCT02676895|81689244|FG000|Overall Study|Adverse Event|0|||
27961110|NCT02676895|81689245|FG001|Overall Study|Adverse Event|3|||
27961111|NCT02676895|81689246|FG002|Overall Study|Adverse Event|1|||
27961112|NCT02676895|81689244|FG000|Overall Study|Lost to Follow-up|0|||
27961113|NCT02676895|81689245|FG001|Overall Study|Lost to Follow-up|0|||
27961114|NCT02676895|81689246|FG002|Overall Study|Lost to Follow-up|1|||
27961115|NCT02676895|81689244|FG000|Overall Study|Withdrawal by Subject|0|||
27961116|NCT02676895|81689245|FG001|Overall Study|Withdrawal by Subject|0|||
27961117|NCT02676895|81689246|FG002|Overall Study|Withdrawal by Subject|1|||
27961118|NCT01063348|81689251|FG000|Overall Study|Lost to Follow-up|3|||
27961119|NCT01063348|81689252|FG001|Overall Study|Lost to Follow-up|10|||
27961120|NCT01815424|81689253|FG000|Week 0 to 16|Adverse Event|1|||
27961121|NCT01815424|81689254|FG001|Week 0 to 16|Adverse Event|3|||
27961122|NCT01815424|81689255|FG002|Week 0 to 16|Adverse Event|3|||
27961123|NCT01815424|81689256|FG003|Week 0 to 16|Adverse Event|0|||
27961124|NCT01815424|81689257|FG004|Week 0 to 16|Adverse Event|0|||
27961125|NCT01815424|81689253|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
27961126|NCT01815424|81689254|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27961127|NCT01815424|81689255|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27961128|NCT01815424|81689256|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27961129|NCT01815424|81689257|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
27961130|NCT01815424|81689253|FG000|Week 0 to 16|Lost to Follow-up|0|||
27961131|NCT01815424|81689254|FG001|Week 0 to 16|Lost to Follow-up|1|||
27961132|NCT01815424|81689255|FG002|Week 0 to 16|Lost to Follow-up|0|||
27961133|NCT01815424|81689256|FG003|Week 0 to 16|Lost to Follow-up|0|||
27961134|NCT01815424|81689257|FG004|Week 0 to 16|Lost to Follow-up|0|||
27961135|NCT01815424|81689253|FG000|Week 0 to 16|Withdrawal by Subject|0|||
27961136|NCT01815424|81689254|FG001|Week 0 to 16|Withdrawal by Subject|0|||
27961137|NCT01815424|81689255|FG002|Week 0 to 16|Withdrawal by Subject|1|||
27961138|NCT01815424|81689256|FG003|Week 0 to 16|Withdrawal by Subject|0|||
27961139|NCT01815424|81689257|FG004|Week 0 to 16|Withdrawal by Subject|0|||
27961140|NCT01815424|81689253|FG000|Week 0 to 16|Other|1|||
27961141|NCT01815424|81689254|FG001|Week 0 to 16|Other|0|||
27961142|NCT01815424|81689255|FG002|Week 0 to 16|Other|3|||
27961143|NCT01815424|81689256|FG003|Week 0 to 16|Other|0|||
27961144|NCT01815424|81689257|FG004|Week 0 to 16|Other|0|||
27961145|NCT01815424|81689253|FG000|Week 0 to 16|Protocol Violation|1|||
27961146|NCT01815424|81689254|FG001|Week 0 to 16|Protocol Violation|0|||
27961147|NCT01815424|81689255|FG002|Week 0 to 16|Protocol Violation|0|||
27961148|NCT01815424|81689256|FG003|Week 0 to 16|Protocol Violation|0|||
27961149|NCT01815424|81689257|FG004|Week 0 to 16|Protocol Violation|0|||
27961150|NCT01815424|81689253|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
27961151|NCT01815424|81689254|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
27961152|NCT01815424|81689255|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
27961153|NCT01815424|81689256|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
27961154|NCT01815424|81689257|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
27961155|NCT01815424|81689253|FG000|Week 16 to 52|Other|0|||
27961156|NCT01815424|81689254|FG001|Week 16 to 52|Other|1|||
27961157|NCT01815424|81689255|FG002|Week 16 to 52|Other|0|||
27961158|NCT01815424|81689256|FG003|Week 16 to 52|Other|0|||
27961159|NCT01815424|81689257|FG004|Week 16 to 52|Other|0|||
27961160|NCT01815424|81689253|FG000|Week 16 to 52|Adverse Event|0|||
27961161|NCT01815424|81689254|FG001|Week 16 to 52|Adverse Event|0|||
27961162|NCT01815424|81689255|FG002|Week 16 to 52|Adverse Event|0|||
27961163|NCT01815424|81689256|FG003|Week 16 to 52|Adverse Event|0|||
27961164|NCT01815424|81689257|FG004|Week 16 to 52|Adverse Event|1|||
27961165|NCT01815424|81689253|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
27961166|NCT01815424|81689254|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
27961167|NCT01815424|81689255|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
27961168|NCT01815424|81689256|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
27961169|NCT01815424|81689257|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
27961170|NCT01815424|81689253|FG000|Week 16 to 52|Lost to Follow-up|0|||
27961171|NCT01815424|81689254|FG001|Week 16 to 52|Lost to Follow-up|2|||
27961172|NCT01815424|81689255|FG002|Week 16 to 52|Lost to Follow-up|0|||
27961173|NCT01815424|81689256|FG003|Week 16 to 52|Lost to Follow-up|2|||
27961174|NCT01815424|81689257|FG004|Week 16 to 52|Lost to Follow-up|1|||
27961175|NCT01815424|81689253|FG000|Week 16 to 52|Withdrawal by Subject|1|||
27961176|NCT01815424|81689254|FG001|Week 16 to 52|Withdrawal by Subject|2|||
27961177|NCT01815424|81689255|FG002|Week 16 to 52|Withdrawal by Subject|0|||
27961178|NCT01815424|81689256|FG003|Week 16 to 52|Withdrawal by Subject|0|||
27961179|NCT01815424|81689257|FG004|Week 16 to 52|Withdrawal by Subject|0|||
27961180|NCT02148263|81689258|FG000|Overall Study|Withdrawal by Subject|3|||
27961181|NCT02148263|81689259|FG001|Overall Study|Withdrawal by Subject|2|||
27961182|NCT02779777|81689265|FG000|Overall Study|Disease Progression|1|||
27961183|NCT02779777|81689266|FG001|Overall Study|Disease Progression|0|||
27961184|NCT02779777|81689267|FG002|Overall Study|Disease Progression|0|||
27961185|NCT02779777|81689265|FG000|Overall Study|Adverse Event|3|||
27961186|NCT02779777|81689266|FG001|Overall Study|Adverse Event|1|||
27961187|NCT02779777|81689267|FG002|Overall Study|Adverse Event|0|||
27961188|NCT02779777|81689265|FG000|Overall Study|Physician Decision|9|||
27961189|NCT02779777|81689266|FG001|Overall Study|Physician Decision|0|||
27961190|NCT02779777|81689267|FG002|Overall Study|Physician Decision|1|||
27961191|NCT02779777|81689265|FG000|Overall Study|Withdrawal by Subject|1|||
27562583|NCT00878709|80246307|FG001|Overall Study|Other Reasons|84|||
27562584|NCT01466387|80246308|FG000|Overall Study|Adverse Event|0|||
27562585|NCT01466387|80246309|FG001|Overall Study|Adverse Event|0|||
27562586|NCT01466387|80246310|FG002|Overall Study|Adverse Event|1|||
27961192|NCT02779777|81689266|FG001|Overall Study|Withdrawal by Subject|0|||
27961193|NCT02779777|81689267|FG002|Overall Study|Withdrawal by Subject|0|||
27961194|NCT00334737|81689270|FG000|Hospital Phase|Death|1|||
27961195|NCT00334737|81689271|FG001|Hospital Phase|Death|2|||
27961196|NCT00334737|81689272|FG002|Hospital Phase|Death|3|||
27961197|NCT00334737|81689270|FG000|Hospital Phase|Withdrawal by Subject|0|||
27961198|NCT00334737|81689271|FG001|Hospital Phase|Withdrawal by Subject|0|||
27961199|NCT00334737|81689272|FG002|Hospital Phase|Withdrawal by Subject|1|||
27961200|NCT00334737|81689270|FG000|Hospital Phase|Did not receive study drug|1|||
27961201|NCT00334737|81689271|FG001|Hospital Phase|Did not receive study drug|0|||
27961202|NCT00334737|81689272|FG002|Hospital Phase|Did not receive study drug|0|||
27961203|NCT00334737|81689270|FG000|Follow up Phase|Lost to Follow-up|5|||
27961204|NCT00334737|81689271|FG001|Follow up Phase|Lost to Follow-up|3|||
27961205|NCT00334737|81689272|FG002|Follow up Phase|Lost to Follow-up|6|||
27961206|NCT05332392|81689273|FG000|Overall Study|Did not meet inclusion criteria|25|||
27961207|NCT05332392|81689273|FG000|Overall Study|Principal Investigator's decision|17|||
27961208|NCT05332392|81689273|FG000|Overall Study|Adverse Event|1|||
27961209|NCT05332392|81689273|FG000|Overall Study|Subject's decision|1|||
27961210|NCT02229825|81689278|FG000|Overall Study|Personal Reasons|0|||
27961211|NCT02229825|81689279|FG001|Overall Study|Personal Reasons|1|||
27961212|NCT02229825|81689278|FG000|Overall Study|Refused continuing medication|7|||
27961213|NCT02229825|81689279|FG001|Overall Study|Refused continuing medication|6|||
27961214|NCT02229825|81689278|FG000|Overall Study|Lost to Follow-up|1|||
27961215|NCT02229825|81689279|FG001|Overall Study|Lost to Follow-up|2|||
27961216|NCT02229825|81689278|FG000|Overall Study|Protocol Violation|1|||
27961217|NCT02229825|81689279|FG001|Overall Study|Protocol Violation|1|||
27961218|NCT02229825|81689278|FG000|Overall Study|Lack of Efficacy|4|||
27961219|NCT02229825|81689279|FG001|Overall Study|Lack of Efficacy|10|||
27961220|NCT02229825|81689278|FG000|Overall Study|Adverse Event|11|||
27961221|NCT02229825|81689279|FG001|Overall Study|Adverse Event|9|||
27562587|NCT01466387|80246311|FG003|Overall Study|Adverse Event|1|||
27562588|NCT01466387|80246312|FG004|Overall Study|Adverse Event|0|||
27562589|NCT01466387|80246313|FG005|Overall Study|Adverse Event|0|||
27562590|NCT01466387|80246308|FG000|Overall Study|Lost to Follow-up|0|||
27562591|NCT01466387|80246309|FG001|Overall Study|Lost to Follow-up|0|||
27562592|NCT01466387|80246310|FG002|Overall Study|Lost to Follow-up|0|||
27562593|NCT01466387|80246311|FG003|Overall Study|Lost to Follow-up|0|||
27562594|NCT01466387|80246312|FG004|Overall Study|Lost to Follow-up|0|||
27562595|NCT01466387|80246313|FG005|Overall Study|Lost to Follow-up|1|||
27562596|NCT01466387|80246308|FG000|Overall Study|Protocol Violation|1|||
27961222|NCT02229825|81689278|FG000|Overall Study|Not treated|0|||
27562597|NCT01466387|80246309|FG001|Overall Study|Protocol Violation|0|||
27562598|NCT01466387|80246310|FG002|Overall Study|Protocol Violation|0|||
27562599|NCT01466387|80246311|FG003|Overall Study|Protocol Violation|1|||
27562600|NCT01466387|80246312|FG004|Overall Study|Protocol Violation|0|||
27562601|NCT01466387|80246313|FG005|Overall Study|Protocol Violation|0|||
27961223|NCT02229825|81689279|FG001|Overall Study|Not treated|1|||
27961224|NCT02522429|81689280|FG000|Overall Study|Lost to Follow-up|8|||
27961225|NCT02522429|81689280|FG000|Overall Study|Adverse Event|2|||
27562602|NCT02016482|80249879|FG000|Period A|Adverse Event|3|||
27961226|NCT02522429|81689280|FG000|Overall Study|Death|1|||
27961227|NCT02522429|81689280|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
27961228|NCT01309204|81689281|FG000|Overall Study|Adverse Event|48|||
27961229|NCT01309204|81689282|FG001|Overall Study|Adverse Event|58|||
27961230|NCT01309204|81689281|FG000|Overall Study|Lost to Follow-up|2|||
27961231|NCT01309204|81689282|FG001|Overall Study|Lost to Follow-up|2|||
27961232|NCT01309204|81689281|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
27961233|NCT01309204|81689282|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
27961234|NCT01309204|81689281|FG000|Overall Study|Inadequate control of IOP|4|||
27961235|NCT01309204|81689282|FG001|Overall Study|Inadequate control of IOP|4|||
27961236|NCT01309204|81689281|FG000|Overall Study|Other|4|||
27961237|NCT01309204|81689282|FG001|Overall Study|Other|1|||
27961238|NCT01582009|81689283|FG000|Overall Study|Withdrawal by Subject|1|||
27961239|NCT01582009|81689283|FG000|Overall Study|Physician Decision|1|||
27961240|NCT01467466|81689284|FG000|Overall Study|Withdrawal by Subject|15|||
27961241|NCT01467466|81689285|FG001|Overall Study|Withdrawal by Subject|18|||
27961242|NCT01467466|81689286|FG002|Overall Study|Withdrawal by Subject|13|||
27961243|NCT01467466|81689287|FG003|Overall Study|Withdrawal by Subject|11|||
27961244|NCT01467466|81689284|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
27961245|NCT01467466|81689285|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
27961246|NCT01467466|81689286|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
27961247|NCT01467466|81689287|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
27961248|NCT01467466|81689284|FG000|Overall Study|Procedure Cancelled|46|||
27961249|NCT01467466|81689285|FG001|Overall Study|Procedure Cancelled|45|||
27961250|NCT01467466|81689286|FG002|Overall Study|Procedure Cancelled|25|||
27961251|NCT01467466|81689287|FG003|Overall Study|Procedure Cancelled|29|||
27961252|NCT01467466|81689284|FG000|Overall Study|No Endpoint Blood Draw|38|||
27961253|NCT01467466|81689285|FG001|Overall Study|No Endpoint Blood Draw|32|||
27961254|NCT01467466|81689286|FG002|Overall Study|No Endpoint Blood Draw|51|||
27961255|NCT01467466|81689287|FG003|Overall Study|No Endpoint Blood Draw|43|||
27961256|NCT02364037|81689288|FG000|Overall Study|Withdrawal by Subject|7|||
27961257|NCT02364037|81689289|FG001|Overall Study|Withdrawal by Subject|4|||
27961258|NCT02364037|81689288|FG000|Overall Study|Lost to Follow-up|37|||
27961259|NCT02364037|81689289|FG001|Overall Study|Lost to Follow-up|49|||
27961260|NCT02103062|81689290|FG000|Overall Study|Adverse Event|1|||
27961261|NCT02103062|81689291|FG001|Overall Study|Adverse Event|2|||
27961262|NCT02103062|81689290|FG000|Overall Study|Progressive Disease|17|||
27961263|NCT02103062|81689291|FG001|Overall Study|Progressive Disease|20|||
27961264|NCT02103062|81689290|FG000|Overall Study|Death|0|||
27961265|NCT02103062|81689291|FG001|Overall Study|Death|1|||
27961266|NCT01453036|81689292|FG000|Overall Study|Lost to Follow-up|26|||
27961267|NCT01453036|81689293|FG001|Overall Study|Lost to Follow-up|115|||
27961268|NCT01453036|81689294|FG002|Overall Study|Lost to Follow-up|31|||
27961269|NCT03604497|81689295|FG000|Overall Study|Protocol Violation|52|||
27961270|NCT03782259|81689296|FG000|Overall Study|Lost to Follow-up|1|||
27961271|NCT03782259|81689297|FG001|Overall Study|Lost to Follow-up|1|||
27961272|NCT03782259|81689296|FG000|Overall Study|Moved out of state|0|||
27961273|NCT03782259|81689297|FG001|Overall Study|Moved out of state|2|||
27961274|NCT03782259|81689296|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
27961275|NCT03782259|81689297|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
27961276|NCT03782259|81689296|FG000|Overall Study|Subject discontinued intervention|1|||
27961277|NCT03782259|81689297|FG001|Overall Study|Subject discontinued intervention|0|||
27961278|NCT04194944|81689298|FG000|Overall Study|Lost to Follow-up|3|||
27961279|NCT04194944|81689299|FG001|Overall Study|Lost to Follow-up|0|||
27961280|NCT04194944|81689298|FG000|Overall Study|Withdrawal by Subject|2|||
27961281|NCT04194944|81689299|FG001|Overall Study|Withdrawal by Subject|2|||
27961282|NCT04194944|81689298|FG000|Overall Study|On Treatment|93|||
27961283|NCT04194944|81689299|FG001|Overall Study|On Treatment|30|||
27961284|NCT01772550|81689300|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
27961285|NCT01772550|81689301|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
27961286|NCT01772550|81689302|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
27961287|NCT01772550|81689300|FG000|Overall Study|Adverse Event|0|||
27961288|NCT01772550|81689301|FG001|Overall Study|Adverse Event|0|||
27961289|NCT01772550|81689302|FG002|Overall Study|Adverse Event|1|||
27961290|NCT00938912|81689303|FG000|Overall Study|Withdrawal by Subject|28|||
27961291|NCT00938912|81689303|FG000|Overall Study|Lost to Follow-up|4|||
27961292|NCT00938912|81689303|FG000|Overall Study|Lack of Efficacy|43|||
27961293|NCT00938912|81689303|FG000|Overall Study|Adverse event, non-fatal|24|||
27961294|NCT00938912|81689303|FG000|Overall Study|Adverse event, fatal|1|||
27961295|NCT00938912|81689303|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
27961296|NCT00938912|81689303|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
27961297|NCT00938912|81689303|FG000|Overall Study|Participant needed prohibit medication|1|||
27961298|NCT00938912|81689303|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
27961299|NCT00938912|81689303|FG000|Overall Study|Did not meet Eligibility criteria|1|||
27961300|NCT00938912|81689303|FG000|Overall Study|Participant relocated not related to AE|1|||
27961301|NCT00938912|81689303|FG000|Overall Study|Participant moved to another city|1|||
27961302|NCT00938912|81689303|FG000|Overall Study|Participant experienced break through seizures|1|||
27961303|NCT00938912|81689303|FG000|Overall Study|No longer wished to participate in the study|1|||
27961304|NCT00938912|81689303|FG000|Overall Study|Protocol Deviation|2|||
27961305|NCT01804049|81689306|FG000|Overall Study|Adverse Event|2|||
27961306|NCT01804049|81689307|FG001|Overall Study|Adverse Event|10|||
27961307|NCT01804049|81689306|FG000|Overall Study|Lost to Follow-up|2|||
27961308|NCT01804049|81689307|FG001|Overall Study|Lost to Follow-up|1|||
27961309|NCT01804049|81689306|FG000|Overall Study|Decreased interest/personal|4|||
27961310|NCT01804049|81689307|FG001|Overall Study|Decreased interest/personal|5|||
27961311|NCT01804049|81689306|FG000|Overall Study|Other health concerns|2|||
27961312|NCT01804049|81689307|FG001|Overall Study|Other health concerns|7|||
27961313|NCT01804049|81689306|FG000|Overall Study|Moved out of area|0|||
27961314|NCT01804049|81689307|FG001|Overall Study|Moved out of area|7|||
27961315|NCT01804049|81689306|FG000|Overall Study|other MD recommended|1|||
27961316|NCT01804049|81689307|FG001|Overall Study|other MD recommended|1|||
27961317|NCT01804049|81689306|FG000|Overall Study|Enrollment in dual studies|0|||
27961318|NCT01804049|81689307|FG001|Overall Study|Enrollment in dual studies|1|||
27961319|NCT00211172|81689308|FG000|Overall Study|Died or lost health plan eligibility|39|||
27961320|NCT00211172|81689309|FG001|Overall Study|Died or lost health plan eligibility|32|||
27961321|NCT04703192|81689310|FG000|Overall Study|Withdrawal by Subject|2|||
27961322|NCT04703192|81689311|FG001|Overall Study|Withdrawal by Subject|0|||
27961323|NCT04703192|81689310|FG000|Overall Study|Death|3|||
27961324|NCT04703192|81689311|FG001|Overall Study|Death|1|||
27961325|NCT04703192|81689310|FG000|Overall Study|Adverse Event|13|||
27961326|NCT04703192|81689311|FG001|Overall Study|Adverse Event|2|||
27961327|NCT04703192|81689310|FG000|Overall Study|Progressive or Relapsed Disease|46|||
27961328|NCT04703192|81689311|FG001|Overall Study|Progressive or Relapsed Disease|7|||
27961329|NCT04703192|81689310|FG000|Overall Study|Clinical Progression|19|||
27961330|NCT04703192|81689311|FG001|Overall Study|Clinical Progression|8|||
27961331|NCT04703192|81689310|FG000|Overall Study|Lost to Follow-up|1|||
27961332|NCT04703192|81689311|FG001|Overall Study|Lost to Follow-up|0|||
27961333|NCT04703192|81689310|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
27961334|NCT04703192|81689311|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
27961335|NCT04703192|81689310|FG000|Overall Study|Other|5|||
27961336|NCT04703192|81689311|FG001|Overall Study|Other|1|||
27961337|NCT03900728|81689312|FG000|Overall Study|No text responses|0|||
27961338|NCT03900728|81689313|FG001|Overall Study|No text responses|0|||
27961339|NCT03900728|81689314|FG002|Overall Study|No text responses|4|||
27961340|NCT02923531|81689315|FG000|Overall Study|Adverse Event|4|||
27961341|NCT02923531|81689315|FG000|Overall Study|Clinical Deterioration|1|||
27961342|NCT02923531|81689315|FG000|Overall Study|Disease Progression|3|||
27961343|NCT02923531|81689315|FG000|Overall Study|Study Termination|1|||
27961344|NCT00803738|81689316|FG000|Overall Study|Adverse Event|3|||
27961345|NCT00803738|81689317|FG001|Overall Study|Adverse Event|5|||
27961346|NCT00803738|81689316|FG000|Overall Study|Lost to Follow-up|4|||
27961347|NCT00803738|81689317|FG001|Overall Study|Lost to Follow-up|4|||
27961348|NCT00803738|81689316|FG000|Overall Study|Protocol Violation|18|||
27961349|NCT00803738|81689317|FG001|Overall Study|Protocol Violation|10|||
27961350|NCT00803738|81689316|FG000|Overall Study|Withdrawal by Subject|1|||
27961351|NCT00803738|81689317|FG001|Overall Study|Withdrawal by Subject|4|||
27961352|NCT00803738|81689316|FG000|Overall Study|Lack of Efficacy|10|||
27961353|NCT00803738|81689317|FG001|Overall Study|Lack of Efficacy|16|||
27961354|NCT00803738|81689316|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
27961355|NCT00803738|81689317|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
27961356|NCT00803738|81689316|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
27961357|NCT00803738|81689317|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
27961358|NCT01206140|81689324|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
27961359|NCT01206140|81689325|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
27961360|NCT00910910|81689333|FG000|Overall Study|Adverse Event|63|||
27961361|NCT00910910|81689334|FG001|Overall Study|Adverse Event|35|||
27961362|NCT00910910|81689333|FG000|Overall Study|PD without histologic change|27|||
27961363|NCT00910910|81689334|FG001|Overall Study|PD without histologic change|23|||
27961364|NCT00910910|81689333|FG000|Overall Study|PD with histologic change|0|||
27961365|NCT00910910|81689334|FG001|Overall Study|PD with histologic change|2|||
27961366|NCT00910910|81689333|FG000|Overall Study|Withdrawal by Subject|7|||
27961367|NCT00910910|81689334|FG001|Overall Study|Withdrawal by Subject|5|||
27961368|NCT00910910|81689333|FG000|Overall Study|Lost to Follow-up|2|||
27961369|NCT00910910|81689334|FG001|Overall Study|Lost to Follow-up|2|||
27961370|NCT00910910|81689333|FG000|Overall Study|Death|9|||
27961371|NCT00910910|81689334|FG001|Overall Study|Death|3|||
27961372|NCT00910910|81689333|FG000|Overall Study|Protocol Violation|2|||
27961373|NCT00910910|81689334|FG001|Overall Study|Protocol Violation|2|||
27961374|NCT00910910|81689333|FG000|Overall Study|Completed 13 cycles of treatment|0|||
27961375|NCT00910910|81689334|FG001|Overall Study|Completed 13 cycles of treatment|118|||
27961376|NCT00910910|81689333|FG000|Overall Study|Other|114|||
27961377|NCT00910910|81689334|FG001|Overall Study|Other|32|||
27961378|NCT00910910|81689333|FG000|Overall Study|Untreated before cycle 1|1|||
27961379|NCT00910910|81689334|FG001|Overall Study|Untreated before cycle 1|2|||
27961380|NCT01635998|81689335|FG000|Overall Study|Death|1|||
27961381|NCT01635998|81689336|FG001|Overall Study|Death|1|||
27961382|NCT01635998|81689335|FG000|Overall Study|Lost to Follow-up|2|||
27961383|NCT01635998|81689336|FG001|Overall Study|Lost to Follow-up|1|||
27961384|NCT01635998|81689335|FG000|Overall Study|Withdrawal by Subject|1|||
27961385|NCT01635998|81689336|FG001|Overall Study|Withdrawal by Subject|5|||
27961386|NCT00322049|81691632|FG000|Overall Study|Moved out of area|0|||
27961387|NCT00322049|81691633|FG001|Overall Study|Moved out of area|0|||
27961388|NCT00322049|81691634|FG002|Overall Study|Moved out of area|0|||
27961389|NCT00322049|81691635|FG003|Overall Study|Moved out of area|1|||
27961390|NCT00322049|81691632|FG000|Overall Study|Infected with Dengue during study|0|||
27961391|NCT00322049|81691633|FG001|Overall Study|Infected with Dengue during study|1|||
27961392|NCT00322049|81691634|FG002|Overall Study|Infected with Dengue during study|0|||
27961393|NCT00322049|81691635|FG003|Overall Study|Infected with Dengue during study|0|||
27961394|NCT02595866|81691639|FG000|Overall Study|Adverse Event|2|||
27961395|NCT02595866|81691640|FG001|Overall Study|Adverse Event|5|||
27961396|NCT02595866|81691639|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
27961397|NCT02595866|81691640|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
27961398|NCT02595866|81691639|FG000|Overall Study|Death|0|||
27961399|NCT02595866|81691640|FG001|Overall Study|Death|1|||
27961400|NCT02595866|81691639|FG000|Overall Study|Incarceration|1|||
27961401|NCT02595866|81691640|FG001|Overall Study|Incarceration|0|||
27961402|NCT02595866|81691639|FG000|Overall Study|Lack of Efficacy|17|||
27961403|NCT02595866|81691640|FG001|Overall Study|Lack of Efficacy|7|||
27961404|NCT02595866|81691639|FG000|Overall Study|Physician Decision|4|||
27961405|NCT02595866|81691640|FG001|Overall Study|Physician Decision|3|||
27961406|NCT02595866|81691639|FG000|Overall Study|Switched to Alternative Treatment|1|||
27961407|NCT02595866|81691640|FG001|Overall Study|Switched to Alternative Treatment|0|||
27961408|NCT02595866|81691639|FG000|Overall Study|Study Terminated|0|||
27961409|NCT02595866|81691640|FG001|Overall Study|Study Terminated|4|||
27961410|NCT02595866|81691639|FG000|Overall Study|Withdrawal by Subject|6|||
27961411|NCT02595866|81691640|FG001|Overall Study|Withdrawal by Subject|1|||
27961412|NCT03592771|81691645|FG000|Overall Study|Adverse Event|2|||
27961413|NCT03592771|81691646|FG001|Overall Study|Adverse Event|0|||
27961414|NCT03592771|81691647|FG002|Overall Study|Adverse Event|1|||
27961415|NCT03592771|81691645|FG000|Overall Study|Death|0|||
27961416|NCT03592771|81691646|FG001|Overall Study|Death|1|||
27961417|NCT03592771|81691647|FG002|Overall Study|Death|1|||
27961418|NCT03592771|81691645|FG000|Overall Study|Lost to Follow-up|5|||
27961419|NCT03592771|81691646|FG001|Overall Study|Lost to Follow-up|11|||
27961420|NCT03592771|81691647|FG002|Overall Study|Lost to Follow-up|15|||
27961421|NCT03592771|81691645|FG000|Overall Study|Withdrawal by Subject|0|||
27961422|NCT03592771|81691646|FG001|Overall Study|Withdrawal by Subject|2|||
27961423|NCT03592771|81691647|FG002|Overall Study|Withdrawal by Subject|0|||
27961424|NCT01232127|81691648|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
27961425|NCT01232127|81691649|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
27961426|NCT01232127|81691650|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
27961427|NCT01107392|81691651|FG000|Overall Study|Adverse Event|2|||
27961428|NCT01107392|81691652|FG001|Overall Study|Adverse Event|0|||
27961429|NCT01107392|81691651|FG000|Overall Study|Personal Reasons|2|||
27562603|NCT02016482|80249880|FG001|Period A|Adverse Event|5|||
27961430|NCT01107392|81691652|FG001|Overall Study|Personal Reasons|3|||
27961431|NCT01107392|81691651|FG000|Overall Study|Administrative decision|1|||
27961432|NCT01107392|81691652|FG001|Overall Study|Administrative decision|0|||
27961433|NCT01248728|81691654|FG000|Overall Study|Adverse Event|1|||
27961434|NCT01248728|81691655|FG001|Overall Study|Adverse Event|1|||
27961435|NCT01248728|81691654|FG000|Overall Study|Withdrawal by Subject|2|||
27961436|NCT01248728|81691655|FG001|Overall Study|Withdrawal by Subject|1|||
27961437|NCT01248728|81691654|FG000|Overall Study|Lack of Efficacy|1|||
27961438|NCT01248728|81691655|FG001|Overall Study|Lack of Efficacy|0|||
27961439|NCT05141175|81691656|FG000|Overall Study|Withdrawal by Subject|1|||
27961440|NCT01637584|81691657|FG000|Overall Study|Withdrawal by Subject|1|||
27961441|NCT01637584|81691658|FG001|Overall Study|Withdrawal by Subject|3|||
27961442|NCT03046446|81691662|FG000|Overall Study|Lack of Efficacy|7|||
27961443|NCT03046446|81691662|FG000|Overall Study|Adverse Event|6|||
27961444|NCT03046446|81691662|FG000|Overall Study|Lost to Follow-up|3|||
27961445|NCT03046446|81691662|FG000|Overall Study|Withdrawal by Subject|14|||
27961446|NCT03046446|81691662|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
27961447|NCT03046446|81691662|FG000|Overall Study|Disease Progression (see caveats)|25|||
27961448|NCT03046446|81691662|FG000|Overall Study|Non OA related knee surgery|1|||
27961449|NCT01262560|81691665|FG000|Overall Study|Protocol Violation|0|||
27961450|NCT01262560|81691666|FG001|Overall Study|Protocol Violation|1|||
27961451|NCT01262560|81691667|FG002|Overall Study|Protocol Violation|2|||
27961452|NCT01846299|81691669|FG000|Overall Study|Physician Decision|4|||
27961453|NCT01846299|81691670|FG001|Overall Study|Physician Decision|2|||
27961454|NCT01846299|81691669|FG000|Overall Study|Protocol deviation|1|||
27961455|NCT01846299|81691670|FG001|Overall Study|Protocol deviation|0|||
27961456|NCT01846299|81691669|FG000|Overall Study|Death|1|||
27961457|NCT01846299|81691670|FG001|Overall Study|Death|2|||
27961458|NCT01846299|81691669|FG000|Overall Study|Lost to Follow-up|3|||
27961459|NCT01846299|81691670|FG001|Overall Study|Lost to Follow-up|0|||
27961460|NCT01846299|81691669|FG000|Overall Study|Withdrawal by Subject|1|||
27961461|NCT01846299|81691670|FG001|Overall Study|Withdrawal by Subject|6|||
27961462|NCT01846299|81691669|FG000|Overall Study|Adverse Event|2|||
27961463|NCT01846299|81691670|FG001|Overall Study|Adverse Event|0|||
27961464|NCT00244725|81691671|FG000|Overall Study|Lost to Follow-up|3|||
27961465|NCT00244725|81691672|FG001|Overall Study|Lost to Follow-up|4|||
27961466|NCT00244725|81691673|FG002|Overall Study|Lost to Follow-up|9|||
27961467|NCT00244725|81691674|FG003|Overall Study|Lost to Follow-up|2|||
27961468|NCT00244725|81691671|FG000|Overall Study|Withdrawal by Subject|9|||
27961469|NCT00244725|81691672|FG001|Overall Study|Withdrawal by Subject|7|||
27961470|NCT00244725|81691673|FG002|Overall Study|Withdrawal by Subject|7|||
27961471|NCT00244725|81691674|FG003|Overall Study|Withdrawal by Subject|8|||
27961472|NCT00244725|81691671|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
27961473|NCT00244725|81691672|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
27961474|NCT00244725|81691673|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
27961475|NCT00244725|81691674|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
27961476|NCT00244725|81691671|FG000|Overall Study|Physician Decision|3|||
27961477|NCT00244725|81691672|FG001|Overall Study|Physician Decision|0|||
27961478|NCT00244725|81691673|FG002|Overall Study|Physician Decision|1|||
27961479|NCT00244725|81691674|FG003|Overall Study|Physician Decision|2|||
27961480|NCT00244725|81691671|FG000|Overall Study|Adverse Events|3|||
27961481|NCT00244725|81691672|FG001|Overall Study|Adverse Events|1|||
27961482|NCT00244725|81691673|FG002|Overall Study|Adverse Events|4|||
27961483|NCT00244725|81691674|FG003|Overall Study|Adverse Events|4|||
27961484|NCT00244725|81691671|FG000|Overall Study|Withdrwal by participant|1|||
27961485|NCT00244725|81691672|FG001|Overall Study|Withdrwal by participant|0|||
27961486|NCT00244725|81691673|FG002|Overall Study|Withdrwal by participant|0|||
27961487|NCT00244725|81691674|FG003|Overall Study|Withdrwal by participant|1|||
27961488|NCT00244725|81691671|FG000|Overall Study|Liver function test abnormality|2|||
27961489|NCT00244725|81691672|FG001|Overall Study|Liver function test abnormality|0|||
27961490|NCT00244725|81691673|FG002|Overall Study|Liver function test abnormality|0|||
27961491|NCT00244725|81691674|FG003|Overall Study|Liver function test abnormality|1|||
27961492|NCT00244725|81691671|FG000|Overall Study|Sponsor withdrew the participant|1|||
27961493|NCT00244725|81691672|FG001|Overall Study|Sponsor withdrew the participant|0|||
27961494|NCT00244725|81691673|FG002|Overall Study|Sponsor withdrew the participant|0|||
27961495|NCT00244725|81691674|FG003|Overall Study|Sponsor withdrew the participant|1|||
27961496|NCT00244725|81691671|FG000|Overall Study|Mediciation Error|0|||
27961497|NCT00244725|81691672|FG001|Overall Study|Mediciation Error|1|||
27961498|NCT00244725|81691673|FG002|Overall Study|Mediciation Error|0|||
27961499|NCT00244725|81691674|FG003|Overall Study|Mediciation Error|0|||
27961500|NCT00244725|81691671|FG000|Overall Study|Rehab Refused to allow participantion|0|||
27961501|NCT00244725|81691672|FG001|Overall Study|Rehab Refused to allow participantion|1|||
27961502|NCT00244725|81691673|FG002|Overall Study|Rehab Refused to allow participantion|0|||
27961503|NCT00244725|81691674|FG003|Overall Study|Rehab Refused to allow participantion|0|||
27961504|NCT00244725|81691671|FG000|Overall Study|Headache|0|||
27961505|NCT00244725|81691672|FG001|Overall Study|Headache|1|||
27961506|NCT00244725|81691673|FG002|Overall Study|Headache|0|||
27961507|NCT00244725|81691674|FG003|Overall Study|Headache|0|||
27961508|NCT00244725|81691671|FG000|Overall Study|Received prohibited medication|0|||
27961509|NCT00244725|81691672|FG001|Overall Study|Received prohibited medication|1|||
27961510|NCT00244725|81691673|FG002|Overall Study|Received prohibited medication|0|||
27961511|NCT00244725|81691674|FG003|Overall Study|Received prohibited medication|1|||
27961512|NCT00244725|81691671|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
27961513|NCT00244725|81691672|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
27961514|NCT00244725|81691673|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
27961515|NCT00244725|81691674|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
27961516|NCT00244725|81691671|FG000|Overall Study|Administrative reason|0|||
27961517|NCT00244725|81691672|FG001|Overall Study|Administrative reason|0|||
27961518|NCT00244725|81691673|FG002|Overall Study|Administrative reason|1|||
27961519|NCT00244725|81691674|FG003|Overall Study|Administrative reason|0|||
27961520|NCT00244725|81691671|FG000|Overall Study|Vomit|0|||
27961521|NCT00244725|81691672|FG001|Overall Study|Vomit|0|||
27961522|NCT00244725|81691673|FG002|Overall Study|Vomit|1|||
27961523|NCT00244725|81691674|FG003|Overall Study|Vomit|0|||
27961524|NCT00244725|81691671|FG000|Overall Study|Failed to follow-up|0|||
27961525|NCT00244725|81691672|FG001|Overall Study|Failed to follow-up|0|||
27961526|NCT00244725|81691673|FG002|Overall Study|Failed to follow-up|1|||
27961527|NCT00244725|81691674|FG003|Overall Study|Failed to follow-up|1|||
27961528|NCT00735553|81691676|FG000|Overall Study|Study prematurely terminated|77|||
27961529|NCT02366923|81691677|FG000|Overall Study|Withdrawal by Subject|1|||
27961530|NCT02366923|81691677|FG000|Overall Study|Positive Slit Lamp Findings|2|||
27961531|NCT02366923|81691677|FG000|Overall Study|High Astigmatism|3|||
27961532|NCT00288015|81691678|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
27961533|NCT00288015|81691678|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
27961534|NCT00288015|81691678|FG000|First Response Assessment|Withdrawal by Subject|1|||
27961535|NCT00288015|81691678|FG000|First Response Assessment|Death|1|||
27961536|NCT00288015|81691678|FG000|First Response Assessment|Physician Decision|2|||
27961537|NCT00288015|81691678|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
27961538|NCT00288015|81691678|FG000|Follow up for Survival x 2 Years|Death|13|||
27961539|NCT00288015|81691678|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
27961540|NCT00288015|81691678|FG000|Follow up for Survival x 2 Years|Other|9|||
27961541|NCT02466425|81691680|FG000|Overall Study|Adverse Event|3|||
27961542|NCT02466425|81691681|FG001|Overall Study|Adverse Event|11|||
27961543|NCT02466425|81691680|FG000|Overall Study|Lack of Efficacy|4|||
27961544|NCT02466425|81691681|FG001|Overall Study|Lack of Efficacy|1|||
27961545|NCT02466425|81691680|FG000|Overall Study|Lost to Follow-up|3|||
27961546|NCT02466425|81691681|FG001|Overall Study|Lost to Follow-up|0|||
27961547|NCT02466425|81691680|FG000|Overall Study|Protocol Violation|1|||
27961548|NCT02466425|81691681|FG001|Overall Study|Protocol Violation|0|||
27961549|NCT02466425|81691680|FG000|Overall Study|Withdrawal by Subject|0|||
27961550|NCT02466425|81691681|FG001|Overall Study|Withdrawal by Subject|1|||
27961551|NCT02466425|81691680|FG000|Overall Study|Other|1|||
27961552|NCT02466425|81691681|FG001|Overall Study|Other|3|||
27961553|NCT02466425|81691680|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27961554|NCT02466425|81691681|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27961555|NCT01916824|81691682|FG000|Overall Study|Lost to Follow-up|3|||
27961556|NCT01916824|81691683|FG001|Overall Study|Lost to Follow-up|6|||
27961557|NCT01916824|81691682|FG000|Overall Study|Physician Decision|2|||
27961558|NCT01916824|81691683|FG001|Overall Study|Physician Decision|0|||
27961559|NCT01916824|81691682|FG000|Overall Study|Withdrawal by Subject|2|||
27961560|NCT01916824|81691683|FG001|Overall Study|Withdrawal by Subject|3|||
27961561|NCT02720523|81691684|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
27961562|NCT02720523|81691685|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
27961563|NCT02720523|81691686|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
27961564|NCT02720523|81691687|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
27961565|NCT02720523|81691688|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
27961566|NCT02720523|81691689|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
27961567|NCT02720523|81691690|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
27961568|NCT02720523|81691684|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
27961569|NCT02720523|81691685|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27961570|NCT02720523|81691686|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27961571|NCT02720523|81691687|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27961572|NCT02720523|81691688|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27961573|NCT02720523|81691689|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27961574|NCT02720523|81691690|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27961575|NCT02720523|81691684|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
27961576|NCT02720523|81691685|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27961577|NCT02720523|81691686|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27961578|NCT02720523|81691687|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27961579|NCT02720523|81691688|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27961580|NCT02720523|81691689|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27961581|NCT02720523|81691690|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
27961582|NCT02720523|81691684|FG000|Period 1: Placebo-controlled Period|Other|0|||
27961583|NCT02720523|81691685|FG001|Period 1: Placebo-controlled Period|Other|0|||
27961584|NCT02720523|81691686|FG002|Period 1: Placebo-controlled Period|Other|1|||
27961585|NCT02720523|81691687|FG003|Period 1: Placebo-controlled Period|Other|1|||
27961586|NCT02720523|81691688|FG004|Period 1: Placebo-controlled Period|Other|0|||
27961587|NCT02720523|81691689|FG005|Period 1: Placebo-controlled Period|Other|0|||
27961588|NCT02720523|81691690|FG006|Period 1: Placebo-controlled Period|Other|0|||
27961589|NCT02720523|81691684|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
27961590|NCT02720523|81691685|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
27961591|NCT02720523|81691686|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
27961592|NCT02720523|81691687|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
27961593|NCT02720523|81691688|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
27961594|NCT02720523|81691689|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
27961595|NCT02720523|81691690|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
27961596|NCT02720523|81691684|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
27961597|NCT02720523|81691685|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
27961598|NCT02720523|81691686|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
27961599|NCT02720523|81691687|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
27961600|NCT02720523|81691688|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
27961601|NCT02720523|81691689|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
27961602|NCT02720523|81691690|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
27961603|NCT02720523|81691684|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
27961604|NCT02720523|81691685|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
27961605|NCT02720523|81691686|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
27961606|NCT02720523|81691687|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
27961607|NCT02720523|81691688|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
27961608|NCT02720523|81691689|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
27961609|NCT02720523|81691690|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
27961610|NCT02720523|81691684|FG000|Period 2: Long-term Extension Period|Other|0|||
27961611|NCT02720523|81691685|FG001|Period 2: Long-term Extension Period|Other|0|||
27961612|NCT02720523|81691686|FG002|Period 2: Long-term Extension Period|Other|0|||
27961613|NCT02720523|81691687|FG003|Period 2: Long-term Extension Period|Other|0|||
27961614|NCT02720523|81691688|FG004|Period 2: Long-term Extension Period|Other|2|||
27961615|NCT02720523|81691689|FG005|Period 2: Long-term Extension Period|Other|0|||
27961616|NCT02720523|81691690|FG006|Period 2: Long-term Extension Period|Other|3|||
27961617|NCT03035864|81691693|FG000|Treatment Period|Adverse Event|1|||
27961618|NCT03035864|81691694|FG001|Treatment Period|Adverse Event|0|||
27961619|NCT03035864|81691693|FG000|Treatment Period|Other|3|||
27961620|NCT03035864|81691694|FG001|Treatment Period|Other|1|||
27961621|NCT03035864|81691693|FG000|Follow-up Period|Adverse Event|1|||
27961622|NCT03035864|81691694|FG001|Follow-up Period|Adverse Event|0|||
27961623|NCT03035864|81691693|FG000|Follow-up Period|Lost to Follow-up|6|||
27961624|NCT03035864|81691694|FG001|Follow-up Period|Lost to Follow-up|2|||
27961625|NCT03035864|81691693|FG000|Follow-up Period|Physician Decision|1|||
27961626|NCT03035864|81691694|FG001|Follow-up Period|Physician Decision|0|||
27961627|NCT03035864|81691693|FG000|Follow-up Period|Other|3|||
27961628|NCT03035864|81691694|FG001|Follow-up Period|Other|2|||
27961629|NCT02010593|81691702|FG000|Overall Study|Lost to Follow-up|1|||
27961630|NCT02010593|81691703|FG001|Overall Study|Lost to Follow-up|0|||
27961631|NCT02010593|81691702|FG000|Overall Study|Physician Decision|1|||
27961632|NCT02010593|81691703|FG001|Overall Study|Physician Decision|0|||
27961633|NCT02010593|81691702|FG000|Overall Study|Unable to adhere to visit schedule|0|||
27961634|NCT02010593|81691703|FG001|Overall Study|Unable to adhere to visit schedule|2|||
27961635|NCT04644276|81691704|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
27961636|NCT04644276|81691705|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
27961637|NCT04644276|81691706|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
27961638|NCT05010070|81691712|FG000|Overall Study|Lost to Follow-up|1|||
27961639|NCT05010070|81691712|FG000|Overall Study|Withdrawal by Subject|1|||
27961640|NCT00460655|81691713|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
27961641|NCT00460655|81691714|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27961642|NCT00460655|81691715|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27961643|NCT00460655|81691716|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27961644|NCT00460655|81691713|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
27961645|NCT00460655|81691714|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27961646|NCT00460655|81691715|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27961647|NCT00460655|81691716|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27961648|NCT00460655|81691713|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
27961649|NCT00460655|81691714|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
27961650|NCT00460655|81691715|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
27961651|NCT00460655|81691716|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
27961652|NCT00460655|81691713|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27961653|NCT00460655|81691714|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27961654|NCT00460655|81691715|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
27961655|NCT00460655|81691716|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
27961656|NCT00460655|81691713|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27961657|NCT00460655|81691714|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27961658|NCT00460655|81691715|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
27961659|NCT00460655|81691716|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
27961660|NCT00460655|81691713|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
27961661|NCT00460655|81691714|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
27961662|NCT00460655|81691715|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
27961663|NCT00460655|81691716|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
27961664|NCT00579553|81691719|FG000|Overall Study|Lost to Follow-up|16|||
27961665|NCT00579553|81691720|FG001|Overall Study|Lost to Follow-up|13|||
27961666|NCT01048242|81691721|FG000|Overall Study|See study flow chart|4|||
27961667|NCT01048242|81691722|FG001|Overall Study|See study flow chart|2|||
27961668|NCT00851890|81691723|FG000|Overall Study|Lost to Follow-up|0|||
27961669|NCT00851890|81691724|FG001|Overall Study|Lost to Follow-up|1|||
27961670|NCT00851890|81691725|FG002|Overall Study|Lost to Follow-up|0|||
27961671|NCT00851890|81691726|FG003|Overall Study|Lost to Follow-up|1|||
27961672|NCT03012828|81691729|FG000|Overall Study|Lost to Follow-up|1|||
27961673|NCT03012828|81691730|FG001|Overall Study|Lost to Follow-up|0|||
27961674|NCT03012828|81691731|FG002|Overall Study|Lost to Follow-up|1|||
27961675|NCT03012828|81691732|FG003|Overall Study|Lost to Follow-up|0|||
27961676|NCT03012828|81691733|FG004|Overall Study|Lost to Follow-up|1|||
27961677|NCT03012828|81691734|FG005|Overall Study|Lost to Follow-up|0|||
27961678|NCT03012828|81691729|FG000|Overall Study|Withdrawal by Subject|0|||
27961679|NCT03012828|81691730|FG001|Overall Study|Withdrawal by Subject|0|||
27961680|NCT03012828|81691731|FG002|Overall Study|Withdrawal by Subject|1|||
27961681|NCT03012828|81691732|FG003|Overall Study|Withdrawal by Subject|0|||
27961682|NCT03012828|81691733|FG004|Overall Study|Withdrawal by Subject|0|||
27961683|NCT03012828|81691734|FG005|Overall Study|Withdrawal by Subject|1|||
27961684|NCT03012828|81691729|FG000|Overall Study|Non-compliance with protocol|0|||
27961685|NCT03012828|81691730|FG001|Overall Study|Non-compliance with protocol|0|||
27961686|NCT03012828|81691731|FG002|Overall Study|Non-compliance with protocol|0|||
27961687|NCT03012828|81691732|FG003|Overall Study|Non-compliance with protocol|0|||
27961688|NCT03012828|81691733|FG004|Overall Study|Non-compliance with protocol|1|||
27961689|NCT03012828|81691734|FG005|Overall Study|Non-compliance with protocol|0|||
27961690|NCT03012828|81691729|FG000|Overall Study|Delay to last visit would delay DBL|0|||
27961691|NCT03012828|81691730|FG001|Overall Study|Delay to last visit would delay DBL|0|||
27961692|NCT03012828|81691731|FG002|Overall Study|Delay to last visit would delay DBL|0|||
27961693|NCT03012828|81691732|FG003|Overall Study|Delay to last visit would delay DBL|0|||
27961694|NCT03012828|81691733|FG004|Overall Study|Delay to last visit would delay DBL|0|||
27961695|NCT03012828|81691734|FG005|Overall Study|Delay to last visit would delay DBL|1|||
27961696|NCT03374358|81691735|FG000|Overall Study|Withdrawal by Subject|0|||
27961697|NCT03374358|81691736|FG001|Overall Study|Withdrawal by Subject|2|||
27961698|NCT00430989|81691737|FG000|Overall Study|Lost to Follow-up|2|||
27961699|NCT00430989|81691738|FG001|Overall Study|Lost to Follow-up|3|||
27961700|NCT00430989|81691737|FG000|Overall Study|Withdrawal by Subject|15|||
27961701|NCT00430989|81691738|FG001|Overall Study|Withdrawal by Subject|14|||
27961702|NCT00430989|81691737|FG000|Overall Study|Protocol Violation|30|||
27961703|NCT00430989|81691738|FG001|Overall Study|Protocol Violation|37|||
27961704|NCT00430989|81691737|FG000|Overall Study|Not eligible|13|||
27961705|NCT00430989|81691738|FG001|Overall Study|Not eligible|6|||
27961706|NCT02236572|81691739|FG000|Overall Study|Withdrawal by Subject|1|||
27961707|NCT02236572|81691739|FG000|Overall Study|Protocol Violation|1|||
27961708|NCT02236572|81691739|FG000|Overall Study|Lost to Follow-up|1|||
27961709|NCT05005273|81691743|FG000|Overall Study|Study Terminated|1|||
27961710|NCT05005273|81691744|FG001|Overall Study|Study Terminated|0|||
27961711|NCT00570778|81691749|FG000|Overall Study|Protocol deviation|2|||
27961712|NCT00570778|81691750|FG001|Overall Study|Protocol deviation|1|||
27961713|NCT00570778|81691751|FG002|Overall Study|Protocol deviation|2|||
27961714|NCT00570778|81691752|FG003|Overall Study|Protocol deviation|2|||
27961715|NCT00570778|81691749|FG000|Overall Study|Adverse Event|0|||
27961716|NCT00570778|81691750|FG001|Overall Study|Adverse Event|1|||
27961717|NCT00570778|81691751|FG002|Overall Study|Adverse Event|4|||
27961718|NCT00570778|81691752|FG003|Overall Study|Adverse Event|1|||
27961719|NCT00570778|81691749|FG000|Overall Study|Subject withdrew consent|0|||
27961720|NCT00570778|81691750|FG001|Overall Study|Subject withdrew consent|1|||
27961721|NCT00570778|81691751|FG002|Overall Study|Subject withdrew consent|0|||
27961722|NCT00570778|81691752|FG003|Overall Study|Subject withdrew consent|1|||
27961723|NCT00570778|81691749|FG000|Overall Study|Abnormal test procedure|1|||
27961724|NCT00570778|81691750|FG001|Overall Study|Abnormal test procedure|0|||
27961725|NCT00570778|81691751|FG002|Overall Study|Abnormal test procedure|0|||
27961726|NCT00570778|81691752|FG003|Overall Study|Abnormal test procedure|0|||
27961727|NCT00570778|81691749|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27961728|NCT00570778|81691750|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27961729|NCT00570778|81691751|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27961730|NCT00570778|81691752|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27961731|NCT00570778|81691749|FG000|Overall Study|Lost to Follow-up|0|||
27961732|NCT00570778|81691750|FG001|Overall Study|Lost to Follow-up|0|||
27961733|NCT00570778|81691751|FG002|Overall Study|Lost to Follow-up|1|||
27961734|NCT00570778|81691752|FG003|Overall Study|Lost to Follow-up|0|||
27961735|NCT00570778|81691749|FG000|Overall Study|Subject no longer requires study drug|0|||
27961736|NCT00570778|81691750|FG001|Overall Study|Subject no longer requires study drug|1|||
27961737|NCT00570778|81691751|FG002|Overall Study|Subject no longer requires study drug|0|||
27961738|NCT00570778|81691752|FG003|Overall Study|Subject no longer requires study drug|0|||
27961739|NCT00770562|81691753|FG000|Overall Study|Did not take treatment|1|||
27961740|NCT00770562|81691754|FG001|Overall Study|Did not take treatment|1|||
27961741|NCT01650831|81691755|FG000|Overall Study|Screen failure|1|||
27961742|NCT01693250|81691758|FG000|Overall Study|Lost to Follow-up|2|||
27961743|NCT01693250|81691759|FG001|Overall Study|Lost to Follow-up|2|||
27961744|NCT05059301|81691760|FG000|Overall Study|Adverse Event|0|||
27961745|NCT05059301|81691761|FG001|Overall Study|Adverse Event|2|||
27961746|NCT05059301|81691762|FG002|Overall Study|Adverse Event|2|||
27961747|NCT05059301|81691760|FG000|Overall Study|Lost to Follow-up|2|||
27961748|NCT05059301|81691761|FG001|Overall Study|Lost to Follow-up|3|||
27961749|NCT05059301|81691762|FG002|Overall Study|Lost to Follow-up|3|||
27961750|NCT03799952|81691774|FG000|Overall Study|Program was too easy, discontinued|1|||
27961751|NCT03799952|81691775|FG001|Overall Study|Program was too easy, discontinued|0|||
27961752|NCT03799952|81691774|FG000|Overall Study|Lost to Follow-up|0|||
27961753|NCT03799952|81691775|FG001|Overall Study|Lost to Follow-up|2|||
27961754|NCT02016716|81691776|FG000|Overall Study|Withdrawal by Subject|5|||
27961755|NCT02016716|81691777|FG001|Overall Study|Withdrawal by Subject|5|||
27961756|NCT02016716|81691778|FG002|Overall Study|Withdrawal by Subject|5|||
27961757|NCT02016716|81691776|FG000|Overall Study|Protocol-specified Criteria|0|||
27961758|NCT02016716|81691777|FG001|Overall Study|Protocol-specified Criteria|1|||
27961759|NCT02016716|81691778|FG002|Overall Study|Protocol-specified Criteria|0|||
27961760|NCT02016716|81691776|FG000|Overall Study|Lost to Follow-up|1|||
27961761|NCT02016716|81691777|FG001|Overall Study|Lost to Follow-up|2|||
27961762|NCT02016716|81691778|FG002|Overall Study|Lost to Follow-up|1|||
27961763|NCT03028129|81691779|FG000|Overall Study|Adverse Event|13|||
27961764|NCT03028129|81691780|FG001|Overall Study|Adverse Event|2|||
27961765|NCT03028129|81691779|FG000|Overall Study|Lost to Follow-up|50|||
27961766|NCT03028129|81691780|FG001|Overall Study|Lost to Follow-up|38|||
27961767|NCT03028129|81691779|FG000|Overall Study|Physician Decision|0|||
27961768|NCT03028129|81691780|FG001|Overall Study|Physician Decision|1|||
27961769|NCT03028129|81691779|FG000|Overall Study|Protocol Violation|1|||
27961770|NCT03028129|81691780|FG001|Overall Study|Protocol Violation|1|||
27961771|NCT03028129|81691779|FG000|Overall Study|Withdrawal by Subject|62|||
27961772|NCT03028129|81691780|FG001|Overall Study|Withdrawal by Subject|45|||
27961773|NCT00988052|81691781|FG000|Overall Study|Missing|1|||
27961774|NCT00988052|81691782|FG001|Overall Study|Missing|0|||
27961775|NCT00988052|81691781|FG000|Overall Study|Teva requested subject withdrawal|3|||
27961776|NCT00988052|81691782|FG001|Overall Study|Teva requested subject withdrawal|1|||
27961777|NCT00988052|81691781|FG000|Overall Study|Death|1|||
27961778|NCT00988052|81691782|FG001|Overall Study|Death|3|||
27961779|NCT00988052|81691781|FG000|Overall Study|Protocol Violation|6|||
27961780|NCT00988052|81691782|FG001|Overall Study|Protocol Violation|5|||
27961781|NCT00988052|81691781|FG000|Overall Study|Pregnancy|6|||
27961782|NCT00988052|81691782|FG001|Overall Study|Pregnancy|6|||
27961783|NCT00988052|81691781|FG000|Overall Study|Lack of Efficacy|8|||
27961784|NCT00988052|81691782|FG001|Overall Study|Lack of Efficacy|7|||
27961785|NCT00988052|81691781|FG000|Overall Study|Lost to Follow-up|6|||
27961786|NCT00988052|81691782|FG001|Overall Study|Lost to Follow-up|11|||
27961787|NCT00988052|81691781|FG000|Overall Study|Physician Decision|27|||
27961788|NCT00988052|81691782|FG001|Overall Study|Physician Decision|28|||
27961789|NCT00988052|81691781|FG000|Overall Study|Adverse Event|35|||
27961790|NCT00988052|81691782|FG001|Overall Study|Adverse Event|28|||
27961791|NCT00988052|81691781|FG000|Overall Study|Withdrawal by Subject|90|||
27961792|NCT00988052|81691782|FG001|Overall Study|Withdrawal by Subject|91|||
27961793|NCT00988052|81691781|FG000|Overall Study|Study terminated by sponsor|240|||
27961794|NCT00988052|81691782|FG001|Overall Study|Study terminated by sponsor|236|||
27961795|NCT00995436|81691784|FG000|Overall Study|Withdrawal by Subject|2|||
27961796|NCT00995436|81691785|FG001|Overall Study|Withdrawal by Subject|5|||
27961797|NCT00995436|81691786|FG002|Overall Study|Withdrawal by Subject|0|||
27961798|NCT00758069|81691788|FG000|Overall Study|Lack of Efficacy|0|||
27961799|NCT00758069|81691789|FG001|Overall Study|Lack of Efficacy|0|||
27961800|NCT00758069|81691790|FG002|Overall Study|Lack of Efficacy|1|||
27961801|NCT00758069|81691788|FG000|Overall Study|Incorrect Study Drug|1|||
27961802|NCT00758069|81691789|FG001|Overall Study|Incorrect Study Drug|0|||
27961803|NCT00758069|81691790|FG002|Overall Study|Incorrect Study Drug|0|||
27961804|NCT00124072|81691791|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
27961805|NCT00124072|81691792|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
27961806|NCT00124072|81691793|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
27961807|NCT00124072|81691794|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
27961808|NCT00124072|81691791|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
27961809|NCT00124072|81691792|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
27961810|NCT00124072|81691793|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
27961811|NCT00124072|81691794|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
27961812|NCT00124072|81691791|FG000|Overall Study|Death|499|||
27961813|NCT00124072|81691792|FG001|Overall Study|Death|484|||
27961814|NCT00124072|81691793|FG002|Overall Study|Death|471|||
27961815|NCT00124072|81691794|FG003|Overall Study|Death|480|||
27961816|NCT02413996|81691797|FG000|Overall Study|not comfortable with the intervention|9|||
27961817|NCT02413996|81691798|FG001|Overall Study|not comfortable with the intervention|2|||
27961818|NCT00620373|81691799|FG000|Overall Study|Unverified cancer status|33|||
27961819|NCT02997865|81691800|FG000|Overall Study|Death|2|||
27961820|NCT02997865|81691801|FG001|Overall Study|Death|1|||
27961821|NCT02997865|81691800|FG000|Overall Study|Lost to Follow-up|6|||
27961822|NCT02997865|81691801|FG001|Overall Study|Lost to Follow-up|3|||
27961823|NCT02997865|81691800|FG000|Overall Study|Withdrawal by Subject|5|||
27961824|NCT02997865|81691801|FG001|Overall Study|Withdrawal by Subject|0|||
27961825|NCT03183063|81691802|FG000|Overall Study|Withdrawal by Subject|2|||
27961826|NCT03183063|81691803|FG001|Overall Study|Withdrawal by Subject|0|||
27961827|NCT03183063|81691804|FG002|Overall Study|Withdrawal by Subject|0|||
27961828|NCT03183063|81691802|FG000|Overall Study|Physician Decision|3|||
27961829|NCT03183063|81691803|FG001|Overall Study|Physician Decision|4|||
27961830|NCT03183063|81691804|FG002|Overall Study|Physician Decision|4|||
27961831|NCT00040742|81691805|FG000|Overall Study|Death|0|||
27961832|NCT00040742|81691806|FG001|Overall Study|Death|0|||
27961833|NCT00040742|81691807|FG002|Overall Study|Death|1|||
27961834|NCT00040742|81691808|FG003|Overall Study|Death|0|||
27961835|NCT00040742|81691805|FG000|Overall Study|Adverse Event|15|||
27961836|NCT00040742|81691806|FG001|Overall Study|Adverse Event|16|||
27961837|NCT00040742|81691807|FG002|Overall Study|Adverse Event|21|||
27961838|NCT00040742|81691808|FG003|Overall Study|Adverse Event|9|||
27961839|NCT00040742|81691805|FG000|Overall Study|Withdrawal by Subject|7|||
27961840|NCT00040742|81691806|FG001|Overall Study|Withdrawal by Subject|15|||
27961841|NCT00040742|81691807|FG002|Overall Study|Withdrawal by Subject|10|||
27961842|NCT00040742|81691808|FG003|Overall Study|Withdrawal by Subject|13|||
27961843|NCT00040742|81691805|FG000|Overall Study|Chemotoxicity|4|||
27961844|NCT00040742|81691806|FG001|Overall Study|Chemotoxicity|3|||
27961845|NCT00040742|81691807|FG002|Overall Study|Chemotoxicity|5|||
27961846|NCT00040742|81691808|FG003|Overall Study|Chemotoxicity|2|||
27961847|NCT00040742|81691805|FG000|Overall Study|Incomplete Forms|6|||
27961848|NCT00040742|81691806|FG001|Overall Study|Incomplete Forms|10|||
27961849|NCT00040742|81691807|FG002|Overall Study|Incomplete Forms|4|||
27961850|NCT00040742|81691808|FG003|Overall Study|Incomplete Forms|5|||
27961851|NCT00040742|81691805|FG000|Overall Study|Other medical|7|||
27961852|NCT00040742|81691806|FG001|Overall Study|Other medical|5|||
27961853|NCT00040742|81691807|FG002|Overall Study|Other medical|5|||
27961854|NCT00040742|81691808|FG003|Overall Study|Other medical|5|||
27961855|NCT00861692|81691809|FG000|Overall Study|Death|6|||
27961856|NCT03835481|81691810|FG000|Double-blind Period|Other not stated below|0|||
27961857|NCT03835481|81691811|FG001|Double-blind Period|Other not stated below|0|||
27961858|NCT03835481|81691812|FG002|Double-blind Period|Other not stated below|0|||
27961859|NCT03835481|81691813|FG003|Double-blind Period|Other not stated below|1|||
27961860|NCT03835481|81691814|FG004|Double-blind Period|Other not stated below|1|||
27961861|NCT03835481|81691810|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
27961862|NCT03835481|81691811|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
27961863|NCT03835481|81691812|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
27961864|NCT03835481|81691813|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
27961865|NCT03835481|81691814|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
27961866|NCT03835481|81691810|FG000|Double-blind Period|Withdrawal by Subject|0|||
27961867|NCT03835481|81691811|FG001|Double-blind Period|Withdrawal by Subject|0|||
27961868|NCT03835481|81691812|FG002|Double-blind Period|Withdrawal by Subject|1|||
27961869|NCT03835481|81691813|FG003|Double-blind Period|Withdrawal by Subject|0|||
27961870|NCT03835481|81691814|FG004|Double-blind Period|Withdrawal by Subject|5|||
27961871|NCT03835481|81691810|FG000|Double-blind Period|Lost to Follow-up|0|||
27961872|NCT03835481|81691811|FG001|Double-blind Period|Lost to Follow-up|0|||
27961873|NCT03835481|81691812|FG002|Double-blind Period|Lost to Follow-up|0|||
27961874|NCT03835481|81691813|FG003|Double-blind Period|Lost to Follow-up|1|||
27961875|NCT03835481|81691814|FG004|Double-blind Period|Lost to Follow-up|0|||
27961876|NCT03835481|81691810|FG000|Double-blind Period|Protocol Violation|0|||
27961877|NCT03835481|81691811|FG001|Double-blind Period|Protocol Violation|2|||
27961878|NCT03835481|81691812|FG002|Double-blind Period|Protocol Violation|0|||
27961879|NCT03835481|81691813|FG003|Double-blind Period|Protocol Violation|1|||
27961880|NCT03835481|81691814|FG004|Double-blind Period|Protocol Violation|0|||
27961881|NCT03835481|81691810|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
27961882|NCT03835481|81691811|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
27961883|NCT03835481|81691812|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
27961884|NCT03835481|81691813|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
27961885|NCT03835481|81691814|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
27961886|NCT03835481|81691810|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
27961887|NCT03835481|81691811|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
27961888|NCT03835481|81691812|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
27961889|NCT03835481|81691813|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
27961890|NCT03835481|81691814|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
27961891|NCT03835481|81691810|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
27961892|NCT03835481|81691811|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
27961893|NCT03835481|81691812|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
27961894|NCT03835481|81691813|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
27961895|NCT03835481|81691814|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
27961896|NCT03835481|81691810|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
27961897|NCT03835481|81691811|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
27961898|NCT03835481|81691812|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
27961899|NCT03835481|81691813|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
27961900|NCT03835481|81691814|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
27961901|NCT03835481|81691810|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
27961902|NCT03835481|81691811|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
27961903|NCT03835481|81691812|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
27961904|NCT03835481|81691813|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
27961905|NCT03835481|81691814|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
27961906|NCT03835481|81691810|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
27961907|NCT03835481|81691811|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
27961908|NCT03835481|81691812|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
27961909|NCT03835481|81691813|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
27961910|NCT03835481|81691814|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
27961911|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
27961912|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
27961913|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
27961914|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
27961915|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
27961916|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
27961917|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
27961918|NCT01673854|81691823|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
27961919|NCT01673854|81691823|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
27961920|NCT01673854|81691823|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
27961921|NCT01673854|81691823|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
27961922|NCT01673854|81691823|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
27961923|NCT02151903|81691824|FG000|Overall Study|Withdrawal by Subject|1|||
27961924|NCT02151903|81691825|FG001|Overall Study|Withdrawal by Subject|0|||
27961925|NCT02151903|81691824|FG000|Overall Study|Progressive disease|2|||
27961926|NCT02151903|81691825|FG001|Overall Study|Progressive disease|1|||
27961927|NCT00739310|81691826|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
27961928|NCT00739310|81691826|FG000|Overall Study|Withdrawal by Subject|1|||
27961929|NCT00739310|81691826|FG000|Overall Study|Lost to Follow-up|2|||
27961930|NCT00703846|81691829|FG000|Overall Study|Adverse Event|8|||
27961931|NCT00703846|81691829|FG000|Overall Study|Lost to Follow-up|55|||
27961932|NCT00703846|81691829|FG000|Overall Study|Lack of Efficacy|15|||
27562604|NCT02016482|80249879|FG000|Period A|Withdrawal by Subject|3|||
27562605|NCT02016482|80249880|FG001|Period A|Withdrawal by Subject|4|||
27562606|NCT02016482|80249879|FG000|Period A|Lost to Follow-up|3|||
27562607|NCT02016482|80249880|FG001|Period A|Lost to Follow-up|3|||
27562608|NCT02016482|80249879|FG000|Period A|Lack of Efficacy|2|||
27562609|NCT02016482|80249880|FG001|Period A|Lack of Efficacy|1|||
27562610|NCT02016482|80249879|FG000|Period A|Other|3|||
27562611|NCT02016482|80249880|FG001|Period A|Other|0|||
27562612|NCT02016482|80249879|FG000|Period A|Protocol Violation|0|||
27562613|NCT02016482|80249880|FG001|Period A|Protocol Violation|1|||
27562614|NCT02016482|80249879|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
27562615|NCT02016482|80249880|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
27562616|NCT02016482|80249879|FG000|Period B|Withdrawal by Subject|1|||
27562617|NCT02016482|80249880|FG001|Period B|Withdrawal by Subject|1|||
27562618|NCT02016482|80249879|FG000|Period B|Lost to Follow-up|2|||
27562619|NCT02016482|80249880|FG001|Period B|Lost to Follow-up|0|||
27562620|NCT02016482|80249879|FG000|Period B|Lack of Efficacy|6|||
27562621|NCT02016482|80249880|FG001|Period B|Lack of Efficacy|4|||
27562622|NCT02016482|80249879|FG000|Period B|Other|4|||
27562623|NCT02016482|80249880|FG001|Period B|Other|0|||
27562624|NCT02016482|80249879|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
27756911|NCT00006604|80936559|FG001|Overall Study|Death|0|||
27562625|NCT02016482|80249880|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
27562626|NCT00679263|80249885|FG000|Visit 2/Dose 1|Adverse Event|1|||
27562627|NCT00679263|80249886|FG001|Visit 2/Dose 1|Adverse Event|0|||
27562628|NCT00679263|80249887|FG002|Visit 2/Dose 1|Adverse Event|0|||
27562629|NCT00679263|80249885|FG000|Visit 2/Dose 1|subject not compliance|1|||
27562630|NCT00679263|80249886|FG001|Visit 2/Dose 1|subject not compliance|1|||
27562631|NCT00679263|80249887|FG002|Visit 2/Dose 1|subject not compliance|0|||
27562632|NCT01132547|80249889|FG000|Overall Study|Withdrawal by Subject|3|||
27562633|NCT01132547|80249890|FG001|Overall Study|Withdrawal by Subject|1|||
27562634|NCT01132547|80249889|FG000|Overall Study|Death|1|||
27562635|NCT01132547|80249890|FG001|Overall Study|Death|0|||
27562636|NCT00329407|80249893|FG000|Overall Study|Withdrawal by Subject|1|||
27562637|NCT02197806|80249894|FG000|Overall Study|Adverse Event|0|||
27562638|NCT02197806|80249895|FG001|Overall Study|Adverse Event|1|||
27562639|NCT02197806|80249896|FG002|Overall Study|Adverse Event|0|||
27562640|NCT02197806|80249897|FG003|Overall Study|Adverse Event|1|||
27562641|NCT01471379|80249904|FG000|Overall Study|Adverse Event|1|||
27562642|NCT01471379|80249905|FG001|Overall Study|Adverse Event|0|||
27562643|NCT01471379|80249906|FG002|Overall Study|Adverse Event|0|||
27756912|NCT00006604|80936560|FG002|Overall Study|Death|0|||
27756913|NCT00006604|80936561|FG003|Overall Study|Death|0|||
27756914|NCT00006604|80936562|FG004|Overall Study|Death|0|||
27756915|NCT00006604|80936563|FG005|Overall Study|Death|0|||
27756916|NCT00006604|80936564|FG006|Overall Study|Death|0|||
27756917|NCT00006604|80936565|FG007|Overall Study|Death|0|||
27756918|NCT00006604|80936566|FG008|Overall Study|Death|0|||
27756919|NCT00006604|80936567|FG009|Overall Study|Death|1|||
27756920|NCT00006604|80936568|FG010|Overall Study|Death|1|||
27756921|NCT00006604|80936569|FG011|Overall Study|Death|1|||
27756922|NCT00006604|80936570|FG012|Overall Study|Death|0|||
27756923|NCT00006604|80936571|FG013|Overall Study|Death|0|||
27756924|NCT00006604|80936572|FG014|Overall Study|Death|0|||
27756925|NCT00006604|80936573|FG015|Overall Study|Death|0|||
27756926|NCT00006604|80936574|FG016|Overall Study|Death|0|||
27756927|NCT00006604|80936558|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27756928|NCT00006604|80936559|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27756929|NCT00006604|80936560|FG002|Overall Study|Severe debilitation, unable to continue|0|||
27756930|NCT00006604|80936561|FG003|Overall Study|Severe debilitation, unable to continue|0|||
27756931|NCT00006604|80936562|FG004|Overall Study|Severe debilitation, unable to continue|0|||
27756932|NCT00006604|80936563|FG005|Overall Study|Severe debilitation, unable to continue|0|||
27756933|NCT00006604|80936564|FG006|Overall Study|Severe debilitation, unable to continue|3|||
27756934|NCT00006604|80936565|FG007|Overall Study|Severe debilitation, unable to continue|0|||
27756935|NCT00006604|80936566|FG008|Overall Study|Severe debilitation, unable to continue|0|||
27859167|NCT04594707|81319258|FG002|Overall Study|Death|2|||
27756936|NCT00006604|80936567|FG009|Overall Study|Severe debilitation, unable to continue|5|||
27756937|NCT00006604|80936568|FG010|Overall Study|Severe debilitation, unable to continue|0|||
27756938|NCT00006604|80936569|FG011|Overall Study|Severe debilitation, unable to continue|2|||
27756939|NCT00006604|80936570|FG012|Overall Study|Severe debilitation, unable to continue|1|||
27756940|NCT00006604|80936571|FG013|Overall Study|Severe debilitation, unable to continue|0|||
27756941|NCT00006604|80936572|FG014|Overall Study|Severe debilitation, unable to continue|2|||
27756942|NCT00006604|80936573|FG015|Overall Study|Severe debilitation, unable to continue|0|||
27756943|NCT00006604|80936574|FG016|Overall Study|Severe debilitation, unable to continue|0|||
27756944|NCT00006604|80936558|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
27756945|NCT00006604|80936559|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
27756946|NCT00006604|80936560|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
27756947|NCT00006604|80936561|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
27562644|NCT01471379|80249904|FG000|Overall Study|Study terminated|0|||
27562645|NCT01471379|80249905|FG001|Overall Study|Study terminated|1|||
27562646|NCT01471379|80249906|FG002|Overall Study|Study terminated|0|||
27562647|NCT00454987|80249907|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
27562648|NCT00454987|80249908|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
27562649|NCT00454987|80249909|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
27562650|NCT00454987|80249907|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
27562651|NCT00454987|80249908|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
27562652|NCT00454987|80249909|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
27562653|NCT00454987|80249907|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
27562654|NCT00454987|80249908|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
27562655|NCT00454987|80249909|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
27562656|NCT03571581|80249910|FG000|Overall Study|Death|2|||
27562657|NCT03571581|80249910|FG000|Overall Study|Withdrawal by Subject|2|||
27562658|NCT02255500|80249911|FG000|Overall Study|Withdrawal by Subject|1|||
27562659|NCT02255500|80249912|FG001|Overall Study|Withdrawal by Subject|0|||
27562660|NCT02723084|80249913|FG000|Overall Study|Withdrawal by Subject|1|||
27562661|NCT02723084|80249914|FG001|Overall Study|Withdrawal by Subject|1|||
27562662|NCT02723084|80249913|FG000|Overall Study|Lost to Follow-up|3|||
27562663|NCT02723084|80249914|FG001|Overall Study|Lost to Follow-up|0|||
27562664|NCT01480076|80249915|FG000|Overall Study|Run-in Failure|52|||
27562665|NCT01480076|80249915|FG000|Overall Study|Adverse Event|39|||
27562666|NCT01480076|80249915|FG000|Overall Study|Death|2|||
27562667|NCT01480076|80249915|FG000|Overall Study|Disease Progression|5|||
27562668|NCT01480076|80249915|FG000|Overall Study|Non-compliance With Study Protocol|15|||
27562669|NCT01480076|80249915|FG000|Overall Study|Withdrawal by Subject|105|||
27562670|NCT01480076|80249915|FG000|Overall Study|Lost to Follow-up|7|||
27562671|NCT01480076|80249915|FG000|Overall Study|Investigator Decision|13|||
27562672|NCT01480076|80249915|FG000|Overall Study|Other|52|||
27562673|NCT04824131|80249916|FG000|CAB LA Oral Phase|Adverse Event|1|||
27562674|NCT04824131|80249916|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
27562675|NCT04824131|80249916|FG000|Step 3|Withdrawal by Subject|2|||
27562676|NCT00520975|80249919|FG000|Overall Study|Disease progression|31|||
27562677|NCT00520975|80249920|FG001|Overall Study|Disease progression|23|||
27562678|NCT00520975|80249919|FG000|Overall Study|Adverse Event|7|||
27562679|NCT00520975|80249920|FG001|Overall Study|Adverse Event|10|||
27562680|NCT00520975|80249919|FG000|Overall Study|Death|0|||
27562681|NCT00520975|80249920|FG001|Overall Study|Death|2|||
27562682|NCT00520975|80249919|FG000|Overall Study|Withdrawal by Subject|3|||
27562683|NCT00520975|80249920|FG001|Overall Study|Withdrawal by Subject|5|||
27562684|NCT00520975|80249919|FG000|Overall Study|Other therapy|2|||
27562685|NCT00520975|80249920|FG001|Overall Study|Other therapy|4|||
27562686|NCT00520975|80249919|FG000|Overall Study|Other reasons|4|||
27562687|NCT00520975|80249920|FG001|Overall Study|Other reasons|2|||
27562688|NCT00520975|80249919|FG000|Overall Study|Not start protocol therapy|1|||
27562689|NCT00520975|80249920|FG001|Overall Study|Not start protocol therapy|2|||
27562690|NCT02784821|80249921|FG000|Overall Study|Death|0|||
27562691|NCT02784821|80249922|FG001|Overall Study|Death|5|||
27562692|NCT02784821|80249923|FG002|Overall Study|Death|4|||
27562693|NCT02784821|80249924|FG003|Overall Study|Death|5|||
27562694|NCT03204981|80249925|FG000|Overall Study|Physician Decision|2|||
27562695|NCT03204981|80249925|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
27562696|NCT00946712|80249930|FG000|Overall Study|Adverse Event|118|||
27562697|NCT00946712|80249931|FG001|Overall Study|Adverse Event|124|||
27562698|NCT00946712|80249930|FG000|Overall Study|Disease progression|308|||
27562699|NCT00946712|80249931|FG001|Overall Study|Disease progression|404|||
27562700|NCT00946712|80249930|FG000|Overall Study|Death|21|||
27562701|NCT00946712|80249931|FG001|Overall Study|Death|22|||
27562702|NCT00946712|80249930|FG000|Overall Study|No treatment given|25|||
27562703|NCT00946712|80249931|FG001|Overall Study|No treatment given|29|||
27562704|NCT00946712|80249930|FG000|Overall Study|Other reasons|61|||
27562705|NCT00946712|80249931|FG001|Overall Study|Other reasons|73|||
27562706|NCT00946712|80249930|FG000|Overall Study|On Treatment|0|||
27562707|NCT00946712|80249931|FG001|Overall Study|On Treatment|4|||
27562708|NCT00946712|80249930|FG000|Overall Study|Ineligible|14|||
27562709|NCT00946712|80249931|FG001|Overall Study|Ineligible|6|||
27562710|NCT02206828|80249934|FG000|Overall Study|Lost to Follow-up|7|||
27562711|NCT00501293|80249940|FG000|Optimization Period|Enrolled in error|1|||
27562712|NCT00501293|80249941|FG001|Optimization Period|Enrolled in error|0|||
27562713|NCT00501293|80249940|FG000|Maintenance Period|Withdrawal by Subject|14|||
27562714|NCT00501293|80249941|FG001|Maintenance Period|Withdrawal by Subject|13|||
27562715|NCT00501293|80249940|FG000|Maintenance Period|Lost to Follow-up|12|||
27562716|NCT00501293|80249941|FG001|Maintenance Period|Lost to Follow-up|7|||
27562717|NCT00501293|80249940|FG000|Maintenance Period|Adverse Event|6|||
27562718|NCT00501293|80249941|FG001|Maintenance Period|Adverse Event|6|||
27562719|NCT00501293|80249940|FG000|Maintenance Period|Protocol Violation|2|||
27562720|NCT00501293|80249941|FG001|Maintenance Period|Protocol Violation|1|||
27562721|NCT00501293|80249940|FG000|Maintenance Period|Lack of Efficacy|4|||
27562722|NCT00501293|80249941|FG001|Maintenance Period|Lack of Efficacy|1|||
27562723|NCT00501293|80249940|FG000|Maintenance Period|Noncompliant with study medication|5|||
27562724|NCT00501293|80249941|FG001|Maintenance Period|Noncompliant with study medication|0|||
27562725|NCT00501293|80249940|FG000|Maintenance Period|Went into rehabilitation|1|||
27562726|NCT00501293|80249941|FG001|Maintenance Period|Went into rehabilitation|0|||
27562727|NCT00501293|80249940|FG000|Maintenance Period|Would not wear patch|1|||
27562728|NCT00501293|80249941|FG001|Maintenance Period|Would not wear patch|0|||
27562729|NCT00501293|80249940|FG000|Maintenance Period|Application site reaction|1|||
27562730|NCT00501293|80249941|FG001|Maintenance Period|Application site reaction|0|||
27562731|NCT00951665|80249942|FG000|Phase 1b|Adverse Event|2|||
27562732|NCT00951665|80249943|FG001|Phase 1b|Adverse Event|1|||
27562733|NCT00951665|80249944|FG002|Phase 1b|Adverse Event|0|||
27562734|NCT00951665|80249945|FG003|Phase 1b|Adverse Event|1|||
27562735|NCT00951665|80249946|FG004|Phase 1b|Adverse Event|0|||
27562736|NCT00951665|80249947|FG005|Phase 1b|Adverse Event|0|||
27562737|NCT00951665|80249942|FG000|Phase 1b|Death|1|||
27562738|NCT00951665|80249943|FG001|Phase 1b|Death|0|||
27562739|NCT00951665|80249944|FG002|Phase 1b|Death|2|||
27562740|NCT00951665|80249945|FG003|Phase 1b|Death|0|||
27562741|NCT00951665|80249946|FG004|Phase 1b|Death|0|||
27562742|NCT00951665|80249947|FG005|Phase 1b|Death|0|||
27562743|NCT00951665|80249942|FG000|Phase 1b|Physician Decision|4|||
27562744|NCT00951665|80249943|FG001|Phase 1b|Physician Decision|0|||
27562745|NCT00951665|80249944|FG002|Phase 1b|Physician Decision|1|||
27562746|NCT00951665|80249945|FG003|Phase 1b|Physician Decision|0|||
27562747|NCT00951665|80249946|FG004|Phase 1b|Physician Decision|0|||
27562748|NCT00951665|80249947|FG005|Phase 1b|Physician Decision|0|||
27562749|NCT00951665|80249942|FG000|Phase 1b|Withdrawal by Subject|0|||
27562750|NCT00951665|80249943|FG001|Phase 1b|Withdrawal by Subject|1|||
27562751|NCT00951665|80249944|FG002|Phase 1b|Withdrawal by Subject|0|||
27562752|NCT00951665|80249945|FG003|Phase 1b|Withdrawal by Subject|0|||
27562753|NCT00951665|80249946|FG004|Phase 1b|Withdrawal by Subject|0|||
27562754|NCT00951665|80249947|FG005|Phase 1b|Withdrawal by Subject|0|||
27562755|NCT00951665|80249942|FG000|Phase 1b|Disease Progression|13|||
27562756|NCT00951665|80249943|FG001|Phase 1b|Disease Progression|2|||
27562757|NCT00951665|80249944|FG002|Phase 1b|Disease Progression|14|||
27562758|NCT00951665|80249945|FG003|Phase 1b|Disease Progression|0|||
27562759|NCT00951665|80249946|FG004|Phase 1b|Disease Progression|0|||
27562760|NCT00951665|80249947|FG005|Phase 1b|Disease Progression|0|||
27756948|NCT00006604|80936562|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
27562761|NCT00951665|80249942|FG000|Phase 1b|Protocol Violation|2|||
27859168|NCT04594707|81319256|FG000|Overall Study|Lung Transplant|0|||
27562762|NCT00951665|80249943|FG001|Phase 1b|Protocol Violation|0|||
27562763|NCT00951665|80249944|FG002|Phase 1b|Protocol Violation|0|||
27562764|NCT00951665|80249945|FG003|Phase 1b|Protocol Violation|0|||
27562765|NCT00951665|80249946|FG004|Phase 1b|Protocol Violation|0|||
27562766|NCT00951665|80249947|FG005|Phase 1b|Protocol Violation|0|||
27562767|NCT00951665|80249942|FG000|Phase 2a|Adverse Event|0|||
27562768|NCT00951665|80249943|FG001|Phase 2a|Adverse Event|0|||
27756949|NCT00006604|80936563|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
27562769|NCT00951665|80249944|FG002|Phase 2a|Adverse Event|0|||
27562770|NCT00951665|80249945|FG003|Phase 2a|Adverse Event|0|||
27562771|NCT00951665|80249946|FG004|Phase 2a|Adverse Event|2|||
27562772|NCT00951665|80249947|FG005|Phase 2a|Adverse Event|0|||
27562773|NCT00951665|80249942|FG000|Phase 2a|Death|0|||
27562774|NCT00951665|80249943|FG001|Phase 2a|Death|0|||
27562775|NCT00951665|80249944|FG002|Phase 2a|Death|0|||
27562776|NCT00951665|80249945|FG003|Phase 2a|Death|0|||
27562777|NCT00951665|80249946|FG004|Phase 2a|Death|1|||
27562778|NCT00951665|80249947|FG005|Phase 2a|Death|1|||
27562779|NCT00951665|80249942|FG000|Phase 2a|Lost to Follow-up|0|||
27562780|NCT00951665|80249943|FG001|Phase 2a|Lost to Follow-up|0|||
27562781|NCT00951665|80249944|FG002|Phase 2a|Lost to Follow-up|0|||
27562782|NCT00951665|80249945|FG003|Phase 2a|Lost to Follow-up|0|||
27562783|NCT00951665|80249946|FG004|Phase 2a|Lost to Follow-up|1|||
27562784|NCT00951665|80249947|FG005|Phase 2a|Lost to Follow-up|0|||
27562785|NCT00951665|80249942|FG000|Phase 2a|Physician Decision|0|||
27562786|NCT00951665|80249943|FG001|Phase 2a|Physician Decision|0|||
27562787|NCT00951665|80249944|FG002|Phase 2a|Physician Decision|0|||
27562788|NCT00951665|80249945|FG003|Phase 2a|Physician Decision|0|||
27562789|NCT00951665|80249946|FG004|Phase 2a|Physician Decision|0|||
27562790|NCT00951665|80249947|FG005|Phase 2a|Physician Decision|1|||
27562791|NCT00951665|80249942|FG000|Phase 2a|Withdrawal by Subject|0|||
27562792|NCT00951665|80249943|FG001|Phase 2a|Withdrawal by Subject|0|||
27562793|NCT00951665|80249944|FG002|Phase 2a|Withdrawal by Subject|0|||
27562794|NCT00951665|80249945|FG003|Phase 2a|Withdrawal by Subject|0|||
27562795|NCT00951665|80249946|FG004|Phase 2a|Withdrawal by Subject|2|||
27562796|NCT00951665|80249947|FG005|Phase 2a|Withdrawal by Subject|0|||
27562797|NCT00951665|80249942|FG000|Phase 2a|Disease Progression|0|||
27562798|NCT00951665|80249943|FG001|Phase 2a|Disease Progression|0|||
27562799|NCT00951665|80249944|FG002|Phase 2a|Disease Progression|0|||
27562800|NCT00951665|80249945|FG003|Phase 2a|Disease Progression|0|||
27562801|NCT00951665|80249946|FG004|Phase 2a|Disease Progression|6|||
27562802|NCT00951665|80249947|FG005|Phase 2a|Disease Progression|5|||
27562803|NCT03897179|80249948|FG000|Overall Study|Withdrawal by Subject|1|||
27562804|NCT00071760|80249949|FG000|Overall Study|Adverse Event|2|||
27562805|NCT00071760|80249950|FG001|Overall Study|Adverse Event|1|||
27562806|NCT00071760|80249949|FG000|Overall Study|Lost to Follow-up|0|||
27562807|NCT00071760|80249950|FG001|Overall Study|Lost to Follow-up|3|||
27562808|NCT00071760|80249949|FG000|Overall Study|Protocol Violation|1|||
27562809|NCT00071760|80249950|FG001|Overall Study|Protocol Violation|0|||
27562810|NCT00071760|80249949|FG000|Overall Study|Withdrawal by Subject|0|||
27562811|NCT00071760|80249950|FG001|Overall Study|Withdrawal by Subject|1|||
27562812|NCT00071760|80249949|FG000|Overall Study|Insufficient Viral Load Response|1|||
27562813|NCT00071760|80249950|FG001|Overall Study|Insufficient Viral Load Response|1|||
27562814|NCT00071760|80249949|FG000|Overall Study|Lack of availability of RTV|1|||
27562815|NCT00071760|80249950|FG001|Overall Study|Lack of availability of RTV|0|||
27562816|NCT00071760|80249949|FG000|Overall Study|Physician Decision|2|||
27562817|NCT00071760|80249950|FG001|Overall Study|Physician Decision|1|||
27562818|NCT00071760|80249949|FG000|Overall Study|Relocation|0|||
27562819|NCT00071760|80249950|FG001|Overall Study|Relocation|1|||
27562820|NCT01265849|80249951|FG000|Overall Study|Randomized//Treatment not initiated|1|||
27562821|NCT01265849|80249952|FG001|Overall Study|Randomized//Treatment not initiated|4|||
27562822|NCT01265849|80249953|FG002|Overall Study|Randomized//Treatment not initiated|0|||
27562823|NCT01265849|80249951|FG000|Overall Study|Physician Decision|1|||
27562824|NCT01265849|80249952|FG001|Overall Study|Physician Decision|2|||
27562825|NCT01265849|80249953|FG002|Overall Study|Physician Decision|0|||
27562826|NCT01265849|80249951|FG000|Overall Study|Lost to Follow-up|18|||
27562827|NCT01265849|80249952|FG001|Overall Study|Lost to Follow-up|15|||
27562828|NCT01265849|80249953|FG002|Overall Study|Lost to Follow-up|5|||
27562829|NCT01265849|80249951|FG000|Overall Study|Not otherwise specified|1|||
27562830|NCT01265849|80249952|FG001|Overall Study|Not otherwise specified|6|||
27562831|NCT01265849|80249953|FG002|Overall Study|Not otherwise specified|1|||
27562832|NCT01265849|80249951|FG000|Overall Study|Withdrawal by Subject|25|||
27562833|NCT01265849|80249952|FG001|Overall Study|Withdrawal by Subject|34|||
27562834|NCT01265849|80249953|FG002|Overall Study|Withdrawal by Subject|13|||
27562835|NCT01092182|80249954|FG000|Overall Study|Death|0|||
27562836|NCT01092182|80249955|FG001|Overall Study|Death|5|||
27562837|NCT01092182|80249956|FG002|Overall Study|Death|3|||
27562838|NCT01092182|80249954|FG000|Overall Study|participant safety|1|||
27562839|NCT01092182|80249955|FG001|Overall Study|participant safety|2|||
27562840|NCT01092182|80249956|FG002|Overall Study|participant safety|0|||
27562841|NCT01092182|80249954|FG000|Overall Study|Physician Decision|0|||
27562842|NCT01092182|80249955|FG001|Overall Study|Physician Decision|6|||
27562843|NCT01092182|80249956|FG002|Overall Study|Physician Decision|0|||
27562844|NCT01092182|80249954|FG000|Overall Study|Did not meet criteria|0|||
27562845|NCT01092182|80249955|FG001|Overall Study|Did not meet criteria|0|||
27562846|NCT01092182|80249956|FG002|Overall Study|Did not meet criteria|25|||
27562847|NCT01092182|80249954|FG000|Overall Study|Non-compliance|0|||
27562848|NCT01092182|80249955|FG001|Overall Study|Non-compliance|3|||
27562849|NCT01092182|80249956|FG002|Overall Study|Non-compliance|0|||
27562850|NCT01092182|80249954|FG000|Overall Study|Participant refused follow-up|0|||
27562851|NCT01092182|80249955|FG001|Overall Study|Participant refused follow-up|2|||
27562852|NCT01092182|80249956|FG002|Overall Study|Participant refused follow-up|0|||
27562853|NCT02604212|80249957|FG000|Overall Study|Study Terminated by Sponsor|2|||
27562854|NCT02604212|80249958|FG001|Overall Study|Study Terminated by Sponsor|1|||
27562855|NCT02604212|80249959|FG002|Overall Study|Study Terminated by Sponsor|3|||
27562856|NCT02604212|80249960|FG003|Overall Study|Study Terminated by Sponsor|3|||
27562857|NCT02604212|80249957|FG000|Overall Study|Withdrawal by Subject|0|||
27562858|NCT02604212|80249958|FG001|Overall Study|Withdrawal by Subject|0|||
27562859|NCT02604212|80249959|FG002|Overall Study|Withdrawal by Subject|1|||
27562860|NCT02604212|80249960|FG003|Overall Study|Withdrawal by Subject|0|||
27562861|NCT02171260|80249963|FG000|Overall Study|Death|0|||
27562862|NCT02171260|80249964|FG001|Overall Study|Death|0|||
27562863|NCT02171260|80249965|FG002|Overall Study|Death|0|||
27562864|NCT02171260|80249966|FG003|Overall Study|Death|1|||
27562865|NCT02171260|80249963|FG000|Overall Study|Physician Decision|1|||
27562866|NCT02171260|80249964|FG001|Overall Study|Physician Decision|0|||
27562867|NCT02171260|80249965|FG002|Overall Study|Physician Decision|1|||
27562868|NCT02171260|80249966|FG003|Overall Study|Physician Decision|0|||
27562869|NCT02171260|80249963|FG000|Overall Study|Withdrawal by Subject|1|||
27562870|NCT02171260|80249964|FG001|Overall Study|Withdrawal by Subject|0|||
27562871|NCT02171260|80249965|FG002|Overall Study|Withdrawal by Subject|0|||
27562872|NCT02171260|80249966|FG003|Overall Study|Withdrawal by Subject|0|||
27562873|NCT02171260|80249963|FG000|Overall Study|Evidence of progressive disease|4|||
27562874|NCT02171260|80249964|FG001|Overall Study|Evidence of progressive disease|6|||
27562875|NCT02171260|80249965|FG002|Overall Study|Evidence of progressive disease|4|||
27562876|NCT02171260|80249966|FG003|Overall Study|Evidence of progressive disease|4|||
27562877|NCT01050257|80249967|FG000|Overall Study|Adverse Event|4|||
27562878|NCT01050257|80249968|FG001|Overall Study|Adverse Event|4|||
27562879|NCT01050257|80249969|FG002|Overall Study|Adverse Event|2|||
27562880|NCT01050257|80249967|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
27562881|NCT01050257|80249968|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
27562882|NCT01050257|80249969|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
27562883|NCT01050257|80249967|FG000|Overall Study|Withdrawal by Subject|0|||
27562884|NCT01050257|80249968|FG001|Overall Study|Withdrawal by Subject|3|||
27562885|NCT01050257|80249969|FG002|Overall Study|Withdrawal by Subject|0|||
27562886|NCT01050257|80249967|FG000|Overall Study|No reason specified|0|||
27562887|NCT01050257|80249968|FG001|Overall Study|No reason specified|0|||
27562888|NCT01050257|80249969|FG002|Overall Study|No reason specified|2|||
27562889|NCT01050257|80249967|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
27562890|NCT01050257|80249968|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
27562891|NCT01050257|80249969|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
27562892|NCT01050257|80249967|FG000|Overall Study|Violation criteria|0|||
27562893|NCT01050257|80249968|FG001|Overall Study|Violation criteria|1|||
27562894|NCT01050257|80249969|FG002|Overall Study|Violation criteria|0|||
27562895|NCT01050257|80249967|FG000|Overall Study|Failure to return|0|||
27562896|NCT01050257|80249968|FG001|Overall Study|Failure to return|2|||
27562897|NCT01050257|80249969|FG002|Overall Study|Failure to return|0|||
27562898|NCT01050257|80249967|FG000|Overall Study|Death|0|||
27562899|NCT01050257|80249968|FG001|Overall Study|Death|0|||
27562900|NCT01050257|80249969|FG002|Overall Study|Death|1|||
27562901|NCT04404855|80249970|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
27562902|NCT04404855|80249971|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
27562903|NCT00665353|80249972|FG000|Study Step 1|Adverse Event|1|||
27562904|NCT00665353|80249972|FG000|Study Step 1|Withdrawal by Subject|2|||
27562905|NCT00665353|80249972|FG000|Study Step 2|Lost to Follow-up|2|||
27562906|NCT00665353|80249972|FG000|Study Step 2|Lack of Efficacy|12|||
27562907|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
27562908|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
27562909|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
27562910|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
27562911|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
27562912|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
27562913|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
27562914|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
27562915|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
27562916|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
27562917|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
27562918|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
27562919|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
27562920|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
27562921|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
27562922|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
27562923|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
27562924|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
27562925|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
27562926|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
27562927|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
27562928|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
27562929|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
27562930|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
27562931|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
27562932|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
27562933|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
27562934|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
27562935|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
27562936|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
27562937|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
27562938|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
27562939|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
27562940|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
27562941|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
27562942|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
27562943|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
27562944|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
27562945|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
27562946|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
27562947|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
27562948|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
27562949|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
27562950|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
27562951|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
27562952|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
27562953|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
27562954|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
27562955|NCT03720470|80249976|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
27562956|NCT03720470|80249977|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
27562957|NCT03720470|80249978|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
27562958|NCT03720470|80249979|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
27562959|NCT03720470|80249980|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
27562960|NCT03720470|80249981|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
27562961|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
27562962|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
27562963|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
27562964|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
27562965|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
27562966|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
27562967|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
27562968|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
27562969|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
27562970|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
27562971|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
27562972|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
27562973|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
27562974|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
27562975|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
27562976|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
27562977|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
27562978|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
27562979|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
27562980|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
27562981|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
27562982|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
27562983|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
27562984|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
27562985|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
27562986|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
27562987|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
27562988|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
27562989|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
27562990|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
27562991|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
27562992|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
27562993|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
27562994|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
27562995|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
27562996|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
27562997|NCT03720470|80249976|FG000|Treatment Period: Final 4 Weeks|Other|0|||
27562998|NCT03720470|80249977|FG001|Treatment Period: Final 4 Weeks|Other|1|||
27562999|NCT03720470|80249978|FG002|Treatment Period: Final 4 Weeks|Other|0|||
27563000|NCT03720470|80249979|FG003|Treatment Period: Final 4 Weeks|Other|2|||
27563001|NCT03720470|80249980|FG004|Treatment Period: Final 4 Weeks|Other|1|||
27563002|NCT03720470|80249981|FG005|Treatment Period: Final 4 Weeks|Other|0|||
27563003|NCT00445965|80249988|FG000|Overall Study|Adverse Event|2|||
27563004|NCT00445965|80249988|FG000|Overall Study|Physician Decision|1|||
27563005|NCT00445965|80249988|FG000|Overall Study|Enrolled but not treated|1|||
27563006|NCT00445965|80249988|FG000|Overall Study|Removed due to progressive disease|29|||
27563007|NCT01132482|80249993|FG000|Overall Study|Adverse Event|1|||
27563008|NCT01132482|80249994|FG001|Overall Study|Adverse Event|0|||
27563009|NCT01990495|80249995|FG000|Overall Study|Physician Decision|5|||
27563010|NCT01990495|80249996|FG001|Overall Study|Physician Decision|4|||
27563011|NCT03745937|80249997|FG000|Overall Study|Withdrawal by Subject|0|||
27563012|NCT03745937|80249998|FG001|Overall Study|Withdrawal by Subject|0|||
27563013|NCT03745937|80249999|FG002|Overall Study|Withdrawal by Subject|0|||
27563014|NCT03745937|80250000|FG003|Overall Study|Withdrawal by Subject|1|||
27563015|NCT03745937|80249997|FG000|Overall Study|Not-specifed|0|||
27563016|NCT03745937|80249998|FG001|Overall Study|Not-specifed|1|||
27563017|NCT03745937|80249999|FG002|Overall Study|Not-specifed|0|||
27563018|NCT03745937|80250000|FG003|Overall Study|Not-specifed|1|||
27563019|NCT01522365|80250001|FG000|Overall Study|Withdrawal by Subject|1|||
27563020|NCT01522365|80250002|FG001|Overall Study|Withdrawal by Subject|1|||
27563021|NCT01522365|80250001|FG000|Overall Study|Lost to Follow-up|1|||
27563022|NCT01522365|80250002|FG001|Overall Study|Lost to Follow-up|1|||
27563023|NCT00352846|80250005|FG000|Overall Study|Disease progression|0|||
27563024|NCT00352846|80250006|FG001|Overall Study|Disease progression|2|||
27563025|NCT00352846|80250005|FG000|Overall Study|Withdrawal by Subject|3|||
27563026|NCT00352846|80250006|FG001|Overall Study|Withdrawal by Subject|8|||
27563027|NCT00352846|80250005|FG000|Overall Study|Ineligible|3|||
27563028|NCT00352846|80250006|FG001|Overall Study|Ineligible|2|||
27563029|NCT00352846|80250005|FG000|Overall Study|Non-compliance|2|||
27563030|NCT00352846|80250006|FG001|Overall Study|Non-compliance|0|||
27563031|NCT00352846|80250005|FG000|Overall Study|Death|0|||
27563032|NCT00352846|80250006|FG001|Overall Study|Death|1|||
27563033|NCT00460031|80250007|FG000|Overall Study|Adverse Event|5|||
27563034|NCT00460031|80250007|FG000|Overall Study|Withdrawal by Subject|5|||
27563035|NCT00460031|80250007|FG000|Overall Study|Death|1|||
27563036|NCT02788981|80250008|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
27563037|NCT02788981|80250009|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
27563038|NCT03025542|80250010|FG000|Overall Study|Adverse Event|0|||
27563039|NCT03025542|80250011|FG001|Overall Study|Adverse Event|2|||
27563040|NCT03025542|80250010|FG000|Overall Study|Lost to Follow-up|1|||
27563041|NCT03025542|80250011|FG001|Overall Study|Lost to Follow-up|0|||
27563042|NCT03025542|80250010|FG000|Overall Study|Withdrawal by Subject|1|||
27563043|NCT03025542|80250011|FG001|Overall Study|Withdrawal by Subject|0|||
27563044|NCT01086540|80250014|FG000|Overall Study|Death|3|||
27563045|NCT01086540|80250015|FG001|Overall Study|Death|1|||
27563046|NCT01086540|80250014|FG000|Overall Study|Physician Decision|2|||
27563047|NCT01086540|80250015|FG001|Overall Study|Physician Decision|1|||
27563048|NCT01086540|80250014|FG000|Overall Study|Addition of new therapy for PAH|1|||
27563049|NCT01086540|80250015|FG001|Overall Study|Addition of new therapy for PAH|0|||
27563050|NCT02636868|80250018|FG000|Overall Study|Death|0|||
27563051|NCT02636868|80250019|FG001|Overall Study|Death|1|||
27563052|NCT02636868|80250020|FG002|Overall Study|Death|2|||
27563053|NCT05045144|80250021|FG000|Overall Study|Lost to Follow-up|3|||
27563054|NCT05045144|80250022|FG001|Overall Study|Lost to Follow-up|2|||
27563055|NCT05045144|80250023|FG002|Overall Study|Lost to Follow-up|3|||
27563056|NCT05045144|80250024|FG003|Overall Study|Lost to Follow-up|5|||
27563057|NCT05045144|80250025|FG004|Overall Study|Lost to Follow-up|13|||
27563058|NCT05045144|80250021|FG000|Overall Study|Withdrawal by Subject|0|||
27563059|NCT05045144|80250022|FG001|Overall Study|Withdrawal by Subject|1|||
27563060|NCT05045144|80250023|FG002|Overall Study|Withdrawal by Subject|0|||
27563061|NCT05045144|80250024|FG003|Overall Study|Withdrawal by Subject|0|||
27563062|NCT05045144|80250025|FG004|Overall Study|Withdrawal by Subject|0|||
27563063|NCT05045144|80250021|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27563064|NCT05045144|80250022|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27563065|NCT05045144|80250023|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27563066|NCT05045144|80250024|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27563067|NCT05045144|80250025|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27563068|NCT00453921|80250026|FG000|Overall Study|Withdrawal by Subject|1|||
27563069|NCT00453921|80250027|FG001|Overall Study|Withdrawal by Subject|1|||
27563070|NCT00453921|80250028|FG002|Overall Study|Withdrawal by Subject|1|||
27563071|NCT00453921|80250029|FG003|Overall Study|Withdrawal by Subject|1|||
27563072|NCT00453921|80250026|FG000|Overall Study|Lost to Follow-up|0|||
27563073|NCT00453921|80250027|FG001|Overall Study|Lost to Follow-up|0|||
27563074|NCT00453921|80250028|FG002|Overall Study|Lost to Follow-up|1|||
27563075|NCT00453921|80250029|FG003|Overall Study|Lost to Follow-up|0|||
27563076|NCT04120974|80250030|FG000|Overall Study|Death|1|||
27563077|NCT04120974|80250030|FG000|Overall Study|Physician Decision|1|||
27563078|NCT04120974|80250030|FG000|Overall Study|Lost to Follow-up|6|||
27563079|NCT01046682|80250031|FG000|Overall Study|Adverse Event|2|||
27563080|NCT01046682|80250032|FG001|Overall Study|Adverse Event|0|||
27563081|NCT02446236|80250033|FG000|Overall Study|Screen Failure|1|||
27563082|NCT02446236|80250034|FG001|Overall Study|Screen Failure|0|||
27563083|NCT02446236|80250035|FG002|Overall Study|Screen Failure|1|||
27563084|NCT02446236|80250033|FG000|Overall Study|Actively Receiving Therapy|0|||
27563085|NCT02446236|80250034|FG001|Overall Study|Actively Receiving Therapy|0|||
27563086|NCT02446236|80250035|FG002|Overall Study|Actively Receiving Therapy|1|||
27563087|NCT02515045|80250038|FG000|Overall Study|Adverse Event|0|||
27563088|NCT02515045|80250039|FG001|Overall Study|Adverse Event|3|||
27563089|NCT02515045|80250040|FG002|Overall Study|Adverse Event|3|||
27563090|NCT02515045|80250038|FG000|Overall Study|Lost to Follow-up|0|||
27563091|NCT02515045|80250039|FG001|Overall Study|Lost to Follow-up|1|||
27563092|NCT02515045|80250040|FG002|Overall Study|Lost to Follow-up|1|||
27563093|NCT00945009|80250043|FG000|Overall Study|Lack of Efficacy|10|||
27563094|NCT00945009|80250044|FG001|Overall Study|Lack of Efficacy|0|||
27563095|NCT00945009|80250045|FG002|Overall Study|Lack of Efficacy|0|||
27563096|NCT00945009|80250043|FG000|Overall Study|Physician Decision|21|||
27563097|NCT00945009|80250044|FG001|Overall Study|Physician Decision|4|||
27563098|NCT00945009|80250045|FG002|Overall Study|Physician Decision|3|||
27563099|NCT00945009|80250043|FG000|Overall Study|Protocol Violation|6|||
27563100|NCT00945009|80250044|FG001|Overall Study|Protocol Violation|1|||
27563101|NCT00945009|80250045|FG002|Overall Study|Protocol Violation|0|||
27563102|NCT00945009|80250043|FG000|Overall Study|Withdrawal by Subject|1|||
27563103|NCT00945009|80250044|FG001|Overall Study|Withdrawal by Subject|0|||
27563104|NCT00945009|80250045|FG002|Overall Study|Withdrawal by Subject|0|||
27563105|NCT00945009|80250043|FG000|Overall Study|Ineligible|6|||
27563106|NCT00945009|80250044|FG001|Overall Study|Ineligible|1|||
27563107|NCT00945009|80250045|FG002|Overall Study|Ineligible|0|||
27563108|NCT00945009|80250043|FG000|Overall Study|Inevaluable|0|||
27563109|NCT00945009|80250044|FG001|Overall Study|Inevaluable|1|||
27563110|NCT00945009|80250045|FG002|Overall Study|Inevaluable|0|||
27563111|NCT00945009|80250043|FG000|Overall Study|Refusal of further protocol|1|||
27563112|NCT00945009|80250044|FG001|Overall Study|Refusal of further protocol|0|||
27563113|NCT00945009|80250045|FG002|Overall Study|Refusal of further protocol|0|||
27563114|NCT00171223|80250048|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
27563115|NCT00171223|80250049|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
27563116|NCT00171223|80250050|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
27563117|NCT00171223|80250048|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
27563118|NCT00171223|80250049|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
27563119|NCT00171223|80250050|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
27563120|NCT00171223|80250048|FG000|Overall Study|Abnormal Procedure|1|||
27563121|NCT00171223|80250049|FG001|Overall Study|Abnormal Procedure|0|||
27563122|NCT00171223|80250050|FG002|Overall Study|Abnormal Procedure|0|||
27563123|NCT00171223|80250048|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
27563124|NCT00171223|80250049|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
27563125|NCT00171223|80250050|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
27563126|NCT00171223|80250048|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
27563127|NCT00171223|80250049|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
27563128|NCT00171223|80250050|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
27563129|NCT00171223|80250048|FG000|Overall Study|Protocol Violation|2|||
27563130|NCT00171223|80250049|FG001|Overall Study|Protocol Violation|2|||
27563131|NCT00171223|80250050|FG002|Overall Study|Protocol Violation|3|||
27563132|NCT00171223|80250048|FG000|Overall Study|Participant Withdrew Consent|12|||
27563133|NCT00171223|80250049|FG001|Overall Study|Participant Withdrew Consent|21|||
27563134|NCT00171223|80250050|FG002|Overall Study|Participant Withdrew Consent|15|||
27563135|NCT00171223|80250048|FG000|Overall Study|Lost to Follow-up|5|||
27563136|NCT00171223|80250049|FG001|Overall Study|Lost to Follow-up|2|||
27563137|NCT00171223|80250050|FG002|Overall Study|Lost to Follow-up|3|||
27563138|NCT00171223|80250048|FG000|Overall Study|Administrative Problems|4|||
27563139|NCT00171223|80250049|FG001|Overall Study|Administrative Problems|7|||
27563140|NCT00171223|80250050|FG002|Overall Study|Administrative Problems|6|||
27563141|NCT00171223|80250048|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
27563142|NCT00171223|80250049|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
27563143|NCT00171223|80250050|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
27563144|NCT00171223|80250048|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
27563145|NCT00171223|80250049|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
27563146|NCT00171223|80250050|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
27563147|NCT02489344|80250051|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
27563148|NCT02489344|80250051|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
27563149|NCT02489344|80250051|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
27563150|NCT02489344|80250051|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
27563151|NCT00857220|80250054|FG000|Overall Study|Adverse Event|35|||
27563152|NCT00857220|80250054|FG000|Overall Study|Death|1|||
27563153|NCT00857220|80250054|FG000|Overall Study|Lack of Efficacy|11|||
27563154|NCT00857220|80250054|FG000|Overall Study|Lost to Follow-up|30|||
27563155|NCT00857220|80250054|FG000|Overall Study|Physician Decision|4|||
27563156|NCT00857220|80250054|FG000|Overall Study|Protocol Violation|16|||
27563157|NCT00857220|80250054|FG000|Overall Study|Withdrawal by Subject|67|||
27563158|NCT00857220|80250054|FG000|Overall Study|Clinical Hold|6|||
27563159|NCT00857220|80250054|FG000|Overall Study|Site Closed|5|||
27563160|NCT00857220|80250054|FG000|Overall Study|Miscellaneous|8|||
27563161|NCT01455012|80250058|FG000|Overall Study|Adverse Event|0|||
27563162|NCT01455012|80250059|FG001|Overall Study|Adverse Event|2|||
27563163|NCT01455012|80250058|FG000|Overall Study|Lack of Efficacy|6|||
27563164|NCT01455012|80250059|FG001|Overall Study|Lack of Efficacy|1|||
27563165|NCT01455012|80250058|FG000|Overall Study|Withdrawal by Subject|3|||
27563166|NCT01455012|80250059|FG001|Overall Study|Withdrawal by Subject|1|||
27563167|NCT01455012|80250058|FG000|Overall Study|Unknown reason|2|||
27563168|NCT01455012|80250059|FG001|Overall Study|Unknown reason|0|||
27563169|NCT04117347|80250060|FG000|Overall Study|Adverse Event|0|||
27563170|NCT04117347|80250061|FG001|Overall Study|Adverse Event|0|||
27563171|NCT04117347|80250062|FG002|Overall Study|Adverse Event|1|||
27563172|NCT04117347|80250060|FG000|Overall Study|No time for study|0|||
27563173|NCT04117347|80250061|FG001|Overall Study|No time for study|2|||
27563174|NCT04117347|80250062|FG002|Overall Study|No time for study|0|||
27563175|NCT04117347|80250060|FG000|Overall Study|Family emergency|1|||
27563176|NCT04117347|80250061|FG001|Overall Study|Family emergency|0|||
27563177|NCT04117347|80250062|FG002|Overall Study|Family emergency|0|||
27563178|NCT02389998|80250063|FG000|Overall Study|car accident|1|||
27563179|NCT02389998|80250064|FG001|Overall Study|car accident|0|||
27563180|NCT01523886|80250065|FG000|Overall Study|surgery cancelled|0|||
27563181|NCT01523886|80250066|FG001|Overall Study|surgery cancelled|1|||
27563182|NCT01288287|80250067|FG000|Overall Study|Lost to Follow-up|8|||
27563183|NCT01288287|80250067|FG000|Overall Study|Withdrawal by Subject|4|||
27563184|NCT01288287|80250067|FG000|Overall Study|Lack of Efficacy|13|||
27563185|NCT01288287|80250067|FG000|Overall Study|Other Reason|13|||
27563186|NCT01288287|80250067|FG000|Overall Study|Unknown Reason|1|||
27563187|NCT01288287|80250067|FG000|Overall Study|Unknown Status|7|||
27563188|NCT01955161|80250068|FG000|Overall Study|Withdrawal before treatment|2|||
27563189|NCT01955161|80250069|FG001|Overall Study|Withdrawal before treatment|0|||
27563190|NCT01955161|80250070|FG002|Overall Study|Withdrawal before treatment|1|||
27563191|NCT01955161|80250068|FG000|Overall Study|Adverse Event|10|||
27563192|NCT01955161|80250069|FG001|Overall Study|Adverse Event|14|||
27563193|NCT01955161|80250070|FG002|Overall Study|Adverse Event|15|||
27563194|NCT01955161|80250068|FG000|Overall Study|Death|1|||
27563195|NCT01955161|80250069|FG001|Overall Study|Death|1|||
27563196|NCT01955161|80250070|FG002|Overall Study|Death|3|||
27563197|NCT01955161|80250068|FG000|Overall Study|Withdrawal by Subject|9|||
27563198|NCT01955161|80250069|FG001|Overall Study|Withdrawal by Subject|8|||
27563199|NCT01955161|80250070|FG002|Overall Study|Withdrawal by Subject|12|||
27563200|NCT01955161|80250068|FG000|Overall Study|Protocol Violation|2|||
27563201|NCT01955161|80250069|FG001|Overall Study|Protocol Violation|0|||
27563202|NCT01955161|80250070|FG002|Overall Study|Protocol Violation|0|||
27563203|NCT01955161|80250068|FG000|Overall Study|Other reason: physician decision|0|||
27563204|NCT01955161|80250069|FG001|Overall Study|Other reason: physician decision|1|||
27563205|NCT01955161|80250070|FG002|Overall Study|Other reason: physician decision|1|||
27563206|NCT01955161|80250068|FG000|Overall Study|Other reason: disallowed medication|1|||
27563207|NCT01955161|80250069|FG001|Overall Study|Other reason: disallowed medication|0|||
27563208|NCT01955161|80250070|FG002|Overall Study|Other reason: disallowed medication|1|||
27563209|NCT01955161|80250068|FG000|Overall Study|Other reason: caregiver unavailable|1|||
27563210|NCT01955161|80250069|FG001|Overall Study|Other reason: caregiver unavailable|0|||
27563211|NCT01955161|80250070|FG002|Overall Study|Other reason: caregiver unavailable|0|||
27563212|NCT01955161|80250068|FG000|Overall Study|Other reason: moved to nursing home|0|||
27563213|NCT01955161|80250069|FG001|Overall Study|Other reason: moved to nursing home|1|||
27563214|NCT01955161|80250070|FG002|Overall Study|Other reason: moved to nursing home|0|||
27563215|NCT01955161|80250068|FG000|Overall Study|Other reason: insufficient compliance|0|||
27563216|NCT01955161|80250069|FG001|Overall Study|Other reason: insufficient compliance|0|||
27563217|NCT01955161|80250070|FG002|Overall Study|Other reason: insufficient compliance|1|||
27563218|NCT01955161|80250068|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
27563219|NCT01955161|80250069|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
27563220|NCT01955161|80250070|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
27563221|NCT01955161|80250068|FG000|Overall Study|Other reason: patient's will|0|||
27563222|NCT01955161|80250069|FG001|Overall Study|Other reason: patient's will|0|||
27563223|NCT01955161|80250070|FG002|Overall Study|Other reason: patient's will|1|||
27563224|NCT00772707|80250071|FG000|Overall Study|Withdrawn|3|||
27563225|NCT00238121|80250074|FG000|Overall Study|Withdrawal by Subject|1|||
27563226|NCT00238121|80250075|FG001|Overall Study|Withdrawal by Subject|1|||
27563227|NCT00238121|80250074|FG000|Overall Study|Adverse Event|2|||
27563228|NCT00238121|80250075|FG001|Overall Study|Adverse Event|1|||
27563229|NCT01327300|80250079|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
27563230|NCT01327300|80250080|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
27563231|NCT03311659|80250081|FG000|Overall Study|Protocol Violation|1|||
27563232|NCT00108160|80250084|FG000|Overall Study|Lost to Follow-up|25|||
27563233|NCT00108160|80250085|FG001|Overall Study|Lost to Follow-up|12|||
27563234|NCT00108160|80250084|FG000|Overall Study|Death|1|||
27563235|NCT00108160|80250085|FG001|Overall Study|Death|2|||
27563236|NCT00108160|80250084|FG000|Overall Study|Withdrawal by Subject|4|||
27563237|NCT00108160|80250085|FG001|Overall Study|Withdrawal by Subject|2|||
27563238|NCT00108160|80250084|FG000|Overall Study|Protocol Violation|9|||
27563239|NCT00108160|80250085|FG001|Overall Study|Protocol Violation|5|||
27563240|NCT04007523|80250088|FG000|Overall Study|Withdrawal by Subject|0|||
27563241|NCT04007523|80250089|FG001|Overall Study|Withdrawal by Subject|1|||
27563242|NCT04007523|80250090|FG002|Overall Study|Withdrawal by Subject|1|||
27563243|NCT04007523|80250091|FG003|Overall Study|Withdrawal by Subject|0|||
27563244|NCT04007523|80250088|FG000|Overall Study|ICU Transfer|0|||
27563245|NCT04007523|80250089|FG001|Overall Study|ICU Transfer|1|||
27563246|NCT04007523|80250090|FG002|Overall Study|ICU Transfer|0|||
27563247|NCT04007523|80250091|FG003|Overall Study|ICU Transfer|0|||
27563248|NCT04007523|80250088|FG000|Overall Study|COVID hospital closure|0|||
27563249|NCT04007523|80250089|FG001|Overall Study|COVID hospital closure|0|||
27563250|NCT04007523|80250090|FG002|Overall Study|COVID hospital closure|1|||
27563251|NCT04007523|80250091|FG003|Overall Study|COVID hospital closure|2|||
27563252|NCT04007523|80250088|FG000|Overall Study|Surgery cancelled|0|||
27563253|NCT04007523|80250089|FG001|Overall Study|Surgery cancelled|0|||
27563254|NCT04007523|80250090|FG002|Overall Study|Surgery cancelled|1|||
27563255|NCT04007523|80250091|FG003|Overall Study|Surgery cancelled|1|||
27563256|NCT02225743|80250095|FG000|Overall Study|Withdrawal by Subject|18|||
27563257|NCT02747420|80250099|FG000|Overall Study|Lost to Follow-up|4|||
27563258|NCT02747420|80250100|FG001|Overall Study|Lost to Follow-up|2|||
27563259|NCT02747420|80250099|FG000|Overall Study|Withdrawal by Subject|3|||
27563260|NCT02747420|80250100|FG001|Overall Study|Withdrawal by Subject|2|||
27563261|NCT00536107|80250101|FG000|Overall Study|Death|5|||
27563262|NCT00536107|80250102|FG001|Overall Study|Death|1|||
27563263|NCT00536107|80250101|FG000|Overall Study|Incorrect enrolment|1|||
27563264|NCT00536107|80250102|FG001|Overall Study|Incorrect enrolment|0|||
27563265|NCT00536107|80250101|FG000|Overall Study|Withdrawal by Subject|0|||
27563266|NCT00536107|80250102|FG001|Overall Study|Withdrawal by Subject|1|||
27563267|NCT00536107|80250101|FG000|Overall Study|Study Termination|2|||
27563268|NCT00536107|80250102|FG001|Overall Study|Study Termination|4|||
27563269|NCT00704535|80250103|FG000|Overall Study|Adverse Event|2|||
27563270|NCT00704535|80250103|FG000|Overall Study|Death|2|||
27563271|NCT00704535|80250103|FG000|Overall Study|Lost to Follow-up|8|||
27563272|NCT00704535|80250103|FG000|Overall Study|Protocol Violation|10|||
27563273|NCT00704535|80250103|FG000|Overall Study|Completed status not on Case Report Form|124|||
27563274|NCT02120950|80250105|FG000|Overall Study|Adverse Event|5|||
27563275|NCT02120950|80250106|FG001|Overall Study|Adverse Event|4|||
27563276|NCT02120950|80250107|FG002|Overall Study|Adverse Event|3|||
27563277|NCT02120950|80250105|FG000|Overall Study|Death|3|||
27563278|NCT02120950|80250106|FG001|Overall Study|Death|0|||
27563279|NCT02120950|80250107|FG002|Overall Study|Death|1|||
27563280|NCT02120950|80250105|FG000|Overall Study|Withdrawal by Subject|6|||
27563281|NCT02120950|80250106|FG001|Overall Study|Withdrawal by Subject|3|||
27563282|NCT02120950|80250107|FG002|Overall Study|Withdrawal by Subject|2|||
27563283|NCT02120950|80250105|FG000|Overall Study|Protocol Violation|1|||
27563284|NCT02120950|80250106|FG001|Overall Study|Protocol Violation|1|||
27563285|NCT02120950|80250107|FG002|Overall Study|Protocol Violation|7|||
27563286|NCT02120950|80250105|FG000|Overall Study|Other reasons|5|||
27563287|NCT02120950|80250106|FG001|Overall Study|Other reasons|4|||
27563288|NCT02120950|80250107|FG002|Overall Study|Other reasons|1|||
27563289|NCT02120950|80250105|FG000|Overall Study|Lost to Follow-up|0|||
27563290|NCT02120950|80250106|FG001|Overall Study|Lost to Follow-up|2|||
27563291|NCT02120950|80250107|FG002|Overall Study|Lost to Follow-up|1|||
27563292|NCT00149747|80250110|FG000|Overall Study|Death|1|||
27563293|NCT00149747|80250111|FG001|Overall Study|Death|0|||
27563294|NCT00149747|80250110|FG000|Overall Study|Withdrawal by Subject|3|||
27563295|NCT00149747|80250111|FG001|Overall Study|Withdrawal by Subject|3|||
27563296|NCT02411292|80250112|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
27563297|NCT02411292|80250112|FG000|Overall Study|Death|2|||
27563298|NCT02411292|80250112|FG000|Overall Study|Lost to Follow-up|3|||
27563299|NCT00930579|80250113|FG000|Overall Study|Withdrawal by Subject|1|||
27563300|NCT00930579|80250113|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
27563301|NCT01374087|80250122|FG000|Overall Study|Adverse Event|1|||
27563302|NCT01374087|80250123|FG001|Overall Study|Adverse Event|0|||
27563303|NCT01374087|80250122|FG000|Overall Study|Disease progression|2|||
27563304|NCT01374087|80250123|FG001|Overall Study|Disease progression|2|||
27563305|NCT01374087|80250122|FG000|Overall Study|Study discontinued|13|||
27563306|NCT01374087|80250123|FG001|Overall Study|Study discontinued|13|||
27563307|NCT01870583|80250127|FG000|Overall Study|Protocol Violation|0|||
27563308|NCT01870583|80250128|FG001|Overall Study|Protocol Violation|5|||
27563309|NCT01870583|80250129|FG002|Overall Study|Protocol Violation|3|||
27563310|NCT01870583|80250127|FG000|Overall Study|Lost to Follow-up|11|||
27563311|NCT01870583|80250128|FG001|Overall Study|Lost to Follow-up|13|||
27563312|NCT01870583|80250129|FG002|Overall Study|Lost to Follow-up|5|||
27563313|NCT01030523|80250130|FG000|Initial Study (5 Years)|Death|1|||
27563314|NCT01030523|80250131|FG001|Initial Study (5 Years)|Death|0|||
27563315|NCT01030523|80250130|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
27563316|NCT01030523|80250131|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
27563317|NCT01030523|80250130|FG000|Initial Study (5 Years)|Implant failure|1|||
27563318|NCT01030523|80250131|FG001|Initial Study (5 Years)|Implant failure|0|||
27563319|NCT01030523|80250130|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
27563320|NCT01030523|80250131|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
27563321|NCT01030523|80250130|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
27563322|NCT01030523|80250131|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
27563323|NCT01030523|80250130|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
27563324|NCT01030523|80250131|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
27563325|NCT02981342|80250132|FG000|Overall Study|Adverse Event|0|||
27563326|NCT02981342|80250133|FG001|Overall Study|Adverse Event|0|||
27563327|NCT02981342|80250134|FG002|Overall Study|Adverse Event|0|||
27563328|NCT02981342|80250135|FG003|Overall Study|Adverse Event|1|||
27563329|NCT02981342|80250132|FG000|Overall Study|Death|0|||
27563330|NCT02981342|80250133|FG001|Overall Study|Death|9|||
27563331|NCT02981342|80250134|FG002|Overall Study|Death|9|||
27563332|NCT02981342|80250135|FG003|Overall Study|Death|4|||
27563333|NCT02981342|80250132|FG000|Overall Study|Withdrawal by Subject|0|||
27563334|NCT02981342|80250133|FG001|Overall Study|Withdrawal by Subject|0|||
27563335|NCT02981342|80250134|FG002|Overall Study|Withdrawal by Subject|3|||
27563336|NCT02981342|80250135|FG003|Overall Study|Withdrawal by Subject|1|||
27563337|NCT02981342|80250132|FG000|Overall Study|Study closed by sponsor|0|||
27563338|NCT02981342|80250133|FG001|Overall Study|Study closed by sponsor|0|||
27563339|NCT02981342|80250134|FG002|Overall Study|Study closed by sponsor|1|||
27563340|NCT02981342|80250135|FG003|Overall Study|Study closed by sponsor|1|||
27563341|NCT02981342|80250132|FG000|Overall Study|Randomized, Never Treated|0|||
27563342|NCT02981342|80250133|FG001|Overall Study|Randomized, Never Treated|1|||
27563343|NCT02981342|80250134|FG002|Overall Study|Randomized, Never Treated|0|||
27563344|NCT02981342|80250135|FG003|Overall Study|Randomized, Never Treated|7|||
27563345|NCT02981342|80250132|FG000|Overall Study|Lost to Follow-up|0|||
27563346|NCT02981342|80250133|FG001|Overall Study|Lost to Follow-up|1|||
27563347|NCT02981342|80250134|FG002|Overall Study|Lost to Follow-up|0|||
27563348|NCT02981342|80250135|FG003|Overall Study|Lost to Follow-up|0|||
27563349|NCT00923559|80250136|FG000|Overall Study|Lost to Follow-up|2|||
27563350|NCT00923559|80250137|FG001|Overall Study|Lost to Follow-up|3|||
27563351|NCT02136576|80250145|FG000|Overall Study|Lost to Follow-up|2|||
27563352|NCT02136576|80250146|FG001|Overall Study|Lost to Follow-up|0|||
27563353|NCT02136576|80250147|FG002|Overall Study|Lost to Follow-up|0|||
27563354|NCT00623727|80250152|FG000|Double Blind (DB)|Adverse Event|1|||
27563355|NCT00623727|80250153|FG001|Double Blind (DB)|Adverse Event|3|||
27563356|NCT00623727|80250152|FG000|Double Blind (DB)|Physician Decision|0|||
27563357|NCT00623727|80250153|FG001|Double Blind (DB)|Physician Decision|1|||
27563358|NCT00623727|80250152|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
27563359|NCT00623727|80250153|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
27563360|NCT00623727|80250152|FG000|Double Blind (DB)|Lack of Efficacy|2|||
27563361|NCT00623727|80250153|FG001|Double Blind (DB)|Lack of Efficacy|2|||
27563362|NCT00623727|80250152|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
27563363|NCT00623727|80250153|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
27563364|NCT00623727|80250152|FG000|Double Blind (DB)|Lost to Follow-up|1|||
27563365|NCT00623727|80250153|FG001|Double Blind (DB)|Lost to Follow-up|1|||
27563366|NCT00623727|80250152|FG000|Double Blind (DB)|Protocol Violation|2|||
27563367|NCT00623727|80250153|FG001|Double Blind (DB)|Protocol Violation|2|||
27563368|NCT00623727|80250152|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
27563369|NCT00623727|80250153|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
27563370|NCT00623727|80250152|FG000|Open Label Follow-up|Study termination|0|||
27563371|NCT00623727|80250153|FG001|Open Label Follow-up|Study termination|6|||
27563372|NCT00623727|80250152|FG000|Open Label Follow-up|Participant convenience|0|||
27563373|NCT00623727|80250153|FG001|Open Label Follow-up|Participant convenience|1|||
27563374|NCT03774433|80250161|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
27563375|NCT00192504|80250164|FG000|Overall Study|Lost to Follow-up|1|||
27563376|NCT00192504|80250165|FG001|Overall Study|Lost to Follow-up|0|||
27563377|NCT00192504|80250166|FG002|Overall Study|Lost to Follow-up|0|||
27563378|NCT00192504|80250167|FG003|Overall Study|Lost to Follow-up|0|||
27563379|NCT00192504|80250164|FG000|Overall Study|Dosing window missed|0|||
27563380|NCT00192504|80250165|FG001|Overall Study|Dosing window missed|0|||
27563381|NCT00192504|80250166|FG002|Overall Study|Dosing window missed|1|||
27563382|NCT00192504|80250167|FG003|Overall Study|Dosing window missed|0|||
27563383|NCT00605475|80250170|FG000|Overall Study|Abnormal Laboratory Values|0|||
27563384|NCT00605475|80250171|FG001|Overall Study|Abnormal Laboratory Values|0|||
27563385|NCT00605475|80250172|FG002|Overall Study|Abnormal Laboratory Values|0|||
27563386|NCT00605475|80250173|FG003|Overall Study|Abnormal Laboratory Values|0|||
27563387|NCT00605475|80250174|FG004|Overall Study|Abnormal Laboratory Values|0|||
27563388|NCT00605475|80250175|FG005|Overall Study|Abnormal Laboratory Values|0|||
27563389|NCT00605475|80250176|FG006|Overall Study|Abnormal Laboratory Values|0|||
27563390|NCT00605475|80250177|FG007|Overall Study|Abnormal Laboratory Values|0|||
27563391|NCT00605475|80250178|FG008|Overall Study|Abnormal Laboratory Values|1|||
27563392|NCT00605475|80250179|FG009|Overall Study|Abnormal Laboratory Values|0|||
27563393|NCT00605475|80250170|FG000|Overall Study|Administrative problems|0|||
27563394|NCT00605475|80250171|FG001|Overall Study|Administrative problems|0|||
27563395|NCT00605475|80250172|FG002|Overall Study|Administrative problems|0|||
27563396|NCT00605475|80250173|FG003|Overall Study|Administrative problems|0|||
27563397|NCT00605475|80250174|FG004|Overall Study|Administrative problems|0|||
27563398|NCT00605475|80250175|FG005|Overall Study|Administrative problems|0|||
27563399|NCT00605475|80250176|FG006|Overall Study|Administrative problems|1|||
27563400|NCT00605475|80250177|FG007|Overall Study|Administrative problems|0|||
27563401|NCT00605475|80250178|FG008|Overall Study|Administrative problems|0|||
27563402|NCT00605475|80250179|FG009|Overall Study|Administrative problems|0|||
27563403|NCT00605475|80250170|FG000|Overall Study|Lost to Follow-up|0|||
27563404|NCT00605475|80250171|FG001|Overall Study|Lost to Follow-up|0|||
27563405|NCT00605475|80250172|FG002|Overall Study|Lost to Follow-up|0|||
27563406|NCT00605475|80250173|FG003|Overall Study|Lost to Follow-up|0|||
27563407|NCT00605475|80250174|FG004|Overall Study|Lost to Follow-up|0|||
27563408|NCT00605475|80250175|FG005|Overall Study|Lost to Follow-up|0|||
27563409|NCT00605475|80250176|FG006|Overall Study|Lost to Follow-up|0|||
27563410|NCT00605475|80250177|FG007|Overall Study|Lost to Follow-up|0|||
27563411|NCT00605475|80250178|FG008|Overall Study|Lost to Follow-up|1|||
27563412|NCT00605475|80250179|FG009|Overall Study|Lost to Follow-up|1|||
27563413|NCT00605475|80250170|FG000|Overall Study|Protocol Violation|0|||
27563414|NCT00605475|80250171|FG001|Overall Study|Protocol Violation|0|||
27563415|NCT00605475|80250172|FG002|Overall Study|Protocol Violation|0|||
27563416|NCT00605475|80250173|FG003|Overall Study|Protocol Violation|0|||
27563417|NCT00605475|80250174|FG004|Overall Study|Protocol Violation|1|||
27563418|NCT00605475|80250175|FG005|Overall Study|Protocol Violation|0|||
27563419|NCT00605475|80250176|FG006|Overall Study|Protocol Violation|0|||
27563420|NCT00605475|80250177|FG007|Overall Study|Protocol Violation|0|||
27563421|NCT00605475|80250178|FG008|Overall Study|Protocol Violation|0|||
27563422|NCT00605475|80250179|FG009|Overall Study|Protocol Violation|0|||
27563423|NCT00605475|80250170|FG000|Overall Study|Withdrawal by Subject|0|||
27563424|NCT00605475|80250171|FG001|Overall Study|Withdrawal by Subject|0|||
27563425|NCT00605475|80250172|FG002|Overall Study|Withdrawal by Subject|0|||
27563426|NCT00605475|80250173|FG003|Overall Study|Withdrawal by Subject|0|||
27563427|NCT00605475|80250174|FG004|Overall Study|Withdrawal by Subject|0|||
27563428|NCT00605475|80250175|FG005|Overall Study|Withdrawal by Subject|2|||
27563429|NCT00605475|80250176|FG006|Overall Study|Withdrawal by Subject|0|||
27563430|NCT00605475|80250177|FG007|Overall Study|Withdrawal by Subject|0|||
27563431|NCT00605475|80250178|FG008|Overall Study|Withdrawal by Subject|0|||
27563432|NCT00605475|80250179|FG009|Overall Study|Withdrawal by Subject|1|||
27563433|NCT00409617|80250183|FG000|Overall Study|Adverse Event|57|||
27563434|NCT00409617|80250183|FG000|Overall Study|Lack of Efficacy|54|||
27563435|NCT00409617|80250183|FG000|Overall Study|Lost to Follow-up|2|||
27563436|NCT00409617|80250183|FG000|Overall Study|Protocol Violation|24|||
27563437|NCT00409617|80250183|FG000|Overall Study|Withdrawal by Subject|8|||
27563438|NCT00409617|80250183|FG000|Overall Study|Administrative reasons|1|||
27563439|NCT00409617|80250183|FG000|Overall Study|Not described|14|||
27563440|NCT01324388|80250184|FG000|Part 1 of Study|Adverse Event|2|||
27563441|NCT01324388|80250185|FG001|Part 1 of Study|Adverse Event|0|||
27563442|NCT01324388|80250186|FG002|Part 1 of Study|Adverse Event|0|||
27563443|NCT01324388|80250187|FG003|Part 1 of Study|Adverse Event|0|||
27563444|NCT01324388|80250184|FG000|Part 1 of Study|Protocol Violation|1|||
27563445|NCT01324388|80250185|FG001|Part 1 of Study|Protocol Violation|2|||
27563446|NCT01324388|80250186|FG002|Part 1 of Study|Protocol Violation|0|||
27563447|NCT01324388|80250187|FG003|Part 1 of Study|Protocol Violation|0|||
27563448|NCT01324388|80250184|FG000|Part 1 of Study|Physician Decision|1|||
27563449|NCT01324388|80250185|FG001|Part 1 of Study|Physician Decision|0|||
27563450|NCT01324388|80250186|FG002|Part 1 of Study|Physician Decision|0|||
27563451|NCT01324388|80250187|FG003|Part 1 of Study|Physician Decision|0|||
27563452|NCT01324388|80250184|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
27563453|NCT01324388|80250185|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
27563454|NCT01324388|80250186|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
27563455|NCT01324388|80250187|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
27563456|NCT01324388|80250184|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
27563457|NCT01324388|80250185|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
27563458|NCT01324388|80250186|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
27563459|NCT01324388|80250187|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
27563460|NCT03739112|80250188|FG000|Overall Study|Adverse Event|2|||
27563461|NCT03739112|80250189|FG001|Overall Study|Adverse Event|2|||
27563462|NCT03739112|80250188|FG000|Overall Study|Withdrawal by Subject|38|||
27563463|NCT03739112|80250189|FG001|Overall Study|Withdrawal by Subject|19|||
27563464|NCT03739112|80250188|FG000|Overall Study|Lost to Follow-up|31|||
27563465|NCT03739112|80250189|FG001|Overall Study|Lost to Follow-up|33|||
27563466|NCT03739112|80250188|FG000|Overall Study|Protocol Deviation|12|||
27563467|NCT03739112|80250189|FG001|Overall Study|Protocol Deviation|9|||
27563468|NCT03739112|80250188|FG000|Overall Study|Physician Decision|1|||
27563469|NCT03739112|80250189|FG001|Overall Study|Physician Decision|0|||
27563470|NCT03739112|80250188|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
27563471|NCT03739112|80250189|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
27563472|NCT03739112|80250188|FG000|Overall Study|Site went on hold|65|||
27563473|NCT03739112|80250189|FG001|Overall Study|Site went on hold|67|||
27563474|NCT03739112|80250188|FG000|Overall Study|Other than specified|8|||
27563475|NCT03739112|80250189|FG001|Overall Study|Other than specified|5|||
27563476|NCT03739112|80250188|FG000|Overall Study|Randomized but not vaccinated|31|||
27563477|NCT03739112|80250189|FG001|Overall Study|Randomized but not vaccinated|25|||
27563478|NCT02867709|80250190|FG000|Treatment Period|Adverse Event|1|||
27563479|NCT02867709|80250191|FG001|Treatment Period|Adverse Event|1|||
27563480|NCT02867709|80250192|FG002|Treatment Period|Adverse Event|2|||
27563481|NCT02867709|80250190|FG000|Treatment Period|Withdrawal of Consent|7|||
27563482|NCT02867709|80250191|FG001|Treatment Period|Withdrawal of Consent|9|||
27563483|NCT02867709|80250192|FG002|Treatment Period|Withdrawal of Consent|8|||
27563484|NCT02867709|80250190|FG000|Treatment Period|Lost to Follow-up|17|||
27563485|NCT02867709|80250191|FG001|Treatment Period|Lost to Follow-up|20|||
27563486|NCT02867709|80250192|FG002|Treatment Period|Lost to Follow-up|20|||
27563487|NCT02867709|80250190|FG000|Treatment Period|Lack of Qualifying Event|42|||
27563488|NCT02867709|80250191|FG001|Treatment Period|Lack of Qualifying Event|55|||
27563489|NCT02867709|80250192|FG002|Treatment Period|Lack of Qualifying Event|42|||
27563490|NCT02867709|80250190|FG000|Treatment Period|Protocol Violation|3|||
27563491|NCT02867709|80250191|FG001|Treatment Period|Protocol Violation|2|||
27563492|NCT02867709|80250192|FG002|Treatment Period|Protocol Violation|3|||
27563493|NCT02867709|80250190|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
27563494|NCT02867709|80250191|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
27563495|NCT02867709|80250192|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
27563496|NCT02867709|80250190|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
27563497|NCT02867709|80250191|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
27563498|NCT02867709|80250192|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
27563499|NCT02867709|80250190|FG000|Safety Follow-up Period|Pregnancy|0|||
27563500|NCT02867709|80250191|FG001|Safety Follow-up Period|Pregnancy|1|||
27563501|NCT02867709|80250192|FG002|Safety Follow-up Period|Pregnancy|0|||
27563502|NCT02867709|80250190|FG000|Safety Follow-up Period|Protocol Violation|0|||
27563503|NCT02867709|80250191|FG001|Safety Follow-up Period|Protocol Violation|1|||
27563504|NCT02867709|80250192|FG002|Safety Follow-up Period|Protocol Violation|1|||
27563505|NCT00477672|80250193|FG000|Overall Study|Adverse Event|3|||
27563506|NCT00477672|80250194|FG001|Overall Study|Adverse Event|5|||
27563507|NCT00477672|80250195|FG002|Overall Study|Adverse Event|6|||
27563508|NCT00477672|80250193|FG000|Overall Study|Death|0|||
27563509|NCT00477672|80250194|FG001|Overall Study|Death|1|||
27563510|NCT00477672|80250195|FG002|Overall Study|Death|0|||
27563511|NCT00477672|80250193|FG000|Overall Study|Disease progression|0|||
27563512|NCT00477672|80250194|FG001|Overall Study|Disease progression|1|||
27563513|NCT00477672|80250195|FG002|Overall Study|Disease progression|0|||
27563514|NCT00477672|80250193|FG000|Overall Study|Physician Decision|1|||
27563515|NCT00477672|80250194|FG001|Overall Study|Physician Decision|0|||
27563516|NCT00477672|80250195|FG002|Overall Study|Physician Decision|0|||
27563517|NCT00477672|80250193|FG000|Overall Study|Protocol noncompliance|0|||
27563518|NCT00477672|80250194|FG001|Overall Study|Protocol noncompliance|2|||
27563519|NCT00477672|80250195|FG002|Overall Study|Protocol noncompliance|0|||
27563520|NCT00477672|80250193|FG000|Overall Study|Consent withdrawn|2|||
27563521|NCT00477672|80250194|FG001|Overall Study|Consent withdrawn|5|||
27563522|NCT00477672|80250195|FG002|Overall Study|Consent withdrawn|10|||
27563523|NCT00477672|80250193|FG000|Overall Study|Discretion of Sponsor|1|||
27563524|NCT00477672|80250194|FG001|Overall Study|Discretion of Sponsor|2|||
27563525|NCT00477672|80250195|FG002|Overall Study|Discretion of Sponsor|0|||
27563526|NCT01765153|80250196|FG000|Training Phase 1|Format of intervention differed|1|||
27563527|NCT01765153|80250197|FG001|Training Phase 1|Format of intervention differed|0|||
27563528|NCT01765153|80250196|FG000|Training Phase 1|Poor participation in intervention|0|||
27563529|NCT01765153|80250197|FG001|Training Phase 1|Poor participation in intervention|1|||
27563530|NCT01765153|80250196|FG000|Rest Phase 1|Withdrawal by Subject|0|||
27563531|NCT01765153|80250197|FG001|Rest Phase 1|Withdrawal by Subject|1|||
27563532|NCT01765153|80250196|FG000|Training Phase 2|Withdrawal by Subject|0|||
27563533|NCT01765153|80250197|FG001|Training Phase 2|Withdrawal by Subject|1|||
27563534|NCT01765153|80250196|FG000|Rest Phase 2|Lost to Follow-up|2|||
27563535|NCT01765153|80250197|FG001|Rest Phase 2|Lost to Follow-up|1|||
27563536|NCT04532099|80250198|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
27563537|NCT04532099|80250199|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
27563538|NCT04532099|80250200|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
27563539|NCT02232425|80250202|FG000|Overall Study|Lost to Follow-up|6|||
27563540|NCT02232425|80250203|FG001|Overall Study|Lost to Follow-up|2|||
27563541|NCT02232425|80250202|FG000|Overall Study|Adverse Event|2|||
27563542|NCT02232425|80250203|FG001|Overall Study|Adverse Event|0|||
27563543|NCT02232425|80250202|FG000|Overall Study|Withdrawal by Subject|5|||
27563544|NCT02232425|80250203|FG001|Overall Study|Withdrawal by Subject|6|||
27563545|NCT02232425|80250202|FG000|Overall Study|Lack of Efficacy|1|||
27563546|NCT02232425|80250203|FG001|Overall Study|Lack of Efficacy|0|||
27563547|NCT00464568|80250204|FG000|Overall Study|Adverse Event|2|||
27563548|NCT00101907|80250205|FG000|Overall Study|Adverse Event|1|||
27563549|NCT00101907|80250206|FG001|Overall Study|Adverse Event|0|||
27563550|NCT00101907|80250207|FG002|Overall Study|Adverse Event|0|||
27563551|NCT00101907|80250208|FG003|Overall Study|Adverse Event|0|||
27563552|NCT00101907|80250209|FG004|Overall Study|Adverse Event|0|||
27563553|NCT00101907|80250210|FG005|Overall Study|Adverse Event|0|||
27563554|NCT00101907|80250205|FG000|Overall Study|Death|0|||
27563555|NCT00101907|80250206|FG001|Overall Study|Death|1|||
27563556|NCT00101907|80250207|FG002|Overall Study|Death|0|||
27563557|NCT00101907|80250208|FG003|Overall Study|Death|0|||
27563558|NCT00101907|80250209|FG004|Overall Study|Death|3|||
27563559|NCT00101907|80250210|FG005|Overall Study|Death|0|||
27563560|NCT00101907|80250205|FG000|Overall Study|Physician Decision|0|||
27563561|NCT00101907|80250206|FG001|Overall Study|Physician Decision|0|||
27563562|NCT00101907|80250207|FG002|Overall Study|Physician Decision|0|||
27563563|NCT00101907|80250208|FG003|Overall Study|Physician Decision|1|||
27563564|NCT00101907|80250209|FG004|Overall Study|Physician Decision|1|||
27563565|NCT00101907|80250210|FG005|Overall Study|Physician Decision|0|||
27563566|NCT00101907|80250205|FG000|Overall Study|Withdrawal by Subject|1|||
27563567|NCT00101907|80250206|FG001|Overall Study|Withdrawal by Subject|0|||
27563568|NCT00101907|80250207|FG002|Overall Study|Withdrawal by Subject|1|||
27563569|NCT00101907|80250208|FG003|Overall Study|Withdrawal by Subject|0|||
27563570|NCT00101907|80250209|FG004|Overall Study|Withdrawal by Subject|1|||
27563571|NCT00101907|80250210|FG005|Overall Study|Withdrawal by Subject|0|||
27563572|NCT00278954|80250211|FG000|Overall Study|Adverse Event|3|||
27563573|NCT00278954|80250211|FG000|Overall Study|Lost to Follow-up|1|||
27563574|NCT00278954|80250211|FG000|Overall Study|Withdrawal by Subject|1|||
27563575|NCT01085097|80253487|FG000|Overall Study|Adverse Event|0|||
27563576|NCT01085097|80253488|FG001|Overall Study|Adverse Event|0|||
27563577|NCT01085097|80253489|FG002|Overall Study|Adverse Event|2|||
27563578|NCT01085097|80253487|FG000|Overall Study|Treatment failure|2|||
27563579|NCT01085097|80253488|FG001|Overall Study|Treatment failure|0|||
27563580|NCT01085097|80253489|FG002|Overall Study|Treatment failure|0|||
27563581|NCT01614990|80253491|FG000|Overall Study|Protocol Violation|1|||
27563582|NCT01614990|80253492|FG001|Overall Study|Protocol Violation|1|||
27563583|NCT02410954|80253493|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
27563584|NCT02410954|80253494|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
27563585|NCT02410954|80253493|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
27563586|NCT02410954|80253494|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
27563587|NCT01474876|80253498|FG000|Overall Study|Adverse Event|11|||
27563588|NCT01474876|80253499|FG001|Overall Study|Adverse Event|5|||
27563589|NCT01474876|80253500|FG002|Overall Study|Adverse Event|0|||
27563590|NCT01474876|80253498|FG000|Overall Study|Serious Adverse Event|2|||
27563591|NCT01474876|80253499|FG001|Overall Study|Serious Adverse Event|3|||
27563592|NCT01474876|80253500|FG002|Overall Study|Serious Adverse Event|0|||
27563593|NCT01474876|80253498|FG000|Overall Study|Lost to Follow-up|5|||
27563594|NCT01474876|80253499|FG001|Overall Study|Lost to Follow-up|4|||
27563595|NCT01474876|80253500|FG002|Overall Study|Lost to Follow-up|0|||
27563596|NCT01474876|80253498|FG000|Overall Study|Investigator's decision|28|||
27563597|NCT01474876|80253499|FG001|Overall Study|Investigator's decision|6|||
27563598|NCT01474876|80253500|FG002|Overall Study|Investigator's decision|0|||
27563599|NCT01474876|80253498|FG000|Overall Study|Patient's request|19|||
27563600|NCT01474876|80253499|FG001|Overall Study|Patient's request|5|||
27563601|NCT01474876|80253500|FG002|Overall Study|Patient's request|0|||
27563602|NCT01474876|80253498|FG000|Overall Study|Investigator's decision and pt request|1|||
27563603|NCT01474876|80253499|FG001|Overall Study|Investigator's decision and pt request|0|||
27563604|NCT01474876|80253500|FG002|Overall Study|Investigator's decision and pt request|0|||
27563605|NCT02741700|80253501|FG000|Overall Study|Lost to Follow-up|17|||
27563606|NCT02741700|80253502|FG001|Overall Study|Lost to Follow-up|8|||
27563607|NCT02741700|80253501|FG000|Overall Study|Withdrawal by Subject|2|||
27563608|NCT02741700|80253502|FG001|Overall Study|Withdrawal by Subject|5|||
27563609|NCT02741700|80253501|FG000|Overall Study|Physician Decision|3|||
27563610|NCT02741700|80253502|FG001|Overall Study|Physician Decision|0|||
27563611|NCT02741700|80253501|FG000|Overall Study|Moved out of State|0|||
27563612|NCT02741700|80253502|FG001|Overall Study|Moved out of State|1|||
27563613|NCT02741700|80253501|FG000|Overall Study|Death|4|||
27563614|NCT02741700|80253502|FG001|Overall Study|Death|5|||
27563615|NCT01012622|80253503|FG000|Overall Study|Withdrawal by Subject|6|||
27563616|NCT01012622|80253503|FG000|Overall Study|Lost to Follow-up|5|||
27563617|NCT01012622|80253503|FG000|Overall Study|Adverse Event|7|||
27563618|NCT01012622|80253503|FG000|Overall Study|non-compliance with the drug|9|||
27563619|NCT01012622|80253503|FG000|Overall Study|Other|1|||
27563620|NCT01012622|80253503|FG000|Overall Study|screening failure|1|||
27563621|NCT01012622|80253503|FG000|Overall Study|withdrawal of consent by a parent|2|||
27563622|NCT02276872|80253504|FG000|Overall Study|Adverse Event|1|||
27563623|NCT02276872|80253505|FG001|Overall Study|Adverse Event|0|||
27563624|NCT02276872|80253506|FG002|Overall Study|Adverse Event|0|||
27563625|NCT03886220|80253507|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
27563626|NCT03886220|80253508|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
27563627|NCT03886220|80253507|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
27563628|NCT03886220|80253508|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27563629|NCT03886220|80253507|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
27563630|NCT03886220|80253508|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
27563631|NCT02874742|80253509|FG000|Overall Study|Death|0|||
27563632|NCT02874742|80253510|FG001|Overall Study|Death|1|||
27563633|NCT02874742|80253511|FG002|Overall Study|Death|0|||
27563634|NCT02874742|80253509|FG000|Overall Study|Lost to Follow-up|5|||
27563635|NCT02874742|80253510|FG001|Overall Study|Lost to Follow-up|4|||
27563636|NCT02874742|80253511|FG002|Overall Study|Lost to Follow-up|1|||
27563637|NCT02874742|80253509|FG000|Overall Study|Withdrawal by Subject|17|||
27563638|NCT02874742|80253510|FG001|Overall Study|Withdrawal by Subject|8|||
27563639|NCT02874742|80253511|FG002|Overall Study|Withdrawal by Subject|0|||
27563640|NCT02874742|80253509|FG000|Overall Study|Other|4|||
27563641|NCT02874742|80253510|FG001|Overall Study|Other|1|||
27563642|NCT02874742|80253511|FG002|Overall Study|Other|0|||
27563643|NCT02874742|80253509|FG000|Overall Study|Progressive Disease|1|||
27563644|NCT02874742|80253510|FG001|Overall Study|Progressive Disease|0|||
27563645|NCT02874742|80253511|FG002|Overall Study|Progressive Disease|0|||
27563646|NCT02874742|80253509|FG000|Overall Study|Screen Failure|0|||
27563647|NCT02874742|80253510|FG001|Overall Study|Screen Failure|2|||
27563648|NCT02874742|80253511|FG002|Overall Study|Screen Failure|0|||
27563649|NCT03989440|80253512|FG000|Overall Study|COVID-19 travel restrictions|0|||
27563650|NCT03989440|80253513|FG001|Overall Study|COVID-19 travel restrictions|0|||
27563651|NCT03989440|80253514|FG002|Overall Study|COVID-19 travel restrictions|1|||
27563652|NCT03989440|80253515|FG003|Overall Study|COVID-19 travel restrictions|0|||
27563653|NCT03989440|80253516|FG004|Overall Study|COVID-19 travel restrictions|0|||
27563654|NCT03989440|80253517|FG005|Overall Study|COVID-19 travel restrictions|0|||
27563655|NCT03989440|80253512|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
27563656|NCT03989440|80253513|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
27563657|NCT03989440|80253514|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
27563658|NCT03989440|80253515|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
27563659|NCT03989440|80253516|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
27563660|NCT03989440|80253517|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
27563661|NCT01464346|80253525|FG000|Overall Study|Withdrawal by Subject|0|||
27563662|NCT01464346|80253526|FG001|Overall Study|Withdrawal by Subject|0|||
27563663|NCT01464346|80253527|FG002|Overall Study|Withdrawal by Subject|1|||
27563664|NCT03144674|80253530|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
27563665|NCT03144674|80253531|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
27563666|NCT03144674|80253532|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
27563667|NCT03144674|80253533|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
27563668|NCT03144674|80253530|FG000|Overall Study|Death|3|||
27563669|NCT03144674|80253531|FG001|Overall Study|Death|1|||
27563670|NCT03144674|80253532|FG002|Overall Study|Death|1|||
27563671|NCT03144674|80253533|FG003|Overall Study|Death|10|||
27563672|NCT03144674|80253530|FG000|Overall Study|Lost to Follow-up|0|||
27563673|NCT03144674|80253531|FG001|Overall Study|Lost to Follow-up|1|||
27563674|NCT03144674|80253532|FG002|Overall Study|Lost to Follow-up|1|||
27563675|NCT03144674|80253533|FG003|Overall Study|Lost to Follow-up|1|||
27563676|NCT03144674|80253530|FG000|Overall Study|Withdrawal by Participant|0|||
27563677|NCT03144674|80253531|FG001|Overall Study|Withdrawal by Participant|0|||
27563678|NCT03144674|80253532|FG002|Overall Study|Withdrawal by Participant|0|||
27563679|NCT03144674|80253533|FG003|Overall Study|Withdrawal by Participant|3|||
27563680|NCT03144674|80253530|FG000|Overall Study|Reason not Specified|0|||
27563681|NCT03144674|80253531|FG001|Overall Study|Reason not Specified|0|||
27563682|NCT03144674|80253532|FG002|Overall Study|Reason not Specified|2|||
27563683|NCT03144674|80253533|FG003|Overall Study|Reason not Specified|4|||
27563684|NCT00335972|80253536|FG000|Overall Study|not given treatments|0|||
27563685|NCT00335972|80253537|FG001|Overall Study|not given treatments|3|||
27563686|NCT02775344|80253542|FG000|Overall Study|No ovarian cyst identified|3|||
27563687|NCT02775344|80253543|FG001|Overall Study|No ovarian cyst identified|2|||
27563688|NCT00939809|80253544|FG000|Overall Study|Adverse Event|2|||
27563689|NCT00939809|80253544|FG000|Overall Study|Death|1|||
27563690|NCT00651755|80253547|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
27563691|NCT00651755|80253548|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
27563692|NCT00651755|80253547|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
27563693|NCT00651755|80253548|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
27563694|NCT02068222|80253549|FG000|Overall Study|Lost to Follow-up|1|||
27563695|NCT01848756|80253551|FG000|Overall Study|Adverse Event|1|||
27563696|NCT01848756|80253551|FG000|Overall Study|Withdrawal by Subject|1|||
27563697|NCT01848756|80253551|FG000|Overall Study|Enrolled in Error|1|||
27563698|NCT04668950|80253552|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
27563699|NCT04668950|80253553|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
27563700|NCT04668950|80253552|FG000|Overall Study|Could not confirm started study medication|15|||
27563701|NCT04668950|80253553|FG001|Overall Study|Could not confirm started study medication|15|||
27563702|NCT04668950|80253552|FG000|Overall Study|Could not confirm baseline status|6|||
27563703|NCT04668950|80253553|FG001|Overall Study|Could not confirm baseline status|2|||
27563704|NCT04668950|80253552|FG000|Overall Study|Drop out and did not start medication|15|||
27563705|NCT04668950|80253553|FG001|Overall Study|Drop out and did not start medication|17|||
27563706|NCT04668950|80253552|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
27563707|NCT04668950|80253553|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
27563708|NCT04668950|80253552|FG000|Overall Study|Other|2|||
27563709|NCT04668950|80253553|FG001|Overall Study|Other|4|||
27563710|NCT04865354|80253556|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
27563711|NCT04865354|80253557|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
27563712|NCT04865354|80253556|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
27563713|NCT04865354|80253557|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
27563714|NCT04865354|80253556|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
27563715|NCT04865354|80253557|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
27563716|NCT02275481|80253561|FG000|Overall Study|Death|2|||
27563717|NCT02275481|80253562|FG001|Overall Study|Death|1|||
27563718|NCT02275481|80253561|FG000|Overall Study|Lost to Follow-up|2|||
27563719|NCT02275481|80253562|FG001|Overall Study|Lost to Follow-up|0|||
27563720|NCT02275481|80253561|FG000|Overall Study|Withdrawal by Subject|3|||
27563721|NCT02275481|80253562|FG001|Overall Study|Withdrawal by Subject|0|||
27563722|NCT02275481|80253561|FG000|Overall Study|all other reasons combined|2|||
27563723|NCT02275481|80253562|FG001|Overall Study|all other reasons combined|1|||
27563724|NCT02275481|80253561|FG000|Overall Study|Physician Decision|0|||
27563725|NCT02275481|80253562|FG001|Overall Study|Physician Decision|1|||
27563726|NCT03560531|80253563|FG000|Overall Study|Death|4|||
27563727|NCT03560531|80253564|FG001|Overall Study|Death|1|||
27563728|NCT03560531|80253565|FG002|Overall Study|Death|1|||
27563729|NCT03560531|80253566|FG003|Overall Study|Death|2|||
27563730|NCT03560531|80253567|FG004|Overall Study|Death|6|||
27563731|NCT03560531|80253568|FG005|Overall Study|Death|1|||
27563732|NCT03560531|80253569|FG006|Overall Study|Death|4|||
27563733|NCT03560531|80253570|FG007|Overall Study|Death|8|||
27563734|NCT03560531|80253571|FG008|Overall Study|Death|1|||
27563735|NCT03560531|80253572|FG009|Overall Study|Death|3|||
27563736|NCT03560531|80253573|FG010|Overall Study|Death|2|||
27563737|NCT03560531|80253574|FG011|Overall Study|Death|0|||
27563738|NCT03560531|80253575|FG012|Overall Study|Death|4|||
27563739|NCT03560531|80253576|FG013|Overall Study|Death|1|||
27563740|NCT03560531|80253563|FG000|Overall Study|Lost to Follow-up|1|||
27563741|NCT03560531|80253564|FG001|Overall Study|Lost to Follow-up|1|||
27563742|NCT03560531|80253565|FG002|Overall Study|Lost to Follow-up|0|||
27563743|NCT03560531|80253566|FG003|Overall Study|Lost to Follow-up|0|||
27563744|NCT03560531|80253567|FG004|Overall Study|Lost to Follow-up|0|||
27563745|NCT03560531|80253568|FG005|Overall Study|Lost to Follow-up|0|||
27563746|NCT03560531|80253569|FG006|Overall Study|Lost to Follow-up|1|||
27563747|NCT03560531|80253570|FG007|Overall Study|Lost to Follow-up|0|||
27563748|NCT03560531|80253571|FG008|Overall Study|Lost to Follow-up|0|||
27563749|NCT03560531|80253572|FG009|Overall Study|Lost to Follow-up|0|||
27563750|NCT03560531|80253573|FG010|Overall Study|Lost to Follow-up|0|||
27563751|NCT03560531|80253574|FG011|Overall Study|Lost to Follow-up|0|||
27563752|NCT03560531|80253575|FG012|Overall Study|Lost to Follow-up|0|||
27563753|NCT03560531|80253576|FG013|Overall Study|Lost to Follow-up|0|||
27563754|NCT03560531|80253563|FG000|Overall Study|Withdrawal by Subject|1|||
27563755|NCT03560531|80253564|FG001|Overall Study|Withdrawal by Subject|0|||
27563756|NCT03560531|80253565|FG002|Overall Study|Withdrawal by Subject|0|||
27563757|NCT03560531|80253566|FG003|Overall Study|Withdrawal by Subject|0|||
27563758|NCT03560531|80253567|FG004|Overall Study|Withdrawal by Subject|0|||
27563759|NCT03560531|80253568|FG005|Overall Study|Withdrawal by Subject|0|||
27563760|NCT03560531|80253569|FG006|Overall Study|Withdrawal by Subject|0|||
27563761|NCT03560531|80253570|FG007|Overall Study|Withdrawal by Subject|3|||
27563762|NCT03560531|80253571|FG008|Overall Study|Withdrawal by Subject|2|||
27563763|NCT03560531|80253572|FG009|Overall Study|Withdrawal by Subject|0|||
27563764|NCT03560531|80253573|FG010|Overall Study|Withdrawal by Subject|0|||
27563765|NCT03560531|80253574|FG011|Overall Study|Withdrawal by Subject|0|||
27563766|NCT03560531|80253575|FG012|Overall Study|Withdrawal by Subject|2|||
27563767|NCT03560531|80253576|FG013|Overall Study|Withdrawal by Subject|0|||
27563768|NCT03560531|80253563|FG000|Overall Study|Study end per-protocol|1|||
27563769|NCT03560531|80253564|FG001|Overall Study|Study end per-protocol|1|||
27563770|NCT03560531|80253565|FG002|Overall Study|Study end per-protocol|2|||
27563771|NCT03560531|80253566|FG003|Overall Study|Study end per-protocol|0|||
27563772|NCT03560531|80253567|FG004|Overall Study|Study end per-protocol|1|||
27563773|NCT03560531|80253568|FG005|Overall Study|Study end per-protocol|0|||
27563774|NCT03560531|80253569|FG006|Overall Study|Study end per-protocol|0|||
27563775|NCT03560531|80253570|FG007|Overall Study|Study end per-protocol|0|||
27563776|NCT03560531|80253571|FG008|Overall Study|Study end per-protocol|0|||
27563777|NCT03560531|80253572|FG009|Overall Study|Study end per-protocol|0|||
27563778|NCT03560531|80253573|FG010|Overall Study|Study end per-protocol|0|||
27563779|NCT03560531|80253574|FG011|Overall Study|Study end per-protocol|0|||
27563780|NCT03560531|80253575|FG012|Overall Study|Study end per-protocol|0|||
27563781|NCT03560531|80253576|FG013|Overall Study|Study end per-protocol|0|||
27563782|NCT03560531|80253563|FG000|Overall Study|Early study termination by sponsor|9|||
27563783|NCT03560531|80253564|FG001|Overall Study|Early study termination by sponsor|0|||
27563784|NCT03560531|80253565|FG002|Overall Study|Early study termination by sponsor|0|||
27563785|NCT03560531|80253566|FG003|Overall Study|Early study termination by sponsor|4|||
27563786|NCT03560531|80253567|FG004|Overall Study|Early study termination by sponsor|8|||
27563787|NCT03560531|80253568|FG005|Overall Study|Early study termination by sponsor|2|||
27563788|NCT03560531|80253569|FG006|Overall Study|Early study termination by sponsor|5|||
27563789|NCT03560531|80253570|FG007|Overall Study|Early study termination by sponsor|64|||
27563790|NCT03560531|80253571|FG008|Overall Study|Early study termination by sponsor|7|||
27563791|NCT03560531|80253572|FG009|Overall Study|Early study termination by sponsor|2|||
27563792|NCT03560531|80253573|FG010|Overall Study|Early study termination by sponsor|16|||
27563793|NCT03560531|80253574|FG011|Overall Study|Early study termination by sponsor|2|||
27563794|NCT03560531|80253575|FG012|Overall Study|Early study termination by sponsor|6|||
27563795|NCT03560531|80253576|FG013|Overall Study|Early study termination by sponsor|2|||
27563796|NCT00325754|80253578|FG000|Overall Study|Adverse Event|4|||
27563797|NCT00325754|80253579|FG001|Overall Study|Adverse Event|1|||
27563798|NCT00265343|80253583|FG000|Overall Study|Adverse Event|10|||
27563799|NCT00265343|80253584|FG001|Overall Study|Adverse Event|7|||
27563800|NCT00265343|80253583|FG000|Overall Study|Withdrawal by Subject|3|||
27563801|NCT00265343|80253584|FG001|Overall Study|Withdrawal by Subject|9|||
27563802|NCT00265343|80253583|FG000|Overall Study|Other|8|||
27563803|NCT00265343|80253584|FG001|Overall Study|Other|3|||
27563804|NCT03412084|80253585|FG000|Overall Study|Withdrawal by Subject|2|||
27563805|NCT03412084|80253586|FG001|Overall Study|Withdrawal by Subject|0|||
27563806|NCT03412084|80253585|FG000|Overall Study|Participant moved|1|||
27563807|NCT03412084|80253586|FG001|Overall Study|Participant moved|0|||
27563808|NCT03412084|80253585|FG000|Overall Study|Lost to Follow-up|1|||
27563809|NCT03412084|80253586|FG001|Overall Study|Lost to Follow-up|1|||
27563810|NCT00003901|80253587|FG000|Overall Study|Adverse Event|1|||
27563811|NCT00003901|80253587|FG000|Overall Study|Withdrawal by Subject|1|||
27563812|NCT00003901|80253587|FG000|Overall Study|Ineligible|6|||
27563813|NCT00003901|80253587|FG000|Overall Study|CT Scan not within protocol requirement|2|||
27563814|NCT00003901|80253587|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
27563815|NCT00003901|80253587|FG000|Overall Study|Medical problems|6|||
27563816|NCT02618434|80253591|FG000|Overall Study|Withdrawal by Subject|0|||
27563817|NCT02618434|80253592|FG001|Overall Study|Withdrawal by Subject|2|||
27563818|NCT02618434|80253593|FG002|Overall Study|Withdrawal by Subject|3|||
27563819|NCT02618434|80253591|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
27563820|NCT02618434|80253592|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
27563821|NCT02618434|80253593|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
27563822|NCT02618434|80253591|FG000|Overall Study|Lost to Follow-up|3|||
27563823|NCT02618434|80253592|FG001|Overall Study|Lost to Follow-up|1|||
27563824|NCT02618434|80253593|FG002|Overall Study|Lost to Follow-up|3|||
27563825|NCT02618434|80253591|FG000|Overall Study|Adverse Event|1|||
27563826|NCT02618434|80253592|FG001|Overall Study|Adverse Event|0|||
27563827|NCT02618434|80253593|FG002|Overall Study|Adverse Event|12|||
27563828|NCT02618434|80253591|FG000|Overall Study|Physician Decision|0|||
27563829|NCT02618434|80253592|FG001|Overall Study|Physician Decision|1|||
27563830|NCT02618434|80253593|FG002|Overall Study|Physician Decision|0|||
27563831|NCT02618434|80253591|FG000|Overall Study|Protocol Violation|0|||
27563832|NCT02618434|80253592|FG001|Overall Study|Protocol Violation|0|||
27563833|NCT02618434|80253593|FG002|Overall Study|Protocol Violation|1|||
27563834|NCT02618434|80253591|FG000|Overall Study|Other, Multiple categories|1|||
27563835|NCT02618434|80253592|FG001|Overall Study|Other, Multiple categories|1|||
27563836|NCT02618434|80253593|FG002|Overall Study|Other, Multiple categories|1|||
27563837|NCT02369341|80253594|FG000|Overall Study|Migrated/moved from study area|1|||
27563838|NCT02369341|80253595|FG001|Overall Study|Migrated/moved from study area|0|||
27563839|NCT01644175|80253596|FG000|Overall Study|Randomized But Not Treated|0|||
27563840|NCT01644175|80253597|FG001|Overall Study|Randomized But Not Treated|2|||
27563841|NCT01644175|80253596|FG000|Overall Study|Adverse Event|8|||
27563842|NCT01644175|80253597|FG001|Overall Study|Adverse Event|13|||
27563843|NCT01644175|80253596|FG000|Overall Study|Death|1|||
27563844|NCT01644175|80253597|FG001|Overall Study|Death|2|||
27563845|NCT01644175|80253596|FG000|Overall Study|Poor compliance to protocol|9|||
27563846|NCT01644175|80253597|FG001|Overall Study|Poor compliance to protocol|10|||
27563847|NCT01644175|80253596|FG000|Overall Study|Physician Decision|1|||
27563848|NCT01644175|80253597|FG001|Overall Study|Physician Decision|2|||
27563849|NCT01644175|80253596|FG000|Overall Study|Participant Moved|1|||
27563850|NCT01644175|80253597|FG001|Overall Study|Participant Moved|2|||
27563851|NCT01644175|80253596|FG000|Overall Study|Consent withdrawn by participant|3|||
27563852|NCT01644175|80253597|FG001|Overall Study|Consent withdrawn by participant|4|||
27563853|NCT01644175|80253596|FG000|Overall Study|Related to Autoinjector Administration|2|||
27563854|NCT01644175|80253597|FG001|Overall Study|Related to Autoinjector Administration|1|||
27563855|NCT01644175|80253596|FG000|Overall Study|Last visit outside protocol visit window|4|||
27563856|NCT01644175|80253597|FG001|Overall Study|Last visit outside protocol visit window|11|||
27563857|NCT01644175|80253596|FG000|Overall Study|Selection criteria finally not met|0|||
27563858|NCT01644175|80253597|FG001|Overall Study|Selection criteria finally not met|1|||
27563859|NCT01644175|80253596|FG000|Overall Study|Site closure|2|||
27563860|NCT01644175|80253597|FG001|Overall Study|Site closure|2|||
27563861|NCT01644175|80253596|FG000|Overall Study|Lost to Follow-up|1|||
27563862|NCT01644175|80253597|FG001|Overall Study|Lost to Follow-up|0|||
27563863|NCT01644175|80253596|FG000|Overall Study|Other than specified above|0|||
27563864|NCT01644175|80253597|FG001|Overall Study|Other than specified above|3|||
27563865|NCT01277523|80253598|FG000|Overall Study|Adverse Event|1|||
27563866|NCT01277523|80253599|FG001|Overall Study|Adverse Event|0|||
27563867|NCT01277523|80253600|FG002|Overall Study|Adverse Event|0|||
27563868|NCT01277523|80253598|FG000|Overall Study|Protocol Violation|2|||
27563869|NCT01277523|80253599|FG001|Overall Study|Protocol Violation|0|||
27563870|NCT01277523|80253600|FG002|Overall Study|Protocol Violation|0|||
27563871|NCT01277523|80253598|FG000|Overall Study|Other Reason not Defined|0|||
27563872|NCT01277523|80253599|FG001|Overall Study|Other Reason not Defined|1|||
27563873|NCT01277523|80253600|FG002|Overall Study|Other Reason not Defined|0|||
27563874|NCT03274986|80253604|FG000|Overall Study|Withdrawal by Subject|0|||
27563875|NCT03274986|80253605|FG001|Overall Study|Withdrawal by Subject|1|||
27563876|NCT03274986|80253604|FG000|Overall Study|Lost to Follow-up|0|||
27563877|NCT03274986|80253605|FG001|Overall Study|Lost to Follow-up|1|||
27563878|NCT03745144|80253608|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
27563879|NCT03745144|80253609|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
27563880|NCT03745144|80253610|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
27563881|NCT03745144|80253608|FG000|Period 1|Other|0|||
27563882|NCT03745144|80253609|FG001|Period 1|Other|0|||
27563883|NCT03745144|80253610|FG002|Period 1|Other|1|||
27563884|NCT01062555|80253611|FG000|Phase 1|Death|10|||
27563885|NCT01062555|80253612|FG001|Phase 1|Death|17|||
27563886|NCT01062555|80253613|FG002|Phase 1|Death|0|||
27563887|NCT01062555|80253614|FG003|Phase 1|Death|0|||
27563888|NCT01062555|80253611|FG000|Phase 1|Graft Failure|12|||
27563889|NCT01062555|80253612|FG001|Phase 1|Graft Failure|8|||
27563890|NCT01062555|80253613|FG002|Phase 1|Graft Failure|0|||
27563891|NCT01062555|80253614|FG003|Phase 1|Graft Failure|0|||
27563892|NCT01062555|80253611|FG000|Phase 1|Withdrawal by Subject|1|||
27563893|NCT01062555|80253612|FG001|Phase 1|Withdrawal by Subject|1|||
27563894|NCT01062555|80253613|FG002|Phase 1|Withdrawal by Subject|0|||
27563895|NCT01062555|80253614|FG003|Phase 1|Withdrawal by Subject|0|||
27563896|NCT01062555|80253611|FG000|Phase 2|Death|0|||
27563897|NCT01062555|80253612|FG001|Phase 2|Death|0|||
27563898|NCT01062555|80253613|FG002|Phase 2|Death|8|||
27563899|NCT01062555|80253614|FG003|Phase 2|Death|3|||
27563900|NCT01062555|80253611|FG000|Phase 2|Graft failure|0|||
27563901|NCT01062555|80253612|FG001|Phase 2|Graft failure|0|||
27563902|NCT01062555|80253613|FG002|Phase 2|Graft failure|7|||
27563903|NCT01062555|80253614|FG003|Phase 2|Graft failure|4|||
27563904|NCT01062555|80253611|FG000|Phase 2|Withdrawal by Subject|0|||
27563905|NCT01062555|80253612|FG001|Phase 2|Withdrawal by Subject|0|||
27563906|NCT01062555|80253613|FG002|Phase 2|Withdrawal by Subject|0|||
27563907|NCT01062555|80253614|FG003|Phase 2|Withdrawal by Subject|7|||
27563908|NCT01062555|80253611|FG000|Phase 2|Protocol Violation|0|||
27563909|NCT01062555|80253612|FG001|Phase 2|Protocol Violation|0|||
27563910|NCT01062555|80253613|FG002|Phase 2|Protocol Violation|0|||
27563911|NCT01062555|80253614|FG003|Phase 2|Protocol Violation|3|||
27563912|NCT01062555|80253611|FG000|Phase 2|Physician Decision|0|||
27563913|NCT01062555|80253612|FG001|Phase 2|Physician Decision|0|||
27563914|NCT01062555|80253613|FG002|Phase 2|Physician Decision|0|||
27563915|NCT01062555|80253614|FG003|Phase 2|Physician Decision|17|||
27563916|NCT01179477|80253617|FG000|Overall Study|Death|542|||
27563917|NCT01179477|80253617|FG000|Overall Study|Unsuccessful implant|80|||
27563918|NCT01179477|80253617|FG000|Overall Study|Non-death withdrawal|438|||
27563919|NCT01179477|80253617|FG000|Overall Study|Did not complete final visit|27|||
27563920|NCT00644969|80253618|FG000|Treatment Phase|Randomized, not treated|1|||
27563921|NCT00644969|80253619|FG001|Treatment Phase|Randomized, not treated|0|||
27563922|NCT00644969|80253618|FG000|Treatment Phase|Adverse Event|3|||
27563923|NCT00644969|80253619|FG001|Treatment Phase|Adverse Event|0|||
27563924|NCT00644969|80253618|FG000|Treatment Phase|Withdrawal by Subject|4|||
27563925|NCT00644969|80253619|FG001|Treatment Phase|Withdrawal by Subject|0|||
27563926|NCT00644969|80253618|FG000|Treatment Phase|Lost to Follow-up|2|||
27563927|NCT00644969|80253619|FG001|Treatment Phase|Lost to Follow-up|2|||
27563928|NCT00644969|80253618|FG000|Treatment Phase|Other|4|||
27563929|NCT00644969|80253619|FG001|Treatment Phase|Other|1|||
27563930|NCT00644969|80253618|FG000|Post Treatment Phase|Death|1|||
27563931|NCT00644969|80253619|FG001|Post Treatment Phase|Death|0|||
27563932|NCT00644969|80253618|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
27563933|NCT00644969|80253619|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
27563934|NCT00644969|80253618|FG000|Post Treatment Phase|Lost to Follow-up|4|||
27563935|NCT00644969|80253619|FG001|Post Treatment Phase|Lost to Follow-up|1|||
27563936|NCT00644969|80253618|FG000|Post Treatment Phase|Other|1|||
27563937|NCT00644969|80253619|FG001|Post Treatment Phase|Other|0|||
27563938|NCT04809220|80253621|FG000|Overall Study|Adverse Event|4|||
27563939|NCT04809220|80253622|FG001|Overall Study|Adverse Event|0|||
27563940|NCT04809220|80253621|FG000|Overall Study|Death|1|||
27563941|NCT04809220|80253622|FG001|Overall Study|Death|0|||
27563942|NCT04809220|80253621|FG000|Overall Study|Lost to Follow-up|3|||
27563943|NCT04809220|80253622|FG001|Overall Study|Lost to Follow-up|0|||
27563944|NCT04809220|80253621|FG000|Overall Study|Physician Decision|0|||
27563945|NCT04809220|80253622|FG001|Overall Study|Physician Decision|1|||
27563946|NCT04809220|80253621|FG000|Overall Study|Withdrawal by Subject|9|||
27563947|NCT04809220|80253622|FG001|Overall Study|Withdrawal by Subject|5|||
27563948|NCT04809220|80253621|FG000|Overall Study|Due to long-term overseas business trips|1|||
27563949|NCT04809220|80253622|FG001|Overall Study|Due to long-term overseas business trips|0|||
27563950|NCT02053753|80253623|FG000|Overall Study|Withdrawal by Subject|2|||
27563951|NCT02053753|80253624|FG001|Overall Study|Withdrawal by Subject|4|||
27563952|NCT02053753|80253623|FG000|Overall Study|Decision by Sponsor|1|||
27563953|NCT02053753|80253624|FG001|Overall Study|Decision by Sponsor|1|||
27563954|NCT02053753|80253623|FG000|Overall Study|Lost to Follow-up|4|||
27563955|NCT02053753|80253624|FG001|Overall Study|Lost to Follow-up|3|||
27563956|NCT01774786|80253627|FG000|Overall Study|Death|300|||
27563957|NCT01774786|80253628|FG001|Overall Study|Death|319|||
27563958|NCT01774786|80253627|FG000|Overall Study|Lost to Follow-up|6|||
27563959|NCT01774786|80253628|FG001|Overall Study|Lost to Follow-up|7|||
27563960|NCT01774786|80253627|FG000|Overall Study|Withdrawal by Subject|18|||
27563961|NCT01774786|80253628|FG001|Overall Study|Withdrawal by Subject|14|||
27563962|NCT01774786|80253627|FG000|Overall Study|Physician Decision|2|||
27563963|NCT01774786|80253628|FG001|Overall Study|Physician Decision|0|||
27563964|NCT01774786|80253627|FG000|Overall Study|Non-compliance|0|||
27563965|NCT01774786|80253628|FG001|Overall Study|Non-compliance|1|||
27563966|NCT01774786|80253627|FG000|Overall Study|Reason Not Specified|2|||
27563967|NCT01774786|80253628|FG001|Overall Study|Reason Not Specified|5|||
27563968|NCT03265249|80253629|FG000|Overall Study|Withdrawal by Subject|0|||
27563969|NCT03265249|80253630|FG001|Overall Study|Withdrawal by Subject|1|||
27563970|NCT01290666|80253639|FG000|Overall Study|Lost to Follow-up|11|||
27563971|NCT01290666|80253639|FG000|Overall Study|Withdrawal by Subject|23|||
27563972|NCT01290666|80253639|FG000|Overall Study|Early Termination of Study|4|||
27563973|NCT02420691|80253640|FG000|Overall Study|Adverse Event|3|||
27563974|NCT02420691|80253640|FG000|Overall Study|Withdrawal by Subject|3|||
27563975|NCT03320564|80253641|FG000|Overall Study|Protocol Violation|1|||
27563976|NCT01988103|80253642|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
27563977|NCT01988103|80253643|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
27563978|NCT01988103|80253644|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
27563979|NCT01988103|80253645|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
27563980|NCT01988103|80253646|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
27563981|NCT01988103|80253642|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
27563982|NCT01988103|80253643|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
27563983|NCT01988103|80253644|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
27563984|NCT01988103|80253645|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
27563985|NCT01988103|80253646|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
27563986|NCT01988103|80253642|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
27563987|NCT01988103|80253643|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
27563988|NCT01988103|80253644|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
27563989|NCT01988103|80253645|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27563990|NCT01988103|80253646|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
27563991|NCT01988103|80253642|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
27563992|NCT01988103|80253643|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
27563993|NCT01988103|80253644|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
27563994|NCT01988103|80253645|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
27563995|NCT01988103|80253646|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
27563996|NCT01988103|80253642|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
27563997|NCT01988103|80253643|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
27563998|NCT01988103|80253644|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
27563999|NCT01988103|80253645|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
27564000|NCT01988103|80253646|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
27564001|NCT01988103|80253642|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
27564002|NCT01988103|80253643|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
27564003|NCT01988103|80253644|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
27564004|NCT01988103|80253645|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
27564005|NCT01988103|80253646|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
27564006|NCT01988103|80253642|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
27564007|NCT01988103|80253643|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
27564008|NCT01988103|80253644|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
27564009|NCT01988103|80253645|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
27564010|NCT01988103|80253646|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
27564011|NCT01068509|80253647|FG000|Overall Study|Death|0|||
27564012|NCT01068509|80253648|FG001|Overall Study|Death|0|||
27564013|NCT01068509|80253649|FG002|Overall Study|Death|1|||
27564014|NCT01068509|80253647|FG000|Overall Study|Disease Progression|5|||
27564015|NCT01068509|80253648|FG001|Overall Study|Disease Progression|20|||
27564016|NCT01068509|80253649|FG002|Overall Study|Disease Progression|18|||
27564017|NCT01068509|80253647|FG000|Overall Study|Lost to Follow-up|1|||
27564018|NCT01068509|80253648|FG001|Overall Study|Lost to Follow-up|0|||
27564019|NCT01068509|80253649|FG002|Overall Study|Lost to Follow-up|0|||
27564020|NCT01068509|80253647|FG000|Overall Study|Withdrew Consent|0|||
27564021|NCT01068509|80253648|FG001|Overall Study|Withdrew Consent|1|||
27564022|NCT01068509|80253649|FG002|Overall Study|Withdrew Consent|2|||
27564023|NCT01068509|80253647|FG000|Overall Study|Reason Not Specified|0|||
27564024|NCT01068509|80253648|FG001|Overall Study|Reason Not Specified|1|||
27564025|NCT01068509|80253649|FG002|Overall Study|Reason Not Specified|0|||
27564026|NCT01816893|80253650|FG000|Washout Period|Withdrawal by Subject|2|||
27564027|NCT01816893|80253651|FG001|Washout Period|Withdrawal by Subject|0|||
27564028|NCT03760146|80253652|FG000|Overall Study|Adverse Event|11|||
27564029|NCT03760146|80253653|FG001|Overall Study|Adverse Event|8|||
27564030|NCT03760146|80253654|FG002|Overall Study|Adverse Event|0|||
27564031|NCT03760146|80253655|FG003|Overall Study|Adverse Event|0|||
27564032|NCT03760146|80253656|FG004|Overall Study|Adverse Event|0|||
27564033|NCT03760146|80253657|FG005|Overall Study|Adverse Event|0|||
27564034|NCT03760146|80253652|FG000|Overall Study|Death|1|||
27564035|NCT03760146|80253653|FG001|Overall Study|Death|0|||
27564036|NCT03760146|80253654|FG002|Overall Study|Death|0|||
27564037|NCT03760146|80253655|FG003|Overall Study|Death|0|||
27564038|NCT03760146|80253656|FG004|Overall Study|Death|0|||
27564039|NCT03760146|80253657|FG005|Overall Study|Death|0|||
27564040|NCT03760146|80253652|FG000|Overall Study|Lost to Follow-up|41|||
27564041|NCT03760146|80253653|FG001|Overall Study|Lost to Follow-up|28|||
27564042|NCT03760146|80253654|FG002|Overall Study|Lost to Follow-up|9|||
27564043|NCT03760146|80253655|FG003|Overall Study|Lost to Follow-up|2|||
27564044|NCT03760146|80253656|FG004|Overall Study|Lost to Follow-up|14|||
27564045|NCT03760146|80253657|FG005|Overall Study|Lost to Follow-up|8|||
27564046|NCT03760146|80253652|FG000|Overall Study|No longer met eligibility criteria|3|||
27564047|NCT03760146|80253653|FG001|Overall Study|No longer met eligibility criteria|9|||
27564048|NCT03760146|80253654|FG002|Overall Study|No longer met eligibility criteria|0|||
27564049|NCT03760146|80253655|FG003|Overall Study|No longer met eligibility criteria|0|||
27564050|NCT03760146|80253656|FG004|Overall Study|No longer met eligibility criteria|1|||
27564051|NCT03760146|80253657|FG005|Overall Study|No longer met eligibility criteria|0|||
27564052|NCT03760146|80253652|FG000|Overall Study|Protocol Violation|21|||
27564053|NCT03760146|80253653|FG001|Overall Study|Protocol Violation|13|||
27564054|NCT03760146|80253654|FG002|Overall Study|Protocol Violation|1|||
27564055|NCT03760146|80253655|FG003|Overall Study|Protocol Violation|0|||
27564056|NCT03760146|80253656|FG004|Overall Study|Protocol Violation|1|||
27564057|NCT03760146|80253657|FG005|Overall Study|Protocol Violation|0|||
27564058|NCT03760146|80253652|FG000|Overall Study|Withdrawal by Subject|19|||
27564059|NCT03760146|80253653|FG001|Overall Study|Withdrawal by Subject|20|||
27564060|NCT03760146|80253654|FG002|Overall Study|Withdrawal by Subject|1|||
27564061|NCT03760146|80253655|FG003|Overall Study|Withdrawal by Subject|0|||
27564062|NCT03760146|80253656|FG004|Overall Study|Withdrawal by Subject|1|||
27564063|NCT03760146|80253657|FG005|Overall Study|Withdrawal by Subject|0|||
27564064|NCT04552587|80253660|FG000|Overall Study|Lost to Follow-up|4|||
27564065|NCT02726074|80253673|FG000|Overall Study|Withdrawal by Subject|4|||
27564066|NCT02726074|80253673|FG000|Overall Study|Adverse Event|14|||
27564067|NCT02726074|80253673|FG000|Overall Study|Protocol Violation|3|||
27564068|NCT02726074|80253673|FG000|Overall Study|Lost to Follow-up|2|||
27564069|NCT02726074|80253673|FG000|Overall Study|Others|3|||
27564070|NCT01817725|80253674|FG000|Overall Study|Withdrawal by Subject|1|||
27564071|NCT00112502|80253677|FG000|Overall Study|Withdrawal by Subject|0|||
27564072|NCT00112502|80253678|FG001|Overall Study|Withdrawal by Subject|1|||
27564073|NCT00112502|80253679|FG002|Overall Study|Withdrawal by Subject|1|||
27564074|NCT00112502|80253680|FG003|Overall Study|Withdrawal by Subject|4|||
27564075|NCT00112502|80253681|FG004|Overall Study|Withdrawal by Subject|2|||
27564076|NCT00112502|80253682|FG005|Overall Study|Withdrawal by Subject|5|||
27564077|NCT00112502|80253683|FG006|Overall Study|Withdrawal by Subject|3|||
27564078|NCT00112502|80253684|FG007|Overall Study|Withdrawal by Subject|7|||
27564079|NCT03131440|80253685|FG000|Overall Study|Withdrawal by Subject|1|||
27564080|NCT03131440|80253686|FG001|Overall Study|Withdrawal by Subject|3|||
27564081|NCT03131440|80253687|FG002|Overall Study|Withdrawal by Subject|0|||
27564082|NCT03131440|80253688|FG003|Overall Study|Withdrawal by Subject|0|||
27564083|NCT03131440|80253689|FG004|Overall Study|Withdrawal by Subject|1|||
27564084|NCT03131440|80253690|FG005|Overall Study|Withdrawal by Subject|0|||
27564085|NCT03131440|80253691|FG006|Overall Study|Withdrawal by Subject|0|||
27564086|NCT03131440|80253692|FG007|Overall Study|Withdrawal by Subject|1|||
27564087|NCT03131440|80253693|FG008|Overall Study|Withdrawal by Subject|1|||
27564088|NCT03131440|80253694|FG009|Overall Study|Withdrawal by Subject|1|||
27564089|NCT03131440|80253695|FG010|Overall Study|Withdrawal by Subject|0|||
27564090|NCT03131440|80253696|FG011|Overall Study|Withdrawal by Subject|1|||
27564091|NCT03131440|80253697|FG012|Overall Study|Withdrawal by Subject|1|||
27564092|NCT03131440|80253698|FG013|Overall Study|Withdrawal by Subject|0|||
27564093|NCT03131440|80253699|FG014|Overall Study|Withdrawal by Subject|1|||
27564094|NCT03131440|80253700|FG015|Overall Study|Withdrawal by Subject|0|||
27564095|NCT03131440|80253701|FG016|Overall Study|Withdrawal by Subject|0|||
27564096|NCT03131440|80253702|FG017|Overall Study|Withdrawal by Subject|0|||
27564097|NCT03131440|80253703|FG018|Overall Study|Withdrawal by Subject|1|||
27564098|NCT03131440|80253704|FG019|Overall Study|Withdrawal by Subject|0|||
27564099|NCT03131440|80253705|FG020|Overall Study|Withdrawal by Subject|1|||
27564100|NCT03131440|80253706|FG021|Overall Study|Withdrawal by Subject|1|||
27564101|NCT03131440|80253707|FG022|Overall Study|Withdrawal by Subject|1|||
27564102|NCT03131440|80253708|FG023|Overall Study|Withdrawal by Subject|0|||
27564103|NCT03131440|80253709|FG024|Overall Study|Withdrawal by Subject|0|||
27564104|NCT03131440|80253710|FG025|Overall Study|Withdrawal by Subject|0|||
27564105|NCT03131440|80253711|FG026|Overall Study|Withdrawal by Subject|0|||
27564106|NCT03131440|80253712|FG027|Overall Study|Withdrawal by Subject|0|||
27564107|NCT03131440|80253713|FG028|Overall Study|Withdrawal by Subject|0|||
27564108|NCT03131440|80253714|FG029|Overall Study|Withdrawal by Subject|0|||
27564109|NCT03131440|80253715|FG030|Overall Study|Withdrawal by Subject|1|||
27564110|NCT03131440|80253716|FG031|Overall Study|Withdrawal by Subject|0|||
27564111|NCT03131440|80253685|FG000|Overall Study|Lost to Follow-up|0|||
27564112|NCT03131440|80253686|FG001|Overall Study|Lost to Follow-up|0|||
27564113|NCT03131440|80253687|FG002|Overall Study|Lost to Follow-up|0|||
27564114|NCT03131440|80253688|FG003|Overall Study|Lost to Follow-up|0|||
27564115|NCT03131440|80253689|FG004|Overall Study|Lost to Follow-up|0|||
27564116|NCT03131440|80253690|FG005|Overall Study|Lost to Follow-up|1|||
27564117|NCT03131440|80253691|FG006|Overall Study|Lost to Follow-up|0|||
27564118|NCT03131440|80253692|FG007|Overall Study|Lost to Follow-up|0|||
27564119|NCT03131440|80253693|FG008|Overall Study|Lost to Follow-up|0|||
27564120|NCT03131440|80253694|FG009|Overall Study|Lost to Follow-up|0|||
27564121|NCT03131440|80253695|FG010|Overall Study|Lost to Follow-up|0|||
27564122|NCT03131440|80253696|FG011|Overall Study|Lost to Follow-up|0|||
27564123|NCT03131440|80253697|FG012|Overall Study|Lost to Follow-up|0|||
27564124|NCT03131440|80253698|FG013|Overall Study|Lost to Follow-up|0|||
27564125|NCT03131440|80253699|FG014|Overall Study|Lost to Follow-up|0|||
27564126|NCT03131440|80253700|FG015|Overall Study|Lost to Follow-up|0|||
27564127|NCT03131440|80253701|FG016|Overall Study|Lost to Follow-up|0|||
27564128|NCT03131440|80253702|FG017|Overall Study|Lost to Follow-up|0|||
27564129|NCT03131440|80253703|FG018|Overall Study|Lost to Follow-up|0|||
27564130|NCT03131440|80253704|FG019|Overall Study|Lost to Follow-up|2|||
27564131|NCT03131440|80253705|FG020|Overall Study|Lost to Follow-up|1|||
27564132|NCT03131440|80253706|FG021|Overall Study|Lost to Follow-up|0|||
27564133|NCT03131440|80253707|FG022|Overall Study|Lost to Follow-up|1|||
27564134|NCT03131440|80253708|FG023|Overall Study|Lost to Follow-up|0|||
27564135|NCT03131440|80253709|FG024|Overall Study|Lost to Follow-up|1|||
27564136|NCT03131440|80253710|FG025|Overall Study|Lost to Follow-up|0|||
27564137|NCT03131440|80253711|FG026|Overall Study|Lost to Follow-up|0|||
27564138|NCT03131440|80253712|FG027|Overall Study|Lost to Follow-up|2|||
27564139|NCT03131440|80253713|FG028|Overall Study|Lost to Follow-up|0|||
27564140|NCT03131440|80253714|FG029|Overall Study|Lost to Follow-up|2|||
27564141|NCT03131440|80253715|FG030|Overall Study|Lost to Follow-up|0|||
27564142|NCT03131440|80253716|FG031|Overall Study|Lost to Follow-up|0|||
27564143|NCT03131440|80253685|FG000|Overall Study|Death|0|||
27564144|NCT03131440|80253686|FG001|Overall Study|Death|0|||
27564145|NCT03131440|80253687|FG002|Overall Study|Death|0|||
27564146|NCT03131440|80253688|FG003|Overall Study|Death|0|||
27564147|NCT03131440|80253689|FG004|Overall Study|Death|0|||
27564148|NCT03131440|80253690|FG005|Overall Study|Death|0|||
27564149|NCT03131440|80253691|FG006|Overall Study|Death|0|||
27564150|NCT03131440|80253692|FG007|Overall Study|Death|0|||
27564151|NCT03131440|80253693|FG008|Overall Study|Death|0|||
27564152|NCT03131440|80253694|FG009|Overall Study|Death|0|||
27564153|NCT03131440|80253695|FG010|Overall Study|Death|0|||
27564154|NCT03131440|80253696|FG011|Overall Study|Death|0|||
27564155|NCT03131440|80253697|FG012|Overall Study|Death|0|||
27564156|NCT03131440|80253698|FG013|Overall Study|Death|0|||
27564157|NCT03131440|80253699|FG014|Overall Study|Death|0|||
27564158|NCT03131440|80253700|FG015|Overall Study|Death|0|||
27564159|NCT03131440|80253701|FG016|Overall Study|Death|0|||
27564160|NCT03131440|80253702|FG017|Overall Study|Death|0|||
27564161|NCT03131440|80253703|FG018|Overall Study|Death|0|||
27564162|NCT03131440|80253704|FG019|Overall Study|Death|0|||
27564163|NCT03131440|80253705|FG020|Overall Study|Death|0|||
27564164|NCT03131440|80253706|FG021|Overall Study|Death|0|||
27564165|NCT03131440|80253707|FG022|Overall Study|Death|0|||
27564166|NCT03131440|80253708|FG023|Overall Study|Death|0|||
27564167|NCT03131440|80253709|FG024|Overall Study|Death|0|||
27564168|NCT03131440|80253710|FG025|Overall Study|Death|1|||
27564169|NCT03131440|80253711|FG026|Overall Study|Death|0|||
27564170|NCT03131440|80253712|FG027|Overall Study|Death|0|||
27564171|NCT03131440|80253713|FG028|Overall Study|Death|0|||
27564172|NCT03131440|80253714|FG029|Overall Study|Death|0|||
27564173|NCT03131440|80253715|FG030|Overall Study|Death|0|||
27564174|NCT03131440|80253716|FG031|Overall Study|Death|0|||
27564175|NCT01505608|80253723|FG000|Phase I|Lack of Efficacy|0|||
27564176|NCT01505608|80253724|FG001|Phase I|Lack of Efficacy|4|||
27564177|NCT01505608|80253723|FG000|Phase I|Adverse Event|0|||
27564178|NCT01505608|80253724|FG001|Phase I|Adverse Event|1|||
27564179|NCT01505608|80253723|FG000|Phase I|Withdrawal by Subject|0|||
27564180|NCT01505608|80253724|FG001|Phase I|Withdrawal by Subject|1|||
27564181|NCT01505608|80253723|FG000|Phase II|Lack of Efficacy|2|||
27564182|NCT01505608|80253724|FG001|Phase II|Lack of Efficacy|1|||
27564183|NCT01505608|80253723|FG000|Phase II|Protocol Violation|0|||
27564184|NCT01505608|80253724|FG001|Phase II|Protocol Violation|1|||
27564185|NCT01400516|80253728|FG000|Primary Trial|Withdrawal by Subject|0|||
27564186|NCT01400516|80253729|FG001|Primary Trial|Withdrawal by Subject|2|||
27564187|NCT01708174|80253730|FG000|Treatment Period|Withdrawal by Subject|1|||
27564188|NCT01708174|80253731|FG001|Treatment Period|Withdrawal by Subject|0|||
27564189|NCT01708174|80253732|FG002|Treatment Period|Withdrawal by Subject|0|||
27564190|NCT01708174|80253730|FG000|Treatment Period|Progressive disease|0|||
27564191|NCT01708174|80253731|FG001|Treatment Period|Progressive disease|1|||
27564192|NCT01708174|80253732|FG002|Treatment Period|Progressive disease|0|||
27564193|NCT01708174|80253730|FG000|Treatment Period|Death|0|||
27564194|NCT01708174|80253731|FG001|Treatment Period|Death|0|||
27564195|NCT01708174|80253732|FG002|Treatment Period|Death|1|||
27564196|NCT01708174|80253730|FG000|Treatment Period|Adverse Event|0|||
27564197|NCT01708174|80253731|FG001|Treatment Period|Adverse Event|1|||
27564198|NCT01708174|80253732|FG002|Treatment Period|Adverse Event|0|||
27564199|NCT00304356|80253733|FG000|Nitazoxanide|Physician Decision|5|||
27564200|NCT00304356|80253733|FG000|Nitazoxanide|Physician Decision|1|||
27564201|NCT00304356|80253733|FG000|Nitazoxanide|number is 0|1|||
27564202|NCT00304356|80253733|FG000|Nitazoxanide|Physician Decision|1|||
27564203|NCT00304356|80253733|FG000|Nitazoxanide|Physician Decision|1|||
27564204|NCT00304356|80253733|FG000|Nitazoxanide|Physician Decision|1|||
27564205|NCT03165110|80253735|FG000|Overall Study|Anroid phone software incompatibility|1|||
27564206|NCT01176266|80253736|FG000|Overall Study|Death|6|||
27564207|NCT01176266|80253736|FG000|Overall Study|Withdrawal by Subject|3|||
27564208|NCT01163279|80253741|FG000|Overall Study|Withdrawal by Subject|2|||
27564209|NCT01163279|80253742|FG001|Overall Study|Withdrawal by Subject|0|||
27564210|NCT05071183|80253746|FG000|Overall Study|Death|1|||
27564211|NCT05071183|80253747|FG001|Overall Study|Death|2|||
27564212|NCT05071183|80253748|FG002|Overall Study|Death|0|||
27564213|NCT05071183|80253746|FG000|Overall Study|Other Reasons|1|||
27564214|NCT05071183|80253747|FG001|Overall Study|Other Reasons|3|||
27564215|NCT05071183|80253748|FG002|Overall Study|Other Reasons|2|||
27564216|NCT00733746|80253751|FG000|Overall Study|Ineligible|5|||
27564217|NCT00791518|80253752|FG000|Overall Study|Protocol Violation|93|||
27564218|NCT01324349|80253754|FG000|Overall Study|Death|1|||
27564219|NCT01324349|80253755|FG001|Overall Study|Death|1|||
27564220|NCT01324349|80253754|FG000|Overall Study|Withdrawal by Subject|0|||
27564221|NCT01324349|80253755|FG001|Overall Study|Withdrawal by Subject|1|||
27564222|NCT01367158|80253760|FG000|Overall Study|Withdrew consent|0|||
27564223|NCT01367158|80253761|FG001|Overall Study|Withdrew consent|2|||
27564224|NCT01367158|80253762|FG002|Overall Study|Withdrew consent|1|||
27564225|NCT01367158|80253763|FG003|Overall Study|Withdrew consent|0|||
27564226|NCT01367158|80253764|FG004|Overall Study|Withdrew consent|2|||
27564227|NCT01367158|80253765|FG005|Overall Study|Withdrew consent|0|||
27564228|NCT01367158|80253766|FG006|Overall Study|Withdrew consent|0|||
27564229|NCT01367158|80253767|FG007|Overall Study|Withdrew consent|1|||
27564230|NCT01367158|80253768|FG008|Overall Study|Withdrew consent|0|||
27564231|NCT01367158|80253769|FG009|Overall Study|Withdrew consent|0|||
27564232|NCT01367158|80253770|FG010|Overall Study|Withdrew consent|0|||
27564233|NCT01367158|80253760|FG000|Overall Study|Lost to Follow-up|0|||
27564234|NCT01367158|80253761|FG001|Overall Study|Lost to Follow-up|0|||
27564235|NCT01367158|80253762|FG002|Overall Study|Lost to Follow-up|0|||
27564236|NCT01367158|80253763|FG003|Overall Study|Lost to Follow-up|1|||
27564237|NCT01367158|80253764|FG004|Overall Study|Lost to Follow-up|0|||
27564238|NCT01367158|80253765|FG005|Overall Study|Lost to Follow-up|2|||
27564239|NCT01367158|80253766|FG006|Overall Study|Lost to Follow-up|0|||
27564240|NCT01367158|80253767|FG007|Overall Study|Lost to Follow-up|1|||
27564241|NCT01367158|80253768|FG008|Overall Study|Lost to Follow-up|0|||
27564242|NCT01367158|80253769|FG009|Overall Study|Lost to Follow-up|0|||
27564243|NCT01367158|80253770|FG010|Overall Study|Lost to Follow-up|1|||
27564244|NCT01367158|80253760|FG000|Overall Study|Protocol Violation|0|||
27564245|NCT01367158|80253761|FG001|Overall Study|Protocol Violation|1|||
27564246|NCT01367158|80253762|FG002|Overall Study|Protocol Violation|0|||
27564247|NCT01367158|80253763|FG003|Overall Study|Protocol Violation|0|||
27564248|NCT01367158|80253764|FG004|Overall Study|Protocol Violation|0|||
27564249|NCT01367158|80253765|FG005|Overall Study|Protocol Violation|0|||
27564250|NCT01367158|80253766|FG006|Overall Study|Protocol Violation|0|||
27564251|NCT01367158|80253767|FG007|Overall Study|Protocol Violation|0|||
27564252|NCT01367158|80253768|FG008|Overall Study|Protocol Violation|0|||
27564253|NCT01367158|80253769|FG009|Overall Study|Protocol Violation|0|||
27564254|NCT01367158|80253770|FG010|Overall Study|Protocol Violation|0|||
27564255|NCT02625090|80253771|FG000|Overall Study|Participant wants to be pregnant|2|||
27564256|NCT02625090|80253771|FG000|Overall Study|For the Promoter|1|||
27564257|NCT02625090|80253771|FG000|Overall Study|Sponsor's Decision|9|||
27564258|NCT02625090|80253771|FG000|Overall Study|Somnolence|1|||
27564259|NCT02625090|80253771|FG000|Overall Study|Study terminated by Sponsor|7|||
27564260|NCT02625090|80253771|FG000|Overall Study|Negative Benefit/Risk|1|||
27564261|NCT02625090|80253771|FG000|Overall Study|Protocol Deviation|2|||
27564262|NCT02625090|80253771|FG000|Overall Study|Lack of Efficacy|16|||
27564263|NCT02625090|80253771|FG000|Overall Study|Adverse Event|3|||
27564264|NCT02968979|80253774|FG000|Overall Study|Protocol Violation|7|||
27564265|NCT02968979|80253774|FG000|Overall Study|Withdrawal by Subject|1|||
27564266|NCT02141282|80253776|FG000|Overall Study|Adverse event, not related to progression|8|||
27564267|NCT02141282|80253777|FG001|Overall Study|Adverse event, not related to progression|1|||
27564268|NCT02141282|80253778|FG002|Overall Study|Adverse event, not related to progression|3|||
27564269|NCT02141282|80253779|FG003|Overall Study|Adverse event, not related to progression|1|||
27564270|NCT02141282|80253776|FG000|Overall Study|Adverse event, related to progression|1|||
27564271|NCT02141282|80253777|FG001|Overall Study|Adverse event, related to progression|0|||
27564272|NCT02141282|80253778|FG002|Overall Study|Adverse event, related to progression|2|||
27564273|NCT02141282|80253779|FG003|Overall Study|Adverse event, related to progression|0|||
27564274|NCT02141282|80253776|FG000|Overall Study|COVID-19 infection|1|||
27564275|NCT02141282|80253777|FG001|Overall Study|COVID-19 infection|0|||
27564276|NCT02141282|80253778|FG002|Overall Study|COVID-19 infection|0|||
27564277|NCT02141282|80253779|FG003|Overall Study|COVID-19 infection|0|||
27564278|NCT02141282|80253776|FG000|Overall Study|Lost to Follow-up|0|||
27564279|NCT02141282|80253777|FG001|Overall Study|Lost to Follow-up|0|||
27564280|NCT02141282|80253778|FG002|Overall Study|Lost to Follow-up|4|||
27564281|NCT02141282|80253779|FG003|Overall Study|Lost to Follow-up|2|||
27564282|NCT02141282|80253776|FG000|Overall Study|Other, not specified|14|||
27564283|NCT02141282|80253777|FG001|Overall Study|Other, not specified|11|||
27564284|NCT02141282|80253778|FG002|Overall Study|Other, not specified|23|||
27564285|NCT02141282|80253779|FG003|Overall Study|Other, not specified|9|||
27564286|NCT02141282|80253776|FG000|Overall Study|Progressive disease, Richter's|4|||
27564287|NCT02141282|80253777|FG001|Overall Study|Progressive disease, Richter's|1|||
27564288|NCT02141282|80253778|FG002|Overall Study|Progressive disease, Richter's|1|||
27564289|NCT02141282|80253779|FG003|Overall Study|Progressive disease, Richter's|1|||
27564290|NCT02141282|80253776|FG000|Overall Study|Progressive disease per protocol|12|||
27564291|NCT02141282|80253777|FG001|Overall Study|Progressive disease per protocol|7|||
27564292|NCT02141282|80253778|FG002|Overall Study|Progressive disease per protocol|9|||
27564293|NCT02141282|80253779|FG003|Overall Study|Progressive disease per protocol|2|||
27564294|NCT02141282|80253776|FG000|Overall Study|Stem cell transplant|1|||
27564295|NCT02141282|80253777|FG001|Overall Study|Stem cell transplant|0|||
27564296|NCT02141282|80253778|FG002|Overall Study|Stem cell transplant|1|||
27564297|NCT02141282|80253779|FG003|Overall Study|Stem cell transplant|0|||
27564298|NCT02141282|80253776|FG000|Overall Study|Study terminated by Sponsor|0|||
27564299|NCT02141282|80253777|FG001|Overall Study|Study terminated by Sponsor|1|||
27564300|NCT02141282|80253778|FG002|Overall Study|Study terminated by Sponsor|0|||
27564301|NCT02141282|80253779|FG003|Overall Study|Study terminated by Sponsor|0|||
27564302|NCT02141282|80253776|FG000|Overall Study|Subject non-compliance|0|||
27564303|NCT02141282|80253777|FG001|Overall Study|Subject non-compliance|0|||
27564304|NCT02141282|80253778|FG002|Overall Study|Subject non-compliance|1|||
27564305|NCT02141282|80253779|FG003|Overall Study|Subject non-compliance|0|||
27564306|NCT02141282|80253776|FG000|Overall Study|Withdrew consent|2|||
27564307|NCT02141282|80253777|FG001|Overall Study|Withdrew consent|0|||
27564308|NCT02141282|80253778|FG002|Overall Study|Withdrew consent|4|||
27564309|NCT02141282|80253779|FG003|Overall Study|Withdrew consent|0|||
27564310|NCT00491387|80253780|FG000|Overall Study|study terminated|20|||
27564311|NCT02574247|80253785|FG000|Overall Study|Withdrawal by Subject|1|||
27564312|NCT02574247|80253786|FG001|Overall Study|Withdrawal by Subject|0|||
27564313|NCT02574247|80253787|FG002|Overall Study|Withdrawal by Subject|0|||
27564314|NCT02574247|80253785|FG000|Overall Study|Did not meet inclusion criteria|4|||
27564315|NCT02574247|80253786|FG001|Overall Study|Did not meet inclusion criteria|3|||
27564316|NCT02574247|80253787|FG002|Overall Study|Did not meet inclusion criteria|5|||
27564317|NCT02132767|80253788|FG000|Overall Study|Death|3|||
27564318|NCT02132767|80253789|FG001|Overall Study|Death|2|||
27564319|NCT02132767|80253788|FG000|Overall Study|Withdrawal by Subject|10|||
27564320|NCT02132767|80253789|FG001|Overall Study|Withdrawal by Subject|9|||
27564321|NCT02132767|80253788|FG000|Overall Study|Lost to Follow-up|4|||
27564322|NCT02132767|80253789|FG001|Overall Study|Lost to Follow-up|4|||
27564323|NCT00371254|80253791|FG000|Overall Study|Disease progression|13|||
27564324|NCT00371254|80253792|FG001|Overall Study|Disease progression|13|||
27564325|NCT00371254|80253791|FG000|Overall Study|Study drug toxicity|3|||
27564326|NCT00371254|80253792|FG001|Overall Study|Study drug toxicity|5|||
27564327|NCT00371254|80253791|FG000|Overall Study|Subject request|5|||
27564328|NCT00371254|80253792|FG001|Overall Study|Subject request|0|||
27564329|NCT00371254|80253791|FG000|Overall Study|Investigator Decision|2|||
27564330|NCT00371254|80253792|FG001|Overall Study|Investigator Decision|0|||
27564331|NCT00371254|80253791|FG000|Overall Study|Adverse event unrelated to study drug|0|||
27564332|NCT00371254|80253792|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27564333|NCT00371254|80253791|FG000|Overall Study|Lost to Follow-up|0|||
27564334|NCT00371254|80253792|FG001|Overall Study|Lost to Follow-up|1|||
27564335|NCT00371254|80253791|FG000|Overall Study|Withdrawal by Subject|0|||
27564336|NCT00371254|80253792|FG001|Overall Study|Withdrawal by Subject|1|||
27564337|NCT03200899|80253797|FG000|Overall Study|Lost to Follow-up|10|||
27564338|NCT03200899|80253798|FG001|Overall Study|Lost to Follow-up|23|||
27564339|NCT01574612|80253799|FG000|Overall Study|Adverse Event|3|||
27564340|NCT01574612|80253799|FG000|Overall Study|non compliant with drug|2|||
27564341|NCT01574612|80253799|FG000|Overall Study|Withdrawal by Subject|1|||
27564342|NCT01574612|80253799|FG000|Overall Study|Lost to Follow-up|2|||
27564343|NCT03020823|80253801|FG000|Overall Study|Physician Decision|4|||
27564344|NCT03020823|80253801|FG000|Overall Study|Lack of Efficacy|4|||
27564345|NCT03020823|80253801|FG000|Overall Study|Adverse Event|2|||
27564346|NCT02347189|80253802|FG000|Overall Study|No implant attempted of study device|9|||
27564347|NCT02347189|80253802|FG000|Overall Study|No primary outcome data available|2|||
27564348|NCT00026793|80253803|FG000|Overall Study|Death on study due to underlying disease|4|||
27564349|NCT00026793|80253803|FG000|Overall Study|Physician Decision|2|||
27564350|NCT00026793|80253803|FG000|Overall Study|Off study|2|||
27564351|NCT02385266|80253804|FG000|Overall Study|Withdrawal by Subject|1|||
27564352|NCT02385266|80253805|FG001|Overall Study|Withdrawal by Subject|3|||
27564353|NCT04327999|80253806|FG000|Overall Study|Protocol Violation|1|||
27564354|NCT00451321|80253807|FG000|Overall Study|Lost to Follow-up|3|||
27564355|NCT00451321|80253808|FG001|Overall Study|Lost to Follow-up|3|||
27564356|NCT00451321|80253809|FG002|Overall Study|Lost to Follow-up|1|||
27564357|NCT00451321|80253810|FG003|Overall Study|Lost to Follow-up|3|||
27564358|NCT00451321|80253811|FG004|Overall Study|Lost to Follow-up|0|||
27564359|NCT00451321|80253812|FG005|Overall Study|Lost to Follow-up|1|||
27564360|NCT00451321|80253813|FG006|Overall Study|Lost to Follow-up|0|||
27564361|NCT00451321|80253814|FG007|Overall Study|Lost to Follow-up|0|||
27564362|NCT00451321|80253807|FG000|Overall Study|Withdrawal by Subject|3|||
27564363|NCT00451321|80253808|FG001|Overall Study|Withdrawal by Subject|1|||
27564364|NCT00451321|80253809|FG002|Overall Study|Withdrawal by Subject|0|||
27564365|NCT00451321|80253810|FG003|Overall Study|Withdrawal by Subject|4|||
27564366|NCT00451321|80253811|FG004|Overall Study|Withdrawal by Subject|0|||
27564367|NCT00451321|80253812|FG005|Overall Study|Withdrawal by Subject|0|||
27564368|NCT00451321|80253813|FG006|Overall Study|Withdrawal by Subject|0|||
27564369|NCT00451321|80253814|FG007|Overall Study|Withdrawal by Subject|0|||
27564370|NCT00451321|80253807|FG000|Overall Study|Study closed/terminated|1|||
27564371|NCT00451321|80253808|FG001|Overall Study|Study closed/terminated|1|||
27564372|NCT00451321|80253809|FG002|Overall Study|Study closed/terminated|17|||
27564373|NCT00451321|80253810|FG003|Overall Study|Study closed/terminated|5|||
27564374|NCT00451321|80253811|FG004|Overall Study|Study closed/terminated|7|||
27564375|NCT00451321|80253812|FG005|Overall Study|Study closed/terminated|7|||
27564376|NCT00451321|80253813|FG006|Overall Study|Study closed/terminated|5|||
27564377|NCT00451321|80253814|FG007|Overall Study|Study closed/terminated|3|||
27564378|NCT00451321|80253807|FG000|Overall Study|Sponsor decision to amend protocol|0|||
27564379|NCT00451321|80253808|FG001|Overall Study|Sponsor decision to amend protocol|0|||
27564380|NCT00451321|80253809|FG002|Overall Study|Sponsor decision to amend protocol|0|||
27564381|NCT00451321|80253810|FG003|Overall Study|Sponsor decision to amend protocol|0|||
27564382|NCT00451321|80253811|FG004|Overall Study|Sponsor decision to amend protocol|0|||
27564383|NCT00451321|80253812|FG005|Overall Study|Sponsor decision to amend protocol|1|||
27564384|NCT00451321|80253813|FG006|Overall Study|Sponsor decision to amend protocol|1|||
27564385|NCT00451321|80253814|FG007|Overall Study|Sponsor decision to amend protocol|3|||
27564386|NCT01165138|80253815|FG000|Overall Study|Adverse Event|0|||
27564387|NCT01165138|80253816|FG001|Overall Study|Adverse Event|1|||
27564388|NCT01165138|80253817|FG002|Overall Study|Adverse Event|0|||
27564389|NCT01165138|80253818|FG003|Overall Study|Adverse Event|2|||
27564390|NCT01165138|80253815|FG000|Overall Study|Lack of Efficacy|0|||
27564391|NCT01165138|80253816|FG001|Overall Study|Lack of Efficacy|32|||
27564392|NCT01165138|80253817|FG002|Overall Study|Lack of Efficacy|6|||
27564393|NCT01165138|80253818|FG003|Overall Study|Lack of Efficacy|7|||
27564394|NCT01165138|80253815|FG000|Overall Study|Protocol Violation|0|||
27564395|NCT01165138|80253816|FG001|Overall Study|Protocol Violation|7|||
27564396|NCT01165138|80253817|FG002|Overall Study|Protocol Violation|0|||
27564397|NCT01165138|80253818|FG003|Overall Study|Protocol Violation|2|||
27564398|NCT01165138|80253815|FG000|Overall Study|Lost to Follow-up|0|||
27564399|NCT01165138|80253816|FG001|Overall Study|Lost to Follow-up|0|||
27564400|NCT01165138|80253817|FG002|Overall Study|Lost to Follow-up|1|||
27564401|NCT01165138|80253818|FG003|Overall Study|Lost to Follow-up|2|||
27564402|NCT01165138|80253815|FG000|Overall Study|Physician Decision|0|||
27564403|NCT01165138|80253816|FG001|Overall Study|Physician Decision|6|||
27564404|NCT01165138|80253817|FG002|Overall Study|Physician Decision|7|||
27564405|NCT01165138|80253818|FG003|Overall Study|Physician Decision|6|||
27564406|NCT01165138|80253815|FG000|Overall Study|Withdrawal by Subject|0|||
27564407|NCT01165138|80253816|FG001|Overall Study|Withdrawal by Subject|6|||
27564408|NCT01165138|80253817|FG002|Overall Study|Withdrawal by Subject|6|||
27564409|NCT01165138|80253818|FG003|Overall Study|Withdrawal by Subject|3|||
27564410|NCT00885755|80256304|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
27564411|NCT00885755|80256305|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
27564412|NCT00885755|80256306|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
27564413|NCT00885755|80256304|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
27564414|NCT00885755|80256305|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
27564415|NCT00885755|80256306|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
27564416|NCT00885755|80256304|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
27564417|NCT00885755|80256305|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
27564418|NCT00885755|80256306|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
27564419|NCT00885755|80256304|FG000|Part I: Trastuzumab+Taxane|Death|0|||
27564420|NCT00885755|80256305|FG001|Part I: Trastuzumab+Taxane|Death|0|||
27564421|NCT00885755|80256306|FG002|Part I: Trastuzumab+Taxane|Death|1|||
27564422|NCT00885755|80256304|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
27564423|NCT00885755|80256305|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
27564424|NCT00885755|80256306|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
27564425|NCT02098109|80256311|FG000|Overall Study|Protocol Violation|3|||
27564426|NCT02098109|80256312|FG001|Overall Study|Protocol Violation|0|||
27564427|NCT00746941|80256321|FG000|Overall Study|Death|2|||
27564428|NCT00746941|80256322|FG001|Overall Study|Death|0|||
27564429|NCT00746941|80256323|FG002|Overall Study|Death|0|||
27564430|NCT00746941|80256324|FG003|Overall Study|Death|6|||
27564431|NCT00746941|80256321|FG000|Overall Study|Physician Decision|0|||
27564432|NCT00746941|80256322|FG001|Overall Study|Physician Decision|0|||
27564433|NCT00746941|80256323|FG002|Overall Study|Physician Decision|2|||
27564434|NCT00746941|80256324|FG003|Overall Study|Physician Decision|0|||
27564435|NCT00746941|80256321|FG000|Overall Study|Withdrawal by Subject|3|||
27564436|NCT00746941|80256322|FG001|Overall Study|Withdrawal by Subject|0|||
27564437|NCT00746941|80256323|FG002|Overall Study|Withdrawal by Subject|0|||
27564438|NCT00746941|80256324|FG003|Overall Study|Withdrawal by Subject|2|||
27564439|NCT00746941|80256321|FG000|Overall Study|Other, reason not provided|2|||
27564440|NCT00746941|80256322|FG001|Overall Study|Other, reason not provided|4|||
27564441|NCT00746941|80256323|FG002|Overall Study|Other, reason not provided|0|||
27564442|NCT00746941|80256324|FG003|Overall Study|Other, reason not provided|4|||
27564443|NCT00746941|80256321|FG000|Overall Study|Adverse Event|0|||
27564444|NCT00746941|80256322|FG001|Overall Study|Adverse Event|0|||
27564445|NCT00746941|80256323|FG002|Overall Study|Adverse Event|0|||
27564446|NCT00746941|80256324|FG003|Overall Study|Adverse Event|1|||
27564447|NCT01838642|80256325|FG000|Overall Study|Died on study|1|||
27564448|NCT00735878|80256328|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
27564449|NCT00735878|80256329|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
27564450|NCT00735878|80256330|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
27564451|NCT01454570|80256332|FG000|Overall Study|Withdrawal by Subject|2|||
27564452|NCT01454570|80256332|FG000|Overall Study|Screen Failure|7|||
27564453|NCT00323492|80256333|FG000|Study Phase 1|Adverse Event|2|||
27564454|NCT00323492|80256334|FG001|Study Phase 1|Adverse Event|0|||
27564455|NCT00323492|80256335|FG002|Study Phase 1|Adverse Event|0|||
27564456|NCT00323492|80256333|FG000|Study Phase 2|Adverse Event|1|||
27564457|NCT00323492|80256334|FG001|Study Phase 2|Adverse Event|0|||
27564458|NCT00323492|80256335|FG002|Study Phase 2|Adverse Event|0|||
27564459|NCT00323492|80256333|FG000|Study Phase 2|Physician Decision|1|||
27564460|NCT00323492|80256334|FG001|Study Phase 2|Physician Decision|0|||
27564461|NCT00323492|80256335|FG002|Study Phase 2|Physician Decision|0|||
27564462|NCT00323492|80256333|FG000|Study Phase 2|Lost to Follow-up|1|||
27564463|NCT00323492|80256334|FG001|Study Phase 2|Lost to Follow-up|0|||
27564464|NCT00323492|80256335|FG002|Study Phase 2|Lost to Follow-up|0|||
27564465|NCT00323492|80256333|FG000|Study Phase 2|Withdrawal by Subject|0|||
27564466|NCT00323492|80256334|FG001|Study Phase 2|Withdrawal by Subject|1|||
27564467|NCT00323492|80256335|FG002|Study Phase 2|Withdrawal by Subject|0|||
27564468|NCT00323492|80256333|FG000|Study Phase 2|Noncompliance with study schedule|0|||
27564469|NCT00323492|80256334|FG001|Study Phase 2|Noncompliance with study schedule|0|||
27564470|NCT00323492|80256335|FG002|Study Phase 2|Noncompliance with study schedule|1|||
27564471|NCT00323492|80256333|FG000|Study Phase 2|Protocol Violation|1|||
27564472|NCT00323492|80256334|FG001|Study Phase 2|Protocol Violation|0|||
27564473|NCT00323492|80256335|FG002|Study Phase 2|Protocol Violation|0|||
27564474|NCT00316199|80256336|FG000|Overall Study|Adverse Event|2|||
27564475|NCT00316199|80256336|FG000|Overall Study|Death|8|||
27564476|NCT00316199|80256336|FG000|Overall Study|Lost to Follow-up|2|||
27564477|NCT00174915|80256337|FG000|Overall Study|Lost to Follow-up|19|||
27564478|NCT00174915|80256338|FG001|Overall Study|Lost to Follow-up|17|||
27564479|NCT00174915|80256339|FG002|Overall Study|Lost to Follow-up|9|||
27564480|NCT00174915|80256340|FG003|Overall Study|Lost to Follow-up|17|||
27564481|NCT00174915|80256341|FG004|Overall Study|Lost to Follow-up|10|||
27564482|NCT00174915|80256337|FG000|Overall Study|Adverse Event|18|||
27564483|NCT00174915|80256338|FG001|Overall Study|Adverse Event|16|||
27564484|NCT00174915|80256339|FG002|Overall Study|Adverse Event|11|||
27564485|NCT00174915|80256340|FG003|Overall Study|Adverse Event|18|||
27564486|NCT00174915|80256341|FG004|Overall Study|Adverse Event|5|||
27564487|NCT00174915|80256337|FG000|Overall Study|Personal Reason(s)|16|||
27564488|NCT00174915|80256338|FG001|Overall Study|Personal Reason(s)|16|||
27564489|NCT00174915|80256339|FG002|Overall Study|Personal Reason(s)|9|||
27564490|NCT00174915|80256340|FG003|Overall Study|Personal Reason(s)|9|||
27564491|NCT00174915|80256341|FG004|Overall Study|Personal Reason(s)|9|||
27564492|NCT00174915|80256337|FG000|Overall Study|Other|15|||
27564493|NCT00174915|80256338|FG001|Overall Study|Other|8|||
27564494|NCT00174915|80256339|FG002|Overall Study|Other|6|||
27564495|NCT00174915|80256340|FG003|Overall Study|Other|5|||
27564496|NCT00174915|80256341|FG004|Overall Study|Other|3|||
27564497|NCT00174915|80256337|FG000|Overall Study|Gout Flare|13|||
27564498|NCT00174915|80256338|FG001|Overall Study|Gout Flare|6|||
27564499|NCT00174915|80256339|FG002|Overall Study|Gout Flare|8|||
27564500|NCT00174915|80256340|FG003|Overall Study|Gout Flare|1|||
27564501|NCT00174915|80256341|FG004|Overall Study|Gout Flare|0|||
27564502|NCT00174915|80256337|FG000|Overall Study|Protocol Violation|6|||
27564503|NCT00174915|80256338|FG001|Overall Study|Protocol Violation|3|||
27564504|NCT00174915|80256339|FG002|Overall Study|Protocol Violation|3|||
27564505|NCT00174915|80256340|FG003|Overall Study|Protocol Violation|6|||
27564506|NCT00174915|80256341|FG004|Overall Study|Protocol Violation|3|||
27564507|NCT00174915|80256337|FG000|Overall Study|Therapeutic Failure|6|||
27564508|NCT00174915|80256338|FG001|Overall Study|Therapeutic Failure|3|||
27564509|NCT00174915|80256339|FG002|Overall Study|Therapeutic Failure|2|||
27564510|NCT00174915|80256340|FG003|Overall Study|Therapeutic Failure|1|||
27564511|NCT00174915|80256341|FG004|Overall Study|Therapeutic Failure|3|||
27564512|NCT04307446|80256342|FG000|Overall Study|Lost to Follow-up|2|||
27564513|NCT04307446|80256343|FG001|Overall Study|Lost to Follow-up|0|||
27564514|NCT02253810|80256344|FG000|Overall Study|Withdrawal by Subject|2|||
27564515|NCT02253810|80256345|FG001|Overall Study|Withdrawal by Subject|1|||
27564516|NCT02253810|80256344|FG000|Overall Study|Unknown concomitant procedure|3|||
27564517|NCT02253810|80256345|FG001|Overall Study|Unknown concomitant procedure|2|||
27564518|NCT00729183|80256346|FG000|Overall Study|Adverse Event|11|||
27564519|NCT00729183|80256347|FG001|Overall Study|Adverse Event|5|||
27564520|NCT00729183|80256346|FG000|Overall Study|Lack of Efficacy|0|||
27564521|NCT00729183|80256347|FG001|Overall Study|Lack of Efficacy|1|||
27564522|NCT00729183|80256346|FG000|Overall Study|Lost to Follow-up|3|||
27564523|NCT00729183|80256347|FG001|Overall Study|Lost to Follow-up|1|||
27564524|NCT00729183|80256346|FG000|Overall Study|Physician Decision|1|||
27564525|NCT00729183|80256347|FG001|Overall Study|Physician Decision|1|||
27564526|NCT00729183|80256346|FG000|Overall Study|Protocol Violation|1|||
27564527|NCT00729183|80256347|FG001|Overall Study|Protocol Violation|0|||
27564528|NCT00729183|80256346|FG000|Overall Study|Withdrawal by Subject|9|||
27564529|NCT00729183|80256347|FG001|Overall Study|Withdrawal by Subject|7|||
27564530|NCT02642432|80256348|FG000|Overall Study|Adverse Event|2|||
27564531|NCT02642432|80256348|FG000|Overall Study|Withdrew Consent|1|||
27564532|NCT02642432|80256348|FG000|Overall Study|Lost to Follow-up|2|||
27564533|NCT02642432|80256348|FG000|Overall Study|Other|3|||
27564534|NCT00048542|80256350|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27564535|NCT00048542|80256351|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
27564536|NCT00048542|80256352|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27564537|NCT00048542|80256353|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27564538|NCT00048542|80256354|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
27564539|NCT00048542|80256355|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
27564540|NCT00048542|80256356|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
27564541|NCT00048542|80256357|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
27564542|NCT00048542|80256350|FG000|Double-Blind Phase|Protocol Violation|0|||
27564543|NCT00048542|80256351|FG001|Double-Blind Phase|Protocol Violation|0|||
27564544|NCT00048542|80256352|FG002|Double-Blind Phase|Protocol Violation|1|||
27564545|NCT00048542|80256353|FG003|Double-Blind Phase|Protocol Violation|0|||
27564546|NCT00048542|80256354|FG004|Double-Blind Phase|Protocol Violation|0|||
27564547|NCT00048542|80256355|FG005|Double-Blind Phase|Protocol Violation|0|||
27564548|NCT00048542|80256356|FG006|Double-Blind Phase|Protocol Violation|0|||
27564549|NCT00048542|80256357|FG007|Double-Blind Phase|Protocol Violation|0|||
27564550|NCT00048542|80256350|FG000|Double-Blind Phase|Sponsor request or decision|2|||
27564551|NCT00048542|80256351|FG001|Double-Blind Phase|Sponsor request or decision|0|||
27564552|NCT00048542|80256352|FG002|Double-Blind Phase|Sponsor request or decision|0|||
27564553|NCT00048542|80256353|FG003|Double-Blind Phase|Sponsor request or decision|0|||
27564554|NCT00048542|80256354|FG004|Double-Blind Phase|Sponsor request or decision|0|||
27564555|NCT00048542|80256355|FG005|Double-Blind Phase|Sponsor request or decision|0|||
27564556|NCT00048542|80256356|FG006|Double-Blind Phase|Sponsor request or decision|0|||
27564557|NCT00048542|80256357|FG007|Double-Blind Phase|Sponsor request or decision|0|||
27564558|NCT00048542|80256350|FG000|Double-Blind Phase|Randomized in error|1|||
27564559|NCT00048542|80256351|FG001|Double-Blind Phase|Randomized in error|0|||
27564560|NCT00048542|80256352|FG002|Double-Blind Phase|Randomized in error|0|||
27564561|NCT00048542|80256353|FG003|Double-Blind Phase|Randomized in error|0|||
27564562|NCT00048542|80256354|FG004|Double-Blind Phase|Randomized in error|0|||
27564563|NCT00048542|80256355|FG005|Double-Blind Phase|Randomized in error|0|||
27564564|NCT00048542|80256356|FG006|Double-Blind Phase|Randomized in error|0|||
27564565|NCT00048542|80256357|FG007|Double-Blind Phase|Randomized in error|0|||
27564566|NCT00048542|80256350|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
27564567|NCT00048542|80256351|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
27564568|NCT00048542|80256352|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
27564569|NCT00048542|80256353|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
27564570|NCT00048542|80256354|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
27655402|NCT02548585|80577016|FG000|Overall Study|Withdrawal by Subject|0|||
27655403|NCT02548585|80577017|FG001|Overall Study|Withdrawal by Subject|0|||
27655404|NCT02548585|80577018|FG002|Overall Study|Withdrawal by Subject|0|||
27655405|NCT02548585|80577019|FG003|Overall Study|Withdrawal by Subject|0|||
27655406|NCT02548585|80577020|FG004|Overall Study|Withdrawal by Subject|0|||
27655407|NCT02548585|80577021|FG005|Overall Study|Withdrawal by Subject|1|||
27655408|NCT02548585|80577022|FG006|Overall Study|Withdrawal by Subject|0|||
27655409|NCT02548585|80577016|FG000|Overall Study|Lost to Follow-up|1|||
27655410|NCT02548585|80577017|FG001|Overall Study|Lost to Follow-up|0|||
27655411|NCT02548585|80577018|FG002|Overall Study|Lost to Follow-up|0|||
27655412|NCT02548585|80577019|FG003|Overall Study|Lost to Follow-up|0|||
27655413|NCT02548585|80577020|FG004|Overall Study|Lost to Follow-up|0|||
27655414|NCT02548585|80577021|FG005|Overall Study|Lost to Follow-up|0|||
27655415|NCT02548585|80577022|FG006|Overall Study|Lost to Follow-up|0|||
27655416|NCT02548585|80577016|FG000|Overall Study|Other|1|||
27655417|NCT02548585|80577017|FG001|Overall Study|Other|0|||
27655418|NCT02548585|80577018|FG002|Overall Study|Other|0|||
27655419|NCT02548585|80577019|FG003|Overall Study|Other|2|||
27655420|NCT02548585|80577020|FG004|Overall Study|Other|3|||
27655421|NCT02548585|80577021|FG005|Overall Study|Other|0|||
27655422|NCT02548585|80577022|FG006|Overall Study|Other|1|||
27655423|NCT02548585|80577016|FG000|Overall Study|Randomized but not treated|0|||
27655424|NCT02548585|80577017|FG001|Overall Study|Randomized but not treated|0|||
27655425|NCT02548585|80577018|FG002|Overall Study|Randomized but not treated|0|||
27655426|NCT02548585|80577019|FG003|Overall Study|Randomized but not treated|0|||
27655427|NCT02548585|80577020|FG004|Overall Study|Randomized but not treated|0|||
27655428|NCT02548585|80577021|FG005|Overall Study|Randomized but not treated|1|||
27655429|NCT02548585|80577022|FG006|Overall Study|Randomized but not treated|0|||
27655430|NCT01699178|80577023|FG000|Overall Study|Adverse Event|1|||
27655431|NCT01699178|80577024|FG001|Overall Study|Adverse Event|5|||
27655432|NCT01699178|80577023|FG000|Overall Study|Lost to Follow-up|1|||
27655433|NCT01699178|80577024|FG001|Overall Study|Lost to Follow-up|6|||
27655434|NCT01699178|80577023|FG000|Overall Study|Non-compliance with Study Drug|3|||
27655435|NCT01699178|80577024|FG001|Overall Study|Non-compliance with Study Drug|1|||
27655436|NCT01699178|80577023|FG000|Overall Study|Physician Decision|1|||
27655437|NCT01699178|80577024|FG001|Overall Study|Physician Decision|0|||
27655438|NCT01699178|80577023|FG000|Overall Study|Withdrawal by Subject|4|||
27655439|NCT01699178|80577024|FG001|Overall Study|Withdrawal by Subject|12|||
27655440|NCT01699178|80577023|FG000|Overall Study|Hematocrit >54%|1|||
27655441|NCT01699178|80577024|FG001|Overall Study|Hematocrit >54%|1|||
27655442|NCT01699178|80577023|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
27655443|NCT01699178|80577024|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
27655444|NCT01699178|80577023|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
27655445|NCT01699178|80577024|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
27655446|NCT01280721|80577025|FG000|Overall Study|Adverse Event|4|||
27655447|NCT01280721|80577025|FG000|Overall Study|Physician Decision|3|||
27655448|NCT01280721|80577025|FG000|Overall Study|Withdrawal by Subject|6|||
27655449|NCT01280721|80577025|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
27655450|NCT01280721|80577025|FG000|Overall Study|No tolerability for the lowest dose|2|||
27655451|NCT00742560|80577026|FG000|Overall Study|Adverse Event|0|||
27655452|NCT00742560|80577027|FG001|Overall Study|Adverse Event|0|||
27655453|NCT00742560|80577028|FG002|Overall Study|Adverse Event|1|||
27655454|NCT00742560|80577029|FG003|Overall Study|Adverse Event|1|||
27655455|NCT00742560|80577030|FG004|Overall Study|Adverse Event|1|||
27655456|NCT00742560|80577026|FG000|Overall Study|Death|0|||
27655457|NCT00742560|80577027|FG001|Overall Study|Death|2|||
27655458|NCT00742560|80577028|FG002|Overall Study|Death|0|||
27655459|NCT00742560|80577029|FG003|Overall Study|Death|2|||
27655460|NCT00742560|80577030|FG004|Overall Study|Death|3|||
27655461|NCT00742560|80577026|FG000|Overall Study|Subject's Decision|1|||
27655462|NCT00742560|80577027|FG001|Overall Study|Subject's Decision|0|||
27655463|NCT00742560|80577028|FG002|Overall Study|Subject's Decision|2|||
27564571|NCT00048542|80256355|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
27564572|NCT00048542|80256356|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
27564573|NCT00048542|80256357|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
27564574|NCT00048542|80256350|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
27564575|NCT00048542|80256351|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
27564576|NCT00048542|80256352|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
27564577|NCT00048542|80256353|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
27564578|NCT00048542|80256354|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
27655464|NCT00742560|80577029|FG003|Overall Study|Subject's Decision|3|||
27655465|NCT00742560|80577030|FG004|Overall Study|Subject's Decision|3|||
27655466|NCT00742560|80577026|FG000|Overall Study|Investigator's Decision|0|||
27564579|NCT00048542|80256355|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
27564580|NCT00048542|80256356|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
27564581|NCT00048542|80256357|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
27564582|NCT00048542|80256350|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
27564583|NCT00048542|80256351|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
27564584|NCT00048542|80256352|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
27564585|NCT00048542|80256353|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
27564586|NCT00048542|80256354|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
27564587|NCT00048542|80256355|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
27564588|NCT00048542|80256356|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
27564589|NCT00048542|80256357|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
27564590|NCT00048542|80256350|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
27564591|NCT00048542|80256351|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
27564592|NCT00048542|80256352|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
27564593|NCT00048542|80256353|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
27564594|NCT00048542|80256354|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
27564595|NCT00048542|80256355|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
27564596|NCT00048542|80256356|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
27564597|NCT00048542|80256357|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
27564598|NCT00048542|80256350|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
27564599|NCT00048542|80256351|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
27564600|NCT00048542|80256352|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
27655467|NCT00742560|80577027|FG001|Overall Study|Investigator's Decision|0|||
27655468|NCT00742560|80577028|FG002|Overall Study|Investigator's Decision|4|||
27655469|NCT00742560|80577029|FG003|Overall Study|Investigator's Decision|1|||
27655470|NCT00742560|80577030|FG004|Overall Study|Investigator's Decision|0|||
27655471|NCT00742560|80577026|FG000|Overall Study|Disease Progression|1|||
27655472|NCT00742560|80577027|FG001|Overall Study|Disease Progression|0|||
27564601|NCT00048542|80256353|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
27564602|NCT00048542|80256354|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
27564603|NCT00048542|80256355|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
27564604|NCT00048542|80256356|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
27564605|NCT00048542|80256357|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
27564606|NCT00048542|80256350|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27564607|NCT00048542|80256351|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27564608|NCT00048542|80256352|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27564609|NCT00048542|80256353|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27564610|NCT00048542|80256354|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27564611|NCT00048542|80256355|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
27564612|NCT00048542|80256356|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
27564613|NCT00048542|80256357|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
27564614|NCT00048542|80256350|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27564615|NCT00048542|80256351|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27564616|NCT00048542|80256352|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27564617|NCT00048542|80256353|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27564618|NCT00048542|80256354|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27564619|NCT00048542|80256355|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
27655473|NCT00742560|80577028|FG002|Overall Study|Disease Progression|5|||
27655474|NCT00742560|80577029|FG003|Overall Study|Disease Progression|17|||
27655475|NCT00742560|80577030|FG004|Overall Study|Disease Progression|16|||
27655476|NCT00742560|80577026|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
27655477|NCT00742560|80577027|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
27655478|NCT00742560|80577028|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
27655479|NCT00742560|80577029|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
27655480|NCT00742560|80577030|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
27655481|NCT00742560|80577026|FG000|Overall Study|Other|0|||
27655482|NCT00742560|80577027|FG001|Overall Study|Other|1|||
27655483|NCT00742560|80577028|FG002|Overall Study|Other|8|||
27655484|NCT00742560|80577029|FG003|Overall Study|Other|9|||
27655485|NCT00742560|80577030|FG004|Overall Study|Other|9|||
27655486|NCT00742560|80577026|FG000|Overall Study|MIssing|0|||
27655487|NCT00742560|80577027|FG001|Overall Study|MIssing|0|||
27655488|NCT00742560|80577028|FG002|Overall Study|MIssing|0|||
27655489|NCT00742560|80577029|FG003|Overall Study|MIssing|0|||
27655490|NCT00742560|80577030|FG004|Overall Study|MIssing|1|||
27655491|NCT03209492|80577031|FG000|Overall Study|Case Report Forms Uncollected|5|||
27655492|NCT03344458|80577032|FG000|Overall Study|Physician Decision|1|||
27655493|NCT03344458|80577032|FG000|Overall Study|Withdrawal by Subject|16|||
27655494|NCT03344458|80577032|FG000|Overall Study|Other reasons|10|||
27655495|NCT03344458|80577032|FG000|Overall Study|Lost to Follow-up|9|||
27655496|NCT03344458|80577032|FG000|Overall Study|Protocol Violation|3|||
27655497|NCT00440037|80577033|FG000|Overall Study|Withdrawal by Subject|6|||
27655498|NCT00440037|80577033|FG000|Overall Study|Administrative decision|3|||
27655499|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
27564620|NCT00048542|80256356|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
27564621|NCT00048542|80256357|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
27564622|NCT00048542|80256350|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
27564623|NCT00048542|80256351|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
27564624|NCT00048542|80256352|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
27564625|NCT00048542|80256353|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
27564626|NCT00048542|80256354|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
27564627|NCT00048542|80256355|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
27564628|NCT00048542|80256356|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
27564629|NCT00048542|80256357|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
27564630|NCT00048542|80256350|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
27564631|NCT00048542|80256351|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
27564632|NCT00048542|80256352|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
27564633|NCT00048542|80256353|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
27564634|NCT00048542|80256354|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
27655500|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
27655501|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
27655502|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
27655503|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
27655504|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
27655505|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
27655506|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
27756950|NCT00006604|80936564|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
27756951|NCT00006604|80936565|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
27655507|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
27655508|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
27655509|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
27655510|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
27655511|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
27655512|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
27655513|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
27655514|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
27655515|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
27655516|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
27655517|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
27655518|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
27655519|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
27655520|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
27655521|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
27655522|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
27655523|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
27655524|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
27655525|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
27655526|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
27655527|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
27655528|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
27655529|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
27655530|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
27655531|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
27655532|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
27655533|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
27655534|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
27655535|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
27655536|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
27655537|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
27655538|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
27655539|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
27655540|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
27655541|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
27655542|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
27655543|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
27655544|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
27655545|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
27655546|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
27655547|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
27655548|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
27655549|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
27655550|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
27655551|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
27655552|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
27655553|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
27655554|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
27655555|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
27655556|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
27655557|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
27655558|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
27655559|NCT03395197|80577036|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
27655560|NCT03395197|80577037|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
27655561|NCT03395197|80577038|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
27655562|NCT03395197|80577039|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
27655563|NCT03395197|80577040|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
27655564|NCT03395197|80577041|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
27655565|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Death|0|||
27564635|NCT00048542|80256355|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
27564636|NCT00048542|80256356|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
27564637|NCT00048542|80256357|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
27564638|NCT00048542|80256350|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27564639|NCT00048542|80256351|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27564640|NCT00048542|80256352|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27564641|NCT00048542|80256353|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27564642|NCT00048542|80256354|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27655566|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Death|0|||
27655567|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Death|0|||
27564643|NCT00048542|80256355|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
27564644|NCT00048542|80256356|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
27655568|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Death|0|||
27655569|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Death|1|||
27655570|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Death|4|||
27655571|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
27564645|NCT00048542|80256357|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
27564646|NCT00048542|80256350|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27564647|NCT00048542|80256351|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27564648|NCT00048542|80256352|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27655572|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
27655573|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
27655574|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
27655575|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
27564649|NCT00048542|80256353|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27564650|NCT00048542|80256354|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27564651|NCT00048542|80256355|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
27564652|NCT00048542|80256356|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
27564653|NCT00048542|80256357|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
27564654|NCT02028988|80256358|FG000|Overall Study|Withdrawal by Subject|2|||
27564655|NCT00271947|80256359|FG000|Overall Study|Lost to Follow-up|1|||
27564656|NCT03406858|80256364|FG000|Overall Study|Failure to receive treatment drug.|1|||
27564657|NCT03406858|80256364|FG000|Overall Study|ineligible|1|||
27564658|NCT04105998|80256369|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
27564659|NCT04105998|80256370|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
27859169|NCT04594707|81319257|FG001|Overall Study|Lung Transplant|0|||
27564660|NCT00588822|80256372|FG000|Overall Study|progression of disease|8|||
27564661|NCT01712256|80256373|FG000|Overall Study|Lost to Follow-up|1|||
27564662|NCT02250443|80256374|FG000|Overall Study|Administrative problems|7|||
27564663|NCT02250443|80256374|FG000|Overall Study|Adverse Event|3|||
27564664|NCT00291668|80256375|FG000|Overall Study|Lack of Efficacy|1|||
27564665|NCT00291668|80256376|FG001|Overall Study|Lack of Efficacy|0|||
27564666|NCT00291668|80256377|FG002|Overall Study|Lack of Efficacy|0|||
27564667|NCT00291668|80256375|FG000|Overall Study|SAE, non-fatal|1|||
27564668|NCT00291668|80256376|FG001|Overall Study|SAE, non-fatal|1|||
27564669|NCT00291668|80256377|FG002|Overall Study|SAE, non-fatal|1|||
27564670|NCT00291668|80256375|FG000|Overall Study|AE, non-serious non-fatal|1|||
27564671|NCT00291668|80256376|FG001|Overall Study|AE, non-serious non-fatal|0|||
27564672|NCT00291668|80256377|FG002|Overall Study|AE, non-serious non-fatal|0|||
27564673|NCT00291668|80256375|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27564674|NCT00291668|80256376|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27564675|NCT00291668|80256377|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27564676|NCT01559012|80256378|FG000|Overall Study|Withdrawal by Subject|0|||
27564677|NCT01559012|80256379|FG001|Overall Study|Withdrawal by Subject|1|||
27564678|NCT02018458|80256380|FG000|Overall Study|Death|4|||
27564679|NCT03526458|80256394|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
27564680|NCT03526458|80256395|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
27564681|NCT03526458|80256394|FG000|Overall Study|Stone passed, surgery cancelled|2|||
27564682|NCT03526458|80256395|FG001|Overall Study|Stone passed, surgery cancelled|1|||
27564683|NCT03526458|80256394|FG000|Overall Study|Withdrawal by Subject|1|||
27564684|NCT03526458|80256395|FG001|Overall Study|Withdrawal by Subject|0|||
27564685|NCT03526458|80256394|FG000|Overall Study|Physician Decision|2|||
27564686|NCT03526458|80256395|FG001|Overall Study|Physician Decision|1|||
27564687|NCT03526458|80256394|FG000|Overall Study|Lack of equipment|1|||
27564688|NCT03526458|80256395|FG001|Overall Study|Lack of equipment|1|||
27564689|NCT01894152|80256396|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
27564690|NCT02295995|80256397|FG000|Overall Study|Lost to Follow-up|5|||
27564691|NCT02295995|80256398|FG001|Overall Study|Lost to Follow-up|1|||
27564692|NCT01359254|80256400|FG000|Overall Study|Death|1|||
27564693|NCT01359254|80256401|FG001|Overall Study|Death|0|||
27564694|NCT01592344|80256402|FG000|Overall Study|Adverse Event|1|||
27564695|NCT01592344|80256403|FG001|Overall Study|Adverse Event|1|||
27564696|NCT01592344|80256402|FG000|Overall Study|Lack of Efficacy|1|||
27564697|NCT01592344|80256403|FG001|Overall Study|Lack of Efficacy|0|||
27564698|NCT01592344|80256402|FG000|Overall Study|not available at primary outcome visit|2|||
27564699|NCT01592344|80256403|FG001|Overall Study|not available at primary outcome visit|4|||
27564700|NCT02211131|80256404|FG000|Overall Study|Death|26|||
27564701|NCT02211131|80256405|FG001|Overall Study|Death|16|||
27564702|NCT02211131|80256404|FG000|Overall Study|Lost to Follow-up|4|||
27564703|NCT02211131|80256405|FG001|Overall Study|Lost to Follow-up|3|||
27564704|NCT02211131|80256404|FG000|Overall Study|Decision by Sponsor|1|||
27564705|NCT02211131|80256405|FG001|Overall Study|Decision by Sponsor|1|||
27564706|NCT02211131|80256404|FG000|Overall Study|Withdrawal by Subject|3|||
27564707|NCT02211131|80256405|FG001|Overall Study|Withdrawal by Subject|8|||
27564708|NCT03724812|80256406|FG000|Overall Study|Missed Visit|1|||
27564709|NCT03724812|80256406|FG000|Overall Study|Death|2|||
27564710|NCT03724812|80256406|FG000|Overall Study|Withdrawal by Subject|1|||
27564711|NCT03318315|80256409|FG000|Overall Study|Lost to Follow-up|3|||
27564712|NCT03318315|80256410|FG001|Overall Study|Lost to Follow-up|2|||
27564713|NCT03318315|80256411|FG002|Overall Study|Lost to Follow-up|1|||
27564714|NCT03318315|80256409|FG000|Overall Study|Protocol Violation|1|||
27564715|NCT03318315|80256410|FG001|Overall Study|Protocol Violation|1|||
27564716|NCT03318315|80256411|FG002|Overall Study|Protocol Violation|1|||
27564717|NCT03318315|80256409|FG000|Overall Study|Withdrawal by Subject|0|||
27564718|NCT03318315|80256410|FG001|Overall Study|Withdrawal by Subject|0|||
27564719|NCT03318315|80256411|FG002|Overall Study|Withdrawal by Subject|2|||
27564720|NCT00778700|80256412|FG000|Overall Study|Adverse Event|6|||
27564721|NCT00778700|80256413|FG001|Overall Study|Adverse Event|1|||
27564722|NCT00778700|80256414|FG002|Overall Study|Adverse Event|3|||
27564723|NCT00778700|80256415|FG003|Overall Study|Adverse Event|5|||
27564724|NCT00778700|80256412|FG000|Overall Study|Protocol Violation|1|||
27564725|NCT00778700|80256413|FG001|Overall Study|Protocol Violation|1|||
27564726|NCT00778700|80256414|FG002|Overall Study|Protocol Violation|0|||
27564727|NCT00778700|80256415|FG003|Overall Study|Protocol Violation|0|||
27564728|NCT00778700|80256412|FG000|Overall Study|Subject Withdrew Consent|6|||
27564729|NCT00778700|80256413|FG001|Overall Study|Subject Withdrew Consent|4|||
27564730|NCT00778700|80256414|FG002|Overall Study|Subject Withdrew Consent|1|||
27564731|NCT00778700|80256415|FG003|Overall Study|Subject Withdrew Consent|4|||
27564732|NCT00778700|80256412|FG000|Overall Study|Lost to Follow-up|3|||
27564733|NCT00778700|80256413|FG001|Overall Study|Lost to Follow-up|1|||
27564734|NCT00778700|80256414|FG002|Overall Study|Lost to Follow-up|0|||
27564735|NCT00778700|80256415|FG003|Overall Study|Lost to Follow-up|1|||
27564736|NCT00778700|80256412|FG000|Overall Study|Reason not Specified|2|||
27564737|NCT00778700|80256413|FG001|Overall Study|Reason not Specified|0|||
27564738|NCT00778700|80256414|FG002|Overall Study|Reason not Specified|1|||
27564739|NCT00778700|80256415|FG003|Overall Study|Reason not Specified|3|||
27564740|NCT00778700|80256412|FG000|Overall Study|Other|0|||
27564741|NCT00778700|80256413|FG001|Overall Study|Other|0|||
27564742|NCT00778700|80256414|FG002|Overall Study|Other|1|||
27564743|NCT00778700|80256415|FG003|Overall Study|Other|0|||
27564744|NCT01549964|80256421|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
27564745|NCT01549964|80256422|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
27564746|NCT01549964|80256423|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
27564747|NCT01549964|80256424|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
27564748|NCT01549964|80256421|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
27564749|NCT01549964|80256422|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
27564750|NCT01549964|80256423|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
27564751|NCT01549964|80256424|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
27564752|NCT01549964|80256421|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
27564753|NCT01549964|80256422|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
27564754|NCT01549964|80256423|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
27564755|NCT01549964|80256424|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
27564756|NCT01549964|80256421|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
27564757|NCT01549964|80256422|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
27564758|NCT01549964|80256423|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
27564759|NCT01549964|80256424|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
27564760|NCT01549964|80256421|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
27564761|NCT01549964|80256422|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
27564762|NCT01549964|80256423|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
27564763|NCT01549964|80256424|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
27564764|NCT01549964|80256421|FG000|24-Week Treatment Period|Other|1|||
27564765|NCT01549964|80256422|FG001|24-Week Treatment Period|Other|0|||
27564766|NCT01549964|80256423|FG002|24-Week Treatment Period|Other|1|||
27564767|NCT01549964|80256424|FG003|24-Week Treatment Period|Other|0|||
27564768|NCT01549964|80256421|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
27564769|NCT01549964|80256422|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
27564770|NCT01549964|80256423|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
27564771|NCT01549964|80256424|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
27564772|NCT01549964|80256421|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
27564773|NCT01549964|80256422|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
27564774|NCT01549964|80256423|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
27564775|NCT01549964|80256424|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
27564776|NCT01549964|80256421|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
27564777|NCT01549964|80256422|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
27564778|NCT01549964|80256423|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
27564779|NCT01549964|80256424|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
27564780|NCT01549964|80256421|FG000|80-Week Extension Period|Pregnancy|0|||
27564781|NCT01549964|80256422|FG001|80-Week Extension Period|Pregnancy|0|||
27564782|NCT01549964|80256423|FG002|80-Week Extension Period|Pregnancy|1|||
27564783|NCT01549964|80256424|FG003|80-Week Extension Period|Pregnancy|0|||
27564784|NCT01549964|80256421|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
27564785|NCT01549964|80256422|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
27564786|NCT01549964|80256423|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
27564787|NCT01549964|80256424|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
27564788|NCT01549964|80256421|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
27564789|NCT01549964|80256422|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
27564790|NCT01549964|80256423|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
27564791|NCT01549964|80256424|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
27564792|NCT01549964|80256421|FG000|80-Week Extension Period|Lost to Follow-up|1|||
27564793|NCT01549964|80256422|FG001|80-Week Extension Period|Lost to Follow-up|0|||
27564794|NCT01549964|80256423|FG002|80-Week Extension Period|Lost to Follow-up|2|||
27564795|NCT01549964|80256424|FG003|80-Week Extension Period|Lost to Follow-up|1|||
27564796|NCT01549964|80256421|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
27564797|NCT01549964|80256422|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
27564798|NCT01549964|80256423|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
27564799|NCT01549964|80256424|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
27564800|NCT04254978|80256429|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
27564801|NCT04254978|80256429|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
27564802|NCT04254978|80256429|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
27564803|NCT04254978|80256429|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
27564804|NCT04254978|80256429|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
27564805|NCT04254978|80256429|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
27564806|NCT03329690|80256433|FG000|Overall Study|Progressive disease per RECIST|85|||
27564807|NCT03329690|80256434|FG001|Overall Study|Progressive disease per RECIST|44|||
27564808|NCT03329690|80256435|FG002|Overall Study|Progressive disease per RECIST|6|||
27564809|NCT03329690|80256436|FG003|Overall Study|Progressive disease per RECIST|16|||
27564810|NCT03329690|80256437|FG004|Overall Study|Progressive disease per RECIST|20|||
27564811|NCT03329690|80256433|FG000|Overall Study|Clinical progression|7|||
27564812|NCT03329690|80256434|FG001|Overall Study|Clinical progression|4|||
27564813|NCT03329690|80256435|FG002|Overall Study|Clinical progression|1|||
27564814|NCT03329690|80256436|FG003|Overall Study|Clinical progression|1|||
27564815|NCT03329690|80256437|FG004|Overall Study|Clinical progression|1|||
27564816|NCT03329690|80256433|FG000|Overall Study|Adverse Event|22|||
27564817|NCT03329690|80256434|FG001|Overall Study|Adverse Event|4|||
27564818|NCT03329690|80256435|FG002|Overall Study|Adverse Event|0|||
27564819|NCT03329690|80256436|FG003|Overall Study|Adverse Event|1|||
27564820|NCT03329690|80256437|FG004|Overall Study|Adverse Event|2|||
27564821|NCT03329690|80256433|FG000|Overall Study|Death|2|||
27564822|NCT03329690|80256434|FG001|Overall Study|Death|0|||
27564823|NCT03329690|80256435|FG002|Overall Study|Death|0|||
27564824|NCT03329690|80256436|FG003|Overall Study|Death|1|||
27564825|NCT03329690|80256437|FG004|Overall Study|Death|0|||
27564826|NCT03329690|80256433|FG000|Overall Study|Withdrawal by Subject|2|||
27564827|NCT03329690|80256434|FG001|Overall Study|Withdrawal by Subject|3|||
27564828|NCT03329690|80256435|FG002|Overall Study|Withdrawal by Subject|0|||
27564829|NCT03329690|80256436|FG003|Overall Study|Withdrawal by Subject|1|||
27564830|NCT03329690|80256437|FG004|Overall Study|Withdrawal by Subject|0|||
27564831|NCT03329690|80256433|FG000|Overall Study|Physician Decision|1|||
27564832|NCT03329690|80256434|FG001|Overall Study|Physician Decision|0|||
27564833|NCT03329690|80256435|FG002|Overall Study|Physician Decision|0|||
27564834|NCT03329690|80256436|FG003|Overall Study|Physician Decision|0|||
27564835|NCT03329690|80256437|FG004|Overall Study|Physician Decision|1|||
27564836|NCT03329690|80256433|FG000|Overall Study|Miscellaneous|6|||
27564837|NCT03329690|80256434|FG001|Overall Study|Miscellaneous|0|||
27564838|NCT03329690|80256435|FG002|Overall Study|Miscellaneous|0|||
27564839|NCT03329690|80256436|FG003|Overall Study|Miscellaneous|0|||
27564840|NCT03329690|80256437|FG004|Overall Study|Miscellaneous|0|||
27564841|NCT03329690|80256433|FG000|Overall Study|Did not receive treatment|1|||
27564842|NCT03329690|80256434|FG001|Overall Study|Did not receive treatment|0|||
27564843|NCT03329690|80256435|FG002|Overall Study|Did not receive treatment|0|||
27564844|NCT03329690|80256436|FG003|Overall Study|Did not receive treatment|1|||
27564845|NCT03329690|80256437|FG004|Overall Study|Did not receive treatment|0|||
27564846|NCT02246673|80256438|FG000|Overall Study|Sponsor Decision|1|||
27564847|NCT02246673|80256439|FG001|Overall Study|Sponsor Decision|0|||
27564848|NCT02246673|80256440|FG002|Overall Study|Sponsor Decision|0|||
27564849|NCT02246673|80256441|FG003|Overall Study|Sponsor Decision|0|||
27564850|NCT02246673|80256442|FG004|Overall Study|Sponsor Decision|0|||
27564851|NCT02246673|80256438|FG000|Overall Study|Withdrawal by Subject|0|||
27564852|NCT02246673|80256439|FG001|Overall Study|Withdrawal by Subject|0|||
27564853|NCT02246673|80256440|FG002|Overall Study|Withdrawal by Subject|0|||
27564854|NCT02246673|80256441|FG003|Overall Study|Withdrawal by Subject|0|||
27564855|NCT02246673|80256442|FG004|Overall Study|Withdrawal by Subject|1|||
27564856|NCT02246673|80256438|FG000|Overall Study|Lost to Follow-up|0|||
27564857|NCT02246673|80256439|FG001|Overall Study|Lost to Follow-up|0|||
27564858|NCT02246673|80256440|FG002|Overall Study|Lost to Follow-up|0|||
27564859|NCT02246673|80256441|FG003|Overall Study|Lost to Follow-up|1|||
27564860|NCT02246673|80256442|FG004|Overall Study|Lost to Follow-up|0|||
27564861|NCT02246673|80256438|FG000|Overall Study|Protocol Violation|0|||
27564862|NCT02246673|80256439|FG001|Overall Study|Protocol Violation|0|||
27564863|NCT02246673|80256440|FG002|Overall Study|Protocol Violation|0|||
27564864|NCT02246673|80256441|FG003|Overall Study|Protocol Violation|1|||
27564865|NCT02246673|80256442|FG004|Overall Study|Protocol Violation|0|||
27564866|NCT00798369|80256445|FG000|Overall Study|Subject withdrew consent|0|||
27564867|NCT00798369|80256446|FG001|Overall Study|Subject withdrew consent|0|||
27564868|NCT00798369|80256447|FG002|Overall Study|Subject withdrew consent|1|||
27564869|NCT00798369|80256448|FG003|Overall Study|Subject withdrew consent|1|||
27564870|NCT00798369|80256449|FG004|Overall Study|Subject withdrew consent|0|||
27564871|NCT00798369|80256450|FG005|Overall Study|Subject withdrew consent|2|||
27564872|NCT00798369|80256445|FG000|Overall Study|Lost to Follow-up|1|||
27564873|NCT00798369|80256446|FG001|Overall Study|Lost to Follow-up|1|||
27564874|NCT00798369|80256447|FG002|Overall Study|Lost to Follow-up|1|||
27564875|NCT00798369|80256448|FG003|Overall Study|Lost to Follow-up|0|||
27564876|NCT00798369|80256449|FG004|Overall Study|Lost to Follow-up|1|||
27564877|NCT00798369|80256450|FG005|Overall Study|Lost to Follow-up|0|||
27564878|NCT00798369|80256445|FG000|Overall Study|Adminstrative problems|0|||
27564879|NCT00798369|80256446|FG001|Overall Study|Adminstrative problems|0|||
27564880|NCT00798369|80256447|FG002|Overall Study|Adminstrative problems|0|||
27564881|NCT00798369|80256448|FG003|Overall Study|Adminstrative problems|0|||
27564882|NCT00798369|80256449|FG004|Overall Study|Adminstrative problems|0|||
27564883|NCT00798369|80256450|FG005|Overall Study|Adminstrative problems|1|||
27564884|NCT03343483|80256451|FG000|Overall Study|Death|0|||
27564885|NCT03343483|80256452|FG001|Overall Study|Death|3|||
27564886|NCT03343483|80256451|FG000|Overall Study|Lost to Follow-up|9|||
27564887|NCT03343483|80256452|FG001|Overall Study|Lost to Follow-up|13|||
27564888|NCT03343483|80256451|FG000|Overall Study|Withdrawal by Subject|8|||
27564889|NCT03343483|80256452|FG001|Overall Study|Withdrawal by Subject|17|||
27564890|NCT02939560|80256453|FG000|Overall Study|Withdrawal by Subject|2|||
27564891|NCT02939560|80256453|FG000|Overall Study|Protocol Violation|1|||
27564892|NCT01524627|80256454|FG000|Overall Study|Physician Decision|0|||
27564893|NCT01524627|80256455|FG001|Overall Study|Physician Decision|1|||
27564894|NCT01524627|80256454|FG000|Overall Study|Lost to Follow-up|1|||
27564895|NCT01524627|80256455|FG001|Overall Study|Lost to Follow-up|1|||
27564896|NCT00314574|80256456|FG000|Overall Study|Death|3|||
27564897|NCT00314574|80256457|FG001|Overall Study|Death|0|||
27564898|NCT00314574|80256456|FG000|Overall Study|Adverse Event|11|||
27564899|NCT00314574|80256457|FG001|Overall Study|Adverse Event|16|||
27564900|NCT00314574|80256456|FG000|Overall Study|Lost to Follow-up|19|||
27564901|NCT00314574|80256457|FG001|Overall Study|Lost to Follow-up|25|||
27564902|NCT00314574|80256456|FG000|Overall Study|Withdrawal by Subject|33|||
27564903|NCT00314574|80256457|FG001|Overall Study|Withdrawal by Subject|22|||
27564904|NCT00314574|80256456|FG000|Overall Study|Physician Decision|22|||
27564905|NCT00314574|80256457|FG001|Overall Study|Physician Decision|15|||
27564906|NCT00314574|80256456|FG000|Overall Study|Pregnancy|6|||
27564907|NCT00314574|80256457|FG001|Overall Study|Pregnancy|4|||
27564908|NCT00314574|80256456|FG000|Overall Study|Data unknown at database lock|0|||
27564909|NCT00314574|80256457|FG001|Overall Study|Data unknown at database lock|1|||
27564910|NCT01527682|80256461|FG000|Overall Study|Protocol Violation|8|||
27564911|NCT00673179|80256462|FG000|Overall Study|Toxicity/Complications|3|||
27564912|NCT00673179|80256463|FG001|Overall Study|Toxicity/Complications|0|||
27564913|NCT02226003|80256464|FG000|Overall Study|Lost to Follow-up|2|||
27564914|NCT02226003|80256465|FG001|Overall Study|Lost to Follow-up|1|||
27564915|NCT02226003|80256466|FG002|Overall Study|Lost to Follow-up|3|||
27564916|NCT02226003|80256464|FG000|Overall Study|Withdrawal by Subject|0|||
27564917|NCT02226003|80256465|FG001|Overall Study|Withdrawal by Subject|0|||
27564918|NCT02226003|80256466|FG002|Overall Study|Withdrawal by Subject|3|||
27564919|NCT01514760|80256476|FG000|Overall Study|Lost to Follow-up|2|||
27564920|NCT01476696|80256479|FG000|Overall Study|Sponsor decision|2|||
27564921|NCT01476696|80256480|FG001|Overall Study|Sponsor decision|1|||
27564922|NCT01476696|80256481|FG002|Overall Study|Sponsor decision|0|||
27564923|NCT01476696|80256479|FG000|Overall Study|Withdrawal by Subject|1|||
27564924|NCT01476696|80256480|FG001|Overall Study|Withdrawal by Subject|0|||
27564925|NCT01476696|80256481|FG002|Overall Study|Withdrawal by Subject|0|||
27564926|NCT01623596|80256484|FG000|Overall Study|Abnormal laboratory values|2|||
27564927|NCT01623596|80256485|FG001|Overall Study|Abnormal laboratory values|0|||
27564928|NCT01623596|80256484|FG000|Overall Study|Administrative problems|9|||
27564929|NCT01623596|80256485|FG001|Overall Study|Administrative problems|13|||
27564930|NCT01623596|80256484|FG000|Overall Study|Adverse Event|20|||
27564931|NCT01623596|80256485|FG001|Overall Study|Adverse Event|29|||
27564932|NCT01623596|80256484|FG000|Overall Study|Death|0|||
27564933|NCT01623596|80256485|FG001|Overall Study|Death|2|||
27564934|NCT01623596|80256484|FG000|Overall Study|Lost to Follow-up|12|||
27564935|NCT01623596|80256485|FG001|Overall Study|Lost to Follow-up|16|||
27564936|NCT01623596|80256484|FG000|Overall Study|Withdrawal by Subject|13|||
27564937|NCT01623596|80256485|FG001|Overall Study|Withdrawal by Subject|31|||
27564938|NCT01623596|80256484|FG000|Overall Study|Patient no longer requires study drug|1|||
27564939|NCT01623596|80256485|FG001|Overall Study|Patient no longer requires study drug|0|||
27564940|NCT01623596|80256484|FG000|Overall Study|Protocol Violation|0|||
27564941|NCT01623596|80256485|FG001|Overall Study|Protocol Violation|6|||
27564942|NCT01623596|80256484|FG000|Overall Study|Lack of Efficacy|5|||
27564943|NCT01623596|80256485|FG001|Overall Study|Lack of Efficacy|3|||
27564944|NCT04151290|80256486|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
27564945|NCT00004888|80256489|FG000|Overall Study|Adverse Event|5|||
27564946|NCT00004888|80256490|FG001|Overall Study|Adverse Event|10|||
27564947|NCT00004888|80256489|FG000|Overall Study|Withdrawal by Subject|0|||
27564948|NCT00004888|80256490|FG001|Overall Study|Withdrawal by Subject|3|||
27564949|NCT00004888|80256489|FG000|Overall Study|Physician Decision|1|||
27564950|NCT00004888|80256490|FG001|Overall Study|Physician Decision|1|||
27564951|NCT00004888|80256489|FG000|Overall Study|Progressive Disease|4|||
27564952|NCT00004888|80256490|FG001|Overall Study|Progressive Disease|9|||
27564953|NCT00004888|80256489|FG000|Overall Study|Death without progressive disease|0|||
27564954|NCT00004888|80256490|FG001|Overall Study|Death without progressive disease|1|||
27564955|NCT00004888|80256489|FG000|Overall Study|Toxic death|1|||
27564956|NCT00004888|80256490|FG001|Overall Study|Toxic death|0|||
27564957|NCT02486042|80256491|FG000|Overall Study|Physician Decision|1|||
27564958|NCT02486042|80256492|FG001|Overall Study|Physician Decision|7|||
27564959|NCT02486042|80256491|FG000|Overall Study|Hospital transfer|2|||
27564960|NCT02486042|80256492|FG001|Overall Study|Hospital transfer|2|||
27564961|NCT02486042|80256491|FG000|Overall Study|Withdrawal by Subject|0|||
27564962|NCT02486042|80256492|FG001|Overall Study|Withdrawal by Subject|2|||
27564963|NCT05333900|80256501|FG000|Overall Study|Protocol Violation|0|||
27564964|NCT05333900|80256502|FG001|Overall Study|Protocol Violation|1|||
27564965|NCT05333900|80256501|FG000|Overall Study|Withdrawal by Subject|0|||
27564966|NCT05333900|80256502|FG001|Overall Study|Withdrawal by Subject|1|||
27564967|NCT05333900|80256501|FG000|Overall Study|COVID-19 Pandemic|1|||
27564968|NCT05333900|80256502|FG001|Overall Study|COVID-19 Pandemic|1|||
27564969|NCT01528072|80256509|FG000|Overall Study|Withdrawal by Subject|5|||
27564970|NCT01528072|80256509|FG000|Overall Study|Physician Decision|1|||
27564971|NCT01528072|80256509|FG000|Overall Study|Determined not eligible by AEAC|1|||
27564972|NCT01528072|80256509|FG000|Overall Study|Missed Visit|2|||
27564973|NCT01528072|80256509|FG000|Overall Study|Lost to Follow-up|5|||
27564974|NCT01528072|80256509|FG000|Overall Study|Explanted|2|||
27564975|NCT01528072|80256509|FG000|Overall Study|Site Closure|4|||
27564976|NCT01528072|80256509|FG000|Overall Study|Death|2|||
27564977|NCT01528072|80256509|FG000|Overall Study|Early Termination of Study|52|||
27564978|NCT03424265|80256510|FG000|Overall Study|screening failure|1|||
27564979|NCT03424265|80256511|FG001|Overall Study|screening failure|0|||
27564980|NCT03424265|80256510|FG000|Overall Study|Withdrawal by Subject|0|||
27564981|NCT03424265|80256511|FG001|Overall Study|Withdrawal by Subject|2|||
27564982|NCT01413360|80256512|FG000|Overall Study|Lost to Follow-up|2|||
27564983|NCT01413360|80256512|FG000|Overall Study|Adverse Event|1|||
27564984|NCT02580357|80256515|FG000|Overall Study|Lost to Follow-up|2|||
27564985|NCT02580357|80256516|FG001|Overall Study|Lost to Follow-up|0|||
27564986|NCT02580357|80256517|FG002|Overall Study|Lost to Follow-up|0|||
27564987|NCT02580357|80256515|FG000|Overall Study|Protocol Violation|1|||
27564988|NCT02580357|80256516|FG001|Overall Study|Protocol Violation|0|||
27564989|NCT02580357|80256517|FG002|Overall Study|Protocol Violation|0|||
27564990|NCT01859494|80256520|FG000|Overall Study|Adverse Event|1|||
27564991|NCT03608774|80256521|FG000|Overall Study|Lost to Follow-up|5|||
27564992|NCT03608774|80256522|FG001|Overall Study|Lost to Follow-up|5|||
27564993|NCT03608774|80256521|FG000|Overall Study|Withdrawal by Subject|1|||
27564994|NCT03608774|80256522|FG001|Overall Study|Withdrawal by Subject|0|||
27564995|NCT03608774|80256521|FG000|Overall Study|Protocol Violation|1|||
27564996|NCT03608774|80256522|FG001|Overall Study|Protocol Violation|0|||
27564997|NCT03608774|80256521|FG000|Overall Study|Not eligible at enrollment|0|||
27564998|NCT03608774|80256522|FG001|Overall Study|Not eligible at enrollment|1|||
27564999|NCT03608774|80256521|FG000|Overall Study|Health related event|0|||
27565000|NCT03608774|80256522|FG001|Overall Study|Health related event|1|||
27565001|NCT01586819|80256524|FG000|Overall Study|Withdrawal by Subject|1|||
27565002|NCT01586819|80256525|FG001|Overall Study|Withdrawal by Subject|0|||
27565003|NCT02520011|80256526|FG000|Overall Study|Adverse Event|0|||
27565004|NCT02520011|80256527|FG001|Overall Study|Adverse Event|1|||
27565005|NCT02520011|80256528|FG002|Overall Study|Adverse Event|2|||
27565006|NCT02520011|80256526|FG000|Overall Study|Death|0|||
27565007|NCT02520011|80256527|FG001|Overall Study|Death|8|||
27565008|NCT02520011|80256528|FG002|Overall Study|Death|1|||
27565009|NCT02520011|80256526|FG000|Overall Study|Lack of Efficacy|4|||
27565010|NCT02520011|80256527|FG001|Overall Study|Lack of Efficacy|26|||
27565011|NCT02520011|80256528|FG002|Overall Study|Lack of Efficacy|4|||
27565012|NCT02520011|80256526|FG000|Overall Study|Physician Decision|0|||
27565013|NCT02520011|80256527|FG001|Overall Study|Physician Decision|2|||
27565014|NCT02520011|80256528|FG002|Overall Study|Physician Decision|0|||
27565015|NCT02520011|80256526|FG000|Overall Study|Withdrawal by Subject|1|||
27565016|NCT02520011|80256527|FG001|Overall Study|Withdrawal by Subject|3|||
27565017|NCT02520011|80256528|FG002|Overall Study|Withdrawal by Subject|0|||
27565018|NCT02520011|80256526|FG000|Overall Study|Protocol Deviation|0|||
27565019|NCT02520011|80256527|FG001|Overall Study|Protocol Deviation|1|||
27565020|NCT02520011|80256528|FG002|Overall Study|Protocol Deviation|0|||
27565021|NCT02520011|80256526|FG000|Overall Study|Patient went to hospice|0|||
27565022|NCT02520011|80256527|FG001|Overall Study|Patient went to hospice|1|||
27565023|NCT02520011|80256528|FG002|Overall Study|Patient went to hospice|0|||
27565024|NCT02520011|80256526|FG000|Overall Study|Progressive disease following response|0|||
27565025|NCT02520011|80256527|FG001|Overall Study|Progressive disease following response|4|||
27565026|NCT02520011|80256528|FG002|Overall Study|Progressive disease following response|2|||
27565027|NCT02120794|80256530|FG000|Overall Study|Withdrawal by Subject|43|||
27565028|NCT02120794|80256530|FG000|Overall Study|Adverse Event|10|||
27565029|NCT02120794|80256530|FG000|Overall Study|Physician Decision|4|||
27565030|NCT02120794|80256530|FG000|Overall Study|Due to insurance coverage|1|||
27565031|NCT01319877|80256536|FG000|Overall Study|Lost to Follow-up|100|||
27565032|NCT01319877|80256537|FG001|Overall Study|Lost to Follow-up|37|||
27565033|NCT01319877|80256536|FG000|Overall Study|Physician Decision|2|||
27565034|NCT01319877|80256537|FG001|Overall Study|Physician Decision|0|||
27565035|NCT01319877|80256536|FG000|Overall Study|Disease Progression|2|||
27565036|NCT01319877|80256537|FG001|Overall Study|Disease Progression|2|||
27565037|NCT01319877|80256536|FG000|Overall Study|Withdrawal by Subject|0|||
27565038|NCT01319877|80256537|FG001|Overall Study|Withdrawal by Subject|1|||
27565039|NCT01319877|80256536|FG000|Overall Study|Reason Not Specified|4|||
27565040|NCT01319877|80256537|FG001|Overall Study|Reason Not Specified|5|||
27565041|NCT01124643|80256538|FG000|Overall Study|Death|1|||
27565042|NCT00751348|80256539|FG000|Overall Study|Withdrawal by Subject|5|||
27565043|NCT00751348|80256540|FG001|Overall Study|Withdrawal by Subject|2|||
27565044|NCT00751348|80256539|FG000|Overall Study|Migration from study area|1|||
27565045|NCT00751348|80256540|FG001|Overall Study|Migration from study area|0|||
27565046|NCT01148511|80256541|FG000|Exposed to Study Drug|Protocol Violation|2|||
27565047|NCT01148511|80256542|FG001|Exposed to Study Drug|Protocol Violation|0|||
27565048|NCT01148511|80256543|FG002|Exposed to Study Drug|Protocol Violation|0|||
27565049|NCT01148511|80256541|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
27565050|NCT01148511|80256542|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
27565051|NCT01148511|80256543|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
27565052|NCT01148511|80256541|FG000|Randomized|Adverse Event|0|||
27565053|NCT01148511|80256542|FG001|Randomized|Adverse Event|1|||
27565054|NCT01148511|80256543|FG002|Randomized|Adverse Event|0|||
27565055|NCT01148511|80256541|FG000|Randomized|Protocol Violation|0|||
27565056|NCT01148511|80256542|FG001|Randomized|Protocol Violation|2|||
27565057|NCT01148511|80256543|FG002|Randomized|Protocol Violation|1|||
27565058|NCT01148511|80256541|FG000|Randomized|Lost to Follow-up|0|||
27565059|NCT01148511|80256542|FG001|Randomized|Lost to Follow-up|1|||
27565060|NCT01148511|80256543|FG002|Randomized|Lost to Follow-up|1|||
27565061|NCT01148511|80256541|FG000|Randomized|Consent withdrawal|0|||
27565062|NCT01148511|80256542|FG001|Randomized|Consent withdrawal|5|||
27565063|NCT01148511|80256543|FG002|Randomized|Consent withdrawal|3|||
27565064|NCT01148511|80256541|FG000|Randomized|Other|0|||
27565065|NCT01148511|80256542|FG001|Randomized|Other|1|||
27565066|NCT01148511|80256543|FG002|Randomized|Other|1|||
27565067|NCT04568590|80256544|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
27565068|NCT00698581|80256545|FG000|Overall Study|Lack of Efficacy|23|||
27565069|NCT00698581|80256546|FG001|Overall Study|Lack of Efficacy|11|||
27565070|NCT00698581|80256545|FG000|Overall Study|Withdrawal by Subject|6|||
27565071|NCT00698581|80256546|FG001|Overall Study|Withdrawal by Subject|0|||
27565072|NCT00698581|80256545|FG000|Overall Study|Other reason|9|||
27565073|NCT00698581|80256546|FG001|Overall Study|Other reason|1|||
27565074|NCT00698581|80256545|FG000|Overall Study|SAE, non-fatal|1|||
27565075|NCT00698581|80256546|FG001|Overall Study|SAE, non-fatal|0|||
27565076|NCT00698581|80256545|FG000|Overall Study|AE, non-serious non-fatal|4|||
27565077|NCT00698581|80256546|FG001|Overall Study|AE, non-serious non-fatal|0|||
27565078|NCT00698581|80256545|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27565079|NCT00698581|80256546|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27565080|NCT00698581|80256545|FG000|Overall Study|AE of unknown type|1|||
27565081|NCT00698581|80256546|FG001|Overall Study|AE of unknown type|0|||
27565082|NCT00858442|80256547|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
27565083|NCT00858442|80256548|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
27565084|NCT01852812|80256549|FG000|Overall Study|Adverse Event|0|||
27565085|NCT01852812|80256550|FG001|Overall Study|Adverse Event|0|||
27565086|NCT01852812|80256551|FG002|Overall Study|Adverse Event|1|||
27565087|NCT01852812|80256549|FG000|Overall Study|Non-compliance With Study Drug|0|||
27565088|NCT01852812|80256550|FG001|Overall Study|Non-compliance With Study Drug|1|||
27565089|NCT01852812|80256551|FG002|Overall Study|Non-compliance With Study Drug|0|||
27565090|NCT00244712|80256556|FG000|Overall Study|Adverse Event|20|||
27565091|NCT00244712|80256557|FG001|Overall Study|Adverse Event|21|||
27565092|NCT00244712|80256556|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
27565093|NCT00244712|80256557|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
27565094|NCT00244712|80256556|FG000|Overall Study|Lack of Compliance|10|||
27565095|NCT00244712|80256557|FG001|Overall Study|Lack of Compliance|11|||
27565096|NCT00244712|80256556|FG000|Overall Study|Lost to Follow-up|45|||
27565097|NCT00244712|80256557|FG001|Overall Study|Lost to Follow-up|52|||
27565098|NCT00244712|80256556|FG000|Overall Study|Withdrawal by Subject|13|||
27565099|NCT00244712|80256557|FG001|Overall Study|Withdrawal by Subject|23|||
27565100|NCT00244712|80256556|FG000|Overall Study|Protocol Violation, disease progression|13|||
27565101|NCT00244712|80256557|FG001|Overall Study|Protocol Violation, disease progression|11|||
27565102|NCT02290821|80259896|FG000|Overall Study|Withdrawal by Subject|1|||
27565103|NCT02290821|80259897|FG001|Overall Study|Withdrawal by Subject|1|||
27565104|NCT02290821|80259896|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
27565105|NCT02290821|80259897|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
27565106|NCT02290821|80259896|FG000|Overall Study|Lost to Follow-up|3|||
27565107|NCT02290821|80259897|FG001|Overall Study|Lost to Follow-up|2|||
27565108|NCT00006478|80259905|FG000|Overall Study|Vaccine could not be produced|1|||
27565109|NCT00006478|80259905|FG000|Overall Study|Physician Decision|6|||
27565110|NCT02046148|80259906|FG000|Overall Study|Lost to Follow-up|1|||
27565111|NCT02046148|80259907|FG001|Overall Study|Lost to Follow-up|1|||
27565112|NCT02046148|80259906|FG000|Overall Study|Withdrawal by Subject|0|||
27565113|NCT02046148|80259907|FG001|Overall Study|Withdrawal by Subject|2|||
27565114|NCT00851799|80259909|FG000|Overall Study|Death|1|||
27565115|NCT00851799|80259910|FG001|Overall Study|Death|0|||
27565116|NCT00851799|80259911|FG002|Overall Study|Death|1|||
27565117|NCT00851799|80259909|FG000|Overall Study|Lost to Follow-up|5|||
27565118|NCT00851799|80259910|FG001|Overall Study|Lost to Follow-up|3|||
27565119|NCT00851799|80259911|FG002|Overall Study|Lost to Follow-up|10|||
27565120|NCT00851799|80259909|FG000|Overall Study|Not able to get to clinic|8|||
27565121|NCT00851799|80259910|FG001|Overall Study|Not able to get to clinic|5|||
27565122|NCT00851799|80259911|FG002|Overall Study|Not able to get to clinic|9|||
27565123|NCT00851799|80259909|FG000|Overall Study|Not willing to adhere to requirements|1|||
27565124|NCT00851799|80259910|FG001|Overall Study|Not willing to adhere to requirements|2|||
27565125|NCT00851799|80259911|FG002|Overall Study|Not willing to adhere to requirements|2|||
27565126|NCT00851799|80259909|FG000|Overall Study|Withdrew consent prior study completion|1|||
27565127|NCT00851799|80259910|FG001|Overall Study|Withdrew consent prior study completion|2|||
27565128|NCT00851799|80259911|FG002|Overall Study|Withdrew consent prior study completion|1|||
27565129|NCT00851799|80259909|FG000|Overall Study|Severe Debilitation|0|||
27565130|NCT00851799|80259910|FG001|Overall Study|Severe Debilitation|1|||
27565131|NCT00851799|80259911|FG002|Overall Study|Severe Debilitation|0|||
27565132|NCT00851799|80259909|FG000|Overall Study|Completed protocol due to pregnancy|0|||
27565133|NCT00851799|80259910|FG001|Overall Study|Completed protocol due to pregnancy|0|||
27565134|NCT00851799|80259911|FG002|Overall Study|Completed protocol due to pregnancy|1|||
27565135|NCT00278109|80259916|FG000|Overall Study|Adverse Event|3|||
27565136|NCT00278109|80259916|FG000|Overall Study|social circumstances|1|||
27565137|NCT00312494|80259917|FG000|Overall Study|Randomized; not treated with study drug|9|||
27565138|NCT00312494|80259918|FG001|Overall Study|Randomized; not treated with study drug|10|||
27565139|NCT00312494|80259919|FG002|Overall Study|Randomized; not treated with study drug|5|||
27565140|NCT00312494|80259917|FG000|Overall Study|Adverse Event|33|||
27565141|NCT00312494|80259918|FG001|Overall Study|Adverse Event|15|||
27565142|NCT00312494|80259919|FG002|Overall Study|Adverse Event|11|||
27565143|NCT00312494|80259917|FG000|Overall Study|Lack of Efficacy|4|||
27565144|NCT00312494|80259918|FG001|Overall Study|Lack of Efficacy|6|||
27565145|NCT00312494|80259919|FG002|Overall Study|Lack of Efficacy|8|||
27565146|NCT00312494|80259917|FG000|Overall Study|Laboratory abnormality|1|||
27565147|NCT00312494|80259918|FG001|Overall Study|Laboratory abnormality|0|||
27565148|NCT00312494|80259919|FG002|Overall Study|Laboratory abnormality|0|||
27565149|NCT00312494|80259917|FG000|Overall Study|Lost to Follow-up|8|||
27565150|NCT00312494|80259918|FG001|Overall Study|Lost to Follow-up|8|||
27565151|NCT00312494|80259919|FG002|Overall Study|Lost to Follow-up|8|||
27565152|NCT00312494|80259917|FG000|Overall Study|Withdrawal by Subject|6|||
27565153|NCT00312494|80259918|FG001|Overall Study|Withdrawal by Subject|9|||
27565154|NCT00312494|80259919|FG002|Overall Study|Withdrawal by Subject|10|||
27565155|NCT00312494|80259917|FG000|Overall Study|Other|10|||
27565156|NCT00312494|80259918|FG001|Overall Study|Other|10|||
27565157|NCT00312494|80259919|FG002|Overall Study|Other|1|||
27565158|NCT00076011|80259920|FG000|Overall Study|Death|1|||
27565159|NCT00076011|80259920|FG000|Overall Study|Adverse Event|10|||
27565160|NCT00076011|80259920|FG000|Overall Study|Lack of Efficacy|25|||
27565161|NCT00076011|80259920|FG000|Overall Study|Withdrawal by Subject|1|||
27565162|NCT00076011|80259920|FG000|Overall Study|Study terminated by sponsor|3|||
27565163|NCT00076011|80259920|FG000|Overall Study|Other|11|||
27565164|NCT00076011|80259920|FG000|Overall Study|Ongoing|1|||
27565165|NCT00531232|80259921|FG000|Overall Study|Investigator decision|0|||
27565166|NCT00531232|80259922|FG001|Overall Study|Investigator decision|0|||
27565167|NCT00531232|80259923|FG002|Overall Study|Investigator decision|4|||
27565168|NCT00531232|80259921|FG000|Overall Study|Participants refused further treatment|0|||
27565169|NCT00531232|80259922|FG001|Overall Study|Participants refused further treatment|1|||
27565170|NCT00531232|80259923|FG002|Overall Study|Participants refused further treatment|2|||
27565171|NCT00531232|80259921|FG000|Overall Study|Adverse events (AEs)|1|||
27565172|NCT00531232|80259922|FG001|Overall Study|Adverse events (AEs)|2|||
27565173|NCT00531232|80259923|FG002|Overall Study|Adverse events (AEs)|2|||
27565174|NCT00531232|80259921|FG000|Overall Study|Treatment failure|1|||
27565175|NCT00531232|80259922|FG001|Overall Study|Treatment failure|3|||
27565176|NCT00531232|80259923|FG002|Overall Study|Treatment failure|7|||
27565177|NCT00531232|80259921|FG000|Overall Study|Disease recurrence|0|||
27565178|NCT00531232|80259922|FG001|Overall Study|Disease recurrence|0|||
27565179|NCT00531232|80259923|FG002|Overall Study|Disease recurrence|1|||
27565180|NCT00531232|80259921|FG000|Overall Study|Deceased|2|||
27565181|NCT00531232|80259922|FG001|Overall Study|Deceased|2|||
27565182|NCT00531232|80259923|FG002|Overall Study|Deceased|2|||
27565183|NCT00531232|80259921|FG000|Overall Study|Withdrawal by Subject|0|||
27565184|NCT00531232|80259922|FG001|Overall Study|Withdrawal by Subject|1|||
27565185|NCT00531232|80259923|FG002|Overall Study|Withdrawal by Subject|2|||
27565186|NCT00531232|80259921|FG000|Overall Study|Other|0|||
27565187|NCT00531232|80259922|FG001|Overall Study|Other|0|||
27565188|NCT00531232|80259923|FG002|Overall Study|Other|5|||
27565189|NCT02141997|80259925|FG000|Overall Study|Adverse Event|0|||
27565190|NCT02141997|80259926|FG001|Overall Study|Adverse Event|2|||
27565191|NCT02141997|80259927|FG002|Overall Study|Adverse Event|0|||
27565192|NCT02141997|80259928|FG003|Overall Study|Adverse Event|1|||
27565193|NCT02141997|80259925|FG000|Overall Study|Participant noncompliance|1|||
27565194|NCT02141997|80259926|FG001|Overall Study|Participant noncompliance|0|||
27565195|NCT02141997|80259927|FG002|Overall Study|Participant noncompliance|0|||
27565196|NCT02141997|80259928|FG003|Overall Study|Participant noncompliance|0|||
27565197|NCT02141997|80259925|FG000|Overall Study|Withdrew consent|1|||
27565198|NCT02141997|80259926|FG001|Overall Study|Withdrew consent|0|||
27565199|NCT02141997|80259927|FG002|Overall Study|Withdrew consent|3|||
27565200|NCT02141997|80259928|FG003|Overall Study|Withdrew consent|0|||
27565201|NCT02141997|80259925|FG000|Overall Study|Other|1|||
27565202|NCT02141997|80259926|FG001|Overall Study|Other|4|||
27565203|NCT02141997|80259927|FG002|Overall Study|Other|0|||
27565204|NCT02141997|80259928|FG003|Overall Study|Other|0|||
27565205|NCT00978068|80259932|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
27565206|NCT00978068|80259933|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
27565207|NCT00978068|80259932|FG000|Overall Study|Death|1|||
27565208|NCT00978068|80259933|FG001|Overall Study|Death|2|||
27565209|NCT00978068|80259932|FG000|Overall Study|Lost to Follow-up|1|||
27565210|NCT00978068|80259933|FG001|Overall Study|Lost to Follow-up|2|||
27565211|NCT00978068|80259932|FG000|Overall Study|Physician Decision|0|||
27565212|NCT00978068|80259933|FG001|Overall Study|Physician Decision|1|||
27655576|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
27655577|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
27655578|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
27655579|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
27655580|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
27655581|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
27655582|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
27655583|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
27655584|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
27655585|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
27655586|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
27655587|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
27655588|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
27655589|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
27655590|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
27655591|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
27655592|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
27655593|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
27655594|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
27655595|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
27655596|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
27655597|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
27655598|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
27655599|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
27655600|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
27655601|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
27655602|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
27655603|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
27655604|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
27655605|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
27655606|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
27655607|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Other|0|||
27655608|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Other|0|||
27655609|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Other|0|||
27655610|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Other|0|||
27655611|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Other|3|||
27655612|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Other|3|||
27655613|NCT03395197|80577036|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
27655614|NCT03395197|80577037|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
27655615|NCT03395197|80577038|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
27655616|NCT03395197|80577039|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
27655617|NCT03395197|80577040|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
27655618|NCT03395197|80577041|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
27655619|NCT01732757|80577042|FG000|Overall Study|Lost to Follow-up|1|||
27655620|NCT01732757|80577043|FG001|Overall Study|Lost to Follow-up|0|||
27655621|NCT01732757|80577044|FG002|Overall Study|Lost to Follow-up|0|||
27655622|NCT01077284|80577045|FG000|Overall Study|Adverse Event|2|||
27655623|NCT01077284|80577046|FG001|Overall Study|Adverse Event|0|||
27655624|NCT01077284|80577047|FG002|Overall Study|Adverse Event|1|||
27655625|NCT01077284|80577045|FG000|Overall Study|Lost to Follow-up|1|||
27655626|NCT01077284|80577046|FG001|Overall Study|Lost to Follow-up|2|||
27655627|NCT01077284|80577047|FG002|Overall Study|Lost to Follow-up|0|||
27655628|NCT01077284|80577045|FG000|Overall Study|Withdrawal by Subject|2|||
27565213|NCT00978068|80259932|FG000|Overall Study|Unable to Comply with Study|0|||
27655629|NCT01077284|80577046|FG001|Overall Study|Withdrawal by Subject|3|||
27655630|NCT01077284|80577047|FG002|Overall Study|Withdrawal by Subject|1|||
27655631|NCT01077284|80577045|FG000|Overall Study|Other|0|||
27655632|NCT01077284|80577046|FG001|Overall Study|Other|0|||
27655633|NCT01077284|80577047|FG002|Overall Study|Other|1|||
27655634|NCT00274287|80577050|FG000|Overall Study|Withdrawal by Subject|1|||
27655635|NCT00274287|80577050|FG000|Overall Study|subject non-compliance|1|||
27655636|NCT01405508|80580024|FG000|Overall Study|AE, non-serious non-fatal|1|||
27655637|NCT01405508|80580025|FG001|Overall Study|AE, non-serious non-fatal|1|||
27655638|NCT01405508|80580026|FG002|Overall Study|AE, non-serious non-fatal|0|||
27655639|NCT01405508|80580027|FG003|Overall Study|AE, non-serious non-fatal|0|||
27655640|NCT00828139|80580030|FG000|Overall Study|Adverse Event|8|||
27655641|NCT00828139|80580031|FG001|Overall Study|Adverse Event|1|||
27655642|NCT00828139|80580032|FG002|Overall Study|Adverse Event|10|||
27655643|NCT00828139|80580033|FG003|Overall Study|Adverse Event|5|||
27655644|NCT00828139|80580030|FG000|Overall Study|Death|2|||
27655645|NCT00828139|80580031|FG001|Overall Study|Death|1|||
27565214|NCT00978068|80259933|FG001|Overall Study|Unable to Comply with Study|2|||
27565215|NCT03999892|80259934|FG000|Overall Study|Lost to Follow-up|1|||
27565216|NCT03034954|80259935|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
27565217|NCT03034954|80259936|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
27565218|NCT02159521|80259939|FG000|Overall Study|Enrolled but not treated|3|||
27565219|NCT02159521|80259939|FG000|Overall Study|Withdrawal by Subject|7|||
27565220|NCT02159521|80259939|FG000|Overall Study|Lost to Follow-up|6|||
27565221|NCT02159521|80259939|FG000|Overall Study|Death|1|||
27565222|NCT02159521|80259939|FG000|Overall Study|Other than specified|1|||
27565223|NCT01224639|80259940|FG000|Overall Study|Withdrawal by Subject|0|||
27565224|NCT01224639|80259941|FG001|Overall Study|Withdrawal by Subject|0|||
27565225|NCT01224639|80259942|FG002|Overall Study|Withdrawal by Subject|0|||
27565226|NCT01224639|80259943|FG003|Overall Study|Withdrawal by Subject|0|||
27565227|NCT01224639|80259944|FG004|Overall Study|Withdrawal by Subject|2|||
27565228|NCT01224639|80259945|FG005|Overall Study|Withdrawal by Subject|0|||
27565229|NCT01224639|80259946|FG006|Overall Study|Withdrawal by Subject|1|||
27565230|NCT01224639|80259947|FG007|Overall Study|Withdrawal by Subject|1|||
27565231|NCT01224639|80259940|FG000|Overall Study|Adverse Event|0|||
27565232|NCT01224639|80259941|FG001|Overall Study|Adverse Event|0|||
27565233|NCT01224639|80259942|FG002|Overall Study|Adverse Event|0|||
27565234|NCT01224639|80259943|FG003|Overall Study|Adverse Event|0|||
27565235|NCT01224639|80259944|FG004|Overall Study|Adverse Event|0|||
27565236|NCT01224639|80259945|FG005|Overall Study|Adverse Event|0|||
27565237|NCT01224639|80259946|FG006|Overall Study|Adverse Event|0|||
27565238|NCT01224639|80259947|FG007|Overall Study|Adverse Event|1|||
27565239|NCT05129488|80259950|FG000|Overall Study|Protocol Violation|3|||
27565240|NCT01104636|80259952|FG000|Overall Study|Lack of Efficacy|43|||
27565241|NCT01104636|80259952|FG000|Overall Study|Lost to Follow-up|24|||
27565242|NCT01104636|80259952|FG000|Overall Study|Withdrawal by Subject|4|||
27565243|NCT01104636|80259952|FG000|Overall Study|Other|43|||
27565244|NCT01104636|80259952|FG000|Overall Study|Study terminated by sponsor|1|||
27565245|NCT01104636|80259952|FG000|Overall Study|Pregnancy|2|||
27565246|NCT01104636|80259952|FG000|Overall Study|Adverse Event|40|||
27565247|NCT01104636|80259952|FG000|Overall Study|Ongoing|21|||
27565248|NCT01289847|80259953|FG000|Overall Study|Patient could not comply with visits|1|||
27565249|NCT01526889|80259954|FG000|Treatment Period|Adverse Event|2|||
27565250|NCT01526889|80259955|FG001|Treatment Period|Adverse Event|0|||
27565251|NCT01526889|80259954|FG000|Treatment Extension Period|Administrative problems|1|||
27565252|NCT01526889|80259955|FG001|Treatment Extension Period|Administrative problems|0|||
27565253|NCT04608500|80259956|FG000|Overall Study|Adverse Event|2|||
27565254|NCT04608500|80259957|FG001|Overall Study|Adverse Event|0|||
27565255|NCT04608500|80259956|FG000|Overall Study|Lost to Follow-up|15|||
27565256|NCT04608500|80259957|FG001|Overall Study|Lost to Follow-up|9|||
27565257|NCT04608500|80259956|FG000|Overall Study|Participant request|11|||
27565258|NCT04608500|80259957|FG001|Overall Study|Participant request|7|||
27565259|NCT04608500|80259956|FG000|Overall Study|Protocol Violation|1|||
27565260|NCT04608500|80259957|FG001|Overall Study|Protocol Violation|0|||
27565261|NCT04608500|80259956|FG000|Overall Study|Other|6|||
27565262|NCT04608500|80259957|FG001|Overall Study|Other|2|||
27655646|NCT00828139|80580032|FG002|Overall Study|Death|0|||
27655647|NCT00828139|80580033|FG003|Overall Study|Death|2|||
27655648|NCT00828139|80580030|FG000|Overall Study|Refusal unrelated to toxicity|3|||
27655649|NCT00828139|80580031|FG001|Overall Study|Refusal unrelated to toxicity|4|||
27565263|NCT01652664|80259963|FG000|Overall Study|Treatment Failure|5|||
27565264|NCT01652664|80259964|FG001|Overall Study|Treatment Failure|1|||
27565265|NCT01652664|80259963|FG000|Overall Study|Inadequate IOP control|1|||
27565266|NCT01652664|80259964|FG001|Overall Study|Inadequate IOP control|0|||
27565267|NCT00449644|80259965|FG000|Overall Study|Adverse Event|0|||
27565268|NCT00449644|80259966|FG001|Overall Study|Adverse Event|0|||
27565269|NCT00449644|80259967|FG002|Overall Study|Adverse Event|3|||
27565270|NCT00449644|80259968|FG003|Overall Study|Adverse Event|5|||
27565271|NCT00449644|80259965|FG000|Overall Study|Death|1|||
27565272|NCT00449644|80259966|FG001|Overall Study|Death|0|||
27565273|NCT00449644|80259967|FG002|Overall Study|Death|6|||
27565274|NCT00449644|80259968|FG003|Overall Study|Death|1|||
27565275|NCT00449644|80259965|FG000|Overall Study|Lost to Follow-up|1|||
27565276|NCT00449644|80259966|FG001|Overall Study|Lost to Follow-up|1|||
27565277|NCT00449644|80259967|FG002|Overall Study|Lost to Follow-up|5|||
27565278|NCT00449644|80259968|FG003|Overall Study|Lost to Follow-up|3|||
27565279|NCT00449644|80259965|FG000|Overall Study|Pregnancy|0|||
27565280|NCT00449644|80259966|FG001|Overall Study|Pregnancy|0|||
27565281|NCT00449644|80259967|FG002|Overall Study|Pregnancy|3|||
27565282|NCT00449644|80259968|FG003|Overall Study|Pregnancy|2|||
27565283|NCT00449644|80259965|FG000|Overall Study|Protocol Violation|4|||
27565284|NCT00449644|80259966|FG001|Overall Study|Protocol Violation|4|||
27565285|NCT00449644|80259967|FG002|Overall Study|Protocol Violation|3|||
27565286|NCT00449644|80259968|FG003|Overall Study|Protocol Violation|7|||
27565287|NCT00449644|80259965|FG000|Overall Study|Withdrawal by Subject|3|||
27565288|NCT00449644|80259966|FG001|Overall Study|Withdrawal by Subject|4|||
27565289|NCT00449644|80259967|FG002|Overall Study|Withdrawal by Subject|6|||
27565290|NCT00449644|80259968|FG003|Overall Study|Withdrawal by Subject|7|||
27565291|NCT00449644|80259965|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
27565292|NCT00449644|80259966|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
27565293|NCT00449644|80259967|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
27565294|NCT00449644|80259968|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
27565295|NCT00449644|80259965|FG000|Overall Study|Other|1|||
27565296|NCT00449644|80259966|FG001|Overall Study|Other|4|||
27565297|NCT00449644|80259967|FG002|Overall Study|Other|1|||
27565298|NCT00449644|80259968|FG003|Overall Study|Other|0|||
27565299|NCT00449644|80259965|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
27565300|NCT00449644|80259966|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
27565301|NCT00449644|80259967|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
27565302|NCT00449644|80259968|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
27565303|NCT02780804|80259969|FG000|Overall Study|Death|1|||
27565304|NCT02780804|80259970|FG001|Overall Study|Death|0|||
27565305|NCT02780804|80259971|FG002|Overall Study|Death|0|||
27565306|NCT02780804|80259969|FG000|Overall Study|Lack of Efficacy|5|||
27565307|NCT02780804|80259970|FG001|Overall Study|Lack of Efficacy|8|||
27565308|NCT02780804|80259971|FG002|Overall Study|Lack of Efficacy|4|||
27565309|NCT02780804|80259969|FG000|Overall Study|Physician Decision|0|||
27565310|NCT02780804|80259970|FG001|Overall Study|Physician Decision|0|||
27565311|NCT02780804|80259971|FG002|Overall Study|Physician Decision|2|||
27565312|NCT02780804|80259969|FG000|Overall Study|Withdrawal by Subject|0|||
27565313|NCT02780804|80259970|FG001|Overall Study|Withdrawal by Subject|1|||
27565314|NCT02780804|80259971|FG002|Overall Study|Withdrawal by Subject|0|||
27565315|NCT02291055|80259972|FG000|Overall Study|Death|2|||
27565316|NCT02291055|80259973|FG001|Overall Study|Death|2|||
27565317|NCT02291055|80259974|FG002|Overall Study|Death|5|||
27565318|NCT02291055|80259975|FG003|Overall Study|Death|8|||
27565319|NCT02291055|80259976|FG004|Overall Study|Death|12|||
27565320|NCT02291055|80259972|FG000|Overall Study|Lost to Follow-up|0|||
27565321|NCT02291055|80259973|FG001|Overall Study|Lost to Follow-up|0|||
27565322|NCT02291055|80259974|FG002|Overall Study|Lost to Follow-up|0|||
27565323|NCT02291055|80259975|FG003|Overall Study|Lost to Follow-up|1|||
27565324|NCT02291055|80259976|FG004|Overall Study|Lost to Follow-up|2|||
27565325|NCT02291055|80259972|FG000|Overall Study|Withdrawal by Subject|3|||
27565326|NCT02291055|80259973|FG001|Overall Study|Withdrawal by Subject|1|||
27565327|NCT02291055|80259974|FG002|Overall Study|Withdrawal by Subject|1|||
27565328|NCT02291055|80259975|FG003|Overall Study|Withdrawal by Subject|5|||
27565329|NCT02291055|80259976|FG004|Overall Study|Withdrawal by Subject|10|||
27565330|NCT02291055|80259972|FG000|Overall Study|Progressive Disease|0|||
27565331|NCT02291055|80259973|FG001|Overall Study|Progressive Disease|0|||
27565332|NCT02291055|80259974|FG002|Overall Study|Progressive Disease|1|||
27565333|NCT02291055|80259975|FG003|Overall Study|Progressive Disease|4|||
27565334|NCT02291055|80259976|FG004|Overall Study|Progressive Disease|2|||
27565335|NCT02291055|80259972|FG000|Overall Study|Study Terminated by Sponsor|0|||
27565336|NCT02291055|80259973|FG001|Overall Study|Study Terminated by Sponsor|0|||
27565337|NCT02291055|80259974|FG002|Overall Study|Study Terminated by Sponsor|0|||
27565338|NCT02291055|80259975|FG003|Overall Study|Study Terminated by Sponsor|5|||
27565339|NCT02291055|80259976|FG004|Overall Study|Study Terminated by Sponsor|1|||
27565340|NCT02291055|80259972|FG000|Overall Study|Other|0|||
27565341|NCT02291055|80259973|FG001|Overall Study|Other|2|||
27756952|NCT00006604|80936566|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
27565342|NCT02291055|80259974|FG002|Overall Study|Other|1|||
27565343|NCT02291055|80259975|FG003|Overall Study|Other|4|||
27565344|NCT02291055|80259976|FG004|Overall Study|Other|0|||
27565345|NCT00500292|80259977|FG000|Overall Study|Adverse Event|3|||
27565346|NCT00500292|80259978|FG001|Overall Study|Adverse Event|6|||
27565347|NCT00500292|80259979|FG002|Overall Study|Adverse Event|4|||
27565348|NCT00500292|80259977|FG000|Overall Study|Condition under investigation worsened|21|||
27565349|NCT00500292|80259978|FG001|Overall Study|Condition under investigation worsened|23|||
27565350|NCT00500292|80259979|FG002|Overall Study|Condition under investigation worsened|19|||
27565351|NCT00500292|80259977|FG000|Overall Study|Withdrawal by Subject|0|||
27565352|NCT00500292|80259978|FG001|Overall Study|Withdrawal by Subject|1|||
27565353|NCT00500292|80259979|FG002|Overall Study|Withdrawal by Subject|0|||
27565354|NCT00500292|80259977|FG000|Overall Study|Other|1|||
27565355|NCT00500292|80259978|FG001|Overall Study|Other|1|||
27565356|NCT00500292|80259979|FG002|Overall Study|Other|4|||
27565357|NCT04014075|80259982|FG000|Overall Study|Progressive Disease|48|||
27565358|NCT04014075|80259982|FG000|Overall Study|Adverse Event|11|||
27565359|NCT04014075|80259982|FG000|Overall Study|Clinical Progression|4|||
27565360|NCT04014075|80259982|FG000|Overall Study|Death|2|||
27565361|NCT04014075|80259982|FG000|Overall Study|Withdrawal by Subject|2|||
27565362|NCT04014075|80259982|FG000|Overall Study|Miscellaneous|1|||
27565363|NCT04014075|80259982|FG000|Overall Study|Physician Decision|1|||
27565364|NCT04248933|80259983|FG000|Overall Study|Lost to Follow-up|9|||
27565365|NCT04248933|80259983|FG000|Overall Study|Withdrawal by Subject|2|||
27565366|NCT01150123|80259985|FG000|Overall Study|Withdrawal by Subject|1|||
27565367|NCT01150123|80259986|FG001|Overall Study|Withdrawal by Subject|1|||
27565368|NCT01150123|80259987|FG002|Overall Study|Withdrawal by Subject|2|||
27565369|NCT01150123|80259988|FG003|Overall Study|Withdrawal by Subject|1|||
27565370|NCT01150123|80259989|FG004|Overall Study|Withdrawal by Subject|1|||
27565371|NCT01150123|80259990|FG005|Overall Study|Withdrawal by Subject|1|||
27565372|NCT01150123|80259991|FG006|Overall Study|Withdrawal by Subject|0|||
27565373|NCT01150123|80259992|FG007|Overall Study|Withdrawal by Subject|3|||
27565374|NCT01150123|80259993|FG008|Overall Study|Withdrawal by Subject|2|||
27565375|NCT01150123|80259994|FG009|Overall Study|Withdrawal by Subject|0|||
27565376|NCT01150123|80259995|FG010|Overall Study|Withdrawal by Subject|1|||
27565377|NCT01150123|80259996|FG011|Overall Study|Withdrawal by Subject|0|||
27565378|NCT01150123|80259997|FG012|Overall Study|Withdrawal by Subject|1|||
27565379|NCT01150123|80259998|FG013|Overall Study|Withdrawal by Subject|0|||
27565380|NCT01150123|80259999|FG014|Overall Study|Withdrawal by Subject|0|||
27565381|NCT01150123|80260000|FG015|Overall Study|Withdrawal by Subject|1|||
27565382|NCT01150123|80260001|FG016|Overall Study|Withdrawal by Subject|0|||
27565383|NCT01150123|80260002|FG017|Overall Study|Withdrawal by Subject|1|||
27565384|NCT01150123|80259985|FG000|Overall Study|Lost to Follow-up|2|||
27565385|NCT01150123|80259986|FG001|Overall Study|Lost to Follow-up|1|||
27565386|NCT01150123|80259987|FG002|Overall Study|Lost to Follow-up|2|||
27565387|NCT01150123|80259988|FG003|Overall Study|Lost to Follow-up|2|||
27565388|NCT01150123|80259989|FG004|Overall Study|Lost to Follow-up|2|||
27565389|NCT01150123|80259990|FG005|Overall Study|Lost to Follow-up|5|||
27565390|NCT01150123|80259991|FG006|Overall Study|Lost to Follow-up|0|||
27565391|NCT01150123|80259992|FG007|Overall Study|Lost to Follow-up|0|||
27565392|NCT01150123|80259993|FG008|Overall Study|Lost to Follow-up|3|||
27565393|NCT01150123|80259994|FG009|Overall Study|Lost to Follow-up|1|||
27565394|NCT01150123|80259995|FG010|Overall Study|Lost to Follow-up|1|||
27565395|NCT01150123|80259996|FG011|Overall Study|Lost to Follow-up|1|||
27565396|NCT01150123|80259997|FG012|Overall Study|Lost to Follow-up|2|||
27565397|NCT01150123|80259998|FG013|Overall Study|Lost to Follow-up|0|||
27565398|NCT01150123|80259999|FG014|Overall Study|Lost to Follow-up|0|||
27565399|NCT01150123|80260000|FG015|Overall Study|Lost to Follow-up|0|||
27565400|NCT01150123|80260001|FG016|Overall Study|Lost to Follow-up|0|||
27565401|NCT01150123|80260002|FG017|Overall Study|Lost to Follow-up|0|||
27565402|NCT00896337|80260003|FG000|Overall Study|Death|7|||
27565403|NCT00896337|80260003|FG000|Overall Study|Withdrawal by Subject|7|||
27565404|NCT00896337|80260003|FG000|Overall Study|Lost to Follow-up|11|||
27565405|NCT00914810|80260007|FG000|Overall Study|Withdrawal by Subject|1|||
27565406|NCT00914810|80260008|FG001|Overall Study|Withdrawal by Subject|0|||
27565407|NCT00914810|80260007|FG000|Overall Study|Relocated out of state|1|||
27565408|NCT00914810|80260008|FG001|Overall Study|Relocated out of state|0|||
27565409|NCT00914810|80260007|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
27565410|NCT00914810|80260008|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
27565411|NCT01921179|80260011|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
27565412|NCT01921179|80260012|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
27565413|NCT01921179|80260011|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
27565414|NCT01921179|80260012|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
27565415|NCT01251380|80260013|FG000|Overall Study|Other (Not otherwise specified)|12|||
27565416|NCT01251380|80260013|FG000|Overall Study|Withdrawal by Subject|6|||
27565417|NCT01251380|80260013|FG000|Overall Study|Lack of Efficacy|1|||
27565418|NCT01251380|80260013|FG000|Overall Study|Adverse Event|1|||
27565419|NCT01251380|80260013|FG000|Overall Study|Lost to Follow-up|2|||
27565420|NCT03220217|80260016|FG000|Overall Study|Withdrawal by Subject|0|||
27565421|NCT03220217|80260017|FG001|Overall Study|Withdrawal by Subject|1|||
27565422|NCT03220217|80260018|FG002|Overall Study|Withdrawal by Subject|0|||
27565423|NCT03220217|80260016|FG000|Overall Study|Subject Missed Procedure|0|||
27565424|NCT03220217|80260017|FG001|Overall Study|Subject Missed Procedure|0|||
27565425|NCT03220217|80260018|FG002|Overall Study|Subject Missed Procedure|1|||
27859170|NCT04594707|81319258|FG002|Overall Study|Lung Transplant|1|||
27565426|NCT01120756|80260019|FG000|Overall Study|Withdrawal by Subject|1|||
27565427|NCT01120756|80260020|FG001|Overall Study|Withdrawal by Subject|1|||
27565428|NCT00811577|80260021|FG000|Overall Study|Lost to Follow-up|7|||
27565429|NCT00811577|80260022|FG001|Overall Study|Lost to Follow-up|1|||
27565430|NCT00811577|80260021|FG000|Overall Study|Withdrawal by Subject|3|||
27565431|NCT00811577|80260022|FG001|Overall Study|Withdrawal by Subject|0|||
27565432|NCT01531387|80260026|FG000|Overall Study|Early termination of study|11|||
27565433|NCT01531387|80260027|FG001|Overall Study|Early termination of study|11|||
27565434|NCT03873987|80260034|FG000|Overall Study|Adverse Event|1|||
27565435|NCT03873987|80260035|FG001|Overall Study|Adverse Event|0|||
27565436|NCT03873987|80260034|FG000|Overall Study|staff was unable to start a new IV line|1|||
27565437|NCT03873987|80260035|FG001|Overall Study|staff was unable to start a new IV line|0|||
27565438|NCT03873987|80260034|FG000|Overall Study|Lost to Follow-up|0|||
27565439|NCT03873987|80260035|FG001|Overall Study|Lost to Follow-up|1|||
27565440|NCT01498952|80260036|FG000|Overall Study|Death|2|||
27565441|NCT01498952|80260037|FG001|Overall Study|Death|2|||
27565442|NCT01498952|80260038|FG002|Overall Study|Death|0|||
27565443|NCT01498952|80260039|FG003|Overall Study|Death|0|||
27565444|NCT01498952|80260040|FG004|Overall Study|Death|0|||
27565445|NCT02612428|80260041|FG000|VTL-308|Death|14|||
27565446|NCT02612428|80260042|FG001|VTL-308|Death|16|||
27565447|NCT02612428|80260041|FG000|VTL-308|Withdrawal by Subject|0|||
27565448|NCT02612428|80260042|FG001|VTL-308|Withdrawal by Subject|1|||
27565449|NCT02612428|80260041|FG000|VTL-308E|Death|9|||
27565450|NCT02612428|80260042|FG001|VTL-308E|Death|7|||
27565451|NCT02612428|80260041|FG000|VTL-308E|Lost to Follow-up|2|||
27565452|NCT02612428|80260042|FG001|VTL-308E|Lost to Follow-up|0|||
27565453|NCT01554618|80260045|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
27565454|NCT01554618|80260046|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
27565455|NCT01554618|80260045|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
27565456|NCT01554618|80260046|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
27565457|NCT01554618|80260045|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
27565458|NCT01554618|80260046|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
27565459|NCT01554618|80260045|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
27565460|NCT01554618|80260046|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
27565461|NCT01554618|80260045|FG000|Open-Label Extension Period|Physician Decision|0|||
27565462|NCT01554618|80260046|FG001|Open-Label Extension Period|Physician Decision|1|||
27565463|NCT01554618|80260045|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
27565464|NCT01554618|80260046|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
27565465|NCT00718328|80260047|FG000|Overall Study|Lost to Follow-up|1|||
27565466|NCT00718328|80260048|FG001|Overall Study|Lost to Follow-up|0|||
27565467|NCT02073279|80260050|FG000|Double-blind Period|Adverse Event|1|||
27565468|NCT02073279|80260051|FG001|Double-blind Period|Adverse Event|1|||
27565469|NCT02073279|80260050|FG000|Double-blind Period|Switched to another treatment|1|||
27565470|NCT02073279|80260051|FG001|Double-blind Period|Switched to another treatment|2|||
27565471|NCT02073279|80260050|FG000|Double-blind Period|Protocol Violation|0|||
27565472|NCT02073279|80260051|FG001|Double-blind Period|Protocol Violation|1|||
27565473|NCT02073279|80260050|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
27565474|NCT02073279|80260051|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
27565475|NCT02073279|80260050|FG000|Double-blind Period|Withdrawal by Subject|2|||
27565476|NCT02073279|80260051|FG001|Double-blind Period|Withdrawal by Subject|2|||
27565477|NCT02073279|80260050|FG000|Open-label Extension Period|Adverse Event|1|||
27565478|NCT02073279|80260051|FG001|Open-label Extension Period|Adverse Event|0|||
27565479|NCT02073279|80260050|FG000|Open-label Extension Period|Lack of Efficacy|1|||
27565480|NCT02073279|80260051|FG001|Open-label Extension Period|Lack of Efficacy|0|||
27565481|NCT02073279|80260050|FG000|Open-label Extension Period|Lost to Follow-up|0|||
27565482|NCT02073279|80260051|FG001|Open-label Extension Period|Lost to Follow-up|4|||
27565483|NCT02073279|80260050|FG000|Open-label Extension Period|Switched to another treatment|1|||
27565484|NCT02073279|80260051|FG001|Open-label Extension Period|Switched to another treatment|4|||
27565485|NCT02073279|80260050|FG000|Open-label Extension Period|Protocol Violation|0|||
27565486|NCT02073279|80260051|FG001|Open-label Extension Period|Protocol Violation|1|||
27565487|NCT02073279|80260050|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
27565488|NCT02073279|80260051|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
27565489|NCT02073279|80260050|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
27565490|NCT02073279|80260051|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
27565491|NCT02466555|80260052|FG000|Overall Study|Lost to Follow-up|2|||
27565492|NCT01478321|80260058|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
27565493|NCT01478321|80260058|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
27565494|NCT01478321|80260058|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
27565495|NCT01478321|80260058|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
27565496|NCT01478321|80260058|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
27565497|NCT01478321|80260058|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
27565498|NCT01478321|80260058|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
27565499|NCT01478321|80260058|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
27565500|NCT03642717|80260061|FG000|Overall Study|Lost to Follow-up|2|||
27565501|NCT03642717|80260061|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
27565502|NCT03642717|80260061|FG000|Overall Study|Taken study drug prior to contract date|3|||
27565503|NCT00702403|80260062|FG000|From Consent to Engraftment|Progressive leukemia|6|||
27565504|NCT00702403|80260062|FG000|From Consent to Engraftment|Critically ill|2|||
27565505|NCT00702403|80260062|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
27565506|NCT00702403|80260062|FG000|From Consent to Engraftment|Myocardial infarction|1|||
27565507|NCT00702403|80260062|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
27565508|NCT00702403|80260062|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
27565509|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
27565510|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
27565511|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Non-compliance|2|||
27565512|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
27565513|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
27565514|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Suicide|1|||
27565515|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
27565516|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
27565517|NCT00702403|80260062|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
27565518|NCT01393405|80260063|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
27565519|NCT01393405|80260064|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
27565520|NCT01393405|80260065|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
27565521|NCT01393405|80260063|FG000|Induction Period (week1-16)|Adverse Event|16|||
27565522|NCT01393405|80260064|FG001|Induction Period (week1-16)|Adverse Event|0|||
27565523|NCT01393405|80260065|FG002|Induction Period (week1-16)|Adverse Event|0|||
27565524|NCT01393405|80260063|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
27565525|NCT01393405|80260064|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
27565526|NCT01393405|80260065|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
27565527|NCT01393405|80260063|FG000|Maintenance Period Week|Lack of Efficacy|0|||
27565528|NCT01393405|80260064|FG001|Maintenance Period Week|Lack of Efficacy|22|||
27565529|NCT01393405|80260065|FG002|Maintenance Period Week|Lack of Efficacy|22|||
27565530|NCT01393405|80260063|FG000|Maintenance Period Week|Adverse Event|0|||
27565531|NCT01393405|80260064|FG001|Maintenance Period Week|Adverse Event|5|||
27565532|NCT01393405|80260065|FG002|Maintenance Period Week|Adverse Event|2|||
27565533|NCT01393405|80260063|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
27565534|NCT01393405|80260064|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
27565535|NCT01393405|80260065|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
27565536|NCT01393405|80260063|FG000|Maintenance Period Week|Lost to Follow-up|0|||
27565537|NCT01393405|80260064|FG001|Maintenance Period Week|Lost to Follow-up|1|||
27565538|NCT01393405|80260065|FG002|Maintenance Period Week|Lost to Follow-up|0|||
27565539|NCT03257631|80260066|FG000|Overall Study|Death|1|||
27565540|NCT03257631|80260067|FG001|Overall Study|Death|0|||
27565541|NCT03257631|80260068|FG002|Overall Study|Death|1|||
27565542|NCT03257631|80260069|FG003|Overall Study|Death|1|||
27565543|NCT03257631|80260066|FG000|Overall Study|Progressive Disease|10|||
27565544|NCT03257631|80260067|FG001|Overall Study|Progressive Disease|9|||
27565545|NCT03257631|80260068|FG002|Overall Study|Progressive Disease|17|||
27565546|NCT03257631|80260069|FG003|Overall Study|Progressive Disease|8|||
27565547|NCT03257631|80260066|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27565548|NCT03257631|80260067|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27565549|NCT03257631|80260068|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
27565550|NCT03257631|80260069|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
27565551|NCT03257631|80260066|FG000|Overall Study|Adverse Event|0|||
27565552|NCT03257631|80260067|FG001|Overall Study|Adverse Event|0|||
27565553|NCT03257631|80260068|FG002|Overall Study|Adverse Event|2|||
27565554|NCT03257631|80260069|FG003|Overall Study|Adverse Event|0|||
27565555|NCT02357940|80260074|FG000|Overall Study|Adverse Event|0|||
27565556|NCT02357940|80260075|FG001|Overall Study|Adverse Event|1|||
27565557|NCT02357940|80260074|FG000|Overall Study|Investigator's judgement|0|||
27565558|NCT02357940|80260075|FG001|Overall Study|Investigator's judgement|1|||
27565559|NCT01177540|80260076|FG000|Overall Study|Adverse Event|1|||
27565560|NCT01177540|80260077|FG001|Overall Study|Adverse Event|0|||
27565561|NCT00235872|80260079|FG000|Overall Study|Adverse Event|34|||
27565562|NCT00235872|80260079|FG000|Overall Study|Death|1|||
27565563|NCT00235872|80260079|FG000|Overall Study|Lost to Follow-up|1|||
27565564|NCT00235872|80260079|FG000|Overall Study|Withdrawal by Subject|50|||
27565565|NCT00235872|80260079|FG000|Overall Study|Administrative reason|61|||
27565566|NCT01334866|80260083|FG000|Overall Study|Withdrawal by Subject|10|||
27565567|NCT01334866|80260083|FG000|Overall Study|Lost to Follow-up|3|||
27565568|NCT01334866|80260083|FG000|Overall Study|Physician Decision|3|||
27565569|NCT01334866|80260083|FG000|Overall Study|medically necessary prior to procedure|2|||
27565570|NCT01334866|80260083|FG000|Overall Study|medically necessary post-procedure|1|||
27565571|NCT04475588|80260087|FG000|Overall Study|Adverse Event|2|||
27565572|NCT04475588|80260088|FG001|Overall Study|Adverse Event|0|||
27565573|NCT02865915|80260094|FG000|Overall Study|Pregnancy|1|||
27565574|NCT02865915|80260095|FG001|Overall Study|Pregnancy|0|||
27565575|NCT02865915|80260094|FG000|Overall Study|Withdrawal by Subject|1|||
27565576|NCT02865915|80260095|FG001|Overall Study|Withdrawal by Subject|1|||
27565577|NCT02865915|80260094|FG000|Overall Study|Adverse Event|0|||
27565578|NCT02865915|80260095|FG001|Overall Study|Adverse Event|4|||
27565579|NCT02865915|80260094|FG000|Overall Study|Lost to Follow-up|0|||
27565580|NCT02865915|80260095|FG001|Overall Study|Lost to Follow-up|1|||
27565581|NCT02865915|80260094|FG000|Overall Study|Protocol Violation|0|||
27565582|NCT02865915|80260095|FG001|Overall Study|Protocol Violation|1|||
27565583|NCT02865915|80260094|FG000|Overall Study|Study terminated by sponsor|23|||
27565584|NCT02865915|80260095|FG001|Overall Study|Study terminated by sponsor|18|||
27565585|NCT02865915|80260094|FG000|Overall Study|Dosing group discontinued|0|||
27565586|NCT02865915|80260095|FG001|Overall Study|Dosing group discontinued|5|||
27565587|NCT04898673|80260097|FG000|Overall Study|Screenfail|1|||
27565588|NCT04898673|80260098|FG001|Overall Study|Screenfail|0|||
27565589|NCT02319031|80260107|FG000|Treatment Period|Death|1|||
27565590|NCT02319031|80260108|FG001|Treatment Period|Death|0|||
27565591|NCT02558790|80260111|FG000|Overall Study|Lost to Follow-up|2|||
27565592|NCT02558790|80260111|FG000|Overall Study|Physician Decision|1|||
27565593|NCT02558790|80260111|FG000|Overall Study|Withdrawal by Subject|1|||
27565594|NCT02558790|80260111|FG000|Overall Study|Screen Fail|3|||
27565595|NCT03465878|80260112|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
27565596|NCT03465878|80260113|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
27565597|NCT03465878|80260114|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
27565598|NCT03465878|80260115|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
27565599|NCT03465878|80260112|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
27565600|NCT03465878|80260113|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
27565601|NCT03465878|80260114|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
27565602|NCT03465878|80260115|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
27565603|NCT03465878|80260112|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
27565604|NCT03465878|80260113|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
27565605|NCT03465878|80260114|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
27565606|NCT03465878|80260115|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
27565607|NCT02357147|80260116|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
27565608|NCT02357147|80260117|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
27565609|NCT02357147|80260116|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
27565610|NCT02357147|80260117|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
27565611|NCT02357147|80260116|FG000|Combination Treatment Phase|Investigator Discretion|1|||
27565612|NCT02357147|80260117|FG001|Combination Treatment Phase|Investigator Discretion|1|||
27565613|NCT02357147|80260116|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
27565614|NCT02357147|80260117|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
27565615|NCT02357147|80260116|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
27565616|NCT02357147|80260117|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
27565617|NCT02357147|80260116|FG000|Combination Treatment Phase|Adverse Event|12|||
27565618|NCT02357147|80260117|FG001|Combination Treatment Phase|Adverse Event|4|||
27565619|NCT02357147|80260116|FG000|Combination Treatment Phase|Death|1|||
27565620|NCT02357147|80260117|FG001|Combination Treatment Phase|Death|1|||
27565621|NCT02357147|80260116|FG000|Combination Treatment Phase|Sponsor Decision|0|||
27565622|NCT02357147|80260117|FG001|Combination Treatment Phase|Sponsor Decision|12|||
27565623|NCT02357147|80260116|FG000|Combination Treatment Phase|Other|1|||
27565624|NCT02357147|80260117|FG001|Combination Treatment Phase|Other|0|||
27565625|NCT02357147|80260116|FG000|Combination Treatment Phase|Not treated|0|||
27565626|NCT02357147|80260117|FG001|Combination Treatment Phase|Not treated|2|||
27565627|NCT02357147|80260116|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
27565628|NCT02357147|80260117|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
27565629|NCT02357147|80260116|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27565630|NCT02357147|80260117|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
27565631|NCT02357147|80260116|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
27565632|NCT02357147|80260117|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
27565633|NCT02357147|80260116|FG000|Maintenance Treatment Phase|Adverse Event|0|||
27565634|NCT02357147|80260117|FG001|Maintenance Treatment Phase|Adverse Event|3|||
27565635|NCT02357147|80260116|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
27565636|NCT02357147|80260117|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
27565637|NCT02357147|80260116|FG000|Maintenance Treatment Phase|Not Treated|1|||
27565638|NCT02357147|80260117|FG001|Maintenance Treatment Phase|Not Treated|0|||
27565639|NCT01498458|80260118|FG000|Overall Study|Adverse Event|4|||
27565640|NCT01498458|80260118|FG000|Overall Study|Physician Decision|3|||
27565641|NCT02641379|80260119|FG000|Overall Study|Exclusion criterion during screening|1|||
27565642|NCT02641379|80260120|FG001|Overall Study|Exclusion criterion during screening|0|||
27565643|NCT02641379|80260121|FG002|Overall Study|Exclusion criterion during screening|0|||
27565644|NCT02641379|80260122|FG003|Overall Study|Exclusion criterion during screening|1|||
27565645|NCT02641379|80260123|FG004|Overall Study|Exclusion criterion during screening|2|||
27565646|NCT02641379|80260124|FG005|Overall Study|Exclusion criterion during screening|0|||
27565647|NCT02641379|80260125|FG006|Overall Study|Exclusion criterion during screening|0|||
27565648|NCT02641379|80260126|FG007|Overall Study|Exclusion criterion during screening|0|||
27565649|NCT02641379|80260127|FG008|Overall Study|Exclusion criterion during screening|0|||
27565650|NCT02641379|80260128|FG009|Overall Study|Exclusion criterion during screening|0|||
27565651|NCT02641379|80260129|FG010|Overall Study|Exclusion criterion during screening|0|||
27565652|NCT02641379|80260119|FG000|Overall Study|Withdrawal of informed consent|0|||
27565653|NCT02641379|80260120|FG001|Overall Study|Withdrawal of informed consent|1|||
27565654|NCT02641379|80260121|FG002|Overall Study|Withdrawal of informed consent|0|||
27565655|NCT02641379|80260122|FG003|Overall Study|Withdrawal of informed consent|0|||
27565656|NCT02641379|80260123|FG004|Overall Study|Withdrawal of informed consent|0|||
27565657|NCT02641379|80260124|FG005|Overall Study|Withdrawal of informed consent|0|||
27565658|NCT02641379|80260125|FG006|Overall Study|Withdrawal of informed consent|0|||
27565659|NCT02641379|80260126|FG007|Overall Study|Withdrawal of informed consent|1|||
27565660|NCT02641379|80260127|FG008|Overall Study|Withdrawal of informed consent|0|||
27565661|NCT02641379|80260128|FG009|Overall Study|Withdrawal of informed consent|0|||
27565662|NCT02641379|80260129|FG010|Overall Study|Withdrawal of informed consent|0|||
27565663|NCT02641379|80260119|FG000|Overall Study|Adverse Event|7|||
27565664|NCT02641379|80260120|FG001|Overall Study|Adverse Event|8|||
27565665|NCT02641379|80260121|FG002|Overall Study|Adverse Event|2|||
27565666|NCT02641379|80260122|FG003|Overall Study|Adverse Event|2|||
27565667|NCT02641379|80260123|FG004|Overall Study|Adverse Event|5|||
27565668|NCT02641379|80260124|FG005|Overall Study|Adverse Event|1|||
27565669|NCT02641379|80260125|FG006|Overall Study|Adverse Event|5|||
27565670|NCT02641379|80260126|FG007|Overall Study|Adverse Event|0|||
27565671|NCT02641379|80260127|FG008|Overall Study|Adverse Event|1|||
27565672|NCT02641379|80260128|FG009|Overall Study|Adverse Event|1|||
27565673|NCT02641379|80260129|FG010|Overall Study|Adverse Event|5|||
27565674|NCT02641379|80260119|FG000|Overall Study|Lack of Efficacy|0|||
27565675|NCT02641379|80260120|FG001|Overall Study|Lack of Efficacy|0|||
27565676|NCT02641379|80260121|FG002|Overall Study|Lack of Efficacy|2|||
27565677|NCT02641379|80260122|FG003|Overall Study|Lack of Efficacy|0|||
27565678|NCT02641379|80260123|FG004|Overall Study|Lack of Efficacy|0|||
27565679|NCT02641379|80260124|FG005|Overall Study|Lack of Efficacy|2|||
27565680|NCT02641379|80260125|FG006|Overall Study|Lack of Efficacy|0|||
27565681|NCT02641379|80260126|FG007|Overall Study|Lack of Efficacy|5|||
27565682|NCT02641379|80260127|FG008|Overall Study|Lack of Efficacy|0|||
27565683|NCT02641379|80260128|FG009|Overall Study|Lack of Efficacy|0|||
27565684|NCT02641379|80260129|FG010|Overall Study|Lack of Efficacy|0|||
27565685|NCT02641379|80260119|FG000|Overall Study|Participant unable to attend study visit|4|||
27565686|NCT02641379|80260120|FG001|Overall Study|Participant unable to attend study visit|10|||
27565687|NCT02641379|80260121|FG002|Overall Study|Participant unable to attend study visit|1|||
27565688|NCT02641379|80260122|FG003|Overall Study|Participant unable to attend study visit|2|||
27565689|NCT02641379|80260123|FG004|Overall Study|Participant unable to attend study visit|5|||
27565690|NCT02641379|80260124|FG005|Overall Study|Participant unable to attend study visit|1|||
27565691|NCT02641379|80260125|FG006|Overall Study|Participant unable to attend study visit|1|||
27565692|NCT02641379|80260126|FG007|Overall Study|Participant unable to attend study visit|1|||
27565693|NCT02641379|80260127|FG008|Overall Study|Participant unable to attend study visit|0|||
27565694|NCT02641379|80260128|FG009|Overall Study|Participant unable to attend study visit|2|||
27565695|NCT02641379|80260129|FG010|Overall Study|Participant unable to attend study visit|0|||
27565696|NCT02641379|80260119|FG000|Overall Study|Participant's compliance|0|||
27565697|NCT02641379|80260120|FG001|Overall Study|Participant's compliance|1|||
27565698|NCT02641379|80260121|FG002|Overall Study|Participant's compliance|0|||
27565699|NCT02641379|80260122|FG003|Overall Study|Participant's compliance|1|||
27565700|NCT02641379|80260123|FG004|Overall Study|Participant's compliance|0|||
27565701|NCT02641379|80260124|FG005|Overall Study|Participant's compliance|2|||
27565702|NCT02641379|80260125|FG006|Overall Study|Participant's compliance|0|||
27565703|NCT02641379|80260126|FG007|Overall Study|Participant's compliance|0|||
27565704|NCT02641379|80260127|FG008|Overall Study|Participant's compliance|1|||
27565705|NCT02641379|80260128|FG009|Overall Study|Participant's compliance|1|||
27565706|NCT02641379|80260129|FG010|Overall Study|Participant's compliance|1|||
27565707|NCT02641379|80260119|FG000|Overall Study|Participant cannot be reached|4|||
27565708|NCT02641379|80260120|FG001|Overall Study|Participant cannot be reached|4|||
27565709|NCT02641379|80260121|FG002|Overall Study|Participant cannot be reached|0|||
27565710|NCT02641379|80260122|FG003|Overall Study|Participant cannot be reached|8|||
27565711|NCT02641379|80260123|FG004|Overall Study|Participant cannot be reached|2|||
27565712|NCT02641379|80260124|FG005|Overall Study|Participant cannot be reached|1|||
27565713|NCT02641379|80260125|FG006|Overall Study|Participant cannot be reached|0|||
27565714|NCT02641379|80260126|FG007|Overall Study|Participant cannot be reached|1|||
27565715|NCT02641379|80260127|FG008|Overall Study|Participant cannot be reached|0|||
27565716|NCT02641379|80260128|FG009|Overall Study|Participant cannot be reached|2|||
27565717|NCT02641379|80260129|FG010|Overall Study|Participant cannot be reached|1|||
27565718|NCT02641379|80260119|FG000|Overall Study|PCR positive at Week 24|15|||
27565719|NCT02641379|80260120|FG001|Overall Study|PCR positive at Week 24|21|||
27565720|NCT02641379|80260121|FG002|Overall Study|PCR positive at Week 24|62|||
27565721|NCT02641379|80260122|FG003|Overall Study|PCR positive at Week 24|0|||
27565722|NCT02641379|80260123|FG004|Overall Study|PCR positive at Week 24|0|||
27565723|NCT02641379|80260124|FG005|Overall Study|PCR positive at Week 24|6|||
27565724|NCT02641379|80260125|FG006|Overall Study|PCR positive at Week 24|3|||
27565725|NCT02641379|80260126|FG007|Overall Study|PCR positive at Week 24|8|||
27565726|NCT02641379|80260127|FG008|Overall Study|PCR positive at Week 24|0|||
27565727|NCT02641379|80260128|FG009|Overall Study|PCR positive at Week 24|1|||
27565728|NCT02641379|80260129|FG010|Overall Study|PCR positive at Week 24|0|||
27565729|NCT02641379|80260119|FG000|Overall Study|PCR positive at follow up 2|1|||
27565730|NCT02641379|80260120|FG001|Overall Study|PCR positive at follow up 2|0|||
27565731|NCT02641379|80260121|FG002|Overall Study|PCR positive at follow up 2|0|||
27565732|NCT02641379|80260122|FG003|Overall Study|PCR positive at follow up 2|0|||
27565733|NCT02641379|80260123|FG004|Overall Study|PCR positive at follow up 2|0|||
27565734|NCT02641379|80260124|FG005|Overall Study|PCR positive at follow up 2|0|||
27565735|NCT02641379|80260125|FG006|Overall Study|PCR positive at follow up 2|0|||
27565736|NCT02641379|80260126|FG007|Overall Study|PCR positive at follow up 2|0|||
27565737|NCT02641379|80260127|FG008|Overall Study|PCR positive at follow up 2|0|||
27565738|NCT02641379|80260128|FG009|Overall Study|PCR positive at follow up 2|0|||
27565739|NCT02641379|80260129|FG010|Overall Study|PCR positive at follow up 2|0|||
27565740|NCT02641379|80260119|FG000|Overall Study|Participant showed relapse|1|||
27565741|NCT02641379|80260120|FG001|Overall Study|Participant showed relapse|0|||
27565742|NCT02641379|80260121|FG002|Overall Study|Participant showed relapse|0|||
27565743|NCT02641379|80260122|FG003|Overall Study|Participant showed relapse|0|||
27565744|NCT02641379|80260123|FG004|Overall Study|Participant showed relapse|0|||
27565745|NCT02641379|80260124|FG005|Overall Study|Participant showed relapse|0|||
27565746|NCT02641379|80260125|FG006|Overall Study|Participant showed relapse|1|||
27565747|NCT02641379|80260126|FG007|Overall Study|Participant showed relapse|0|||
27565748|NCT02641379|80260127|FG008|Overall Study|Participant showed relapse|0|||
27565749|NCT02641379|80260128|FG009|Overall Study|Participant showed relapse|0|||
27565750|NCT02641379|80260129|FG010|Overall Study|Participant showed relapse|0|||
27565751|NCT02641379|80260119|FG000|Overall Study|Participant stopped study/treatment|1|||
27565752|NCT02641379|80260120|FG001|Overall Study|Participant stopped study/treatment|3|||
27565753|NCT02641379|80260121|FG002|Overall Study|Participant stopped study/treatment|1|||
27565754|NCT02641379|80260122|FG003|Overall Study|Participant stopped study/treatment|0|||
27565755|NCT02641379|80260123|FG004|Overall Study|Participant stopped study/treatment|0|||
27565756|NCT02641379|80260124|FG005|Overall Study|Participant stopped study/treatment|1|||
27565757|NCT02641379|80260125|FG006|Overall Study|Participant stopped study/treatment|2|||
27565758|NCT02641379|80260126|FG007|Overall Study|Participant stopped study/treatment|0|||
27565759|NCT02641379|80260127|FG008|Overall Study|Participant stopped study/treatment|1|||
27565760|NCT02641379|80260128|FG009|Overall Study|Participant stopped study/treatment|0|||
27565761|NCT02641379|80260129|FG010|Overall Study|Participant stopped study/treatment|0|||
27565762|NCT02641379|80260119|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
27565763|NCT02641379|80260120|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
27565764|NCT02641379|80260121|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
27565765|NCT02641379|80260122|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
27565766|NCT02641379|80260123|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
27565767|NCT02641379|80260124|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
27565768|NCT02641379|80260125|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
27565769|NCT02641379|80260126|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
27565770|NCT02641379|80260127|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
27565771|NCT02641379|80260128|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
27565772|NCT02641379|80260129|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
27565773|NCT02641379|80260119|FG000|Overall Study|Financial problems|0|||
27565774|NCT02641379|80260120|FG001|Overall Study|Financial problems|1|||
27565775|NCT02641379|80260121|FG002|Overall Study|Financial problems|0|||
27565776|NCT02641379|80260122|FG003|Overall Study|Financial problems|0|||
27565777|NCT02641379|80260123|FG004|Overall Study|Financial problems|0|||
27565778|NCT02641379|80260124|FG005|Overall Study|Financial problems|0|||
27565779|NCT02641379|80260125|FG006|Overall Study|Financial problems|0|||
27565780|NCT02641379|80260126|FG007|Overall Study|Financial problems|0|||
27565781|NCT02641379|80260127|FG008|Overall Study|Financial problems|0|||
27565782|NCT02641379|80260128|FG009|Overall Study|Financial problems|0|||
27961933|NCT00703846|81691829|FG000|Overall Study|Noncompliance with Study Treatment|2|||
27565783|NCT02641379|80260129|FG010|Overall Study|Financial problems|0|||
27565784|NCT02641379|80260119|FG000|Overall Study|PCR positive at Week 68|0|||
27565785|NCT02641379|80260120|FG001|Overall Study|PCR positive at Week 68|1|||
27565786|NCT02641379|80260121|FG002|Overall Study|PCR positive at Week 68|0|||
27565787|NCT02641379|80260122|FG003|Overall Study|PCR positive at Week 68|0|||
27565788|NCT02641379|80260123|FG004|Overall Study|PCR positive at Week 68|0|||
27565789|NCT02641379|80260124|FG005|Overall Study|PCR positive at Week 68|0|||
27565790|NCT02641379|80260125|FG006|Overall Study|PCR positive at Week 68|0|||
27565791|NCT02641379|80260126|FG007|Overall Study|PCR positive at Week 68|0|||
27565792|NCT02641379|80260127|FG008|Overall Study|PCR positive at Week 68|0|||
27565793|NCT02641379|80260128|FG009|Overall Study|PCR positive at Week 68|0|||
27565794|NCT02641379|80260129|FG010|Overall Study|PCR positive at Week 68|0|||
27565795|NCT02641379|80260119|FG000|Overall Study|PCR positive at Week 48|0|||
27565796|NCT02641379|80260120|FG001|Overall Study|PCR positive at Week 48|1|||
27565797|NCT02641379|80260121|FG002|Overall Study|PCR positive at Week 48|0|||
27565798|NCT02641379|80260122|FG003|Overall Study|PCR positive at Week 48|0|||
27565799|NCT02641379|80260123|FG004|Overall Study|PCR positive at Week 48|0|||
27565800|NCT02641379|80260124|FG005|Overall Study|PCR positive at Week 48|0|||
27565801|NCT02641379|80260125|FG006|Overall Study|PCR positive at Week 48|0|||
27565802|NCT02641379|80260126|FG007|Overall Study|PCR positive at Week 48|0|||
27565803|NCT02641379|80260127|FG008|Overall Study|PCR positive at Week 48|0|||
27565804|NCT02641379|80260128|FG009|Overall Study|PCR positive at Week 48|0|||
27565805|NCT02641379|80260129|FG010|Overall Study|PCR positive at Week 48|0|||
27565806|NCT02641379|80260119|FG000|Overall Study|PCR not performed at Week 12|0|||
27565807|NCT02641379|80260120|FG001|Overall Study|PCR not performed at Week 12|0|||
27565808|NCT02641379|80260121|FG002|Overall Study|PCR not performed at Week 12|1|||
27565809|NCT02641379|80260122|FG003|Overall Study|PCR not performed at Week 12|0|||
27565810|NCT02641379|80260123|FG004|Overall Study|PCR not performed at Week 12|0|||
27565811|NCT02641379|80260124|FG005|Overall Study|PCR not performed at Week 12|0|||
27565812|NCT02641379|80260125|FG006|Overall Study|PCR not performed at Week 12|0|||
27565813|NCT02641379|80260126|FG007|Overall Study|PCR not performed at Week 12|0|||
27565814|NCT02641379|80260127|FG008|Overall Study|PCR not performed at Week 12|0|||
27565815|NCT02641379|80260128|FG009|Overall Study|PCR not performed at Week 12|0|||
27565816|NCT02641379|80260129|FG010|Overall Study|PCR not performed at Week 12|0|||
27565817|NCT02641379|80260119|FG000|Overall Study|No PCR at baseline|0|||
27565818|NCT02641379|80260120|FG001|Overall Study|No PCR at baseline|0|||
27565819|NCT02641379|80260121|FG002|Overall Study|No PCR at baseline|1|||
27565820|NCT02641379|80260122|FG003|Overall Study|No PCR at baseline|0|||
27565821|NCT02641379|80260123|FG004|Overall Study|No PCR at baseline|0|||
27565822|NCT02641379|80260124|FG005|Overall Study|No PCR at baseline|0|||
27565823|NCT02641379|80260125|FG006|Overall Study|No PCR at baseline|0|||
27565824|NCT02641379|80260126|FG007|Overall Study|No PCR at baseline|0|||
27565825|NCT02641379|80260127|FG008|Overall Study|No PCR at baseline|0|||
27565826|NCT02641379|80260128|FG009|Overall Study|No PCR at baseline|0|||
27565827|NCT02641379|80260129|FG010|Overall Study|No PCR at baseline|0|||
27565828|NCT02641379|80260119|FG000|Overall Study|PCR positive at Week 28|0|||
27565829|NCT02641379|80260120|FG001|Overall Study|PCR positive at Week 28|0|||
27565830|NCT02641379|80260121|FG002|Overall Study|PCR positive at Week 28|1|||
27565831|NCT02641379|80260122|FG003|Overall Study|PCR positive at Week 28|0|||
27565832|NCT02641379|80260123|FG004|Overall Study|PCR positive at Week 28|0|||
27565833|NCT02641379|80260124|FG005|Overall Study|PCR positive at Week 28|0|||
27565834|NCT02641379|80260125|FG006|Overall Study|PCR positive at Week 28|0|||
27565835|NCT02641379|80260126|FG007|Overall Study|PCR positive at Week 28|0|||
27565836|NCT02641379|80260127|FG008|Overall Study|PCR positive at Week 28|0|||
27565837|NCT02641379|80260128|FG009|Overall Study|PCR positive at Week 28|0|||
27565838|NCT02641379|80260129|FG010|Overall Study|PCR positive at Week 28|0|||
27565839|NCT02641379|80260119|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
27565840|NCT02641379|80260120|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
27565841|NCT02641379|80260121|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
27565842|NCT02641379|80260122|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
27565843|NCT02641379|80260123|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
27565844|NCT02641379|80260124|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
27565845|NCT02641379|80260125|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
27565846|NCT02641379|80260126|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
27565847|NCT02641379|80260127|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
27565848|NCT02641379|80260128|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
27565849|NCT02641379|80260129|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
27565850|NCT02641379|80260119|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
27565851|NCT02641379|80260120|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
27565852|NCT02641379|80260121|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
27565853|NCT02641379|80260122|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
27565854|NCT02641379|80260123|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
27565855|NCT02641379|80260124|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
27565856|NCT02641379|80260125|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
27565857|NCT02641379|80260126|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
27565858|NCT02641379|80260127|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
27565859|NCT02641379|80260128|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
27565860|NCT02641379|80260129|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
27565861|NCT02641379|80260119|FG000|Overall Study|Baseline viral load unavailable|0|||
27565862|NCT02641379|80260120|FG001|Overall Study|Baseline viral load unavailable|0|||
27565863|NCT02641379|80260121|FG002|Overall Study|Baseline viral load unavailable|0|||
27565864|NCT02641379|80260122|FG003|Overall Study|Baseline viral load unavailable|1|||
27565865|NCT02641379|80260123|FG004|Overall Study|Baseline viral load unavailable|0|||
27565866|NCT02641379|80260124|FG005|Overall Study|Baseline viral load unavailable|0|||
27565867|NCT02641379|80260125|FG006|Overall Study|Baseline viral load unavailable|0|||
27565868|NCT02641379|80260126|FG007|Overall Study|Baseline viral load unavailable|0|||
27565869|NCT02641379|80260127|FG008|Overall Study|Baseline viral load unavailable|0|||
27565870|NCT02641379|80260128|FG009|Overall Study|Baseline viral load unavailable|0|||
27565871|NCT02641379|80260129|FG010|Overall Study|Baseline viral load unavailable|0|||
27565872|NCT02641379|80260119|FG000|Overall Study|Blood could not be drawn|0|||
27565873|NCT02641379|80260120|FG001|Overall Study|Blood could not be drawn|0|||
27565874|NCT02641379|80260121|FG002|Overall Study|Blood could not be drawn|0|||
27565875|NCT02641379|80260122|FG003|Overall Study|Blood could not be drawn|0|||
27565876|NCT02641379|80260123|FG004|Overall Study|Blood could not be drawn|1|||
27565877|NCT02641379|80260124|FG005|Overall Study|Blood could not be drawn|0|||
27565878|NCT02641379|80260125|FG006|Overall Study|Blood could not be drawn|0|||
27565879|NCT02641379|80260126|FG007|Overall Study|Blood could not be drawn|0|||
27565880|NCT02641379|80260127|FG008|Overall Study|Blood could not be drawn|0|||
27565881|NCT02641379|80260128|FG009|Overall Study|Blood could not be drawn|0|||
27565882|NCT02641379|80260129|FG010|Overall Study|Blood could not be drawn|0|||
27565883|NCT02641379|80260119|FG000|Overall Study|Protocol Violation|0|||
27565884|NCT02641379|80260120|FG001|Overall Study|Protocol Violation|0|||
27565885|NCT02641379|80260121|FG002|Overall Study|Protocol Violation|0|||
27565886|NCT02641379|80260122|FG003|Overall Study|Protocol Violation|0|||
27565887|NCT02641379|80260123|FG004|Overall Study|Protocol Violation|2|||
27565888|NCT02641379|80260124|FG005|Overall Study|Protocol Violation|0|||
27565889|NCT02641379|80260125|FG006|Overall Study|Protocol Violation|0|||
27565890|NCT02641379|80260126|FG007|Overall Study|Protocol Violation|0|||
27565891|NCT02641379|80260127|FG008|Overall Study|Protocol Violation|1|||
27565892|NCT02641379|80260128|FG009|Overall Study|Protocol Violation|0|||
27565893|NCT02641379|80260129|FG010|Overall Study|Protocol Violation|0|||
27565894|NCT02641379|80260119|FG000|Overall Study|Participation in sili rescue study|0|||
27565895|NCT02641379|80260120|FG001|Overall Study|Participation in sili rescue study|0|||
27565896|NCT02641379|80260121|FG002|Overall Study|Participation in sili rescue study|0|||
27565897|NCT02641379|80260122|FG003|Overall Study|Participation in sili rescue study|0|||
27565898|NCT02641379|80260123|FG004|Overall Study|Participation in sili rescue study|0|||
27565899|NCT02641379|80260124|FG005|Overall Study|Participation in sili rescue study|1|||
27565900|NCT02641379|80260125|FG006|Overall Study|Participation in sili rescue study|0|||
27565901|NCT02641379|80260126|FG007|Overall Study|Participation in sili rescue study|0|||
27565902|NCT02641379|80260127|FG008|Overall Study|Participation in sili rescue study|0|||
27565903|NCT02641379|80260128|FG009|Overall Study|Participation in sili rescue study|0|||
27565904|NCT02641379|80260129|FG010|Overall Study|Participation in sili rescue study|0|||
27565905|NCT02641379|80260119|FG000|Overall Study|Lost to Follow-up|0|||
27565906|NCT02641379|80260120|FG001|Overall Study|Lost to Follow-up|0|||
27565907|NCT02641379|80260121|FG002|Overall Study|Lost to Follow-up|0|||
27565908|NCT02641379|80260122|FG003|Overall Study|Lost to Follow-up|0|||
27565909|NCT02641379|80260123|FG004|Overall Study|Lost to Follow-up|0|||
27565910|NCT02641379|80260124|FG005|Overall Study|Lost to Follow-up|0|||
27565911|NCT02641379|80260125|FG006|Overall Study|Lost to Follow-up|0|||
27565912|NCT02641379|80260126|FG007|Overall Study|Lost to Follow-up|0|||
27565913|NCT02641379|80260127|FG008|Overall Study|Lost to Follow-up|1|||
27565914|NCT02641379|80260128|FG009|Overall Study|Lost to Follow-up|0|||
27565915|NCT02641379|80260129|FG010|Overall Study|Lost to Follow-up|0|||
27565916|NCT02641379|80260119|FG000|Overall Study|Source data not found|0|||
27565917|NCT02641379|80260120|FG001|Overall Study|Source data not found|0|||
27565918|NCT02641379|80260121|FG002|Overall Study|Source data not found|0|||
27565919|NCT02641379|80260122|FG003|Overall Study|Source data not found|0|||
27565920|NCT02641379|80260123|FG004|Overall Study|Source data not found|0|||
27565921|NCT02641379|80260124|FG005|Overall Study|Source data not found|1|||
27565922|NCT02641379|80260125|FG006|Overall Study|Source data not found|0|||
27565923|NCT02641379|80260126|FG007|Overall Study|Source data not found|0|||
27565924|NCT02641379|80260127|FG008|Overall Study|Source data not found|0|||
27565925|NCT02641379|80260128|FG009|Overall Study|Source data not found|0|||
27565926|NCT02641379|80260129|FG010|Overall Study|Source data not found|0|||
27565927|NCT02641379|80260119|FG000|Overall Study|Participant showed weight reduction|0|||
27565928|NCT02641379|80260120|FG001|Overall Study|Participant showed weight reduction|0|||
27565929|NCT02641379|80260121|FG002|Overall Study|Participant showed weight reduction|0|||
27565930|NCT02641379|80260122|FG003|Overall Study|Participant showed weight reduction|0|||
27565931|NCT02641379|80260123|FG004|Overall Study|Participant showed weight reduction|0|||
27565932|NCT02641379|80260124|FG005|Overall Study|Participant showed weight reduction|0|||
27565933|NCT02641379|80260125|FG006|Overall Study|Participant showed weight reduction|0|||
27565934|NCT02641379|80260126|FG007|Overall Study|Participant showed weight reduction|1|||
27565935|NCT02641379|80260127|FG008|Overall Study|Participant showed weight reduction|0|||
27565936|NCT02641379|80260128|FG009|Overall Study|Participant showed weight reduction|0|||
27565937|NCT02641379|80260129|FG010|Overall Study|Participant showed weight reduction|0|||
27565938|NCT02641379|80260119|FG000|Overall Study|Non-response Week 12|0|||
27565939|NCT02641379|80260120|FG001|Overall Study|Non-response Week 12|0|||
27565940|NCT02641379|80260121|FG002|Overall Study|Non-response Week 12|0|||
27565941|NCT02641379|80260122|FG003|Overall Study|Non-response Week 12|0|||
27565942|NCT02641379|80260123|FG004|Overall Study|Non-response Week 12|0|||
27565943|NCT02641379|80260124|FG005|Overall Study|Non-response Week 12|0|||
27565944|NCT02641379|80260125|FG006|Overall Study|Non-response Week 12|0|||
27565945|NCT02641379|80260126|FG007|Overall Study|Non-response Week 12|1|||
27565946|NCT02641379|80260127|FG008|Overall Study|Non-response Week 12|0|||
27565947|NCT02641379|80260128|FG009|Overall Study|Non-response Week 12|0|||
27565948|NCT02641379|80260129|FG010|Overall Study|Non-response Week 12|0|||
27565949|NCT02641379|80260119|FG000|Overall Study|No 2 Log drop at Week 12|0|||
27565950|NCT02641379|80260120|FG001|Overall Study|No 2 Log drop at Week 12|0|||
27565951|NCT02641379|80260121|FG002|Overall Study|No 2 Log drop at Week 12|0|||
27565952|NCT02641379|80260122|FG003|Overall Study|No 2 Log drop at Week 12|0|||
27565953|NCT02641379|80260123|FG004|Overall Study|No 2 Log drop at Week 12|0|||
27565954|NCT02641379|80260124|FG005|Overall Study|No 2 Log drop at Week 12|0|||
27565955|NCT02641379|80260125|FG006|Overall Study|No 2 Log drop at Week 12|0|||
27565956|NCT02641379|80260126|FG007|Overall Study|No 2 Log drop at Week 12|0|||
27565957|NCT02641379|80260127|FG008|Overall Study|No 2 Log drop at Week 12|0|||
27565958|NCT02641379|80260128|FG009|Overall Study|No 2 Log drop at Week 12|0|||
27565959|NCT02641379|80260129|FG010|Overall Study|No 2 Log drop at Week 12|1|||
27565960|NCT02641379|80260119|FG000|Overall Study|Negative PCR result|0|||
27565961|NCT02641379|80260120|FG001|Overall Study|Negative PCR result|0|||
27565962|NCT02641379|80260121|FG002|Overall Study|Negative PCR result|0|||
27565963|NCT02641379|80260122|FG003|Overall Study|Negative PCR result|0|||
27565964|NCT02641379|80260123|FG004|Overall Study|Negative PCR result|0|||
27565965|NCT02641379|80260124|FG005|Overall Study|Negative PCR result|0|||
27565966|NCT02641379|80260125|FG006|Overall Study|Negative PCR result|0|||
27565967|NCT02641379|80260126|FG007|Overall Study|Negative PCR result|0|||
27565968|NCT02641379|80260127|FG008|Overall Study|Negative PCR result|0|||
27565969|NCT02641379|80260128|FG009|Overall Study|Negative PCR result|1|||
27565970|NCT02641379|80260129|FG010|Overall Study|Negative PCR result|0|||
27565971|NCT02641379|80260119|FG000|Overall Study|Participant's PCR high|0|||
27565972|NCT02641379|80260120|FG001|Overall Study|Participant's PCR high|0|||
27565973|NCT02641379|80260121|FG002|Overall Study|Participant's PCR high|0|||
27565974|NCT02641379|80260122|FG003|Overall Study|Participant's PCR high|0|||
27565975|NCT02641379|80260123|FG004|Overall Study|Participant's PCR high|0|||
27565976|NCT02641379|80260124|FG005|Overall Study|Participant's PCR high|0|||
27565977|NCT02641379|80260125|FG006|Overall Study|Participant's PCR high|0|||
27565978|NCT02641379|80260126|FG007|Overall Study|Participant's PCR high|1|||
27565979|NCT02641379|80260127|FG008|Overall Study|Participant's PCR high|0|||
27565980|NCT02641379|80260128|FG009|Overall Study|Participant's PCR high|0|||
27565981|NCT02641379|80260129|FG010|Overall Study|Participant's PCR high|0|||
27565982|NCT02641379|80260119|FG000|Overall Study|Participant treated after Week 24|0|||
27565983|NCT02641379|80260120|FG001|Overall Study|Participant treated after Week 24|0|||
27565984|NCT02641379|80260121|FG002|Overall Study|Participant treated after Week 24|0|||
27565985|NCT02641379|80260122|FG003|Overall Study|Participant treated after Week 24|0|||
27565986|NCT02641379|80260123|FG004|Overall Study|Participant treated after Week 24|0|||
27565987|NCT02641379|80260124|FG005|Overall Study|Participant treated after Week 24|0|||
27565988|NCT02641379|80260125|FG006|Overall Study|Participant treated after Week 24|0|||
27565989|NCT02641379|80260126|FG007|Overall Study|Participant treated after Week 24|0|||
27565990|NCT02641379|80260127|FG008|Overall Study|Participant treated after Week 24|1|||
27565991|NCT02641379|80260128|FG009|Overall Study|Participant treated after Week 24|0|||
27565992|NCT02641379|80260129|FG010|Overall Study|Participant treated after Week 24|0|||
27655650|NCT00828139|80580032|FG002|Overall Study|Refusal unrelated to toxicity|5|||
27655651|NCT00828139|80580033|FG003|Overall Study|Refusal unrelated to toxicity|3|||
27565993|NCT02641379|80260119|FG000|Overall Study|Missing PCR result at Week 8|0|||
27565994|NCT02641379|80260120|FG001|Overall Study|Missing PCR result at Week 8|0|||
27565995|NCT02641379|80260121|FG002|Overall Study|Missing PCR result at Week 8|0|||
27565996|NCT02641379|80260122|FG003|Overall Study|Missing PCR result at Week 8|0|||
27565997|NCT02641379|80260123|FG004|Overall Study|Missing PCR result at Week 8|0|||
27565998|NCT02641379|80260124|FG005|Overall Study|Missing PCR result at Week 8|0|||
27565999|NCT02641379|80260125|FG006|Overall Study|Missing PCR result at Week 8|0|||
27566000|NCT02641379|80260126|FG007|Overall Study|Missing PCR result at Week 8|0|||
27566001|NCT02641379|80260127|FG008|Overall Study|Missing PCR result at Week 8|0|||
27566002|NCT02641379|80260128|FG009|Overall Study|Missing PCR result at Week 8|1|||
27566003|NCT02641379|80260129|FG010|Overall Study|Missing PCR result at Week 8|0|||
27566004|NCT02641379|80260119|FG000|Overall Study|PCR positive|0|||
27566005|NCT02641379|80260120|FG001|Overall Study|PCR positive|0|||
27566006|NCT02641379|80260121|FG002|Overall Study|PCR positive|0|||
27566007|NCT02641379|80260122|FG003|Overall Study|PCR positive|0|||
27566008|NCT02641379|80260123|FG004|Overall Study|PCR positive|0|||
27566009|NCT02641379|80260124|FG005|Overall Study|PCR positive|0|||
27566010|NCT02641379|80260125|FG006|Overall Study|PCR positive|1|||
27566011|NCT02641379|80260126|FG007|Overall Study|PCR positive|0|||
27566012|NCT02641379|80260127|FG008|Overall Study|PCR positive|0|||
27566013|NCT02641379|80260128|FG009|Overall Study|PCR positive|0|||
27566014|NCT02641379|80260129|FG010|Overall Study|PCR positive|0|||
27566015|NCT04059146|80260130|FG000|Overall Study|Withdrawal by Subject|0|||
27566016|NCT04059146|80260131|FG001|Overall Study|Withdrawal by Subject|1|||
27566017|NCT04656132|80260132|FG000|Overall Study|Lost to Follow-up|4|||
27566018|NCT04656132|80260132|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
27566019|NCT02680639|80260141|FG000|Screening Period|Screen Failure|7|||
27566020|NCT02680639|80260142|FG001|Screening Period|Screen Failure|0|||
27566021|NCT02680639|80260143|FG002|Screening Period|Screen Failure|0|||
27566022|NCT05620576|80260144|FG000|Overall Study|Adverse Event|1|||
27566023|NCT05620576|80260145|FG001|Overall Study|Adverse Event|1|||
27655652|NCT00828139|80580030|FG000|Overall Study|Disease Progression|24|||
27655653|NCT00828139|80580031|FG001|Overall Study|Disease Progression|33|||
27655654|NCT00828139|80580032|FG002|Overall Study|Disease Progression|35|||
27655655|NCT00828139|80580033|FG003|Overall Study|Disease Progression|39|||
27655656|NCT00828139|80580030|FG000|Overall Study|Other|4|||
27655657|NCT00828139|80580031|FG001|Overall Study|Other|2|||
27566024|NCT05620576|80260144|FG000|Overall Study|Lost to Follow-up|3|||
27566025|NCT05620576|80260145|FG001|Overall Study|Lost to Follow-up|1|||
27566026|NCT05620576|80260144|FG000|Overall Study|Physician Decision|0|||
27655658|NCT00828139|80580032|FG002|Overall Study|Other|5|||
27655659|NCT00828139|80580033|FG003|Overall Study|Other|2|||
27655660|NCT00443820|80580036|FG000|Overall Study|Adverse Event|1|||
27566027|NCT05620576|80260145|FG001|Overall Study|Physician Decision|1|||
27655661|NCT00443820|80580037|FG001|Overall Study|Adverse Event|1|||
27655662|NCT00443820|80580038|FG002|Overall Study|Adverse Event|0|||
27655663|NCT00443820|80580039|FG003|Overall Study|Adverse Event|0|||
27566028|NCT05620576|80260144|FG000|Overall Study|Protocol Deviation|1|||
27566029|NCT05620576|80260145|FG001|Overall Study|Protocol Deviation|1|||
27566030|NCT05620576|80260144|FG000|Overall Study|Withdrawal by Subject|2|||
27566031|NCT05620576|80260145|FG001|Overall Study|Withdrawal by Subject|3|||
27566032|NCT02689258|80260146|FG000|Overall Study|Subject Non-Compliance|0|||
27566033|NCT02689258|80260147|FG001|Overall Study|Subject Non-Compliance|1|||
27566034|NCT02689258|80260148|FG002|Overall Study|Subject Non-Compliance|0|||
27566035|NCT02689258|80260149|FG003|Overall Study|Subject Non-Compliance|0|||
27566036|NCT02689258|80260150|FG004|Overall Study|Subject Non-Compliance|0|||
27566037|NCT02689258|80260151|FG005|Overall Study|Subject Non-Compliance|0|||
27566038|NCT02689258|80260152|FG006|Overall Study|Subject Non-Compliance|0|||
27566039|NCT02689258|80260153|FG007|Overall Study|Subject Non-Compliance|0|||
27566040|NCT02689258|80260154|FG008|Overall Study|Subject Non-Compliance|0|||
27566041|NCT02689258|80260155|FG009|Overall Study|Subject Non-Compliance|0|||
27566042|NCT02689258|80260156|FG010|Overall Study|Subject Non-Compliance|0|||
27566043|NCT02689258|80260157|FG011|Overall Study|Subject Non-Compliance|0|||
27566044|NCT02689258|80260146|FG000|Overall Study|Subject Refusal to Continue|0|||
27566045|NCT02689258|80260147|FG001|Overall Study|Subject Refusal to Continue|1|||
27566046|NCT02689258|80260148|FG002|Overall Study|Subject Refusal to Continue|0|||
27566047|NCT02689258|80260149|FG003|Overall Study|Subject Refusal to Continue|0|||
27566048|NCT02689258|80260150|FG004|Overall Study|Subject Refusal to Continue|0|||
27566049|NCT02689258|80260151|FG005|Overall Study|Subject Refusal to Continue|0|||
27566050|NCT02689258|80260152|FG006|Overall Study|Subject Refusal to Continue|0|||
27566051|NCT02689258|80260153|FG007|Overall Study|Subject Refusal to Continue|0|||
27566052|NCT02689258|80260154|FG008|Overall Study|Subject Refusal to Continue|1|||
27566053|NCT02689258|80260155|FG009|Overall Study|Subject Refusal to Continue|0|||
27566054|NCT02689258|80260156|FG010|Overall Study|Subject Refusal to Continue|0|||
27566055|NCT02689258|80260157|FG011|Overall Study|Subject Refusal to Continue|1|||
27566056|NCT02689258|80260146|FG000|Overall Study|Other|0|||
27566057|NCT02689258|80260147|FG001|Overall Study|Other|2|||
27566058|NCT02689258|80260148|FG002|Overall Study|Other|0|||
27566059|NCT02689258|80260149|FG003|Overall Study|Other|0|||
27566060|NCT02689258|80260150|FG004|Overall Study|Other|1|||
27566061|NCT02689258|80260151|FG005|Overall Study|Other|0|||
27566062|NCT02689258|80260152|FG006|Overall Study|Other|0|||
27566063|NCT02689258|80260153|FG007|Overall Study|Other|0|||
27566064|NCT02689258|80260154|FG008|Overall Study|Other|1|||
27566065|NCT02689258|80260155|FG009|Overall Study|Other|0|||
27566066|NCT02689258|80260156|FG010|Overall Study|Other|0|||
27566067|NCT02689258|80260157|FG011|Overall Study|Other|0|||
27566068|NCT00603746|80260158|FG000|Overall Study|Adverse Event|2|||
27566069|NCT00603746|80260159|FG001|Overall Study|Adverse Event|3|||
27566070|NCT00603746|80260160|FG002|Overall Study|Adverse Event|0|||
27566071|NCT00603746|80260161|FG003|Overall Study|Adverse Event|1|||
27566072|NCT00603746|80260162|FG004|Overall Study|Adverse Event|0|||
27566073|NCT00603746|80260163|FG005|Overall Study|Adverse Event|4|||
27566074|NCT00603746|80260158|FG000|Overall Study|Lack of Efficacy|34|||
27566075|NCT00603746|80260159|FG001|Overall Study|Lack of Efficacy|11|||
27566076|NCT00603746|80260160|FG002|Overall Study|Lack of Efficacy|6|||
27566077|NCT00603746|80260161|FG003|Overall Study|Lack of Efficacy|11|||
27566078|NCT00603746|80260162|FG004|Overall Study|Lack of Efficacy|12|||
27566079|NCT00603746|80260163|FG005|Overall Study|Lack of Efficacy|8|||
27566080|NCT00603746|80260158|FG000|Overall Study|Protocol Violation|0|||
27566081|NCT00603746|80260159|FG001|Overall Study|Protocol Violation|3|||
27566082|NCT00603746|80260160|FG002|Overall Study|Protocol Violation|1|||
27566083|NCT00603746|80260161|FG003|Overall Study|Protocol Violation|0|||
27566084|NCT00603746|80260162|FG004|Overall Study|Protocol Violation|1|||
27566085|NCT00603746|80260163|FG005|Overall Study|Protocol Violation|0|||
27566086|NCT00603746|80260158|FG000|Overall Study|Lost to Follow-up|0|||
27566087|NCT00603746|80260159|FG001|Overall Study|Lost to Follow-up|1|||
27566088|NCT00603746|80260160|FG002|Overall Study|Lost to Follow-up|1|||
27566089|NCT00603746|80260161|FG003|Overall Study|Lost to Follow-up|0|||
27566090|NCT00603746|80260162|FG004|Overall Study|Lost to Follow-up|0|||
27566091|NCT00603746|80260163|FG005|Overall Study|Lost to Follow-up|0|||
27566092|NCT00603746|80260158|FG000|Overall Study|Physician Decision|1|||
27566093|NCT00603746|80260159|FG001|Overall Study|Physician Decision|0|||
27566094|NCT00603746|80260160|FG002|Overall Study|Physician Decision|0|||
27566095|NCT00603746|80260161|FG003|Overall Study|Physician Decision|0|||
27566096|NCT00603746|80260162|FG004|Overall Study|Physician Decision|1|||
27566097|NCT00603746|80260163|FG005|Overall Study|Physician Decision|0|||
27566098|NCT00603746|80260158|FG000|Overall Study|Withdrawal by Subject|1|||
27566099|NCT00603746|80260159|FG001|Overall Study|Withdrawal by Subject|0|||
27566100|NCT00603746|80260160|FG002|Overall Study|Withdrawal by Subject|0|||
27566101|NCT00603746|80260161|FG003|Overall Study|Withdrawal by Subject|1|||
27566102|NCT00603746|80260162|FG004|Overall Study|Withdrawal by Subject|3|||
27566103|NCT00603746|80260163|FG005|Overall Study|Withdrawal by Subject|1|||
27566104|NCT01462357|80260166|FG000|Overall Study|Death|0|||
27566105|NCT01462357|80260167|FG001|Overall Study|Death|0|||
27566106|NCT01462357|80260168|FG002|Overall Study|Death|1|||
27566107|NCT01462357|80260166|FG000|Overall Study|Withdrawal by Subject|3|||
27566108|NCT01462357|80260167|FG001|Overall Study|Withdrawal by Subject|11|||
27566109|NCT01462357|80260168|FG002|Overall Study|Withdrawal by Subject|3|||
27566110|NCT01462357|80260166|FG000|Overall Study|Migrated/moved from study area|2|||
27566111|NCT01462357|80260167|FG001|Overall Study|Migrated/moved from study area|3|||
27566112|NCT01462357|80260168|FG002|Overall Study|Migrated/moved from study area|1|||
27566113|NCT01462357|80260166|FG000|Overall Study|Lost to Follow-up|3|||
27566114|NCT01462357|80260167|FG001|Overall Study|Lost to Follow-up|5|||
27566115|NCT01462357|80260168|FG002|Overall Study|Lost to Follow-up|7|||
27566116|NCT00407563|80260173|FG000|Overall Study|Patient continues on treatment|1|||
27566117|NCT01957462|80260178|FG000|Test Period 1|Withdrawal by Subject|1|||
27566118|NCT01957462|80260179|FG001|Test Period 1|Withdrawal by Subject|0|||
27566119|NCT01957462|80260178|FG000|Test Period 1|Adverse Event|1|||
27566120|NCT01957462|80260179|FG001|Test Period 1|Adverse Event|0|||
27566121|NCT00302458|80260180|FG000|Overall Study|Lost to Follow-up|1|||
27566122|NCT00302458|80260180|FG000|Overall Study|Ineligible after screening|1|||
27566123|NCT00302458|80260180|FG000|Overall Study|Withdrawal by Subject|1|||
27566124|NCT04782856|80260181|FG000|Overall Study|Withdrawal by Subject|0|||
27566125|NCT04782856|80260182|FG001|Overall Study|Withdrawal by Subject|1|||
27566126|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
27566127|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
27566128|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
27566129|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
27566130|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
27566131|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
27566132|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
27566133|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27566134|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27566135|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27566136|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
27566137|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
27566138|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
27566139|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
27566140|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
27566141|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
27566142|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27566143|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27566144|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27566145|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
27566146|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
27566147|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
27566148|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
27566149|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
27566150|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
27566151|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27566152|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
27566153|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27566154|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27566155|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
27566156|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
27566157|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
27566158|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
27566159|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
27566160|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
27566161|NCT03373383|80260183|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
27566162|NCT03373383|80260184|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
27566163|NCT03373383|80260185|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
27566164|NCT03373383|80260186|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
27566165|NCT03373383|80260187|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
27566166|NCT03373383|80260183|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
27566167|NCT03373383|80260184|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27566168|NCT03373383|80260185|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27566169|NCT03373383|80260186|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27566170|NCT03373383|80260187|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
27566171|NCT01928862|80260188|FG000|Overall Study|Lost to Follow-up|1|||
27566172|NCT01928862|80260189|FG001|Overall Study|Lost to Follow-up|0|||
27566173|NCT01928862|80260190|FG002|Overall Study|Lost to Follow-up|0|||
27566174|NCT01928862|80260191|FG003|Overall Study|Lost to Follow-up|0|||
27566175|NCT01928862|80260192|FG004|Overall Study|Lost to Follow-up|1|||
27566176|NCT01380184|80260196|FG000|Part 1 (19 Days)|Adverse Event|1|||
27566177|NCT01380184|80260196|FG000|Part 2|Adverse Event|5|||
27566178|NCT01380184|80260196|FG000|Part 2|Disease Progression|8|||
27566179|NCT01380184|80260196|FG000|Part 2|Lost to Follow-up|1|||
27566180|NCT02945410|80260197|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27566181|NCT02945410|80260198|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
27566182|NCT02945410|80260199|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27566183|NCT02945410|80260200|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27566184|NCT02945410|80260201|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27566185|NCT02945410|80260202|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27566186|NCT02945410|80260197|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
27566187|NCT02945410|80260198|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
27566188|NCT02945410|80260199|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
27566189|NCT02945410|80260200|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
27566190|NCT02945410|80260201|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
27566191|NCT02945410|80260202|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
27566192|NCT02945410|80260197|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
27566193|NCT02945410|80260198|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
27566194|NCT02945410|80260199|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
27566195|NCT02945410|80260200|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
27566196|NCT02945410|80260201|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
27566197|NCT02945410|80260202|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
27566198|NCT00116831|80260211|FG000|Overall Study|Adverse Event|14|||
27566199|NCT00116831|80260212|FG001|Overall Study|Adverse Event|16|||
27566200|NCT00116831|80260211|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
27566201|NCT00116831|80260212|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
27566202|NCT00116831|80260211|FG000|Overall Study|Lost to Follow-up|8|||
27566203|NCT00116831|80260212|FG001|Overall Study|Lost to Follow-up|6|||
27566204|NCT00116831|80260211|FG000|Overall Study|Protocol Violation|3|||
27566205|NCT00116831|80260212|FG001|Overall Study|Protocol Violation|6|||
27566206|NCT00116831|80260211|FG000|Overall Study|Hypoglycaemic events|1|||
27566207|NCT00116831|80260212|FG001|Overall Study|Hypoglycaemic events|0|||
27566208|NCT00116831|80260211|FG000|Overall Study|Low haemoglobin on screening|1|||
27566209|NCT00116831|80260212|FG001|Overall Study|Low haemoglobin on screening|0|||
27566210|NCT00116831|80260211|FG000|Overall Study|Withdrawn investigational product|1|||
27566211|NCT00116831|80260212|FG001|Overall Study|Withdrawn investigational product|0|||
27566212|NCT00116831|80260211|FG000|Overall Study|Withdrawal by Subject|32|||
27566213|NCT00116831|80260212|FG001|Overall Study|Withdrawal by Subject|32|||
27566214|NCT00116831|80260211|FG000|Overall Study|Insufficient therapeutic effect|0|||
27566215|NCT00116831|80260212|FG001|Overall Study|Insufficient therapeutic effect|1|||
27566216|NCT00116831|80260211|FG000|Overall Study|Missing data for participant|1|||
27566217|NCT00116831|80260212|FG001|Overall Study|Missing data for participant|0|||
27566218|NCT02436759|80263208|FG000|Overall Study|Adverse Event|3|||
27566219|NCT02436759|80263209|FG001|Overall Study|Adverse Event|0|||
27566220|NCT02436759|80263208|FG000|Overall Study|Protocol Violation|1|||
27566221|NCT02436759|80263209|FG001|Overall Study|Protocol Violation|0|||
27566222|NCT02436759|80263208|FG000|Overall Study|Withdrawal by Subject|0|||
27566223|NCT02436759|80263209|FG001|Overall Study|Withdrawal by Subject|1|||
27566224|NCT03239470|80263212|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
27566225|NCT03239470|80263213|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
27566226|NCT03025828|80263214|FG000|Overall Study|Lost to Follow-up|1|||
27566227|NCT02972632|80263215|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
27566228|NCT02972632|80263215|FG000|Overall Study|Lost to Follow-up|4|||
27566229|NCT02972632|80263215|FG000|Overall Study|Voluntary Withdrawal|10|||
27566230|NCT00806546|80263216|FG000|Overall Study|Enrolled, not treated|35|||
27566231|NCT00806546|80263216|FG000|Overall Study|Lost to Follow-up|32|||
27566232|NCT00806546|80263216|FG000|Overall Study|Adverse Event|74|||
27566233|NCT00806546|80263216|FG000|Overall Study|Withdrawal by Subject|75|||
27566234|NCT00806546|80263216|FG000|Overall Study|Protocol Violation|49|||
27566235|NCT00806546|80263216|FG000|Overall Study|Various|42|||
27566236|NCT02678676|80263219|FG000|Overall Study|Death|619|||
27566237|NCT02678676|80263220|FG001|Overall Study|Death|649|||
27566238|NCT02678676|80263219|FG000|Overall Study|Withdrawal by Subject|13|||
27566239|NCT02678676|80263220|FG001|Overall Study|Withdrawal by Subject|5|||
27566240|NCT02678676|80263219|FG000|Overall Study|Lost to Follow-up|171|||
27566241|NCT02678676|80263220|FG001|Overall Study|Lost to Follow-up|151|||
27566242|NCT02678676|80263219|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
27566243|NCT02678676|80263220|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
27655664|NCT00443820|80580036|FG000|Overall Study|Lack of Efficacy|3|||
27655665|NCT00443820|80580037|FG001|Overall Study|Lack of Efficacy|2|||
27655666|NCT00443820|80580038|FG002|Overall Study|Lack of Efficacy|1|||
27655667|NCT00443820|80580039|FG003|Overall Study|Lack of Efficacy|1|||
27655668|NCT00443820|80580036|FG000|Overall Study|Protocol Violation|2|||
27655669|NCT00443820|80580037|FG001|Overall Study|Protocol Violation|1|||
27655670|NCT00443820|80580038|FG002|Overall Study|Protocol Violation|2|||
27655671|NCT00443820|80580039|FG003|Overall Study|Protocol Violation|1|||
27655672|NCT00443820|80580036|FG000|Overall Study|Withdrawal by Subject|6|||
27655673|NCT00443820|80580037|FG001|Overall Study|Withdrawal by Subject|7|||
27655674|NCT00443820|80580038|FG002|Overall Study|Withdrawal by Subject|8|||
27655675|NCT00443820|80580039|FG003|Overall Study|Withdrawal by Subject|9|||
27655676|NCT00443820|80580036|FG000|Overall Study|Lost to Follow-up|9|||
27655677|NCT00443820|80580037|FG001|Overall Study|Lost to Follow-up|8|||
27655678|NCT00443820|80580038|FG002|Overall Study|Lost to Follow-up|6|||
27655679|NCT00443820|80580039|FG003|Overall Study|Lost to Follow-up|5|||
27655680|NCT00443820|80580036|FG000|Overall Study|Administrative problems|0|||
27655681|NCT00443820|80580037|FG001|Overall Study|Administrative problems|0|||
27655682|NCT00443820|80580038|FG002|Overall Study|Administrative problems|0|||
27566244|NCT02442778|80263221|FG000|Overall Study|Adverse Event|2|||
27566245|NCT02442778|80263222|FG001|Overall Study|Adverse Event|6|||
27566246|NCT02442778|80263223|FG002|Overall Study|Adverse Event|6|||
27566247|NCT02442778|80263221|FG000|Overall Study|Death|0|||
27566248|NCT02442778|80263222|FG001|Overall Study|Death|2|||
27566249|NCT02442778|80263223|FG002|Overall Study|Death|0|||
27566250|NCT02442778|80263221|FG000|Overall Study|Lack of Efficacy|1|||
27566251|NCT02442778|80263222|FG001|Overall Study|Lack of Efficacy|0|||
27566252|NCT02442778|80263223|FG002|Overall Study|Lack of Efficacy|0|||
27566253|NCT02442778|80263221|FG000|Overall Study|Lost to Follow-up|1|||
27566254|NCT02442778|80263222|FG001|Overall Study|Lost to Follow-up|1|||
27566255|NCT02442778|80263223|FG002|Overall Study|Lost to Follow-up|1|||
27566256|NCT02442778|80263221|FG000|Overall Study|Non-compliance with study drug|2|||
27566257|NCT02442778|80263222|FG001|Overall Study|Non-compliance with study drug|0|||
27566258|NCT02442778|80263223|FG002|Overall Study|Non-compliance with study drug|1|||
27566259|NCT02442778|80263221|FG000|Overall Study|Physician Decision|1|||
27566260|NCT02442778|80263222|FG001|Overall Study|Physician Decision|1|||
27566261|NCT02442778|80263223|FG002|Overall Study|Physician Decision|1|||
27566262|NCT02442778|80263221|FG000|Overall Study|Protocol Deviation|3|||
27566263|NCT02442778|80263222|FG001|Overall Study|Protocol Deviation|0|||
27566264|NCT02442778|80263223|FG002|Overall Study|Protocol Deviation|1|||
27566265|NCT02442778|80263221|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
27566266|NCT02442778|80263222|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
27566267|NCT02442778|80263223|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
27566268|NCT02442778|80263221|FG000|Overall Study|Withdrawal by Subject|4|||
27566269|NCT02442778|80263222|FG001|Overall Study|Withdrawal by Subject|4|||
27566270|NCT02442778|80263223|FG002|Overall Study|Withdrawal by Subject|3|||
27566271|NCT02442778|80263221|FG000|Overall Study|Reason not specified|1|||
27566272|NCT02442778|80263222|FG001|Overall Study|Reason not specified|4|||
27566273|NCT02442778|80263223|FG002|Overall Study|Reason not specified|0|||
27566274|NCT02818777|80263226|FG000|Overall Study|Adverse Event|3|||
27566275|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
27566276|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
27566277|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
27566278|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
27566279|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
27566280|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
27566281|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
27566282|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
27566283|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
27566284|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
27566285|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
27566286|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
27566287|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
27566288|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
27566289|NCT03434041|80263233|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
27566290|NCT03434041|80263234|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
27566291|NCT03434041|80263233|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
27566292|NCT03434041|80263234|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
27566293|NCT03434041|80263233|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
27566294|NCT03434041|80263234|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
27566295|NCT03434041|80263233|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
27566296|NCT03434041|80263234|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
27566297|NCT02734810|80263235|FG000|Overall Study|Adverse Event|1|||
27566298|NCT02734810|80263236|FG001|Overall Study|Adverse Event|0|||
27566299|NCT02734810|80263235|FG000|Overall Study|Lack of Efficacy|1|||
27566300|NCT02734810|80263236|FG001|Overall Study|Lack of Efficacy|0|||
27566301|NCT00642668|80263238|FG000|Overall Study|Lost to Follow-up|1|||
27566302|NCT00642668|80263238|FG000|Overall Study|Adverse Event|2|||
27566303|NCT00642668|80263238|FG000|Overall Study|Death|2|||
27566304|NCT00642668|80263238|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27566305|NCT00642668|80263238|FG000|Overall Study|Failure to Return|1|||
27655683|NCT00443820|80580039|FG003|Overall Study|Administrative problems|1|||
27566306|NCT00642668|80263238|FG000|Overall Study|Dialysis Initiation|5|||
27566307|NCT00642668|80263238|FG000|Overall Study|Blood Transfusion|2|||
27566308|NCT00922766|80263240|FG000|Overall Study|Death|3|||
27566309|NCT00922766|80263240|FG000|Overall Study|Withdrawal by Subject|2|||
27566310|NCT00922766|80263240|FG000|Overall Study|Other|1|||
27566311|NCT00922766|80263240|FG000|Overall Study|Adverse Event|1|||
27566312|NCT01752855|80263243|FG000|Overall Study|Adverse Event|1|||
27566313|NCT01752855|80263244|FG001|Overall Study|Adverse Event|0|||
27566314|NCT01752855|80263243|FG000|Overall Study|Withdrew Consent|0|||
27566315|NCT01752855|80263244|FG001|Overall Study|Withdrew Consent|2|||
27566316|NCT01752855|80263243|FG000|Overall Study|Lack of Efficacy|0|||
27566317|NCT01752855|80263244|FG001|Overall Study|Lack of Efficacy|2|||
27566318|NCT01822132|80263245|FG000|Overall Study|Lost to Follow-up|4|||
27566319|NCT01822132|80263246|FG001|Overall Study|Lost to Follow-up|2|||
27566320|NCT01215227|80263247|FG000|Overall Study|Adverse Event|11|||
27566321|NCT01215227|80263248|FG001|Overall Study|Adverse Event|11|||
27566322|NCT01215227|80263249|FG002|Overall Study|Adverse Event|4|||
27566323|NCT01215227|80263250|FG003|Overall Study|Adverse Event|8|||
27566324|NCT01215227|80263251|FG004|Overall Study|Adverse Event|7|||
27566325|NCT01215227|80263252|FG005|Overall Study|Adverse Event|6|||
27566326|NCT01215227|80263247|FG000|Overall Study|Treatment Failure|8|||
27566327|NCT01215227|80263248|FG001|Overall Study|Treatment Failure|4|||
27566328|NCT01215227|80263249|FG002|Overall Study|Treatment Failure|1|||
27566329|NCT01215227|80263250|FG003|Overall Study|Treatment Failure|5|||
27566330|NCT01215227|80263251|FG004|Overall Study|Treatment Failure|1|||
27566331|NCT01215227|80263252|FG005|Overall Study|Treatment Failure|1|||
27566332|NCT01215227|80263247|FG000|Overall Study|Lost to Follow-up|1|||
27566333|NCT01215227|80263248|FG001|Overall Study|Lost to Follow-up|4|||
27566334|NCT01215227|80263249|FG002|Overall Study|Lost to Follow-up|1|||
27566335|NCT01215227|80263250|FG003|Overall Study|Lost to Follow-up|1|||
27566336|NCT01215227|80263251|FG004|Overall Study|Lost to Follow-up|1|||
27566337|NCT01215227|80263252|FG005|Overall Study|Lost to Follow-up|2|||
27566338|NCT01215227|80263247|FG000|Overall Study|Subject Withdrew Consent|16|||
27566339|NCT01215227|80263248|FG001|Overall Study|Subject Withdrew Consent|20|||
27566340|NCT01215227|80263249|FG002|Overall Study|Subject Withdrew Consent|7|||
27655684|NCT00443820|80580036|FG000|Overall Study|Death|0|||
27655685|NCT00443820|80580037|FG001|Overall Study|Death|0|||
27655686|NCT00443820|80580038|FG002|Overall Study|Death|1|||
27655687|NCT00443820|80580039|FG003|Overall Study|Death|0|||
27655688|NCT04271254|80580040|FG000|Overall Study|Withdrawal by Subject|3|||
27655689|NCT01261793|80580047|FG000|Overall Study|Lack of Efficacy|44|||
27655690|NCT01261793|80580048|FG001|Overall Study|Lack of Efficacy|37|||
27655691|NCT01261793|80580049|FG002|Overall Study|Lack of Efficacy|32|||
27655692|NCT01261793|80580047|FG000|Overall Study|Protocol Violation|3|||
27655693|NCT01261793|80580048|FG001|Overall Study|Protocol Violation|5|||
27655694|NCT01261793|80580049|FG002|Overall Study|Protocol Violation|6|||
27655695|NCT01261793|80580047|FG000|Overall Study|Lost to Follow-up|10|||
27655696|NCT01261793|80580048|FG001|Overall Study|Lost to Follow-up|3|||
27655697|NCT01261793|80580049|FG002|Overall Study|Lost to Follow-up|7|||
27655698|NCT01261793|80580047|FG000|Overall Study|Withdrawal by Subject|12|||
27655699|NCT01261793|80580048|FG001|Overall Study|Withdrawal by Subject|14|||
27655700|NCT01261793|80580049|FG002|Overall Study|Withdrawal by Subject|14|||
27655701|NCT01261793|80580047|FG000|Overall Study|Death|3|||
27655702|NCT01261793|80580048|FG001|Overall Study|Death|1|||
27655703|NCT01261793|80580049|FG002|Overall Study|Death|0|||
27655704|NCT01261793|80580047|FG000|Overall Study|Adverse Event|9|||
27655705|NCT01261793|80580048|FG001|Overall Study|Adverse Event|24|||
27655706|NCT01261793|80580049|FG002|Overall Study|Adverse Event|19|||
27655707|NCT01261793|80580047|FG000|Overall Study|Patient non-availability|1|||
27655708|NCT01261793|80580048|FG001|Overall Study|Patient non-availability|1|||
27655709|NCT01261793|80580049|FG002|Overall Study|Patient non-availability|1|||
27655710|NCT01261793|80580047|FG000|Overall Study|Suspected pregnancy|1|||
27655711|NCT01261793|80580048|FG001|Overall Study|Suspected pregnancy|1|||
27655712|NCT01261793|80580049|FG002|Overall Study|Suspected pregnancy|0|||
27655713|NCT01261793|80580047|FG000|Overall Study|Patient non-compliance|1|||
27655714|NCT01261793|80580048|FG001|Overall Study|Patient non-compliance|0|||
27655715|NCT01261793|80580049|FG002|Overall Study|Patient non-compliance|1|||
27655716|NCT01261793|80580047|FG000|Overall Study|Patient pregnant|1|||
27566341|NCT01215227|80263250|FG003|Overall Study|Subject Withdrew Consent|10|||
27566342|NCT01215227|80263251|FG004|Overall Study|Subject Withdrew Consent|11|||
27566343|NCT01215227|80263252|FG005|Overall Study|Subject Withdrew Consent|8|||
27655717|NCT01261793|80580048|FG001|Overall Study|Patient pregnant|0|||
27655718|NCT01261793|80580049|FG002|Overall Study|Patient pregnant|0|||
27655719|NCT01261793|80580047|FG000|Overall Study|Outside the study area|0|||
27655720|NCT01261793|80580048|FG001|Overall Study|Outside the study area|2|||
27655721|NCT01261793|80580049|FG002|Overall Study|Outside the study area|1|||
27655722|NCT01261793|80580047|FG000|Overall Study|Lack of efficacy & patient not available|0|||
27566344|NCT01215227|80263247|FG000|Overall Study|Non-Compliance With Protocol|2|||
27566345|NCT01215227|80263248|FG001|Overall Study|Non-Compliance With Protocol|6|||
27655723|NCT01261793|80580048|FG001|Overall Study|Lack of efficacy & patient not available|1|||
27655724|NCT01261793|80580049|FG002|Overall Study|Lack of efficacy & patient not available|0|||
27655725|NCT01261793|80580047|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
27655726|NCT01261793|80580048|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
27655727|NCT01261793|80580049|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
27655728|NCT01261793|80580047|FG000|Overall Study|Randomization error|0|||
27655729|NCT01261793|80580048|FG001|Overall Study|Randomization error|1|||
27655730|NCT01261793|80580049|FG002|Overall Study|Randomization error|0|||
27655731|NCT01261793|80580047|FG000|Overall Study|Patient unable to start IV line|0|||
27655732|NCT01261793|80580048|FG001|Overall Study|Patient unable to start IV line|0|||
27655733|NCT01261793|80580049|FG002|Overall Study|Patient unable to start IV line|1|||
27655734|NCT00472082|80580050|FG000|Overall Study|Study prematurely terminated|5|||
27655735|NCT03034772|80580051|FG000|Overall Study|Adverse Event|0|||
27655736|NCT03034772|80580052|FG001|Overall Study|Adverse Event|1|||
27655737|NCT03034772|80580051|FG000|Overall Study|Withdrawal by Subject|0|||
27655738|NCT03034772|80580052|FG001|Overall Study|Withdrawal by Subject|1|||
27655739|NCT00157209|80580056|FG000|Overall Study|Ongoing at data cut-off|10|||
27655740|NCT00157209|80580057|FG001|Overall Study|Ongoing at data cut-off|0|||
27655741|NCT01562275|80580058|FG000|Stage 1|Adverse Event|0|||
27655742|NCT01562275|80580059|FG001|Stage 1|Adverse Event|0|||
27655743|NCT01562275|80580060|FG002|Stage 1|Adverse Event|0|||
27655744|NCT01562275|80580061|FG003|Stage 1|Adverse Event|1|||
27655745|NCT01562275|80580062|FG004|Stage 1|Adverse Event|1|||
27655746|NCT01562275|80580063|FG005|Stage 1|Adverse Event|0|||
27655747|NCT01562275|80580064|FG006|Stage 1|Adverse Event|0|||
27655748|NCT01562275|80580065|FG007|Stage 1|Adverse Event|0|||
27655749|NCT01562275|80580066|FG008|Stage 1|Adverse Event|0|||
27655750|NCT01562275|80580067|FG009|Stage 1|Adverse Event|1|||
27655751|NCT01562275|80580068|FG010|Stage 1|Adverse Event|0|||
27655752|NCT01562275|80580069|FG011|Stage 1|Adverse Event|0|||
27655753|NCT01562275|80580070|FG012|Stage 1|Adverse Event|0|||
27655754|NCT01562275|80580058|FG000|Stage 1|Death|1|||
27655755|NCT01562275|80580059|FG001|Stage 1|Death|0|||
27655756|NCT01562275|80580060|FG002|Stage 1|Death|0|||
27655757|NCT01562275|80580061|FG003|Stage 1|Death|0|||
27655758|NCT01562275|80580062|FG004|Stage 1|Death|0|||
27655759|NCT01562275|80580063|FG005|Stage 1|Death|0|||
27655760|NCT01562275|80580064|FG006|Stage 1|Death|0|||
27566346|NCT01215227|80263249|FG002|Overall Study|Non-Compliance With Protocol|1|||
27566347|NCT01215227|80263250|FG003|Overall Study|Non-Compliance With Protocol|0|||
27566348|NCT01215227|80263251|FG004|Overall Study|Non-Compliance With Protocol|0|||
27566349|NCT01215227|80263252|FG005|Overall Study|Non-Compliance With Protocol|0|||
27566350|NCT01215227|80263247|FG000|Overall Study|Administrative|83|||
27566351|NCT01215227|80263248|FG001|Overall Study|Administrative|73|||
27566352|NCT01215227|80263249|FG002|Overall Study|Administrative|42|||
27566353|NCT01215227|80263250|FG003|Overall Study|Administrative|24|||
27566354|NCT01215227|80263251|FG004|Overall Study|Administrative|28|||
27566355|NCT01215227|80263252|FG005|Overall Study|Administrative|40|||
27566356|NCT01215227|80263247|FG000|Overall Study|Missing Status|0|||
27566357|NCT01215227|80263248|FG001|Overall Study|Missing Status|1|||
27566358|NCT01215227|80263249|FG002|Overall Study|Missing Status|0|||
27566359|NCT01215227|80263250|FG003|Overall Study|Missing Status|0|||
27566360|NCT01215227|80263251|FG004|Overall Study|Missing Status|0|||
27566361|NCT01215227|80263252|FG005|Overall Study|Missing Status|0|||
27566362|NCT01215227|80263247|FG000|Overall Study|Randomized but not treated|0|||
27566363|NCT01215227|80263248|FG001|Overall Study|Randomized but not treated|0|||
27566364|NCT01215227|80263249|FG002|Overall Study|Randomized but not treated|1|||
27566365|NCT01215227|80263250|FG003|Overall Study|Randomized but not treated|1|||
27566366|NCT01215227|80263251|FG004|Overall Study|Randomized but not treated|0|||
27566367|NCT01215227|80263252|FG005|Overall Study|Randomized but not treated|1|||
27566368|NCT04327986|80263255|FG000|Overall Study|Physician Decision|2|||
27566369|NCT04327986|80263256|FG001|Overall Study|Physician Decision|0|||
27566370|NCT04327986|80263257|FG002|Overall Study|Physician Decision|0|||
27566371|NCT04327986|80263255|FG000|Overall Study|Death|1|||
27566372|NCT04327986|80263256|FG001|Overall Study|Death|0|||
27566373|NCT04327986|80263257|FG002|Overall Study|Death|0|||
27566374|NCT00573755|80263258|FG000|Overall Study|Still receiving treatment|1|||
27566375|NCT00573755|80263259|FG001|Overall Study|Still receiving treatment|0|||
27566376|NCT00218296|80263264|FG000|Overall Study|Lost to Follow-up|9|||
27566377|NCT00218296|80263265|FG001|Overall Study|Lost to Follow-up|7|||
27566378|NCT00218296|80263264|FG000|Overall Study|Withdrawal by Subject|36|||
27566379|NCT00218296|80263265|FG001|Overall Study|Withdrawal by Subject|47|||
27655761|NCT01562275|80580065|FG007|Stage 1|Death|0|||
27655762|NCT01562275|80580066|FG008|Stage 1|Death|0|||
27655763|NCT01562275|80580067|FG009|Stage 1|Death|0|||
27655764|NCT01562275|80580068|FG010|Stage 1|Death|0|||
27655765|NCT01562275|80580069|FG011|Stage 1|Death|0|||
27566380|NCT00218296|80263264|FG000|Overall Study|Randomized but did not enter treatment|66|||
27655766|NCT01562275|80580070|FG012|Stage 1|Death|0|||
27655767|NCT01562275|80580058|FG000|Stage 1|Non Compliance|0|||
27655768|NCT01562275|80580059|FG001|Stage 1|Non Compliance|0|||
27655769|NCT01562275|80580060|FG002|Stage 1|Non Compliance|1|||
27566381|NCT00218296|80263265|FG001|Overall Study|Randomized but did not enter treatment|67|||
27566382|NCT01806896|80263266|FG000|Overall Study|Adverse Event|2|||
27566383|NCT01806896|80263267|FG001|Overall Study|Adverse Event|0|||
27566384|NCT01806896|80263266|FG000|Overall Study|Other|1|||
27566385|NCT01806896|80263267|FG001|Overall Study|Other|0|||
27566386|NCT00006489|80263270|FG000|Overall Study|Adverse Event|3|||
27566387|NCT00006489|80263271|FG001|Overall Study|Adverse Event|2|||
27566388|NCT00006489|80263272|FG002|Overall Study|Adverse Event|4|||
27566389|NCT00006489|80263273|FG003|Overall Study|Adverse Event|3|||
27566390|NCT00006489|80263270|FG000|Overall Study|Withdrawal by Subject|10|||
27566391|NCT00006489|80263271|FG001|Overall Study|Withdrawal by Subject|9|||
27566392|NCT00006489|80263272|FG002|Overall Study|Withdrawal by Subject|9|||
27566393|NCT00006489|80263273|FG003|Overall Study|Withdrawal by Subject|6|||
27566394|NCT00006489|80263270|FG000|Overall Study|Scheduling Conflict|0|||
27566395|NCT00006489|80263271|FG001|Overall Study|Scheduling Conflict|3|||
27566396|NCT00006489|80263272|FG002|Overall Study|Scheduling Conflict|2|||
27566397|NCT00006489|80263273|FG003|Overall Study|Scheduling Conflict|1|||
27566398|NCT00006489|80263270|FG000|Overall Study|Death|0|||
27566399|NCT00006489|80263271|FG001|Overall Study|Death|0|||
27566400|NCT00006489|80263272|FG002|Overall Study|Death|0|||
27566401|NCT00006489|80263273|FG003|Overall Study|Death|1|||
27566402|NCT02586493|80263274|FG000|Overall Study|Adverse Event|4|||
27566403|NCT02586493|80263274|FG000|Overall Study|Protocol Violation|6|||
27566404|NCT02586493|80263274|FG000|Overall Study|Lost to Follow-up|1|||
27566405|NCT02586493|80263274|FG000|Overall Study|Withdrawal by Subject|1|||
27566406|NCT02276612|80263275|FG000|Overall Study|Death|1|||
27566407|NCT02276612|80263276|FG001|Overall Study|Death|0|||
27566408|NCT02276612|80263275|FG000|Overall Study|Pregnancy|1|||
27566409|NCT02276612|80263276|FG001|Overall Study|Pregnancy|0|||
27566410|NCT02276612|80263275|FG000|Overall Study|Withdrew Consent|1|||
27566411|NCT02276612|80263276|FG001|Overall Study|Withdrew Consent|0|||
27566412|NCT02276612|80263275|FG000|Overall Study|Lost to Follow-up|1|||
27566413|NCT02276612|80263276|FG001|Overall Study|Lost to Follow-up|0|||
27566414|NCT02013167|80263277|FG000|Overall Study|Withdrawal by Subject|15|||
27566415|NCT02013167|80263278|FG001|Overall Study|Withdrawal by Subject|14|||
27566416|NCT02013167|80263277|FG000|Overall Study|Sponsor Decision|1|||
27566417|NCT02013167|80263278|FG001|Overall Study|Sponsor Decision|3|||
27566418|NCT02013167|80263277|FG000|Overall Study|Lost to Follow-up|0|||
27566419|NCT02013167|80263278|FG001|Overall Study|Lost to Follow-up|1|||
27566420|NCT02013167|80263277|FG000|Overall Study|Death|85|||
27566421|NCT02013167|80263278|FG001|Overall Study|Death|160|||
27566422|NCT01398956|80263279|FG000|Overall Study|Withdrawal by Subject|4|||
27566423|NCT01398956|80263279|FG000|Overall Study|AE, non-serious non-fatal|4|||
27566424|NCT01398956|80263279|FG000|Overall Study|Withdrawal Criteria No.3|1|||
27566425|NCT01398956|80263279|FG000|Overall Study|Subject moved a long distance|1|||
27566426|NCT00694369|80263280|FG000|Overall Study|Adverse Event|0|||
27566427|NCT00694369|80263281|FG001|Overall Study|Adverse Event|1|||
27566428|NCT00694369|80263282|FG002|Overall Study|Adverse Event|0|||
27566429|NCT00694369|80263283|FG003|Overall Study|Adverse Event|1|||
27566430|NCT00694369|80263284|FG004|Overall Study|Adverse Event|3|||
27566431|NCT00694369|80263280|FG000|Overall Study|Lost to Follow-up|0|||
27566432|NCT00694369|80263281|FG001|Overall Study|Lost to Follow-up|0|||
27566433|NCT00694369|80263282|FG002|Overall Study|Lost to Follow-up|1|||
27566434|NCT00694369|80263283|FG003|Overall Study|Lost to Follow-up|1|||
27566435|NCT00694369|80263284|FG004|Overall Study|Lost to Follow-up|0|||
27566436|NCT00694369|80263280|FG000|Overall Study|Physician Decision|0|||
27566437|NCT00694369|80263281|FG001|Overall Study|Physician Decision|0|||
27566438|NCT00694369|80263282|FG002|Overall Study|Physician Decision|0|||
27566439|NCT00694369|80263283|FG003|Overall Study|Physician Decision|0|||
27566440|NCT00694369|80263284|FG004|Overall Study|Physician Decision|1|||
27566441|NCT00694369|80263280|FG000|Overall Study|Protocol Violation|0|||
27566442|NCT00694369|80263281|FG001|Overall Study|Protocol Violation|1|||
27566443|NCT00694369|80263282|FG002|Overall Study|Protocol Violation|0|||
27566444|NCT00694369|80263283|FG003|Overall Study|Protocol Violation|0|||
27566445|NCT00694369|80263284|FG004|Overall Study|Protocol Violation|0|||
27566446|NCT00694369|80263280|FG000|Overall Study|Withdrawal by Subject|1|||
27566447|NCT00694369|80263281|FG001|Overall Study|Withdrawal by Subject|1|||
27566448|NCT00694369|80263282|FG002|Overall Study|Withdrawal by Subject|1|||
27566449|NCT00694369|80263283|FG003|Overall Study|Withdrawal by Subject|1|||
27566450|NCT00694369|80263284|FG004|Overall Study|Withdrawal by Subject|2|||
27566451|NCT01293240|80263286|FG000|Overall Study|Noncompliance|2|||
27566452|NCT02871739|80263313|FG000|Overall Study|Lost to Follow-up|3|||
27566453|NCT02871739|80263314|FG001|Overall Study|Lost to Follow-up|2|||
27566454|NCT02871739|80263315|FG002|Overall Study|Lost to Follow-up|0|||
27566455|NCT02871739|80263316|FG003|Overall Study|Lost to Follow-up|2|||
27566456|NCT02174848|80263323|FG000|Overall Study|Adverse Event|2|||
27566457|NCT02174848|80263324|FG001|Overall Study|Adverse Event|1|||
27566458|NCT02174848|80263323|FG000|Overall Study|Withdrawal by Subject|3|||
27566459|NCT02174848|80263324|FG001|Overall Study|Withdrawal by Subject|3|||
27566460|NCT02174848|80263323|FG000|Overall Study|Lost to Follow-up|0|||
27566461|NCT02174848|80263324|FG001|Overall Study|Lost to Follow-up|1|||
27566462|NCT02174848|80263323|FG000|Overall Study|Worsening of disease|1|||
27566463|NCT02174848|80263324|FG001|Overall Study|Worsening of disease|1|||
27566464|NCT02174848|80263323|FG000|Overall Study|Unable to comply with study requirements|1|||
27566465|NCT02174848|80263324|FG001|Overall Study|Unable to comply with study requirements|0|||
27566466|NCT01527292|80263325|FG000|Overall Study|Physician Decision|0|||
27566467|NCT01527292|80263326|FG001|Overall Study|Physician Decision|3|||
27566468|NCT02603432|80263327|FG000|Overall Study|Adverse Event|1|||
27566469|NCT02603432|80263328|FG001|Overall Study|Adverse Event|0|||
27566470|NCT02603432|80263327|FG000|Overall Study|Death|221|||
27566471|NCT02603432|80263328|FG001|Overall Study|Death|242|||
27566472|NCT02603432|80263327|FG000|Overall Study|Lost to Follow-up|3|||
27566473|NCT02603432|80263328|FG001|Overall Study|Lost to Follow-up|9|||
27566474|NCT02603432|80263327|FG000|Overall Study|Progressive Disease|7|||
27566475|NCT02603432|80263328|FG001|Overall Study|Progressive Disease|5|||
27566476|NCT02603432|80263327|FG000|Overall Study|Withdrawal by Subject|12|||
27566477|NCT02603432|80263328|FG001|Overall Study|Withdrawal by Subject|18|||
27566478|NCT02603432|80263327|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
27566479|NCT02603432|80263328|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27566480|NCT02603432|80263327|FG000|Overall Study|Study terminated by sponsor|74|||
27566481|NCT02603432|80263328|FG001|Overall Study|Study terminated by sponsor|75|||
27566482|NCT02603432|80263327|FG000|Overall Study|Other|13|||
27566483|NCT02603432|80263328|FG001|Overall Study|Other|0|||
27566484|NCT00578175|80263329|FG000|Overall Study|Adverse Event|0|||
27566485|NCT00578175|80263330|FG001|Overall Study|Adverse Event|1|||
27566486|NCT00578175|80263331|FG002|Overall Study|Adverse Event|1|||
27566487|NCT00578175|80263329|FG000|Overall Study|Other reasons|70|||
27566488|NCT00578175|80263330|FG001|Overall Study|Other reasons|42|||
27566489|NCT00578175|80263331|FG002|Overall Study|Other reasons|23|||
27566490|NCT02579265|80263332|FG000|Overall Study|Weaned off earlier than 28 days|44|||
27566491|NCT02579265|80263333|FG001|Overall Study|Weaned off earlier than 28 days|43|||
27655770|NCT01562275|80580061|FG003|Stage 1|Non Compliance|0|||
27655771|NCT01562275|80580062|FG004|Stage 1|Non Compliance|0|||
27655772|NCT01562275|80580063|FG005|Stage 1|Non Compliance|0|||
27655773|NCT01562275|80580064|FG006|Stage 1|Non Compliance|0|||
27655774|NCT01562275|80580065|FG007|Stage 1|Non Compliance|0|||
27655775|NCT01562275|80580066|FG008|Stage 1|Non Compliance|0|||
27655776|NCT01562275|80580067|FG009|Stage 1|Non Compliance|0|||
27655777|NCT01562275|80580068|FG010|Stage 1|Non Compliance|0|||
27655778|NCT01562275|80580069|FG011|Stage 1|Non Compliance|0|||
27655779|NCT01562275|80580070|FG012|Stage 1|Non Compliance|0|||
27655780|NCT01562275|80580058|FG000|Stage 1|Physician Decision|0|||
27655781|NCT01562275|80580059|FG001|Stage 1|Physician Decision|0|||
27655782|NCT01562275|80580060|FG002|Stage 1|Physician Decision|0|||
27655783|NCT01562275|80580061|FG003|Stage 1|Physician Decision|0|||
27655784|NCT01562275|80580062|FG004|Stage 1|Physician Decision|1|||
27655785|NCT01562275|80580063|FG005|Stage 1|Physician Decision|0|||
27655786|NCT01562275|80580064|FG006|Stage 1|Physician Decision|1|||
27655787|NCT01562275|80580065|FG007|Stage 1|Physician Decision|0|||
27655788|NCT01562275|80580066|FG008|Stage 1|Physician Decision|1|||
27655789|NCT01562275|80580067|FG009|Stage 1|Physician Decision|0|||
27655790|NCT01562275|80580068|FG010|Stage 1|Physician Decision|0|||
27655791|NCT01562275|80580069|FG011|Stage 1|Physician Decision|0|||
27655792|NCT01562275|80580070|FG012|Stage 1|Physician Decision|0|||
27655793|NCT01562275|80580058|FG000|Stage 1|Progression of Disease|2|||
27655794|NCT01562275|80580059|FG001|Stage 1|Progression of Disease|6|||
27655795|NCT01562275|80580060|FG002|Stage 1|Progression of Disease|2|||
27655796|NCT01562275|80580061|FG003|Stage 1|Progression of Disease|1|||
27655797|NCT01562275|80580062|FG004|Stage 1|Progression of Disease|2|||
27655798|NCT01562275|80580063|FG005|Stage 1|Progression of Disease|4|||
27655799|NCT01562275|80580064|FG006|Stage 1|Progression of Disease|1|||
27655800|NCT01562275|80580065|FG007|Stage 1|Progression of Disease|7|||
27655801|NCT01562275|80580066|FG008|Stage 1|Progression of Disease|2|||
27655802|NCT01562275|80580067|FG009|Stage 1|Progression of Disease|5|||
27655803|NCT01562275|80580068|FG010|Stage 1|Progression of Disease|3|||
27655804|NCT01562275|80580069|FG011|Stage 1|Progression of Disease|0|||
27655805|NCT01562275|80580070|FG012|Stage 1|Progression of Disease|0|||
27655806|NCT01562275|80580058|FG000|Stage 1|Withdrawal by Subject|0|||
27655807|NCT01562275|80580059|FG001|Stage 1|Withdrawal by Subject|1|||
27655808|NCT01562275|80580060|FG002|Stage 1|Withdrawal by Subject|0|||
27655809|NCT01562275|80580061|FG003|Stage 1|Withdrawal by Subject|2|||
27655810|NCT01562275|80580062|FG004|Stage 1|Withdrawal by Subject|0|||
27655811|NCT01562275|80580063|FG005|Stage 1|Withdrawal by Subject|0|||
27566492|NCT02579265|80263332|FG000|Overall Study|Adverse Event|2|||
27566493|NCT02579265|80263333|FG001|Overall Study|Adverse Event|0|||
27655812|NCT01562275|80580064|FG006|Stage 1|Withdrawal by Subject|1|||
27655813|NCT01562275|80580065|FG007|Stage 1|Withdrawal by Subject|0|||
27655814|NCT01562275|80580066|FG008|Stage 1|Withdrawal by Subject|0|||
27655815|NCT01562275|80580067|FG009|Stage 1|Withdrawal by Subject|1|||
27655816|NCT01562275|80580068|FG010|Stage 1|Withdrawal by Subject|0|||
27655817|NCT01562275|80580069|FG011|Stage 1|Withdrawal by Subject|0|||
27655818|NCT01562275|80580070|FG012|Stage 1|Withdrawal by Subject|0|||
27655819|NCT01562275|80580058|FG000|Stage 2|Death|0|||
27655820|NCT01562275|80580059|FG001|Stage 2|Death|0|||
27655821|NCT01562275|80580060|FG002|Stage 2|Death|0|||
27655822|NCT01562275|80580061|FG003|Stage 2|Death|0|||
27655823|NCT01562275|80580062|FG004|Stage 2|Death|0|||
27655824|NCT01562275|80580063|FG005|Stage 2|Death|0|||
27655825|NCT01562275|80580064|FG006|Stage 2|Death|0|||
27655826|NCT01562275|80580065|FG007|Stage 2|Death|0|||
27655827|NCT01562275|80580066|FG008|Stage 2|Death|0|||
27655828|NCT01562275|80580067|FG009|Stage 2|Death|0|||
27655829|NCT01562275|80580068|FG010|Stage 2|Death|0|||
27655830|NCT01562275|80580069|FG011|Stage 2|Death|2|||
27655831|NCT01562275|80580070|FG012|Stage 2|Death|1|||
27655832|NCT01562275|80580058|FG000|Stage 2|Progression of Disease|0|||
27655833|NCT01562275|80580059|FG001|Stage 2|Progression of Disease|0|||
27655834|NCT01562275|80580060|FG002|Stage 2|Progression of Disease|0|||
27655835|NCT01562275|80580061|FG003|Stage 2|Progression of Disease|0|||
27655836|NCT01562275|80580062|FG004|Stage 2|Progression of Disease|0|||
27655837|NCT01562275|80580063|FG005|Stage 2|Progression of Disease|0|||
27655838|NCT01562275|80580064|FG006|Stage 2|Progression of Disease|0|||
27655839|NCT01562275|80580065|FG007|Stage 2|Progression of Disease|0|||
27655840|NCT01562275|80580066|FG008|Stage 2|Progression of Disease|0|||
27655841|NCT01562275|80580067|FG009|Stage 2|Progression of Disease|0|||
27655842|NCT01562275|80580068|FG010|Stage 2|Progression of Disease|0|||
27655843|NCT01562275|80580069|FG011|Stage 2|Progression of Disease|12|||
27655844|NCT01562275|80580070|FG012|Stage 2|Progression of Disease|4|||
27655845|NCT01241448|80580071|FG000|Overall Study|Adverse Event|1|||
27655846|NCT01241448|80580072|FG001|Overall Study|Adverse Event|0|||
27655847|NCT01241448|80580073|FG002|Overall Study|Adverse Event|2|||
27655848|NCT01241448|80580074|FG003|Overall Study|Adverse Event|2|||
27655849|NCT01241448|80580071|FG000|Overall Study|Lost to Follow-up|2|||
27655850|NCT01241448|80580072|FG001|Overall Study|Lost to Follow-up|1|||
27655851|NCT01241448|80580073|FG002|Overall Study|Lost to Follow-up|1|||
27655852|NCT01241448|80580074|FG003|Overall Study|Lost to Follow-up|1|||
27655853|NCT01241448|80580071|FG000|Overall Study|Physician Decision|0|||
27655854|NCT01241448|80580072|FG001|Overall Study|Physician Decision|2|||
27655855|NCT01241448|80580073|FG002|Overall Study|Physician Decision|0|||
27655856|NCT01241448|80580074|FG003|Overall Study|Physician Decision|0|||
27655857|NCT01241448|80580071|FG000|Overall Study|Protocol Violation|10|||
27655858|NCT01241448|80580072|FG001|Overall Study|Protocol Violation|5|||
27655859|NCT01241448|80580073|FG002|Overall Study|Protocol Violation|3|||
27655860|NCT01241448|80580074|FG003|Overall Study|Protocol Violation|6|||
27655861|NCT01241448|80580071|FG000|Overall Study|Sponsor Decision|17|||
27655862|NCT01241448|80580072|FG001|Overall Study|Sponsor Decision|14|||
27655863|NCT01241448|80580073|FG002|Overall Study|Sponsor Decision|12|||
27655864|NCT01241448|80580074|FG003|Overall Study|Sponsor Decision|6|||
27655865|NCT01241448|80580071|FG000|Overall Study|Withdrawal by Subject|4|||
27655866|NCT01241448|80580072|FG001|Overall Study|Withdrawal by Subject|5|||
27655867|NCT01241448|80580073|FG002|Overall Study|Withdrawal by Subject|3|||
27655868|NCT01241448|80580074|FG003|Overall Study|Withdrawal by Subject|6|||
27655869|NCT01241448|80580071|FG000|Overall Study|Excluded due to data integrity issues|3|||
27655870|NCT01241448|80580072|FG001|Overall Study|Excluded due to data integrity issues|2|||
27655871|NCT01241448|80580073|FG002|Overall Study|Excluded due to data integrity issues|2|||
27655872|NCT01241448|80580074|FG003|Overall Study|Excluded due to data integrity issues|2|||
27655873|NCT04743999|80580080|FG000|3-month Questionnaire|Death|1|||
27655874|NCT04743999|80580080|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
27655875|NCT04743999|80580080|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
27655876|NCT04743999|80580080|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
27655877|NCT00663923|80580088|FG000|Overall Study|Lost to Follow-up|2|||
27655878|NCT01207453|80580089|FG000|First Intervention|Adverse Event|2|||
27655879|NCT01207453|80580090|FG001|First Intervention|Adverse Event|1|||
27655880|NCT01207453|80580089|FG000|Washout|Adverse Event|1|||
27655881|NCT01207453|80580090|FG001|Washout|Adverse Event|0|||
27655882|NCT01207453|80580089|FG000|Washout|Lost to Follow-up|1|||
27655883|NCT01207453|80580090|FG001|Washout|Lost to Follow-up|0|||
27655884|NCT01207453|80580089|FG000|2nd Intervention|Adverse Event|1|||
27655885|NCT01207453|80580090|FG001|2nd Intervention|Adverse Event|2|||
27655886|NCT01207453|80580089|FG000|2nd Intervention|Lost to Follow-up|1|||
27655887|NCT01207453|80580090|FG001|2nd Intervention|Lost to Follow-up|0|||
27655888|NCT00379210|80580097|FG000|Overall Study|Withdrawal by Subject|10|||
27655889|NCT00379210|80580098|FG001|Overall Study|Withdrawal by Subject|7|||
27655890|NCT01123356|80580099|FG000|Overall Study|Adverse Event|2|||
27655891|NCT01123356|80580099|FG000|Overall Study|Lack of Efficacy|4|||
27655892|NCT01123356|80580099|FG000|Overall Study|Withdrawal by Subject|1|||
27655893|NCT01912599|80580100|FG000|Overall Study|Withdrawal by Subject|0|||
27655894|NCT01912599|80580101|FG001|Overall Study|Withdrawal by Subject|1|||
27655895|NCT00848198|80580102|FG000|Overall Study|Incomplete Case Report Forms|15|||
27655896|NCT01075815|80580108|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
27655897|NCT01075815|80580109|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
27655898|NCT01075815|80580108|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
27655899|NCT01075815|80580109|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
27655900|NCT01075815|80580108|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
27655901|NCT01075815|80580109|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
27655902|NCT00409747|80580115|FG000|Overall Study|Withdrawal by Subject|1|||
27655903|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
27655904|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
27655905|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
27655906|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
27655907|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
27655908|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
27655909|NCT03557307|80580116|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
27655910|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
27655911|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|Death|3|||
27655912|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
27655913|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
27655914|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
27655915|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
27655916|NCT03557307|80580116|FG000|Period 2: Maintenance Phase|other|3|||
27655917|NCT03394508|80580117|FG000|Overall Study|Protocol Violation|0|||
27655918|NCT03394508|80580118|FG001|Overall Study|Protocol Violation|3|||
27655919|NCT03394508|80580117|FG000|Overall Study|Lost to Follow-up|1|||
27655920|NCT03394508|80580118|FG001|Overall Study|Lost to Follow-up|0|||
27655921|NCT02205476|80580121|FG000|Overall Study|Study termination by Sponsor|7|||
27655922|NCT02205476|80580122|FG001|Overall Study|Study termination by Sponsor|3|||
27655923|NCT02604199|80580124|FG000|Overall Study|Pregnancy|0|||
27655924|NCT02604199|80580125|FG001|Overall Study|Pregnancy|0|||
27655925|NCT02604199|80580126|FG002|Overall Study|Pregnancy|0|||
27655926|NCT02604199|80580127|FG003|Overall Study|Pregnancy|1|||
27655927|NCT02604199|80580124|FG000|Overall Study|Study terminated by sponsor|0|||
27655928|NCT02604199|80580125|FG001|Overall Study|Study terminated by sponsor|2|||
27655929|NCT02604199|80580126|FG002|Overall Study|Study terminated by sponsor|0|||
27655930|NCT02604199|80580127|FG003|Overall Study|Study terminated by sponsor|2|||
27655931|NCT02604199|80580124|FG000|Overall Study|Withdrawal by Subject|0|||
27655932|NCT02604199|80580125|FG001|Overall Study|Withdrawal by Subject|1|||
27655933|NCT02604199|80580126|FG002|Overall Study|Withdrawal by Subject|0|||
27655934|NCT02604199|80580127|FG003|Overall Study|Withdrawal by Subject|0|||
27655935|NCT02203513|80580128|FG000|Overall Study|Refused further treatment|2|||
27655936|NCT02203513|80580129|FG001|Overall Study|Refused further treatment|0|||
27655937|NCT02203513|80580130|FG002|Overall Study|Refused further treatment|1|||
27655938|NCT02203513|80580131|FG003|Overall Study|Refused further treatment|0|||
27655939|NCT02203513|80580132|FG004|Overall Study|Refused further treatment|0|||
27655940|NCT02203513|80580128|FG000|Overall Study|Switched to alternative treatment|3|||
27655941|NCT02203513|80580129|FG001|Overall Study|Switched to alternative treatment|4|||
27655942|NCT02203513|80580130|FG002|Overall Study|Switched to alternative treatment|0|||
27655943|NCT02203513|80580131|FG003|Overall Study|Switched to alternative treatment|0|||
27655944|NCT02203513|80580132|FG004|Overall Study|Switched to alternative treatment|4|||
27655945|NCT02203513|80580128|FG000|Overall Study|Did not receive investigational product (IP)|0|||
27655946|NCT02203513|80580129|FG001|Overall Study|Did not receive investigational product (IP)|1|||
27655947|NCT02203513|80580130|FG002|Overall Study|Did not receive investigational product (IP)|0|||
27655948|NCT02203513|80580131|FG003|Overall Study|Did not receive investigational product (IP)|0|||
27655949|NCT02203513|80580132|FG004|Overall Study|Did not receive investigational product (IP)|0|||
27655950|NCT02203513|80580128|FG000|Overall Study|Death (unrelated to study therapy)|1|||
27655951|NCT02203513|80580129|FG001|Overall Study|Death (unrelated to study therapy)|3|||
27655952|NCT02203513|80580130|FG002|Overall Study|Death (unrelated to study therapy)|1|||
27655953|NCT02203513|80580131|FG003|Overall Study|Death (unrelated to study therapy)|0|||
27655954|NCT02203513|80580132|FG004|Overall Study|Death (unrelated to study therapy)|2|||
27655955|NCT02203513|80580128|FG000|Overall Study|Lost to Follow-up|0|||
27655956|NCT02203513|80580129|FG001|Overall Study|Lost to Follow-up|0|||
27655957|NCT02203513|80580130|FG002|Overall Study|Lost to Follow-up|1|||
27655958|NCT02203513|80580131|FG003|Overall Study|Lost to Follow-up|1|||
27655959|NCT02203513|80580132|FG004|Overall Study|Lost to Follow-up|0|||
27655960|NCT00905255|80580135|FG000|Overall Study|Adverse Event|7|||
27655961|NCT00905255|80580136|FG001|Overall Study|Adverse Event|5|||
27655962|NCT00905255|80580135|FG000|Overall Study|Withdrawal by Subject|5|||
27655963|NCT00905255|80580136|FG001|Overall Study|Withdrawal by Subject|4|||
27655964|NCT00905255|80580135|FG000|Overall Study|Familial and Personal Reasons|1|||
27655965|NCT00905255|80580136|FG001|Overall Study|Familial and Personal Reasons|0|||
27655966|NCT04626128|80580137|FG000|Overall Study|Withdrawal by Subject|0|||
27655967|NCT04626128|80580138|FG001|Overall Study|Withdrawal by Subject|1|||
27655968|NCT04626128|80580139|FG002|Overall Study|Withdrawal by Subject|0|||
27655969|NCT04626128|80580140|FG003|Overall Study|Withdrawal by Subject|0|||
27655970|NCT01102426|80580141|FG000|Overall Study|Randomized but not treated|4|||
27655971|NCT01102426|80580142|FG001|Overall Study|Randomized but not treated|1|||
27655972|NCT01102426|80580141|FG000|Overall Study|Adverse Events (treatment-related)|15|||
27655973|NCT01102426|80580142|FG001|Overall Study|Adverse Events (treatment-related)|8|||
27655974|NCT01102426|80580141|FG000|Overall Study|Physician Decision|9|||
27655975|NCT01102426|80580142|FG001|Overall Study|Physician Decision|6|||
27655976|NCT01102426|80580141|FG000|Overall Study|Progressive Disease|85|||
27655977|NCT01102426|80580142|FG001|Overall Study|Progressive Disease|44|||
27655978|NCT01102426|80580141|FG000|Overall Study|Adverse Events (unrelated to|9|||
27655979|NCT01102426|80580142|FG001|Overall Study|Adverse Events (unrelated to|1|||
27655980|NCT01102426|80580141|FG000|Overall Study|Patient Refusal|24|||
27655981|NCT01102426|80580142|FG001|Overall Study|Patient Refusal|12|||
27655982|NCT01102426|80580141|FG000|Overall Study|Death (due to adverse events|0|||
27655983|NCT01102426|80580142|FG001|Overall Study|Death (due to adverse events|1|||
27655984|NCT01102426|80580141|FG000|Overall Study|Death (non-related to the study|19|||
27655985|NCT01102426|80580142|FG001|Overall Study|Death (non-related to the study|8|||
27655986|NCT01320683|80580143|FG000|Overall Study|Positive antibody response|1|||
27655987|NCT03849300|80580144|FG000|Overall Study|move out to different area|1|||
27655988|NCT03849300|80580145|FG001|Overall Study|move out to different area|3|||
27655989|NCT03849300|80580146|FG002|Overall Study|move out to different area|1|||
27655990|NCT03849300|80580147|FG003|Overall Study|move out to different area|4|||
27655991|NCT03849300|80580144|FG000|Overall Study|scheduling/transportation conflict|4|||
27655992|NCT03849300|80580145|FG001|Overall Study|scheduling/transportation conflict|4|||
27655993|NCT03849300|80580146|FG002|Overall Study|scheduling/transportation conflict|3|||
27655994|NCT03849300|80580147|FG003|Overall Study|scheduling/transportation conflict|2|||
27655995|NCT04050722|80580148|FG000|Overall Study|Withdrawal by Subject|1|||
27655996|NCT04050722|80580149|FG001|Overall Study|Withdrawal by Subject|0|||
27655997|NCT00889863|80580150|FG000|Part I: Open Label|Death|1|||
27655998|NCT00889863|80580151|FG001|Part I: Open Label|Death|0|||
27655999|NCT00889863|80580150|FG000|Part I: Open Label|Adverse Event|4|||
27656000|NCT00889863|80580151|FG001|Part I: Open Label|Adverse Event|0|||
27656001|NCT00889863|80580150|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
27656002|NCT00889863|80580151|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
27656003|NCT00889863|80580150|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
27656004|NCT00889863|80580151|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
27656005|NCT00889863|80580150|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
27656006|NCT00889863|80580151|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
27656007|NCT00889863|80580150|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
27656008|NCT00889863|80580151|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
27656009|NCT00889863|80580150|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
27656010|NCT00889863|80580151|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
27656011|NCT04908800|80580154|FG000|Overall Study|Adverse Event|0|||
27656012|NCT04908800|80580155|FG001|Overall Study|Adverse Event|0|||
27656013|NCT04908800|80580156|FG002|Overall Study|Adverse Event|0|||
27656014|NCT04908800|80580157|FG003|Overall Study|Adverse Event|0|||
27656015|NCT04908800|80580158|FG004|Overall Study|Adverse Event|0|||
27656016|NCT04908800|80580159|FG005|Overall Study|Adverse Event|0|||
27656017|NCT04908800|80580160|FG006|Overall Study|Adverse Event|0|||
27656018|NCT04908800|80580161|FG007|Overall Study|Adverse Event|0|||
27656019|NCT04908800|80580162|FG008|Overall Study|Adverse Event|0|||
27656020|NCT04908800|80580163|FG009|Overall Study|Adverse Event|0|||
27656021|NCT04908800|80580164|FG010|Overall Study|Adverse Event|1|||
27656022|NCT04908800|80580165|FG011|Overall Study|Adverse Event|0|||
27656023|NCT04908800|80580166|FG012|Overall Study|Adverse Event|0|||
27656024|NCT02612285|80580167|FG000|Overall Study|Withdrawal by Subject|1|||
27656025|NCT00748098|80580168|FG000|First Treatment Intervention Period|Adverse Event|1|||
27656026|NCT00748098|80580169|FG001|First Treatment Intervention Period|Adverse Event|1|||
27656027|NCT00748098|80580168|FG000|First Treatment Intervention Period|Protocol Violation|1|||
27656028|NCT00748098|80580169|FG001|First Treatment Intervention Period|Protocol Violation|0|||
27656029|NCT00748098|80580168|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
27656030|NCT00748098|80580169|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
27656031|NCT00748098|80580168|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
27656032|NCT00748098|80580169|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
27656033|NCT00748098|80580168|FG000|First Taper Period|Protocol Violation|1|||
27656034|NCT00748098|80580169|FG001|First Taper Period|Protocol Violation|0|||
27656035|NCT00748098|80580168|FG000|First Taper Period|Withdrawal by Subject|2|||
27656036|NCT00748098|80580169|FG001|First Taper Period|Withdrawal by Subject|0|||
27656037|NCT00748098|80580168|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
27656038|NCT00748098|80580169|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
27656039|NCT00748098|80580168|FG000|1-Week Washout Period|Adverse Event|0|||
27656040|NCT00748098|80580169|FG001|1-Week Washout Period|Adverse Event|1|||
27656041|NCT00748098|80580168|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
27656042|NCT00748098|80580169|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
27656043|NCT00748098|80580168|FG000|Second Treatment Intervention Period|Adverse Event|4|||
27656044|NCT00748098|80580169|FG001|Second Treatment Intervention Period|Adverse Event|1|||
27656045|NCT00748098|80580168|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
27656046|NCT00748098|80580169|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
27656047|NCT00748098|80580168|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
27656048|NCT00748098|80580169|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
27656049|NCT01131325|80580177|FG000|Overall Study|Adverse Event|1|||
27656050|NCT01131325|80580177|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
27656051|NCT04184622|80580178|FG000|Overall Study|Adverse Event|7|||
27656052|NCT04184622|80580179|FG001|Overall Study|Adverse Event|7|||
27656053|NCT04184622|80580180|FG002|Overall Study|Adverse Event|11|||
27656054|NCT04184622|80580181|FG003|Overall Study|Adverse Event|8|||
27656055|NCT04184622|80580178|FG000|Overall Study|Death|4|||
27656056|NCT04184622|80580179|FG001|Overall Study|Death|4|||
27656057|NCT04184622|80580180|FG002|Overall Study|Death|2|||
27656058|NCT04184622|80580181|FG003|Overall Study|Death|1|||
27656059|NCT04184622|80580178|FG000|Overall Study|Lost to Follow-up|41|||
27656060|NCT04184622|80580179|FG001|Overall Study|Lost to Follow-up|19|||
27656061|NCT04184622|80580180|FG002|Overall Study|Lost to Follow-up|20|||
27656062|NCT04184622|80580181|FG003|Overall Study|Lost to Follow-up|15|||
27656063|NCT04184622|80580178|FG000|Overall Study|Missing Weight at Week 72|1|||
27656064|NCT04184622|80580179|FG001|Overall Study|Missing Weight at Week 72|0|||
27656065|NCT04184622|80580180|FG002|Overall Study|Missing Weight at Week 72|1|||
27656066|NCT04184622|80580181|FG003|Overall Study|Missing Weight at Week 72|0|||
27656067|NCT04184622|80580178|FG000|Overall Study|Other - as reported by the investigator|22|||
27656068|NCT04184622|80580179|FG001|Overall Study|Other - as reported by the investigator|7|||
27656069|NCT04184622|80580180|FG002|Overall Study|Other - as reported by the investigator|5|||
27656070|NCT04184622|80580181|FG003|Overall Study|Other - as reported by the investigator|12|||
27656071|NCT04184622|80580178|FG000|Overall Study|Physician Decision|0|||
27656072|NCT04184622|80580179|FG001|Overall Study|Physician Decision|0|||
27656073|NCT04184622|80580180|FG002|Overall Study|Physician Decision|3|||
27656074|NCT04184622|80580181|FG003|Overall Study|Physician Decision|1|||
27656075|NCT04184622|80580178|FG000|Overall Study|Pregnancy|4|||
27656076|NCT04184622|80580179|FG001|Overall Study|Pregnancy|4|||
27656077|NCT04184622|80580180|FG002|Overall Study|Pregnancy|3|||
27656078|NCT04184622|80580181|FG003|Overall Study|Pregnancy|5|||
27656079|NCT04184622|80580178|FG000|Overall Study|Protocol Deviation|1|||
27656080|NCT04184622|80580179|FG001|Overall Study|Protocol Deviation|0|||
27656081|NCT04184622|80580180|FG002|Overall Study|Protocol Deviation|0|||
27656082|NCT04184622|80580181|FG003|Overall Study|Protocol Deviation|0|||
27656083|NCT04184622|80580178|FG000|Overall Study|Withdrawal by Subject|68|||
27656084|NCT04184622|80580179|FG001|Overall Study|Withdrawal by Subject|28|||
27656085|NCT04184622|80580180|FG002|Overall Study|Withdrawal by Subject|29|||
27656086|NCT04184622|80580181|FG003|Overall Study|Withdrawal by Subject|22|||
27656087|NCT04361617|80580183|FG000|Overall Study|Withdrawal by Subject|0|||
27656088|NCT04361617|80580184|FG001|Overall Study|Withdrawal by Subject|1|||
27656089|NCT02465866|80580187|FG000|Period 3|Withdrawal by Subject|0|||
27656090|NCT02465866|80580188|FG001|Period 3|Withdrawal by Subject|1|||
27656091|NCT02465866|80580189|FG002|Period 3|Withdrawal by Subject|0|||
27656092|NCT02465866|80580190|FG003|Period 3|Withdrawal by Subject|0|||
27656093|NCT01648699|80580191|FG000|Overall Study|Death|1|||
27656094|NCT01648699|80580191|FG000|Overall Study|Lost to Follow-up|2|||
27656095|NCT01648699|80580191|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
27656096|NCT00451906|80580194|FG000|Overall Study|Adverse Event|515|||
27656097|NCT00451906|80580194|FG000|Overall Study|Lost to Follow-up|31|||
27656098|NCT00451906|80580194|FG000|Overall Study|Withdrawal by Subject|111|||
27656099|NCT00451906|80580194|FG000|Overall Study|Protocol Violation|21|||
27656100|NCT00451906|80580194|FG000|Overall Study|Progressive disease|1328|||
27656101|NCT00451906|80580194|FG000|Overall Study|Termination of the study|108|||
27656102|NCT00451906|80580194|FG000|Overall Study|Other Reasons|121|||
27656103|NCT00451906|80580194|FG000|Overall Study|Did not complete final visit|4|||
27656104|NCT02659059|80580195|FG000|Overall Study|Other reasons|6|||
27656105|NCT02659059|80580196|FG001|Overall Study|Other reasons|1|||
27656106|NCT02659059|80580195|FG000|Overall Study|Disease Progression|143|||
27566494|NCT02579265|80263332|FG000|Overall Study|Any other reason not specified|0|||
27566495|NCT02579265|80263333|FG001|Overall Study|Any other reason not specified|2|||
27566496|NCT02579265|80263332|FG000|Overall Study|Withdrawal by Subject|2|||
27566497|NCT02579265|80263333|FG001|Overall Study|Withdrawal by Subject|0|||
27566498|NCT02579265|80263332|FG000|Overall Study|Physician Decision|1|||
27566499|NCT02579265|80263333|FG001|Overall Study|Physician Decision|0|||
27566500|NCT02579265|80263332|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
27566501|NCT02579265|80263333|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
27566502|NCT05402995|80263334|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
27566503|NCT05402995|80263335|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
27656107|NCT02659059|80580196|FG001|Overall Study|Disease Progression|16|||
27656108|NCT02659059|80580195|FG000|Overall Study|Study Drug toxicity|56|||
27656109|NCT02659059|80580196|FG001|Overall Study|Study Drug toxicity|9|||
27656110|NCT02659059|80580195|FG000|Overall Study|Death|3|||
27656111|NCT02659059|80580196|FG001|Overall Study|Death|1|||
27656112|NCT02659059|80580195|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
27656113|NCT02659059|80580196|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
27656114|NCT02659059|80580195|FG000|Overall Study|Participant request to discontinue study treatment|5|||
27656115|NCT02659059|80580196|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27656116|NCT02659059|80580195|FG000|Overall Study|Participant withdrew consent|6|||
27656117|NCT02659059|80580196|FG001|Overall Study|Participant withdrew consent|1|||
27656118|NCT00587171|80580197|FG000|Overall Study|Lost to Follow-up|1|||
27656119|NCT00587171|80580198|FG001|Overall Study|Lost to Follow-up|1|||
27656120|NCT01393964|80580199|FG000|Overall Study|Disease Progression|4|||
27656121|NCT01393964|80580200|FG001|Overall Study|Disease Progression|3|||
27656122|NCT01393964|80580201|FG002|Overall Study|Disease Progression|5|||
27656123|NCT01393964|80580199|FG000|Overall Study|Study drug toxicity|1|||
27656124|NCT01393964|80580200|FG001|Overall Study|Study drug toxicity|0|||
27656125|NCT01393964|80580201|FG002|Overall Study|Study drug toxicity|0|||
27656126|NCT01393964|80580199|FG000|Overall Study|Withdrawal by Subject|0|||
27656127|NCT01393964|80580200|FG001|Overall Study|Withdrawal by Subject|0|||
27656128|NCT01393964|80580201|FG002|Overall Study|Withdrawal by Subject|1|||
27656129|NCT01393964|80580199|FG000|Overall Study|Adverse event unrelated to study drug|0|||
27656130|NCT01393964|80580200|FG001|Overall Study|Adverse event unrelated to study drug|3|||
27656131|NCT01393964|80580201|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27656132|NCT01393964|80580199|FG000|Overall Study|Subject request stop study treatment|0|||
27656133|NCT01393964|80580200|FG001|Overall Study|Subject request stop study treatment|1|||
27656134|NCT01393964|80580201|FG002|Overall Study|Subject request stop study treatment|0|||
27656135|NCT01393964|80580199|FG000|Overall Study|Subject decided to move to transplant|1|||
27656136|NCT01393964|80580200|FG001|Overall Study|Subject decided to move to transplant|0|||
27656137|NCT01393964|80580201|FG002|Overall Study|Subject decided to move to transplant|0|||
27656138|NCT01393964|80580199|FG000|Overall Study|Subject switched to commercial supply|1|||
27656139|NCT01393964|80580200|FG001|Overall Study|Subject switched to commercial supply|0|||
27656140|NCT01393964|80580201|FG002|Overall Study|Subject switched to commercial supply|2|||
27656141|NCT01393964|80580199|FG000|Overall Study|Subject plateaued in terms of effect|1|||
27656142|NCT01393964|80580200|FG001|Overall Study|Subject plateaued in terms of effect|0|||
27656143|NCT01393964|80580201|FG002|Overall Study|Subject plateaued in terms of effect|0|||
27656144|NCT01393964|80580199|FG000|Overall Study|Investigator removed subject from study|0|||
27656145|NCT01393964|80580200|FG001|Overall Study|Investigator removed subject from study|1|||
27656146|NCT01393964|80580201|FG002|Overall Study|Investigator removed subject from study|0|||
27656147|NCT01393964|80580199|FG000|Overall Study|Subject converted to roll-over study|0|||
27656148|NCT01393964|80580200|FG001|Overall Study|Subject converted to roll-over study|1|||
27656149|NCT01393964|80580201|FG002|Overall Study|Subject converted to roll-over study|0|||
27656150|NCT01393964|80580199|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
27656151|NCT01393964|80580200|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
27656152|NCT01393964|80580201|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
27656153|NCT04676763|80580202|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
27656154|NCT04676763|80580203|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
27656155|NCT04676763|80580204|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
27656156|NCT04676763|80580202|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
27656157|NCT04676763|80580203|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
27656158|NCT04676763|80580204|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
27656159|NCT04676763|80580202|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
27656160|NCT04676763|80580203|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
27656161|NCT04676763|80580204|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
27656162|NCT03529942|80580205|FG000|Overall Study|Withdrawal by Subject|13|||
27656163|NCT03529942|80580205|FG000|Overall Study|Physician Decision|1|||
27656164|NCT03529942|80580205|FG000|Overall Study|Lost to Follow-up|7|||
27656165|NCT03529942|80580205|FG000|Overall Study|Needle inserted but no drug administered|1|||
27656166|NCT03529942|80580205|FG000|Overall Study|Personal reasons|1|||
27656167|NCT01280656|80580212|FG000|Overall Study|Adverse Event|1|||
27656168|NCT01280656|80580213|FG001|Overall Study|Adverse Event|14|||
27656169|NCT01280656|80580214|FG002|Overall Study|Adverse Event|13|||
27656170|NCT01280656|80580212|FG000|Overall Study|Lack of Efficacy|1|||
27656171|NCT01280656|80580213|FG001|Overall Study|Lack of Efficacy|22|||
27656172|NCT01280656|80580214|FG002|Overall Study|Lack of Efficacy|38|||
27656173|NCT01280656|80580212|FG000|Overall Study|Treatment shortening (RGT)|0|||
27656174|NCT01280656|80580213|FG001|Overall Study|Treatment shortening (RGT)|4|||
27656175|NCT01280656|80580214|FG002|Overall Study|Treatment shortening (RGT)|5|||
27656176|NCT01280656|80580212|FG000|Overall Study|Other|1|||
27656177|NCT01280656|80580213|FG001|Overall Study|Other|7|||
27656178|NCT01280656|80580214|FG002|Overall Study|Other|7|||
27656179|NCT02005484|80580216|FG000|Overall Study|Death|1|||
27656180|NCT02005484|80580216|FG000|Overall Study|Disease progression|1|||
27656181|NCT02005484|80580216|FG000|Overall Study|Changed to a Different Study|1|||
27656182|NCT02005484|80580216|FG000|Overall Study|Sponsor decision|1|||
27656183|NCT03696342|80580217|FG000|Overall Study|Lost to Follow-up|1|||
27656184|NCT03696342|80580218|FG001|Overall Study|Lost to Follow-up|0|||
27656185|NCT01922102|80580219|FG000|Overall Study|Withdrawal by Subject|7|||
27656186|NCT01922102|80580220|FG001|Overall Study|Withdrawal by Subject|3|||
27656187|NCT01922102|80580221|FG002|Overall Study|Withdrawal by Subject|7|||
27656188|NCT01922102|80580219|FG000|Overall Study|Physician Decision|0|||
27656189|NCT01922102|80580220|FG001|Overall Study|Physician Decision|2|||
27656190|NCT01922102|80580221|FG002|Overall Study|Physician Decision|1|||
27656191|NCT01922102|80580219|FG000|Overall Study|Adverse Event|1|||
27656192|NCT01922102|80580220|FG001|Overall Study|Adverse Event|2|||
27656193|NCT01922102|80580221|FG002|Overall Study|Adverse Event|0|||
27656194|NCT01922102|80580219|FG000|Overall Study|Lost to Follow-up|1|||
27656195|NCT01922102|80580220|FG001|Overall Study|Lost to Follow-up|0|||
27656196|NCT01922102|80580221|FG002|Overall Study|Lost to Follow-up|0|||
27656197|NCT01922102|80580219|FG000|Overall Study|Administrative problems|0|||
27656198|NCT01922102|80580220|FG001|Overall Study|Administrative problems|2|||
27656199|NCT01922102|80580221|FG002|Overall Study|Administrative problems|0|||
27656200|NCT04617847|80580227|FG000|Overall Study|Withdrawal by Subject|1|||
27656201|NCT04617847|80580228|FG001|Overall Study|Withdrawal by Subject|0|||
27656202|NCT04617847|80580227|FG000|Overall Study|Adverse Event|0|||
27656203|NCT04617847|80580228|FG001|Overall Study|Adverse Event|2|||
27656204|NCT04617847|80580227|FG000|Overall Study|Death|0|||
27656205|NCT04617847|80580228|FG001|Overall Study|Death|1|||
27656206|NCT04617847|80580227|FG000|Overall Study|Termination of Study by Sponsor|2|||
27656207|NCT04617847|80580228|FG001|Overall Study|Termination of Study by Sponsor|21|||
27656208|NCT01755598|80580235|FG000|Overall Study|Other|109|||
27656209|NCT01755598|80580236|FG001|Overall Study|Other|109|||
27656210|NCT01755598|80580235|FG000|Overall Study|Lost to Follow-up|32|||
27656211|NCT01755598|80580236|FG001|Overall Study|Lost to Follow-up|43|||
27656212|NCT01755598|80580235|FG000|Overall Study|Migrated/moved from study area|76|||
27656213|NCT01755598|80580236|FG001|Overall Study|Migrated/moved from study area|65|||
27656214|NCT01755598|80580235|FG000|Overall Study|Withdrawal by Subject|22|||
27656215|NCT01755598|80580236|FG001|Overall Study|Withdrawal by Subject|31|||
27656216|NCT01755598|80580235|FG000|Overall Study|Protocol Violation|7|||
27656217|NCT01755598|80580236|FG001|Overall Study|Protocol Violation|7|||
27566504|NCT05402995|80263336|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
27566505|NCT05402995|80263337|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
27566506|NCT02515942|80263348|FG000|Overall Study|Adverse Event|5|||
27566507|NCT02515942|80263349|FG001|Overall Study|Adverse Event|0|||
27566508|NCT02515942|80263350|FG002|Overall Study|Adverse Event|0|||
27566509|NCT02515942|80263348|FG000|Overall Study|Death|0|||
27566510|NCT02515942|80263349|FG001|Overall Study|Death|0|||
27566511|NCT02515942|80263350|FG002|Overall Study|Death|1|||
27566512|NCT02515942|80263348|FG000|Overall Study|Lack of Efficacy|0|||
27566513|NCT02515942|80263349|FG001|Overall Study|Lack of Efficacy|0|||
27656218|NCT01755598|80580235|FG000|Overall Study|Adverse Event|19|||
27656219|NCT01755598|80580236|FG001|Overall Study|Adverse Event|28|||
27656220|NCT01426217|80580237|FG000|Overall Study|lost sample|8|||
27656221|NCT01426217|80580238|FG001|Overall Study|lost sample|14|||
27656222|NCT02069379|80580239|FG000|Baseline Measurements|Lost to Follow-up|1|||
27656223|NCT02069379|80580240|FG001|Baseline Measurements|Lost to Follow-up|0|||
27656224|NCT02069379|80580241|FG002|Baseline Measurements|Lost to Follow-up|0|||
27656225|NCT02069379|80580242|FG003|Baseline Measurements|Lost to Follow-up|0|||
27656226|NCT02069379|80580239|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
27656227|NCT02069379|80580240|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
27656228|NCT02069379|80580241|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
27656229|NCT02069379|80580242|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
27656230|NCT02069379|80580239|FG000|First Treatment Arm|Lost to Follow-up|0|||
27656231|NCT02069379|80580240|FG001|First Treatment Arm|Lost to Follow-up|1|||
27656232|NCT02069379|80580241|FG002|First Treatment Arm|Lost to Follow-up|1|||
27656233|NCT02069379|80580242|FG003|First Treatment Arm|Lost to Follow-up|0|||
27656234|NCT02069379|80580239|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
27656235|NCT02069379|80580240|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
27656236|NCT02069379|80580241|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
27656237|NCT02069379|80580242|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
27656238|NCT02069379|80580239|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
27656239|NCT02069379|80580240|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
27656240|NCT02069379|80580241|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
27656241|NCT02069379|80580242|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
27656242|NCT02069379|80580239|FG000|Second Treatment Arm|Lost to Follow-up|0|||
27656243|NCT02069379|80580240|FG001|Second Treatment Arm|Lost to Follow-up|0|||
27656244|NCT02069379|80580241|FG002|Second Treatment Arm|Lost to Follow-up|1|||
27566514|NCT02515942|80263350|FG002|Overall Study|Lack of Efficacy|1|||
27566515|NCT02515942|80263348|FG000|Overall Study|Lost to Follow-up|2|||
27656245|NCT02069379|80580242|FG003|Second Treatment Arm|Lost to Follow-up|0|||
27656246|NCT03219216|80580245|FG000|Overall Study|Lost to Follow-up|0|||
27656247|NCT03219216|80580246|FG001|Overall Study|Lost to Follow-up|1|||
27656248|NCT01133678|80580250|FG000|Overall Study|Death|1|||
27656249|NCT01133678|80580251|FG001|Overall Study|Death|1|||
27656250|NCT02213094|80580252|FG000|Overall Study|Adverse Event|1|||
27656251|NCT02213094|80580253|FG001|Overall Study|Adverse Event|0|||
27656252|NCT02389894|80580257|FG000|Overall Study|Death|4|||
27656253|NCT02389894|80580258|FG001|Overall Study|Death|5|||
27656254|NCT02389894|80580259|FG002|Overall Study|Death|3|||
27656255|NCT02389894|80580257|FG000|Overall Study|Withdrawal by Subject|2|||
27656256|NCT02389894|80580258|FG001|Overall Study|Withdrawal by Subject|4|||
27656257|NCT02389894|80580259|FG002|Overall Study|Withdrawal by Subject|5|||
27656258|NCT02389894|80580257|FG000|Overall Study|Lost to Follow-up|2|||
27656259|NCT02389894|80580258|FG001|Overall Study|Lost to Follow-up|1|||
27656260|NCT02389894|80580259|FG002|Overall Study|Lost to Follow-up|1|||
27656261|NCT04454125|80580262|FG000|Overall Study|Lost to Follow-up|0|||
27656262|NCT04454125|80580263|FG001|Overall Study|Lost to Follow-up|1|||
27656263|NCT00447499|80580266|FG000|Overall Study|Adverse Event|1|||
27656264|NCT00447499|80580266|FG000|Overall Study|Patient Decision|4|||
27656265|NCT00447499|80580266|FG000|Overall Study|Sponsor Decision|1|||
27656266|NCT00447499|80580266|FG000|Overall Study|Physician Decision|1|||
27656267|NCT01469819|80580267|FG000|Overall Study|Withdrawal by Subject|1|||
27656268|NCT01469819|80580267|FG000|Overall Study|Did not meet inclusionary criteria|2|||
27656269|NCT01469819|80580267|FG000|Overall Study|Could not swallow SmartPill|2|||
27656270|NCT01469819|80580267|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
27656271|NCT01263223|80580271|FG000|Period 2|Withdrawal by Subject|0|||
27656272|NCT01263223|80580272|FG001|Period 2|Withdrawal by Subject|1|||
27656273|NCT01263223|80580271|FG000|7-day Follow-up|Withdrawal by Subject|0|||
27656274|NCT01263223|80580272|FG001|7-day Follow-up|Withdrawal by Subject|1|||
27656275|NCT01263223|80580271|FG000|7-day Follow-up|Lost to Follow-up|1|||
27656276|NCT01263223|80580272|FG001|7-day Follow-up|Lost to Follow-up|0|||
27656277|NCT00215943|80580279|FG000|Overall Study|Disease Progression|3|||
27566516|NCT02515942|80263349|FG001|Overall Study|Lost to Follow-up|0|||
27566517|NCT02515942|80263350|FG002|Overall Study|Lost to Follow-up|0|||
27566518|NCT02515942|80263348|FG000|Overall Study|Withdrawal by Subject|0|||
27566519|NCT02515942|80263349|FG001|Overall Study|Withdrawal by Subject|3|||
27566520|NCT02515942|80263350|FG002|Overall Study|Withdrawal by Subject|2|||
27566521|NCT00451035|80263352|FG000|Overall Study|Disease progression|11|||
27566522|NCT00451035|80263352|FG000|Overall Study|Death|3|||
27566523|NCT00451035|80263352|FG000|Overall Study|New anti-neoplastic therapy|3|||
27566524|NCT02404350|80263354|FG000|Overall Study|Adverse Event|2|||
27566525|NCT02404350|80263355|FG001|Overall Study|Adverse Event|2|||
27566526|NCT02404350|80263356|FG002|Overall Study|Adverse Event|3|||
27566527|NCT02404350|80263357|FG003|Overall Study|Adverse Event|9|||
27566528|NCT02404350|80263354|FG000|Overall Study|Lack of Efficacy|3|||
27566529|NCT02404350|80263355|FG001|Overall Study|Lack of Efficacy|1|||
27566530|NCT02404350|80263356|FG002|Overall Study|Lack of Efficacy|0|||
27566531|NCT02404350|80263357|FG003|Overall Study|Lack of Efficacy|3|||
27566532|NCT02404350|80263354|FG000|Overall Study|Lost to Follow-up|2|||
27566533|NCT02404350|80263355|FG001|Overall Study|Lost to Follow-up|0|||
27566534|NCT02404350|80263356|FG002|Overall Study|Lost to Follow-up|0|||
27566535|NCT02404350|80263357|FG003|Overall Study|Lost to Follow-up|1|||
27566536|NCT02404350|80263354|FG000|Overall Study|Physician Decision|1|||
27566537|NCT02404350|80263355|FG001|Overall Study|Physician Decision|0|||
27566538|NCT02404350|80263356|FG002|Overall Study|Physician Decision|0|||
27566539|NCT02404350|80263357|FG003|Overall Study|Physician Decision|2|||
27566540|NCT02404350|80263354|FG000|Overall Study|Pregnancy|0|||
27566541|NCT02404350|80263355|FG001|Overall Study|Pregnancy|0|||
27566542|NCT02404350|80263356|FG002|Overall Study|Pregnancy|0|||
27566543|NCT02404350|80263357|FG003|Overall Study|Pregnancy|1|||
27566544|NCT02404350|80263354|FG000|Overall Study|Withdrawal by Subject|7|||
27566545|NCT02404350|80263355|FG001|Overall Study|Withdrawal by Subject|3|||
27566546|NCT02404350|80263356|FG002|Overall Study|Withdrawal by Subject|3|||
27566547|NCT02404350|80263357|FG003|Overall Study|Withdrawal by Subject|19|||
27566548|NCT02404350|80263354|FG000|Overall Study|Due to Non-compliance with treatment|0|||
27566549|NCT02404350|80263355|FG001|Overall Study|Due to Non-compliance with treatment|0|||
27566550|NCT02404350|80263356|FG002|Overall Study|Due to Non-compliance with treatment|0|||
27566551|NCT02404350|80263357|FG003|Overall Study|Due to Non-compliance with treatment|1|||
27566552|NCT02404350|80263354|FG000|Overall Study|Due to Technical problems|0|||
27566553|NCT02404350|80263355|FG001|Overall Study|Due to Technical problems|0|||
27566554|NCT02404350|80263356|FG002|Overall Study|Due to Technical problems|0|||
27566555|NCT02404350|80263357|FG003|Overall Study|Due to Technical problems|1|||
27566556|NCT01113879|80263359|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
27566557|NCT01113879|80263360|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
27566558|NCT01023581|80263364|FG000|Overall Study|Adverse Event|4|||
27566559|NCT01023581|80263365|FG001|Overall Study|Adverse Event|4|||
27566560|NCT01023581|80263366|FG002|Overall Study|Adverse Event|7|||
27656278|NCT00215943|80580280|FG001|Overall Study|Disease Progression|5|||
27656279|NCT00215943|80580279|FG000|Overall Study|Alternate therapy|0|||
27656280|NCT00215943|80580280|FG001|Overall Study|Alternate therapy|1|||
27656281|NCT00215943|80580279|FG000|Overall Study|Adverse Event|3|||
27656282|NCT00215943|80580280|FG001|Overall Study|Adverse Event|6|||
27656283|NCT00215943|80580279|FG000|Overall Study|Other disease|0|||
27656284|NCT00215943|80580280|FG001|Overall Study|Other disease|1|||
27656285|NCT00215943|80580279|FG000|Overall Study|Other complications|3|||
27656286|NCT00215943|80580280|FG001|Overall Study|Other complications|1|||
27656287|NCT03873038|80580283|FG000|Part 2|Withdrawal by Subject|0|||
27656288|NCT03873038|80580284|FG001|Part 2|Withdrawal by Subject|0|||
27656289|NCT03873038|80580285|FG002|Part 2|Withdrawal by Subject|0|||
27656290|NCT03873038|80580286|FG003|Part 2|Withdrawal by Subject|0|||
27656291|NCT03873038|80580287|FG004|Part 2|Withdrawal by Subject|0|||
27656292|NCT03873038|80580288|FG005|Part 2|Withdrawal by Subject|1|||
27656293|NCT03873038|80580283|FG000|Part 2|Unknon|0|||
27756953|NCT00006604|80936567|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
27756954|NCT00006604|80936568|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
27756955|NCT00006604|80936569|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
27756956|NCT00006604|80936570|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
27756957|NCT00006604|80936571|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
27656294|NCT03873038|80580284|FG001|Part 2|Unknon|0|||
27656295|NCT03873038|80580285|FG002|Part 2|Unknon|0|||
27656296|NCT03873038|80580286|FG003|Part 2|Unknon|0|||
27656297|NCT03873038|80580287|FG004|Part 2|Unknon|1|||
27656298|NCT03873038|80580288|FG005|Part 2|Unknon|0|||
27656299|NCT01215253|80580291|FG000|Overall Study|Withdrawal by Subject|57|||
27656300|NCT01215253|80580292|FG001|Overall Study|Withdrawal by Subject|35|||
27656301|NCT01215253|80580291|FG000|Overall Study|Physician Decision|9|||
27656302|NCT01215253|80580292|FG001|Overall Study|Physician Decision|12|||
27656303|NCT01215253|80580291|FG000|Overall Study|Lost to Follow-up|6|||
27656304|NCT01215253|80580292|FG001|Overall Study|Lost to Follow-up|4|||
27656305|NCT01215253|80580291|FG000|Overall Study|Other|14|||
27656306|NCT01215253|80580292|FG001|Overall Study|Other|12|||
27656307|NCT01322347|80580293|FG000|Overall Study|Adverse Event|7|||
27656308|NCT01322347|80580294|FG001|Overall Study|Adverse Event|2|||
27656309|NCT01322347|80580293|FG000|Overall Study|Death|5|||
27656310|NCT01322347|80580294|FG001|Overall Study|Death|3|||
27656311|NCT01322347|80580293|FG000|Overall Study|Physician Decision|2|||
27656312|NCT01322347|80580294|FG001|Overall Study|Physician Decision|1|||
27656313|NCT01322347|80580293|FG000|Overall Study|Protocol Violation|5|||
27656314|NCT01322347|80580294|FG001|Overall Study|Protocol Violation|2|||
27656315|NCT01322347|80580293|FG000|Overall Study|Withdrawal by Subject|1|||
27656316|NCT01322347|80580294|FG001|Overall Study|Withdrawal by Subject|4|||
27656317|NCT01322347|80580293|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
27656318|NCT01322347|80580294|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
27656319|NCT01322347|80580293|FG000|Overall Study|blood transfusion|5|||
27656320|NCT01322347|80580294|FG001|Overall Study|blood transfusion|5|||
27656321|NCT01322347|80580293|FG000|Overall Study|sponsor decision|1|||
27656322|NCT01322347|80580294|FG001|Overall Study|sponsor decision|3|||
27656323|NCT01322347|80580293|FG000|Overall Study|ineligible|6|||
27656324|NCT01322347|80580294|FG001|Overall Study|ineligible|3|||
27656325|NCT01322347|80580293|FG000|Overall Study|kidney transplant|3|||
27656326|NCT01322347|80580294|FG001|Overall Study|kidney transplant|1|||
27656327|NCT01322347|80580293|FG000|Overall Study|study drug withheld > 12 wks|0|||
27656328|NCT01322347|80580294|FG001|Overall Study|study drug withheld > 12 wks|1|||
27656329|NCT01322347|80580293|FG000|Overall Study|moved/changed dialysis|2|||
27656330|NCT01322347|80580294|FG001|Overall Study|moved/changed dialysis|4|||
27656331|NCT03562117|80580301|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
27656332|NCT03562117|80580302|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
27656333|NCT03562117|80580303|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
27656334|NCT00547300|80580304|FG000|Overall Study|Study was Administratively Terminated|25|||
27656335|NCT00547300|80580305|FG001|Overall Study|Study was Administratively Terminated|24|||
27656336|NCT00547300|80580304|FG000|Overall Study|Did not Meet Entry Criteria|0|||
27656337|NCT00547300|80580305|FG001|Overall Study|Did not Meet Entry Criteria|2|||
27656338|NCT01807234|80580314|FG000|Overall Study|Lost to Follow-up|2|||
27656339|NCT01807234|80580315|FG001|Overall Study|Lost to Follow-up|5|||
27656340|NCT01807234|80580316|FG002|Overall Study|Lost to Follow-up|1|||
27656341|NCT01807234|80580317|FG003|Overall Study|Lost to Follow-up|1|||
27656342|NCT01807234|80580318|FG004|Overall Study|Lost to Follow-up|1|||
27656343|NCT01807234|80580319|FG005|Overall Study|Lost to Follow-up|2|||
27656344|NCT01807234|80580314|FG000|Overall Study|Withdrawal by Subject|3|||
27656345|NCT01807234|80580315|FG001|Overall Study|Withdrawal by Subject|1|||
27656346|NCT01807234|80580316|FG002|Overall Study|Withdrawal by Subject|1|||
27656347|NCT01807234|80580317|FG003|Overall Study|Withdrawal by Subject|1|||
27656348|NCT01807234|80580318|FG004|Overall Study|Withdrawal by Subject|2|||
27656349|NCT01807234|80580319|FG005|Overall Study|Withdrawal by Subject|1|||
27656350|NCT01807234|80580314|FG000|Overall Study|Lack of Efficacy|0|||
27656351|NCT01807234|80580315|FG001|Overall Study|Lack of Efficacy|0|||
27656352|NCT01807234|80580316|FG002|Overall Study|Lack of Efficacy|0|||
27656353|NCT01807234|80580317|FG003|Overall Study|Lack of Efficacy|0|||
27656354|NCT01807234|80580318|FG004|Overall Study|Lack of Efficacy|1|||
27656355|NCT01807234|80580319|FG005|Overall Study|Lack of Efficacy|1|||
27656356|NCT00596960|80580322|FG000|Overall Study|Death|1|||
27656357|NCT00596960|80580323|FG001|Overall Study|Death|2|||
27656358|NCT00596960|80580322|FG000|Overall Study|Lost to Follow-up|6|||
27656359|NCT00596960|80580323|FG001|Overall Study|Lost to Follow-up|5|||
27656360|NCT00596960|80580322|FG000|Overall Study|Withdrawal by Subject|1|||
27656361|NCT00596960|80580323|FG001|Overall Study|Withdrawal by Subject|0|||
27656362|NCT00596960|80580322|FG000|Overall Study|Incarcerated|2|||
27656363|NCT00596960|80580323|FG001|Overall Study|Incarcerated|0|||
27656364|NCT00596960|80580322|FG000|Overall Study|Physician Decision|1|||
27656365|NCT00596960|80580323|FG001|Overall Study|Physician Decision|0|||
27656366|NCT00596960|80580322|FG000|Overall Study|Protocol Violation|0|||
27656367|NCT00596960|80580323|FG001|Overall Study|Protocol Violation|1|||
27656368|NCT00596960|80580322|FG000|Overall Study|No alcohol use data|0|||
27656369|NCT00596960|80580323|FG001|Overall Study|No alcohol use data|1|||
27656370|NCT01804140|80580324|FG000|Overall Study|No sampling or biopsy procedures done|114|||
27656371|NCT00942188|80580325|FG000|Overall Study|Adverse Event|0|||
27656372|NCT00942188|80580326|FG001|Overall Study|Adverse Event|3|||
27656373|NCT00942188|80580327|FG002|Overall Study|Adverse Event|2|||
27656374|NCT00942188|80580328|FG003|Overall Study|Adverse Event|0|||
27656375|NCT00942188|80580325|FG000|Overall Study|Lack of Efficacy|0|||
27656376|NCT00942188|80580326|FG001|Overall Study|Lack of Efficacy|0|||
27656377|NCT00942188|80580327|FG002|Overall Study|Lack of Efficacy|0|||
27656378|NCT00942188|80580328|FG003|Overall Study|Lack of Efficacy|1|||
27656379|NCT00942188|80580325|FG000|Overall Study|Protocol Violation|1|||
27656380|NCT00942188|80580326|FG001|Overall Study|Protocol Violation|1|||
27656381|NCT00942188|80580327|FG002|Overall Study|Protocol Violation|0|||
27656382|NCT00942188|80580328|FG003|Overall Study|Protocol Violation|0|||
27656383|NCT00942188|80580325|FG000|Overall Study|Lost to Follow-up|2|||
27656384|NCT00942188|80580326|FG001|Overall Study|Lost to Follow-up|1|||
27656385|NCT00942188|80580327|FG002|Overall Study|Lost to Follow-up|2|||
27656386|NCT00942188|80580328|FG003|Overall Study|Lost to Follow-up|0|||
27756958|NCT00006604|80936572|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
27756959|NCT00006604|80936573|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
27756960|NCT00006604|80936574|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
27756961|NCT00006604|80936558|FG000|Overall Study|Site closing|0|||
27656387|NCT00942188|80580325|FG000|Overall Study|Withdrawal by Subject|1|||
27656388|NCT00942188|80580326|FG001|Overall Study|Withdrawal by Subject|3|||
27656389|NCT00942188|80580327|FG002|Overall Study|Withdrawal by Subject|4|||
27656390|NCT00942188|80580328|FG003|Overall Study|Withdrawal by Subject|2|||
27656391|NCT00942188|80580325|FG000|Overall Study|Physician Decision|0|||
27656392|NCT00942188|80580326|FG001|Overall Study|Physician Decision|0|||
27656393|NCT00942188|80580327|FG002|Overall Study|Physician Decision|1|||
27656394|NCT00942188|80580328|FG003|Overall Study|Physician Decision|0|||
27656395|NCT00942188|80580325|FG000|Overall Study|Sponsor Decision|0|||
27656396|NCT00942188|80580326|FG001|Overall Study|Sponsor Decision|2|||
27656397|NCT00942188|80580327|FG002|Overall Study|Sponsor Decision|0|||
27656398|NCT00942188|80580328|FG003|Overall Study|Sponsor Decision|1|||
27656399|NCT00409006|80580329|FG000|Overall Study|Death|15|||
27656400|NCT00409006|80580330|FG001|Overall Study|Death|6|||
27656401|NCT00409006|80580329|FG000|Overall Study|Lost to Follow-up|1|||
27656402|NCT00409006|80580330|FG001|Overall Study|Lost to Follow-up|2|||
27656403|NCT00409006|80580329|FG000|Overall Study|Withdrawal by Subject|3|||
27656404|NCT00409006|80580330|FG001|Overall Study|Withdrawal by Subject|2|||
27656405|NCT00409006|80580329|FG000|Overall Study|Physician Decision|1|||
27656406|NCT00409006|80580330|FG001|Overall Study|Physician Decision|2|||
27656407|NCT00700999|80580331|FG000|Overall Study|Lost to Follow-up|7|||
27656408|NCT00700999|80580332|FG001|Overall Study|Lost to Follow-up|7|||
27656409|NCT00700999|80580331|FG000|Overall Study|Excluded - did not meet study criteria|0|||
27656410|NCT00700999|80580332|FG001|Overall Study|Excluded - did not meet study criteria|1|||
27656411|NCT00700999|80580331|FG000|Overall Study|Withdrawal by Subject|8|||
27656412|NCT00700999|80580332|FG001|Overall Study|Withdrawal by Subject|1|||
27656413|NCT03020914|80583173|FG000|Overall Study|Surgery Cancelled|1|||
27656414|NCT03020914|80583174|FG001|Overall Study|Surgery Cancelled|0|||
27756962|NCT00006604|80936559|FG001|Overall Study|Site closing|0|||
27756963|NCT00006604|80936560|FG002|Overall Study|Site closing|1|||
27756964|NCT00006604|80936561|FG003|Overall Study|Site closing|1|||
27756965|NCT00006604|80936562|FG004|Overall Study|Site closing|0|||
27756966|NCT00006604|80936563|FG005|Overall Study|Site closing|0|||
27656415|NCT04474691|80583175|FG000|Overall Study|Withdrawal by Subject|9|||
27656416|NCT02097056|80583181|FG000|Overall Study|Protocol Violation|2|||
27656417|NCT02097056|80583181|FG000|Overall Study|Withdrawal by Subject|15|||
27656418|NCT02097056|80583181|FG000|Overall Study|Lost to Follow-up|2|||
27656419|NCT02097056|80583181|FG000|Overall Study|Adverse Event|37|||
27656420|NCT02097056|80583181|FG000|Overall Study|Other|2|||
27656421|NCT03508830|80583182|FG000|Overall Study|Withdrawal by Subject|3|||
27656422|NCT03508830|80583183|FG001|Overall Study|Withdrawal by Subject|4|||
27656423|NCT03508830|80583182|FG000|Overall Study|Physician Decision|2|||
27656424|NCT03508830|80583183|FG001|Overall Study|Physician Decision|2|||
27656425|NCT00422162|80583184|FG000|Overall Study|Adverse Event|11|||
27656426|NCT00422162|80583185|FG001|Overall Study|Adverse Event|9|||
27656427|NCT00422162|80583184|FG000|Overall Study|Lack of Efficacy|4|||
27656428|NCT00422162|80583185|FG001|Overall Study|Lack of Efficacy|10|||
27656429|NCT00422162|80583184|FG000|Overall Study|Withdrawal by Subject|7|||
27656430|NCT00422162|80583185|FG001|Overall Study|Withdrawal by Subject|6|||
27656431|NCT00422162|80583184|FG000|Overall Study|Lost to Follow-up|1|||
27656432|NCT00422162|80583185|FG001|Overall Study|Lost to Follow-up|2|||
27656433|NCT00422162|80583184|FG000|Overall Study|Non-Compliant with Protocol|1|||
27656434|NCT00422162|80583185|FG001|Overall Study|Non-Compliant with Protocol|1|||
27656435|NCT00422162|80583184|FG000|Overall Study|Other|0|||
27656436|NCT00422162|80583185|FG001|Overall Study|Other|1|||
27656437|NCT00422162|80583184|FG000|Overall Study|Didn't Receive Treatment|0|||
27656438|NCT00422162|80583185|FG001|Overall Study|Didn't Receive Treatment|1|||
27756967|NCT00006604|80936564|FG006|Overall Study|Site closing|0|||
27756968|NCT00006604|80936565|FG007|Overall Study|Site closing|1|||
27756969|NCT00006604|80936566|FG008|Overall Study|Site closing|0|||
27756970|NCT00006604|80936567|FG009|Overall Study|Site closing|0|||
27756971|NCT00006604|80936568|FG010|Overall Study|Site closing|0|||
27656439|NCT02163499|80583186|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
27656440|NCT02163499|80583186|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
27656441|NCT02163499|80583186|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
27656442|NCT02163499|80583186|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
27656443|NCT02163499|80583186|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
27656444|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
27656445|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
27656446|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
27656447|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
27656448|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
27656449|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
27656450|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
27656451|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
27656452|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
27656453|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Death|8|||
27656454|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
27656455|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
27656456|NCT02163499|80583186|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
27656457|NCT01277302|80583188|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
27656458|NCT01277302|80583189|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
27656459|NCT01277302|80583190|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
27656460|NCT01277302|80583188|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
27656461|NCT01277302|80583189|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
27656462|NCT01277302|80583190|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
27656463|NCT01277302|80583188|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
27656464|NCT01277302|80583189|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
27656465|NCT01277302|80583190|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
27656466|NCT01277302|80583188|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
27656467|NCT01277302|80583189|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
27656468|NCT01277302|80583190|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
27656469|NCT01277302|80583188|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
27656470|NCT01277302|80583189|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
27656471|NCT01277302|80583190|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
27656472|NCT01277302|80583188|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
27656473|NCT01277302|80583189|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
27656474|NCT01277302|80583190|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
27656475|NCT01277302|80583188|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
27756972|NCT00006604|80936569|FG011|Overall Study|Site closing|1|||
27756973|NCT00006604|80936570|FG012|Overall Study|Site closing|1|||
27756974|NCT00006604|80936571|FG013|Overall Study|Site closing|1|||
27756975|NCT00006604|80936572|FG014|Overall Study|Site closing|0|||
27756976|NCT00006604|80936573|FG015|Overall Study|Site closing|0|||
27756977|NCT00006604|80936574|FG016|Overall Study|Site closing|1|||
27756978|NCT00006604|80936558|FG000|Overall Study|Withdrawal by Subject|1|||
27756979|NCT00006604|80936559|FG001|Overall Study|Withdrawal by Subject|0|||
27756980|NCT00006604|80936560|FG002|Overall Study|Withdrawal by Subject|2|||
27756981|NCT00006604|80936561|FG003|Overall Study|Withdrawal by Subject|0|||
27756982|NCT00006604|80936562|FG004|Overall Study|Withdrawal by Subject|1|||
27756983|NCT00006604|80936563|FG005|Overall Study|Withdrawal by Subject|2|||
27756984|NCT00006604|80936564|FG006|Overall Study|Withdrawal by Subject|2|||
27756985|NCT00006604|80936565|FG007|Overall Study|Withdrawal by Subject|0|||
27756986|NCT00006604|80936566|FG008|Overall Study|Withdrawal by Subject|1|||
27756987|NCT00006604|80936567|FG009|Overall Study|Withdrawal by Subject|3|||
27756988|NCT00006604|80936568|FG010|Overall Study|Withdrawal by Subject|2|||
27756989|NCT00006604|80936569|FG011|Overall Study|Withdrawal by Subject|0|||
27756990|NCT00006604|80936570|FG012|Overall Study|Withdrawal by Subject|1|||
27756991|NCT00006604|80936571|FG013|Overall Study|Withdrawal by Subject|2|||
27756992|NCT00006604|80936572|FG014|Overall Study|Withdrawal by Subject|1|||
27656476|NCT01277302|80583189|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
27656477|NCT01277302|80583190|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
27656478|NCT01277302|80583188|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
27656479|NCT01277302|80583189|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
27656480|NCT01277302|80583190|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
27656481|NCT01277302|80583188|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
27656482|NCT01277302|80583189|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
27656483|NCT01277302|80583190|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
27656484|NCT01768572|80583191|FG000|Overall Study|Adverse Event|7|||
27656485|NCT01768572|80583192|FG001|Overall Study|Adverse Event|8|||
27656486|NCT01768572|80583193|FG002|Overall Study|Adverse Event|4|||
27656487|NCT01768572|80583191|FG000|Overall Study|Lack of Efficacy|1|||
27656488|NCT01768572|80583192|FG001|Overall Study|Lack of Efficacy|3|||
27656489|NCT01768572|80583193|FG002|Overall Study|Lack of Efficacy|1|||
27656490|NCT01768572|80583191|FG000|Overall Study|Other, Not due to an adverse event|1|||
27656491|NCT01768572|80583192|FG001|Overall Study|Other, Not due to an adverse event|1|||
27656492|NCT01768572|80583193|FG002|Overall Study|Other, Not due to an adverse event|1|||
27656493|NCT03740919|80583194|FG000|Lead-in Period|Lost to Follow-up|1|||
27656494|NCT03740919|80583195|FG001|Lead-in Period|Lost to Follow-up|0|||
27656495|NCT03740919|80583196|FG002|Lead-in Period|Lost to Follow-up|0|||
27656496|NCT03740919|80583197|FG003|Lead-in Period|Lost to Follow-up|0|||
27656497|NCT03740919|80583194|FG000|Lead-in Period|Physician Decision|2|||
27656498|NCT03740919|80583195|FG001|Lead-in Period|Physician Decision|0|||
27656499|NCT03740919|80583196|FG002|Lead-in Period|Physician Decision|0|||
27656500|NCT03740919|80583197|FG003|Lead-in Period|Physician Decision|0|||
27656501|NCT03740919|80583194|FG000|Lead-in Period|Protocol Violation|1|||
27656502|NCT03740919|80583195|FG001|Lead-in Period|Protocol Violation|0|||
27656503|NCT03740919|80583196|FG002|Lead-in Period|Protocol Violation|0|||
27656504|NCT03740919|80583197|FG003|Lead-in Period|Protocol Violation|0|||
27656505|NCT03740919|80583194|FG000|Lead-in Period|Withdrawal by Subject|10|||
27656506|NCT03740919|80583195|FG001|Lead-in Period|Withdrawal by Subject|0|||
27756993|NCT00006604|80936573|FG015|Overall Study|Withdrawal by Subject|0|||
27756994|NCT00006604|80936574|FG016|Overall Study|Withdrawal by Subject|1|||
27756995|NCT00006604|80936558|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
27756996|NCT00006604|80936559|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
27756997|NCT00006604|80936560|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
27756998|NCT00006604|80936561|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
27756999|NCT00006604|80936562|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
27757000|NCT00006604|80936563|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
27757001|NCT00006604|80936564|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
27757002|NCT00006604|80936565|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
27757003|NCT00006604|80936566|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
27757004|NCT00006604|80936567|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
27757005|NCT00006604|80936568|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
27757006|NCT00006604|80936569|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
27757007|NCT00006604|80936570|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
27757008|NCT00006604|80936571|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
27757009|NCT00006604|80936572|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
27757010|NCT00006604|80936573|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
27757011|NCT00006604|80936574|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
27757012|NCT00006604|80936558|FG000|Overall Study|Lost to Follow-up|0|||
27757013|NCT00006604|80936559|FG001|Overall Study|Lost to Follow-up|0|||
27757014|NCT00006604|80936560|FG002|Overall Study|Lost to Follow-up|0|||
27757015|NCT00006604|80936561|FG003|Overall Study|Lost to Follow-up|0|||
27757016|NCT00006604|80936562|FG004|Overall Study|Lost to Follow-up|0|||
27757017|NCT00006604|80936563|FG005|Overall Study|Lost to Follow-up|0|||
27757018|NCT00006604|80936564|FG006|Overall Study|Lost to Follow-up|0|||
27757019|NCT00006604|80936565|FG007|Overall Study|Lost to Follow-up|1|||
27757020|NCT00006604|80936566|FG008|Overall Study|Lost to Follow-up|0|||
27757021|NCT00006604|80936567|FG009|Overall Study|Lost to Follow-up|2|||
27757022|NCT00006604|80936568|FG010|Overall Study|Lost to Follow-up|0|||
27757023|NCT00006604|80936569|FG011|Overall Study|Lost to Follow-up|0|||
27757024|NCT00006604|80936570|FG012|Overall Study|Lost to Follow-up|0|||
27757025|NCT00006604|80936571|FG013|Overall Study|Lost to Follow-up|0|||
27757026|NCT00006604|80936572|FG014|Overall Study|Lost to Follow-up|0|||
27656507|NCT03740919|80583196|FG002|Lead-in Period|Withdrawal by Subject|0|||
27757027|NCT00006604|80936573|FG015|Overall Study|Lost to Follow-up|1|||
27757028|NCT00006604|80936574|FG016|Overall Study|Lost to Follow-up|3|||
27757029|NCT00006604|80936558|FG000|Overall Study|Other Reason|0|||
27757030|NCT00006604|80936559|FG001|Overall Study|Other Reason|0|||
27757031|NCT00006604|80936560|FG002|Overall Study|Other Reason|0|||
27757032|NCT00006604|80936561|FG003|Overall Study|Other Reason|0|||
27757033|NCT00006604|80936562|FG004|Overall Study|Other Reason|0|||
27757034|NCT00006604|80936563|FG005|Overall Study|Other Reason|1|||
27757035|NCT00006604|80936564|FG006|Overall Study|Other Reason|0|||
27757036|NCT00006604|80936565|FG007|Overall Study|Other Reason|0|||
27757037|NCT00006604|80936566|FG008|Overall Study|Other Reason|0|||
27757038|NCT00006604|80936567|FG009|Overall Study|Other Reason|1|||
27757039|NCT00006604|80936568|FG010|Overall Study|Other Reason|0|||
27757040|NCT00006604|80936569|FG011|Overall Study|Other Reason|0|||
27757041|NCT00006604|80936570|FG012|Overall Study|Other Reason|0|||
27757042|NCT00006604|80936571|FG013|Overall Study|Other Reason|0|||
27757043|NCT00006604|80936572|FG014|Overall Study|Other Reason|0|||
27757044|NCT00006604|80936573|FG015|Overall Study|Other Reason|0|||
27757045|NCT00006604|80936574|FG016|Overall Study|Other Reason|0|||
27757046|NCT01575197|80936575|FG000|Overall Study|Migration out of study area|1|||
27757047|NCT01575197|80936576|FG001|Overall Study|Migration out of study area|5|||
27757048|NCT01575197|80936577|FG002|Overall Study|Migration out of study area|4|||
27757049|NCT01575197|80936575|FG000|Overall Study|SAE|0|||
27757050|NCT01575197|80936576|FG001|Overall Study|SAE|1|||
27757051|NCT01575197|80936577|FG002|Overall Study|SAE|0|||
27757052|NCT01575197|80936575|FG000|Overall Study|Lost to Follow-up|0|||
27757053|NCT01575197|80936576|FG001|Overall Study|Lost to Follow-up|1|||
27757054|NCT01575197|80936577|FG002|Overall Study|Lost to Follow-up|0|||
27757055|NCT01575197|80936575|FG000|Overall Study|Withdrawal by Subject|0|||
27757056|NCT01575197|80936576|FG001|Overall Study|Withdrawal by Subject|1|||
27757057|NCT01575197|80936577|FG002|Overall Study|Withdrawal by Subject|1|||
27757058|NCT01575197|80936575|FG000|Overall Study|Protocol Violation|2|||
27757059|NCT01575197|80936576|FG001|Overall Study|Protocol Violation|1|||
27757060|NCT01575197|80936577|FG002|Overall Study|Protocol Violation|1|||
27757061|NCT00592553|80936578|FG000|Overall Study|Protocol Noncompliance|1|||
27757062|NCT00592553|80936579|FG001|Overall Study|Protocol Noncompliance|0|||
27757063|NCT00592553|80936580|FG002|Overall Study|Protocol Noncompliance|0|||
27757064|NCT01797965|80936581|FG000|Overall Study|Adverse Event|104|||
27757065|NCT01797965|80936582|FG001|Overall Study|Adverse Event|129|||
27757066|NCT01797965|80936583|FG002|Overall Study|Adverse Event|4|||
27757067|NCT01797965|80936584|FG003|Overall Study|Adverse Event|21|||
27757068|NCT01797965|80936581|FG000|Overall Study|Lost to Follow-up|9|||
27757069|NCT01797965|80936582|FG001|Overall Study|Lost to Follow-up|8|||
27757070|NCT01797965|80936583|FG002|Overall Study|Lost to Follow-up|1|||
27757071|NCT01797965|80936584|FG003|Overall Study|Lost to Follow-up|2|||
27757072|NCT01797965|80936581|FG000|Overall Study|Consent withdrawn|130|||
27757073|NCT01797965|80936582|FG001|Overall Study|Consent withdrawn|117|||
27656508|NCT03740919|80583197|FG003|Lead-in Period|Withdrawal by Subject|0|||
27656509|NCT03740919|80583194|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
27656510|NCT03740919|80583195|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
27656511|NCT03740919|80583196|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
27656512|NCT03740919|80583197|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
27656513|NCT03740919|80583194|FG000|Lead-in Period|Study Task Too Burdensome|1|||
27656514|NCT03740919|80583195|FG001|Lead-in Period|Study Task Too Burdensome|0|||
27656515|NCT03740919|80583196|FG002|Lead-in Period|Study Task Too Burdensome|0|||
27656516|NCT03740919|80583197|FG003|Lead-in Period|Study Task Too Burdensome|0|||
27656517|NCT03740919|80583194|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
27656518|NCT03740919|80583195|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
27656519|NCT03740919|80583196|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
27656520|NCT03740919|80583197|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
27656521|NCT03740919|80583194|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
27656522|NCT03740919|80583195|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
27656523|NCT03740919|80583196|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
27656524|NCT03740919|80583197|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
27656525|NCT03740919|80583194|FG000|Treatment Period|Adverse Event|0|||
27656526|NCT03740919|80583195|FG001|Treatment Period|Adverse Event|0|||
27656527|NCT03740919|80583196|FG002|Treatment Period|Adverse Event|2|||
27656528|NCT03740919|80583197|FG003|Treatment Period|Adverse Event|0|||
27656529|NCT03740919|80583194|FG000|Treatment Period|Protocol Violation|0|||
27757074|NCT01797965|80936583|FG002|Overall Study|Consent withdrawn|3|||
27757075|NCT01797965|80936584|FG003|Overall Study|Consent withdrawn|35|||
27757076|NCT01797965|80936581|FG000|Overall Study|Investigator decision|21|||
27757077|NCT01797965|80936582|FG001|Overall Study|Investigator decision|15|||
27757078|NCT01797965|80936583|FG002|Overall Study|Investigator decision|0|||
27757079|NCT01797965|80936584|FG003|Overall Study|Investigator decision|0|||
27757080|NCT01797965|80936581|FG000|Overall Study|Death|2|||
27757081|NCT01797965|80936582|FG001|Overall Study|Death|4|||
27656530|NCT03740919|80583195|FG001|Treatment Period|Protocol Violation|1|||
27656531|NCT03740919|80583196|FG002|Treatment Period|Protocol Violation|0|||
27656532|NCT03740919|80583197|FG003|Treatment Period|Protocol Violation|0|||
27656533|NCT03740919|80583194|FG000|Treatment Period|Withdrawal by Subject|0|||
27656534|NCT03740919|80583195|FG001|Treatment Period|Withdrawal by Subject|7|||
27656535|NCT03740919|80583196|FG002|Treatment Period|Withdrawal by Subject|6|||
27656536|NCT03740919|80583197|FG003|Treatment Period|Withdrawal by Subject|2|||
27656537|NCT03740919|80583194|FG000|Treatment Period|Terminated by Sponsor|0|||
27656538|NCT03740919|80583195|FG001|Treatment Period|Terminated by Sponsor|1|||
27656539|NCT03740919|80583196|FG002|Treatment Period|Terminated by Sponsor|0|||
27656540|NCT03740919|80583197|FG003|Treatment Period|Terminated by Sponsor|0|||
27656541|NCT03740919|80583194|FG000|Treatment Period|Issue with Insulin Pump|0|||
27656542|NCT03740919|80583195|FG001|Treatment Period|Issue with Insulin Pump|1|||
27656543|NCT03740919|80583196|FG002|Treatment Period|Issue with Insulin Pump|0|||
27656544|NCT03740919|80583197|FG003|Treatment Period|Issue with Insulin Pump|0|||
27656545|NCT03740919|80583194|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
27656546|NCT03740919|80583195|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
27656547|NCT03740919|80583196|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
27656548|NCT03740919|80583197|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
27656549|NCT03740919|80583194|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
27656550|NCT03740919|80583195|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
27656551|NCT03740919|80583196|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
27656552|NCT03740919|80583197|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
27656553|NCT03740919|80583194|FG000|Treatment Period|Not Completing Diary|0|||
27656554|NCT03740919|80583195|FG001|Treatment Period|Not Completing Diary|0|||
27656555|NCT03740919|80583196|FG002|Treatment Period|Not Completing Diary|1|||
27656556|NCT03740919|80583197|FG003|Treatment Period|Not Completing Diary|0|||
27656557|NCT03740919|80583194|FG000|Treatment Period|Insulin Painful to Participant|0|||
27656558|NCT03740919|80583195|FG001|Treatment Period|Insulin Painful to Participant|0|||
27656559|NCT03740919|80583196|FG002|Treatment Period|Insulin Painful to Participant|1|||
27656560|NCT03740919|80583197|FG003|Treatment Period|Insulin Painful to Participant|0|||
27656561|NCT00472199|80583198|FG000|Overall Study|Adverse Event|19|||
27656562|NCT00472199|80583199|FG001|Overall Study|Adverse Event|23|||
27656563|NCT00472199|80583198|FG000|Overall Study|Lack of Efficacy|4|||
27656564|NCT00472199|80583199|FG001|Overall Study|Lack of Efficacy|25|||
27656565|NCT00472199|80583198|FG000|Overall Study|Lost to Follow-up|2|||
27656566|NCT00472199|80583199|FG001|Overall Study|Lost to Follow-up|4|||
27656567|NCT00472199|80583198|FG000|Overall Study|Protocol Violation|3|||
27656568|NCT00472199|80583199|FG001|Overall Study|Protocol Violation|2|||
27656569|NCT00472199|80583198|FG000|Overall Study|Withdrawal by Subject|6|||
27656570|NCT00472199|80583199|FG001|Overall Study|Withdrawal by Subject|5|||
27656571|NCT00472199|80583198|FG000|Overall Study|personal reason|0|||
27656572|NCT00472199|80583199|FG001|Overall Study|personal reason|1|||
27656573|NCT00472199|80583198|FG000|Overall Study|patient was asymptomatic|1|||
27656574|NCT00472199|80583199|FG001|Overall Study|patient was asymptomatic|0|||
27656575|NCT05287178|80583200|FG000|Overall Study|Lost to Follow-up|2|||
27656576|NCT00871494|80583203|FG000|Overall Study|Protocol Violation|5|||
27656577|NCT00871494|80583203|FG000|Overall Study|Lack of Efficacy|4|||
27656578|NCT00871494|80583203|FG000|Overall Study|Adverse Event|4|||
27656579|NCT00871494|80583203|FG000|Overall Study|Lost to Follow-up|1|||
27656580|NCT00755716|80583204|FG000|Overall Study|Adverse Event|1|||
27656581|NCT00755716|80583205|FG001|Overall Study|Adverse Event|4|||
27566561|NCT01023581|80263367|FG003|Overall Study|Adverse Event|3|||
27566562|NCT01023581|80263368|FG004|Overall Study|Adverse Event|2|||
27566563|NCT01023581|80263369|FG005|Overall Study|Adverse Event|5|||
27566564|NCT01023581|80263370|FG006|Overall Study|Adverse Event|11|||
27566565|NCT01023581|80263364|FG000|Overall Study|Major protocol deviation|2|||
27566566|NCT01023581|80263365|FG001|Overall Study|Major protocol deviation|0|||
27566567|NCT01023581|80263366|FG002|Overall Study|Major protocol deviation|3|||
27656582|NCT00755716|80583206|FG002|Overall Study|Adverse Event|1|||
27656583|NCT00755716|80583204|FG000|Overall Study|Lack of Efficacy|2|||
27656584|NCT00755716|80583205|FG001|Overall Study|Lack of Efficacy|0|||
27656585|NCT00755716|80583206|FG002|Overall Study|Lack of Efficacy|0|||
27656586|NCT00755716|80583204|FG000|Overall Study|Lost to Follow-up|5|||
27656587|NCT00755716|80583205|FG001|Overall Study|Lost to Follow-up|3|||
27656588|NCT00755716|80583206|FG002|Overall Study|Lost to Follow-up|1|||
27656589|NCT00755716|80583204|FG000|Overall Study|work schedule issues|0|||
27656590|NCT00755716|80583205|FG001|Overall Study|work schedule issues|1|||
27566568|NCT01023581|80263367|FG003|Overall Study|Major protocol deviation|0|||
27566569|NCT01023581|80263368|FG004|Overall Study|Major protocol deviation|0|||
27566570|NCT01023581|80263369|FG005|Overall Study|Major protocol deviation|0|||
27566571|NCT01023581|80263370|FG006|Overall Study|Major protocol deviation|0|||
27566572|NCT01023581|80263364|FG000|Overall Study|Lost to Follow-up|4|||
27566573|NCT01023581|80263365|FG001|Overall Study|Lost to Follow-up|8|||
27656591|NCT00755716|80583206|FG002|Overall Study|work schedule issues|1|||
27566574|NCT01023581|80263366|FG002|Overall Study|Lost to Follow-up|7|||
27566575|NCT01023581|80263367|FG003|Overall Study|Lost to Follow-up|2|||
27656592|NCT01695993|80583207|FG000|Overall Study|Lost to Follow-up|2|||
27656593|NCT01695993|80583208|FG001|Overall Study|Lost to Follow-up|1|||
27656594|NCT01695993|80583209|FG002|Overall Study|Lost to Follow-up|3|||
27656595|NCT01695993|80583207|FG000|Overall Study|Withdrawal by Subject|2|||
27656596|NCT01695993|80583208|FG001|Overall Study|Withdrawal by Subject|2|||
27656597|NCT01695993|80583209|FG002|Overall Study|Withdrawal by Subject|2|||
27656598|NCT01695993|80583207|FG000|Overall Study|To ill to continue|1|||
27656599|NCT01695993|80583208|FG001|Overall Study|To ill to continue|2|||
27656600|NCT01695993|80583209|FG002|Overall Study|To ill to continue|0|||
27656601|NCT01695993|80583207|FG000|Overall Study|Changed Medical Facility|0|||
27656602|NCT01695993|80583208|FG001|Overall Study|Changed Medical Facility|0|||
27656603|NCT01695993|80583209|FG002|Overall Study|Changed Medical Facility|1|||
27656604|NCT01544309|80583211|FG000|Overall Study|Withdrawal by Subject|12|||
27656605|NCT01544309|80583212|FG001|Overall Study|Withdrawal by Subject|7|||
27656606|NCT01544309|80583211|FG000|Overall Study|Protocol Violation|2|||
27656607|NCT01544309|80583212|FG001|Overall Study|Protocol Violation|1|||
27656608|NCT01544309|80583211|FG000|Overall Study|Physician Decision|4|||
27656609|NCT01544309|80583212|FG001|Overall Study|Physician Decision|1|||
27656610|NCT01544309|80583211|FG000|Overall Study|Not performed pre-dose examination|1|||
27656611|NCT01544309|80583212|FG001|Overall Study|Not performed pre-dose examination|2|||
27656612|NCT01544309|80583211|FG000|Overall Study|Administered prohibit prior medication|1|||
27656613|NCT01544309|80583212|FG001|Overall Study|Administered prohibit prior medication|0|||
27656614|NCT02335242|80583213|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
27656615|NCT02335242|80583214|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
27656616|NCT02335242|80583213|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
27656617|NCT02335242|80583214|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27656618|NCT02335242|80583213|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
27656619|NCT02335242|80583214|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
27656620|NCT02889809|80583219|FG000|Overall Study|Withdrawal by Subject|30|||
27656621|NCT02889809|80583220|FG001|Overall Study|Withdrawal by Subject|21|||
27656622|NCT02889809|80583219|FG000|Overall Study|Lost to Follow-up|1|||
27656623|NCT02889809|80583220|FG001|Overall Study|Lost to Follow-up|1|||
27656624|NCT02889809|80583219|FG000|Overall Study|Site Closed|12|||
27656625|NCT02889809|80583220|FG001|Overall Study|Site Closed|11|||
27656626|NCT00914732|80583221|FG000|Overall Study|Lost to Follow-up|6|||
27656627|NCT00914732|80583222|FG001|Overall Study|Lost to Follow-up|7|||
27656628|NCT00914732|80583223|FG002|Overall Study|Lost to Follow-up|9|||
27656629|NCT00914732|80583221|FG000|Overall Study|Withdrawal by Subject|3|||
27656630|NCT00914732|80583222|FG001|Overall Study|Withdrawal by Subject|0|||
27656631|NCT00914732|80583223|FG002|Overall Study|Withdrawal by Subject|2|||
27656632|NCT00914732|80583221|FG000|Overall Study|Adverse Event|1|||
27656633|NCT00914732|80583222|FG001|Overall Study|Adverse Event|0|||
27656634|NCT00914732|80583223|FG002|Overall Study|Adverse Event|0|||
27656635|NCT03928821|80583224|FG000|Overall Study|Death|0|||
27656636|NCT03928821|80583225|FG001|Overall Study|Death|1|||
27656637|NCT03928821|80583226|FG002|Overall Study|Death|0|||
27656638|NCT03928821|80583227|FG003|Overall Study|Death|0|||
27656639|NCT03928821|80583224|FG000|Overall Study|Lost to Follow-up|0|||
27656640|NCT03928821|80583225|FG001|Overall Study|Lost to Follow-up|2|||
27656641|NCT03928821|80583226|FG002|Overall Study|Lost to Follow-up|3|||
27656642|NCT03928821|80583227|FG003|Overall Study|Lost to Follow-up|0|||
27656643|NCT03928821|80583224|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27656644|NCT03928821|80583225|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27656645|NCT03928821|80583226|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27656646|NCT03928821|80583227|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
27656647|NCT00396409|80583231|FG000|Period 1 - 2007|Adverse Event|0|||
27656648|NCT00396409|80583232|FG001|Period 1 - 2007|Adverse Event|1|||
27656649|NCT00396409|80583231|FG000|Period 1 - 2007|Lack of Efficacy|0|||
27656650|NCT00396409|80583232|FG001|Period 1 - 2007|Lack of Efficacy|1|||
27656651|NCT00396409|80583231|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
27656652|NCT00396409|80583232|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
27656653|NCT00396409|80583231|FG000|Period 1 - 2007|Lost to Follow-up|2|||
27656654|NCT00396409|80583232|FG001|Period 1 - 2007|Lost to Follow-up|3|||
27656655|NCT00396409|80583231|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
27656656|NCT00396409|80583232|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
27656657|NCT00396409|80583231|FG000|Period 2 - 2008|Protocol Violation|1|||
27656658|NCT00396409|80583232|FG001|Period 2 - 2008|Protocol Violation|0|||
27656659|NCT00396409|80583231|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
27656660|NCT00396409|80583232|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
27656661|NCT00396409|80583231|FG000|Period 2 - 2008|Lost to Follow-up|3|||
27656662|NCT00396409|80583232|FG001|Period 2 - 2008|Lost to Follow-up|1|||
27656663|NCT02097420|80583235|FG000|Overall Study|Death|6|||
27757082|NCT01797965|80936583|FG002|Overall Study|Death|0|||
27757083|NCT01797965|80936584|FG003|Overall Study|Death|0|||
27656664|NCT02097420|80583235|FG000|Overall Study|Valve explanted|13|||
27656665|NCT02097420|80583235|FG000|Overall Study|Other Reason|1|||
27656666|NCT01072149|80583236|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656667|NCT01072149|80583237|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656668|NCT01072149|80583238|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27656669|NCT01072149|80583239|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656670|NCT01072149|80583240|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656671|NCT01072149|80583241|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656672|NCT01072149|80583242|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27757084|NCT01797965|80936581|FG000|Overall Study|Disease progression, defined by protocol|3|||
27757085|NCT01797965|80936582|FG001|Overall Study|Disease progression, defined by protocol|1|||
27757086|NCT01797965|80936583|FG002|Overall Study|Disease progression, defined by protocol|0|||
27757087|NCT01797965|80936584|FG003|Overall Study|Disease progression, defined by protocol|0|||
27757088|NCT01797965|80936581|FG000|Overall Study|Reason Not Specified|280|||
27757089|NCT01797965|80936582|FG001|Overall Study|Reason Not Specified|295|||
27757090|NCT01797965|80936583|FG002|Overall Study|Reason Not Specified|0|||
27757091|NCT01797965|80936584|FG003|Overall Study|Reason Not Specified|15|||
27757092|NCT01265420|80936585|FG000|Overall Study|Lost to Follow-up|1|||
27757093|NCT00992784|80936586|FG000|Overall Study|Adverse Event|2|||
27757094|NCT00992784|80936587|FG001|Overall Study|Adverse Event|1|||
27757095|NCT00992784|80936588|FG002|Overall Study|Adverse Event|0|||
27757096|NCT00992784|80936586|FG000|Overall Study|Withdrawal by Subject|1|||
27757097|NCT00992784|80936587|FG001|Overall Study|Withdrawal by Subject|1|||
27757098|NCT00992784|80936588|FG002|Overall Study|Withdrawal by Subject|1|||
27757099|NCT01980706|80936595|FG000|Overall Study|Withdrawal by Subject|9|||
27757100|NCT01980706|80936596|FG001|Overall Study|Withdrawal by Subject|6|||
27757101|NCT01980706|80936597|FG002|Overall Study|Withdrawal by Subject|2|||
27757102|NCT01980706|80936595|FG000|Overall Study|Adverse Event|1|||
27757103|NCT01980706|80936596|FG001|Overall Study|Adverse Event|2|||
27757104|NCT01980706|80936597|FG002|Overall Study|Adverse Event|5|||
27757105|NCT01980706|80936595|FG000|Overall Study|Lost to Follow-up|3|||
27757106|NCT01980706|80936596|FG001|Overall Study|Lost to Follow-up|4|||
27757107|NCT01980706|80936597|FG002|Overall Study|Lost to Follow-up|3|||
27757108|NCT01980706|80936595|FG000|Overall Study|miscellaneous|4|||
27757109|NCT01980706|80936596|FG001|Overall Study|miscellaneous|5|||
27757110|NCT01980706|80936597|FG002|Overall Study|miscellaneous|3|||
27757111|NCT03137121|80936598|FG000|Overall Study|Withdrawal by Subject|0|||
27757112|NCT03137121|80936599|FG001|Overall Study|Withdrawal by Subject|1|||
27757113|NCT02237157|80936600|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
27757114|NCT02237157|80936601|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
27757115|NCT02237157|80936602|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
27757116|NCT02237157|80936603|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
27757117|NCT02237157|80936600|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
27757118|NCT02237157|80936601|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
27757119|NCT02237157|80936602|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
27757120|NCT02237157|80936603|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
27757121|NCT00254293|80936604|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
27757122|NCT00254293|80936605|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
27757123|NCT00254293|80936606|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
27757124|NCT00254293|80936607|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
27757125|NCT00254293|80936608|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
27757126|NCT00254293|80936609|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
27757127|NCT00254293|80936610|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
27757128|NCT00254293|80936604|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
27757129|NCT00254293|80936605|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
27757130|NCT00254293|80936606|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
27757131|NCT00254293|80936607|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
27757132|NCT00254293|80936608|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
27757133|NCT00254293|80936609|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
27757134|NCT00254293|80936610|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
27757135|NCT00254293|80936604|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27757136|NCT00254293|80936605|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27757137|NCT00254293|80936606|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
27757138|NCT00254293|80936607|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27757139|NCT00254293|80936608|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27757140|NCT00254293|80936609|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27757141|NCT00254293|80936610|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
27757142|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Death|0|||
27757143|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Death|0|||
27566576|NCT01023581|80263368|FG004|Overall Study|Lost to Follow-up|5|||
27757144|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Death|1|||
27757145|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Death|0|||
27757146|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Death|0|||
27757147|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Death|0|||
27757148|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Death|0|||
27757149|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
27757150|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
27757151|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
27757152|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
27757153|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
27757154|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
27757155|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
27757156|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
27757157|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
27757158|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
27757159|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
27757160|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
27757161|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
27757162|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
27757163|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
27757164|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
27757165|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
27757166|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
27757167|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
27757168|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
27757169|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
27757170|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
27757171|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
27757172|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
27757173|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
27757174|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
27757175|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
27757176|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
27757177|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
27757178|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
27757179|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
27757180|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
27757181|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
27757182|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
27757183|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
27757184|NCT00254293|80936604|FG000|LTE Open Label Variable SC Dosing|Other|0|||
27757185|NCT00254293|80936605|FG001|LTE Open Label Variable SC Dosing|Other|0|||
27757186|NCT00254293|80936606|FG002|LTE Open Label Variable SC Dosing|Other|2|||
27757187|NCT00254293|80936607|FG003|LTE Open Label Variable SC Dosing|Other|0|||
27757188|NCT00254293|80936608|FG004|LTE Open Label Variable SC Dosing|Other|0|||
27757189|NCT00254293|80936609|FG005|LTE Open Label Variable SC Dosing|Other|0|||
27757190|NCT00254293|80936610|FG006|LTE Open Label Variable SC Dosing|Other|0|||
27757191|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Death|0|||
27757192|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Death|0|||
27757193|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Death|0|||
27757194|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Death|0|||
27757195|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Death|0|||
27757196|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Death|0|||
27757197|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Death|3|||
27757198|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
27757199|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
27757200|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
27757201|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
27757202|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
27757203|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
27757204|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
27757205|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27757206|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27757207|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27757208|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27757209|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27757210|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
27757211|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
27757212|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27757213|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27757214|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27757215|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27757216|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27757217|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
27757218|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
27757219|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27757220|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27757221|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27757222|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27757223|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27757224|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
27757225|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
27757226|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
27757227|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
27757228|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
27757229|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
27757230|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
27757231|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
27757232|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
27757233|NCT00254293|80936604|FG000|LTE Open Label Fixed Dosing|Other|0|||
27757234|NCT00254293|80936605|FG001|LTE Open Label Fixed Dosing|Other|0|||
27757235|NCT00254293|80936606|FG002|LTE Open Label Fixed Dosing|Other|0|||
27757236|NCT00254293|80936607|FG003|LTE Open Label Fixed Dosing|Other|0|||
27757237|NCT00254293|80936608|FG004|LTE Open Label Fixed Dosing|Other|0|||
27757238|NCT00254293|80936609|FG005|LTE Open Label Fixed Dosing|Other|0|||
27757239|NCT00254293|80936610|FG006|LTE Open Label Fixed Dosing|Other|1|||
27757240|NCT00575094|80936611|FG000|Overall Study|Adverse Event|2|||
27757241|NCT00575094|80936611|FG000|Overall Study|Withdrawal by Subject|1|||
27757242|NCT02432040|80936612|FG000|Overall Study|Lack of Efficacy|3|||
27757243|NCT02432040|80936613|FG001|Overall Study|Lack of Efficacy|0|||
27757244|NCT02432040|80936612|FG000|Overall Study|Lost to Follow-up|4|||
27757245|NCT02432040|80936613|FG001|Overall Study|Lost to Follow-up|5|||
27757246|NCT02432040|80936612|FG000|Overall Study|Physician Decision|1|||
27757247|NCT02432040|80936613|FG001|Overall Study|Physician Decision|1|||
27757248|NCT01089582|80936614|FG000|Overall Study|Death|2|||
27757249|NCT01089582|80936614|FG000|Overall Study|Adverse Event|15|||
27757250|NCT01089582|80936614|FG000|Overall Study|Lost to Follow-up|8|||
27757251|NCT01089582|80936614|FG000|Overall Study|Other|4|||
27757252|NCT01089582|80936614|FG000|Overall Study|Withdrawal by Subject|1|||
27757253|NCT01357915|80936618|FG000|Overall Study|Lost to Follow-up|3|||
27757254|NCT01357915|80936619|FG001|Overall Study|Lost to Follow-up|0|||
27757255|NCT01354353|80936620|FG000|Overall Study|Adverse Event|1|||
27757256|NCT01354353|80936621|FG001|Overall Study|Adverse Event|0|||
27757257|NCT01354353|80936622|FG002|Overall Study|Adverse Event|0|||
27757258|NCT01354353|80936623|FG003|Overall Study|Adverse Event|4|||
27757259|NCT01354353|80936624|FG004|Overall Study|Adverse Event|0|||
27757260|NCT01354353|80936625|FG005|Overall Study|Adverse Event|5|||
27757261|NCT01354353|80936620|FG000|Overall Study|Entry Criteria Not Met|0|||
27757262|NCT01354353|80936621|FG001|Overall Study|Entry Criteria Not Met|0|||
27757263|NCT01354353|80936622|FG002|Overall Study|Entry Criteria Not Met|0|||
27757264|NCT01354353|80936623|FG003|Overall Study|Entry Criteria Not Met|1|||
27757265|NCT01354353|80936624|FG004|Overall Study|Entry Criteria Not Met|1|||
27757266|NCT01354353|80936625|FG005|Overall Study|Entry Criteria Not Met|0|||
27757267|NCT01354353|80936620|FG000|Overall Study|Physician Decision|0|||
27757268|NCT01354353|80936621|FG001|Overall Study|Physician Decision|1|||
27757269|NCT01354353|80936622|FG002|Overall Study|Physician Decision|1|||
27757270|NCT01354353|80936623|FG003|Overall Study|Physician Decision|0|||
27757271|NCT01354353|80936624|FG004|Overall Study|Physician Decision|0|||
27757272|NCT01354353|80936625|FG005|Overall Study|Physician Decision|0|||
27757273|NCT01354353|80936620|FG000|Overall Study|Withdrawal by Subject|2|||
27757274|NCT01354353|80936621|FG001|Overall Study|Withdrawal by Subject|0|||
27757275|NCT01354353|80936622|FG002|Overall Study|Withdrawal by Subject|1|||
27757276|NCT01354353|80936623|FG003|Overall Study|Withdrawal by Subject|0|||
27757277|NCT01354353|80936624|FG004|Overall Study|Withdrawal by Subject|0|||
27757278|NCT01354353|80936625|FG005|Overall Study|Withdrawal by Subject|1|||
27757279|NCT02681055|80936626|FG000|Weeks 5-12|Adverse Event|1|||
27757280|NCT02808312|80936627|FG000|Overall Study|Enrolled but Never Treated|0|||
27757281|NCT02808312|80936628|FG001|Overall Study|Enrolled but Never Treated|0|||
27757282|NCT02808312|80936629|FG002|Overall Study|Enrolled but Never Treated|1|||
27757283|NCT02808312|80936630|FG003|Overall Study|Enrolled but Never Treated|0|||
27757284|NCT02808312|80936631|FG004|Overall Study|Enrolled but Never Treated|0|||
27757285|NCT02723591|80936636|FG000|Overall Study|Adverse Event|48|||
27757286|NCT02723591|80936637|FG001|Overall Study|Adverse Event|40|||
27757287|NCT02723591|80936636|FG000|Overall Study|Death|2|||
27757288|NCT02723591|80936637|FG001|Overall Study|Death|2|||
27757289|NCT02723591|80936636|FG000|Overall Study|Lack of Efficacy|4|||
27757290|NCT02723591|80936637|FG001|Overall Study|Lack of Efficacy|3|||
27757291|NCT02723591|80936636|FG000|Overall Study|Lost to Follow-up|1|||
27757292|NCT02723591|80936637|FG001|Overall Study|Lost to Follow-up|7|||
27757293|NCT02723591|80936636|FG000|Overall Study|Protocol Violation|20|||
27757294|NCT02723591|80936637|FG001|Overall Study|Protocol Violation|23|||
27757295|NCT02723591|80936636|FG000|Overall Study|Withdrawal by Subject|4|||
27757296|NCT02723591|80936637|FG001|Overall Study|Withdrawal by Subject|8|||
27757297|NCT02723591|80936636|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
27757298|NCT02723591|80936637|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
27757299|NCT02723591|80936636|FG000|Overall Study|Miscellaneous|5|||
27757300|NCT02723591|80936637|FG001|Overall Study|Miscellaneous|6|||
27757301|NCT01441115|80936638|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
27757302|NCT00608530|80936639|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
27757303|NCT00608530|80936640|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
27757304|NCT00608530|80936641|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
27757305|NCT00608530|80936642|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
27757306|NCT00608530|80936639|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
27757307|NCT00608530|80936640|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
27757308|NCT00608530|80936641|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
27757309|NCT00608530|80936642|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
27757310|NCT00608530|80936639|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
27757311|NCT00608530|80936640|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
27757312|NCT00608530|80936641|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
27757313|NCT00608530|80936642|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
27757314|NCT00608530|80936639|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
27757315|NCT00608530|80936640|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
27757316|NCT00608530|80936641|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
27757317|NCT00608530|80936642|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
27757318|NCT00608530|80936639|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
27757319|NCT00608530|80936640|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
27757320|NCT00608530|80936641|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
27757321|NCT00608530|80936642|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
27757322|NCT00608530|80936639|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
27757323|NCT00608530|80936640|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
27757324|NCT00608530|80936641|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
27757325|NCT00608530|80936642|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
27757326|NCT00844649|80936643|FG000|Overall Study|Progressive Disease|196|||
27757327|NCT00844649|80936644|FG001|Overall Study|Progressive Disease|245|||
27757328|NCT00844649|80936643|FG000|Overall Study|Adverse Event|128|||
27757329|NCT00844649|80936644|FG001|Overall Study|Adverse Event|73|||
27757330|NCT00844649|80936643|FG000|Overall Study|Physician Decision|25|||
27757331|NCT00844649|80936644|FG001|Overall Study|Physician Decision|18|||
27757332|NCT00844649|80936643|FG000|Overall Study|Protocol Violation|10|||
27757333|NCT00844649|80936644|FG001|Overall Study|Protocol Violation|6|||
27757334|NCT00844649|80936643|FG000|Overall Study|Withdrawal by Subject|28|||
27757335|NCT00844649|80936644|FG001|Overall Study|Withdrawal by Subject|39|||
27757336|NCT00844649|80936643|FG000|Overall Study|Other|7|||
27757337|NCT00844649|80936644|FG001|Overall Study|Other|10|||
27757338|NCT00844649|80936643|FG000|Overall Study|Withdrew prior to starting treatment|11|||
27757339|NCT00844649|80936644|FG001|Overall Study|Withdrew prior to starting treatment|27|||
27757340|NCT03544268|80936646|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
27757341|NCT03544268|80936647|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
27757342|NCT02106455|80936649|FG000|Overall Study|Case Report Form Uncollected|6|||
27757343|NCT02106455|80936649|FG000|Overall Study|Protocol Deviation|2|||
27757344|NCT02365584|80936650|FG000|Overall Study|Adverse Event|2|||
27757345|NCT02365584|80936651|FG001|Overall Study|Adverse Event|2|||
27757346|NCT02365584|80936650|FG000|Overall Study|Withdrawal by Subject|1|||
27757347|NCT02365584|80936651|FG001|Overall Study|Withdrawal by Subject|0|||
27757348|NCT02365584|80936650|FG000|Overall Study|Disease Progression|9|||
27757349|NCT02365584|80936651|FG001|Overall Study|Disease Progression|12|||
27757350|NCT01397552|80936652|FG000|Overall Study|Adverse Event|1|||
27757351|NCT01397552|80936653|FG001|Overall Study|Adverse Event|0|||
27757352|NCT01397552|80936652|FG000|Overall Study|Withdrawal by Subject|2|||
27757353|NCT01397552|80936653|FG001|Overall Study|Withdrawal by Subject|1|||
27757354|NCT00789958|80936654|FG000|Overall Study|Adverse Event|3|||
27757355|NCT00789958|80936654|FG000|Overall Study|Withdrawal by Subject|4|||
27757356|NCT00789958|80936654|FG000|Overall Study|Progression|3|||
27757357|NCT00789958|80936654|FG000|Overall Study|not protocol specified|1|||
27757358|NCT00789958|80936654|FG000|Overall Study|Not eligible/not analyzable|26|||
27757359|NCT00748553|80936657|FG000|Overall Study|Adverse Event|0|||
27757360|NCT00748553|80936658|FG001|Overall Study|Adverse Event|1|||
27757361|NCT00748553|80936657|FG000|Overall Study|disease progression|2|||
27757362|NCT00748553|80936658|FG001|Overall Study|disease progression|0|||
27757363|NCT00748553|80936657|FG000|Overall Study|noncompliance|1|||
27757364|NCT00748553|80936658|FG001|Overall Study|noncompliance|0|||
27757365|NCT04587453|80936659|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
27757366|NCT04587453|80936660|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
27757367|NCT00353496|80936661|FG000|Overall Study|Adverse Event|1|||
27757368|NCT00353496|80936662|FG001|Overall Study|Adverse Event|0|||
27757369|NCT00353496|80936661|FG000|Overall Study|Protocol Violation|2|||
27757370|NCT00353496|80936662|FG001|Overall Study|Protocol Violation|2|||
27757371|NCT00353496|80936661|FG000|Overall Study|Withdrawal by Subject|3|||
27757372|NCT00353496|80936662|FG001|Overall Study|Withdrawal by Subject|4|||
27757373|NCT00353496|80936661|FG000|Overall Study|Physician Decision|6|||
27757374|NCT00353496|80936662|FG001|Overall Study|Physician Decision|9|||
27757375|NCT00353496|80936661|FG000|Overall Study|Not otherwise specified|4|||
27757376|NCT00353496|80936662|FG001|Overall Study|Not otherwise specified|2|||
27757377|NCT04311177|80936663|FG000|Overall Study|Adverse Event|3|||
27757378|NCT04311177|80936664|FG001|Overall Study|Adverse Event|1|||
27757379|NCT04311177|80936663|FG000|Overall Study|Physician Decision|4|||
27757380|NCT04311177|80936664|FG001|Overall Study|Physician Decision|3|||
27757381|NCT04311177|80936663|FG000|Overall Study|Withdrawal by Subject|1|||
27757382|NCT04311177|80936664|FG001|Overall Study|Withdrawal by Subject|0|||
27757383|NCT03053427|80936668|FG000|Overall Study|Adverse Event|4|||
27757384|NCT03053427|80936669|FG001|Overall Study|Adverse Event|4|||
27757385|NCT03053427|80936668|FG000|Overall Study|Lack of Efficacy|1|||
27757386|NCT03053427|80936669|FG001|Overall Study|Lack of Efficacy|3|||
27757387|NCT03053427|80936668|FG000|Overall Study|Lost to Follow-up|2|||
27757388|NCT03053427|80936669|FG001|Overall Study|Lost to Follow-up|2|||
27757389|NCT03053427|80936668|FG000|Overall Study|Worsening of the target disease|0|||
27757390|NCT03053427|80936669|FG001|Overall Study|Worsening of the target disease|1|||
27757391|NCT03053427|80936668|FG000|Overall Study|Protocol Deviation|3|||
27757392|NCT03053427|80936669|FG001|Overall Study|Protocol Deviation|3|||
27757393|NCT03053427|80936668|FG000|Overall Study|Withdrawal by Subject|3|||
27757394|NCT03053427|80936669|FG001|Overall Study|Withdrawal by Subject|2|||
27757395|NCT03053427|80936668|FG000|Overall Study|Miscellaneous|0|||
27757396|NCT03053427|80936669|FG001|Overall Study|Miscellaneous|1|||
27757397|NCT02648724|80936670|FG000|Overall Study|Withdrawal by Subject|0|||
27757398|NCT02648724|80936671|FG001|Overall Study|Withdrawal by Subject|1|||
27757399|NCT02648724|80936672|FG002|Overall Study|Withdrawal by Subject|1|||
27757400|NCT02648724|80936673|FG003|Overall Study|Withdrawal by Subject|0|||
27757401|NCT02648724|80936674|FG004|Overall Study|Withdrawal by Subject|1|||
27757402|NCT02648724|80936675|FG005|Overall Study|Withdrawal by Subject|0|||
27757403|NCT02648724|80936676|FG006|Overall Study|Withdrawal by Subject|0|||
27757404|NCT02648724|80936670|FG000|Overall Study|Progressive disease|2|||
27757405|NCT02648724|80936671|FG001|Overall Study|Progressive disease|2|||
27757406|NCT02648724|80936672|FG002|Overall Study|Progressive disease|2|||
27757407|NCT02648724|80936673|FG003|Overall Study|Progressive disease|3|||
27757408|NCT02648724|80936674|FG004|Overall Study|Progressive disease|22|||
27757409|NCT02648724|80936675|FG005|Overall Study|Progressive disease|7|||
27757410|NCT02648724|80936676|FG006|Overall Study|Progressive disease|8|||
27757411|NCT02648724|80936670|FG000|Overall Study|Other reason (unknown)|1|||
27757412|NCT02648724|80936671|FG001|Overall Study|Other reason (unknown)|0|||
27757413|NCT02648724|80936672|FG002|Overall Study|Other reason (unknown)|0|||
27757414|NCT02648724|80936673|FG003|Overall Study|Other reason (unknown)|0|||
27757415|NCT02648724|80936674|FG004|Overall Study|Other reason (unknown)|0|||
27757416|NCT02648724|80936675|FG005|Overall Study|Other reason (unknown)|0|||
27757417|NCT02648724|80936676|FG006|Overall Study|Other reason (unknown)|0|||
27757418|NCT02648724|80936670|FG000|Overall Study|Protocol Violation|0|||
27757419|NCT02648724|80936671|FG001|Overall Study|Protocol Violation|0|||
27757420|NCT02648724|80936672|FG002|Overall Study|Protocol Violation|0|||
27757421|NCT02648724|80936673|FG003|Overall Study|Protocol Violation|0|||
27757422|NCT02648724|80936674|FG004|Overall Study|Protocol Violation|1|||
27757423|NCT02648724|80936675|FG005|Overall Study|Protocol Violation|0|||
27757424|NCT02648724|80936676|FG006|Overall Study|Protocol Violation|0|||
27757425|NCT02648724|80936670|FG000|Overall Study|Death|0|||
27757426|NCT02648724|80936671|FG001|Overall Study|Death|0|||
27757427|NCT02648724|80936672|FG002|Overall Study|Death|0|||
27757428|NCT02648724|80936673|FG003|Overall Study|Death|0|||
27757429|NCT02648724|80936674|FG004|Overall Study|Death|0|||
27757430|NCT02648724|80936675|FG005|Overall Study|Death|0|||
27757431|NCT02648724|80936676|FG006|Overall Study|Death|3|||
27757432|NCT02648724|80936670|FG000|Overall Study|Physician Decision|0|||
27757433|NCT02648724|80936671|FG001|Overall Study|Physician Decision|0|||
27757434|NCT02648724|80936672|FG002|Overall Study|Physician Decision|0|||
27757435|NCT02648724|80936673|FG003|Overall Study|Physician Decision|0|||
27757436|NCT02648724|80936674|FG004|Overall Study|Physician Decision|1|||
27757437|NCT02648724|80936675|FG005|Overall Study|Physician Decision|0|||
27757438|NCT02648724|80936676|FG006|Overall Study|Physician Decision|1|||
27757439|NCT02648724|80936670|FG000|Overall Study|Transferred to named patient program|0|||
27757440|NCT02648724|80936671|FG001|Overall Study|Transferred to named patient program|0|||
27757441|NCT02648724|80936672|FG002|Overall Study|Transferred to named patient program|0|||
27757442|NCT02648724|80936673|FG003|Overall Study|Transferred to named patient program|0|||
27757443|NCT02648724|80936674|FG004|Overall Study|Transferred to named patient program|0|||
27757444|NCT02648724|80936675|FG005|Overall Study|Transferred to named patient program|1|||
27757445|NCT02648724|80936676|FG006|Overall Study|Transferred to named patient program|0|||
27757446|NCT00751114|80936677|FG000|Overall Study|Adverse Event|2|||
27757447|NCT00751114|80936678|FG001|Overall Study|Adverse Event|4|||
27757448|NCT00751114|80936677|FG000|Overall Study|Protocol Violation|8|||
27757449|NCT00751114|80936678|FG001|Overall Study|Protocol Violation|9|||
27757450|NCT00751114|80936677|FG000|Overall Study|Withdrawal by Subject|9|||
27757451|NCT00751114|80936678|FG001|Overall Study|Withdrawal by Subject|4|||
27757452|NCT00751114|80936677|FG000|Overall Study|Lost to Follow-up|4|||
27757453|NCT00751114|80936678|FG001|Overall Study|Lost to Follow-up|7|||
27757454|NCT00751114|80936677|FG000|Overall Study|Lack of Efficacy|0|||
27757455|NCT00751114|80936678|FG001|Overall Study|Lack of Efficacy|7|||
27757456|NCT00751114|80936677|FG000|Overall Study|Not Treated|13|||
27757457|NCT00751114|80936678|FG001|Overall Study|Not Treated|1|||
27757458|NCT00751114|80936677|FG000|Overall Study|Out of country for 2 months|1|||
27757459|NCT00751114|80936678|FG001|Overall Study|Out of country for 2 months|0|||
27757460|NCT00751114|80936677|FG000|Overall Study|Move to another city|1|||
27757461|NCT00751114|80936678|FG001|Overall Study|Move to another city|0|||
27757462|NCT00310388|80936685|FG000|Primary Reporting Phase|Adverse Event|101|||
27757463|NCT00310388|80936686|FG001|Primary Reporting Phase|Adverse Event|0|||
27757464|NCT00310388|80936685|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
27757465|NCT00310388|80936686|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
27757466|NCT00310388|80936685|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
27757467|NCT00310388|80936686|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
27757468|NCT00310388|80936685|FG000|Primary Reporting Phase|Protocol Violation|10|||
27757469|NCT00310388|80936686|FG001|Primary Reporting Phase|Protocol Violation|0|||
27757470|NCT00310388|80936685|FG000|Primary Reporting Phase|Pregnancy|3|||
27757471|NCT00310388|80936686|FG001|Primary Reporting Phase|Pregnancy|0|||
27757472|NCT00310388|80936685|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
27757473|NCT00310388|80936686|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
27757474|NCT00310388|80936685|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
27757475|NCT00310388|80936686|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
27757476|NCT00310388|80936685|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
27757477|NCT00310388|80936686|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
27757478|NCT00310388|80936685|FG000|Primary Reporting Phase|Physician Decision|2|||
27757479|NCT00310388|80936686|FG001|Primary Reporting Phase|Physician Decision|0|||
27757480|NCT00310388|80936685|FG000|Primary Reporting Phase|Request of the sponsor|19|||
27757481|NCT00310388|80936686|FG001|Primary Reporting Phase|Request of the sponsor|0|||
27757482|NCT00310388|80936685|FG000|Primary Reporting Phase|Failed to return|8|||
27757483|NCT00310388|80936686|FG001|Primary Reporting Phase|Failed to return|0|||
27757484|NCT00310388|80936685|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
27757485|NCT00310388|80936686|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
27757486|NCT00310388|80936685|FG000|Primary Reporting Phase|Participant request|2|||
27757487|NCT00310388|80936686|FG001|Primary Reporting Phase|Participant request|0|||
27757488|NCT00310388|80936685|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
27757489|NCT00310388|80936686|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
27757490|NCT00310388|80936685|FG000|Primary Reporting Phase|Discontinuation of study|1|||
27757491|NCT00310388|80936686|FG001|Primary Reporting Phase|Discontinuation of study|0|||
27757492|NCT00310388|80936685|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
27757493|NCT00310388|80936686|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
27757494|NCT00310388|80936685|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
27757495|NCT00310388|80936686|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
27757496|NCT00310388|80936685|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
27757497|NCT00310388|80936686|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
27757498|NCT00310388|80936685|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
27757499|NCT00310388|80936686|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
27757500|NCT00310388|80936685|FG000|Primary Reporting Phase|Participant passed away|1|||
27757501|NCT00310388|80936686|FG001|Primary Reporting Phase|Participant passed away|0|||
27757502|NCT00310388|80936685|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
27757503|NCT00310388|80936686|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
27757504|NCT00310388|80936685|FG000|Primary Reporting Phase|Missing|1|||
27757505|NCT00310388|80936686|FG001|Primary Reporting Phase|Missing|0|||
27757506|NCT00310388|80936685|FG000|Primary Reporting Phase|Other|1|||
27757507|NCT00310388|80936686|FG001|Primary Reporting Phase|Other|0|||
27757508|NCT00310388|80936685|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
27757509|NCT00310388|80936686|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
27757510|NCT00310388|80936685|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
27757511|NCT00310388|80936686|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
27757512|NCT00310388|80936685|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
27757513|NCT00310388|80936686|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
27757514|NCT00310388|80936685|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
27757515|NCT00310388|80936686|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
27757516|NCT00592852|80936687|FG000|Overall Study|Non-compliance|1|||
27757517|NCT00592852|80936687|FG000|Overall Study|Adverse Event|3|||
27757518|NCT00592852|80936687|FG000|Overall Study|Found ineligible|1|||
27757519|NCT00592852|80936687|FG000|Overall Study|Withdrawal by Subject|1|||
27757520|NCT04494633|80936688|FG000|Overall Study|Lost to Follow-up|5|||
27757521|NCT04494633|80936689|FG001|Overall Study|Lost to Follow-up|3|||
27757522|NCT04494633|80936688|FG000|Overall Study|Protocol Violation|1|||
27757523|NCT04494633|80936689|FG001|Overall Study|Protocol Violation|1|||
27757524|NCT01019486|80936690|FG000|Overall Study|Withdrawal by Subject|1|||
27757525|NCT01019486|80936691|FG001|Overall Study|Withdrawal by Subject|1|||
27757526|NCT01019486|80936692|FG002|Overall Study|Withdrawal by Subject|1|||
27757527|NCT00138424|80936693|FG000|Overall Study|Physician Decision|0|||
27757528|NCT00138424|80936694|FG001|Overall Study|Physician Decision|1|||
27757529|NCT00138424|80936695|FG002|Overall Study|Physician Decision|0|||
27757530|NCT00138424|80936696|FG003|Overall Study|Physician Decision|0|||
27757531|NCT01606761|80936697|FG000|Prior to Week 24|Lost to Follow-up|0|||
27757532|NCT01606761|80936698|FG001|Prior to Week 24|Lost to Follow-up|3|||
27757533|NCT01606761|80936699|FG002|Prior to Week 24|Lost to Follow-up|2|||
27757534|NCT01606761|80936700|FG003|Prior to Week 24|Lost to Follow-up|0|||
27757535|NCT01606761|80936701|FG004|Prior to Week 24|Lost to Follow-up|0|||
27757536|NCT01606761|80936697|FG000|Prior to Week 24|Withdrawal by Subject|12|||
27757537|NCT01606761|80936698|FG001|Prior to Week 24|Withdrawal by Subject|10|||
27757538|NCT01606761|80936699|FG002|Prior to Week 24|Withdrawal by Subject|9|||
27757539|NCT01606761|80936700|FG003|Prior to Week 24|Withdrawal by Subject|0|||
27757540|NCT01606761|80936701|FG004|Prior to Week 24|Withdrawal by Subject|0|||
27757541|NCT01606761|80936697|FG000|Prior to Week 24|Adverse Event|11|||
27757542|NCT01606761|80936698|FG001|Prior to Week 24|Adverse Event|18|||
27757543|NCT01606761|80936699|FG002|Prior to Week 24|Adverse Event|22|||
27757544|NCT01606761|80936700|FG003|Prior to Week 24|Adverse Event|0|||
27757545|NCT01606761|80936701|FG004|Prior to Week 24|Adverse Event|0|||
27757546|NCT01606761|80936697|FG000|Prior to Week 24|Lack of Efficacy|15|||
27757547|NCT01606761|80936698|FG001|Prior to Week 24|Lack of Efficacy|14|||
27757548|NCT01606761|80936699|FG002|Prior to Week 24|Lack of Efficacy|8|||
27757549|NCT01606761|80936700|FG003|Prior to Week 24|Lack of Efficacy|0|||
27757550|NCT01606761|80936701|FG004|Prior to Week 24|Lack of Efficacy|0|||
27757551|NCT01606761|80936697|FG000|Prior to Week 24|Physician Decision|0|||
27757552|NCT01606761|80936698|FG001|Prior to Week 24|Physician Decision|3|||
27757553|NCT01606761|80936699|FG002|Prior to Week 24|Physician Decision|1|||
27757554|NCT01606761|80936700|FG003|Prior to Week 24|Physician Decision|0|||
27757555|NCT01606761|80936701|FG004|Prior to Week 24|Physician Decision|0|||
27757556|NCT01606761|80936697|FG000|Prior to Week 24|Other|4|||
27757557|NCT01606761|80936698|FG001|Prior to Week 24|Other|7|||
27757558|NCT01606761|80936699|FG002|Prior to Week 24|Other|5|||
27757559|NCT01606761|80936700|FG003|Prior to Week 24|Other|0|||
27757560|NCT01606761|80936701|FG004|Prior to Week 24|Other|0|||
27757561|NCT01606761|80936697|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
27757562|NCT01606761|80936698|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
27757563|NCT01606761|80936699|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
27757564|NCT01606761|80936700|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
27757565|NCT01606761|80936701|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
27757566|NCT01606761|80936697|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
27757567|NCT01606761|80936698|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
27757568|NCT01606761|80936699|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
27757569|NCT01606761|80936700|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
27757570|NCT01606761|80936701|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
27757571|NCT01606761|80936697|FG000|Week 24 to Week 52|Adverse Event|0|||
27757572|NCT01606761|80936698|FG001|Week 24 to Week 52|Adverse Event|11|||
27757573|NCT01606761|80936699|FG002|Week 24 to Week 52|Adverse Event|14|||
27757574|NCT01606761|80936700|FG003|Week 24 to Week 52|Adverse Event|3|||
27757575|NCT01606761|80936701|FG004|Week 24 to Week 52|Adverse Event|15|||
27757576|NCT01606761|80936697|FG000|Week 24 to Week 52|Death|0|||
27757577|NCT01606761|80936698|FG001|Week 24 to Week 52|Death|0|||
27757578|NCT01606761|80936699|FG002|Week 24 to Week 52|Death|2|||
27757579|NCT01606761|80936700|FG003|Week 24 to Week 52|Death|1|||
27757580|NCT01606761|80936701|FG004|Week 24 to Week 52|Death|0|||
27757581|NCT01606761|80936697|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
27757582|NCT01606761|80936698|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
27757583|NCT01606761|80936699|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
27757584|NCT01606761|80936700|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
27757585|NCT01606761|80936701|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
27757586|NCT01606761|80936697|FG000|Week 24 to Week 52|Physician Decision|0|||
27757587|NCT01606761|80936698|FG001|Week 24 to Week 52|Physician Decision|1|||
27757588|NCT01606761|80936699|FG002|Week 24 to Week 52|Physician Decision|1|||
27757589|NCT01606761|80936700|FG003|Week 24 to Week 52|Physician Decision|0|||
27757590|NCT01606761|80936701|FG004|Week 24 to Week 52|Physician Decision|0|||
27757591|NCT01606761|80936697|FG000|Week 24 to Week 52|Other|0|||
27757592|NCT01606761|80936698|FG001|Week 24 to Week 52|Other|1|||
27757593|NCT01606761|80936699|FG002|Week 24 to Week 52|Other|5|||
27757594|NCT01606761|80936700|FG003|Week 24 to Week 52|Other|2|||
27757595|NCT01606761|80936701|FG004|Week 24 to Week 52|Other|2|||
27757596|NCT01606761|80936697|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
27757597|NCT01606761|80936698|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
27757598|NCT01606761|80936699|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
27757599|NCT01606761|80936700|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
27757600|NCT01606761|80936701|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
27757601|NCT01606761|80936697|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
27757602|NCT01606761|80936698|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
27757603|NCT01606761|80936699|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
27757604|NCT01606761|80936700|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
27757605|NCT01606761|80936701|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
27757606|NCT01606761|80936697|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
27757607|NCT01606761|80936698|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
27757608|NCT01606761|80936699|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
27757609|NCT01606761|80936700|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
27757610|NCT01606761|80936701|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
27757611|NCT01606761|80936697|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
27757612|NCT01606761|80936698|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
27757613|NCT01606761|80936699|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
27757614|NCT01606761|80936700|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
27757615|NCT01606761|80936701|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
27757616|NCT04465396|80936702|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
27757617|NCT04465396|80936703|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
27757618|NCT04465396|80936704|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
27757619|NCT04465396|80936705|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
27757620|NCT00579501|80936706|FG000|Overall Study|Death|1|||
27757621|NCT00579501|80936706|FG000|Overall Study|End of neoadjuvant therapy|25|||
27757622|NCT00579501|80936706|FG000|Overall Study|toxicity|1|||
27757623|NCT00579501|80936706|FG000|Overall Study|Secondary lesion|1|||
27757624|NCT00579501|80936706|FG000|Overall Study|Radiation therapy before surgery|1|||
27757625|NCT01694420|80936707|FG000|Overall Study|Lost to Follow-up|3|||
27757626|NCT01086150|80936710|FG000|Overall Study|Withdrawal by Subject|0|||
27757627|NCT01086150|80936711|FG001|Overall Study|Withdrawal by Subject|4|||
27757628|NCT01086150|80936712|FG002|Overall Study|Withdrawal by Subject|1|||
27757629|NCT01086150|80936710|FG000|Overall Study|Lost to Follow-up|0|||
27757630|NCT01086150|80936711|FG001|Overall Study|Lost to Follow-up|1|||
27757631|NCT01086150|80936712|FG002|Overall Study|Lost to Follow-up|0|||
27757632|NCT01086150|80936710|FG000|Overall Study|Screen Failure|0|||
27757633|NCT01086150|80936711|FG001|Overall Study|Screen Failure|1|||
27757634|NCT01086150|80936712|FG002|Overall Study|Screen Failure|0|||
27757635|NCT00393913|80936716|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
27757636|NCT00393913|80936716|FG000|Initial Assessment|Withdrawal by Subject|16|||
27757637|NCT00393913|80936716|FG000|CPAP|Withdrawal by Subject|3|||
27757638|NCT00393913|80936716|FG000|CPAP|Physician Decision|1|||
27757639|NCT00393913|80936716|FG000|CPAP|TEchnical problem with CPAP|3|||
27757640|NCT00929734|80936718|FG000|Overall Study|Lost to Follow-up|2|||
27757641|NCT00929734|80936719|FG001|Overall Study|Lost to Follow-up|1|||
27757642|NCT00929734|80936718|FG000|Overall Study|Withdrawal by Subject|0|||
27757643|NCT00929734|80936719|FG001|Overall Study|Withdrawal by Subject|2|||
27757644|NCT00805545|80936720|FG000|Overall Study|Protocol Violation|3|||
27757645|NCT00805545|80936721|FG001|Overall Study|Protocol Violation|2|||
27757646|NCT00805545|80936720|FG000|Overall Study|Protocol Violation|3|||
27757647|NCT00805545|80936721|FG001|Overall Study|Protocol Violation|1|||
27757648|NCT00311181|80936723|FG000|Overall Study|Final DFTs were not obtained|96|||
27757649|NCT01973452|80936724|FG000|Overall Study|Lack of Efficacy|0|||
27757650|NCT01973452|80936725|FG001|Overall Study|Lack of Efficacy|1|||
27757651|NCT01973452|80936724|FG000|Overall Study|Lost to Follow-up|1|||
27757652|NCT01973452|80936725|FG001|Overall Study|Lost to Follow-up|0|||
27757653|NCT01973452|80936724|FG000|Overall Study|Withdrawal by Subject|10|||
27757654|NCT01973452|80936725|FG001|Overall Study|Withdrawal by Subject|9|||
27757655|NCT01973452|80936724|FG000|Overall Study|Ineligible|1|||
27757656|NCT01973452|80936725|FG001|Overall Study|Ineligible|1|||
27757657|NCT01973452|80936724|FG000|Overall Study|Surgery canceled by participant|5|||
27757658|NCT01973452|80936725|FG001|Overall Study|Surgery canceled by participant|3|||
27757659|NCT01608724|80936726|FG000|Overall Study|Withdrawal by Subject|131|||
27757660|NCT01608724|80936726|FG000|Overall Study|Lost to Follow-up|41|||
27757661|NCT01608724|80936726|FG000|Overall Study|Study-specific discontinuation criteria|32|||
27757662|NCT01608724|80936726|FG000|Overall Study|Adverse Event|29|||
27757663|NCT01608724|80936726|FG000|Overall Study|Protocol Violation|6|||
27757664|NCT01608724|80936726|FG000|Overall Study|bood sugar too high, etc.|3|||
27757665|NCT01608724|80936726|FG000|Overall Study|Safety reasons|1|||
27757666|NCT02855450|80936729|FG000|Overall Study|Adverse Event|1|||
27757667|NCT02855450|80936730|FG001|Overall Study|Adverse Event|0|||
27757668|NCT02855450|80936729|FG000|Overall Study|Lost to Follow-up|4|||
27757669|NCT02855450|80936730|FG001|Overall Study|Lost to Follow-up|0|||
27757670|NCT01982773|80936738|FG000|Overall Study|Withdrawal by Subject|1|||
27757671|NCT01982773|80936739|FG001|Overall Study|Withdrawal by Subject|3|||
27757672|NCT01982773|80936738|FG000|Overall Study|Lost to Follow-up|7|||
27757673|NCT01982773|80936739|FG001|Overall Study|Lost to Follow-up|1|||
27757674|NCT04321252|80936740|FG000|Overall Study|Withdrawal by Subject|0|||
27757675|NCT04321252|80936741|FG001|Overall Study|Withdrawal by Subject|0|||
27757676|NCT04321252|80936742|FG002|Overall Study|Withdrawal by Subject|0|||
27757677|NCT04321252|80936743|FG003|Overall Study|Withdrawal by Subject|0|||
27757678|NCT04321252|80936744|FG004|Overall Study|Withdrawal by Subject|0|||
27757679|NCT04321252|80936745|FG005|Overall Study|Withdrawal by Subject|1|||
27757680|NCT04321252|80936746|FG006|Overall Study|Withdrawal by Subject|0|||
27757681|NCT04321252|80936747|FG007|Overall Study|Withdrawal by Subject|0|||
27757682|NCT04321252|80936748|FG008|Overall Study|Withdrawal by Subject|0|||
27757683|NCT00363246|80936749|FG000|Overall Study|Death|40|||
27757684|NCT00363246|80936749|FG000|Overall Study|Withdrawal by Subject|19|||
27757685|NCT00363246|80936749|FG000|Overall Study|Lost to Follow-up|14|||
27757686|NCT00363246|80936749|FG000|Overall Study|Bad health|6|||
27757687|NCT00363246|80936749|FG000|Overall Study|Stopped using wheelchair|11|||
27757688|NCT00363246|80936749|FG000|Overall Study|Subject expressed security concerns|2|||
27757689|NCT00363246|80936749|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
27757690|NCT04507867|80936750|FG000|Overall Study|Death|7|||
27757691|NCT04507867|80936751|FG001|Overall Study|Death|1|||
27757692|NCT00115765|80936752|FG000|Overall Study|Withdrawal by Subject|22|||
27757693|NCT00115765|80936753|FG001|Overall Study|Withdrawal by Subject|53|||
27757694|NCT00115765|80936754|FG002|Overall Study|Withdrawal by Subject|76|||
27757695|NCT00115765|80936755|FG003|Overall Study|Withdrawal by Subject|15|||
27757696|NCT00115765|80936752|FG000|Overall Study|Physician Decision|4|||
27757697|NCT00115765|80936753|FG001|Overall Study|Physician Decision|15|||
27757698|NCT00115765|80936754|FG002|Overall Study|Physician Decision|18|||
27757699|NCT00115765|80936755|FG003|Overall Study|Physician Decision|13|||
27757700|NCT00115765|80936752|FG000|Overall Study|Lost to Follow-up|3|||
27757701|NCT00115765|80936753|FG001|Overall Study|Lost to Follow-up|20|||
27757702|NCT00115765|80936754|FG002|Overall Study|Lost to Follow-up|18|||
27757703|NCT00115765|80936755|FG003|Overall Study|Lost to Follow-up|1|||
27757704|NCT00115765|80936752|FG000|Overall Study|Other|6|||
27757705|NCT00115765|80936753|FG001|Overall Study|Other|12|||
27757706|NCT00115765|80936754|FG002|Overall Study|Other|9|||
27757707|NCT00115765|80936755|FG003|Overall Study|Other|2|||
27757708|NCT01860534|80936757|FG000|ROP #1|Needed treatment for ROP|0|||
27757709|NCT01860534|80936758|FG001|ROP #1|Needed treatment for ROP|1|||
27757710|NCT01860534|80936757|FG000|ROP #2|discharged prior to ROP #2|1|||
27757711|NCT01860534|80936758|FG001|ROP #2|discharged prior to ROP #2|0|||
27757712|NCT00190983|80936759|FG000|Overall Study|Inevaluable (never treated)|2|||
27757713|NCT00960934|80936760|FG000|Overall Study|Adverse Event|2|||
27757714|NCT00960934|80936761|FG001|Overall Study|Adverse Event|3|||
27757715|NCT00960934|80936762|FG002|Overall Study|Adverse Event|3|||
27757716|NCT00960934|80936763|FG003|Overall Study|Adverse Event|2|||
27757717|NCT00960934|80936764|FG004|Overall Study|Adverse Event|4|||
27757718|NCT00960934|80936765|FG005|Overall Study|Adverse Event|3|||
27757719|NCT00960934|80936760|FG000|Overall Study|Lack of Efficacy|1|||
27757720|NCT00960934|80936761|FG001|Overall Study|Lack of Efficacy|0|||
27757721|NCT00960934|80936762|FG002|Overall Study|Lack of Efficacy|0|||
27757722|NCT00960934|80936763|FG003|Overall Study|Lack of Efficacy|0|||
27757723|NCT00960934|80936764|FG004|Overall Study|Lack of Efficacy|0|||
27757724|NCT00960934|80936765|FG005|Overall Study|Lack of Efficacy|0|||
27757725|NCT00960934|80936760|FG000|Overall Study|Lost to Follow-up|0|||
27757726|NCT00960934|80936761|FG001|Overall Study|Lost to Follow-up|1|||
27757727|NCT00960934|80936762|FG002|Overall Study|Lost to Follow-up|0|||
27757728|NCT00960934|80936763|FG003|Overall Study|Lost to Follow-up|0|||
27757729|NCT00960934|80936764|FG004|Overall Study|Lost to Follow-up|0|||
27757730|NCT00960934|80936765|FG005|Overall Study|Lost to Follow-up|0|||
27566577|NCT01023581|80263369|FG005|Overall Study|Lost to Follow-up|2|||
27757731|NCT00960934|80936760|FG000|Overall Study|Other|2|||
27757732|NCT00960934|80936761|FG001|Overall Study|Other|1|||
27757733|NCT00960934|80936762|FG002|Overall Study|Other|5|||
27757734|NCT00960934|80936763|FG003|Overall Study|Other|4|||
27757735|NCT00960934|80936764|FG004|Overall Study|Other|2|||
27757736|NCT00960934|80936765|FG005|Overall Study|Other|2|||
27757737|NCT00960934|80936760|FG000|Overall Study|Physician Decision|0|||
27757738|NCT00960934|80936761|FG001|Overall Study|Physician Decision|1|||
27757739|NCT00960934|80936762|FG002|Overall Study|Physician Decision|0|||
27757740|NCT00960934|80936763|FG003|Overall Study|Physician Decision|0|||
27757741|NCT00960934|80936764|FG004|Overall Study|Physician Decision|0|||
27757742|NCT00960934|80936765|FG005|Overall Study|Physician Decision|0|||
27757743|NCT00960934|80936760|FG000|Overall Study|Progressive Disease|1|||
27757744|NCT00960934|80936761|FG001|Overall Study|Progressive Disease|1|||
27757745|NCT00960934|80936762|FG002|Overall Study|Progressive Disease|0|||
27757746|NCT00960934|80936763|FG003|Overall Study|Progressive Disease|0|||
27757747|NCT00960934|80936764|FG004|Overall Study|Progressive Disease|1|||
27757748|NCT00960934|80936765|FG005|Overall Study|Progressive Disease|1|||
27757749|NCT00960934|80936760|FG000|Overall Study|Protocol Violation|3|||
27757750|NCT00960934|80936761|FG001|Overall Study|Protocol Violation|4|||
27757751|NCT00960934|80936762|FG002|Overall Study|Protocol Violation|0|||
27757752|NCT00960934|80936763|FG003|Overall Study|Protocol Violation|3|||
27757753|NCT00960934|80936764|FG004|Overall Study|Protocol Violation|3|||
27757754|NCT00960934|80936765|FG005|Overall Study|Protocol Violation|2|||
27757755|NCT00960934|80936760|FG000|Overall Study|Withdrawal by Subject|5|||
27757756|NCT00960934|80936761|FG001|Overall Study|Withdrawal by Subject|6|||
27757757|NCT00960934|80936762|FG002|Overall Study|Withdrawal by Subject|4|||
27757758|NCT00960934|80936763|FG003|Overall Study|Withdrawal by Subject|5|||
27757759|NCT00960934|80936764|FG004|Overall Study|Withdrawal by Subject|5|||
27757760|NCT00960934|80936765|FG005|Overall Study|Withdrawal by Subject|7|||
27757761|NCT00960934|80936760|FG000|Overall Study|Study Terminated by Sponsor|50|||
27757762|NCT00960934|80936761|FG001|Overall Study|Study Terminated by Sponsor|46|||
27757763|NCT00960934|80936762|FG002|Overall Study|Study Terminated by Sponsor|52|||
27757764|NCT00960934|80936763|FG003|Overall Study|Study Terminated by Sponsor|50|||
27757765|NCT00960934|80936764|FG004|Overall Study|Study Terminated by Sponsor|49|||
27757766|NCT00960934|80936765|FG005|Overall Study|Study Terminated by Sponsor|49|||
27757767|NCT03550131|80939935|FG000|Overall Study|Lost to Follow-up|16|||
27757768|NCT03550131|80939936|FG001|Overall Study|Lost to Follow-up|24|||
27757769|NCT03550131|80939935|FG000|Overall Study|Withdrawal by Subject|36|||
27757770|NCT03550131|80939936|FG001|Overall Study|Withdrawal by Subject|28|||
27757771|NCT03550131|80939935|FG000|Overall Study|Illness of dyad member|10|||
27757772|NCT03550131|80939936|FG001|Overall Study|Illness of dyad member|2|||
27757773|NCT03550131|80939935|FG000|Overall Study|Death of person with dementia|4|||
27757774|NCT03550131|80939936|FG001|Overall Study|Death of person with dementia|8|||
27757775|NCT03488251|80939940|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
27757776|NCT03488251|80939941|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
27757777|NCT03488251|80939942|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
27757778|NCT03488251|80939943|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
27757779|NCT03488251|80939940|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
27757780|NCT03488251|80939941|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
27757781|NCT03488251|80939942|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
27757782|NCT03488251|80939943|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
27757783|NCT03488251|80939940|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
27757784|NCT03488251|80939941|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
27757785|NCT03488251|80939942|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
27757786|NCT03488251|80939943|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
27757787|NCT03488251|80939940|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
27757788|NCT03488251|80939941|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
27757789|NCT03488251|80939942|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
27757790|NCT03488251|80939943|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
27757791|NCT03488251|80939940|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
27757792|NCT03488251|80939941|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
27757793|NCT03488251|80939942|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
27757794|NCT03488251|80939943|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
27757795|NCT00165841|80939946|FG000|Overall Study|Adverse Event|2|||
27757796|NCT00165841|80939947|FG001|Overall Study|Adverse Event|3|||
27757797|NCT00165841|80939946|FG000|Overall Study|Lack of Efficacy|6|||
27757798|NCT00165841|80939947|FG001|Overall Study|Lack of Efficacy|33|||
27757799|NCT00165841|80939946|FG000|Overall Study|Lost to Follow-up|4|||
27757800|NCT00165841|80939947|FG001|Overall Study|Lost to Follow-up|4|||
27757801|NCT00165841|80939946|FG000|Overall Study|Withdrawal by Subject|7|||
27757802|NCT00165841|80939947|FG001|Overall Study|Withdrawal by Subject|8|||
27757803|NCT00165841|80939946|FG000|Overall Study|Physician Decision|1|||
27757804|NCT00165841|80939947|FG001|Overall Study|Physician Decision|0|||
27757805|NCT00165841|80939946|FG000|Overall Study|Protocol Violation|6|||
27757806|NCT00165841|80939947|FG001|Overall Study|Protocol Violation|8|||
27757807|NCT00165841|80939946|FG000|Overall Study|Other|3|||
27757808|NCT00165841|80939947|FG001|Overall Study|Other|5|||
27757809|NCT00165841|80939946|FG000|Overall Study|Medication Noncompliance|1|||
27757810|NCT00165841|80939947|FG001|Overall Study|Medication Noncompliance|1|||
27757811|NCT00848250|80939950|FG000|Overall Study|surgery was completed without cardiopulm|0|||
27757812|NCT00848250|80939951|FG001|Overall Study|surgery was completed without cardiopulm|1|||
27757813|NCT05294211|80939952|FG000|Overall Study|Withdrawal by Subject|3|||
27757814|NCT05294211|80939952|FG000|Overall Study|Physician Decision|2|||
27757815|NCT05294211|80939952|FG000|Overall Study|Progressed to active labor|1|||
27757816|NCT05294211|80939952|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
27757817|NCT05294211|80939952|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
27757818|NCT02695524|80939955|FG000|Overall Study|Lost to Follow-up|3|||
27757819|NCT02695524|80939956|FG001|Overall Study|Lost to Follow-up|2|||
27757820|NCT02695524|80939955|FG000|Overall Study|Death|0|||
27757821|NCT02695524|80939956|FG001|Overall Study|Death|1|||
27757822|NCT03337139|80939957|FG000|Phase I|Withdrawal by Subject|10|||
27757823|NCT03337139|80939958|FG001|Phase I|Withdrawal by Subject|0|||
27757824|NCT00831441|80939959|FG000|Randomized|Death|82|||
27757825|NCT00831441|80939960|FG001|Randomized|Death|81|||
27757826|NCT00831441|80939959|FG000|Randomized|Adverse Event|248|||
27757827|NCT00831441|80939960|FG001|Randomized|Adverse Event|321|||
27757828|NCT00831441|80939959|FG000|Randomized|Emergency procedure|2|||
27757829|NCT00831441|80939960|FG001|Randomized|Emergency procedure|2|||
27757830|NCT00831441|80939959|FG000|Randomized|Elective procedure|26|||
27757831|NCT00831441|80939960|FG001|Randomized|Elective procedure|25|||
27757832|NCT00831441|80939959|FG000|Randomized|Physician Decision|26|||
27757833|NCT00831441|80939960|FG001|Randomized|Physician Decision|35|||
27757834|NCT00831441|80939959|FG000|Randomized|No longer met criteria|13|||
27757835|NCT00831441|80939960|FG001|Randomized|No longer met criteria|19|||
27757836|NCT00831441|80939959|FG000|Randomized|Withdrawal by Subject|178|||
27757837|NCT00831441|80939960|FG001|Randomized|Withdrawal by Subject|212|||
27757838|NCT00831441|80939959|FG000|Randomized|Lost to Follow-up|26|||
27757839|NCT00831441|80939960|FG001|Randomized|Lost to Follow-up|35|||
27757840|NCT00831441|80939959|FG000|Randomized|Administrative reason by sponsor|2780|||
27757841|NCT00831441|80939960|FG001|Randomized|Administrative reason by sponsor|2671|||
27757842|NCT00831441|80939959|FG000|Randomized|poor/non-compliance|30|||
27757843|NCT00831441|80939960|FG001|Randomized|poor/non-compliance|38|||
27757844|NCT00831441|80939959|FG000|Randomized|non-specified|276|||
27757845|NCT00831441|80939960|FG001|Randomized|non-specified|266|||
27757846|NCT00831441|80939959|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
27757847|NCT00831441|80939960|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
27757848|NCT00831441|80939959|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
27757849|NCT00831441|80939960|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
27757850|NCT00831441|80939959|FG000|Follow Up (30 Days)|Death|63|||
27757851|NCT00831441|80939960|FG001|Follow Up (30 Days)|Death|86|||
27757852|NCT00831441|80939959|FG000|Follow Up (30 Days)|non-specified|16|||
27757853|NCT00831441|80939960|FG001|Follow Up (30 Days)|non-specified|26|||
27757854|NCT00831441|80939959|FG000|Follow Up (30 Days)|missing end of study status|0|||
27757855|NCT00831441|80939960|FG001|Follow Up (30 Days)|missing end of study status|1|||
27757856|NCT00438399|80939961|FG000|Overall Study|Lost to Follow-up|2|||
27757857|NCT00438399|80939962|FG001|Overall Study|Lost to Follow-up|2|||
27757858|NCT00438399|80939963|FG002|Overall Study|Lost to Follow-up|1|||
27757859|NCT00438399|80939964|FG003|Overall Study|Lost to Follow-up|1|||
27757860|NCT00438399|80939965|FG004|Overall Study|Lost to Follow-up|1|||
27757861|NCT00438399|80939966|FG005|Overall Study|Lost to Follow-up|1|||
27757862|NCT00438399|80939961|FG000|Overall Study|Adverse Event|0|||
27757863|NCT00438399|80939962|FG001|Overall Study|Adverse Event|0|||
27757864|NCT00438399|80939963|FG002|Overall Study|Adverse Event|1|||
27757865|NCT00438399|80939964|FG003|Overall Study|Adverse Event|1|||
27757866|NCT00438399|80939965|FG004|Overall Study|Adverse Event|0|||
27757867|NCT00438399|80939966|FG005|Overall Study|Adverse Event|1|||
27757868|NCT00438399|80939961|FG000|Overall Study|Withdrawal by Subject|5|||
27757869|NCT00438399|80939962|FG001|Overall Study|Withdrawal by Subject|6|||
27757870|NCT00438399|80939963|FG002|Overall Study|Withdrawal by Subject|3|||
27757871|NCT00438399|80939964|FG003|Overall Study|Withdrawal by Subject|2|||
27757872|NCT00438399|80939965|FG004|Overall Study|Withdrawal by Subject|2|||
27757873|NCT00438399|80939966|FG005|Overall Study|Withdrawal by Subject|2|||
27757874|NCT00438399|80939961|FG000|Overall Study|Protocol Violation|0|||
27757875|NCT00438399|80939962|FG001|Overall Study|Protocol Violation|0|||
27757876|NCT00438399|80939963|FG002|Overall Study|Protocol Violation|1|||
27757877|NCT00438399|80939964|FG003|Overall Study|Protocol Violation|0|||
27757878|NCT00438399|80939965|FG004|Overall Study|Protocol Violation|0|||
27757879|NCT00438399|80939966|FG005|Overall Study|Protocol Violation|1|||
27757880|NCT00438399|80939961|FG000|Overall Study|Subje stopped study|0|||
27757881|NCT00438399|80939962|FG001|Overall Study|Subje stopped study|0|||
27757882|NCT00438399|80939963|FG002|Overall Study|Subje stopped study|1|||
27757883|NCT00438399|80939964|FG003|Overall Study|Subje stopped study|0|||
27757884|NCT00438399|80939965|FG004|Overall Study|Subje stopped study|0|||
27757885|NCT00438399|80939966|FG005|Overall Study|Subje stopped study|0|||
27757886|NCT00438399|80939961|FG000|Overall Study|Pregnancy|0|||
27757887|NCT00438399|80939962|FG001|Overall Study|Pregnancy|0|||
27757888|NCT00438399|80939963|FG002|Overall Study|Pregnancy|0|||
27757889|NCT00438399|80939964|FG003|Overall Study|Pregnancy|0|||
27757890|NCT00438399|80939965|FG004|Overall Study|Pregnancy|0|||
27757891|NCT00438399|80939966|FG005|Overall Study|Pregnancy|1|||
27757892|NCT00438399|80939961|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
27757893|NCT00438399|80939962|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
27757894|NCT00438399|80939963|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
27757895|NCT00438399|80939964|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
27757896|NCT00438399|80939965|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
27757897|NCT00438399|80939966|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
27757898|NCT00675103|80939967|FG000|Overall Study|Lack of Efficacy|2|||
27757899|NCT00675103|80939967|FG000|Overall Study|Adverse Event|1|||
27757900|NCT03225716|80939968|FG000|Overall Study|Withdrawal by Subject|2|||
27757901|NCT03225716|80939969|FG001|Overall Study|Withdrawal by Subject|2|||
27757902|NCT03225716|80939970|FG002|Overall Study|Withdrawal by Subject|0|||
27757903|NCT03225716|80939968|FG000|Overall Study|Lack of Efficacy|1|||
27757904|NCT03225716|80939969|FG001|Overall Study|Lack of Efficacy|0|||
27757905|NCT03225716|80939970|FG002|Overall Study|Lack of Efficacy|0|||
27757906|NCT03225716|80939968|FG000|Overall Study|Adverse Event|2|||
27757907|NCT03225716|80939969|FG001|Overall Study|Adverse Event|0|||
27757908|NCT03225716|80939970|FG002|Overall Study|Adverse Event|1|||
27757909|NCT03225716|80939968|FG000|Overall Study|Study early termination by Sponsor|0|||
27757910|NCT03225716|80939969|FG001|Overall Study|Study early termination by Sponsor|0|||
27757911|NCT03225716|80939970|FG002|Overall Study|Study early termination by Sponsor|2|||
27757912|NCT00755846|80939971|FG000|Overall Study|Adverse Event|0|||
27757913|NCT00755846|80939972|FG001|Overall Study|Adverse Event|0|||
27757914|NCT00755846|80939973|FG002|Overall Study|Adverse Event|0|||
27757915|NCT00755846|80939974|FG003|Overall Study|Adverse Event|1|||
27757916|NCT00755846|80939975|FG004|Overall Study|Adverse Event|3|||
27757917|NCT00755846|80939976|FG005|Overall Study|Adverse Event|2|||
27757918|NCT00755846|80939971|FG000|Overall Study|Protocol Violation|1|||
27757919|NCT00755846|80939972|FG001|Overall Study|Protocol Violation|1|||
27757920|NCT00755846|80939973|FG002|Overall Study|Protocol Violation|1|||
27757921|NCT00755846|80939974|FG003|Overall Study|Protocol Violation|1|||
27757922|NCT00755846|80939975|FG004|Overall Study|Protocol Violation|1|||
27757923|NCT00755846|80939976|FG005|Overall Study|Protocol Violation|1|||
27757924|NCT00755846|80939971|FG000|Overall Study|Lost to Follow-up|0|||
27757925|NCT00755846|80939972|FG001|Overall Study|Lost to Follow-up|2|||
27757926|NCT00755846|80939973|FG002|Overall Study|Lost to Follow-up|1|||
27757927|NCT00755846|80939974|FG003|Overall Study|Lost to Follow-up|0|||
27757928|NCT00755846|80939975|FG004|Overall Study|Lost to Follow-up|4|||
27757929|NCT00755846|80939976|FG005|Overall Study|Lost to Follow-up|2|||
27757930|NCT00755846|80939971|FG000|Overall Study|Withdrawal by Subject|2|||
27757931|NCT00755846|80939972|FG001|Overall Study|Withdrawal by Subject|3|||
27757932|NCT00755846|80939973|FG002|Overall Study|Withdrawal by Subject|5|||
27757933|NCT00755846|80939974|FG003|Overall Study|Withdrawal by Subject|2|||
27757934|NCT00755846|80939975|FG004|Overall Study|Withdrawal by Subject|0|||
27757935|NCT00755846|80939976|FG005|Overall Study|Withdrawal by Subject|1|||
27757936|NCT00755846|80939971|FG000|Overall Study|Hyperglycemic Rescue|21|||
27757937|NCT00755846|80939972|FG001|Overall Study|Hyperglycemic Rescue|7|||
27757938|NCT00755846|80939973|FG002|Overall Study|Hyperglycemic Rescue|5|||
27757939|NCT00755846|80939974|FG003|Overall Study|Hyperglycemic Rescue|8|||
27757940|NCT00755846|80939975|FG004|Overall Study|Hyperglycemic Rescue|8|||
27757941|NCT00755846|80939976|FG005|Overall Study|Hyperglycemic Rescue|7|||
27757942|NCT00755846|80939971|FG000|Overall Study|Physician Decision|1|||
27757943|NCT00755846|80939972|FG001|Overall Study|Physician Decision|3|||
27757944|NCT00755846|80939973|FG002|Overall Study|Physician Decision|0|||
27757945|NCT00755846|80939974|FG003|Overall Study|Physician Decision|1|||
27757946|NCT00755846|80939975|FG004|Overall Study|Physician Decision|0|||
27757947|NCT00755846|80939976|FG005|Overall Study|Physician Decision|1|||
27757948|NCT00755846|80939971|FG000|Overall Study|Administrative Error|0|||
27757949|NCT00755846|80939972|FG001|Overall Study|Administrative Error|1|||
27757950|NCT00755846|80939973|FG002|Overall Study|Administrative Error|0|||
27757951|NCT00755846|80939974|FG003|Overall Study|Administrative Error|0|||
27757952|NCT00755846|80939975|FG004|Overall Study|Administrative Error|0|||
27757953|NCT00755846|80939976|FG005|Overall Study|Administrative Error|0|||
27757954|NCT00755846|80939971|FG000|Overall Study|Participant Non-compliance|0|||
27757955|NCT00755846|80939972|FG001|Overall Study|Participant Non-compliance|0|||
27757956|NCT00755846|80939973|FG002|Overall Study|Participant Non-compliance|0|||
27757957|NCT00755846|80939974|FG003|Overall Study|Participant Non-compliance|0|||
27757958|NCT00755846|80939975|FG004|Overall Study|Participant Non-compliance|1|||
27757959|NCT00755846|80939976|FG005|Overall Study|Participant Non-compliance|0|||
27757960|NCT00946881|80939981|FG000|First Treatment|Withdrawal by Subject|1|||
27757961|NCT00946881|80939981|FG000|First Treatment|Patient relocated to another state|1|||
27757962|NCT00946881|80939981|FG000|Retreatment|Withdrawal by Subject|1|||
27757963|NCT04831515|80939982|FG000|First Intervention|Adverse Event|0|||
27757964|NCT04831515|80939983|FG001|First Intervention|Adverse Event|1|||
27757965|NCT01905150|80939984|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
27757966|NCT01905150|80939985|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
27757967|NCT03695393|80939986|FG000|Overall Study|Death|3|||
27757968|NCT03695393|80939987|FG001|Overall Study|Death|1|||
27757969|NCT03695393|80939986|FG000|Overall Study|Lost to Follow-up|0|||
27757970|NCT03695393|80939987|FG001|Overall Study|Lost to Follow-up|1|||
27757971|NCT03004469|80939988|FG000|Overall Study|Adverse Event|6|||
27757972|NCT03004469|80939989|FG001|Overall Study|Adverse Event|4|||
27757973|NCT03004469|80939990|FG002|Overall Study|Adverse Event|6|||
27757974|NCT03004469|80939988|FG000|Overall Study|Lack of Efficacy|1|||
27757975|NCT03004469|80939989|FG001|Overall Study|Lack of Efficacy|0|||
27757976|NCT03004469|80939990|FG002|Overall Study|Lack of Efficacy|1|||
27757977|NCT03004469|80939988|FG000|Overall Study|Lost to Follow-up|23|||
27757978|NCT03004469|80939989|FG001|Overall Study|Lost to Follow-up|14|||
27757979|NCT03004469|80939990|FG002|Overall Study|Lost to Follow-up|6|||
27757980|NCT03004469|80939988|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27757981|NCT03004469|80939989|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27757982|NCT03004469|80939990|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27757983|NCT03004469|80939988|FG000|Overall Study|Protocol Violation|0|||
27757984|NCT03004469|80939989|FG001|Overall Study|Protocol Violation|0|||
27757985|NCT03004469|80939990|FG002|Overall Study|Protocol Violation|1|||
27757986|NCT03004469|80939988|FG000|Overall Study|Withdrawal by Subject|29|||
27757987|NCT03004469|80939989|FG001|Overall Study|Withdrawal by Subject|27|||
27757988|NCT03004469|80939990|FG002|Overall Study|Withdrawal by Subject|10|||
27757989|NCT03004469|80939988|FG000|Overall Study|Other unspecified reason|0|||
27757990|NCT03004469|80939989|FG001|Overall Study|Other unspecified reason|4|||
27757991|NCT03004469|80939990|FG002|Overall Study|Other unspecified reason|1|||
27757992|NCT01195363|80939991|FG000|Overall Study|Lost to Follow-up|7|||
27757993|NCT01195363|80939992|FG001|Overall Study|Lost to Follow-up|4|||
27757994|NCT01195363|80939991|FG000|Overall Study|Adverse Event|3|||
27757995|NCT01195363|80939992|FG001|Overall Study|Adverse Event|1|||
27757996|NCT01195363|80939991|FG000|Overall Study|Lack of Efficacy|0|||
27757997|NCT01195363|80939992|FG001|Overall Study|Lack of Efficacy|4|||
27757998|NCT01195363|80939991|FG000|Overall Study|incarceration|1|||
27757999|NCT01195363|80939992|FG001|Overall Study|incarceration|0|||
27758000|NCT01767519|80939993|FG000|Overall Study|Other Reasons|4|||
27758001|NCT01767519|80939994|FG001|Overall Study|Other Reasons|4|||
27758002|NCT01767519|80939995|FG002|Overall Study|Other Reasons|2|||
27758003|NCT01767519|80939993|FG000|Overall Study|Protocol Violation|0|||
27758004|NCT01767519|80939994|FG001|Overall Study|Protocol Violation|3|||
27758005|NCT01767519|80939995|FG002|Overall Study|Protocol Violation|0|||
27758006|NCT01767519|80939993|FG000|Overall Study|Personal Reasons|1|||
27758007|NCT01767519|80939994|FG001|Overall Study|Personal Reasons|0|||
27758008|NCT01767519|80939995|FG002|Overall Study|Personal Reasons|0|||
27758009|NCT01767519|80939993|FG000|Overall Study|Lost to Follow-up|3|||
27758010|NCT01767519|80939994|FG001|Overall Study|Lost to Follow-up|1|||
27758011|NCT01767519|80939995|FG002|Overall Study|Lost to Follow-up|2|||
27758012|NCT01767519|80939993|FG000|Overall Study|Lack of Efficacy|1|||
27758013|NCT01767519|80939994|FG001|Overall Study|Lack of Efficacy|0|||
27758014|NCT01767519|80939995|FG002|Overall Study|Lack of Efficacy|0|||
27758015|NCT01767519|80939993|FG000|Overall Study|Adverse Event|5|||
27758016|NCT01767519|80939994|FG001|Overall Study|Adverse Event|5|||
27758017|NCT01767519|80939995|FG002|Overall Study|Adverse Event|1|||
27758018|NCT04876599|80939996|FG000|Overall Study|Missed|2|||
27758019|NCT04876599|80939997|FG001|Overall Study|Missed|0|||
27758020|NCT04876599|80939996|FG000|Overall Study|Declined|2|||
27758021|NCT04876599|80939997|FG001|Overall Study|Declined|3|||
27758022|NCT01486784|80940000|FG000|Overall Study|Withdrawal by Subject|0|||
27758023|NCT01486784|80940001|FG001|Overall Study|Withdrawal by Subject|0|||
27758024|NCT01486784|80940002|FG002|Overall Study|Withdrawal by Subject|1|||
27758025|NCT01486784|80940003|FG003|Overall Study|Withdrawal by Subject|0|||
27758026|NCT01486784|80940004|FG004|Overall Study|Withdrawal by Subject|1|||
27758027|NCT01486784|80940005|FG005|Overall Study|Withdrawal by Subject|2|||
27758028|NCT01486784|80940000|FG000|Overall Study|Subject did not meet entry criteria|0|||
27758029|NCT01486784|80940001|FG001|Overall Study|Subject did not meet entry criteria|0|||
27758030|NCT01486784|80940002|FG002|Overall Study|Subject did not meet entry criteria|0|||
27758031|NCT01486784|80940003|FG003|Overall Study|Subject did not meet entry criteria|0|||
27758032|NCT01486784|80940004|FG004|Overall Study|Subject did not meet entry criteria|1|||
27758033|NCT01486784|80940005|FG005|Overall Study|Subject did not meet entry criteria|0|||
27758034|NCT01486784|80940000|FG000|Overall Study|Death|0|||
27758035|NCT01486784|80940001|FG001|Overall Study|Death|0|||
27758036|NCT01486784|80940002|FG002|Overall Study|Death|0|||
27758037|NCT01486784|80940003|FG003|Overall Study|Death|0|||
27758038|NCT01486784|80940004|FG004|Overall Study|Death|0|||
27758039|NCT01486784|80940005|FG005|Overall Study|Death|1|||
27758040|NCT03303092|80940006|FG000|Overall Study|Adverse Event|1|||
27758041|NCT03303092|80940007|FG001|Overall Study|Adverse Event|0|||
27758042|NCT03303092|80940008|FG002|Overall Study|Adverse Event|1|||
27758043|NCT03303092|80940006|FG000|Overall Study|Protocol Violation|1|||
27758044|NCT03303092|80940007|FG001|Overall Study|Protocol Violation|5|||
27758045|NCT03303092|80940008|FG002|Overall Study|Protocol Violation|1|||
27758046|NCT03303092|80940006|FG000|Overall Study|Withdrawal by Subject|1|||
27758047|NCT03303092|80940007|FG001|Overall Study|Withdrawal by Subject|1|||
27758048|NCT03303092|80940008|FG002|Overall Study|Withdrawal by Subject|3|||
27758049|NCT01511107|80940013|FG000|Overall Study|Ineligible|3|||
27758050|NCT01511107|80940014|FG001|Overall Study|Ineligible|2|||
27758051|NCT01511107|80940013|FG000|Overall Study|Lost to Follow-up|10|||
27758052|NCT01511107|80940014|FG001|Overall Study|Lost to Follow-up|19|||
27758053|NCT01511107|80940013|FG000|Overall Study|Withdrawal by Subject|9|||
27758054|NCT01511107|80940014|FG001|Overall Study|Withdrawal by Subject|20|||
27758055|NCT02701192|80940015|FG000|Overall Study|Protocol Violation|2|||
27758056|NCT02701192|80940015|FG000|Overall Study|Lost to Follow-up|4|||
27758057|NCT00747617|80940016|FG000|Overall Study|Lost to Follow-up|3|||
27758058|NCT00747617|80940017|FG001|Overall Study|Lost to Follow-up|1|||
27758059|NCT02561299|80940018|FG000|Overall Study|Death|2|||
27758060|NCT02561299|80940019|FG001|Overall Study|Death|4|||
27758061|NCT02561299|80940018|FG000|Overall Study|Lost to Follow-up|1|||
27758062|NCT02561299|80940019|FG001|Overall Study|Lost to Follow-up|0|||
27758063|NCT02561299|80940018|FG000|Overall Study|Withdrawal by Subject|2|||
27758064|NCT02561299|80940019|FG001|Overall Study|Withdrawal by Subject|2|||
27758065|NCT03115476|80940020|FG000|LP0084-1369|Death|1|||
27758066|NCT03115476|80940021|FG001|LP0084-1369|Death|0|||
27758067|NCT03115476|80940022|FG002|LP0084-1369|Death|2|||
27758068|NCT03115476|80940020|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
27758069|NCT03115476|80940021|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
27758070|NCT03115476|80940022|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
27758071|NCT04543955|80940023|FG000|Overall Study|Company cancelled study|1|||
27758072|NCT04543955|80940024|FG001|Overall Study|Company cancelled study|0|||
27758073|NCT02208024|80940025|FG000|Overall Study|Withdrawal by Subject|1|||
27758074|NCT01588353|80940026|FG000|Step2|Withdrawal by Subject|0|||
27758075|NCT01588353|80940027|FG001|Step2|Withdrawal by Subject|1|||
27758076|NCT01588353|80940028|FG002|Step2|Withdrawal by Subject|0|||
27758077|NCT01588353|80940026|FG000|Step3|Adverse Event|0|||
27758078|NCT01588353|80940027|FG001|Step3|Adverse Event|0|||
27758079|NCT01588353|80940028|FG002|Step3|Adverse Event|2|||
27758080|NCT01518244|80940029|FG000|Overall Study|Adverse Event|3|||
27758081|NCT01999946|80940030|FG000|Overall Study|Participant not released from jail|2|||
27758082|NCT01999946|80940031|FG001|Overall Study|Participant not released from jail|2|||
27758083|NCT01999946|80940032|FG002|Overall Study|Participant not released from jail|0|||
27758084|NCT01999946|80940030|FG000|Overall Study|Not included in primary outcome analysis|0|||
27758085|NCT01999946|80940031|FG001|Overall Study|Not included in primary outcome analysis|0|||
27758086|NCT01999946|80940032|FG002|Overall Study|Not included in primary outcome analysis|79|||
27758087|NCT01536119|80940033|FG000|Overall Study|Lost to Follow-up|17|||
27758088|NCT01536119|80940034|FG001|Overall Study|Lost to Follow-up|14|||
27758089|NCT02115113|80940037|FG000|Participants in Run-in Period|Death|0|||
27758090|NCT02115113|80940038|FG001|Participants in Run-in Period|Death|0|||
27758091|NCT02115113|80940039|FG002|Participants in Run-in Period|Death|1|||
27758092|NCT02115113|80940037|FG000|Participants in Run-in Period|Administrative problems|0|||
27758093|NCT02115113|80940038|FG001|Participants in Run-in Period|Administrative problems|0|||
27758094|NCT02115113|80940039|FG002|Participants in Run-in Period|Administrative problems|1|||
27758095|NCT02115113|80940037|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
27758096|NCT02115113|80940038|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
27758097|NCT02115113|80940039|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
27758098|NCT02115113|80940037|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
27758099|NCT02115113|80940038|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
27758100|NCT02115113|80940039|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
27758101|NCT02115113|80940037|FG000|Participants Randomized|Lost to Follow-up|1|||
27758102|NCT02115113|80940038|FG001|Participants Randomized|Lost to Follow-up|0|||
27758103|NCT02115113|80940039|FG002|Participants Randomized|Lost to Follow-up|0|||
27758104|NCT02115113|80940037|FG000|Participants Randomized|Death|1|||
27758105|NCT02115113|80940038|FG001|Participants Randomized|Death|0|||
27758106|NCT02115113|80940039|FG002|Participants Randomized|Death|0|||
27758107|NCT01653158|80940041|FG000|Overall Study|Death|0|||
27758108|NCT01653158|80940042|FG001|Overall Study|Death|0|||
27758109|NCT01653158|80940043|FG002|Overall Study|Death|0|||
27758110|NCT01653158|80940044|FG003|Overall Study|Death|1|||
27758111|NCT01653158|80940045|FG004|Overall Study|Death|0|||
27758112|NCT01653158|80940046|FG005|Overall Study|Death|0|||
27758113|NCT01653158|80940047|FG006|Overall Study|Death|0|||
27758114|NCT01653158|80940048|FG007|Overall Study|Death|2|||
27758115|NCT01653158|80940041|FG000|Overall Study|Adverse Event|0|||
27758116|NCT01653158|80940042|FG001|Overall Study|Adverse Event|0|||
27758117|NCT01653158|80940043|FG002|Overall Study|Adverse Event|0|||
27758118|NCT01653158|80940044|FG003|Overall Study|Adverse Event|1|||
27758119|NCT01653158|80940045|FG004|Overall Study|Adverse Event|0|||
27758120|NCT01653158|80940046|FG005|Overall Study|Adverse Event|0|||
27758121|NCT01653158|80940047|FG006|Overall Study|Adverse Event|0|||
27758122|NCT01653158|80940048|FG007|Overall Study|Adverse Event|3|||
27758123|NCT01653158|80940041|FG000|Overall Study|Other|0|||
27758124|NCT01653158|80940042|FG001|Overall Study|Other|0|||
27758125|NCT01653158|80940043|FG002|Overall Study|Other|0|||
27758126|NCT01653158|80940044|FG003|Overall Study|Other|0|||
27758127|NCT01653158|80940045|FG004|Overall Study|Other|0|||
27758128|NCT01653158|80940046|FG005|Overall Study|Other|0|||
27758129|NCT01653158|80940047|FG006|Overall Study|Other|0|||
27758130|NCT01653158|80940048|FG007|Overall Study|Other|1|||
27758131|NCT01653158|80940041|FG000|Overall Study|Progressive disease|0|||
27758132|NCT01653158|80940042|FG001|Overall Study|Progressive disease|0|||
27758133|NCT01653158|80940043|FG002|Overall Study|Progressive disease|0|||
27758134|NCT01653158|80940044|FG003|Overall Study|Progressive disease|0|||
27758135|NCT01653158|80940045|FG004|Overall Study|Progressive disease|1|||
27758136|NCT01653158|80940046|FG005|Overall Study|Progressive disease|1|||
27758137|NCT01653158|80940047|FG006|Overall Study|Progressive disease|2|||
27758138|NCT01653158|80940048|FG007|Overall Study|Progressive disease|9|||
27758139|NCT01653158|80940041|FG000|Overall Study|Withdrawal by Subject|1|||
27758140|NCT01653158|80940042|FG001|Overall Study|Withdrawal by Subject|0|||
27758141|NCT01653158|80940043|FG002|Overall Study|Withdrawal by Subject|0|||
27758142|NCT01653158|80940044|FG003|Overall Study|Withdrawal by Subject|0|||
27758143|NCT01653158|80940045|FG004|Overall Study|Withdrawal by Subject|0|||
27758144|NCT01653158|80940046|FG005|Overall Study|Withdrawal by Subject|0|||
27758145|NCT01653158|80940047|FG006|Overall Study|Withdrawal by Subject|0|||
27758146|NCT01653158|80940048|FG007|Overall Study|Withdrawal by Subject|0|||
27758147|NCT03095521|80940051|FG000|Overall Study|Withdrawal by Subject|0|||
27758148|NCT03095521|80940052|FG001|Overall Study|Withdrawal by Subject|1|||
27758149|NCT03095521|80940051|FG000|Overall Study|Lost to Follow-up|0|||
27758150|NCT03095521|80940052|FG001|Overall Study|Lost to Follow-up|1|||
27758151|NCT02397694|80940059|FG000|Double-Blinded Phase|Adverse Event|1|||
27758152|NCT02397694|80940060|FG001|Double-Blinded Phase|Adverse Event|0|||
27758153|NCT02397694|80940059|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
27758154|NCT02397694|80940060|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
27758155|NCT02397694|80940059|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
27758156|NCT02397694|80940060|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
27758157|NCT02397694|80940059|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
27758158|NCT02397694|80940060|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
27758159|NCT02397694|80940059|FG000|Open Label Extension Phase|Protocol Violation|1|||
27758160|NCT02397694|80940060|FG001|Open Label Extension Phase|Protocol Violation|0|||
27758161|NCT02397694|80940059|FG000|Open Label Extension Phase|Withdrew Consent|3|||
27758162|NCT02397694|80940060|FG001|Open Label Extension Phase|Withdrew Consent|1|||
27758163|NCT02397694|80940059|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
27758164|NCT02397694|80940060|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
27758165|NCT00423735|80940061|FG000|Overall Study|Ineligible / No protocol treatment|8|||
27758166|NCT00423735|80940062|FG001|Overall Study|Ineligible / No protocol treatment|6|||
27758167|NCT00423735|80940063|FG002|Overall Study|Ineligible / No protocol treatment|0|||
27758168|NCT00165646|80940064|FG000|Overall Study|Adverse Event|1|||
27758169|NCT00165646|80940065|FG001|Overall Study|Adverse Event|1|||
27758170|NCT00165646|80940066|FG002|Overall Study|Adverse Event|1|||
27758171|NCT00165646|80940064|FG000|Overall Study|Lack of Efficacy|1|||
27758172|NCT00165646|80940065|FG001|Overall Study|Lack of Efficacy|2|||
27758173|NCT00165646|80940066|FG002|Overall Study|Lack of Efficacy|0|||
27758174|NCT00165646|80940064|FG000|Overall Study|Withdrawal by Subject|0|||
27758175|NCT00165646|80940065|FG001|Overall Study|Withdrawal by Subject|2|||
27758176|NCT00165646|80940066|FG002|Overall Study|Withdrawal by Subject|1|||
27758177|NCT00165646|80940064|FG000|Overall Study|Physician Decision|2|||
27758178|NCT00165646|80940065|FG001|Overall Study|Physician Decision|0|||
27758179|NCT00165646|80940066|FG002|Overall Study|Physician Decision|2|||
27758180|NCT00165646|80940064|FG000|Overall Study|Protocol Violation|1|||
27758181|NCT00165646|80940065|FG001|Overall Study|Protocol Violation|0|||
27758182|NCT00165646|80940066|FG002|Overall Study|Protocol Violation|0|||
27758183|NCT00296725|80940067|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
27758184|NCT00296725|80940067|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
27758185|NCT00296725|80940067|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
27758186|NCT02927873|80940068|FG000|Overall Study|Lost to Follow-up|0|||
27758187|NCT02927873|80940069|FG001|Overall Study|Lost to Follow-up|1|||
27758188|NCT02927873|80940070|FG002|Overall Study|Lost to Follow-up|0|||
27758189|NCT02927873|80940071|FG003|Overall Study|Lost to Follow-up|0|||
27758190|NCT02927873|80940072|FG004|Overall Study|Lost to Follow-up|0|||
27758191|NCT02927873|80940073|FG005|Overall Study|Lost to Follow-up|0|||
27758192|NCT02927873|80940068|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27758193|NCT02927873|80940069|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
27758194|NCT02927873|80940070|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27758195|NCT02927873|80940071|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27758196|NCT02927873|80940072|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27758197|NCT02927873|80940073|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27758198|NCT02927873|80940068|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758199|NCT02927873|80940069|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758200|NCT02927873|80940070|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27566578|NCT01023581|80263370|FG006|Overall Study|Lost to Follow-up|2|||
27758201|NCT02927873|80940071|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758202|NCT02927873|80940072|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758203|NCT02927873|80940073|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27758204|NCT02927873|80940068|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
27758205|NCT02927873|80940069|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
27758206|NCT02927873|80940070|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
27758207|NCT02927873|80940071|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
27758208|NCT02927873|80940072|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
27758209|NCT02927873|80940073|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
27758210|NCT02927873|80940068|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
27758211|NCT02927873|80940069|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
27758212|NCT02927873|80940070|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
27758213|NCT02927873|80940071|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
27758214|NCT02927873|80940072|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
27758215|NCT02927873|80940073|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
27758216|NCT02927873|80940068|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
27758217|NCT02927873|80940069|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
27758218|NCT02927873|80940070|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
27758219|NCT02927873|80940071|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
27758220|NCT02927873|80940072|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
27758221|NCT02927873|80940073|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
27758222|NCT03337152|80940074|FG000|Overall Study|Physician Decision|1|||
27758223|NCT03337152|80940075|FG001|Overall Study|Physician Decision|0|||
27758224|NCT03337152|80940074|FG000|Overall Study|Lost to Follow-up|1|||
27758225|NCT03337152|80940075|FG001|Overall Study|Lost to Follow-up|3|||
27758226|NCT03337152|80940074|FG000|Overall Study|Adverse Event|3|||
27758227|NCT03337152|80940075|FG001|Overall Study|Adverse Event|1|||
27758228|NCT03337152|80940074|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
27758229|NCT03337152|80940075|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
27758230|NCT00523341|80940076|FG000|Overall Study|Withdrawal by Subject|399|||
27758231|NCT00523341|80940077|FG001|Overall Study|Withdrawal by Subject|427|||
27758232|NCT00523341|80940076|FG000|Overall Study|Other|181|||
27758233|NCT00523341|80940077|FG001|Overall Study|Other|198|||
27758234|NCT00523341|80940076|FG000|Overall Study|Adverse Event|122|||
27758235|NCT00523341|80940077|FG001|Overall Study|Adverse Event|155|||
27758236|NCT00523341|80940076|FG000|Overall Study|Death|101|||
27758237|NCT00523341|80940077|FG001|Overall Study|Death|110|||
27758238|NCT00523341|80940076|FG000|Overall Study|Lost to Follow-up|73|||
27758239|NCT00523341|80940077|FG001|Overall Study|Lost to Follow-up|61|||
27758240|NCT00523341|80940076|FG000|Overall Study|Non-compliance|20|||
27758241|NCT00523341|80940077|FG001|Overall Study|Non-compliance|13|||
27758242|NCT00523341|80940076|FG000|Overall Study|Physician Decision|14|||
27758243|NCT00523341|80940077|FG001|Overall Study|Physician Decision|13|||
27758244|NCT00523341|80940076|FG000|Overall Study|Requirement for Alternative Therapy|4|||
27758245|NCT00523341|80940077|FG001|Overall Study|Requirement for Alternative Therapy|14|||
27758246|NCT00523341|80940076|FG000|Overall Study|Protocol Deviation|6|||
27758247|NCT00523341|80940077|FG001|Overall Study|Protocol Deviation|5|||
27758248|NCT00523341|80940076|FG000|Overall Study|Ineligibility Determined|3|||
27758249|NCT00523341|80940077|FG001|Overall Study|Ineligibility Determined|4|||
27758250|NCT00523341|80940076|FG000|Overall Study|Disease Progression|1|||
27758251|NCT00523341|80940077|FG001|Overall Study|Disease Progression|0|||
27758252|NCT01956240|80940078|FG000|Overall Study|Lost to Follow-up|6|||
27758253|NCT01956240|80940079|FG001|Overall Study|Lost to Follow-up|20|||
27758254|NCT01956240|80940078|FG000|Overall Study|Adverse Event|17|||
27758255|NCT01956240|80940079|FG001|Overall Study|Adverse Event|4|||
27758256|NCT04533815|80940080|FG000|Overall Study|Adverse Event|2|||
27758257|NCT04533815|80940080|FG000|Overall Study|Site withdrew|5|||
27758258|NCT00667251|80940081|FG000|Overall Study|Adverse Event|13|||
27758259|NCT00667251|80940082|FG001|Overall Study|Adverse Event|4|||
27758260|NCT00667251|80940081|FG000|Overall Study|Withdrawal by Subject|6|||
27758261|NCT00667251|80940082|FG001|Overall Study|Withdrawal by Subject|2|||
27758262|NCT00667251|80940081|FG000|Overall Study|Other/missing|46|||
27758263|NCT00667251|80940082|FG001|Overall Study|Other/missing|84|||
27758264|NCT00667251|80940081|FG000|Overall Study|Intercurrent Illness|4|||
27758265|NCT00667251|80940082|FG001|Overall Study|Intercurrent Illness|3|||
27758266|NCT00667251|80940081|FG000|Overall Study|Symptomatic progression|1|||
27758267|NCT00667251|80940082|FG001|Overall Study|Symptomatic progression|2|||
27758268|NCT03589885|80940086|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
27758269|NCT03589885|80940087|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
27758270|NCT03589885|80940088|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
27758271|NCT03589885|80940089|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
27758272|NCT03589885|80940090|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
27758273|NCT03589885|80940086|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
27758274|NCT03589885|80940087|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
27758275|NCT03589885|80940088|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
27758276|NCT03589885|80940089|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
27758277|NCT03589885|80940090|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
27758278|NCT03589885|80940086|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
27758279|NCT03589885|80940087|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
27758280|NCT03589885|80940088|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
27758281|NCT03589885|80940089|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
27758282|NCT03589885|80940090|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
27758283|NCT03589885|80940086|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
27758284|NCT03589885|80940087|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
27758285|NCT03589885|80940088|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
27758286|NCT03589885|80940089|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
27758287|NCT03589885|80940090|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
27758288|NCT03589885|80940086|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
27758289|NCT03589885|80940087|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
27758290|NCT03589885|80940088|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
27758291|NCT03589885|80940089|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
27758292|NCT03589885|80940090|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
27758293|NCT03589885|80940086|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
27758294|NCT03589885|80940087|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
27758295|NCT03589885|80940088|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
27758296|NCT03589885|80940089|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
27758297|NCT03589885|80940090|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
27758298|NCT03589885|80940086|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
27758299|NCT03589885|80940087|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
27758300|NCT03589885|80940088|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
27758301|NCT03589885|80940089|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
27758302|NCT03589885|80940090|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
27758303|NCT03589885|80940086|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
27758304|NCT03589885|80940087|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
27758305|NCT03589885|80940088|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
27758306|NCT03589885|80940089|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
27758307|NCT03589885|80940090|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
27758308|NCT00082758|80940093|FG000|Overall Study|Adverse Event|0|||
27758309|NCT00082758|80940094|FG001|Overall Study|Adverse Event|2|||
27758310|NCT00082758|80940095|FG002|Overall Study|Adverse Event|0|||
27758311|NCT00082758|80940093|FG000|Overall Study|Lack of Efficacy|12|||
27758312|NCT00082758|80940094|FG001|Overall Study|Lack of Efficacy|13|||
27758313|NCT00082758|80940095|FG002|Overall Study|Lack of Efficacy|0|||
27758314|NCT00082758|80940093|FG000|Overall Study|Physician Decision|0|||
27758315|NCT00082758|80940094|FG001|Overall Study|Physician Decision|1|||
27758316|NCT00082758|80940095|FG002|Overall Study|Physician Decision|0|||
27758317|NCT00082758|80940093|FG000|Overall Study|Withdrawal by Subject|3|||
27758318|NCT00082758|80940094|FG001|Overall Study|Withdrawal by Subject|0|||
27758319|NCT00082758|80940095|FG002|Overall Study|Withdrawal by Subject|0|||
27758320|NCT00082758|80940093|FG000|Overall Study|Protocol Violation|0|||
27758321|NCT00082758|80940094|FG001|Overall Study|Protocol Violation|1|||
27758322|NCT00082758|80940095|FG002|Overall Study|Protocol Violation|0|||
27758323|NCT00064350|80940096|FG000|Induction Treatment|Disease Progression|5|||
27758324|NCT00064350|80940097|FG001|Induction Treatment|Disease Progression|1|||
27758325|NCT00064350|80940098|FG002|Induction Treatment|Disease Progression|110|||
27758326|NCT00064350|80940096|FG000|Induction Treatment|Adverse Event|0|||
27758327|NCT00064350|80940097|FG001|Induction Treatment|Adverse Event|2|||
27758328|NCT00064350|80940098|FG002|Induction Treatment|Adverse Event|49|||
27758329|NCT00064350|80940096|FG000|Induction Treatment|Death|0|||
27758330|NCT00064350|80940097|FG001|Induction Treatment|Death|0|||
27758331|NCT00064350|80940098|FG002|Induction Treatment|Death|9|||
27758332|NCT00064350|80940096|FG000|Induction Treatment|Withdrawal by Subject|0|||
27758333|NCT00064350|80940097|FG001|Induction Treatment|Withdrawal by Subject|0|||
27758334|NCT00064350|80940098|FG002|Induction Treatment|Withdrawal by Subject|21|||
27758335|NCT00064350|80940096|FG000|Induction Treatment|Ineligible or never started treatment|3|||
27758336|NCT00064350|80940097|FG001|Induction Treatment|Ineligible or never started treatment|6|||
27758337|NCT00064350|80940098|FG002|Induction Treatment|Ineligible or never started treatment|34|||
27758338|NCT00064350|80940096|FG000|Induction Treatment|Other|0|||
27758339|NCT00064350|80940097|FG001|Induction Treatment|Other|0|||
27758340|NCT00064350|80940098|FG002|Induction Treatment|Other|13|||
27758341|NCT00064350|80940096|FG000|Randomization|Adverse Event|8|||
27758342|NCT00064350|80940097|FG001|Randomization|Adverse Event|3|||
27758343|NCT00064350|80940098|FG002|Randomization|Adverse Event|0|||
27758344|NCT00064350|80940096|FG000|Randomization|Death|3|||
27758345|NCT00064350|80940097|FG001|Randomization|Death|0|||
27758346|NCT00064350|80940098|FG002|Randomization|Death|0|||
27758347|NCT00064350|80940096|FG000|Randomization|Withdrawal by Subject|1|||
27758348|NCT00064350|80940097|FG001|Randomization|Withdrawal by Subject|0|||
27758349|NCT00064350|80940098|FG002|Randomization|Withdrawal by Subject|0|||
27758350|NCT00064350|80940096|FG000|Randomization|Ineligible or never started treatment|9|||
27758351|NCT00064350|80940097|FG001|Randomization|Ineligible or never started treatment|15|||
27758352|NCT00064350|80940098|FG002|Randomization|Ineligible or never started treatment|0|||
27758353|NCT00064350|80940096|FG000|Randomization|Other|5|||
27758354|NCT00064350|80940097|FG001|Randomization|Other|0|||
27758355|NCT00064350|80940098|FG002|Randomization|Other|0|||
27758356|NCT00064350|80940096|FG000|Cross-Over|Adverse Event|0|||
27758357|NCT00064350|80940097|FG001|Cross-Over|Adverse Event|1|||
27758358|NCT00064350|80940098|FG002|Cross-Over|Adverse Event|0|||
27758359|NCT00064350|80940096|FG000|Cross-Over|Death|1|||
27758360|NCT00064350|80940097|FG001|Cross-Over|Death|3|||
27758361|NCT00064350|80940098|FG002|Cross-Over|Death|0|||
27758362|NCT00064350|80940096|FG000|Cross-Over|Withdrawal by Subject|2|||
27758363|NCT00064350|80940097|FG001|Cross-Over|Withdrawal by Subject|2|||
27758364|NCT00064350|80940098|FG002|Cross-Over|Withdrawal by Subject|0|||
27758365|NCT00064350|80940096|FG000|Cross-Over|Ineligible or never started treatment|3|||
27758366|NCT00064350|80940097|FG001|Cross-Over|Ineligible or never started treatment|6|||
27758367|NCT00064350|80940098|FG002|Cross-Over|Ineligible or never started treatment|0|||
27758368|NCT00064350|80940096|FG000|Cross-Over|Other|0|||
27758369|NCT00064350|80940097|FG001|Cross-Over|Other|2|||
27758370|NCT00064350|80940098|FG002|Cross-Over|Other|0|||
27758371|NCT00315705|80940099|FG000|Phase 1|Refused further treatment|1|||
27758372|NCT00315705|80940099|FG000|Phase 1|Failure to achieve response|8|||
27758373|NCT00315705|80940099|FG000|Phase 1|Disease relapse|4|||
27758374|NCT00315705|80940099|FG000|Phase 1|Scheduled for transplant|9|||
27758375|NCT00315705|80940099|FG000|Phase 1|Death|3|||
27758376|NCT00315705|80940099|FG000|Phase 2|Physician Decision|4|||
27758377|NCT00315705|80940099|FG000|Phase 2|Adverse Event|1|||
27758378|NCT00315705|80940099|FG000|Phase 2|Failure to achieve response|3|||
27758379|NCT00315705|80940099|FG000|Phase 2|Disease relapse|1|||
27758380|NCT00315705|80940099|FG000|Phase 2|Scheduled for transplant|8|||
27758381|NCT00315705|80940099|FG000|Phase 2|Other|1|||
27758382|NCT00315705|80940099|FG000|Phase 2|Death|7|||
27758383|NCT00262080|80940106|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
27758384|NCT00262080|80940107|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27758385|NCT00262080|80940108|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
27758386|NCT00262080|80940106|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
27758387|NCT00262080|80940107|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
27758388|NCT00262080|80940108|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
27758389|NCT00262080|80940106|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
27758390|NCT00262080|80940107|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
27758391|NCT00262080|80940108|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
27758392|NCT00262080|80940106|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
27758393|NCT00262080|80940107|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
27758394|NCT00262080|80940108|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
27758395|NCT00262080|80940106|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
27758396|NCT00262080|80940107|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
27758397|NCT00262080|80940108|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
27758398|NCT00262080|80940106|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
27758399|NCT00262080|80940107|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
27758400|NCT00262080|80940108|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
27758401|NCT00819585|80940113|FG000|Core Study|Adverse Event|2|||
27758402|NCT00819585|80940114|FG001|Core Study|Adverse Event|1|||
27758403|NCT00819585|80940115|FG002|Core Study|Adverse Event|1|||
27758404|NCT00819585|80940116|FG003|Core Study|Adverse Event|4|||
27758405|NCT00819585|80940117|FG004|Core Study|Adverse Event|1|||
27758406|NCT00819585|80940118|FG005|Core Study|Adverse Event|0|||
27758407|NCT00819585|80940119|FG006|Core Study|Adverse Event|2|||
27758408|NCT00819585|80940120|FG007|Core Study|Adverse Event|0|||
27758409|NCT00819585|80940121|FG008|Core Study|Adverse Event|0|||
27758410|NCT00819585|80940122|FG009|Core Study|Adverse Event|0|||
27758411|NCT00819585|80940123|FG010|Core Study|Adverse Event|0|||
27758412|NCT00819585|80940113|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
27758413|NCT00819585|80940114|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
27758414|NCT00819585|80940115|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
27758415|NCT00819585|80940116|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
27758416|NCT00819585|80940117|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
27758417|NCT00819585|80940118|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
27758418|NCT00819585|80940119|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
27758419|NCT00819585|80940120|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
27758420|NCT00819585|80940121|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
27758421|NCT00819585|80940122|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
27758422|NCT00819585|80940123|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
27758423|NCT00819585|80940113|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758424|NCT00819585|80940114|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
27758425|NCT00819585|80940115|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758426|NCT00819585|80940116|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758427|NCT00819585|80940117|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758428|NCT00819585|80940118|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758429|NCT00819585|80940119|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
27758430|NCT00819585|80940120|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758431|NCT00819585|80940121|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758432|NCT00819585|80940122|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758433|NCT00819585|80940123|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
27758434|NCT00819585|80940113|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
27758435|NCT00819585|80940114|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
27758436|NCT00819585|80940115|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
27758437|NCT00819585|80940116|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
27758438|NCT00819585|80940117|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
27758439|NCT00819585|80940118|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
27758440|NCT00819585|80940119|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
27758441|NCT00819585|80940120|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
27758442|NCT00819585|80940121|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
27758443|NCT00819585|80940122|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
27758444|NCT00819585|80940123|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
27758445|NCT00819585|80940113|FG000|Core Study|Subject Withdrew Consent|0|||
27758446|NCT00819585|80940114|FG001|Core Study|Subject Withdrew Consent|3|||
27758447|NCT00819585|80940115|FG002|Core Study|Subject Withdrew Consent|2|||
27758448|NCT00819585|80940116|FG003|Core Study|Subject Withdrew Consent|1|||
27758449|NCT00819585|80940117|FG004|Core Study|Subject Withdrew Consent|0|||
27758450|NCT00819585|80940118|FG005|Core Study|Subject Withdrew Consent|0|||
27758451|NCT00819585|80940119|FG006|Core Study|Subject Withdrew Consent|3|||
27758452|NCT00819585|80940120|FG007|Core Study|Subject Withdrew Consent|0|||
27758453|NCT00819585|80940121|FG008|Core Study|Subject Withdrew Consent|0|||
27758454|NCT00819585|80940122|FG009|Core Study|Subject Withdrew Consent|0|||
27758455|NCT00819585|80940123|FG010|Core Study|Subject Withdrew Consent|0|||
27758456|NCT00819585|80940113|FG000|Core Study|Lost to Follow-up|2|||
27758457|NCT00819585|80940114|FG001|Core Study|Lost to Follow-up|1|||
27758458|NCT00819585|80940115|FG002|Core Study|Lost to Follow-up|2|||
27758459|NCT00819585|80940116|FG003|Core Study|Lost to Follow-up|0|||
27758460|NCT00819585|80940117|FG004|Core Study|Lost to Follow-up|1|||
27758461|NCT00819585|80940118|FG005|Core Study|Lost to Follow-up|1|||
27758462|NCT00819585|80940119|FG006|Core Study|Lost to Follow-up|1|||
27758463|NCT00819585|80940120|FG007|Core Study|Lost to Follow-up|0|||
27758464|NCT00819585|80940121|FG008|Core Study|Lost to Follow-up|0|||
27758465|NCT00819585|80940122|FG009|Core Study|Lost to Follow-up|0|||
27758466|NCT00819585|80940123|FG010|Core Study|Lost to Follow-up|0|||
27758467|NCT00819585|80940113|FG000|Core Study|Administrative Problems|0|||
27758468|NCT00819585|80940114|FG001|Core Study|Administrative Problems|0|||
27758469|NCT00819585|80940115|FG002|Core Study|Administrative Problems|0|||
27758470|NCT00819585|80940116|FG003|Core Study|Administrative Problems|0|||
27758471|NCT00819585|80940117|FG004|Core Study|Administrative Problems|0|||
27758472|NCT00819585|80940118|FG005|Core Study|Administrative Problems|0|||
27758473|NCT00819585|80940119|FG006|Core Study|Administrative Problems|2|||
27758474|NCT00819585|80940120|FG007|Core Study|Administrative Problems|0|||
27758475|NCT00819585|80940121|FG008|Core Study|Administrative Problems|0|||
27758476|NCT00819585|80940122|FG009|Core Study|Administrative Problems|0|||
27758477|NCT00819585|80940123|FG010|Core Study|Administrative Problems|0|||
27758478|NCT00819585|80940113|FG000|Core Study|Death|0|||
27758479|NCT00819585|80940114|FG001|Core Study|Death|0|||
27758480|NCT00819585|80940115|FG002|Core Study|Death|0|||
27758481|NCT00819585|80940116|FG003|Core Study|Death|0|||
27758482|NCT00819585|80940117|FG004|Core Study|Death|0|||
27758483|NCT00819585|80940118|FG005|Core Study|Death|0|||
27758484|NCT00819585|80940119|FG006|Core Study|Death|1|||
27758485|NCT00819585|80940120|FG007|Core Study|Death|0|||
27758486|NCT00819585|80940121|FG008|Core Study|Death|0|||
27758487|NCT00819585|80940122|FG009|Core Study|Death|0|||
27758488|NCT00819585|80940123|FG010|Core Study|Death|0|||
27758489|NCT00819585|80940113|FG000|Core Study|Protocol Violation|0|||
27758490|NCT00819585|80940114|FG001|Core Study|Protocol Violation|0|||
27758491|NCT00819585|80940115|FG002|Core Study|Protocol Violation|1|||
27758492|NCT00819585|80940116|FG003|Core Study|Protocol Violation|0|||
27758493|NCT00819585|80940117|FG004|Core Study|Protocol Violation|0|||
27758494|NCT00819585|80940118|FG005|Core Study|Protocol Violation|1|||
27758495|NCT00819585|80940119|FG006|Core Study|Protocol Violation|3|||
27758496|NCT00819585|80940120|FG007|Core Study|Protocol Violation|0|||
27758497|NCT00819585|80940121|FG008|Core Study|Protocol Violation|0|||
27758498|NCT00819585|80940122|FG009|Core Study|Protocol Violation|0|||
27758499|NCT00819585|80940123|FG010|Core Study|Protocol Violation|0|||
27758500|NCT00819585|80940113|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
27758501|NCT00819585|80940114|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
27758502|NCT00819585|80940115|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
27758503|NCT00819585|80940116|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
27758504|NCT00819585|80940117|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
27758505|NCT00819585|80940118|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
27758506|NCT00819585|80940119|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
27758507|NCT00819585|80940120|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
27758508|NCT00819585|80940121|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
27758509|NCT00819585|80940122|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
27758510|NCT00819585|80940123|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
27758511|NCT00819585|80940113|FG000|Extension Study|Subject Withdrew Consent|0|||
27758512|NCT00819585|80940114|FG001|Extension Study|Subject Withdrew Consent|0|||
27758513|NCT00819585|80940115|FG002|Extension Study|Subject Withdrew Consent|0|||
27758514|NCT00819585|80940116|FG003|Extension Study|Subject Withdrew Consent|0|||
27758515|NCT00819585|80940117|FG004|Extension Study|Subject Withdrew Consent|0|||
27758516|NCT00819585|80940118|FG005|Extension Study|Subject Withdrew Consent|0|||
27758517|NCT00819585|80940119|FG006|Extension Study|Subject Withdrew Consent|0|||
27758518|NCT00819585|80940120|FG007|Extension Study|Subject Withdrew Consent|0|||
27758519|NCT00819585|80940121|FG008|Extension Study|Subject Withdrew Consent|3|||
27758520|NCT00819585|80940122|FG009|Extension Study|Subject Withdrew Consent|0|||
27758521|NCT00819585|80940123|FG010|Extension Study|Subject Withdrew Consent|1|||
27758522|NCT00819585|80940113|FG000|Extension Study|Lost to Follow-up|0|||
27758523|NCT00819585|80940114|FG001|Extension Study|Lost to Follow-up|0|||
27758524|NCT00819585|80940115|FG002|Extension Study|Lost to Follow-up|0|||
27758525|NCT00819585|80940116|FG003|Extension Study|Lost to Follow-up|0|||
27758526|NCT00819585|80940117|FG004|Extension Study|Lost to Follow-up|0|||
27758527|NCT00819585|80940118|FG005|Extension Study|Lost to Follow-up|0|||
27758528|NCT00819585|80940119|FG006|Extension Study|Lost to Follow-up|0|||
27758529|NCT00819585|80940120|FG007|Extension Study|Lost to Follow-up|0|||
27758530|NCT00819585|80940121|FG008|Extension Study|Lost to Follow-up|2|||
27758531|NCT00819585|80940122|FG009|Extension Study|Lost to Follow-up|1|||
27758532|NCT00819585|80940123|FG010|Extension Study|Lost to Follow-up|1|||
27758533|NCT00819585|80940113|FG000|Extension Study|Death|0|||
27758534|NCT00819585|80940114|FG001|Extension Study|Death|0|||
27758535|NCT00819585|80940115|FG002|Extension Study|Death|0|||
27758536|NCT00819585|80940116|FG003|Extension Study|Death|0|||
27758537|NCT00819585|80940117|FG004|Extension Study|Death|0|||
27758538|NCT00819585|80940118|FG005|Extension Study|Death|0|||
27758539|NCT00819585|80940119|FG006|Extension Study|Death|0|||
27758540|NCT00819585|80940120|FG007|Extension Study|Death|0|||
27758541|NCT00819585|80940121|FG008|Extension Study|Death|2|||
27758542|NCT00819585|80940122|FG009|Extension Study|Death|0|||
27758543|NCT00819585|80940123|FG010|Extension Study|Death|0|||
27758544|NCT03497429|80940124|FG000|Overall Study|Progressive disease|3|||
27758545|NCT03497429|80940125|FG001|Overall Study|Progressive disease|4|||
27758546|NCT03497429|80940124|FG000|Overall Study|Adverse Event|0|||
27758547|NCT03497429|80940125|FG001|Overall Study|Adverse Event|2|||
27758548|NCT00507416|80940128|FG000|Overall Study|Adverse Event|58|||
27758549|NCT00507416|80940129|FG001|Overall Study|Adverse Event|67|||
27758550|NCT00507416|80940130|FG002|Overall Study|Adverse Event|65|||
27758551|NCT00507416|80940128|FG000|Overall Study|Protocol Violation|1|||
27758552|NCT00507416|80940129|FG001|Overall Study|Protocol Violation|2|||
27758553|NCT00507416|80940130|FG002|Overall Study|Protocol Violation|0|||
27758554|NCT00507416|80940128|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
27758555|NCT00507416|80940129|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
27758556|NCT00507416|80940130|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
27758557|NCT00507416|80940128|FG000|Overall Study|Progressive Disease|20|||
27758558|NCT00507416|80940129|FG001|Overall Study|Progressive Disease|10|||
27758559|NCT00507416|80940130|FG002|Overall Study|Progressive Disease|13|||
27758560|NCT00507416|80940128|FG000|Overall Study|Patient declined further treatment|18|||
27758561|NCT00507416|80940129|FG001|Overall Study|Patient declined further treatment|14|||
27758562|NCT00507416|80940130|FG002|Overall Study|Patient declined further treatment|11|||
27758563|NCT00507416|80940128|FG000|Overall Study|Other|11|||
27758564|NCT00507416|80940129|FG001|Overall Study|Other|16|||
27758565|NCT00507416|80940130|FG002|Overall Study|Other|13|||
27758566|NCT00507416|80940128|FG000|Overall Study|Did not Receive Study Treatment|3|||
27758567|NCT00507416|80940129|FG001|Overall Study|Did not Receive Study Treatment|9|||
27758568|NCT00507416|80940130|FG002|Overall Study|Did not Receive Study Treatment|4|||
27758569|NCT03583372|80940134|FG000|Overall Study|Withdrawal by Subject|6|||
27758570|NCT03583372|80940135|FG001|Overall Study|Withdrawal by Subject|11|||
27758571|NCT03583372|80940136|FG002|Overall Study|Withdrawal by Subject|7|||
27758572|NCT03583372|80940137|FG003|Overall Study|Withdrawal by Subject|8|||
27758573|NCT03583372|80940134|FG000|Overall Study|Lost to Follow-up|4|||
27758574|NCT03583372|80940135|FG001|Overall Study|Lost to Follow-up|6|||
27758575|NCT03583372|80940136|FG002|Overall Study|Lost to Follow-up|3|||
27758576|NCT03583372|80940137|FG003|Overall Study|Lost to Follow-up|2|||
27758577|NCT03583372|80940134|FG000|Overall Study|Adverse Event|1|||
27758578|NCT03583372|80940135|FG001|Overall Study|Adverse Event|3|||
27758579|NCT03583372|80940136|FG002|Overall Study|Adverse Event|4|||
27758580|NCT03583372|80940137|FG003|Overall Study|Adverse Event|4|||
27758581|NCT03583372|80940134|FG000|Overall Study|Physician Decision|0|||
27758582|NCT03583372|80940135|FG001|Overall Study|Physician Decision|1|||
27656673|NCT01072149|80583243|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27758583|NCT03583372|80940136|FG002|Overall Study|Physician Decision|1|||
27758584|NCT03583372|80940137|FG003|Overall Study|Physician Decision|1|||
27758585|NCT03583372|80940134|FG000|Overall Study|Lack of Efficacy|0|||
27758586|NCT03583372|80940135|FG001|Overall Study|Lack of Efficacy|1|||
27758587|NCT03583372|80940136|FG002|Overall Study|Lack of Efficacy|0|||
27758588|NCT03583372|80940137|FG003|Overall Study|Lack of Efficacy|1|||
27758589|NCT03583372|80940134|FG000|Overall Study|Death|1|||
27758590|NCT03583372|80940135|FG001|Overall Study|Death|0|||
27758591|NCT03583372|80940136|FG002|Overall Study|Death|0|||
27758592|NCT03583372|80940137|FG003|Overall Study|Death|0|||
27656674|NCT01072149|80583244|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656675|NCT01072149|80583245|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656676|NCT01072149|80583246|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656677|NCT01072149|80583247|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656678|NCT01072149|80583248|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656679|NCT01072149|80583249|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656680|NCT01072149|80583250|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656681|NCT01072149|80583251|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656682|NCT01072149|80583252|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656683|NCT01072149|80583253|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27656684|NCT01072149|80583236|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656685|NCT01072149|80583237|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656686|NCT01072149|80583238|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656687|NCT01072149|80583239|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656688|NCT01072149|80583240|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656689|NCT01072149|80583241|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656690|NCT01072149|80583242|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656691|NCT01072149|80583243|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656692|NCT01072149|80583244|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656693|NCT01072149|80583245|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656694|NCT01072149|80583246|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656695|NCT01072149|80583247|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656696|NCT01072149|80583248|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656697|NCT01072149|80583249|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656698|NCT01072149|80583250|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656699|NCT01072149|80583251|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656700|NCT01072149|80583252|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
27656701|NCT01072149|80583253|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
27656702|NCT01072149|80583236|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656703|NCT01072149|80583237|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656704|NCT01072149|80583238|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656705|NCT01072149|80583239|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656706|NCT01072149|80583240|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656707|NCT01072149|80583241|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656708|NCT01072149|80583242|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656709|NCT01072149|80583243|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656710|NCT01072149|80583244|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656711|NCT01072149|80583245|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656712|NCT01072149|80583246|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
27656713|NCT01072149|80583247|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656714|NCT01072149|80583248|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656715|NCT01072149|80583249|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656716|NCT01072149|80583250|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656717|NCT01072149|80583251|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656718|NCT01072149|80583252|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656719|NCT01072149|80583253|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27656720|NCT01072149|80583236|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656721|NCT01072149|80583237|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
27656722|NCT01072149|80583238|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656723|NCT01072149|80583239|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656724|NCT01072149|80583240|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656725|NCT01072149|80583241|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656726|NCT01072149|80583242|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27758593|NCT03583372|80940134|FG000|Overall Study|Protocol Violation|0|||
27758594|NCT03583372|80940135|FG001|Overall Study|Protocol Violation|1|||
27758595|NCT03583372|80940136|FG002|Overall Study|Protocol Violation|0|||
27758596|NCT03583372|80940137|FG003|Overall Study|Protocol Violation|0|||
27758597|NCT03583372|80940134|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
27758598|NCT03583372|80940135|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
27758599|NCT03583372|80940136|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
27758600|NCT03583372|80940137|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
27758601|NCT03583372|80940134|FG000|Overall Study|Did Not Receive Study Drug|0|||
27758602|NCT03583372|80940135|FG001|Overall Study|Did Not Receive Study Drug|1|||
27758603|NCT03583372|80940136|FG002|Overall Study|Did Not Receive Study Drug|0|||
27758604|NCT03583372|80940137|FG003|Overall Study|Did Not Receive Study Drug|0|||
27758605|NCT03583372|80940134|FG000|Overall Study|Captured as Other in the Database|1|||
27758606|NCT03583372|80940135|FG001|Overall Study|Captured as Other in the Database|2|||
27758607|NCT03583372|80940136|FG002|Overall Study|Captured as Other in the Database|4|||
27758608|NCT03583372|80940137|FG003|Overall Study|Captured as Other in the Database|1|||
27758609|NCT01561560|80940141|FG000|First Two Weeks of Wear|Time/job conflict|0|||
27758610|NCT01561560|80940142|FG001|First Two Weeks of Wear|Time/job conflict|1|||
27758611|NCT01561560|80940141|FG000|First Two Weeks of Wear|Adverse Event|0|||
27758612|NCT01561560|80940142|FG001|First Two Weeks of Wear|Adverse Event|1|||
27758613|NCT01561560|80940141|FG000|Second Two Weeks of Wear|Adverse Event|0|||
27758614|NCT01561560|80940142|FG001|Second Two Weeks of Wear|Adverse Event|1|||
27758615|NCT00501046|80940145|FG000|Overall Study|Adverse Event|21|||
27758616|NCT00501046|80940146|FG001|Overall Study|Adverse Event|25|||
27758617|NCT00501046|80940145|FG000|Overall Study|Death|23|||
27758618|NCT00501046|80940146|FG001|Overall Study|Death|30|||
27758619|NCT00501046|80940145|FG000|Overall Study|Lost to Follow-up|14|||
27758620|NCT00501046|80940146|FG001|Overall Study|Lost to Follow-up|13|||
27758621|NCT00501046|80940145|FG000|Overall Study|Physician Decision|7|||
27758622|NCT00501046|80940146|FG001|Overall Study|Physician Decision|2|||
27758623|NCT00501046|80940145|FG000|Overall Study|Pregnancy|0|||
27758624|NCT00501046|80940146|FG001|Overall Study|Pregnancy|3|||
27758625|NCT00501046|80940145|FG000|Overall Study|Protocol Violation|2|||
27758626|NCT00501046|80940146|FG001|Overall Study|Protocol Violation|1|||
27758627|NCT00501046|80940145|FG000|Overall Study|Withdrawal by Subject|84|||
27758628|NCT00501046|80940146|FG001|Overall Study|Withdrawal by Subject|83|||
27758629|NCT00501046|80940145|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
27758630|NCT00501046|80940146|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
27758631|NCT02124707|80940151|FG000|Overall Study|Adverse Event|5|||
27758632|NCT02124707|80940151|FG000|Overall Study|Physician Decision|1|||
27758633|NCT02124707|80940151|FG000|Overall Study|Death|1|||
27758634|NCT02232087|80940154|FG000|Overall Study|Withdrawal by Subject|2|||
27758635|NCT02232087|80940155|FG001|Overall Study|Withdrawal by Subject|0|||
27758636|NCT02232087|80940156|FG002|Overall Study|Withdrawal by Subject|0|||
27758637|NCT02232087|80940157|FG003|Overall Study|Withdrawal by Subject|0|||
27758638|NCT02232087|80940158|FG004|Overall Study|Withdrawal by Subject|0|||
27758639|NCT02232087|80940159|FG005|Overall Study|Withdrawal by Subject|1|||
27758640|NCT02232087|80940154|FG000|Overall Study|poor inhalation technique|0|||
27758641|NCT02232087|80940155|FG001|Overall Study|poor inhalation technique|1|||
27758642|NCT02232087|80940156|FG002|Overall Study|poor inhalation technique|0|||
27758643|NCT02232087|80940157|FG003|Overall Study|poor inhalation technique|0|||
27758644|NCT02232087|80940158|FG004|Overall Study|poor inhalation technique|0|||
27758645|NCT02232087|80940159|FG005|Overall Study|poor inhalation technique|2|||
27758646|NCT02232087|80940154|FG000|Overall Study|protocol stop criteria|0|||
27758647|NCT02232087|80940155|FG001|Overall Study|protocol stop criteria|1|||
27758648|NCT02232087|80940156|FG002|Overall Study|protocol stop criteria|0|||
27758649|NCT02232087|80940157|FG003|Overall Study|protocol stop criteria|1|||
27758650|NCT02232087|80940158|FG004|Overall Study|protocol stop criteria|0|||
27758651|NCT02232087|80940159|FG005|Overall Study|protocol stop criteria|0|||
27758652|NCT02232087|80940154|FG000|Overall Study|Adverse Event|0|||
27758653|NCT02232087|80940155|FG001|Overall Study|Adverse Event|0|||
27758654|NCT02232087|80940156|FG002|Overall Study|Adverse Event|0|||
27758655|NCT02232087|80940157|FG003|Overall Study|Adverse Event|0|||
27758656|NCT02232087|80940158|FG004|Overall Study|Adverse Event|1|||
27656727|NCT01072149|80583243|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27758657|NCT02232087|80940159|FG005|Overall Study|Adverse Event|0|||
27758658|NCT02157506|80940160|FG000|Overall Study|Adverse Event|0|||
27758659|NCT02157506|80940161|FG001|Overall Study|Adverse Event|1|||
27758660|NCT02157506|80940162|FG002|Overall Study|Adverse Event|0|||
27758661|NCT02157506|80940163|FG003|Overall Study|Adverse Event|0|||
27758662|NCT02157506|80940164|FG004|Overall Study|Adverse Event|0|||
27758663|NCT02157506|80940160|FG000|Overall Study|Lost to Follow-up|0|||
27758664|NCT02157506|80940161|FG001|Overall Study|Lost to Follow-up|0|||
27758665|NCT02157506|80940162|FG002|Overall Study|Lost to Follow-up|1|||
27758666|NCT02157506|80940163|FG003|Overall Study|Lost to Follow-up|0|||
27758667|NCT02157506|80940164|FG004|Overall Study|Lost to Follow-up|0|||
27758668|NCT01935336|80940171|FG000|Overall Study|Adverse Event|1|||
27758669|NCT01935336|80940172|FG001|Overall Study|Adverse Event|0|||
27758670|NCT01935336|80940173|FG002|Overall Study|Adverse Event|0|||
27758671|NCT01935336|80940174|FG003|Overall Study|Adverse Event|0|||
27758672|NCT01935336|80940171|FG000|Overall Study|Progressive disease|5|||
27758673|NCT01935336|80940172|FG001|Overall Study|Progressive disease|3|||
27758674|NCT01935336|80940173|FG002|Overall Study|Progressive disease|47|||
27758675|NCT01935336|80940174|FG003|Overall Study|Progressive disease|66|||
27758676|NCT02662985|80940175|FG000|Treatment Period 1|Adverse Event|0|||
27758677|NCT02662985|80940176|FG001|Treatment Period 1|Adverse Event|2|||
27758678|NCT02662985|80940175|FG000|Treatment Period 1|Protocol Violation|0|||
27758679|NCT02662985|80940176|FG001|Treatment Period 1|Protocol Violation|1|||
27758680|NCT02662985|80940175|FG000|Treatment Period 1|Physician Decision|1|||
27758681|NCT02662985|80940176|FG001|Treatment Period 1|Physician Decision|0|||
27758682|NCT02662985|80940175|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27758683|NCT02662985|80940176|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27758684|NCT02662985|80940175|FG000|Treatment Period 2|Lack of Efficacy|0|||
27758685|NCT02662985|80940176|FG001|Treatment Period 2|Lack of Efficacy|1|||
27758686|NCT02662985|80940175|FG000|Treatment Period 2|Lost to Follow-up|1|||
27758687|NCT02662985|80940176|FG001|Treatment Period 2|Lost to Follow-up|0|||
27758688|NCT02662985|80940175|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
27758689|NCT02662985|80940176|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
27758690|NCT02662985|80940175|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
27758691|NCT02662985|80940176|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
27758692|NCT02662985|80940175|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
27758693|NCT02662985|80940176|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
27758694|NCT02662985|80940175|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
27758695|NCT02662985|80940176|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
27758696|NCT02662985|80940175|FG000|Treatment Period 3 (Extension Period)|Death|0|||
27758697|NCT02662985|80940176|FG001|Treatment Period 3 (Extension Period)|Death|1|||
27758698|NCT01114373|80940177|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
27758699|NCT01114373|80940178|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
27758700|NCT01114373|80940177|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
27758701|NCT01114373|80940178|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
27758702|NCT01114373|80940177|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
27758703|NCT01114373|80940178|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
27758704|NCT01114373|80940177|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
27758705|NCT01114373|80940178|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
27758706|NCT00738374|80940180|FG000|Induction Treatment Phase|Adverse Event|14|||
27758707|NCT00738374|80940181|FG001|Induction Treatment Phase|Adverse Event|0|||
27758708|NCT00738374|80940182|FG002|Induction Treatment Phase|Adverse Event|0|||
27758709|NCT00738374|80940183|FG003|Induction Treatment Phase|Adverse Event|0|||
27758710|NCT00738374|80940180|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
27758711|NCT00738374|80940181|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
27758712|NCT00738374|80940182|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
27758713|NCT00738374|80940183|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
27758714|NCT00738374|80940180|FG000|Induction Treatment Phase|Physician Decision|2|||
27758715|NCT00738374|80940181|FG001|Induction Treatment Phase|Physician Decision|0|||
27758716|NCT00738374|80940182|FG002|Induction Treatment Phase|Physician Decision|0|||
27758717|NCT00738374|80940183|FG003|Induction Treatment Phase|Physician Decision|0|||
27758718|NCT00738374|80940180|FG000|Induction Treatment Phase|Protocol Violation|2|||
27758719|NCT00738374|80940181|FG001|Induction Treatment Phase|Protocol Violation|0|||
27758720|NCT00738374|80940182|FG002|Induction Treatment Phase|Protocol Violation|0|||
27758721|NCT00738374|80940183|FG003|Induction Treatment Phase|Protocol Violation|0|||
27758722|NCT00738374|80940180|FG000|Induction Treatment Phase|Non-compliance|1|||
27758723|NCT00738374|80940181|FG001|Induction Treatment Phase|Non-compliance|0|||
27758724|NCT00738374|80940182|FG002|Induction Treatment Phase|Non-compliance|0|||
27758725|NCT00738374|80940183|FG003|Induction Treatment Phase|Non-compliance|0|||
27758726|NCT00738374|80940180|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
27758727|NCT00738374|80940181|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
27758728|NCT00738374|80940182|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
27758729|NCT00738374|80940183|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
27758730|NCT00738374|80940180|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
27758731|NCT00738374|80940181|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
27758732|NCT00738374|80940182|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
27758733|NCT00738374|80940183|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
27758734|NCT00738374|80940180|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
27758735|NCT00738374|80940181|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
27758736|NCT00738374|80940182|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
27758737|NCT00738374|80940183|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
27758738|NCT00738374|80940180|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
27758739|NCT00738374|80940181|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
27758740|NCT00738374|80940182|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
27758741|NCT00738374|80940183|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
27758742|NCT00738374|80940180|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
27758743|NCT00738374|80940181|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
27758744|NCT00738374|80940182|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
27758745|NCT00738374|80940183|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
27758746|NCT00738374|80940180|FG000|Maintenance Treatment/Observation Phase|Other|0|||
27758747|NCT00738374|80940181|FG001|Maintenance Treatment/Observation Phase|Other|1|||
27758748|NCT00738374|80940182|FG002|Maintenance Treatment/Observation Phase|Other|0|||
27758749|NCT00738374|80940183|FG003|Maintenance Treatment/Observation Phase|Other|0|||
27758750|NCT00441441|80940187|FG000|Overall Study|Adverse Event|2|||
27758751|NCT00441441|80940188|FG001|Overall Study|Adverse Event|1|||
27758752|NCT00441441|80940187|FG000|Overall Study|Protocol Violation|4|||
27758753|NCT00441441|80940188|FG001|Overall Study|Protocol Violation|6|||
27758754|NCT00441441|80940187|FG000|Overall Study|Exacerbation of asthma|1|||
27758755|NCT00441441|80940188|FG001|Overall Study|Exacerbation of asthma|2|||
27758756|NCT00441441|80940187|FG000|Overall Study|Withdrawal by Subject|1|||
27758757|NCT00441441|80940188|FG001|Overall Study|Withdrawal by Subject|2|||
27758758|NCT00441441|80940187|FG000|Overall Study|Other|3|||
27758759|NCT00441441|80940188|FG001|Overall Study|Other|3|||
27758760|NCT04124692|80940195|FG000|Overall Study|Medical reason|0|||
27758761|NCT04124692|80940196|FG001|Overall Study|Medical reason|1|||
27758762|NCT04124692|80940195|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
27758763|NCT04124692|80940196|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
27758764|NCT04124692|80940195|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
27758765|NCT04124692|80940196|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
27758766|NCT04124692|80940195|FG000|Overall Study|Lost to Follow-up|2|||
27758767|NCT04124692|80940196|FG001|Overall Study|Lost to Follow-up|4|||
27758768|NCT04124692|80940195|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
27758769|NCT04124692|80940196|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
27758770|NCT00059215|80940197|FG000|Overall Study|Adverse Event|5|||
27758771|NCT00059215|80940198|FG001|Overall Study|Adverse Event|5|||
27758772|NCT00059215|80940199|FG002|Overall Study|Adverse Event|9|||
27758773|NCT00059215|80940200|FG003|Overall Study|Adverse Event|9|||
27758774|NCT00059215|80940197|FG000|Overall Study|Death|0|||
27758775|NCT00059215|80940198|FG001|Overall Study|Death|0|||
27758776|NCT00059215|80940199|FG002|Overall Study|Death|3|||
27758777|NCT00059215|80940200|FG003|Overall Study|Death|0|||
27758778|NCT00059215|80940197|FG000|Overall Study|Lost to Follow-up|1|||
27758779|NCT00059215|80940198|FG001|Overall Study|Lost to Follow-up|2|||
27758780|NCT00059215|80940199|FG002|Overall Study|Lost to Follow-up|0|||
27758781|NCT00059215|80940200|FG003|Overall Study|Lost to Follow-up|0|||
27758782|NCT00059215|80940197|FG000|Overall Study|Withdrawal by Subject|4|||
27758783|NCT00059215|80940198|FG001|Overall Study|Withdrawal by Subject|4|||
27758784|NCT00059215|80940199|FG002|Overall Study|Withdrawal by Subject|1|||
27758785|NCT00059215|80940200|FG003|Overall Study|Withdrawal by Subject|3|||
27758786|NCT00059215|80940197|FG000|Overall Study|Protocol Violation|1|||
27758787|NCT00059215|80940198|FG001|Overall Study|Protocol Violation|0|||
27758788|NCT00059215|80940199|FG002|Overall Study|Protocol Violation|1|||
27758789|NCT00059215|80940200|FG003|Overall Study|Protocol Violation|0|||
27758790|NCT00059215|80940197|FG000|Overall Study|Protocol entry criteria not met|1|||
27758791|NCT00059215|80940198|FG001|Overall Study|Protocol entry criteria not met|1|||
27758792|NCT00059215|80940199|FG002|Overall Study|Protocol entry criteria not met|0|||
27758793|NCT00059215|80940200|FG003|Overall Study|Protocol entry criteria not met|2|||
27758794|NCT00059215|80940197|FG000|Overall Study|Physician Decision|1|||
27758795|NCT00059215|80940198|FG001|Overall Study|Physician Decision|2|||
27758796|NCT00059215|80940199|FG002|Overall Study|Physician Decision|1|||
27758797|NCT00059215|80940200|FG003|Overall Study|Physician Decision|1|||
27758798|NCT00511342|80940201|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
27758799|NCT00511342|80940202|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
27758800|NCT00511342|80940201|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
27758801|NCT00511342|80940202|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
27758802|NCT00511342|80940201|FG000|Overall Study|Pregnancy|0|||
27758803|NCT00511342|80940202|FG001|Overall Study|Pregnancy|1|||
27758804|NCT00511342|80940201|FG000|Overall Study|Pregnancy wish|0|||
27758805|NCT00511342|80940202|FG001|Overall Study|Pregnancy wish|1|||
27758806|NCT00511342|80940201|FG000|Overall Study|Lost to Follow-up|1|||
27758807|NCT00511342|80940202|FG001|Overall Study|Lost to Follow-up|5|||
27758808|NCT00511342|80940201|FG000|Overall Study|Other Reason|2|||
27758809|NCT00511342|80940202|FG001|Overall Study|Other Reason|2|||
27758810|NCT03628417|80940206|FG000|Overall Study|Death|1|||
27758811|NCT03628417|80940207|FG001|Overall Study|Death|1|||
27656728|NCT01072149|80583244|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27758812|NCT00084929|80940208|FG000|Overall Study|ineligible - medical contraindication|1|||
27758813|NCT00084929|80940208|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
27758814|NCT00084929|80940208|FG000|Overall Study|Ineligible - Medical history|6|||
27758815|NCT00084929|80940208|FG000|Overall Study|Withdrawal by Subject|10|||
27758816|NCT00084929|80940208|FG000|Overall Study|Missing/incomplete CTC exam|9|||
27758817|NCT00084929|80940208|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
27758818|NCT02338492|80940209|FG000|Overall Study|Death|32|||
27758819|NCT02338492|80940209|FG000|Overall Study|Adverse Event|3|||
27758820|NCT02338492|80940209|FG000|Overall Study|Lost to Follow-up|4|||
27758821|NCT02338492|80940209|FG000|Overall Study|Reason not captured above|6|||
27758822|NCT03814590|80940210|FG000|Overall Study|Adverse Event|0|||
27758823|NCT03814590|80940211|FG001|Overall Study|Adverse Event|0|||
27758824|NCT03814590|80940212|FG002|Overall Study|Adverse Event|0|||
27758825|NCT03814590|80940213|FG003|Overall Study|Adverse Event|0|||
27758826|NCT03814590|80940214|FG004|Overall Study|Adverse Event|0|||
27758827|NCT03814590|80940215|FG005|Overall Study|Adverse Event|1|||
27758828|NCT03814590|80940216|FG006|Overall Study|Adverse Event|1|||
27758829|NCT03814590|80940217|FG007|Overall Study|Adverse Event|1|||
27758830|NCT03814590|80940218|FG008|Overall Study|Adverse Event|0|||
27758831|NCT03814590|80940219|FG009|Overall Study|Adverse Event|0|||
27758832|NCT03814590|80940220|FG010|Overall Study|Adverse Event|1|||
27758833|NCT03814590|80940221|FG011|Overall Study|Adverse Event|0|||
27758834|NCT03814590|80940222|FG012|Overall Study|Adverse Event|3|||
27758835|NCT03814590|80940223|FG013|Overall Study|Adverse Event|0|||
27758836|NCT03814590|80940210|FG000|Overall Study|Lost to Follow-up|0|||
27758837|NCT03814590|80940211|FG001|Overall Study|Lost to Follow-up|2|||
27758838|NCT03814590|80940212|FG002|Overall Study|Lost to Follow-up|1|||
27758839|NCT03814590|80940213|FG003|Overall Study|Lost to Follow-up|0|||
27758840|NCT03814590|80940214|FG004|Overall Study|Lost to Follow-up|1|||
27758841|NCT03814590|80940215|FG005|Overall Study|Lost to Follow-up|1|||
27758842|NCT03814590|80940216|FG006|Overall Study|Lost to Follow-up|1|||
27758843|NCT03814590|80940217|FG007|Overall Study|Lost to Follow-up|1|||
27758844|NCT03814590|80940218|FG008|Overall Study|Lost to Follow-up|0|||
27758845|NCT03814590|80940219|FG009|Overall Study|Lost to Follow-up|0|||
27758846|NCT03814590|80940220|FG010|Overall Study|Lost to Follow-up|1|||
27758847|NCT03814590|80940221|FG011|Overall Study|Lost to Follow-up|0|||
27758848|NCT03814590|80940222|FG012|Overall Study|Lost to Follow-up|0|||
27758849|NCT03814590|80940223|FG013|Overall Study|Lost to Follow-up|1|||
27758850|NCT03814590|80940210|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758851|NCT03814590|80940211|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758852|NCT03814590|80940212|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758853|NCT03814590|80940213|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758854|NCT03814590|80940214|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758855|NCT03814590|80940215|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758856|NCT03814590|80940216|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758857|NCT03814590|80940217|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758858|NCT03814590|80940218|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758859|NCT03814590|80940219|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
27758860|NCT03814590|80940220|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758861|NCT03814590|80940221|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758862|NCT03814590|80940222|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758863|NCT03814590|80940223|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
27758864|NCT03814590|80940210|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758865|NCT03814590|80940211|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758866|NCT03814590|80940212|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758867|NCT03814590|80940213|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758868|NCT03814590|80940214|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758869|NCT03814590|80940215|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
27758870|NCT03814590|80940216|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
27758871|NCT03814590|80940217|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
27758872|NCT03814590|80940218|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758873|NCT03814590|80940219|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
27758874|NCT03814590|80940220|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
27758875|NCT03814590|80940221|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
27758876|NCT03814590|80940222|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
27758877|NCT03814590|80940223|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
27758878|NCT03814590|80940210|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758879|NCT03814590|80940211|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758880|NCT03814590|80940212|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758881|NCT03814590|80940213|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758882|NCT03814590|80940214|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758883|NCT03814590|80940215|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758884|NCT03814590|80940216|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758885|NCT03814590|80940217|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27758886|NCT03814590|80940218|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758887|NCT03814590|80940219|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27758888|NCT03814590|80940220|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758889|NCT03814590|80940221|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758890|NCT03814590|80940222|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758891|NCT03814590|80940223|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27758892|NCT03814590|80940210|FG000|Overall Study|UNKNOWN REASON|0|||
27758893|NCT03814590|80940211|FG001|Overall Study|UNKNOWN REASON|0|||
27758894|NCT03814590|80940212|FG002|Overall Study|UNKNOWN REASON|0|||
27758895|NCT03814590|80940213|FG003|Overall Study|UNKNOWN REASON|0|||
27758896|NCT03814590|80940214|FG004|Overall Study|UNKNOWN REASON|0|||
27758897|NCT03814590|80940215|FG005|Overall Study|UNKNOWN REASON|0|||
27758898|NCT03814590|80940216|FG006|Overall Study|UNKNOWN REASON|0|||
27758899|NCT03814590|80940217|FG007|Overall Study|UNKNOWN REASON|1|||
27758900|NCT03814590|80940218|FG008|Overall Study|UNKNOWN REASON|0|||
27758901|NCT03814590|80940219|FG009|Overall Study|UNKNOWN REASON|0|||
27758902|NCT03814590|80940220|FG010|Overall Study|UNKNOWN REASON|0|||
27758903|NCT03814590|80940221|FG011|Overall Study|UNKNOWN REASON|0|||
27758904|NCT03814590|80940222|FG012|Overall Study|UNKNOWN REASON|0|||
27758905|NCT03814590|80940223|FG013|Overall Study|UNKNOWN REASON|0|||
27758906|NCT03089216|80940224|FG000|Overall Study|Adverse Event|0|||
27758907|NCT03089216|80940225|FG001|Overall Study|Adverse Event|0|||
27758908|NCT03089216|80940226|FG002|Overall Study|Adverse Event|0|||
27758909|NCT03089216|80940227|FG003|Overall Study|Adverse Event|1|||
27758910|NCT00946530|80940228|FG000|Overall Study|Withdrawal by Subject|0|||
27758911|NCT00946530|80940229|FG001|Overall Study|Withdrawal by Subject|3|||
27758912|NCT00946530|80940230|FG002|Overall Study|Withdrawal by Subject|0|||
27758913|NCT00946530|80940231|FG003|Overall Study|Withdrawal by Subject|3|||
27758914|NCT00946530|80940228|FG000|Overall Study|Physician Decision|1|||
27758915|NCT00946530|80940229|FG001|Overall Study|Physician Decision|1|||
27758916|NCT00946530|80940230|FG002|Overall Study|Physician Decision|1|||
27758917|NCT00946530|80940231|FG003|Overall Study|Physician Decision|1|||
27758918|NCT00012012|80940235|FG000|Overall Study|Protocol Violation|1|||
27758919|NCT00012012|80940236|FG001|Overall Study|Protocol Violation|1|||
27758920|NCT00012012|80940235|FG000|Overall Study|Withdrawal by Subject|0|||
27758921|NCT00012012|80940236|FG001|Overall Study|Withdrawal by Subject|2|||
27758922|NCT00980343|80940237|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
27758923|NCT00980343|80940238|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
27758924|NCT01429077|80940239|FG000|Overall Study|Lost to Follow-up|0|||
27758925|NCT01429077|80940240|FG001|Overall Study|Lost to Follow-up|3|||
27758926|NCT00424528|80940241|FG000|Overall Study|Adverse Event|2|||
27758927|NCT00424528|80940242|FG001|Overall Study|Adverse Event|1|||
27758928|NCT00424528|80940243|FG002|Overall Study|Adverse Event|2|||
27758929|NCT00424528|80940241|FG000|Overall Study|Protocol Violation|1|||
27758930|NCT00424528|80940242|FG001|Overall Study|Protocol Violation|1|||
27758931|NCT00424528|80940243|FG002|Overall Study|Protocol Violation|0|||
27758932|NCT00424528|80940241|FG000|Overall Study|Lost to Follow-up|0|||
27758933|NCT00424528|80940242|FG001|Overall Study|Lost to Follow-up|1|||
27758934|NCT00424528|80940243|FG002|Overall Study|Lost to Follow-up|0|||
27758935|NCT00424528|80940241|FG000|Overall Study|noncompliance with study requirements|2|||
27758936|NCT00424528|80940242|FG001|Overall Study|noncompliance with study requirements|1|||
27758937|NCT00424528|80940243|FG002|Overall Study|noncompliance with study requirements|2|||
27758938|NCT00390416|80940250|FG000|Overall Study|Withdrawal by Subject|1|||
27758939|NCT00390416|80940250|FG000|Overall Study|Not treated|3|||
27758940|NCT03162055|80940254|FG000|Overall Study|Adverse Event|6|||
27758941|NCT03162055|80940255|FG001|Overall Study|Adverse Event|5|||
27758942|NCT03162055|80940254|FG000|Overall Study|Death|3|||
27758943|NCT03162055|80940255|FG001|Overall Study|Death|3|||
27758944|NCT03162055|80940254|FG000|Overall Study|Lost to Follow-up|0|||
27758945|NCT03162055|80940255|FG001|Overall Study|Lost to Follow-up|1|||
27758946|NCT03162055|80940254|FG000|Overall Study|Study-specific withdrawal criteria|22|||
27758947|NCT03162055|80940255|FG001|Overall Study|Study-specific withdrawal criteria|14|||
27758948|NCT03162055|80940254|FG000|Overall Study|Withdrawal by Subject|17|||
27758949|NCT03162055|80940255|FG001|Overall Study|Withdrawal by Subject|2|||
27758950|NCT03162055|80940254|FG000|Overall Study|Did not receive treatment|2|||
27758951|NCT03162055|80940255|FG001|Overall Study|Did not receive treatment|0|||
27758952|NCT03162055|80940254|FG000|Overall Study|Incorrect randomization|4|||
27758953|NCT03162055|80940255|FG001|Overall Study|Incorrect randomization|3|||
27758954|NCT03162055|80940254|FG000|Overall Study|Other|8|||
27758955|NCT03162055|80940255|FG001|Overall Study|Other|15|||
27758956|NCT01094730|80943222|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
27758957|NCT01094730|80943223|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
27758958|NCT01094730|80943222|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
27758959|NCT01094730|80943223|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
27758960|NCT01094730|80943222|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
27758961|NCT01094730|80943223|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
27758962|NCT01094730|80943222|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
27758963|NCT01094730|80943223|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
27758964|NCT01094730|80943222|FG000|Period 2 (14 Days)|Protocol Violation|2|||
27758965|NCT01094730|80943223|FG001|Period 2 (14 Days)|Protocol Violation|0|||
27758966|NCT01094730|80943222|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
27758967|NCT01094730|80943223|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
27758968|NCT01094730|80943222|FG000|Period 2 (14 Days)|Adverse Event|0|||
27758969|NCT01094730|80943223|FG001|Period 2 (14 Days)|Adverse Event|1|||
27758970|NCT01094730|80943222|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
27758971|NCT01094730|80943223|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
27758972|NCT01167582|80943225|FG000|Overall Study|Lost to Follow-up|0|||
27758973|NCT01167582|80943226|FG001|Overall Study|Lost to Follow-up|1|||
27758974|NCT01928485|80943229|FG000|Overall Study|Physician Decision|0|||
27758975|NCT01928485|80943230|FG001|Overall Study|Physician Decision|1|||
27758976|NCT02702011|80943231|FG000|Overall Study|Withdrawal by Subject|0|||
27758977|NCT02702011|80943232|FG001|Overall Study|Withdrawal by Subject|1|||
27758978|NCT02702011|80943233|FG002|Overall Study|Withdrawal by Subject|0|||
27758979|NCT02702011|80943234|FG003|Overall Study|Withdrawal by Subject|0|||
27758980|NCT01757405|80943238|FG000|Overall Study|Lost to Follow-up|1|||
27758981|NCT01757405|80943239|FG001|Overall Study|Lost to Follow-up|1|||
27758982|NCT01757405|80943238|FG000|Overall Study|Withdrawal by Subject|0|||
27758983|NCT01757405|80943239|FG001|Overall Study|Withdrawal by Subject|1|||
27758984|NCT02056834|80943242|FG000|Overall Study|Lost to Follow-up|7|||
27758985|NCT01295580|80943244|FG000|Overall Study|Protocol Violation|4|||
27758986|NCT01295580|80943245|FG001|Overall Study|Protocol Violation|2|||
27758987|NCT01295580|80943244|FG000|Overall Study|Withdrawal by Subject|1|||
27758988|NCT01295580|80943245|FG001|Overall Study|Withdrawal by Subject|4|||
27758989|NCT01295580|80943244|FG000|Overall Study|Adverse Event|2|||
27758990|NCT01295580|80943245|FG001|Overall Study|Adverse Event|1|||
27758991|NCT01295580|80943244|FG000|Overall Study|Lost to Follow-up|1|||
27758992|NCT01295580|80943245|FG001|Overall Study|Lost to Follow-up|0|||
27758993|NCT01295580|80943244|FG000|Overall Study|Lack of Efficacy|1|||
27758994|NCT01295580|80943245|FG001|Overall Study|Lack of Efficacy|0|||
27758995|NCT01295580|80943244|FG000|Overall Study|Other: inconvenience|1|||
27758996|NCT01295580|80943245|FG001|Overall Study|Other: inconvenience|0|||
27758997|NCT01295580|80943244|FG000|Overall Study|Other: family objection|0|||
27758998|NCT01295580|80943245|FG001|Overall Study|Other: family objection|1|||
27758999|NCT00255086|80943246|FG000|Overall Study|Adverse Event|1|||
27759000|NCT00255086|80943247|FG001|Overall Study|Adverse Event|1|||
27759001|NCT00255086|80943246|FG000|Overall Study|Protocol Violation|1|||
27759002|NCT00255086|80943247|FG001|Overall Study|Protocol Violation|1|||
27759003|NCT03655717|80943248|FG000|Overall Study|Withdrawal by Subject|4|||
27759004|NCT03655717|80943249|FG001|Overall Study|Withdrawal by Subject|8|||
27759005|NCT03655717|80943250|FG002|Overall Study|Withdrawal by Subject|1|||
27759006|NCT03655717|80943251|FG003|Overall Study|Withdrawal by Subject|0|||
27759007|NCT03655717|80943252|FG004|Overall Study|Withdrawal by Subject|0|||
27759008|NCT03655717|80943253|FG005|Overall Study|Withdrawal by Subject|1|||
27759009|NCT03655717|80943254|FG006|Overall Study|Withdrawal by Subject|3|||
27759010|NCT03655717|80943255|FG007|Overall Study|Withdrawal by Subject|1|||
27759011|NCT03655717|80943256|FG008|Overall Study|Withdrawal by Subject|2|||
27759012|NCT03655717|80943257|FG009|Overall Study|Withdrawal by Subject|0|||
27759013|NCT03655717|80943258|FG010|Overall Study|Withdrawal by Subject|0|||
27759014|NCT03655717|80943259|FG011|Overall Study|Withdrawal by Subject|1|||
27759015|NCT03655717|80943260|FG012|Overall Study|Withdrawal by Subject|0|||
27759016|NCT03655717|80943261|FG013|Overall Study|Withdrawal by Subject|3|||
27759017|NCT03655717|80943262|FG014|Overall Study|Withdrawal by Subject|0|||
27759018|NCT03655717|80943263|FG015|Overall Study|Withdrawal by Subject|1|||
27759019|NCT03655717|80943264|FG016|Overall Study|Withdrawal by Subject|0|||
27759020|NCT03655717|80943265|FG017|Overall Study|Withdrawal by Subject|0|||
27759021|NCT03655717|80943266|FG018|Overall Study|Withdrawal by Subject|1|||
27759022|NCT03655717|80943267|FG019|Overall Study|Withdrawal by Subject|0|||
27759023|NCT03655717|80943268|FG020|Overall Study|Withdrawal by Subject|0|||
27759024|NCT03655717|80943269|FG021|Overall Study|Withdrawal by Subject|1|||
27759025|NCT03655717|80943270|FG022|Overall Study|Withdrawal by Subject|2|||
27759026|NCT03655717|80943271|FG023|Overall Study|Withdrawal by Subject|1|||
27759027|NCT03655717|80943272|FG024|Overall Study|Withdrawal by Subject|1|||
27759028|NCT03655717|80943273|FG025|Overall Study|Withdrawal by Subject|0|||
27759029|NCT03655717|80943248|FG000|Overall Study|Physician Decision|3|||
27759030|NCT03655717|80943249|FG001|Overall Study|Physician Decision|3|||
27759031|NCT03655717|80943250|FG002|Overall Study|Physician Decision|0|||
27759032|NCT03655717|80943251|FG003|Overall Study|Physician Decision|0|||
27759033|NCT03655717|80943252|FG004|Overall Study|Physician Decision|0|||
27759034|NCT03655717|80943253|FG005|Overall Study|Physician Decision|0|||
27759035|NCT03655717|80943254|FG006|Overall Study|Physician Decision|0|||
27759036|NCT03655717|80943255|FG007|Overall Study|Physician Decision|0|||
27759037|NCT03655717|80943256|FG008|Overall Study|Physician Decision|0|||
27759038|NCT03655717|80943257|FG009|Overall Study|Physician Decision|1|||
27759039|NCT03655717|80943258|FG010|Overall Study|Physician Decision|0|||
27759040|NCT03655717|80943259|FG011|Overall Study|Physician Decision|0|||
27759041|NCT03655717|80943260|FG012|Overall Study|Physician Decision|0|||
27759042|NCT03655717|80943261|FG013|Overall Study|Physician Decision|0|||
27759043|NCT03655717|80943262|FG014|Overall Study|Physician Decision|0|||
27759044|NCT03655717|80943263|FG015|Overall Study|Physician Decision|0|||
27759045|NCT03655717|80943264|FG016|Overall Study|Physician Decision|0|||
27759046|NCT03655717|80943265|FG017|Overall Study|Physician Decision|0|||
27759047|NCT03655717|80943266|FG018|Overall Study|Physician Decision|0|||
27759048|NCT03655717|80943267|FG019|Overall Study|Physician Decision|1|||
27759049|NCT03655717|80943268|FG020|Overall Study|Physician Decision|0|||
27759050|NCT03655717|80943269|FG021|Overall Study|Physician Decision|0|||
27759051|NCT03655717|80943270|FG022|Overall Study|Physician Decision|0|||
27759052|NCT03655717|80943271|FG023|Overall Study|Physician Decision|1|||
27759053|NCT03655717|80943272|FG024|Overall Study|Physician Decision|0|||
27759054|NCT03655717|80943273|FG025|Overall Study|Physician Decision|0|||
27759055|NCT03655717|80943248|FG000|Overall Study|Lost to Follow-up|3|||
27759056|NCT03655717|80943249|FG001|Overall Study|Lost to Follow-up|1|||
27759057|NCT03655717|80943250|FG002|Overall Study|Lost to Follow-up|0|||
27759058|NCT03655717|80943251|FG003|Overall Study|Lost to Follow-up|1|||
27759059|NCT03655717|80943252|FG004|Overall Study|Lost to Follow-up|0|||
27759060|NCT03655717|80943253|FG005|Overall Study|Lost to Follow-up|1|||
27759061|NCT03655717|80943254|FG006|Overall Study|Lost to Follow-up|0|||
27759062|NCT03655717|80943255|FG007|Overall Study|Lost to Follow-up|0|||
27759063|NCT03655717|80943256|FG008|Overall Study|Lost to Follow-up|0|||
27759064|NCT03655717|80943257|FG009|Overall Study|Lost to Follow-up|0|||
27759065|NCT03655717|80943258|FG010|Overall Study|Lost to Follow-up|0|||
27759066|NCT03655717|80943259|FG011|Overall Study|Lost to Follow-up|1|||
27759067|NCT03655717|80943260|FG012|Overall Study|Lost to Follow-up|0|||
27759068|NCT03655717|80943261|FG013|Overall Study|Lost to Follow-up|0|||
27759069|NCT03655717|80943262|FG014|Overall Study|Lost to Follow-up|0|||
27759070|NCT03655717|80943263|FG015|Overall Study|Lost to Follow-up|0|||
27759071|NCT03655717|80943264|FG016|Overall Study|Lost to Follow-up|0|||
27759072|NCT03655717|80943265|FG017|Overall Study|Lost to Follow-up|0|||
27759073|NCT03655717|80943266|FG018|Overall Study|Lost to Follow-up|0|||
27759074|NCT03655717|80943267|FG019|Overall Study|Lost to Follow-up|0|||
27759075|NCT03655717|80943268|FG020|Overall Study|Lost to Follow-up|0|||
27759076|NCT03655717|80943269|FG021|Overall Study|Lost to Follow-up|0|||
27759077|NCT03655717|80943270|FG022|Overall Study|Lost to Follow-up|0|||
27759078|NCT03655717|80943271|FG023|Overall Study|Lost to Follow-up|0|||
27759079|NCT03655717|80943272|FG024|Overall Study|Lost to Follow-up|0|||
27759080|NCT03655717|80943273|FG025|Overall Study|Lost to Follow-up|0|||
27759081|NCT01996748|80943274|FG000|Overall Study|Personal reason|1|||
27759082|NCT01996748|80943275|FG001|Overall Study|Personal reason|0|||
27759083|NCT01996748|80943274|FG000|Overall Study|Physician Decision|2|||
27759084|NCT01996748|80943275|FG001|Overall Study|Physician Decision|0|||
27759085|NCT01996748|80943274|FG000|Overall Study|Adverse Event|1|||
27759086|NCT01996748|80943275|FG001|Overall Study|Adverse Event|4|||
27759087|NCT01996748|80943274|FG000|Overall Study|Withdrawal by Subject|0|||
27759088|NCT01996748|80943275|FG001|Overall Study|Withdrawal by Subject|1|||
27759089|NCT01996748|80943274|FG000|Overall Study|Lost to Follow-up|4|||
27759090|NCT01996748|80943275|FG001|Overall Study|Lost to Follow-up|1|||
27759091|NCT00171314|80943279|FG000|Overall Study|Adverse Event|44|||
27759092|NCT00171314|80943280|FG001|Overall Study|Adverse Event|41|||
27759093|NCT00171314|80943279|FG000|Overall Study|Lack of Efficacy|19|||
27759094|NCT00171314|80943280|FG001|Overall Study|Lack of Efficacy|14|||
27759095|NCT00171314|80943279|FG000|Overall Study|Withdrawal by Subject|9|||
27759096|NCT00171314|80943280|FG001|Overall Study|Withdrawal by Subject|6|||
27759097|NCT00171314|80943279|FG000|Overall Study|Abnormal Test Procedure Results|9|||
27759098|NCT00171314|80943280|FG001|Overall Study|Abnormal Test Procedure Results|3|||
27759099|NCT00171314|80943279|FG000|Overall Study|Protocol Violation|3|||
27759100|NCT00171314|80943280|FG001|Overall Study|Protocol Violation|7|||
27759101|NCT00171314|80943279|FG000|Overall Study|Administrative Problems|4|||
27759102|NCT00171314|80943280|FG001|Overall Study|Administrative Problems|3|||
27759103|NCT00171314|80943279|FG000|Overall Study|Lost to Follow-up|1|||
27759104|NCT00171314|80943280|FG001|Overall Study|Lost to Follow-up|3|||
27759105|NCT00171314|80943279|FG000|Overall Study|Death|2|||
27759106|NCT00171314|80943280|FG001|Overall Study|Death|1|||
27759107|NCT02559206|80943283|FG000|Overall Study|Adverse Event|0|||
27759108|NCT02559206|80943284|FG001|Overall Study|Adverse Event|4|||
27759109|NCT02559206|80943285|FG002|Overall Study|Adverse Event|1|||
27759110|NCT02559206|80943286|FG003|Overall Study|Adverse Event|5|||
27759111|NCT02559206|80943287|FG004|Overall Study|Adverse Event|3|||
27759112|NCT02559206|80943288|FG005|Overall Study|Adverse Event|0|||
27759113|NCT02559206|80943289|FG006|Overall Study|Adverse Event|1|||
27759114|NCT02559206|80943290|FG007|Overall Study|Adverse Event|0|||
27759115|NCT02559206|80943283|FG000|Overall Study|Protocol Violation|1|||
27759116|NCT02559206|80943284|FG001|Overall Study|Protocol Violation|0|||
27759117|NCT02559206|80943285|FG002|Overall Study|Protocol Violation|1|||
27759118|NCT02559206|80943286|FG003|Overall Study|Protocol Violation|0|||
27759119|NCT02559206|80943287|FG004|Overall Study|Protocol Violation|0|||
27759120|NCT02559206|80943288|FG005|Overall Study|Protocol Violation|2|||
27759121|NCT02559206|80943289|FG006|Overall Study|Protocol Violation|0|||
27759122|NCT02559206|80943290|FG007|Overall Study|Protocol Violation|0|||
27759123|NCT02559206|80943283|FG000|Overall Study|Withdrawal by Subject|3|||
27759124|NCT02559206|80943284|FG001|Overall Study|Withdrawal by Subject|3|||
27759125|NCT02559206|80943285|FG002|Overall Study|Withdrawal by Subject|1|||
27759126|NCT02559206|80943286|FG003|Overall Study|Withdrawal by Subject|3|||
27759127|NCT02559206|80943287|FG004|Overall Study|Withdrawal by Subject|5|||
27759128|NCT02559206|80943288|FG005|Overall Study|Withdrawal by Subject|4|||
27759129|NCT02559206|80943289|FG006|Overall Study|Withdrawal by Subject|1|||
27759130|NCT02559206|80943290|FG007|Overall Study|Withdrawal by Subject|2|||
27759131|NCT02559206|80943283|FG000|Overall Study|Lost to Follow-up|3|||
27759132|NCT02559206|80943284|FG001|Overall Study|Lost to Follow-up|5|||
27759133|NCT02559206|80943285|FG002|Overall Study|Lost to Follow-up|3|||
27759134|NCT02559206|80943286|FG003|Overall Study|Lost to Follow-up|3|||
27759135|NCT02559206|80943287|FG004|Overall Study|Lost to Follow-up|2|||
27759136|NCT02559206|80943288|FG005|Overall Study|Lost to Follow-up|5|||
27759137|NCT02559206|80943289|FG006|Overall Study|Lost to Follow-up|1|||
27759138|NCT02559206|80943290|FG007|Overall Study|Lost to Follow-up|4|||
27759139|NCT02559206|80943283|FG000|Overall Study|Lack of Efficacy|1|||
27759140|NCT02559206|80943284|FG001|Overall Study|Lack of Efficacy|0|||
27759141|NCT02559206|80943285|FG002|Overall Study|Lack of Efficacy|3|||
27759142|NCT02559206|80943286|FG003|Overall Study|Lack of Efficacy|2|||
27759143|NCT02559206|80943287|FG004|Overall Study|Lack of Efficacy|2|||
27759144|NCT02559206|80943288|FG005|Overall Study|Lack of Efficacy|3|||
27759145|NCT02559206|80943289|FG006|Overall Study|Lack of Efficacy|3|||
27759146|NCT02559206|80943290|FG007|Overall Study|Lack of Efficacy|3|||
27759147|NCT02559206|80943283|FG000|Overall Study|Other Not Specified|0|||
27759148|NCT02559206|80943284|FG001|Overall Study|Other Not Specified|0|||
27759149|NCT02559206|80943285|FG002|Overall Study|Other Not Specified|0|||
27759150|NCT02559206|80943286|FG003|Overall Study|Other Not Specified|1|||
27759151|NCT02559206|80943287|FG004|Overall Study|Other Not Specified|0|||
27759152|NCT02559206|80943288|FG005|Overall Study|Other Not Specified|0|||
27759153|NCT02559206|80943289|FG006|Overall Study|Other Not Specified|0|||
27759154|NCT02559206|80943290|FG007|Overall Study|Other Not Specified|0|||
27759155|NCT04093258|80943292|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
27759156|NCT04093258|80943293|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
27759157|NCT00589979|80943296|FG000|Run-In Period|Adverse Event|5|||
27759158|NCT00589979|80943297|FG001|Run-In Period|Adverse Event|0|||
27759159|NCT00589979|80943298|FG002|Run-In Period|Adverse Event|0|||
27759160|NCT00589979|80943296|FG000|Run-In Period|Protocol Violation|3|||
27759161|NCT00589979|80943297|FG001|Run-In Period|Protocol Violation|0|||
27759162|NCT00589979|80943298|FG002|Run-In Period|Protocol Violation|0|||
27759163|NCT00589979|80943296|FG000|Run-In Period|Did not qualify for randomization|54|||
27759164|NCT00589979|80943297|FG001|Run-In Period|Did not qualify for randomization|0|||
27759165|NCT00589979|80943298|FG002|Run-In Period|Did not qualify for randomization|0|||
27759166|NCT00589979|80943296|FG000|Run-In Period|Withdrawal by Subject|10|||
27759167|NCT00589979|80943297|FG001|Run-In Period|Withdrawal by Subject|0|||
27759168|NCT00589979|80943298|FG002|Run-In Period|Withdrawal by Subject|0|||
27759169|NCT00589979|80943296|FG000|Run-In Period|Informed Consent Withdrawn|4|||
27759170|NCT00589979|80943297|FG001|Run-In Period|Informed Consent Withdrawn|0|||
27759171|NCT00589979|80943298|FG002|Run-In Period|Informed Consent Withdrawn|0|||
27759172|NCT00589979|80943296|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
27759173|NCT00589979|80943297|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
27759174|NCT00589979|80943298|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
27759175|NCT00589979|80943296|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
27759176|NCT00589979|80943297|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
27759177|NCT00589979|80943298|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
27759178|NCT00589979|80943296|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
27759179|NCT00589979|80943297|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
27759180|NCT00589979|80943298|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
27759181|NCT00589979|80943296|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
27759182|NCT00589979|80943297|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
27759183|NCT00589979|80943298|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
27759184|NCT00589979|80943296|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
27759185|NCT00589979|80943297|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
27759186|NCT00589979|80943298|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
27759187|NCT00589979|80943296|FG000|Double-Blind Treatment Period 2|Other|0|||
27759188|NCT00589979|80943297|FG001|Double-Blind Treatment Period 2|Other|0|||
27759189|NCT00589979|80943298|FG002|Double-Blind Treatment Period 2|Other|1|||
27759190|NCT00589979|80943296|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
27759191|NCT00589979|80943297|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
27759192|NCT00589979|80943298|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
27759193|NCT00589979|80943296|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
27759194|NCT00589979|80943297|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
27759195|NCT00589979|80943298|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
27759196|NCT02387372|80943304|FG000|Overall Study|Not Treated|1|||
27759197|NCT02387372|80943305|FG001|Overall Study|Not Treated|0|||
27759198|NCT01413542|80943308|FG000|Overall Study|Physician Decision|1|||
27759199|NCT01413542|80943309|FG001|Overall Study|Physician Decision|0|||
27759200|NCT01413542|80943310|FG002|Overall Study|Physician Decision|3|||
27759201|NCT01413542|80943311|FG003|Overall Study|Physician Decision|0|||
27759202|NCT01413542|80943308|FG000|Overall Study|Adverse Event|0|||
27759203|NCT01413542|80943309|FG001|Overall Study|Adverse Event|0|||
27759204|NCT01413542|80943310|FG002|Overall Study|Adverse Event|0|||
27759205|NCT01413542|80943311|FG003|Overall Study|Adverse Event|1|||
27759206|NCT03498287|80943312|FG000|Overall Study|Withdrawal by Subject|3|||
27759207|NCT03498287|80943313|FG001|Overall Study|Withdrawal by Subject|0|||
27759208|NCT03498287|80943312|FG000|Overall Study|Protocol Violation|0|||
27759209|NCT03498287|80943313|FG001|Overall Study|Protocol Violation|4|||
27759210|NCT03498287|80943312|FG000|Overall Study|Adverse Event|0|||
27759211|NCT03498287|80943313|FG001|Overall Study|Adverse Event|1|||
27759220|NCT03956225|80943323|FG000|Overall Study|Lack of Efficacy|1|||
27759221|NCT03956225|80943324|FG001|Overall Study|Lack of Efficacy|1|||
27759222|NCT03956225|80943323|FG000|Overall Study|Lost to Follow-up|0|||
27759223|NCT03956225|80943324|FG001|Overall Study|Lost to Follow-up|1|||
27759224|NCT03956225|80943323|FG000|Overall Study|Withdrawal by Subject|2|||
27759225|NCT03956225|80943324|FG001|Overall Study|Withdrawal by Subject|1|||
27759226|NCT03956225|80943323|FG000|Overall Study|Other Reasons|2|||
27759227|NCT03956225|80943324|FG001|Overall Study|Other Reasons|1|||
27759228|NCT00853489|80943327|FG000|Overall Study|Lost to Follow-up|5|||
27759229|NCT00853489|80943328|FG001|Overall Study|Lost to Follow-up|2|||
27759230|NCT03364335|80943329|FG000|Overall Study|Adverse Event|3|||
27759231|NCT03364335|80943330|FG001|Overall Study|Adverse Event|4|||
27759232|NCT03364335|80943331|FG002|Overall Study|Adverse Event|1|||
27759233|NCT03364335|80943332|FG003|Overall Study|Adverse Event|2|||
27759234|NCT03364335|80943333|FG004|Overall Study|Adverse Event|0|||
27759235|NCT03364335|80943329|FG000|Overall Study|Lost to Follow-up|7|||
27759236|NCT03364335|80943330|FG001|Overall Study|Lost to Follow-up|7|||
27759237|NCT03364335|80943331|FG002|Overall Study|Lost to Follow-up|10|||
27759238|NCT03364335|80943332|FG003|Overall Study|Lost to Follow-up|11|||
27759239|NCT03364335|80943333|FG004|Overall Study|Lost to Follow-up|11|||
27759240|NCT03364673|80943336|FG000|Overall Study|Withdrawal by Subject|2|||
27759241|NCT03364673|80943336|FG000|Overall Study|Injury unrelated to study|3|||
27759242|NCT01740388|80943341|FG000|Overall Study|Withdrawal by Subject|1|||
27759243|NCT01740388|80943342|FG001|Overall Study|Withdrawal by Subject|2|||
27759244|NCT01740388|80943341|FG000|Overall Study|Lost to Follow-up|2|||
27759245|NCT01740388|80943342|FG001|Overall Study|Lost to Follow-up|0|||
27759246|NCT01740388|80943341|FG000|Overall Study|Physician Decision|2|||
27759247|NCT01740388|80943342|FG001|Overall Study|Physician Decision|6|||
27759248|NCT01740388|80943341|FG000|Overall Study|Subjects missing data, completed|41|||
27759249|NCT01740388|80943342|FG001|Overall Study|Subjects missing data, completed|36|||
27759250|NCT00668200|80943343|FG000|Overall Study|Withdrawal by Subject|2|||
27759251|NCT00668200|80943343|FG000|Overall Study|Lost to Follow-up|1|||
27759252|NCT02062463|80943344|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
27759253|NCT02062463|80943345|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
27759254|NCT02062463|80943346|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
27759255|NCT02062463|80943347|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
27759256|NCT02062463|80943344|FG000|Stage 2|Adverse Event|0|||
27759257|NCT02062463|80943345|FG001|Stage 2|Adverse Event|0|||
27759258|NCT02062463|80943346|FG002|Stage 2|Adverse Event|12|||
27759259|NCT02062463|80943347|FG003|Stage 2|Adverse Event|20|||
27759260|NCT02062463|80943344|FG000|Stage 2|Lack of Efficacy|0|||
27759261|NCT02062463|80943345|FG001|Stage 2|Lack of Efficacy|0|||
27759262|NCT02062463|80943346|FG002|Stage 2|Lack of Efficacy|3|||
27759263|NCT02062463|80943347|FG003|Stage 2|Lack of Efficacy|4|||
27759264|NCT02062463|80943344|FG000|Stage 2|Lost to Follow-up|0|||
27759265|NCT02062463|80943345|FG001|Stage 2|Lost to Follow-up|0|||
27759266|NCT02062463|80943346|FG002|Stage 2|Lost to Follow-up|20|||
27759267|NCT02062463|80943347|FG003|Stage 2|Lost to Follow-up|20|||
27759268|NCT02062463|80943344|FG000|Stage 2|Non-Compliance|0|||
27759269|NCT02062463|80943345|FG001|Stage 2|Non-Compliance|0|||
27759270|NCT02062463|80943346|FG002|Stage 2|Non-Compliance|0|||
27759271|NCT02062463|80943347|FG003|Stage 2|Non-Compliance|1|||
27759272|NCT02062463|80943344|FG000|Stage 2|Other than specified|0|||
27759273|NCT02062463|80943345|FG001|Stage 2|Other than specified|0|||
27759274|NCT02062463|80943346|FG002|Stage 2|Other than specified|3|||
27759275|NCT02062463|80943347|FG003|Stage 2|Other than specified|1|||
27759276|NCT02062463|80943344|FG000|Stage 2|Withdrawal by Subject|0|||
27759277|NCT02062463|80943345|FG001|Stage 2|Withdrawal by Subject|0|||
27759278|NCT02062463|80943346|FG002|Stage 2|Withdrawal by Subject|15|||
27759279|NCT02062463|80943347|FG003|Stage 2|Withdrawal by Subject|10|||
27759280|NCT01107405|80943348|FG000|Overall Study|Adverse Event|1|||
27759281|NCT01107405|80943349|FG001|Overall Study|Adverse Event|1|||
27759282|NCT01107405|80943350|FG002|Overall Study|Adverse Event|0|||
27759283|NCT01107405|80943351|FG003|Overall Study|Adverse Event|0|||
27759284|NCT01107405|80943352|FG004|Overall Study|Adverse Event|2|||
27759285|NCT01107405|80943348|FG000|Overall Study|Withdrawal by Subject|1|||
27759286|NCT01107405|80943349|FG001|Overall Study|Withdrawal by Subject|0|||
27759287|NCT01107405|80943350|FG002|Overall Study|Withdrawal by Subject|1|||
27759288|NCT01107405|80943351|FG003|Overall Study|Withdrawal by Subject|2|||
27759289|NCT01107405|80943352|FG004|Overall Study|Withdrawal by Subject|1|||
27759290|NCT01107405|80943348|FG000|Overall Study|Protocol Violation|0|||
27759291|NCT01107405|80943349|FG001|Overall Study|Protocol Violation|0|||
27759292|NCT01107405|80943350|FG002|Overall Study|Protocol Violation|1|||
27759293|NCT01107405|80943351|FG003|Overall Study|Protocol Violation|1|||
27759294|NCT01107405|80943352|FG004|Overall Study|Protocol Violation|0|||
27759295|NCT04169061|80943353|FG000|Overall Study|Adverse Event|2|||
27759296|NCT04169061|80943353|FG000|Overall Study|Death|1|||
27759297|NCT04169061|80943353|FG000|Overall Study|Withdrawal by Subject|1|||
27759298|NCT04169061|80943353|FG000|Overall Study|Protocol Violation|1|||
27759299|NCT01021813|80943361|FG000|DB Treatment Phase|Adverse Event|60|||
27759300|NCT01021813|80943362|FG001|DB Treatment Phase|Adverse Event|22|||
27759301|NCT01021813|80943363|FG002|DB Treatment Phase|Adverse Event|0|||
27759302|NCT01021813|80943364|FG003|DB Treatment Phase|Adverse Event|0|||
27759303|NCT01021813|80943365|FG004|DB Treatment Phase|Adverse Event|0|||
27759304|NCT01021813|80943361|FG000|DB Treatment Phase|Lack of Efficacy|44|||
27759305|NCT01021813|80943362|FG001|DB Treatment Phase|Lack of Efficacy|28|||
27759306|NCT01021813|80943363|FG002|DB Treatment Phase|Lack of Efficacy|0|||
27759307|NCT01021813|80943364|FG003|DB Treatment Phase|Lack of Efficacy|0|||
27759308|NCT01021813|80943365|FG004|DB Treatment Phase|Lack of Efficacy|0|||
27759309|NCT01021813|80943361|FG000|DB Treatment Phase|Lost to Follow-up|14|||
27759310|NCT01021813|80943362|FG001|DB Treatment Phase|Lost to Follow-up|12|||
27759311|NCT01021813|80943363|FG002|DB Treatment Phase|Lost to Follow-up|0|||
27759312|NCT01021813|80943364|FG003|DB Treatment Phase|Lost to Follow-up|0|||
27759313|NCT01021813|80943365|FG004|DB Treatment Phase|Lost to Follow-up|0|||
27759314|NCT01021813|80943361|FG000|DB Treatment Phase|Physician Decision|17|||
27759315|NCT01021813|80943362|FG001|DB Treatment Phase|Physician Decision|8|||
27759316|NCT01021813|80943363|FG002|DB Treatment Phase|Physician Decision|0|||
27759317|NCT01021813|80943364|FG003|DB Treatment Phase|Physician Decision|0|||
27759318|NCT01021813|80943365|FG004|DB Treatment Phase|Physician Decision|0|||
27759319|NCT01021813|80943361|FG000|DB Treatment Phase|Pregnancy|1|||
27759320|NCT01021813|80943362|FG001|DB Treatment Phase|Pregnancy|0|||
27759321|NCT01021813|80943363|FG002|DB Treatment Phase|Pregnancy|0|||
27759322|NCT01021813|80943364|FG003|DB Treatment Phase|Pregnancy|0|||
27759323|NCT01021813|80943365|FG004|DB Treatment Phase|Pregnancy|0|||
27759324|NCT01021813|80943361|FG000|DB Treatment Phase|Protocol Violation|4|||
27759325|NCT01021813|80943362|FG001|DB Treatment Phase|Protocol Violation|3|||
27759326|NCT01021813|80943363|FG002|DB Treatment Phase|Protocol Violation|0|||
27759327|NCT01021813|80943364|FG003|DB Treatment Phase|Protocol Violation|0|||
27759328|NCT01021813|80943365|FG004|DB Treatment Phase|Protocol Violation|0|||
27759329|NCT01021813|80943361|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
27759330|NCT01021813|80943362|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
27759331|NCT01021813|80943363|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
27759332|NCT01021813|80943364|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
27759333|NCT01021813|80943365|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
27759334|NCT01021813|80943361|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
27759335|NCT01021813|80943362|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
27759336|NCT01021813|80943363|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
27759337|NCT01021813|80943364|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
27759338|NCT01021813|80943365|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
27759339|NCT01021813|80943361|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27759340|NCT01021813|80943362|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27759341|NCT01021813|80943363|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27759342|NCT01021813|80943364|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
27759343|NCT01021813|80943365|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
27759344|NCT01021813|80943361|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27759345|NCT01021813|80943362|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27759346|NCT01021813|80943363|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27759347|NCT01021813|80943364|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
27759348|NCT01021813|80943365|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
27759349|NCT01021813|80943361|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27759350|NCT01021813|80943362|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27759351|NCT01021813|80943363|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
27759352|NCT01021813|80943364|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27759353|NCT01021813|80943365|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
27759354|NCT01021813|80943361|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
27759355|NCT01021813|80943362|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
27759356|NCT01021813|80943363|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
27759357|NCT01021813|80943364|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
27759358|NCT01021813|80943365|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
27759359|NCT01194804|80943369|FG000|Overall Study|Withdrawal by Subject|1|||
27759360|NCT00192036|80943370|FG000|Overall Study|Protocol Violation|3|||
27759361|NCT00192036|80943370|FG000|Overall Study|Adverse Event|6|||
27759362|NCT00192036|80943370|FG000|Overall Study|Patient/Physician Perception|1|||
27759363|NCT00192036|80943370|FG000|Overall Study|Objective Tumor Progression|4|||
27759364|NCT00192036|80943370|FG000|Overall Study|Clinical Disease Progression|1|||
27759365|NCT00192036|80943370|FG000|Overall Study|Death|1|||
27759366|NCT00192036|80943370|FG000|Overall Study|Unknown or Not Specified|5|||
27759367|NCT03325556|80943375|FG000|Open-label Period|Lack of Response in OL period|70|||
27759368|NCT03325556|80943376|FG001|Open-label Period|Lack of Response in OL period|0|||
27759369|NCT03325556|80943377|FG002|Open-label Period|Lack of Response in OL period|0|||
27759370|NCT03325556|80943375|FG000|Open-label Period|Adverse Event|27|||
27759371|NCT03325556|80943376|FG001|Open-label Period|Adverse Event|0|||
27759372|NCT03325556|80943377|FG002|Open-label Period|Adverse Event|0|||
27759373|NCT03325556|80943375|FG000|Open-label Period|Death|1|||
27759374|NCT03325556|80943376|FG001|Open-label Period|Death|0|||
27759375|NCT03325556|80943377|FG002|Open-label Period|Death|0|||
27759376|NCT03325556|80943375|FG000|Open-label Period|Lost to Follow-up|1|||
27759377|NCT03325556|80943376|FG001|Open-label Period|Lost to Follow-up|0|||
27759378|NCT03325556|80943377|FG002|Open-label Period|Lost to Follow-up|0|||
27759379|NCT03325556|80943375|FG000|Open-label Period|Non-compliance with study drug|5|||
27759380|NCT03325556|80943376|FG001|Open-label Period|Non-compliance with study drug|0|||
27759381|NCT03325556|80943377|FG002|Open-label Period|Non-compliance with study drug|0|||
27759382|NCT03325556|80943375|FG000|Open-label Period|Use of prohibited medication|1|||
27759383|NCT03325556|80943376|FG001|Open-label Period|Use of prohibited medication|0|||
27759384|NCT03325556|80943377|FG002|Open-label Period|Use of prohibited medication|0|||
27759385|NCT03325556|80943375|FG000|Open-label Period|Protocol Violation|4|||
27759386|NCT03325556|80943376|FG001|Open-label Period|Protocol Violation|0|||
27759387|NCT03325556|80943377|FG002|Open-label Period|Protocol Violation|0|||
27759388|NCT03325556|80943375|FG000|Open-label Period|Withdrawal by Subject|17|||
27759389|NCT03325556|80943376|FG001|Open-label Period|Withdrawal by Subject|0|||
27759390|NCT03325556|80943377|FG002|Open-label Period|Withdrawal by Subject|0|||
27759391|NCT03325556|80943375|FG000|Open-label Period|Not otherwise specified|8|||
27759392|NCT03325556|80943376|FG001|Open-label Period|Not otherwise specified|0|||
27759393|NCT03325556|80943377|FG002|Open-label Period|Not otherwise specified|0|||
27759394|NCT03325556|80943375|FG000|Open-label Period|Administrative discont. at study termination|41|||
27759395|NCT03325556|80943376|FG001|Open-label Period|Administrative discont. at study termination|0|||
27759396|NCT03325556|80943377|FG002|Open-label Period|Administrative discont. at study termination|0|||
27759397|NCT03325556|80943375|FG000|Double-blind Period|Relapse|0|||
27759398|NCT03325556|80943376|FG001|Double-blind Period|Relapse|15|||
27759399|NCT03325556|80943377|FG002|Double-blind Period|Relapse|34|||
27759400|NCT03325556|80943375|FG000|Double-blind Period|Adverse Event|0|||
27759401|NCT03325556|80943376|FG001|Double-blind Period|Adverse Event|3|||
27759402|NCT03325556|80943377|FG002|Double-blind Period|Adverse Event|1|||
27759403|NCT03325556|80943375|FG000|Double-blind Period|Noncompliance with study drug|0|||
27759404|NCT03325556|80943376|FG001|Double-blind Period|Noncompliance with study drug|0|||
27759405|NCT03325556|80943377|FG002|Double-blind Period|Noncompliance with study drug|1|||
27759406|NCT03325556|80943375|FG000|Double-blind Period|Use of prohibited medication|0|||
27759407|NCT03325556|80943376|FG001|Double-blind Period|Use of prohibited medication|1|||
27759408|NCT03325556|80943377|FG002|Double-blind Period|Use of prohibited medication|0|||
27759409|NCT03325556|80943375|FG000|Double-blind Period|Physician Decision|0|||
27759410|NCT03325556|80943376|FG001|Double-blind Period|Physician Decision|0|||
27759411|NCT03325556|80943377|FG002|Double-blind Period|Physician Decision|1|||
27759412|NCT03325556|80943375|FG000|Double-blind Period|Withdrawal by Subject|0|||
27566579|NCT01023581|80263364|FG000|Overall Study|Withdrawal by Subject|13|||
27759413|NCT03325556|80943376|FG001|Double-blind Period|Withdrawal by Subject|6|||
27759414|NCT03325556|80943377|FG002|Double-blind Period|Withdrawal by Subject|4|||
27759415|NCT03325556|80943375|FG000|Double-blind Period|Not otherwise specified|0|||
27759416|NCT03325556|80943376|FG001|Double-blind Period|Not otherwise specified|1|||
27759417|NCT03325556|80943377|FG002|Double-blind Period|Not otherwise specified|5|||
27759418|NCT03325556|80943375|FG000|Double-blind Period|Administrative discont. at study termination|0|||
27759419|NCT03325556|80943376|FG001|Double-blind Period|Administrative discont. at study termination|35|||
27759420|NCT03325556|80943377|FG002|Double-blind Period|Administrative discont. at study termination|31|||
27759421|NCT01844830|80943378|FG000|Overall Study|Withdrawal by Subject|1|||
27759422|NCT01844830|80943379|FG001|Overall Study|Withdrawal by Subject|0|||
27759423|NCT00488592|80943382|FG000|Overall Study|Withdrawal by Subject|1|||
27759424|NCT00488592|80943382|FG000|Overall Study|Disease progression|1|||
27759425|NCT00488592|80943382|FG000|Overall Study|Enrolled but not treated|1|||
27759426|NCT03712345|80943383|FG000|Overall Study|Failure to meet randomization criteria|0|||
27759427|NCT03712345|80943384|FG001|Overall Study|Failure to meet randomization criteria|0|||
27759428|NCT03712345|80943385|FG002|Overall Study|Failure to meet randomization criteria|1|||
27759429|NCT01875367|80943388|FG000|Overall Study|Not complete at least 2 questionaries|4|||
27759430|NCT01875367|80943389|FG001|Overall Study|Not complete at least 2 questionaries|2|||
27759431|NCT01875367|80943388|FG000|Overall Study|Not receive study treatment|1|||
27759432|NCT01875367|80943389|FG001|Overall Study|Not receive study treatment|0|||
27759433|NCT01401465|80943390|FG000|Treatment Period 1|Adverse Event|4|||
27759434|NCT01401465|80943391|FG001|Treatment Period 1|Adverse Event|1|||
27759435|NCT01401465|80943390|FG000|Treatment Period 1|Pregnancy|0|||
27759436|NCT01401465|80943391|FG001|Treatment Period 1|Pregnancy|1|||
27759437|NCT01401465|80943390|FG000|Treatment Period 1|Protocol Violation|5|||
27759438|NCT01401465|80943391|FG001|Treatment Period 1|Protocol Violation|0|||
27759439|NCT01401465|80943390|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27759440|NCT01401465|80943391|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27759441|NCT01401465|80943390|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
27759442|NCT01401465|80943391|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
27759443|NCT01401465|80943390|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
27759444|NCT01401465|80943391|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
27759445|NCT01401465|80943390|FG000|Treatment Period 1|Scheduling Difficulties|1|||
27759446|NCT01401465|80943391|FG001|Treatment Period 1|Scheduling Difficulties|1|||
27759447|NCT01401465|80943390|FG000|Treatment Period 2|Lost to Follow-up|0|||
27759448|NCT01401465|80943391|FG001|Treatment Period 2|Lost to Follow-up|1|||
27759449|NCT01401465|80943390|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27759450|NCT01401465|80943391|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27759451|NCT00964158|80943392|FG000|Overall Study|Lost to Follow-up|0|||
27759452|NCT00964158|80943393|FG001|Overall Study|Lost to Follow-up|1|||
27759453|NCT00964158|80943394|FG002|Overall Study|Lost to Follow-up|2|||
27759454|NCT00964158|80943392|FG000|Overall Study|Withdrawal by Subject|0|||
27759455|NCT00964158|80943393|FG001|Overall Study|Withdrawal by Subject|0|||
27759456|NCT00964158|80943394|FG002|Overall Study|Withdrawal by Subject|6|||
27759457|NCT00973921|80943395|FG000|Overall Study|IVUS results were not available|9|||
27759458|NCT04092816|80943396|FG000|Overall Study|Lost to Follow-up|1|||
27759459|NCT04092816|80943397|FG001|Overall Study|Lost to Follow-up|2|||
27759460|NCT00878215|80943398|FG000|Overall Study|Determined to be ineligible|0|||
27759461|NCT00878215|80943399|FG001|Overall Study|Determined to be ineligible|10|||
27759462|NCT00878215|80943400|FG002|Overall Study|Determined to be ineligible|0|||
27759463|NCT00878215|80943401|FG003|Overall Study|Determined to be ineligible|0|||
27759464|NCT01397448|80943402|FG000|Overall Study|Adverse Event|4|||
27759465|NCT01397448|80943403|FG001|Overall Study|Adverse Event|4|||
27759466|NCT01397448|80943404|FG002|Overall Study|Adverse Event|6|||
27759467|NCT01397448|80943402|FG000|Overall Study|Withdrawal by Subject|4|||
27759468|NCT01397448|80943403|FG001|Overall Study|Withdrawal by Subject|4|||
27759469|NCT01397448|80943404|FG002|Overall Study|Withdrawal by Subject|3|||
27759470|NCT01397448|80943402|FG000|Overall Study|Lack of Efficacy|2|||
27759471|NCT01397448|80943403|FG001|Overall Study|Lack of Efficacy|0|||
27759472|NCT01397448|80943404|FG002|Overall Study|Lack of Efficacy|5|||
27759473|NCT01397448|80943402|FG000|Overall Study|Other|8|||
27759474|NCT01397448|80943403|FG001|Overall Study|Other|7|||
27759475|NCT01397448|80943404|FG002|Overall Study|Other|4|||
27759476|NCT02947022|80943406|FG000|Overall Study|Study Stopped|1|||
27759477|NCT04410198|80943407|FG000|Overall Study|Death|10|||
27759478|NCT04410198|80943407|FG000|Overall Study|Withdrawal by Subject|7|||
27759479|NCT04410198|80943407|FG000|Overall Study|Transferred/Relocation|4|||
27759480|NCT04410198|80943407|FG000|Overall Study|Kidney Transplant|9|||
27759481|NCT04410198|80943407|FG000|Overall Study|Adverse Event|4|||
27759482|NCT04410198|80943407|FG000|Overall Study|Physician Decision|2|||
27759483|NCT04410198|80943407|FG000|Overall Study|Other than specified|1|||
27759484|NCT02670330|80943408|FG000|Overall Study|Protocol Deviation|1|||
27759485|NCT02670330|80943409|FG001|Overall Study|Protocol Deviation|0|||
27759486|NCT02670330|80943408|FG000|Overall Study|Study Terminated By Sponsor|36|||
27759487|NCT02670330|80943409|FG001|Overall Study|Study Terminated By Sponsor|43|||
27759488|NCT02670330|80943408|FG000|Overall Study|Adverse Event|1|||
27759489|NCT02670330|80943409|FG001|Overall Study|Adverse Event|3|||
27759490|NCT02670330|80943408|FG000|Overall Study|Withdrawal by Subject|34|||
27759491|NCT02670330|80943409|FG001|Overall Study|Withdrawal by Subject|29|||
27759492|NCT02670330|80943408|FG000|Overall Study|Lost to Follow-up|3|||
27759493|NCT02670330|80943409|FG001|Overall Study|Lost to Follow-up|2|||
27759494|NCT04348656|80943415|FG000|Overall Study|Withdrawal by Subject|2|||
27759495|NCT04348656|80943416|FG001|Overall Study|Withdrawal by Subject|0|||
27759496|NCT04348656|80943415|FG000|Overall Study|Lost to Follow-up|11|||
27759497|NCT04348656|80943416|FG001|Overall Study|Lost to Follow-up|6|||
27759498|NCT00567541|80943417|FG000|Overall Study|Adverse Event|0|||
27759499|NCT00567541|80943418|FG001|Overall Study|Adverse Event|1|||
27759500|NCT01895452|80943419|FG000|Overall Study|Adverse Event|1|||
27759501|NCT01895452|80943420|FG001|Overall Study|Adverse Event|4|||
27759502|NCT01895452|80943419|FG000|Overall Study|Lost to Follow-up|1|||
27759503|NCT01895452|80943420|FG001|Overall Study|Lost to Follow-up|5|||
27759504|NCT01895452|80943419|FG000|Overall Study|Pregnancy|0|||
27759505|NCT01895452|80943420|FG001|Overall Study|Pregnancy|1|||
27759506|NCT01895452|80943419|FG000|Overall Study|Withdrawal by Subject|2|||
27759507|NCT01895452|80943420|FG001|Overall Study|Withdrawal by Subject|14|||
27759508|NCT01895452|80943419|FG000|Overall Study|Underlying disease|0|||
27759509|NCT01895452|80943420|FG001|Overall Study|Underlying disease|3|||
27759510|NCT01895452|80943419|FG000|Overall Study|Noncompliance with study drug|0|||
27759511|NCT01895452|80943420|FG001|Overall Study|Noncompliance with study drug|1|||
27759512|NCT00111475|80943421|FG000|Overall Study|Lost to Follow-up|0|||
27759513|NCT00111475|80943422|FG001|Overall Study|Lost to Follow-up|0|||
27759514|NCT00111475|80943423|FG002|Overall Study|Lost to Follow-up|0|||
27759515|NCT00111475|80943424|FG003|Overall Study|Lost to Follow-up|0|||
27759516|NCT00111475|80943425|FG004|Overall Study|Lost to Follow-up|0|||
27759517|NCT00111475|80943426|FG005|Overall Study|Lost to Follow-up|1|||
27759518|NCT00111475|80943427|FG006|Overall Study|Lost to Follow-up|0|||
27759519|NCT00111475|80943428|FG007|Overall Study|Lost to Follow-up|0|||
27759520|NCT00111475|80943429|FG008|Overall Study|Lost to Follow-up|0|||
27759521|NCT00111475|80943430|FG009|Overall Study|Lost to Follow-up|0|||
27759522|NCT00259740|80943431|FG000|Overall Study|Physician Decision|1|||
27759523|NCT00259740|80943432|FG001|Overall Study|Physician Decision|1|||
27759524|NCT00259740|80943431|FG000|Overall Study|Adverse Event|0|||
27759525|NCT00259740|80943432|FG001|Overall Study|Adverse Event|2|||
27759526|NCT00259740|80943431|FG000|Overall Study|Withdrawal by Subject|2|||
27759527|NCT00259740|80943432|FG001|Overall Study|Withdrawal by Subject|6|||
27759528|NCT00259740|80943431|FG000|Overall Study|Death|1|||
27759529|NCT00259740|80943432|FG001|Overall Study|Death|1|||
27759530|NCT00259740|80943431|FG000|Overall Study|Disease progression|19|||
27759531|NCT00259740|80943432|FG001|Overall Study|Disease progression|36|||
27759532|NCT00259740|80943431|FG000|Overall Study|Ongoing|17|||
27759533|NCT00259740|80943432|FG001|Overall Study|Ongoing|3|||
27759534|NCT00259740|80943431|FG000|Overall Study|Other|3|||
27759535|NCT00259740|80943432|FG001|Overall Study|Other|0|||
27759536|NCT00259740|80943431|FG000|Overall Study|Requirement for alternative therapy|0|||
27759537|NCT00259740|80943432|FG001|Overall Study|Requirement for alternative therapy|4|||
27759538|NCT01182337|80943437|FG000|Overall Study|Withdrawal by Subject|3|||
27759539|NCT01182337|80943438|FG001|Overall Study|Withdrawal by Subject|1|||
27759540|NCT01182337|80943437|FG000|Overall Study|Lost to Follow-up|0|||
27759541|NCT01182337|80943438|FG001|Overall Study|Lost to Follow-up|1|||
27759542|NCT00413062|80943446|FG000|Overall Study|Adverse event/serious adverse event|289|||
27759543|NCT00413062|80943447|FG001|Overall Study|Adverse event/serious adverse event|56|||
27759544|NCT00413062|80943446|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
27759545|NCT00413062|80943447|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
27759546|NCT00413062|80943446|FG000|Overall Study|Withdrawal of informed consent|111|||
27759547|NCT00413062|80943447|FG001|Overall Study|Withdrawal of informed consent|36|||
27759548|NCT00413062|80943446|FG000|Overall Study|Pregnancy|15|||
27759549|NCT00413062|80943447|FG001|Overall Study|Pregnancy|5|||
27759550|NCT00413062|80943446|FG000|Overall Study|Pregnancy wish|17|||
27759551|NCT00413062|80943447|FG001|Overall Study|Pregnancy wish|6|||
27759552|NCT00413062|80943446|FG000|Overall Study|Lost to Follow-up|175|||
27759553|NCT00413062|80943447|FG001|Overall Study|Lost to Follow-up|73|||
27759554|NCT00413062|80943446|FG000|Overall Study|Other reason|70|||
27759555|NCT00413062|80943447|FG001|Overall Study|Other reason|34|||
27759556|NCT05590767|80943457|FG000|Overall Study|Protocol Violation|1|||
27759557|NCT05590767|80943457|FG000|Overall Study|surgery canceled|1|||
27759558|NCT05590767|80943457|FG000|Overall Study|interscalene brachial block not performed|1|||
27759559|NCT00762372|80943458|FG000|Overall Study|Adverse Event|1|||
27759560|NCT00762372|80943459|FG001|Overall Study|Adverse Event|0|||
27759561|NCT00762372|80943460|FG002|Overall Study|Adverse Event|0|||
27759562|NCT00650091|80943461|FG000|Amended Study Design|Withdrawal by Subject|12|||
27759563|NCT00650091|80943462|FG001|Amended Study Design|Withdrawal by Subject|11|||
27759564|NCT00650091|80943463|FG002|Amended Study Design|Withdrawal by Subject|0|||
27759565|NCT00650091|80943461|FG000|Amended Study Design|Physician Decision|5|||
27759566|NCT00650091|80943462|FG001|Amended Study Design|Physician Decision|0|||
27759567|NCT00650091|80943463|FG002|Amended Study Design|Physician Decision|0|||
27759568|NCT00650091|80943461|FG000|Amended Study Design|Adverse Event|1|||
27759569|NCT00650091|80943462|FG001|Amended Study Design|Adverse Event|4|||
27759570|NCT00650091|80943463|FG002|Amended Study Design|Adverse Event|0|||
27759571|NCT00650091|80943461|FG000|Amended Study Design|Lung transplantation|4|||
27759572|NCT00650091|80943462|FG001|Amended Study Design|Lung transplantation|2|||
27759573|NCT00650091|80943463|FG002|Amended Study Design|Lung transplantation|0|||
27759574|NCT00650091|80943461|FG000|Amended Study Design|Other|1|||
27759575|NCT00650091|80943462|FG001|Amended Study Design|Other|3|||
27759576|NCT00650091|80943463|FG002|Amended Study Design|Other|0|||
27759577|NCT01317615|80943466|FG000|Overall Study|Disease progression|25|||
27759578|NCT01317615|80943466|FG000|Overall Study|New cancer therapy|5|||
27759579|NCT01317615|80943466|FG000|Overall Study|Death|6|||
27759580|NCT01317615|80943466|FG000|Overall Study|Withdrawal by Subject|5|||
27759581|NCT01317615|80943466|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27759582|NCT01317615|80943466|FG000|Overall Study|Adverse Event|7|||
27759583|NCT00479557|80943467|FG000|Overall Study|Death|0|||
27759584|NCT00479557|80943468|FG001|Overall Study|Death|0|||
27759585|NCT00479557|80943469|FG002|Overall Study|Death|0|||
27759586|NCT00479557|80943470|FG003|Overall Study|Death|0|||
27759587|NCT00479557|80943471|FG004|Overall Study|Death|0|||
27759588|NCT00479557|80943472|FG005|Overall Study|Death|1|||
27759589|NCT00479557|80943473|FG006|Overall Study|Death|0|||
27759590|NCT00479557|80943467|FG000|Overall Study|Lack of Efficacy|1|||
27759591|NCT00479557|80943468|FG001|Overall Study|Lack of Efficacy|0|||
27759592|NCT00479557|80943469|FG002|Overall Study|Lack of Efficacy|0|||
27759593|NCT00479557|80943470|FG003|Overall Study|Lack of Efficacy|0|||
27759594|NCT00479557|80943471|FG004|Overall Study|Lack of Efficacy|0|||
27759595|NCT00479557|80943472|FG005|Overall Study|Lack of Efficacy|0|||
27759596|NCT00479557|80943473|FG006|Overall Study|Lack of Efficacy|0|||
27759597|NCT00479557|80943467|FG000|Overall Study|Lost to Follow-up|0|||
27759598|NCT00479557|80943468|FG001|Overall Study|Lost to Follow-up|2|||
27759599|NCT00479557|80943469|FG002|Overall Study|Lost to Follow-up|0|||
27759600|NCT00479557|80943470|FG003|Overall Study|Lost to Follow-up|2|||
27759601|NCT00479557|80943471|FG004|Overall Study|Lost to Follow-up|0|||
27759602|NCT00479557|80943472|FG005|Overall Study|Lost to Follow-up|0|||
27759603|NCT00479557|80943473|FG006|Overall Study|Lost to Follow-up|0|||
27759604|NCT00479557|80943467|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
27759605|NCT00479557|80943468|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
27759606|NCT00479557|80943469|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
27759607|NCT00479557|80943470|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
27759608|NCT00479557|80943471|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
27759609|NCT00479557|80943472|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
27759610|NCT00479557|80943473|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
27759611|NCT00479557|80943467|FG000|Overall Study|AE not related to Study Drug|1|||
27759612|NCT00479557|80943468|FG001|Overall Study|AE not related to Study Drug|3|||
27759613|NCT00479557|80943469|FG002|Overall Study|AE not related to Study Drug|0|||
27759614|NCT00479557|80943470|FG003|Overall Study|AE not related to Study Drug|0|||
27759615|NCT00479557|80943471|FG004|Overall Study|AE not related to Study Drug|2|||
27759616|NCT00479557|80943472|FG005|Overall Study|AE not related to Study Drug|2|||
27759617|NCT00479557|80943473|FG006|Overall Study|AE not related to Study Drug|1|||
27759618|NCT00479557|80943467|FG000|Overall Study|Caregiver Request|2|||
27759619|NCT00479557|80943468|FG001|Overall Study|Caregiver Request|2|||
27759620|NCT00479557|80943469|FG002|Overall Study|Caregiver Request|2|||
27759621|NCT00479557|80943470|FG003|Overall Study|Caregiver Request|0|||
27759622|NCT00479557|80943471|FG004|Overall Study|Caregiver Request|1|||
27759623|NCT00479557|80943472|FG005|Overall Study|Caregiver Request|2|||
27759624|NCT00479557|80943473|FG006|Overall Study|Caregiver Request|0|||
27759625|NCT00479557|80943467|FG000|Overall Study|Investigator Request|0|||
27759626|NCT00479557|80943468|FG001|Overall Study|Investigator Request|0|||
27759627|NCT00479557|80943469|FG002|Overall Study|Investigator Request|1|||
27759628|NCT00479557|80943470|FG003|Overall Study|Investigator Request|0|||
27759629|NCT00479557|80943471|FG004|Overall Study|Investigator Request|0|||
27759630|NCT00479557|80943472|FG005|Overall Study|Investigator Request|0|||
27759631|NCT00479557|80943473|FG006|Overall Study|Investigator Request|0|||
27759632|NCT00479557|80943467|FG000|Overall Study|Subject Request|3|||
27759633|NCT00479557|80943468|FG001|Overall Study|Subject Request|0|||
27759634|NCT00479557|80943469|FG002|Overall Study|Subject Request|1|||
27759635|NCT00479557|80943470|FG003|Overall Study|Subject Request|1|||
27759636|NCT00479557|80943471|FG004|Overall Study|Subject Request|1|||
27759637|NCT00479557|80943472|FG005|Overall Study|Subject Request|4|||
27759638|NCT00479557|80943473|FG006|Overall Study|Subject Request|1|||
27759639|NCT00479557|80943467|FG000|Overall Study|Other|2|||
27759640|NCT00479557|80943468|FG001|Overall Study|Other|3|||
27759641|NCT00479557|80943469|FG002|Overall Study|Other|1|||
27759642|NCT00479557|80943470|FG003|Overall Study|Other|0|||
27759643|NCT00479557|80943471|FG004|Overall Study|Other|0|||
27759644|NCT00479557|80943472|FG005|Overall Study|Other|3|||
27759645|NCT00479557|80943473|FG006|Overall Study|Other|0|||
27759646|NCT01030458|80943482|FG000|Overall Study|Lost to Follow-up|9|||
27759647|NCT01030458|80943483|FG001|Overall Study|Lost to Follow-up|10|||
27759648|NCT01030458|80943482|FG000|Overall Study|Withdrawal by Subject|2|||
27759649|NCT01030458|80943483|FG001|Overall Study|Withdrawal by Subject|3|||
27759650|NCT01030458|80943482|FG000|Overall Study|Logistical reasons|9|||
27759651|NCT01030458|80943483|FG001|Overall Study|Logistical reasons|5|||
27759652|NCT01030458|80943482|FG000|Overall Study|Moved or changed job|6|||
27759653|NCT01030458|80943483|FG001|Overall Study|Moved or changed job|13|||
27759654|NCT01030458|80943482|FG000|Overall Study|Side effect of medication|1|||
27759655|NCT01030458|80943483|FG001|Overall Study|Side effect of medication|1|||
27759656|NCT01582971|80943487|FG000|Overall Study|Death|2|||
27759657|NCT01582971|80943488|FG001|Overall Study|Death|1|||
27759658|NCT01582971|80943487|FG000|Overall Study|Lost to Follow-up|18|||
27759659|NCT01582971|80943488|FG001|Overall Study|Lost to Follow-up|21|||
27759660|NCT01582971|80943487|FG000|Overall Study|Withdrawal by Subject|4|||
27759661|NCT01582971|80943488|FG001|Overall Study|Withdrawal by Subject|2|||
27759662|NCT01582971|80943487|FG000|Overall Study|Other|15|||
27759663|NCT01582971|80943488|FG001|Overall Study|Other|13|||
27759664|NCT04096326|80943489|FG000|Overall Study|Withdrawal by Subject|0|||
27759665|NCT04096326|80943490|FG001|Overall Study|Withdrawal by Subject|0|||
27759666|NCT04096326|80943491|FG002|Overall Study|Withdrawal by Subject|0|||
27759667|NCT04096326|80943492|FG003|Overall Study|Withdrawal by Subject|0|||
27759668|NCT04096326|80943493|FG004|Overall Study|Withdrawal by Subject|0|||
27759669|NCT04096326|80943494|FG005|Overall Study|Withdrawal by Subject|0|||
27759670|NCT04096326|80943495|FG006|Overall Study|Withdrawal by Subject|1|||
27759671|NCT04096326|80943496|FG007|Overall Study|Withdrawal by Subject|0|||
27759672|NCT04096326|80943497|FG008|Overall Study|Withdrawal by Subject|0|||
27759673|NCT04096326|80943498|FG009|Overall Study|Withdrawal by Subject|0|||
27759674|NCT04096326|80943489|FG000|Overall Study|Lost to Follow-up|0|||
27759675|NCT04096326|80943490|FG001|Overall Study|Lost to Follow-up|1|||
27759676|NCT04096326|80943491|FG002|Overall Study|Lost to Follow-up|0|||
27759677|NCT04096326|80943492|FG003|Overall Study|Lost to Follow-up|0|||
27759678|NCT04096326|80943493|FG004|Overall Study|Lost to Follow-up|0|||
27759679|NCT04096326|80943494|FG005|Overall Study|Lost to Follow-up|0|||
27759680|NCT04096326|80943495|FG006|Overall Study|Lost to Follow-up|0|||
27759681|NCT04096326|80943496|FG007|Overall Study|Lost to Follow-up|0|||
27759682|NCT04096326|80943497|FG008|Overall Study|Lost to Follow-up|0|||
27759683|NCT04096326|80943498|FG009|Overall Study|Lost to Follow-up|0|||
27759684|NCT04096326|80943489|FG000|Overall Study|COVID-19-related reasons|0|||
27759685|NCT04096326|80943490|FG001|Overall Study|COVID-19-related reasons|0|||
27759686|NCT04096326|80943491|FG002|Overall Study|COVID-19-related reasons|0|||
27759687|NCT04096326|80943492|FG003|Overall Study|COVID-19-related reasons|0|||
27759688|NCT04096326|80943493|FG004|Overall Study|COVID-19-related reasons|1|||
27759689|NCT04096326|80943494|FG005|Overall Study|COVID-19-related reasons|5|||
27759690|NCT04096326|80943495|FG006|Overall Study|COVID-19-related reasons|0|||
27759691|NCT04096326|80943496|FG007|Overall Study|COVID-19-related reasons|0|||
27759692|NCT04096326|80943497|FG008|Overall Study|COVID-19-related reasons|0|||
27759693|NCT04096326|80943498|FG009|Overall Study|COVID-19-related reasons|0|||
27759694|NCT02702518|80943501|FG000|Overall Study|Lost to Follow-up|3|||
27759695|NCT02702518|80943502|FG001|Overall Study|Lost to Follow-up|4|||
27759696|NCT02716194|80943507|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
27759697|NCT02716194|80943508|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
27759698|NCT02716194|80943509|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
27759699|NCT00574496|80943515|FG000|Overall Study|Withdrawal by Subject|1|||
27759700|NCT00781599|80943516|FG000|Overall Study|Lost to Follow-up|7|||
27759701|NCT00781599|80943517|FG001|Overall Study|Lost to Follow-up|4|||
27759702|NCT02294318|80943518|FG000|Overall Study|Worsening of drinking|3|||
27759703|NCT02294318|80943519|FG001|Overall Study|Worsening of drinking|0|||
27759704|NCT02294318|80943518|FG000|Overall Study|Not exposed to intervention|0|||
27759705|NCT02294318|80943519|FG001|Overall Study|Not exposed to intervention|2|||
27759706|NCT02227108|80943520|FG000|Overall Study|Did not receive treatment|2|||
27759707|NCT02227108|80943520|FG000|Overall Study|Other|3|||
27759708|NCT02227108|80943520|FG000|Overall Study|Progressive disease|17|||
27759709|NCT02227108|80943520|FG000|Overall Study|Initiation of alternative therapy|2|||
27759710|NCT02227108|80943520|FG000|Overall Study|Investigator discretion|1|||
27759711|NCT02227108|80943520|FG000|Overall Study|Adverse Event|6|||
27759712|NCT03334396|80943521|FG000|Overall Study|Adverse Event|1|||
27759713|NCT03334396|80943522|FG001|Overall Study|Adverse Event|0|||
27759714|NCT03334396|80943523|FG002|Overall Study|Adverse Event|1|||
27759715|NCT03334396|80943524|FG003|Overall Study|Adverse Event|0|||
27759716|NCT03334396|80943525|FG004|Overall Study|Adverse Event|0|||
27759717|NCT03334396|80943526|FG005|Overall Study|Adverse Event|0|||
27759718|NCT03334396|80943527|FG006|Overall Study|Adverse Event|0|||
27759719|NCT03334396|80943528|FG007|Overall Study|Adverse Event|0|||
27759720|NCT03334396|80943521|FG000|Overall Study|Lack of Efficacy|10|||
27759721|NCT03334396|80943522|FG001|Overall Study|Lack of Efficacy|4|||
27759722|NCT03334396|80943523|FG002|Overall Study|Lack of Efficacy|1|||
27759723|NCT03334396|80943524|FG003|Overall Study|Lack of Efficacy|3|||
27759724|NCT03334396|80943525|FG004|Overall Study|Lack of Efficacy|1|||
27759725|NCT03334396|80943526|FG005|Overall Study|Lack of Efficacy|0|||
27759726|NCT03334396|80943527|FG006|Overall Study|Lack of Efficacy|0|||
27759727|NCT03334396|80943528|FG007|Overall Study|Lack of Efficacy|1|||
27759728|NCT03334396|80943521|FG000|Overall Study|Lost to Follow-up|0|||
27759729|NCT03334396|80943522|FG001|Overall Study|Lost to Follow-up|0|||
27759730|NCT03334396|80943523|FG002|Overall Study|Lost to Follow-up|1|||
27759731|NCT03334396|80943524|FG003|Overall Study|Lost to Follow-up|0|||
27759732|NCT03334396|80943525|FG004|Overall Study|Lost to Follow-up|0|||
27759733|NCT03334396|80943526|FG005|Overall Study|Lost to Follow-up|0|||
27759734|NCT03334396|80943527|FG006|Overall Study|Lost to Follow-up|1|||
27759735|NCT03334396|80943528|FG007|Overall Study|Lost to Follow-up|0|||
27759736|NCT03334396|80943521|FG000|Overall Study|Physician Decision|1|||
27759737|NCT03334396|80943522|FG001|Overall Study|Physician Decision|0|||
27759738|NCT03334396|80943523|FG002|Overall Study|Physician Decision|0|||
27759739|NCT03334396|80943524|FG003|Overall Study|Physician Decision|0|||
27759740|NCT03334396|80943525|FG004|Overall Study|Physician Decision|0|||
27759741|NCT03334396|80943526|FG005|Overall Study|Physician Decision|0|||
27759742|NCT03334396|80943527|FG006|Overall Study|Physician Decision|0|||
27759743|NCT03334396|80943528|FG007|Overall Study|Physician Decision|0|||
27759744|NCT03334396|80943521|FG000|Overall Study|Withdrawal by Subject|10|||
27759745|NCT03334396|80943522|FG001|Overall Study|Withdrawal by Subject|5|||
27759746|NCT03334396|80943523|FG002|Overall Study|Withdrawal by Subject|7|||
27759747|NCT03334396|80943524|FG003|Overall Study|Withdrawal by Subject|2|||
27759748|NCT03334396|80943525|FG004|Overall Study|Withdrawal by Subject|2|||
27759749|NCT03334396|80943526|FG005|Overall Study|Withdrawal by Subject|1|||
27759750|NCT03334396|80943527|FG006|Overall Study|Withdrawal by Subject|2|||
27759751|NCT03334396|80943528|FG007|Overall Study|Withdrawal by Subject|0|||
27759752|NCT03334396|80943521|FG000|Overall Study|Pregnancy|0|||
27759753|NCT03334396|80943522|FG001|Overall Study|Pregnancy|1|||
27759754|NCT03334396|80943523|FG002|Overall Study|Pregnancy|0|||
27759755|NCT03334396|80943524|FG003|Overall Study|Pregnancy|0|||
27759756|NCT03334396|80943525|FG004|Overall Study|Pregnancy|0|||
27759757|NCT03334396|80943526|FG005|Overall Study|Pregnancy|0|||
27759758|NCT03334396|80943527|FG006|Overall Study|Pregnancy|0|||
27759759|NCT03334396|80943528|FG007|Overall Study|Pregnancy|0|||
27759760|NCT03334396|80943521|FG000|Overall Study|Ineligible|0|||
27759761|NCT03334396|80943522|FG001|Overall Study|Ineligible|1|||
27759762|NCT03334396|80943523|FG002|Overall Study|Ineligible|0|||
27759763|NCT03334396|80943524|FG003|Overall Study|Ineligible|0|||
27759764|NCT03334396|80943525|FG004|Overall Study|Ineligible|0|||
27759765|NCT03334396|80943526|FG005|Overall Study|Ineligible|0|||
27759766|NCT03334396|80943527|FG006|Overall Study|Ineligible|0|||
27759767|NCT03334396|80943528|FG007|Overall Study|Ineligible|0|||
27759768|NCT03334396|80943521|FG000|Overall Study|Started New Job|1|||
27759769|NCT03334396|80943522|FG001|Overall Study|Started New Job|0|||
27759770|NCT03334396|80943523|FG002|Overall Study|Started New Job|0|||
27759771|NCT03334396|80943524|FG003|Overall Study|Started New Job|0|||
27759772|NCT03334396|80943525|FG004|Overall Study|Started New Job|0|||
27759773|NCT03334396|80943526|FG005|Overall Study|Started New Job|0|||
27759774|NCT03334396|80943527|FG006|Overall Study|Started New Job|0|||
27759775|NCT03334396|80943528|FG007|Overall Study|Started New Job|0|||
27759776|NCT00618449|80943529|FG000|Overall Study|Lost to Follow-up|98|||
27759777|NCT00618449|80943530|FG001|Overall Study|Lost to Follow-up|110|||
27759778|NCT03730194|80943531|FG000|First Stage Treatment|Withdrawal by Subject|1|||
27759779|NCT03730194|80943532|FG001|First Stage Treatment|Withdrawal by Subject|1|||
27759780|NCT03730194|80943533|FG002|First Stage Treatment|Withdrawal by Subject|0|||
27759781|NCT03730194|80943534|FG003|First Stage Treatment|Withdrawal by Subject|0|||
27759782|NCT03730194|80943535|FG004|First Stage Treatment|Withdrawal by Subject|0|||
27859171|NCT04594707|81319256|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
27859172|NCT04594707|81319257|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
27859173|NCT04594707|81319258|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
27859174|NCT04594707|81319256|FG000|Overall Study|Study Terminated By Sponsor|19|||
27859175|NCT04594707|81319257|FG001|Overall Study|Study Terminated By Sponsor|47|||
27859176|NCT04594707|81319258|FG002|Overall Study|Study Terminated By Sponsor|41|||
27859177|NCT04594707|81319256|FG000|Overall Study|Withdrawal by Subject|1|||
27859178|NCT04594707|81319257|FG001|Overall Study|Withdrawal by Subject|0|||
27859179|NCT04594707|81319258|FG002|Overall Study|Withdrawal by Subject|2|||
27759783|NCT03730194|80943536|FG005|First Stage Treatment|Withdrawal by Subject|0|||
27759784|NCT03730194|80943531|FG000|First Stage Treatment|Protocol Violation|3|||
27759785|NCT03730194|80943532|FG001|First Stage Treatment|Protocol Violation|3|||
27759786|NCT03730194|80943533|FG002|First Stage Treatment|Protocol Violation|0|||
27759787|NCT03730194|80943534|FG003|First Stage Treatment|Protocol Violation|0|||
27759788|NCT03730194|80943535|FG004|First Stage Treatment|Protocol Violation|0|||
27759789|NCT03730194|80943536|FG005|First Stage Treatment|Protocol Violation|0|||
27759790|NCT01120379|80943538|FG000|One Year Timepoint|Withdrawal by Subject|41|||
27759791|NCT01120379|80943538|FG000|One Year Timepoint|Lost to Follow-up|115|||
27759792|NCT01120379|80943538|FG000|One Year Timepoint|Death|108|||
27759793|NCT01120379|80943538|FG000|One Year Timepoint|Physician Decision|9|||
27759794|NCT01120379|80943538|FG000|One Year Timepoint|Any other reason for early termination|5|||
27859180|NCT02994940|81319261|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
27859181|NCT02994940|81319262|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
27859182|NCT02994940|81319261|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
27859183|NCT02994940|81319262|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
27859184|NCT02994940|81319261|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
27859185|NCT02994940|81319262|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
27859186|NCT00780910|81319265|FG000|Overall Study|Adverse Event|2|||
27859187|NCT03327792|81319266|FG000|Overall Study|Adverse Event|4|||
27859188|NCT03327792|81319267|FG001|Overall Study|Adverse Event|0|||
27859189|NCT03327792|81319266|FG000|Overall Study|Family/Personal issues|3|||
27859190|NCT03327792|81319267|FG001|Overall Study|Family/Personal issues|2|||
27859191|NCT03327792|81319266|FG000|Overall Study|Lost to Follow-up|0|||
27859192|NCT03327792|81319267|FG001|Overall Study|Lost to Follow-up|1|||
27859193|NCT02968849|81319268|FG000|Overall Study|Death|8|||
27859194|NCT02968849|81319269|FG001|Overall Study|Death|10|||
27859195|NCT02968849|81319268|FG000|Overall Study|Lost to Follow-up|31|||
27859196|NCT02968849|81319269|FG001|Overall Study|Lost to Follow-up|29|||
27859197|NCT02968849|81319268|FG000|Overall Study|Withdrawal by Subject|73|||
27859198|NCT02968849|81319269|FG001|Overall Study|Withdrawal by Subject|64|||
27859199|NCT02968849|81319268|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
27859200|NCT02968849|81319269|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
27859201|NCT02968849|81319268|FG000|Overall Study|Physician Decision|6|||
27759795|NCT01120379|80943538|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
27759796|NCT01120379|80943538|FG000|Two Year Timepoint|Lost to Follow-up|87|||
27759797|NCT01120379|80943538|FG000|Two Year Timepoint|Death|123|||
27759798|NCT01120379|80943538|FG000|Two Year Timepoint|Physician Decision|12|||
27656729|NCT01072149|80583245|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27759799|NCT01120379|80943538|FG000|Two Year Timepoint|Any other reason for early termination|4|||
27759800|NCT01120379|80943538|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
27859202|NCT02968849|81319269|FG001|Overall Study|Physician Decision|9|||
27859203|NCT02968849|81319268|FG000|Overall Study|Other|16|||
27859204|NCT02968849|81319269|FG001|Overall Study|Other|10|||
27859205|NCT01437943|81319274|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
27859206|NCT01437943|81319275|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
27859207|NCT01437943|81319274|FG000|Overall Study|Subject expressed pregnancy plans|1|||
27859208|NCT01437943|81319275|FG001|Overall Study|Subject expressed pregnancy plans|0|||
27859209|NCT01437943|81319274|FG000|Overall Study|Adverse Event|2|||
27859210|NCT01437943|81319275|FG001|Overall Study|Adverse Event|0|||
27859211|NCT01085734|81319276|FG000|Overall Study|Adverse Event|0|||
27656730|NCT01072149|80583246|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656731|NCT01072149|80583247|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656732|NCT01072149|80583248|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656733|NCT01072149|80583249|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656734|NCT01072149|80583250|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656735|NCT01072149|80583251|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656736|NCT01072149|80583252|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656737|NCT01072149|80583253|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27656738|NCT01072149|80583236|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656739|NCT01072149|80583237|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656740|NCT01072149|80583238|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
27656741|NCT01072149|80583239|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656742|NCT01072149|80583240|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656743|NCT01072149|80583241|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656744|NCT01072149|80583242|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656745|NCT01072149|80583243|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656746|NCT01072149|80583244|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656747|NCT01072149|80583245|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656748|NCT01072149|80583246|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656749|NCT01072149|80583247|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656750|NCT01072149|80583248|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656751|NCT01072149|80583249|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27859212|NCT01085734|81319277|FG001|Overall Study|Adverse Event|2|||
27656752|NCT01072149|80583250|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27759801|NCT01120379|80943538|FG000|Three Year Timepoint|Lost to Follow-up|43|||
27759802|NCT01120379|80943538|FG000|Three Year Timepoint|Death|120|||
27759803|NCT01120379|80943538|FG000|Three Year Timepoint|Physician Decision|9|||
27859213|NCT01085734|81319276|FG000|Overall Study|Death|1|||
27656753|NCT01072149|80583251|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27859214|NCT01085734|81319277|FG001|Overall Study|Death|0|||
27859215|NCT01085734|81319276|FG000|Overall Study|Lost to Follow-up|0|||
27859216|NCT01085734|81319277|FG001|Overall Study|Lost to Follow-up|1|||
27759804|NCT01120379|80943538|FG000|Three Year Timepoint|Any other reason for early termination|17|||
27759805|NCT01120379|80943538|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
27759806|NCT01120379|80943538|FG000|Four Year Timepoint|Lost to Follow-up|10|||
27759807|NCT01120379|80943538|FG000|Four Year Timepoint|Death|131|||
27759808|NCT01120379|80943538|FG000|Four Year Timepoint|Physician Decision|5|||
27759809|NCT01120379|80943538|FG000|Four Year Timepoint|Any other reason for early termination|217|||
27759810|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
27759811|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
27759812|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
27759813|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
27759814|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
27759815|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
27759816|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
27759817|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
27759818|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
27759819|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
27759820|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
27759821|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
27759822|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
27759823|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
27759824|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
27759825|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
27759826|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
27759827|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27759828|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
27759829|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
27759830|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
27759831|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27759832|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27759833|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27759834|NCT01106625|80943541|FG000|Core Period: Baseline to Week 26|Other|8|||
27759835|NCT01106625|80943542|FG001|Core Period: Baseline to Week 26|Other|7|||
27759836|NCT01106625|80943543|FG002|Core Period: Baseline to Week 26|Other|4|||
27759837|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
27759838|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
27759839|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
27759840|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
27759841|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
27759842|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27759843|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27759844|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27759845|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
27759846|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27759847|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27759848|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27759849|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
27759850|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27759851|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27759852|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
27759853|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
27759854|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
27759855|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
27759856|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
27759857|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
27759858|NCT01106625|80943541|FG000|Extension Period: Week 26 to Week 52|Other|5|||
27759859|NCT01106625|80943542|FG001|Extension Period: Week 26 to Week 52|Other|5|||
27759860|NCT01106625|80943543|FG002|Extension Period: Week 26 to Week 52|Other|4|||
27759861|NCT00229203|80943544|FG000|Overall Study|Progressive disease|18|||
27759862|NCT00229203|80943545|FG001|Overall Study|Progressive disease|9|||
27759863|NCT00229203|80943544|FG000|Overall Study|Toxicity|6|||
27759864|NCT00229203|80943545|FG001|Overall Study|Toxicity|1|||
27759865|NCT00229203|80943544|FG000|Overall Study|Death|4|||
27759866|NCT00229203|80943545|FG001|Overall Study|Death|2|||
27759867|NCT00229203|80943544|FG000|Overall Study|Other|3|||
27759868|NCT00229203|80943545|FG001|Overall Study|Other|3|||
27759869|NCT00229203|80943544|FG000|Overall Study|Withdrawal by Subject|1|||
27759870|NCT00229203|80943545|FG001|Overall Study|Withdrawal by Subject|4|||
27759871|NCT00817206|80943546|FG000|Overall Study|Adverse Event|10|||
27759872|NCT00817206|80943547|FG001|Overall Study|Adverse Event|3|||
27759873|NCT00817206|80943546|FG000|Overall Study|Protocol Violation|0|||
27759874|NCT00817206|80943547|FG001|Overall Study|Protocol Violation|2|||
27759875|NCT00817206|80943546|FG000|Overall Study|Lost to Follow-up|0|||
27759876|NCT00817206|80943547|FG001|Overall Study|Lost to Follow-up|1|||
27759877|NCT00817206|80943546|FG000|Overall Study|Death|2|||
27759878|NCT00817206|80943547|FG001|Overall Study|Death|0|||
27759879|NCT00817206|80943546|FG000|Overall Study|Withdrawal by Subject|7|||
27759880|NCT00817206|80943547|FG001|Overall Study|Withdrawal by Subject|3|||
27759881|NCT00817206|80943546|FG000|Overall Study|Physician Decision|2|||
27759882|NCT00817206|80943547|FG001|Overall Study|Physician Decision|0|||
27759883|NCT00623467|80943553|FG000|Overall Study|Lost to Follow-up|1|||
27759884|NCT00623467|80943553|FG000|Overall Study|Protocol Violation|4|||
27759885|NCT00623467|80943553|FG000|Overall Study|Withdrawal by Subject|2|||
27759886|NCT01391819|80943554|FG000|Overall Study|Withdrawal by Subject|56|||
27759887|NCT01391819|80943554|FG000|Overall Study|Migrated/moved from study area|82|||
27759888|NCT01391819|80943554|FG000|Overall Study|Lost to Follow-up|252|||
27759889|NCT01391819|80943554|FG000|Overall Study|Death|3|||
27759890|NCT01391819|80943554|FG000|Overall Study|Other|9|||
27759891|NCT04900038|80943555|FG000|Overall Study|Adverse Event|1|||
27759892|NCT04900038|80943556|FG001|Overall Study|Adverse Event|0|||
27759893|NCT04900038|80943557|FG002|Overall Study|Adverse Event|1|||
27759894|NCT04900038|80943558|FG003|Overall Study|Adverse Event|1|||
27759895|NCT04900038|80943555|FG000|Overall Study|Withdrawal by Subject|0|||
27759896|NCT04900038|80943556|FG001|Overall Study|Withdrawal by Subject|1|||
27759897|NCT04900038|80943557|FG002|Overall Study|Withdrawal by Subject|0|||
27759898|NCT04900038|80943558|FG003|Overall Study|Withdrawal by Subject|0|||
27759899|NCT04900038|80943555|FG000|Overall Study|Study terminated by sponsor|18|||
27759900|NCT04900038|80943556|FG001|Overall Study|Study terminated by sponsor|15|||
27759901|NCT04900038|80943557|FG002|Overall Study|Study terminated by sponsor|17|||
27759902|NCT04900038|80943558|FG003|Overall Study|Study terminated by sponsor|14|||
27759903|NCT04900038|80943555|FG000|Overall Study|Protocol Deviation|1|||
27759904|NCT04900038|80943556|FG001|Overall Study|Protocol Deviation|1|||
27759905|NCT04900038|80943557|FG002|Overall Study|Protocol Deviation|0|||
27759906|NCT04900038|80943558|FG003|Overall Study|Protocol Deviation|0|||
27759907|NCT04900038|80943555|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
27759908|NCT04900038|80943556|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
27759909|NCT04900038|80943557|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
27759910|NCT04900038|80943558|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
27759911|NCT04900038|80943555|FG000|Overall Study|Lost to Follow-up|0|||
27759912|NCT04900038|80943556|FG001|Overall Study|Lost to Follow-up|0|||
27759913|NCT04900038|80943557|FG002|Overall Study|Lost to Follow-up|0|||
27759914|NCT04900038|80943558|FG003|Overall Study|Lost to Follow-up|1|||
27759915|NCT02785952|80943559|FG000|Overall Study|Adverse Event|31|||
27759916|NCT02785952|80943560|FG001|Overall Study|Adverse Event|19|||
27759917|NCT02785952|80943559|FG000|Overall Study|Refusal unrelated to adverse events|10|||
27759918|NCT02785952|80943560|FG001|Overall Study|Refusal unrelated to adverse events|5|||
27759919|NCT02785952|80943559|FG000|Overall Study|Disease progression/relapse|61|||
27759920|NCT02785952|80943560|FG001|Overall Study|Disease progression/relapse|89|||
27759921|NCT02785952|80943559|FG000|Overall Study|Death|11|||
27759922|NCT02785952|80943560|FG001|Overall Study|Death|7|||
27759923|NCT02785952|80943559|FG000|Overall Study|Other- not protocol specified|6|||
27759924|NCT02785952|80943560|FG001|Overall Study|Other- not protocol specified|4|||
27759925|NCT02785952|80943559|FG000|Overall Study|On protocol treatment|6|||
27759926|NCT02785952|80943560|FG001|Overall Study|On protocol treatment|3|||
27759927|NCT02530671|80943561|FG000|Overall Study|Lost to Follow-up|2|||
27759928|NCT02530671|80943562|FG001|Overall Study|Lost to Follow-up|0|||
27759929|NCT02530671|80943561|FG000|Overall Study|Withdrawal by Subject|1|||
27759930|NCT02530671|80943562|FG001|Overall Study|Withdrawal by Subject|0|||
27759931|NCT03247413|80943563|FG000|Overall Study|Lost to Follow-up|28|||
27759932|NCT00289185|80943564|FG000|Overall Study|Withdrawal by Subject|4|||
27759933|NCT00289185|80943565|FG001|Overall Study|Withdrawal by Subject|8|||
27759934|NCT00289185|80943564|FG000|Overall Study|Lost to Follow-up|23|||
27759935|NCT00289185|80943565|FG001|Overall Study|Lost to Follow-up|17|||
27759936|NCT00289185|80943564|FG000|Overall Study|Death|1|||
27759937|NCT00289185|80943565|FG001|Overall Study|Death|1|||
27759938|NCT00205699|80946682|FG000|Overall Study|Lost to Follow-up|1|||
27759939|NCT00205699|80946683|FG001|Overall Study|Lost to Follow-up|3|||
27759940|NCT00205699|80946684|FG002|Overall Study|Lost to Follow-up|5|||
27759941|NCT00205699|80946682|FG000|Overall Study|Adverse Event|1|||
27759942|NCT00205699|80946683|FG001|Overall Study|Adverse Event|0|||
27759943|NCT00205699|80946684|FG002|Overall Study|Adverse Event|0|||
27759944|NCT00205699|80946682|FG000|Overall Study|Withdrawal by Subject|1|||
27759945|NCT00205699|80946683|FG001|Overall Study|Withdrawal by Subject|2|||
27759946|NCT00205699|80946684|FG002|Overall Study|Withdrawal by Subject|1|||
27759947|NCT00205699|80946682|FG000|Overall Study|Lack of Efficacy|0|||
27759948|NCT00205699|80946683|FG001|Overall Study|Lack of Efficacy|1|||
27759949|NCT00205699|80946684|FG002|Overall Study|Lack of Efficacy|0|||
27759950|NCT02614287|80946685|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
27759951|NCT02614287|80946686|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
27759952|NCT02614287|80946685|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
27759953|NCT02614287|80946686|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
27759954|NCT02614287|80946685|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
27759955|NCT02614287|80946686|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
27759956|NCT02614287|80946685|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
27759957|NCT02614287|80946686|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
27759958|NCT02614287|80946685|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
27759959|NCT02614287|80946686|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
27759960|NCT02614287|80946685|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
27759961|NCT02614287|80946686|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
27759962|NCT02614287|80946685|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
27759963|NCT02614287|80946686|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
27759964|NCT02614287|80946685|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
27759965|NCT02614287|80946686|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
27759966|NCT02807363|80946687|FG000|Dosing Period|Adverse Event|0|||
27759967|NCT02807363|80946688|FG001|Dosing Period|Adverse Event|1|||
27759968|NCT02807363|80946689|FG002|Dosing Period|Adverse Event|0|||
27759969|NCT02807363|80946690|FG003|Dosing Period|Adverse Event|0|||
27759970|NCT01736254|80946691|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
27759971|NCT01736254|80946691|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
27759972|NCT05319080|80946692|FG000|Overall Study|Withdrawal by Subject|2|||
27759973|NCT05319080|80946692|FG000|Overall Study|Physician Decision|4|||
27759974|NCT03943953|80946695|FG000|Trial of ITG 1|Lost to Follow-up|19|||
27759975|NCT03943953|80946696|FG001|Trial of ITG 1|Lost to Follow-up|1|||
27759976|NCT03943953|80946695|FG000|Trial of ITG 2|Lost to Follow-up|8|||
27759977|NCT03943953|80946696|FG001|Trial of ITG 2|Lost to Follow-up|0|||
27759978|NCT03943953|80946695|FG000|Trial of ITG 3|Lost to Follow-up|2|||
27759979|NCT03943953|80946696|FG001|Trial of ITG 3|Lost to Follow-up|0|||
27759980|NCT03943953|80946695|FG000|Trial of ITG 4|Lost to Follow-up|2|||
27759981|NCT03943953|80946696|FG001|Trial of ITG 4|Lost to Follow-up|0|||
27759982|NCT00643487|80946700|FG000|Overall Study|Technical difficulty|3|||
27759983|NCT05254613|80946701|FG000|Overall Study|Lost to Follow-up|0|||
27759984|NCT05254613|80946702|FG001|Overall Study|Lost to Follow-up|0|||
27759985|NCT05254613|80946703|FG002|Overall Study|Lost to Follow-up|1|||
27759986|NCT01315847|80946704|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
27759987|NCT01315847|80946705|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
27759988|NCT01315847|80946704|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
27759989|NCT01315847|80946705|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
27759990|NCT01927419|80946706|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27759991|NCT01927419|80946707|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
27759992|NCT01927419|80946706|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
27759993|NCT01927419|80946707|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
27759994|NCT01927419|80946706|FG000|Treatment Period|Disease progression|17|||
27759995|NCT01927419|80946707|FG001|Treatment Period|Disease progression|20|||
27759996|NCT01927419|80946706|FG000|Treatment Period|Study drug toxicity|48|||
27759997|NCT01927419|80946707|FG001|Treatment Period|Study drug toxicity|10|||
27759998|NCT01927419|80946706|FG000|Treatment Period|Death|0|||
27759999|NCT01927419|80946707|FG001|Treatment Period|Death|1|||
27760000|NCT01927419|80946706|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
27760001|NCT01927419|80946707|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
27760002|NCT01927419|80946706|FG000|Treatment Period|Participant request to discontinue|12|||
27760003|NCT01927419|80946707|FG001|Treatment Period|Participant request to discontinue|4|||
27760004|NCT01927419|80946706|FG000|Treatment Period|Withdrawal by Subject|1|||
27760005|NCT01927419|80946707|FG001|Treatment Period|Withdrawal by Subject|1|||
27760006|NCT01927419|80946706|FG000|Treatment Period|Maximum Clinical Benefit|6|||
27760007|NCT01927419|80946707|FG001|Treatment Period|Maximum Clinical Benefit|2|||
27760008|NCT01927419|80946706|FG000|Treatment Period|Other reasons|3|||
27760009|NCT01927419|80946707|FG001|Treatment Period|Other reasons|4|||
27760010|NCT01927419|80946706|FG000|Treatment Period|Not Reported|1|||
27760011|NCT01927419|80946707|FG001|Treatment Period|Not Reported|1|||
27760012|NCT03543358|80946710|FG000|Overall Study|Death|1|||
27760013|NCT03543358|80946711|FG001|Overall Study|Death|0|||
27760014|NCT03543358|80946710|FG000|Overall Study|Disease Progression|1|||
27760015|NCT03543358|80946711|FG001|Overall Study|Disease Progression|0|||
27760016|NCT03543358|80946710|FG000|Overall Study|Parent Study Closure|1|||
27760017|NCT03543358|80946711|FG001|Overall Study|Parent Study Closure|0|||
27760018|NCT01840228|80946714|FG000|Overall Study|Lost to Follow-up|1|||
27760019|NCT01840228|80946715|FG001|Overall Study|Lost to Follow-up|1|||
27760020|NCT04724733|80946716|FG000|Overall Study|Lost to Follow-up|1|||
27760021|NCT04724733|80946717|FG001|Overall Study|Lost to Follow-up|1|||
27760022|NCT04724733|80946718|FG002|Overall Study|Lost to Follow-up|1|||
27760023|NCT00862121|80946727|FG000|Overall Study|Adverse Event|1|||
27760024|NCT00862121|80946728|FG001|Overall Study|Adverse Event|2|||
27760025|NCT00862121|80946727|FG000|Overall Study|Lack of Efficacy|0|||
27760026|NCT00862121|80946728|FG001|Overall Study|Lack of Efficacy|3|||
27760027|NCT00862121|80946727|FG000|Overall Study|Protocol Violation|0|||
27760028|NCT00862121|80946728|FG001|Overall Study|Protocol Violation|1|||
27760029|NCT00862121|80946727|FG000|Overall Study|Exclusion criterion violation|0|||
27760030|NCT00862121|80946728|FG001|Overall Study|Exclusion criterion violation|1|||
27760031|NCT00862121|80946727|FG000|Overall Study|Incorrect randomisation|0|||
27760032|NCT00862121|80946728|FG001|Overall Study|Incorrect randomisation|1|||
27760033|NCT01188096|80946731|FG000|Overall Study|progression of disease|4|||
27760034|NCT01188096|80946731|FG000|Overall Study|Withdrawal by Subject|2|||
27760035|NCT01230749|80946735|FG000|Overall Study|Adverse Event|0|||
27760036|NCT01230749|80946736|FG001|Overall Study|Adverse Event|0|||
27760037|NCT01230749|80946737|FG002|Overall Study|Adverse Event|0|||
27760038|NCT01230749|80946738|FG003|Overall Study|Adverse Event|1|||
27760039|NCT01230749|80946735|FG000|Overall Study|Physician Decision|0|||
27760040|NCT01230749|80946736|FG001|Overall Study|Physician Decision|0|||
27760041|NCT01230749|80946737|FG002|Overall Study|Physician Decision|1|||
27760042|NCT01230749|80946738|FG003|Overall Study|Physician Decision|0|||
27760043|NCT01230749|80946735|FG000|Overall Study|Withdrawal by Subject|0|||
27760044|NCT01230749|80946736|FG001|Overall Study|Withdrawal by Subject|1|||
27760045|NCT01230749|80946737|FG002|Overall Study|Withdrawal by Subject|0|||
27760046|NCT01230749|80946738|FG003|Overall Study|Withdrawal by Subject|0|||
27760047|NCT01230749|80946735|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
27760048|NCT01230749|80946736|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
27760049|NCT01230749|80946737|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
27760050|NCT01230749|80946738|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
27760051|NCT01033487|80946741|FG000|Fourth Intervention Period|Adverse Event|0|||
27760052|NCT01033487|80946742|FG001|Fourth Intervention Period|Adverse Event|0|||
27760053|NCT01033487|80946743|FG002|Fourth Intervention Period|Adverse Event|0|||
27760054|NCT01033487|80946744|FG003|Fourth Intervention Period|Adverse Event|0|||
27760055|NCT01033487|80946745|FG004|Fourth Intervention Period|Adverse Event|0|||
27760056|NCT01033487|80946746|FG005|Fourth Intervention Period|Adverse Event|0|||
27760057|NCT01033487|80946747|FG006|Fourth Intervention Period|Adverse Event|0|||
27760058|NCT01033487|80946748|FG007|Fourth Intervention Period|Adverse Event|0|||
27760059|NCT01033487|80946749|FG008|Fourth Intervention Period|Adverse Event|1|||
27760060|NCT01033487|80946750|FG009|Fourth Intervention Period|Adverse Event|0|||
27760061|NCT03074149|80946751|FG000|Overall Study|Reason unknown|22|||
27760062|NCT03074149|80946752|FG001|Overall Study|Reason unknown|35|||
27760063|NCT03074149|80946751|FG000|Overall Study|Death|10|||
27760064|NCT03074149|80946752|FG001|Overall Study|Death|45|||
27760065|NCT03726333|80946757|FG000|Overall Study|Progressive Disease|0|||
27760066|NCT03726333|80946758|FG001|Overall Study|Progressive Disease|0|||
27760067|NCT03726333|80946759|FG002|Overall Study|Progressive Disease|1|||
27760068|NCT03726333|80946760|FG003|Overall Study|Progressive Disease|0|||
27760069|NCT03726333|80946761|FG004|Overall Study|Progressive Disease|0|||
27760070|NCT01431144|80946762|FG000|Overall Study|Implant mobility and removal|2|||
27760071|NCT01431144|80946763|FG001|Overall Study|Implant mobility and removal|0|||
27760072|NCT04682353|80946766|FG000|Overall Study|Lost to Follow-up|0|||
27760073|NCT04682353|80946767|FG001|Overall Study|Lost to Follow-up|1|||
27760074|NCT04682353|80946768|FG002|Overall Study|Lost to Follow-up|0|||
27760075|NCT04682353|80946769|FG003|Overall Study|Lost to Follow-up|1|||
27760076|NCT04682353|80946766|FG000|Overall Study|Personal reasons|0|||
27760077|NCT04682353|80946767|FG001|Overall Study|Personal reasons|1|||
27760078|NCT04682353|80946768|FG002|Overall Study|Personal reasons|0|||
27760079|NCT04682353|80946769|FG003|Overall Study|Personal reasons|0|||
27760080|NCT01175213|80946772|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
27760081|NCT01175213|80946773|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
27760082|NCT01175213|80946772|FG000|IGSC, 10%/rHuPH20|Death|1|||
27760083|NCT01175213|80946773|FG001|IGSC, 10%/rHuPH20|Death|0|||
27760084|NCT01175213|80946772|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
27760085|NCT01175213|80946773|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
27760086|NCT01175213|80946772|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
27760087|NCT01175213|80946773|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
27760088|NCT01175213|80946772|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
27760089|NCT01175213|80946773|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
27760090|NCT01175213|80946772|FG000|Safety Follow-up|Adverse Event|1|||
27760091|NCT01175213|80946773|FG001|Safety Follow-up|Adverse Event|0|||
27760092|NCT00373490|80946777|FG000|Overall Study|Adverse Event|0|||
27760093|NCT00373490|80946778|FG001|Overall Study|Adverse Event|1|||
27760094|NCT00373490|80946777|FG000|Overall Study|Lack of Efficacy|9|||
27760095|NCT00373490|80946778|FG001|Overall Study|Lack of Efficacy|4|||
27760096|NCT00373490|80946777|FG000|Overall Study|Withdrawal by Subject|0|||
27760097|NCT00373490|80946778|FG001|Overall Study|Withdrawal by Subject|1|||
27760098|NCT02862548|80946779|FG000|Randomized Phase (Up to Week 48)|Death|0|||
27760099|NCT02862548|80946780|FG001|Randomized Phase (Up to Week 48)|Death|1|||
27760100|NCT02862548|80946779|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
27760101|NCT02862548|80946780|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
27760102|NCT02862548|80946779|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
27760103|NCT02862548|80946780|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
27760104|NCT02862548|80946779|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
27760105|NCT02862548|80946780|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
27760106|NCT01995136|80946781|FG000|Overall Study|Change in residence|1|||
27760107|NCT00789191|80946782|FG000|Overall Study|Adverse Event|2|||
27760108|NCT00789191|80946783|FG001|Overall Study|Adverse Event|4|||
27760109|NCT00789191|80946782|FG000|Overall Study|Lack of Efficacy|0|||
27760110|NCT00789191|80946783|FG001|Overall Study|Lack of Efficacy|5|||
27760111|NCT00789191|80946782|FG000|Overall Study|Protocol Violation|5|||
27760112|NCT00789191|80946783|FG001|Overall Study|Protocol Violation|3|||
27760113|NCT00789191|80946782|FG000|Overall Study|Withdrawal Criteria|2|||
27760114|NCT00789191|80946783|FG001|Overall Study|Withdrawal Criteria|4|||
27760115|NCT00789191|80946782|FG000|Overall Study|Unclassified|5|||
27760116|NCT00789191|80946783|FG001|Overall Study|Unclassified|3|||
27760117|NCT01700985|80946785|FG000|Overall Study|Incarcerated|0|||
27760118|NCT01700985|80946786|FG001|Overall Study|Incarcerated|1|||
27760119|NCT03101514|80946787|FG000|Overall Study|Withdrawal by Subject|4|||
27760120|NCT03101514|80946787|FG000|Overall Study|Protocol Violation|2|||
27760121|NCT03101514|80946787|FG000|Overall Study|patient's information was incomplete|1|||
27760122|NCT02555657|80946788|FG000|Overall Study|Death|274|||
27760123|NCT02555657|80946789|FG001|Overall Study|Death|262|||
27760124|NCT02555657|80946788|FG000|Overall Study|Physician Decision|0|||
27760125|NCT02555657|80946789|FG001|Overall Study|Physician Decision|1|||
27760126|NCT02555657|80946788|FG000|Overall Study|Sponsor Decision|27|||
27760127|NCT02555657|80946789|FG001|Overall Study|Sponsor Decision|15|||
27760128|NCT02555657|80946788|FG000|Overall Study|Withdrawal by Subject|11|||
27760129|NCT02555657|80946789|FG001|Overall Study|Withdrawal by Subject|32|||
27760130|NCT03067129|80946790|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
27760131|NCT03067129|80946791|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
27760132|NCT03067129|80946792|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
27760133|NCT03067129|80946793|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
27760134|NCT03067129|80946790|FG000|Overall Study|Withdrawal by Subject|0|||
27760135|NCT03067129|80946791|FG001|Overall Study|Withdrawal by Subject|0|||
27760136|NCT03067129|80946792|FG002|Overall Study|Withdrawal by Subject|1|||
27760137|NCT03067129|80946793|FG003|Overall Study|Withdrawal by Subject|2|||
27760138|NCT03067129|80946790|FG000|Overall Study|Lost to Follow-up|5|||
27760139|NCT03067129|80946791|FG001|Overall Study|Lost to Follow-up|5|||
27760140|NCT03067129|80946792|FG002|Overall Study|Lost to Follow-up|4|||
27760141|NCT03067129|80946793|FG003|Overall Study|Lost to Follow-up|3|||
27760142|NCT02193828|80946794|FG000|Overall Study|Withdrawal by Subject|0|||
27760143|NCT02193828|80946795|FG001|Overall Study|Withdrawal by Subject|0|||
27760144|NCT02193828|80946796|FG002|Overall Study|Withdrawal by Subject|1|||
27760145|NCT02193828|80946797|FG003|Overall Study|Withdrawal by Subject|1|||
27760146|NCT01764256|80946798|FG000|Received All Vaccinations|Adverse Event|1|||
27760147|NCT01764256|80946799|FG001|Received All Vaccinations|Adverse Event|1|||
27760148|NCT01764256|80946800|FG002|Received All Vaccinations|Adverse Event|0|||
27760149|NCT01764256|80946801|FG003|Received All Vaccinations|Adverse Event|0|||
27760150|NCT01764256|80946798|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
27760151|NCT01764256|80946799|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
27760152|NCT01764256|80946800|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
27760153|NCT01764256|80946801|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
27760154|NCT01764256|80946798|FG000|Received All Vaccinations|Lost to Follow-up|1|||
27760155|NCT01764256|80946799|FG001|Received All Vaccinations|Lost to Follow-up|0|||
27760156|NCT01764256|80946800|FG002|Received All Vaccinations|Lost to Follow-up|0|||
27760157|NCT01764256|80946801|FG003|Received All Vaccinations|Lost to Follow-up|0|||
27760158|NCT01764256|80946798|FG000|Completed Study|Lost to Follow-up|0|||
27760159|NCT01764256|80946799|FG001|Completed Study|Lost to Follow-up|0|||
27760160|NCT01764256|80946800|FG002|Completed Study|Lost to Follow-up|0|||
27760161|NCT01764256|80946801|FG003|Completed Study|Lost to Follow-up|1|||
27760162|NCT03454412|80946802|FG000|Baseline Assesment|Physician Decision|12|||
27760163|NCT02310906|80946803|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
27760164|NCT02310906|80946804|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
27760165|NCT02310906|80946805|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
27760166|NCT02310906|80946806|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
27760167|NCT02310906|80946803|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
27760168|NCT02310906|80946804|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
27760169|NCT02310906|80946805|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
27760170|NCT02310906|80946806|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
27760171|NCT02310906|80946803|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
27760172|NCT02310906|80946804|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
27760173|NCT02310906|80946805|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
27760174|NCT02310906|80946806|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
27760175|NCT02310906|80946803|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
27760176|NCT02310906|80946804|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
27760177|NCT02310906|80946805|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
27760178|NCT02310906|80946806|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
27760179|NCT02802878|80946807|FG000|Overall Study|Withdrawal by Subject|3|||
27760180|NCT02802878|80946808|FG001|Overall Study|Withdrawal by Subject|3|||
27760181|NCT02802878|80946807|FG000|Overall Study|Protocol Violation|1|||
27760182|NCT02802878|80946808|FG001|Overall Study|Protocol Violation|0|||
27760183|NCT00349752|80946809|FG000|Overall Study|Adverse Event|8|||
27760184|NCT00349752|80946810|FG001|Overall Study|Adverse Event|12|||
27760185|NCT00349752|80946809|FG000|Overall Study|Lack of Efficacy|37|||
27760186|NCT00349752|80946810|FG001|Overall Study|Lack of Efficacy|42|||
27760187|NCT00349752|80946809|FG000|Overall Study|Lost to Follow-up|4|||
27760188|NCT00349752|80946810|FG001|Overall Study|Lost to Follow-up|2|||
27760189|NCT00349752|80946809|FG000|Overall Study|Personal reasons|6|||
27760190|NCT00349752|80946810|FG001|Overall Study|Personal reasons|5|||
27859217|NCT01085734|81319276|FG000|Overall Study|Withdrawal by Subject|0|||
27859218|NCT01085734|81319277|FG001|Overall Study|Withdrawal by Subject|1|||
27859219|NCT02712333|81319278|FG000|First Period|Withdrawal by Subject|3|||
27859220|NCT02712333|81319279|FG001|First Period|Withdrawal by Subject|2|||
27859221|NCT03186781|81319280|FG000|Overall Study|Lost to Follow-up|0|||
27859222|NCT03186781|81319281|FG001|Overall Study|Lost to Follow-up|0|||
27859223|NCT03186781|81319282|FG002|Overall Study|Lost to Follow-up|1|||
27859224|NCT03186781|81319283|FG003|Overall Study|Lost to Follow-up|0|||
27859225|NCT03186781|81319284|FG004|Overall Study|Lost to Follow-up|1|||
27859226|NCT03186781|81319285|FG005|Overall Study|Lost to Follow-up|0|||
27859227|NCT03186781|81319280|FG000|Overall Study|Moved from Area|0|||
27859228|NCT03186781|81319281|FG001|Overall Study|Moved from Area|0|||
27859229|NCT03186781|81319282|FG002|Overall Study|Moved from Area|0|||
27859230|NCT03186781|81319283|FG003|Overall Study|Moved from Area|0|||
27859231|NCT03186781|81319284|FG004|Overall Study|Moved from Area|1|||
27859232|NCT03186781|81319285|FG005|Overall Study|Moved from Area|0|||
27859233|NCT03186781|81319280|FG000|Overall Study|Withdrawal by Subject|0|||
27859234|NCT03186781|81319281|FG001|Overall Study|Withdrawal by Subject|0|||
27859235|NCT03186781|81319282|FG002|Overall Study|Withdrawal by Subject|0|||
27859236|NCT03186781|81319283|FG003|Overall Study|Withdrawal by Subject|0|||
27859237|NCT03186781|81319284|FG004|Overall Study|Withdrawal by Subject|1|||
27859238|NCT03186781|81319285|FG005|Overall Study|Withdrawal by Subject|0|||
27859239|NCT02393248|81319286|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859240|NCT02393248|81319287|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
27859241|NCT02393248|81319288|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859242|NCT02393248|81319289|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859243|NCT02393248|81319290|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859244|NCT02393248|81319291|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
27859245|NCT02393248|81319292|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
27859246|NCT02393248|81319293|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859247|NCT02393248|81319294|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859248|NCT02393248|81319295|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859249|NCT02393248|81319296|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859250|NCT02393248|81319297|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27760191|NCT00349752|80946809|FG000|Overall Study|Other: Required exclusionary medication|0|||
27760192|NCT00349752|80946810|FG001|Overall Study|Other: Required exclusionary medication|1|||
27859251|NCT02393248|81319298|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859252|NCT02393248|81319299|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859253|NCT02393248|81319300|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27760193|NCT00349752|80946809|FG000|Overall Study|Other: Non compliance|0|||
27760194|NCT00349752|80946810|FG001|Overall Study|Other: Non compliance|1|||
27760195|NCT00349752|80946809|FG000|Overall Study|Other: Patient stopped steroids|0|||
27760196|NCT00349752|80946810|FG001|Overall Study|Other: Patient stopped steroids|1|||
27760197|NCT00349752|80946809|FG000|Overall Study|Other: Patient's steroid use|1|||
27760198|NCT00349752|80946810|FG001|Overall Study|Other: Patient's steroid use|0|||
27760199|NCT00349752|80946809|FG000|Overall Study|Other: Ineligible|1|||
27760200|NCT00349752|80946810|FG001|Overall Study|Other: Ineligible|0|||
27859254|NCT02393248|81319301|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859255|NCT02393248|81319302|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859256|NCT02393248|81319303|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859257|NCT02393248|81319304|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859258|NCT02393248|81319305|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859259|NCT02393248|81319306|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27760201|NCT00349752|80946809|FG000|Overall Study|Other: Inadvertently unblinded|1|||
27760202|NCT00349752|80946810|FG001|Overall Study|Other: Inadvertently unblinded|0|||
27760203|NCT00349752|80946809|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
27760204|NCT00349752|80946810|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
27760205|NCT03457103|80946811|FG000|Overall Study|illness/hospitalization|4|||
27859260|NCT02393248|81319307|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859261|NCT02393248|81319308|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859262|NCT02393248|81319309|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27859263|NCT02393248|81319310|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
27760206|NCT03457103|80946812|FG001|Overall Study|illness/hospitalization|2|||
27760207|NCT03457103|80946811|FG000|Overall Study|Lost to Follow-up|2|||
27760208|NCT03457103|80946812|FG001|Overall Study|Lost to Follow-up|1|||
27859264|NCT02393248|81319286|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859265|NCT02393248|81319287|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
27859266|NCT02393248|81319288|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859267|NCT02393248|81319289|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859268|NCT02393248|81319290|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859269|NCT02393248|81319291|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859270|NCT02393248|81319292|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859271|NCT02393248|81319293|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859272|NCT02393248|81319294|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859273|NCT02393248|81319295|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859274|NCT02393248|81319296|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859275|NCT02393248|81319297|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859276|NCT02393248|81319298|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859277|NCT02393248|81319299|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859278|NCT02393248|81319300|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859279|NCT02393248|81319301|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859280|NCT02393248|81319302|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859281|NCT02393248|81319303|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859282|NCT02393248|81319304|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859283|NCT02393248|81319305|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859284|NCT02393248|81319306|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859285|NCT02393248|81319307|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859286|NCT02393248|81319308|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859287|NCT02393248|81319309|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859288|NCT02393248|81319310|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
27859289|NCT02393248|81319286|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
27859290|NCT02393248|81319287|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
27859291|NCT02393248|81319288|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
27859292|NCT02393248|81319289|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
27859293|NCT02393248|81319290|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
27859294|NCT02393248|81319291|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
27859295|NCT02393248|81319292|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
27859296|NCT02393248|81319293|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
27859297|NCT02393248|81319294|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
27859298|NCT02393248|81319295|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
27859299|NCT02393248|81319296|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
27760209|NCT03457103|80946811|FG000|Overall Study|Withdrawal by Subject|1|||
27760210|NCT03457103|80946812|FG001|Overall Study|Withdrawal by Subject|2|||
27760211|NCT03457103|80946811|FG000|Overall Study|financial/ insurance issues|1|||
27760212|NCT03457103|80946812|FG001|Overall Study|financial/ insurance issues|1|||
27760213|NCT01697267|80946825|FG000|Overall Study|Death|3|||
27760214|NCT01697267|80946826|FG001|Overall Study|Death|1|||
27760215|NCT01697267|80946825|FG000|Overall Study|Withdrawal by Subject|5|||
27760216|NCT01697267|80946826|FG001|Overall Study|Withdrawal by Subject|5|||
27760217|NCT01697267|80946825|FG000|Overall Study|Adverse Event|2|||
27760218|NCT01697267|80946826|FG001|Overall Study|Adverse Event|1|||
27760219|NCT01697267|80946825|FG000|Overall Study|Lost to Follow-up|2|||
27760220|NCT01697267|80946826|FG001|Overall Study|Lost to Follow-up|4|||
27760221|NCT01697267|80946825|FG000|Overall Study|Physician Decision|2|||
27760222|NCT01697267|80946826|FG001|Overall Study|Physician Decision|4|||
27760223|NCT00868166|80946828|FG000|Overall Study|Death|58|||
27760224|NCT00868166|80946829|FG001|Overall Study|Death|65|||
27760225|NCT00868166|80946828|FG000|Overall Study|Withdrawal by Subject|33|||
27760226|NCT00868166|80946829|FG001|Overall Study|Withdrawal by Subject|25|||
27760227|NCT00868166|80946828|FG000|Overall Study|Protocol Violation|1|||
27859300|NCT02393248|81319297|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
27859301|NCT02393248|81319298|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
27859302|NCT02393248|81319299|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
27859303|NCT02393248|81319300|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
27760228|NCT00868166|80946829|FG001|Overall Study|Protocol Violation|0|||
27760229|NCT00868166|80946828|FG000|Overall Study|Lost to Follow-up|1|||
27760230|NCT00868166|80946829|FG001|Overall Study|Lost to Follow-up|3|||
27760231|NCT00868166|80946828|FG000|Overall Study|Adverse Event|9|||
27760232|NCT00868166|80946829|FG001|Overall Study|Adverse Event|10|||
27760233|NCT00868166|80946828|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
27760234|NCT00868166|80946829|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
27760235|NCT00868166|80946828|FG000|Overall Study|Non-compliance with IMP|1|||
27760236|NCT00868166|80946829|FG001|Overall Study|Non-compliance with IMP|1|||
27760237|NCT02726113|80946832|FG000|Total Enrollment|Physician Decision|0|||
27760238|NCT02726113|80946833|FG001|Total Enrollment|Physician Decision|1|||
27760239|NCT02726113|80946832|FG000|Total Enrollment|Protocol Violation|1|||
27760240|NCT02726113|80946833|FG001|Total Enrollment|Protocol Violation|0|||
27760241|NCT02726113|80946832|FG000|Total Enrollment|Withdrawal by Subject|2|||
27760242|NCT02726113|80946833|FG001|Total Enrollment|Withdrawal by Subject|1|||
27760243|NCT02726113|80946832|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
27760244|NCT02726113|80946833|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
27760245|NCT02726113|80946832|FG000|Genomic Analysis|Protocol Violation|1|||
27760246|NCT02726113|80946833|FG001|Genomic Analysis|Protocol Violation|0|||
27760247|NCT02726113|80946832|FG000|Genomic Analysis|Withdrawal by Subject|2|||
27760248|NCT02726113|80946833|FG001|Genomic Analysis|Withdrawal by Subject|1|||
27760249|NCT02726113|80946832|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
27760250|NCT02726113|80946833|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
27760251|NCT00111917|80946834|FG000|Overall Study|Withdrawal by Subject|1|||
27760252|NCT00111917|80946835|FG001|Overall Study|Withdrawal by Subject|1|||
27760253|NCT02853032|80946836|FG000|Overall Study|Adverse Event|4|||
27760254|NCT02853032|80946837|FG001|Overall Study|Adverse Event|0|||
27760255|NCT02853032|80946836|FG000|Overall Study|Withdrawal by Subject|3|||
27760256|NCT02853032|80946837|FG001|Overall Study|Withdrawal by Subject|1|||
27760257|NCT02853032|80946836|FG000|Overall Study|Requested to withdraw from all treatment|2|||
27760258|NCT02853032|80946837|FG001|Overall Study|Requested to withdraw from all treatment|2|||
27760259|NCT04404010|80946840|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
27760260|NCT04404010|80946841|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
27760261|NCT00630812|80946847|FG000|Randomisation to First Dose|Adverse Event|1|||
27760262|NCT00630812|80946848|FG001|Randomisation to First Dose|Adverse Event|1|||
27760263|NCT00630812|80946847|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
27760264|NCT00630812|80946848|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
27760265|NCT00630812|80946847|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
27760266|NCT00630812|80946848|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
27760267|NCT00630812|80946847|FG000|Randomisation to First Dose|Protocol Violation|4|||
27760268|NCT00630812|80946848|FG001|Randomisation to First Dose|Protocol Violation|1|||
27760269|NCT00630812|80946847|FG000|Double Blind Treatment Period|Adverse Event|13|||
27760270|NCT00630812|80946848|FG001|Double Blind Treatment Period|Adverse Event|5|||
27656754|NCT01072149|80583252|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656755|NCT01072149|80583253|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27656756|NCT01072149|80583236|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656757|NCT01072149|80583237|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656758|NCT01072149|80583238|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656759|NCT01072149|80583239|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656760|NCT01072149|80583240|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656761|NCT01072149|80583241|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656762|NCT01072149|80583242|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656763|NCT01072149|80583243|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
27656764|NCT01072149|80583244|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656765|NCT01072149|80583245|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656766|NCT01072149|80583246|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656767|NCT01072149|80583247|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656768|NCT01072149|80583248|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656769|NCT01072149|80583249|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656770|NCT01072149|80583250|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656771|NCT01072149|80583251|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
27656772|NCT01072149|80583252|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
27859304|NCT02393248|81319301|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
27859305|NCT02393248|81319302|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
27859306|NCT02393248|81319303|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
27859307|NCT02393248|81319304|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
27859308|NCT02393248|81319305|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
27859309|NCT02393248|81319306|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
27859310|NCT02393248|81319307|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
27859311|NCT02393248|81319308|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
27859312|NCT02393248|81319309|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
27859313|NCT02393248|81319310|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
27859314|NCT02393248|81319286|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
27859315|NCT02393248|81319287|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859316|NCT02393248|81319288|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859317|NCT02393248|81319289|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859318|NCT02393248|81319290|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859319|NCT02393248|81319291|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859320|NCT02393248|81319292|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859321|NCT02393248|81319293|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859322|NCT02393248|81319294|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859323|NCT02393248|81319295|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859324|NCT02393248|81319296|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859325|NCT02393248|81319297|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859326|NCT02393248|81319298|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27656773|NCT01072149|80583253|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
27859327|NCT02393248|81319299|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859328|NCT02393248|81319300|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859329|NCT02393248|81319301|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859330|NCT02393248|81319302|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859331|NCT02393248|81319303|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859332|NCT02393248|81319304|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859333|NCT02393248|81319305|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859334|NCT02393248|81319306|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859335|NCT02393248|81319307|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859336|NCT02393248|81319308|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859337|NCT02393248|81319309|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859338|NCT02393248|81319310|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
27859339|NCT02393248|81319286|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859340|NCT02393248|81319287|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859341|NCT02393248|81319288|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859342|NCT02393248|81319289|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859343|NCT02393248|81319290|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859344|NCT02393248|81319291|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
27859345|NCT02393248|81319292|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
27656774|NCT01072149|80583236|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
27656775|NCT01072149|80583237|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
27656776|NCT01072149|80583238|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
27656777|NCT01072149|80583239|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
27656778|NCT01072149|80583240|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
27656779|NCT01072149|80583241|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
27656780|NCT01072149|80583242|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
27656781|NCT01072149|80583243|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
27656782|NCT01072149|80583244|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
27859346|NCT02393248|81319293|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859347|NCT02393248|81319294|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27656783|NCT01072149|80583245|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
27760271|NCT00630812|80946847|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
27760272|NCT00630812|80946848|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27760273|NCT00630812|80946847|FG000|Double Blind Treatment Period|Physician Decision|2|||
27760274|NCT00630812|80946848|FG001|Double Blind Treatment Period|Physician Decision|1|||
27760275|NCT00630812|80946847|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27859348|NCT02393248|81319295|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
27859349|NCT02393248|81319296|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859350|NCT02393248|81319297|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859351|NCT02393248|81319298|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859352|NCT02393248|81319299|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859353|NCT02393248|81319300|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27760276|NCT00630812|80946848|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27760277|NCT00630812|80946847|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
27760278|NCT00630812|80946848|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
27760279|NCT00630812|80946847|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
27760280|NCT00630812|80946848|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
27760281|NCT00630812|80946847|FG000|Double Blind Treatment Period|Non-compliance|0|||
27760282|NCT00630812|80946848|FG001|Double Blind Treatment Period|Non-compliance|1|||
27760283|NCT00174785|80946849|FG000|Overall Study|Adverse Event|293|||
27760284|NCT00174785|80946850|FG001|Overall Study|Adverse Event|191|||
27760285|NCT00174785|80946849|FG000|Overall Study|Protocol Violation|14|||
27760286|NCT00174785|80946850|FG001|Overall Study|Protocol Violation|14|||
27760287|NCT00174785|80946849|FG000|Overall Study|Withdrawal by Subject|173|||
27760288|NCT00174785|80946850|FG001|Overall Study|Withdrawal by Subject|175|||
27760289|NCT00174785|80946849|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
27760290|NCT00174785|80946850|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
27760291|NCT00174785|80946849|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
27760292|NCT00174785|80946850|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
27760293|NCT00174785|80946849|FG000|Overall Study|Other prohibited medication|5|||
27760294|NCT00174785|80946850|FG001|Overall Study|Other prohibited medication|3|||
27760295|NCT00174785|80946849|FG000|Overall Study|Family request|6|||
27760296|NCT00174785|80946850|FG001|Overall Study|Family request|8|||
27760297|NCT00174785|80946849|FG000|Overall Study|Not pre-specified/Not coded|56|||
27760298|NCT00174785|80946850|FG001|Overall Study|Not pre-specified/Not coded|70|||
27760299|NCT02180217|80946851|FG000|Overall Study|Adverse Event|3|||
27760300|NCT02180217|80946852|FG001|Overall Study|Adverse Event|2|||
27760301|NCT02180217|80946853|FG002|Overall Study|Adverse Event|22|||
27760302|NCT02180217|80946851|FG000|Overall Study|Death|1|||
27760303|NCT02180217|80946852|FG001|Overall Study|Death|1|||
27760304|NCT02180217|80946853|FG002|Overall Study|Death|0|||
27760305|NCT02180217|80946851|FG000|Overall Study|Withdrawal by Subject|1|||
27760306|NCT02180217|80946852|FG001|Overall Study|Withdrawal by Subject|1|||
27760307|NCT02180217|80946853|FG002|Overall Study|Withdrawal by Subject|4|||
27760308|NCT02180217|80946851|FG000|Overall Study|Subject/Guardian decision|5|||
27760309|NCT02180217|80946852|FG001|Overall Study|Subject/Guardian decision|3|||
27760310|NCT02180217|80946853|FG002|Overall Study|Subject/Guardian decision|6|||
27760311|NCT02180217|80946851|FG000|Overall Study|Physician Decision|1|||
27760312|NCT02180217|80946852|FG001|Overall Study|Physician Decision|1|||
27760313|NCT02180217|80946853|FG002|Overall Study|Physician Decision|6|||
27760314|NCT02180217|80946851|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27760315|NCT02180217|80946852|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27760316|NCT02180217|80946853|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27760317|NCT00280150|80946854|FG000|Overall Study|Adverse Event|0|||
27760318|NCT00280150|80946855|FG001|Overall Study|Adverse Event|1|||
27760319|NCT00280150|80946856|FG002|Overall Study|Adverse Event|2|||
27760320|NCT00280150|80946857|FG003|Overall Study|Adverse Event|3|||
27760321|NCT00280150|80946854|FG000|Overall Study|Lack of Efficacy|0|||
27760322|NCT00280150|80946855|FG001|Overall Study|Lack of Efficacy|0|||
27760323|NCT00280150|80946856|FG002|Overall Study|Lack of Efficacy|0|||
27760324|NCT00280150|80946857|FG003|Overall Study|Lack of Efficacy|3|||
27760325|NCT00280150|80946854|FG000|Overall Study|Physician Decision|0|||
27760326|NCT00280150|80946855|FG001|Overall Study|Physician Decision|0|||
27760327|NCT00280150|80946856|FG002|Overall Study|Physician Decision|0|||
27760328|NCT00280150|80946857|FG003|Overall Study|Physician Decision|1|||
27760329|NCT00280150|80946854|FG000|Overall Study|Protocol Violation|0|||
27760330|NCT00280150|80946855|FG001|Overall Study|Protocol Violation|0|||
27760331|NCT00280150|80946856|FG002|Overall Study|Protocol Violation|0|||
27760332|NCT00280150|80946857|FG003|Overall Study|Protocol Violation|1|||
27760333|NCT00280150|80946854|FG000|Overall Study|Withdrawal by Subject|0|||
27760334|NCT00280150|80946855|FG001|Overall Study|Withdrawal by Subject|0|||
27760335|NCT00280150|80946856|FG002|Overall Study|Withdrawal by Subject|0|||
27760336|NCT00280150|80946857|FG003|Overall Study|Withdrawal by Subject|1|||
27760337|NCT00280150|80946854|FG000|Overall Study|Did not get consolidation therapy|3|||
27760338|NCT00280150|80946855|FG001|Overall Study|Did not get consolidation therapy|0|||
27760339|NCT00280150|80946856|FG002|Overall Study|Did not get consolidation therapy|3|||
27760340|NCT00280150|80946857|FG003|Overall Study|Did not get consolidation therapy|0|||
27760341|NCT00280150|80946854|FG000|Overall Study|Declining Performance Status|0|||
27760342|NCT00280150|80946855|FG001|Overall Study|Declining Performance Status|0|||
27760343|NCT00280150|80946856|FG002|Overall Study|Declining Performance Status|0|||
27760344|NCT00280150|80946857|FG003|Overall Study|Declining Performance Status|1|||
27760345|NCT01681576|80946862|FG000|Period 1|Adverse Event|1|||
27760346|NCT01681576|80946863|FG001|Period 1|Adverse Event|0|||
27760347|NCT01681576|80946862|FG000|Period 1|Protocol Deviation|1|||
27760348|NCT01681576|80946863|FG001|Period 1|Protocol Deviation|0|||
27760349|NCT01681576|80946862|FG000|Period 2|subject/guardian decision|3|||
27760350|NCT01681576|80946863|FG001|Period 2|subject/guardian decision|1|||
27859354|NCT02393248|81319301|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859355|NCT02393248|81319302|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859356|NCT02393248|81319303|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859357|NCT02393248|81319304|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859358|NCT02393248|81319305|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859359|NCT02393248|81319306|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859360|NCT02393248|81319307|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859361|NCT02393248|81319308|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859362|NCT02393248|81319309|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27760351|NCT01681576|80946862|FG000|Period 2|Non-compliance with study treatment|1|||
27760352|NCT01681576|80946863|FG001|Period 2|Non-compliance with study treatment|0|||
27859363|NCT02393248|81319310|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
27859364|NCT02393248|81319286|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859365|NCT02393248|81319287|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859366|NCT02393248|81319288|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859367|NCT02393248|81319289|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859368|NCT02393248|81319290|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859369|NCT02393248|81319291|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859370|NCT02393248|81319292|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
27859371|NCT02393248|81319293|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859372|NCT02393248|81319294|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859373|NCT02393248|81319295|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859374|NCT02393248|81319296|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859375|NCT02393248|81319297|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859376|NCT02393248|81319298|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859377|NCT02393248|81319299|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859378|NCT02393248|81319300|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859379|NCT02393248|81319301|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859380|NCT02393248|81319302|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859381|NCT02393248|81319303|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859382|NCT02393248|81319304|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859383|NCT02393248|81319305|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859384|NCT02393248|81319306|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859385|NCT02393248|81319307|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859386|NCT02393248|81319308|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27886601|NCT01435018|81418120|FG000|Overall Study|Not willing to adhere to requirements|0|||
27656784|NCT01072149|80583246|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
27760353|NCT02429258|80946867|FG000|Overall Study|Withdrawal by Subject|2|||
27760354|NCT02429258|80946868|FG001|Overall Study|Withdrawal by Subject|0|||
27760355|NCT02429258|80946867|FG000|Overall Study|Protocol Violation|0|||
27760356|NCT02429258|80946868|FG001|Overall Study|Protocol Violation|1|||
27760357|NCT02326467|80946870|FG000|Overall Study|Withdrawal by Subject|1|||
27760358|NCT01151540|80946871|FG000|Overall Study|Other|2|||
27760359|NCT01151540|80946871|FG000|Overall Study|Adverse event, non-fatal|4|||
27760360|NCT01151540|80946871|FG000|Overall Study|Withdrawal by Subject|7|||
27760361|NCT00067470|80946872|FG000|Overall Study|Withdrawal by Subject|0|||
27760362|NCT00067470|80946873|FG001|Overall Study|Withdrawal by Subject|1|||
27760363|NCT00788697|80946875|FG000|Overall Study|No study drug administered|12|||
27760364|NCT00788697|80946875|FG000|Overall Study|Training Patients|74|||
27760365|NCT00788697|80946875|FG000|Overall Study|no truth standard procedure available|5|||
27760366|NCT00788697|80946875|FG000|Overall Study|Technically inadequate truth standard|1|||
27760367|NCT00788697|80946875|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
27760368|NCT01009983|80946882|FG000|Overall Study|necessary scans not completed|1|||
27760369|NCT00795509|80946883|FG000|Overall Study|Protocol Violation|31|||
27760370|NCT01185249|80946884|FG000|Overall Study|Patients discharged or change in status|42|||
27760371|NCT00634114|80946891|FG000|Overall Study|Adverse Event|6|||
27760372|NCT00634114|80946892|FG001|Overall Study|Adverse Event|8|||
27760373|NCT00634114|80946893|FG002|Overall Study|Adverse Event|3|||
27760374|NCT00634114|80946891|FG000|Overall Study|Withdrawal by Subject|9|||
27760375|NCT00634114|80946892|FG001|Overall Study|Withdrawal by Subject|6|||
27760376|NCT00634114|80946893|FG002|Overall Study|Withdrawal by Subject|11|||
27760377|NCT00634114|80946891|FG000|Overall Study|Lost to Follow-up|0|||
27760378|NCT00634114|80946892|FG001|Overall Study|Lost to Follow-up|0|||
27760379|NCT00634114|80946893|FG002|Overall Study|Lost to Follow-up|1|||
27760380|NCT00634114|80946891|FG000|Overall Study|Protocol Violation|3|||
27760381|NCT00634114|80946892|FG001|Overall Study|Protocol Violation|3|||
27760382|NCT00634114|80946893|FG002|Overall Study|Protocol Violation|1|||
27760383|NCT00634114|80946891|FG000|Overall Study|Pregnancy|1|||
27760384|NCT00634114|80946892|FG001|Overall Study|Pregnancy|0|||
27760385|NCT00634114|80946893|FG002|Overall Study|Pregnancy|0|||
27859387|NCT02393248|81319309|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859388|NCT02393248|81319310|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
27859389|NCT02393248|81319286|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859390|NCT02393248|81319287|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859391|NCT02393248|81319288|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859392|NCT02393248|81319289|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859393|NCT02393248|81319290|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859394|NCT02393248|81319291|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859395|NCT02393248|81319292|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859396|NCT02393248|81319293|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859397|NCT02393248|81319294|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859398|NCT02393248|81319295|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859399|NCT02393248|81319296|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859400|NCT02393248|81319297|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
27859401|NCT02393248|81319298|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
27859402|NCT02393248|81319299|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
27859403|NCT02393248|81319300|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
27859404|NCT02393248|81319301|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859405|NCT02393248|81319302|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859406|NCT02393248|81319303|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859407|NCT02393248|81319304|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859408|NCT02393248|81319305|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859409|NCT02393248|81319306|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859410|NCT02393248|81319307|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859411|NCT02393248|81319308|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859412|NCT02393248|81319309|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859413|NCT02393248|81319310|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
27859414|NCT02393248|81319286|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859415|NCT02393248|81319287|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859416|NCT02393248|81319288|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859417|NCT02393248|81319289|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859418|NCT02393248|81319290|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27760386|NCT00634114|80946891|FG000|Overall Study|Incorrect enrolment|0|||
27760387|NCT00634114|80946892|FG001|Overall Study|Incorrect enrolment|1|||
27760388|NCT00634114|80946893|FG002|Overall Study|Incorrect enrolment|0|||
27760389|NCT00634114|80946891|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
27760390|NCT00634114|80946892|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
27760391|NCT00634114|80946893|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
27760392|NCT00634114|80946891|FG000|Overall Study|Difficult to continue|3|||
27760393|NCT00634114|80946892|FG001|Overall Study|Difficult to continue|1|||
27760394|NCT00634114|80946893|FG002|Overall Study|Difficult to continue|1|||
27760395|NCT00634114|80946891|FG000|Overall Study|Other reason|1|||
27760396|NCT00634114|80946892|FG001|Overall Study|Other reason|1|||
27760397|NCT00634114|80946893|FG002|Overall Study|Other reason|1|||
27760398|NCT00475540|80946894|FG000|36 Months|Lost to Follow-up|4|||
27760399|NCT00475540|80946895|FG001|36 Months|Lost to Follow-up|4|||
27760400|NCT00475540|80946894|FG000|36 Months|Death|1|||
27760401|NCT00475540|80946895|FG001|36 Months|Death|2|||
27760402|NCT00475540|80946894|FG000|36 Months|Censored due to reoperation|3|||
27760403|NCT00475540|80946895|FG001|36 Months|Censored due to reoperation|0|||
27760404|NCT03428997|80946896|FG000|Overall Study|Sponsor decision.|1|||
27760405|NCT03428997|80946896|FG000|Overall Study|Withdrawal by Subject|3|||
27760406|NCT03428997|80946896|FG000|Overall Study|Lost to Follow-up|4|||
27760407|NCT00664209|80946897|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
27760408|NCT00664209|80946897|FG000|Study Treatment Period|Physician Decision|4|||
27760409|NCT00664209|80946897|FG000|Study Treatment Period|Withdrawal by Subject|2|||
27760410|NCT02133742|80946902|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
27760411|NCT02133742|80946902|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
27760412|NCT02133742|80946902|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
27760413|NCT02133742|80946902|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
27760414|NCT02133742|80946902|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
27760415|NCT02219087|80946906|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
27760416|NCT02219087|80946907|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
27760417|NCT01479374|80946908|FG000|Overall Study|Adverse Event|2|||
27760418|NCT01479374|80946909|FG001|Overall Study|Adverse Event|1|||
27859419|NCT02393248|81319291|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859420|NCT02393248|81319292|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859421|NCT02393248|81319293|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859422|NCT02393248|81319294|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859423|NCT02393248|81319295|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859424|NCT02393248|81319296|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
27859425|NCT02393248|81319297|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
27859426|NCT02393248|81319298|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859427|NCT02393248|81319299|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859428|NCT02393248|81319300|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859429|NCT02393248|81319301|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859430|NCT02393248|81319302|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859431|NCT02393248|81319303|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859432|NCT02393248|81319304|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859433|NCT02393248|81319305|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859434|NCT02393248|81319306|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859435|NCT02393248|81319307|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859436|NCT02393248|81319308|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859437|NCT02393248|81319309|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859438|NCT02393248|81319310|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
27859439|NCT02393248|81319286|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
27859440|NCT02393248|81319287|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
27859441|NCT02393248|81319288|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
27859442|NCT02393248|81319289|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
27859443|NCT02393248|81319290|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
27859444|NCT02393248|81319291|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
27859445|NCT02393248|81319292|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
27859446|NCT02393248|81319293|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
27859447|NCT02393248|81319294|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
27859448|NCT02393248|81319295|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
27859449|NCT02393248|81319296|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
27859450|NCT02393248|81319297|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
27859451|NCT02393248|81319298|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
27859452|NCT02393248|81319299|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
27859453|NCT02393248|81319300|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
27859454|NCT02393248|81319301|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
27859455|NCT02393248|81319302|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
27859456|NCT02393248|81319303|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
27859457|NCT02393248|81319304|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
27859458|NCT02393248|81319305|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
27859459|NCT02393248|81319306|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
27859460|NCT02393248|81319307|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
27859461|NCT02393248|81319308|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
27859462|NCT02393248|81319309|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
27859463|NCT02393248|81319310|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
27859464|NCT02393248|81319286|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859465|NCT02393248|81319287|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859466|NCT02393248|81319288|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859467|NCT02393248|81319289|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859468|NCT02393248|81319290|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859469|NCT02393248|81319291|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859470|NCT02393248|81319292|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859471|NCT02393248|81319293|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859472|NCT02393248|81319294|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859473|NCT02393248|81319295|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27760419|NCT01479374|80946910|FG002|Overall Study|Adverse Event|0|||
27859474|NCT02393248|81319296|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859475|NCT02393248|81319297|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
27859476|NCT02393248|81319298|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859477|NCT02393248|81319299|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
27859478|NCT02393248|81319300|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859479|NCT02393248|81319301|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859480|NCT02393248|81319302|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859481|NCT02393248|81319303|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859482|NCT02393248|81319304|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859483|NCT02393248|81319305|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859484|NCT02393248|81319306|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859485|NCT02393248|81319307|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859486|NCT02393248|81319308|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859487|NCT02393248|81319309|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859488|NCT02393248|81319310|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
27859489|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859490|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859491|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859492|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859493|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859494|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859495|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859496|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27760420|NCT01479374|80946908|FG000|Overall Study|Lost to Follow-up|1|||
27760421|NCT01479374|80946909|FG001|Overall Study|Lost to Follow-up|2|||
27760422|NCT01479374|80946910|FG002|Overall Study|Lost to Follow-up|0|||
27760423|NCT01479374|80946908|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
27760424|NCT01479374|80946909|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
27760425|NCT01479374|80946910|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
27760426|NCT01479374|80946908|FG000|Overall Study|Other|0|||
27760427|NCT01479374|80946909|FG001|Overall Study|Other|4|||
27760428|NCT01479374|80946910|FG002|Overall Study|Other|5|||
27760429|NCT01958125|80946915|FG000|Overall Study|Missing diary data|2|||
27760430|NCT01958125|80946916|FG001|Overall Study|Missing diary data|6|||
27760431|NCT01958125|80946915|FG000|Overall Study|No headache attacks|0|||
27760432|NCT01958125|80946916|FG001|Overall Study|No headache attacks|2|||
27760433|NCT00599027|80946917|FG000|Overall Study|Withdrawal by Subject|1|||
27760434|NCT00599027|80946918|FG001|Overall Study|Withdrawal by Subject|1|||
27760435|NCT00599027|80946917|FG000|Overall Study|Adverse Event|0|||
27760436|NCT00599027|80946918|FG001|Overall Study|Adverse Event|1|||
27760437|NCT00599027|80946917|FG000|Overall Study|Treatment Failure|0|||
27760438|NCT00599027|80946918|FG001|Overall Study|Treatment Failure|1|||
27760439|NCT03297216|80946919|FG000|Overall Study|Death|0|||
27760440|NCT03297216|80946920|FG001|Overall Study|Death|1|||
27760441|NCT03297216|80946919|FG000|Overall Study|Miscarriage|0|||
27760442|NCT03297216|80946920|FG001|Overall Study|Miscarriage|2|||
27760443|NCT03297216|80946919|FG000|Overall Study|Lost to Follow-up|3|||
27760444|NCT03297216|80946920|FG001|Overall Study|Lost to Follow-up|2|||
27760445|NCT01594333|80946921|FG000|Overall Study|Death|96|||
27760446|NCT01594333|80946922|FG001|Overall Study|Death|83|||
27760447|NCT01594333|80946921|FG000|Overall Study|Lost to Follow-up|5|||
27760448|NCT01594333|80946922|FG001|Overall Study|Lost to Follow-up|5|||
27760449|NCT01594333|80946921|FG000|Overall Study|Withdrawal by Subject|60|||
27760450|NCT01594333|80946922|FG001|Overall Study|Withdrawal by Subject|63|||
27760451|NCT00642018|80946924|FG000|Overall Study|Adverse Event|11|||
27760452|NCT00642018|80946925|FG001|Overall Study|Adverse Event|36|||
27760453|NCT00642018|80946924|FG000|Overall Study|Withdrawal by Subject|4|||
27760454|NCT00642018|80946925|FG001|Overall Study|Withdrawal by Subject|10|||
27760455|NCT00642018|80946924|FG000|Overall Study|Progressive Disease|13|||
27760456|NCT00642018|80946925|FG001|Overall Study|Progressive Disease|18|||
27760457|NCT00642018|80946924|FG000|Overall Study|Physician Decision|0|||
27760458|NCT00642018|80946925|FG001|Overall Study|Physician Decision|10|||
27760459|NCT00642018|80946924|FG000|Overall Study|Protocol Violation|0|||
27760460|NCT00642018|80946925|FG001|Overall Study|Protocol Violation|1|||
27760461|NCT00642018|80946924|FG000|Overall Study|Death|0|||
27760462|NCT00642018|80946925|FG001|Overall Study|Death|3|||
27760463|NCT00642018|80946924|FG000|Overall Study|Entry Criteria Not Met|0|||
27760464|NCT00642018|80946925|FG001|Overall Study|Entry Criteria Not Met|1|||
27760465|NCT00433446|80946929|FG000|Overall Study|Adverse Event|4|||
27760466|NCT00433446|80946929|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
27760467|NCT00433446|80946929|FG000|Overall Study|Progression|44|||
27760468|NCT00433446|80946929|FG000|Overall Study|Other - Not Protocol specified|3|||
27760469|NCT00433446|80946929|FG000|Overall Study|Ineligible|9|||
27760470|NCT02887859|80946931|FG000|Overall Study|Ongoing|6|||
27760471|NCT02887859|80946931|FG000|Overall Study|Adverse Event|7|||
27760472|NCT02887859|80946931|FG000|Overall Study|Death|1|||
27760473|NCT02887859|80946931|FG000|Overall Study|Physician Decision|1|||
27760474|NCT03172481|80946932|FG000|Double-blind|Withdrawal by Subject|1|||
27760475|NCT03172481|80946933|FG001|Double-blind|Withdrawal by Subject|0|||
27760476|NCT02680587|80946934|FG000|Overall Study|Withdrawal by Subject|1|||
27859497|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859498|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859499|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859500|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859501|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859502|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859503|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859504|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859505|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859506|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859507|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
27859508|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859509|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
27859510|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
27859511|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859512|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
27859513|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
27859514|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Death|0|||
27859515|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Death|0|||
27859516|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Death|0|||
27859517|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Death|0|||
27859518|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Death|0|||
27859519|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Death|0|||
27859520|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Death|0|||
27859521|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Death|0|||
27859522|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Death|0|||
27859523|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Death|0|||
27859524|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Death|0|||
27859525|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Death|0|||
27859526|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Death|0|||
27859527|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Death|0|||
27859528|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Death|0|||
27859529|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Death|1|||
27859530|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Death|7|||
27760477|NCT02680587|80946935|FG001|Overall Study|Withdrawal by Subject|0|||
27760478|NCT00565058|80946936|FG000|Overall Study|Adverse Event|1|||
27760479|NCT00565058|80946937|FG001|Overall Study|Adverse Event|0|||
27760480|NCT01088438|80946938|FG000|Overall Study|Withdrawal by Subject|11|||
27760481|NCT01088438|80946939|FG001|Overall Study|Withdrawal by Subject|6|||
27760482|NCT01088438|80946938|FG000|Overall Study|Lost to Follow-up|18|||
27760483|NCT01088438|80946939|FG001|Overall Study|Lost to Follow-up|30|||
27760484|NCT01578785|80946940|FG000|Overall Study|Withdrawal by Subject|0|||
27760485|NCT01578785|80946941|FG001|Overall Study|Withdrawal by Subject|1|||
27760486|NCT01578785|80946940|FG000|Overall Study|Study terminated by sponsor|59|||
27760487|NCT01578785|80946941|FG001|Overall Study|Study terminated by sponsor|118|||
27760488|NCT01026389|80946942|FG000|Overall Study|Withdrawal by Subject|1|||
27760489|NCT01026389|80946943|FG001|Overall Study|Withdrawal by Subject|3|||
27760490|NCT01026389|80946942|FG000|Overall Study|change of treatment, patient moved|4|||
27760491|NCT01026389|80946943|FG001|Overall Study|change of treatment, patient moved|2|||
27760492|NCT04511819|80946944|FG000|Overall Study|Non-compliance with study drug|5|||
27760493|NCT04511819|80946945|FG001|Overall Study|Non-compliance with study drug|1|||
27760494|NCT04511819|80946944|FG000|Overall Study|Withdrawal by Subject|0|||
27859531|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Death|5|||
27859532|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Death|5|||
27859533|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Death|3|||
27859534|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Death|7|||
27859535|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Death|5|||
27859536|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Death|6|||
27760495|NCT04511819|80946945|FG001|Overall Study|Withdrawal by Subject|3|||
27760496|NCT04511819|80946944|FG000|Overall Study|Adverse Event|0|||
27760497|NCT04511819|80946945|FG001|Overall Study|Adverse Event|1|||
27760498|NCT04511819|80946944|FG000|Overall Study|Protocol deviation|1|||
27760499|NCT04511819|80946945|FG001|Overall Study|Protocol deviation|0|||
27760500|NCT00194025|80946946|FG000|Overall Study|Adverse Event|1|||
27760501|NCT00194025|80946946|FG000|Overall Study|non-adherence with study medication|4|||
27760502|NCT01464788|80946947|FG000|Overall Study|Lost to Follow-up|0|||
27760503|NCT01464788|80946948|FG001|Overall Study|Lost to Follow-up|1|||
27760504|NCT01464788|80946949|FG002|Overall Study|Lost to Follow-up|0|||
27760505|NCT01464788|80946947|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
27859537|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Death|3|||
27859538|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Death|0|||
27859539|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859540|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859541|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859542|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859543|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859544|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859545|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859546|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859547|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859548|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859549|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859550|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859551|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859552|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859553|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859554|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859555|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859556|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27859557|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27859558|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
27859559|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27859560|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27859561|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27760506|NCT01464788|80946948|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
27760507|NCT01464788|80946949|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
27760508|NCT05425719|80946950|FG000|Overall Study|Lost to Follow-up|4|||
27760509|NCT05425719|80946951|FG001|Overall Study|Lost to Follow-up|0|||
27760510|NCT05425719|80946950|FG000|Overall Study|Withdrew consent|1|||
27760511|NCT05425719|80946951|FG001|Overall Study|Withdrew consent|1|||
27760512|NCT01586806|80946958|FG000|Overall Study|Protocol Violation|0|||
27760513|NCT01586806|80946959|FG001|Overall Study|Protocol Violation|1|||
27760514|NCT01586806|80946960|FG002|Overall Study|Protocol Violation|0|||
27760515|NCT01586806|80946958|FG000|Overall Study|Withdrawal by Subject|1|||
27760516|NCT01586806|80946959|FG001|Overall Study|Withdrawal by Subject|0|||
27760517|NCT01586806|80946960|FG002|Overall Study|Withdrawal by Subject|0|||
27760518|NCT01586806|80946958|FG000|Overall Study|Lost to Follow-up|2|||
27760519|NCT01586806|80946959|FG001|Overall Study|Lost to Follow-up|3|||
27760520|NCT01586806|80946960|FG002|Overall Study|Lost to Follow-up|2|||
27760521|NCT00131664|80946961|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
27760522|NCT00131664|80946962|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
27760523|NCT00131664|80946963|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
27760524|NCT00131664|80946964|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
27760525|NCT00131664|80946965|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
27760526|NCT00131664|80946966|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
27760527|NCT00131664|80946961|FG000|First Period (First 6 Months)|Death|0|||
27760528|NCT00131664|80946962|FG001|First Period (First 6 Months)|Death|1|||
27760529|NCT00131664|80946963|FG002|First Period (First 6 Months)|Death|0|||
27760530|NCT00131664|80946964|FG003|First Period (First 6 Months)|Death|0|||
27760531|NCT00131664|80946965|FG004|First Period (First 6 Months)|Death|0|||
27760532|NCT00131664|80946966|FG005|First Period (First 6 Months)|Death|0|||
27760533|NCT00131664|80946961|FG000|First Period (First 6 Months)|Protocol Violation|2|||
27760534|NCT00131664|80946962|FG001|First Period (First 6 Months)|Protocol Violation|2|||
27760535|NCT00131664|80946963|FG002|First Period (First 6 Months)|Protocol Violation|1|||
27760536|NCT00131664|80946964|FG003|First Period (First 6 Months)|Protocol Violation|0|||
27760537|NCT00131664|80946965|FG004|First Period (First 6 Months)|Protocol Violation|0|||
27760538|NCT00131664|80946966|FG005|First Period (First 6 Months)|Protocol Violation|0|||
27760539|NCT00131664|80946961|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
27760540|NCT00131664|80946962|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
27760541|NCT00131664|80946963|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
27760542|NCT00131664|80946964|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
27760543|NCT00131664|80946965|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
27760544|NCT00131664|80946966|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
27760545|NCT00131664|80946961|FG000|First Period (First 6 Months)|Adverse Event|9|||
27760546|NCT00131664|80946962|FG001|First Period (First 6 Months)|Adverse Event|4|||
27760547|NCT00131664|80946963|FG002|First Period (First 6 Months)|Adverse Event|5|||
27760548|NCT00131664|80946964|FG003|First Period (First 6 Months)|Adverse Event|0|||
27760549|NCT00131664|80946965|FG004|First Period (First 6 Months)|Adverse Event|0|||
27760550|NCT00131664|80946966|FG005|First Period (First 6 Months)|Adverse Event|0|||
27760551|NCT00131664|80946961|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
27760552|NCT00131664|80946962|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
27760553|NCT00131664|80946963|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
27760554|NCT00131664|80946964|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
27760555|NCT00131664|80946965|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
27760556|NCT00131664|80946966|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
27760557|NCT00131664|80946961|FG000|First Period (First 6 Months)|Administrative reasons|2|||
27760558|NCT00131664|80946962|FG001|First Period (First 6 Months)|Administrative reasons|0|||
27760559|NCT00131664|80946963|FG002|First Period (First 6 Months)|Administrative reasons|5|||
27760560|NCT00131664|80946964|FG003|First Period (First 6 Months)|Administrative reasons|0|||
27760561|NCT00131664|80946965|FG004|First Period (First 6 Months)|Administrative reasons|0|||
27760562|NCT00131664|80946966|FG005|First Period (First 6 Months)|Administrative reasons|0|||
27760563|NCT00131664|80946961|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
27760564|NCT00131664|80946962|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
27760565|NCT00131664|80946963|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
27760566|NCT00131664|80946964|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
27760567|NCT00131664|80946965|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
27760568|NCT00131664|80946966|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
27760569|NCT00131664|80946961|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
27760570|NCT00131664|80946962|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
27760571|NCT00131664|80946963|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
27760572|NCT00131664|80946964|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
27760573|NCT00131664|80946965|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
27760574|NCT00131664|80946966|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
27760575|NCT00131664|80946961|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
27760576|NCT00131664|80946962|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
27760577|NCT00131664|80946963|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
27760578|NCT00131664|80946964|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
27760579|NCT00131664|80946965|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
27760580|NCT00131664|80946966|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
27760581|NCT00131664|80946961|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
27760582|NCT00131664|80946962|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
27760583|NCT00131664|80946963|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
27760584|NCT00131664|80946964|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
27760585|NCT00131664|80946965|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
27760586|NCT00131664|80946966|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
27760587|NCT00131664|80946961|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
27760588|NCT00131664|80946962|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
27760589|NCT00131664|80946963|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
27760590|NCT00131664|80946964|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
27760591|NCT00131664|80946965|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
27760592|NCT00131664|80946966|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
27760593|NCT00131664|80946961|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
27760594|NCT00131664|80946962|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
27760595|NCT00131664|80946963|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
27760596|NCT00131664|80946964|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
27760597|NCT00131664|80946965|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
27760598|NCT00131664|80946966|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
27760599|NCT00506948|80946977|FG000|Overall Study|Death|4|||
27760600|NCT00506948|80946977|FG000|Overall Study|Adverse Event|5|||
27760601|NCT00506948|80946977|FG000|Overall Study|Physician Decision|1|||
27760602|NCT01381718|80950559|FG000|Overall Study|Withdrawal by Subject|2|||
27760603|NCT01381718|80950560|FG001|Overall Study|Withdrawal by Subject|5|||
27760604|NCT01381718|80950559|FG000|Overall Study|Lost to Follow-up|3|||
27760605|NCT01381718|80950560|FG001|Overall Study|Lost to Follow-up|5|||
27760606|NCT01381718|80950559|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
27760607|NCT01381718|80950560|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
27760608|NCT00318565|80950561|FG000|Overall Study|Excluded per protocol|24|||
27760609|NCT02919683|80950563|FG000|Post-Surgery Follow-Up|Death|2|||
27760610|NCT02919683|80950564|FG001|Post-Surgery Follow-Up|Death|2|||
27760611|NCT02919683|80950563|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
27760612|NCT02919683|80950564|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
27760613|NCT04126031|80950566|FG000|Part A|Withdrawal by Subject|0|||
27760614|NCT04126031|80950567|FG001|Part A|Withdrawal by Subject|0|||
27760615|NCT04126031|80950568|FG002|Part A|Withdrawal by Subject|1|||
27760616|NCT04126031|80950569|FG003|Part A|Withdrawal by Subject|0|||
27760617|NCT04126031|80950570|FG004|Part A|Withdrawal by Subject|0|||
27760618|NCT04126031|80950571|FG005|Part A|Withdrawal by Subject|0|||
27760619|NCT04126031|80950566|FG000|Part A|Other|1|||
27760620|NCT04126031|80950567|FG001|Part A|Other|0|||
27656785|NCT01072149|80583247|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
27656786|NCT01072149|80583248|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
27656787|NCT01072149|80583249|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
27656788|NCT01072149|80583250|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
27656789|NCT01072149|80583251|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
27656790|NCT01072149|80583252|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
27656791|NCT01072149|80583253|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
27656792|NCT01072149|80583236|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656793|NCT01072149|80583237|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656794|NCT01072149|80583238|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656795|NCT01072149|80583239|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656796|NCT01072149|80583240|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656797|NCT01072149|80583241|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656798|NCT01072149|80583242|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656799|NCT01072149|80583243|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656800|NCT01072149|80583244|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656801|NCT01072149|80583245|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656802|NCT01072149|80583246|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656803|NCT01072149|80583247|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656804|NCT01072149|80583248|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656805|NCT01072149|80583249|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656806|NCT01072149|80583250|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656807|NCT01072149|80583251|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
27656808|NCT01072149|80583252|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656809|NCT01072149|80583253|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
27656810|NCT01072149|80583236|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
27656811|NCT01072149|80583237|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
27656812|NCT01072149|80583238|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
27656813|NCT01072149|80583239|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
27656814|NCT01072149|80583240|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
27656815|NCT01072149|80583241|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
27656816|NCT01072149|80583242|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
27656817|NCT01072149|80583243|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
27656818|NCT01072149|80583244|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
27656819|NCT01072149|80583245|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
27656820|NCT01072149|80583246|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
27656821|NCT01072149|80583247|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
27656822|NCT01072149|80583248|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
27656823|NCT01072149|80583249|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
27656824|NCT01072149|80583250|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
27656825|NCT01072149|80583251|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
27656826|NCT01072149|80583252|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
27656827|NCT01072149|80583253|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
27656828|NCT01072149|80583236|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656829|NCT01072149|80583237|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656830|NCT01072149|80583238|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656831|NCT01072149|80583239|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656832|NCT01072149|80583240|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656833|NCT01072149|80583241|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656834|NCT01072149|80583242|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656835|NCT01072149|80583243|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656836|NCT01072149|80583244|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27760621|NCT04126031|80950568|FG002|Part A|Other|0|||
27656837|NCT01072149|80583245|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656838|NCT01072149|80583246|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656839|NCT01072149|80583247|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656840|NCT01072149|80583248|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
27656841|NCT01072149|80583249|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656842|NCT01072149|80583250|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656843|NCT01072149|80583251|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27760622|NCT04126031|80950569|FG003|Part A|Other|0|||
27760623|NCT04126031|80950570|FG004|Part A|Other|0|||
27760624|NCT04126031|80950571|FG005|Part A|Other|0|||
27760625|NCT04126031|80950566|FG000|Part B|Adverse Event|0|||
27760626|NCT04126031|80950567|FG001|Part B|Adverse Event|0|||
27760627|NCT04126031|80950568|FG002|Part B|Adverse Event|0|||
27760628|NCT04126031|80950569|FG003|Part B|Adverse Event|0|||
27760629|NCT04126031|80950570|FG004|Part B|Adverse Event|0|||
27760630|NCT04126031|80950571|FG005|Part B|Adverse Event|2|||
27760631|NCT04126031|80950566|FG000|Part B|Pre-existing hypertransaminasemia|0|||
27760632|NCT04126031|80950567|FG001|Part B|Pre-existing hypertransaminasemia|0|||
27760633|NCT04126031|80950568|FG002|Part B|Pre-existing hypertransaminasemia|0|||
27760634|NCT04126031|80950569|FG003|Part B|Pre-existing hypertransaminasemia|0|||
27760635|NCT04126031|80950570|FG004|Part B|Pre-existing hypertransaminasemia|1|||
27760636|NCT04126031|80950571|FG005|Part B|Pre-existing hypertransaminasemia|0|||
27760637|NCT00426556|80950574|FG000|Phase I - Core Phase|Disease Progression|0|||
27760638|NCT00426556|80950575|FG001|Phase I - Core Phase|Disease Progression|6|||
27760639|NCT00426556|80950576|FG002|Phase I - Core Phase|Disease Progression|2|||
27760640|NCT00426556|80950577|FG003|Phase I - Core Phase|Disease Progression|0|||
27760641|NCT00426556|80950574|FG000|Phase I - Core Phase|Adverse Event|1|||
27760642|NCT00426556|80950575|FG001|Phase I - Core Phase|Adverse Event|3|||
27760643|NCT00426556|80950576|FG002|Phase I - Core Phase|Adverse Event|1|||
27760644|NCT00426556|80950577|FG003|Phase I - Core Phase|Adverse Event|0|||
27760645|NCT00426556|80950574|FG000|Phase I - Core Phase|Death|0|||
27760646|NCT00426556|80950575|FG001|Phase I - Core Phase|Death|1|||
27760647|NCT00426556|80950576|FG002|Phase I - Core Phase|Death|0|||
27760648|NCT00426556|80950577|FG003|Phase I - Core Phase|Death|0|||
27760649|NCT00426556|80950574|FG000|Phase I - Extension Phase|Adverse Event|0|||
27760650|NCT00426556|80950575|FG001|Phase I - Extension Phase|Adverse Event|1|||
27760651|NCT00426556|80950576|FG002|Phase I - Extension Phase|Adverse Event|1|||
27760652|NCT00426556|80950577|FG003|Phase I - Extension Phase|Adverse Event|0|||
27760653|NCT00426556|80950574|FG000|Phase I - Extension Phase|Disease Progression|5|||
27760654|NCT00426556|80950575|FG001|Phase I - Extension Phase|Disease Progression|5|||
27760655|NCT00426556|80950576|FG002|Phase I - Extension Phase|Disease Progression|6|||
27760656|NCT00426556|80950577|FG003|Phase I - Extension Phase|Disease Progression|0|||
27760657|NCT00426556|80950574|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
27760658|NCT00426556|80950575|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
27859562|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
27760659|NCT00426556|80950576|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
27760660|NCT00426556|80950577|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
27760661|NCT00426556|80950574|FG000|Phase II - Core Phase|Disease Progression|0|||
27760662|NCT00426556|80950575|FG001|Phase II - Core Phase|Disease Progression|0|||
27760663|NCT00426556|80950576|FG002|Phase II - Core Phase|Disease Progression|0|||
27760664|NCT00426556|80950577|FG003|Phase II - Core Phase|Disease Progression|16|||
27760665|NCT00426556|80950574|FG000|Phase II - Core Phase|Adverse Event|0|||
27760666|NCT00426556|80950575|FG001|Phase II - Core Phase|Adverse Event|0|||
27760667|NCT00426556|80950576|FG002|Phase II - Core Phase|Adverse Event|0|||
27760668|NCT00426556|80950577|FG003|Phase II - Core Phase|Adverse Event|8|||
27760669|NCT00426556|80950574|FG000|Phase II - Extension Phase|Disease Progression|0|||
27760670|NCT00426556|80950575|FG001|Phase II - Extension Phase|Disease Progression|0|||
27760671|NCT00426556|80950576|FG002|Phase II - Extension Phase|Disease Progression|0|||
27760672|NCT00426556|80950577|FG003|Phase II - Extension Phase|Disease Progression|21|||
27760673|NCT00426556|80950574|FG000|Phase II - Extension Phase|Adverse Event|0|||
27760674|NCT00426556|80950575|FG001|Phase II - Extension Phase|Adverse Event|0|||
27760675|NCT00426556|80950576|FG002|Phase II - Extension Phase|Adverse Event|0|||
27760676|NCT00426556|80950577|FG003|Phase II - Extension Phase|Adverse Event|2|||
27760677|NCT00213980|80950579|FG000|Overall Study|Withdrawal by Subject|3|||
27760678|NCT00213980|80950580|FG001|Overall Study|Withdrawal by Subject|1|||
27760679|NCT00213980|80950579|FG000|Overall Study|Adverse Event|1|||
27760680|NCT00213980|80950580|FG001|Overall Study|Adverse Event|1|||
27760681|NCT00213980|80950579|FG000|Overall Study|Disease progression|0|||
27760682|NCT00213980|80950580|FG001|Overall Study|Disease progression|2|||
27760683|NCT00213980|80950579|FG000|Overall Study|Developed ovarian cancer|1|||
27760684|NCT00213980|80950580|FG001|Overall Study|Developed ovarian cancer|0|||
27760685|NCT00213980|80950579|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
27760686|NCT00213980|80950580|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
27760687|NCT03519516|80950581|FG000|Overall Study|Adverse Event|0|||
27760688|NCT03519516|80950582|FG001|Overall Study|Adverse Event|1|||
27760689|NCT01205451|80950585|FG000|Overall Study|Lost to Follow-up|1|||
27760690|NCT01205451|80950586|FG001|Overall Study|Lost to Follow-up|1|||
27760691|NCT01205451|80950585|FG000|Overall Study|Withdrawal by Subject|5|||
27760692|NCT01205451|80950586|FG001|Overall Study|Withdrawal by Subject|9|||
27760693|NCT01074658|80950590|FG000|Overall Study|No implant attempted|19|||
27760694|NCT00997321|80950591|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
27760695|NCT00997321|80950592|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
27760696|NCT00718666|80950599|FG000|Booster Phase Year 5|No active participation request|0|||
27760697|NCT00718666|80950600|FG001|Booster Phase Year 5|No active participation request|0|||
27760698|NCT00718666|80950601|FG002|Booster Phase Year 5|No active participation request|1|||
27760699|NCT00718666|80950599|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
27760700|NCT00718666|80950600|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
27760701|NCT00718666|80950601|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
27760702|NCT00718666|80950599|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
27760703|NCT00718666|80950600|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
27760704|NCT00718666|80950601|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
27760705|NCT00718666|80950599|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
27760706|NCT00718666|80950600|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
27760707|NCT00718666|80950601|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
27760708|NCT01529385|80950611|FG000|Overall Study|Lost to Follow-up|2|||
27760709|NCT01529385|80950612|FG001|Overall Study|Lost to Follow-up|1|||
27760710|NCT01195831|80950613|FG000|Overall Study|Lost to Follow-up|2|||
27760711|NCT01195831|80950614|FG001|Overall Study|Lost to Follow-up|4|||
27760712|NCT01195831|80950613|FG000|Overall Study|Withdrawal by Subject|2|||
27760713|NCT01195831|80950614|FG001|Overall Study|Withdrawal by Subject|2|||
27760714|NCT01195831|80950613|FG000|Overall Study|Adverse Event|4|||
27760715|NCT01195831|80950614|FG001|Overall Study|Adverse Event|2|||
27760716|NCT01195831|80950613|FG000|Overall Study|Protocol Violation|0|||
27760717|NCT01195831|80950614|FG001|Overall Study|Protocol Violation|2|||
27760718|NCT00405821|80950619|FG000|Overall Study|Death|5|||
27760719|NCT00405821|80950620|FG001|Overall Study|Death|7|||
27760720|NCT00405821|80950619|FG000|Overall Study|Lost to Follow-up|7|||
27760721|NCT00405821|80950620|FG001|Overall Study|Lost to Follow-up|7|||
27760722|NCT00405821|80950619|FG000|Overall Study|Protocol Violation|1|||
27760723|NCT00405821|80950620|FG001|Overall Study|Protocol Violation|0|||
27760724|NCT00405821|80950619|FG000|Overall Study|initiated ART|9|||
27760725|NCT00405821|80950620|FG001|Overall Study|initiated ART|8|||
27760726|NCT00779324|80950621|FG000|Overall Study|Lost to Follow-up|2|||
27760727|NCT00779324|80950622|FG001|Overall Study|Lost to Follow-up|1|||
27760728|NCT00779324|80950621|FG000|Overall Study|Withdrawal by Subject|4|||
27760729|NCT00779324|80950622|FG001|Overall Study|Withdrawal by Subject|2|||
27760730|NCT00779324|80950621|FG000|Overall Study|Missed visit|1|||
27760731|NCT00779324|80950622|FG001|Overall Study|Missed visit|1|||
27760732|NCT01217190|80950626|FG000|Second Dosing|Withdrawal by Subject|0|||
27760733|NCT01217190|80950627|FG001|Second Dosing|Withdrawal by Subject|2|||
27760734|NCT00995670|80950628|FG000|Overall Study|Failed arterial cannulation|1|||
27760735|NCT00995670|80950629|FG001|Overall Study|Failed arterial cannulation|0|||
27760736|NCT00995670|80950630|FG002|Overall Study|Failed arterial cannulation|3|||
27760737|NCT01654523|80950633|FG000|Overall Study|Withdrawal by Subject|1|||
27760738|NCT03446651|80950634|FG000|Overall Study|Lost to Follow-up|4|||
27760739|NCT03446651|80950635|FG001|Overall Study|Lost to Follow-up|0|||
27760740|NCT03446651|80950634|FG000|Overall Study|Open Label Participants|5|||
27760741|NCT03446651|80950635|FG001|Overall Study|Open Label Participants|0|||
27760742|NCT01409993|80950636|FG000|Overall Study|Adverse Event|4|||
27760743|NCT01409993|80950637|FG001|Overall Study|Adverse Event|4|||
27760744|NCT01409993|80950638|FG002|Overall Study|Adverse Event|3|||
27760745|NCT01409993|80950639|FG003|Overall Study|Adverse Event|1|||
27760746|NCT01409993|80950636|FG000|Overall Study|Withdrawal by Subject|0|||
27760747|NCT01409993|80950637|FG001|Overall Study|Withdrawal by Subject|0|||
27760748|NCT01409993|80950638|FG002|Overall Study|Withdrawal by Subject|0|||
27760749|NCT01409993|80950639|FG003|Overall Study|Withdrawal by Subject|4|||
27760750|NCT01409993|80950636|FG000|Overall Study|Lost to Follow-up|0|||
27760751|NCT01409993|80950637|FG001|Overall Study|Lost to Follow-up|1|||
27760752|NCT01409993|80950638|FG002|Overall Study|Lost to Follow-up|0|||
27760753|NCT01409993|80950639|FG003|Overall Study|Lost to Follow-up|0|||
27760754|NCT00699842|80950641|FG000|Overall Study|Death|0|||
27760755|NCT00699842|80950642|FG001|Overall Study|Death|1|||
27760756|NCT00699842|80950643|FG002|Overall Study|Death|0|||
27760757|NCT00369967|80950646|FG000|Overall Study|Lost to Follow-up|23|||
27760758|NCT00369967|80950647|FG001|Overall Study|Lost to Follow-up|12|||
27760759|NCT00363051|80950648|FG000|Overall Study|Adminstrative problems|1|||
27760760|NCT00363051|80950649|FG001|Overall Study|Adminstrative problems|1|||
27760761|NCT00363051|80950648|FG000|Overall Study|Adverse Event|21|||
27760762|NCT00363051|80950649|FG001|Overall Study|Adverse Event|12|||
27760763|NCT00363051|80950648|FG000|Overall Study|New Cancer Therapy|2|||
27760764|NCT00363051|80950649|FG001|Overall Study|New Cancer Therapy|1|||
27760765|NCT00363051|80950648|FG000|Overall Study|Withdrawal by Subject|11|||
27760766|NCT00363051|80950649|FG001|Overall Study|Withdrawal by Subject|3|||
27760767|NCT00363051|80950648|FG000|Overall Study|Lost to Follow-up|0|||
27760768|NCT00363051|80950649|FG001|Overall Study|Lost to Follow-up|1|||
27760769|NCT00363051|80950648|FG000|Overall Study|Protocol Violation|0|||
27760770|NCT00363051|80950649|FG001|Overall Study|Protocol Violation|2|||
27760771|NCT00363051|80950648|FG000|Overall Study|Death|3|||
27760772|NCT00363051|80950649|FG001|Overall Study|Death|2|||
27760773|NCT00502320|80950650|FG000|Overall Study|Lost to Follow-up|1|||
27760774|NCT00502320|80950651|FG001|Overall Study|Lost to Follow-up|1|||
27760775|NCT00502320|80950650|FG000|Overall Study|Withdrew Consent|1|||
27760776|NCT00502320|80950651|FG001|Overall Study|Withdrew Consent|0|||
27760777|NCT00502320|80950650|FG000|Overall Study|No longer met criteria|1|||
27760778|NCT00502320|80950651|FG001|Overall Study|No longer met criteria|0|||
27760779|NCT00502320|80950650|FG000|Overall Study|Screen Failure|0|||
27760780|NCT00502320|80950651|FG001|Overall Study|Screen Failure|1|||
27760781|NCT00502320|80950650|FG000|Overall Study|Adverse Event|3|||
27760782|NCT00502320|80950651|FG001|Overall Study|Adverse Event|5|||
27760783|NCT05101486|80950654|FG000|Overall Study|Death|1|||
27760784|NCT05101486|80950655|FG001|Overall Study|Death|0|||
27760785|NCT05101486|80950656|FG002|Overall Study|Death|1|||
27760786|NCT05101486|80950654|FG000|Overall Study|Lost to Follow-up|12|||
27760787|NCT05101486|80950655|FG001|Overall Study|Lost to Follow-up|8|||
27760788|NCT05101486|80950656|FG002|Overall Study|Lost to Follow-up|17|||
27760789|NCT05101486|80950654|FG000|Overall Study|Physician Decision|1|||
27760790|NCT05101486|80950655|FG001|Overall Study|Physician Decision|0|||
27760791|NCT05101486|80950656|FG002|Overall Study|Physician Decision|0|||
27760792|NCT05101486|80950654|FG000|Overall Study|Protocol Violation|0|||
27760793|NCT05101486|80950655|FG001|Overall Study|Protocol Violation|0|||
27760794|NCT05101486|80950656|FG002|Overall Study|Protocol Violation|1|||
27760795|NCT05101486|80950654|FG000|Overall Study|Withdrawal by Subject|5|||
27760796|NCT05101486|80950655|FG001|Overall Study|Withdrawal by Subject|2|||
27760797|NCT05101486|80950656|FG002|Overall Study|Withdrawal by Subject|4|||
27760798|NCT05101486|80950654|FG000|Overall Study|Randomized but not vaccinated|1|||
27760799|NCT05101486|80950655|FG001|Overall Study|Randomized but not vaccinated|1|||
27760800|NCT05101486|80950656|FG002|Overall Study|Randomized but not vaccinated|1|||
27760801|NCT00098020|80950657|FG000|Overall Study|Adverse Event|2|||
27760802|NCT00098020|80950657|FG000|Overall Study|Lost to Follow-up|1|||
27760803|NCT00098020|80950657|FG000|Overall Study|elevated liver enzymes|1|||
27760804|NCT00098020|80950657|FG000|Overall Study|Low urine PCR|1|||
27760805|NCT00098020|80950657|FG000|Overall Study|Low epidermal growth factor receptor|1|||
27760806|NCT01164865|80950660|FG000|Overall Study|Lost to Follow-up|2|||
27760807|NCT01164865|80950661|FG001|Overall Study|Lost to Follow-up|1|||
27760808|NCT00839423|80950662|FG000|Overall Study|Adverse Event|4|||
27760809|NCT00839423|80950663|FG001|Overall Study|Adverse Event|3|||
27760810|NCT00839423|80950664|FG002|Overall Study|Adverse Event|7|||
27760811|NCT00839423|80950665|FG003|Overall Study|Adverse Event|16|||
27760812|NCT00839423|80950662|FG000|Overall Study|Lack of Efficacy|6|||
27760813|NCT00839423|80950663|FG001|Overall Study|Lack of Efficacy|6|||
27760814|NCT00839423|80950664|FG002|Overall Study|Lack of Efficacy|3|||
27760815|NCT00839423|80950665|FG003|Overall Study|Lack of Efficacy|2|||
27760816|NCT00839423|80950662|FG000|Overall Study|Non-compliance|0|||
27760817|NCT00839423|80950663|FG001|Overall Study|Non-compliance|0|||
27760818|NCT00839423|80950664|FG002|Overall Study|Non-compliance|0|||
27760819|NCT00839423|80950665|FG003|Overall Study|Non-compliance|1|||
27760820|NCT00839423|80950662|FG000|Overall Study|Protocol Violation|0|||
27760821|NCT00839423|80950663|FG001|Overall Study|Protocol Violation|1|||
27760822|NCT00839423|80950664|FG002|Overall Study|Protocol Violation|2|||
27760823|NCT00839423|80950665|FG003|Overall Study|Protocol Violation|0|||
27760824|NCT00839423|80950662|FG000|Overall Study|Withdrawal of consent|4|||
27760825|NCT00839423|80950663|FG001|Overall Study|Withdrawal of consent|0|||
27760826|NCT00839423|80950664|FG002|Overall Study|Withdrawal of consent|4|||
27760827|NCT00839423|80950665|FG003|Overall Study|Withdrawal of consent|1|||
27760828|NCT00839423|80950662|FG000|Overall Study|Lost to Follow-up|1|||
27760829|NCT00839423|80950663|FG001|Overall Study|Lost to Follow-up|0|||
27760830|NCT00839423|80950664|FG002|Overall Study|Lost to Follow-up|1|||
27760831|NCT00839423|80950665|FG003|Overall Study|Lost to Follow-up|0|||
27760832|NCT00839423|80950662|FG000|Overall Study|Administrative or other reasons|3|||
27760833|NCT00839423|80950663|FG001|Overall Study|Administrative or other reasons|0|||
27760834|NCT00839423|80950664|FG002|Overall Study|Administrative or other reasons|1|||
27859563|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
27859564|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Disease Progression|0|||
27859565|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Disease Progression|0|||
27859566|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Disease Progression|0|||
27859567|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Disease Progression|0|||
27859568|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Disease Progression|0|||
27859569|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Disease Progression|0|||
27859570|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Disease Progression|0|||
27859571|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Disease Progression|0|||
27859572|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Disease Progression|0|||
27859573|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Disease Progression|0|||
27859574|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Disease Progression|0|||
27859575|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Disease Progression|0|||
27859576|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Disease Progression|0|||
27859577|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Disease Progression|0|||
27760835|NCT00839423|80950665|FG003|Overall Study|Administrative or other reasons|0|||
27760836|NCT03954444|80950667|FG000|Overall Study|Withdrawal by Subject|5|||
27760837|NCT03954444|80950668|FG001|Overall Study|Withdrawal by Subject|5|||
27760838|NCT03954444|80950669|FG002|Overall Study|Withdrawal by Subject|5|||
27760839|NCT03954444|80950667|FG000|Overall Study|Adverse Event|1|||
27760840|NCT03954444|80950668|FG001|Overall Study|Adverse Event|3|||
27859578|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Disease Progression|0|||
27760841|NCT03954444|80950669|FG002|Overall Study|Adverse Event|2|||
27760842|NCT03954444|80950667|FG000|Overall Study|Protocol Violation|0|||
27760843|NCT03954444|80950668|FG001|Overall Study|Protocol Violation|3|||
27760844|NCT03954444|80950669|FG002|Overall Study|Protocol Violation|5|||
27760845|NCT03954444|80950667|FG000|Overall Study|Use of prohibited therapy|1|||
27760846|NCT03954444|80950668|FG001|Overall Study|Use of prohibited therapy|1|||
27760847|NCT03954444|80950669|FG002|Overall Study|Use of prohibited therapy|2|||
27760848|NCT03954444|80950667|FG000|Overall Study|Lost to Follow-up|1|||
27760849|NCT03954444|80950668|FG001|Overall Study|Lost to Follow-up|0|||
27760850|NCT03954444|80950669|FG002|Overall Study|Lost to Follow-up|1|||
27760851|NCT03954444|80950667|FG000|Overall Study|Non-compliant with study drug application|2|||
27760852|NCT03954444|80950668|FG001|Overall Study|Non-compliant with study drug application|2|||
27760853|NCT03954444|80950669|FG002|Overall Study|Non-compliant with study drug application|0|||
27760854|NCT03954444|80950667|FG000|Overall Study|Administrative reasons|0|||
27760855|NCT03954444|80950668|FG001|Overall Study|Administrative reasons|0|||
27760856|NCT03954444|80950669|FG002|Overall Study|Administrative reasons|1|||
27760857|NCT03954444|80950667|FG000|Overall Study|Miscellaneous|3|||
27760858|NCT03954444|80950668|FG001|Overall Study|Miscellaneous|2|||
27760859|NCT03954444|80950669|FG002|Overall Study|Miscellaneous|1|||
27760860|NCT01318512|80950673|FG000|Maintenance Period (6 Months)|Death|2|||
27760861|NCT01318512|80950673|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
27760862|NCT03987919|80950674|FG000|Overall Study|Adverse Event|1|||
27760863|NCT03987919|80950675|FG001|Overall Study|Adverse Event|4|||
27760864|NCT03987919|80950676|FG002|Overall Study|Adverse Event|1|||
27760865|NCT03987919|80950677|FG003|Overall Study|Adverse Event|3|||
27760866|NCT03987919|80950674|FG000|Overall Study|Death|4|||
27859579|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Disease Progression|0|||
27859580|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Disease Progression|0|||
27859581|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Disease Progression|0|||
27859582|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Disease Progression|0|||
27760867|NCT03987919|80950675|FG001|Overall Study|Death|4|||
27760868|NCT03987919|80950676|FG002|Overall Study|Death|4|||
27760869|NCT03987919|80950677|FG003|Overall Study|Death|1|||
27760870|NCT03987919|80950674|FG000|Overall Study|Lost to Follow-up|5|||
27760871|NCT03987919|80950675|FG001|Overall Study|Lost to Follow-up|6|||
27760872|NCT03987919|80950676|FG002|Overall Study|Lost to Follow-up|8|||
27760873|NCT03987919|80950677|FG003|Overall Study|Lost to Follow-up|12|||
27760874|NCT03987919|80950674|FG000|Overall Study|Physician Decision|0|||
27760875|NCT03987919|80950675|FG001|Overall Study|Physician Decision|2|||
27760876|NCT03987919|80950676|FG002|Overall Study|Physician Decision|0|||
27760877|NCT03987919|80950677|FG003|Overall Study|Physician Decision|4|||
27760878|NCT03987919|80950674|FG000|Overall Study|Pregnancy|1|||
27760879|NCT03987919|80950675|FG001|Overall Study|Pregnancy|0|||
27760880|NCT03987919|80950676|FG002|Overall Study|Pregnancy|1|||
27760881|NCT03987919|80950677|FG003|Overall Study|Pregnancy|1|||
27760882|NCT03987919|80950674|FG000|Overall Study|Protocol Violation|0|||
27760883|NCT03987919|80950675|FG001|Overall Study|Protocol Violation|1|||
27760884|NCT03987919|80950676|FG002|Overall Study|Protocol Violation|0|||
27760885|NCT03987919|80950677|FG003|Overall Study|Protocol Violation|0|||
27760886|NCT03987919|80950674|FG000|Overall Study|Site terminated by Sponsor|0|||
27760887|NCT03987919|80950675|FG001|Overall Study|Site terminated by Sponsor|0|||
27760888|NCT03987919|80950676|FG002|Overall Study|Site terminated by Sponsor|0|||
27859583|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Disease Progression|0|||
27859584|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Disease Progression|2|||
27859585|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Disease Progression|1|||
27859586|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Disease Progression|0|||
27859587|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Disease Progression|0|||
27859588|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Disease Progression|0|||
27859589|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859590|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859591|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859592|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859593|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859594|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
27760889|NCT03987919|80950677|FG003|Overall Study|Site terminated by Sponsor|1|||
27760890|NCT03987919|80950674|FG000|Overall Study|Withdrawal by Subject|7|||
27859595|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
27760891|NCT03987919|80950675|FG001|Overall Study|Withdrawal by Subject|7|||
27760892|NCT03987919|80950676|FG002|Overall Study|Withdrawal by Subject|8|||
27760893|NCT03987919|80950677|FG003|Overall Study|Withdrawal by Subject|4|||
27760894|NCT03987919|80950674|FG000|Overall Study|Other - as reported by the investigator|1|||
27760895|NCT03987919|80950675|FG001|Overall Study|Other - as reported by the investigator|3|||
27760896|NCT03987919|80950676|FG002|Overall Study|Other - as reported by the investigator|2|||
27760897|NCT03987919|80950677|FG003|Overall Study|Other - as reported by the investigator|0|||
27760898|NCT02721251|80950678|FG000|Overall Study|Withdrawal by Subject|8|||
27760899|NCT02721251|80950679|FG001|Overall Study|Withdrawal by Subject|7|||
27859596|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859597|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859598|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859599|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859600|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859601|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859602|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859603|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859604|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859605|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859606|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859607|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859608|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859609|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
27859610|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
27859611|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859612|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859613|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
27859614|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859615|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859616|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859617|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859618|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859619|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859620|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859621|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859622|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859623|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859624|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859625|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859626|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859627|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859628|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859629|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859630|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859631|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859632|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859633|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859634|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
27859635|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27760900|NCT02721251|80950680|FG002|Overall Study|Withdrawal by Subject|9|||
27760901|NCT02721251|80950678|FG000|Overall Study|poor adherence|2|||
27760902|NCT02721251|80950679|FG001|Overall Study|poor adherence|2|||
27760903|NCT02721251|80950680|FG002|Overall Study|poor adherence|2|||
27760904|NCT00593840|80950681|FG000|Overall Study|Withdrawal by Subject|1|||
27760905|NCT00844285|80950682|FG000|Overall Study|Other|0|||
27760906|NCT00844285|80950683|FG001|Overall Study|Other|1|||
27760907|NCT00844285|80950684|FG002|Overall Study|Other|0|||
27760908|NCT00844285|80950682|FG000|Overall Study|Other than specified|95|||
27760909|NCT00844285|80950683|FG001|Overall Study|Other than specified|129|||
27760910|NCT00844285|80950684|FG002|Overall Study|Other than specified|12|||
27760911|NCT00844285|80950682|FG000|Overall Study|Site closure|256|||
27760912|NCT00844285|80950683|FG001|Overall Study|Site closure|450|||
27760913|NCT00844285|80950684|FG002|Overall Study|Site closure|50|||
27760914|NCT00844285|80950682|FG000|Overall Study|Follow-up < 8 years|16|||
27760915|NCT00844285|80950683|FG001|Overall Study|Follow-up < 8 years|23|||
27760916|NCT00844285|80950684|FG002|Overall Study|Follow-up < 8 years|4|||
27760917|NCT00844285|80950682|FG000|Overall Study|Protocol Violation|26|||
27760918|NCT00844285|80950683|FG001|Overall Study|Protocol Violation|28|||
27760919|NCT00844285|80950684|FG002|Overall Study|Protocol Violation|54|||
27760920|NCT00844285|80950682|FG000|Overall Study|Death|22|||
27760921|NCT00844285|80950683|FG001|Overall Study|Death|21|||
27760922|NCT00844285|80950684|FG002|Overall Study|Death|8|||
27760923|NCT00844285|80950682|FG000|Overall Study|Withdrew Consent|344|||
27859636|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859637|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859638|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
27859639|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Adverse Event|0|||
27859640|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Adverse Event|0|||
27859641|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Adverse Event|0|||
27760924|NCT00844285|80950683|FG001|Overall Study|Withdrew Consent|466|||
27760925|NCT00844285|80950684|FG002|Overall Study|Withdrew Consent|70|||
27760926|NCT00844285|80950682|FG000|Overall Study|Lost to Follow-up|330|||
27760927|NCT00844285|80950683|FG001|Overall Study|Lost to Follow-up|486|||
27760928|NCT00844285|80950684|FG002|Overall Study|Lost to Follow-up|74|||
27760929|NCT00729326|80950687|FG000|Overall Study|Lost to Follow-up|2|||
27760930|NCT00729326|80950688|FG001|Overall Study|Lost to Follow-up|0|||
27859642|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Adverse Event|0|||
27859643|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Adverse Event|0|||
27859644|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Adverse Event|0|||
27859645|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Adverse Event|0|||
27859646|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Adverse Event|0|||
27859647|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Adverse Event|0|||
27859648|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Adverse Event|0|||
27859649|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Adverse Event|0|||
27859650|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Adverse Event|0|||
27859651|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Adverse Event|0|||
27859652|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Adverse Event|0|||
27859653|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Adverse Event|0|||
27859654|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Adverse Event|0|||
27859655|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Adverse Event|0|||
27859656|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Adverse Event|0|||
27859657|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Adverse Event|0|||
27859658|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Adverse Event|0|||
27859659|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Adverse Event|0|||
27859660|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Adverse Event|0|||
27859661|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Adverse Event|0|||
27859662|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Adverse Event|1|||
27859663|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Adverse Event|0|||
27656844|NCT01072149|80583252|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27760931|NCT00729326|80950687|FG000|Overall Study|Physician Decision|0|||
27760932|NCT00729326|80950688|FG001|Overall Study|Physician Decision|1|||
27760933|NCT00729326|80950687|FG000|Overall Study|Protocol Violation|3|||
27760934|NCT00729326|80950688|FG001|Overall Study|Protocol Violation|2|||
27760935|NCT00729326|80950687|FG000|Overall Study|Subject Decision|4|||
27760936|NCT00729326|80950688|FG001|Overall Study|Subject Decision|4|||
27760937|NCT00729326|80950687|FG000|Overall Study|Sponsor Decision|1|||
27760938|NCT00729326|80950688|FG001|Overall Study|Sponsor Decision|2|||
27760939|NCT02709083|80950689|FG000|Overall Study|Original PI left institution|7|||
27760940|NCT01763866|80950690|FG000|Overall Study|Withdrawal by Subject|2|||
27760941|NCT01763866|80950691|FG001|Overall Study|Withdrawal by Subject|1|||
27760942|NCT01763866|80950692|FG002|Overall Study|Withdrawal by Subject|4|||
27760943|NCT01763866|80950693|FG003|Overall Study|Withdrawal by Subject|0|||
27760944|NCT01763866|80950694|FG004|Overall Study|Withdrawal by Subject|0|||
27760945|NCT01763866|80950695|FG005|Overall Study|Withdrawal by Subject|3|||
27760946|NCT01763866|80950696|FG006|Overall Study|Withdrawal by Subject|4|||
27760947|NCT01763866|80950697|FG007|Overall Study|Withdrawal by Subject|0|||
27760948|NCT01763866|80950698|FG008|Overall Study|Withdrawal by Subject|1|||
27760949|NCT01763866|80950699|FG009|Overall Study|Withdrawal by Subject|1|||
27760950|NCT01763866|80950700|FG010|Overall Study|Withdrawal by Subject|2|||
27760951|NCT01763866|80950701|FG011|Overall Study|Withdrawal by Subject|2|||
27760952|NCT01763866|80950702|FG012|Overall Study|Withdrawal by Subject|2|||
27760953|NCT01763866|80950703|FG013|Overall Study|Withdrawal by Subject|0|||
27760954|NCT01763866|80950704|FG014|Overall Study|Withdrawal by Subject|6|||
27760955|NCT01763866|80950705|FG015|Overall Study|Withdrawal by Subject|3|||
27760956|NCT01763866|80950706|FG016|Overall Study|Withdrawal by Subject|0|||
27760957|NCT01763866|80950707|FG017|Overall Study|Withdrawal by Subject|1|||
27760958|NCT01763866|80950708|FG018|Overall Study|Withdrawal by Subject|1|||
27760959|NCT01763866|80950709|FG019|Overall Study|Withdrawal by Subject|1|||
27760960|NCT01763866|80950710|FG020|Overall Study|Withdrawal by Subject|2|||
27760961|NCT01763866|80950711|FG021|Overall Study|Withdrawal by Subject|1|||
27760962|NCT01763866|80950712|FG022|Overall Study|Withdrawal by Subject|2|||
27760963|NCT01763866|80950713|FG023|Overall Study|Withdrawal by Subject|1|||
27760964|NCT01763866|80950690|FG000|Overall Study|Decision by sponsor|0|||
27760965|NCT01763866|80950691|FG001|Overall Study|Decision by sponsor|0|||
27760966|NCT01763866|80950692|FG002|Overall Study|Decision by sponsor|1|||
27760967|NCT01763866|80950693|FG003|Overall Study|Decision by sponsor|0|||
27760968|NCT01763866|80950694|FG004|Overall Study|Decision by sponsor|2|||
27859664|NCT02393248|81319286|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859665|NCT02393248|81319287|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859666|NCT02393248|81319288|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27760969|NCT01763866|80950695|FG005|Overall Study|Decision by sponsor|0|||
27760970|NCT01763866|80950696|FG006|Overall Study|Decision by sponsor|2|||
27760971|NCT01763866|80950697|FG007|Overall Study|Decision by sponsor|0|||
27760972|NCT01763866|80950698|FG008|Overall Study|Decision by sponsor|2|||
27859667|NCT02393248|81319289|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859668|NCT02393248|81319290|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859669|NCT02393248|81319291|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859670|NCT02393248|81319292|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859671|NCT02393248|81319293|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859672|NCT02393248|81319294|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859673|NCT02393248|81319295|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859674|NCT02393248|81319296|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859675|NCT02393248|81319297|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859676|NCT02393248|81319298|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859677|NCT02393248|81319299|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859678|NCT02393248|81319300|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27760973|NCT01763866|80950699|FG009|Overall Study|Decision by sponsor|0|||
27760974|NCT01763866|80950700|FG010|Overall Study|Decision by sponsor|6|||
27859679|NCT02393248|81319301|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859680|NCT02393248|81319302|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859681|NCT02393248|81319303|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859682|NCT02393248|81319304|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859683|NCT02393248|81319305|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859684|NCT02393248|81319306|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859685|NCT02393248|81319307|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859686|NCT02393248|81319308|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859687|NCT02393248|81319309|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
27859688|NCT02393248|81319310|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
27859689|NCT02932306|81319314|FG000|Overall Study|Withdrawal by Subject|16|||
27859690|NCT02932306|81319315|FG001|Overall Study|Withdrawal by Subject|25|||
27859691|NCT02932306|81319314|FG000|Overall Study|Adverse Event|3|||
27859692|NCT02932306|81319315|FG001|Overall Study|Adverse Event|0|||
27859693|NCT02932306|81319314|FG000|Overall Study|Pregnancy|2|||
27859694|NCT02932306|81319315|FG001|Overall Study|Pregnancy|0|||
27859695|NCT02932306|81319314|FG000|Overall Study|Protocol Violation|1|||
27859696|NCT02932306|81319315|FG001|Overall Study|Protocol Violation|1|||
27859697|NCT02932306|81319314|FG000|Overall Study|Noncompliance with Study Drug|1|||
27859698|NCT02932306|81319315|FG001|Overall Study|Noncompliance with Study Drug|1|||
27859699|NCT02932306|81319314|FG000|Overall Study|Lost to Follow-up|36|||
27859700|NCT02932306|81319315|FG001|Overall Study|Lost to Follow-up|40|||
27859701|NCT02932306|81319314|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
27859702|NCT02932306|81319315|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
27859703|NCT02932306|81319314|FG000|Overall Study|Lack of Efficacy|0|||
27859704|NCT02932306|81319315|FG001|Overall Study|Lack of Efficacy|2|||
27859705|NCT02932306|81319314|FG000|Overall Study|Worsening condition|2|||
27859706|NCT02932306|81319315|FG001|Overall Study|Worsening condition|0|||
27859707|NCT02932306|81319314|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
27859708|NCT02932306|81319315|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
27859709|NCT02087189|81319316|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
27859710|NCT02293863|81319317|FG000|Overall Study|Death|4|||
27859711|NCT02293863|81319318|FG001|Overall Study|Death|6|||
27859712|NCT02293863|81319319|FG002|Overall Study|Death|4|||
27859713|NCT02293863|81319317|FG000|Overall Study|Lost to Follow-up|2|||
27859714|NCT02293863|81319318|FG001|Overall Study|Lost to Follow-up|2|||
27859715|NCT02293863|81319319|FG002|Overall Study|Lost to Follow-up|2|||
27859716|NCT02293863|81319317|FG000|Overall Study|Withdrawal by Subject|3|||
27859717|NCT02293863|81319318|FG001|Overall Study|Withdrawal by Subject|3|||
27859718|NCT02293863|81319319|FG002|Overall Study|Withdrawal by Subject|1|||
27859719|NCT02293863|81319317|FG000|Overall Study|Reason Not Specified|0|||
27859720|NCT02293863|81319318|FG001|Overall Study|Reason Not Specified|2|||
27859721|NCT02293863|81319319|FG002|Overall Study|Reason Not Specified|2|||
27859722|NCT03249792|81319325|FG000|Arms 1, 2, and 4|Death|1|||
27760975|NCT01763866|80950701|FG011|Overall Study|Decision by sponsor|0|||
27760976|NCT01763866|80950702|FG012|Overall Study|Decision by sponsor|1|||
27760977|NCT01763866|80950703|FG013|Overall Study|Decision by sponsor|0|||
27760978|NCT01763866|80950704|FG014|Overall Study|Decision by sponsor|5|||
27760979|NCT01763866|80950705|FG015|Overall Study|Decision by sponsor|0|||
27760980|NCT01763866|80950706|FG016|Overall Study|Decision by sponsor|0|||
27760981|NCT01763866|80950707|FG017|Overall Study|Decision by sponsor|0|||
27760982|NCT01763866|80950708|FG018|Overall Study|Decision by sponsor|4|||
27760983|NCT01763866|80950709|FG019|Overall Study|Decision by sponsor|0|||
27760984|NCT01763866|80950710|FG020|Overall Study|Decision by sponsor|2|||
27760985|NCT01763866|80950711|FG021|Overall Study|Decision by sponsor|0|||
27760986|NCT01763866|80950712|FG022|Overall Study|Decision by sponsor|1|||
27760987|NCT01763866|80950713|FG023|Overall Study|Decision by sponsor|0|||
27760988|NCT01763866|80950690|FG000|Overall Study|Lost to Follow-up|0|||
27760989|NCT01763866|80950691|FG001|Overall Study|Lost to Follow-up|0|||
27760990|NCT01763866|80950692|FG002|Overall Study|Lost to Follow-up|0|||
27760991|NCT01763866|80950693|FG003|Overall Study|Lost to Follow-up|0|||
27760992|NCT01763866|80950694|FG004|Overall Study|Lost to Follow-up|0|||
27760993|NCT01763866|80950695|FG005|Overall Study|Lost to Follow-up|0|||
27760994|NCT01763866|80950696|FG006|Overall Study|Lost to Follow-up|1|||
27760995|NCT01763866|80950697|FG007|Overall Study|Lost to Follow-up|0|||
27760996|NCT01763866|80950698|FG008|Overall Study|Lost to Follow-up|0|||
27760997|NCT01763866|80950699|FG009|Overall Study|Lost to Follow-up|0|||
27760998|NCT01763866|80950700|FG010|Overall Study|Lost to Follow-up|0|||
27760999|NCT01763866|80950701|FG011|Overall Study|Lost to Follow-up|0|||
27761000|NCT01763866|80950702|FG012|Overall Study|Lost to Follow-up|1|||
27761001|NCT01763866|80950703|FG013|Overall Study|Lost to Follow-up|0|||
27761002|NCT01763866|80950704|FG014|Overall Study|Lost to Follow-up|1|||
27761003|NCT01763866|80950705|FG015|Overall Study|Lost to Follow-up|0|||
27761004|NCT01763866|80950706|FG016|Overall Study|Lost to Follow-up|0|||
27761005|NCT01763866|80950707|FG017|Overall Study|Lost to Follow-up|0|||
27859723|NCT03249792|81319326|FG001|Arms 1, 2, and 4|Death|1|||
27859724|NCT03249792|81319327|FG002|Arms 1, 2, and 4|Death|0|||
27859725|NCT03249792|81319328|FG003|Arms 1, 2, and 4|Death|2|||
27859726|NCT03249792|81319329|FG004|Arms 1, 2, and 4|Death|3|||
27859727|NCT03249792|81319330|FG005|Arms 1, 2, and 4|Death|2|||
27859728|NCT03249792|81319331|FG006|Arms 1, 2, and 4|Death|2|||
27859729|NCT03249792|81319332|FG007|Arms 1, 2, and 4|Death|4|||
27859730|NCT03249792|81319333|FG008|Arms 1, 2, and 4|Death|2|||
27859731|NCT03249792|81319334|FG009|Arms 1, 2, and 4|Death|1|||
27859732|NCT03249792|81319335|FG010|Arms 1, 2, and 4|Death|7|||
27859733|NCT03249792|81319336|FG011|Arms 1, 2, and 4|Death|7|||
27859734|NCT03249792|81319337|FG012|Arms 1, 2, and 4|Death|12|||
27859735|NCT03249792|81319338|FG013|Arms 1, 2, and 4|Death|7|||
27859736|NCT03249792|81319339|FG014|Arms 1, 2, and 4|Death|0|||
27859737|NCT03249792|81319340|FG015|Arms 1, 2, and 4|Death|4|||
27859738|NCT03249792|81319341|FG016|Arms 1, 2, and 4|Death|4|||
27859739|NCT03249792|81319342|FG017|Arms 1, 2, and 4|Death|12|||
27859740|NCT03249792|81319343|FG018|Arms 1, 2, and 4|Death|6|||
27859741|NCT03249792|81319344|FG019|Arms 1, 2, and 4|Death|4|||
27859742|NCT03249792|81319345|FG020|Arms 1, 2, and 4|Death|2|||
27859743|NCT03249792|81319346|FG021|Arms 1, 2, and 4|Death|3|||
27859744|NCT03249792|81319347|FG022|Arms 1, 2, and 4|Death|1|||
27859745|NCT03249792|81319348|FG023|Arms 1, 2, and 4|Death|1|||
27859746|NCT03249792|81319349|FG024|Arms 1, 2, and 4|Death|4|||
27859747|NCT03249792|81319350|FG025|Arms 1, 2, and 4|Death|0|||
27859748|NCT03249792|81319351|FG026|Arms 1, 2, and 4|Death|0|||
27859749|NCT03249792|81319352|FG027|Arms 1, 2, and 4|Death|0|||
27859750|NCT03249792|81319353|FG028|Arms 1, 2, and 4|Death|0|||
27859751|NCT03249792|81319354|FG029|Arms 1, 2, and 4|Death|0|||
27859752|NCT03249792|81319355|FG030|Arms 1, 2, and 4|Death|0|||
27859753|NCT03249792|81319356|FG031|Arms 1, 2, and 4|Death|0|||
27859754|NCT03249792|81319357|FG032|Arms 1, 2, and 4|Death|0|||
27859755|NCT03249792|81319325|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859756|NCT03249792|81319326|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859757|NCT03249792|81319327|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
27859758|NCT03249792|81319328|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859759|NCT03249792|81319329|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27761006|NCT01763866|80950708|FG018|Overall Study|Lost to Follow-up|1|||
27761007|NCT01763866|80950709|FG019|Overall Study|Lost to Follow-up|1|||
27761008|NCT01763866|80950710|FG020|Overall Study|Lost to Follow-up|0|||
27761009|NCT01763866|80950711|FG021|Overall Study|Lost to Follow-up|0|||
27761010|NCT01763866|80950712|FG022|Overall Study|Lost to Follow-up|0|||
27761011|NCT01763866|80950713|FG023|Overall Study|Lost to Follow-up|1|||
27761012|NCT01763866|80950690|FG000|Overall Study|Death|0|||
27761013|NCT01763866|80950691|FG001|Overall Study|Death|0|||
27761014|NCT01763866|80950692|FG002|Overall Study|Death|0|||
27761015|NCT01763866|80950693|FG003|Overall Study|Death|0|||
27761016|NCT01763866|80950694|FG004|Overall Study|Death|0|||
27761017|NCT01763866|80950695|FG005|Overall Study|Death|0|||
27761018|NCT01763866|80950696|FG006|Overall Study|Death|0|||
27761019|NCT01763866|80950697|FG007|Overall Study|Death|0|||
27761020|NCT01763866|80950698|FG008|Overall Study|Death|0|||
27761021|NCT01763866|80950699|FG009|Overall Study|Death|0|||
27761022|NCT01763866|80950700|FG010|Overall Study|Death|0|||
27761023|NCT01763866|80950701|FG011|Overall Study|Death|0|||
27859760|NCT03249792|81319330|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
27859761|NCT03249792|81319331|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
27859762|NCT03249792|81319332|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27761024|NCT01763866|80950702|FG012|Overall Study|Death|0|||
27761025|NCT01763866|80950703|FG013|Overall Study|Death|0|||
27761026|NCT01763866|80950704|FG014|Overall Study|Death|0|||
27761027|NCT01763866|80950705|FG015|Overall Study|Death|0|||
27761028|NCT01763866|80950706|FG016|Overall Study|Death|1|||
27761029|NCT01763866|80950707|FG017|Overall Study|Death|0|||
27761030|NCT01763866|80950708|FG018|Overall Study|Death|0|||
27761031|NCT01763866|80950709|FG019|Overall Study|Death|0|||
27761032|NCT01763866|80950710|FG020|Overall Study|Death|0|||
27761033|NCT01763866|80950711|FG021|Overall Study|Death|0|||
27761034|NCT01763866|80950712|FG022|Overall Study|Death|0|||
27761035|NCT01763866|80950713|FG023|Overall Study|Death|0|||
27761036|NCT04603391|80950714|FG000|First Intervention (4 Days)|Adverse Event|1|||
27761037|NCT04603391|80950715|FG001|First Intervention (4 Days)|Adverse Event|0|||
27761038|NCT04603391|80950714|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
27761039|NCT04603391|80950715|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
27761040|NCT03700736|80950716|FG000|Overall Study|Pregnancy|1|||
27761041|NCT03700736|80950717|FG001|Overall Study|Pregnancy|1|||
27859763|NCT03249792|81319333|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
27859764|NCT03249792|81319334|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
27859765|NCT03249792|81319335|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
27859766|NCT03249792|81319336|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
27859767|NCT03249792|81319337|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
27859768|NCT03249792|81319338|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
27859769|NCT03249792|81319339|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859770|NCT03249792|81319340|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859771|NCT03249792|81319341|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
27859772|NCT03249792|81319342|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859773|NCT03249792|81319343|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
27859774|NCT03249792|81319344|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27761042|NCT03700736|80950716|FG000|Overall Study|Withdrawal by Subject|2|||
27566580|NCT01023581|80263365|FG001|Overall Study|Withdrawal by Subject|8|||
27566581|NCT01023581|80263366|FG002|Overall Study|Withdrawal by Subject|16|||
27566582|NCT01023581|80263367|FG003|Overall Study|Withdrawal by Subject|10|||
27566583|NCT01023581|80263368|FG004|Overall Study|Withdrawal by Subject|6|||
27566584|NCT01023581|80263369|FG005|Overall Study|Withdrawal by Subject|8|||
27566585|NCT01023581|80263370|FG006|Overall Study|Withdrawal by Subject|5|||
27566586|NCT01023581|80263364|FG000|Overall Study|Pregnancy|0|||
27566587|NCT01023581|80263365|FG001|Overall Study|Pregnancy|0|||
27566588|NCT01023581|80263366|FG002|Overall Study|Pregnancy|0|||
27566589|NCT01023581|80263367|FG003|Overall Study|Pregnancy|2|||
27566590|NCT01023581|80263368|FG004|Overall Study|Pregnancy|0|||
27566591|NCT01023581|80263369|FG005|Overall Study|Pregnancy|1|||
27566592|NCT01023581|80263370|FG006|Overall Study|Pregnancy|0|||
27566593|NCT01023581|80263364|FG000|Overall Study|Lack of Efficacy|9|||
27566594|NCT01023581|80263365|FG001|Overall Study|Lack of Efficacy|3|||
27566595|NCT01023581|80263366|FG002|Overall Study|Lack of Efficacy|6|||
27566596|NCT01023581|80263367|FG003|Overall Study|Lack of Efficacy|2|||
27566597|NCT01023581|80263368|FG004|Overall Study|Lack of Efficacy|1|||
27566598|NCT01023581|80263369|FG005|Overall Study|Lack of Efficacy|2|||
27566599|NCT01023581|80263370|FG006|Overall Study|Lack of Efficacy|1|||
27566600|NCT01023581|80263364|FG000|Overall Study|Physician Decision|2|||
27566601|NCT01023581|80263365|FG001|Overall Study|Physician Decision|0|||
27566602|NCT01023581|80263366|FG002|Overall Study|Physician Decision|2|||
27566603|NCT01023581|80263367|FG003|Overall Study|Physician Decision|1|||
27566604|NCT01023581|80263368|FG004|Overall Study|Physician Decision|1|||
27566605|NCT01023581|80263369|FG005|Overall Study|Physician Decision|1|||
27566606|NCT01023581|80263370|FG006|Overall Study|Physician Decision|1|||
27566607|NCT01023581|80263364|FG000|Overall Study|Other|1|||
27566608|NCT01023581|80263365|FG001|Overall Study|Other|0|||
27566609|NCT01023581|80263366|FG002|Overall Study|Other|1|||
27566610|NCT01023581|80263367|FG003|Overall Study|Other|0|||
27566611|NCT01023581|80263368|FG004|Overall Study|Other|1|||
27566612|NCT01023581|80263369|FG005|Overall Study|Other|0|||
27566613|NCT01023581|80263370|FG006|Overall Study|Other|0|||
27566614|NCT00697515|80263376|FG000|Dose Optimization Period|Adverse Event|4|||
27761043|NCT03700736|80950717|FG001|Overall Study|Withdrawal by Subject|6|||
27566615|NCT00697515|80263377|FG001|Dose Optimization Period|Adverse Event|0|||
27566616|NCT00697515|80263376|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
27566617|NCT00697515|80263377|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
27566618|NCT00697515|80263376|FG000|Dose Optimization Period|Lost to Follow-up|2|||
27566619|NCT00697515|80263377|FG001|Dose Optimization Period|Lost to Follow-up|0|||
27566620|NCT00697515|80263376|FG000|Dose Optimization Period|sponsor request|2|||
27566621|NCT00697515|80263377|FG001|Dose Optimization Period|sponsor request|0|||
27566622|NCT00697515|80263376|FG000|Dose Optimization Period|called to active duty|1|||
27566623|NCT00697515|80263377|FG001|Dose Optimization Period|called to active duty|0|||
27566624|NCT00697515|80263376|FG000|Dose Optimization Period|elevated QTc|1|||
27566625|NCT00697515|80263377|FG001|Dose Optimization Period|elevated QTc|0|||
27566626|NCT00697515|80263376|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
27566627|NCT00697515|80263377|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
27566628|NCT00697515|80263376|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
27566629|NCT00697515|80263377|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
27566630|NCT00697515|80263376|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
27566631|NCT00697515|80263377|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
27566632|NCT00697515|80263376|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
27566633|NCT00697515|80263377|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
27566634|NCT01187043|80263378|FG000|Overall Study|Adverse Event|0|||
27566635|NCT01187043|80263379|FG001|Overall Study|Adverse Event|0|||
27566636|NCT01187043|80263380|FG002|Overall Study|Adverse Event|0|||
27566637|NCT01187043|80263381|FG003|Overall Study|Adverse Event|0|||
27566638|NCT01187043|80263382|FG004|Overall Study|Adverse Event|1|||
27566639|NCT01187043|80263378|FG000|Overall Study|Unable to make scheduled visits|1|||
27566640|NCT01187043|80263379|FG001|Overall Study|Unable to make scheduled visits|0|||
27566641|NCT01187043|80263380|FG002|Overall Study|Unable to make scheduled visits|4|||
27566642|NCT01187043|80263381|FG003|Overall Study|Unable to make scheduled visits|0|||
27566643|NCT01187043|80263382|FG004|Overall Study|Unable to make scheduled visits|1|||
27566644|NCT02082210|80263384|FG000|Overall Study|Death|0|||
27761044|NCT04176445|80950719|FG000|Overall Study|Adverse Event|0|||
27761045|NCT04176445|80950720|FG001|Overall Study|Adverse Event|1|||
27566645|NCT02082210|80263385|FG001|Overall Study|Death|0|||
27566646|NCT02082210|80263386|FG002|Overall Study|Death|1|||
27761046|NCT04176445|80950719|FG000|Overall Study|change plans weaning after first intervention|0|||
27761047|NCT04176445|80950720|FG001|Overall Study|change plans weaning after first intervention|1|||
27761048|NCT00756886|80950726|FG000|Overall Study|Lost to Follow-up|1|||
27761049|NCT00756886|80950727|FG001|Overall Study|Lost to Follow-up|0|||
27761050|NCT00756886|80950726|FG000|Overall Study|Adverse Event|0|||
27761051|NCT00756886|80950727|FG001|Overall Study|Adverse Event|3|||
27761052|NCT00756886|80950726|FG000|Overall Study|Lack of Efficacy|1|||
27761053|NCT00756886|80950727|FG001|Overall Study|Lack of Efficacy|0|||
27761054|NCT00756886|80950726|FG000|Overall Study|Ineligible|9|||
27761055|NCT00756886|80950727|FG001|Overall Study|Ineligible|4|||
27761056|NCT03341923|80950730|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
27761057|NCT03341923|80950731|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
27761058|NCT00987623|80950732|FG000|Overall Study|Lost to Follow-up|2|||
27761059|NCT00987623|80950733|FG001|Overall Study|Lost to Follow-up|1|||
27761060|NCT00987623|80950732|FG000|Overall Study|Time/job conflict|2|||
27761061|NCT00987623|80950733|FG001|Overall Study|Time/job conflict|0|||
27761062|NCT00987623|80950732|FG000|Overall Study|Discomfort|1|||
27761063|NCT00987623|80950733|FG001|Overall Study|Discomfort|0|||
27761064|NCT00987623|80950732|FG000|Overall Study|Biomicroscopy|0|||
27761065|NCT00987623|80950733|FG001|Overall Study|Biomicroscopy|1|||
27761066|NCT00987623|80950732|FG000|Overall Study|Influenza|0|||
27761067|NCT00987623|80950733|FG001|Overall Study|Influenza|1|||
27761068|NCT01054976|80950734|FG000|Overall Study|Adverse Event|16|||
27761069|NCT01054976|80950734|FG000|Overall Study|Uncooperative participations to study|7|||
27761070|NCT01054976|80950734|FG000|Overall Study|Withdrawal by Subject|4|||
27761071|NCT01054976|80950734|FG000|Overall Study|Other|8|||
27761072|NCT03094832|80950746|FG000|Overall Study|Lost to Follow-up|0|||
27761073|NCT03094832|80950747|FG001|Overall Study|Lost to Follow-up|0|||
27761074|NCT03094832|80950748|FG002|Overall Study|Lost to Follow-up|0|||
27761075|NCT03094832|80950749|FG003|Overall Study|Lost to Follow-up|1|||
27761076|NCT03094832|80950750|FG004|Overall Study|Lost to Follow-up|1|||
27566647|NCT02082210|80263387|FG003|Overall Study|Death|1|||
27859775|NCT03249792|81319345|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859776|NCT03249792|81319346|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859777|NCT03249792|81319347|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
27566648|NCT02082210|80263388|FG004|Overall Study|Death|1|||
27566649|NCT02082210|80263389|FG005|Overall Study|Death|0|||
27566650|NCT02082210|80263384|FG000|Overall Study|Withdrawal by Subject|0|||
27566651|NCT02082210|80263385|FG001|Overall Study|Withdrawal by Subject|0|||
27566652|NCT02082210|80263386|FG002|Overall Study|Withdrawal by Subject|0|||
27566653|NCT02082210|80263387|FG003|Overall Study|Withdrawal by Subject|1|||
27566654|NCT02082210|80263388|FG004|Overall Study|Withdrawal by Subject|2|||
27566655|NCT02082210|80263389|FG005|Overall Study|Withdrawal by Subject|2|||
27566656|NCT02082210|80263384|FG000|Overall Study|Clinical Progression|0|||
27566657|NCT02082210|80263385|FG001|Overall Study|Clinical Progression|0|||
27566658|NCT02082210|80263386|FG002|Overall Study|Clinical Progression|0|||
27761077|NCT03094832|80950746|FG000|Overall Study|Death|1|||
27761078|NCT03094832|80950747|FG001|Overall Study|Death|0|||
27761079|NCT03094832|80950748|FG002|Overall Study|Death|0|||
27656845|NCT01072149|80583253|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
27656846|NCT01072149|80583236|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27761080|NCT03094832|80950749|FG003|Overall Study|Death|0|||
27761081|NCT03094832|80950750|FG004|Overall Study|Death|0|||
27761082|NCT03094832|80950746|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27761083|NCT03094832|80950747|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27761084|NCT03094832|80950748|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27761085|NCT03094832|80950749|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27761086|NCT03094832|80950750|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27761087|NCT03094832|80950746|FG000|Overall Study|Other|13|||
27761088|NCT03094832|80950747|FG001|Overall Study|Other|20|||
27761089|NCT03094832|80950748|FG002|Overall Study|Other|1|||
27566659|NCT02082210|80263387|FG003|Overall Study|Clinical Progression|1|||
27566660|NCT02082210|80263388|FG004|Overall Study|Clinical Progression|0|||
27566661|NCT02082210|80263389|FG005|Overall Study|Clinical Progression|0|||
27566662|NCT02082210|80263384|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
27566663|NCT02082210|80263385|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
27656847|NCT01072149|80583237|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27761090|NCT03094832|80950749|FG003|Overall Study|Other|7|||
27761091|NCT03094832|80950750|FG004|Overall Study|Other|1|||
27761092|NCT01890512|80950755|FG000|Overall Study|Physician Decision|1|||
27656848|NCT01072149|80583238|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
27656849|NCT01072149|80583239|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656850|NCT01072149|80583240|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27761093|NCT01890512|80950755|FG000|Overall Study|Withdrawal by Subject|1|||
27761094|NCT01890512|80950755|FG000|Overall Study|Protocol Violation|1|||
27761095|NCT00493974|80950762|FG000|Overall Study|Death|1|||
27761096|NCT00493974|80950763|FG001|Overall Study|Death|2|||
27761097|NCT00493974|80950762|FG000|Overall Study|Withdrawal by Subject|8|||
27761098|NCT00493974|80950763|FG001|Overall Study|Withdrawal by Subject|6|||
27761099|NCT00493974|80950762|FG000|Overall Study|Lost to Follow-up|4|||
27761100|NCT00493974|80950763|FG001|Overall Study|Lost to Follow-up|6|||
27761101|NCT00870818|80950773|FG000|Overall Study|Lost to Follow-up|3|||
27761102|NCT00870818|80950774|FG001|Overall Study|Lost to Follow-up|2|||
27761103|NCT00870818|80950775|FG002|Overall Study|Lost to Follow-up|1|||
27761104|NCT00870818|80950776|FG003|Overall Study|Lost to Follow-up|0|||
27761105|NCT00870818|80950777|FG004|Overall Study|Lost to Follow-up|0|||
27761106|NCT00870818|80950773|FG000|Overall Study|Withdrawal by Subject|0|||
27761107|NCT00870818|80950774|FG001|Overall Study|Withdrawal by Subject|0|||
27761108|NCT00870818|80950775|FG002|Overall Study|Withdrawal by Subject|1|||
27761109|NCT00870818|80950776|FG003|Overall Study|Withdrawal by Subject|2|||
27761110|NCT00870818|80950777|FG004|Overall Study|Withdrawal by Subject|0|||
27761111|NCT00870818|80950773|FG000|Overall Study|Terminated by sponsor|29|||
27761112|NCT00870818|80950774|FG001|Overall Study|Terminated by sponsor|70|||
27761113|NCT00870818|80950775|FG002|Overall Study|Terminated by sponsor|36|||
27761114|NCT00870818|80950776|FG003|Overall Study|Terminated by sponsor|36|||
27761115|NCT00870818|80950777|FG004|Overall Study|Terminated by sponsor|38|||
27761116|NCT00870818|80950773|FG000|Overall Study|Other|0|||
27761117|NCT00870818|80950774|FG001|Overall Study|Other|1|||
27761118|NCT00870818|80950775|FG002|Overall Study|Other|0|||
27761119|NCT00870818|80950776|FG003|Overall Study|Other|0|||
27761120|NCT00870818|80950777|FG004|Overall Study|Other|0|||
27761121|NCT00418379|80950778|FG000|Year 1|Adverse Event|9|||
27761122|NCT00418379|80950779|FG001|Year 1|Adverse Event|15|||
27761123|NCT00418379|80950780|FG002|Year 1|Adverse Event|3|||
27761124|NCT00418379|80950778|FG000|Year 1|Withdrawal by Subject|7|||
27761125|NCT00418379|80950779|FG001|Year 1|Withdrawal by Subject|8|||
27761126|NCT00418379|80950780|FG002|Year 1|Withdrawal by Subject|5|||
27761127|NCT00418379|80950778|FG000|Year 1|Any other reason not above-mentioned|2|||
27761128|NCT00418379|80950779|FG001|Year 1|Any other reason not above-mentioned|5|||
27761129|NCT00418379|80950780|FG002|Year 1|Any other reason not above-mentioned|7|||
27761130|NCT00418379|80950778|FG000|Year 2|Adverse Event|5|||
27761131|NCT00418379|80950779|FG001|Year 2|Adverse Event|2|||
27761132|NCT00418379|80950780|FG002|Year 2|Adverse Event|1|||
27761133|NCT00418379|80950778|FG000|Year 2|Withdrawal by Subject|1|||
27761134|NCT00418379|80950779|FG001|Year 2|Withdrawal by Subject|1|||
27761135|NCT00418379|80950780|FG002|Year 2|Withdrawal by Subject|3|||
27761136|NCT00418379|80950778|FG000|Year 2|Any other reason not above-mentioned|2|||
27761137|NCT00418379|80950779|FG001|Year 2|Any other reason not above-mentioned|1|||
27761138|NCT00418379|80950780|FG002|Year 2|Any other reason not above-mentioned|6|||
27761139|NCT00418379|80950778|FG000|Year 3|Withdrawal by Subject|1|||
27761140|NCT00418379|80950779|FG001|Year 3|Withdrawal by Subject|1|||
27761141|NCT00418379|80950780|FG002|Year 3|Withdrawal by Subject|2|||
27761142|NCT00418379|80950778|FG000|Year 3|Any other reason not above-mentioned|2|||
27761143|NCT00418379|80950779|FG001|Year 3|Any other reason not above-mentioned|1|||
27761144|NCT00418379|80950780|FG002|Year 3|Any other reason not above-mentioned|1|||
27761145|NCT00418379|80950778|FG000|Year 4|Adverse Event|0|||
27761146|NCT00418379|80950779|FG001|Year 4|Adverse Event|1|||
27761147|NCT00418379|80950780|FG002|Year 4|Adverse Event|0|||
27761148|NCT00418379|80950778|FG000|Year 4|Withdrawal by Subject|2|||
27761149|NCT00418379|80950779|FG001|Year 4|Withdrawal by Subject|3|||
27761150|NCT00418379|80950780|FG002|Year 4|Withdrawal by Subject|2|||
27761151|NCT00418379|80950778|FG000|Year 4|Any other reason not above-mentioned|1|||
27761152|NCT00418379|80950779|FG001|Year 4|Any other reason not above-mentioned|1|||
27761153|NCT00418379|80950780|FG002|Year 4|Any other reason not above-mentioned|0|||
27761154|NCT00418379|80950778|FG000|Year 5|Adverse Event|0|||
27761155|NCT00418379|80950779|FG001|Year 5|Adverse Event|1|||
27761156|NCT00418379|80950780|FG002|Year 5|Adverse Event|0|||
27761157|NCT00418379|80950778|FG000|Year 5|Any other reason not above-mentioned|2|||
27761158|NCT00418379|80950779|FG001|Year 5|Any other reason not above-mentioned|4|||
27761159|NCT00418379|80950780|FG002|Year 5|Any other reason not above-mentioned|3|||
27761160|NCT01815580|80950781|FG000|Overall Study|Lost to Follow-up|4|||
27761161|NCT01815580|80950782|FG001|Overall Study|Lost to Follow-up|7|||
27761162|NCT01815580|80950781|FG000|Overall Study|Withdrawal by Subject|3|||
27761163|NCT01815580|80950782|FG001|Overall Study|Withdrawal by Subject|4|||
27761164|NCT01815580|80950781|FG000|Overall Study|Excluded from analysis|5|||
27761165|NCT01815580|80950782|FG001|Overall Study|Excluded from analysis|4|||
27761166|NCT01769469|80950783|FG000|Overall Study|Consent Withdrawn|5|||
27761167|NCT01769469|80950783|FG000|Overall Study|Moved Out Of Area|3|||
27566664|NCT02082210|80263386|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
27566665|NCT02082210|80263387|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
27566666|NCT02082210|80263388|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
27566667|NCT02082210|80263389|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
27566668|NCT02082210|80263384|FG000|Overall Study|Physician Decision|0|||
27566669|NCT02082210|80263385|FG001|Overall Study|Physician Decision|0|||
27566670|NCT02082210|80263386|FG002|Overall Study|Physician Decision|1|||
27566671|NCT02082210|80263387|FG003|Overall Study|Physician Decision|1|||
27566672|NCT02082210|80263388|FG004|Overall Study|Physician Decision|0|||
27566673|NCT02082210|80263389|FG005|Overall Study|Physician Decision|0|||
27566674|NCT00908960|80263390|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
27566675|NCT00908960|80263391|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
27566676|NCT00908960|80263392|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
27566677|NCT02535741|80263393|FG000|Overall Study|Adverse Event|3|||
27566678|NCT02535741|80263393|FG000|Overall Study|Withdrawal by Subject|9|||
27566679|NCT02535741|80263393|FG000|Overall Study|Lost to Follow-up|10|||
27566680|NCT02535741|80263393|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
27566681|NCT02535741|80263393|FG000|Overall Study|Missing data|6|||
27566682|NCT03979638|80263394|FG000|Period 1|Physician Decision|1|||
27566683|NCT03979638|80263395|FG001|Period 1|Physician Decision|1|||
27566684|NCT03979638|80263394|FG000|Period 1|Withdrawal by Subject|4|||
27566685|NCT03979638|80263395|FG001|Period 1|Withdrawal by Subject|3|||
27566686|NCT03979638|80263394|FG000|Period 1|Study terminated by Sponsor|1|||
27566687|NCT03979638|80263395|FG001|Period 1|Study terminated by Sponsor|3|||
27566688|NCT03979638|80263394|FG000|Period 1|Protocol Violation|1|||
27566689|NCT03979638|80263395|FG001|Period 1|Protocol Violation|0|||
27566690|NCT03979638|80263394|FG000|Period 2|Study terminated by Sponsor|1|||
27566691|NCT03979638|80263395|FG001|Period 2|Study terminated by Sponsor|1|||
27566692|NCT01342510|80263405|FG000|Overall Study|Protocol Violation|12|||
27566693|NCT01342510|80263406|FG001|Overall Study|Protocol Violation|6|||
27566694|NCT01342510|80263407|FG002|Overall Study|Protocol Violation|13|||
27566695|NCT01342510|80263408|FG003|Overall Study|Protocol Violation|11|||
27566696|NCT03161483|80263409|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
27566697|NCT03161483|80263410|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
27566698|NCT03161483|80263411|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
27566699|NCT03161483|80263412|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
27761168|NCT01769469|80950783|FG000|Overall Study|Lost to Follow-up|17|||
27566700|NCT03161483|80263409|FG000|Treatment Period|Death|1|||
27761169|NCT01769469|80950783|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
27761170|NCT01769469|80950783|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
27761171|NCT01309841|80950784|FG000|Overall Study|Other|0|||
27566701|NCT03161483|80263410|FG001|Treatment Period|Death|0|||
27566702|NCT03161483|80263411|FG002|Treatment Period|Death|0|||
27566703|NCT03161483|80263412|FG003|Treatment Period|Death|0|||
27761172|NCT01309841|80950785|FG001|Overall Study|Other|1|||
27761173|NCT01309841|80950786|FG002|Overall Study|Other|1|||
27761174|NCT01309841|80950784|FG000|Overall Study|Lost to Follow-up|7|||
27761175|NCT01309841|80950785|FG001|Overall Study|Lost to Follow-up|6|||
27761176|NCT01309841|80950786|FG002|Overall Study|Lost to Follow-up|4|||
27566704|NCT03161483|80263409|FG000|Treatment Period|Adverse Event|5|||
27566705|NCT03161483|80263410|FG001|Treatment Period|Adverse Event|2|||
27566706|NCT03161483|80263411|FG002|Treatment Period|Adverse Event|1|||
27566707|NCT03161483|80263412|FG003|Treatment Period|Adverse Event|11|||
27566708|NCT03161483|80263409|FG000|Treatment Period|Pregnancy|1|||
27566709|NCT03161483|80263410|FG001|Treatment Period|Pregnancy|0|||
27566710|NCT03161483|80263411|FG002|Treatment Period|Pregnancy|0|||
27566711|NCT03161483|80263412|FG003|Treatment Period|Pregnancy|0|||
27566712|NCT03161483|80263409|FG000|Treatment Period|Lack of Efficacy|0|||
27566713|NCT03161483|80263410|FG001|Treatment Period|Lack of Efficacy|0|||
27566714|NCT03161483|80263411|FG002|Treatment Period|Lack of Efficacy|0|||
27566715|NCT03161483|80263412|FG003|Treatment Period|Lack of Efficacy|1|||
27566716|NCT03161483|80263409|FG000|Treatment Period|Withdrawal by Subject|2|||
27566717|NCT03161483|80263410|FG001|Treatment Period|Withdrawal by Subject|5|||
27566718|NCT03161483|80263411|FG002|Treatment Period|Withdrawal by Subject|2|||
27566719|NCT03161483|80263412|FG003|Treatment Period|Withdrawal by Subject|6|||
27566720|NCT03161483|80263409|FG000|Treatment Period|Lost to Follow-up|0|||
27566721|NCT03161483|80263410|FG001|Treatment Period|Lost to Follow-up|0|||
27566722|NCT03161483|80263411|FG002|Treatment Period|Lost to Follow-up|0|||
27761177|NCT01309841|80950784|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
27761178|NCT01309841|80950785|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27761179|NCT01309841|80950786|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
27656851|NCT01072149|80583241|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656852|NCT01072149|80583242|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27566723|NCT03161483|80263412|FG003|Treatment Period|Lost to Follow-up|1|||
27566724|NCT03161483|80263409|FG000|Treatment Period|Protocol Violation|0|||
27566725|NCT03161483|80263410|FG001|Treatment Period|Protocol Violation|0|||
27566726|NCT03161483|80263411|FG002|Treatment Period|Protocol Violation|0|||
27656853|NCT01072149|80583243|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27566727|NCT03161483|80263412|FG003|Treatment Period|Protocol Violation|1|||
27566728|NCT03161483|80263409|FG000|Treatment Period|Other reasons|1|||
27566729|NCT03161483|80263410|FG001|Treatment Period|Other reasons|1|||
27566730|NCT03161483|80263411|FG002|Treatment Period|Other reasons|0|||
27566731|NCT03161483|80263412|FG003|Treatment Period|Other reasons|0|||
27566732|NCT00696137|80263413|FG000|Overall Study|Withdrawal by Subject|2|||
27566733|NCT00973479|80263421|FG000|Overall Study|Lost to Follow-up|0|||
27656854|NCT01072149|80583244|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656855|NCT01072149|80583245|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656856|NCT01072149|80583246|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656857|NCT01072149|80583247|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656858|NCT01072149|80583248|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656859|NCT01072149|80583249|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
27656860|NCT01072149|80583250|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656861|NCT01072149|80583251|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656862|NCT01072149|80583252|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656863|NCT01072149|80583253|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
27656864|NCT02516202|80583254|FG000|Overall Study|Withdrawal by Subject|1|||
27656865|NCT02516202|80583255|FG001|Overall Study|Withdrawal by Subject|0|||
27656866|NCT02516202|80583256|FG002|Overall Study|Withdrawal by Subject|1|||
27656867|NCT02516202|80583254|FG000|Overall Study|Lost to Follow-up|1|||
27656868|NCT02516202|80583255|FG001|Overall Study|Lost to Follow-up|1|||
27656869|NCT02516202|80583256|FG002|Overall Study|Lost to Follow-up|1|||
27656870|NCT02516202|80583254|FG000|Overall Study|Stopped Follow-up|0|||
27656871|NCT02516202|80583255|FG001|Overall Study|Stopped Follow-up|0|||
27656872|NCT02516202|80583256|FG002|Overall Study|Stopped Follow-up|1|||
27656873|NCT02959866|80583259|FG000|Overall Study|Withdrawal by Subject|1|||
27656874|NCT03481725|80583260|FG000|Overall Study|Withdrawal by Subject|1|||
27656875|NCT03481725|80583261|FG001|Overall Study|Withdrawal by Subject|0|||
27656876|NCT03839355|80583262|FG000|Overall Study|Withdrawal by Subject|1|||
27656877|NCT03839355|80583263|FG001|Overall Study|Withdrawal by Subject|0|||
27656878|NCT05431543|80583266|FG000|Overall Study|Medical History|1|||
27656879|NCT05431543|80583267|FG001|Overall Study|Medical History|0|||
27656880|NCT05431543|80583268|FG002|Overall Study|Medical History|0|||
27656881|NCT00304278|80583269|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
27656882|NCT00304278|80583269|FG000|Overall Study|PT had medical condition preventing TX|1|||
27656883|NCT00087516|80583270|FG000|Overall Study|Adverse Event|10|||
27656884|NCT00087516|80583271|FG001|Overall Study|Adverse Event|10|||
27656885|NCT00087516|80583272|FG002|Overall Study|Adverse Event|3|||
27656886|NCT00087516|80583273|FG003|Overall Study|Adverse Event|6|||
27656887|NCT00087516|80583270|FG000|Overall Study|Lack of Efficacy|82|||
27656888|NCT00087516|80583271|FG001|Overall Study|Lack of Efficacy|80|||
27656889|NCT00087516|80583272|FG002|Overall Study|Lack of Efficacy|39|||
27656890|NCT00087516|80583273|FG003|Overall Study|Lack of Efficacy|29|||
27656891|NCT00087516|80583270|FG000|Overall Study|Lost to Follow-up|8|||
27656892|NCT00087516|80583271|FG001|Overall Study|Lost to Follow-up|6|||
27656893|NCT00087516|80583272|FG002|Overall Study|Lost to Follow-up|5|||
27656894|NCT00087516|80583273|FG003|Overall Study|Lost to Follow-up|5|||
27656895|NCT00087516|80583270|FG000|Overall Study|Protocol Violation|4|||
27656896|NCT00087516|80583271|FG001|Overall Study|Protocol Violation|8|||
27656897|NCT00087516|80583272|FG002|Overall Study|Protocol Violation|3|||
27656898|NCT00087516|80583273|FG003|Overall Study|Protocol Violation|6|||
27656899|NCT00087516|80583270|FG000|Overall Study|Withdrawal by Subject|16|||
27656900|NCT00087516|80583271|FG001|Overall Study|Withdrawal by Subject|27|||
27656901|NCT00087516|80583272|FG002|Overall Study|Withdrawal by Subject|11|||
27656902|NCT00087516|80583273|FG003|Overall Study|Withdrawal by Subject|12|||
27656903|NCT00087516|80583270|FG000|Overall Study|Site terminated|0|||
27656904|NCT00087516|80583271|FG001|Overall Study|Site terminated|2|||
27656905|NCT00087516|80583272|FG002|Overall Study|Site terminated|1|||
27656906|NCT00087516|80583273|FG003|Overall Study|Site terminated|0|||
27656907|NCT00087516|80583270|FG000|Overall Study|Protocol specified discontinuation|35|||
27656908|NCT00087516|80583271|FG001|Overall Study|Protocol specified discontinuation|33|||
27656909|NCT00087516|80583272|FG002|Overall Study|Protocol specified discontinuation|33|||
27656910|NCT00087516|80583273|FG003|Overall Study|Protocol specified discontinuation|26|||
27656911|NCT00087516|80583270|FG000|Overall Study|Patient moved|3|||
27656912|NCT00087516|80583271|FG001|Overall Study|Patient moved|2|||
27656913|NCT00087516|80583272|FG002|Overall Study|Patient moved|1|||
27656914|NCT00087516|80583273|FG003|Overall Study|Patient moved|0|||
27656915|NCT00087516|80583270|FG000|Overall Study|Patient was non-compliant|3|||
27761180|NCT01309841|80950784|FG000|Overall Study|Lack of Efficacy|0|||
27566734|NCT00973479|80263422|FG001|Overall Study|Lost to Follow-up|3|||
27566735|NCT00973479|80263421|FG000|Overall Study|Death|2|||
27656916|NCT00087516|80583271|FG001|Overall Study|Patient was non-compliant|1|||
27656917|NCT00087516|80583272|FG002|Overall Study|Patient was non-compliant|0|||
27656918|NCT00087516|80583273|FG003|Overall Study|Patient was non-compliant|0|||
27566736|NCT00973479|80263422|FG001|Overall Study|Death|2|||
27566737|NCT00973479|80263421|FG000|Overall Study|Withdrawal by Subject|15|||
27656919|NCT00087516|80583270|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
27656920|NCT00087516|80583271|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
27656921|NCT00087516|80583272|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
27656922|NCT00087516|80583273|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
27656923|NCT00087516|80583270|FG000|Overall Study|Other|0|||
27656924|NCT00087516|80583271|FG001|Overall Study|Other|0|||
27656925|NCT00087516|80583272|FG002|Overall Study|Other|1|||
27656926|NCT00087516|80583273|FG003|Overall Study|Other|0|||
27656927|NCT02092285|80583274|FG000|Induction Phase|Adverse Event|7|||
27656928|NCT02092285|80583274|FG000|Induction Phase|Physician Decision|4|||
27656929|NCT02092285|80583274|FG000|Induction Phase|Pregnancy|1|||
27656930|NCT02092285|80583274|FG000|Induction Phase|Relapse/Recurrence|7|||
27656931|NCT02092285|80583274|FG000|Induction Phase|Withdrawal by Subject|2|||
27656932|NCT02092285|80583274|FG000|Induction Phase|Lack of Efficacy|14|||
27656933|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
27656934|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
27656935|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
27656936|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
27656937|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
27656938|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
27656939|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
27761181|NCT01309841|80950785|FG001|Overall Study|Lack of Efficacy|0|||
27761182|NCT01309841|80950786|FG002|Overall Study|Lack of Efficacy|2|||
27761183|NCT01309841|80950784|FG000|Overall Study|Adverse Event|9|||
27761184|NCT01309841|80950785|FG001|Overall Study|Adverse Event|22|||
27761185|NCT01309841|80950786|FG002|Overall Study|Adverse Event|11|||
27761186|NCT01309841|80950784|FG000|Overall Study|Death|1|||
27761187|NCT01309841|80950785|FG001|Overall Study|Death|0|||
27761188|NCT01309841|80950786|FG002|Overall Study|Death|0|||
27761189|NCT01309841|80950784|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27761190|NCT01309841|80950785|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27761191|NCT01309841|80950786|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
27761192|NCT01309841|80950784|FG000|Overall Study|Withdrawal by Subject|17|||
27761193|NCT01309841|80950785|FG001|Overall Study|Withdrawal by Subject|6|||
27761194|NCT01309841|80950786|FG002|Overall Study|Withdrawal by Subject|13|||
27761195|NCT01309841|80950784|FG000|Overall Study|Did Not Receive Treatment|2|||
27859778|NCT03249792|81319348|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
27859779|NCT03249792|81319349|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859780|NCT03249792|81319350|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859781|NCT03249792|81319351|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859782|NCT03249792|81319352|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859783|NCT03249792|81319353|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859784|NCT03249792|81319354|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859785|NCT03249792|81319355|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859786|NCT03249792|81319356|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859787|NCT03249792|81319357|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
27859788|NCT03249792|81319325|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
27859789|NCT03249792|81319326|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
27859790|NCT03249792|81319327|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
27859791|NCT03249792|81319328|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
27859792|NCT03249792|81319329|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
27859793|NCT03249792|81319330|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
27859794|NCT03249792|81319331|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
27859795|NCT03249792|81319332|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
27859796|NCT03249792|81319333|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
27859797|NCT03249792|81319334|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
27859798|NCT03249792|81319335|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
27859799|NCT03249792|81319336|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
27859800|NCT03249792|81319337|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
27859801|NCT03249792|81319338|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
27859802|NCT03249792|81319339|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
27859803|NCT03249792|81319340|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
27859804|NCT03249792|81319341|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
27859805|NCT03249792|81319342|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
27656940|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
27656941|NCT02092285|80583274|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
27656942|NCT00267956|80583275|FG000|Controlled Period|Adverse Event|4|||
27656943|NCT00267956|80583276|FG001|Controlled Period|Adverse Event|1|||
27656944|NCT00267956|80583277|FG002|Controlled Period|Adverse Event|0|||
27656945|NCT00267956|80583278|FG003|Controlled Period|Adverse Event|0|||
27656946|NCT00267956|80583275|FG000|Controlled Period|Lack of Efficacy|4|||
27859806|NCT03249792|81319343|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
27859807|NCT03249792|81319344|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
27859808|NCT03249792|81319345|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
27859809|NCT03249792|81319346|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
27859810|NCT03249792|81319347|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
27859811|NCT03249792|81319348|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
27859812|NCT03249792|81319349|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
27859813|NCT03249792|81319350|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
27859814|NCT03249792|81319351|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
27859815|NCT03249792|81319352|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
27859816|NCT03249792|81319353|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
27859817|NCT03249792|81319354|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
27859818|NCT03249792|81319355|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
27859819|NCT03249792|81319356|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
27859820|NCT03249792|81319357|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
27859821|NCT03249792|81319325|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859822|NCT03249792|81319326|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
27656947|NCT00267956|80583276|FG001|Controlled Period|Lack of Efficacy|2|||
27761196|NCT01309841|80950785|FG001|Overall Study|Did Not Receive Treatment|0|||
27761197|NCT01309841|80950786|FG002|Overall Study|Did Not Receive Treatment|1|||
27761198|NCT01309841|80950784|FG000|Overall Study|Severe non-compliance with protocol|0|||
27761199|NCT01309841|80950785|FG001|Overall Study|Severe non-compliance with protocol|5|||
27761200|NCT01309841|80950786|FG002|Overall Study|Severe non-compliance with protocol|2|||
27761201|NCT03600714|80950787|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
27859823|NCT03249792|81319327|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859824|NCT03249792|81319328|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859825|NCT03249792|81319329|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859826|NCT03249792|81319330|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859827|NCT03249792|81319331|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859828|NCT03249792|81319332|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859829|NCT03249792|81319333|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
27859830|NCT03249792|81319334|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859831|NCT03249792|81319335|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859832|NCT03249792|81319336|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859833|NCT03249792|81319337|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859834|NCT03249792|81319338|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
27566738|NCT00973479|80263422|FG001|Overall Study|Withdrawal by Subject|16|||
27566739|NCT00973479|80263421|FG000|Overall Study|Lack of Efficacy|5|||
27566740|NCT00973479|80263422|FG001|Overall Study|Lack of Efficacy|7|||
27566741|NCT00973479|80263421|FG000|Overall Study|Adverse Event|12|||
27566742|NCT00973479|80263422|FG001|Overall Study|Adverse Event|32|||
27656948|NCT00267956|80583277|FG002|Controlled Period|Lack of Efficacy|0|||
27656949|NCT00267956|80583278|FG003|Controlled Period|Lack of Efficacy|0|||
27656950|NCT00267956|80583275|FG000|Controlled Period|Lost to Follow-up|2|||
27761202|NCT01313208|80950788|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
27761203|NCT01313208|80950789|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
27859835|NCT03249792|81319339|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
27566743|NCT00973479|80263421|FG000|Overall Study|Protocol Violation|2|||
27566744|NCT00973479|80263422|FG001|Overall Study|Protocol Violation|2|||
27566745|NCT00973479|80263421|FG000|Overall Study|Other|1|||
27566746|NCT00973479|80263422|FG001|Overall Study|Other|7|||
27566747|NCT01124604|80263423|FG000|Overall Study|Adverse Event|10|||
27566748|NCT01124604|80263424|FG001|Overall Study|Adverse Event|1|||
27761204|NCT01313208|80950788|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
27761205|NCT01313208|80950789|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
27859836|NCT03249792|81319340|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859837|NCT03249792|81319341|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
27859838|NCT03249792|81319342|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
27859839|NCT03249792|81319343|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859840|NCT03249792|81319344|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
27859841|NCT03249792|81319345|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859842|NCT03249792|81319346|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859843|NCT03249792|81319347|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859844|NCT03249792|81319348|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859845|NCT03249792|81319349|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859846|NCT03249792|81319350|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
27566749|NCT01124604|80263423|FG000|Overall Study|Lack of Efficacy|1|||
27566750|NCT01124604|80263424|FG001|Overall Study|Lack of Efficacy|0|||
27566751|NCT01124604|80263423|FG000|Overall Study|Withdrawal by Subject|4|||
27656951|NCT00267956|80583276|FG001|Controlled Period|Lost to Follow-up|0|||
27859847|NCT03249792|81319351|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859848|NCT03249792|81319352|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859849|NCT03249792|81319353|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859850|NCT03249792|81319354|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859851|NCT03249792|81319355|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859852|NCT03249792|81319356|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859853|NCT03249792|81319357|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
27859854|NCT03249792|81319325|FG000|Switch Over Period|Withdrawal by Subject|0|||
27859855|NCT03249792|81319326|FG001|Switch Over Period|Withdrawal by Subject|0|||
27859856|NCT03249792|81319327|FG002|Switch Over Period|Withdrawal by Subject|0|||
27859857|NCT03249792|81319328|FG003|Switch Over Period|Withdrawal by Subject|0|||
27859858|NCT03249792|81319329|FG004|Switch Over Period|Withdrawal by Subject|0|||
27859859|NCT03249792|81319330|FG005|Switch Over Period|Withdrawal by Subject|0|||
27859860|NCT03249792|81319331|FG006|Switch Over Period|Withdrawal by Subject|0|||
27859861|NCT03249792|81319332|FG007|Switch Over Period|Withdrawal by Subject|0|||
27859862|NCT03249792|81319333|FG008|Switch Over Period|Withdrawal by Subject|0|||
27859863|NCT03249792|81319334|FG009|Switch Over Period|Withdrawal by Subject|0|||
27859864|NCT03249792|81319335|FG010|Switch Over Period|Withdrawal by Subject|0|||
27859865|NCT03249792|81319336|FG011|Switch Over Period|Withdrawal by Subject|0|||
27859866|NCT03249792|81319337|FG012|Switch Over Period|Withdrawal by Subject|0|||
27859867|NCT03249792|81319338|FG013|Switch Over Period|Withdrawal by Subject|0|||
27859868|NCT03249792|81319339|FG014|Switch Over Period|Withdrawal by Subject|0|||
27859869|NCT03249792|81319340|FG015|Switch Over Period|Withdrawal by Subject|0|||
27859870|NCT03249792|81319341|FG016|Switch Over Period|Withdrawal by Subject|0|||
27566752|NCT01124604|80263424|FG001|Overall Study|Withdrawal by Subject|0|||
27566753|NCT01124604|80263423|FG000|Overall Study|Disease Progression|0|||
27566754|NCT01124604|80263424|FG001|Overall Study|Disease Progression|1|||
27859871|NCT03249792|81319342|FG017|Switch Over Period|Withdrawal by Subject|0|||
27859872|NCT03249792|81319343|FG018|Switch Over Period|Withdrawal by Subject|0|||
27566755|NCT03026257|80263425|FG000|Overall Study|Adverse Event|3|||
27566756|NCT03026257|80263426|FG001|Overall Study|Adverse Event|0|||
27566757|NCT03026257|80263427|FG002|Overall Study|Adverse Event|0|||
27566758|NCT03026257|80263428|FG003|Overall Study|Adverse Event|0|||
27566759|NCT03026257|80263429|FG004|Overall Study|Adverse Event|0|||
27566760|NCT03026257|80263430|FG005|Overall Study|Adverse Event|0|||
27566761|NCT03026257|80263425|FG000|Overall Study|Lost to Follow-up|1|||
27566762|NCT03026257|80263426|FG001|Overall Study|Lost to Follow-up|0|||
27566763|NCT03026257|80263427|FG002|Overall Study|Lost to Follow-up|0|||
27566764|NCT03026257|80263428|FG003|Overall Study|Lost to Follow-up|0|||
27566765|NCT03026257|80263429|FG004|Overall Study|Lost to Follow-up|0|||
27566766|NCT03026257|80263430|FG005|Overall Study|Lost to Follow-up|0|||
27566767|NCT03026257|80263425|FG000|Overall Study|Protocol Violation|1|||
27566768|NCT03026257|80263426|FG001|Overall Study|Protocol Violation|0|||
27566769|NCT03026257|80263427|FG002|Overall Study|Protocol Violation|0|||
27566770|NCT03026257|80263428|FG003|Overall Study|Protocol Violation|1|||
27566771|NCT03026257|80263429|FG004|Overall Study|Protocol Violation|1|||
27566772|NCT03026257|80263430|FG005|Overall Study|Protocol Violation|0|||
27566773|NCT03026257|80263425|FG000|Overall Study|Withdrawal by Subject|1|||
27566774|NCT03026257|80263426|FG001|Overall Study|Withdrawal by Subject|1|||
27566775|NCT03026257|80263427|FG002|Overall Study|Withdrawal by Subject|0|||
27566776|NCT03026257|80263428|FG003|Overall Study|Withdrawal by Subject|0|||
27566777|NCT03026257|80263429|FG004|Overall Study|Withdrawal by Subject|0|||
27566778|NCT03026257|80263430|FG005|Overall Study|Withdrawal by Subject|0|||
27566779|NCT01365273|80263431|FG000|Overall Study|Lost to Follow-up|1|||
27566780|NCT01365273|80263432|FG001|Overall Study|Lost to Follow-up|0|||
27566781|NCT01365273|80263431|FG000|Overall Study|Protocol Violation|0|||
27656952|NCT00267956|80583277|FG002|Controlled Period|Lost to Follow-up|0|||
27656953|NCT00267956|80583278|FG003|Controlled Period|Lost to Follow-up|0|||
27656954|NCT00267956|80583275|FG000|Controlled Period|Withdrew consent|3|||
27656955|NCT00267956|80583276|FG001|Controlled Period|Withdrew consent|1|||
27656956|NCT00267956|80583277|FG002|Controlled Period|Withdrew consent|0|||
27656957|NCT00267956|80583278|FG003|Controlled Period|Withdrew consent|0|||
27656958|NCT00267956|80583275|FG000|After Controlled Period|Adverse Event|0|||
27761206|NCT01313208|80950788|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
27566782|NCT01365273|80263432|FG001|Overall Study|Protocol Violation|1|||
27566783|NCT01365273|80263431|FG000|Overall Study|Physician Decision|1|||
27566784|NCT01365273|80263432|FG001|Overall Study|Physician Decision|0|||
27566785|NCT00660348|80263433|FG000|Overall Study|Withdrawal by Subject|1|||
27566786|NCT00660348|80263434|FG001|Overall Study|Withdrawal by Subject|0|||
27566787|NCT02596854|80263435|FG000|Overall Study|Withdrawn|8|||
27566788|NCT01498640|80263436|FG000|Overall Study|Lost to Follow-up|1|||
27566789|NCT01498640|80263436|FG000|Overall Study|Death|1|||
27566790|NCT01498640|80263436|FG000|Overall Study|Other|3|||
27566791|NCT01217060|80263437|FG000|Overall Study|Withdrawal by Subject|1|||
27859873|NCT03249792|81319344|FG019|Switch Over Period|Withdrawal by Subject|0|||
27859874|NCT03249792|81319345|FG020|Switch Over Period|Withdrawal by Subject|0|||
27859875|NCT03249792|81319346|FG021|Switch Over Period|Withdrawal by Subject|0|||
27859876|NCT03249792|81319347|FG022|Switch Over Period|Withdrawal by Subject|0|||
27859877|NCT03249792|81319348|FG023|Switch Over Period|Withdrawal by Subject|0|||
27859878|NCT03249792|81319349|FG024|Switch Over Period|Withdrawal by Subject|0|||
27656959|NCT00267956|80583276|FG001|After Controlled Period|Adverse Event|0|||
27656960|NCT00267956|80583277|FG002|After Controlled Period|Adverse Event|2|||
27656961|NCT00267956|80583278|FG003|After Controlled Period|Adverse Event|1|||
27656962|NCT00267956|80583275|FG000|After Controlled Period|Lack of Efficacy|0|||
27656963|NCT00267956|80583276|FG001|After Controlled Period|Lack of Efficacy|0|||
27656964|NCT00267956|80583277|FG002|After Controlled Period|Lack of Efficacy|1|||
27656965|NCT00267956|80583278|FG003|After Controlled Period|Lack of Efficacy|1|||
27859879|NCT03249792|81319350|FG025|Switch Over Period|Withdrawal by Subject|0|||
27859880|NCT03249792|81319351|FG026|Switch Over Period|Withdrawal by Subject|0|||
27859881|NCT03249792|81319352|FG027|Switch Over Period|Withdrawal by Subject|0|||
27859882|NCT03249792|81319353|FG028|Switch Over Period|Withdrawal by Subject|0|||
27859883|NCT03249792|81319354|FG029|Switch Over Period|Withdrawal by Subject|0|||
27859884|NCT03249792|81319355|FG030|Switch Over Period|Withdrawal by Subject|0|||
27859885|NCT03249792|81319356|FG031|Switch Over Period|Withdrawal by Subject|1|||
27859886|NCT03249792|81319357|FG032|Switch Over Period|Withdrawal by Subject|0|||
27859887|NCT03249792|81319325|FG000|Switch Over Period|Progressive Disease|0|||
27859888|NCT03249792|81319326|FG001|Switch Over Period|Progressive Disease|0|||
27566792|NCT03595878|80263443|FG000|Overall Study|Death|2|||
27566793|NCT03595878|80263444|FG001|Overall Study|Death|1|||
27566794|NCT03595878|80263445|FG002|Overall Study|Death|0|||
27566795|NCT03595878|80263443|FG000|Overall Study|Disease progression|2|||
27566796|NCT03595878|80263444|FG001|Overall Study|Disease progression|1|||
27566797|NCT03595878|80263445|FG002|Overall Study|Disease progression|2|||
27566798|NCT03662542|80263449|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
27566799|NCT03662542|80263450|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566800|NCT03662542|80263451|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566801|NCT03662542|80263452|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566802|NCT03662542|80263453|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566803|NCT03662542|80263454|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566804|NCT03662542|80263455|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566805|NCT03662542|80263456|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566806|NCT03662542|80263457|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
27566807|NCT03662542|80263449|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566808|NCT03662542|80263450|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
27566809|NCT03662542|80263451|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566810|NCT03662542|80263452|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566811|NCT03662542|80263453|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566812|NCT03662542|80263454|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566813|NCT03662542|80263455|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566814|NCT03662542|80263456|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566815|NCT03662542|80263457|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
27566816|NCT03662542|80263449|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
27566817|NCT03662542|80263450|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
27566818|NCT03662542|80263451|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
27566819|NCT03662542|80263452|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
27566820|NCT03662542|80263453|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
27566821|NCT03662542|80263454|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
27566822|NCT03662542|80263455|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
27566823|NCT03662542|80263456|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
27566824|NCT03662542|80263457|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
27566825|NCT03662542|80263449|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
27566826|NCT03662542|80263450|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566827|NCT03662542|80263451|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566828|NCT03662542|80263452|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566829|NCT03662542|80263453|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566830|NCT03662542|80263454|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566831|NCT03662542|80263455|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566832|NCT03662542|80263456|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566833|NCT03662542|80263457|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
27566834|NCT03662542|80263449|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27566835|NCT03662542|80263450|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27566836|NCT03662542|80263451|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27566837|NCT03662542|80263452|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27566838|NCT03662542|80263453|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27566839|NCT03662542|80263454|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
27656966|NCT00267956|80583275|FG000|After Controlled Period|Lost to Follow-up|0|||
27566840|NCT03662542|80263455|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27859889|NCT03249792|81319327|FG002|Switch Over Period|Progressive Disease|0|||
27566841|NCT03662542|80263456|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27859890|NCT03249792|81319328|FG003|Switch Over Period|Progressive Disease|0|||
27656967|NCT00267956|80583276|FG001|After Controlled Period|Lost to Follow-up|0|||
27656968|NCT00267956|80583277|FG002|After Controlled Period|Lost to Follow-up|1|||
27656969|NCT00267956|80583278|FG003|After Controlled Period|Lost to Follow-up|0|||
27656970|NCT00267956|80583275|FG000|After Controlled Period|Withdrew consent|0|||
27656971|NCT00267956|80583276|FG001|After Controlled Period|Withdrew consent|0|||
27656972|NCT00267956|80583277|FG002|After Controlled Period|Withdrew consent|1|||
27656973|NCT00267956|80583278|FG003|After Controlled Period|Withdrew consent|0|||
27656974|NCT03672188|80583279|FG000|Overall Study|Withdrawal by Subject|0|||
27656975|NCT03672188|80583280|FG001|Overall Study|Withdrawal by Subject|0|||
27566842|NCT03662542|80263457|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
27566843|NCT03662542|80263449|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27656976|NCT03672188|80583281|FG002|Overall Study|Withdrawal by Subject|0|||
27656977|NCT03672188|80583282|FG003|Overall Study|Withdrawal by Subject|3|||
27859891|NCT03249792|81319329|FG004|Switch Over Period|Progressive Disease|0|||
27859892|NCT03249792|81319330|FG005|Switch Over Period|Progressive Disease|0|||
27859893|NCT03249792|81319331|FG006|Switch Over Period|Progressive Disease|0|||
27859894|NCT03249792|81319332|FG007|Switch Over Period|Progressive Disease|0|||
27859895|NCT03249792|81319333|FG008|Switch Over Period|Progressive Disease|0|||
27859896|NCT03249792|81319334|FG009|Switch Over Period|Progressive Disease|0|||
27859897|NCT03249792|81319335|FG010|Switch Over Period|Progressive Disease|0|||
27859898|NCT03249792|81319336|FG011|Switch Over Period|Progressive Disease|0|||
27859899|NCT03249792|81319337|FG012|Switch Over Period|Progressive Disease|0|||
27859900|NCT03249792|81319338|FG013|Switch Over Period|Progressive Disease|0|||
27859901|NCT03249792|81319339|FG014|Switch Over Period|Progressive Disease|0|||
27656978|NCT03672188|80583283|FG004|Overall Study|Withdrawal by Subject|0|||
27859902|NCT03249792|81319340|FG015|Switch Over Period|Progressive Disease|0|||
27859903|NCT03249792|81319341|FG016|Switch Over Period|Progressive Disease|0|||
27859904|NCT03249792|81319342|FG017|Switch Over Period|Progressive Disease|0|||
27566844|NCT03662542|80263450|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27566845|NCT03662542|80263451|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27566846|NCT03662542|80263452|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
27566847|NCT03662542|80263453|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
27566848|NCT03662542|80263454|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27566849|NCT03662542|80263455|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27566850|NCT03662542|80263456|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27566851|NCT03662542|80263457|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
27566852|NCT03662542|80263449|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
27566853|NCT03662542|80263450|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
27566854|NCT03662542|80263451|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
27566855|NCT03662542|80263452|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
27566856|NCT03662542|80263453|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
27566857|NCT03662542|80263454|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
27566858|NCT03662542|80263455|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
27566859|NCT03662542|80263456|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
27859905|NCT03249792|81319343|FG018|Switch Over Period|Progressive Disease|0|||
27859906|NCT03249792|81319344|FG019|Switch Over Period|Progressive Disease|0|||
27859907|NCT03249792|81319345|FG020|Switch Over Period|Progressive Disease|0|||
27656979|NCT03672188|80583284|FG005|Overall Study|Withdrawal by Subject|0|||
27656980|NCT03672188|80583285|FG006|Overall Study|Withdrawal by Subject|0|||
27656981|NCT03672188|80583286|FG007|Overall Study|Withdrawal by Subject|0|||
27656982|NCT03672188|80583287|FG008|Overall Study|Withdrawal by Subject|0|||
27656983|NCT03672188|80583288|FG009|Overall Study|Withdrawal by Subject|0|||
27656984|NCT03672188|80583289|FG010|Overall Study|Withdrawal by Subject|0|||
27656985|NCT03672188|80583290|FG011|Overall Study|Withdrawal by Subject|0|||
27656986|NCT03672188|80583291|FG012|Overall Study|Withdrawal by Subject|0|||
27656987|NCT03672188|80583292|FG013|Overall Study|Withdrawal by Subject|0|||
27656988|NCT03672188|80583293|FG014|Overall Study|Withdrawal by Subject|0|||
27656989|NCT03672188|80583279|FG000|Overall Study|Death|0|||
27656990|NCT03672188|80583280|FG001|Overall Study|Death|0|||
27656991|NCT03672188|80583281|FG002|Overall Study|Death|0|||
27656992|NCT03672188|80583282|FG003|Overall Study|Death|0|||
27566860|NCT03662542|80263457|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
27566861|NCT03662542|80263449|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27656993|NCT03672188|80583283|FG004|Overall Study|Death|0|||
27656994|NCT03672188|80583284|FG005|Overall Study|Death|0|||
27656995|NCT03672188|80583285|FG006|Overall Study|Death|0|||
27656996|NCT03672188|80583286|FG007|Overall Study|Death|0|||
27656997|NCT03672188|80583287|FG008|Overall Study|Death|0|||
27656998|NCT03672188|80583288|FG009|Overall Study|Death|0|||
27656999|NCT03672188|80583289|FG010|Overall Study|Death|0|||
27657000|NCT03672188|80583290|FG011|Overall Study|Death|0|||
27657001|NCT03672188|80583291|FG012|Overall Study|Death|1|||
27657002|NCT03672188|80583292|FG013|Overall Study|Death|0|||
27657003|NCT03672188|80583293|FG014|Overall Study|Death|0|||
27657004|NCT03672188|80583279|FG000|Overall Study|Lost to Follow-up|0|||
27657005|NCT03672188|80583280|FG001|Overall Study|Lost to Follow-up|0|||
27657006|NCT03672188|80583281|FG002|Overall Study|Lost to Follow-up|1|||
27657007|NCT03672188|80583282|FG003|Overall Study|Lost to Follow-up|0|||
27657008|NCT03672188|80583283|FG004|Overall Study|Lost to Follow-up|0|||
27657009|NCT03672188|80583284|FG005|Overall Study|Lost to Follow-up|0|||
27657010|NCT03672188|80583285|FG006|Overall Study|Lost to Follow-up|0|||
27657011|NCT03672188|80583286|FG007|Overall Study|Lost to Follow-up|0|||
27657012|NCT03672188|80583287|FG008|Overall Study|Lost to Follow-up|0|||
27657013|NCT03672188|80583288|FG009|Overall Study|Lost to Follow-up|0|||
27657014|NCT03672188|80583289|FG010|Overall Study|Lost to Follow-up|0|||
27657015|NCT03672188|80583290|FG011|Overall Study|Lost to Follow-up|0|||
27657016|NCT03672188|80583291|FG012|Overall Study|Lost to Follow-up|0|||
27657017|NCT03672188|80583292|FG013|Overall Study|Lost to Follow-up|0|||
27657018|NCT03672188|80583293|FG014|Overall Study|Lost to Follow-up|0|||
27566862|NCT03662542|80263450|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27566863|NCT03662542|80263451|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27566864|NCT03662542|80263452|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27566865|NCT03662542|80263453|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
27566866|NCT03662542|80263454|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
27566867|NCT03662542|80263455|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27566868|NCT03662542|80263456|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27566869|NCT03662542|80263457|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
27566870|NCT03662542|80263449|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566871|NCT03662542|80263450|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566872|NCT03662542|80263451|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566873|NCT03662542|80263452|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566874|NCT03662542|80263453|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566875|NCT03662542|80263454|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
27566876|NCT03662542|80263455|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566877|NCT03662542|80263456|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566878|NCT03662542|80263457|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
27566879|NCT03662542|80263449|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566880|NCT03662542|80263450|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566881|NCT03662542|80263451|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566882|NCT03662542|80263452|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566883|NCT03662542|80263453|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566884|NCT03662542|80263454|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566885|NCT03662542|80263455|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566886|NCT03662542|80263456|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
27566887|NCT03662542|80263457|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
27566888|NCT03662542|80263449|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27566889|NCT03662542|80263450|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27657019|NCT00538629|80583294|FG000|Overall Study|At subject's request|1|||
27657020|NCT00538629|80583294|FG000|Overall Study|Adverse Event|2|||
27657021|NCT00538629|80583294|FG000|Overall Study|Lack of Efficacy|12|||
27657022|NCT00538629|80583294|FG000|Overall Study|Lost to Follow-up|6|||
27657023|NCT00538629|80583294|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
27657024|NCT02379078|80583299|FG000|Overall Study|Lost to Follow-up|33|||
27657025|NCT02379078|80583300|FG001|Overall Study|Lost to Follow-up|30|||
27566890|NCT03662542|80263451|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27566891|NCT03662542|80263452|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27566892|NCT03662542|80263453|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27566893|NCT03662542|80263454|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27566894|NCT03662542|80263455|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
27566895|NCT03662542|80263456|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
27859908|NCT03249792|81319346|FG021|Switch Over Period|Progressive Disease|0|||
27859909|NCT03249792|81319347|FG022|Switch Over Period|Progressive Disease|0|||
27859910|NCT03249792|81319348|FG023|Switch Over Period|Progressive Disease|0|||
27859911|NCT03249792|81319349|FG024|Switch Over Period|Progressive Disease|0|||
27859912|NCT03249792|81319350|FG025|Switch Over Period|Progressive Disease|0|||
27859913|NCT03249792|81319351|FG026|Switch Over Period|Progressive Disease|1|||
27859914|NCT03249792|81319352|FG027|Switch Over Period|Progressive Disease|0|||
27859915|NCT03249792|81319353|FG028|Switch Over Period|Progressive Disease|1|||
27859916|NCT03249792|81319354|FG029|Switch Over Period|Progressive Disease|2|||
27859917|NCT03249792|81319355|FG030|Switch Over Period|Progressive Disease|1|||
27859918|NCT03249792|81319356|FG031|Switch Over Period|Progressive Disease|0|||
27859919|NCT03249792|81319357|FG032|Switch Over Period|Progressive Disease|1|||
27859920|NCT03249792|81319325|FG000|Switch Over Period|Adverse Event|0|||
27859921|NCT03249792|81319326|FG001|Switch Over Period|Adverse Event|0|||
27859922|NCT03249792|81319327|FG002|Switch Over Period|Adverse Event|0|||
27859923|NCT03249792|81319328|FG003|Switch Over Period|Adverse Event|0|||
27859924|NCT03249792|81319329|FG004|Switch Over Period|Adverse Event|0|||
27859925|NCT03249792|81319330|FG005|Switch Over Period|Adverse Event|0|||
27859926|NCT03249792|81319331|FG006|Switch Over Period|Adverse Event|0|||
27859927|NCT03249792|81319332|FG007|Switch Over Period|Adverse Event|0|||
27566896|NCT03662542|80263457|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
27566897|NCT03662542|80263449|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566898|NCT03662542|80263450|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566899|NCT03662542|80263451|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566900|NCT03662542|80263452|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566901|NCT03662542|80263453|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566902|NCT03662542|80263454|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566903|NCT03662542|80263455|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
27566904|NCT03662542|80263456|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
27566905|NCT03662542|80263457|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
27566906|NCT03662542|80263449|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
27566907|NCT03662542|80263450|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
27566908|NCT03662542|80263451|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
27566909|NCT03662542|80263452|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
27566910|NCT03662542|80263453|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
27566911|NCT03662542|80263454|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
27566912|NCT03662542|80263455|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
27566913|NCT03662542|80263456|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
27566914|NCT03662542|80263457|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
27566915|NCT04356963|80263462|FG000|First Session|Withdrawal by Subject|1|||
27566916|NCT04356963|80263462|FG000|Second Session|Withdrawal by Subject|3|||
27566917|NCT04356963|80263462|FG000|Second Session|Lost to Follow-up|1|||
27566918|NCT04356963|80263462|FG000|Third Session|Lost to Follow-up|6|||
27566919|NCT04356963|80263462|FG000|Third Session|Withdrawal by Subject|1|||
27566920|NCT00902564|80263463|FG000|Overall Study|Withdrawal by Subject|2|||
27566921|NCT01675882|80263464|FG000|Overall Study|Adverse Event|0|||
27566922|NCT01675882|80263465|FG001|Overall Study|Adverse Event|2|||
27566923|NCT01675882|80263466|FG002|Overall Study|Adverse Event|1|||
27566924|NCT01675882|80263467|FG003|Overall Study|Adverse Event|0|||
27566925|NCT01675882|80263464|FG000|Overall Study|Participant unwilling to continue|2|||
27566926|NCT01675882|80263465|FG001|Overall Study|Participant unwilling to continue|4|||
27566927|NCT01675882|80263466|FG002|Overall Study|Participant unwilling to continue|2|||
27566928|NCT01675882|80263467|FG003|Overall Study|Participant unwilling to continue|1|||
27566929|NCT01675882|80263464|FG000|Overall Study|Lost to Follow-up|0|||
27859928|NCT03249792|81319333|FG008|Switch Over Period|Adverse Event|0|||
27859929|NCT03249792|81319334|FG009|Switch Over Period|Adverse Event|0|||
27859930|NCT03249792|81319335|FG010|Switch Over Period|Adverse Event|0|||
27859931|NCT03249792|81319336|FG011|Switch Over Period|Adverse Event|0|||
27566930|NCT01675882|80263465|FG001|Overall Study|Lost to Follow-up|1|||
27566931|NCT01675882|80263466|FG002|Overall Study|Lost to Follow-up|0|||
27859932|NCT03249792|81319337|FG012|Switch Over Period|Adverse Event|0|||
27859933|NCT03249792|81319338|FG013|Switch Over Period|Adverse Event|0|||
27566932|NCT01675882|80263467|FG003|Overall Study|Lost to Follow-up|0|||
27859934|NCT03249792|81319339|FG014|Switch Over Period|Adverse Event|0|||
27859935|NCT03249792|81319340|FG015|Switch Over Period|Adverse Event|0|||
27859936|NCT03249792|81319341|FG016|Switch Over Period|Adverse Event|0|||
27859937|NCT03249792|81319342|FG017|Switch Over Period|Adverse Event|0|||
27859938|NCT03249792|81319343|FG018|Switch Over Period|Adverse Event|0|||
27859939|NCT03249792|81319344|FG019|Switch Over Period|Adverse Event|0|||
27566933|NCT01675882|80263464|FG000|Overall Study|Non-compliance|0|||
27566934|NCT01675882|80263465|FG001|Overall Study|Non-compliance|0|||
27566935|NCT01675882|80263466|FG002|Overall Study|Non-compliance|0|||
27566936|NCT01675882|80263467|FG003|Overall Study|Non-compliance|1|||
27566937|NCT01350128|80263468|FG000|Overall Study|Withdrawal by Subject|3|||
27566938|NCT01350128|80263468|FG000|Overall Study|Protocol discontinuation criteria|8|||
27566939|NCT01350128|80263468|FG000|Overall Study|Physician Decision|1|||
27566940|NCT01350128|80263468|FG000|Overall Study|Lost to Follow-up|2|||
27566941|NCT01869192|80263469|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
27566942|NCT01869192|80263470|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
27566943|NCT01869192|80263469|FG000|Postoperative Chemotherapy|Physician Decision|0|||
27566944|NCT01869192|80263470|FG001|Postoperative Chemotherapy|Physician Decision|2|||
27566945|NCT03509675|80263472|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
27566946|NCT03509675|80263473|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
27566947|NCT03509675|80263472|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
27566948|NCT03509675|80263473|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
27566949|NCT03509675|80263472|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
27566950|NCT03509675|80263473|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
27566951|NCT03509675|80263472|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
27566952|NCT03509675|80263473|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
27566953|NCT00854581|80263474|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
27566954|NCT00854581|80263474|FG000|Induction (Up to Day 21)|Death|1|||
27566955|NCT00854581|80263474|FG000|Induction (Up to Day 21)|Physician Decision|1|||
27566956|NCT00854581|80263474|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
27566957|NCT05179421|80263475|FG000|First Infusion Day|Adverse Event|1|||
27566958|NCT05179421|80263476|FG001|First Infusion Day|Adverse Event|0|||
27566959|NCT01660412|80263480|FG000|Overall Study|Protocol Violation|0|||
27566960|NCT01660412|80263481|FG001|Overall Study|Protocol Violation|3|||
27566961|NCT00542919|80263483|FG000|Overall Study|Adverse Event|1|||
27566962|NCT00542919|80263484|FG001|Overall Study|Adverse Event|5|||
27566963|NCT00542919|80263485|FG002|Overall Study|Adverse Event|1|||
27566964|NCT00542919|80263483|FG000|Overall Study|Withdrawal by Subject|1|||
27859940|NCT03249792|81319345|FG020|Switch Over Period|Adverse Event|0|||
27859941|NCT03249792|81319346|FG021|Switch Over Period|Adverse Event|0|||
27859942|NCT03249792|81319347|FG022|Switch Over Period|Adverse Event|0|||
27859943|NCT03249792|81319348|FG023|Switch Over Period|Adverse Event|0|||
27859944|NCT03249792|81319349|FG024|Switch Over Period|Adverse Event|0|||
27859945|NCT03249792|81319350|FG025|Switch Over Period|Adverse Event|1|||
27859946|NCT03249792|81319351|FG026|Switch Over Period|Adverse Event|0|||
27859947|NCT03249792|81319352|FG027|Switch Over Period|Adverse Event|1|||
27859948|NCT03249792|81319353|FG028|Switch Over Period|Adverse Event|0|||
27859949|NCT03249792|81319354|FG029|Switch Over Period|Adverse Event|0|||
27859950|NCT03249792|81319355|FG030|Switch Over Period|Adverse Event|0|||
27859951|NCT03249792|81319356|FG031|Switch Over Period|Adverse Event|0|||
27566965|NCT00542919|80263484|FG001|Overall Study|Withdrawal by Subject|0|||
27566966|NCT00542919|80263485|FG002|Overall Study|Withdrawal by Subject|3|||
27566967|NCT00542919|80263483|FG000|Overall Study|Physician Decision|2|||
27566968|NCT00542919|80263484|FG001|Overall Study|Physician Decision|2|||
27566969|NCT00542919|80263485|FG002|Overall Study|Physician Decision|1|||
27566970|NCT00542919|80263483|FG000|Overall Study|Sponsor Decision|1|||
27566971|NCT00542919|80263484|FG001|Overall Study|Sponsor Decision|0|||
27566972|NCT00542919|80263485|FG002|Overall Study|Sponsor Decision|0|||
27566973|NCT00542919|80263483|FG000|Overall Study|Lost to Follow-up|2|||
27566974|NCT00542919|80263484|FG001|Overall Study|Lost to Follow-up|0|||
27566975|NCT00542919|80263485|FG002|Overall Study|Lost to Follow-up|1|||
27566976|NCT01859507|80263491|FG000|Overall Study|left the country|4|||
27761207|NCT01313208|80950789|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
27761208|NCT01313208|80950788|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
27761209|NCT01313208|80950789|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
27566977|NCT03388138|80263492|FG000|Overall Study|Protocol Violation|1|||
27566978|NCT03388138|80263493|FG001|Overall Study|Protocol Violation|0|||
27566979|NCT02488681|80263496|FG000|Overall Study|Implant unsuccessful|7|||
27761210|NCT01313208|80950788|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
27761211|NCT01313208|80950789|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
27566980|NCT00549562|80263497|FG000|Overall Study|Adverse Event|1|||
27566981|NCT00549562|80263497|FG000|Overall Study|Lack of Efficacy|1|||
27566982|NCT04649164|80263499|FG000|Overall Study|Withdrawal by Subject|1|||
27566983|NCT04649164|80263500|FG001|Overall Study|Withdrawal by Subject|1|||
27761212|NCT01313208|80950788|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
27761213|NCT01313208|80950789|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
27761214|NCT01313208|80950788|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
27859952|NCT03249792|81319357|FG032|Switch Over Period|Adverse Event|0|||
27566984|NCT04649164|80263501|FG002|Overall Study|Withdrawal by Subject|2|||
27566985|NCT04649164|80263499|FG000|Overall Study|Participant's care recipient expired|0|||
27566986|NCT04649164|80263500|FG001|Overall Study|Participant's care recipient expired|0|||
27566987|NCT04649164|80263501|FG002|Overall Study|Participant's care recipient expired|2|||
27566988|NCT02439320|80263504|FG000|Overall Study|Adverse Event|0|||
27566989|NCT02439320|80263505|FG001|Overall Study|Adverse Event|2|||
27566990|NCT02439320|80263506|FG002|Overall Study|Adverse Event|0|||
27566991|NCT02439320|80263504|FG000|Overall Study|Lost to Follow-up|37|||
27566992|NCT02439320|80263505|FG001|Overall Study|Lost to Follow-up|34|||
27566993|NCT02439320|80263506|FG002|Overall Study|Lost to Follow-up|42|||
27566994|NCT02439320|80263504|FG000|Overall Study|Death|0|||
27566995|NCT02439320|80263505|FG001|Overall Study|Death|1|||
27566996|NCT02439320|80263506|FG002|Overall Study|Death|0|||
27566997|NCT02439320|80263504|FG000|Overall Study|Noncompliance with Protocol|10|||
27566998|NCT02439320|80263505|FG001|Overall Study|Noncompliance with Protocol|11|||
27566999|NCT02439320|80263506|FG002|Overall Study|Noncompliance with Protocol|7|||
27567000|NCT02439320|80263504|FG000|Overall Study|Pregnancy|0|||
27567001|NCT02439320|80263505|FG001|Overall Study|Pregnancy|1|||
27567002|NCT02439320|80263506|FG002|Overall Study|Pregnancy|1|||
27567003|NCT02439320|80263504|FG000|Overall Study|Withdrawal by Subject|12|||
27567004|NCT02439320|80263505|FG001|Overall Study|Withdrawal by Subject|16|||
27567005|NCT02439320|80263506|FG002|Overall Study|Withdrawal by Subject|14|||
27567006|NCT02439320|80263504|FG000|Overall Study|Physician Decision|2|||
27567007|NCT02439320|80263505|FG001|Overall Study|Physician Decision|1|||
27567008|NCT02439320|80263506|FG002|Overall Study|Physician Decision|0|||
27567009|NCT02439320|80263504|FG000|Overall Study|Sponsor Request|0|||
27567010|NCT02439320|80263505|FG001|Overall Study|Sponsor Request|2|||
27567011|NCT02439320|80263506|FG002|Overall Study|Sponsor Request|1|||
27567012|NCT02439320|80263504|FG000|Overall Study|Randomization Failure|35|||
27567013|NCT02439320|80263505|FG001|Overall Study|Randomization Failure|46|||
27567014|NCT02439320|80263506|FG002|Overall Study|Randomization Failure|34|||
27567015|NCT03238911|80263507|FG000|Overall Study|Withdrawal by Subject|1|||
27567016|NCT03238911|80263508|FG001|Overall Study|Withdrawal by Subject|2|||
27567017|NCT03238911|80263507|FG000|Overall Study|Lost to Follow-up|2|||
27567018|NCT03238911|80263508|FG001|Overall Study|Lost to Follow-up|1|||
27567019|NCT01446965|80263510|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
27567020|NCT01446965|80263511|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
27567021|NCT01446965|80263510|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
27567022|NCT01446965|80263511|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
27567023|NCT01418209|80263512|FG000|Overall Study|Withdrawal by Subject|1|||
27567024|NCT01418209|80263513|FG001|Overall Study|Withdrawal by Subject|0|||
27567025|NCT01418209|80263514|FG002|Overall Study|Withdrawal by Subject|1|||
27567026|NCT01418209|80263512|FG000|Overall Study|Did not provide hot flash diary data|1|||
27567027|NCT01418209|80263513|FG001|Overall Study|Did not provide hot flash diary data|3|||
27567028|NCT01418209|80263514|FG002|Overall Study|Did not provide hot flash diary data|3|||
27567029|NCT00344773|80263515|FG000|Overall Study|Adverse Event|2|||
27567030|NCT00344773|80263515|FG000|Overall Study|Objective Disease Progression|16|||
27567031|NCT00344773|80263515|FG000|Overall Study|Withdrawal by Subject|1|||
27567032|NCT00344773|80263515|FG000|Overall Study|Not Eligible for the study|2|||
27567033|NCT00006916|80263524|FG000|Overall Study|Device not inserted|4|||
27567034|NCT00006916|80263524|FG000|Overall Study|Complication of device insertion|1|||
27567035|NCT00615056|80263525|FG000|Overall Study|Death|31|||
27567036|NCT00615056|80263526|FG001|Overall Study|Death|31|||
27567037|NCT00615056|80263527|FG002|Overall Study|Death|21|||
27567038|NCT00615056|80263528|FG003|Overall Study|Death|23|||
27567039|NCT00615056|80263525|FG000|Overall Study|Lost to Follow-up|1|||
27567040|NCT00615056|80263526|FG001|Overall Study|Lost to Follow-up|2|||
27567041|NCT00615056|80263527|FG002|Overall Study|Lost to Follow-up|4|||
27567042|NCT00615056|80263528|FG003|Overall Study|Lost to Follow-up|5|||
27567043|NCT00615056|80263525|FG000|Overall Study|Other|13|||
27567044|NCT00615056|80263526|FG001|Overall Study|Other|15|||
27567045|NCT00615056|80263527|FG002|Overall Study|Other|10|||
27567046|NCT00615056|80263528|FG003|Overall Study|Other|7|||
27567047|NCT00615056|80263525|FG000|Overall Study|Objective progression or relapse|0|||
27567048|NCT00615056|80263526|FG001|Overall Study|Objective progression or relapse|2|||
27567049|NCT00615056|80263527|FG002|Overall Study|Objective progression or relapse|0|||
27567050|NCT00615056|80263528|FG003|Overall Study|Objective progression or relapse|0|||
27567051|NCT00615056|80263525|FG000|Overall Study|Withdrawal by Subject|0|||
27567052|NCT00615056|80263526|FG001|Overall Study|Withdrawal by Subject|1|||
27567053|NCT00615056|80263527|FG002|Overall Study|Withdrawal by Subject|1|||
27567054|NCT00615056|80263528|FG003|Overall Study|Withdrawal by Subject|0|||
27567055|NCT00615056|80263525|FG000|Overall Study|Discontinued by Sponsor|1|||
27567056|NCT00615056|80263526|FG001|Overall Study|Discontinued by Sponsor|0|||
27567057|NCT00615056|80263527|FG002|Overall Study|Discontinued by Sponsor|0|||
27567058|NCT00615056|80263528|FG003|Overall Study|Discontinued by Sponsor|0|||
27567059|NCT00615056|80263525|FG000|Overall Study|Randomized but not treated|3|||
27567060|NCT00615056|80263526|FG001|Overall Study|Randomized but not treated|0|||
27567061|NCT00615056|80263527|FG002|Overall Study|Randomized but not treated|0|||
27567062|NCT00615056|80263528|FG003|Overall Study|Randomized but not treated|0|||
27567063|NCT04536727|80263529|FG000|Overall Study|Lost to Follow-up|1|||
27567064|NCT04536727|80263530|FG001|Overall Study|Lost to Follow-up|1|||
27567065|NCT04536727|80263529|FG000|Overall Study|Death|0|||
27567066|NCT04536727|80263530|FG001|Overall Study|Death|1|||
27567067|NCT00634088|80263531|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
27567068|NCT00634088|80263532|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
27567069|NCT00634088|80263533|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
27567070|NCT00634088|80263534|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
27567071|NCT00634088|80263531|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
27567072|NCT00634088|80263532|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
27567073|NCT00634088|80263533|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
27567074|NCT00634088|80263534|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
27567075|NCT00634088|80263531|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
27567076|NCT00634088|80263532|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
27567077|NCT00634088|80263533|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
27567078|NCT00634088|80263534|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
27567079|NCT00634088|80263531|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
27567080|NCT00634088|80263532|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
27761215|NCT01313208|80950789|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
27761216|NCT01313208|80950788|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
27761217|NCT01313208|80950789|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
27761218|NCT01313208|80950788|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
27859953|NCT00394524|81319363|FG000|Overall Study|Protocol Violation|2|||
27859954|NCT00394524|81319364|FG001|Overall Study|Protocol Violation|3|||
27567081|NCT00634088|80263533|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
27567082|NCT00634088|80263534|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
27567083|NCT00634088|80263531|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
27567084|NCT00634088|80263532|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
27567085|NCT00634088|80263533|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
27567086|NCT00634088|80263534|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
27567087|NCT00634088|80263531|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
27567088|NCT00634088|80263532|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
27567089|NCT00634088|80263533|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
27567090|NCT00634088|80263534|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
27567091|NCT00136084|80263536|FG000|Overall Study|Death|12|||
27859955|NCT00394524|81319363|FG000|Overall Study|Death|1|||
27859956|NCT00394524|81319364|FG001|Overall Study|Death|0|||
27859957|NCT00394524|81319363|FG000|Overall Study|Withdrawal by Subject|0|||
27859958|NCT00394524|81319364|FG001|Overall Study|Withdrawal by Subject|1|||
27567092|NCT00136084|80263537|FG001|Overall Study|Death|5|||
27567093|NCT00136084|80263536|FG000|Overall Study|Unacceptable toxicity|8|||
27567094|NCT00136084|80263537|FG001|Overall Study|Unacceptable toxicity|11|||
27567095|NCT00136084|80263536|FG000|Overall Study|Relapse|20|||
27567096|NCT00136084|80263537|FG001|Overall Study|Relapse|23|||
27567097|NCT00136084|80263536|FG000|Overall Study|Lost to Follow-up|2|||
27567098|NCT00136084|80263537|FG001|Overall Study|Lost to Follow-up|0|||
27567099|NCT00136084|80263536|FG000|Overall Study|No Response|1|||
27567100|NCT00136084|80263537|FG001|Overall Study|No Response|2|||
27567101|NCT00136084|80263536|FG000|Overall Study|Withdrawal by Subject|5|||
27567102|NCT00136084|80263537|FG001|Overall Study|Withdrawal by Subject|1|||
27567103|NCT04056195|80263538|FG000|Overall Study|Adverse Event|1|||
27859959|NCT01735955|81319369|FG000|Overall Study|Administrative problems|1|||
27859960|NCT01735955|81319369|FG000|Overall Study|Patient/guardian decision|1|||
27859961|NCT01735955|81319369|FG000|Overall Study|Patient withdrew consent|2|||
27859962|NCT01735955|81319369|FG000|Overall Study|Physician Decision|4|||
27859963|NCT01735955|81319369|FG000|Overall Study|Disease progression|24|||
27859964|NCT01735955|81319369|FG000|Overall Study|Adverse Event|5|||
27859965|NCT00186888|81319370|FG000|Overall Study|Toxicity|0|||
27859966|NCT00186888|81319371|FG001|Overall Study|Toxicity|1|||
27567104|NCT04056195|80263539|FG001|Overall Study|Adverse Event|0|||
27567105|NCT04056195|80263540|FG002|Overall Study|Adverse Event|0|||
27567106|NCT04056195|80263538|FG000|Overall Study|Withdrawal by Subject|0|||
27567107|NCT04056195|80263539|FG001|Overall Study|Withdrawal by Subject|1|||
27567108|NCT04056195|80263540|FG002|Overall Study|Withdrawal by Subject|1|||
27859967|NCT00186888|81319372|FG002|Overall Study|Toxicity|0|||
27859968|NCT00186888|81319370|FG000|Overall Study|Relapse or progression of disease|4|||
27859969|NCT00186888|81319371|FG001|Overall Study|Relapse or progression of disease|2|||
27859970|NCT00186888|81319372|FG002|Overall Study|Relapse or progression of disease|0|||
27567109|NCT04056195|80263538|FG000|Overall Study|Physician Decision|1|||
27567110|NCT04056195|80263539|FG001|Overall Study|Physician Decision|1|||
27567111|NCT04056195|80263540|FG002|Overall Study|Physician Decision|1|||
27567112|NCT00663052|80263541|FG000|Overall Study|Adverse Event|6|||
27567113|NCT00663052|80263542|FG001|Overall Study|Adverse Event|3|||
27567114|NCT00663052|80263541|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
27567115|NCT00663052|80263542|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27657026|NCT02379078|80583299|FG000|Overall Study|Withdrawal by Subject|6|||
27859971|NCT04581369|81319376|FG000|Overall Study|Death|7|||
27859972|NCT04581369|81319377|FG001|Overall Study|Death|6|||
27761219|NCT01313208|80950789|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
27761220|NCT00836277|80950790|FG000|Overall Study|Not evaluable for response|6|||
27761221|NCT02188719|80950791|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
27761222|NCT02188719|80950792|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
27761223|NCT02188719|80950793|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
27761224|NCT02188719|80950794|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
27761225|NCT00293423|80950800|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
27761226|NCT00293423|80950801|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
27761227|NCT00293423|80950800|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
27761228|NCT00293423|80950801|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
27761229|NCT00293423|80950800|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
27761230|NCT00293423|80950801|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
27761231|NCT00293423|80950800|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
27761232|NCT00293423|80950801|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
27761233|NCT00293423|80950800|FG000|Surgical Resection|processing error during surgical resection|1|||
27761234|NCT00293423|80950801|FG001|Surgical Resection|processing error during surgical resection|0|||
27761235|NCT00293423|80950800|FG000|Surgical Resection|Withdrawal by Subject|4|||
27761236|NCT00293423|80950801|FG001|Surgical Resection|Withdrawal by Subject|0|||
27761237|NCT00293423|80950800|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
27761238|NCT00293423|80950801|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
27761239|NCT01354431|80950803|FG000|Pre-Treatment Period|Not reported|1|||
27761240|NCT01354431|80950804|FG001|Pre-Treatment Period|Not reported|0|||
27761241|NCT01354431|80950805|FG002|Pre-Treatment Period|Not reported|0|||
27761242|NCT01354431|80950803|FG000|Treatment Period|Disease Progression|50|||
27761243|NCT01354431|80950804|FG001|Treatment Period|Disease Progression|40|||
27761244|NCT01354431|80950805|FG002|Treatment Period|Disease Progression|44|||
27761245|NCT01354431|80950803|FG000|Treatment Period|Study Drug Toxicity|5|||
27761246|NCT01354431|80950804|FG001|Treatment Period|Study Drug Toxicity|8|||
27859973|NCT04581369|81319378|FG002|Overall Study|Death|0|||
27859974|NCT04581369|81319376|FG000|Overall Study|Lost to Follow-up|7|||
27859975|NCT04581369|81319377|FG001|Overall Study|Lost to Follow-up|3|||
27859976|NCT04581369|81319378|FG002|Overall Study|Lost to Follow-up|0|||
27859977|NCT04581369|81319376|FG000|Overall Study|liver transplant|2|||
27859978|NCT04581369|81319377|FG001|Overall Study|liver transplant|2|||
27859979|NCT04581369|81319378|FG002|Overall Study|liver transplant|0|||
27859980|NCT04581369|81319376|FG000|Overall Study|transitioned to hospice care|0|||
27859981|NCT04581369|81319377|FG001|Overall Study|transitioned to hospice care|5|||
27859982|NCT04581369|81319378|FG002|Overall Study|transitioned to hospice care|0|||
27859983|NCT01739348|81319380|FG000|Part I (Base Study)|Adverse Event|41|||
27859984|NCT01739348|81319381|FG001|Part I (Base Study)|Adverse Event|52|||
27859985|NCT01739348|81319382|FG002|Part I (Base Study)|Adverse Event|8|||
27859986|NCT01739348|81319383|FG003|Part I (Base Study)|Adverse Event|33|||
27859987|NCT01739348|81319380|FG000|Part I (Base Study)|Death|10|||
27859988|NCT01739348|81319381|FG001|Part I (Base Study)|Death|7|||
27859989|NCT01739348|81319382|FG002|Part I (Base Study)|Death|2|||
27859990|NCT01739348|81319383|FG003|Part I (Base Study)|Death|8|||
27859991|NCT01739348|81319380|FG000|Part I (Base Study)|Lack of Efficacy|3|||
27859992|NCT01739348|81319381|FG001|Part I (Base Study)|Lack of Efficacy|8|||
27859993|NCT01739348|81319382|FG002|Part I (Base Study)|Lack of Efficacy|0|||
27859994|NCT01739348|81319383|FG003|Part I (Base Study)|Lack of Efficacy|7|||
27567116|NCT00663052|80263541|FG000|Overall Study|Protocol Violation|1|||
27567117|NCT00663052|80263542|FG001|Overall Study|Protocol Violation|0|||
27859995|NCT01739348|81319380|FG000|Part I (Base Study)|Lost to Follow-up|4|||
27859996|NCT01739348|81319381|FG001|Part I (Base Study)|Lost to Follow-up|2|||
27859997|NCT01739348|81319382|FG002|Part I (Base Study)|Lost to Follow-up|4|||
27859998|NCT01739348|81319383|FG003|Part I (Base Study)|Lost to Follow-up|4|||
27859999|NCT01739348|81319380|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
27860000|NCT01739348|81319381|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
27860001|NCT01739348|81319382|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
27860002|NCT01739348|81319383|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
27860003|NCT01739348|81319380|FG000|Part I (Base Study)|Physician Decision|10|||
27860004|NCT01739348|81319381|FG001|Part I (Base Study)|Physician Decision|7|||
27860005|NCT01739348|81319382|FG002|Part I (Base Study)|Physician Decision|1|||
27860006|NCT01739348|81319383|FG003|Part I (Base Study)|Physician Decision|4|||
27860007|NCT01739348|81319380|FG000|Part I (Base Study)|Protocol Violation|2|||
27860008|NCT01739348|81319381|FG001|Part I (Base Study)|Protocol Violation|0|||
27860009|NCT01739348|81319382|FG002|Part I (Base Study)|Protocol Violation|1|||
27860010|NCT01739348|81319383|FG003|Part I (Base Study)|Protocol Violation|2|||
27860011|NCT01739348|81319380|FG000|Part I (Base Study)|Screen Failure|2|||
27860012|NCT01739348|81319381|FG001|Part I (Base Study)|Screen Failure|0|||
27860013|NCT01739348|81319382|FG002|Part I (Base Study)|Screen Failure|0|||
27860014|NCT01739348|81319383|FG003|Part I (Base Study)|Screen Failure|0|||
27860015|NCT01739348|81319380|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
27860016|NCT01739348|81319381|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
27860017|NCT01739348|81319382|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
27860018|NCT01739348|81319383|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
27860019|NCT01739348|81319380|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
27860020|NCT01739348|81319381|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
27860021|NCT01739348|81319382|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
27860022|NCT01739348|81319383|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
27860023|NCT01739348|81319380|FG000|Part I (Base Study)|Participant Moved|4|||
27860024|NCT01739348|81319381|FG001|Part I (Base Study)|Participant Moved|3|||
27860025|NCT01739348|81319382|FG002|Part I (Base Study)|Participant Moved|1|||
27860026|NCT01739348|81319383|FG003|Part I (Base Study)|Participant Moved|7|||
27860027|NCT01739348|81319380|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
27860028|NCT01739348|81319381|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
27860029|NCT01739348|81319382|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
27860030|NCT01739348|81319383|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
27860031|NCT01739348|81319380|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
27860032|NCT01739348|81319381|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
27860033|NCT01739348|81319382|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
27860034|NCT01739348|81319383|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
27860035|NCT01739348|81319380|FG000|Part II (Extension Study)|Adverse Event|10|||
27860036|NCT01739348|81319381|FG001|Part II (Extension Study)|Adverse Event|11|||
27860037|NCT01739348|81319382|FG002|Part II (Extension Study)|Adverse Event|7|||
27860038|NCT01739348|81319383|FG003|Part II (Extension Study)|Adverse Event|26|||
27860039|NCT01739348|81319380|FG000|Part II (Extension Study)|Death|3|||
27860040|NCT01739348|81319381|FG001|Part II (Extension Study)|Death|3|||
27860041|NCT01739348|81319382|FG002|Part II (Extension Study)|Death|2|||
27860042|NCT01739348|81319383|FG003|Part II (Extension Study)|Death|6|||
27860043|NCT01739348|81319380|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
27860044|NCT01739348|81319381|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
27860045|NCT01739348|81319382|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
27860046|NCT01739348|81319383|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
27860047|NCT01739348|81319380|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
27860048|NCT01739348|81319381|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
27860049|NCT01739348|81319382|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
27860050|NCT01739348|81319383|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
27860051|NCT01739348|81319380|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
27860052|NCT01739348|81319381|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
27860053|NCT01739348|81319382|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
27860054|NCT01739348|81319383|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
27860055|NCT01739348|81319380|FG000|Part II (Extension Study)|Physician Decision|7|||
27860056|NCT01739348|81319381|FG001|Part II (Extension Study)|Physician Decision|11|||
27860057|NCT01739348|81319382|FG002|Part II (Extension Study)|Physician Decision|6|||
27860058|NCT01739348|81319383|FG003|Part II (Extension Study)|Physician Decision|12|||
27860059|NCT01739348|81319380|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
27860060|NCT01739348|81319381|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
27860061|NCT01739348|81319382|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
27860062|NCT01739348|81319383|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
27860063|NCT01739348|81319380|FG000|Part II (Extension Study)|Participant Moved|3|||
27860064|NCT01739348|81319381|FG001|Part II (Extension Study)|Participant Moved|3|||
27860065|NCT01739348|81319382|FG002|Part II (Extension Study)|Participant Moved|0|||
27860066|NCT01739348|81319383|FG003|Part II (Extension Study)|Participant Moved|3|||
27860067|NCT01739348|81319380|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
27860068|NCT01739348|81319381|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
27860069|NCT01739348|81319382|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
27860070|NCT01739348|81319383|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
27860071|NCT01739348|81319380|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
27860072|NCT01739348|81319381|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
27860073|NCT01739348|81319382|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
27860074|NCT01739348|81319383|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
27860075|NCT02992418|81319388|FG000|Overall Study|Withdrawal by Subject|11|||
27860076|NCT02992418|81319389|FG001|Overall Study|Withdrawal by Subject|12|||
27860077|NCT02992418|81319388|FG000|Overall Study|Non-compliance with the protocol|308|||
27860078|NCT02992418|81319389|FG001|Overall Study|Non-compliance with the protocol|308|||
27860079|NCT02992418|81319388|FG000|Overall Study|Lost to Follow-up|27|||
27860080|NCT02992418|81319389|FG001|Overall Study|Lost to Follow-up|22|||
27860081|NCT00609518|81319390|FG000|Overall Study|Death from Study Disease|32|||
27860082|NCT00609518|81319391|FG001|Overall Study|Death from Study Disease|32|||
27860083|NCT00609518|81319390|FG000|Overall Study|Withdrawal by Subject|5|||
27860084|NCT00609518|81319391|FG001|Overall Study|Withdrawal by Subject|3|||
27860085|NCT00609518|81319390|FG000|Overall Study|Lost to Follow-up|3|||
27860086|NCT00609518|81319391|FG001|Overall Study|Lost to Follow-up|0|||
27860087|NCT00609518|81319390|FG000|Overall Study|Physician Decision|1|||
27860088|NCT00609518|81319391|FG001|Overall Study|Physician Decision|3|||
27860089|NCT00609518|81319390|FG000|Overall Study|Death from Adverse Event|2|||
27860090|NCT00609518|81319391|FG001|Overall Study|Death from Adverse Event|2|||
27860091|NCT01087489|81319392|FG000|Overall Study|enrolled in another VA study|0|||
27860092|NCT01087489|81319393|FG001|Overall Study|enrolled in another VA study|1|||
27860093|NCT01087489|81319392|FG000|Overall Study|Death|0|||
27860094|NCT01087489|81319393|FG001|Overall Study|Death|1|||
27860095|NCT01087489|81319392|FG000|Overall Study|unable to survey by telephone|0|||
27860096|NCT01087489|81319393|FG001|Overall Study|unable to survey by telephone|1|||
27860097|NCT01292226|81319398|FG000|Overall Study|Adverse Event|5|||
27860098|NCT01292226|81319398|FG000|Overall Study|Death|1|||
27860099|NCT01292226|81319398|FG000|Overall Study|Graft loss|1|||
27860100|NCT01292226|81319398|FG000|Overall Study|Protocol Violation|3|||
27860101|NCT01292226|81319398|FG000|Overall Study|Withdrawal by Subject|1|||
27860102|NCT01292226|81319398|FG000|Overall Study|Other|2|||
27860103|NCT04844762|81319399|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860104|NCT04844762|81319400|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860105|NCT04844762|81319401|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
27860106|NCT04844762|81319402|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860107|NCT04844762|81319403|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860108|NCT04844762|81319404|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27567118|NCT00663052|80263541|FG000|Overall Study|Withdrawal by Subject|2|||
27567119|NCT00663052|80263542|FG001|Overall Study|Withdrawal by Subject|5|||
27567120|NCT00663052|80263541|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
27567121|NCT00663052|80263542|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
27567122|NCT00663052|80263541|FG000|Overall Study|Other|0|||
27567123|NCT00663052|80263542|FG001|Overall Study|Other|1|||
27567124|NCT00962104|80263543|FG000|Overall Study|Adverse Event|10|||
27567125|NCT00962104|80263544|FG001|Overall Study|Adverse Event|3|||
27567126|NCT00962104|80263543|FG000|Overall Study|Entry Criteria Not Met|1|||
27567127|NCT00962104|80263544|FG001|Overall Study|Entry Criteria Not Met|2|||
27567128|NCT00962104|80263543|FG000|Overall Study|Lack of Efficacy|0|||
27567129|NCT00962104|80263544|FG001|Overall Study|Lack of Efficacy|1|||
27567130|NCT00962104|80263543|FG000|Overall Study|Lost to Follow-up|10|||
27567131|NCT00962104|80263544|FG001|Overall Study|Lost to Follow-up|4|||
27567132|NCT00962104|80263543|FG000|Overall Study|Physician Decision|1|||
27567133|NCT00962104|80263544|FG001|Overall Study|Physician Decision|0|||
27567134|NCT00962104|80263543|FG000|Overall Study|Protocol Violation|6|||
27567135|NCT00962104|80263544|FG001|Overall Study|Protocol Violation|8|||
27567136|NCT00962104|80263543|FG000|Overall Study|Sponsor Decision|0|||
27567137|NCT00962104|80263544|FG001|Overall Study|Sponsor Decision|1|||
27567138|NCT00962104|80263543|FG000|Overall Study|Withdrawal by Subject|10|||
27567139|NCT00962104|80263544|FG001|Overall Study|Withdrawal by Subject|6|||
27567140|NCT00962104|80263543|FG000|Overall Study|Other|2|||
27567141|NCT00962104|80263544|FG001|Overall Study|Other|0|||
27567142|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
27567143|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
27567144|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
27567145|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
27567146|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
27567147|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
27567148|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
27567149|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
27860109|NCT04844762|81319399|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
27860110|NCT04844762|81319400|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
27860111|NCT04844762|81319401|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
27567150|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
27567151|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
27860112|NCT04844762|81319402|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
27567152|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
27567153|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
27567154|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
27567155|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
27567156|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
27567157|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
27567158|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
27567159|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
27567160|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
27567161|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
27567162|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
27567163|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
27567164|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
27567165|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
27567166|NCT00277212|80263547|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
27567167|NCT00277212|80263548|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
27567168|NCT00277212|80263549|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
27567169|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
27567170|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
27567171|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
27567172|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
27567173|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
27567174|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
27567175|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
27567176|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
27567177|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
27567178|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
27567179|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
27567180|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
27567181|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
27567182|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
27567183|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
27567184|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
27567185|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
27567186|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
27567187|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
27567188|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
27567189|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
27567190|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
27567191|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
27567192|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
27567193|NCT00277212|80263547|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
27567194|NCT00277212|80263548|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
27567195|NCT00277212|80263549|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
27567196|NCT02113956|80263550|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
27567197|NCT02113956|80263551|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
27567198|NCT02113956|80263550|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
27567199|NCT02113956|80263551|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
27567200|NCT02113956|80263550|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
27567201|NCT02113956|80263551|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
27567202|NCT01706003|80263552|FG000|Overall Study|Withdrawal by Subject|2|||
27567203|NCT01706003|80263553|FG001|Overall Study|Withdrawal by Subject|0|||
27567204|NCT01706003|80263552|FG000|Overall Study|Not scheduled|3|||
27567205|NCT01706003|80263553|FG001|Overall Study|Not scheduled|0|||
27567206|NCT01706003|80263552|FG000|Overall Study|Lost to Follow-up|6|||
27567207|NCT01706003|80263553|FG001|Overall Study|Lost to Follow-up|4|||
27567208|NCT01452412|80263554|FG000|Overall Study|Withdrawal by Subject|15|||
27567209|NCT01452412|80263555|FG001|Overall Study|Withdrawal by Subject|11|||
27567210|NCT01452412|80263554|FG000|Overall Study|Adverse Event|4|||
27567211|NCT01452412|80263555|FG001|Overall Study|Adverse Event|3|||
27567212|NCT01452412|80263554|FG000|Overall Study|Lost to Follow-up|5|||
27567213|NCT01452412|80263555|FG001|Overall Study|Lost to Follow-up|3|||
27567214|NCT01452412|80263554|FG000|Overall Study|Death|1|||
27567215|NCT01452412|80263555|FG001|Overall Study|Death|0|||
27567216|NCT01452412|80263554|FG000|Overall Study|Initiated dialysis|1|||
27567217|NCT01452412|80263555|FG001|Overall Study|Initiated dialysis|0|||
27567218|NCT01452412|80263554|FG000|Overall Study|Other|2|||
27567219|NCT01452412|80263555|FG001|Overall Study|Other|0|||
27567220|NCT02519712|80267167|FG000|Overall Study|Disease Relapse|1|||
27567221|NCT02519712|80267167|FG000|Overall Study|Disease Progression|1|||
27567222|NCT02519712|80267167|FG000|Overall Study|Accruals are donors|2|||
27567223|NCT01063764|80267169|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
27567224|NCT01063764|80267169|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
27567225|NCT01063764|80267169|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
27567226|NCT01063764|80267169|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
27567227|NCT01063764|80267169|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
27567228|NCT01063764|80267169|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
27567229|NCT01063764|80267169|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
27567230|NCT00558103|80267171|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
27567231|NCT00558103|80267172|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
27567232|NCT00558103|80267173|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
27567233|NCT00558103|80267174|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
27567234|NCT00558103|80267175|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
27567235|NCT00558103|80267176|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
27567236|NCT00558103|80267171|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
27567237|NCT00558103|80267172|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
27567238|NCT00558103|80267173|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
27567239|NCT00558103|80267174|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
27567240|NCT00558103|80267175|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
27567241|NCT00558103|80267176|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
27567242|NCT00558103|80267171|FG000|Randomized Treatment Phase|Disease Progression|1|||
27567243|NCT00558103|80267172|FG001|Randomized Treatment Phase|Disease Progression|0|||
27567244|NCT00558103|80267173|FG002|Randomized Treatment Phase|Disease Progression|1|||
27567245|NCT00558103|80267174|FG003|Randomized Treatment Phase|Disease Progression|0|||
27567246|NCT00558103|80267175|FG004|Randomized Treatment Phase|Disease Progression|0|||
27567247|NCT00558103|80267176|FG005|Randomized Treatment Phase|Disease Progression|0|||
27567248|NCT00558103|80267171|FG000|Randomized Treatment Phase|Adverse Event|0|||
27567249|NCT00558103|80267172|FG001|Randomized Treatment Phase|Adverse Event|0|||
27567250|NCT00558103|80267173|FG002|Randomized Treatment Phase|Adverse Event|0|||
27567251|NCT00558103|80267174|FG003|Randomized Treatment Phase|Adverse Event|1|||
27567252|NCT00558103|80267175|FG004|Randomized Treatment Phase|Adverse Event|1|||
27567253|NCT00558103|80267176|FG005|Randomized Treatment Phase|Adverse Event|0|||
27567254|NCT00558103|80267171|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
27567255|NCT00558103|80267172|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
27567256|NCT00558103|80267173|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
27567257|NCT00558103|80267174|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
27567258|NCT00558103|80267175|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
27567259|NCT00558103|80267176|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
27567260|NCT00558103|80267171|FG000|Monotherapy Extension Phase|Disease Progression|0|||
27567261|NCT00558103|80267172|FG001|Monotherapy Extension Phase|Disease Progression|0|||
27567262|NCT00558103|80267173|FG002|Monotherapy Extension Phase|Disease Progression|0|||
27567263|NCT00558103|80267174|FG003|Monotherapy Extension Phase|Disease Progression|0|||
27567264|NCT00558103|80267175|FG004|Monotherapy Extension Phase|Disease Progression|0|||
27567265|NCT00558103|80267176|FG005|Monotherapy Extension Phase|Disease Progression|8|||
27567266|NCT00453999|80267179|FG000|Overall Study|Adverse Event|1|||
27860113|NCT04844762|81319403|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
27567267|NCT00453999|80267180|FG001|Overall Study|Adverse Event|2|||
27567268|NCT00453999|80267181|FG002|Overall Study|Adverse Event|1|||
27567269|NCT00453999|80267179|FG000|Overall Study|Lost to Follow-up|0|||
27567270|NCT00453999|80267180|FG001|Overall Study|Lost to Follow-up|1|||
27567271|NCT00453999|80267181|FG002|Overall Study|Lost to Follow-up|1|||
27567272|NCT00453999|80267179|FG000|Overall Study|Withdrawal by Subject|2|||
27567273|NCT00453999|80267180|FG001|Overall Study|Withdrawal by Subject|1|||
27567274|NCT00453999|80267181|FG002|Overall Study|Withdrawal by Subject|1|||
27567275|NCT00453999|80267179|FG000|Overall Study|Subject Request|2|||
27567276|NCT00453999|80267180|FG001|Overall Study|Subject Request|1|||
27567277|NCT00453999|80267181|FG002|Overall Study|Subject Request|0|||
27567278|NCT00445328|80267182|FG000|Overall Study|Death|0|||
27567279|NCT00445328|80267183|FG001|Overall Study|Death|1|||
27567280|NCT00445328|80267182|FG000|Overall Study|Adverse Event|0|||
27567281|NCT00445328|80267183|FG001|Overall Study|Adverse Event|3|||
27567282|NCT00445328|80267182|FG000|Overall Study|Other|0|||
27567283|NCT00445328|80267183|FG001|Overall Study|Other|2|||
27567284|NCT00445328|80267182|FG000|Overall Study|Withdrawal by Subject|2|||
27567285|NCT00445328|80267183|FG001|Overall Study|Withdrawal by Subject|0|||
27567286|NCT00445328|80267182|FG000|Overall Study|Protocol Violation|1|||
27567287|NCT00445328|80267183|FG001|Overall Study|Protocol Violation|0|||
27567288|NCT00913744|80267184|FG000|Overall Study|Adverse Event|2|||
27567289|NCT00913744|80267185|FG001|Overall Study|Adverse Event|0|||
27567290|NCT00913744|80267184|FG000|Overall Study|Withdrawal by Subject|2|||
27567291|NCT00913744|80267185|FG001|Overall Study|Withdrawal by Subject|1|||
27567292|NCT00913744|80267184|FG000|Overall Study|Death|1|||
27567293|NCT00913744|80267185|FG001|Overall Study|Death|0|||
27567294|NCT01736696|80267186|FG000|Overall Study|Withdrawal by Subject|0|||
27567295|NCT01736696|80267187|FG001|Overall Study|Withdrawal by Subject|0|||
27567296|NCT01736696|80267188|FG002|Overall Study|Withdrawal by Subject|1|||
27567297|NCT01736696|80267189|FG003|Overall Study|Withdrawal by Subject|0|||
27567298|NCT01736696|80267190|FG004|Overall Study|Withdrawal by Subject|0|||
27567299|NCT01736696|80267191|FG005|Overall Study|Withdrawal by Subject|0|||
27567300|NCT01736696|80267192|FG006|Overall Study|Withdrawal by Subject|0|||
27567301|NCT03299192|80267194|FG000|Overall Study|Fell before classes started|1|||
27567302|NCT03299192|80267195|FG001|Overall Study|Fell before classes started|0|||
27567303|NCT03299192|80267196|FG002|Overall Study|Fell before classes started|0|||
27567304|NCT03299192|80267194|FG000|Overall Study|Other|0|||
27567305|NCT03299192|80267195|FG001|Overall Study|Other|2|||
27567306|NCT03299192|80267196|FG002|Overall Study|Other|1|||
27567307|NCT03168464|80267197|FG000|Overall Study|Death|9|||
27567308|NCT03168464|80267197|FG000|Overall Study|Progression of disease|6|||
27567309|NCT00480779|80267198|FG000|Overall Study|Other|2|||
27567310|NCT00480779|80267199|FG001|Overall Study|Other|0|||
27567311|NCT00480779|80267198|FG000|Overall Study|Job and Health-related|0|||
27567312|NCT00480779|80267199|FG001|Overall Study|Job and Health-related|3|||
27567313|NCT01009099|80267209|FG000|Overall Study|Lost to Follow-up|1|||
27567314|NCT01009099|80267210|FG001|Overall Study|Lost to Follow-up|0|||
27567315|NCT01009099|80267209|FG000|Overall Study|Physician Decision|3|||
27567316|NCT01009099|80267210|FG001|Overall Study|Physician Decision|2|||
27567317|NCT01009099|80267209|FG000|Overall Study|Withdrawal by Subject|1|||
27567318|NCT01009099|80267210|FG001|Overall Study|Withdrawal by Subject|1|||
27567319|NCT01009099|80267209|FG000|Overall Study|Death|0|||
27567320|NCT01009099|80267210|FG001|Overall Study|Death|1|||
27567321|NCT04248816|80267211|FG000|Overall Study|Ineligible post-randomization|7|||
27567322|NCT04248816|80267212|FG001|Overall Study|Ineligible post-randomization|21|||
27860114|NCT04844762|81319404|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
27860115|NCT04844762|81319399|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27567323|NCT04248816|80267213|FG002|Overall Study|Ineligible post-randomization|25|||
27567324|NCT00127712|80267214|FG000|Overall Study|Adverse Event|3|||
27567325|NCT00127712|80267215|FG001|Overall Study|Adverse Event|0|||
27860116|NCT04844762|81319400|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27567326|NCT00127712|80267214|FG000|Overall Study|Lack of GI access to continue|2|||
27567327|NCT00127712|80267215|FG001|Overall Study|Lack of GI access to continue|0|||
27567328|NCT01520363|80267216|FG000|Overall Study|Withdrawal by Subject|2|||
27567329|NCT01520363|80267217|FG001|Overall Study|Withdrawal by Subject|0|||
27567330|NCT04200248|80267218|FG000|Overall Study|Personal reasons|0|||
27567331|NCT04200248|80267219|FG001|Overall Study|Personal reasons|0|||
27567332|NCT04200248|80267220|FG002|Overall Study|Personal reasons|1|||
27567333|NCT04200248|80267218|FG000|Overall Study|Discontinued prior to treatment|3|||
27567334|NCT04200248|80267219|FG001|Overall Study|Discontinued prior to treatment|3|||
27567335|NCT04200248|80267220|FG002|Overall Study|Discontinued prior to treatment|2|||
27567336|NCT03323658|80267221|FG000|Overall Study|Adverse Event|0|||
27567337|NCT03323658|80267222|FG001|Overall Study|Adverse Event|1|||
27567338|NCT03323658|80267223|FG002|Overall Study|Adverse Event|0|||
27860117|NCT04844762|81319401|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
27860118|NCT04844762|81319402|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
27860119|NCT04844762|81319403|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860120|NCT04844762|81319404|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
27860121|NCT04844762|81319399|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860122|NCT04844762|81319400|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860123|NCT04844762|81319401|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
27860124|NCT04844762|81319402|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
27860125|NCT04844762|81319403|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
27860126|NCT04844762|81319404|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860127|NCT04844762|81319399|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
27567339|NCT00856908|80267236|FG000|Overall Study|Lost to Follow-up|1|||
27567340|NCT00856908|80267237|FG001|Overall Study|Lost to Follow-up|0|||
27567341|NCT00097721|80267243|FG000|Overall Study|Adverse Event|8|||
27567342|NCT00097721|80267244|FG001|Overall Study|Adverse Event|1|||
27567343|NCT00097721|80267243|FG000|Overall Study|Withdrawal by Subject|6|||
27567344|NCT00097721|80267244|FG001|Overall Study|Withdrawal by Subject|1|||
27567345|NCT00097721|80267243|FG000|Overall Study|Progressive Disease|55|||
27567346|NCT00097721|80267244|FG001|Overall Study|Progressive Disease|27|||
27567347|NCT00097721|80267243|FG000|Overall Study|Physician Decision|1|||
27567348|NCT00097721|80267244|FG001|Overall Study|Physician Decision|3|||
27567349|NCT00097721|80267243|FG000|Overall Study|Reason not given|1|||
27567350|NCT00097721|80267244|FG001|Overall Study|Reason not given|1|||
27567351|NCT03336216|80267245|FG000|Randomization|Not reported|2|||
27567352|NCT03336216|80267246|FG001|Randomization|Not reported|0|||
27567353|NCT03336216|80267247|FG002|Randomization|Not reported|1|||
27567354|NCT03336216|80267248|FG003|Randomization|Not reported|0|||
27567355|NCT03336216|80267245|FG000|Randomization|Other reasons|1|||
27567356|NCT03336216|80267246|FG001|Randomization|Other reasons|1|||
27567357|NCT03336216|80267247|FG002|Randomization|Other reasons|1|||
27567358|NCT03336216|80267248|FG003|Randomization|Other reasons|0|||
27567359|NCT03336216|80267245|FG000|Randomization|Participant no longer meets study criteria|0|||
27567360|NCT03336216|80267246|FG001|Randomization|Participant no longer meets study criteria|2|||
27567361|NCT03336216|80267247|FG002|Randomization|Participant no longer meets study criteria|4|||
27567362|NCT03336216|80267248|FG003|Randomization|Participant no longer meets study criteria|1|||
27567363|NCT03336216|80267245|FG000|Randomization|Lost to Follow-up|1|||
27567364|NCT03336216|80267246|FG001|Randomization|Lost to Follow-up|0|||
27567365|NCT03336216|80267247|FG002|Randomization|Lost to Follow-up|0|||
27567366|NCT03336216|80267248|FG003|Randomization|Lost to Follow-up|0|||
27567367|NCT03336216|80267245|FG000|Randomization|Participant withdrew consent|9|||
27567368|NCT03336216|80267246|FG001|Randomization|Participant withdrew consent|1|||
27567369|NCT03336216|80267247|FG002|Randomization|Participant withdrew consent|0|||
27567370|NCT03336216|80267248|FG003|Randomization|Participant withdrew consent|0|||
27567371|NCT03336216|80267245|FG000|Randomization|Adverse Event|1|||
27567372|NCT03336216|80267246|FG001|Randomization|Adverse Event|1|||
27567373|NCT03336216|80267247|FG002|Randomization|Adverse Event|0|||
27567374|NCT03336216|80267248|FG003|Randomization|Adverse Event|0|||
27567375|NCT03336216|80267245|FG000|Treatment|Adverse Event|2|||
27567376|NCT03336216|80267246|FG001|Treatment|Adverse Event|3|||
27567377|NCT03336216|80267247|FG002|Treatment|Adverse Event|4|||
27567378|NCT03336216|80267248|FG003|Treatment|Adverse Event|4|||
27567379|NCT03336216|80267245|FG000|Treatment|Participant request to discontinue treatment|2|||
27567380|NCT03336216|80267246|FG001|Treatment|Participant request to discontinue treatment|1|||
27567381|NCT03336216|80267247|FG002|Treatment|Participant request to discontinue treatment|2|||
27567382|NCT03336216|80267248|FG003|Treatment|Participant request to discontinue treatment|2|||
27567383|NCT03336216|80267245|FG000|Treatment|Participant withdrew consent|7|||
27567384|NCT03336216|80267246|FG001|Treatment|Participant withdrew consent|2|||
27761247|NCT01354431|80950805|FG002|Treatment Period|Study Drug Toxicity|4|||
27761248|NCT01354431|80950803|FG000|Treatment Period|Death|0|||
27761249|NCT01354431|80950804|FG001|Treatment Period|Death|1|||
27567385|NCT03336216|80267247|FG002|Treatment|Participant withdrew consent|3|||
27567386|NCT03336216|80267248|FG003|Treatment|Participant withdrew consent|2|||
27567387|NCT03336216|80267245|FG000|Treatment|Death|2|||
27567388|NCT03336216|80267246|FG001|Treatment|Death|3|||
27567389|NCT03336216|80267247|FG002|Treatment|Death|3|||
27761250|NCT01354431|80950805|FG002|Treatment Period|Death|0|||
27567390|NCT03336216|80267248|FG003|Treatment|Death|4|||
27567391|NCT03336216|80267245|FG000|Treatment|Participant no longer meets study criteria|0|||
27567392|NCT03336216|80267246|FG001|Treatment|Participant no longer meets study criteria|1|||
27761251|NCT01354431|80950803|FG000|Treatment Period|AE unrelated to study drug|1|||
27567393|NCT03336216|80267247|FG002|Treatment|Participant no longer meets study criteria|0|||
27567394|NCT03336216|80267248|FG003|Treatment|Participant no longer meets study criteria|0|||
27567395|NCT03336216|80267245|FG000|Treatment|Other reasons|2|||
27567396|NCT03336216|80267246|FG001|Treatment|Other reasons|0|||
27567397|NCT03336216|80267247|FG002|Treatment|Other reasons|0|||
27567398|NCT03336216|80267248|FG003|Treatment|Other reasons|3|||
27567399|NCT03336216|80267245|FG000|Treatment|Disease progression|23|||
27567400|NCT03336216|80267246|FG001|Treatment|Disease progression|34|||
27567401|NCT03336216|80267247|FG002|Treatment|Disease progression|33|||
27761252|NCT01354431|80950804|FG001|Treatment Period|AE unrelated to study drug|2|||
27860128|NCT04844762|81319400|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
27567402|NCT03336216|80267248|FG003|Treatment|Disease progression|26|||
27567403|NCT03336216|80267245|FG000|Treatment|Study drug toxicity|0|||
27567404|NCT03336216|80267246|FG001|Treatment|Study drug toxicity|3|||
27567405|NCT03336216|80267247|FG002|Treatment|Study drug toxicity|2|||
27567406|NCT03336216|80267248|FG003|Treatment|Study drug toxicity|0|||
27567407|NCT03336216|80267245|FG000|Treatment|Adverse Event unrelated to study drug|1|||
27567408|NCT03336216|80267246|FG001|Treatment|Adverse Event unrelated to study drug|1|||
27567409|NCT03336216|80267247|FG002|Treatment|Adverse Event unrelated to study drug|1|||
27567410|NCT03336216|80267248|FG003|Treatment|Adverse Event unrelated to study drug|0|||
27567411|NCT03336216|80267245|FG000|Treatment|Disease Recurrence|1|||
27567412|NCT03336216|80267246|FG001|Treatment|Disease Recurrence|0|||
27567413|NCT03336216|80267247|FG002|Treatment|Disease Recurrence|0|||
27567414|NCT03336216|80267248|FG003|Treatment|Disease Recurrence|0|||
27567415|NCT00588445|80267249|FG000|Overall Study|Protocol Violation|1|||
27567416|NCT00588445|80267249|FG000|Overall Study|Withdrawal by Subject|3|||
27567417|NCT00588445|80267249|FG000|Overall Study|Disease Progression|1|||
27567418|NCT00588445|80267249|FG000|Overall Study|Not Treated|10|||
27567419|NCT00449956|80267256|FG000|Overall Study|Adverse Event|7|||
27567420|NCT00449956|80267257|FG001|Overall Study|Adverse Event|1|||
27567421|NCT00449956|80267258|FG002|Overall Study|Adverse Event|6|||
27567422|NCT00449956|80267256|FG000|Overall Study|Lack of Efficacy|0|||
27567423|NCT00449956|80267257|FG001|Overall Study|Lack of Efficacy|0|||
27567424|NCT00449956|80267258|FG002|Overall Study|Lack of Efficacy|1|||
27567425|NCT00449956|80267256|FG000|Overall Study|Protocol Violation|1|||
27567426|NCT00449956|80267257|FG001|Overall Study|Protocol Violation|1|||
27567427|NCT00449956|80267258|FG002|Overall Study|Protocol Violation|1|||
27567428|NCT00449956|80267256|FG000|Overall Study|Withdrawal by Subject|0|||
27567429|NCT00449956|80267257|FG001|Overall Study|Withdrawal by Subject|1|||
27567430|NCT00449956|80267258|FG002|Overall Study|Withdrawal by Subject|0|||
27567431|NCT00449956|80267256|FG000|Overall Study|Physician Decision|2|||
27567432|NCT00449956|80267257|FG001|Overall Study|Physician Decision|1|||
27567433|NCT00449956|80267258|FG002|Overall Study|Physician Decision|1|||
27567434|NCT01203072|80267259|FG000|Overall Study|Adverse Event|5|||
27567435|NCT01203072|80267260|FG001|Overall Study|Adverse Event|3|||
27567436|NCT01203072|80267261|FG002|Overall Study|Adverse Event|2|||
27567437|NCT01203072|80267262|FG003|Overall Study|Adverse Event|4|||
27567438|NCT01203072|80267263|FG004|Overall Study|Adverse Event|2|||
27567439|NCT01203072|80267259|FG000|Overall Study|Lack of Efficacy|1|||
27567440|NCT01203072|80267260|FG001|Overall Study|Lack of Efficacy|0|||
27567441|NCT01203072|80267261|FG002|Overall Study|Lack of Efficacy|0|||
27567442|NCT01203072|80267262|FG003|Overall Study|Lack of Efficacy|0|||
27567443|NCT01203072|80267263|FG004|Overall Study|Lack of Efficacy|0|||
27567444|NCT01203072|80267259|FG000|Overall Study|Lost to Follow-up|0|||
27567445|NCT01203072|80267260|FG001|Overall Study|Lost to Follow-up|1|||
27567446|NCT01203072|80267261|FG002|Overall Study|Lost to Follow-up|0|||
27567447|NCT01203072|80267262|FG003|Overall Study|Lost to Follow-up|0|||
27567448|NCT01203072|80267263|FG004|Overall Study|Lost to Follow-up|0|||
27567449|NCT01203072|80267259|FG000|Overall Study|Protocol Violation|2|||
27567450|NCT01203072|80267260|FG001|Overall Study|Protocol Violation|0|||
27567451|NCT01203072|80267261|FG002|Overall Study|Protocol Violation|0|||
27567452|NCT01203072|80267262|FG003|Overall Study|Protocol Violation|0|||
27567453|NCT01203072|80267263|FG004|Overall Study|Protocol Violation|1|||
27567454|NCT01203072|80267259|FG000|Overall Study|Withdrawal by Subject|2|||
27761253|NCT01354431|80950805|FG002|Treatment Period|AE unrelated to study drug|5|||
27761254|NCT01354431|80950803|FG000|Treatment Period|Participant request to discontinue|2|||
27860129|NCT04844762|81319401|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27567455|NCT01203072|80267260|FG001|Overall Study|Withdrawal by Subject|2|||
27567456|NCT01203072|80267261|FG002|Overall Study|Withdrawal by Subject|1|||
27567457|NCT01203072|80267262|FG003|Overall Study|Withdrawal by Subject|2|||
27567458|NCT01203072|80267263|FG004|Overall Study|Withdrawal by Subject|3|||
27567459|NCT00748215|80267264|FG000|Overall Study|Withdrawal by Subject|7|||
27567460|NCT00748215|80267265|FG001|Overall Study|Withdrawal by Subject|7|||
27567461|NCT00748215|80267264|FG000|Overall Study|Treatment change|2|||
27567462|NCT00748215|80267265|FG001|Overall Study|Treatment change|1|||
27567463|NCT00748215|80267264|FG000|Overall Study|Change in patient condition|0|||
27567464|NCT00748215|80267265|FG001|Overall Study|Change in patient condition|3|||
27567465|NCT00748215|80267264|FG000|Overall Study|Non-compliant|0|||
27567466|NCT00748215|80267265|FG001|Overall Study|Non-compliant|2|||
27567467|NCT00748215|80267264|FG000|Overall Study|Adverse Event|0|||
27567468|NCT00748215|80267265|FG001|Overall Study|Adverse Event|5|||
27567469|NCT02321462|80267291|FG000|Overall Study|Withdrawal by Subject|5|||
27567470|NCT02321462|80267292|FG001|Overall Study|Withdrawal by Subject|2|||
27567471|NCT02321462|80267291|FG000|Overall Study|Subject withdrawn before any treatment|1|||
27567472|NCT02321462|80267292|FG001|Overall Study|Subject withdrawn before any treatment|1|||
27567473|NCT02910167|80267293|FG000|Overall Study|Adverse Event|1|||
27567474|NCT02910167|80267293|FG000|Overall Study|Lost to Follow-up|18|||
27567475|NCT02281552|80267301|FG000|Overall Study|Medication error|1|||
27567476|NCT02281552|80267302|FG001|Overall Study|Medication error|0|||
27567477|NCT02281552|80267301|FG000|Overall Study|Insufficient clinical response|0|||
27567478|NCT02281552|80267302|FG001|Overall Study|Insufficient clinical response|1|||
27567479|NCT02281552|80267301|FG000|Overall Study|Adverse Event|3|||
27657027|NCT02379078|80583300|FG001|Overall Study|Withdrawal by Subject|5|||
27657028|NCT02525744|80583301|FG000|Period 1|Physician Decision|0|||
27657029|NCT02525744|80583302|FG001|Period 1|Physician Decision|0|||
27657030|NCT02525744|80583303|FG002|Period 1|Physician Decision|1|||
27657031|NCT02525744|80583304|FG003|Period 1|Physician Decision|0|||
27657032|NCT02525744|80583301|FG000|Period 3|Adverse Event|0|||
27657033|NCT02525744|80583302|FG001|Period 3|Adverse Event|1|||
27657034|NCT02525744|80583303|FG002|Period 3|Adverse Event|0|||
27657035|NCT02525744|80583304|FG003|Period 3|Adverse Event|0|||
27657036|NCT02525744|80583301|FG000|Period 4|Withdrawal by Subject|1|||
27657037|NCT02525744|80583302|FG001|Period 4|Withdrawal by Subject|0|||
27657038|NCT02525744|80583303|FG002|Period 4|Withdrawal by Subject|0|||
27657039|NCT02525744|80583304|FG003|Period 4|Withdrawal by Subject|0|||
27657040|NCT02525744|80583301|FG000|Period 5|Physician Decision|1|||
27761255|NCT01354431|80950804|FG001|Treatment Period|Participant request to discontinue|2|||
27761256|NCT01354431|80950805|FG002|Treatment Period|Participant request to discontinue|1|||
27761257|NCT01354431|80950803|FG000|Treatment Period|Participant withdrew consent|0|||
27761258|NCT01354431|80950804|FG001|Treatment Period|Participant withdrew consent|1|||
27761259|NCT01354431|80950805|FG002|Treatment Period|Participant withdrew consent|0|||
27761260|NCT01354431|80950803|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
27761261|NCT01354431|80950804|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
27761262|NCT01354431|80950805|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
27761263|NCT03196193|80950807|FG000|Overall Study|Adverse Event|1|||
27761264|NCT03196193|80950808|FG001|Overall Study|Adverse Event|0|||
27761265|NCT03196193|80950807|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
27761266|NCT03196193|80950808|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
27761267|NCT02565615|80950810|FG000|Overall Study|Death|0|||
27761268|NCT02565615|80950811|FG001|Overall Study|Death|1|||
27761269|NCT02565615|80950812|FG002|Overall Study|Death|0|||
27761270|NCT02565615|80950813|FG003|Overall Study|Death|0|||
27761271|NCT02565615|80950814|FG004|Overall Study|Death|4|||
27761272|NCT02565615|80950810|FG000|Overall Study|Not willing to participate in study|2|||
27761273|NCT02565615|80950811|FG001|Overall Study|Not willing to participate in study|21|||
27761274|NCT02565615|80950812|FG002|Overall Study|Not willing to participate in study|0|||
27761275|NCT02565615|80950813|FG003|Overall Study|Not willing to participate in study|1|||
27567480|NCT02281552|80267302|FG001|Overall Study|Adverse Event|9|||
27567481|NCT04220411|80267304|FG000|Overall Study|Adverse Event|0|||
27567482|NCT04220411|80267305|FG001|Overall Study|Adverse Event|0|||
27567483|NCT04220411|80267306|FG002|Overall Study|Adverse Event|0|||
27567484|NCT04220411|80267307|FG003|Overall Study|Adverse Event|1|||
27657041|NCT02525744|80583302|FG001|Period 5|Physician Decision|0|||
27657042|NCT02525744|80583303|FG002|Period 5|Physician Decision|0|||
27761276|NCT02565615|80950814|FG004|Overall Study|Not willing to participate in study|169|||
27761277|NCT02565615|80950810|FG000|Overall Study|Lost to Follow-up|0|||
27761278|NCT02565615|80950811|FG001|Overall Study|Lost to Follow-up|4|||
27761279|NCT02565615|80950812|FG002|Overall Study|Lost to Follow-up|0|||
27761280|NCT02565615|80950813|FG003|Overall Study|Lost to Follow-up|1|||
27761281|NCT02565615|80950814|FG004|Overall Study|Lost to Follow-up|765|||
27761282|NCT02565615|80950810|FG000|Overall Study|Not meeting eligibility criteria|0|||
27761283|NCT02565615|80950811|FG001|Overall Study|Not meeting eligibility criteria|7|||
27761284|NCT02565615|80950812|FG002|Overall Study|Not meeting eligibility criteria|0|||
27761285|NCT02565615|80950813|FG003|Overall Study|Not meeting eligibility criteria|0|||
27761286|NCT02565615|80950814|FG004|Overall Study|Not meeting eligibility criteria|25|||
27761287|NCT02565615|80950810|FG000|Overall Study|Reason not defined|0|||
27761288|NCT02565615|80950811|FG001|Overall Study|Reason not defined|2|||
27761289|NCT02565615|80950812|FG002|Overall Study|Reason not defined|0|||
27761290|NCT02565615|80950813|FG003|Overall Study|Reason not defined|1|||
27761291|NCT02565615|80950814|FG004|Overall Study|Reason not defined|62|||
27761292|NCT02565615|80950810|FG000|Overall Study|Adverse Event|1|||
27761293|NCT02565615|80950811|FG001|Overall Study|Adverse Event|1|||
27761294|NCT02565615|80950812|FG002|Overall Study|Adverse Event|0|||
27761295|NCT02565615|80950813|FG003|Overall Study|Adverse Event|0|||
27761296|NCT02565615|80950814|FG004|Overall Study|Adverse Event|9|||
27761297|NCT02565615|80950810|FG000|Overall Study|Untreated|0|||
27761298|NCT02565615|80950811|FG001|Overall Study|Untreated|0|||
27761299|NCT02565615|80950812|FG002|Overall Study|Untreated|0|||
27761300|NCT02565615|80950813|FG003|Overall Study|Untreated|0|||
27761301|NCT02565615|80950814|FG004|Overall Study|Untreated|567|||
27761302|NCT05631548|80950816|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
27761303|NCT05631548|80950817|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
27761304|NCT02293902|80950818|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
27761305|NCT02293902|80950819|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
27761306|NCT02293902|80950820|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
27761307|NCT02293902|80950821|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
27761308|NCT02293902|80950822|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
27761309|NCT02293902|80950818|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
27761310|NCT02293902|80950819|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
27761311|NCT02293902|80950820|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
27761312|NCT02293902|80950821|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
27761313|NCT02293902|80950822|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
27761314|NCT02293902|80950818|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
27761315|NCT02293902|80950819|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27761316|NCT02293902|80950820|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27761317|NCT02293902|80950821|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27761318|NCT02293902|80950822|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
27761319|NCT02293902|80950818|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
27761320|NCT02293902|80950819|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
27761321|NCT02293902|80950820|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
27761322|NCT02293902|80950821|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
27761323|NCT02293902|80950822|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
27761324|NCT02293902|80950818|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
27860130|NCT04844762|81319402|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27657043|NCT02525744|80583304|FG003|Period 5|Physician Decision|0|||
27657044|NCT04295499|80583313|FG000|Overall Study|moving out of state|1|||
27657045|NCT04295499|80583314|FG001|Overall Study|moving out of state|0|||
27657046|NCT04295499|80583313|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
27657047|NCT04295499|80583314|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
27657048|NCT02489799|80583315|FG000|Overall Study|Lost to Follow-up|4|||
27657049|NCT02489799|80583316|FG001|Overall Study|Lost to Follow-up|1|||
27657050|NCT02489799|80583315|FG000|Overall Study|Failure to Maintain Eligibility|4|||
27657051|NCT02489799|80583316|FG001|Overall Study|Failure to Maintain Eligibility|6|||
27657052|NCT02489799|80583315|FG000|Overall Study|Withdrawal by Subject|1|||
27860131|NCT04844762|81319403|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27657053|NCT02489799|80583316|FG001|Overall Study|Withdrawal by Subject|1|||
27657054|NCT02489799|80583315|FG000|Overall Study|Death|0|||
27657055|NCT02489799|80583316|FG001|Overall Study|Death|1|||
27657056|NCT01587703|80583318|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
27657057|NCT01587703|80583319|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657058|NCT01587703|80583320|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657059|NCT01587703|80583321|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27761325|NCT02293902|80950819|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
27761326|NCT02293902|80950820|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
27761327|NCT02293902|80950821|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
27657060|NCT01587703|80583322|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657061|NCT01587703|80583323|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657062|NCT01587703|80583324|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657063|NCT01587703|80583325|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27761328|NCT02293902|80950822|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
27761329|NCT03404518|80950823|FG000|Overall Study|Lost to Follow-up|28|||
27761330|NCT03404518|80950824|FG001|Overall Study|Lost to Follow-up|30|||
27761331|NCT03404518|80950823|FG000|Overall Study|Protocol Violation|13|||
27761332|NCT03404518|80950824|FG001|Overall Study|Protocol Violation|6|||
27761333|NCT02677220|80950828|FG000|Overall Study|Adverse Event|1|||
27761334|NCT00843843|80950831|FG000|Overall Study|Physician Decision|1|||
27761335|NCT00843843|80950832|FG001|Overall Study|Physician Decision|1|||
27761336|NCT00843843|80950831|FG000|Overall Study|Protocol Violation|1|||
27761337|NCT00843843|80950832|FG001|Overall Study|Protocol Violation|1|||
27761338|NCT02379390|80950833|FG000|Overall Study|Adverse Event|1|||
27761339|NCT02379390|80950834|FG001|Overall Study|Adverse Event|1|||
27761340|NCT02379390|80950833|FG000|Overall Study|Investigator's decision|1|||
27761341|NCT02379390|80950834|FG001|Overall Study|Investigator's decision|0|||
27761342|NCT02379390|80950833|FG000|Overall Study|Study Termination|0|||
27761343|NCT02379390|80950834|FG001|Overall Study|Study Termination|1|||
27761344|NCT01244191|80950837|FG000|Overall Study|Progressive disease|295|||
27761345|NCT01244191|80950838|FG001|Overall Study|Progressive disease|350|||
27761346|NCT01244191|80950837|FG000|Overall Study|Clinical disease progression|54|||
27761347|NCT01244191|80950838|FG001|Overall Study|Clinical disease progression|36|||
27761348|NCT01244191|80950837|FG000|Overall Study|Adverse Event|65|||
27761349|NCT01244191|80950838|FG001|Overall Study|Adverse Event|48|||
27761350|NCT01244191|80950837|FG000|Overall Study|Death|22|||
27761351|NCT01244191|80950838|FG001|Overall Study|Death|29|||
27761352|NCT01244191|80950837|FG000|Overall Study|Lost to Follow-up|0|||
27761353|NCT01244191|80950838|FG001|Overall Study|Lost to Follow-up|2|||
27761354|NCT01244191|80950837|FG000|Overall Study|Protocol Violation|1|||
27761355|NCT01244191|80950838|FG001|Overall Study|Protocol Violation|2|||
27761356|NCT01244191|80950837|FG000|Overall Study|Withdrawal by Subject|31|||
27761357|NCT01244191|80950838|FG001|Overall Study|Withdrawal by Subject|23|||
27761358|NCT01244191|80950837|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
27761359|NCT01244191|80950838|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
27761360|NCT04577183|80950839|FG000|Overall Study|Death|1|||
27761361|NCT04577183|80950839|FG000|Overall Study|Withdrawal by Subject|3|||
27761362|NCT04577183|80950839|FG000|Overall Study|Early termination|2|||
27761363|NCT00126581|80950840|FG000|Overall Study|Adverse Event|3|||
27761364|NCT00126581|80950841|FG001|Overall Study|Adverse Event|7|||
27761365|NCT00126581|80950840|FG000|Overall Study|Death|3|||
27761366|NCT00126581|80950841|FG001|Overall Study|Death|2|||
27761367|NCT00126581|80950840|FG000|Overall Study|Withdrawal by Subject|1|||
27761368|NCT00126581|80950841|FG001|Overall Study|Withdrawal by Subject|4|||
27761369|NCT00126581|80950840|FG000|Overall Study|Alternative therapy|3|||
27761370|NCT00126581|80950841|FG001|Overall Study|Alternative therapy|3|||
27761371|NCT00126581|80950840|FG000|Overall Study|Other illness/MD discretion|3|||
27761372|NCT00126581|80950841|FG001|Overall Study|Other illness/MD discretion|4|||
27761373|NCT02260648|80950842|FG000|Overall Study|Adverse Event|3|||
27761374|NCT02260648|80950843|FG001|Overall Study|Adverse Event|0|||
27761375|NCT02260648|80950844|FG002|Overall Study|Adverse Event|1|||
27761376|NCT02260648|80950842|FG000|Overall Study|Withdrawal by Subject|1|||
27761377|NCT02260648|80950843|FG001|Overall Study|Withdrawal by Subject|1|||
27761378|NCT02260648|80950844|FG002|Overall Study|Withdrawal by Subject|0|||
27761379|NCT02260648|80950842|FG000|Overall Study|Protocol Violation|1|||
27761380|NCT02260648|80950843|FG001|Overall Study|Protocol Violation|0|||
27761381|NCT02260648|80950844|FG002|Overall Study|Protocol Violation|0|||
27761382|NCT02260648|80950842|FG000|Overall Study|Discontinue Due to Study Termination|13|||
27761383|NCT02260648|80950843|FG001|Overall Study|Discontinue Due to Study Termination|12|||
27761384|NCT02260648|80950844|FG002|Overall Study|Discontinue Due to Study Termination|7|||
27761385|NCT00003476|80950845|FG000|Overall Study|Not evaluable|1|||
27761386|NCT00333619|80950846|FG000|Overall Study|Death|12|||
27761387|NCT00333619|80950847|FG001|Overall Study|Death|6|||
27761388|NCT00333619|80950846|FG000|Overall Study|Withdrawal by Subject|6|||
27761389|NCT00333619|80950847|FG001|Overall Study|Withdrawal by Subject|1|||
27567485|NCT02196324|80267310|FG000|Overall Study|Withdrawal by Subject|8|||
27761390|NCT00333619|80950846|FG000|Overall Study|Lost to Follow-up|3|||
27761391|NCT00333619|80950847|FG001|Overall Study|Lost to Follow-up|3|||
27761392|NCT04354155|80950848|FG000|Overall Study|Withdrawal by Subject|1|||
27761393|NCT04354155|80950848|FG000|Overall Study|Did not meet criteria for study intervention|1|||
27761394|NCT00594204|80950849|FG000|Overall Study|Adverse Event|15|||
27761395|NCT00594204|80950850|FG001|Overall Study|Adverse Event|3|||
27761396|NCT00594204|80950849|FG000|Overall Study|Lost to Follow-up|9|||
27761397|NCT00594204|80950850|FG001|Overall Study|Lost to Follow-up|5|||
27761398|NCT00594204|80950849|FG000|Overall Study|Withdrawal by Subject|23|||
27761399|NCT00594204|80950850|FG001|Overall Study|Withdrawal by Subject|29|||
27761400|NCT00594204|80950849|FG000|Overall Study|Other|4|||
27761401|NCT00594204|80950850|FG001|Overall Study|Other|3|||
27761402|NCT00594204|80950849|FG000|Overall Study|Lack of Efficacy|3|||
27761403|NCT00594204|80950850|FG001|Overall Study|Lack of Efficacy|4|||
27761404|NCT00594204|80950849|FG000|Overall Study|Randomized but not treated|4|||
27761405|NCT00594204|80950850|FG001|Overall Study|Randomized but not treated|1|||
27761406|NCT01406652|80950854|FG000|Overall Study|Lost-to-follow-up|3|||
27761407|NCT01406652|80950855|FG001|Overall Study|Lost-to-follow-up|4|||
27761408|NCT01406652|80950854|FG000|Overall Study|Withdrawal by Subject|2|||
27761409|NCT01406652|80950855|FG001|Overall Study|Withdrawal by Subject|2|||
27761410|NCT01406652|80950854|FG000|Overall Study|Insufficient follow-up|5|||
27761411|NCT01406652|80950855|FG001|Overall Study|Insufficient follow-up|4|||
27761412|NCT01406652|80950854|FG000|Overall Study|Infection not sure|10|||
27761413|NCT01406652|80950855|FG001|Overall Study|Infection not sure|10|||
27761414|NCT04199793|80950856|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
27761415|NCT04199793|80950857|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
27761416|NCT04199793|80950856|FG000|Overall Study|Withdrawal by Subject|1|||
27761417|NCT04199793|80950857|FG001|Overall Study|Withdrawal by Subject|1|||
27761418|NCT00617656|80950858|FG000|Overall Study|Inclusion error|4|||
27761419|NCT00617656|80950859|FG001|Overall Study|Inclusion error|4|||
27761420|NCT00617656|80950860|FG002|Overall Study|Inclusion error|0|||
27761421|NCT00617656|80950861|FG003|Overall Study|Inclusion error|0|||
27761422|NCT00617656|80950858|FG000|Overall Study|Missing data|44|||
27761423|NCT00617656|80950859|FG001|Overall Study|Missing data|30|||
27761424|NCT00617656|80950860|FG002|Overall Study|Missing data|13|||
27860132|NCT04844762|81319404|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27860133|NCT04844762|81319399|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
27860134|NCT04844762|81319400|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27567486|NCT02196324|80267311|FG001|Overall Study|Withdrawal by Subject|4|||
27567487|NCT02196324|80267310|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
27567488|NCT02196324|80267311|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
27567489|NCT02196324|80267310|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
27567490|NCT02196324|80267311|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
27567491|NCT02196324|80267310|FG000|Overall Study|Other|1|||
27567492|NCT02196324|80267311|FG001|Overall Study|Other|0|||
27567493|NCT02622828|80267318|FG000|Overall Study|participant withdrew|3|||
27567494|NCT02286193|80267319|FG000|Overall Study|Referred: CRS unable to make contact|62|||
27567495|NCT02286193|80267319|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
27567496|NCT02286193|80267319|FG000|Overall Study|Referred: Declined service|38|||
27567497|NCT01482767|80267323|FG000|Overall Study|Death|1|||
27567498|NCT01482767|80267324|FG001|Overall Study|Death|1|||
27567499|NCT01482767|80267323|FG000|Overall Study|Withdrawal by Subject|7|||
27567500|NCT01482767|80267324|FG001|Overall Study|Withdrawal by Subject|5|||
27567501|NCT01482767|80267323|FG000|Overall Study|Lost to Follow-up|12|||
27567502|NCT01482767|80267324|FG001|Overall Study|Lost to Follow-up|6|||
27567503|NCT01482767|80267323|FG000|Overall Study|Adverse Event|0|||
27567504|NCT01482767|80267324|FG001|Overall Study|Adverse Event|3|||
27567505|NCT01482767|80267323|FG000|Overall Study|Site closure|22|||
27567506|NCT01482767|80267324|FG001|Overall Study|Site closure|14|||
27567507|NCT01482767|80267323|FG000|Overall Study|Non-adherence to study requirements|4|||
27567508|NCT01482767|80267324|FG001|Overall Study|Non-adherence to study requirements|7|||
27567509|NCT01482767|80267323|FG000|Overall Study|Alternate HCV treatment|7|||
27567510|NCT01482767|80267324|FG001|Overall Study|Alternate HCV treatment|8|||
27567511|NCT01482767|80267323|FG000|Overall Study|Ineligible|0|||
27567512|NCT01482767|80267324|FG001|Overall Study|Ineligible|5|||
27567513|NCT01482767|80267323|FG000|Overall Study|Nurse error|1|||
27567514|NCT01482767|80267324|FG001|Overall Study|Nurse error|0|||
27567515|NCT00697346|80267325|FG000|Overall Study|Adverse Event|4|||
27567516|NCT00697346|80267326|FG001|Overall Study|Adverse Event|5|||
27567517|NCT00697346|80267327|FG002|Overall Study|Adverse Event|0|||
27567518|NCT00697346|80267325|FG000|Overall Study|Progressive Disease|19|||
27567519|NCT00697346|80267326|FG001|Overall Study|Progressive Disease|18|||
27567520|NCT00697346|80267327|FG002|Overall Study|Progressive Disease|0|||
27567521|NCT00697346|80267325|FG000|Overall Study|Symptomatic Deterioration|0|||
27761425|NCT00617656|80950861|FG003|Overall Study|Missing data|6|||
27761426|NCT00617656|80950858|FG000|Overall Study|Withdrawal by Subject|0|||
27761427|NCT00617656|80950859|FG001|Overall Study|Withdrawal by Subject|2|||
27761428|NCT00617656|80950860|FG002|Overall Study|Withdrawal by Subject|0|||
27567522|NCT00697346|80267326|FG001|Overall Study|Symptomatic Deterioration|1|||
27567523|NCT00697346|80267327|FG002|Overall Study|Symptomatic Deterioration|0|||
27567524|NCT00697346|80267325|FG000|Overall Study|Withdrawal by Subject|2|||
27567525|NCT00697346|80267326|FG001|Overall Study|Withdrawal by Subject|2|||
27567526|NCT00697346|80267327|FG002|Overall Study|Withdrawal by Subject|0|||
27567527|NCT00697346|80267325|FG000|Overall Study|Reason not Specified|3|||
27567528|NCT00697346|80267326|FG001|Overall Study|Reason not Specified|0|||
27761429|NCT00617656|80950861|FG003|Overall Study|Withdrawal by Subject|0|||
27761430|NCT02585999|80950862|FG000|Overall Study|Lost to Follow-up|1|||
27761431|NCT02585999|80950862|FG000|Overall Study|Protocol Violation|1|||
27761432|NCT02505542|80950863|FG000|Part A: Open-Label Period|Adverse Event|31|||
27761433|NCT02505542|80950864|FG001|Part A: Open-Label Period|Adverse Event|0|||
27761434|NCT02505542|80950865|FG002|Part A: Open-Label Period|Adverse Event|0|||
27761435|NCT02505542|80950866|FG003|Part A: Open-Label Period|Adverse Event|0|||
27761436|NCT02505542|80950863|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
27761437|NCT02505542|80950864|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
27761438|NCT02505542|80950865|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
27761439|NCT02505542|80950866|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
27761440|NCT02505542|80950863|FG000|Part A: Open-Label Period|Protocol Violation|1|||
27761441|NCT02505542|80950864|FG001|Part A: Open-Label Period|Protocol Violation|0|||
27761442|NCT02505542|80950865|FG002|Part A: Open-Label Period|Protocol Violation|0|||
27761443|NCT02505542|80950866|FG003|Part A: Open-Label Period|Protocol Violation|0|||
27761444|NCT02505542|80950863|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
27761445|NCT02505542|80950864|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
27761446|NCT02505542|80950865|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
27761447|NCT02505542|80950866|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
27761448|NCT02505542|80950863|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
27761449|NCT02505542|80950864|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
27761450|NCT02505542|80950865|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
27761451|NCT02505542|80950866|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
27761452|NCT02505542|80950863|FG000|Part A: Open-Label Period|New medical history available|1|||
27761453|NCT02505542|80950864|FG001|Part A: Open-Label Period|New medical history available|0|||
27761454|NCT02505542|80950865|FG002|Part A: Open-Label Period|New medical history available|0|||
27761455|NCT02505542|80950866|FG003|Part A: Open-Label Period|New medical history available|0|||
27761456|NCT02505542|80950863|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
27761457|NCT02505542|80950864|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
27761458|NCT02505542|80950865|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
27761459|NCT02505542|80950866|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
27761460|NCT02505542|80950863|FG000|Part A: Open-Label Period|Pregnancy|2|||
27761461|NCT02505542|80950864|FG001|Part A: Open-Label Period|Pregnancy|0|||
27761462|NCT02505542|80950865|FG002|Part A: Open-Label Period|Pregnancy|0|||
27761463|NCT02505542|80950866|FG003|Part A: Open-Label Period|Pregnancy|0|||
27761464|NCT02505542|80950863|FG000|Part A: Open-Label Period|Sponsor directive|1|||
27761465|NCT02505542|80950864|FG001|Part A: Open-Label Period|Sponsor directive|0|||
27567529|NCT00697346|80267327|FG002|Overall Study|Reason not Specified|1|||
27567530|NCT02506816|80267330|FG000|Overall Study|Adverse Event|3|||
27567531|NCT00486265|80267333|FG000|Overall Study|Adverse Event|1|||
27567532|NCT00486265|80267333|FG000|Overall Study|Lack of Efficacy|8|||
27567533|NCT01417481|80267334|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27567534|NCT01417481|80267335|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27567535|NCT01982253|80267339|FG000|Overall Study|Withdrawal by Subject|1|||
27567536|NCT01982253|80267340|FG001|Overall Study|Withdrawal by Subject|0|||
27567537|NCT01982253|80267341|FG002|Overall Study|Withdrawal by Subject|0|||
27567538|NCT01982253|80267339|FG000|Overall Study|Study terminated by sponsor|1|||
27567539|NCT01982253|80267340|FG001|Overall Study|Study terminated by sponsor|4|||
27567540|NCT01982253|80267341|FG002|Overall Study|Study terminated by sponsor|4|||
27567541|NCT02529137|80267342|FG000|Overall Study|Discontinuation for different reasons|8|||
27567542|NCT01904604|80267343|FG000|Overall Study|Withdrew before receiving dosing|0|||
27567543|NCT01904604|80267344|FG001|Overall Study|Withdrew before receiving dosing|1|||
27567544|NCT01904604|80267345|FG002|Overall Study|Withdrew before receiving dosing|0|||
27567545|NCT01904604|80267343|FG000|Overall Study|Non-compliance|1|||
27567546|NCT01904604|80267344|FG001|Overall Study|Non-compliance|0|||
27567547|NCT01904604|80267345|FG002|Overall Study|Non-compliance|0|||
27657064|NCT01587703|80583326|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657065|NCT01587703|80583327|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657066|NCT01587703|80583328|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657067|NCT01587703|80583329|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657068|NCT01587703|80583330|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657069|NCT01587703|80583331|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657070|NCT01587703|80583332|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657071|NCT01587703|80583333|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657072|NCT01587703|80583334|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657073|NCT01587703|80583335|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657074|NCT01587703|80583336|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
27657075|NCT01587703|80583318|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657076|NCT01587703|80583319|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27567548|NCT01904604|80267343|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
27567549|NCT01904604|80267344|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
27567550|NCT01904604|80267345|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
27567551|NCT01904604|80267343|FG000|Overall Study|Patch site reactions|1|||
27567552|NCT01904604|80267344|FG001|Overall Study|Patch site reactions|1|||
27567553|NCT01904604|80267345|FG002|Overall Study|Patch site reactions|0|||
27567554|NCT01904604|80267343|FG000|Overall Study|Increased syncope|0|||
27567555|NCT01904604|80267344|FG001|Overall Study|Increased syncope|1|||
27567556|NCT01904604|80267345|FG002|Overall Study|Increased syncope|0|||
27567557|NCT01904604|80267343|FG000|Overall Study|Unrelated illness|0|||
27567558|NCT01904604|80267344|FG001|Overall Study|Unrelated illness|1|||
27567559|NCT01904604|80267345|FG002|Overall Study|Unrelated illness|0|||
27567560|NCT01904604|80267343|FG000|Overall Study|Passed Week 52 OFC|1|||
27567561|NCT01904604|80267344|FG001|Overall Study|Passed Week 52 OFC|0|||
27567562|NCT01904604|80267345|FG002|Overall Study|Passed Week 52 OFC|0|||
27567563|NCT01904604|80267343|FG000|Overall Study|Withdrawal by Subject|1|||
27567564|NCT01904604|80267344|FG001|Overall Study|Withdrawal by Subject|2|||
27567565|NCT01904604|80267345|FG002|Overall Study|Withdrawal by Subject|0|||
27567566|NCT01904604|80267343|FG000|Overall Study|Participant Relocated|1|||
27567567|NCT01904604|80267344|FG001|Overall Study|Participant Relocated|1|||
27567568|NCT01904604|80267345|FG002|Overall Study|Participant Relocated|1|||
27567569|NCT01904604|80267343|FG000|Overall Study|Lost to Follow-up|0|||
27567570|NCT01904604|80267344|FG001|Overall Study|Lost to Follow-up|0|||
27567571|NCT01904604|80267345|FG002|Overall Study|Lost to Follow-up|1|||
27567572|NCT00590954|80267346|FG000|Overall Study|Inevaluable|2|||
27567573|NCT00058825|80267347|FG000|Overall Study|Relapse|9|||
27567574|NCT00058825|80267347|FG000|Overall Study|Progressive Disease|5|||
27567575|NCT00058825|80267347|FG000|Overall Study|Graft Failure|5|||
27567576|NCT00058825|80267347|FG000|Overall Study|Death|3|||
27567577|NCT00907374|80267348|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
27567578|NCT00907374|80267349|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
27567579|NCT02659020|80267350|FG000|Overall Study|Adverse Event|0|||
27567580|NCT02659020|80267351|FG001|Overall Study|Adverse Event|0|||
27567581|NCT02659020|80267352|FG002|Overall Study|Adverse Event|0|||
27567582|NCT02659020|80267353|FG003|Overall Study|Adverse Event|2|||
27567583|NCT02659020|80267354|FG004|Overall Study|Adverse Event|0|||
27567584|NCT02659020|80267355|FG005|Overall Study|Adverse Event|0|||
27567585|NCT02659020|80267356|FG006|Overall Study|Adverse Event|2|||
27860135|NCT04844762|81319401|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860136|NCT04844762|81319402|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860137|NCT04844762|81319403|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860138|NCT04844762|81319404|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860139|NCT04844762|81319399|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860140|NCT04844762|81319400|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860141|NCT04844762|81319401|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860142|NCT04844762|81319402|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860143|NCT04844762|81319403|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
27860144|NCT04844762|81319404|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
27860145|NCT04844762|81319399|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
27860146|NCT04844762|81319400|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27860147|NCT04844762|81319401|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27860148|NCT04844762|81319402|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27860149|NCT04844762|81319403|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27860150|NCT04844762|81319404|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
27860151|NCT04844762|81319399|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
27860152|NCT04844762|81319400|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860153|NCT04844762|81319401|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860154|NCT04844762|81319402|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860155|NCT04844762|81319403|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
27860156|NCT04844762|81319404|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
27860157|NCT04844762|81319399|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
27860158|NCT04844762|81319400|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
27860159|NCT04844762|81319401|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
27860160|NCT04844762|81319402|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
27860161|NCT04844762|81319403|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
27860162|NCT04844762|81319404|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
27860163|NCT04844762|81319399|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
27567586|NCT02659020|80267350|FG000|Overall Study|Lost to Follow-up|1|||
27567587|NCT02659020|80267351|FG001|Overall Study|Lost to Follow-up|2|||
27567588|NCT02659020|80267352|FG002|Overall Study|Lost to Follow-up|1|||
27567589|NCT02659020|80267353|FG003|Overall Study|Lost to Follow-up|6|||
27567590|NCT02659020|80267354|FG004|Overall Study|Lost to Follow-up|1|||
27567591|NCT02659020|80267355|FG005|Overall Study|Lost to Follow-up|5|||
27567592|NCT02659020|80267356|FG006|Overall Study|Lost to Follow-up|0|||
27567593|NCT02659020|80267350|FG000|Overall Study|Physician Decision|0|||
27567594|NCT02659020|80267351|FG001|Overall Study|Physician Decision|0|||
27567595|NCT02659020|80267352|FG002|Overall Study|Physician Decision|0|||
27567596|NCT02659020|80267353|FG003|Overall Study|Physician Decision|1|||
27567597|NCT02659020|80267354|FG004|Overall Study|Physician Decision|1|||
27567598|NCT02659020|80267355|FG005|Overall Study|Physician Decision|0|||
27567599|NCT02659020|80267356|FG006|Overall Study|Physician Decision|1|||
27567600|NCT02659020|80267350|FG000|Overall Study|Withdrawal by Subject|2|||
27567601|NCT02659020|80267351|FG001|Overall Study|Withdrawal by Subject|1|||
27567602|NCT02659020|80267352|FG002|Overall Study|Withdrawal by Subject|0|||
27567603|NCT02659020|80267353|FG003|Overall Study|Withdrawal by Subject|3|||
27567604|NCT02659020|80267354|FG004|Overall Study|Withdrawal by Subject|3|||
27567605|NCT02659020|80267355|FG005|Overall Study|Withdrawal by Subject|6|||
27567606|NCT02659020|80267356|FG006|Overall Study|Withdrawal by Subject|3|||
27567607|NCT02659020|80267350|FG000|Overall Study|Progressive Disease|0|||
27567608|NCT02659020|80267351|FG001|Overall Study|Progressive Disease|0|||
27567609|NCT02659020|80267352|FG002|Overall Study|Progressive Disease|0|||
27567610|NCT02659020|80267353|FG003|Overall Study|Progressive Disease|4|||
27567611|NCT02659020|80267354|FG004|Overall Study|Progressive Disease|1|||
27567612|NCT02659020|80267355|FG005|Overall Study|Progressive Disease|0|||
27567613|NCT02659020|80267356|FG006|Overall Study|Progressive Disease|2|||
27567614|NCT04753164|80267357|FG000|Overall Study|Adverse Event|0|||
27567615|NCT04753164|80267358|FG001|Overall Study|Adverse Event|2|||
27567616|NCT04753164|80267357|FG000|Overall Study|Withdrawal by Subject|9|||
27567617|NCT04753164|80267358|FG001|Overall Study|Withdrawal by Subject|7|||
27567618|NCT04753164|80267357|FG000|Overall Study|Lost to Follow-up|6|||
27567619|NCT04753164|80267358|FG001|Overall Study|Lost to Follow-up|6|||
27567620|NCT04753164|80267357|FG000|Overall Study|Other|12|||
27567621|NCT04753164|80267358|FG001|Overall Study|Other|5|||
27567622|NCT00066066|80267359|FG000|Overall Study|Lost to Follow-up|6|||
27567623|NCT00066066|80267360|FG001|Overall Study|Lost to Follow-up|4|||
27761466|NCT02505542|80950865|FG002|Part A: Open-Label Period|Sponsor directive|0|||
27761467|NCT02505542|80950866|FG003|Part A: Open-Label Period|Sponsor directive|0|||
27761468|NCT02505542|80950863|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
27761469|NCT02505542|80950864|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
27761470|NCT02505542|80950865|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
27761471|NCT02505542|80950866|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
27761472|NCT02505542|80950863|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
27761473|NCT02505542|80950864|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
27761474|NCT02505542|80950865|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
27761475|NCT02505542|80950866|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
27761476|NCT02505542|80950863|FG000|Part A: Open-Label Period|Non-compliance|1|||
27761477|NCT02505542|80950864|FG001|Part A: Open-Label Period|Non-compliance|0|||
27761478|NCT02505542|80950865|FG002|Part A: Open-Label Period|Non-compliance|0|||
27761479|NCT02505542|80950866|FG003|Part A: Open-Label Period|Non-compliance|0|||
27761480|NCT02505542|80950863|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
27761481|NCT02505542|80950864|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
27761482|NCT02505542|80950865|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
27761483|NCT02505542|80950866|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
27761484|NCT02505542|80950863|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
27761485|NCT02505542|80950864|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
27761486|NCT02505542|80950865|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
27761487|NCT02505542|80950866|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
27761488|NCT02505542|80950863|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
27761489|NCT02505542|80950864|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
27761490|NCT02505542|80950865|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
27761491|NCT02505542|80950866|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
27761492|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Adverse Event|0|||
27761493|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Adverse Event|0|||
27761494|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Adverse Event|1|||
27860164|NCT04844762|81319400|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
27567624|NCT00066066|80267361|FG002|Overall Study|Lost to Follow-up|7|||
27567625|NCT00066066|80267362|FG003|Overall Study|Lost to Follow-up|4|||
27567626|NCT00066066|80267363|FG004|Overall Study|Lost to Follow-up|3|||
27567627|NCT00066066|80267364|FG005|Overall Study|Lost to Follow-up|5|||
27567628|NCT03551210|80267365|FG000|Overall Study|Adverse Event|5|||
27567629|NCT03551210|80267366|FG001|Overall Study|Adverse Event|6|||
27567630|NCT03551210|80267365|FG000|Overall Study|Withdrawal by Subject|1|||
27567631|NCT03551210|80267366|FG001|Overall Study|Withdrawal by Subject|7|||
27567632|NCT03551210|80267365|FG000|Overall Study|Needed in other antibiotic treatment|2|||
27567633|NCT03551210|80267366|FG001|Overall Study|Needed in other antibiotic treatment|5|||
27761495|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Adverse Event|3|||
27761496|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
27761497|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
27761498|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
27761499|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
27761500|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
27761501|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
27761502|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
27761503|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
27761504|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
27761505|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
27761506|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
27761507|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
27761508|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
27761509|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
27761510|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
27761511|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
27761512|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
27761513|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
27761514|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
27761515|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
27761516|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
27761517|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
27761518|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
27761519|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
27761520|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Miscalculation|0|||
27761521|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Miscalculation|1|||
27761522|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Miscalculation|0|||
27761523|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Miscalculation|0|||
27761524|NCT02505542|80950863|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
27761525|NCT02505542|80950864|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
27761526|NCT02505542|80950865|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
27761527|NCT02505542|80950866|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
27761528|NCT00949910|80950867|FG000|Overall Study|Progressive Disease|3750|||
27761529|NCT00949910|80950867|FG000|Overall Study|Symptomatic Deterioration|1088|||
27761530|NCT00949910|80950867|FG000|Overall Study|Lost to Follow-up|100|||
27761531|NCT00949910|80950867|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
27761532|NCT00949910|80950867|FG000|Overall Study|Participant Refusal|390|||
27761533|NCT00949910|80950867|FG000|Overall Study|Death Due to Malignant Disease|456|||
27761534|NCT00949910|80950867|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
27761535|NCT00949910|80950867|FG000|Overall Study|Death Due to Adverse Event|115|||
27761536|NCT00949910|80950867|FG000|Overall Study|Death Due to Toxicity|3|||
27761537|NCT00949910|80950867|FG000|Overall Study|Death from Unknown Cause|5|||
27761538|NCT00949910|80950867|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
27761539|NCT00949910|80950867|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
27761540|NCT00949910|80950867|FG000|Overall Study|Switched to Commercial Treatment|4|||
27761541|NCT00949910|80950867|FG000|Overall Study|Violation of Eligibility|23|||
27761542|NCT00949910|80950867|FG000|Overall Study|Logistical Reasons|13|||
27761543|NCT00949910|80950867|FG000|Overall Study|Non-Compliance|10|||
27761544|NCT00949910|80950867|FG000|Overall Study|Prolonged Dosing Interruption|4|||
27761545|NCT00949910|80950867|FG000|Overall Study|Adverse Event|83|||
27761546|NCT00949910|80950867|FG000|Overall Study|Serious Adverse Event|6|||
27761547|NCT00949910|80950867|FG000|Overall Study|Physician/Participant Decision|7|||
27761548|NCT00949910|80950867|FG000|Overall Study|Other|4|||
27860165|NCT04844762|81319401|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
27860166|NCT04844762|81319402|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
27761549|NCT00949910|80950867|FG000|Overall Study|No Data|9|||
27761550|NCT01204697|80950868|FG000|Overall Study|Death|26|||
27761551|NCT01204697|80950869|FG001|Overall Study|Death|27|||
27761552|NCT01204697|80950868|FG000|Overall Study|Lost to Follow-up|3|||
27761553|NCT01204697|80950869|FG001|Overall Study|Lost to Follow-up|4|||
27761554|NCT01204697|80950868|FG000|Overall Study|Withdrawal by Subject|2|||
27761555|NCT01204697|80950869|FG001|Overall Study|Withdrawal by Subject|4|||
27761556|NCT01204697|80950868|FG000|Overall Study|Randomized, but not treated|0|||
27761557|NCT01204697|80950869|FG001|Overall Study|Randomized, but not treated|1|||
27761558|NCT00400712|80950872|FG000|Overall Study|Death|1|||
27761559|NCT00400712|80950873|FG001|Overall Study|Death|0|||
27761560|NCT00400712|80950872|FG000|Overall Study|Withdrawal by Subject|11|||
27761561|NCT00400712|80950873|FG001|Overall Study|Withdrawal by Subject|12|||
27761562|NCT00400712|80950872|FG000|Overall Study|Physician Decision|5|||
27761563|NCT00400712|80950873|FG001|Overall Study|Physician Decision|4|||
27761564|NCT00555906|80950874|FG000|Phase 1|Objective Progression or Relapse|3|||
27761565|NCT00555906|80950875|FG001|Phase 1|Objective Progression or Relapse|5|||
27761566|NCT00555906|80950876|FG002|Phase 1|Objective Progression or Relapse|3|||
27761567|NCT00555906|80950877|FG003|Phase 1|Objective Progression or Relapse|1|||
27761568|NCT00555906|80950878|FG004|Phase 1|Objective Progression or Relapse|0|||
27761569|NCT00555906|80950874|FG000|Phase 1|Global Deterioration of Health Status|0|||
27761570|NCT00555906|80950875|FG001|Phase 1|Global Deterioration of Health Status|1|||
27761571|NCT00555906|80950876|FG002|Phase 1|Global Deterioration of Health Status|1|||
27761572|NCT00555906|80950877|FG003|Phase 1|Global Deterioration of Health Status|1|||
27761573|NCT00555906|80950878|FG004|Phase 1|Global Deterioration of Health Status|0|||
27761574|NCT00555906|80950874|FG000|Phase 1|Adverse Event|0|||
27761575|NCT00555906|80950875|FG001|Phase 1|Adverse Event|0|||
27761576|NCT00555906|80950876|FG002|Phase 1|Adverse Event|3|||
27761577|NCT00555906|80950877|FG003|Phase 1|Adverse Event|2|||
27761578|NCT00555906|80950878|FG004|Phase 1|Adverse Event|0|||
27761579|NCT00555906|80950874|FG000|Phase 1|Withdrawal by Subject|0|||
27761580|NCT00555906|80950875|FG001|Phase 1|Withdrawal by Subject|0|||
27761581|NCT00555906|80950876|FG002|Phase 1|Withdrawal by Subject|0|||
27761582|NCT00555906|80950877|FG003|Phase 1|Withdrawal by Subject|1|||
27761583|NCT00555906|80950878|FG004|Phase 1|Withdrawal by Subject|0|||
27761584|NCT00555906|80950874|FG000|Phase 2|Adverse Event|0|||
27761585|NCT00555906|80950875|FG001|Phase 2|Adverse Event|0|||
27761586|NCT00555906|80950876|FG002|Phase 2|Adverse Event|0|||
27761587|NCT00555906|80950877|FG003|Phase 2|Adverse Event|0|||
27761588|NCT00555906|80950878|FG004|Phase 2|Adverse Event|4|||
27761589|NCT00555906|80950874|FG000|Phase 2|Global Deterioration of Health Status|0|||
27761590|NCT00555906|80950875|FG001|Phase 2|Global Deterioration of Health Status|0|||
27761591|NCT00555906|80950876|FG002|Phase 2|Global Deterioration of Health Status|0|||
27761592|NCT00555906|80950877|FG003|Phase 2|Global Deterioration of Health Status|0|||
27761593|NCT00555906|80950878|FG004|Phase 2|Global Deterioration of Health Status|2|||
27761594|NCT00555906|80950874|FG000|Phase 2|Objective Progression or Relapse|0|||
27761595|NCT00555906|80950875|FG001|Phase 2|Objective Progression or Relapse|0|||
27761596|NCT00555906|80950876|FG002|Phase 2|Objective Progression or Relapse|0|||
27761597|NCT00555906|80950877|FG003|Phase 2|Objective Progression or Relapse|0|||
27761598|NCT00555906|80950878|FG004|Phase 2|Objective Progression or Relapse|16|||
27761599|NCT00555906|80950874|FG000|Phase 2|Withdrawal by Subject|0|||
27761600|NCT00555906|80950875|FG001|Phase 2|Withdrawal by Subject|0|||
27761601|NCT00555906|80950876|FG002|Phase 2|Withdrawal by Subject|0|||
27761602|NCT00555906|80950877|FG003|Phase 2|Withdrawal by Subject|0|||
27761603|NCT00555906|80950878|FG004|Phase 2|Withdrawal by Subject|2|||
27761604|NCT00555906|80950874|FG000|Phase 2|Other|0|||
27761605|NCT00555906|80950875|FG001|Phase 2|Other|0|||
27761606|NCT00555906|80950876|FG002|Phase 2|Other|0|||
27761607|NCT00555906|80950877|FG003|Phase 2|Other|0|||
27761608|NCT00555906|80950878|FG004|Phase 2|Other|6|||
27761609|NCT00555906|80950874|FG000|Phase 2|Randomized but not Treated|0|||
27761610|NCT00555906|80950875|FG001|Phase 2|Randomized but not Treated|0|||
27761611|NCT00555906|80950876|FG002|Phase 2|Randomized but not Treated|0|||
27761612|NCT00555906|80950877|FG003|Phase 2|Randomized but not Treated|0|||
27761613|NCT00555906|80950878|FG004|Phase 2|Randomized but not Treated|2|||
27761614|NCT00304915|80950879|FG000|Overall Study|Lost to Follow-up|11|||
27761615|NCT00304915|80950880|FG001|Overall Study|Lost to Follow-up|11|||
27761616|NCT00304915|80950879|FG000|Overall Study|Death|4|||
27761617|NCT00304915|80950880|FG001|Overall Study|Death|5|||
27761618|NCT00304915|80950879|FG000|Overall Study|Withdrawal by Subject|3|||
27761619|NCT00304915|80950880|FG001|Overall Study|Withdrawal by Subject|0|||
27761620|NCT02420223|80950886|FG000|Overall Study|Adverse Event|1|||
27761621|NCT02420223|80950887|FG001|Overall Study|Adverse Event|0|||
27761622|NCT02420223|80950886|FG000|Overall Study|Physician Decision|0|||
27761623|NCT02420223|80950887|FG001|Overall Study|Physician Decision|2|||
27761624|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
27761625|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
27761626|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
27761627|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
27761628|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
27761629|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
27567634|NCT03551210|80267365|FG000|Overall Study|Lost to Follow-up|1|||
27761630|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
27761631|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
27761632|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
27761633|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
27761634|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
27761635|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
27761636|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
27761637|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
27761638|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
27761639|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27761640|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27761641|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27761642|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
27761643|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
27761644|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
27761645|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
27860167|NCT04844762|81319403|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
27860168|NCT04844762|81319404|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
27860169|NCT00368979|81319405|FG000|Overall Study|Adverse Event|9|||
27860170|NCT00368979|81319406|FG001|Overall Study|Adverse Event|16|||
27657077|NCT01587703|80583320|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657078|NCT01587703|80583321|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657079|NCT01587703|80583322|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657080|NCT01587703|80583323|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
27657081|NCT01587703|80583324|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657082|NCT01587703|80583325|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
27657083|NCT01587703|80583326|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27567635|NCT03551210|80267366|FG001|Overall Study|Lost to Follow-up|1|||
27567636|NCT03551210|80267365|FG000|Overall Study|Absence of visit 4 and 5|1|||
27567637|NCT03551210|80267366|FG001|Overall Study|Absence of visit 4 and 5|0|||
27567638|NCT03551210|80267365|FG000|Overall Study|No drug for dispensing|0|||
27567639|NCT03551210|80267366|FG001|Overall Study|No drug for dispensing|1|||
27567640|NCT00313612|80267369|FG000|Overall Study|Patient never received treatment|0|||
27567641|NCT00313612|80267370|FG001|Overall Study|Patient never received treatment|1|||
27567642|NCT03818516|80267371|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
27567643|NCT02063737|80267375|FG000|Overall Study|Lost to Follow-up|11|||
27567644|NCT02063737|80267376|FG001|Overall Study|Lost to Follow-up|4|||
27567645|NCT01723163|80267377|FG000|Treatment Phase|Withdrawal by Subject|14|||
27567646|NCT01723163|80267378|FG001|Treatment Phase|Withdrawal by Subject|6|||
27567647|NCT01723163|80267377|FG000|Treatment Phase|Withdrawal by PI|5|||
27567648|NCT01723163|80267378|FG001|Treatment Phase|Withdrawal by PI|1|||
27567649|NCT01723163|80267377|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
27567650|NCT01723163|80267378|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
27657084|NCT01587703|80583327|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657085|NCT01587703|80583328|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657086|NCT01587703|80583329|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657087|NCT01587703|80583330|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657088|NCT01587703|80583331|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657089|NCT01587703|80583332|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657090|NCT01587703|80583333|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657091|NCT01587703|80583334|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657092|NCT01587703|80583335|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657093|NCT01587703|80583336|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
27657094|NCT01587703|80583318|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657095|NCT01587703|80583319|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657096|NCT01587703|80583320|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657097|NCT01587703|80583321|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657098|NCT01587703|80583322|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657099|NCT01587703|80583323|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657100|NCT01587703|80583324|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
27657101|NCT01587703|80583325|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657102|NCT01587703|80583326|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657103|NCT01587703|80583327|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657104|NCT01587703|80583328|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657105|NCT01587703|80583329|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657106|NCT01587703|80583330|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657107|NCT01587703|80583331|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657108|NCT01587703|80583332|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657109|NCT01587703|80583333|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657110|NCT01587703|80583334|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27761646|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
27761647|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
27761648|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
27860171|NCT00368979|81319405|FG000|Overall Study|Lack of Efficacy|5|||
27860172|NCT00368979|81319406|FG001|Overall Study|Lack of Efficacy|3|||
27567651|NCT01723163|80267377|FG000|3-Month Follow-up|Unable to Contact|12|||
27567652|NCT01723163|80267378|FG001|3-Month Follow-up|Unable to Contact|19|||
27567653|NCT01723163|80267377|FG000|6-Month Follow-up|Death|1|||
27567654|NCT01723163|80267378|FG001|6-Month Follow-up|Death|0|||
27657111|NCT01587703|80583335|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657112|NCT01587703|80583336|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
27657113|NCT01587703|80583318|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
27657114|NCT01587703|80583319|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
27657115|NCT01587703|80583320|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
27657116|NCT01587703|80583321|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
27657117|NCT01587703|80583322|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
27657118|NCT01587703|80583323|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
27657119|NCT01587703|80583324|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
27657120|NCT01587703|80583325|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
27860173|NCT00368979|81319405|FG000|Overall Study|Other|3|||
27860174|NCT00368979|81319406|FG001|Overall Study|Other|1|||
27860175|NCT00368979|81319405|FG000|Overall Study|Lost to Follow-up|1|||
27860176|NCT00368979|81319406|FG001|Overall Study|Lost to Follow-up|0|||
27860177|NCT00368979|81319405|FG000|Overall Study|Protocol Violation|2|||
27860178|NCT00368979|81319406|FG001|Overall Study|Protocol Violation|1|||
27860179|NCT00368979|81319405|FG000|Overall Study|Withdrawal by Subject|5|||
27657121|NCT01587703|80583326|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657122|NCT01587703|80583327|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657123|NCT01587703|80583328|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657124|NCT01587703|80583329|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657125|NCT01587703|80583330|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657126|NCT01587703|80583331|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657127|NCT01587703|80583332|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657128|NCT01587703|80583333|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657129|NCT01587703|80583334|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657130|NCT01587703|80583335|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657131|NCT01587703|80583336|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
27657132|NCT01587703|80583318|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657133|NCT01587703|80583319|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657134|NCT01587703|80583320|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657135|NCT01587703|80583321|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657136|NCT01587703|80583322|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657137|NCT01587703|80583323|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657138|NCT01587703|80583324|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657139|NCT01587703|80583325|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657140|NCT01587703|80583326|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
27657141|NCT01587703|80583327|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
27657142|NCT01587703|80583328|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
27657143|NCT01587703|80583329|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657144|NCT01587703|80583330|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657145|NCT01587703|80583331|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657146|NCT01587703|80583332|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657147|NCT01587703|80583333|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657148|NCT01587703|80583334|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657149|NCT01587703|80583335|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27860180|NCT00368979|81319406|FG001|Overall Study|Withdrawal by Subject|9|||
27860181|NCT05819203|81319407|FG000|Overall Study|Protocol Violation|1|||
27860182|NCT05819203|81319408|FG001|Overall Study|Protocol Violation|2|||
27860183|NCT05819203|81319407|FG000|Overall Study|Withdrawal by Subject|1|||
27567655|NCT01723163|80267377|FG000|6-Month Follow-up|Unable to Contact|17|||
27567656|NCT01723163|80267378|FG001|6-Month Follow-up|Unable to Contact|15|||
27567657|NCT01723163|80267377|FG000|12-Month Follow-up|Death|1|||
27567658|NCT01723163|80267378|FG001|12-Month Follow-up|Death|0|||
27567659|NCT01723163|80267377|FG000|12-Month Follow-up|Unable to Contact|23|||
27567660|NCT01723163|80267378|FG001|12-Month Follow-up|Unable to Contact|28|||
27567661|NCT01275066|80267383|FG000|Overall Study|Withdrawal by Subject|0|||
27567662|NCT01275066|80267384|FG001|Overall Study|Withdrawal by Subject|0|||
27567663|NCT01275066|80267385|FG002|Overall Study|Withdrawal by Subject|1|||
27567664|NCT01275066|80267383|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
27567665|NCT01275066|80267384|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
27567666|NCT01275066|80267385|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
27567667|NCT03792672|80267386|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
27567668|NCT03792672|80267387|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
27567669|NCT03792672|80267388|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
27657150|NCT01587703|80583336|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
27657151|NCT01587703|80583318|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657152|NCT01587703|80583319|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657153|NCT01587703|80583320|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27860184|NCT05819203|81319408|FG001|Overall Study|Withdrawal by Subject|0|||
27860185|NCT00923273|81319409|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27860186|NCT00923273|81319410|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27567670|NCT03792672|80267389|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
27567671|NCT03792672|80267390|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
27567672|NCT03792672|80267391|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
27567673|NCT03792672|80267386|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
27567674|NCT03792672|80267387|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
27567675|NCT03792672|80267388|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
27567676|NCT03792672|80267389|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
27567677|NCT03792672|80267390|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
27567678|NCT03792672|80267391|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
27567679|NCT03792672|80267386|FG000|Treatment Period 4 (2 Days)|Other|1|||
27567680|NCT03792672|80267387|FG001|Treatment Period 4 (2 Days)|Other|0|||
27567681|NCT03792672|80267388|FG002|Treatment Period 4 (2 Days)|Other|0|||
27567682|NCT03792672|80267389|FG003|Treatment Period 4 (2 Days)|Other|0|||
27567683|NCT03792672|80267390|FG004|Treatment Period 4 (2 Days)|Other|0|||
27567684|NCT03792672|80267391|FG005|Treatment Period 4 (2 Days)|Other|0|||
27567685|NCT00692770|80267392|FG000|Overall Study|Protocol Violation|2|||
27567686|NCT00692770|80267393|FG001|Overall Study|Protocol Violation|7|||
27567687|NCT00692770|80267392|FG000|Overall Study|Withdrawal by Subject|97|||
27567688|NCT00692770|80267393|FG001|Overall Study|Withdrawal by Subject|36|||
27567689|NCT00692770|80267392|FG000|Overall Study|Adverse Event|136|||
27567690|NCT00692770|80267393|FG001|Overall Study|Adverse Event|41|||
27567691|NCT00692770|80267392|FG000|Overall Study|Death|10|||
27567692|NCT00692770|80267393|FG001|Overall Study|Death|5|||
27567693|NCT00692770|80267392|FG000|Overall Study|Lost to Follow-up|7|||
27567694|NCT00692770|80267393|FG001|Overall Study|Lost to Follow-up|3|||
27567695|NCT00692770|80267392|FG000|Overall Study|Non-compliant with study medication|11|||
27567696|NCT00692770|80267393|FG001|Overall Study|Non-compliant with study medication|5|||
27567697|NCT00692770|80267392|FG000|Overall Study|Progression by clinical judgment|2|||
27567698|NCT00692770|80267393|FG001|Overall Study|Progression by clinical judgment|3|||
27860187|NCT00923273|81319411|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27567699|NCT00692770|80267392|FG000|Overall Study|Physician decision not protocol driven|10|||
27567700|NCT00692770|80267393|FG001|Overall Study|Physician decision not protocol driven|14|||
27567701|NCT00692770|80267392|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
27567702|NCT00692770|80267393|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
27567703|NCT00692770|80267392|FG000|Overall Study|Protocol driven decision point|3|||
27567704|NCT00692770|80267393|FG001|Overall Study|Protocol driven decision point|7|||
27567705|NCT00692770|80267392|FG000|Overall Study|Completed all planned assessments|79|||
27567706|NCT00692770|80267393|FG001|Overall Study|Completed all planned assessments|101|||
27567707|NCT00692770|80267392|FG000|Overall Study|Radiological and clinical progression|8|||
27567708|NCT00692770|80267393|FG001|Overall Study|Radiological and clinical progression|8|||
27567709|NCT00692770|80267392|FG000|Overall Study|Clinical endpoint reached|16|||
27567710|NCT00692770|80267393|FG001|Overall Study|Clinical endpoint reached|43|||
27567711|NCT00692770|80267392|FG000|Overall Study|Study terminated by sponsor|2|||
27567712|NCT00692770|80267393|FG001|Overall Study|Study terminated by sponsor|2|||
27567713|NCT00692770|80267392|FG000|Overall Study|Randomized but not treated|3|||
27567714|NCT00692770|80267393|FG001|Overall Study|Randomized but not treated|4|||
27567715|NCT00850395|80267394|FG000|Overall Study|Death|1|||
27567716|NCT00850395|80267394|FG000|Overall Study|Adverse Event|1|||
27567717|NCT00850395|80267394|FG000|Overall Study|Insufficient clinical response|3|||
27567718|NCT00850395|80267394|FG000|Overall Study|Other|5|||
27567719|NCT03829046|80267400|FG000|Overall Study|Withdrawal by Subject|1|||
27567720|NCT03829046|80267401|FG001|Overall Study|Withdrawal by Subject|0|||
27567721|NCT04033159|80267402|FG000|Washout Period|Physician Decision|0|||
27567722|NCT04033159|80267403|FG001|Washout Period|Physician Decision|1|||
27567723|NCT04033159|80267404|FG002|Washout Period|Physician Decision|0|||
27567724|NCT04033159|80267402|FG000|Washout Period|Study terminated by Sponsor|0|||
27567725|NCT04033159|80267403|FG001|Washout Period|Study terminated by Sponsor|7|||
27567726|NCT04033159|80267404|FG002|Washout Period|Study terminated by Sponsor|0|||
27567727|NCT04033159|80267402|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
27567728|NCT04033159|80267403|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
27567729|NCT04033159|80267404|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
27567730|NCT01727141|80267405|FG000|Overall Study|Physician Decision|0|||
27567731|NCT01727141|80267406|FG001|Overall Study|Physician Decision|1|||
27567732|NCT01727141|80267407|FG002|Overall Study|Physician Decision|0|||
27567733|NCT01727141|80267408|FG003|Overall Study|Physician Decision|2|||
27567734|NCT01727141|80267405|FG000|Overall Study|Lost to Follow-up|0|||
27860188|NCT00923273|81319412|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
27860189|NCT00923273|81319413|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
27567735|NCT01727141|80267406|FG001|Overall Study|Lost to Follow-up|2|||
27567736|NCT01727141|80267407|FG002|Overall Study|Lost to Follow-up|0|||
27567737|NCT01727141|80267408|FG003|Overall Study|Lost to Follow-up|0|||
27567738|NCT01727141|80267405|FG000|Overall Study|Death|0|||
27567739|NCT01727141|80267406|FG001|Overall Study|Death|1|||
27567740|NCT01727141|80267407|FG002|Overall Study|Death|1|||
27567741|NCT01727141|80267408|FG003|Overall Study|Death|1|||
27567742|NCT01727141|80267405|FG000|Overall Study|Protocol deviation|1|||
27567743|NCT01727141|80267406|FG001|Overall Study|Protocol deviation|1|||
27567744|NCT01727141|80267407|FG002|Overall Study|Protocol deviation|0|||
27567745|NCT01727141|80267408|FG003|Overall Study|Protocol deviation|1|||
27567746|NCT01727141|80267405|FG000|Overall Study|Withdrawal by Subject|4|||
27567747|NCT01727141|80267406|FG001|Overall Study|Withdrawal by Subject|4|||
27567748|NCT01727141|80267407|FG002|Overall Study|Withdrawal by Subject|2|||
27860190|NCT00923273|81319409|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27860191|NCT00923273|81319410|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27860192|NCT00923273|81319411|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27860193|NCT00923273|81319412|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
27860194|NCT00923273|81319413|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
27860195|NCT02377427|81319414|FG000|Part A (Up to Week 20)|Physician Decision|1|||
27860196|NCT02377427|81319415|FG001|Part A (Up to Week 20)|Physician Decision|0|||
27860197|NCT02377427|81319416|FG002|Part A (Up to Week 20)|Physician Decision|0|||
27860198|NCT02377427|81319417|FG003|Part A (Up to Week 20)|Physician Decision|0|||
27860199|NCT02377427|81319418|FG004|Part A (Up to Week 20)|Physician Decision|0|||
27860200|NCT02377427|81319414|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
27860201|NCT02377427|81319415|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27860202|NCT02377427|81319416|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27860203|NCT02377427|81319417|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27860204|NCT02377427|81319418|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
27567749|NCT01727141|80267408|FG003|Overall Study|Withdrawal by Subject|11|||
27567750|NCT01851720|80267415|FG000|Overall Study|Lost to Follow-up|0|||
27567751|NCT01851720|80267416|FG001|Overall Study|Lost to Follow-up|1|||
27567752|NCT00706641|80267417|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
27567753|NCT00706641|80267417|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
27567754|NCT00706641|80267417|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
27567755|NCT00805935|80267418|FG000|Overall Study|Stimulation Failure|1|||
27567756|NCT00805935|80267419|FG001|Overall Study|Stimulation Failure|5|||
27567757|NCT00805935|80267420|FG002|Overall Study|Stimulation Failure|2|||
27567758|NCT00805935|80267421|FG003|Overall Study|Stimulation Failure|2|||
27567759|NCT00805935|80267418|FG000|Overall Study|Cycle cancelled|0|||
27567760|NCT00805935|80267419|FG001|Overall Study|Cycle cancelled|0|||
27567761|NCT00805935|80267420|FG002|Overall Study|Cycle cancelled|2|||
27567762|NCT00805935|80267421|FG003|Overall Study|Cycle cancelled|0|||
27567763|NCT00805935|80267418|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
27567764|NCT00805935|80267419|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
27567765|NCT00805935|80267420|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
27567766|NCT00805935|80267421|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
27567767|NCT00805935|80267418|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
27567768|NCT00805935|80267419|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
27567769|NCT00805935|80267420|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
27567770|NCT00805935|80267421|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
27567771|NCT00805935|80267418|FG000|Overall Study|Lost to Follow-up|1|||
27567772|NCT00805935|80267419|FG001|Overall Study|Lost to Follow-up|0|||
27567773|NCT00805935|80267420|FG002|Overall Study|Lost to Follow-up|0|||
27657154|NCT01587703|80583321|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657155|NCT01587703|80583322|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27567774|NCT00805935|80267421|FG003|Overall Study|Lost to Follow-up|0|||
27567775|NCT00805935|80267418|FG000|Overall Study|No positive serum pregnancy|8|||
27567776|NCT00805935|80267419|FG001|Overall Study|No positive serum pregnancy|7|||
27567777|NCT00805935|80267420|FG002|Overall Study|No positive serum pregnancy|6|||
27657156|NCT01587703|80583323|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657157|NCT01587703|80583324|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657158|NCT01587703|80583325|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657159|NCT01587703|80583326|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
27657160|NCT01587703|80583327|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657161|NCT01587703|80583328|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
27657162|NCT01587703|80583329|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657163|NCT01587703|80583330|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657164|NCT01587703|80583331|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657165|NCT01587703|80583332|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657166|NCT01587703|80583333|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657167|NCT01587703|80583334|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657168|NCT01587703|80583335|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27860205|NCT02377427|81319414|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
27567778|NCT00805935|80267421|FG003|Overall Study|No positive serum pregnancy|5|||
27860206|NCT02377427|81319415|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27657169|NCT01587703|80583336|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
27657170|NCT01587703|80583318|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27567779|NCT00805935|80267418|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27567780|NCT00805935|80267419|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27567781|NCT00805935|80267420|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27567782|NCT00805935|80267421|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
27657171|NCT01587703|80583319|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657172|NCT01587703|80583320|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657173|NCT01587703|80583321|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657174|NCT01587703|80583322|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657175|NCT01587703|80583323|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657176|NCT01587703|80583324|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657177|NCT01587703|80583325|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657178|NCT01587703|80583326|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657179|NCT01587703|80583327|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
27657180|NCT01587703|80583328|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
27657181|NCT01587703|80583329|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657182|NCT01587703|80583330|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657183|NCT01587703|80583331|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657184|NCT01587703|80583332|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657185|NCT01587703|80583333|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657186|NCT01587703|80583334|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657187|NCT01587703|80583335|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657188|NCT01587703|80583336|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
27657189|NCT01587703|80583318|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657190|NCT01587703|80583319|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657191|NCT01587703|80583320|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657192|NCT01587703|80583321|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657193|NCT01587703|80583322|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657194|NCT01587703|80583323|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657195|NCT01587703|80583324|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657196|NCT01587703|80583325|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657197|NCT01587703|80583326|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
27657198|NCT01587703|80583327|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657199|NCT01587703|80583328|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657200|NCT01587703|80583329|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657201|NCT01587703|80583330|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657202|NCT01587703|80583331|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657203|NCT01587703|80583332|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657204|NCT01587703|80583333|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657205|NCT01587703|80583334|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657206|NCT01587703|80583335|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657207|NCT01587703|80583336|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
27657208|NCT01587703|80583318|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657209|NCT01587703|80583319|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657210|NCT01587703|80583320|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657211|NCT01587703|80583321|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657212|NCT01587703|80583322|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27567783|NCT00805935|80267418|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
27567784|NCT00805935|80267419|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
27567785|NCT00805935|80267420|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
27567786|NCT00805935|80267421|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
27567787|NCT00805935|80267418|FG000|Overall Study|Biochemical pregnancy|0|||
27567788|NCT00805935|80267419|FG001|Overall Study|Biochemical pregnancy|1|||
27567789|NCT00805935|80267420|FG002|Overall Study|Biochemical pregnancy|0|||
27567790|NCT00805935|80267421|FG003|Overall Study|Biochemical pregnancy|0|||
27567791|NCT00805935|80267418|FG000|Overall Study|Chemical pregnancy|0|||
27567792|NCT00805935|80267419|FG001|Overall Study|Chemical pregnancy|5|||
27657213|NCT01587703|80583323|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657214|NCT01587703|80583324|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657215|NCT01587703|80583325|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657216|NCT01587703|80583326|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657217|NCT01587703|80583327|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657218|NCT01587703|80583328|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27567793|NCT00805935|80267420|FG002|Overall Study|Chemical pregnancy|3|||
27657219|NCT01587703|80583329|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657220|NCT01587703|80583330|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657221|NCT01587703|80583331|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657222|NCT01587703|80583332|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657223|NCT01587703|80583333|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657224|NCT01587703|80583334|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27860207|NCT02377427|81319416|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27860208|NCT02377427|81319417|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27860209|NCT02377427|81319418|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
27860210|NCT02377427|81319414|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27860211|NCT02377427|81319415|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27860212|NCT02377427|81319416|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
27860213|NCT02377427|81319417|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27860214|NCT02377427|81319418|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
27860215|NCT01220297|81319419|FG000|Overall Study|Death|2|||
27860216|NCT01220297|81319419|FG000|Overall Study|Lost to Follow-up|1|||
27567794|NCT00805935|80267421|FG003|Overall Study|Chemical pregnancy|2|||
27567795|NCT00805935|80267418|FG000|Overall Study|Ectopic pregnancy|0|||
27567796|NCT00805935|80267419|FG001|Overall Study|Ectopic pregnancy|0|||
27567797|NCT00805935|80267420|FG002|Overall Study|Ectopic pregnancy|1|||
27567798|NCT00805935|80267421|FG003|Overall Study|Ectopic pregnancy|0|||
27567799|NCT00805935|80267418|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
27567800|NCT00805935|80267419|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
27567801|NCT00805935|80267420|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
27567802|NCT00805935|80267421|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
27567803|NCT02086110|80267422|FG000|Overall Study|Withdrawal by Subject|1|||
27567804|NCT02086110|80267423|FG001|Overall Study|Withdrawal by Subject|1|||
27567805|NCT00813358|80267426|FG000|Overall Study|Death|32|||
27567806|NCT00813358|80267426|FG000|Overall Study|Lost to Follow-up|12|||
27567807|NCT00813358|80267426|FG000|Overall Study|other endpoints|5|||
27567808|NCT00813358|80267426|FG000|Overall Study|Withdrawal by Subject|20|||
27567809|NCT03690388|80267430|FG000|Overall Study|Adverse Event|8|||
27567810|NCT03690388|80267431|FG001|Overall Study|Adverse Event|1|||
27567811|NCT03690388|80267430|FG000|Overall Study|Radiographic Progression|14|||
27567812|NCT03690388|80267431|FG001|Overall Study|Radiographic Progression|29|||
27567813|NCT03690388|80267430|FG000|Overall Study|Clinical deterioration|10|||
27567814|NCT03690388|80267431|FG001|Overall Study|Clinical deterioration|6|||
27567815|NCT03690388|80267430|FG000|Overall Study|Withdrawal by Subject|2|||
27567816|NCT03690388|80267431|FG001|Overall Study|Withdrawal by Subject|0|||
27567817|NCT03690388|80267430|FG000|Overall Study|Lack of Efficacy|1|||
27567818|NCT03690388|80267431|FG001|Overall Study|Lack of Efficacy|0|||
27567819|NCT03690388|80267430|FG000|Overall Study|Lost to Follow-up|1|||
27567820|NCT03690388|80267431|FG001|Overall Study|Lost to Follow-up|0|||
27567821|NCT04145895|80267434|FG000|Overall Study|Physician Decision|2|||
27567822|NCT04145895|80267435|FG001|Overall Study|Physician Decision|0|||
27567823|NCT04145895|80267434|FG000|Overall Study|Withdrawal by Subject|0|||
27567824|NCT04145895|80267435|FG001|Overall Study|Withdrawal by Subject|2|||
27567825|NCT02501096|80267436|FG000|Overall Study|Lost to Follow-up|0|||
27567826|NCT02501096|80267437|FG001|Overall Study|Lost to Follow-up|0|||
27567827|NCT02501096|80267438|FG002|Overall Study|Lost to Follow-up|0|||
27567828|NCT02501096|80267439|FG003|Overall Study|Lost to Follow-up|0|||
27567829|NCT02501096|80267440|FG004|Overall Study|Lost to Follow-up|1|||
27567830|NCT02501096|80267441|FG005|Overall Study|Lost to Follow-up|1|||
27567831|NCT02501096|80267442|FG006|Overall Study|Lost to Follow-up|3|||
27567832|NCT02501096|80267443|FG007|Overall Study|Lost to Follow-up|0|||
27567833|NCT02501096|80267444|FG008|Overall Study|Lost to Follow-up|0|||
27567834|NCT02501096|80267436|FG000|Overall Study|Withdrawal by Subject|1|||
27567835|NCT02501096|80267437|FG001|Overall Study|Withdrawal by Subject|0|||
27567836|NCT02501096|80267438|FG002|Overall Study|Withdrawal by Subject|7|||
27567837|NCT02501096|80267439|FG003|Overall Study|Withdrawal by Subject|13|||
27567838|NCT02501096|80267440|FG004|Overall Study|Withdrawal by Subject|2|||
27567839|NCT02501096|80267441|FG005|Overall Study|Withdrawal by Subject|2|||
27567840|NCT02501096|80267442|FG006|Overall Study|Withdrawal by Subject|2|||
27567841|NCT02501096|80267443|FG007|Overall Study|Withdrawal by Subject|3|||
27567842|NCT02501096|80267444|FG008|Overall Study|Withdrawal by Subject|0|||
27567843|NCT02501096|80267436|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
27567844|NCT02501096|80267437|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
27567845|NCT02501096|80267438|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
27567846|NCT02501096|80267439|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
27567847|NCT02501096|80267440|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
27567848|NCT02501096|80267441|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
27860217|NCT00593736|81319420|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
27860218|NCT00593736|81319421|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
27657225|NCT01587703|80583335|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
27657226|NCT01587703|80583336|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
27657227|NCT01587703|80583318|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657228|NCT01587703|80583319|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657229|NCT01587703|80583320|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657230|NCT01587703|80583321|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657231|NCT01587703|80583322|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657232|NCT01587703|80583323|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657233|NCT01587703|80583324|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657234|NCT01587703|80583325|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657235|NCT01587703|80583326|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657236|NCT01587703|80583327|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657237|NCT01587703|80583328|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657238|NCT01587703|80583329|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657239|NCT01587703|80583330|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27860219|NCT00593736|81319422|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
27860220|NCT00593736|81319423|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
27860221|NCT00593736|81319420|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
27860222|NCT00593736|81319421|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
27860223|NCT00593736|81319422|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
27860224|NCT00593736|81319423|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
27860225|NCT00593736|81319420|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
27860226|NCT00593736|81319421|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
27860227|NCT00593736|81319422|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
27860228|NCT00593736|81319423|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
27860229|NCT00593736|81319420|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
27860230|NCT00593736|81319421|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
27860231|NCT00593736|81319422|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
27860232|NCT00593736|81319423|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
27860233|NCT00593736|81319420|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
27860234|NCT00593736|81319421|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
27860235|NCT00593736|81319422|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
27860236|NCT00593736|81319423|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
27860237|NCT00593736|81319420|FG000|Screening Period and Placebo Run-in|Various|0|||
27860238|NCT00593736|81319421|FG001|Screening Period and Placebo Run-in|Various|0|||
27860239|NCT00593736|81319422|FG002|Screening Period and Placebo Run-in|Various|0|||
27860240|NCT00593736|81319423|FG003|Screening Period and Placebo Run-in|Various|25|||
27860241|NCT00593736|81319420|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
27860242|NCT00593736|81319421|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
27860243|NCT00593736|81319422|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
27860244|NCT00593736|81319423|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
27860245|NCT00593736|81319420|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
27860246|NCT00593736|81319421|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
27860247|NCT00593736|81319422|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
27860248|NCT00593736|81319423|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
27860249|NCT00593736|81319420|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
27860250|NCT00593736|81319421|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
27860251|NCT00593736|81319422|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
27657240|NCT01587703|80583331|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657241|NCT01587703|80583332|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657242|NCT01587703|80583333|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657243|NCT01587703|80583334|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
27657244|NCT01587703|80583335|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
27657245|NCT01587703|80583336|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
27657246|NCT01587703|80583318|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657247|NCT01587703|80583319|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657248|NCT01587703|80583320|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657249|NCT01587703|80583321|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657250|NCT01587703|80583322|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657251|NCT01587703|80583323|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657252|NCT01587703|80583324|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657253|NCT01587703|80583325|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657254|NCT01587703|80583326|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657255|NCT01587703|80583327|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27860252|NCT00593736|81319423|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
27657256|NCT01587703|80583328|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657257|NCT01587703|80583329|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657258|NCT01587703|80583330|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657259|NCT01587703|80583331|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657260|NCT01587703|80583332|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657261|NCT01587703|80583333|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
27657262|NCT01587703|80583334|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657263|NCT01587703|80583335|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657264|NCT01587703|80583336|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
27657265|NCT01587703|80583318|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657266|NCT01587703|80583319|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657267|NCT01587703|80583320|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657268|NCT01587703|80583321|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657269|NCT01587703|80583322|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657270|NCT01587703|80583323|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657271|NCT01587703|80583324|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657272|NCT01587703|80583325|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657273|NCT01587703|80583326|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657274|NCT01587703|80583327|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657275|NCT01587703|80583328|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657276|NCT01587703|80583329|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
27657277|NCT01587703|80583330|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657278|NCT01587703|80583331|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657279|NCT01587703|80583332|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
27657280|NCT01587703|80583333|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657281|NCT01587703|80583334|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657282|NCT01587703|80583335|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657283|NCT01587703|80583336|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
27657284|NCT01587703|80583318|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657285|NCT01587703|80583319|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657286|NCT01587703|80583320|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657287|NCT01587703|80583321|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657288|NCT01587703|80583322|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657289|NCT01587703|80583323|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657290|NCT01587703|80583324|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657291|NCT01587703|80583325|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657292|NCT01587703|80583326|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657293|NCT01587703|80583327|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657294|NCT01587703|80583328|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657295|NCT01587703|80583329|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
27657296|NCT01587703|80583330|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
27657297|NCT01587703|80583331|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
27657298|NCT01587703|80583332|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
27657299|NCT01587703|80583333|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
27657300|NCT01587703|80583334|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
27657301|NCT01587703|80583335|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657302|NCT01587703|80583336|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
27657303|NCT01587703|80583318|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657304|NCT01587703|80583319|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657305|NCT01587703|80583320|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657306|NCT01587703|80583321|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657307|NCT01587703|80583322|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
27567849|NCT02501096|80267442|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
27657308|NCT01587703|80583323|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657309|NCT01587703|80583324|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657310|NCT01587703|80583325|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657311|NCT01587703|80583326|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657312|NCT01587703|80583327|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657313|NCT01587703|80583328|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657314|NCT01587703|80583329|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
27657315|NCT01587703|80583330|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
27567850|NCT02501096|80267443|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
27567851|NCT02501096|80267444|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
27567852|NCT02501096|80267436|FG000|Overall Study|Death|1|||
27567853|NCT02501096|80267437|FG001|Overall Study|Death|1|||
27567854|NCT02501096|80267438|FG002|Overall Study|Death|88|||
27567855|NCT02501096|80267439|FG003|Overall Study|Death|74|||
27567856|NCT02501096|80267440|FG004|Overall Study|Death|15|||
27567857|NCT02501096|80267441|FG005|Overall Study|Death|16|||
27657316|NCT01587703|80583331|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
27657317|NCT01587703|80583332|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
27657318|NCT01587703|80583333|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
27657319|NCT01587703|80583334|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
27657320|NCT01587703|80583335|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657321|NCT01587703|80583336|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
27657322|NCT01587703|80583318|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657323|NCT01587703|80583319|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657324|NCT01587703|80583320|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657325|NCT01587703|80583321|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657326|NCT01587703|80583322|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657327|NCT01587703|80583323|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657328|NCT01587703|80583324|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657329|NCT01587703|80583325|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657330|NCT01587703|80583326|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657331|NCT01587703|80583327|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657332|NCT01587703|80583328|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657333|NCT01587703|80583329|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
27657334|NCT01587703|80583330|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657335|NCT01587703|80583331|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657336|NCT01587703|80583332|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657337|NCT01587703|80583333|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657338|NCT01587703|80583334|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657339|NCT01587703|80583335|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657340|NCT01587703|80583336|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
27657341|NCT01540474|80583337|FG000|Vaccination Period|Lost to Follow-up|0|||
27657342|NCT01540474|80583338|FG001|Vaccination Period|Lost to Follow-up|1|||
27657343|NCT01540474|80583339|FG002|Vaccination Period|Lost to Follow-up|0|||
27657344|NCT01540474|80583340|FG003|Vaccination Period|Lost to Follow-up|0|||
27657345|NCT02722278|80583341|FG000|Overall Study|Withdrawal by Subject|5|||
27657346|NCT02722278|80583342|FG001|Overall Study|Withdrawal by Subject|3|||
27657347|NCT02722278|80583341|FG000|Overall Study|Adverse Event|4|||
27657348|NCT02722278|80583342|FG001|Overall Study|Adverse Event|1|||
27657349|NCT02722278|80583341|FG000|Overall Study|Lost to Follow-up|2|||
27657350|NCT02722278|80583342|FG001|Overall Study|Lost to Follow-up|0|||
27657351|NCT02722278|80583341|FG000|Overall Study|Protocol Violation|1|||
27657352|NCT02722278|80583342|FG001|Overall Study|Protocol Violation|0|||
27657353|NCT02722278|80583341|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
27657354|NCT02722278|80583342|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
27657355|NCT02722278|80583341|FG000|Overall Study|Subject declined after tx assignment|0|||
27657356|NCT02722278|80583342|FG001|Overall Study|Subject declined after tx assignment|1|||
27657357|NCT02722278|80583341|FG000|Overall Study|Site closure not study related|0|||
27657358|NCT02722278|80583342|FG001|Overall Study|Site closure not study related|1|||
27657359|NCT05265247|80583343|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
27657360|NCT05265247|80583344|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
27657361|NCT05265247|80583343|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
27657362|NCT05265247|80583344|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
27657363|NCT05265247|80583343|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
27657364|NCT05265247|80583344|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
27657365|NCT01864200|80583345|FG000|Overall Study|Lost to Follow-up|1|||
27657366|NCT01864200|80583346|FG001|Overall Study|Lost to Follow-up|3|||
27657367|NCT01864200|80583345|FG000|Overall Study|Protocol Violation|1|||
27657368|NCT01864200|80583346|FG001|Overall Study|Protocol Violation|0|||
27657369|NCT05203822|80583347|FG000|Overall Study|Adverse Event|1|||
27657370|NCT05203822|80583347|FG000|Overall Study|Withdrawal by Subject|1|||
27657371|NCT03694210|80583348|FG000|Overall Study|Death|1|||
27657372|NCT03694210|80583348|FG000|Overall Study|Screen Failure|7|||
27657373|NCT02135445|80583355|FG000|Overall Study|Lost to Follow-up|1|||
27657374|NCT02135445|80583356|FG001|Overall Study|Lost to Follow-up|0|||
27657375|NCT02135445|80583355|FG000|Overall Study|Withdrawal by Subject|1|||
27657376|NCT02135445|80583356|FG001|Overall Study|Withdrawal by Subject|0|||
27657377|NCT01786551|80583357|FG000|Overall Study|Participant withdrew consent|2|||
27657378|NCT01989156|80583362|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
27657379|NCT01989156|80583363|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27657380|NCT01989156|80583364|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
27657381|NCT01989156|80583362|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
27657382|NCT01989156|80583363|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
27657383|NCT01989156|80583364|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
27657384|NCT01989156|80583362|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
27657385|NCT01989156|80583363|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
27657386|NCT01989156|80583364|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
27657387|NCT01989156|80583362|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
27657388|NCT01989156|80583363|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
27657389|NCT01989156|80583364|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
27657390|NCT01989156|80583362|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
27657391|NCT01989156|80583363|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
27657392|NCT01989156|80583364|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
27657393|NCT01989156|80583362|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
27657394|NCT01989156|80583363|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
27657395|NCT01989156|80583364|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
27657396|NCT01989156|80583362|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
27657397|NCT01989156|80583363|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
27657398|NCT01989156|80583364|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
27657399|NCT01989156|80583362|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
27657400|NCT01989156|80583363|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
27657401|NCT01989156|80583364|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
27657402|NCT01636258|80583367|FG000|Overall Study|Lost to Follow-up|1|||
27657403|NCT01636258|80583368|FG001|Overall Study|Lost to Follow-up|0|||
27657404|NCT00794573|80583373|FG000|Overall Study|Death|3|||
27657405|NCT00794573|80583374|FG001|Overall Study|Death|0|||
27657406|NCT00794573|80583373|FG000|Overall Study|Withdrawal by Subject|9|||
27657407|NCT00794573|80583374|FG001|Overall Study|Withdrawal by Subject|12|||
27657408|NCT00794573|80583373|FG000|Overall Study|Lost to Follow-up|26|||
27657409|NCT00794573|80583374|FG001|Overall Study|Lost to Follow-up|33|||
27657410|NCT03018288|80583375|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
27657411|NCT03018288|80583376|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
27657412|NCT03018288|80583377|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
27657413|NCT03018288|80583378|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
27657414|NCT03018288|80583375|FG000|Overall Study|Participant withdrew consent.|0|||
27657415|NCT03018288|80583376|FG001|Overall Study|Participant withdrew consent.|0|||
27657416|NCT03018288|80583377|FG002|Overall Study|Participant withdrew consent.|1|||
27657417|NCT03018288|80583378|FG003|Overall Study|Participant withdrew consent.|0|||
27657418|NCT03018288|80583375|FG000|Overall Study|Switched to alternative treatment.|0|||
27657419|NCT03018288|80583376|FG001|Overall Study|Switched to alternative treatment.|0|||
27657420|NCT03018288|80583377|FG002|Overall Study|Switched to alternative treatment.|1|||
27657421|NCT03018288|80583378|FG003|Overall Study|Switched to alternative treatment.|0|||
27657422|NCT03018288|80583375|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
27657423|NCT03018288|80583376|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
27657424|NCT03018288|80583377|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
27657425|NCT03018288|80583378|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
27657426|NCT03018288|80583375|FG000|Overall Study|Screen failures|0|||
27657427|NCT03018288|80583376|FG001|Overall Study|Screen failures|0|||
27657428|NCT03018288|80583377|FG002|Overall Study|Screen failures|0|||
27657429|NCT03018288|80583378|FG003|Overall Study|Screen failures|51|||
27657430|NCT03018288|80583375|FG000|Overall Study|Chose treatment outside of UNC|0|||
27657431|NCT03018288|80583376|FG001|Overall Study|Chose treatment outside of UNC|0|||
27657432|NCT03018288|80583377|FG002|Overall Study|Chose treatment outside of UNC|0|||
27657433|NCT03018288|80583378|FG003|Overall Study|Chose treatment outside of UNC|1|||
27657434|NCT03018288|80583375|FG000|Overall Study|Unable to comply with protocol requirements|1|||
27657435|NCT03018288|80583376|FG001|Overall Study|Unable to comply with protocol requirements|1|||
27657436|NCT03018288|80583377|FG002|Overall Study|Unable to comply with protocol requirements|0|||
27657437|NCT03018288|80583378|FG003|Overall Study|Unable to comply with protocol requirements|1|||
27657438|NCT03018288|80583375|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
27657439|NCT03018288|80583376|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
27657440|NCT03018288|80583377|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
27657441|NCT03018288|80583378|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
27657442|NCT03018288|80583375|FG000|Overall Study|Physician Decision|0|||
27657443|NCT03018288|80583376|FG001|Overall Study|Physician Decision|0|||
27657444|NCT03018288|80583377|FG002|Overall Study|Physician Decision|0|||
27657445|NCT03018288|80583378|FG003|Overall Study|Physician Decision|1|||
27657446|NCT02577315|80583382|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27657447|NCT02577315|80583383|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
27657448|NCT01848483|80583384|FG000|Overall Study|Death|2|||
27657449|NCT01848483|80583385|FG001|Overall Study|Death|1|||
27657450|NCT01848483|80583384|FG000|Overall Study|Lost to Follow-up|6|||
27657451|NCT01848483|80583385|FG001|Overall Study|Lost to Follow-up|8|||
27657452|NCT01848483|80583384|FG000|Overall Study|Withdrawal by Subject|1|||
27860253|NCT00593736|81319420|FG000|Treatment Period and Placebo Run-out|Various|1|||
27657453|NCT01848483|80583385|FG001|Overall Study|Withdrawal by Subject|0|||
27860254|NCT00593736|81319421|FG001|Treatment Period and Placebo Run-out|Various|1|||
27657454|NCT01848483|80583384|FG000|Overall Study|Incarceration|2|||
27657455|NCT01848483|80583385|FG001|Overall Study|Incarceration|2|||
27657456|NCT01064856|80583386|FG000|Double-blind (DB) Period|Adverse Event|1|||
27657457|NCT01064856|80583387|FG001|Double-blind (DB) Period|Adverse Event|0|||
27657458|NCT01064856|80583388|FG002|Double-blind (DB) Period|Adverse Event|0|||
27657459|NCT01064856|80583389|FG003|Double-blind (DB) Period|Adverse Event|0|||
27657460|NCT01064856|80583386|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
27657461|NCT01064856|80583387|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
27657462|NCT01064856|80583388|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
27657463|NCT01064856|80583389|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
27657464|NCT01064856|80583386|FG000|Open-label (OL) Period|Adverse Event|0|||
27657465|NCT01064856|80583387|FG001|Open-label (OL) Period|Adverse Event|0|||
27657466|NCT01064856|80583388|FG002|Open-label (OL) Period|Adverse Event|12|||
27657467|NCT01064856|80583389|FG003|Open-label (OL) Period|Adverse Event|6|||
27657468|NCT01064856|80583386|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
27657469|NCT01064856|80583387|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
27657470|NCT01064856|80583388|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
27657471|NCT01064856|80583389|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
27657472|NCT01064856|80583386|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
27657473|NCT01064856|80583387|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
27657474|NCT01064856|80583388|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
27657475|NCT01064856|80583389|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
27657476|NCT01064856|80583386|FG000|Open-label (OL) Period|Other|0|||
27657477|NCT01064856|80583387|FG001|Open-label (OL) Period|Other|0|||
27657478|NCT01064856|80583388|FG002|Open-label (OL) Period|Other|7|||
27657479|NCT01064856|80583389|FG003|Open-label (OL) Period|Other|7|||
27657480|NCT01525875|80583394|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
27657481|NCT01525875|80583395|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
27657482|NCT01525875|80583394|FG000|Open-label Period|Lost to Follow-up|0|||
27657483|NCT01525875|80583395|FG001|Open-label Period|Lost to Follow-up|2|||
27657484|NCT00561678|80583396|FG000|Overall Study|Withdrawal by Subject|4|||
27657485|NCT00561678|80583397|FG001|Overall Study|Withdrawal by Subject|3|||
27657486|NCT00561678|80583396|FG000|Overall Study|surgery cancelled|1|||
27657487|NCT00561678|80583397|FG001|Overall Study|surgery cancelled|1|||
27657488|NCT00561678|80583396|FG000|Overall Study|surgery rescheduled to different site|2|||
27657489|NCT00561678|80583397|FG001|Overall Study|surgery rescheduled to different site|2|||
27657490|NCT00561678|80583396|FG000|Overall Study|anesthesia provider refusal|1|||
27657491|NCT00561678|80583397|FG001|Overall Study|anesthesia provider refusal|0|||
27657492|NCT01654289|80583398|FG000|Overall Study|Withdrawal by Subject|10|||
27657493|NCT01654289|80583399|FG001|Overall Study|Withdrawal by Subject|8|||
27657494|NCT01654289|80583400|FG002|Overall Study|Withdrawal by Subject|5|||
27657495|NCT01654289|80583398|FG000|Overall Study|Withdrew from intervention only|17|||
27657496|NCT01654289|80583399|FG001|Overall Study|Withdrew from intervention only|20|||
27657497|NCT01654289|80583400|FG002|Overall Study|Withdrew from intervention only|0|||
27657498|NCT05274906|80583402|FG000|Overall Study|Withdrawal by Subject|2|||
27657499|NCT05274906|80583403|FG001|Overall Study|Withdrawal by Subject|1|||
27657500|NCT02206607|80583406|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
27657501|NCT02206607|80583407|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
27657502|NCT02206607|80583408|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
27657503|NCT02206607|80583409|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
27657504|NCT02206607|80583410|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
27657505|NCT02206607|80583406|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
27657506|NCT02206607|80583407|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
27657507|NCT02206607|80583408|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
27657508|NCT02206607|80583409|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
27657509|NCT02206607|80583410|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
27657510|NCT02105688|80583413|FG000|Part A: Double-Blind|Adverse Event|1|||
27657511|NCT02105688|80583414|FG001|Part A: Double-Blind|Adverse Event|0|||
27657512|NCT02105688|80583413|FG000|Part A: Double-Blind|Death|0|||
27657513|NCT02105688|80583414|FG001|Part A: Double-Blind|Death|1|||
27657514|NCT02105688|80583413|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
27657515|NCT02105688|80583414|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
27657516|NCT02105688|80583413|FG000|Part A: Double-Blind|Physician Decision|0|||
27657517|NCT02105688|80583414|FG001|Part A: Double-Blind|Physician Decision|1|||
27657518|NCT02105688|80583413|FG000|Part A: Double-Blind|Status Unknown|0|||
27657519|NCT02105688|80583414|FG001|Part A: Double-Blind|Status Unknown|2|||
27657520|NCT02105688|80583413|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
27657521|NCT02105688|80583414|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
27657522|NCT02105688|80583413|FG000|Part B: Observational Follow-up|Death|2|||
27657523|NCT02105688|80583414|FG001|Part B: Observational Follow-up|Death|1|||
27657524|NCT02105688|80583413|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
27657525|NCT02105688|80583414|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
27657526|NCT02105688|80583413|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
27657527|NCT02105688|80583414|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
27657528|NCT02105688|80583413|FG000|Part B: Observational Follow-up|Physician Decision|3|||
27657529|NCT02105688|80583414|FG001|Part B: Observational Follow-up|Physician Decision|1|||
27657530|NCT00080119|80583415|FG000|Overall Study|Discontinued because of study closure|0|||
27657531|NCT00080119|80583416|FG001|Overall Study|Discontinued because of study closure|0|||
27657532|NCT00080119|80583417|FG002|Overall Study|Discontinued because of study closure|130|||
27657533|NCT00080119|80583418|FG003|Overall Study|Discontinued because of study closure|141|||
27657534|NCT00080119|80583415|FG000|Overall Study|Unable to get to clinic|24|||
27657535|NCT00080119|80583416|FG001|Overall Study|Unable to get to clinic|24|||
27657536|NCT00080119|80583417|FG002|Overall Study|Unable to get to clinic|7|||
27657537|NCT00080119|80583418|FG003|Overall Study|Unable to get to clinic|1|||
27657538|NCT00080119|80583415|FG000|Overall Study|Consent withdrawn|13|||
27657539|NCT00080119|80583416|FG001|Overall Study|Consent withdrawn|17|||
27657540|NCT00080119|80583417|FG002|Overall Study|Consent withdrawn|4|||
27657541|NCT00080119|80583418|FG003|Overall Study|Consent withdrawn|6|||
27657542|NCT00080119|80583415|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
27657543|NCT00080119|80583416|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
27657544|NCT00080119|80583417|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
27657545|NCT00080119|80583418|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
27657546|NCT00080119|80583415|FG000|Overall Study|Lost to Follow-up|16|||
27657547|NCT00080119|80583416|FG001|Overall Study|Lost to Follow-up|19|||
27657548|NCT00080119|80583417|FG002|Overall Study|Lost to Follow-up|19|||
27657549|NCT00080119|80583418|FG003|Overall Study|Lost to Follow-up|14|||
27657550|NCT04879823|80583419|FG000|Overall Study|Physician Decision|3|||
27657551|NCT04879823|80583420|FG001|Overall Study|Physician Decision|1|||
27657552|NCT04879823|80583419|FG000|Overall Study|Protocol Violation|2|||
27657553|NCT04879823|80583420|FG001|Overall Study|Protocol Violation|3|||
27657554|NCT04879823|80583419|FG000|Overall Study|Lost to Follow-up|43|||
27657555|NCT04879823|80583420|FG001|Overall Study|Lost to Follow-up|35|||
27657556|NCT01767376|80583429|FG000|Overall Study|Lost to Follow-up|3|||
27657557|NCT01767376|80583430|FG001|Overall Study|Lost to Follow-up|2|||
27657558|NCT01767376|80583431|FG002|Overall Study|Lost to Follow-up|0|||
27657559|NCT01767376|80583429|FG000|Overall Study|Withdrawal by Subject|1|||
27657560|NCT01767376|80583430|FG001|Overall Study|Withdrawal by Subject|1|||
27657561|NCT01767376|80583431|FG002|Overall Study|Withdrawal by Subject|0|||
27657562|NCT02121808|80583432|FG000|Overall Study|Technical problem|3|||
27657563|NCT03906240|80583433|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
27657564|NCT03906240|80583434|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
27657565|NCT03906240|80583433|FG000|Overall Study|Lost to Follow-up|1|||
27657566|NCT03906240|80583434|FG001|Overall Study|Lost to Follow-up|0|||
27657567|NCT03906240|80583433|FG000|Overall Study|Withdrawal by Subject|0|||
27657568|NCT03906240|80583434|FG001|Overall Study|Withdrawal by Subject|1|||
27657569|NCT01014013|80583435|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
27657570|NCT01014013|80583436|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
27657571|NCT01014013|80583435|FG000|Overall Study|Clinical adverse experience|4|||
27657572|NCT01014013|80583436|FG001|Overall Study|Clinical adverse experience|2|||
27657573|NCT01014013|80583435|FG000|Overall Study|Laboratory adverse experience|1|||
27657574|NCT01014013|80583436|FG001|Overall Study|Laboratory adverse experience|1|||
27657575|NCT01014013|80583435|FG000|Overall Study|Protocol Violation|1|||
27657576|NCT01014013|80583436|FG001|Overall Study|Protocol Violation|3|||
27657577|NCT01014013|80583435|FG000|Overall Study|Withdrawal by Subject|7|||
27657578|NCT01014013|80583436|FG001|Overall Study|Withdrawal by Subject|4|||
27657579|NCT01014013|80583435|FG000|Overall Study|Clinical/microbiologic failure|1|||
27657580|NCT01014013|80583436|FG001|Overall Study|Clinical/microbiologic failure|2|||
27657581|NCT01014013|80583435|FG000|Overall Study|Pathogen culture = no growth|26|||
27657582|NCT01014013|80583436|FG001|Overall Study|Pathogen culture = no growth|34|||
27657583|NCT01014013|80583435|FG000|Overall Study|Negative urine culture|2|||
27657584|NCT01014013|80583436|FG001|Overall Study|Negative urine culture|0|||
27657585|NCT01014013|80583435|FG000|Overall Study|Pathogen resistant|7|||
27657586|NCT01014013|80583436|FG001|Overall Study|Pathogen resistant|4|||
27657587|NCT01014013|80583435|FG000|Overall Study|Physician Decision|0|||
27657588|NCT01014013|80583436|FG001|Overall Study|Physician Decision|1|||
27657589|NCT01014013|80583435|FG000|Overall Study|Another antibiotic therapy required|0|||
27657590|NCT01014013|80583436|FG001|Overall Study|Another antibiotic therapy required|1|||
27657591|NCT01014013|80583435|FG000|Overall Study|Appendectomy|1|||
27657592|NCT01014013|80583436|FG001|Overall Study|Appendectomy|0|||
27657593|NCT01014013|80583435|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
27657594|NCT01014013|80583436|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
27657595|NCT01196741|80583440|FG000|Overall Study|Disease progression|34|||
27657596|NCT01196741|80583441|FG001|Overall Study|Disease progression|14|||
27657597|NCT01196741|80583440|FG000|Overall Study|Adverse Event|10|||
27657598|NCT01196741|80583441|FG001|Overall Study|Adverse Event|6|||
27657599|NCT01196741|80583440|FG000|Overall Study|Serious Adverse Event|3|||
27657600|NCT01196741|80583441|FG001|Overall Study|Serious Adverse Event|1|||
27657601|NCT01196741|80583440|FG000|Overall Study|Dose limiting Adverse Event|2|||
27657602|NCT01196741|80583441|FG001|Overall Study|Dose limiting Adverse Event|1|||
27657603|NCT01196741|80583440|FG000|Overall Study|Withdrawal by Subject|3|||
27657604|NCT01196741|80583441|FG001|Overall Study|Withdrawal by Subject|0|||
27657605|NCT01196741|80583440|FG000|Overall Study|Other reason|3|||
27657606|NCT01196741|80583441|FG001|Overall Study|Other reason|3|||
27657607|NCT01196741|80583440|FG000|Overall Study|Other|3|||
27657608|NCT01196741|80583441|FG001|Overall Study|Other|2|||
27657609|NCT01196741|80583440|FG000|Overall Study|Protocol Violation|2|||
27657610|NCT01196741|80583441|FG001|Overall Study|Protocol Violation|1|||
27657611|NCT01078571|80583447|FG000|Overall Study|Adverse Event|36|||
27657612|NCT01078571|80583447|FG000|Overall Study|Lack of effectiveness|36|||
27657613|NCT01078571|80583447|FG000|Overall Study|Reason not reported|21|||
27657614|NCT01078571|80583447|FG000|Overall Study|Withdrawal by Subject|12|||
27657615|NCT01078571|80583447|FG000|Overall Study|Lost to Follow-up|8|||
27657616|NCT01078571|80583447|FG000|Overall Study|Protocol Violation|2|||
27657617|NCT03530345|80583448|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
27657618|NCT03530345|80583449|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
27657619|NCT03530345|80583448|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
27657620|NCT03530345|80583449|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
27657621|NCT03530345|80583448|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
27657622|NCT03530345|80583449|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
27657623|NCT03530345|80583448|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
27657624|NCT03530345|80583449|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
27657625|NCT00296504|80583450|FG000|Interim Analysis|Withdrawal by Subject|8|||
27657626|NCT00296504|80583451|FG001|Interim Analysis|Withdrawal by Subject|0|||
27657627|NCT00296504|80583452|FG002|Interim Analysis|Withdrawal by Subject|12|||
27657628|NCT00296504|80583453|FG003|Interim Analysis|Withdrawal by Subject|0|||
27657629|NCT00296504|80583454|FG004|Interim Analysis|Withdrawal by Subject|5|||
27657630|NCT00296504|80583455|FG005|Interim Analysis|Withdrawal by Subject|5|||
27657631|NCT00296504|80583456|FG006|Interim Analysis|Withdrawal by Subject|9|||
27657632|NCT00296504|80583457|FG007|Interim Analysis|Withdrawal by Subject|3|||
27657633|NCT00296504|80583458|FG008|Interim Analysis|Withdrawal by Subject|0|||
27657634|NCT00296504|80583450|FG000|Interim Analysis|Lost to Follow-up|13|||
27657635|NCT00296504|80583451|FG001|Interim Analysis|Lost to Follow-up|3|||
27657636|NCT00296504|80583452|FG002|Interim Analysis|Lost to Follow-up|26|||
27657637|NCT00296504|80583453|FG003|Interim Analysis|Lost to Follow-up|8|||
27657638|NCT00296504|80583454|FG004|Interim Analysis|Lost to Follow-up|14|||
27657639|NCT00296504|80583455|FG005|Interim Analysis|Lost to Follow-up|4|||
27657640|NCT00296504|80583456|FG006|Interim Analysis|Lost to Follow-up|11|||
27657641|NCT00296504|80583457|FG007|Interim Analysis|Lost to Follow-up|4|||
27657642|NCT00296504|80583458|FG008|Interim Analysis|Lost to Follow-up|0|||
27657643|NCT00296504|80583450|FG000|Interim Analysis|Clinical Progression|1|||
27657644|NCT00296504|80583451|FG001|Interim Analysis|Clinical Progression|0|||
27657645|NCT00296504|80583452|FG002|Interim Analysis|Clinical Progression|1|||
27657646|NCT00296504|80583453|FG003|Interim Analysis|Clinical Progression|1|||
27657647|NCT00296504|80583454|FG004|Interim Analysis|Clinical Progression|0|||
27657648|NCT00296504|80583455|FG005|Interim Analysis|Clinical Progression|2|||
27657649|NCT00296504|80583456|FG006|Interim Analysis|Clinical Progression|1|||
27657650|NCT00296504|80583457|FG007|Interim Analysis|Clinical Progression|2|||
27657651|NCT00296504|80583458|FG008|Interim Analysis|Clinical Progression|0|||
27657652|NCT00296504|80583450|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
27657653|NCT00296504|80583451|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
27657654|NCT00296504|80583452|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
27657655|NCT00296504|80583453|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
27657656|NCT00296504|80583454|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
27657657|NCT00296504|80583455|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
27657658|NCT00296504|80583456|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
27657659|NCT00296504|80583457|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
27657660|NCT00296504|80583458|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
27657661|NCT00296504|80583450|FG000|Interim Analysis|Adverse Event|0|||
27657662|NCT00296504|80583451|FG001|Interim Analysis|Adverse Event|0|||
27657663|NCT00296504|80583452|FG002|Interim Analysis|Adverse Event|13|||
27657664|NCT00296504|80583453|FG003|Interim Analysis|Adverse Event|4|||
27657665|NCT00296504|80583454|FG004|Interim Analysis|Adverse Event|6|||
27657666|NCT00296504|80583455|FG005|Interim Analysis|Adverse Event|3|||
27657667|NCT00296504|80583456|FG006|Interim Analysis|Adverse Event|4|||
27657668|NCT00296504|80583457|FG007|Interim Analysis|Adverse Event|5|||
27657669|NCT00296504|80583458|FG008|Interim Analysis|Adverse Event|0|||
27657670|NCT00296504|80583450|FG000|Interim Analysis|Protocol Violation|0|||
27657671|NCT00296504|80583451|FG001|Interim Analysis|Protocol Violation|0|||
27657672|NCT00296504|80583452|FG002|Interim Analysis|Protocol Violation|2|||
27657673|NCT00296504|80583453|FG003|Interim Analysis|Protocol Violation|0|||
27657674|NCT00296504|80583454|FG004|Interim Analysis|Protocol Violation|1|||
27657675|NCT00296504|80583455|FG005|Interim Analysis|Protocol Violation|0|||
27657676|NCT00296504|80583456|FG006|Interim Analysis|Protocol Violation|0|||
27657677|NCT00296504|80583457|FG007|Interim Analysis|Protocol Violation|1|||
27657678|NCT00296504|80583458|FG008|Interim Analysis|Protocol Violation|0|||
27657679|NCT00296504|80583450|FG000|Interim Analysis|Insufficient CD4 Response|0|||
27657680|NCT00296504|80583451|FG001|Interim Analysis|Insufficient CD4 Response|0|||
27657681|NCT00296504|80583452|FG002|Interim Analysis|Insufficient CD4 Response|0|||
27567858|NCT02501096|80267442|FG006|Overall Study|Death|15|||
27567859|NCT02501096|80267443|FG007|Overall Study|Death|16|||
27567860|NCT02501096|80267444|FG008|Overall Study|Death|1|||
27567861|NCT03711162|80267445|FG000|Overall Study|Adverse Event|5|||
27567862|NCT03711162|80267446|FG001|Overall Study|Adverse Event|2|||
27567863|NCT03711162|80267447|FG002|Overall Study|Adverse Event|4|||
27567864|NCT03711162|80267445|FG000|Overall Study|Death|11|||
27567865|NCT03711162|80267446|FG001|Overall Study|Death|7|||
27567866|NCT03711162|80267447|FG002|Overall Study|Death|8|||
27567867|NCT03711162|80267445|FG000|Overall Study|Lost to Follow-up|1|||
27567868|NCT03711162|80267446|FG001|Overall Study|Lost to Follow-up|0|||
27567869|NCT03711162|80267447|FG002|Overall Study|Lost to Follow-up|1|||
27567870|NCT03711162|80267445|FG000|Overall Study|Study Terminated by Sponsor|139|||
27567871|NCT03711162|80267446|FG001|Overall Study|Study Terminated by Sponsor|152|||
27567872|NCT03711162|80267447|FG002|Overall Study|Study Terminated by Sponsor|146|||
27567873|NCT03711162|80267445|FG000|Overall Study|Withdrawal by Subject|17|||
27567874|NCT03711162|80267446|FG001|Overall Study|Withdrawal by Subject|10|||
27567875|NCT03711162|80267447|FG002|Overall Study|Withdrawal by Subject|10|||
27567876|NCT03711162|80267445|FG000|Overall Study|Miscellaneous|1|||
27567877|NCT03711162|80267446|FG001|Overall Study|Miscellaneous|2|||
27567878|NCT03711162|80267447|FG002|Overall Study|Miscellaneous|2|||
27567879|NCT03711162|80267445|FG000|Overall Study|Not Treated|1|||
27567880|NCT03711162|80267446|FG001|Overall Study|Not Treated|0|||
27567881|NCT03711162|80267447|FG002|Overall Study|Not Treated|1|||
27567882|NCT03711162|80267445|FG000|Overall Study|Physician Decision|0|||
27567883|NCT03711162|80267446|FG001|Overall Study|Physician Decision|2|||
27567884|NCT03711162|80267447|FG002|Overall Study|Physician Decision|0|||
27567885|NCT03711162|80267445|FG000|Overall Study|Lack of Efficacy|0|||
27567886|NCT03711162|80267446|FG001|Overall Study|Lack of Efficacy|0|||
27567887|NCT03711162|80267447|FG002|Overall Study|Lack of Efficacy|2|||
27567888|NCT03711162|80267445|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
27567889|NCT03711162|80267446|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
27567890|NCT03711162|80267447|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
27567891|NCT00606892|80267453|FG000|First Intervention|Protocol Violation|1|||
27567892|NCT00606892|80267454|FG001|First Intervention|Protocol Violation|4|||
27567893|NCT04098458|80267458|FG000|Overall Study|Death|1|||
27567894|NCT04098458|80267458|FG000|Overall Study|did not meet study inclusion criteria|3|||
27567895|NCT01652716|80267459|FG000|Overall Study|Loss of glucose control|1|||
27567896|NCT01652716|80267460|FG001|Overall Study|Loss of glucose control|0|||
27567897|NCT01652716|80267459|FG000|Overall Study|Administrative|0|||
27567898|NCT01652716|80267460|FG001|Overall Study|Administrative|2|||
27567899|NCT01652716|80267459|FG000|Overall Study|Investigator decision|1|||
27567900|NCT01652716|80267460|FG001|Overall Study|Investigator decision|4|||
27567901|NCT01652716|80267459|FG000|Overall Study|Lost to Follow-up|12|||
27567902|NCT01652716|80267460|FG001|Overall Study|Lost to Follow-up|11|||
27567903|NCT01652716|80267459|FG000|Overall Study|Protocol Violation|2|||
27567904|NCT01652716|80267460|FG001|Overall Study|Protocol Violation|1|||
27567905|NCT01652716|80267459|FG000|Overall Study|Adverse Event|7|||
27567906|NCT01652716|80267460|FG001|Overall Study|Adverse Event|10|||
27567907|NCT01652716|80267459|FG000|Overall Study|Withdrawal by Subject|33|||
27567908|NCT01652716|80267460|FG001|Overall Study|Withdrawal by Subject|18|||
27567909|NCT02385799|80267468|FG000|Overall Study|Lost to Follow-up|1|||
27567910|NCT02385799|80267469|FG001|Overall Study|Lost to Follow-up|2|||
27567911|NCT02385799|80267468|FG000|Overall Study|Adverse Event|4|||
27567912|NCT02385799|80267469|FG001|Overall Study|Adverse Event|2|||
27567913|NCT02385799|80267468|FG000|Overall Study|Withdrawal by Subject|0|||
27567914|NCT02385799|80267469|FG001|Overall Study|Withdrawal by Subject|4|||
27567915|NCT01063595|80267470|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
27567916|NCT01063595|80267471|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
27567917|NCT01063595|80267470|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
27567918|NCT01063595|80267471|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
27567919|NCT01063595|80267470|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
27567920|NCT01063595|80267471|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
27567921|NCT01063595|80267470|FG000|First Intervention|Adverse Event|1|||
27567922|NCT01063595|80267471|FG001|First Intervention|Adverse Event|4|||
27567923|NCT01063595|80267470|FG000|First Intervention|Withdrawal by Subject|1|||
27567924|NCT01063595|80267471|FG001|First Intervention|Withdrawal by Subject|0|||
27567925|NCT01063595|80267470|FG000|First Intervention|Reason not Specified|0|||
27567926|NCT01063595|80267471|FG001|First Intervention|Reason not Specified|1|||
27567927|NCT03240133|80267472|FG000|Overall Study|Withdrawal by Subject|0|||
27657682|NCT00296504|80583453|FG003|Interim Analysis|Insufficient CD4 Response|0|||
27657683|NCT00296504|80583454|FG004|Interim Analysis|Insufficient CD4 Response|1|||
27657684|NCT00296504|80583455|FG005|Interim Analysis|Insufficient CD4 Response|1|||
27657685|NCT00296504|80583456|FG006|Interim Analysis|Insufficient CD4 Response|0|||
27657686|NCT00296504|80583457|FG007|Interim Analysis|Insufficient CD4 Response|0|||
27657687|NCT00296504|80583458|FG008|Interim Analysis|Insufficient CD4 Response|0|||
27657688|NCT00296504|80583450|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
27657689|NCT00296504|80583451|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
27657690|NCT00296504|80583452|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
27657691|NCT00296504|80583453|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
27657692|NCT00296504|80583454|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
27657693|NCT00296504|80583455|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
27657694|NCT00296504|80583456|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
27657695|NCT00296504|80583457|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
27657696|NCT00296504|80583458|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
27657697|NCT00296504|80583450|FG000|Interim Analysis|Pregnancy|4|||
27657698|NCT00296504|80583451|FG001|Interim Analysis|Pregnancy|1|||
27657699|NCT00296504|80583452|FG002|Interim Analysis|Pregnancy|4|||
27657700|NCT00296504|80583453|FG003|Interim Analysis|Pregnancy|2|||
27657701|NCT00296504|80583454|FG004|Interim Analysis|Pregnancy|0|||
27657702|NCT00296504|80583455|FG005|Interim Analysis|Pregnancy|1|||
27657703|NCT00296504|80583456|FG006|Interim Analysis|Pregnancy|1|||
27657704|NCT00296504|80583457|FG007|Interim Analysis|Pregnancy|1|||
27657705|NCT00296504|80583458|FG008|Interim Analysis|Pregnancy|0|||
27657706|NCT00296504|80583450|FG000|Interim Analysis|Death|1|||
27657707|NCT00296504|80583451|FG001|Interim Analysis|Death|0|||
27657708|NCT00296504|80583452|FG002|Interim Analysis|Death|3|||
27657709|NCT00296504|80583453|FG003|Interim Analysis|Death|0|||
27657710|NCT00296504|80583454|FG004|Interim Analysis|Death|0|||
27657711|NCT00296504|80583455|FG005|Interim Analysis|Death|0|||
27657712|NCT00296504|80583456|FG006|Interim Analysis|Death|0|||
27657713|NCT00296504|80583457|FG007|Interim Analysis|Death|0|||
27657714|NCT00296504|80583458|FG008|Interim Analysis|Death|0|||
27657715|NCT00296504|80583450|FG000|Interim Analysis|Participant Non-compliant|0|||
27657716|NCT00296504|80583451|FG001|Interim Analysis|Participant Non-compliant|1|||
27657717|NCT00296504|80583452|FG002|Interim Analysis|Participant Non-compliant|2|||
27657718|NCT00296504|80583453|FG003|Interim Analysis|Participant Non-compliant|1|||
27657719|NCT00296504|80583454|FG004|Interim Analysis|Participant Non-compliant|1|||
27657720|NCT00296504|80583455|FG005|Interim Analysis|Participant Non-compliant|3|||
27657721|NCT00296504|80583456|FG006|Interim Analysis|Participant Non-compliant|6|||
27657722|NCT00296504|80583457|FG007|Interim Analysis|Participant Non-compliant|2|||
27657723|NCT00296504|80583458|FG008|Interim Analysis|Participant Non-compliant|0|||
27657724|NCT00296504|80583450|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657725|NCT00296504|80583451|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657726|NCT00296504|80583452|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
27657727|NCT00296504|80583453|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657728|NCT00296504|80583454|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657729|NCT00296504|80583455|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
27657730|NCT00296504|80583456|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657731|NCT00296504|80583457|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657732|NCT00296504|80583458|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
27657733|NCT00296504|80583450|FG000|Interim Analysis|To Simplify Treatment|0|||
27657734|NCT00296504|80583451|FG001|Interim Analysis|To Simplify Treatment|0|||
27657735|NCT00296504|80583452|FG002|Interim Analysis|To Simplify Treatment|1|||
27657736|NCT00296504|80583453|FG003|Interim Analysis|To Simplify Treatment|0|||
27657737|NCT00296504|80583454|FG004|Interim Analysis|To Simplify Treatment|0|||
27567928|NCT03240133|80267473|FG001|Overall Study|Withdrawal by Subject|1|||
27567929|NCT03240133|80267474|FG002|Overall Study|Withdrawal by Subject|0|||
27567930|NCT03240133|80267472|FG000|Overall Study|Adverse Event|1|||
27567931|NCT03240133|80267473|FG001|Overall Study|Adverse Event|1|||
27567932|NCT03240133|80267474|FG002|Overall Study|Adverse Event|0|||
27567933|NCT03240133|80267472|FG000|Overall Study|Rash|1|||
27567934|NCT03240133|80267473|FG001|Overall Study|Rash|0|||
27567935|NCT03240133|80267474|FG002|Overall Study|Rash|0|||
27657738|NCT00296504|80583455|FG005|Interim Analysis|To Simplify Treatment|0|||
27657739|NCT00296504|80583456|FG006|Interim Analysis|To Simplify Treatment|2|||
27657740|NCT00296504|80583457|FG007|Interim Analysis|To Simplify Treatment|0|||
27657741|NCT00296504|80583458|FG008|Interim Analysis|To Simplify Treatment|0|||
27657742|NCT00296504|80583450|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657743|NCT00296504|80583451|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657744|NCT00296504|80583452|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
27657745|NCT00296504|80583453|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657746|NCT00296504|80583454|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
27567936|NCT03240133|80267472|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
27657747|NCT00296504|80583455|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657748|NCT00296504|80583456|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657749|NCT00296504|80583457|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657750|NCT00296504|80583458|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
27657751|NCT00296504|80583450|FG000|Interim Analysis|Participant Moved|1|||
27657752|NCT00296504|80583451|FG001|Interim Analysis|Participant Moved|0|||
27657753|NCT00296504|80583452|FG002|Interim Analysis|Participant Moved|1|||
27657754|NCT00296504|80583453|FG003|Interim Analysis|Participant Moved|0|||
27657755|NCT00296504|80583454|FG004|Interim Analysis|Participant Moved|0|||
27657756|NCT00296504|80583455|FG005|Interim Analysis|Participant Moved|1|||
27657757|NCT00296504|80583456|FG006|Interim Analysis|Participant Moved|1|||
27657758|NCT00296504|80583457|FG007|Interim Analysis|Participant Moved|0|||
27657759|NCT00296504|80583458|FG008|Interim Analysis|Participant Moved|0|||
27657760|NCT00296504|80583450|FG000|Interim Analysis|Participant Was Incarcerated|2|||
27657761|NCT00296504|80583451|FG001|Interim Analysis|Participant Was Incarcerated|0|||
27657762|NCT00296504|80583452|FG002|Interim Analysis|Participant Was Incarcerated|1|||
27657763|NCT00296504|80583453|FG003|Interim Analysis|Participant Was Incarcerated|0|||
27657764|NCT00296504|80583454|FG004|Interim Analysis|Participant Was Incarcerated|0|||
27657765|NCT00296504|80583455|FG005|Interim Analysis|Participant Was Incarcerated|0|||
27657766|NCT00296504|80583456|FG006|Interim Analysis|Participant Was Incarcerated|0|||
27657767|NCT00296504|80583457|FG007|Interim Analysis|Participant Was Incarcerated|0|||
27657768|NCT00296504|80583458|FG008|Interim Analysis|Participant Was Incarcerated|0|||
27657769|NCT00296504|80583450|FG000|Interim Analysis|Resistance to FPV|0|||
27860255|NCT00593736|81319422|FG002|Treatment Period and Placebo Run-out|Various|1|||
27860256|NCT00593736|81319423|FG003|Treatment Period and Placebo Run-out|Various|0|||
27860257|NCT00307437|81319424|FG000|Controlled Period|Adverse Event|7|||
27860258|NCT00307437|81319425|FG001|Controlled Period|Adverse Event|2|||
27860259|NCT00307437|81319426|FG002|Controlled Period|Adverse Event|5|||
27860260|NCT00307437|81319427|FG003|Controlled Period|Adverse Event|0|||
27860261|NCT00307437|81319428|FG004|Controlled Period|Adverse Event|0|||
27860262|NCT00307437|81319429|FG005|Controlled Period|Adverse Event|0|||
27860263|NCT00307437|81319430|FG006|Controlled Period|Adverse Event|0|||
27860264|NCT00307437|81319424|FG000|Controlled Period|Death|0|||
27860265|NCT00307437|81319425|FG001|Controlled Period|Death|0|||
27860266|NCT00307437|81319426|FG002|Controlled Period|Death|1|||
27860267|NCT00307437|81319427|FG003|Controlled Period|Death|0|||
27860268|NCT00307437|81319428|FG004|Controlled Period|Death|0|||
27860269|NCT00307437|81319429|FG005|Controlled Period|Death|0|||
27860270|NCT00307437|81319430|FG006|Controlled Period|Death|0|||
27860271|NCT00307437|81319424|FG000|Controlled Period|Lack of Efficacy|2|||
27860272|NCT00307437|81319425|FG001|Controlled Period|Lack of Efficacy|0|||
27860273|NCT00307437|81319426|FG002|Controlled Period|Lack of Efficacy|0|||
27860274|NCT00307437|81319427|FG003|Controlled Period|Lack of Efficacy|0|||
27860275|NCT00307437|81319428|FG004|Controlled Period|Lack of Efficacy|0|||
27860276|NCT00307437|81319429|FG005|Controlled Period|Lack of Efficacy|0|||
27860277|NCT00307437|81319430|FG006|Controlled Period|Lack of Efficacy|0|||
27860278|NCT00307437|81319424|FG000|Controlled Period|Lost to Follow-up|2|||
27860279|NCT00307437|81319425|FG001|Controlled Period|Lost to Follow-up|3|||
27860280|NCT00307437|81319426|FG002|Controlled Period|Lost to Follow-up|0|||
27860281|NCT00307437|81319427|FG003|Controlled Period|Lost to Follow-up|0|||
27860282|NCT00307437|81319428|FG004|Controlled Period|Lost to Follow-up|0|||
27860283|NCT00307437|81319429|FG005|Controlled Period|Lost to Follow-up|0|||
27860284|NCT00307437|81319430|FG006|Controlled Period|Lost to Follow-up|0|||
27860285|NCT00307437|81319424|FG000|Controlled Period|Other|5|||
27860286|NCT00307437|81319425|FG001|Controlled Period|Other|1|||
27860287|NCT00307437|81319426|FG002|Controlled Period|Other|3|||
27567937|NCT03240133|80267473|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
27567938|NCT03240133|80267474|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
27567939|NCT03240133|80267472|FG000|Overall Study|Intercurrent illness.|0|||
27567940|NCT03240133|80267473|FG001|Overall Study|Intercurrent illness.|1|||
27567941|NCT03240133|80267474|FG002|Overall Study|Intercurrent illness.|0|||
27567942|NCT03240133|80267472|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
27567943|NCT03240133|80267473|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
27567944|NCT03240133|80267474|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
27567945|NCT01200797|80267475|FG000|Overall Study|symptomatic deterioration|2|||
27567946|NCT01200797|80267475|FG000|Overall Study|Adverse Event|4|||
27567947|NCT01200797|80267475|FG000|Overall Study|Disease Progression|13|||
27657770|NCT00296504|80583451|FG001|Interim Analysis|Resistance to FPV|0|||
27657771|NCT00296504|80583452|FG002|Interim Analysis|Resistance to FPV|1|||
27860288|NCT00307437|81319427|FG003|Controlled Period|Other|0|||
27860289|NCT00307437|81319428|FG004|Controlled Period|Other|0|||
27860290|NCT00307437|81319429|FG005|Controlled Period|Other|0|||
27860291|NCT00307437|81319430|FG006|Controlled Period|Other|0|||
27860292|NCT00307437|81319424|FG000|After Controlled Period|Adverse Event|0|||
27860293|NCT00307437|81319425|FG001|After Controlled Period|Adverse Event|0|||
27657772|NCT00296504|80583453|FG003|Interim Analysis|Resistance to FPV|0|||
27657773|NCT00296504|80583454|FG004|Interim Analysis|Resistance to FPV|0|||
27657774|NCT00296504|80583455|FG005|Interim Analysis|Resistance to FPV|0|||
27657775|NCT00296504|80583456|FG006|Interim Analysis|Resistance to FPV|0|||
27657776|NCT00296504|80583457|FG007|Interim Analysis|Resistance to FPV|0|||
27657777|NCT00296504|80583458|FG008|Interim Analysis|Resistance to FPV|0|||
27657778|NCT00296504|80583450|FG000|Interim Analysis|Physician Decision|0|||
27860294|NCT00307437|81319426|FG002|After Controlled Period|Adverse Event|0|||
27860295|NCT00307437|81319427|FG003|After Controlled Period|Adverse Event|18|||
27860296|NCT00307437|81319428|FG004|After Controlled Period|Adverse Event|16|||
27860297|NCT00307437|81319429|FG005|After Controlled Period|Adverse Event|31|||
27860298|NCT00307437|81319430|FG006|After Controlled Period|Adverse Event|40|||
27860299|NCT00307437|81319424|FG000|After Controlled Period|Death|0|||
27860300|NCT00307437|81319425|FG001|After Controlled Period|Death|0|||
27860301|NCT00307437|81319426|FG002|After Controlled Period|Death|0|||
27860302|NCT00307437|81319427|FG003|After Controlled Period|Death|3|||
27860303|NCT00307437|81319428|FG004|After Controlled Period|Death|1|||
27860304|NCT00307437|81319429|FG005|After Controlled Period|Death|1|||
27860305|NCT00307437|81319430|FG006|After Controlled Period|Death|3|||
27860306|NCT00307437|81319424|FG000|After Controlled Period|Lack of Efficacy|0|||
27860307|NCT00307437|81319425|FG001|After Controlled Period|Lack of Efficacy|0|||
27860308|NCT00307437|81319426|FG002|After Controlled Period|Lack of Efficacy|0|||
27860309|NCT00307437|81319427|FG003|After Controlled Period|Lack of Efficacy|15|||
27860310|NCT00307437|81319428|FG004|After Controlled Period|Lack of Efficacy|17|||
27567948|NCT00666757|80267476|FG000|Overall Study|Lost to Follow-up|39|||
27567949|NCT00666757|80267477|FG001|Overall Study|Lost to Follow-up|35|||
27567950|NCT00666757|80267476|FG000|Overall Study|Protocol Violation|23|||
27567951|NCT00666757|80267477|FG001|Overall Study|Protocol Violation|24|||
27567952|NCT00666757|80267476|FG000|Overall Study|Adverse Event|22|||
27567953|NCT00666757|80267477|FG001|Overall Study|Adverse Event|12|||
27567954|NCT00666757|80267476|FG000|Overall Study|Withdrawal by Subject|13|||
27567955|NCT00666757|80267477|FG001|Overall Study|Withdrawal by Subject|17|||
27567956|NCT00666757|80267476|FG000|Overall Study|Lack of Efficacy|3|||
27567957|NCT00666757|80267477|FG001|Overall Study|Lack of Efficacy|6|||
27567958|NCT00666757|80267476|FG000|Overall Study|Physician Decision|0|||
27567959|NCT00666757|80267477|FG001|Overall Study|Physician Decision|2|||
27567960|NCT00666757|80267476|FG000|Overall Study|Sponsor decision|0|||
27567961|NCT00666757|80267477|FG001|Overall Study|Sponsor decision|1|||
27567962|NCT00394212|80267483|FG000|Overall Study|Lost to Follow-up|3|||
27567963|NCT00394212|80267484|FG001|Overall Study|Lost to Follow-up|0|||
27567964|NCT00394212|80267483|FG000|Overall Study|Withdrawal by Subject|4|||
27567965|NCT00394212|80267484|FG001|Overall Study|Withdrawal by Subject|1|||
27567966|NCT01649375|80267485|FG000|Up to Week 16|Adverse Event|2|||
27567967|NCT01649375|80267486|FG001|Up to Week 16|Adverse Event|5|||
27567968|NCT01649375|80267487|FG002|Up to Week 16|Adverse Event|4|||
27567969|NCT01649375|80267488|FG003|Up to Week 16|Adverse Event|0|||
27567970|NCT01649375|80267489|FG004|Up to Week 16|Adverse Event|0|||
27567971|NCT01649375|80267485|FG000|Up to Week 16|Lack of Efficacy|0|||
27567972|NCT01649375|80267486|FG001|Up to Week 16|Lack of Efficacy|0|||
27567973|NCT01649375|80267487|FG002|Up to Week 16|Lack of Efficacy|1|||
27567974|NCT01649375|80267488|FG003|Up to Week 16|Lack of Efficacy|0|||
27567975|NCT01649375|80267489|FG004|Up to Week 16|Lack of Efficacy|0|||
27567976|NCT01649375|80267485|FG000|Up to Week 16|Physician Decision|0|||
27567977|NCT01649375|80267486|FG001|Up to Week 16|Physician Decision|0|||
27567978|NCT01649375|80267487|FG002|Up to Week 16|Physician Decision|1|||
27567979|NCT01649375|80267488|FG003|Up to Week 16|Physician Decision|0|||
27567980|NCT01649375|80267489|FG004|Up to Week 16|Physician Decision|0|||
27567981|NCT01649375|80267485|FG000|Up to Week 16|Withdrawal by Subject|2|||
27567982|NCT01649375|80267486|FG001|Up to Week 16|Withdrawal by Subject|1|||
27567983|NCT01649375|80267487|FG002|Up to Week 16|Withdrawal by Subject|2|||
27567984|NCT01649375|80267488|FG003|Up to Week 16|Withdrawal by Subject|0|||
27567985|NCT01649375|80267489|FG004|Up to Week 16|Withdrawal by Subject|0|||
27567986|NCT01649375|80267485|FG000|Up to Week 16|Death|1|||
27567987|NCT01649375|80267486|FG001|Up to Week 16|Death|0|||
27567988|NCT01649375|80267487|FG002|Up to Week 16|Death|0|||
27567989|NCT01649375|80267488|FG003|Up to Week 16|Death|0|||
27567990|NCT01649375|80267489|FG004|Up to Week 16|Death|0|||
27567991|NCT01649375|80267485|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
27567992|NCT01649375|80267486|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
27567993|NCT01649375|80267487|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
27567994|NCT01649375|80267488|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
27567995|NCT01649375|80267489|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
27657779|NCT00296504|80583451|FG001|Interim Analysis|Physician Decision|0|||
27860311|NCT00307437|81319429|FG005|After Controlled Period|Lack of Efficacy|37|||
27860312|NCT00307437|81319430|FG006|After Controlled Period|Lack of Efficacy|24|||
27860313|NCT00307437|81319424|FG000|After Controlled Period|Lost to Follow-up|0|||
27567996|NCT01649375|80267485|FG000|Week 16 up to Week 260|Non-compliance|0|||
27567997|NCT01649375|80267486|FG001|Week 16 up to Week 260|Non-compliance|1|||
27567998|NCT01649375|80267487|FG002|Week 16 up to Week 260|Non-compliance|0|||
27657780|NCT00296504|80583452|FG002|Interim Analysis|Physician Decision|1|||
27657781|NCT00296504|80583453|FG003|Interim Analysis|Physician Decision|0|||
27657782|NCT00296504|80583454|FG004|Interim Analysis|Physician Decision|0|||
27657783|NCT00296504|80583455|FG005|Interim Analysis|Physician Decision|0|||
27657784|NCT00296504|80583456|FG006|Interim Analysis|Physician Decision|0|||
27657785|NCT00296504|80583457|FG007|Interim Analysis|Physician Decision|0|||
27657786|NCT00296504|80583458|FG008|Interim Analysis|Physician Decision|0|||
27657787|NCT00296504|80583450|FG000|Interim Analysis|Principle Investigator Discretion|2|||
27657788|NCT00296504|80583451|FG001|Interim Analysis|Principle Investigator Discretion|0|||
27657789|NCT00296504|80583452|FG002|Interim Analysis|Principle Investigator Discretion|1|||
27657790|NCT00296504|80583453|FG003|Interim Analysis|Principle Investigator Discretion|1|||
27657791|NCT00296504|80583454|FG004|Interim Analysis|Principle Investigator Discretion|0|||
27657792|NCT00296504|80583455|FG005|Interim Analysis|Principle Investigator Discretion|0|||
27657793|NCT00296504|80583456|FG006|Interim Analysis|Principle Investigator Discretion|0|||
27657794|NCT00296504|80583457|FG007|Interim Analysis|Principle Investigator Discretion|0|||
27657795|NCT00296504|80583458|FG008|Interim Analysis|Principle Investigator Discretion|0|||
27657796|NCT00296504|80583450|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
27657797|NCT00296504|80583451|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
27657798|NCT00296504|80583452|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
27657799|NCT00296504|80583453|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
27657800|NCT00296504|80583454|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
27657801|NCT00296504|80583455|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
27657802|NCT00296504|80583456|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
27657803|NCT00296504|80583457|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
27657804|NCT00296504|80583458|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
27657805|NCT00296504|80583450|FG000|Interim Analysis|Non-adherence|2|||
27657806|NCT00296504|80583451|FG001|Interim Analysis|Non-adherence|0|||
27657807|NCT00296504|80583452|FG002|Interim Analysis|Non-adherence|0|||
27657808|NCT00296504|80583453|FG003|Interim Analysis|Non-adherence|0|||
27657809|NCT00296504|80583454|FG004|Interim Analysis|Non-adherence|1|||
27657810|NCT00296504|80583455|FG005|Interim Analysis|Non-adherence|0|||
27657811|NCT00296504|80583456|FG006|Interim Analysis|Non-adherence|0|||
27657812|NCT00296504|80583457|FG007|Interim Analysis|Non-adherence|1|||
27657813|NCT00296504|80583458|FG008|Interim Analysis|Non-adherence|0|||
27657814|NCT00296504|80583450|FG000|Interim Analysis|Site Closing|1|||
27657815|NCT00296504|80583451|FG001|Interim Analysis|Site Closing|0|||
27657816|NCT00296504|80583452|FG002|Interim Analysis|Site Closing|0|||
27657817|NCT00296504|80583453|FG003|Interim Analysis|Site Closing|0|||
27657818|NCT00296504|80583454|FG004|Interim Analysis|Site Closing|0|||
27657819|NCT00296504|80583455|FG005|Interim Analysis|Site Closing|1|||
27657820|NCT00296504|80583456|FG006|Interim Analysis|Site Closing|2|||
27657821|NCT00296504|80583457|FG007|Interim Analysis|Site Closing|0|||
27657822|NCT00296504|80583458|FG008|Interim Analysis|Site Closing|0|||
27761649|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
27761650|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
27567999|NCT01649375|80267488|FG003|Week 16 up to Week 260|Non-compliance|1|||
27657823|NCT00296504|80583450|FG000|Interim Analysis|Lack of Personnel at Site|1|||
27657824|NCT00296504|80583451|FG001|Interim Analysis|Lack of Personnel at Site|0|||
27657825|NCT00296504|80583452|FG002|Interim Analysis|Lack of Personnel at Site|0|||
27657826|NCT00296504|80583453|FG003|Interim Analysis|Lack of Personnel at Site|0|||
27657827|NCT00296504|80583454|FG004|Interim Analysis|Lack of Personnel at Site|0|||
27568000|NCT01649375|80267489|FG004|Week 16 up to Week 260|Non-compliance|0|||
27568001|NCT01649375|80267485|FG000|Week 16 up to Week 260|Physician Decision|0|||
27568002|NCT01649375|80267486|FG001|Week 16 up to Week 260|Physician Decision|2|||
27568003|NCT01649375|80267487|FG002|Week 16 up to Week 260|Physician Decision|0|||
27568004|NCT01649375|80267488|FG003|Week 16 up to Week 260|Physician Decision|0|||
27568005|NCT01649375|80267489|FG004|Week 16 up to Week 260|Physician Decision|0|||
27568006|NCT01649375|80267485|FG000|Week 16 up to Week 260|Technical issues|0|||
27568007|NCT01649375|80267486|FG001|Week 16 up to Week 260|Technical issues|1|||
27568008|NCT01649375|80267487|FG002|Week 16 up to Week 260|Technical issues|0|||
27568009|NCT01649375|80267488|FG003|Week 16 up to Week 260|Technical issues|1|||
27568010|NCT01649375|80267489|FG004|Week 16 up to Week 260|Technical issues|0|||
27568011|NCT01649375|80267485|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
27568012|NCT01649375|80267486|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
27568013|NCT01649375|80267487|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
27657828|NCT00296504|80583455|FG005|Interim Analysis|Lack of Personnel at Site|0|||
27657829|NCT00296504|80583456|FG006|Interim Analysis|Lack of Personnel at Site|0|||
27657830|NCT00296504|80583457|FG007|Interim Analysis|Lack of Personnel at Site|0|||
27657831|NCT00296504|80583458|FG008|Interim Analysis|Lack of Personnel at Site|0|||
27657832|NCT00296504|80583450|FG000|Interim Analysis|Missed Schedule Date|1|||
27657833|NCT00296504|80583451|FG001|Interim Analysis|Missed Schedule Date|0|||
27761651|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
27657834|NCT00296504|80583452|FG002|Interim Analysis|Missed Schedule Date|0|||
27657835|NCT00296504|80583453|FG003|Interim Analysis|Missed Schedule Date|0|||
27657836|NCT00296504|80583454|FG004|Interim Analysis|Missed Schedule Date|0|||
27657837|NCT00296504|80583455|FG005|Interim Analysis|Missed Schedule Date|0|||
27657838|NCT00296504|80583456|FG006|Interim Analysis|Missed Schedule Date|0|||
27657839|NCT00296504|80583457|FG007|Interim Analysis|Missed Schedule Date|0|||
27657840|NCT00296504|80583458|FG008|Interim Analysis|Missed Schedule Date|0|||
27657841|NCT00296504|80583450|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
27657842|NCT00296504|80583451|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
27657843|NCT00296504|80583452|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
27657844|NCT00296504|80583453|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
27657845|NCT00296504|80583454|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
27657846|NCT00296504|80583455|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
27657847|NCT00296504|80583456|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
27657848|NCT00296504|80583457|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
27657849|NCT00296504|80583458|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
27657850|NCT00296504|80583450|FG000|Interim Analysis|Participant Stopped|0|||
27657851|NCT00296504|80583451|FG001|Interim Analysis|Participant Stopped|0|||
27657852|NCT00296504|80583452|FG002|Interim Analysis|Participant Stopped|0|||
27657853|NCT00296504|80583453|FG003|Interim Analysis|Participant Stopped|0|||
27657854|NCT00296504|80583454|FG004|Interim Analysis|Participant Stopped|1|||
27657855|NCT00296504|80583455|FG005|Interim Analysis|Participant Stopped|0|||
27657856|NCT00296504|80583456|FG006|Interim Analysis|Participant Stopped|0|||
27657857|NCT00296504|80583457|FG007|Interim Analysis|Participant Stopped|0|||
27657858|NCT00296504|80583458|FG008|Interim Analysis|Participant Stopped|0|||
27657859|NCT00296504|80583450|FG000|Interim Analysis|Physician and Participant Decision|0|||
27657860|NCT00296504|80583451|FG001|Interim Analysis|Physician and Participant Decision|0|||
27657861|NCT00296504|80583452|FG002|Interim Analysis|Physician and Participant Decision|0|||
27657862|NCT00296504|80583453|FG003|Interim Analysis|Physician and Participant Decision|0|||
27657863|NCT00296504|80583454|FG004|Interim Analysis|Physician and Participant Decision|0|||
27657864|NCT00296504|80583455|FG005|Interim Analysis|Physician and Participant Decision|1|||
27657865|NCT00296504|80583456|FG006|Interim Analysis|Physician and Participant Decision|0|||
27657866|NCT00296504|80583457|FG007|Interim Analysis|Physician and Participant Decision|0|||
27657867|NCT00296504|80583458|FG008|Interim Analysis|Physician and Participant Decision|0|||
27657868|NCT00296504|80583450|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
27657869|NCT00296504|80583451|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
27657870|NCT00296504|80583452|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
27657871|NCT00296504|80583453|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
27657872|NCT00296504|80583454|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
27657873|NCT00296504|80583455|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
27860314|NCT00307437|81319425|FG001|After Controlled Period|Lost to Follow-up|0|||
27860315|NCT00307437|81319426|FG002|After Controlled Period|Lost to Follow-up|0|||
27860316|NCT00307437|81319427|FG003|After Controlled Period|Lost to Follow-up|7|||
27860317|NCT00307437|81319428|FG004|After Controlled Period|Lost to Follow-up|12|||
27860318|NCT00307437|81319429|FG005|After Controlled Period|Lost to Follow-up|13|||
27657874|NCT00296504|80583456|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
27657875|NCT00296504|80583457|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
27657876|NCT00296504|80583458|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
27657877|NCT00296504|80583450|FG000|Interim Analysis|Study Ended|0|||
27657878|NCT00296504|80583451|FG001|Interim Analysis|Study Ended|0|||
27657879|NCT00296504|80583452|FG002|Interim Analysis|Study Ended|0|||
27657880|NCT00296504|80583453|FG003|Interim Analysis|Study Ended|0|||
27657881|NCT00296504|80583454|FG004|Interim Analysis|Study Ended|0|||
27761652|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
27761653|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
27860319|NCT00307437|81319430|FG006|After Controlled Period|Lost to Follow-up|18|||
27860320|NCT00307437|81319424|FG000|After Controlled Period|Other|0|||
27860321|NCT00307437|81319425|FG001|After Controlled Period|Other|0|||
27860322|NCT00307437|81319426|FG002|After Controlled Period|Other|0|||
27860323|NCT00307437|81319427|FG003|After Controlled Period|Other|15|||
27657882|NCT00296504|80583455|FG005|Interim Analysis|Study Ended|0|||
27657883|NCT00296504|80583456|FG006|Interim Analysis|Study Ended|1|||
27657884|NCT00296504|80583457|FG007|Interim Analysis|Study Ended|0|||
27657885|NCT00296504|80583458|FG008|Interim Analysis|Study Ended|0|||
27761654|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
27860324|NCT00307437|81319428|FG004|After Controlled Period|Other|9|||
27657886|NCT00296504|80583450|FG000|Interim Analysis|Participant Needed Interferon|0|||
27657887|NCT00296504|80583451|FG001|Interim Analysis|Participant Needed Interferon|0|||
27657888|NCT00296504|80583452|FG002|Interim Analysis|Participant Needed Interferon|0|||
27657889|NCT00296504|80583453|FG003|Interim Analysis|Participant Needed Interferon|0|||
27657890|NCT00296504|80583454|FG004|Interim Analysis|Participant Needed Interferon|0|||
27657891|NCT00296504|80583455|FG005|Interim Analysis|Participant Needed Interferon|0|||
27657892|NCT00296504|80583456|FG006|Interim Analysis|Participant Needed Interferon|0|||
27657893|NCT00296504|80583457|FG007|Interim Analysis|Participant Needed Interferon|1|||
27657894|NCT00296504|80583458|FG008|Interim Analysis|Participant Needed Interferon|0|||
27657895|NCT00296504|80583450|FG000|Interim Analysis|Ongoing|32|||
27657896|NCT00296504|80583451|FG001|Interim Analysis|Ongoing|12|||
27657897|NCT00296504|80583452|FG002|Interim Analysis|Ongoing|16|||
27657898|NCT00296504|80583453|FG003|Interim Analysis|Ongoing|22|||
27657899|NCT00296504|80583454|FG004|Interim Analysis|Ongoing|0|||
27657900|NCT00296504|80583455|FG005|Interim Analysis|Ongoing|0|||
27657901|NCT00296504|80583456|FG006|Interim Analysis|Ongoing|30|||
27657902|NCT00296504|80583457|FG007|Interim Analysis|Ongoing|1|||
27568014|NCT01649375|80267488|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
27568015|NCT01649375|80267489|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
27568016|NCT01649375|80267485|FG000|Week 16 up to Week 260|Death|1|||
27568017|NCT01649375|80267486|FG001|Week 16 up to Week 260|Death|1|||
27568018|NCT01649375|80267487|FG002|Week 16 up to Week 260|Death|0|||
27568019|NCT01649375|80267488|FG003|Week 16 up to Week 260|Death|0|||
27568020|NCT01649375|80267489|FG004|Week 16 up to Week 260|Death|0|||
27568021|NCT01649375|80267485|FG000|Week 16 up to Week 260|Adverse Event|5|||
27568022|NCT01649375|80267486|FG001|Week 16 up to Week 260|Adverse Event|2|||
27568023|NCT01649375|80267487|FG002|Week 16 up to Week 260|Adverse Event|0|||
27568024|NCT01649375|80267488|FG003|Week 16 up to Week 260|Adverse Event|3|||
27568025|NCT01649375|80267489|FG004|Week 16 up to Week 260|Adverse Event|2|||
27568026|NCT00489853|80267492|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
27568027|NCT00489853|80267493|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
27568028|NCT00489853|80267494|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
27568029|NCT00489853|80267492|FG000|Wash-out Period 1|Adverse Event|0|||
27568030|NCT00489853|80267493|FG001|Wash-out Period 1|Adverse Event|1|||
27568031|NCT00489853|80267494|FG002|Wash-out Period 1|Adverse Event|1|||
27568032|NCT00489853|80267492|FG000|Wash-out Period 1|Protocol Violation|0|||
27568033|NCT00489853|80267493|FG001|Wash-out Period 1|Protocol Violation|1|||
27568034|NCT00489853|80267494|FG002|Wash-out Period 1|Protocol Violation|1|||
27568035|NCT00489853|80267492|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
27568036|NCT00489853|80267493|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
27568037|NCT00489853|80267494|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
27568038|NCT00489853|80267492|FG000|Wash-out Period 2|Adverse Event|1|||
27568039|NCT00489853|80267493|FG001|Wash-out Period 2|Adverse Event|1|||
27568040|NCT00489853|80267494|FG002|Wash-out Period 2|Adverse Event|0|||
27568041|NCT00489853|80267492|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
27568042|NCT00489853|80267493|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
27568043|NCT00489853|80267494|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
27568044|NCT00489853|80267492|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
27568045|NCT00489853|80267493|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
27568046|NCT00489853|80267494|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
27568047|NCT02027844|80267497|FG000|Overall Study|Withdrawal by Subject|3|||
27568048|NCT02027844|80267498|FG001|Overall Study|Withdrawal by Subject|2|||
27568049|NCT02027844|80267499|FG002|Overall Study|Withdrawal by Subject|1|||
27568050|NCT02027844|80267497|FG000|Overall Study|Lost to Follow-up|0|||
27568051|NCT02027844|80267498|FG001|Overall Study|Lost to Follow-up|2|||
27568052|NCT02027844|80267499|FG002|Overall Study|Lost to Follow-up|1|||
27568053|NCT02027844|80267497|FG000|Overall Study|Protocol Violation|0|||
27568054|NCT02027844|80267498|FG001|Overall Study|Protocol Violation|2|||
27568055|NCT02027844|80267499|FG002|Overall Study|Protocol Violation|0|||
27568056|NCT02027844|80267497|FG000|Overall Study|Incomlete data|2|||
27568057|NCT02027844|80267498|FG001|Overall Study|Incomlete data|0|||
27568058|NCT02027844|80267499|FG002|Overall Study|Incomlete data|0|||
27860325|NCT00307437|81319429|FG005|After Controlled Period|Other|40|||
27860326|NCT00307437|81319430|FG006|After Controlled Period|Other|28|||
27568059|NCT02789176|80267500|FG000|Overall Study|Death|0|||
27568060|NCT02789176|80267501|FG001|Overall Study|Death|0|||
27568061|NCT02789176|80267502|FG002|Overall Study|Death|3|||
27568062|NCT02789176|80267503|FG003|Overall Study|Death|0|||
27568063|NCT02789176|80267500|FG000|Overall Study|Withdrawal by Subject|0|||
27568064|NCT02789176|80267501|FG001|Overall Study|Withdrawal by Subject|0|||
27568065|NCT02789176|80267502|FG002|Overall Study|Withdrawal by Subject|1|||
27657903|NCT00296504|80583458|FG008|Interim Analysis|Ongoing|0|||
27657904|NCT00296504|80583450|FG000|Final Analysis|Withdrawal by Subject|0|||
27657905|NCT00296504|80583451|FG001|Final Analysis|Withdrawal by Subject|0|||
27657906|NCT00296504|80583452|FG002|Final Analysis|Withdrawal by Subject|0|||
27568066|NCT02789176|80267503|FG003|Overall Study|Withdrawal by Subject|0|||
27568067|NCT02789176|80267500|FG000|Overall Study|Lost to Follow-up|8|||
27568068|NCT02789176|80267501|FG001|Overall Study|Lost to Follow-up|2|||
27568069|NCT02789176|80267502|FG002|Overall Study|Lost to Follow-up|6|||
27657907|NCT00296504|80583453|FG003|Final Analysis|Withdrawal by Subject|0|||
27657908|NCT00296504|80583454|FG004|Final Analysis|Withdrawal by Subject|0|||
27657909|NCT00296504|80583455|FG005|Final Analysis|Withdrawal by Subject|0|||
27657910|NCT00296504|80583456|FG006|Final Analysis|Withdrawal by Subject|0|||
27657911|NCT00296504|80583457|FG007|Final Analysis|Withdrawal by Subject|0|||
27657912|NCT00296504|80583458|FG008|Final Analysis|Withdrawal by Subject|1|||
27657913|NCT00296504|80583450|FG000|Final Analysis|Lost to Follow-up|0|||
27657914|NCT00296504|80583451|FG001|Final Analysis|Lost to Follow-up|0|||
27657915|NCT00296504|80583452|FG002|Final Analysis|Lost to Follow-up|0|||
27657916|NCT00296504|80583453|FG003|Final Analysis|Lost to Follow-up|0|||
27657917|NCT00296504|80583454|FG004|Final Analysis|Lost to Follow-up|0|||
27657918|NCT00296504|80583455|FG005|Final Analysis|Lost to Follow-up|0|||
27657919|NCT00296504|80583456|FG006|Final Analysis|Lost to Follow-up|0|||
27657920|NCT00296504|80583457|FG007|Final Analysis|Lost to Follow-up|0|||
27657921|NCT00296504|80583458|FG008|Final Analysis|Lost to Follow-up|5|||
27657922|NCT00296504|80583450|FG000|Final Analysis|Insufficient Viral Load Response|0|||
27657923|NCT00296504|80583451|FG001|Final Analysis|Insufficient Viral Load Response|0|||
27657924|NCT00296504|80583452|FG002|Final Analysis|Insufficient Viral Load Response|0|||
27657925|NCT00296504|80583453|FG003|Final Analysis|Insufficient Viral Load Response|0|||
27657926|NCT00296504|80583454|FG004|Final Analysis|Insufficient Viral Load Response|0|||
27657927|NCT00296504|80583455|FG005|Final Analysis|Insufficient Viral Load Response|0|||
27657928|NCT00296504|80583456|FG006|Final Analysis|Insufficient Viral Load Response|0|||
27657929|NCT00296504|80583457|FG007|Final Analysis|Insufficient Viral Load Response|0|||
27657930|NCT00296504|80583458|FG008|Final Analysis|Insufficient Viral Load Response|6|||
27657931|NCT00296504|80583450|FG000|Final Analysis|Adverse Event|0|||
27657932|NCT00296504|80583451|FG001|Final Analysis|Adverse Event|0|||
27657933|NCT00296504|80583452|FG002|Final Analysis|Adverse Event|0|||
27657934|NCT00296504|80583453|FG003|Final Analysis|Adverse Event|0|||
27657935|NCT00296504|80583454|FG004|Final Analysis|Adverse Event|0|||
27657936|NCT00296504|80583455|FG005|Final Analysis|Adverse Event|0|||
27657937|NCT00296504|80583456|FG006|Final Analysis|Adverse Event|0|||
27657938|NCT00296504|80583457|FG007|Final Analysis|Adverse Event|0|||
27657939|NCT00296504|80583458|FG008|Final Analysis|Adverse Event|2|||
27657940|NCT00296504|80583450|FG000|Final Analysis|Pregnancy|0|||
27657941|NCT00296504|80583451|FG001|Final Analysis|Pregnancy|0|||
27657942|NCT00296504|80583452|FG002|Final Analysis|Pregnancy|0|||
27657943|NCT00296504|80583453|FG003|Final Analysis|Pregnancy|0|||
27657944|NCT00296504|80583454|FG004|Final Analysis|Pregnancy|0|||
27657945|NCT00296504|80583455|FG005|Final Analysis|Pregnancy|0|||
27657946|NCT00296504|80583456|FG006|Final Analysis|Pregnancy|0|||
27657947|NCT00296504|80583457|FG007|Final Analysis|Pregnancy|0|||
27657948|NCT00296504|80583458|FG008|Final Analysis|Pregnancy|4|||
27657949|NCT00296504|80583450|FG000|Final Analysis|Tuberculosis|0|||
27657950|NCT00296504|80583451|FG001|Final Analysis|Tuberculosis|0|||
27657951|NCT00296504|80583452|FG002|Final Analysis|Tuberculosis|0|||
27657952|NCT00296504|80583453|FG003|Final Analysis|Tuberculosis|0|||
27657953|NCT00296504|80583454|FG004|Final Analysis|Tuberculosis|0|||
27657954|NCT00296504|80583455|FG005|Final Analysis|Tuberculosis|0|||
27657955|NCT00296504|80583456|FG006|Final Analysis|Tuberculosis|0|||
27657956|NCT00296504|80583457|FG007|Final Analysis|Tuberculosis|0|||
27657957|NCT00296504|80583458|FG008|Final Analysis|Tuberculosis|1|||
27657958|NCT00296504|80583450|FG000|Final Analysis|Participant Moved to Another Country|0|||
27657959|NCT00296504|80583451|FG001|Final Analysis|Participant Moved to Another Country|0|||
27657960|NCT00296504|80583452|FG002|Final Analysis|Participant Moved to Another Country|0|||
27657961|NCT00296504|80583453|FG003|Final Analysis|Participant Moved to Another Country|0|||
27657962|NCT00296504|80583454|FG004|Final Analysis|Participant Moved to Another Country|0|||
27657963|NCT00296504|80583455|FG005|Final Analysis|Participant Moved to Another Country|0|||
27657964|NCT00296504|80583456|FG006|Final Analysis|Participant Moved to Another Country|0|||
27657965|NCT00296504|80583457|FG007|Final Analysis|Participant Moved to Another Country|0|||
27657966|NCT00296504|80583458|FG008|Final Analysis|Participant Moved to Another Country|1|||
27860327|NCT00144781|81319435|FG000|Overall Study|Adverse Event|0|||
27860328|NCT00144781|81319436|FG001|Overall Study|Adverse Event|1|||
27657967|NCT00296504|80583450|FG000|Final Analysis|Poor Adherence|0|||
27657968|NCT00296504|80583451|FG001|Final Analysis|Poor Adherence|0|||
27657969|NCT00296504|80583452|FG002|Final Analysis|Poor Adherence|0|||
27657970|NCT00296504|80583453|FG003|Final Analysis|Poor Adherence|0|||
27657971|NCT00296504|80583454|FG004|Final Analysis|Poor Adherence|0|||
27657972|NCT00296504|80583455|FG005|Final Analysis|Poor Adherence|0|||
27657973|NCT00296504|80583456|FG006|Final Analysis|Poor Adherence|0|||
27657974|NCT00296504|80583457|FG007|Final Analysis|Poor Adherence|0|||
27860329|NCT00144781|81319437|FG002|Overall Study|Adverse Event|0|||
27657975|NCT00296504|80583458|FG008|Final Analysis|Poor Adherence|1|||
27860330|NCT00144781|81319438|FG003|Overall Study|Adverse Event|0|||
27657976|NCT02374476|80583463|FG000|VT Induced Ablation|Screening Failures|36|||
27657977|NCT02374476|80583464|FG001|VT Induced Ablation|Screening Failures|0|||
27657978|NCT02374476|80583465|FG002|VT Induced Ablation|Screening Failures|0|||
27657979|NCT02374476|80583463|FG000|Arm Assignment|Withdrawal by Subject|0|||
27657980|NCT02374476|80583464|FG001|Arm Assignment|Withdrawal by Subject|0|||
27860331|NCT00144781|81319435|FG000|Overall Study|Non-compliant|0|||
27657981|NCT02374476|80583465|FG002|Arm Assignment|Withdrawal by Subject|1|||
27657982|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
27657983|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
27657984|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
27657985|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Other|1|||
27657986|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Other|0|||
27657987|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Other|0|||
27657988|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Physician Decision|3|||
27657989|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Physician Decision|0|||
27657990|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Physician Decision|0|||
27657991|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
27657992|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
27657993|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
27657994|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
27657995|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
27657996|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
27657997|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Adverse Event|18|||
27657998|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Adverse Event|0|||
27657999|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Adverse Event|0|||
27658000|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
27658001|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
27658002|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
27658003|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
27658004|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
27658005|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
27658006|NCT03030599|80583466|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
27658007|NCT03030599|80583467|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
27658008|NCT03030599|80583468|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
27658009|NCT03030599|80583466|FG000|Stable Dose|Protocol deviation|3|||
27658010|NCT03030599|80583467|FG001|Stable Dose|Protocol deviation|0|||
27658011|NCT03030599|80583468|FG002|Stable Dose|Protocol deviation|0|||
27658012|NCT03030599|80583466|FG000|Stable Dose|Adverse Event|1|||
27658013|NCT03030599|80583467|FG001|Stable Dose|Adverse Event|0|||
27658014|NCT03030599|80583468|FG002|Stable Dose|Adverse Event|0|||
27658015|NCT03030599|80583466|FG000|Stable Dose|Lost to Follow-up|1|||
27658016|NCT03030599|80583467|FG001|Stable Dose|Lost to Follow-up|0|||
27658017|NCT03030599|80583468|FG002|Stable Dose|Lost to Follow-up|0|||
27658018|NCT03030599|80583466|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
27658019|NCT03030599|80583467|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
27860332|NCT00144781|81319436|FG001|Overall Study|Non-compliant|1|||
27860333|NCT00144781|81319437|FG002|Overall Study|Non-compliant|0|||
27860334|NCT00144781|81319438|FG003|Overall Study|Non-compliant|0|||
27860335|NCT00867503|81319439|FG000|Overall Study|Withdrawal by Subject|1|||
27860336|NCT02740699|81319440|FG000|Overall Study|Lost to Follow-up|5|||
27860337|NCT02740699|81319440|FG000|Overall Study|Withdrawal by Subject|14|||
27860338|NCT02740699|81319440|FG000|Overall Study|Physician Decision|5|||
27860339|NCT01006135|81319442|FG000|Overall Study|Adverse Event|22|||
27658020|NCT03030599|80583468|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
27658021|NCT03030599|80583466|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
27658022|NCT03030599|80583467|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
27658023|NCT03030599|80583468|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
27860340|NCT01006135|81319442|FG000|Overall Study|Protocol Violation|14|||
27860341|NCT01006135|81319442|FG000|Overall Study|Lost to Follow-up|32|||
27860342|NCT01006135|81319442|FG000|Overall Study|Other|72|||
27860343|NCT01085201|81319443|FG000|Overall Study|Scheduling conflict|1|||
27860344|NCT01085201|81319444|FG001|Overall Study|Scheduling conflict|0|||
27860345|NCT01085201|81319445|FG002|Overall Study|Scheduling conflict|1|||
27860346|NCT01085201|81319446|FG003|Overall Study|Scheduling conflict|0|||
27860347|NCT01085201|81319447|FG004|Overall Study|Scheduling conflict|0|||
27860348|NCT01085201|81319443|FG000|Overall Study|Unknown- no study drug|2|||
27860349|NCT01085201|81319444|FG001|Overall Study|Unknown- no study drug|0|||
27860350|NCT01085201|81319445|FG002|Overall Study|Unknown- no study drug|0|||
27860351|NCT01085201|81319446|FG003|Overall Study|Unknown- no study drug|0|||
27860352|NCT01085201|81319447|FG004|Overall Study|Unknown- no study drug|0|||
27860353|NCT01085201|81319443|FG000|Overall Study|Fond ineligible after consent|0|||
27860354|NCT01085201|81319444|FG001|Overall Study|Fond ineligible after consent|1|||
27658024|NCT03030599|80583466|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
27658025|NCT03030599|80583467|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
27658026|NCT03030599|80583468|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
27860355|NCT01085201|81319445|FG002|Overall Study|Fond ineligible after consent|1|||
27860356|NCT01085201|81319446|FG003|Overall Study|Fond ineligible after consent|0|||
27860357|NCT01085201|81319447|FG004|Overall Study|Fond ineligible after consent|0|||
27860358|NCT01724489|81319448|FG000|Overall Study|Adverse Event|8|||
27860359|NCT01724489|81319449|FG001|Overall Study|Adverse Event|3|||
27860360|NCT01724489|81319448|FG000|Overall Study|Surgery, medication|1|||
27860361|NCT01724489|81319449|FG001|Overall Study|Surgery, medication|1|||
27860362|NCT01724489|81319448|FG000|Overall Study|Lost to Follow-up|1|||
27860363|NCT01724489|81319449|FG001|Overall Study|Lost to Follow-up|2|||
27860364|NCT01724489|81319448|FG000|Overall Study|Withdrawal by Subject|6|||
27860365|NCT01724489|81319449|FG001|Overall Study|Withdrawal by Subject|6|||
27886602|NCT01435018|81418121|FG001|Overall Study|Not willing to adhere to requirements|2|||
27886603|NCT01435018|81418122|FG002|Overall Study|Not willing to adhere to requirements|3|||
27886604|NCT01435018|81418120|FG000|Overall Study|Not able to get to clinic|2|||
27886605|NCT01435018|81418121|FG001|Overall Study|Not able to get to clinic|0|||
27886606|NCT01435018|81418122|FG002|Overall Study|Not able to get to clinic|2|||
27886607|NCT01435018|81418120|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27886608|NCT01435018|81418121|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27886609|NCT01435018|81418122|FG002|Overall Study|Severe debilitation, unable to continue|1|||
27886610|NCT01435018|81418120|FG000|Overall Study|Unable to contact participant/parent|1|||
27886611|NCT01435018|81418121|FG001|Overall Study|Unable to contact participant/parent|1|||
27658027|NCT03030599|80583466|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
27658028|NCT03030599|80583467|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
27658029|NCT03030599|80583468|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
27658030|NCT03030599|80583466|FG000|Open-label Extension|Adverse Event|3|||
27658031|NCT03030599|80583467|FG001|Open-label Extension|Adverse Event|0|||
27658032|NCT03030599|80583468|FG002|Open-label Extension|Adverse Event|0|||
27658033|NCT03030599|80583466|FG000|Open-label Extension|Lost to Follow-up|2|||
27658034|NCT03030599|80583467|FG001|Open-label Extension|Lost to Follow-up|0|||
27658035|NCT03030599|80583468|FG002|Open-label Extension|Lost to Follow-up|0|||
27658036|NCT03030599|80583466|FG000|Open-label Extension|Lack of Efficacy|1|||
27658037|NCT03030599|80583467|FG001|Open-label Extension|Lack of Efficacy|0|||
27658038|NCT03030599|80583468|FG002|Open-label Extension|Lack of Efficacy|0|||
27658039|NCT03030599|80583466|FG000|Open-label Extension|Other Reason|1|||
27658040|NCT03030599|80583467|FG001|Open-label Extension|Other Reason|0|||
27658041|NCT03030599|80583468|FG002|Open-label Extension|Other Reason|0|||
27658042|NCT01018992|80583473|FG000|Overall Study|Adverse Event|8|||
27658043|NCT01018992|80583474|FG001|Overall Study|Adverse Event|3|||
27658044|NCT01018992|80583473|FG000|Overall Study|Withdrawal by Subject|3|||
27658045|NCT01018992|80583474|FG001|Overall Study|Withdrawal by Subject|8|||
27658046|NCT01018992|80583473|FG000|Overall Study|Protocol Violation|0|||
27658047|NCT01018992|80583474|FG001|Overall Study|Protocol Violation|4|||
27658048|NCT01018992|80583473|FG000|Overall Study|Lost to Follow-up|5|||
27658049|NCT01018992|80583474|FG001|Overall Study|Lost to Follow-up|1|||
27658050|NCT01762345|80583475|FG000|Overall Study|Adverse Event|5|||
27658051|NCT01762345|80583475|FG000|Overall Study|Protocol Violation|2|||
27658052|NCT00788671|80583477|FG000|Overall Study|Death|2|||
27568070|NCT02789176|80267503|FG003|Overall Study|Lost to Follow-up|1|||
27568071|NCT00903617|80267506|FG000|Overall Study|Adverse Event|0|||
27568072|NCT00903617|80267507|FG001|Overall Study|Adverse Event|1|||
27568073|NCT00903617|80267508|FG002|Overall Study|Adverse Event|1|||
27568074|NCT00903617|80267509|FG003|Overall Study|Adverse Event|0|||
27568075|NCT00903617|80267506|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27658053|NCT00788671|80583477|FG000|Overall Study|Unable to biopsy|1|||
27658054|NCT00788671|80583477|FG000|Overall Study|Withdrawal by Subject|4|||
27658055|NCT00788671|80583477|FG000|Overall Study|IUD expulsed|1|||
27886612|NCT01435018|81418122|FG002|Overall Study|Unable to contact participant/parent|1|||
27886613|NCT01435018|81418120|FG000|Overall Study|Enrollment Violation|0|||
27886614|NCT01435018|81418121|FG001|Overall Study|Enrollment Violation|1|||
27886615|NCT01435018|81418122|FG002|Overall Study|Enrollment Violation|0|||
27886616|NCT01435018|81418120|FG000|Overall Study|Never started chemotherapy|3|||
27886617|NCT01435018|81418121|FG001|Overall Study|Never started chemotherapy|0|||
27658056|NCT00788671|80583477|FG000|Overall Study|Lost to follow up|2|||
27658057|NCT00930644|80583478|FG000|Overall Study|Withdrawal by Subject|4|||
27658058|NCT00930644|80583478|FG000|Overall Study|Physician Decision|2|||
27658059|NCT00930644|80583478|FG000|Overall Study|Death|1|||
27658060|NCT00930644|80583478|FG000|Overall Study|Adverse Event|16|||
27658061|NCT03444155|80586627|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
27886618|NCT01435018|81418122|FG002|Overall Study|Never started chemotherapy|1|||
27886619|NCT00619892|81418125|FG000|Overall Study|Adverse Event|3|||
27568076|NCT00903617|80267507|FG001|Overall Study|Protocol-defined stopping criteria|2|||
27658062|NCT03444155|80586628|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
27658063|NCT01780584|80586629|FG000|Overall Study|Death|1|||
27658064|NCT01780584|80586630|FG001|Overall Study|Death|0|||
27568077|NCT00903617|80267508|FG002|Overall Study|Protocol-defined stopping criteria|0|||
27658065|NCT01780584|80586631|FG002|Overall Study|Death|1|||
27658066|NCT01780584|80586629|FG000|Overall Study|Adverse Event|0|||
27658067|NCT01780584|80586630|FG001|Overall Study|Adverse Event|1|||
27658068|NCT01780584|80586631|FG002|Overall Study|Adverse Event|0|||
27658069|NCT01780584|80586629|FG000|Overall Study|Protocol Violation|0|||
27658070|NCT01780584|80586630|FG001|Overall Study|Protocol Violation|0|||
27658071|NCT01780584|80586631|FG002|Overall Study|Protocol Violation|1|||
27658072|NCT01655498|80586632|FG000|Overall Study|Unrelated health issue|2|||
27658073|NCT01655498|80586632|FG000|Overall Study|Protocol Violation|2|||
27658074|NCT01655498|80586632|FG000|Overall Study|Withdrawal by Subject|1|||
27658075|NCT01358175|80586638|FG000|Overall Study|Death|1|||
27658076|NCT01358175|80586639|FG001|Overall Study|Death|0|||
27658077|NCT01358175|80586640|FG002|Overall Study|Death|1|||
27658078|NCT01358175|80586638|FG000|Overall Study|Withdrawal by Subject|9|||
27658079|NCT01358175|80586639|FG001|Overall Study|Withdrawal by Subject|5|||
27658080|NCT01358175|80586640|FG002|Overall Study|Withdrawal by Subject|10|||
27658081|NCT01358175|80586638|FG000|Overall Study|Technical issues|0|||
27658082|NCT01358175|80586639|FG001|Overall Study|Technical issues|1|||
27658083|NCT01358175|80586640|FG002|Overall Study|Technical issues|0|||
27658084|NCT01358175|80586638|FG000|Overall Study|Pregnancy|0|||
27658085|NCT01358175|80586639|FG001|Overall Study|Pregnancy|1|||
27658086|NCT01358175|80586640|FG002|Overall Study|Pregnancy|0|||
27658087|NCT01358175|80586638|FG000|Overall Study|Physician Decision|1|||
27658088|NCT01358175|80586639|FG001|Overall Study|Physician Decision|0|||
27658089|NCT01358175|80586640|FG002|Overall Study|Physician Decision|0|||
27658090|NCT01358175|80586638|FG000|Overall Study|Non Compliance with Study Treatment|0|||
27658091|NCT01358175|80586639|FG001|Overall Study|Non Compliance with Study Treatment|1|||
27658092|NCT01358175|80586640|FG002|Overall Study|Non Compliance with Study Treatment|1|||
27658093|NCT01358175|80586638|FG000|Overall Study|Lost to Follow-up|1|||
27658094|NCT01358175|80586639|FG001|Overall Study|Lost to Follow-up|1|||
27658095|NCT01358175|80586640|FG002|Overall Study|Lost to Follow-up|3|||
27658096|NCT01358175|80586638|FG000|Overall Study|Lack of Efficacy|3|||
27658097|NCT01358175|80586639|FG001|Overall Study|Lack of Efficacy|8|||
27658098|NCT01358175|80586640|FG002|Overall Study|Lack of Efficacy|6|||
27658099|NCT01358175|80586638|FG000|Overall Study|Adverse Event|6|||
27658100|NCT01358175|80586639|FG001|Overall Study|Adverse Event|11|||
27658101|NCT01358175|80586640|FG002|Overall Study|Adverse Event|11|||
27658102|NCT01350102|80586641|FG000|Overall Study|Adverse Event|0|||
27658103|NCT01350102|80586642|FG001|Overall Study|Adverse Event|0|||
27658104|NCT01350102|80586643|FG002|Overall Study|Adverse Event|1|||
27658105|NCT01350102|80586644|FG003|Overall Study|Adverse Event|0|||
27658106|NCT01799993|80586652|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
27658107|NCT01799993|80586653|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
27658108|NCT01799993|80586652|FG000|Overall Study|Death|61|||
27658109|NCT01799993|80586653|FG001|Overall Study|Death|45|||
27658110|NCT01799993|80586652|FG000|Overall Study|Withdrawal by Subject|23|||
27658111|NCT01799993|80586653|FG001|Overall Study|Withdrawal by Subject|24|||
27658112|NCT01799993|80586652|FG000|Overall Study|Lost to Follow-up|5|||
27658113|NCT01799993|80586653|FG001|Overall Study|Lost to Follow-up|8|||
27658114|NCT01799993|80586652|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
27658115|NCT01799993|80586653|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
27658116|NCT01799993|80586652|FG000|Overall Study|Protocol driven decision point|0|||
27658117|NCT01799993|80586653|FG001|Overall Study|Protocol driven decision point|3|||
27658118|NCT01799993|80586652|FG000|Overall Study|Protocol Violation|1|||
27658119|NCT01799993|80586653|FG001|Overall Study|Protocol Violation|1|||
27658120|NCT01799993|80586652|FG000|Overall Study|Deterioration of general conditions|2|||
27658121|NCT01799993|80586653|FG001|Overall Study|Deterioration of general conditions|0|||
27658122|NCT01799993|80586652|FG000|Overall Study|Screen failure|0|||
27658123|NCT01799993|80586653|FG001|Overall Study|Screen failure|1|||
27658124|NCT01799993|80586652|FG000|Overall Study|Adverse Event|1|||
27658125|NCT01799993|80586653|FG001|Overall Study|Adverse Event|0|||
27658126|NCT01799993|80586652|FG000|Overall Study|Lack of Efficacy|1|||
27658127|NCT01799993|80586653|FG001|Overall Study|Lack of Efficacy|0|||
27658128|NCT01799993|80586652|FG000|Overall Study|Recovery|0|||
27658129|NCT01799993|80586653|FG001|Overall Study|Recovery|1|||
27658130|NCT01799993|80586652|FG000|Overall Study|Logistical difficulties|1|||
27658131|NCT01799993|80586653|FG001|Overall Study|Logistical difficulties|0|||
27658132|NCT01799993|80586652|FG000|Overall Study|Protocol deviation|1|||
27658133|NCT01799993|80586653|FG001|Overall Study|Protocol deviation|0|||
27761655|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
27761656|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
27860366|NCT01206101|81322668|FG000|Overall Study|Adverse Event|1|||
27658134|NCT01799993|80586652|FG000|Overall Study|Non-compliance with medical device|1|||
27658135|NCT01799993|80586653|FG001|Overall Study|Non-compliance with medical device|0|||
27658136|NCT01799993|80586652|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27658137|NCT01799993|80586653|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27658138|NCT01799993|80586652|FG000|Overall Study|Other|1|||
27658139|NCT01799993|80586653|FG001|Overall Study|Other|0|||
27658140|NCT01799993|80586652|FG000|Overall Study|Subject didn't return for follow-up|0|||
27658141|NCT01799993|80586653|FG001|Overall Study|Subject didn't return for follow-up|1|||
27658142|NCT00609245|80586654|FG000|Overall Study|Adverse Event|1|||
27658143|NCT04620733|80586655|FG000|Overall Study|Adverse Event|4|||
27658144|NCT04620733|80586656|FG001|Overall Study|Adverse Event|3|||
27658145|NCT04620733|80586655|FG000|Overall Study|Withdrawal by Subject|2|||
27658146|NCT04620733|80586656|FG001|Overall Study|Withdrawal by Subject|5|||
27658147|NCT04620733|80586655|FG000|Overall Study|Lost to Follow-up|1|||
27658148|NCT04620733|80586656|FG001|Overall Study|Lost to Follow-up|1|||
27658149|NCT04620733|80586655|FG000|Overall Study|Protocol Deviation|1|||
27658150|NCT04620733|80586656|FG001|Overall Study|Protocol Deviation|1|||
27658151|NCT04620733|80586655|FG000|Overall Study|Reason Not Specified|0|||
27658152|NCT04620733|80586656|FG001|Overall Study|Reason Not Specified|1|||
27658153|NCT03751280|80586657|FG000|Overall Study|Adverse Event|0|||
27658154|NCT03751280|80586658|FG001|Overall Study|Adverse Event|1|||
27860367|NCT01206101|81322669|FG001|Overall Study|Adverse Event|0|||
27860368|NCT01206101|81322668|FG000|Overall Study|Physician Decision|0|||
27860369|NCT01206101|81322669|FG001|Overall Study|Physician Decision|1|||
27860370|NCT01206101|81322668|FG000|Overall Study|Unclassified|1|||
27860371|NCT01206101|81322669|FG001|Overall Study|Unclassified|0|||
27860372|NCT01685840|81322670|FG000|Overall Study|Death|77|||
27860373|NCT01685840|81322671|FG001|Overall Study|Death|66|||
27860374|NCT01685840|81322670|FG000|Overall Study|Lost to Follow-up|27|||
27860375|NCT01685840|81322671|FG001|Overall Study|Lost to Follow-up|25|||
27860376|NCT01685840|81322670|FG000|Overall Study|Physician Decision|3|||
27860377|NCT01685840|81322671|FG001|Overall Study|Physician Decision|7|||
27860378|NCT01685840|81322670|FG000|Overall Study|Withdrawal by Subject|14|||
27860379|NCT01685840|81322671|FG001|Overall Study|Withdrawal by Subject|17|||
27860380|NCT01685840|81322670|FG000|Overall Study|Futility|197|||
27860381|NCT01685840|81322671|FG001|Overall Study|Futility|200|||
27860382|NCT01685840|81322670|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
27860383|NCT01685840|81322671|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
27568078|NCT00903617|80267509|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27568079|NCT00903617|80267506|FG000|Overall Study|Lost to Follow-up|2|||
27568080|NCT00903617|80267507|FG001|Overall Study|Lost to Follow-up|0|||
27568081|NCT00903617|80267508|FG002|Overall Study|Lost to Follow-up|1|||
27568082|NCT00903617|80267509|FG003|Overall Study|Lost to Follow-up|1|||
27568083|NCT00903617|80267506|FG000|Overall Study|Withdrawal by Subject|1|||
27568084|NCT00903617|80267507|FG001|Overall Study|Withdrawal by Subject|2|||
27568085|NCT00903617|80267508|FG002|Overall Study|Withdrawal by Subject|3|||
27568086|NCT00903617|80267509|FG003|Overall Study|Withdrawal by Subject|0|||
27568087|NCT04365699|80267510|FG000|Overall Study|Death|2|||
27568088|NCT04365699|80267511|FG001|Overall Study|Death|5|||
27568089|NCT04365699|80267512|FG002|Overall Study|Death|15|||
27568090|NCT01236755|80267514|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
27568091|NCT01236755|80267514|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
27568092|NCT01236755|80267514|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
27568093|NCT01236755|80267514|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
27568094|NCT02244580|80267515|FG000|Overall Study|No cancer tissues available|241|||
27568095|NCT00116558|80267516|FG000|Overall Study|Death|11|||
27568096|NCT00116558|80267517|FG001|Overall Study|Death|5|||
27568097|NCT00116558|80267518|FG002|Overall Study|Death|3|||
27568098|NCT00116558|80267516|FG000|Overall Study|Withdrawal by Subject|17|||
27568099|NCT00116558|80267517|FG001|Overall Study|Withdrawal by Subject|3|||
27568100|NCT00116558|80267518|FG002|Overall Study|Withdrawal by Subject|12|||
27568101|NCT00116558|80267516|FG000|Overall Study|disease progression|3|||
27568102|NCT00116558|80267517|FG001|Overall Study|disease progression|7|||
27568103|NCT00116558|80267518|FG002|Overall Study|disease progression|18|||
27568104|NCT01856790|80267523|FG000|Closed Loop Control|Withdrawal by Subject|2|||
27568105|NCT01856790|80267523|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
27568106|NCT02114879|80267531|FG000|Overall Study|Withdrawal by Subject|9|||
27568107|NCT02114879|80267532|FG001|Overall Study|Withdrawal by Subject|5|||
27568108|NCT02114879|80267531|FG000|Overall Study|Death|6|||
27568109|NCT02114879|80267532|FG001|Overall Study|Death|11|||
27568110|NCT02114879|80267531|FG000|Overall Study|Lost to Follow-up|4|||
27568111|NCT02114879|80267532|FG001|Overall Study|Lost to Follow-up|6|||
27568112|NCT02114879|80267531|FG000|Overall Study|Physician Decision|0|||
27658155|NCT03751280|80586657|FG000|Overall Study|Lost to Follow-up|3|||
27658156|NCT03751280|80586658|FG001|Overall Study|Lost to Follow-up|5|||
27860384|NCT00806286|81322672|FG000|Overall Study|Adverse Event|5|||
27860385|NCT00806286|81322673|FG001|Overall Study|Adverse Event|2|||
27860386|NCT00806286|81322674|FG002|Overall Study|Adverse Event|0|||
27860387|NCT00806286|81322672|FG000|Overall Study|Disease progression|31|||
27568113|NCT02114879|80267532|FG001|Overall Study|Physician Decision|2|||
27568114|NCT00677807|80267535|FG000|Overall Study|Adverse Event|4|||
27568115|NCT00677807|80267536|FG001|Overall Study|Adverse Event|1|||
27568116|NCT00677807|80267537|FG002|Overall Study|Adverse Event|6|||
27568117|NCT00677807|80267535|FG000|Overall Study|Lack of Efficacy|0|||
27658157|NCT03751280|80586657|FG000|Overall Study|Physician Decision|0|||
27658158|NCT03751280|80586658|FG001|Overall Study|Physician Decision|2|||
27658159|NCT03751280|80586657|FG000|Overall Study|Protocol Violation|0|||
27860388|NCT00806286|81322673|FG001|Overall Study|Disease progression|38|||
27860389|NCT00806286|81322674|FG002|Overall Study|Disease progression|1|||
27658160|NCT03751280|80586658|FG001|Overall Study|Protocol Violation|2|||
27658161|NCT03751280|80586657|FG000|Overall Study|Withdrawal by Subject|5|||
27658162|NCT03751280|80586658|FG001|Overall Study|Withdrawal by Subject|2|||
27658163|NCT03320941|80586659|FG000|Overall Study|subject/guardian decision|0|||
27658164|NCT03320941|80586660|FG001|Overall Study|subject/guardian decision|0|||
27658165|NCT03320941|80586661|FG002|Overall Study|subject/guardian decision|0|||
27658166|NCT03320941|80586662|FG003|Overall Study|subject/guardian decision|1|||
27658167|NCT03320941|80586663|FG004|Overall Study|subject/guardian decision|0|||
27658168|NCT01524887|80586668|FG000|Overall Study|Withdrawal by Subject|6|||
27658169|NCT01524887|80586669|FG001|Overall Study|Withdrawal by Subject|2|||
27658170|NCT01524887|80586670|FG002|Overall Study|Withdrawal by Subject|3|||
27658171|NCT01524887|80586668|FG000|Overall Study|Adverse Event|5|||
27658172|NCT01524887|80586669|FG001|Overall Study|Adverse Event|1|||
27658173|NCT01524887|80586670|FG002|Overall Study|Adverse Event|1|||
27658174|NCT01524887|80586668|FG000|Overall Study|Protocol Violation|0|||
27658175|NCT01524887|80586669|FG001|Overall Study|Protocol Violation|0|||
27658176|NCT01524887|80586670|FG002|Overall Study|Protocol Violation|1|||
27658177|NCT01524887|80586668|FG000|Overall Study|Study termination|73|||
27658178|NCT01524887|80586669|FG001|Overall Study|Study termination|87|||
27658179|NCT01524887|80586670|FG002|Overall Study|Study termination|79|||
27658180|NCT01524887|80586668|FG000|Overall Study|Withdrawal by Caregiver|0|||
27658181|NCT01524887|80586669|FG001|Overall Study|Withdrawal by Caregiver|0|||
27658182|NCT01524887|80586670|FG002|Overall Study|Withdrawal by Caregiver|2|||
27658183|NCT01524887|80586668|FG000|Overall Study|Use of prohibited medication|1|||
27658184|NCT01524887|80586669|FG001|Overall Study|Use of prohibited medication|0|||
27658185|NCT01524887|80586670|FG002|Overall Study|Use of prohibited medication|0|||
27658186|NCT01182285|80586674|FG000|First Intervention Week 1-10|Disease progression|1|||
27658187|NCT01182285|80586675|FG001|First Intervention Week 1-10|Disease progression|0|||
27658188|NCT01182285|80586676|FG002|First Intervention Week 1-10|Disease progression|0|||
27658189|NCT01182285|80586674|FG000|First Intervention Week 1-10|Adverse Event|1|||
27658190|NCT01182285|80586675|FG001|First Intervention Week 1-10|Adverse Event|0|||
27658191|NCT01182285|80586676|FG002|First Intervention Week 1-10|Adverse Event|0|||
27658192|NCT01182285|80586674|FG000|First Intervention Week 1-10|Non-compliance|1|||
27658193|NCT01182285|80586675|FG001|First Intervention Week 1-10|Non-compliance|0|||
27658194|NCT01182285|80586676|FG002|First Intervention Week 1-10|Non-compliance|0|||
27658195|NCT01182285|80586674|FG000|Third Intervention Week 11-52|Disease Progression|0|||
27658196|NCT01182285|80586675|FG001|Third Intervention Week 11-52|Disease Progression|0|||
27658197|NCT01182285|80586676|FG002|Third Intervention Week 11-52|Disease Progression|6|||
27658198|NCT01182285|80586674|FG000|Third Intervention Week 11-52|Other|0|||
27658199|NCT01182285|80586675|FG001|Third Intervention Week 11-52|Other|0|||
27658200|NCT01182285|80586676|FG002|Third Intervention Week 11-52|Other|2|||
27658201|NCT01270347|80586679|FG000|Core Phase|Adverse Event|1|||
27658202|NCT01270347|80586680|FG001|Core Phase|Adverse Event|6|||
27658203|NCT01270347|80586679|FG000|Core Phase|Withdrawal by Subject|1|||
27658204|NCT01270347|80586680|FG001|Core Phase|Withdrawal by Subject|2|||
27658205|NCT01270347|80586679|FG000|Core Phase|Lost to Follow-up|0|||
27860390|NCT00806286|81322672|FG000|Overall Study|Death|1|||
27860391|NCT00806286|81322673|FG001|Overall Study|Death|6|||
27860392|NCT00806286|81322674|FG002|Overall Study|Death|0|||
27658206|NCT01270347|80586680|FG001|Core Phase|Lost to Follow-up|1|||
27658207|NCT01270347|80586679|FG000|Core Phase|Miscellaneous|8|||
27658208|NCT01270347|80586680|FG001|Core Phase|Miscellaneous|14|||
27658209|NCT01270347|80586679|FG000|Extension Phase|Adverse Event|1|||
27658210|NCT01270347|80586680|FG001|Extension Phase|Adverse Event|3|||
27658211|NCT01270347|80586679|FG000|Extension Phase|Withdrawal by Subject|3|||
27658212|NCT01270347|80586680|FG001|Extension Phase|Withdrawal by Subject|4|||
27658213|NCT01270347|80586679|FG000|Extension Phase|Miscellaneous|2|||
27658214|NCT01270347|80586680|FG001|Extension Phase|Miscellaneous|2|||
27658215|NCT02418819|80586686|FG000|Overall Study|Adverse Event|0|||
27658216|NCT02418819|80586687|FG001|Overall Study|Adverse Event|0|||
27658217|NCT02418819|80586688|FG002|Overall Study|Adverse Event|1|||
27658218|NCT02418819|80586689|FG003|Overall Study|Adverse Event|0|||
27658219|NCT02418819|80586686|FG000|Overall Study|Lost to Follow-up|1|||
27658220|NCT02418819|80586687|FG001|Overall Study|Lost to Follow-up|0|||
27658221|NCT02418819|80586688|FG002|Overall Study|Lost to Follow-up|0|||
27658222|NCT02418819|80586689|FG003|Overall Study|Lost to Follow-up|0|||
27658223|NCT02418819|80586686|FG000|Overall Study|No longer meets eligibility criteria|0|||
27658224|NCT02418819|80586687|FG001|Overall Study|No longer meets eligibility criteria|0|||
27860393|NCT00806286|81322672|FG000|Overall Study|Lost to Follow-up|0|||
27860394|NCT00806286|81322673|FG001|Overall Study|Lost to Follow-up|1|||
27658225|NCT02418819|80586688|FG002|Overall Study|No longer meets eligibility criteria|1|||
27658226|NCT02418819|80586689|FG003|Overall Study|No longer meets eligibility criteria|0|||
27761657|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
27761658|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
27658227|NCT02418819|80586686|FG000|Overall Study|No longer willing to participate|0|||
27761659|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
27658228|NCT02418819|80586687|FG001|Overall Study|No longer willing to participate|0|||
27658229|NCT02418819|80586688|FG002|Overall Study|No longer willing to participate|2|||
27658230|NCT02418819|80586689|FG003|Overall Study|No longer willing to participate|1|||
27658231|NCT01975701|80586691|FG000|Overall Study|Lost to Follow-up|1|||
27658232|NCT01975701|80586691|FG000|Overall Study|Death|23|||
27658233|NCT01975701|80586691|FG000|Overall Study|Physician Decision|1|||
27658234|NCT00331799|80586692|FG000|Overall Study|Withdrawal by Subject|2|||
27658235|NCT00331799|80586692|FG000|Overall Study|Sedation|1|||
27658236|NCT03976102|80586693|FG000|Overall Study|Withdrawal by Subject|4|||
27658237|NCT03976102|80586694|FG001|Overall Study|Withdrawal by Subject|4|||
27860395|NCT00806286|81322674|FG002|Overall Study|Lost to Follow-up|0|||
27860396|NCT00806286|81322672|FG000|Overall Study|Withdrawal by Subject|8|||
27860397|NCT00806286|81322673|FG001|Overall Study|Withdrawal by Subject|3|||
27860398|NCT00806286|81322674|FG002|Overall Study|Withdrawal by Subject|1|||
27860399|NCT00806286|81322672|FG000|Overall Study|Physician Decision|2|||
27860400|NCT00806286|81322673|FG001|Overall Study|Physician Decision|2|||
27860401|NCT00806286|81322674|FG002|Overall Study|Physician Decision|0|||
27860402|NCT00806286|81322672|FG000|Overall Study|Due to a variety of reasons|7|||
27860403|NCT00806286|81322673|FG001|Overall Study|Due to a variety of reasons|2|||
27860404|NCT00806286|81322674|FG002|Overall Study|Due to a variety of reasons|1|||
27860405|NCT02752906|81322675|FG000|Overall Study|Protocol Violation|2|||
27860406|NCT02752906|81322676|FG001|Overall Study|Protocol Violation|1|||
27860407|NCT02752906|81322675|FG000|Overall Study|Withdrawal by Subject|2|||
27860408|NCT02752906|81322676|FG001|Overall Study|Withdrawal by Subject|2|||
27860409|NCT02752906|81322675|FG000|Overall Study|Lost to Follow-up|3|||
27860410|NCT02752906|81322676|FG001|Overall Study|Lost to Follow-up|2|||
27860411|NCT02640053|81322687|FG000|Overall Study|Withdrawal by Subject|2|||
27658238|NCT03976102|80586693|FG000|Overall Study|Adverse Event|2|||
27658239|NCT03976102|80586694|FG001|Overall Study|Adverse Event|4|||
27658240|NCT03976102|80586693|FG000|Overall Study|Not related to Covid-19|9|||
27761660|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
27761661|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
27761662|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
27761663|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
27761664|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
27761665|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
27761666|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
27761667|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
27761668|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
27761669|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
27761670|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
27761671|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
27761672|NCT03444870|80950892|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
27761673|NCT03444870|80950893|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
27761674|NCT03444870|80950894|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
27761675|NCT03444870|80950895|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
27761676|NCT03444870|80950896|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
27761677|NCT03444870|80950897|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
27761678|NCT03444870|80950892|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
27761679|NCT03444870|80950893|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
27761680|NCT03444870|80950894|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
27761681|NCT03444870|80950895|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
27761682|NCT03444870|80950896|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
27761683|NCT03444870|80950897|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
27761684|NCT03444870|80950892|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
27761685|NCT03444870|80950893|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
27761686|NCT03444870|80950894|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
27761687|NCT03444870|80950895|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
27761688|NCT03444870|80950896|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
27761689|NCT03444870|80950897|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
27761690|NCT03444870|80950892|FG000|Open-Label Extension (OLE) Period|Death|0|||
27761691|NCT03444870|80950893|FG001|Open-Label Extension (OLE) Period|Death|0|||
27761692|NCT03444870|80950894|FG002|Open-Label Extension (OLE) Period|Death|0|||
27761693|NCT03444870|80950895|FG003|Open-Label Extension (OLE) Period|Death|0|||
27761694|NCT03444870|80950896|FG004|Open-Label Extension (OLE) Period|Death|1|||
27761695|NCT03444870|80950897|FG005|Open-Label Extension (OLE) Period|Death|0|||
27761696|NCT01670656|80950898|FG000|Overall Study|Non-compliance with study drug|0|||
27761697|NCT01670656|80950899|FG001|Overall Study|Non-compliance with study drug|0|||
27761698|NCT01670656|80950900|FG002|Overall Study|Non-compliance with study drug|3|||
27761699|NCT01670656|80950901|FG003|Overall Study|Non-compliance with study drug|0|||
27658241|NCT03976102|80586694|FG001|Overall Study|Not related to Covid-19|13|||
27658242|NCT03976102|80586693|FG000|Overall Study|Lost to Follow-up|0|||
27658243|NCT03976102|80586694|FG001|Overall Study|Lost to Follow-up|2|||
27658244|NCT03976102|80586693|FG000|Overall Study|Death|3|||
27658245|NCT03976102|80586694|FG001|Overall Study|Death|2|||
27658246|NCT03976102|80586693|FG000|Overall Study|Physician Decision|1|||
27658247|NCT03976102|80586694|FG001|Overall Study|Physician Decision|1|||
27658248|NCT03647709|80586695|FG000|Overall Study|Lost to Follow-up|5|||
27658249|NCT03647709|80586695|FG000|Overall Study|Physician Decision|6|||
27658250|NCT03647709|80586695|FG000|Overall Study|Withdrawal by Subject|3|||
27658251|NCT01038128|80586696|FG000|Overall Study|Lack of Efficacy|1|||
27658252|NCT01038128|80586696|FG000|Overall Study|Lost to Follow-up|1|||
27658253|NCT01038128|80586696|FG000|Overall Study|Withdrawal by Subject|2|||
27658254|NCT03120949|80586697|FG000|Overall Study|randomized in error|1|||
27658255|NCT03120949|80586698|FG001|Overall Study|randomized in error|0|||
27658256|NCT03120949|80586697|FG000|Overall Study|Death|13|||
27658257|NCT03120949|80586698|FG001|Overall Study|Death|13|||
27658258|NCT03120949|80586697|FG000|Overall Study|Lost to Follow-up|23|||
27658259|NCT03120949|80586698|FG001|Overall Study|Lost to Follow-up|13|||
27658260|NCT03120949|80586697|FG000|Overall Study|Withdrawal by Subject|139|||
27658261|NCT03120949|80586698|FG001|Overall Study|Withdrawal by Subject|124|||
27658262|NCT03120949|80586697|FG000|Overall Study|Covid-19|43|||
27658263|NCT03120949|80586698|FG001|Overall Study|Covid-19|34|||
27658264|NCT03120949|80586697|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
27658265|NCT03120949|80586698|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
27658266|NCT03120949|80586697|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
27658267|NCT03120949|80586698|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
27658268|NCT03120949|80586697|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
27658269|NCT03120949|80586698|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
27658270|NCT03120949|80586697|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
27658271|NCT03120949|80586698|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
27658272|NCT03120949|80586697|FG000|Overall Study|Site was closed|2|||
27658273|NCT03120949|80586698|FG001|Overall Study|Site was closed|3|||
27658274|NCT03120949|80586697|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
27658275|NCT03120949|80586698|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
27658276|NCT03120949|80586697|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
27658277|NCT03120949|80586698|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
27658278|NCT03120949|80586697|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
27658279|NCT03120949|80586698|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
27658280|NCT03120949|80586697|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
27658281|NCT03120949|80586698|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
27658282|NCT03120949|80586697|FG000|Overall Study|Other: Adverse Event|0|||
27860412|NCT02640053|81322688|FG001|Overall Study|Withdrawal by Subject|1|||
27860413|NCT02640053|81322687|FG000|Overall Study|Adverse Event|1|||
27860414|NCT02640053|81322688|FG001|Overall Study|Adverse Event|1|||
27658283|NCT03120949|80586698|FG001|Overall Study|Other: Adverse Event|1|||
27658284|NCT03120949|80586697|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
27658285|NCT03120949|80586698|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
27658286|NCT03120949|80586697|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
27658287|NCT03120949|80586698|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
27658288|NCT03120949|80586697|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
27761700|NCT01670656|80950902|FG004|Overall Study|Non-compliance with study drug|1|||
27761701|NCT01670656|80950898|FG000|Overall Study|Pregnancy|0|||
27761702|NCT01670656|80950899|FG001|Overall Study|Pregnancy|0|||
27761703|NCT01670656|80950900|FG002|Overall Study|Pregnancy|0|||
27761704|NCT01670656|80950901|FG003|Overall Study|Pregnancy|0|||
27761705|NCT01670656|80950902|FG004|Overall Study|Pregnancy|1|||
27761706|NCT01670656|80950898|FG000|Overall Study|Withdrawal by Subject|1|||
27761707|NCT01670656|80950899|FG001|Overall Study|Withdrawal by Subject|1|||
27761708|NCT01670656|80950900|FG002|Overall Study|Withdrawal by Subject|0|||
27761709|NCT01670656|80950901|FG003|Overall Study|Withdrawal by Subject|0|||
27761710|NCT01670656|80950902|FG004|Overall Study|Withdrawal by Subject|0|||
27761711|NCT01670656|80950898|FG000|Overall Study|Non-compliance with protocol|0|||
27761712|NCT01670656|80950899|FG001|Overall Study|Non-compliance with protocol|3|||
27761713|NCT01670656|80950900|FG002|Overall Study|Non-compliance with protocol|1|||
27761714|NCT01670656|80950901|FG003|Overall Study|Non-compliance with protocol|1|||
27761715|NCT01670656|80950902|FG004|Overall Study|Non-compliance with protocol|2|||
27761716|NCT01670656|80950898|FG000|Overall Study|Adverse Event|2|||
27860415|NCT02640053|81322687|FG000|Overall Study|Alternative Therapy|1|||
27860416|NCT02640053|81322688|FG001|Overall Study|Alternative Therapy|1|||
27860417|NCT02640053|81322687|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
27860418|NCT02640053|81322688|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
27860419|NCT03210714|81322689|FG000|Overall Study|Adverse Event|6|||
27860420|NCT03210714|81322689|FG000|Overall Study|Physician Decision|1|||
27568118|NCT00677807|80267536|FG001|Overall Study|Lack of Efficacy|0|||
27658289|NCT03120949|80586698|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
27658290|NCT03120949|80586697|FG000|Overall Study|Personal Reasons|0|||
27658291|NCT03120949|80586698|FG001|Overall Study|Personal Reasons|1|||
27658292|NCT03120949|80586697|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
27658293|NCT03120949|80586698|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
27658294|NCT03120949|80586697|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
27658295|NCT03120949|80586698|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
27658296|NCT03120949|80586697|FG000|Overall Study|Compliance With Medication|0|||
27658297|NCT03120949|80586698|FG001|Overall Study|Compliance With Medication|1|||
27658298|NCT03120949|80586697|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
27658299|NCT03120949|80586698|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
27658300|NCT03120949|80586697|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
27658301|NCT03120949|80586698|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
27658302|NCT03120949|80586697|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
27658303|NCT03120949|80586698|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
27658304|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
27658305|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
27658306|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
27658307|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
27658308|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
27658309|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
27658310|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
27658311|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
27658312|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
27658313|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
27658314|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
27658315|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
27658316|NCT01345253|80586702|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
27658317|NCT01345253|80586703|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
27658318|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
27658319|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
27658320|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
27658321|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
27658322|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
27658323|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
27658324|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
27658325|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
27761717|NCT01670656|80950899|FG001|Overall Study|Adverse Event|2|||
27761718|NCT01670656|80950900|FG002|Overall Study|Adverse Event|2|||
27761719|NCT01670656|80950901|FG003|Overall Study|Adverse Event|3|||
27761720|NCT01670656|80950902|FG004|Overall Study|Adverse Event|3|||
27761721|NCT01670656|80950898|FG000|Overall Study|Subject withdrew consent|0|||
27761722|NCT01670656|80950899|FG001|Overall Study|Subject withdrew consent|1|||
27761723|NCT01670656|80950900|FG002|Overall Study|Subject withdrew consent|2|||
27761724|NCT01670656|80950901|FG003|Overall Study|Subject withdrew consent|1|||
27761725|NCT01670656|80950902|FG004|Overall Study|Subject withdrew consent|1|||
27761726|NCT01670656|80950898|FG000|Overall Study|Lost to Follow-up|0|||
27761727|NCT01670656|80950899|FG001|Overall Study|Lost to Follow-up|0|||
27761728|NCT01670656|80950900|FG002|Overall Study|Lost to Follow-up|0|||
27761729|NCT01670656|80950901|FG003|Overall Study|Lost to Follow-up|0|||
27761730|NCT01670656|80950902|FG004|Overall Study|Lost to Follow-up|3|||
27761731|NCT01670656|80950898|FG000|Overall Study|Subject moved|0|||
27761732|NCT01670656|80950899|FG001|Overall Study|Subject moved|0|||
27761733|NCT01670656|80950900|FG002|Overall Study|Subject moved|0|||
27761734|NCT01670656|80950901|FG003|Overall Study|Subject moved|1|||
27761735|NCT01670656|80950902|FG004|Overall Study|Subject moved|0|||
27761736|NCT01610076|80950903|FG000|Overall Study|Technical issue with video|0|||
27761737|NCT01610076|80950904|FG001|Overall Study|Technical issue with video|1|||
27761738|NCT01610076|80950903|FG000|Overall Study|Lost to Follow-up|3|||
27761739|NCT01610076|80950904|FG001|Overall Study|Lost to Follow-up|4|||
27761740|NCT00178464|80950906|FG000|Overall Study|Withdrawal by Subject|1|||
27761741|NCT00178464|80950906|FG000|Overall Study|Physician Decision|1|||
27860421|NCT03210714|81322689|FG000|Overall Study|Progressive disease|11|||
27886620|NCT00619892|81418126|FG001|Overall Study|Adverse Event|0|||
27658326|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
27658327|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
27658328|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
27658329|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
27658330|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
27658331|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
27658332|NCT01345253|80586702|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
27658333|NCT01345253|80586703|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
27658334|NCT04543942|80586704|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
27658335|NCT04543942|80586705|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
27658336|NCT04543942|80586704|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
27658337|NCT04543942|80586705|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
27658338|NCT00402298|80586706|FG000|Overall Study|Withdrawal by Subject|1|||
27658339|NCT00402298|80586707|FG001|Overall Study|Withdrawal by Subject|0|||
27658340|NCT01816165|80586708|FG000|Overall Study|Adverse Event|1|||
27658341|NCT01816165|80586709|FG001|Overall Study|Adverse Event|0|||
27658342|NCT01816165|80586710|FG002|Overall Study|Adverse Event|0|||
27658343|NCT01816165|80586711|FG003|Overall Study|Adverse Event|0|||
27658344|NCT04839289|80586712|FG000|Overall Study|Withdrawal by Subject|1|||
27658345|NCT04839289|80586713|FG001|Overall Study|Withdrawal by Subject|0|||
27658346|NCT01021683|80586714|FG000|Overall Study|Lack of Efficacy|12|||
27658347|NCT01021683|80586714|FG000|Overall Study|Recovery of neutrophil count|51|||
27658348|NCT01021683|80586714|FG000|Overall Study|Other|8|||
27658349|NCT02812706|80586715|FG000|Phase 1|Adverse Event|0|||
27658350|NCT02812706|80586716|FG001|Phase 1|Adverse Event|2|||
27658351|NCT02812706|80586717|FG002|Phase 1|Adverse Event|0|||
27658352|NCT02812706|80586715|FG000|Phase 1|Progressive disease|3|||
27658353|NCT02812706|80586716|FG001|Phase 1|Progressive disease|3|||
27658354|NCT02812706|80586717|FG002|Phase 1|Progressive disease|0|||
27658355|NCT02812706|80586715|FG000|Phase 2|Adverse Event|0|||
27658356|NCT02812706|80586716|FG001|Phase 2|Adverse Event|0|||
27860422|NCT03210714|81322689|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
27860423|NCT01329549|81322690|FG000|Overall Study|Withdrawal by Subject|1|||
27860424|NCT01329549|81322690|FG000|Overall Study|Adverse Event|1|||
27860425|NCT03017612|81322691|FG000|Overall Study|Adverse Event|2|||
27860426|NCT05014412|81322692|FG000|Overall Study|Death|11|||
27860427|NCT05014412|81322693|FG001|Overall Study|Death|7|||
27860428|NCT05014412|81322694|FG002|Overall Study|Death|4|||
27860429|NCT05014412|81322695|FG003|Overall Study|Death|7|||
27860430|NCT05014412|81322692|FG000|Overall Study|Withdrawal by Subject|1|||
27860431|NCT05014412|81322693|FG001|Overall Study|Withdrawal by Subject|1|||
27860432|NCT05014412|81322694|FG002|Overall Study|Withdrawal by Subject|1|||
27860433|NCT05014412|81322695|FG003|Overall Study|Withdrawal by Subject|2|||
27860434|NCT05014412|81322692|FG000|Overall Study|Ongoing|21|||
27860435|NCT05014412|81322693|FG001|Overall Study|Ongoing|4|||
27860436|NCT05014412|81322694|FG002|Overall Study|Ongoing|6|||
27860437|NCT05014412|81322695|FG003|Overall Study|Ongoing|20|||
27860438|NCT01635283|81322696|FG000|Overall Study|Tumor Progression|3|||
27658357|NCT02812706|80586717|FG002|Phase 2|Adverse Event|2|||
27658358|NCT02812706|80586715|FG000|Phase 2|Progressive disease|0|||
27658359|NCT02812706|80586716|FG001|Phase 2|Progressive disease|0|||
27658360|NCT02812706|80586717|FG002|Phase 2|Progressive disease|22|||
27658361|NCT02812706|80586715|FG000|Phase 2|Other-Unspecified|0|||
27658362|NCT02812706|80586716|FG001|Phase 2|Other-Unspecified|0|||
27658363|NCT02812706|80586717|FG002|Phase 2|Other-Unspecified|4|||
27658364|NCT01863368|80586718|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
27658365|NCT01863368|80586719|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
27658366|NCT01863368|80586718|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
27658367|NCT01863368|80586719|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
27658368|NCT01863368|80586718|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
27860439|NCT01635283|81322696|FG000|Overall Study|Lost to Follow-up|1|||
27860440|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Death|89|||
27658369|NCT01863368|80586719|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
27658370|NCT01863368|80586718|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
27658371|NCT01863368|80586719|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
27658372|NCT01863368|80586718|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
27658373|NCT01863368|80586719|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
27658374|NCT01863368|80586718|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
27658375|NCT01863368|80586719|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
27658376|NCT01204775|80586720|FG000|Overall Study|Poor/non-compliance|0|||
27658377|NCT01204775|80586721|FG001|Overall Study|Poor/non-compliance|1|||
27860441|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Death|193|||
27860442|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Death|198|||
27860443|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
27860444|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
27658378|NCT01204775|80586720|FG000|Overall Study|Withdrawal by Subject|1|||
27658379|NCT01204775|80586721|FG001|Overall Study|Withdrawal by Subject|0|||
27860445|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
27860446|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
27860447|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
27860448|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
27860449|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
27568119|NCT00677807|80267537|FG002|Overall Study|Lack of Efficacy|2|||
27568120|NCT00677807|80267535|FG000|Overall Study|Participant no longer needs study drug|0|||
27568121|NCT00677807|80267536|FG001|Overall Study|Participant no longer needs study drug|0|||
27568122|NCT00677807|80267537|FG002|Overall Study|Participant no longer needs study drug|1|||
27658380|NCT03449979|80586722|FG000|Overall Study|Technical difficulty|0|||
27658381|NCT03449979|80586723|FG001|Overall Study|Technical difficulty|0|||
27658382|NCT03449979|80586724|FG002|Overall Study|Technical difficulty|0|||
27761742|NCT01954251|80950909|FG000|Overall Study|Adverse Event|5|||
27568123|NCT00677807|80267535|FG000|Overall Study|Withdrawal by Subject|10|||
27568124|NCT00677807|80267536|FG001|Overall Study|Withdrawal by Subject|3|||
27568125|NCT00677807|80267537|FG002|Overall Study|Withdrawal by Subject|6|||
27568126|NCT00677807|80267535|FG000|Overall Study|Lost to Follow-up|2|||
27568127|NCT00677807|80267536|FG001|Overall Study|Lost to Follow-up|2|||
27568128|NCT00677807|80267537|FG002|Overall Study|Lost to Follow-up|2|||
27568129|NCT00677807|80267535|FG000|Overall Study|Administrative problems|1|||
27568130|NCT00677807|80267536|FG001|Overall Study|Administrative problems|1|||
27568131|NCT00677807|80267537|FG002|Overall Study|Administrative problems|2|||
27568132|NCT00677807|80267535|FG000|Overall Study|Death|0|||
27568133|NCT00677807|80267536|FG001|Overall Study|Death|1|||
27568134|NCT00677807|80267537|FG002|Overall Study|Death|1|||
27568135|NCT00677807|80267535|FG000|Overall Study|Protocol Deviation|1|||
27568136|NCT00677807|80267536|FG001|Overall Study|Protocol Deviation|3|||
27568137|NCT00677807|80267537|FG002|Overall Study|Protocol Deviation|0|||
27568138|NCT02731729|80271180|FG000|Overall Study|Death|2|||
27568139|NCT02731729|80271181|FG001|Overall Study|Death|2|||
27568140|NCT02731729|80271180|FG000|Overall Study|Study terminated by Sponsor|6|||
27568141|NCT02731729|80271181|FG001|Overall Study|Study terminated by Sponsor|6|||
27568142|NCT02731729|80271180|FG000|Overall Study|Withdrawal by Subject|1|||
27568143|NCT02731729|80271181|FG001|Overall Study|Withdrawal by Subject|0|||
27568144|NCT00994448|80271182|FG000|Overall Study|Adverse Event|1|||
27568145|NCT00994448|80271183|FG001|Overall Study|Adverse Event|0|||
27568146|NCT00994448|80271182|FG000|Overall Study|Lost to Follow-up|5|||
27761743|NCT01954251|80950910|FG001|Overall Study|Adverse Event|7|||
27761744|NCT01954251|80950909|FG000|Overall Study|Lost to Follow-up|6|||
27761745|NCT01954251|80950910|FG001|Overall Study|Lost to Follow-up|6|||
27761746|NCT01954251|80950909|FG000|Overall Study|Withdrawal by Subject|2|||
27761747|NCT01954251|80950910|FG001|Overall Study|Withdrawal by Subject|6|||
27761748|NCT00673894|80950911|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
27761749|NCT00673894|80950912|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
27761750|NCT00673894|80950911|FG000|First Intervention 4 Weeks|Adverse Event|1|||
27761751|NCT00673894|80950912|FG001|First Intervention 4 Weeks|Adverse Event|0|||
27761752|NCT02322411|80950913|FG000|Overall Study|Lost to Follow-up|4|||
27761753|NCT02322411|80950914|FG001|Overall Study|Lost to Follow-up|7|||
27761754|NCT02322411|80950913|FG000|Overall Study|Withdrawal by Subject|1|||
27761755|NCT02322411|80950914|FG001|Overall Study|Withdrawal by Subject|0|||
27761756|NCT01830816|80950915|FG000|Overall Study|Progressive Disease|12|||
27761757|NCT01830816|80950916|FG001|Overall Study|Progressive Disease|7|||
27761758|NCT01830816|80950917|FG002|Overall Study|Progressive Disease|7|||
27761759|NCT01830816|80950915|FG000|Overall Study|Adverse Event|3|||
27761760|NCT01830816|80950916|FG001|Overall Study|Adverse Event|4|||
27761761|NCT01830816|80950917|FG002|Overall Study|Adverse Event|0|||
27761762|NCT01830816|80950915|FG000|Overall Study|Study Terminated by Sponsor|1|||
27761763|NCT01830816|80950916|FG001|Overall Study|Study Terminated by Sponsor|1|||
27761764|NCT01830816|80950917|FG002|Overall Study|Study Terminated by Sponsor|0|||
27761765|NCT01830816|80950915|FG000|Overall Study|Withdrawal by Subject|1|||
27761766|NCT01830816|80950916|FG001|Overall Study|Withdrawal by Subject|1|||
27761767|NCT01830816|80950917|FG002|Overall Study|Withdrawal by Subject|0|||
27761768|NCT01830816|80950915|FG000|Overall Study|Lost to Follow-up|0|||
27761769|NCT01830816|80950916|FG001|Overall Study|Lost to Follow-up|1|||
27761770|NCT01830816|80950917|FG002|Overall Study|Lost to Follow-up|0|||
27761771|NCT01830816|80950915|FG000|Overall Study|Symptomatic Deterioration|1|||
27761772|NCT01830816|80950916|FG001|Overall Study|Symptomatic Deterioration|0|||
27761773|NCT01830816|80950917|FG002|Overall Study|Symptomatic Deterioration|0|||
27568147|NCT00994448|80271183|FG001|Overall Study|Lost to Follow-up|1|||
27568148|NCT00994448|80271182|FG000|Overall Study|Withdrawal by Subject|1|||
27568149|NCT00994448|80271183|FG001|Overall Study|Withdrawal by Subject|1|||
27568150|NCT00994448|80271182|FG000|Overall Study|Physician Decision|1|||
27568151|NCT00994448|80271183|FG001|Overall Study|Physician Decision|0|||
27568152|NCT00717769|80271184|FG000|Overall Study|Adverse Event|9|||
27860450|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
27860451|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
27860452|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
27860453|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
27860454|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
27860455|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
27860456|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
27860457|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
27860458|NCT02031458|81322699|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
27860459|NCT02031458|81322700|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
27860460|NCT02031458|81322701|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
27860461|NCT02031458|81322699|FG000|Baseline to May 8, 2015|Death|36|||
27860462|NCT02031458|81322700|FG001|Baseline to May 8, 2015|Death|87|||
27860463|NCT02031458|81322701|FG002|Baseline to May 8, 2015|Death|100|||
27860464|NCT02031458|81322699|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
27860465|NCT02031458|81322700|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
27860466|NCT02031458|81322701|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
27860467|NCT02031458|81322699|FG000|Baseline to May 8, 2015|Physician Decision|0|||
27860468|NCT02031458|81322700|FG001|Baseline to May 8, 2015|Physician Decision|1|||
27860469|NCT02031458|81322701|FG002|Baseline to May 8, 2015|Physician Decision|0|||
27860470|NCT02031458|81322699|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
27860471|NCT02031458|81322700|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
27860472|NCT02031458|81322701|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
27860473|NCT02031458|81322699|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
27860474|NCT02031458|81322700|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
27860475|NCT02031458|81322701|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
27761774|NCT01830816|80950915|FG000|Overall Study|Reason not Specified|2|||
27761775|NCT01830816|80950916|FG001|Overall Study|Reason not Specified|0|||
27761776|NCT01830816|80950917|FG002|Overall Study|Reason not Specified|0|||
27860476|NCT02031458|81322699|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
27860477|NCT02031458|81322700|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
27860478|NCT02031458|81322701|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
27860479|NCT02031458|81322699|FG000|Baseline to May 8, 2015|On Treatment|43|||
27860480|NCT02031458|81322700|FG001|Baseline to May 8, 2015|On Treatment|81|||
27568153|NCT00717769|80271185|FG001|Overall Study|Adverse Event|6|||
27568154|NCT00717769|80271186|FG002|Overall Study|Adverse Event|1|||
27568155|NCT00717769|80271184|FG000|Overall Study|Lack of compliance|0|||
27568156|NCT00717769|80271185|FG001|Overall Study|Lack of compliance|2|||
27568157|NCT00717769|80271186|FG002|Overall Study|Lack of compliance|0|||
27568158|NCT00717769|80271184|FG000|Overall Study|Lost to Follow-up|3|||
27568159|NCT00717769|80271185|FG001|Overall Study|Lost to Follow-up|4|||
27568160|NCT00717769|80271186|FG002|Overall Study|Lost to Follow-up|0|||
27568161|NCT00717769|80271184|FG000|Overall Study|Lack of Efficacy|1|||
27568162|NCT00717769|80271185|FG001|Overall Study|Lack of Efficacy|2|||
27568163|NCT00717769|80271186|FG002|Overall Study|Lack of Efficacy|0|||
27568164|NCT00717769|80271184|FG000|Overall Study|Protocol Violation|0|||
27568165|NCT00717769|80271185|FG001|Overall Study|Protocol Violation|2|||
27568166|NCT00717769|80271186|FG002|Overall Study|Protocol Violation|0|||
27568167|NCT00717769|80271184|FG000|Overall Study|Sponsor decision|1|||
27568168|NCT00717769|80271185|FG001|Overall Study|Sponsor decision|0|||
27568169|NCT00717769|80271186|FG002|Overall Study|Sponsor decision|10|||
27568170|NCT00717769|80271184|FG000|Overall Study|Withdrew consent|2|||
27568171|NCT00717769|80271185|FG001|Overall Study|Withdrew consent|2|||
27568172|NCT00717769|80271186|FG002|Overall Study|Withdrew consent|0|||
27568173|NCT01488097|80271189|FG000|Overall Study|Lost to Follow-up|1|||
27568174|NCT00314366|80271190|FG000|Overall Study|not treated due to patient medical condi|1|||
27568175|NCT00314366|80271191|FG001|Overall Study|not treated due to patient medical condi|0|||
27568176|NCT02268409|80271192|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
27568177|NCT02268409|80271192|FG000|Overall Study|Death|1|||
27568178|NCT02268409|80271192|FG000|Overall Study|Lost to Follow-up|1|||
27568179|NCT02268409|80271192|FG000|Overall Study|Protocol Violation|3|||
27568180|NCT02268409|80271192|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
27568181|NCT02268409|80271192|FG000|Overall Study|Withdrawal by Subject|5|||
27568182|NCT02167256|80271193|FG000|Overall Study|Adverse Event|13|||
27568183|NCT02167256|80271194|FG001|Overall Study|Adverse Event|6|||
27860481|NCT02031458|81322701|FG002|Baseline to May 8, 2015|On Treatment|73|||
27860482|NCT02031458|81322699|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
27860483|NCT02031458|81322700|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
27761777|NCT02270684|80950918|FG000|Overall Study|Lost to Follow-up|0|||
27761778|NCT02270684|80950919|FG001|Overall Study|Lost to Follow-up|3|||
27568184|NCT02167256|80271193|FG000|Overall Study|Withdrawal by Subject|4|||
27568185|NCT02167256|80271194|FG001|Overall Study|Withdrawal by Subject|4|||
27568186|NCT02167256|80271193|FG000|Overall Study|non-compliance|3|||
27568187|NCT02167256|80271194|FG001|Overall Study|non-compliance|0|||
27860484|NCT02031458|81322701|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
27860485|NCT03323437|81322702|FG000|Overall Study|Withdrawal by Subject|0|||
27860486|NCT03323437|81322703|FG001|Overall Study|Withdrawal by Subject|4|||
27860487|NCT01147107|81322704|FG000|Overall Study|Lack of Efficacy|5|||
27860488|NCT01147107|81322705|FG001|Overall Study|Lack of Efficacy|0|||
27860489|NCT01147107|81322704|FG000|Overall Study|Withdrawal by Subject|1|||
27860490|NCT01147107|81322705|FG001|Overall Study|Withdrawal by Subject|1|||
27860491|NCT03262038|81322706|FG000|Overall Study|Withdrawal by Subject|0|||
27860492|NCT03262038|81322707|FG001|Overall Study|Withdrawal by Subject|1|||
27860493|NCT01955083|81322708|FG000|Overall Study|Lost to Follow-up|1|||
27860494|NCT01955083|81322709|FG001|Overall Study|Lost to Follow-up|1|||
27860495|NCT02085135|81322710|FG000|Overall Study|Adverse Event|4|||
27860496|NCT02085135|81322711|FG001|Overall Study|Adverse Event|7|||
27860497|NCT02085135|81322710|FG000|Overall Study|Lost to Follow-up|2|||
27860498|NCT02085135|81322711|FG001|Overall Study|Lost to Follow-up|2|||
27860499|NCT02085135|81322710|FG000|Overall Study|Withdrawal by Subject|3|||
27860500|NCT02085135|81322711|FG001|Overall Study|Withdrawal by Subject|0|||
27860501|NCT02085135|81322710|FG000|Overall Study|Lack of Efficacy|2|||
27860502|NCT02085135|81322711|FG001|Overall Study|Lack of Efficacy|0|||
27860503|NCT04241315|81322712|FG000|Overall Study|Withdrawal by Subject|0|||
27860504|NCT04241315|81322713|FG001|Overall Study|Withdrawal by Subject|1|||
27860505|NCT00777036|81322714|FG000|On Treatment|Reason Not Specified|4|||
27860506|NCT00777036|81322715|FG001|On Treatment|Reason Not Specified|7|||
27860507|NCT00777036|81322716|FG002|On Treatment|Reason Not Specified|12|||
27860508|NCT00777036|81322714|FG000|On Treatment|Failure to Meet Study Criteria|0|||
27860509|NCT00777036|81322715|FG001|On Treatment|Failure to Meet Study Criteria|1|||
27860510|NCT00777036|81322716|FG002|On Treatment|Failure to Meet Study Criteria|0|||
27860511|NCT00777036|81322714|FG000|On Treatment|Non-compliance with Study Drug|1|||
27860512|NCT00777036|81322715|FG001|On Treatment|Non-compliance with Study Drug|0|||
27860513|NCT00777036|81322716|FG002|On Treatment|Non-compliance with Study Drug|0|||
27860514|NCT00777036|81322714|FG000|On Treatment|Maximum Clinical Benefit|2|||
27860515|NCT00777036|81322715|FG001|On Treatment|Maximum Clinical Benefit|0|||
27860516|NCT00777036|81322716|FG002|On Treatment|Maximum Clinical Benefit|1|||
27860517|NCT00777036|81322714|FG000|On Treatment|Withdrawal by Subject|3|||
27860518|NCT00777036|81322715|FG001|On Treatment|Withdrawal by Subject|2|||
27860519|NCT00777036|81322716|FG002|On Treatment|Withdrawal by Subject|3|||
27860520|NCT00777036|81322714|FG000|On Treatment|Death|0|||
27860521|NCT00777036|81322715|FG001|On Treatment|Death|2|||
27860522|NCT00777036|81322716|FG002|On Treatment|Death|0|||
27860523|NCT00777036|81322714|FG000|On Treatment|Study Drug Toxicity|0|||
27658383|NCT03449979|80586725|FG003|Overall Study|Technical difficulty|1|||
27658384|NCT01631825|80586726|FG000|Overall Study|Adverse Event|42|||
27658385|NCT01631825|80586726|FG000|Overall Study|Lack of Efficacy|7|||
27658386|NCT01631825|80586726|FG000|Overall Study|Withdrawal by Subject|9|||
27658387|NCT01631825|80586726|FG000|Overall Study|Protocol Violation|4|||
27658388|NCT01631825|80586726|FG000|Overall Study|Discontinuation criteria|1|||
27658389|NCT01631825|80586726|FG000|Overall Study|Physician Decision|2|||
27658390|NCT00730925|80586727|FG000|Overall Study|Progressive Disease|21|||
27658391|NCT00730925|80586727|FG000|Overall Study|Dose reducing Event|2|||
27658392|NCT00730925|80586727|FG000|Overall Study|Other Averse Event|7|||
27658393|NCT00730925|80586727|FG000|Overall Study|Protocol Violation|1|||
27658394|NCT00730925|80586727|FG000|Overall Study|Withdrawal by Subject|1|||
27658395|NCT00730925|80586727|FG000|Overall Study|Switch to combination therapy|8|||
27658396|NCT00730925|80586727|FG000|Overall Study|Other|1|||
27658397|NCT01375777|80586728|FG000|Overall Study|Withdrawal by Subject|0|||
27658398|NCT01375777|80586729|FG001|Overall Study|Withdrawal by Subject|2|||
27658399|NCT01375777|80586730|FG002|Overall Study|Withdrawal by Subject|1|||
27658400|NCT01375777|80586731|FG003|Overall Study|Withdrawal by Subject|0|||
27658401|NCT01375777|80586732|FG004|Overall Study|Withdrawal by Subject|1|||
27658402|NCT01375777|80586733|FG005|Overall Study|Withdrawal by Subject|1|||
27658403|NCT01375777|80586734|FG006|Overall Study|Withdrawal by Subject|1|||
27658404|NCT01375777|80586735|FG007|Overall Study|Withdrawal by Subject|2|||
27658405|NCT01375777|80586736|FG008|Overall Study|Withdrawal by Subject|1|||
27860524|NCT00777036|81322715|FG001|On Treatment|Study Drug Toxicity|0|||
27860525|NCT00777036|81322716|FG002|On Treatment|Study Drug Toxicity|1|||
27860526|NCT00777036|81322714|FG000|On Treatment|Progressive Disease|5|||
27860527|NCT00777036|81322715|FG001|On Treatment|Progressive Disease|4|||
27658406|NCT01375777|80586728|FG000|Overall Study|Lost to Follow-up|1|||
27658407|NCT01375777|80586729|FG001|Overall Study|Lost to Follow-up|0|||
27658408|NCT01375777|80586730|FG002|Overall Study|Lost to Follow-up|0|||
27860528|NCT00777036|81322716|FG002|On Treatment|Progressive Disease|6|||
27860529|NCT00777036|81322714|FG000|Follow-Up|Lost to Follow-up|1|||
27860530|NCT00777036|81322715|FG001|Follow-Up|Lost to Follow-up|0|||
27860531|NCT00777036|81322716|FG002|Follow-Up|Lost to Follow-up|0|||
27658409|NCT01375777|80586731|FG003|Overall Study|Lost to Follow-up|0|||
27658410|NCT01375777|80586732|FG004|Overall Study|Lost to Follow-up|0|||
27860532|NCT00777036|81322714|FG000|Follow-Up|Reason Not Specified|2|||
27860533|NCT00777036|81322715|FG001|Follow-Up|Reason Not Specified|0|||
27658411|NCT01375777|80586733|FG005|Overall Study|Lost to Follow-up|0|||
27658412|NCT01375777|80586734|FG006|Overall Study|Lost to Follow-up|1|||
27658413|NCT01375777|80586735|FG007|Overall Study|Lost to Follow-up|0|||
27658414|NCT01375777|80586736|FG008|Overall Study|Lost to Follow-up|0|||
27658415|NCT01375777|80586728|FG000|Overall Study|Other|1|||
27658416|NCT01375777|80586729|FG001|Overall Study|Other|1|||
27658417|NCT01375777|80586730|FG002|Overall Study|Other|0|||
27658418|NCT01375777|80586731|FG003|Overall Study|Other|0|||
27658419|NCT01375777|80586732|FG004|Overall Study|Other|0|||
27658420|NCT01375777|80586733|FG005|Overall Study|Other|0|||
27658421|NCT01375777|80586734|FG006|Overall Study|Other|0|||
27658422|NCT01375777|80586735|FG007|Overall Study|Other|0|||
27658423|NCT01375777|80586736|FG008|Overall Study|Other|1|||
27658424|NCT00248794|80586737|FG000|Overall Study|Lost to Follow-up|6|||
27658425|NCT00248794|80586738|FG001|Overall Study|Lost to Follow-up|8|||
27860534|NCT00777036|81322716|FG002|Follow-Up|Reason Not Specified|0|||
27860535|NCT00777036|81322714|FG000|Follow-Up|Withdrawal by Subject|1|||
27860536|NCT00777036|81322715|FG001|Follow-Up|Withdrawal by Subject|0|||
27860537|NCT00777036|81322716|FG002|Follow-Up|Withdrawal by Subject|4|||
27860538|NCT00777036|81322714|FG000|Follow-Up|Death|1|||
27860539|NCT00777036|81322715|FG001|Follow-Up|Death|8|||
27860540|NCT00777036|81322716|FG002|Follow-Up|Death|0|||
27860541|NCT04762277|81322718|FG000|Overall Study|Withdrawal by Subject|0|||
27860542|NCT04762277|81322719|FG001|Overall Study|Withdrawal by Subject|2|||
27860543|NCT04762277|81322718|FG000|Overall Study|Protocol Violation|0|||
27860544|NCT04762277|81322719|FG001|Overall Study|Protocol Violation|1|||
27860545|NCT04762277|81322718|FG000|Overall Study|Adverse Event|1|||
27860546|NCT04762277|81322719|FG001|Overall Study|Adverse Event|0|||
27860547|NCT03610516|81322720|FG000|Treatment Epoch|Adverse Event|3|||
27860548|NCT03610516|81322721|FG001|Treatment Epoch|Adverse Event|1|||
27860549|NCT03610516|81322720|FG000|Treatment Epoch|Death|1|||
27860550|NCT03610516|81322721|FG001|Treatment Epoch|Death|0|||
27860551|NCT03610516|81322720|FG000|Treatment Epoch|Lack of Efficacy|0|||
27860552|NCT03610516|81322721|FG001|Treatment Epoch|Lack of Efficacy|1|||
27658426|NCT00248794|80586739|FG002|Overall Study|Lost to Follow-up|3|||
27658427|NCT04175392|80586740|FG000|Overall Study|Withdrawal by Subject|3|||
27658428|NCT04175392|80586741|FG001|Overall Study|Withdrawal by Subject|2|||
27761779|NCT02270684|80950918|FG000|Overall Study|Study terminated|1|||
27658429|NCT00555620|80586742|FG000|Overall Study|Death|0|||
27658430|NCT00555620|80586743|FG001|Overall Study|Death|1|||
27658431|NCT00555620|80586744|FG002|Overall Study|Death|0|||
27658432|NCT00555620|80586745|FG003|Overall Study|Death|0|||
27658433|NCT00555620|80586746|FG004|Overall Study|Death|0|||
27658434|NCT00555620|80586747|FG005|Overall Study|Death|1|||
27761780|NCT02270684|80950919|FG001|Overall Study|Study terminated|0|||
27761781|NCT00776555|80950923|FG000|Overall Study|Study terminated|3|||
27761782|NCT00776555|80950924|FG001|Overall Study|Study terminated|0|||
27761783|NCT02207556|80950925|FG000|Overall Study|Physician Decision|1|||
27761784|NCT02207556|80950926|FG001|Overall Study|Physician Decision|0|||
27761785|NCT02207556|80950925|FG000|Overall Study|Withdrawal by Subject|1|||
27761786|NCT02207556|80950926|FG001|Overall Study|Withdrawal by Subject|0|||
27761787|NCT02207556|80950925|FG000|Overall Study|Death|0|||
27761788|NCT02207556|80950926|FG001|Overall Study|Death|5|||
27761789|NCT03017846|80950927|FG000|Overall Study|Lost to Follow-up|3|||
27761790|NCT03017846|80950927|FG000|Overall Study|Adverse Event|2|||
27761791|NCT00282568|80954057|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
27761792|NCT00282568|80954057|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
27761793|NCT00282568|80954057|FG000|Extended Treatment Period|Adverse Event|17|||
27761794|NCT00282568|80954057|FG000|Extended Treatment Period|Non-compliance|4|||
27761795|NCT00282568|80954057|FG000|Extended Treatment Period|Physician Decision|1|||
27761796|NCT00282568|80954057|FG000|Extended Treatment Period|Lost to Follow-up|2|||
27761797|NCT03115112|80954058|FG000|Overall Study|Adverse Event|5|||
27761798|NCT03115112|80954059|FG001|Overall Study|Adverse Event|1|||
27761799|NCT03115112|80954058|FG000|Overall Study|Withdrawal by Subject|4|||
27761800|NCT03115112|80954059|FG001|Overall Study|Withdrawal by Subject|2|||
27761801|NCT03115112|80954058|FG000|Overall Study|Lost to Follow-up|0|||
27761802|NCT03115112|80954059|FG001|Overall Study|Lost to Follow-up|1|||
27761803|NCT03115112|80954058|FG000|Overall Study|Death|1|||
27761804|NCT03115112|80954059|FG001|Overall Study|Death|0|||
27761805|NCT03115112|80954058|FG000|Overall Study|Pregnancy|1|||
27761806|NCT03115112|80954059|FG001|Overall Study|Pregnancy|0|||
27761807|NCT03115112|80954058|FG000|Overall Study|Site closure|1|||
27761808|NCT03115112|80954059|FG001|Overall Study|Site closure|1|||
27761809|NCT04209530|80954060|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
27761810|NCT04209530|80954061|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
27761811|NCT04209530|80954060|FG000|Overall Study|Withdrawal by Subject|0|||
27761812|NCT04209530|80954061|FG001|Overall Study|Withdrawal by Subject|1|||
27761813|NCT00120289|80954062|FG000|Overall Study|Death|96|||
27860553|NCT03610516|81322720|FG000|Treatment Epoch|No longer requires treatment|1|||
27860554|NCT03610516|81322721|FG001|Treatment Epoch|No longer requires treatment|0|||
27860555|NCT03610516|81322720|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
27860556|NCT03610516|81322721|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
27860557|NCT03610516|81322720|FG000|Treatment Epoch|Physician Decision|8|||
27860558|NCT03610516|81322721|FG001|Treatment Epoch|Physician Decision|5|||
27860559|NCT03610516|81322720|FG000|Treatment Epoch|Protocol Deviation|1|||
27860560|NCT03610516|81322721|FG001|Treatment Epoch|Protocol Deviation|0|||
27860561|NCT03610516|81322720|FG000|Treatment Epoch|Withdrawal by Subject|3|||
27860562|NCT03610516|81322721|FG001|Treatment Epoch|Withdrawal by Subject|1|||
27860563|NCT03610516|81322720|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
27860564|NCT03610516|81322721|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
27860565|NCT03610516|81322720|FG000|Post-Treatment Follow-up|Death|1|||
27860566|NCT03610516|81322721|FG001|Post-Treatment Follow-up|Death|0|||
27860567|NCT05005312|81322724|FG000|Overall Study|Enrolled, but not treated|0|||
27860568|NCT05005312|81322725|FG001|Overall Study|Enrolled, but not treated|1|||
27860569|NCT04325204|81322726|FG000|Overall Study|Death|0|||
27860570|NCT04325204|81322727|FG001|Overall Study|Death|1|||
27860571|NCT04325204|81322726|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
27860572|NCT04325204|81322727|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
27860573|NCT04325204|81322726|FG000|Overall Study|Lost to Follow-up|8|||
27860574|NCT04325204|81322727|FG001|Overall Study|Lost to Follow-up|8|||
27860575|NCT04325204|81322726|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
27860576|NCT04325204|81322727|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
27860577|NCT01438996|81322728|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
27860578|NCT01438996|81322729|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
27860579|NCT01438996|81322730|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
27860580|NCT02910063|81322731|FG000|Phase 2|Withdrawal by Subject|3|||
27860581|NCT02910063|81322732|FG001|Phase 2|Withdrawal by Subject|0|||
27860582|NCT02910063|81322733|FG002|Phase 2|Withdrawal by Subject|0|||
27860583|NCT02910063|81322731|FG000|Phase 2|Lost to Follow-up|1|||
27860584|NCT02910063|81322732|FG001|Phase 2|Lost to Follow-up|0|||
27860585|NCT02910063|81322733|FG002|Phase 2|Lost to Follow-up|0|||
27860586|NCT02910063|81322731|FG000|Phase 2|Death|24|||
27860587|NCT02910063|81322732|FG001|Phase 2|Death|0|||
27658435|NCT00555620|80586742|FG000|Overall Study|Study terminated by sponsor|0|||
27658436|NCT00555620|80586743|FG001|Overall Study|Study terminated by sponsor|0|||
27658437|NCT00555620|80586744|FG002|Overall Study|Study terminated by sponsor|1|||
27658438|NCT00555620|80586745|FG003|Overall Study|Study terminated by sponsor|0|||
27658439|NCT00555620|80586746|FG004|Overall Study|Study terminated by sponsor|0|||
27658440|NCT00555620|80586747|FG005|Overall Study|Study terminated by sponsor|0|||
27658441|NCT00555620|80586742|FG000|Overall Study|Adverse Event|0|||
27761814|NCT00120289|80954063|FG001|Overall Study|Death|82|||
27860588|NCT02910063|81322733|FG002|Phase 2|Death|0|||
27860589|NCT03694327|81322738|FG000|Overall Study|Lost to Follow-up|13|||
27860590|NCT03694327|81322739|FG001|Overall Study|Lost to Follow-up|23|||
27860591|NCT02186834|81322740|FG000|Dose Escalation|Death|0|||
27860592|NCT02186834|81322741|FG001|Dose Escalation|Death|0|||
27860593|NCT02186834|81322742|FG002|Dose Escalation|Death|0|||
27568188|NCT02167256|80271193|FG000|Overall Study|Study partner unable to participate|1|||
27568189|NCT02167256|80271194|FG001|Overall Study|Study partner unable to participate|0|||
27568190|NCT04211337|80271200|FG000|Overall Study|On Treatment|175|||
27568191|NCT04211337|80271201|FG001|Overall Study|On Treatment|40|||
27568192|NCT04211337|80271200|FG000|Overall Study|Withdrawal by Subject|0|||
27568193|NCT04211337|80271201|FG001|Overall Study|Withdrawal by Subject|2|||
27568194|NCT01494610|80271202|FG000|Period 1|Withdrawal by Subject|1|||
27568195|NCT01494610|80271203|FG001|Period 1|Withdrawal by Subject|1|||
27568196|NCT01494610|80271202|FG000|Period 3|Adverse Event|1|||
27568197|NCT01494610|80271203|FG001|Period 3|Adverse Event|0|||
27568198|NCT01494610|80271202|FG000|Period 3|Withdrawal by Subject|1|||
27568199|NCT01494610|80271203|FG001|Period 3|Withdrawal by Subject|0|||
27568200|NCT01494610|80271202|FG000|Period 4|Protocol Violation|1|||
27568201|NCT01494610|80271203|FG001|Period 4|Protocol Violation|0|||
27568202|NCT00262067|80271210|FG000|Overall Study|Death|190|||
27568203|NCT00262067|80271211|FG001|Overall Study|Death|89|||
27568204|NCT00262067|80271212|FG002|Overall Study|Death|186|||
27568205|NCT00262067|80271213|FG003|Overall Study|Death|99|||
27568206|NCT00262067|80271210|FG000|Overall Study|Lost to Follow-up|5|||
27568207|NCT00262067|80271211|FG001|Overall Study|Lost to Follow-up|4|||
27568208|NCT00262067|80271212|FG002|Overall Study|Lost to Follow-up|7|||
27568209|NCT00262067|80271213|FG003|Overall Study|Lost to Follow-up|5|||
27568210|NCT00262067|80271210|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
27568211|NCT00262067|80271211|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
27568212|NCT00262067|80271212|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
27658442|NCT00555620|80586743|FG001|Overall Study|Adverse Event|0|||
27860594|NCT02186834|81322743|FG003|Dose Escalation|Death|1|||
27658443|NCT00555620|80586744|FG002|Overall Study|Adverse Event|1|||
27658444|NCT00555620|80586745|FG003|Overall Study|Adverse Event|5|||
27658445|NCT00555620|80586746|FG004|Overall Study|Adverse Event|0|||
27658446|NCT00555620|80586747|FG005|Overall Study|Adverse Event|1|||
27658447|NCT00555620|80586742|FG000|Overall Study|Objective progression or relapse|6|||
27860595|NCT02186834|81322744|FG004|Dose Escalation|Death|0|||
27860596|NCT02186834|81322745|FG005|Dose Escalation|Death|0|||
27860597|NCT02186834|81322740|FG000|Treatment at RP2D|Died prior to treatment|0|||
27860598|NCT02186834|81322741|FG001|Treatment at RP2D|Died prior to treatment|0|||
27860599|NCT02186834|81322742|FG002|Treatment at RP2D|Died prior to treatment|0|||
27860600|NCT02186834|81322743|FG003|Treatment at RP2D|Died prior to treatment|0|||
27860601|NCT02186834|81322744|FG004|Treatment at RP2D|Died prior to treatment|0|||
27860602|NCT02186834|81322745|FG005|Treatment at RP2D|Died prior to treatment|1|||
27860603|NCT01293539|81322746|FG000|Overall Study|Physician Decision|1|||
27860604|NCT00951496|81322747|FG000|Overall Study|Did not initiate study treatment|10|||
27860605|NCT00951496|81322748|FG001|Overall Study|Did not initiate study treatment|8|||
27860606|NCT00951496|81322749|FG002|Overall Study|Did not initiate study treatment|13|||
27860607|NCT01866098|81322750|FG000|Overall Study|Lost to Follow-up|11|||
27860608|NCT01866098|81322751|FG001|Overall Study|Lost to Follow-up|18|||
27658448|NCT00555620|80586743|FG001|Overall Study|Objective progression or relapse|5|||
27658449|NCT00555620|80586744|FG002|Overall Study|Objective progression or relapse|12|||
27658450|NCT00555620|80586745|FG003|Overall Study|Objective progression or relapse|17|||
27658451|NCT00555620|80586746|FG004|Overall Study|Objective progression or relapse|3|||
27658452|NCT00555620|80586747|FG005|Overall Study|Objective progression or relapse|16|||
27860609|NCT01866098|81322752|FG002|Overall Study|Lost to Follow-up|13|||
27860610|NCT01866098|81322750|FG000|Overall Study|Physician Decision|0|||
27860611|NCT01866098|81322751|FG001|Overall Study|Physician Decision|1|||
27860612|NCT01866098|81322752|FG002|Overall Study|Physician Decision|2|||
27860613|NCT01866098|81322750|FG000|Overall Study|Adverse Event|1|||
27860614|NCT01866098|81322751|FG001|Overall Study|Adverse Event|5|||
27658453|NCT00555620|80586742|FG000|Overall Study|Participant refused treatment|0|||
27658454|NCT00555620|80586743|FG001|Overall Study|Participant refused treatment|1|||
27658455|NCT00555620|80586744|FG002|Overall Study|Participant refused treatment|1|||
27658456|NCT00555620|80586745|FG003|Overall Study|Participant refused treatment|0|||
27658457|NCT00555620|80586746|FG004|Overall Study|Participant refused treatment|0|||
27658458|NCT00555620|80586747|FG005|Overall Study|Participant refused treatment|1|||
27658459|NCT00555620|80586742|FG000|Overall Study|Other|0|||
27658460|NCT00555620|80586743|FG001|Overall Study|Other|0|||
27658461|NCT00555620|80586744|FG002|Overall Study|Other|0|||
27658462|NCT00555620|80586745|FG003|Overall Study|Other|1|||
27658463|NCT00555620|80586746|FG004|Overall Study|Other|0|||
27658464|NCT00555620|80586747|FG005|Overall Study|Other|3|||
27658465|NCT02164578|80586748|FG000|Treatment Period|Withdrawal by Subject|3|||
27658466|NCT02164578|80586749|FG001|Treatment Period|Withdrawal by Subject|3|||
27658467|NCT02164578|80586748|FG000|Treatment Period|Adverse Event|13|||
27658468|NCT02164578|80586749|FG001|Treatment Period|Adverse Event|6|||
27658469|NCT02164578|80586748|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
27658470|NCT02164578|80586749|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
27658471|NCT02164578|80586748|FG000|Treatment Period|Protocol Violation|0|||
27658472|NCT02164578|80586749|FG001|Treatment Period|Protocol Violation|2|||
27658473|NCT02164578|80586748|FG000|Extension Period|Withdrawal by Subject|2|||
27658474|NCT02164578|80586749|FG001|Extension Period|Withdrawal by Subject|0|||
27658475|NCT02164578|80586748|FG000|Extension Period|Adverse Event|4|||
27658476|NCT02164578|80586749|FG001|Extension Period|Adverse Event|0|||
27658477|NCT02164578|80586748|FG000|Extension Period|Expiry of study medication|1|||
27658478|NCT02164578|80586749|FG001|Extension Period|Expiry of study medication|0|||
27658479|NCT02164578|80586748|FG000|Extension Period|Protocol Violation|0|||
27658480|NCT02164578|80586749|FG001|Extension Period|Protocol Violation|1|||
27658481|NCT01812707|80586754|FG000|Overall Study|Adverse Event|0|||
27658482|NCT01812707|80586755|FG001|Overall Study|Adverse Event|0|||
27658483|NCT01812707|80586756|FG002|Overall Study|Adverse Event|0|||
27658484|NCT01812707|80586757|FG003|Overall Study|Adverse Event|2|||
27658485|NCT01812707|80586754|FG000|Overall Study|Poor compliance to protocol|1|||
27761815|NCT00120289|80954062|FG000|Overall Study|Lost to Follow-up|11|||
27761816|NCT00120289|80954063|FG001|Overall Study|Lost to Follow-up|14|||
27860615|NCT01866098|81322752|FG002|Overall Study|Adverse Event|4|||
27860616|NCT01866098|81322750|FG000|Overall Study|Protocol Violation|1|||
27658486|NCT01812707|80586755|FG001|Overall Study|Poor compliance to protocol|0|||
27658487|NCT01812707|80586756|FG002|Overall Study|Poor compliance to protocol|0|||
27658488|NCT01812707|80586757|FG003|Overall Study|Poor compliance to protocol|0|||
27658489|NCT01812707|80586754|FG000|Overall Study|Consent withdrawn by participant|1|||
27860617|NCT01866098|81322751|FG001|Overall Study|Protocol Violation|0|||
27860618|NCT01866098|81322752|FG002|Overall Study|Protocol Violation|0|||
27860619|NCT01866098|81322750|FG000|Overall Study|Withdrawal by Subject|1|||
27860620|NCT01866098|81322751|FG001|Overall Study|Withdrawal by Subject|2|||
27658490|NCT01812707|80586755|FG001|Overall Study|Consent withdrawn by participant|0|||
27658491|NCT01812707|80586756|FG002|Overall Study|Consent withdrawn by participant|0|||
27658492|NCT01812707|80586757|FG003|Overall Study|Consent withdrawn by participant|0|||
27658493|NCT00665392|80586758|FG000|Overall Study|not treated|1|||
27658494|NCT00857311|80586759|FG000|Overall Study|Lost to Follow-up|1|||
27658495|NCT00857311|80586760|FG001|Overall Study|Lost to Follow-up|0|||
27658496|NCT00857311|80586761|FG002|Overall Study|Lost to Follow-up|0|||
27658497|NCT00857311|80586762|FG003|Overall Study|Lost to Follow-up|0|||
27658498|NCT01268488|80586763|FG000|Overall Study|Adverse Event|3|||
27761817|NCT00120289|80954062|FG000|Overall Study|Withdrawal by Subject|14|||
27761818|NCT00120289|80954063|FG001|Overall Study|Withdrawal by Subject|13|||
27761819|NCT01575899|80954072|FG000|Overall Study|Lost to Follow-up|3|||
27761820|NCT01575899|80954073|FG001|Overall Study|Lost to Follow-up|4|||
27761821|NCT01575899|80954074|FG002|Overall Study|Lost to Follow-up|2|||
27761822|NCT01575899|80954072|FG000|Overall Study|Protocol Violation|2|||
27761823|NCT01575899|80954073|FG001|Overall Study|Protocol Violation|1|||
27761824|NCT01575899|80954074|FG002|Overall Study|Protocol Violation|0|||
27761825|NCT00830960|80954075|FG000|Overall Study|Death|5|||
27761826|NCT00830960|80954076|FG001|Overall Study|Death|4|||
27761827|NCT00830960|80954077|FG002|Overall Study|Death|3|||
27761828|NCT00830960|80954078|FG003|Overall Study|Death|2|||
27568213|NCT00262067|80271213|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
27568214|NCT00262067|80271210|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
27568215|NCT00262067|80271211|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
27568216|NCT00262067|80271212|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
27568217|NCT00262067|80271213|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
27568218|NCT00655564|80271216|FG000|Overall Study|Adverse Event|1|||
27568219|NCT00655564|80271216|FG000|Overall Study|Lost to Follow-up|1|||
27568220|NCT00655564|80271216|FG000|Overall Study|Desired Alternate Therapy|1|||
27568221|NCT00805766|80271217|FG000|Screening Period|Adverse Event|1|||
27568222|NCT00805766|80271217|FG000|Screening Period|Lack of Efficacy|2|||
27568223|NCT00805766|80271217|FG000|Screening Period|Pregnancy|1|||
27568224|NCT00805766|80271217|FG000|Screening Period|Responder|2|||
27568225|NCT00805766|80271217|FG000|Increased Dose Period|Adverse Event|4|||
27568226|NCT00805766|80271217|FG000|Increased Dose Period|Lack of Efficacy|7|||
27568227|NCT00805766|80271217|FG000|Increased Dose Period|Pregnancy|1|||
27568228|NCT00805766|80271217|FG000|Increased Dose Period|Withdrawal by Subject|1|||
27568229|NCT01802775|80271218|FG000|Overall Study|Death|0|||
27568230|NCT01802775|80271219|FG001|Overall Study|Death|3|||
27568231|NCT01802775|80271218|FG000|Overall Study|Reason not provided|0|||
27568232|NCT01802775|80271219|FG001|Overall Study|Reason not provided|1|||
27568233|NCT01802775|80271218|FG000|Overall Study|Physician Decision|1|||
27568234|NCT01802775|80271219|FG001|Overall Study|Physician Decision|0|||
27568235|NCT01802775|80271218|FG000|Overall Study|Adverse Event|1|||
27568236|NCT01802775|80271219|FG001|Overall Study|Adverse Event|1|||
27568237|NCT01802775|80271218|FG000|Overall Study|Withdrawal by Subject|3|||
27568238|NCT01802775|80271219|FG001|Overall Study|Withdrawal by Subject|5|||
27568239|NCT01802775|80271218|FG000|Overall Study|Lost to Follow-up|1|||
27568240|NCT01802775|80271219|FG001|Overall Study|Lost to Follow-up|2|||
27568241|NCT00439556|80271224|FG000|Overall Study|Patient was taken off study for non-comp|0|||
27568242|NCT00439556|80271225|FG001|Overall Study|Patient was taken off study for non-comp|1|||
27568243|NCT00439556|80271226|FG002|Overall Study|Patient was taken off study for non-comp|0|||
27568244|NCT03044197|80271227|FG000|Overall Study|Withdrawal by Subject|3|||
27568245|NCT03044197|80271228|FG001|Overall Study|Withdrawal by Subject|1|||
27568246|NCT00581776|80271229|FG000|Overall Study|Disease progression or no response|3|||
27568247|NCT03139916|80271232|FG000|Overall Study|Withdrawal by Subject|2|||
27568248|NCT03139916|80271232|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
27568249|NCT02129803|80271238|FG000|Overall Study|Protocol Violation|4|||
27568250|NCT02129803|80271239|FG001|Overall Study|Protocol Violation|0|||
27568251|NCT02129803|80271238|FG000|Overall Study|Physician Decision|0|||
27568252|NCT02129803|80271239|FG001|Overall Study|Physician Decision|1|||
27568253|NCT02129803|80271238|FG000|Overall Study|Difficulty sleeping|1|||
27568254|NCT02129803|80271239|FG001|Overall Study|Difficulty sleeping|0|||
27568255|NCT02129803|80271238|FG000|Overall Study|Morning headache|0|||
27568256|NCT02129803|80271239|FG001|Overall Study|Morning headache|1|||
27568257|NCT02129803|80271238|FG000|Overall Study|Withdrawal by Subject|1|||
27568258|NCT02129803|80271239|FG001|Overall Study|Withdrawal by Subject|1|||
27568259|NCT01070316|80271240|FG000|Extension Phase|Lack of Efficacy|3|||
27568260|NCT01070316|80271240|FG000|Extension Phase|Withdrawal by Subject|1|||
27568261|NCT02457325|80271248|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
27568262|NCT02457325|80271249|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
27658499|NCT01268488|80586763|FG000|Overall Study|Physician Decision|2|||
27658500|NCT04267393|80586764|FG000|Randomization|Adverse Event|1|||
27658501|NCT04267393|80586765|FG001|Randomization|Adverse Event|0|||
27761829|NCT00830960|80954079|FG004|Overall Study|Death|6|||
27568263|NCT02563028|80271250|FG000|Overall Study|Lack of equipment|1|||
27761830|NCT00830960|80954080|FG005|Overall Study|Death|1|||
27860621|NCT01866098|81322752|FG002|Overall Study|Withdrawal by Subject|0|||
27860622|NCT01866098|81322750|FG000|Overall Study|Unrelated Hospitalization|2|||
27860623|NCT01866098|81322751|FG001|Overall Study|Unrelated Hospitalization|0|||
27860624|NCT01866098|81322752|FG002|Overall Study|Unrelated Hospitalization|1|||
27860625|NCT01866098|81322750|FG000|Overall Study|Non-compliance|1|||
27658502|NCT04267393|80586766|FG002|Randomization|Adverse Event|0|||
27860626|NCT01866098|81322751|FG001|Overall Study|Non-compliance|0|||
27860627|NCT01866098|81322752|FG002|Overall Study|Non-compliance|1|||
27860628|NCT01866098|81322750|FG000|Overall Study|Pregnancy|2|||
27860629|NCT01866098|81322751|FG001|Overall Study|Pregnancy|0|||
27860630|NCT01866098|81322752|FG002|Overall Study|Pregnancy|0|||
27860631|NCT01866098|81322750|FG000|Overall Study|Death|0|||
27860632|NCT01866098|81322751|FG001|Overall Study|Death|1|||
27860633|NCT01866098|81322752|FG002|Overall Study|Death|0|||
27860634|NCT00371397|81322757|FG000|Session 1|Withdrawal by Subject|1|||
27658503|NCT04267393|80586764|FG000|Randomization|Administrative Reasons by Sponsor|0|||
27658504|NCT04267393|80586765|FG001|Randomization|Administrative Reasons by Sponsor|1|||
27658505|NCT04267393|80586766|FG002|Randomization|Administrative Reasons by Sponsor|0|||
27658506|NCT04267393|80586764|FG000|Treatment Period|Adverse Event|0|||
27658507|NCT04267393|80586765|FG001|Treatment Period|Adverse Event|2|||
27658508|NCT04267393|80586766|FG002|Treatment Period|Adverse Event|3|||
27658509|NCT04267393|80586764|FG000|Treatment Period|Participant Withdrew Consent|0|||
27658510|NCT04267393|80586765|FG001|Treatment Period|Participant Withdrew Consent|0|||
27658511|NCT04267393|80586766|FG002|Treatment Period|Participant Withdrew Consent|1|||
27658512|NCT04267393|80586764|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
27658513|NCT04267393|80586765|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
27568264|NCT02563028|80271250|FG000|Overall Study|Unable to elicit VEP post induction|1|||
27568265|NCT03569371|80271255|FG000|Overall Study|Lack of Efficacy|1|||
27568266|NCT03569371|80271255|FG000|Overall Study|Lost to Follow-up|1|||
27568267|NCT03569371|80271255|FG000|Overall Study|Adverse Event|1|||
27568268|NCT00283439|80271261|FG000|Overall Study|Adverse Event|0|||
27568269|NCT00283439|80271262|FG001|Overall Study|Adverse Event|0|||
27568270|NCT00283439|80271263|FG002|Overall Study|Adverse Event|0|||
27568271|NCT00283439|80271264|FG003|Overall Study|Adverse Event|1|||
27568272|NCT00283439|80271261|FG000|Overall Study|Death|0|||
27568273|NCT00283439|80271262|FG001|Overall Study|Death|0|||
27568274|NCT00283439|80271263|FG002|Overall Study|Death|1|||
27568275|NCT00283439|80271264|FG003|Overall Study|Death|0|||
27568276|NCT00283439|80271261|FG000|Overall Study|Disease progression|0|||
27568277|NCT00283439|80271262|FG001|Overall Study|Disease progression|1|||
27568278|NCT00283439|80271263|FG002|Overall Study|Disease progression|0|||
27568279|NCT00283439|80271264|FG003|Overall Study|Disease progression|0|||
27568280|NCT00283439|80271261|FG000|Overall Study|Requirement for alternative therapy|1|||
27568281|NCT00283439|80271262|FG001|Overall Study|Requirement for alternative therapy|2|||
27568282|NCT00283439|80271263|FG002|Overall Study|Requirement for alternative therapy|5|||
27568283|NCT00283439|80271264|FG003|Overall Study|Requirement for alternative therapy|2|||
27568284|NCT00283439|80271261|FG000|Overall Study|Stem cell transplant|6|||
27568285|NCT00283439|80271262|FG001|Overall Study|Stem cell transplant|6|||
27568286|NCT00283439|80271263|FG002|Overall Study|Stem cell transplant|4|||
27568287|NCT00283439|80271264|FG003|Overall Study|Stem cell transplant|3|||
27568288|NCT00283439|80271261|FG000|Overall Study|Treatment discontinued|0|||
27568289|NCT00283439|80271262|FG001|Overall Study|Treatment discontinued|2|||
27568290|NCT00283439|80271263|FG002|Overall Study|Treatment discontinued|1|||
27568291|NCT00283439|80271264|FG003|Overall Study|Treatment discontinued|3|||
27568292|NCT00283439|80271261|FG000|Overall Study|Other|1|||
27568293|NCT00283439|80271262|FG001|Overall Study|Other|0|||
27568294|NCT00283439|80271263|FG002|Overall Study|Other|0|||
27568295|NCT00283439|80271264|FG003|Overall Study|Other|0|||
27658514|NCT04267393|80586766|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
27860635|NCT00371397|81322758|FG001|Session 1|Withdrawal by Subject|0|||
27860636|NCT00371397|81322759|FG002|Session 1|Withdrawal by Subject|0|||
27860637|NCT00371397|81322760|FG003|Session 1|Withdrawal by Subject|0|||
27860638|NCT00371397|81322761|FG004|Session 1|Withdrawal by Subject|0|||
27860639|NCT00371397|81322762|FG005|Session 1|Withdrawal by Subject|0|||
27568296|NCT02346136|80271268|FG000|Overall Study|Withdrawal by Subject|7|||
27568297|NCT02346136|80271269|FG001|Overall Study|Withdrawal by Subject|5|||
27658515|NCT00376259|80586769|FG000|Overall Study|Sponsor request - study termination|21|||
27658516|NCT00376259|80586770|FG001|Overall Study|Sponsor request - study termination|21|||
27658517|NCT00376259|80586769|FG000|Overall Study|Patient request|1|||
27658518|NCT00376259|80586770|FG001|Overall Study|Patient request|0|||
27658519|NCT01876823|80586771|FG000|Overall Study|Withdrawal by Subject|5|||
27658520|NCT01876823|80586771|FG000|Overall Study|Physician Decision|2|||
27658521|NCT01876823|80586771|FG000|Overall Study|Patients moved|2|||
27658522|NCT00841321|80586772|FG000|Overall Study|Lost to Follow-up|1|||
27658523|NCT00841321|80586773|FG001|Overall Study|Lost to Follow-up|1|||
27658524|NCT00841321|80586772|FG000|Overall Study|Adverse Event|0|||
27658525|NCT00841321|80586773|FG001|Overall Study|Adverse Event|2|||
27658526|NCT00607789|80586774|FG000|Overall Study|Adverse Event|3|||
27658527|NCT00607789|80586775|FG001|Overall Study|Adverse Event|0|||
27860640|NCT00371397|81322763|FG006|Session 1|Withdrawal by Subject|0|||
27860641|NCT00371397|81322764|FG007|Session 1|Withdrawal by Subject|1|||
27761831|NCT00830960|80954075|FG000|Overall Study|Lost to Follow-up|1|||
27761832|NCT00830960|80954076|FG001|Overall Study|Lost to Follow-up|1|||
27761833|NCT00830960|80954077|FG002|Overall Study|Lost to Follow-up|1|||
27761834|NCT00830960|80954078|FG003|Overall Study|Lost to Follow-up|0|||
27761835|NCT00830960|80954079|FG004|Overall Study|Lost to Follow-up|0|||
27761836|NCT00830960|80954080|FG005|Overall Study|Lost to Follow-up|1|||
27761837|NCT00830960|80954075|FG000|Overall Study|Withdrawal by Subject|19|||
27761838|NCT00830960|80954076|FG001|Overall Study|Withdrawal by Subject|19|||
27761839|NCT00830960|80954077|FG002|Overall Study|Withdrawal by Subject|18|||
27761840|NCT00830960|80954078|FG003|Overall Study|Withdrawal by Subject|23|||
27761841|NCT00830960|80954079|FG004|Overall Study|Withdrawal by Subject|16|||
27761842|NCT00830960|80954080|FG005|Overall Study|Withdrawal by Subject|21|||
27761843|NCT00830960|80954075|FG000|Overall Study|Sponsor Decision|1|||
27761844|NCT00830960|80954076|FG001|Overall Study|Sponsor Decision|2|||
27761845|NCT00830960|80954077|FG002|Overall Study|Sponsor Decision|3|||
27761846|NCT00830960|80954078|FG003|Overall Study|Sponsor Decision|4|||
27761847|NCT00830960|80954079|FG004|Overall Study|Sponsor Decision|5|||
27761848|NCT00830960|80954080|FG005|Overall Study|Sponsor Decision|7|||
27761849|NCT00830960|80954075|FG000|Overall Study|No study drug received|7|||
27761850|NCT00830960|80954076|FG001|Overall Study|No study drug received|2|||
27761851|NCT00830960|80954077|FG002|Overall Study|No study drug received|4|||
27761852|NCT00830960|80954078|FG003|Overall Study|No study drug received|3|||
27761853|NCT00830960|80954079|FG004|Overall Study|No study drug received|5|||
27761854|NCT00830960|80954080|FG005|Overall Study|No study drug received|7|||
27761855|NCT04111107|80954084|FG000|Overall Study|Withdrawal by Subject|6|||
27761856|NCT04111107|80954084|FG000|Overall Study|Declining Health|5|||
27761857|NCT01626989|80954085|FG000|Screening Period|Screen Failure|15|||
27761858|NCT01626989|80954086|FG001|Screening Period|Screen Failure|0|||
27761859|NCT01626989|80954087|FG002|Screening Period|Screen Failure|0|||
27761860|NCT01626989|80954085|FG000|Screening Period|Withdrawal by Subject|2|||
27761861|NCT01626989|80954086|FG001|Screening Period|Withdrawal by Subject|0|||
27761862|NCT01626989|80954087|FG002|Screening Period|Withdrawal by Subject|0|||
27761863|NCT02475850|80954088|FG000|Overall Study|Death|155|||
27761864|NCT02475850|80954089|FG001|Overall Study|Death|141|||
27761865|NCT02475850|80954088|FG000|Overall Study|Lost to Follow-up|217|||
27761866|NCT02475850|80954089|FG001|Overall Study|Lost to Follow-up|188|||
27761867|NCT02475850|80954088|FG000|Overall Study|Withdrawal by Subject|221|||
27761868|NCT02475850|80954089|FG001|Overall Study|Withdrawal by Subject|155|||
27761869|NCT00871377|80954090|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27761870|NCT00871377|80954091|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27761871|NCT00871377|80954092|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
27761872|NCT00871377|80954093|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27761873|NCT00871377|80954094|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27761874|NCT00871377|80954095|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27761875|NCT00871377|80954090|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27761876|NCT00871377|80954091|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27761877|NCT00871377|80954092|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27761878|NCT00871377|80954093|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27761879|NCT00871377|80954094|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
27761880|NCT00871377|80954095|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
27761881|NCT00871377|80954090|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
27761882|NCT00871377|80954091|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761883|NCT00871377|80954092|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761884|NCT00871377|80954093|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761885|NCT00871377|80954094|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761886|NCT00871377|80954095|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761887|NCT00871377|80954090|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761888|NCT00871377|80954091|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761889|NCT00871377|80954092|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
27761890|NCT00871377|80954093|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
27658528|NCT00607789|80586774|FG000|Overall Study|Lack of Efficacy|0|||
27860642|NCT00371397|81322765|FG008|Session 1|Withdrawal by Subject|0|||
27860643|NCT00371397|81322766|FG009|Session 1|Withdrawal by Subject|0|||
27860644|NCT00371397|81322767|FG010|Session 1|Withdrawal by Subject|0|||
27658529|NCT00607789|80586775|FG001|Overall Study|Lack of Efficacy|1|||
27658530|NCT00607789|80586774|FG000|Overall Study|Inadequate adherence|3|||
27658531|NCT00607789|80586775|FG001|Overall Study|Inadequate adherence|0|||
27658532|NCT00607789|80586774|FG000|Overall Study|Lost to Follow-up|0|||
27658533|NCT00607789|80586775|FG001|Overall Study|Lost to Follow-up|5|||
27658534|NCT00607789|80586774|FG000|Overall Study|Withdrawal by Subject|1|||
27658535|NCT00607789|80586775|FG001|Overall Study|Withdrawal by Subject|0|||
27658536|NCT02542293|80586776|FG000|Overall Study|Death|367|||
27658537|NCT02542293|80586777|FG001|Overall Study|Death|377|||
27658538|NCT02542293|80586776|FG000|Overall Study|Withdrawal by Subject|8|||
27658539|NCT02542293|80586777|FG001|Overall Study|Withdrawal by Subject|19|||
27658540|NCT02854436|80586778|FG000|Overall Study|Adverse Event|1|||
27658541|NCT02854436|80586778|FG000|Overall Study|Death|208|||
27658542|NCT02854436|80586778|FG000|Overall Study|Lost to Follow-up|5|||
27761891|NCT00871377|80954094|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
27860645|NCT00371397|81322768|FG011|Session 1|Withdrawal by Subject|0|||
27860646|NCT01340768|81322771|FG000|Overall Study|Lost to Follow-up|10|||
27860647|NCT01340768|81322772|FG001|Overall Study|Lost to Follow-up|4|||
27860648|NCT01340768|81322771|FG000|Overall Study|Withdrawal by Subject|5|||
27860649|NCT01340768|81322772|FG001|Overall Study|Withdrawal by Subject|1|||
27568298|NCT02346136|80271268|FG000|Overall Study|Death|1|||
27568299|NCT02346136|80271269|FG001|Overall Study|Death|0|||
27568300|NCT02346136|80271268|FG000|Overall Study|Study termination|14|||
27568301|NCT02346136|80271269|FG001|Overall Study|Study termination|18|||
27568302|NCT00129129|80271270|FG000|Primary Phase|Adverse Event|2|||
27568303|NCT00129129|80271271|FG001|Primary Phase|Adverse Event|1|||
27568304|NCT00129129|80271272|FG002|Primary Phase|Adverse Event|0|||
27568305|NCT00129129|80271273|FG003|Primary Phase|Adverse Event|0|||
27568306|NCT00129129|80271274|FG004|Primary Phase|Adverse Event|0|||
27568307|NCT00129129|80271270|FG000|Primary Phase|Withdrawal by Subject|12|||
27568308|NCT00129129|80271271|FG001|Primary Phase|Withdrawal by Subject|10|||
27568309|NCT00129129|80271272|FG002|Primary Phase|Withdrawal by Subject|0|||
27568310|NCT00129129|80271273|FG003|Primary Phase|Withdrawal by Subject|0|||
27568311|NCT00129129|80271274|FG004|Primary Phase|Withdrawal by Subject|0|||
27568312|NCT00129129|80271270|FG000|Primary Phase|Migration from study area|1|||
27568313|NCT00129129|80271271|FG001|Primary Phase|Migration from study area|3|||
27568314|NCT00129129|80271272|FG002|Primary Phase|Migration from study area|0|||
27568315|NCT00129129|80271273|FG003|Primary Phase|Migration from study area|0|||
27568316|NCT00129129|80271274|FG004|Primary Phase|Migration from study area|0|||
27568317|NCT00129129|80271270|FG000|Primary Phase|Lost to Follow-up|8|||
27568318|NCT00129129|80271271|FG001|Primary Phase|Lost to Follow-up|6|||
27568319|NCT00129129|80271272|FG002|Primary Phase|Lost to Follow-up|0|||
27568320|NCT00129129|80271273|FG003|Primary Phase|Lost to Follow-up|0|||
27568321|NCT00129129|80271274|FG004|Primary Phase|Lost to Follow-up|0|||
27568322|NCT00129129|80271270|FG000|Primary Phase|Other|2|||
27568323|NCT00129129|80271271|FG001|Primary Phase|Other|5|||
27568324|NCT00129129|80271272|FG002|Primary Phase|Other|0|||
27568325|NCT00129129|80271273|FG003|Primary Phase|Other|0|||
27568326|NCT00129129|80271274|FG004|Primary Phase|Other|0|||
27568327|NCT00129129|80271270|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
27568328|NCT00129129|80271271|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
27568329|NCT00129129|80271272|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
27568330|NCT00129129|80271273|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
27568331|NCT00129129|80271274|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
27568332|NCT00129129|80271270|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
27568333|NCT00129129|80271271|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
27568334|NCT00129129|80271272|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
27568335|NCT00129129|80271273|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
27568336|NCT00129129|80271274|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
27568337|NCT00129129|80271270|FG000|Fourth Dose Phase|Migration from study area|0|||
27658543|NCT02854436|80586778|FG000|Overall Study|Withdrawal by Subject|24|||
27658544|NCT02854436|80586778|FG000|Overall Study|Other|45|||
27860650|NCT01340768|81322771|FG000|Overall Study|Other|2|||
27658545|NCT02854436|80586778|FG000|Overall Study|Physician Decision|6|||
27658546|NCT00203502|80586779|FG000|Overall Study|Death|1|||
27658547|NCT03614923|80586789|FG000|Overall Study|Withdrawal by Subject|2|||
27658548|NCT03614923|80586790|FG001|Overall Study|Withdrawal by Subject|1|||
27658549|NCT03614923|80586791|FG002|Overall Study|Withdrawal by Subject|1|||
27658550|NCT03614923|80586789|FG000|Overall Study|Adverse Event|0|||
27658551|NCT03614923|80586790|FG001|Overall Study|Adverse Event|2|||
27658552|NCT03614923|80586791|FG002|Overall Study|Adverse Event|1|||
27658553|NCT03614923|80586789|FG000|Overall Study|Lost to Follow-up|1|||
27658554|NCT03614923|80586790|FG001|Overall Study|Lost to Follow-up|0|||
27658555|NCT03614923|80586791|FG002|Overall Study|Lost to Follow-up|1|||
27658556|NCT03614923|80586789|FG000|Overall Study|Lack of Efficacy|2|||
27658557|NCT03614923|80586790|FG001|Overall Study|Lack of Efficacy|0|||
27658558|NCT03614923|80586791|FG002|Overall Study|Lack of Efficacy|1|||
27658559|NCT03614923|80586789|FG000|Overall Study|Non-compliance|0|||
27658560|NCT03614923|80586790|FG001|Overall Study|Non-compliance|1|||
27658561|NCT03614923|80586791|FG002|Overall Study|Non-compliance|0|||
27658562|NCT03614923|80586789|FG000|Overall Study|Other|0|||
27658563|NCT03614923|80586790|FG001|Overall Study|Other|1|||
27658564|NCT03614923|80586791|FG002|Overall Study|Other|1|||
27658565|NCT01090076|80586792|FG000|Overall Study|Death|1|||
27658566|NCT01090076|80586793|FG001|Overall Study|Death|1|||
27658567|NCT01090076|80586792|FG000|Overall Study|Withdrawal by Subject|0|||
27658568|NCT01090076|80586793|FG001|Overall Study|Withdrawal by Subject|1|||
27658569|NCT03575572|80586794|FG000|Overall Study|Withdrawal by Subject|2|||
27658570|NCT03575572|80586794|FG000|Overall Study|Physician Decision|2|||
27658571|NCT00170950|80586795|FG000|Overall Study|Death|236|||
27658572|NCT00170950|80586796|FG001|Overall Study|Death|274|||
27658573|NCT00170950|80586795|FG000|Overall Study|Withdrawal by Subject|496|||
27658574|NCT00170950|80586796|FG001|Overall Study|Withdrawal by Subject|498|||
27658575|NCT00170950|80586795|FG000|Overall Study|Lost to Follow-up|134|||
27658576|NCT00170950|80586796|FG001|Overall Study|Lost to Follow-up|115|||
27658577|NCT00170950|80586795|FG000|Overall Study|Missing|2|||
27658578|NCT00170950|80586796|FG001|Overall Study|Missing|1|||
27658579|NCT00170950|80586795|FG000|Overall Study|Termination Data Not Recorded|17|||
27658580|NCT00170950|80586796|FG001|Overall Study|Termination Data Not Recorded|22|||
27658581|NCT02014402|80586799|FG000|Overall Study|Adverse Event|1|||
27658582|NCT02014402|80586800|FG001|Overall Study|Adverse Event|0|||
27658583|NCT02014402|80586801|FG002|Overall Study|Adverse Event|0|||
27658584|NCT02014402|80586802|FG003|Overall Study|Adverse Event|0|||
27658585|NCT02014402|80586799|FG000|Overall Study|Withdrawal by Subject|1|||
27658586|NCT02014402|80586800|FG001|Overall Study|Withdrawal by Subject|2|||
27658587|NCT02014402|80586801|FG002|Overall Study|Withdrawal by Subject|2|||
27658588|NCT02014402|80586802|FG003|Overall Study|Withdrawal by Subject|1|||
27658589|NCT02014402|80586799|FG000|Overall Study|Subject did not have transportation|0|||
27658590|NCT02014402|80586800|FG001|Overall Study|Subject did not have transportation|1|||
27658591|NCT02014402|80586801|FG002|Overall Study|Subject did not have transportation|0|||
27658592|NCT02014402|80586802|FG003|Overall Study|Subject did not have transportation|0|||
27658593|NCT02014402|80586799|FG000|Overall Study|Lost to Follow-up|0|||
27658594|NCT02014402|80586800|FG001|Overall Study|Lost to Follow-up|0|||
27658595|NCT02014402|80586801|FG002|Overall Study|Lost to Follow-up|1|||
27658596|NCT02014402|80586802|FG003|Overall Study|Lost to Follow-up|2|||
27658597|NCT03960437|80586803|FG000|Overall Study|Removed by PI|4|||
27658598|NCT03960437|80586803|FG000|Overall Study|Lost to Follow-up|2|||
27658599|NCT03960437|80586803|FG000|Overall Study|Withdrawal by Subject|1|||
27658600|NCT03960437|80586803|FG000|Overall Study|Death|2|||
27658601|NCT04736602|80586804|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
27658602|NCT04736602|80586804|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
27658603|NCT02152995|80586805|FG000|Overall Study|Withdrawal by Subject|1|||
27658604|NCT02152995|80586806|FG001|Overall Study|Withdrawal by Subject|0|||
27658605|NCT02267746|80586807|FG000|Overall Study|Adverse Event|0|||
27658606|NCT02267746|80586808|FG001|Overall Study|Adverse Event|2|||
27658607|NCT02267746|80586809|FG002|Overall Study|Adverse Event|1|||
27658608|NCT02267746|80586807|FG000|Overall Study|Protocol Violation|8|||
27658609|NCT02267746|80586808|FG001|Overall Study|Protocol Violation|7|||
27658610|NCT02267746|80586809|FG002|Overall Study|Protocol Violation|3|||
27658611|NCT02267746|80586807|FG000|Overall Study|Lack of Efficacy|11|||
27658612|NCT02267746|80586808|FG001|Overall Study|Lack of Efficacy|11|||
27658613|NCT02267746|80586809|FG002|Overall Study|Lack of Efficacy|15|||
27658614|NCT02267746|80586807|FG000|Overall Study|Protocol Violation|1|||
27658615|NCT02267746|80586808|FG001|Overall Study|Protocol Violation|2|||
27761892|NCT00871377|80954095|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
27761893|NCT00871377|80954090|FG000|Third Intervention (10 Weeks)|Death|0|||
27658616|NCT02267746|80586809|FG002|Overall Study|Protocol Violation|1|||
27658617|NCT02267746|80586807|FG000|Overall Study|Miscellaneous|1|||
27658618|NCT02267746|80586808|FG001|Overall Study|Miscellaneous|0|||
27658619|NCT02267746|80586809|FG002|Overall Study|Miscellaneous|1|||
27658620|NCT01877720|80586812|FG000|Overall Study|Adverse Event|1|||
27658621|NCT01877720|80586813|FG001|Overall Study|Adverse Event|0|||
27658622|NCT00139659|80586814|FG000|Overall Study|Adverse Event|12|||
27658623|NCT00139659|80586815|FG001|Overall Study|Adverse Event|1|||
27658624|NCT00139659|80586814|FG000|Overall Study|Lack of Efficacy|1|||
27658625|NCT00139659|80586815|FG001|Overall Study|Lack of Efficacy|1|||
27658626|NCT00139659|80586814|FG000|Overall Study|Lost to Follow-up|7|||
27658627|NCT00139659|80586815|FG001|Overall Study|Lost to Follow-up|3|||
27658628|NCT00139659|80586814|FG000|Overall Study|Reason not Specified|6|||
27658629|NCT00139659|80586815|FG001|Overall Study|Reason not Specified|3|||
27658630|NCT00139659|80586814|FG000|Overall Study|Withdrawal by Subject|14|||
27658631|NCT00139659|80586815|FG001|Overall Study|Withdrawal by Subject|10|||
27658632|NCT03761849|80586816|FG000|Overall Study|transferred to OpenLabelExtension|35|||
27658633|NCT03761849|80586817|FG001|Overall Study|transferred to OpenLabelExtension|34|||
27658634|NCT03761849|80586818|FG002|Overall Study|transferred to OpenLabelExtension|36|||
27658635|NCT03761849|80586819|FG003|Overall Study|transferred to OpenLabelExtension|0|||
27658636|NCT03761849|80586820|FG004|Overall Study|transferred to OpenLabelExtension|0|||
27658637|NCT03761849|80586821|FG005|Overall Study|transferred to OpenLabelExtension|0|||
27658638|NCT03761849|80586816|FG000|Overall Study|Adverse Event|1|||
27658639|NCT03761849|80586817|FG001|Overall Study|Adverse Event|0|||
27658640|NCT03761849|80586818|FG002|Overall Study|Adverse Event|0|||
27658641|NCT03761849|80586819|FG003|Overall Study|Adverse Event|0|||
27658642|NCT03761849|80586820|FG004|Overall Study|Adverse Event|2|||
27658643|NCT03761849|80586821|FG005|Overall Study|Adverse Event|3|||
27658644|NCT03761849|80586816|FG000|Overall Study|Withdrawal by Subject|0|||
27658645|NCT03761849|80586817|FG001|Overall Study|Withdrawal by Subject|0|||
27658646|NCT03761849|80586818|FG002|Overall Study|Withdrawal by Subject|0|||
27658647|NCT03761849|80586819|FG003|Overall Study|Withdrawal by Subject|41|||
27658648|NCT03761849|80586820|FG004|Overall Study|Withdrawal by Subject|43|||
27658649|NCT03761849|80586821|FG005|Overall Study|Withdrawal by Subject|35|||
27658650|NCT03761849|80586816|FG000|Overall Study|Lost to Follow-up|0|||
27658651|NCT03761849|80586817|FG001|Overall Study|Lost to Follow-up|1|||
27658652|NCT03761849|80586818|FG002|Overall Study|Lost to Follow-up|0|||
27658653|NCT03761849|80586819|FG003|Overall Study|Lost to Follow-up|2|||
27658654|NCT03761849|80586820|FG004|Overall Study|Lost to Follow-up|4|||
27658655|NCT03761849|80586821|FG005|Overall Study|Lost to Follow-up|5|||
27658656|NCT03761849|80586816|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
27658657|NCT03761849|80586817|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
27658658|NCT03761849|80586818|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
27658659|NCT03761849|80586819|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
27658660|NCT03761849|80586820|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
27658661|NCT03761849|80586821|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
27658662|NCT03761849|80586816|FG000|Overall Study|Physician Decision|0|||
27658663|NCT03761849|80586817|FG001|Overall Study|Physician Decision|0|||
27658664|NCT03761849|80586818|FG002|Overall Study|Physician Decision|0|||
27658665|NCT03761849|80586819|FG003|Overall Study|Physician Decision|1|||
27658666|NCT03761849|80586820|FG004|Overall Study|Physician Decision|4|||
27658667|NCT03761849|80586821|FG005|Overall Study|Physician Decision|4|||
27658668|NCT03761849|80586816|FG000|Overall Study|Death|0|||
27658669|NCT03761849|80586817|FG001|Overall Study|Death|0|||
27658670|NCT03761849|80586818|FG002|Overall Study|Death|0|||
27658671|NCT03761849|80586819|FG003|Overall Study|Death|1|||
27658672|NCT03761849|80586820|FG004|Overall Study|Death|1|||
27658673|NCT03761849|80586821|FG005|Overall Study|Death|3|||
27658674|NCT03761849|80586816|FG000|Overall Study|Protocol Violation|0|||
27658675|NCT03761849|80586817|FG001|Overall Study|Protocol Violation|0|||
27658676|NCT03761849|80586818|FG002|Overall Study|Protocol Violation|0|||
27658677|NCT03761849|80586819|FG003|Overall Study|Protocol Violation|2|||
27658678|NCT03761849|80586820|FG004|Overall Study|Protocol Violation|2|||
27658679|NCT03761849|80586821|FG005|Overall Study|Protocol Violation|1|||
27658680|NCT03761849|80586816|FG000|Overall Study|Participant could not come to site|0|||
27658681|NCT03761849|80586817|FG001|Overall Study|Participant could not come to site|0|||
27658682|NCT03761849|80586818|FG002|Overall Study|Participant could not come to site|0|||
27658683|NCT03761849|80586819|FG003|Overall Study|Participant could not come to site|0|||
27658684|NCT03761849|80586820|FG004|Overall Study|Participant could not come to site|1|||
27761894|NCT00871377|80954091|FG001|Third Intervention (10 Weeks)|Death|0|||
27761895|NCT00871377|80954092|FG002|Third Intervention (10 Weeks)|Death|0|||
27761896|NCT00871377|80954093|FG003|Third Intervention (10 Weeks)|Death|1|||
27860651|NCT01340768|81322772|FG001|Overall Study|Other|0|||
27658685|NCT03761849|80586821|FG005|Overall Study|Participant could not come to site|0|||
27658686|NCT03761849|80586816|FG000|Overall Study|SF- safety Finding|0|||
27658687|NCT03761849|80586817|FG001|Overall Study|SF- safety Finding|0|||
27658688|NCT03761849|80586818|FG002|Overall Study|SF- safety Finding|0|||
27658689|NCT03761849|80586819|FG003|Overall Study|SF- safety Finding|0|||
27658690|NCT03761849|80586820|FG004|Overall Study|SF- safety Finding|0|||
27658691|NCT03761849|80586821|FG005|Overall Study|SF- safety Finding|1|||
27658692|NCT03761849|80586816|FG000|Overall Study|Patient did not attend visit|0|||
27658693|NCT03761849|80586817|FG001|Overall Study|Patient did not attend visit|0|||
27658694|NCT03761849|80586818|FG002|Overall Study|Patient did not attend visit|0|||
27658695|NCT03761849|80586819|FG003|Overall Study|Patient did not attend visit|0|||
27658696|NCT03761849|80586820|FG004|Overall Study|Patient did not attend visit|0|||
27658697|NCT03761849|80586821|FG005|Overall Study|Patient did not attend visit|1|||
27658698|NCT00070707|80586825|FG000|Overall Study|Adverse Event|1|||
27658699|NCT00070707|80586826|FG001|Overall Study|Adverse Event|2|||
27658700|NCT00070707|80586825|FG000|Overall Study|Lack of Efficacy|4|||
27658701|NCT00070707|80586826|FG001|Overall Study|Lack of Efficacy|1|||
27658702|NCT00070707|80586825|FG000|Overall Study|Protocol Violation|8|||
27658703|NCT00070707|80586826|FG001|Overall Study|Protocol Violation|4|||
27658704|NCT00070707|80586825|FG000|Overall Study|Unrelated to Study Medication|1|||
27658705|NCT00070707|80586826|FG001|Overall Study|Unrelated to Study Medication|0|||
27658706|NCT01770509|80586829|FG000|Overall Study|Injury|0|||
27658707|NCT01770509|80586830|FG001|Overall Study|Injury|1|||
27658708|NCT01770509|80586829|FG000|Overall Study|Lost to Follow-up|1|||
27658709|NCT01770509|80586830|FG001|Overall Study|Lost to Follow-up|2|||
27658710|NCT00464737|80586831|FG000|Overall Study|Adverse Event|12|||
27658711|NCT00464737|80586832|FG001|Overall Study|Adverse Event|17|||
27658712|NCT00464737|80586833|FG002|Overall Study|Adverse Event|33|||
27658713|NCT00464737|80586831|FG000|Overall Study|Lack of Efficacy|7|||
27658714|NCT00464737|80586832|FG001|Overall Study|Lack of Efficacy|7|||
27658715|NCT00464737|80586833|FG002|Overall Study|Lack of Efficacy|4|||
27658716|NCT00464737|80586831|FG000|Overall Study|Withdrawal by Subject|5|||
27658717|NCT00464737|80586832|FG001|Overall Study|Withdrawal by Subject|3|||
27658718|NCT00464737|80586833|FG002|Overall Study|Withdrawal by Subject|5|||
27658719|NCT00464737|80586831|FG000|Overall Study|Protocol Violation|1|||
27658720|NCT00464737|80586832|FG001|Overall Study|Protocol Violation|1|||
27658721|NCT00464737|80586833|FG002|Overall Study|Protocol Violation|5|||
27658722|NCT00464737|80586831|FG000|Overall Study|Non-compliance|0|||
27658723|NCT00464737|80586832|FG001|Overall Study|Non-compliance|1|||
27658724|NCT00464737|80586833|FG002|Overall Study|Non-compliance|1|||
27658725|NCT00464737|80586831|FG000|Overall Study|Lost to Follow-up|5|||
27658726|NCT00464737|80586832|FG001|Overall Study|Lost to Follow-up|2|||
27658727|NCT00464737|80586833|FG002|Overall Study|Lost to Follow-up|5|||
27658728|NCT00464737|80586831|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
27658729|NCT00464737|80586832|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
27658730|NCT00464737|80586833|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
27658731|NCT00464737|80586831|FG000|Overall Study|Other: Subject left town; family illness|1|||
27658732|NCT00464737|80586832|FG001|Overall Study|Other: Subject left town; family illness|0|||
27658733|NCT00464737|80586833|FG002|Overall Study|Other: Subject left town; family illness|0|||
27658734|NCT00464737|80586831|FG000|Overall Study|Other: Study demands too great|0|||
27658735|NCT00464737|80586832|FG001|Overall Study|Other: Study demands too great|1|||
27658736|NCT00464737|80586833|FG002|Overall Study|Other: Study demands too great|0|||
27658737|NCT00464737|80586831|FG000|Overall Study|Other: Personal family reasons|0|||
27658738|NCT00464737|80586832|FG001|Overall Study|Other: Personal family reasons|0|||
27658739|NCT00464737|80586833|FG002|Overall Study|Other: Personal family reasons|1|||
27658740|NCT00464737|80586831|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
27658741|NCT00464737|80586832|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
27658742|NCT00464737|80586833|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
27658743|NCT03640754|80586840|FG000|Overall Study|Withdrawal by Subject|1|||
27658744|NCT03640754|80586841|FG001|Overall Study|Withdrawal by Subject|0|||
27658745|NCT03640754|80586840|FG000|Overall Study|Lost to Follow-up|0|||
27658746|NCT03640754|80586841|FG001|Overall Study|Lost to Follow-up|1|||
27658747|NCT01945593|80586844|FG000|Overall Study|Adverse Event|0|||
27658748|NCT01945593|80586845|FG001|Overall Study|Adverse Event|0|||
27658749|NCT01945593|80586846|FG002|Overall Study|Adverse Event|0|||
27658750|NCT01945593|80586847|FG003|Overall Study|Adverse Event|5|||
27658751|NCT01945593|80586844|FG000|Overall Study|Physician Decision|0|||
27658752|NCT01945593|80586845|FG001|Overall Study|Physician Decision|0|||
27658753|NCT01945593|80586846|FG002|Overall Study|Physician Decision|1|||
27658754|NCT01945593|80586847|FG003|Overall Study|Physician Decision|1|||
27658755|NCT01945593|80586844|FG000|Overall Study|Withdrawal by Subject|0|||
27658756|NCT01945593|80586845|FG001|Overall Study|Withdrawal by Subject|2|||
27658757|NCT01945593|80586846|FG002|Overall Study|Withdrawal by Subject|0|||
27658758|NCT01945593|80586847|FG003|Overall Study|Withdrawal by Subject|4|||
27658759|NCT01945593|80586844|FG000|Overall Study|Protocol Violation|0|||
27658760|NCT01945593|80586845|FG001|Overall Study|Protocol Violation|2|||
27658761|NCT01945593|80586846|FG002|Overall Study|Protocol Violation|1|||
27658762|NCT01945593|80586847|FG003|Overall Study|Protocol Violation|3|||
27658763|NCT01945593|80586844|FG000|Overall Study|Death|0|||
27658764|NCT01945593|80586845|FG001|Overall Study|Death|0|||
27658765|NCT01945593|80586846|FG002|Overall Study|Death|1|||
27658766|NCT01945593|80586847|FG003|Overall Study|Death|0|||
27658767|NCT01945593|80586844|FG000|Overall Study|Other: Terminated|0|||
27658768|NCT01945593|80586845|FG001|Overall Study|Other: Terminated|0|||
27658769|NCT01945593|80586846|FG002|Overall Study|Other: Terminated|0|||
27658770|NCT01945593|80586847|FG003|Overall Study|Other: Terminated|1|||
27658771|NCT01945593|80586844|FG000|Overall Study|Other: Surgical Procedure|0|||
27658772|NCT01945593|80586845|FG001|Overall Study|Other: Surgical Procedure|2|||
27658773|NCT01945593|80586846|FG002|Overall Study|Other: Surgical Procedure|0|||
27658774|NCT01945593|80586847|FG003|Overall Study|Other: Surgical Procedure|6|||
27658775|NCT01945593|80586844|FG000|Overall Study|Other: Screen Failure|0|||
27658776|NCT01945593|80586845|FG001|Overall Study|Other: Screen Failure|2|||
27658777|NCT01945593|80586846|FG002|Overall Study|Other: Screen Failure|0|||
27568338|NCT00129129|80271271|FG001|Fourth Dose Phase|Migration from study area|0|||
27568339|NCT00129129|80271272|FG002|Fourth Dose Phase|Migration from study area|0|||
27658778|NCT01945593|80586847|FG003|Overall Study|Other: Screen Failure|0|||
27658779|NCT00676663|80586848|FG000|Overall Study|Death|43|||
27658780|NCT00676663|80586849|FG001|Overall Study|Death|27|||
27658781|NCT00676663|80586848|FG000|Overall Study|Withdrew Consent|1|||
27658782|NCT00676663|80586849|FG001|Overall Study|Withdrew Consent|8|||
27658783|NCT00676663|80586848|FG000|Overall Study|Lost to Follow-up|1|||
27658784|NCT00676663|80586849|FG001|Overall Study|Lost to Follow-up|3|||
27658785|NCT02305797|80586850|FG000|Overall Study|Adverse Event|11|||
27658786|NCT02305797|80586851|FG001|Overall Study|Adverse Event|2|||
27658787|NCT02305797|80586850|FG000|Overall Study|Withdrawal by Subject|9|||
27658788|NCT02305797|80586851|FG001|Overall Study|Withdrawal by Subject|10|||
27658789|NCT02305797|80586850|FG000|Overall Study|Lack of Efficacy|6|||
27658790|NCT02305797|80586851|FG001|Overall Study|Lack of Efficacy|0|||
27658791|NCT02305797|80586850|FG000|Overall Study|Lost to Follow-up|5|||
27658792|NCT02305797|80586851|FG001|Overall Study|Lost to Follow-up|11|||
27658793|NCT02305797|80586850|FG000|Overall Study|Pregnancy|0|||
27658794|NCT02305797|80586851|FG001|Overall Study|Pregnancy|2|||
27658795|NCT02305797|80586850|FG000|Overall Study|Noncompliance|14|||
27658796|NCT02305797|80586851|FG001|Overall Study|Noncompliance|12|||
27658797|NCT02305797|80586850|FG000|Overall Study|Reason not collected|0|||
27658798|NCT02305797|80586851|FG001|Overall Study|Reason not collected|1|||
27658799|NCT02359552|80586852|FG000|Overall Study|Lost to Follow-up|3|||
27658800|NCT02359552|80586853|FG001|Overall Study|Lost to Follow-up|4|||
27658801|NCT00443755|80586854|FG000|Overall Study|Withdrawal by Subject|2|||
27658802|NCT00443755|80586855|FG001|Overall Study|Withdrawal by Subject|1|||
27658803|NCT01774929|80586858|FG000|Overall Study|Adverse Event|3|||
27658804|NCT01825785|80586867|FG000|Overall Study|Adverse Event|0|||
27658805|NCT01825785|80586868|FG001|Overall Study|Adverse Event|0|||
27658806|NCT01825785|80586869|FG002|Overall Study|Adverse Event|0|||
27658807|NCT01825785|80586870|FG003|Overall Study|Adverse Event|0|||
27658808|NCT01825785|80586871|FG004|Overall Study|Adverse Event|1|||
27658809|NCT01825785|80586872|FG005|Overall Study|Adverse Event|0|||
27658810|NCT01825785|80586873|FG006|Overall Study|Adverse Event|0|||
27568340|NCT00129129|80271273|FG003|Fourth Dose Phase|Migration from study area|0|||
27568341|NCT00129129|80271274|FG004|Fourth Dose Phase|Migration from study area|2|||
27568342|NCT00129129|80271270|FG000|Fourth Dose Phase|Other|0|||
27568343|NCT00129129|80271271|FG001|Fourth Dose Phase|Other|0|||
27568344|NCT00129129|80271272|FG002|Fourth Dose Phase|Other|0|||
27568345|NCT00129129|80271273|FG003|Fourth Dose Phase|Other|1|||
27568346|NCT00129129|80271274|FG004|Fourth Dose Phase|Other|1|||
27568347|NCT00129129|80271270|FG000|Fourth Dose Phase|Protocol Violation|0|||
27568348|NCT00129129|80271271|FG001|Fourth Dose Phase|Protocol Violation|0|||
27568349|NCT00129129|80271272|FG002|Fourth Dose Phase|Protocol Violation|0|||
27568350|NCT00129129|80271273|FG003|Fourth Dose Phase|Protocol Violation|1|||
27568351|NCT00129129|80271274|FG004|Fourth Dose Phase|Protocol Violation|0|||
27568352|NCT02308735|80271275|FG000|Overall Study|Physician Decision|2|||
27568353|NCT02308735|80271276|FG001|Overall Study|Physician Decision|0|||
27568354|NCT02308735|80271277|FG002|Overall Study|Physician Decision|0|||
27568355|NCT02308735|80271278|FG003|Overall Study|Physician Decision|2|||
27568356|NCT00207142|80271279|FG000|Induction Phase|Adverse Event|9|||
27568357|NCT00207142|80271280|FG001|Induction Phase|Adverse Event|0|||
27568358|NCT00207142|80271281|FG002|Induction Phase|Adverse Event|0|||
27568359|NCT00207142|80271282|FG003|Induction Phase|Adverse Event|0|||
27568360|NCT00207142|80271279|FG000|Induction Phase|Death|1|||
27568361|NCT00207142|80271280|FG001|Induction Phase|Death|0|||
27568362|NCT00207142|80271281|FG002|Induction Phase|Death|0|||
27568363|NCT00207142|80271282|FG003|Induction Phase|Death|0|||
27568364|NCT00207142|80271279|FG000|Induction Phase|Lack of Efficacy|1|||
27568365|NCT00207142|80271280|FG001|Induction Phase|Lack of Efficacy|0|||
27568366|NCT00207142|80271281|FG002|Induction Phase|Lack of Efficacy|0|||
27568367|NCT00207142|80271282|FG003|Induction Phase|Lack of Efficacy|0|||
27568368|NCT00207142|80271279|FG000|Induction Phase|Lost to Follow-up|5|||
27568369|NCT00207142|80271280|FG001|Induction Phase|Lost to Follow-up|0|||
27568370|NCT00207142|80271281|FG002|Induction Phase|Lost to Follow-up|0|||
27658811|NCT01825785|80586867|FG000|Overall Study|Withdrawal by Subject|0|||
27658812|NCT01825785|80586868|FG001|Overall Study|Withdrawal by Subject|0|||
27658813|NCT01825785|80586869|FG002|Overall Study|Withdrawal by Subject|0|||
27658814|NCT01825785|80586870|FG003|Overall Study|Withdrawal by Subject|0|||
27658815|NCT01825785|80586871|FG004|Overall Study|Withdrawal by Subject|1|||
27658816|NCT01825785|80586872|FG005|Overall Study|Withdrawal by Subject|1|||
27568371|NCT00207142|80271282|FG003|Induction Phase|Lost to Follow-up|0|||
27658817|NCT01825785|80586873|FG006|Overall Study|Withdrawal by Subject|0|||
27658818|NCT03214198|80586874|FG000|Overall Study|Case Report Forms Uncollected|18|||
27658819|NCT03214198|80586874|FG000|Overall Study|Protocol Deviation|18|||
27658820|NCT01348763|80586875|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
27658821|NCT01348763|80586875|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
27658822|NCT02213458|80586876|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
27658823|NCT02213458|80586877|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
27658824|NCT02213458|80586876|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
27658825|NCT02213458|80586877|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
27658826|NCT02213458|80586876|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
27658827|NCT02213458|80586877|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
27658828|NCT02213458|80586876|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
27658829|NCT02213458|80586877|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
27658830|NCT02213458|80586876|FG000|Overall Study|Refused re-consent|6|||
27658831|NCT02213458|80586877|FG001|Overall Study|Refused re-consent|0|||
27658832|NCT02213458|80586876|FG000|Overall Study|Lost to Follow-up|2|||
27658833|NCT02213458|80586877|FG001|Overall Study|Lost to Follow-up|2|||
27658834|NCT02213458|80586876|FG000|Overall Study|Withdrawal by Subject|26|||
27658835|NCT02213458|80586877|FG001|Overall Study|Withdrawal by Subject|8|||
27658836|NCT02268526|80586878|FG000|Overall Study|Adverse Event|0|||
27658837|NCT02268526|80586879|FG001|Overall Study|Adverse Event|2|||
27658838|NCT02268526|80586880|FG002|Overall Study|Adverse Event|1|||
27658839|NCT02268526|80586878|FG000|Overall Study|Death|1|||
27658840|NCT02268526|80586879|FG001|Overall Study|Death|11|||
27658841|NCT02268526|80586880|FG002|Overall Study|Death|0|||
27658842|NCT02268526|80586878|FG000|Overall Study|protocol deviation|0|||
27658843|NCT02268526|80586879|FG001|Overall Study|protocol deviation|1|||
27658844|NCT02268526|80586880|FG002|Overall Study|protocol deviation|0|||
27658845|NCT02268526|80586878|FG000|Overall Study|Physician Decision|0|||
27658846|NCT02268526|80586879|FG001|Overall Study|Physician Decision|0|||
27658847|NCT02268526|80586880|FG002|Overall Study|Physician Decision|1|||
27658848|NCT02268526|80586878|FG000|Overall Study|Subject/guardian decision|0|||
27658849|NCT02268526|80586879|FG001|Overall Study|Subject/guardian decision|7|||
27658850|NCT02268526|80586880|FG002|Overall Study|Subject/guardian decision|3|||
27658851|NCT02246647|80586881|FG000|Overall Study|Withdrawal by Subject|1|||
27658852|NCT02246647|80586882|FG001|Overall Study|Withdrawal by Subject|1|||
27658853|NCT00050167|80586883|FG000|Overall Study|not eligible not invasive|1|||
27658854|NCT00050167|80586884|FG001|Overall Study|not eligible not invasive|1|||
27658855|NCT00308113|80586885|FG000|Overall Study|Protocol closure|0|||
27658856|NCT00308113|80586886|FG001|Overall Study|Protocol closure|0|||
27658857|NCT00308113|80586887|FG002|Overall Study|Protocol closure|0|||
27658858|NCT00308113|80586888|FG003|Overall Study|Protocol closure|1|||
27658859|NCT03441789|80586889|FG000|Overall Study|Withdrawal by Subject|1|||
27658860|NCT03441789|80586890|FG001|Overall Study|Withdrawal by Subject|1|||
27658861|NCT03441789|80586889|FG000|Overall Study|Adverse Event|0|||
27658862|NCT03441789|80586890|FG001|Overall Study|Adverse Event|1|||
27658863|NCT03441789|80586889|FG000|Overall Study|Protocol Violation|0|||
27658864|NCT03441789|80586890|FG001|Overall Study|Protocol Violation|1|||
27658865|NCT03441789|80586889|FG000|Overall Study|Lost to Follow-up|0|||
27658866|NCT03441789|80586890|FG001|Overall Study|Lost to Follow-up|1|||
27658867|NCT01332318|80586891|FG000|Overall Study|Adverse Event|0|||
27658868|NCT01332318|80586892|FG001|Overall Study|Adverse Event|3|||
27658869|NCT01332318|80586893|FG002|Overall Study|Adverse Event|0|||
27658870|NCT01332318|80586894|FG003|Overall Study|Adverse Event|0|||
27658871|NCT01332318|80586891|FG000|Overall Study|Withdrawal by Subject|1|||
27658872|NCT01332318|80586892|FG001|Overall Study|Withdrawal by Subject|1|||
27658873|NCT01332318|80586893|FG002|Overall Study|Withdrawal by Subject|0|||
27658874|NCT01332318|80586894|FG003|Overall Study|Withdrawal by Subject|1|||
27658875|NCT01332318|80586891|FG000|Overall Study|Protocol Violation|1|||
27658876|NCT01332318|80586892|FG001|Overall Study|Protocol Violation|0|||
27658877|NCT01332318|80586893|FG002|Overall Study|Protocol Violation|1|||
27658878|NCT01332318|80586894|FG003|Overall Study|Protocol Violation|1|||
27761897|NCT00871377|80954094|FG004|Third Intervention (10 Weeks)|Death|0|||
27761898|NCT00871377|80954095|FG005|Third Intervention (10 Weeks)|Death|0|||
27761899|NCT01360762|80954097|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
27761900|NCT01360762|80954097|FG000|Main Study Period (12-month Treatment)|Death|5|||
27761901|NCT01360762|80954097|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
27761902|NCT01360762|80954097|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
27658879|NCT04908488|80586896|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
27658880|NCT04908488|80586897|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
27761903|NCT01360762|80954097|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
27658881|NCT04908488|80586896|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
27658882|NCT04908488|80586897|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
27658883|NCT00108355|80589781|FG000|Overall Study|Peritonitis at index paracentesis|1|||
27658884|NCT00108355|80589782|FG001|Overall Study|Peritonitis at index paracentesis|1|||
27658885|NCT00108355|80589781|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
27658886|NCT00108355|80589782|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
27658887|NCT02066389|80589783|FG000|Overall Study|Adverse Event|1|||
27658888|NCT02066389|80589784|FG001|Overall Study|Adverse Event|1|||
27658889|NCT02066389|80589785|FG002|Overall Study|Adverse Event|1|||
27658890|NCT02066389|80589786|FG003|Overall Study|Adverse Event|1|||
27658891|NCT02066389|80589787|FG004|Overall Study|Adverse Event|5|||
27658892|NCT02066389|80589788|FG005|Overall Study|Adverse Event|1|||
27658893|NCT02066389|80589783|FG000|Overall Study|Withdrawal by Subject|4|||
27658894|NCT02066389|80589784|FG001|Overall Study|Withdrawal by Subject|0|||
27658895|NCT02066389|80589785|FG002|Overall Study|Withdrawal by Subject|5|||
27658896|NCT02066389|80589786|FG003|Overall Study|Withdrawal by Subject|1|||
27658897|NCT02066389|80589787|FG004|Overall Study|Withdrawal by Subject|1|||
27658898|NCT02066389|80589788|FG005|Overall Study|Withdrawal by Subject|2|||
27658899|NCT02066389|80589783|FG000|Overall Study|Lost to Follow-up|0|||
27658900|NCT02066389|80589784|FG001|Overall Study|Lost to Follow-up|0|||
27658901|NCT02066389|80589785|FG002|Overall Study|Lost to Follow-up|0|||
27658902|NCT02066389|80589786|FG003|Overall Study|Lost to Follow-up|1|||
27658903|NCT02066389|80589787|FG004|Overall Study|Lost to Follow-up|1|||
27658904|NCT02066389|80589788|FG005|Overall Study|Lost to Follow-up|1|||
27658905|NCT02066389|80589783|FG000|Overall Study|Randomized in Error|0|||
27658906|NCT02066389|80589784|FG001|Overall Study|Randomized in Error|0|||
27658907|NCT02066389|80589785|FG002|Overall Study|Randomized in Error|0|||
27658908|NCT02066389|80589786|FG003|Overall Study|Randomized in Error|0|||
27658909|NCT02066389|80589787|FG004|Overall Study|Randomized in Error|0|||
27658910|NCT02066389|80589788|FG005|Overall Study|Randomized in Error|1|||
27658911|NCT01808144|80589789|FG000|Overall Study|Death|1|||
27860652|NCT03265288|81322777|FG000|Overall Study|Adverse Event|0|||
27568372|NCT00207142|80271279|FG000|Induction Phase|Physician Decision|2|||
27568373|NCT00207142|80271280|FG001|Induction Phase|Physician Decision|0|||
27568374|NCT00207142|80271281|FG002|Induction Phase|Physician Decision|0|||
27568375|NCT00207142|80271282|FG003|Induction Phase|Physician Decision|0|||
27568376|NCT00207142|80271279|FG000|Induction Phase|Poor/noncompliance|2|||
27568377|NCT00207142|80271280|FG001|Induction Phase|Poor/noncompliance|0|||
27568378|NCT00207142|80271281|FG002|Induction Phase|Poor/noncompliance|0|||
27568379|NCT00207142|80271282|FG003|Induction Phase|Poor/noncompliance|0|||
27568380|NCT00207142|80271279|FG000|Induction Phase|Pregnancy|1|||
27568381|NCT00207142|80271280|FG001|Induction Phase|Pregnancy|0|||
27568382|NCT00207142|80271281|FG002|Induction Phase|Pregnancy|0|||
27568383|NCT00207142|80271282|FG003|Induction Phase|Pregnancy|0|||
27568384|NCT00207142|80271279|FG000|Induction Phase|Subject no longer meets study criteria|3|||
27568385|NCT00207142|80271280|FG001|Induction Phase|Subject no longer meets study criteria|0|||
27568386|NCT00207142|80271281|FG002|Induction Phase|Subject no longer meets study criteria|0|||
27568387|NCT00207142|80271282|FG003|Induction Phase|Subject no longer meets study criteria|0|||
27568388|NCT00207142|80271279|FG000|Induction Phase|Withdrawal by Subject|4|||
27568389|NCT00207142|80271280|FG001|Induction Phase|Withdrawal by Subject|0|||
27568390|NCT00207142|80271281|FG002|Induction Phase|Withdrawal by Subject|0|||
27568391|NCT00207142|80271282|FG003|Induction Phase|Withdrawal by Subject|0|||
27568392|NCT00207142|80271279|FG000|Induction Phase|Incarceration|1|||
27568393|NCT00207142|80271280|FG001|Induction Phase|Incarceration|0|||
27568394|NCT00207142|80271281|FG002|Induction Phase|Incarceration|0|||
27568395|NCT00207142|80271282|FG003|Induction Phase|Incarceration|0|||
27568396|NCT00207142|80271279|FG000|Induction Phase|Missing lab data|1|||
27568397|NCT00207142|80271280|FG001|Induction Phase|Missing lab data|0|||
27568398|NCT00207142|80271281|FG002|Induction Phase|Missing lab data|0|||
27568399|NCT00207142|80271282|FG003|Induction Phase|Missing lab data|0|||
27568400|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
27568401|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
27568402|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
27568403|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
27568404|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
27568405|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
27568406|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
27568407|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
27568408|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
27568409|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
27568410|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
27568411|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
27568412|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
27568413|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
27568414|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
27568415|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
27568416|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
27568417|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
27658912|NCT01808144|80589790|FG001|Overall Study|Death|0|||
27658913|NCT01808144|80589789|FG000|Overall Study|Withdrawal by Subject|16|||
27761904|NCT01360762|80954097|FG000|Whole Study Period|Lost to Follow-up|10|||
27761905|NCT01360762|80954097|FG000|Whole Study Period|Death|7|||
27761906|NCT01360762|80954097|FG000|Whole Study Period|Patient relapsed|18|||
27761907|NCT01360762|80954097|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
27761908|NCT04046341|80954098|FG000|Overall Study|Lost to Follow-up|2|||
27761909|NCT04046341|80954098|FG000|Overall Study|Withdrawal by Subject|1|||
27761910|NCT02616185|80954099|FG000|Overall Study|Death|0|||
27761911|NCT02616185|80954100|FG001|Overall Study|Death|0|||
27761912|NCT02616185|80954101|FG002|Overall Study|Death|0|||
27761913|NCT02616185|80954102|FG003|Overall Study|Death|1|||
27761914|NCT02616185|80954103|FG004|Overall Study|Death|2|||
27761915|NCT02616185|80954104|FG005|Overall Study|Death|0|||
27761916|NCT02616185|80954105|FG006|Overall Study|Death|0|||
27761917|NCT02616185|80954106|FG007|Overall Study|Death|2|||
27761918|NCT02616185|80954107|FG008|Overall Study|Death|1|||
27761919|NCT02616185|80954099|FG000|Overall Study|Study terminated by sponsor|0|||
27761920|NCT02616185|80954100|FG001|Overall Study|Study terminated by sponsor|0|||
27761921|NCT02616185|80954101|FG002|Overall Study|Study terminated by sponsor|1|||
27761922|NCT02616185|80954102|FG003|Overall Study|Study terminated by sponsor|0|||
27761923|NCT02616185|80954103|FG004|Overall Study|Study terminated by sponsor|0|||
27761924|NCT02616185|80954104|FG005|Overall Study|Study terminated by sponsor|0|||
27761925|NCT02616185|80954105|FG006|Overall Study|Study terminated by sponsor|5|||
27761926|NCT02616185|80954106|FG007|Overall Study|Study terminated by sponsor|2|||
27761927|NCT02616185|80954107|FG008|Overall Study|Study terminated by sponsor|0|||
27761928|NCT02616185|80954099|FG000|Overall Study|Participant refused further follow-up|1|||
27761929|NCT02616185|80954100|FG001|Overall Study|Participant refused further follow-up|1|||
27761930|NCT02616185|80954101|FG002|Overall Study|Participant refused further follow-up|2|||
27761931|NCT02616185|80954102|FG003|Overall Study|Participant refused further follow-up|3|||
27761932|NCT02616185|80954103|FG004|Overall Study|Participant refused further follow-up|4|||
27761933|NCT02616185|80954104|FG005|Overall Study|Participant refused further follow-up|0|||
27761934|NCT02616185|80954105|FG006|Overall Study|Participant refused further follow-up|3|||
27761935|NCT02616185|80954106|FG007|Overall Study|Participant refused further follow-up|4|||
27761936|NCT02616185|80954107|FG008|Overall Study|Participant refused further follow-up|3|||
27761937|NCT02616185|80954099|FG000|Overall Study|Not reported|0|||
27761938|NCT02616185|80954100|FG001|Overall Study|Not reported|0|||
27761939|NCT02616185|80954101|FG002|Overall Study|Not reported|0|||
27761940|NCT02616185|80954102|FG003|Overall Study|Not reported|1|||
27761941|NCT02616185|80954103|FG004|Overall Study|Not reported|3|||
27761942|NCT02616185|80954104|FG005|Overall Study|Not reported|1|||
27761943|NCT02616185|80954105|FG006|Overall Study|Not reported|0|||
27761944|NCT02616185|80954106|FG007|Overall Study|Not reported|5|||
27761945|NCT02616185|80954107|FG008|Overall Study|Not reported|2|||
27761946|NCT02690207|80954111|FG000|Overall Study|Lost to Follow-up|48|||
27761947|NCT02690207|80954111|FG000|Overall Study|Withdrawal by Subject|46|||
27761948|NCT02690207|80954111|FG000|Overall Study|Protocol Violation|2|||
27761949|NCT02690207|80954111|FG000|Overall Study|Serious adverse event|110|||
27761950|NCT02690207|80954111|FG000|Overall Study|Non-serious Adverse Event|18|||
27761951|NCT02690207|80954111|FG000|Overall Study|Migrated/moved from study area|5|||
27761952|NCT02690207|80954111|FG000|Overall Study|Suspected HZ Episode|1|||
27761953|NCT02690207|80954111|FG000|Overall Study|Other reasons for withdrawal|23|||
27761954|NCT02227849|80954112|FG000|Overall Study|Adverse Event|4|||
27761955|NCT02227849|80954112|FG000|Overall Study|Physician Decision|1|||
27761956|NCT02227849|80954112|FG000|Overall Study|Withdrawal by Subject|3|||
27761957|NCT00643604|80954113|FG000|Overall Study|Death|1|||
27761958|NCT02120157|80954114|FG000|Overall Study|Death|8|||
27761959|NCT04929613|80954115|FG000|Overall Study|Withdrawal by Subject|12|||
27761960|NCT00889681|80954116|FG000|Overall Study|Not meeting qualification Criteria|2|||
27761961|NCT00889681|80954116|FG000|Overall Study|Insurance disapproval|1|||
27761962|NCT01116687|80954117|FG000|Overall Study|Withdrawal by Subject|4|||
27761963|NCT03287245|80954118|FG000|Overall Study|Study terminated by sponsor|3|||
27761964|NCT03287245|80954119|FG001|Overall Study|Study terminated by sponsor|0|||
27761965|NCT03287245|80954120|FG002|Overall Study|Study terminated by sponsor|3|||
27761966|NCT03287245|80954121|FG003|Overall Study|Study terminated by sponsor|1|||
27761967|NCT03287245|80954118|FG000|Overall Study|Adverse Event|1|||
27761968|NCT03287245|80954119|FG001|Overall Study|Adverse Event|0|||
27761969|NCT03287245|80954120|FG002|Overall Study|Adverse Event|0|||
27761970|NCT03287245|80954121|FG003|Overall Study|Adverse Event|0|||
27761971|NCT03287245|80954118|FG000|Overall Study|Withdrawal by Subject|8|||
27761972|NCT03287245|80954119|FG001|Overall Study|Withdrawal by Subject|3|||
27761973|NCT03287245|80954120|FG002|Overall Study|Withdrawal by Subject|3|||
27761974|NCT03287245|80954121|FG003|Overall Study|Withdrawal by Subject|0|||
27761975|NCT03287245|80954118|FG000|Overall Study|Physician Decision|3|||
27761976|NCT03287245|80954119|FG001|Overall Study|Physician Decision|2|||
27761977|NCT03287245|80954120|FG002|Overall Study|Physician Decision|0|||
27761978|NCT03287245|80954121|FG003|Overall Study|Physician Decision|0|||
27761979|NCT00108953|80954122|FG000|Follow-up|Death|18|||
27761980|NCT00108953|80954123|FG001|Follow-up|Death|26|||
27761981|NCT00108953|80954122|FG000|Follow-up|Lost to Follow-up|1|||
27761982|NCT00108953|80954123|FG001|Follow-up|Lost to Follow-up|1|||
27761983|NCT00108953|80954122|FG000|Follow-up|Study terminated by sponsor|10|||
27761984|NCT00108953|80954123|FG001|Follow-up|Study terminated by sponsor|6|||
27761985|NCT00168064|80954124|FG000|Overall Study|Adverse Event|26|||
27761986|NCT00168064|80954125|FG001|Overall Study|Adverse Event|22|||
27761987|NCT00168064|80954124|FG000|Overall Study|Withdrawal by Subject|3|||
27761988|NCT00168064|80954125|FG001|Overall Study|Withdrawal by Subject|4|||
27761989|NCT00168064|80954124|FG000|Overall Study|Lack of Efficacy|4|||
27761990|NCT00168064|80954125|FG001|Overall Study|Lack of Efficacy|4|||
27761991|NCT00168064|80954124|FG000|Overall Study|Lost to Follow-up|4|||
27761992|NCT00168064|80954125|FG001|Overall Study|Lost to Follow-up|3|||
27658914|NCT01808144|80589790|FG001|Overall Study|Withdrawal by Subject|23|||
27658915|NCT01808144|80589789|FG000|Overall Study|Lost to Follow-up|6|||
27658916|NCT01808144|80589790|FG001|Overall Study|Lost to Follow-up|3|||
27658917|NCT01808144|80589789|FG000|Overall Study|Protocol Violation|6|||
27658918|NCT01808144|80589790|FG001|Overall Study|Protocol Violation|6|||
27658919|NCT01808144|80589789|FG000|Overall Study|Gout flare|0|||
27658920|NCT01808144|80589790|FG001|Overall Study|Gout flare|1|||
27658921|NCT01808144|80589789|FG000|Overall Study|Adverse Event|11|||
27658922|NCT01808144|80589790|FG001|Overall Study|Adverse Event|15|||
27658923|NCT00417989|80589791|FG000|Overall Study|Withdrawal by Subject|13|||
27658924|NCT00417989|80589792|FG001|Overall Study|Withdrawal by Subject|13|||
27658925|NCT00417989|80589791|FG000|Overall Study|Lost to Follow-up|1|||
27658926|NCT00417989|80589792|FG001|Overall Study|Lost to Follow-up|6|||
27658927|NCT00417989|80589791|FG000|Overall Study|Protocol Violation|1|||
27658928|NCT00417989|80589792|FG001|Overall Study|Protocol Violation|0|||
27658929|NCT00417989|80589791|FG000|Overall Study|Death|0|||
27658930|NCT00417989|80589792|FG001|Overall Study|Death|1|||
27658931|NCT00417989|80589791|FG000|Overall Study|Physician Decision|5|||
27658932|NCT00417989|80589792|FG001|Overall Study|Physician Decision|2|||
27658933|NCT03048058|80589798|FG000|Overall Study|Lost to Follow-up|4|||
27658934|NCT03048058|80589799|FG001|Overall Study|Lost to Follow-up|0|||
27658935|NCT03048058|80589798|FG000|Overall Study|Withdrawal by Subject|0|||
27658936|NCT03048058|80589799|FG001|Overall Study|Withdrawal by Subject|4|||
27658937|NCT03409276|80589800|FG000|Overall Study|Withdrawal by Subject|0|||
27658938|NCT03409276|80589801|FG001|Overall Study|Withdrawal by Subject|0|||
27658939|NCT03409276|80589802|FG002|Overall Study|Withdrawal by Subject|0|||
27658940|NCT03409276|80589803|FG003|Overall Study|Withdrawal by Subject|0|||
27658941|NCT03409276|80589804|FG004|Overall Study|Withdrawal by Subject|1|||
27658942|NCT03409276|80589800|FG000|Overall Study|Lost to Follow-up|0|||
27658943|NCT03409276|80589801|FG001|Overall Study|Lost to Follow-up|0|||
27658944|NCT03409276|80589802|FG002|Overall Study|Lost to Follow-up|0|||
27658945|NCT03409276|80589803|FG003|Overall Study|Lost to Follow-up|2|||
27658946|NCT03409276|80589804|FG004|Overall Study|Lost to Follow-up|2|||
27658947|NCT03436797|80589805|FG000|Main Study|Withdrawal by Subject|2|||
27658948|NCT03436797|80589805|FG000|Main Study|Adverse Event|4|||
27658949|NCT03436797|80589805|FG000|Main Study|Lost to Follow-up|1|||
27658950|NCT03436797|80589805|FG000|Main Study|Death|1|||
27658951|NCT03436797|80589805|FG000|Main Study|Non-Specific|2|||
27658952|NCT03436797|80589805|FG000|Extended Dosing|Patient decision|1|||
27658953|NCT02522299|80589806|FG000|Overall Study|Adverse Event|2|||
27658954|NCT02522299|80589807|FG001|Overall Study|Adverse Event|0|||
27658955|NCT02522299|80589806|FG000|Overall Study|Physician Decision|0|||
27658956|NCT02522299|80589807|FG001|Overall Study|Physician Decision|1|||
27658957|NCT02522299|80589806|FG000|Overall Study|Withdrawal by Subject|2|||
27658958|NCT02522299|80589807|FG001|Overall Study|Withdrawal by Subject|0|||
27658959|NCT02632747|80589815|FG000|Wash-out Period|Adverse Event|1|||
27658960|NCT02632747|80589816|FG001|Wash-out Period|Adverse Event|0|||
27658961|NCT01304940|80589817|FG000|Overall Study|not meet symptom severity requirement|3|||
27658962|NCT01304940|80589818|FG001|Overall Study|not meet symptom severity requirement|0|||
27658963|NCT01294358|80589819|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27658964|NCT01294358|80589820|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
27658965|NCT01294358|80589821|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27658966|NCT01294358|80589822|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27658967|NCT01294358|80589823|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
27658968|NCT01294358|80589819|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27658969|NCT01294358|80589820|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27658970|NCT01294358|80589821|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
27658971|NCT01294358|80589822|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27658972|NCT01294358|80589823|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
27761993|NCT00168064|80954124|FG000|Overall Study|Non-compliance|2|||
27761994|NCT00168064|80954125|FG001|Overall Study|Non-compliance|3|||
27658973|NCT01294358|80589819|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27658974|NCT01294358|80589820|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27658975|NCT01294358|80589821|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27658976|NCT01294358|80589822|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
27658977|NCT01294358|80589823|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
27658978|NCT01294358|80589819|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27658979|NCT01294358|80589820|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27658980|NCT01294358|80589821|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27658981|NCT01294358|80589822|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
27658982|NCT01294358|80589823|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
27658983|NCT00988429|80589826|FG000|Overall Study|Adverse Event|9|||
27658984|NCT00988429|80589827|FG001|Overall Study|Adverse Event|21|||
27658985|NCT00988429|80589828|FG002|Overall Study|Adverse Event|45|||
27658986|NCT00988429|80589826|FG000|Overall Study|Lack of Efficacy|0|||
27658987|NCT00988429|80589827|FG001|Overall Study|Lack of Efficacy|0|||
27658988|NCT00988429|80589828|FG002|Overall Study|Lack of Efficacy|1|||
27658989|NCT00988429|80589826|FG000|Overall Study|Non-Compliance with Study Drug|5|||
27658990|NCT00988429|80589827|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27658991|NCT00988429|80589828|FG002|Overall Study|Non-Compliance with Study Drug|3|||
27658992|NCT00988429|80589826|FG000|Overall Study|Physician Decision|1|||
27658993|NCT00988429|80589827|FG001|Overall Study|Physician Decision|0|||
27658994|NCT00988429|80589828|FG002|Overall Study|Physician Decision|3|||
27658995|NCT00988429|80589826|FG000|Overall Study|Pregnancy|2|||
27761995|NCT00168064|80954124|FG000|Overall Study|Concurrent Illness|4|||
27568418|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
27568419|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
27568420|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
27568421|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
27568422|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
27568423|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
27568424|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
27568425|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
27568426|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
27568427|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
27568428|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Death|0|||
27568429|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Death|0|||
27568430|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Death|0|||
27568431|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Death|1|||
27568432|NCT00207142|80271279|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
27568433|NCT00207142|80271280|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
27568434|NCT00207142|80271281|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
27568435|NCT00207142|80271282|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
27568436|NCT00397982|80271283|FG000|Overall Study|Withdrawal by Subject|1|||
27568437|NCT00397982|80271283|FG000|Overall Study|Adverse Event|1|||
27568438|NCT00397982|80271283|FG000|Overall Study|noncompliance|1|||
27568439|NCT00397982|80271283|FG000|Overall Study|Unrelated health issues|1|||
27568440|NCT00969553|80271298|FG000|Overall Study|Progressive disease (PD)|2|||
27568441|NCT00969553|80271299|FG001|Overall Study|Progressive disease (PD)|2|||
27568442|NCT00969553|80271300|FG002|Overall Study|Progressive disease (PD)|6|||
27568443|NCT00969553|80271301|FG003|Overall Study|Progressive disease (PD)|9|||
27568444|NCT00969553|80271302|FG004|Overall Study|Progressive disease (PD)|2|||
27568445|NCT00969553|80271303|FG005|Overall Study|Progressive disease (PD)|4|||
27568446|NCT00969553|80271304|FG006|Overall Study|Progressive disease (PD)|2|||
27568447|NCT00969553|80271305|FG007|Overall Study|Progressive disease (PD)|12|||
27568448|NCT00969553|80271306|FG008|Overall Study|Progressive disease (PD)|3|||
27568449|NCT00969553|80271298|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568450|NCT00969553|80271299|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568451|NCT00969553|80271300|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568452|NCT00969553|80271301|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568453|NCT00969553|80271302|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
27568454|NCT00969553|80271303|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568455|NCT00969553|80271304|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568456|NCT00969553|80271305|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568457|NCT00969553|80271306|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
27568458|NCT00969553|80271298|FG000|Overall Study|Other Adverse Event|0|||
27568459|NCT00969553|80271299|FG001|Overall Study|Other Adverse Event|0|||
27568460|NCT00969553|80271300|FG002|Overall Study|Other Adverse Event|0|||
27568461|NCT00969553|80271301|FG003|Overall Study|Other Adverse Event|1|||
27568462|NCT00969553|80271302|FG004|Overall Study|Other Adverse Event|0|||
27568463|NCT00969553|80271303|FG005|Overall Study|Other Adverse Event|0|||
27568464|NCT00969553|80271304|FG006|Overall Study|Other Adverse Event|1|||
27568465|NCT00969553|80271305|FG007|Overall Study|Other Adverse Event|0|||
27568466|NCT00969553|80271306|FG008|Overall Study|Other Adverse Event|0|||
27568467|NCT00969553|80271298|FG000|Overall Study|Refused cont. medication|1|||
27568468|NCT00969553|80271299|FG001|Overall Study|Refused cont. medication|1|||
27568469|NCT00969553|80271300|FG002|Overall Study|Refused cont. medication|0|||
27568470|NCT00969553|80271301|FG003|Overall Study|Refused cont. medication|2|||
27658996|NCT00988429|80589827|FG001|Overall Study|Pregnancy|1|||
27658997|NCT00988429|80589828|FG002|Overall Study|Pregnancy|0|||
27658998|NCT00988429|80589826|FG000|Overall Study|Protocol Violation|4|||
27658999|NCT00988429|80589827|FG001|Overall Study|Protocol Violation|3|||
27659000|NCT00988429|80589828|FG002|Overall Study|Protocol Violation|3|||
27659001|NCT00988429|80589826|FG000|Overall Study|Withdrawal by Subject|7|||
27659002|NCT00988429|80589827|FG001|Overall Study|Withdrawal by Subject|7|||
27659003|NCT00988429|80589828|FG002|Overall Study|Withdrawal by Subject|12|||
27659004|NCT00988429|80589826|FG000|Overall Study|Administrative Reasons|1|||
27659005|NCT00988429|80589827|FG001|Overall Study|Administrative Reasons|2|||
27659006|NCT00988429|80589828|FG002|Overall Study|Administrative Reasons|1|||
27659007|NCT00988429|80589826|FG000|Overall Study|other reasons|8|||
27659008|NCT00988429|80589827|FG001|Overall Study|other reasons|8|||
27659009|NCT00988429|80589828|FG002|Overall Study|other reasons|1|||
27659010|NCT03861078|80589829|FG000|Overall Study|COVID-19 shut down|4|||
27659011|NCT03861078|80589829|FG000|Overall Study|Lost to Follow-up|1|||
27659012|NCT03861078|80589829|FG000|Overall Study|Protocol Violation|2|||
27659013|NCT03861078|80589829|FG000|Overall Study|lack of venous access|1|||
27659014|NCT03651271|80589830|FG000|Overall Study|Death|4|||
27659015|NCT03651271|80589831|FG001|Overall Study|Death|37|||
27659016|NCT03651271|80589832|FG002|Overall Study|Death|0|||
27659017|NCT03651271|80589833|FG003|Overall Study|Death|2|||
27659018|NCT03651271|80589834|FG004|Overall Study|Death|6|||
27659019|NCT03651271|80589830|FG000|Overall Study|Lost to Follow-up|1|||
27659020|NCT03651271|80589831|FG001|Overall Study|Lost to Follow-up|5|||
27659021|NCT03651271|80589832|FG002|Overall Study|Lost to Follow-up|0|||
27659022|NCT03651271|80589833|FG003|Overall Study|Lost to Follow-up|1|||
27659023|NCT03651271|80589834|FG004|Overall Study|Lost to Follow-up|0|||
27659024|NCT03651271|80589830|FG000|Overall Study|Physician Decision|0|||
27659025|NCT03651271|80589831|FG001|Overall Study|Physician Decision|2|||
27659026|NCT03651271|80589832|FG002|Overall Study|Physician Decision|0|||
27659027|NCT03651271|80589833|FG003|Overall Study|Physician Decision|0|||
27659028|NCT03651271|80589834|FG004|Overall Study|Physician Decision|0|||
27659029|NCT03651271|80589830|FG000|Overall Study|Withdrawal by Subject|1|||
27659030|NCT03651271|80589831|FG001|Overall Study|Withdrawal by Subject|15|||
27659031|NCT03651271|80589832|FG002|Overall Study|Withdrawal by Subject|0|||
27659032|NCT03651271|80589833|FG003|Overall Study|Withdrawal by Subject|0|||
27761996|NCT00168064|80954125|FG001|Overall Study|Concurrent Illness|3|||
27860653|NCT03265288|81322778|FG001|Overall Study|Adverse Event|1|||
27860654|NCT03265288|81322777|FG000|Overall Study|Withdrawal by Subject|13|||
27860655|NCT03265288|81322778|FG001|Overall Study|Withdrawal by Subject|5|||
27860656|NCT03265288|81322777|FG000|Overall Study|Drug Withdrawn|3|||
27860657|NCT03265288|81322778|FG001|Overall Study|Drug Withdrawn|3|||
27860658|NCT03265288|81322777|FG000|Overall Study|Any Other Reason|7|||
27860659|NCT03265288|81322778|FG001|Overall Study|Any Other Reason|3|||
27860660|NCT01004003|81322781|FG000|Overall Study|Progressive disease|2|||
27860661|NCT01004003|81322782|FG001|Overall Study|Progressive disease|1|||
27568471|NCT00969553|80271302|FG004|Overall Study|Refused cont. medication|0|||
27568472|NCT00969553|80271303|FG005|Overall Study|Refused cont. medication|0|||
27568473|NCT00969553|80271304|FG006|Overall Study|Refused cont. medication|0|||
27568474|NCT00969553|80271305|FG007|Overall Study|Refused cont. medication|1|||
27568475|NCT00969553|80271306|FG008|Overall Study|Refused cont. medication|0|||
27568476|NCT00969553|80271298|FG000|Overall Study|Not specified above|0|||
27568477|NCT00969553|80271299|FG001|Overall Study|Not specified above|0|||
27568478|NCT00969553|80271300|FG002|Overall Study|Not specified above|0|||
27568479|NCT00969553|80271301|FG003|Overall Study|Not specified above|4|||
27568480|NCT00969553|80271302|FG004|Overall Study|Not specified above|0|||
27568481|NCT00969553|80271303|FG005|Overall Study|Not specified above|0|||
27568482|NCT00969553|80271304|FG006|Overall Study|Not specified above|1|||
27568483|NCT00969553|80271305|FG007|Overall Study|Not specified above|1|||
27568484|NCT00969553|80271306|FG008|Overall Study|Not specified above|0|||
27568485|NCT02703636|80271307|FG000|Overall Study|Adverse Event|14|||
27568486|NCT02703636|80271307|FG000|Overall Study|Study stopped by sponsor|1|||
27568487|NCT02703636|80271307|FG000|Overall Study|Withdrawal by Subject|1|||
27568488|NCT02350309|80271314|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
27568489|NCT02350309|80271315|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
27568490|NCT02350309|80271316|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
27568491|NCT02350309|80271317|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
27568492|NCT02350309|80271318|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
27568493|NCT02350309|80271319|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
27568494|NCT02350309|80271314|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
27568495|NCT02350309|80271315|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
27568496|NCT02350309|80271316|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
27568497|NCT02350309|80271317|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
27568498|NCT02350309|80271318|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
27568499|NCT02350309|80271319|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
27568500|NCT04372602|80271320|FG000|Overall Study|Withdrawal by Subject|1|||
27568501|NCT04372602|80271321|FG001|Overall Study|Withdrawal by Subject|1|||
27659033|NCT03651271|80589834|FG004|Overall Study|Withdrawal by Subject|1|||
27659034|NCT03651271|80589830|FG000|Overall Study|Patient medically unable to continue|0|||
27659035|NCT03651271|80589831|FG001|Overall Study|Patient medically unable to continue|0|||
27659036|NCT03651271|80589832|FG002|Overall Study|Patient medically unable to continue|0|||
27659037|NCT03651271|80589833|FG003|Overall Study|Patient medically unable to continue|1|||
27659038|NCT03651271|80589834|FG004|Overall Study|Patient medically unable to continue|0|||
27659039|NCT01527500|80589835|FG000|Part A|Administrative|11|||
27659040|NCT01527500|80589836|FG001|Part A|Administrative|7|||
27659041|NCT01527500|80589835|FG000|Part A|Adverse Event|4|||
27659042|NCT01527500|80589836|FG001|Part A|Adverse Event|2|||
27659043|NCT01527500|80589835|FG000|Part A|Death|4|||
27659044|NCT01527500|80589836|FG001|Part A|Death|1|||
27659045|NCT01527500|80589835|FG000|Part A|Lost to Follow-up|0|||
27659046|NCT01527500|80589836|FG001|Part A|Lost to Follow-up|1|||
27659047|NCT01527500|80589835|FG000|Part A|Protocol Deviation|9|||
27659048|NCT01527500|80589836|FG001|Part A|Protocol Deviation|2|||
27659049|NCT01527500|80589835|FG000|Part A|Withdrawal by Subject|2|||
27659050|NCT01527500|80589836|FG001|Part A|Withdrawal by Subject|0|||
27659051|NCT01527500|80589835|FG000|Part B|Adverse Event|1|||
27659052|NCT01527500|80589836|FG001|Part B|Adverse Event|0|||
27659053|NCT00312845|80589841|FG000|Overall Study|Adverse Event|19|||
27659054|NCT00312845|80589842|FG001|Overall Study|Adverse Event|5|||
27659055|NCT00312845|80589841|FG000|Overall Study|Death|2|||
27659056|NCT00312845|80589842|FG001|Overall Study|Death|2|||
27659057|NCT00312845|80589841|FG000|Overall Study|Withdrawal by Subject|14|||
27659058|NCT00312845|80589842|FG001|Overall Study|Withdrawal by Subject|6|||
27659059|NCT00312845|80589841|FG000|Overall Study|Disease Progression|56|||
27659060|NCT00312845|80589842|FG001|Overall Study|Disease Progression|77|||
27659061|NCT00312845|80589841|FG000|Overall Study|Lost to Follow-up|2|||
27659062|NCT00312845|80589842|FG001|Overall Study|Lost to Follow-up|0|||
27659063|NCT00312845|80589841|FG000|Overall Study|Other|6|||
27659064|NCT00312845|80589842|FG001|Overall Study|Other|5|||
27659065|NCT03613454|80589843|FG000|Overall Study|Protocol Violation|1|||
27659066|NCT03613454|80589844|FG001|Overall Study|Protocol Violation|0|||
27659067|NCT03613454|80589843|FG000|Overall Study|Protocol Violation|0|||
27659068|NCT03613454|80589844|FG001|Overall Study|Protocol Violation|1|||
27659069|NCT02592434|80589845|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
27659070|NCT02592434|80589846|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
27659071|NCT02592434|80589847|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
27659072|NCT02592434|80589845|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
27659073|NCT02592434|80589846|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
27659074|NCT02592434|80589847|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
27659075|NCT02592434|80589845|FG000|Open-Label Phase (18 Weeks)|Other|3|||
27659076|NCT02592434|80589846|FG001|Open-Label Phase (18 Weeks)|Other|0|||
27659077|NCT02592434|80589847|FG002|Open-Label Phase (18 Weeks)|Other|0|||
27659078|NCT02592434|80589845|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
27659079|NCT02592434|80589846|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
27659080|NCT02592434|80589847|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
27659081|NCT02592434|80589845|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
27659082|NCT02592434|80589846|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
27659083|NCT02592434|80589847|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
27659084|NCT02592434|80589845|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
27659085|NCT02592434|80589846|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
27659086|NCT02592434|80589847|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
27659087|NCT02592434|80589845|FG000|Double Blind Phase (26 Weeks)|Other|0|||
27659088|NCT02592434|80589846|FG001|Double Blind Phase (26 Weeks)|Other|1|||
27659089|NCT02592434|80589847|FG002|Double Blind Phase (26 Weeks)|Other|0|||
27659090|NCT02592434|80589845|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
27659091|NCT02592434|80589846|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
27659092|NCT02592434|80589847|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
27659093|NCT02592434|80589845|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
27659094|NCT02592434|80589846|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
27659095|NCT02592434|80589847|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
27659096|NCT02592434|80589845|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
27659097|NCT02592434|80589846|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
27659098|NCT02592434|80589847|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
27659099|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
27659100|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
27659101|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
27659102|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
27659103|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
27659104|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
27659105|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
27860662|NCT01004003|81322783|FG002|Overall Study|Progressive disease|1|||
27659106|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
27659107|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
27659108|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
27659109|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
27659110|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
27659111|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
27659112|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
27659113|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
27860663|NCT01004003|81322784|FG003|Overall Study|Progressive disease|0|||
27860664|NCT01004003|81322785|FG004|Overall Study|Progressive disease|2|||
27860665|NCT01004003|81322786|FG005|Overall Study|Progressive disease|1|||
27860666|NCT01004003|81322787|FG006|Overall Study|Progressive disease|1|||
27860667|NCT01004003|81322788|FG007|Overall Study|Progressive disease|39|||
27860668|NCT01004003|81322789|FG008|Overall Study|Progressive disease|22|||
27860669|NCT01004003|81322781|FG000|Overall Study|Adverse Event|4|||
27860670|NCT01004003|81322782|FG001|Overall Study|Adverse Event|2|||
27860671|NCT01004003|81322783|FG002|Overall Study|Adverse Event|3|||
27860672|NCT01004003|81322784|FG003|Overall Study|Adverse Event|3|||
27659114|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
27659115|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
27659116|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
27659117|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
27659118|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
27659119|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
27659120|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
27659121|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
27659122|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
27659123|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
27659124|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
27659125|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
27659126|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
27659127|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
27659128|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
27659129|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
27659130|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
27659131|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
27659132|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
27659133|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
27659134|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
27659135|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
27659136|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
27659137|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
27659138|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
27761997|NCT00168064|80954124|FG000|Overall Study|Subject's Best interest|2|||
27860673|NCT01004003|81322785|FG004|Overall Study|Adverse Event|2|||
27860674|NCT01004003|81322786|FG005|Overall Study|Adverse Event|2|||
27860675|NCT01004003|81322787|FG006|Overall Study|Adverse Event|7|||
27860676|NCT01004003|81322788|FG007|Overall Study|Adverse Event|21|||
27860677|NCT01004003|81322789|FG008|Overall Study|Adverse Event|6|||
27860678|NCT01004003|81322781|FG000|Overall Study|Refused to continue taking trial med.|0|||
27860679|NCT01004003|81322782|FG001|Overall Study|Refused to continue taking trial med.|0|||
27860680|NCT01004003|81322783|FG002|Overall Study|Refused to continue taking trial med.|0|||
27860681|NCT01004003|81322784|FG003|Overall Study|Refused to continue taking trial med.|0|||
27860682|NCT01004003|81322785|FG004|Overall Study|Refused to continue taking trial med.|0|||
27860683|NCT01004003|81322786|FG005|Overall Study|Refused to continue taking trial med.|0|||
27860684|NCT01004003|81322787|FG006|Overall Study|Refused to continue taking trial med.|0|||
27860685|NCT01004003|81322788|FG007|Overall Study|Refused to continue taking trial med.|0|||
27860686|NCT01004003|81322789|FG008|Overall Study|Refused to continue taking trial med.|2|||
27860687|NCT01004003|81322781|FG000|Overall Study|Other|0|||
27860688|NCT01004003|81322782|FG001|Overall Study|Other|0|||
27860689|NCT01004003|81322783|FG002|Overall Study|Other|0|||
27860690|NCT01004003|81322784|FG003|Overall Study|Other|0|||
27860691|NCT01004003|81322785|FG004|Overall Study|Other|0|||
27860692|NCT01004003|81322786|FG005|Overall Study|Other|1|||
27761998|NCT00168064|80954125|FG001|Overall Study|Subject's Best interest|2|||
27860693|NCT01004003|81322787|FG006|Overall Study|Other|0|||
27860694|NCT01004003|81322788|FG007|Overall Study|Other|0|||
27860695|NCT01004003|81322789|FG008|Overall Study|Other|0|||
27860696|NCT04007991|81322790|FG000|Overall Study|Withdrawal by Subject|1|||
27860697|NCT04007991|81322791|FG001|Overall Study|Withdrawal by Subject|1|||
27860698|NCT04007991|81322790|FG000|Overall Study|Physician Decision|1|||
27860699|NCT04007991|81322791|FG001|Overall Study|Physician Decision|1|||
27860700|NCT04007991|81322790|FG000|Overall Study|Non-compliance with Study Drug|0|||
27860701|NCT04007991|81322791|FG001|Overall Study|Non-compliance with Study Drug|1|||
27860702|NCT04007991|81322790|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
27860703|NCT04007991|81322791|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
27860704|NCT04007991|81322790|FG000|Overall Study|Adverse event, non-fatal|5|||
27860705|NCT04007991|81322791|FG001|Overall Study|Adverse event, non-fatal|0|||
27860706|NCT04007991|81322790|FG000|Overall Study|Lost to Follow-up|2|||
27860707|NCT04007991|81322791|FG001|Overall Study|Lost to Follow-up|1|||
27860708|NCT01982812|81322794|FG000|Overall Study|Death|1|||
27659139|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
27659140|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
27659141|NCT03524092|80589848|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
27659142|NCT03524092|80589849|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
27659143|NCT03524092|80589850|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
27659144|NCT03524092|80589851|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
27659145|NCT03524092|80589852|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
27659146|NCT03524092|80589853|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
27659147|NCT03524092|80589848|FG000|Loss of Response Rescue Period|Adverse Event|0|||
27659148|NCT03524092|80589849|FG001|Loss of Response Rescue Period|Adverse Event|0|||
27659149|NCT03524092|80589850|FG002|Loss of Response Rescue Period|Adverse Event|0|||
27659150|NCT03524092|80589851|FG003|Loss of Response Rescue Period|Adverse Event|2|||
27659151|NCT03524092|80589852|FG004|Loss of Response Rescue Period|Adverse Event|0|||
27659152|NCT03524092|80589853|FG005|Loss of Response Rescue Period|Adverse Event|0|||
27659153|NCT03524092|80589848|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
27659154|NCT03524092|80589849|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
27659155|NCT03524092|80589850|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
27659156|NCT03524092|80589851|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
27659157|NCT03524092|80589852|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
27659158|NCT03524092|80589853|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
27659159|NCT03524092|80589848|FG000|Loss of Response Rescue Period|Pregnancy|0|||
27659160|NCT03524092|80589849|FG001|Loss of Response Rescue Period|Pregnancy|0|||
27659161|NCT03524092|80589850|FG002|Loss of Response Rescue Period|Pregnancy|0|||
27659162|NCT03524092|80589851|FG003|Loss of Response Rescue Period|Pregnancy|1|||
27659163|NCT03524092|80589852|FG004|Loss of Response Rescue Period|Pregnancy|0|||
27659164|NCT03524092|80589853|FG005|Loss of Response Rescue Period|Pregnancy|0|||
27659165|NCT03524092|80589848|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
27659166|NCT03524092|80589849|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
27659167|NCT03524092|80589850|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
27659168|NCT03524092|80589851|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
27659169|NCT03524092|80589852|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
27659170|NCT03524092|80589853|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
27659171|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
27659172|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
27659173|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
27659174|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
27659175|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
27659176|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
27659177|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
27659178|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
27659179|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
27659180|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
27659181|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
27659182|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
27659183|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
27659184|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
27659185|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
27659186|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
27659187|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
27659188|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
27659189|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
27659190|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
27659191|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
27761999|NCT00168064|80954124|FG000|Overall Study|Various|4|||
27762000|NCT00168064|80954125|FG001|Overall Study|Various|3|||
27762001|NCT01819506|80954126|FG000|Overall Study|Physician Decision|5|||
27762002|NCT01819506|80954127|FG001|Overall Study|Physician Decision|2|||
27762003|NCT01819506|80954126|FG000|Overall Study|Withdrawal by Subject|3|||
27659192|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
27659193|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
27659194|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
27659195|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
27659196|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
27659197|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
27659198|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
27659199|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
27659200|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
27659201|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
27659202|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
27659203|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
27659204|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
27659205|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
27659206|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
27659207|NCT03524092|80589848|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
27659208|NCT03524092|80589849|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
27659209|NCT03524092|80589850|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
27659210|NCT03524092|80589851|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
27659211|NCT03524092|80589852|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
27659212|NCT03524092|80589853|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
27659213|NCT03524092|80589848|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
27659214|NCT03524092|80589849|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
27659215|NCT03524092|80589850|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
27659216|NCT03524092|80589851|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
27659217|NCT03524092|80589852|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
27659218|NCT03524092|80589853|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
27659219|NCT03524092|80589848|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
27659220|NCT03524092|80589849|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
27659221|NCT03524092|80589850|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
27659222|NCT03524092|80589851|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
27659223|NCT03524092|80589852|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
27659224|NCT03524092|80589853|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
27659225|NCT03524092|80589848|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
27762004|NCT01819506|80954127|FG001|Overall Study|Withdrawal by Subject|3|||
27762005|NCT00377429|80954132|FG000|Overall Study|Withdrawal by Subject|5|||
27762006|NCT00377429|80954132|FG000|Overall Study|Adverse Event|8|||
27860709|NCT01982812|81322795|FG001|Overall Study|Death|5|||
27860710|NCT01982812|81322794|FG000|Overall Study|Adverse Event|0|||
27860711|NCT01982812|81322795|FG001|Overall Study|Adverse Event|5|||
27860712|NCT03317834|81322797|FG000|Overall Study|Death|2|||
27860713|NCT03317834|81322797|FG000|Overall Study|Device Revision|5|||
27860714|NCT03317834|81322797|FG000|Overall Study|Withdrawal by Subject|13|||
27860715|NCT03317834|81322797|FG000|Overall Study|Lost to Follow-up|13|||
27860716|NCT00824616|81322798|FG000|Overall Study|Adverse Event|2|||
27860717|NCT00824616|81322799|FG001|Overall Study|Adverse Event|1|||
27860718|NCT00824616|81322798|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
27860719|NCT00824616|81322799|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
27860720|NCT00824616|81322798|FG000|Overall Study|Hyperglycemia|1|||
27860721|NCT00824616|81322799|FG001|Overall Study|Hyperglycemia|1|||
27860722|NCT00824616|81322798|FG000|Overall Study|Lack of Efficacy|2|||
27860723|NCT00824616|81322799|FG001|Overall Study|Lack of Efficacy|1|||
27860724|NCT00824616|81322798|FG000|Overall Study|Lost to Follow-up|0|||
27860725|NCT00824616|81322799|FG001|Overall Study|Lost to Follow-up|1|||
27860726|NCT00824616|81322798|FG000|Overall Study|Withdrawal by Subject|1|||
27860727|NCT00824616|81322799|FG001|Overall Study|Withdrawal by Subject|1|||
27860728|NCT02116608|81322803|FG000|Overall Study|Lost to Follow-up|0|||
27860729|NCT02116608|81322804|FG001|Overall Study|Lost to Follow-up|0|||
27860730|NCT02116608|81322805|FG002|Overall Study|Lost to Follow-up|1|||
27860731|NCT02116608|81322803|FG000|Overall Study|Physician Decision|0|||
27860732|NCT02116608|81322804|FG001|Overall Study|Physician Decision|1|||
27762007|NCT00377429|80954132|FG000|Overall Study|Physician Decision|1|||
27762008|NCT00377429|80954132|FG000|Overall Study|Patient non-compliance|1|||
27762009|NCT02007954|80954140|FG000|Overall Study|Received liver transplant|3|||
27762010|NCT02007954|80954140|FG000|Overall Study|Switch in treatment modality|2|||
27762011|NCT02007954|80954140|FG000|Overall Study|Disease progression and unrelated AE|1|||
27762012|NCT02007954|80954140|FG000|Overall Study|Death|1|||
27860733|NCT02116608|81322805|FG002|Overall Study|Physician Decision|0|||
27860734|NCT02116608|81322803|FG000|Overall Study|Death|0|||
27860735|NCT02116608|81322804|FG001|Overall Study|Death|1|||
27860736|NCT02116608|81322805|FG002|Overall Study|Death|0|||
27860737|NCT00205803|81322808|FG000|Infant Series|Lost to Follow-up|10|||
27659226|NCT03524092|80589849|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
27659227|NCT03524092|80589850|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
27659228|NCT03524092|80589851|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
27659229|NCT03524092|80589852|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
27659230|NCT03524092|80589853|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
27659231|NCT03524092|80589848|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
27659232|NCT03524092|80589849|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
27659233|NCT03524092|80589850|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
27659234|NCT03524092|80589851|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
27659235|NCT03524092|80589852|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
27659236|NCT03524092|80589853|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
27659237|NCT02963922|80589854|FG000|Overall Study|Adverse Event|15|||
27659238|NCT02963922|80589855|FG001|Overall Study|Adverse Event|6|||
27659239|NCT02963922|80589854|FG000|Overall Study|Protocol deviation|6|||
27659240|NCT02963922|80589855|FG001|Overall Study|Protocol deviation|6|||
27659241|NCT02963922|80589854|FG000|Overall Study|Lack of Efficacy|1|||
27659242|NCT02963922|80589855|FG001|Overall Study|Lack of Efficacy|1|||
27659243|NCT02963922|80589854|FG000|Overall Study|Lost to Follow-up|2|||
27659244|NCT02963922|80589855|FG001|Overall Study|Lost to Follow-up|3|||
27659245|NCT02963922|80589854|FG000|Overall Study|Other|8|||
27659246|NCT02963922|80589855|FG001|Overall Study|Other|14|||
27659247|NCT00278395|80589856|FG000|Overall Study|Adverse Event|2|||
27659248|NCT00278395|80589856|FG000|Overall Study|Nonevaluable|1|||
27659249|NCT02188784|80589857|FG000|Overall Study|Death|3|||
27659250|NCT02188784|80589858|FG001|Overall Study|Death|1|||
27659251|NCT02188784|80589857|FG000|Overall Study|Lost to Follow-up|1|||
27659252|NCT02188784|80589858|FG001|Overall Study|Lost to Follow-up|0|||
27659253|NCT02188784|80589857|FG000|Overall Study|Withdrawal by Subject|3|||
27659254|NCT02188784|80589858|FG001|Overall Study|Withdrawal by Subject|9|||
27659255|NCT02188784|80589857|FG000|Overall Study|Physician Decision|2|||
27659256|NCT02188784|80589858|FG001|Overall Study|Physician Decision|3|||
27659257|NCT01148017|80589861|FG000|Overall Study|Withdrawal by Subject|31|||
27659258|NCT01148017|80589862|FG001|Overall Study|Withdrawal by Subject|14|||
27659259|NCT01148017|80589863|FG002|Overall Study|Withdrawal by Subject|0|||
27659260|NCT01148017|80589864|FG003|Overall Study|Withdrawal by Subject|0|||
27659261|NCT01148017|80589861|FG000|Overall Study|Lost to Follow-up|23|||
27659262|NCT01148017|80589862|FG001|Overall Study|Lost to Follow-up|10|||
27659263|NCT01148017|80589863|FG002|Overall Study|Lost to Follow-up|0|||
27659264|NCT01148017|80589864|FG003|Overall Study|Lost to Follow-up|0|||
27659265|NCT01148017|80589861|FG000|Overall Study|Inappropriate enrollment|1|||
27659266|NCT01148017|80589862|FG001|Overall Study|Inappropriate enrollment|0|||
27659267|NCT01148017|80589863|FG002|Overall Study|Inappropriate enrollment|0|||
27659268|NCT01148017|80589864|FG003|Overall Study|Inappropriate enrollment|0|||
27860738|NCT00205803|81322809|FG001|Infant Series|Lost to Follow-up|4|||
27860739|NCT00205803|81322808|FG000|Infant Series|Withdrawal by Subject|2|||
27860740|NCT00205803|81322809|FG001|Infant Series|Withdrawal by Subject|5|||
27860741|NCT00205803|81322808|FG000|Infant Series|Physician Decision|3|||
27860742|NCT00205803|81322809|FG001|Infant Series|Physician Decision|1|||
27860743|NCT00205803|81322808|FG000|Infant Series|Protocol Violation|1|||
27860744|NCT00205803|81322809|FG001|Infant Series|Protocol Violation|0|||
27860745|NCT00205803|81322808|FG000|Infant Series|Lost Kaiser coverage|0|||
27860746|NCT00205803|81322809|FG001|Infant Series|Lost Kaiser coverage|1|||
27860747|NCT00205803|81322808|FG000|Infant Series|Non-compliant|1|||
27860748|NCT00205803|81322809|FG001|Infant Series|Non-compliant|0|||
27860749|NCT00205803|81322808|FG000|Infant Series|Sponsor request|1|||
27860750|NCT00205803|81322809|FG001|Infant Series|Sponsor request|0|||
27860751|NCT00205803|81322808|FG000|After Infant Series|Adverse Event|1|||
27860752|NCT00205803|81322809|FG001|After Infant Series|Adverse Event|1|||
27860753|NCT00205803|81322808|FG000|After Infant Series|Protocol Violation|1|||
27860754|NCT00205803|81322809|FG001|After Infant Series|Protocol Violation|1|||
27659269|NCT01148017|80589861|FG000|Overall Study|Administrative reason|22|||
27659270|NCT01148017|80589862|FG001|Overall Study|Administrative reason|9|||
27659271|NCT01148017|80589863|FG002|Overall Study|Administrative reason|0|||
27659272|NCT01148017|80589864|FG003|Overall Study|Administrative reason|0|||
27659273|NCT01148017|80589861|FG000|Overall Study|Unable to classify|3|||
27860755|NCT00205803|81322808|FG000|After Infant Series|Lost to Follow-up|2|||
27659274|NCT01148017|80589862|FG001|Overall Study|Unable to classify|1|||
27860756|NCT00205803|81322809|FG001|After Infant Series|Lost to Follow-up|1|||
27860757|NCT00205803|81322808|FG000|After Infant Series|Physician Decision|3|||
27860758|NCT00205803|81322809|FG001|After Infant Series|Physician Decision|2|||
27860759|NCT00205803|81322808|FG000|After Infant Series|Withdrawal by Subject|1|||
27860760|NCT00205803|81322809|FG001|After Infant Series|Withdrawal by Subject|4|||
27659275|NCT01148017|80589863|FG002|Overall Study|Unable to classify|0|||
27659276|NCT01148017|80589864|FG003|Overall Study|Unable to classify|0|||
27659277|NCT00714688|80589865|FG000|Overall Study|Lack of Efficacy|14|||
27659278|NCT00714688|80589866|FG001|Overall Study|Lack of Efficacy|1|||
27659279|NCT00714688|80589867|FG002|Overall Study|Lack of Efficacy|4|||
27659280|NCT00714688|80589865|FG000|Overall Study|Withdrawal by Subject|4|||
27659281|NCT00714688|80589866|FG001|Overall Study|Withdrawal by Subject|3|||
27659282|NCT00714688|80589867|FG002|Overall Study|Withdrawal by Subject|3|||
27659283|NCT00714688|80589865|FG000|Overall Study|Lost to Follow-up|5|||
27659284|NCT00714688|80589866|FG001|Overall Study|Lost to Follow-up|2|||
27659285|NCT00714688|80589867|FG002|Overall Study|Lost to Follow-up|0|||
27659286|NCT00714688|80589865|FG000|Overall Study|Adverse Event|2|||
27659287|NCT00714688|80589866|FG001|Overall Study|Adverse Event|15|||
27659288|NCT00714688|80589867|FG002|Overall Study|Adverse Event|19|||
27659289|NCT00714688|80589865|FG000|Overall Study|Subject Non-compliant|3|||
27659290|NCT00714688|80589866|FG001|Overall Study|Subject Non-compliant|5|||
27659291|NCT00714688|80589867|FG002|Overall Study|Subject Non-compliant|5|||
27659292|NCT00714688|80589865|FG000|Overall Study|Ineligible to Continue the Study|0|||
27659293|NCT00714688|80589866|FG001|Overall Study|Ineligible to Continue the Study|1|||
27659294|NCT00714688|80589867|FG002|Overall Study|Ineligible to Continue the Study|1|||
27762013|NCT04585451|80954141|FG000|Overall Study|Withdrawal by Subject|26|||
27860761|NCT00205803|81322808|FG000|After Infant Series|Other|10|||
27860762|NCT00205803|81322809|FG001|After Infant Series|Other|4|||
27860763|NCT00205803|81322808|FG000|Toddler Dose|Lost to Follow-up|2|||
27860764|NCT00205803|81322809|FG001|Toddler Dose|Lost to Follow-up|3|||
27860765|NCT01473524|81322812|FG000|DB Phase|Adverse Event|4|||
27860766|NCT01473524|81322813|FG001|DB Phase|Adverse Event|8|||
27860767|NCT01473524|81322814|FG002|DB Phase|Adverse Event|2|||
27860768|NCT01473524|81322815|FG003|DB Phase|Adverse Event|0|||
27860769|NCT01473524|81322816|FG004|DB Phase|Adverse Event|0|||
27860770|NCT01473524|81322817|FG005|DB Phase|Adverse Event|0|||
27860771|NCT01473524|81322812|FG000|DB Phase|Death|1|||
27860772|NCT01473524|81322813|FG001|DB Phase|Death|0|||
27860773|NCT01473524|81322814|FG002|DB Phase|Death|0|||
27860774|NCT01473524|81322815|FG003|DB Phase|Death|0|||
27860775|NCT01473524|81322816|FG004|DB Phase|Death|0|||
27860776|NCT01473524|81322817|FG005|DB Phase|Death|0|||
27860777|NCT01473524|81322812|FG000|DB Phase|Withdrawal by Subject|2|||
27860778|NCT01473524|81322813|FG001|DB Phase|Withdrawal by Subject|1|||
27860779|NCT01473524|81322814|FG002|DB Phase|Withdrawal by Subject|1|||
27860780|NCT01473524|81322815|FG003|DB Phase|Withdrawal by Subject|0|||
27860781|NCT01473524|81322816|FG004|DB Phase|Withdrawal by Subject|0|||
27860782|NCT01473524|81322817|FG005|DB Phase|Withdrawal by Subject|0|||
27860783|NCT01473524|81322812|FG000|LTSE Phase|Withdrawal by Subject|0|||
27860784|NCT01473524|81322813|FG001|LTSE Phase|Withdrawal by Subject|0|||
27860785|NCT01473524|81322814|FG002|LTSE Phase|Withdrawal by Subject|0|||
27860786|NCT01473524|81322815|FG003|LTSE Phase|Withdrawal by Subject|3|||
27860787|NCT01473524|81322816|FG004|LTSE Phase|Withdrawal by Subject|3|||
27860788|NCT01473524|81322817|FG005|LTSE Phase|Withdrawal by Subject|6|||
27860789|NCT01473524|81322812|FG000|LTSE Phase|Death|0|||
27860790|NCT01473524|81322813|FG001|LTSE Phase|Death|0|||
27860791|NCT01473524|81322814|FG002|LTSE Phase|Death|0|||
27860792|NCT01473524|81322815|FG003|LTSE Phase|Death|0|||
27860793|NCT01473524|81322816|FG004|LTSE Phase|Death|1|||
27860794|NCT01473524|81322817|FG005|LTSE Phase|Death|0|||
27860795|NCT01473524|81322812|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
27860796|NCT01473524|81322813|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
27860797|NCT01473524|81322814|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
27860798|NCT01473524|81322815|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
27860799|NCT01473524|81322816|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
27860800|NCT01473524|81322817|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
27860801|NCT01473524|81322812|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
27860802|NCT01473524|81322813|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
27860803|NCT01473524|81322814|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
27860804|NCT01473524|81322815|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
27659295|NCT00714688|80589865|FG000|Overall Study|Sponsor's Decision|0|||
27659296|NCT00714688|80589866|FG001|Overall Study|Sponsor's Decision|2|||
27659297|NCT00714688|80589867|FG002|Overall Study|Sponsor's Decision|0|||
27659298|NCT00714688|80589865|FG000|Overall Study|Other|1|||
27659299|NCT00714688|80589866|FG001|Overall Study|Other|6|||
27659300|NCT00714688|80589867|FG002|Overall Study|Other|5|||
27659301|NCT01113541|80589868|FG000|Overall Study|Withdrawal by Subject|1|||
27659302|NCT01113541|80589868|FG000|Overall Study|Protocol Violation|1|||
27659303|NCT01113541|80589868|FG000|Overall Study|Study Terminated by Sponsor|7|||
27659304|NCT01113541|80589868|FG000|Overall Study|Adverse Event|4|||
27762014|NCT04585451|80954142|FG001|Overall Study|Withdrawal by Subject|0|||
27762015|NCT01374217|80954147|FG000|Overall Study|Lack of Efficacy|13|||
27860805|NCT01473524|81322816|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
27860806|NCT01473524|81322817|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
27860807|NCT01473524|81322812|FG000|LTSE Phase|Lost to Follow-up|0|||
27860808|NCT01473524|81322813|FG001|LTSE Phase|Lost to Follow-up|0|||
27659305|NCT01753323|80589873|FG000|Overall Study|Lack of Efficacy|0|||
27659306|NCT01753323|80589874|FG001|Overall Study|Lack of Efficacy|0|||
27659307|NCT01753323|80589875|FG002|Overall Study|Lack of Efficacy|8|||
27659308|NCT01753323|80589873|FG000|Overall Study|Protocol deviation|1|||
27659309|NCT01753323|80589874|FG001|Overall Study|Protocol deviation|0|||
27659310|NCT01753323|80589875|FG002|Overall Study|Protocol deviation|0|||
27659311|NCT01753323|80589873|FG000|Overall Study|Adverse Event|0|||
27659312|NCT01753323|80589874|FG001|Overall Study|Adverse Event|0|||
27659313|NCT01753323|80589875|FG002|Overall Study|Adverse Event|1|||
27659314|NCT01061775|80589878|FG000|Overall Study|Physician Decision|2|||
27659315|NCT01061775|80589878|FG000|Overall Study|Lost to Follow-up|1|||
27659316|NCT00910871|80589879|FG000|Overall Study|Adverse Event|5|||
27659317|NCT00910871|80589879|FG000|Overall Study|Death|12|||
27659318|NCT00910871|80589879|FG000|Overall Study|Lost to Follow-up|8|||
27659319|NCT00910871|80589879|FG000|Overall Study|Protocol Violation|11|||
27659320|NCT00910871|80589879|FG000|Overall Study|Withdrawal by Subject|12|||
27659321|NCT00910871|80589879|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
27659322|NCT00910871|80589879|FG000|Overall Study|Undefined|1|||
27659323|NCT02499835|80589888|FG000|Overall Study|Withdrawal by Subject|1|||
27659324|NCT02499835|80589889|FG001|Overall Study|Withdrawal by Subject|0|||
27659325|NCT02499835|80589890|FG002|Overall Study|Withdrawal by Subject|0|||
27659326|NCT02499835|80589891|FG003|Overall Study|Withdrawal by Subject|1|||
27659327|NCT02499835|80589888|FG000|Overall Study|Physician Decision|0|||
27659328|NCT02499835|80589889|FG001|Overall Study|Physician Decision|3|||
27659329|NCT02499835|80589890|FG002|Overall Study|Physician Decision|18|||
27659330|NCT02499835|80589891|FG003|Overall Study|Physician Decision|7|||
27659331|NCT02499835|80589888|FG000|Overall Study|Adverse Event|0|||
27659332|NCT02499835|80589889|FG001|Overall Study|Adverse Event|0|||
27659333|NCT02499835|80589890|FG002|Overall Study|Adverse Event|0|||
27659334|NCT02499835|80589891|FG003|Overall Study|Adverse Event|1|||
27659335|NCT02499835|80589888|FG000|Overall Study|Disease progression|2|||
27659336|NCT02499835|80589889|FG001|Overall Study|Disease progression|1|||
27659337|NCT02499835|80589890|FG002|Overall Study|Disease progression|0|||
27659338|NCT02499835|80589891|FG003|Overall Study|Disease progression|7|||
27659339|NCT01106586|80589892|FG000|Overall Study|Adverse Event|9|||
27659340|NCT01106586|80589893|FG001|Overall Study|Adverse Event|15|||
27659341|NCT01106586|80589892|FG000|Overall Study|Death|1|||
27659342|NCT01106586|80589893|FG001|Overall Study|Death|3|||
27659343|NCT01106586|80589892|FG000|Overall Study|Pregnancy|2|||
27659344|NCT01106586|80589893|FG001|Overall Study|Pregnancy|2|||
27659345|NCT01106586|80589892|FG000|Overall Study|Lack of Efficacy|1|||
27659346|NCT01106586|80589893|FG001|Overall Study|Lack of Efficacy|0|||
27762016|NCT01283997|80954148|FG000|Overall Study|Physician Decision|8|||
27860809|NCT01473524|81322814|FG002|LTSE Phase|Lost to Follow-up|0|||
27860810|NCT01473524|81322815|FG003|LTSE Phase|Lost to Follow-up|1|||
27860811|NCT01473524|81322816|FG004|LTSE Phase|Lost to Follow-up|3|||
27860812|NCT01473524|81322817|FG005|LTSE Phase|Lost to Follow-up|2|||
27860813|NCT01473524|81322812|FG000|LTSE Phase|Principal Investigator Decision|0|||
27860814|NCT01473524|81322813|FG001|LTSE Phase|Principal Investigator Decision|0|||
27860815|NCT01473524|81322814|FG002|LTSE Phase|Principal Investigator Decision|0|||
27860816|NCT01473524|81322815|FG003|LTSE Phase|Principal Investigator Decision|1|||
27860817|NCT01473524|81322816|FG004|LTSE Phase|Principal Investigator Decision|1|||
27860818|NCT01473524|81322817|FG005|LTSE Phase|Principal Investigator Decision|3|||
27860819|NCT01473524|81322812|FG000|LTSE Phase|Liver Transplantation|0|||
27860820|NCT01473524|81322813|FG001|LTSE Phase|Liver Transplantation|0|||
27860821|NCT01473524|81322814|FG002|LTSE Phase|Liver Transplantation|0|||
27860822|NCT01473524|81322815|FG003|LTSE Phase|Liver Transplantation|0|||
27860823|NCT01473524|81322816|FG004|LTSE Phase|Liver Transplantation|0|||
27860824|NCT01473524|81322817|FG005|LTSE Phase|Liver Transplantation|1|||
27860825|NCT01473524|81322812|FG000|LTSE Phase|Pregnancy|0|||
27860826|NCT01473524|81322813|FG001|LTSE Phase|Pregnancy|0|||
27659347|NCT01106586|80589892|FG000|Overall Study|Investigator's Discretion|5|||
27659348|NCT01106586|80589893|FG001|Overall Study|Investigator's Discretion|8|||
27659349|NCT01106586|80589892|FG000|Overall Study|Withdrew Consent|18|||
27659350|NCT01106586|80589893|FG001|Overall Study|Withdrew Consent|30|||
27659351|NCT01106586|80589892|FG000|Overall Study|Lost to Follow-up|24|||
27659352|NCT01106586|80589893|FG001|Overall Study|Lost to Follow-up|20|||
27659353|NCT01106586|80589892|FG000|Overall Study|Participant Noncompliance|12|||
27659354|NCT01106586|80589893|FG001|Overall Study|Participant Noncompliance|10|||
27659355|NCT01106586|80589892|FG000|Overall Study|Protocol Violation|1|||
27659356|NCT01106586|80589893|FG001|Overall Study|Protocol Violation|0|||
27762017|NCT01283997|80954149|FG001|Overall Study|Physician Decision|10|||
27762018|NCT01283997|80954148|FG000|Overall Study|Withdrawal by Subject|3|||
27762019|NCT01283997|80954149|FG001|Overall Study|Withdrawal by Subject|2|||
27762020|NCT01283997|80954148|FG000|Overall Study|Physically unable to continue|0|||
27762021|NCT01283997|80954149|FG001|Overall Study|Physically unable to continue|1|||
27762022|NCT01283997|80954148|FG000|Overall Study|Progressive disease|1|||
27762023|NCT01283997|80954149|FG001|Overall Study|Progressive disease|0|||
27860827|NCT01473524|81322814|FG002|LTSE Phase|Pregnancy|0|||
27860828|NCT01473524|81322815|FG003|LTSE Phase|Pregnancy|1|||
27762024|NCT01283997|80954148|FG000|Overall Study|Other|4|||
27762025|NCT01283997|80954149|FG001|Overall Study|Other|4|||
27762026|NCT01989754|80954152|FG000|Overall Study|Withdrawal by Subject|10|||
27762027|NCT01989754|80954153|FG001|Overall Study|Withdrawal by Subject|14|||
27762028|NCT01989754|80954152|FG000|Overall Study|Lost to Follow-up|28|||
27762029|NCT01989754|80954153|FG001|Overall Study|Lost to Follow-up|20|||
27762030|NCT01989754|80954152|FG000|Overall Study|Closed Site|1|||
27762031|NCT01989754|80954153|FG001|Overall Study|Closed Site|1|||
27762032|NCT00892957|80954154|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
27762033|NCT00892957|80954155|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
27762034|NCT00892957|80954154|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
27762035|NCT00892957|80954155|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
27762036|NCT03846219|80954158|FG000|Overall Study|Withdrawal by Subject|3|||
27762037|NCT03846219|80954159|FG001|Overall Study|Withdrawal by Subject|2|||
27762038|NCT03846219|80954160|FG002|Overall Study|Withdrawal by Subject|2|||
27762039|NCT03846219|80954158|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
27762040|NCT03846219|80954159|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
27762041|NCT03846219|80954160|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
27762042|NCT03846219|80954158|FG000|Overall Study|Physician Decision|0|||
27762043|NCT03846219|80954159|FG001|Overall Study|Physician Decision|0|||
27762044|NCT03846219|80954160|FG002|Overall Study|Physician Decision|2|||
27762045|NCT00600028|80954161|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27762046|NCT00600028|80954162|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
27762047|NCT00600028|80954161|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
27762048|NCT00600028|80954162|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
27762049|NCT00600028|80954161|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
27762050|NCT00600028|80954162|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
27762051|NCT03833817|80954163|FG000|Overall Study|Withdrawal by Subject|3|||
27659357|NCT01106586|80589892|FG000|Overall Study|Participant Transferred to Another Study|212|||
27659358|NCT01106586|80589893|FG001|Overall Study|Participant Transferred to Another Study|197|||
27659359|NCT00784277|80589895|FG000|IR Treatment|Adverse Event|4|||
27659360|NCT00784277|80589896|FG001|IR Treatment|Adverse Event|8|||
27659361|NCT00784277|80589897|FG002|IR Treatment|Adverse Event|19|||
27659362|NCT00784277|80589898|FG003|IR Treatment|Adverse Event|35|||
27659363|NCT00784277|80589899|FG004|IR Treatment|Adverse Event|0|||
27659364|NCT00784277|80589900|FG005|IR Treatment|Adverse Event|0|||
27659365|NCT00784277|80589901|FG006|IR Treatment|Adverse Event|0|||
27659366|NCT00784277|80589895|FG000|IR Treatment|Lack of Efficacy|4|||
27659367|NCT00784277|80589896|FG001|IR Treatment|Lack of Efficacy|4|||
27659368|NCT00784277|80589897|FG002|IR Treatment|Lack of Efficacy|1|||
27659369|NCT00784277|80589898|FG003|IR Treatment|Lack of Efficacy|0|||
27659370|NCT00784277|80589899|FG004|IR Treatment|Lack of Efficacy|0|||
27659371|NCT00784277|80589900|FG005|IR Treatment|Lack of Efficacy|0|||
27659372|NCT00784277|80589901|FG006|IR Treatment|Lack of Efficacy|0|||
27659373|NCT00784277|80589895|FG000|IR Treatment|Lost to Follow-up|1|||
27659374|NCT00784277|80589896|FG001|IR Treatment|Lost to Follow-up|0|||
27659375|NCT00784277|80589897|FG002|IR Treatment|Lost to Follow-up|1|||
27659376|NCT00784277|80589898|FG003|IR Treatment|Lost to Follow-up|0|||
27659377|NCT00784277|80589899|FG004|IR Treatment|Lost to Follow-up|0|||
27659378|NCT00784277|80589900|FG005|IR Treatment|Lost to Follow-up|0|||
27659379|NCT00784277|80589901|FG006|IR Treatment|Lost to Follow-up|0|||
27659380|NCT00784277|80589895|FG000|IR Treatment|Withdrawal by Subject|5|||
27659381|NCT00784277|80589896|FG001|IR Treatment|Withdrawal by Subject|1|||
27659382|NCT00784277|80589897|FG002|IR Treatment|Withdrawal by Subject|4|||
27659383|NCT00784277|80589898|FG003|IR Treatment|Withdrawal by Subject|6|||
27659384|NCT00784277|80589899|FG004|IR Treatment|Withdrawal by Subject|0|||
27659385|NCT00784277|80589900|FG005|IR Treatment|Withdrawal by Subject|0|||
27659386|NCT00784277|80589901|FG006|IR Treatment|Withdrawal by Subject|0|||
27659387|NCT00784277|80589895|FG000|IR Treatment|Resolution Of Pain|0|||
27659388|NCT00784277|80589896|FG001|IR Treatment|Resolution Of Pain|1|||
27762052|NCT03833817|80954164|FG001|Overall Study|Withdrawal by Subject|3|||
27762053|NCT03833817|80954163|FG000|Overall Study|Lost to Follow-up|3|||
27762054|NCT03833817|80954164|FG001|Overall Study|Lost to Follow-up|3|||
27762055|NCT02395653|80954165|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
27762056|NCT02395653|80954165|FG000|Overall Study|Consent Withdrawn at Screening|1|||
27762057|NCT02395653|80954165|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
27762058|NCT02395653|80954165|FG000|Overall Study|Investigator Decision at Screening|1|||
27762059|NCT02395653|80954165|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
27762060|NCT02395653|80954165|FG000|Overall Study|Withdrawal by Subject|1|||
27568502|NCT04372602|80271320|FG000|Overall Study|Adverse Event|0|||
27659389|NCT00784277|80589897|FG002|IR Treatment|Resolution Of Pain|0|||
27659390|NCT00784277|80589898|FG003|IR Treatment|Resolution Of Pain|0|||
27659391|NCT00784277|80589899|FG004|IR Treatment|Resolution Of Pain|0|||
27659392|NCT00784277|80589900|FG005|IR Treatment|Resolution Of Pain|0|||
27659393|NCT00784277|80589901|FG006|IR Treatment|Resolution Of Pain|0|||
27659394|NCT00784277|80589895|FG000|IR Treatment|Other|2|||
27659395|NCT00784277|80589896|FG001|IR Treatment|Other|3|||
27659396|NCT00784277|80589897|FG002|IR Treatment|Other|3|||
27659397|NCT00784277|80589898|FG003|IR Treatment|Other|2|||
27659398|NCT00784277|80589899|FG004|IR Treatment|Other|0|||
27659399|NCT00784277|80589900|FG005|IR Treatment|Other|0|||
27659400|NCT00784277|80589901|FG006|IR Treatment|Other|0|||
27659401|NCT00784277|80589895|FG000|ER Treatment|Adverse Event|0|||
27659402|NCT00784277|80589896|FG001|ER Treatment|Adverse Event|0|||
27659403|NCT00784277|80589897|FG002|ER Treatment|Adverse Event|0|||
27659404|NCT00784277|80589898|FG003|ER Treatment|Adverse Event|0|||
27659405|NCT00784277|80589899|FG004|ER Treatment|Adverse Event|1|||
27659406|NCT00784277|80589900|FG005|ER Treatment|Adverse Event|7|||
27659407|NCT00784277|80589901|FG006|ER Treatment|Adverse Event|7|||
27659408|NCT00784277|80589895|FG000|ER Treatment|Lack of Efficacy|0|||
27659409|NCT00784277|80589896|FG001|ER Treatment|Lack of Efficacy|0|||
27659410|NCT00784277|80589897|FG002|ER Treatment|Lack of Efficacy|0|||
27659411|NCT00784277|80589898|FG003|ER Treatment|Lack of Efficacy|0|||
27659412|NCT00784277|80589899|FG004|ER Treatment|Lack of Efficacy|3|||
27659413|NCT00784277|80589900|FG005|ER Treatment|Lack of Efficacy|4|||
27659414|NCT00784277|80589901|FG006|ER Treatment|Lack of Efficacy|0|||
27659415|NCT00784277|80589895|FG000|ER Treatment|Lost to Follow-up|0|||
27659416|NCT00784277|80589896|FG001|ER Treatment|Lost to Follow-up|0|||
27659417|NCT00784277|80589897|FG002|ER Treatment|Lost to Follow-up|0|||
27659418|NCT00784277|80589898|FG003|ER Treatment|Lost to Follow-up|0|||
27659419|NCT00784277|80589899|FG004|ER Treatment|Lost to Follow-up|0|||
27659420|NCT00784277|80589900|FG005|ER Treatment|Lost to Follow-up|2|||
27659421|NCT00784277|80589901|FG006|ER Treatment|Lost to Follow-up|0|||
27659422|NCT00784277|80589895|FG000|ER Treatment|Withdrawal by Subject|0|||
27659423|NCT00784277|80589896|FG001|ER Treatment|Withdrawal by Subject|0|||
27659424|NCT00784277|80589897|FG002|ER Treatment|Withdrawal by Subject|0|||
27659425|NCT00784277|80589898|FG003|ER Treatment|Withdrawal by Subject|0|||
27659426|NCT00784277|80589899|FG004|ER Treatment|Withdrawal by Subject|2|||
27659427|NCT00784277|80589900|FG005|ER Treatment|Withdrawal by Subject|5|||
27659428|NCT00784277|80589901|FG006|ER Treatment|Withdrawal by Subject|3|||
27659429|NCT00784277|80589895|FG000|ER Treatment|Study Medication Non-Compliant|0|||
27659430|NCT00784277|80589896|FG001|ER Treatment|Study Medication Non-Compliant|0|||
27659431|NCT00784277|80589897|FG002|ER Treatment|Study Medication Non-Compliant|0|||
27659432|NCT00784277|80589898|FG003|ER Treatment|Study Medication Non-Compliant|0|||
27659433|NCT00784277|80589899|FG004|ER Treatment|Study Medication Non-Compliant|2|||
27659434|NCT00784277|80589900|FG005|ER Treatment|Study Medication Non-Compliant|3|||
27659435|NCT00784277|80589901|FG006|ER Treatment|Study Medication Non-Compliant|3|||
27659436|NCT00784277|80589895|FG000|ER Treatment|Other|0|||
27659437|NCT00784277|80589896|FG001|ER Treatment|Other|0|||
27659438|NCT00784277|80589897|FG002|ER Treatment|Other|0|||
27762061|NCT02395653|80954165|FG000|Overall Study|Lost to Follow-up|1|||
27762062|NCT01071096|80954166|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
27762063|NCT01071096|80954167|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
27762064|NCT01199055|80954168|FG000|Overall Study|Death|0|||
27762065|NCT01199055|80954169|FG001|Overall Study|Death|1|||
27762066|NCT01199055|80954170|FG002|Overall Study|Death|0|||
27762067|NCT01199055|80954168|FG000|Overall Study|Physician Decision|0|||
27762068|NCT01199055|80954169|FG001|Overall Study|Physician Decision|1|||
27762069|NCT01199055|80954170|FG002|Overall Study|Physician Decision|1|||
27762070|NCT01199055|80954168|FG000|Overall Study|Progressive disease|2|||
27762071|NCT01199055|80954169|FG001|Overall Study|Progressive disease|1|||
27762072|NCT01199055|80954170|FG002|Overall Study|Progressive disease|2|||
27762073|NCT01199055|80954168|FG000|Overall Study|Withdrawal by Subject|0|||
27762074|NCT01199055|80954169|FG001|Overall Study|Withdrawal by Subject|0|||
27762075|NCT01199055|80954170|FG002|Overall Study|Withdrawal by Subject|1|||
27762076|NCT02247401|80954180|FG000|Overall Study|Adverse Event|1|||
27762077|NCT02247401|80954181|FG001|Overall Study|Adverse Event|0|||
27762078|NCT02247401|80954182|FG002|Overall Study|Adverse Event|0|||
27762079|NCT02247401|80954180|FG000|Overall Study|Withdrawal by Subject|4|||
27762080|NCT02247401|80954181|FG001|Overall Study|Withdrawal by Subject|1|||
27762081|NCT02247401|80954182|FG002|Overall Study|Withdrawal by Subject|1|||
27762082|NCT02247401|80954180|FG000|Overall Study|Lost to Follow-up|1|||
27762083|NCT02247401|80954181|FG001|Overall Study|Lost to Follow-up|1|||
27860829|NCT01473524|81322816|FG004|LTSE Phase|Pregnancy|0|||
27659439|NCT00784277|80589898|FG003|ER Treatment|Other|0|||
27659440|NCT00784277|80589899|FG004|ER Treatment|Other|1|||
27659441|NCT00784277|80589900|FG005|ER Treatment|Other|3|||
27659442|NCT00784277|80589901|FG006|ER Treatment|Other|2|||
27659443|NCT01323309|80589904|FG000|Overall Study|Death|9|||
27659444|NCT01323309|80589905|FG001|Overall Study|Death|15|||
27659445|NCT01323309|80589906|FG002|Overall Study|Death|5|||
27659446|NCT01323309|80589904|FG000|Overall Study|Lost to Follow-up|11|||
27659447|NCT01323309|80589905|FG001|Overall Study|Lost to Follow-up|14|||
27659448|NCT01323309|80589906|FG002|Overall Study|Lost to Follow-up|24|||
27659449|NCT01323309|80589904|FG000|Overall Study|Withdrawal by Subject|14|||
27762084|NCT02247401|80954182|FG002|Overall Study|Lost to Follow-up|1|||
27762085|NCT00441103|80954183|FG000|Overall Study|Adverse Event|2|||
27762086|NCT00441103|80954184|FG001|Overall Study|Adverse Event|1|||
27762087|NCT00441103|80954183|FG000|Overall Study|Death|1|||
27762088|NCT00441103|80954184|FG001|Overall Study|Death|0|||
27762089|NCT00441103|80954183|FG000|Overall Study|Disease Progression|2|||
27762090|NCT00441103|80954184|FG001|Overall Study|Disease Progression|0|||
27762091|NCT00441103|80954183|FG000|Overall Study|Lost to Follow-up|1|||
27762092|NCT00441103|80954184|FG001|Overall Study|Lost to Follow-up|0|||
27762093|NCT00441103|80954183|FG000|Overall Study|Protocol Violation|1|||
27762094|NCT00441103|80954184|FG001|Overall Study|Protocol Violation|0|||
27762095|NCT00441103|80954183|FG000|Overall Study|Participant unable to use Rebiject II|1|||
27762096|NCT00441103|80954184|FG001|Overall Study|Participant unable to use Rebiject II|0|||
27762097|NCT00441103|80954183|FG000|Overall Study|Participant refused MRI|1|||
27762098|NCT00441103|80954184|FG001|Overall Study|Participant refused MRI|0|||
27762099|NCT00441103|80954183|FG000|Overall Study|Inclusion criteria absent|1|||
27762100|NCT00441103|80954184|FG001|Overall Study|Inclusion criteria absent|0|||
27762101|NCT00441103|80954183|FG000|Overall Study|Non-compliant|0|||
27762102|NCT00441103|80954184|FG001|Overall Study|Non-compliant|1|||
27762103|NCT00441103|80954183|FG000|Overall Study|Participant decided to withdraw|1|||
27860830|NCT01473524|81322817|FG005|LTSE Phase|Pregnancy|0|||
27860831|NCT01473524|81322812|FG000|LTSE Phase|Protocol Violation|0|||
27659450|NCT01323309|80589905|FG001|Overall Study|Withdrawal by Subject|14|||
27659451|NCT01323309|80589906|FG002|Overall Study|Withdrawal by Subject|18|||
27762104|NCT00441103|80954184|FG001|Overall Study|Participant decided to withdraw|0|||
27762105|NCT00441103|80954183|FG000|Overall Study|Participant's reason|0|||
27762106|NCT00441103|80954184|FG001|Overall Study|Participant's reason|1|||
27762107|NCT00441103|80954183|FG000|Overall Study|Participant decided to stop|0|||
27762108|NCT00441103|80954184|FG001|Overall Study|Participant decided to stop|1|||
27762109|NCT00225147|80954185|FG000|Open-label Phase|Lost to Follow-up|0|||
27762110|NCT00225147|80954186|FG001|Open-label Phase|Lost to Follow-up|0|||
27762111|NCT00225147|80954187|FG002|Open-label Phase|Lost to Follow-up|0|||
27762112|NCT00225147|80954188|FG003|Open-label Phase|Lost to Follow-up|4|||
27762113|NCT00225147|80954185|FG000|Open-label Phase|Withdrawal by Subject|0|||
27762114|NCT00225147|80954186|FG001|Open-label Phase|Withdrawal by Subject|0|||
27762115|NCT00225147|80954187|FG002|Open-label Phase|Withdrawal by Subject|0|||
27762116|NCT00225147|80954188|FG003|Open-label Phase|Withdrawal by Subject|6|||
27860832|NCT01473524|81322813|FG001|LTSE Phase|Protocol Violation|0|||
27860833|NCT01473524|81322814|FG002|LTSE Phase|Protocol Violation|0|||
27860834|NCT01473524|81322815|FG003|LTSE Phase|Protocol Violation|0|||
27860835|NCT01473524|81322816|FG004|LTSE Phase|Protocol Violation|0|||
27659452|NCT01323309|80589904|FG000|Overall Study|Disease progression|5|||
27659453|NCT01323309|80589905|FG001|Overall Study|Disease progression|11|||
27659454|NCT01323309|80589906|FG002|Overall Study|Disease progression|4|||
27659455|NCT04585815|80589907|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
27659456|NCT04585815|80589908|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
27659457|NCT04585815|80589909|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
27659458|NCT04585815|80589910|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
27659459|NCT04585815|80589911|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
27659460|NCT04585815|80589912|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
27659461|NCT04585815|80589913|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
27659462|NCT04585815|80589907|FG000|Sub-study A- Treatment Phase|Death|0|||
27659463|NCT04585815|80589908|FG001|Sub-study A- Treatment Phase|Death|1|||
27659464|NCT04585815|80589909|FG002|Sub-study A- Treatment Phase|Death|0|||
27659465|NCT04585815|80589910|FG003|Sub-study A- Treatment Phase|Death|0|||
27659466|NCT04585815|80589911|FG004|Sub-study A- Treatment Phase|Death|0|||
27659467|NCT04585815|80589912|FG005|Sub-study A- Treatment Phase|Death|0|||
27659468|NCT04585815|80589913|FG006|Sub-study A- Treatment Phase|Death|0|||
27659469|NCT04585815|80589907|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
27659470|NCT04585815|80589908|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27659471|NCT04585815|80589909|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27659472|NCT04585815|80589910|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27659473|NCT04585815|80589911|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27659474|NCT04585815|80589912|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27860836|NCT01473524|81322817|FG005|LTSE Phase|Protocol Violation|1|||
27659475|NCT04585815|80589913|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
27659476|NCT04585815|80589907|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27659477|NCT04585815|80589908|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
27659478|NCT04585815|80589909|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27762117|NCT01392378|80954193|FG000|Infant Series|Adverse Event|0|||
27762118|NCT01392378|80954194|FG001|Infant Series|Adverse Event|0|||
27762119|NCT01392378|80954195|FG002|Infant Series|Adverse Event|0|||
27762120|NCT01392378|80954196|FG003|Infant Series|Adverse Event|1|||
27762121|NCT01392378|80954197|FG004|Infant Series|Adverse Event|0|||
27860837|NCT03146962|81322818|FG000|Overall Study|Lost to Follow-up|1|||
27860838|NCT03146962|81322819|FG001|Overall Study|Lost to Follow-up|1|||
27659479|NCT04585815|80589910|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27659480|NCT04585815|80589911|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27659481|NCT04585815|80589912|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27659482|NCT04585815|80589913|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
27659483|NCT04585815|80589907|FG000|Sub-study A- Treatment Phase|Other|1|||
27659484|NCT04585815|80589908|FG001|Sub-study A- Treatment Phase|Other|0|||
27659485|NCT04585815|80589909|FG002|Sub-study A- Treatment Phase|Other|0|||
27659486|NCT04585815|80589910|FG003|Sub-study A- Treatment Phase|Other|0|||
27659487|NCT04585815|80589911|FG004|Sub-study A- Treatment Phase|Other|0|||
27659488|NCT04585815|80589912|FG005|Sub-study A- Treatment Phase|Other|0|||
27659489|NCT04585815|80589913|FG006|Sub-study A- Treatment Phase|Other|0|||
27659490|NCT04585815|80589907|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
27659491|NCT04585815|80589908|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
27659492|NCT04585815|80589909|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
27659493|NCT04585815|80589910|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
27659494|NCT04585815|80589911|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
27860839|NCT03146962|81322820|FG002|Overall Study|Lost to Follow-up|0|||
27860840|NCT03146962|81322821|FG003|Overall Study|Lost to Follow-up|0|||
27860841|NCT03146962|81322822|FG004|Overall Study|Lost to Follow-up|0|||
27860842|NCT03146962|81322823|FG005|Overall Study|Lost to Follow-up|0|||
27860843|NCT03146962|81322824|FG006|Overall Study|Lost to Follow-up|0|||
27860844|NCT03146962|81322825|FG007|Overall Study|Lost to Follow-up|0|||
27860845|NCT03146962|81322826|FG008|Overall Study|Lost to Follow-up|0|||
27860846|NCT03146962|81322827|FG009|Overall Study|Lost to Follow-up|0|||
27860847|NCT03146962|81322818|FG000|Overall Study|Adverse Event|0|||
27860848|NCT03146962|81322819|FG001|Overall Study|Adverse Event|3|||
27860849|NCT03146962|81322820|FG002|Overall Study|Adverse Event|0|||
27860850|NCT03146962|81322821|FG003|Overall Study|Adverse Event|0|||
27860851|NCT03146962|81322822|FG004|Overall Study|Adverse Event|0|||
27860852|NCT03146962|81322823|FG005|Overall Study|Adverse Event|0|||
27860853|NCT03146962|81322824|FG006|Overall Study|Adverse Event|0|||
27860854|NCT03146962|81322825|FG007|Overall Study|Adverse Event|1|||
27860855|NCT03146962|81322826|FG008|Overall Study|Adverse Event|0|||
27860856|NCT03146962|81322827|FG009|Overall Study|Adverse Event|0|||
27860857|NCT03146962|81322818|FG000|Overall Study|Withdrawal by Subject|0|||
27860858|NCT03146962|81322819|FG001|Overall Study|Withdrawal by Subject|0|||
27860859|NCT03146962|81322820|FG002|Overall Study|Withdrawal by Subject|0|||
27860860|NCT03146962|81322821|FG003|Overall Study|Withdrawal by Subject|0|||
27860861|NCT03146962|81322822|FG004|Overall Study|Withdrawal by Subject|1|||
27860862|NCT03146962|81322823|FG005|Overall Study|Withdrawal by Subject|0|||
27860863|NCT03146962|81322824|FG006|Overall Study|Withdrawal by Subject|0|||
27860864|NCT03146962|81322825|FG007|Overall Study|Withdrawal by Subject|0|||
27860865|NCT03146962|81322826|FG008|Overall Study|Withdrawal by Subject|0|||
27860866|NCT03146962|81322827|FG009|Overall Study|Withdrawal by Subject|0|||
27860867|NCT03146962|81322818|FG000|Overall Study|Death|0|||
27860868|NCT03146962|81322819|FG001|Overall Study|Death|1|||
27860869|NCT03146962|81322820|FG002|Overall Study|Death|0|||
27860870|NCT03146962|81322821|FG003|Overall Study|Death|0|||
27860871|NCT03146962|81322822|FG004|Overall Study|Death|0|||
27860872|NCT03146962|81322823|FG005|Overall Study|Death|0|||
27860873|NCT03146962|81322824|FG006|Overall Study|Death|0|||
27659495|NCT04585815|80589912|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
27659496|NCT04585815|80589913|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
27659497|NCT04585815|80589907|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27659498|NCT04585815|80589908|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
27659499|NCT04585815|80589909|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27659500|NCT04585815|80589910|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27659501|NCT04585815|80589911|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27659502|NCT04585815|80589912|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27659503|NCT04585815|80589913|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
27659504|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
27659505|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
27659506|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
27659507|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
27659508|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
27659509|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
27659510|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
27860874|NCT03146962|81322825|FG007|Overall Study|Death|0|||
27860875|NCT03146962|81322826|FG008|Overall Study|Death|0|||
27659511|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Death|0|||
27860876|NCT03146962|81322827|FG009|Overall Study|Death|0|||
27860877|NCT03146962|81322818|FG000|Overall Study|COVID Precautions|1|||
27860878|NCT03146962|81322819|FG001|Overall Study|COVID Precautions|0|||
27860879|NCT03146962|81322820|FG002|Overall Study|COVID Precautions|0|||
27860880|NCT03146962|81322821|FG003|Overall Study|COVID Precautions|0|||
27860881|NCT03146962|81322822|FG004|Overall Study|COVID Precautions|0|||
27659512|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Death|0|||
27659513|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Death|0|||
27659514|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Death|1|||
27659515|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Death|0|||
27659516|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Death|0|||
27659517|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Death|0|||
27659518|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
27659519|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
27659520|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
27659521|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
27659522|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
27659523|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
27659524|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
27659525|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
27659526|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
27659527|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
27659528|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
27659529|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
27659530|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
27659531|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
27659532|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
27659533|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
27659534|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
27659535|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
27659536|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
27659537|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
27659538|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
27659539|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
27659540|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
27659541|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
27762122|NCT01392378|80954193|FG000|Infant Series|Lost to Follow-up|0|||
27762123|NCT01392378|80954194|FG001|Infant Series|Lost to Follow-up|0|||
27762124|NCT01392378|80954195|FG002|Infant Series|Lost to Follow-up|0|||
27762125|NCT01392378|80954196|FG003|Infant Series|Lost to Follow-up|1|||
27762126|NCT01392378|80954197|FG004|Infant Series|Lost to Follow-up|0|||
27762127|NCT01392378|80954193|FG000|Infant Series|Protocol Violation|0|||
27762128|NCT01392378|80954194|FG001|Infant Series|Protocol Violation|1|||
27762129|NCT01392378|80954195|FG002|Infant Series|Protocol Violation|0|||
27762130|NCT01392378|80954196|FG003|Infant Series|Protocol Violation|0|||
27762131|NCT01392378|80954197|FG004|Infant Series|Protocol Violation|0|||
27860882|NCT03146962|81322823|FG005|Overall Study|COVID Precautions|0|||
27860883|NCT03146962|81322824|FG006|Overall Study|COVID Precautions|0|||
27860884|NCT03146962|81322825|FG007|Overall Study|COVID Precautions|0|||
27860885|NCT03146962|81322826|FG008|Overall Study|COVID Precautions|0|||
27860886|NCT03146962|81322827|FG009|Overall Study|COVID Precautions|0|||
27860887|NCT03146962|81322818|FG000|Overall Study|Physician Decision|0|||
27860888|NCT03146962|81322819|FG001|Overall Study|Physician Decision|0|||
27860889|NCT03146962|81322820|FG002|Overall Study|Physician Decision|0|||
27860890|NCT03146962|81322821|FG003|Overall Study|Physician Decision|0|||
27860891|NCT03146962|81322822|FG004|Overall Study|Physician Decision|0|||
27860892|NCT03146962|81322823|FG005|Overall Study|Physician Decision|0|||
27860893|NCT03146962|81322824|FG006|Overall Study|Physician Decision|0|||
27860894|NCT03146962|81322825|FG007|Overall Study|Physician Decision|0|||
27860895|NCT03146962|81322826|FG008|Overall Study|Physician Decision|0|||
27860896|NCT03146962|81322827|FG009|Overall Study|Physician Decision|1|||
27860897|NCT03146962|81322818|FG000|Overall Study|Started New Treatment|0|||
27860898|NCT03146962|81322819|FG001|Overall Study|Started New Treatment|1|||
27860899|NCT03146962|81322820|FG002|Overall Study|Started New Treatment|0|||
27860900|NCT03146962|81322821|FG003|Overall Study|Started New Treatment|0|||
27860901|NCT03146962|81322822|FG004|Overall Study|Started New Treatment|0|||
27860902|NCT03146962|81322823|FG005|Overall Study|Started New Treatment|0|||
27860903|NCT03146962|81322824|FG006|Overall Study|Started New Treatment|0|||
27762132|NCT01392378|80954193|FG000|Infant Series|Withdrawal by Parent|4|||
27762133|NCT01392378|80954194|FG001|Infant Series|Withdrawal by Parent|1|||
27762134|NCT01392378|80954195|FG002|Infant Series|Withdrawal by Parent|0|||
27762135|NCT01392378|80954196|FG003|Infant Series|Withdrawal by Parent|0|||
27860904|NCT03146962|81322825|FG007|Overall Study|Started New Treatment|0|||
27860905|NCT03146962|81322826|FG008|Overall Study|Started New Treatment|0|||
27860906|NCT03146962|81322827|FG009|Overall Study|Started New Treatment|0|||
27860907|NCT05314816|81322829|FG000|Overall Study|Lost to Follow-up|5|||
27860908|NCT05314816|81322830|FG001|Overall Study|Lost to Follow-up|0|||
27762136|NCT01392378|80954197|FG004|Infant Series|Withdrawal by Parent|0|||
27762137|NCT01392378|80954193|FG000|After Infant Series|Lost to Follow-up|0|||
27762138|NCT01392378|80954194|FG001|After Infant Series|Lost to Follow-up|0|||
27762139|NCT01392378|80954195|FG002|After Infant Series|Lost to Follow-up|1|||
27762140|NCT01392378|80954196|FG003|After Infant Series|Lost to Follow-up|0|||
27762141|NCT01392378|80954197|FG004|After Infant Series|Lost to Follow-up|0|||
27860909|NCT05314816|81322831|FG002|Overall Study|Lost to Follow-up|1|||
27860910|NCT05314816|81322829|FG000|Overall Study|Protocol Violation|13|||
27860911|NCT05314816|81322830|FG001|Overall Study|Protocol Violation|8|||
27860912|NCT05314816|81322831|FG002|Overall Study|Protocol Violation|0|||
27860913|NCT00866658|81322832|FG000|Overall Study|Adverse Event|5|||
27860914|NCT00866658|81322833|FG001|Overall Study|Adverse Event|14|||
27860915|NCT00866658|81322832|FG000|Overall Study|Lack of Efficacy|2|||
27860916|NCT00866658|81322833|FG001|Overall Study|Lack of Efficacy|1|||
27860917|NCT00866658|81322832|FG000|Overall Study|Withdrawal by Subject|1|||
27860918|NCT00866658|81322833|FG001|Overall Study|Withdrawal by Subject|0|||
27860919|NCT00866658|81322832|FG000|Overall Study|Protocol Violation|1|||
27568503|NCT04372602|80271321|FG001|Overall Study|Adverse Event|1|||
27568504|NCT04372602|80271320|FG000|Overall Study|Transitioned to comfort care|0|||
27659542|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
27659543|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
27659544|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
27659545|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
27659546|NCT04585815|80589907|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
27659547|NCT04585815|80589908|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
27659548|NCT04585815|80589909|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
27659549|NCT04585815|80589910|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
27659550|NCT04585815|80589911|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
27659551|NCT04585815|80589912|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
27762142|NCT01392378|80954193|FG000|After Infant Series|Withdrawal by Parent|0|||
27762143|NCT01392378|80954194|FG001|After Infant Series|Withdrawal by Parent|1|||
27762144|NCT01392378|80954195|FG002|After Infant Series|Withdrawal by Parent|1|||
27762145|NCT01392378|80954196|FG003|After Infant Series|Withdrawal by Parent|0|||
27762146|NCT01392378|80954197|FG004|After Infant Series|Withdrawal by Parent|1|||
27762147|NCT01392378|80954193|FG000|Toddler Dose|Lost to Follow-up|0|||
27762148|NCT01392378|80954194|FG001|Toddler Dose|Lost to Follow-up|0|||
27762149|NCT01392378|80954195|FG002|Toddler Dose|Lost to Follow-up|0|||
27762150|NCT01392378|80954196|FG003|Toddler Dose|Lost to Follow-up|1|||
27762151|NCT01392378|80954197|FG004|Toddler Dose|Lost to Follow-up|0|||
27762152|NCT01392378|80954193|FG000|Toddler Dose|Withdrawal by Parent|0|||
27762153|NCT01392378|80954194|FG001|Toddler Dose|Withdrawal by Parent|1|||
27762154|NCT01392378|80954195|FG002|Toddler Dose|Withdrawal by Parent|0|||
27762155|NCT01392378|80954196|FG003|Toddler Dose|Withdrawal by Parent|1|||
27762156|NCT01392378|80954197|FG004|Toddler Dose|Withdrawal by Parent|1|||
27762157|NCT00862654|80954198|FG000|Overall Study|Lack of Efficacy|1|||
27762158|NCT00862654|80954199|FG001|Overall Study|Lack of Efficacy|0|||
27762159|NCT00862654|80954200|FG002|Overall Study|Lack of Efficacy|1|||
27762160|NCT00862654|80954201|FG003|Overall Study|Lack of Efficacy|0|||
27762161|NCT00862654|80954198|FG000|Overall Study|Lost to Follow-up|1|||
27762162|NCT00862654|80954199|FG001|Overall Study|Lost to Follow-up|2|||
27762163|NCT00862654|80954200|FG002|Overall Study|Lost to Follow-up|1|||
27762164|NCT00862654|80954201|FG003|Overall Study|Lost to Follow-up|3|||
27762165|NCT00862654|80954198|FG000|Overall Study|Adverse Event|0|||
27762166|NCT00862654|80954199|FG001|Overall Study|Adverse Event|1|||
27762167|NCT00862654|80954200|FG002|Overall Study|Adverse Event|1|||
27762168|NCT00862654|80954201|FG003|Overall Study|Adverse Event|0|||
27762169|NCT00862654|80954198|FG000|Overall Study|Pregnancy|1|||
27762170|NCT00862654|80954199|FG001|Overall Study|Pregnancy|1|||
27762171|NCT00862654|80954200|FG002|Overall Study|Pregnancy|0|||
27762172|NCT00862654|80954201|FG003|Overall Study|Pregnancy|0|||
27762173|NCT00862654|80954198|FG000|Overall Study|Withdrawal by Subject|2|||
27860920|NCT00866658|81322833|FG001|Overall Study|Protocol Violation|1|||
27860921|NCT00866658|81322832|FG000|Overall Study|Familial and Personal Reasons|4|||
27860922|NCT00866658|81322833|FG001|Overall Study|Familial and Personal Reasons|5|||
27860923|NCT03783039|81322841|FG000|Overall Study|Death|2|||
27860924|NCT03783039|81322842|FG001|Overall Study|Death|1|||
27860925|NCT02315196|81322843|FG000|Overall Study|Withdrew consent|9|||
27568505|NCT04372602|80271321|FG001|Overall Study|Transitioned to comfort care|1|||
27568506|NCT01364428|80271327|FG000|Overall Study|Adverse Event|1|||
27568507|NCT01364428|80271328|FG001|Overall Study|Adverse Event|2|||
27568508|NCT01364428|80271327|FG000|Overall Study|Protocol Violation|2|||
27568509|NCT01364428|80271328|FG001|Overall Study|Protocol Violation|0|||
27568510|NCT01364428|80271327|FG000|Overall Study|Withdrawal Criteria|14|||
27568511|NCT01364428|80271328|FG001|Overall Study|Withdrawal Criteria|10|||
27568512|NCT01364428|80271327|FG000|Overall Study|Other|3|||
27568513|NCT01364428|80271328|FG001|Overall Study|Other|3|||
27568514|NCT01449526|80271329|FG000|Overall Study|Lost to Follow-up|1|||
27568515|NCT01449526|80271330|FG001|Overall Study|Lost to Follow-up|2|||
27659552|NCT04585815|80589913|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
27659553|NCT04585815|80589907|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
27659554|NCT04585815|80589908|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
27659555|NCT04585815|80589909|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
27659556|NCT04585815|80589910|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
27659557|NCT04585815|80589911|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
27659558|NCT04585815|80589912|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
27659559|NCT04585815|80589913|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
27659560|NCT04585815|80589907|FG000|Sub-study B- Follow-up Phase|Death|0|||
27659561|NCT04585815|80589908|FG001|Sub-study B- Follow-up Phase|Death|0|||
27659562|NCT04585815|80589909|FG002|Sub-study B- Follow-up Phase|Death|1|||
27659563|NCT04585815|80589910|FG003|Sub-study B- Follow-up Phase|Death|3|||
27659564|NCT04585815|80589911|FG004|Sub-study B- Follow-up Phase|Death|0|||
27659565|NCT04585815|80589912|FG005|Sub-study B- Follow-up Phase|Death|0|||
27659566|NCT04585815|80589913|FG006|Sub-study B- Follow-up Phase|Death|1|||
27659567|NCT00473512|80589916|FG000|Period 1 (Phase 1)|Adverse Event|0|||
27659568|NCT00473512|80589917|FG001|Period 1 (Phase 1)|Adverse Event|0|||
27659569|NCT00473512|80589918|FG002|Period 1 (Phase 1)|Adverse Event|0|||
27659570|NCT00473512|80589919|FG003|Period 1 (Phase 1)|Adverse Event|5|||
27659571|NCT00473512|80589920|FG004|Period 1 (Phase 1)|Adverse Event|0|||
27659572|NCT00473512|80589916|FG000|Period 1 (Phase 1)|Death|0|||
27659573|NCT00473512|80589917|FG001|Period 1 (Phase 1)|Death|0|||
27659574|NCT00473512|80589918|FG002|Period 1 (Phase 1)|Death|0|||
27659575|NCT00473512|80589919|FG003|Period 1 (Phase 1)|Death|1|||
27659576|NCT00473512|80589920|FG004|Period 1 (Phase 1)|Death|0|||
27659577|NCT00473512|80589916|FG000|Period 1 (Phase 1)|Disease Progression|1|||
27659578|NCT00473512|80589917|FG001|Period 1 (Phase 1)|Disease Progression|1|||
27659579|NCT00473512|80589918|FG002|Period 1 (Phase 1)|Disease Progression|0|||
27659580|NCT00473512|80589919|FG003|Period 1 (Phase 1)|Disease Progression|10|||
27659581|NCT00473512|80589920|FG004|Period 1 (Phase 1)|Disease Progression|1|||
27659582|NCT00473512|80589916|FG000|Period 1 (Phase 1)|Other|0|||
27659583|NCT00473512|80589917|FG001|Period 1 (Phase 1)|Other|0|||
27659584|NCT00473512|80589918|FG002|Period 1 (Phase 1)|Other|0|||
27659585|NCT00473512|80589919|FG003|Period 1 (Phase 1)|Other|1|||
27659586|NCT00473512|80589920|FG004|Period 1 (Phase 1)|Other|0|||
27659587|NCT00473512|80589916|FG000|Period 2 (Phase 2)|Adverse Event|0|||
27659588|NCT00473512|80589917|FG001|Period 2 (Phase 2)|Adverse Event|0|||
27659589|NCT00473512|80589918|FG002|Period 2 (Phase 2)|Adverse Event|0|||
27659590|NCT00473512|80589919|FG003|Period 2 (Phase 2)|Adverse Event|1|||
27659591|NCT00473512|80589920|FG004|Period 2 (Phase 2)|Adverse Event|0|||
27659592|NCT00473512|80589916|FG000|Period 2 (Phase 2)|Death|0|||
27659593|NCT00473512|80589917|FG001|Period 2 (Phase 2)|Death|0|||
27659594|NCT00473512|80589918|FG002|Period 2 (Phase 2)|Death|0|||
27659595|NCT00473512|80589919|FG003|Period 2 (Phase 2)|Death|1|||
27762174|NCT00862654|80954199|FG001|Overall Study|Withdrawal by Subject|2|||
27762175|NCT00862654|80954200|FG002|Overall Study|Withdrawal by Subject|2|||
27762176|NCT00862654|80954201|FG003|Overall Study|Withdrawal by Subject|3|||
27762177|NCT00862654|80954198|FG000|Overall Study|Subject mistake|0|||
27762178|NCT00862654|80954199|FG001|Overall Study|Subject mistake|1|||
27762179|NCT00862654|80954200|FG002|Overall Study|Subject mistake|0|||
27762180|NCT00862654|80954201|FG003|Overall Study|Subject mistake|0|||
27762181|NCT00862654|80954198|FG000|Overall Study|Familly constraint|0|||
27762182|NCT00862654|80954199|FG001|Overall Study|Familly constraint|1|||
27762183|NCT00862654|80954200|FG002|Overall Study|Familly constraint|0|||
27762184|NCT00862654|80954201|FG003|Overall Study|Familly constraint|0|||
27762185|NCT00862654|80954198|FG000|Overall Study|Never used study drugs|1|||
27762186|NCT00862654|80954199|FG001|Overall Study|Never used study drugs|0|||
27762187|NCT00862654|80954200|FG002|Overall Study|Never used study drugs|0|||
27762188|NCT00862654|80954201|FG003|Overall Study|Never used study drugs|0|||
27659596|NCT00473512|80589920|FG004|Period 2 (Phase 2)|Death|1|||
27762189|NCT00862654|80954198|FG000|Overall Study|Included after end of inclusions|0|||
27659597|NCT00473512|80589916|FG000|Period 2 (Phase 2)|Disease Progression|0|||
27659598|NCT00473512|80589917|FG001|Period 2 (Phase 2)|Disease Progression|2|||
27762190|NCT00862654|80954199|FG001|Overall Study|Included after end of inclusions|0|||
27762191|NCT00862654|80954200|FG002|Overall Study|Included after end of inclusions|1|||
27659599|NCT00473512|80589918|FG002|Period 2 (Phase 2)|Disease Progression|2|||
27659600|NCT00473512|80589919|FG003|Period 2 (Phase 2)|Disease Progression|17|||
27659601|NCT00473512|80589920|FG004|Period 2 (Phase 2)|Disease Progression|1|||
27659602|NCT00473512|80589916|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27659603|NCT00473512|80589917|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27659604|NCT00473512|80589918|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27659605|NCT00473512|80589919|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
27659606|NCT00473512|80589920|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
27659607|NCT00473512|80589916|FG000|Period 2 (Phase 2)|Other|1|||
27659608|NCT00473512|80589917|FG001|Period 2 (Phase 2)|Other|0|||
27659609|NCT00473512|80589918|FG002|Period 2 (Phase 2)|Other|0|||
27659610|NCT00473512|80589919|FG003|Period 2 (Phase 2)|Other|3|||
27659611|NCT00473512|80589920|FG004|Period 2 (Phase 2)|Other|0|||
27659612|NCT03332589|80589921|FG000|Overall Study|Lack of Efficacy|2|||
27659613|NCT03332589|80589922|FG001|Overall Study|Lack of Efficacy|0|||
27659614|NCT03332589|80589923|FG002|Overall Study|Lack of Efficacy|0|||
27659615|NCT03332589|80589921|FG000|Overall Study|Adverse Event|1|||
27659616|NCT03332589|80589922|FG001|Overall Study|Adverse Event|0|||
27659617|NCT03332589|80589923|FG002|Overall Study|Adverse Event|0|||
27659618|NCT03332589|80589921|FG000|Overall Study|Death|1|||
27659619|NCT03332589|80589922|FG001|Overall Study|Death|0|||
27659620|NCT03332589|80589923|FG002|Overall Study|Death|0|||
27659621|NCT00702520|80589924|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
27659622|NCT00702520|80589925|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
27659623|NCT00702520|80589926|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
27659624|NCT00702520|80589927|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
27659625|NCT00702520|80589924|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
27659626|NCT00702520|80589925|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
27659627|NCT00702520|80589926|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
27659628|NCT00702520|80589927|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
27659629|NCT00702520|80589924|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
27659630|NCT00702520|80589925|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
27659631|NCT00702520|80589926|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
27659632|NCT00702520|80589927|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
27659633|NCT04088500|80589929|FG000|Overall Study|Reason unknown|1|||
27659634|NCT04088500|80589929|FG000|Overall Study|Participant withdrew consent|1|||
27659635|NCT04088500|80589929|FG000|Overall Study|Disease progression|3|||
27659636|NCT01544153|80589930|FG000|Overall Study|Under 18|0|||
27659637|NCT01544153|80589931|FG001|Overall Study|Under 18|1|||
27659638|NCT01544153|80589932|FG002|Overall Study|Under 18|0|||
27659639|NCT01544153|80589933|FG003|Overall Study|Under 18|0|||
27659640|NCT01544153|80589930|FG000|Overall Study|Non-smoker|0|||
27659641|NCT01544153|80589931|FG001|Overall Study|Non-smoker|0|||
27659642|NCT01544153|80589932|FG002|Overall Study|Non-smoker|1|||
27659643|NCT01544153|80589933|FG003|Overall Study|Non-smoker|0|||
27659644|NCT02820298|80589938|FG000|Overall Study|Withdrawal by Subject|0|||
27659645|NCT02820298|80589939|FG001|Overall Study|Withdrawal by Subject|1|||
27659646|NCT02820298|80589938|FG000|Overall Study|Physician Decision|1|||
27659647|NCT02820298|80589939|FG001|Overall Study|Physician Decision|0|||
27659648|NCT02820298|80589938|FG000|Overall Study|Protocol Violation|0|||
27659649|NCT02820298|80589939|FG001|Overall Study|Protocol Violation|1|||
27659650|NCT02339506|80589943|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
27659651|NCT02339506|80589944|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
27659652|NCT02339506|80589943|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
27659653|NCT02339506|80589944|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
27659654|NCT01129011|80589945|FG000|Overall Study|Adverse Event|20|||
27659655|NCT01129011|80589946|FG001|Overall Study|Adverse Event|30|||
27659656|NCT01129011|80589945|FG000|Overall Study|Withdrawal by Subject|24|||
27659657|NCT01129011|80589946|FG001|Overall Study|Withdrawal by Subject|8|||
27659658|NCT01129011|80589945|FG000|Overall Study|Lost to Follow-up|6|||
27659659|NCT01129011|80589946|FG001|Overall Study|Lost to Follow-up|7|||
27659660|NCT01129011|80589945|FG000|Overall Study|Duodenal Ulcer|2|||
27659661|NCT01129011|80589946|FG001|Overall Study|Duodenal Ulcer|8|||
27659662|NCT01129011|80589945|FG000|Overall Study|misc|7|||
27659663|NCT01129011|80589946|FG001|Overall Study|misc|4|||
27659664|NCT00002540|80589947|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
27659665|NCT00002540|80589948|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
27659666|NCT00002540|80589947|FG000|Overall Study|Died Before Randomization|2|||
27659667|NCT00002540|80589948|FG001|Overall Study|Died Before Randomization|6|||
27659668|NCT00002540|80589947|FG000|Overall Study|Died Before ASU (Control)|202|||
27659669|NCT00002540|80589948|FG001|Overall Study|Died Before ASU (Control)|0|||
27659670|NCT00002540|80589947|FG000|Overall Study|Refused ASU (Control)|597|||
27659671|NCT00002540|80589948|FG001|Overall Study|Refused ASU (Control)|0|||
27659672|NCT00002540|80589947|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
27659673|NCT00002540|80589948|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
27659674|NCT00511147|80589951|FG000|Overall Study|Withdrawal by Subject|1|||
27659675|NCT00511147|80589951|FG000|Overall Study|Disease progression|5|||
27762192|NCT00862654|80954201|FG003|Overall Study|Included after end of inclusions|0|||
27762193|NCT02119026|80954202|FG000|1st-line Treatment|Adverse Event|9|||
27659676|NCT00511147|80589951|FG000|Overall Study|Required platelet transfusion|1|||
27659677|NCT03605745|80589952|FG000|Overall Study|Study was terminated for business reasons|47|||
27659678|NCT00839306|80589953|FG000|Overall Study|Adverse Event|3|||
27659679|NCT00839306|80589954|FG001|Overall Study|Adverse Event|5|||
27659680|NCT00839306|80589953|FG000|Overall Study|Lost to Follow-up|6|||
27659681|NCT00839306|80589954|FG001|Overall Study|Lost to Follow-up|9|||
27659682|NCT00839306|80589953|FG000|Overall Study|Withdrawal by Subject|5|||
27659683|NCT00839306|80589954|FG001|Overall Study|Withdrawal by Subject|7|||
27762194|NCT02119026|80954203|FG001|1st-line Treatment|Adverse Event|14|||
27659684|NCT00839306|80589953|FG000|Overall Study|Lack of Efficacy|5|||
27659685|NCT00839306|80589954|FG001|Overall Study|Lack of Efficacy|4|||
27659686|NCT00839306|80589953|FG000|Overall Study|Other|6|||
27659687|NCT00839306|80589954|FG001|Overall Study|Other|18|||
27659688|NCT04089332|80589955|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
27659689|NCT04089332|80589955|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
27659690|NCT04089332|80589955|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
27659691|NCT02056873|80589956|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
27659692|NCT04049578|80589962|FG000|Overall Study|Physician Decision|1|||
27659693|NCT03023878|80589963|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
27659694|NCT03023878|80589963|FG000|Pre-Study Run-In Period|Death|1|||
27659695|NCT03023878|80589963|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
27659696|NCT03023878|80589963|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
27659697|NCT03023878|80589963|FG000|Treatment Period|Disease Progression|1|||
27659698|NCT03023878|80589963|FG000|Treatment Period|Withdrawal by Subject|1|||
27659699|NCT03023878|80589963|FG000|Treatment Period|Adverse Event|1|||
27659700|NCT03023878|80589963|FG000|Long Term Follow-Up Period|Death|2|||
27659701|NCT04380688|80589966|FG000|Overall Study|Death|2|||
27659702|NCT04380688|80589967|FG001|Overall Study|Death|2|||
27659703|NCT04380688|80589966|FG000|Overall Study|Lost to Follow-up|2|||
27659704|NCT04380688|80589967|FG001|Overall Study|Lost to Follow-up|4|||
27659705|NCT04380688|80589966|FG000|Overall Study|Withdrawal by Subject|3|||
27659706|NCT04380688|80589967|FG001|Overall Study|Withdrawal by Subject|3|||
27659707|NCT00884793|80589968|FG000|Overall Study|Withdrawal by Subject|1|||
27659708|NCT05361304|80589969|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
27659709|NCT05361304|80589970|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
27659710|NCT05361304|80589969|FG000|Overall Study|COVID-19 Related|1|||
27659711|NCT05361304|80589970|FG001|Overall Study|COVID-19 Related|2|||
27659712|NCT05361304|80589969|FG000|Overall Study|Withdrawal by Subject|1|||
27659713|NCT05361304|80589970|FG001|Overall Study|Withdrawal by Subject|0|||
27659714|NCT02065895|80589971|FG000|Overall Study|Protocol Violation|1|||
27659715|NCT02065895|80589972|FG001|Overall Study|Protocol Violation|0|||
27659716|NCT02065895|80589973|FG002|Overall Study|Protocol Violation|0|||
27659717|NCT02065895|80589974|FG003|Overall Study|Protocol Violation|1|||
27659718|NCT02065895|80589975|FG004|Overall Study|Protocol Violation|0|||
27659719|NCT02065895|80589976|FG005|Overall Study|Protocol Violation|0|||
27659720|NCT02065895|80589971|FG000|Overall Study|Scheduling conflicts|0|||
27659721|NCT02065895|80589972|FG001|Overall Study|Scheduling conflicts|1|||
27659722|NCT02065895|80589973|FG002|Overall Study|Scheduling conflicts|0|||
27659723|NCT02065895|80589974|FG003|Overall Study|Scheduling conflicts|0|||
27659724|NCT02065895|80589975|FG004|Overall Study|Scheduling conflicts|0|||
27659725|NCT02065895|80589976|FG005|Overall Study|Scheduling conflicts|0|||
27659726|NCT00919061|80589977|FG000|Overall Study|Adverse Event|1|||
27659727|NCT00919061|80589977|FG000|Overall Study|Withdrawal by Subject|1|||
27659728|NCT04435522|80589978|FG000|Overall Study|Withdrawal by Subject|2|||
27659729|NCT01622088|80589979|FG000|Overall Study|Adverse Event|20|||
27659730|NCT01622088|80589979|FG000|Overall Study|Lost to Follow-up|1|||
27659731|NCT01622088|80589979|FG000|Overall Study|Withdrawal by Subject|20|||
27659732|NCT01622088|80589979|FG000|Overall Study|Investigator Decision|1|||
27659733|NCT01622088|80589979|FG000|Overall Study|Death|53|||
27659734|NCT01622088|80589979|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
27659735|NCT02176018|80589980|FG000|Overall Study|Adverse Event|0|||
27659736|NCT02176018|80589981|FG001|Overall Study|Adverse Event|2|||
27659737|NCT02176018|80589980|FG000|Overall Study|Lost to Follow-up|3|||
27659738|NCT02176018|80589981|FG001|Overall Study|Lost to Follow-up|1|||
27659739|NCT02176018|80589980|FG000|Overall Study|Protocol Violation|1|||
27659740|NCT02176018|80589981|FG001|Overall Study|Protocol Violation|1|||
27659741|NCT02176018|80589980|FG000|Overall Study|Withdrawal by Subject|1|||
27659742|NCT02176018|80589981|FG001|Overall Study|Withdrawal by Subject|2|||
27659743|NCT03816332|80589985|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
27659744|NCT03816332|80589985|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
27659745|NCT00515112|80589986|FG000|Overall Study|Death|0|||
27659746|NCT00515112|80589987|FG001|Overall Study|Death|1|||
27659747|NCT00515112|80589986|FG000|Overall Study|The study was terminated|3|||
27659748|NCT00515112|80589987|FG001|Overall Study|The study was terminated|2|||
27659749|NCT01107912|80589990|FG000|Period 1|Adverse Event|0|||
27659750|NCT01107912|80589991|FG001|Period 1|Adverse Event|0|||
27659751|NCT01107912|80589992|FG002|Period 1|Adverse Event|0|||
27659752|NCT01107912|80589993|FG003|Period 1|Adverse Event|0|||
27659753|NCT01107912|80589994|FG004|Period 1|Adverse Event|2|||
27659754|NCT01107912|80589995|FG005|Period 1|Adverse Event|0|||
27659755|NCT01107912|80589990|FG000|Period 1|Physician Decision|0|||
27659756|NCT01107912|80589991|FG001|Period 1|Physician Decision|0|||
27659757|NCT01107912|80589992|FG002|Period 1|Physician Decision|0|||
27659758|NCT01107912|80589993|FG003|Period 1|Physician Decision|0|||
27659759|NCT01107912|80589994|FG004|Period 1|Physician Decision|1|||
27860926|NCT00827632|81322844|FG000|Overall Study|Lost to Follow-up|8|||
27659760|NCT01107912|80589995|FG005|Period 1|Physician Decision|0|||
27659761|NCT01107912|80589990|FG000|Period 1|Withdrawal by Subject|1|||
27659762|NCT01107912|80589991|FG001|Period 1|Withdrawal by Subject|0|||
27568516|NCT01449526|80271329|FG000|Overall Study|Withdrawal by Subject|1|||
27568517|NCT01449526|80271330|FG001|Overall Study|Withdrawal by Subject|1|||
27762195|NCT02119026|80954202|FG000|1st-line Treatment|Physician Decision|3|||
27860927|NCT00827632|81322845|FG001|Overall Study|Lost to Follow-up|12|||
27860928|NCT00827632|81322844|FG000|Overall Study|Early withdrawal|14|||
27860929|NCT00827632|81322845|FG001|Overall Study|Early withdrawal|11|||
27860930|NCT01635218|81322846|FG000|Overall Study|Lost to Follow-up|3|||
27568518|NCT01449526|80271329|FG000|Overall Study|Symptoms/complaints|0|||
27568519|NCT01449526|80271330|FG001|Overall Study|Symptoms/complaints|1|||
27568520|NCT01449526|80271329|FG000|Overall Study|Lack of Motivation|0|||
27568521|NCT01449526|80271330|FG001|Overall Study|Lack of Motivation|1|||
27568522|NCT01449526|80271329|FG000|Overall Study|Cannot maintain visits|0|||
27568523|NCT01449526|80271330|FG001|Overall Study|Cannot maintain visits|1|||
27568524|NCT04371380|80271335|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
27568525|NCT04371380|80271336|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
27568526|NCT04371380|80271337|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
27568527|NCT03080961|80271339|FG000|Overall Study|Withdrawal by Subject|3|||
27568528|NCT02540954|80271340|FG000|Overall Study|Physician Decision|3|||
27568529|NCT02540954|80271341|FG001|Overall Study|Physician Decision|1|||
27568530|NCT02540954|80271340|FG000|Overall Study|Withdrawal by Subject|6|||
27568531|NCT02540954|80271341|FG001|Overall Study|Withdrawal by Subject|5|||
27568532|NCT02540954|80271340|FG000|Overall Study|Lost to Follow-up|1|||
27568533|NCT02540954|80271341|FG001|Overall Study|Lost to Follow-up|1|||
27568534|NCT02540954|80271340|FG000|Overall Study|Adverse Event|4|||
27568535|NCT02540954|80271341|FG001|Overall Study|Adverse Event|2|||
27568536|NCT02540954|80271340|FG000|Overall Study|Death|0|||
27568537|NCT02540954|80271341|FG001|Overall Study|Death|3|||
27568538|NCT02540954|80271340|FG000|Overall Study|Treatment failure|1|||
27568539|NCT02540954|80271341|FG001|Overall Study|Treatment failure|0|||
27568540|NCT02540954|80271340|FG000|Overall Study|Other reason|4|||
27568541|NCT02540954|80271341|FG001|Overall Study|Other reason|2|||
27568542|NCT02239536|80271351|FG000|Overall Study|Non-neoplastic polyp|23|||
27568543|NCT02239536|80271352|FG001|Overall Study|Non-neoplastic polyp|17|||
27568544|NCT03913091|80271360|FG000|Overall Study|Lost to Follow-up|18|||
27568545|NCT03913091|80271361|FG001|Overall Study|Lost to Follow-up|11|||
27568546|NCT03913091|80271360|FG000|Overall Study|Required additional meds/surgery|1|||
27568547|NCT03913091|80271361|FG001|Overall Study|Required additional meds/surgery|2|||
27568548|NCT03913091|80271360|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
27568549|NCT03913091|80271361|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
27568550|NCT03338062|80271367|FG000|Overall Study|Alternative Therapy|1|||
27568551|NCT03338062|80271368|FG001|Overall Study|Alternative Therapy|0|||
27568552|NCT01116232|80271369|FG000|Overall Study|Progressive diease|4|||
27568553|NCT02155738|80271370|FG000|Overall Study|Missing critical information|1|||
27568554|NCT02155738|80271371|FG001|Overall Study|Missing critical information|0|||
27568555|NCT02155738|80271372|FG002|Overall Study|Missing critical information|0|||
27568556|NCT02155738|80271373|FG003|Overall Study|Missing critical information|1|||
27568557|NCT00297037|80271374|FG000|Overall Study|Withdrawal by Subject|2|||
27568558|NCT00297037|80271375|FG001|Overall Study|Withdrawal by Subject|0|||
27568559|NCT02476968|80271376|FG000|Overall Study|Other|0|||
27568560|NCT02476968|80271377|FG001|Overall Study|Other|2|||
27568561|NCT02476968|80271378|FG002|Overall Study|Other|0|||
27568562|NCT02476968|80271376|FG000|Overall Study|Lost to Follow-up|10|||
27568563|NCT02476968|80271377|FG001|Overall Study|Lost to Follow-up|0|||
27568564|NCT02476968|80271378|FG002|Overall Study|Lost to Follow-up|1|||
27568565|NCT02476968|80271376|FG000|Overall Study|Death|48|||
27568566|NCT02476968|80271377|FG001|Overall Study|Death|8|||
27568567|NCT02476968|80271378|FG002|Overall Study|Death|1|||
27568568|NCT02476968|80271376|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27568569|NCT02476968|80271377|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27568570|NCT02476968|80271378|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27568571|NCT02476968|80271376|FG000|Overall Study|Patient decision|37|||
27568572|NCT02476968|80271377|FG001|Overall Study|Patient decision|8|||
27568573|NCT02476968|80271378|FG002|Overall Study|Patient decision|0|||
27568574|NCT01945489|80271379|FG000|Cycle 1|Adverse Event|2|||
27568575|NCT01945489|80271380|FG001|Cycle 1|Adverse Event|0|||
27568576|NCT01945489|80271379|FG000|Cycle 1|Lost to Follow-up|4|||
27568577|NCT01945489|80271380|FG001|Cycle 1|Lost to Follow-up|0|||
27568578|NCT01945489|80271379|FG000|Cycle 1|Personal Reasons|4|||
27568579|NCT01945489|80271380|FG001|Cycle 1|Personal Reasons|2|||
27568580|NCT01945489|80271379|FG000|Cycle 1|Protocol Violation|0|||
27568581|NCT01945489|80271380|FG001|Cycle 1|Protocol Violation|1|||
27568582|NCT01945489|80271379|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
27659763|NCT01107912|80589992|FG002|Period 1|Withdrawal by Subject|0|||
27568583|NCT01945489|80271380|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
27762196|NCT02119026|80954203|FG001|1st-line Treatment|Physician Decision|8|||
27659764|NCT01107912|80589993|FG003|Period 1|Withdrawal by Subject|0|||
27659765|NCT01107912|80589994|FG004|Period 1|Withdrawal by Subject|0|||
27659766|NCT01107912|80589995|FG005|Period 1|Withdrawal by Subject|0|||
27659767|NCT01107912|80589990|FG000|Period 2|Physician Decision|0|||
27659768|NCT01107912|80589991|FG001|Period 2|Physician Decision|0|||
27659769|NCT01107912|80589992|FG002|Period 2|Physician Decision|1|||
27659770|NCT01107912|80589993|FG003|Period 2|Physician Decision|0|||
27659771|NCT01107912|80589994|FG004|Period 2|Physician Decision|0|||
27659772|NCT01107912|80589995|FG005|Period 2|Physician Decision|0|||
27659773|NCT01107912|80589990|FG000|Period 3|Adverse Event|0|||
27659774|NCT01107912|80589991|FG001|Period 3|Adverse Event|1|||
27659775|NCT01107912|80589992|FG002|Period 3|Adverse Event|1|||
27659776|NCT01107912|80589993|FG003|Period 3|Adverse Event|0|||
27659777|NCT01107912|80589994|FG004|Period 3|Adverse Event|0|||
27659778|NCT01107912|80589995|FG005|Period 3|Adverse Event|0|||
27659779|NCT01107912|80589990|FG000|Period 3|Withdrawal by Subject|0|||
27659780|NCT01107912|80589991|FG001|Period 3|Withdrawal by Subject|0|||
27659781|NCT01107912|80589992|FG002|Period 3|Withdrawal by Subject|0|||
27659782|NCT01107912|80589993|FG003|Period 3|Withdrawal by Subject|1|||
27659783|NCT01107912|80589994|FG004|Period 3|Withdrawal by Subject|0|||
27659784|NCT01107912|80589995|FG005|Period 3|Withdrawal by Subject|0|||
27659785|NCT02543294|80589996|FG000|Overall Study|Lost to Follow-up|3|||
27659786|NCT02543294|80589996|FG000|Overall Study|Physician Decision|2|||
27659787|NCT02543294|80589996|FG000|Overall Study|Withdrawal by Subject|7|||
27659788|NCT03050372|80589997|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
27659789|NCT03050372|80589998|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
27659790|NCT03050372|80589997|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
27659791|NCT03050372|80589998|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
27659792|NCT02282917|80589999|FG000|Overall Study|Withdrawal by Subject|1|||
27659793|NCT02282917|80589999|FG000|Overall Study|Screen Failure/Not Eligible|1|||
27659794|NCT01721759|80590000|FG000|Treatment Period|Disease Progression|85|||
27659795|NCT01721759|80590000|FG000|Treatment Period|Study drug toxicity|14|||
27659796|NCT01721759|80590000|FG000|Treatment Period|Death|1|||
27659797|NCT01721759|80590000|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
27659798|NCT01721759|80590000|FG000|Treatment Period|Participant request to withdraw|3|||
27659799|NCT01721759|80590000|FG000|Treatment Period|Other Reasons|3|||
27659800|NCT01721759|80590000|FG000|End of Study Period|Participant Withdrew Consent|5|||
27659801|NCT01721759|80590000|FG000|End of Study Period|Death|101|||
27659802|NCT01721759|80590000|FG000|End of Study Period|Lost to Follow-up|1|||
27659803|NCT01721759|80590000|FG000|End of Study Period|Other Reasons|10|||
27659804|NCT01536795|80590001|FG000|Overall Study|Lost to Follow-up|0|||
27659805|NCT01536795|80590002|FG001|Overall Study|Lost to Follow-up|2|||
27659806|NCT01536795|80590001|FG000|Overall Study|Lack of Efficacy|1|||
27659807|NCT01536795|80590002|FG001|Overall Study|Lack of Efficacy|0|||
27659808|NCT02475733|80590003|FG000|Overall Study|Withdrawal by Subject|1|||
27659809|NCT02475733|80590004|FG001|Overall Study|Withdrawal by Subject|0|||
27659810|NCT02475733|80590003|FG000|Overall Study|Physician Decision|1|||
27659811|NCT02475733|80590004|FG001|Overall Study|Physician Decision|0|||
27659812|NCT04385849|80590005|FG000|Overall Study|Lost to Follow-up|1|||
27659813|NCT04385849|80590006|FG001|Overall Study|Lost to Follow-up|0|||
27659814|NCT00191984|80590012|FG000|Overall Study|Disease Progression|21|||
27659815|NCT00191984|80590012|FG000|Overall Study|Adverse Event|4|||
27659816|NCT00191984|80590012|FG000|Overall Study|Death|2|||
27659817|NCT00191984|80590012|FG000|Overall Study|Entry Criteria Exclusion|1|||
27659818|NCT00191984|80590012|FG000|Overall Study|Withdrawal by Subject|7|||
27659819|NCT00191984|80590012|FG000|Overall Study|Physician Decision|4|||
27659820|NCT03151551|80590013|FG000|Open-Label Treatment Period|Adverse Event|0|||
27659821|NCT03151551|80590014|FG001|Open-Label Treatment Period|Adverse Event|2|||
27659822|NCT03151551|80590013|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
27659823|NCT03151551|80590014|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
27659824|NCT03151551|80590013|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
27659825|NCT03151551|80590014|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
27659826|NCT03151551|80590013|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
27659827|NCT03151551|80590014|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
27659828|NCT03151551|80590013|FG000|Open-Label Treatment Period|Physician Decision|3|||
27659829|NCT03151551|80590014|FG001|Open-Label Treatment Period|Physician Decision|0|||
27659830|NCT03151551|80590013|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
27659831|NCT03151551|80590014|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
27659832|NCT03151551|80590013|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
27659833|NCT03151551|80590014|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
27659834|NCT03151551|80590013|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
27659835|NCT03151551|80590014|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
27659836|NCT03151551|80590013|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
27659837|NCT03151551|80590014|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
27659838|NCT03151551|80590013|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
27659839|NCT03151551|80590014|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
27659840|NCT00443599|80590015|FG000|Overall Study|Physician Decision|2|||
27659841|NCT00443599|80590016|FG001|Overall Study|Physician Decision|1|||
27659842|NCT00443599|80590015|FG000|Overall Study|Death|1|||
27659843|NCT00443599|80590016|FG001|Overall Study|Death|1|||
27659844|NCT00443599|80590015|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
27659845|NCT00443599|80590016|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
27659846|NCT00647699|80590017|FG000|Overall Study|Lost to Follow-up|5|||
27659847|NCT00647699|80590018|FG001|Overall Study|Lost to Follow-up|4|||
27659848|NCT00647699|80590017|FG000|Overall Study|Withdrawal by Subject|3|||
27659849|NCT00647699|80590018|FG001|Overall Study|Withdrawal by Subject|8|||
27659850|NCT03360071|80590019|FG000|Overall Study|Lost to Follow-up|1|||
27659851|NCT03360071|80590020|FG001|Overall Study|Lost to Follow-up|0|||
27659852|NCT02877680|80590021|FG000|Overall Study|Lost to Follow-up|1|||
27659853|NCT02877680|80590022|FG001|Overall Study|Lost to Follow-up|1|||
27659854|NCT01177228|80590025|FG000|Overall Study|Positive tuberculosis test|0|||
27659855|NCT01177228|80590026|FG001|Overall Study|Positive tuberculosis test|1|||
27659856|NCT01177228|80590027|FG002|Overall Study|Positive tuberculosis test|0|||
27659857|NCT01177228|80590028|FG003|Overall Study|Positive tuberculosis test|0|||
27659858|NCT01177228|80590025|FG000|Overall Study|Worsening disease activity|1|||
27659859|NCT01177228|80590026|FG001|Overall Study|Worsening disease activity|0|||
27659860|NCT01177228|80590027|FG002|Overall Study|Worsening disease activity|0|||
27659861|NCT01177228|80590028|FG003|Overall Study|Worsening disease activity|0|||
27659862|NCT01177228|80590025|FG000|Overall Study|Withdrawal by Subject|0|||
27659863|NCT01177228|80590026|FG001|Overall Study|Withdrawal by Subject|1|||
27659864|NCT01177228|80590027|FG002|Overall Study|Withdrawal by Subject|0|||
27659865|NCT01177228|80590028|FG003|Overall Study|Withdrawal by Subject|0|||
27659866|NCT02798861|80590029|FG000|Overall Study|Lost to Follow-up|22|||
27860931|NCT01635218|81322847|FG001|Overall Study|Lost to Follow-up|7|||
27860932|NCT01635218|81322848|FG002|Overall Study|Lost to Follow-up|6|||
27860933|NCT00537303|81322849|FG000|Overall Study|Adverse Event|1|||
27860934|NCT00537303|81322850|FG001|Overall Study|Adverse Event|4|||
27860935|NCT00537303|81322849|FG000|Overall Study|Lack of Efficacy|6|||
27860936|NCT00537303|81322850|FG001|Overall Study|Lack of Efficacy|7|||
27860937|NCT00537303|81322849|FG000|Overall Study|Protocol Violation|8|||
27659867|NCT02798861|80590029|FG000|Overall Study|Withdrawal by Subject|1|||
27659868|NCT04206384|80590032|FG000|Overall Study|Withdrawal by Subject|8|||
27659869|NCT04206384|80590032|FG000|Overall Study|Adverse Event|2|||
27659870|NCT01697592|80590037|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
27659871|NCT01697592|80590038|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659872|NCT01697592|80590039|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659873|NCT01697592|80590040|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659874|NCT01697592|80590041|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659875|NCT01697592|80590042|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659876|NCT01697592|80590043|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659877|NCT01697592|80590044|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659878|NCT01697592|80590045|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659879|NCT01697592|80590046|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
27659880|NCT01697592|80590037|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659881|NCT01697592|80590038|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659882|NCT01697592|80590039|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659883|NCT01697592|80590040|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659884|NCT01697592|80590041|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659885|NCT01697592|80590042|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
27659886|NCT01697592|80590043|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659887|NCT01697592|80590044|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659888|NCT01697592|80590045|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27659889|NCT01697592|80590046|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27568584|NCT01945489|80271379|FG000|Cycle 2|Adverse Event|1|||
27659890|NCT01697592|80590037|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
27659891|NCT01697592|80590038|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659892|NCT01697592|80590039|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659893|NCT01697592|80590040|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659894|NCT01697592|80590041|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659895|NCT01697592|80590042|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659896|NCT01697592|80590043|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659897|NCT01697592|80590044|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659898|NCT01697592|80590045|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659899|NCT01697592|80590046|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27659900|NCT01697592|80590037|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27659901|NCT01697592|80590038|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27659902|NCT01697592|80590039|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27659903|NCT01697592|80590040|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27860938|NCT00537303|81322850|FG001|Overall Study|Protocol Violation|4|||
27659904|NCT01697592|80590041|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27659905|NCT01697592|80590042|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27659906|NCT01697592|80590043|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27659907|NCT01697592|80590044|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27659908|NCT01697592|80590045|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27659909|NCT01697592|80590046|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27659910|NCT01697592|80590037|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27659911|NCT01697592|80590038|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
27659912|NCT01697592|80590039|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
27659913|NCT01697592|80590040|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
27659914|NCT01697592|80590041|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27659915|NCT01697592|80590042|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27659916|NCT01697592|80590043|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
27659917|NCT01697592|80590044|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27659918|NCT01697592|80590045|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27659919|NCT01697592|80590046|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
27659920|NCT01697592|80590037|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
27659921|NCT01697592|80590038|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659922|NCT01697592|80590039|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659923|NCT01697592|80590040|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
27659924|NCT01697592|80590041|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659925|NCT01697592|80590042|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659926|NCT01697592|80590043|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659927|NCT01697592|80590044|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659928|NCT01697592|80590045|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659929|NCT01697592|80590046|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
27659930|NCT01697592|80590037|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
27659931|NCT01697592|80590038|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659932|NCT01697592|80590039|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659933|NCT01697592|80590040|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659934|NCT01697592|80590041|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659935|NCT01697592|80590042|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
27659936|NCT01697592|80590043|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659937|NCT01697592|80590044|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
27659938|NCT01697592|80590045|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659939|NCT01697592|80590046|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
27659940|NCT01697592|80590037|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
27659941|NCT01697592|80590038|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27659942|NCT01697592|80590039|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27659943|NCT01697592|80590040|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
27659944|NCT01697592|80590041|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
27659945|NCT01697592|80590042|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27659946|NCT01697592|80590043|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
27659947|NCT01697592|80590044|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
27659948|NCT01697592|80590045|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
27659949|NCT01697592|80590046|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
27659950|NCT03802513|80590047|FG000|Overall Study|Lost to Follow-up|1|||
27659951|NCT01257698|80590051|FG000|Overall Study|Protocol Violation|4|||
27659952|NCT01257698|80590052|FG001|Overall Study|Protocol Violation|0|||
27659953|NCT01023022|80590053|FG000|Overall Study|Death|5|||
27659954|NCT01023022|80590053|FG000|Overall Study|Lost to Follow-up|7|||
27659955|NCT01023022|80590053|FG000|Overall Study|due to technical issues|2|||
27762197|NCT02119026|80954202|FG000|1st-line Treatment|Withdrawal by Subject|4|||
27762198|NCT02119026|80954203|FG001|1st-line Treatment|Withdrawal by Subject|10|||
27762199|NCT02119026|80954202|FG000|1st-line Treatment|Patient condition or compliance|6|||
27762200|NCT02119026|80954203|FG001|1st-line Treatment|Patient condition or compliance|4|||
27762201|NCT02119026|80954202|FG000|1st-line Treatment|Surgery of metastases|2|||
27762202|NCT02119026|80954203|FG001|1st-line Treatment|Surgery of metastases|1|||
27762203|NCT02119026|80954202|FG000|1st-line Treatment|Death|2|||
27762204|NCT02119026|80954203|FG001|1st-line Treatment|Death|1|||
27659956|NCT03356145|80590056|FG000|Overall Study|Withdrawal by Subject|2|||
27659957|NCT03356145|80590057|FG001|Overall Study|Withdrawal by Subject|1|||
27762205|NCT02119026|80954202|FG000|2nd-line Treatment|Lost to Follow-up|2|||
27762206|NCT02119026|80954203|FG001|2nd-line Treatment|Lost to Follow-up|0|||
27762207|NCT02119026|80954202|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
27762208|NCT02119026|80954203|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
27762209|NCT02119026|80954202|FG000|2nd-line Treatment|Adverse Event|4|||
27659958|NCT03356145|80590056|FG000|Overall Study|Did not meet inclusion criteria|1|||
27659959|NCT03356145|80590057|FG001|Overall Study|Did not meet inclusion criteria|0|||
27659960|NCT03469258|80590060|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
27659961|NCT00938041|80590062|FG000|Overall Study|Lost to Follow-up|6|||
27762210|NCT02119026|80954203|FG001|2nd-line Treatment|Adverse Event|1|||
27762211|NCT01117012|80954208|FG000|Overall Study|Adverse Event|0|||
27762212|NCT01117012|80954209|FG001|Overall Study|Adverse Event|1|||
27762213|NCT01117012|80954208|FG000|Overall Study|Death|1|||
27762214|NCT01117012|80954209|FG001|Overall Study|Death|1|||
27762215|NCT01117012|80954208|FG000|Overall Study|Withdrawal by Subject|3|||
27762216|NCT01117012|80954209|FG001|Overall Study|Withdrawal by Subject|0|||
27762217|NCT01117012|80954208|FG000|Overall Study|Undefined|4|||
27762218|NCT01117012|80954209|FG001|Overall Study|Undefined|3|||
27762219|NCT01181102|80954211|FG000|Overall Study|Adverse Event|28|||
27762220|NCT01181102|80954212|FG001|Overall Study|Adverse Event|26|||
27762221|NCT01181102|80954211|FG000|Overall Study|Lack of Efficacy|3|||
27762222|NCT01181102|80954212|FG001|Overall Study|Lack of Efficacy|1|||
27762223|NCT01181102|80954211|FG000|Overall Study|Lost to Follow-up|2|||
27762224|NCT01181102|80954212|FG001|Overall Study|Lost to Follow-up|0|||
27762225|NCT01181102|80954211|FG000|Overall Study|Physician Decision|3|||
27762226|NCT01181102|80954212|FG001|Overall Study|Physician Decision|1|||
27762227|NCT01181102|80954211|FG000|Overall Study|Protocol Violation|5|||
27762228|NCT01181102|80954212|FG001|Overall Study|Protocol Violation|6|||
27762229|NCT01181102|80954211|FG000|Overall Study|Withdrawal by Subject|10|||
27762230|NCT01181102|80954212|FG001|Overall Study|Withdrawal by Subject|12|||
27762231|NCT02767856|80954213|FG000|Overall Study|Lost to Follow-up|9|||
27762232|NCT02767856|80954214|FG001|Overall Study|Lost to Follow-up|1|||
27762233|NCT02767856|80954213|FG000|Overall Study|Withdrawal by Subject|2|||
27762234|NCT02767856|80954214|FG001|Overall Study|Withdrawal by Subject|1|||
27762235|NCT01184846|80954215|FG000|Overall Study|Adverse Event|2|||
27762236|NCT01184846|80954215|FG000|Overall Study|Insufficient response|1|||
27762237|NCT01957787|80954216|FG000|Overall Study|Death|18|||
27762238|NCT01957787|80954216|FG000|Overall Study|Lost to Follow-up|3|||
27762239|NCT01957787|80954216|FG000|Overall Study|Withdrawal by Subject|3|||
27860939|NCT00537303|81322849|FG000|Overall Study|Withdrawal criteria|3|||
27860940|NCT00537303|81322850|FG001|Overall Study|Withdrawal criteria|3|||
27860941|NCT00537303|81322849|FG000|Overall Study|Unclassified|8|||
27860942|NCT00537303|81322850|FG001|Overall Study|Unclassified|7|||
27860943|NCT04715932|81322851|FG000|Overall Study|Lost to Follow-up|1|||
27860944|NCT04715932|81322852|FG001|Overall Study|Lost to Follow-up|0|||
27860945|NCT05199090|81322853|FG000|Overall Study|Adverse Event|1|||
27659962|NCT00938041|80590062|FG000|Overall Study|Received Alternative Therapy|1|||
27659963|NCT00938041|80590062|FG000|Overall Study|Progressive Disease|5|||
27659964|NCT00938041|80590062|FG000|Overall Study|Death|12|||
27659965|NCT00938041|80590062|FG000|Overall Study|Adrenal Insufficiency|3|||
27659966|NCT05066230|80590063|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
27659967|NCT05066230|80590064|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
27659968|NCT05066230|80590063|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
27659969|NCT05066230|80590064|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
27659970|NCT05066230|80590063|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
27659971|NCT05066230|80590064|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
27659972|NCT05066230|80590063|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
27659973|NCT05066230|80590064|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
27659974|NCT05066230|80590063|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
27659975|NCT05066230|80590064|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
27659976|NCT05066230|80590063|FG000|After Week 48|Adverse Event|1|||
27659977|NCT05066230|80590064|FG001|After Week 48|Adverse Event|0|||
27659978|NCT05066230|80590063|FG000|After Week 48|Non-compliance with study schedule|1|||
27659979|NCT05066230|80590064|FG001|After Week 48|Non-compliance with study schedule|0|||
27659980|NCT05066230|80590063|FG000|After Week 48|Withdrawal by Subject|0|||
27659981|NCT05066230|80590064|FG001|After Week 48|Withdrawal by Subject|1|||
27659982|NCT05066230|80590063|FG000|After Week 48|Lost to Follow-up|3|||
27659983|NCT05066230|80590064|FG001|After Week 48|Lost to Follow-up|3|||
27659984|NCT05066230|80590063|FG000|After Week 48|Sponsor Request|115|||
27659985|NCT05066230|80590064|FG001|After Week 48|Sponsor Request|111|||
27659986|NCT02473913|80590065|FG000|Overall Study|Lost to Follow-up|3|||
27659987|NCT02473913|80590066|FG001|Overall Study|Lost to Follow-up|3|||
27762240|NCT01957787|80954216|FG000|Overall Study|Entered Hospice or Similar Program|2|||
27762241|NCT01957787|80954216|FG000|Overall Study|Index Tumor(s) Resected|2|||
27762242|NCT01957787|80954216|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
27762243|NCT01957787|80954216|FG000|Overall Study|Local therapy, not cryoablation|6|||
27762244|NCT02921763|80954217|FG000|Overall Study|Adverse Event|4|||
27762245|NCT02921763|80954217|FG000|Overall Study|Lost to Follow-up|4|||
27762246|NCT02921763|80954217|FG000|Overall Study|Lack of Efficacy|3|||
27860946|NCT05199090|81322854|FG001|Overall Study|Adverse Event|4|||
27860947|NCT05199090|81322855|FG002|Overall Study|Adverse Event|0|||
27762247|NCT02921763|80954217|FG000|Overall Study|Protocol Violation|2|||
27762248|NCT02921763|80954217|FG000|Overall Study|Withdrawal by Subject|2|||
27762249|NCT02921763|80954217|FG000|Overall Study|Physician Decision|1|||
27762250|NCT02921763|80954217|FG000|Overall Study|No data obtained|2|||
27860948|NCT05199090|81322856|FG003|Overall Study|Adverse Event|0|||
27860949|NCT05199090|81322857|FG004|Overall Study|Adverse Event|0|||
27860950|NCT05199090|81322858|FG005|Overall Study|Adverse Event|0|||
27860951|NCT05199090|81322853|FG000|Overall Study|Lost to Follow-up|1|||
27860952|NCT05199090|81322854|FG001|Overall Study|Lost to Follow-up|0|||
27860953|NCT05199090|81322855|FG002|Overall Study|Lost to Follow-up|1|||
27860954|NCT05199090|81322856|FG003|Overall Study|Lost to Follow-up|4|||
27860955|NCT05199090|81322857|FG004|Overall Study|Lost to Follow-up|0|||
27860956|NCT05199090|81322858|FG005|Overall Study|Lost to Follow-up|5|||
27860957|NCT05199090|81322853|FG000|Overall Study|Physician Decision|0|||
27860958|NCT05199090|81322854|FG001|Overall Study|Physician Decision|0|||
27659988|NCT01124916|80590067|FG000|Overall Study|Lost to Follow-up|3|||
27659989|NCT01124916|80590068|FG001|Overall Study|Lost to Follow-up|2|||
27659990|NCT01190449|80590087|FG000|Overall Study|Ineligible|0|||
27659991|NCT01190449|80590088|FG001|Overall Study|Ineligible|4|||
27659992|NCT04150250|80590089|FG000|Overall Study|Lost to Follow-up|0|||
27659993|NCT04150250|80590090|FG001|Overall Study|Lost to Follow-up|2|||
27659994|NCT01636778|80590094|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
27659995|NCT01636778|80590095|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
27659996|NCT01636778|80590096|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
27659997|NCT01636778|80590094|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
27659998|NCT01636778|80590095|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
27659999|NCT01636778|80590096|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
27660000|NCT01636778|80590094|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
27660001|NCT01636778|80590095|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
27660002|NCT01636778|80590096|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
27660003|NCT01636778|80590094|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
27660004|NCT01636778|80590095|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
27660005|NCT01636778|80590096|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
27660006|NCT01636778|80590094|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
27660007|NCT01636778|80590095|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
27660008|NCT01636778|80590096|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
27660009|NCT01636778|80590094|FG000|Follow-up Period After Part 2|Other|0|||
27660010|NCT01636778|80590095|FG001|Follow-up Period After Part 2|Other|0|||
27660011|NCT01636778|80590096|FG002|Follow-up Period After Part 2|Other|1|||
27660012|NCT01636778|80590094|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
27660013|NCT01636778|80590095|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
27660014|NCT01636778|80590096|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
27660015|NCT01636778|80590094|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
27660016|NCT01636778|80590095|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
27660017|NCT01636778|80590096|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
27660018|NCT00850993|80590098|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
27860959|NCT05199090|81322855|FG002|Overall Study|Physician Decision|0|||
27860960|NCT05199090|81322856|FG003|Overall Study|Physician Decision|0|||
27660019|NCT00850993|80590099|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
27660020|NCT00850993|80590100|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
27660021|NCT00850993|80590101|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
27660022|NCT00316589|80590102|FG000|Overall Study|Withdrawal by Subject|0|||
27660023|NCT00316589|80590103|FG001|Overall Study|Withdrawal by Subject|5|||
27660024|NCT00316589|80590104|FG002|Overall Study|Withdrawal by Subject|0|||
27660025|NCT00316589|80590105|FG003|Overall Study|Withdrawal by Subject|1|||
27660026|NCT00316589|80590102|FG000|Overall Study|Subject unwilling/unable to comply|0|||
27660027|NCT00316589|80590103|FG001|Overall Study|Subject unwilling/unable to comply|6|||
27660028|NCT00316589|80590104|FG002|Overall Study|Subject unwilling/unable to comply|0|||
27660029|NCT00316589|80590105|FG003|Overall Study|Subject unwilling/unable to comply|2|||
27660030|NCT00316589|80590102|FG000|Overall Study|Adverse Event|1|||
27660031|NCT00316589|80590103|FG001|Overall Study|Adverse Event|0|||
27660032|NCT00316589|80590104|FG002|Overall Study|Adverse Event|0|||
27660033|NCT00316589|80590105|FG003|Overall Study|Adverse Event|1|||
27660034|NCT00316589|80590102|FG000|Overall Study|Physician Decision|0|||
27660035|NCT00316589|80590103|FG001|Overall Study|Physician Decision|1|||
27660036|NCT00316589|80590104|FG002|Overall Study|Physician Decision|0|||
27660037|NCT00316589|80590105|FG003|Overall Study|Physician Decision|0|||
27860961|NCT05199090|81322857|FG004|Overall Study|Physician Decision|0|||
27660038|NCT00316589|80590102|FG000|Overall Study|Other reason|0|||
27660039|NCT00316589|80590103|FG001|Overall Study|Other reason|12|||
27660040|NCT00316589|80590104|FG002|Overall Study|Other reason|1|||
27660041|NCT00316589|80590105|FG003|Overall Study|Other reason|1|||
27860962|NCT05199090|81322858|FG005|Overall Study|Physician Decision|1|||
27860963|NCT05199090|81322853|FG000|Overall Study|Study terminated by sponsor|0|||
27860964|NCT05199090|81322854|FG001|Overall Study|Study terminated by sponsor|6|||
27660042|NCT05109117|80593419|FG000|Overall Study|Lost to Follow-up|1|||
27860965|NCT05199090|81322855|FG002|Overall Study|Study terminated by sponsor|0|||
27860966|NCT05199090|81322856|FG003|Overall Study|Study terminated by sponsor|0|||
27860967|NCT05199090|81322857|FG004|Overall Study|Study terminated by sponsor|0|||
27660043|NCT05109117|80593419|FG000|Overall Study|Discontinued for non-compliance|1|||
27660044|NCT02879448|80593421|FG000|Overall Study|No implant attempt|17|||
27660045|NCT02879448|80593422|FG001|Overall Study|No implant attempt|28|||
27660046|NCT02879448|80593421|FG000|Overall Study|Withdrawal by Subject|20|||
27660047|NCT02879448|80593422|FG001|Overall Study|Withdrawal by Subject|46|||
27660048|NCT02879448|80593421|FG000|Overall Study|Death|63|||
27660049|NCT02879448|80593422|FG001|Overall Study|Death|85|||
27660050|NCT02879448|80593421|FG000|Overall Study|Lost to Follow-up|3|||
27660051|NCT02879448|80593422|FG001|Overall Study|Lost to Follow-up|4|||
27660052|NCT02879448|80593421|FG000|Overall Study|Missing visit|34|||
27660053|NCT02879448|80593422|FG001|Overall Study|Missing visit|39|||
27660054|NCT02879448|80593421|FG000|Overall Study|Pending evaluation|1|||
27660055|NCT02879448|80593422|FG001|Overall Study|Pending evaluation|0|||
27660056|NCT00734851|80593425|FG000|Overall Study|Withdrawal by Subject|2|||
27660057|NCT00734851|80593425|FG000|Overall Study|Lost to Follow-up|1|||
27660058|NCT00734851|80593425|FG000|Overall Study|Physician Decision|18|||
27660059|NCT00645099|80593426|FG000|Overall Study|Lack of Efficacy|15|||
27660060|NCT00645099|80593427|FG001|Overall Study|Lack of Efficacy|6|||
27660061|NCT00645099|80593426|FG000|Overall Study|Withdrawal by Subject|30|||
27660062|NCT00645099|80593427|FG001|Overall Study|Withdrawal by Subject|22|||
27660063|NCT00645099|80593426|FG000|Overall Study|Lost to Follow-up|6|||
27660064|NCT00645099|80593427|FG001|Overall Study|Lost to Follow-up|4|||
27660065|NCT00645099|80593426|FG000|Overall Study|Adverse Event|11|||
27660066|NCT00645099|80593427|FG001|Overall Study|Adverse Event|5|||
27660067|NCT00645099|80593426|FG000|Overall Study|Other|9|||
27660068|NCT00645099|80593427|FG001|Overall Study|Other|5|||
27660069|NCT03341312|80593430|FG000|Period 1|Withdrawal by Subject|0|||
27660070|NCT03341312|80593431|FG001|Period 1|Withdrawal by Subject|1|||
27660071|NCT03341312|80593432|FG002|Period 1|Withdrawal by Subject|0|||
27660072|NCT03341312|80593433|FG003|Period 1|Withdrawal by Subject|0|||
27660073|NCT01745380|80593434|FG000|Overall Study|Lost to Follow-up|1|||
27660074|NCT01745380|80593435|FG001|Overall Study|Lost to Follow-up|0|||
27660075|NCT01745380|80593434|FG000|Overall Study|Lack of Efficacy|0|||
27660076|NCT01745380|80593435|FG001|Overall Study|Lack of Efficacy|1|||
27660077|NCT01446042|80593443|FG000|Overall Study|Withdrawal by Subject|12|||
27660078|NCT01446042|80593444|FG001|Overall Study|Withdrawal by Subject|2|||
27660079|NCT01446042|80593445|FG002|Overall Study|Withdrawal by Subject|4|||
27660080|NCT01446042|80593443|FG000|Overall Study|Adverse Event|1|||
27660081|NCT01446042|80593444|FG001|Overall Study|Adverse Event|0|||
27660082|NCT01446042|80593445|FG002|Overall Study|Adverse Event|4|||
27660083|NCT01446042|80593443|FG000|Overall Study|Lost to Follow-up|5|||
27660084|NCT01446042|80593444|FG001|Overall Study|Lost to Follow-up|0|||
27660085|NCT01446042|80593445|FG002|Overall Study|Lost to Follow-up|0|||
27660086|NCT01446042|80593443|FG000|Overall Study|Other reasons|2|||
27660087|NCT01446042|80593444|FG001|Overall Study|Other reasons|1|||
27660088|NCT01446042|80593445|FG002|Overall Study|Other reasons|1|||
27660089|NCT03512288|80593446|FG000|Overall Study|Adverse Event|1|||
27660090|NCT03512288|80593447|FG001|Overall Study|Adverse Event|0|||
27660091|NCT03512288|80593446|FG000|Overall Study|Lost to Follow-up|12|||
27660092|NCT03512288|80593447|FG001|Overall Study|Lost to Follow-up|15|||
27660093|NCT03512288|80593446|FG000|Overall Study|Physician Decision|0|||
27660094|NCT03512288|80593447|FG001|Overall Study|Physician Decision|2|||
27660095|NCT03512288|80593446|FG000|Overall Study|Protocol Violation|6|||
27660096|NCT03512288|80593447|FG001|Overall Study|Protocol Violation|4|||
27660097|NCT03512288|80593446|FG000|Overall Study|Medication error without associated adverse event|1|||
27660098|NCT03512288|80593447|FG001|Overall Study|Medication error without associated adverse event|0|||
27660099|NCT03512288|80593446|FG000|Overall Study|No longer met eligibility criteria|5|||
27660100|NCT03512288|80593447|FG001|Overall Study|No longer met eligibility criteria|2|||
27660101|NCT03512288|80593446|FG000|Overall Study|Withdrawal by parent/guardian|14|||
27660102|NCT03512288|80593447|FG001|Overall Study|Withdrawal by parent/guardian|18|||
27660103|NCT03512288|80593446|FG000|Overall Study|Other|1|||
27860968|NCT05199090|81322858|FG005|Overall Study|Study terminated by sponsor|5|||
27660104|NCT03512288|80593447|FG001|Overall Study|Other|1|||
27660105|NCT03512288|80593446|FG000|Overall Study|Randomized but not treated|1|||
27660106|NCT03512288|80593447|FG001|Overall Study|Randomized but not treated|1|||
27660107|NCT02085408|80593448|FG000|Step 1: Induction|Disease Progression|19|||
27660108|NCT02085408|80593449|FG001|Step 1: Induction|Disease Progression|19|||
27660109|NCT02085408|80593448|FG000|Step 1: Induction|Adverse Event|18|||
27660110|NCT02085408|80593449|FG001|Step 1: Induction|Adverse Event|17|||
27660111|NCT02085408|80593448|FG000|Step 1: Induction|Death|33|||
27660112|NCT02085408|80593449|FG001|Step 1: Induction|Death|30|||
27660113|NCT02085408|80593448|FG000|Step 1: Induction|Withdrawal by Subject|16|||
27660114|NCT02085408|80593449|FG001|Step 1: Induction|Withdrawal by Subject|8|||
27660115|NCT02085408|80593448|FG000|Step 1: Induction|Alternative Therapy|15|||
27660116|NCT02085408|80593449|FG001|Step 1: Induction|Alternative Therapy|19|||
27660117|NCT02085408|80593448|FG000|Step 1: Induction|Complicating Disease|2|||
27660118|NCT02085408|80593449|FG001|Step 1: Induction|Complicating Disease|3|||
27660119|NCT02085408|80593448|FG000|Step 1: Induction|Other|27|||
27660120|NCT02085408|80593449|FG001|Step 1: Induction|Other|39|||
27660121|NCT02085408|80593448|FG000|Step 1: Induction|Never started treatment|6|||
27660122|NCT02085408|80593449|FG001|Step 1: Induction|Never started treatment|4|||
27660123|NCT02085408|80593448|FG000|Step 2: Consolidation|Disease Progression|5|||
27660124|NCT02085408|80593449|FG001|Step 2: Consolidation|Disease Progression|20|||
27660125|NCT02085408|80593448|FG000|Step 2: Consolidation|Adverse Event|9|||
27660126|NCT02085408|80593449|FG001|Step 2: Consolidation|Adverse Event|8|||
27660127|NCT02085408|80593448|FG000|Step 2: Consolidation|Death|4|||
27660128|NCT02085408|80593449|FG001|Step 2: Consolidation|Death|3|||
27660129|NCT02085408|80593448|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
27660130|NCT02085408|80593449|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
27660131|NCT02085408|80593448|FG000|Step 2: Consolidation|Alternative Therapy|9|||
27660132|NCT02085408|80593449|FG001|Step 2: Consolidation|Alternative Therapy|3|||
27660133|NCT02085408|80593448|FG000|Step 2: Consolidation|Complicating Disease|0|||
27660134|NCT02085408|80593449|FG001|Step 2: Consolidation|Complicating Disease|2|||
27660135|NCT02085408|80593448|FG000|Step 2: Consolidation|Other|6|||
27660136|NCT02085408|80593449|FG001|Step 2: Consolidation|Other|6|||
27660137|NCT02085408|80593448|FG000|Step 2: Consolidation|Never started treatment|4|||
27660138|NCT02085408|80593449|FG001|Step 2: Consolidation|Never started treatment|3|||
27660139|NCT02085408|80593448|FG000|Step 3: Maintenance|Disease Progression|13|||
27660140|NCT02085408|80593449|FG001|Step 3: Maintenance|Disease Progression|11|||
27660141|NCT02085408|80593448|FG000|Step 3: Maintenance|Adverse Event|2|||
27660142|NCT02085408|80593449|FG001|Step 3: Maintenance|Adverse Event|4|||
27660143|NCT02085408|80593448|FG000|Step 3: Maintenance|Death|1|||
27660144|NCT02085408|80593449|FG001|Step 3: Maintenance|Death|2|||
27660145|NCT02085408|80593448|FG000|Step 3: Maintenance|Alternative Therapy|1|||
27660146|NCT02085408|80593449|FG001|Step 3: Maintenance|Alternative Therapy|1|||
27660147|NCT02085408|80593448|FG000|Step 3: Maintenance|Complicating Disease|0|||
27660148|NCT02085408|80593449|FG001|Step 3: Maintenance|Complicating Disease|1|||
27660149|NCT02085408|80593448|FG000|Step 3: Maintenance|Other|3|||
27660150|NCT02085408|80593449|FG001|Step 3: Maintenance|Other|2|||
27660151|NCT02085408|80593448|FG000|Step 3: Maintenance|Never started treatment|5|||
27660152|NCT02085408|80593449|FG001|Step 3: Maintenance|Never started treatment|1|||
27660153|NCT02023099|80593450|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
27660154|NCT02023099|80593451|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
27660155|NCT02023099|80593452|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
27660156|NCT02023099|80593450|FG000|Overall Study|Withdrawn Consent|3|||
27660157|NCT02023099|80593451|FG001|Overall Study|Withdrawn Consent|0|||
27660158|NCT02023099|80593452|FG002|Overall Study|Withdrawn Consent|1|||
27660159|NCT02023099|80593450|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
27660160|NCT02023099|80593451|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
27660161|NCT02023099|80593452|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
27660162|NCT03972137|80593456|FG000|Overall Study|Lost to Follow-up|2|||
27660163|NCT03972137|80593456|FG000|Overall Study|Withdrawal by Subject|4|||
27660164|NCT04288778|80593457|FG000|Overall Study|Withdrawal by Subject|2|||
27660165|NCT04288778|80593457|FG000|Overall Study|Adverse Event|5|||
27660166|NCT04288778|80593457|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27660167|NCT04288778|80593457|FG000|Overall Study|Other|1|||
27660168|NCT04288778|80593457|FG000|Overall Study|Started but not treated|2|||
27660169|NCT04564027|80593458|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
27660170|NCT04564027|80593459|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
27660171|NCT04564027|80593460|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
27660172|NCT04564027|80593461|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
27660173|NCT00244751|80593462|FG000|Overall Study|Adverse Event|7|||
27660174|NCT00244751|80593463|FG001|Overall Study|Adverse Event|7|||
27660175|NCT00244751|80593464|FG002|Overall Study|Adverse Event|5|||
27660176|NCT00244751|80593462|FG000|Overall Study|Lost to Follow-up|0|||
27660177|NCT00244751|80593463|FG001|Overall Study|Lost to Follow-up|1|||
27660178|NCT00244751|80593464|FG002|Overall Study|Lost to Follow-up|0|||
27660179|NCT00244751|80593462|FG000|Overall Study|Protocol Violation|1|||
27660180|NCT00244751|80593463|FG001|Overall Study|Protocol Violation|0|||
27660181|NCT00244751|80593464|FG002|Overall Study|Protocol Violation|1|||
27660182|NCT00244751|80593462|FG000|Overall Study|Withdrawal by Subject|7|||
27860969|NCT05199090|81322853|FG000|Overall Study|Subject decision|0|||
27860970|NCT05199090|81322854|FG001|Overall Study|Subject decision|4|||
27860971|NCT05199090|81322855|FG002|Overall Study|Subject decision|0|||
27860972|NCT05199090|81322856|FG003|Overall Study|Subject decision|2|||
27860973|NCT05199090|81322857|FG004|Overall Study|Subject decision|5|||
27660183|NCT00244751|80593463|FG001|Overall Study|Withdrawal by Subject|5|||
27660184|NCT00244751|80593464|FG002|Overall Study|Withdrawal by Subject|3|||
27660185|NCT00244751|80593462|FG000|Overall Study|Elevated liver enzymes|1|||
27660186|NCT00244751|80593463|FG001|Overall Study|Elevated liver enzymes|0|||
27660187|NCT00244751|80593464|FG002|Overall Study|Elevated liver enzymes|0|||
27660188|NCT00244751|80593462|FG000|Overall Study|Lack of compliance with protocol|0|||
27660189|NCT00244751|80593463|FG001|Overall Study|Lack of compliance with protocol|1|||
27660190|NCT00244751|80593464|FG002|Overall Study|Lack of compliance with protocol|0|||
27660191|NCT00244751|80593462|FG000|Overall Study|Safety reasons|0|||
27660192|NCT00244751|80593463|FG001|Overall Study|Safety reasons|1|||
27660193|NCT00244751|80593464|FG002|Overall Study|Safety reasons|0|||
27660194|NCT00244751|80593462|FG000|Overall Study|Participant randomized by mistake|0|||
27660195|NCT00244751|80593463|FG001|Overall Study|Participant randomized by mistake|0|||
27660196|NCT00244751|80593464|FG002|Overall Study|Participant randomized by mistake|1|||
27660197|NCT05006703|80593465|FG000|Overall Study|Withdrawal by Subject|1|||
27660198|NCT05006703|80593466|FG001|Overall Study|Withdrawal by Subject|0|||
27660199|NCT05006703|80593465|FG000|Overall Study|Lost to Follow-up|13|||
27660200|NCT05006703|80593466|FG001|Overall Study|Lost to Follow-up|5|||
27660201|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
27660202|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
27660203|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
27660204|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
27660205|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Death|0|||
27660206|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Death|0|||
27660207|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Death|1|||
27660208|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Death|0|||
27660209|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
27660210|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
27660211|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
27660212|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
27660213|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27660214|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
27660215|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
27660216|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
27660217|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
27660218|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
27860974|NCT05199090|81322858|FG005|Overall Study|Subject decision|2|||
27860975|NCT00168818|81322859|FG000|Overall Study|Adverse Event|23|||
27660219|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
27660220|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
27660221|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
27660222|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
27660223|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
27660224|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
27660225|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
27660226|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
27660227|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
27660228|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
27660229|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Other|2|||
27660230|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Other|0|||
27660231|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Other|0|||
27660232|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Other|0|||
27660233|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
27860976|NCT00168818|81322860|FG001|Overall Study|Adverse Event|29|||
27860977|NCT00168818|81322861|FG002|Overall Study|Adverse Event|31|||
27860978|NCT00168818|81322859|FG000|Overall Study|Protocol Violation|16|||
27860979|NCT00168818|81322860|FG001|Overall Study|Protocol Violation|11|||
27860980|NCT00168818|81322861|FG002|Overall Study|Protocol Violation|11|||
27860981|NCT00168818|81322859|FG000|Overall Study|Lost to Follow-up|13|||
27860982|NCT00168818|81322860|FG001|Overall Study|Lost to Follow-up|4|||
27860983|NCT00168818|81322861|FG002|Overall Study|Lost to Follow-up|15|||
27860984|NCT00168818|81322859|FG000|Overall Study|Withdrawal by Subject|43|||
27860985|NCT00168818|81322860|FG001|Overall Study|Withdrawal by Subject|41|||
27860986|NCT00168818|81322861|FG002|Overall Study|Withdrawal by Subject|37|||
27860987|NCT00168818|81322859|FG000|Overall Study|Other|22|||
27860988|NCT00168818|81322860|FG001|Overall Study|Other|24|||
27860989|NCT00168818|81322861|FG002|Overall Study|Other|30|||
27860990|NCT00168818|81322859|FG000|Treatment|Adverse Event|77|||
27860991|NCT00168818|81322860|FG001|Treatment|Adverse Event|89|||
27860992|NCT00168818|81322861|FG002|Treatment|Adverse Event|68|||
27860993|NCT00168818|81322859|FG000|Treatment|Protocol Violation|8|||
27860994|NCT00168818|81322860|FG001|Treatment|Protocol Violation|11|||
27568585|NCT01945489|80271380|FG001|Cycle 2|Adverse Event|0|||
27860995|NCT00168818|81322861|FG002|Treatment|Protocol Violation|11|||
27660234|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
27660235|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
27660236|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
27660237|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
27660238|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
27860996|NCT00168818|81322859|FG000|Treatment|Lost to Follow-up|0|||
27860997|NCT00168818|81322860|FG001|Treatment|Lost to Follow-up|2|||
27860998|NCT00168818|81322861|FG002|Treatment|Lost to Follow-up|1|||
27860999|NCT00168818|81322859|FG000|Treatment|Withdrawal by Subject|25|||
27861000|NCT00168818|81322860|FG001|Treatment|Withdrawal by Subject|20|||
27861001|NCT00168818|81322861|FG002|Treatment|Withdrawal by Subject|22|||
27660239|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
27660240|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
27660241|NCT03845517|80593467|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
27660242|NCT03845517|80593468|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
27660243|NCT03845517|80593469|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
27660244|NCT03845517|80593470|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
27660245|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
27660246|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
27660247|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
27762251|NCT03627494|80954219|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
27861002|NCT00168818|81322859|FG000|Treatment|Other|23|||
27861003|NCT00168818|81322860|FG001|Treatment|Other|29|||
27861004|NCT00168818|81322861|FG002|Treatment|Other|31|||
27861005|NCT00565617|81322863|FG000|Overall Study|Withdrawal by Subject|1|||
27861006|NCT00094861|81322865|FG000|Overall Study|Adverse Event|5|||
27861007|NCT00094861|81322866|FG001|Overall Study|Adverse Event|2|||
27861008|NCT00094861|81322865|FG000|Overall Study|Withdrawal by Subject|5|||
27762252|NCT03627494|80954220|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762253|NCT03627494|80954221|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
27762254|NCT03627494|80954222|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762255|NCT03627494|80954223|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762256|NCT03627494|80954224|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762257|NCT03627494|80954225|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762258|NCT03627494|80954226|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762259|NCT03627494|80954227|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762260|NCT03627494|80954228|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762261|NCT03627494|80954229|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762262|NCT03627494|80954230|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
27762263|NCT03627494|80954219|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762264|NCT03627494|80954220|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762265|NCT03627494|80954221|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762266|NCT03627494|80954222|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762267|NCT03627494|80954223|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762268|NCT03627494|80954224|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762269|NCT03627494|80954225|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762270|NCT03627494|80954226|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762271|NCT03627494|80954227|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
27762272|NCT03627494|80954228|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762273|NCT03627494|80954229|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762274|NCT03627494|80954230|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
27762275|NCT03627494|80954219|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762276|NCT03627494|80954220|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
27861009|NCT00094861|81322866|FG001|Overall Study|Withdrawal by Subject|3|||
27861010|NCT00094861|81322865|FG000|Overall Study|Physician Decision|1|||
27861011|NCT00094861|81322866|FG001|Overall Study|Physician Decision|1|||
27660248|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
27660249|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Death|0|||
27660250|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Death|0|||
27762277|NCT03627494|80954221|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762278|NCT03627494|80954222|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762279|NCT03627494|80954223|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762280|NCT03627494|80954224|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762281|NCT03627494|80954225|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762282|NCT03627494|80954226|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762283|NCT03627494|80954227|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762284|NCT03627494|80954228|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
27762285|NCT03627494|80954229|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
27762286|NCT03627494|80954230|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
27762287|NCT03495453|80954231|FG000|Overall Study|Withdrawal by Subject|0|||
27762288|NCT03495453|80954232|FG001|Overall Study|Withdrawal by Subject|1|||
27762289|NCT02282982|80954234|FG000|Overall Study|Lost to Follow-up|15|||
27762290|NCT02282982|80954234|FG000|Overall Study|Withdrew consent|2|||
27762291|NCT02282982|80954234|FG000|Overall Study|Death|4|||
27762292|NCT02282982|80954234|FG000|Overall Study|Lack of product|156|||
27861012|NCT00094861|81322865|FG000|Overall Study|Lost to Follow-up|0|||
27861013|NCT00094861|81322866|FG001|Overall Study|Lost to Follow-up|1|||
27660251|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Death|1|||
27861014|NCT00094861|81322865|FG000|Overall Study|Death|4|||
27861015|NCT00094861|81322866|FG001|Overall Study|Death|2|||
27861016|NCT00094861|81322865|FG000|Overall Study|Other|3|||
27861017|NCT00094861|81322866|FG001|Overall Study|Other|0|||
27861018|NCT01210612|81322867|FG000|Overall Study|Withdrawal by Subject|0|||
27762293|NCT02282982|80954234|FG000|Overall Study|Palivizumab is ended|11|||
27762294|NCT02282982|80954234|FG000|Overall Study|Other, not specified|18|||
27762295|NCT01879319|80954236|FG000|Overall Study|Withdrawal by Subject|1|||
27762296|NCT01879319|80954237|FG001|Overall Study|Withdrawal by Subject|0|||
27762297|NCT01879319|80954236|FG000|Overall Study|Lost to Follow-up|1|||
27660252|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Death|1|||
27660253|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
27660254|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
27660255|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
27660256|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
27660257|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
27660258|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
27660259|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
27660260|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
27660261|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
27660262|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
27660263|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
27660264|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
27660265|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Other|1|||
27660266|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Other|0|||
27660267|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Other|1|||
27660268|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Other|0|||
27660269|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
27660270|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
27660271|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
27660272|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
27660273|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
27660274|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
27660275|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
27660276|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
27660277|NCT03845517|80593467|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
27660278|NCT03845517|80593468|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
27660279|NCT03845517|80593469|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
27660280|NCT03845517|80593470|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
27660281|NCT00005908|80593471|FG000|Overall Study|Withdrawal by Subject|1|||
27660282|NCT00005908|80593472|FG001|Overall Study|Withdrawal by Subject|0|||
27660283|NCT01234675|80593473|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
27762298|NCT01879319|80954237|FG001|Overall Study|Lost to Follow-up|5|||
27762299|NCT00971425|80954238|FG000|Overall Study|Adverse Event|1|||
27762300|NCT00971425|80954239|FG001|Overall Study|Adverse Event|1|||
27762301|NCT00971425|80954238|FG000|Overall Study|Withdrawal by Subject|0|||
27762302|NCT00971425|80954239|FG001|Overall Study|Withdrawal by Subject|1|||
27762303|NCT04154943|80954240|FG000|Overall Study|Study Ongoing|68|||
27762304|NCT04154943|80954240|FG000|Overall Study|Lost to Follow-up|1|||
27762305|NCT04154943|80954240|FG000|Overall Study|Decision by the Investigator|1|||
27762306|NCT04154943|80954240|FG000|Overall Study|Death|5|||
27762307|NCT04154943|80954240|FG000|Overall Study|Withdrawal by Subject|4|||
27762308|NCT03805971|80954248|FG000|Overall Study|Withdrawal by Subject|1|||
27762309|NCT03805971|80954248|FG000|Overall Study|Protocol Violation|2|||
27762310|NCT00290589|80954249|FG000|Overall Study|Lost to Follow-up|2|||
27762311|NCT00290589|80954250|FG001|Overall Study|Lost to Follow-up|2|||
27660284|NCT01234675|80593474|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27660285|NCT01234675|80593473|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27660286|NCT01234675|80593474|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
27660287|NCT01283971|80593477|FG000|Overall Study|Adverse Event|3|||
27660288|NCT01283971|80593478|FG001|Overall Study|Adverse Event|5|||
27660289|NCT01283971|80593477|FG000|Overall Study|Insufficient therapeutic responses|3|||
27660290|NCT01283971|80593478|FG001|Overall Study|Insufficient therapeutic responses|3|||
27660291|NCT01283971|80593477|FG000|Overall Study|Protocol Violation|5|||
27660292|NCT01283971|80593478|FG001|Overall Study|Protocol Violation|1|||
27660293|NCT01283971|80593477|FG000|Overall Study|Refused treatment|3|||
27660294|NCT01283971|80593478|FG001|Overall Study|Refused treatment|1|||
27660295|NCT01283971|80593477|FG000|Overall Study|Failure to return|0|||
27660296|NCT01283971|80593478|FG001|Overall Study|Failure to return|1|||
27660297|NCT01283971|80593477|FG000|Overall Study|Administrative reasons|1|||
27660298|NCT01283971|80593478|FG001|Overall Study|Administrative reasons|1|||
27660299|NCT00006436|80593482|FG000|Overall Study|Refused further treatment|2|||
27660300|NCT00006436|80593482|FG000|Overall Study|Declined to participate (before treatment started)|1|||
27660301|NCT01838499|80593483|FG000|Overall Study|Protocol Violation|0|||
27660302|NCT01838499|80593484|FG001|Overall Study|Protocol Violation|1|||
27762312|NCT03372603|80954251|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
27660303|NCT01838499|80593483|FG000|Overall Study|Lost to Follow-up|2|||
27660304|NCT01838499|80593484|FG001|Overall Study|Lost to Follow-up|4|||
27660305|NCT01838499|80593483|FG000|Overall Study|Lack of Efficacy|1|||
27762313|NCT03372603|80954252|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
27762314|NCT03372603|80954251|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
27762315|NCT03372603|80954252|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
27762316|NCT04142216|80954255|FG000|Overall Study|Hospitalization|0|||
27762317|NCT04142216|80954256|FG001|Overall Study|Hospitalization|2|||
27762318|NCT04142216|80954255|FG000|Overall Study|Death|3|||
27762319|NCT04142216|80954256|FG001|Overall Study|Death|1|||
27762320|NCT04142216|80954255|FG000|Overall Study|Referral to another hemodialysis unit|3|||
27762321|NCT04142216|80954256|FG001|Overall Study|Referral to another hemodialysis unit|2|||
27762322|NCT04142216|80954255|FG000|Overall Study|Use of clove|0|||
27762323|NCT04142216|80954256|FG001|Overall Study|Use of clove|1|||
27762324|NCT01993615|80954257|FG000|Overall Study|Death|1|||
27762325|NCT01993615|80954258|FG001|Overall Study|Death|0|||
27762326|NCT02017899|80954259|FG000|Overall Study|Withdrawal by Subject|0|||
27762327|NCT02017899|80954260|FG001|Overall Study|Withdrawal by Subject|0|||
27762328|NCT02017899|80954261|FG002|Overall Study|Withdrawal by Subject|0|||
27762329|NCT02017899|80954262|FG003|Overall Study|Withdrawal by Subject|1|||
27762330|NCT02017899|80954263|FG004|Overall Study|Withdrawal by Subject|1|||
27762331|NCT02017899|80954264|FG005|Overall Study|Withdrawal by Subject|0|||
27762332|NCT01928082|80954268|FG000|Overall Study|Study terminated.|1|||
27762333|NCT02494778|80954274|FG000|Overall Study|Death|3|||
27762334|NCT02494778|80954274|FG000|Overall Study|Other|173|||
27762335|NCT02494778|80954274|FG000|Overall Study|Lack of Efficacy|4|||
27762336|NCT02494778|80954274|FG000|Overall Study|Adverse Event|18|||
27762337|NCT02494778|80954274|FG000|Overall Study|Withdrawal by Subject|20|||
27762338|NCT02494778|80954274|FG000|Overall Study|Lost to Follow-up|2|||
27762339|NCT02494778|80954274|FG000|Overall Study|Noncompliant with study drug admin.|1|||
27762340|NCT02293993|80954275|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
27762341|NCT02293993|80954276|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
27762342|NCT02293993|80954277|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
27762343|NCT02293993|80954278|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
27762344|NCT02293993|80954275|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
27762345|NCT02293993|80954276|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
27762346|NCT02293993|80954277|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
27762347|NCT02293993|80954278|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
27762348|NCT02293993|80954275|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
27762349|NCT02293993|80954276|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
27762350|NCT02293993|80954277|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
27762351|NCT02293993|80954278|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
27762352|NCT02293993|80954275|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
27762353|NCT02293993|80954276|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
27762354|NCT02293993|80954277|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
27762355|NCT02293993|80954278|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
27660306|NCT01838499|80593484|FG001|Overall Study|Lack of Efficacy|2|||
27660307|NCT01838499|80593483|FG000|Overall Study|Adverse Event|2|||
27660308|NCT01838499|80593484|FG001|Overall Study|Adverse Event|1|||
27660309|NCT01838499|80593483|FG000|Overall Study|Withdrawal by Subject|19|||
27660310|NCT01838499|80593484|FG001|Overall Study|Withdrawal by Subject|9|||
27660311|NCT00265096|80593496|FG000|Overall Study|Adverse Event|14|||
27660312|NCT00265096|80593497|FG001|Overall Study|Adverse Event|18|||
27660313|NCT00265096|80593498|FG002|Overall Study|Adverse Event|18|||
27660314|NCT00265096|80593496|FG000|Overall Study|Lost to Follow-up|2|||
27660315|NCT00265096|80593497|FG001|Overall Study|Lost to Follow-up|5|||
27660316|NCT00265096|80593498|FG002|Overall Study|Lost to Follow-up|3|||
27660317|NCT00265096|80593496|FG000|Overall Study|Death|0|||
27660318|NCT00265096|80593497|FG001|Overall Study|Death|1|||
27660319|NCT00265096|80593498|FG002|Overall Study|Death|2|||
27660320|NCT00265096|80593496|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
27660321|NCT00265096|80593497|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27660322|NCT00265096|80593498|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
27660323|NCT00265096|80593496|FG000|Overall Study|Other|11|||
27660324|NCT00265096|80593497|FG001|Overall Study|Other|19|||
27660325|NCT00265096|80593498|FG002|Overall Study|Other|10|||
27660326|NCT01678898|80593501|FG000|PB-102-F01|Adverse Event|0|||
27660327|NCT01678898|80593502|FG001|PB-102-F01|Adverse Event|1|||
27762356|NCT02293993|80954275|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
27832918|NCT04583423|81219401|FG000|Overall Study|Study Terminated by Sponsor|32|||
27832919|NCT04583423|81219402|FG001|Overall Study|Study Terminated by Sponsor|35|||
27832920|NCT04583423|81219403|FG002|Overall Study|Study Terminated by Sponsor|36|||
27832921|NCT04583423|81219404|FG003|Overall Study|Study Terminated by Sponsor|33|||
27660328|NCT01678898|80593503|FG002|PB-102-F01|Adverse Event|0|||
27660329|NCT01678898|80593501|FG000|PB-102-F01|Physician Decision|0|||
27832922|NCT04583423|81219401|FG000|Overall Study|Withdrawal by Subject|3|||
27660330|NCT01678898|80593502|FG001|PB-102-F01|Physician Decision|1|||
27660331|NCT01678898|80593503|FG002|PB-102-F01|Physician Decision|0|||
27660332|NCT04393779|80593504|FG000|Overall Study|Death|1|||
27660333|NCT04393779|80593504|FG000|Overall Study|Device reintervention or explant|4|||
27660334|NCT00527514|80593505|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
27660335|NCT00527514|80593505|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
27660336|NCT00527514|80593505|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
27660337|NCT00527514|80593505|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
27660338|NCT00527514|80593505|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
27660339|NCT00527514|80593505|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
27660340|NCT00527514|80593505|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
27660341|NCT02762500|80593506|FG000|Overall Study|Lack of Efficacy|1|||
27660342|NCT02762500|80593507|FG001|Overall Study|Lack of Efficacy|0|||
27660343|NCT02762500|80593506|FG000|Overall Study|Withdrawal by Subject|1|||
27660344|NCT02762500|80593507|FG001|Overall Study|Withdrawal by Subject|1|||
27660345|NCT02762500|80593506|FG000|Overall Study|Adverse Event|0|||
27660346|NCT02762500|80593507|FG001|Overall Study|Adverse Event|2|||
27660347|NCT04203199|80593508|FG000|First Intervention Period|Lost to Follow-up|0|||
27660348|NCT04203199|80593509|FG001|First Intervention Period|Lost to Follow-up|1|||
27660349|NCT04203199|80593508|FG000|Second Intervention Period|Medication change|1|||
27660350|NCT04203199|80593509|FG001|Second Intervention Period|Medication change|0|||
27660351|NCT02101554|80593516|FG000|Overall Study|Protocol Violation|0|||
27660352|NCT02101554|80593517|FG001|Overall Study|Protocol Violation|1|||
27660353|NCT02101554|80593518|FG002|Overall Study|Protocol Violation|0|||
27660354|NCT02101554|80593516|FG000|Overall Study|Insufficient Clinical Response|0|||
27660355|NCT02101554|80593517|FG001|Overall Study|Insufficient Clinical Response|2|||
27660356|NCT02101554|80593518|FG002|Overall Study|Insufficient Clinical Response|0|||
27660357|NCT02101554|80593516|FG000|Overall Study|Adverse Event|2|||
27660358|NCT02101554|80593517|FG001|Overall Study|Adverse Event|1|||
27660359|NCT02101554|80593518|FG002|Overall Study|Adverse Event|1|||
27660360|NCT02101554|80593516|FG000|Overall Study|Lost to Follow-up|0|||
27660361|NCT02101554|80593517|FG001|Overall Study|Lost to Follow-up|1|||
27660362|NCT02101554|80593518|FG002|Overall Study|Lost to Follow-up|0|||
27660363|NCT02101554|80593516|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
27660364|NCT02101554|80593517|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
27660365|NCT02101554|80593518|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
27660366|NCT00276016|80593521|FG000|Intervention 1|Withdrawal by Subject|0|||
27660367|NCT00276016|80593522|FG001|Intervention 1|Withdrawal by Subject|1|||
27660368|NCT00276016|80593523|FG002|Intervention 1|Withdrawal by Subject|0|||
27660369|NCT00276016|80593524|FG003|Intervention 1|Withdrawal by Subject|0|||
27660370|NCT00276016|80593525|FG004|Intervention 1|Withdrawal by Subject|0|||
27660371|NCT00276016|80593526|FG005|Intervention 1|Withdrawal by Subject|0|||
27660372|NCT01190228|80593527|FG000|Overall Study|Protocol Violation|4|||
27660373|NCT01190228|80593528|FG001|Overall Study|Protocol Violation|0|||
27660374|NCT01190228|80593529|FG002|Overall Study|Protocol Violation|0|||
27660375|NCT01190228|80593527|FG000|Overall Study|Withdrawal by Subject|1|||
27660376|NCT01190228|80593528|FG001|Overall Study|Withdrawal by Subject|0|||
27660377|NCT01190228|80593529|FG002|Overall Study|Withdrawal by Subject|0|||
27660378|NCT03749616|80593537|FG000|Overall Study|Lost to Follow-up|4|||
27660379|NCT03749616|80593538|FG001|Overall Study|Lost to Follow-up|7|||
27660380|NCT03749616|80593537|FG000|Overall Study|Screen Failure|1|||
27660381|NCT03749616|80593538|FG001|Overall Study|Screen Failure|1|||
27660382|NCT03749616|80593537|FG000|Overall Study|Withdrawal by Subject|2|||
27660383|NCT03749616|80593538|FG001|Overall Study|Withdrawal by Subject|0|||
27660384|NCT02446912|80593539|FG000|Overall Study|Adverse Event|3|||
27660385|NCT02446912|80593540|FG001|Overall Study|Adverse Event|13|||
27660386|NCT02446912|80593541|FG002|Overall Study|Adverse Event|5|||
27660387|NCT02446912|80593539|FG000|Overall Study|Condition under investigation worsened|0|||
27660388|NCT02446912|80593540|FG001|Overall Study|Condition under investigation worsened|1|||
27660389|NCT02446912|80593541|FG002|Overall Study|Condition under investigation worsened|1|||
27660390|NCT02446912|80593539|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27660391|NCT02446912|80593540|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27660392|NCT02446912|80593541|FG002|Overall Study|Study-specific withdrawal criteria|0|||
27660393|NCT02446912|80593539|FG000|Overall Study|Lack of Efficacy|1|||
27660394|NCT02446912|80593540|FG001|Overall Study|Lack of Efficacy|4|||
27660395|NCT02446912|80593541|FG002|Overall Study|Lack of Efficacy|7|||
27660396|NCT02446912|80593539|FG000|Overall Study|Lost to Follow-up|0|||
27660397|NCT02446912|80593540|FG001|Overall Study|Lost to Follow-up|0|||
27660398|NCT02446912|80593541|FG002|Overall Study|Lost to Follow-up|2|||
27660399|NCT02446912|80593539|FG000|Overall Study|Severe non-compliance to protocol|1|||
27660400|NCT02446912|80593540|FG001|Overall Study|Severe non-compliance to protocol|0|||
27660401|NCT02446912|80593541|FG002|Overall Study|Severe non-compliance to protocol|1|||
27660402|NCT02446912|80593539|FG000|Overall Study|Withdrawal by Subject|10|||
27660403|NCT02446912|80593540|FG001|Overall Study|Withdrawal by Subject|15|||
27660404|NCT02446912|80593541|FG002|Overall Study|Withdrawal by Subject|15|||
27660405|NCT02446912|80593539|FG000|Overall Study|Miscellaneous|2|||
27660406|NCT02446912|80593540|FG001|Overall Study|Miscellaneous|2|||
27660407|NCT02446912|80593541|FG002|Overall Study|Miscellaneous|4|||
27660408|NCT00449033|80593543|FG000|Treatment Period|Adverse Event|117|||
27660409|NCT00449033|80593544|FG001|Treatment Period|Adverse Event|83|||
27660410|NCT00449033|80593543|FG000|Treatment Period|Death|21|||
27762357|NCT02293993|80954276|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
27762358|NCT02293993|80954277|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
27762359|NCT02293993|80954278|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
27762360|NCT02671461|80954279|FG000|Treatment|Adverse Event|0|||
27762361|NCT02671461|80954280|FG001|Treatment|Adverse Event|0|||
27660411|NCT00449033|80593544|FG001|Treatment Period|Death|12|||
27660412|NCT00449033|80593543|FG000|Treatment Period|Lost to Follow-up|0|||
27762362|NCT02671461|80954281|FG002|Treatment|Adverse Event|1|||
27762363|NCT02671461|80954279|FG000|Treatment|Administrative Reason by Sponsor|1|||
27762364|NCT02671461|80954280|FG001|Treatment|Administrative Reason by Sponsor|3|||
27762365|NCT02671461|80954281|FG002|Treatment|Administrative Reason by Sponsor|4|||
27568586|NCT01945489|80271379|FG000|Cycle 2|Lost to Follow-up|0|||
27660413|NCT00449033|80593544|FG001|Treatment Period|Lost to Follow-up|2|||
27660414|NCT00449033|80593543|FG000|Treatment Period|Physician Decision|4|||
27660415|NCT00449033|80593544|FG001|Treatment Period|Physician Decision|5|||
27660416|NCT00449033|80593543|FG000|Treatment Period|Protocol Violation|8|||
27660417|NCT00449033|80593544|FG001|Treatment Period|Protocol Violation|7|||
27660418|NCT00449033|80593543|FG000|Treatment Period|Disease Progression|231|||
27660419|NCT00449033|80593544|FG001|Treatment Period|Disease Progression|288|||
27660420|NCT00449033|80593543|FG000|Treatment Period|Consent Withdrawn|36|||
27660421|NCT00449033|80593544|FG001|Treatment Period|Consent Withdrawn|20|||
27660422|NCT00449033|80593543|FG000|Treatment Period|Amended Protocol Criteria|22|||
27660423|NCT00449033|80593544|FG001|Treatment Period|Amended Protocol Criteria|18|||
27660424|NCT00449033|80593543|FG000|Treatment Period|Non-compliance|7|||
27660425|NCT00449033|80593544|FG001|Treatment Period|Non-compliance|8|||
27660426|NCT00449033|80593543|FG000|Treatment Period|Second Malignancy|0|||
27660427|NCT00449033|80593544|FG001|Treatment Period|Second Malignancy|1|||
27660428|NCT00449033|80593543|FG000|Treatment Period|Reason Missing|0|||
27660429|NCT00449033|80593544|FG001|Treatment Period|Reason Missing|4|||
27660430|NCT00449033|80593543|FG000|Treatment Period|Treatment Ongoing|6|||
27660431|NCT00449033|80593544|FG001|Treatment Period|Treatment Ongoing|4|||
27660432|NCT00449033|80593543|FG000|Follow-up Period|Death|299|||
27660433|NCT00449033|80593544|FG001|Follow-up Period|Death|311|||
27660434|NCT00449033|80593543|FG000|Follow-up Period|Lost to Follow-up|6|||
27660435|NCT00449033|80593544|FG001|Follow-up Period|Lost to Follow-up|10|||
27660436|NCT00449033|80593543|FG000|Follow-up Period|Reason Missing|120|||
27660437|NCT00449033|80593544|FG001|Follow-up Period|Reason Missing|113|||
27660438|NCT03997409|80593545|FG000|Overall Study|Protocol Violation|1|||
27660439|NCT03997409|80593546|FG001|Overall Study|Protocol Violation|1|||
27660440|NCT03997409|80593547|FG002|Overall Study|Protocol Violation|0|||
27660441|NCT03997409|80593545|FG000|Overall Study|Withdrawal by Subject|3|||
27660442|NCT03997409|80593546|FG001|Overall Study|Withdrawal by Subject|0|||
27660443|NCT03997409|80593547|FG002|Overall Study|Withdrawal by Subject|0|||
27660444|NCT03997409|80593545|FG000|Overall Study|Lost to Follow-up|0|||
27660445|NCT03997409|80593546|FG001|Overall Study|Lost to Follow-up|0|||
27660446|NCT03997409|80593547|FG002|Overall Study|Lost to Follow-up|1|||
27660447|NCT01114217|80593549|FG000|Overall Study|Adverse Event|5|||
27660448|NCT01114217|80593550|FG001|Overall Study|Adverse Event|3|||
27660449|NCT01114217|80593549|FG000|Overall Study|Lost to Follow-up|17|||
27660450|NCT01114217|80593550|FG001|Overall Study|Lost to Follow-up|33|||
27660451|NCT01114217|80593549|FG000|Overall Study|Withdrawal by Subject|21|||
27660452|NCT01114217|80593550|FG001|Overall Study|Withdrawal by Subject|28|||
27660453|NCT01114217|80593549|FG000|Overall Study|Other-Clerical Error|3|||
27660454|NCT01114217|80593550|FG001|Overall Study|Other-Clerical Error|0|||
27660455|NCT01114217|80593549|FG000|Overall Study|Other-Early termination|6|||
27861019|NCT01210612|81322868|FG001|Overall Study|Withdrawal by Subject|2|||
27568587|NCT01945489|80271380|FG001|Cycle 2|Lost to Follow-up|1|||
27568588|NCT01132495|80271383|FG000|Overall Study|Various reasons|40|||
27660456|NCT01114217|80593550|FG001|Overall Study|Other-Early termination|10|||
27660457|NCT01114217|80593549|FG000|Overall Study|Other-Procedure|1|||
27660458|NCT01114217|80593550|FG001|Overall Study|Other-Procedure|1|||
27660459|NCT01114217|80593549|FG000|Overall Study|Other-Pregnancy|2|||
27660460|NCT01114217|80593550|FG001|Overall Study|Other-Pregnancy|4|||
27660461|NCT01114217|80593549|FG000|Overall Study|Other-Protocol Violation|1|||
27660462|NCT01114217|80593550|FG001|Overall Study|Other-Protocol Violation|3|||
27660463|NCT01114217|80593549|FG000|Overall Study|Other-Lack of Efficacy|1|||
27660464|NCT01114217|80593550|FG001|Overall Study|Other-Lack of Efficacy|0|||
27660465|NCT01114217|80593549|FG000|Overall Study|Other-Non Compliance|2|||
27660466|NCT01114217|80593550|FG001|Overall Study|Other-Non Compliance|0|||
27660467|NCT01114217|80593549|FG000|Overall Study|Other-Physician Decision|1|||
27660468|NCT01114217|80593550|FG001|Overall Study|Other-Physician Decision|1|||
27660469|NCT01114217|80593549|FG000|Overall Study|Other-Sponsor Decision|10|||
27660470|NCT01114217|80593550|FG001|Overall Study|Other-Sponsor Decision|12|||
27660471|NCT01114217|80593549|FG000|Overall Study|Other-Study Termination|0|||
27660472|NCT01114217|80593550|FG001|Overall Study|Other-Study Termination|1|||
27660473|NCT01114217|80593549|FG000|Overall Study|Other-Study Withdrawn|1|||
27660474|NCT01114217|80593550|FG001|Overall Study|Other-Study Withdrawn|1|||
27660475|NCT01114217|80593549|FG000|Overall Study|Other-Site Stopped Communicating|2|||
27660476|NCT01114217|80593550|FG001|Overall Study|Other-Site Stopped Communicating|0|||
27660477|NCT01114217|80593549|FG000|Overall Study|Other-Lost to Follow-up|1|||
27660478|NCT01114217|80593550|FG001|Overall Study|Other-Lost to Follow-up|0|||
27660479|NCT01114217|80593549|FG000|Overall Study|Other-Withdrawal by Subject|1|||
27660480|NCT01114217|80593550|FG001|Overall Study|Other-Withdrawal by Subject|1|||
27660481|NCT04088136|80593551|FG000|Overall Study|Withdrawal by Subject|5|||
27660482|NCT04088136|80593552|FG001|Overall Study|Withdrawal by Subject|0|||
27660483|NCT04088136|80593551|FG000|Overall Study|Lack of Efficacy|0|||
27660484|NCT04088136|80593552|FG001|Overall Study|Lack of Efficacy|1|||
27660485|NCT01601821|80593553|FG000|Overall Study|Death|2|||
27660486|NCT01601821|80593554|FG001|Overall Study|Death|5|||
27660487|NCT01601821|80593553|FG000|Overall Study|Protocol Violation|2|||
27660488|NCT01601821|80593554|FG001|Overall Study|Protocol Violation|2|||
27660489|NCT01601821|80593553|FG000|Overall Study|Lost to Follow-up|6|||
27660490|NCT01601821|80593554|FG001|Overall Study|Lost to Follow-up|14|||
27660491|NCT01601821|80593553|FG000|Overall Study|Withdrawal by Subject|1|||
27660492|NCT01601821|80593554|FG001|Overall Study|Withdrawal by Subject|0|||
27660493|NCT01601821|80593553|FG000|Overall Study|Graft Loss|6|||
27660494|NCT01601821|80593554|FG001|Overall Study|Graft Loss|6|||
27660495|NCT01601821|80593553|FG000|Overall Study|Study Events|7|||
27660496|NCT01601821|80593554|FG001|Overall Study|Study Events|1|||
27660497|NCT01601821|80593553|FG000|Overall Study|Other|5|||
27660498|NCT01601821|80593554|FG001|Overall Study|Other|1|||
27660499|NCT03899259|80593555|FG000|Overall Study|Adverse Event|5|||
27660500|NCT03899259|80593556|FG001|Overall Study|Adverse Event|4|||
27660501|NCT03899259|80593557|FG002|Overall Study|Adverse Event|6|||
27660502|NCT03899259|80593555|FG000|Overall Study|Lack of Efficacy|5|||
27660503|NCT03899259|80593556|FG001|Overall Study|Lack of Efficacy|0|||
27762366|NCT02671461|80954279|FG000|Treatment|Randomized, not treated|1|||
27762367|NCT02671461|80954280|FG001|Treatment|Randomized, not treated|0|||
27762368|NCT02671461|80954281|FG002|Treatment|Randomized, not treated|0|||
27762369|NCT02671461|80954279|FG000|Follow-up|Withdrawal by Subject|1|||
27762370|NCT02671461|80954280|FG001|Follow-up|Withdrawal by Subject|0|||
27762371|NCT02671461|80954281|FG002|Follow-up|Withdrawal by Subject|0|||
27762372|NCT02671461|80954279|FG000|Follow-up|Lost to Follow-up|0|||
27762373|NCT02671461|80954280|FG001|Follow-up|Lost to Follow-up|0|||
27762374|NCT02671461|80954281|FG002|Follow-up|Lost to Follow-up|1|||
27762375|NCT02671461|80954279|FG000|Follow-up|Administrative Reason by Sponsor|0|||
27762376|NCT02671461|80954280|FG001|Follow-up|Administrative Reason by Sponsor|1|||
27762377|NCT02671461|80954281|FG002|Follow-up|Administrative Reason by Sponsor|0|||
27762378|NCT02029638|80954285|FG000|Overall Study|Death|0|||
27762379|NCT02029638|80954286|FG001|Overall Study|Death|0|||
27762380|NCT02029638|80954287|FG002|Overall Study|Death|1|||
27762381|NCT02029638|80954285|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
27762382|NCT02029638|80954286|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
27762383|NCT02029638|80954287|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
27762384|NCT04031404|80954288|FG000|Baseline|Lost to Follow-up|0|||
27660504|NCT03899259|80593557|FG002|Overall Study|Lack of Efficacy|2|||
27660505|NCT03899259|80593555|FG000|Overall Study|Pregnancy|3|||
27660506|NCT03899259|80593556|FG001|Overall Study|Pregnancy|0|||
27660507|NCT03899259|80593557|FG002|Overall Study|Pregnancy|1|||
27660508|NCT03899259|80593555|FG000|Overall Study|Physician Decision|0|||
27660509|NCT03899259|80593556|FG001|Overall Study|Physician Decision|1|||
27660510|NCT03899259|80593557|FG002|Overall Study|Physician Decision|0|||
27660511|NCT03899259|80593555|FG000|Overall Study|Protocol Deviation|1|||
27660512|NCT03899259|80593556|FG001|Overall Study|Protocol Deviation|1|||
27660513|NCT03899259|80593557|FG002|Overall Study|Protocol Deviation|1|||
27660514|NCT03899259|80593555|FG000|Overall Study|Withdrawal by Subject|8|||
27660515|NCT03899259|80593556|FG001|Overall Study|Withdrawal by Subject|10|||
27660516|NCT03899259|80593557|FG002|Overall Study|Withdrawal by Subject|12|||
27660517|NCT03899259|80593555|FG000|Overall Study|Lost to Follow-up|5|||
27762385|NCT04031404|80954289|FG001|Baseline|Lost to Follow-up|1|||
27762386|NCT04031404|80954288|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
27762387|NCT04031404|80954289|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
27660518|NCT03899259|80593556|FG001|Overall Study|Lost to Follow-up|6|||
27660519|NCT03899259|80593557|FG002|Overall Study|Lost to Follow-up|2|||
27660520|NCT03899259|80593555|FG000|Overall Study|Lack of Adherence|1|||
27660521|NCT03899259|80593556|FG001|Overall Study|Lack of Adherence|0|||
27660522|NCT03899259|80593557|FG002|Overall Study|Lack of Adherence|0|||
27762388|NCT04031404|80954288|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
27886621|NCT00619892|81418125|FG000|Overall Study|Lost to Follow-up|0|||
27660523|NCT03899259|80593555|FG000|Overall Study|Screen Failure|1|||
27660524|NCT03899259|80593556|FG001|Overall Study|Screen Failure|0|||
27660525|NCT03899259|80593557|FG002|Overall Study|Screen Failure|0|||
27660526|NCT03899259|80593555|FG000|Overall Study|Ongoing Study Participation|127|||
27660527|NCT03899259|80593556|FG001|Overall Study|Ongoing Study Participation|134|||
27660528|NCT03899259|80593557|FG002|Overall Study|Ongoing Study Participation|210|||
27660529|NCT05294328|80593558|FG000|Overall Study|Adverse Event|1|||
27660530|NCT05294328|80593559|FG001|Overall Study|Adverse Event|0|||
27660531|NCT05294328|80593560|FG002|Overall Study|Adverse Event|0|||
27660532|NCT05294328|80593558|FG000|Overall Study|Physician Decision|1|||
27660533|NCT05294328|80593559|FG001|Overall Study|Physician Decision|1|||
27660534|NCT05294328|80593560|FG002|Overall Study|Physician Decision|0|||
27660535|NCT05294328|80593558|FG000|Overall Study|Withdrawal by Subject|0|||
27660536|NCT05294328|80593559|FG001|Overall Study|Withdrawal by Subject|2|||
27660537|NCT05294328|80593560|FG002|Overall Study|Withdrawal by Subject|1|||
27660538|NCT05294328|80593558|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
27660539|NCT05294328|80593559|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
27861020|NCT03275064|81322869|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
27861021|NCT03275064|81322870|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
27861022|NCT03275064|81322871|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
27861023|NCT03275064|81322872|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
27886622|NCT00619892|81418126|FG001|Overall Study|Lost to Follow-up|1|||
27660540|NCT05294328|80593560|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
27660541|NCT00525915|80593561|FG000|Overall Study|Non-Compliance|0|||
27660542|NCT00525915|80593562|FG001|Overall Study|Non-Compliance|1|||
27660543|NCT00525915|80593561|FG000|Overall Study|Disease Progression|5|||
27660544|NCT00525915|80593562|FG001|Overall Study|Disease Progression|6|||
27660545|NCT00525915|80593561|FG000|Overall Study|Withdrawal by Subject|1|||
27660546|NCT00525915|80593562|FG001|Overall Study|Withdrawal by Subject|0|||
27660547|NCT00525915|80593561|FG000|Overall Study|Refused Surgery|1|||
27660548|NCT00525915|80593562|FG001|Overall Study|Refused Surgery|2|||
27660549|NCT00525915|80593561|FG000|Overall Study|Unrelated illness|1|||
27660550|NCT00525915|80593562|FG001|Overall Study|Unrelated illness|0|||
27660551|NCT00145496|80593568|FG000|Overall Study|Adverse Event|42|||
27660552|NCT00145496|80593569|FG001|Overall Study|Adverse Event|30|||
27660553|NCT00145496|80593568|FG000|Overall Study|Lack of Efficacy|12|||
27660554|NCT00145496|80593569|FG001|Overall Study|Lack of Efficacy|7|||
27660555|NCT00145496|80593568|FG000|Overall Study|Withdrawal by Subject|32|||
27660556|NCT00145496|80593569|FG001|Overall Study|Withdrawal by Subject|26|||
27660557|NCT00145496|80593568|FG000|Overall Study|Lost to Follow-up|12|||
27660558|NCT00145496|80593569|FG001|Overall Study|Lost to Follow-up|5|||
27660559|NCT00145496|80593568|FG000|Overall Study|Other|25|||
27660560|NCT00145496|80593569|FG001|Overall Study|Other|13|||
27660561|NCT01901302|80593576|FG000|Overall Study|Adverse Event|2|||
27660562|NCT01901302|80593577|FG001|Overall Study|Adverse Event|1|||
27660563|NCT01901302|80593576|FG000|Overall Study|Lack of Efficacy|0|||
27660564|NCT01901302|80593577|FG001|Overall Study|Lack of Efficacy|2|||
27660565|NCT01901302|80593576|FG000|Overall Study|Study Terminated by Sponsor|23|||
27660566|NCT01901302|80593577|FG001|Overall Study|Study Terminated by Sponsor|20|||
27660567|NCT01901302|80593576|FG000|Overall Study|Withdrawal by Subject|2|||
27660568|NCT01901302|80593577|FG001|Overall Study|Withdrawal by Subject|0|||
27660569|NCT01374971|80593580|FG000|Overall Study|Withdrawal by Subject|1|||
27660570|NCT03915951|80593581|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
27660571|NCT03915951|80593582|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
27660572|NCT03915951|80593581|FG000|Overall Study|Adverse Event|12|||
27660573|NCT03915951|80593582|FG001|Overall Study|Adverse Event|6|||
27660574|NCT03915951|80593581|FG000|Overall Study|Disease progression (radiological)|17|||
27660575|NCT03915951|80593582|FG001|Overall Study|Disease progression (radiological)|15|||
27660576|NCT03915951|80593581|FG000|Overall Study|Disease progression (clinical)|4|||
27660577|NCT03915951|80593582|FG001|Overall Study|Disease progression (clinical)|1|||
27660578|NCT03915951|80593581|FG000|Overall Study|Patient decision|0|||
27660579|NCT03915951|80593582|FG001|Overall Study|Patient decision|4|||
27660580|NCT03915951|80593581|FG000|Overall Study|Investigator decision|0|||
27660581|NCT03915951|80593582|FG001|Overall Study|Investigator decision|1|||
27660582|NCT03915951|80593581|FG000|Overall Study|Consent withdrawn|1|||
27660583|NCT03915951|80593582|FG001|Overall Study|Consent withdrawn|1|||
27660584|NCT03915951|80593581|FG000|Overall Study|Death|0|||
27660585|NCT03915951|80593582|FG001|Overall Study|Death|3|||
27660586|NCT00147745|80593583|FG000|Overall Study|Withdrawal by Subject|1|||
27660587|NCT00147745|80593584|FG001|Overall Study|Withdrawal by Subject|0|||
27660588|NCT00147745|80593585|FG002|Overall Study|Withdrawal by Subject|0|||
27660589|NCT04372186|80593588|FG000|Overall Study|Death|24|||
27660590|NCT04372186|80593589|FG001|Overall Study|Death|11|||
27660591|NCT04372186|80593588|FG000|Overall Study|Transferred to a different facility for care|0|||
27660592|NCT04372186|80593589|FG001|Overall Study|Transferred to a different facility for care|2|||
27660593|NCT03873714|80593592|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
27660594|NCT00246129|80593593|FG000|Overall Study|Lost to Follow-up|1|||
27660595|NCT00246129|80593594|FG001|Overall Study|Lost to Follow-up|0|||
27660596|NCT00246129|80593593|FG000|Overall Study|Death|2|||
27660597|NCT00246129|80593594|FG001|Overall Study|Death|1|||
27660598|NCT00246129|80593593|FG000|Overall Study|suffered primary non-function|1|||
27660599|NCT00246129|80593594|FG001|Overall Study|suffered primary non-function|0|||
27660600|NCT00246129|80593593|FG000|Overall Study|grafts failed|3|||
27660601|NCT00246129|80593594|FG001|Overall Study|grafts failed|1|||
27660602|NCT02040532|80593617|FG000|Overall Study|Lost to Follow-up|1|||
27660603|NCT02040532|80593617|FG000|Overall Study|Physician Decision|4|||
27660604|NCT02040532|80593617|FG000|Overall Study|Adverse Event|4|||
27660605|NCT02040532|80593617|FG000|Overall Study|Withdrawal by Subject|3|||
27660606|NCT01951105|80593619|FG000|Overall Study|Adverse Event|0|||
27660607|NCT01951105|80593620|FG001|Overall Study|Adverse Event|5|||
27660608|NCT01951105|80593621|FG002|Overall Study|Adverse Event|0|||
27660609|NCT01951105|80593619|FG000|Overall Study|Lost to Follow-up|0|||
27660610|NCT01951105|80593620|FG001|Overall Study|Lost to Follow-up|1|||
27660611|NCT01951105|80593621|FG002|Overall Study|Lost to Follow-up|0|||
27660612|NCT01951105|80593619|FG000|Overall Study|Protocol Violation|1|||
27660613|NCT01951105|80593620|FG001|Overall Study|Protocol Violation|1|||
27660614|NCT01951105|80593621|FG002|Overall Study|Protocol Violation|1|||
27660615|NCT01951105|80593619|FG000|Overall Study|Withdrawal by Subject|0|||
27660616|NCT01951105|80593620|FG001|Overall Study|Withdrawal by Subject|3|||
27660617|NCT01951105|80593621|FG002|Overall Study|Withdrawal by Subject|1|||
27660618|NCT02507297|80593622|FG000|Overall Study|Withdrawal by Subject|1|||
27660619|NCT02507297|80593623|FG001|Overall Study|Withdrawal by Subject|0|||
27660620|NCT02507297|80593622|FG000|Overall Study|Lost to Follow-up|0|||
27660621|NCT02507297|80593623|FG001|Overall Study|Lost to Follow-up|1|||
27660622|NCT03340766|80593626|FG000|Overall Study|Withdrawal by Subject|2|||
27660623|NCT03340766|80593627|FG001|Overall Study|Withdrawal by Subject|1|||
27660624|NCT03340766|80593628|FG002|Overall Study|Withdrawal by Subject|3|||
27660625|NCT03340766|80593626|FG000|Overall Study|Lost to Follow-up|0|||
27660626|NCT03340766|80593627|FG001|Overall Study|Lost to Follow-up|0|||
27660627|NCT03340766|80593628|FG002|Overall Study|Lost to Follow-up|1|||
27660628|NCT03340766|80593626|FG000|Overall Study|Death|6|||
27660629|NCT03340766|80593627|FG001|Overall Study|Death|7|||
27660630|NCT03340766|80593628|FG002|Overall Study|Death|4|||
27660631|NCT04468633|80593632|FG000|Overall Study|Withdrawal by Subject|4|||
27660632|NCT04468633|80593633|FG001|Overall Study|Withdrawal by Subject|0|||
27660633|NCT02849509|80593635|FG000|Overall Study|Worsening of disease under study|1|||
27660634|NCT02849509|80593636|FG001|Overall Study|Worsening of disease under study|1|||
27660635|NCT02849509|80593637|FG002|Overall Study|Worsening of disease under study|1|||
27660636|NCT02849509|80593635|FG000|Overall Study|Worsening of other pre-existing disease|0|||
27660637|NCT02849509|80593636|FG001|Overall Study|Worsening of other pre-existing disease|1|||
27660638|NCT02849509|80593637|FG002|Overall Study|Worsening of other pre-existing disease|2|||
27660639|NCT02849509|80593635|FG000|Overall Study|Other adverse event|36|||
27660640|NCT02849509|80593636|FG001|Overall Study|Other adverse event|41|||
27660641|NCT02849509|80593637|FG002|Overall Study|Other adverse event|8|||
27660642|NCT02849509|80593635|FG000|Overall Study|Withdrawal by Subject|6|||
27660643|NCT02849509|80593636|FG001|Overall Study|Withdrawal by Subject|17|||
27660644|NCT02849509|80593637|FG002|Overall Study|Withdrawal by Subject|12|||
27660645|NCT02849509|80593635|FG000|Overall Study|Lost to Follow-up|27|||
27660646|NCT02849509|80593636|FG001|Overall Study|Lost to Follow-up|67|||
27660647|NCT02849509|80593637|FG002|Overall Study|Lost to Follow-up|36|||
27660648|NCT02849509|80593635|FG000|Overall Study|Other, reason not specified|14|||
27660649|NCT02849509|80593636|FG001|Overall Study|Other, reason not specified|29|||
27660650|NCT02849509|80593637|FG002|Overall Study|Other, reason not specified|25|||
27660651|NCT02849509|80593635|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
27660652|NCT02849509|80593636|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
27660653|NCT02849509|80593637|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
27660654|NCT03745651|80593642|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
27660655|NCT03745651|80593643|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
27660656|NCT03745651|80593644|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27660657|NCT03745651|80593645|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27660658|NCT03745651|80593646|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27660659|NCT03745651|80593647|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27660660|NCT03745651|80593648|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27660661|NCT03745651|80593642|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
27660662|NCT03745651|80593643|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
27660663|NCT03745651|80593644|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
27660664|NCT03745651|80593645|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27660665|NCT03745651|80593646|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27660666|NCT03745651|80593647|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27660667|NCT03745651|80593648|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27660668|NCT03745651|80593642|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
27660669|NCT03745651|80593643|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27660670|NCT03745651|80593644|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
27660671|NCT03745651|80593645|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27660672|NCT03745651|80593646|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27660673|NCT03745651|80593647|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27660674|NCT03745651|80593648|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27660675|NCT03745651|80593642|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27660676|NCT03745651|80593643|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
27660677|NCT03745651|80593644|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27660678|NCT03745651|80593645|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27660679|NCT03745651|80593646|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27660680|NCT03745651|80593647|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27660681|NCT03745651|80593648|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27660682|NCT03745651|80593642|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
27660683|NCT03745651|80593643|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
27660684|NCT03745651|80593644|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
27660685|NCT03745651|80593645|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27660686|NCT03745651|80593646|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27660687|NCT03745651|80593647|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27660688|NCT03745651|80593648|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27660689|NCT03745651|80593642|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
27660690|NCT03745651|80593643|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
27660691|NCT03745651|80593644|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
27660692|NCT03745651|80593645|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27660693|NCT03745651|80593646|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27660694|NCT03745651|80593647|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27660695|NCT03745651|80593648|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
27660696|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27660697|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27660698|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27660699|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27660700|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27660701|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
27660702|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27660703|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27568589|NCT01132495|80271384|FG001|Overall Study|Various reasons|38|||
27568590|NCT01132495|80271385|FG002|Overall Study|Various reasons|20|||
27568591|NCT01132495|80271386|FG003|Overall Study|Various reasons|12|||
27568592|NCT00594464|80271392|FG000|Overall Study|Withdrawal by Subject|1|||
27568593|NCT00594464|80271392|FG000|Overall Study|Delay in operation|2|||
27568594|NCT00743652|80271393|FG000|Overall Study|Parent/Legal Guardian Request|3|||
27568595|NCT00743652|80271394|FG001|Overall Study|Parent/Legal Guardian Request|2|||
27568596|NCT00743652|80271395|FG002|Overall Study|Parent/Legal Guardian Request|2|||
27568597|NCT00743652|80271396|FG003|Overall Study|Parent/Legal Guardian Request|2|||
27660704|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27660705|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27660706|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
27660707|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27660708|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
27660709|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
27660710|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27660711|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27660712|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27660713|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
27660714|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
27660715|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
27660716|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
27660717|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27660718|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27568598|NCT00743652|80271397|FG004|Overall Study|Parent/Legal Guardian Request|0|||
27568599|NCT00743652|80271393|FG000|Overall Study|Adverse Event|3|||
27568600|NCT00743652|80271394|FG001|Overall Study|Adverse Event|0|||
27568601|NCT00743652|80271395|FG002|Overall Study|Adverse Event|0|||
27660719|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27660720|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
27660721|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27660722|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
27660723|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
27660724|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27660725|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27660726|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27660727|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
27660728|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27660729|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
27660730|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
27660731|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27660732|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27660733|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27660734|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27660735|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27660736|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
27660737|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27660738|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27660739|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27660740|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27660741|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
27660742|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
27861024|NCT03275064|81322873|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
27660743|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
27660744|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
27660745|NCT03745651|80593642|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27660746|NCT03745651|80593643|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27660747|NCT03745651|80593644|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27660748|NCT03745651|80593645|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
27660749|NCT03745651|80593646|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
27660750|NCT03745651|80593647|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
27660751|NCT03745651|80593648|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
27660752|NCT00946088|80593649|FG000|Overall Study|Withdrawal by Subject|0|||
27660753|NCT00946088|80593650|FG001|Overall Study|Withdrawal by Subject|1|||
27660754|NCT03924193|80593655|FG000|Overall Study|Adverse Event|10|||
27660755|NCT03924193|80593656|FG001|Overall Study|Adverse Event|0|||
27660756|NCT03924193|80593657|FG002|Overall Study|Adverse Event|10|||
27660757|NCT03924193|80593655|FG000|Overall Study|Withdrawal by Subject|5|||
27660758|NCT03924193|80593656|FG001|Overall Study|Withdrawal by Subject|10|||
27660759|NCT03924193|80593657|FG002|Overall Study|Withdrawal by Subject|2|||
27660760|NCT02350127|80593661|FG000|4-Month Assessment|Withdrawal by Subject|10|||
27660761|NCT02350127|80593662|FG001|4-Month Assessment|Withdrawal by Subject|9|||
27660762|NCT02350127|80593661|FG000|4-Month Assessment|Death|1|||
27660763|NCT02350127|80593662|FG001|4-Month Assessment|Death|0|||
27660764|NCT02350127|80593661|FG000|8-Month Assessment|Death|1|||
27660765|NCT02350127|80593662|FG001|8-Month Assessment|Death|1|||
27861025|NCT03275064|81322869|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
27861026|NCT03275064|81322870|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
27861027|NCT03275064|81322871|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
27660766|NCT02350127|80593661|FG000|8-Month Assessment|Withdrawal by Subject|5|||
27660767|NCT02350127|80593662|FG001|8-Month Assessment|Withdrawal by Subject|8|||
27660768|NCT03087851|80593663|FG000|Overall Study|Withdraw on medical grounds|0|||
27660769|NCT03087851|80593664|FG001|Overall Study|Withdraw on medical grounds|1|||
27660770|NCT03087851|80593665|FG002|Overall Study|Withdraw on medical grounds|2|||
27660771|NCT00500539|80593669|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
27660772|NCT00500539|80593669|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
27660773|NCT00500539|80593669|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
27660774|NCT00500539|80593669|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
27660775|NCT00500539|80593669|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
27660776|NCT00500539|80593669|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
27660777|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
27660778|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
27861028|NCT03275064|81322872|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
27861029|NCT03275064|81322873|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
27660779|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
27660780|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
27660781|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Death|1|||
27660782|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
27660783|NCT00500539|80593669|FG000|Follow-up Period (16 Weeks)|Missing|3|||
27660784|NCT05740371|80593674|FG000|Overall Study|Death|1|||
27660785|NCT01757171|80593675|FG000|Overall Study|Adverse Event|5|||
27660786|NCT01757171|80593676|FG001|Overall Study|Adverse Event|1|||
27660787|NCT01757171|80593675|FG000|Overall Study|Disease Progression|1|||
27660788|NCT01757171|80593676|FG001|Overall Study|Disease Progression|0|||
27660789|NCT01757171|80593675|FG000|Overall Study|Hospitalization|1|||
27660790|NCT01757171|80593676|FG001|Overall Study|Hospitalization|0|||
27660791|NCT01757171|80593675|FG000|Overall Study|ECOG decline|1|||
27660792|NCT01757171|80593676|FG001|Overall Study|ECOG decline|0|||
27660793|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
27660794|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
27660795|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
27660796|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
27660797|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
27660798|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
27660799|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
27660800|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
27660801|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
27660802|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
27660803|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
27660804|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
27660805|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
27660806|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
27660807|NCT02971683|80593681|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
27660808|NCT02971683|80593682|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
27660809|NCT02971683|80593681|FG000|Open-Label|Lost to Follow-up|1|||
27660810|NCT02971683|80593682|FG001|Open-Label|Lost to Follow-up|0|||
27660811|NCT02971683|80593681|FG000|Open-Label|Participants withdrew consent|0|||
27660812|NCT02971683|80593682|FG001|Open-Label|Participants withdrew consent|2|||
27660813|NCT02971683|80593681|FG000|Open-Label|Participant request to discontinue study treatment|1|||
27660814|NCT02971683|80593682|FG001|Open-Label|Participant request to discontinue study treatment|0|||
27660815|NCT02971683|80593681|FG000|Open-Label|Lack of Efficacy|2|||
27660816|NCT02971683|80593682|FG001|Open-Label|Lack of Efficacy|0|||
27660817|NCT02971683|80593681|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
27660818|NCT02971683|80593682|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
27660819|NCT02971683|80593681|FG000|Long-Term Open Label|Participant withdrew consent|1|||
27660820|NCT02971683|80593682|FG001|Long-Term Open Label|Participant withdrew consent|0|||
27660821|NCT02971683|80593681|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
27762389|NCT04031404|80954289|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
27861030|NCT03275064|81322869|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
27861031|NCT03275064|81322870|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
27861032|NCT03275064|81322871|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
27861033|NCT03275064|81322872|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
27861034|NCT03275064|81322873|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
27861035|NCT03275064|81322869|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
27762390|NCT04031404|80954288|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
27762391|NCT04031404|80954289|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
27762392|NCT04031404|80954288|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
27762393|NCT04031404|80954289|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
27762394|NCT00453180|80954292|FG000|Overall Study|Lost to Follow-up|2|||
27762395|NCT00453180|80954293|FG001|Overall Study|Lost to Follow-up|1|||
27762396|NCT00453180|80954292|FG000|Overall Study|Adverse Event|1|||
27762397|NCT00453180|80954293|FG001|Overall Study|Adverse Event|2|||
27762398|NCT01419080|80954296|FG000|Overall Study|Withdrawal by Subject|75|||
27762399|NCT01419080|80954296|FG000|Overall Study|Death|30|||
27861036|NCT03275064|81322870|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
27660822|NCT02971683|80593682|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
27660823|NCT02971683|80593681|FG000|Long-Term Open Label|Adverse Event|1|||
27660824|NCT02971683|80593682|FG001|Long-Term Open Label|Adverse Event|2|||
27660825|NCT02971683|80593681|FG000|Long-Term Open Label|Lack of Efficacy|1|||
27660826|NCT02971683|80593682|FG001|Long-Term Open Label|Lack of Efficacy|1|||
27660827|NCT02625922|80593683|FG000|Overall Study|Non-availability of IMP|1|||
27762400|NCT01419080|80954296|FG000|Overall Study|Lost to Follow-up|23|||
27762401|NCT01419080|80954296|FG000|Overall Study|Too Ill|3|||
27762402|NCT02758613|80954298|FG000|Treatment|Physician and Sponsor Decision|1|||
27762403|NCT02758613|80954299|FG001|Treatment|Physician and Sponsor Decision|0|||
27660828|NCT02625922|80593684|FG001|Overall Study|Non-availability of IMP|1|||
27660829|NCT02625922|80593683|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
27660830|NCT02625922|80593684|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
27660831|NCT04748445|80593689|FG000|Overall Study|No longer met eligibility criteria|12|||
27660832|NCT04748445|80593689|FG000|Overall Study|Other|36|||
27660833|NCT04748445|80593689|FG000|Overall Study|Withdrawal by Subject|553|||
27660834|NCT04748445|80593689|FG000|Overall Study|Lost to Follow-up|30|||
27660835|NCT00274846|80593690|FG000|Overall Study|Did not receive adequate NK cells|1|||
27660836|NCT01136733|80593693|FG000|Phase 1b|Adverse Event|0|||
27660837|NCT01136733|80593694|FG001|Phase 1b|Adverse Event|3|||
27660838|NCT01136733|80593695|FG002|Phase 1b|Adverse Event|1|||
27660839|NCT01136733|80593696|FG003|Phase 1b|Adverse Event|0|||
27660840|NCT01136733|80593697|FG004|Phase 1b|Adverse Event|0|||
27660841|NCT01136733|80593698|FG005|Phase 1b|Adverse Event|0|||
27660842|NCT01136733|80593699|FG006|Phase 1b|Adverse Event|0|||
27660843|NCT01136733|80593693|FG000|Phase 1b|Participant Choice|0|||
27660844|NCT01136733|80593694|FG001|Phase 1b|Participant Choice|0|||
27660845|NCT01136733|80593695|FG002|Phase 1b|Participant Choice|1|||
27660846|NCT01136733|80593696|FG003|Phase 1b|Participant Choice|0|||
27660847|NCT01136733|80593697|FG004|Phase 1b|Participant Choice|0|||
27660848|NCT01136733|80593698|FG005|Phase 1b|Participant Choice|0|||
27660849|NCT01136733|80593699|FG006|Phase 1b|Participant Choice|0|||
27660850|NCT01136733|80593693|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
27660851|NCT01136733|80593694|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
27660852|NCT01136733|80593695|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
27660853|NCT01136733|80593696|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
27660854|NCT01136733|80593697|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
27660855|NCT01136733|80593698|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
27660856|NCT01136733|80593699|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
27660857|NCT01136733|80593693|FG000|Phase 1b|Clinical Progression|1|||
27660858|NCT01136733|80593694|FG001|Phase 1b|Clinical Progression|1|||
27762404|NCT02758613|80954300|FG002|Treatment|Physician and Sponsor Decision|0|||
27762405|NCT02758613|80954301|FG003|Treatment|Physician and Sponsor Decision|0|||
27762406|NCT02758613|80954298|FG000|Treatment|Withdrawal by Subject|1|||
27762407|NCT02758613|80954299|FG001|Treatment|Withdrawal by Subject|0|||
27762408|NCT02758613|80954300|FG002|Treatment|Withdrawal by Subject|1|||
27762409|NCT02758613|80954301|FG003|Treatment|Withdrawal by Subject|0|||
27861037|NCT03275064|81322871|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
27861038|NCT03275064|81322872|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
27861039|NCT03275064|81322873|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
27861040|NCT03275064|81322869|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
27861041|NCT03275064|81322870|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
27861042|NCT03275064|81322871|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
27861043|NCT03275064|81322872|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
27861044|NCT03275064|81322873|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
27861045|NCT02504671|81322874|FG000|Overall Study|Withdrawal by Subject|1|||
27861046|NCT02504671|81322875|FG001|Overall Study|Withdrawal by Subject|5|||
27660859|NCT01136733|80593695|FG002|Phase 1b|Clinical Progression|0|||
27660860|NCT01136733|80593696|FG003|Phase 1b|Clinical Progression|0|||
27660861|NCT01136733|80593697|FG004|Phase 1b|Clinical Progression|0|||
27660862|NCT01136733|80593698|FG005|Phase 1b|Clinical Progression|0|||
27660863|NCT01136733|80593699|FG006|Phase 1b|Clinical Progression|0|||
27660864|NCT01136733|80593693|FG000|Phase 2|Disease Progression|0|||
27762410|NCT02394808|80954302|FG000|Period 1|Unsatisfactory lens fitting|0|||
27762411|NCT02394808|80954303|FG001|Period 1|Unsatisfactory lens fitting|1|||
27762412|NCT02394808|80954302|FG000|Period 2|Lost to Follow-up|1|||
27762413|NCT02394808|80954303|FG001|Period 2|Lost to Follow-up|0|||
27861047|NCT02504671|81322876|FG002|Overall Study|Withdrawal by Subject|4|||
27660865|NCT01136733|80593694|FG001|Phase 2|Disease Progression|0|||
27660866|NCT01136733|80593695|FG002|Phase 2|Disease Progression|0|||
27861048|NCT02504671|81322877|FG003|Overall Study|Withdrawal by Subject|4|||
27861049|NCT02504671|81322878|FG004|Overall Study|Withdrawal by Subject|5|||
27861050|NCT02504671|81322879|FG005|Overall Study|Withdrawal by Subject|3|||
27861051|NCT02504671|81322874|FG000|Overall Study|Lack of Efficacy|1|||
27861052|NCT02504671|81322875|FG001|Overall Study|Lack of Efficacy|3|||
27762414|NCT00818207|80954306|FG000|Overall Study|Adverse Event|6|||
27762415|NCT00818207|80954307|FG001|Overall Study|Adverse Event|0|||
27861053|NCT02504671|81322876|FG002|Overall Study|Lack of Efficacy|1|||
27568602|NCT00743652|80271396|FG003|Overall Study|Adverse Event|0|||
27660867|NCT01136733|80593696|FG003|Phase 2|Disease Progression|0|||
27660868|NCT01136733|80593697|FG004|Phase 2|Disease Progression|30|||
27660869|NCT01136733|80593698|FG005|Phase 2|Disease Progression|32|||
27660870|NCT01136733|80593699|FG006|Phase 2|Disease Progression|38|||
27660871|NCT01136733|80593693|FG000|Phase 2|Adverse Event|0|||
27660872|NCT01136733|80593694|FG001|Phase 2|Adverse Event|0|||
27762416|NCT00818207|80954306|FG000|Overall Study|Lost to Follow-up|160|||
27762417|NCT00818207|80954307|FG001|Overall Study|Lost to Follow-up|146|||
27660873|NCT01136733|80593695|FG002|Phase 2|Adverse Event|0|||
27660874|NCT01136733|80593696|FG003|Phase 2|Adverse Event|0|||
27660875|NCT01136733|80593697|FG004|Phase 2|Adverse Event|11|||
27660876|NCT01136733|80593698|FG005|Phase 2|Adverse Event|13|||
27660877|NCT01136733|80593699|FG006|Phase 2|Adverse Event|5|||
27660878|NCT01136733|80593693|FG000|Phase 2|Participant Choice|0|||
27660879|NCT01136733|80593694|FG001|Phase 2|Participant Choice|0|||
27660880|NCT01136733|80593695|FG002|Phase 2|Participant Choice|0|||
27660881|NCT01136733|80593696|FG003|Phase 2|Participant Choice|0|||
27660882|NCT01136733|80593697|FG004|Phase 2|Participant Choice|3|||
27660883|NCT01136733|80593698|FG005|Phase 2|Participant Choice|0|||
27660884|NCT01136733|80593699|FG006|Phase 2|Participant Choice|1|||
27660885|NCT01136733|80593693|FG000|Phase 2|Administrative-Withdrew Consent|0|||
27660886|NCT01136733|80593694|FG001|Phase 2|Administrative-Withdrew Consent|0|||
27660887|NCT01136733|80593695|FG002|Phase 2|Administrative-Withdrew Consent|0|||
27660888|NCT01136733|80593696|FG003|Phase 2|Administrative-Withdrew Consent|0|||
27660889|NCT01136733|80593697|FG004|Phase 2|Administrative-Withdrew Consent|1|||
27660890|NCT01136733|80593698|FG005|Phase 2|Administrative-Withdrew Consent|0|||
27660891|NCT01136733|80593699|FG006|Phase 2|Administrative-Withdrew Consent|0|||
27660892|NCT01136733|80593693|FG000|Phase 2|Other|0|||
27660893|NCT01136733|80593694|FG001|Phase 2|Other|0|||
27660894|NCT01136733|80593695|FG002|Phase 2|Other|0|||
27660895|NCT01136733|80593696|FG003|Phase 2|Other|0|||
27660896|NCT01136733|80593697|FG004|Phase 2|Other|6|||
27660897|NCT01136733|80593698|FG005|Phase 2|Other|7|||
27660898|NCT01136733|80593699|FG006|Phase 2|Other|6|||
27660899|NCT04523571|80593700|FG000|Received 2 Doses|Withdrawal by Subject|0|||
27660900|NCT04523571|80593701|FG001|Received 2 Doses|Withdrawal by Subject|0|||
27660901|NCT04523571|80593702|FG002|Received 2 Doses|Withdrawal by Subject|0|||
27660902|NCT04523571|80593703|FG003|Received 2 Doses|Withdrawal by Subject|1|||
27660903|NCT04523571|80593704|FG004|Received 2 Doses|Withdrawal by Subject|1|||
27660904|NCT04523571|80593705|FG005|Received 2 Doses|Withdrawal by Subject|0|||
27660905|NCT04523571|80593700|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
27660906|NCT04523571|80593701|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
27762418|NCT00818207|80954306|FG000|Overall Study|Multiple reasons|11|||
27762419|NCT00818207|80954307|FG001|Overall Study|Multiple reasons|12|||
27660907|NCT04523571|80593702|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
27660908|NCT04523571|80593703|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
27660909|NCT04523571|80593704|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
27660910|NCT04523571|80593705|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
27660911|NCT04523571|80593700|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
27660912|NCT04523571|80593701|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
27660913|NCT04523571|80593702|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
27660914|NCT04523571|80593703|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
27660915|NCT04523571|80593704|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
27660916|NCT04523571|80593705|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
27660917|NCT04523571|80593700|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
27762420|NCT00818207|80954306|FG000|Overall Study|Withdrawal by Subject|42|||
27762421|NCT00818207|80954307|FG001|Overall Study|Withdrawal by Subject|104|||
27762422|NCT00818207|80954306|FG000|Overall Study|Death|3|||
27861054|NCT02504671|81322877|FG003|Overall Study|Lack of Efficacy|0|||
27861055|NCT02504671|81322878|FG004|Overall Study|Lack of Efficacy|4|||
27568603|NCT00743652|80271397|FG004|Overall Study|Adverse Event|0|||
27568604|NCT00743652|80271393|FG000|Overall Study|Death|2|||
27568605|NCT00743652|80271394|FG001|Overall Study|Death|0|||
27568606|NCT00743652|80271395|FG002|Overall Study|Death|0|||
27568607|NCT00743652|80271396|FG003|Overall Study|Death|0|||
27568608|NCT00743652|80271397|FG004|Overall Study|Death|0|||
27568609|NCT00743652|80271393|FG000|Overall Study|Investigator Request|0|||
27568610|NCT00743652|80271394|FG001|Overall Study|Investigator Request|0|||
27568611|NCT00743652|80271395|FG002|Overall Study|Investigator Request|0|||
27568612|NCT00743652|80271396|FG003|Overall Study|Investigator Request|2|||
27568613|NCT00743652|80271397|FG004|Overall Study|Investigator Request|0|||
27568614|NCT00743652|80271393|FG000|Overall Study|Other|1|||
27568615|NCT00743652|80271394|FG001|Overall Study|Other|1|||
27568616|NCT00743652|80271395|FG002|Overall Study|Other|0|||
27568617|NCT00743652|80271396|FG003|Overall Study|Other|0|||
27568618|NCT00743652|80271397|FG004|Overall Study|Other|0|||
27568619|NCT00743652|80271393|FG000|Overall Study|Lost to Follow-up|1|||
27568620|NCT00743652|80271394|FG001|Overall Study|Lost to Follow-up|0|||
27568621|NCT00743652|80271395|FG002|Overall Study|Lost to Follow-up|0|||
27568622|NCT00743652|80271396|FG003|Overall Study|Lost to Follow-up|0|||
27568623|NCT00743652|80271397|FG004|Overall Study|Lost to Follow-up|0|||
27568624|NCT01072201|80271405|FG000|Overall Study|Lost to Follow-up|0|||
27568625|NCT01072201|80271406|FG001|Overall Study|Lost to Follow-up|1|||
27568626|NCT00613509|80271407|FG000|Cycle 1|Adverse Event|2|||
27568627|NCT00613509|80271408|FG001|Cycle 1|Adverse Event|1|||
27660918|NCT04523571|80593701|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
27660919|NCT04523571|80593702|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
27660920|NCT04523571|80593703|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
27660921|NCT04523571|80593704|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
27660922|NCT04523571|80593705|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
27660923|NCT02498418|80593707|FG000|Overall Study|Lack of Efficacy|0|||
27660924|NCT02498418|80593708|FG001|Overall Study|Lack of Efficacy|0|||
27660925|NCT02498418|80593709|FG002|Overall Study|Lack of Efficacy|1|||
27660926|NCT02498418|80593707|FG000|Overall Study|Withdrawal by Subject|2|||
27660927|NCT02498418|80593708|FG001|Overall Study|Withdrawal by Subject|0|||
27660928|NCT02498418|80593709|FG002|Overall Study|Withdrawal by Subject|3|||
27660929|NCT02498418|80593707|FG000|Overall Study|Lost to Follow-up|0|||
27660930|NCT02498418|80593708|FG001|Overall Study|Lost to Follow-up|1|||
27660931|NCT02498418|80593709|FG002|Overall Study|Lost to Follow-up|1|||
27660932|NCT02498418|80593707|FG000|Overall Study|Participant taken prohibited medication|0|||
27660933|NCT02498418|80593708|FG001|Overall Study|Participant taken prohibited medication|1|||
27660934|NCT02498418|80593709|FG002|Overall Study|Participant taken prohibited medication|1|||
27660935|NCT00747149|80593710|FG000|Overall Study|Adverse Event|0|||
27660936|NCT00747149|80593711|FG001|Overall Study|Adverse Event|15|||
27660937|NCT00747149|80593710|FG000|Overall Study|Lost to Follow-up|0|||
27660938|NCT00747149|80593711|FG001|Overall Study|Lost to Follow-up|10|||
27660939|NCT00747149|80593710|FG000|Overall Study|Withdrawal by Subject|0|||
27660940|NCT00747149|80593711|FG001|Overall Study|Withdrawal by Subject|6|||
27660941|NCT00747149|80593710|FG000|Overall Study|Did not receive treatment|0|||
27660942|NCT00747149|80593711|FG001|Overall Study|Did not receive treatment|1|||
27660943|NCT00747149|80593710|FG000|Overall Study|Incorrect enrollment|0|||
27660944|NCT00747149|80593711|FG001|Overall Study|Incorrect enrollment|6|||
27660945|NCT00747149|80593710|FG000|Overall Study|Severe non-compliance to protocol|0|||
27660946|NCT00747149|80593711|FG001|Overall Study|Severe non-compliance to protocol|1|||
27660947|NCT00747149|80593710|FG000|Overall Study|Not reported|1|||
27660948|NCT00747149|80593711|FG001|Overall Study|Not reported|4|||
27660949|NCT00495612|80593718|FG000|Overall Study|Lost to Follow-up|1|||
27660950|NCT00495612|80593719|FG001|Overall Study|Lost to Follow-up|0|||
27660951|NCT00495612|80593718|FG000|Overall Study|Subject's Decision to Withdraw|3|||
27660952|NCT00495612|80593719|FG001|Overall Study|Subject's Decision to Withdraw|0|||
27660953|NCT03302559|80593722|FG000|Overall Study|Adverse Event|2|||
27660954|NCT03302559|80593722|FG000|Overall Study|Lost to Follow-up|1|||
27660955|NCT03302559|80593722|FG000|Overall Study|Withdrew Consent|3|||
27660956|NCT01870999|80593725|FG000|Overall Study|Adverse Event|0|||
27660957|NCT01870999|80593726|FG001|Overall Study|Adverse Event|4|||
27660958|NCT01870999|80593727|FG002|Overall Study|Adverse Event|1|||
27660959|NCT01870999|80593725|FG000|Overall Study|Subject met withdrawal criteria|3|||
27660960|NCT01870999|80593726|FG001|Overall Study|Subject met withdrawal criteria|2|||
27660961|NCT01870999|80593727|FG002|Overall Study|Subject met withdrawal criteria|0|||
27660962|NCT01870999|80593725|FG000|Overall Study|Subject withdrawn by Investigator|1|||
27660963|NCT01870999|80593726|FG001|Overall Study|Subject withdrawn by Investigator|0|||
27660964|NCT01870999|80593727|FG002|Overall Study|Subject withdrawn by Investigator|0|||
27660965|NCT01870999|80593725|FG000|Overall Study|Withdrawal by Subject|0|||
27660966|NCT01870999|80593726|FG001|Overall Study|Withdrawal by Subject|2|||
27660967|NCT01870999|80593727|FG002|Overall Study|Withdrawal by Subject|5|||
27660968|NCT01870999|80593725|FG000|Overall Study|Protocol Violation|0|||
27660969|NCT01870999|80593726|FG001|Overall Study|Protocol Violation|0|||
27660970|NCT01870999|80593727|FG002|Overall Study|Protocol Violation|1|||
27660971|NCT03169530|80593728|FG000|Overall Study|Study ended by NIH|15|||
27660972|NCT03169530|80593729|FG001|Overall Study|Study ended by NIH|17|||
27660973|NCT00126555|80593730|FG000|Overall Study|Withdrawal by Subject|1|||
27660974|NCT00126555|80593730|FG000|Overall Study|Adverse Event|2|||
27660975|NCT00126555|80593730|FG000|Overall Study|Progressive Disease|3|||
27660976|NCT01514864|80593736|FG000|Overall Study|Disease progression|7|||
27660977|NCT01514864|80593737|FG001|Overall Study|Disease progression|5|||
27660978|NCT01514864|80593736|FG000|Overall Study|Study drug toxicity|2|||
27660979|NCT01514864|80593737|FG001|Overall Study|Study drug toxicity|0|||
27660980|NCT03049306|80593739|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
27762423|NCT00818207|80954307|FG001|Overall Study|Death|5|||
27762424|NCT02384395|80954309|FG000|Overall Study|Physician Decision|4|||
27660981|NCT03049306|80593740|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
27660982|NCT00774306|80593742|FG000|Overall Study|Adverse Event|3|||
27660983|NCT00774306|80593743|FG001|Overall Study|Adverse Event|0|||
27660984|NCT00774306|80593744|FG002|Overall Study|Adverse Event|0|||
27660985|NCT00774306|80593745|FG003|Overall Study|Adverse Event|0|||
27762425|NCT02384395|80954309|FG000|Overall Study|Withdrawal by Subject|3|||
27660986|NCT00774306|80593742|FG000|Overall Study|Protocol Violation|2|||
27660987|NCT00774306|80593743|FG001|Overall Study|Protocol Violation|0|||
27660988|NCT00774306|80593744|FG002|Overall Study|Protocol Violation|3|||
27660989|NCT00774306|80593745|FG003|Overall Study|Protocol Violation|0|||
27660990|NCT00774306|80593742|FG000|Overall Study|Withdrawal by Subject|6|||
27660991|NCT00774306|80593743|FG001|Overall Study|Withdrawal by Subject|1|||
27660992|NCT00774306|80593744|FG002|Overall Study|Withdrawal by Subject|1|||
27660993|NCT00774306|80593745|FG003|Overall Study|Withdrawal by Subject|0|||
27660994|NCT00774306|80593742|FG000|Overall Study|Lost to Follow-up|6|||
27660995|NCT00774306|80593743|FG001|Overall Study|Lost to Follow-up|0|||
27660996|NCT00774306|80593744|FG002|Overall Study|Lost to Follow-up|4|||
27660997|NCT00774306|80593745|FG003|Overall Study|Lost to Follow-up|5|||
27660998|NCT00774306|80593742|FG000|Overall Study|Death|1|||
27660999|NCT00774306|80593743|FG001|Overall Study|Death|1|||
27861056|NCT02504671|81322879|FG005|Overall Study|Lack of Efficacy|4|||
27861057|NCT02504671|81322874|FG000|Overall Study|Adverse Event|1|||
27568628|NCT00613509|80271407|FG000|Cycle 1|Disease Progression|2|||
27661000|NCT00774306|80593744|FG002|Overall Study|Death|0|||
27661001|NCT00774306|80593745|FG003|Overall Study|Death|0|||
27661002|NCT02409732|80596742|FG000|Overall Study|Withdrawal by Subject|4|||
27661003|NCT02409732|80596742|FG000|Overall Study|Lost to Follow-up|2|||
27661004|NCT04194541|80596743|FG000|Day 1 Through 13|Lost to Follow-up|3|||
27661005|NCT04194541|80596743|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
27661006|NCT04194541|80596743|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
27661007|NCT02744898|80596744|FG000|Overall Study|Progressive Disease|2|||
27661008|NCT02744898|80596744|FG000|Overall Study|Physician Decision|1|||
27661009|NCT02744898|80596744|FG000|Overall Study|Toxicity|1|||
27661010|NCT02556918|80596753|FG000|Overall Study|Protocol Violation|5|||
27661011|NCT02556918|80596754|FG001|Overall Study|Protocol Violation|6|||
27661012|NCT02556918|80596753|FG000|Overall Study|Withdrawal by Subject|4|||
27661013|NCT02556918|80596754|FG001|Overall Study|Withdrawal by Subject|4|||
27661014|NCT01032200|80596755|FG000|Overall Study|Death|1|||
27661015|NCT01032200|80596756|FG001|Overall Study|Death|1|||
27661016|NCT01032200|80596755|FG000|Overall Study|Withdrawal by Subject|1|||
27661017|NCT01032200|80596756|FG001|Overall Study|Withdrawal by Subject|3|||
27661018|NCT01032200|80596755|FG000|Overall Study|Toxicity|0|||
27661019|NCT01032200|80596756|FG001|Overall Study|Toxicity|2|||
27661020|NCT01032200|80596755|FG000|Overall Study|Progression|1|||
27661021|NCT01032200|80596756|FG001|Overall Study|Progression|0|||
27661022|NCT01032200|80596755|FG000|Overall Study|Multiple|1|||
27661023|NCT01032200|80596756|FG001|Overall Study|Multiple|1|||
27661024|NCT04054193|80596757|FG000|Cycle 1|Physician Decision|1|||
27661025|NCT04054193|80596757|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
27661026|NCT04054193|80596757|FG000|Cycle 1|Allocated but not treated|3|||
27661027|NCT04054193|80596757|FG000|Cycles 2-3|Physician Decision|2|||
27661028|NCT04054193|80596757|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
27661029|NCT04054193|80596757|FG000|Cycles 2-3|Various reasons|17|||
27661030|NCT03786783|80596761|FG000|Overall Study|Death|1|||
27661031|NCT03786783|80596761|FG000|Overall Study|Physician Decision|6|||
27661032|NCT03786783|80596761|FG000|Overall Study|Withdrawal by Subject|2|||
27661033|NCT03786783|80596761|FG000|Overall Study|Disease Progression|7|||
27661034|NCT03786783|80596761|FG000|Overall Study|Patient/Parent Refusal|4|||
27661035|NCT00562484|80596762|FG000|Overall Study|Adverse Event|6|||
27661036|NCT00562484|80596763|FG001|Overall Study|Adverse Event|1|||
27661037|NCT00562484|80596762|FG000|Overall Study|Protocol Violation|11|||
27661038|NCT00562484|80596763|FG001|Overall Study|Protocol Violation|2|||
27661039|NCT00562484|80596762|FG000|Overall Study|Withdrawal by Subject|12|||
27661040|NCT00562484|80596763|FG001|Overall Study|Withdrawal by Subject|9|||
27661041|NCT00562484|80596762|FG000|Overall Study|Moved away from the study area|20|||
27661042|NCT00562484|80596763|FG001|Overall Study|Moved away from the study area|9|||
27661043|NCT00562484|80596762|FG000|Overall Study|Lost to Follow-up|132|||
27661044|NCT00562484|80596763|FG001|Overall Study|Lost to Follow-up|71|||
27661045|NCT00562484|80596762|FG000|Overall Study|Reason not provided or not specified|25|||
27661046|NCT00562484|80596763|FG001|Overall Study|Reason not provided or not specified|12|||
27661047|NCT01502371|80596764|FG000|Overall Study|Withdrawal by Subject|1|||
27661048|NCT01502371|80596765|FG001|Overall Study|Withdrawal by Subject|2|||
27661049|NCT01502371|80596766|FG002|Overall Study|Withdrawal by Subject|1|||
27661050|NCT01502371|80596767|FG003|Overall Study|Withdrawal by Subject|1|||
27661051|NCT01502371|80596768|FG004|Overall Study|Withdrawal by Subject|1|||
27661052|NCT01502371|80596764|FG000|Overall Study|Adverse Event|2|||
27661053|NCT01502371|80596765|FG001|Overall Study|Adverse Event|1|||
27568629|NCT00613509|80271408|FG001|Cycle 1|Disease Progression|6|||
27568630|NCT00613509|80271407|FG000|Cycle 1|Unacceptable Toxicity|1|||
27568631|NCT00613509|80271408|FG001|Cycle 1|Unacceptable Toxicity|0|||
27568632|NCT00613509|80271407|FG000|Cycle 1|Other administrative reason|0|||
27568633|NCT00613509|80271408|FG001|Cycle 1|Other administrative reason|1|||
27568634|NCT00348556|80271409|FG000|Overall Study|Adverse Event|1|||
27568635|NCT00414388|80271412|FG000|Overall Study|Adverse Event|1|||
27568636|NCT01399593|80271413|FG000|Overall Study|Physician Decision|1|||
27568637|NCT01399593|80271414|FG001|Overall Study|Physician Decision|0|||
27568638|NCT01399593|80271413|FG000|Overall Study|Adverse Event|1|||
27661054|NCT01502371|80596766|FG002|Overall Study|Adverse Event|0|||
27661055|NCT01502371|80596767|FG003|Overall Study|Adverse Event|4|||
27661056|NCT01502371|80596768|FG004|Overall Study|Adverse Event|3|||
27661057|NCT01502371|80596764|FG000|Overall Study|Treatment Failure|22|||
27661058|NCT01502371|80596765|FG001|Overall Study|Treatment Failure|20|||
27661059|NCT01502371|80596766|FG002|Overall Study|Treatment Failure|12|||
27661060|NCT01502371|80596767|FG003|Overall Study|Treatment Failure|19|||
27661061|NCT01502371|80596768|FG004|Overall Study|Treatment Failure|30|||
27661062|NCT01502371|80596764|FG000|Overall Study|Lack of Efficacy|3|||
27661063|NCT01502371|80596765|FG001|Overall Study|Lack of Efficacy|3|||
27661064|NCT01502371|80596766|FG002|Overall Study|Lack of Efficacy|2|||
27661065|NCT01502371|80596767|FG003|Overall Study|Lack of Efficacy|2|||
27661066|NCT01502371|80596768|FG004|Overall Study|Lack of Efficacy|4|||
27661067|NCT01502371|80596764|FG000|Overall Study|Physician Decision|3|||
27661068|NCT01502371|80596765|FG001|Overall Study|Physician Decision|0|||
27661069|NCT01502371|80596766|FG002|Overall Study|Physician Decision|0|||
27661070|NCT01502371|80596767|FG003|Overall Study|Physician Decision|0|||
27661071|NCT01502371|80596768|FG004|Overall Study|Physician Decision|1|||
27661072|NCT01502371|80596764|FG000|Overall Study|Noncompliance with Study Drug|0|||
27661073|NCT01502371|80596765|FG001|Overall Study|Noncompliance with Study Drug|0|||
27661074|NCT01502371|80596766|FG002|Overall Study|Noncompliance with Study Drug|1|||
27661075|NCT01502371|80596767|FG003|Overall Study|Noncompliance with Study Drug|2|||
27661076|NCT01502371|80596768|FG004|Overall Study|Noncompliance with Study Drug|1|||
27661077|NCT01502371|80596764|FG000|Overall Study|Technical Problems|1|||
27661078|NCT01502371|80596765|FG001|Overall Study|Technical Problems|0|||
27661079|NCT01502371|80596766|FG002|Overall Study|Technical Problems|2|||
27661080|NCT01502371|80596767|FG003|Overall Study|Technical Problems|4|||
27661081|NCT01502371|80596768|FG004|Overall Study|Technical Problems|1|||
27661082|NCT01502371|80596764|FG000|Overall Study|Protocol Violation|9|||
27661083|NCT01502371|80596765|FG001|Overall Study|Protocol Violation|5|||
27661084|NCT01502371|80596766|FG002|Overall Study|Protocol Violation|6|||
27661085|NCT01502371|80596767|FG003|Overall Study|Protocol Violation|5|||
27661086|NCT01502371|80596768|FG004|Overall Study|Protocol Violation|10|||
27661087|NCT01502371|80596764|FG000|Overall Study|Excluded Medication|0|||
27661088|NCT01502371|80596765|FG001|Overall Study|Excluded Medication|1|||
27661089|NCT01502371|80596766|FG002|Overall Study|Excluded Medication|1|||
27661090|NCT01502371|80596767|FG003|Overall Study|Excluded Medication|0|||
27661091|NCT01502371|80596768|FG004|Overall Study|Excluded Medication|1|||
27661092|NCT00762502|80596769|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
27661093|NCT00762502|80596770|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
27661094|NCT00762502|80596771|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
27661095|NCT00762502|80596769|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
27661096|NCT00762502|80596770|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
27661097|NCT00762502|80596771|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
27661098|NCT00762502|80596769|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
27661099|NCT00762502|80596770|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
27661100|NCT00762502|80596771|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
27661101|NCT00460577|80596772|FG000|Overall Study|Protocol Violation|2|||
27661102|NCT00460577|80596773|FG001|Overall Study|Protocol Violation|6|||
27661103|NCT05153499|80596774|FG000|Overall Study|Withdrawal by Subject|1|||
27661104|NCT05153499|80596775|FG001|Overall Study|Withdrawal by Subject|0|||
27661105|NCT05153499|80596774|FG000|Overall Study|Clinical Hold|1|||
27661106|NCT05153499|80596775|FG001|Overall Study|Clinical Hold|0|||
27661107|NCT05153499|80596774|FG000|Overall Study|Study Termination|6|||
27762426|NCT02384395|80954309|FG000|Overall Study|Lost to Follow-up|3|||
27762427|NCT01207388|80954310|FG000|Overall Study|Death|67|||
27762428|NCT01207388|80954310|FG000|Overall Study|Withdrawal by Subject|1|||
27762429|NCT00270998|80954313|FG000|3 Month Follow-up|Adverse Event|1|||
27661108|NCT05153499|80596775|FG001|Overall Study|Study Termination|5|||
27661109|NCT01072396|80596778|FG000|Period One|Adverse Event|1|||
27661110|NCT01072396|80596779|FG001|Period One|Adverse Event|1|||
27661111|NCT01072396|80596778|FG000|Period One|Protocol Violation|2|||
27661112|NCT01072396|80596779|FG001|Period One|Protocol Violation|1|||
27661113|NCT01072396|80596778|FG000|Period One|Withdrawal by Subject|2|||
27661114|NCT01072396|80596779|FG001|Period One|Withdrawal by Subject|0|||
27661115|NCT01072396|80596778|FG000|Washout Period|Missing termination information|0|||
27661116|NCT01072396|80596779|FG001|Washout Period|Missing termination information|1|||
27661117|NCT01072396|80596778|FG000|Period Two|Adverse Event|0|||
27861058|NCT02504671|81322875|FG001|Overall Study|Adverse Event|1|||
27661118|NCT01072396|80596779|FG001|Period Two|Adverse Event|3|||
27661119|NCT01072396|80596778|FG000|Period Two|Lost to Follow-up|1|||
27661120|NCT01072396|80596779|FG001|Period Two|Lost to Follow-up|0|||
27661121|NCT03314233|80596780|FG000|Overall Study|No longer eligible at time of delivery|1|||
27661122|NCT02212197|80596785|FG000|Overall Study|Need for radiotherapy|1|||
27661123|NCT02212197|80596786|FG001|Overall Study|Need for radiotherapy|0|||
27762430|NCT00270998|80954314|FG001|3 Month Follow-up|Adverse Event|0|||
27762431|NCT00270998|80954315|FG002|3 Month Follow-up|Adverse Event|0|||
27861059|NCT02504671|81322876|FG002|Overall Study|Adverse Event|0|||
27661124|NCT02212197|80596787|FG002|Overall Study|Need for radiotherapy|0|||
27661125|NCT01878253|80596788|FG000|Overall Study|Death|1|||
27661126|NCT01878253|80596788|FG000|Overall Study|SIdus System Removal|3|||
27861060|NCT02504671|81322877|FG003|Overall Study|Adverse Event|1|||
27661127|NCT01878253|80596788|FG000|Overall Study|Withdrawal by Subject|1|||
27861061|NCT02504671|81322878|FG004|Overall Study|Adverse Event|0|||
27762432|NCT00270998|80954313|FG000|3 Month Follow-up|Lack of Efficacy|1|||
27762433|NCT00270998|80954314|FG001|3 Month Follow-up|Lack of Efficacy|2|||
27762434|NCT00270998|80954315|FG002|3 Month Follow-up|Lack of Efficacy|1|||
27762435|NCT00270998|80954313|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
27762436|NCT00270998|80954314|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
27762437|NCT00270998|80954315|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
27762438|NCT00270998|80954313|FG000|3 Month Follow-up|Pessary did not fit|12|||
27762439|NCT00270998|80954314|FG001|3 Month Follow-up|Pessary did not fit|0|||
27762440|NCT00270998|80954315|FG002|3 Month Follow-up|Pessary did not fit|0|||
27762441|NCT00270998|80954313|FG000|3 Month Follow-up|Personal/family health|1|||
27762442|NCT00270998|80954314|FG001|3 Month Follow-up|Personal/family health|1|||
27762443|NCT00270998|80954315|FG002|3 Month Follow-up|Personal/family health|0|||
27762444|NCT00270998|80954313|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
27762445|NCT00270998|80954314|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
27762446|NCT00270998|80954315|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
27861062|NCT02504671|81322879|FG005|Overall Study|Adverse Event|2|||
27861063|NCT02504671|81322874|FG000|Overall Study|Protocol Violation|2|||
27861064|NCT02504671|81322875|FG001|Overall Study|Protocol Violation|1|||
27661128|NCT01878253|80596788|FG000|Overall Study|Lost to Follow-up|2|||
27661129|NCT01878253|80596788|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
27661130|NCT02711553|80596791|FG000|Overall Study|Withdrawal by Subject|2|||
27661131|NCT02711553|80596792|FG001|Overall Study|Withdrawal by Subject|1|||
27661132|NCT02711553|80596793|FG002|Overall Study|Withdrawal by Subject|1|||
27661133|NCT02711553|80596794|FG003|Overall Study|Withdrawal by Subject|0|||
27661134|NCT02711553|80596791|FG000|Overall Study|Lost to Follow-up|3|||
27661135|NCT02711553|80596792|FG001|Overall Study|Lost to Follow-up|3|||
27762447|NCT00270998|80954313|FG000|12 Month Follow-up|Lack of Efficacy|5|||
27762448|NCT00270998|80954314|FG001|12 Month Follow-up|Lack of Efficacy|4|||
27762449|NCT00270998|80954315|FG002|12 Month Follow-up|Lack of Efficacy|3|||
27762450|NCT00270998|80954313|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
27762451|NCT00270998|80954314|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
27762452|NCT00270998|80954315|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
27762453|NCT00270998|80954313|FG000|12 Month Follow-up|Pessary did not fit|1|||
27762454|NCT00270998|80954314|FG001|12 Month Follow-up|Pessary did not fit|0|||
27762455|NCT00270998|80954315|FG002|12 Month Follow-up|Pessary did not fit|0|||
27762456|NCT00270998|80954313|FG000|12 Month Follow-up|Personal/family health|0|||
27762457|NCT00270998|80954314|FG001|12 Month Follow-up|Personal/family health|5|||
27762458|NCT00270998|80954315|FG002|12 Month Follow-up|Personal/family health|1|||
27762459|NCT00270998|80954313|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
27762460|NCT00270998|80954314|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
27762461|NCT00270998|80954315|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
27762462|NCT03803202|80957443|FG000|Overall Study|Other|0|||
27762463|NCT03803202|80957444|FG001|Overall Study|Other|1|||
27762464|NCT03803202|80957445|FG002|Overall Study|Other|0|||
27762465|NCT03803202|80957446|FG003|Overall Study|Other|0|||
27762466|NCT03803202|80957447|FG004|Overall Study|Other|0|||
27762467|NCT03803202|80957448|FG005|Overall Study|Other|0|||
27762468|NCT03803202|80957449|FG006|Overall Study|Other|0|||
27762469|NCT03803202|80957450|FG007|Overall Study|Other|0|||
27762470|NCT03803202|80957451|FG008|Overall Study|Other|0|||
27762471|NCT03803202|80957443|FG000|Overall Study|Death|0|||
27762472|NCT03803202|80957444|FG001|Overall Study|Death|0|||
27762473|NCT03803202|80957445|FG002|Overall Study|Death|0|||
27762474|NCT03803202|80957446|FG003|Overall Study|Death|0|||
27762475|NCT03803202|80957447|FG004|Overall Study|Death|0|||
27762476|NCT03803202|80957448|FG005|Overall Study|Death|1|||
27762477|NCT03803202|80957449|FG006|Overall Study|Death|0|||
27762478|NCT03803202|80957450|FG007|Overall Study|Death|0|||
27861065|NCT02504671|81322876|FG002|Overall Study|Protocol Violation|0|||
27861066|NCT02504671|81322877|FG003|Overall Study|Protocol Violation|0|||
27861067|NCT02504671|81322878|FG004|Overall Study|Protocol Violation|0|||
27661136|NCT02711553|80596793|FG002|Overall Study|Lost to Follow-up|6|||
27762479|NCT03803202|80957451|FG008|Overall Study|Death|0|||
27762480|NCT03803202|80957443|FG000|Overall Study|Withdrawal by Subject|0|||
27762481|NCT03803202|80957444|FG001|Overall Study|Withdrawal by Subject|0|||
27762482|NCT03803202|80957445|FG002|Overall Study|Withdrawal by Subject|1|||
27762483|NCT03803202|80957446|FG003|Overall Study|Withdrawal by Subject|0|||
27861068|NCT02504671|81322879|FG005|Overall Study|Protocol Violation|1|||
27661137|NCT02711553|80596794|FG003|Overall Study|Lost to Follow-up|3|||
27661138|NCT02711553|80596791|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
27762484|NCT03803202|80957447|FG004|Overall Study|Withdrawal by Subject|0|||
27861069|NCT02504671|81322874|FG000|Overall Study|Lost to Follow-up|0|||
27762485|NCT03803202|80957448|FG005|Overall Study|Withdrawal by Subject|0|||
27762486|NCT03803202|80957449|FG006|Overall Study|Withdrawal by Subject|0|||
27762487|NCT03803202|80957450|FG007|Overall Study|Withdrawal by Subject|1|||
27762488|NCT03803202|80957451|FG008|Overall Study|Withdrawal by Subject|0|||
27762489|NCT03803202|80957443|FG000|Overall Study|Lost to Follow-up|0|||
27762490|NCT03803202|80957444|FG001|Overall Study|Lost to Follow-up|0|||
27762491|NCT03803202|80957445|FG002|Overall Study|Lost to Follow-up|0|||
27762492|NCT03803202|80957446|FG003|Overall Study|Lost to Follow-up|1|||
27762493|NCT03803202|80957447|FG004|Overall Study|Lost to Follow-up|1|||
27762494|NCT03803202|80957448|FG005|Overall Study|Lost to Follow-up|0|||
27762495|NCT03803202|80957449|FG006|Overall Study|Lost to Follow-up|1|||
27762496|NCT03803202|80957450|FG007|Overall Study|Lost to Follow-up|0|||
27762497|NCT03803202|80957451|FG008|Overall Study|Lost to Follow-up|0|||
27762498|NCT00187889|80957452|FG000|Overall Study|Withdrawal by Subject|6|||
27762499|NCT00187889|80957453|FG001|Overall Study|Withdrawal by Subject|4|||
27762500|NCT01280266|80957454|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
27762501|NCT01280266|80957455|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
27762502|NCT01280266|80957454|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
27762503|NCT01280266|80957455|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
27762504|NCT02146248|80957456|FG000|Overall Study|Withdrawal by Subject|2|||
27762505|NCT01203787|80957457|FG000|Overall Study|Death|12|||
27762506|NCT01203787|80957458|FG001|Overall Study|Death|10|||
27762507|NCT01203787|80957457|FG000|Overall Study|Withdrawal by Subject|6|||
27762508|NCT01203787|80957458|FG001|Overall Study|Withdrawal by Subject|2|||
27762509|NCT01203787|80957457|FG000|Overall Study|Lost to Follow-up|2|||
27762510|NCT01203787|80957458|FG001|Overall Study|Lost to Follow-up|0|||
27762511|NCT01203787|80957457|FG000|Overall Study|Adverse Event|11|||
27762512|NCT01203787|80957458|FG001|Overall Study|Adverse Event|15|||
27762513|NCT00691093|80957462|FG000|Overall Study|Adverse Event|1|||
27762514|NCT00691093|80957462|FG000|Overall Study|Lost to Follow-up|1|||
27762515|NCT00691093|80957462|FG000|Overall Study|Lack of Efficacy|1|||
27762516|NCT00691093|80957462|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
27762517|NCT00842361|80957463|FG000|Overall Study|Protocol Violation|1|||
27762518|NCT00842361|80957464|FG001|Overall Study|Protocol Violation|0|||
27762519|NCT00842361|80957463|FG000|Overall Study|Unclassified|0|||
27762520|NCT00842361|80957464|FG001|Overall Study|Unclassified|2|||
27762521|NCT02586077|80957465|FG000|Overall Study|Withdrawal by Subject|1|||
27762522|NCT02586077|80957465|FG000|Overall Study|Physician Decision|4|||
27762523|NCT02586077|80957465|FG000|Overall Study|Lost to Follow-up|3|||
27762524|NCT00485589|80957471|FG000|Overall Study|Death|2|||
27762525|NCT00485589|80957472|FG001|Overall Study|Death|2|||
27762526|NCT00485589|80957473|FG002|Overall Study|Death|0|||
27762527|NCT00485589|80957471|FG000|Overall Study|Failure to return|6|||
27762528|NCT00485589|80957472|FG001|Overall Study|Failure to return|5|||
27762529|NCT00485589|80957473|FG002|Overall Study|Failure to return|1|||
27762530|NCT00485589|80957471|FG000|Overall Study|Protocol Violation|1|||
27762531|NCT00485589|80957472|FG001|Overall Study|Protocol Violation|0|||
27762532|NCT00485589|80957473|FG002|Overall Study|Protocol Violation|0|||
27762533|NCT00485589|80957471|FG000|Overall Study|Violation of selection criteria at entry|0|||
27762534|NCT00485589|80957472|FG001|Overall Study|Violation of selection criteria at entry|3|||
27762535|NCT00485589|80957473|FG002|Overall Study|Violation of selection criteria at entry|1|||
27762536|NCT00485589|80957471|FG000|Overall Study|Administrative/Other|1|||
27762537|NCT00485589|80957472|FG001|Overall Study|Administrative/Other|2|||
27762538|NCT00485589|80957473|FG002|Overall Study|Administrative/Other|1|||
27762539|NCT00485589|80957471|FG000|Overall Study|Insufficient therapeutic response|10|||
27762540|NCT00485589|80957472|FG001|Overall Study|Insufficient therapeutic response|3|||
27762541|NCT00485589|80957473|FG002|Overall Study|Insufficient therapeutic response|1|||
27762542|NCT00485589|80957471|FG000|Overall Study|Refused treatment/did not cooperate|1|||
27661139|NCT02711553|80596792|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
27661140|NCT02711553|80596793|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
27661141|NCT02711553|80596794|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
27661142|NCT01485991|80596795|FG000|Overall Study|Adverse Event|0|||
27661143|NCT01485991|80596796|FG001|Overall Study|Adverse Event|4|||
27762543|NCT00485589|80957472|FG001|Overall Study|Refused treatment/did not cooperate|0|||
27762544|NCT00485589|80957473|FG002|Overall Study|Refused treatment/did not cooperate|2|||
27762545|NCT00485589|80957471|FG000|Overall Study|Withdrawal by Subject|3|||
27762546|NCT00485589|80957472|FG001|Overall Study|Withdrawal by Subject|2|||
27762547|NCT00485589|80957473|FG002|Overall Study|Withdrawal by Subject|2|||
27762548|NCT00485589|80957471|FG000|Overall Study|Adverse Event|3|||
27762549|NCT00485589|80957472|FG001|Overall Study|Adverse Event|3|||
27762550|NCT00485589|80957473|FG002|Overall Study|Adverse Event|10|||
27762551|NCT02475395|80957475|FG000|Overall Study|Protocol Violation|30|||
27661144|NCT01485991|80596795|FG000|Overall Study|Lost to Follow-up|13|||
27661145|NCT01485991|80596796|FG001|Overall Study|Lost to Follow-up|10|||
27661146|NCT01485991|80596795|FG000|Overall Study|Withdrawal by Subject|13|||
27762552|NCT02475395|80957476|FG001|Overall Study|Protocol Violation|3|||
27762553|NCT00615914|80957480|FG000|Overall Study|Adverse Event|274|||
27661147|NCT01485991|80596796|FG001|Overall Study|Withdrawal by Subject|20|||
27762554|NCT00615914|80957480|FG000|Overall Study|Death|20|||
27762555|NCT00615914|80957480|FG000|Overall Study|Lack of Efficacy|59|||
27762556|NCT00615914|80957480|FG000|Overall Study|Lost to Follow-up|187|||
27661148|NCT01485991|80596795|FG000|Overall Study|randomized but not treated|6|||
27661149|NCT01485991|80596796|FG001|Overall Study|randomized but not treated|2|||
27661150|NCT02391116|80596797|FG000|Treatment|Withdrawal by Subject|1|||
27762557|NCT00615914|80957480|FG000|Overall Study|Withdrawal by Subject|16|||
27762558|NCT00615914|80957480|FG000|Overall Study|Physician Decision|4|||
27762559|NCT00615914|80957480|FG000|Overall Study|No data was collected.|65|||
27762560|NCT00615914|80957480|FG000|Overall Study|No treatment|2|||
27762561|NCT00615914|80957480|FG000|Overall Study|Irregularly enrolled patients|10|||
27762562|NCT04671342|80957481|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
27762563|NCT04671342|80957481|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
27762564|NCT04671342|80957481|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
27762565|NCT04671342|80957481|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
27661151|NCT02391116|80596797|FG000|Treatment|Protocol Violation|1|||
27661152|NCT02391116|80596797|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
27661153|NCT02391116|80596797|FG000|Treatment|AE with Clinical PD|3|||
27661154|NCT02391116|80596797|FG000|Safety Follow-up|Adverse Event|1|||
27661155|NCT02391116|80596797|FG000|Safety Follow-up|Withdrawal by Subject|4|||
27661156|NCT02391116|80596797|FG000|Safety Follow-up|Switching to Other Therapy|4|||
27661157|NCT02391116|80596797|FG000|Safety Follow-up|No Follow Up|1|||
27661158|NCT02391116|80596797|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
27661159|NCT02391116|80596797|FG000|Active Follow-up|Withdrawal by Subject|1|||
27661160|NCT02391116|80596797|FG000|Active Follow-up|Switching to Other Therapy|2|||
27661161|NCT02391116|80596797|FG000|Survival Follow-up|Withdrawal by Subject|3|||
27661162|NCT02391116|80596797|FG000|Survival Follow-up|Switching to Other Therapy|1|||
27661163|NCT03282799|80596802|FG000|Overall Study|Pregnancy|1|||
27661164|NCT03282799|80596803|FG001|Overall Study|Pregnancy|0|||
27661165|NCT03282799|80596802|FG000|Overall Study|Physician Decision|1|||
27661166|NCT03282799|80596803|FG001|Overall Study|Physician Decision|0|||
27661167|NCT00588341|80596804|FG000|Overall Study|Withdrawal by Subject|3|||
27661168|NCT00588341|80596804|FG000|Overall Study|Not treated due to metastatic disease|1|||
27661169|NCT00588341|80596804|FG000|Overall Study|Patient ineligible|1|||
27661170|NCT05878990|80596807|FG000|Overall Study|Lost to Follow-up|7|||
27661171|NCT05878990|80596807|FG000|Overall Study|Withdrawal by Subject|1|||
27661172|NCT04057937|80596808|FG000|Placebo-controlled Phase|Adverse Event|3|||
27661173|NCT04057937|80596809|FG001|Placebo-controlled Phase|Adverse Event|0|||
27661174|NCT04057937|80596808|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
27661175|NCT04057937|80596809|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
27661176|NCT04057937|80596808|FG000|Active-treatment Phase|Pregnancy|0|||
27661177|NCT04057937|80596809|FG001|Active-treatment Phase|Pregnancy|1|||
27661178|NCT04057937|80596808|FG000|Active-treatment Phase|Physician Decision|0|||
27661179|NCT04057937|80596809|FG001|Active-treatment Phase|Physician Decision|1|||
27661180|NCT01503515|80596810|FG000|Overall Study|Adverse Event|4|||
27661181|NCT01503515|80596811|FG001|Overall Study|Adverse Event|5|||
27661182|NCT01503515|80596810|FG000|Overall Study|Death|0|||
27661183|NCT01503515|80596811|FG001|Overall Study|Death|1|||
27661184|NCT01503515|80596810|FG000|Overall Study|Physician Decision|14|||
27661185|NCT01503515|80596811|FG001|Overall Study|Physician Decision|23|||
27661186|NCT01503515|80596810|FG000|Overall Study|Withdrawal by Subject|0|||
27661187|NCT01503515|80596811|FG001|Overall Study|Withdrawal by Subject|1|||
27661188|NCT01503515|80596810|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
27661189|NCT01503515|80596811|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
27661190|NCT01503515|80596810|FG000|Overall Study|Ineligible|1|||
27661191|NCT01503515|80596811|FG001|Overall Study|Ineligible|1|||
27661192|NCT00130728|80596812|FG000|Overall Study|Death|258|||
27661193|NCT00130728|80596813|FG001|Overall Study|Death|258|||
27661194|NCT00130728|80596812|FG000|Overall Study|Lost to Follow-up|4|||
27661195|NCT00130728|80596813|FG001|Overall Study|Lost to Follow-up|0|||
27661196|NCT00130728|80596812|FG000|Overall Study|Withdrawal by Subject|0|||
27661197|NCT00130728|80596813|FG001|Overall Study|Withdrawal by Subject|2|||
27661198|NCT03319719|80596814|FG000|Overall Study|Lost to Follow-up|1|||
27661199|NCT04369664|80596817|FG000|Overall Study|Physician Decision|1|||
27661200|NCT04369664|80596818|FG001|Overall Study|Physician Decision|0|||
27762566|NCT04671342|80957481|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
27661201|NCT00981578|80596822|FG000|Overall Study|Death|1|||
27661202|NCT00981578|80596822|FG000|Overall Study|Withdrawal by Subject|2|||
27661203|NCT00711555|80596827|FG000|Overall Study|Adverse Event|3|||
27661204|NCT04374253|80596828|FG000|Overall Study|Adverse Event|0|||
27661205|NCT04374253|80596829|FG001|Overall Study|Adverse Event|26|||
27661206|NCT04374253|80596830|FG002|Overall Study|Adverse Event|2|||
27762567|NCT04671342|80957481|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
27661207|NCT04374253|80596831|FG003|Overall Study|Adverse Event|12|||
27661208|NCT04374253|80596828|FG000|Overall Study|Study terminated by sponsor|13|||
27661209|NCT04374253|80596829|FG001|Overall Study|Study terminated by sponsor|593|||
27661210|NCT04374253|80596830|FG002|Overall Study|Study terminated by sponsor|21|||
27661211|NCT04374253|80596831|FG003|Overall Study|Study terminated by sponsor|567|||
27661212|NCT04374253|80596828|FG000|Overall Study|Withdrawal by Subject|0|||
27762568|NCT02759861|80957483|FG000|Overall Study|Death|1|||
27861070|NCT02504671|81322875|FG001|Overall Study|Lost to Follow-up|0|||
27861071|NCT02504671|81322876|FG002|Overall Study|Lost to Follow-up|2|||
27861072|NCT02504671|81322877|FG003|Overall Study|Lost to Follow-up|0|||
27861073|NCT02504671|81322878|FG004|Overall Study|Lost to Follow-up|0|||
27861074|NCT02504671|81322879|FG005|Overall Study|Lost to Follow-up|1|||
27861075|NCT02504671|81322874|FG000|Overall Study|Protocol defined stopping criteria|7|||
27861076|NCT02504671|81322875|FG001|Overall Study|Protocol defined stopping criteria|4|||
27861077|NCT02504671|81322876|FG002|Overall Study|Protocol defined stopping criteria|3|||
27861078|NCT02504671|81322877|FG003|Overall Study|Protocol defined stopping criteria|5|||
27861079|NCT02504671|81322878|FG004|Overall Study|Protocol defined stopping criteria|3|||
27861080|NCT02504671|81322879|FG005|Overall Study|Protocol defined stopping criteria|3|||
27861081|NCT00642278|81322880|FG000|Overall Study|Adverse Event|2|||
27661213|NCT04374253|80596829|FG001|Overall Study|Withdrawal by Subject|55|||
27661214|NCT04374253|80596830|FG002|Overall Study|Withdrawal by Subject|3|||
27661215|NCT04374253|80596831|FG003|Overall Study|Withdrawal by Subject|40|||
27661216|NCT04374253|80596828|FG000|Overall Study|Physician Decision|1|||
27661217|NCT04374253|80596829|FG001|Overall Study|Physician Decision|10|||
27661218|NCT04374253|80596830|FG002|Overall Study|Physician Decision|1|||
27661219|NCT04374253|80596831|FG003|Overall Study|Physician Decision|10|||
27661220|NCT04374253|80596828|FG000|Overall Study|Protocol Violation|0|||
27661221|NCT04374253|80596829|FG001|Overall Study|Protocol Violation|0|||
27661222|NCT04374253|80596830|FG002|Overall Study|Protocol Violation|0|||
27661223|NCT04374253|80596831|FG003|Overall Study|Protocol Violation|2|||
27661224|NCT04374253|80596828|FG000|Overall Study|Death|0|||
27661225|NCT04374253|80596829|FG001|Overall Study|Death|3|||
27661226|NCT04374253|80596830|FG002|Overall Study|Death|1|||
27661227|NCT04374253|80596831|FG003|Overall Study|Death|1|||
27661228|NCT04374253|80596828|FG000|Overall Study|Lack of Efficacy|0|||
27661229|NCT04374253|80596829|FG001|Overall Study|Lack of Efficacy|0|||
27661230|NCT04374253|80596830|FG002|Overall Study|Lack of Efficacy|0|||
27661231|NCT04374253|80596831|FG003|Overall Study|Lack of Efficacy|1|||
27661232|NCT04374253|80596828|FG000|Overall Study|Lost to Follow-up|1|||
27661233|NCT04374253|80596829|FG001|Overall Study|Lost to Follow-up|1|||
27661234|NCT04374253|80596830|FG002|Overall Study|Lost to Follow-up|0|||
27661235|NCT04374253|80596831|FG003|Overall Study|Lost to Follow-up|2|||
27661236|NCT04374253|80596828|FG000|Overall Study|Reason Not Specified|0|||
27661237|NCT04374253|80596829|FG001|Overall Study|Reason Not Specified|8|||
27661238|NCT04374253|80596830|FG002|Overall Study|Reason Not Specified|0|||
27661239|NCT04374253|80596831|FG003|Overall Study|Reason Not Specified|8|||
27661240|NCT03233204|80596834|FG000|Overall Study|Adverse Event|1|||
27661241|NCT03233204|80596834|FG000|Overall Study|Death|1|||
27661242|NCT03233204|80596834|FG000|Overall Study|Withdrawal by Subject|1|||
27661243|NCT03233204|80596834|FG000|Overall Study|Progressive Disease|3|||
27661244|NCT01951261|80596837|FG000|Overall Study|Death|1|||
27661245|NCT01951261|80596838|FG001|Overall Study|Death|0|||
27661246|NCT01951261|80596837|FG000|Overall Study|Lost to Follow-up|4|||
27661247|NCT01951261|80596838|FG001|Overall Study|Lost to Follow-up|3|||
27661248|NCT01951261|80596837|FG000|Overall Study|Protocol Violation|4|||
27661249|NCT01951261|80596838|FG001|Overall Study|Protocol Violation|3|||
27661250|NCT00428441|80596839|FG000|Overall Study|Lost to Follow-up|1|||
27661251|NCT00382408|80596847|FG000|Overall Study|Did not meet protocol requirement|3|||
27661252|NCT00382408|80596848|FG001|Overall Study|Did not meet protocol requirement|3|||
27661253|NCT00382408|80596847|FG000|Overall Study|Protocol Violation|2|||
27661254|NCT00382408|80596848|FG001|Overall Study|Protocol Violation|2|||
27661255|NCT00382408|80596847|FG000|Overall Study|Physician Decision|1|||
27661256|NCT00382408|80596848|FG001|Overall Study|Physician Decision|0|||
27661257|NCT00382408|80596847|FG000|Overall Study|Withdrawal by Subject|17|||
27661258|NCT00382408|80596848|FG001|Overall Study|Withdrawal by Subject|6|||
27661259|NCT00382408|80596847|FG000|Overall Study|Pregnancy|2|||
27661260|NCT00382408|80596848|FG001|Overall Study|Pregnancy|0|||
27661261|NCT00382408|80596847|FG000|Overall Study|Lost to Follow-up|19|||
27861082|NCT00642278|81322881|FG001|Overall Study|Adverse Event|1|||
27661262|NCT00382408|80596848|FG001|Overall Study|Lost to Follow-up|8|||
27661263|NCT00382408|80596847|FG000|Overall Study|Other|100|||
27661264|NCT00382408|80596848|FG001|Overall Study|Other|35|||
27661265|NCT01498445|80596849|FG000|Overall Study|Lack of Efficacy|0|||
27661266|NCT01498445|80596850|FG001|Overall Study|Lack of Efficacy|0|||
27661267|NCT01498445|80596851|FG002|Overall Study|Lack of Efficacy|1|||
27661268|NCT01498445|80596852|FG003|Overall Study|Lack of Efficacy|2|||
27661269|NCT01498445|80596853|FG004|Overall Study|Lack of Efficacy|0|||
27661270|NCT01498445|80596854|FG005|Overall Study|Lack of Efficacy|0|||
27661271|NCT01498445|80596849|FG000|Overall Study|Screen Failure|0|||
27861083|NCT00642278|81322882|FG002|Overall Study|Adverse Event|3|||
27661272|NCT01498445|80596850|FG001|Overall Study|Screen Failure|0|||
27661273|NCT01498445|80596851|FG002|Overall Study|Screen Failure|0|||
27861084|NCT00642278|81322883|FG003|Overall Study|Adverse Event|1|||
27661274|NCT01498445|80596852|FG003|Overall Study|Screen Failure|0|||
27661275|NCT01498445|80596853|FG004|Overall Study|Screen Failure|1|||
27661276|NCT01498445|80596854|FG005|Overall Study|Screen Failure|1|||
27661277|NCT05041439|80596864|FG000|Overall Study|Withdrawal by Subject|1|||
27661278|NCT05041439|80596865|FG001|Overall Study|Withdrawal by Subject|1|||
27661279|NCT05041439|80596864|FG000|Overall Study|Death|1|||
27661280|NCT05041439|80596865|FG001|Overall Study|Death|0|||
27661281|NCT01898442|80596873|FG000|Overall Study|Hemolysis/technical problems|1|||
27661282|NCT01898442|80596874|FG001|Overall Study|Hemolysis/technical problems|2|||
27661283|NCT01898442|80596875|FG002|Overall Study|Hemolysis/technical problems|2|||
27661284|NCT01898442|80596873|FG000|Overall Study|Patient vomited pills|0|||
27661285|NCT01898442|80596874|FG001|Overall Study|Patient vomited pills|0|||
27661286|NCT01898442|80596875|FG002|Overall Study|Patient vomited pills|1|||
27661287|NCT01345188|80596876|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
27661288|NCT01345188|80596876|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
27661289|NCT03334747|80596880|FG000|Treatment Phase|Technical problems|0|||
27661290|NCT03334747|80596881|FG001|Treatment Phase|Technical problems|0|||
27661291|NCT03334747|80596882|FG002|Treatment Phase|Technical problems|0|||
27661292|NCT03334747|80596883|FG003|Treatment Phase|Technical problems|0|||
27661293|NCT03334747|80596884|FG004|Treatment Phase|Technical problems|1|||
27661294|NCT03334747|80596885|FG005|Treatment Phase|Technical problems|0|||
27661295|NCT03334747|80596886|FG006|Treatment Phase|Technical problems|0|||
27661296|NCT03334747|80596887|FG007|Treatment Phase|Technical problems|0|||
27762569|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
27762570|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
27762571|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
27762572|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
27762573|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
27762574|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
27762575|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Death|1|||
27762576|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Death|3|||
27762577|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
27568639|NCT01399593|80271414|FG001|Overall Study|Adverse Event|0|||
27568640|NCT01399593|80271413|FG000|Overall Study|Death|1|||
27568641|NCT01399593|80271414|FG001|Overall Study|Death|1|||
27568642|NCT01399593|80271413|FG000|Overall Study|Transplantectomy|0|||
27568643|NCT01399593|80271414|FG001|Overall Study|Transplantectomy|1|||
27568644|NCT00747435|80271415|FG000|Overall Study|Lost to Follow-up|2|||
27568645|NCT00747435|80271415|FG000|Overall Study|Withdrawal by Subject|3|||
27568646|NCT00747435|80271415|FG000|Overall Study|Still undergoing follow up|1|||
27568647|NCT04238728|80271416|FG000|Overall Study|Withdrawal by Subject|1|||
27568648|NCT04238728|80271416|FG000|Overall Study|Lost to Follow-up|2|||
27568649|NCT01755416|80271417|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
27568650|NCT01755416|80271418|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
27568651|NCT03149237|80271420|FG000|Overall Study|Withdrawal by Subject|4|||
27568652|NCT03149237|80271421|FG001|Overall Study|Withdrawal by Subject|5|||
27568653|NCT02932904|80271422|FG000|Overall Study|Reason not Specified|1|||
27568654|NCT02932904|80271423|FG001|Overall Study|Reason not Specified|0|||
27568655|NCT02932904|80271424|FG002|Overall Study|Reason not Specified|2|||
27568656|NCT02932904|80271425|FG003|Overall Study|Reason not Specified|2|||
27568657|NCT02932904|80271422|FG000|Overall Study|Noncompliance with Study Drug|2|||
27568658|NCT02932904|80271423|FG001|Overall Study|Noncompliance with Study Drug|3|||
27568659|NCT02932904|80271424|FG002|Overall Study|Noncompliance with Study Drug|3|||
27568660|NCT02932904|80271425|FG003|Overall Study|Noncompliance with Study Drug|4|||
27568661|NCT02932904|80271422|FG000|Overall Study|Pregnancy|0|||
27568662|NCT02932904|80271423|FG001|Overall Study|Pregnancy|1|||
27568663|NCT02932904|80271424|FG002|Overall Study|Pregnancy|1|||
27568664|NCT02932904|80271425|FG003|Overall Study|Pregnancy|0|||
27568665|NCT02932904|80271422|FG000|Overall Study|Study Termination|0|||
27568666|NCT02932904|80271423|FG001|Overall Study|Study Termination|1|||
27568667|NCT02932904|80271424|FG002|Overall Study|Study Termination|0|||
27568668|NCT02932904|80271425|FG003|Overall Study|Study Termination|0|||
27568669|NCT02932904|80271422|FG000|Overall Study|Voluntary Withdrawal|2|||
27568670|NCT02932904|80271423|FG001|Overall Study|Voluntary Withdrawal|1|||
27568671|NCT02932904|80271424|FG002|Overall Study|Voluntary Withdrawal|4|||
27568672|NCT02932904|80271425|FG003|Overall Study|Voluntary Withdrawal|2|||
27568673|NCT02932904|80271422|FG000|Overall Study|Lost to Follow-up|5|||
27568674|NCT02932904|80271423|FG001|Overall Study|Lost to Follow-up|3|||
27568675|NCT02932904|80271424|FG002|Overall Study|Lost to Follow-up|6|||
27568676|NCT02932904|80271425|FG003|Overall Study|Lost to Follow-up|0|||
27568677|NCT02932904|80271422|FG000|Overall Study|Significant Protocol Deviation|2|||
27568678|NCT02932904|80271423|FG001|Overall Study|Significant Protocol Deviation|3|||
27568679|NCT02932904|80271424|FG002|Overall Study|Significant Protocol Deviation|6|||
27568680|NCT02932904|80271425|FG003|Overall Study|Significant Protocol Deviation|1|||
27661297|NCT03334747|80596888|FG008|Treatment Phase|Technical problems|0|||
27661298|NCT03334747|80596880|FG000|Treatment Phase|Subject/guardian decision|1|||
27661299|NCT03334747|80596881|FG001|Treatment Phase|Subject/guardian decision|0|||
27661300|NCT03334747|80596882|FG002|Treatment Phase|Subject/guardian decision|0|||
27661301|NCT03334747|80596883|FG003|Treatment Phase|Subject/guardian decision|0|||
27661302|NCT03334747|80596884|FG004|Treatment Phase|Subject/guardian decision|0|||
27661303|NCT03334747|80596885|FG005|Treatment Phase|Subject/guardian decision|1|||
27661304|NCT03334747|80596886|FG006|Treatment Phase|Subject/guardian decision|0|||
27661305|NCT03334747|80596887|FG007|Treatment Phase|Subject/guardian decision|0|||
27661306|NCT03334747|80596888|FG008|Treatment Phase|Subject/guardian decision|0|||
27661307|NCT03334747|80596880|FG000|Follow-Up Phase|Subject/guardian decision|0|||
27661308|NCT03334747|80596881|FG001|Follow-Up Phase|Subject/guardian decision|0|||
27661309|NCT03334747|80596882|FG002|Follow-Up Phase|Subject/guardian decision|0|||
27661310|NCT03334747|80596883|FG003|Follow-Up Phase|Subject/guardian decision|0|||
27661311|NCT03334747|80596884|FG004|Follow-Up Phase|Subject/guardian decision|0|||
27661312|NCT03334747|80596885|FG005|Follow-Up Phase|Subject/guardian decision|0|||
27661313|NCT03334747|80596886|FG006|Follow-Up Phase|Subject/guardian decision|1|||
27661314|NCT03334747|80596887|FG007|Follow-Up Phase|Subject/guardian decision|0|||
27661315|NCT03334747|80596888|FG008|Follow-Up Phase|Subject/guardian decision|1|||
27661316|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Adverse Event|3|||
27661317|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Adverse Event|0|||
27661318|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
27661319|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
27661320|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Disease Progression|23|||
27661321|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Disease Progression|22|||
27661322|NCT01379521|80596893|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
27661323|NCT01379521|80596894|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
27661324|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
27661325|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
27661326|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
27661327|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
27661328|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
27661329|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
27661330|NCT01379521|80596893|FG000|Overall Study -Treatment Period|Death|2|||
27661331|NCT01379521|80596894|FG001|Overall Study -Treatment Period|Death|1|||
27661332|NCT01379521|80596893|FG000|Post-Treatment Evaluations|Disease Progression|22|||
27661333|NCT01379521|80596894|FG001|Post-Treatment Evaluations|Disease Progression|20|||
27661334|NCT01379521|80596893|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
27661335|NCT01379521|80596894|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
27661336|NCT01379521|80596893|FG000|Post-Treatment Evaluations|Death|1|||
27861085|NCT00642278|81322884|FG004|Overall Study|Adverse Event|2|||
27861086|NCT00642278|81322885|FG005|Overall Study|Adverse Event|2|||
27861087|NCT00642278|81322886|FG006|Overall Study|Adverse Event|0|||
27861088|NCT00642278|81322880|FG000|Overall Study|Lack of Efficacy|0|||
27861089|NCT00642278|81322881|FG001|Overall Study|Lack of Efficacy|1|||
27861090|NCT00642278|81322882|FG002|Overall Study|Lack of Efficacy|0|||
27861091|NCT00642278|81322883|FG003|Overall Study|Lack of Efficacy|0|||
27661337|NCT01379521|80596894|FG001|Post-Treatment Evaluations|Death|0|||
27661338|NCT00168805|80596900|FG000|Overall Study|Adverse Event|7|||
27661339|NCT00168805|80596901|FG001|Overall Study|Adverse Event|11|||
27661340|NCT00168805|80596902|FG002|Overall Study|Adverse Event|16|||
27661341|NCT00168805|80596900|FG000|Overall Study|Protocol Violation|12|||
27661342|NCT00168805|80596901|FG001|Overall Study|Protocol Violation|11|||
27661343|NCT00168805|80596902|FG002|Overall Study|Protocol Violation|8|||
27661344|NCT00168805|80596900|FG000|Overall Study|Lost to Follow-up|12|||
27661345|NCT00168805|80596901|FG001|Overall Study|Lost to Follow-up|17|||
27661346|NCT00168805|80596902|FG002|Overall Study|Lost to Follow-up|11|||
27661347|NCT00168805|80596900|FG000|Overall Study|Withdrawal by Subject|16|||
27661348|NCT00168805|80596901|FG001|Overall Study|Withdrawal by Subject|18|||
27661349|NCT00168805|80596902|FG002|Overall Study|Withdrawal by Subject|21|||
27661350|NCT00168805|80596900|FG000|Overall Study|Other|24|||
27661351|NCT00168805|80596901|FG001|Overall Study|Other|21|||
27661352|NCT00168805|80596902|FG002|Overall Study|Other|22|||
27661353|NCT00168805|80596900|FG000|Treatment|Adverse Event|25|||
27661354|NCT00168805|80596901|FG001|Treatment|Adverse Event|26|||
27661355|NCT00168805|80596902|FG002|Treatment|Adverse Event|32|||
27661356|NCT00168805|80596900|FG000|Treatment|Protocol Violation|3|||
27661357|NCT00168805|80596901|FG001|Treatment|Protocol Violation|5|||
27861092|NCT00642278|81322884|FG004|Overall Study|Lack of Efficacy|0|||
27861093|NCT00642278|81322885|FG005|Overall Study|Lack of Efficacy|0|||
27661358|NCT00168805|80596902|FG002|Treatment|Protocol Violation|5|||
27661359|NCT00168805|80596900|FG000|Treatment|Withdrawal by Subject|3|||
27661360|NCT00168805|80596901|FG001|Treatment|Withdrawal by Subject|7|||
27661361|NCT00168805|80596902|FG002|Treatment|Withdrawal by Subject|8|||
27661362|NCT00168805|80596900|FG000|Treatment|Other|18|||
27861094|NCT00642278|81322886|FG006|Overall Study|Lack of Efficacy|0|||
27861095|NCT00642278|81322880|FG000|Overall Study|Lost to Follow-up|5|||
27861096|NCT00642278|81322881|FG001|Overall Study|Lost to Follow-up|1|||
27861097|NCT00642278|81322882|FG002|Overall Study|Lost to Follow-up|0|||
27661363|NCT00168805|80596901|FG001|Treatment|Other|18|||
27661364|NCT00168805|80596902|FG002|Treatment|Other|17|||
27661365|NCT02784535|80596903|FG000|Overall Study|Adverse Event|1|||
27661366|NCT02784535|80596904|FG001|Overall Study|Adverse Event|0|||
27661367|NCT02784535|80596903|FG000|Overall Study|Withdrawal by Subject|0|||
27661368|NCT02784535|80596904|FG001|Overall Study|Withdrawal by Subject|1|||
27661369|NCT02784535|80596903|FG000|Overall Study|Physician Decision|0|||
27661370|NCT02784535|80596904|FG001|Overall Study|Physician Decision|1|||
27661371|NCT04044352|80596905|FG000|Overall Study|Lost to Follow-up|9|||
27661372|NCT04044352|80596905|FG000|Overall Study|Withdrawal by Subject|2|||
27661373|NCT02243605|80596906|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
27661374|NCT02243605|80596907|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
27661375|NCT02243605|80596906|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
27661376|NCT02243605|80596907|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
27661377|NCT02243605|80596906|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
27661378|NCT02243605|80596907|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
27661379|NCT02243605|80596906|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
27661380|NCT02243605|80596907|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
27661381|NCT02243605|80596906|FG000|Stage 2 - Final Analysis Population|Progression|0|||
27661382|NCT02243605|80596907|FG001|Stage 2 - Final Analysis Population|Progression|1|||
27661383|NCT02186015|80596908|FG000|Overall Study|Physician Decision|1|||
27661384|NCT02186015|80596909|FG001|Overall Study|Physician Decision|0|||
27661385|NCT03738397|80596910|FG000|Overall Study|Adverse Event|3|||
27661386|NCT03738397|80596911|FG001|Overall Study|Adverse Event|7|||
27661387|NCT03738397|80596910|FG000|Overall Study|Withdrawal by Subject|8|||
27661388|NCT03738397|80596911|FG001|Overall Study|Withdrawal by Subject|11|||
27661389|NCT03738397|80596910|FG000|Overall Study|Lost to Follow-up|7|||
27661390|NCT03738397|80596911|FG001|Overall Study|Lost to Follow-up|5|||
27661391|NCT03738397|80596910|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
27661392|NCT03738397|80596911|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
27661393|NCT03738397|80596910|FG000|Overall Study|Other|4|||
27661394|NCT03738397|80596911|FG001|Overall Study|Other|6|||
27661395|NCT00404547|80596912|FG000|Overall Study|Adverse Event|39|||
27661396|NCT00404547|80596913|FG001|Overall Study|Adverse Event|6|||
27661397|NCT00404547|80596912|FG000|Overall Study|Withdrawal by Subject|19|||
27661398|NCT00404547|80596913|FG001|Overall Study|Withdrawal by Subject|2|||
27661399|NCT00404547|80596912|FG000|Overall Study|Protocol Violation|0|||
27661400|NCT00404547|80596913|FG001|Overall Study|Protocol Violation|1|||
27661401|NCT00404547|80596912|FG000|Overall Study|Lost to Follow-up|20|||
27661402|NCT00404547|80596913|FG001|Overall Study|Lost to Follow-up|9|||
27661403|NCT00404547|80596912|FG000|Overall Study|Lack of compliance|5|||
27661404|NCT00404547|80596913|FG001|Overall Study|Lack of compliance|1|||
27661405|NCT00404547|80596912|FG000|Overall Study|Other|4|||
27661406|NCT00404547|80596913|FG001|Overall Study|Other|0|||
27661407|NCT00404547|80596912|FG000|Overall Study|Reason not stated|3|||
27661408|NCT00404547|80596913|FG001|Overall Study|Reason not stated|6|||
27661409|NCT00092456|80596914|FG000|Overall Study|Adverse Event|0|||
27661410|NCT00092456|80596915|FG001|Overall Study|Adverse Event|0|||
27661411|NCT00092456|80596916|FG002|Overall Study|Adverse Event|1|||
27661412|NCT00092456|80596917|FG003|Overall Study|Adverse Event|1|||
27661413|NCT00092456|80596914|FG000|Overall Study|Lost to Follow-up|2|||
27661414|NCT00092456|80596915|FG001|Overall Study|Lost to Follow-up|2|||
27661415|NCT00092456|80596916|FG002|Overall Study|Lost to Follow-up|1|||
27661416|NCT00092456|80596917|FG003|Overall Study|Lost to Follow-up|2|||
27661417|NCT00092456|80596914|FG000|Overall Study|Protocol Violation|5|||
27661418|NCT00092456|80596915|FG001|Overall Study|Protocol Violation|7|||
27661419|NCT00092456|80596916|FG002|Overall Study|Protocol Violation|8|||
27661420|NCT00092456|80596917|FG003|Overall Study|Protocol Violation|6|||
27661421|NCT00092456|80596914|FG000|Overall Study|Withdrawal by Subject|13|||
27661422|NCT00092456|80596915|FG001|Overall Study|Withdrawal by Subject|5|||
27661423|NCT00092456|80596916|FG002|Overall Study|Withdrawal by Subject|16|||
27661424|NCT00092456|80596917|FG003|Overall Study|Withdrawal by Subject|6|||
27661425|NCT00092456|80596914|FG000|Overall Study|Moved|1|||
27661426|NCT00092456|80596915|FG001|Overall Study|Moved|1|||
27661427|NCT00092456|80596916|FG002|Overall Study|Moved|0|||
27661428|NCT00092456|80596917|FG003|Overall Study|Moved|1|||
27661429|NCT00092456|80596914|FG000|Overall Study|Other|4|||
27661430|NCT00092456|80596915|FG001|Overall Study|Other|2|||
27661431|NCT00092456|80596916|FG002|Overall Study|Other|3|||
27661432|NCT00092456|80596917|FG003|Overall Study|Other|0|||
27661433|NCT01482819|80596918|FG000|Overall Study|Lost to Follow-up|2|||
27762578|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
27661434|NCT01568112|80596919|FG000|Overall Study|Randomized But Not Treated|0|||
27661435|NCT01568112|80596920|FG001|Overall Study|Randomized But Not Treated|1|||
27661436|NCT01568112|80596921|FG002|Overall Study|Randomized But Not Treated|0|||
27661437|NCT01568112|80596922|FG003|Overall Study|Randomized But Not Treated|0|||
27661438|NCT01568112|80596919|FG000|Overall Study|Withdrew due to Adverse Event|2|||
27661439|NCT01568112|80596920|FG001|Overall Study|Withdrew due to Adverse Event|4|||
27661440|NCT01568112|80596921|FG002|Overall Study|Withdrew due to Adverse Event|6|||
27661441|NCT01568112|80596922|FG003|Overall Study|Withdrew due to Adverse Event|3|||
27661442|NCT01568112|80596919|FG000|Overall Study|Lost to Follow-up|0|||
27661443|NCT01568112|80596920|FG001|Overall Study|Lost to Follow-up|0|||
27661444|NCT01568112|80596921|FG002|Overall Study|Lost to Follow-up|0|||
27661445|NCT01568112|80596922|FG003|Overall Study|Lost to Follow-up|1|||
27661446|NCT01568112|80596919|FG000|Overall Study|Withdrawal by Subject|2|||
27661447|NCT01568112|80596920|FG001|Overall Study|Withdrawal by Subject|3|||
27661448|NCT01568112|80596921|FG002|Overall Study|Withdrawal by Subject|0|||
27661449|NCT01568112|80596922|FG003|Overall Study|Withdrawal by Subject|7|||
27661450|NCT01568112|80596919|FG000|Overall Study|Withdrawal by Physician|1|||
27661451|NCT01568112|80596920|FG001|Overall Study|Withdrawal by Physician|0|||
27861098|NCT00642278|81322883|FG003|Overall Study|Lost to Follow-up|1|||
27661452|NCT01568112|80596921|FG002|Overall Study|Withdrawal by Physician|1|||
27661453|NCT01568112|80596922|FG003|Overall Study|Withdrawal by Physician|1|||
27661454|NCT02785900|80596924|FG000|Overall Study|Study Termination by Sponsor|64|||
27661455|NCT02785900|80596925|FG001|Overall Study|Study Termination by Sponsor|81|||
27661456|NCT02785900|80596924|FG000|Overall Study|Death|46|||
27661457|NCT02785900|80596925|FG001|Overall Study|Death|32|||
27661458|NCT02785900|80596924|FG000|Overall Study|Withdrawal by Subject|4|||
27661459|NCT02785900|80596925|FG001|Overall Study|Withdrawal by Subject|8|||
27861099|NCT00642278|81322884|FG004|Overall Study|Lost to Follow-up|0|||
27861100|NCT00642278|81322885|FG005|Overall Study|Lost to Follow-up|1|||
27861101|NCT00642278|81322886|FG006|Overall Study|Lost to Follow-up|1|||
27861102|NCT00642278|81322880|FG000|Overall Study|Physician Decision|0|||
27861103|NCT00642278|81322881|FG001|Overall Study|Physician Decision|0|||
27861104|NCT00642278|81322882|FG002|Overall Study|Physician Decision|0|||
27861105|NCT00642278|81322883|FG003|Overall Study|Physician Decision|1|||
27861106|NCT00642278|81322884|FG004|Overall Study|Physician Decision|0|||
27861107|NCT00642278|81322885|FG005|Overall Study|Physician Decision|0|||
27861108|NCT00642278|81322886|FG006|Overall Study|Physician Decision|0|||
27861109|NCT00642278|81322880|FG000|Overall Study|Protocol Violation|0|||
27861110|NCT00642278|81322881|FG001|Overall Study|Protocol Violation|0|||
27861111|NCT00642278|81322882|FG002|Overall Study|Protocol Violation|1|||
27568681|NCT02932904|80271422|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
27568682|NCT02932904|80271423|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
27661460|NCT02785900|80596924|FG000|Overall Study|Physician Decision|3|||
27661461|NCT02785900|80596925|FG001|Overall Study|Physician Decision|2|||
27661462|NCT03325608|80596934|FG000|Overall Study|Lost to Follow-up|23|||
27568683|NCT02932904|80271424|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27568684|NCT02932904|80271425|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
27568685|NCT02932904|80271422|FG000|Overall Study|Randomized But Not Treated|1|||
27568686|NCT02932904|80271423|FG001|Overall Study|Randomized But Not Treated|1|||
27568687|NCT02932904|80271424|FG002|Overall Study|Randomized But Not Treated|0|||
27568688|NCT02932904|80271425|FG003|Overall Study|Randomized But Not Treated|2|||
27568689|NCT02584504|80271431|FG000|Double-blind Treatment|Participant withdrew consent|0|||
27568690|NCT02584504|80271432|FG001|Double-blind Treatment|Participant withdrew consent|0|||
27568691|NCT02584504|80271433|FG002|Double-blind Treatment|Participant withdrew consent|1|||
27568692|NCT02584504|80271431|FG000|Double-blind Treatment|Adverse Event|0|||
27568693|NCT02584504|80271432|FG001|Double-blind Treatment|Adverse Event|1|||
27568694|NCT02584504|80271433|FG002|Double-blind Treatment|Adverse Event|0|||
27568695|NCT02584504|80271431|FG000|Double-blind Treatment|Family Matter|0|||
27568696|NCT02584504|80271432|FG001|Double-blind Treatment|Family Matter|1|||
27568697|NCT02584504|80271433|FG002|Double-blind Treatment|Family Matter|0|||
27568698|NCT02584504|80271431|FG000|Open-label Treatment|Participant withdrew consent|0|||
27568699|NCT02584504|80271432|FG001|Open-label Treatment|Participant withdrew consent|0|||
27568700|NCT02584504|80271433|FG002|Open-label Treatment|Participant withdrew consent|4|||
27568701|NCT02584504|80271431|FG000|Open-label Treatment|Adverse Event|2|||
27568702|NCT02584504|80271432|FG001|Open-label Treatment|Adverse Event|2|||
27568703|NCT02584504|80271433|FG002|Open-label Treatment|Adverse Event|3|||
27568704|NCT02584504|80271431|FG000|Open-label Treatment|Physician Decision|0|||
27568705|NCT02584504|80271432|FG001|Open-label Treatment|Physician Decision|1|||
27661463|NCT03325608|80596935|FG001|Overall Study|Lost to Follow-up|23|||
27661464|NCT03325608|80596936|FG002|Overall Study|Lost to Follow-up|30|||
27568706|NCT02584504|80271433|FG002|Open-label Treatment|Physician Decision|0|||
27661465|NCT03325608|80596937|FG003|Overall Study|Lost to Follow-up|30|||
27661466|NCT03325608|80596934|FG000|Overall Study|Death of Caregiver|0|||
27661467|NCT03325608|80596935|FG001|Overall Study|Death of Caregiver|0|||
27661468|NCT03325608|80596936|FG002|Overall Study|Death of Caregiver|2|||
27861112|NCT00642278|81322883|FG003|Overall Study|Protocol Violation|1|||
27861113|NCT00642278|81322884|FG004|Overall Study|Protocol Violation|0|||
27861114|NCT00642278|81322885|FG005|Overall Study|Protocol Violation|1|||
27861115|NCT00642278|81322886|FG006|Overall Study|Protocol Violation|2|||
27861116|NCT00642278|81322880|FG000|Overall Study|Withdrawal by Subject|1|||
27861117|NCT00642278|81322881|FG001|Overall Study|Withdrawal by Subject|1|||
27861118|NCT00642278|81322882|FG002|Overall Study|Withdrawal by Subject|1|||
27661469|NCT03325608|80596937|FG003|Overall Study|Death of Caregiver|2|||
27661470|NCT03325608|80596934|FG000|Overall Study|Death of Care Recipient|34|||
27661471|NCT03325608|80596935|FG001|Overall Study|Death of Care Recipient|34|||
27661472|NCT03325608|80596936|FG002|Overall Study|Death of Care Recipient|28|||
27661473|NCT03325608|80596937|FG003|Overall Study|Death of Care Recipient|28|||
27661474|NCT03325608|80596934|FG000|Overall Study|Withdrawal by Subject|49|||
27661475|NCT03325608|80596935|FG001|Overall Study|Withdrawal by Subject|49|||
27661476|NCT03325608|80596936|FG002|Overall Study|Withdrawal by Subject|35|||
27661477|NCT03325608|80596937|FG003|Overall Study|Withdrawal by Subject|35|||
27661478|NCT03325608|80596934|FG000|Overall Study|Ineligible|7|||
27661479|NCT03325608|80596935|FG001|Overall Study|Ineligible|7|||
27661480|NCT03325608|80596936|FG002|Overall Study|Ineligible|5|||
27661481|NCT03325608|80596937|FG003|Overall Study|Ineligible|5|||
27661482|NCT01284634|80596942|FG000|Overall Study|Adverse Event|1|||
27661483|NCT01284634|80596943|FG001|Overall Study|Adverse Event|0|||
27661484|NCT01284634|80596944|FG002|Overall Study|Adverse Event|2|||
27661485|NCT01284634|80596945|FG003|Overall Study|Adverse Event|1|||
27661486|NCT02490878|80596949|FG000|Overall Study|deemed ineligible|0|||
27861119|NCT00642278|81322883|FG003|Overall Study|Withdrawal by Subject|3|||
27861120|NCT00642278|81322884|FG004|Overall Study|Withdrawal by Subject|6|||
27861121|NCT00642278|81322885|FG005|Overall Study|Withdrawal by Subject|2|||
27661487|NCT02490878|80596950|FG001|Overall Study|deemed ineligible|1|||
27661488|NCT02490878|80596949|FG000|Overall Study|progression prior to treatment|0|||
27661489|NCT02490878|80596950|FG001|Overall Study|progression prior to treatment|1|||
27661490|NCT02490878|80596949|FG000|Overall Study|only submitted baseline QOL|0|||
27661491|NCT02490878|80596950|FG001|Overall Study|only submitted baseline QOL|1|||
27661492|NCT01093222|80596951|FG000|Overall Study|Ineligible|6|||
27661493|NCT01093222|80596951|FG000|Overall Study|Adverse Event|7|||
27661494|NCT01093222|80596951|FG000|Overall Study|Progression/relapse|24|||
27661495|NCT01093222|80596951|FG000|Overall Study|Death|2|||
27661496|NCT01093222|80596951|FG000|Overall Study|Not protocol specified|1|||
27661497|NCT03794609|80596952|FG000|Overall Study|Other|10|||
27661498|NCT03794609|80596952|FG000|Overall Study|Withdrawal by Subject|66|||
27661499|NCT03794609|80596952|FG000|Overall Study|The child is enrolled in an interventional study|70|||
27661500|NCT03794609|80596952|FG000|Overall Study|Inclusion/exclusion criteria|8|||
27661501|NCT03794609|80596952|FG000|Overall Study|At sponsor's request|151|||
27661502|NCT03794609|80596952|FG000|Overall Study|Physician Decision|1|||
27661503|NCT03794609|80596952|FG000|Overall Study|Lost to Follow-up|5|||
27661504|NCT02123797|80596953|FG000|Baseline Intervention|Death|9|||
27661505|NCT02123797|80596954|FG001|Baseline Intervention|Death|16|||
27661506|NCT02123797|80596955|FG002|Baseline Intervention|Death|0|||
27661507|NCT02123797|80596956|FG003|Baseline Intervention|Death|0|||
27661508|NCT02123797|80596957|FG004|Baseline Intervention|Death|0|||
27661509|NCT02123797|80596953|FG000|Baseline Intervention|Withdrawal by Subject|2|||
27661510|NCT02123797|80596954|FG001|Baseline Intervention|Withdrawal by Subject|8|||
27661511|NCT02123797|80596955|FG002|Baseline Intervention|Withdrawal by Subject|0|||
27661512|NCT02123797|80596956|FG003|Baseline Intervention|Withdrawal by Subject|0|||
27661513|NCT02123797|80596957|FG004|Baseline Intervention|Withdrawal by Subject|0|||
27661514|NCT02123797|80596953|FG000|Baseline Intervention|Relocation|2|||
27661515|NCT02123797|80596954|FG001|Baseline Intervention|Relocation|0|||
27661516|NCT02123797|80596955|FG002|Baseline Intervention|Relocation|0|||
27661517|NCT02123797|80596956|FG003|Baseline Intervention|Relocation|0|||
27661518|NCT02123797|80596957|FG004|Baseline Intervention|Relocation|0|||
27661519|NCT02123797|80596953|FG000|Baseline Intervention|Out of window for initial survey|6|||
27661520|NCT02123797|80596954|FG001|Baseline Intervention|Out of window for initial survey|13|||
27661521|NCT02123797|80596955|FG002|Baseline Intervention|Out of window for initial survey|0|||
27661522|NCT02123797|80596956|FG003|Baseline Intervention|Out of window for initial survey|0|||
27661523|NCT02123797|80596957|FG004|Baseline Intervention|Out of window for initial survey|0|||
27661524|NCT02123797|80596953|FG000|Baseline Intervention|Lost to Follow-up|0|||
27661525|NCT02123797|80596954|FG001|Baseline Intervention|Lost to Follow-up|5|||
27661526|NCT02123797|80596955|FG002|Baseline Intervention|Lost to Follow-up|0|||
27661527|NCT02123797|80596956|FG003|Baseline Intervention|Lost to Follow-up|0|||
27661528|NCT02123797|80596957|FG004|Baseline Intervention|Lost to Follow-up|0|||
27661529|NCT02123797|80596953|FG000|Baseline Intervention|Other Disease|3|||
27661530|NCT02123797|80596954|FG001|Baseline Intervention|Other Disease|0|||
27661531|NCT02123797|80596955|FG002|Baseline Intervention|Other Disease|0|||
27661532|NCT02123797|80596956|FG003|Baseline Intervention|Other Disease|0|||
27661533|NCT02123797|80596957|FG004|Baseline Intervention|Other Disease|0|||
27661534|NCT02123797|80596953|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
27661535|NCT02123797|80596954|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
27661536|NCT02123797|80596955|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
27661537|NCT02123797|80596956|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
27661538|NCT02123797|80596957|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
27861122|NCT00642278|81322886|FG006|Overall Study|Withdrawal by Subject|2|||
27861123|NCT00642278|81322880|FG000|Overall Study|Noncompliance with study drug regimen|0|||
27661539|NCT02123797|80596953|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
27661540|NCT02123797|80596954|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
27661541|NCT02123797|80596955|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
27661542|NCT02123797|80596956|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
27661543|NCT02123797|80596957|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
27661544|NCT02123797|80596953|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
27661545|NCT02123797|80596954|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
27861124|NCT00642278|81322881|FG001|Overall Study|Noncompliance with study drug regimen|0|||
27661546|NCT02123797|80596955|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27661547|NCT02123797|80596956|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27661548|NCT02123797|80596957|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27661549|NCT02123797|80596953|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
27661550|NCT02123797|80596954|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
27661551|NCT02123797|80596955|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
27661552|NCT02123797|80596956|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
27661553|NCT02123797|80596957|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
27661554|NCT02123797|80596953|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
27661555|NCT02123797|80596954|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
27661556|NCT02123797|80596955|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
27661557|NCT02123797|80596956|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
27661558|NCT02123797|80596957|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
27661559|NCT02123797|80596953|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
27661560|NCT02123797|80596954|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
27661561|NCT02123797|80596955|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
27661562|NCT02123797|80596956|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
27661563|NCT02123797|80596957|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
27661564|NCT02123797|80596953|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
27661565|NCT02123797|80596954|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
27661566|NCT02123797|80596955|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
27661567|NCT02123797|80596956|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
27661568|NCT02123797|80596957|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
27762579|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
27762580|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
27762581|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
27762582|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
27762583|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
27861125|NCT00642278|81322882|FG002|Overall Study|Noncompliance with study drug regimen|0|||
27861126|NCT00642278|81322883|FG003|Overall Study|Noncompliance with study drug regimen|1|||
27861127|NCT00642278|81322884|FG004|Overall Study|Noncompliance with study drug regimen|0|||
27861128|NCT00642278|81322885|FG005|Overall Study|Noncompliance with study drug regimen|0|||
27861129|NCT00642278|81322886|FG006|Overall Study|Noncompliance with study drug regimen|0|||
27762584|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
27762585|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
27762586|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
27762587|NCT02553317|80957484|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
27762588|NCT02553317|80957485|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
27762589|NCT00631540|80957488|FG000|Overall Study|Withdrawal by Subject|5|||
27762590|NCT00631540|80957488|FG000|Overall Study|Death|4|||
27762591|NCT00631540|80957488|FG000|Overall Study|Lost to Follow-up|2|||
27762592|NCT00631540|80957488|FG000|Overall Study|Core Lab Data Unavailable|3|||
27762593|NCT02447458|80957492|FG000|Overall Study|Other|0|||
27762594|NCT02447458|80957493|FG001|Overall Study|Other|0|||
27762595|NCT02447458|80957494|FG002|Overall Study|Other|1|||
27762596|NCT02447458|80957495|FG003|Overall Study|Other|0|||
27762597|NCT02447458|80957496|FG004|Overall Study|Other|0|||
27762598|NCT02447458|80957497|FG005|Overall Study|Other|0|||
27762599|NCT01359046|80957501|FG000|Overall Study|Did not receive allocated intervention|6|||
27762600|NCT01359046|80957502|FG001|Overall Study|Did not receive allocated intervention|6|||
27762601|NCT01359046|80957501|FG000|Overall Study|Physician Decision|1|||
27762602|NCT01359046|80957502|FG001|Overall Study|Physician Decision|11|||
27762603|NCT02581982|80957503|FG000|Overall Study|Lack of Efficacy|12|||
27762604|NCT02581982|80957503|FG000|Overall Study|Adverse Event|3|||
27762605|NCT02581982|80957503|FG000|Overall Study|Physician Decision|1|||
27762606|NCT04325906|80957514|FG000|Overall Study|Withdrawal by Subject|2|||
27762607|NCT04325906|80957515|FG001|Overall Study|Withdrawal by Subject|0|||
27762608|NCT02168803|80957520|FG000|Overall Study|Lost to Follow-up|1|||
27762609|NCT02168803|80957521|FG001|Overall Study|Lost to Follow-up|0|||
27762610|NCT02168803|80957522|FG002|Overall Study|Lost to Follow-up|1|||
27861130|NCT00642278|81322880|FG000|Overall Study|Other|2|||
27861131|NCT00642278|81322881|FG001|Overall Study|Other|1|||
27861132|NCT00642278|81322882|FG002|Overall Study|Other|0|||
27661569|NCT02123797|80596953|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
27661570|NCT02123797|80596954|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
27661571|NCT02123797|80596955|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27661572|NCT02123797|80596956|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27661573|NCT02123797|80596957|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
27661574|NCT02123797|80596953|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
27661575|NCT02123797|80596954|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
27661576|NCT02123797|80596955|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
27661577|NCT02123797|80596956|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
27661578|NCT02123797|80596957|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
27661579|NCT00837096|80596960|FG000|Overall Study|Physician Decision|1|||
27661580|NCT00837096|80596961|FG001|Overall Study|Physician Decision|1|||
27661581|NCT00837096|80596960|FG000|Overall Study|Not reported|9|||
27661582|NCT00837096|80596961|FG001|Overall Study|Not reported|8|||
27661583|NCT01066897|80596962|FG000|Overall Study|Withdrawal by Subject|1|||
27661584|NCT01066897|80596963|FG001|Overall Study|Withdrawal by Subject|0|||
27661585|NCT01066897|80596962|FG000|Overall Study|stopped study after developing the flu.|1|||
27661586|NCT01066897|80596963|FG001|Overall Study|stopped study after developing the flu.|0|||
27661587|NCT01313299|80596964|FG000|Overall Study|Adverse Event|3|||
27661588|NCT01313299|80596965|FG001|Overall Study|Adverse Event|1|||
27661589|NCT01313299|80596966|FG002|Overall Study|Adverse Event|1|||
27661590|NCT01313299|80596964|FG000|Overall Study|Lost to Follow-up|1|||
27861133|NCT00642278|81322883|FG003|Overall Study|Other|1|||
27661591|NCT01313299|80596965|FG001|Overall Study|Lost to Follow-up|0|||
27661592|NCT01313299|80596966|FG002|Overall Study|Lost to Follow-up|0|||
27661593|NCT01313299|80596964|FG000|Overall Study|Protocol Violation|2|||
27661594|NCT01313299|80596965|FG001|Overall Study|Protocol Violation|0|||
27661595|NCT01313299|80596966|FG002|Overall Study|Protocol Violation|0|||
27661596|NCT01313299|80596964|FG000|Overall Study|Withdrawal by Subject|1|||
27661597|NCT01313299|80596965|FG001|Overall Study|Withdrawal by Subject|0|||
27661598|NCT01313299|80596966|FG002|Overall Study|Withdrawal by Subject|2|||
27861134|NCT00642278|81322884|FG004|Overall Study|Other|0|||
27861135|NCT00642278|81322885|FG005|Overall Study|Other|1|||
27861136|NCT00642278|81322886|FG006|Overall Study|Other|0|||
27861137|NCT01248013|81322887|FG000|Overall Study|Withdrawal by Subject|14|||
27861138|NCT00839254|81322890|FG000|Overall Study|Protocol Violation|0|||
27861139|NCT00839254|81322891|FG001|Overall Study|Protocol Violation|1|||
27861140|NCT00839254|81322892|FG002|Overall Study|Protocol Violation|1|||
27861141|NCT00839254|81322893|FG003|Overall Study|Protocol Violation|1|||
27861142|NCT00839254|81322894|FG004|Overall Study|Protocol Violation|0|||
27861143|NCT00839254|81322895|FG005|Overall Study|Protocol Violation|0|||
27861144|NCT00839254|81322896|FG006|Overall Study|Protocol Violation|1|||
27861145|NCT00839254|81322897|FG007|Overall Study|Protocol Violation|2|||
27861146|NCT00839254|81322890|FG000|Overall Study|Physician Decision|0|||
27861147|NCT00839254|81322891|FG001|Overall Study|Physician Decision|1|||
27861148|NCT00839254|81322892|FG002|Overall Study|Physician Decision|0|||
27861149|NCT00839254|81322893|FG003|Overall Study|Physician Decision|0|||
27861150|NCT00839254|81322894|FG004|Overall Study|Physician Decision|0|||
27861151|NCT00839254|81322895|FG005|Overall Study|Physician Decision|0|||
27861152|NCT00839254|81322896|FG006|Overall Study|Physician Decision|0|||
27861153|NCT00839254|81322897|FG007|Overall Study|Physician Decision|1|||
27861154|NCT00839254|81322890|FG000|Overall Study|Wrong treatment number allocation|0|||
27861155|NCT00839254|81322891|FG001|Overall Study|Wrong treatment number allocation|1|||
27861156|NCT00839254|81322892|FG002|Overall Study|Wrong treatment number allocation|0|||
27861157|NCT00839254|81322893|FG003|Overall Study|Wrong treatment number allocation|0|||
27861158|NCT00839254|81322894|FG004|Overall Study|Wrong treatment number allocation|0|||
27861159|NCT00839254|81322895|FG005|Overall Study|Wrong treatment number allocation|1|||
27861160|NCT00839254|81322896|FG006|Overall Study|Wrong treatment number allocation|0|||
27861161|NCT00839254|81322897|FG007|Overall Study|Wrong treatment number allocation|0|||
27861162|NCT00839254|81322890|FG000|Overall Study|Adverse Event|12|||
27861163|NCT00839254|81322891|FG001|Overall Study|Adverse Event|6|||
27861164|NCT00839254|81322892|FG002|Overall Study|Adverse Event|3|||
27861165|NCT00839254|81322893|FG003|Overall Study|Adverse Event|5|||
27861166|NCT00839254|81322894|FG004|Overall Study|Adverse Event|2|||
27861167|NCT00839254|81322895|FG005|Overall Study|Adverse Event|1|||
27861168|NCT00839254|81322896|FG006|Overall Study|Adverse Event|0|||
27861169|NCT00839254|81322897|FG007|Overall Study|Adverse Event|1|||
27861170|NCT00839254|81322890|FG000|Overall Study|Withdrawal by Subject|87|||
27861171|NCT00839254|81322891|FG001|Overall Study|Withdrawal by Subject|53|||
27861172|NCT00839254|81322892|FG002|Overall Study|Withdrawal by Subject|54|||
27861173|NCT00839254|81322893|FG003|Overall Study|Withdrawal by Subject|32|||
27861174|NCT00839254|81322894|FG004|Overall Study|Withdrawal by Subject|27|||
27861175|NCT00839254|81322895|FG005|Overall Study|Withdrawal by Subject|15|||
27861176|NCT00839254|81322896|FG006|Overall Study|Withdrawal by Subject|22|||
27861177|NCT00839254|81322897|FG007|Overall Study|Withdrawal by Subject|9|||
27861178|NCT00839254|81322890|FG000|Overall Study|Wrong group allocation|0|||
27861179|NCT00839254|81322891|FG001|Overall Study|Wrong group allocation|0|||
27861180|NCT00839254|81322892|FG002|Overall Study|Wrong group allocation|0|||
27861181|NCT00839254|81322893|FG003|Overall Study|Wrong group allocation|0|||
27861182|NCT00839254|81322894|FG004|Overall Study|Wrong group allocation|0|||
27861183|NCT00839254|81322895|FG005|Overall Study|Wrong group allocation|0|||
27861184|NCT00839254|81322896|FG006|Overall Study|Wrong group allocation|1|||
27661599|NCT01313299|80596964|FG000|Overall Study|Family reason and moved out of state|0|||
27661600|NCT01313299|80596965|FG001|Overall Study|Family reason and moved out of state|2|||
27661601|NCT01313299|80596966|FG002|Overall Study|Family reason and moved out of state|0|||
27661602|NCT01313299|80596964|FG000|Overall Study|Lack of subject compliance|0|||
27661603|NCT01313299|80596965|FG001|Overall Study|Lack of subject compliance|0|||
27661604|NCT01313299|80596966|FG002|Overall Study|Lack of subject compliance|1|||
27661605|NCT00228813|80596967|FG000|Overall Study|Death|4|||
27661606|NCT03029234|80596970|FG000|Overall Study|Sponsor Decision|1|||
27661607|NCT03029234|80596970|FG000|Overall Study|Withdrawal by Subject|5|||
27661608|NCT03029234|80596970|FG000|Overall Study|Death|91|||
27661609|NCT03029234|80596970|FG000|Overall Study|Lost to Follow-up|2|||
27661610|NCT05012397|80596971|FG000|Overall Study|Death|10|||
27661611|NCT05012397|80596971|FG000|Overall Study|Physician Decision|9|||
27661612|NCT05012397|80596971|FG000|Overall Study|Withdrawal by Subject|5|||
27661613|NCT05012397|80596971|FG000|Overall Study|Lost to Follow-up|2|||
27661614|NCT04783519|80596974|FG000|Overall Study|Withdrawal by Subject|2|||
27661615|NCT04783519|80596975|FG001|Overall Study|Withdrawal by Subject|7|||
27661616|NCT04783519|80596976|FG002|Overall Study|Withdrawal by Subject|3|||
27661617|NCT04783519|80596974|FG000|Overall Study|Lost to Follow-up|9|||
27661618|NCT04783519|80596975|FG001|Overall Study|Lost to Follow-up|7|||
27661619|NCT04783519|80596976|FG002|Overall Study|Lost to Follow-up|6|||
27661620|NCT01424189|80596981|FG000|Overall Study|Adverse Event|1|||
27661621|NCT01424189|80596982|FG001|Overall Study|Adverse Event|0|||
27661622|NCT01424189|80596981|FG000|Overall Study|Lost to Follow-up|4|||
27661623|NCT01424189|80596982|FG001|Overall Study|Lost to Follow-up|1|||
27661624|NCT01424189|80596981|FG000|Overall Study|Withdrawal by Subject|4|||
27661625|NCT01424189|80596982|FG001|Overall Study|Withdrawal by Subject|4|||
27661626|NCT01424189|80596981|FG000|Overall Study|Subject moved|1|||
27568707|NCT02584504|80271431|FG000|Open-label Treatment|Entered but not treated|0|||
27568708|NCT02584504|80271432|FG001|Open-label Treatment|Entered but not treated|1|||
27568709|NCT02584504|80271433|FG002|Open-label Treatment|Entered but not treated|1|||
27568710|NCT02016625|80271434|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
27568711|NCT02016625|80271435|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
27568712|NCT02016625|80271434|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
27661627|NCT01424189|80596982|FG001|Overall Study|Subject moved|0|||
27661628|NCT01424189|80596981|FG000|Overall Study|Death|3|||
27661629|NCT01424189|80596982|FG001|Overall Study|Death|1|||
27661630|NCT00187135|80596983|FG000|Visit One|Withdrawal by Subject|1|||
27661631|NCT00187135|80596984|FG001|Visit One|Withdrawal by Subject|0|||
27661632|NCT00187135|80596985|FG002|Visit One|Withdrawal by Subject|0|||
27661633|NCT00187135|80596986|FG003|Visit One|Withdrawal by Subject|0|||
27661634|NCT00187135|80596987|FG004|Visit One|Withdrawal by Subject|0|||
27661635|NCT00187135|80596988|FG005|Visit One|Withdrawal by Subject|1|||
27661636|NCT00187135|80596983|FG000|Visit One|Physician Decision|3|||
27661637|NCT00187135|80596984|FG001|Visit One|Physician Decision|1|||
27661638|NCT00187135|80596985|FG002|Visit One|Physician Decision|0|||
27661639|NCT00187135|80596986|FG003|Visit One|Physician Decision|0|||
27661640|NCT00187135|80596987|FG004|Visit One|Physician Decision|0|||
27661641|NCT00187135|80596988|FG005|Visit One|Physician Decision|1|||
27661642|NCT00187135|80596983|FG000|Visit Two|Death|0|||
27661643|NCT00187135|80596984|FG001|Visit Two|Death|0|||
27661644|NCT00187135|80596985|FG002|Visit Two|Death|0|||
27661645|NCT00187135|80596986|FG003|Visit Two|Death|1|||
27661646|NCT00187135|80596987|FG004|Visit Two|Death|0|||
27762611|NCT02168803|80957520|FG000|Overall Study|Withdrawal by Subject|1|||
27762612|NCT02168803|80957521|FG001|Overall Study|Withdrawal by Subject|1|||
27762613|NCT02168803|80957522|FG002|Overall Study|Withdrawal by Subject|2|||
27762614|NCT02168803|80957520|FG000|Overall Study|Physician Decision|0|||
27762615|NCT02168803|80957521|FG001|Overall Study|Physician Decision|1|||
27568713|NCT02016625|80271435|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
27762616|NCT02168803|80957522|FG002|Overall Study|Physician Decision|0|||
27762617|NCT02168803|80957520|FG000|Overall Study|Adverse Event|0|||
27762618|NCT02168803|80957521|FG001|Overall Study|Adverse Event|1|||
27762619|NCT02168803|80957522|FG002|Overall Study|Adverse Event|1|||
27762620|NCT02168803|80957520|FG000|Overall Study|Death|0|||
27762621|NCT02168803|80957521|FG001|Overall Study|Death|0|||
27762622|NCT02168803|80957522|FG002|Overall Study|Death|1|||
27762623|NCT02168803|80957520|FG000|Overall Study|Sponsor Decision|0|||
27762624|NCT02168803|80957521|FG001|Overall Study|Sponsor Decision|0|||
27762625|NCT02168803|80957522|FG002|Overall Study|Sponsor Decision|1|||
27762626|NCT05109702|80957528|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
27762627|NCT05109702|80957529|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
27762628|NCT05109702|80957530|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
27762629|NCT05109702|80957528|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
27762630|NCT05109702|80957529|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
27762631|NCT05109702|80957530|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
27762632|NCT05109702|80957528|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
27762633|NCT05109702|80957529|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
27762634|NCT05109702|80957530|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
27762635|NCT05109702|80957528|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
27762636|NCT05109702|80957529|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
27762637|NCT05109702|80957530|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
27762638|NCT05109702|80957528|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
27762639|NCT05109702|80957529|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
27762640|NCT05109702|80957530|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
27762641|NCT04685499|80957531|FG000|Overall Study|Study Terminated Early|1|||
27762642|NCT02713789|80957532|FG000|Overall Study|Lost to Follow-up|0|||
27762643|NCT02713789|80957533|FG001|Overall Study|Lost to Follow-up|1|||
27762644|NCT02713789|80957534|FG002|Overall Study|Lost to Follow-up|1|||
27762645|NCT03986190|80957535|FG000|Overall Study|Withdrawal by Subject|12|||
27762646|NCT03986190|80957536|FG001|Overall Study|Withdrawal by Subject|0|||
27762647|NCT02871401|80957537|FG000|Overall Study|Adverse Event|1|||
27762648|NCT02871401|80957538|FG001|Overall Study|Adverse Event|0|||
27762649|NCT00039741|80957539|FG000|Overall Study|Death|0|||
27762650|NCT00039741|80957540|FG001|Overall Study|Death|1|||
27762651|NCT00039741|80957541|FG002|Overall Study|Death|0|||
27762652|NCT00039741|80957542|FG003|Overall Study|Death|0|||
27762653|NCT00039741|80957539|FG000|Overall Study|Lost to Follow-up|3|||
27762654|NCT00039741|80957540|FG001|Overall Study|Lost to Follow-up|1|||
27762655|NCT00039741|80957541|FG002|Overall Study|Lost to Follow-up|5|||
27762656|NCT00039741|80957542|FG003|Overall Study|Lost to Follow-up|2|||
27762657|NCT00039741|80957539|FG000|Overall Study|Confounding medical condition|1|||
27762658|NCT00039741|80957540|FG001|Overall Study|Confounding medical condition|0|||
27762659|NCT00039741|80957541|FG002|Overall Study|Confounding medical condition|0|||
27762660|NCT00039741|80957542|FG003|Overall Study|Confounding medical condition|0|||
27762661|NCT00039741|80957539|FG000|Overall Study|Not able to get to clinic|5|||
27661647|NCT00187135|80596988|FG005|Visit Two|Death|1|||
27661648|NCT00187135|80596983|FG000|Visit Two|Physician Decision|1|||
27661649|NCT00187135|80596984|FG001|Visit Two|Physician Decision|0|||
27661650|NCT00187135|80596985|FG002|Visit Two|Physician Decision|0|||
27661651|NCT00187135|80596986|FG003|Visit Two|Physician Decision|0|||
27661652|NCT00187135|80596987|FG004|Visit Two|Physician Decision|0|||
27661653|NCT00187135|80596988|FG005|Visit Two|Physician Decision|0|||
27661654|NCT00187135|80596983|FG000|Visit Two|Withdrawal by Subject|1|||
27661655|NCT00187135|80596984|FG001|Visit Two|Withdrawal by Subject|1|||
27661656|NCT00187135|80596985|FG002|Visit Two|Withdrawal by Subject|1|||
27661657|NCT00187135|80596986|FG003|Visit Two|Withdrawal by Subject|0|||
27661658|NCT00187135|80596987|FG004|Visit Two|Withdrawal by Subject|1|||
27661659|NCT00187135|80596988|FG005|Visit Two|Withdrawal by Subject|1|||
27661660|NCT00187135|80596983|FG000|Visit Two|Study Discontinued|3|||
27661661|NCT00187135|80596984|FG001|Visit Two|Study Discontinued|2|||
27661662|NCT00187135|80596985|FG002|Visit Two|Study Discontinued|1|||
27661663|NCT00187135|80596986|FG003|Visit Two|Study Discontinued|7|||
27661664|NCT00187135|80596987|FG004|Visit Two|Study Discontinued|5|||
27661665|NCT00187135|80596988|FG005|Visit Two|Study Discontinued|6|||
27661666|NCT00187135|80596983|FG000|Visit Three|Death|0|||
27661667|NCT00187135|80596984|FG001|Visit Three|Death|0|||
27661668|NCT00187135|80596985|FG002|Visit Three|Death|1|||
27661669|NCT00187135|80596986|FG003|Visit Three|Death|0|||
27661670|NCT00187135|80596987|FG004|Visit Three|Death|1|||
27661671|NCT00187135|80596988|FG005|Visit Three|Death|0|||
27661672|NCT00187135|80596983|FG000|Visit Three|Withdrawal by Subject|0|||
27661673|NCT00187135|80596984|FG001|Visit Three|Withdrawal by Subject|1|||
27661674|NCT00187135|80596985|FG002|Visit Three|Withdrawal by Subject|1|||
27661675|NCT00187135|80596986|FG003|Visit Three|Withdrawal by Subject|2|||
27661676|NCT00187135|80596987|FG004|Visit Three|Withdrawal by Subject|0|||
27661677|NCT00187135|80596988|FG005|Visit Three|Withdrawal by Subject|0|||
27661678|NCT00187135|80596983|FG000|Visit Three|Study Discontinued|7|||
27661679|NCT00187135|80596984|FG001|Visit Three|Study Discontinued|6|||
27661680|NCT00187135|80596985|FG002|Visit Three|Study Discontinued|7|||
27661681|NCT00187135|80596986|FG003|Visit Three|Study Discontinued|7|||
27661682|NCT00187135|80596987|FG004|Visit Three|Study Discontinued|7|||
27661683|NCT00187135|80596988|FG005|Visit Three|Study Discontinued|6|||
27661684|NCT00580047|80596989|FG000|Overall Study|Lost to Follow-up|1|||
27661685|NCT00580047|80596990|FG001|Overall Study|Lost to Follow-up|1|||
27762662|NCT00039741|80957540|FG001|Overall Study|Not able to get to clinic|2|||
27762663|NCT00039741|80957541|FG002|Overall Study|Not able to get to clinic|0|||
27661686|NCT00580047|80596991|FG002|Overall Study|Lost to Follow-up|0|||
27661687|NCT00580047|80596989|FG000|Overall Study|Withdrawal by Subject|1|||
27661688|NCT00580047|80596990|FG001|Overall Study|Withdrawal by Subject|1|||
27661689|NCT00580047|80596991|FG002|Overall Study|Withdrawal by Subject|2|||
27661690|NCT00580047|80596989|FG000|Overall Study|Withdrawal by Subject|1|||
27661691|NCT00580047|80596990|FG001|Overall Study|Withdrawal by Subject|0|||
27661692|NCT00580047|80596991|FG002|Overall Study|Withdrawal by Subject|0|||
27661693|NCT00759681|80596992|FG000|Overall Study|Death|2|||
27661694|NCT00759681|80596993|FG001|Overall Study|Death|5|||
27661695|NCT00759681|80596992|FG000|Overall Study|Lost to Follow-up|8|||
27661696|NCT00759681|80596993|FG001|Overall Study|Lost to Follow-up|5|||
27661697|NCT00975130|80596998|FG000|Study Part 1|Adverse Event|150|||
27661698|NCT00975130|80596999|FG001|Study Part 1|Adverse Event|0|||
27661699|NCT00975130|80597000|FG002|Study Part 1|Adverse Event|0|||
27661700|NCT00975130|80596998|FG000|Study Part 1|Lost to Follow-up|19|||
27661701|NCT00975130|80596999|FG001|Study Part 1|Lost to Follow-up|0|||
27661702|NCT00975130|80597000|FG002|Study Part 1|Lost to Follow-up|0|||
27661703|NCT00975130|80596998|FG000|Study Part 1|Withdrawal by Subject|61|||
27661704|NCT00975130|80596999|FG001|Study Part 1|Withdrawal by Subject|0|||
27661705|NCT00975130|80597000|FG002|Study Part 1|Withdrawal by Subject|0|||
27661706|NCT00975130|80596998|FG000|Study Part 1|Protocol Violation|13|||
27661707|NCT00975130|80596999|FG001|Study Part 1|Protocol Violation|0|||
27661708|NCT00975130|80597000|FG002|Study Part 1|Protocol Violation|0|||
27661709|NCT00975130|80596998|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
27661710|NCT00975130|80596999|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
27661711|NCT00975130|80597000|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
27661712|NCT00975130|80596998|FG000|Study Part 1|Administrative|4|||
27661713|NCT00975130|80596999|FG001|Study Part 1|Administrative|0|||
27661714|NCT00975130|80597000|FG002|Study Part 1|Administrative|0|||
27661715|NCT00975130|80596998|FG000|Study Part 1|Withdrew Consent|24|||
27661716|NCT00975130|80596999|FG001|Study Part 1|Withdrew Consent|0|||
27661717|NCT00975130|80597000|FG002|Study Part 1|Withdrew Consent|0|||
27661718|NCT00975130|80596998|FG000|Study Part 2|Adverse Event|0|||
27661719|NCT00975130|80596999|FG001|Study Part 2|Adverse Event|14|||
27661720|NCT00975130|80597000|FG002|Study Part 2|Adverse Event|7|||
27661721|NCT00975130|80596998|FG000|Study Part 2|Lost to Follow-up|0|||
27661722|NCT00975130|80596999|FG001|Study Part 2|Lost to Follow-up|0|||
27661723|NCT00975130|80597000|FG002|Study Part 2|Lost to Follow-up|1|||
27661724|NCT00975130|80596998|FG000|Study Part 2|Withdrawal by Subject|0|||
27661725|NCT00975130|80596999|FG001|Study Part 2|Withdrawal by Subject|13|||
27661726|NCT00975130|80597000|FG002|Study Part 2|Withdrawal by Subject|5|||
27661727|NCT00975130|80596998|FG000|Study Part 2|Withdrew Consent|0|||
27661728|NCT00975130|80596999|FG001|Study Part 2|Withdrew Consent|6|||
27661729|NCT00975130|80597000|FG002|Study Part 2|Withdrew Consent|2|||
27661730|NCT00975130|80596998|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
27661731|NCT00975130|80596999|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
27661732|NCT00975130|80597000|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
27661733|NCT00975130|80596998|FG000|Study Part 2|Administrative|0|||
27661734|NCT00975130|80596999|FG001|Study Part 2|Administrative|1|||
27661735|NCT00975130|80597000|FG002|Study Part 2|Administrative|0|||
27661736|NCT00975130|80596998|FG000|Study Part 2|Protocol Violation|0|||
27661737|NCT00975130|80596999|FG001|Study Part 2|Protocol Violation|0|||
27661738|NCT00975130|80597000|FG002|Study Part 2|Protocol Violation|1|||
27661739|NCT01047306|80597001|FG000|Overall Study|Withdrawal by Subject|2|||
27661740|NCT01047306|80597002|FG001|Overall Study|Withdrawal by Subject|0|||
27661741|NCT01047306|80597001|FG000|Overall Study|Lost to Follow-up|1|||
27661742|NCT01047306|80597002|FG001|Overall Study|Lost to Follow-up|0|||
27661743|NCT01475370|80597003|FG000|Overall Study|Exacerbation of primary disease|2|||
27661744|NCT01475370|80597004|FG001|Overall Study|Exacerbation of primary disease|2|||
27661745|NCT01475370|80597005|FG002|Overall Study|Exacerbation of primary disease|2|||
27661746|NCT01475370|80597003|FG000|Overall Study|Study drug administration difficult|0|||
27661747|NCT01475370|80597004|FG001|Overall Study|Study drug administration difficult|1|||
27661748|NCT01475370|80597005|FG002|Overall Study|Study drug administration difficult|1|||
27661749|NCT01475370|80597003|FG000|Overall Study|Other than specified|1|||
27661750|NCT01475370|80597004|FG001|Overall Study|Other than specified|0|||
27661751|NCT01475370|80597005|FG002|Overall Study|Other than specified|0|||
27661752|NCT01536535|80597006|FG000|Overall Study|Withdrawal by Subject|10|||
27661753|NCT01536535|80597007|FG001|Overall Study|Withdrawal by Subject|5|||
27661754|NCT01536535|80597006|FG000|Overall Study|Lost to Follow-up|4|||
27661755|NCT01536535|80597007|FG001|Overall Study|Lost to Follow-up|6|||
27661756|NCT01536535|80597006|FG000|Overall Study|Physician Decision|1|||
27661757|NCT01536535|80597007|FG001|Overall Study|Physician Decision|1|||
27661758|NCT01536535|80597006|FG000|Overall Study|Participant moved|0|||
27661759|NCT01536535|80597007|FG001|Overall Study|Participant moved|1|||
27661760|NCT00509925|80597010|FG000|Overall Study|Personal reasons|0|||
27661761|NCT00509925|80597011|FG001|Overall Study|Personal reasons|1|||
27661762|NCT03722485|80597012|FG000|Overall Study|Withdrawal by Subject|1|||
27661763|NCT03722485|80597013|FG001|Overall Study|Withdrawal by Subject|0|||
27661764|NCT03722485|80597012|FG000|Overall Study|Adverse Event|0|||
27661765|NCT03722485|80597013|FG001|Overall Study|Adverse Event|2|||
27661766|NCT03722485|80597012|FG000|Overall Study|subject discharged prior to study completion|1|||
27661767|NCT03722485|80597013|FG001|Overall Study|subject discharged prior to study completion|5|||
27861185|NCT00839254|81322897|FG007|Overall Study|Wrong group allocation|0|||
27861186|NCT00839254|81322890|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
27861187|NCT00839254|81322891|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
27861188|NCT00839254|81322892|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
27861189|NCT00839254|81322893|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
27861190|NCT00839254|81322894|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
27861191|NCT00839254|81322895|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
27861192|NCT00839254|81322896|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
27861193|NCT00839254|81322897|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
27861194|NCT00839254|81322890|FG000|Overall Study|Withdrawn due to non-compliance|2|||
27861195|NCT00839254|81322891|FG001|Overall Study|Withdrawn due to non-compliance|0|||
27861196|NCT00839254|81322892|FG002|Overall Study|Withdrawn due to non-compliance|0|||
27661768|NCT03722485|80597012|FG000|Overall Study|eligibility criteria not met|2|||
27661769|NCT03722485|80597013|FG001|Overall Study|eligibility criteria not met|0|||
27661770|NCT02136797|80597014|FG000|Overall Study|Not Treated|8|||
27661771|NCT00762723|80597015|FG000|Overall Study|Study Terminated slow enrollement|5|||
27661772|NCT00762723|80597016|FG001|Overall Study|Study Terminated slow enrollement|5|||
27661773|NCT00762723|80597017|FG002|Overall Study|Study Terminated slow enrollement|3|||
27661774|NCT01403805|80597018|FG000|Overall Study|Withdrawal by Subject|0|||
27661775|NCT01403805|80597019|FG001|Overall Study|Withdrawal by Subject|4|||
27661776|NCT01403805|80597018|FG000|Overall Study|Lost to Follow-up|0|||
27661777|NCT01403805|80597019|FG001|Overall Study|Lost to Follow-up|2|||
27661778|NCT01403805|80597018|FG000|Overall Study|Death|0|||
27661779|NCT01403805|80597019|FG001|Overall Study|Death|1|||
27661780|NCT02256488|80599815|FG000|Overall Study|Lost to Follow-up|6|||
27661781|NCT02256488|80599816|FG001|Overall Study|Lost to Follow-up|6|||
27661782|NCT02256488|80599817|FG002|Overall Study|Lost to Follow-up|9|||
27661783|NCT02256488|80599818|FG003|Overall Study|Lost to Follow-up|3|||
27661784|NCT02256488|80599815|FG000|Overall Study|OTHER|1|||
27661785|NCT02256488|80599816|FG001|Overall Study|OTHER|0|||
27661786|NCT02256488|80599817|FG002|Overall Study|OTHER|1|||
27661787|NCT02256488|80599818|FG003|Overall Study|OTHER|1|||
27661788|NCT02256488|80599815|FG000|Overall Study|Withdrawal by Subject|1|||
27661789|NCT02256488|80599816|FG001|Overall Study|Withdrawal by Subject|0|||
27661790|NCT02256488|80599817|FG002|Overall Study|Withdrawal by Subject|0|||
27661791|NCT02256488|80599818|FG003|Overall Study|Withdrawal by Subject|2|||
27661792|NCT02273180|80599819|FG000|Overall Study|Adverse Event|2|||
27661793|NCT02273180|80599820|FG001|Overall Study|Adverse Event|2|||
27661794|NCT02273180|80599819|FG000|Overall Study|Lack of Efficacy|1|||
27661795|NCT02273180|80599820|FG001|Overall Study|Lack of Efficacy|0|||
27661796|NCT02273180|80599819|FG000|Overall Study|Protocol Violation|1|||
27661797|NCT02273180|80599820|FG001|Overall Study|Protocol Violation|7|||
27661798|NCT02273180|80599819|FG000|Overall Study|Randomized but not treated|1|||
27661799|NCT02273180|80599820|FG001|Overall Study|Randomized but not treated|0|||
27661800|NCT02273180|80599819|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
27661801|NCT02273180|80599820|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
27661802|NCT02273180|80599819|FG000|Overall Study|Other than specified above|21|||
27661803|NCT02273180|80599820|FG001|Overall Study|Other than specified above|10|||
27762664|NCT00039741|80957542|FG003|Overall Study|Not able to get to clinic|3|||
27762665|NCT00039741|80957539|FG000|Overall Study|Moved|3|||
27762666|NCT00039741|80957540|FG001|Overall Study|Moved|2|||
27762667|NCT00039741|80957541|FG002|Overall Study|Moved|3|||
27762668|NCT00039741|80957542|FG003|Overall Study|Moved|6|||
27762669|NCT00039741|80957539|FG000|Overall Study|Non-compliance with protocol|1|||
27762670|NCT00039741|80957540|FG001|Overall Study|Non-compliance with protocol|0|||
27762671|NCT00039741|80957541|FG002|Overall Study|Non-compliance with protocol|1|||
27762672|NCT00039741|80957542|FG003|Overall Study|Non-compliance with protocol|0|||
27762673|NCT00039741|80957539|FG000|Overall Study|Withdrew consent|0|||
27762674|NCT00039741|80957540|FG001|Overall Study|Withdrew consent|5|||
27762675|NCT00039741|80957541|FG002|Overall Study|Withdrew consent|0|||
27762676|NCT00039741|80957542|FG003|Overall Study|Withdrew consent|1|||
27762677|NCT00039741|80957539|FG000|Overall Study|Missed final visit|2|||
27762678|NCT00039741|80957540|FG001|Overall Study|Missed final visit|1|||
27762679|NCT00039741|80957541|FG002|Overall Study|Missed final visit|2|||
27762680|NCT00039741|80957542|FG003|Overall Study|Missed final visit|2|||
27762681|NCT03505749|80957544|FG000|Overall Study|Lost to Follow-up|7|||
27762682|NCT03505749|80957545|FG001|Overall Study|Lost to Follow-up|11|||
27762683|NCT03505749|80957544|FG000|Overall Study|Withdrawal by Subject|6|||
27661804|NCT00111839|80599821|FG000|Overall Study|Disease Progression|30|||
27661805|NCT00111839|80599822|FG001|Overall Study|Disease Progression|33|||
27661806|NCT00111839|80599823|FG002|Overall Study|Disease Progression|33|||
27661807|NCT00111839|80599821|FG000|Overall Study|Adverse Event|5|||
27661808|NCT00111839|80599822|FG001|Overall Study|Adverse Event|3|||
27762684|NCT03505749|80957545|FG001|Overall Study|Withdrawal by Subject|0|||
27661809|NCT00111839|80599823|FG002|Overall Study|Adverse Event|1|||
27861197|NCT00839254|81322893|FG003|Overall Study|Withdrawn due to non-compliance|0|||
27861198|NCT00839254|81322894|FG004|Overall Study|Withdrawn due to non-compliance|0|||
27861199|NCT00839254|81322895|FG005|Overall Study|Withdrawn due to non-compliance|0|||
27568714|NCT02016625|80271434|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
27568715|NCT02016625|80271435|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
27568716|NCT01933048|80271437|FG000|Overall Study|Lost to Follow-up|15|||
27568717|NCT01933048|80271438|FG001|Overall Study|Lost to Follow-up|18|||
27568718|NCT01933048|80271437|FG000|Overall Study|personal reasons|1|||
27568719|NCT01933048|80271438|FG001|Overall Study|personal reasons|1|||
27568720|NCT01933048|80271437|FG000|Overall Study|Protocol Violation|7|||
27568721|NCT01933048|80271438|FG001|Overall Study|Protocol Violation|8|||
27568722|NCT01933048|80271437|FG000|Overall Study|Physician Decision|1|||
27568723|NCT01933048|80271438|FG001|Overall Study|Physician Decision|0|||
27568724|NCT01933048|80271437|FG000|Overall Study|unknown reasons|1|||
27568725|NCT01933048|80271438|FG001|Overall Study|unknown reasons|1|||
27568726|NCT03925324|80271439|FG000|Overall Study|Death|1|||
27568727|NCT03925324|80271440|FG001|Overall Study|Death|1|||
27568728|NCT03181542|80271441|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
27568729|NCT03181542|80271442|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
27568730|NCT03013543|80271447|FG000|Overall Study|Withdrawal by Subject|0|||
27568731|NCT03013543|80271448|FG001|Overall Study|Withdrawal by Subject|2|||
27568732|NCT03013543|80271449|FG002|Overall Study|Withdrawal by Subject|0|||
27568733|NCT03013543|80271450|FG003|Overall Study|Withdrawal by Subject|5|||
27568734|NCT03013543|80271451|FG004|Overall Study|Withdrawal by Subject|6|||
27568735|NCT03013543|80271452|FG005|Overall Study|Withdrawal by Subject|2|||
27568736|NCT03013543|80271453|FG006|Overall Study|Withdrawal by Subject|3|||
27568737|NCT03013543|80271454|FG007|Overall Study|Withdrawal by Subject|1|||
27568738|NCT03013543|80271455|FG008|Overall Study|Withdrawal by Subject|0|||
27568739|NCT03013543|80271456|FG009|Overall Study|Withdrawal by Subject|4|||
27568740|NCT03013543|80271447|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27568741|NCT03013543|80271448|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
27568742|NCT03013543|80271449|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
27568743|NCT03013543|80271450|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
27568744|NCT03013543|80271451|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
27568745|NCT03013543|80271452|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
27568746|NCT03013543|80271453|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
27568747|NCT03013543|80271454|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
27568748|NCT03013543|80271455|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
27568749|NCT03013543|80271456|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
27568750|NCT03013543|80271447|FG000|Overall Study|Other|0|||
27568751|NCT03013543|80271448|FG001|Overall Study|Other|0|||
27568752|NCT03013543|80271449|FG002|Overall Study|Other|2|||
27568753|NCT03013543|80271450|FG003|Overall Study|Other|0|||
27568754|NCT03013543|80271451|FG004|Overall Study|Other|2|||
27568755|NCT03013543|80271452|FG005|Overall Study|Other|0|||
27568756|NCT03013543|80271453|FG006|Overall Study|Other|0|||
27568757|NCT03013543|80271454|FG007|Overall Study|Other|0|||
27568758|NCT03013543|80271455|FG008|Overall Study|Other|1|||
27568759|NCT03013543|80271456|FG009|Overall Study|Other|0|||
27568760|NCT03013543|80271447|FG000|Overall Study|Adverse Event|0|||
27568761|NCT03013543|80271448|FG001|Overall Study|Adverse Event|0|||
27661810|NCT00111839|80599821|FG000|Overall Study|Protocol Violation|2|||
27661811|NCT00111839|80599822|FG001|Overall Study|Protocol Violation|4|||
27661812|NCT00111839|80599823|FG002|Overall Study|Protocol Violation|2|||
27661813|NCT00111839|80599821|FG000|Overall Study|Death|1|||
27661814|NCT00111839|80599822|FG001|Overall Study|Death|1|||
27661815|NCT00111839|80599823|FG002|Overall Study|Death|6|||
27661816|NCT00111839|80599821|FG000|Overall Study|Withdrawal by Subject|2|||
27661817|NCT00111839|80599822|FG001|Overall Study|Withdrawal by Subject|2|||
27661818|NCT00111839|80599823|FG002|Overall Study|Withdrawal by Subject|2|||
27661819|NCT00111839|80599821|FG000|Overall Study|Lost to Follow-up|1|||
27661820|NCT00111839|80599822|FG001|Overall Study|Lost to Follow-up|0|||
27661821|NCT00111839|80599823|FG002|Overall Study|Lost to Follow-up|0|||
27568762|NCT03013543|80271449|FG002|Overall Study|Adverse Event|0|||
27568763|NCT03013543|80271450|FG003|Overall Study|Adverse Event|3|||
27568764|NCT03013543|80271451|FG004|Overall Study|Adverse Event|2|||
27568765|NCT03013543|80271452|FG005|Overall Study|Adverse Event|1|||
27568766|NCT03013543|80271453|FG006|Overall Study|Adverse Event|3|||
27568767|NCT03013543|80271454|FG007|Overall Study|Adverse Event|8|||
27568768|NCT03013543|80271455|FG008|Overall Study|Adverse Event|0|||
27568769|NCT03013543|80271456|FG009|Overall Study|Adverse Event|2|||
27568770|NCT03013543|80271447|FG000|Overall Study|Death|0|||
27568771|NCT03013543|80271448|FG001|Overall Study|Death|0|||
27568772|NCT03013543|80271449|FG002|Overall Study|Death|0|||
27568773|NCT03013543|80271450|FG003|Overall Study|Death|1|||
27661822|NCT00111839|80599821|FG000|Overall Study|Logistical Constraint|1|||
27861200|NCT00839254|81322896|FG006|Overall Study|Withdrawn due to non-compliance|0|||
27861201|NCT00839254|81322897|FG007|Overall Study|Withdrawn due to non-compliance|0|||
27861202|NCT00839254|81322890|FG000|Overall Study|Lost to Follow-up|51|||
27861203|NCT00839254|81322891|FG001|Overall Study|Lost to Follow-up|30|||
27861204|NCT00839254|81322892|FG002|Overall Study|Lost to Follow-up|32|||
27861205|NCT00839254|81322893|FG003|Overall Study|Lost to Follow-up|24|||
27861206|NCT00839254|81322894|FG004|Overall Study|Lost to Follow-up|8|||
27861207|NCT00839254|81322895|FG005|Overall Study|Lost to Follow-up|8|||
27861208|NCT00839254|81322896|FG006|Overall Study|Lost to Follow-up|4|||
27861209|NCT00839254|81322897|FG007|Overall Study|Lost to Follow-up|2|||
27861210|NCT03207243|81322898|FG000|Overall Study|Adverse Event|2|||
27861211|NCT03207243|81322899|FG001|Overall Study|Adverse Event|2|||
27861212|NCT03207243|81322898|FG000|Overall Study|Loss of Asthma Control|47|||
27861213|NCT03207243|81322899|FG001|Overall Study|Loss of Asthma Control|31|||
27861214|NCT03207243|81322898|FG000|Overall Study|Withdrawal by Subject|2|||
27861215|NCT03207243|81322899|FG001|Overall Study|Withdrawal by Subject|4|||
27861216|NCT03207243|81322898|FG000|Overall Study|Physician Decision|1|||
27861217|NCT03207243|81322899|FG001|Overall Study|Physician Decision|1|||
27861218|NCT03207243|81322898|FG000|Overall Study|Lost to Follow-up|0|||
27661823|NCT00111839|80599822|FG001|Overall Study|Logistical Constraint|0|||
27661824|NCT00111839|80599823|FG002|Overall Study|Logistical Constraint|0|||
27661825|NCT00111839|80599821|FG000|Overall Study|Other|6|||
27661826|NCT00111839|80599822|FG001|Overall Study|Other|3|||
27661827|NCT00111839|80599823|FG002|Overall Study|Other|3|||
27661828|NCT00111839|80599821|FG000|Overall Study|Randomized but Not Treated|0|||
27661829|NCT00111839|80599822|FG001|Overall Study|Randomized but Not Treated|0|||
27661830|NCT00111839|80599823|FG002|Overall Study|Randomized but Not Treated|2|||
27661831|NCT02081196|80599824|FG000|Overall Study|Lost to Follow-up|1|||
27661832|NCT00946998|80599825|FG000|Overall Study|Exited prior to first outcome assessment|5|||
27661833|NCT00946998|80599826|FG001|Overall Study|Exited prior to first outcome assessment|3|||
27762685|NCT03505749|80957544|FG000|Overall Study|Discharged from treatment|3|||
27762686|NCT03505749|80957545|FG001|Overall Study|Discharged from treatment|6|||
27762687|NCT04656418|80957549|FG000|Overall Study|Withdrawal by Subject|1|||
27762688|NCT04656418|80957550|FG001|Overall Study|Withdrawal by Subject|3|||
27762689|NCT03625141|80957555|FG000|Overall Study|Adverse Event|0|||
27762690|NCT03625141|80957556|FG001|Overall Study|Adverse Event|2|||
27762691|NCT03625141|80957555|FG000|Overall Study|Study Terminated By Sponsor|1|||
27762692|NCT03625141|80957556|FG001|Overall Study|Study Terminated By Sponsor|13|||
27762693|NCT03625141|80957555|FG000|Overall Study|Withdrawal by Subject|3|||
27762694|NCT03625141|80957556|FG001|Overall Study|Withdrawal by Subject|0|||
27762695|NCT03625141|80957555|FG000|Overall Study|Withdrawal Of Consent|0|||
27762696|NCT03625141|80957556|FG001|Overall Study|Withdrawal Of Consent|1|||
27762697|NCT03625141|80957555|FG000|Overall Study|Death|11|||
27762698|NCT03625141|80957556|FG001|Overall Study|Death|47|||
27762699|NCT03625141|80957555|FG000|Overall Study|Progressive Disease|0|||
27762700|NCT03625141|80957556|FG001|Overall Study|Progressive Disease|2|||
27762701|NCT03728140|80957559|FG000|Overall Study|Abnormal embryo transfer operation|10|||
27762702|NCT03728140|80957560|FG001|Overall Study|Abnormal embryo transfer operation|7|||
27762703|NCT01894477|80957561|FG000|Overall Study|Protocol Violation|0|||
27762704|NCT01894477|80957562|FG001|Overall Study|Protocol Violation|1|||
27762705|NCT01894477|80957561|FG000|Overall Study|protocol changed due SC changed to cord|0|||
27762706|NCT01894477|80957562|FG001|Overall Study|protocol changed due SC changed to cord|1|||
27762707|NCT00719953|80957563|FG000|Overall Study|Adverse Event|4|||
27762708|NCT00405652|80957564|FG000|Overall Study|Adverse Event|4|||
27762709|NCT02022033|80957569|FG000|Overall Study|Physician Decision|1|||
27762710|NCT03517449|80957570|FG000|Overall Study|Death|184|||
27762711|NCT03517449|80957571|FG001|Overall Study|Death|236|||
27762712|NCT03517449|80957570|FG000|Overall Study|Lost to Follow-up|0|||
27762713|NCT03517449|80957571|FG001|Overall Study|Lost to Follow-up|2|||
27762714|NCT03517449|80957570|FG000|Overall Study|Withdrawal by Subject|7|||
27762715|NCT03517449|80957571|FG001|Overall Study|Withdrawal by Subject|26|||
27762716|NCT03517449|80957570|FG000|Overall Study|Participants Ongoing|220|||
27762717|NCT03517449|80957571|FG001|Overall Study|Participants Ongoing|152|||
27762718|NCT00936117|80957572|FG000|Overall Study|Adverse Event|7|||
27762719|NCT00936117|80957572|FG000|Overall Study|Unable to continue oral medication|3|||
27861219|NCT03207243|81322899|FG001|Overall Study|Lost to Follow-up|1|||
27861220|NCT03207243|81322898|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
27861221|NCT03207243|81322899|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
27861222|NCT03207243|81322898|FG000|Overall Study|Protocol Violation|0|||
27661834|NCT01012999|80599831|FG000|Overall Study|Protocol Violation|1|||
27661835|NCT04175834|80599832|FG000|Overall Study|Withdrawal by Subject|1|||
27762720|NCT02513771|80957573|FG000|Overall Study|Lost to Follow-up|1|||
27861223|NCT03207243|81322899|FG001|Overall Study|Protocol Violation|3|||
27861224|NCT02049450|81322900|FG000|Overall Study|Adverse Event|2|||
27861225|NCT02049450|81322900|FG000|Overall Study|Withdrawal by Subject|1|||
27861226|NCT02049450|81322900|FG000|Overall Study|Patients/guardian decision|1|||
27861227|NCT01200992|81322905|FG000|Overall Study|Study terminated early|35|||
27661836|NCT04175834|80599833|FG001|Overall Study|Withdrawal by Subject|0|||
27661837|NCT01679613|80599836|FG000|Overall Study|other than stated above|0|||
27661838|NCT01679613|80599837|FG001|Overall Study|other than stated above|1|||
27661839|NCT01679613|80599838|FG002|Overall Study|other than stated above|2|||
27661840|NCT01679613|80599839|FG003|Overall Study|other than stated above|2|||
27661841|NCT02965599|80599840|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
27661842|NCT02965599|80599841|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
27661843|NCT01075100|80599842|FG000|Overall Study|Adverse Event|15|||
27661844|NCT01075100|80599843|FG001|Overall Study|Adverse Event|18|||
27661845|NCT01075100|80599842|FG000|Overall Study|Patient Request|4|||
27661846|NCT01075100|80599843|FG001|Overall Study|Patient Request|4|||
27661847|NCT01075100|80599842|FG000|Overall Study|Investigator Request|2|||
27661848|NCT01075100|80599843|FG001|Overall Study|Investigator Request|1|||
27661849|NCT01075100|80599842|FG000|Overall Study|Disease Progression|25|||
27661850|NCT01075100|80599843|FG001|Overall Study|Disease Progression|29|||
27661851|NCT01075100|80599842|FG000|Overall Study|Other|3|||
27661852|NCT01075100|80599843|FG001|Overall Study|Other|1|||
27661853|NCT03740737|80599844|FG000|Overall Study|Protocol deviation|13|||
27661854|NCT03740737|80599845|FG001|Overall Study|Protocol deviation|0|||
27661855|NCT03740737|80599844|FG000|Overall Study|Adverse Event|2|||
27661856|NCT03740737|80599845|FG001|Overall Study|Adverse Event|0|||
27661857|NCT03740737|80599844|FG000|Overall Study|Lost to Follow-up|1|||
27661858|NCT03740737|80599845|FG001|Overall Study|Lost to Follow-up|0|||
27661859|NCT03740737|80599844|FG000|Overall Study|Randomization failure|1|||
27661860|NCT03740737|80599845|FG001|Overall Study|Randomization failure|0|||
27661861|NCT03740737|80599844|FG000|Overall Study|Participant withdrew consent|1|||
27661862|NCT03740737|80599845|FG001|Overall Study|Participant withdrew consent|0|||
27661863|NCT03740737|80599844|FG000|Overall Study|Participant withdrew from trial|2|||
27661864|NCT03740737|80599845|FG001|Overall Study|Participant withdrew from trial|1|||
27661865|NCT04413149|80599851|FG000|Overall Study|Death|10|||
27661866|NCT04413149|80599852|FG001|Overall Study|Death|5|||
27661867|NCT04413149|80599851|FG000|Overall Study|Lung transplantation|1|||
27661868|NCT04413149|80599852|FG001|Overall Study|Lung transplantation|0|||
27661869|NCT03785210|80599853|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
27661870|NCT03785210|80599854|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
27661871|NCT02029521|80599855|FG000|Overall Study|Protocol Violation|1|||
27661872|NCT02029521|80599856|FG001|Overall Study|Protocol Violation|0|||
27661873|NCT02029521|80599855|FG000|Overall Study|Withdrawal by Subject|1|||
27661874|NCT02029521|80599856|FG001|Overall Study|Withdrawal by Subject|1|||
27661875|NCT01685047|80599857|FG000|Overall Study|Withdrawal by Subject|20|||
27661876|NCT01685047|80599857|FG000|Overall Study|Death|26|||
27661877|NCT01685047|80599857|FG000|Overall Study|Lost to Follow-up|8|||
27661878|NCT01685047|80599857|FG000|Overall Study|Physician Decision|25|||
27661879|NCT01685047|80599857|FG000|Overall Study|Adverse Event|5|||
27661880|NCT01685047|80599857|FG000|Overall Study|patient withdrawn by sponsor|1|||
27661881|NCT02161185|80599861|FG000|Treatment Phase|Administrative/Other|7|||
27661882|NCT00577096|80599865|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
27661883|NCT00577096|80599866|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
27661884|NCT00577096|80599865|FG000|Short Term Participation|Withdrawal by Subject|3|||
27661885|NCT00577096|80599866|FG001|Short Term Participation|Withdrawal by Subject|5|||
27661886|NCT00577096|80599865|FG000|Short Term Participation|Death|1|||
27661887|NCT00577096|80599866|FG001|Short Term Participation|Death|1|||
27661888|NCT02775214|80599867|FG000|Overall Study|Withdrawal by Subject|2|||
27661889|NCT02775214|80599868|FG001|Overall Study|Withdrawal by Subject|0|||
27661890|NCT04491136|80599869|FG000|Overall Study|Patient withdraw informed consent|9|||
27661891|NCT04491136|80599869|FG000|Overall Study|Adverse Event|2|||
27661892|NCT04491136|80599869|FG000|Overall Study|Death|3|||
27661893|NCT04491136|80599869|FG000|Overall Study|Lost to Follow-up|3|||
27661894|NCT04491136|80599869|FG000|Overall Study|Physician Decision|45|||
27661895|NCT04491136|80599869|FG000|Overall Study|sponsor terminated the study early|16|||
27661896|NCT04491136|80599869|FG000|Overall Study|Patient/guardian's decision|1|||
27661897|NCT00776984|80599870|FG000|Overall Study|Adverse Event|8|||
27661898|NCT00776984|80599871|FG001|Overall Study|Adverse Event|2|||
27661899|NCT00776984|80599870|FG000|Overall Study|Protocol Violation|4|||
27661900|NCT00776984|80599871|FG001|Overall Study|Protocol Violation|2|||
27661901|NCT00776984|80599870|FG000|Overall Study|Lost to Follow-up|2|||
27661902|NCT00776984|80599871|FG001|Overall Study|Lost to Follow-up|0|||
27661903|NCT00776984|80599870|FG000|Overall Study|Withdrawal by Subject|12|||
27661904|NCT00776984|80599871|FG001|Overall Study|Withdrawal by Subject|7|||
27661905|NCT00776984|80599870|FG000|Overall Study|Lack of Efficacy|0|||
27661906|NCT00776984|80599871|FG001|Overall Study|Lack of Efficacy|1|||
27661907|NCT00776984|80599870|FG000|Overall Study|Other|5|||
27661908|NCT00776984|80599871|FG001|Overall Study|Other|9|||
27661909|NCT00705614|80599874|FG000|Initial Intervention|Adverse Event|40|||
27661910|NCT00705614|80599875|FG001|Initial Intervention|Adverse Event|21|||
27661911|NCT00705614|80599874|FG000|Initial Intervention|Lost to Follow-up|310|||
27762721|NCT02513771|80957574|FG001|Overall Study|Lost to Follow-up|1|||
27661912|NCT00705614|80599875|FG001|Initial Intervention|Lost to Follow-up|191|||
27661913|NCT00705614|80599874|FG000|Initial Intervention|Withdrawal by Subject|114|||
27661914|NCT00705614|80599875|FG001|Initial Intervention|Withdrawal by Subject|71|||
27661915|NCT00705614|80599874|FG000|Initial Intervention|Administrative Reason|51|||
27661916|NCT00705614|80599875|FG001|Initial Intervention|Administrative Reason|38|||
27661917|NCT00705614|80599874|FG000|Initial Intervention|Status completion unknown|3|||
27661918|NCT00705614|80599875|FG001|Initial Intervention|Status completion unknown|0|||
27661919|NCT00705614|80599874|FG000|Switch to Remicade|Adverse Event|0|||
27661920|NCT00705614|80599875|FG001|Switch to Remicade|Adverse Event|5|||
27661921|NCT00705614|80599874|FG000|Switch to Remicade|Lost to Follow-up|0|||
27661922|NCT00705614|80599875|FG001|Switch to Remicade|Lost to Follow-up|23|||
27661923|NCT00705614|80599874|FG000|Switch to Remicade|Withdrawal by Subject|0|||
27661924|NCT00705614|80599875|FG001|Switch to Remicade|Withdrawal by Subject|12|||
27661925|NCT00705614|80599874|FG000|Switch to Remicade|Administrative Reason|0|||
27661926|NCT00705614|80599875|FG001|Switch to Remicade|Administrative Reason|9|||
27661927|NCT04883541|80599876|FG000|Overall Study|Not attending regular yoga class|16|||
27861228|NCT01200992|81322906|FG001|Overall Study|Study terminated early|41|||
27861229|NCT01200992|81322905|FG000|Overall Study|Randomized but not treated|2|||
27861230|NCT01200992|81322906|FG001|Overall Study|Randomized but not treated|0|||
27861231|NCT02425904|81322909|FG000|Overall Study|Lost to Follow-up|1|||
27861232|NCT02425904|81322910|FG001|Overall Study|Lost to Follow-up|0|||
27861233|NCT02425904|81322909|FG000|Overall Study|Withdrawal by Subject|2|||
27861234|NCT02425904|81322910|FG001|Overall Study|Withdrawal by Subject|0|||
27762722|NCT02513771|80957573|FG000|Overall Study|Not being able to get to clinic|1|||
27762723|NCT02513771|80957574|FG001|Overall Study|Not being able to get to clinic|0|||
27762724|NCT01103778|80957575|FG000|Overall Study|Lost to Follow-up|1|||
27762725|NCT01103778|80957575|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
27762726|NCT01103778|80957575|FG000|Overall Study|Screen failure|1|||
27762727|NCT03310580|80957576|FG000|Overall Study|Adverse Event|0|||
27762728|NCT03310580|80957577|FG001|Overall Study|Adverse Event|1|||
27762729|NCT03310580|80957578|FG002|Overall Study|Adverse Event|0|||
27762730|NCT01179347|80957580|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
27762731|NCT01179347|80957581|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
27861235|NCT02425904|81322909|FG000|Overall Study|Death|0|||
27861236|NCT02425904|81322910|FG001|Overall Study|Death|3|||
27861237|NCT02278055|81322911|FG000|Overall Study|Adverse Event|1|||
27861238|NCT02278055|81322911|FG000|Overall Study|Lost to Follow-up|1|||
27861239|NCT02278055|81322911|FG000|Overall Study|Withdrawal by Subject|2|||
27861240|NCT02278055|81322911|FG000|Overall Study|Progressive Disease|4|||
27861241|NCT03853148|81322915|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
27861242|NCT03853148|81322916|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
27861243|NCT03853148|81322917|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
27861244|NCT03853148|81322918|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
27861245|NCT00699283|81322921|FG000|Overall Study|Lack of Efficacy|15|||
27861246|NCT00699283|81322922|FG001|Overall Study|Lack of Efficacy|5|||
27861247|NCT00699283|81322921|FG000|Overall Study|Lost to Follow-up|2|||
27861248|NCT00699283|81322922|FG001|Overall Study|Lost to Follow-up|0|||
27861249|NCT00699283|81322921|FG000|Overall Study|Withdrawal by Subject|1|||
27861250|NCT00699283|81322922|FG001|Overall Study|Withdrawal by Subject|0|||
27861251|NCT00699283|81322921|FG000|Overall Study|Other Reason|5|||
27861252|NCT00699283|81322922|FG001|Overall Study|Other Reason|1|||
27861253|NCT00699283|81322921|FG000|Overall Study|SAE, non-fatal|1|||
27861254|NCT00699283|81322922|FG001|Overall Study|SAE, non-fatal|1|||
27861255|NCT00699283|81322921|FG000|Overall Study|AE, non-serious non-fatal|8|||
27861256|NCT00699283|81322922|FG001|Overall Study|AE, non-serious non-fatal|1|||
27861257|NCT00699283|81322921|FG000|Overall Study|AE of unknown type|1|||
27861258|NCT00699283|81322922|FG001|Overall Study|AE of unknown type|0|||
27861259|NCT03678285|81322923|FG000|Overall Study|Adverse Event|2|||
27762732|NCT01179347|80957580|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
27762733|NCT01179347|80957581|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
27861260|NCT03678285|81322923|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
27661928|NCT04883541|80599877|FG001|Overall Study|Not attending regular yoga class|0|||
27661929|NCT04883541|80599876|FG000|Overall Study|Not attending the pregnancy school|0|||
27661930|NCT04883541|80599877|FG001|Overall Study|Not attending the pregnancy school|9|||
27661931|NCT01887418|80599878|FG000|Overall Study|Travelling difficulties|0|||
27661932|NCT01887418|80599879|FG001|Overall Study|Travelling difficulties|0|||
27661933|NCT01887418|80599880|FG002|Overall Study|Travelling difficulties|1|||
27661934|NCT00678899|80599883|FG000|Overall Study|Adverse Event|1|||
27762734|NCT01179347|80957580|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
27762735|NCT01179347|80957581|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
27762736|NCT01179347|80957580|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
27861261|NCT03678285|81322923|FG000|Overall Study|Dehydrated prior to start of workout|1|||
27861262|NCT01822275|81322927|FG000|Overall Study|Withdrawal by Subject|3|||
27661935|NCT00116584|80599884|FG000|Overall Study|Withdrawal by Subject|1|||
27661936|NCT00116584|80599885|FG001|Overall Study|Withdrawal by Subject|0|||
27661937|NCT00116584|80599884|FG000|Overall Study|Protocol Violation|1|||
27661938|NCT00116584|80599885|FG001|Overall Study|Protocol Violation|1|||
27661939|NCT00240097|80599886|FG000|Part I|Adverse Event|1|||
27661940|NCT00240097|80599886|FG000|Part I|Death|1|||
27661941|NCT00240097|80599886|FG000|Part I|histology|1|||
27661942|NCT00240097|80599886|FG000|Part I|unevaluable|1|||
27661943|NCT00240097|80599886|FG000|Part II|did not continue from Part I|23|||
27661944|NCT01116440|80599889|FG000|Treatment|Withdrawal by Subject|2|||
27661945|NCT01116440|80599890|FG001|Treatment|Withdrawal by Subject|2|||
27661946|NCT01116440|80599889|FG000|Treatment|Lost to Follow-up|1|||
27661947|NCT01116440|80599890|FG001|Treatment|Lost to Follow-up|1|||
27661948|NCT01116440|80599889|FG000|Treatment|Protocol Violation|0|||
27661949|NCT01116440|80599890|FG001|Treatment|Protocol Violation|2|||
27661950|NCT01116440|80599889|FG000|Treatment|Lack of Efficacy|0|||
27661951|NCT01116440|80599890|FG001|Treatment|Lack of Efficacy|1|||
27661952|NCT01116440|80599889|FG000|Treatment|Adverse Event|0|||
27661953|NCT01116440|80599890|FG001|Treatment|Adverse Event|1|||
27661954|NCT01116440|80599889|FG000|Withdrawal|Withdrawal by Subject|0|||
27661955|NCT01116440|80599890|FG001|Withdrawal|Withdrawal by Subject|1|||
27661956|NCT01116440|80599889|FG000|Withdrawal|Lost to Follow-up|0|||
27661957|NCT01116440|80599890|FG001|Withdrawal|Lost to Follow-up|1|||
27661958|NCT01116440|80599889|FG000|Follow-up|Lost to Follow-up|0|||
27661959|NCT01116440|80599890|FG001|Follow-up|Lost to Follow-up|1|||
27661960|NCT01116440|80599889|FG000|Follow-up|Withdrawal by Subject|0|||
27762737|NCT01179347|80957581|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
27861263|NCT01822275|81322927|FG000|Overall Study|Adverse Event|3|||
27861264|NCT01822275|81322927|FG000|Overall Study|Progression|14|||
27861265|NCT01822275|81322927|FG000|Overall Study|Physician Decision|2|||
27861266|NCT00729248|81322930|FG000|Overall Study|Physician Decision|2|||
27861267|NCT00000378|81322931|FG000|Overall Study|Lack of Efficacy|16|||
27861268|NCT00000378|81322932|FG001|Overall Study|Lack of Efficacy|14|||
27861269|NCT01844856|81322933|FG000|Overall Study|Lost to Follow-up|15|||
27861270|NCT01844856|81322934|FG001|Overall Study|Lost to Follow-up|3|||
27861271|NCT01844856|81322933|FG000|Overall Study|Adverse Event|3|||
27861272|NCT01844856|81322934|FG001|Overall Study|Adverse Event|6|||
27762738|NCT01179347|80957580|FG000|Double-blind Period (12 Weeks)|Other|2|||
27762739|NCT01179347|80957581|FG001|Double-blind Period (12 Weeks)|Other|4|||
27762740|NCT01179347|80957580|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
27762741|NCT01179347|80957581|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
27762742|NCT01179347|80957580|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
27762743|NCT01179347|80957581|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
27762744|NCT01179347|80957580|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
27762745|NCT01179347|80957581|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
27762746|NCT01179347|80957580|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
27762747|NCT01179347|80957581|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
27762748|NCT01179347|80957580|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
27762749|NCT01179347|80957581|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
27762750|NCT01179347|80957580|FG000|Open-label Period (12 Weeks)|Other|7|||
27762751|NCT01179347|80957581|FG001|Open-label Period (12 Weeks)|Other|4|||
27762752|NCT03371732|80957582|FG000|Overall Study|Withdrawal by Subject|9|||
27762753|NCT03371732|80957583|FG001|Overall Study|Withdrawal by Subject|3|||
27762754|NCT03371732|80957582|FG000|Overall Study|Refusal to continue|3|||
27762755|NCT03371732|80957583|FG001|Overall Study|Refusal to continue|4|||
27762756|NCT02148211|80957587|FG000|Overall Study|Lost to Follow-up|352|||
27762757|NCT01170702|80957588|FG000|Overall Study|Exclusion criteria met after consent|1|||
27861273|NCT01844856|81322933|FG000|Overall Study|Withdrawal by Subject|3|||
27861274|NCT01844856|81322934|FG001|Overall Study|Withdrawal by Subject|2|||
27861275|NCT01844856|81322933|FG000|Overall Study|Noncompliance|2|||
27861276|NCT01844856|81322934|FG001|Overall Study|Noncompliance|3|||
27861277|NCT01844856|81322933|FG000|Overall Study|Enterococcus Resistant|0|||
27861278|NCT01844856|81322934|FG001|Overall Study|Enterococcus Resistant|1|||
27762758|NCT01170702|80957589|FG001|Overall Study|Exclusion criteria met after consent|2|||
27762759|NCT01170702|80957590|FG002|Overall Study|Exclusion criteria met after consent|0|||
27661961|NCT01116440|80599890|FG001|Follow-up|Withdrawal by Subject|1|||
27861279|NCT01844856|81322933|FG000|Overall Study|Inadvertently Not Scheduled|1|||
27861280|NCT01844856|81322934|FG001|Overall Study|Inadvertently Not Scheduled|0|||
27661962|NCT01882088|80599891|FG000|Overall Study|Intolerance of esophageal manometry|1|||
27661963|NCT01882088|80599891|FG000|Overall Study|no possibility to place the catheter|1|||
27762760|NCT01170702|80957591|FG003|Overall Study|Exclusion criteria met after consent|2|||
27762761|NCT00965146|80957592|FG000|Overall Study|Death|7|||
27861281|NCT01844856|81322933|FG000|Overall Study|Randomized but was a Screen Failure|0|||
27861282|NCT01844856|81322934|FG001|Overall Study|Randomized but was a Screen Failure|1|||
27861283|NCT04106661|81322935|FG000|Overall Study|Protocol Violation|3|||
27861284|NCT04106661|81322936|FG001|Overall Study|Protocol Violation|0|||
27861285|NCT04106661|81322935|FG000|Overall Study|Scheduling difficulties|1|||
27861286|NCT04106661|81322936|FG001|Overall Study|Scheduling difficulties|1|||
27861287|NCT01783548|81322938|FG000|Overall Study|Adverse Event|8|||
27861288|NCT01783548|81322939|FG001|Overall Study|Adverse Event|4|||
27861289|NCT01783548|81322938|FG000|Overall Study|Withdrawal by Subject|11|||
27861290|NCT01783548|81322939|FG001|Overall Study|Withdrawal by Subject|8|||
27861291|NCT01783548|81322938|FG000|Overall Study|Non-compliance|4|||
27861292|NCT01783548|81322939|FG001|Overall Study|Non-compliance|0|||
27861293|NCT01783548|81322938|FG000|Overall Study|Protocol Violation|2|||
27861294|NCT01783548|81322939|FG001|Overall Study|Protocol Violation|2|||
27861295|NCT01783548|81322938|FG000|Overall Study|Lost to Follow-up|8|||
27861296|NCT01783548|81322939|FG001|Overall Study|Lost to Follow-up|3|||
27861297|NCT01783548|81322938|FG000|Overall Study|Lack of Efficacy|1|||
27861298|NCT01783548|81322939|FG001|Overall Study|Lack of Efficacy|1|||
27861299|NCT03839823|81322940|FG000|Overall Study|Adverse Event|8|||
27762762|NCT00965146|80957592|FG000|Overall Study|Lost to Follow-up|22|||
27762763|NCT00965146|80957592|FG000|Overall Study|Withdrawal by Subject|17|||
27762764|NCT00965146|80957592|FG000|Overall Study|Unable to return|1|||
27762765|NCT00965146|80957592|FG000|Overall Study|Unwilling to return|11|||
27762766|NCT00965146|80957592|FG000|Overall Study|Intercurrent illness|1|||
27762767|NCT00965146|80957592|FG000|Overall Study|Revision / Removal of Study Implant|6|||
27762768|NCT00965146|80957592|FG000|Overall Study|Overall Study Termination|145|||
27762769|NCT00676208|80957595|FG000|Overall Study|Lost to Follow-up|0|||
27861300|NCT03839823|81322941|FG001|Overall Study|Adverse Event|4|||
27861301|NCT03839823|81322940|FG000|Overall Study|Death|1|||
27861302|NCT03839823|81322941|FG001|Overall Study|Death|0|||
27861303|NCT03839823|81322940|FG000|Overall Study|Physician Decision|1|||
27861304|NCT03839823|81322941|FG001|Overall Study|Physician Decision|5|||
27861305|NCT03839823|81322940|FG000|Overall Study|Progressive Disease (PD)|65|||
27861306|NCT03839823|81322941|FG001|Overall Study|Progressive Disease (PD)|65|||
27861307|NCT03839823|81322940|FG000|Overall Study|Subject Decision|2|||
27861308|NCT03839823|81322941|FG001|Overall Study|Subject Decision|9|||
27861309|NCT03839823|81322940|FG000|Overall Study|Not Treated|0|||
27861310|NCT03839823|81322941|FG001|Overall Study|Not Treated|10|||
27861311|NCT05307510|81322942|FG000|Overall Study|Lost to Follow-up|3|||
27861312|NCT05307510|81322943|FG001|Overall Study|Lost to Follow-up|6|||
27861313|NCT05307510|81322942|FG000|Overall Study|Withdrawal by Subject|0|||
27861314|NCT05307510|81322943|FG001|Overall Study|Withdrawal by Subject|1|||
27861315|NCT04480710|81322946|FG000|Overall Study|Adverse Event|0|||
27861316|NCT04480710|81322947|FG001|Overall Study|Adverse Event|2|||
27861317|NCT04480710|81322948|FG002|Overall Study|Adverse Event|0|||
27861318|NCT04480710|81322949|FG003|Overall Study|Adverse Event|0|||
27861319|NCT04480710|81322946|FG000|Overall Study|Withdrawal by Subject|0|||
27861320|NCT04480710|81322947|FG001|Overall Study|Withdrawal by Subject|1|||
27861321|NCT04480710|81322948|FG002|Overall Study|Withdrawal by Subject|0|||
27861322|NCT04480710|81322949|FG003|Overall Study|Withdrawal by Subject|0|||
27861323|NCT04480710|81322946|FG000|Overall Study|Physician Decision|0|||
27861324|NCT04480710|81322947|FG001|Overall Study|Physician Decision|0|||
27861325|NCT04480710|81322948|FG002|Overall Study|Physician Decision|1|||
27762770|NCT00676208|80957596|FG001|Overall Study|Lost to Follow-up|2|||
27762771|NCT00676208|80957595|FG000|Overall Study|Incomplete data|2|||
27762772|NCT00676208|80957596|FG001|Overall Study|Incomplete data|4|||
27762773|NCT03219567|80957597|FG000|Overall Study|Withdrawal by Subject|0|||
27762774|NCT03219567|80957598|FG001|Overall Study|Withdrawal by Subject|1|||
27762775|NCT02034552|80957599|FG000|Overall Study|Never treated|3|||
27762776|NCT02034552|80957600|FG001|Overall Study|Never treated|2|||
27762777|NCT02034552|80957601|FG002|Overall Study|Never treated|0|||
27762778|NCT02034552|80957599|FG000|Overall Study|Radiological progression|3|||
27762779|NCT02034552|80957600|FG001|Overall Study|Radiological progression|5|||
27861326|NCT04480710|81322949|FG003|Overall Study|Physician Decision|0|||
27861327|NCT04868968|81322950|FG000|Overall Study|Lost to Follow-up|1|||
27762780|NCT02034552|80957601|FG002|Overall Study|Radiological progression|4|||
27762781|NCT02034552|80957599|FG000|Overall Study|AE not assoc. with disease progression|1|||
27861328|NCT04502212|81322951|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
27861329|NCT04502212|81322951|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
27861330|NCT01421511|81322952|FG000|Overall Study|Lost to Follow-up|11|||
27861331|NCT01421511|81322953|FG001|Overall Study|Lost to Follow-up|14|||
27661964|NCT01882088|80599891|FG000|Overall Study|Protocol Violation|1|||
27762782|NCT02034552|80957600|FG001|Overall Study|AE not assoc. with disease progression|4|||
27861332|NCT01421511|81322952|FG000|Overall Study|Randomized but didn't receive study drug|1|||
27861333|NCT01421511|81322953|FG001|Overall Study|Randomized but didn't receive study drug|7|||
27861334|NCT01421511|81322952|FG000|Overall Study|Physician Decision|0|||
27861335|NCT01421511|81322953|FG001|Overall Study|Physician Decision|1|||
27861336|NCT01421511|81322952|FG000|Overall Study|Withdrawal by Subject|6|||
27861337|NCT01421511|81322953|FG001|Overall Study|Withdrawal by Subject|5|||
27861338|NCT01421511|81322952|FG000|Overall Study|Death|1|||
27861339|NCT01421511|81322953|FG001|Overall Study|Death|1|||
27861340|NCT04711902|81322955|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
27861341|NCT04711902|81322956|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
27861342|NCT04711902|81322957|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
27861343|NCT04711902|81322958|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
27861344|NCT04711902|81322959|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
27861345|NCT04711902|81322960|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
27861346|NCT01307111|81322961|FG000|IUD Insertion|Lost to Follow-up|2|||
27861347|NCT01307111|81322962|FG001|IUD Insertion|Lost to Follow-up|0|||
27861348|NCT01307111|81322961|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
27861349|NCT01307111|81322962|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
27861350|NCT02342639|81322963|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
27861351|NCT02342639|81322964|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
27861352|NCT02342639|81322963|FG000|Overall Study|Protocol Violation|0|||
27861353|NCT02342639|81322964|FG001|Overall Study|Protocol Violation|2|||
27861354|NCT00908310|81322973|FG000|Overall Study|Death|37|||
27861355|NCT00908310|81322973|FG000|Overall Study|Withdrawal by Subject|7|||
27861356|NCT00908310|81322973|FG000|Overall Study|Lost to Follow-up|7|||
27861357|NCT00908310|81322973|FG000|Overall Study|Screening failure|5|||
27861358|NCT00908310|81322973|FG000|Overall Study|Other reasons|4|||
27861359|NCT04576923|81322974|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
27861360|NCT00741286|81322977|FG000|Overall Study|Lost to Follow-up|15|||
27861361|NCT00741286|81322978|FG001|Overall Study|Lost to Follow-up|10|||
27861362|NCT00741286|81322977|FG000|Overall Study|Adverse Event|1|||
27861363|NCT00741286|81322978|FG001|Overall Study|Adverse Event|6|||
27861364|NCT00741286|81322977|FG000|Overall Study|Protocol Violation|3|||
27861365|NCT00741286|81322978|FG001|Overall Study|Protocol Violation|2|||
27861366|NCT00741286|81322977|FG000|Overall Study|Primary Outcome|1|||
27861367|NCT00741286|81322978|FG001|Overall Study|Primary Outcome|1|||
27861368|NCT01136967|81322980|FG000|Overall Study|Adverse Event|9|||
27861369|NCT01136967|81322981|FG001|Overall Study|Adverse Event|12|||
27861370|NCT01136967|81322980|FG000|Overall Study|Participant Choice|8|||
27861371|NCT01136967|81322981|FG001|Overall Study|Participant Choice|3|||
27861372|NCT01136967|81322980|FG000|Overall Study|Lost to Follow-up|0|||
27861373|NCT01136967|81322981|FG001|Overall Study|Lost to Follow-up|1|||
27861374|NCT01136967|81322980|FG000|Overall Study|Withdrawal by Subject|1|||
27861375|NCT01136967|81322981|FG001|Overall Study|Withdrawal by Subject|2|||
27861376|NCT01136967|81322980|FG000|Overall Study|Clinical Progression|3|||
27861377|NCT01136967|81322981|FG001|Overall Study|Clinical Progression|5|||
27861378|NCT01136967|81322980|FG000|Overall Study|Radiation|1|||
27861379|NCT01136967|81322981|FG001|Overall Study|Radiation|0|||
27861380|NCT01136967|81322980|FG000|Overall Study|Non-compliance|1|||
27861381|NCT01136967|81322981|FG001|Overall Study|Non-compliance|0|||
27861382|NCT01136967|81322980|FG000|Overall Study|Investigator's Choice|1|||
27762783|NCT02034552|80957601|FG002|Overall Study|AE not assoc. with disease progression|2|||
27762784|NCT02034552|80957599|FG000|Overall Study|AE associated with disease progression|0|||
27762785|NCT02034552|80957600|FG001|Overall Study|AE associated with disease progression|1|||
27762786|NCT02034552|80957601|FG002|Overall Study|AE associated with disease progression|0|||
27762787|NCT02034552|80957599|FG000|Overall Study|Withdrawal by Subject|2|||
27762788|NCT02034552|80957600|FG001|Overall Study|Withdrawal by Subject|1|||
27762789|NCT02034552|80957601|FG002|Overall Study|Withdrawal by Subject|1|||
27762790|NCT02034552|80957599|FG000|Overall Study|Non-compliance with study drug|0|||
27861383|NCT01136967|81322981|FG001|Overall Study|Investigator's Choice|1|||
27762791|NCT02034552|80957600|FG001|Overall Study|Non-compliance with study drug|0|||
27762792|NCT02034552|80957601|FG002|Overall Study|Non-compliance with study drug|1|||
27762793|NCT02034552|80957599|FG000|Overall Study|Clinical progression|5|||
27762794|NCT02034552|80957600|FG001|Overall Study|Clinical progression|7|||
27762795|NCT02034552|80957601|FG002|Overall Study|Clinical progression|9|||
27762796|NCT02273037|80957602|FG000|Overall Study|Lost to Follow-up|1|||
27762797|NCT02273037|80957603|FG001|Overall Study|Lost to Follow-up|0|||
27762798|NCT02273037|80957602|FG000|Overall Study|Delivered before monitoring initiated|1|||
27762799|NCT02273037|80957603|FG001|Overall Study|Delivered before monitoring initiated|3|||
27762800|NCT02273037|80957602|FG000|Overall Study|Breech delivery|2|||
27762801|NCT02273037|80957603|FG001|Overall Study|Breech delivery|3|||
27861384|NCT01136967|81322980|FG000|Overall Study|Increase in Lesion Size|0|||
27861385|NCT01136967|81322981|FG001|Overall Study|Increase in Lesion Size|2|||
27861386|NCT01136967|81322980|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
27861387|NCT01136967|81322981|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
27861388|NCT03968978|81322984|FG000|Overall Study|Adverse Event|1|||
27861389|NCT03968978|81322985|FG001|Overall Study|Adverse Event|0|||
27861390|NCT00605540|81322986|FG000|Overall Study|Death|15|||
27861391|NCT00605540|81322986|FG000|Overall Study|Lost to Follow-up|23|||
27861392|NCT00492024|81322987|FG000|Treatment|Adverse Event|3|||
27861393|NCT00492024|81322988|FG001|Treatment|Adverse Event|1|||
27861394|NCT00492024|81322987|FG000|Treatment|Lack of Efficacy|21|||
27762802|NCT02273037|80957602|FG000|Overall Study|Multiple delivery|2|||
27762803|NCT02273037|80957603|FG001|Overall Study|Multiple delivery|2|||
27762804|NCT02273037|80957602|FG000|Overall Study|Other complication|2|||
27762805|NCT02273037|80957603|FG001|Overall Study|Other complication|0|||
27861395|NCT00492024|81322988|FG001|Treatment|Lack of Efficacy|20|||
27861396|NCT00492024|81322987|FG000|Treatment|Lost to Follow-up|3|||
27861397|NCT00492024|81322988|FG001|Treatment|Lost to Follow-up|1|||
27861398|NCT00492024|81322987|FG000|Treatment|Withdrawal by Subject|2|||
27568774|NCT03013543|80271451|FG004|Overall Study|Death|0|||
27568775|NCT03013543|80271452|FG005|Overall Study|Death|0|||
27568776|NCT03013543|80271453|FG006|Overall Study|Death|0|||
27568777|NCT03013543|80271454|FG007|Overall Study|Death|0|||
27568778|NCT03013543|80271455|FG008|Overall Study|Death|0|||
27568779|NCT03013543|80271456|FG009|Overall Study|Death|0|||
27661965|NCT01882088|80599891|FG000|Overall Study|inadequate pH-impedance tracings|2|||
27661966|NCT01924806|80599897|FG000|Overall Study|Physician Decision|2|||
27661967|NCT01924806|80599898|FG001|Overall Study|Physician Decision|1|||
27661968|NCT01329419|80599899|FG000|Overall Study|Protocol Violation|235|||
27661969|NCT02368691|80599900|FG000|Overall Study|Death|13|||
27661970|NCT02368691|80599900|FG000|Overall Study|Lack of Efficacy|15|||
27661971|NCT02368691|80599900|FG000|Overall Study|Physician Decision|4|||
27661972|NCT00372255|80599901|FG000|Overall Study|Withdrawn for other reasons|2|||
27661973|NCT00372255|80599902|FG001|Overall Study|Withdrawn for other reasons|1|||
27661974|NCT06247488|80599903|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
27661975|NCT06247488|80599904|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
27661976|NCT06247488|80599905|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
27661977|NCT06247488|80599906|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
27661978|NCT06247488|80599907|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
27661979|NCT06247488|80599908|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
27661980|NCT06247488|80599903|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
27661981|NCT06247488|80599904|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
27661982|NCT06247488|80599905|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
27661983|NCT06247488|80599906|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
27661984|NCT06247488|80599907|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
27762806|NCT01369849|80957605|FG000|Overall Study|Ineligible prior to treatment|0|||
27762807|NCT01369849|80957606|FG001|Overall Study|Ineligible prior to treatment|0|||
27762808|NCT01369849|80957607|FG002|Overall Study|Ineligible prior to treatment|1|||
27762809|NCT01369849|80957605|FG000|Overall Study|Ineligible after receiving treatment|0|||
27762810|NCT01369849|80957606|FG001|Overall Study|Ineligible after receiving treatment|1|||
27762811|NCT01369849|80957607|FG002|Overall Study|Ineligible after receiving treatment|0|||
27762812|NCT02849626|80957612|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
27762813|NCT02849626|80957613|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
27762814|NCT02849626|80957614|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
27762815|NCT02849626|80957615|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
27762816|NCT02849626|80957612|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
27762817|NCT02849626|80957613|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
27762818|NCT02849626|80957614|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
27762819|NCT02849626|80957615|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
27762820|NCT02849626|80957612|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
27762821|NCT02849626|80957613|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
27762822|NCT02849626|80957614|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
27762823|NCT02849626|80957615|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
27762824|NCT02849626|80957612|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
27762825|NCT02849626|80957613|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
27762826|NCT02849626|80957614|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
27762827|NCT02849626|80957615|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
27762828|NCT02849626|80957612|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
27762829|NCT02849626|80957613|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
27762830|NCT02849626|80957614|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
27762831|NCT02849626|80957615|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
27762832|NCT02849626|80957612|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
27762833|NCT02849626|80957613|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
27762834|NCT02849626|80957614|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
27762835|NCT02849626|80957615|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
27762836|NCT02849626|80957612|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
27762837|NCT02849626|80957613|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
27762838|NCT02849626|80957614|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
27762839|NCT02849626|80957615|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
27762840|NCT02849626|80957612|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
27762841|NCT02849626|80957613|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
27861399|NCT00492024|81322988|FG001|Treatment|Withdrawal by Subject|0|||
27568780|NCT03013543|80271447|FG000|Overall Study|Lack of Efficacy|0|||
27661985|NCT06247488|80599908|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
27661986|NCT06247488|80599903|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
27661987|NCT06247488|80599904|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
27661988|NCT06247488|80599905|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
27661989|NCT06247488|80599906|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
27661990|NCT06247488|80599907|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
27661991|NCT06247488|80599908|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
27661992|NCT06247488|80599903|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
27661993|NCT06247488|80599904|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
27661994|NCT06247488|80599905|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
27661995|NCT06247488|80599906|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
27661996|NCT06247488|80599907|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
27661997|NCT06247488|80599908|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
27661998|NCT06247488|80599903|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
27661999|NCT06247488|80599904|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
27662000|NCT06247488|80599905|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
27662001|NCT06247488|80599906|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
27662002|NCT06247488|80599907|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
27662003|NCT06247488|80599908|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
27662004|NCT06247488|80599903|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
27662005|NCT06247488|80599904|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
27662006|NCT06247488|80599905|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
27662007|NCT06247488|80599906|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
27662008|NCT06247488|80599907|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
27662009|NCT06247488|80599908|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
27662010|NCT06247488|80599903|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
27662011|NCT06247488|80599904|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
27662012|NCT06247488|80599905|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
27662013|NCT06247488|80599906|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
27662014|NCT06247488|80599907|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
27662015|NCT06247488|80599908|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
27662016|NCT04688086|80599911|FG000|Overall Study|Lost to Follow-up|164|||
27662017|NCT04688086|80599911|FG000|Overall Study|Imaging error;|64|||
27662018|NCT01838447|80599912|FG000|Overall Study|Change in surgical plan|1|||
27762842|NCT02849626|80957614|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
27861400|NCT00492024|81322987|FG000|Follow up|Lack of Efficacy|0|||
27861401|NCT00492024|81322988|FG001|Follow up|Lack of Efficacy|1|||
27861402|NCT00492024|81322987|FG000|Follow up|Lost to Follow-up|1|||
27568781|NCT03013543|80271448|FG001|Overall Study|Lack of Efficacy|0|||
27762843|NCT02849626|80957615|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
27762844|NCT02849626|80957612|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
27762845|NCT02849626|80957613|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
27762846|NCT02849626|80957614|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
27762847|NCT02849626|80957615|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
27762848|NCT02849626|80957612|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
27762849|NCT02849626|80957613|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
27762850|NCT02849626|80957614|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
27762851|NCT02849626|80957615|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
27762852|NCT02849626|80957612|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
27762853|NCT02849626|80957613|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
27762854|NCT02849626|80957614|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
27762855|NCT02849626|80957615|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
27762856|NCT00992186|80957618|FG000|Overall Study|Withdrawal by Subject|2|||
27762857|NCT00992186|80957618|FG000|Overall Study|Protocol Violation|1|||
27762858|NCT00992186|80957618|FG000|Overall Study|Physician Decision|1|||
27762859|NCT00992186|80957618|FG000|Overall Study|Adverse Event|9|||
27762860|NCT00992186|80957618|FG000|Overall Study|Progressive Disease|30|||
27762861|NCT00992186|80957618|FG000|Overall Study|Refusal To Receive Study Agent|3|||
27762862|NCT00881361|80957629|FG000|Overall Study|Terminated prior to surgery|27|||
27762863|NCT00881361|80957630|FG001|Overall Study|Terminated prior to surgery|7|||
27762864|NCT00881361|80957631|FG002|Overall Study|Terminated prior to surgery|0|||
27762865|NCT00881361|80957629|FG000|Overall Study|Ineligible|17|||
27861403|NCT00492024|81322988|FG001|Follow up|Lost to Follow-up|1|||
27568782|NCT03013543|80271449|FG002|Overall Study|Lack of Efficacy|0|||
27568783|NCT03013543|80271450|FG003|Overall Study|Lack of Efficacy|1|||
27568784|NCT03013543|80271451|FG004|Overall Study|Lack of Efficacy|0|||
27568785|NCT03013543|80271452|FG005|Overall Study|Lack of Efficacy|0|||
27568786|NCT03013543|80271453|FG006|Overall Study|Lack of Efficacy|0|||
27568787|NCT03013543|80271454|FG007|Overall Study|Lack of Efficacy|0|||
27568788|NCT03013543|80271455|FG008|Overall Study|Lack of Efficacy|0|||
27568789|NCT03013543|80271456|FG009|Overall Study|Lack of Efficacy|0|||
27662019|NCT01838447|80599913|FG001|Overall Study|Change in surgical plan|2|||
27662020|NCT01838447|80599912|FG000|Overall Study|Withdrawal by Subject|1|||
27662021|NCT01838447|80599913|FG001|Overall Study|Withdrawal by Subject|1|||
27662022|NCT01040403|80599914|FG000|Overall Study|Adverse Event|10|||
27662023|NCT01040403|80599914|FG000|Overall Study|Protocol Violation|2|||
27662024|NCT01040403|80599914|FG000|Overall Study|Lost to Follow-up|1|||
27662025|NCT01040403|80599914|FG000|Overall Study|Not treated|1|||
27662026|NCT01040403|80599914|FG000|Overall Study|Other reason not defined above|6|||
27662027|NCT02025985|80599917|FG000|Overall Study|Consent withdrawn|0|||
27662028|NCT02025985|80599918|FG001|Overall Study|Consent withdrawn|0|||
27762866|NCT00881361|80957630|FG001|Overall Study|Ineligible|2|||
27762867|NCT00881361|80957631|FG002|Overall Study|Ineligible|2|||
27861404|NCT02903030|81326017|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27662029|NCT02025985|80599919|FG002|Overall Study|Consent withdrawn|1|||
27662030|NCT02025985|80599920|FG003|Overall Study|Consent withdrawn|0|||
27662031|NCT02025985|80599921|FG004|Overall Study|Consent withdrawn|0|||
27662032|NCT02025985|80599917|FG000|Overall Study|Termination of study by Sponsor|4|||
27662033|NCT02025985|80599918|FG001|Overall Study|Termination of study by Sponsor|3|||
27662034|NCT02025985|80599919|FG002|Overall Study|Termination of study by Sponsor|1|||
27662035|NCT02025985|80599920|FG003|Overall Study|Termination of study by Sponsor|1|||
27861405|NCT02903030|81326018|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
27861406|NCT01341782|81326019|FG000|Overall Study|Adverse Event|1|||
27861407|NCT01341782|81326020|FG001|Overall Study|Adverse Event|1|||
27861408|NCT01341782|81326019|FG000|Overall Study|Withdrawal by Subject|6|||
27861409|NCT01341782|81326020|FG001|Overall Study|Withdrawal by Subject|5|||
27861410|NCT01341782|81326019|FG000|Overall Study|Missed 3 consecutive doses|0|||
27861411|NCT01341782|81326020|FG001|Overall Study|Missed 3 consecutive doses|4|||
27861412|NCT01341782|81326019|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
27861413|NCT01341782|81326020|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
27861414|NCT01341782|81326019|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
27861415|NCT01341782|81326020|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
27861416|NCT01341782|81326019|FG000|Overall Study|Other|5|||
27861417|NCT01341782|81326020|FG001|Overall Study|Other|0|||
27861418|NCT04630158|81326024|FG000|Overall Study|Adverse Event|1|||
27861419|NCT04630158|81326025|FG001|Overall Study|Adverse Event|1|||
27861420|NCT04630158|81326026|FG002|Overall Study|Adverse Event|1|||
27861421|NCT04630158|81326024|FG000|Overall Study|Physician Decision|0|||
27861422|NCT04630158|81326025|FG001|Overall Study|Physician Decision|2|||
27861423|NCT04630158|81326026|FG002|Overall Study|Physician Decision|0|||
27662036|NCT02025985|80599921|FG004|Overall Study|Termination of study by Sponsor|3|||
27662037|NCT02025985|80599917|FG000|Overall Study|Death|21|||
27662038|NCT02025985|80599918|FG001|Overall Study|Death|20|||
27662039|NCT02025985|80599919|FG002|Overall Study|Death|23|||
27662040|NCT02025985|80599920|FG003|Overall Study|Death|20|||
27662041|NCT02025985|80599921|FG004|Overall Study|Death|17|||
27662042|NCT00727259|80599922|FG000|Overall Study|Not all questionnaires completed|1055|||
27662043|NCT03036124|80599923|FG000|Overall Study|Lost to Follow-up|0|||
27662044|NCT03036124|80599924|FG001|Overall Study|Lost to Follow-up|2|||
27662045|NCT03036124|80599923|FG000|Overall Study|Withdrawal by Subject|5|||
27662046|NCT03036124|80599924|FG001|Overall Study|Withdrawal by Subject|4|||
27662047|NCT01103141|80599925|FG000|Overall Study|Death|0|||
27662048|NCT01103141|80599926|FG001|Overall Study|Death|1|||
27662049|NCT01103141|80599925|FG000|Overall Study|Lost to Follow-up|2|||
27662050|NCT01103141|80599926|FG001|Overall Study|Lost to Follow-up|1|||
27662051|NCT03078751|80599927|FG000|Overall Study|Adverse Event|4|||
27662052|NCT03078751|80599928|FG001|Overall Study|Adverse Event|0|||
27762868|NCT01975246|80957632|FG000|Overall Study|Adverse Event|2|||
27762869|NCT01975246|80957633|FG001|Overall Study|Adverse Event|1|||
27762870|NCT01975246|80957632|FG000|Overall Study|Lack of Efficacy|1|||
27762871|NCT01975246|80957633|FG001|Overall Study|Lack of Efficacy|0|||
27762872|NCT01975246|80957632|FG000|Overall Study|Protocol Violation|1|||
27762873|NCT01975246|80957633|FG001|Overall Study|Protocol Violation|0|||
27662053|NCT03078751|80599927|FG000|Overall Study|Physician Decision|1|||
27662054|NCT03078751|80599928|FG001|Overall Study|Physician Decision|0|||
27662055|NCT03078751|80599927|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
27662056|NCT03078751|80599928|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
27662057|NCT03078751|80599927|FG000|Overall Study|Subject/guardian decision|8|||
27662058|NCT03078751|80599928|FG001|Overall Study|Subject/guardian decision|1|||
27662059|NCT03078751|80599927|FG000|Overall Study|Untreated|0|||
27662060|NCT03078751|80599928|FG001|Overall Study|Untreated|4|||
27662061|NCT03226106|80599929|FG000|Overall Study|Withdrawal by Subject|2|||
27662062|NCT03226106|80599930|FG001|Overall Study|Withdrawal by Subject|0|||
27762874|NCT01975246|80957632|FG000|Overall Study|Other than stated|0|||
27762875|NCT01975246|80957633|FG001|Overall Study|Other than stated|1|||
27861424|NCT04630158|81326024|FG000|Overall Study|Protocol Violation|1|||
27861425|NCT04630158|81326025|FG001|Overall Study|Protocol Violation|0|||
27861426|NCT04630158|81326026|FG002|Overall Study|Protocol Violation|1|||
27861427|NCT04630158|81326024|FG000|Overall Study|Withdrawal by Subject|2|||
27662063|NCT03226106|80599929|FG000|Overall Study|Adverse Event|1|||
27662064|NCT03226106|80599930|FG001|Overall Study|Adverse Event|0|||
27662065|NCT03226106|80599929|FG000|Overall Study|Lost to Follow-up|2|||
27662066|NCT03226106|80599930|FG001|Overall Study|Lost to Follow-up|0|||
27662067|NCT02679079|80599931|FG000|Overall Study|Adverse Event|2|||
27662068|NCT02679079|80599932|FG001|Overall Study|Adverse Event|0|||
27662069|NCT02679079|80599933|FG002|Overall Study|Adverse Event|2|||
27662070|NCT02679079|80599931|FG000|Overall Study|Protocol Violation|0|||
27662071|NCT02679079|80599932|FG001|Overall Study|Protocol Violation|1|||
27662072|NCT02679079|80599933|FG002|Overall Study|Protocol Violation|0|||
27662073|NCT02679079|80599931|FG000|Overall Study|Withdrawal by Subject|2|||
27662074|NCT02679079|80599932|FG001|Overall Study|Withdrawal by Subject|1|||
27662075|NCT02679079|80599933|FG002|Overall Study|Withdrawal by Subject|0|||
27662076|NCT00348283|80599934|FG000|Induction|Adverse Event|0|||
27662077|NCT00348283|80599935|FG001|Induction|Adverse Event|2|||
27662078|NCT00348283|80599934|FG000|Induction|Protocol Violation|0|||
27662079|NCT00348283|80599935|FG001|Induction|Protocol Violation|4|||
27662080|NCT00348283|80599934|FG000|Double Blind|Adverse Event|2|||
27662081|NCT00348283|80599935|FG001|Double Blind|Adverse Event|5|||
27662082|NCT00348283|80599934|FG000|Double Blind|Withdrawal by Subject|1|||
27662083|NCT00348283|80599935|FG001|Double Blind|Withdrawal by Subject|1|||
27662084|NCT00348283|80599934|FG000|Double Blind|Protocol Violation|0|||
27662085|NCT00348283|80599935|FG001|Double Blind|Protocol Violation|1|||
27662086|NCT00348283|80599934|FG000|Double Blind|Lack of Efficacy|2|||
27662087|NCT00348283|80599935|FG001|Double Blind|Lack of Efficacy|2|||
27662088|NCT00348283|80599934|FG000|Double Blind|Pregnancy|0|||
27662089|NCT00348283|80599935|FG001|Double Blind|Pregnancy|1|||
27662090|NCT00348283|80599934|FG000|Open Label|Adverse Event|0|||
27662091|NCT00348283|80599935|FG001|Open Label|Adverse Event|8|||
27662092|NCT00348283|80599934|FG000|Open Label|Withdrawal by Subject|0|||
27662093|NCT00348283|80599935|FG001|Open Label|Withdrawal by Subject|4|||
27662094|NCT00348283|80599934|FG000|Open Label|Lost to Follow-up|0|||
27662095|NCT00348283|80599935|FG001|Open Label|Lost to Follow-up|1|||
27662096|NCT00348283|80599934|FG000|Open Label|Lack of Efficacy|0|||
27662097|NCT00348283|80599935|FG001|Open Label|Lack of Efficacy|13|||
27662098|NCT00348283|80599934|FG000|Open Label|Administrative reasons|0|||
27662099|NCT00348283|80599935|FG001|Open Label|Administrative reasons|5|||
27662100|NCT00348283|80599934|FG000|Open Label|Subject moved to the United States|0|||
27662101|NCT00348283|80599935|FG001|Open Label|Subject moved to the United States|1|||
27662102|NCT00348283|80599934|FG000|Open Label|Pregnancy|0|||
27662103|NCT00348283|80599935|FG001|Open Label|Pregnancy|1|||
27662104|NCT00348283|80599934|FG000|Open Label|Sponsor decision|0|||
27662105|NCT00348283|80599935|FG001|Open Label|Sponsor decision|1|||
27662106|NCT00640042|80599936|FG000|Enrollment|Did not receive study drug|83|||
27662107|NCT04814992|80599942|FG000|Overall Study|Withdrawal by Subject|6|||
27662108|NCT04814992|80599943|FG001|Overall Study|Withdrawal by Subject|3|||
27662109|NCT04814992|80599942|FG000|Overall Study|Lost to Follow-up|1|||
27662110|NCT04814992|80599943|FG001|Overall Study|Lost to Follow-up|4|||
27662111|NCT02706834|80599944|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27662112|NCT02706834|80599945|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27662113|NCT02706834|80599946|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27662114|NCT02706834|80599947|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
27662115|NCT02706834|80599948|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27662116|NCT02706834|80599949|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
27662117|NCT02706834|80599950|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
27662118|NCT02706834|80599951|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
27662119|NCT02706834|80599952|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
27662120|NCT02706834|80599953|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
27662121|NCT02706834|80599954|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
27662122|NCT02706834|80599944|FG000|Overall Study|Lost to Follow-up|0|||
27662123|NCT02706834|80599945|FG001|Overall Study|Lost to Follow-up|0|||
27662124|NCT02706834|80599946|FG002|Overall Study|Lost to Follow-up|1|||
27662125|NCT02706834|80599947|FG003|Overall Study|Lost to Follow-up|0|||
27662126|NCT02706834|80599948|FG004|Overall Study|Lost to Follow-up|0|||
27662127|NCT02706834|80599949|FG005|Overall Study|Lost to Follow-up|0|||
27662128|NCT02706834|80599950|FG006|Overall Study|Lost to Follow-up|0|||
27662129|NCT02706834|80599951|FG007|Overall Study|Lost to Follow-up|0|||
27662130|NCT02706834|80599952|FG008|Overall Study|Lost to Follow-up|0|||
27662131|NCT02706834|80599953|FG009|Overall Study|Lost to Follow-up|0|||
27662132|NCT02706834|80599954|FG010|Overall Study|Lost to Follow-up|0|||
27662133|NCT02706834|80599944|FG000|Overall Study|Voluntary Withdrawal|1|||
27662134|NCT02706834|80599945|FG001|Overall Study|Voluntary Withdrawal|0|||
27662135|NCT02706834|80599946|FG002|Overall Study|Voluntary Withdrawal|0|||
27662136|NCT02706834|80599947|FG003|Overall Study|Voluntary Withdrawal|0|||
27662137|NCT02706834|80599948|FG004|Overall Study|Voluntary Withdrawal|0|||
27662138|NCT02706834|80599949|FG005|Overall Study|Voluntary Withdrawal|0|||
27662139|NCT02706834|80599950|FG006|Overall Study|Voluntary Withdrawal|0|||
27662140|NCT02706834|80599951|FG007|Overall Study|Voluntary Withdrawal|0|||
27762876|NCT00792701|80957637|FG000|Overall Study|Adverse Event|0|||
27762877|NCT00792701|80957638|FG001|Overall Study|Adverse Event|22|||
27762878|NCT00792701|80957637|FG000|Overall Study|Ineligible|1|||
27762879|NCT00792701|80957638|FG001|Overall Study|Ineligible|3|||
27762880|NCT00792701|80957637|FG000|Overall Study|Withdrawal by Subject|1|||
27762881|NCT00792701|80957638|FG001|Overall Study|Withdrawal by Subject|19|||
27762882|NCT00792701|80957637|FG000|Overall Study|Not protocol specified|17|||
27762883|NCT00792701|80957638|FG001|Overall Study|Not protocol specified|0|||
27762884|NCT04721977|80957639|FG000|Overall Study|Death|15|||
27762885|NCT04721977|80957639|FG000|Overall Study|Ongoing|51|||
27762886|NCT01686958|80957642|FG000|Overall Study|Withdrawal by Subject|1|||
27762887|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
27861428|NCT04630158|81326025|FG001|Overall Study|Withdrawal by Subject|1|||
27662141|NCT02706834|80599952|FG008|Overall Study|Voluntary Withdrawal|0|||
27662142|NCT02706834|80599953|FG009|Overall Study|Voluntary Withdrawal|1|||
27662143|NCT02706834|80599954|FG010|Overall Study|Voluntary Withdrawal|0|||
27662144|NCT02706834|80599944|FG000|Overall Study|Other Reason Not Specified|1|||
27662145|NCT02706834|80599945|FG001|Overall Study|Other Reason Not Specified|0|||
27662146|NCT02706834|80599946|FG002|Overall Study|Other Reason Not Specified|0|||
27662147|NCT02706834|80599947|FG003|Overall Study|Other Reason Not Specified|0|||
27662148|NCT02706834|80599948|FG004|Overall Study|Other Reason Not Specified|1|||
27662149|NCT02706834|80599949|FG005|Overall Study|Other Reason Not Specified|0|||
27662150|NCT02706834|80599950|FG006|Overall Study|Other Reason Not Specified|0|||
27662151|NCT02706834|80599951|FG007|Overall Study|Other Reason Not Specified|0|||
27662152|NCT02706834|80599952|FG008|Overall Study|Other Reason Not Specified|0|||
27662153|NCT02706834|80599953|FG009|Overall Study|Other Reason Not Specified|0|||
27662154|NCT02706834|80599954|FG010|Overall Study|Other Reason Not Specified|0|||
27662155|NCT02131155|80599956|FG000|Overall Study|Adverse Event|1|||
27662156|NCT02131155|80599957|FG001|Overall Study|Adverse Event|0|||
27762888|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
27762889|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
27861429|NCT04630158|81326026|FG002|Overall Study|Withdrawal by Subject|2|||
27861430|NCT00253448|81326027|FG000|Overall Study|Withdrawal by Subject|1|||
27861431|NCT01094886|81326028|FG000|Overall Study|Adverse Event|2|||
27861432|NCT01094886|81326028|FG000|Overall Study|Withdrawal by Subject|5|||
27861433|NCT03196635|81326029|FG000|Overall Study|Withdrawal by Subject|1|||
27861434|NCT01823835|81326032|FG000|Overall Study|Adverse Event|0|||
27861435|NCT01823835|81326033|FG001|Overall Study|Adverse Event|0|||
27861436|NCT01823835|81326034|FG002|Overall Study|Adverse Event|0|||
27861437|NCT01823835|81326035|FG003|Overall Study|Adverse Event|0|||
27861438|NCT01823835|81326036|FG004|Overall Study|Adverse Event|1|||
27861439|NCT01823835|81326037|FG005|Overall Study|Adverse Event|0|||
27861440|NCT01823835|81326038|FG006|Overall Study|Adverse Event|1|||
27861441|NCT01823835|81326039|FG007|Overall Study|Adverse Event|0|||
27861442|NCT01823835|81326040|FG008|Overall Study|Adverse Event|0|||
27861443|NCT01823835|81326041|FG009|Overall Study|Adverse Event|0|||
27861444|NCT01823835|81326042|FG010|Overall Study|Adverse Event|1|||
27861445|NCT01823835|81326043|FG011|Overall Study|Adverse Event|2|||
27861446|NCT01823835|81326044|FG012|Overall Study|Adverse Event|0|||
27861447|NCT01823835|81326045|FG013|Overall Study|Adverse Event|0|||
27861448|NCT01823835|81326046|FG014|Overall Study|Adverse Event|0|||
27861449|NCT01823835|81326032|FG000|Overall Study|Physician Decision|0|||
27861450|NCT01823835|81326033|FG001|Overall Study|Physician Decision|0|||
27861451|NCT01823835|81326034|FG002|Overall Study|Physician Decision|0|||
27861452|NCT01823835|81326035|FG003|Overall Study|Physician Decision|0|||
27861453|NCT01823835|81326036|FG004|Overall Study|Physician Decision|0|||
27861454|NCT01823835|81326037|FG005|Overall Study|Physician Decision|0|||
27861455|NCT01823835|81326038|FG006|Overall Study|Physician Decision|0|||
27861456|NCT01823835|81326039|FG007|Overall Study|Physician Decision|0|||
27861457|NCT01823835|81326040|FG008|Overall Study|Physician Decision|0|||
27861458|NCT01823835|81326041|FG009|Overall Study|Physician Decision|0|||
27861459|NCT01823835|81326042|FG010|Overall Study|Physician Decision|0|||
27861460|NCT01823835|81326043|FG011|Overall Study|Physician Decision|2|||
27861461|NCT01823835|81326044|FG012|Overall Study|Physician Decision|0|||
27861462|NCT01823835|81326045|FG013|Overall Study|Physician Decision|0|||
27861463|NCT01823835|81326046|FG014|Overall Study|Physician Decision|0|||
27861464|NCT01823835|81326032|FG000|Overall Study|Progressive Disease|3|||
27861465|NCT01823835|81326033|FG001|Overall Study|Progressive Disease|4|||
27861466|NCT01823835|81326034|FG002|Overall Study|Progressive Disease|3|||
27861467|NCT01823835|81326035|FG003|Overall Study|Progressive Disease|6|||
27861468|NCT01823835|81326036|FG004|Overall Study|Progressive Disease|4|||
27662157|NCT02131155|80599956|FG000|Overall Study|Treatment completed|1|||
27662158|NCT02131155|80599957|FG001|Overall Study|Treatment completed|0|||
27662159|NCT02131155|80599956|FG000|Overall Study|Primary tumour recurrence|2|||
27861469|NCT01823835|81326037|FG005|Overall Study|Progressive Disease|6|||
27861470|NCT01823835|81326038|FG006|Overall Study|Progressive Disease|5|||
27861471|NCT01823835|81326039|FG007|Overall Study|Progressive Disease|3|||
27861472|NCT01823835|81326040|FG008|Overall Study|Progressive Disease|3|||
27861473|NCT01823835|81326041|FG009|Overall Study|Progressive Disease|18|||
27861474|NCT01823835|81326042|FG010|Overall Study|Progressive Disease|8|||
27861475|NCT01823835|81326043|FG011|Overall Study|Progressive Disease|46|||
27861476|NCT01823835|81326044|FG012|Overall Study|Progressive Disease|18|||
27861477|NCT01823835|81326045|FG013|Overall Study|Progressive Disease|4|||
27861478|NCT01823835|81326046|FG014|Overall Study|Progressive Disease|6|||
27861479|NCT01823835|81326032|FG000|Overall Study|Study Termination|0|||
27861480|NCT01823835|81326033|FG001|Overall Study|Study Termination|0|||
27861481|NCT01823835|81326034|FG002|Overall Study|Study Termination|0|||
27662160|NCT02131155|80599957|FG001|Overall Study|Primary tumour recurrence|1|||
27662161|NCT02131155|80599956|FG000|Overall Study|Refused to continue study medication|1|||
27662162|NCT02131155|80599957|FG001|Overall Study|Refused to continue study medication|0|||
27662163|NCT02131155|80599956|FG000|Overall Study|Study early termination|20|||
27662164|NCT02131155|80599957|FG001|Overall Study|Study early termination|10|||
27662165|NCT01363297|80599958|FG000|Overall Study|Other|0|||
27662166|NCT01363297|80599959|FG001|Overall Study|Other|0|||
27662167|NCT01363297|80599960|FG002|Overall Study|Other|0|||
27662168|NCT01363297|80599961|FG003|Overall Study|Other|0|||
27662169|NCT01363297|80599962|FG004|Overall Study|Other|1|||
27662170|NCT01363297|80599958|FG000|Overall Study|Death|3|||
27662171|NCT01363297|80599959|FG001|Overall Study|Death|6|||
27662172|NCT01363297|80599960|FG002|Overall Study|Death|6|||
27662173|NCT01363297|80599961|FG003|Overall Study|Death|10|||
27662174|NCT01363297|80599962|FG004|Overall Study|Death|30|||
27662175|NCT02864342|80599963|FG000|Overall Study|Eligibility Criteria Deviation|2|||
27662176|NCT02864342|80599964|FG001|Overall Study|Eligibility Criteria Deviation|3|||
27662177|NCT02864342|80599963|FG000|Overall Study|Withdrawal by Subject|4|||
27662178|NCT02864342|80599964|FG001|Overall Study|Withdrawal by Subject|2|||
27662179|NCT02864342|80599963|FG000|Overall Study|Device Technology Issue|6|||
27662180|NCT02864342|80599964|FG001|Overall Study|Device Technology Issue|7|||
27662181|NCT02864342|80599963|FG000|Overall Study|Death|0|||
27662182|NCT02864342|80599964|FG001|Overall Study|Death|1|||
27662183|NCT02864342|80599963|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
27662184|NCT02864342|80599964|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
27662185|NCT02864342|80599963|FG000|Overall Study|Lost to Follow-up|1|||
27662186|NCT02864342|80599964|FG001|Overall Study|Lost to Follow-up|5|||
27662187|NCT02864342|80599963|FG000|Overall Study|Lost Device|1|||
27662188|NCT02864342|80599964|FG001|Overall Study|Lost Device|0|||
27861482|NCT01823835|81326035|FG003|Overall Study|Study Termination|0|||
27861483|NCT01823835|81326036|FG004|Overall Study|Study Termination|1|||
27861484|NCT01823835|81326037|FG005|Overall Study|Study Termination|0|||
27662189|NCT02864342|80599963|FG000|Overall Study|Adverse Event|1|||
27662190|NCT02864342|80599964|FG001|Overall Study|Adverse Event|0|||
27662191|NCT02515097|80599966|FG000|Overall Study|Lost to Follow-up|4|||
27662192|NCT02515097|80599967|FG001|Overall Study|Lost to Follow-up|2|||
27662193|NCT02515097|80599966|FG000|Overall Study|Withdrawal by Subject|1|||
27662194|NCT02515097|80599967|FG001|Overall Study|Withdrawal by Subject|3|||
27762890|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
27762891|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
27762892|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
27762893|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
27762894|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
27762895|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
27762896|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
27762897|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
27762898|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
27762899|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
27762900|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
27762901|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
27861485|NCT01823835|81326038|FG006|Overall Study|Study Termination|0|||
27662195|NCT02515097|80599966|FG000|Overall Study|Adverse Event|2|||
27662196|NCT02515097|80599967|FG001|Overall Study|Adverse Event|1|||
27662197|NCT02504502|80599971|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
27662198|NCT02504502|80599972|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
27662199|NCT02504502|80599971|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
27662200|NCT02504502|80599972|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
27662201|NCT00489489|80599975|FG000|Overall Study|Not treated due to protocol violation|0|||
27662202|NCT00489489|80599976|FG001|Overall Study|Not treated due to protocol violation|1|||
27762902|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
27861486|NCT01823835|81326039|FG007|Overall Study|Study Termination|0|||
27861487|NCT01823835|81326040|FG008|Overall Study|Study Termination|0|||
27662203|NCT00489489|80599977|FG002|Overall Study|Not treated due to protocol violation|1|||
27861488|NCT01823835|81326041|FG009|Overall Study|Study Termination|0|||
27662204|NCT00489489|80599975|FG000|Overall Study|Adverse Event|1|||
27662205|NCT00489489|80599976|FG001|Overall Study|Adverse Event|1|||
27662206|NCT00489489|80599977|FG002|Overall Study|Adverse Event|1|||
27662207|NCT00489489|80599975|FG000|Overall Study|Protocol Violation|1|||
27662208|NCT00489489|80599976|FG001|Overall Study|Protocol Violation|0|||
27662209|NCT00489489|80599977|FG002|Overall Study|Protocol Violation|1|||
27662210|NCT00489489|80599975|FG000|Overall Study|Progressive disease|0|||
27662211|NCT00489489|80599976|FG001|Overall Study|Progressive disease|1|||
27662212|NCT00489489|80599977|FG002|Overall Study|Progressive disease|0|||
27662213|NCT00489489|80599975|FG000|Overall Study|Participant did not wish to continue|1|||
27662214|NCT00489489|80599976|FG001|Overall Study|Participant did not wish to continue|1|||
27662215|NCT00489489|80599977|FG002|Overall Study|Participant did not wish to continue|0|||
27662216|NCT00489489|80599975|FG000|Overall Study|Other than above|0|||
27662217|NCT00489489|80599976|FG001|Overall Study|Other than above|1|||
27662218|NCT00489489|80599977|FG002|Overall Study|Other than above|0|||
27662219|NCT03568708|80599981|FG000|Overall Study|Withdrawal by Subject|1|||
27662220|NCT03568708|80599982|FG001|Overall Study|Withdrawal by Subject|1|||
27662221|NCT03568708|80599981|FG000|Overall Study|Lost to Follow-up|0|||
27662222|NCT03568708|80599982|FG001|Overall Study|Lost to Follow-up|1|||
27662223|NCT01193283|80599983|FG000|Overall Study|Death|1|||
27662224|NCT01812837|80599988|FG000|Overall Study|Lost to Follow-up|1|||
27662225|NCT01812837|80599989|FG001|Overall Study|Lost to Follow-up|1|||
27662226|NCT01812837|80599990|FG002|Overall Study|Lost to Follow-up|0|||
27662227|NCT01812837|80599988|FG000|Overall Study|Protocol Violation|1|||
27662228|NCT01812837|80599989|FG001|Overall Study|Protocol Violation|0|||
27762903|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
27762904|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
27762905|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
27762906|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
27762907|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
27762908|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
27762909|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
27861489|NCT01823835|81326042|FG010|Overall Study|Study Termination|0|||
27861490|NCT01823835|81326043|FG011|Overall Study|Study Termination|1|||
27861491|NCT01823835|81326044|FG012|Overall Study|Study Termination|0|||
27861492|NCT01823835|81326045|FG013|Overall Study|Study Termination|0|||
27861493|NCT01823835|81326046|FG014|Overall Study|Study Termination|0|||
27861494|NCT01823835|81326032|FG000|Overall Study|Withdrawal by Subject|0|||
27861495|NCT01823835|81326033|FG001|Overall Study|Withdrawal by Subject|0|||
27861496|NCT01823835|81326034|FG002|Overall Study|Withdrawal by Subject|1|||
27861497|NCT01823835|81326035|FG003|Overall Study|Withdrawal by Subject|0|||
27861498|NCT01823835|81326036|FG004|Overall Study|Withdrawal by Subject|0|||
27861499|NCT01823835|81326037|FG005|Overall Study|Withdrawal by Subject|0|||
27861500|NCT01823835|81326038|FG006|Overall Study|Withdrawal by Subject|0|||
27662229|NCT01812837|80599990|FG002|Overall Study|Protocol Violation|0|||
27662230|NCT01078584|80599993|FG000|Overall Study|Final Status Unknown|1073|||
27662231|NCT01078584|80599993|FG000|Overall Study|Lost to Follow-up|670|||
27662232|NCT01078584|80599993|FG000|Overall Study|Non-serious Adverse Event|577|||
27662233|NCT01078584|80599993|FG000|Overall Study|Withdrawal of Consent|244|||
27662234|NCT01078584|80599993|FG000|Overall Study|Physician Withdrew from Study|90|||
27762910|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
27762911|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
27762912|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
27762913|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
27762914|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
27762915|NCT00476996|80957643|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
27762916|NCT00476996|80957644|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
27762917|NCT00476996|80957645|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
27762918|NCT00476996|80957646|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
27762919|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
27762920|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
27762921|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
27662235|NCT01078584|80599993|FG000|Overall Study|Non-compliance|67|||
27662236|NCT01078584|80599993|FG000|Overall Study|Blood Pressure Controlled|49|||
27662237|NCT01078584|80599993|FG000|Overall Study|Physician Switched Medication|26|||
27762922|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
27861501|NCT01823835|81326039|FG007|Overall Study|Withdrawal by Subject|0|||
27861502|NCT01823835|81326040|FG008|Overall Study|Withdrawal by Subject|0|||
27662238|NCT01078584|80599993|FG000|Overall Study|Physician Discontinued Patient|12|||
27662239|NCT01078584|80599993|FG000|Overall Study|Lack of Efficacy|98|||
27662240|NCT01078584|80599993|FG000|Overall Study|Protocol Violation|75|||
27662241|NCT01078584|80599993|FG000|Overall Study|Serious Adverse Event|27|||
27861503|NCT01823835|81326041|FG009|Overall Study|Withdrawal by Subject|1|||
27861504|NCT01823835|81326042|FG010|Overall Study|Withdrawal by Subject|1|||
27662242|NCT01078584|80599993|FG000|Overall Study|Multiple Reasons|2|||
27662243|NCT01026103|80599994|FG000|Overall Study|Physician Decision|1|||
27662244|NCT01026103|80599994|FG000|Overall Study|did not receive study device bc of error|1|||
27662245|NCT01024036|80599995|FG000|Blinded Treatment|Adverse Event|1|||
27662246|NCT01024036|80599996|FG001|Blinded Treatment|Adverse Event|1|||
27662247|NCT01024036|80599995|FG000|Blinded Treatment|Lack of Efficacy|16|||
27662248|NCT01024036|80599996|FG001|Blinded Treatment|Lack of Efficacy|14|||
27662249|NCT01024036|80599995|FG000|Blinded Treatment|Physician Decision|1|||
27662250|NCT01024036|80599996|FG001|Blinded Treatment|Physician Decision|0|||
27861505|NCT01823835|81326043|FG011|Overall Study|Withdrawal by Subject|2|||
27861506|NCT01823835|81326044|FG012|Overall Study|Withdrawal by Subject|1|||
27861507|NCT01823835|81326045|FG013|Overall Study|Withdrawal by Subject|0|||
27861508|NCT01823835|81326046|FG014|Overall Study|Withdrawal by Subject|0|||
27861509|NCT04400682|81326047|FG000|Period 1|Withdrawal by Subject|1|||
27861510|NCT04400682|81326048|FG001|Period 1|Withdrawal by Subject|4|||
27861511|NCT01104779|81326049|FG000|Overall Study|Protocol Violation|1|||
27861512|NCT01104779|81326050|FG001|Overall Study|Protocol Violation|2|||
27861513|NCT01104779|81326051|FG002|Overall Study|Protocol Violation|2|||
27861514|NCT01104779|81326049|FG000|Overall Study|Lack of Efficacy|26|||
27861515|NCT01104779|81326050|FG001|Overall Study|Lack of Efficacy|12|||
27861516|NCT01104779|81326051|FG002|Overall Study|Lack of Efficacy|13|||
27861517|NCT01104779|81326049|FG000|Overall Study|Adverse Event|13|||
27861518|NCT01104779|81326050|FG001|Overall Study|Adverse Event|14|||
27662251|NCT01024036|80599995|FG000|Blinded Treatment|Death|0|||
27662252|NCT01024036|80599996|FG001|Blinded Treatment|Death|2|||
27662253|NCT01024036|80599995|FG000|Blinded Treatment|Withdrawal by Subject|4|||
27662254|NCT01024036|80599996|FG001|Blinded Treatment|Withdrawal by Subject|3|||
27662255|NCT01024036|80599995|FG000|Unblinded Treatment|Adverse Event|0|||
27662256|NCT01024036|80599996|FG001|Unblinded Treatment|Adverse Event|1|||
27662257|NCT01024036|80599995|FG000|Unblinded Treatment|Lack of Efficacy|0|||
27762923|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
27762924|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
27861519|NCT01104779|81326051|FG002|Overall Study|Adverse Event|13|||
27861520|NCT01104779|81326049|FG000|Overall Study|Did not meet inc/exc criteria|1|||
27861521|NCT01104779|81326050|FG001|Overall Study|Did not meet inc/exc criteria|1|||
27861522|NCT01104779|81326051|FG002|Overall Study|Did not meet inc/exc criteria|1|||
27861523|NCT01104779|81326049|FG000|Overall Study|Other reasons|0|||
27861524|NCT01104779|81326050|FG001|Overall Study|Other reasons|1|||
27861525|NCT01104779|81326051|FG002|Overall Study|Other reasons|0|||
27861526|NCT01104779|81326049|FG000|Overall Study|Lost to Follow-up|2|||
27861527|NCT01104779|81326050|FG001|Overall Study|Lost to Follow-up|0|||
27861528|NCT01104779|81326051|FG002|Overall Study|Lost to Follow-up|1|||
27861529|NCT01104779|81326049|FG000|Overall Study|Withdrawal by Subject|16|||
27861530|NCT01104779|81326050|FG001|Overall Study|Withdrawal by Subject|25|||
27861531|NCT01104779|81326051|FG002|Overall Study|Withdrawal by Subject|32|||
27861532|NCT01398514|81326054|FG000|Overall Study|Adverse Event|1|||
27861533|NCT01398514|81326055|FG001|Overall Study|Adverse Event|0|||
27861534|NCT01398514|81326054|FG000|Overall Study|Non-compliance with study procedures|2|||
27861535|NCT01398514|81326055|FG001|Overall Study|Non-compliance with study procedures|0|||
27861536|NCT01398514|81326054|FG000|Overall Study|Physiologic non-responsiveness|1|||
27861537|NCT01398514|81326055|FG001|Overall Study|Physiologic non-responsiveness|3|||
27861538|NCT01398514|81326054|FG000|Overall Study|Failure to show a conditioned response|4|||
27861539|NCT01398514|81326055|FG001|Overall Study|Failure to show a conditioned response|3|||
27861540|NCT04123561|81326062|FG000|Overall Study|Lost to Follow-up|20|||
27861541|NCT04123561|81326063|FG001|Overall Study|Lost to Follow-up|12|||
27861542|NCT04123561|81326064|FG002|Overall Study|Lost to Follow-up|5|||
27861543|NCT04123561|81326062|FG000|Overall Study|Withdrawal by Subject|9|||
27861544|NCT04123561|81326063|FG001|Overall Study|Withdrawal by Subject|7|||
27861545|NCT04123561|81326064|FG002|Overall Study|Withdrawal by Subject|9|||
27568790|NCT03013543|80271447|FG000|Overall Study|Lost to Follow-up|0|||
27568791|NCT03013543|80271448|FG001|Overall Study|Lost to Follow-up|0|||
27662258|NCT01024036|80599996|FG001|Unblinded Treatment|Lack of Efficacy|2|||
27662259|NCT01024036|80599995|FG000|Follow-Up Period|Lost to Follow-up|1|||
27662260|NCT01024036|80599996|FG001|Follow-Up Period|Lost to Follow-up|1|||
27662261|NCT01024036|80599995|FG000|Follow-Up Period|Withdrawal by Subject|0|||
27762925|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
27662262|NCT01024036|80599996|FG001|Follow-Up Period|Withdrawal by Subject|1|||
27762926|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
27762927|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Death|0|||
27762928|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Death|0|||
27762929|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Death|0|||
27762930|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Death|7|||
27762931|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
27861546|NCT04123561|81326062|FG000|Overall Study|Lack of Efficacy|7|||
27861547|NCT04123561|81326063|FG001|Overall Study|Lack of Efficacy|8|||
27861548|NCT04123561|81326064|FG002|Overall Study|Lack of Efficacy|6|||
27662263|NCT01024036|80599995|FG000|Follow-Up Period|Adverse Event|4|||
27662264|NCT01024036|80599996|FG001|Follow-Up Period|Adverse Event|1|||
27861549|NCT04123561|81326062|FG000|Overall Study|Adverse Event|5|||
27861550|NCT04123561|81326063|FG001|Overall Study|Adverse Event|2|||
27861551|NCT04123561|81326064|FG002|Overall Study|Adverse Event|3|||
27861552|NCT04123561|81326062|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
27861553|NCT04123561|81326063|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
27861554|NCT04123561|81326064|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
27861555|NCT04123561|81326062|FG000|Overall Study|Death|0|||
27861556|NCT04123561|81326063|FG001|Overall Study|Death|0|||
27861557|NCT04123561|81326064|FG002|Overall Study|Death|1|||
27861558|NCT04123561|81326062|FG000|Overall Study|Protocol Violation|0|||
27861559|NCT04123561|81326063|FG001|Overall Study|Protocol Violation|1|||
27861560|NCT04123561|81326064|FG002|Overall Study|Protocol Violation|0|||
27861561|NCT00049530|81326067|FG000|Overall Study|Lack of Efficacy|25|||
27861562|NCT00049530|81326067|FG000|Overall Study|Adverse Event|2|||
27861563|NCT00049530|81326067|FG000|Overall Study|Death|1|||
27861564|NCT00049530|81326067|FG000|Overall Study|symptomatic deterioration|1|||
27861565|NCT00049530|81326067|FG000|Overall Study|ineligible|3|||
27861566|NCT00928707|81326068|FG000|Overall Study|Protocol Violation|1|||
27861567|NCT00928707|81326069|FG001|Overall Study|Protocol Violation|0|||
27861568|NCT03819049|81326070|FG000|Overall Study|Lost to Follow-up|1|||
27861569|NCT03819049|81326071|FG001|Overall Study|Lost to Follow-up|2|||
27861570|NCT03819049|81326072|FG002|Overall Study|Lost to Follow-up|9|||
27662265|NCT01107353|80599997|FG000|Overall Study|Positive Drug Screen|1|||
27861571|NCT03819049|81326073|FG003|Overall Study|Lost to Follow-up|0|||
27662266|NCT01107353|80599998|FG001|Overall Study|Positive Drug Screen|0|||
27662267|NCT00509821|80600001|FG000|Study Period 1 (Induction)|Death|0|||
27662268|NCT00509821|80600002|FG001|Study Period 1 (Induction)|Death|1|||
27662269|NCT00509821|80600001|FG000|Study Period 1 (Induction)|Adverse Event|0|||
27662270|NCT00509821|80600002|FG001|Study Period 1 (Induction)|Adverse Event|2|||
27662271|NCT00509821|80600001|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
27662272|NCT00509821|80600002|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
27662273|NCT01703988|80600003|FG000|Overall Study|Investigator Judgment|0|||
27662274|NCT01703988|80600004|FG001|Overall Study|Investigator Judgment|0|||
27662275|NCT01703988|80600005|FG002|Overall Study|Investigator Judgment|0|||
27662276|NCT01703988|80600006|FG003|Overall Study|Investigator Judgment|1|||
27662277|NCT01959607|80600007|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
27662278|NCT01959607|80600008|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
27662279|NCT01959607|80600009|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27662280|NCT01959607|80600010|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
27662281|NCT02236598|80600011|FG000|Overall Study|Adverse Event|0|||
27662282|NCT02236598|80600012|FG001|Overall Study|Adverse Event|1|||
27662283|NCT02236598|80600011|FG000|Overall Study|Withdrawal by Subject|0|||
27662284|NCT02236598|80600012|FG001|Overall Study|Withdrawal by Subject|1|||
27662285|NCT01129115|80600020|FG000|Overall Study|Adverse Event|1|||
27662286|NCT01129115|80600021|FG001|Overall Study|Adverse Event|2|||
27662287|NCT01129115|80600022|FG002|Overall Study|Adverse Event|3|||
27662288|NCT01129115|80600023|FG003|Overall Study|Adverse Event|3|||
27662289|NCT01129115|80600020|FG000|Overall Study|Withdrawal by Subject|1|||
27662290|NCT01129115|80600021|FG001|Overall Study|Withdrawal by Subject|3|||
27662291|NCT01129115|80600022|FG002|Overall Study|Withdrawal by Subject|1|||
27662292|NCT01129115|80600023|FG003|Overall Study|Withdrawal by Subject|4|||
27662293|NCT01129115|80600020|FG000|Overall Study|Protocol Violation|0|||
27662294|NCT01129115|80600021|FG001|Overall Study|Protocol Violation|2|||
27662295|NCT01129115|80600022|FG002|Overall Study|Protocol Violation|2|||
27662296|NCT01129115|80600023|FG003|Overall Study|Protocol Violation|2|||
27662297|NCT01732627|80600024|FG000|Overall Study|Withdrawal by Subject|1|||
27662298|NCT01732627|80600025|FG001|Overall Study|Withdrawal by Subject|0|||
27662299|NCT02005029|80600026|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
27662300|NCT02005029|80600027|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
27662301|NCT03326193|80600028|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
27662302|NCT03326193|80600028|FG000|Overall Study|Death|19|||
27662303|NCT03326193|80600028|FG000|Overall Study|Withdrawal by Subject|8|||
27662304|NCT02809677|80600036|FG000|Overall Study|Withdrawal by Subject|8|||
27861572|NCT03819049|81326074|FG004|Overall Study|Lost to Follow-up|3|||
27861573|NCT03819049|81326075|FG005|Overall Study|Lost to Follow-up|1|||
27861574|NCT03819049|81326076|FG006|Overall Study|Lost to Follow-up|0|||
27861575|NCT03819049|81326070|FG000|Overall Study|Withdrawal by Subject|0|||
27861576|NCT03819049|81326071|FG001|Overall Study|Withdrawal by Subject|0|||
27861577|NCT03819049|81326072|FG002|Overall Study|Withdrawal by Subject|18|||
27662305|NCT01572493|80600037|FG000|Overall Study|Physician Decision|1|||
27662306|NCT01572493|80600038|FG001|Overall Study|Physician Decision|0|||
27662307|NCT01572493|80600039|FG002|Overall Study|Physician Decision|0|||
27662308|NCT01572493|80600040|FG003|Overall Study|Physician Decision|0|||
27662309|NCT01572493|80600041|FG004|Overall Study|Physician Decision|0|||
27662310|NCT01572493|80600042|FG005|Overall Study|Physician Decision|0|||
27861578|NCT03819049|81326073|FG003|Overall Study|Withdrawal by Subject|0|||
27662311|NCT01572493|80600043|FG006|Overall Study|Physician Decision|0|||
27662312|NCT01572493|80600044|FG007|Overall Study|Physician Decision|0|||
27662313|NCT01572493|80600045|FG008|Overall Study|Physician Decision|0|||
27662314|NCT01572493|80600037|FG000|Overall Study|Switched to alternative treatment|0|||
27662315|NCT01572493|80600038|FG001|Overall Study|Switched to alternative treatment|1|||
27861579|NCT03819049|81326074|FG004|Overall Study|Withdrawal by Subject|10|||
27861580|NCT03819049|81326075|FG005|Overall Study|Withdrawal by Subject|9|||
27861581|NCT03819049|81326076|FG006|Overall Study|Withdrawal by Subject|1|||
27861582|NCT03819049|81326070|FG000|Overall Study|Ongoing|0|||
27861583|NCT03819049|81326071|FG001|Overall Study|Ongoing|0|||
27861584|NCT03819049|81326072|FG002|Overall Study|Ongoing|75|||
27861585|NCT03819049|81326073|FG003|Overall Study|Ongoing|0|||
27861586|NCT03819049|81326074|FG004|Overall Study|Ongoing|41|||
27861587|NCT03819049|81326075|FG005|Overall Study|Ongoing|0|||
27861588|NCT03819049|81326076|FG006|Overall Study|Ongoing|0|||
27861589|NCT03819049|81326070|FG000|Overall Study|Other|0|||
27861590|NCT03819049|81326071|FG001|Overall Study|Other|0|||
27861591|NCT03819049|81326072|FG002|Overall Study|Other|2|||
27861592|NCT03819049|81326073|FG003|Overall Study|Other|0|||
27861593|NCT03819049|81326074|FG004|Overall Study|Other|0|||
27861594|NCT03819049|81326075|FG005|Overall Study|Other|0|||
27861595|NCT03819049|81326076|FG006|Overall Study|Other|0|||
27861596|NCT03819049|81326070|FG000|Overall Study|Randomized but not vaccinated|0|||
27861597|NCT03819049|81326071|FG001|Overall Study|Randomized but not vaccinated|0|||
27861598|NCT03819049|81326072|FG002|Overall Study|Randomized but not vaccinated|0|||
27861599|NCT03819049|81326073|FG003|Overall Study|Randomized but not vaccinated|1|||
27861600|NCT03819049|81326074|FG004|Overall Study|Randomized but not vaccinated|0|||
27861601|NCT03819049|81326075|FG005|Overall Study|Randomized but not vaccinated|2|||
27861602|NCT03819049|81326076|FG006|Overall Study|Randomized but not vaccinated|1|||
27861603|NCT03819049|81326070|FG000|Overall Study|Physician Decision|0|||
27861604|NCT03819049|81326071|FG001|Overall Study|Physician Decision|0|||
27861605|NCT03819049|81326072|FG002|Overall Study|Physician Decision|0|||
27861606|NCT03819049|81326073|FG003|Overall Study|Physician Decision|0|||
27568792|NCT03013543|80271449|FG002|Overall Study|Lost to Follow-up|0|||
27662316|NCT01572493|80600039|FG002|Overall Study|Switched to alternative treatment|2|||
27662317|NCT01572493|80600040|FG003|Overall Study|Switched to alternative treatment|1|||
27662318|NCT01572493|80600041|FG004|Overall Study|Switched to alternative treatment|2|||
27662319|NCT01572493|80600042|FG005|Overall Study|Switched to alternative treatment|0|||
27662320|NCT01572493|80600043|FG006|Overall Study|Switched to alternative treatment|2|||
27662321|NCT01572493|80600044|FG007|Overall Study|Switched to alternative treatment|0|||
27762932|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
27762933|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
27762934|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
27762935|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
27762936|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
27762937|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
27861607|NCT03819049|81326074|FG004|Overall Study|Physician Decision|0|||
27861608|NCT03819049|81326075|FG005|Overall Study|Physician Decision|0|||
27861609|NCT03819049|81326076|FG006|Overall Study|Physician Decision|1|||
27861610|NCT01934335|81326077|FG000|Overall Study|Withdrawal by Subject|1|||
27861611|NCT01934335|81326078|FG001|Overall Study|Withdrawal by Subject|1|||
27861612|NCT03200912|81326079|FG000|Overall Study|Adverse Event|3|||
27861613|NCT03200912|81326080|FG001|Overall Study|Adverse Event|0|||
27861614|NCT03200912|81326081|FG002|Overall Study|Adverse Event|0|||
27861615|NCT03200912|81326079|FG000|Overall Study|Withdrawal by Subject|1|||
27861616|NCT03200912|81326080|FG001|Overall Study|Withdrawal by Subject|2|||
27861617|NCT03200912|81326081|FG002|Overall Study|Withdrawal by Subject|4|||
27861618|NCT03200912|81326079|FG000|Overall Study|Non-compliance with study drug|0|||
27861619|NCT03200912|81326080|FG001|Overall Study|Non-compliance with study drug|1|||
27861620|NCT03200912|81326081|FG002|Overall Study|Non-compliance with study drug|0|||
27861621|NCT04628793|81326082|FG000|Overall Study|Study terminated by sponsor|0|||
27861622|NCT04628793|81326083|FG001|Overall Study|Study terminated by sponsor|0|||
27861623|NCT04628793|81326084|FG002|Overall Study|Study terminated by sponsor|8|||
27861624|NCT04628793|81326082|FG000|Overall Study|Withdrawal by Subject|2|||
27861625|NCT04628793|81326083|FG001|Overall Study|Withdrawal by Subject|3|||
27762938|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
27762939|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
27762940|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
27861626|NCT04628793|81326084|FG002|Overall Study|Withdrawal by Subject|0|||
27662322|NCT01572493|80600045|FG008|Overall Study|Switched to alternative treatment|2|||
27662323|NCT01572493|80600037|FG000|Overall Study|Death|0|||
27662324|NCT01572493|80600038|FG001|Overall Study|Death|0|||
27861627|NCT04628793|81326082|FG000|Overall Study|Lost to Follow-up|0|||
27861628|NCT04628793|81326083|FG001|Overall Study|Lost to Follow-up|1|||
27861629|NCT04628793|81326084|FG002|Overall Study|Lost to Follow-up|0|||
27861630|NCT03477903|81326085|FG000|Overall Study|Study Terminated by Sponsor|1|||
27861631|NCT02521376|81326086|FG000|Overall Study|Enrolled, But Not Treated|1|||
27861632|NCT02521376|81326087|FG001|Overall Study|Enrolled, But Not Treated|0|||
27861633|NCT02521376|81326088|FG002|Overall Study|Enrolled, But Not Treated|0|||
27861634|NCT02521376|81326089|FG003|Overall Study|Enrolled, But Not Treated|0|||
27861635|NCT04710979|81326103|FG000|Overall Study|Lost to Follow-up|2|||
27861636|NCT04710979|81326104|FG001|Overall Study|Lost to Follow-up|4|||
27861637|NCT04710979|81326103|FG000|Overall Study|Withdrawal by Subject|1|||
27861638|NCT04710979|81326104|FG001|Overall Study|Withdrawal by Subject|0|||
27861639|NCT03480386|81326105|FG000|Overall Study|Did not complete measures at 3-months|17|||
27861640|NCT03480386|81326106|FG001|Overall Study|Did not complete measures at 3-months|14|||
27861641|NCT03480386|81326105|FG000|Overall Study|No baseline measures|11|||
27861642|NCT03480386|81326106|FG001|Overall Study|No baseline measures|14|||
27861643|NCT03480386|81326105|FG000|Overall Study|Death|0|||
27861644|NCT03480386|81326106|FG001|Overall Study|Death|5|||
27861645|NCT03480386|81326105|FG000|Overall Study|Withdrawal by Subject|12|||
27861646|NCT03480386|81326106|FG001|Overall Study|Withdrawal by Subject|8|||
27861647|NCT03480386|81326105|FG000|Overall Study|Lost to Follow-up|2|||
27861648|NCT03480386|81326106|FG001|Overall Study|Lost to Follow-up|1|||
27861649|NCT03480386|81326105|FG000|Overall Study|Complicating disease|0|||
27861650|NCT03480386|81326106|FG001|Overall Study|Complicating disease|1|||
27861651|NCT03480386|81326105|FG000|Overall Study|Disease progression|3|||
27861652|NCT03480386|81326106|FG001|Overall Study|Disease progression|0|||
27861653|NCT03480386|81326105|FG000|Overall Study|Became ineligible|0|||
27861654|NCT03480386|81326106|FG001|Overall Study|Became ineligible|2|||
27861655|NCT04784533|81326107|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
27861656|NCT04784533|81326108|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
27861657|NCT04784533|81326109|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861658|NCT04784533|81326110|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861659|NCT04784533|81326111|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861660|NCT04784533|81326112|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861661|NCT04784533|81326113|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861662|NCT04784533|81326114|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861663|NCT04784533|81326115|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861664|NCT04784533|81326116|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
27861665|NCT04784533|81326107|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
27861666|NCT04784533|81326108|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
27861667|NCT04784533|81326109|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861668|NCT04784533|81326110|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861669|NCT04784533|81326111|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861670|NCT04784533|81326112|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861671|NCT04784533|81326113|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861672|NCT04784533|81326114|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861673|NCT04784533|81326115|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861674|NCT04784533|81326116|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
27861675|NCT04784533|81326107|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861676|NCT04784533|81326108|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
27861677|NCT04784533|81326109|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861678|NCT04784533|81326110|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861679|NCT04784533|81326111|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861680|NCT04784533|81326112|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861681|NCT04784533|81326113|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861682|NCT04784533|81326114|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861683|NCT04784533|81326115|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861684|NCT04784533|81326116|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
27861685|NCT04784533|81326107|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
27861686|NCT04784533|81326108|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861687|NCT04784533|81326109|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861688|NCT04784533|81326110|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861689|NCT04784533|81326111|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861690|NCT04784533|81326112|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861691|NCT04784533|81326113|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861692|NCT04784533|81326114|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861693|NCT04784533|81326115|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861694|NCT04784533|81326116|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
27861695|NCT04784533|81326107|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
27861696|NCT04784533|81326108|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
27861697|NCT04784533|81326109|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861698|NCT04784533|81326110|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861699|NCT04784533|81326111|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861700|NCT04784533|81326112|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861701|NCT04784533|81326113|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861702|NCT04784533|81326114|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861703|NCT04784533|81326115|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861704|NCT04784533|81326116|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
27861705|NCT04784533|81326107|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
27861706|NCT04784533|81326108|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
27861707|NCT04784533|81326109|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27762941|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
27762942|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
27762943|NCT00476996|80957643|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
27762944|NCT00476996|80957644|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
27762945|NCT00476996|80957645|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
27762946|NCT00476996|80957646|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
27762947|NCT01018511|80957647|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
27762948|NCT01018511|80957648|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
27762949|NCT01018511|80957649|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
27762950|NCT01018511|80957650|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
27762951|NCT01018511|80957647|FG000|Overall Study|Adverse Event|5|||
27762952|NCT01018511|80957648|FG001|Overall Study|Adverse Event|9|||
27762953|NCT01018511|80957649|FG002|Overall Study|Adverse Event|13|||
27762954|NCT01018511|80957650|FG003|Overall Study|Adverse Event|10|||
27861708|NCT04784533|81326110|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861709|NCT04784533|81326111|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861710|NCT04784533|81326112|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861711|NCT04784533|81326113|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861712|NCT04784533|81326114|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861713|NCT04784533|81326115|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861714|NCT04784533|81326116|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
27861715|NCT04784533|81326107|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861716|NCT04784533|81326108|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861717|NCT04784533|81326109|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
27861718|NCT04784533|81326110|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861719|NCT04784533|81326111|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861720|NCT04784533|81326112|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861721|NCT04784533|81326113|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27762955|NCT01018511|80957647|FG000|Overall Study|Lack of Efficacy|4|||
27762956|NCT01018511|80957648|FG001|Overall Study|Lack of Efficacy|1|||
27762957|NCT01018511|80957649|FG002|Overall Study|Lack of Efficacy|1|||
27762958|NCT01018511|80957650|FG003|Overall Study|Lack of Efficacy|2|||
27762959|NCT01018511|80957647|FG000|Overall Study|Withdrawal by Subject|6|||
27762960|NCT01018511|80957648|FG001|Overall Study|Withdrawal by Subject|5|||
27762961|NCT01018511|80957649|FG002|Overall Study|Withdrawal by Subject|11|||
27762962|NCT01018511|80957650|FG003|Overall Study|Withdrawal by Subject|9|||
27762963|NCT01018511|80957647|FG000|Overall Study|Lost to Follow-up|0|||
27762964|NCT01018511|80957648|FG001|Overall Study|Lost to Follow-up|0|||
27762965|NCT01018511|80957649|FG002|Overall Study|Lost to Follow-up|1|||
27762966|NCT01018511|80957650|FG003|Overall Study|Lost to Follow-up|0|||
27762967|NCT01018511|80957647|FG000|Overall Study|Protocol Violation|5|||
27762968|NCT01018511|80957648|FG001|Overall Study|Protocol Violation|8|||
27762969|NCT01018511|80957649|FG002|Overall Study|Protocol Violation|7|||
27762970|NCT01018511|80957650|FG003|Overall Study|Protocol Violation|9|||
27762971|NCT01018511|80957647|FG000|Overall Study|Miscellaneous|0|||
27762972|NCT01018511|80957648|FG001|Overall Study|Miscellaneous|2|||
27762973|NCT01018511|80957649|FG002|Overall Study|Miscellaneous|0|||
27762974|NCT01018511|80957650|FG003|Overall Study|Miscellaneous|0|||
27762975|NCT00793182|80957651|FG000|Overall Study|Adverse Event|0|||
27762976|NCT00793182|80957652|FG001|Overall Study|Adverse Event|1|||
27762977|NCT02483078|80957654|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
27762978|NCT02483078|80957655|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
27762979|NCT02483078|80957654|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
27762980|NCT02483078|80957655|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
27762981|NCT02483078|80957654|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
27762982|NCT02483078|80957655|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
27762983|NCT02483078|80957654|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
27762984|NCT02483078|80957655|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
27762985|NCT02483078|80957654|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
27762986|NCT02483078|80957655|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
27762987|NCT02483078|80957654|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
27861722|NCT04784533|81326114|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861723|NCT04784533|81326115|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861724|NCT04784533|81326116|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
27861725|NCT04784533|81326107|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861726|NCT04784533|81326108|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861727|NCT04784533|81326109|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861728|NCT04784533|81326110|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861729|NCT04784533|81326111|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861730|NCT04784533|81326112|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861731|NCT04784533|81326113|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861732|NCT04784533|81326114|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861733|NCT04784533|81326115|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
27861734|NCT04784533|81326116|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
27861735|NCT04784533|81326107|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27861736|NCT04784533|81326108|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27861737|NCT04784533|81326109|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27861738|NCT04784533|81326110|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27861739|NCT04784533|81326111|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27861740|NCT04784533|81326112|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27662325|NCT01572493|80600039|FG002|Overall Study|Death|0|||
27662326|NCT01572493|80600040|FG003|Overall Study|Death|1|||
27662327|NCT01572493|80600041|FG004|Overall Study|Death|0|||
27662328|NCT01572493|80600042|FG005|Overall Study|Death|1|||
27662329|NCT01572493|80600043|FG006|Overall Study|Death|0|||
27662330|NCT01572493|80600044|FG007|Overall Study|Death|0|||
27662331|NCT01572493|80600045|FG008|Overall Study|Death|0|||
27662332|NCT01572493|80600037|FG000|Overall Study|Adverse Event|0|||
27662333|NCT01572493|80600038|FG001|Overall Study|Adverse Event|0|||
27662334|NCT01572493|80600039|FG002|Overall Study|Adverse Event|0|||
27662335|NCT01572493|80600040|FG003|Overall Study|Adverse Event|0|||
27762988|NCT02483078|80957655|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
27762989|NCT02527148|80957656|FG000|Overall Study|Did not receive study intervention|1|||
27762990|NCT02527148|80957657|FG001|Overall Study|Did not receive study intervention|0|||
27762991|NCT00603733|80957665|FG000|Active Phase ITT|Adverse Event|8|||
27762992|NCT00603733|80957666|FG001|Active Phase ITT|Adverse Event|7|||
27762993|NCT00603733|80957665|FG000|Active Phase ITT|Withdrawal by Subject|0|||
27762994|NCT00603733|80957666|FG001|Active Phase ITT|Withdrawal by Subject|3|||
27762995|NCT00603733|80957665|FG000|Active Phase ITT|Lost to Follow-up|0|||
27762996|NCT00603733|80957666|FG001|Active Phase ITT|Lost to Follow-up|1|||
27762997|NCT00603733|80957665|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
27762998|NCT00603733|80957666|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
27762999|NCT00603733|80957665|FG000|Active Phase ITT|Lack of Efficacy|1|||
27763000|NCT00603733|80957666|FG001|Active Phase ITT|Lack of Efficacy|2|||
27763001|NCT00603733|80957665|FG000|Active Phase ITT|Subject moved, site closed|1|||
27763002|NCT00603733|80957666|FG001|Active Phase ITT|Subject moved, site closed|1|||
27763003|NCT00603733|80957665|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
27763004|NCT00603733|80957666|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
27763005|NCT00603733|80957665|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
27763006|NCT00603733|80957666|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
27763007|NCT00603733|80957665|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
27763008|NCT00603733|80957666|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
27763009|NCT00603733|80957665|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
27763010|NCT00603733|80957666|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
27763011|NCT00603733|80957665|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
27763012|NCT00603733|80957666|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
27662336|NCT01572493|80600041|FG004|Overall Study|Adverse Event|0|||
27662337|NCT01572493|80600042|FG005|Overall Study|Adverse Event|0|||
27662338|NCT01572493|80600043|FG006|Overall Study|Adverse Event|1|||
27662339|NCT01572493|80600044|FG007|Overall Study|Adverse Event|0|||
27763013|NCT00603733|80957665|FG000|Maintenance Phase ITT|Adverse Event|3|||
27763014|NCT00603733|80957666|FG001|Maintenance Phase ITT|Adverse Event|6|||
27763015|NCT00603733|80957665|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
27861741|NCT04784533|81326113|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27662340|NCT01572493|80600045|FG008|Overall Study|Adverse Event|0|||
27662341|NCT02261285|80600046|FG000|Overall Study|Disease progression|0|||
27662342|NCT02261285|80600047|FG001|Overall Study|Disease progression|0|||
27662343|NCT02261285|80600048|FG002|Overall Study|Disease progression|1|||
27662344|NCT02598934|80600051|FG000|Overall Study|Adverse Event|11|||
27763016|NCT00603733|80957666|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
27763017|NCT00603733|80957665|FG000|Maintenance Phase ITT|Protocol Violation|1|||
27763018|NCT00603733|80957666|FG001|Maintenance Phase ITT|Protocol Violation|1|||
27662345|NCT02598934|80600052|FG001|Overall Study|Adverse Event|13|||
27662346|NCT02598934|80600051|FG000|Overall Study|Failure to Return|3|||
27662347|NCT02598934|80600052|FG001|Overall Study|Failure to Return|3|||
27763019|NCT00603733|80957665|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
27662348|NCT02598934|80600051|FG000|Overall Study|Withdrawal by Subject|2|||
27662349|NCT02598934|80600052|FG001|Overall Study|Withdrawal by Subject|3|||
27662350|NCT02598934|80600051|FG000|Overall Study|Administrative|2|||
27662351|NCT02598934|80600052|FG001|Overall Study|Administrative|1|||
27662352|NCT02598934|80600051|FG000|Overall Study|Protocol Violation|1|||
27662353|NCT02598934|80600052|FG001|Overall Study|Protocol Violation|2|||
27662354|NCT04750577|80600055|FG000|Overall Study|Adverse Event|2|||
27662355|NCT04750577|80600056|FG001|Overall Study|Adverse Event|10|||
27662356|NCT04750577|80600057|FG002|Overall Study|Adverse Event|8|||
27662357|NCT04750577|80600058|FG003|Overall Study|Adverse Event|1|||
27662358|NCT04750577|80600055|FG000|Overall Study|Change of residence|0|||
27662359|NCT04750577|80600056|FG001|Overall Study|Change of residence|0|||
27662360|NCT04750577|80600057|FG002|Overall Study|Change of residence|1|||
27662361|NCT04750577|80600058|FG003|Overall Study|Change of residence|0|||
27662362|NCT04750577|80600055|FG000|Overall Study|Burden of study procedures|0|||
27662363|NCT04750577|80600056|FG001|Overall Study|Burden of study procedures|2|||
27662364|NCT04750577|80600057|FG002|Overall Study|Burden of study procedures|2|||
27662365|NCT04750577|80600058|FG003|Overall Study|Burden of study procedures|0|||
27662366|NCT04750577|80600055|FG000|Overall Study|Prematurely discontinued|0|||
27662367|NCT04750577|80600056|FG001|Overall Study|Prematurely discontinued|0|||
27662368|NCT04750577|80600057|FG002|Overall Study|Prematurely discontinued|0|||
27662369|NCT04750577|80600058|FG003|Overall Study|Prematurely discontinued|2|||
27861742|NCT04784533|81326114|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
27861743|NCT04784533|81326115|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
27861744|NCT04784533|81326116|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
27861745|NCT00856375|81326117|FG000|Overall Study|Other|0|||
27861746|NCT00856375|81326118|FG001|Overall Study|Other|1|||
27861747|NCT00856375|81326117|FG000|Overall Study|Death|32|||
27861748|NCT00856375|81326118|FG001|Overall Study|Death|30|||
27861749|NCT00856375|81326117|FG000|Overall Study|Sponsor Terminated Study|7|||
27861750|NCT00856375|81326118|FG001|Overall Study|Sponsor Terminated Study|7|||
27861751|NCT00856375|81326117|FG000|Overall Study|Withdrawal by Subject|2|||
27861752|NCT00856375|81326118|FG001|Overall Study|Withdrawal by Subject|1|||
27861753|NCT00856375|81326117|FG000|Overall Study|Lost to Follow-up|1|||
27861754|NCT00856375|81326118|FG001|Overall Study|Lost to Follow-up|2|||
27861755|NCT01439009|81326119|FG000|Overall Study|Physician Decision|5|||
27662370|NCT04750577|80600055|FG000|Overall Study|Protocol deviation|1|||
27662371|NCT04750577|80600056|FG001|Overall Study|Protocol deviation|1|||
27662372|NCT04750577|80600057|FG002|Overall Study|Protocol deviation|1|||
27662373|NCT04750577|80600058|FG003|Overall Study|Protocol deviation|1|||
27662374|NCT04750577|80600055|FG000|Overall Study|Other than listed|3|||
27662375|NCT04750577|80600056|FG001|Overall Study|Other than listed|2|||
27662376|NCT04750577|80600057|FG002|Overall Study|Other than listed|2|||
27662377|NCT04750577|80600058|FG003|Overall Study|Other than listed|1|||
27662378|NCT04750577|80600055|FG000|Overall Study|Not treated|0|||
27662379|NCT04750577|80600056|FG001|Overall Study|Not treated|0|||
27662380|NCT04750577|80600057|FG002|Overall Study|Not treated|0|||
27662381|NCT04750577|80600058|FG003|Overall Study|Not treated|2|||
27662382|NCT03184519|80600061|FG000|Overall Study|Lost to Follow-up|6|||
27662383|NCT03184519|80600061|FG000|Overall Study|Physician Decision|21|||
27861756|NCT01439009|81326120|FG001|Overall Study|Physician Decision|3|||
27861757|NCT01439009|81326119|FG000|Overall Study|Protocol Violation|2|||
27861758|NCT01439009|81326120|FG001|Overall Study|Protocol Violation|0|||
27861759|NCT01439009|81326119|FG000|Overall Study|Deviation of exclusion criteria|1|||
27861760|NCT01439009|81326120|FG001|Overall Study|Deviation of exclusion criteria|0|||
27861761|NCT01778686|81326121|FG000|Overall Study|Adverse Event|0|||
27861762|NCT01778686|81326122|FG001|Overall Study|Adverse Event|0|||
27861763|NCT01778686|81326123|FG002|Overall Study|Adverse Event|1|||
27861764|NCT02714426|81326124|FG000|Overall Study|Withdrawal by Subject|2|||
27861765|NCT02714426|81326125|FG001|Overall Study|Withdrawal by Subject|2|||
27861766|NCT01434810|81326128|FG000|Overall Study|Did not receive treatment|11|||
27568793|NCT03013543|80271450|FG003|Overall Study|Lost to Follow-up|1|||
27662384|NCT02567227|80600062|FG000|9 Weeks|Adverse Event|5|||
27568794|NCT03013543|80271451|FG004|Overall Study|Lost to Follow-up|0|||
27662385|NCT02567227|80600063|FG001|9 Weeks|Adverse Event|5|||
27861767|NCT01434810|81326129|FG001|Overall Study|Did not receive treatment|3|||
27861768|NCT01434810|81326128|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
27861769|NCT01434810|81326129|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
27568795|NCT03013543|80271452|FG005|Overall Study|Lost to Follow-up|0|||
27568796|NCT03013543|80271453|FG006|Overall Study|Lost to Follow-up|1|||
27568797|NCT03013543|80271454|FG007|Overall Study|Lost to Follow-up|0|||
27568798|NCT03013543|80271455|FG008|Overall Study|Lost to Follow-up|0|||
27568799|NCT03013543|80271456|FG009|Overall Study|Lost to Follow-up|2|||
27568800|NCT03013543|80271447|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27568801|NCT03013543|80271448|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27568802|NCT03013543|80271449|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27568803|NCT03013543|80271450|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27568804|NCT03013543|80271451|FG004|Overall Study|Non-Compliance With Study Drug|0|||
27861770|NCT00552578|81326131|FG000|Overall Study|Lost to Follow-up|1|||
27861771|NCT00552578|81326132|FG001|Overall Study|Lost to Follow-up|1|||
27861772|NCT01221363|81326133|FG000|Overall Study|Pregnancy|1|||
27861773|NCT01221363|81326134|FG001|Overall Study|Pregnancy|0|||
27861774|NCT01221363|81326133|FG000|Overall Study|Withdrawal by Subject|11|||
27861775|NCT01221363|81326134|FG001|Overall Study|Withdrawal by Subject|5|||
27861776|NCT03654599|81326137|FG000|Overall Study|Lost to Follow-up|14|||
27861777|NCT03654599|81326138|FG001|Overall Study|Lost to Follow-up|12|||
27861778|NCT03654599|81326137|FG000|Overall Study|Death|8|||
27861779|NCT03654599|81326138|FG001|Overall Study|Death|6|||
27861780|NCT03654599|81326137|FG000|Overall Study|Withdrawal by Subject|6|||
27861781|NCT03654599|81326138|FG001|Overall Study|Withdrawal by Subject|4|||
27861782|NCT00919854|81326139|FG000|Overall Study|Adverse Event|1|||
27861783|NCT03954834|81326148|FG000|Overall Study|Adverse Event|1|||
27861784|NCT03954834|81326149|FG001|Overall Study|Adverse Event|3|||
27861785|NCT03954834|81326150|FG002|Overall Study|Adverse Event|1|||
27861786|NCT03954834|81326151|FG003|Overall Study|Adverse Event|1|||
27861787|NCT03954834|81326148|FG000|Overall Study|Death|0|||
27861788|NCT03954834|81326149|FG001|Overall Study|Death|0|||
27861789|NCT03954834|81326150|FG002|Overall Study|Death|0|||
27861790|NCT03954834|81326151|FG003|Overall Study|Death|1|||
27861791|NCT03954834|81326148|FG000|Overall Study|Physician Decision|0|||
27861792|NCT03954834|81326149|FG001|Overall Study|Physician Decision|1|||
27861793|NCT03954834|81326150|FG002|Overall Study|Physician Decision|0|||
27861794|NCT03954834|81326151|FG003|Overall Study|Physician Decision|2|||
27861795|NCT03954834|81326148|FG000|Overall Study|Protocol Violation|1|||
27861796|NCT03954834|81326149|FG001|Overall Study|Protocol Violation|0|||
27861797|NCT03954834|81326150|FG002|Overall Study|Protocol Violation|0|||
27861798|NCT03954834|81326151|FG003|Overall Study|Protocol Violation|1|||
27861799|NCT03954834|81326148|FG000|Overall Study|Withdrawal by Subject|2|||
27861800|NCT03954834|81326149|FG001|Overall Study|Withdrawal by Subject|3|||
27861801|NCT03954834|81326150|FG002|Overall Study|Withdrawal by Subject|13|||
27861802|NCT03954834|81326151|FG003|Overall Study|Withdrawal by Subject|6|||
27861803|NCT03954834|81326148|FG000|Overall Study|Participant left the country|0|||
27861804|NCT03954834|81326149|FG001|Overall Study|Participant left the country|0|||
27861805|NCT03954834|81326150|FG002|Overall Study|Participant left the country|1|||
27861806|NCT03954834|81326151|FG003|Overall Study|Participant left the country|0|||
27861807|NCT03954834|81326148|FG000|Overall Study|Lost to Follow-up|3|||
27861808|NCT03954834|81326149|FG001|Overall Study|Lost to Follow-up|2|||
27861809|NCT03954834|81326150|FG002|Overall Study|Lost to Follow-up|3|||
27861810|NCT03954834|81326151|FG003|Overall Study|Lost to Follow-up|5|||
27861811|NCT01283035|81326152|FG000|Overall Study|Subject later found ineligible|1|||
27861812|NCT00206323|81326153|FG000|Overall Study|Lack of Efficacy|4|||
27861813|NCT00206323|81326154|FG001|Overall Study|Lack of Efficacy|1|||
27861814|NCT00206323|81326153|FG000|Overall Study|Adverse Event|1|||
27861815|NCT00206323|81326154|FG001|Overall Study|Adverse Event|1|||
27861816|NCT00206323|81326153|FG000|Overall Study|Lost to Follow-up|1|||
27861817|NCT00206323|81326154|FG001|Overall Study|Lost to Follow-up|1|||
27861818|NCT02473523|81326159|FG000|Overall Study|Death|1|||
27662386|NCT02567227|80600062|FG000|9 Weeks|Withdrawal by Subject|18|||
27662387|NCT02567227|80600063|FG001|9 Weeks|Withdrawal by Subject|8|||
27662388|NCT02567227|80600062|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
27662389|NCT02567227|80600063|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
27662390|NCT02567227|80600062|FG000|6 Month|Death|2|||
27662391|NCT02567227|80600063|FG001|6 Month|Death|0|||
27662392|NCT02567227|80600062|FG000|6 Month|Lost to Follow-up|43|||
27662393|NCT02567227|80600063|FG001|6 Month|Lost to Follow-up|40|||
27662394|NCT02567227|80600062|FG000|12 Months|Lost to Follow-up|31|||
27662395|NCT02567227|80600063|FG001|12 Months|Lost to Follow-up|32|||
27662396|NCT02567227|80600062|FG000|12 Months|Death|0|||
27662397|NCT02567227|80600063|FG001|12 Months|Death|2|||
27662398|NCT01369147|80600064|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
27662399|NCT01369147|80600065|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
27662400|NCT01369147|80600066|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
27662401|NCT01960114|80600069|FG000|Overall Study|Adverse Event|1|||
27861819|NCT02473523|81326159|FG000|Overall Study|Lost to Follow-up|1|||
27861820|NCT03489109|81326171|FG000|Overall Study|Lost to Follow-up|1|||
27861821|NCT03489109|81326172|FG001|Overall Study|Lost to Follow-up|2|||
27861822|NCT01831258|81326173|FG000|Overall Study|Withdrawal by Subject|2|||
27662402|NCT01960114|80600070|FG001|Overall Study|Adverse Event|0|||
27861823|NCT01831258|81326174|FG001|Overall Study|Withdrawal by Subject|1|||
27861824|NCT01831258|81326173|FG000|Overall Study|Lost to Follow-up|3|||
27861825|NCT01831258|81326174|FG001|Overall Study|Lost to Follow-up|2|||
27861826|NCT02466685|81326175|FG000|Overall Study|Adverse Event|5|||
27861827|NCT02466685|81326176|FG001|Overall Study|Adverse Event|2|||
27861828|NCT02466685|81326175|FG000|Overall Study|Lost to Follow-up|1|||
27861829|NCT02466685|81326176|FG001|Overall Study|Lost to Follow-up|1|||
27861830|NCT02466685|81326175|FG000|Overall Study|Withdrawal by Subject|1|||
27861831|NCT02466685|81326176|FG001|Overall Study|Withdrawal by Subject|0|||
27861832|NCT02466685|81326175|FG000|Overall Study|Physician Decision|1|||
27662403|NCT01960114|80600069|FG000|Overall Study|Could not swallow study medication|0|||
27662404|NCT01960114|80600070|FG001|Overall Study|Could not swallow study medication|1|||
27662405|NCT00728884|80600073|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
27662406|NCT00728884|80600073|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
27662407|NCT02573883|80600074|FG000|Six Month Follow Up|Lost to Follow-up|1|||
27662408|NCT02573883|80600075|FG001|Six Month Follow Up|Lost to Follow-up|0|||
27662409|NCT02573883|80600076|FG002|Six Month Follow Up|Lost to Follow-up|0|||
27662410|NCT02573883|80600077|FG003|Six Month Follow Up|Lost to Follow-up|0|||
27662411|NCT02573883|80600074|FG000|One Year Follow Up|Lost to Follow-up|2|||
27662412|NCT02573883|80600075|FG001|One Year Follow Up|Lost to Follow-up|1|||
27662413|NCT02573883|80600076|FG002|One Year Follow Up|Lost to Follow-up|0|||
27662414|NCT02573883|80600077|FG003|One Year Follow Up|Lost to Follow-up|0|||
27662415|NCT02382406|80600078|FG000|Study Treatment|Disease Progression|8|||
27662416|NCT02382406|80600079|FG001|Study Treatment|Disease Progression|0|||
27662417|NCT02382406|80600080|FG002|Study Treatment|Disease Progression|20|||
27662418|NCT02382406|80600078|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
27662419|NCT02382406|80600079|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
27662420|NCT02382406|80600080|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
27662421|NCT02382406|80600078|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
27662422|NCT02382406|80600079|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
27662423|NCT02382406|80600080|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
27662424|NCT02382406|80600078|FG000|Study Treatment|symptomatic deterioration|1|||
27662425|NCT02382406|80600079|FG001|Study Treatment|symptomatic deterioration|0|||
27662426|NCT02382406|80600080|FG002|Study Treatment|symptomatic deterioration|1|||
27662427|NCT02382406|80600078|FG000|Study Treatment|Death|0|||
27662428|NCT02382406|80600079|FG001|Study Treatment|Death|0|||
27662429|NCT02382406|80600080|FG002|Study Treatment|Death|2|||
27662430|NCT02382406|80600078|FG000|Follow up|Death|11|||
27662431|NCT02382406|80600079|FG001|Follow up|Death|0|||
27662432|NCT02382406|80600080|FG002|Follow up|Death|19|||
27662433|NCT02382406|80600078|FG000|Follow up|Symptomatic deterioration|1|||
27662434|NCT02382406|80600079|FG001|Follow up|Symptomatic deterioration|0|||
27662435|NCT02382406|80600080|FG002|Follow up|Symptomatic deterioration|1|||
27662436|NCT02382406|80600078|FG000|Follow up|Patient Refused Follow-up|1|||
27662437|NCT02382406|80600079|FG001|Follow up|Patient Refused Follow-up|0|||
27662438|NCT02382406|80600080|FG002|Follow up|Patient Refused Follow-up|0|||
27662439|NCT02382406|80600078|FG000|Follow up|Study Terminated|1|||
27763020|NCT00603733|80957666|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
27763021|NCT00603733|80957665|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
27763022|NCT00603733|80957666|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
27763023|NCT00603733|80957665|FG000|Maintenance Phase ITT|Physician Decision|0|||
27763024|NCT00603733|80957666|FG001|Maintenance Phase ITT|Physician Decision|1|||
27763025|NCT00603733|80957665|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
27763026|NCT00603733|80957666|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
27763027|NCT00804843|80957667|FG000|Overall Study|Protocol Violation|1|||
27763028|NCT00804843|80957668|FG001|Overall Study|Protocol Violation|0|||
27763029|NCT00804843|80957667|FG000|Overall Study|Adverse Event|8|||
27763030|NCT00804843|80957668|FG001|Overall Study|Adverse Event|5|||
27763031|NCT00804843|80957667|FG000|Overall Study|Withdrawal by Subject|1|||
27763032|NCT00804843|80957668|FG001|Overall Study|Withdrawal by Subject|2|||
27763033|NCT00326417|80957669|FG000|Overall Study|Withdrawal by Subject|0|||
27763034|NCT00326417|80957670|FG001|Overall Study|Withdrawal by Subject|0|||
27763035|NCT00326417|80957671|FG002|Overall Study|Withdrawal by Subject|1|||
27763036|NCT00326417|80957672|FG003|Overall Study|Withdrawal by Subject|0|||
27763037|NCT00326417|80957669|FG000|Overall Study|Arm Closed|7|||
27763038|NCT00326417|80957670|FG001|Overall Study|Arm Closed|0|||
27763039|NCT00326417|80957671|FG002|Overall Study|Arm Closed|0|||
27763040|NCT00326417|80957672|FG003|Overall Study|Arm Closed|3|||
27763041|NCT00326417|80957669|FG000|Overall Study|Death|7|||
27763042|NCT00326417|80957670|FG001|Overall Study|Death|0|||
27763043|NCT00326417|80957671|FG002|Overall Study|Death|0|||
27662440|NCT02382406|80600079|FG001|Follow up|Study Terminated|0|||
27662441|NCT02382406|80600080|FG002|Follow up|Study Terminated|8|||
27662442|NCT02382406|80600078|FG000|Follow up|Withdrawal by Subject|0|||
27662443|NCT02382406|80600079|FG001|Follow up|Withdrawal by Subject|0|||
27662444|NCT02382406|80600080|FG002|Follow up|Withdrawal by Subject|2|||
27662445|NCT05335005|80602766|FG000|Overall Study|Lost to Follow-up|1|||
27662446|NCT02865135|80602767|FG000|Overall Study|Death|0|||
27662447|NCT02865135|80602768|FG001|Overall Study|Death|1|||
27662448|NCT02865135|80602769|FG002|Overall Study|Death|0|||
27763044|NCT00326417|80957672|FG003|Overall Study|Death|0|||
27763045|NCT02472795|80957674|FG000|Overall Study|Adverse Event|0|||
27763046|NCT02472795|80957675|FG001|Overall Study|Adverse Event|1|||
27763047|NCT02472795|80957676|FG002|Overall Study|Adverse Event|0|||
27763048|NCT02472795|80957677|FG003|Overall Study|Adverse Event|0|||
27763049|NCT02472795|80957678|FG004|Overall Study|Adverse Event|2|||
27763050|NCT02472795|80957674|FG000|Overall Study|Withdrawal by Subject|0|||
27763051|NCT02472795|80957675|FG001|Overall Study|Withdrawal by Subject|0|||
27763052|NCT02472795|80957676|FG002|Overall Study|Withdrawal by Subject|0|||
27763053|NCT02472795|80957677|FG003|Overall Study|Withdrawal by Subject|0|||
27763054|NCT02472795|80957678|FG004|Overall Study|Withdrawal by Subject|1|||
27763055|NCT00014911|80957682|FG000|Overall Study|Adverse Event|1|||
27763056|NCT00014911|80957682|FG000|Overall Study|Lost to Follow-up|1|||
27763057|NCT00014911|80957682|FG000|Overall Study|Withdrawal by Subject|6|||
27763058|NCT00014911|80957682|FG000|Overall Study|Unknown Reasons|2|||
27763059|NCT00014911|80957682|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
27763060|NCT00425113|80957683|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
27763061|NCT00425113|80957684|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
27763062|NCT00425113|80957683|FG000|Overall Study|diagnosis of abdominal TB|0|||
27763063|NCT00425113|80957684|FG001|Overall Study|diagnosis of abdominal TB|1|||
27763064|NCT00425113|80957683|FG000|Overall Study|missing study drug more than 14 days|0|||
27763065|NCT00425113|80957684|FG001|Overall Study|missing study drug more than 14 days|1|||
27763066|NCT00425113|80957683|FG000|Overall Study|Withdrawal by Subject|1|||
27763067|NCT00425113|80957684|FG001|Overall Study|Withdrawal by Subject|0|||
27763068|NCT01797445|80957685|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
27763069|NCT01797445|80957686|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
27763070|NCT01797445|80957685|FG000|Double-Blind Phase|Adverse Event|3|||
27763071|NCT01797445|80957686|FG001|Double-Blind Phase|Adverse Event|0|||
27763072|NCT01797445|80957685|FG000|Double-Blind Phase|Death|5|||
27763073|NCT01797445|80957686|FG001|Double-Blind Phase|Death|4|||
27763074|NCT01797445|80957685|FG000|Double-Blind Phase|Pregnancy|0|||
27763075|NCT01797445|80957686|FG001|Double-Blind Phase|Pregnancy|1|||
27763076|NCT01797445|80957685|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27763077|NCT01797445|80957686|FG001|Double-Blind Phase|Lack of Efficacy|2|||
27763078|NCT01797445|80957685|FG000|Double-Blind Phase|Investigator's Discretion|15|||
27763079|NCT01797445|80957686|FG001|Double-Blind Phase|Investigator's Discretion|17|||
27763080|NCT01797445|80957685|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
27763081|NCT01797445|80957686|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
27763082|NCT01797445|80957685|FG000|Double-Blind Phase|Protocol Violation|0|||
27763083|NCT01797445|80957686|FG001|Double-Blind Phase|Protocol Violation|1|||
27763084|NCT01797445|80957685|FG000|Double-Blind Phase|Withdrew Consent|20|||
27763085|NCT01797445|80957686|FG001|Double-Blind Phase|Withdrew Consent|35|||
27763086|NCT01797445|80957685|FG000|Double-Blind Phase|Lost to Follow-up|34|||
27763087|NCT01797445|80957686|FG001|Double-Blind Phase|Lost to Follow-up|26|||
27763088|NCT01797445|80957685|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
27763089|NCT01797445|80957686|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
27763090|NCT03657810|80957691|FG000|Overall Study|Adverse Event|0|||
27763091|NCT03657810|80957692|FG001|Overall Study|Adverse Event|1|||
27763092|NCT03657810|80957693|FG002|Overall Study|Adverse Event|0|||
27763093|NCT03657810|80957691|FG000|Overall Study|Lack of Efficacy|4|||
27763094|NCT03657810|80957692|FG001|Overall Study|Lack of Efficacy|1|||
27763095|NCT03657810|80957693|FG002|Overall Study|Lack of Efficacy|3|||
27763096|NCT03657810|80957691|FG000|Overall Study|Protocol Violation|1|||
27763097|NCT03657810|80957692|FG001|Overall Study|Protocol Violation|0|||
27763098|NCT03657810|80957693|FG002|Overall Study|Protocol Violation|0|||
27763099|NCT03657810|80957691|FG000|Overall Study|Lost to Follow-up|0|||
27763100|NCT03657810|80957692|FG001|Overall Study|Lost to Follow-up|1|||
27763101|NCT03657810|80957693|FG002|Overall Study|Lost to Follow-up|0|||
27763102|NCT03657810|80957691|FG000|Overall Study|Not provided|0|||
27763103|NCT03657810|80957692|FG001|Overall Study|Not provided|1|||
27763104|NCT03657810|80957693|FG002|Overall Study|Not provided|0|||
27861833|NCT02466685|81326176|FG001|Overall Study|Physician Decision|1|||
27861834|NCT00660400|81326177|FG000|Overall Study|Lack of insurance approval|1|||
27662449|NCT02865135|80602767|FG000|Overall Study|Progression|6|||
27662450|NCT02865135|80602768|FG001|Overall Study|Progression|2|||
27662451|NCT02865135|80602769|FG002|Overall Study|Progression|2|||
27662452|NCT01946529|80602770|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
27662453|NCT01946529|80602771|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
27662454|NCT01946529|80602772|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
27662455|NCT01946529|80602770|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
27662456|NCT01946529|80602771|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
27662457|NCT01946529|80602772|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
27662458|NCT02068352|80602773|FG000|Overall Study|Lost to Follow-up|0|||
27763105|NCT04507776|80957694|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
27763106|NCT00880763|80957697|FG000|Extension Period (Part 2)|Adverse Event|0|||
27763107|NCT00880763|80957698|FG001|Extension Period (Part 2)|Adverse Event|0|||
27763108|NCT00880763|80957699|FG002|Extension Period (Part 2)|Adverse Event|1|||
27763109|NCT00880763|80957700|FG003|Extension Period (Part 2)|Adverse Event|1|||
27763110|NCT00880763|80957697|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
27763111|NCT00880763|80957698|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
27763112|NCT00880763|80957699|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
27763113|NCT00880763|80957700|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
27861835|NCT00660400|81326177|FG000|Overall Study|Suboptimal organ function|1|||
27662459|NCT02068352|80602774|FG001|Overall Study|Lost to Follow-up|2|||
27662460|NCT02068352|80602775|FG002|Overall Study|Lost to Follow-up|0|||
27662461|NCT02068352|80602773|FG000|Overall Study|Adverse Event|4|||
27662462|NCT02068352|80602774|FG001|Overall Study|Adverse Event|2|||
27662463|NCT02068352|80602775|FG002|Overall Study|Adverse Event|7|||
27662464|NCT02068352|80602773|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
27662465|NCT02068352|80602774|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
27662466|NCT02068352|80602775|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
27662467|NCT02068352|80602773|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
27662468|NCT02068352|80602774|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
27662469|NCT02068352|80602775|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
27662470|NCT02068352|80602773|FG000|Overall Study|Protocol Deviation|0|||
27662471|NCT02068352|80602774|FG001|Overall Study|Protocol Deviation|0|||
27662472|NCT02068352|80602775|FG002|Overall Study|Protocol Deviation|1|||
27763114|NCT00880763|80957697|FG000|Extension Period (Part 2)|Physician Decision|0|||
27763115|NCT00880763|80957698|FG001|Extension Period (Part 2)|Physician Decision|1|||
27763116|NCT00880763|80957699|FG002|Extension Period (Part 2)|Physician Decision|1|||
27763117|NCT00880763|80957700|FG003|Extension Period (Part 2)|Physician Decision|0|||
27763118|NCT00880763|80957697|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
27763119|NCT00880763|80957698|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
27763120|NCT00880763|80957699|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
27763121|NCT00880763|80957700|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
27763122|NCT03495817|80957701|FG000|26 Week Open Label|Adverse Event|3|||
27763123|NCT03495817|80957701|FG000|26 Week Open Label|Withdrawal by Subject|4|||
27763124|NCT03495817|80957701|FG000|26 Week Open Label|Lost to Follow-up|1|||
27763125|NCT03495817|80957701|FG000|26 Week Extension|Lost to Follow-up|2|||
27763126|NCT02528253|80957702|FG000|Overall Study|Adverse Event|3|||
27763127|NCT02528253|80957703|FG001|Overall Study|Adverse Event|4|||
27763128|NCT02528253|80957704|FG002|Overall Study|Adverse Event|4|||
27763129|NCT02528253|80957705|FG003|Overall Study|Adverse Event|8|||
27763130|NCT02528253|80957706|FG004|Overall Study|Adverse Event|18|||
27763131|NCT02528253|80957702|FG000|Overall Study|Death|2|||
27763132|NCT02528253|80957703|FG001|Overall Study|Death|2|||
27763133|NCT02528253|80957704|FG002|Overall Study|Death|1|||
27763134|NCT02528253|80957705|FG003|Overall Study|Death|0|||
27763135|NCT02528253|80957706|FG004|Overall Study|Death|1|||
27763136|NCT02528253|80957702|FG000|Overall Study|Insufficient clinical response|7|||
27763137|NCT02528253|80957703|FG001|Overall Study|Insufficient clinical response|10|||
27763138|NCT02528253|80957704|FG002|Overall Study|Insufficient clinical response|13|||
27763139|NCT02528253|80957705|FG003|Overall Study|Insufficient clinical response|12|||
27763140|NCT02528253|80957706|FG004|Overall Study|Insufficient clinical response|16|||
27763141|NCT02528253|80957702|FG000|Overall Study|Lost to Follow-up|16|||
27763142|NCT02528253|80957703|FG001|Overall Study|Lost to Follow-up|9|||
27763143|NCT02528253|80957704|FG002|Overall Study|Lost to Follow-up|31|||
27763144|NCT02528253|80957705|FG003|Overall Study|Lost to Follow-up|16|||
27763145|NCT02528253|80957706|FG004|Overall Study|Lost to Follow-up|34|||
27763146|NCT02528253|80957702|FG000|Overall Study|Other|21|||
27763147|NCT02528253|80957703|FG001|Overall Study|Other|22|||
27763148|NCT02528253|80957704|FG002|Overall Study|Other|58|||
27763149|NCT02528253|80957705|FG003|Overall Study|Other|52|||
27763150|NCT02528253|80957706|FG004|Overall Study|Other|76|||
27763151|NCT02528253|80957702|FG000|Overall Study|Withdrawal by Subject|25|||
27763152|NCT02528253|80957703|FG001|Overall Study|Withdrawal by Subject|20|||
27763153|NCT02528253|80957704|FG002|Overall Study|Withdrawal by Subject|29|||
27763154|NCT02528253|80957705|FG003|Overall Study|Withdrawal by Subject|48|||
27763155|NCT02528253|80957706|FG004|Overall Study|Withdrawal by Subject|73|||
27763156|NCT02528253|80957702|FG000|Overall Study|Protocol Violation|1|||
27763157|NCT02528253|80957703|FG001|Overall Study|Protocol Violation|2|||
27763158|NCT02528253|80957704|FG002|Overall Study|Protocol Violation|4|||
27763159|NCT02528253|80957705|FG003|Overall Study|Protocol Violation|0|||
27763160|NCT02528253|80957706|FG004|Overall Study|Protocol Violation|4|||
27763161|NCT02528253|80957702|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
27763162|NCT02528253|80957703|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
27763163|NCT02528253|80957704|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
27763164|NCT02528253|80957705|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
27763165|NCT02528253|80957706|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
27763166|NCT00424294|80957707|FG000|Overall Study|Adverse Event|4|||
27763167|NCT00424294|80957708|FG001|Overall Study|Adverse Event|10|||
27763168|NCT00424294|80957707|FG000|Overall Study|Lack of Efficacy|2|||
27763169|NCT00424294|80957708|FG001|Overall Study|Lack of Efficacy|1|||
27763170|NCT00424294|80957707|FG000|Overall Study|Withdrawal by Subject|1|||
27763171|NCT00424294|80957708|FG001|Overall Study|Withdrawal by Subject|2|||
27763172|NCT00424294|80957707|FG000|Overall Study|Other|0|||
27861836|NCT00660400|81326177|FG000|Overall Study|Intracranial hemorrhage|1|||
27763173|NCT00424294|80957708|FG001|Overall Study|Other|2|||
27763174|NCT00424294|80957707|FG000|Overall Study|Randomized but not Treated|1|||
27861837|NCT00660400|81326177|FG000|Overall Study|Withdrawal by Subject|1|||
27763175|NCT00424294|80957708|FG001|Overall Study|Randomized but not Treated|0|||
27763176|NCT02031432|80957711|FG000|Overall Study|Protocol Violation|1|||
27763177|NCT02031432|80957711|FG000|Overall Study|Lack of Efficacy|5|||
27763178|NCT02031432|80957711|FG000|Overall Study|Cancer Progression|2|||
27763179|NCT02031432|80957711|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
27763180|NCT02031432|80957711|FG000|Overall Study|Adverse Event|8|||
27763181|NCT02031432|80957711|FG000|Overall Study|Withdrawal by Subject|5|||
27763182|NCT02031432|80957711|FG000|Overall Study|Lost to Follow-up|1|||
27763183|NCT02031432|80957711|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
27763184|NCT02031432|80957711|FG000|Overall Study|Death|10|||
27763185|NCT01019252|80957716|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
27763186|NCT01019252|80957717|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
27763187|NCT01019252|80957716|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
27763188|NCT01019252|80957717|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
27763189|NCT01019252|80957716|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
27662473|NCT01732926|80602776|FG000|Overall Study|Study Terminated by Sponsor|168|||
27662474|NCT01732926|80602777|FG001|Overall Study|Study Terminated by Sponsor|80|||
27662475|NCT01732926|80602776|FG000|Overall Study|Withdrawal by Subject|46|||
27763190|NCT01019252|80957717|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
27763191|NCT01019252|80957716|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
27763192|NCT01019252|80957717|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
27763193|NCT01688635|80957718|FG000|Washout 1|Withdrawal by Subject|1|||
27763194|NCT01688635|80957719|FG001|Washout 1|Withdrawal by Subject|0|||
27763195|NCT01688635|80957718|FG000|Washout 1|Adverse Event|0|||
27763196|NCT01688635|80957719|FG001|Washout 1|Adverse Event|1|||
27763197|NCT01688635|80957718|FG000|Washout 1|Physician Decision|0|||
27763198|NCT01688635|80957719|FG001|Washout 1|Physician Decision|1|||
27662476|NCT01732926|80602777|FG001|Overall Study|Withdrawal by Subject|8|||
27662477|NCT01732926|80602776|FG000|Overall Study|Physician Decision|24|||
27662478|NCT01732926|80602777|FG001|Overall Study|Physician Decision|11|||
27662479|NCT01732926|80602776|FG000|Overall Study|Other Reason|21|||
27662480|NCT01732926|80602777|FG001|Overall Study|Other Reason|4|||
27662481|NCT01732926|80602776|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
27662482|NCT01732926|80602777|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
27662483|NCT01732926|80602776|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
27662484|NCT01732926|80602777|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
27662485|NCT02093897|80602778|FG000|Overall Study|Physician Decision|1|||
27662486|NCT02093897|80602778|FG000|Overall Study|Planned age group closure - no's reached|17|||
27662487|NCT02093897|80602778|FG000|Overall Study|Adverse event, non-fatal|1|||
27662488|NCT01533181|80602779|FG000|Overall Study|Disease progression pre-active treatment|0|||
27662489|NCT01533181|80602780|FG001|Overall Study|Disease progression pre-active treatment|1|||
27662490|NCT01533181|80602779|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
27662491|NCT01533181|80602780|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
27662492|NCT00550771|80602781|FG000|Overall Study|Adverse Event|11|||
27662493|NCT00550771|80602782|FG001|Overall Study|Adverse Event|3|||
27662494|NCT00550771|80602781|FG000|Overall Study|Discontinued for study-related reasons|0|||
27662495|NCT00550771|80602782|FG001|Overall Study|Discontinued for study-related reasons|1|||
27662496|NCT00550771|80602781|FG000|Overall Study|Physician Decision|2|||
27662497|NCT00550771|80602782|FG001|Overall Study|Physician Decision|0|||
27662498|NCT00550771|80602781|FG000|Overall Study|Withdrawal by Subject|0|||
27662499|NCT00550771|80602782|FG001|Overall Study|Withdrawal by Subject|1|||
27662500|NCT00550771|80602781|FG000|Overall Study|Protocol Violation|4|||
27662501|NCT00550771|80602782|FG001|Overall Study|Protocol Violation|5|||
27662502|NCT02777242|80602783|FG000|Overall Study|Other|2|||
27662503|NCT02777242|80602783|FG000|Overall Study|Lost to Follow-up|1|||
27662504|NCT02777242|80602783|FG000|Overall Study|Multiple|1|||
27662505|NCT02777242|80602783|FG000|Overall Study|Sponsor's request|1|||
27662506|NCT02777242|80602783|FG000|Overall Study|Withdrawal by Subject|1|||
27662507|NCT02864147|80602788|FG000|Overall Study|Withdrawal by Subject|3|||
27662508|NCT02864147|80602789|FG001|Overall Study|Withdrawal by Subject|2|||
27662509|NCT02864147|80602790|FG002|Overall Study|Withdrawal by Subject|1|||
27662510|NCT02864147|80602788|FG000|Overall Study|Lost to Follow-up|0|||
27662511|NCT02864147|80602789|FG001|Overall Study|Lost to Follow-up|4|||
27662512|NCT02864147|80602790|FG002|Overall Study|Lost to Follow-up|0|||
27662513|NCT02864147|80602788|FG000|Overall Study|Adverse Event|0|||
27662514|NCT02864147|80602789|FG001|Overall Study|Adverse Event|1|||
27662515|NCT02864147|80602790|FG002|Overall Study|Adverse Event|0|||
27662516|NCT02864147|80602788|FG000|Overall Study|Pregnancy|4|||
27662517|NCT02864147|80602789|FG001|Overall Study|Pregnancy|0|||
27662518|NCT02864147|80602790|FG002|Overall Study|Pregnancy|0|||
27662519|NCT02864147|80602788|FG000|Overall Study|Physician Decision|0|||
27763199|NCT01688635|80957718|FG000|Washout 2|Physician Decision|1|||
27763200|NCT01688635|80957719|FG001|Washout 2|Physician Decision|0|||
27763201|NCT01688635|80957718|FG000|Washout 2|Withdrawal by Subject|1|||
27763202|NCT01688635|80957719|FG001|Washout 2|Withdrawal by Subject|0|||
27763203|NCT01688635|80957718|FG000|Washout 2|Sponsor Decision|1|||
27763204|NCT01688635|80957719|FG001|Washout 2|Sponsor Decision|2|||
27763205|NCT01688635|80957718|FG000|Washout 3|Withdrawal by Subject|1|||
27763206|NCT01688635|80957719|FG001|Washout 3|Withdrawal by Subject|0|||
27763207|NCT00166517|80957720|FG000|Overall Study|Lost to Follow-up|1|||
27763208|NCT00166517|80957721|FG001|Overall Study|Lost to Follow-up|0|||
27763209|NCT00166517|80957720|FG000|Overall Study|Protocol Violation|4|||
27763210|NCT00166517|80957721|FG001|Overall Study|Protocol Violation|1|||
27763211|NCT00166517|80957720|FG000|Overall Study|Withdrawal by Subject|0|||
27763212|NCT00166517|80957721|FG001|Overall Study|Withdrawal by Subject|1|||
27763213|NCT03814005|80962579|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
27763214|NCT03814005|80962580|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
27763215|NCT03814005|80962581|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
27763216|NCT03814005|80962579|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
27763217|NCT03814005|80962580|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
27763218|NCT03814005|80962581|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
27763219|NCT03814005|80962579|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
27763220|NCT03814005|80962580|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
27763221|NCT03814005|80962581|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
27763222|NCT03814005|80962579|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
27763223|NCT03814005|80962580|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
27763224|NCT03814005|80962581|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
27763225|NCT03814005|80962579|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
27763226|NCT03814005|80962580|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
27763227|NCT03814005|80962581|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
27763228|NCT03814005|80962579|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
27763229|NCT03814005|80962580|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
27763230|NCT03814005|80962581|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
27763231|NCT01419015|80962588|FG000|Overall Study|Death|2|||
27763232|NCT00004732|80962589|FG000|Overall Study|Withdrawal by Subject|36|||
27763233|NCT00004732|80962590|FG001|Overall Study|Withdrawal by Subject|64|||
27763234|NCT00004732|80962589|FG000|Overall Study|Lost to Follow-up|33|||
27763235|NCT00004732|80962590|FG001|Overall Study|Lost to Follow-up|47|||
27763236|NCT02727660|80962591|FG000|Overall Study|Lack of Efficacy|40|||
27763237|NCT02727660|80962592|FG001|Overall Study|Lack of Efficacy|40|||
27763238|NCT02727660|80962593|FG002|Overall Study|Lack of Efficacy|70|||
27763239|NCT02727660|80962591|FG000|Overall Study|Adverse Event|28|||
27763240|NCT02727660|80962592|FG001|Overall Study|Adverse Event|21|||
27763241|NCT02727660|80962593|FG002|Overall Study|Adverse Event|32|||
27763242|NCT02727660|80962591|FG000|Overall Study|Withdrawal by Subject|26|||
27763243|NCT02727660|80962592|FG001|Overall Study|Withdrawal by Subject|25|||
27763244|NCT02727660|80962593|FG002|Overall Study|Withdrawal by Subject|30|||
27763245|NCT02727660|80962591|FG000|Overall Study|Physician Decision|3|||
27763246|NCT02727660|80962592|FG001|Overall Study|Physician Decision|8|||
27763247|NCT02727660|80962593|FG002|Overall Study|Physician Decision|14|||
27763248|NCT02727660|80962591|FG000|Overall Study|Lost to Follow-up|5|||
27763249|NCT02727660|80962592|FG001|Overall Study|Lost to Follow-up|9|||
27763250|NCT02727660|80962593|FG002|Overall Study|Lost to Follow-up|8|||
27763251|NCT02727660|80962591|FG000|Overall Study|Protocol Violation|7|||
27763252|NCT02727660|80962592|FG001|Overall Study|Protocol Violation|5|||
27763253|NCT02727660|80962593|FG002|Overall Study|Protocol Violation|5|||
27763254|NCT02727660|80962591|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
27763255|NCT02727660|80962592|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
27763256|NCT02727660|80962593|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
27763257|NCT02727660|80962591|FG000|Overall Study|Administrative Reasons|2|||
27763258|NCT02727660|80962592|FG001|Overall Study|Administrative Reasons|3|||
27763259|NCT02727660|80962593|FG002|Overall Study|Administrative Reasons|4|||
27763260|NCT02378883|80962594|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
27763261|NCT02378883|80962594|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
27763262|NCT02378883|80962594|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
27763263|NCT02378883|80962594|FG000|30 Day Follow-Up|Physician Decision|2|||
27662520|NCT02864147|80602789|FG001|Overall Study|Physician Decision|0|||
27763264|NCT02378883|80962594|FG000|30 Day Follow-Up|Missed Visit|2|||
27763265|NCT02378883|80962594|FG000|30 Day Follow-Up|Death|1|||
27763266|NCT02378883|80962594|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
27763267|NCT02378883|80962594|FG000|12 Months Follow-Up|Death|2|||
27763268|NCT00345540|80962597|FG000|Overall Study|Withdrawal by Subject|1|||
27763269|NCT05563714|80962602|FG000|Overall Study|Death|2|||
27763270|NCT05563714|80962603|FG001|Overall Study|Death|2|||
27763271|NCT05563714|80962604|FG002|Overall Study|Death|0|||
27763272|NCT05563714|80962605|FG003|Overall Study|Death|0|||
27763273|NCT05563714|80962602|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
27763274|NCT05563714|80962603|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
27763275|NCT05563714|80962604|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
27832923|NCT04583423|81219402|FG001|Overall Study|Withdrawal by Subject|1|||
27763276|NCT05563714|80962605|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
27763277|NCT05563714|80962602|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
27763278|NCT05563714|80962603|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
27763279|NCT05563714|80962604|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
27763280|NCT05563714|80962605|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
27763281|NCT05563714|80962602|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
27763282|NCT05563714|80962603|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
27763283|NCT05563714|80962604|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
27763284|NCT05563714|80962605|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
27763285|NCT05563714|80962602|FG000|Overall Study|Lost to Follow-up|22|||
27763286|NCT05563714|80962603|FG001|Overall Study|Lost to Follow-up|19|||
27763287|NCT05563714|80962604|FG002|Overall Study|Lost to Follow-up|0|||
27763288|NCT05563714|80962605|FG003|Overall Study|Lost to Follow-up|0|||
27763289|NCT00305604|80962606|FG000|Overall Study|Adverse Event|6|||
27763290|NCT00305604|80962607|FG001|Overall Study|Adverse Event|3|||
27662521|NCT02864147|80602790|FG002|Overall Study|Physician Decision|1|||
27662522|NCT02864147|80602788|FG000|Overall Study|Opted for excisional procedures|0|||
27662523|NCT02864147|80602789|FG001|Overall Study|Opted for excisional procedures|0|||
27662524|NCT02864147|80602790|FG002|Overall Study|Opted for excisional procedures|3|||
27662525|NCT02329223|80602793|FG000|Overall Study|Withdrawal by Subject|1|||
27662526|NCT02329223|80602794|FG001|Overall Study|Withdrawal by Subject|2|||
27763291|NCT00305604|80962606|FG000|Overall Study|Lack of Efficacy|11|||
27763292|NCT00305604|80962607|FG001|Overall Study|Lack of Efficacy|18|||
27763293|NCT00305604|80962606|FG000|Overall Study|Lost to Follow-up|0|||
27763294|NCT00305604|80962607|FG001|Overall Study|Lost to Follow-up|4|||
27763295|NCT00305604|80962606|FG000|Overall Study|Protocol Violation|2|||
27763296|NCT00305604|80962607|FG001|Overall Study|Protocol Violation|1|||
27763297|NCT00305604|80962606|FG000|Overall Study|Withdrawal by Subject|12|||
27763298|NCT00305604|80962607|FG001|Overall Study|Withdrawal by Subject|21|||
27763299|NCT00305604|80962606|FG000|Overall Study|Patient moved|1|||
27763300|NCT00305604|80962607|FG001|Overall Study|Patient moved|0|||
27763301|NCT01153841|80962608|FG000|Overall Study|Adverse Event|1|||
27763302|NCT01153841|80962609|FG001|Overall Study|Adverse Event|0|||
27763303|NCT01153841|80962608|FG000|Overall Study|Withdrawal by Subject|1|||
27763304|NCT01153841|80962609|FG001|Overall Study|Withdrawal by Subject|0|||
27763305|NCT01153841|80962608|FG000|Overall Study|Protocol Violation|2|||
27763306|NCT01153841|80962609|FG001|Overall Study|Protocol Violation|0|||
27763307|NCT01153841|80962608|FG000|Overall Study|Lost to Follow-up|2|||
27763308|NCT01153841|80962609|FG001|Overall Study|Lost to Follow-up|0|||
27861838|NCT04386616|81326178|FG000|Overall Study|Death|22|||
27861839|NCT04386616|81326179|FG001|Overall Study|Death|22|||
27861840|NCT04386616|81326180|FG002|Overall Study|Death|21|||
27662527|NCT02329223|80602795|FG002|Overall Study|Withdrawal by Subject|5|||
27662528|NCT02329223|80602793|FG000|Overall Study|Physician Decision|0|||
27662529|NCT02329223|80602794|FG001|Overall Study|Physician Decision|0|||
27662530|NCT02329223|80602795|FG002|Overall Study|Physician Decision|1|||
27763309|NCT01576406|80962610|FG000|Overall Study|Lost to Follow-up|1|||
27662531|NCT02329223|80602793|FG000|Overall Study|Adverse Event|0|||
27662532|NCT02329223|80602794|FG001|Overall Study|Adverse Event|1|||
27662533|NCT02329223|80602795|FG002|Overall Study|Adverse Event|0|||
27662534|NCT01123642|80602797|FG000|Overall Study|Lost to Follow-up|23|||
27662535|NCT01123642|80602797|FG000|Overall Study|Withdrawal by Subject|9|||
27662536|NCT01123642|80602797|FG000|Overall Study|ineligible at baseline assessment|36|||
27662537|NCT01049984|80602798|FG000|Overall Study|Withdrawal by Subject|1|||
27662538|NCT01049984|80602799|FG001|Overall Study|Withdrawal by Subject|5|||
27662539|NCT01049984|80602798|FG000|Overall Study|Protocol Violation|3|||
27568805|NCT03013543|80271452|FG005|Overall Study|Non-Compliance With Study Drug|0|||
27568806|NCT03013543|80271453|FG006|Overall Study|Non-Compliance With Study Drug|0|||
27662540|NCT01049984|80602799|FG001|Overall Study|Protocol Violation|4|||
27662541|NCT01049984|80602798|FG000|Overall Study|Lost to Follow-up|2|||
27662542|NCT01049984|80602799|FG001|Overall Study|Lost to Follow-up|1|||
27662543|NCT01049984|80602798|FG000|Overall Study|Adverse Event|13|||
27662544|NCT01049984|80602799|FG001|Overall Study|Adverse Event|7|||
27662545|NCT01049984|80602798|FG000|Overall Study|Treatment failure|0|||
27763310|NCT01576406|80962611|FG001|Overall Study|Lost to Follow-up|2|||
27763311|NCT01576406|80962612|FG002|Overall Study|Lost to Follow-up|0|||
27763312|NCT01576406|80962613|FG003|Overall Study|Lost to Follow-up|0|||
27763313|NCT01576406|80962614|FG004|Overall Study|Lost to Follow-up|0|||
27568807|NCT03013543|80271454|FG007|Overall Study|Non-Compliance With Study Drug|0|||
27662546|NCT01049984|80602799|FG001|Overall Study|Treatment failure|2|||
27662547|NCT00434577|80602800|FG000|Months 0-3|Serious Adverse Event|0|||
27662548|NCT00434577|80602801|FG001|Months 0-3|Serious Adverse Event|0|||
27662549|NCT00434577|80602802|FG002|Months 0-3|Serious Adverse Event|1|||
27662550|NCT00434577|80602803|FG003|Months 0-3|Serious Adverse Event|0|||
27763314|NCT01576406|80962615|FG005|Overall Study|Lost to Follow-up|0|||
27763315|NCT01576406|80962610|FG000|Overall Study|Death|3|||
27763316|NCT01576406|80962611|FG001|Overall Study|Death|4|||
27763317|NCT01576406|80962612|FG002|Overall Study|Death|8|||
27763318|NCT01576406|80962613|FG003|Overall Study|Death|5|||
27763319|NCT01576406|80962614|FG004|Overall Study|Death|7|||
27763320|NCT01576406|80962615|FG005|Overall Study|Death|9|||
27763321|NCT01576406|80962610|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27763322|NCT01576406|80962611|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27763323|NCT01576406|80962612|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
27763324|NCT01576406|80962613|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
27763325|NCT01576406|80962614|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27763326|NCT01576406|80962615|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
27763327|NCT01576406|80962610|FG000|Overall Study|Withdrawal the consent|2|||
27763328|NCT01576406|80962611|FG001|Overall Study|Withdrawal the consent|2|||
27763329|NCT01576406|80962612|FG002|Overall Study|Withdrawal the consent|5|||
27763330|NCT01576406|80962613|FG003|Overall Study|Withdrawal the consent|1|||
27763331|NCT01576406|80962614|FG004|Overall Study|Withdrawal the consent|1|||
27763332|NCT01576406|80962615|FG005|Overall Study|Withdrawal the consent|3|||
27763333|NCT01576406|80962610|FG000|Overall Study|Other|0|||
27763334|NCT01576406|80962611|FG001|Overall Study|Other|0|||
27763335|NCT01576406|80962612|FG002|Overall Study|Other|2|||
27763336|NCT01576406|80962613|FG003|Overall Study|Other|2|||
27763337|NCT01576406|80962614|FG004|Overall Study|Other|0|||
27763338|NCT01576406|80962615|FG005|Overall Study|Other|0|||
27763339|NCT03750240|80962616|FG000|Overall Study|Technical Difficulties|2|||
27763340|NCT05200455|80962617|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
27763341|NCT04179786|80962618|FG000|Overall Study|Withdrawal by Subject|8|||
27763342|NCT00781963|80962619|FG000|Overall Study|Death|3|||
27763343|NCT00781963|80962620|FG001|Overall Study|Death|0|||
27763344|NCT00781963|80962619|FG000|Overall Study|Lost to Follow-up|2|||
27763345|NCT00781963|80962620|FG001|Overall Study|Lost to Follow-up|1|||
27763346|NCT00781963|80962619|FG000|Overall Study|Withdrawal by Subject|3|||
27763347|NCT00781963|80962620|FG001|Overall Study|Withdrawal by Subject|1|||
27763348|NCT00781963|80962619|FG000|Overall Study|Refused follow-up|9|||
27763349|NCT00781963|80962620|FG001|Overall Study|Refused follow-up|0|||
27763350|NCT02198651|80962621|FG000|Lead-in Period|Withdrew consent|13|||
27763351|NCT02198651|80962622|FG001|Lead-in Period|Withdrew consent|0|||
27763352|NCT02198651|80962623|FG002|Lead-in Period|Withdrew consent|0|||
27763353|NCT02198651|80962624|FG003|Lead-in Period|Withdrew consent|0|||
27763354|NCT02198651|80962625|FG004|Lead-in Period|Withdrew consent|0|||
27763355|NCT02198651|80962621|FG000|Lead-in Period|Adverse Event|2|||
27763356|NCT02198651|80962622|FG001|Lead-in Period|Adverse Event|0|||
27763357|NCT02198651|80962623|FG002|Lead-in Period|Adverse Event|0|||
27763358|NCT02198651|80962624|FG003|Lead-in Period|Adverse Event|0|||
27763359|NCT02198651|80962625|FG004|Lead-in Period|Adverse Event|0|||
27763360|NCT02198651|80962621|FG000|Lead-in Period|Other, not specified|22|||
27763361|NCT02198651|80962622|FG001|Lead-in Period|Other, not specified|0|||
27763362|NCT02198651|80962623|FG002|Lead-in Period|Other, not specified|0|||
27763363|NCT02198651|80962624|FG003|Lead-in Period|Other, not specified|0|||
27763364|NCT02198651|80962625|FG004|Lead-in Period|Other, not specified|0|||
27763365|NCT02198651|80962621|FG000|Double-blind Period|Withdrew consent|0|||
27763366|NCT02198651|80962622|FG001|Double-blind Period|Withdrew consent|4|||
27763367|NCT02198651|80962623|FG002|Double-blind Period|Withdrew consent|0|||
27763368|NCT02198651|80962624|FG003|Double-blind Period|Withdrew consent|0|||
27763369|NCT02198651|80962625|FG004|Double-blind Period|Withdrew consent|0|||
27763370|NCT02198651|80962621|FG000|Double-blind Period|Adverse Event|0|||
27763371|NCT02198651|80962622|FG001|Double-blind Period|Adverse Event|1|||
27763372|NCT02198651|80962623|FG002|Double-blind Period|Adverse Event|0|||
27763373|NCT02198651|80962624|FG003|Double-blind Period|Adverse Event|0|||
27763374|NCT02198651|80962625|FG004|Double-blind Period|Adverse Event|0|||
27763375|NCT02198651|80962621|FG000|Double-blind Period|Other, not specified|0|||
27763376|NCT02198651|80962622|FG001|Double-blind Period|Other, not specified|4|||
27763377|NCT02198651|80962623|FG002|Double-blind Period|Other, not specified|1|||
27763378|NCT02198651|80962624|FG003|Double-blind Period|Other, not specified|0|||
27763379|NCT02198651|80962625|FG004|Double-blind Period|Other, not specified|0|||
27763380|NCT02198651|80962621|FG000|Open-label Rescue Period|Withdrew consent|0|||
27763381|NCT02198651|80962622|FG001|Open-label Rescue Period|Withdrew consent|0|||
27568808|NCT03013543|80271455|FG008|Overall Study|Non-Compliance With Study Drug|1|||
27763382|NCT02198651|80962623|FG002|Open-label Rescue Period|Withdrew consent|0|||
27568809|NCT03013543|80271456|FG009|Overall Study|Non-Compliance With Study Drug|0|||
27763383|NCT02198651|80962624|FG003|Open-label Rescue Period|Withdrew consent|2|||
27763384|NCT02198651|80962625|FG004|Open-label Rescue Period|Withdrew consent|0|||
27763385|NCT02198651|80962621|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27763386|NCT02198651|80962622|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27763387|NCT02198651|80962623|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27763388|NCT02198651|80962624|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
27763389|NCT02198651|80962625|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
27763390|NCT00109772|80962626|FG000|Double-blind Treatment|Adverse Event|14|||
27763391|NCT00109772|80962627|FG001|Double-blind Treatment|Adverse Event|5|||
27763392|NCT00109772|80962626|FG000|Double-blind Treatment|Lack of Efficacy|1|||
27763393|NCT00109772|80962627|FG001|Double-blind Treatment|Lack of Efficacy|0|||
27763394|NCT00109772|80962626|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
27763395|NCT00109772|80962627|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
27763396|NCT00109772|80962626|FG000|Double-blind Treatment|Lost to Follow-up|2|||
27763397|NCT00109772|80962627|FG001|Double-blind Treatment|Lost to Follow-up|3|||
27763398|NCT00109772|80962626|FG000|Double-blind Treatment|Protocol Violation|0|||
27763399|NCT00109772|80962627|FG001|Double-blind Treatment|Protocol Violation|1|||
27763400|NCT00109772|80962626|FG000|Double-blind Treatment|Other|0|||
27763401|NCT00109772|80962627|FG001|Double-blind Treatment|Other|4|||
27763402|NCT00109772|80962626|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
27763403|NCT00109772|80962627|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
27763404|NCT00109772|80962626|FG000|Open-label Extension|Adverse Event|10|||
27763405|NCT00109772|80962627|FG001|Open-label Extension|Adverse Event|19|||
27763406|NCT00109772|80962626|FG000|Open-label Extension|Lack of Efficacy|19|||
27763407|NCT00109772|80962627|FG001|Open-label Extension|Lack of Efficacy|11|||
27763408|NCT00109772|80962626|FG000|Open-label Extension|Withdrawal by Subject|9|||
27763409|NCT00109772|80962627|FG001|Open-label Extension|Withdrawal by Subject|6|||
27763410|NCT00109772|80962626|FG000|Open-label Extension|Lost to Follow-up|1|||
27763411|NCT00109772|80962627|FG001|Open-label Extension|Lost to Follow-up|0|||
27763412|NCT00109772|80962626|FG000|Open-label Extension|Death|0|||
27763413|NCT00109772|80962627|FG001|Open-label Extension|Death|1|||
27763414|NCT00109772|80962626|FG000|Open-label Extension|Protocol Violation|2|||
27763415|NCT00109772|80962627|FG001|Open-label Extension|Protocol Violation|2|||
27763416|NCT00109772|80962626|FG000|Open-label Extension|Other|4|||
27763417|NCT00109772|80962627|FG001|Open-label Extension|Other|10|||
27763418|NCT04247815|80962628|FG000|Overall Study|Adverse Event|1|||
27763419|NCT04247815|80962629|FG001|Overall Study|Adverse Event|0|||
27763420|NCT04247815|80962628|FG000|Overall Study|Withdrawal by Subject|1|||
27763421|NCT04247815|80962629|FG001|Overall Study|Withdrawal by Subject|0|||
27763422|NCT04247815|80962628|FG000|Overall Study|Protocol Violation|0|||
27763423|NCT04247815|80962629|FG001|Overall Study|Protocol Violation|1|||
27763424|NCT03654755|80962630|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
27763425|NCT03654755|80962631|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
27763426|NCT03654755|80962632|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
27763427|NCT03654755|80962630|FG000|Overall Study|Withdrawal by Subject|2|||
27763428|NCT03654755|80962631|FG001|Overall Study|Withdrawal by Subject|4|||
27763429|NCT03654755|80962632|FG002|Overall Study|Withdrawal by Subject|8|||
27763430|NCT03654755|80962630|FG000|Overall Study|Lost to Follow-up|1|||
27763431|NCT03654755|80962631|FG001|Overall Study|Lost to Follow-up|3|||
27763432|NCT03654755|80962632|FG002|Overall Study|Lost to Follow-up|7|||
27763433|NCT03654755|80962630|FG000|Overall Study|Physician Decision|0|||
27763434|NCT03654755|80962631|FG001|Overall Study|Physician Decision|1|||
27763435|NCT03654755|80962632|FG002|Overall Study|Physician Decision|0|||
27763436|NCT03654755|80962630|FG000|Overall Study|Adverse Event|0|||
27763437|NCT03654755|80962631|FG001|Overall Study|Adverse Event|0|||
27763438|NCT03654755|80962632|FG002|Overall Study|Adverse Event|4|||
27763439|NCT03654755|80962630|FG000|Overall Study|Lack of Efficacy|0|||
27763440|NCT03654755|80962631|FG001|Overall Study|Lack of Efficacy|0|||
27763441|NCT03654755|80962632|FG002|Overall Study|Lack of Efficacy|1|||
27763442|NCT01601470|80962635|FG000|Period 2 - LCZ696|Physician Decision|1|||
27763443|NCT01641991|80962643|FG000|Overall Study|Physician Decision|0|||
27763444|NCT01641991|80962644|FG001|Overall Study|Physician Decision|1|||
27763445|NCT01641991|80962645|FG002|Overall Study|Physician Decision|7|||
27763446|NCT01641991|80962646|FG003|Overall Study|Physician Decision|5|||
27763447|NCT01641991|80962643|FG000|Overall Study|Withdrawal by Subject|4|||
27763448|NCT01641991|80962644|FG001|Overall Study|Withdrawal by Subject|2|||
27763449|NCT01641991|80962645|FG002|Overall Study|Withdrawal by Subject|1|||
27763450|NCT01641991|80962646|FG003|Overall Study|Withdrawal by Subject|5|||
27763451|NCT01641991|80962643|FG000|Overall Study|Adverse Event|2|||
27763452|NCT01641991|80962644|FG001|Overall Study|Adverse Event|1|||
27763453|NCT01641991|80962645|FG002|Overall Study|Adverse Event|2|||
27763454|NCT01641991|80962646|FG003|Overall Study|Adverse Event|1|||
27763455|NCT01641991|80962643|FG000|Overall Study|Lost to Follow-up|0|||
27763456|NCT01641991|80962644|FG001|Overall Study|Lost to Follow-up|2|||
27763457|NCT01641991|80962645|FG002|Overall Study|Lost to Follow-up|3|||
27763458|NCT01641991|80962646|FG003|Overall Study|Lost to Follow-up|1|||
27763459|NCT01641991|80962643|FG000|Overall Study|Protocol Violation|1|||
27763460|NCT01641991|80962644|FG001|Overall Study|Protocol Violation|1|||
27763461|NCT01641991|80962645|FG002|Overall Study|Protocol Violation|3|||
27763462|NCT01641991|80962646|FG003|Overall Study|Protocol Violation|0|||
27763463|NCT01641991|80962643|FG000|Overall Study|Pregnancy|0|||
27763464|NCT01641991|80962644|FG001|Overall Study|Pregnancy|0|||
27763465|NCT01641991|80962645|FG002|Overall Study|Pregnancy|1|||
27763466|NCT01641991|80962646|FG003|Overall Study|Pregnancy|0|||
27763467|NCT01641991|80962643|FG000|Overall Study|no longer eligible|2|||
27763468|NCT01641991|80962644|FG001|Overall Study|no longer eligible|1|||
27763469|NCT01641991|80962645|FG002|Overall Study|no longer eligible|0|||
27763470|NCT01641991|80962646|FG003|Overall Study|no longer eligible|4|||
27763471|NCT01245764|80962647|FG000|Study Phase A|Other|3|||
27763472|NCT01245764|80962648|FG001|Study Phase A|Other|2|||
27763473|NCT01245764|80962649|FG002|Study Phase A|Other|3|||
27763474|NCT01245764|80962650|FG003|Study Phase A|Other|1|||
27763475|NCT01245764|80962647|FG000|Study Phase A|Protocol Violation|6|||
27763476|NCT01245764|80962648|FG001|Study Phase A|Protocol Violation|3|||
27763477|NCT01245764|80962649|FG002|Study Phase A|Protocol Violation|2|||
27763478|NCT01245764|80962650|FG003|Study Phase A|Protocol Violation|2|||
27763479|NCT01245764|80962647|FG000|Study Phase A|Lost to Follow-up|0|||
27763480|NCT01245764|80962648|FG001|Study Phase A|Lost to Follow-up|0|||
27763481|NCT01245764|80962649|FG002|Study Phase A|Lost to Follow-up|5|||
27662551|NCT00434577|80602804|FG004|Months 0-3|Serious Adverse Event|0|||
27662552|NCT00434577|80602800|FG000|Months 0-3|Adverse Event|0|||
27662553|NCT00434577|80602801|FG001|Months 0-3|Adverse Event|1|||
27763482|NCT01245764|80962650|FG003|Study Phase A|Lost to Follow-up|0|||
27662554|NCT00434577|80602802|FG002|Months 0-3|Adverse Event|1|||
27662555|NCT00434577|80602803|FG003|Months 0-3|Adverse Event|0|||
27662556|NCT00434577|80602804|FG004|Months 0-3|Adverse Event|0|||
27662557|NCT00434577|80602800|FG000|Months 0-3|Lost to Follow-up|0|||
27662558|NCT00434577|80602801|FG001|Months 0-3|Lost to Follow-up|0|||
27662559|NCT00434577|80602802|FG002|Months 0-3|Lost to Follow-up|0|||
27662560|NCT00434577|80602803|FG003|Months 0-3|Lost to Follow-up|0|||
27662561|NCT00434577|80602804|FG004|Months 0-3|Lost to Follow-up|2|||
27662562|NCT00434577|80602800|FG000|Months 0-3|Protocol Violation|1|||
27662563|NCT00434577|80602801|FG001|Months 0-3|Protocol Violation|0|||
27662564|NCT00434577|80602802|FG002|Months 0-3|Protocol Violation|1|||
27662565|NCT00434577|80602803|FG003|Months 0-3|Protocol Violation|0|||
27662566|NCT00434577|80602804|FG004|Months 0-3|Protocol Violation|0|||
27662567|NCT00434577|80602800|FG000|Months 0-3|Withdrawal by Subject|2|||
27662568|NCT00434577|80602801|FG001|Months 0-3|Withdrawal by Subject|1|||
27662569|NCT00434577|80602802|FG002|Months 0-3|Withdrawal by Subject|1|||
27662570|NCT00434577|80602803|FG003|Months 0-3|Withdrawal by Subject|1|||
27662571|NCT00434577|80602804|FG004|Months 0-3|Withdrawal by Subject|1|||
27662572|NCT05177770|80602805|FG000|Overall Study|Death|4|||
27662573|NCT05177770|80602805|FG000|Overall Study|Withdrawal by Subject|1|||
27662574|NCT05177770|80602805|FG000|Overall Study|Adverse Event prior to dosing|1|||
27662575|NCT00317603|80602808|FG000|Overall Study|Progressive Disease|3|||
27662576|NCT01537120|80602809|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
27662577|NCT01537120|80602809|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
27662578|NCT03275402|80602810|FG000|Overall Study|Death|17|||
27662579|NCT03275402|80602810|FG000|Overall Study|Study terminated by sponsor|21|||
27662580|NCT03275402|80602810|FG000|Overall Study|Withdrawal by Subject|1|||
27662581|NCT02621047|80602813|FG000|Overall Study|Adverse Event|0|||
27662582|NCT02621047|80602814|FG001|Overall Study|Adverse Event|0|||
27662583|NCT02621047|80602815|FG002|Overall Study|Adverse Event|1|||
27662584|NCT01395914|80602820|FG000|Overall Study|Unrelated to study drug AE|6|||
27662585|NCT01395914|80602821|FG001|Overall Study|Unrelated to study drug AE|1|||
27662586|NCT01395914|80602820|FG000|Overall Study|Death|23|||
27662587|NCT01395914|80602821|FG001|Overall Study|Death|17|||
27763483|NCT00196196|80962652|FG000|Overall Study|Withdrawal by Subject|2|||
27763484|NCT00196196|80962652|FG000|Overall Study|Did not have required condition (hydroce|5|||
27763485|NCT04449276|80962653|FG000|Overall Study|Adverse Event|1|||
27763486|NCT04449276|80962654|FG001|Overall Study|Adverse Event|2|||
27763487|NCT04449276|80962655|FG002|Overall Study|Adverse Event|0|||
27662588|NCT01395914|80602820|FG000|Overall Study|Other|9|||
27662589|NCT01395914|80602821|FG001|Overall Study|Other|3|||
27662590|NCT01395914|80602820|FG000|Overall Study|Withdrawal by patient|27|||
27662591|NCT01395914|80602821|FG001|Overall Study|Withdrawal by patient|14|||
27662592|NCT01395914|80602820|FG000|Overall Study|Study drug-related AE|1|||
27763488|NCT04449276|80962656|FG003|Overall Study|Adverse Event|0|||
27763489|NCT04449276|80962657|FG004|Overall Study|Adverse Event|2|||
27763490|NCT04449276|80962658|FG005|Overall Study|Adverse Event|0|||
27763491|NCT04449276|80962659|FG006|Overall Study|Adverse Event|0|||
27763492|NCT04449276|80962660|FG007|Overall Study|Adverse Event|1|||
27763493|NCT04449276|80962653|FG000|Overall Study|Withdrawal by Subject|2|||
27662593|NCT01395914|80602821|FG001|Overall Study|Study drug-related AE|0|||
27763494|NCT04449276|80962654|FG001|Overall Study|Withdrawal by Subject|0|||
27662594|NCT01395914|80602820|FG000|Overall Study|Lost to Follow-up|6|||
27662595|NCT01395914|80602821|FG001|Overall Study|Lost to Follow-up|2|||
27763495|NCT04449276|80962655|FG002|Overall Study|Withdrawal by Subject|0|||
27763496|NCT04449276|80962656|FG003|Overall Study|Withdrawal by Subject|1|||
27763497|NCT04449276|80962657|FG004|Overall Study|Withdrawal by Subject|0|||
27662596|NCT05060237|80602823|FG000|Overall Study|Withdrawal by Subject|4|||
27662597|NCT05060237|80602823|FG000|Overall Study|Screening failure|8|||
27861841|NCT04386616|81326178|FG000|Overall Study|Lost to Follow-up|5|||
27763498|NCT04449276|80962658|FG005|Overall Study|Withdrawal by Subject|0|||
27763499|NCT04449276|80962659|FG006|Overall Study|Withdrawal by Subject|0|||
27763500|NCT04449276|80962660|FG007|Overall Study|Withdrawal by Subject|0|||
27763501|NCT04449276|80962653|FG000|Overall Study|Other|0|||
27763502|NCT04449276|80962654|FG001|Overall Study|Other|2|||
27763503|NCT04449276|80962655|FG002|Overall Study|Other|3|||
27763504|NCT04449276|80962656|FG003|Overall Study|Other|2|||
27763505|NCT04449276|80962657|FG004|Overall Study|Other|0|||
27763506|NCT04449276|80962658|FG005|Overall Study|Other|0|||
27763507|NCT04449276|80962659|FG006|Overall Study|Other|0|||
27763508|NCT04449276|80962660|FG007|Overall Study|Other|1|||
27763509|NCT01595438|80962664|FG000|Overall Study|Lost to Follow-up|20|||
27763510|NCT01595438|80962665|FG001|Overall Study|Lost to Follow-up|20|||
27763511|NCT01595438|80962664|FG000|Overall Study|Withdrawal by Subject|12|||
27763512|NCT01595438|80962665|FG001|Overall Study|Withdrawal by Subject|12|||
27763513|NCT01595438|80962664|FG000|Overall Study|Other Eligibility criteria|11|||
27763514|NCT01595438|80962665|FG001|Overall Study|Other Eligibility criteria|9|||
27763515|NCT00563368|80962669|FG000|Overall Study|Lost to Follow-up|14|||
27763516|NCT00563368|80962670|FG001|Overall Study|Lost to Follow-up|14|||
27763517|NCT00563368|80962671|FG002|Overall Study|Lost to Follow-up|12|||
27763518|NCT00563368|80962672|FG003|Overall Study|Lost to Follow-up|6|||
27763519|NCT00563368|80962673|FG004|Overall Study|Lost to Follow-up|9|||
27763520|NCT00563368|80962674|FG005|Overall Study|Lost to Follow-up|8|||
27763521|NCT00563368|80962675|FG006|Overall Study|Lost to Follow-up|9|||
27763522|NCT00563368|80962669|FG000|Overall Study|Adverse Event|3|||
27763523|NCT00563368|80962670|FG001|Overall Study|Adverse Event|4|||
27763524|NCT00563368|80962671|FG002|Overall Study|Adverse Event|5|||
27763525|NCT00563368|80962672|FG003|Overall Study|Adverse Event|9|||
27763526|NCT00563368|80962673|FG004|Overall Study|Adverse Event|6|||
27763527|NCT00563368|80962674|FG005|Overall Study|Adverse Event|10|||
27763528|NCT00563368|80962675|FG006|Overall Study|Adverse Event|17|||
27763529|NCT00563368|80962669|FG000|Overall Study|Withdrawal by Subject|11|||
27763530|NCT00563368|80962670|FG001|Overall Study|Withdrawal by Subject|6|||
27861842|NCT04386616|81326179|FG001|Overall Study|Lost to Follow-up|8|||
27861843|NCT04386616|81326180|FG002|Overall Study|Lost to Follow-up|6|||
27662598|NCT00507429|80602824|FG000|Treatment Phase|Disease Progression|12|||
27662599|NCT00507429|80602825|FG001|Treatment Phase|Disease Progression|5|||
27662600|NCT00507429|80602824|FG000|Treatment Phase|Adverse Event|12|||
27662601|NCT00507429|80602825|FG001|Treatment Phase|Adverse Event|5|||
27662602|NCT00507429|80602824|FG000|Treatment Phase|Withdrawal by Subject|3|||
27662603|NCT00507429|80602825|FG001|Treatment Phase|Withdrawal by Subject|3|||
27662604|NCT00507429|80602824|FG000|Treatment Phase|Physician Decision|4|||
27662605|NCT00507429|80602825|FG001|Treatment Phase|Physician Decision|2|||
27662606|NCT00507429|80602824|FG000|Treatment Phase|Other|6|||
27662607|NCT00507429|80602825|FG001|Treatment Phase|Other|3|||
27662608|NCT00507429|80602824|FG000|Maintenance Phase|Progressive Disease|14|||
27662609|NCT00507429|80602825|FG001|Maintenance Phase|Progressive Disease|0|||
27861844|NCT04386616|81326178|FG000|Overall Study|Withdrawal by Subject|2|||
27861845|NCT04386616|81326179|FG001|Overall Study|Withdrawal by Subject|4|||
27861846|NCT04386616|81326180|FG002|Overall Study|Withdrawal by Subject|1|||
27861847|NCT04386616|81326178|FG000|Overall Study|Adverse Event|1|||
27861848|NCT04386616|81326179|FG001|Overall Study|Adverse Event|1|||
27861849|NCT04386616|81326180|FG002|Overall Study|Adverse Event|0|||
27662610|NCT00666835|80602827|FG000|Overall Study|Withdrawal by Subject|5|||
27662611|NCT00666835|80602828|FG001|Overall Study|Withdrawal by Subject|2|||
27662612|NCT00666835|80602827|FG000|Overall Study|Lack of Efficacy|0|||
27662613|NCT00666835|80602828|FG001|Overall Study|Lack of Efficacy|1|||
27662614|NCT00666835|80602827|FG000|Overall Study|Incl./excl. not fulfilled|7|||
27662615|NCT00666835|80602828|FG001|Overall Study|Incl./excl. not fulfilled|2|||
27662616|NCT00666835|80602827|FG000|Overall Study|Adverse Event|7|||
27662617|NCT00666835|80602828|FG001|Overall Study|Adverse Event|6|||
27662618|NCT00666835|80602827|FG000|Overall Study|Protocol Violation|2|||
27763531|NCT00563368|80962671|FG002|Overall Study|Withdrawal by Subject|5|||
27861850|NCT00229723|81326187|FG000|Concomitant Phase|Adverse Event|4|||
27861851|NCT00229723|81326188|FG001|Concomitant Phase|Adverse Event|2|||
27763532|NCT00563368|80962672|FG003|Overall Study|Withdrawal by Subject|7|||
27763533|NCT00563368|80962673|FG004|Overall Study|Withdrawal by Subject|8|||
27763534|NCT00563368|80962674|FG005|Overall Study|Withdrawal by Subject|5|||
27763535|NCT00563368|80962675|FG006|Overall Study|Withdrawal by Subject|4|||
27763536|NCT00563368|80962669|FG000|Overall Study|protocol non-compliance|1|||
27763537|NCT00563368|80962670|FG001|Overall Study|protocol non-compliance|1|||
27861852|NCT00229723|81326189|FG002|Concomitant Phase|Adverse Event|5|||
27861853|NCT00229723|81326190|FG003|Concomitant Phase|Adverse Event|2|||
27861854|NCT00229723|81326191|FG004|Concomitant Phase|Adverse Event|0|||
27861855|NCT00229723|81326192|FG005|Concomitant Phase|Adverse Event|1|||
27662619|NCT00666835|80602828|FG001|Overall Study|Protocol Violation|0|||
27763538|NCT00563368|80962671|FG002|Overall Study|protocol non-compliance|2|||
27763539|NCT00563368|80962672|FG003|Overall Study|protocol non-compliance|1|||
27861856|NCT00229723|81326193|FG006|Concomitant Phase|Adverse Event|2|||
27763540|NCT00563368|80962673|FG004|Overall Study|protocol non-compliance|0|||
27763541|NCT00563368|80962674|FG005|Overall Study|protocol non-compliance|1|||
27763542|NCT00563368|80962675|FG006|Overall Study|protocol non-compliance|3|||
27763543|NCT00563368|80962669|FG000|Overall Study|Pregnancy|1|||
27763544|NCT00563368|80962670|FG001|Overall Study|Pregnancy|0|||
27763545|NCT00563368|80962671|FG002|Overall Study|Pregnancy|1|||
27763546|NCT00563368|80962672|FG003|Overall Study|Pregnancy|2|||
27763547|NCT00563368|80962673|FG004|Overall Study|Pregnancy|1|||
27763548|NCT00563368|80962674|FG005|Overall Study|Pregnancy|2|||
27763549|NCT00563368|80962675|FG006|Overall Study|Pregnancy|0|||
27763550|NCT00563368|80962669|FG000|Overall Study|requirement for restricted medication|0|||
27763551|NCT00563368|80962670|FG001|Overall Study|requirement for restricted medication|0|||
27763552|NCT00563368|80962671|FG002|Overall Study|requirement for restricted medication|2|||
27861857|NCT00229723|81326187|FG000|Concomitant Phase|Objective disease progression|0|||
27861858|NCT00229723|81326188|FG001|Concomitant Phase|Objective disease progression|0|||
27861859|NCT00229723|81326189|FG002|Concomitant Phase|Objective disease progression|0|||
27861860|NCT00229723|81326190|FG003|Concomitant Phase|Objective disease progression|0|||
27861861|NCT00229723|81326191|FG004|Concomitant Phase|Objective disease progression|0|||
27861862|NCT00229723|81326192|FG005|Concomitant Phase|Objective disease progression|0|||
27861863|NCT00229723|81326193|FG006|Concomitant Phase|Objective disease progression|0|||
27861864|NCT00229723|81326187|FG000|Concomitant Phase|Clinical progression|0|||
27861865|NCT00229723|81326188|FG001|Concomitant Phase|Clinical progression|0|||
27861866|NCT00229723|81326189|FG002|Concomitant Phase|Clinical progression|0|||
27861867|NCT00229723|81326190|FG003|Concomitant Phase|Clinical progression|0|||
27861868|NCT00229723|81326191|FG004|Concomitant Phase|Clinical progression|0|||
27861869|NCT00229723|81326192|FG005|Concomitant Phase|Clinical progression|0|||
27861870|NCT00229723|81326193|FG006|Concomitant Phase|Clinical progression|1|||
27861871|NCT00229723|81326187|FG000|Concomitant Phase|Lost to Follow-up|0|||
27861872|NCT00229723|81326188|FG001|Concomitant Phase|Lost to Follow-up|0|||
27861873|NCT00229723|81326189|FG002|Concomitant Phase|Lost to Follow-up|0|||
27763553|NCT00563368|80962672|FG003|Overall Study|requirement for restricted medication|0|||
27763554|NCT00563368|80962673|FG004|Overall Study|requirement for restricted medication|0|||
27763555|NCT00563368|80962674|FG005|Overall Study|requirement for restricted medication|0|||
27763556|NCT00563368|80962675|FG006|Overall Study|requirement for restricted medication|0|||
27763557|NCT00563368|80962669|FG000|Overall Study|Other|5|||
27763558|NCT00563368|80962670|FG001|Overall Study|Other|5|||
27763559|NCT00563368|80962671|FG002|Overall Study|Other|3|||
27763560|NCT00563368|80962672|FG003|Overall Study|Other|4|||
27763561|NCT00563368|80962673|FG004|Overall Study|Other|4|||
27763562|NCT00563368|80962674|FG005|Overall Study|Other|4|||
27763563|NCT00563368|80962675|FG006|Overall Study|Other|0|||
27763564|NCT03276572|80962679|FG000|Overall Study|In follow-up|0|||
27763565|NCT03276572|80962680|FG001|Overall Study|In follow-up|0|||
27763566|NCT03276572|80962681|FG002|Overall Study|In follow-up|0|||
27763567|NCT03276572|80962682|FG003|Overall Study|In follow-up|0|||
27763568|NCT03276572|80962683|FG004|Overall Study|In follow-up|0|||
27763569|NCT03276572|80962684|FG005|Overall Study|In follow-up|1|||
27763570|NCT03276572|80962685|FG006|Overall Study|In follow-up|1|||
27763571|NCT03276572|80962679|FG000|Overall Study|Lost to Follow-up|0|||
27763572|NCT03276572|80962680|FG001|Overall Study|Lost to Follow-up|0|||
27763573|NCT03276572|80962681|FG002|Overall Study|Lost to Follow-up|0|||
27763574|NCT03276572|80962682|FG003|Overall Study|Lost to Follow-up|0|||
27763575|NCT03276572|80962683|FG004|Overall Study|Lost to Follow-up|0|||
27861874|NCT00229723|81326190|FG003|Concomitant Phase|Lost to Follow-up|0|||
27763576|NCT03276572|80962684|FG005|Overall Study|Lost to Follow-up|0|||
27763577|NCT03276572|80962685|FG006|Overall Study|Lost to Follow-up|1|||
27763578|NCT00871572|80962691|FG000|Overall Study|Adverse Event|0|||
27763579|NCT00871572|80962692|FG001|Overall Study|Adverse Event|2|||
27763580|NCT00871572|80962693|FG002|Overall Study|Adverse Event|0|||
27763581|NCT00871572|80962694|FG003|Overall Study|Adverse Event|3|||
27763582|NCT00871572|80962691|FG000|Overall Study|Investigator Decision|0|||
27763583|NCT00871572|80962692|FG001|Overall Study|Investigator Decision|1|||
27763584|NCT00871572|80962693|FG002|Overall Study|Investigator Decision|0|||
27763585|NCT00871572|80962694|FG003|Overall Study|Investigator Decision|1|||
27763586|NCT00871572|80962691|FG000|Overall Study|Lost to Follow-up|0|||
27763587|NCT00871572|80962692|FG001|Overall Study|Lost to Follow-up|1|||
27763588|NCT00871572|80962693|FG002|Overall Study|Lost to Follow-up|0|||
27763589|NCT00871572|80962694|FG003|Overall Study|Lost to Follow-up|1|||
27763590|NCT00871572|80962691|FG000|Overall Study|Protocol Violation|0|||
27763591|NCT00871572|80962692|FG001|Overall Study|Protocol Violation|0|||
27763592|NCT00871572|80962693|FG002|Overall Study|Protocol Violation|1|||
27763593|NCT00871572|80962694|FG003|Overall Study|Protocol Violation|1|||
27763594|NCT00871572|80962691|FG000|Overall Study|Sponsor Decision|1|||
27861875|NCT00229723|81326191|FG004|Concomitant Phase|Lost to Follow-up|1|||
27861876|NCT00229723|81326192|FG005|Concomitant Phase|Lost to Follow-up|0|||
27861877|NCT00229723|81326193|FG006|Concomitant Phase|Lost to Follow-up|0|||
27763595|NCT00871572|80962692|FG001|Overall Study|Sponsor Decision|0|||
27763596|NCT00871572|80962693|FG002|Overall Study|Sponsor Decision|0|||
27763597|NCT00871572|80962694|FG003|Overall Study|Sponsor Decision|0|||
27763598|NCT00871572|80962691|FG000|Overall Study|Withdrawal by Subject|1|||
27763599|NCT00871572|80962692|FG001|Overall Study|Withdrawal by Subject|2|||
27763600|NCT00871572|80962693|FG002|Overall Study|Withdrawal by Subject|3|||
27763601|NCT00871572|80962694|FG003|Overall Study|Withdrawal by Subject|1|||
27763602|NCT04295356|80962695|FG000|Overall Study|Physician Decision|1|||
27763603|NCT04295356|80962696|FG001|Overall Study|Physician Decision|0|||
27763604|NCT04295356|80962695|FG000|Overall Study|Lost to Follow-up|0|||
27861878|NCT00229723|81326187|FG000|Concomitant Phase|Informed consent withdrawn|3|||
27861879|NCT00229723|81326188|FG001|Concomitant Phase|Informed consent withdrawn|2|||
27861880|NCT00229723|81326189|FG002|Concomitant Phase|Informed consent withdrawn|0|||
27861881|NCT00229723|81326190|FG003|Concomitant Phase|Informed consent withdrawn|2|||
27861882|NCT00229723|81326191|FG004|Concomitant Phase|Informed consent withdrawn|0|||
27861883|NCT00229723|81326192|FG005|Concomitant Phase|Informed consent withdrawn|0|||
27861884|NCT00229723|81326193|FG006|Concomitant Phase|Informed consent withdrawn|0|||
27861885|NCT00229723|81326187|FG000|Concomitant Phase|Severe non-compliance|0|||
27861886|NCT00229723|81326188|FG001|Concomitant Phase|Severe non-compliance|1|||
27861887|NCT00229723|81326189|FG002|Concomitant Phase|Severe non-compliance|0|||
27861888|NCT00229723|81326190|FG003|Concomitant Phase|Severe non-compliance|0|||
27861889|NCT00229723|81326191|FG004|Concomitant Phase|Severe non-compliance|1|||
27861890|NCT00229723|81326192|FG005|Concomitant Phase|Severe non-compliance|0|||
27861891|NCT00229723|81326193|FG006|Concomitant Phase|Severe non-compliance|0|||
27861892|NCT00229723|81326187|FG000|Concomitant Phase|Other|3|||
27861893|NCT00229723|81326188|FG001|Concomitant Phase|Other|0|||
27861894|NCT00229723|81326189|FG002|Concomitant Phase|Other|1|||
27861895|NCT00229723|81326190|FG003|Concomitant Phase|Other|1|||
27861896|NCT00229723|81326191|FG004|Concomitant Phase|Other|0|||
27861897|NCT00229723|81326192|FG005|Concomitant Phase|Other|2|||
27861898|NCT00229723|81326193|FG006|Concomitant Phase|Other|0|||
27861899|NCT00229723|81326187|FG000|Maintenance Phase|Adverse Event|7|||
27861900|NCT00229723|81326188|FG001|Maintenance Phase|Adverse Event|2|||
27861901|NCT00229723|81326189|FG002|Maintenance Phase|Adverse Event|1|||
27861902|NCT00229723|81326190|FG003|Maintenance Phase|Adverse Event|4|||
27861903|NCT00229723|81326191|FG004|Maintenance Phase|Adverse Event|7|||
27861904|NCT00229723|81326192|FG005|Maintenance Phase|Adverse Event|5|||
27861905|NCT00229723|81326193|FG006|Maintenance Phase|Adverse Event|2|||
27861906|NCT00229723|81326187|FG000|Maintenance Phase|Objective disease progression|5|||
27861907|NCT00229723|81326188|FG001|Maintenance Phase|Objective disease progression|5|||
27861908|NCT00229723|81326189|FG002|Maintenance Phase|Objective disease progression|3|||
27861909|NCT00229723|81326190|FG003|Maintenance Phase|Objective disease progression|6|||
27861910|NCT00229723|81326191|FG004|Maintenance Phase|Objective disease progression|2|||
27861911|NCT00229723|81326192|FG005|Maintenance Phase|Objective disease progression|9|||
27861912|NCT00229723|81326193|FG006|Maintenance Phase|Objective disease progression|5|||
27861913|NCT00229723|81326187|FG000|Maintenance Phase|Clinical progression|4|||
27861914|NCT00229723|81326188|FG001|Maintenance Phase|Clinical progression|1|||
27861915|NCT00229723|81326189|FG002|Maintenance Phase|Clinical progression|2|||
27861916|NCT00229723|81326190|FG003|Maintenance Phase|Clinical progression|2|||
27861917|NCT00229723|81326191|FG004|Maintenance Phase|Clinical progression|1|||
27861918|NCT00229723|81326192|FG005|Maintenance Phase|Clinical progression|1|||
27861919|NCT00229723|81326193|FG006|Maintenance Phase|Clinical progression|1|||
27861920|NCT00229723|81326187|FG000|Maintenance Phase|Lost to Follow-up|0|||
27861921|NCT00229723|81326188|FG001|Maintenance Phase|Lost to Follow-up|1|||
27861922|NCT00229723|81326189|FG002|Maintenance Phase|Lost to Follow-up|2|||
27861923|NCT00229723|81326190|FG003|Maintenance Phase|Lost to Follow-up|2|||
27662620|NCT00666835|80602827|FG000|Overall Study|Death|15|||
27763605|NCT04295356|80962696|FG001|Overall Study|Lost to Follow-up|3|||
27763606|NCT04295356|80962695|FG000|Overall Study|Protocol Violation|0|||
27763607|NCT04295356|80962696|FG001|Overall Study|Protocol Violation|1|||
27763608|NCT02248857|80962697|FG000|3 Month|Withdrawal by Subject|9|||
27861924|NCT00229723|81326191|FG004|Maintenance Phase|Lost to Follow-up|0|||
27861925|NCT00229723|81326192|FG005|Maintenance Phase|Lost to Follow-up|0|||
27861926|NCT00229723|81326193|FG006|Maintenance Phase|Lost to Follow-up|1|||
27861927|NCT00229723|81326187|FG000|Maintenance Phase|Informed consent withdrawn|1|||
27861928|NCT00229723|81326188|FG001|Maintenance Phase|Informed consent withdrawn|0|||
27861929|NCT00229723|81326189|FG002|Maintenance Phase|Informed consent withdrawn|0|||
27861930|NCT00229723|81326190|FG003|Maintenance Phase|Informed consent withdrawn|1|||
27861931|NCT00229723|81326191|FG004|Maintenance Phase|Informed consent withdrawn|1|||
27861932|NCT00229723|81326192|FG005|Maintenance Phase|Informed consent withdrawn|1|||
27763609|NCT02248857|80962698|FG001|3 Month|Withdrawal by Subject|3|||
27763610|NCT02248857|80962699|FG002|3 Month|Withdrawal by Subject|4|||
27861933|NCT00229723|81326193|FG006|Maintenance Phase|Informed consent withdrawn|0|||
27861934|NCT00229723|81326187|FG000|Maintenance Phase|Severe non-compliance|3|||
27861935|NCT00229723|81326188|FG001|Maintenance Phase|Severe non-compliance|1|||
27861936|NCT00229723|81326189|FG002|Maintenance Phase|Severe non-compliance|0|||
27861937|NCT00229723|81326190|FG003|Maintenance Phase|Severe non-compliance|0|||
27861938|NCT00229723|81326191|FG004|Maintenance Phase|Severe non-compliance|1|||
27568810|NCT03013543|80271447|FG000|Overall Study|Physician Decision|0|||
27568811|NCT03013543|80271448|FG001|Overall Study|Physician Decision|0|||
27568812|NCT03013543|80271449|FG002|Overall Study|Physician Decision|0|||
27861939|NCT00229723|81326192|FG005|Maintenance Phase|Severe non-compliance|0|||
27861940|NCT00229723|81326193|FG006|Maintenance Phase|Severe non-compliance|0|||
27861941|NCT00229723|81326187|FG000|Maintenance Phase|Other|5|||
27861942|NCT00229723|81326188|FG001|Maintenance Phase|Other|4|||
27861943|NCT00229723|81326189|FG002|Maintenance Phase|Other|1|||
27861944|NCT00229723|81326190|FG003|Maintenance Phase|Other|2|||
27861945|NCT00229723|81326191|FG004|Maintenance Phase|Other|3|||
27861946|NCT00229723|81326192|FG005|Maintenance Phase|Other|3|||
27861947|NCT00229723|81326193|FG006|Maintenance Phase|Other|1|||
27861948|NCT02704403|81326194|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
27861949|NCT02704403|81326195|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
27861950|NCT02704403|81326194|FG000|Overall Study|Administrative reasons by sponsor|1251|||
27861951|NCT02704403|81326195|FG001|Overall Study|Administrative reasons by sponsor|616|||
27861952|NCT02704403|81326194|FG000|Overall Study|Death|4|||
27861953|NCT02704403|81326195|FG001|Overall Study|Death|3|||
27861954|NCT02704403|81326194|FG000|Overall Study|Endpoint event|52|||
27861955|NCT02704403|81326195|FG001|Overall Study|Endpoint event|24|||
27861956|NCT02704403|81326194|FG000|Overall Study|Lost to Follow-up|22|||
27861957|NCT02704403|81326195|FG001|Overall Study|Lost to Follow-up|11|||
27861958|NCT02704403|81326194|FG000|Overall Study|Protocol Violation|15|||
27861959|NCT02704403|81326195|FG001|Overall Study|Protocol Violation|15|||
27861960|NCT02704403|81326194|FG000|Overall Study|Adverse Event|2|||
27861961|NCT02704403|81326195|FG001|Overall Study|Adverse Event|0|||
27861962|NCT02704403|81326194|FG000|Overall Study|Withdrawal by Subject|85|||
27861963|NCT02704403|81326195|FG001|Overall Study|Withdrawal by Subject|45|||
27861964|NCT02704403|81326194|FG000|Overall Study|Investigator decision|1|||
27861965|NCT02704403|81326195|FG001|Overall Study|Investigator decision|1|||
27861966|NCT02704403|81326194|FG000|Overall Study|Follow-up not possible|1|||
27961934|NCT00703846|81691829|FG000|Overall Study|Withdrawal by Subject|40|||
27961935|NCT00703846|81691829|FG000|Overall Study|Death|1|||
27961936|NCT00703846|81691829|FG000|Overall Study|Other|14|||
27961937|NCT00703846|81691829|FG000|Overall Study|Did Not Receive Study Drug|2|||
27961938|NCT01104545|81691830|FG000|Overall Study|Adverse Event|0|||
27961939|NCT01104545|81691831|FG001|Overall Study|Adverse Event|1|||
27961940|NCT01104545|81691832|FG002|Overall Study|Adverse Event|2|||
27961941|NCT00709319|81691833|FG000|Overall Study|Death|4|||
27961942|NCT00709319|81691833|FG000|Overall Study|Withdrawal by Subject|2|||
27961943|NCT02446769|81691834|FG000|Screening Period|Screen Failure|11|||
27961944|NCT02446769|81691835|FG001|Screening Period|Screen Failure|0|||
27961945|NCT02446769|81691836|FG002|Screening Period|Screen Failure|0|||
27961946|NCT02446769|81691834|FG000|Study Period|Randomized in Error|0|||
27961947|NCT02446769|81691835|FG001|Study Period|Randomized in Error|2|||
27961948|NCT02446769|81691836|FG002|Study Period|Randomized in Error|0|||
27961949|NCT00326001|81691839|FG000|Overall Study|Adverse Event|4|||
27961950|NCT00326001|81691840|FG001|Overall Study|Adverse Event|5|||
27961951|NCT00326001|81691839|FG000|Overall Study|Physician Decision|3|||
27961952|NCT00326001|81691840|FG001|Overall Study|Physician Decision|3|||
27961953|NCT00582712|81691842|FG000|Overall Study|Adverse Event|1|||
27961954|NCT00582712|81691842|FG000|Overall Study|Lack of Efficacy|1|||
27961955|NCT00582712|81691842|FG000|Overall Study|Withdrawal by Subject|1|||
27961956|NCT00582712|81691842|FG000|Overall Study|Complicating disease requiring treatment|1|||
27961957|NCT00255723|81691843|FG000|Overall Study|Adverse Event|1|||
27961958|NCT00255723|81691844|FG001|Overall Study|Adverse Event|1|||
27961959|NCT00255723|81691843|FG000|Overall Study|Death|0|||
27961960|NCT00255723|81691844|FG001|Overall Study|Death|1|||
27961961|NCT00255723|81691843|FG000|Overall Study|Response Data Not Available|1|||
27961962|NCT00255723|81691844|FG001|Overall Study|Response Data Not Available|0|||
27961963|NCT01901614|81691845|FG000|Overall Study|Adverse Event|0|||
27961964|NCT01901614|81691846|FG001|Overall Study|Adverse Event|1|||
27961965|NCT01901614|81691845|FG000|Overall Study|Lost to Follow-up|1|||
27961966|NCT01901614|81691846|FG001|Overall Study|Lost to Follow-up|0|||
27961967|NCT01901614|81691845|FG000|Overall Study|Screen Fail|1|||
27961968|NCT01901614|81691846|FG001|Overall Study|Screen Fail|0|||
27961969|NCT00923351|81691853|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
27568813|NCT03013543|80271450|FG003|Overall Study|Physician Decision|0|||
27568814|NCT03013543|80271451|FG004|Overall Study|Physician Decision|1|||
27861967|NCT02704403|81326195|FG001|Overall Study|Follow-up not possible|2|||
27861968|NCT00940316|81326196|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
27861969|NCT00940316|81326197|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
27961970|NCT00923351|81691854|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
27961971|NCT00923351|81691855|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
27961972|NCT02391311|81691860|FG000|Overall Study|Lost to Follow-up|2|||
27961973|NCT02391311|81691861|FG001|Overall Study|Lost to Follow-up|1|||
27961974|NCT02391311|81691860|FG000|Overall Study|deemed ineligible after baseline|1|||
27961975|NCT02391311|81691861|FG001|Overall Study|deemed ineligible after baseline|1|||
27961976|NCT00399568|81691862|FG000|Overall Study|Adverse Event|1|||
27961977|NCT00399568|81691863|FG001|Overall Study|Adverse Event|2|||
27961978|NCT00399568|81691862|FG000|Overall Study|Withdrawal by Subject|7|||
27961979|NCT00399568|81691863|FG001|Overall Study|Withdrawal by Subject|3|||
27961980|NCT00399568|81691862|FG000|Overall Study|Protocol non-compliance|2|||
27961981|NCT00399568|81691863|FG001|Overall Study|Protocol non-compliance|2|||
27961982|NCT00399568|81691862|FG000|Overall Study|Lost to Follow-up|2|||
27961983|NCT00399568|81691863|FG001|Overall Study|Lost to Follow-up|2|||
27763611|NCT02248857|80962697|FG000|3 Month|Unable to reach for 3 month|35|||
27763612|NCT02248857|80962698|FG001|3 Month|Unable to reach for 3 month|29|||
27763613|NCT02248857|80962699|FG002|3 Month|Unable to reach for 3 month|26|||
27763614|NCT02248857|80962697|FG000|3 Month|Partially completed, unable to finish|2|||
27763615|NCT02248857|80962698|FG001|3 Month|Partially completed, unable to finish|2|||
27763616|NCT02248857|80962699|FG002|3 Month|Partially completed, unable to finish|1|||
27763617|NCT02248857|80962697|FG000|6 Month|Lost to Follow-up|27|||
27763618|NCT02248857|80962698|FG001|6 Month|Lost to Follow-up|26|||
27763619|NCT02248857|80962699|FG002|6 Month|Lost to Follow-up|15|||
27763620|NCT02248857|80962697|FG000|6 Month|Partially completed, unable to finish|0|||
27763621|NCT02248857|80962698|FG001|6 Month|Partially completed, unable to finish|1|||
27763622|NCT02248857|80962699|FG002|6 Month|Partially completed, unable to finish|0|||
27763623|NCT02248857|80962697|FG000|6 Month|Withdrawal by Subject|0|||
27763624|NCT02248857|80962698|FG001|6 Month|Withdrawal by Subject|2|||
27763625|NCT02248857|80962699|FG002|6 Month|Withdrawal by Subject|2|||
27763626|NCT02248857|80962697|FG000|6 Month|Death|1|||
27763627|NCT02248857|80962698|FG001|6 Month|Death|0|||
27763628|NCT02248857|80962699|FG002|6 Month|Death|0|||
27763629|NCT03034057|80962702|FG000|Overall Study|Withdrawal by Subject|10|||
27763630|NCT03034057|80962702|FG000|Overall Study|Protocol Violation|1|||
27763631|NCT03034057|80962702|FG000|Overall Study|Not defined|2|||
27763632|NCT03034057|80962702|FG000|Overall Study|Lost to Follow-up|19|||
27763633|NCT03034057|80962702|FG000|Overall Study|Adverse Event|22|||
27763634|NCT03034057|80962702|FG000|Overall Study|Medication error without associated AE|1|||
27763635|NCT00637377|80962705|FG000|Overall Study|Adverse Event|2|||
27763636|NCT00637377|80962706|FG001|Overall Study|Adverse Event|6|||
27763637|NCT00637377|80962707|FG002|Overall Study|Adverse Event|8|||
27763638|NCT00637377|80962708|FG003|Overall Study|Adverse Event|9|||
27763639|NCT00637377|80962705|FG000|Overall Study|Death|1|||
27763640|NCT00637377|80962706|FG001|Overall Study|Death|3|||
27763641|NCT00637377|80962707|FG002|Overall Study|Death|2|||
27763642|NCT00637377|80962708|FG003|Overall Study|Death|1|||
27763643|NCT00637377|80962705|FG000|Overall Study|Lack of Efficacy|0|||
27763644|NCT00637377|80962706|FG001|Overall Study|Lack of Efficacy|0|||
27763645|NCT00637377|80962707|FG002|Overall Study|Lack of Efficacy|1|||
27763646|NCT00637377|80962708|FG003|Overall Study|Lack of Efficacy|1|||
27763647|NCT00637377|80962705|FG000|Overall Study|Lost to Follow-up|4|||
27763648|NCT00637377|80962706|FG001|Overall Study|Lost to Follow-up|1|||
27763649|NCT00637377|80962707|FG002|Overall Study|Lost to Follow-up|2|||
27763650|NCT00637377|80962708|FG003|Overall Study|Lost to Follow-up|2|||
27763651|NCT00637377|80962705|FG000|Overall Study|Protocol Violation|2|||
27763652|NCT00637377|80962706|FG001|Overall Study|Protocol Violation|1|||
27763653|NCT00637377|80962707|FG002|Overall Study|Protocol Violation|1|||
27763654|NCT00637377|80962708|FG003|Overall Study|Protocol Violation|0|||
27763655|NCT00637377|80962705|FG000|Overall Study|Withdrawal by Subject|11|||
27763656|NCT00637377|80962706|FG001|Overall Study|Withdrawal by Subject|15|||
27763657|NCT00637377|80962707|FG002|Overall Study|Withdrawal by Subject|13|||
27763658|NCT00637377|80962708|FG003|Overall Study|Withdrawal by Subject|11|||
27763659|NCT00637377|80962705|FG000|Overall Study|Other (no further information available)|7|||
27763660|NCT00637377|80962706|FG001|Overall Study|Other (no further information available)|6|||
27763661|NCT00637377|80962707|FG002|Overall Study|Other (no further information available)|10|||
27763662|NCT00637377|80962708|FG003|Overall Study|Other (no further information available)|5|||
27763663|NCT03271307|80962711|FG000|Overall Study|Lost to Follow-up|0|||
27763664|NCT03271307|80962712|FG001|Overall Study|Lost to Follow-up|0|||
27763665|NCT03271307|80962713|FG002|Overall Study|Lost to Follow-up|0|||
27763666|NCT03271307|80962714|FG003|Overall Study|Lost to Follow-up|28|||
27763667|NCT03271307|80962715|FG004|Overall Study|Lost to Follow-up|91|||
27763668|NCT02678312|80962716|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
27763669|NCT02678312|80962717|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27763670|NCT02678312|80962718|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27763671|NCT02678312|80962719|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27763672|NCT02678312|80962720|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
27763673|NCT02678312|80962716|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
27763674|NCT02678312|80962717|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27763675|NCT02678312|80962718|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27763676|NCT02678312|80962719|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27961984|NCT04294459|81691864|FG000|Overall Study|Adverse Event|0|||
27961985|NCT04294459|81691865|FG001|Overall Study|Adverse Event|1|||
27961986|NCT02623205|81691866|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
27961987|NCT02623205|81691867|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
27961988|NCT02689206|81691868|FG000|Overall Study|Adverse Event|0|||
27961989|NCT02689206|81691869|FG001|Overall Study|Adverse Event|0|||
27961990|NCT02689206|81691870|FG002|Overall Study|Adverse Event|1|||
27961991|NCT02689206|81691871|FG003|Overall Study|Adverse Event|0|||
27662621|NCT00666835|80602828|FG001|Overall Study|Death|4|||
27662622|NCT00666835|80602827|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
27662623|NCT00666835|80602828|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
27662624|NCT00666835|80602827|FG000|Overall Study|Hemoglobulin concentration|4|||
27662625|NCT00666835|80602828|FG001|Overall Study|Hemoglobulin concentration|3|||
27662626|NCT00666835|80602827|FG000|Overall Study|Planned operation|2|||
27662627|NCT00666835|80602828|FG001|Overall Study|Planned operation|0|||
27662628|NCT00666835|80602827|FG000|Overall Study|Physician Decision|1|||
27662629|NCT00666835|80602828|FG001|Overall Study|Physician Decision|2|||
27662630|NCT05135156|80602829|FG000|Overall Study|Lost to Follow-up|0|||
27662631|NCT05135156|80602830|FG001|Overall Study|Lost to Follow-up|0|||
27662632|NCT05135156|80602831|FG002|Overall Study|Lost to Follow-up|2|||
27662633|NCT03635775|80602839|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
27662634|NCT03635775|80602840|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
27662635|NCT03635775|80602841|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
27662636|NCT03635775|80602842|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
27662637|NCT00990821|80602843|FG000|Overall Study|Withdrawal by Subject|0|||
27662638|NCT00990821|80602844|FG001|Overall Study|Withdrawal by Subject|2|||
27662639|NCT00990821|80602845|FG002|Overall Study|Withdrawal by Subject|0|||
27662640|NCT00990821|80602846|FG003|Overall Study|Withdrawal by Subject|0|||
27662641|NCT00990821|80602847|FG004|Overall Study|Withdrawal by Subject|3|||
27662642|NCT00990821|80602848|FG005|Overall Study|Withdrawal by Subject|3|||
27662643|NCT00990821|80602849|FG006|Overall Study|Withdrawal by Subject|1|||
27662644|NCT00990821|80602850|FG007|Overall Study|Withdrawal by Subject|0|||
27662645|NCT00990821|80602851|FG008|Overall Study|Withdrawal by Subject|0|||
27662646|NCT00990821|80602852|FG009|Overall Study|Withdrawal by Subject|1|||
27662647|NCT00990821|80602853|FG010|Overall Study|Withdrawal by Subject|3|||
27662648|NCT00990821|80602854|FG011|Overall Study|Withdrawal by Subject|5|||
27662649|NCT00990821|80602855|FG012|Overall Study|Withdrawal by Subject|2|||
27662650|NCT00990821|80602856|FG013|Overall Study|Withdrawal by Subject|1|||
27662651|NCT02392429|80602857|FG000|Screening|Screen failure|15|||
27662652|NCT02392429|80602857|FG000|Enrolled Participants|Ineligible due to disease|3|||
27662653|NCT02392429|80602857|FG000|Enrolled Participants|Withdrawal by Subject|4|||
27662654|NCT02392429|80602857|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
27662655|NCT02392429|80602857|FG000|Evaluable|Death|5|||
27662656|NCT02392429|80602857|FG000|Evaluable|Withdrawal by Subject|1|||
27662657|NCT02392429|80602857|FG000|Evaluable|Adverse Event|1|||
27662658|NCT02392429|80602857|FG000|Evaluable|remission bone marrow biopsy|3|||
27662659|NCT02642159|80602858|FG000|Overall Study|Randomized but not treated|1|||
27662660|NCT02642159|80602859|FG001|Overall Study|Randomized but not treated|0|||
27662661|NCT02642159|80602858|FG000|Overall Study|Adverse Event|10|||
27662662|NCT02642159|80602859|FG001|Overall Study|Adverse Event|4|||
27662663|NCT02642159|80602858|FG000|Overall Study|Withdrawal by Subject|9|||
27662664|NCT02642159|80602859|FG001|Overall Study|Withdrawal by Subject|1|||
27662665|NCT02642159|80602858|FG000|Overall Study|Poor compliance to study protocol|1|||
27662666|NCT02642159|80602859|FG001|Overall Study|Poor compliance to study protocol|0|||
27662667|NCT02642159|80602858|FG000|Overall Study|Other than specified above|10|||
27662668|NCT02642159|80602859|FG001|Overall Study|Other than specified above|3|||
27662669|NCT01020487|80602860|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
27662670|NCT01020487|80602861|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
27662671|NCT01020487|80602862|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
27662672|NCT01020487|80602860|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
27662673|NCT01020487|80602861|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
27662674|NCT01020487|80602862|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
27662675|NCT01020487|80602860|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
27662676|NCT01020487|80602861|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
27662677|NCT01020487|80602862|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
27662678|NCT01020487|80602860|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
27662679|NCT01020487|80602861|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
27662680|NCT01020487|80602862|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
27662681|NCT01020487|80602860|FG000|Part 2 Open-label Period|Adverse Event|0|||
27662682|NCT01020487|80602861|FG001|Part 2 Open-label Period|Adverse Event|4|||
27662683|NCT01020487|80602862|FG002|Part 2 Open-label Period|Adverse Event|1|||
27662684|NCT02660034|80602863|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
27662685|NCT02660034|80602864|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
27662686|NCT02660034|80602865|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
27961992|NCT02689206|81691872|FG004|Overall Study|Adverse Event|2|||
27961993|NCT02689206|81691868|FG000|Overall Study|Protocol Violation|1|||
27662687|NCT02660034|80602866|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
27662688|NCT02660034|80602867|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
27662689|NCT02660034|80602868|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
27662690|NCT02660034|80602869|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
27662691|NCT02660034|80602870|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
27662692|NCT02660034|80602871|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
27662693|NCT02660034|80602872|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
27662694|NCT02660034|80602873|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
27662695|NCT02660034|80602874|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
27662696|NCT02660034|80602875|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
27861970|NCT00940316|81326198|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
27861971|NCT00940316|81326196|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
27861972|NCT00940316|81326197|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
27861973|NCT00940316|81326198|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
27861974|NCT00940316|81326196|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
27861975|NCT00940316|81326197|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
27861976|NCT00940316|81326198|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
27861977|NCT00940316|81326196|FG000|Treated After Cycle 5|Adverse Event|0|||
27861978|NCT00940316|81326197|FG001|Treated After Cycle 5|Adverse Event|0|||
27861979|NCT00940316|81326198|FG002|Treated After Cycle 5|Adverse Event|1|||
27861980|NCT00940316|81326196|FG000|Treated After Cycle 5|Progressive disease|0|||
27861981|NCT00940316|81326197|FG001|Treated After Cycle 5|Progressive disease|1|||
27861982|NCT00940316|81326198|FG002|Treated After Cycle 5|Progressive disease|0|||
27861983|NCT02092467|81326200|FG000|Overall Study|Death|49|||
27861984|NCT02092467|81326201|FG001|Overall Study|Death|66|||
27861985|NCT02092467|81326202|FG002|Overall Study|Death|38|||
27961994|NCT02689206|81691869|FG001|Overall Study|Protocol Violation|0|||
27662697|NCT02660034|80602876|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
27662698|NCT02660034|80602863|FG000|Overall Study|Progressive Disease (Clinical)|7|||
27662699|NCT02660034|80602864|FG001|Overall Study|Progressive Disease (Clinical)|8|||
27662700|NCT02660034|80602865|FG002|Overall Study|Progressive Disease (Clinical)|3|||
27662701|NCT02660034|80602866|FG003|Overall Study|Progressive Disease (Clinical)|9|||
27662702|NCT02660034|80602867|FG004|Overall Study|Progressive Disease (Clinical)|3|||
27662703|NCT02660034|80602868|FG005|Overall Study|Progressive Disease (Clinical)|0|||
27662704|NCT02660034|80602869|FG006|Overall Study|Progressive Disease (Clinical)|0|||
27662705|NCT02660034|80602870|FG007|Overall Study|Progressive Disease (Clinical)|0|||
27662706|NCT02660034|80602871|FG008|Overall Study|Progressive Disease (Clinical)|0|||
27662707|NCT02660034|80602872|FG009|Overall Study|Progressive Disease (Clinical)|0|||
27662708|NCT02660034|80602873|FG010|Overall Study|Progressive Disease (Clinical)|0|||
27662709|NCT02660034|80602874|FG011|Overall Study|Progressive Disease (Clinical)|0|||
27662710|NCT02660034|80602875|FG012|Overall Study|Progressive Disease (Clinical)|0|||
27662711|NCT02660034|80602876|FG013|Overall Study|Progressive Disease (Clinical)|0|||
27662712|NCT02660034|80602863|FG000|Overall Study|Lost to Follow-up|0|||
27662713|NCT02660034|80602864|FG001|Overall Study|Lost to Follow-up|0|||
27662714|NCT02660034|80602865|FG002|Overall Study|Lost to Follow-up|1|||
27662715|NCT02660034|80602866|FG003|Overall Study|Lost to Follow-up|1|||
27662716|NCT02660034|80602867|FG004|Overall Study|Lost to Follow-up|0|||
27662717|NCT02660034|80602868|FG005|Overall Study|Lost to Follow-up|0|||
27662718|NCT02660034|80602869|FG006|Overall Study|Lost to Follow-up|0|||
27662719|NCT02660034|80602870|FG007|Overall Study|Lost to Follow-up|0|||
27662720|NCT02660034|80602871|FG008|Overall Study|Lost to Follow-up|0|||
27662721|NCT02660034|80602872|FG009|Overall Study|Lost to Follow-up|1|||
27662722|NCT02660034|80602873|FG010|Overall Study|Lost to Follow-up|1|||
27662723|NCT02660034|80602874|FG011|Overall Study|Lost to Follow-up|1|||
27662724|NCT02660034|80602875|FG012|Overall Study|Lost to Follow-up|0|||
27662725|NCT02660034|80602876|FG013|Overall Study|Lost to Follow-up|0|||
27662726|NCT02660034|80602863|FG000|Overall Study|Participant moved into special access scheme|1|||
27662727|NCT02660034|80602864|FG001|Overall Study|Participant moved into special access scheme|2|||
27662728|NCT02660034|80602865|FG002|Overall Study|Participant moved into special access scheme|0|||
27662729|NCT02660034|80602866|FG003|Overall Study|Participant moved into special access scheme|0|||
27662730|NCT02660034|80602867|FG004|Overall Study|Participant moved into special access scheme|0|||
27662731|NCT02660034|80602868|FG005|Overall Study|Participant moved into special access scheme|0|||
27763677|NCT02678312|80962720|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
27763678|NCT02678312|80962716|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
27763679|NCT02678312|80962717|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27763680|NCT02678312|80962718|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27763681|NCT02678312|80962719|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27763682|NCT02678312|80962720|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
27763683|NCT02678312|80962716|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
27763684|NCT02678312|80962717|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
27861986|NCT02092467|81326200|FG000|Overall Study|Lost to Follow-up|38|||
27763685|NCT02678312|80962718|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
27763686|NCT02678312|80962719|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
27763687|NCT02678312|80962720|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
27763688|NCT02678312|80962716|FG000|Part 2 Double Blind Epoch|Death|0|||
27763689|NCT02678312|80962717|FG001|Part 2 Double Blind Epoch|Death|0|||
27763690|NCT02678312|80962718|FG002|Part 2 Double Blind Epoch|Death|0|||
27763691|NCT02678312|80962719|FG003|Part 2 Double Blind Epoch|Death|8|||
27763692|NCT02678312|80962720|FG004|Part 2 Double Blind Epoch|Death|12|||
27763693|NCT02678312|80962716|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
27763694|NCT02678312|80962717|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
27763695|NCT02678312|80962718|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
27763696|NCT02678312|80962719|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
27763697|NCT02678312|80962720|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
27763698|NCT02678312|80962716|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27763699|NCT02678312|80962717|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27763700|NCT02678312|80962718|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27763701|NCT02678312|80962719|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
27763702|NCT02678312|80962720|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
27763703|NCT02678312|80962716|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
27763704|NCT02678312|80962717|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
27763705|NCT02678312|80962718|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
27763706|NCT02678312|80962719|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
27763707|NCT02678312|80962720|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
27763708|NCT04095442|80962721|FG000|Overall Study|Lost to Follow-up|0|||
27763709|NCT04095442|80962722|FG001|Overall Study|Lost to Follow-up|1|||
27763710|NCT04095442|80962721|FG000|Overall Study|Screen failure|1|||
27961995|NCT02689206|81691870|FG002|Overall Study|Protocol Violation|0|||
27961996|NCT02689206|81691871|FG003|Overall Study|Protocol Violation|1|||
27961997|NCT02689206|81691872|FG004|Overall Study|Protocol Violation|2|||
27961998|NCT02689206|81691868|FG000|Overall Study|Other: Reached stopping criteria|0|||
27961999|NCT02689206|81691869|FG001|Overall Study|Other: Reached stopping criteria|1|||
27962000|NCT02689206|81691870|FG002|Overall Study|Other: Reached stopping criteria|2|||
27962001|NCT02689206|81691871|FG003|Overall Study|Other: Reached stopping criteria|3|||
27962002|NCT02689206|81691872|FG004|Overall Study|Other: Reached stopping criteria|4|||
27962003|NCT02689206|81691868|FG000|Overall Study|Physician Decision|1|||
27962004|NCT02689206|81691869|FG001|Overall Study|Physician Decision|0|||
27962005|NCT02689206|81691870|FG002|Overall Study|Physician Decision|0|||
27962006|NCT02689206|81691871|FG003|Overall Study|Physician Decision|0|||
27763711|NCT04095442|80962722|FG001|Overall Study|Screen failure|0|||
27763712|NCT00628758|80962726|FG000|Overall Study|Adverse Event|2|||
27962007|NCT02689206|81691872|FG004|Overall Study|Physician Decision|0|||
27962008|NCT02689206|81691868|FG000|Overall Study|Withdrawal by Subject|1|||
27962009|NCT02689206|81691869|FG001|Overall Study|Withdrawal by Subject|0|||
27962010|NCT02689206|81691870|FG002|Overall Study|Withdrawal by Subject|1|||
27962011|NCT02689206|81691871|FG003|Overall Study|Withdrawal by Subject|0|||
27962012|NCT02689206|81691872|FG004|Overall Study|Withdrawal by Subject|0|||
27962013|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
27962014|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
27962015|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
27962016|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
27962017|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
27962018|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
27962019|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
27962020|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
27962021|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
27962022|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
27962023|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
27763713|NCT00628758|80962727|FG001|Overall Study|Adverse Event|3|||
27763714|NCT00628758|80962726|FG000|Overall Study|Withdrawal by Subject|6|||
27763715|NCT00628758|80962727|FG001|Overall Study|Withdrawal by Subject|3|||
27763716|NCT00628758|80962726|FG000|Overall Study|Death|1|||
27763717|NCT00628758|80962727|FG001|Overall Study|Death|0|||
27763718|NCT00628758|80962726|FG000|Overall Study|Protocol Violation|5|||
27763719|NCT00628758|80962727|FG001|Overall Study|Protocol Violation|1|||
27763720|NCT00628758|80962726|FG000|Overall Study|Lost to Follow-up|25|||
27763721|NCT00628758|80962727|FG001|Overall Study|Lost to Follow-up|31|||
27763722|NCT00628758|80962726|FG000|Overall Study|Pregnancy|2|||
27763723|NCT00628758|80962727|FG001|Overall Study|Pregnancy|2|||
27763724|NCT00628758|80962726|FG000|Overall Study|Investigator Moved|3|||
27763725|NCT00628758|80962727|FG001|Overall Study|Investigator Moved|0|||
27763726|NCT00628758|80962726|FG000|Overall Study|Treatment Failure|0|||
27763727|NCT00628758|80962727|FG001|Overall Study|Treatment Failure|2|||
27962024|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
27962025|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
27763728|NCT04377672|80962730|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
27763729|NCT00728936|80962731|FG000|Overall Study|Withdrawal by Subject|0|||
27763730|NCT00728936|80962732|FG001|Overall Study|Withdrawal by Subject|0|||
27763731|NCT00728936|80962733|FG002|Overall Study|Withdrawal by Subject|0|||
27763732|NCT00728936|80962734|FG003|Overall Study|Withdrawal by Subject|0|||
27763733|NCT00728936|80962735|FG004|Overall Study|Withdrawal by Subject|0|||
27763734|NCT00728936|80962736|FG005|Overall Study|Withdrawal by Subject|1|||
27763735|NCT00728936|80962737|FG006|Overall Study|Withdrawal by Subject|0|||
27763736|NCT03199638|80962741|FG000|Overall Study|inability to drink glutamine during regularly|0|||
27763737|NCT03199638|80962742|FG001|Overall Study|inability to drink glutamine during regularly|2|||
27763738|NCT00990249|80962743|FG000|Overall Study|Disease Progression|8|||
27763739|NCT00990249|80962743|FG000|Overall Study|Non-Compliance|1|||
27763740|NCT00990249|80962743|FG000|Overall Study|Death|2|||
27763741|NCT00990249|80962743|FG000|Overall Study|Not treated|2|||
27763742|NCT01185704|80962746|FG000|Overall Study|Randomized but not treated|3|||
27763743|NCT01185704|80962747|FG001|Overall Study|Randomized but not treated|3|||
27763744|NCT01185704|80962746|FG000|Overall Study|Lack of ovarian response|5|||
27763745|NCT01185704|80962747|FG001|Overall Study|Lack of ovarian response|1|||
27763746|NCT01185704|80962746|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
27962026|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
27962027|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
27962028|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
27962029|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
27962030|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
27962031|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
27962032|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
27962033|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
27962034|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
27962035|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
27962036|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
27962037|NCT01672879|81691873|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
27962038|NCT01672879|81691874|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
27962039|NCT01672879|81691875|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
27962040|NCT01672879|81691873|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
27962041|NCT01672879|81691874|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
27962042|NCT01672879|81691875|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
27962043|NCT01672879|81691873|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
27962044|NCT01672879|81691874|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
27962045|NCT01672879|81691875|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
27962046|NCT01672879|81691873|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
27962047|NCT01672879|81691874|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
27962048|NCT01672879|81691875|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
27962049|NCT01672879|81691873|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
27962050|NCT01672879|81691874|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
27763747|NCT01185704|80962747|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
27763748|NCT01185704|80962746|FG000|Overall Study|Ectopic pregnancy|0|||
27763749|NCT01185704|80962747|FG001|Overall Study|Ectopic pregnancy|1|||
27763750|NCT02667457|80962752|FG000|Overall Study|Withdrawal by Subject|1|||
27763751|NCT02667457|80962753|FG001|Overall Study|Withdrawal by Subject|0|||
27763752|NCT02667457|80962752|FG000|Overall Study|Other Reason|0|||
27763753|NCT02667457|80962753|FG001|Overall Study|Other Reason|2|||
27763754|NCT02174861|80962754|FG000|Overall Study|Decision by sponsor|8|||
27763755|NCT02174861|80962754|FG000|Overall Study|Withdrawal by Subject|124|||
27763756|NCT02174861|80962754|FG000|Overall Study|Lost to Follow-up|26|||
27763757|NCT01342952|80962757|FG000|Overall Study|Adverse Event|0|||
27763758|NCT01342952|80962758|FG001|Overall Study|Adverse Event|5|||
27763759|NCT01342952|80962759|FG002|Overall Study|Adverse Event|1|||
27763760|NCT01342952|80962760|FG003|Overall Study|Adverse Event|0|||
27763761|NCT01342952|80962757|FG000|Overall Study|Lost to Follow-up|0|||
27763762|NCT01342952|80962758|FG001|Overall Study|Lost to Follow-up|2|||
27763763|NCT01342952|80962759|FG002|Overall Study|Lost to Follow-up|0|||
27763764|NCT01342952|80962760|FG003|Overall Study|Lost to Follow-up|0|||
27763765|NCT01342952|80962757|FG000|Overall Study|Withdrawal by Subject|1|||
27763766|NCT01342952|80962758|FG001|Overall Study|Withdrawal by Subject|1|||
27763767|NCT01342952|80962759|FG002|Overall Study|Withdrawal by Subject|0|||
27763768|NCT01342952|80962760|FG003|Overall Study|Withdrawal by Subject|0|||
27763769|NCT01342952|80962757|FG000|Overall Study|Physician Decision|3|||
27763770|NCT01342952|80962758|FG001|Overall Study|Physician Decision|3|||
27763771|NCT01342952|80962759|FG002|Overall Study|Physician Decision|1|||
27763772|NCT01342952|80962760|FG003|Overall Study|Physician Decision|0|||
27962051|NCT01672879|81691875|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
27962052|NCT02936869|81691878|FG000|Overall Study|Lost to Follow-up|1|||
27763773|NCT02151682|80962761|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27763774|NCT02151682|80962762|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
27763775|NCT02151682|80962763|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27763776|NCT02151682|80962764|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27763777|NCT02151682|80962765|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27763778|NCT02151682|80962766|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
27763779|NCT02151682|80962761|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27763780|NCT02151682|80962762|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
27763781|NCT02151682|80962763|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27763782|NCT02151682|80962764|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27763783|NCT02151682|80962765|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27763784|NCT02151682|80962766|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
27763785|NCT02151682|80962761|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27763786|NCT02151682|80962762|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
27763787|NCT02151682|80962763|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27763788|NCT02151682|80962764|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27763789|NCT02151682|80962765|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27763790|NCT02151682|80962766|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
27763791|NCT02151682|80962761|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
27763792|NCT02151682|80962762|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
27763793|NCT02151682|80962763|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27763794|NCT02151682|80962764|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27763795|NCT02151682|80962765|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27763796|NCT02151682|80962766|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
27763797|NCT02151682|80962761|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
27763798|NCT02151682|80962762|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27763799|NCT02151682|80962763|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27763800|NCT02151682|80962764|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27763801|NCT02151682|80962765|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27763802|NCT02151682|80962766|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
27763803|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27763804|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27763805|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
27763806|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27763807|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27763808|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
27763809|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
27763810|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
27763811|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
27763812|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
27763813|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
27763814|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
27763815|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27763816|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27763817|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
27763818|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
27763819|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27763820|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
27763821|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27763822|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27763823|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
27763824|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27763825|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27763826|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
27763827|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27763828|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27763829|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
27763830|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27763831|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27763832|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
27763833|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27763834|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27763835|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
27568815|NCT03013543|80271452|FG005|Overall Study|Physician Decision|0|||
27763836|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27962053|NCT02936869|81691879|FG001|Overall Study|Lost to Follow-up|3|||
27962054|NCT02936869|81691878|FG000|Overall Study|Death|0|||
27962055|NCT02936869|81691879|FG001|Overall Study|Death|1|||
27962056|NCT02936869|81691878|FG000|Overall Study|Legal Case|0|||
27962057|NCT02936869|81691879|FG001|Overall Study|Legal Case|1|||
27962058|NCT02936869|81691878|FG000|Overall Study|Protocol Violation|1|||
27962059|NCT02936869|81691879|FG001|Overall Study|Protocol Violation|0|||
27962060|NCT02201329|81695003|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
27962061|NCT02201329|81695003|FG000|Overall Study|Withdrawal by Subject|2|||
27962062|NCT02036580|81695007|FG000|Overall Study|Withdrawal by Subject|0|||
27962063|NCT02036580|81695008|FG001|Overall Study|Withdrawal by Subject|1|||
27962064|NCT02036580|81695009|FG002|Overall Study|Withdrawal by Subject|0|||
27962065|NCT02036580|81695007|FG000|Overall Study|Adverse Event|1|||
27662732|NCT02660034|80602869|FG006|Overall Study|Participant moved into special access scheme|0|||
27662733|NCT02660034|80602870|FG007|Overall Study|Participant moved into special access scheme|0|||
27662734|NCT02660034|80602871|FG008|Overall Study|Participant moved into special access scheme|0|||
27662735|NCT02660034|80602872|FG009|Overall Study|Participant moved into special access scheme|0|||
27662736|NCT02660034|80602873|FG010|Overall Study|Participant moved into special access scheme|0|||
27662737|NCT02660034|80602874|FG011|Overall Study|Participant moved into special access scheme|0|||
27662738|NCT02660034|80602875|FG012|Overall Study|Participant moved into special access scheme|0|||
27662739|NCT02660034|80602876|FG013|Overall Study|Participant moved into special access scheme|0|||
27662740|NCT02660034|80602863|FG000|Overall Study|Adverse Event|1|||
27662741|NCT02660034|80602864|FG001|Overall Study|Adverse Event|0|||
27662742|NCT02660034|80602865|FG002|Overall Study|Adverse Event|0|||
27662743|NCT02660034|80602866|FG003|Overall Study|Adverse Event|0|||
27662744|NCT02660034|80602867|FG004|Overall Study|Adverse Event|0|||
27662745|NCT02660034|80602868|FG005|Overall Study|Adverse Event|0|||
27662746|NCT02660034|80602869|FG006|Overall Study|Adverse Event|0|||
27662747|NCT02660034|80602870|FG007|Overall Study|Adverse Event|0|||
27662748|NCT02660034|80602871|FG008|Overall Study|Adverse Event|0|||
27662749|NCT02660034|80602872|FG009|Overall Study|Adverse Event|0|||
27662750|NCT02660034|80602873|FG010|Overall Study|Adverse Event|0|||
27861987|NCT02092467|81326201|FG001|Overall Study|Lost to Follow-up|35|||
27662751|NCT02660034|80602874|FG011|Overall Study|Adverse Event|0|||
27662752|NCT02660034|80602875|FG012|Overall Study|Adverse Event|0|||
27662753|NCT02660034|80602876|FG013|Overall Study|Adverse Event|0|||
27662754|NCT02660034|80602863|FG000|Overall Study|Sponsor Decision|0|||
27662755|NCT02660034|80602864|FG001|Overall Study|Sponsor Decision|1|||
27662756|NCT02660034|80602865|FG002|Overall Study|Sponsor Decision|2|||
27662757|NCT02660034|80602866|FG003|Overall Study|Sponsor Decision|2|||
27662758|NCT02660034|80602867|FG004|Overall Study|Sponsor Decision|3|||
27662759|NCT02660034|80602868|FG005|Overall Study|Sponsor Decision|0|||
27662760|NCT02660034|80602869|FG006|Overall Study|Sponsor Decision|0|||
27662761|NCT02660034|80602870|FG007|Overall Study|Sponsor Decision|0|||
27662762|NCT02660034|80602871|FG008|Overall Study|Sponsor Decision|0|||
27662763|NCT02660034|80602872|FG009|Overall Study|Sponsor Decision|0|||
27662764|NCT02660034|80602873|FG010|Overall Study|Sponsor Decision|0|||
27662765|NCT02660034|80602874|FG011|Overall Study|Sponsor Decision|0|||
27763837|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27763838|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
27763839|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
27763840|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
27763841|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
27763842|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
27763843|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
27763844|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
27763845|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
27763846|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
27763847|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
27763848|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
27763849|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
27763850|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
27763851|NCT02151682|80962761|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27763852|NCT02151682|80962762|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27763853|NCT02151682|80962763|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
27763854|NCT02151682|80962764|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27763855|NCT02151682|80962765|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27763856|NCT02151682|80962766|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
27763857|NCT02151682|80962761|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27763858|NCT02151682|80962762|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27962066|NCT02036580|81695008|FG001|Overall Study|Adverse Event|0|||
27962067|NCT02036580|81695009|FG002|Overall Study|Adverse Event|0|||
27763859|NCT02151682|80962763|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27763860|NCT02151682|80962764|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27763861|NCT02151682|80962765|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
27662766|NCT02660034|80602875|FG012|Overall Study|Sponsor Decision|0|||
27662767|NCT02660034|80602876|FG013|Overall Study|Sponsor Decision|1|||
27662768|NCT02660034|80602863|FG000|Overall Study|Withdrawal by Subject|0|||
27662769|NCT02660034|80602864|FG001|Overall Study|Withdrawal by Subject|0|||
27662770|NCT02660034|80602865|FG002|Overall Study|Withdrawal by Subject|0|||
27662771|NCT02660034|80602866|FG003|Overall Study|Withdrawal by Subject|0|||
27662772|NCT02660034|80602867|FG004|Overall Study|Withdrawal by Subject|0|||
27662773|NCT02660034|80602868|FG005|Overall Study|Withdrawal by Subject|0|||
27662774|NCT02660034|80602869|FG006|Overall Study|Withdrawal by Subject|1|||
27662775|NCT02660034|80602870|FG007|Overall Study|Withdrawal by Subject|1|||
27662776|NCT02660034|80602871|FG008|Overall Study|Withdrawal by Subject|1|||
27662777|NCT02660034|80602872|FG009|Overall Study|Withdrawal by Subject|0|||
27662778|NCT02660034|80602873|FG010|Overall Study|Withdrawal by Subject|0|||
27662779|NCT02660034|80602874|FG011|Overall Study|Withdrawal by Subject|1|||
27662780|NCT02660034|80602875|FG012|Overall Study|Withdrawal by Subject|2|||
27662781|NCT02660034|80602876|FG013|Overall Study|Withdrawal by Subject|0|||
27662782|NCT02660034|80602863|FG000|Overall Study|Death|0|||
27662783|NCT02660034|80602864|FG001|Overall Study|Death|0|||
27662784|NCT02660034|80602865|FG002|Overall Study|Death|0|||
27662785|NCT02660034|80602866|FG003|Overall Study|Death|0|||
27662786|NCT02660034|80602867|FG004|Overall Study|Death|0|||
27662787|NCT02660034|80602868|FG005|Overall Study|Death|13|||
27662788|NCT02660034|80602869|FG006|Overall Study|Death|14|||
27662789|NCT02660034|80602870|FG007|Overall Study|Death|10|||
27662790|NCT02660034|80602871|FG008|Overall Study|Death|9|||
27662791|NCT02660034|80602872|FG009|Overall Study|Death|21|||
27662792|NCT02660034|80602873|FG010|Overall Study|Death|17|||
27662793|NCT02660034|80602874|FG011|Overall Study|Death|15|||
27662794|NCT02660034|80602875|FG012|Overall Study|Death|18|||
27662795|NCT02660034|80602876|FG013|Overall Study|Death|7|||
27662796|NCT02660034|80602863|FG000|Overall Study|Physician Decision|0|||
27662797|NCT02660034|80602864|FG001|Overall Study|Physician Decision|0|||
27662798|NCT02660034|80602865|FG002|Overall Study|Physician Decision|0|||
27662799|NCT02660034|80602866|FG003|Overall Study|Physician Decision|0|||
27662800|NCT02660034|80602867|FG004|Overall Study|Physician Decision|0|||
27662801|NCT02660034|80602868|FG005|Overall Study|Physician Decision|0|||
27662802|NCT02660034|80602869|FG006|Overall Study|Physician Decision|0|||
27662803|NCT02660034|80602870|FG007|Overall Study|Physician Decision|0|||
27662804|NCT02660034|80602871|FG008|Overall Study|Physician Decision|0|||
27662805|NCT02660034|80602872|FG009|Overall Study|Physician Decision|0|||
27662806|NCT02660034|80602873|FG010|Overall Study|Physician Decision|0|||
27662807|NCT02660034|80602874|FG011|Overall Study|Physician Decision|0|||
27662808|NCT02660034|80602875|FG012|Overall Study|Physician Decision|0|||
27662809|NCT02660034|80602876|FG013|Overall Study|Physician Decision|1|||
27662810|NCT02660034|80602863|FG000|Overall Study|Participants transferred to LTE|0|||
27662811|NCT02660034|80602864|FG001|Overall Study|Participants transferred to LTE|0|||
27662812|NCT02660034|80602865|FG002|Overall Study|Participants transferred to LTE|0|||
27662813|NCT02660034|80602866|FG003|Overall Study|Participants transferred to LTE|0|||
27662814|NCT02660034|80602867|FG004|Overall Study|Participants transferred to LTE|0|||
27662815|NCT02660034|80602868|FG005|Overall Study|Participants transferred to LTE|10|||
27662816|NCT02660034|80602869|FG006|Overall Study|Participants transferred to LTE|8|||
27662817|NCT02660034|80602870|FG007|Overall Study|Participants transferred to LTE|8|||
27662818|NCT02660034|80602871|FG008|Overall Study|Participants transferred to LTE|10|||
27662819|NCT02660034|80602872|FG009|Overall Study|Participants transferred to LTE|1|||
27662820|NCT02660034|80602873|FG010|Overall Study|Participants transferred to LTE|2|||
27662821|NCT02660034|80602874|FG011|Overall Study|Participants transferred to LTE|4|||
27662822|NCT02660034|80602875|FG012|Overall Study|Participants transferred to LTE|1|||
27662823|NCT02660034|80602876|FG013|Overall Study|Participants transferred to LTE|1|||
27662824|NCT01203956|80602880|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
27662825|NCT01203956|80602881|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
27763862|NCT02151682|80962766|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
27763863|NCT02151682|80962761|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27763864|NCT02151682|80962762|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27763865|NCT02151682|80962763|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27662826|NCT02262364|80602884|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
27662827|NCT00627523|80602887|FG000|Overall Study|Lack of Efficacy|1|||
27662828|NCT00627523|80602888|FG001|Overall Study|Lack of Efficacy|0|||
27662829|NCT00627523|80602887|FG000|Overall Study|Withdrawal by Subject|0|||
27662830|NCT00627523|80602888|FG001|Overall Study|Withdrawal by Subject|2|||
27662831|NCT00627523|80602887|FG000|Overall Study|Other|1|||
27662832|NCT00627523|80602888|FG001|Overall Study|Other|0|||
27662833|NCT03322514|80602890|FG000|Overall Study|Withdrawal by Subject|1|||
27662834|NCT03322514|80602891|FG001|Overall Study|Withdrawal by Subject|1|||
27763866|NCT02151682|80962764|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27763867|NCT02151682|80962765|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
27763868|NCT02151682|80962766|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
27763869|NCT02151682|80962761|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27763870|NCT02151682|80962762|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27763871|NCT02151682|80962763|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27763872|NCT02151682|80962764|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27763873|NCT02151682|80962765|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
27763874|NCT02151682|80962766|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
27763875|NCT02151682|80962761|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27763876|NCT02151682|80962762|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27763877|NCT02151682|80962763|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27763878|NCT02151682|80962764|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27763879|NCT02151682|80962765|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
27763880|NCT02151682|80962766|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
27763881|NCT01610206|80962769|FG000|Overall Study|Adverse Event|10|||
27763882|NCT01610206|80962770|FG001|Overall Study|Adverse Event|30|||
27763883|NCT00436982|80962773|FG000|Overall Study|Withdrawal by Subject|3|||
27763884|NCT00436982|80962774|FG001|Overall Study|Withdrawal by Subject|1|||
27763885|NCT00436982|80962773|FG000|Overall Study|Did not receive allocated intervention|0|||
27763886|NCT00436982|80962774|FG001|Overall Study|Did not receive allocated intervention|1|||
27763887|NCT00436982|80962773|FG000|Overall Study|no RSA data|1|||
27763888|NCT00436982|80962774|FG001|Overall Study|no RSA data|2|||
27763889|NCT01602549|80962775|FG000|Overall Study|Protocol Violation|0|||
27763890|NCT01602549|80962776|FG001|Overall Study|Protocol Violation|1|||
27763891|NCT01602549|80962775|FG000|Overall Study|Withdrawal by Subject|1|||
27763892|NCT01602549|80962776|FG001|Overall Study|Withdrawal by Subject|0|||
27763893|NCT02674685|80962778|FG000|Overall Study|Withdrawal by Subject|4|||
27763894|NCT02661464|80962779|FG000|Overall Study|Lost to Follow-up|28|||
27763895|NCT02661464|80962780|FG001|Overall Study|Lost to Follow-up|0|||
27763896|NCT02661464|80962781|FG002|Overall Study|Lost to Follow-up|0|||
27763897|NCT02661464|80962782|FG003|Overall Study|Lost to Follow-up|0|||
27763898|NCT02661464|80962779|FG000|Overall Study|Withdrawal by Subject|3|||
27763899|NCT02661464|80962780|FG001|Overall Study|Withdrawal by Subject|1|||
27962068|NCT02974140|81695012|FG000|Overall Study|Adverse Event|2|||
27962069|NCT02974140|81695012|FG000|Overall Study|Lost to Follow-up|1|||
27962070|NCT02974140|81695012|FG000|Overall Study|Study Terminated by Sponsor|36|||
27962071|NCT00293813|81695013|FG000|Overall Study|Physician Decision|0|||
27962072|NCT00293813|81695014|FG001|Overall Study|Physician Decision|1|||
27962073|NCT00293813|81695015|FG002|Overall Study|Physician Decision|0|||
27962074|NCT00293813|81695013|FG000|Overall Study|Adverse Event|3|||
27962075|NCT00293813|81695014|FG001|Overall Study|Adverse Event|1|||
27962076|NCT00293813|81695015|FG002|Overall Study|Adverse Event|1|||
27962077|NCT00293813|81695013|FG000|Overall Study|Withdrawal by Subject|7|||
27962078|NCT00293813|81695014|FG001|Overall Study|Withdrawal by Subject|4|||
27962079|NCT00293813|81695015|FG002|Overall Study|Withdrawal by Subject|4|||
27962080|NCT00293813|81695013|FG000|Overall Study|Lost to Follow-up|3|||
27861988|NCT02092467|81326202|FG002|Overall Study|Lost to Follow-up|40|||
27861989|NCT02092467|81326200|FG000|Overall Study|Global Deterioration of Health Status|1|||
27861990|NCT02092467|81326201|FG001|Overall Study|Global Deterioration of Health Status|0|||
27861991|NCT02092467|81326202|FG002|Overall Study|Global Deterioration of Health Status|0|||
27861992|NCT02092467|81326200|FG000|Overall Study|Other|32|||
27861993|NCT02092467|81326201|FG001|Overall Study|Other|30|||
27861994|NCT02092467|81326202|FG002|Overall Study|Other|24|||
27861995|NCT02092467|81326200|FG000|Overall Study|Withdrawal by Subject|282|||
27861996|NCT02092467|81326201|FG001|Overall Study|Withdrawal by Subject|327|||
27861997|NCT02092467|81326202|FG002|Overall Study|Withdrawal by Subject|289|||
27861998|NCT02092467|81326200|FG000|Overall Study|Randomized but not treated|2|||
27861999|NCT02092467|81326201|FG001|Overall Study|Randomized but not treated|1|||
27862000|NCT02092467|81326202|FG002|Overall Study|Randomized but not treated|7|||
27862001|NCT01753297|81326203|FG000|Overall Study|Lost to Follow-up|7|||
27862002|NCT01753297|81326204|FG001|Overall Study|Lost to Follow-up|2|||
27862003|NCT01753297|81326203|FG000|Overall Study|Withdrawal by Subject|26|||
27862004|NCT01753297|81326204|FG001|Overall Study|Withdrawal by Subject|23|||
27763900|NCT02661464|80962781|FG002|Overall Study|Withdrawal by Subject|0|||
27763901|NCT02661464|80962782|FG003|Overall Study|Withdrawal by Subject|0|||
27962081|NCT00293813|81695014|FG001|Overall Study|Lost to Follow-up|2|||
27763902|NCT02661464|80962779|FG000|Overall Study|Participants terminated prematurely|288|||
27763903|NCT02661464|80962780|FG001|Overall Study|Participants terminated prematurely|52|||
27763904|NCT02661464|80962781|FG002|Overall Study|Participants terminated prematurely|1|||
27962082|NCT00293813|81695015|FG002|Overall Study|Lost to Follow-up|3|||
27763905|NCT02661464|80962782|FG003|Overall Study|Participants terminated prematurely|1|||
27962083|NCT00293813|81695013|FG000|Overall Study|Noncompliance|0|||
27568816|NCT03013543|80271453|FG006|Overall Study|Physician Decision|0|||
27962084|NCT00293813|81695014|FG001|Overall Study|Noncompliance|1|||
27862005|NCT01753297|81326203|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
27862006|NCT01753297|81326204|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
27862007|NCT01753297|81326203|FG000|Overall Study|Death|0|||
27862008|NCT01753297|81326204|FG001|Overall Study|Death|2|||
27862009|NCT01753297|81326203|FG000|Overall Study|Did not attend end of study visit|7|||
27862010|NCT01753297|81326204|FG001|Overall Study|Did not attend end of study visit|8|||
27862011|NCT01275430|81326210|FG000|Overall Study|Adverse Event|1|||
27862012|NCT01275430|81326210|FG000|Overall Study|No Contrast Injection|6|||
27862013|NCT01275430|81326210|FG000|Overall Study|Device Malfunction|1|||
27862014|NCT01275430|81326210|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
27862015|NCT00509795|81326214|FG000|Overall Study|Adverse Event|4|||
27862016|NCT00509795|81326215|FG001|Overall Study|Adverse Event|3|||
27862017|NCT00509795|81326216|FG002|Overall Study|Adverse Event|5|||
27862018|NCT00509795|81326217|FG003|Overall Study|Adverse Event|4|||
27862019|NCT00509795|81326214|FG000|Overall Study|Death|3|||
27862020|NCT00509795|81326215|FG001|Overall Study|Death|1|||
27862021|NCT00509795|81326216|FG002|Overall Study|Death|2|||
27862022|NCT00509795|81326217|FG003|Overall Study|Death|7|||
27862023|NCT00509795|81326214|FG000|Overall Study|Lack of Efficacy|0|||
27862024|NCT00509795|81326215|FG001|Overall Study|Lack of Efficacy|0|||
27862025|NCT00509795|81326216|FG002|Overall Study|Lack of Efficacy|2|||
27862026|NCT00509795|81326217|FG003|Overall Study|Lack of Efficacy|2|||
27862027|NCT00509795|81326214|FG000|Overall Study|Lost to Follow-up|1|||
27862028|NCT00509795|81326215|FG001|Overall Study|Lost to Follow-up|2|||
27862029|NCT00509795|81326216|FG002|Overall Study|Lost to Follow-up|4|||
27862030|NCT00509795|81326217|FG003|Overall Study|Lost to Follow-up|4|||
27862031|NCT00509795|81326214|FG000|Overall Study|OTHER|1|||
27862032|NCT00509795|81326215|FG001|Overall Study|OTHER|0|||
27862033|NCT00509795|81326216|FG002|Overall Study|OTHER|4|||
27862034|NCT00509795|81326217|FG003|Overall Study|OTHER|1|||
27862035|NCT00509795|81326214|FG000|Overall Study|Protocol Violation|3|||
27862036|NCT00509795|81326215|FG001|Overall Study|Protocol Violation|0|||
27763906|NCT02661464|80962779|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
27763907|NCT02661464|80962780|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
27763908|NCT02661464|80962781|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
27763909|NCT02661464|80962782|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
27763910|NCT00118911|80962783|FG000|Overall Study|Withdrawal by Subject|2|||
27763911|NCT00118911|80962784|FG001|Overall Study|Withdrawal by Subject|5|||
27763912|NCT01293006|80962785|FG000|Period 2|Lost to Follow-up|1|||
27763913|NCT01293006|80962786|FG001|Period 2|Lost to Follow-up|0|||
27763914|NCT01293006|80962787|FG002|Period 2|Lost to Follow-up|0|||
27763915|NCT01293006|80962788|FG003|Period 2|Lost to Follow-up|0|||
27763916|NCT01412060|80962789|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
27763917|NCT01412060|80962790|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
27763918|NCT01412060|80962791|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
27763919|NCT01412060|80962789|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
27763920|NCT01412060|80962790|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
27763921|NCT01412060|80962791|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
27763922|NCT01412060|80962789|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
27763923|NCT01412060|80962790|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
27763924|NCT01412060|80962791|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
27763925|NCT01412060|80962789|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
27763926|NCT01412060|80962790|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
27763927|NCT01412060|80962791|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
27763928|NCT01412060|80962789|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
27763929|NCT01412060|80962790|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
27763930|NCT01412060|80962791|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
27763931|NCT01412060|80962789|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
27763932|NCT01412060|80962790|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
27763933|NCT01412060|80962791|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
27763934|NCT01412060|80962789|FG000|Period Between RIP and SP|Adverse Event|4|||
27862037|NCT00509795|81326216|FG002|Overall Study|Protocol Violation|3|||
27862038|NCT00509795|81326217|FG003|Overall Study|Protocol Violation|1|||
27763935|NCT01412060|80962790|FG001|Period Between RIP and SP|Adverse Event|0|||
27763936|NCT01412060|80962791|FG002|Period Between RIP and SP|Adverse Event|0|||
27862039|NCT00509795|81326214|FG000|Overall Study|Withdrawal by Subject|10|||
27862040|NCT00509795|81326215|FG001|Overall Study|Withdrawal by Subject|5|||
27862041|NCT00509795|81326216|FG002|Overall Study|Withdrawal by Subject|7|||
27862042|NCT00509795|81326217|FG003|Overall Study|Withdrawal by Subject|8|||
27862043|NCT01449812|81326218|FG000|Overall Study|Migrated/moved from study area|1|||
27862044|NCT01449812|81326219|FG001|Overall Study|Migrated/moved from study area|0|||
27862045|NCT01449812|81326220|FG002|Overall Study|Migrated/moved from study area|0|||
27862046|NCT01449812|81326218|FG000|Overall Study|Withdrawal by Subject|0|||
27862047|NCT01449812|81326219|FG001|Overall Study|Withdrawal by Subject|0|||
27763937|NCT01412060|80962789|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
27763938|NCT01412060|80962790|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
27763939|NCT01412060|80962791|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
27763940|NCT01412060|80962789|FG000|Period Between RIP and SP|Protocol Violation|2|||
27763941|NCT01412060|80962790|FG001|Period Between RIP and SP|Protocol Violation|0|||
27763942|NCT01412060|80962791|FG002|Period Between RIP and SP|Protocol Violation|0|||
27763943|NCT01412060|80962789|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
27763944|NCT01412060|80962790|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
27763945|NCT01412060|80962791|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
27763946|NCT01412060|80962789|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
27763947|NCT01412060|80962790|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
27763948|NCT01412060|80962791|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
27763949|NCT01412060|80962789|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
27763950|NCT01412060|80962790|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
27763951|NCT01412060|80962791|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
27862048|NCT01449812|81326220|FG002|Overall Study|Withdrawal by Subject|1|||
27662835|NCT01494298|80602892|FG000|Overall Study|Protocol Violation|2|||
27862049|NCT01449812|81326218|FG000|Overall Study|Lost to Follow-up|1|||
27862050|NCT01449812|81326219|FG001|Overall Study|Lost to Follow-up|0|||
27662836|NCT01494298|80602893|FG001|Overall Study|Protocol Violation|8|||
27662837|NCT01287416|80602898|FG000|Pre-post Training|Withdrawal by Subject|17|||
27662838|NCT01287416|80602899|FG001|Pre-post Training|Withdrawal by Subject|24|||
27662839|NCT01287416|80602898|FG000|Pre-post Training|Lost to Follow-up|5|||
27662840|NCT01287416|80602899|FG001|Pre-post Training|Lost to Follow-up|1|||
27662841|NCT01287416|80602898|FG000|6 Month Follow-up|Lost to Follow-up|3|||
27662842|NCT01287416|80602899|FG001|6 Month Follow-up|Lost to Follow-up|2|||
27662843|NCT00497198|80602900|FG000|Overall Study|Adverse Event|4|||
27662844|NCT00497198|80602901|FG001|Overall Study|Adverse Event|2|||
27662845|NCT00497198|80602900|FG000|Overall Study|Physician Decision|1|||
27662846|NCT00497198|80602901|FG001|Overall Study|Physician Decision|2|||
27662847|NCT00497198|80602900|FG000|Overall Study|Withdrawal by Subject|0|||
27662848|NCT00497198|80602901|FG001|Overall Study|Withdrawal by Subject|1|||
27662849|NCT03045302|80602902|FG000|Overall Study|Pre-treatment adverse event|1|||
27662850|NCT02030847|80602903|FG000|Overall Study|Death|10|||
27662851|NCT02030847|80602903|FG000|Overall Study|Disease Progression|15|||
27662852|NCT02030847|80602903|FG000|Overall Study|New Cancer Therapy|8|||
27662853|NCT02030847|80602903|FG000|Overall Study|Physician Decision|3|||
27662854|NCT02030847|80602903|FG000|Overall Study|Withdrawal by Subject|1|||
27662855|NCT01902381|80602904|FG000|Overall Study|Withdrawal by Subject|1|||
27662856|NCT01730118|80602905|FG000|Dose Escalation|Death on study|5|||
27662857|NCT01730118|80602906|FG001|Dose Escalation|Death on study|7|||
27662858|NCT01730118|80602907|FG002|Dose Escalation|Death on study|2|||
27662859|NCT01730118|80602908|FG003|Dose Escalation|Death on study|6|||
27662860|NCT01730118|80602909|FG004|Dose Escalation|Death on study|0|||
27662861|NCT01730118|80602910|FG005|Dose Escalation|Death on study|0|||
27662862|NCT01730118|80602911|FG006|Dose Escalation|Death on study|0|||
27662863|NCT01730118|80602905|FG000|Dose Escalation|Died before treatment|0|||
27662864|NCT01730118|80602906|FG001|Dose Escalation|Died before treatment|0|||
27662865|NCT01730118|80602907|FG002|Dose Escalation|Died before treatment|0|||
27662866|NCT01730118|80602908|FG003|Dose Escalation|Died before treatment|0|||
27662867|NCT01730118|80602909|FG004|Dose Escalation|Died before treatment|0|||
27662868|NCT01730118|80602910|FG005|Dose Escalation|Died before treatment|0|||
27662869|NCT01730118|80602911|FG006|Dose Escalation|Died before treatment|1|||
27662870|NCT01730118|80602905|FG000|Dose Escalation|Chose to start a different treatment|1|||
27662871|NCT01730118|80602906|FG001|Dose Escalation|Chose to start a different treatment|0|||
27662872|NCT01730118|80602907|FG002|Dose Escalation|Chose to start a different treatment|0|||
27662873|NCT01730118|80602908|FG003|Dose Escalation|Chose to start a different treatment|0|||
27763952|NCT01412060|80962789|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
27962085|NCT00293813|81695015|FG002|Overall Study|Noncompliance|0|||
27962086|NCT01498692|81695016|FG000|Overall Study|Death|4|||
27962087|NCT01498692|81695016|FG000|Overall Study|Withdrawal by Subject|1|||
27962088|NCT01498692|81695016|FG000|Overall Study|Missed 12-month visit|3|||
27962089|NCT03525600|81695017|FG000|Overall Study|Adverse Event|9|||
27662874|NCT01730118|80602909|FG004|Dose Escalation|Chose to start a different treatment|0|||
27662875|NCT01730118|80602910|FG005|Dose Escalation|Chose to start a different treatment|0|||
27662876|NCT01730118|80602911|FG006|Dose Escalation|Chose to start a different treatment|0|||
27962090|NCT03525600|81695018|FG001|Overall Study|Adverse Event|6|||
27662877|NCT01730118|80602905|FG000|Dose Escalation|Withdrawal by Subject|0|||
27662878|NCT01730118|80602906|FG001|Dose Escalation|Withdrawal by Subject|0|||
27662879|NCT01730118|80602907|FG002|Dose Escalation|Withdrawal by Subject|1|||
27662880|NCT01730118|80602908|FG003|Dose Escalation|Withdrawal by Subject|0|||
27862051|NCT01449812|81326220|FG002|Overall Study|Lost to Follow-up|0|||
27662881|NCT01730118|80602909|FG004|Dose Escalation|Withdrawal by Subject|0|||
27662882|NCT01730118|80602910|FG005|Dose Escalation|Withdrawal by Subject|0|||
27962091|NCT03525600|81695019|FG002|Overall Study|Adverse Event|5|||
27962092|NCT03525600|81695020|FG003|Overall Study|Adverse Event|3|||
27962093|NCT03525600|81695017|FG000|Overall Study|Lost to Follow-up|2|||
27962094|NCT03525600|81695018|FG001|Overall Study|Lost to Follow-up|4|||
27962095|NCT03525600|81695019|FG002|Overall Study|Lost to Follow-up|4|||
27962096|NCT03525600|81695020|FG003|Overall Study|Lost to Follow-up|0|||
27962097|NCT03525600|81695017|FG000|Overall Study|Physician Decision|1|||
27962098|NCT03525600|81695018|FG001|Overall Study|Physician Decision|0|||
27962099|NCT03525600|81695019|FG002|Overall Study|Physician Decision|2|||
27962100|NCT03525600|81695020|FG003|Overall Study|Physician Decision|0|||
27962101|NCT03525600|81695017|FG000|Overall Study|Consent withdrawal|36|||
27862052|NCT01755767|81326222|FG000|Overall Study|Progressive Disease|8|||
27862053|NCT01755767|81326223|FG001|Overall Study|Progressive Disease|7|||
27862054|NCT01755767|81326224|FG002|Overall Study|Progressive Disease|91|||
27862055|NCT01755767|81326225|FG003|Overall Study|Progressive Disease|43|||
27862056|NCT01755767|81326222|FG000|Overall Study|Clinical Disease Progression|4|||
27862057|NCT01755767|81326223|FG001|Overall Study|Clinical Disease Progression|2|||
27862058|NCT01755767|81326224|FG002|Overall Study|Clinical Disease Progression|29|||
27862059|NCT01755767|81326225|FG003|Overall Study|Clinical Disease Progression|20|||
27962102|NCT03525600|81695018|FG001|Overall Study|Consent withdrawal|20|||
27662883|NCT01730118|80602911|FG006|Dose Escalation|Withdrawal by Subject|0|||
27662884|NCT01730118|80602905|FG000|Dose Escalation|Disease progression prior to treatment|0|||
27662885|NCT01730118|80602906|FG001|Dose Escalation|Disease progression prior to treatment|0|||
27662886|NCT01730118|80602907|FG002|Dose Escalation|Disease progression prior to treatment|0|||
27662887|NCT01730118|80602908|FG003|Dose Escalation|Disease progression prior to treatment|0|||
27662888|NCT01730118|80602909|FG004|Dose Escalation|Disease progression prior to treatment|0|||
27662889|NCT01730118|80602910|FG005|Dose Escalation|Disease progression prior to treatment|0|||
27662890|NCT01730118|80602911|FG006|Dose Escalation|Disease progression prior to treatment|1|||
27662891|NCT01730118|80602905|FG000|Dose Expansion|Death|0|||
27662892|NCT01730118|80602906|FG001|Dose Expansion|Death|0|||
27662893|NCT01730118|80602907|FG002|Dose Expansion|Death|0|||
27662894|NCT01730118|80602908|FG003|Dose Expansion|Death|0|||
27662895|NCT01730118|80602909|FG004|Dose Expansion|Death|1|||
27662896|NCT01730118|80602910|FG005|Dose Expansion|Death|0|||
27662897|NCT01730118|80602911|FG006|Dose Expansion|Death|0|||
27662898|NCT01730118|80602905|FG000|Dose Expansion|Other medical condition|0|||
27662899|NCT01730118|80602906|FG001|Dose Expansion|Other medical condition|0|||
27662900|NCT01730118|80602907|FG002|Dose Expansion|Other medical condition|0|||
27662901|NCT01730118|80602908|FG003|Dose Expansion|Other medical condition|0|||
27662902|NCT01730118|80602909|FG004|Dose Expansion|Other medical condition|1|||
27662903|NCT01730118|80602910|FG005|Dose Expansion|Other medical condition|0|||
27662904|NCT01730118|80602911|FG006|Dose Expansion|Other medical condition|0|||
27662905|NCT01730118|80602905|FG000|Dose Expansion|Withdrawal by Subject|0|||
27662906|NCT01730118|80602906|FG001|Dose Expansion|Withdrawal by Subject|0|||
27662907|NCT01730118|80602907|FG002|Dose Expansion|Withdrawal by Subject|0|||
27662908|NCT01730118|80602908|FG003|Dose Expansion|Withdrawal by Subject|0|||
27662909|NCT01730118|80602909|FG004|Dose Expansion|Withdrawal by Subject|1|||
27662910|NCT01730118|80602910|FG005|Dose Expansion|Withdrawal by Subject|0|||
27662911|NCT01730118|80602911|FG006|Dose Expansion|Withdrawal by Subject|0|||
27662912|NCT01730118|80602905|FG000|Dose Expansion|Disease progression|0|||
27763953|NCT01412060|80962790|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
27763954|NCT01412060|80962791|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
27763955|NCT01412060|80962789|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
27763956|NCT01412060|80962790|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
27763957|NCT01412060|80962791|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
27763958|NCT01412060|80962789|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
27763959|NCT01412060|80962790|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
27763960|NCT01412060|80962791|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
27763961|NCT01412060|80962789|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
27763962|NCT01412060|80962790|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
27763963|NCT01412060|80962791|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
27763964|NCT01412060|80962789|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
27763965|NCT01412060|80962790|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
27763966|NCT01412060|80962791|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
27763967|NCT01412060|80962789|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
27763968|NCT01412060|80962790|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
27763969|NCT01412060|80962791|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
27763970|NCT01412060|80962789|FG000|Period Between SP and DBP|Protocol Violation|2|||
27763971|NCT01412060|80962790|FG001|Period Between SP and DBP|Protocol Violation|0|||
27763972|NCT01412060|80962791|FG002|Period Between SP and DBP|Protocol Violation|0|||
27763973|NCT01412060|80962789|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
27862060|NCT01755767|81326222|FG000|Overall Study|Radiographic Disease Progression|9|||
27763974|NCT01412060|80962790|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
27763975|NCT01412060|80962791|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
27763976|NCT01412060|80962789|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
27763977|NCT01412060|80962790|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
27763978|NCT01412060|80962791|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
27763979|NCT01412060|80962789|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
27763980|NCT01412060|80962790|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
27763981|NCT01412060|80962791|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
27763982|NCT01412060|80962789|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
27763983|NCT01412060|80962790|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
27763984|NCT01412060|80962791|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
27763985|NCT01412060|80962789|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
27763986|NCT01412060|80962790|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
27763987|NCT01412060|80962791|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
27763988|NCT01412060|80962789|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
27763989|NCT01412060|80962790|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
27763990|NCT01412060|80962791|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
27763991|NCT01412060|80962789|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
27763992|NCT01412060|80962790|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
27763993|NCT01412060|80962791|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
27763994|NCT01412060|80962789|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
27763995|NCT01412060|80962790|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
27962103|NCT03525600|81695019|FG002|Overall Study|Consent withdrawal|6|||
27962104|NCT03525600|81695020|FG003|Overall Study|Consent withdrawal|13|||
27962105|NCT03525600|81695017|FG000|Overall Study|Death|7|||
27962106|NCT03525600|81695018|FG001|Overall Study|Death|6|||
27962107|NCT03525600|81695019|FG002|Overall Study|Death|4|||
27962108|NCT03525600|81695020|FG003|Overall Study|Death|3|||
27962109|NCT03525600|81695017|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
27962110|NCT03525600|81695018|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
27962111|NCT03525600|81695019|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
27962112|NCT03525600|81695020|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
27962113|NCT03525600|81695017|FG000|Overall Study|Other|0|||
27962114|NCT03525600|81695018|FG001|Overall Study|Other|1|||
27962115|NCT03525600|81695019|FG002|Overall Study|Other|0|||
27962116|NCT03525600|81695020|FG003|Overall Study|Other|0|||
27962117|NCT02342288|81695026|FG000|Overall Study|no protocol anesthesiologist available|3|||
27962118|NCT02342288|81695027|FG001|Overall Study|no protocol anesthesiologist available|2|||
27962119|NCT02342288|81695026|FG000|Overall Study|anesthesia leak in system|1|||
27962120|NCT02342288|81695027|FG001|Overall Study|anesthesia leak in system|0|||
27962121|NCT02342288|81695026|FG000|Overall Study|Withdrawal by Subject|1|||
27962122|NCT02342288|81695027|FG001|Overall Study|Withdrawal by Subject|0|||
27763996|NCT01412060|80962791|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
27763997|NCT01412060|80962789|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
27763998|NCT01412060|80962790|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
27763999|NCT01412060|80962791|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
27764000|NCT01412060|80962789|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
27764001|NCT01412060|80962790|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
27764002|NCT01412060|80962791|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
27764003|NCT01677624|80962792|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
27764004|NCT01548417|80962794|FG000|Overall Study|Withdrawal by Subject|0|||
27764005|NCT01548417|80962795|FG001|Overall Study|Withdrawal by Subject|2|||
27764006|NCT01231607|80962804|FG000|Overall Study|Adverse Event|0|||
27764007|NCT01231607|80962805|FG001|Overall Study|Adverse Event|8|||
27764008|NCT01231607|80962806|FG002|Overall Study|Adverse Event|4|||
27764009|NCT01231607|80962807|FG003|Overall Study|Adverse Event|4|||
27764010|NCT01231607|80962808|FG004|Overall Study|Adverse Event|5|||
27764011|NCT01231607|80962804|FG000|Overall Study|Lost to Follow-up|13|||
27764012|NCT01231607|80962805|FG001|Overall Study|Lost to Follow-up|11|||
27764013|NCT01231607|80962806|FG002|Overall Study|Lost to Follow-up|10|||
27764014|NCT01231607|80962807|FG003|Overall Study|Lost to Follow-up|10|||
27962123|NCT02342288|81695026|FG000|Overall Study|coordinator contaminated with blood|0|||
27962124|NCT02342288|81695027|FG001|Overall Study|coordinator contaminated with blood|1|||
27764015|NCT01231607|80962808|FG004|Overall Study|Lost to Follow-up|4|||
27764016|NCT01231607|80962804|FG000|Overall Study|Physician Decision|4|||
27764017|NCT01231607|80962805|FG001|Overall Study|Physician Decision|4|||
27764018|NCT01231607|80962806|FG002|Overall Study|Physician Decision|3|||
27962125|NCT02342288|81695026|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
27764019|NCT01231607|80962807|FG003|Overall Study|Physician Decision|5|||
27764020|NCT01231607|80962808|FG004|Overall Study|Physician Decision|4|||
27962126|NCT02342288|81695027|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
27962127|NCT02342288|81695026|FG000|Overall Study|coordinator not available|0|||
27962128|NCT02342288|81695027|FG001|Overall Study|coordinator not available|2|||
27962129|NCT01995526|81695028|FG000|Overall Study|Physician Decision|1|||
27962130|NCT00814580|81695032|FG000|Overall Study|Adverse Event|6|||
27962131|NCT00814580|81695033|FG001|Overall Study|Adverse Event|15|||
27962132|NCT00814580|81695032|FG000|Overall Study|Lack of Efficacy|18|||
27962133|NCT00814580|81695033|FG001|Overall Study|Lack of Efficacy|25|||
27962134|NCT00814580|81695032|FG000|Overall Study|Protocol Violation|2|||
27962135|NCT00814580|81695033|FG001|Overall Study|Protocol Violation|0|||
27962136|NCT00814580|81695032|FG000|Overall Study|Withdrawal by Subject|2|||
27962137|NCT00814580|81695033|FG001|Overall Study|Withdrawal by Subject|2|||
27962138|NCT00814580|81695032|FG000|Overall Study|Other|1|||
27962139|NCT00814580|81695033|FG001|Overall Study|Other|3|||
27962140|NCT00814580|81695032|FG000|Overall Study|Did Not Take Drug|2|||
27962141|NCT00814580|81695033|FG001|Overall Study|Did Not Take Drug|2|||
27962142|NCT00375505|81695034|FG000|Overall Study|Adverse Event|1|||
27962143|NCT00375505|81695035|FG001|Overall Study|Adverse Event|2|||
27962144|NCT03583359|81695036|FG000|Overall Study|Withdrawal by Subject|15|||
27962145|NCT03583359|81695037|FG001|Overall Study|Withdrawal by Subject|6|||
27962146|NCT03583359|81695036|FG000|Overall Study|Lost to Follow-up|12|||
27962147|NCT03583359|81695037|FG001|Overall Study|Lost to Follow-up|3|||
27962148|NCT03583359|81695036|FG000|Overall Study|Adverse Event|0|||
27962149|NCT03583359|81695037|FG001|Overall Study|Adverse Event|1|||
27962150|NCT03583359|81695036|FG000|Overall Study|Protocol Violation|0|||
27962151|NCT03583359|81695037|FG001|Overall Study|Protocol Violation|1|||
27962152|NCT03583359|81695036|FG000|Overall Study|Other|2|||
27962153|NCT03583359|81695037|FG001|Overall Study|Other|1|||
27962154|NCT03050450|81695041|FG000|Overall Study|Physician Decision|1|||
27962155|NCT03050450|81695042|FG001|Overall Study|Physician Decision|0|||
27962156|NCT03050450|81695043|FG002|Overall Study|Physician Decision|0|||
27662913|NCT01730118|80602906|FG001|Dose Expansion|Disease progression|0|||
27962157|NCT03050450|81695044|FG003|Overall Study|Physician Decision|0|||
27962158|NCT03050450|81695045|FG004|Overall Study|Physician Decision|0|||
27962159|NCT02526212|81695046|FG000|Overall Study|Incarceration|1|||
27962160|NCT02526212|81695047|FG001|Overall Study|Incarceration|0|||
27962161|NCT02526212|81695046|FG000|Overall Study|Lost to Follow-up|1|||
27962162|NCT02526212|81695047|FG001|Overall Study|Lost to Follow-up|0|||
27962163|NCT02526212|81695046|FG000|Overall Study|Death|0|||
27962164|NCT02526212|81695047|FG001|Overall Study|Death|1|||
27962165|NCT01823107|81695048|FG000|Overall Study|Withdrawal by Subject|1|||
27962166|NCT00902850|81695049|FG000|Overall Study|Physician Decision|2|||
27962167|NCT00902850|81695050|FG001|Overall Study|Physician Decision|2|||
27962168|NCT01773967|81695053|FG000|Overall Study|Lost to Follow-up|15|||
27962169|NCT01773967|81695054|FG001|Overall Study|Lost to Follow-up|13|||
27962170|NCT03663569|81695060|FG000|Overall Study|Discontinuation of study|11|||
27962171|NCT03663569|81695060|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
27962172|NCT03663569|81695060|FG000|Overall Study|Deceased patient|6|||
27962173|NCT03663569|81695060|FG000|Overall Study|Lost to Follow-up|18|||
27962174|NCT03663569|81695060|FG000|Overall Study|Withdrawal of consent|5|||
27962175|NCT03663569|81695060|FG000|Overall Study|Patient's request|11|||
27962176|NCT03663569|81695060|FG000|Overall Study|Adverse Event|4|||
27962177|NCT03663569|81695060|FG000|Overall Study|Not come to second visit|3|||
27962178|NCT03663569|81695060|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
27962179|NCT03663569|81695060|FG000|Overall Study|Serious adverse event|1|||
27962180|NCT04776161|81695061|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
27962181|NCT04776161|81695062|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
27962182|NCT04776161|81695063|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
27962183|NCT04776161|81695061|FG000|Overall Study|Withdrawal by Subject|1|||
27662914|NCT01730118|80602907|FG002|Dose Expansion|Disease progression|0|||
27662915|NCT01730118|80602908|FG003|Dose Expansion|Disease progression|0|||
27662916|NCT01730118|80602909|FG004|Dose Expansion|Disease progression|0|||
27662917|NCT01730118|80602910|FG005|Dose Expansion|Disease progression|1|||
27662918|NCT01730118|80602911|FG006|Dose Expansion|Disease progression|0|||
27662919|NCT01730118|80602905|FG000|Dose Expansion|Inability to return|0|||
27662920|NCT01730118|80602906|FG001|Dose Expansion|Inability to return|0|||
27764021|NCT01231607|80962804|FG000|Overall Study|Protocol Violation|3|||
27764022|NCT01231607|80962805|FG001|Overall Study|Protocol Violation|2|||
27962184|NCT04776161|81695062|FG001|Overall Study|Withdrawal by Subject|0|||
27962185|NCT04776161|81695063|FG002|Overall Study|Withdrawal by Subject|1|||
27962186|NCT04776161|81695061|FG000|Overall Study|Adverse Event|0|||
27962187|NCT04776161|81695062|FG001|Overall Study|Adverse Event|1|||
27962188|NCT04776161|81695063|FG002|Overall Study|Adverse Event|1|||
27962189|NCT01864148|81695064|FG000|Overall Study|Other|2|||
27962190|NCT01864148|81695065|FG001|Overall Study|Other|1|||
27962191|NCT01864148|81695066|FG002|Overall Study|Other|1|||
27962192|NCT01864148|81695067|FG003|Overall Study|Other|3|||
27962193|NCT01864148|81695068|FG004|Overall Study|Other|1|||
27962194|NCT01864148|81695064|FG000|Overall Study|Death|0|||
27962195|NCT01864148|81695065|FG001|Overall Study|Death|0|||
27962196|NCT01864148|81695066|FG002|Overall Study|Death|0|||
27962197|NCT01864148|81695067|FG003|Overall Study|Death|1|||
27962198|NCT01864148|81695068|FG004|Overall Study|Death|0|||
27962199|NCT01864148|81695064|FG000|Overall Study|Investigator Decision|5|||
27962200|NCT01864148|81695065|FG001|Overall Study|Investigator Decision|0|||
27962201|NCT01864148|81695066|FG002|Overall Study|Investigator Decision|0|||
27962202|NCT01864148|81695067|FG003|Overall Study|Investigator Decision|4|||
27662921|NCT01730118|80602907|FG002|Dose Expansion|Inability to return|0|||
27662922|NCT01730118|80602908|FG003|Dose Expansion|Inability to return|0|||
27662923|NCT01730118|80602909|FG004|Dose Expansion|Inability to return|0|||
27764023|NCT01231607|80962806|FG002|Overall Study|Protocol Violation|0|||
27764024|NCT01231607|80962807|FG003|Overall Study|Protocol Violation|2|||
27764025|NCT01231607|80962808|FG004|Overall Study|Protocol Violation|2|||
27764026|NCT01231607|80962804|FG000|Overall Study|Withdrawal by Subject|9|||
27764027|NCT01231607|80962805|FG001|Overall Study|Withdrawal by Subject|9|||
27764028|NCT01231607|80962806|FG002|Overall Study|Withdrawal by Subject|14|||
27764029|NCT01231607|80962807|FG003|Overall Study|Withdrawal by Subject|17|||
27764030|NCT01231607|80962808|FG004|Overall Study|Withdrawal by Subject|9|||
27764031|NCT01946412|80962809|FG000|Overall Study|Adverse Event|1|||
27764032|NCT01946412|80962809|FG000|Overall Study|Non-Compliance|1|||
27764033|NCT01946412|80962809|FG000|Overall Study|Continued with commercial Kalydeco|2|||
27764034|NCT01946412|80962809|FG000|Overall Study|Difficulty in swallowing|1|||
27764035|NCT00089479|80962810|FG000|Overall Study|Death|108|||
27764036|NCT00089479|80962811|FG001|Overall Study|Death|75|||
27764037|NCT00089479|80962810|FG000|Overall Study|Withdrawal by Subject|86|||
27764038|NCT00089479|80962811|FG001|Overall Study|Withdrawal by Subject|107|||
27764039|NCT00089479|80962810|FG000|Overall Study|Lost to Follow-up|137|||
27764040|NCT00089479|80962811|FG001|Overall Study|Lost to Follow-up|107|||
27764041|NCT02141217|80962812|FG000|Overall Study|Adverse Event|1|||
27764042|NCT02141217|80962813|FG001|Overall Study|Adverse Event|2|||
27764043|NCT02141217|80962812|FG000|Overall Study|Protocol Violation|1|||
27764044|NCT02141217|80962813|FG001|Overall Study|Protocol Violation|4|||
27764045|NCT02141217|80962812|FG000|Overall Study|Withdrawal by Subject|6|||
27764046|NCT02141217|80962813|FG001|Overall Study|Withdrawal by Subject|0|||
27764047|NCT02141217|80962812|FG000|Overall Study|Lost to Follow-up|1|||
27764048|NCT02141217|80962813|FG001|Overall Study|Lost to Follow-up|1|||
27764049|NCT02141217|80962812|FG000|Overall Study|Physician Decision|1|||
27764050|NCT02141217|80962813|FG001|Overall Study|Physician Decision|0|||
27764051|NCT02141217|80962812|FG000|Overall Study|Surgical Intervention|1|||
27764052|NCT02141217|80962813|FG001|Overall Study|Surgical Intervention|1|||
27764053|NCT02287402|80962818|FG000|Treatment Period|Adverse Event|17|||
27764054|NCT02287402|80962818|FG000|Treatment Period|Voluntary Withdrawal|10|||
27764055|NCT02287402|80962818|FG000|Follow-up|Lost to Follow-up|1|||
27764056|NCT02287402|80962818|FG000|Follow-up|Voluntary Withdrawal|2|||
27764057|NCT01824693|80962819|FG000|Overall Study|Death|0|||
27764058|NCT01824693|80962820|FG001|Overall Study|Death|1|||
27764059|NCT01824693|80962821|FG002|Overall Study|Death|0|||
27764060|NCT01824693|80962819|FG000|Overall Study|Physician Decision|1|||
27764061|NCT01824693|80962820|FG001|Overall Study|Physician Decision|1|||
27764062|NCT01824693|80962821|FG002|Overall Study|Physician Decision|1|||
27764063|NCT01824693|80962819|FG000|Overall Study|Withdrawal by Subject|0|||
27764064|NCT01824693|80962820|FG001|Overall Study|Withdrawal by Subject|0|||
27764065|NCT01824693|80962821|FG002|Overall Study|Withdrawal by Subject|1|||
27764066|NCT01824693|80962819|FG000|Overall Study|Progressive Disease|0|||
27764067|NCT01824693|80962820|FG001|Overall Study|Progressive Disease|5|||
27764068|NCT01824693|80962821|FG002|Overall Study|Progressive Disease|0|||
27764069|NCT01824693|80962819|FG000|Overall Study|Ineligible|0|||
27764070|NCT01824693|80962820|FG001|Overall Study|Ineligible|0|||
27764071|NCT01824693|80962821|FG002|Overall Study|Ineligible|3|||
27764072|NCT01824693|80962819|FG000|Overall Study|No Transplant Planned|0|||
27764073|NCT01824693|80962820|FG001|Overall Study|No Transplant Planned|0|||
27764074|NCT01824693|80962821|FG002|Overall Study|No Transplant Planned|10|||
27764075|NCT02156804|80962822|FG000|Overall Study|Withdrawal by Subject|1|||
27764076|NCT02807844|80962823|FG000|Overall Study|Physician Decision|0|||
27764077|NCT02807844|80962824|FG001|Overall Study|Physician Decision|0|||
27764078|NCT02807844|80962825|FG002|Overall Study|Physician Decision|0|||
27862061|NCT01755767|81326223|FG001|Overall Study|Radiographic Disease Progression|4|||
27764079|NCT02807844|80962826|FG003|Overall Study|Physician Decision|0|||
27862062|NCT01755767|81326224|FG002|Overall Study|Radiographic Disease Progression|44|||
27862063|NCT01755767|81326225|FG003|Overall Study|Radiographic Disease Progression|27|||
27862064|NCT01755767|81326222|FG000|Overall Study|Adverse Event|6|||
27862065|NCT01755767|81326223|FG001|Overall Study|Adverse Event|0|||
27862066|NCT01755767|81326224|FG002|Overall Study|Adverse Event|28|||
27862067|NCT01755767|81326225|FG003|Overall Study|Adverse Event|11|||
27862068|NCT01755767|81326222|FG000|Overall Study|Death|1|||
27764080|NCT02807844|80962827|FG004|Overall Study|Physician Decision|0|||
27862069|NCT01755767|81326223|FG001|Overall Study|Death|2|||
27862070|NCT01755767|81326224|FG002|Overall Study|Death|15|||
27862071|NCT01755767|81326225|FG003|Overall Study|Death|4|||
27962203|NCT01864148|81695068|FG004|Overall Study|Investigator Decision|6|||
27962204|NCT01864148|81695064|FG000|Overall Study|Withdrawal by Subject|9|||
27962205|NCT01864148|81695065|FG001|Overall Study|Withdrawal by Subject|2|||
27568817|NCT03013543|80271454|FG007|Overall Study|Physician Decision|0|||
27568818|NCT03013543|80271455|FG008|Overall Study|Physician Decision|0|||
27568819|NCT03013543|80271456|FG009|Overall Study|Physician Decision|0|||
27764081|NCT02807844|80962828|FG005|Overall Study|Physician Decision|0|||
27764082|NCT02807844|80962829|FG006|Overall Study|Physician Decision|3|||
27764083|NCT02807844|80962830|FG007|Overall Study|Physician Decision|0|||
27764084|NCT02807844|80962831|FG008|Overall Study|Physician Decision|1|||
27764085|NCT02807844|80962832|FG009|Overall Study|Physician Decision|2|||
27764086|NCT02807844|80962823|FG000|Overall Study|Death|0|||
27764087|NCT02807844|80962824|FG001|Overall Study|Death|0|||
27764088|NCT02807844|80962825|FG002|Overall Study|Death|2|||
27764089|NCT02807844|80962826|FG003|Overall Study|Death|4|||
27764090|NCT02807844|80962827|FG004|Overall Study|Death|1|||
27568820|NCT03013543|80271447|FG000|Overall Study|Protocol Violation|0|||
27568821|NCT03013543|80271448|FG001|Overall Study|Protocol Violation|0|||
27568822|NCT03013543|80271449|FG002|Overall Study|Protocol Violation|0|||
27662924|NCT01730118|80602910|FG005|Dose Expansion|Inability to return|1|||
27662925|NCT01730118|80602911|FG006|Dose Expansion|Inability to return|0|||
27662926|NCT01730118|80602905|FG000|Dose Expansion|Physician Decision|0|||
27662927|NCT01730118|80602906|FG001|Dose Expansion|Physician Decision|0|||
27662928|NCT01730118|80602907|FG002|Dose Expansion|Physician Decision|0|||
27662929|NCT01730118|80602908|FG003|Dose Expansion|Physician Decision|0|||
27662930|NCT01730118|80602909|FG004|Dose Expansion|Physician Decision|0|||
27662931|NCT01730118|80602910|FG005|Dose Expansion|Physician Decision|1|||
27662932|NCT01730118|80602911|FG006|Dose Expansion|Physician Decision|0|||
27662933|NCT02212301|80602918|FG000|Period 1|Lost to Follow-up|0|||
27662934|NCT02212301|80602919|FG001|Period 1|Lost to Follow-up|1|||
27662935|NCT00744796|80602920|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
27662936|NCT00230971|80602921|FG000|Randomization|No study drug administered|3|||
27662937|NCT00230971|80602922|FG001|Randomization|No study drug administered|3|||
27662938|NCT00230971|80602921|FG000|Baseline Participants|Lost to Follow-up|5|||
27662939|NCT00230971|80602922|FG001|Baseline Participants|Lost to Follow-up|12|||
27662940|NCT00230971|80602921|FG000|Baseline Participants|Death|6|||
27662941|NCT00230971|80602922|FG001|Baseline Participants|Death|5|||
27662942|NCT00230971|80602921|FG000|Baseline Participants|Withdrawal by Subject|7|||
27662943|NCT00230971|80602922|FG001|Baseline Participants|Withdrawal by Subject|1|||
27662944|NCT00230971|80602921|FG000|Baseline Participants|Adverse Event|1|||
27662945|NCT00230971|80602922|FG001|Baseline Participants|Adverse Event|0|||
27662946|NCT00230971|80602921|FG000|Baseline Participants|No bacteria observed|1|||
27662947|NCT00230971|80602922|FG001|Baseline Participants|No bacteria observed|0|||
27662948|NCT00230971|80602921|FG000|Baseline Participants|Failure to return|1|||
27662949|NCT00230971|80602922|FG001|Baseline Participants|Failure to return|1|||
27662950|NCT00230971|80602921|FG000|Baseline Participants|Reintervention|1|||
27662951|NCT00230971|80602922|FG001|Baseline Participants|Reintervention|0|||
27662952|NCT01126879|80602923|FG000|Overall Study|Progressive Disease|3|||
27662953|NCT01126879|80602924|FG001|Overall Study|Progressive Disease|1|||
27662954|NCT01126879|80602923|FG000|Overall Study|Withdrawal by Subject|1|||
27662955|NCT01126879|80602924|FG001|Overall Study|Withdrawal by Subject|0|||
27662956|NCT01126879|80602923|FG000|Overall Study|Adverse Event|0|||
27662957|NCT01126879|80602924|FG001|Overall Study|Adverse Event|1|||
27662958|NCT01126879|80602923|FG000|Overall Study|Physician Decision|1|||
27662959|NCT01126879|80602924|FG001|Overall Study|Physician Decision|0|||
27662960|NCT00377312|80602925|FG000|Overall Study|Adverse Event|1|||
27662961|NCT00377312|80602926|FG001|Overall Study|Adverse Event|1|||
27662962|NCT05372913|80602927|FG000|Overall Study|Withdrawal by Subject|0|||
27662963|NCT05372913|80602928|FG001|Overall Study|Withdrawal by Subject|2|||
27662964|NCT05372913|80602927|FG000|Overall Study|Protocol Violation|2|||
27662965|NCT05372913|80602928|FG001|Overall Study|Protocol Violation|2|||
27662966|NCT05372913|80602927|FG000|Overall Study|Adverse Event|0|||
27662967|NCT05372913|80602928|FG001|Overall Study|Adverse Event|1|||
27662968|NCT02544113|80602929|FG000|Overall Study|Death|3|||
27662969|NCT02544113|80602930|FG001|Overall Study|Death|4|||
27662970|NCT03974100|80602934|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
27662971|NCT03974100|80602935|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
27662972|NCT03974100|80602936|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
27662973|NCT03974100|80602937|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
27662974|NCT03974100|80602938|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
27662975|NCT03974100|80602934|FG000|TP1 - Day 1 to Week 52|Death|1|||
27962206|NCT01864148|81695066|FG002|Overall Study|Withdrawal by Subject|6|||
27568823|NCT03013543|80271450|FG003|Overall Study|Protocol Violation|0|||
27568824|NCT03013543|80271451|FG004|Overall Study|Protocol Violation|0|||
27568825|NCT03013543|80271452|FG005|Overall Study|Protocol Violation|0|||
27662976|NCT03974100|80602935|FG001|TP1 - Day 1 to Week 52|Death|0|||
27662977|NCT03974100|80602936|FG002|TP1 - Day 1 to Week 52|Death|0|||
27662978|NCT03974100|80602937|FG003|TP1 - Day 1 to Week 52|Death|0|||
27764091|NCT02807844|80962828|FG005|Overall Study|Death|2|||
27962207|NCT01864148|81695067|FG003|Overall Study|Withdrawal by Subject|8|||
27764092|NCT02807844|80962829|FG006|Overall Study|Death|1|||
27764093|NCT02807844|80962830|FG007|Overall Study|Death|2|||
27764094|NCT02807844|80962831|FG008|Overall Study|Death|0|||
27764095|NCT02807844|80962832|FG009|Overall Study|Death|1|||
27962208|NCT01864148|81695068|FG004|Overall Study|Withdrawal by Subject|8|||
27962209|NCT01864148|81695064|FG000|Overall Study|Lost to Follow-up|0|||
27962210|NCT01864148|81695065|FG001|Overall Study|Lost to Follow-up|0|||
27962211|NCT01864148|81695066|FG002|Overall Study|Lost to Follow-up|0|||
27962212|NCT01864148|81695067|FG003|Overall Study|Lost to Follow-up|2|||
27962213|NCT01864148|81695068|FG004|Overall Study|Lost to Follow-up|1|||
27962214|NCT01864148|81695064|FG000|Overall Study|Adverse Event|4|||
27962215|NCT01864148|81695065|FG001|Overall Study|Adverse Event|2|||
27662979|NCT03974100|80602938|FG004|TP1 - Day 1 to Week 52|Death|0|||
27662980|NCT03974100|80602934|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
27662981|NCT03974100|80602935|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
27662982|NCT03974100|80602936|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
27662983|NCT03974100|80602937|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
27662984|NCT03974100|80602938|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
27662985|NCT03974100|80602934|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
27662986|NCT03974100|80602935|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
27662987|NCT03974100|80602936|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
27662988|NCT03974100|80602937|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
27662989|NCT03974100|80602938|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
27662990|NCT03974100|80602934|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
27662991|NCT03974100|80602935|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
27662992|NCT03974100|80602936|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
27662993|NCT03974100|80602937|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
27662994|NCT03974100|80602938|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
27662995|NCT03974100|80602934|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
27662996|NCT03974100|80602935|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
27662997|NCT03974100|80602936|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
27662998|NCT03974100|80602937|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
27662999|NCT03974100|80602938|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
27663000|NCT03974100|80602934|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
27663001|NCT03974100|80602935|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
27663002|NCT03974100|80602936|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
27663003|NCT03974100|80602937|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
27663004|NCT03974100|80602938|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
27663005|NCT01675050|80602939|FG000|Period One Treatment|Withdrawal by Subject|1|||
27663006|NCT01675050|80602940|FG001|Period One Treatment|Withdrawal by Subject|0|||
27663007|NCT01215032|80602941|FG000|Overall Study|Adverse Event|3|||
27663008|NCT01215032|80602941|FG000|Overall Study|Lack of Efficacy|17|||
27663009|NCT02166047|80602942|FG000|Overall Study|Withdrawal by Participant|0|||
27663010|NCT02166047|80602943|FG001|Overall Study|Withdrawal by Participant|1|||
27663011|NCT02166047|80602944|FG002|Overall Study|Withdrawal by Participant|2|||
27663012|NCT02166047|80602945|FG003|Overall Study|Withdrawal by Participant|0|||
27663013|NCT02166047|80602946|FG004|Overall Study|Withdrawal by Participant|0|||
27663014|NCT02166047|80602947|FG005|Overall Study|Withdrawal by Participant|0|||
27663015|NCT02166047|80602948|FG006|Overall Study|Withdrawal by Participant|1|||
27663016|NCT02166047|80602949|FG007|Overall Study|Withdrawal by Participant|0|||
27663017|NCT02166047|80602950|FG008|Overall Study|Withdrawal by Participant|0|||
27663018|NCT02166047|80602951|FG009|Overall Study|Withdrawal by Participant|0|||
27663019|NCT02166047|80602952|FG010|Overall Study|Withdrawal by Participant|0|||
27663020|NCT02166047|80602953|FG011|Overall Study|Withdrawal by Participant|0|||
27663021|NCT02166047|80602942|FG000|Overall Study|Adverse Event|0|||
27663022|NCT02166047|80602943|FG001|Overall Study|Adverse Event|0|||
27663023|NCT02166047|80602944|FG002|Overall Study|Adverse Event|0|||
27663024|NCT02166047|80602945|FG003|Overall Study|Adverse Event|0|||
27663025|NCT02166047|80602946|FG004|Overall Study|Adverse Event|1|||
27663026|NCT02166047|80602947|FG005|Overall Study|Adverse Event|0|||
27663027|NCT02166047|80602948|FG006|Overall Study|Adverse Event|1|||
27663028|NCT02166047|80602949|FG007|Overall Study|Adverse Event|0|||
27663029|NCT02166047|80602950|FG008|Overall Study|Adverse Event|0|||
27663030|NCT02166047|80602951|FG009|Overall Study|Adverse Event|0|||
27663031|NCT02166047|80602952|FG010|Overall Study|Adverse Event|2|||
27663032|NCT02166047|80602953|FG011|Overall Study|Adverse Event|0|||
27663033|NCT03303521|80602954|FG000|Overall Study|Withdrawal by Subject|2|||
27764096|NCT02807844|80962823|FG000|Overall Study|Withdrawal by Subject|0|||
27764097|NCT02807844|80962824|FG001|Overall Study|Withdrawal by Subject|0|||
27764098|NCT02807844|80962825|FG002|Overall Study|Withdrawal by Subject|2|||
27764099|NCT02807844|80962826|FG003|Overall Study|Withdrawal by Subject|1|||
27663034|NCT03303521|80602955|FG001|Overall Study|Withdrawal by Subject|0|||
27663035|NCT03303521|80602954|FG000|Overall Study|Death|1|||
27663036|NCT03303521|80602955|FG001|Overall Study|Death|0|||
27764100|NCT02807844|80962827|FG004|Overall Study|Withdrawal by Subject|1|||
27663037|NCT03303521|80602954|FG000|Overall Study|Kidney transplantation|0|||
27962216|NCT01864148|81695066|FG002|Overall Study|Adverse Event|4|||
27962217|NCT01864148|81695067|FG003|Overall Study|Adverse Event|7|||
27962218|NCT01864148|81695068|FG004|Overall Study|Adverse Event|7|||
27962219|NCT01864148|81695064|FG000|Overall Study|Not Dosed|0|||
27962220|NCT01864148|81695065|FG001|Overall Study|Not Dosed|0|||
27962221|NCT01864148|81695066|FG002|Overall Study|Not Dosed|0|||
27962222|NCT01864148|81695067|FG003|Overall Study|Not Dosed|1|||
27962223|NCT01864148|81695068|FG004|Overall Study|Not Dosed|0|||
27962224|NCT01279044|81695076|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
27962225|NCT01279044|81695077|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
27962226|NCT01279044|81695078|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
27962227|NCT01279044|81695076|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
27962228|NCT01279044|81695077|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
27962229|NCT01279044|81695078|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
27962230|NCT01279044|81695076|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
27962231|NCT01279044|81695077|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
27962232|NCT01279044|81695078|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
27962233|NCT02038946|81695079|FG000|Overall Study|Death|5|||
27962234|NCT02038946|81695079|FG000|Overall Study|Withdrawal by Subject|3|||
27962235|NCT02038946|81695079|FG000|Overall Study|Lost to Follow-up|2|||
27962236|NCT02038946|81695079|FG000|Overall Study|Other reasons|2|||
27962237|NCT04512001|81695080|FG000|Week 0 to Week 24|Adverse Event|14|||
27962238|NCT04512001|81695081|FG001|Week 0 to Week 24|Adverse Event|10|||
27962239|NCT04512001|81695082|FG002|Week 0 to Week 24|Adverse Event|0|||
27962240|NCT04512001|81695083|FG003|Week 0 to Week 24|Adverse Event|0|||
27962241|NCT04512001|81695084|FG004|Week 0 to Week 24|Adverse Event|0|||
27962242|NCT04512001|81695080|FG000|Week 0 to Week 24|Death|0|||
27962243|NCT04512001|81695081|FG001|Week 0 to Week 24|Death|2|||
27962244|NCT04512001|81695082|FG002|Week 0 to Week 24|Death|0|||
27962245|NCT04512001|81695083|FG003|Week 0 to Week 24|Death|0|||
27962246|NCT04512001|81695084|FG004|Week 0 to Week 24|Death|0|||
27962247|NCT04512001|81695080|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
27962248|NCT04512001|81695081|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
27962249|NCT04512001|81695082|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
27962250|NCT04512001|81695083|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
27962251|NCT04512001|81695084|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
27962252|NCT04512001|81695080|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
27962253|NCT04512001|81695081|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
27962254|NCT04512001|81695082|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
27962255|NCT04512001|81695083|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
27962256|NCT04512001|81695084|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
27962257|NCT04512001|81695080|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
27962258|NCT04512001|81695081|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
27962259|NCT04512001|81695082|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
27962260|NCT04512001|81695083|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
27962261|NCT04512001|81695084|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
27962262|NCT04512001|81695080|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
27962263|NCT04512001|81695081|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
27962264|NCT04512001|81695082|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
27663038|NCT03303521|80602955|FG001|Overall Study|Kidney transplantation|1|||
27663039|NCT03303521|80602954|FG000|Overall Study|Investigational product discontinuation|0|||
27962265|NCT04512001|81695083|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
27962266|NCT04512001|81695084|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
27663040|NCT03303521|80602955|FG001|Overall Study|Investigational product discontinuation|1|||
27663041|NCT03303521|80602954|FG000|Overall Study|Transferred to non-study dialysis center|1|||
27663042|NCT03303521|80602955|FG001|Overall Study|Transferred to non-study dialysis center|0|||
27663043|NCT03303521|80602954|FG000|Overall Study|Non-comliance to study protocol|0|||
27663044|NCT03303521|80602955|FG001|Overall Study|Non-comliance to study protocol|1|||
27663045|NCT03303521|80602954|FG000|Overall Study|Adverse Event|1|||
27663046|NCT03303521|80602955|FG001|Overall Study|Adverse Event|0|||
27663047|NCT02551692|80602958|FG000|Overall Study|Lost to Follow-up|0|||
27663048|NCT02551692|80602959|FG001|Overall Study|Lost to Follow-up|1|||
27663049|NCT02551692|80602960|FG002|Overall Study|Lost to Follow-up|4|||
27663050|NCT02551692|80602958|FG000|Overall Study|Withdrawal by Subject|1|||
27663051|NCT02551692|80602959|FG001|Overall Study|Withdrawal by Subject|0|||
27962267|NCT04512001|81695080|FG000|Week 24 to Week 63|Adverse Event|0|||
27962268|NCT04512001|81695081|FG001|Week 24 to Week 63|Adverse Event|0|||
27962269|NCT04512001|81695082|FG002|Week 24 to Week 63|Adverse Event|13|||
27962270|NCT04512001|81695083|FG003|Week 24 to Week 63|Adverse Event|8|||
27962271|NCT04512001|81695084|FG004|Week 24 to Week 63|Adverse Event|6|||
27962272|NCT04512001|81695080|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
27962273|NCT04512001|81695081|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
27962274|NCT04512001|81695082|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
27962275|NCT04512001|81695083|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
27962276|NCT04512001|81695084|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
27962277|NCT04512001|81695080|FG000|Week 24 to Week 63|Death|0|||
27962278|NCT04512001|81695081|FG001|Week 24 to Week 63|Death|0|||
27962279|NCT04512001|81695082|FG002|Week 24 to Week 63|Death|0|||
27962280|NCT04512001|81695083|FG003|Week 24 to Week 63|Death|1|||
27962281|NCT04512001|81695084|FG004|Week 24 to Week 63|Death|1|||
27962282|NCT04512001|81695080|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
27962283|NCT04512001|81695081|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
27962284|NCT04512001|81695082|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
27962285|NCT04512001|81695083|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
27962286|NCT04512001|81695084|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
27764101|NCT02807844|80962828|FG005|Overall Study|Withdrawal by Subject|0|||
27764102|NCT02807844|80962829|FG006|Overall Study|Withdrawal by Subject|1|||
27764103|NCT02807844|80962830|FG007|Overall Study|Withdrawal by Subject|0|||
27764104|NCT02807844|80962831|FG008|Overall Study|Withdrawal by Subject|0|||
27764105|NCT02807844|80962832|FG009|Overall Study|Withdrawal by Subject|0|||
27764106|NCT02807844|80962823|FG000|Overall Study|Progressive disease|5|||
27764107|NCT02807844|80962824|FG001|Overall Study|Progressive disease|12|||
27764108|NCT02807844|80962825|FG002|Overall Study|Progressive disease|8|||
27764109|NCT02807844|80962826|FG003|Overall Study|Progressive disease|8|||
27764110|NCT02807844|80962827|FG004|Overall Study|Progressive disease|3|||
27764111|NCT02807844|80962828|FG005|Overall Study|Progressive disease|8|||
27764112|NCT02807844|80962829|FG006|Overall Study|Progressive disease|14|||
27764113|NCT02807844|80962830|FG007|Overall Study|Progressive disease|17|||
27764114|NCT02807844|80962831|FG008|Overall Study|Progressive disease|19|||
27764115|NCT02807844|80962832|FG009|Overall Study|Progressive disease|15|||
27764116|NCT02807844|80962823|FG000|Overall Study|Adverse Event|1|||
27764117|NCT02807844|80962824|FG001|Overall Study|Adverse Event|0|||
27764118|NCT02807844|80962825|FG002|Overall Study|Adverse Event|0|||
27764119|NCT02807844|80962826|FG003|Overall Study|Adverse Event|0|||
27764120|NCT02807844|80962827|FG004|Overall Study|Adverse Event|1|||
27764121|NCT02807844|80962828|FG005|Overall Study|Adverse Event|1|||
27764122|NCT02807844|80962829|FG006|Overall Study|Adverse Event|1|||
27764123|NCT02807844|80962830|FG007|Overall Study|Adverse Event|1|||
27764124|NCT02807844|80962831|FG008|Overall Study|Adverse Event|1|||
27764125|NCT02807844|80962832|FG009|Overall Study|Adverse Event|2|||
27764126|NCT01337167|80962833|FG000|Infant Series|Adverse Event|1|||
27764127|NCT01337167|80962834|FG001|Infant Series|Adverse Event|1|||
27764128|NCT01337167|80962833|FG000|Infant Series|Death|1|||
27764129|NCT01337167|80962834|FG001|Infant Series|Death|1|||
27764130|NCT01337167|80962833|FG000|Infant Series|Lost to Follow-up|13|||
27962287|NCT04512001|81695080|FG000|Week 24 to Week 63|Miscellaneous|0|||
27962288|NCT04512001|81695081|FG001|Week 24 to Week 63|Miscellaneous|0|||
27962289|NCT04512001|81695082|FG002|Week 24 to Week 63|Miscellaneous|3|||
27962290|NCT04512001|81695083|FG003|Week 24 to Week 63|Miscellaneous|2|||
27962291|NCT04512001|81695084|FG004|Week 24 to Week 63|Miscellaneous|1|||
27962292|NCT01802580|81695085|FG000|Overall Study|Physician Decision|1|||
27962293|NCT01802580|81695086|FG001|Overall Study|Physician Decision|0|||
27962294|NCT01802580|81695085|FG000|Overall Study|Protocol Violation|2|||
27962295|NCT01802580|81695086|FG001|Overall Study|Protocol Violation|0|||
27962296|NCT01802580|81695085|FG000|Overall Study|Withdrawal by Subject|5|||
27962297|NCT01802580|81695086|FG001|Overall Study|Withdrawal by Subject|6|||
27962298|NCT01802580|81695085|FG000|Overall Study|Other|1|||
27962299|NCT01802580|81695086|FG001|Overall Study|Other|3|||
27962300|NCT01802580|81695085|FG000|Overall Study|Lack of Efficacy|0|||
27962301|NCT01802580|81695086|FG001|Overall Study|Lack of Efficacy|2|||
27764131|NCT01337167|80962834|FG001|Infant Series|Lost to Follow-up|7|||
27764132|NCT01337167|80962833|FG000|Infant Series|Non-compliance with study drug|2|||
27764133|NCT01337167|80962834|FG001|Infant Series|Non-compliance with study drug|1|||
27962302|NCT03458325|81695090|FG000|Overall Study|Withdrawal by Subject|1|||
27962303|NCT03367403|81695091|FG000|Overall Study|Adverse Event|20|||
27962304|NCT03367403|81695092|FG001|Overall Study|Adverse Event|6|||
27962305|NCT03367403|81695093|FG002|Overall Study|Adverse Event|2|||
27962306|NCT03367403|81695091|FG000|Overall Study|Withdrawal by Subject|12|||
27962307|NCT03367403|81695092|FG001|Overall Study|Withdrawal by Subject|13|||
27764134|NCT01337167|80962833|FG000|Infant Series|Physician Decision|3|||
27764135|NCT01337167|80962834|FG001|Infant Series|Physician Decision|1|||
27764136|NCT01337167|80962833|FG000|Infant Series|Protocol Violation|22|||
27764137|NCT01337167|80962834|FG001|Infant Series|Protocol Violation|9|||
27764138|NCT01337167|80962833|FG000|Infant Series|Withdrawal by Subject|15|||
27962308|NCT03367403|81695093|FG002|Overall Study|Withdrawal by Subject|1|||
27764139|NCT01337167|80962834|FG001|Infant Series|Withdrawal by Subject|4|||
27764140|NCT01337167|80962833|FG000|Infant Series|Randomized but not vaccinated|5|||
27764141|NCT01337167|80962834|FG001|Infant Series|Randomized but not vaccinated|3|||
27764142|NCT01337167|80962833|FG000|Interim Period|Lost to Follow-up|51|||
27764143|NCT01337167|80962834|FG001|Interim Period|Lost to Follow-up|23|||
27764144|NCT01337167|80962833|FG000|Interim Period|Non-compliance with study drug|1|||
27962309|NCT03367403|81695091|FG000|Overall Study|Death|1|||
27962310|NCT03367403|81695092|FG001|Overall Study|Death|2|||
27962311|NCT03367403|81695093|FG002|Overall Study|Death|0|||
27962312|NCT03367403|81695091|FG000|Overall Study|Physician Decision|0|||
27962313|NCT03367403|81695092|FG001|Overall Study|Physician Decision|1|||
27962314|NCT03367403|81695093|FG002|Overall Study|Physician Decision|0|||
27962315|NCT03367403|81695091|FG000|Overall Study|Protocol Violation|1|||
27962316|NCT03367403|81695092|FG001|Overall Study|Protocol Violation|1|||
27962317|NCT03367403|81695093|FG002|Overall Study|Protocol Violation|0|||
27962318|NCT03367403|81695091|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
27962319|NCT03367403|81695092|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
27962320|NCT03367403|81695093|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
27962321|NCT03367403|81695091|FG000|Overall Study|COVID-19|3|||
27962322|NCT03367403|81695092|FG001|Overall Study|COVID-19|6|||
27962323|NCT03367403|81695093|FG002|Overall Study|COVID-19|0|||
27962324|NCT03367403|81695091|FG000|Overall Study|Abuse of Alcohol Intake|0|||
27962325|NCT03367403|81695092|FG001|Overall Study|Abuse of Alcohol Intake|1|||
27962326|NCT03367403|81695093|FG002|Overall Study|Abuse of Alcohol Intake|0|||
27962327|NCT03367403|81695091|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
27764145|NCT01337167|80962834|FG001|Interim Period|Non-compliance with study drug|0|||
27764146|NCT01337167|80962833|FG000|Interim Period|Physician Decision|6|||
27764147|NCT01337167|80962834|FG001|Interim Period|Physician Decision|3|||
27764148|NCT01337167|80962833|FG000|Interim Period|Protocol Violation|5|||
27764149|NCT01337167|80962834|FG001|Interim Period|Protocol Violation|3|||
27764150|NCT01337167|80962833|FG000|Interim Period|Withdrawal by Subject|18|||
27764151|NCT01337167|80962834|FG001|Interim Period|Withdrawal by Subject|10|||
27764152|NCT01337167|80962833|FG000|Interim Period|Other protocol criterion not met|0|||
27764153|NCT01337167|80962834|FG001|Interim Period|Other protocol criterion not met|1|||
27764154|NCT01337167|80962833|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
27764155|NCT01337167|80962834|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
27764156|NCT01337167|80962833|FG000|Toddler Vaccinations|Protocol Violation|0|||
27764157|NCT01337167|80962834|FG001|Toddler Vaccinations|Protocol Violation|1|||
27764158|NCT01337167|80962833|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
27764159|NCT01337167|80962834|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
27764160|NCT01061736|80962838|FG000|Overall Study|Dose regimen not selected|0|||
27764161|NCT01061736|80962839|FG001|Overall Study|Dose regimen not selected|0|||
27764162|NCT01061736|80962840|FG002|Overall Study|Dose regimen not selected|0|||
27764163|NCT01061736|80962841|FG003|Overall Study|Dose regimen not selected|0|||
27764164|NCT01061736|80962842|FG004|Overall Study|Dose regimen not selected|0|||
27764165|NCT01061736|80962843|FG005|Overall Study|Dose regimen not selected|0|||
27764166|NCT01061736|80962844|FG006|Overall Study|Dose regimen not selected|79|||
27764167|NCT01061736|80962845|FG007|Overall Study|Dose regimen not selected|0|||
27764168|NCT01061736|80962846|FG008|Overall Study|Dose regimen not selected|0|||
27764169|NCT01061736|80962847|FG009|Overall Study|Dose regimen not selected|0|||
27764170|NCT01061736|80962838|FG000|Overall Study|Adverse Event|13|||
27764171|NCT01061736|80962839|FG001|Overall Study|Adverse Event|1|||
27764172|NCT01061736|80962840|FG002|Overall Study|Adverse Event|3|||
27764173|NCT01061736|80962841|FG003|Overall Study|Adverse Event|2|||
27764174|NCT01061736|80962842|FG004|Overall Study|Adverse Event|4|||
27764175|NCT01061736|80962843|FG005|Overall Study|Adverse Event|1|||
27764176|NCT01061736|80962844|FG006|Overall Study|Adverse Event|4|||
27764177|NCT01061736|80962845|FG007|Overall Study|Adverse Event|63|||
27764178|NCT01061736|80962846|FG008|Overall Study|Adverse Event|67|||
27764179|NCT01061736|80962847|FG009|Overall Study|Adverse Event|34|||
27764180|NCT01061736|80962838|FG000|Overall Study|Lack of Efficacy|0|||
27764181|NCT01061736|80962839|FG001|Overall Study|Lack of Efficacy|2|||
27764182|NCT01061736|80962840|FG002|Overall Study|Lack of Efficacy|1|||
27764183|NCT01061736|80962841|FG003|Overall Study|Lack of Efficacy|1|||
27764184|NCT01061736|80962842|FG004|Overall Study|Lack of Efficacy|1|||
27764185|NCT01061736|80962843|FG005|Overall Study|Lack of Efficacy|2|||
27764186|NCT01061736|80962844|FG006|Overall Study|Lack of Efficacy|1|||
27764187|NCT01061736|80962845|FG007|Overall Study|Lack of Efficacy|9|||
27962328|NCT03367403|81695092|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
27962329|NCT03367403|81695093|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
27962330|NCT03146663|81695094|FG000|Overall Study|Did not receive study treatment|1|||
27962331|NCT03146663|81695095|FG001|Overall Study|Did not receive study treatment|1|||
27962332|NCT01014767|81695096|FG000|Overall Study|PI left institution, data unavailable|12|||
27962333|NCT01014767|81695097|FG001|Overall Study|PI left institution, data unavailable|1|||
27764188|NCT01061736|80962846|FG008|Overall Study|Lack of Efficacy|9|||
27764189|NCT01061736|80962847|FG009|Overall Study|Lack of Efficacy|10|||
27764190|NCT01061736|80962838|FG000|Overall Study|Poor compliance to protocol|0|||
27764191|NCT01061736|80962839|FG001|Overall Study|Poor compliance to protocol|0|||
27764192|NCT01061736|80962840|FG002|Overall Study|Poor compliance to protocol|0|||
27764193|NCT01061736|80962841|FG003|Overall Study|Poor compliance to protocol|0|||
27764194|NCT01061736|80962842|FG004|Overall Study|Poor compliance to protocol|0|||
27764195|NCT01061736|80962843|FG005|Overall Study|Poor compliance to protocol|0|||
27764196|NCT01061736|80962844|FG006|Overall Study|Poor compliance to protocol|0|||
27764197|NCT01061736|80962845|FG007|Overall Study|Poor compliance to protocol|2|||
27764198|NCT01061736|80962846|FG008|Overall Study|Poor compliance to protocol|5|||
27764199|NCT01061736|80962847|FG009|Overall Study|Poor compliance to protocol|9|||
27764200|NCT01061736|80962838|FG000|Overall Study|Not treated|0|||
27764201|NCT01061736|80962839|FG001|Overall Study|Not treated|0|||
27764202|NCT01061736|80962840|FG002|Overall Study|Not treated|0|||
27764203|NCT01061736|80962841|FG003|Overall Study|Not treated|0|||
27764204|NCT01061736|80962842|FG004|Overall Study|Not treated|1|||
27764205|NCT01061736|80962843|FG005|Overall Study|Not treated|0|||
27764206|NCT01061736|80962844|FG006|Overall Study|Not treated|0|||
27764207|NCT01061736|80962845|FG007|Overall Study|Not treated|2|||
27764208|NCT01061736|80962846|FG008|Overall Study|Not treated|1|||
27764209|NCT01061736|80962847|FG009|Overall Study|Not treated|0|||
27764210|NCT01061736|80962838|FG000|Overall Study|Other than specified above|0|||
27764211|NCT01061736|80962839|FG001|Overall Study|Other than specified above|1|||
27764212|NCT01061736|80962840|FG002|Overall Study|Other than specified above|2|||
27764213|NCT01061736|80962841|FG003|Overall Study|Other than specified above|0|||
27764214|NCT01061736|80962842|FG004|Overall Study|Other than specified above|1|||
27764215|NCT01061736|80962843|FG005|Overall Study|Other than specified above|0|||
27764216|NCT01061736|80962844|FG006|Overall Study|Other than specified above|0|||
27764217|NCT01061736|80962845|FG007|Overall Study|Other than specified above|18|||
27764218|NCT01061736|80962846|FG008|Overall Study|Other than specified above|15|||
27764219|NCT01061736|80962847|FG009|Overall Study|Other than specified above|21|||
27764220|NCT04019795|80962849|FG000|Overall Study|Withdrawal by Subject|1|||
27764221|NCT04019795|80962850|FG001|Overall Study|Withdrawal by Subject|2|||
27764222|NCT04019795|80962851|FG002|Overall Study|Withdrawal by Subject|2|||
27764223|NCT04019795|80962852|FG003|Overall Study|Withdrawal by Subject|1|||
27764224|NCT04019795|80962849|FG000|Overall Study|Lost to Follow-up|0|||
27764225|NCT04019795|80962850|FG001|Overall Study|Lost to Follow-up|1|||
27764226|NCT04019795|80962851|FG002|Overall Study|Lost to Follow-up|1|||
27764227|NCT04019795|80962852|FG003|Overall Study|Lost to Follow-up|2|||
27764228|NCT04019795|80962849|FG000|Overall Study|Treatment non-compliance|3|||
27764229|NCT04019795|80962850|FG001|Overall Study|Treatment non-compliance|1|||
27764230|NCT04019795|80962851|FG002|Overall Study|Treatment non-compliance|2|||
27764231|NCT04019795|80962852|FG003|Overall Study|Treatment non-compliance|0|||
27764232|NCT04019795|80962849|FG000|Overall Study|Physician Decision|0|||
27764233|NCT04019795|80962850|FG001|Overall Study|Physician Decision|0|||
27764234|NCT04019795|80962851|FG002|Overall Study|Physician Decision|1|||
27764235|NCT04019795|80962852|FG003|Overall Study|Physician Decision|0|||
27764236|NCT04019795|80962849|FG000|Overall Study|Adverse Event|1|||
27764237|NCT04019795|80962850|FG001|Overall Study|Adverse Event|0|||
27764238|NCT04019795|80962851|FG002|Overall Study|Adverse Event|0|||
27764239|NCT04019795|80962852|FG003|Overall Study|Adverse Event|0|||
27764240|NCT02261883|80962853|FG000|Overall Study|Death|3|||
27764241|NCT02261883|80962854|FG001|Overall Study|Death|2|||
27764242|NCT02261883|80962853|FG000|Overall Study|Physician Decision|1|||
27764243|NCT02261883|80962854|FG001|Overall Study|Physician Decision|0|||
27764244|NCT02261883|80962853|FG000|Overall Study|Protocol Violation|1|||
27764245|NCT02261883|80962854|FG001|Overall Study|Protocol Violation|0|||
27764246|NCT02261883|80962853|FG000|Overall Study|Withdrawal by Subject|0|||
27764247|NCT02261883|80962854|FG001|Overall Study|Withdrawal by Subject|1|||
27764248|NCT02261883|80962853|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
27764249|NCT02261883|80962854|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
27764250|NCT01617655|80962855|FG000|Overall Study|Adverse Event|2|||
27764251|NCT01617655|80962856|FG001|Overall Study|Adverse Event|3|||
27764252|NCT01617655|80962855|FG000|Overall Study|Poor compliance to protocol|1|||
27764253|NCT01617655|80962856|FG001|Overall Study|Poor compliance to protocol|4|||
27764254|NCT01617655|80962855|FG000|Overall Study|Participants moved|0|||
27764255|NCT01617655|80962856|FG001|Overall Study|Participants moved|4|||
27764256|NCT01617655|80962855|FG000|Overall Study|Consent withdrawn by participant|1|||
27764257|NCT01617655|80962856|FG001|Overall Study|Consent withdrawn by participant|1|||
27764258|NCT01617655|80962855|FG000|Overall Study|Last visit outside protocol visit window|1|||
27764259|NCT01617655|80962856|FG001|Overall Study|Last visit outside protocol visit window|10|||
27764260|NCT01617655|80962855|FG000|Overall Study|Site closure|3|||
27764261|NCT01617655|80962856|FG001|Overall Study|Site closure|5|||
27764262|NCT01617655|80962855|FG000|Overall Study|Other than specified above|1|||
27764263|NCT01617655|80962856|FG001|Overall Study|Other than specified above|2|||
27764264|NCT02591238|80962857|FG000|Overall Study|Pregnancy|1|||
27764265|NCT02591238|80962858|FG001|Overall Study|Pregnancy|0|||
27764266|NCT02591238|80962859|FG002|Overall Study|Pregnancy|0|||
27764267|NCT02591238|80962860|FG003|Overall Study|Pregnancy|0|||
27764268|NCT02591238|80962857|FG000|Overall Study|Withdrawal by Subject|0|||
27764269|NCT02591238|80962858|FG001|Overall Study|Withdrawal by Subject|0|||
27764270|NCT02591238|80962859|FG002|Overall Study|Withdrawal by Subject|0|||
27764271|NCT02591238|80962860|FG003|Overall Study|Withdrawal by Subject|1|||
27764272|NCT02591238|80962857|FG000|Overall Study|influenza|0|||
27764273|NCT02591238|80962858|FG001|Overall Study|influenza|0|||
27764274|NCT02591238|80962859|FG002|Overall Study|influenza|0|||
27764275|NCT02591238|80962860|FG003|Overall Study|influenza|1|||
27962334|NCT01014767|81695098|FG002|Overall Study|PI left institution, data unavailable|4|||
27962335|NCT01014767|81695099|FG003|Overall Study|PI left institution, data unavailable|1|||
27962336|NCT02954887|81695100|FG000|Overall Study|Withdrawal by Subject|3|||
27962337|NCT02954887|81695100|FG000|Overall Study|Lack of Efficacy|3|||
27764276|NCT02591238|80962857|FG000|Overall Study|personal circumstances|0|||
27764277|NCT02591238|80962858|FG001|Overall Study|personal circumstances|0|||
27764278|NCT02591238|80962859|FG002|Overall Study|personal circumstances|0|||
27764279|NCT02591238|80962860|FG003|Overall Study|personal circumstances|1|||
27764280|NCT02591238|80962857|FG000|Overall Study|personal circumstances|0|||
27764281|NCT02591238|80962858|FG001|Overall Study|personal circumstances|1|||
27764282|NCT02591238|80962859|FG002|Overall Study|personal circumstances|0|||
27764283|NCT02591238|80962860|FG003|Overall Study|personal circumstances|0|||
27764284|NCT05567393|80962861|FG000|Overall Study|Voluntary Withdrawal|0|||
27764285|NCT05567393|80962862|FG001|Overall Study|Voluntary Withdrawal|0|||
27764286|NCT05567393|80962863|FG002|Overall Study|Voluntary Withdrawal|0|||
27764287|NCT05567393|80962864|FG003|Overall Study|Voluntary Withdrawal|0|||
27764288|NCT05567393|80962865|FG004|Overall Study|Voluntary Withdrawal|0|||
27764289|NCT05567393|80962866|FG005|Overall Study|Voluntary Withdrawal|0|||
27764290|NCT05567393|80962867|FG006|Overall Study|Voluntary Withdrawal|0|||
27764291|NCT05567393|80962868|FG007|Overall Study|Voluntary Withdrawal|0|||
27764292|NCT05567393|80962869|FG008|Overall Study|Voluntary Withdrawal|0|||
27764293|NCT05567393|80962870|FG009|Overall Study|Voluntary Withdrawal|0|||
27764294|NCT05567393|80962871|FG010|Overall Study|Voluntary Withdrawal|0|||
27764295|NCT05567393|80962872|FG011|Overall Study|Voluntary Withdrawal|0|||
27764296|NCT05567393|80962873|FG012|Overall Study|Voluntary Withdrawal|0|||
27764297|NCT05567393|80962874|FG013|Overall Study|Voluntary Withdrawal|1|||
27764298|NCT05567393|80962875|FG014|Overall Study|Voluntary Withdrawal|0|||
27764299|NCT05567393|80962876|FG015|Overall Study|Voluntary Withdrawal|0|||
27764300|NCT05567393|80962877|FG016|Overall Study|Voluntary Withdrawal|0|||
27764301|NCT05567393|80962878|FG017|Overall Study|Voluntary Withdrawal|0|||
27764302|NCT02394795|80962879|FG000|Overall Study|Adverse Event|92|||
27764303|NCT02394795|80962880|FG001|Overall Study|Adverse Event|70|||
27764304|NCT02394795|80962879|FG000|Overall Study|Lost to Follow-up|0|||
27764305|NCT02394795|80962880|FG001|Overall Study|Lost to Follow-up|1|||
27764306|NCT02394795|80962879|FG000|Overall Study|Withdrawal by Subject|17|||
27764307|NCT02394795|80962880|FG001|Overall Study|Withdrawal by Subject|26|||
27764308|NCT02394795|80962879|FG000|Overall Study|Lack of Efficacy|181|||
27764309|NCT02394795|80962880|FG001|Overall Study|Lack of Efficacy|211|||
27764310|NCT02394795|80962879|FG000|Overall Study|Death|4|||
27764311|NCT02394795|80962880|FG001|Overall Study|Death|5|||
27764312|NCT02394795|80962879|FG000|Overall Study|Physician Decision|109|||
27764313|NCT02394795|80962880|FG001|Overall Study|Physician Decision|93|||
27764314|NCT02810951|80962883|FG000|Overall Study|Adverse Event|1|||
27764315|NCT02999100|80962887|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
27764316|NCT02999100|80962888|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
27764317|NCT02999100|80962889|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
27764318|NCT02999100|80962890|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
27764319|NCT02999100|80962891|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
27764320|NCT02999100|80962892|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
27764321|NCT02999100|80962887|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
27764322|NCT02999100|80962888|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
27764323|NCT02999100|80962889|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
27764324|NCT02999100|80962890|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
27764325|NCT02999100|80962891|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
27764326|NCT02999100|80962892|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
27764327|NCT02999100|80962887|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
27764328|NCT02999100|80962888|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
27764329|NCT02999100|80962889|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
27764330|NCT02999100|80962890|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
27764331|NCT02999100|80962891|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
27764332|NCT02999100|80962892|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
27764333|NCT01747811|80962911|FG000|Overall Study|Lack of Efficacy|2|||
27764334|NCT01747811|80962912|FG001|Overall Study|Lack of Efficacy|4|||
27764335|NCT02910583|80962913|FG000|Overall Study|Withdrawal by Subject|6|||
27962338|NCT02954887|81695100|FG000|Overall Study|Other|1|||
27962339|NCT02243371|81695101|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
27764336|NCT02910583|80962914|FG001|Overall Study|Withdrawal by Subject|7|||
27764337|NCT02910583|80962913|FG000|Overall Study|Other, Not Specified|1|||
27764338|NCT02910583|80962914|FG001|Overall Study|Other, Not Specified|0|||
27764339|NCT01838590|80962915|FG000|Overall Study|Lack of Efficacy|12|||
27764340|NCT01838590|80962916|FG001|Overall Study|Lack of Efficacy|4|||
27764341|NCT01838590|80962915|FG000|Overall Study|Lost to Follow-up|0|||
27764342|NCT01838590|80962916|FG001|Overall Study|Lost to Follow-up|1|||
27764343|NCT03084718|80962918|FG000|Overall Study|Withdrawal by Subject|4|||
27764344|NCT03084718|80962919|FG001|Overall Study|Withdrawal by Subject|3|||
27764345|NCT03084718|80962920|FG002|Overall Study|Withdrawal by Subject|4|||
27764346|NCT03084718|80962921|FG003|Overall Study|Withdrawal by Subject|0|||
27764347|NCT03084718|80962922|FG004|Overall Study|Withdrawal by Subject|0|||
27764348|NCT03084718|80962918|FG000|Overall Study|Physician Decision|1|||
27764349|NCT03084718|80962919|FG001|Overall Study|Physician Decision|0|||
27568826|NCT03013543|80271453|FG006|Overall Study|Protocol Violation|0|||
27663052|NCT02551692|80602960|FG002|Overall Study|Withdrawal by Subject|1|||
27764350|NCT03084718|80962920|FG002|Overall Study|Physician Decision|0|||
27764351|NCT03084718|80962921|FG003|Overall Study|Physician Decision|0|||
27764352|NCT03084718|80962922|FG004|Overall Study|Physician Decision|0|||
27764353|NCT03084718|80962918|FG000|Overall Study|Adverse Event|3|||
27764354|NCT03084718|80962919|FG001|Overall Study|Adverse Event|5|||
27764355|NCT03084718|80962920|FG002|Overall Study|Adverse Event|5|||
27764356|NCT03084718|80962921|FG003|Overall Study|Adverse Event|8|||
27663053|NCT02998918|80602975|FG000|Overall Study|Withdrawal by Subject|1|||
27663054|NCT02998918|80602976|FG001|Overall Study|Withdrawal by Subject|0|||
27663055|NCT01797705|80602977|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
27663056|NCT01797705|80602977|FG000|Overall Study|Withdrawal by Subject|1|||
27663057|NCT03410108|80602981|FG000|Overall Study|Ongoing|41|||
27663058|NCT03410108|80602981|FG000|Overall Study|Adverse Event|4|||
27663059|NCT03410108|80602981|FG000|Overall Study|Progressive Disease|58|||
27663060|NCT03410108|80602981|FG000|Overall Study|Withdrawal by Subject|1|||
27663061|NCT03193216|80602988|FG000|Overall Study|Lost to Follow-up|1|||
27663062|NCT03193216|80602989|FG001|Overall Study|Lost to Follow-up|0|||
27663063|NCT03193216|80602988|FG000|Overall Study|Withdrawal by Subject|5|||
27663064|NCT03193216|80602989|FG001|Overall Study|Withdrawal by Subject|0|||
27663065|NCT03193216|80602988|FG000|Overall Study|Physician Decision|4|||
27663066|NCT03193216|80602989|FG001|Overall Study|Physician Decision|0|||
27663067|NCT00809783|80602990|FG000|Overall Study|Death|1|||
27663068|NCT00809783|80602991|FG001|Overall Study|Death|0|||
27663069|NCT00809783|80602992|FG002|Overall Study|Death|0|||
27663070|NCT00809783|80602990|FG000|Overall Study|Adverse Event|34|||
27663071|NCT00809783|80602991|FG001|Overall Study|Adverse Event|52|||
27663072|NCT00809783|80602992|FG002|Overall Study|Adverse Event|71|||
27663073|NCT00809783|80602990|FG000|Overall Study|Lack of Efficacy|39|||
27663074|NCT00809783|80602991|FG001|Overall Study|Lack of Efficacy|52|||
27663075|NCT00809783|80602992|FG002|Overall Study|Lack of Efficacy|63|||
27663076|NCT00809783|80602990|FG000|Overall Study|Lost to Follow-up|0|||
27663077|NCT00809783|80602991|FG001|Overall Study|Lost to Follow-up|3|||
27663078|NCT00809783|80602992|FG002|Overall Study|Lost to Follow-up|4|||
27663079|NCT00809783|80602990|FG000|Overall Study|Withdrawal by Subject|47|||
27663080|NCT00809783|80602991|FG001|Overall Study|Withdrawal by Subject|72|||
27663081|NCT00809783|80602992|FG002|Overall Study|Withdrawal by Subject|64|||
27663082|NCT00809783|80602990|FG000|Overall Study|Protocol Violation|2|||
27663083|NCT00809783|80602991|FG001|Overall Study|Protocol Violation|6|||
27663084|NCT00809783|80602992|FG002|Overall Study|Protocol Violation|5|||
27663085|NCT00809783|80602990|FG000|Overall Study|Randomized, but not treated|3|||
27663086|NCT00809783|80602991|FG001|Overall Study|Randomized, but not treated|0|||
27663087|NCT00809783|80602992|FG002|Overall Study|Randomized, but not treated|2|||
27663088|NCT00809783|80602990|FG000|Overall Study|Study Terminated by Sponsor|378|||
27663089|NCT00809783|80602991|FG001|Overall Study|Study Terminated by Sponsor|626|||
27663090|NCT00809783|80602992|FG002|Overall Study|Study Terminated by Sponsor|565|||
27663091|NCT00809783|80602990|FG000|Overall Study|Other|21|||
27663092|NCT00809783|80602991|FG001|Overall Study|Other|21|||
27663093|NCT00809783|80602992|FG002|Overall Study|Other|16|||
27663094|NCT02229396|80602994|FG000|Overall Study|Adverse Event|6|||
27663095|NCT02229396|80602995|FG001|Overall Study|Adverse Event|12|||
27663096|NCT02229396|80602996|FG002|Overall Study|Adverse Event|12|||
27663097|NCT02229396|80602994|FG000|Overall Study|Death|2|||
27663098|NCT02229396|80602995|FG001|Overall Study|Death|3|||
27663099|NCT02229396|80602996|FG002|Overall Study|Death|1|||
27663100|NCT02229396|80602994|FG000|Overall Study|Lost to Follow-up|14|||
27663101|NCT02229396|80602995|FG001|Overall Study|Lost to Follow-up|14|||
27663102|NCT02229396|80602996|FG002|Overall Study|Lost to Follow-up|21|||
27663103|NCT02229396|80602994|FG000|Overall Study|Protocol Violation|2|||
27663104|NCT02229396|80602995|FG001|Overall Study|Protocol Violation|1|||
27663105|NCT02229396|80602996|FG002|Overall Study|Protocol Violation|0|||
27663106|NCT02229396|80602994|FG000|Overall Study|Patient Incorrectly Randomized|0|||
27663107|NCT02229396|80602995|FG001|Overall Study|Patient Incorrectly Randomized|0|||
27663108|NCT02229396|80602996|FG002|Overall Study|Patient Incorrectly Randomized|1|||
27663109|NCT02229396|80602994|FG000|Overall Study|Other|10|||
27663110|NCT02229396|80602995|FG001|Overall Study|Other|18|||
27663111|NCT02229396|80602996|FG002|Overall Study|Other|15|||
27663112|NCT02229396|80602994|FG000|Overall Study|Withdrawal by Subject|42|||
27663113|NCT02229396|80602995|FG001|Overall Study|Withdrawal by Subject|28|||
27663114|NCT02229396|80602996|FG002|Overall Study|Withdrawal by Subject|41|||
27663115|NCT02229396|80602994|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
27663116|NCT02229396|80602995|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27764357|NCT03084718|80962922|FG004|Overall Study|Adverse Event|2|||
27764358|NCT03084718|80962918|FG000|Overall Study|Lack of Efficacy|2|||
27764359|NCT03084718|80962919|FG001|Overall Study|Lack of Efficacy|0|||
27764360|NCT03084718|80962920|FG002|Overall Study|Lack of Efficacy|1|||
27764361|NCT03084718|80962921|FG003|Overall Study|Lack of Efficacy|4|||
27764362|NCT03084718|80962922|FG004|Overall Study|Lack of Efficacy|0|||
27764363|NCT03084718|80962918|FG000|Overall Study|Lost to Follow-up|0|||
27764364|NCT03084718|80962919|FG001|Overall Study|Lost to Follow-up|1|||
27764365|NCT03084718|80962920|FG002|Overall Study|Lost to Follow-up|0|||
27764366|NCT03084718|80962921|FG003|Overall Study|Lost to Follow-up|0|||
27764367|NCT03084718|80962922|FG004|Overall Study|Lost to Follow-up|2|||
27764368|NCT03084718|80962918|FG000|Overall Study|Protocol Violation|0|||
27764369|NCT03084718|80962919|FG001|Overall Study|Protocol Violation|0|||
27764370|NCT03084718|80962920|FG002|Overall Study|Protocol Violation|1|||
27764371|NCT03084718|80962921|FG003|Overall Study|Protocol Violation|0|||
27764372|NCT03084718|80962922|FG004|Overall Study|Protocol Violation|0|||
27764373|NCT03084718|80962918|FG000|Overall Study|Death|0|||
27764374|NCT03084718|80962919|FG001|Overall Study|Death|1|||
27764375|NCT03084718|80962920|FG002|Overall Study|Death|0|||
27764376|NCT03084718|80962921|FG003|Overall Study|Death|0|||
27764377|NCT03084718|80962922|FG004|Overall Study|Death|0|||
27764378|NCT03084718|80962918|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
27764379|NCT03084718|80962919|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
27764380|NCT03084718|80962920|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
27764381|NCT03084718|80962921|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
27764382|NCT03084718|80962922|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
27764383|NCT03205982|80962923|FG000|Overall Study|Lost to Follow-up|20|||
27764384|NCT03205982|80962924|FG001|Overall Study|Lost to Follow-up|19|||
27764385|NCT03205982|80962923|FG000|Overall Study|Withdrawal by Subject|4|||
27764386|NCT03205982|80962924|FG001|Overall Study|Withdrawal by Subject|3|||
27764387|NCT03205982|80962923|FG000|Overall Study|Withdrawal by PI|0|||
27764388|NCT03205982|80962924|FG001|Overall Study|Withdrawal by PI|1|||
27764389|NCT02501902|80962932|FG000|Overall Study|Subject Refused Further Follow-up|0|||
27764390|NCT02501902|80962933|FG001|Overall Study|Subject Refused Further Follow-up|0|||
27764391|NCT02501902|80962934|FG002|Overall Study|Subject Refused Further Follow-up|0|||
27764392|NCT02501902|80962935|FG003|Overall Study|Subject Refused Further Follow-up|0|||
27764393|NCT02501902|80962936|FG004|Overall Study|Subject Refused Further Follow-up|0|||
27764394|NCT02501902|80962937|FG005|Overall Study|Subject Refused Further Follow-up|0|||
27764395|NCT02501902|80962938|FG006|Overall Study|Subject Refused Further Follow-up|0|||
27764396|NCT02501902|80962939|FG007|Overall Study|Subject Refused Further Follow-up|1|||
27764397|NCT02501902|80962932|FG000|Overall Study|Study Terminated by Sponsor|0|||
27764398|NCT02501902|80962933|FG001|Overall Study|Study Terminated by Sponsor|3|||
27764399|NCT02501902|80962934|FG002|Overall Study|Study Terminated by Sponsor|0|||
27764400|NCT02501902|80962935|FG003|Overall Study|Study Terminated by Sponsor|1|||
27764401|NCT02501902|80962936|FG004|Overall Study|Study Terminated by Sponsor|1|||
27764402|NCT02501902|80962937|FG005|Overall Study|Study Terminated by Sponsor|0|||
27764403|NCT02501902|80962938|FG006|Overall Study|Study Terminated by Sponsor|2|||
27764404|NCT02501902|80962939|FG007|Overall Study|Study Terminated by Sponsor|4|||
27764405|NCT02501902|80962932|FG000|Overall Study|Death|3|||
27764406|NCT02501902|80962933|FG001|Overall Study|Death|4|||
27764407|NCT02501902|80962934|FG002|Overall Study|Death|4|||
27764408|NCT02501902|80962935|FG003|Overall Study|Death|10|||
27764409|NCT02501902|80962936|FG004|Overall Study|Death|10|||
27764410|NCT02501902|80962937|FG005|Overall Study|Death|11|||
27764411|NCT02501902|80962938|FG006|Overall Study|Death|7|||
27764412|NCT02501902|80962939|FG007|Overall Study|Death|15|||
27764413|NCT00646113|80962940|FG000|Overall Study|Lost to Follow-up|5|||
27764414|NCT00646113|80962940|FG000|Overall Study|Adverse Event|3|||
27764415|NCT00753688|80962943|FG000|Overall Study|Death|102|||
27764416|NCT00753688|80962944|FG001|Overall Study|Death|203|||
27764417|NCT00753688|80962943|FG000|Overall Study|Missing|4|||
27764418|NCT00753688|80962944|FG001|Overall Study|Missing|9|||
27764419|NCT00753688|80962943|FG000|Overall Study|Participant Withdrew Consent|2|||
27764420|NCT00753688|80962944|FG001|Overall Study|Participant Withdrew Consent|2|||
27764421|NCT00753688|80962943|FG000|Overall Study|Ongoing - in Follow-up|15|||
27764422|NCT00753688|80962944|FG001|Overall Study|Ongoing - in Follow-up|31|||
27764423|NCT00753688|80962943|FG000|Overall Study|Adverse Event|0|||
27764424|NCT00753688|80962944|FG001|Overall Study|Adverse Event|1|||
27764425|NCT01170221|80962945|FG000|Overall Study|Lost to Follow-up|22|||
27764426|NCT01170221|80962946|FG001|Overall Study|Lost to Follow-up|21|||
27764427|NCT01170221|80962945|FG000|Overall Study|Withdrawal by Subject|9|||
27764428|NCT01170221|80962946|FG001|Overall Study|Withdrawal by Subject|7|||
27764429|NCT01170221|80962945|FG000|Overall Study|Subject completed only screening and LFU|1|||
27764430|NCT01170221|80962946|FG001|Overall Study|Subject completed only screening and LFU|0|||
27764431|NCT01170221|80962945|FG000|Overall Study|Randomized but not treated|1|||
27764432|NCT01170221|80962946|FG001|Overall Study|Randomized but not treated|0|||
27764433|NCT03097614|80962950|FG000|Overall Study|Adverse Event|3|||
27764434|NCT03434418|80962953|FG000|Overall Study|Disease Progression|11|||
27764435|NCT03434418|80962953|FG000|Overall Study|Adverse Event|2|||
27764436|NCT03434418|80962953|FG000|Overall Study|Physician Decision|1|||
27764437|NCT03434418|80962953|FG000|Overall Study|Decline in Performance Status (PS)|1|||
27764438|NCT03595384|80962958|FG000|Overall Study|Other time commitments|8|||
27764439|NCT03595384|80962958|FG000|Overall Study|Changes to session time|7|||
27764440|NCT03595384|80962958|FG000|Overall Study|Relocation out of country|1|||
27764441|NCT02023112|80962959|FG000|Overall Study|Withdrawal by Subject|2|||
27764442|NCT02023112|80962960|FG001|Overall Study|Withdrawal by Subject|1|||
27764443|NCT01459068|80962961|FG000|Overall Study|Withdrawal by Subject|8|||
27764444|NCT01459068|80962962|FG001|Overall Study|Withdrawal by Subject|18|||
27764445|NCT01459068|80962961|FG000|Overall Study|Lost to Follow-up|31|||
27764446|NCT01459068|80962962|FG001|Overall Study|Lost to Follow-up|15|||
27764447|NCT01459068|80962961|FG000|Overall Study|Death|0|||
27764448|NCT01459068|80962962|FG001|Overall Study|Death|1|||
27764449|NCT00105560|80966255|FG000|Overall Study|Lost to Follow-up|1|||
27764450|NCT03485222|80966256|FG000|Overall Study|Death|0|||
27764451|NCT03485222|80966257|FG001|Overall Study|Death|1|||
27764452|NCT03485222|80966256|FG000|Overall Study|Lost to Follow-up|2|||
27764453|NCT03485222|80966257|FG001|Overall Study|Lost to Follow-up|1|||
27764454|NCT01410799|80966260|FG000|Overall Study|PI decision|13|||
27764455|NCT00719862|80966261|FG000|Overall Study|Adverse Event|1|||
27764456|NCT00719862|80966262|FG001|Overall Study|Adverse Event|2|||
27764457|NCT00719862|80966261|FG000|Overall Study|Lack of Efficacy|3|||
27764458|NCT00719862|80966262|FG001|Overall Study|Lack of Efficacy|0|||
27764459|NCT00719862|80966261|FG000|Overall Study|Non-Compliance|1|||
27764460|NCT00719862|80966262|FG001|Overall Study|Non-Compliance|0|||
27764461|NCT00719862|80966261|FG000|Overall Study|Withdrawal by Subject|1|||
27764462|NCT00719862|80966262|FG001|Overall Study|Withdrawal by Subject|0|||
27764463|NCT00719862|80966261|FG000|Overall Study|Lost to Follow-up|0|||
27764464|NCT00719862|80966262|FG001|Overall Study|Lost to Follow-up|1|||
27764465|NCT00719862|80966261|FG000|Overall Study|Other|2|||
27764466|NCT00719862|80966262|FG001|Overall Study|Other|3|||
27764467|NCT00617591|80966265|FG000|Overall Study|Withdrew consent during Induction|4|||
27764468|NCT00617591|80966265|FG000|Overall Study|Withdrew consent during Maintenance|6|||
27764469|NCT01646398|80966268|FG000|Overall Study|Withdrawal by Subject|1|||
27764470|NCT01646398|80966269|FG001|Overall Study|Withdrawal by Subject|0|||
27764471|NCT03032510|80966272|FG000|Overall Study|Adverse Event|5|||
27764472|NCT03032510|80966273|FG001|Overall Study|Adverse Event|2|||
27764473|NCT03032510|80966272|FG000|Overall Study|Lost to Follow-up|8|||
27764474|NCT03032510|80966273|FG001|Overall Study|Lost to Follow-up|7|||
27764475|NCT03032510|80966272|FG000|Overall Study|Withdrawal by Subject|8|||
27764476|NCT03032510|80966273|FG001|Overall Study|Withdrawal by Subject|7|||
27764477|NCT03032510|80966272|FG000|Overall Study|Subject noncompliance|4|||
27764478|NCT03032510|80966273|FG001|Overall Study|Subject noncompliance|2|||
27764479|NCT03032510|80966272|FG000|Overall Study|Physician Decision|2|||
27764480|NCT03032510|80966273|FG001|Overall Study|Physician Decision|0|||
27764481|NCT03210220|80966276|FG000|Overall Study|Physician Decision|1|||
27764482|NCT03210220|80966277|FG001|Overall Study|Physician Decision|0|||
27764483|NCT01357980|80966278|FG000|Overall Study|Lack of Efficacy|0|||
27764484|NCT01357980|80966279|FG001|Overall Study|Lack of Efficacy|1|||
27764485|NCT01357980|80966280|FG002|Overall Study|Lack of Efficacy|0|||
27764486|NCT01357980|80966281|FG003|Overall Study|Lack of Efficacy|0|||
27764487|NCT01357980|80966278|FG000|Overall Study|Consent withdrawn|0|||
27764488|NCT01357980|80966279|FG001|Overall Study|Consent withdrawn|0|||
27764489|NCT01357980|80966280|FG002|Overall Study|Consent withdrawn|1|||
27764490|NCT01357980|80966281|FG003|Overall Study|Consent withdrawn|0|||
27764491|NCT03559192|80966287|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
27764492|NCT03559192|80966288|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
27764493|NCT03559192|80966289|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
27764494|NCT03559192|80966287|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
27764495|NCT03559192|80966288|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
27764496|NCT03559192|80966289|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
27764497|NCT03559192|80966287|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
27764498|NCT03559192|80966288|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
27764499|NCT03559192|80966289|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
27764500|NCT03559192|80966287|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
27764501|NCT03559192|80966288|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
27764502|NCT03559192|80966289|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
27764503|NCT03559192|80966287|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
27764504|NCT03559192|80966288|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
27764505|NCT03559192|80966289|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
27764506|NCT03559192|80966287|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
27764507|NCT03559192|80966288|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
27764508|NCT03559192|80966289|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
27764509|NCT03559192|80966287|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
27764510|NCT03559192|80966288|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
27764511|NCT03559192|80966289|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
27764512|NCT03559192|80966287|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
27764513|NCT03559192|80966288|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
27764514|NCT03559192|80966289|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
27764515|NCT03559192|80966287|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
27764516|NCT03559192|80966288|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
27764517|NCT03559192|80966289|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
27764518|NCT01624506|80966291|FG000|Overall Study|Lost to Follow-up|29|||
27764519|NCT01624506|80966292|FG001|Overall Study|Lost to Follow-up|15|||
27764520|NCT01624506|80966291|FG000|Overall Study|Withdrawal by Subject|9|||
27764521|NCT01624506|80966292|FG001|Overall Study|Withdrawal by Subject|2|||
27764522|NCT01624506|80966291|FG000|Overall Study|Death|1|||
27663117|NCT02229396|80602996|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
27663118|NCT02229396|80602994|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
27663119|NCT02229396|80602995|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
27663120|NCT02229396|80602996|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
27663121|NCT01894256|80603001|FG000|Part A|Adverse Event|0|||
27663122|NCT01894256|80603002|FG001|Part A|Adverse Event|1|||
27663123|NCT01894256|80603003|FG002|Part A|Adverse Event|0|||
27663124|NCT01894256|80603001|FG000|Part B|Death|0|||
27663125|NCT01894256|80603002|FG001|Part B|Death|1|||
27663126|NCT01894256|80603003|FG002|Part B|Death|1|||
27663127|NCT01894256|80603001|FG000|Part B|Withdrawal by Subject|0|||
27663128|NCT01894256|80603002|FG001|Part B|Withdrawal by Subject|1|||
27663129|NCT01894256|80603003|FG002|Part B|Withdrawal by Subject|0|||
27663130|NCT01894256|80603001|FG000|Part B|Lack of Efficacy|15|||
27663131|NCT01894256|80603002|FG001|Part B|Lack of Efficacy|12|||
27663132|NCT01894256|80603003|FG002|Part B|Lack of Efficacy|13|||
27663133|NCT03461211|80603005|FG000|Overall Study|Adverse Event|1|||
27663134|NCT03461211|80603006|FG001|Overall Study|Adverse Event|1|||
27663135|NCT03461211|80603005|FG000|Overall Study|Lack of Efficacy|0|||
27663136|NCT03461211|80603006|FG001|Overall Study|Lack of Efficacy|1|||
27663137|NCT04872101|80603007|FG000|Overall Study|Withdrawal by Subject|10|||
27663138|NCT04872101|80603008|FG001|Overall Study|Withdrawal by Subject|16|||
27663139|NCT04872101|80603007|FG000|Overall Study|Lack of Efficacy|6|||
27663140|NCT04872101|80603008|FG001|Overall Study|Lack of Efficacy|14|||
27663141|NCT04872101|80603007|FG000|Overall Study|Adverse Event|1|||
27663142|NCT04872101|80603008|FG001|Overall Study|Adverse Event|6|||
27663143|NCT04872101|80603007|FG000|Overall Study|Lost to Follow-up|2|||
27663144|NCT04872101|80603008|FG001|Overall Study|Lost to Follow-up|1|||
27663145|NCT04872101|80603007|FG000|Overall Study|Pregnancy|2|||
27663146|NCT04872101|80603008|FG001|Overall Study|Pregnancy|0|||
27663147|NCT04872101|80603007|FG000|Overall Study|Prohibited Medication|1|||
27663148|NCT04872101|80603008|FG001|Overall Study|Prohibited Medication|0|||
27663149|NCT04872101|80603007|FG000|Overall Study|Not dosed|1|||
27663150|NCT04872101|80603008|FG001|Overall Study|Not dosed|0|||
27663151|NCT05244226|80603011|FG000|Overall Study|Adverse Event|1|||
27663152|NCT05244226|80603012|FG001|Overall Study|Adverse Event|0|||
27663153|NCT05244226|80603013|FG002|Overall Study|Adverse Event|0|||
27663154|NCT05244226|80603011|FG000|Overall Study|Lost to Follow-up|0|||
27663155|NCT05244226|80603012|FG001|Overall Study|Lost to Follow-up|0|||
27663156|NCT05244226|80603013|FG002|Overall Study|Lost to Follow-up|1|||
27663157|NCT05244226|80603011|FG000|Overall Study|Protocol Violation|0|||
27663158|NCT05244226|80603012|FG001|Overall Study|Protocol Violation|2|||
27663159|NCT05244226|80603013|FG002|Overall Study|Protocol Violation|2|||
27663160|NCT03168425|80603014|FG000|Overall Study|Lost to Follow-up|5|||
27663161|NCT03168425|80603015|FG001|Overall Study|Lost to Follow-up|8|||
27663162|NCT03168425|80603014|FG000|Overall Study|unable to confirm post op opioids|2|||
27663163|NCT03168425|80603015|FG001|Overall Study|unable to confirm post op opioids|3|||
27663164|NCT02815735|80603016|FG000|First Intervention (4 Weeks)|Discomfort|1|||
27663165|NCT02815735|80603017|FG001|First Intervention (4 Weeks)|Discomfort|0|||
27663166|NCT02815735|80603016|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
27663167|NCT02815735|80603017|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
27663168|NCT02815735|80603016|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
27663169|NCT02815735|80603017|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
27663170|NCT02815735|80603016|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
27663171|NCT02815735|80603017|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
27663172|NCT02391545|80603018|FG000|Overall Study|Death|0|||
27663173|NCT02391545|80603019|FG001|Overall Study|Death|2|||
27663174|NCT02391545|80603018|FG000|Overall Study|Lost to Follow-up|0|||
27663175|NCT02391545|80603019|FG001|Overall Study|Lost to Follow-up|1|||
27663176|NCT02391545|80603018|FG000|Overall Study|Termination of study by sponsor|20|||
27663177|NCT02391545|80603019|FG001|Overall Study|Termination of study by sponsor|20|||
27663178|NCT02391545|80603018|FG000|Overall Study|Withdrawal by Subject|0|||
27663179|NCT02391545|80603019|FG001|Overall Study|Withdrawal by Subject|1|||
27764523|NCT01624506|80966292|FG001|Overall Study|Death|0|||
27764524|NCT01624506|80966291|FG000|Overall Study|LINX explants|23|||
27764525|NCT01624506|80966292|FG001|Overall Study|LINX explants|0|||
27764526|NCT01624506|80966291|FG000|Overall Study|Adverse Event|3|||
27764527|NCT01624506|80966292|FG001|Overall Study|Adverse Event|0|||
27764528|NCT00970268|80966293|FG000|Overall Study|Withdrawal by Subject|12|||
27764529|NCT00970268|80966294|FG001|Overall Study|Withdrawal by Subject|19|||
27764530|NCT00970268|80966293|FG000|Overall Study|Adverse Event|15|||
27764531|NCT00970268|80966294|FG001|Overall Study|Adverse Event|12|||
27764532|NCT00970268|80966293|FG000|Overall Study|Lack of Efficacy|3|||
27764533|NCT00970268|80966294|FG001|Overall Study|Lack of Efficacy|6|||
27764534|NCT00970268|80966293|FG000|Overall Study|Protocol Violation|4|||
27764535|NCT00970268|80966294|FG001|Overall Study|Protocol Violation|7|||
27764536|NCT00970268|80966293|FG000|Overall Study|Other Reason|3|||
27764537|NCT00970268|80966294|FG001|Overall Study|Other Reason|1|||
27764538|NCT00970268|80966293|FG000|Overall Study|COPD Exacerbation|4|||
27764539|NCT00970268|80966294|FG001|Overall Study|COPD Exacerbation|2|||
27764540|NCT00970268|80966293|FG000|Overall Study|Lost to Follow-up|1|||
27764541|NCT00970268|80966294|FG001|Overall Study|Lost to Follow-up|2|||
27764542|NCT00970268|80966293|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
27764543|NCT00970268|80966294|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
27764544|NCT03479216|80966295|FG000|Overall Study|Withdrawal by Subject|3|||
27764545|NCT03479216|80966296|FG001|Overall Study|Withdrawal by Subject|2|||
27764546|NCT03479216|80966295|FG000|Overall Study|Physician Decision|2|||
27764547|NCT03479216|80966296|FG001|Overall Study|Physician Decision|3|||
27764548|NCT00085917|80966297|FG000|Overall Study|Adverse Event|4|||
27764549|NCT00085917|80966298|FG001|Overall Study|Adverse Event|3|||
27764550|NCT01957709|80966301|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
27764551|NCT01296698|80966302|FG000|Overall Study|Adverse Event|1|||
27764552|NCT01296698|80966303|FG001|Overall Study|Adverse Event|0|||
27764553|NCT01296698|80966302|FG000|Overall Study|Death|1|||
27764554|NCT01296698|80966303|FG001|Overall Study|Death|0|||
27764555|NCT01296698|80966302|FG000|Overall Study|Lost to Follow-up|19|||
27764556|NCT01296698|80966303|FG001|Overall Study|Lost to Follow-up|1|||
27764557|NCT01296698|80966302|FG000|Overall Study|Withdrawal by Subject|12|||
27764558|NCT01296698|80966303|FG001|Overall Study|Withdrawal by Subject|0|||
27764559|NCT01296698|80966302|FG000|Overall Study|Difficulty Contacting Subject|2|||
27764560|NCT01296698|80966303|FG001|Overall Study|Difficulty Contacting Subject|0|||
27764561|NCT01296698|80966302|FG000|Overall Study|Study Terminated by Sponsor|209|||
27764562|NCT01296698|80966303|FG001|Overall Study|Study Terminated by Sponsor|12|||
27764563|NCT01270958|80966306|FG000|Overall Study|Lost to Follow-up|2|||
27764564|NCT01270958|80966306|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
27764565|NCT00877006|80966307|FG000|Treatment Period|Death|2|||
27764566|NCT00877006|80966308|FG001|Treatment Period|Death|1|||
27764567|NCT00877006|80966307|FG000|Treatment Period|Adverse Event|10|||
27764568|NCT00877006|80966308|FG001|Treatment Period|Adverse Event|3|||
27764569|NCT00877006|80966307|FG000|Treatment Period|Withdrawal by Subject|2|||
27764570|NCT00877006|80966308|FG001|Treatment Period|Withdrawal by Subject|3|||
27764571|NCT00877006|80966307|FG000|Treatment Period|Protocol Violation|1|||
27764572|NCT00877006|80966308|FG001|Treatment Period|Protocol Violation|0|||
27764573|NCT00877006|80966307|FG000|Treatment Period|Lost to Follow-up|0|||
27764574|NCT00877006|80966308|FG001|Treatment Period|Lost to Follow-up|1|||
27764575|NCT00877006|80966307|FG000|Treatment Period|Disease Progression|1|||
27764576|NCT00877006|80966308|FG001|Treatment Period|Disease Progression|2|||
27764577|NCT00877006|80966307|FG000|Treatment Period|Started New Treatment Regimen|2|||
27764578|NCT00877006|80966308|FG001|Treatment Period|Started New Treatment Regimen|5|||
27764579|NCT00877006|80966307|FG000|Treatment Period|Other|4|||
27764580|NCT00877006|80966308|FG001|Treatment Period|Other|4|||
27764581|NCT00877006|80966307|FG000|Treatment Period|Randomized but Not Treated|3|||
27764582|NCT00877006|80966308|FG001|Treatment Period|Randomized but Not Treated|8|||
27764583|NCT00877006|80966307|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
27764584|NCT00877006|80966308|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
27764585|NCT00877006|80966307|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
27764586|NCT00877006|80966308|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
27764587|NCT00877006|80966307|FG000|Long-Term Follow-up Period|Death|26|||
27764588|NCT00877006|80966308|FG001|Long-Term Follow-up Period|Death|18|||
27764589|NCT00877006|80966307|FG000|Long-Term Follow-up Period|Other|7|||
27764590|NCT00877006|80966308|FG001|Long-Term Follow-up Period|Other|9|||
27764591|NCT00525785|80966309|FG000|Overall Study|Withdrawal by Subject|1|||
27764592|NCT00525785|80966309|FG000|Overall Study|Lack of Efficacy|1|||
27862072|NCT01755767|81326222|FG000|Overall Study|Subject Decision|0|||
27764593|NCT00525785|80966309|FG000|Overall Study|Physician Decision|1|||
27764594|NCT02228564|80966310|FG000|Overall Study|Withdrawal by Subject|10|||
27764595|NCT02228564|80966310|FG000|Overall Study|Death|11|||
27764596|NCT02228564|80966310|FG000|Overall Study|Physician Decision|5|||
27764597|NCT02228564|80966310|FG000|Overall Study|Lost to Follow-up|17|||
27764598|NCT02228564|80966310|FG000|Overall Study|Other|6|||
27764599|NCT01532570|80966313|FG000|Overall Study|Lack of Efficacy|1|||
27764600|NCT01532570|80966314|FG001|Overall Study|Lack of Efficacy|0|||
27764601|NCT01532570|80966315|FG002|Overall Study|Lack of Efficacy|0|||
27764602|NCT01532570|80966316|FG003|Overall Study|Lack of Efficacy|0|||
27764603|NCT01532570|80966313|FG000|Overall Study|Withdrawal by Subject|0|||
27764604|NCT01532570|80966314|FG001|Overall Study|Withdrawal by Subject|1|||
27764605|NCT01532570|80966315|FG002|Overall Study|Withdrawal by Subject|0|||
27764606|NCT01532570|80966316|FG003|Overall Study|Withdrawal by Subject|0|||
27764607|NCT00505752|80966322|FG000|Overall Study|Adverse Event|1|||
27764608|NCT00505752|80966323|FG001|Overall Study|Adverse Event|0|||
27764609|NCT00505752|80966324|FG002|Overall Study|Adverse Event|1|||
27764610|NCT00505752|80966325|FG003|Overall Study|Adverse Event|0|||
27764611|NCT00505752|80966322|FG000|Overall Study|Lost to Follow-up|1|||
27764612|NCT00505752|80966323|FG001|Overall Study|Lost to Follow-up|0|||
27764613|NCT00505752|80966324|FG002|Overall Study|Lost to Follow-up|0|||
27764614|NCT00505752|80966325|FG003|Overall Study|Lost to Follow-up|0|||
27764615|NCT00505752|80966322|FG000|Overall Study|Lack of ovarian response|1|||
27764616|NCT00505752|80966323|FG001|Overall Study|Lack of ovarian response|3|||
27764617|NCT00505752|80966324|FG002|Overall Study|Lack of ovarian response|0|||
27764618|NCT00505752|80966325|FG003|Overall Study|Lack of ovarian response|0|||
27764619|NCT00505752|80966322|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27764620|NCT00505752|80966323|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27764621|NCT00505752|80966324|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
27764622|NCT00505752|80966325|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27764623|NCT00505752|80966322|FG000|Overall Study|No oocytes retrieved|0|||
27764624|NCT00505752|80966323|FG001|Overall Study|No oocytes retrieved|2|||
27764625|NCT00505752|80966324|FG002|Overall Study|No oocytes retrieved|0|||
27764626|NCT00505752|80966325|FG003|Overall Study|No oocytes retrieved|1|||
27764627|NCT00505752|80966322|FG000|Overall Study|No Fertilization|1|||
27764628|NCT00505752|80966323|FG001|Overall Study|No Fertilization|1|||
27764629|NCT00505752|80966324|FG002|Overall Study|No Fertilization|2|||
27764630|NCT00505752|80966325|FG003|Overall Study|No Fertilization|1|||
27764631|NCT00505752|80966322|FG000|Overall Study|All embryos/blastocysts discarded|0|||
27764632|NCT00505752|80966323|FG001|Overall Study|All embryos/blastocysts discarded|0|||
27764633|NCT00505752|80966324|FG002|Overall Study|All embryos/blastocysts discarded|1|||
27764634|NCT00505752|80966325|FG003|Overall Study|All embryos/blastocysts discarded|1|||
27764635|NCT00505752|80966322|FG000|Overall Study|Other|1|||
27764636|NCT00505752|80966323|FG001|Overall Study|Other|2|||
27764637|NCT00505752|80966324|FG002|Overall Study|Other|1|||
27764638|NCT00505752|80966325|FG003|Overall Study|Other|2|||
27764639|NCT01082367|80966328|FG000|Double-blind Period|Administrative problems|0|||
27764640|NCT01082367|80966329|FG001|Double-blind Period|Administrative problems|1|||
27764641|NCT01082367|80966328|FG000|Double-blind Period|Lack of Efficacy|5|||
27764642|NCT01082367|80966329|FG001|Double-blind Period|Lack of Efficacy|11|||
27764643|NCT01082367|80966328|FG000|Double-blind Period|Adverse Event|0|||
27764644|NCT01082367|80966329|FG001|Double-blind Period|Adverse Event|1|||
27764645|NCT01082367|80966328|FG000|Follow-up (F-U) Period|Administrative problems|1|||
27764646|NCT01082367|80966329|FG001|Follow-up (F-U) Period|Administrative problems|0|||
27568827|NCT03013543|80271454|FG007|Overall Study|Protocol Violation|0|||
27568828|NCT03013543|80271455|FG008|Overall Study|Protocol Violation|0|||
27568829|NCT03013543|80271456|FG009|Overall Study|Protocol Violation|1|||
27568830|NCT00547703|80271458|FG000|Overall Study|Lost to Follow-up|1|||
27568831|NCT00547703|80271459|FG001|Overall Study|Lost to Follow-up|0|||
27568832|NCT02347527|80271463|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
27568833|NCT02347527|80271464|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
27764647|NCT01082367|80966328|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
27764648|NCT01082367|80966329|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
27764649|NCT01082367|80966328|FG000|Follow-up (F-U) Period|Adverse Event|0|||
27764650|NCT01082367|80966329|FG001|Follow-up (F-U) Period|Adverse Event|1|||
27764651|NCT00618995|80966330|FG000|Period 1|Adverse Event|0|||
27764652|NCT00618995|80966331|FG001|Period 1|Adverse Event|0|||
27764653|NCT00618995|80966332|FG002|Period 1|Adverse Event|1|||
27962340|NCT02243371|81695102|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
27962341|NCT02243371|81695101|FG000|Overall Study|Death (unrelated)|2|||
27764654|NCT00618995|80966333|FG003|Period 1|Adverse Event|0|||
27568834|NCT02347527|80271465|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
27764655|NCT00618995|80966330|FG000|Period 1|Protocol Violation|0|||
27764656|NCT00618995|80966331|FG001|Period 1|Protocol Violation|1|||
27764657|NCT00618995|80966332|FG002|Period 1|Protocol Violation|1|||
27764658|NCT00618995|80966333|FG003|Period 1|Protocol Violation|0|||
27962342|NCT02243371|81695102|FG001|Overall Study|Death (unrelated)|4|||
27568835|NCT02347527|80271466|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
27764659|NCT00618995|80966330|FG000|Period 2|Protocol Violation|0|||
27764660|NCT00618995|80966331|FG001|Period 2|Protocol Violation|0|||
27764661|NCT00618995|80966332|FG002|Period 2|Protocol Violation|1|||
27764662|NCT00618995|80966333|FG003|Period 2|Protocol Violation|0|||
27764663|NCT00618995|80966330|FG000|Period 4|Adverse Event|1|||
27764664|NCT00618995|80966331|FG001|Period 4|Adverse Event|0|||
27764665|NCT00618995|80966332|FG002|Period 4|Adverse Event|0|||
27764666|NCT00618995|80966333|FG003|Period 4|Adverse Event|0|||
27764667|NCT02146833|80966337|FG000|Overall Study|Death|10|||
27764668|NCT02146833|80966337|FG000|Overall Study|No longer consented to study treatment|1|||
27764669|NCT00764946|80966338|FG000|Overall Study|Lack of Efficacy|1|||
27764670|NCT00764946|80966339|FG001|Overall Study|Lack of Efficacy|0|||
27764671|NCT00764946|80966340|FG002|Overall Study|Lack of Efficacy|0|||
27764672|NCT00764946|80966338|FG000|Overall Study|Lost to Follow-up|3|||
27764673|NCT00764946|80966339|FG001|Overall Study|Lost to Follow-up|4|||
27764674|NCT00764946|80966340|FG002|Overall Study|Lost to Follow-up|0|||
27764675|NCT00764946|80966338|FG000|Overall Study|Physician Decision|2|||
27764676|NCT00764946|80966339|FG001|Overall Study|Physician Decision|4|||
27764677|NCT00764946|80966340|FG002|Overall Study|Physician Decision|0|||
27764678|NCT00764946|80966338|FG000|Overall Study|Adverse Event|3|||
27764679|NCT00764946|80966339|FG001|Overall Study|Adverse Event|2|||
27764680|NCT00764946|80966340|FG002|Overall Study|Adverse Event|1|||
27764681|NCT00764946|80966338|FG000|Overall Study|Withdrawal by Subject|3|||
27764682|NCT00764946|80966339|FG001|Overall Study|Withdrawal by Subject|6|||
27764683|NCT00764946|80966340|FG002|Overall Study|Withdrawal by Subject|2|||
27764684|NCT00764946|80966338|FG000|Overall Study|Never Treated|1|||
27764685|NCT00764946|80966339|FG001|Overall Study|Never Treated|1|||
27764686|NCT00764946|80966340|FG002|Overall Study|Never Treated|1|||
27764687|NCT01225172|80966341|FG000|Overall Study|Subject decision to stop|1|||
27764688|NCT01225172|80966342|FG001|Overall Study|Subject decision to stop|0|||
27764689|NCT01225172|80966341|FG000|Overall Study|Subject request to discontinue treatment|3|||
27764690|NCT01225172|80966342|FG001|Overall Study|Subject request to discontinue treatment|1|||
27764691|NCT01225172|80966341|FG000|Overall Study|Subject no longer meets study criteria|1|||
27764692|NCT01225172|80966342|FG001|Overall Study|Subject no longer meets study criteria|0|||
27764693|NCT01225172|80966341|FG000|Overall Study|Withdrawal by Subject|1|||
27764694|NCT01225172|80966342|FG001|Overall Study|Withdrawal by Subject|0|||
27764695|NCT02224638|80966343|FG000|Overall Study|Adverse Event|1|||
27764696|NCT02224638|80966344|FG001|Overall Study|Adverse Event|1|||
27764697|NCT00879437|80966350|FG000|Overall Study|Protocol Violation|0|||
27764698|NCT00879437|80966351|FG001|Overall Study|Protocol Violation|1|||
27764699|NCT00879437|80966350|FG000|Overall Study|Death|1|||
27764700|NCT00879437|80966351|FG001|Overall Study|Death|0|||
27764701|NCT02700919|80966352|FG000|Overall Study|Physician Decision|1|||
27764702|NCT02700919|80966353|FG001|Overall Study|Physician Decision|0|||
27764703|NCT02700919|80966354|FG002|Overall Study|Physician Decision|0|||
27764704|NCT02700919|80966352|FG000|Overall Study|Protocol Violation|1|||
27764705|NCT02700919|80966353|FG001|Overall Study|Protocol Violation|0|||
27764706|NCT02700919|80966354|FG002|Overall Study|Protocol Violation|0|||
27764707|NCT02700919|80966352|FG000|Overall Study|Adverse Event|1|||
27764708|NCT02700919|80966353|FG001|Overall Study|Adverse Event|3|||
27764709|NCT02700919|80966354|FG002|Overall Study|Adverse Event|1|||
27764710|NCT02700919|80966352|FG000|Overall Study|Withdrawal by Subject|5|||
27764711|NCT02700919|80966353|FG001|Overall Study|Withdrawal by Subject|8|||
27764712|NCT02700919|80966354|FG002|Overall Study|Withdrawal by Subject|2|||
27764713|NCT02700919|80966352|FG000|Overall Study|Lost to Follow-up|2|||
27764714|NCT02700919|80966353|FG001|Overall Study|Lost to Follow-up|0|||
27764715|NCT02700919|80966354|FG002|Overall Study|Lost to Follow-up|0|||
27764716|NCT02700919|80966352|FG000|Overall Study|Other|2|||
27764717|NCT02700919|80966353|FG001|Overall Study|Other|1|||
27764718|NCT02700919|80966354|FG002|Overall Study|Other|1|||
27764719|NCT01925612|80966361|FG000|Overall Study|Progressive Disease|1|||
27764720|NCT01925612|80966362|FG001|Overall Study|Progressive Disease|1|||
27764721|NCT01925612|80966363|FG002|Overall Study|Progressive Disease|1|||
27764722|NCT01925612|80966364|FG003|Overall Study|Progressive Disease|0|||
27764723|NCT01925612|80966365|FG004|Overall Study|Progressive Disease|0|||
27764724|NCT01925612|80966361|FG000|Overall Study|Adverse Event|3|||
27764725|NCT01925612|80966362|FG001|Overall Study|Adverse Event|3|||
27764726|NCT01925612|80966363|FG002|Overall Study|Adverse Event|0|||
27764727|NCT01925612|80966364|FG003|Overall Study|Adverse Event|1|||
27962343|NCT02243371|81695101|FG000|Overall Study|Adverse Event (unrelated)|0|||
27962344|NCT02243371|81695102|FG001|Overall Study|Adverse Event (unrelated)|1|||
27962345|NCT02243371|81695101|FG000|Overall Study|Lack of Clinical Benefit|0|||
27962346|NCT02243371|81695102|FG001|Overall Study|Lack of Clinical Benefit|1|||
27764728|NCT01925612|80966365|FG004|Overall Study|Adverse Event|2|||
27764729|NCT00865189|80966369|FG000|Overall Study|Other|1|||
27764730|NCT00865189|80966370|FG001|Overall Study|Other|2|||
27764731|NCT00865189|80966369|FG000|Overall Study|Death|4|||
27764732|NCT00865189|80966370|FG001|Overall Study|Death|11|||
27962347|NCT02243371|81695101|FG000|Overall Study|Withdrawal by Subject|0|||
27764733|NCT00865189|80966369|FG000|Overall Study|Lost to Follow-up|6|||
27764734|NCT00865189|80966370|FG001|Overall Study|Lost to Follow-up|6|||
27764735|NCT00865189|80966369|FG000|Overall Study|Withdrawal by Subject|1|||
27764736|NCT00865189|80966370|FG001|Overall Study|Withdrawal by Subject|0|||
27764737|NCT01135017|80966373|FG000|Overall Study|Adverse Event|3|||
27764738|NCT01135017|80966374|FG001|Overall Study|Adverse Event|8|||
27764739|NCT01135017|80966373|FG000|Overall Study|Other than above|3|||
27764740|NCT01135017|80966374|FG001|Overall Study|Other than above|4|||
27764741|NCT01425749|80966381|FG000|Overall Study|progression of melanoma|0|||
27764742|NCT01425749|80966382|FG001|Overall Study|progression of melanoma|1|||
27764743|NCT00851253|80966383|FG000|Overall Study|Disease Progression|1|||
27764744|NCT00851253|80966384|FG001|Overall Study|Disease Progression|0|||
27764745|NCT04992546|80966389|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
27764746|NCT04992546|80966389|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
27764747|NCT04992546|80966389|FG000|Open-Label Treatment Period|Adverse Event|3|||
27764748|NCT04992546|80966389|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
27764749|NCT03332303|80966390|FG000|Overall Study|Participant did not dose|1|||
27764750|NCT03332303|80966391|FG001|Overall Study|Participant did not dose|2|||
27764751|NCT03332303|80966392|FG002|Overall Study|Participant did not dose|0|||
27764752|NCT03332303|80966390|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
27764753|NCT03332303|80966391|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
27764754|NCT03332303|80966392|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
27764755|NCT03332303|80966390|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
27764756|NCT03332303|80966391|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
27764757|NCT03332303|80966392|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
27764758|NCT03332303|80966390|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
27764759|NCT03332303|80966391|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
27764760|NCT03332303|80966392|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
27764761|NCT03332303|80966390|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
27764762|NCT03332303|80966391|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
27764763|NCT03332303|80966392|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
27764764|NCT03332303|80966390|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
27764765|NCT03332303|80966391|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
27764766|NCT03332303|80966392|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
27764767|NCT03332303|80966390|FG000|Overall Study|Participant had a significant protocol deviation|0|||
27764768|NCT03332303|80966391|FG001|Overall Study|Participant had a significant protocol deviation|1|||
27764769|NCT03332303|80966392|FG002|Overall Study|Participant had a significant protocol deviation|0|||
27764770|NCT01677507|80966393|FG000|Initial Assignment|Adverse Event|0|||
27764771|NCT01677507|80966394|FG001|Initial Assignment|Adverse Event|1|||
27764772|NCT01677507|80966393|FG000|Initial Assignment|Protocol Violation|0|||
27764773|NCT01677507|80966394|FG001|Initial Assignment|Protocol Violation|1|||
27764774|NCT01677507|80966393|FG000|Second Assigment|Withdrawal by Subject|2|||
27764775|NCT01677507|80966394|FG001|Second Assigment|Withdrawal by Subject|2|||
27764776|NCT01677507|80966393|FG000|Second Assigment|Adverse Event|1|||
27764777|NCT01677507|80966394|FG001|Second Assigment|Adverse Event|3|||
27764778|NCT01453998|80966396|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
27764779|NCT01453998|80966397|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
27764780|NCT01453998|80966398|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
27764781|NCT00351819|80966399|FG000|Overall Study|Lost to Follow-up|4|||
27764782|NCT00351819|80966400|FG001|Overall Study|Lost to Follow-up|4|||
27764783|NCT00351819|80966399|FG000|Overall Study|Withdrawal by Subject|0|||
27764784|NCT00351819|80966400|FG001|Overall Study|Withdrawal by Subject|4|||
27764785|NCT00351819|80966399|FG000|Overall Study|Elevated PSA|1|||
27764786|NCT00351819|80966400|FG001|Overall Study|Elevated PSA|1|||
27764787|NCT00351819|80966399|FG000|Overall Study|Traumatic ankle fracture|1|||
27764788|NCT00351819|80966400|FG001|Overall Study|Traumatic ankle fracture|0|||
27764789|NCT00351819|80966399|FG000|Overall Study|Unprofessional behavior|1|||
27764790|NCT00351819|80966400|FG001|Overall Study|Unprofessional behavior|0|||
27862073|NCT01755767|81326223|FG001|Overall Study|Subject Decision|0|||
27862074|NCT01755767|81326224|FG002|Overall Study|Subject Decision|10|||
27862075|NCT01755767|81326225|FG003|Overall Study|Subject Decision|3|||
27962348|NCT02243371|81695102|FG001|Overall Study|Withdrawal by Subject|2|||
27663180|NCT02391545|80603018|FG000|Overall Study|Other Reasons|6|||
27663181|NCT02391545|80603019|FG001|Overall Study|Other Reasons|4|||
27663182|NCT04043806|80603020|FG000|Overall Study|Commercial drug is available for participants|13|||
27663183|NCT04043806|80603020|FG000|Overall Study|Physician Decision|2|||
27663184|NCT04043806|80603020|FG000|Overall Study|Other|12|||
27663185|NCT04043806|80603020|FG000|Overall Study|Adverse Event|2|||
27663186|NCT04043806|80603020|FG000|Overall Study|Lost to Follow-up|6|||
27663187|NCT04043806|80603020|FG000|Overall Study|Other non-compliance|2|||
27663188|NCT04043806|80603020|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
27663189|NCT04043806|80603020|FG000|Overall Study|Never Dosed|1|||
27663190|NCT02979613|80603024|FG000|Double-Blind Phase|Withdrew Consent|2|||
27663191|NCT02979613|80603025|FG001|Double-Blind Phase|Withdrew Consent|4|||
27663192|NCT02979613|80603024|FG000|Double-Blind Phase|Pregnancy|2|||
27663193|NCT02979613|80603025|FG001|Double-Blind Phase|Pregnancy|2|||
27764791|NCT00351819|80966399|FG000|Overall Study|Non-compliance|0|||
27764792|NCT00351819|80966400|FG001|Overall Study|Non-compliance|1|||
27764793|NCT00351819|80966399|FG000|Overall Study|Incarcerated|0|||
27764794|NCT00351819|80966400|FG001|Overall Study|Incarcerated|1|||
27764795|NCT00351819|80966399|FG000|Overall Study|Enrolled in another trial|0|||
27764796|NCT00351819|80966400|FG001|Overall Study|Enrolled in another trial|1|||
27764797|NCT02016898|80966401|FG000|Overall Study|Death|1|||
27764798|NCT02016898|80966402|FG001|Overall Study|Death|1|||
27764799|NCT02016898|80966401|FG000|Overall Study|Lost to Follow-up|4|||
27764800|NCT02016898|80966402|FG001|Overall Study|Lost to Follow-up|4|||
27764801|NCT02917629|80966405|FG000|Overall Study|Withdrawal by Subject|0|||
27764802|NCT02917629|80966406|FG001|Overall Study|Withdrawal by Subject|1|||
27764803|NCT03587584|80966408|FG000|Overall Study|SOC deviations|4|||
27764804|NCT03587584|80966409|FG001|Overall Study|SOC deviations|6|||
27764805|NCT03587584|80966408|FG000|Overall Study|Incomplete data|0|||
27764806|NCT03587584|80966409|FG001|Overall Study|Incomplete data|3|||
27764807|NCT00391807|80966410|FG000|Overall Study|Did not receive study medication|23|||
27764808|NCT00391807|80966410|FG000|Overall Study|Adverse Event|177|||
27764809|NCT00391807|80966410|FG000|Overall Study|Pregnancy|25|||
27764810|NCT00391807|80966410|FG000|Overall Study|Lost to Follow-up|227|||
27764811|NCT00391807|80966410|FG000|Overall Study|Withdrawal by Subject|147|||
27764812|NCT00391807|80966410|FG000|Overall Study|Protocol Violation|20|||
27764813|NCT00391807|80966410|FG000|Overall Study|Various|96|||
27764814|NCT00282867|80966411|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
27764815|NCT00282867|80966412|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
27764816|NCT00282867|80966413|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
27764817|NCT00050960|80966414|FG000|Overall Study|Progressive Disease|137|||
27764818|NCT00050960|80966415|FG001|Overall Study|Progressive Disease|93|||
27764819|NCT00050960|80966414|FG000|Overall Study|Stable Disease|19|||
27764820|NCT00050960|80966415|FG001|Overall Study|Stable Disease|48|||
27764821|NCT00050960|80966414|FG000|Overall Study|Partial Response|14|||
27764822|NCT00050960|80966415|FG001|Overall Study|Partial Response|19|||
27764823|NCT00050960|80966414|FG000|Overall Study|Complete Response|0|||
27764824|NCT00050960|80966415|FG001|Overall Study|Complete Response|2|||
27764825|NCT00050960|80966414|FG000|Overall Study|Adverse Event|62|||
27764826|NCT00050960|80966415|FG001|Overall Study|Adverse Event|61|||
27764827|NCT00050960|80966414|FG000|Overall Study|Lost to Follow-up|0|||
27764828|NCT00050960|80966415|FG001|Overall Study|Lost to Follow-up|1|||
27764829|NCT00050960|80966414|FG000|Overall Study|Withdrawal by Subject|23|||
27764830|NCT00050960|80966415|FG001|Overall Study|Withdrawal by Subject|18|||
27764831|NCT00050960|80966414|FG000|Overall Study|Administrative|31|||
27764832|NCT00050960|80966415|FG001|Overall Study|Administrative|46|||
27764833|NCT00050960|80966414|FG000|Overall Study|Non-compliance|3|||
27764834|NCT00050960|80966415|FG001|Overall Study|Non-compliance|1|||
27764835|NCT00050960|80966414|FG000|Overall Study|Death|13|||
27764836|NCT00050960|80966415|FG001|Overall Study|Death|15|||
27764837|NCT01167153|80966421|FG000|Overall Study|Non-effective therapy|1|||
27764838|NCT01167153|80966422|FG001|Overall Study|Non-effective therapy|4|||
27764839|NCT01167153|80966421|FG000|Overall Study|AE including clinical laboratory AE|2|||
27764840|NCT01167153|80966422|FG001|Overall Study|AE including clinical laboratory AE|8|||
27764841|NCT01167153|80966421|FG000|Overall Study|Hypotension|1|||
27764842|NCT01167153|80966422|FG001|Overall Study|Hypotension|0|||
27764843|NCT01167153|80966421|FG000|Overall Study|Lost to Follow-up|7|||
27764844|NCT01167153|80966422|FG001|Overall Study|Lost to Follow-up|9|||
27764845|NCT01167153|80966421|FG000|Overall Study|Non-compliance to concomitant medication|0|||
27764846|NCT01167153|80966422|FG001|Overall Study|Non-compliance to concomitant medication|2|||
27764847|NCT01167153|80966421|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
27764848|NCT01167153|80966422|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
27764849|NCT01167153|80966421|FG000|Overall Study|Withdrawal consent|1|||
27764850|NCT01167153|80966422|FG001|Overall Study|Withdrawal consent|1|||
27962349|NCT02318368|81695103|FG000|Overall Study|Withdrawal by Subject|2|||
27962350|NCT02318368|81695104|FG001|Overall Study|Withdrawal by Subject|0|||
27764851|NCT01167153|80966421|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
27764852|NCT01167153|80966422|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
27764853|NCT01297309|80966423|FG000|Overall Study|Eligibility failure|2|||
27764854|NCT01297309|80966423|FG000|Overall Study|Screen failure|2|||
27962351|NCT02318368|81695103|FG000|Overall Study|Study terminated by the sponsor|5|||
27764855|NCT01297309|80966423|FG000|Overall Study|Withdrawal by Subject|5|||
27764856|NCT01297309|80966423|FG000|Overall Study|Adverse Event|1|||
27764857|NCT01297309|80966423|FG000|Overall Study|Investigator Decision|2|||
27764858|NCT01297309|80966423|FG000|Overall Study|Death|1|||
27764859|NCT01297309|80966423|FG000|Overall Study|Participant not entering extensionperiod|1|||
27764860|NCT02966353|80966426|FG000|Overall Study|Withdrawal by Subject|7|||
27764861|NCT02966353|80966426|FG000|Overall Study|Adverse Event|4|||
27764862|NCT02966353|80966426|FG000|Overall Study|Death|4|||
27764863|NCT02966353|80966426|FG000|Overall Study|Physician Decision|3|||
27764864|NCT02966353|80966426|FG000|Overall Study|Progressive disease|2|||
27764865|NCT02966353|80966426|FG000|Overall Study|Protocol deviation|2|||
27764866|NCT01188538|80966427|FG000|Overall Study|Lost to Follow-up|0|||
27764867|NCT01188538|80966428|FG001|Overall Study|Lost to Follow-up|1|||
27764868|NCT01504971|80966429|FG000|Overall Study|Physician Decision|13|||
27764869|NCT01998880|80966430|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
27764870|NCT01998880|80966431|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
27764871|NCT01998880|80966430|FG000|Overall Study|Disease Progression|1|||
27764872|NCT01998880|80966431|FG001|Overall Study|Disease Progression|8|||
27764873|NCT01998880|80966430|FG000|Overall Study|Withdrew Consent|2|||
27764874|NCT01998880|80966431|FG001|Overall Study|Withdrew Consent|1|||
27764875|NCT01998880|80966430|FG000|Overall Study|Death|3|||
27764876|NCT01998880|80966431|FG001|Overall Study|Death|6|||
27764877|NCT01998880|80966430|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27764878|NCT01998880|80966431|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27764879|NCT01998880|80966430|FG000|Overall Study|Administrative/Other|1|||
27764880|NCT01998880|80966431|FG001|Overall Study|Administrative/Other|1|||
27962352|NCT02318368|81695104|FG001|Overall Study|Study terminated by the sponsor|2|||
27962353|NCT02318368|81695103|FG000|Overall Study|Death|0|||
27962354|NCT02318368|81695104|FG001|Overall Study|Death|1|||
27962355|NCT00349349|81695105|FG000|Overall Study|Adverse Event|5|||
27962356|NCT00349349|81695106|FG001|Overall Study|Adverse Event|6|||
27962357|NCT00349349|81695107|FG002|Overall Study|Adverse Event|2|||
27962358|NCT00349349|81695105|FG000|Overall Study|Withdrawal by Subject|5|||
27962359|NCT00349349|81695106|FG001|Overall Study|Withdrawal by Subject|2|||
27962360|NCT00349349|81695107|FG002|Overall Study|Withdrawal by Subject|1|||
27962361|NCT00349349|81695105|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
27962362|NCT00349349|81695106|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
27962363|NCT00349349|81695107|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
27962364|NCT00349349|81695105|FG000|Overall Study|Death|13|||
27962365|NCT00349349|81695106|FG001|Overall Study|Death|10|||
27962366|NCT00349349|81695107|FG002|Overall Study|Death|1|||
27962367|NCT00349349|81695105|FG000|Overall Study|Other Treatment Selected|2|||
27962368|NCT00349349|81695106|FG001|Overall Study|Other Treatment Selected|0|||
27962369|NCT00349349|81695107|FG002|Overall Study|Other Treatment Selected|0|||
27962370|NCT00349349|81695105|FG000|Overall Study|Participant Reduced General Condition|0|||
27962371|NCT00349349|81695106|FG001|Overall Study|Participant Reduced General Condition|1|||
27962372|NCT00349349|81695107|FG002|Overall Study|Participant Reduced General Condition|0|||
27962373|NCT00349349|81695105|FG000|Overall Study|Physician Decision|1|||
27568836|NCT02347527|80271463|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
27663194|NCT02979613|80603024|FG000|Double-Blind Phase|Adverse Event|2|||
27663195|NCT02979613|80603025|FG001|Double-Blind Phase|Adverse Event|0|||
27663196|NCT02979613|80603024|FG000|Double-Blind Phase|Lost to Follow-up|1|||
27663197|NCT02979613|80603025|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27663198|NCT02979613|80603024|FG000|Double-Blind Phase|Protocol Violation|1|||
27663199|NCT02979613|80603025|FG001|Double-Blind Phase|Protocol Violation|1|||
27663200|NCT02979613|80603024|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
27663201|NCT02979613|80603025|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
27663202|NCT02979613|80603024|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
27663203|NCT02979613|80603025|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
27663204|NCT02979613|80603024|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
27663205|NCT02979613|80603025|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
27663206|NCT02979613|80603024|FG000|Open-Label Extension (OLE) Phase|Death|0|||
27663207|NCT02979613|80603025|FG001|Open-Label Extension (OLE) Phase|Death|1|||
27663208|NCT02979613|80603024|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
27663209|NCT02979613|80603025|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
27663210|NCT01276509|80603026|FG000|Overall Study|Adverse Event|9|||
27663211|NCT01276509|80603027|FG001|Overall Study|Adverse Event|8|||
27663212|NCT01276509|80603028|FG002|Overall Study|Adverse Event|4|||
27663213|NCT01276509|80603029|FG003|Overall Study|Adverse Event|3|||
27663214|NCT01276509|80603026|FG000|Overall Study|Lack of Efficacy|2|||
27663215|NCT01276509|80603027|FG001|Overall Study|Lack of Efficacy|1|||
27663216|NCT01276509|80603028|FG002|Overall Study|Lack of Efficacy|1|||
27663217|NCT01276509|80603029|FG003|Overall Study|Lack of Efficacy|2|||
27663218|NCT01276509|80603026|FG000|Overall Study|Pregnancy|1|||
27663219|NCT01276509|80603027|FG001|Overall Study|Pregnancy|0|||
27663220|NCT01276509|80603028|FG002|Overall Study|Pregnancy|0|||
27663221|NCT01276509|80603029|FG003|Overall Study|Pregnancy|0|||
27663222|NCT01276509|80603026|FG000|Overall Study|Withdrawal by Subject|1|||
27663223|NCT01276509|80603027|FG001|Overall Study|Withdrawal by Subject|2|||
27764881|NCT01998880|80966430|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
27764882|NCT01998880|80966431|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27764883|NCT01998880|80966430|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
27663224|NCT01276509|80603028|FG002|Overall Study|Withdrawal by Subject|0|||
27663225|NCT01276509|80603029|FG003|Overall Study|Withdrawal by Subject|0|||
27663226|NCT01276509|80603026|FG000|Overall Study|Other|0|||
27663227|NCT01276509|80603027|FG001|Overall Study|Other|1|||
27764884|NCT01998880|80966431|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27764885|NCT01998880|80966430|FG000|Overall Study|Did Not Receive Treatment|3|||
27764886|NCT01998880|80966431|FG001|Overall Study|Did Not Receive Treatment|2|||
27764887|NCT00141037|80966432|FG000|Overall Study|Physician Decision|1|||
27764888|NCT00141037|80966433|FG001|Overall Study|Physician Decision|2|||
27764889|NCT00141037|80966432|FG000|Overall Study|Lost to Follow-up|3|||
27764890|NCT00141037|80966433|FG001|Overall Study|Lost to Follow-up|1|||
27764891|NCT00141037|80966432|FG000|Overall Study|Protocol Violation|0|||
27764892|NCT00141037|80966433|FG001|Overall Study|Protocol Violation|2|||
27764893|NCT00141037|80966432|FG000|Overall Study|Withdrawal by Subject|2|||
27764894|NCT00141037|80966433|FG001|Overall Study|Withdrawal by Subject|1|||
27764895|NCT00141037|80966432|FG000|Overall Study|Other|0|||
27764896|NCT00141037|80966433|FG001|Overall Study|Other|1|||
27764897|NCT00141037|80966432|FG000|Overall Study|Moved from area|1|||
27764898|NCT00141037|80966433|FG001|Overall Study|Moved from area|7|||
27764899|NCT00141037|80966432|FG000|Overall Study|Graft Failure|3|||
27764900|NCT00141037|80966433|FG001|Overall Study|Graft Failure|4|||
27764901|NCT02939599|80966434|FG000|Overall Study|Adverse Event|1|||
27764902|NCT02939599|80966435|FG001|Overall Study|Adverse Event|0|||
27764903|NCT02939599|80966434|FG000|Overall Study|Study Terminated By Sponsor|2|||
27764904|NCT02939599|80966435|FG001|Overall Study|Study Terminated By Sponsor|2|||
27764905|NCT01924299|80966436|FG000|Period 2|Withdrawal by Subject|1|||
27764906|NCT01924299|80966437|FG001|Period 2|Withdrawal by Subject|0|||
27764907|NCT01924299|80966436|FG000|Period 2|Adverse Event|0|||
27764908|NCT01924299|80966437|FG001|Period 2|Adverse Event|1|||
27764909|NCT00605722|80966438|FG000|Overall Study|Adverse Event|6|||
27764910|NCT00605722|80966438|FG000|Overall Study|Insufficient therapeutic response|44|||
27764911|NCT00605722|80966438|FG000|Overall Study|Failure to return|1|||
27764912|NCT00089999|80966439|FG000|Overall Study|Adverse Event|4|||
27764913|NCT00089999|80966440|FG001|Overall Study|Adverse Event|7|||
27764914|NCT00089999|80966439|FG000|Overall Study|Withdrawal by Subject|0|||
27764915|NCT00089999|80966440|FG001|Overall Study|Withdrawal by Subject|4|||
27764916|NCT00089999|80966439|FG000|Overall Study|Lost to Follow-up|2|||
27764917|NCT00089999|80966440|FG001|Overall Study|Lost to Follow-up|1|||
27764918|NCT00089999|80966439|FG000|Overall Study|Radiological Progression of Cancer|52|||
27764919|NCT00089999|80966440|FG001|Overall Study|Radiological Progression of Cancer|44|||
27764920|NCT00089999|80966439|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
27764921|NCT00089999|80966440|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
27764922|NCT00089999|80966439|FG000|Overall Study|Death|3|||
27764923|NCT00089999|80966440|FG001|Overall Study|Death|3|||
27764924|NCT00089999|80966439|FG000|Overall Study|Poor General Condition|1|||
27764925|NCT00089999|80966440|FG001|Overall Study|Poor General Condition|0|||
27764926|NCT00089999|80966439|FG000|Overall Study|Clinical Progression|1|||
27764927|NCT00089999|80966440|FG001|Overall Study|Clinical Progression|2|||
27764928|NCT00089999|80966439|FG000|Overall Study|Physician Decision|2|||
27764929|NCT00089999|80966440|FG001|Overall Study|Physician Decision|2|||
27764930|NCT00089999|80966439|FG000|Overall Study|Patient Underwent Surgery|2|||
27764931|NCT00089999|80966440|FG001|Overall Study|Patient Underwent Surgery|0|||
27764932|NCT00089999|80966439|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
27764933|NCT00089999|80966440|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
27764934|NCT02924688|80966442|FG000|Overall Study|Adverse Event|9|||
27764935|NCT02924688|80966443|FG001|Overall Study|Adverse Event|3|||
27764936|NCT02924688|80966444|FG002|Overall Study|Adverse Event|2|||
27764937|NCT02924688|80966445|FG003|Overall Study|Adverse Event|2|||
27962374|NCT00349349|81695106|FG001|Overall Study|Physician Decision|2|||
27962375|NCT00349349|81695107|FG002|Overall Study|Physician Decision|1|||
27962376|NCT00349349|81695105|FG000|Overall Study|No Response|0|||
27962377|NCT00349349|81695106|FG001|Overall Study|No Response|3|||
27764938|NCT02924688|80966446|FG004|Overall Study|Adverse Event|3|||
27764939|NCT02924688|80966447|FG005|Overall Study|Adverse Event|2|||
27764940|NCT02924688|80966442|FG000|Overall Study|Lack of Efficacy|2|||
27764941|NCT02924688|80966443|FG001|Overall Study|Lack of Efficacy|3|||
27764942|NCT02924688|80966444|FG002|Overall Study|Lack of Efficacy|4|||
27764943|NCT02924688|80966445|FG003|Overall Study|Lack of Efficacy|2|||
27764944|NCT02924688|80966446|FG004|Overall Study|Lack of Efficacy|1|||
27764945|NCT02924688|80966447|FG005|Overall Study|Lack of Efficacy|1|||
27764946|NCT02924688|80966442|FG000|Overall Study|Protocol Violation|3|||
27764947|NCT02924688|80966443|FG001|Overall Study|Protocol Violation|7|||
27764948|NCT02924688|80966444|FG002|Overall Study|Protocol Violation|5|||
27764949|NCT02924688|80966445|FG003|Overall Study|Protocol Violation|6|||
27764950|NCT02924688|80966446|FG004|Overall Study|Protocol Violation|2|||
27764951|NCT02924688|80966447|FG005|Overall Study|Protocol Violation|2|||
27764952|NCT02924688|80966442|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
27764953|NCT02924688|80966443|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
27962378|NCT00349349|81695107|FG002|Overall Study|No Response|0|||
27962379|NCT00349349|81695105|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
27764954|NCT02924688|80966444|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
27764955|NCT02924688|80966445|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
27962380|NCT00349349|81695106|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
27962381|NCT00349349|81695107|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
27962382|NCT00682929|81695108|FG000|Overall Study|Adverse Event|4|||
27764956|NCT02924688|80966446|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
27862076|NCT01755767|81326222|FG000|Overall Study|Withdrawal by Subject|0|||
27764957|NCT02924688|80966447|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
27764958|NCT02924688|80966442|FG000|Overall Study|Lost to Follow-up|2|||
27764959|NCT02924688|80966443|FG001|Overall Study|Lost to Follow-up|4|||
27764960|NCT02924688|80966444|FG002|Overall Study|Lost to Follow-up|2|||
27764961|NCT02924688|80966445|FG003|Overall Study|Lost to Follow-up|4|||
27764962|NCT02924688|80966446|FG004|Overall Study|Lost to Follow-up|2|||
27764963|NCT02924688|80966447|FG005|Overall Study|Lost to Follow-up|4|||
27764964|NCT02924688|80966442|FG000|Overall Study|Physician Decision|2|||
27764965|NCT02924688|80966443|FG001|Overall Study|Physician Decision|1|||
27764966|NCT02924688|80966444|FG002|Overall Study|Physician Decision|0|||
27764967|NCT02924688|80966445|FG003|Overall Study|Physician Decision|1|||
27764968|NCT02924688|80966446|FG004|Overall Study|Physician Decision|1|||
27764969|NCT02924688|80966447|FG005|Overall Study|Physician Decision|1|||
27764970|NCT02924688|80966442|FG000|Overall Study|Withdrawal by Subject|14|||
27764971|NCT02924688|80966443|FG001|Overall Study|Withdrawal by Subject|13|||
27764972|NCT02924688|80966444|FG002|Overall Study|Withdrawal by Subject|9|||
27764973|NCT02924688|80966445|FG003|Overall Study|Withdrawal by Subject|12|||
27764974|NCT02924688|80966446|FG004|Overall Study|Withdrawal by Subject|13|||
27764975|NCT02924688|80966447|FG005|Overall Study|Withdrawal by Subject|14|||
27764976|NCT00924729|80966448|FG000|Overall Study|insufficient volume for analysis|1|||
27764977|NCT00924729|80966449|FG001|Overall Study|insufficient volume for analysis|0|||
27764978|NCT00924729|80966448|FG000|Overall Study|Protocol Violation|1|||
27764979|NCT00924729|80966449|FG001|Overall Study|Protocol Violation|0|||
27764980|NCT01828099|80966450|FG000|Overall Study|Adverse Event|15|||
27764981|NCT01828099|80966451|FG001|Overall Study|Adverse Event|18|||
27764982|NCT01828099|80966450|FG000|Overall Study|Death|9|||
27764983|NCT01828099|80966451|FG001|Overall Study|Death|11|||
27764984|NCT01828099|80966450|FG000|Overall Study|Lost to Follow-up|2|||
27764985|NCT01828099|80966451|FG001|Overall Study|Lost to Follow-up|0|||
27764986|NCT01828099|80966450|FG000|Overall Study|Non-compliance with study treatment|2|||
27764987|NCT01828099|80966451|FG001|Overall Study|Non-compliance with study treatment|0|||
27764988|NCT01828099|80966450|FG000|Overall Study|Physician Decision|7|||
27764989|NCT01828099|80966451|FG001|Overall Study|Physician Decision|11|||
27764990|NCT01828099|80966450|FG000|Overall Study|Progressive disease|51|||
27764991|NCT01828099|80966451|FG001|Overall Study|Progressive disease|94|||
27764992|NCT01828099|80966450|FG000|Overall Study|Protocol Violation|1|||
27764993|NCT01828099|80966451|FG001|Overall Study|Protocol Violation|0|||
27764994|NCT01828099|80966450|FG000|Overall Study|Subject/guardian decision|7|||
27764995|NCT01828099|80966451|FG001|Overall Study|Subject/guardian decision|23|||
27764996|NCT03326869|80966456|FG000|Overall Study|Study data has been lost to natural disa|1|||
27764997|NCT03326869|80966457|FG001|Overall Study|Study data has been lost to natural disa|1|||
27764998|NCT01522443|80966458|FG000|Overall Study|No longer receiving clinical benefit|36|||
27764999|NCT01522443|80966459|FG001|Overall Study|No longer receiving clinical benefit|28|||
27765000|NCT01522443|80966458|FG000|Overall Study|Adverse Event|10|||
27765001|NCT01522443|80966459|FG001|Overall Study|Adverse Event|15|||
27765002|NCT01522443|80966458|FG000|Overall Study|Withdrawal by Subject|5|||
27765003|NCT01522443|80966459|FG001|Overall Study|Withdrawal by Subject|8|||
27765004|NCT01522443|80966458|FG000|Overall Study|No study treatment given|1|||
27765005|NCT01522443|80966459|FG001|Overall Study|No study treatment given|1|||
27765006|NCT01522443|80966458|FG000|Overall Study|Other|1|||
27765007|NCT01522443|80966459|FG001|Overall Study|Other|3|||
27765008|NCT00994162|80966462|FG000|Overall Study|Withdrawal by Subject|1|||
27765009|NCT00994162|80966462|FG000|Overall Study|Lost to Follow-up|2|||
27765010|NCT00994162|80966462|FG000|Overall Study|Product Complaint|1|||
27765011|NCT00994162|80966462|FG000|Overall Study|Poor Compliance|5|||
27765012|NCT00994162|80966462|FG000|Overall Study|Lack of Response|3|||
27765013|NCT00994162|80966462|FG000|Overall Study|Discharged from Hospital|4|||
27765014|NCT00994162|80966462|FG000|Overall Study|Death|2|||
27765015|NCT00994162|80966462|FG000|Overall Study|Care Transferred to Another Physician|2|||
27765016|NCT00994162|80966462|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
27765017|NCT00994162|80966462|FG000|Overall Study|Physician Decision|2|||
27765018|NCT00994162|80966462|FG000|Overall Study|Surrounding Wound Erythematous|1|||
27862077|NCT01755767|81326223|FG001|Overall Study|Withdrawal by Subject|0|||
27765019|NCT00994162|80966462|FG000|Overall Study|Machine Losing Vaccum|1|||
27765020|NCT00994162|80966462|FG000|Overall Study|Patient Lived Too Far Away|1|||
27765021|NCT00994162|80966462|FG000|Overall Study|Above Knee Amputation|1|||
27862078|NCT01755767|81326224|FG002|Overall Study|Withdrawal by Subject|2|||
27862079|NCT01755767|81326225|FG003|Overall Study|Withdrawal by Subject|1|||
27765022|NCT00994162|80966462|FG000|Overall Study|Reason Not Reported By Site|1|||
27765023|NCT02267278|80966464|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
27962383|NCT00682929|81695109|FG001|Overall Study|Adverse Event|1|||
27862080|NCT01755767|81326222|FG000|Overall Study|Other|0|||
27962384|NCT00682929|81695110|FG002|Overall Study|Adverse Event|1|||
27765024|NCT02267278|80966464|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
27765025|NCT02267278|80966464|FG000|Overall Study|Developed new cancer diagnoses|2|||
27765026|NCT02267278|80966464|FG000|Overall Study|prescribed prohibited medication|1|||
27765027|NCT03351478|80966465|FG000|Overall Study|At the subject's own request|11|||
27765028|NCT03351478|80966466|FG001|Overall Study|At the subject's own request|12|||
27765029|NCT03351478|80966467|FG002|Overall Study|At the subject's own request|5|||
27765030|NCT03351478|80966465|FG000|Overall Study|Adverse Event|1|||
27765031|NCT03351478|80966466|FG001|Overall Study|Adverse Event|2|||
27765032|NCT03351478|80966467|FG002|Overall Study|Adverse Event|1|||
27765033|NCT03351478|80966465|FG000|Overall Study|Poor compliance to protocol|1|||
27765034|NCT03351478|80966466|FG001|Overall Study|Poor compliance to protocol|0|||
27765035|NCT03351478|80966467|FG002|Overall Study|Poor compliance to protocol|0|||
27765036|NCT03351478|80966465|FG000|Overall Study|Reason not Specified|1|||
27765037|NCT03351478|80966466|FG001|Overall Study|Reason not Specified|3|||
27765038|NCT03351478|80966467|FG002|Overall Study|Reason not Specified|0|||
27765039|NCT03351478|80966465|FG000|Overall Study|Lost to Follow-up|0|||
27765040|NCT03351478|80966466|FG001|Overall Study|Lost to Follow-up|0|||
27765041|NCT03351478|80966467|FG002|Overall Study|Lost to Follow-up|1|||
27765042|NCT00510484|80966471|FG000|Wash-out Period|Adverse Event|0|||
27765043|NCT00510484|80966472|FG001|Wash-out Period|Adverse Event|1|||
27765044|NCT01142193|80966473|FG000|Overall Study|Adverse Event|12|||
27765045|NCT01142193|80966474|FG001|Overall Study|Adverse Event|4|||
27765046|NCT01142193|80966473|FG000|Overall Study|Lack of Efficacy|2|||
27765047|NCT01142193|80966474|FG001|Overall Study|Lack of Efficacy|1|||
27765048|NCT01142193|80966473|FG000|Overall Study|Physician Decision|1|||
27765049|NCT01142193|80966474|FG001|Overall Study|Physician Decision|1|||
27765050|NCT01142193|80966473|FG000|Overall Study|Withdrawal by Subject|4|||
27765051|NCT01142193|80966474|FG001|Overall Study|Withdrawal by Subject|3|||
27765052|NCT01142193|80966473|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
27765053|NCT01142193|80966474|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
27765054|NCT01142193|80966473|FG000|Overall Study|Other|1|||
27765055|NCT01142193|80966474|FG001|Overall Study|Other|2|||
27765056|NCT02899377|80966478|FG000|Overall Study|Adverse Event|1|||
27765057|NCT02899377|80966479|FG001|Overall Study|Adverse Event|0|||
27765058|NCT03549117|80966480|FG000|Overall Study|Withdrawal by Subject|1|||
27765059|NCT03549117|80966481|FG001|Overall Study|Withdrawal by Subject|0|||
27765060|NCT03097029|80966482|FG000|Overall Study|Withdrawal by Subject|1|||
27765061|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
27765062|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
27765063|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
27765064|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
27765065|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
27765066|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
27765067|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
27765068|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
27765069|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
27765070|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
27765071|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27765072|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27765073|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27765074|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
27765075|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
27765076|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
27765077|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
27765078|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
27765079|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
27962385|NCT00682929|81695108|FG000|Overall Study|Withdrawal by Subject|1|||
27962386|NCT00682929|81695109|FG001|Overall Study|Withdrawal by Subject|2|||
27962387|NCT00682929|81695110|FG002|Overall Study|Withdrawal by Subject|1|||
27765080|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
27765081|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
27765082|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
27765083|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
27765084|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
27765085|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
27765086|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Other|1|||
27765087|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Other|0|||
27765088|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Other|0|||
27765089|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Other|0|||
27765090|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Other|1|||
27765091|NCT02980692|80966485|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
27765092|NCT02980692|80966486|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
27765093|NCT02980692|80966487|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
27765094|NCT02980692|80966488|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
27765095|NCT02980692|80966489|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
27765096|NCT02980692|80966485|FG000|Double-blind Follow-up Period|Adverse Event|0|||
27765097|NCT02980692|80966486|FG001|Double-blind Follow-up Period|Adverse Event|0|||
27765098|NCT02980692|80966487|FG002|Double-blind Follow-up Period|Adverse Event|0|||
27765099|NCT02980692|80966488|FG003|Double-blind Follow-up Period|Adverse Event|1|||
27765100|NCT02980692|80966489|FG004|Double-blind Follow-up Period|Adverse Event|1|||
27765101|NCT02980692|80966485|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
27765102|NCT02980692|80966486|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
27765103|NCT02980692|80966487|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
27765104|NCT02980692|80966488|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
27765105|NCT02980692|80966489|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
27765106|NCT02980692|80966485|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
27765107|NCT02980692|80966486|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
27765108|NCT02980692|80966487|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
27765109|NCT02980692|80966488|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
27765110|NCT02980692|80966489|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
27765111|NCT02980692|80966485|FG000|Double-blind Follow-up Period|Pregnancy|0|||
27765112|NCT02980692|80966486|FG001|Double-blind Follow-up Period|Pregnancy|0|||
27765113|NCT02980692|80966487|FG002|Double-blind Follow-up Period|Pregnancy|1|||
27765114|NCT02980692|80966488|FG003|Double-blind Follow-up Period|Pregnancy|1|||
27765115|NCT02980692|80966489|FG004|Double-blind Follow-up Period|Pregnancy|0|||
27765116|NCT02980692|80966485|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
27765117|NCT02980692|80966486|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
27765118|NCT02980692|80966487|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
27765119|NCT02980692|80966488|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
27765120|NCT02980692|80966489|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
27765121|NCT02980692|80966485|FG000|Double-blind Follow-up Period|Other|0|||
27765122|NCT02980692|80966486|FG001|Double-blind Follow-up Period|Other|0|||
27765123|NCT02980692|80966487|FG002|Double-blind Follow-up Period|Other|1|||
27765124|NCT02980692|80966488|FG003|Double-blind Follow-up Period|Other|1|||
27765125|NCT02980692|80966489|FG004|Double-blind Follow-up Period|Other|3|||
27765126|NCT01444898|80966490|FG000|Overall Study|Withdrawal by Subject|1|||
27765127|NCT04681729|80966491|FG000|Overall Study|Lack of Efficacy|2|||
27765128|NCT04681729|80966492|FG001|Overall Study|Lack of Efficacy|2|||
27765129|NCT04681729|80966491|FG000|Overall Study|Withdrawal by Subject|8|||
27765130|NCT04681729|80966492|FG001|Overall Study|Withdrawal by Subject|9|||
27765131|NCT02064205|80966497|FG000|Overall Study|Withdrawal by Subject|1|||
27765132|NCT00065442|80966498|FG000|Overall Study|Lost to Follow-up|1|||
27765133|NCT00065442|80966499|FG001|Overall Study|Lost to Follow-up|1|||
27765134|NCT00065442|80966498|FG000|Overall Study|Death|121|||
27765135|NCT00065442|80966499|FG001|Overall Study|Death|210|||
27765136|NCT00065442|80966498|FG000|Overall Study|Withdrawal by Subject|3|||
27765137|NCT00065442|80966499|FG001|Overall Study|Withdrawal by Subject|9|||
27765138|NCT00856986|80966502|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
27765139|NCT00856986|80966503|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
27765140|NCT00856986|80966504|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
27765141|NCT00856986|80966505|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
27765142|NCT00856986|80966506|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
27568837|NCT02347527|80271464|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
27568838|NCT02347527|80271465|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
27765143|NCT00856986|80966502|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27765144|NCT00856986|80966503|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27765145|NCT00856986|80966504|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27765146|NCT00856986|80966505|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
27765147|NCT00856986|80966506|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
27765148|NCT00856986|80966502|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27765149|NCT00856986|80966503|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27765150|NCT00856986|80966504|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27765151|NCT00856986|80966505|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
27765152|NCT00856986|80966506|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
27765153|NCT00856986|80966502|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27765154|NCT00856986|80966503|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27765155|NCT00856986|80966504|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27663228|NCT01276509|80603028|FG002|Overall Study|Other|0|||
27765156|NCT00856986|80966505|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
27765157|NCT00856986|80966506|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
27663229|NCT01276509|80603029|FG003|Overall Study|Other|0|||
27663230|NCT02604342|80603030|FG000|Overall Study|Death|32|||
27765158|NCT00856986|80966502|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27765159|NCT00856986|80966503|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27765160|NCT00856986|80966504|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27765161|NCT00856986|80966505|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
27765162|NCT00856986|80966506|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
27765163|NCT00856986|80966502|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
27765164|NCT00856986|80966503|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
27765165|NCT00856986|80966504|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
27765166|NCT00856986|80966505|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
27862081|NCT01755767|81326223|FG001|Overall Study|Other|0|||
27862082|NCT01755767|81326224|FG002|Overall Study|Other|2|||
27663231|NCT02604342|80603031|FG001|Overall Study|Death|16|||
27663232|NCT02604342|80603030|FG000|Overall Study|Progression of disease|1|||
27663233|NCT02604342|80603031|FG001|Overall Study|Progression of disease|0|||
27663234|NCT02604342|80603030|FG000|Overall Study|Withdrawal by Subject|5|||
27663235|NCT02604342|80603031|FG001|Overall Study|Withdrawal by Subject|6|||
27663236|NCT02604342|80603030|FG000|Overall Study|Other|1|||
27663237|NCT02604342|80603031|FG001|Overall Study|Other|0|||
27663238|NCT02604342|80603030|FG000|Overall Study|Study Termination by Sponsor|1|||
27663239|NCT02604342|80603031|FG001|Overall Study|Study Termination by Sponsor|0|||
27663240|NCT02604342|80603030|FG000|Overall Study|Lost to Follow-up|1|||
27663241|NCT02604342|80603031|FG001|Overall Study|Lost to Follow-up|1|||
27663242|NCT02604342|80603030|FG000|Overall Study|Physician Decision|2|||
27663243|NCT02604342|80603031|FG001|Overall Study|Physician Decision|0|||
27663244|NCT00385697|80603032|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
27663245|NCT00385697|80603033|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
27663246|NCT00385697|80603034|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
27663247|NCT00385697|80603035|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
27663248|NCT00385697|80603036|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
27663249|NCT00385697|80603032|FG000|Open-label Segment 1|Lost to Follow-up|1|||
27663250|NCT00385697|80603033|FG001|Open-label Segment 1|Lost to Follow-up|0|||
27663251|NCT00385697|80603034|FG002|Open-label Segment 1|Lost to Follow-up|0|||
27663252|NCT00385697|80603035|FG003|Open-label Segment 1|Lost to Follow-up|0|||
27663253|NCT00385697|80603036|FG004|Open-label Segment 1|Lost to Follow-up|0|||
27663254|NCT00385697|80603032|FG000|Double-blind Segment 2|Adverse Event|0|||
27663255|NCT00385697|80603033|FG001|Double-blind Segment 2|Adverse Event|3|||
27663256|NCT00385697|80603034|FG002|Double-blind Segment 2|Adverse Event|1|||
27663257|NCT00385697|80603035|FG003|Double-blind Segment 2|Adverse Event|0|||
27663258|NCT00385697|80603036|FG004|Double-blind Segment 2|Adverse Event|0|||
27663259|NCT00385697|80603032|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
27663260|NCT00385697|80603033|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
27663261|NCT00385697|80603034|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
27663262|NCT00385697|80603035|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
27663263|NCT00385697|80603036|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
27663264|NCT00385697|80603032|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
27663265|NCT00385697|80603033|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
27663266|NCT00385697|80603034|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
27663267|NCT00385697|80603035|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
27663268|NCT00385697|80603036|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
27663269|NCT00385697|80603032|FG000|Double-blind Segment 2|Other|0|||
27663270|NCT00385697|80603033|FG001|Double-blind Segment 2|Other|2|||
27663271|NCT00385697|80603034|FG002|Double-blind Segment 2|Other|0|||
27663272|NCT00385697|80603035|FG003|Double-blind Segment 2|Other|0|||
27663273|NCT00385697|80603036|FG004|Double-blind Segment 2|Other|0|||
27663274|NCT01670188|80603037|FG000|Overall Study|Death|0|||
27663275|NCT01670188|80603038|FG001|Overall Study|Death|1|||
27663276|NCT01954771|80603042|FG000|Overall Study|Missing HbA1c of end-point|1|||
27663277|NCT01954771|80603043|FG001|Overall Study|Missing HbA1c of end-point|1|||
27663278|NCT01954771|80603044|FG002|Overall Study|Missing HbA1c of end-point|0|||
27663279|NCT01954771|80603042|FG000|Overall Study|Missing CGMS of end-point|1|||
27663280|NCT01954771|80603043|FG001|Overall Study|Missing CGMS of end-point|1|||
27663281|NCT01954771|80603044|FG002|Overall Study|Missing CGMS of end-point|0|||
27663282|NCT01954771|80603042|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
27663283|NCT01954771|80603043|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
27765167|NCT00856986|80966506|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
27765168|NCT00856986|80966502|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
27765169|NCT00856986|80966503|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
27765170|NCT00856986|80966504|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
27862083|NCT01755767|81326225|FG003|Overall Study|Other|3|||
27663284|NCT01954771|80603044|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
27663285|NCT02600897|80603045|FG000|Overall Study|Death|1|||
27663286|NCT02600897|80603046|FG001|Overall Study|Death|2|||
27962388|NCT00682929|81695108|FG000|Overall Study|dosing compliance < 80%|0|||
27962389|NCT00682929|81695109|FG001|Overall Study|dosing compliance < 80%|2|||
27962390|NCT00682929|81695110|FG002|Overall Study|dosing compliance < 80%|0|||
27962391|NCT00682929|81695108|FG000|Overall Study|lag in DEA renewal|1|||
27962392|NCT00682929|81695109|FG001|Overall Study|lag in DEA renewal|0|||
27962393|NCT00682929|81695110|FG002|Overall Study|lag in DEA renewal|0|||
27962394|NCT05002985|81695112|FG000|Overall Study|Withdrawal by Subject|1|||
27962395|NCT03148275|81695113|FG000|Overall Study|Death|6|||
27962396|NCT03148275|81695113|FG000|Overall Study|Adverse Event|3|||
27962397|NCT03148275|81695113|FG000|Overall Study|Liver transplant|2|||
27962398|NCT03148275|81695113|FG000|Overall Study|Patient decision|5|||
27962399|NCT03148275|81695113|FG000|Overall Study|transition to commercial drug|1|||
27962400|NCT03148275|81695113|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
27962401|NCT00161616|81695114|FG000|Overall Study|Withdrawal by Subject|6|||
27962402|NCT00161616|81695115|FG001|Overall Study|Withdrawal by Subject|5|||
27663287|NCT02600897|80603047|FG002|Overall Study|Death|1|||
27663288|NCT02600897|80603048|FG003|Overall Study|Death|2|||
27663289|NCT02600897|80603049|FG004|Overall Study|Death|3|||
27663290|NCT02600897|80603050|FG005|Overall Study|Death|2|||
27663291|NCT02600897|80603051|FG006|Overall Study|Death|10|||
27663292|NCT02600897|80603052|FG007|Overall Study|Death|7|||
27663293|NCT02600897|80603053|FG008|Overall Study|Death|20|||
27663294|NCT02600897|80603045|FG000|Overall Study|Lost to Follow-up|1|||
27663295|NCT02600897|80603046|FG001|Overall Study|Lost to Follow-up|0|||
27663296|NCT02600897|80603047|FG002|Overall Study|Lost to Follow-up|0|||
27663297|NCT02600897|80603048|FG003|Overall Study|Lost to Follow-up|0|||
27663298|NCT02600897|80603049|FG004|Overall Study|Lost to Follow-up|0|||
27663299|NCT02600897|80603050|FG005|Overall Study|Lost to Follow-up|0|||
27663300|NCT02600897|80603051|FG006|Overall Study|Lost to Follow-up|0|||
27663301|NCT02600897|80603052|FG007|Overall Study|Lost to Follow-up|1|||
27663302|NCT02600897|80603053|FG008|Overall Study|Lost to Follow-up|0|||
27663303|NCT02600897|80603045|FG000|Overall Study|Withdrawal by Subject|0|||
27663304|NCT02600897|80603046|FG001|Overall Study|Withdrawal by Subject|0|||
27663305|NCT02600897|80603047|FG002|Overall Study|Withdrawal by Subject|0|||
27663306|NCT02600897|80603048|FG003|Overall Study|Withdrawal by Subject|0|||
27663307|NCT02600897|80603049|FG004|Overall Study|Withdrawal by Subject|0|||
27663308|NCT02600897|80603050|FG005|Overall Study|Withdrawal by Subject|0|||
27663309|NCT02600897|80603051|FG006|Overall Study|Withdrawal by Subject|0|||
27663310|NCT02600897|80603052|FG007|Overall Study|Withdrawal by Subject|4|||
27663311|NCT02600897|80603053|FG008|Overall Study|Withdrawal by Subject|2|||
27663312|NCT02600897|80603045|FG000|Overall Study|Reason Not Specified|0|||
27663313|NCT02600897|80603046|FG001|Overall Study|Reason Not Specified|0|||
27663314|NCT02600897|80603047|FG002|Overall Study|Reason Not Specified|0|||
27663315|NCT02600897|80603048|FG003|Overall Study|Reason Not Specified|0|||
27663316|NCT02600897|80603049|FG004|Overall Study|Reason Not Specified|0|||
27663317|NCT02600897|80603050|FG005|Overall Study|Reason Not Specified|0|||
27663318|NCT02600897|80603051|FG006|Overall Study|Reason Not Specified|0|||
27663319|NCT02600897|80603052|FG007|Overall Study|Reason Not Specified|0|||
27663320|NCT02600897|80603053|FG008|Overall Study|Reason Not Specified|1|||
27663321|NCT01592383|80603054|FG000|Overall Study|Adverse Event|1|||
27663322|NCT01177137|80606400|FG000|Overall Study|Withdrawal by Subject|10|||
27663323|NCT01177137|80606401|FG001|Overall Study|Withdrawal by Subject|10|||
27663324|NCT01177137|80606402|FG002|Overall Study|Withdrawal by Subject|2|||
27663325|NCT03175198|80606403|FG000|Overall Study|Adverse Event|480|||
27663326|NCT03175198|80606403|FG000|Overall Study|No actual visit|120|||
27663327|NCT03175198|80606403|FG000|Overall Study|Registration rule not followed|4|||
27663328|NCT03175198|80606403|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
27663329|NCT03175198|80606403|FG000|Overall Study|Other personal reason|509|||
27663330|NCT03175198|80606403|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
27663331|NCT03175198|80606403|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
27663332|NCT03175198|80606403|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
27663333|NCT03175198|80606403|FG000|Overall Study|To conduct invasive treatment of operation|53|||
27663334|NCT03175198|80606403|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
27663335|NCT03840200|80606411|FG000|Overall Study|Death|6|||
27663336|NCT03840200|80606412|FG001|Overall Study|Death|3|||
27663337|NCT03840200|80606413|FG002|Overall Study|Death|6|||
27663338|NCT03840200|80606414|FG003|Overall Study|Death|10|||
27663339|NCT03840200|80606411|FG000|Overall Study|Reason Not Specified|2|||
27663340|NCT03840200|80606412|FG001|Overall Study|Reason Not Specified|2|||
27663341|NCT03840200|80606413|FG002|Overall Study|Reason Not Specified|1|||
27663342|NCT03840200|80606414|FG003|Overall Study|Reason Not Specified|15|||
27663343|NCT03840200|80606411|FG000|Overall Study|Physician Decision|0|||
27663344|NCT03840200|80606412|FG001|Overall Study|Physician Decision|0|||
27663345|NCT03840200|80606413|FG002|Overall Study|Physician Decision|0|||
27663346|NCT03840200|80606414|FG003|Overall Study|Physician Decision|2|||
27663347|NCT03840200|80606411|FG000|Overall Study|Progressive Disease|0|||
27962403|NCT00161616|81695114|FG000|Overall Study|Physician Decision|1|||
27765171|NCT00856986|80966505|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
27765172|NCT00856986|80966506|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
27765173|NCT00856986|80966502|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
27765174|NCT00856986|80966503|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
27765175|NCT00856986|80966504|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
27765176|NCT00856986|80966505|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
27765177|NCT00856986|80966506|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
27765178|NCT00856986|80966502|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
27765179|NCT00856986|80966503|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
27765180|NCT00856986|80966504|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
27765181|NCT00856986|80966505|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
27765182|NCT00856986|80966506|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
27765183|NCT00856986|80966502|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
27765184|NCT00856986|80966503|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
27765185|NCT00856986|80966504|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
27765186|NCT00856986|80966505|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
27765187|NCT00856986|80966506|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
27765188|NCT00856986|80966502|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
27765189|NCT00856986|80966503|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
27765190|NCT00856986|80966504|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
27765191|NCT00856986|80966505|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
27765192|NCT00856986|80966506|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
27765193|NCT00856986|80966502|FG000|Main Period, Weeks 0-26|Unclassified|7|||
27765194|NCT00856986|80966503|FG001|Main Period, Weeks 0-26|Unclassified|6|||
27765195|NCT00856986|80966504|FG002|Main Period, Weeks 0-26|Unclassified|7|||
27765196|NCT00856986|80966505|FG003|Main Period, Weeks 0-26|Unclassified|0|||
27765197|NCT00856986|80966506|FG004|Main Period, Weeks 0-26|Unclassified|0|||
27765198|NCT00856986|80966502|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
27765199|NCT00856986|80966503|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
27765200|NCT00856986|80966504|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
27765201|NCT00856986|80966505|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
27765202|NCT00856986|80966506|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
27765203|NCT00856986|80966502|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
27765204|NCT00856986|80966503|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
27765205|NCT00856986|80966504|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
27765206|NCT00856986|80966505|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
27765207|NCT00856986|80966506|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
27568839|NCT02347527|80271466|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
27568840|NCT02347527|80271463|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
27568841|NCT02347527|80271464|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
27765208|NCT00856986|80966502|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
27765209|NCT00856986|80966503|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
27765210|NCT00856986|80966504|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
27962404|NCT00161616|81695115|FG001|Overall Study|Physician Decision|0|||
27962405|NCT00161616|81695114|FG000|Overall Study|Death|1|||
27663348|NCT03840200|80606412|FG001|Overall Study|Progressive Disease|0|||
27765211|NCT00856986|80966505|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
27962406|NCT00161616|81695115|FG001|Overall Study|Death|1|||
27663349|NCT03840200|80606413|FG002|Overall Study|Progressive Disease|0|||
27663350|NCT03840200|80606414|FG003|Overall Study|Progressive Disease|1|||
27663351|NCT03840200|80606411|FG000|Overall Study|Withdrawal by Subject|0|||
27663352|NCT03840200|80606412|FG001|Overall Study|Withdrawal by Subject|1|||
27663353|NCT03840200|80606413|FG002|Overall Study|Withdrawal by Subject|0|||
27663354|NCT03840200|80606414|FG003|Overall Study|Withdrawal by Subject|2|||
27663355|NCT00255944|80606418|FG000|Overall Study|Lost to Follow-up|797|||
27663356|NCT00255944|80606419|FG001|Overall Study|Lost to Follow-up|834|||
27663357|NCT00651937|80606420|FG000|Overall Study|Withdrawal by Subject|4|||
27663358|NCT00651937|80606421|FG001|Overall Study|Withdrawal by Subject|1|||
27663359|NCT03022045|80606423|FG000|Overall Study|Adverse Event|0|||
27663360|NCT03022045|80606424|FG001|Overall Study|Adverse Event|1|||
27663361|NCT03022045|80606423|FG000|Overall Study|Withdrawal by Subject|1|||
27663362|NCT03022045|80606424|FG001|Overall Study|Withdrawal by Subject|1|||
27663363|NCT02250183|80606425|FG000|Overall Study|Withdrawal by Subject|2|||
27663364|NCT02250183|80606425|FG000|Overall Study|Adverse Event|5|||
27663365|NCT02250183|80606425|FG000|Overall Study|Lost to Follow-up|1|||
27663366|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
27765212|NCT00856986|80966506|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
27765213|NCT00856986|80966502|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
27765214|NCT00856986|80966503|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
27765215|NCT00856986|80966504|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
27765216|NCT00856986|80966505|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
27765217|NCT00856986|80966506|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
27765218|NCT00856986|80966502|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
27962407|NCT00161616|81695114|FG000|Overall Study|Lost to Follow-up|17|||
27962408|NCT00161616|81695115|FG001|Overall Study|Lost to Follow-up|13|||
27962409|NCT00161616|81695114|FG000|Overall Study|Protocol deviation|1|||
27962410|NCT00161616|81695115|FG001|Overall Study|Protocol deviation|0|||
27663367|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
27663368|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
27663369|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
27663370|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
27663371|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
27663372|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
27663373|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
27663374|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
27663375|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
27663376|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
27663377|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
27663378|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
27663379|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
27663380|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
27663381|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
27663382|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
27663383|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
27663384|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
27663385|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
27663386|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
27663387|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
27663388|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
27663389|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
27663390|NCT02269917|80606426|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
27663391|NCT02269917|80606427|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
27663392|NCT02269917|80606428|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
27663393|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
27663394|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
27663395|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
27663396|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
27663397|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
27663398|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
27663399|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27663400|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27663401|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
27663402|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27663403|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27663404|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
27663405|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
27663406|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
27663407|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
27663408|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
27663409|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
27663410|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
27663411|NCT02269917|80606426|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
27663412|NCT02269917|80606427|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
27663413|NCT02269917|80606428|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
27663414|NCT01747837|80606429|FG000|Overall Study|Lost to Follow-up|5|||
27663415|NCT01747837|80606430|FG001|Overall Study|Lost to Follow-up|2|||
27663416|NCT01747837|80606429|FG000|Overall Study|Death|4|||
27663417|NCT01747837|80606430|FG001|Overall Study|Death|4|||
27663418|NCT02287883|80606431|FG000|Overall Study|Death|8|||
27663419|NCT02287883|80606432|FG001|Overall Study|Death|7|||
27663420|NCT02287883|80606431|FG000|Overall Study|No longer eligible|222|||
27663421|NCT02287883|80606432|FG001|Overall Study|No longer eligible|182|||
27663422|NCT02287883|80606431|FG000|Overall Study|Non-response to survey|229|||
27663423|NCT02287883|80606432|FG001|Overall Study|Non-response to survey|237|||
27663424|NCT00069277|80606433|FG000|Overall Study|Adverse Event|3|||
27663425|NCT00069277|80606433|FG000|Overall Study|Withdrawal by Subject|1|||
27663426|NCT00069277|80606433|FG000|Overall Study|Progressive Disease|15|||
27663427|NCT00069277|80606433|FG000|Overall Study|Physician Decision|2|||
27663428|NCT03015181|80606434|FG000|Overall Study|Enrolled, but product never administered|1|||
27663429|NCT03015181|80606435|FG001|Overall Study|Enrolled, but product never administered|0|||
27862084|NCT01755767|81326222|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
27962411|NCT04830215|81695116|FG000|Overall Study|Adverse Event|6|||
27765219|NCT00856986|80966503|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
27765220|NCT00856986|80966504|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
27765221|NCT00856986|80966505|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
27765222|NCT00856986|80966506|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
27765223|NCT00856986|80966502|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
27765224|NCT00856986|80966503|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
27765225|NCT00856986|80966504|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
27765226|NCT00856986|80966505|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
27765227|NCT00856986|80966506|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
27765228|NCT01125293|80966507|FG000|Overall Study|Disease Progression|1|||
27765229|NCT01125293|80966508|FG001|Overall Study|Disease Progression|3|||
27765230|NCT01125293|80966509|FG002|Overall Study|Disease Progression|4|||
27765231|NCT01125293|80966510|FG003|Overall Study|Disease Progression|3|||
27765232|NCT01125293|80966511|FG004|Overall Study|Disease Progression|5|||
27765233|NCT01125293|80966512|FG005|Overall Study|Disease Progression|12|||
27765234|NCT01125293|80966507|FG000|Overall Study|Adverse Event|1|||
27765235|NCT01125293|80966508|FG001|Overall Study|Adverse Event|0|||
27765236|NCT01125293|80966509|FG002|Overall Study|Adverse Event|0|||
27765237|NCT01125293|80966510|FG003|Overall Study|Adverse Event|0|||
27765238|NCT01125293|80966511|FG004|Overall Study|Adverse Event|2|||
27765239|NCT01125293|80966512|FG005|Overall Study|Adverse Event|8|||
27765240|NCT01125293|80966507|FG000|Overall Study|Symptomatic Deterioration|1|||
27765241|NCT01125293|80966508|FG001|Overall Study|Symptomatic Deterioration|0|||
27765242|NCT01125293|80966509|FG002|Overall Study|Symptomatic Deterioration|0|||
27765243|NCT01125293|80966510|FG003|Overall Study|Symptomatic Deterioration|0|||
27765244|NCT01125293|80966511|FG004|Overall Study|Symptomatic Deterioration|0|||
27765245|NCT01125293|80966512|FG005|Overall Study|Symptomatic Deterioration|0|||
27765246|NCT01125293|80966507|FG000|Overall Study|Death|0|||
27765247|NCT01125293|80966508|FG001|Overall Study|Death|0|||
27765248|NCT01125293|80966509|FG002|Overall Study|Death|0|||
27765249|NCT01125293|80966510|FG003|Overall Study|Death|0|||
27765250|NCT01125293|80966511|FG004|Overall Study|Death|1|||
27765251|NCT01125293|80966512|FG005|Overall Study|Death|0|||
27765252|NCT01125293|80966507|FG000|Overall Study|Withdrawal by Subject|0|||
27765253|NCT01125293|80966508|FG001|Overall Study|Withdrawal by Subject|0|||
27765254|NCT01125293|80966509|FG002|Overall Study|Withdrawal by Subject|0|||
27765255|NCT01125293|80966510|FG003|Overall Study|Withdrawal by Subject|0|||
27765256|NCT01125293|80966511|FG004|Overall Study|Withdrawal by Subject|2|||
27765257|NCT01125293|80966512|FG005|Overall Study|Withdrawal by Subject|1|||
27765258|NCT01125293|80966507|FG000|Overall Study|Physician Decision|0|||
27765259|NCT01125293|80966508|FG001|Overall Study|Physician Decision|0|||
27765260|NCT01125293|80966509|FG002|Overall Study|Physician Decision|0|||
27765261|NCT01125293|80966510|FG003|Overall Study|Physician Decision|0|||
27765262|NCT01125293|80966511|FG004|Overall Study|Physician Decision|0|||
27765263|NCT01125293|80966512|FG005|Overall Study|Physician Decision|2|||
27765264|NCT00973622|80966513|FG000|Overall Study|did not attend MRI|14|||
27765265|NCT00973622|80966514|FG001|Overall Study|did not attend MRI|3|||
27765266|NCT00973622|80966513|FG000|Overall Study|did not pass MRI screen|6|||
27765267|NCT00973622|80966514|FG001|Overall Study|did not pass MRI screen|0|||
27765268|NCT00973622|80966513|FG000|Overall Study|did not complete rTMS sessions|11|||
27765269|NCT00973622|80966514|FG001|Overall Study|did not complete rTMS sessions|2|||
27765270|NCT00387348|80966515|FG000|Overall Study|Death|1|||
27765271|NCT00387348|80966516|FG001|Overall Study|Death|1|||
27765272|NCT00387348|80966517|FG002|Overall Study|Death|0|||
27765273|NCT00387348|80966515|FG000|Overall Study|Physician Decision|1|||
27765274|NCT00387348|80966516|FG001|Overall Study|Physician Decision|0|||
27765275|NCT00387348|80966517|FG002|Overall Study|Physician Decision|1|||
27765276|NCT00387348|80966515|FG000|Overall Study|Withdrawal by Subject|0|||
27765277|NCT00387348|80966516|FG001|Overall Study|Withdrawal by Subject|2|||
27765278|NCT00387348|80966517|FG002|Overall Study|Withdrawal by Subject|2|||
27765279|NCT00387348|80966515|FG000|Overall Study|Adverse Event|1|||
27765280|NCT00387348|80966516|FG001|Overall Study|Adverse Event|0|||
27765281|NCT00387348|80966517|FG002|Overall Study|Adverse Event|1|||
27765282|NCT01827319|80966520|FG000|Overall Study|Lost to Follow-up|3|||
27765283|NCT02137837|80966521|FG000|Overall Study|Adverse Event|0|||
27765284|NCT02137837|80966522|FG001|Overall Study|Adverse Event|2|||
27765285|NCT02137837|80966523|FG002|Overall Study|Adverse Event|1|||
27765286|NCT02137837|80966521|FG000|Overall Study|Refusal unrelated to adverse event|2|||
27765287|NCT02137837|80966522|FG001|Overall Study|Refusal unrelated to adverse event|2|||
27765288|NCT02137837|80966523|FG002|Overall Study|Refusal unrelated to adverse event|1|||
27765289|NCT02137837|80966521|FG000|Overall Study|Progression/relapse|9|||
27765290|NCT02137837|80966522|FG001|Overall Study|Progression/relapse|7|||
27765291|NCT02137837|80966523|FG002|Overall Study|Progression/relapse|7|||
27765292|NCT02137837|80966521|FG000|Overall Study|Not protocol specified|2|||
27765293|NCT02137837|80966522|FG001|Overall Study|Not protocol specified|1|||
27765294|NCT02137837|80966523|FG002|Overall Study|Not protocol specified|3|||
27765295|NCT00903370|80966524|FG000|Overall Study|Death|13|||
27765296|NCT00903370|80966525|FG001|Overall Study|Death|10|||
27765297|NCT00903370|80966524|FG000|Overall Study|Withdrawal by Subject|9|||
27765298|NCT00903370|80966525|FG001|Overall Study|Withdrawal by Subject|6|||
27765299|NCT00903370|80966524|FG000|Overall Study|Lost to Follow-up|6|||
27765300|NCT00903370|80966525|FG001|Overall Study|Lost to Follow-up|8|||
27765301|NCT04294095|80966529|FG000|Overall Study|Adverse Event|1|||
27765302|NCT04294095|80966530|FG001|Overall Study|Adverse Event|0|||
27765303|NCT01742078|80966537|FG000|Overall Study|Withdrawal by Subject|0|||
27765304|NCT01742078|80966538|FG001|Overall Study|Withdrawal by Subject|0|||
27765305|NCT01742078|80966539|FG002|Overall Study|Withdrawal by Subject|0|||
27765306|NCT01742078|80966540|FG003|Overall Study|Withdrawal by Subject|1|||
27765307|NCT01742078|80966541|FG004|Overall Study|Withdrawal by Subject|0|||
27765308|NCT01742078|80966542|FG005|Overall Study|Withdrawal by Subject|0|||
27765309|NCT01742078|80966543|FG006|Overall Study|Withdrawal by Subject|0|||
27765310|NCT01742078|80966544|FG007|Overall Study|Withdrawal by Subject|0|||
27765311|NCT01742078|80966545|FG008|Overall Study|Withdrawal by Subject|0|||
27765312|NCT00376246|80966550|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
27765313|NCT00376246|80966551|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
27765314|NCT00376246|80966550|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27765315|NCT00376246|80966551|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
27765316|NCT00376246|80966550|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
27765317|NCT00376246|80966551|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27765318|NCT00062647|80969489|FG000|Overall Study|Death|2|||
27765319|NCT00062647|80969490|FG001|Overall Study|Death|2|||
27765320|NCT00062647|80969489|FG000|Overall Study|Adverse Event|1|||
27765321|NCT00062647|80969490|FG001|Overall Study|Adverse Event|1|||
27765322|NCT00062647|80969489|FG000|Overall Study|Withdrawal by Subject|2|||
27765323|NCT00062647|80969490|FG001|Overall Study|Withdrawal by Subject|1|||
27765324|NCT00062647|80969489|FG000|Overall Study|Protocol Violation|1|||
27765325|NCT00062647|80969490|FG001|Overall Study|Protocol Violation|0|||
27765326|NCT00062647|80969489|FG000|Overall Study|Lost to Follow-up|1|||
27765327|NCT00062647|80969490|FG001|Overall Study|Lost to Follow-up|2|||
27765328|NCT00062647|80969489|FG000|Overall Study|Failed continuation criteria|4|||
27765329|NCT00062647|80969490|FG001|Overall Study|Failed continuation criteria|2|||
27765330|NCT00062647|80969489|FG000|Overall Study|Other|4|||
27765331|NCT00062647|80969490|FG001|Overall Study|Other|4|||
27862085|NCT01755767|81326223|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
27962412|NCT04830215|81695116|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
27962413|NCT04830215|81695116|FG000|Overall Study|Withdrawal by Subject|3|||
27962414|NCT04830215|81695116|FG000|Overall Study|Protocol Deviation|1|||
27568842|NCT02347527|80271465|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
27568843|NCT02347527|80271466|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
27765332|NCT00062647|80969489|FG000|Overall Study|Never received study treatment|1|||
27765333|NCT00062647|80969490|FG001|Overall Study|Never received study treatment|1|||
27765334|NCT00179517|80969491|FG000|Overall Study|Withdrawal by Subject|2|||
27765335|NCT00179517|80969492|FG001|Overall Study|Withdrawal by Subject|1|||
27765336|NCT03148756|80969499|FG000|Overall Study|Study Terminated|0|||
27765337|NCT03148756|80969500|FG001|Overall Study|Study Terminated|1|||
27765338|NCT02685995|80969502|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
27765339|NCT02685995|80969503|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
27765340|NCT00239356|80969504|FG000|Overall Study|Lack of Efficacy|1|||
27765341|NCT00239356|80969505|FG001|Overall Study|Lack of Efficacy|0|||
27765342|NCT00239356|80969504|FG000|Overall Study|Adverse Event|6|||
27765343|NCT00239356|80969505|FG001|Overall Study|Adverse Event|0|||
27862086|NCT01755767|81326224|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
27765344|NCT00239356|80969504|FG000|Overall Study|Withdrawal by Subject|15|||
27765345|NCT00239356|80969505|FG001|Overall Study|Withdrawal by Subject|6|||
27765346|NCT00239356|80969504|FG000|Overall Study|Lost to Follow-up|3|||
27765347|NCT00239356|80969505|FG001|Overall Study|Lost to Follow-up|0|||
27862087|NCT01755767|81326225|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
27862088|NCT02283983|81326226|FG000|Overall Study|Inclusion criteria not met|0|||
27862089|NCT02283983|81326227|FG001|Overall Study|Inclusion criteria not met|1|||
27862090|NCT02283983|81326226|FG000|Overall Study|Withdrawal by Subject|4|||
27862091|NCT02283983|81326227|FG001|Overall Study|Withdrawal by Subject|2|||
27862092|NCT02283983|81326226|FG000|Overall Study|Protocol Violation|0|||
27862093|NCT02283983|81326227|FG001|Overall Study|Protocol Violation|4|||
27862094|NCT02283983|81326226|FG000|Overall Study|Physician Decision|2|||
27862095|NCT02283983|81326227|FG001|Overall Study|Physician Decision|4|||
27862096|NCT02283983|81326226|FG000|Overall Study|Death|1|||
27862097|NCT02283983|81326227|FG001|Overall Study|Death|0|||
27862098|NCT02283983|81326226|FG000|Overall Study|Adverse Event|1|||
27862099|NCT02283983|81326227|FG001|Overall Study|Adverse Event|0|||
27862100|NCT02283983|81326226|FG000|Overall Study|Lost to Follow-up|9|||
27862101|NCT02283983|81326227|FG001|Overall Study|Lost to Follow-up|8|||
27862102|NCT02283983|81326226|FG000|Overall Study|Relapse|1|||
27862103|NCT02283983|81326227|FG001|Overall Study|Relapse|0|||
27765348|NCT00239356|80969504|FG000|Overall Study|poor/non-compliance|2|||
27765349|NCT00239356|80969505|FG001|Overall Study|poor/non-compliance|0|||
27765350|NCT00239356|80969504|FG000|Overall Study|Pregnancy|1|||
27765351|NCT00239356|80969505|FG001|Overall Study|Pregnancy|0|||
27765352|NCT00239356|80969504|FG000|Overall Study|Administrative reason|0|||
27765353|NCT00239356|80969505|FG001|Overall Study|Administrative reason|1|||
27765354|NCT00239356|80969504|FG000|Overall Study|Drug available on market|11|||
27765355|NCT00239356|80969505|FG001|Overall Study|Drug available on market|2|||
27765356|NCT00961116|80969506|FG000|Washout Period of 7 Days|Adverse Event|1|||
27765357|NCT00961116|80969507|FG001|Washout Period of 7 Days|Adverse Event|1|||
27765358|NCT00961116|80969506|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27765359|NCT00961116|80969507|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27765360|NCT00961116|80969506|FG000|Washout Period of 7 Days|Protocol Violation|0|||
27765361|NCT00961116|80969507|FG001|Washout Period of 7 Days|Protocol Violation|1|||
27765362|NCT01255306|80969508|FG000|Overall Study|Physician Decision|1|||
27765363|NCT01255306|80969509|FG001|Overall Study|Physician Decision|1|||
27765364|NCT02759562|80969510|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
27765365|NCT02759562|80969511|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
27765366|NCT02759562|80969510|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
27765367|NCT02759562|80969511|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
27765368|NCT01332019|80969512|FG000|Overall Study|Was Not Dosed|1|||
27765369|NCT01332019|80969513|FG001|Overall Study|Was Not Dosed|0|||
27765370|NCT01332019|80969512|FG000|Overall Study|Other|16|||
27765371|NCT01332019|80969513|FG001|Overall Study|Other|18|||
27765372|NCT01332019|80969512|FG000|Overall Study|Death|2|||
27765373|NCT01332019|80969513|FG001|Overall Study|Death|1|||
27765374|NCT01332019|80969512|FG000|Overall Study|Physician Decision|4|||
27765375|NCT01332019|80969513|FG001|Overall Study|Physician Decision|3|||
27765376|NCT01332019|80969512|FG000|Overall Study|Withdrawal by Subject|73|||
27765377|NCT01332019|80969513|FG001|Overall Study|Withdrawal by Subject|71|||
27765378|NCT01332019|80969512|FG000|Overall Study|Lost to Follow-up|4|||
27765379|NCT01332019|80969513|FG001|Overall Study|Lost to Follow-up|7|||
27765380|NCT01332019|80969512|FG000|Overall Study|Adverse Event|13|||
27862104|NCT03058289|81326228|FG000|Overall Study|Radiographic Deterioration|0|||
27862105|NCT03058289|81326229|FG001|Overall Study|Radiographic Deterioration|3|||
27962415|NCT02705105|81695117|FG000|Treatment|Objective Disease Progression|1|||
27962416|NCT02705105|81695118|FG001|Treatment|Objective Disease Progression|50|||
27962417|NCT02705105|81695117|FG000|Treatment|Withdrawal by Subject|3|||
27862106|NCT03058289|81326230|FG002|Overall Study|Radiographic Deterioration|1|||
27862107|NCT03058289|81326231|FG003|Overall Study|Radiographic Deterioration|2|||
27765381|NCT01332019|80969513|FG001|Overall Study|Adverse Event|22|||
27862108|NCT03058289|81326232|FG004|Overall Study|Radiographic Deterioration|6|||
27862109|NCT03058289|81326233|FG005|Overall Study|Radiographic Deterioration|3|||
27862110|NCT03058289|81326234|FG006|Overall Study|Radiographic Deterioration|0|||
27862111|NCT03058289|81326235|FG007|Overall Study|Radiographic Deterioration|4|||
27862112|NCT03058289|81326236|FG008|Overall Study|Radiographic Deterioration|2|||
27862113|NCT03058289|81326228|FG000|Overall Study|Adverse Event|2|||
27862114|NCT03058289|81326229|FG001|Overall Study|Adverse Event|0|||
27862115|NCT03058289|81326230|FG002|Overall Study|Adverse Event|1|||
27862116|NCT03058289|81326231|FG003|Overall Study|Adverse Event|3|||
27862117|NCT03058289|81326232|FG004|Overall Study|Adverse Event|1|||
27862118|NCT03058289|81326233|FG005|Overall Study|Adverse Event|0|||
27862119|NCT03058289|81326234|FG006|Overall Study|Adverse Event|1|||
27862120|NCT03058289|81326235|FG007|Overall Study|Adverse Event|3|||
27862121|NCT03058289|81326236|FG008|Overall Study|Adverse Event|0|||
27862122|NCT03058289|81326228|FG000|Overall Study|Withdrawal by Subject|0|||
27862123|NCT03058289|81326229|FG001|Overall Study|Withdrawal by Subject|0|||
27862124|NCT03058289|81326230|FG002|Overall Study|Withdrawal by Subject|0|||
27862125|NCT03058289|81326231|FG003|Overall Study|Withdrawal by Subject|2|||
27862126|NCT03058289|81326232|FG004|Overall Study|Withdrawal by Subject|0|||
27862127|NCT03058289|81326233|FG005|Overall Study|Withdrawal by Subject|2|||
27765382|NCT03841526|80969514|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
27765383|NCT03841526|80969515|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
27765384|NCT03841526|80969516|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
27765385|NCT03841526|80969517|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
27765386|NCT03841526|80969518|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
27765387|NCT03841526|80969519|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
27765388|NCT03841526|80969514|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
27765389|NCT03841526|80969515|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
27765390|NCT03841526|80969516|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
27765391|NCT03841526|80969517|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
27765392|NCT03841526|80969518|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
27765393|NCT03841526|80969519|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
27765394|NCT03841526|80969514|FG000|Outpatient Phase Treatment|Physician Decision|0|||
27862128|NCT03058289|81326234|FG006|Overall Study|Withdrawal by Subject|0|||
27862129|NCT03058289|81326235|FG007|Overall Study|Withdrawal by Subject|4|||
27765395|NCT03841526|80969515|FG001|Outpatient Phase Treatment|Physician Decision|1|||
27765396|NCT03841526|80969516|FG002|Outpatient Phase Treatment|Physician Decision|0|||
27765397|NCT03841526|80969517|FG003|Outpatient Phase Treatment|Physician Decision|0|||
27765398|NCT03841526|80969518|FG004|Outpatient Phase Treatment|Physician Decision|0|||
27765399|NCT03841526|80969519|FG005|Outpatient Phase Treatment|Physician Decision|0|||
27862130|NCT03058289|81326236|FG008|Overall Study|Withdrawal by Subject|1|||
27862131|NCT03058289|81326228|FG000|Overall Study|Physician Decision|1|||
27765400|NCT03841526|80969514|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
27765401|NCT03841526|80969515|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
27765402|NCT03841526|80969516|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
27765403|NCT03841526|80969517|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
27765404|NCT03841526|80969518|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
27765405|NCT03841526|80969519|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
27862132|NCT03058289|81326229|FG001|Overall Study|Physician Decision|0|||
27663430|NCT03015181|80606436|FG002|Overall Study|Enrolled, but product never administered|0|||
27663431|NCT03015181|80606437|FG003|Overall Study|Enrolled, but product never administered|0|||
27663432|NCT03015181|80606438|FG004|Overall Study|Enrolled, but product never administered|0|||
27663433|NCT03015181|80606439|FG005|Overall Study|Enrolled, but product never administered|0|||
27663434|NCT03015181|80606440|FG006|Overall Study|Enrolled, but product never administered|0|||
27663435|NCT03015181|80606434|FG000|Overall Study|Withdrawal by Subject|0|||
27663436|NCT03015181|80606435|FG001|Overall Study|Withdrawal by Subject|0|||
27663437|NCT03015181|80606436|FG002|Overall Study|Withdrawal by Subject|0|||
27663438|NCT03015181|80606437|FG003|Overall Study|Withdrawal by Subject|0|||
27663439|NCT03015181|80606438|FG004|Overall Study|Withdrawal by Subject|0|||
27663440|NCT03015181|80606439|FG005|Overall Study|Withdrawal by Subject|1|||
27663441|NCT03015181|80606440|FG006|Overall Study|Withdrawal by Subject|0|||
27663442|NCT03015181|80606434|FG000|Overall Study|Physician Decision|0|||
27663443|NCT03015181|80606435|FG001|Overall Study|Physician Decision|0|||
27663444|NCT03015181|80606436|FG002|Overall Study|Physician Decision|0|||
27663445|NCT03015181|80606437|FG003|Overall Study|Physician Decision|0|||
27663446|NCT03015181|80606438|FG004|Overall Study|Physician Decision|0|||
27862133|NCT03058289|81326230|FG002|Overall Study|Physician Decision|0|||
27862134|NCT03058289|81326231|FG003|Overall Study|Physician Decision|2|||
27862135|NCT03058289|81326232|FG004|Overall Study|Physician Decision|1|||
27862136|NCT03058289|81326233|FG005|Overall Study|Physician Decision|0|||
27862137|NCT03058289|81326234|FG006|Overall Study|Physician Decision|2|||
27862138|NCT03058289|81326235|FG007|Overall Study|Physician Decision|3|||
27862139|NCT03058289|81326236|FG008|Overall Study|Physician Decision|0|||
27862140|NCT03058289|81326228|FG000|Overall Study|Clinical Deterioration|2|||
27862141|NCT03058289|81326229|FG001|Overall Study|Clinical Deterioration|0|||
27862142|NCT03058289|81326230|FG002|Overall Study|Clinical Deterioration|0|||
27862143|NCT03058289|81326231|FG003|Overall Study|Clinical Deterioration|2|||
27862144|NCT03058289|81326232|FG004|Overall Study|Clinical Deterioration|1|||
27962418|NCT02705105|81695118|FG001|Treatment|Withdrawal by Subject|5|||
27962419|NCT02705105|81695117|FG000|Treatment|Adverse Event|0|||
27962420|NCT02705105|81695118|FG001|Treatment|Adverse Event|17|||
27962421|NCT02705105|81695117|FG000|Treatment|Clinical Disease Progression|0|||
27962422|NCT02705105|81695118|FG001|Treatment|Clinical Disease Progression|32|||
27962423|NCT02705105|81695117|FG000|Treatment|Physician Decision|0|||
27962424|NCT02705105|81695118|FG001|Treatment|Physician Decision|3|||
27962425|NCT02705105|81695117|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
27962426|NCT02705105|81695118|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
27962427|NCT02705105|81695117|FG000|Follow-Up|Death|3|||
27962428|NCT02705105|81695118|FG001|Follow-Up|Death|68|||
27962429|NCT02705105|81695117|FG000|Follow-Up|Withdrawal by Subject|1|||
27962430|NCT02705105|81695118|FG001|Follow-Up|Withdrawal by Subject|14|||
27962431|NCT02705105|81695117|FG000|Follow-Up|Study Terminated|0|||
27962432|NCT02705105|81695118|FG001|Follow-Up|Study Terminated|26|||
27962433|NCT02705105|81695117|FG000|Follow-Up|Discontinued per Amendment 3|0|||
27663447|NCT03015181|80606439|FG005|Overall Study|Physician Decision|0|||
27663448|NCT03015181|80606440|FG006|Overall Study|Physician Decision|1|||
27663449|NCT00510783|80606441|FG000|Overall Study|Lost to Follow-up|29|||
27663450|NCT00510783|80606442|FG001|Overall Study|Lost to Follow-up|25|||
27962434|NCT02705105|81695118|FG001|Follow-Up|Discontinued per Amendment 3|2|||
27962435|NCT00282087|81695119|FG000|Overall Study|Death|1|||
27962436|NCT02597452|81695125|FG000|Overall Study|testing incomplete|30|||
27663451|NCT00510783|80606441|FG000|Overall Study|Withdrawal by Subject|2|||
27663452|NCT00510783|80606442|FG001|Overall Study|Withdrawal by Subject|3|||
27663453|NCT00510783|80606441|FG000|Overall Study|Protocol Violation|0|||
27663454|NCT00510783|80606442|FG001|Overall Study|Protocol Violation|1|||
27765406|NCT03911869|80969520|FG000|Safety Lead-in Phase|Death|7|||
27765407|NCT03911869|80969521|FG001|Safety Lead-in Phase|Death|0|||
27962437|NCT01947283|81695126|FG000|Overall Study|Death|1|||
27962438|NCT01947283|81695127|FG001|Overall Study|Death|1|||
27962439|NCT01947283|81695128|FG002|Overall Study|Death|1|||
27962440|NCT01947283|81695129|FG003|Overall Study|Death|0|||
27962441|NCT01947283|81695130|FG004|Overall Study|Death|0|||
27765408|NCT03911869|80969522|FG002|Safety Lead-in Phase|Death|0|||
27765409|NCT03911869|80969520|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
27765410|NCT03911869|80969521|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
27765411|NCT03911869|80969522|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
27765412|NCT03911869|80969520|FG000|Safety Lead-in Phase|Other|1|||
27765413|NCT03911869|80969521|FG001|Safety Lead-in Phase|Other|0|||
27765414|NCT03911869|80969522|FG002|Safety Lead-in Phase|Other|0|||
27765415|NCT03911869|80969520|FG000|Phase 2|Death|0|||
27765416|NCT03911869|80969521|FG001|Phase 2|Death|3|||
27765417|NCT03911869|80969522|FG002|Phase 2|Death|0|||
27765418|NCT02514772|80969526|FG000|Overall Study|Adverse Event|1|||
27765419|NCT02514772|80969527|FG001|Overall Study|Adverse Event|0|||
27765420|NCT02514772|80969526|FG000|Overall Study|Death|0|||
27765421|NCT02514772|80969527|FG001|Overall Study|Death|1|||
27765422|NCT02514772|80969526|FG000|Overall Study|Withdrawal by Subject|2|||
27765423|NCT02514772|80969527|FG001|Overall Study|Withdrawal by Subject|1|||
27765424|NCT01467661|80969528|FG000|Overall Study|Adverse Event|16|||
27765425|NCT01467661|80969528|FG000|Overall Study|Withdrawal by Subject|1|||
27765426|NCT01467661|80969528|FG000|Overall Study|Lack of Efficacy|3|||
27765427|NCT01467661|80969528|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
27765428|NCT01563107|80969529|FG000|Overall Study|Physician Decision|0|||
27765429|NCT01563107|80969530|FG001|Overall Study|Physician Decision|1|||
27765430|NCT01563107|80969531|FG002|Overall Study|Physician Decision|1|||
27765431|NCT01563107|80969532|FG003|Overall Study|Physician Decision|3|||
27765432|NCT01563107|80969529|FG000|Overall Study|Withdrawal by Subject|1|||
27765433|NCT01563107|80969530|FG001|Overall Study|Withdrawal by Subject|2|||
27765434|NCT01563107|80969531|FG002|Overall Study|Withdrawal by Subject|1|||
27765435|NCT01563107|80969532|FG003|Overall Study|Withdrawal by Subject|2|||
27765436|NCT03673956|80969533|FG000|Overall Study|Lost to Follow-up|1|||
27765437|NCT03673956|80969534|FG001|Overall Study|Lost to Follow-up|0|||
27765438|NCT03673956|80969535|FG002|Overall Study|Lost to Follow-up|0|||
27765439|NCT03673956|80969536|FG003|Overall Study|Lost to Follow-up|0|||
27765440|NCT03673956|80969533|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
27765441|NCT03673956|80969534|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
27765442|NCT03673956|80969535|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
27765443|NCT03673956|80969536|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
27765444|NCT01814826|80969542|FG000|Overall Study|Other|3|||
27765445|NCT01814826|80969543|FG001|Overall Study|Other|5|||
27765446|NCT01814826|80969544|FG002|Overall Study|Other|0|||
27765447|NCT01814826|80969542|FG000|Overall Study|Death|29|||
27765448|NCT01814826|80969543|FG001|Overall Study|Death|24|||
27765449|NCT01814826|80969544|FG002|Overall Study|Death|3|||
27962442|NCT01947283|81695131|FG005|Overall Study|Death|0|||
27962443|NCT01947283|81695132|FG006|Overall Study|Death|0|||
27962444|NCT01947283|81695126|FG000|Overall Study|Lost to Follow-up|4|||
27962445|NCT01947283|81695127|FG001|Overall Study|Lost to Follow-up|6|||
27962446|NCT01947283|81695128|FG002|Overall Study|Lost to Follow-up|5|||
27962447|NCT01947283|81695129|FG003|Overall Study|Lost to Follow-up|5|||
27962448|NCT01947283|81695130|FG004|Overall Study|Lost to Follow-up|0|||
27765450|NCT01181778|80969546|FG000|Overall Study|Physician Decision|48|||
27765451|NCT05441540|80969550|FG000|Overall Study|Withdrawal by Subject|2|||
27765452|NCT00260429|80969552|FG000|Overall Study|failure to follow appointments|1|||
27765453|NCT00260429|80969553|FG001|Overall Study|failure to follow appointments|0|||
27765454|NCT00260429|80969552|FG000|Overall Study|scheduled hand surgery|1|||
27765455|NCT00260429|80969553|FG001|Overall Study|scheduled hand surgery|0|||
27765456|NCT03094611|80969554|FG000|Overall Study|Lack of Efficacy|1|||
27765457|NCT03094611|80969554|FG000|Overall Study|Stem Cell Transplant|1|||
27765458|NCT03820726|80969555|FG000|Overall Study|Other than listed|23|||
27862145|NCT03058289|81326233|FG005|Overall Study|Clinical Deterioration|1|||
27862146|NCT03058289|81326234|FG006|Overall Study|Clinical Deterioration|0|||
27862147|NCT03058289|81326235|FG007|Overall Study|Clinical Deterioration|3|||
27862148|NCT03058289|81326236|FG008|Overall Study|Clinical Deterioration|2|||
27862149|NCT03058289|81326228|FG000|Overall Study|Lost to Follow-up|0|||
27862150|NCT03058289|81326229|FG001|Overall Study|Lost to Follow-up|0|||
27862151|NCT03058289|81326230|FG002|Overall Study|Lost to Follow-up|0|||
27862152|NCT03058289|81326231|FG003|Overall Study|Lost to Follow-up|0|||
27862153|NCT03058289|81326232|FG004|Overall Study|Lost to Follow-up|1|||
27862154|NCT03058289|81326233|FG005|Overall Study|Lost to Follow-up|0|||
27862155|NCT03058289|81326234|FG006|Overall Study|Lost to Follow-up|0|||
27862156|NCT03058289|81326235|FG007|Overall Study|Lost to Follow-up|0|||
27862157|NCT03058289|81326236|FG008|Overall Study|Lost to Follow-up|0|||
27862158|NCT03058289|81326228|FG000|Overall Study|Refused Further Treatment|0|||
27862159|NCT03058289|81326229|FG001|Overall Study|Refused Further Treatment|0|||
27862160|NCT03058289|81326230|FG002|Overall Study|Refused Further Treatment|1|||
27862161|NCT03058289|81326231|FG003|Overall Study|Refused Further Treatment|0|||
27862162|NCT03058289|81326232|FG004|Overall Study|Refused Further Treatment|1|||
27862163|NCT03058289|81326233|FG005|Overall Study|Refused Further Treatment|0|||
27962449|NCT01947283|81695131|FG005|Overall Study|Lost to Follow-up|2|||
27962450|NCT01947283|81695132|FG006|Overall Study|Lost to Follow-up|5|||
27962451|NCT01947283|81695126|FG000|Overall Study|Withdrawal by Subject|10|||
27962452|NCT01947283|81695127|FG001|Overall Study|Withdrawal by Subject|8|||
27962453|NCT01947283|81695128|FG002|Overall Study|Withdrawal by Subject|4|||
27962454|NCT01947283|81695129|FG003|Overall Study|Withdrawal by Subject|1|||
27962455|NCT01947283|81695130|FG004|Overall Study|Withdrawal by Subject|0|||
27962456|NCT01947283|81695131|FG005|Overall Study|Withdrawal by Subject|0|||
27962457|NCT01947283|81695132|FG006|Overall Study|Withdrawal by Subject|2|||
27962458|NCT01947283|81695126|FG000|Overall Study|No Clinical Recording|12|||
27962459|NCT01947283|81695127|FG001|Overall Study|No Clinical Recording|6|||
27962460|NCT01947283|81695128|FG002|Overall Study|No Clinical Recording|8|||
27962461|NCT01947283|81695129|FG003|Overall Study|No Clinical Recording|10|||
27962462|NCT01947283|81695130|FG004|Overall Study|No Clinical Recording|0|||
27962463|NCT01947283|81695131|FG005|Overall Study|No Clinical Recording|0|||
27962464|NCT01947283|81695132|FG006|Overall Study|No Clinical Recording|0|||
27962465|NCT01947283|81695126|FG000|Overall Study|Non-coding Clinical Recording language|0|||
27962466|NCT01947283|81695127|FG001|Overall Study|Non-coding Clinical Recording language|0|||
27962467|NCT01947283|81695128|FG002|Overall Study|Non-coding Clinical Recording language|0|||
27962468|NCT01947283|81695129|FG003|Overall Study|Non-coding Clinical Recording language|1|||
27962469|NCT01947283|81695130|FG004|Overall Study|Non-coding Clinical Recording language|0|||
27962470|NCT01947283|81695131|FG005|Overall Study|Non-coding Clinical Recording language|0|||
27962471|NCT01947283|81695132|FG006|Overall Study|Non-coding Clinical Recording language|0|||
27962472|NCT01947283|81695126|FG000|Overall Study|Missing Follow-up Assessment|2|||
27962473|NCT01947283|81695127|FG001|Overall Study|Missing Follow-up Assessment|2|||
27962474|NCT01947283|81695128|FG002|Overall Study|Missing Follow-up Assessment|3|||
27962475|NCT01947283|81695129|FG003|Overall Study|Missing Follow-up Assessment|0|||
27962476|NCT01947283|81695130|FG004|Overall Study|Missing Follow-up Assessment|0|||
27962477|NCT01947283|81695131|FG005|Overall Study|Missing Follow-up Assessment|2|||
27962478|NCT01947283|81695132|FG006|Overall Study|Missing Follow-up Assessment|0|||
27962479|NCT01947283|81695126|FG000|Overall Study|No patients were enrolled in study|0|||
27962480|NCT01947283|81695127|FG001|Overall Study|No patients were enrolled in study|0|||
27962481|NCT01947283|81695128|FG002|Overall Study|No patients were enrolled in study|0|||
27962482|NCT01947283|81695129|FG003|Overall Study|No patients were enrolled in study|0|||
27962483|NCT01947283|81695130|FG004|Overall Study|No patients were enrolled in study|0|||
27962484|NCT01947283|81695131|FG005|Overall Study|No patients were enrolled in study|3|||
27962485|NCT01947283|81695132|FG006|Overall Study|No patients were enrolled in study|1|||
27962486|NCT01803880|81695144|FG000|Overall Study|Adverse Event|1|||
27962487|NCT01803880|81695145|FG001|Overall Study|Adverse Event|0|||
27962488|NCT01803880|81695146|FG002|Overall Study|Adverse Event|0|||
27962489|NCT01803880|81695144|FG000|Overall Study|Withdrawal by Subject|1|||
27962490|NCT01803880|81695145|FG001|Overall Study|Withdrawal by Subject|1|||
27962491|NCT01803880|81695146|FG002|Overall Study|Withdrawal by Subject|4|||
27962492|NCT01803880|81695144|FG000|Overall Study|Physician Decision|0|||
27962493|NCT01803880|81695145|FG001|Overall Study|Physician Decision|0|||
27962494|NCT01803880|81695146|FG002|Overall Study|Physician Decision|1|||
27962495|NCT01803880|81695144|FG000|Overall Study|Unable to return for follow-up visits|0|||
27962496|NCT01803880|81695145|FG001|Overall Study|Unable to return for follow-up visits|1|||
27962497|NCT01803880|81695146|FG002|Overall Study|Unable to return for follow-up visits|2|||
27962498|NCT01803880|81695144|FG000|Overall Study|Lost to Follow-up|1|||
27962499|NCT01803880|81695145|FG001|Overall Study|Lost to Follow-up|2|||
27962500|NCT01803880|81695146|FG002|Overall Study|Lost to Follow-up|3|||
27962501|NCT01803880|81695144|FG000|Overall Study|Protocol Violation|1|||
27962502|NCT01803880|81695145|FG001|Overall Study|Protocol Violation|0|||
27962503|NCT01803880|81695146|FG002|Overall Study|Protocol Violation|0|||
27962504|NCT01803880|81695144|FG000|Overall Study|Early study termination|0|||
27962505|NCT01803880|81695145|FG001|Overall Study|Early study termination|6|||
27962506|NCT01803880|81695146|FG002|Overall Study|Early study termination|5|||
27962507|NCT01803880|81695144|FG000|Overall Study|Incomplete data entry by sites|2|||
27962508|NCT01803880|81695145|FG001|Overall Study|Incomplete data entry by sites|0|||
27962509|NCT01803880|81695146|FG002|Overall Study|Incomplete data entry by sites|0|||
27962510|NCT01643408|81695157|FG000|Overall Study|Adverse Event|12|||
27962511|NCT01643408|81695157|FG000|Overall Study|Other|2|||
27962512|NCT01169701|81695159|FG000|Overall Study|Lost to Follow-up|1|||
27962513|NCT01169701|81695160|FG001|Overall Study|Lost to Follow-up|1|||
27962514|NCT01169701|81695159|FG000|Overall Study|Withdrawal by Subject|1|||
27962515|NCT01169701|81695160|FG001|Overall Study|Withdrawal by Subject|3|||
27962516|NCT01169701|81695159|FG000|Overall Study|Adverse Event|1|||
27962517|NCT01169701|81695160|FG001|Overall Study|Adverse Event|2|||
27962518|NCT01169701|81695159|FG000|Overall Study|Exclusion criteria|2|||
27962519|NCT01169701|81695160|FG001|Overall Study|Exclusion criteria|0|||
27962520|NCT01169701|81695159|FG000|Overall Study|Death|0|||
27962521|NCT01169701|81695160|FG001|Overall Study|Death|1|||
27962522|NCT01169701|81695159|FG000|Overall Study|Administrative problems|0|||
27962523|NCT01169701|81695160|FG001|Overall Study|Administrative problems|1|||
27962524|NCT01169701|81695159|FG000|Overall Study|Serious adverse event|0|||
27663455|NCT03746483|80606444|FG000|Overall Study|Adverse Event|0|||
27765459|NCT03820726|80969555|FG000|Overall Study|Withdrawal by Subject|37|||
27765460|NCT03820726|80969555|FG000|Overall Study|Lost to Follow-up|3|||
27765461|NCT03820726|80969555|FG000|Overall Study|Protocol deviation|1|||
27765462|NCT03820726|80969555|FG000|Overall Study|Adverse Event|146|||
27765463|NCT03820726|80969555|FG000|Overall Study|Not treated|1|||
27765464|NCT03039738|80969556|FG000|Overall Study|Incomplete data sets|54|||
27765465|NCT03039738|80969557|FG001|Overall Study|Incomplete data sets|0|||
27765466|NCT03136484|80969562|FG000|Overall Study|Withdrawal by Subject|19|||
27765467|NCT03136484|80969563|FG001|Overall Study|Withdrawal by Subject|14|||
27765468|NCT03136484|80969562|FG000|Overall Study|Lost to Follow-up|7|||
27765469|NCT03136484|80969563|FG001|Overall Study|Lost to Follow-up|8|||
27765470|NCT03136484|80969562|FG000|Overall Study|Death|1|||
27765471|NCT03136484|80969563|FG001|Overall Study|Death|0|||
27765472|NCT03363919|80969576|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
27765473|NCT03363919|80969577|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
27765474|NCT03363919|80969576|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
27765475|NCT03363919|80969577|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
27765476|NCT01162304|80969578|FG000|Overall Study|Beck scale to high|11|||
27765477|NCT03549429|80969582|FG000|Overall Study|Protocol Violation|5|||
27765478|NCT03549429|80969583|FG001|Overall Study|Protocol Violation|3|||
27765479|NCT04209400|80969586|FG000|Overall Study|Withdrawal by Subject|0|||
27765480|NCT04209400|80969587|FG001|Overall Study|Withdrawal by Subject|1|||
27765481|NCT01079195|80969589|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
27765482|NCT01079195|80969589|FG000|Overall Study|No Documentation Available|437|||
27765483|NCT01079195|80969589|FG000|Overall Study|Adverse Event|157|||
27765484|NCT01079195|80969589|FG000|Overall Study|Reason Unknown|39|||
27765485|NCT01079195|80969589|FG000|Overall Study|Withdrawal by Subject|18|||
27765486|NCT01079195|80969589|FG000|Overall Study|Financial Reasons|15|||
27765487|NCT01079195|80969589|FG000|Overall Study|Lack of Effectiveness|12|||
27765488|NCT01079195|80969589|FG000|Overall Study|Physician Decision|4|||
27765489|NCT01079195|80969589|FG000|Overall Study|Improved Status of Participant|4|||
27765490|NCT01079195|80969589|FG000|Overall Study|No Follow-up Documentation Available|4|||
27765491|NCT01079195|80969589|FG000|Overall Study|Non-compliance|2|||
27765492|NCT00669032|80969590|FG000|Overall Study|Lost to Follow-up|6|||
27765493|NCT00669032|80969591|FG001|Overall Study|Lost to Follow-up|5|||
27765494|NCT00669032|80969590|FG000|Overall Study|Lack of Efficacy|8|||
27765495|NCT00669032|80969591|FG001|Overall Study|Lack of Efficacy|19|||
27765496|NCT00669032|80969590|FG000|Overall Study|Withdrawal by Subject|12|||
27765497|NCT00669032|80969591|FG001|Overall Study|Withdrawal by Subject|13|||
27765498|NCT00669032|80969590|FG000|Overall Study|Adverse Event|12|||
27765499|NCT00669032|80969591|FG001|Overall Study|Adverse Event|16|||
27765500|NCT00669032|80969590|FG000|Overall Study|Physician Decision|1|||
27765501|NCT00669032|80969591|FG001|Overall Study|Physician Decision|1|||
27765502|NCT00669032|80969590|FG000|Overall Study|No fulfilment of the selection criteria|5|||
27765503|NCT00669032|80969591|FG001|Overall Study|No fulfilment of the selection criteria|5|||
27765504|NCT00861380|80969594|FG000|Overall Study|Withdrawal Information not recorded|8427|||
27962525|NCT01169701|81695160|FG001|Overall Study|Serious adverse event|1|||
27962526|NCT01169701|81695159|FG000|Overall Study|Sponsor decision|0|||
27663456|NCT03746483|80606445|FG001|Overall Study|Adverse Event|1|||
27663457|NCT03746483|80606444|FG000|Overall Study|Lack of Efficacy|3|||
27663458|NCT03746483|80606445|FG001|Overall Study|Lack of Efficacy|2|||
27663459|NCT03746483|80606444|FG000|Overall Study|Lost to Follow-up|1|||
27663460|NCT03746483|80606445|FG001|Overall Study|Lost to Follow-up|0|||
27663461|NCT03746483|80606444|FG000|Overall Study|Protocol Violation|2|||
27663462|NCT03746483|80606445|FG001|Overall Study|Protocol Violation|0|||
27663463|NCT01184859|80606446|FG000|Period 1: Single Dose|Insufficient urine production|0|||
27663464|NCT01184859|80606447|FG001|Period 1: Single Dose|Insufficient urine production|1|||
27663465|NCT01184859|80606448|FG002|Period 1: Single Dose|Insufficient urine production|0|||
27663466|NCT01184859|80606449|FG003|Period 1: Single Dose|Insufficient urine production|0|||
27663467|NCT01184859|80606450|FG004|Period 1: Single Dose|Insufficient urine production|0|||
27663468|NCT01184859|80606446|FG000|Period 1: Single Dose|Protocol Violation|0|||
27663469|NCT01184859|80606447|FG001|Period 1: Single Dose|Protocol Violation|1|||
27663470|NCT01184859|80606448|FG002|Period 1: Single Dose|Protocol Violation|0|||
27663471|NCT01184859|80606449|FG003|Period 1: Single Dose|Protocol Violation|0|||
27663472|NCT01184859|80606450|FG004|Period 1: Single Dose|Protocol Violation|0|||
27663473|NCT01184859|80606446|FG000|Period 1: Single Dose|Adverse Event|0|||
27663474|NCT01184859|80606447|FG001|Period 1: Single Dose|Adverse Event|0|||
27663475|NCT01184859|80606448|FG002|Period 1: Single Dose|Adverse Event|0|||
27663476|NCT01184859|80606449|FG003|Period 1: Single Dose|Adverse Event|0|||
27663477|NCT01184859|80606450|FG004|Period 1: Single Dose|Adverse Event|1|||
27663478|NCT01184859|80606446|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27663479|NCT01184859|80606447|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27765505|NCT00861380|80969595|FG001|Overall Study|Withdrawal Information not recorded|9112|||
27765506|NCT00861380|80969596|FG002|Overall Study|Withdrawal Information not recorded|8872|||
27765507|NCT00861380|80969597|FG003|Overall Study|Withdrawal Information not recorded|3689|||
27765508|NCT00861380|80969598|FG004|Overall Study|Withdrawal Information not recorded|1812|||
27765509|NCT00861380|80969599|FG005|Overall Study|Withdrawal Information not recorded|6249|||
27765510|NCT00861380|80969600|FG006|Overall Study|Withdrawal Information not recorded|3020|||
27765511|NCT01438307|80969605|FG000|Overall Study|Death|1|||
27765512|NCT01438307|80969606|FG001|Overall Study|Death|1|||
27765513|NCT00023712|80969607|FG000|Overall Study|Not platinum sensitive|1|||
27765514|NCT00023712|80969608|FG001|Overall Study|Not platinum sensitive|0|||
27765515|NCT00023712|80969607|FG000|Overall Study|Never treated|1|||
27765516|NCT00023712|80969608|FG001|Overall Study|Never treated|1|||
27765517|NCT03407170|80969611|FG000|Overall Study|Adverse Event|1|||
27765518|NCT00709124|80969612|FG000|Overall Study|Death|3|||
27765519|NCT00709124|80969613|FG001|Overall Study|Death|1|||
27765520|NCT00709124|80969612|FG000|Overall Study|encephalopathy; can't do assessment|1|||
27765521|NCT00709124|80969613|FG001|Overall Study|encephalopathy; can't do assessment|0|||
27765522|NCT00340834|80969614|FG000|Core Phase of Study|Adverse Event|26|||
27765523|NCT00340834|80969615|FG001|Core Phase of Study|Adverse Event|9|||
27765524|NCT00340834|80969616|FG002|Core Phase of Study|Adverse Event|9|||
27765525|NCT00340834|80969617|FG003|Core Phase of Study|Adverse Event|0|||
27765526|NCT00340834|80969618|FG004|Core Phase of Study|Adverse Event|0|||
27765527|NCT00340834|80969614|FG000|Core Phase of Study|Withdrawal by Subject|11|||
27765528|NCT00340834|80969615|FG001|Core Phase of Study|Withdrawal by Subject|9|||
27765529|NCT00340834|80969616|FG002|Core Phase of Study|Withdrawal by Subject|16|||
27765530|NCT00340834|80969617|FG003|Core Phase of Study|Withdrawal by Subject|0|||
27765531|NCT00340834|80969618|FG004|Core Phase of Study|Withdrawal by Subject|0|||
27765532|NCT00340834|80969614|FG000|Core Phase of Study|Administrative Problems|6|||
27765533|NCT00340834|80969615|FG001|Core Phase of Study|Administrative Problems|2|||
27765534|NCT00340834|80969616|FG002|Core Phase of Study|Administrative Problems|7|||
27765535|NCT00340834|80969617|FG003|Core Phase of Study|Administrative Problems|0|||
27765536|NCT00340834|80969618|FG004|Core Phase of Study|Administrative Problems|0|||
27765537|NCT00340834|80969614|FG000|Core Phase of Study|Lack of Efficacy|3|||
27765538|NCT00340834|80969615|FG001|Core Phase of Study|Lack of Efficacy|3|||
27765539|NCT00340834|80969616|FG002|Core Phase of Study|Lack of Efficacy|7|||
27765540|NCT00340834|80969617|FG003|Core Phase of Study|Lack of Efficacy|0|||
27765541|NCT00340834|80969618|FG004|Core Phase of Study|Lack of Efficacy|0|||
27765542|NCT00340834|80969614|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
27765543|NCT00340834|80969615|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
27765544|NCT00340834|80969616|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
27765545|NCT00340834|80969617|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
27765546|NCT00340834|80969618|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
27765547|NCT00340834|80969614|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
27765548|NCT00340834|80969615|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
27765549|NCT00340834|80969616|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
27765550|NCT00340834|80969617|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
27765551|NCT00340834|80969618|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
27765552|NCT00340834|80969614|FG000|Core Phase of Study|Lost to Follow-up|1|||
27765553|NCT00340834|80969615|FG001|Core Phase of Study|Lost to Follow-up|1|||
27765554|NCT00340834|80969616|FG002|Core Phase of Study|Lost to Follow-up|4|||
27765555|NCT00340834|80969617|FG003|Core Phase of Study|Lost to Follow-up|0|||
27765556|NCT00340834|80969618|FG004|Core Phase of Study|Lost to Follow-up|0|||
27765557|NCT00340834|80969614|FG000|Core Phase of Study|Death|2|||
27765558|NCT00340834|80969615|FG001|Core Phase of Study|Death|0|||
27765559|NCT00340834|80969616|FG002|Core Phase of Study|Death|0|||
27765560|NCT00340834|80969617|FG003|Core Phase of Study|Death|0|||
27765561|NCT00340834|80969618|FG004|Core Phase of Study|Death|0|||
27765562|NCT00340834|80969614|FG000|Core Phase of Study|Protocol Violation|0|||
27765563|NCT00340834|80969615|FG001|Core Phase of Study|Protocol Violation|0|||
27765564|NCT00340834|80969616|FG002|Core Phase of Study|Protocol Violation|2|||
27765565|NCT00340834|80969617|FG003|Core Phase of Study|Protocol Violation|0|||
27765566|NCT00340834|80969618|FG004|Core Phase of Study|Protocol Violation|0|||
27765567|NCT00340834|80969614|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
27765568|NCT00340834|80969615|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
27765569|NCT00340834|80969616|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
27765570|NCT00340834|80969617|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
27765571|NCT00340834|80969618|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
27765572|NCT00340834|80969614|FG000|Extension Phase of Study|Subject withdrew consent|26|||
27765573|NCT00340834|80969615|FG001|Extension Phase of Study|Subject withdrew consent|31|||
27765574|NCT00340834|80969616|FG002|Extension Phase of Study|Subject withdrew consent|0|||
27765575|NCT00340834|80969617|FG003|Extension Phase of Study|Subject withdrew consent|12|||
27765576|NCT00340834|80969618|FG004|Extension Phase of Study|Subject withdrew consent|15|||
27765577|NCT00340834|80969614|FG000|Extension Phase of Study|Adverse Event|21|||
27765578|NCT00340834|80969615|FG001|Extension Phase of Study|Adverse Event|22|||
27765579|NCT00340834|80969616|FG002|Extension Phase of Study|Adverse Event|0|||
27765580|NCT00340834|80969617|FG003|Extension Phase of Study|Adverse Event|19|||
27765581|NCT00340834|80969618|FG004|Extension Phase of Study|Adverse Event|7|||
27765582|NCT00340834|80969614|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
27765583|NCT00340834|80969615|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
27765584|NCT00340834|80969616|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
27765585|NCT00340834|80969617|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
27765586|NCT00340834|80969618|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
27765587|NCT00340834|80969614|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
27765588|NCT00340834|80969615|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
27765589|NCT00340834|80969616|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
27765590|NCT00340834|80969617|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
27765591|NCT00340834|80969618|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
27765592|NCT00340834|80969614|FG000|Extension Phase of Study|Lost to Follow-up|1|||
27765593|NCT00340834|80969615|FG001|Extension Phase of Study|Lost to Follow-up|1|||
27765594|NCT00340834|80969616|FG002|Extension Phase of Study|Lost to Follow-up|0|||
27765595|NCT00340834|80969617|FG003|Extension Phase of Study|Lost to Follow-up|2|||
27765596|NCT00340834|80969618|FG004|Extension Phase of Study|Lost to Follow-up|3|||
27765597|NCT00340834|80969614|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
27765598|NCT00340834|80969615|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
27765599|NCT00340834|80969616|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
27765600|NCT00340834|80969617|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
27765601|NCT00340834|80969618|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
27765602|NCT00340834|80969614|FG000|Extension Phase of Study|Administrative problems|3|||
27765603|NCT00340834|80969615|FG001|Extension Phase of Study|Administrative problems|0|||
27765604|NCT00340834|80969616|FG002|Extension Phase of Study|Administrative problems|0|||
27765605|NCT00340834|80969617|FG003|Extension Phase of Study|Administrative problems|1|||
27765606|NCT00340834|80969618|FG004|Extension Phase of Study|Administrative problems|1|||
27765607|NCT00340834|80969614|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
27765608|NCT00340834|80969615|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
27765609|NCT00340834|80969616|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
27765610|NCT00340834|80969617|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
27765611|NCT00340834|80969618|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
27765612|NCT00340834|80969614|FG000|Extension Phase of Study|Protocol Violation|3|||
27765613|NCT00340834|80969615|FG001|Extension Phase of Study|Protocol Violation|0|||
27765614|NCT00340834|80969616|FG002|Extension Phase of Study|Protocol Violation|0|||
27765615|NCT00340834|80969617|FG003|Extension Phase of Study|Protocol Violation|0|||
27765616|NCT00340834|80969618|FG004|Extension Phase of Study|Protocol Violation|0|||
27765617|NCT00340834|80969614|FG000|Extension Phase of Study|Death|0|||
27765618|NCT00340834|80969615|FG001|Extension Phase of Study|Death|0|||
27765619|NCT00340834|80969616|FG002|Extension Phase of Study|Death|0|||
27765620|NCT00340834|80969617|FG003|Extension Phase of Study|Death|0|||
27765621|NCT00340834|80969618|FG004|Extension Phase of Study|Death|1|||
27765622|NCT02566109|80969619|FG000|Overall Study|Withdrawal by Subject|1|||
27765623|NCT01148693|80969622|FG000|Overall Study|Attempts for cannulation were failed|13|||
27765624|NCT01148693|80969623|FG001|Overall Study|Attempts for cannulation were failed|10|||
27765625|NCT01090102|80969624|FG000|First 12 Weeks|Withdrawal by Subject|1|||
27765626|NCT01090102|80969625|FG001|First 12 Weeks|Withdrawal by Subject|1|||
27765627|NCT01090102|80969624|FG000|First 12 Weeks|Adverse Event|2|||
27765628|NCT01090102|80969625|FG001|First 12 Weeks|Adverse Event|0|||
27765629|NCT01090102|80969624|FG000|First 12 Weeks|Death|1|||
27765630|NCT01090102|80969625|FG001|First 12 Weeks|Death|1|||
27765631|NCT01090102|80969624|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
27765632|NCT01090102|80969625|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
27765633|NCT01807949|80969626|FG000|Overall Study|Adverse Event|1|||
27765634|NCT01807949|80969627|FG001|Overall Study|Adverse Event|2|||
27765635|NCT01807949|80969628|FG002|Overall Study|Adverse Event|2|||
27765636|NCT01807949|80969626|FG000|Overall Study|Withdrawal by Subject|1|||
27765637|NCT01807949|80969627|FG001|Overall Study|Withdrawal by Subject|2|||
27765638|NCT01807949|80969628|FG002|Overall Study|Withdrawal by Subject|2|||
27765639|NCT01807949|80969626|FG000|Overall Study|Non-Compliance|0|||
27765640|NCT01807949|80969627|FG001|Overall Study|Non-Compliance|0|||
27765641|NCT01807949|80969628|FG002|Overall Study|Non-Compliance|1|||
27765642|NCT01807949|80969626|FG000|Overall Study|Undefined|0|||
27765643|NCT01807949|80969627|FG001|Overall Study|Undefined|1|||
27765644|NCT01807949|80969628|FG002|Overall Study|Undefined|2|||
27765645|NCT01807949|80969626|FG000|Overall Study|Randomized But Not Treated|0|||
27765646|NCT01807949|80969627|FG001|Overall Study|Randomized But Not Treated|2|||
27962527|NCT01169701|81695160|FG001|Overall Study|Sponsor decision|1|||
27962528|NCT00615719|81695161|FG000|Overall Study|Physician Decision|5|||
27962529|NCT01032070|81695162|FG000|Overall Study|Disease progression|13|||
27962530|NCT01032070|81695163|FG001|Overall Study|Disease progression|8|||
27962531|NCT01032070|81695162|FG000|Overall Study|Medical or ethical reasons|0|||
27962532|NCT01032070|81695163|FG001|Overall Study|Medical or ethical reasons|2|||
27962533|NCT01032070|81695162|FG000|Overall Study|Withdrawal by Subject|0|||
27962534|NCT01032070|81695163|FG001|Overall Study|Withdrawal by Subject|2|||
27962535|NCT01059864|81695166|FG000|Open-Label Run-In Phase|Adverse Event|7|||
27962536|NCT01059864|81695167|FG001|Open-Label Run-In Phase|Adverse Event|0|||
27962537|NCT01059864|81695168|FG002|Open-Label Run-In Phase|Adverse Event|0|||
27962538|NCT01059864|81695166|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
27962539|NCT01059864|81695167|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
27962540|NCT01059864|81695168|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
27962541|NCT01059864|81695166|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
27962542|NCT01059864|81695167|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
27962543|NCT01059864|81695168|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
27962544|NCT01059864|81695166|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
27962545|NCT01059864|81695167|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
27962546|NCT01059864|81695168|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
27962547|NCT01059864|81695166|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
27962548|NCT01059864|81695167|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
27962549|NCT01059864|81695168|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
27962550|NCT01059864|81695166|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27962551|NCT01059864|81695167|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27962552|NCT01059864|81695168|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
27962553|NCT03941964|81695169|FG000|Overall Study|Adverse Event|1|||
27962554|NCT03941964|81695170|FG001|Overall Study|Adverse Event|8|||
27962555|NCT03941964|81695169|FG000|Overall Study|Progressive disease|7|||
27962556|NCT03941964|81695170|FG001|Overall Study|Progressive disease|3|||
27962557|NCT03941964|81695169|FG000|Overall Study|Lack of Efficacy|0|||
27962558|NCT03941964|81695170|FG001|Overall Study|Lack of Efficacy|1|||
27962559|NCT03941964|81695169|FG000|Overall Study|Death|3|||
27962560|NCT03941964|81695170|FG001|Overall Study|Death|1|||
27962561|NCT03941964|81695169|FG000|Overall Study|Withdrew consent|1|||
27962562|NCT03941964|81695170|FG001|Overall Study|Withdrew consent|3|||
27962563|NCT03941964|81695169|FG000|Overall Study|Physician Decision|9|||
27962564|NCT03941964|81695170|FG001|Overall Study|Physician Decision|2|||
27962565|NCT03941964|81695169|FG000|Overall Study|Other, not specified|2|||
27962566|NCT03941964|81695170|FG001|Overall Study|Other, not specified|1|||
27962567|NCT00182078|81695171|FG000|Overall Study|Withdrawal by Subject|1|||
27962568|NCT00182078|81695172|FG001|Overall Study|Withdrawal by Subject|0|||
27962569|NCT01732510|81695173|FG000|Overall Study|Adverse Event|0|||
27962570|NCT01732510|81695174|FG001|Overall Study|Adverse Event|1|||
27962571|NCT01732510|81695175|FG002|Overall Study|Adverse Event|1|||
27962572|NCT01732510|81695176|FG003|Overall Study|Adverse Event|0|||
27962573|NCT01732510|81695177|FG004|Overall Study|Adverse Event|0|||
27962574|NCT01732510|81695178|FG005|Overall Study|Adverse Event|0|||
27962575|NCT01732510|81695179|FG006|Overall Study|Adverse Event|1|||
27962576|NCT01732510|81695173|FG000|Overall Study|Protocol Violation|0|||
27962577|NCT01732510|81695174|FG001|Overall Study|Protocol Violation|0|||
27962578|NCT01732510|81695175|FG002|Overall Study|Protocol Violation|0|||
27962579|NCT01732510|81695176|FG003|Overall Study|Protocol Violation|1|||
27962580|NCT01732510|81695177|FG004|Overall Study|Protocol Violation|0|||
27962581|NCT01732510|81695178|FG005|Overall Study|Protocol Violation|0|||
27962582|NCT01732510|81695179|FG006|Overall Study|Protocol Violation|0|||
27962583|NCT01732510|81695173|FG000|Overall Study|Withdrawal by Subject|1|||
27962584|NCT01732510|81695174|FG001|Overall Study|Withdrawal by Subject|3|||
27962585|NCT01732510|81695175|FG002|Overall Study|Withdrawal by Subject|2|||
27962586|NCT01732510|81695176|FG003|Overall Study|Withdrawal by Subject|1|||
27962587|NCT01732510|81695177|FG004|Overall Study|Withdrawal by Subject|5|||
27962588|NCT01732510|81695178|FG005|Overall Study|Withdrawal by Subject|0|||
27962589|NCT01732510|81695179|FG006|Overall Study|Withdrawal by Subject|1|||
27962590|NCT01732510|81695173|FG000|Overall Study|Lost to Follow-up|0|||
27962591|NCT01732510|81695174|FG001|Overall Study|Lost to Follow-up|0|||
27962592|NCT01732510|81695175|FG002|Overall Study|Lost to Follow-up|1|||
27962593|NCT01732510|81695176|FG003|Overall Study|Lost to Follow-up|1|||
27962594|NCT01732510|81695177|FG004|Overall Study|Lost to Follow-up|0|||
27962595|NCT01732510|81695178|FG005|Overall Study|Lost to Follow-up|1|||
27962596|NCT01732510|81695179|FG006|Overall Study|Lost to Follow-up|0|||
27962597|NCT01732510|81695173|FG000|Overall Study|Physician Decision|0|||
27962598|NCT01732510|81695174|FG001|Overall Study|Physician Decision|1|||
27962599|NCT01732510|81695175|FG002|Overall Study|Physician Decision|0|||
27962600|NCT01732510|81695176|FG003|Overall Study|Physician Decision|0|||
27962601|NCT01732510|81695177|FG004|Overall Study|Physician Decision|0|||
27962602|NCT01732510|81695178|FG005|Overall Study|Physician Decision|0|||
27962603|NCT01732510|81695179|FG006|Overall Study|Physician Decision|0|||
27962604|NCT01732510|81695173|FG000|Overall Study|Pregnancy|0|||
27962605|NCT01732510|81695174|FG001|Overall Study|Pregnancy|0|||
27962606|NCT01732510|81695175|FG002|Overall Study|Pregnancy|0|||
27962607|NCT01732510|81695176|FG003|Overall Study|Pregnancy|1|||
27962608|NCT01732510|81695177|FG004|Overall Study|Pregnancy|0|||
27962609|NCT01732510|81695178|FG005|Overall Study|Pregnancy|0|||
27962610|NCT01732510|81695179|FG006|Overall Study|Pregnancy|0|||
27962611|NCT01732510|81695173|FG000|Overall Study|Study Terminated By Sponsor|0|||
27962612|NCT01732510|81695174|FG001|Overall Study|Study Terminated By Sponsor|0|||
27962613|NCT01732510|81695175|FG002|Overall Study|Study Terminated By Sponsor|0|||
27962614|NCT01732510|81695176|FG003|Overall Study|Study Terminated By Sponsor|1|||
27962615|NCT01732510|81695177|FG004|Overall Study|Study Terminated By Sponsor|0|||
27765647|NCT01807949|80969628|FG002|Overall Study|Randomized But Not Treated|2|||
27765648|NCT02670915|80969629|FG000|Overall Study|Withdrawal by Subject|0|||
27765649|NCT02670915|80969630|FG001|Overall Study|Withdrawal by Subject|1|||
27765650|NCT02670915|80969631|FG002|Overall Study|Withdrawal by Subject|4|||
27765651|NCT02670915|80969629|FG000|Overall Study|Withdrawal by parent/guardian|4|||
27765652|NCT02670915|80969630|FG001|Overall Study|Withdrawal by parent/guardian|4|||
27765653|NCT02670915|80969631|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27765654|NCT02670915|80969629|FG000|Overall Study|Unclassified|0|||
27765655|NCT02670915|80969630|FG001|Overall Study|Unclassified|3|||
27765656|NCT02670915|80969631|FG002|Overall Study|Unclassified|0|||
27765657|NCT01072448|80969635|FG000|Overall Study|Adverse Event|9|||
27765658|NCT01072448|80969636|FG001|Overall Study|Adverse Event|10|||
27765659|NCT01072448|80969635|FG000|Overall Study|Subject withdrew consent|4|||
27765660|NCT01072448|80969636|FG001|Overall Study|Subject withdrew consent|9|||
27765661|NCT01072448|80969635|FG000|Overall Study|Protocol deviation|3|||
27765662|NCT01072448|80969636|FG001|Overall Study|Protocol deviation|4|||
27765663|NCT01072448|80969635|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27765664|NCT01072448|80969636|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27765665|NCT01072448|80969635|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27765666|NCT01072448|80969636|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27765667|NCT01072448|80969635|FG000|Overall Study|Lost to Follow-up|1|||
27765668|NCT01072448|80969636|FG001|Overall Study|Lost to Follow-up|1|||
27765669|NCT01072448|80969635|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27765670|NCT01072448|80969636|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27765671|NCT01072448|80969635|FG000|Overall Study|Death|0|||
27765672|NCT01072448|80969636|FG001|Overall Study|Death|2|||
27765673|NCT01061567|80969637|FG000|Overall Study|Adverse Event|32|||
27765674|NCT01061567|80969637|FG000|Overall Study|Death|2|||
27765675|NCT01061567|80969637|FG000|Overall Study|Lack of Efficacy|3|||
27962616|NCT01732510|81695178|FG005|Overall Study|Study Terminated By Sponsor|12|||
27962617|NCT01732510|81695179|FG006|Overall Study|Study Terminated By Sponsor|6|||
27962618|NCT03107052|81695183|FG000|Overall Study|Adverse Event|6|||
27962619|NCT03107052|81695184|FG001|Overall Study|Adverse Event|1|||
27962620|NCT03107052|81695185|FG002|Overall Study|Adverse Event|2|||
27962621|NCT03107052|81695183|FG000|Overall Study|Withdrawal by Subject|9|||
27962622|NCT03107052|81695184|FG001|Overall Study|Withdrawal by Subject|5|||
27962623|NCT03107052|81695185|FG002|Overall Study|Withdrawal by Subject|8|||
27962624|NCT03107052|81695183|FG000|Overall Study|Protocol Violation|6|||
27962625|NCT03107052|81695184|FG001|Overall Study|Protocol Violation|0|||
27962626|NCT03107052|81695185|FG002|Overall Study|Protocol Violation|3|||
27962627|NCT03107052|81695183|FG000|Overall Study|Lost to Follow-up|4|||
27962628|NCT03107052|81695184|FG001|Overall Study|Lost to Follow-up|0|||
27962629|NCT03107052|81695185|FG002|Overall Study|Lost to Follow-up|1|||
27962630|NCT03107052|81695183|FG000|Overall Study|Lack of Efficacy|23|||
27962631|NCT03107052|81695184|FG001|Overall Study|Lack of Efficacy|7|||
27962632|NCT03107052|81695185|FG002|Overall Study|Lack of Efficacy|4|||
27962633|NCT03107052|81695183|FG000|Overall Study|Other than specified|4|||
27962634|NCT03107052|81695184|FG001|Overall Study|Other than specified|2|||
27962635|NCT03107052|81695185|FG002|Overall Study|Other than specified|0|||
27962636|NCT03107052|81695183|FG000|Overall Study|Study terminated due to futility|67|||
27962637|NCT03107052|81695184|FG001|Overall Study|Study terminated due to futility|31|||
27962638|NCT03107052|81695185|FG002|Overall Study|Study terminated due to futility|23|||
27962639|NCT02277691|81695186|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
27765676|NCT01061567|80969637|FG000|Overall Study|Lost to Follow-up|24|||
27765677|NCT01061567|80969637|FG000|Overall Study|Protocol Violation|1|||
27765678|NCT01061567|80969637|FG000|Overall Study|Withdrawal by Subject|11|||
27765679|NCT01061567|80969637|FG000|Overall Study|Other reason than stated above|3|||
27765680|NCT01455415|80969638|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
27765681|NCT01455415|80969639|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
27962640|NCT02277691|81695186|FG000|Overall Study|Voluntary Withdrawal|7|||
27962641|NCT02277691|81695186|FG000|Overall Study|Lack of Efficacy|5|||
27962642|NCT02277691|81695186|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
27962643|NCT00606411|81695187|FG000|Overall Study|Adverse Event|1|||
27962644|NCT00606411|81695188|FG001|Overall Study|Adverse Event|2|||
27962645|NCT00606411|81695187|FG000|Overall Study|Lack of Adherence|1|||
27962646|NCT00606411|81695188|FG001|Overall Study|Lack of Adherence|1|||
27962647|NCT00606411|81695187|FG000|Overall Study|Lack of Efficacy|1|||
27962648|NCT00606411|81695188|FG001|Overall Study|Lack of Efficacy|1|||
27962649|NCT00606411|81695187|FG000|Overall Study|Withdrawal by Subject|2|||
27962650|NCT00606411|81695188|FG001|Overall Study|Withdrawal by Subject|0|||
27962651|NCT00606411|81695187|FG000|Overall Study|Lost to Follow-up|1|||
27962652|NCT00606411|81695188|FG001|Overall Study|Lost to Follow-up|2|||
27962653|NCT00606411|81695187|FG000|Overall Study|Move out of state|0|||
27962654|NCT00606411|81695188|FG001|Overall Study|Move out of state|1|||
27962655|NCT02443337|81695191|FG000|Overall Study|Adverse Event|0|||
27962656|NCT02443337|81695192|FG001|Overall Study|Adverse Event|1|||
27962657|NCT02443337|81695191|FG000|Overall Study|Clinical Progressive Disease|3|||
27962658|NCT02443337|81695192|FG001|Overall Study|Clinical Progressive Disease|0|||
27962659|NCT02443337|81695191|FG000|Overall Study|Withdrawal by Subject|2|||
27765682|NCT01455415|80969638|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
27765683|NCT01455415|80969639|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
27765684|NCT01455415|80969638|FG000|Period 1|Drug Error not Associated to AE|0|||
27765685|NCT01455415|80969639|FG001|Period 1|Drug Error not Associated to AE|1|||
27765686|NCT01455415|80969638|FG000|Period 1|AE Not Related to Study Drug|2|||
27765687|NCT01455415|80969639|FG001|Period 1|AE Not Related to Study Drug|6|||
27765688|NCT01455415|80969638|FG000|Period 1|Withdrawal by Subject|4|||
27765689|NCT01455415|80969639|FG001|Period 1|Withdrawal by Subject|5|||
27765690|NCT01455415|80969638|FG000|Period 1|Unspecified Reason|1|||
27765691|NCT01455415|80969639|FG001|Period 1|Unspecified Reason|1|||
27962660|NCT02443337|81695192|FG001|Overall Study|Withdrawal by Subject|1|||
27962661|NCT00175916|81695197|FG000|Overall Study|Death|19|||
27962662|NCT00175916|81695197|FG000|Overall Study|Adverse Event|81|||
27962663|NCT00175916|81695197|FG000|Overall Study|Lack of Efficacy|354|||
27962664|NCT00175916|81695197|FG000|Overall Study|Lost to Follow-up|17|||
27962665|NCT00175916|81695197|FG000|Overall Study|Subject Choice|98|||
27962666|NCT00175916|81695197|FG000|Overall Study|Lack of compliance|8|||
27962667|NCT00175916|81695197|FG000|Overall Study|Patient cannot record seizures|1|||
27962668|NCT00175916|81695197|FG000|Overall Study|Sponsor decision|17|||
27962669|NCT00175916|81695197|FG000|Overall Study|Vigabatrin intake|1|||
27962670|NCT00175916|81695197|FG000|Overall Study|Suicidal behaviour|1|||
27962671|NCT00175916|81695197|FG000|Overall Study|Withdrawal by Subject|1|||
27962672|NCT00175916|81695197|FG000|Overall Study|Seizure - free|4|||
27962673|NCT00175916|81695197|FG000|Overall Study|Administrative reason|1|||
27962674|NCT00175916|81695197|FG000|Overall Study|Pregnancy|1|||
27962675|NCT00175916|81695197|FG000|Overall Study|Patient's request|2|||
27962676|NCT00175916|81695197|FG000|Overall Study|Treating physiciant's choice|1|||
27962677|NCT00175916|81695197|FG000|Overall Study|Moved overseas|1|||
27962678|NCT00175916|81695197|FG000|Overall Study|Loss of job and economic burden|1|||
27962679|NCT00175916|81695197|FG000|Overall Study|Site was closed|9|||
27962680|NCT00175916|81695197|FG000|Overall Study|Patient went to prison|1|||
27962681|NCT00292045|81695198|FG000|Core Study (Through Week 13)|Adverse Event|1|||
27962682|NCT00292045|81695198|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
27962683|NCT03226249|81695200|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
27962684|NCT03226249|81695200|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
27962685|NCT03226249|81695200|FG000|Survival Follow-up|Patients still in follow-up.|30|||
27962686|NCT01670279|81695201|FG000|Overall Study|Adverse Event|0|||
27962687|NCT01670279|81695202|FG001|Overall Study|Adverse Event|1|||
27962688|NCT01670279|81695203|FG002|Overall Study|Adverse Event|0|||
27962689|NCT01670279|81695204|FG003|Overall Study|Adverse Event|0|||
27765692|NCT01455415|80969638|FG000|Period 1|Protocol Violation|0|||
27765693|NCT01455415|80969639|FG001|Period 1|Protocol Violation|2|||
27765694|NCT01455415|80969638|FG000|Washout|AE Related to Study Drug|2|||
27765695|NCT01455415|80969639|FG001|Washout|AE Related to Study Drug|0|||
27765696|NCT01455415|80969638|FG000|Washout|Lost to Follow-up|1|||
27765697|NCT01455415|80969639|FG001|Washout|Lost to Follow-up|0|||
27765698|NCT01455415|80969638|FG000|Washout|Drug Error not Associated to AE|2|||
27765699|NCT01455415|80969639|FG001|Washout|Drug Error not Associated to AE|1|||
27765700|NCT01455415|80969638|FG000|Washout|AE Not Related to Study Drug|2|||
27765701|NCT01455415|80969639|FG001|Washout|AE Not Related to Study Drug|3|||
27765702|NCT01455415|80969638|FG000|Washout|Unspecified Reason|1|||
27765703|NCT01455415|80969639|FG001|Washout|Unspecified Reason|2|||
27962690|NCT01670279|81695201|FG000|Overall Study|Physician Decision|0|||
27962691|NCT01670279|81695202|FG001|Overall Study|Physician Decision|1|||
27962692|NCT01670279|81695203|FG002|Overall Study|Physician Decision|0|||
27962693|NCT01670279|81695204|FG003|Overall Study|Physician Decision|0|||
27962694|NCT01670279|81695201|FG000|Overall Study|Participant met withdrawal criteria|0|||
27962695|NCT01670279|81695202|FG001|Overall Study|Participant met withdrawal criteria|0|||
27962696|NCT01670279|81695203|FG002|Overall Study|Participant met withdrawal criteria|0|||
27765704|NCT01455415|80969638|FG000|Washout|Protocol Violation|0|||
27765705|NCT01455415|80969639|FG001|Washout|Protocol Violation|1|||
27765706|NCT01455415|80969638|FG000|Period 2|AE Related to Study Drug|1|||
27765707|NCT01455415|80969639|FG001|Period 2|AE Related to Study Drug|2|||
27962697|NCT01670279|81695204|FG003|Overall Study|Participant met withdrawal criteria|1|||
27962698|NCT03326063|81695205|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
27962699|NCT03326063|81695206|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
27765708|NCT01455415|80969638|FG000|Period 2|Lost to Follow-up|2|||
27765709|NCT01455415|80969639|FG001|Period 2|Lost to Follow-up|1|||
27765710|NCT01455415|80969638|FG000|Period 2|AE Not Related to Study Drug|2|||
27765711|NCT01455415|80969639|FG001|Period 2|AE Not Related to Study Drug|1|||
27765712|NCT01455415|80969638|FG000|Period 2|Lack of Efficacy|2|||
27765713|NCT01455415|80969639|FG001|Period 2|Lack of Efficacy|0|||
27765714|NCT01455415|80969638|FG000|Period 2|Withdrawal by Subject|2|||
27765715|NCT01455415|80969639|FG001|Period 2|Withdrawal by Subject|3|||
27765716|NCT01455415|80969638|FG000|Period 2|Unspecified Reason|2|||
27765717|NCT01455415|80969639|FG001|Period 2|Unspecified Reason|3|||
27765718|NCT01455415|80969638|FG000|Period 2|Protocol Violation|2|||
27765719|NCT01455415|80969639|FG001|Period 2|Protocol Violation|0|||
27765720|NCT01455415|80969638|FG000|Follow-up|AE Related to Study Drug|0|||
27765721|NCT01455415|80969639|FG001|Follow-up|AE Related to Study Drug|1|||
27765722|NCT01455415|80969638|FG000|Follow-up|Lack of Efficacy|0|||
27765723|NCT01455415|80969639|FG001|Follow-up|Lack of Efficacy|1|||
27765724|NCT01455415|80969638|FG000|Follow-up|Withdrawal by Subject|2|||
27765725|NCT01455415|80969639|FG001|Follow-up|Withdrawal by Subject|0|||
27765726|NCT01455415|80969638|FG000|Follow-up|Unspecified Reason|1|||
27765727|NCT01455415|80969639|FG001|Follow-up|Unspecified Reason|0|||
27765728|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
27765729|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
27765730|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
27765731|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
27765732|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
27765733|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
27765734|NCT00996593|80969640|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
27765735|NCT00996593|80969640|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
27765736|NCT00996593|80969640|FG000|Long-Term Follow-Up|Site Closed|1|||
27765737|NCT00884221|80969641|FG000|Overall Study|Withdrawal by Subject|0|||
27765738|NCT00884221|80969642|FG001|Overall Study|Withdrawal by Subject|3|||
27765739|NCT00884221|80969641|FG000|Overall Study|Adverse Event|6|||
27765740|NCT00884221|80969642|FG001|Overall Study|Adverse Event|3|||
27765741|NCT00884221|80969641|FG000|Overall Study|Protocol Violation|16|||
27765742|NCT00884221|80969642|FG001|Overall Study|Protocol Violation|13|||
27765743|NCT00884221|80969641|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
27765744|NCT00884221|80969642|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
27765745|NCT00033371|80969648|FG000|Overall Study|Adverse Event|1|||
27765746|NCT00033371|80969649|FG001|Overall Study|Adverse Event|5|||
27765747|NCT00033371|80969648|FG000|Overall Study|Lost to Follow-up|2|||
27765748|NCT00033371|80969649|FG001|Overall Study|Lost to Follow-up|1|||
27765749|NCT00033371|80969648|FG000|Overall Study|Withdrawal by Subject|3|||
27765750|NCT00033371|80969649|FG001|Overall Study|Withdrawal by Subject|3|||
27765751|NCT00033371|80969648|FG000|Overall Study|Disease Progression|0|||
27765752|NCT00033371|80969649|FG001|Overall Study|Disease Progression|1|||
27765753|NCT01306032|80969650|FG000|First Intervention|Adverse Event|1|||
27765754|NCT01306032|80969651|FG001|First Intervention|Adverse Event|0|||
27765755|NCT01306032|80969652|FG002|First Intervention|Adverse Event|1|||
27765756|NCT01306032|80969653|FG003|First Intervention|Adverse Event|0|||
27765757|NCT01306032|80969654|FG004|First Intervention|Adverse Event|0|||
27765758|NCT01306032|80969655|FG005|First Intervention|Adverse Event|1|||
27765759|NCT01306032|80969650|FG000|First Intervention|Withdrawal by Subject|0|||
27765760|NCT01306032|80969651|FG001|First Intervention|Withdrawal by Subject|2|||
27765761|NCT01306032|80969652|FG002|First Intervention|Withdrawal by Subject|0|||
27765762|NCT01306032|80969653|FG003|First Intervention|Withdrawal by Subject|1|||
27765763|NCT01306032|80969654|FG004|First Intervention|Withdrawal by Subject|0|||
27765764|NCT01306032|80969655|FG005|First Intervention|Withdrawal by Subject|0|||
27765765|NCT01306032|80969650|FG000|First Intervention|Death|0|||
27765766|NCT01306032|80969651|FG001|First Intervention|Death|0|||
27765767|NCT01306032|80969652|FG002|First Intervention|Death|1|||
27765768|NCT01306032|80969653|FG003|First Intervention|Death|0|||
27765769|NCT01306032|80969654|FG004|First Intervention|Death|0|||
27765770|NCT01306032|80969655|FG005|First Intervention|Death|0|||
27765771|NCT01306032|80969650|FG000|First Intervention|Ineligible|0|||
27765772|NCT01306032|80969651|FG001|First Intervention|Ineligible|0|||
27765773|NCT01306032|80969652|FG002|First Intervention|Ineligible|0|||
27765774|NCT01306032|80969653|FG003|First Intervention|Ineligible|0|||
27765775|NCT01306032|80969654|FG004|First Intervention|Ineligible|0|||
27765776|NCT01306032|80969655|FG005|First Intervention|Ineligible|1|||
27765777|NCT01306032|80969650|FG000|First Intervention|Progressive disease|0|||
27765778|NCT01306032|80969651|FG001|First Intervention|Progressive disease|0|||
27765779|NCT01306032|80969652|FG002|First Intervention|Progressive disease|0|||
27765780|NCT01306032|80969653|FG003|First Intervention|Progressive disease|0|||
27765781|NCT01306032|80969654|FG004|First Intervention|Progressive disease|2|||
27765782|NCT01306032|80969655|FG005|First Intervention|Progressive disease|0|||
27765783|NCT01306032|80969650|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
27765784|NCT01306032|80969651|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
27765785|NCT01306032|80969652|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
27765786|NCT01306032|80969653|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
27765787|NCT01306032|80969654|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
27765788|NCT01306032|80969655|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
27765789|NCT01306032|80969650|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
27765790|NCT01306032|80969651|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
27765791|NCT01306032|80969652|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
27765792|NCT01306032|80969653|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
27765793|NCT01306032|80969654|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
27765794|NCT01306032|80969655|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
27765795|NCT03447821|80969656|FG000|Overall Study|Withdrawal by Subject|1|||
27765796|NCT03447821|80969657|FG001|Overall Study|Withdrawal by Subject|1|||
27765797|NCT03447821|80969658|FG002|Overall Study|Withdrawal by Subject|0|||
27765798|NCT03447821|80969656|FG000|Overall Study|Lost to Follow-up|0|||
27765799|NCT03447821|80969657|FG001|Overall Study|Lost to Follow-up|0|||
27765800|NCT03447821|80969658|FG002|Overall Study|Lost to Follow-up|1|||
27765801|NCT01896856|80969659|FG000|Overall Study|Transportation issues / Non-compliance|0|||
27765802|NCT01896856|80969660|FG001|Overall Study|Transportation issues / Non-compliance|0|||
27765803|NCT01896856|80969661|FG002|Overall Study|Transportation issues / Non-compliance|1|||
27765804|NCT01896856|80969662|FG003|Overall Study|Transportation issues / Non-compliance|0|||
27765805|NCT01896856|80969663|FG004|Overall Study|Transportation issues / Non-compliance|0|||
27765806|NCT01896856|80969664|FG005|Overall Study|Transportation issues / Non-compliance|0|||
27765807|NCT00801892|80969665|FG000|Main Study Period|Withdrawal by Subject|0|||
27765808|NCT00801892|80969666|FG001|Main Study Period|Withdrawal by Subject|1|||
27765809|NCT00801892|80969665|FG000|Sham Crossover Period|Lost to Follow-up|0|||
27765810|NCT00801892|80969666|FG001|Sham Crossover Period|Lost to Follow-up|2|||
27765811|NCT00888615|80969667|FG000|Overall Study|No treatment|2|||
27765812|NCT03057951|80969671|FG000|Overall Study|Adverse Event|553|||
27765813|NCT03057951|80969672|FG001|Overall Study|Adverse Event|575|||
27663480|NCT01184859|80606448|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27663481|NCT01184859|80606449|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
27663482|NCT01184859|80606450|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
27663483|NCT01184859|80606446|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
27765814|NCT03057951|80969671|FG000|Overall Study|Protocol Violation|30|||
27765815|NCT03057951|80969672|FG001|Overall Study|Protocol Violation|24|||
27765816|NCT03057951|80969671|FG000|Overall Study|Lost to Follow-up|6|||
27765817|NCT03057951|80969672|FG001|Overall Study|Lost to Follow-up|16|||
27765818|NCT03057951|80969671|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
27765819|NCT03057951|80969672|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
27765820|NCT03057951|80969671|FG000|Overall Study|Study drug stopped, reason missing|6|||
27765821|NCT03057951|80969672|FG001|Overall Study|Study drug stopped, reason missing|1|||
27765822|NCT03057951|80969671|FG000|Overall Study|Medical advice|6|||
27765823|NCT03057951|80969672|FG001|Overall Study|Medical advice|2|||
27862164|NCT03058289|81326234|FG006|Overall Study|Refused Further Treatment|0|||
27862165|NCT03058289|81326235|FG007|Overall Study|Refused Further Treatment|0|||
27862166|NCT03058289|81326236|FG008|Overall Study|Refused Further Treatment|0|||
27862167|NCT03058289|81326228|FG000|Overall Study|Rapid Progression of Disease|0|||
27862168|NCT03058289|81326229|FG001|Overall Study|Rapid Progression of Disease|0|||
27862169|NCT03058289|81326230|FG002|Overall Study|Rapid Progression of Disease|0|||
27862170|NCT03058289|81326231|FG003|Overall Study|Rapid Progression of Disease|1|||
27962700|NCT00451958|81695207|FG000|CS21A (NCT00451958)|Adverse Event|21|||
27962701|NCT00451958|81695208|FG001|CS21A (NCT00451958)|Adverse Event|34|||
27962702|NCT00451958|81695209|FG002|CS21A (NCT00451958)|Adverse Event|14|||
27962703|NCT00451958|81695210|FG003|CS21A (NCT00451958)|Adverse Event|17|||
27962704|NCT00451958|81695211|FG004|CS21A (NCT00451958)|Adverse Event|0|||
27962705|NCT00451958|81695207|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
27962706|NCT00451958|81695208|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
27962707|NCT00451958|81695209|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
27962708|NCT00451958|81695210|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
27962709|NCT00451958|81695211|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
27962710|NCT00451958|81695207|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
27962711|NCT00451958|81695208|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
27962712|NCT00451958|81695209|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
27962713|NCT00451958|81695210|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
27962714|NCT00451958|81695211|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
27765824|NCT03057951|80969671|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
27765825|NCT03057951|80969672|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
27765826|NCT03057951|80969671|FG000|Overall Study|Investigator decision|2|||
27765827|NCT03057951|80969672|FG001|Overall Study|Investigator decision|0|||
27765828|NCT03057951|80969671|FG000|Overall Study|Patient decision|5|||
27765829|NCT03057951|80969672|FG001|Overall Study|Patient decision|2|||
27765830|NCT03057951|80969671|FG000|Overall Study|Not attending study visits|3|||
27765831|NCT03057951|80969672|FG001|Overall Study|Not attending study visits|0|||
27765832|NCT03057951|80969671|FG000|Overall Study|Patient moved away|3|||
27765833|NCT03057951|80969672|FG001|Overall Study|Patient moved away|4|||
27765834|NCT03057951|80969671|FG000|Overall Study|Other reason than stated above|23|||
27765835|NCT03057951|80969672|FG001|Overall Study|Other reason than stated above|29|||
27765836|NCT03057951|80969671|FG000|Overall Study|Not treated|2|||
27765837|NCT03057951|80969672|FG001|Overall Study|Not treated|1|||
27765838|NCT01149343|80969673|FG000|Overall Study|Withdrawal by Subject|1|||
27765839|NCT01149343|80969674|FG001|Overall Study|Withdrawal by Subject|1|||
27765840|NCT01149343|80969675|FG002|Overall Study|Withdrawal by Subject|1|||
27765841|NCT01149343|80969676|FG003|Overall Study|Withdrawal by Subject|5|||
27765842|NCT01149343|80969673|FG000|Overall Study|Death|10|||
27765843|NCT01149343|80969674|FG001|Overall Study|Death|13|||
27765844|NCT01149343|80969675|FG002|Overall Study|Death|18|||
27765845|NCT01149343|80969676|FG003|Overall Study|Death|18|||
27765846|NCT01149343|80969673|FG000|Overall Study|Lost to Follow-up|1|||
27765847|NCT01149343|80969674|FG001|Overall Study|Lost to Follow-up|0|||
27765848|NCT01149343|80969675|FG002|Overall Study|Lost to Follow-up|0|||
27765849|NCT01149343|80969676|FG003|Overall Study|Lost to Follow-up|1|||
27765850|NCT01149343|80969673|FG000|Overall Study|Other|8|||
27765851|NCT01149343|80969674|FG001|Overall Study|Other|10|||
27765852|NCT01149343|80969675|FG002|Overall Study|Other|2|||
27765853|NCT01149343|80969676|FG003|Overall Study|Other|14|||
27765854|NCT01149343|80969673|FG000|Overall Study|Sponsor study termination|0|||
27765855|NCT01149343|80969674|FG001|Overall Study|Sponsor study termination|0|||
27765856|NCT01149343|80969675|FG002|Overall Study|Sponsor study termination|0|||
27765857|NCT01149343|80969676|FG003|Overall Study|Sponsor study termination|2|||
27765858|NCT01149343|80969673|FG000|Overall Study|Recurrence / Progressive disease|0|||
27765859|NCT01149343|80969674|FG001|Overall Study|Recurrence / Progressive disease|0|||
27765860|NCT01149343|80969675|FG002|Overall Study|Recurrence / Progressive disease|1|||
27765861|NCT01149343|80969676|FG003|Overall Study|Recurrence / Progressive disease|0|||
27765862|NCT00555568|80969677|FG000|Overall Study|Lost to Follow-up|26|||
27765863|NCT00555568|80969678|FG001|Overall Study|Lost to Follow-up|16|||
27765864|NCT00555568|80969679|FG002|Overall Study|Lost to Follow-up|16|||
27765865|NCT00422903|80969680|FG000|Overall Study|Disease Progression|3|||
27765866|NCT00422903|80969681|FG001|Overall Study|Disease Progression|1|||
27765867|NCT00422903|80969680|FG000|Overall Study|Adverse Event|0|||
27765868|NCT00422903|80969681|FG001|Overall Study|Adverse Event|2|||
27765869|NCT00422903|80969680|FG000|Overall Study|Informed Consent Withdrawn|1|||
27765870|NCT00422903|80969681|FG001|Overall Study|Informed Consent Withdrawn|2|||
27765871|NCT01998399|80969683|FG000|Overall Study|Lost to Follow-up|1|||
27765872|NCT01998399|80969684|FG001|Overall Study|Lost to Follow-up|3|||
27765873|NCT01998399|80969683|FG000|Overall Study|Death|4|||
27765874|NCT01998399|80969684|FG001|Overall Study|Death|2|||
27765875|NCT01998399|80969683|FG000|Overall Study|Study stopped before dosing completed|3|||
27765876|NCT01998399|80969684|FG001|Overall Study|Study stopped before dosing completed|3|||
27765877|NCT01998399|80969683|FG000|Overall Study|Withdrawal by Subject|0|||
27765878|NCT01998399|80969684|FG001|Overall Study|Withdrawal by Subject|1|||
27765879|NCT00966693|80969685|FG000|Overall Study|Adverse Event|0|||
27765880|NCT00966693|80969686|FG001|Overall Study|Adverse Event|0|||
27765881|NCT00966693|80969687|FG002|Overall Study|Adverse Event|1|||
27765882|NCT00966693|80969688|FG003|Overall Study|Adverse Event|2|||
27765883|NCT00966693|80969685|FG000|Overall Study|Death|0|||
27765884|NCT00966693|80969686|FG001|Overall Study|Death|0|||
27765885|NCT00966693|80969687|FG002|Overall Study|Death|1|||
27765886|NCT00966693|80969688|FG003|Overall Study|Death|0|||
27765887|NCT00966693|80969685|FG000|Overall Study|Withdrawal by Subject|1|||
27765888|NCT00966693|80969686|FG001|Overall Study|Withdrawal by Subject|0|||
27765889|NCT00966693|80969687|FG002|Overall Study|Withdrawal by Subject|0|||
27765890|NCT00966693|80969688|FG003|Overall Study|Withdrawal by Subject|5|||
27765891|NCT00966693|80969685|FG000|Overall Study|Disease Progression|0|||
27765892|NCT00966693|80969686|FG001|Overall Study|Disease Progression|0|||
27765893|NCT00966693|80969687|FG002|Overall Study|Disease Progression|1|||
27765894|NCT00966693|80969688|FG003|Overall Study|Disease Progression|16|||
27765895|NCT00807014|80969689|FG000|Overall Study|Participant Considered Disease Cured|13|||
27765896|NCT00807014|80969690|FG001|Overall Study|Participant Considered Disease Cured|2|||
27765897|NCT00807014|80969689|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
27765898|NCT00807014|80969690|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
27765899|NCT00807014|80969689|FG000|Overall Study|Protocol Violation|2|||
27765900|NCT00807014|80969690|FG001|Overall Study|Protocol Violation|8|||
27765901|NCT00807014|80969689|FG000|Overall Study|Adverse Event|0|||
27765902|NCT00807014|80969690|FG001|Overall Study|Adverse Event|2|||
27765903|NCT00807014|80969689|FG000|Overall Study|Lost to Follow-up|9|||
27765904|NCT00807014|80969690|FG001|Overall Study|Lost to Follow-up|7|||
27765905|NCT00807014|80969689|FG000|Overall Study|Recovery|1|||
27765906|NCT00807014|80969690|FG001|Overall Study|Recovery|0|||
27765907|NCT00807014|80969689|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
27765908|NCT00807014|80969690|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
27765909|NCT01732107|80969694|FG000|Overall Study|Adverse Event|2|||
27765910|NCT01732107|80969694|FG000|Overall Study|Disease Progression|8|||
27765911|NCT01732107|80969694|FG000|Overall Study|Physician Decision|1|||
27765912|NCT01732107|80969694|FG000|Overall Study|Withdrawal by Subject|2|||
27765913|NCT02806947|80969695|FG000|Overall Study|Withdrawal by Subject|5|||
27765914|NCT02806947|80969696|FG001|Overall Study|Withdrawal by Subject|1|||
27765915|NCT03819218|80969699|FG000|Overall Study|Protocol Violation|1|||
27765916|NCT02062398|80969703|FG000|Overall Study|Implant removal|1|||
27962715|NCT00451958|81695207|FG000|CS21A (NCT00451958)|Physician Decision|2|||
27962716|NCT00451958|81695208|FG001|CS21A (NCT00451958)|Physician Decision|4|||
27962717|NCT00451958|81695209|FG002|CS21A (NCT00451958)|Physician Decision|4|||
27962718|NCT00451958|81695210|FG003|CS21A (NCT00451958)|Physician Decision|4|||
27962719|NCT00451958|81695211|FG004|CS21A (NCT00451958)|Physician Decision|0|||
27962720|NCT00451958|81695207|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
27962721|NCT00451958|81695208|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
27962722|NCT00451958|81695209|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
27962723|NCT00451958|81695210|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
27962724|NCT00451958|81695211|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
27962725|NCT00451958|81695207|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
27962726|NCT00451958|81695208|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
27962727|NCT00451958|81695209|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
27962728|NCT00451958|81695210|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
27962729|NCT00451958|81695211|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
27663484|NCT01184859|80606447|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27663485|NCT01184859|80606448|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27663486|NCT01184859|80606449|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27663487|NCT01184859|80606450|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
27663488|NCT02110225|80606451|FG000|Overall Study|Lost to Follow-up|0|||
27663489|NCT02110225|80606452|FG001|Overall Study|Lost to Follow-up|1|||
27663490|NCT02110225|80606453|FG002|Overall Study|Lost to Follow-up|0|||
27663491|NCT02996097|80606455|FG000|Overall Study|Lost to Follow-up|11|||
27663492|NCT02996097|80606456|FG001|Overall Study|Lost to Follow-up|11|||
27663493|NCT03357471|80606457|FG000|Overall Study|Adverse Event|1|||
27663494|NCT03357471|80606458|FG001|Overall Study|Adverse Event|0|||
27663495|NCT03357471|80606457|FG000|Overall Study|Lost to Follow-up|1|||
27663496|NCT03357471|80606458|FG001|Overall Study|Lost to Follow-up|0|||
27663497|NCT00907517|80606459|FG000|Overall Study|Progressive Disease|3|||
27663498|NCT00907517|80606460|FG001|Overall Study|Progressive Disease|3|||
27663499|NCT00907517|80606461|FG002|Overall Study|Progressive Disease|4|||
27663500|NCT00907517|80606462|FG003|Overall Study|Progressive Disease|4|||
27663501|NCT00907517|80606463|FG004|Overall Study|Progressive Disease|4|||
27663502|NCT00907517|80606459|FG000|Overall Study|Symptomatic Deterioration|0|||
27663503|NCT00907517|80606460|FG001|Overall Study|Symptomatic Deterioration|0|||
27663504|NCT00907517|80606461|FG002|Overall Study|Symptomatic Deterioration|0|||
27663505|NCT00907517|80606462|FG003|Overall Study|Symptomatic Deterioration|0|||
27663506|NCT00907517|80606463|FG004|Overall Study|Symptomatic Deterioration|1|||
27663507|NCT00920699|80606464|FG000|Overall Study|Withdrawal by Subject|2|||
27663508|NCT00920699|80606465|FG001|Overall Study|Withdrawal by Subject|0|||
27663509|NCT00920699|80606466|FG002|Overall Study|Withdrawal by Subject|2|||
27663510|NCT00920699|80606464|FG000|Overall Study|no longer met eligibility|0|||
27663511|NCT00920699|80606465|FG001|Overall Study|no longer met eligibility|1|||
27663512|NCT00920699|80606466|FG002|Overall Study|no longer met eligibility|0|||
27663513|NCT00920699|80606464|FG000|Overall Study|Lost to Follow-up|0|||
27663514|NCT00920699|80606465|FG001|Overall Study|Lost to Follow-up|0|||
27663515|NCT00920699|80606466|FG002|Overall Study|Lost to Follow-up|2|||
27663516|NCT00475735|80606469|FG000|Treatment Period 1|Adverse Event|2|||
27663517|NCT00475735|80606470|FG001|Treatment Period 1|Adverse Event|0|||
27663518|NCT00475735|80606471|FG002|Treatment Period 1|Adverse Event|0|||
27663519|NCT00475735|80606472|FG003|Treatment Period 1|Adverse Event|0|||
27663520|NCT00475735|80606473|FG004|Treatment Period 1|Adverse Event|0|||
27663521|NCT00475735|80606474|FG005|Treatment Period 1|Adverse Event|0|||
27663522|NCT00475735|80606469|FG000|Treatment Period 1|Lack of Efficacy|1|||
27663523|NCT00475735|80606470|FG001|Treatment Period 1|Lack of Efficacy|0|||
27663524|NCT00475735|80606471|FG002|Treatment Period 1|Lack of Efficacy|0|||
27663525|NCT00475735|80606472|FG003|Treatment Period 1|Lack of Efficacy|0|||
27663526|NCT00475735|80606473|FG004|Treatment Period 1|Lack of Efficacy|0|||
27663527|NCT00475735|80606474|FG005|Treatment Period 1|Lack of Efficacy|0|||
27663528|NCT00475735|80606469|FG000|Treatment Period 1|Lost to Follow-up|0|||
27663529|NCT00475735|80606470|FG001|Treatment Period 1|Lost to Follow-up|0|||
27663530|NCT00475735|80606471|FG002|Treatment Period 1|Lost to Follow-up|0|||
27663531|NCT00475735|80606472|FG003|Treatment Period 1|Lost to Follow-up|0|||
27663532|NCT00475735|80606473|FG004|Treatment Period 1|Lost to Follow-up|0|||
27663533|NCT00475735|80606474|FG005|Treatment Period 1|Lost to Follow-up|1|||
27663534|NCT00475735|80606469|FG000|Treatment Period 1|Protocol Violation|0|||
27765917|NCT00249795|80969706|FG000|Overall Study|Not treated|16|||
27962730|NCT00711594|81695212|FG000|Overall Study|Progressive disease|2|||
27962731|NCT00711594|81695213|FG001|Overall Study|Progressive disease|2|||
27765918|NCT00249795|80969707|FG001|Overall Study|Not treated|14|||
27765919|NCT00249795|80969706|FG000|Overall Study|Symptomatic hypotension|127|||
27765920|NCT00249795|80969707|FG001|Overall Study|Symptomatic hypotension|64|||
27765921|NCT00249795|80969706|FG000|Overall Study|Other Serious Adverse Event|84|||
27765922|NCT00249795|80969707|FG001|Overall Study|Other Serious Adverse Event|93|||
27765923|NCT00249795|80969706|FG000|Overall Study|Qualifying condition not present|26|||
27765924|NCT00249795|80969707|FG001|Overall Study|Qualifying condition not present|29|||
27765925|NCT00249795|80969706|FG000|Overall Study|Withdrawal by Subject|678|||
27765926|NCT00249795|80969707|FG001|Overall Study|Withdrawal by Subject|742|||
27765927|NCT00249795|80969706|FG000|Overall Study|Thromboembolic / outcome event|39|||
27765928|NCT00249795|80969707|FG001|Overall Study|Thromboembolic / outcome event|45|||
27765929|NCT00249795|80969706|FG000|Overall Study|Oral anticoagulant required|2|||
27765930|NCT00249795|80969707|FG001|Overall Study|Oral anticoagulant required|0|||
27765931|NCT00249795|80969706|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
27765932|NCT00249795|80969707|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
27765933|NCT00249795|80969706|FG000|Overall Study|Non-compliance|71|||
27765934|NCT00249795|80969707|FG001|Overall Study|Non-compliance|69|||
27765935|NCT00249795|80969706|FG000|Overall Study|Study drug intolerance|3|||
27765936|NCT00249795|80969707|FG001|Overall Study|Study drug intolerance|3|||
27765937|NCT00249795|80969706|FG000|Overall Study|Other adverse events (non-serious)|188|||
27765938|NCT00249795|80969707|FG001|Overall Study|Other adverse events (non-serious)|159|||
27765939|NCT00249795|80969706|FG000|Overall Study|Physician withdrew consent|71|||
27765940|NCT00249795|80969707|FG001|Overall Study|Physician withdrew consent|63|||
27765941|NCT00249795|80969706|FG000|Overall Study|Surgery / procedure|4|||
27765942|NCT00249795|80969707|FG001|Overall Study|Surgery / procedure|5|||
27765943|NCT00249795|80969706|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
27765944|NCT00249795|80969707|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
27765945|NCT00249795|80969706|FG000|Overall Study|Lightheadedness / dizziness|15|||
27765946|NCT00249795|80969707|FG001|Overall Study|Lightheadedness / dizziness|11|||
27765947|NCT00249795|80969706|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
27765948|NCT00249795|80969707|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
27765949|NCT00249795|80969706|FG000|Overall Study|Other contraindicated medication|1|||
27765950|NCT00249795|80969707|FG001|Overall Study|Other contraindicated medication|1|||
27765951|NCT00249795|80969706|FG000|Overall Study|Event related to cardiac condition|17|||
27765952|NCT00249795|80969707|FG001|Overall Study|Event related to cardiac condition|16|||
27765953|NCT00249795|80969706|FG000|Overall Study|Patient not wish to continue after May08|4|||
27765954|NCT00249795|80969707|FG001|Overall Study|Patient not wish to continue after May08|6|||
27765955|NCT00249795|80969706|FG000|Overall Study|Site not agree to continue after May08|1|||
27765956|NCT00249795|80969707|FG001|Overall Study|Site not agree to continue after May08|1|||
27765957|NCT00249795|80969706|FG000|Overall Study|Lost to Follow-up|0|||
27765958|NCT00249795|80969707|FG001|Overall Study|Lost to Follow-up|2|||
27765959|NCT00249795|80969706|FG000|Overall Study|Missing|0|||
27765960|NCT00249795|80969707|FG001|Overall Study|Missing|1|||
27765961|NCT04397796|80969713|FG000|Overall Study|Death|3|||
27765962|NCT04397796|80969714|FG001|Overall Study|Death|1|||
27765963|NCT01293084|80969715|FG000|Overall Study|Physician Decision|3|||
27765964|NCT01293084|80969715|FG000|Overall Study|Withdrawal by Subject|2|||
27765965|NCT02150213|80969716|FG000|Overall Study|Lost to Follow-up|1|||
27765966|NCT02150213|80969716|FG000|Overall Study|Withdrawal by Subject|1|||
27765967|NCT00435994|80969717|FG000|Overall Study|Lost to Follow-up|7|||
27765968|NCT00435994|80969718|FG001|Overall Study|Lost to Follow-up|0|||
27765969|NCT00435994|80969719|FG002|Overall Study|Lost to Follow-up|0|||
27765970|NCT03024255|80969720|FG000|Overall Study|Adverse Event|1|||
27765971|NCT03024255|80969721|FG001|Overall Study|Adverse Event|4|||
27765972|NCT03024255|80969722|FG002|Overall Study|Adverse Event|8|||
27765973|NCT03024255|80969723|FG003|Overall Study|Adverse Event|0|||
27765974|NCT03024255|80969720|FG000|Overall Study|Withdrawal by Subject|3|||
27765975|NCT03024255|80969721|FG001|Overall Study|Withdrawal by Subject|1|||
27765976|NCT03024255|80969722|FG002|Overall Study|Withdrawal by Subject|0|||
27765977|NCT03024255|80969723|FG003|Overall Study|Withdrawal by Subject|3|||
27765978|NCT03024255|80969720|FG000|Overall Study|Protocol Violation|0|||
27765979|NCT03024255|80969721|FG001|Overall Study|Protocol Violation|0|||
27765980|NCT03024255|80969722|FG002|Overall Study|Protocol Violation|2|||
27765981|NCT03024255|80969723|FG003|Overall Study|Protocol Violation|0|||
27765982|NCT03024255|80969720|FG000|Overall Study|Lost to Follow-up|1|||
27765983|NCT03024255|80969721|FG001|Overall Study|Lost to Follow-up|2|||
27765984|NCT03024255|80969722|FG002|Overall Study|Lost to Follow-up|1|||
27765985|NCT03024255|80969723|FG003|Overall Study|Lost to Follow-up|1|||
27765986|NCT03024255|80969720|FG000|Overall Study|Lack of Efficacy|1|||
27765987|NCT03024255|80969721|FG001|Overall Study|Lack of Efficacy|0|||
27765988|NCT03024255|80969722|FG002|Overall Study|Lack of Efficacy|0|||
27765989|NCT03024255|80969723|FG003|Overall Study|Lack of Efficacy|0|||
27765990|NCT03024255|80969720|FG000|Overall Study|Protocol Noncompliance|1|||
27765991|NCT03024255|80969721|FG001|Overall Study|Protocol Noncompliance|1|||
27765992|NCT03024255|80969722|FG002|Overall Study|Protocol Noncompliance|0|||
27765993|NCT03024255|80969723|FG003|Overall Study|Protocol Noncompliance|1|||
27765994|NCT00418717|80969724|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
27765995|NCT00418717|80969724|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
27765996|NCT00367432|80969725|FG000|First Period (16 Weeks)|Adverse Event|6|||
27765997|NCT00367432|80969726|FG001|First Period (16 Weeks)|Adverse Event|0|||
27765998|NCT00367432|80969725|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
27765999|NCT00367432|80969726|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
27766000|NCT00367432|80969725|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
27766001|NCT00367432|80969726|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
27766002|NCT00367432|80969725|FG000|First Period (16 Weeks)|Other Reason|2|||
27766003|NCT00367432|80969726|FG001|First Period (16 Weeks)|Other Reason|0|||
27766004|NCT00367432|80969725|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
27766005|NCT00367432|80969726|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
27766006|NCT00367432|80969725|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
27766007|NCT00367432|80969726|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
27766008|NCT00367432|80969725|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
27766009|NCT00367432|80969726|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
27766010|NCT00367432|80969725|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
27766011|NCT00367432|80969726|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
27766012|NCT00367432|80969725|FG000|Second Period (up to 54 Months)|Other Reason|6|||
27766013|NCT00367432|80969726|FG001|Second Period (up to 54 Months)|Other Reason|2|||
27766014|NCT00927758|80969730|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27766015|NCT00927758|80969731|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27766016|NCT00927758|80969732|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27766017|NCT00927758|80969733|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
27766018|NCT00927758|80969734|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
27766019|NCT00927758|80969735|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
27766020|NCT00927758|80969730|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
27766021|NCT00927758|80969731|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
27766022|NCT00927758|80969732|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
27766023|NCT00927758|80969733|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
27766024|NCT00927758|80969734|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
27766025|NCT00927758|80969735|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
27766026|NCT02177175|80969736|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
27766027|NCT02177175|80969737|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
27766028|NCT00209170|80969738|FG000|Overall Study|Adverse Event|0|||
27766029|NCT00209170|80969739|FG001|Overall Study|Adverse Event|1|||
27766030|NCT00209170|80969738|FG000|Overall Study|Withdrawal by Subject|2|||
27766031|NCT00209170|80969739|FG001|Overall Study|Withdrawal by Subject|1|||
27766032|NCT00209170|80969738|FG000|Overall Study|Lack of Efficacy|0|||
27766033|NCT00209170|80969739|FG001|Overall Study|Lack of Efficacy|1|||
27766034|NCT01878097|80969740|FG000|Baseline|Surveys not fully completed|2497|||
27766035|NCT01878097|80969741|FG001|Baseline|Surveys not fully completed|1800|||
27766036|NCT01878097|80969740|FG000|Implementation Year 1|Surveys not fully completed|3202|||
27766037|NCT01878097|80969741|FG001|Implementation Year 1|Surveys not fully completed|2549|||
27766038|NCT01878097|80969740|FG000|Implementation Year 2|Surveys not fully completed|3281|||
27766039|NCT01878097|80969741|FG001|Implementation Year 2|Surveys not fully completed|2841|||
27766040|NCT01878097|80969740|FG000|Implementation Year 3|Surveys not fully completed|3494|||
27766041|NCT01878097|80969741|FG001|Implementation Year 3|Surveys not fully completed|2980|||
27766042|NCT01878097|80969740|FG000|Implementation Year 4|Surveys not fully completed|3604|||
27766043|NCT01878097|80969741|FG001|Implementation Year 4|Surveys not fully completed|3007|||
27766044|NCT01451398|80969742|FG000|Overall Study|Adverse Event|7|||
27766045|NCT01451398|80969743|FG001|Overall Study|Adverse Event|9|||
27766046|NCT01451398|80969742|FG000|Overall Study|Protocol Violation|1|||
27962732|NCT00711594|81695214|FG002|Overall Study|Progressive disease|6|||
27962733|NCT00711594|81695215|FG003|Overall Study|Progressive disease|44|||
27766047|NCT01451398|80969743|FG001|Overall Study|Protocol Violation|2|||
27766048|NCT01451398|80969742|FG000|Overall Study|Physician Decision|1|||
27766049|NCT01451398|80969743|FG001|Overall Study|Physician Decision|1|||
27766050|NCT01451398|80969742|FG000|Overall Study|Withdrawal by Subject|10|||
27766051|NCT01451398|80969743|FG001|Overall Study|Withdrawal by Subject|14|||
27766052|NCT01451398|80969742|FG000|Overall Study|Lost to Follow-up|6|||
27766053|NCT01451398|80969743|FG001|Overall Study|Lost to Follow-up|4|||
27766054|NCT01451398|80969742|FG000|Overall Study|Non-compliance with study drug|1|||
27766055|NCT01451398|80969743|FG001|Overall Study|Non-compliance with study drug|3|||
27766056|NCT01451398|80969742|FG000|Overall Study|Non-compliance with protocol|1|||
27766057|NCT01451398|80969743|FG001|Overall Study|Non-compliance with protocol|1|||
27766058|NCT01451398|80969742|FG000|Overall Study|Moved out of country|0|||
27766059|NCT01451398|80969743|FG001|Overall Study|Moved out of country|1|||
27962734|NCT00711594|81695212|FG000|Overall Study|Other Adverse Event|1|||
27766060|NCT01451398|80969742|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
27766061|NCT01451398|80969743|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
27766062|NCT01451398|80969742|FG000|Overall Study|Lack of Efficacy|0|||
27766063|NCT01451398|80969743|FG001|Overall Study|Lack of Efficacy|1|||
27766064|NCT03365947|80969745|FG000|Overall Study|Lost to Follow-up|0|||
27766065|NCT03365947|80969746|FG001|Overall Study|Lost to Follow-up|0|||
27766066|NCT03365947|80969747|FG002|Overall Study|Lost to Follow-up|0|||
27766067|NCT03365947|80969748|FG003|Overall Study|Lost to Follow-up|0|||
27766068|NCT03365947|80969749|FG004|Overall Study|Lost to Follow-up|0|||
27766069|NCT03365947|80969750|FG005|Overall Study|Lost to Follow-up|1|||
27766070|NCT03365947|80969751|FG006|Overall Study|Lost to Follow-up|0|||
27766071|NCT03365947|80969752|FG007|Overall Study|Lost to Follow-up|0|||
27766072|NCT03365947|80969753|FG008|Overall Study|Lost to Follow-up|0|||
27766073|NCT03365947|80969754|FG009|Overall Study|Lost to Follow-up|0|||
27766074|NCT03365947|80969755|FG010|Overall Study|Lost to Follow-up|0|||
27766075|NCT03365947|80969756|FG011|Overall Study|Lost to Follow-up|0|||
27766076|NCT03365947|80969757|FG012|Overall Study|Lost to Follow-up|0|||
27766077|NCT03365947|80969758|FG013|Overall Study|Lost to Follow-up|0|||
27766078|NCT03365947|80969759|FG014|Overall Study|Lost to Follow-up|0|||
27766079|NCT03365947|80969760|FG015|Overall Study|Lost to Follow-up|0|||
27766080|NCT03365947|80969761|FG016|Overall Study|Lost to Follow-up|0|||
27766081|NCT03365947|80969762|FG017|Overall Study|Lost to Follow-up|0|||
27766082|NCT03365947|80969763|FG018|Overall Study|Lost to Follow-up|0|||
27766083|NCT00425100|80973016|FG000|Overall Study|Adverse Event|36|||
27766084|NCT00425100|80973016|FG000|Overall Study|Lack of Efficacy|4|||
27766085|NCT00425100|80973016|FG000|Overall Study|Lost to Follow-up|2|||
27766086|NCT00425100|80973016|FG000|Overall Study|Protocol Violation|4|||
27766087|NCT00425100|80973016|FG000|Overall Study|Withdrawal by Subject|7|||
27766088|NCT00967226|80973019|FG000|Overall Study|Adverse Event|0|||
27766089|NCT00967226|80973020|FG001|Overall Study|Adverse Event|5|||
27766090|NCT00967226|80973019|FG000|Overall Study|Protocol Violation|2|||
27766091|NCT00967226|80973020|FG001|Overall Study|Protocol Violation|0|||
27766092|NCT00967226|80973019|FG000|Overall Study|Physician Decision|0|||
27766093|NCT00967226|80973020|FG001|Overall Study|Physician Decision|1|||
27766094|NCT02670928|80973024|FG000|Overall Study|Adverse Event|3|||
27766095|NCT02670928|80973025|FG001|Overall Study|Adverse Event|1|||
27766096|NCT02670928|80973024|FG000|Overall Study|Withdrawal by Subject|4|||
27766097|NCT02670928|80973025|FG001|Overall Study|Withdrawal by Subject|0|||
27766098|NCT02670928|80973024|FG000|Overall Study|Lost to Follow-up|1|||
27766099|NCT02670928|80973025|FG001|Overall Study|Lost to Follow-up|0|||
27766100|NCT02670928|80973024|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
27766101|NCT02670928|80973025|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
27766102|NCT01263093|80973033|FG000|Washout|Physician Decision|1|||
27766103|NCT01263093|80973034|FG001|Washout|Physician Decision|0|||
27766104|NCT01263093|80973033|FG000|Period 2|Adverse Event|1|||
27766105|NCT01263093|80973034|FG001|Period 2|Adverse Event|0|||
27766106|NCT02571972|80973035|FG000|Overall Study|Protocol Violation|2|||
27766107|NCT02571972|80973035|FG000|Overall Study|Withdrawal by Subject|2|||
27766108|NCT04114539|80973041|FG000|Overall Study|Adverse Event|14|||
27766109|NCT04114539|80973041|FG000|Overall Study|Lost to Follow-up|2|||
27766110|NCT04114539|80973041|FG000|Overall Study|Non-compliance with Protocol|2|||
27766111|NCT04114539|80973041|FG000|Overall Study|Non-compliance with Study Drug|1|||
27766112|NCT04114539|80973041|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
27766113|NCT04114539|80973041|FG000|Overall Study|Withdrew consent|10|||
27766114|NCT04114539|80973041|FG000|Overall Study|Others not specified|5|||
27766115|NCT04114539|80973041|FG000|Overall Study|Investigator Decision|2|||
27766116|NCT04024462|80973042|FG000|Overall Study|Withdrawal by Subject|6|||
27766117|NCT04024462|80973043|FG001|Overall Study|Withdrawal by Subject|7|||
27766118|NCT04024462|80973042|FG000|Overall Study|Progressive Disease|0|||
27766119|NCT04024462|80973043|FG001|Overall Study|Progressive Disease|1|||
27766120|NCT04024462|80973042|FG000|Overall Study|Adverse Event|0|||
27568844|NCT02347527|80271463|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
27568845|NCT02347527|80271464|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
27568846|NCT02347527|80271465|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
27766121|NCT04024462|80973043|FG001|Overall Study|Adverse Event|1|||
27766122|NCT04024462|80973042|FG000|Overall Study|Death|0|||
27766123|NCT04024462|80973043|FG001|Overall Study|Death|1|||
27766124|NCT04024462|80973042|FG000|Overall Study|Lost to Follow-up|1|||
27766125|NCT04024462|80973043|FG001|Overall Study|Lost to Follow-up|0|||
27766126|NCT04024462|80973042|FG000|Overall Study|Ongoing in the Study|94|||
27766127|NCT04024462|80973043|FG001|Overall Study|Ongoing in the Study|89|||
27766128|NCT02088541|80973044|FG000|Overall Study|Adverse Event|3|||
27766129|NCT02088541|80973045|FG001|Overall Study|Adverse Event|0|||
27766130|NCT02088541|80973046|FG002|Overall Study|Adverse Event|3|||
27766131|NCT02088541|80973047|FG003|Overall Study|Adverse Event|3|||
27766132|NCT02088541|80973048|FG004|Overall Study|Adverse Event|0|||
27962735|NCT00711594|81695213|FG001|Overall Study|Other Adverse Event|0|||
27766133|NCT02088541|80973044|FG000|Overall Study|Death|51|||
27766134|NCT02088541|80973045|FG001|Overall Study|Death|21|||
27766135|NCT02088541|80973046|FG002|Overall Study|Death|85|||
27766136|NCT02088541|80973047|FG003|Overall Study|Death|28|||
27766137|NCT02088541|80973048|FG004|Overall Study|Death|38|||
27766138|NCT02088541|80973044|FG000|Overall Study|Lost to Follow-up|2|||
27766139|NCT02088541|80973045|FG001|Overall Study|Lost to Follow-up|0|||
27766140|NCT02088541|80973046|FG002|Overall Study|Lost to Follow-up|1|||
27766141|NCT02088541|80973047|FG003|Overall Study|Lost to Follow-up|0|||
27766142|NCT02088541|80973048|FG004|Overall Study|Lost to Follow-up|0|||
27766143|NCT02088541|80973044|FG000|Overall Study|Physician Decision|2|||
27766144|NCT02088541|80973045|FG001|Overall Study|Physician Decision|1|||
27766145|NCT02088541|80973046|FG002|Overall Study|Physician Decision|2|||
27766146|NCT02088541|80973047|FG003|Overall Study|Physician Decision|0|||
27766147|NCT02088541|80973048|FG004|Overall Study|Physician Decision|2|||
27766148|NCT02088541|80973044|FG000|Overall Study|Disease progression|7|||
27766149|NCT02088541|80973045|FG001|Overall Study|Disease progression|1|||
27766150|NCT02088541|80973046|FG002|Overall Study|Disease progression|2|||
27766151|NCT02088541|80973047|FG003|Overall Study|Disease progression|3|||
27766152|NCT02088541|80973048|FG004|Overall Study|Disease progression|1|||
27766153|NCT02088541|80973044|FG000|Overall Study|Study terminated by sponsor|1|||
27766154|NCT02088541|80973045|FG001|Overall Study|Study terminated by sponsor|1|||
27766155|NCT02088541|80973046|FG002|Overall Study|Study terminated by sponsor|12|||
27766156|NCT02088541|80973047|FG003|Overall Study|Study terminated by sponsor|2|||
27766157|NCT02088541|80973048|FG004|Overall Study|Study terminated by sponsor|6|||
27766158|NCT02088541|80973044|FG000|Overall Study|Withdrawal by Subject|3|||
27766159|NCT02088541|80973045|FG001|Overall Study|Withdrawal by Subject|2|||
27766160|NCT02088541|80973046|FG002|Overall Study|Withdrawal by Subject|9|||
27766161|NCT02088541|80973047|FG003|Overall Study|Withdrawal by Subject|7|||
27766162|NCT02088541|80973048|FG004|Overall Study|Withdrawal by Subject|10|||
27766163|NCT02088541|80973044|FG000|Overall Study|Other|2|||
27766164|NCT02088541|80973045|FG001|Overall Study|Other|1|||
27766165|NCT02088541|80973046|FG002|Overall Study|Other|3|||
27766166|NCT02088541|80973047|FG003|Overall Study|Other|1|||
27766167|NCT02088541|80973048|FG004|Overall Study|Other|1|||
27962736|NCT00711594|81695214|FG002|Overall Study|Other Adverse Event|0|||
27962737|NCT00711594|81695215|FG003|Overall Study|Other Adverse Event|16|||
27962738|NCT00711594|81695212|FG000|Overall Study|Withdrawal by Subject|0|||
27962739|NCT00711594|81695213|FG001|Overall Study|Withdrawal by Subject|1|||
27962740|NCT00711594|81695214|FG002|Overall Study|Withdrawal by Subject|0|||
27962741|NCT00711594|81695215|FG003|Overall Study|Withdrawal by Subject|2|||
27962742|NCT02817776|81695218|FG000|Overall Study|Excluded|33|||
27962743|NCT02817776|81695218|FG000|Overall Study|Lost to Follow-up|20|||
27962744|NCT02817776|81695218|FG000|Overall Study|Withdrawal by Subject|33|||
27766168|NCT01281189|80973049|FG000|Overall Study|Adverse Event|7|||
27766169|NCT01281189|80973050|FG001|Overall Study|Adverse Event|9|||
27766170|NCT01281189|80973049|FG000|Overall Study|Lost to Follow-up|6|||
27766171|NCT01281189|80973050|FG001|Overall Study|Lost to Follow-up|4|||
27766172|NCT01281189|80973049|FG000|Overall Study|Withdrawal by Subject|21|||
27766173|NCT01281189|80973050|FG001|Overall Study|Withdrawal by Subject|24|||
27766174|NCT01281189|80973049|FG000|Overall Study|Physician Decision|2|||
27766175|NCT01281189|80973050|FG001|Overall Study|Physician Decision|3|||
27766176|NCT01281189|80973049|FG000|Overall Study|Death|103|||
27766177|NCT01281189|80973050|FG001|Overall Study|Death|91|||
27766178|NCT01281189|80973049|FG000|Overall Study|Other|8|||
27766179|NCT01281189|80973050|FG001|Overall Study|Other|12|||
27766180|NCT03488238|80973051|FG000|Overall Study|Equipment malfunction|1|||
27766181|NCT03488238|80973051|FG000|Overall Study|Adverse Event|1|||
27766182|NCT01192204|80973055|FG000|Overall Study|could not keep recall appointments|1|||
27766183|NCT01192204|80973056|FG001|Overall Study|could not keep recall appointments|0|||
27766184|NCT03628599|80973057|FG000|Overall Study|Adverse Event|0|||
27766185|NCT03628599|80973058|FG001|Overall Study|Adverse Event|1|||
27766186|NCT04702984|80973059|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
27766187|NCT00571688|80973060|FG000|Overall Study|Lost to Follow-up|3|||
27766188|NCT00571688|80973061|FG001|Overall Study|Lost to Follow-up|6|||
27766189|NCT00571688|80973060|FG000|Overall Study|subject did not tolerate Consta|1|||
27766190|NCT00571688|80973061|FG001|Overall Study|subject did not tolerate Consta|0|||
27766191|NCT00571688|80973060|FG000|Overall Study|subject moved out of the area|1|||
27766192|NCT00571688|80973061|FG001|Overall Study|subject moved out of the area|0|||
27766193|NCT01705587|80973064|FG000|Overall Study|Withdrawal by Subject|0|||
27766194|NCT01705587|80973065|FG001|Overall Study|Withdrawal by Subject|1|||
27766195|NCT00323310|80973068|FG000|Overall Study|Withdrawal by Subject|1|||
27766196|NCT00323310|80973068|FG000|Overall Study|a parent refused blood draw|1|||
27766197|NCT00323310|80973068|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
27766198|NCT01357889|80973071|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
27766199|NCT01357889|80973072|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
27766200|NCT01357889|80973071|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
27766201|NCT01357889|80973072|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
27962745|NCT02817776|81695218|FG000|Overall Study|Death|2|||
27962746|NCT00391053|81695224|FG000|Overall Study|Serious Adverse Events|1|||
27962747|NCT00391053|81695225|FG001|Overall Study|Serious Adverse Events|0|||
27766202|NCT01357889|80973071|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
27766203|NCT01357889|80973072|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
27766204|NCT01357889|80973071|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
27766205|NCT01357889|80973072|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
27766206|NCT01357889|80973071|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
27766207|NCT01357889|80973072|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
27766208|NCT01357889|80973071|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
27766209|NCT01357889|80973072|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
27766210|NCT01357889|80973071|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
27766211|NCT01357889|80973072|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
27766212|NCT01357889|80973071|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
27766213|NCT01357889|80973072|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
27766214|NCT01357889|80973071|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
27568847|NCT02347527|80271466|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
27663535|NCT00475735|80606470|FG001|Treatment Period 1|Protocol Violation|0|||
27663536|NCT00475735|80606471|FG002|Treatment Period 1|Protocol Violation|0|||
27663537|NCT00475735|80606472|FG003|Treatment Period 1|Protocol Violation|1|||
27663538|NCT00475735|80606473|FG004|Treatment Period 1|Protocol Violation|0|||
27663539|NCT00475735|80606474|FG005|Treatment Period 1|Protocol Violation|0|||
27663540|NCT00475735|80606469|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27663541|NCT00475735|80606470|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27663542|NCT00475735|80606471|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27663543|NCT00475735|80606472|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27663544|NCT00475735|80606473|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27663545|NCT00475735|80606474|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27663546|NCT00475735|80606469|FG000|Treatment Period 1|DC due to AE but continuing|0|||
27663547|NCT00475735|80606470|FG001|Treatment Period 1|DC due to AE but continuing|0|||
27663548|NCT00475735|80606471|FG002|Treatment Period 1|DC due to AE but continuing|0|||
27663549|NCT00475735|80606472|FG003|Treatment Period 1|DC due to AE but continuing|1|||
27663550|NCT00475735|80606473|FG004|Treatment Period 1|DC due to AE but continuing|2|||
27663551|NCT00475735|80606474|FG005|Treatment Period 1|DC due to AE but continuing|2|||
27663552|NCT00475735|80606469|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27663553|NCT00475735|80606470|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
27663554|NCT00475735|80606471|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27663555|NCT00475735|80606472|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27663556|NCT00475735|80606473|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27663557|NCT00475735|80606474|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
27663558|NCT00475735|80606469|FG000|Treatment Washout|Lost to Follow-up|0|||
27663559|NCT00475735|80606470|FG001|Treatment Washout|Lost to Follow-up|1|||
27663560|NCT00475735|80606471|FG002|Treatment Washout|Lost to Follow-up|0|||
27663561|NCT00475735|80606472|FG003|Treatment Washout|Lost to Follow-up|0|||
27663562|NCT00475735|80606473|FG004|Treatment Washout|Lost to Follow-up|0|||
27663563|NCT00475735|80606474|FG005|Treatment Washout|Lost to Follow-up|0|||
27663564|NCT00475735|80606469|FG000|Treatment Washout|Protocol Violation|0|||
27663565|NCT00475735|80606470|FG001|Treatment Washout|Protocol Violation|1|||
27663566|NCT00475735|80606471|FG002|Treatment Washout|Protocol Violation|0|||
27663567|NCT00475735|80606472|FG003|Treatment Washout|Protocol Violation|0|||
27663568|NCT00475735|80606473|FG004|Treatment Washout|Protocol Violation|0|||
27663569|NCT00475735|80606474|FG005|Treatment Washout|Protocol Violation|0|||
27663570|NCT00475735|80606469|FG000|Treatment Period 2|Adverse Event|0|||
27663571|NCT00475735|80606470|FG001|Treatment Period 2|Adverse Event|1|||
27663572|NCT00475735|80606471|FG002|Treatment Period 2|Adverse Event|0|||
27663573|NCT00475735|80606472|FG003|Treatment Period 2|Adverse Event|2|||
27663574|NCT00475735|80606473|FG004|Treatment Period 2|Adverse Event|0|||
27663575|NCT00475735|80606474|FG005|Treatment Period 2|Adverse Event|0|||
27663576|NCT00475735|80606469|FG000|Treatment Period 2|Lack of Efficacy|0|||
27663577|NCT00475735|80606470|FG001|Treatment Period 2|Lack of Efficacy|0|||
27663578|NCT00475735|80606471|FG002|Treatment Period 2|Lack of Efficacy|0|||
27663579|NCT00475735|80606472|FG003|Treatment Period 2|Lack of Efficacy|0|||
27663580|NCT00475735|80606473|FG004|Treatment Period 2|Lack of Efficacy|0|||
27663581|NCT00475735|80606474|FG005|Treatment Period 2|Lack of Efficacy|1|||
27663582|NCT00475735|80606469|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27663583|NCT00475735|80606470|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27663584|NCT00475735|80606471|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27663585|NCT00475735|80606472|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27663586|NCT00475735|80606473|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27663587|NCT00475735|80606474|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27663588|NCT02995733|80606478|FG000|Overall Study|Study site closed|9|||
27663589|NCT02995733|80606479|FG001|Overall Study|Study site closed|10|||
27663590|NCT02995733|80606478|FG000|Overall Study|Death|3|||
27663591|NCT02995733|80606479|FG001|Overall Study|Death|4|||
27663592|NCT02995733|80606478|FG000|Overall Study|Withdrawal by Subject|6|||
27766215|NCT01357889|80973072|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
27766216|NCT01357889|80973071|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
27766217|NCT01357889|80973072|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
27766218|NCT01357889|80973071|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
27766219|NCT01357889|80973072|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
27766220|NCT01357889|80973071|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
27766221|NCT01357889|80973072|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
27766222|NCT01357889|80973071|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
27766223|NCT01357889|80973072|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
27766224|NCT00724815|80973073|FG000|Overall Study|Randomized, not treated|31|||
27766225|NCT00724815|80973074|FG001|Overall Study|Randomized, not treated|30|||
27766226|NCT00724815|80973073|FG000|Overall Study|Adverse Event|5|||
27766227|NCT00724815|80973074|FG001|Overall Study|Adverse Event|3|||
27766228|NCT00724815|80973073|FG000|Overall Study|Lost to Follow-up|4|||
27766229|NCT00724815|80973074|FG001|Overall Study|Lost to Follow-up|1|||
27766230|NCT00724815|80973073|FG000|Overall Study|Other Various|3|||
27766231|NCT00724815|80973074|FG001|Overall Study|Other Various|5|||
27766232|NCT00981747|80973078|FG000|Losartan|Withdrawal by Subject|1|||
27766233|NCT00981747|80973078|FG000|Losartan|Death|1|||
27766234|NCT00981747|80973078|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
27766235|NCT01494987|80973086|FG000|Overall Study|Adverse Event|6|||
27766236|NCT01494987|80973087|FG001|Overall Study|Adverse Event|5|||
27766237|NCT01494987|80973086|FG000|Overall Study|Hyperglycemia|6|||
27766238|NCT01494987|80973087|FG001|Overall Study|Hyperglycemia|4|||
27766239|NCT01494987|80973086|FG000|Overall Study|Investigator's Discretion|1|||
27766240|NCT01494987|80973087|FG001|Overall Study|Investigator's Discretion|2|||
27766241|NCT01494987|80973086|FG000|Overall Study|Lost to Follow-up|1|||
27766242|NCT01494987|80973087|FG001|Overall Study|Lost to Follow-up|1|||
27766243|NCT01494987|80973086|FG000|Overall Study|Protocol Violation|3|||
27766244|NCT01494987|80973087|FG001|Overall Study|Protocol Violation|3|||
27766245|NCT01494987|80973086|FG000|Overall Study|Subject Non-Compliance|9|||
27766246|NCT01494987|80973087|FG001|Overall Study|Subject Non-Compliance|10|||
27766247|NCT01494987|80973086|FG000|Overall Study|Subject Withdrew Consent|2|||
27766248|NCT01494987|80973087|FG001|Overall Study|Subject Withdrew Consent|3|||
27766249|NCT02142504|80973088|FG000|Overall Study|Protocol Violation|2|||
27766250|NCT02142504|80973089|FG001|Overall Study|Protocol Violation|1|||
27766251|NCT02142504|80973090|FG002|Overall Study|Protocol Violation|2|||
27766252|NCT02142504|80973088|FG000|Overall Study|Adverse Event|2|||
27766253|NCT02142504|80973089|FG001|Overall Study|Adverse Event|3|||
27766254|NCT02142504|80973090|FG002|Overall Study|Adverse Event|4|||
27766255|NCT02142504|80973088|FG000|Overall Study|Lost to Follow-up|12|||
27766256|NCT02142504|80973089|FG001|Overall Study|Lost to Follow-up|19|||
27766257|NCT02142504|80973090|FG002|Overall Study|Lost to Follow-up|17|||
27766258|NCT02142504|80973088|FG000|Overall Study|Withdrawal by Subject|7|||
27766259|NCT02142504|80973089|FG001|Overall Study|Withdrawal by Subject|9|||
27766260|NCT02142504|80973090|FG002|Overall Study|Withdrawal by Subject|11|||
27766261|NCT02142504|80973088|FG000|Overall Study|Pregnancy|4|||
27766262|NCT02142504|80973089|FG001|Overall Study|Pregnancy|4|||
27766263|NCT02142504|80973090|FG002|Overall Study|Pregnancy|2|||
27766264|NCT02142504|80973088|FG000|Overall Study|Physician Decision|0|||
27766265|NCT02142504|80973089|FG001|Overall Study|Physician Decision|1|||
27766266|NCT02142504|80973090|FG002|Overall Study|Physician Decision|3|||
27766267|NCT02142504|80973088|FG000|Overall Study|Reason Not Specified|4|||
27766268|NCT02142504|80973089|FG001|Overall Study|Reason Not Specified|5|||
27962748|NCT00391053|81695226|FG002|Overall Study|Serious Adverse Events|1|||
27962749|NCT00391053|81695227|FG003|Overall Study|Serious Adverse Events|4|||
27962750|NCT00391053|81695224|FG000|Overall Study|Protocol Violation|2|||
27962751|NCT00391053|81695225|FG001|Overall Study|Protocol Violation|0|||
27962752|NCT00391053|81695226|FG002|Overall Study|Protocol Violation|0|||
27962753|NCT00391053|81695227|FG003|Overall Study|Protocol Violation|0|||
27766269|NCT02142504|80973090|FG002|Overall Study|Reason Not Specified|4|||
27766270|NCT00092677|80973091|FG000|Overall Study|Lost to Follow-up|0|||
27766271|NCT00092677|80973092|FG001|Overall Study|Lost to Follow-up|2|||
27766272|NCT00092677|80973091|FG000|Overall Study|Adminstrative|5|||
27766273|NCT00092677|80973092|FG001|Overall Study|Adminstrative|9|||
27766274|NCT00830115|80973094|FG000|Overall Study|Adverse Event|2|||
27766275|NCT00830115|80973094|FG000|Overall Study|Improvement/recovery|1|||
27766276|NCT00045630|80973095|FG000|Overall Study|Adverse Event|1|||
27766277|NCT00045630|80973095|FG000|Overall Study|Refusal unrelated to adverse event|1|||
27766278|NCT00045630|80973095|FG000|Overall Study|Progression/relapse|1|||
27766279|NCT00045630|80973095|FG000|Overall Study|Death|1|||
27766280|NCT00045630|80973095|FG000|Overall Study|Ineligible|2|||
27766281|NCT03339401|80973096|FG000|Overall Study|Death|2|||
27766282|NCT03339401|80973097|FG001|Overall Study|Death|1|||
27766283|NCT03339401|80973096|FG000|Overall Study|Withdrawal by Subject|2|||
27962754|NCT00391053|81695224|FG000|Overall Study|Lost to Follow-up|1|||
27962755|NCT00391053|81695225|FG001|Overall Study|Lost to Follow-up|0|||
27962756|NCT00391053|81695226|FG002|Overall Study|Lost to Follow-up|0|||
27766284|NCT03339401|80973097|FG001|Overall Study|Withdrawal by Subject|0|||
27962757|NCT00391053|81695227|FG003|Overall Study|Lost to Follow-up|5|||
27962758|NCT00391053|81695224|FG000|Overall Study|Withdrawal by Subject|5|||
27962759|NCT00391053|81695225|FG001|Overall Study|Withdrawal by Subject|1|||
27962760|NCT00391053|81695226|FG002|Overall Study|Withdrawal by Subject|1|||
27962761|NCT00391053|81695227|FG003|Overall Study|Withdrawal by Subject|1|||
27962762|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
27962763|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
27962764|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
27962765|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
27962766|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
27962767|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
27962768|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
27962769|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
27962770|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
27962771|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
27766285|NCT03339401|80973096|FG000|Overall Study|Study terminated|4|||
27766286|NCT03339401|80973097|FG001|Overall Study|Study terminated|3|||
27766287|NCT03339401|80973096|FG000|Overall Study|Investigator Decision|1|||
27766288|NCT03339401|80973097|FG001|Overall Study|Investigator Decision|0|||
27766289|NCT00268463|80973100|FG000|Overall Study|study terminated due to low accrual|10|||
27766290|NCT00268463|80973101|FG001|Overall Study|study terminated due to low accrual|12|||
27766291|NCT00696436|80973104|FG000|Overall Study|Adverse Event|7|||
27766292|NCT00696436|80973105|FG001|Overall Study|Adverse Event|9|||
27766293|NCT00696436|80973106|FG002|Overall Study|Adverse Event|8|||
27766294|NCT00696436|80973107|FG003|Overall Study|Adverse Event|6|||
27766295|NCT00696436|80973108|FG004|Overall Study|Adverse Event|4|||
27766296|NCT00696436|80973104|FG000|Overall Study|Protocol Violation|3|||
27766297|NCT00696436|80973105|FG001|Overall Study|Protocol Violation|2|||
27766298|NCT00696436|80973106|FG002|Overall Study|Protocol Violation|2|||
27766299|NCT00696436|80973107|FG003|Overall Study|Protocol Violation|0|||
27766300|NCT00696436|80973108|FG004|Overall Study|Protocol Violation|1|||
27766301|NCT00696436|80973104|FG000|Overall Study|Lost to Follow-up|1|||
27766302|NCT00696436|80973105|FG001|Overall Study|Lost to Follow-up|6|||
27766303|NCT00696436|80973106|FG002|Overall Study|Lost to Follow-up|2|||
27766304|NCT00696436|80973107|FG003|Overall Study|Lost to Follow-up|4|||
27766305|NCT00696436|80973108|FG004|Overall Study|Lost to Follow-up|3|||
27766306|NCT00696436|80973104|FG000|Overall Study|Withdrawal by Subject|4|||
27766307|NCT00696436|80973105|FG001|Overall Study|Withdrawal by Subject|11|||
27766308|NCT00696436|80973106|FG002|Overall Study|Withdrawal by Subject|5|||
27766309|NCT00696436|80973107|FG003|Overall Study|Withdrawal by Subject|7|||
27766310|NCT00696436|80973108|FG004|Overall Study|Withdrawal by Subject|1|||
27766311|NCT00696436|80973104|FG000|Overall Study|Lack of Efficacy|3|||
27766312|NCT00696436|80973105|FG001|Overall Study|Lack of Efficacy|1|||
27766313|NCT00696436|80973106|FG002|Overall Study|Lack of Efficacy|5|||
27766314|NCT00696436|80973107|FG003|Overall Study|Lack of Efficacy|2|||
27766315|NCT00696436|80973108|FG004|Overall Study|Lack of Efficacy|4|||
27766316|NCT00696436|80973104|FG000|Overall Study|Participant Unavailability|2|||
27766317|NCT00696436|80973105|FG001|Overall Study|Participant Unavailability|0|||
27766318|NCT00696436|80973106|FG002|Overall Study|Participant Unavailability|2|||
27766319|NCT00696436|80973107|FG003|Overall Study|Participant Unavailability|1|||
27766320|NCT00696436|80973108|FG004|Overall Study|Participant Unavailability|0|||
27766321|NCT00696436|80973104|FG000|Overall Study|Administrative Error|2|||
27766322|NCT00696436|80973105|FG001|Overall Study|Administrative Error|0|||
27766323|NCT00696436|80973106|FG002|Overall Study|Administrative Error|2|||
27766324|NCT00696436|80973107|FG003|Overall Study|Administrative Error|0|||
27766325|NCT00696436|80973108|FG004|Overall Study|Administrative Error|0|||
27766326|NCT00696436|80973104|FG000|Overall Study|Participant Non-compliance|0|||
27766327|NCT00696436|80973105|FG001|Overall Study|Participant Non-compliance|0|||
27766328|NCT00696436|80973106|FG002|Overall Study|Participant Non-compliance|1|||
27766329|NCT00696436|80973107|FG003|Overall Study|Participant Non-compliance|2|||
27766330|NCT00696436|80973108|FG004|Overall Study|Participant Non-compliance|0|||
27766331|NCT00696436|80973104|FG000|Overall Study|Administrative Decision|1|||
27766332|NCT00696436|80973105|FG001|Overall Study|Administrative Decision|0|||
27766333|NCT00696436|80973106|FG002|Overall Study|Administrative Decision|0|||
27766334|NCT00696436|80973107|FG003|Overall Study|Administrative Decision|0|||
27766335|NCT00696436|80973108|FG004|Overall Study|Administrative Decision|0|||
27766336|NCT00696436|80973104|FG000|Overall Study|Missing|0|||
27766337|NCT00696436|80973105|FG001|Overall Study|Missing|1|||
27766338|NCT00696436|80973106|FG002|Overall Study|Missing|1|||
27766339|NCT00696436|80973107|FG003|Overall Study|Missing|0|||
27766340|NCT00696436|80973108|FG004|Overall Study|Missing|0|||
27962772|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
27962773|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
27766341|NCT02633046|80973110|FG000|Overall Study|Adverse Event|8|||
27766342|NCT02633046|80973110|FG000|Overall Study|Physician Decision|7|||
27766343|NCT02633046|80973110|FG000|Overall Study|Withdrawal by Subject|8|||
27766344|NCT02633046|80973110|FG000|Overall Study|Increased proteinuria|2|||
27766345|NCT02633046|80973110|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
27766346|NCT02633046|80973110|FG000|Overall Study|Mutual decision patient and physician|1|||
27766347|NCT00132314|80973118|FG000|Overall Study|Lost to Follow-up|70|||
27766348|NCT00132314|80973119|FG001|Overall Study|Lost to Follow-up|62|||
27766349|NCT00132314|80973118|FG000|Overall Study|Lacked SSN|1|||
27766350|NCT00132314|80973119|FG001|Overall Study|Lacked SSN|3|||
27766351|NCT00132314|80973118|FG000|Overall Study|Refused intervention at baseline|2|||
27766352|NCT00132314|80973119|FG001|Overall Study|Refused intervention at baseline|7|||
27766353|NCT01809197|80973122|FG000|Overall Study|Lost to Follow-up|4|||
27766354|NCT01809197|80973123|FG001|Overall Study|Lost to Follow-up|2|||
27766355|NCT01809197|80973122|FG000|Overall Study|Adverse Event|2|||
27766356|NCT01809197|80973123|FG001|Overall Study|Adverse Event|3|||
27766357|NCT01809197|80973122|FG000|Overall Study|Failed slit lamp exam|1|||
27766358|NCT01809197|80973123|FG001|Overall Study|Failed slit lamp exam|0|||
27766359|NCT01809197|80973122|FG000|Overall Study|Non-Compliance|1|||
27766360|NCT01809197|80973123|FG001|Overall Study|Non-Compliance|1|||
27766361|NCT01809197|80973122|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
27766362|NCT01809197|80973123|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
27766363|NCT01809197|80973122|FG000|Overall Study|Withdrawal by Subject|1|||
27766364|NCT01809197|80973123|FG001|Overall Study|Withdrawal by Subject|1|||
27766365|NCT01809197|80973122|FG000|Overall Study|Product not available|0|||
27766366|NCT01809197|80973123|FG001|Overall Study|Product not available|1|||
27766367|NCT02126670|80973127|FG000|Overall Study|Withdrawal by Subject|1|||
27766368|NCT02126670|80973128|FG001|Overall Study|Withdrawal by Subject|0|||
27766369|NCT02126670|80973129|FG002|Overall Study|Withdrawal by Subject|0|||
27766370|NCT02126670|80973130|FG003|Overall Study|Withdrawal by Subject|1|||
27766371|NCT01235728|80973131|FG000|Overall Study|Protocol Violation|0|||
27766372|NCT01235728|80973132|FG001|Overall Study|Protocol Violation|0|||
27766373|NCT01235728|80973133|FG002|Overall Study|Protocol Violation|0|||
27766374|NCT01235728|80973134|FG003|Overall Study|Protocol Violation|1|||
27766375|NCT01235728|80973135|FG004|Overall Study|Protocol Violation|0|||
27766376|NCT01235728|80973136|FG005|Overall Study|Protocol Violation|0|||
27766377|NCT01235728|80973137|FG006|Overall Study|Protocol Violation|0|||
27766378|NCT01235728|80973138|FG007|Overall Study|Protocol Violation|0|||
27766379|NCT00431496|80973139|FG000|Overall Study|Adverse Event|3|||
27766380|NCT00431496|80973139|FG000|Overall Study|Lost to Follow-up|1|||
27766381|NCT00431496|80973139|FG000|Overall Study|Withdrawal by Subject|2|||
27766382|NCT00431496|80973139|FG000|Overall Study|Protocol-specified criteria|5|||
27766383|NCT02905825|80973140|FG000|Overall Study|Protocol Violation|11|||
27766384|NCT02905825|80973140|FG000|Overall Study|Device Malfunction|1|||
27766385|NCT01779648|80973146|FG000|Overall Study|Protocol Violation|1|||
27766386|NCT01779648|80973147|FG001|Overall Study|Protocol Violation|0|||
27766387|NCT03371251|80973148|FG000|Overall Study|Withdrawal by Subject|1|||
27766388|NCT03371251|80973149|FG001|Overall Study|Withdrawal by Subject|0|||
27766389|NCT03371251|80973150|FG002|Overall Study|Withdrawal by Subject|1|||
27766390|NCT03371251|80973151|FG003|Overall Study|Withdrawal by Subject|0|||
27766391|NCT03371251|80973152|FG004|Overall Study|Withdrawal by Subject|2|||
27766392|NCT03371251|80973153|FG005|Overall Study|Withdrawal by Subject|2|||
27766393|NCT03371251|80973148|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
27766394|NCT03371251|80973149|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
27766395|NCT03371251|80973150|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
27766396|NCT03371251|80973151|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
27766397|NCT03371251|80973152|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
27766398|NCT03371251|80973153|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
27766399|NCT03371251|80973148|FG000|Overall Study|Adverse Event|0|||
27766400|NCT03371251|80973149|FG001|Overall Study|Adverse Event|0|||
27766401|NCT03371251|80973150|FG002|Overall Study|Adverse Event|0|||
27766402|NCT03371251|80973151|FG003|Overall Study|Adverse Event|0|||
27766403|NCT03371251|80973152|FG004|Overall Study|Adverse Event|1|||
27766404|NCT03371251|80973153|FG005|Overall Study|Adverse Event|0|||
27766405|NCT03371251|80973148|FG000|Overall Study|Decision by Sponsor|0|||
27766406|NCT03371251|80973149|FG001|Overall Study|Decision by Sponsor|0|||
27766407|NCT03371251|80973150|FG002|Overall Study|Decision by Sponsor|0|||
27766408|NCT03371251|80973151|FG003|Overall Study|Decision by Sponsor|0|||
27766409|NCT03371251|80973152|FG004|Overall Study|Decision by Sponsor|2|||
27766410|NCT03371251|80973153|FG005|Overall Study|Decision by Sponsor|0|||
27766411|NCT05742841|80973154|FG000|Overall Study|Withdrawal by Subject|1|||
27766412|NCT05742841|80973154|FG000|Overall Study|Lost to Follow-up|1|||
27766413|NCT00510068|80973158|FG000|Double-blind Period|Disease progression|98|||
27766414|NCT00510068|80973159|FG001|Double-blind Period|Disease progression|169|||
27766415|NCT00510068|80973158|FG000|Double-blind Period|Final primary analysis|52|||
27962774|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
27962775|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
27962776|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
27962777|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
27766416|NCT00510068|80973159|FG001|Double-blind Period|Final primary analysis|18|||
27962778|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
27962779|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
27962780|NCT02831855|81695231|FG000|Open Label Phase (24 Weeks)|Other|4|||
27962781|NCT02831855|81695232|FG001|Open Label Phase (24 Weeks)|Other|0|||
27962782|NCT02831855|81695233|FG002|Open Label Phase (24 Weeks)|Other|0|||
27962783|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
27962784|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
27962785|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
27962786|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Death|0|||
27962787|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Death|0|||
27766417|NCT00510068|80973158|FG000|Double-blind Period|Adverse Event|37|||
27766418|NCT00510068|80973159|FG001|Double-blind Period|Adverse Event|7|||
27766419|NCT00510068|80973158|FG000|Double-blind Period|Withdrawal by Subject|8|||
27766420|NCT00510068|80973159|FG001|Double-blind Period|Withdrawal by Subject|6|||
27766421|NCT00510068|80973158|FG000|Double-blind Period|Death|4|||
27766422|NCT00510068|80973159|FG001|Double-blind Period|Death|3|||
27766423|NCT00510068|80973158|FG000|Double-blind Period|Abnormal test result (s)|1|||
27766424|NCT00510068|80973159|FG001|Double-blind Period|Abnormal test result (s)|0|||
27766425|NCT00510068|80973158|FG000|Double-blind Period|Lost to Follow-up|1|||
27766426|NCT00510068|80973159|FG001|Double-blind Period|Lost to Follow-up|0|||
27766427|NCT00510068|80973158|FG000|Double-blind Period|Protocol Violation|6|||
27766428|NCT00510068|80973159|FG001|Double-blind Period|Protocol Violation|0|||
27766429|NCT00510068|80973158|FG000|Open-label Period|Disease Progression|124|||
27766430|NCT00510068|80973159|FG001|Open-label Period|Disease Progression|0|||
27766431|NCT00510068|80973158|FG000|Open-label Period|Adverse Event|46|||
27766432|NCT00510068|80973159|FG001|Open-label Period|Adverse Event|0|||
27766433|NCT00510068|80973158|FG000|Open-label Period|Withdrawal by Subject|21|||
27766434|NCT00510068|80973159|FG001|Open-label Period|Withdrawal by Subject|0|||
27766435|NCT00510068|80973158|FG000|Open-label Period|Administrative problems|17|||
27962788|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Death|2|||
27962789|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
27962790|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
27962791|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
27962792|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
27962793|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
27962794|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
27962795|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
27962796|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
27568848|NCT02347527|80271463|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
27568849|NCT02347527|80271464|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
27568850|NCT02347527|80271465|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
27568851|NCT02347527|80271466|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
27568852|NCT00788827|80271469|FG000|Overall Study|Lack of Efficacy|2|||
27766436|NCT00510068|80973159|FG001|Open-label Period|Administrative problems|0|||
27766437|NCT00510068|80973158|FG000|Open-label Period|Death|7|||
27766438|NCT00510068|80973159|FG001|Open-label Period|Death|0|||
27766439|NCT00510068|80973158|FG000|Open-label Period|New cancer therapy|7|||
27766440|NCT00510068|80973159|FG001|Open-label Period|New cancer therapy|0|||
27766441|NCT00510068|80973158|FG000|Open-label Period|Protocol Violation|2|||
27766442|NCT00510068|80973159|FG001|Open-label Period|Protocol Violation|0|||
27766443|NCT00510068|80973158|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
27766444|NCT00510068|80973159|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
27766445|NCT00438464|80973163|FG000|Overall Study|Terminated Early|14|||
27766446|NCT00438464|80973164|FG001|Overall Study|Terminated Early|5|||
27766447|NCT00438464|80973163|FG000|Overall Study|Incomplete data submission|0|||
27766448|NCT00438464|80973164|FG001|Overall Study|Incomplete data submission|2|||
27766449|NCT00291499|80973165|FG000|Overall Study|Adverse Event|3|||
27766450|NCT00291499|80973166|FG001|Overall Study|Adverse Event|8|||
27962797|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
27962798|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Other|0|||
27962799|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Other|2|||
27766451|NCT00291499|80973165|FG000|Overall Study|Change to other therapy|2|||
27766452|NCT00291499|80973166|FG001|Overall Study|Change to other therapy|1|||
27766453|NCT00291499|80973165|FG000|Overall Study|Intercurrent illness|1|||
27766454|NCT00291499|80973166|FG001|Overall Study|Intercurrent illness|0|||
27766455|NCT00291499|80973165|FG000|Overall Study|Protocol Violation|2|||
27766456|NCT00291499|80973166|FG001|Overall Study|Protocol Violation|2|||
27766457|NCT00291499|80973165|FG000|Overall Study|Other reasons|1|||
27766458|NCT00291499|80973166|FG001|Overall Study|Other reasons|4|||
27962800|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Other|5|||
27766459|NCT01194869|80973169|FG000|Overall Study|Disease Progression|2|||
27766460|NCT01194869|80973169|FG000|Overall Study|Toxicity|2|||
27766461|NCT05552859|80973175|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
27766462|NCT05552859|80973176|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
27766463|NCT01002742|80973179|FG000|Overall Study|Determined to be ineligible|0|||
27766464|NCT01002742|80973180|FG001|Overall Study|Determined to be ineligible|1|||
27766465|NCT00636441|80973182|FG000|Overall Study|Adverse Event|0|||
27766466|NCT00636441|80973183|FG001|Overall Study|Adverse Event|1|||
27766467|NCT00636441|80973184|FG002|Overall Study|Adverse Event|1|||
27766468|NCT00636441|80973185|FG003|Overall Study|Adverse Event|0|||
27766469|NCT00636441|80973186|FG004|Overall Study|Adverse Event|0|||
27766470|NCT00636441|80973187|FG005|Overall Study|Adverse Event|1|||
27766471|NCT00636441|80973188|FG006|Overall Study|Adverse Event|0|||
27766472|NCT00636441|80973182|FG000|Overall Study|Late, ineligible|0|||
27766473|NCT00636441|80973183|FG001|Overall Study|Late, ineligible|0|||
27766474|NCT00636441|80973184|FG002|Overall Study|Late, ineligible|0|||
27766475|NCT00636441|80973185|FG003|Overall Study|Late, ineligible|0|||
27766476|NCT00636441|80973186|FG004|Overall Study|Late, ineligible|0|||
27766477|NCT00636441|80973187|FG005|Overall Study|Late, ineligible|0|||
27766478|NCT00636441|80973188|FG006|Overall Study|Late, ineligible|1|||
27766479|NCT00636441|80973182|FG000|Overall Study|Screen Failure|0|||
27766480|NCT00636441|80973183|FG001|Overall Study|Screen Failure|0|||
27766481|NCT00636441|80973184|FG002|Overall Study|Screen Failure|0|||
27766482|NCT00636441|80973185|FG003|Overall Study|Screen Failure|0|||
27766483|NCT00636441|80973186|FG004|Overall Study|Screen Failure|0|||
27766484|NCT00636441|80973187|FG005|Overall Study|Screen Failure|0|||
27766485|NCT00636441|80973188|FG006|Overall Study|Screen Failure|17|||
27766486|NCT00389441|80973197|FG000|Overall Study|Adverse Event|7|||
27766487|NCT00389441|80973197|FG000|Overall Study|Death|4|||
27766488|NCT00389441|80973197|FG000|Overall Study|Lost to Follow-up|2|||
27766489|NCT00389441|80973197|FG000|Overall Study|Withdrawal by Subject|4|||
27766490|NCT00389441|80973197|FG000|Overall Study|Physician Decision|1|||
27766491|NCT00389441|80973197|FG000|Overall Study|Protocol Violation|1|||
27766492|NCT00389441|80973197|FG000|Overall Study|Global deterioration of health status|4|||
27766493|NCT00389441|80973197|FG000|Overall Study|Objective progression or relapse|26|||
27766494|NCT00389441|80973197|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
27766495|NCT00389441|80973197|FG000|Overall Study|Clinical progression|1|||
27766496|NCT00587301|80973198|FG000|Overall Study|Screen Failure|9|||
27766497|NCT00587301|80973198|FG000|Overall Study|Lost to Follow-up|22|||
27766498|NCT00587301|80973198|FG000|Overall Study|Withdrawal by Subject|7|||
27766499|NCT00587301|80973198|FG000|Overall Study|Protocol Violation|7|||
27766500|NCT01742091|80973199|FG000|Overall Study|Adverse Event|0|||
27766501|NCT01742091|80973200|FG001|Overall Study|Adverse Event|0|||
27766502|NCT01742091|80973201|FG002|Overall Study|Adverse Event|0|||
27766503|NCT01742091|80973202|FG003|Overall Study|Adverse Event|0|||
27766504|NCT01742091|80973203|FG004|Overall Study|Adverse Event|1|||
27766505|NCT01742091|80973204|FG005|Overall Study|Adverse Event|0|||
27766506|NCT01742091|80973199|FG000|Overall Study|Physician Decision|0|||
27766507|NCT01742091|80973200|FG001|Overall Study|Physician Decision|0|||
27766508|NCT01742091|80973201|FG002|Overall Study|Physician Decision|0|||
27766509|NCT01742091|80973202|FG003|Overall Study|Physician Decision|0|||
27766510|NCT01742091|80973203|FG004|Overall Study|Physician Decision|0|||
27766511|NCT01742091|80973204|FG005|Overall Study|Physician Decision|1|||
27766512|NCT01742091|80973199|FG000|Overall Study|Withdrawal by Subject|0|||
27766513|NCT01742091|80973200|FG001|Overall Study|Withdrawal by Subject|0|||
27766514|NCT01742091|80973201|FG002|Overall Study|Withdrawal by Subject|0|||
27766515|NCT01742091|80973202|FG003|Overall Study|Withdrawal by Subject|1|||
27766516|NCT01742091|80973203|FG004|Overall Study|Withdrawal by Subject|0|||
27766517|NCT01742091|80973204|FG005|Overall Study|Withdrawal by Subject|0|||
27766518|NCT01742091|80973199|FG000|Overall Study|Lost to Follow-up|0|||
27766519|NCT01742091|80973200|FG001|Overall Study|Lost to Follow-up|0|||
27766520|NCT01742091|80973201|FG002|Overall Study|Lost to Follow-up|0|||
27766521|NCT01742091|80973202|FG003|Overall Study|Lost to Follow-up|0|||
27766522|NCT01742091|80973203|FG004|Overall Study|Lost to Follow-up|0|||
27568853|NCT02658890|80271470|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27766523|NCT01742091|80973204|FG005|Overall Study|Lost to Follow-up|1|||
27766524|NCT00091026|80973207|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
27766525|NCT00091026|80973208|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
27766526|NCT00091026|80973207|FG000|Overall Study|Patient withdrew and never received trea|0|||
27766527|NCT00091026|80973208|FG001|Overall Study|Patient withdrew and never received trea|2|||
27766528|NCT00091026|80973207|FG000|Overall Study|Unknown-never received treatment|0|||
27766529|NCT00091026|80973208|FG001|Overall Study|Unknown-never received treatment|1|||
27568854|NCT02658890|80271471|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27766530|NCT02580240|80973209|FG000|Overall Study|Physician Decision|2|||
27766531|NCT02580240|80973210|FG001|Overall Study|Physician Decision|0|||
27766532|NCT04583969|80973213|FG000|Overall Study|Death|31|||
27766533|NCT04583969|80973214|FG001|Overall Study|Death|38|||
27766534|NCT04583969|80973213|FG000|Overall Study|Lost to Follow-up|16|||
27766535|NCT04583969|80973214|FG001|Overall Study|Lost to Follow-up|13|||
27766536|NCT04583969|80973213|FG000|Overall Study|Protocol Violation|1|||
27766537|NCT04583969|80973214|FG001|Overall Study|Protocol Violation|0|||
27568855|NCT02658890|80271472|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568856|NCT02658890|80271473|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568857|NCT02658890|80271474|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568858|NCT02658890|80271475|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568859|NCT02658890|80271476|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568860|NCT02658890|80271477|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568861|NCT02658890|80271478|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
27568862|NCT02658890|80271479|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568863|NCT02658890|80271480|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568864|NCT02658890|80271481|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568865|NCT02658890|80271482|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568866|NCT02658890|80271483|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568867|NCT02658890|80271484|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568868|NCT02658890|80271485|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568869|NCT02658890|80271486|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27766538|NCT04583969|80973213|FG000|Overall Study|Withdrawal by Subject|3|||
27766539|NCT04583969|80973214|FG001|Overall Study|Withdrawal by Subject|3|||
27766540|NCT04583969|80973213|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
27766541|NCT04583969|80973214|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
27766542|NCT04583969|80973213|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
27766543|NCT04583969|80973214|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
27766544|NCT04583969|80973213|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
27766545|NCT04583969|80973214|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
27962801|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
27962802|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
27962803|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
27962804|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
27962805|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
27962806|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
27962807|NCT02831855|81695231|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
27962808|NCT02831855|81695232|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
27962809|NCT02831855|81695233|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
27766546|NCT04583969|80973213|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
27766547|NCT04583969|80973214|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
27766548|NCT04583969|80973213|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
27766549|NCT04583969|80973214|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
27766550|NCT00912340|80973215|FG000|Overall Study|Adverse Event|2|||
27766551|NCT00912340|80973216|FG001|Overall Study|Adverse Event|4|||
27766552|NCT00912340|80973217|FG002|Overall Study|Adverse Event|0|||
27766553|NCT00912340|80973215|FG000|Overall Study|Protocol revised to remove arm|0|||
27766554|NCT00912340|80973216|FG001|Overall Study|Protocol revised to remove arm|0|||
27766555|NCT00912340|80973217|FG002|Overall Study|Protocol revised to remove arm|4|||
27766556|NCT00653328|80973218|FG000|Overall Study|Withdrawal by Subject|1|||
27766557|NCT00653328|80973218|FG000|Overall Study|Adverse Event|2|||
27766558|NCT00653328|80973218|FG000|Overall Study|Disease progression|10|||
27766559|NCT00653328|80973218|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
27766560|NCT01068717|80973219|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
27766561|NCT01068717|80973220|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
27766562|NCT01068717|80973221|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
27766563|NCT01068717|80973222|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
27766564|NCT02186561|80973225|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
27766565|NCT02186561|80973225|FG000|Enrollment|Enrollment Cap Reached|5|||
27766566|NCT02186561|80973225|FG000|Enrollment|Insurance Denial|2|||
27766567|NCT02186561|80973225|FG000|Enrollment|Withdrawal by Subject|2|||
27766568|NCT02186561|80973225|FG000|Enrollment|Investigator Withdrew Consent|1|||
27766569|NCT02186561|80973225|FG000|30-Day Post Index Procedure Visit|Death|1|||
27766570|NCT02186561|80973225|FG000|1- Year Post Index Procedure Visit|Death|1|||
27766571|NCT02186561|80973225|FG000|1- Year Post Index Procedure Visit|Missed|1|||
27766572|NCT04581863|80973226|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
27766573|NCT04581863|80973227|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
27766574|NCT02773368|80973228|FG000|Overall Study|Lost to Follow-up|4|||
27962810|NCT00662831|81695234|FG000|Overall Study|Death|4|||
27568870|NCT02658890|80271487|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27766575|NCT02773368|80973229|FG001|Overall Study|Lost to Follow-up|1|||
27766576|NCT02773368|80973228|FG000|Overall Study|Withdrawal by Subject|5|||
27766577|NCT02773368|80973229|FG001|Overall Study|Withdrawal by Subject|1|||
27766578|NCT02773368|80973228|FG000|Overall Study|Unclassified|1|||
27766579|NCT02773368|80973229|FG001|Overall Study|Unclassified|1|||
27766580|NCT02773368|80973228|FG000|Overall Study|Missing|0|||
27766581|NCT02773368|80973229|FG001|Overall Study|Missing|1|||
27766582|NCT01253187|80973233|FG000|Period 2|Withdrawal by Subject|0|||
27766583|NCT01253187|80973234|FG001|Period 2|Withdrawal by Subject|0|||
27766584|NCT01253187|80973235|FG002|Period 2|Withdrawal by Subject|0|||
27766585|NCT01253187|80973236|FG003|Period 2|Withdrawal by Subject|0|||
27766586|NCT01253187|80973237|FG004|Period 2|Withdrawal by Subject|1|||
27766587|NCT01253187|80973238|FG005|Period 2|Withdrawal by Subject|0|||
27766588|NCT01253187|80973233|FG000|Period 3|Pregnancy|1|||
27766589|NCT01253187|80973234|FG001|Period 3|Pregnancy|0|||
27766590|NCT01253187|80973235|FG002|Period 3|Pregnancy|0|||
27766591|NCT01253187|80973236|FG003|Period 3|Pregnancy|0|||
27766592|NCT01253187|80973237|FG004|Period 3|Pregnancy|0|||
27766593|NCT01253187|80973238|FG005|Period 3|Pregnancy|0|||
27766594|NCT01253187|80973233|FG000|Period 3|difficulty with blood sampling|0|||
27766595|NCT01253187|80973234|FG001|Period 3|difficulty with blood sampling|1|||
27766596|NCT01253187|80973235|FG002|Period 3|difficulty with blood sampling|0|||
27766597|NCT01253187|80973236|FG003|Period 3|difficulty with blood sampling|0|||
27766598|NCT01253187|80973237|FG004|Period 3|difficulty with blood sampling|0|||
27766599|NCT01253187|80973238|FG005|Period 3|difficulty with blood sampling|0|||
27766600|NCT01253187|80973233|FG000|Period 3|non-compliance|0|||
27766601|NCT01253187|80973234|FG001|Period 3|non-compliance|0|||
27766602|NCT01253187|80973235|FG002|Period 3|non-compliance|0|||
27766603|NCT01253187|80973236|FG003|Period 3|non-compliance|0|||
27766604|NCT01253187|80973237|FG004|Period 3|non-compliance|1|||
27766605|NCT01253187|80973238|FG005|Period 3|non-compliance|0|||
27766606|NCT04605159|80973241|FG000|Overall Study|Adverse Event|6|||
27766607|NCT04605159|80973242|FG001|Overall Study|Adverse Event|3|||
27766608|NCT04605159|80973243|FG002|Overall Study|Adverse Event|21|||
27766609|NCT04605159|80973244|FG003|Overall Study|Adverse Event|4|||
27766610|NCT04605159|80973241|FG000|Overall Study|Lost to Follow-up|74|||
27766611|NCT04605159|80973242|FG001|Overall Study|Lost to Follow-up|45|||
27766612|NCT04605159|80973243|FG002|Overall Study|Lost to Follow-up|119|||
27766613|NCT04605159|80973244|FG003|Overall Study|Lost to Follow-up|80|||
27766614|NCT04605159|80973241|FG000|Overall Study|Protocol Violation|4|||
27766615|NCT04605159|80973242|FG001|Overall Study|Protocol Violation|5|||
27766616|NCT04605159|80973243|FG002|Overall Study|Protocol Violation|2|||
27766617|NCT04605159|80973244|FG003|Overall Study|Protocol Violation|0|||
27766618|NCT04605159|80973241|FG000|Overall Study|Withdrawal by Subject|66|||
27766619|NCT04605159|80973242|FG001|Overall Study|Withdrawal by Subject|37|||
27766620|NCT04605159|80973243|FG002|Overall Study|Withdrawal by Subject|68|||
27766621|NCT04605159|80973244|FG003|Overall Study|Withdrawal by Subject|50|||
27766622|NCT04605159|80973241|FG000|Overall Study|Migrated / moved from the study area|32|||
27766623|NCT04605159|80973242|FG001|Overall Study|Migrated / moved from the study area|22|||
27766624|NCT04605159|80973243|FG002|Overall Study|Migrated / moved from the study area|41|||
27766625|NCT04605159|80973244|FG003|Overall Study|Migrated / moved from the study area|21|||
27766626|NCT04605159|80973241|FG000|Overall Study|Other|1|||
27766627|NCT04605159|80973242|FG001|Overall Study|Other|2|||
27766628|NCT04605159|80973243|FG002|Overall Study|Other|7|||
27766629|NCT04605159|80973244|FG003|Overall Study|Other|3|||
27766630|NCT00608842|80973245|FG000|Overall Study|Participant's Request|0|||
27766631|NCT00608842|80973246|FG001|Overall Study|Participant's Request|1|||
27766632|NCT00608842|80973247|FG002|Overall Study|Participant's Request|2|||
27766633|NCT00608842|80973248|FG003|Overall Study|Participant's Request|1|||
27766634|NCT00608842|80973245|FG000|Overall Study|Lost to Follow-up|1|||
27766635|NCT00608842|80973246|FG001|Overall Study|Lost to Follow-up|0|||
27766636|NCT00608842|80973247|FG002|Overall Study|Lost to Follow-up|0|||
27766637|NCT00608842|80973248|FG003|Overall Study|Lost to Follow-up|0|||
27766638|NCT03934203|80973249|FG000|Overall Study|Adverse Event|0|||
27766639|NCT03934203|80973250|FG001|Overall Study|Adverse Event|0|||
27766640|NCT03934203|80973251|FG002|Overall Study|Adverse Event|1|||
27766641|NCT03934203|80973252|FG003|Overall Study|Adverse Event|0|||
27766642|NCT03934203|80973253|FG004|Overall Study|Adverse Event|1|||
27766643|NCT03934203|80973254|FG005|Overall Study|Adverse Event|0|||
27766644|NCT03934203|80973255|FG006|Overall Study|Adverse Event|2|||
27766645|NCT03934203|80973256|FG007|Overall Study|Adverse Event|0|||
27766646|NCT03934203|80973257|FG008|Overall Study|Adverse Event|0|||
27766647|NCT03934203|80973258|FG009|Overall Study|Adverse Event|0|||
27766648|NCT03934203|80973259|FG010|Overall Study|Adverse Event|0|||
27766649|NCT03934203|80973260|FG011|Overall Study|Adverse Event|0|||
27766650|NCT03934203|80973261|FG012|Overall Study|Adverse Event|0|||
27766651|NCT03934203|80973262|FG013|Overall Study|Adverse Event|1|||
27766652|NCT03934203|80973263|FG014|Overall Study|Adverse Event|0|||
27766653|NCT02091921|80973264|FG000|Overall Study|Adverse Event|3|||
27766654|NCT00443846|80973274|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
27766655|NCT00443846|80973275|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
27766656|NCT00443846|80973274|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
27766657|NCT00443846|80973275|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
27766658|NCT00443846|80973274|FG000|Overall Study|Adverse Event|0|||
27766659|NCT00443846|80973275|FG001|Overall Study|Adverse Event|1|||
27766660|NCT00443846|80973274|FG000|Overall Study|Personal reason|8|||
27766661|NCT00443846|80973275|FG001|Overall Study|Personal reason|3|||
27766662|NCT00443846|80973274|FG000|Overall Study|Lost to Follow-up|1|||
27766663|NCT00443846|80973275|FG001|Overall Study|Lost to Follow-up|2|||
27766664|NCT02460978|80973277|FG000|Overall Study|Adverse Event|17|||
27766665|NCT02460978|80973278|FG001|Overall Study|Adverse Event|11|||
27766666|NCT02460978|80973279|FG002|Overall Study|Adverse Event|11|||
27766667|NCT02460978|80973277|FG000|Overall Study|Withdrawal by Subject|5|||
27766668|NCT02460978|80973278|FG001|Overall Study|Withdrawal by Subject|5|||
27766669|NCT02460978|80973279|FG002|Overall Study|Withdrawal by Subject|14|||
27766670|NCT02460978|80973277|FG000|Overall Study|Lost to Follow-up|2|||
27766671|NCT02460978|80973278|FG001|Overall Study|Lost to Follow-up|3|||
27766672|NCT02460978|80973279|FG002|Overall Study|Lost to Follow-up|1|||
27766673|NCT02460978|80973277|FG000|Overall Study|Protocol Violation|1|||
27766674|NCT02460978|80973278|FG001|Overall Study|Protocol Violation|1|||
27766675|NCT02460978|80973279|FG002|Overall Study|Protocol Violation|1|||
27766676|NCT02460978|80973277|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
27766677|NCT02460978|80973278|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
27766678|NCT02460978|80973279|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
27766679|NCT02460978|80973277|FG000|Overall Study|Pregnancy|0|||
27766680|NCT02460978|80973278|FG001|Overall Study|Pregnancy|0|||
27766681|NCT02460978|80973279|FG002|Overall Study|Pregnancy|2|||
27766682|NCT01851863|80973281|FG000|Overall Study|Did not receive study medication|2|||
27766683|NCT01851863|80973282|FG001|Overall Study|Did not receive study medication|5|||
27766684|NCT01851863|80973283|FG002|Overall Study|Did not receive study medication|3|||
27766685|NCT01851863|80973284|FG003|Overall Study|Did not receive study medication|0|||
27766686|NCT01851863|80973281|FG000|Overall Study|Lost to Follow-up|3|||
27766687|NCT01851863|80973282|FG001|Overall Study|Lost to Follow-up|4|||
27766688|NCT01851863|80973283|FG002|Overall Study|Lost to Follow-up|2|||
27766689|NCT01851863|80973284|FG003|Overall Study|Lost to Follow-up|3|||
27766690|NCT00718523|80973285|FG000|Overall Study|Withdrawal by Subject|5|||
27766691|NCT00718523|80973286|FG001|Overall Study|Withdrawal by Subject|7|||
27766692|NCT00718523|80973285|FG000|Overall Study|Death|13|||
27766693|NCT00718523|80973286|FG001|Overall Study|Death|17|||
27766694|NCT01803711|80973287|FG000|Overall Study|Adverse Event|1|||
27766695|NCT01803711|80973288|FG001|Overall Study|Adverse Event|1|||
27766696|NCT03175562|80973289|FG000|Overall Study|Adverse Event|1|||
27766697|NCT03175562|80973289|FG000|Overall Study|Lost to Follow-up|3|||
27766698|NCT03175562|80973289|FG000|Overall Study|Withdrawal by Subject|7|||
27766699|NCT03175562|80973289|FG000|Overall Study|Other (Not Specified)|5|||
27766700|NCT01457924|80973290|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
27766701|NCT01457924|80973291|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
27766702|NCT01457924|80973292|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
27766703|NCT01457924|80973293|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
27766704|NCT01457924|80973294|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
27766705|NCT01457924|80973290|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27766706|NCT01457924|80973291|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27766707|NCT01457924|80973292|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27766708|NCT01457924|80973293|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
27766709|NCT01457924|80973294|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
27766710|NCT01457924|80973290|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
27766711|NCT01457924|80973291|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
27766712|NCT01457924|80973292|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
27766713|NCT01457924|80973293|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
27766714|NCT01457924|80973294|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
27568871|NCT02658890|80271488|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568872|NCT02658890|80271489|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568873|NCT02658890|80271490|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568874|NCT02658890|80271491|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568875|NCT02658890|80271492|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568876|NCT02658890|80271493|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27766715|NCT01457924|80973290|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
27766716|NCT01457924|80973291|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
27766717|NCT01457924|80973292|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
27766718|NCT01457924|80973293|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
27766719|NCT01457924|80973294|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
27766720|NCT01457924|80973290|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
27766721|NCT01457924|80973291|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
27568877|NCT02658890|80271494|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568878|NCT02658890|80271495|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568879|NCT02658890|80271496|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27568880|NCT02658890|80271470|FG000|Treatment Phase|Adverse Event|0|||
27568881|NCT02658890|80271471|FG001|Treatment Phase|Adverse Event|1|||
27568882|NCT02658890|80271472|FG002|Treatment Phase|Adverse Event|2|||
27568883|NCT02658890|80271473|FG003|Treatment Phase|Adverse Event|2|||
27568884|NCT02658890|80271474|FG004|Treatment Phase|Adverse Event|1|||
27568885|NCT02658890|80271475|FG005|Treatment Phase|Adverse Event|0|||
27568886|NCT02658890|80271476|FG006|Treatment Phase|Adverse Event|0|||
27568887|NCT02658890|80271477|FG007|Treatment Phase|Adverse Event|2|||
27568888|NCT02658890|80271478|FG008|Treatment Phase|Adverse Event|1|||
27568889|NCT02658890|80271479|FG009|Treatment Phase|Adverse Event|2|||
27568890|NCT02658890|80271480|FG010|Treatment Phase|Adverse Event|3|||
27568891|NCT02658890|80271481|FG011|Treatment Phase|Adverse Event|0|||
27568892|NCT02658890|80271482|FG012|Treatment Phase|Adverse Event|1|||
27568893|NCT02658890|80271483|FG013|Treatment Phase|Adverse Event|4|||
27568894|NCT02658890|80271484|FG014|Treatment Phase|Adverse Event|0|||
27568895|NCT02658890|80271485|FG015|Treatment Phase|Adverse Event|0|||
27568896|NCT02658890|80271486|FG016|Treatment Phase|Adverse Event|0|||
27568897|NCT02658890|80271487|FG017|Treatment Phase|Adverse Event|0|||
27568898|NCT02658890|80271488|FG018|Treatment Phase|Adverse Event|5|||
27568899|NCT02658890|80271489|FG019|Treatment Phase|Adverse Event|1|||
27568900|NCT02658890|80271490|FG020|Treatment Phase|Adverse Event|3|||
27568901|NCT02658890|80271491|FG021|Treatment Phase|Adverse Event|0|||
27568902|NCT02658890|80271492|FG022|Treatment Phase|Adverse Event|5|||
27568903|NCT02658890|80271493|FG023|Treatment Phase|Adverse Event|0|||
27568904|NCT02658890|80271494|FG024|Treatment Phase|Adverse Event|0|||
27568905|NCT02658890|80271495|FG025|Treatment Phase|Adverse Event|2|||
27568906|NCT02658890|80271496|FG026|Treatment Phase|Adverse Event|1|||
27568907|NCT02658890|80271470|FG000|Treatment Phase|Death|0|||
27568908|NCT02658890|80271471|FG001|Treatment Phase|Death|0|||
27568909|NCT02658890|80271472|FG002|Treatment Phase|Death|0|||
27568910|NCT02658890|80271473|FG003|Treatment Phase|Death|0|||
27568911|NCT02658890|80271474|FG004|Treatment Phase|Death|0|||
27568912|NCT02658890|80271475|FG005|Treatment Phase|Death|0|||
27568913|NCT02658890|80271476|FG006|Treatment Phase|Death|0|||
27568914|NCT02658890|80271477|FG007|Treatment Phase|Death|0|||
27568915|NCT02658890|80271478|FG008|Treatment Phase|Death|0|||
27568916|NCT02658890|80271479|FG009|Treatment Phase|Death|0|||
27568917|NCT02658890|80271480|FG010|Treatment Phase|Death|0|||
27568918|NCT02658890|80271481|FG011|Treatment Phase|Death|0|||
27568919|NCT02658890|80271482|FG012|Treatment Phase|Death|0|||
27568920|NCT02658890|80271483|FG013|Treatment Phase|Death|0|||
27568921|NCT02658890|80271484|FG014|Treatment Phase|Death|0|||
27962811|NCT00662831|81695235|FG001|Overall Study|Death|1|||
27962812|NCT00662831|81695234|FG000|Overall Study|Lack of Efficacy|6|||
27962813|NCT00662831|81695235|FG001|Overall Study|Lack of Efficacy|6|||
27962814|NCT00662831|81695234|FG000|Overall Study|Lost to Follow-up|1|||
27962815|NCT00662831|81695235|FG001|Overall Study|Lost to Follow-up|0|||
27962816|NCT00662831|81695234|FG000|Overall Study|Withdrawal by Subject|2|||
27962817|NCT00662831|81695235|FG001|Overall Study|Withdrawal by Subject|1|||
27962818|NCT00662831|81695234|FG000|Overall Study|Other|62|||
27962819|NCT00662831|81695235|FG001|Overall Study|Other|31|||
27962820|NCT00662831|81695234|FG000|Overall Study|Protocol Violation|8|||
27962821|NCT00662831|81695235|FG001|Overall Study|Protocol Violation|4|||
27962822|NCT00662831|81695234|FG000|Overall Study|Adverse Event|23|||
27568922|NCT02658890|80271485|FG015|Treatment Phase|Death|0|||
27568923|NCT02658890|80271486|FG016|Treatment Phase|Death|0|||
27568924|NCT02658890|80271487|FG017|Treatment Phase|Death|0|||
27568925|NCT02658890|80271488|FG018|Treatment Phase|Death|1|||
27568926|NCT02658890|80271489|FG019|Treatment Phase|Death|0|||
27568927|NCT02658890|80271490|FG020|Treatment Phase|Death|0|||
27568928|NCT02658890|80271491|FG021|Treatment Phase|Death|0|||
27962823|NCT00662831|81695235|FG001|Overall Study|Adverse Event|16|||
27568929|NCT02658890|80271492|FG022|Treatment Phase|Death|0|||
27568930|NCT02658890|80271493|FG023|Treatment Phase|Death|0|||
27568931|NCT02658890|80271494|FG024|Treatment Phase|Death|0|||
27568932|NCT02658890|80271495|FG025|Treatment Phase|Death|0|||
27568933|NCT02658890|80271496|FG026|Treatment Phase|Death|0|||
27568934|NCT02658890|80271470|FG000|Treatment Phase|Lost to Follow-up|0|||
27568935|NCT02658890|80271471|FG001|Treatment Phase|Lost to Follow-up|0|||
27568936|NCT02658890|80271472|FG002|Treatment Phase|Lost to Follow-up|0|||
27568937|NCT02658890|80271473|FG003|Treatment Phase|Lost to Follow-up|0|||
27962824|NCT01270880|81695236|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
27962825|NCT04560816|81695237|FG000|Overall Study|Withdrawal by Subject|1|||
27568938|NCT02658890|80271474|FG004|Treatment Phase|Lost to Follow-up|0|||
27568939|NCT02658890|80271475|FG005|Treatment Phase|Lost to Follow-up|0|||
27568940|NCT02658890|80271476|FG006|Treatment Phase|Lost to Follow-up|1|||
27568941|NCT02658890|80271477|FG007|Treatment Phase|Lost to Follow-up|0|||
27568942|NCT02658890|80271478|FG008|Treatment Phase|Lost to Follow-up|0|||
27568943|NCT02658890|80271479|FG009|Treatment Phase|Lost to Follow-up|0|||
27766722|NCT01457924|80973292|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
27766723|NCT01457924|80973293|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
27766724|NCT01457924|80973294|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
27766725|NCT01457924|80973290|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
27766726|NCT01457924|80973291|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
27962826|NCT04560816|81695238|FG001|Overall Study|Withdrawal by Subject|1|||
27962827|NCT04560816|81695239|FG002|Overall Study|Withdrawal by Subject|1|||
27962828|NCT04560816|81695240|FG003|Overall Study|Withdrawal by Subject|0|||
27962829|NCT04560816|81695241|FG004|Overall Study|Withdrawal by Subject|3|||
27962830|NCT04560816|81695242|FG005|Overall Study|Withdrawal by Subject|0|||
27962831|NCT04560816|81695237|FG000|Overall Study|Lost to Follow-up|1|||
27962832|NCT04560816|81695238|FG001|Overall Study|Lost to Follow-up|0|||
27962833|NCT04560816|81695239|FG002|Overall Study|Lost to Follow-up|0|||
27766727|NCT01457924|80973292|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
27766728|NCT01457924|80973293|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
27766729|NCT01457924|80973294|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
27766730|NCT01457924|80973290|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
27766731|NCT01457924|80973291|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
27766732|NCT01457924|80973292|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
27766733|NCT01457924|80973293|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
27766734|NCT01457924|80973294|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
27766735|NCT01457924|80973290|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
27766736|NCT01457924|80973291|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
27766737|NCT01457924|80973292|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
27766738|NCT01457924|80973293|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
27766739|NCT01457924|80973294|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
27766740|NCT01457924|80973290|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27766741|NCT01457924|80973291|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27766742|NCT01457924|80973292|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27766743|NCT01457924|80973293|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
27766744|NCT01457924|80973294|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
27766745|NCT01457924|80973290|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
27766746|NCT01457924|80973291|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
27766747|NCT01457924|80973292|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
27766748|NCT01457924|80973293|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
27766749|NCT01457924|80973294|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
27766750|NCT01457924|80973290|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
27766751|NCT01457924|80973291|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
27766752|NCT01457924|80973292|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
27766753|NCT01457924|80973293|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
27962834|NCT04560816|81695240|FG003|Overall Study|Lost to Follow-up|0|||
27962835|NCT04560816|81695241|FG004|Overall Study|Lost to Follow-up|0|||
27962836|NCT04560816|81695242|FG005|Overall Study|Lost to Follow-up|0|||
27962837|NCT04560816|81695237|FG000|Overall Study|Protocol Violation|1|||
27962838|NCT04560816|81695238|FG001|Overall Study|Protocol Violation|0|||
27962839|NCT04560816|81695239|FG002|Overall Study|Protocol Violation|0|||
27962840|NCT04560816|81695240|FG003|Overall Study|Protocol Violation|0|||
27962841|NCT04560816|81695241|FG004|Overall Study|Protocol Violation|0|||
27962842|NCT04560816|81695242|FG005|Overall Study|Protocol Violation|0|||
27962843|NCT01144416|81695243|FG000|Intervention Period|Adverse Event|5|||
27962844|NCT01144416|81695244|FG001|Intervention Period|Adverse Event|6|||
27962845|NCT01144416|81695243|FG000|Intervention Period|Insufficient ovarian response|11|||
27962846|NCT01144416|81695244|FG001|Intervention Period|Insufficient ovarian response|17|||
27962847|NCT01144416|81695243|FG000|Intervention Period|Risk of OHSS|0|||
27962848|NCT01144416|81695244|FG001|Intervention Period|Risk of OHSS|1|||
27962849|NCT01144416|81695243|FG000|Intervention Period|Too high ovarian response|4|||
27962850|NCT01144416|81695244|FG001|Intervention Period|Too high ovarian response|2|||
27962851|NCT01144416|81695243|FG000|Intervention Period|No/too few/bad oocytes|7|||
27962852|NCT01144416|81695244|FG001|Intervention Period|No/too few/bad oocytes|5|||
27962853|NCT01144416|81695243|FG000|Intervention Period|No or abnormal fertilization|25|||
27766754|NCT01457924|80973294|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
27766755|NCT01457924|80973290|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
27962854|NCT01144416|81695244|FG001|Intervention Period|No or abnormal fertilization|10|||
27962855|NCT01144416|81695243|FG000|Intervention Period|No/too few/bad quality embryos|3|||
27568944|NCT02658890|80271480|FG010|Treatment Phase|Lost to Follow-up|0|||
27663593|NCT02995733|80606479|FG001|Overall Study|Withdrawal by Subject|2|||
27663594|NCT02995733|80606478|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
27766756|NCT01457924|80973291|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
27766757|NCT01457924|80973292|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
27766758|NCT01457924|80973293|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
27962856|NCT01144416|81695244|FG001|Intervention Period|No/too few/bad quality embryos|3|||
27962857|NCT01144416|81695243|FG000|Intervention Period|Other|7|||
27962858|NCT01144416|81695244|FG001|Intervention Period|Other|5|||
27962859|NCT01925768|81695247|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27962860|NCT01925768|81695248|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27962861|NCT01925768|81695247|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27962862|NCT01925768|81695248|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
27962863|NCT01925768|81695247|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
27962864|NCT01925768|81695248|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
27962865|NCT01925768|81695247|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
27962866|NCT01925768|81695248|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
27962867|NCT01925768|81695247|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
27962868|NCT01925768|81695248|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
27962869|NCT01925768|81695247|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
27962870|NCT01925768|81695248|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
27962871|NCT01925768|81695247|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
27962872|NCT01925768|81695248|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
27568945|NCT02658890|80271481|FG011|Treatment Phase|Lost to Follow-up|0|||
27766759|NCT01457924|80973294|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
27766760|NCT01457924|80973290|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
27766761|NCT01457924|80973291|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
27766762|NCT01457924|80973292|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
27766763|NCT01457924|80973293|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
27766764|NCT01457924|80973294|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
27766765|NCT00796003|80973296|FG000|Overall Study|Disease Progression|2|||
27766766|NCT00796003|80973297|FG001|Overall Study|Disease Progression|13|||
27766767|NCT00796003|80973296|FG000|Overall Study|Adverse Event|1|||
27766768|NCT00796003|80973297|FG001|Overall Study|Adverse Event|7|||
27766769|NCT00796003|80973296|FG000|Overall Study|Specified organ function not met|0|||
27766770|NCT00796003|80973297|FG001|Overall Study|Specified organ function not met|1|||
27766771|NCT00796003|80973296|FG000|Overall Study|Physician Decision|0|||
27766772|NCT00796003|80973297|FG001|Overall Study|Physician Decision|4|||
27766773|NCT00796003|80973296|FG000|Overall Study|Withdrawal by Subject|0|||
27766774|NCT00796003|80973297|FG001|Overall Study|Withdrawal by Subject|1|||
27766775|NCT00796003|80973296|FG000|Overall Study|Other|0|||
27766776|NCT00796003|80973297|FG001|Overall Study|Other|1|||
27766777|NCT00796003|80973296|FG000|Overall Study|Participants Not treated|0|||
27766778|NCT00796003|80973297|FG001|Overall Study|Participants Not treated|2|||
27766779|NCT01822223|80973301|FG000|Overall Study|Death|0|||
27766780|NCT01822223|80973302|FG001|Overall Study|Death|1|||
27766781|NCT00047008|80973303|FG000|Overall Study|Withdrawn consent|2|||
27766782|NCT00047008|80973304|FG001|Overall Study|Withdrawn consent|3|||
27766783|NCT00047008|80973303|FG000|Overall Study|Ineligible|9|||
27766784|NCT00047008|80973304|FG001|Overall Study|Ineligible|8|||
27766785|NCT00651313|80973305|FG000|Overall Study|Adverse Event|0|||
27766786|NCT00651313|80973306|FG001|Overall Study|Adverse Event|1|||
27766787|NCT00651313|80973305|FG000|Overall Study|Withdrawal by Subject|3|||
27766788|NCT00651313|80973306|FG001|Overall Study|Withdrawal by Subject|1|||
27766789|NCT00651313|80973305|FG000|Overall Study|Lost to Follow-up|1|||
27766790|NCT00651313|80973306|FG001|Overall Study|Lost to Follow-up|1|||
27766791|NCT00651313|80973305|FG000|Overall Study|Adminstrative Discontinuation|2|||
27766792|NCT00651313|80973306|FG001|Overall Study|Adminstrative Discontinuation|3|||
27766793|NCT03287869|80973309|FG000|Overall Study|Adverse Event|14|||
27766794|NCT03287869|80973310|FG001|Overall Study|Adverse Event|12|||
27766795|NCT03287869|80973309|FG000|Overall Study|Lack of Efficacy|1|||
27766796|NCT03287869|80973310|FG001|Overall Study|Lack of Efficacy|0|||
27766797|NCT03287869|80973309|FG000|Overall Study|Lost to Follow-up|13|||
27766798|NCT03287869|80973310|FG001|Overall Study|Lost to Follow-up|19|||
27766799|NCT03287869|80973309|FG000|Overall Study|Non-Compliance With Study Drug|5|||
27766800|NCT03287869|80973310|FG001|Overall Study|Non-Compliance With Study Drug|9|||
27862171|NCT03058289|81326232|FG004|Overall Study|Rapid Progression of Disease|0|||
27862172|NCT03058289|81326233|FG005|Overall Study|Rapid Progression of Disease|0|||
27862173|NCT03058289|81326234|FG006|Overall Study|Rapid Progression of Disease|0|||
27862174|NCT03058289|81326235|FG007|Overall Study|Rapid Progression of Disease|0|||
27862175|NCT03058289|81326236|FG008|Overall Study|Rapid Progression of Disease|0|||
27862176|NCT02114385|81326237|FG000|Overall Study|Withdrawal by Subject|3|||
27862177|NCT02114385|81326238|FG001|Overall Study|Withdrawal by Subject|2|||
27862178|NCT02114385|81326237|FG000|Overall Study|Lost to Follow-up|0|||
27862179|NCT02114385|81326238|FG001|Overall Study|Lost to Follow-up|6|||
27862180|NCT02906358|81326239|FG000|Overall Study|Withdrawal by Subject|10|||
27862181|NCT02906358|81326240|FG001|Overall Study|Withdrawal by Subject|7|||
27862182|NCT02906358|81326239|FG000|Overall Study|Lost to Follow-up|12|||
27862183|NCT02906358|81326240|FG001|Overall Study|Lost to Follow-up|15|||
27862184|NCT03279692|81326241|FG000|Overall Study|Withdrawal by Subject|1|||
27862185|NCT02774642|81326244|FG000|Overall Study|Lost to Follow-up|9|||
27766801|NCT03287869|80973309|FG000|Overall Study|Progressive Disease|1|||
27766802|NCT03287869|80973310|FG001|Overall Study|Progressive Disease|0|||
27766803|NCT03287869|80973309|FG000|Overall Study|Protocol Deviation|2|||
27766804|NCT03287869|80973310|FG001|Overall Study|Protocol Deviation|1|||
27766805|NCT03287869|80973309|FG000|Overall Study|Withdrawal by Subject|36|||
27766806|NCT03287869|80973310|FG001|Overall Study|Withdrawal by Subject|43|||
27766807|NCT03287869|80973309|FG000|Overall Study|Early Closure of the Site|0|||
27766808|NCT03287869|80973310|FG001|Overall Study|Early Closure of the Site|1|||
27766809|NCT03287869|80973309|FG000|Overall Study|Physician Decision|5|||
27766810|NCT03287869|80973310|FG001|Overall Study|Physician Decision|5|||
27766811|NCT03287869|80973309|FG000|Overall Study|Reason not Specified|6|||
27766812|NCT03287869|80973310|FG001|Overall Study|Reason not Specified|3|||
27766813|NCT01599806|80973313|FG000|Overall Study|Lost to Follow-up|20|||
27766814|NCT01599806|80973314|FG001|Overall Study|Lost to Follow-up|20|||
27766815|NCT01599806|80973313|FG000|Overall Study|Withdrawal by Subject|12|||
27766816|NCT01599806|80973314|FG001|Overall Study|Withdrawal by Subject|12|||
27766817|NCT01599806|80973313|FG000|Overall Study|Other Eligibility criteria|11|||
27766818|NCT01599806|80973314|FG001|Overall Study|Other Eligibility criteria|9|||
27766819|NCT02427100|80973315|FG000|Overall Study|Lost to Follow-up|0|||
27766820|NCT02427100|80973316|FG001|Overall Study|Lost to Follow-up|2|||
27766821|NCT03235726|80973320|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766822|NCT03235726|80973321|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766823|NCT03235726|80973322|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766824|NCT03235726|80973323|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766825|NCT03235726|80973324|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
27766826|NCT03235726|80973325|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766827|NCT03235726|80973326|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766828|NCT03235726|80973327|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766829|NCT03235726|80973328|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766830|NCT03235726|80973329|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
27766831|NCT03235726|80973320|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766832|NCT03235726|80973321|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766833|NCT03235726|80973322|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766834|NCT03235726|80973323|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766835|NCT03235726|80973324|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
27766836|NCT03235726|80973325|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766837|NCT03235726|80973326|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766838|NCT03235726|80973327|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766839|NCT03235726|80973328|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766840|NCT03235726|80973329|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
27766841|NCT02574481|80973330|FG000|Overall Study|Withdrawal by Subject|29|||
27766842|NCT02574481|80973331|FG001|Overall Study|Withdrawal by Subject|15|||
27766843|NCT02574481|80973332|FG002|Overall Study|Withdrawal by Subject|4|||
27766844|NCT02574481|80973333|FG003|Overall Study|Withdrawal by Subject|1|||
27766845|NCT02574481|80973330|FG000|Overall Study|Adverse Event|5|||
27766846|NCT02574481|80973331|FG001|Overall Study|Adverse Event|1|||
27766847|NCT02574481|80973332|FG002|Overall Study|Adverse Event|1|||
27766848|NCT02574481|80973333|FG003|Overall Study|Adverse Event|0|||
27766849|NCT02574481|80973330|FG000|Overall Study|Visit Missed|15|||
27766850|NCT02574481|80973331|FG001|Overall Study|Visit Missed|7|||
27766851|NCT02574481|80973332|FG002|Overall Study|Visit Missed|5|||
27766852|NCT02574481|80973333|FG003|Overall Study|Visit Missed|0|||
27766853|NCT02574481|80973330|FG000|Overall Study|Other|7|||
27766854|NCT02574481|80973331|FG001|Overall Study|Other|2|||
27766855|NCT02574481|80973332|FG002|Overall Study|Other|0|||
27766856|NCT02574481|80973333|FG003|Overall Study|Other|0|||
27766857|NCT02574481|80973330|FG000|Overall Study|Death|48|||
27766858|NCT02574481|80973331|FG001|Overall Study|Death|26|||
27766859|NCT02574481|80973332|FG002|Overall Study|Death|12|||
27766860|NCT02574481|80973333|FG003|Overall Study|Death|4|||
27766861|NCT02574481|80973330|FG000|Overall Study|Physician Decision|5|||
27766862|NCT02574481|80973331|FG001|Overall Study|Physician Decision|2|||
27766863|NCT02574481|80973332|FG002|Overall Study|Physician Decision|0|||
27766864|NCT02574481|80973333|FG003|Overall Study|Physician Decision|0|||
27766865|NCT02574481|80973330|FG000|Overall Study|Lost to Follow-up|5|||
27766866|NCT02574481|80973331|FG001|Overall Study|Lost to Follow-up|1|||
27766867|NCT02574481|80973332|FG002|Overall Study|Lost to Follow-up|3|||
27766868|NCT02574481|80973333|FG003|Overall Study|Lost to Follow-up|0|||
27766869|NCT00701103|80973339|FG000|Overall Study|Adverse Event|0|||
27766870|NCT00701103|80973340|FG001|Overall Study|Adverse Event|0|||
27766871|NCT00701103|80973341|FG002|Overall Study|Adverse Event|1|||
27766872|NCT00701103|80973342|FG003|Overall Study|Adverse Event|1|||
27766873|NCT00701103|80973343|FG004|Overall Study|Adverse Event|0|||
27766874|NCT00701103|80973344|FG005|Overall Study|Adverse Event|1|||
27766875|NCT00701103|80973345|FG006|Overall Study|Adverse Event|1|||
27766876|NCT00701103|80973346|FG007|Overall Study|Adverse Event|0|||
27766877|NCT00701103|80973347|FG008|Overall Study|Adverse Event|0|||
27766878|NCT00701103|80973348|FG009|Overall Study|Adverse Event|2|||
27766879|NCT00701103|80973349|FG010|Overall Study|Adverse Event|0|||
27766880|NCT00701103|80973339|FG000|Overall Study|Progressive Disease|5|||
27766881|NCT00701103|80973340|FG001|Overall Study|Progressive Disease|2|||
27766882|NCT00701103|80973341|FG002|Overall Study|Progressive Disease|6|||
27766883|NCT00701103|80973342|FG003|Overall Study|Progressive Disease|5|||
27766884|NCT00701103|80973343|FG004|Overall Study|Progressive Disease|6|||
27766885|NCT00701103|80973344|FG005|Overall Study|Progressive Disease|5|||
27766886|NCT00701103|80973345|FG006|Overall Study|Progressive Disease|7|||
27766887|NCT00701103|80973346|FG007|Overall Study|Progressive Disease|7|||
27766888|NCT00701103|80973347|FG008|Overall Study|Progressive Disease|8|||
27766889|NCT00701103|80973348|FG009|Overall Study|Progressive Disease|8|||
27766890|NCT00701103|80973349|FG010|Overall Study|Progressive Disease|11|||
27766891|NCT00701103|80973339|FG000|Overall Study|Withdrawal by Subject|0|||
27766892|NCT00701103|80973340|FG001|Overall Study|Withdrawal by Subject|1|||
27766893|NCT00701103|80973341|FG002|Overall Study|Withdrawal by Subject|1|||
27766894|NCT00701103|80973342|FG003|Overall Study|Withdrawal by Subject|0|||
27766895|NCT00701103|80973343|FG004|Overall Study|Withdrawal by Subject|0|||
27766896|NCT00701103|80973344|FG005|Overall Study|Withdrawal by Subject|0|||
27766897|NCT00701103|80973345|FG006|Overall Study|Withdrawal by Subject|0|||
27766898|NCT00701103|80973346|FG007|Overall Study|Withdrawal by Subject|0|||
27766899|NCT00701103|80973347|FG008|Overall Study|Withdrawal by Subject|0|||
27766900|NCT00701103|80973348|FG009|Overall Study|Withdrawal by Subject|0|||
27766901|NCT00701103|80973349|FG010|Overall Study|Withdrawal by Subject|0|||
27766902|NCT00701103|80973339|FG000|Overall Study|Other|0|||
27766903|NCT00701103|80973340|FG001|Overall Study|Other|0|||
27766904|NCT00701103|80973341|FG002|Overall Study|Other|0|||
27766905|NCT00701103|80973342|FG003|Overall Study|Other|0|||
27766906|NCT00701103|80973343|FG004|Overall Study|Other|0|||
27766907|NCT00701103|80973344|FG005|Overall Study|Other|0|||
27766908|NCT00701103|80973345|FG006|Overall Study|Other|0|||
27766909|NCT00701103|80973346|FG007|Overall Study|Other|0|||
27766910|NCT00701103|80973347|FG008|Overall Study|Other|1|||
27766911|NCT00701103|80973348|FG009|Overall Study|Other|1|||
27766912|NCT00701103|80973349|FG010|Overall Study|Other|0|||
27766913|NCT01601704|80973350|FG000|Overall Study|Randomized but not dispensed study med|1|||
27766914|NCT01601704|80973351|FG001|Overall Study|Randomized but not dispensed study med|4|||
27766915|NCT01570309|80973352|FG000|Overall Study|Withdrawal by Subject|3|||
27766916|NCT01570309|80973353|FG001|Overall Study|Withdrawal by Subject|3|||
27766917|NCT01213264|80973355|FG000|Overall Study|Adverse Event|1|||
27766918|NCT01213264|80973356|FG001|Overall Study|Adverse Event|0|||
27766919|NCT01213264|80973357|FG002|Overall Study|Adverse Event|0|||
27766920|NCT01213264|80973355|FG000|Overall Study|Lost to Follow-up|1|||
27766921|NCT01213264|80973356|FG001|Overall Study|Lost to Follow-up|2|||
27766922|NCT01213264|80973357|FG002|Overall Study|Lost to Follow-up|6|||
27766923|NCT00520299|80976879|FG000|Overall Study|Withdrawal by Subject|0|||
27568946|NCT02658890|80271482|FG012|Treatment Phase|Lost to Follow-up|0|||
27568947|NCT02658890|80271483|FG013|Treatment Phase|Lost to Follow-up|0|||
27568948|NCT02658890|80271484|FG014|Treatment Phase|Lost to Follow-up|0|||
27568949|NCT02658890|80271485|FG015|Treatment Phase|Lost to Follow-up|0|||
27568950|NCT02658890|80271486|FG016|Treatment Phase|Lost to Follow-up|0|||
27568951|NCT02658890|80271487|FG017|Treatment Phase|Lost to Follow-up|0|||
27568952|NCT02658890|80271488|FG018|Treatment Phase|Lost to Follow-up|0|||
27663595|NCT02995733|80606479|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
27663596|NCT02995733|80606478|FG000|Overall Study|Lost to Follow-up|48|||
27663597|NCT02995733|80606479|FG001|Overall Study|Lost to Follow-up|37|||
27663598|NCT02995733|80606478|FG000|Overall Study|Other|0|||
27663599|NCT02995733|80606479|FG001|Overall Study|Other|1|||
27663600|NCT02469077|80606480|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
27663601|NCT02469077|80606481|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
27663602|NCT02469077|80606480|FG000|Post Randomization/Intervention Period|Relocated|1|||
27663603|NCT02469077|80606481|FG001|Post Randomization/Intervention Period|Relocated|1|||
27663604|NCT02469077|80606480|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
27766924|NCT00520299|80976880|FG001|Overall Study|Withdrawal by Subject|0|||
27766925|NCT00520299|80976881|FG002|Overall Study|Withdrawal by Subject|2|||
27766926|NCT00520299|80976879|FG000|Overall Study|Progressive disease|0|||
27766927|NCT00520299|80976880|FG001|Overall Study|Progressive disease|3|||
27766928|NCT00520299|80976881|FG002|Overall Study|Progressive disease|4|||
27568953|NCT02658890|80271489|FG019|Treatment Phase|Lost to Follow-up|0|||
27766929|NCT00064077|80976882|FG000|Overall Study|Improper prior treatment|1|||
27568954|NCT02658890|80271490|FG020|Treatment Phase|Lost to Follow-up|0|||
27663605|NCT02469077|80606481|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
27766930|NCT00064077|80976883|FG001|Overall Study|Improper prior treatment|0|||
27766931|NCT00064077|80976884|FG002|Overall Study|Improper prior treatment|0|||
27766932|NCT00064077|80976885|FG003|Overall Study|Improper prior treatment|0|||
27766933|NCT00064077|80976882|FG000|Overall Study|Poor risk|2|||
27766934|NCT00064077|80976883|FG001|Overall Study|Poor risk|0|||
27766935|NCT00064077|80976884|FG002|Overall Study|Poor risk|1|||
27766936|NCT00064077|80976885|FG003|Overall Study|Poor risk|1|||
27766937|NCT00064077|80976882|FG000|Overall Study|Pathology|10|||
27766938|NCT00064077|80976883|FG001|Overall Study|Pathology|7|||
27766939|NCT00064077|80976884|FG002|Overall Study|Pathology|3|||
27766940|NCT00064077|80976885|FG003|Overall Study|Pathology|4|||
27766941|NCT00064077|80976882|FG000|Overall Study|No surgery|0|||
27766942|NCT00064077|80976883|FG001|Overall Study|No surgery|0|||
27766943|NCT00064077|80976884|FG002|Overall Study|No surgery|1|||
27766944|NCT00064077|80976885|FG003|Overall Study|No surgery|0|||
27766945|NCT00064077|80976882|FG000|Overall Study|No tumor|0|||
27766946|NCT00064077|80976883|FG001|Overall Study|No tumor|0|||
27766947|NCT00064077|80976884|FG002|Overall Study|No tumor|1|||
27766948|NCT00064077|80976885|FG003|Overall Study|No tumor|0|||
27766949|NCT00064077|80976882|FG000|Overall Study|Other reasons|2|||
27766950|NCT00064077|80976883|FG001|Overall Study|Other reasons|2|||
27766951|NCT00064077|80976884|FG002|Overall Study|Other reasons|1|||
27766952|NCT00064077|80976885|FG003|Overall Study|Other reasons|2|||
27766953|NCT00732641|80976886|FG000|Overall Study|Relapse or Progressive Disease|65|||
27766954|NCT00732641|80976887|FG001|Overall Study|Relapse or Progressive Disease|101|||
27766955|NCT00732641|80976886|FG000|Overall Study|Serious Adverse Events|12|||
27766956|NCT00732641|80976887|FG001|Overall Study|Serious Adverse Events|3|||
27766957|NCT00732641|80976886|FG000|Overall Study|Physician Decision|6|||
27766958|NCT00732641|80976887|FG001|Overall Study|Physician Decision|0|||
27766959|NCT00732641|80976886|FG000|Overall Study|Withdrawal by Subject|4|||
27766960|NCT00732641|80976887|FG001|Overall Study|Withdrawal by Subject|2|||
27766961|NCT00732641|80976886|FG000|Overall Study|Unable to Complete|1|||
27766962|NCT00732641|80976887|FG001|Overall Study|Unable to Complete|1|||
27766963|NCT00732641|80976886|FG000|Overall Study|Other|18|||
27766964|NCT00732641|80976887|FG001|Overall Study|Other|5|||
27766965|NCT01390038|80976888|FG000|Overall Study|Death|1|||
27766966|NCT01390038|80976888|FG000|Overall Study|Lost to Follow-up|1|||
27766967|NCT01390038|80976888|FG000|Overall Study|Withdrawal by Subject|4|||
27766968|NCT01390038|80976888|FG000|Overall Study|Simpliciti System Removal|2|||
27766969|NCT02873208|80976895|FG000|Overall Study|Withdrawal by Subject|36|||
27766970|NCT02873208|80976895|FG000|Overall Study|Lost to Follow-up|22|||
27766971|NCT02873208|80976895|FG000|Overall Study|Adverse Event|15|||
27766972|NCT02873208|80976895|FG000|Overall Study|Non-compliance with study drug|12|||
27766973|NCT02873208|80976895|FG000|Overall Study|Protocol Violation|8|||
27766974|NCT02873208|80976895|FG000|Overall Study|Pregnancy|2|||
27962873|NCT01925768|81695247|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
27962874|NCT01925768|81695248|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
27962875|NCT01925768|81695247|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
27568955|NCT02658890|80271491|FG021|Treatment Phase|Lost to Follow-up|0|||
27568956|NCT02658890|80271492|FG022|Treatment Phase|Lost to Follow-up|0|||
27766975|NCT02873208|80976895|FG000|Overall Study|Incarceration|1|||
27766976|NCT02873208|80976895|FG000|Overall Study|Lack of Efficacy|1|||
27766977|NCT02873208|80976895|FG000|Overall Study|Physician Decision|1|||
27766978|NCT01369225|80976896|FG000|Overall Study|Withdrawal by Subject|1|||
27766979|NCT01369225|80976897|FG001|Overall Study|Withdrawal by Subject|0|||
27766980|NCT01369225|80976898|FG002|Overall Study|Withdrawal by Subject|2|||
27766981|NCT01369225|80976899|FG003|Overall Study|Withdrawal by Subject|1|||
27766982|NCT01369225|80976900|FG004|Overall Study|Withdrawal by Subject|0|||
27766983|NCT01369225|80976901|FG005|Overall Study|Withdrawal by Subject|0|||
27766984|NCT01369225|80976896|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
27766985|NCT01369225|80976897|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
27766986|NCT01369225|80976898|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
27766987|NCT01369225|80976899|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
27766988|NCT01369225|80976900|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
27766989|NCT01369225|80976901|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
27766990|NCT01369225|80976896|FG000|Overall Study|Other|1|||
27766991|NCT01369225|80976897|FG001|Overall Study|Other|0|||
27568957|NCT02658890|80271493|FG023|Treatment Phase|Lost to Follow-up|0|||
27766992|NCT01369225|80976898|FG002|Overall Study|Other|0|||
27766993|NCT01369225|80976899|FG003|Overall Study|Other|0|||
27766994|NCT01369225|80976900|FG004|Overall Study|Other|1|||
27766995|NCT01369225|80976901|FG005|Overall Study|Other|0|||
27766996|NCT01369225|80976896|FG000|Overall Study|Adverse Event|0|||
27766997|NCT01369225|80976897|FG001|Overall Study|Adverse Event|0|||
27766998|NCT01369225|80976898|FG002|Overall Study|Adverse Event|0|||
27766999|NCT01369225|80976899|FG003|Overall Study|Adverse Event|1|||
27767000|NCT01369225|80976900|FG004|Overall Study|Adverse Event|1|||
27767001|NCT01369225|80976901|FG005|Overall Study|Adverse Event|0|||
27767002|NCT03483116|80976902|FG000|Overall Study|Adverse Event|0|||
27767003|NCT03483116|80976903|FG001|Overall Study|Adverse Event|1|||
27767004|NCT03483116|80976904|FG002|Overall Study|Adverse Event|0|||
27767005|NCT03483116|80976905|FG003|Overall Study|Adverse Event|1|||
27767006|NCT03483116|80976902|FG000|Overall Study|Protocol Violation|1|||
27767007|NCT03483116|80976903|FG001|Overall Study|Protocol Violation|0|||
27767008|NCT03483116|80976904|FG002|Overall Study|Protocol Violation|0|||
27767009|NCT03483116|80976905|FG003|Overall Study|Protocol Violation|7|||
27767010|NCT03483116|80976902|FG000|Overall Study|Lost to Follow-up|9|||
27767011|NCT03483116|80976903|FG001|Overall Study|Lost to Follow-up|4|||
27767012|NCT03483116|80976904|FG002|Overall Study|Lost to Follow-up|9|||
27767013|NCT03483116|80976905|FG003|Overall Study|Lost to Follow-up|5|||
27767014|NCT03483116|80976902|FG000|Overall Study|Death|1|||
27767015|NCT03483116|80976903|FG001|Overall Study|Death|0|||
27767016|NCT03483116|80976904|FG002|Overall Study|Death|2|||
27767017|NCT03483116|80976905|FG003|Overall Study|Death|1|||
27767018|NCT03483116|80976902|FG000|Overall Study|Withdrawal by Subject|14|||
27767019|NCT03483116|80976903|FG001|Overall Study|Withdrawal by Subject|16|||
27767020|NCT03483116|80976904|FG002|Overall Study|Withdrawal by Subject|14|||
27767021|NCT03483116|80976905|FG003|Overall Study|Withdrawal by Subject|16|||
27767022|NCT03483116|80976902|FG000|Overall Study|Unknown other reason|3|||
27767023|NCT03483116|80976903|FG001|Overall Study|Unknown other reason|2|||
27767024|NCT03483116|80976904|FG002|Overall Study|Unknown other reason|1|||
27767025|NCT03483116|80976905|FG003|Overall Study|Unknown other reason|1|||
27767026|NCT01590212|80976906|FG000|Overall Study|Withdrawal by Subject|2|||
27767027|NCT01590212|80976907|FG001|Overall Study|Withdrawal by Subject|2|||
27767028|NCT01590212|80976908|FG002|Overall Study|Withdrawal by Subject|2|||
27767029|NCT01590212|80976906|FG000|Overall Study|Lost to Follow-up|1|||
27767030|NCT01590212|80976907|FG001|Overall Study|Lost to Follow-up|2|||
27767031|NCT01590212|80976908|FG002|Overall Study|Lost to Follow-up|3|||
27767032|NCT00813917|80976911|FG000|Overall Study|Adverse Event|0|||
27767033|NCT00813917|80976912|FG001|Overall Study|Adverse Event|1|||
27767034|NCT00813917|80976911|FG000|Overall Study|Withdrawal by Subject|3|||
27767035|NCT00813917|80976912|FG001|Overall Study|Withdrawal by Subject|4|||
27767036|NCT00813917|80976911|FG000|Overall Study|Lost to Follow-up|3|||
27767037|NCT00813917|80976912|FG001|Overall Study|Lost to Follow-up|1|||
27767038|NCT00719537|80976915|FG000|Overall Study|Withdrawal by Subject|1|||
27767039|NCT00719537|80976916|FG001|Overall Study|Withdrawal by Subject|0|||
27767040|NCT00719537|80976915|FG000|Overall Study|Lost to Follow-up|0|||
27767041|NCT00719537|80976916|FG001|Overall Study|Lost to Follow-up|1|||
27767042|NCT03725293|80976917|FG000|Overall Study|Physician Decision|9|||
27767043|NCT03725293|80976918|FG001|Overall Study|Physician Decision|6|||
27767044|NCT03725293|80976917|FG000|Overall Study|alternative vascular access needs|1|||
27767045|NCT03725293|80976918|FG001|Overall Study|alternative vascular access needs|2|||
27767046|NCT03725293|80976917|FG000|Overall Study|venous anatomy screen failures|2|||
27767047|NCT03725293|80976918|FG001|Overall Study|venous anatomy screen failures|1|||
27767048|NCT02290340|80976928|FG000|Overall Study|Lost to Follow-up|0|||
27767049|NCT02290340|80976929|FG001|Overall Study|Lost to Follow-up|0|||
27767050|NCT02290340|80976930|FG002|Overall Study|Lost to Follow-up|0|||
27767051|NCT02290340|80976931|FG003|Overall Study|Lost to Follow-up|1|||
27767052|NCT02290340|80976928|FG000|Overall Study|Withdrawal by Subject|1|||
27767053|NCT02290340|80976929|FG001|Overall Study|Withdrawal by Subject|0|||
27767054|NCT02290340|80976930|FG002|Overall Study|Withdrawal by Subject|0|||
27767055|NCT02290340|80976931|FG003|Overall Study|Withdrawal by Subject|0|||
27767056|NCT02290340|80976928|FG000|Overall Study|Other|1|||
27767057|NCT02290340|80976929|FG001|Overall Study|Other|0|||
27767058|NCT02290340|80976930|FG002|Overall Study|Other|0|||
27767059|NCT02290340|80976931|FG003|Overall Study|Other|1|||
27767060|NCT02910219|80976934|FG000|Overall Study|Withdrawal by Subject|1|||
27767061|NCT02910219|80976935|FG001|Overall Study|Withdrawal by Subject|1|||
27767062|NCT03446612|80976942|FG000|Overall Study|Protocol defined stopping criteria|0|||
27767063|NCT03446612|80976943|FG001|Overall Study|Protocol defined stopping criteria|1|||
27767064|NCT00361218|80976944|FG000|Overall Study|Lost to Follow-up|11|||
27767065|NCT00361218|80976944|FG000|Overall Study|Personal Reasons|7|||
27767066|NCT00361218|80976944|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
27767067|NCT01250756|80976945|FG000|Infant Series|Withdrawal by Subject|4|||
27767068|NCT01250756|80976946|FG001|Infant Series|Withdrawal by Subject|5|||
27767069|NCT01250756|80976945|FG000|Infant Series|Randomized, Not Vaccinated|2|||
27767070|NCT01250756|80976946|FG001|Infant Series|Randomized, Not Vaccinated|2|||
27767071|NCT01250756|80976945|FG000|Infant Series|Other|22|||
27767072|NCT01250756|80976946|FG001|Infant Series|Other|0|||
27767073|NCT01250756|80976945|FG000|After Infant Series|Adverse Event|5|||
27767074|NCT01250756|80976946|FG001|After Infant Series|Adverse Event|2|||
27767075|NCT01250756|80976945|FG000|After Infant Series|Withdrawal by Subject|4|||
27767076|NCT01250756|80976946|FG001|After Infant Series|Withdrawal by Subject|1|||
27767077|NCT01250756|80976945|FG000|After Infant Series|Other|2|||
27767078|NCT01250756|80976946|FG001|After Infant Series|Other|1|||
27767079|NCT01250756|80976945|FG000|Toddler Dose|Adverse Event|0|||
27767080|NCT01250756|80976946|FG001|Toddler Dose|Adverse Event|1|||
27767081|NCT01250756|80976945|FG000|After Toddler Dose|Adverse Event|0|||
27767082|NCT01250756|80976946|FG001|After Toddler Dose|Adverse Event|1|||
27767083|NCT01335698|80976947|FG000|Treatment Stage 1|Lack of Efficacy|3|||
27767084|NCT01335698|80976948|FG001|Treatment Stage 1|Lack of Efficacy|1|||
27767085|NCT01335698|80976949|FG002|Treatment Stage 1|Lack of Efficacy|3|||
27767086|NCT01335698|80976950|FG003|Treatment Stage 1|Lack of Efficacy|3|||
27767087|NCT01335698|80976951|FG004|Treatment Stage 1|Lack of Efficacy|1|||
27962876|NCT01925768|81695248|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
27962877|NCT01925768|81695247|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
27962878|NCT01925768|81695248|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
27962879|NCT01925768|81695247|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
27962880|NCT01925768|81695248|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
27962881|NCT00661726|81695254|FG000|Overall Study|Adverse Event|1|||
27962882|NCT03265145|81695255|FG000|Overall Study|Protocol Violation|2|||
27962883|NCT03265145|81695256|FG001|Overall Study|Protocol Violation|0|||
27962884|NCT03265145|81695255|FG000|Overall Study|Adverse Event|1|||
27962885|NCT03265145|81695256|FG001|Overall Study|Adverse Event|0|||
27663606|NCT02469077|80606480|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
27663607|NCT02469077|80606481|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
27663608|NCT03220776|80606482|FG000|Overall Study|Claustrophobia|0|||
27663609|NCT03220776|80606483|FG001|Overall Study|Claustrophobia|1|||
27663610|NCT03220776|80606484|FG002|Overall Study|Claustrophobia|1|||
27663611|NCT03220776|80606485|FG003|Overall Study|Claustrophobia|0|||
27663612|NCT03220776|80606486|FG004|Overall Study|Claustrophobia|1|||
27663613|NCT03220776|80606487|FG005|Overall Study|Claustrophobia|0|||
27663614|NCT03220776|80606482|FG000|Overall Study|MRI Equipment Failure|1|||
27663615|NCT03220776|80606483|FG001|Overall Study|MRI Equipment Failure|0|||
27663616|NCT03220776|80606484|FG002|Overall Study|MRI Equipment Failure|0|||
27663617|NCT03220776|80606485|FG003|Overall Study|MRI Equipment Failure|0|||
27663618|NCT03220776|80606486|FG004|Overall Study|MRI Equipment Failure|0|||
27663619|NCT03220776|80606487|FG005|Overall Study|MRI Equipment Failure|0|||
27663620|NCT03220776|80606482|FG000|Overall Study|Inclimate Weather|0|||
27663621|NCT03220776|80606483|FG001|Overall Study|Inclimate Weather|0|||
27663622|NCT03220776|80606484|FG002|Overall Study|Inclimate Weather|0|||
27663623|NCT03220776|80606485|FG003|Overall Study|Inclimate Weather|0|||
27663624|NCT03220776|80606486|FG004|Overall Study|Inclimate Weather|0|||
27663625|NCT03220776|80606487|FG005|Overall Study|Inclimate Weather|1|||
27663626|NCT03220776|80606482|FG000|Overall Study|Physician Decision|0|||
27663627|NCT03220776|80606483|FG001|Overall Study|Physician Decision|0|||
27663628|NCT03220776|80606484|FG002|Overall Study|Physician Decision|0|||
27663629|NCT03220776|80606485|FG003|Overall Study|Physician Decision|1|||
27663630|NCT03220776|80606486|FG004|Overall Study|Physician Decision|0|||
27663631|NCT03220776|80606487|FG005|Overall Study|Physician Decision|0|||
27663632|NCT03220776|80606482|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
27663633|NCT03220776|80606483|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
27663634|NCT03220776|80606484|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
27663635|NCT03220776|80606485|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
27663636|NCT03220776|80606486|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
27663637|NCT03220776|80606487|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
27663638|NCT03220776|80606482|FG000|Overall Study|Protocol Violation|0|||
27663639|NCT03220776|80606483|FG001|Overall Study|Protocol Violation|0|||
27663640|NCT03220776|80606484|FG002|Overall Study|Protocol Violation|0|||
27663641|NCT03220776|80606485|FG003|Overall Study|Protocol Violation|2|||
27663642|NCT03220776|80606486|FG004|Overall Study|Protocol Violation|0|||
27663643|NCT03220776|80606487|FG005|Overall Study|Protocol Violation|1|||
27663644|NCT03220776|80606482|FG000|Overall Study|Withdrawal by Subject|1|||
27663645|NCT03220776|80606483|FG001|Overall Study|Withdrawal by Subject|0|||
27663646|NCT03220776|80606484|FG002|Overall Study|Withdrawal by Subject|0|||
27663647|NCT03220776|80606485|FG003|Overall Study|Withdrawal by Subject|0|||
27663648|NCT03220776|80606486|FG004|Overall Study|Withdrawal by Subject|0|||
27663649|NCT03220776|80606487|FG005|Overall Study|Withdrawal by Subject|0|||
27663650|NCT03042559|80606488|FG000|Overall Study|drop out|1|||
27663651|NCT03042559|80606489|FG001|Overall Study|drop out|1|||
27663652|NCT02538471|80606492|FG000|Overall Study|Progression of disease|2|||
27663653|NCT00644332|80606493|FG000|Overall Study|Adverse Event|11|||
27663654|NCT00644332|80606493|FG000|Overall Study|Withdrawal by Subject|6|||
27663655|NCT00644332|80606493|FG000|Overall Study|Completion Status Unknown|2|||
27663656|NCT00644332|80606493|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
27663657|NCT00644332|80606493|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
27663658|NCT04572997|80606494|FG000|Overall Study|Adverse Event|1|||
27663659|NCT03226353|80606497|FG000|Overall Study|Withdrawal by Subject|1|||
27663660|NCT03226353|80606497|FG000|Overall Study|Screen Failure|5|||
27663661|NCT04984278|80606498|FG000|Period 1|Withdrawal by Subject|1|||
27663662|NCT04984278|80606499|FG001|Period 1|Withdrawal by Subject|0|||
27663663|NCT04984278|80606498|FG000|Period 1|Other|0|||
27663664|NCT04984278|80606499|FG001|Period 1|Other|1|||
27767088|NCT01335698|80976947|FG000|Treatment Stage 1|Adverse Event|1|||
27663665|NCT04984278|80606498|FG000|Period 2|Adverse Event|1|||
27663666|NCT04984278|80606499|FG001|Period 2|Adverse Event|0|||
27663667|NCT04984278|80606498|FG000|Period 2|Other|0|||
27962886|NCT03265145|81695255|FG000|Overall Study|Withdrawal by Subject|23|||
27962887|NCT03265145|81695256|FG001|Overall Study|Withdrawal by Subject|19|||
27767089|NCT01335698|80976948|FG001|Treatment Stage 1|Adverse Event|2|||
27767090|NCT01335698|80976949|FG002|Treatment Stage 1|Adverse Event|2|||
27767091|NCT01335698|80976950|FG003|Treatment Stage 1|Adverse Event|1|||
27767092|NCT01335698|80976951|FG004|Treatment Stage 1|Adverse Event|1|||
27767093|NCT01335698|80976947|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
27767094|NCT01335698|80976948|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
27767095|NCT01335698|80976949|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
27767096|NCT01335698|80976950|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
27767097|NCT01335698|80976951|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
27767098|NCT01335698|80976947|FG000|Treatment Stage 1|Lost to Follow-up|1|||
27767099|NCT01335698|80976948|FG001|Treatment Stage 1|Lost to Follow-up|1|||
27767100|NCT01335698|80976949|FG002|Treatment Stage 1|Lost to Follow-up|0|||
27767101|NCT01335698|80976950|FG003|Treatment Stage 1|Lost to Follow-up|0|||
27767102|NCT01335698|80976951|FG004|Treatment Stage 1|Lost to Follow-up|0|||
27767103|NCT01335698|80976947|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
27767104|NCT01335698|80976948|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
27767105|NCT01335698|80976949|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
27767106|NCT01335698|80976950|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
27767107|NCT01335698|80976951|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
27767108|NCT01335698|80976947|FG000|Treatment Stage 1|No longer meets study criteria|1|||
27767109|NCT01335698|80976948|FG001|Treatment Stage 1|No longer meets study criteria|1|||
27767110|NCT01335698|80976949|FG002|Treatment Stage 1|No longer meets study criteria|0|||
27767111|NCT01335698|80976950|FG003|Treatment Stage 1|No longer meets study criteria|1|||
27767112|NCT01335698|80976951|FG004|Treatment Stage 1|No longer meets study criteria|0|||
27767113|NCT01335698|80976947|FG000|Treatment Stage 1|Other|1|||
27767114|NCT01335698|80976948|FG001|Treatment Stage 1|Other|0|||
27767115|NCT01335698|80976949|FG002|Treatment Stage 1|Other|0|||
27767116|NCT01335698|80976950|FG003|Treatment Stage 1|Other|1|||
27767117|NCT01335698|80976951|FG004|Treatment Stage 1|Other|0|||
27767118|NCT01335698|80976947|FG000|Treatment Stage 2|Lack of Efficacy|2|||
27767119|NCT01335698|80976948|FG001|Treatment Stage 2|Lack of Efficacy|1|||
27767120|NCT01335698|80976949|FG002|Treatment Stage 2|Lack of Efficacy|3|||
27767121|NCT01335698|80976950|FG003|Treatment Stage 2|Lack of Efficacy|1|||
27767122|NCT01335698|80976951|FG004|Treatment Stage 2|Lack of Efficacy|0|||
27767123|NCT01335698|80976947|FG000|Treatment Stage 2|Adverse Event|2|||
27767124|NCT01335698|80976948|FG001|Treatment Stage 2|Adverse Event|0|||
27767125|NCT01335698|80976949|FG002|Treatment Stage 2|Adverse Event|0|||
27962888|NCT03265145|81695255|FG000|Overall Study|Death|12|||
27962889|NCT03265145|81695256|FG001|Overall Study|Death|12|||
27962890|NCT03265145|81695255|FG000|Overall Study|Lost to Follow-up|13|||
27962891|NCT03265145|81695256|FG001|Overall Study|Lost to Follow-up|9|||
27962892|NCT03265145|81695255|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
27962893|NCT03265145|81695256|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
27962894|NCT03265145|81695255|FG000|Overall Study|Switched back to previous medication|1|||
27568958|NCT02658890|80271494|FG024|Treatment Phase|Lost to Follow-up|0|||
27568959|NCT02658890|80271495|FG025|Treatment Phase|Lost to Follow-up|0|||
27663668|NCT04984278|80606499|FG001|Period 2|Other|1|||
27663669|NCT03036150|80606500|FG000|Overall Study|Withdrawal by Subject|8|||
27663670|NCT03036150|80606501|FG001|Overall Study|Withdrawal by Subject|3|||
27663671|NCT03036150|80606500|FG000|Overall Study|Lost to Follow-up|2|||
27663672|NCT03036150|80606501|FG001|Overall Study|Lost to Follow-up|2|||
27663673|NCT00105521|80606502|FG000|Overall Study|Other|1|||
27663674|NCT00105521|80606503|FG001|Overall Study|Other|1|||
27663675|NCT00105521|80606504|FG002|Overall Study|Other|2|||
27663676|NCT00105521|80606505|FG003|Overall Study|Other|0|||
27663677|NCT00105521|80606502|FG000|Overall Study|Adverse Event|10|||
27663678|NCT00105521|80606503|FG001|Overall Study|Adverse Event|4|||
27663679|NCT00105521|80606504|FG002|Overall Study|Adverse Event|10|||
27663680|NCT00105521|80606505|FG003|Overall Study|Adverse Event|8|||
27663681|NCT00105521|80606502|FG000|Overall Study|Withdrawal by Subject|1|||
27663682|NCT00105521|80606503|FG001|Overall Study|Withdrawal by Subject|0|||
27663683|NCT00105521|80606504|FG002|Overall Study|Withdrawal by Subject|1|||
27663684|NCT00105521|80606505|FG003|Overall Study|Withdrawal by Subject|4|||
27663685|NCT00105521|80606502|FG000|Overall Study|Lack of Efficacy|0|||
27663686|NCT00105521|80606503|FG001|Overall Study|Lack of Efficacy|0|||
27663687|NCT00105521|80606504|FG002|Overall Study|Lack of Efficacy|0|||
27663688|NCT00105521|80606505|FG003|Overall Study|Lack of Efficacy|1|||
27663689|NCT00105521|80606502|FG000|Overall Study|Protocol Violation|3|||
27663690|NCT00105521|80606503|FG001|Overall Study|Protocol Violation|5|||
27663691|NCT00105521|80606504|FG002|Overall Study|Protocol Violation|4|||
27663692|NCT00105521|80606505|FG003|Overall Study|Protocol Violation|4|||
27767126|NCT01335698|80976950|FG003|Treatment Stage 2|Adverse Event|3|||
27767127|NCT01335698|80976951|FG004|Treatment Stage 2|Adverse Event|0|||
27767128|NCT01335698|80976947|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
27767129|NCT01335698|80976948|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
27767130|NCT01335698|80976949|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
27962895|NCT03265145|81695256|FG001|Overall Study|Switched back to previous medication|0|||
27862186|NCT02774642|81326245|FG001|Overall Study|Lost to Follow-up|7|||
27568960|NCT02658890|80271496|FG026|Treatment Phase|Lost to Follow-up|0|||
27568961|NCT02658890|80271470|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
27568962|NCT02658890|80271471|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
27568963|NCT02658890|80271472|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
27663693|NCT00105521|80606502|FG000|Overall Study|Lost to Follow-up|0|||
27663694|NCT00105521|80606503|FG001|Overall Study|Lost to Follow-up|1|||
27663695|NCT00105521|80606504|FG002|Overall Study|Lost to Follow-up|0|||
27663696|NCT00105521|80606505|FG003|Overall Study|Lost to Follow-up|0|||
27663697|NCT02581189|80606506|FG000|Overall Study|Failure to return|36|||
27663698|NCT02581189|80606506|FG000|Overall Study|Withdrew consent|5|||
27663699|NCT02581189|80606506|FG000|Overall Study|Death|3|||
27663700|NCT02581189|80606506|FG000|Overall Study|Insufficient virological response|2|||
27663701|NCT02581189|80606506|FG000|Overall Study|Other, not specified|7|||
27663702|NCT00498433|80606507|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
27663703|NCT00498433|80606508|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
27663704|NCT00498433|80606509|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
27663705|NCT00498433|80606507|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
27663706|NCT00498433|80606508|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
27663707|NCT00498433|80606509|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
27663708|NCT00498433|80606507|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
27663709|NCT00498433|80606508|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
27663710|NCT00498433|80606509|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
27663711|NCT00498433|80606507|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
27663712|NCT00498433|80606508|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
27663713|NCT00498433|80606509|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
27663714|NCT00899379|80606515|FG000|Overall Study|Adverse Event|2|||
27663715|NCT00899379|80606516|FG001|Overall Study|Adverse Event|2|||
27663716|NCT00899379|80606517|FG002|Overall Study|Adverse Event|1|||
27663717|NCT00899379|80606518|FG003|Overall Study|Adverse Event|1|||
27663718|NCT00899379|80606519|FG004|Overall Study|Adverse Event|2|||
27663719|NCT00899379|80606515|FG000|Overall Study|Lack of Efficacy|0|||
27663720|NCT00899379|80606516|FG001|Overall Study|Lack of Efficacy|4|||
27663721|NCT00899379|80606517|FG002|Overall Study|Lack of Efficacy|3|||
27663722|NCT00899379|80606518|FG003|Overall Study|Lack of Efficacy|0|||
27663723|NCT00899379|80606519|FG004|Overall Study|Lack of Efficacy|1|||
27663724|NCT00899379|80606515|FG000|Overall Study|Lost to Follow-up|9|||
27663725|NCT00899379|80606516|FG001|Overall Study|Lost to Follow-up|3|||
27663726|NCT00899379|80606517|FG002|Overall Study|Lost to Follow-up|0|||
27663727|NCT00899379|80606518|FG003|Overall Study|Lost to Follow-up|6|||
27663728|NCT00899379|80606519|FG004|Overall Study|Lost to Follow-up|2|||
27663729|NCT00899379|80606515|FG000|Overall Study|Protocol Violation|0|||
27663730|NCT00899379|80606516|FG001|Overall Study|Protocol Violation|0|||
27663731|NCT00899379|80606517|FG002|Overall Study|Protocol Violation|1|||
27663732|NCT00899379|80606518|FG003|Overall Study|Protocol Violation|1|||
27663733|NCT00899379|80606519|FG004|Overall Study|Protocol Violation|0|||
27663734|NCT00899379|80606515|FG000|Overall Study|Withdrawal by Subject|2|||
27663735|NCT00899379|80606516|FG001|Overall Study|Withdrawal by Subject|4|||
27663736|NCT00899379|80606517|FG002|Overall Study|Withdrawal by Subject|2|||
27663737|NCT00899379|80606518|FG003|Overall Study|Withdrawal by Subject|3|||
27663738|NCT00899379|80606519|FG004|Overall Study|Withdrawal by Subject|6|||
27663739|NCT00899379|80606515|FG000|Overall Study|Pregnancy|0|||
27663740|NCT00899379|80606516|FG001|Overall Study|Pregnancy|0|||
27663741|NCT00899379|80606517|FG002|Overall Study|Pregnancy|1|||
27663742|NCT00899379|80606518|FG003|Overall Study|Pregnancy|0|||
27663743|NCT00899379|80606519|FG004|Overall Study|Pregnancy|1|||
27663744|NCT00899379|80606515|FG000|Overall Study|Patient Uncooperative|0|||
27663745|NCT00899379|80606516|FG001|Overall Study|Patient Uncooperative|1|||
27663746|NCT00899379|80606517|FG002|Overall Study|Patient Uncooperative|0|||
27663747|NCT00899379|80606518|FG003|Overall Study|Patient Uncooperative|1|||
27663748|NCT00899379|80606519|FG004|Overall Study|Patient Uncooperative|2|||
27663749|NCT00899379|80606515|FG000|Overall Study|Abnormal Baseline ECG|0|||
27663750|NCT00899379|80606516|FG001|Overall Study|Abnormal Baseline ECG|0|||
27663751|NCT00899379|80606517|FG002|Overall Study|Abnormal Baseline ECG|0|||
27663752|NCT00899379|80606518|FG003|Overall Study|Abnormal Baseline ECG|1|||
27663753|NCT00899379|80606519|FG004|Overall Study|Abnormal Baseline ECG|0|||
27663754|NCT00899379|80606515|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
27663755|NCT00899379|80606516|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
27663756|NCT00899379|80606517|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
27663757|NCT00899379|80606518|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27663758|NCT00899379|80606519|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27663759|NCT00899379|80606515|FG000|Overall Study|Not Completed/Entered Extn|5|||
27663760|NCT00899379|80606516|FG001|Overall Study|Not Completed/Entered Extn|1|||
27663761|NCT00899379|80606517|FG002|Overall Study|Not Completed/Entered Extn|6|||
27663762|NCT00899379|80606518|FG003|Overall Study|Not Completed/Entered Extn|4|||
27962896|NCT03265145|81695255|FG000|Overall Study|Did not want to take medication|1|||
27767131|NCT01335698|80976950|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
27767132|NCT01335698|80976951|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
27767133|NCT01335698|80976947|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
27767134|NCT01335698|80976948|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
27767135|NCT01335698|80976949|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
27767136|NCT01335698|80976950|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
27767137|NCT01335698|80976951|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
27767138|NCT01335698|80976947|FG000|Treatment Stage 2|Lost to Follow-up|1|||
27767139|NCT01335698|80976948|FG001|Treatment Stage 2|Lost to Follow-up|0|||
27767140|NCT01335698|80976949|FG002|Treatment Stage 2|Lost to Follow-up|0|||
27767141|NCT01335698|80976950|FG003|Treatment Stage 2|Lost to Follow-up|0|||
27767142|NCT01335698|80976951|FG004|Treatment Stage 2|Lost to Follow-up|0|||
27767143|NCT01335698|80976947|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
27767144|NCT01335698|80976948|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
27767145|NCT01335698|80976949|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
27767146|NCT01335698|80976950|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
27767147|NCT01335698|80976951|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
27767148|NCT01335698|80976947|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
27767149|NCT01335698|80976948|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
27767150|NCT01335698|80976949|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
27767151|NCT01335698|80976950|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
27767152|NCT01335698|80976951|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
27767153|NCT01335698|80976947|FG000|Treatment Stage 2|Switched to another formulation|1|||
27767154|NCT01335698|80976948|FG001|Treatment Stage 2|Switched to another formulation|1|||
27767155|NCT01335698|80976949|FG002|Treatment Stage 2|Switched to another formulation|0|||
27767156|NCT01335698|80976950|FG003|Treatment Stage 2|Switched to another formulation|0|||
27767157|NCT01335698|80976951|FG004|Treatment Stage 2|Switched to another formulation|0|||
27767158|NCT02096042|80976957|FG000|Overall Study|Disease Progression|1|||
27767159|NCT02096042|80976958|FG001|Overall Study|Disease Progression|0|||
27767160|NCT02096042|80976959|FG002|Overall Study|Disease Progression|0|||
27767161|NCT04018612|80976960|FG000|Overall Study|Withdrawal by Subject|1|||
27767162|NCT04018612|80976961|FG001|Overall Study|Withdrawal by Subject|0|||
27767163|NCT04018612|80976962|FG002|Overall Study|Withdrawal by Subject|1|||
27767164|NCT01544478|80976965|FG000|Overall Study|Adverse Event|1|||
27767165|NCT01544478|80976965|FG000|Overall Study|Death|1|||
27767166|NCT01544478|80976965|FG000|Overall Study|Lost to Follow-up|48|||
27767167|NCT01544478|80976965|FG000|Overall Study|Physician Decision|15|||
27767168|NCT01544478|80976965|FG000|Overall Study|Pregnancy|1|||
27767169|NCT01544478|80976965|FG000|Overall Study|Withdrawal by Subject|52|||
27767170|NCT00094835|80976966|FG000|Overall Study|Physician Decision|1|||
27767171|NCT00094835|80976967|FG001|Overall Study|Physician Decision|0|||
27767172|NCT00094835|80976968|FG002|Overall Study|Physician Decision|0|||
27767173|NCT00094835|80976969|FG003|Overall Study|Physician Decision|0|||
27767174|NCT00094835|80976970|FG004|Overall Study|Physician Decision|0|||
27767175|NCT00094835|80976971|FG005|Overall Study|Physician Decision|1|||
27767176|NCT00094835|80976972|FG006|Overall Study|Physician Decision|0|||
27767177|NCT00094835|80976966|FG000|Overall Study|Withdrawal by Subject|0|||
27767178|NCT00094835|80976967|FG001|Overall Study|Withdrawal by Subject|0|||
27767179|NCT00094835|80976968|FG002|Overall Study|Withdrawal by Subject|0|||
27767180|NCT00094835|80976969|FG003|Overall Study|Withdrawal by Subject|0|||
27767181|NCT00094835|80976970|FG004|Overall Study|Withdrawal by Subject|0|||
27767182|NCT00094835|80976971|FG005|Overall Study|Withdrawal by Subject|0|||
27767183|NCT00094835|80976972|FG006|Overall Study|Withdrawal by Subject|1|||
27767184|NCT00094835|80976966|FG000|Overall Study|Lost to Follow-up|0|||
27767185|NCT00094835|80976967|FG001|Overall Study|Lost to Follow-up|0|||
27767186|NCT00094835|80976968|FG002|Overall Study|Lost to Follow-up|0|||
27767187|NCT00094835|80976969|FG003|Overall Study|Lost to Follow-up|0|||
27767188|NCT00094835|80976970|FG004|Overall Study|Lost to Follow-up|1|||
27767189|NCT00094835|80976971|FG005|Overall Study|Lost to Follow-up|0|||
27767190|NCT00094835|80976972|FG006|Overall Study|Lost to Follow-up|0|||
27767191|NCT00094835|80976966|FG000|Overall Study|Death|1|||
27767192|NCT00094835|80976967|FG001|Overall Study|Death|0|||
27767193|NCT00094835|80976968|FG002|Overall Study|Death|0|||
27767194|NCT00094835|80976969|FG003|Overall Study|Death|0|||
27767195|NCT00094835|80976970|FG004|Overall Study|Death|1|||
27767196|NCT00094835|80976971|FG005|Overall Study|Death|0|||
27767197|NCT00094835|80976972|FG006|Overall Study|Death|0|||
27767198|NCT00094835|80976966|FG000|Overall Study|Non-compliance|1|||
27767199|NCT00094835|80976967|FG001|Overall Study|Non-compliance|2|||
27767200|NCT00094835|80976968|FG002|Overall Study|Non-compliance|2|||
27767201|NCT00094835|80976969|FG003|Overall Study|Non-compliance|0|||
27767202|NCT00094835|80976970|FG004|Overall Study|Non-compliance|2|||
27767203|NCT00094835|80976971|FG005|Overall Study|Non-compliance|2|||
27767204|NCT00094835|80976972|FG006|Overall Study|Non-compliance|1|||
27767205|NCT00094835|80976966|FG000|Overall Study|Other|1|||
27767206|NCT00094835|80976967|FG001|Overall Study|Other|1|||
27767207|NCT00094835|80976968|FG002|Overall Study|Other|1|||
27767208|NCT00094835|80976969|FG003|Overall Study|Other|1|||
27767209|NCT00094835|80976970|FG004|Overall Study|Other|0|||
27767210|NCT00094835|80976971|FG005|Overall Study|Other|0|||
27767211|NCT00094835|80976972|FG006|Overall Study|Other|0|||
27767212|NCT03934541|80976973|FG000|Overall Study|Study Terminated by Sponsor|0|||
27767213|NCT03934541|80976974|FG001|Overall Study|Study Terminated by Sponsor|1|||
27767214|NCT03934541|80976975|FG002|Overall Study|Study Terminated by Sponsor|0|||
27767215|NCT03934541|80976976|FG003|Overall Study|Study Terminated by Sponsor|0|||
27767216|NCT01373918|80976977|FG000|Overall Study|Physician Decision|0|||
27767217|NCT01373918|80976978|FG001|Overall Study|Physician Decision|1|||
27767218|NCT02254551|80976980|FG000|Dose Escalation|Physician Decision|1|||
27767219|NCT02254551|80976980|FG000|Dose Escalation|Dose-limiting toxicity|2|||
27767220|NCT01313078|80976981|FG000|Overall Study|Death|1|||
27767221|NCT01313078|80976981|FG000|Overall Study|Discontinued study drug|1|||
27767222|NCT01313078|80976981|FG000|Overall Study|Withdrawal by Subject|1|||
27767223|NCT00830804|80976982|FG000|Overall Study|Lost to Follow-up|4|||
27767224|NCT00830804|80976982|FG000|Overall Study|Death|1|||
27767225|NCT00830804|80976982|FG000|Overall Study|Unable to get to clinic|7|||
27767226|NCT00830804|80976982|FG000|Overall Study|Consent withdrawn|2|||
27767227|NCT00830804|80976982|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
27767228|NCT05159362|80976985|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
27767229|NCT05159362|80976986|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
27767230|NCT05159362|80976987|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
27767231|NCT01527110|80976991|FG000|Overall Study|Adverse Event|1|||
27767232|NCT00416312|80976992|FG000|Overall Study|tumors not visible on imaging|2|||
27767233|NCT03209362|80976993|FG000|Overall Study|Adverse Event|0|||
27767234|NCT03209362|80976994|FG001|Overall Study|Adverse Event|1|||
27767235|NCT03209362|80976993|FG000|Overall Study|Lost to Follow-up|0|||
27767236|NCT03209362|80976994|FG001|Overall Study|Lost to Follow-up|1|||
27767237|NCT03209362|80976993|FG000|Overall Study|Withdrawal by Subject|2|||
27767238|NCT03209362|80976994|FG001|Overall Study|Withdrawal by Subject|0|||
27767239|NCT03209362|80976993|FG000|Overall Study|Other|0|||
27962897|NCT03265145|81695256|FG001|Overall Study|Did not want to take medication|0|||
27962898|NCT03265145|81695255|FG000|Overall Study|Subject could not afford medication|0|||
27962899|NCT03265145|81695256|FG001|Overall Study|Subject could not afford medication|1|||
27962900|NCT03265145|81695255|FG000|Overall Study|Site closed|2|||
27962901|NCT03265145|81695256|FG001|Overall Study|Site closed|3|||
27962902|NCT03265145|81695255|FG000|Overall Study|Incorrectly randomized|16|||
27962903|NCT03265145|81695256|FG001|Overall Study|Incorrectly randomized|6|||
27962904|NCT03265145|81695255|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
27962905|NCT03265145|81695256|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
27962906|NCT03265145|81695255|FG000|Overall Study|Physician Decision|0|||
27962907|NCT03265145|81695256|FG001|Overall Study|Physician Decision|3|||
27962908|NCT03265145|81695255|FG000|Overall Study|Subject transferred to another facility|0|||
27962909|NCT03265145|81695256|FG001|Overall Study|Subject transferred to another facility|1|||
27962910|NCT00880269|81695261|FG000|Overall Study|Protocol Violation|1|||
27962911|NCT00880269|81695262|FG001|Overall Study|Protocol Violation|0|||
27962912|NCT00880269|81695261|FG000|Overall Study|Disease Progression|13|||
27962913|NCT00880269|81695262|FG001|Overall Study|Disease Progression|11|||
27962914|NCT00880269|81695261|FG000|Overall Study|New Cancer Therapy|1|||
27962915|NCT00880269|81695262|FG001|Overall Study|New Cancer Therapy|0|||
27962916|NCT00880269|81695261|FG000|Overall Study|Death|4|||
27962917|NCT00880269|81695262|FG001|Overall Study|Death|2|||
27962918|NCT00880269|81695261|FG000|Overall Study|Lost to Follow-up|0|||
27962919|NCT00880269|81695262|FG001|Overall Study|Lost to Follow-up|1|||
27962920|NCT00880269|81695261|FG000|Overall Study|Withdrawal by Subject|3|||
27962921|NCT00880269|81695262|FG001|Overall Study|Withdrawal by Subject|4|||
27962922|NCT00880269|81695261|FG000|Overall Study|Adverse Event|10|||
27962923|NCT00880269|81695262|FG001|Overall Study|Adverse Event|9|||
27663763|NCT00899379|80606519|FG004|Overall Study|Not Completed/Entered Extn|3|||
27663764|NCT00899379|80606515|FG000|Overall Study|Study Terminated|3|||
27663765|NCT00899379|80606516|FG001|Overall Study|Study Terminated|0|||
27663766|NCT00899379|80606517|FG002|Overall Study|Study Terminated|3|||
27663767|NCT00899379|80606518|FG003|Overall Study|Study Terminated|3|||
27663768|NCT00899379|80606519|FG004|Overall Study|Study Terminated|1|||
27663769|NCT00899379|80606515|FG000|Overall Study|Lost to Follow-up|3|||
27663770|NCT00899379|80606516|FG001|Overall Study|Lost to Follow-up|1|||
27663771|NCT00899379|80606517|FG002|Overall Study|Lost to Follow-up|0|||
27663772|NCT00899379|80606518|FG003|Overall Study|Lost to Follow-up|2|||
27663773|NCT00899379|80606519|FG004|Overall Study|Lost to Follow-up|5|||
27663774|NCT00899379|80606515|FG000|Overall Study|Withdrawal by Subject|4|||
27663775|NCT00899379|80606516|FG001|Overall Study|Withdrawal by Subject|7|||
27962924|NCT02808897|81695263|FG000|Overall Study|Lost to Follow-up|9|||
27663776|NCT00899379|80606517|FG002|Overall Study|Withdrawal by Subject|4|||
27962925|NCT02808897|81695264|FG001|Overall Study|Lost to Follow-up|11|||
27663777|NCT00899379|80606518|FG003|Overall Study|Withdrawal by Subject|7|||
27663778|NCT00899379|80606519|FG004|Overall Study|Withdrawal by Subject|2|||
27663779|NCT00899379|80606515|FG000|Overall Study|Pregnancy|1|||
27767240|NCT03209362|80976994|FG001|Overall Study|Other|1|||
27767241|NCT02337686|80976995|FG000|Overall Study|Adverse Event|1|||
27767242|NCT04839393|80976996|FG000|Overall Study|Adverse Event|0|||
27767243|NCT04839393|80976997|FG001|Overall Study|Adverse Event|0|||
27767244|NCT04839393|80976998|FG002|Overall Study|Adverse Event|2|||
27767245|NCT04839393|80976996|FG000|Overall Study|Withdrawal by participant|0|||
27767246|NCT04839393|80976997|FG001|Overall Study|Withdrawal by participant|0|||
27767247|NCT04839393|80976998|FG002|Overall Study|Withdrawal by participant|1|||
27767248|NCT01040845|80976999|FG000|Overall Study|Withdrawal by Subject|1|||
27767249|NCT01040845|80977000|FG001|Overall Study|Withdrawal by Subject|1|||
27767250|NCT01040845|80976999|FG000|Overall Study|Physician Decision|1|||
27767251|NCT01040845|80977000|FG001|Overall Study|Physician Decision|0|||
27767252|NCT01400139|80977001|FG000|HYD Core Study|Adverse Event|210|||
27767253|NCT01400139|80977001|FG000|HYD Core Study|Lack of Efficacy|59|||
27767254|NCT01400139|80977001|FG000|HYD Core Study|Withdrawal by Subject|114|||
27767255|NCT01400139|80977001|FG000|HYD Core Study|Lost to Follow-up|39|||
27962926|NCT05559905|81695265|FG000|Overall Study|Withdrawal by Subject|1|||
27962927|NCT05559905|81695266|FG001|Overall Study|Withdrawal by Subject|0|||
27962928|NCT05559905|81695267|FG002|Overall Study|Withdrawal by Subject|0|||
27962929|NCT05559905|81695265|FG000|Overall Study|Not Reported|1|||
27962930|NCT05559905|81695266|FG001|Overall Study|Not Reported|0|||
27962931|NCT05559905|81695267|FG002|Overall Study|Not Reported|0|||
27962932|NCT00070109|81695268|FG000|Overall Study|Death|1|||
27962933|NCT00070109|81695269|FG001|Overall Study|Death|1|||
27962934|NCT00070109|81695270|FG002|Overall Study|Death|0|||
27962935|NCT00070109|81695271|FG003|Overall Study|Death|0|||
27962936|NCT00070109|81695272|FG004|Overall Study|Death|1|||
27962937|NCT00070109|81695268|FG000|Overall Study|Lack of Efficacy|6|||
27962938|NCT00070109|81695269|FG001|Overall Study|Lack of Efficacy|4|||
27962939|NCT00070109|81695270|FG002|Overall Study|Lack of Efficacy|5|||
27962940|NCT00070109|81695271|FG003|Overall Study|Lack of Efficacy|15|||
27962941|NCT00070109|81695272|FG004|Overall Study|Lack of Efficacy|5|||
27962942|NCT00070109|81695268|FG000|Overall Study|Physician Decision|1|||
27962943|NCT00070109|81695269|FG001|Overall Study|Physician Decision|0|||
27962944|NCT00070109|81695270|FG002|Overall Study|Physician Decision|0|||
27962945|NCT00070109|81695271|FG003|Overall Study|Physician Decision|0|||
27962946|NCT00070109|81695272|FG004|Overall Study|Physician Decision|0|||
27962947|NCT00070109|81695268|FG000|Overall Study|Withdrawal by Subject|0|||
27962948|NCT00070109|81695269|FG001|Overall Study|Withdrawal by Subject|1|||
27962949|NCT00070109|81695270|FG002|Overall Study|Withdrawal by Subject|1|||
27962950|NCT00070109|81695271|FG003|Overall Study|Withdrawal by Subject|0|||
27962951|NCT00070109|81695272|FG004|Overall Study|Withdrawal by Subject|0|||
27962952|NCT00070109|81695268|FG000|Overall Study|Adverse Event|0|||
27962953|NCT00070109|81695269|FG001|Overall Study|Adverse Event|0|||
27962954|NCT00070109|81695270|FG002|Overall Study|Adverse Event|2|||
27962955|NCT00070109|81695271|FG003|Overall Study|Adverse Event|4|||
27962956|NCT00070109|81695272|FG004|Overall Study|Adverse Event|2|||
27767256|NCT01400139|80977001|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
27767257|NCT01400139|80977001|FG000|HYD Core Study|Administrative|56|||
27767258|NCT01400139|80977001|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
27767259|NCT01400139|80977001|FG000|HYD Extension Period|Adverse Event|8|||
27767260|NCT01400139|80977001|FG000|HYD Extension Period|Withdrawal by Subject|5|||
27767261|NCT01400139|80977001|FG000|HYD Extension Period|Administrative|10|||
27767262|NCT01024920|80977002|FG000|Overall Study|Progressive disease|47|||
27767263|NCT01024920|80977003|FG001|Overall Study|Progressive disease|25|||
27767264|NCT01024920|80977002|FG000|Overall Study|Adverse Event|8|||
27767265|NCT01024920|80977003|FG001|Overall Study|Adverse Event|4|||
27767266|NCT01024920|80977002|FG000|Overall Study|Lost to Follow-up|0|||
27767267|NCT01024920|80977003|FG001|Overall Study|Lost to Follow-up|1|||
27767268|NCT01024920|80977002|FG000|Overall Study|Patient refusal to continue|4|||
27767269|NCT01024920|80977003|FG001|Overall Study|Patient refusal to continue|0|||
27767270|NCT01024920|80977002|FG000|Overall Study|Other than listed|5|||
27962957|NCT00070109|81695268|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
27962958|NCT00070109|81695269|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
27962959|NCT00070109|81695270|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
27962960|NCT00070109|81695271|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
27962961|NCT00070109|81695272|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
27962962|NCT02858440|81695275|FG000|Overall Study|Lost to Follow-up|3|||
27767271|NCT01024920|80977003|FG001|Overall Study|Other than listed|1|||
27767272|NCT01024920|80977002|FG000|Overall Study|Not treated|3|||
27962963|NCT02858440|81695275|FG000|Overall Study|Protocol Violation|2|||
27767273|NCT01024920|80977003|FG001|Overall Study|Not treated|0|||
27767274|NCT01024920|80977002|FG000|Overall Study|Protocol Violation|0|||
27767275|NCT01024920|80977003|FG001|Overall Study|Protocol Violation|1|||
27767276|NCT02067533|80977006|FG000|Overall Study|Lost to Follow-up|4|||
27962964|NCT02858440|81695275|FG000|Overall Study|Consent withdrawal|3|||
27767277|NCT02067533|80977007|FG001|Overall Study|Lost to Follow-up|2|||
27767278|NCT01947894|80977008|FG000|Overall Study|Other|3|||
27767279|NCT01947894|80977009|FG001|Overall Study|Other|4|||
27767280|NCT01947894|80977010|FG002|Overall Study|Other|3|||
27767281|NCT01947894|80977008|FG000|Overall Study|Withdrawal by Subject|12|||
27767282|NCT01947894|80977009|FG001|Overall Study|Withdrawal by Subject|4|||
27767283|NCT01947894|80977010|FG002|Overall Study|Withdrawal by Subject|1|||
27767284|NCT01947894|80977008|FG000|Overall Study|Death|12|||
27767285|NCT01947894|80977009|FG001|Overall Study|Death|1|||
27767286|NCT01947894|80977010|FG002|Overall Study|Death|0|||
27962965|NCT02858440|81695275|FG000|Overall Study|Migrated/moved from study area|4|||
27962966|NCT01536561|81695276|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
27962967|NCT01536561|81695276|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
27962968|NCT01536561|81695276|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
27962969|NCT01536561|81695276|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
27962970|NCT01536561|81695276|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
27962971|NCT01536561|81695276|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
27663780|NCT00899379|80606516|FG001|Overall Study|Pregnancy|0|||
27663781|NCT00899379|80606517|FG002|Overall Study|Pregnancy|0|||
27663782|NCT00899379|80606518|FG003|Overall Study|Pregnancy|0|||
27663783|NCT00899379|80606519|FG004|Overall Study|Pregnancy|0|||
27663784|NCT00899379|80606515|FG000|Overall Study|Patient Uncooperative|0|||
27663785|NCT00899379|80606516|FG001|Overall Study|Patient Uncooperative|0|||
27663786|NCT00899379|80606517|FG002|Overall Study|Patient Uncooperative|0|||
27663787|NCT00899379|80606518|FG003|Overall Study|Patient Uncooperative|1|||
27663788|NCT00899379|80606519|FG004|Overall Study|Patient Uncooperative|0|||
27663789|NCT00899379|80606515|FG000|Overall Study|Abnormal Prestudy Labs|0|||
27663790|NCT00899379|80606516|FG001|Overall Study|Abnormal Prestudy Labs|0|||
27663791|NCT00899379|80606517|FG002|Overall Study|Abnormal Prestudy Labs|0|||
27663792|NCT00899379|80606518|FG003|Overall Study|Abnormal Prestudy Labs|0|||
27663793|NCT00899379|80606519|FG004|Overall Study|Abnormal Prestudy Labs|2|||
27663794|NCT00899379|80606515|FG000|Overall Study|Abnormal Baseline ECG|0|||
27663795|NCT00899379|80606516|FG001|Overall Study|Abnormal Baseline ECG|0|||
27663796|NCT00899379|80606517|FG002|Overall Study|Abnormal Baseline ECG|1|||
27663797|NCT00899379|80606518|FG003|Overall Study|Abnormal Baseline ECG|1|||
27663798|NCT00899379|80606519|FG004|Overall Study|Abnormal Baseline ECG|0|||
27663799|NCT00899379|80606515|FG000|Overall Study|No Attack Pretreatment|3|||
27663800|NCT00899379|80606516|FG001|Overall Study|No Attack Pretreatment|5|||
27663801|NCT00899379|80606517|FG002|Overall Study|No Attack Pretreatment|5|||
27663802|NCT00899379|80606518|FG003|Overall Study|No Attack Pretreatment|6|||
27663803|NCT00899379|80606519|FG004|Overall Study|No Attack Pretreatment|4|||
27663804|NCT00899379|80606515|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
27663805|NCT00899379|80606516|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27663806|NCT00899379|80606517|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27663807|NCT00899379|80606518|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27663808|NCT00899379|80606519|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27663809|NCT00899379|80606515|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
27663810|NCT00899379|80606516|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
27663811|NCT00899379|80606517|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
27663812|NCT00899379|80606518|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
27663813|NCT00899379|80606519|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
27767287|NCT01947894|80977008|FG000|Overall Study|Physician Decision|2|||
27767288|NCT01947894|80977009|FG001|Overall Study|Physician Decision|0|||
27962972|NCT00854724|81698850|FG000|First Intervention|Withdrawal by Subject|1|||
27962973|NCT00854724|81698851|FG001|First Intervention|Withdrawal by Subject|1|||
27962974|NCT00854724|81698850|FG000|Washout|Protocol Violation|1|||
27962975|NCT00854724|81698851|FG001|Washout|Protocol Violation|0|||
27962976|NCT00854724|81698850|FG000|Washout|Withdrawal by Subject|0|||
27962977|NCT00854724|81698851|FG001|Washout|Withdrawal by Subject|1|||
27962978|NCT00854724|81698850|FG000|Second Intervention|Protocol Violation|1|||
27962979|NCT00854724|81698851|FG001|Second Intervention|Protocol Violation|0|||
27962980|NCT00854724|81698850|FG000|Second Intervention|Physician Decision|0|||
27962981|NCT00854724|81698851|FG001|Second Intervention|Physician Decision|1|||
27962982|NCT05069597|81698852|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
27962983|NCT05069597|81698853|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
27962984|NCT00438360|81698854|FG000|Overall Study|Adverse Event|6|||
27962985|NCT00438360|81698855|FG001|Overall Study|Adverse Event|1|||
27962986|NCT00438360|81698854|FG000|Overall Study|Lack of Efficacy|42|||
27962987|NCT00438360|81698855|FG001|Overall Study|Lack of Efficacy|27|||
27962988|NCT00438360|81698854|FG000|Overall Study|Other|24|||
27962989|NCT00438360|81698855|FG001|Overall Study|Other|15|||
27962990|NCT02644096|81698858|FG000|Overall Study|Withdrawal by Subject|28|||
27962991|NCT02644096|81698859|FG001|Overall Study|Withdrawal by Subject|25|||
27962992|NCT02836717|81698860|FG000|Test Phase|Lack of Efficacy|14|||
27962993|NCT02836717|81698861|FG001|Test Phase|Lack of Efficacy|8|||
27962994|NCT02836717|81698862|FG002|Test Phase|Lack of Efficacy|0|||
27962995|NCT02836717|81698860|FG000|Study Phase|Adverse Event|2|||
27962996|NCT02836717|81698861|FG001|Study Phase|Adverse Event|0|||
27962997|NCT02836717|81698862|FG002|Study Phase|Adverse Event|0|||
27962998|NCT02836717|81698860|FG000|Study Phase|Lack of Efficacy|8|||
27962999|NCT02836717|81698861|FG001|Study Phase|Lack of Efficacy|6|||
27963000|NCT02836717|81698862|FG002|Study Phase|Lack of Efficacy|1|||
27963001|NCT02836717|81698860|FG000|Study Phase|Withdrawal by Subject|1|||
27963002|NCT02836717|81698861|FG001|Study Phase|Withdrawal by Subject|0|||
27963003|NCT02836717|81698862|FG002|Study Phase|Withdrawal by Subject|0|||
27963004|NCT02836717|81698860|FG000|Study Phase|Death|1|||
27963005|NCT02836717|81698861|FG001|Study Phase|Death|0|||
27767289|NCT01947894|80977010|FG002|Overall Study|Physician Decision|0|||
27767290|NCT01947894|80977008|FG000|Overall Study|Adverse Event|5|||
27767291|NCT01947894|80977009|FG001|Overall Study|Adverse Event|1|||
27767292|NCT01947894|80977010|FG002|Overall Study|Adverse Event|0|||
27767293|NCT01947894|80977008|FG000|Overall Study|Switched to other growth hormone brand|53|||
27767294|NCT01947894|80977009|FG001|Overall Study|Switched to other growth hormone brand|8|||
27767295|NCT01947894|80977010|FG002|Overall Study|Switched to other growth hormone brand|23|||
27767296|NCT00802867|80977011|FG000|Overall Study|Lost to Follow-up|6|||
27767297|NCT00802867|80977011|FG000|Overall Study|Protocol Violation|6|||
27767298|NCT00802867|80977011|FG000|Overall Study|Withdrawal by Subject|1|||
27767299|NCT01484561|80977012|FG000|Overall Study|Lack of Efficacy|3|||
27767300|NCT01484561|80977013|FG001|Overall Study|Lack of Efficacy|1|||
27767301|NCT01484561|80977012|FG000|Overall Study|Lost to Follow-up|1|||
27767302|NCT01484561|80977013|FG001|Overall Study|Lost to Follow-up|0|||
27767303|NCT01484561|80977012|FG000|Overall Study|Withdrawal by Subject|3|||
27767304|NCT01484561|80977013|FG001|Overall Study|Withdrawal by Subject|0|||
27767305|NCT01484561|80977012|FG000|Overall Study|Other|1|||
27767306|NCT01484561|80977013|FG001|Overall Study|Other|1|||
27767307|NCT01484561|80977012|FG000|Overall Study|Adverse Event|1|||
27767308|NCT01484561|80977013|FG001|Overall Study|Adverse Event|4|||
27767309|NCT04968353|80977016|FG000|Overall Study|Non-compliance|1|||
27767310|NCT04968353|80977017|FG001|Overall Study|Non-compliance|0|||
27767311|NCT04968353|80977018|FG002|Overall Study|Non-compliance|2|||
27767312|NCT04968353|80977019|FG003|Overall Study|Non-compliance|0|||
27767313|NCT01153893|80977020|FG000|Overall Study|Adverse Event|1|||
27767314|NCT01153893|80977021|FG001|Overall Study|Adverse Event|0|||
27767315|NCT01001234|80977024|FG000|Overall Study|Withdrawal by Subject|2|||
27767316|NCT01001234|80977025|FG001|Overall Study|Withdrawal by Subject|0|||
27767317|NCT01001234|80977026|FG002|Overall Study|Withdrawal by Subject|3|||
27767318|NCT01001234|80977027|FG003|Overall Study|Withdrawal by Subject|0|||
27767319|NCT01001234|80977028|FG004|Overall Study|Withdrawal by Subject|0|||
27767320|NCT01001234|80977024|FG000|Overall Study|Protocol Violation|34|||
27767321|NCT01001234|80977025|FG001|Overall Study|Protocol Violation|3|||
27767322|NCT01001234|80977026|FG002|Overall Study|Protocol Violation|19|||
27767323|NCT01001234|80977027|FG003|Overall Study|Protocol Violation|18|||
27767324|NCT01001234|80977028|FG004|Overall Study|Protocol Violation|0|||
27767325|NCT01001234|80977024|FG000|Overall Study|Lost to Follow-up|0|||
27963006|NCT02836717|81698862|FG002|Study Phase|Death|0|||
27963007|NCT02836717|81698860|FG000|Study Phase|abdominal surgeries|2|||
27963008|NCT02836717|81698861|FG001|Study Phase|abdominal surgeries|1|||
27963009|NCT02836717|81698862|FG002|Study Phase|abdominal surgeries|0|||
27963010|NCT03292874|81698863|FG000|Overall Study|Due to pandemic|5|||
27767326|NCT01001234|80977025|FG001|Overall Study|Lost to Follow-up|0|||
27963011|NCT03726658|81698864|FG000|Overall Study|Lost to Follow-up|0|||
27963012|NCT03726658|81698865|FG001|Overall Study|Lost to Follow-up|0|||
27963013|NCT03726658|81698866|FG002|Overall Study|Lost to Follow-up|2|||
27767327|NCT01001234|80977026|FG002|Overall Study|Lost to Follow-up|1|||
27767328|NCT01001234|80977027|FG003|Overall Study|Lost to Follow-up|2|||
27767329|NCT01001234|80977028|FG004|Overall Study|Lost to Follow-up|0|||
27767330|NCT01001234|80977024|FG000|Overall Study|Physician Decision|1|||
27767331|NCT01001234|80977025|FG001|Overall Study|Physician Decision|0|||
27767332|NCT01001234|80977026|FG002|Overall Study|Physician Decision|0|||
27767333|NCT01001234|80977027|FG003|Overall Study|Physician Decision|0|||
27767334|NCT01001234|80977028|FG004|Overall Study|Physician Decision|0|||
27767335|NCT01001234|80977024|FG000|Overall Study|Not Treated: Adverse Event|1|||
27767336|NCT01001234|80977025|FG001|Overall Study|Not Treated: Adverse Event|0|||
27767337|NCT01001234|80977026|FG002|Overall Study|Not Treated: Adverse Event|0|||
27767338|NCT01001234|80977027|FG003|Overall Study|Not Treated: Adverse Event|0|||
27767339|NCT01001234|80977028|FG004|Overall Study|Not Treated: Adverse Event|0|||
27767340|NCT01001234|80977024|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
27767341|NCT01001234|80977025|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
27767342|NCT01001234|80977026|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
27767343|NCT01001234|80977027|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
27767344|NCT01001234|80977028|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
27767345|NCT01001234|80977024|FG000|Overall Study|Not Treated: Protocol Violation|3|||
27767346|NCT01001234|80977025|FG001|Overall Study|Not Treated: Protocol Violation|0|||
27767347|NCT01001234|80977026|FG002|Overall Study|Not Treated: Protocol Violation|0|||
27767348|NCT01001234|80977027|FG003|Overall Study|Not Treated: Protocol Violation|0|||
27767349|NCT01001234|80977028|FG004|Overall Study|Not Treated: Protocol Violation|0|||
27767350|NCT01001234|80977024|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
27767351|NCT01001234|80977025|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
27767352|NCT01001234|80977026|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
27767353|NCT01001234|80977027|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
27767354|NCT01001234|80977028|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
27767355|NCT01001234|80977024|FG000|Overall Study|Not Treated: Pregnancy|3|||
27767356|NCT01001234|80977025|FG001|Overall Study|Not Treated: Pregnancy|0|||
27767357|NCT01001234|80977026|FG002|Overall Study|Not Treated: Pregnancy|0|||
27767358|NCT01001234|80977027|FG003|Overall Study|Not Treated: Pregnancy|0|||
27767359|NCT01001234|80977028|FG004|Overall Study|Not Treated: Pregnancy|0|||
27767360|NCT01001234|80977024|FG000|Overall Study|Not Treated: Physician Decision|37|||
27767361|NCT01001234|80977025|FG001|Overall Study|Not Treated: Physician Decision|4|||
27767362|NCT01001234|80977026|FG002|Overall Study|Not Treated: Physician Decision|0|||
27767363|NCT01001234|80977027|FG003|Overall Study|Not Treated: Physician Decision|0|||
27767364|NCT01001234|80977028|FG004|Overall Study|Not Treated: Physician Decision|0|||
27767365|NCT01001234|80977024|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
27767366|NCT01001234|80977025|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
27767367|NCT01001234|80977026|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
27767368|NCT01001234|80977027|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
27767369|NCT01001234|80977028|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
27767370|NCT00415519|80977029|FG000|Overall Study|Adverse Event|1|||
27767371|NCT00415519|80977030|FG001|Overall Study|Adverse Event|0|||
27767372|NCT00415519|80977029|FG000|Overall Study|Withdrawal by Subject|2|||
27767373|NCT00415519|80977030|FG001|Overall Study|Withdrawal by Subject|0|||
27767374|NCT00415519|80977029|FG000|Overall Study|Patient's convenience|1|||
27767375|NCT00415519|80977030|FG001|Overall Study|Patient's convenience|0|||
27767376|NCT02306161|80977031|FG000|Overall Study|Death|1|||
27767377|NCT02306161|80977032|FG001|Overall Study|Death|3|||
27767378|NCT02306161|80977031|FG000|Overall Study|Lack of Efficacy|20|||
27767379|NCT02306161|80977032|FG001|Overall Study|Lack of Efficacy|43|||
27767380|NCT02306161|80977031|FG000|Overall Study|Physician Decision|30|||
27767381|NCT02306161|80977032|FG001|Overall Study|Physician Decision|18|||
27767382|NCT02306161|80977031|FG000|Overall Study|Withdrawal by Subject|4|||
27767383|NCT02306161|80977032|FG001|Overall Study|Withdrawal by Subject|0|||
27767384|NCT02306161|80977031|FG000|Overall Study|Ineligible|9|||
27767385|NCT02306161|80977032|FG001|Overall Study|Ineligible|5|||
27767386|NCT01938001|80977033|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
27767387|NCT01938001|80977034|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
27767388|NCT01938001|80977033|FG000|Pre-Treatment|Death|1|||
27767389|NCT01938001|80977034|FG001|Pre-Treatment|Death|0|||
27767390|NCT01938001|80977033|FG000|Treatment|Death|2|||
27767391|NCT01938001|80977034|FG001|Treatment|Death|0|||
27767392|NCT01938001|80977033|FG000|Treatment|Adverse Event|14|||
27767393|NCT01938001|80977034|FG001|Treatment|Adverse Event|8|||
27767394|NCT01938001|80977033|FG000|Treatment|Progressive Disease|21|||
27767395|NCT01938001|80977034|FG001|Treatment|Progressive Disease|54|||
27767396|NCT01938001|80977033|FG000|Treatment|Withdrawal by Subject|13|||
27767397|NCT01938001|80977034|FG001|Treatment|Withdrawal by Subject|7|||
27767398|NCT01938001|80977033|FG000|Treatment|Other reasons|2|||
27767399|NCT01938001|80977034|FG001|Treatment|Other reasons|1|||
27767400|NCT02057068|80977036|FG000|Overall Study|Withdrawal by Subject|2|||
27767401|NCT02057068|80977037|FG001|Overall Study|Withdrawal by Subject|2|||
27767402|NCT02057068|80977036|FG000|Overall Study|Caregiver (CG) Health|0|||
27767403|NCT02057068|80977037|FG001|Overall Study|Caregiver (CG) Health|2|||
27767404|NCT02057068|80977036|FG000|Overall Study|Carepartner (CP) Health|4|||
27767405|NCT02057068|80977037|FG001|Overall Study|Carepartner (CP) Health|2|||
27767406|NCT02057068|80977036|FG000|Overall Study|Lost to Follow-up|2|||
27767407|NCT02057068|80977037|FG001|Overall Study|Lost to Follow-up|2|||
27767408|NCT03000686|80977038|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
27767409|NCT03000686|80977039|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
27767410|NCT03000686|80977040|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
27767411|NCT03000686|80977041|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
27767412|NCT00050622|80977047|FG000|Overall Study|Adverse Event|1|||
27767413|NCT04186663|80977048|FG000|Overall Study|Lost to Follow-up|1|||
27767414|NCT04186663|80977048|FG000|Overall Study|Unable to complete blood draw|3|||
27767415|NCT02983799|80977049|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
27767416|NCT02983799|80977050|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
27767417|NCT02983799|80977051|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
27767418|NCT02983799|80977052|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
27963014|NCT03726658|81698867|FG003|Overall Study|Lost to Follow-up|0|||
27963015|NCT03726658|81698868|FG004|Overall Study|Lost to Follow-up|0|||
27963016|NCT03726658|81698869|FG005|Overall Study|Lost to Follow-up|1|||
27767419|NCT02983799|80977053|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
27767420|NCT02983799|80977049|FG000|Overall Study|Death|20|||
27767421|NCT02983799|80977050|FG001|Overall Study|Death|5|||
27767422|NCT02983799|80977051|FG002|Overall Study|Death|23|||
27767423|NCT02983799|80977052|FG003|Overall Study|Death|47|||
27767424|NCT02983799|80977053|FG004|Overall Study|Death|7|||
27767425|NCT02983799|80977049|FG000|Overall Study|Withdrawal by Subject|1|||
27767426|NCT02983799|80977050|FG001|Overall Study|Withdrawal by Subject|0|||
27767427|NCT02983799|80977051|FG002|Overall Study|Withdrawal by Subject|3|||
27767428|NCT02983799|80977052|FG003|Overall Study|Withdrawal by Subject|4|||
27767429|NCT02983799|80977053|FG004|Overall Study|Withdrawal by Subject|1|||
27767430|NCT02983799|80977049|FG000|Overall Study|Protocol Violation|0|||
27767431|NCT02983799|80977050|FG001|Overall Study|Protocol Violation|1|||
27767432|NCT02983799|80977051|FG002|Overall Study|Protocol Violation|0|||
27767433|NCT02983799|80977052|FG003|Overall Study|Protocol Violation|0|||
27767434|NCT02983799|80977053|FG004|Overall Study|Protocol Violation|1|||
27767435|NCT02983799|80977049|FG000|Overall Study|Lost to Follow-up|1|||
27767436|NCT02983799|80977050|FG001|Overall Study|Lost to Follow-up|0|||
27767437|NCT02983799|80977051|FG002|Overall Study|Lost to Follow-up|1|||
27767438|NCT02983799|80977052|FG003|Overall Study|Lost to Follow-up|0|||
27767439|NCT02983799|80977053|FG004|Overall Study|Lost to Follow-up|0|||
27767440|NCT04423757|80977055|FG000|Overall Study|Adverse Event|2|||
27767441|NCT04423757|80977056|FG001|Overall Study|Adverse Event|0|||
27767442|NCT04423757|80977055|FG000|Overall Study|Not treated|1|||
27767443|NCT04423757|80977056|FG001|Overall Study|Not treated|1|||
27767444|NCT04857892|80977057|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
27767445|NCT04857892|80977058|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
27767446|NCT04857892|80977059|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
27767447|NCT04857892|80977060|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
27767448|NCT04857892|80977061|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
27767449|NCT04857892|80977057|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
27767450|NCT04857892|80977058|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
27767451|NCT04857892|80977059|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
27767452|NCT04857892|80977060|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
27767453|NCT04857892|80977061|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
27767454|NCT04857892|80977057|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
27767455|NCT04857892|80977058|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
27767456|NCT04857892|80977059|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
27767457|NCT04857892|80977060|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
27767458|NCT04857892|80977061|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
27767459|NCT01015820|80977064|FG000|Overall Study|Suboptimal measurements|1|||
27767460|NCT01015820|80977065|FG001|Overall Study|Suboptimal measurements|0|||
27963017|NCT03726658|81698870|FG006|Overall Study|Lost to Follow-up|1|||
27963018|NCT03726658|81698864|FG000|Overall Study|Withdrawal by Subject|1|||
27963019|NCT03726658|81698865|FG001|Overall Study|Withdrawal by Subject|0|||
27963020|NCT03726658|81698866|FG002|Overall Study|Withdrawal by Subject|0|||
27963021|NCT03726658|81698867|FG003|Overall Study|Withdrawal by Subject|0|||
27767461|NCT02384993|80977067|FG000|Overall Study|Adverse Event|0|||
27767462|NCT02384993|80977068|FG001|Overall Study|Adverse Event|1|||
27767463|NCT03619837|80977073|FG000|Screening|received organs from HCV-negative donors|47|||
27767464|NCT03619837|80977073|FG000|Screening|died on the wait-list|2|||
27767465|NCT03619837|80977073|FG000|Screening|remained on the wait list|40|||
27767466|NCT03619837|80977073|FG000|Screening|didn't meet eligibility criteria|3|||
27767467|NCT03619837|80977073|FG000|Screening|withdrew consent|2|||
27767468|NCT03619837|80977073|FG000|Screening|never listed for HCV-viremic donor|1|||
27963022|NCT03726658|81698868|FG004|Overall Study|Withdrawal by Subject|6|||
27963023|NCT03726658|81698869|FG005|Overall Study|Withdrawal by Subject|4|||
27963024|NCT03726658|81698870|FG006|Overall Study|Withdrawal by Subject|2|||
27963025|NCT03726658|81698864|FG000|Overall Study|Pregnancy|0|||
27963026|NCT03726658|81698865|FG001|Overall Study|Pregnancy|0|||
27963027|NCT03726658|81698866|FG002|Overall Study|Pregnancy|0|||
27963028|NCT03726658|81698867|FG003|Overall Study|Pregnancy|0|||
27963029|NCT03726658|81698868|FG004|Overall Study|Pregnancy|0|||
27963030|NCT03726658|81698869|FG005|Overall Study|Pregnancy|0|||
27963031|NCT03726658|81698870|FG006|Overall Study|Pregnancy|1|||
27963032|NCT03726658|81698864|FG000|Overall Study|Not Reported|0|||
27963033|NCT03726658|81698865|FG001|Overall Study|Not Reported|0|||
27963034|NCT03726658|81698866|FG002|Overall Study|Not Reported|0|||
27963035|NCT03726658|81698867|FG003|Overall Study|Not Reported|0|||
27963036|NCT03726658|81698868|FG004|Overall Study|Not Reported|0|||
27963037|NCT03726658|81698869|FG005|Overall Study|Not Reported|0|||
27963038|NCT03726658|81698870|FG006|Overall Study|Not Reported|1|||
27963039|NCT00082368|81698871|FG000|Overall Study|Not treated-pt had poor IV access|1|||
27963040|NCT02674464|81698874|FG000|Overall Study|Death|10|||
27963041|NCT02674464|81698875|FG001|Overall Study|Death|21|||
27963042|NCT02674464|81698874|FG000|Overall Study|Withdrawal by Subject|24|||
27963043|NCT02674464|81698875|FG001|Overall Study|Withdrawal by Subject|44|||
27963044|NCT02674464|81698874|FG000|Overall Study|Lost to Follow-up|97|||
27963045|NCT02674464|81698875|FG001|Overall Study|Lost to Follow-up|92|||
27963046|NCT02674464|81698874|FG000|Overall Study|Outside survey window|6|||
27963047|NCT02674464|81698875|FG001|Overall Study|Outside survey window|3|||
27963048|NCT01047007|81698876|FG000|Overall Study|Adverse Event|0|||
27963049|NCT01047007|81698877|FG001|Overall Study|Adverse Event|2|||
27963050|NCT01047007|81698878|FG002|Overall Study|Adverse Event|1|||
27963051|NCT01047007|81698879|FG003|Overall Study|Adverse Event|0|||
27963052|NCT01047007|81698876|FG000|Overall Study|Progressive Disease|2|||
27963053|NCT01047007|81698877|FG001|Overall Study|Progressive Disease|4|||
27963054|NCT01047007|81698878|FG002|Overall Study|Progressive Disease|1|||
27963055|NCT01047007|81698879|FG003|Overall Study|Progressive Disease|0|||
27963056|NCT02964273|81698880|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
27963057|NCT02964273|81698881|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
27767469|NCT03619837|80977073|FG000|Screening|developed exclusion criteria|2|||
27767470|NCT03619837|80977073|FG000|Screening|excluded by the investigator due to non-compliance|1|||
27767471|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
27767472|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
27767473|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
27767474|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
27767475|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
27767476|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
27767477|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
27767478|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
27767479|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27767480|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27767481|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27767482|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27767483|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27767484|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
27767485|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
27767486|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
27767487|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
27767488|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
27767489|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
27767490|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
27767491|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
27767492|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
27767493|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27963058|NCT02964273|81698882|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
27767494|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27767495|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27767496|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27963059|NCT02964273|81698883|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
27963060|NCT02964273|81698880|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
27963061|NCT02964273|81698881|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
27963062|NCT02964273|81698882|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
27963063|NCT02964273|81698883|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
27963064|NCT02964273|81698880|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
27963065|NCT02964273|81698881|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
27963066|NCT02964273|81698882|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
27963067|NCT02964273|81698883|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
27767497|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27767498|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
27767499|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
27767500|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27767501|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27767502|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27767503|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27767504|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27767505|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
27767506|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
27767507|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27862187|NCT05384171|81326246|FG000|Overall Study|Lost to Follow-up|9|||
27963068|NCT02964273|81698880|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
27963069|NCT02964273|81698881|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
27963070|NCT02964273|81698882|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
27963071|NCT02964273|81698883|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
27963072|NCT02964273|81698880|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
27963073|NCT02964273|81698881|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
27963074|NCT02964273|81698882|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
27963075|NCT02964273|81698883|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
27963076|NCT02964273|81698880|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
27963077|NCT02964273|81698881|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
27963078|NCT02964273|81698882|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
27963079|NCT02964273|81698883|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
27963080|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
27963081|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
27963082|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
27963083|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
27963084|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
27963085|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
27963086|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
27963087|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
27963088|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
27663814|NCT02137239|80606521|FG000|Overall Study|Discontinued Study Treatment|0|||
27663815|NCT02137239|80606522|FG001|Overall Study|Discontinued Study Treatment|3|||
27663816|NCT02137239|80606521|FG000|Overall Study|Withdrew Consent|1|||
27663817|NCT02137239|80606522|FG001|Overall Study|Withdrew Consent|1|||
27663818|NCT02137239|80606521|FG000|Overall Study|Adverse Event|2|||
27663819|NCT02137239|80606522|FG001|Overall Study|Adverse Event|2|||
27663820|NCT03900715|80606528|FG000|Overall Study|Protocol Deviation|1|||
27663821|NCT03900715|80606528|FG000|Overall Study|Lack of Efficacy|1|||
27663822|NCT03900715|80606528|FG000|Overall Study|Progressive Disease|6|||
27663823|NCT03900715|80606528|FG000|Overall Study|Adverse Event|2|||
27663824|NCT03900715|80606528|FG000|Overall Study|Other reasons|11|||
27663825|NCT00858247|80606530|FG000|Baseline Assessment|Withdrawal by Subject|1|||
27663826|NCT00858247|80606531|FG001|Baseline Assessment|Withdrawal by Subject|1|||
27663827|NCT00858247|80606530|FG000|Baseline Assessment|Poor IV access|1|||
27663828|NCT00858247|80606531|FG001|Baseline Assessment|Poor IV access|0|||
27663829|NCT00858247|80606530|FG000|Baseline Assessment|Protocol Violation|0|||
27663830|NCT00858247|80606531|FG001|Baseline Assessment|Protocol Violation|1|||
27663831|NCT00858247|80606530|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
27663832|NCT00858247|80606531|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
27663833|NCT01191697|80606533|FG000|Overall Study|Death|1|||
27663834|NCT01191697|80606533|FG000|Overall Study|Physician Decision|2|||
27663835|NCT01191697|80606533|FG000|Overall Study|Pursue chemoradiation|2|||
27663836|NCT01191697|80606533|FG000|Overall Study|Break from chemotherapy|2|||
27663837|NCT01191697|80606533|FG000|Overall Study|Withdrawal by Subject|1|||
27663838|NCT01191697|80606533|FG000|Overall Study|Surveillance|1|||
27663839|NCT01191697|80606533|FG000|Overall Study|Adverse Event|2|||
27663840|NCT01191697|80606533|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
27663841|NCT01191697|80606533|FG000|Overall Study|Not completed but analyzed|25|||
27663842|NCT03132753|80606534|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
27663843|NCT03132753|80606535|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
27663844|NCT03132753|80606534|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
27663845|NCT03132753|80606535|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
27663846|NCT03494985|80606536|FG000|Overall Study|Adverse Event|3|||
27663847|NCT03494985|80606537|FG001|Overall Study|Adverse Event|2|||
27663848|NCT03494985|80606538|FG002|Overall Study|Adverse Event|3|||
27663849|NCT03494985|80606539|FG003|Overall Study|Adverse Event|0|||
27663850|NCT03494985|80606536|FG000|Overall Study|Other (Withdrawal of consent)|2|||
27767508|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27767509|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27767510|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27767511|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27767512|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
27767513|NCT02120352|80977074|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
27767514|NCT02120352|80977075|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
27767515|NCT02120352|80977076|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
27767516|NCT02120352|80977077|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
27767517|NCT02120352|80977078|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
27767518|NCT02120352|80977079|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
27767519|NCT02120352|80977080|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
27767520|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
27767521|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
27767522|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
27767523|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
27963089|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
27963090|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27963091|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27963092|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
27963093|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
27963094|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
27963095|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
27963096|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
27963097|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
27963098|NCT03162796|81698884|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
27963099|NCT03162796|81698885|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
27963100|NCT03162796|81698886|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
27963101|NCT03162796|81698884|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
27767524|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
27767525|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
27767526|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
27767527|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
27767528|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
27767529|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
27767530|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
27767531|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
27767532|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
27767533|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
27767534|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
27767535|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
27767536|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
27767537|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
27767538|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
27767539|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
27767540|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
27767541|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
27767542|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
27767543|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
27767544|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
27767545|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
27767546|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
27767547|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
27767548|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
27767549|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
27767550|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
27767551|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
27767552|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
27767553|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
27767554|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
27767555|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
27767556|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
27767557|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
27767558|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
27767559|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
27767560|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
27767561|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
27767562|NCT02120352|80977074|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
27767563|NCT02120352|80977075|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
27767564|NCT02120352|80977076|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
27767565|NCT02120352|80977077|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
27767566|NCT02120352|80977078|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
27767567|NCT02120352|80977079|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
27767568|NCT02120352|80977080|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
27767569|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
27767570|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
27767571|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
27767572|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
27767573|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
27767574|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
27767575|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
27767576|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
27963102|NCT03162796|81698885|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
27963103|NCT03162796|81698886|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
27963104|NCT03162796|81698884|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
27963105|NCT03162796|81698885|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
27963106|NCT03162796|81698886|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
27963107|NCT03162796|81698884|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
27963108|NCT03162796|81698885|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
27963109|NCT03162796|81698886|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
27963110|NCT03162796|81698884|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
27963111|NCT03162796|81698885|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
27963112|NCT03162796|81698886|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
27767577|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
27767578|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
27767579|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
27767580|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
27767581|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
27767582|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
27767583|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
27767584|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
27767585|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
27767586|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
27767587|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
27767588|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
27767589|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
27767590|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
27767591|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
27767592|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
27767593|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
27767594|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
27767595|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
27767596|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
27767597|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
27767598|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
27767599|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
27767600|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
27767601|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
27767602|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
27767603|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
27767604|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
27767605|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
27767606|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
27767607|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
27767608|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
27862188|NCT05384171|81326247|FG001|Overall Study|Lost to Follow-up|9|||
27963113|NCT02125838|81698887|FG000|Overall Study|Lost to Follow-up|4|||
27963114|NCT02125838|81698888|FG001|Overall Study|Lost to Follow-up|4|||
27568964|NCT02658890|80271473|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
27663851|NCT03494985|80606537|FG001|Overall Study|Other (Withdrawal of consent)|3|||
27767609|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
27767610|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
27767611|NCT02120352|80977074|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
27767612|NCT02120352|80977075|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
27767613|NCT02120352|80977076|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
27767614|NCT02120352|80977077|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
27767615|NCT02120352|80977078|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
27767616|NCT02120352|80977079|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
27767617|NCT02120352|80977080|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
27767618|NCT02120352|80977074|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
27767619|NCT02120352|80977075|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
27767620|NCT02120352|80977076|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
27767621|NCT02120352|80977077|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
27568965|NCT02658890|80271474|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
27568966|NCT02658890|80271475|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
27568967|NCT02658890|80271476|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
27663852|NCT03494985|80606538|FG002|Overall Study|Other (Withdrawal of consent)|2|||
27663853|NCT03494985|80606539|FG003|Overall Study|Other (Withdrawal of consent)|5|||
27663854|NCT03494985|80606536|FG000|Overall Study|Other (Not specified)|0|||
27663855|NCT03494985|80606537|FG001|Overall Study|Other (Not specified)|1|||
27663856|NCT03494985|80606538|FG002|Overall Study|Other (Not specified)|1|||
27663857|NCT03494985|80606539|FG003|Overall Study|Other (Not specified)|0|||
27663858|NCT02847637|80606544|FG000|Overall Study|Withdrawal by Subject|0|||
27663859|NCT02847637|80606545|FG001|Overall Study|Withdrawal by Subject|1|||
27663860|NCT02847637|80606546|FG002|Overall Study|Withdrawal by Subject|1|||
27663861|NCT02847637|80606547|FG003|Overall Study|Withdrawal by Subject|0|||
27663862|NCT02847637|80606544|FG000|Overall Study|Lost to Follow-up|1|||
27663863|NCT02847637|80606545|FG001|Overall Study|Lost to Follow-up|1|||
27663864|NCT02847637|80606546|FG002|Overall Study|Lost to Follow-up|0|||
27663865|NCT02847637|80606547|FG003|Overall Study|Lost to Follow-up|0|||
27663866|NCT00760877|80606548|FG000|Overall Study|Protocol Violation|1|||
27663867|NCT00760877|80606549|FG001|Overall Study|Protocol Violation|0|||
27663868|NCT00760877|80606548|FG000|Overall Study|Non-compliance with protocol treatment|2|||
27663869|NCT00760877|80606549|FG001|Overall Study|Non-compliance with protocol treatment|1|||
27663870|NCT00760877|80606548|FG000|Overall Study|Pregnancy|1|||
27663871|NCT00760877|80606549|FG001|Overall Study|Pregnancy|4|||
27663872|NCT00760877|80606548|FG000|Overall Study|Death|2|||
27663873|NCT00760877|80606549|FG001|Overall Study|Death|1|||
27663874|NCT00760877|80606548|FG000|Overall Study|Withdrawal by Subject|7|||
27663875|NCT00760877|80606549|FG001|Overall Study|Withdrawal by Subject|3|||
27568968|NCT02658890|80271477|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
27568969|NCT02658890|80271478|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
27568970|NCT02658890|80271479|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
27568971|NCT02658890|80271480|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
27568972|NCT02658890|80271481|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
27568973|NCT02658890|80271482|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
27568974|NCT02658890|80271483|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
27568975|NCT02658890|80271484|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
27568976|NCT02658890|80271485|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
27568977|NCT02658890|80271486|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
27568978|NCT02658890|80271487|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
27568979|NCT02658890|80271488|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
27568980|NCT02658890|80271489|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
27568981|NCT02658890|80271490|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
27568982|NCT02658890|80271491|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
27568983|NCT02658890|80271492|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
27568984|NCT02658890|80271493|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
27568985|NCT02658890|80271494|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
27568986|NCT02658890|80271495|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
27568987|NCT02658890|80271496|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
27568988|NCT02658890|80271470|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
27568989|NCT02658890|80271471|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
27568990|NCT02658890|80271472|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
27568991|NCT02658890|80271473|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
27568992|NCT02658890|80271474|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
27568993|NCT02658890|80271475|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
27568994|NCT02658890|80271476|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
27568995|NCT02658890|80271477|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
27568996|NCT02658890|80271478|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
27568997|NCT02658890|80271479|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
27568998|NCT02658890|80271480|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
27568999|NCT02658890|80271481|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
27963115|NCT02370368|81698889|FG000|Overall Study|Adverse Event|1|||
27963116|NCT02370368|81698890|FG001|Overall Study|Adverse Event|2|||
27963117|NCT02370368|81698889|FG000|Overall Study|Withdrawal by Subject|5|||
27963118|NCT02370368|81698890|FG001|Overall Study|Withdrawal by Subject|4|||
27963119|NCT02943070|81698891|FG000|Overall Study|Physician Decision|1|||
27963120|NCT02943070|81698891|FG000|Overall Study|Adverse Event|2|||
27963121|NCT02943070|81698891|FG000|Overall Study|Death|2|||
27963122|NCT02943070|81698891|FG000|Overall Study|Withdrawal by Subject|3|||
27963123|NCT02943070|81698891|FG000|Overall Study|Lost to Follow-up|4|||
27963124|NCT02943070|81698891|FG000|Overall Study|Retreatment or TURP|13|||
27963125|NCT02943070|81698891|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
27963126|NCT01977729|81698892|FG000|Overall Study|Study terminated|1|||
27963127|NCT00368745|81698893|FG000|Double-blind Treatment Period|Adverse Event|6|||
27963128|NCT00368745|81698894|FG001|Double-blind Treatment Period|Adverse Event|6|||
27963129|NCT00368745|81698893|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
27963130|NCT00368745|81698894|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
27963131|NCT00368745|81698893|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
27963132|NCT00368745|81698894|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27963133|NCT00368745|81698893|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
27963134|NCT00368745|81698894|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
27767622|NCT02120352|80977078|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
27767623|NCT02120352|80977079|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
27767624|NCT02120352|80977080|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
27767625|NCT02709109|80977081|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
27767626|NCT02709109|80977082|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
27767627|NCT02709109|80977083|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
27767628|NCT02709109|80977084|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
27767629|NCT02709109|80977081|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
27767630|NCT02709109|80977082|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
27767631|NCT02709109|80977083|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
27767632|NCT02709109|80977084|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
27767633|NCT02709109|80977081|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
27767634|NCT02709109|80977082|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
27767635|NCT02709109|80977083|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
27767636|NCT02709109|80977084|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
27767637|NCT02709109|80977081|FG000|Washout Period (28 Days)|Other|2|||
27767638|NCT02709109|80977082|FG001|Washout Period (28 Days)|Other|2|||
27767639|NCT02709109|80977083|FG002|Washout Period (28 Days)|Other|3|||
27767640|NCT02709109|80977084|FG003|Washout Period (28 Days)|Other|0|||
27767641|NCT02709109|80977081|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
27767642|NCT02709109|80977082|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
27767643|NCT02709109|80977083|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
27767644|NCT02709109|80977084|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
27767645|NCT02709109|80977081|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
27767646|NCT02709109|80977082|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
27767647|NCT02709109|80977083|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
27767648|NCT02709109|80977084|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
27767649|NCT02709109|80977081|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
27767650|NCT02709109|80977082|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
27767651|NCT02709109|80977083|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
27767652|NCT02709109|80977084|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
27767653|NCT02709109|80977081|FG000|Treatment Period 2 (28 Days)|Other|0|||
27767654|NCT02709109|80977082|FG001|Treatment Period 2 (28 Days)|Other|0|||
27767655|NCT02709109|80977083|FG002|Treatment Period 2 (28 Days)|Other|1|||
27767656|NCT02709109|80977084|FG003|Treatment Period 2 (28 Days)|Other|0|||
27767657|NCT00379236|80977085|FG000|Double-blind|Adverse Event|11|||
27767658|NCT00379236|80977086|FG001|Double-blind|Adverse Event|6|||
27767659|NCT00379236|80977087|FG002|Double-blind|Adverse Event|0|||
27767660|NCT00379236|80977085|FG000|Double-blind|Protocol Violation|3|||
27767661|NCT00379236|80977086|FG001|Double-blind|Protocol Violation|3|||
27767662|NCT00379236|80977087|FG002|Double-blind|Protocol Violation|0|||
27767663|NCT00379236|80977085|FG000|Double-blind|Withdrawal by Subject|12|||
27767664|NCT00379236|80977086|FG001|Double-blind|Withdrawal by Subject|13|||
27767665|NCT00379236|80977087|FG002|Double-blind|Withdrawal by Subject|0|||
27767666|NCT00379236|80977085|FG000|Double-blind|Lost to Follow-up|4|||
27767667|NCT00379236|80977086|FG001|Double-blind|Lost to Follow-up|3|||
27767668|NCT00379236|80977087|FG002|Double-blind|Lost to Follow-up|0|||
27963135|NCT00368745|81698893|FG000|Double-blind Treatment Period|Other|7|||
27963136|NCT00368745|81698894|FG001|Double-blind Treatment Period|Other|6|||
27767669|NCT00379236|80977085|FG000|Double-blind|Use of exclusionary medication|1|||
27963137|NCT02147197|81698895|FG000|Overall Study|Adverse Event|1|||
27963138|NCT02147197|81698896|FG001|Overall Study|Adverse Event|0|||
27767670|NCT00379236|80977086|FG001|Double-blind|Use of exclusionary medication|2|||
27767671|NCT00379236|80977087|FG002|Double-blind|Use of exclusionary medication|0|||
27767672|NCT00379236|80977085|FG000|Double-blind|Other|3|||
27767673|NCT00379236|80977086|FG001|Double-blind|Other|7|||
27767674|NCT00379236|80977087|FG002|Double-blind|Other|0|||
27767675|NCT00379236|80977085|FG000|Double-blind|Data could not be retrieved|2|||
27767676|NCT00379236|80977086|FG001|Double-blind|Data could not be retrieved|2|||
27767677|NCT00379236|80977087|FG002|Double-blind|Data could not be retrieved|0|||
27767678|NCT00379236|80977085|FG000|Open-label Extension|Adverse Event|0|||
27767679|NCT00379236|80977086|FG001|Open-label Extension|Adverse Event|0|||
27767680|NCT00379236|80977087|FG002|Open-label Extension|Adverse Event|13|||
27767681|NCT00379236|80977085|FG000|Open-label Extension|Protocol Violation|0|||
27767682|NCT00379236|80977086|FG001|Open-label Extension|Protocol Violation|0|||
27767683|NCT00379236|80977087|FG002|Open-label Extension|Protocol Violation|7|||
27767684|NCT00379236|80977085|FG000|Open-label Extension|Withdrawal by Subject|0|||
27767685|NCT00379236|80977086|FG001|Open-label Extension|Withdrawal by Subject|0|||
27767686|NCT00379236|80977087|FG002|Open-label Extension|Withdrawal by Subject|13|||
27767687|NCT00379236|80977085|FG000|Open-label Extension|Lost to Follow-up|0|||
27767688|NCT00379236|80977086|FG001|Open-label Extension|Lost to Follow-up|0|||
27767689|NCT00379236|80977087|FG002|Open-label Extension|Lost to Follow-up|12|||
27767690|NCT00379236|80977085|FG000|Open-label Extension|Use of exclusionary medication|0|||
27767691|NCT00379236|80977086|FG001|Open-label Extension|Use of exclusionary medication|0|||
27767692|NCT00379236|80977087|FG002|Open-label Extension|Use of exclusionary medication|3|||
27767693|NCT00379236|80977085|FG000|Open-label Extension|Other|0|||
27767694|NCT00379236|80977086|FG001|Open-label Extension|Other|0|||
27767695|NCT00379236|80977087|FG002|Open-label Extension|Other|7|||
27767696|NCT00562640|80977088|FG000|Overall Study|Death|0|||
27767697|NCT00562640|80977089|FG001|Overall Study|Death|1|||
27767698|NCT00562640|80977090|FG002|Overall Study|Death|1|||
27767699|NCT00562640|80977091|FG003|Overall Study|Death|0|||
27767700|NCT03379376|80977092|FG000|Overall Study|Lost to Follow-up|2|||
27767701|NCT03379376|80977092|FG000|Overall Study|Did not wish to complete follow up|1|||
27767702|NCT03379376|80977092|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
27767703|NCT03379376|80977092|FG000|Overall Study|Death|1|||
27767704|NCT01181141|80977096|FG000|Overall Study|Adverse Event|2|||
27767705|NCT01181141|80977097|FG001|Overall Study|Adverse Event|1|||
27767706|NCT01181141|80977096|FG000|Overall Study|Lack of Efficacy|1|||
27767707|NCT01181141|80977097|FG001|Overall Study|Lack of Efficacy|0|||
27767708|NCT01181141|80977096|FG000|Overall Study|Lost to Follow-up|1|||
27767709|NCT01181141|80977097|FG001|Overall Study|Lost to Follow-up|1|||
27767710|NCT01181141|80977096|FG000|Overall Study|Physician Decision|2|||
27767711|NCT01181141|80977097|FG001|Overall Study|Physician Decision|0|||
27767712|NCT01181141|80977096|FG000|Overall Study|Protocol Violation|3|||
27767713|NCT01181141|80977097|FG001|Overall Study|Protocol Violation|1|||
27767714|NCT01181141|80977096|FG000|Overall Study|Withdrawal by Subject|3|||
27767715|NCT01181141|80977097|FG001|Overall Study|Withdrawal by Subject|1|||
27767716|NCT00659126|80977098|FG000|Overall Study|Adverse Event|2|||
27767717|NCT00659126|80977099|FG001|Overall Study|Adverse Event|2|||
27767718|NCT00659126|80977098|FG000|Overall Study|Screen failure|1|||
27767719|NCT00659126|80977099|FG001|Overall Study|Screen failure|1|||
27767720|NCT00659126|80977098|FG000|Overall Study|Technical problems with MRI|0|||
27767721|NCT00659126|80977099|FG001|Overall Study|Technical problems with MRI|1|||
27767722|NCT01263444|80977100|FG000|Overall Study|Adverse Event|8|||
27767723|NCT01263444|80977100|FG000|Overall Study|Withdrawal by Subject|1|||
27767724|NCT01263444|80977100|FG000|Overall Study|Protocol Violation|1|||
27767725|NCT00469209|80977101|FG000|Overall Study|Adverse Event|1|||
27767726|NCT00469209|80977102|FG001|Overall Study|Adverse Event|0|||
27767727|NCT00469209|80977103|FG002|Overall Study|Adverse Event|1|||
27767728|NCT01302691|80977106|FG000|Overall Study|Adverse Event|2|||
27767729|NCT01302691|80977107|FG001|Overall Study|Adverse Event|0|||
27767730|NCT01302691|80977106|FG000|Overall Study|Death|0|||
27767731|NCT01302691|80977107|FG001|Overall Study|Death|1|||
27767732|NCT01302691|80977106|FG000|Overall Study|Lost to Follow-up|1|||
27663876|NCT00760877|80606548|FG000|Overall Study|Adverse Event|19|||
27663877|NCT00760877|80606549|FG001|Overall Study|Adverse Event|12|||
27767733|NCT01302691|80977107|FG001|Overall Study|Lost to Follow-up|0|||
27767734|NCT01302691|80977106|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
27767735|NCT01302691|80977107|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
27767736|NCT01302691|80977106|FG000|Overall Study|Physician Decision|0|||
27569000|NCT02658890|80271482|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
27767737|NCT01302691|80977107|FG001|Overall Study|Physician Decision|1|||
27767738|NCT01302691|80977106|FG000|Overall Study|Protocol Violation|1|||
27767739|NCT01302691|80977107|FG001|Overall Study|Protocol Violation|0|||
27767740|NCT01449955|80977108|FG000|Overall Study|Withdrawal by Subject|1|||
27767741|NCT01449955|80977109|FG001|Overall Study|Withdrawal by Subject|2|||
27767742|NCT03395223|80977110|FG000|Overall Study|Lost to Follow-up|3|||
27767743|NCT03395223|80977110|FG000|Overall Study|Other|1|||
27767744|NCT03146403|80977111|FG000|Overall Study|Withdrawal by Subject|0|||
27767745|NCT03146403|80977112|FG001|Overall Study|Withdrawal by Subject|3|||
27767746|NCT03146403|80977111|FG000|Overall Study|Lost to Follow-up|2|||
27963139|NCT02147197|81698897|FG002|Overall Study|Adverse Event|0|||
27963140|NCT02147197|81698895|FG000|Overall Study|Withdrawal of Consent|4|||
27963141|NCT02147197|81698896|FG001|Overall Study|Withdrawal of Consent|3|||
27963142|NCT02147197|81698897|FG002|Overall Study|Withdrawal of Consent|2|||
27963143|NCT02147197|81698895|FG000|Overall Study|Lost to Follow-up|2|||
27963144|NCT02147197|81698896|FG001|Overall Study|Lost to Follow-up|3|||
27963145|NCT02147197|81698897|FG002|Overall Study|Lost to Follow-up|1|||
27963146|NCT02147197|81698895|FG000|Overall Study|Protocol Violation|1|||
27963147|NCT02147197|81698896|FG001|Overall Study|Protocol Violation|0|||
27963148|NCT02147197|81698897|FG002|Overall Study|Protocol Violation|3|||
27963149|NCT02147197|81698895|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27963150|NCT02147197|81698896|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27963151|NCT02147197|81698897|FG002|Overall Study|Other Miscellaneous Reasons|3|||
27963152|NCT00935493|81698898|FG000|Overall Study|Lost to Follow-up|1|||
27963153|NCT00935493|81698899|FG001|Overall Study|Lost to Follow-up|1|||
27963154|NCT00935493|81698900|FG002|Overall Study|Lost to Follow-up|1|||
27963155|NCT00935493|81698898|FG000|Overall Study|Treatment Discontinued|0|||
27963156|NCT00935493|81698899|FG001|Overall Study|Treatment Discontinued|1|||
27963157|NCT00935493|81698900|FG002|Overall Study|Treatment Discontinued|0|||
27963158|NCT01147250|81698909|FG000|Overall Study|Lost to Follow-up|14|||
27963159|NCT01147250|81698910|FG001|Overall Study|Lost to Follow-up|11|||
27963160|NCT01147250|81698909|FG000|Overall Study|Withdrawal by Subject|83|||
27963161|NCT01147250|81698910|FG001|Overall Study|Withdrawal by Subject|88|||
27963162|NCT01147250|81698909|FG000|Overall Study|Site termination by sponsor|13|||
27963163|NCT01147250|81698910|FG001|Overall Study|Site termination by sponsor|5|||
27963164|NCT01147250|81698909|FG000|Overall Study|Other than specified|0|||
27963165|NCT01147250|81698910|FG001|Overall Study|Other than specified|1|||
27963166|NCT02628600|81698915|FG000|Overall Study|Death|2|||
27963167|NCT02628600|81698916|FG001|Overall Study|Death|1|||
27767747|NCT03146403|80977112|FG001|Overall Study|Lost to Follow-up|0|||
27767748|NCT02023268|80977130|FG000|Overall Study|Lack of Efficacy|0|||
27767749|NCT02023268|80977131|FG001|Overall Study|Lack of Efficacy|1|||
27767750|NCT02023268|80977130|FG000|Overall Study|Adverse Event|0|||
27767751|NCT02023268|80977131|FG001|Overall Study|Adverse Event|2|||
27767752|NCT02023268|80977130|FG000|Overall Study|Withdrawal by Subject|0|||
27767753|NCT02023268|80977131|FG001|Overall Study|Withdrawal by Subject|1|||
27767754|NCT01929707|80977143|FG000|Intervention Period 1|Lost to Follow-up|0|||
27767755|NCT01929707|80977144|FG001|Intervention Period 1|Lost to Follow-up|0|||
27767756|NCT01929707|80977145|FG002|Intervention Period 1|Lost to Follow-up|0|||
27767757|NCT01929707|80977146|FG003|Intervention Period 1|Lost to Follow-up|1|||
27767758|NCT01929707|80977147|FG004|Intervention Period 1|Lost to Follow-up|0|||
27767759|NCT01929707|80977148|FG005|Intervention Period 1|Lost to Follow-up|0|||
27767760|NCT01929707|80977149|FG006|Intervention Period 1|Lost to Follow-up|0|||
27767761|NCT01929707|80977150|FG007|Intervention Period 1|Lost to Follow-up|0|||
27767762|NCT01929707|80977143|FG000|Intervention Period 1|Withdrawal by Subject|0|||
27767763|NCT01929707|80977144|FG001|Intervention Period 1|Withdrawal by Subject|0|||
27767764|NCT01929707|80977145|FG002|Intervention Period 1|Withdrawal by Subject|0|||
27767765|NCT01929707|80977146|FG003|Intervention Period 1|Withdrawal by Subject|2|||
27767766|NCT01929707|80977147|FG004|Intervention Period 1|Withdrawal by Subject|0|||
27767767|NCT01929707|80977148|FG005|Intervention Period 1|Withdrawal by Subject|0|||
27767768|NCT01929707|80977149|FG006|Intervention Period 1|Withdrawal by Subject|0|||
27767769|NCT01929707|80977150|FG007|Intervention Period 1|Withdrawal by Subject|0|||
27767770|NCT01929707|80977143|FG000|Intervention Period 2|Withdrawal by Subject|0|||
27767771|NCT01929707|80977144|FG001|Intervention Period 2|Withdrawal by Subject|0|||
27767772|NCT01929707|80977145|FG002|Intervention Period 2|Withdrawal by Subject|0|||
27767773|NCT01929707|80977146|FG003|Intervention Period 2|Withdrawal by Subject|0|||
27767774|NCT01929707|80977147|FG004|Intervention Period 2|Withdrawal by Subject|0|||
27767775|NCT01929707|80977148|FG005|Intervention Period 2|Withdrawal by Subject|2|||
27767776|NCT01929707|80977149|FG006|Intervention Period 2|Withdrawal by Subject|0|||
27767777|NCT01929707|80977150|FG007|Intervention Period 2|Withdrawal by Subject|0|||
27767778|NCT01981109|80977151|FG000|Overall Study|Death|36|||
27963168|NCT02628600|81698915|FG000|Overall Study|Adverse Event|3|||
27963169|NCT02628600|81698916|FG001|Overall Study|Adverse Event|20|||
27963170|NCT02628600|81698915|FG000|Overall Study|Protocol Violation|0|||
27767779|NCT01981109|80977151|FG000|Overall Study|Withdrawal by Subject|40|||
27767780|NCT01981109|80977151|FG000|Overall Study|Lost to Follow-up|9|||
27767781|NCT01981109|80977151|FG000|Overall Study|No Discontinuation Documentation|37|||
27767782|NCT01981109|80977151|FG000|Overall Study|Study Termination|100|||
27767783|NCT01981109|80977151|FG000|Overall Study|No data available|2|||
27767784|NCT01156532|80977152|FG000|Overall Study|Family Reasons|1|||
27767785|NCT01156532|80977152|FG000|Overall Study|Lost to Follow-up|1|||
27963171|NCT02628600|81698916|FG001|Overall Study|Protocol Violation|1|||
27963172|NCT02628600|81698915|FG000|Overall Study|Lack of Efficacy|2|||
27963173|NCT02628600|81698916|FG001|Overall Study|Lack of Efficacy|0|||
27767786|NCT01517412|80977154|FG000|Overall Study|Adverse Event|10|||
27767787|NCT01517412|80977155|FG001|Overall Study|Adverse Event|11|||
27767788|NCT01517412|80977154|FG000|Overall Study|Lack of Efficacy|10|||
27767789|NCT01517412|80977155|FG001|Overall Study|Lack of Efficacy|5|||
27767790|NCT01517412|80977154|FG000|Overall Study|Poor compliance to protocol|8|||
27767791|NCT01517412|80977155|FG001|Overall Study|Poor compliance to protocol|3|||
27767792|NCT01517412|80977154|FG000|Overall Study|Other than specified above|8|||
27767793|NCT01517412|80977155|FG001|Overall Study|Other than specified above|5|||
27767794|NCT02896192|80977156|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
27767795|NCT02896192|80977156|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
27767796|NCT02896192|80977156|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
27767797|NCT03693404|80977157|FG000|Overall Study|Withdrawal by Subject|1|||
27767798|NCT03693404|80977158|FG001|Overall Study|Withdrawal by Subject|0|||
27767799|NCT03693404|80977157|FG000|Overall Study|Lost to Follow-up|0|||
27767800|NCT03693404|80977158|FG001|Overall Study|Lost to Follow-up|5|||
27767801|NCT03693404|80977157|FG000|Overall Study|Excluded from Analysis|0|||
27767802|NCT03693404|80977158|FG001|Overall Study|Excluded from Analysis|1|||
27767803|NCT05263921|80977160|FG000|Overall Study|Other: family emergency.|0|||
27767804|NCT05263921|80977161|FG001|Overall Study|Other: family emergency.|0|||
27767805|NCT05263921|80977162|FG002|Overall Study|Other: family emergency.|1|||
27767806|NCT05263921|80977163|FG003|Overall Study|Other: family emergency.|0|||
27767807|NCT01202760|80977166|FG000|Overall Study|Entry Criteria Not Met|0|||
27767808|NCT01202760|80977167|FG001|Overall Study|Entry Criteria Not Met|3|||
27767809|NCT01202760|80977168|FG002|Overall Study|Entry Criteria Not Met|1|||
27767810|NCT01202760|80977166|FG000|Overall Study|Adverse Event|11|||
27767811|NCT01202760|80977167|FG001|Overall Study|Adverse Event|9|||
27767812|NCT01202760|80977168|FG002|Overall Study|Adverse Event|10|||
27767813|NCT01202760|80977166|FG000|Overall Study|Death|2|||
27767814|NCT01202760|80977167|FG001|Overall Study|Death|1|||
27767815|NCT01202760|80977168|FG002|Overall Study|Death|0|||
27767816|NCT01202760|80977166|FG000|Overall Study|Lack of Efficacy|6|||
27767817|NCT01202760|80977167|FG001|Overall Study|Lack of Efficacy|8|||
27767818|NCT01202760|80977168|FG002|Overall Study|Lack of Efficacy|7|||
27767819|NCT01202760|80977166|FG000|Overall Study|Lost to Follow-up|0|||
27767820|NCT01202760|80977167|FG001|Overall Study|Lost to Follow-up|2|||
27767821|NCT01202760|80977168|FG002|Overall Study|Lost to Follow-up|1|||
27767822|NCT01202760|80977166|FG000|Overall Study|Parent / Caregiver Decision|0|||
27767823|NCT01202760|80977167|FG001|Overall Study|Parent / Caregiver Decision|1|||
27767824|NCT01202760|80977168|FG002|Overall Study|Parent / Caregiver Decision|0|||
27767825|NCT01202760|80977166|FG000|Overall Study|Withdrawal by Subject|17|||
27767826|NCT01202760|80977167|FG001|Overall Study|Withdrawal by Subject|18|||
27767827|NCT01202760|80977168|FG002|Overall Study|Withdrawal by Subject|14|||
27767828|NCT01202760|80977166|FG000|Overall Study|Physician Decision|0|||
27767829|NCT01202760|80977167|FG001|Overall Study|Physician Decision|1|||
27767830|NCT01202760|80977168|FG002|Overall Study|Physician Decision|0|||
27767831|NCT01202760|80977166|FG000|Overall Study|Protocol Violation|7|||
27963174|NCT02628600|81698915|FG000|Overall Study|Withdrawal by Subject|13|||
27767832|NCT01202760|80977167|FG001|Overall Study|Protocol Violation|5|||
27767833|NCT01202760|80977168|FG002|Overall Study|Protocol Violation|2|||
27767834|NCT01202760|80977166|FG000|Overall Study|Sponsor Decision|4|||
27767835|NCT01202760|80977167|FG001|Overall Study|Sponsor Decision|4|||
27767836|NCT01202760|80977168|FG002|Overall Study|Sponsor Decision|0|||
27767837|NCT01042938|80977169|FG000|Overall Study|Withdrawal by Subject|1|||
27767838|NCT01042938|80977170|FG001|Overall Study|Withdrawal by Subject|1|||
27767839|NCT01042938|80977169|FG000|Overall Study|Protocol Violation|1|||
27767840|NCT01042938|80977170|FG001|Overall Study|Protocol Violation|1|||
27767841|NCT01042938|80977169|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
27767842|NCT01042938|80977170|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
27767843|NCT03943446|80977171|FG000|Overall Study|Lost to Follow-up|0|||
27767844|NCT03943446|80977172|FG001|Overall Study|Lost to Follow-up|0|||
27767845|NCT03943446|80977173|FG002|Overall Study|Lost to Follow-up|1|||
27767846|NCT03943446|80977171|FG000|Overall Study|Withdrawal by Subject|1|||
27767847|NCT03943446|80977172|FG001|Overall Study|Withdrawal by Subject|1|||
27767848|NCT03943446|80977173|FG002|Overall Study|Withdrawal by Subject|2|||
27767849|NCT03943446|80977171|FG000|Overall Study|Study Terminated by Sponsor|1|||
27767850|NCT03943446|80977172|FG001|Overall Study|Study Terminated by Sponsor|2|||
27963175|NCT02628600|81698916|FG001|Overall Study|Withdrawal by Subject|8|||
27767851|NCT03943446|80977173|FG002|Overall Study|Study Terminated by Sponsor|1|||
27767852|NCT03943446|80977171|FG000|Overall Study|Reason not Specified|5|||
27767853|NCT03943446|80977172|FG001|Overall Study|Reason not Specified|1|||
27767854|NCT03943446|80977173|FG002|Overall Study|Reason not Specified|3|||
27767855|NCT01376245|80977174|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
27767856|NCT01376245|80977175|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27963176|NCT02628600|81698915|FG000|Overall Study|Lost to Follow-up|1|||
27767857|NCT01376245|80977176|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27963177|NCT02628600|81698916|FG001|Overall Study|Lost to Follow-up|0|||
27767858|NCT01376245|80977177|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27767859|NCT01376245|80977178|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
27767860|NCT01376245|80977174|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
27963178|NCT02628600|81698915|FG000|Overall Study|Physician Decision|2|||
27963179|NCT02628600|81698916|FG001|Overall Study|Physician Decision|2|||
27963180|NCT02628600|81698915|FG000|Overall Study|Other not specified|1|||
27963181|NCT02628600|81698916|FG001|Overall Study|Other not specified|0|||
27963182|NCT02297815|81698917|FG000|Overall Study|Lost to Follow-up|236|||
27963183|NCT02297815|81698918|FG001|Overall Study|Lost to Follow-up|140|||
27963184|NCT01208324|81698919|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
27963185|NCT01208324|81698920|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
27963186|NCT01208324|81698921|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
27963187|NCT01208324|81698922|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
27963188|NCT02263326|81698923|FG000|Overall Study|Lost to Follow-up|1|||
27963189|NCT02263326|81698924|FG001|Overall Study|Lost to Follow-up|1|||
27963190|NCT01268046|81698925|FG000|Overall Study|Withdrawal by Subject|1|||
27963191|NCT01268046|81698926|FG001|Overall Study|Withdrawal by Subject|0|||
27963192|NCT01268046|81698927|FG002|Overall Study|Withdrawal by Subject|0|||
27963193|NCT01268046|81698928|FG003|Overall Study|Withdrawal by Subject|1|||
27963194|NCT01268046|81698925|FG000|Overall Study|Lost to Follow-up|0|||
27963195|NCT01268046|81698926|FG001|Overall Study|Lost to Follow-up|0|||
27963196|NCT01268046|81698927|FG002|Overall Study|Lost to Follow-up|1|||
27963197|NCT01268046|81698928|FG003|Overall Study|Lost to Follow-up|0|||
27963198|NCT00783835|81698930|FG000|Overall Study|Adverse Event|3|||
27767861|NCT01376245|80977175|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27767862|NCT01376245|80977176|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27767863|NCT01376245|80977177|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27767864|NCT01376245|80977178|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
27767865|NCT01376245|80977174|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
27767866|NCT01376245|80977175|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27767867|NCT01376245|80977176|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27767868|NCT01376245|80977177|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27767869|NCT01376245|80977178|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
27767870|NCT01376245|80977174|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
27767871|NCT01376245|80977175|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27767872|NCT01376245|80977176|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27767873|NCT01376245|80977177|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27767874|NCT01376245|80977178|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
27767875|NCT01376245|80977174|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
27767876|NCT01376245|80977175|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27767877|NCT01376245|80977176|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27767878|NCT01376245|80977177|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27767879|NCT01376245|80977178|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
27767880|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27767881|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
27767882|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
27767883|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
27767884|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
27767885|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27767886|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
27767887|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
27767888|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
27767889|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
27767890|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27767891|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27767892|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27767893|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27767894|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
27767895|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27963199|NCT00783835|81698930|FG000|Overall Study|Medical Criteria|1|||
27963200|NCT00783835|81698930|FG000|Overall Study|Withdrawal by Subject|2|||
27963201|NCT00783835|81698930|FG000|Overall Study|Lost to Follow-up|1|||
27963202|NCT00783835|81698930|FG000|Overall Study|Participant not Adherent|3|||
27963203|NCT01500252|81698931|FG000|Overall Study|Death|4|||
27963204|NCT01500252|81698932|FG001|Overall Study|Death|2|||
27963205|NCT01500252|81698931|FG000|Overall Study|Lost to Follow-up|5|||
27963206|NCT01500252|81698932|FG001|Overall Study|Lost to Follow-up|4|||
27963207|NCT01336712|81698933|FG000|Overall Study|Death|2|||
27963208|NCT01336712|81698933|FG000|Overall Study|Lack of Efficacy|1|||
27963209|NCT04072835|81698937|FG000|Overall Study|Overall trial ended|603|||
27963210|NCT04072835|81698937|FG000|Overall Study|Ablation|97|||
27963211|NCT04072835|81698937|FG000|Overall Study|Withdrawal of consent|66|||
27963212|NCT04072835|81698937|FG000|Overall Study|Physician Decision|50|||
27963213|NCT04072835|81698937|FG000|Overall Study|Lost to Follow-up|39|||
27963214|NCT04072835|81698937|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
27963215|NCT04072835|81698937|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
27963216|NCT04072835|81698937|FG000|Overall Study|Adverse Event|25|||
27963217|NCT04072835|81698937|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
27963218|NCT04072835|81698937|FG000|Overall Study|Death|11|||
27963219|NCT04072835|81698937|FG000|Overall Study|Participant felt the drug did not work|8|||
27963220|NCT04072835|81698937|FG000|Overall Study|Participant tolerability|5|||
27963221|NCT04072835|81698937|FG000|Overall Study|Missing|5|||
27963222|NCT04072835|81698937|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
27963223|NCT04072835|81698937|FG000|Overall Study|Pregnancy|3|||
27963224|NCT00260832|81698938|FG000|Overall Study|Adverse Event|26|||
27963225|NCT00260832|81698939|FG001|Overall Study|Adverse Event|19|||
27963226|NCT00260832|81698938|FG000|Overall Study|Progression|116|||
27963227|NCT00260832|81698939|FG001|Overall Study|Progression|96|||
27963228|NCT00260832|81698938|FG000|Overall Study|Withdrawal by Subject|15|||
27963229|NCT00260832|81698939|FG001|Overall Study|Withdrawal by Subject|17|||
27963230|NCT00260832|81698938|FG000|Overall Study|Physician Decision|15|||
27963231|NCT00260832|81698939|FG001|Overall Study|Physician Decision|9|||
27963232|NCT00260832|81698938|FG000|Overall Study|Death|43|||
27963233|NCT00260832|81698939|FG001|Overall Study|Death|62|||
27963234|NCT00260832|81698938|FG000|Overall Study|Other|10|||
27963235|NCT00260832|81698939|FG001|Overall Study|Other|7|||
27963236|NCT00260832|81698938|FG000|Overall Study|Protocol Violation|3|||
27963237|NCT00260832|81698939|FG001|Overall Study|Protocol Violation|1|||
27963238|NCT02998671|81698940|FG000|Period 1|Study Terminated By Sponsor|2|||
27963239|NCT02998671|81698941|FG001|Period 1|Study Terminated By Sponsor|1|||
27963240|NCT02998671|81698942|FG002|Period 1|Study Terminated By Sponsor|0|||
27963241|NCT02998671|81698943|FG003|Period 1|Study Terminated By Sponsor|0|||
27963242|NCT02998671|81698944|FG004|Period 1|Study Terminated By Sponsor|1|||
27963243|NCT02998671|81698940|FG000|Period 1|Withdrawal by Subject|1|||
27963244|NCT02998671|81698941|FG001|Period 1|Withdrawal by Subject|2|||
27963245|NCT02998671|81698942|FG002|Period 1|Withdrawal by Subject|0|||
27963246|NCT02998671|81698943|FG003|Period 1|Withdrawal by Subject|0|||
27663878|NCT00760877|80606548|FG000|Overall Study|Participant diagnosed with AML|0|||
27663879|NCT00760877|80606549|FG001|Overall Study|Participant diagnosed with AML|1|||
27663880|NCT00760877|80606548|FG000|Overall Study|Participant not eligible to cross-over|0|||
27663881|NCT00760877|80606549|FG001|Overall Study|Participant not eligible to cross-over|1|||
27663882|NCT00760877|80606548|FG000|Overall Study|Physician Decision|1|||
27663883|NCT00760877|80606549|FG001|Overall Study|Physician Decision|2|||
27663884|NCT00760877|80606548|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
27663885|NCT00760877|80606549|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
27663886|NCT00760877|80606548|FG000|Overall Study|Treatment failure|1|||
27663887|NCT00760877|80606549|FG001|Overall Study|Treatment failure|0|||
27963247|NCT02998671|81698944|FG004|Period 1|Withdrawal by Subject|2|||
27963248|NCT02998671|81698940|FG000|Period 1|Pregnancy|1|||
27569001|NCT02658890|80271483|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
27963249|NCT02998671|81698941|FG001|Period 1|Pregnancy|0|||
27963250|NCT02998671|81698942|FG002|Period 1|Pregnancy|0|||
27663888|NCT00931918|80606553|FG000|Overall Study|Adverse Event|4|||
27663889|NCT00931918|80606554|FG001|Overall Study|Adverse Event|6|||
27663890|NCT00931918|80606553|FG000|Overall Study|Progressive Disease|2|||
27963251|NCT02998671|81698943|FG003|Period 1|Pregnancy|0|||
27963252|NCT02998671|81698944|FG004|Period 1|Pregnancy|0|||
27963253|NCT02998671|81698940|FG000|Period 1|Adverse Event|0|||
27767896|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
27767897|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
27767898|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
27767899|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27767900|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27767901|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27767902|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27767903|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27767904|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27767905|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27767906|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
27767907|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
27767908|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
27767909|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
27767910|NCT01376245|80977174|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27767911|NCT01376245|80977175|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
27767912|NCT01376245|80977176|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27767913|NCT01376245|80977177|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
27767914|NCT01376245|80977178|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
27767915|NCT00565812|80977186|FG000|Overall Study|Death|2|||
27767916|NCT00565812|80977187|FG001|Overall Study|Death|1|||
27767917|NCT00565812|80977188|FG002|Overall Study|Death|3|||
27767918|NCT00565812|80977186|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
27767919|NCT00565812|80977187|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
27767920|NCT00565812|80977188|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
27767921|NCT00565812|80977186|FG000|Overall Study|Lost to Follow-up|10|||
27767922|NCT00565812|80977187|FG001|Overall Study|Lost to Follow-up|8|||
27767923|NCT00565812|80977188|FG002|Overall Study|Lost to Follow-up|8|||
27767924|NCT00565812|80977186|FG000|Overall Study|Withdrawal by Subject|58|||
27767925|NCT00565812|80977187|FG001|Overall Study|Withdrawal by Subject|47|||
27767926|NCT00565812|80977188|FG002|Overall Study|Withdrawal by Subject|48|||
27767927|NCT00565812|80977186|FG000|Overall Study|Work Schedule|5|||
27767928|NCT00565812|80977187|FG001|Overall Study|Work Schedule|3|||
27767929|NCT00565812|80977188|FG002|Overall Study|Work Schedule|1|||
27767930|NCT00565812|80977186|FG000|Overall Study|Protocol Violation|2|||
27767931|NCT00565812|80977187|FG001|Overall Study|Protocol Violation|6|||
27767932|NCT00565812|80977188|FG002|Overall Study|Protocol Violation|4|||
27767933|NCT00565812|80977186|FG000|Overall Study|Adverse Event|41|||
27767934|NCT00565812|80977187|FG001|Overall Study|Adverse Event|54|||
27767935|NCT00565812|80977188|FG002|Overall Study|Adverse Event|40|||
27767936|NCT00565812|80977186|FG000|Overall Study|Jury Duty|1|||
27767937|NCT00565812|80977187|FG001|Overall Study|Jury Duty|0|||
27767938|NCT00565812|80977188|FG002|Overall Study|Jury Duty|0|||
27767939|NCT00565812|80977186|FG000|Overall Study|Relocated Out of Area|5|||
27767940|NCT00565812|80977187|FG001|Overall Study|Relocated Out of Area|8|||
27767941|NCT00565812|80977188|FG002|Overall Study|Relocated Out of Area|9|||
27767942|NCT00565812|80977186|FG000|Overall Study|Sponsor Decision|1|||
27767943|NCT00565812|80977187|FG001|Overall Study|Sponsor Decision|5|||
27767944|NCT00565812|80977188|FG002|Overall Study|Sponsor Decision|1|||
27963254|NCT02998671|81698941|FG001|Period 1|Adverse Event|0|||
27963255|NCT02998671|81698942|FG002|Period 1|Adverse Event|0|||
27963256|NCT02998671|81698943|FG003|Period 1|Adverse Event|0|||
27963257|NCT02998671|81698944|FG004|Period 1|Adverse Event|1|||
27767945|NCT00565812|80977186|FG000|Overall Study|Domestic Reasons|7|||
27767946|NCT00565812|80977187|FG001|Overall Study|Domestic Reasons|1|||
27767947|NCT00565812|80977188|FG002|Overall Study|Domestic Reasons|3|||
27767948|NCT00565812|80977186|FG000|Overall Study|Research Site Closure|6|||
27767949|NCT00565812|80977187|FG001|Overall Study|Research Site Closure|1|||
27767950|NCT00565812|80977188|FG002|Overall Study|Research Site Closure|8|||
27767951|NCT00565812|80977186|FG000|Overall Study|Surgical Intervention|0|||
27767952|NCT00565812|80977187|FG001|Overall Study|Surgical Intervention|1|||
27767953|NCT00565812|80977188|FG002|Overall Study|Surgical Intervention|2|||
27767954|NCT00565812|80977186|FG000|Overall Study|Low Compliance|1|||
27767955|NCT00565812|80977187|FG001|Overall Study|Low Compliance|0|||
27767956|NCT00565812|80977188|FG002|Overall Study|Low Compliance|1|||
27767957|NCT00565812|80977186|FG000|Overall Study|Follow-up Visit Not Completed|2|||
27767958|NCT00565812|80977187|FG001|Overall Study|Follow-up Visit Not Completed|0|||
27767959|NCT00565812|80977188|FG002|Overall Study|Follow-up Visit Not Completed|1|||
27767960|NCT00565812|80977186|FG000|Overall Study|Physician Decision|2|||
27767961|NCT00565812|80977187|FG001|Overall Study|Physician Decision|0|||
27663891|NCT00931918|80606554|FG001|Overall Study|Progressive Disease|1|||
27767962|NCT00565812|80977188|FG002|Overall Study|Physician Decision|0|||
27963258|NCT02998671|81698940|FG000|Period 2|Adverse Event|0|||
27963259|NCT02998671|81698941|FG001|Period 2|Adverse Event|1|||
27767963|NCT00753623|80977189|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
27767964|NCT00753623|80977190|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
27767965|NCT00753623|80977189|FG000|Phase I (14 Days)|Physician Decision|1|||
27767966|NCT00753623|80977190|FG001|Phase I (14 Days)|Physician Decision|2|||
27767967|NCT00753623|80977189|FG000|Phase I (14 Days)|Adverse Event|0|||
27767968|NCT00753623|80977190|FG001|Phase I (14 Days)|Adverse Event|1|||
27767969|NCT00753623|80977189|FG000|Washout (7 Days)|Physician Decision|1|||
27767970|NCT00753623|80977190|FG001|Washout (7 Days)|Physician Decision|0|||
27767971|NCT00753623|80977189|FG000|Phase II (14 Days)|Physician Decision|0|||
27767972|NCT00753623|80977190|FG001|Phase II (14 Days)|Physician Decision|1|||
27767973|NCT00656084|80977191|FG000|Overall Study|Adverse Event|4|||
27767974|NCT00656084|80977191|FG000|Overall Study|Withdrawal by Subject|1|||
27767975|NCT00656084|80977191|FG000|Overall Study|Patient Request|1|||
27767976|NCT00656084|80977191|FG000|Overall Study|Investigator Request|1|||
27767977|NCT00712933|80979984|FG000|Overall Study|Adverse Event|69|||
27767978|NCT00712933|80979984|FG000|Overall Study|Lack of Efficacy|6|||
27767979|NCT00712933|80979984|FG000|Overall Study|Lost to Follow-up|22|||
27767980|NCT00712933|80979984|FG000|Overall Study|Non-compliance with study drug|13|||
27767981|NCT00712933|80979984|FG000|Overall Study|Other Pregnancy|37|||
27767982|NCT00712933|80979984|FG000|Overall Study|Sponsor decision|14|||
27767983|NCT00712933|80979984|FG000|Overall Study|Withdrew consent|4|||
27767984|NCT00712933|80979984|FG000|Overall Study|Hip replacement surgery|1|||
27767985|NCT00712933|80979984|FG000|Overall Study|Involved in Clinical research|3|||
27767986|NCT00712933|80979984|FG000|Overall Study|Participant hospitalized|1|||
27767987|NCT00712933|80979984|FG000|Overall Study|Participant travelled overseas|2|||
27767988|NCT00712933|80979984|FG000|Overall Study|Death of patient|1|||
27767989|NCT00712933|80979984|FG000|Overall Study|Other Physician decision|1|||
27767990|NCT00712933|80979984|FG000|Overall Study|Not committed to contraception|1|||
27767991|NCT00712933|80979984|FG000|Overall Study|Participant received medication|1|||
27767992|NCT00712933|80979984|FG000|Overall Study|Physician Decision|36|||
27767993|NCT00712933|80979984|FG000|Overall Study|Protocol Violation|4|||
27767994|NCT00712933|80979984|FG000|Overall Study|Withdrawal by Subject|151|||
27767995|NCT00814307|80979985|FG000|Overall Study|Randomized but not treated|1|||
27767996|NCT00814307|80979986|FG001|Overall Study|Randomized but not treated|0|||
27767997|NCT00814307|80979987|FG002|Overall Study|Randomized but not treated|0|||
27767998|NCT00814307|80979988|FG003|Overall Study|Randomized but not treated|0|||
27767999|NCT00814307|80979985|FG000|Overall Study|Adverse Event|3|||
27768000|NCT00814307|80979986|FG001|Overall Study|Adverse Event|9|||
27768001|NCT00814307|80979987|FG002|Overall Study|Adverse Event|3|||
27768002|NCT00814307|80979988|FG003|Overall Study|Adverse Event|2|||
27768003|NCT00814307|80979985|FG000|Overall Study|Lack of Efficacy|1|||
27768004|NCT00814307|80979986|FG001|Overall Study|Lack of Efficacy|1|||
27768005|NCT00814307|80979987|FG002|Overall Study|Lack of Efficacy|3|||
27768006|NCT00814307|80979988|FG003|Overall Study|Lack of Efficacy|4|||
27768007|NCT00814307|80979985|FG000|Overall Study|Other|1|||
27768008|NCT00814307|80979986|FG001|Overall Study|Other|2|||
27768009|NCT00814307|80979987|FG002|Overall Study|Other|0|||
27768010|NCT00814307|80979988|FG003|Overall Study|Other|1|||
27768011|NCT00814307|80979985|FG000|Overall Study|Protocol Violation|2|||
27768012|NCT00814307|80979986|FG001|Overall Study|Protocol Violation|8|||
27768013|NCT00814307|80979987|FG002|Overall Study|Protocol Violation|1|||
27768014|NCT00814307|80979988|FG003|Overall Study|Protocol Violation|1|||
27768015|NCT00814307|80979985|FG000|Overall Study|Withdrawal by Subject|4|||
27768016|NCT00814307|80979986|FG001|Overall Study|Withdrawal by Subject|6|||
27768017|NCT00814307|80979987|FG002|Overall Study|Withdrawal by Subject|0|||
27768018|NCT00814307|80979988|FG003|Overall Study|Withdrawal by Subject|2|||
27768019|NCT00814307|80979985|FG000|Overall Study|Death|0|||
27768020|NCT00814307|80979986|FG001|Overall Study|Death|1|||
27768021|NCT00814307|80979987|FG002|Overall Study|Death|0|||
27768022|NCT00814307|80979988|FG003|Overall Study|Death|0|||
27768023|NCT03970824|80979989|FG000|Overall Study|Withdrawal by Subject|1|||
27768024|NCT03970824|80979990|FG001|Overall Study|Withdrawal by Subject|1|||
27768025|NCT03970824|80979991|FG002|Overall Study|Withdrawal by Subject|3|||
27768026|NCT03970824|80979989|FG000|Overall Study|Lost to Follow-up|0|||
27768027|NCT03970824|80979990|FG001|Overall Study|Lost to Follow-up|2|||
27768028|NCT03970824|80979991|FG002|Overall Study|Lost to Follow-up|1|||
27768029|NCT03970824|80979989|FG000|Overall Study|Adverse Event|1|||
27768030|NCT03970824|80979990|FG001|Overall Study|Adverse Event|0|||
27768031|NCT03970824|80979991|FG002|Overall Study|Adverse Event|0|||
27768032|NCT01176240|80979992|FG000|Study 306A|Lack of Efficacy|2|||
27768033|NCT01176240|80979993|FG001|Study 306A|Lack of Efficacy|1|||
27768034|NCT01176240|80979992|FG000|Study 306A|Protocol Violation|0|||
27768035|NCT01176240|80979993|FG001|Study 306A|Protocol Violation|1|||
27768036|NCT01176240|80979992|FG000|Study 306A|Withdrawal by Subject|0|||
27768037|NCT01176240|80979993|FG001|Study 306A|Withdrawal by Subject|1|||
27768038|NCT01176240|80979992|FG000|Study 306A|Stop due to diverse problems|1|||
27768039|NCT01176240|80979993|FG001|Study 306A|Stop due to diverse problems|0|||
27768040|NCT01176240|80979992|FG000|Study 306B|Lack of Efficacy|5|||
27768041|NCT01176240|80979993|FG001|Study 306B|Lack of Efficacy|3|||
27963260|NCT02998671|81698942|FG002|Period 2|Adverse Event|0|||
27963261|NCT02998671|81698943|FG003|Period 2|Adverse Event|0|||
27963262|NCT02998671|81698944|FG004|Period 2|Adverse Event|0|||
27963263|NCT02998671|81698940|FG000|Period 2|Study Terminated By Sponsor|3|||
27963264|NCT02998671|81698941|FG001|Period 2|Study Terminated By Sponsor|5|||
27963265|NCT02998671|81698942|FG002|Period 2|Study Terminated By Sponsor|1|||
27963266|NCT02998671|81698943|FG003|Period 2|Study Terminated By Sponsor|3|||
27963267|NCT02998671|81698944|FG004|Period 2|Study Terminated By Sponsor|0|||
27963268|NCT02998671|81698940|FG000|Period 2|Withdrawal by Subject|0|||
27963269|NCT02998671|81698941|FG001|Period 2|Withdrawal by Subject|1|||
27963270|NCT02998671|81698942|FG002|Period 2|Withdrawal by Subject|0|||
27963271|NCT02998671|81698943|FG003|Period 2|Withdrawal by Subject|0|||
27963272|NCT02998671|81698944|FG004|Period 2|Withdrawal by Subject|0|||
27963273|NCT02998671|81698940|FG000|Period 2|Lost to Follow-up|0|||
27963274|NCT02998671|81698941|FG001|Period 2|Lost to Follow-up|0|||
27963275|NCT02998671|81698942|FG002|Period 2|Lost to Follow-up|0|||
27768042|NCT01176240|80979992|FG000|Study 306B|Adverse Event|10|||
27768043|NCT01176240|80979993|FG001|Study 306B|Adverse Event|5|||
27768044|NCT01176240|80979992|FG000|Study 306B|Protocol Violation|2|||
27768045|NCT01176240|80979993|FG001|Study 306B|Protocol Violation|3|||
27768046|NCT01176240|80979992|FG000|Study 306B|Withdrawal by Subject|4|||
27768047|NCT01176240|80979993|FG001|Study 306B|Withdrawal by Subject|1|||
27768048|NCT01176240|80979992|FG000|Study 306B|Physician Decision|2|||
27768049|NCT01176240|80979993|FG001|Study 306B|Physician Decision|1|||
27768050|NCT01176240|80979992|FG000|Study 306B|Supine Hypertension|1|||
27768051|NCT01176240|80979993|FG001|Study 306B|Supine Hypertension|2|||
27768052|NCT01176240|80979992|FG000|Study 306B|Lost to Follow-up|0|||
27768053|NCT01176240|80979993|FG001|Study 306B|Lost to Follow-up|1|||
27768054|NCT01176240|80979992|FG000|Study 306B|withdrew prior to dosing|2|||
27768055|NCT01176240|80979993|FG001|Study 306B|withdrew prior to dosing|1|||
27768056|NCT01587274|80979995|FG000|Overall Study|Lost to Follow-up|4|||
27768057|NCT01587274|80979996|FG001|Overall Study|Lost to Follow-up|5|||
27768058|NCT01587274|80979997|FG002|Overall Study|Lost to Follow-up|3|||
27768059|NCT01665768|80980007|FG000|Overall Study|Adverse Event|3|||
27768060|NCT01665768|80980007|FG000|Overall Study|Lack of Efficacy|19|||
27768061|NCT01665768|80980007|FG000|Overall Study|Withdrawal by Subject|1|||
27768062|NCT04362813|80980011|FG000|Overall Study|Death|12|||
27768063|NCT04362813|80980012|FG001|Overall Study|Death|16|||
27768064|NCT04362813|80980011|FG000|Overall Study|Withdrawal by Subject|3|||
27768065|NCT04362813|80980012|FG001|Overall Study|Withdrawal by Subject|1|||
27768066|NCT04362813|80980011|FG000|Overall Study|Protocol Violation|0|||
27768067|NCT04362813|80980012|FG001|Overall Study|Protocol Violation|3|||
27768068|NCT04362813|80980011|FG000|Overall Study|Lost to Follow-up|1|||
27768069|NCT04362813|80980012|FG001|Overall Study|Lost to Follow-up|1|||
27768070|NCT04362813|80980011|FG000|Overall Study|Enrolled but did not receive treatment|2|||
27768071|NCT04362813|80980012|FG001|Overall Study|Enrolled but did not receive treatment|4|||
27768072|NCT03947255|80980013|FG000|Overall Study|Study Closure by Sponsor|2|||
27768073|NCT03947255|80980014|FG001|Overall Study|Study Closure by Sponsor|2|||
27768074|NCT03947255|80980013|FG000|Overall Study|Withdrawal by Subject|2|||
27768075|NCT03947255|80980014|FG001|Overall Study|Withdrawal by Subject|2|||
27768076|NCT03947255|80980013|FG000|Overall Study|Lost to Follow-up|2|||
27768077|NCT03947255|80980014|FG001|Overall Study|Lost to Follow-up|0|||
27768078|NCT03947255|80980013|FG000|Overall Study|Death|0|||
27768079|NCT03947255|80980014|FG001|Overall Study|Death|2|||
27768080|NCT01711541|80980015|FG000|Overall Study|Cancel prior to treatment|0|||
27768081|NCT01711541|80980016|FG001|Overall Study|Cancel prior to treatment|0|||
27768082|NCT01711541|80980017|FG002|Overall Study|Cancel prior to treatment|0|||
27768083|NCT01711541|80980018|FG003|Overall Study|Cancel prior to treatment|1|||
27768084|NCT01711541|80980019|FG004|Overall Study|Cancel prior to treatment|0|||
27768085|NCT01711541|80980015|FG000|Overall Study|Ineligible|0|||
27768086|NCT01711541|80980016|FG001|Overall Study|Ineligible|1|||
27768087|NCT01711541|80980017|FG002|Overall Study|Ineligible|0|||
27768088|NCT01711541|80980018|FG003|Overall Study|Ineligible|0|||
27768089|NCT01711541|80980019|FG004|Overall Study|Ineligible|0|||
27768090|NCT02443805|80980025|FG000|Overall Study|Adverse Event|100|||
27768091|NCT02443805|80980026|FG001|Overall Study|Adverse Event|18|||
27963276|NCT02998671|81698943|FG003|Period 2|Lost to Follow-up|1|||
27768092|NCT02443805|80980025|FG000|Overall Study|Withdrawal by Subject|73|||
27768093|NCT02443805|80980026|FG001|Overall Study|Withdrawal by Subject|74|||
27768094|NCT02443805|80980025|FG000|Overall Study|Lost to Follow-up|19|||
27768095|NCT02443805|80980026|FG001|Overall Study|Lost to Follow-up|14|||
27768096|NCT02443805|80980025|FG000|Overall Study|Pregnancy|6|||
27963277|NCT02998671|81698944|FG004|Period 2|Lost to Follow-up|0|||
27963278|NCT04482439|81698948|FG000|Overall Study|Lost to Follow-up|1|||
27768097|NCT02443805|80980026|FG001|Overall Study|Pregnancy|5|||
27768098|NCT02443805|80980025|FG000|Overall Study|Protocol Violation|2|||
27768099|NCT02443805|80980026|FG001|Overall Study|Protocol Violation|4|||
27768100|NCT02443805|80980025|FG000|Overall Study|Lack of Efficacy|1|||
27963279|NCT04482439|81698948|FG000|Overall Study|Unrelated illness|1|||
27963280|NCT01642901|81698949|FG000|12-month Follow-up|Withdrawal by Subject|1|||
27963281|NCT01642901|81698950|FG001|12-month Follow-up|Withdrawal by Subject|0|||
27963282|NCT02520388|81698951|FG000|Overall Study|Physician Decision|1|||
27963283|NCT02520388|81698952|FG001|Overall Study|Physician Decision|0|||
27963284|NCT02520388|81698951|FG000|Overall Study|Subject or parent/guardian request|0|||
27963285|NCT02520388|81698952|FG001|Overall Study|Subject or parent/guardian request|6|||
27963286|NCT02520388|81698951|FG000|Overall Study|Adverse Event|1|||
27963287|NCT02520388|81698952|FG001|Overall Study|Adverse Event|4|||
27963288|NCT02520388|81698951|FG000|Overall Study|Lost to Follow-up|3|||
27963289|NCT02520388|81698952|FG001|Overall Study|Lost to Follow-up|2|||
27963290|NCT02520388|81698951|FG000|Overall Study|Other (reason not defined)|4|||
27963291|NCT02520388|81698952|FG001|Overall Study|Other (reason not defined)|4|||
27963292|NCT02253433|81698953|FG000|Overall Study|Unable to Contact|9|||
27963293|NCT02253433|81698954|FG001|Overall Study|Unable to Contact|16|||
27963294|NCT02253433|81698953|FG000|Overall Study|Death|1|||
27963295|NCT02253433|81698954|FG001|Overall Study|Death|1|||
27963296|NCT02253433|81698953|FG000|Overall Study|No Longer Interested|3|||
27963297|NCT02253433|81698954|FG001|Overall Study|No Longer Interested|15|||
27963298|NCT02253433|81698953|FG000|Overall Study|Out of Study Area|2|||
27963299|NCT02253433|81698954|FG001|Overall Study|Out of Study Area|7|||
27963300|NCT02253433|81698953|FG000|Overall Study|Uncomfortable with home visitors|0|||
27963301|NCT02253433|81698954|FG001|Overall Study|Uncomfortable with home visitors|3|||
27963302|NCT02253433|81698953|FG000|Overall Study|Unstable Housing/Homeless|0|||
27963303|NCT02253433|81698954|FG001|Overall Study|Unstable Housing/Homeless|7|||
27963304|NCT02253433|81698953|FG000|Overall Study|Too Busy|0|||
27963305|NCT02253433|81698954|FG001|Overall Study|Too Busy|4|||
27963306|NCT02253433|81698953|FG000|Overall Study|Medical or Other Concerns|1|||
27963307|NCT02253433|81698954|FG001|Overall Study|Medical or Other Concerns|2|||
27963308|NCT00500357|81698955|FG000|Overall Study|Death|1|||
27963309|NCT02565147|81698956|FG000|Overall Study|Withdrawal by Subject|5|||
27963310|NCT02565147|81698957|FG001|Overall Study|Withdrawal by Subject|1|||
27963311|NCT02565147|81698956|FG000|Overall Study|Lost to Follow-up|0|||
27963312|NCT02565147|81698957|FG001|Overall Study|Lost to Follow-up|1|||
27963313|NCT02565147|81698956|FG000|Overall Study|Death|1|||
27963314|NCT02565147|81698957|FG001|Overall Study|Death|1|||
27963315|NCT02388165|81698958|FG000|Overall Study|Study terminated by sponsor|5|||
27963316|NCT02388165|81698959|FG001|Overall Study|Study terminated by sponsor|5|||
27963317|NCT02388165|81698958|FG000|Overall Study|Other|11|||
27963318|NCT02388165|81698959|FG001|Overall Study|Other|13|||
27963319|NCT02388165|81698958|FG000|Overall Study|No longer meet eligibility criteria|40|||
27963320|NCT02388165|81698959|FG001|Overall Study|No longer meet eligibility criteria|43|||
27963321|NCT02388165|81698958|FG000|Overall Study|Withdrawal of consent|31|||
27963322|NCT02388165|81698959|FG001|Overall Study|Withdrawal of consent|32|||
27963323|NCT02388165|81698958|FG000|Overall Study|Lost to Follow-up|19|||
27963324|NCT02388165|81698959|FG001|Overall Study|Lost to Follow-up|20|||
27768101|NCT02443805|80980026|FG001|Overall Study|Lack of Efficacy|1|||
27768102|NCT02443805|80980025|FG000|Overall Study|Non-compliance with study drug|6|||
27768103|NCT02443805|80980026|FG001|Overall Study|Non-compliance with study drug|4|||
27768104|NCT02443805|80980025|FG000|Overall Study|Withdrawal by parent/guardian|3|||
27768105|NCT02443805|80980026|FG001|Overall Study|Withdrawal by parent/guardian|5|||
27768106|NCT02443805|80980025|FG000|Overall Study|Any other reason not above-mentioned|3|||
27768107|NCT02443805|80980026|FG001|Overall Study|Any other reason not above-mentioned|2|||
27768108|NCT03170258|80980029|FG000|Overall Study|Physician Decision|4|||
27768109|NCT03170258|80980030|FG001|Overall Study|Physician Decision|0|||
27768110|NCT03170258|80980029|FG000|Overall Study|Equipment issues|1|||
27768111|NCT03170258|80980030|FG001|Overall Study|Equipment issues|0|||
27768112|NCT03170258|80980029|FG000|Overall Study|Medication|1|||
27768113|NCT03170258|80980030|FG001|Overall Study|Medication|0|||
27768114|NCT03170258|80980029|FG000|Overall Study|Sleep issues|1|||
27963325|NCT02388165|81698958|FG000|Overall Study|Death|13|||
27963326|NCT02388165|81698959|FG001|Overall Study|Death|10|||
27963327|NCT02388165|81698958|FG000|Overall Study|Adverse Event|3|||
27963328|NCT02388165|81698959|FG001|Overall Study|Adverse Event|5|||
27963329|NCT02388165|81698958|FG000|Overall Study|Did not meet entrance criteria|5|||
27963330|NCT02388165|81698959|FG001|Overall Study|Did not meet entrance criteria|2|||
27963331|NCT00104728|81698962|FG000|Overall Study|screen failures|19|||
27963332|NCT00778336|81698965|FG000|Index Procedure-Discharge|Death|6|||
27963333|NCT00778336|81698966|FG001|Index Procedure-Discharge|Death|3|||
27963334|NCT00778336|81698967|FG002|Index Procedure-Discharge|Death|2|||
27963335|NCT00778336|81698968|FG003|Index Procedure-Discharge|Death|0|||
27768115|NCT03170258|80980030|FG001|Overall Study|Sleep issues|0|||
27768116|NCT00407550|80980034|FG000|Overall Study|Adverse Event|0|||
27768117|NCT00407550|80980035|FG001|Overall Study|Adverse Event|1|||
27768118|NCT00407550|80980034|FG000|Overall Study|Withdrawal by Subject|0|||
27768119|NCT00407550|80980035|FG001|Overall Study|Withdrawal by Subject|2|||
27768120|NCT00407550|80980034|FG000|Overall Study|Death|1|||
27963336|NCT00778336|81698965|FG000|3 Month Follow Up|Lost to Follow-up|15|||
27963337|NCT00778336|81698966|FG001|3 Month Follow Up|Lost to Follow-up|20|||
27768121|NCT00407550|80980035|FG001|Overall Study|Death|0|||
27768122|NCT00407550|80980034|FG000|Overall Study|Insurance or Other medical condition|2|||
27768123|NCT00407550|80980035|FG001|Overall Study|Insurance or Other medical condition|1|||
27768124|NCT00105183|80980037|FG000|Overall Study|Death|19|||
27768125|NCT00105183|80980038|FG001|Overall Study|Death|13|||
27768126|NCT00105183|80980039|FG002|Overall Study|Death|15|||
27768127|NCT00105183|80980037|FG000|Overall Study|Withdrawal by Subject|1|||
27768128|NCT00105183|80980038|FG001|Overall Study|Withdrawal by Subject|1|||
27768129|NCT00105183|80980039|FG002|Overall Study|Withdrawal by Subject|4|||
27768130|NCT00105183|80980037|FG000|Overall Study|Physician Decision|1|||
27768131|NCT00105183|80980038|FG001|Overall Study|Physician Decision|2|||
27768132|NCT00105183|80980039|FG002|Overall Study|Physician Decision|3|||
27768133|NCT00105183|80980037|FG000|Overall Study|Lost to Follow-up|0|||
27768134|NCT00105183|80980038|FG001|Overall Study|Lost to Follow-up|1|||
27768135|NCT00105183|80980039|FG002|Overall Study|Lost to Follow-up|1|||
27768136|NCT00105183|80980037|FG000|Overall Study|Other reason|1|||
27768137|NCT00105183|80980038|FG001|Overall Study|Other reason|2|||
27768138|NCT00105183|80980039|FG002|Overall Study|Other reason|0|||
27768139|NCT02204410|80980050|FG000|Overall Study|Lost to Follow-up|5|||
27768140|NCT02204410|80980050|FG000|Overall Study|Physician Decision|2|||
27768141|NCT02204410|80980050|FG000|Overall Study|Protocol Violation|1|||
27768142|NCT02204410|80980050|FG000|Overall Study|Withdrawal by Subject|3|||
27768143|NCT02197897|80980051|FG000|Overall Study|not eligible|1|||
27768144|NCT01146951|80980059|FG000|Overall Study|Adverse Event|4|||
27768145|NCT01146951|80980060|FG001|Overall Study|Adverse Event|1|||
27768146|NCT00810810|80980061|FG000|Overall Study|Withdrawal by Subject|0|||
27768147|NCT00810810|80980062|FG001|Overall Study|Withdrawal by Subject|8|||
27768148|NCT00810810|80980063|FG002|Overall Study|Withdrawal by Subject|10|||
27768149|NCT00810810|80980064|FG003|Overall Study|Withdrawal by Subject|8|||
27768150|NCT00810810|80980061|FG000|Overall Study|Physician Decision|0|||
27768151|NCT00810810|80980062|FG001|Overall Study|Physician Decision|3|||
27768152|NCT00810810|80980063|FG002|Overall Study|Physician Decision|1|||
27768153|NCT00810810|80980064|FG003|Overall Study|Physician Decision|5|||
27768154|NCT02768103|80980067|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
27768155|NCT04038385|80980072|FG000|Overall Study|Completed baseline assessment only|7|||
27768156|NCT04038385|80980073|FG001|Overall Study|Completed baseline assessment only|4|||
27768157|NCT04038385|80980072|FG000|Overall Study|Moved out of area|4|||
27768158|NCT04038385|80980073|FG001|Overall Study|Moved out of area|2|||
27768159|NCT04038385|80980072|FG000|Overall Study|Discontinued study involvement|6|||
27768160|NCT04038385|80980073|FG001|Overall Study|Discontinued study involvement|1|||
27768161|NCT03168555|80980074|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
27768162|NCT03168555|80980074|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
27768163|NCT03168555|80980074|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
27768164|NCT03168555|80980074|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
27768165|NCT01906476|80980075|FG000|Overall Study|Lost to Follow-up|17|||
27768166|NCT01906476|80980076|FG001|Overall Study|Lost to Follow-up|16|||
27768167|NCT00441480|80980083|FG000|Overall Study|Protocol Violation|1|||
27768168|NCT00441480|80980084|FG001|Overall Study|Protocol Violation|1|||
27768169|NCT00441480|80980083|FG000|Overall Study|Withdrawal by Subject|2|||
27768170|NCT00441480|80980084|FG001|Overall Study|Withdrawal by Subject|3|||
27768171|NCT00212758|80980085|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
27768172|NCT00212758|80980086|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
27768173|NCT00212758|80980085|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
27768174|NCT00212758|80980086|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
27768175|NCT02693691|80980087|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
27768176|NCT02693691|80980087|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
27768177|NCT02693691|80980087|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
27768178|NCT02693691|80980087|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
27768179|NCT02693691|80980087|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
27768180|NCT02693691|80980087|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
27768181|NCT02693691|80980087|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
27768182|NCT00439725|80980088|FG000|Treatment Period|Withdrawal by Subject|22|||
27768183|NCT00439725|80980089|FG001|Treatment Period|Withdrawal by Subject|19|||
27768184|NCT00439725|80980088|FG000|Treatment Period|Study terminated by sponsor|156|||
27768185|NCT00439725|80980089|FG001|Treatment Period|Study terminated by sponsor|148|||
27768186|NCT00439725|80980088|FG000|Treatment Period|Site closed by investigator|1|||
27768187|NCT00439725|80980089|FG001|Treatment Period|Site closed by investigator|2|||
27768188|NCT00439725|80980088|FG000|Treatment Period|Adverse Event|39|||
27768189|NCT00439725|80980089|FG001|Treatment Period|Adverse Event|18|||
27768190|NCT00439725|80980088|FG000|Treatment Period|Physician Decision|1|||
27768191|NCT00439725|80980089|FG001|Treatment Period|Physician Decision|1|||
27768192|NCT00439725|80980088|FG000|Treatment Period|Protocol Violation|2|||
27768193|NCT00439725|80980089|FG001|Treatment Period|Protocol Violation|1|||
27768194|NCT00439725|80980088|FG000|Treatment Period|Clinical endpoint reached|6|||
27768195|NCT00439725|80980089|FG001|Treatment Period|Clinical endpoint reached|50|||
27768196|NCT00439725|80980088|FG000|Treatment Period|Technical problems|1|||
27768197|NCT00439725|80980089|FG001|Treatment Period|Technical problems|0|||
27768198|NCT00439725|80980088|FG000|Treatment Period|Lost to Follow-up|1|||
27768199|NCT00439725|80980089|FG001|Treatment Period|Lost to Follow-up|1|||
27768200|NCT00439725|80980088|FG000|Treatment Period|Participant convenience|1|||
27768201|NCT00439725|80980089|FG001|Treatment Period|Participant convenience|0|||
27768202|NCT00439725|80980088|FG000|Treatment Period|Protocol driven decision point|1|||
27768203|NCT00439725|80980089|FG001|Treatment Period|Protocol driven decision point|1|||
27768204|NCT00439725|80980088|FG000|Treatment Period|Death|1|||
27768205|NCT00439725|80980089|FG001|Treatment Period|Death|1|||
27768206|NCT00439725|80980088|FG000|Treatment Period|Participant did not receive treatment|4|||
27768207|NCT00439725|80980089|FG001|Treatment Period|Participant did not receive treatment|4|||
27768208|NCT00439725|80980088|FG000|Observational Period|Withdrawal by Subject|2|||
27768209|NCT00439725|80980089|FG001|Observational Period|Withdrawal by Subject|2|||
27768210|NCT00439725|80980088|FG000|Observational Period|Lost to Follow-up|0|||
27768211|NCT00439725|80980089|FG001|Observational Period|Lost to Follow-up|1|||
27768212|NCT00439725|80980088|FG000|Observational Period|Death|0|||
27768213|NCT00439725|80980089|FG001|Observational Period|Death|2|||
27768214|NCT00439725|80980088|FG000|Observational Period|Study termination by sponsor|1|||
27768215|NCT00439725|80980089|FG001|Observational Period|Study termination by sponsor|1|||
27768216|NCT00439725|80980088|FG000|Observational Period|Clinical endpoint reached|3|||
27768217|NCT00439725|80980089|FG001|Observational Period|Clinical endpoint reached|1|||
27768218|NCT00439725|80980088|FG000|Observational Period|Technical problems|1|||
27768219|NCT00439725|80980089|FG001|Observational Period|Technical problems|0|||
27768220|NCT00439725|80980088|FG000|Observational Period|Participant convenience|1|||
27768221|NCT00439725|80980089|FG001|Observational Period|Participant convenience|0|||
27768222|NCT01749800|80980090|FG000|Overall Study|not meeting inclusion criteria|3|||
27768223|NCT01749800|80980091|FG001|Overall Study|not meeting inclusion criteria|0|||
27768224|NCT01749800|80980092|FG002|Overall Study|not meeting inclusion criteria|0|||
27768225|NCT01749800|80980090|FG000|Overall Study|Withdrawal by Subject|0|||
27768226|NCT01749800|80980091|FG001|Overall Study|Withdrawal by Subject|1|||
27768227|NCT01749800|80980092|FG002|Overall Study|Withdrawal by Subject|0|||
27768228|NCT03215667|80980093|FG000|Overall Study|Physician Decision|4|||
27768229|NCT01119963|80980094|FG000|Overall Study|Lost to Follow-up|1|||
27768230|NCT01119963|80980095|FG001|Overall Study|Lost to Follow-up|1|||
27768231|NCT00640146|80980096|FG000|Overall Study|Adverse Event|2|||
27768232|NCT00640146|80980097|FG001|Overall Study|Adverse Event|0|||
27768233|NCT00640146|80980096|FG000|Overall Study|Lost to Follow-up|0|||
27768234|NCT00640146|80980097|FG001|Overall Study|Lost to Follow-up|1|||
27768235|NCT00640146|80980096|FG000|Overall Study|Lack of Efficacy|0|||
27768236|NCT00640146|80980097|FG001|Overall Study|Lack of Efficacy|1|||
27768237|NCT00640146|80980096|FG000|Overall Study|Withdrawal by Subject|1|||
27768238|NCT00640146|80980097|FG001|Overall Study|Withdrawal by Subject|1|||
27768239|NCT00640146|80980096|FG000|Overall Study|Randomized but not treated|1|||
27768240|NCT00640146|80980097|FG001|Overall Study|Randomized but not treated|3|||
27768241|NCT00318370|80980098|FG000|Period 1|Lack of Efficacy|5|||
27768242|NCT00318370|80980099|FG001|Period 1|Lack of Efficacy|0|||
27768243|NCT00318370|80980100|FG002|Period 1|Lack of Efficacy|0|||
27768244|NCT00318370|80980098|FG000|Period 1|Physician Decision|1|||
27768245|NCT00318370|80980099|FG001|Period 1|Physician Decision|0|||
27768246|NCT00318370|80980100|FG002|Period 1|Physician Decision|0|||
27768247|NCT00318370|80980098|FG000|Period 1|Withdrawal by Subject|1|||
27768248|NCT00318370|80980099|FG001|Period 1|Withdrawal by Subject|0|||
27768249|NCT00318370|80980100|FG002|Period 1|Withdrawal by Subject|0|||
27768250|NCT00318370|80980098|FG000|Period 2|Adverse Event|0|||
27768251|NCT00318370|80980099|FG001|Period 2|Adverse Event|3|||
27768252|NCT00318370|80980100|FG002|Period 2|Adverse Event|0|||
27768253|NCT00318370|80980098|FG000|Period 2|Lack of Efficacy|0|||
27768254|NCT00318370|80980099|FG001|Period 2|Lack of Efficacy|5|||
27768255|NCT00318370|80980100|FG002|Period 2|Lack of Efficacy|0|||
27768256|NCT00318370|80980098|FG000|Period 2|Physician Decision|0|||
27768257|NCT00318370|80980099|FG001|Period 2|Physician Decision|1|||
27768258|NCT00318370|80980100|FG002|Period 2|Physician Decision|0|||
27963338|NCT00778336|81698967|FG002|3 Month Follow Up|Lost to Follow-up|3|||
27963339|NCT00778336|81698968|FG003|3 Month Follow Up|Lost to Follow-up|0|||
27768259|NCT00318370|80980098|FG000|Period 2|Withdrawal by Subject|0|||
27768260|NCT00318370|80980099|FG001|Period 2|Withdrawal by Subject|1|||
27768261|NCT00318370|80980100|FG002|Period 2|Withdrawal by Subject|0|||
27768262|NCT00318370|80980098|FG000|Period 2|Other|0|||
27963340|NCT00778336|81698965|FG000|3 Month Follow Up|Death|8|||
27768263|NCT00318370|80980099|FG001|Period 2|Other|1|||
27768264|NCT00318370|80980100|FG002|Period 2|Other|0|||
27963341|NCT00778336|81698966|FG001|3 Month Follow Up|Death|3|||
27768265|NCT00318370|80980098|FG000|Period 3|Adverse Event|0|||
27768266|NCT00318370|80980099|FG001|Period 3|Adverse Event|0|||
27768267|NCT00318370|80980100|FG002|Period 3|Adverse Event|1|||
27768268|NCT00318370|80980098|FG000|Period 3|Lack of Efficacy|0|||
27768269|NCT00318370|80980099|FG001|Period 3|Lack of Efficacy|0|||
27768270|NCT00318370|80980100|FG002|Period 3|Lack of Efficacy|24|||
27768271|NCT00318370|80980098|FG000|Period 3|Death|0|||
27768272|NCT00318370|80980099|FG001|Period 3|Death|0|||
27768273|NCT00318370|80980100|FG002|Period 3|Death|1|||
27768274|NCT00318370|80980098|FG000|Period 3|Physician Decision|0|||
27768275|NCT00318370|80980099|FG001|Period 3|Physician Decision|0|||
27768276|NCT00318370|80980100|FG002|Period 3|Physician Decision|1|||
27768277|NCT00318370|80980098|FG000|Period 3|Withdrawal by Subject|0|||
27768278|NCT00318370|80980099|FG001|Period 3|Withdrawal by Subject|0|||
27768279|NCT00318370|80980100|FG002|Period 3|Withdrawal by Subject|3|||
27768280|NCT00318370|80980098|FG000|Period 3|Other|0|||
27768281|NCT00318370|80980099|FG001|Period 3|Other|0|||
27768282|NCT00318370|80980100|FG002|Period 3|Other|3|||
27768283|NCT00762268|80980101|FG000|Overall Study|Withdrawal by Subject|3|||
27768284|NCT00762268|80980102|FG001|Overall Study|Withdrawal by Subject|3|||
27768285|NCT01989572|80980109|FG000|Overall Study|Lack of Efficacy|35|||
27768286|NCT01989572|80980110|FG001|Overall Study|Lack of Efficacy|48|||
27768287|NCT01989572|80980111|FG002|Overall Study|Lack of Efficacy|48|||
27768288|NCT01989572|80980112|FG003|Overall Study|Lack of Efficacy|43|||
27768289|NCT01989572|80980113|FG004|Overall Study|Lack of Efficacy|71|||
27768290|NCT01989572|80980114|FG005|Overall Study|Lack of Efficacy|79|||
27768291|NCT01989572|80980109|FG000|Overall Study|Adverse Event|2|||
27768292|NCT01989572|80980110|FG001|Overall Study|Adverse Event|1|||
27768293|NCT01989572|80980111|FG002|Overall Study|Adverse Event|3|||
27768294|NCT01989572|80980112|FG003|Overall Study|Adverse Event|0|||
27768295|NCT01989572|80980113|FG004|Overall Study|Adverse Event|3|||
27768296|NCT01989572|80980114|FG005|Overall Study|Adverse Event|0|||
27768297|NCT01989572|80980109|FG000|Overall Study|Death|0|||
27768298|NCT01989572|80980110|FG001|Overall Study|Death|0|||
27768299|NCT01989572|80980111|FG002|Overall Study|Death|0|||
27768300|NCT01989572|80980112|FG003|Overall Study|Death|0|||
27768301|NCT01989572|80980113|FG004|Overall Study|Death|1|||
27768302|NCT01989572|80980114|FG005|Overall Study|Death|0|||
27768303|NCT01989572|80980109|FG000|Overall Study|Withdrawal by Subject|4|||
27768304|NCT01989572|80980110|FG001|Overall Study|Withdrawal by Subject|1|||
27768305|NCT01989572|80980111|FG002|Overall Study|Withdrawal by Subject|5|||
27768306|NCT01989572|80980112|FG003|Overall Study|Withdrawal by Subject|1|||
27768307|NCT01989572|80980113|FG004|Overall Study|Withdrawal by Subject|12|||
27768308|NCT01989572|80980114|FG005|Overall Study|Withdrawal by Subject|4|||
27768309|NCT01989572|80980109|FG000|Overall Study|complicating disease|1|||
27768310|NCT01989572|80980110|FG001|Overall Study|complicating disease|1|||
27768311|NCT01989572|80980111|FG002|Overall Study|complicating disease|2|||
27768312|NCT01989572|80980112|FG003|Overall Study|complicating disease|0|||
27768313|NCT01989572|80980113|FG004|Overall Study|complicating disease|1|||
27768314|NCT01989572|80980114|FG005|Overall Study|complicating disease|0|||
27768315|NCT01989572|80980109|FG000|Overall Study|error|2|||
27768316|NCT01989572|80980110|FG001|Overall Study|error|1|||
27768317|NCT01989572|80980111|FG002|Overall Study|error|1|||
27768318|NCT01989572|80980112|FG003|Overall Study|error|1|||
27768319|NCT01989572|80980113|FG004|Overall Study|error|1|||
27768320|NCT01989572|80980114|FG005|Overall Study|error|1|||
27768321|NCT01989572|80980109|FG000|Overall Study|maximum dose reached|0|||
27768322|NCT01989572|80980110|FG001|Overall Study|maximum dose reached|1|||
27768323|NCT01989572|80980111|FG002|Overall Study|maximum dose reached|0|||
27768324|NCT01989572|80980112|FG003|Overall Study|maximum dose reached|0|||
27768325|NCT01989572|80980113|FG004|Overall Study|maximum dose reached|1|||
27768326|NCT01989572|80980114|FG005|Overall Study|maximum dose reached|0|||
27768327|NCT01989572|80980109|FG000|Overall Study|unknown/not specify|3|||
27768328|NCT01989572|80980110|FG001|Overall Study|unknown/not specify|4|||
27768329|NCT01989572|80980111|FG002|Overall Study|unknown/not specify|1|||
27768330|NCT01989572|80980112|FG003|Overall Study|unknown/not specify|3|||
27768331|NCT01989572|80980113|FG004|Overall Study|unknown/not specify|3|||
27768332|NCT01989572|80980114|FG005|Overall Study|unknown/not specify|5|||
27768333|NCT01989572|80980109|FG000|Overall Study|not start protocol therapy|5|||
27768334|NCT01989572|80980110|FG001|Overall Study|not start protocol therapy|1|||
27768335|NCT01989572|80980111|FG002|Overall Study|not start protocol therapy|2|||
27768336|NCT01989572|80980112|FG003|Overall Study|not start protocol therapy|3|||
27768337|NCT01989572|80980113|FG004|Overall Study|not start protocol therapy|4|||
27768338|NCT01989572|80980114|FG005|Overall Study|not start protocol therapy|18|||
27768339|NCT01989572|80980109|FG000|Overall Study|alternative therapy|3|||
27768340|NCT01989572|80980110|FG001|Overall Study|alternative therapy|0|||
27768341|NCT01989572|80980111|FG002|Overall Study|alternative therapy|0|||
27768342|NCT01989572|80980112|FG003|Overall Study|alternative therapy|0|||
27768343|NCT01989572|80980113|FG004|Overall Study|alternative therapy|1|||
27768344|NCT01989572|80980114|FG005|Overall Study|alternative therapy|3|||
27768345|NCT02988219|80980122|FG000|Overall Study|Lack of Efficacy|1|||
27768346|NCT02988219|80980123|FG001|Overall Study|Lack of Efficacy|1|||
27768347|NCT02988219|80980122|FG000|Overall Study|Withdrawal by Subject|0|||
27768348|NCT02988219|80980123|FG001|Overall Study|Withdrawal by Subject|2|||
27768349|NCT01437267|80980124|FG000|Overall Study|Withdrawal by Subject|0|||
27768350|NCT01437267|80980125|FG001|Overall Study|Withdrawal by Subject|0|||
27768351|NCT01437267|80980126|FG002|Overall Study|Withdrawal by Subject|0|||
27768352|NCT01437267|80980127|FG003|Overall Study|Withdrawal by Subject|1|||
27768353|NCT01437267|80980128|FG004|Overall Study|Withdrawal by Subject|0|||
27768354|NCT01437267|80980129|FG005|Overall Study|Withdrawal by Subject|0|||
27768355|NCT01437267|80980124|FG000|Overall Study|Protocol Violation|0|||
27768356|NCT01437267|80980125|FG001|Overall Study|Protocol Violation|1|||
27768357|NCT01437267|80980126|FG002|Overall Study|Protocol Violation|0|||
27768358|NCT01437267|80980127|FG003|Overall Study|Protocol Violation|0|||
27768359|NCT01437267|80980128|FG004|Overall Study|Protocol Violation|0|||
27768360|NCT01437267|80980129|FG005|Overall Study|Protocol Violation|0|||
27768361|NCT01248364|80980130|FG000|Overall Study|Adverse Event|0|||
27768362|NCT01248364|80980131|FG001|Overall Study|Adverse Event|1|||
27768363|NCT01248364|80980132|FG002|Overall Study|Adverse Event|0|||
27768364|NCT01248364|80980133|FG003|Overall Study|Adverse Event|0|||
27768365|NCT00517413|80980139|FG000|Overall Study|Adverse Event|7|||
27768366|NCT00517413|80980139|FG000|Overall Study|Death|13|||
27768367|NCT00517413|80980139|FG000|Overall Study|Protocol Violation|15|||
27768368|NCT00517413|80980139|FG000|Overall Study|Withdrawal by Subject|2|||
27768369|NCT00517413|80980139|FG000|Overall Study|Failure to return|1|||
27768370|NCT00517413|80980139|FG000|Overall Study|Other-Reasons|23|||
27768371|NCT02420795|80980141|FG000|Overall Study|Withdrawal by Subject|1|||
27768372|NCT02420795|80980142|FG001|Overall Study|Withdrawal by Subject|0|||
27768373|NCT02420795|80980143|FG002|Overall Study|Withdrawal by Subject|0|||
27768374|NCT02420795|80980141|FG000|Overall Study|Adverse Event|1|||
27768375|NCT02420795|80980142|FG001|Overall Study|Adverse Event|0|||
27768376|NCT02420795|80980143|FG002|Overall Study|Adverse Event|0|||
27768377|NCT02420795|80980141|FG000|Overall Study|Progressive disease|2|||
27768378|NCT02420795|80980142|FG001|Overall Study|Progressive disease|2|||
27768379|NCT02420795|80980143|FG002|Overall Study|Progressive disease|4|||
27768380|NCT02420795|80980141|FG000|Overall Study|Death|0|||
27768381|NCT02420795|80980142|FG001|Overall Study|Death|0|||
27768382|NCT02420795|80980143|FG002|Overall Study|Death|1|||
27768383|NCT02517268|80980144|FG000|Overall Study|Withdrawal by Subject|1|||
27768384|NCT02517268|80980145|FG001|Overall Study|Withdrawal by Subject|0|||
27768385|NCT02033850|80980148|FG000|Overall Study|Death|1|||
27768386|NCT02033850|80980149|FG001|Overall Study|Death|0|||
27768387|NCT02033850|80980148|FG000|Overall Study|unrelated medical reason|1|||
27768388|NCT02033850|80980149|FG001|Overall Study|unrelated medical reason|1|||
27768389|NCT04285853|80980157|FG000|Overall Study|Withdrawal by Subject|1|||
27768390|NCT04285853|80980158|FG001|Overall Study|Withdrawal by Subject|0|||
27768391|NCT04285853|80980157|FG000|Overall Study|Lost to Follow-up|9|||
27768392|NCT04285853|80980158|FG001|Overall Study|Lost to Follow-up|5|||
27768393|NCT00606177|80980159|FG000|Overall Study|Adverse Event|9|||
27768394|NCT00606177|80980160|FG001|Overall Study|Adverse Event|5|||
27768395|NCT00606177|80980159|FG000|Overall Study|Lack of Efficacy|3|||
27768396|NCT00606177|80980160|FG001|Overall Study|Lack of Efficacy|7|||
27768397|NCT00606177|80980159|FG000|Overall Study|Physician Decision|1|||
27768398|NCT00606177|80980160|FG001|Overall Study|Physician Decision|0|||
27768399|NCT00606177|80980159|FG000|Overall Study|Protocol Violation|1|||
27768400|NCT00606177|80980160|FG001|Overall Study|Protocol Violation|4|||
27768401|NCT00606177|80980159|FG000|Overall Study|Withdrawal by Subject|5|||
27768402|NCT00606177|80980160|FG001|Overall Study|Withdrawal by Subject|6|||
27768403|NCT00606177|80980159|FG000|Overall Study|Progression to depressive phase|6|||
27768404|NCT00606177|80980160|FG001|Overall Study|Progression to depressive phase|1|||
27768405|NCT00606177|80980159|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
27768406|NCT00606177|80980160|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
27768407|NCT00606177|80980159|FG000|Overall Study|Change of residence or other commitments|1|||
27768408|NCT00606177|80980160|FG001|Overall Study|Change of residence or other commitments|1|||
27963342|NCT00778336|81698967|FG002|3 Month Follow Up|Death|2|||
27963343|NCT00778336|81698968|FG003|3 Month Follow Up|Death|0|||
27963344|NCT03604172|81698969|FG000|Overall Study|Lost to Follow-up|1|||
27768409|NCT02650895|80980171|FG000|Overall Study|Withdrawal by Subject|0|||
27768410|NCT02650895|80980172|FG001|Overall Study|Withdrawal by Subject|1|||
27768411|NCT02650895|80980173|FG002|Overall Study|Withdrawal by Subject|0|||
27768412|NCT02650895|80980174|FG003|Overall Study|Withdrawal by Subject|0|||
27768413|NCT02650895|80980175|FG004|Overall Study|Withdrawal by Subject|0|||
27768414|NCT02650895|80980176|FG005|Overall Study|Withdrawal by Subject|0|||
27768415|NCT00499460|80980180|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
27768416|NCT00499460|80980181|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
27768417|NCT00499460|80980180|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
27768418|NCT00499460|80980181|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
27768419|NCT00499460|80980180|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
27768420|NCT00499460|80980181|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
27768421|NCT00355134|80980182|FG000|Core Phase|Withdrawal by Subject|35|||
27768422|NCT00355134|80980183|FG001|Core Phase|Withdrawal by Subject|24|||
27768423|NCT00355134|80980184|FG002|Core Phase|Withdrawal by Subject|35|||
27768424|NCT00355134|80980185|FG003|Core Phase|Withdrawal by Subject|0|||
27963345|NCT03604172|81698970|FG001|Overall Study|Lost to Follow-up|2|||
27768425|NCT00355134|80980186|FG004|Core Phase|Withdrawal by Subject|0|||
27768426|NCT00355134|80980182|FG000|Core Phase|Adverse Event|28|||
27768427|NCT00355134|80980183|FG001|Core Phase|Adverse Event|22|||
27768428|NCT00355134|80980184|FG002|Core Phase|Adverse Event|16|||
27768429|NCT00355134|80980185|FG003|Core Phase|Adverse Event|0|||
27768430|NCT00355134|80980186|FG004|Core Phase|Adverse Event|0|||
27768431|NCT00355134|80980182|FG000|Core Phase|Lost to Follow-up|17|||
27768432|NCT00355134|80980183|FG001|Core Phase|Lost to Follow-up|13|||
27768433|NCT00355134|80980184|FG002|Core Phase|Lost to Follow-up|21|||
27768434|NCT00355134|80980185|FG003|Core Phase|Lost to Follow-up|0|||
27768435|NCT00355134|80980186|FG004|Core Phase|Lost to Follow-up|0|||
27768436|NCT00355134|80980182|FG000|Core Phase|Abnormal laboratory value(s)|19|||
27768437|NCT00355134|80980183|FG001|Core Phase|Abnormal laboratory value(s)|14|||
27768438|NCT00355134|80980184|FG002|Core Phase|Abnormal laboratory value(s)|2|||
27768439|NCT00355134|80980185|FG003|Core Phase|Abnormal laboratory value(s)|0|||
27768440|NCT00355134|80980186|FG004|Core Phase|Abnormal laboratory value(s)|0|||
27768441|NCT00355134|80980182|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
27768442|NCT00355134|80980183|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
27768443|NCT00355134|80980184|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
27768444|NCT00355134|80980185|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
27768445|NCT00355134|80980186|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
27768446|NCT00355134|80980182|FG000|Core Phase|Administrative problems|5|||
27768447|NCT00355134|80980183|FG001|Core Phase|Administrative problems|3|||
27768448|NCT00355134|80980184|FG002|Core Phase|Administrative problems|5|||
27768449|NCT00355134|80980185|FG003|Core Phase|Administrative problems|0|||
27768450|NCT00355134|80980186|FG004|Core Phase|Administrative problems|0|||
27768451|NCT00355134|80980182|FG000|Core Phase|Protocol Violation|3|||
27768452|NCT00355134|80980183|FG001|Core Phase|Protocol Violation|2|||
27768453|NCT00355134|80980184|FG002|Core Phase|Protocol Violation|2|||
27768454|NCT00355134|80980185|FG003|Core Phase|Protocol Violation|0|||
27768455|NCT00355134|80980186|FG004|Core Phase|Protocol Violation|0|||
27768456|NCT00355134|80980182|FG000|Core Phase|Abnormal test procedure result(s)|1|||
27768457|NCT00355134|80980183|FG001|Core Phase|Abnormal test procedure result(s)|2|||
27768458|NCT00355134|80980184|FG002|Core Phase|Abnormal test procedure result(s)|1|||
27768459|NCT00355134|80980185|FG003|Core Phase|Abnormal test procedure result(s)|0|||
27768460|NCT00355134|80980186|FG004|Core Phase|Abnormal test procedure result(s)|0|||
27768461|NCT00355134|80980182|FG000|Core Phase|Condition no longer requires study drug|1|||
27768462|NCT00355134|80980183|FG001|Core Phase|Condition no longer requires study drug|0|||
27768463|NCT00355134|80980184|FG002|Core Phase|Condition no longer requires study drug|1|||
27768464|NCT00355134|80980185|FG003|Core Phase|Condition no longer requires study drug|0|||
27768465|NCT00355134|80980186|FG004|Core Phase|Condition no longer requires study drug|0|||
27768466|NCT00355134|80980182|FG000|Extension Phase|Withdrawal by Subject|7|||
27768467|NCT00355134|80980183|FG001|Extension Phase|Withdrawal by Subject|11|||
27768468|NCT00355134|80980184|FG002|Extension Phase|Withdrawal by Subject|0|||
27768469|NCT00355134|80980185|FG003|Extension Phase|Withdrawal by Subject|7|||
27768470|NCT00355134|80980186|FG004|Extension Phase|Withdrawal by Subject|5|||
27768471|NCT00355134|80980182|FG000|Extension Phase|Adverse Event|13|||
27768472|NCT00355134|80980183|FG001|Extension Phase|Adverse Event|9|||
27768473|NCT00355134|80980184|FG002|Extension Phase|Adverse Event|0|||
27768474|NCT00355134|80980185|FG003|Extension Phase|Adverse Event|3|||
27768475|NCT00355134|80980186|FG004|Extension Phase|Adverse Event|5|||
27768476|NCT00355134|80980182|FG000|Extension Phase|Lost to Follow-up|2|||
27963346|NCT04188834|81698971|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
27963347|NCT04474197|81698972|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
27963348|NCT04474197|81698973|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
27963349|NCT04474197|81698974|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
27963350|NCT04474197|81698975|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
27768477|NCT00355134|80980183|FG001|Extension Phase|Lost to Follow-up|6|||
27768478|NCT00355134|80980184|FG002|Extension Phase|Lost to Follow-up|0|||
27768479|NCT00355134|80980185|FG003|Extension Phase|Lost to Follow-up|2|||
27768480|NCT00355134|80980186|FG004|Extension Phase|Lost to Follow-up|4|||
27768481|NCT00355134|80980182|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
27768482|NCT00355134|80980183|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
27768483|NCT00355134|80980184|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
27768484|NCT00355134|80980185|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
27768485|NCT00355134|80980186|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
27963351|NCT01437111|81698982|FG000|Overall Study|Adverse Event|2|||
27768486|NCT00355134|80980182|FG000|Extension Phase|Administrative problems|2|||
27768487|NCT00355134|80980183|FG001|Extension Phase|Administrative problems|4|||
27768488|NCT00355134|80980184|FG002|Extension Phase|Administrative problems|0|||
27768489|NCT00355134|80980185|FG003|Extension Phase|Administrative problems|1|||
27768490|NCT00355134|80980186|FG004|Extension Phase|Administrative problems|1|||
27768491|NCT00355134|80980182|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
27768492|NCT00355134|80980183|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
27768493|NCT00355134|80980184|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
27768494|NCT00355134|80980185|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
27768495|NCT00355134|80980186|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
27768496|NCT00355134|80980182|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
27768497|NCT00355134|80980183|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
27768498|NCT00355134|80980184|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
27768499|NCT00355134|80980185|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
27768500|NCT00355134|80980186|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
27768501|NCT00355134|80980182|FG000|Extension Phase|Protocol Violation|0|||
27768502|NCT00355134|80980183|FG001|Extension Phase|Protocol Violation|0|||
27768503|NCT00355134|80980184|FG002|Extension Phase|Protocol Violation|0|||
27768504|NCT00355134|80980185|FG003|Extension Phase|Protocol Violation|1|||
27768505|NCT00355134|80980186|FG004|Extension Phase|Protocol Violation|0|||
27768506|NCT00524043|80980192|FG000|Overall Study|Lack of Efficacy|15|||
27768507|NCT00524043|80980193|FG001|Overall Study|Lack of Efficacy|13|||
27768508|NCT00524043|80980194|FG002|Overall Study|Lack of Efficacy|14|||
27768509|NCT00524043|80980192|FG000|Overall Study|Withdrawal by Subject|5|||
27768510|NCT00524043|80980193|FG001|Overall Study|Withdrawal by Subject|7|||
27768511|NCT00524043|80980194|FG002|Overall Study|Withdrawal by Subject|7|||
27768512|NCT00524043|80980192|FG000|Overall Study|Adverse Event|5|||
27768513|NCT00524043|80980193|FG001|Overall Study|Adverse Event|2|||
27768514|NCT00524043|80980194|FG002|Overall Study|Adverse Event|7|||
27768515|NCT00524043|80980192|FG000|Overall Study|Lost to Follow-up|3|||
27768516|NCT00524043|80980193|FG001|Overall Study|Lost to Follow-up|5|||
27768517|NCT00524043|80980194|FG002|Overall Study|Lost to Follow-up|3|||
27768518|NCT00524043|80980192|FG000|Overall Study|Various (eg, incarceration)|2|||
27768519|NCT00524043|80980193|FG001|Overall Study|Various (eg, incarceration)|1|||
27768520|NCT00524043|80980194|FG002|Overall Study|Various (eg, incarceration)|0|||
27768521|NCT04914819|80980219|FG000|Overall Study|Pregnancy|3|||
27768522|NCT04914819|80980220|FG001|Overall Study|Pregnancy|1|||
27768523|NCT04914819|80980219|FG000|Overall Study|Discontinued study|4|||
27768524|NCT04914819|80980220|FG001|Overall Study|Discontinued study|1|||
27768525|NCT04914819|80980219|FG000|Overall Study|Lost to Follow-up|7|||
27768526|NCT04914819|80980220|FG001|Overall Study|Lost to Follow-up|0|||
27768527|NCT00910728|80980221|FG000|Overall Study|Lack of Efficacy|2|||
27768528|NCT00910728|80980222|FG001|Overall Study|Lack of Efficacy|3|||
27768529|NCT00910728|80980223|FG002|Overall Study|Lack of Efficacy|1|||
27768530|NCT00910728|80980224|FG003|Overall Study|Lack of Efficacy|2|||
27768531|NCT00910728|80980225|FG004|Overall Study|Lack of Efficacy|1|||
27768532|NCT00910728|80980226|FG005|Overall Study|Lack of Efficacy|0|||
27768533|NCT00910728|80980227|FG006|Overall Study|Lack of Efficacy|2|||
27768534|NCT00910728|80980228|FG007|Overall Study|Lack of Efficacy|2|||
27768535|NCT00910728|80980229|FG008|Overall Study|Lack of Efficacy|2|||
27768536|NCT00910728|80980221|FG000|Overall Study|Withdrawal by Subject|0|||
27768537|NCT00910728|80980222|FG001|Overall Study|Withdrawal by Subject|0|||
27768538|NCT00910728|80980223|FG002|Overall Study|Withdrawal by Subject|0|||
27768539|NCT00910728|80980224|FG003|Overall Study|Withdrawal by Subject|0|||
27768540|NCT00910728|80980225|FG004|Overall Study|Withdrawal by Subject|3|||
27768541|NCT00910728|80980226|FG005|Overall Study|Withdrawal by Subject|1|||
27768542|NCT00910728|80980227|FG006|Overall Study|Withdrawal by Subject|2|||
27768543|NCT00910728|80980228|FG007|Overall Study|Withdrawal by Subject|0|||
27768544|NCT00910728|80980229|FG008|Overall Study|Withdrawal by Subject|0|||
27768545|NCT00910728|80980221|FG000|Overall Study|(not specified)|2|||
27768546|NCT00910728|80980222|FG001|Overall Study|(not specified)|0|||
27768547|NCT00910728|80980223|FG002|Overall Study|(not specified)|1|||
27768548|NCT00910728|80980224|FG003|Overall Study|(not specified)|0|||
27768549|NCT00910728|80980225|FG004|Overall Study|(not specified)|1|||
27768550|NCT00910728|80980226|FG005|Overall Study|(not specified)|0|||
27768551|NCT00910728|80980227|FG006|Overall Study|(not specified)|0|||
27768552|NCT00910728|80980228|FG007|Overall Study|(not specified)|0|||
27768553|NCT00910728|80980229|FG008|Overall Study|(not specified)|0|||
27768554|NCT00910728|80980221|FG000|Overall Study|Adverse Event|2|||
27768555|NCT00910728|80980222|FG001|Overall Study|Adverse Event|0|||
27768556|NCT00910728|80980223|FG002|Overall Study|Adverse Event|1|||
27768557|NCT00910728|80980224|FG003|Overall Study|Adverse Event|1|||
27569002|NCT02658890|80271484|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
27569003|NCT02658890|80271485|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
27569004|NCT02658890|80271486|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
27768558|NCT00910728|80980225|FG004|Overall Study|Adverse Event|0|||
27768559|NCT00910728|80980226|FG005|Overall Study|Adverse Event|0|||
27768560|NCT00910728|80980227|FG006|Overall Study|Adverse Event|2|||
27768561|NCT00910728|80980228|FG007|Overall Study|Adverse Event|1|||
27768562|NCT00910728|80980229|FG008|Overall Study|Adverse Event|1|||
27768563|NCT02925312|80980232|FG000|Overall Study|Lost to Follow-up|25|||
27768564|NCT02925312|80980233|FG001|Overall Study|Lost to Follow-up|0|||
27768565|NCT02925312|80980232|FG000|Overall Study|Adverse Event|2|||
27768566|NCT02925312|80980233|FG001|Overall Study|Adverse Event|0|||
27768567|NCT00329784|80980236|FG000|Overall Study|Lost to Follow-up|0|||
27768568|NCT00329784|80980237|FG001|Overall Study|Lost to Follow-up|1|||
27768569|NCT00329784|80980238|FG002|Overall Study|Lost to Follow-up|0|||
27768570|NCT00329784|80980239|FG003|Overall Study|Lost to Follow-up|0|||
27768571|NCT00329784|80980236|FG000|Overall Study|Withdrawal by Subject|4|||
27768572|NCT00329784|80980237|FG001|Overall Study|Withdrawal by Subject|2|||
27768573|NCT00329784|80980238|FG002|Overall Study|Withdrawal by Subject|0|||
27768574|NCT00329784|80980239|FG003|Overall Study|Withdrawal by Subject|0|||
27768575|NCT00329784|80980236|FG000|Overall Study|Other|1|||
27768576|NCT00329784|80980237|FG001|Overall Study|Other|2|||
27768577|NCT00329784|80980238|FG002|Overall Study|Other|0|||
27768578|NCT00329784|80980239|FG003|Overall Study|Other|0|||
27768579|NCT04731922|80980240|FG000|Overall Study|Adverse Event|0|||
27768580|NCT04731922|80980241|FG001|Overall Study|Adverse Event|0|||
27768581|NCT04731922|80980242|FG002|Overall Study|Adverse Event|0|||
27768582|NCT04731922|80980243|FG003|Overall Study|Adverse Event|0|||
27768583|NCT04731922|80980244|FG004|Overall Study|Adverse Event|0|||
27768584|NCT04731922|80980245|FG005|Overall Study|Adverse Event|0|||
27768585|NCT04731922|80980246|FG006|Overall Study|Adverse Event|0|||
27768586|NCT04731922|80980247|FG007|Overall Study|Adverse Event|0|||
27768587|NCT04731922|80980248|FG008|Overall Study|Adverse Event|0|||
27768588|NCT04731922|80980249|FG009|Overall Study|Adverse Event|0|||
27768589|NCT04731922|80980250|FG010|Overall Study|Adverse Event|1|||
27768590|NCT04731922|80980251|FG011|Overall Study|Adverse Event|0|||
27768591|NCT04731922|80980252|FG012|Overall Study|Adverse Event|0|||
27768592|NCT04731922|80980253|FG013|Overall Study|Adverse Event|0|||
27768593|NCT04731922|80980254|FG014|Overall Study|Adverse Event|0|||
27768594|NCT04731922|80980255|FG015|Overall Study|Adverse Event|0|||
27768595|NCT04731922|80980256|FG016|Overall Study|Adverse Event|0|||
27768596|NCT04731922|80980240|FG000|Overall Study|Lost to Follow-up|0|||
27768597|NCT04731922|80980241|FG001|Overall Study|Lost to Follow-up|0|||
27768598|NCT04731922|80980242|FG002|Overall Study|Lost to Follow-up|0|||
27768599|NCT04731922|80980243|FG003|Overall Study|Lost to Follow-up|1|||
27768600|NCT04731922|80980244|FG004|Overall Study|Lost to Follow-up|0|||
27768601|NCT04731922|80980245|FG005|Overall Study|Lost to Follow-up|1|||
27768602|NCT04731922|80980246|FG006|Overall Study|Lost to Follow-up|0|||
27768603|NCT04731922|80980247|FG007|Overall Study|Lost to Follow-up|0|||
27768604|NCT04731922|80980248|FG008|Overall Study|Lost to Follow-up|0|||
27768605|NCT04731922|80980249|FG009|Overall Study|Lost to Follow-up|0|||
27768606|NCT04731922|80980250|FG010|Overall Study|Lost to Follow-up|0|||
27768607|NCT04731922|80980251|FG011|Overall Study|Lost to Follow-up|0|||
27768608|NCT04731922|80980252|FG012|Overall Study|Lost to Follow-up|0|||
27768609|NCT04731922|80980253|FG013|Overall Study|Lost to Follow-up|0|||
27768610|NCT04731922|80980254|FG014|Overall Study|Lost to Follow-up|0|||
27768611|NCT04731922|80980255|FG015|Overall Study|Lost to Follow-up|0|||
27768612|NCT04731922|80980256|FG016|Overall Study|Lost to Follow-up|0|||
27768613|NCT04731922|80980240|FG000|Overall Study|Withdrawal by Subject|1|||
27768614|NCT04731922|80980241|FG001|Overall Study|Withdrawal by Subject|0|||
27768615|NCT04731922|80980242|FG002|Overall Study|Withdrawal by Subject|0|||
27768616|NCT04731922|80980243|FG003|Overall Study|Withdrawal by Subject|0|||
27768617|NCT04731922|80980244|FG004|Overall Study|Withdrawal by Subject|1|||
27768618|NCT04731922|80980245|FG005|Overall Study|Withdrawal by Subject|0|||
27768619|NCT04731922|80980246|FG006|Overall Study|Withdrawal by Subject|1|||
27768620|NCT04731922|80980247|FG007|Overall Study|Withdrawal by Subject|0|||
27768621|NCT04731922|80980248|FG008|Overall Study|Withdrawal by Subject|0|||
27768622|NCT04731922|80980249|FG009|Overall Study|Withdrawal by Subject|0|||
27768623|NCT04731922|80980250|FG010|Overall Study|Withdrawal by Subject|0|||
27768624|NCT04731922|80980251|FG011|Overall Study|Withdrawal by Subject|0|||
27768625|NCT04731922|80980252|FG012|Overall Study|Withdrawal by Subject|0|||
27768626|NCT04731922|80980253|FG013|Overall Study|Withdrawal by Subject|1|||
27768627|NCT04731922|80980254|FG014|Overall Study|Withdrawal by Subject|0|||
27768628|NCT04731922|80980255|FG015|Overall Study|Withdrawal by Subject|0|||
27768629|NCT04731922|80980256|FG016|Overall Study|Withdrawal by Subject|0|||
27768630|NCT04731922|80980240|FG000|Overall Study|Other|0|||
27768631|NCT04731922|80980241|FG001|Overall Study|Other|0|||
27768632|NCT04731922|80980242|FG002|Overall Study|Other|0|||
27768633|NCT04731922|80980243|FG003|Overall Study|Other|0|||
27768634|NCT04731922|80980244|FG004|Overall Study|Other|0|||
27768635|NCT04731922|80980245|FG005|Overall Study|Other|0|||
27768636|NCT04731922|80980246|FG006|Overall Study|Other|1|||
27768637|NCT04731922|80980247|FG007|Overall Study|Other|0|||
27768638|NCT04731922|80980248|FG008|Overall Study|Other|0|||
27768639|NCT04731922|80980249|FG009|Overall Study|Other|0|||
27768640|NCT04731922|80980250|FG010|Overall Study|Other|0|||
27768641|NCT04731922|80980251|FG011|Overall Study|Other|0|||
27768642|NCT04731922|80980252|FG012|Overall Study|Other|0|||
27768643|NCT04731922|80980253|FG013|Overall Study|Other|0|||
27768644|NCT04731922|80980254|FG014|Overall Study|Other|0|||
27768645|NCT04731922|80980255|FG015|Overall Study|Other|0|||
27768646|NCT04731922|80980256|FG016|Overall Study|Other|0|||
27768647|NCT01376388|80980257|FG000|Overall Study|Adverse Event|13|||
27768648|NCT01376388|80980257|FG000|Overall Study|Lack of Efficacy|2|||
27768649|NCT01376388|80980257|FG000|Overall Study|Withdrawal by Subject|3|||
27768650|NCT02679781|80980260|FG000|Overall Study|Lost to Follow-up|1|||
27768651|NCT02679781|80980261|FG001|Overall Study|Lost to Follow-up|2|||
27768652|NCT02679781|80980260|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
27768653|NCT02679781|80980261|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
27768654|NCT01690988|80980264|FG000|Overall Study|Withdrawal by Subject|2|||
27768655|NCT01690988|80980265|FG001|Overall Study|Withdrawal by Subject|2|||
27768656|NCT01690988|80980266|FG002|Overall Study|Withdrawal by Subject|3|||
27768657|NCT01690988|80980264|FG000|Overall Study|Physician Decision|0|||
27768658|NCT01690988|80980265|FG001|Overall Study|Physician Decision|0|||
27768659|NCT01690988|80980266|FG002|Overall Study|Physician Decision|1|||
27768660|NCT01690988|80980264|FG000|Overall Study|Operation Cancelled|1|||
27768661|NCT01690988|80980265|FG001|Overall Study|Operation Cancelled|1|||
27768662|NCT01690988|80980266|FG002|Overall Study|Operation Cancelled|0|||
27768663|NCT01690988|80980264|FG000|Overall Study|Determined ineligible|1|||
27768664|NCT01690988|80980265|FG001|Overall Study|Determined ineligible|0|||
27768665|NCT01690988|80980266|FG002|Overall Study|Determined ineligible|0|||
27768666|NCT01690988|80980264|FG000|Overall Study|Death|1|||
27768667|NCT01690988|80980265|FG001|Overall Study|Death|1|||
27768668|NCT01690988|80980266|FG002|Overall Study|Death|1|||
27768669|NCT01690988|80980264|FG000|Overall Study|Sedated|1|||
27768670|NCT01690988|80980265|FG001|Overall Study|Sedated|1|||
27768671|NCT01690988|80980266|FG002|Overall Study|Sedated|2|||
27768672|NCT02116361|80980267|FG000|Overall Study|Pregnancy|0|||
27768673|NCT02116361|80980268|FG001|Overall Study|Pregnancy|0|||
27768674|NCT02116361|80980269|FG002|Overall Study|Pregnancy|0|||
27768675|NCT02116361|80980270|FG003|Overall Study|Pregnancy|1|||
27768676|NCT02116361|80980267|FG000|Overall Study|Protocol Violation|1|||
27768677|NCT02116361|80980268|FG001|Overall Study|Protocol Violation|0|||
27768678|NCT02116361|80980269|FG002|Overall Study|Protocol Violation|0|||
27768679|NCT02116361|80980270|FG003|Overall Study|Protocol Violation|2|||
27768680|NCT02116361|80980267|FG000|Overall Study|Physician Decision|2|||
27768681|NCT02116361|80980268|FG001|Overall Study|Physician Decision|3|||
27768682|NCT02116361|80980269|FG002|Overall Study|Physician Decision|0|||
27768683|NCT02116361|80980270|FG003|Overall Study|Physician Decision|0|||
27768684|NCT02116361|80980267|FG000|Overall Study|Adverse Event|1|||
27768685|NCT02116361|80980268|FG001|Overall Study|Adverse Event|0|||
27768686|NCT02116361|80980269|FG002|Overall Study|Adverse Event|0|||
27768687|NCT02116361|80980270|FG003|Overall Study|Adverse Event|3|||
27768688|NCT02116361|80980267|FG000|Overall Study|Other Reasons|3|||
27768689|NCT02116361|80980268|FG001|Overall Study|Other Reasons|3|||
27768690|NCT02116361|80980269|FG002|Overall Study|Other Reasons|3|||
27768691|NCT02116361|80980270|FG003|Overall Study|Other Reasons|3|||
27768692|NCT02116361|80980267|FG000|Overall Study|Lack of Efficacy|5|||
27768693|NCT02116361|80980268|FG001|Overall Study|Lack of Efficacy|7|||
27768694|NCT02116361|80980269|FG002|Overall Study|Lack of Efficacy|4|||
27768695|NCT02116361|80980270|FG003|Overall Study|Lack of Efficacy|3|||
27768696|NCT02116361|80980267|FG000|Overall Study|Lost to Follow-up|4|||
27768697|NCT02116361|80980268|FG001|Overall Study|Lost to Follow-up|5|||
27768698|NCT02116361|80980269|FG002|Overall Study|Lost to Follow-up|7|||
27768699|NCT02116361|80980270|FG003|Overall Study|Lost to Follow-up|5|||
27768700|NCT02116361|80980267|FG000|Overall Study|Personal Reasons|6|||
27768701|NCT02116361|80980268|FG001|Overall Study|Personal Reasons|6|||
27963352|NCT01437111|81698982|FG000|Overall Study|Withdrawal by Subject|4|||
27963353|NCT01437111|81698982|FG000|Overall Study|Not reported|5|||
27963354|NCT01437111|81698982|FG000|Overall Study|Physician Decision|1|||
27963355|NCT01437111|81698982|FG000|Overall Study|Lost to Follow-up|5|||
27963356|NCT01437111|81698982|FG000|Overall Study|Protocol Violation|1|||
27963357|NCT00887159|81698983|FG000|Overall Study|Disease progression|6|||
27963358|NCT00887159|81698984|FG001|Overall Study|Disease progression|39|||
27963359|NCT00887159|81698985|FG002|Overall Study|Disease progression|33|||
27768702|NCT02116361|80980269|FG002|Overall Study|Personal Reasons|4|||
27768703|NCT02116361|80980270|FG003|Overall Study|Personal Reasons|9|||
27768704|NCT02116361|80980267|FG000|Overall Study|Investigator Decision - Relapse|9|||
27768705|NCT02116361|80980268|FG001|Overall Study|Investigator Decision - Relapse|7|||
27963360|NCT00887159|81698983|FG000|Overall Study|Adverse Event|3|||
27963361|NCT00887159|81698984|FG001|Overall Study|Adverse Event|4|||
27768706|NCT02116361|80980269|FG002|Overall Study|Investigator Decision - Relapse|8|||
27768707|NCT02116361|80980270|FG003|Overall Study|Investigator Decision - Relapse|5|||
27768708|NCT00937326|80980271|FG000|Overall Study|Adverse Event|0|||
27963362|NCT00887159|81698985|FG002|Overall Study|Adverse Event|17|||
27768709|NCT00937326|80980272|FG001|Overall Study|Adverse Event|3|||
27768710|NCT00937326|80980273|FG002|Overall Study|Adverse Event|1|||
27768711|NCT00937326|80980274|FG003|Overall Study|Adverse Event|1|||
27768712|NCT00937326|80980275|FG004|Overall Study|Adverse Event|2|||
27768713|NCT00937326|80980271|FG000|Overall Study|Death|0|||
27768714|NCT00937326|80980272|FG001|Overall Study|Death|0|||
27963363|NCT00887159|81698983|FG000|Overall Study|Death|2|||
27963364|NCT00887159|81698984|FG001|Overall Study|Death|2|||
27963365|NCT00887159|81698985|FG002|Overall Study|Death|0|||
27768715|NCT00937326|80980273|FG002|Overall Study|Death|1|||
27768716|NCT00937326|80980274|FG003|Overall Study|Death|0|||
27768717|NCT00937326|80980275|FG004|Overall Study|Death|0|||
27768718|NCT00937326|80980271|FG000|Overall Study|Withdrawal by Subject|3|||
27768719|NCT00937326|80980272|FG001|Overall Study|Withdrawal by Subject|4|||
27768720|NCT00937326|80980273|FG002|Overall Study|Withdrawal by Subject|1|||
27768721|NCT00937326|80980274|FG003|Overall Study|Withdrawal by Subject|4|||
27768722|NCT00937326|80980275|FG004|Overall Study|Withdrawal by Subject|3|||
27768723|NCT00937326|80980271|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27768724|NCT00937326|80980272|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27768725|NCT00937326|80980273|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
27768726|NCT00937326|80980274|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27768727|NCT00937326|80980275|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
27768728|NCT00880607|80980278|FG000|Overall Study|Physician Decision|2|||
27768729|NCT00880607|80980279|FG001|Overall Study|Physician Decision|2|||
27768730|NCT00880607|80980278|FG000|Overall Study|Protocol Violation|2|||
27768731|NCT00880607|80980279|FG001|Overall Study|Protocol Violation|1|||
27768732|NCT00880607|80980278|FG000|Overall Study|surgery did not extend past L1 level|3|||
27768733|NCT00880607|80980279|FG001|Overall Study|surgery did not extend past L1 level|0|||
27768734|NCT00845845|80980281|FG000|Overall Study|Lost to Follow-up|0|||
27768735|NCT00845845|80980282|FG001|Overall Study|Lost to Follow-up|4|||
27768736|NCT02843178|80980283|FG000|Overall Study|Lost to Follow-up|8|||
27768737|NCT02843178|80980284|FG001|Overall Study|Lost to Follow-up|8|||
27768738|NCT02843178|80980285|FG002|Overall Study|Lost to Follow-up|6|||
27768739|NCT02843178|80980286|FG003|Overall Study|Lost to Follow-up|3|||
27768740|NCT02843178|80980283|FG000|Overall Study|Withdrawal by Subject|0|||
27768741|NCT02843178|80980284|FG001|Overall Study|Withdrawal by Subject|0|||
27768742|NCT02843178|80980285|FG002|Overall Study|Withdrawal by Subject|1|||
27768743|NCT02843178|80980286|FG003|Overall Study|Withdrawal by Subject|1|||
27768744|NCT02715804|80980295|FG000|Overall Study|Death|222|||
27768745|NCT02715804|80980296|FG001|Overall Study|Death|106|||
27768746|NCT02715804|80980295|FG000|Overall Study|Withdrawal by Subject|5|||
27768747|NCT02715804|80980296|FG001|Overall Study|Withdrawal by Subject|4|||
27768748|NCT02715804|80980295|FG000|Overall Study|Other than specified|2|||
27768749|NCT02715804|80980296|FG001|Overall Study|Other than specified|3|||
27768750|NCT03892707|80980299|FG000|Overall Study|Screen failure|6|||
27768751|NCT03892707|80980300|FG001|Overall Study|Screen failure|0|||
27768752|NCT03892707|80980299|FG000|Overall Study|Pain resolution|0|||
27768753|NCT03892707|80980300|FG001|Overall Study|Pain resolution|4|||
27768754|NCT03892707|80980299|FG000|Overall Study|Withdrawal by Subject|0|||
27768755|NCT03892707|80980300|FG001|Overall Study|Withdrawal by Subject|1|||
27768756|NCT03892707|80980299|FG000|Overall Study|Other (long business trip)|0|||
27768757|NCT03892707|80980300|FG001|Overall Study|Other (long business trip)|1|||
27768758|NCT04153929|80984632|FG000|Overall Study|Other than listed|2|||
27768759|NCT04153929|80984633|FG001|Overall Study|Other than listed|2|||
27768760|NCT04153929|80984634|FG002|Overall Study|Other than listed|0|||
27768761|NCT04153929|80984635|FG003|Overall Study|Other than listed|1|||
27768762|NCT04153929|80984636|FG004|Overall Study|Other than listed|0|||
27768763|NCT04153929|80984637|FG005|Overall Study|Other than listed|2|||
27768764|NCT04153929|80984638|FG006|Overall Study|Other than listed|2|||
27768765|NCT04153929|80984639|FG007|Overall Study|Other than listed|1|||
27768766|NCT04153929|80984632|FG000|Overall Study|Lost to Follow-up|2|||
27768767|NCT04153929|80984633|FG001|Overall Study|Lost to Follow-up|1|||
27768768|NCT04153929|80984634|FG002|Overall Study|Lost to Follow-up|0|||
27768769|NCT04153929|80984635|FG003|Overall Study|Lost to Follow-up|1|||
27768770|NCT04153929|80984636|FG004|Overall Study|Lost to Follow-up|1|||
27768771|NCT04153929|80984637|FG005|Overall Study|Lost to Follow-up|0|||
27768772|NCT04153929|80984638|FG006|Overall Study|Lost to Follow-up|0|||
27862189|NCT05384171|81326246|FG000|Overall Study|Withdrawal by Subject|3|||
27862190|NCT05384171|81326247|FG001|Overall Study|Withdrawal by Subject|0|||
27862191|NCT00926783|81326248|FG000|Overall Study|Incomplete CFAE Procedures|3|||
27862192|NCT00926783|81326249|FG001|Overall Study|Incomplete CFAE Procedures|3|||
27768773|NCT04153929|80984639|FG007|Overall Study|Lost to Follow-up|0|||
27768774|NCT04153929|80984632|FG000|Overall Study|Withdrawal by Subject|3|||
27768775|NCT04153929|80984633|FG001|Overall Study|Withdrawal by Subject|1|||
27768776|NCT04153929|80984634|FG002|Overall Study|Withdrawal by Subject|0|||
27768777|NCT04153929|80984635|FG003|Overall Study|Withdrawal by Subject|3|||
27768778|NCT04153929|80984636|FG004|Overall Study|Withdrawal by Subject|1|||
27768779|NCT04153929|80984637|FG005|Overall Study|Withdrawal by Subject|0|||
27768780|NCT04153929|80984638|FG006|Overall Study|Withdrawal by Subject|1|||
27768781|NCT04153929|80984639|FG007|Overall Study|Withdrawal by Subject|0|||
27768782|NCT04153929|80984632|FG000|Overall Study|Protocol Violation|0|||
27768783|NCT04153929|80984633|FG001|Overall Study|Protocol Violation|0|||
27768784|NCT04153929|80984634|FG002|Overall Study|Protocol Violation|0|||
27768785|NCT04153929|80984635|FG003|Overall Study|Protocol Violation|0|||
27768786|NCT04153929|80984636|FG004|Overall Study|Protocol Violation|0|||
27768787|NCT04153929|80984637|FG005|Overall Study|Protocol Violation|0|||
27768788|NCT04153929|80984638|FG006|Overall Study|Protocol Violation|1|||
27768789|NCT04153929|80984639|FG007|Overall Study|Protocol Violation|2|||
27768790|NCT04153929|80984632|FG000|Overall Study|Adverse Event|3|||
27768791|NCT04153929|80984633|FG001|Overall Study|Adverse Event|5|||
27768792|NCT04153929|80984634|FG002|Overall Study|Adverse Event|5|||
27768793|NCT04153929|80984635|FG003|Overall Study|Adverse Event|11|||
27768794|NCT04153929|80984636|FG004|Overall Study|Adverse Event|15|||
27768795|NCT04153929|80984637|FG005|Overall Study|Adverse Event|4|||
27768796|NCT04153929|80984638|FG006|Overall Study|Adverse Event|8|||
27768797|NCT04153929|80984639|FG007|Overall Study|Adverse Event|2|||
27768798|NCT04153929|80984632|FG000|Overall Study|Not treated|1|||
27768799|NCT04153929|80984633|FG001|Overall Study|Not treated|0|||
27768800|NCT04153929|80984634|FG002|Overall Study|Not treated|0|||
27768801|NCT04153929|80984635|FG003|Overall Study|Not treated|0|||
27768802|NCT04153929|80984636|FG004|Overall Study|Not treated|0|||
27768803|NCT04153929|80984637|FG005|Overall Study|Not treated|0|||
27768804|NCT04153929|80984638|FG006|Overall Study|Not treated|1|||
27768805|NCT04153929|80984639|FG007|Overall Study|Not treated|0|||
27768806|NCT02001688|80984640|FG000|Overall Study|Withdrawal by Subject|0|||
27768807|NCT02001688|80984641|FG001|Overall Study|Withdrawal by Subject|0|||
27768808|NCT02001688|80984642|FG002|Overall Study|Withdrawal by Subject|1|||
27768809|NCT02001688|80984640|FG000|Overall Study|Adverse Event|0|||
27768810|NCT02001688|80984641|FG001|Overall Study|Adverse Event|1|||
27768811|NCT02001688|80984642|FG002|Overall Study|Adverse Event|0|||
27768812|NCT00425945|80984643|FG000|Overall Study|Concern about Supplement|2|||
27768813|NCT00425945|80984644|FG001|Overall Study|Concern about Supplement|0|||
27768814|NCT00425945|80984643|FG000|Overall Study|Inconvenience|0|||
27768815|NCT00425945|80984644|FG001|Overall Study|Inconvenience|2|||
27768816|NCT00425945|80984643|FG000|Overall Study|Lost to Follow-up|0|||
27768817|NCT00425945|80984644|FG001|Overall Study|Lost to Follow-up|2|||
27768818|NCT00425945|80984643|FG000|Overall Study|Began hypertension medication|1|||
27768819|NCT00425945|80984644|FG001|Overall Study|Began hypertension medication|0|||
27768820|NCT00425945|80984643|FG000|Overall Study|Began cancer treatments|1|||
27768821|NCT00425945|80984644|FG001|Overall Study|Began cancer treatments|0|||
27768822|NCT00425945|80984643|FG000|Overall Study|Moved from area|0|||
27768823|NCT00425945|80984644|FG001|Overall Study|Moved from area|1|||
27768824|NCT01855425|80984649|FG000|Overall Study|Physician Decision|20|||
27768825|NCT03382262|80984652|FG000|Overall Study|Physician Decision|0|||
27768826|NCT03382262|80984653|FG001|Overall Study|Physician Decision|0|||
27768827|NCT03382262|80984654|FG002|Overall Study|Physician Decision|1|||
27768828|NCT03382262|80984655|FG003|Overall Study|Physician Decision|0|||
27768829|NCT03382262|80984652|FG000|Overall Study|Withdrawal by Subject|0|||
27768830|NCT03382262|80984653|FG001|Overall Study|Withdrawal by Subject|0|||
27768831|NCT03382262|80984654|FG002|Overall Study|Withdrawal by Subject|0|||
27768832|NCT03382262|80984655|FG003|Overall Study|Withdrawal by Subject|1|||
27768833|NCT02829775|80984656|FG000|Overall Study|Death|1|||
27768834|NCT02829775|80984656|FG000|Overall Study|Withdrawal by Subject|3|||
27768835|NCT02829775|80984656|FG000|Overall Study|Disease remission|1|||
27768836|NCT01855945|80984657|FG000|Overall Study|Adverse Event|0|||
27768837|NCT01855945|80984658|FG001|Overall Study|Adverse Event|0|||
27768838|NCT01855945|80984659|FG002|Overall Study|Adverse Event|0|||
27768839|NCT01855945|80984660|FG003|Overall Study|Adverse Event|0|||
27768840|NCT01855945|80984661|FG004|Overall Study|Adverse Event|0|||
27768841|NCT01855945|80984662|FG005|Overall Study|Adverse Event|0|||
27768842|NCT01855945|80984663|FG006|Overall Study|Adverse Event|1|||
27768843|NCT01855945|80984664|FG007|Overall Study|Adverse Event|0|||
27768844|NCT01855945|80984665|FG008|Overall Study|Adverse Event|0|||
27768845|NCT01855945|80984666|FG009|Overall Study|Adverse Event|0|||
27768846|NCT01855945|80984667|FG010|Overall Study|Adverse Event|0|||
27768847|NCT01855945|80984668|FG011|Overall Study|Adverse Event|0|||
27768848|NCT01855945|80984657|FG000|Overall Study|Death|0|||
27768849|NCT01855945|80984658|FG001|Overall Study|Death|0|||
27768850|NCT01855945|80984659|FG002|Overall Study|Death|0|||
27768851|NCT01855945|80984660|FG003|Overall Study|Death|0|||
27768852|NCT01855945|80984661|FG004|Overall Study|Death|0|||
27768853|NCT01855945|80984662|FG005|Overall Study|Death|0|||
27768854|NCT01855945|80984663|FG006|Overall Study|Death|2|||
27768855|NCT01855945|80984664|FG007|Overall Study|Death|0|||
27768856|NCT01855945|80984665|FG008|Overall Study|Death|0|||
27768857|NCT01855945|80984666|FG009|Overall Study|Death|0|||
27768858|NCT01855945|80984667|FG010|Overall Study|Death|0|||
27768859|NCT01855945|80984668|FG011|Overall Study|Death|0|||
27768860|NCT01855945|80984657|FG000|Overall Study|Lost to Follow-up|11|||
27768861|NCT01855945|80984658|FG001|Overall Study|Lost to Follow-up|10|||
27768862|NCT01855945|80984659|FG002|Overall Study|Lost to Follow-up|7|||
27768863|NCT01855945|80984660|FG003|Overall Study|Lost to Follow-up|3|||
27768864|NCT01855945|80984661|FG004|Overall Study|Lost to Follow-up|0|||
27768865|NCT01855945|80984662|FG005|Overall Study|Lost to Follow-up|3|||
27768866|NCT01855945|80984663|FG006|Overall Study|Lost to Follow-up|4|||
27768867|NCT01855945|80984664|FG007|Overall Study|Lost to Follow-up|7|||
27768868|NCT01855945|80984665|FG008|Overall Study|Lost to Follow-up|2|||
27768869|NCT01855945|80984666|FG009|Overall Study|Lost to Follow-up|0|||
27768870|NCT01855945|80984667|FG010|Overall Study|Lost to Follow-up|0|||
27768871|NCT01855945|80984668|FG011|Overall Study|Lost to Follow-up|2|||
27768872|NCT01855945|80984657|FG000|Overall Study|Other - Unclassified|1|||
27768873|NCT01855945|80984658|FG001|Overall Study|Other - Unclassified|1|||
27768874|NCT01855945|80984659|FG002|Overall Study|Other - Unclassified|1|||
27768875|NCT01855945|80984660|FG003|Overall Study|Other - Unclassified|0|||
27768876|NCT01855945|80984661|FG004|Overall Study|Other - Unclassified|0|||
27768877|NCT01855945|80984662|FG005|Overall Study|Other - Unclassified|0|||
27768878|NCT01855945|80984663|FG006|Overall Study|Other - Unclassified|2|||
27768879|NCT01855945|80984664|FG007|Overall Study|Other - Unclassified|1|||
27768880|NCT01855945|80984665|FG008|Overall Study|Other - Unclassified|0|||
27768881|NCT01855945|80984666|FG009|Overall Study|Other - Unclassified|0|||
27768882|NCT01855945|80984667|FG010|Overall Study|Other - Unclassified|1|||
27768883|NCT01855945|80984668|FG011|Overall Study|Other - Unclassified|0|||
27768884|NCT01855945|80984657|FG000|Overall Study|Withdrawal by Subject|4|||
27768885|NCT01855945|80984658|FG001|Overall Study|Withdrawal by Subject|0|||
27768886|NCT01855945|80984659|FG002|Overall Study|Withdrawal by Subject|4|||
27768887|NCT01855945|80984660|FG003|Overall Study|Withdrawal by Subject|1|||
27768888|NCT01855945|80984661|FG004|Overall Study|Withdrawal by Subject|1|||
27768889|NCT01855945|80984662|FG005|Overall Study|Withdrawal by Subject|0|||
27768890|NCT01855945|80984663|FG006|Overall Study|Withdrawal by Subject|1|||
27768891|NCT01855945|80984664|FG007|Overall Study|Withdrawal by Subject|0|||
27768892|NCT01855945|80984665|FG008|Overall Study|Withdrawal by Subject|0|||
27768893|NCT01855945|80984666|FG009|Overall Study|Withdrawal by Subject|2|||
27768894|NCT01855945|80984667|FG010|Overall Study|Withdrawal by Subject|4|||
27768895|NCT01855945|80984668|FG011|Overall Study|Withdrawal by Subject|1|||
27768896|NCT02079519|80984669|FG000|Overall Study|Disease Progression|9|||
27768897|NCT02079519|80984669|FG000|Overall Study|Adverse Event|1|||
27768898|NCT02563925|80984670|FG000|Overall Study|Withdrawal by Subject|2|||
27768899|NCT01105936|80984671|FG000|Period 1|Adverse Event|0|||
27768900|NCT01105936|80984672|FG001|Period 1|Adverse Event|0|||
27768901|NCT01105936|80984673|FG002|Period 1|Adverse Event|0|||
27768902|NCT01105936|80984674|FG003|Period 1|Adverse Event|1|||
27768903|NCT01105936|80984671|FG000|Period 2|Adverse Event|1|||
27768904|NCT01105936|80984672|FG001|Period 2|Adverse Event|0|||
27768905|NCT01105936|80984673|FG002|Period 2|Adverse Event|0|||
27768906|NCT01105936|80984674|FG003|Period 2|Adverse Event|0|||
27768907|NCT01105936|80984671|FG000|Period 3|Protocol Violation|0|||
27768908|NCT01105936|80984672|FG001|Period 3|Protocol Violation|2|||
27768909|NCT01105936|80984673|FG002|Period 3|Protocol Violation|0|||
27768910|NCT01105936|80984674|FG003|Period 3|Protocol Violation|0|||
27768911|NCT00424346|80984682|FG000|Core Study|Adverse Event|5|||
27768912|NCT00424346|80984683|FG001|Core Study|Adverse Event|3|||
27768913|NCT00424346|80984684|FG002|Core Study|Adverse Event|1|||
27768914|NCT00424346|80984685|FG003|Core Study|Adverse Event|1|||
27768915|NCT00424346|80984682|FG000|Core Study|Abnormal Laboratory Values|0|||
27768916|NCT00424346|80984683|FG001|Core Study|Abnormal Laboratory Values|1|||
27768917|NCT00424346|80984684|FG002|Core Study|Abnormal Laboratory Values|0|||
27768918|NCT00424346|80984685|FG003|Core Study|Abnormal Laboratory Values|0|||
27768919|NCT00424346|80984682|FG000|Core Study|Lack of Efficacy|1|||
27768920|NCT00424346|80984683|FG001|Core Study|Lack of Efficacy|3|||
27768921|NCT00424346|80984684|FG002|Core Study|Lack of Efficacy|0|||
27768922|NCT00424346|80984685|FG003|Core Study|Lack of Efficacy|4|||
27768923|NCT00424346|80984682|FG000|Core Study|Withdrawal by Subject|1|||
27768924|NCT00424346|80984683|FG001|Core Study|Withdrawal by Subject|0|||
27768925|NCT00424346|80984684|FG002|Core Study|Withdrawal by Subject|0|||
27768926|NCT00424346|80984685|FG003|Core Study|Withdrawal by Subject|2|||
27768927|NCT00424346|80984682|FG000|Core Study|Lost to Follow-up|1|||
27663892|NCT00931918|80606553|FG000|Overall Study|Symptomatic Deterioration|1|||
27768928|NCT00424346|80984683|FG001|Core Study|Lost to Follow-up|1|||
27768929|NCT00424346|80984684|FG002|Core Study|Lost to Follow-up|0|||
27768930|NCT00424346|80984685|FG003|Core Study|Lost to Follow-up|0|||
27768931|NCT00424346|80984682|FG000|Core Study|Administrative Problems|1|||
27768932|NCT00424346|80984683|FG001|Core Study|Administrative Problems|0|||
27663893|NCT00931918|80606554|FG001|Overall Study|Symptomatic Deterioration|0|||
27663894|NCT00931918|80606553|FG000|Overall Study|Withdrawal by Patient|3|||
27663895|NCT00931918|80606554|FG001|Overall Study|Withdrawal by Patient|4|||
27663896|NCT00931918|80606553|FG000|Overall Study|Other Reason not Specified|4|||
27663897|NCT00931918|80606554|FG001|Overall Study|Other Reason not Specified|4|||
27663898|NCT00931918|80606553|FG000|Overall Study|Did not receive study drug|3|||
27768933|NCT00424346|80984684|FG002|Core Study|Administrative Problems|1|||
27768934|NCT00424346|80984685|FG003|Core Study|Administrative Problems|0|||
27768935|NCT00424346|80984682|FG000|Core Study|Protocol Violation|0|||
27768936|NCT00424346|80984683|FG001|Core Study|Protocol Violation|0|||
27768937|NCT00424346|80984684|FG002|Core Study|Protocol Violation|2|||
27768938|NCT00424346|80984685|FG003|Core Study|Protocol Violation|0|||
27768939|NCT00424346|80984682|FG000|Extension Phase|Adverse Event|0|||
27768940|NCT00424346|80984683|FG001|Extension Phase|Adverse Event|9|||
27768941|NCT00424346|80984684|FG002|Extension Phase|Adverse Event|5|||
27768942|NCT00424346|80984685|FG003|Extension Phase|Adverse Event|4|||
27768943|NCT00424346|80984682|FG000|Extension Phase|Lack of Efficacy|0|||
27768944|NCT00424346|80984683|FG001|Extension Phase|Lack of Efficacy|16|||
27768945|NCT00424346|80984684|FG002|Extension Phase|Lack of Efficacy|14|||
27768946|NCT00424346|80984685|FG003|Extension Phase|Lack of Efficacy|11|||
27768947|NCT00424346|80984682|FG000|Extension Phase|Withdrawal by Subject|0|||
27768948|NCT00424346|80984683|FG001|Extension Phase|Withdrawal by Subject|5|||
27768949|NCT00424346|80984684|FG002|Extension Phase|Withdrawal by Subject|3|||
27768950|NCT00424346|80984685|FG003|Extension Phase|Withdrawal by Subject|4|||
27768951|NCT00424346|80984682|FG000|Extension Phase|Lost to Follow-up|0|||
27768952|NCT00424346|80984683|FG001|Extension Phase|Lost to Follow-up|2|||
27963366|NCT00887159|81698983|FG000|Overall Study|Withdrawal by Subject|4|||
27963367|NCT00887159|81698984|FG001|Overall Study|Withdrawal by Subject|4|||
27963368|NCT00887159|81698985|FG002|Overall Study|Withdrawal by Subject|2|||
27963369|NCT00887159|81698983|FG000|Overall Study|Alternative therapy|2|||
27963370|NCT00887159|81698984|FG001|Overall Study|Alternative therapy|0|||
27963371|NCT00887159|81698985|FG002|Overall Study|Alternative therapy|0|||
27963372|NCT00887159|81698983|FG000|Overall Study|Physician Decision|1|||
27963373|NCT00887159|81698984|FG001|Overall Study|Physician Decision|1|||
27963374|NCT00887159|81698985|FG002|Overall Study|Physician Decision|0|||
27963375|NCT00887159|81698983|FG000|Overall Study|Sympomatic deterioration|1|||
27963376|NCT00887159|81698984|FG001|Overall Study|Sympomatic deterioration|0|||
27963377|NCT00887159|81698985|FG002|Overall Study|Sympomatic deterioration|0|||
27963378|NCT00887159|81698983|FG000|Overall Study|Treatment delayed|1|||
27963379|NCT00887159|81698984|FG001|Overall Study|Treatment delayed|1|||
27963380|NCT00887159|81698985|FG002|Overall Study|Treatment delayed|0|||
27963381|NCT00887159|81698983|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
27963382|NCT00887159|81698984|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
27963383|NCT00887159|81698985|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
27963384|NCT00887159|81698983|FG000|Overall Study|Received more tx instead of observation|1|||
27963385|NCT00887159|81698984|FG001|Overall Study|Received more tx instead of observation|0|||
27963386|NCT00887159|81698985|FG002|Overall Study|Received more tx instead of observation|0|||
27963387|NCT00887159|81698983|FG000|Overall Study|Ineligible|5|||
27963388|NCT00887159|81698984|FG001|Overall Study|Ineligible|1|||
27963389|NCT00887159|81698985|FG002|Overall Study|Ineligible|0|||
27963390|NCT00887159|81698983|FG000|Overall Study|Never started assigned therapy|3|||
27963391|NCT00887159|81698984|FG001|Overall Study|Never started assigned therapy|3|||
27963392|NCT00887159|81698985|FG002|Overall Study|Never started assigned therapy|4|||
27963393|NCT00600106|81698988|FG000|Overall Study|Withdrawal by Subject|1|||
27963394|NCT00600106|81698989|FG001|Overall Study|Withdrawal by Subject|1|||
27963395|NCT02574078|81698990|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963396|NCT02574078|81698991|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963397|NCT02574078|81698992|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963398|NCT02574078|81698993|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963399|NCT02574078|81698994|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963400|NCT02574078|81698995|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27963401|NCT02574078|81698996|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
27963402|NCT02574078|81698997|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963403|NCT02574078|81698998|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27963404|NCT02574078|81698999|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963405|NCT02574078|81699000|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963406|NCT02574078|81699001|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963407|NCT02574078|81699002|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27963408|NCT02574078|81698990|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
27963409|NCT02574078|81698991|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27963410|NCT02574078|81698992|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
27963411|NCT02574078|81698993|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
27963412|NCT02574078|81698994|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
27963413|NCT02574078|81698995|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
27569005|NCT02658890|80271487|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
27569006|NCT02658890|80271488|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
27569007|NCT02658890|80271489|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
27768953|NCT00424346|80984684|FG002|Extension Phase|Lost to Follow-up|0|||
27963414|NCT02574078|81698996|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
27768954|NCT00424346|80984685|FG003|Extension Phase|Lost to Follow-up|0|||
27768955|NCT00424346|80984682|FG000|Extension Phase|Administrative Problems|0|||
27768956|NCT00424346|80984683|FG001|Extension Phase|Administrative Problems|69|||
27963415|NCT02574078|81698997|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
27768957|NCT00424346|80984684|FG002|Extension Phase|Administrative Problems|32|||
27963416|NCT02574078|81698998|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
27963417|NCT02574078|81698999|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
27963418|NCT02574078|81699000|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
27963419|NCT02574078|81699001|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
27963420|NCT02574078|81699002|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
27963421|NCT02574078|81698990|FG000|Pre-Treatment Period|Other reasons|0|||
27963422|NCT02574078|81698991|FG001|Pre-Treatment Period|Other reasons|0|||
27963423|NCT02574078|81698992|FG002|Pre-Treatment Period|Other reasons|0|||
27963424|NCT02574078|81698993|FG003|Pre-Treatment Period|Other reasons|0|||
27963425|NCT02574078|81698994|FG004|Pre-Treatment Period|Other reasons|0|||
27963426|NCT02574078|81698995|FG005|Pre-Treatment Period|Other reasons|0|||
27963427|NCT02574078|81698996|FG006|Pre-Treatment Period|Other reasons|2|||
27963428|NCT02574078|81698997|FG007|Pre-Treatment Period|Other reasons|0|||
27963429|NCT02574078|81698998|FG008|Pre-Treatment Period|Other reasons|0|||
27963430|NCT02574078|81698999|FG009|Pre-Treatment Period|Other reasons|0|||
27963431|NCT02574078|81699000|FG010|Pre-Treatment Period|Other reasons|2|||
27963432|NCT02574078|81699001|FG011|Pre-Treatment Period|Other reasons|0|||
27963433|NCT02574078|81699002|FG012|Pre-Treatment Period|Other reasons|0|||
27963434|NCT02574078|81698990|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
27963435|NCT02574078|81698991|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
27963436|NCT02574078|81698992|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
27963437|NCT02574078|81698993|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
27963438|NCT02574078|81698994|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
27963439|NCT02574078|81698995|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
27963440|NCT02574078|81698996|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
27963441|NCT02574078|81698997|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
27963442|NCT02574078|81698998|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
27963443|NCT02574078|81698999|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
27963444|NCT02574078|81699000|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
27963445|NCT02574078|81699001|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
27963446|NCT02574078|81699002|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
27963447|NCT02574078|81698990|FG000|Treatment Period|Disease progression|6|||
27963448|NCT02574078|81698991|FG001|Treatment Period|Disease progression|4|||
27963449|NCT02574078|81698992|FG002|Treatment Period|Disease progression|7|||
27963450|NCT02574078|81698993|FG003|Treatment Period|Disease progression|18|||
27963451|NCT02574078|81698994|FG004|Treatment Period|Disease progression|16|||
27963452|NCT02574078|81698995|FG005|Treatment Period|Disease progression|26|||
27963453|NCT02574078|81698996|FG006|Treatment Period|Disease progression|5|||
27963454|NCT02574078|81698997|FG007|Treatment Period|Disease progression|9|||
27963455|NCT02574078|81698998|FG008|Treatment Period|Disease progression|8|||
27963456|NCT02574078|81698999|FG009|Treatment Period|Disease progression|5|||
27963457|NCT02574078|81699000|FG010|Treatment Period|Disease progression|20|||
27963458|NCT02574078|81699001|FG011|Treatment Period|Disease progression|29|||
27963459|NCT02574078|81699002|FG012|Treatment Period|Disease progression|2|||
27963460|NCT02574078|81698990|FG000|Treatment Period|Study drug toxicity|1|||
27963461|NCT02574078|81698991|FG001|Treatment Period|Study drug toxicity|1|||
27963462|NCT02574078|81698992|FG002|Treatment Period|Study drug toxicity|0|||
27963463|NCT02574078|81698993|FG003|Treatment Period|Study drug toxicity|5|||
27963464|NCT02574078|81698994|FG004|Treatment Period|Study drug toxicity|3|||
27963465|NCT02574078|81698995|FG005|Treatment Period|Study drug toxicity|1|||
27963466|NCT02574078|81698996|FG006|Treatment Period|Study drug toxicity|2|||
27963467|NCT02574078|81698997|FG007|Treatment Period|Study drug toxicity|0|||
27963468|NCT02574078|81698998|FG008|Treatment Period|Study drug toxicity|2|||
27963469|NCT02574078|81698999|FG009|Treatment Period|Study drug toxicity|1|||
27963470|NCT02574078|81699000|FG010|Treatment Period|Study drug toxicity|16|||
27963471|NCT02574078|81699001|FG011|Treatment Period|Study drug toxicity|2|||
27963472|NCT02574078|81699002|FG012|Treatment Period|Study drug toxicity|4|||
27963473|NCT02574078|81698990|FG000|Treatment Period|Death|2|||
27963474|NCT02574078|81698991|FG001|Treatment Period|Death|0|||
27963475|NCT02574078|81698992|FG002|Treatment Period|Death|0|||
27963476|NCT02574078|81698993|FG003|Treatment Period|Death|0|||
27963477|NCT02574078|81698994|FG004|Treatment Period|Death|1|||
27963478|NCT02574078|81698995|FG005|Treatment Period|Death|1|||
27963479|NCT02574078|81698996|FG006|Treatment Period|Death|1|||
27768958|NCT00424346|80984685|FG003|Extension Phase|Administrative Problems|35|||
27963480|NCT02574078|81698997|FG007|Treatment Period|Death|1|||
27963481|NCT02574078|81698998|FG008|Treatment Period|Death|7|||
27963482|NCT02574078|81698999|FG009|Treatment Period|Death|1|||
27768959|NCT00424346|80984682|FG000|Extension Phase|Death|0|||
27963483|NCT02574078|81699000|FG010|Treatment Period|Death|0|||
27963484|NCT02574078|81699001|FG011|Treatment Period|Death|2|||
27963485|NCT02574078|81699002|FG012|Treatment Period|Death|1|||
27963486|NCT02574078|81698990|FG000|Treatment Period|Adverse event unrelated to drug|0|||
27963487|NCT02574078|81698991|FG001|Treatment Period|Adverse event unrelated to drug|0|||
27963488|NCT02574078|81698992|FG002|Treatment Period|Adverse event unrelated to drug|1|||
27963489|NCT02574078|81698993|FG003|Treatment Period|Adverse event unrelated to drug|0|||
27963490|NCT02574078|81698994|FG004|Treatment Period|Adverse event unrelated to drug|2|||
27963491|NCT02574078|81698995|FG005|Treatment Period|Adverse event unrelated to drug|3|||
27963492|NCT02574078|81698996|FG006|Treatment Period|Adverse event unrelated to drug|0|||
27963493|NCT02574078|81698997|FG007|Treatment Period|Adverse event unrelated to drug|0|||
27963494|NCT02574078|81698998|FG008|Treatment Period|Adverse event unrelated to drug|1|||
27963495|NCT02574078|81698999|FG009|Treatment Period|Adverse event unrelated to drug|2|||
27963496|NCT02574078|81699000|FG010|Treatment Period|Adverse event unrelated to drug|4|||
27963497|NCT02574078|81699001|FG011|Treatment Period|Adverse event unrelated to drug|1|||
27963498|NCT02574078|81699002|FG012|Treatment Period|Adverse event unrelated to drug|0|||
27963499|NCT02574078|81698990|FG000|Treatment Period|Administrative reason by Sponsor|0|||
27963500|NCT02574078|81698991|FG001|Treatment Period|Administrative reason by Sponsor|1|||
27963501|NCT02574078|81698992|FG002|Treatment Period|Administrative reason by Sponsor|0|||
27963502|NCT02574078|81698993|FG003|Treatment Period|Administrative reason by Sponsor|0|||
27963503|NCT02574078|81698994|FG004|Treatment Period|Administrative reason by Sponsor|0|||
27963504|NCT02574078|81698995|FG005|Treatment Period|Administrative reason by Sponsor|0|||
27963505|NCT02574078|81698996|FG006|Treatment Period|Administrative reason by Sponsor|1|||
27963506|NCT02574078|81698997|FG007|Treatment Period|Administrative reason by Sponsor|0|||
27963507|NCT02574078|81698998|FG008|Treatment Period|Administrative reason by Sponsor|0|||
27963508|NCT02574078|81698999|FG009|Treatment Period|Administrative reason by Sponsor|0|||
27963509|NCT02574078|81699000|FG010|Treatment Period|Administrative reason by Sponsor|0|||
27963510|NCT02574078|81699001|FG011|Treatment Period|Administrative reason by Sponsor|0|||
27963511|NCT02574078|81699002|FG012|Treatment Period|Administrative reason by Sponsor|3|||
27963512|NCT02574078|81698990|FG000|Treatment Period|Other reasons|1|||
27963513|NCT02574078|81698991|FG001|Treatment Period|Other reasons|0|||
27963514|NCT02574078|81698992|FG002|Treatment Period|Other reasons|1|||
27963515|NCT02574078|81698993|FG003|Treatment Period|Other reasons|3|||
27963516|NCT02574078|81698994|FG004|Treatment Period|Other reasons|3|||
27963517|NCT02574078|81698995|FG005|Treatment Period|Other reasons|1|||
27963518|NCT02574078|81698996|FG006|Treatment Period|Other reasons|2|||
27963519|NCT02574078|81698997|FG007|Treatment Period|Other reasons|1|||
27963520|NCT02574078|81698998|FG008|Treatment Period|Other reasons|3|||
27963521|NCT02574078|81698999|FG009|Treatment Period|Other reasons|1|||
27963522|NCT02574078|81699000|FG010|Treatment Period|Other reasons|1|||
27963523|NCT02574078|81699001|FG011|Treatment Period|Other reasons|3|||
27963524|NCT02574078|81699002|FG012|Treatment Period|Other reasons|1|||
27963525|NCT02574078|81698990|FG000|Treatment Period|Participant request to stop drug|0|||
27963526|NCT02574078|81698991|FG001|Treatment Period|Participant request to stop drug|0|||
27963527|NCT02574078|81698992|FG002|Treatment Period|Participant request to stop drug|0|||
27963528|NCT02574078|81698993|FG003|Treatment Period|Participant request to stop drug|2|||
27963529|NCT02574078|81698994|FG004|Treatment Period|Participant request to stop drug|4|||
27963530|NCT02574078|81698995|FG005|Treatment Period|Participant request to stop drug|0|||
27963531|NCT02574078|81698996|FG006|Treatment Period|Participant request to stop drug|1|||
27963532|NCT02574078|81698997|FG007|Treatment Period|Participant request to stop drug|0|||
27963533|NCT02574078|81698998|FG008|Treatment Period|Participant request to stop drug|3|||
27963534|NCT02574078|81698999|FG009|Treatment Period|Participant request to stop drug|2|||
27963535|NCT02574078|81699000|FG010|Treatment Period|Participant request to stop drug|2|||
27963536|NCT02574078|81699001|FG011|Treatment Period|Participant request to stop drug|4|||
27963537|NCT02574078|81699002|FG012|Treatment Period|Participant request to stop drug|1|||
27963538|NCT02574078|81698990|FG000|Treatment Period|Participant withdrew consent|0|||
27963539|NCT02574078|81698991|FG001|Treatment Period|Participant withdrew consent|0|||
27963540|NCT02574078|81698992|FG002|Treatment Period|Participant withdrew consent|0|||
27963541|NCT02574078|81698993|FG003|Treatment Period|Participant withdrew consent|0|||
27963542|NCT02574078|81698994|FG004|Treatment Period|Participant withdrew consent|1|||
27963543|NCT02574078|81698995|FG005|Treatment Period|Participant withdrew consent|1|||
27963544|NCT02574078|81698996|FG006|Treatment Period|Participant withdrew consent|0|||
27963545|NCT02574078|81698997|FG007|Treatment Period|Participant withdrew consent|1|||
27963546|NCT02574078|81698998|FG008|Treatment Period|Participant withdrew consent|0|||
27768960|NCT00424346|80984683|FG001|Extension Phase|Death|0|||
27963547|NCT02574078|81698999|FG009|Treatment Period|Participant withdrew consent|2|||
27963548|NCT02574078|81699000|FG010|Treatment Period|Participant withdrew consent|1|||
27963549|NCT02574078|81699001|FG011|Treatment Period|Participant withdrew consent|4|||
27963550|NCT02574078|81699002|FG012|Treatment Period|Participant withdrew consent|1|||
27963551|NCT02574078|81698990|FG000|Treatment Period|Participant no longer meets criteria|0|||
27768961|NCT00424346|80984684|FG002|Extension Phase|Death|0|||
27963552|NCT02574078|81698991|FG001|Treatment Period|Participant no longer meets criteria|0|||
27963553|NCT02574078|81698992|FG002|Treatment Period|Participant no longer meets criteria|0|||
27963554|NCT02574078|81698993|FG003|Treatment Period|Participant no longer meets criteria|0|||
27963555|NCT02574078|81698994|FG004|Treatment Period|Participant no longer meets criteria|1|||
27963556|NCT02574078|81698995|FG005|Treatment Period|Participant no longer meets criteria|0|||
27963557|NCT02574078|81698996|FG006|Treatment Period|Participant no longer meets criteria|0|||
27963558|NCT02574078|81698997|FG007|Treatment Period|Participant no longer meets criteria|0|||
27963559|NCT02574078|81698998|FG008|Treatment Period|Participant no longer meets criteria|0|||
27963560|NCT02574078|81698999|FG009|Treatment Period|Participant no longer meets criteria|1|||
27963561|NCT02574078|81699000|FG010|Treatment Period|Participant no longer meets criteria|1|||
27963562|NCT02574078|81699001|FG011|Treatment Period|Participant no longer meets criteria|1|||
27963563|NCT02574078|81699002|FG012|Treatment Period|Participant no longer meets criteria|0|||
27963564|NCT02574078|81698990|FG000|Treatment Period|Lost to Follow-up|0|||
27963565|NCT02574078|81698991|FG001|Treatment Period|Lost to Follow-up|0|||
27963566|NCT02574078|81698992|FG002|Treatment Period|Lost to Follow-up|0|||
27963567|NCT02574078|81698993|FG003|Treatment Period|Lost to Follow-up|0|||
27963568|NCT02574078|81698994|FG004|Treatment Period|Lost to Follow-up|0|||
27963569|NCT02574078|81698995|FG005|Treatment Period|Lost to Follow-up|0|||
27963570|NCT02574078|81698996|FG006|Treatment Period|Lost to Follow-up|0|||
27963571|NCT02574078|81698997|FG007|Treatment Period|Lost to Follow-up|0|||
27963572|NCT02574078|81698998|FG008|Treatment Period|Lost to Follow-up|0|||
27963573|NCT02574078|81698999|FG009|Treatment Period|Lost to Follow-up|1|||
27963574|NCT02574078|81699000|FG010|Treatment Period|Lost to Follow-up|0|||
27963575|NCT02574078|81699001|FG011|Treatment Period|Lost to Follow-up|1|||
27963576|NCT02574078|81699002|FG012|Treatment Period|Lost to Follow-up|0|||
27963577|NCT02574078|81698990|FG000|Treatment Period|Maximum clinical benefit|0|||
27963578|NCT02574078|81698991|FG001|Treatment Period|Maximum clinical benefit|0|||
27963579|NCT02574078|81698992|FG002|Treatment Period|Maximum clinical benefit|0|||
27963580|NCT02574078|81698993|FG003|Treatment Period|Maximum clinical benefit|0|||
27963581|NCT02574078|81698994|FG004|Treatment Period|Maximum clinical benefit|0|||
27963582|NCT02574078|81698995|FG005|Treatment Period|Maximum clinical benefit|0|||
27963583|NCT02574078|81698996|FG006|Treatment Period|Maximum clinical benefit|0|||
27963584|NCT02574078|81698997|FG007|Treatment Period|Maximum clinical benefit|0|||
27963585|NCT02574078|81698998|FG008|Treatment Period|Maximum clinical benefit|0|||
27963586|NCT02574078|81698999|FG009|Treatment Period|Maximum clinical benefit|1|||
27963587|NCT02574078|81699000|FG010|Treatment Period|Maximum clinical benefit|0|||
27963588|NCT02574078|81699001|FG011|Treatment Period|Maximum clinical benefit|0|||
27963589|NCT02574078|81699002|FG012|Treatment Period|Maximum clinical benefit|0|||
27963590|NCT02038777|81699004|FG000|Overall Study|Death|0|||
27963591|NCT02038777|81699005|FG001|Overall Study|Death|2|||
27963592|NCT02038777|81699006|FG002|Overall Study|Death|0|||
27963593|NCT02038777|81699007|FG003|Overall Study|Death|1|||
27963594|NCT02038777|81699008|FG004|Overall Study|Death|2|||
27963595|NCT02038777|81699009|FG005|Overall Study|Death|4|||
27963596|NCT02038777|81699010|FG006|Overall Study|Death|0|||
27768962|NCT00424346|80984685|FG003|Extension Phase|Death|1|||
27768963|NCT00424346|80984682|FG000|Extension Phase|Protocol Violation|0|||
27768964|NCT00424346|80984683|FG001|Extension Phase|Protocol Violation|1|||
27768965|NCT00424346|80984684|FG002|Extension Phase|Protocol Violation|1|||
27768966|NCT00424346|80984685|FG003|Extension Phase|Protocol Violation|0|||
27768967|NCT04498468|80984686|FG000|Overall Study|Lost to Follow-up|3|||
27768968|NCT00255034|80984687|FG000|Overall Study|Withdrawal by Subject|15|||
27768969|NCT00255034|80984688|FG001|Overall Study|Withdrawal by Subject|38|||
27768970|NCT01922739|80984691|FG000|Titration/Adjustment Period|Adverse Event|3|||
27768971|NCT01922739|80984691|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
27768972|NCT01922739|80984691|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
27768973|NCT01922739|80984691|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
27768974|NCT01922739|80984691|FG000|Open-label Treatment Period|Adverse Event|6|||
27768975|NCT01922739|80984691|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
27768976|NCT01922739|80984691|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
27768977|NCT01922739|80984691|FG000|Open-label Treatment Period|Protocol Violation|5|||
27768978|NCT01922739|80984691|FG000|Open-label Treatment Period|Pregnancy|1|||
27963597|NCT02038777|81699011|FG007|Overall Study|Death|10|||
27963598|NCT02038777|81699004|FG000|Overall Study|Lost to Follow-up|0|||
27963599|NCT02038777|81699005|FG001|Overall Study|Lost to Follow-up|0|||
27963600|NCT02038777|81699006|FG002|Overall Study|Lost to Follow-up|0|||
27963601|NCT02038777|81699007|FG003|Overall Study|Lost to Follow-up|1|||
27963602|NCT02038777|81699008|FG004|Overall Study|Lost to Follow-up|0|||
27963603|NCT02038777|81699009|FG005|Overall Study|Lost to Follow-up|0|||
27963604|NCT02038777|81699010|FG006|Overall Study|Lost to Follow-up|0|||
27963605|NCT02038777|81699011|FG007|Overall Study|Lost to Follow-up|0|||
27963606|NCT02038777|81699004|FG000|Overall Study|Other|0|||
27963607|NCT02038777|81699005|FG001|Overall Study|Other|1|||
27768979|NCT01922739|80984691|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
27963608|NCT02038777|81699006|FG002|Overall Study|Other|0|||
27768980|NCT01922739|80984691|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
27768981|NCT01922739|80984691|FG000|Open-label Treatment Period|Physician Decision|1|||
27768982|NCT01922739|80984691|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
27963609|NCT02038777|81699007|FG003|Overall Study|Other|2|||
27963610|NCT02038777|81699008|FG004|Overall Study|Other|1|||
27963611|NCT02038777|81699009|FG005|Overall Study|Other|0|||
27963612|NCT02038777|81699010|FG006|Overall Study|Other|0|||
27963613|NCT02038777|81699011|FG007|Overall Study|Other|0|||
27963614|NCT02038777|81699004|FG000|Overall Study|Randomized but not treated|0|||
27963615|NCT02038777|81699005|FG001|Overall Study|Randomized but not treated|1|||
27963616|NCT02038777|81699006|FG002|Overall Study|Randomized but not treated|0|||
27963617|NCT02038777|81699007|FG003|Overall Study|Randomized but not treated|0|||
27963618|NCT02038777|81699008|FG004|Overall Study|Randomized but not treated|0|||
27963619|NCT02038777|81699009|FG005|Overall Study|Randomized but not treated|0|||
27963620|NCT02038777|81699010|FG006|Overall Study|Randomized but not treated|0|||
27963621|NCT02038777|81699011|FG007|Overall Study|Randomized but not treated|0|||
27963622|NCT02038777|81699004|FG000|Overall Study|Started Chemotherapy|1|||
27963623|NCT02038777|81699005|FG001|Overall Study|Started Chemotherapy|0|||
27963624|NCT02038777|81699006|FG002|Overall Study|Started Chemotherapy|3|||
27963625|NCT02038777|81699007|FG003|Overall Study|Started Chemotherapy|0|||
27963626|NCT02038777|81699008|FG004|Overall Study|Started Chemotherapy|0|||
27963627|NCT02038777|81699009|FG005|Overall Study|Started Chemotherapy|0|||
27963628|NCT02038777|81699010|FG006|Overall Study|Started Chemotherapy|0|||
27963629|NCT02038777|81699011|FG007|Overall Study|Started Chemotherapy|0|||
27963630|NCT03850093|81699014|FG000|Overall Study|Withdrawal by Subject|1|||
27963631|NCT03850093|81699015|FG001|Overall Study|Withdrawal by Subject|0|||
27963632|NCT03850093|81699016|FG002|Overall Study|Withdrawal by Subject|2|||
27963633|NCT01234480|81699017|FG000|Overall Study|Pregnancy|88|||
27963634|NCT01234480|81699017|FG000|Overall Study|>36/Normal History|50|||
27963635|NCT01234480|81699017|FG000|Overall Study|Age|3|||
27963636|NCT01234480|81699017|FG000|Overall Study|HPV Vaccine History|28|||
27963637|NCT01234480|81699017|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
27963638|NCT01234480|81699017|FG000|Overall Study|Hysterectomy|2|||
27963639|NCT01234480|81699017|FG000|Overall Study|Hysterectomy post enrollment|1|||
27963640|NCT01234480|81699017|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
27963641|NCT01234480|81699017|FG000|Overall Study|Informed Consent Form Violation|30|||
27963642|NCT01234480|81699017|FG000|Overall Study|Incorrect Visit|3|||
27963643|NCT01234480|81699017|FG000|Overall Study|No Florida Lab License|20|||
27963644|NCT01234480|81699017|FG000|Overall Study|Out of Window|42|||
27963645|NCT01234480|81699017|FG000|Overall Study|Sample Processing/Storage|92|||
27963646|NCT01234480|81699017|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
27963647|NCT01234480|81699017|FG000|Overall Study|Site/Subject non-compliance|44|||
27963648|NCT01234480|81699017|FG000|Overall Study|Missing Sample|9|||
27963649|NCT02195700|81699019|FG000|Overall Study|Protocol Violation|0|||
27963650|NCT02195700|81699020|FG001|Overall Study|Protocol Violation|2|||
27963651|NCT02195700|81699019|FG000|Overall Study|Noncompliance|1|||
27963652|NCT02195700|81699020|FG001|Overall Study|Noncompliance|0|||
27963653|NCT02195700|81699019|FG000|Overall Study|Adverse Event|1|||
27963654|NCT02195700|81699020|FG001|Overall Study|Adverse Event|2|||
27963655|NCT02195700|81699019|FG000|Overall Study|Withdrawal by Subject|3|||
27963656|NCT02195700|81699020|FG001|Overall Study|Withdrawal by Subject|2|||
27963657|NCT02195700|81699019|FG000|Overall Study|Lost to Follow-up|1|||
27963658|NCT02195700|81699020|FG001|Overall Study|Lost to Follow-up|1|||
27963659|NCT00456755|81699021|FG000|Overall Study|Lost to Follow-up|2|||
27963660|NCT00456755|81699022|FG001|Overall Study|Lost to Follow-up|1|||
27963661|NCT01262638|81699023|FG000|Overall Study|Adverse Event|3|||
27963662|NCT01262638|81699024|FG001|Overall Study|Adverse Event|4|||
27963663|NCT01262638|81699025|FG002|Overall Study|Adverse Event|3|||
27963664|NCT01262638|81699026|FG003|Overall Study|Adverse Event|4|||
27963665|NCT01262638|81699023|FG000|Overall Study|Protocol Violation|1|||
27963666|NCT01262638|81699024|FG001|Overall Study|Protocol Violation|0|||
27963667|NCT01262638|81699025|FG002|Overall Study|Protocol Violation|0|||
27963668|NCT01262638|81699026|FG003|Overall Study|Protocol Violation|1|||
27963669|NCT01262638|81699023|FG000|Overall Study|Withdrawal by Subject|2|||
27963670|NCT01262638|81699024|FG001|Overall Study|Withdrawal by Subject|1|||
27963671|NCT01262638|81699025|FG002|Overall Study|Withdrawal by Subject|0|||
27963672|NCT01262638|81699026|FG003|Overall Study|Withdrawal by Subject|1|||
27963673|NCT01262638|81699023|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
27963674|NCT01262638|81699024|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
27768983|NCT02671760|80984692|FG000|Overall Study|Lost to Follow-up|0|||
27768984|NCT02671760|80984693|FG001|Overall Study|Lost to Follow-up|1|||
27768985|NCT02671760|80984694|FG002|Overall Study|Lost to Follow-up|0|||
27768986|NCT01143714|80984695|FG000|Overall Study|Adverse Event|4|||
27768987|NCT01143714|80984696|FG001|Overall Study|Adverse Event|2|||
27768988|NCT01143714|80984695|FG000|Overall Study|Withdrawal by Subject|1|||
27768989|NCT01143714|80984696|FG001|Overall Study|Withdrawal by Subject|0|||
27768990|NCT01143714|80984695|FG000|Overall Study|Subject non-compliance|0|||
27768991|NCT01143714|80984696|FG001|Overall Study|Subject non-compliance|1|||
27768992|NCT01143714|80984695|FG000|Overall Study|wound closed = deemed healed|1|||
27768993|NCT01143714|80984696|FG001|Overall Study|wound closed = deemed healed|0|||
27768994|NCT01143714|80984695|FG000|Overall Study|wound size increased|1|||
27768995|NCT01143714|80984696|FG001|Overall Study|wound size increased|0|||
27768996|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
27768997|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
27768998|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
27768999|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
27769000|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
27769001|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
27769002|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
27769003|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
27769004|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
27769005|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
27769006|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
27769007|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
27769008|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
27769009|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
27769010|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
27769011|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
27769012|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
27769013|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
27769014|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
27769015|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
27963675|NCT01262638|81699025|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
27963676|NCT01262638|81699026|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
27963677|NCT01262638|81699023|FG000|Overall Study|Lost to Follow-up|1|||
27963678|NCT01262638|81699024|FG001|Overall Study|Lost to Follow-up|1|||
27963679|NCT01262638|81699025|FG002|Overall Study|Lost to Follow-up|1|||
27963680|NCT01262638|81699026|FG003|Overall Study|Lost to Follow-up|1|||
27963681|NCT01262638|81699023|FG000|Overall Study|Participant Went Out of Town|0|||
27963682|NCT01262638|81699024|FG001|Overall Study|Participant Went Out of Town|0|||
27769016|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
27769017|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
27769018|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
27769019|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
27769020|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
27769021|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
27769022|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
27769023|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
27769024|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
27769025|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
27963683|NCT01262638|81699025|FG002|Overall Study|Participant Went Out of Town|1|||
27963684|NCT01262638|81699026|FG003|Overall Study|Participant Went Out of Town|0|||
27963685|NCT03820986|81699029|FG000|Overall Study|Death|177|||
27963686|NCT03820986|81699030|FG001|Overall Study|Death|156|||
27963687|NCT03820986|81699029|FG000|Overall Study|Lost to Follow-up|0|||
27963688|NCT03820986|81699030|FG001|Overall Study|Lost to Follow-up|1|||
27963689|NCT03820986|81699029|FG000|Overall Study|Withdrawal by Subject|8|||
27963690|NCT03820986|81699030|FG001|Overall Study|Withdrawal by Subject|3|||
27963691|NCT03820986|81699029|FG000|Overall Study|Ongoing|149|||
27963692|NCT03820986|81699030|FG001|Overall Study|Ongoing|180|||
27963693|NCT01221623|81699032|FG000|Overall Study|Withdrawal by Subject|19|||
27963694|NCT01221623|81699033|FG001|Overall Study|Withdrawal by Subject|8|||
27963695|NCT01221623|81699032|FG000|Overall Study|Lost to Follow-up|7|||
27963696|NCT01221623|81699033|FG001|Overall Study|Lost to Follow-up|1|||
27963697|NCT01221623|81699032|FG000|Overall Study|Adverse Event|6|||
27963698|NCT01221623|81699033|FG001|Overall Study|Adverse Event|3|||
27963699|NCT01221623|81699032|FG000|Overall Study|Death|1|||
27963700|NCT01221623|81699033|FG001|Overall Study|Death|0|||
27963701|NCT01221623|81699032|FG000|Overall Study|Other|5|||
27963702|NCT01221623|81699033|FG001|Overall Study|Other|2|||
27963703|NCT00809835|81699034|FG000|Overall Study|Lost to Follow-up|7|||
27963704|NCT00809835|81699035|FG001|Overall Study|Lost to Follow-up|6|||
27963705|NCT00809835|81699036|FG002|Overall Study|Lost to Follow-up|10|||
27963706|NCT00809835|81699037|FG003|Overall Study|Lost to Follow-up|2|||
27963707|NCT00809835|81699034|FG000|Overall Study|Withdrawal by Subject|1|||
27963708|NCT00809835|81699035|FG001|Overall Study|Withdrawal by Subject|1|||
27963709|NCT00809835|81699036|FG002|Overall Study|Withdrawal by Subject|1|||
27963710|NCT00809835|81699037|FG003|Overall Study|Withdrawal by Subject|0|||
27963711|NCT03275246|81699040|FG000|Overall Study|Protocol Violation|5|||
27963712|NCT03275246|81699040|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
27963713|NCT00830375|81699041|FG000|Overall Study|Lost to Follow-up|1|||
27963714|NCT01532921|81699042|FG000|Overall Study|Death|3|||
27963715|NCT01532921|81699042|FG000|Overall Study|Withdrawal by Subject|2|||
27963716|NCT01532921|81699042|FG000|Overall Study|Lost to Follow-up|3|||
27963717|NCT01532921|81699042|FG000|Overall Study|Physician Decision|7|||
27963718|NCT01532921|81699042|FG000|Overall Study|Device was explanted during procedure|1|||
27963719|NCT01188551|81699043|FG000|Overall Study|Pharmacy issues|1|||
27963720|NCT01188551|81699044|FG001|Overall Study|Pharmacy issues|0|||
27963721|NCT01188551|81699045|FG002|Overall Study|Pharmacy issues|0|||
27963722|NCT01188551|81699046|FG003|Overall Study|Pharmacy issues|0|||
27963723|NCT00269113|81699047|FG000|Overall Study|Adverse Event|14|||
27769026|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
27769027|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
27769028|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
27769029|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
27769030|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
27769031|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
27769032|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
27769033|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
27769034|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
27769035|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
27769036|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
27769037|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
27769038|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
27769039|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
27769040|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
27769041|NCT03689972|80984697|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
27769042|NCT03689972|80984698|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
27769043|NCT03689972|80984699|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
27769044|NCT03689972|80984700|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
27769045|NCT03689972|80984701|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
27769046|NCT03689972|80984697|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
27769047|NCT03689972|80984698|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
27769048|NCT03689972|80984699|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
27769049|NCT03689972|80984700|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
27769050|NCT03689972|80984701|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
27769051|NCT03689972|80984697|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
27769052|NCT03689972|80984698|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
27769053|NCT03689972|80984699|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
27769054|NCT03689972|80984700|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
27769055|NCT03689972|80984701|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
27769056|NCT03689972|80984697|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
27769057|NCT03689972|80984698|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
27769058|NCT03689972|80984699|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
27769059|NCT03689972|80984700|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
27769060|NCT03689972|80984701|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
27769061|NCT03689972|80984697|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
27769062|NCT03689972|80984698|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
27769063|NCT03689972|80984699|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
27769064|NCT03689972|80984700|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
27769065|NCT03689972|80984701|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
27769066|NCT03689972|80984697|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
27769067|NCT03689972|80984698|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
27769068|NCT03689972|80984699|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
27963724|NCT00269113|81699048|FG001|Overall Study|Adverse Event|7|||
27963725|NCT00269113|81699047|FG000|Overall Study|Lack of Efficacy|35|||
27963726|NCT00269113|81699048|FG001|Overall Study|Lack of Efficacy|18|||
27769069|NCT03689972|80984700|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
27769070|NCT03689972|80984701|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
27769071|NCT03689972|80984697|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
27769072|NCT03689972|80984698|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
27769073|NCT03689972|80984699|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
27769074|NCT03689972|80984700|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
27769075|NCT03689972|80984701|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
27769076|NCT03689972|80984697|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
27769077|NCT03689972|80984698|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
27963727|NCT00269113|81699047|FG000|Overall Study|Early Improvement|2|||
27963728|NCT00269113|81699048|FG001|Overall Study|Early Improvement|0|||
27769078|NCT03689972|80984699|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
27769079|NCT03689972|80984700|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
27769080|NCT03689972|80984701|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
27769081|NCT03689972|80984697|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
27769082|NCT03689972|80984698|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
27769083|NCT03689972|80984699|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
27769084|NCT03689972|80984700|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
27769085|NCT03689972|80984701|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
27769086|NCT03689972|80984697|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
27769087|NCT03689972|80984698|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
27769088|NCT03689972|80984699|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
27769089|NCT03689972|80984700|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
27769090|NCT03689972|80984701|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
27769091|NCT01997281|80984702|FG000|Overall Study|Withdrawal by Subject|1|||
27769092|NCT01997281|80984703|FG001|Overall Study|Withdrawal by Subject|0|||
27769093|NCT00968708|80984704|FG000|Overall Study|Adverse Event|169|||
27769094|NCT00968708|80984705|FG001|Overall Study|Adverse Event|150|||
27769095|NCT00968708|80984704|FG000|Overall Study|Major Protocol Deviation|0|||
27769096|NCT00968708|80984705|FG001|Overall Study|Major Protocol Deviation|1|||
27769097|NCT00968708|80984704|FG000|Overall Study|Lost to Follow-up|19|||
27769098|NCT00968708|80984705|FG001|Overall Study|Lost to Follow-up|11|||
27769099|NCT00968708|80984704|FG000|Overall Study|Voluntary Withdrawal|104|||
27769100|NCT00968708|80984705|FG001|Overall Study|Voluntary Withdrawal|101|||
27769101|NCT00968708|80984704|FG000|Overall Study|Investigator Discretion|0|||
27769102|NCT00968708|80984705|FG001|Overall Study|Investigator Discretion|1|||
27769103|NCT00968708|80984704|FG000|Overall Study|Other|26|||
27769104|NCT00968708|80984705|FG001|Overall Study|Other|34|||
27769105|NCT01432457|80984706|FG000|Overall Study|Adverse Event|7|||
27769106|NCT01432457|80984707|FG001|Overall Study|Adverse Event|10|||
27769107|NCT01432457|80984708|FG002|Overall Study|Adverse Event|16|||
27769108|NCT01432457|80984706|FG000|Overall Study|Lack of Efficacy|2|||
27769109|NCT01432457|80984707|FG001|Overall Study|Lack of Efficacy|1|||
27963729|NCT00269113|81699047|FG000|Overall Study|Withdrawal by Subject|0|||
27769110|NCT01432457|80984708|FG002|Overall Study|Lack of Efficacy|1|||
27769111|NCT01432457|80984706|FG000|Overall Study|Lost to Follow-up|11|||
27769112|NCT01432457|80984707|FG001|Overall Study|Lost to Follow-up|15|||
27769113|NCT01432457|80984708|FG002|Overall Study|Lost to Follow-up|20|||
27769114|NCT01432457|80984706|FG000|Overall Study|Protocol Violation|3|||
27769115|NCT01432457|80984707|FG001|Overall Study|Protocol Violation|2|||
27769116|NCT01432457|80984708|FG002|Overall Study|Protocol Violation|6|||
27769117|NCT01432457|80984706|FG000|Overall Study|Withdrawal by Subject|6|||
27769118|NCT01432457|80984707|FG001|Overall Study|Withdrawal by Subject|11|||
27769119|NCT01432457|80984708|FG002|Overall Study|Withdrawal by Subject|9|||
27769120|NCT01432457|80984706|FG000|Overall Study|Reasons not defined|2|||
27769121|NCT01432457|80984707|FG001|Overall Study|Reasons not defined|3|||
27769122|NCT01432457|80984708|FG002|Overall Study|Reasons not defined|4|||
27769123|NCT01432457|80984706|FG000|Overall Study|Did not take study drug|6|||
27769124|NCT01432457|80984707|FG001|Overall Study|Did not take study drug|6|||
27769125|NCT01432457|80984708|FG002|Overall Study|Did not take study drug|3|||
27769126|NCT00254163|80984713|FG000|Overall Study|Adverse Event|29|||
27769127|NCT00254163|80984714|FG001|Overall Study|Adverse Event|26|||
27769128|NCT00254163|80984713|FG000|Overall Study|Patient request/withdrew consent|6|||
27769129|NCT00254163|80984714|FG001|Overall Study|Patient request/withdrew consent|4|||
27769130|NCT00254163|80984713|FG000|Overall Study|Investigator request|1|||
27769131|NCT00254163|80984714|FG001|Overall Study|Investigator request|3|||
27769132|NCT00254163|80984713|FG000|Overall Study|Failed entry|1|||
27769133|NCT00254163|80984714|FG001|Overall Study|Failed entry|3|||
27769134|NCT00254163|80984713|FG000|Overall Study|Progressive disease|0|||
27963730|NCT00269113|81699048|FG001|Overall Study|Withdrawal by Subject|2|||
27963731|NCT00269113|81699047|FG000|Overall Study|Death|6|||
27963732|NCT00269113|81699048|FG001|Overall Study|Death|2|||
27963733|NCT00269113|81699047|FG000|Overall Study|Lost to Follow-up|2|||
27963734|NCT00269113|81699048|FG001|Overall Study|Lost to Follow-up|1|||
27963735|NCT00269113|81699047|FG000|Overall Study|Protocol Violation|15|||
27963736|NCT00269113|81699048|FG001|Overall Study|Protocol Violation|5|||
27963737|NCT00269113|81699047|FG000|Overall Study|Other|0|||
27963738|NCT00269113|81699048|FG001|Overall Study|Other|2|||
27963739|NCT04262882|81699051|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
27963740|NCT04262882|81699052|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
27963741|NCT04262882|81699051|FG000|Overall Study|Lost to Follow-up|1|||
27963742|NCT04262882|81699052|FG001|Overall Study|Lost to Follow-up|0|||
27963743|NCT00861757|81699055|FG000|Overall Study|Adverse Event|1|||
27963744|NCT00861757|81699056|FG001|Overall Study|Adverse Event|5|||
27963745|NCT00861757|81699057|FG002|Overall Study|Adverse Event|7|||
27963746|NCT00861757|81699058|FG003|Overall Study|Adverse Event|2|||
27963747|NCT00861757|81699055|FG000|Overall Study|Entry Criteria Not Met|1|||
27963748|NCT00861757|81699056|FG001|Overall Study|Entry Criteria Not Met|2|||
27963749|NCT00861757|81699057|FG002|Overall Study|Entry Criteria Not Met|1|||
27769135|NCT00254163|80984714|FG001|Overall Study|Progressive disease|1|||
27769136|NCT00254163|80984713|FG000|Overall Study|Death|0|||
27769137|NCT00254163|80984714|FG001|Overall Study|Death|1|||
27769138|NCT00254163|80984713|FG000|Overall Study|Other|8|||
27769139|NCT00254163|80984714|FG001|Overall Study|Other|8|||
27769140|NCT00865046|80984717|FG000|Overall Study|Lost to Follow-up|1|||
27769141|NCT00865046|80984718|FG001|Overall Study|Lost to Follow-up|4|||
27769142|NCT00865046|80984719|FG002|Overall Study|Lost to Follow-up|0|||
27769143|NCT00865046|80984717|FG000|Overall Study|Death|0|||
27769144|NCT00865046|80984718|FG001|Overall Study|Death|1|||
27769145|NCT00865046|80984719|FG002|Overall Study|Death|1|||
27769146|NCT00865046|80984717|FG000|Overall Study|Withdrawal by Subject|5|||
27769147|NCT00865046|80984718|FG001|Overall Study|Withdrawal by Subject|0|||
27769148|NCT00865046|80984719|FG002|Overall Study|Withdrawal by Subject|0|||
27769149|NCT00607919|80984720|FG000|Acute Phase|Adverse Event|9|||
27769150|NCT00607919|80984721|FG001|Acute Phase|Adverse Event|2|||
27769151|NCT00607919|80984720|FG000|Acute Phase|Entry Criteria Not Met|1|||
27769152|NCT00607919|80984721|FG001|Acute Phase|Entry Criteria Not Met|1|||
27769153|NCT00607919|80984720|FG000|Acute Phase|Lack of Efficacy|1|||
27769154|NCT00607919|80984721|FG001|Acute Phase|Lack of Efficacy|2|||
27769155|NCT00607919|80984720|FG000|Acute Phase|Lost to Follow-up|9|||
27769156|NCT00607919|80984721|FG001|Acute Phase|Lost to Follow-up|3|||
27769157|NCT00607919|80984720|FG000|Acute Phase|Parent/Caregiver Decision|6|||
27769158|NCT00607919|80984721|FG001|Acute Phase|Parent/Caregiver Decision|4|||
27769159|NCT00607919|80984720|FG000|Acute Phase|Protocol Violation|5|||
27769160|NCT00607919|80984721|FG001|Acute Phase|Protocol Violation|1|||
27769161|NCT00607919|80984720|FG000|Acute Phase|Withdrawal by Subject|3|||
27769162|NCT00607919|80984721|FG001|Acute Phase|Withdrawal by Subject|3|||
27769163|NCT00607919|80984720|FG000|Open-Label Phase|Adverse Event|1|||
27769164|NCT00607919|80984721|FG001|Open-Label Phase|Adverse Event|5|||
27769165|NCT00607919|80984720|FG000|Open-Label Phase|Lost to Follow-up|4|||
27769166|NCT00607919|80984721|FG001|Open-Label Phase|Lost to Follow-up|1|||
27769167|NCT00607919|80984720|FG000|Open-Label Phase|Protocol Violation|2|||
27769168|NCT00607919|80984721|FG001|Open-Label Phase|Protocol Violation|2|||
27769169|NCT00607919|80984720|FG000|Open-Label Phase|Withdrawal by Subject|2|||
27769170|NCT00607919|80984721|FG001|Open-Label Phase|Withdrawal by Subject|2|||
27963750|NCT00861757|81699058|FG003|Overall Study|Entry Criteria Not Met|1|||
27963751|NCT00861757|81699055|FG000|Overall Study|Lack of Efficacy|3|||
27963752|NCT00861757|81699056|FG001|Overall Study|Lack of Efficacy|1|||
27963753|NCT00861757|81699057|FG002|Overall Study|Lack of Efficacy|0|||
27963754|NCT00861757|81699058|FG003|Overall Study|Lack of Efficacy|1|||
27963755|NCT00861757|81699055|FG000|Overall Study|Lost to Follow-up|1|||
27963756|NCT00861757|81699056|FG001|Overall Study|Lost to Follow-up|0|||
27963757|NCT00861757|81699057|FG002|Overall Study|Lost to Follow-up|1|||
27963758|NCT00861757|81699058|FG003|Overall Study|Lost to Follow-up|1|||
27963759|NCT00861757|81699055|FG000|Overall Study|Physician Decision|0|||
27963760|NCT00861757|81699056|FG001|Overall Study|Physician Decision|0|||
27963761|NCT00861757|81699057|FG002|Overall Study|Physician Decision|0|||
27769171|NCT00607919|80984720|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
27769172|NCT00607919|80984721|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
27769173|NCT00412113|80984722|FG000|Overall Study|Adverse Event|11|||
27769174|NCT00412113|80984723|FG001|Overall Study|Adverse Event|15|||
27769175|NCT00412113|80984722|FG000|Overall Study|did not receive treatment|1|||
27769176|NCT00412113|80984723|FG001|Overall Study|did not receive treatment|0|||
27963762|NCT00861757|81699058|FG003|Overall Study|Physician Decision|1|||
27963763|NCT00861757|81699055|FG000|Overall Study|Protocol Violation|2|||
27963764|NCT00861757|81699056|FG001|Overall Study|Protocol Violation|2|||
27963765|NCT00861757|81699057|FG002|Overall Study|Protocol Violation|4|||
27963766|NCT00861757|81699058|FG003|Overall Study|Protocol Violation|1|||
27769177|NCT02255760|80984724|FG000|Overall Study|Lost to Follow-up|0|||
27769178|NCT02255760|80984725|FG001|Overall Study|Lost to Follow-up|1|||
27769179|NCT02255760|80984726|FG002|Overall Study|Lost to Follow-up|0|||
27963767|NCT00861757|81699055|FG000|Overall Study|Withdrawal by Subject|1|||
27963768|NCT00861757|81699056|FG001|Overall Study|Withdrawal by Subject|5|||
27963769|NCT00861757|81699057|FG002|Overall Study|Withdrawal by Subject|5|||
27963770|NCT00861757|81699058|FG003|Overall Study|Withdrawal by Subject|2|||
27963771|NCT00720356|81699059|FG000|Registration to Study|Determined to have methylated MGMT|67|||
27963772|NCT00720356|81699059|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
27963773|NCT00720356|81699059|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
27963774|NCT00720356|81699059|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
27963775|NCT00720356|81699059|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
27963776|NCT00720356|81699059|FG000|Follow up Until Death|Withdrawal by Subject|1|||
27963777|NCT00720356|81699059|FG000|Follow up Until Death|Alive at last data collection|4|||
27963778|NCT01897727|81699060|FG000|Overall Study|Exclusion: central sleep apnea|0|||
27963779|NCT01897727|81699061|FG001|Overall Study|Exclusion: central sleep apnea|1|||
27963780|NCT03748706|81699066|FG000|Overall Study|Lost to Follow-up|1|||
27963781|NCT01667133|81699067|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
27963782|NCT01667133|81699068|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
27963783|NCT01667133|81699069|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
27963784|NCT01667133|81699070|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
27963785|NCT01667133|81699071|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
27963786|NCT01667133|81699072|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
27963787|NCT01667133|81699073|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
27963788|NCT01667133|81699074|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
27963789|NCT01667133|81699075|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
27963790|NCT01667133|81699076|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
27963791|NCT01667133|81699077|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
27963792|NCT01667133|81699078|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
27963793|NCT01667133|81699067|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963794|NCT01667133|81699068|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963795|NCT01667133|81699069|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
27963796|NCT01667133|81699070|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963797|NCT01667133|81699071|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963798|NCT01667133|81699072|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963799|NCT01667133|81699073|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963800|NCT01667133|81699074|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963801|NCT01667133|81699075|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963802|NCT01667133|81699076|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27769180|NCT02255760|80984727|FG003|Overall Study|Lost to Follow-up|0|||
27769181|NCT02255760|80984728|FG004|Overall Study|Lost to Follow-up|0|||
27769182|NCT03597503|80984729|FG000|Overall Study|Withdrawal by Subject|0|||
27769183|NCT03597503|80984730|FG001|Overall Study|Withdrawal by Subject|2|||
27769184|NCT03597503|80984729|FG000|Overall Study|Lost to Follow-up|1|||
27769185|NCT03597503|80984730|FG001|Overall Study|Lost to Follow-up|2|||
27769186|NCT03597503|80984729|FG000|Overall Study|Protocol Violation|1|||
27769187|NCT03597503|80984730|FG001|Overall Study|Protocol Violation|0|||
27769188|NCT00445341|80984739|FG000|Overall Study|refused further treatment|1|||
27769189|NCT00445341|80984739|FG000|Overall Study|taken off treatment too early|1|||
27769190|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
27769191|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
27769192|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
27769193|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
27769194|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
27769195|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
27769196|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
27769197|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
27769198|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
27769199|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
27769200|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
27769201|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
27769202|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
27769203|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
27769204|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
27769205|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
27769206|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
27963803|NCT01667133|81699077|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27769207|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
27769208|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
27963804|NCT01667133|81699078|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
27963805|NCT01667133|81699067|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
27963806|NCT01667133|81699068|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
27963807|NCT01667133|81699069|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
27963808|NCT01667133|81699070|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
27963809|NCT01667133|81699071|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
27769209|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
27769210|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
27769211|NCT01001572|80984741|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
27769212|NCT01001572|80984742|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
27769213|NCT01001572|80984743|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
27769214|NCT01001572|80984741|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27769215|NCT01001572|80984742|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
27769216|NCT01001572|80984743|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
27769217|NCT01001572|80984741|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27769218|NCT01001572|80984742|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
27769219|NCT01001572|80984743|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
27769220|NCT01001572|80984741|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
27769221|NCT01001572|80984742|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
27769222|NCT01001572|80984743|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
27769223|NCT01001572|80984741|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
27769224|NCT01001572|80984742|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
27769225|NCT01001572|80984743|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
27769226|NCT01001572|80984741|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
27769227|NCT01001572|80984742|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
27769228|NCT01001572|80984743|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
27769229|NCT01001572|80984741|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27769230|NCT01001572|80984742|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27769231|NCT01001572|80984743|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27769232|NCT02725268|80984744|FG000|Overall Study|Death|58|||
27769233|NCT02725268|80984745|FG001|Overall Study|Death|59|||
27769234|NCT02725268|80984746|FG002|Overall Study|Death|30|||
27769235|NCT02725268|80984747|FG003|Overall Study|Death|16|||
27769236|NCT02725268|80984744|FG000|Overall Study|Lost to Follow-up|4|||
27769237|NCT02725268|80984745|FG001|Overall Study|Lost to Follow-up|3|||
27769238|NCT02725268|80984746|FG002|Overall Study|Lost to Follow-up|0|||
27769239|NCT02725268|80984747|FG003|Overall Study|Lost to Follow-up|1|||
27769240|NCT02725268|80984744|FG000|Overall Study|Site Terminated by Sponsor|0|||
27769241|NCT02725268|80984745|FG001|Overall Study|Site Terminated by Sponsor|1|||
27769242|NCT02725268|80984746|FG002|Overall Study|Site Terminated by Sponsor|0|||
27769243|NCT02725268|80984747|FG003|Overall Study|Site Terminated by Sponsor|0|||
27769244|NCT02725268|80984744|FG000|Overall Study|Withdrawal by Subject|8|||
27769245|NCT02725268|80984745|FG001|Overall Study|Withdrawal by Subject|6|||
27769246|NCT02725268|80984746|FG002|Overall Study|Withdrawal by Subject|8|||
27769247|NCT02725268|80984747|FG003|Overall Study|Withdrawal by Subject|1|||
27769248|NCT02725268|80984744|FG000|Overall Study|Reason not Specified|2|||
27769249|NCT02725268|80984745|FG001|Overall Study|Reason not Specified|1|||
27769250|NCT02725268|80984746|FG002|Overall Study|Reason not Specified|0|||
27769251|NCT02725268|80984747|FG003|Overall Study|Reason not Specified|0|||
27769252|NCT00527072|80984750|FG000|Overall Study|Adverse Event|13|||
27769253|NCT00527072|80984750|FG000|Overall Study|Lack of Efficacy|11|||
27769254|NCT00527072|80984750|FG000|Overall Study|Lost to Follow-up|3|||
27769255|NCT00527072|80984750|FG000|Overall Study|Protocol Violation|2|||
27769256|NCT00527072|80984750|FG000|Overall Study|Withdrawal by Subject|7|||
27769257|NCT03862495|80984751|FG000|Overall Study|Lost to Follow-up|37|||
27769258|NCT03862495|80984752|FG001|Overall Study|Lost to Follow-up|35|||
27769259|NCT00293241|80984753|FG000|Overall Study|Lost to Follow-up|9|||
27769260|NCT00293241|80984754|FG001|Overall Study|Lost to Follow-up|16|||
27769261|NCT00293241|80984753|FG000|Overall Study|Physician Decision|23|||
27769262|NCT00293241|80984754|FG001|Overall Study|Physician Decision|17|||
27769263|NCT00293241|80984753|FG000|Overall Study|Withdrawal by Subject|4|||
27769264|NCT00293241|80984754|FG001|Overall Study|Withdrawal by Subject|8|||
27769265|NCT03228394|80984759|FG000|Overall Study|Lost to Follow-up|0|||
27769266|NCT03228394|80984760|FG001|Overall Study|Lost to Follow-up|0|||
27769267|NCT03228394|80984761|FG002|Overall Study|Lost to Follow-up|1|||
27569008|NCT02658890|80271490|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
27769268|NCT03228394|80984762|FG003|Overall Study|Lost to Follow-up|1|||
27769269|NCT03228394|80984763|FG004|Overall Study|Lost to Follow-up|0|||
27769270|NCT03228394|80984764|FG005|Overall Study|Lost to Follow-up|0|||
27769271|NCT03228394|80984765|FG006|Overall Study|Lost to Follow-up|2|||
27769272|NCT03228394|80984766|FG007|Overall Study|Lost to Follow-up|0|||
27769273|NCT03228394|80984759|FG000|Overall Study|Withdrawal by Subject|0|||
27769274|NCT03228394|80984760|FG001|Overall Study|Withdrawal by Subject|0|||
27769275|NCT03228394|80984761|FG002|Overall Study|Withdrawal by Subject|1|||
27769276|NCT03228394|80984762|FG003|Overall Study|Withdrawal by Subject|0|||
27769277|NCT03228394|80984763|FG004|Overall Study|Withdrawal by Subject|0|||
27769278|NCT03228394|80984764|FG005|Overall Study|Withdrawal by Subject|0|||
27769279|NCT03228394|80984765|FG006|Overall Study|Withdrawal by Subject|1|||
27769280|NCT03228394|80984766|FG007|Overall Study|Withdrawal by Subject|3|||
27769281|NCT03228394|80984759|FG000|Overall Study|Protocol Violation|0|||
27769282|NCT03228394|80984760|FG001|Overall Study|Protocol Violation|0|||
27769283|NCT03228394|80984761|FG002|Overall Study|Protocol Violation|0|||
27769284|NCT03228394|80984762|FG003|Overall Study|Protocol Violation|1|||
27769285|NCT03228394|80984763|FG004|Overall Study|Protocol Violation|0|||
27769286|NCT03228394|80984764|FG005|Overall Study|Protocol Violation|0|||
27963810|NCT01667133|81699072|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
27963811|NCT01667133|81699073|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
27963812|NCT01667133|81699074|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
27963813|NCT01667133|81699075|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
27963814|NCT01667133|81699076|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
27963815|NCT01667133|81699077|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
27963816|NCT01667133|81699078|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
27963817|NCT01667133|81699067|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963818|NCT01667133|81699068|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963819|NCT01667133|81699069|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963820|NCT01667133|81699070|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
27963821|NCT01667133|81699071|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963822|NCT01667133|81699072|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963823|NCT01667133|81699073|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963824|NCT01667133|81699074|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963825|NCT01667133|81699075|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963826|NCT01667133|81699076|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963827|NCT01667133|81699077|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963828|NCT01667133|81699078|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
27963829|NCT01667133|81699067|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
27963830|NCT01667133|81699068|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
27963831|NCT01667133|81699069|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
27963832|NCT01667133|81699070|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
27963833|NCT01667133|81699071|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
27963834|NCT01667133|81699072|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
27963835|NCT01667133|81699073|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
27963836|NCT01667133|81699074|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
27963837|NCT01667133|81699075|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
27963838|NCT01667133|81699076|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
27963839|NCT01667133|81699077|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
27963840|NCT01667133|81699078|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
27963841|NCT01667133|81699067|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963842|NCT01667133|81699068|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963843|NCT01667133|81699069|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963844|NCT01667133|81699070|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963845|NCT01667133|81699071|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963846|NCT01667133|81699072|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963847|NCT01667133|81699073|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963848|NCT01667133|81699074|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963849|NCT01667133|81699075|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963850|NCT01667133|81699076|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
27963851|NCT01667133|81699077|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963852|NCT01667133|81699078|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
27963853|NCT01667133|81699067|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
27963854|NCT01667133|81699068|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
27963855|NCT01667133|81699069|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
27963856|NCT01667133|81699070|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
27963857|NCT01667133|81699071|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
27963858|NCT01667133|81699072|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
27963859|NCT01667133|81699073|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
27963860|NCT01667133|81699074|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
27963861|NCT01667133|81699075|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
27769287|NCT03228394|80984765|FG006|Overall Study|Protocol Violation|0|||
27769288|NCT03228394|80984766|FG007|Overall Study|Protocol Violation|0|||
27963862|NCT01667133|81699076|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
27963863|NCT01667133|81699077|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
27963864|NCT01667133|81699078|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
27963865|NCT01667133|81699067|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963866|NCT01667133|81699068|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963867|NCT01667133|81699069|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963868|NCT01667133|81699070|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27769289|NCT03228394|80984759|FG000|Overall Study|Physician Decision|0|||
27769290|NCT03228394|80984760|FG001|Overall Study|Physician Decision|0|||
27769291|NCT03228394|80984761|FG002|Overall Study|Physician Decision|0|||
27769292|NCT03228394|80984762|FG003|Overall Study|Physician Decision|0|||
27769293|NCT03228394|80984763|FG004|Overall Study|Physician Decision|0|||
27963869|NCT01667133|81699071|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963870|NCT01667133|81699072|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963871|NCT01667133|81699073|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963872|NCT01667133|81699074|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963873|NCT01667133|81699075|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963874|NCT01667133|81699076|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
27963875|NCT01667133|81699077|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963876|NCT01667133|81699078|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
27963877|NCT01667133|81699067|FG000|Phase 2: Dose-expansion|Death|0|||
27963878|NCT01667133|81699068|FG001|Phase 2: Dose-expansion|Death|0|||
27963879|NCT01667133|81699069|FG002|Phase 2: Dose-expansion|Death|0|||
27963880|NCT01667133|81699070|FG003|Phase 2: Dose-expansion|Death|0|||
27963881|NCT01667133|81699071|FG004|Phase 2: Dose-expansion|Death|0|||
27963882|NCT01667133|81699072|FG005|Phase 2: Dose-expansion|Death|0|||
27963883|NCT01667133|81699073|FG006|Phase 2: Dose-expansion|Death|0|||
27963884|NCT01667133|81699074|FG007|Phase 2: Dose-expansion|Death|0|||
27963885|NCT01667133|81699075|FG008|Phase 2: Dose-expansion|Death|0|||
27769294|NCT03228394|80984764|FG005|Overall Study|Physician Decision|0|||
27769295|NCT03228394|80984765|FG006|Overall Study|Physician Decision|1|||
27769296|NCT03228394|80984766|FG007|Overall Study|Physician Decision|0|||
27769297|NCT03228394|80984759|FG000|Overall Study|Noncompliance|0|||
27769298|NCT03228394|80984760|FG001|Overall Study|Noncompliance|0|||
27769299|NCT03228394|80984761|FG002|Overall Study|Noncompliance|0|||
27963886|NCT01667133|81699076|FG009|Phase 2: Dose-expansion|Death|1|||
27963887|NCT01667133|81699077|FG010|Phase 2: Dose-expansion|Death|0|||
27963888|NCT01667133|81699078|FG011|Phase 2: Dose-expansion|Death|0|||
27963889|NCT01667133|81699067|FG000|Phase 2: Dose-expansion|Other|0|||
27963890|NCT01667133|81699068|FG001|Phase 2: Dose-expansion|Other|0|||
27963891|NCT01667133|81699069|FG002|Phase 2: Dose-expansion|Other|0|||
27963892|NCT01667133|81699070|FG003|Phase 2: Dose-expansion|Other|0|||
27963893|NCT01667133|81699071|FG004|Phase 2: Dose-expansion|Other|0|||
27963894|NCT01667133|81699072|FG005|Phase 2: Dose-expansion|Other|0|||
27963895|NCT01667133|81699073|FG006|Phase 2: Dose-expansion|Other|0|||
27963896|NCT01667133|81699074|FG007|Phase 2: Dose-expansion|Other|0|||
27963897|NCT01667133|81699075|FG008|Phase 2: Dose-expansion|Other|0|||
27963898|NCT01667133|81699076|FG009|Phase 2: Dose-expansion|Other|0|||
27963899|NCT01667133|81699077|FG010|Phase 2: Dose-expansion|Other|0|||
27963900|NCT01667133|81699078|FG011|Phase 2: Dose-expansion|Other|1|||
27963901|NCT00588237|81699079|FG000|Overall Study|Evaluable for toxicity only|3|||
27963902|NCT00588237|81699079|FG000|Overall Study|Patien not treated|1|||
27963903|NCT02817594|81699080|FG000|Overall Study|Withdrawal by Subject|1|||
27963904|NCT02817594|81699080|FG000|Overall Study|Other|1|||
27963905|NCT02817594|81699080|FG000|Overall Study|Did Not Receive Treatment|1|||
27963906|NCT00656058|81699083|FG000|Overall Study|Withdrawal by Subject|2|||
27963907|NCT00656058|81699083|FG000|Overall Study|Withdrawal by Subject|4|||
27963908|NCT04660552|81699086|FG000|Overall Study|Withdrawal by Subject|3|||
27963909|NCT04660552|81699087|FG001|Overall Study|Withdrawal by Subject|1|||
27963910|NCT04532294|81699088|FG000|Overall Study|Withdrawal by Subject|0|||
27963911|NCT04532294|81699089|FG001|Overall Study|Withdrawal by Subject|0|||
27963912|NCT04532294|81699090|FG002|Overall Study|Withdrawal by Subject|1|||
27963913|NCT04532294|81699088|FG000|Overall Study|Participants Not Dosed|0|||
27963914|NCT04532294|81699089|FG001|Overall Study|Participants Not Dosed|0|||
27963915|NCT04532294|81699090|FG002|Overall Study|Participants Not Dosed|2|||
27963916|NCT01030952|81699093|FG000|Overall Study|Protocol Violation|0|||
27963917|NCT01030952|81699094|FG001|Overall Study|Protocol Violation|1|||
27963918|NCT01030952|81699093|FG000|Overall Study|Informed consent withdrawal|1|||
27963919|NCT01030952|81699094|FG001|Overall Study|Informed consent withdrawal|0|||
27963920|NCT01030952|81699093|FG000|Overall Study|Lost to Follow-up|0|||
27963921|NCT01030952|81699094|FG001|Overall Study|Lost to Follow-up|1|||
27963922|NCT01030952|81699093|FG000|Overall Study|Unexplained|1|||
27963923|NCT01030952|81699094|FG001|Overall Study|Unexplained|1|||
27963924|NCT01843673|81699095|FG000|Overall Study|Lack of Efficacy|2|||
27769300|NCT03228394|80984762|FG003|Overall Study|Noncompliance|0|||
27769301|NCT03228394|80984763|FG004|Overall Study|Noncompliance|0|||
27963925|NCT01843673|81699095|FG000|Overall Study|Withdrawal by Subject|4|||
27963926|NCT01823198|81699096|FG000|Overall Study|Physician Decision|0|||
27963927|NCT01823198|81699097|FG001|Overall Study|Physician Decision|1|||
27963928|NCT01823198|81699098|FG002|Overall Study|Physician Decision|0|||
27963929|NCT01823198|81699099|FG003|Overall Study|Physician Decision|0|||
27963930|NCT01823198|81699100|FG004|Overall Study|Physician Decision|0|||
27963931|NCT01823198|81699101|FG005|Overall Study|Physician Decision|3|||
27963932|NCT01823198|81699102|FG006|Overall Study|Physician Decision|3|||
27963933|NCT00301262|81699103|FG000|Double Blind Phase (DB)|Adverse Event|1|||
27963934|NCT00301262|81699104|FG001|Double Blind Phase (DB)|Adverse Event|0|||
27769302|NCT03228394|80984764|FG005|Overall Study|Noncompliance|0|||
27769303|NCT03228394|80984765|FG006|Overall Study|Noncompliance|1|||
27769304|NCT03228394|80984766|FG007|Overall Study|Noncompliance|0|||
27963935|NCT00301262|81699103|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
27963936|NCT00301262|81699104|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
27963937|NCT00301262|81699103|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
27963938|NCT00301262|81699104|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
27963939|NCT00301262|81699103|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
27963940|NCT00301262|81699104|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
27963941|NCT00301262|81699103|FG000|Double Blind Phase (DB)|Other|1|||
27963942|NCT00301262|81699104|FG001|Double Blind Phase (DB)|Other|4|||
27963943|NCT00301262|81699103|FG000|Open Label Phase (OL)|Adverse Event|1|||
27963944|NCT00301262|81699104|FG001|Open Label Phase (OL)|Adverse Event|0|||
27963945|NCT00301262|81699103|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
27963946|NCT00301262|81699104|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
27963947|NCT00301262|81699103|FG000|Open Label Phase (OL)|Other|2|||
27963948|NCT00301262|81699104|FG001|Open Label Phase (OL)|Other|0|||
27963949|NCT01713582|81699105|FG000|Overall Study|Disease progression|3|||
27963950|NCT01713582|81699106|FG001|Overall Study|Disease progression|3|||
27963951|NCT01713582|81699107|FG002|Overall Study|Disease progression|3|||
27963952|NCT01713582|81699108|FG003|Overall Study|Disease progression|2|||
27963953|NCT01713582|81699109|FG004|Overall Study|Disease progression|3|||
27963954|NCT01713582|81699110|FG005|Overall Study|Disease progression|3|||
27963955|NCT01713582|81699111|FG006|Overall Study|Disease progression|3|||
27963956|NCT01713582|81699112|FG007|Overall Study|Disease progression|3|||
27963957|NCT01713582|81699113|FG008|Overall Study|Disease progression|3|||
27963958|NCT01713582|81699114|FG009|Overall Study|Disease progression|11|||
27963959|NCT01713582|81699115|FG010|Overall Study|Disease progression|10|||
27963960|NCT01713582|81699116|FG011|Overall Study|Disease progression|5|||
27963961|NCT01713582|81699117|FG012|Overall Study|Disease progression|3|||
27963962|NCT01713582|81699118|FG013|Overall Study|Disease progression|3|||
27963963|NCT01713582|81699119|FG014|Overall Study|Disease progression|6|||
27963964|NCT01713582|81699120|FG015|Overall Study|Disease progression|6|||
27963965|NCT01713582|81699121|FG016|Overall Study|Disease progression|5|||
27963966|NCT01713582|81699122|FG017|Overall Study|Disease progression|2|||
27963967|NCT01713582|81699123|FG018|Overall Study|Disease progression|3|||
27963968|NCT01713582|81699124|FG019|Overall Study|Disease progression|5|||
27963969|NCT01713582|81699125|FG020|Overall Study|Disease progression|15|||
27963970|NCT01713582|81699105|FG000|Overall Study|Death|0|||
27963971|NCT01713582|81699106|FG001|Overall Study|Death|0|||
27963972|NCT01713582|81699107|FG002|Overall Study|Death|0|||
27963973|NCT01713582|81699108|FG003|Overall Study|Death|1|||
27963974|NCT01713582|81699109|FG004|Overall Study|Death|1|||
27963975|NCT01713582|81699110|FG005|Overall Study|Death|3|||
27963976|NCT01713582|81699111|FG006|Overall Study|Death|3|||
27963977|NCT01713582|81699112|FG007|Overall Study|Death|2|||
27963978|NCT01713582|81699113|FG008|Overall Study|Death|3|||
27963979|NCT01713582|81699114|FG009|Overall Study|Death|4|||
27963980|NCT01713582|81699115|FG010|Overall Study|Death|3|||
27769305|NCT01094808|80984770|FG000|Overall Study|Withdrawal by Subject|1|||
27769306|NCT01094808|80984771|FG001|Overall Study|Withdrawal by Subject|1|||
27769307|NCT01094808|80984772|FG002|Overall Study|Withdrawal by Subject|0|||
27769308|NCT03984812|80984773|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769309|NCT03984812|80984774|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769310|NCT03984812|80984775|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
27769311|NCT03984812|80984776|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769312|NCT03984812|80984777|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769313|NCT03984812|80984778|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769314|NCT03984812|80984779|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769315|NCT03984812|80984780|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769316|NCT03984812|80984781|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769317|NCT03984812|80984782|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769318|NCT03984812|80984783|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
27769319|NCT01000025|80984784|FG000|Overall Study|Adverse Event|43|||
27769320|NCT01000025|80984785|FG001|Overall Study|Adverse Event|2|||
27769321|NCT01000025|80984784|FG000|Overall Study|Withdrawal by Subject|13|||
27769322|NCT01000025|80984785|FG001|Overall Study|Withdrawal by Subject|8|||
27769323|NCT01000025|80984784|FG000|Overall Study|Death|23|||
27769324|NCT01000025|80984785|FG001|Overall Study|Death|13|||
27769325|NCT01000025|80984784|FG000|Overall Study|Lack of Efficacy|363|||
27769326|NCT01000025|80984785|FG001|Overall Study|Lack of Efficacy|208|||
27769327|NCT01000025|80984784|FG000|Overall Study|Intercurrent Illness|26|||
27769328|NCT01000025|80984785|FG001|Overall Study|Intercurrent Illness|7|||
27769329|NCT01634113|80984786|FG000|Overall Study|Not treated|0|||
27769330|NCT01634113|80984787|FG001|Overall Study|Not treated|0|||
27769331|NCT01634113|80984788|FG002|Overall Study|Not treated|1|||
27769332|NCT02657434|80984789|FG000|Overall Study|Study Terminated By Sponsor|64|||
27769333|NCT02657434|80984790|FG001|Overall Study|Study Terminated By Sponsor|82|||
27769334|NCT02657434|80984789|FG000|Overall Study|Death|189|||
27769335|NCT02657434|80984790|FG001|Overall Study|Death|190|||
27769336|NCT02657434|80984789|FG000|Overall Study|Lost to Follow-up|2|||
27769337|NCT02657434|80984790|FG001|Overall Study|Lost to Follow-up|2|||
27769338|NCT02657434|80984789|FG000|Overall Study|Randomization by Error|2|||
27769339|NCT02657434|80984790|FG001|Overall Study|Randomization by Error|0|||
27769340|NCT02657434|80984789|FG000|Overall Study|Withdrawal by Subject|28|||
27769341|NCT02657434|80984790|FG001|Overall Study|Withdrawal by Subject|17|||
27769342|NCT02657434|80984789|FG000|Overall Study|Protocol Violation|1|||
27769343|NCT02657434|80984790|FG001|Overall Study|Protocol Violation|0|||
27769344|NCT02657434|80984789|FG000|Overall Study|Physician Decision|0|||
27769345|NCT02657434|80984790|FG001|Overall Study|Physician Decision|1|||
27769346|NCT01810380|80984794|FG000|Overall Study|Randomised not treated|2|||
27769347|NCT01810380|80984795|FG001|Overall Study|Randomised not treated|1|||
27769348|NCT01810380|80984796|FG002|Overall Study|Randomised not treated|1|||
27769349|NCT01810380|80984794|FG000|Overall Study|Adverse Event|11|||
27769350|NCT01810380|80984795|FG001|Overall Study|Adverse Event|14|||
27769351|NCT01810380|80984796|FG002|Overall Study|Adverse Event|4|||
27769352|NCT01810380|80984794|FG000|Overall Study|Lack of Efficacy|24|||
27769353|NCT01810380|80984795|FG001|Overall Study|Lack of Efficacy|10|||
27769354|NCT01810380|80984796|FG002|Overall Study|Lack of Efficacy|11|||
27769355|NCT01810380|80984794|FG000|Overall Study|Protocol Violation|1|||
27963981|NCT01713582|81699116|FG011|Overall Study|Death|0|||
27963982|NCT01713582|81699117|FG012|Overall Study|Death|0|||
27963983|NCT01713582|81699118|FG013|Overall Study|Death|0|||
27963984|NCT01713582|81699119|FG014|Overall Study|Death|0|||
27963985|NCT01713582|81699120|FG015|Overall Study|Death|0|||
27963986|NCT01713582|81699121|FG016|Overall Study|Death|0|||
27963987|NCT01713582|81699122|FG017|Overall Study|Death|0|||
27963988|NCT01713582|81699123|FG018|Overall Study|Death|0|||
27963989|NCT01713582|81699124|FG019|Overall Study|Death|0|||
27963990|NCT01713582|81699125|FG020|Overall Study|Death|0|||
27963991|NCT01713582|81699105|FG000|Overall Study|Adverse event-related|0|||
27963992|NCT01713582|81699106|FG001|Overall Study|Adverse event-related|0|||
27769356|NCT01810380|80984795|FG001|Overall Study|Protocol Violation|0|||
27769357|NCT01810380|80984796|FG002|Overall Study|Protocol Violation|1|||
27769358|NCT01810380|80984794|FG000|Overall Study|Withdrawal by Subject|6|||
27769359|NCT01810380|80984795|FG001|Overall Study|Withdrawal by Subject|0|||
27769360|NCT01810380|80984796|FG002|Overall Study|Withdrawal by Subject|6|||
27963993|NCT01713582|81699107|FG002|Overall Study|Adverse event-related|0|||
27769361|NCT01810380|80984794|FG000|Overall Study|Administrative or other reasons|11|||
27769362|NCT01810380|80984795|FG001|Overall Study|Administrative or other reasons|13|||
27963994|NCT01713582|81699108|FG003|Overall Study|Adverse event-related|0|||
27963995|NCT01713582|81699109|FG004|Overall Study|Adverse event-related|0|||
27769363|NCT01810380|80984796|FG002|Overall Study|Administrative or other reasons|9|||
27769364|NCT00383708|80984798|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
27769365|NCT00383708|80984798|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
27769366|NCT00383708|80984798|FG000|Run-in Period|Protocol Violation|4|||
27769367|NCT00383708|80984798|FG000|Run-in Period|Adverse Event|2|||
27769368|NCT00383708|80984798|FG000|Run-in Period|Claustrophobia|1|||
27769369|NCT00383708|80984798|FG000|Co-administration Period|Adverse Event|5|||
27769370|NCT00571519|80984799|FG000|Overall Study|Subject withdrew consent|0|||
27769371|NCT00571519|80984800|FG001|Overall Study|Subject withdrew consent|1|||
27769372|NCT00571519|80984801|FG002|Overall Study|Subject withdrew consent|0|||
27769373|NCT00571519|80984802|FG003|Overall Study|Subject withdrew consent|2|||
27769374|NCT00571519|80984803|FG004|Overall Study|Subject withdrew consent|1|||
27769375|NCT00571519|80984804|FG005|Overall Study|Subject withdrew consent|1|||
27769376|NCT00571519|80984805|FG006|Overall Study|Subject withdrew consent|2|||
27769377|NCT00571519|80984799|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
27769378|NCT00571519|80984800|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27769379|NCT00571519|80984801|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
27769380|NCT00571519|80984802|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
27769381|NCT00571519|80984803|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27769382|NCT00571519|80984804|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27769383|NCT00571519|80984805|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
27769384|NCT00571519|80984799|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
27769385|NCT00571519|80984800|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
27769386|NCT00571519|80984801|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
27769387|NCT00571519|80984802|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
27769388|NCT00571519|80984803|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
27769389|NCT00571519|80984804|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
27769390|NCT00571519|80984805|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
27769391|NCT00571519|80984799|FG000|Overall Study|Termination of study by Sponsor|2|||
27769392|NCT00571519|80984800|FG001|Overall Study|Termination of study by Sponsor|7|||
27769393|NCT00571519|80984801|FG002|Overall Study|Termination of study by Sponsor|10|||
27769394|NCT00571519|80984802|FG003|Overall Study|Termination of study by Sponsor|24|||
27769395|NCT00571519|80984803|FG004|Overall Study|Termination of study by Sponsor|8|||
27769396|NCT00571519|80984804|FG005|Overall Study|Termination of study by Sponsor|9|||
27769397|NCT00571519|80984805|FG006|Overall Study|Termination of study by Sponsor|22|||
27769398|NCT00571519|80984799|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27769399|NCT00571519|80984800|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27769400|NCT00571519|80984801|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
27769401|NCT00571519|80984802|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27769402|NCT00571519|80984803|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27769403|NCT00571519|80984804|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27769404|NCT00571519|80984805|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
27769405|NCT01313039|80984806|FG000|Overall Study|Physician Decision|1|||
27769406|NCT01313039|80984806|FG000|Overall Study|Adverse Event|1|||
27769407|NCT01300767|80984810|FG000|Overall Study|Discomfort|2|||
27769408|NCT01300767|80984810|FG000|Overall Study|Biomicroscopy|1|||
27769409|NCT01300767|80984810|FG000|Overall Study|Unacceptable fit|1|||
27769410|NCT00150345|80984811|FG000|Overall Study|Death|5|||
27769411|NCT00150345|80984812|FG001|Overall Study|Death|2|||
27769412|NCT00150345|80984811|FG000|Overall Study|Adverse Event|8|||
27769413|NCT00150345|80984812|FG001|Overall Study|Adverse Event|6|||
27769414|NCT00150345|80984811|FG000|Overall Study|Lack of Efficacy|5|||
27769415|NCT00150345|80984812|FG001|Overall Study|Lack of Efficacy|4|||
27769416|NCT00150345|80984811|FG000|Overall Study|Withdrawal by Subject|3|||
27769417|NCT00150345|80984812|FG001|Overall Study|Withdrawal by Subject|4|||
27769418|NCT00150345|80984811|FG000|Overall Study|Laboratory abnormality|1|||
27769419|NCT00150345|80984812|FG001|Overall Study|Laboratory abnormality|2|||
27769420|NCT00150345|80984811|FG000|Overall Study|Other|12|||
27769421|NCT00150345|80984812|FG001|Overall Study|Other|14|||
27769422|NCT02944513|80984813|FG000|Overall Study|Withdrawal by Subject|4|||
27769423|NCT02944513|80984814|FG001|Overall Study|Withdrawal by Subject|1|||
27769424|NCT01316939|80984816|FG000|Overall Study|Study closed/terminated|26|||
27769425|NCT01316939|80984817|FG001|Overall Study|Study closed/terminated|25|||
27769426|NCT01316939|80984818|FG002|Overall Study|Study closed/terminated|23|||
27769427|NCT01316939|80984816|FG000|Overall Study|Lack of Efficacy|24|||
27769428|NCT01316939|80984817|FG001|Overall Study|Lack of Efficacy|25|||
27769429|NCT01316939|80984818|FG002|Overall Study|Lack of Efficacy|25|||
27769430|NCT01316939|80984816|FG000|Overall Study|Adverse Event|9|||
27769431|NCT01316939|80984817|FG001|Overall Study|Adverse Event|12|||
27769432|NCT01316939|80984818|FG002|Overall Study|Adverse Event|11|||
27769433|NCT01316939|80984816|FG000|Overall Study|Withdrawal by Subject|1|||
27769434|NCT01316939|80984817|FG001|Overall Study|Withdrawal by Subject|3|||
27769435|NCT01316939|80984818|FG002|Overall Study|Withdrawal by Subject|6|||
27769436|NCT01316939|80984816|FG000|Overall Study|Physician Decision|2|||
27769437|NCT01316939|80984817|FG001|Overall Study|Physician Decision|2|||
27769438|NCT01316939|80984818|FG002|Overall Study|Physician Decision|1|||
27769439|NCT01316939|80984816|FG000|Overall Study|Lost to Follow-up|0|||
27769440|NCT01316939|80984817|FG001|Overall Study|Lost to Follow-up|0|||
27769441|NCT01316939|80984818|FG002|Overall Study|Lost to Follow-up|2|||
27769442|NCT01316939|80984816|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
27769443|NCT01316939|80984817|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
27769444|NCT01316939|80984818|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
27769445|NCT01316939|80984816|FG000|Overall Study|Protocol Violation|0|||
27769446|NCT01316939|80984817|FG001|Overall Study|Protocol Violation|1|||
27769447|NCT01316939|80984818|FG002|Overall Study|Protocol Violation|0|||
27769448|NCT05406440|80984821|FG000|Overall Study|Lost to Follow-up|0|||
27769449|NCT05406440|80984822|FG001|Overall Study|Lost to Follow-up|0|||
27769450|NCT05406440|80984823|FG002|Overall Study|Lost to Follow-up|0|||
27963996|NCT01713582|81699110|FG005|Overall Study|Adverse event-related|0|||
27963997|NCT01713582|81699111|FG006|Overall Study|Adverse event-related|0|||
27963998|NCT01713582|81699112|FG007|Overall Study|Adverse event-related|0|||
27963999|NCT01713582|81699113|FG008|Overall Study|Adverse event-related|0|||
27964000|NCT01713582|81699114|FG009|Overall Study|Adverse event-related|1|||
27964001|NCT01713582|81699115|FG010|Overall Study|Adverse event-related|1|||
27964002|NCT01713582|81699116|FG011|Overall Study|Adverse event-related|0|||
27964003|NCT01713582|81699117|FG012|Overall Study|Adverse event-related|0|||
27964004|NCT01713582|81699118|FG013|Overall Study|Adverse event-related|0|||
27964005|NCT01713582|81699119|FG014|Overall Study|Adverse event-related|0|||
27769451|NCT05406440|80984824|FG003|Overall Study|Lost to Follow-up|0|||
27769452|NCT05406440|80984825|FG004|Overall Study|Lost to Follow-up|2|||
27769453|NCT05406440|80984826|FG005|Overall Study|Lost to Follow-up|0|||
27769454|NCT05406440|80984827|FG006|Overall Study|Lost to Follow-up|0|||
27769455|NCT05406440|80984821|FG000|Overall Study|Physician Decision|0|||
27769456|NCT05406440|80984822|FG001|Overall Study|Physician Decision|0|||
27769457|NCT05406440|80984823|FG002|Overall Study|Physician Decision|0|||
27769458|NCT05406440|80984824|FG003|Overall Study|Physician Decision|0|||
27769459|NCT05406440|80984825|FG004|Overall Study|Physician Decision|1|||
27769460|NCT05406440|80984826|FG005|Overall Study|Physician Decision|0|||
27769461|NCT05406440|80984827|FG006|Overall Study|Physician Decision|0|||
27769462|NCT05406440|80984821|FG000|Overall Study|Withdrawal by Subject|0|||
27769463|NCT05406440|80984822|FG001|Overall Study|Withdrawal by Subject|0|||
27769464|NCT05406440|80984823|FG002|Overall Study|Withdrawal by Subject|0|||
27769465|NCT05406440|80984824|FG003|Overall Study|Withdrawal by Subject|0|||
27769466|NCT05406440|80984825|FG004|Overall Study|Withdrawal by Subject|0|||
27769467|NCT05406440|80984826|FG005|Overall Study|Withdrawal by Subject|2|||
27769468|NCT05406440|80984827|FG006|Overall Study|Withdrawal by Subject|0|||
27769469|NCT01352845|80984828|FG000|Overall Study|Lost to Follow-up|313|||
27769470|NCT01352845|80984829|FG001|Overall Study|Lost to Follow-up|92|||
27769471|NCT01352845|80984828|FG000|Overall Study|No Longer Willing to Participate|205|||
27769472|NCT01352845|80984829|FG001|Overall Study|No Longer Willing to Participate|58|||
27769473|NCT01352845|80984828|FG000|Overall Study|Withdrawal by Subject|48|||
27769474|NCT01352845|80984829|FG001|Overall Study|Withdrawal by Subject|16|||
27769475|NCT01352845|80984828|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
27769476|NCT01352845|80984829|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
27769477|NCT01352845|80984828|FG000|Overall Study|Pregnancy|27|||
27769478|NCT01352845|80984829|FG001|Overall Study|Pregnancy|7|||
27769479|NCT01352845|80984828|FG000|Overall Study|Adverse Event|22|||
27769480|NCT01352845|80984829|FG001|Overall Study|Adverse Event|6|||
27769481|NCT01352845|80984828|FG000|Overall Study|Other|17|||
27769482|NCT01352845|80984829|FG001|Overall Study|Other|7|||
27769483|NCT01352845|80984828|FG000|Overall Study|Protocol Violation|12|||
27769484|NCT01352845|80984829|FG001|Overall Study|Protocol Violation|6|||
27769485|NCT01352845|80984828|FG000|Overall Study|Death|3|||
27769486|NCT01352845|80984829|FG001|Overall Study|Death|0|||
27769487|NCT02076334|80984830|FG000|Overall Study|Protocol Violation|1|||
27769488|NCT02076334|80984831|FG001|Overall Study|Protocol Violation|0|||
27769489|NCT02076334|80984832|FG002|Overall Study|Protocol Violation|0|||
27964006|NCT01713582|81699120|FG015|Overall Study|Adverse event-related|0|||
27769490|NCT02076334|80984833|FG003|Overall Study|Protocol Violation|0|||
27964007|NCT01713582|81699121|FG016|Overall Study|Adverse event-related|0|||
27964008|NCT01713582|81699122|FG017|Overall Study|Adverse event-related|0|||
27769491|NCT02076334|80984830|FG000|Overall Study|Lost to Follow-up|0|||
27769492|NCT02076334|80984831|FG001|Overall Study|Lost to Follow-up|1|||
27769493|NCT02076334|80984832|FG002|Overall Study|Lost to Follow-up|1|||
27769494|NCT02076334|80984833|FG003|Overall Study|Lost to Follow-up|0|||
27769495|NCT02076334|80984830|FG000|Overall Study|muscle soreness|0|||
27769496|NCT02076334|80984831|FG001|Overall Study|muscle soreness|0|||
27769497|NCT02076334|80984832|FG002|Overall Study|muscle soreness|0|||
27769498|NCT02076334|80984833|FG003|Overall Study|muscle soreness|1|||
27769499|NCT01931150|80984834|FG000|Overall Study|Withdrawal by Subject|1|||
27769500|NCT01931150|80984835|FG001|Overall Study|Withdrawal by Subject|2|||
27769501|NCT01112982|80984838|FG000|Overall Study|Withdrawal by Subject|1|||
27769502|NCT01112982|80984838|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
27769503|NCT01316380|80984841|FG000|Overall Study|Adverse Event|0|||
27769504|NCT01316380|80984842|FG001|Overall Study|Adverse Event|2|||
27769505|NCT01316380|80984843|FG002|Overall Study|Adverse Event|1|||
27769506|NCT01316380|80984841|FG000|Overall Study|Protocol Violation|0|||
27769507|NCT01316380|80984842|FG001|Overall Study|Protocol Violation|0|||
27769508|NCT01316380|80984843|FG002|Overall Study|Protocol Violation|1|||
27769509|NCT01316380|80984841|FG000|Overall Study|Withdrawal by Subject|1|||
27769510|NCT01316380|80984842|FG001|Overall Study|Withdrawal by Subject|2|||
27769511|NCT01316380|80984843|FG002|Overall Study|Withdrawal by Subject|0|||
27769512|NCT01316380|80984841|FG000|Overall Study|Other|0|||
27769513|NCT01316380|80984842|FG001|Overall Study|Other|1|||
27769514|NCT01316380|80984843|FG002|Overall Study|Other|1|||
27769515|NCT01316380|80984841|FG000|Overall Study|Not treated|1|||
27769516|NCT01316380|80984842|FG001|Overall Study|Not treated|0|||
27769517|NCT01316380|80984843|FG002|Overall Study|Not treated|0|||
27769518|NCT00423592|80984844|FG000|Overall Study|Adverse Event (through Week 12)|2|||
27769519|NCT00423592|80984844|FG000|Overall Study|Adverse Event (post Week 12)|5|||
27769520|NCT00114218|80984847|FG000|Overall Study|Wrong Cell Type|2|||
27769521|NCT00114218|80984847|FG000|Overall Study|Wrong Primary|1|||
27769522|NCT00114218|80984847|FG000|Overall Study|Never Treated|1|||
27769523|NCT03997760|80984849|FG000|Overall Study|Protocol Deviation|0|||
27769524|NCT03997760|80984850|FG001|Overall Study|Protocol Deviation|1|||
27769525|NCT03997760|80984851|FG002|Overall Study|Protocol Deviation|0|||
27769526|NCT03997760|80984852|FG003|Overall Study|Protocol Deviation|0|||
27769527|NCT03907969|80984856|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
27769528|NCT03907969|80984857|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
27569009|NCT02658890|80271491|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
27964009|NCT01713582|81699123|FG018|Overall Study|Adverse event-related|1|||
27964010|NCT01713582|81699124|FG019|Overall Study|Adverse event-related|0|||
27569010|NCT02658890|80271492|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
27663899|NCT00931918|80606554|FG001|Overall Study|Did not receive study drug|2|||
27663900|NCT03280108|80606555|FG000|Overall Study|Lost to Follow-up|2|||
27663901|NCT03280108|80606556|FG001|Overall Study|Lost to Follow-up|0|||
27663902|NCT01837719|80606558|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
27769529|NCT03907969|80984858|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
27769530|NCT03907969|80984859|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
27769531|NCT03907969|80984860|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
27769532|NCT03907969|80984861|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
27769533|NCT03907969|80984862|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
27769534|NCT03907969|80984863|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
27769535|NCT03907969|80984864|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
27769536|NCT03907969|80984865|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
27964011|NCT01713582|81699125|FG020|Overall Study|Adverse event-related|0|||
27964012|NCT01713582|81699105|FG000|Overall Study|Adverse event-unrelated|0|||
27964013|NCT01713582|81699106|FG001|Overall Study|Adverse event-unrelated|0|||
27964014|NCT01713582|81699107|FG002|Overall Study|Adverse event-unrelated|0|||
27964015|NCT01713582|81699108|FG003|Overall Study|Adverse event-unrelated|0|||
27663903|NCT01837719|80606558|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
27663904|NCT02930837|80606559|FG000|Overall Study|Adverse Event|6|||
27663905|NCT02930837|80606559|FG000|Overall Study|Lost to Follow-up|5|||
27769537|NCT03907969|80984866|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
27769538|NCT03907969|80984856|FG000|Monotherapy Part A|Progressive Disease|0|||
27964016|NCT01713582|81699109|FG004|Overall Study|Adverse event-unrelated|0|||
27964017|NCT01713582|81699110|FG005|Overall Study|Adverse event-unrelated|1|||
27663906|NCT02930837|80606559|FG000|Overall Study|Withdrawal by Subject|1|||
27769539|NCT03907969|80984857|FG001|Monotherapy Part A|Progressive Disease|1|||
27769540|NCT03907969|80984858|FG002|Monotherapy Part A|Progressive Disease|0|||
27769541|NCT03907969|80984859|FG003|Monotherapy Part A|Progressive Disease|0|||
27769542|NCT03907969|80984860|FG004|Monotherapy Part A|Progressive Disease|0|||
27769543|NCT03907969|80984861|FG005|Monotherapy Part A|Progressive Disease|1|||
27769544|NCT03907969|80984862|FG006|Monotherapy Part A|Progressive Disease|2|||
27663907|NCT02394925|80606565|FG000|Overall Study|Adverse Event|1|||
27769545|NCT03907969|80984863|FG007|Monotherapy Part A|Progressive Disease|0|||
27769546|NCT03907969|80984864|FG008|Monotherapy Part A|Progressive Disease|0|||
27769547|NCT03907969|80984865|FG009|Monotherapy Part A|Progressive Disease|0|||
27769548|NCT03907969|80984866|FG010|Monotherapy Part A|Progressive Disease|0|||
27769549|NCT03907969|80984856|FG000|Monotherapy Part A|Death|0|||
27769550|NCT03907969|80984857|FG001|Monotherapy Part A|Death|0|||
27964018|NCT01713582|81699111|FG006|Overall Study|Adverse event-unrelated|1|||
27964019|NCT01713582|81699112|FG007|Overall Study|Adverse event-unrelated|1|||
27769551|NCT03907969|80984858|FG002|Monotherapy Part A|Death|1|||
27769552|NCT03907969|80984859|FG003|Monotherapy Part A|Death|1|||
27964020|NCT01713582|81699113|FG008|Overall Study|Adverse event-unrelated|0|||
27964021|NCT01713582|81699114|FG009|Overall Study|Adverse event-unrelated|0|||
27964022|NCT01713582|81699115|FG010|Overall Study|Adverse event-unrelated|0|||
27964023|NCT01713582|81699116|FG011|Overall Study|Adverse event-unrelated|0|||
27964024|NCT01713582|81699117|FG012|Overall Study|Adverse event-unrelated|0|||
27964025|NCT01713582|81699118|FG013|Overall Study|Adverse event-unrelated|1|||
27964026|NCT01713582|81699119|FG014|Overall Study|Adverse event-unrelated|1|||
27964027|NCT01713582|81699120|FG015|Overall Study|Adverse event-unrelated|0|||
27964028|NCT01713582|81699121|FG016|Overall Study|Adverse event-unrelated|0|||
27964029|NCT01713582|81699122|FG017|Overall Study|Adverse event-unrelated|0|||
27964030|NCT01713582|81699123|FG018|Overall Study|Adverse event-unrelated|0|||
27964031|NCT01713582|81699124|FG019|Overall Study|Adverse event-unrelated|0|||
27964032|NCT01713582|81699125|FG020|Overall Study|Adverse event-unrelated|0|||
27964033|NCT01713582|81699105|FG000|Overall Study|Withdrawal of consent|0|||
27964034|NCT01713582|81699106|FG001|Overall Study|Withdrawal of consent|0|||
27964035|NCT01713582|81699107|FG002|Overall Study|Withdrawal of consent|1|||
27964036|NCT01713582|81699108|FG003|Overall Study|Withdrawal of consent|0|||
27964037|NCT01713582|81699109|FG004|Overall Study|Withdrawal of consent|0|||
27964038|NCT01713582|81699110|FG005|Overall Study|Withdrawal of consent|1|||
27964039|NCT01713582|81699111|FG006|Overall Study|Withdrawal of consent|0|||
27964040|NCT01713582|81699112|FG007|Overall Study|Withdrawal of consent|0|||
27964041|NCT01713582|81699113|FG008|Overall Study|Withdrawal of consent|0|||
27964042|NCT01713582|81699114|FG009|Overall Study|Withdrawal of consent|1|||
27964043|NCT01713582|81699115|FG010|Overall Study|Withdrawal of consent|0|||
27964044|NCT01713582|81699116|FG011|Overall Study|Withdrawal of consent|0|||
27964045|NCT01713582|81699117|FG012|Overall Study|Withdrawal of consent|0|||
27964046|NCT01713582|81699118|FG013|Overall Study|Withdrawal of consent|0|||
27964047|NCT01713582|81699119|FG014|Overall Study|Withdrawal of consent|0|||
27964048|NCT01713582|81699120|FG015|Overall Study|Withdrawal of consent|0|||
27964049|NCT01713582|81699121|FG016|Overall Study|Withdrawal of consent|0|||
27964050|NCT01713582|81699122|FG017|Overall Study|Withdrawal of consent|0|||
27964051|NCT01713582|81699123|FG018|Overall Study|Withdrawal of consent|1|||
27964052|NCT01713582|81699124|FG019|Overall Study|Withdrawal of consent|0|||
27964053|NCT01713582|81699125|FG020|Overall Study|Withdrawal of consent|0|||
27964054|NCT01713582|81699105|FG000|Overall Study|Lack of Efficacy|0|||
27964055|NCT01713582|81699106|FG001|Overall Study|Lack of Efficacy|0|||
27964056|NCT01713582|81699107|FG002|Overall Study|Lack of Efficacy|0|||
27964057|NCT01713582|81699108|FG003|Overall Study|Lack of Efficacy|0|||
27964058|NCT01713582|81699109|FG004|Overall Study|Lack of Efficacy|0|||
27964059|NCT01713582|81699110|FG005|Overall Study|Lack of Efficacy|0|||
27964060|NCT01713582|81699111|FG006|Overall Study|Lack of Efficacy|0|||
27964061|NCT01713582|81699112|FG007|Overall Study|Lack of Efficacy|0|||
27964062|NCT01713582|81699113|FG008|Overall Study|Lack of Efficacy|0|||
27964063|NCT01713582|81699114|FG009|Overall Study|Lack of Efficacy|1|||
27964064|NCT01713582|81699115|FG010|Overall Study|Lack of Efficacy|2|||
27964065|NCT01713582|81699116|FG011|Overall Study|Lack of Efficacy|0|||
27964066|NCT01713582|81699117|FG012|Overall Study|Lack of Efficacy|0|||
27964067|NCT01713582|81699118|FG013|Overall Study|Lack of Efficacy|0|||
27964068|NCT01713582|81699119|FG014|Overall Study|Lack of Efficacy|0|||
27964069|NCT01713582|81699120|FG015|Overall Study|Lack of Efficacy|0|||
27964070|NCT01713582|81699121|FG016|Overall Study|Lack of Efficacy|0|||
27964071|NCT01713582|81699122|FG017|Overall Study|Lack of Efficacy|0|||
27964072|NCT01713582|81699123|FG018|Overall Study|Lack of Efficacy|0|||
27964073|NCT01713582|81699124|FG019|Overall Study|Lack of Efficacy|0|||
27964074|NCT01713582|81699125|FG020|Overall Study|Lack of Efficacy|0|||
27964075|NCT01713582|81699105|FG000|Overall Study|Withdrawal by Subject|0|||
27964076|NCT01713582|81699106|FG001|Overall Study|Withdrawal by Subject|0|||
27663908|NCT02394925|80606565|FG000|Overall Study|Lens Discomfort|3|||
27663909|NCT02394925|80606565|FG000|Overall Study|Lens handling difficulities|5|||
27663910|NCT02394925|80606565|FG000|Overall Study|Lost to Follow-up|9|||
27663911|NCT02394925|80606565|FG000|Overall Study|Protocol Violation|5|||
27663912|NCT02394925|80606565|FG000|Overall Study|No longer meet eligibility criteria|1|||
27663913|NCT02394925|80606565|FG000|Overall Study|Unsatisfactory Visual Response|5|||
27964077|NCT01713582|81699107|FG002|Overall Study|Withdrawal by Subject|0|||
27964078|NCT01713582|81699108|FG003|Overall Study|Withdrawal by Subject|0|||
27964079|NCT01713582|81699109|FG004|Overall Study|Withdrawal by Subject|0|||
27964080|NCT01713582|81699110|FG005|Overall Study|Withdrawal by Subject|0|||
27964081|NCT01713582|81699111|FG006|Overall Study|Withdrawal by Subject|0|||
27964082|NCT01713582|81699112|FG007|Overall Study|Withdrawal by Subject|0|||
27964083|NCT01713582|81699113|FG008|Overall Study|Withdrawal by Subject|0|||
27964084|NCT01713582|81699114|FG009|Overall Study|Withdrawal by Subject|0|||
27964085|NCT01713582|81699115|FG010|Overall Study|Withdrawal by Subject|0|||
27964086|NCT01713582|81699116|FG011|Overall Study|Withdrawal by Subject|0|||
27964087|NCT01713582|81699117|FG012|Overall Study|Withdrawal by Subject|0|||
27964088|NCT01713582|81699118|FG013|Overall Study|Withdrawal by Subject|0|||
27964089|NCT01713582|81699119|FG014|Overall Study|Withdrawal by Subject|0|||
27964090|NCT01713582|81699120|FG015|Overall Study|Withdrawal by Subject|0|||
27964091|NCT01713582|81699121|FG016|Overall Study|Withdrawal by Subject|0|||
27769553|NCT03907969|80984860|FG004|Monotherapy Part A|Death|0|||
27769554|NCT03907969|80984861|FG005|Monotherapy Part A|Death|1|||
27769555|NCT03907969|80984862|FG006|Monotherapy Part A|Death|0|||
27769556|NCT03907969|80984863|FG007|Monotherapy Part A|Death|0|||
27769557|NCT03907969|80984864|FG008|Monotherapy Part A|Death|0|||
27769558|NCT03907969|80984865|FG009|Monotherapy Part A|Death|0|||
27769559|NCT03907969|80984866|FG010|Monotherapy Part A|Death|0|||
27769560|NCT03907969|80984856|FG000|Combination Therapy Part A|Adverse Event|0|||
27769561|NCT03907969|80984857|FG001|Combination Therapy Part A|Adverse Event|0|||
27769562|NCT03907969|80984858|FG002|Combination Therapy Part A|Adverse Event|0|||
27769563|NCT03907969|80984859|FG003|Combination Therapy Part A|Adverse Event|0|||
27769564|NCT03907969|80984860|FG004|Combination Therapy Part A|Adverse Event|0|||
27769565|NCT03907969|80984861|FG005|Combination Therapy Part A|Adverse Event|0|||
27769566|NCT03907969|80984862|FG006|Combination Therapy Part A|Adverse Event|0|||
27769567|NCT03907969|80984863|FG007|Combination Therapy Part A|Adverse Event|0|||
27769568|NCT03907969|80984864|FG008|Combination Therapy Part A|Adverse Event|0|||
27769569|NCT03907969|80984865|FG009|Combination Therapy Part A|Adverse Event|1|||
27769570|NCT03907969|80984866|FG010|Combination Therapy Part A|Adverse Event|1|||
27769571|NCT03907969|80984856|FG000|Combination Therapy Part A|Progressive disease|0|||
27769572|NCT03907969|80984857|FG001|Combination Therapy Part A|Progressive disease|0|||
27769573|NCT03907969|80984858|FG002|Combination Therapy Part A|Progressive disease|0|||
27769574|NCT03907969|80984859|FG003|Combination Therapy Part A|Progressive disease|0|||
27769575|NCT03907969|80984860|FG004|Combination Therapy Part A|Progressive disease|0|||
27769576|NCT03907969|80984861|FG005|Combination Therapy Part A|Progressive disease|0|||
27769577|NCT03907969|80984862|FG006|Combination Therapy Part A|Progressive disease|0|||
27769578|NCT03907969|80984863|FG007|Combination Therapy Part A|Progressive disease|1|||
27769579|NCT03907969|80984864|FG008|Combination Therapy Part A|Progressive disease|0|||
27769580|NCT03907969|80984865|FG009|Combination Therapy Part A|Progressive disease|2|||
27769581|NCT03907969|80984866|FG010|Combination Therapy Part A|Progressive disease|3|||
27769582|NCT03907969|80984856|FG000|Combination Therapy Part A|Death|0|||
27769583|NCT03907969|80984857|FG001|Combination Therapy Part A|Death|0|||
27769584|NCT03907969|80984858|FG002|Combination Therapy Part A|Death|0|||
27769585|NCT03907969|80984859|FG003|Combination Therapy Part A|Death|0|||
27769586|NCT03907969|80984860|FG004|Combination Therapy Part A|Death|0|||
27769587|NCT03907969|80984861|FG005|Combination Therapy Part A|Death|0|||
27769588|NCT03907969|80984862|FG006|Combination Therapy Part A|Death|0|||
27769589|NCT03907969|80984863|FG007|Combination Therapy Part A|Death|0|||
27769590|NCT03907969|80984864|FG008|Combination Therapy Part A|Death|1|||
27769591|NCT03907969|80984865|FG009|Combination Therapy Part A|Death|0|||
27769592|NCT03907969|80984866|FG010|Combination Therapy Part A|Death|1|||
27769593|NCT03907969|80984856|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
27769594|NCT03907969|80984857|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
27769595|NCT03907969|80984858|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
27769596|NCT03907969|80984859|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
27769597|NCT03907969|80984860|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
27769598|NCT03907969|80984861|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
27769599|NCT03907969|80984862|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
27769600|NCT03907969|80984863|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
27769601|NCT03907969|80984864|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
27769602|NCT03907969|80984865|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
27569011|NCT02658890|80271493|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
27769603|NCT03907969|80984866|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
27769604|NCT03907969|80984856|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
27769605|NCT03907969|80984857|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
27769606|NCT03907969|80984858|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
27769607|NCT03907969|80984859|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
27769608|NCT03907969|80984860|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
27769609|NCT03907969|80984861|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
27769610|NCT03907969|80984862|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
27769611|NCT03907969|80984863|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
27769612|NCT03907969|80984864|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
27769613|NCT03907969|80984865|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
27769614|NCT03907969|80984866|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
27769615|NCT03907969|80984856|FG000|Combination Therapy Part A|Physician Decision|0|||
27769616|NCT03907969|80984857|FG001|Combination Therapy Part A|Physician Decision|0|||
27769617|NCT03907969|80984858|FG002|Combination Therapy Part A|Physician Decision|0|||
27769618|NCT03907969|80984859|FG003|Combination Therapy Part A|Physician Decision|0|||
27769619|NCT03907969|80984860|FG004|Combination Therapy Part A|Physician Decision|0|||
27769620|NCT03907969|80984861|FG005|Combination Therapy Part A|Physician Decision|0|||
27964092|NCT01713582|81699122|FG017|Overall Study|Withdrawal by Subject|1|||
27964093|NCT01713582|81699123|FG018|Overall Study|Withdrawal by Subject|0|||
27964094|NCT01713582|81699124|FG019|Overall Study|Withdrawal by Subject|0|||
27964095|NCT01713582|81699125|FG020|Overall Study|Withdrawal by Subject|0|||
27964096|NCT01713582|81699105|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
27964097|NCT01713582|81699106|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
27964098|NCT01713582|81699107|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
27964099|NCT01713582|81699108|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
27964100|NCT01713582|81699109|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
27964101|NCT01713582|81699110|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
27964102|NCT01713582|81699111|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
27964103|NCT01713582|81699112|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
27964104|NCT01713582|81699113|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
27964105|NCT01713582|81699114|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
27769621|NCT03907969|80984862|FG006|Combination Therapy Part A|Physician Decision|0|||
27769622|NCT03907969|80984863|FG007|Combination Therapy Part A|Physician Decision|1|||
27769623|NCT03907969|80984864|FG008|Combination Therapy Part A|Physician Decision|0|||
27769624|NCT03907969|80984865|FG009|Combination Therapy Part A|Physician Decision|0|||
27769625|NCT03907969|80984866|FG010|Combination Therapy Part A|Physician Decision|1|||
27769626|NCT00224003|80984867|FG000|Overall Study|Adverse Event|1|||
27769627|NCT00224003|80984867|FG000|Overall Study|Protocol Violation|2|||
27769628|NCT00224003|80984867|FG000|Overall Study|Withdrawal by Subject|1|||
27769629|NCT00224003|80984867|FG000|Overall Study|unk|3|||
27769630|NCT00557323|80984868|FG000|Overall Study|Death|3|||
27769631|NCT00557323|80984868|FG000|Overall Study|Withdrawal by Subject|2|||
27769632|NCT00557323|80984868|FG000|Overall Study|Administrative change|2|||
27769633|NCT02578992|80984869|FG000|Overall Study|equipment not available or malfunction|3|||
27769634|NCT02578992|80984870|FG001|Overall Study|equipment not available or malfunction|3|||
27769635|NCT00429572|80984872|FG000|Overall Study|Disease progression|1|||
27769636|NCT00481988|80984873|FG000|Overall Study|Withdrawal by Subject|1|||
27769637|NCT00481988|80984874|FG001|Overall Study|Withdrawal by Subject|1|||
27769638|NCT03077243|80984875|FG000|Overall Study|Death|1|||
27769639|NCT03077243|80984876|FG001|Overall Study|Death|2|||
27769640|NCT03077243|80984877|FG002|Overall Study|Death|0|||
27769641|NCT03077243|80984878|FG003|Overall Study|Death|0|||
27769642|NCT03077243|80984875|FG000|Overall Study|Withdrawal by Subject|1|||
27769643|NCT03077243|80984876|FG001|Overall Study|Withdrawal by Subject|3|||
27769644|NCT03077243|80984877|FG002|Overall Study|Withdrawal by Subject|0|||
27769645|NCT03077243|80984878|FG003|Overall Study|Withdrawal by Subject|0|||
27769646|NCT03077243|80984875|FG000|Overall Study|Physician Decision|1|||
27769647|NCT03077243|80984876|FG001|Overall Study|Physician Decision|0|||
27769648|NCT03077243|80984877|FG002|Overall Study|Physician Decision|0|||
27769649|NCT03077243|80984878|FG003|Overall Study|Physician Decision|0|||
27769650|NCT03077243|80984875|FG000|Overall Study|Research at two study sites terminated early|0|||
27769651|NCT03077243|80984876|FG001|Overall Study|Research at two study sites terminated early|0|||
27769652|NCT03077243|80984877|FG002|Overall Study|Research at two study sites terminated early|0|||
27769653|NCT03077243|80984878|FG003|Overall Study|Research at two study sites terminated early|69|||
27769654|NCT01614795|80984879|FG000|Overall Study|Adverse Event|0|||
27769655|NCT01614795|80984880|FG001|Overall Study|Adverse Event|0|||
27769656|NCT01614795|80984881|FG002|Overall Study|Adverse Event|1|||
27769657|NCT01614795|80984882|FG003|Overall Study|Adverse Event|1|||
27769658|NCT01614795|80984879|FG000|Overall Study|Lack of Efficacy|10|||
27769659|NCT01614795|80984880|FG001|Overall Study|Lack of Efficacy|10|||
27769660|NCT01614795|80984881|FG002|Overall Study|Lack of Efficacy|9|||
27769661|NCT01614795|80984882|FG003|Overall Study|Lack of Efficacy|8|||
27769662|NCT01614795|80984879|FG000|Overall Study|Physician Decision|1|||
27769663|NCT01614795|80984880|FG001|Overall Study|Physician Decision|0|||
27769664|NCT01614795|80984881|FG002|Overall Study|Physician Decision|1|||
27964106|NCT01713582|81699115|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
27964107|NCT01713582|81699116|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
27964108|NCT01713582|81699117|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
27769665|NCT01614795|80984882|FG003|Overall Study|Physician Decision|1|||
27769666|NCT01614795|80984879|FG000|Overall Study|Withdrawal by Subject|0|||
27769667|NCT01614795|80984880|FG001|Overall Study|Withdrawal by Subject|1|||
27769668|NCT01614795|80984881|FG002|Overall Study|Withdrawal by Subject|0|||
27769669|NCT01614795|80984882|FG003|Overall Study|Withdrawal by Subject|2|||
27769670|NCT01614795|80984879|FG000|Overall Study|Ineligible|0|||
27769671|NCT01614795|80984880|FG001|Overall Study|Ineligible|1|||
27769672|NCT01614795|80984881|FG002|Overall Study|Ineligible|0|||
27769673|NCT01614795|80984882|FG003|Overall Study|Ineligible|0|||
27769674|NCT02920450|80984883|FG000|Overall Study|Death|1|||
27769675|NCT02920450|80984884|FG001|Overall Study|Death|0|||
27769676|NCT02920450|80984885|FG002|Overall Study|Death|0|||
27769677|NCT02920450|80984886|FG003|Overall Study|Death|0|||
27964109|NCT01713582|81699118|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
27964110|NCT01713582|81699119|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
27964111|NCT01713582|81699120|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
27964112|NCT01713582|81699121|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
27964113|NCT01713582|81699122|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
27964114|NCT01713582|81699123|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
27964115|NCT01713582|81699124|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
27964116|NCT01713582|81699125|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
27964117|NCT01713582|81699105|FG000|Overall Study|Disease progression and adverse event|0|||
27964118|NCT01713582|81699106|FG001|Overall Study|Disease progression and adverse event|0|||
27964119|NCT01713582|81699107|FG002|Overall Study|Disease progression and adverse event|0|||
27964120|NCT01713582|81699108|FG003|Overall Study|Disease progression and adverse event|0|||
27964121|NCT01713582|81699109|FG004|Overall Study|Disease progression and adverse event|0|||
27964122|NCT01713582|81699110|FG005|Overall Study|Disease progression and adverse event|0|||
27964123|NCT01713582|81699111|FG006|Overall Study|Disease progression and adverse event|0|||
27964124|NCT01713582|81699112|FG007|Overall Study|Disease progression and adverse event|0|||
27964125|NCT01713582|81699113|FG008|Overall Study|Disease progression and adverse event|0|||
27964126|NCT01713582|81699114|FG009|Overall Study|Disease progression and adverse event|0|||
27964127|NCT01713582|81699115|FG010|Overall Study|Disease progression and adverse event|0|||
27964128|NCT01713582|81699116|FG011|Overall Study|Disease progression and adverse event|0|||
27663914|NCT01225159|80606566|FG000|Overall Study|Change operation|1|||
27769678|NCT02920450|80984883|FG000|Overall Study|Withdrawal by Subject|1|||
27769679|NCT02920450|80984884|FG001|Overall Study|Withdrawal by Subject|0|||
27769680|NCT02920450|80984885|FG002|Overall Study|Withdrawal by Subject|0|||
27769681|NCT02920450|80984886|FG003|Overall Study|Withdrawal by Subject|0|||
27769682|NCT02009930|80984890|FG000|Overall Study|withdrawn|5|||
27769683|NCT01915095|80984895|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
27769684|NCT01915095|80984896|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
27769685|NCT01915095|80984897|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
27769686|NCT01915095|80984898|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
27769687|NCT01915095|80984899|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
27769688|NCT02455388|80984902|FG000|Overall Study|Protocol Violation|1|||
27769689|NCT02455388|80984903|FG001|Overall Study|Protocol Violation|0|||
27769690|NCT02455388|80984904|FG002|Overall Study|Protocol Violation|4|||
27769691|NCT02455388|80984902|FG000|Overall Study|Withdrawal by Subject|0|||
27769692|NCT02455388|80984903|FG001|Overall Study|Withdrawal by Subject|0|||
27769693|NCT02455388|80984904|FG002|Overall Study|Withdrawal by Subject|7|||
27769694|NCT03004976|80984905|FG000|Overall Study|Lost to Follow-up|7|||
27769695|NCT03004976|80984906|FG001|Overall Study|Lost to Follow-up|5|||
27769696|NCT03004976|80984905|FG000|Overall Study|Physician Decision|1|||
27769697|NCT03004976|80984906|FG001|Overall Study|Physician Decision|0|||
27769698|NCT03004976|80984905|FG000|Overall Study|Withdrawal by Subject|1|||
27769699|NCT03004976|80984906|FG001|Overall Study|Withdrawal by Subject|0|||
27769700|NCT03004976|80984905|FG000|Overall Study|Death|4|||
27769701|NCT03004976|80984906|FG001|Overall Study|Death|1|||
27769702|NCT01709708|80984907|FG000|Overall Study|Protocol Violation|1|||
27769703|NCT01709708|80984908|FG001|Overall Study|Protocol Violation|2|||
27862193|NCT02542605|81326250|FG000|Part B: Challenge Phase|Sponsor decision|1|||
27862194|NCT02542605|81326251|FG001|Part B: Challenge Phase|Sponsor decision|0|||
27862195|NCT02542605|81326252|FG002|Part B: Challenge Phase|Sponsor decision|0|||
27862196|NCT02542605|81326250|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
27862197|NCT02542605|81326251|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
27862198|NCT02542605|81326252|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
27862199|NCT04597632|81326253|FG000|Overall Study|Withdrawal by Subject|10|||
27862200|NCT04597632|81326253|FG000|Overall Study|Lost to Follow-up|1|||
27964129|NCT01713582|81699117|FG012|Overall Study|Disease progression and adverse event|0|||
27964130|NCT01713582|81699118|FG013|Overall Study|Disease progression and adverse event|0|||
27964131|NCT01713582|81699119|FG014|Overall Study|Disease progression and adverse event|0|||
27964132|NCT01713582|81699120|FG015|Overall Study|Disease progression and adverse event|0|||
27964133|NCT01713582|81699121|FG016|Overall Study|Disease progression and adverse event|1|||
27964134|NCT01713582|81699122|FG017|Overall Study|Disease progression and adverse event|0|||
27964135|NCT01713582|81699123|FG018|Overall Study|Disease progression and adverse event|0|||
27964136|NCT01713582|81699124|FG019|Overall Study|Disease progression and adverse event|0|||
27964137|NCT01713582|81699125|FG020|Overall Study|Disease progression and adverse event|0|||
27964138|NCT00652743|81699133|FG000|Months 12-18|Lost to Follow-up|1|||
27964139|NCT00652743|81699134|FG001|Months 12-18|Lost to Follow-up|2|||
27964140|NCT00652743|81699135|FG002|Months 12-18|Lost to Follow-up|7|||
27964141|NCT00652743|81699133|FG000|Months 24-30|Other|5|||
27964142|NCT00652743|81699134|FG001|Months 24-30|Other|1|||
27964143|NCT00652743|81699135|FG002|Months 24-30|Other|11|||
27964144|NCT00652743|81699133|FG000|Months 36-42|Serious Adverse Events|0|||
27964145|NCT00652743|81699134|FG001|Months 36-42|Serious Adverse Events|1|||
27964146|NCT00652743|81699135|FG002|Months 36-42|Serious Adverse Events|1|||
27964147|NCT00652743|81699133|FG000|Months 36-42|Withdrawal by Subject|1|||
27964148|NCT00652743|81699134|FG001|Months 36-42|Withdrawal by Subject|1|||
27964149|NCT00652743|81699135|FG002|Months 36-42|Withdrawal by Subject|0|||
27964150|NCT00652743|81699133|FG000|Months 36-42|Lost to Follow-up|0|||
27569012|NCT02658890|80271494|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
27569013|NCT02658890|80271495|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
27569014|NCT02658890|80271496|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
27663915|NCT01225159|80606567|FG001|Overall Study|Change operation|0|||
27663916|NCT02254681|80606568|FG000|Overall Study|Lack of Efficacy|6|||
27769756|NCT00093470|80984923|FG000|Overall Study|Disease progression|39|||
27769757|NCT00093470|80984924|FG001|Overall Study|Disease progression|0|||
27769758|NCT00093470|80984923|FG000|Overall Study|Adverse Event|15|||
27769759|NCT00093470|80984924|FG001|Overall Study|Adverse Event|0|||
27769760|NCT00093470|80984923|FG000|Overall Study|Death|2|||
27769761|NCT00093470|80984924|FG001|Overall Study|Death|0|||
27769762|NCT00093470|80984923|FG000|Overall Study|Withdrawal by Subject|8|||
27769763|NCT00093470|80984924|FG001|Overall Study|Withdrawal by Subject|0|||
27769764|NCT00093470|80984923|FG000|Overall Study|Alternative therapy|2|||
27769765|NCT00093470|80984924|FG001|Overall Study|Alternative therapy|0|||
27769766|NCT00093470|80984923|FG000|Overall Study|Other complicating disease|3|||
27769767|NCT00093470|80984924|FG001|Overall Study|Other complicating disease|0|||
27769768|NCT00093470|80984923|FG000|Overall Study|Physician Decision|2|||
27769769|NCT00093470|80984924|FG001|Overall Study|Physician Decision|0|||
27769770|NCT00093470|80984923|FG000|Overall Study|Never started treatment|1|||
27964151|NCT00652743|81699134|FG001|Months 36-42|Lost to Follow-up|1|||
27964152|NCT00652743|81699135|FG002|Months 36-42|Lost to Follow-up|0|||
27964153|NCT00652743|81699133|FG000|Months 36-42|Migrated/moved from study area|1|||
27964154|NCT00652743|81699134|FG001|Months 36-42|Migrated/moved from study area|0|||
27964155|NCT00652743|81699135|FG002|Months 36-42|Migrated/moved from study area|0|||
27964156|NCT00652743|81699133|FG000|Months 36-42|Other|4|||
27964157|NCT00652743|81699134|FG001|Months 36-42|Other|2|||
27964158|NCT00652743|81699135|FG002|Months 36-42|Other|8|||
27964159|NCT03423238|81699137|FG000|Overall Study|Lost to Follow-up|1|||
27964160|NCT03423238|81699138|FG001|Overall Study|Lost to Follow-up|0|||
27964161|NCT03423238|81699137|FG000|Overall Study|Withdrawal by Subject|1|||
27964162|NCT03423238|81699138|FG001|Overall Study|Withdrawal by Subject|0|||
27964163|NCT02266147|81699144|FG000|PART 1: Dose Escalation|Physician Decision|0|||
27964164|NCT02266147|81699145|FG001|PART 1: Dose Escalation|Physician Decision|0|||
27964165|NCT02266147|81699146|FG002|PART 1: Dose Escalation|Physician Decision|1|||
27964166|NCT02266147|81699147|FG003|PART 1: Dose Escalation|Physician Decision|0|||
27964167|NCT02266147|81699144|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
27964168|NCT02266147|81699145|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
27964169|NCT02266147|81699146|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
27964170|NCT02266147|81699147|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
27964171|NCT02266147|81699144|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
27964172|NCT02266147|81699145|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
27964173|NCT02266147|81699146|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
27964174|NCT02266147|81699147|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
27964175|NCT02266147|81699144|FG000|PART 1: Dose Escalation|Other|1|||
27964176|NCT02266147|81699145|FG001|PART 1: Dose Escalation|Other|1|||
27964177|NCT02266147|81699146|FG002|PART 1: Dose Escalation|Other|0|||
27964178|NCT02266147|81699147|FG003|PART 1: Dose Escalation|Other|0|||
27964179|NCT02266147|81699144|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
27769771|NCT00093470|80984924|FG001|Overall Study|Never started treatment|0|||
27769772|NCT00093470|80984923|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
27769773|NCT00093470|80984924|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
27769774|NCT01611298|80984925|FG000|Overall Study|Relapsed|2|||
27964180|NCT02266147|81699145|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
27964181|NCT02266147|81699146|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
27964182|NCT02266147|81699147|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
27964183|NCT02266147|81699144|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
27964184|NCT02266147|81699145|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
27964185|NCT02266147|81699146|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
27964186|NCT02266147|81699147|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
27964187|NCT02467192|81699148|FG000|Overall Study|Death|1|||
27964188|NCT02467192|81699148|FG000|Overall Study|revealed to have pneumonia before|2|||
27964189|NCT01057693|81699152|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
27964190|NCT01057693|81699153|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
27964191|NCT01057693|81699154|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
27964192|NCT01057693|81699152|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
27964193|NCT01057693|81699153|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
27964194|NCT01057693|81699154|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
27964195|NCT01057693|81699152|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
27964196|NCT01057693|81699153|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
27964197|NCT01057693|81699154|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
27964198|NCT01057693|81699152|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
27964199|NCT01057693|81699153|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
27964200|NCT01057693|81699154|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
27964201|NCT01057693|81699152|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
27964202|NCT01057693|81699153|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
27964203|NCT01057693|81699154|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
27663917|NCT02162771|80606569|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
27964204|NCT01057693|81699152|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
27964205|NCT01057693|81699153|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
27769823|NCT02699125|80984940|FG000|Placebo|Lost to Follow-up|2|||
27769824|NCT02699125|80984941|FG001|Placebo|Lost to Follow-up|0|||
27769825|NCT02699125|80984940|FG000|Placebo|Protocol Violation|1|||
27769826|NCT02699125|80984941|FG001|Placebo|Protocol Violation|0|||
27769827|NCT02699125|80984940|FG000|Placebo|Withdrawal by Subject|0|||
27769828|NCT02699125|80984941|FG001|Placebo|Withdrawal by Subject|4|||
27769829|NCT02699125|80984940|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
27769830|NCT02699125|80984941|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
27769831|NCT00322387|80984942|FG000|Treatment Period|Adverse Event|0|||
27769832|NCT00322387|80984943|FG001|Treatment Period|Adverse Event|1|||
27769833|NCT00322387|80984942|FG000|Follow-up Period|Final assessment not done|1|||
27769834|NCT00322387|80984943|FG001|Follow-up Period|Final assessment not done|3|||
27769835|NCT00322387|80984942|FG000|Follow-up Period|Death|1|||
27769836|NCT00322387|80984943|FG001|Follow-up Period|Death|0|||
27769837|NCT01106391|80984944|FG000|Overall Study|Death|12|||
27769838|NCT01106391|80984944|FG000|Overall Study|Withdrawal by Subject|7|||
27769839|NCT00610207|80984945|FG000|Overall Study|Lost to Follow-up|3|||
27769840|NCT00611767|80984950|FG000|Overall Study|Withdrawal by Subject|4|||
27769841|NCT00611767|80984951|FG001|Overall Study|Withdrawal by Subject|1|||
27769842|NCT00611767|80984950|FG000|Overall Study|Thiopental not available|3|||
27769843|NCT00611767|80984951|FG001|Overall Study|Thiopental not available|0|||
27769844|NCT00611767|80984950|FG000|Overall Study|didn't like the medication|1|||
27769845|NCT00611767|80984951|FG001|Overall Study|didn't like the medication|1|||
27769846|NCT00611767|80984950|FG000|Overall Study|Physician Decision|1|||
27769847|NCT00611767|80984951|FG001|Overall Study|Physician Decision|0|||
27769848|NCT01329341|80984952|FG000|Overall Study|Withdrawal by Subject|44|||
27769849|NCT02820038|80984953|FG000|Overall Study|Lost to Follow-up|7|||
27769850|NCT02820038|80984954|FG001|Overall Study|Lost to Follow-up|11|||
27769851|NCT02820038|80984955|FG002|Overall Study|Lost to Follow-up|2|||
27769852|NCT02820038|80984956|FG003|Overall Study|Lost to Follow-up|9|||
27769853|NCT02820038|80984953|FG000|Overall Study|Withdrawal by Subject|3|||
27769854|NCT02820038|80984954|FG001|Overall Study|Withdrawal by Subject|14|||
27769855|NCT02820038|80984955|FG002|Overall Study|Withdrawal by Subject|3|||
27769856|NCT02820038|80984956|FG003|Overall Study|Withdrawal by Subject|13|||
27769857|NCT00368472|80984957|FG000|Overall Study|Adverse Event|22|||
27769858|NCT00368472|80984957|FG000|Overall Study|Medication non-compliance|4|||
27769859|NCT00368472|80984957|FG000|Overall Study|Protocol Violation|2|||
27769860|NCT00368472|80984957|FG000|Overall Study|Request of Investigator or Sponsor|3|||
27769861|NCT00368472|80984957|FG000|Overall Study|Withdrawal by Subject|40|||
27769862|NCT00368472|80984957|FG000|Overall Study|Diary non-compliance|1|||
27769863|NCT00368472|80984957|FG000|Overall Study|Other|32|||
27769864|NCT00368472|80984957|FG000|Overall Study|Missing Final Disposition Date|1|||
27769865|NCT02786836|80984958|FG000|Overall Study|Death|1|||
27769866|NCT02786836|80984958|FG000|Overall Study|Lack of Efficacy|2|||
27769867|NCT02786836|80984958|FG000|Overall Study|Protocol Violation|3|||
27769868|NCT02786836|80984958|FG000|Overall Study|Withdrawal by Subject|3|||
27769869|NCT02786836|80984958|FG000|Overall Study|Liver Transplantation|2|||
27769870|NCT02786836|80984958|FG000|Overall Study|Device or Pharmacy Issues|3|||
27769871|NCT04445688|80984961|FG000|Washout (One Week)|Adverse Event|2|||
27769872|NCT04445688|80984961|FG000|Washout (One Week)|Withdrawal by Subject|1|||
27769873|NCT00422669|80984962|FG000|Overall Study|The study was terminated early.|98|||
27769874|NCT00422669|80984963|FG001|Overall Study|The study was terminated early.|100|||
27769875|NCT00422669|80984964|FG002|Overall Study|The study was terminated early.|7|||
27769876|NCT03370913|80984967|FG000|Overall Study|Death|1|||
27769877|NCT03370913|80984967|FG000|Overall Study|Lost to Follow-up|1|||
27769878|NCT02260388|80984968|FG000|Overall Study|Lost to Follow-up|2|||
27769879|NCT02260388|80984969|FG001|Overall Study|Lost to Follow-up|8|||
27769880|NCT02260388|80984970|FG002|Overall Study|Lost to Follow-up|3|||
27769881|NCT02260388|80984971|FG003|Overall Study|Lost to Follow-up|4|||
27769882|NCT03706040|80984974|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
27769883|NCT03706040|80984975|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
27769884|NCT03706040|80984976|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
27769885|NCT03706040|80984977|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
27769886|NCT03706040|80984978|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
27769887|NCT03706040|80984979|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
27769888|NCT03706040|80984980|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
27964206|NCT01057693|81699154|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
27964207|NCT01057693|81699152|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
27964208|NCT01057693|81699153|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
27964209|NCT01057693|81699154|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
27964210|NCT01057693|81699152|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
27964211|NCT01057693|81699153|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
27964212|NCT01057693|81699154|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
27964213|NCT01057693|81699152|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
27964214|NCT01057693|81699153|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
27964215|NCT01057693|81699154|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
27964216|NCT01057693|81699152|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
27964217|NCT01057693|81699153|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
27964218|NCT01057693|81699154|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
27964219|NCT01057693|81699152|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
27964220|NCT01057693|81699153|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
27964221|NCT01057693|81699154|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
27964222|NCT01057693|81699152|FG000|Between Single-Blind and Double-Blind|Other|6|||
27964223|NCT01057693|81699153|FG001|Between Single-Blind and Double-Blind|Other|0|||
27964224|NCT01057693|81699154|FG002|Between Single-Blind and Double-Blind|Other|0|||
27964225|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
27964226|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
27964227|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
27964228|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
27769889|NCT03706040|80984974|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
27769890|NCT03706040|80984975|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
27769891|NCT03706040|80984976|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
27769892|NCT03706040|80984977|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
27769893|NCT03706040|80984978|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
27769894|NCT03706040|80984979|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
27769895|NCT03706040|80984980|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
27769896|NCT03706040|80984974|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
27769897|NCT03706040|80984975|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
27964229|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
27964230|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
27964231|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
27964232|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
27964233|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
27663918|NCT02162771|80606570|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
27769898|NCT03706040|80984976|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
27769899|NCT03706040|80984977|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
27769900|NCT03706040|80984978|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
27769901|NCT03706040|80984979|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
27769902|NCT03706040|80984980|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
27769903|NCT03706040|80984974|FG000|Period A (Week 0 to Week 16)|Other|2|||
27769904|NCT03706040|80984975|FG001|Period A (Week 0 to Week 16)|Other|0|||
27769905|NCT03706040|80984976|FG002|Period A (Week 0 to Week 16)|Other|2|||
27769906|NCT03706040|80984977|FG003|Period A (Week 0 to Week 16)|Other|0|||
27769907|NCT03706040|80984978|FG004|Period A (Week 0 to Week 16)|Other|0|||
27769908|NCT03706040|80984979|FG005|Period A (Week 0 to Week 16)|Other|0|||
27769909|NCT03706040|80984980|FG006|Period A (Week 0 to Week 16)|Other|0|||
27769910|NCT03706040|80984974|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
27964234|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
27964235|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
27964236|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
27769911|NCT03706040|80984975|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
27769912|NCT03706040|80984976|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
27769913|NCT03706040|80984977|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
27769914|NCT03706040|80984978|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
27769915|NCT03706040|80984979|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
27769916|NCT03706040|80984980|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
27769917|NCT03706040|80984974|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
27769918|NCT03706040|80984975|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
27769919|NCT03706040|80984976|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
27769920|NCT03706040|80984977|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
27769921|NCT03706040|80984978|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
27769922|NCT03706040|80984979|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
27769923|NCT03706040|80984980|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
27769924|NCT03706040|80984974|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27769925|NCT03706040|80984975|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27769926|NCT03706040|80984976|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27769927|NCT03706040|80984977|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27769928|NCT03706040|80984978|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27769929|NCT03706040|80984979|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
27769930|NCT03706040|80984980|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
27769931|NCT03706040|80984974|FG000|Period B (Week 16 to Week 52)|Other|0|||
27769932|NCT03706040|80984975|FG001|Period B (Week 16 to Week 52)|Other|0|||
27769933|NCT03706040|80984976|FG002|Period B (Week 16 to Week 52)|Other|0|||
27769934|NCT03706040|80984977|FG003|Period B (Week 16 to Week 52)|Other|4|||
27769935|NCT03706040|80984978|FG004|Period B (Week 16 to Week 52)|Other|5|||
27769936|NCT03706040|80984979|FG005|Period B (Week 16 to Week 52)|Other|23|||
27769937|NCT03706040|80984980|FG006|Period B (Week 16 to Week 52)|Other|17|||
27769938|NCT01136746|80984982|FG000|Overall Study|Lost to Follow-up|0|||
27769939|NCT01136746|80984983|FG001|Overall Study|Lost to Follow-up|2|||
27769940|NCT01136746|80984982|FG000|Overall Study|Protocol Violation|2|||
27769941|NCT01136746|80984983|FG001|Overall Study|Protocol Violation|1|||
27769942|NCT01136746|80984982|FG000|Overall Study|Death|1|||
27769943|NCT01136746|80984983|FG001|Overall Study|Death|0|||
27769944|NCT04268303|80988344|FG000|Overall Study|Lost to Follow-up|1|||
27769945|NCT04268303|80988345|FG001|Overall Study|Lost to Follow-up|1|||
27769946|NCT04268303|80988346|FG002|Overall Study|Lost to Follow-up|2|||
27769947|NCT04268303|80988344|FG000|Overall Study|Withdrawal by Subject|0|||
27769948|NCT04268303|80988345|FG001|Overall Study|Withdrawal by Subject|1|||
27769949|NCT04268303|80988346|FG002|Overall Study|Withdrawal by Subject|1|||
27769950|NCT04268303|80988344|FG000|Overall Study|Adverse Event|2|||
27769951|NCT04268303|80988345|FG001|Overall Study|Adverse Event|0|||
27769952|NCT04268303|80988346|FG002|Overall Study|Adverse Event|0|||
27769953|NCT01688999|80988357|FG000|Overall Study|Withdrawal by Subject|5|||
27769954|NCT01688999|80988358|FG001|Overall Study|Withdrawal by Subject|1|||
27964237|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
27964238|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
27964239|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
27964240|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
27964241|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
27964242|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
27964243|NCT01057693|81699152|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
27964244|NCT01057693|81699153|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
27964245|NCT01057693|81699154|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
27964246|NCT01076205|81699155|FG000|Overall Study|Adverse Drug Reaction|299|||
27769955|NCT01688999|80988359|FG002|Overall Study|Withdrawal by Subject|1|||
27769956|NCT01688999|80988357|FG000|Overall Study|Adverse Event|2|||
27769957|NCT01688999|80988358|FG001|Overall Study|Adverse Event|0|||
27769958|NCT01688999|80988359|FG002|Overall Study|Adverse Event|2|||
27769959|NCT01688999|80988357|FG000|Overall Study|Ineligible/Not treated|1|||
27769960|NCT01688999|80988358|FG001|Overall Study|Ineligible/Not treated|0|||
27964247|NCT01076205|81699155|FG000|Overall Study|Lack of Effectiveness|1423|||
27769961|NCT01688999|80988359|FG002|Overall Study|Ineligible/Not treated|0|||
27769962|NCT02025530|80988360|FG000|Overall Study|No longer met elligibility criteria|5|||
27769963|NCT02025530|80988361|FG001|Overall Study|No longer met elligibility criteria|1|||
27769964|NCT01102140|80988362|FG000|Overall Study|Lost to Follow-up|1|||
27769965|NCT01102140|80988363|FG001|Overall Study|Lost to Follow-up|0|||
27769966|NCT01102140|80988362|FG000|Overall Study|Investigator terminated study|2|||
27769967|NCT01102140|80988363|FG001|Overall Study|Investigator terminated study|2|||
27769968|NCT01927068|80988364|FG000|Overall Study|Death|37|||
27769969|NCT01927068|80988365|FG001|Overall Study|Death|3|||
27769970|NCT01927068|80988364|FG000|Overall Study|Withdrawal by Subject|50|||
27769971|NCT01927068|80988365|FG001|Overall Study|Withdrawal by Subject|3|||
27769972|NCT01927068|80988364|FG000|Overall Study|Lost to Follow-up|10|||
27769973|NCT01927068|80988365|FG001|Overall Study|Lost to Follow-up|2|||
27769974|NCT01927068|80988364|FG000|Overall Study|Physician Decision|9|||
27769975|NCT01927068|80988365|FG001|Overall Study|Physician Decision|0|||
27769976|NCT01927068|80988364|FG000|Overall Study|Missed last follow-up visit|2|||
27769977|NCT01927068|80988365|FG001|Overall Study|Missed last follow-up visit|0|||
27769978|NCT01607073|80988368|FG000|Overall Study|Adverse Event|1|||
27769979|NCT02687711|80988371|FG000|Overall Study|Adverse Event|89|||
27769980|NCT02687711|80988371|FG000|Overall Study|Lack of Efficacy|70|||
27769981|NCT02687711|80988371|FG000|Overall Study|Lost to Follow-up|20|||
27769982|NCT02687711|80988371|FG000|Overall Study|Consent withdrawn|15|||
27769983|NCT02687711|80988371|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
27769984|NCT02687711|80988371|FG000|Overall Study|Too expensive|4|||
27769985|NCT02687711|80988371|FG000|Overall Study|Participant moved abroad|1|||
27769986|NCT02687711|80988371|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
27769987|NCT02687711|80988371|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
27769988|NCT02687711|80988371|FG000|Overall Study|Disliked taste|1|||
27769989|NCT02687711|80988371|FG000|Overall Study|Low mood|1|||
27769990|NCT02687711|80988371|FG000|Overall Study|Side effects|1|||
27769991|NCT02687711|80988371|FG000|Overall Study|Change of Hospital|1|||
27769992|NCT02687711|80988371|FG000|Overall Study|Liver Encephalopathy|1|||
27769993|NCT02687711|80988371|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
27769994|NCT02687711|80988371|FG000|Overall Study|Withdrawn due to intake interruption|1|||
27769995|NCT02687711|80988371|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
27769996|NCT02687711|80988371|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
27769997|NCT02687711|80988371|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
27964248|NCT01076205|81699155|FG000|Overall Study|Other Reason|1075|||
27964249|NCT01076205|81699155|FG000|Overall Study|Unknown Reason|71|||
27964250|NCT01076205|81699155|FG000|Overall Study|Lost to Follow-up|3151|||
27964251|NCT02455336|81699156|FG000|Overall Study|Withdrawal by Subject|0|||
27964252|NCT02455336|81699157|FG001|Overall Study|Withdrawal by Subject|2|||
27964253|NCT02455336|81699156|FG000|Overall Study|Adverse Event|3|||
27964254|NCT02455336|81699157|FG001|Overall Study|Adverse Event|0|||
27964255|NCT02455336|81699156|FG000|Overall Study|Non-responder to treatment|2|||
27964256|NCT02455336|81699157|FG001|Overall Study|Non-responder to treatment|0|||
27964257|NCT05420961|81699162|FG000|Overall Study|Withdrawal by Subject|2|||
27964258|NCT05420961|81699163|FG001|Overall Study|Withdrawal by Subject|1|||
27964259|NCT05420961|81699164|FG002|Overall Study|Withdrawal by Subject|1|||
27964260|NCT05420961|81699165|FG003|Overall Study|Withdrawal by Subject|0|||
27964261|NCT05420961|81699166|FG004|Overall Study|Withdrawal by Subject|0|||
27964262|NCT05420961|81699162|FG000|Overall Study|Lost to Follow-up|0|||
27964263|NCT05420961|81699163|FG001|Overall Study|Lost to Follow-up|0|||
27964264|NCT05420961|81699164|FG002|Overall Study|Lost to Follow-up|1|||
27964265|NCT05420961|81699165|FG003|Overall Study|Lost to Follow-up|0|||
27964266|NCT05420961|81699166|FG004|Overall Study|Lost to Follow-up|0|||
27964267|NCT05420961|81699162|FG000|Overall Study|Randomized by mistake without study treatment|0|||
27964268|NCT05420961|81699163|FG001|Overall Study|Randomized by mistake without study treatment|0|||
27964269|NCT05420961|81699164|FG002|Overall Study|Randomized by mistake without study treatment|1|||
27964270|NCT05420961|81699165|FG003|Overall Study|Randomized by mistake without study treatment|0|||
27964271|NCT05420961|81699166|FG004|Overall Study|Randomized by mistake without study treatment|1|||
27964272|NCT03333928|81699167|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
27964273|NCT03333928|81699168|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
27964274|NCT03333928|81699169|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
27769998|NCT04685538|80988373|FG000|Overall Study|Adverse Event|0|||
27964275|NCT03333928|81699167|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
27964276|NCT03333928|81699168|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
27964277|NCT03333928|81699169|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
27964278|NCT03333928|81699167|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
27964279|NCT03333928|81699168|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
27964280|NCT03333928|81699169|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
27964281|NCT03333928|81699167|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
27964282|NCT03333928|81699168|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
27964283|NCT03333928|81699169|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
27964284|NCT03333928|81699167|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
27964285|NCT03333928|81699168|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
27964286|NCT03333928|81699169|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
27769999|NCT04685538|80988374|FG001|Overall Study|Adverse Event|1|||
27770000|NCT04685538|80988373|FG000|Overall Study|Lost to Follow-up|0|||
27770001|NCT04685538|80988374|FG001|Overall Study|Lost to Follow-up|2|||
27770002|NCT01412151|80988375|FG000|Week 0 - 306 - Treatment Period|Death|1|||
27770003|NCT01412151|80988375|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
27770004|NCT01412151|80988375|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
27770005|NCT01412151|80988375|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
27770006|NCT03250624|80988380|FG000|Overall Study|Lack of Efficacy|1|||
27964287|NCT03333928|81699167|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
27770007|NCT03250624|80988381|FG001|Overall Study|Lack of Efficacy|4|||
27770008|NCT03250624|80988380|FG000|Overall Study|Adverse Event|0|||
27770009|NCT03250624|80988381|FG001|Overall Study|Adverse Event|1|||
27770010|NCT03250624|80988380|FG000|Overall Study|Other|1|||
27770011|NCT03250624|80988381|FG001|Overall Study|Other|2|||
27770012|NCT01421069|80988382|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
27770013|NCT01421069|80988382|FG000|Parent Study|Failed to return|3|||
27770014|NCT01421069|80988382|FG000|Parent Study|Withdrawal by Subject|1|||
27770015|NCT01421069|80988382|FG000|Parent Study|Lost to Follow-up|2|||
27770016|NCT01421069|80988382|FG000|Parent Study|Lack of Efficacy|1|||
27770017|NCT01421069|80988382|FG000|Overall Period for Extension Study|Other|2|||
27770018|NCT01421069|80988382|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
27770019|NCT01421069|80988382|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
27770020|NCT01421069|80988382|FG000|Overall Period for Extension Study|Pregnancy|1|||
27770021|NCT01421069|80988382|FG000|Overall Period for Extension Study|Adverse Event|1|||
27770022|NCT01421069|80988382|FG000|Overall Period for Extension Study|Protocol Violation|1|||
27770023|NCT01421069|80988382|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
27770024|NCT01421069|80988382|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
27770025|NCT01421069|80988382|FG000|Active Treatment Period|Other|1|||
27770026|NCT01421069|80988382|FG000|Active Treatment Period|No longer willing to participate in study|8|||
27770027|NCT01421069|80988382|FG000|Active Treatment Period|Insufficient clinical response|1|||
27770028|NCT01421069|80988382|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
27770029|NCT01421069|80988382|FG000|Active Treatment Period|Pregnancy|1|||
27770030|NCT01421069|80988382|FG000|Active Treatment Period|Adverse Event|1|||
27770031|NCT01421069|80988382|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
27770032|NCT01421069|80988382|FG000|Active Treatment Period|Enrolled in observational period|29|||
27770033|NCT01421069|80988382|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
27770034|NCT01421069|80988382|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
27770035|NCT01421069|80988382|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
27770036|NCT01421069|80988382|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
27770037|NCT01421069|80988382|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
27770038|NCT01421069|80988382|FG000|2b. Retreatment Period|Protocol Violation|1|||
27770039|NCT01421069|80988382|FG000|Observational Period|Other|1|||
27770040|NCT01421069|80988382|FG000|Observational Period|No longer willing to participate in study|4|||
27770041|NCT01421069|80988382|FG000|Observational Period|Lost to Follow-up|3|||
27770042|NCT03148795|80988384|FG000|Overall Study|Progressive Disease|1|||
27770043|NCT03457636|80988385|FG000|Overall Study|Lost to Follow-up|2|||
27770044|NCT04363944|80988388|FG000|Overall Study|Withdrawal by Subject|2|||
27770045|NCT04363944|80988389|FG001|Overall Study|Withdrawal by Subject|0|||
27770046|NCT03039569|80988390|FG000|Overall Study|Lost to Follow-up|5|||
27770047|NCT03039569|80988391|FG001|Overall Study|Lost to Follow-up|4|||
27770048|NCT03037307|80988392|FG000|Period 1|Did Not Meet Study Criteria|0|||
27770049|NCT03037307|80988393|FG001|Period 1|Did Not Meet Study Criteria|0|||
27770050|NCT03037307|80988394|FG002|Period 1|Did Not Meet Study Criteria|0|||
27770051|NCT03037307|80988395|FG003|Period 1|Did Not Meet Study Criteria|1|||
27770052|NCT03037307|80988396|FG004|Period 1|Did Not Meet Study Criteria|0|||
27770053|NCT03037307|80988397|FG005|Period 1|Did Not Meet Study Criteria|0|||
27770054|NCT02848313|80988400|FG000|Overall Study|Adverse Event|1|||
27770055|NCT02848313|80988401|FG001|Overall Study|Adverse Event|2|||
27770056|NCT02848313|80988400|FG000|Overall Study|Lack of Efficacy|0|||
27770057|NCT02848313|80988401|FG001|Overall Study|Lack of Efficacy|1|||
27770058|NCT02848313|80988400|FG000|Overall Study|Withdrawal by Subject|1|||
27770059|NCT02848313|80988401|FG001|Overall Study|Withdrawal by Subject|1|||
27770060|NCT02848313|80988400|FG000|Overall Study|Lost to follow up|1|||
27770061|NCT02848313|80988401|FG001|Overall Study|Lost to follow up|0|||
27770062|NCT00572728|80988402|FG000|Overall Study|Withdrawal by Subject|10|||
27770063|NCT00572728|80988402|FG000|Overall Study|Ineligible|3|||
27770064|NCT00572728|80988402|FG000|Overall Study|Enrolled under Amendment 4|5|||
27770065|NCT00572728|80988402|FG000|Overall Study|Offstudy due to complicating disease|1|||
27770066|NCT00572728|80988402|FG000|Overall Study|FLT1 not completed|4|||
27770067|NCT00572728|80988402|FG000|Overall Study|First Chemotherapy not initiated|2|||
27770068|NCT00572728|80988402|FG000|Overall Study|FLT2 not completed|5|||
27770069|NCT00572728|80988402|FG000|Overall Study|Second chemotherapy not initiated|1|||
27770070|NCT00572728|80988402|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
27770071|NCT00572728|80988402|FG000|Overall Study|Pathology missing|1|||
27770072|NCT04964557|80988403|FG000|Overall Study|Withdrawal by Subject|3|||
27770073|NCT04964557|80988404|FG001|Overall Study|Withdrawal by Subject|2|||
27770074|NCT04964557|80988403|FG000|Overall Study|Lost to Follow-up|1|||
27770075|NCT04964557|80988404|FG001|Overall Study|Lost to Follow-up|2|||
27770076|NCT04964557|80988403|FG000|Overall Study|Physician Decision|2|||
27770077|NCT04964557|80988404|FG001|Overall Study|Physician Decision|0|||
27770078|NCT04964557|80988403|FG000|Overall Study|Death|3|||
27770079|NCT04964557|80988404|FG001|Overall Study|Death|0|||
27770080|NCT04964557|80988403|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
27770081|NCT04964557|80988404|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
27770082|NCT02959970|80988409|FG000|Overall Study|Adverse Event|1|||
27770083|NCT02959970|80988410|FG001|Overall Study|Adverse Event|0|||
27770084|NCT02959970|80988409|FG000|Overall Study|Withdrawal by Subject|0|||
27770085|NCT02959970|80988410|FG001|Overall Study|Withdrawal by Subject|2|||
27770086|NCT02959970|80988409|FG000|Overall Study|Lost to Follow-up|1|||
27770087|NCT02959970|80988410|FG001|Overall Study|Lost to Follow-up|5|||
27770088|NCT00044213|80988411|FG000|Overall Study|Withdrawal by Subject|50|||
27770089|NCT00044213|80988412|FG001|Overall Study|Withdrawal by Subject|65|||
27770090|NCT00044213|80988413|FG002|Overall Study|Withdrawal by Subject|91|||
27770091|NCT00044213|80988414|FG003|Overall Study|Withdrawal by Subject|83|||
27770092|NCT00044213|80988411|FG000|Overall Study|Death|42|||
27770093|NCT00044213|80988412|FG001|Overall Study|Death|42|||
27770094|NCT00044213|80988413|FG002|Overall Study|Death|42|||
27770095|NCT00044213|80988414|FG003|Overall Study|Death|49|||
27770096|NCT00044213|80988411|FG000|Overall Study|Lost to Follow-up|8|||
27770097|NCT00044213|80988412|FG001|Overall Study|Lost to Follow-up|5|||
27770098|NCT00044213|80988413|FG002|Overall Study|Lost to Follow-up|5|||
27770099|NCT00044213|80988414|FG003|Overall Study|Lost to Follow-up|4|||
27770100|NCT01802515|80988415|FG000|Overall Study|Withdrawal by Subject|3|||
27770101|NCT01802515|80988416|FG001|Overall Study|Withdrawal by Subject|0|||
27770102|NCT01802515|80988417|FG002|Overall Study|Withdrawal by Subject|0|||
27770103|NCT03788967|80988418|FG000|Overall Study|Lost to Follow-up|14|||
27770104|NCT03788967|80988419|FG001|Overall Study|Lost to Follow-up|10|||
27770105|NCT03788967|80988418|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
27770106|NCT03788967|80988419|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
27770107|NCT03788967|80988418|FG000|Overall Study|Participant Withdrawal of Consent|13|||
27770108|NCT03788967|80988419|FG001|Overall Study|Participant Withdrawal of Consent|5|||
27964288|NCT03333928|81699168|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
27964289|NCT03333928|81699169|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
27964290|NCT03333928|81699167|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
27964291|NCT03333928|81699168|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
27964292|NCT03333928|81699169|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
27964293|NCT03333928|81699167|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
27964294|NCT03333928|81699168|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
27964295|NCT03333928|81699169|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
27964296|NCT02485639|81699171|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
27964297|NCT02485639|81699171|FG000|Overall Study|Early termination|4|||
27964298|NCT02485639|81699171|FG000|Overall Study|Withdrawal by Subject|4|||
27964299|NCT04601532|81699172|FG000|Overall Study|Lost to Follow-up|1|||
27770109|NCT03788967|80988418|FG000|Overall Study|Adverse Event|1|||
27770110|NCT03788967|80988419|FG001|Overall Study|Adverse Event|1|||
27770111|NCT03788967|80988418|FG000|Overall Study|COVID-19|1|||
27770112|NCT03788967|80988419|FG001|Overall Study|COVID-19|2|||
27770113|NCT00614991|80988420|FG000|Overall Study|Adverse Event|3|||
27770114|NCT00614991|80988421|FG001|Overall Study|Adverse Event|3|||
27770115|NCT00614991|80988422|FG002|Overall Study|Adverse Event|0|||
27770116|NCT00614991|80988423|FG003|Overall Study|Adverse Event|0|||
27770117|NCT00614991|80988424|FG004|Overall Study|Adverse Event|1|||
27770118|NCT00614991|80988425|FG005|Overall Study|Adverse Event|0|||
27770119|NCT00641706|80988429|FG000|Overall Study|Adverse Event|2|||
27770120|NCT00641706|80988430|FG001|Overall Study|Adverse Event|1|||
27770121|NCT00641706|80988429|FG000|Overall Study|Withdrawal by Subject|6|||
27770122|NCT00641706|80988430|FG001|Overall Study|Withdrawal by Subject|1|||
27770123|NCT00641706|80988429|FG000|Overall Study|Clinical Decline|1|||
27770124|NCT00641706|80988430|FG001|Overall Study|Clinical Decline|0|||
27770125|NCT00641706|80988429|FG000|Overall Study|Lead Investigator Decision|0|||
27770126|NCT00641706|80988430|FG001|Overall Study|Lead Investigator Decision|1|||
27770127|NCT00588523|80988431|FG000|Overall Study|Not treated|3|||
27770128|NCT03796195|80988432|FG000|Overall Study|Study closed early|1|||
27770129|NCT00899678|80988433|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
27770130|NCT00899678|80988434|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
27770131|NCT00899678|80988435|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
27770132|NCT00899678|80988433|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
27770133|NCT00899678|80988434|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
27964300|NCT04601532|81699173|FG001|Overall Study|Lost to Follow-up|2|||
27964301|NCT04601532|81699172|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
27964302|NCT04601532|81699173|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
27964303|NCT01822899|81699174|FG000|Overall Study|Adverse Event|6|||
27964304|NCT01822899|81699175|FG001|Overall Study|Adverse Event|5|||
27964305|NCT01822899|81699174|FG000|Overall Study|Lack of Efficacy|6|||
27964306|NCT01822899|81699175|FG001|Overall Study|Lack of Efficacy|3|||
27964307|NCT01822899|81699174|FG000|Overall Study|Protocol Violation|6|||
27964308|NCT01822899|81699175|FG001|Overall Study|Protocol Violation|3|||
27964309|NCT01822899|81699174|FG000|Overall Study|Lost to Follow-up|1|||
27964310|NCT01822899|81699175|FG001|Overall Study|Lost to Follow-up|0|||
27964311|NCT01822899|81699174|FG000|Overall Study|Withdrawal by Subject|5|||
27964312|NCT01822899|81699175|FG001|Overall Study|Withdrawal by Subject|7|||
27964313|NCT02237001|81699176|FG000|Overall Study|Lost to Follow-up|2|||
27964314|NCT02237001|81699176|FG000|Overall Study|Withdrawal by Subject|1|||
27964315|NCT02237001|81699176|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
27964316|NCT02237001|81699176|FG000|Overall Study|Re-operation|4|||
27964317|NCT02237001|81699176|FG000|Overall Study|Incarceration|1|||
27964318|NCT01645735|81699177|FG000|Overall Study|Physician Decision|2|||
27964319|NCT01645735|81699178|FG001|Overall Study|Physician Decision|0|||
27964320|NCT01645735|81699177|FG000|Overall Study|Withdrawal by Subject|1|||
27964321|NCT01645735|81699178|FG001|Overall Study|Withdrawal by Subject|0|||
27964322|NCT01645735|81699177|FG000|Overall Study|Protocol Violation|1|||
27964323|NCT01645735|81699178|FG001|Overall Study|Protocol Violation|0|||
27964324|NCT01645735|81699177|FG000|Overall Study|Adverse Event|0|||
27964325|NCT01645735|81699178|FG001|Overall Study|Adverse Event|1|||
27964326|NCT00610857|81699179|FG000|Overall Study|Not evaluable for response|2|||
27770134|NCT00899678|80988435|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
27770135|NCT00899678|80988433|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
27770136|NCT00899678|80988434|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
27770137|NCT00899678|80988435|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
27770138|NCT00899678|80988433|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
27770139|NCT00899678|80988434|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
27770140|NCT00899678|80988435|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
27770141|NCT00899678|80988433|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
27770142|NCT00899678|80988434|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
27770143|NCT00899678|80988435|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
27770144|NCT00899678|80988433|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
27770145|NCT00899678|80988434|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
27770146|NCT00899678|80988435|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
27770147|NCT00899678|80988433|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
27770148|NCT00899678|80988434|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
27770149|NCT00899678|80988435|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
27770150|NCT00899678|80988433|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
27770151|NCT00899678|80988434|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
27770152|NCT00899678|80988435|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
27770153|NCT00899678|80988433|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
27770154|NCT00899678|80988434|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
27862201|NCT04597632|81326253|FG000|Overall Study|Death|1|||
27964327|NCT02314156|81699180|FG000|Overall Study|Adverse Event|1|||
27964328|NCT02314156|81699181|FG001|Overall Study|Adverse Event|0|||
27964329|NCT02314156|81699180|FG000|Overall Study|Withdrawal by Subject|1|||
27964330|NCT02314156|81699181|FG001|Overall Study|Withdrawal by Subject|0|||
27964331|NCT01831466|81699182|FG000|Overall Study|Protocol Violation|1|||
27964332|NCT01831466|81699183|FG001|Overall Study|Protocol Violation|1|||
27964333|NCT01831466|81699184|FG002|Overall Study|Protocol Violation|2|||
27964334|NCT01831466|81699185|FG003|Overall Study|Protocol Violation|0|||
27964335|NCT01831466|81699186|FG004|Overall Study|Protocol Violation|0|||
27964336|NCT01831466|81699187|FG005|Overall Study|Protocol Violation|1|||
27770155|NCT00899678|80988435|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
27770156|NCT03128307|80988436|FG000|Overall Study|Lost to Follow-up|29|||
27770157|NCT03128307|80988436|FG000|Overall Study|Withdrawal by Subject|5|||
27770158|NCT03991936|80988437|FG000|Overall Study|Lost to Follow-up|1|||
27770159|NCT03991936|80988438|FG001|Overall Study|Lost to Follow-up|1|||
27770160|NCT03991936|80988439|FG002|Overall Study|Lost to Follow-up|1|||
27770161|NCT03991936|80988440|FG003|Overall Study|Lost to Follow-up|1|||
27770162|NCT03991936|80988441|FG004|Overall Study|Lost to Follow-up|1|||
27964337|NCT01831466|81699188|FG006|Overall Study|Protocol Violation|0|||
27964338|NCT01831466|81699189|FG007|Overall Study|Protocol Violation|0|||
27964339|NCT01831466|81699190|FG008|Overall Study|Protocol Violation|0|||
27964340|NCT01831466|81699191|FG009|Overall Study|Protocol Violation|0|||
27964341|NCT01831466|81699192|FG010|Overall Study|Protocol Violation|0|||
27964342|NCT01831466|81699193|FG011|Overall Study|Protocol Violation|0|||
27964343|NCT01831466|81699182|FG000|Overall Study|Other|2|||
27964344|NCT01831466|81699183|FG001|Overall Study|Other|3|||
27964345|NCT01831466|81699184|FG002|Overall Study|Other|2|||
27964346|NCT01831466|81699185|FG003|Overall Study|Other|2|||
27964347|NCT01831466|81699186|FG004|Overall Study|Other|2|||
27964348|NCT01831466|81699187|FG005|Overall Study|Other|1|||
27964349|NCT01831466|81699188|FG006|Overall Study|Other|0|||
27964350|NCT01831466|81699189|FG007|Overall Study|Other|0|||
27770163|NCT03621189|80988444|FG000|Overall Study|Withdrawal by Subject|0|||
27770164|NCT03621189|80988445|FG001|Overall Study|Withdrawal by Subject|3|||
27770165|NCT03621189|80988444|FG000|Overall Study|Physician Decision|0|||
27770166|NCT03621189|80988445|FG001|Overall Study|Physician Decision|2|||
27770167|NCT04445051|80988450|FG000|Overall Study|Adverse Event|0|||
27770168|NCT04445051|80988451|FG001|Overall Study|Adverse Event|0|||
27770169|NCT04445051|80988452|FG002|Overall Study|Adverse Event|1|||
27770170|NCT04445051|80988453|FG003|Overall Study|Adverse Event|0|||
27770171|NCT04445051|80988454|FG004|Overall Study|Adverse Event|0|||
27770172|NCT04445051|80988455|FG005|Overall Study|Adverse Event|0|||
27770173|NCT03039790|80988462|FG000|Overall Study|Lost to Follow-up|2|||
27770174|NCT03039790|80988463|FG001|Overall Study|Lost to Follow-up|0|||
27770175|NCT03039790|80988464|FG002|Overall Study|Lost to Follow-up|1|||
27770176|NCT03039790|80988465|FG003|Overall Study|Lost to Follow-up|1|||
27770177|NCT03039790|80988466|FG004|Overall Study|Lost to Follow-up|0|||
27770178|NCT03039790|80988467|FG005|Overall Study|Lost to Follow-up|1|||
27770179|NCT03039790|80988468|FG006|Overall Study|Lost to Follow-up|1|||
27770180|NCT03039790|80988469|FG007|Overall Study|Lost to Follow-up|1|||
27770181|NCT03039790|80988470|FG008|Overall Study|Lost to Follow-up|0|||
27770182|NCT03039790|80988471|FG009|Overall Study|Lost to Follow-up|1|||
27770183|NCT03039790|80988472|FG010|Overall Study|Lost to Follow-up|1|||
27770184|NCT03039790|80988473|FG011|Overall Study|Lost to Follow-up|0|||
27770185|NCT03039790|80988474|FG012|Overall Study|Lost to Follow-up|1|||
27770186|NCT03039790|80988475|FG013|Overall Study|Lost to Follow-up|0|||
27770187|NCT03039790|80988476|FG014|Overall Study|Lost to Follow-up|3|||
27770188|NCT03039790|80988477|FG015|Overall Study|Lost to Follow-up|1|||
27770189|NCT03039790|80988478|FG016|Overall Study|Lost to Follow-up|2|||
27770190|NCT03039790|80988479|FG017|Overall Study|Lost to Follow-up|2|||
27770191|NCT03039790|80988480|FG018|Overall Study|Lost to Follow-up|1|||
27770192|NCT03039790|80988481|FG019|Overall Study|Lost to Follow-up|3|||
27770193|NCT03039790|80988462|FG000|Overall Study|Withdrawal of Consent|1|||
27770194|NCT03039790|80988463|FG001|Overall Study|Withdrawal of Consent|0|||
27770195|NCT03039790|80988464|FG002|Overall Study|Withdrawal of Consent|0|||
27770196|NCT03039790|80988465|FG003|Overall Study|Withdrawal of Consent|1|||
27770197|NCT03039790|80988466|FG004|Overall Study|Withdrawal of Consent|0|||
27770198|NCT03039790|80988467|FG005|Overall Study|Withdrawal of Consent|0|||
27770199|NCT03039790|80988468|FG006|Overall Study|Withdrawal of Consent|0|||
27770200|NCT03039790|80988469|FG007|Overall Study|Withdrawal of Consent|0|||
27770201|NCT03039790|80988470|FG008|Overall Study|Withdrawal of Consent|0|||
27770202|NCT03039790|80988471|FG009|Overall Study|Withdrawal of Consent|1|||
27770203|NCT03039790|80988472|FG010|Overall Study|Withdrawal of Consent|0|||
27770204|NCT03039790|80988473|FG011|Overall Study|Withdrawal of Consent|0|||
27862202|NCT04597632|81326253|FG000|Overall Study|Adverse Event|5|||
27862203|NCT04590040|81326254|FG000|Treatment Period|Lost to Follow-up|2|||
27862204|NCT04590040|81326255|FG001|Treatment Period|Lost to Follow-up|5|||
27862205|NCT04590040|81326256|FG002|Treatment Period|Lost to Follow-up|0|||
27862206|NCT04590040|81326254|FG000|Treatment Period|Physician Decision|0|||
27862207|NCT04590040|81326255|FG001|Treatment Period|Physician Decision|0|||
27770205|NCT03039790|80988474|FG012|Overall Study|Withdrawal of Consent|2|||
27862208|NCT04590040|81326256|FG002|Treatment Period|Physician Decision|2|||
27964351|NCT01831466|81699190|FG008|Overall Study|Other|0|||
27964352|NCT01831466|81699191|FG009|Overall Study|Other|0|||
27770206|NCT03039790|80988475|FG013|Overall Study|Withdrawal of Consent|0|||
27770207|NCT03039790|80988476|FG014|Overall Study|Withdrawal of Consent|1|||
27770208|NCT03039790|80988477|FG015|Overall Study|Withdrawal of Consent|5|||
27770209|NCT03039790|80988478|FG016|Overall Study|Withdrawal of Consent|3|||
27770210|NCT03039790|80988479|FG017|Overall Study|Withdrawal of Consent|0|||
27770211|NCT03039790|80988480|FG018|Overall Study|Withdrawal of Consent|2|||
27964353|NCT01831466|81699192|FG010|Overall Study|Other|0|||
27770212|NCT03039790|80988481|FG019|Overall Study|Withdrawal of Consent|5|||
27770213|NCT03039790|80988462|FG000|Overall Study|Death|0|||
27770214|NCT03039790|80988463|FG001|Overall Study|Death|0|||
27770215|NCT03039790|80988464|FG002|Overall Study|Death|0|||
27770216|NCT03039790|80988465|FG003|Overall Study|Death|0|||
27770217|NCT03039790|80988466|FG004|Overall Study|Death|0|||
27770218|NCT03039790|80988467|FG005|Overall Study|Death|0|||
27770219|NCT03039790|80988468|FG006|Overall Study|Death|0|||
27770220|NCT03039790|80988469|FG007|Overall Study|Death|0|||
27964354|NCT01831466|81699193|FG011|Overall Study|Other|0|||
27964355|NCT01831466|81699182|FG000|Overall Study|Non-compliance with study treatment|2|||
27964356|NCT01831466|81699183|FG001|Overall Study|Non-compliance with study treatment|1|||
27770221|NCT03039790|80988470|FG008|Overall Study|Death|0|||
27770222|NCT03039790|80988471|FG009|Overall Study|Death|0|||
27770223|NCT03039790|80988472|FG010|Overall Study|Death|0|||
27770224|NCT03039790|80988473|FG011|Overall Study|Death|0|||
27770225|NCT03039790|80988474|FG012|Overall Study|Death|0|||
27770226|NCT03039790|80988475|FG013|Overall Study|Death|0|||
27770227|NCT03039790|80988476|FG014|Overall Study|Death|0|||
27770228|NCT03039790|80988477|FG015|Overall Study|Death|1|||
27770229|NCT03039790|80988478|FG016|Overall Study|Death|3|||
27770230|NCT03039790|80988479|FG017|Overall Study|Death|0|||
27770231|NCT03039790|80988480|FG018|Overall Study|Death|2|||
27770232|NCT03039790|80988481|FG019|Overall Study|Death|0|||
27770233|NCT03039790|80988462|FG000|Overall Study|Reason, not Specified|1|||
27770234|NCT03039790|80988463|FG001|Overall Study|Reason, not Specified|0|||
27770235|NCT03039790|80988464|FG002|Overall Study|Reason, not Specified|0|||
27770236|NCT03039790|80988465|FG003|Overall Study|Reason, not Specified|0|||
27770237|NCT03039790|80988466|FG004|Overall Study|Reason, not Specified|0|||
27770238|NCT03039790|80988467|FG005|Overall Study|Reason, not Specified|0|||
27770239|NCT03039790|80988468|FG006|Overall Study|Reason, not Specified|0|||
27770240|NCT03039790|80988469|FG007|Overall Study|Reason, not Specified|0|||
27770241|NCT03039790|80988470|FG008|Overall Study|Reason, not Specified|0|||
27770242|NCT03039790|80988471|FG009|Overall Study|Reason, not Specified|0|||
27770243|NCT03039790|80988472|FG010|Overall Study|Reason, not Specified|0|||
27770244|NCT03039790|80988473|FG011|Overall Study|Reason, not Specified|0|||
27770245|NCT03039790|80988474|FG012|Overall Study|Reason, not Specified|0|||
27770246|NCT03039790|80988475|FG013|Overall Study|Reason, not Specified|0|||
27770247|NCT03039790|80988476|FG014|Overall Study|Reason, not Specified|0|||
27770248|NCT03039790|80988477|FG015|Overall Study|Reason, not Specified|0|||
27770249|NCT03039790|80988478|FG016|Overall Study|Reason, not Specified|2|||
27770250|NCT03039790|80988479|FG017|Overall Study|Reason, not Specified|0|||
27770251|NCT03039790|80988480|FG018|Overall Study|Reason, not Specified|1|||
27770252|NCT03039790|80988481|FG019|Overall Study|Reason, not Specified|0|||
27770253|NCT00770224|80988482|FG000|Step 1: Induction|Adverse Event|3|||
27770254|NCT00770224|80988483|FG001|Step 1: Induction|Adverse Event|0|||
27770255|NCT00770224|80988482|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
27770256|NCT00770224|80988483|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
27770257|NCT00770224|80988482|FG000|Step 1: Induction|Other reason not protocol specified|2|||
27770258|NCT00770224|80988483|FG001|Step 1: Induction|Other reason not protocol specified|0|||
27770259|NCT00770224|80988482|FG000|Step 1: Induction|Ineligible|2|||
27770260|NCT00770224|80988483|FG001|Step 1: Induction|Ineligible|0|||
27770261|NCT00770224|80988482|FG000|Step 1: Induction|No protocol treatment given|1|||
27770262|NCT00770224|80988483|FG001|Step 1: Induction|No protocol treatment given|0|||
27770263|NCT00770224|80988482|FG000|Step 2: Maintenance|Adverse Event|0|||
27770264|NCT00770224|80988483|FG001|Step 2: Maintenance|Adverse Event|10|||
27770265|NCT00770224|80988482|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
27770266|NCT00770224|80988483|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
27770267|NCT00770224|80988482|FG000|Step 2: Maintenance|Progression/relapse|0|||
27770268|NCT00770224|80988483|FG001|Step 2: Maintenance|Progression/relapse|1|||
27770269|NCT00770224|80988482|FG000|Step 2: Maintenance|Death|0|||
27964357|NCT01831466|81699184|FG002|Overall Study|Non-compliance with study treatment|1|||
27964358|NCT01831466|81699185|FG003|Overall Study|Non-compliance with study treatment|0|||
27770270|NCT00770224|80988483|FG001|Step 2: Maintenance|Death|2|||
27770271|NCT00770224|80988482|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
27770272|NCT00770224|80988483|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
27770273|NCT00770224|80988482|FG000|Step 2: Maintenance|Ineligible|0|||
27770274|NCT00770224|80988483|FG001|Step 2: Maintenance|Ineligible|2|||
27770275|NCT03510910|80988484|FG000|Overall Study|Incomplete Survey|2|||
27770276|NCT03510910|80988485|FG001|Overall Study|Incomplete Survey|3|||
27770277|NCT02266004|80988487|FG000|Overall Study|unrelated adverse event|1|||
27770278|NCT02266004|80988487|FG000|Overall Study|Physician Decision|1|||
27770279|NCT01095666|80988489|FG000|Overall Study|Lack of Efficacy|0|||
27770280|NCT01095666|80988490|FG001|Overall Study|Lack of Efficacy|0|||
27770281|NCT01095666|80988491|FG002|Overall Study|Lack of Efficacy|1|||
27770282|NCT01095666|80988489|FG000|Overall Study|Adverse Event|2|||
27770283|NCT01095666|80988490|FG001|Overall Study|Adverse Event|1|||
27770284|NCT01095666|80988491|FG002|Overall Study|Adverse Event|3|||
27770285|NCT01095666|80988489|FG000|Overall Study|Lost to Follow-up|2|||
27770286|NCT01095666|80988490|FG001|Overall Study|Lost to Follow-up|2|||
27770287|NCT01095666|80988491|FG002|Overall Study|Lost to Follow-up|0|||
27770288|NCT01095666|80988489|FG000|Overall Study|Withdrawal by Subject|6|||
27770289|NCT01095666|80988490|FG001|Overall Study|Withdrawal by Subject|6|||
27770290|NCT01095666|80988491|FG002|Overall Study|Withdrawal by Subject|1|||
27770291|NCT01095666|80988489|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
27770292|NCT01095666|80988490|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
27770293|NCT01095666|80988491|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
27770294|NCT03927911|80988492|FG000|Overall Study|problems with eDiary|0|||
27770295|NCT03927911|80988493|FG001|Overall Study|problems with eDiary|1|||
27770296|NCT03927911|80988494|FG002|Overall Study|problems with eDiary|0|||
27770297|NCT03927911|80988495|FG003|Overall Study|problems with eDiary|1|||
27770298|NCT03927911|80988496|FG004|Overall Study|problems with eDiary|0|||
27770299|NCT03927911|80988497|FG005|Overall Study|problems with eDiary|4|||
27770300|NCT03927911|80988492|FG000|Overall Study|Adverse Event|0|||
27770301|NCT03927911|80988493|FG001|Overall Study|Adverse Event|0|||
27770302|NCT03927911|80988494|FG002|Overall Study|Adverse Event|0|||
27964359|NCT01831466|81699186|FG004|Overall Study|Non-compliance with study treatment|0|||
27964360|NCT01831466|81699187|FG005|Overall Study|Non-compliance with study treatment|1|||
27964361|NCT01831466|81699188|FG006|Overall Study|Non-compliance with study treatment|0|||
27964362|NCT01831466|81699189|FG007|Overall Study|Non-compliance with study treatment|0|||
27964363|NCT01831466|81699190|FG008|Overall Study|Non-compliance with study treatment|0|||
27964364|NCT01831466|81699191|FG009|Overall Study|Non-compliance with study treatment|0|||
27964365|NCT01831466|81699192|FG010|Overall Study|Non-compliance with study treatment|0|||
27964366|NCT01831466|81699193|FG011|Overall Study|Non-compliance with study treatment|0|||
27964367|NCT01831466|81699182|FG000|Overall Study|Death|0|||
27964368|NCT01831466|81699183|FG001|Overall Study|Death|1|||
27964369|NCT01831466|81699184|FG002|Overall Study|Death|0|||
27964370|NCT01831466|81699185|FG003|Overall Study|Death|0|||
27964371|NCT01831466|81699186|FG004|Overall Study|Death|0|||
27964372|NCT01831466|81699187|FG005|Overall Study|Death|0|||
27770303|NCT03927911|80988495|FG003|Overall Study|Adverse Event|0|||
27770304|NCT03927911|80988496|FG004|Overall Study|Adverse Event|0|||
27862209|NCT01329900|81326257|FG000|Overall Study|Elevated creatinine/renal function|1|||
27862210|NCT02927366|81326260|FG000|Overall Study|Adverse Event|1|||
27862211|NCT02927366|81326261|FG001|Overall Study|Adverse Event|0|||
27862212|NCT02927366|81326260|FG000|Overall Study|Patient schedule|1|||
27862213|NCT02927366|81326261|FG001|Overall Study|Patient schedule|0|||
27862214|NCT02013674|81326264|FG000|Overall Study|Death|0|||
27862215|NCT02013674|81326265|FG001|Overall Study|Death|1|||
27862216|NCT02013674|81326264|FG000|Overall Study|Lost to Follow-up|1|||
27862217|NCT02013674|81326265|FG001|Overall Study|Lost to Follow-up|0|||
27862218|NCT02257385|81326275|FG000|Overall Study|Adverse Event|12|||
27862219|NCT02257385|81326276|FG001|Overall Study|Adverse Event|8|||
27862220|NCT02257385|81326275|FG000|Overall Study|Lack of Efficacy|1|||
27862221|NCT02257385|81326276|FG001|Overall Study|Lack of Efficacy|2|||
27862222|NCT02257385|81326275|FG000|Overall Study|Protocol Violation|5|||
27862223|NCT02257385|81326276|FG001|Overall Study|Protocol Violation|7|||
27862224|NCT02257385|81326275|FG000|Overall Study|Lost to Follow-up|0|||
27862225|NCT02257385|81326276|FG001|Overall Study|Lost to Follow-up|1|||
27862226|NCT02257385|81326275|FG000|Overall Study|Withdrawal by Subject|4|||
27862227|NCT02257385|81326276|FG001|Overall Study|Withdrawal by Subject|4|||
27862228|NCT00428116|81326277|FG000|Overall Study|Death|1|||
27862229|NCT00428116|81326278|FG001|Overall Study|Death|0|||
27862230|NCT00428116|81326277|FG000|Overall Study|Withdrawal by Subject|1|||
27862231|NCT00428116|81326278|FG001|Overall Study|Withdrawal by Subject|0|||
27862232|NCT00428116|81326277|FG000|Overall Study|Lost to Follow-up|1|||
27862233|NCT00428116|81326278|FG001|Overall Study|Lost to Follow-up|0|||
27862234|NCT03155945|81326283|FG000|Overall Study|Lost to Follow-up|0|||
27862235|NCT03155945|81326284|FG001|Overall Study|Lost to Follow-up|1|||
27862236|NCT03155945|81326283|FG000|Overall Study|Withdrawal by Subject|0|||
27862237|NCT03155945|81326284|FG001|Overall Study|Withdrawal by Subject|1|||
27862238|NCT03155945|81326283|FG000|Overall Study|Other Reason|0|||
27862239|NCT03155945|81326284|FG001|Overall Study|Other Reason|1|||
27862240|NCT00801099|81326286|FG000|Overall Study|Lost to Follow-up|101|||
27862241|NCT02359994|81326288|FG000|Overall Population Study|Adverse Event|1|||
27862242|NCT02359994|81326289|FG001|Overall Population Study|Adverse Event|1|||
27862243|NCT02359994|81326288|FG000|Overall Population Study|Death|1|||
27862244|NCT02359994|81326289|FG001|Overall Population Study|Death|5|||
27862245|NCT02359994|81326288|FG000|Overall Population Study|Lost to Follow-up|1|||
27964373|NCT01831466|81699188|FG006|Overall Study|Death|0|||
27964374|NCT01831466|81699189|FG007|Overall Study|Death|0|||
27569015|NCT02658890|80271470|FG000|Treatment Phase|Other Reasons|0|||
27770305|NCT03927911|80988497|FG005|Overall Study|Adverse Event|1|||
27862246|NCT02359994|81326289|FG001|Overall Population Study|Lost to Follow-up|1|||
27862247|NCT02359994|81326288|FG000|Overall Population Study|Withdrawal by Subject|1|||
27862248|NCT02359994|81326289|FG001|Overall Population Study|Withdrawal by Subject|0|||
27964375|NCT01831466|81699190|FG008|Overall Study|Death|0|||
27964376|NCT01831466|81699191|FG009|Overall Study|Death|0|||
27964377|NCT01831466|81699192|FG010|Overall Study|Death|0|||
27964378|NCT01831466|81699193|FG011|Overall Study|Death|0|||
27964379|NCT01831466|81699182|FG000|Overall Study|Withdrawal by Subject|6|||
27964380|NCT01831466|81699183|FG001|Overall Study|Withdrawal by Subject|3|||
27770306|NCT03927911|80988492|FG000|Overall Study|not treated -study terminated by sponsor|0|||
27770307|NCT03927911|80988493|FG001|Overall Study|not treated -study terminated by sponsor|1|||
27964381|NCT01831466|81699184|FG002|Overall Study|Withdrawal by Subject|3|||
27964382|NCT01831466|81699185|FG003|Overall Study|Withdrawal by Subject|3|||
27964383|NCT01831466|81699186|FG004|Overall Study|Withdrawal by Subject|3|||
27964384|NCT01831466|81699187|FG005|Overall Study|Withdrawal by Subject|5|||
27964385|NCT01831466|81699188|FG006|Overall Study|Withdrawal by Subject|0|||
27964386|NCT01831466|81699189|FG007|Overall Study|Withdrawal by Subject|0|||
27964387|NCT01831466|81699190|FG008|Overall Study|Withdrawal by Subject|0|||
27964388|NCT01831466|81699191|FG009|Overall Study|Withdrawal by Subject|1|||
27964389|NCT01831466|81699192|FG010|Overall Study|Withdrawal by Subject|0|||
27964390|NCT01831466|81699193|FG011|Overall Study|Withdrawal by Subject|1|||
27964391|NCT01831466|81699182|FG000|Overall Study|Lost to Follow-up|0|||
27964392|NCT01831466|81699183|FG001|Overall Study|Lost to Follow-up|1|||
27964393|NCT01831466|81699184|FG002|Overall Study|Lost to Follow-up|4|||
27964394|NCT01831466|81699185|FG003|Overall Study|Lost to Follow-up|2|||
27964395|NCT01831466|81699186|FG004|Overall Study|Lost to Follow-up|0|||
27964396|NCT01831466|81699187|FG005|Overall Study|Lost to Follow-up|3|||
27964397|NCT01831466|81699188|FG006|Overall Study|Lost to Follow-up|0|||
27964398|NCT01831466|81699189|FG007|Overall Study|Lost to Follow-up|0|||
27964399|NCT01831466|81699190|FG008|Overall Study|Lost to Follow-up|0|||
27770308|NCT03927911|80988494|FG002|Overall Study|not treated -study terminated by sponsor|0|||
27770309|NCT03927911|80988495|FG003|Overall Study|not treated -study terminated by sponsor|0|||
27770310|NCT03927911|80988496|FG004|Overall Study|not treated -study terminated by sponsor|0|||
27770311|NCT03927911|80988497|FG005|Overall Study|not treated -study terminated by sponsor|0|||
27770312|NCT03927911|80988492|FG000|Overall Study|Surgery cancelled|0|||
27770313|NCT03927911|80988493|FG001|Overall Study|Surgery cancelled|0|||
27770314|NCT03927911|80988494|FG002|Overall Study|Surgery cancelled|0|||
27770315|NCT03927911|80988495|FG003|Overall Study|Surgery cancelled|1|||
27770316|NCT03927911|80988496|FG004|Overall Study|Surgery cancelled|0|||
27770317|NCT03927911|80988497|FG005|Overall Study|Surgery cancelled|1|||
27770318|NCT03927911|80988492|FG000|Overall Study|Protocol Violation|0|||
27770319|NCT03927911|80988493|FG001|Overall Study|Protocol Violation|0|||
27770320|NCT03927911|80988494|FG002|Overall Study|Protocol Violation|0|||
27770321|NCT03927911|80988495|FG003|Overall Study|Protocol Violation|0|||
27770322|NCT03927911|80988496|FG004|Overall Study|Protocol Violation|0|||
27770323|NCT03927911|80988497|FG005|Overall Study|Protocol Violation|1|||
27770324|NCT03363165|80988498|FG000|3-month Follow-up|Death|0|||
27770325|NCT03363165|80988499|FG001|3-month Follow-up|Death|1|||
27770326|NCT03363165|80988498|FG000|6-month Follow-up|Death|0|||
27770327|NCT03363165|80988499|FG001|6-month Follow-up|Death|1|||
27770328|NCT03363165|80988498|FG000|6-month Follow-up|Withdrawal by Subject|1|||
27770329|NCT03363165|80988499|FG001|6-month Follow-up|Withdrawal by Subject|1|||
27770330|NCT03363165|80988498|FG000|12-month Follow-up|Death|1|||
27770331|NCT03363165|80988499|FG001|12-month Follow-up|Death|1|||
27770332|NCT03363165|80988498|FG000|12-month Follow-up|Withdrawal by Subject|1|||
27770333|NCT03363165|80988499|FG001|12-month Follow-up|Withdrawal by Subject|1|||
27770334|NCT00606294|80988500|FG000|Overall Study|Withdrawal by Subject|36|||
27770335|NCT00606294|80988501|FG001|Overall Study|Withdrawal by Subject|0|||
27770336|NCT01505114|80988504|FG000|Overall Study|Withdrawal by Subject|5|||
27770337|NCT01505114|80988505|FG001|Overall Study|Withdrawal by Subject|4|||
27770338|NCT01505114|80988506|FG002|Overall Study|Withdrawal by Subject|4|||
27770339|NCT01505114|80988507|FG003|Overall Study|Withdrawal by Subject|7|||
27770340|NCT01505114|80988504|FG000|Overall Study|Death|1|||
27770341|NCT01505114|80988505|FG001|Overall Study|Death|0|||
27770342|NCT01505114|80988506|FG002|Overall Study|Death|0|||
27770343|NCT01505114|80988507|FG003|Overall Study|Death|1|||
27770344|NCT01505114|80988504|FG000|Overall Study|unable to adhere to visit schedule|3|||
27964400|NCT01831466|81699191|FG009|Overall Study|Lost to Follow-up|1|||
27770345|NCT01505114|80988505|FG001|Overall Study|unable to adhere to visit schedule|2|||
27770346|NCT01505114|80988506|FG002|Overall Study|unable to adhere to visit schedule|3|||
27964401|NCT01831466|81699192|FG010|Overall Study|Lost to Follow-up|0|||
27770347|NCT01505114|80988507|FG003|Overall Study|unable to adhere to visit schedule|3|||
27770348|NCT01505114|80988504|FG000|Overall Study|Lost to Follow-up|11|||
27770349|NCT01505114|80988505|FG001|Overall Study|Lost to Follow-up|5|||
27770350|NCT01505114|80988506|FG002|Overall Study|Lost to Follow-up|8|||
27770351|NCT01505114|80988507|FG003|Overall Study|Lost to Follow-up|7|||
27770352|NCT01505114|80988504|FG000|Overall Study|relocated|4|||
27964402|NCT01831466|81699193|FG011|Overall Study|Lost to Follow-up|1|||
27964403|NCT01831466|81699182|FG000|Overall Study|Lack of Efficacy|5|||
27964404|NCT01831466|81699183|FG001|Overall Study|Lack of Efficacy|8|||
27964405|NCT01831466|81699184|FG002|Overall Study|Lack of Efficacy|7|||
27964406|NCT01831466|81699185|FG003|Overall Study|Lack of Efficacy|6|||
27770353|NCT01505114|80988505|FG001|Overall Study|relocated|2|||
27770354|NCT01505114|80988506|FG002|Overall Study|relocated|2|||
27770355|NCT01505114|80988507|FG003|Overall Study|relocated|3|||
27770356|NCT01505114|80988504|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
27770357|NCT01505114|80988505|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
27770358|NCT01505114|80988506|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
27770359|NCT01505114|80988507|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
27770360|NCT01505114|80988504|FG000|Overall Study|staff safety concerns|0|||
27770361|NCT01505114|80988505|FG001|Overall Study|staff safety concerns|0|||
27770362|NCT01505114|80988506|FG002|Overall Study|staff safety concerns|0|||
27770363|NCT01505114|80988507|FG003|Overall Study|staff safety concerns|1|||
27770364|NCT01505114|80988504|FG000|Overall Study|investigator decision|1|||
27770365|NCT01505114|80988505|FG001|Overall Study|investigator decision|0|||
27770366|NCT01505114|80988506|FG002|Overall Study|investigator decision|1|||
27770367|NCT01505114|80988507|FG003|Overall Study|investigator decision|0|||
27770368|NCT04058158|80988515|FG000|Period 1|Death|1|||
27770369|NCT04058158|80988516|FG001|Period 1|Death|0|||
27770370|NCT04058158|80988515|FG000|Period 1|Adverse Event|1|||
27770371|NCT04058158|80988516|FG001|Period 1|Adverse Event|1|||
27770372|NCT04058158|80988515|FG000|Period 1|Pregnancy|0|||
27770373|NCT04058158|80988516|FG001|Period 1|Pregnancy|1|||
27770374|NCT03639987|80988521|FG000|Overall Study|Study terminated by sponsor|26|||
27770375|NCT03639987|80988522|FG001|Overall Study|Study terminated by sponsor|25|||
27770376|NCT03639987|80988521|FG000|Overall Study|Lost to Follow-up|0|||
27770377|NCT03639987|80988522|FG001|Overall Study|Lost to Follow-up|1|||
27770378|NCT00262314|80988524|FG000|Overall Study|Changing physicians|38|||
27770379|NCT00262314|80988524|FG000|Overall Study|Death|12|||
27770380|NCT00262314|80988524|FG000|Overall Study|Patient's decision|92|||
27770381|NCT00262314|80988524|FG000|Overall Study|Other|95|||
27770382|NCT00262314|80988524|FG000|Overall Study|Lost to Follow-up|70|||
27770383|NCT00262314|80988524|FG000|Overall Study|Administrative withdrawal|30|||
27770384|NCT01804842|80988525|FG000|Overall Study|Adverse Event|1|||
27770385|NCT01804842|80988526|FG001|Overall Study|Adverse Event|1|||
27770386|NCT01804842|80988527|FG002|Overall Study|Adverse Event|0|||
27770387|NCT01804842|80988525|FG000|Overall Study|Lost to Follow-up|1|||
27770388|NCT01804842|80988526|FG001|Overall Study|Lost to Follow-up|0|||
27770389|NCT01804842|80988527|FG002|Overall Study|Lost to Follow-up|0|||
27770390|NCT01804842|80988525|FG000|Overall Study|Non-Compliance|1|||
27770391|NCT01804842|80988526|FG001|Overall Study|Non-Compliance|1|||
27770392|NCT01804842|80988527|FG002|Overall Study|Non-Compliance|0|||
27770393|NCT01804842|80988525|FG000|Overall Study|Personal Reason|0|||
27770394|NCT01804842|80988526|FG001|Overall Study|Personal Reason|0|||
27770395|NCT01804842|80988527|FG002|Overall Study|Personal Reason|1|||
27770396|NCT02911519|80988528|FG000|Overall Study|Lost to Follow-up|2|||
27770397|NCT02911519|80988529|FG001|Overall Study|Lost to Follow-up|2|||
27770398|NCT02911519|80988528|FG000|Overall Study|Death|0|||
27770399|NCT02911519|80988529|FG001|Overall Study|Death|2|||
27770400|NCT00294684|80988530|FG000|Overall Study|Lost to Follow-up|5|||
27770401|NCT00294684|80988531|FG001|Overall Study|Lost to Follow-up|8|||
27770402|NCT02738580|80988532|FG000|Overall Study|Adverse Event|1|||
27770403|NCT02738580|80988533|FG001|Overall Study|Adverse Event|0|||
27770404|NCT02738580|80988532|FG000|Overall Study|Lack of Efficacy|3|||
27770405|NCT02738580|80988533|FG001|Overall Study|Lack of Efficacy|2|||
27770406|NCT02738580|80988532|FG000|Overall Study|Withdrawal by Subject|0|||
27770407|NCT02738580|80988533|FG001|Overall Study|Withdrawal by Subject|1|||
27770408|NCT02738580|80988532|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
27770409|NCT02738580|80988533|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
27770410|NCT00291187|80988536|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
27770411|NCT00291187|80988537|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
27770412|NCT00291187|80988538|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
27770413|NCT00291187|80988539|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
27770414|NCT04134728|80988540|FG000|Overall Study|Adverse Event|3|||
27964407|NCT01831466|81699186|FG004|Overall Study|Lack of Efficacy|9|||
27964408|NCT01831466|81699187|FG005|Overall Study|Lack of Efficacy|8|||
27964409|NCT01831466|81699188|FG006|Overall Study|Lack of Efficacy|1|||
27770415|NCT04134728|80988541|FG001|Overall Study|Adverse Event|2|||
27770416|NCT04134728|80988542|FG002|Overall Study|Adverse Event|9|||
27770417|NCT04134728|80988543|FG003|Overall Study|Adverse Event|0|||
27770418|NCT04134728|80988544|FG004|Overall Study|Adverse Event|0|||
27770419|NCT04134728|80988545|FG005|Overall Study|Adverse Event|0|||
27770420|NCT04134728|80988540|FG000|Overall Study|Lack of Efficacy|3|||
27770421|NCT04134728|80988541|FG001|Overall Study|Lack of Efficacy|3|||
27770422|NCT04134728|80988542|FG002|Overall Study|Lack of Efficacy|1|||
27964410|NCT01831466|81699189|FG007|Overall Study|Lack of Efficacy|1|||
27964411|NCT01831466|81699190|FG008|Overall Study|Lack of Efficacy|2|||
27770423|NCT04134728|80988543|FG003|Overall Study|Lack of Efficacy|2|||
27770424|NCT04134728|80988544|FG004|Overall Study|Lack of Efficacy|0|||
27770425|NCT04134728|80988545|FG005|Overall Study|Lack of Efficacy|0|||
27770426|NCT04134728|80988540|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
27770427|NCT04134728|80988541|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27770428|NCT04134728|80988542|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
27770429|NCT04134728|80988543|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27770430|NCT04134728|80988544|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27770431|NCT04134728|80988545|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27770432|NCT04134728|80988540|FG000|Overall Study|Protocol Deviation|0|||
27770433|NCT04134728|80988541|FG001|Overall Study|Protocol Deviation|0|||
27770434|NCT04134728|80988542|FG002|Overall Study|Protocol Deviation|1|||
27770435|NCT04134728|80988543|FG003|Overall Study|Protocol Deviation|0|||
27770436|NCT04134728|80988544|FG004|Overall Study|Protocol Deviation|0|||
27770437|NCT04134728|80988545|FG005|Overall Study|Protocol Deviation|0|||
27770438|NCT04134728|80988540|FG000|Overall Study|Informed Consent Withdrawn|3|||
27770439|NCT04134728|80988541|FG001|Overall Study|Informed Consent Withdrawn|6|||
27770440|NCT04134728|80988542|FG002|Overall Study|Informed Consent Withdrawn|8|||
27770441|NCT04134728|80988543|FG003|Overall Study|Informed Consent Withdrawn|1|||
27770442|NCT04134728|80988544|FG004|Overall Study|Informed Consent Withdrawn|1|||
27770443|NCT04134728|80988545|FG005|Overall Study|Informed Consent Withdrawn|0|||
27770444|NCT04134728|80988540|FG000|Overall Study|Physician Decision|2|||
27770445|NCT04134728|80988541|FG001|Overall Study|Physician Decision|0|||
27770446|NCT04134728|80988542|FG002|Overall Study|Physician Decision|0|||
27770447|NCT04134728|80988543|FG003|Overall Study|Physician Decision|0|||
27770448|NCT04134728|80988544|FG004|Overall Study|Physician Decision|0|||
27770449|NCT04134728|80988545|FG005|Overall Study|Physician Decision|0|||
27770450|NCT04134728|80988540|FG000|Overall Study|Lost to Follow-up|1|||
27770451|NCT04134728|80988541|FG001|Overall Study|Lost to Follow-up|2|||
27770452|NCT04134728|80988542|FG002|Overall Study|Lost to Follow-up|1|||
27770453|NCT04134728|80988543|FG003|Overall Study|Lost to Follow-up|0|||
27770454|NCT04134728|80988544|FG004|Overall Study|Lost to Follow-up|0|||
27770455|NCT04134728|80988545|FG005|Overall Study|Lost to Follow-up|1|||
27770456|NCT04134728|80988540|FG000|Overall Study|Investigator Site Closed|0|||
27770457|NCT04134728|80988541|FG001|Overall Study|Investigator Site Closed|1|||
27770458|NCT04134728|80988542|FG002|Overall Study|Investigator Site Closed|1|||
27770459|NCT04134728|80988543|FG003|Overall Study|Investigator Site Closed|0|||
27770460|NCT04134728|80988544|FG004|Overall Study|Investigator Site Closed|0|||
27770461|NCT04134728|80988545|FG005|Overall Study|Investigator Site Closed|0|||
27770462|NCT01041404|80988546|FG000|Overall Study|Adverse Event|45|||
27770463|NCT01041404|80988547|FG001|Overall Study|Adverse Event|35|||
27770464|NCT01041404|80988546|FG000|Overall Study|Lack of Efficacy|200|||
27770465|NCT01041404|80988547|FG001|Overall Study|Lack of Efficacy|210|||
27770466|NCT01041404|80988546|FG000|Overall Study|Violation of Selection Criteria|0|||
27770467|NCT01041404|80988547|FG001|Overall Study|Violation of Selection Criteria|1|||
27770468|NCT01041404|80988546|FG000|Overall Study|Protocol Violation|4|||
27770469|NCT01041404|80988547|FG001|Overall Study|Protocol Violation|0|||
27770470|NCT01041404|80988546|FG000|Overall Study|Withdrawal by Subject|29|||
27770471|NCT01041404|80988547|FG001|Overall Study|Withdrawal by Subject|23|||
27770472|NCT01041404|80988546|FG000|Overall Study|Failure to Return|1|||
27770473|NCT01041404|80988547|FG001|Overall Study|Failure to Return|2|||
27770474|NCT01041404|80988546|FG000|Overall Study|Other|11|||
27770475|NCT01041404|80988547|FG001|Overall Study|Other|23|||
27770476|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
27770477|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
27770478|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
27770479|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
27770480|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
27770481|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
27770482|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
27770483|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
27770484|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
27770485|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
27770486|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
27770487|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
27770488|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
27770489|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
27770490|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
27770491|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
27964412|NCT01831466|81699191|FG009|Overall Study|Lack of Efficacy|2|||
27770492|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
27770493|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
27770494|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
27770495|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
27770496|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
27964413|NCT01831466|81699192|FG010|Overall Study|Lack of Efficacy|2|||
27770497|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
27770498|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
27770499|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
27770500|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
27770501|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
27770502|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
27770503|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
27770504|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
27770505|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
27770506|NCT04757376|80988552|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
27770507|NCT04757376|80988553|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
27770508|NCT04757376|80988554|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
27770509|NCT04757376|80988555|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
27770510|NCT04757376|80988556|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
27770511|NCT04757376|80988552|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
27770512|NCT04757376|80988553|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
27770513|NCT04757376|80988554|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
27770514|NCT04757376|80988555|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
27770515|NCT04757376|80988556|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
27770516|NCT00003838|80988561|FG000|Overall Study|Death|0|||
27770517|NCT00003838|80988562|FG001|Overall Study|Death|12|||
27770518|NCT00003838|80988563|FG002|Overall Study|Death|7|||
27770519|NCT00003838|80988561|FG000|Overall Study|Lost to Follow-up|0|||
27770520|NCT00003838|80988562|FG001|Overall Study|Lost to Follow-up|1|||
27770521|NCT00003838|80988563|FG002|Overall Study|Lost to Follow-up|1|||
27770522|NCT00003838|80988561|FG000|Overall Study|Disease Progression|0|||
27770523|NCT00003838|80988562|FG001|Overall Study|Disease Progression|12|||
27770524|NCT00003838|80988563|FG002|Overall Study|Disease Progression|0|||
27770525|NCT00918346|80988568|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
27770526|NCT00918346|80988569|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
27770527|NCT03682055|80988570|FG000|Overall Study|Lack of Efficacy|1|||
27770528|NCT03682055|80988571|FG001|Overall Study|Lack of Efficacy|2|||
27770529|NCT03682055|80988572|FG002|Overall Study|Lack of Efficacy|1|||
27770530|NCT03682055|80988573|FG003|Overall Study|Lack of Efficacy|2|||
27770531|NCT03682055|80988574|FG004|Overall Study|Lack of Efficacy|1|||
27770532|NCT03682055|80988575|FG005|Overall Study|Lack of Efficacy|3|||
27770533|NCT03682055|80988570|FG000|Overall Study|Withdrawal by Subject|0|||
27770534|NCT03682055|80988571|FG001|Overall Study|Withdrawal by Subject|0|||
27770535|NCT03682055|80988572|FG002|Overall Study|Withdrawal by Subject|0|||
27770536|NCT03682055|80988573|FG003|Overall Study|Withdrawal by Subject|0|||
27770537|NCT03682055|80988574|FG004|Overall Study|Withdrawal by Subject|0|||
27770538|NCT03682055|80988575|FG005|Overall Study|Withdrawal by Subject|1|||
27770539|NCT03682055|80988570|FG000|Overall Study|Termination of Study by Sponsor|0|||
27770540|NCT03682055|80988571|FG001|Overall Study|Termination of Study by Sponsor|0|||
27770541|NCT03682055|80988572|FG002|Overall Study|Termination of Study by Sponsor|0|||
27770542|NCT03682055|80988573|FG003|Overall Study|Termination of Study by Sponsor|0|||
27770543|NCT03682055|80988574|FG004|Overall Study|Termination of Study by Sponsor|0|||
27770544|NCT03682055|80988575|FG005|Overall Study|Termination of Study by Sponsor|3|||
27770545|NCT02999191|80988576|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
27770546|NCT02999191|80988577|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
27770547|NCT02999191|80988578|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
27770548|NCT03654560|80988579|FG000|Overall Study|Death|3|||
27770549|NCT03654560|80988580|FG001|Overall Study|Death|1|||
27770550|NCT03654560|80988579|FG000|Overall Study|Lost to Follow-up|1|||
27770551|NCT03654560|80988580|FG001|Overall Study|Lost to Follow-up|0|||
27770552|NCT00953225|80988581|FG000|Overall Study|Withdrawal by Subject|2|||
27770553|NCT00953225|80988582|FG001|Overall Study|Withdrawal by Subject|0|||
27770554|NCT01496274|80988583|FG000|Overall Study|Protocol Violation|0|||
27770555|NCT01496274|80988584|FG001|Overall Study|Protocol Violation|1|||
27770556|NCT01496274|80988583|FG000|Overall Study|Adverse Event|1|||
27770557|NCT01496274|80988584|FG001|Overall Study|Adverse Event|1|||
27770558|NCT01496274|80988583|FG000|Overall Study|Withdrawal by Subject|2|||
27770559|NCT01496274|80988584|FG001|Overall Study|Withdrawal by Subject|0|||
27964414|NCT01831466|81699193|FG011|Overall Study|Lack of Efficacy|0|||
27770560|NCT01496274|80988583|FG000|Overall Study|Lost to Follow-up|0|||
27964415|NCT01831466|81699182|FG000|Overall Study|Adverse Event|0|||
27964416|NCT01831466|81699183|FG001|Overall Study|Adverse Event|0|||
27964417|NCT01831466|81699184|FG002|Overall Study|Adverse Event|4|||
27964418|NCT01831466|81699185|FG003|Overall Study|Adverse Event|6|||
27770561|NCT01496274|80988584|FG001|Overall Study|Lost to Follow-up|3|||
27770562|NCT00251589|80988597|FG000|Overall Study|Adverse Event|5|||
27770563|NCT00251589|80988598|FG001|Overall Study|Adverse Event|1|||
27770564|NCT00251589|80988599|FG002|Overall Study|Adverse Event|2|||
27770565|NCT00251589|80988600|FG003|Overall Study|Adverse Event|1|||
27770566|NCT00251589|80988597|FG000|Overall Study|Withdrawal by Subject|1|||
27770567|NCT00251589|80988598|FG001|Overall Study|Withdrawal by Subject|1|||
27770568|NCT00251589|80988599|FG002|Overall Study|Withdrawal by Subject|0|||
27770569|NCT00251589|80988600|FG003|Overall Study|Withdrawal by Subject|0|||
27770570|NCT00251589|80988597|FG000|Overall Study|Discontinued due to progressive disease|9|||
27770571|NCT00251589|80988598|FG001|Overall Study|Discontinued due to progressive disease|1|||
27770572|NCT00251589|80988599|FG002|Overall Study|Discontinued due to progressive disease|0|||
27770573|NCT00251589|80988600|FG003|Overall Study|Discontinued due to progressive disease|1|||
27770574|NCT00841672|80988601|FG000|Overall Study|Adverse Event|7|||
27770575|NCT00841672|80988602|FG001|Overall Study|Adverse Event|16|||
27770576|NCT00841672|80988601|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27770577|NCT00841672|80988602|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27770578|NCT00841672|80988601|FG000|Overall Study|Subject withdrew consent|2|||
27770579|NCT00841672|80988602|FG001|Overall Study|Subject withdrew consent|4|||
27770580|NCT00841672|80988601|FG000|Overall Study|Lost to Follow-up|1|||
27770581|NCT00841672|80988602|FG001|Overall Study|Lost to Follow-up|1|||
27770582|NCT00841672|80988601|FG000|Overall Study|Administrative problems|9|||
27770583|NCT00841672|80988602|FG001|Overall Study|Administrative problems|9|||
27770584|NCT00841672|80988601|FG000|Overall Study|Misrandomized|1|||
27770585|NCT00841672|80988602|FG001|Overall Study|Misrandomized|0|||
27770586|NCT00841672|80988601|FG000|Overall Study|Protocol Deviation|0|||
27770587|NCT00841672|80988602|FG001|Overall Study|Protocol Deviation|1|||
27770588|NCT02007252|80988603|FG000|Overall Study|Administrative problems|3|||
27770589|NCT02007252|80988604|FG001|Overall Study|Administrative problems|7|||
27770590|NCT02007252|80988603|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27770591|NCT02007252|80988604|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27770592|NCT02007252|80988603|FG000|Overall Study|Adverse Event|7|||
27770593|NCT02007252|80988604|FG001|Overall Study|Adverse Event|4|||
27770594|NCT03073213|80988607|FG000|Multiple Dose Period|Protocol Violation|0|||
27770595|NCT03073213|80988608|FG001|Multiple Dose Period|Protocol Violation|0|||
27770596|NCT03073213|80988609|FG002|Multiple Dose Period|Protocol Violation|1|||
27770597|NCT02533401|80988615|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
27770598|NCT02533401|80988615|FG000|Overall Study|Death|5|||
27770599|NCT02533401|80988615|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
27770600|NCT02533401|80988615|FG000|Overall Study|Lost to Follow-up|1|||
27770601|NCT02533401|80988615|FG000|Overall Study|Violation of Selection Criteria|1|||
27770602|NCT00804986|80988616|FG000|Overall Study|Adverse Event|0|||
27770603|NCT00804986|80988617|FG001|Overall Study|Adverse Event|1|||
27770604|NCT00804986|80988618|FG002|Overall Study|Adverse Event|2|||
27770605|NCT00804986|80988619|FG003|Overall Study|Adverse Event|1|||
27770606|NCT00804986|80988620|FG004|Overall Study|Adverse Event|3|||
27770607|NCT00804986|80988621|FG005|Overall Study|Adverse Event|0|||
27770608|NCT00804986|80988616|FG000|Overall Study|Lack of Efficacy|0|||
27770609|NCT00804986|80988617|FG001|Overall Study|Lack of Efficacy|0|||
27770610|NCT00804986|80988618|FG002|Overall Study|Lack of Efficacy|0|||
27770611|NCT00804986|80988619|FG003|Overall Study|Lack of Efficacy|1|||
27770612|NCT00804986|80988620|FG004|Overall Study|Lack of Efficacy|0|||
27770613|NCT00804986|80988621|FG005|Overall Study|Lack of Efficacy|3|||
27770614|NCT00804986|80988616|FG000|Overall Study|Lost to Follow-up|0|||
27770615|NCT00804986|80988617|FG001|Overall Study|Lost to Follow-up|0|||
27770616|NCT00804986|80988618|FG002|Overall Study|Lost to Follow-up|0|||
27770617|NCT00804986|80988619|FG003|Overall Study|Lost to Follow-up|1|||
27770618|NCT00804986|80988620|FG004|Overall Study|Lost to Follow-up|1|||
27770619|NCT00804986|80988621|FG005|Overall Study|Lost to Follow-up|3|||
27770620|NCT00804986|80988616|FG000|Overall Study|Protocol Violation|0|||
27964419|NCT01831466|81699186|FG004|Overall Study|Adverse Event|3|||
27964420|NCT01831466|81699187|FG005|Overall Study|Adverse Event|7|||
27663919|NCT02162771|80606569|FG000|Core Study Period (Part 2)|Adverse Event|4|||
27770621|NCT00804986|80988617|FG001|Overall Study|Protocol Violation|1|||
27770622|NCT00804986|80988618|FG002|Overall Study|Protocol Violation|0|||
27770623|NCT00804986|80988619|FG003|Overall Study|Protocol Violation|1|||
27770624|NCT00804986|80988620|FG004|Overall Study|Protocol Violation|0|||
27770625|NCT00804986|80988621|FG005|Overall Study|Protocol Violation|0|||
27770626|NCT00804986|80988616|FG000|Overall Study|Withdrawal by Subject|0|||
27770627|NCT00804986|80988617|FG001|Overall Study|Withdrawal by Subject|3|||
27770628|NCT00804986|80988618|FG002|Overall Study|Withdrawal by Subject|0|||
27964421|NCT01831466|81699188|FG006|Overall Study|Adverse Event|0|||
27663920|NCT02162771|80606570|FG001|Core Study Period (Part 2)|Adverse Event|1|||
27663921|NCT02162771|80606569|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
27964422|NCT01831466|81699189|FG007|Overall Study|Adverse Event|1|||
27770629|NCT00804986|80988619|FG003|Overall Study|Withdrawal by Subject|3|||
27770630|NCT00804986|80988620|FG004|Overall Study|Withdrawal by Subject|5|||
27770631|NCT00804986|80988621|FG005|Overall Study|Withdrawal by Subject|3|||
27770632|NCT00804986|80988616|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
27770633|NCT00804986|80988617|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
27770634|NCT00804986|80988618|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
27770635|NCT00804986|80988619|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
27770636|NCT00804986|80988620|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
27770637|NCT00804986|80988621|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
27770638|NCT00804986|80988616|FG000|Overall Study|Sponsor Decision|0|||
27770639|NCT00804986|80988617|FG001|Overall Study|Sponsor Decision|1|||
27770640|NCT00804986|80988618|FG002|Overall Study|Sponsor Decision|0|||
27770641|NCT00804986|80988619|FG003|Overall Study|Sponsor Decision|0|||
27770642|NCT00804986|80988620|FG004|Overall Study|Sponsor Decision|0|||
27770643|NCT00804986|80988621|FG005|Overall Study|Sponsor Decision|0|||
27770644|NCT00804986|80988616|FG000|Overall Study|Physician Decision|1|||
27770645|NCT00804986|80988617|FG001|Overall Study|Physician Decision|0|||
27770646|NCT00804986|80988618|FG002|Overall Study|Physician Decision|0|||
27770647|NCT00804986|80988619|FG003|Overall Study|Physician Decision|0|||
27770648|NCT00804986|80988620|FG004|Overall Study|Physician Decision|0|||
27770649|NCT00804986|80988621|FG005|Overall Study|Physician Decision|0|||
27770650|NCT05083949|80988625|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
27770651|NCT05083949|80988626|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
27770652|NCT05083949|80988625|FG000|Period 1|Adverse Event|1|||
27770653|NCT05083949|80988626|FG001|Period 1|Adverse Event|1|||
27770654|NCT05083949|80988625|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
27770655|NCT05083949|80988626|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
27770656|NCT05083949|80988625|FG000|Period 2|Adverse Event|0|||
27770657|NCT05083949|80988626|FG001|Period 2|Adverse Event|2|||
27770658|NCT01025232|80988634|FG000|Overall Study|Study drug no longer available|3|||
27770659|NCT01025232|80988635|FG001|Overall Study|Study drug no longer available|6|||
27770660|NCT00653068|80988637|FG000|Overall Study|Death|9|||
27770661|NCT00653068|80988637|FG000|Overall Study|Lack of Efficacy|34|||
27770662|NCT00653068|80988637|FG000|Overall Study|Physician Decision|4|||
27770663|NCT00653068|80988637|FG000|Overall Study|Withdrawal by Subject|1|||
27770664|NCT00653068|80988637|FG000|Overall Study|Ineligible|2|||
27770665|NCT01975675|80988638|FG000|Overall Study|Death|0|||
27770666|NCT01975675|80988639|FG001|Overall Study|Death|1|||
27770667|NCT01975675|80988640|FG002|Overall Study|Death|0|||
27770668|NCT01975675|80988641|FG003|Overall Study|Death|0|||
27770669|NCT03799627|80988644|FG000|Overall Study|Adverse Event|1|||
27770670|NCT03799627|80988645|FG001|Overall Study|Adverse Event|2|||
27770671|NCT03799627|80988646|FG002|Overall Study|Adverse Event|0|||
27770672|NCT03799627|80988647|FG003|Overall Study|Adverse Event|0|||
27770673|NCT03799627|80988648|FG004|Overall Study|Adverse Event|2|||
27770674|NCT03799627|80988649|FG005|Overall Study|Adverse Event|5|||
27770675|NCT03799627|80988650|FG006|Overall Study|Adverse Event|0|||
27770676|NCT03799627|80988651|FG007|Overall Study|Adverse Event|2|||
27770677|NCT03799627|80988652|FG008|Overall Study|Adverse Event|0|||
27770678|NCT03799627|80988644|FG000|Overall Study|Physician Decision|2|||
27770679|NCT03799627|80988645|FG001|Overall Study|Physician Decision|2|||
27770680|NCT03799627|80988646|FG002|Overall Study|Physician Decision|0|||
27770681|NCT03799627|80988647|FG003|Overall Study|Physician Decision|0|||
27770682|NCT03799627|80988648|FG004|Overall Study|Physician Decision|2|||
27770683|NCT03799627|80988649|FG005|Overall Study|Physician Decision|2|||
27770684|NCT03799627|80988650|FG006|Overall Study|Physician Decision|0|||
27770685|NCT03799627|80988651|FG007|Overall Study|Physician Decision|0|||
27770686|NCT03799627|80988652|FG008|Overall Study|Physician Decision|0|||
27770687|NCT03799627|80988644|FG000|Overall Study|Withdrawal by Subject|1|||
27770688|NCT03799627|80988645|FG001|Overall Study|Withdrawal by Subject|1|||
27770689|NCT03799627|80988646|FG002|Overall Study|Withdrawal by Subject|0|||
27770690|NCT03799627|80988647|FG003|Overall Study|Withdrawal by Subject|2|||
27770691|NCT03799627|80988648|FG004|Overall Study|Withdrawal by Subject|0|||
27770692|NCT03799627|80988649|FG005|Overall Study|Withdrawal by Subject|3|||
27770693|NCT03799627|80988650|FG006|Overall Study|Withdrawal by Subject|0|||
27770694|NCT03799627|80988651|FG007|Overall Study|Withdrawal by Subject|0|||
27770695|NCT03799627|80988652|FG008|Overall Study|Withdrawal by Subject|0|||
27770696|NCT03799627|80988644|FG000|Overall Study|Lack of Efficacy|0|||
27770697|NCT03799627|80988645|FG001|Overall Study|Lack of Efficacy|0|||
27770698|NCT03799627|80988646|FG002|Overall Study|Lack of Efficacy|0|||
27770699|NCT03799627|80988647|FG003|Overall Study|Lack of Efficacy|1|||
27770700|NCT03799627|80988648|FG004|Overall Study|Lack of Efficacy|0|||
27770701|NCT03799627|80988649|FG005|Overall Study|Lack of Efficacy|0|||
27770702|NCT03799627|80988650|FG006|Overall Study|Lack of Efficacy|0|||
27770703|NCT03799627|80988651|FG007|Overall Study|Lack of Efficacy|0|||
27770704|NCT03799627|80988652|FG008|Overall Study|Lack of Efficacy|0|||
27770705|NCT03799627|80988644|FG000|Overall Study|Lost to Follow-up|0|||
27770706|NCT03799627|80988645|FG001|Overall Study|Lost to Follow-up|0|||
27770707|NCT03799627|80988646|FG002|Overall Study|Lost to Follow-up|0|||
27770708|NCT03799627|80988647|FG003|Overall Study|Lost to Follow-up|0|||
27770709|NCT03799627|80988648|FG004|Overall Study|Lost to Follow-up|0|||
27770710|NCT03799627|80988649|FG005|Overall Study|Lost to Follow-up|0|||
27770711|NCT03799627|80988650|FG006|Overall Study|Lost to Follow-up|1|||
27770712|NCT03799627|80988651|FG007|Overall Study|Lost to Follow-up|0|||
27770713|NCT03799627|80988652|FG008|Overall Study|Lost to Follow-up|1|||
27770714|NCT03799627|80988644|FG000|Overall Study|Death|0|||
27770715|NCT03799627|80988645|FG001|Overall Study|Death|0|||
27770716|NCT03799627|80988646|FG002|Overall Study|Death|0|||
27770717|NCT03799627|80988647|FG003|Overall Study|Death|1|||
27770718|NCT03799627|80988648|FG004|Overall Study|Death|0|||
27770719|NCT03799627|80988649|FG005|Overall Study|Death|0|||
27770720|NCT03799627|80988650|FG006|Overall Study|Death|0|||
27770721|NCT03799627|80988651|FG007|Overall Study|Death|0|||
27770722|NCT03799627|80988652|FG008|Overall Study|Death|0|||
27770723|NCT03799627|80988644|FG000|Overall Study|Study Drug Put on Hold|1|||
27770724|NCT03799627|80988645|FG001|Overall Study|Study Drug Put on Hold|0|||
27770725|NCT03799627|80988646|FG002|Overall Study|Study Drug Put on Hold|0|||
27964423|NCT01831466|81699190|FG008|Overall Study|Adverse Event|1|||
27964424|NCT01831466|81699191|FG009|Overall Study|Adverse Event|1|||
27964425|NCT01831466|81699192|FG010|Overall Study|Adverse Event|0|||
27964426|NCT01831466|81699193|FG011|Overall Study|Adverse Event|2|||
27964427|NCT02684617|81699194|FG000|Overall Study|Adverse Event|1|||
27964428|NCT02684617|81699195|FG001|Overall Study|Adverse Event|0|||
27964429|NCT02684617|81699196|FG002|Overall Study|Adverse Event|1|||
27964430|NCT02684617|81699194|FG000|Overall Study|Death|8|||
27964431|NCT02684617|81699195|FG001|Overall Study|Death|16|||
27964432|NCT02684617|81699196|FG002|Overall Study|Death|28|||
27964433|NCT02684617|81699194|FG000|Overall Study|Withdrawal by Subject|2|||
27964434|NCT02684617|81699195|FG001|Overall Study|Withdrawal by Subject|0|||
27964435|NCT02684617|81699196|FG002|Overall Study|Withdrawal by Subject|4|||
27964436|NCT02684617|81699194|FG000|Overall Study|Screen Failure|1|||
27770726|NCT03799627|80988647|FG003|Overall Study|Study Drug Put on Hold|0|||
27770727|NCT03799627|80988648|FG004|Overall Study|Study Drug Put on Hold|0|||
27770728|NCT03799627|80988649|FG005|Overall Study|Study Drug Put on Hold|0|||
27770729|NCT03799627|80988650|FG006|Overall Study|Study Drug Put on Hold|0|||
27770730|NCT03799627|80988651|FG007|Overall Study|Study Drug Put on Hold|0|||
27770731|NCT03799627|80988652|FG008|Overall Study|Study Drug Put on Hold|0|||
27770732|NCT03799627|80988644|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
27770733|NCT03799627|80988645|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
27770734|NCT03799627|80988646|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
27770735|NCT03799627|80988647|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
27770736|NCT03799627|80988648|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
27770737|NCT03799627|80988649|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
27770738|NCT03799627|80988650|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
27770739|NCT03799627|80988651|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
27770740|NCT03799627|80988652|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
27770741|NCT03799627|80988644|FG000|Overall Study|Kidney Transplantation|1|||
27770742|NCT03799627|80988645|FG001|Overall Study|Kidney Transplantation|0|||
27770743|NCT03799627|80988646|FG002|Overall Study|Kidney Transplantation|0|||
27770744|NCT03799627|80988647|FG003|Overall Study|Kidney Transplantation|1|||
27770745|NCT03799627|80988648|FG004|Overall Study|Kidney Transplantation|1|||
27770746|NCT03799627|80988649|FG005|Overall Study|Kidney Transplantation|0|||
27770747|NCT03799627|80988650|FG006|Overall Study|Kidney Transplantation|0|||
27770748|NCT03799627|80988651|FG007|Overall Study|Kidney Transplantation|0|||
27770749|NCT03799627|80988652|FG008|Overall Study|Kidney Transplantation|0|||
27770750|NCT03799627|80988644|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
27964437|NCT02684617|81699195|FG001|Overall Study|Screen Failure|0|||
27964438|NCT02684617|81699196|FG002|Overall Study|Screen Failure|2|||
27770751|NCT03799627|80988645|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
27569016|NCT02658890|80271471|FG001|Treatment Phase|Other Reasons|0|||
27770752|NCT03799627|80988646|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
27770753|NCT03799627|80988647|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
27964439|NCT02684617|81699194|FG000|Overall Study|Study Terminated by Sponsor|6|||
27964440|NCT02684617|81699195|FG001|Overall Study|Study Terminated by Sponsor|1|||
27964441|NCT02684617|81699196|FG002|Overall Study|Study Terminated by Sponsor|5|||
27770754|NCT03799627|80988648|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
27770755|NCT03799627|80988649|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
27770756|NCT03799627|80988650|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
27770757|NCT03799627|80988651|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
27770758|NCT03799627|80988652|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
27770759|NCT03799627|80988644|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770760|NCT03799627|80988645|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
27770761|NCT03799627|80988646|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27964442|NCT01061723|81699197|FG000|Overall Study|Adverse Event|0|||
27964443|NCT01061723|81699198|FG001|Overall Study|Adverse Event|2|||
27964444|NCT01061723|81699199|FG002|Overall Study|Adverse Event|5|||
27964445|NCT01061723|81699200|FG003|Overall Study|Adverse Event|5|||
27770762|NCT03799627|80988647|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770763|NCT03799627|80988648|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770764|NCT03799627|80988649|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770765|NCT03799627|80988650|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770766|NCT03799627|80988651|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770767|NCT03799627|80988652|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
27770768|NCT03799627|80988644|FG000|Overall Study|Met Exclusion Criteria|0|||
27770769|NCT03799627|80988645|FG001|Overall Study|Met Exclusion Criteria|0|||
27770770|NCT03799627|80988646|FG002|Overall Study|Met Exclusion Criteria|0|||
27770771|NCT03799627|80988647|FG003|Overall Study|Met Exclusion Criteria|1|||
27770772|NCT03799627|80988648|FG004|Overall Study|Met Exclusion Criteria|0|||
27770773|NCT03799627|80988649|FG005|Overall Study|Met Exclusion Criteria|0|||
27770774|NCT03799627|80988650|FG006|Overall Study|Met Exclusion Criteria|0|||
27770775|NCT03799627|80988651|FG007|Overall Study|Met Exclusion Criteria|0|||
27770776|NCT03799627|80988652|FG008|Overall Study|Met Exclusion Criteria|0|||
27770777|NCT03799627|80988644|FG000|Overall Study|Investigational Product Noncompliance|0|||
27770778|NCT03799627|80988645|FG001|Overall Study|Investigational Product Noncompliance|0|||
27770779|NCT03799627|80988646|FG002|Overall Study|Investigational Product Noncompliance|0|||
27770780|NCT03799627|80988647|FG003|Overall Study|Investigational Product Noncompliance|1|||
27770781|NCT03799627|80988648|FG004|Overall Study|Investigational Product Noncompliance|0|||
27770782|NCT03799627|80988649|FG005|Overall Study|Investigational Product Noncompliance|0|||
27770783|NCT03799627|80988650|FG006|Overall Study|Investigational Product Noncompliance|0|||
27770784|NCT03799627|80988651|FG007|Overall Study|Investigational Product Noncompliance|0|||
27770785|NCT03799627|80988652|FG008|Overall Study|Investigational Product Noncompliance|0|||
27770786|NCT03799627|80988644|FG000|Overall Study|Participant Relocation|0|||
27770787|NCT03799627|80988645|FG001|Overall Study|Participant Relocation|0|||
27770788|NCT03799627|80988646|FG002|Overall Study|Participant Relocation|0|||
27770789|NCT03799627|80988647|FG003|Overall Study|Participant Relocation|1|||
27770790|NCT03799627|80988648|FG004|Overall Study|Participant Relocation|0|||
27770791|NCT03799627|80988649|FG005|Overall Study|Participant Relocation|1|||
27770792|NCT03799627|80988650|FG006|Overall Study|Participant Relocation|0|||
27770793|NCT03799627|80988651|FG007|Overall Study|Participant Relocation|0|||
27770794|NCT03799627|80988652|FG008|Overall Study|Participant Relocation|0|||
27770795|NCT03799627|80988644|FG000|Overall Study|Eurofin Issue|0|||
27770796|NCT03799627|80988645|FG001|Overall Study|Eurofin Issue|0|||
27770797|NCT03799627|80988646|FG002|Overall Study|Eurofin Issue|0|||
27770798|NCT03799627|80988647|FG003|Overall Study|Eurofin Issue|0|||
27770799|NCT03799627|80988648|FG004|Overall Study|Eurofin Issue|1|||
27770800|NCT03799627|80988649|FG005|Overall Study|Eurofin Issue|0|||
27770801|NCT03799627|80988650|FG006|Overall Study|Eurofin Issue|0|||
27770802|NCT03799627|80988651|FG007|Overall Study|Eurofin Issue|0|||
27770803|NCT03799627|80988652|FG008|Overall Study|Eurofin Issue|0|||
27770804|NCT03799627|80988644|FG000|Overall Study|Noncompliance with Site Instructions|0|||
27770805|NCT03799627|80988645|FG001|Overall Study|Noncompliance with Site Instructions|0|||
27770806|NCT03799627|80988646|FG002|Overall Study|Noncompliance with Site Instructions|0|||
27770807|NCT03799627|80988647|FG003|Overall Study|Noncompliance with Site Instructions|0|||
27770808|NCT03799627|80988648|FG004|Overall Study|Noncompliance with Site Instructions|1|||
27770809|NCT03799627|80988649|FG005|Overall Study|Noncompliance with Site Instructions|0|||
27770810|NCT03799627|80988650|FG006|Overall Study|Noncompliance with Site Instructions|0|||
27770811|NCT03799627|80988651|FG007|Overall Study|Noncompliance with Site Instructions|0|||
27770812|NCT03799627|80988652|FG008|Overall Study|Noncompliance with Site Instructions|0|||
27770813|NCT03799627|80988644|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27770814|NCT03799627|80988645|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27964446|NCT01061723|81699201|FG004|Overall Study|Adverse Event|2|||
27964447|NCT01061723|81699202|FG005|Overall Study|Adverse Event|6|||
27770815|NCT03799627|80988646|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27770816|NCT03799627|80988647|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27770817|NCT03799627|80988648|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
27770818|NCT03799627|80988649|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27964448|NCT01061723|81699197|FG000|Overall Study|Lack of Efficacy|2|||
27964449|NCT01061723|81699198|FG001|Overall Study|Lack of Efficacy|3|||
27770819|NCT03799627|80988650|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27770820|NCT03799627|80988651|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27770821|NCT03799627|80988652|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
27770822|NCT03799627|80988644|FG000|Overall Study|Changes In Hemoglobin Values|1|||
27770823|NCT03799627|80988645|FG001|Overall Study|Changes In Hemoglobin Values|2|||
27770824|NCT03799627|80988646|FG002|Overall Study|Changes In Hemoglobin Values|1|||
27770825|NCT03799627|80988647|FG003|Overall Study|Changes In Hemoglobin Values|0|||
27770826|NCT03799627|80988648|FG004|Overall Study|Changes In Hemoglobin Values|0|||
27770827|NCT03799627|80988649|FG005|Overall Study|Changes In Hemoglobin Values|2|||
27770828|NCT03799627|80988650|FG006|Overall Study|Changes In Hemoglobin Values|1|||
27770829|NCT03799627|80988651|FG007|Overall Study|Changes In Hemoglobin Values|0|||
27770830|NCT03799627|80988652|FG008|Overall Study|Changes In Hemoglobin Values|1|||
27770831|NCT02470429|80988653|FG000|Overall Study|Adverse Event|1|||
27770832|NCT02470429|80988654|FG001|Overall Study|Adverse Event|0|||
27770833|NCT02470429|80988653|FG000|Overall Study|Withdrawal by Subject|1|||
27770834|NCT02470429|80988654|FG001|Overall Study|Withdrawal by Subject|0|||
27770835|NCT02215616|80988655|FG000|Overall Study|Sponsor requested to stop study drug|0|||
27770836|NCT02215616|80988656|FG001|Overall Study|Sponsor requested to stop study drug|0|||
27770837|NCT02215616|80988657|FG002|Overall Study|Sponsor requested to stop study drug|1|||
27770838|NCT02215616|80988658|FG003|Overall Study|Sponsor requested to stop study drug|4|||
27770839|NCT02215616|80988655|FG000|Overall Study|Death|1|||
27770840|NCT02215616|80988656|FG001|Overall Study|Death|0|||
27770841|NCT02215616|80988657|FG002|Overall Study|Death|0|||
27770842|NCT02215616|80988658|FG003|Overall Study|Death|0|||
27770843|NCT02215616|80988655|FG000|Overall Study|Adverse Event|7|||
27770844|NCT02215616|80988656|FG001|Overall Study|Adverse Event|4|||
27770845|NCT02215616|80988657|FG002|Overall Study|Adverse Event|9|||
27770846|NCT02215616|80988658|FG003|Overall Study|Adverse Event|2|||
27770847|NCT02215616|80988655|FG000|Overall Study|Withdrawal by Subject|1|||
27770848|NCT02215616|80988656|FG001|Overall Study|Withdrawal by Subject|8|||
27770849|NCT02215616|80988657|FG002|Overall Study|Withdrawal by Subject|2|||
27770850|NCT02215616|80988658|FG003|Overall Study|Withdrawal by Subject|5|||
27770851|NCT02215616|80988655|FG000|Overall Study|Non-compliance|0|||
27770852|NCT02215616|80988656|FG001|Overall Study|Non-compliance|2|||
27770853|NCT02215616|80988657|FG002|Overall Study|Non-compliance|1|||
27770854|NCT02215616|80988658|FG003|Overall Study|Non-compliance|0|||
27770855|NCT02215616|80988655|FG000|Overall Study|Protocol Violation|0|||
27770856|NCT02215616|80988656|FG001|Overall Study|Protocol Violation|2|||
27770857|NCT02215616|80988657|FG002|Overall Study|Protocol Violation|0|||
27770858|NCT02215616|80988658|FG003|Overall Study|Protocol Violation|0|||
27964450|NCT01061723|81699199|FG002|Overall Study|Lack of Efficacy|4|||
27964451|NCT01061723|81699200|FG003|Overall Study|Lack of Efficacy|2|||
27964452|NCT01061723|81699201|FG004|Overall Study|Lack of Efficacy|1|||
27964453|NCT01061723|81699202|FG005|Overall Study|Lack of Efficacy|1|||
27964454|NCT01061723|81699197|FG000|Overall Study|Randomized but not treated|0|||
27964455|NCT01061723|81699198|FG001|Overall Study|Randomized but not treated|0|||
27964456|NCT01061723|81699199|FG002|Overall Study|Randomized but not treated|0|||
27964457|NCT01061723|81699200|FG003|Overall Study|Randomized but not treated|0|||
27964458|NCT01061723|81699201|FG004|Overall Study|Randomized but not treated|0|||
27964459|NCT01061723|81699202|FG005|Overall Study|Randomized but not treated|1|||
27964460|NCT01061723|81699197|FG000|Overall Study|Other than specified above|2|||
27964461|NCT01061723|81699198|FG001|Overall Study|Other than specified above|1|||
27964462|NCT01061723|81699199|FG002|Overall Study|Other than specified above|1|||
27964463|NCT01061723|81699200|FG003|Overall Study|Other than specified above|1|||
27964464|NCT01061723|81699201|FG004|Overall Study|Other than specified above|0|||
27964465|NCT01061723|81699202|FG005|Overall Study|Other than specified above|1|||
27964466|NCT03470194|81699203|FG000|Overall Study|Lost to Follow-up|11|||
27964467|NCT03470194|81699204|FG001|Overall Study|Lost to Follow-up|17|||
27964468|NCT01496287|81699205|FG000|Overall Study|Lost to Follow-up|1|||
27964469|NCT01496287|81699205|FG000|Overall Study|Incomplete anesthesia|5|||
27964470|NCT01901289|81699206|FG000|Overall Study|Death|32|||
27964471|NCT01901289|81699206|FG000|Overall Study|Lost to Follow-up|16|||
27964472|NCT01901289|81699206|FG000|Overall Study|Withdrawal by Subject|35|||
27964473|NCT01901289|81699206|FG000|Overall Study|Other type of endpoint met|2|||
27964474|NCT00294671|81699208|FG000|Overall Study|Lack of Efficacy|11|||
27770859|NCT02215616|80988655|FG000|Overall Study|Lost to Follow-up|1|||
27770860|NCT02215616|80988656|FG001|Overall Study|Lost to Follow-up|1|||
27770861|NCT02215616|80988657|FG002|Overall Study|Lost to Follow-up|0|||
27770862|NCT02215616|80988658|FG003|Overall Study|Lost to Follow-up|1|||
27770863|NCT02215616|80988655|FG000|Overall Study|Other than specified|1|||
27770864|NCT02215616|80988656|FG001|Overall Study|Other than specified|0|||
27770865|NCT02215616|80988657|FG002|Overall Study|Other than specified|1|||
27770866|NCT02215616|80988658|FG003|Overall Study|Other than specified|1|||
27964475|NCT00294671|81699209|FG001|Overall Study|Lack of Efficacy|23|||
27964476|NCT00294671|81699208|FG000|Overall Study|Liver transplant|7|||
27964477|NCT00294671|81699209|FG001|Overall Study|Liver transplant|9|||
27964478|NCT00294671|81699208|FG000|Overall Study|Drug related adverse event (AE)|4|||
27964479|NCT00294671|81699209|FG001|Overall Study|Drug related adverse event (AE)|2|||
27964480|NCT00294671|81699208|FG000|Overall Study|Non-drug related AE|3|||
27964481|NCT00294671|81699209|FG001|Overall Study|Non-drug related AE|2|||
27770867|NCT04083794|80988659|FG000|Overall Study|Lost to Follow-up|9|||
27770868|NCT01750840|80988661|FG000|Overall Study|Lost to Follow-up|4|||
27770869|NCT02959190|80988662|FG000|Open Label|Adverse Event|5|||
27770870|NCT02959190|80988663|FG001|Open Label|Adverse Event|7|||
27964482|NCT00294671|81699208|FG000|Overall Study|Lost to Follow-up|1|||
27964483|NCT00294671|81699209|FG001|Overall Study|Lost to Follow-up|3|||
27964484|NCT00294671|81699208|FG000|Overall Study|Non-compliance|1|||
27964485|NCT00294671|81699209|FG001|Overall Study|Non-compliance|0|||
27964486|NCT00294671|81699208|FG000|Overall Study|Death|0|||
27964487|NCT00294671|81699209|FG001|Overall Study|Death|1|||
27964488|NCT00851552|81699210|FG000|Overall Study|Death|2|||
27964489|NCT00851552|81699210|FG000|Overall Study|Adverse Event|1|||
27964490|NCT00851552|81699210|FG000|Overall Study|Disease Progression|4|||
27964491|NCT03198767|81701538|FG000|Overall Study|Protocol Violation|0|||
27964492|NCT03198767|81701539|FG001|Overall Study|Protocol Violation|0|||
27964493|NCT03198767|81701540|FG002|Overall Study|Protocol Violation|0|||
27964494|NCT03198767|81701541|FG003|Overall Study|Protocol Violation|6|||
27964495|NCT03198767|81701542|FG004|Overall Study|Protocol Violation|0|||
27964496|NCT03198767|81701543|FG005|Overall Study|Protocol Violation|0|||
27964497|NCT03198767|81701544|FG006|Overall Study|Protocol Violation|0|||
27964498|NCT02027311|81701552|FG000|Overall Study|Protocol Violation|3|||
27964499|NCT02027311|81701553|FG001|Overall Study|Protocol Violation|2|||
27964500|NCT00613327|81701554|FG000|Overall Study|Adverse Event|38|||
27964501|NCT00613327|81701554|FG000|Overall Study|Lost to Follow-up|8|||
27964502|NCT00613327|81701554|FG000|Overall Study|Withdrawal by Subject|6|||
27569017|NCT02658890|80271472|FG002|Treatment Phase|Other Reasons|0|||
27770871|NCT02959190|80988664|FG002|Open Label|Adverse Event|3|||
27770872|NCT02959190|80988665|FG003|Open Label|Adverse Event|4|||
27964503|NCT00613327|81701554|FG000|Overall Study|Protocol Violation|2|||
27770873|NCT02959190|80988662|FG000|Open Label|Pregnancy|0|||
27770874|NCT02959190|80988663|FG001|Open Label|Pregnancy|1|||
27770875|NCT02959190|80988664|FG002|Open Label|Pregnancy|0|||
27770876|NCT02959190|80988665|FG003|Open Label|Pregnancy|0|||
27770877|NCT02959190|80988662|FG000|Open Label|Withdrawal by Subject|2|||
27770878|NCT02959190|80988663|FG001|Open Label|Withdrawal by Subject|8|||
27770879|NCT02959190|80988664|FG002|Open Label|Withdrawal by Subject|0|||
27770880|NCT02959190|80988665|FG003|Open Label|Withdrawal by Subject|0|||
27770881|NCT02959190|80988662|FG000|Open Label|Physician Decision|0|||
27770882|NCT02959190|80988663|FG001|Open Label|Physician Decision|0|||
27770883|NCT02959190|80988664|FG002|Open Label|Physician Decision|1|||
27770884|NCT02959190|80988665|FG003|Open Label|Physician Decision|0|||
27770885|NCT02959190|80988662|FG000|Open Label|Protocol Violation|0|||
27770886|NCT02959190|80988663|FG001|Open Label|Protocol Violation|0|||
27770887|NCT02959190|80988664|FG002|Open Label|Protocol Violation|0|||
27770888|NCT02959190|80988665|FG003|Open Label|Protocol Violation|2|||
27770889|NCT02959190|80988662|FG000|Post Treatment Follow Up|Adverse Event|1|||
27770890|NCT02959190|80988663|FG001|Post Treatment Follow Up|Adverse Event|1|||
27770891|NCT02959190|80988664|FG002|Post Treatment Follow Up|Adverse Event|0|||
27770892|NCT02959190|80988665|FG003|Post Treatment Follow Up|Adverse Event|0|||
27770893|NCT02959190|80988662|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
27770894|NCT02959190|80988663|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
27770895|NCT02959190|80988664|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
27770896|NCT02959190|80988665|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
27770897|NCT04599972|80988666|FG000|Overall Study|Withdrawal by Subject|6|||
27770898|NCT04599972|80988667|FG001|Overall Study|Withdrawal by Subject|1|||
27770899|NCT04599972|80988666|FG000|Overall Study|Adverse Event|1|||
27770900|NCT04599972|80988667|FG001|Overall Study|Adverse Event|1|||
27770901|NCT04599972|80988666|FG000|Overall Study|Lost to Follow-up|1|||
27770902|NCT04599972|80988667|FG001|Overall Study|Lost to Follow-up|6|||
27770903|NCT04599972|80988666|FG000|Overall Study|Protocol Violation|1|||
27770904|NCT04599972|80988667|FG001|Overall Study|Protocol Violation|0|||
27770905|NCT04599972|80988666|FG000|Overall Study|Other reason|1|||
27964504|NCT00613327|81701554|FG000|Overall Study|Other|47|||
27770906|NCT04599972|80988667|FG001|Overall Study|Other reason|0|||
27964505|NCT02323126|81701559|FG000|Overall Study|Patient / guardian decision|0|||
27964506|NCT02323126|81701560|FG001|Overall Study|Patient / guardian decision|1|||
27964507|NCT02323126|81701561|FG002|Overall Study|Patient / guardian decision|2|||
27964508|NCT02323126|81701559|FG000|Overall Study|Progressive disease|14|||
27964509|NCT02323126|81701560|FG001|Overall Study|Progressive disease|8|||
27964510|NCT02323126|81701561|FG002|Overall Study|Progressive disease|14|||
27770907|NCT01673490|80988673|FG000|Overall Study|Lost to Follow-up|1|||
27770908|NCT01673490|80988673|FG000|Overall Study|Adverse Event|3|||
27770909|NCT01673490|80988673|FG000|Overall Study|Withdrawal by Subject|3|||
27770910|NCT01685203|80988679|FG000|Overall Study|Lost to Follow-up|3|||
27964511|NCT02323126|81701559|FG000|Overall Study|Physician Decision|0|||
27770911|NCT01685203|80988680|FG001|Overall Study|Lost to Follow-up|3|||
27770912|NCT01685203|80988681|FG002|Overall Study|Lost to Follow-up|0|||
27770913|NCT01685203|80988682|FG003|Overall Study|Lost to Follow-up|1|||
27964512|NCT02323126|81701560|FG001|Overall Study|Physician Decision|1|||
27964513|NCT02323126|81701561|FG002|Overall Study|Physician Decision|3|||
27964514|NCT02323126|81701559|FG000|Overall Study|Death|1|||
27964515|NCT02323126|81701560|FG001|Overall Study|Death|1|||
27964516|NCT02323126|81701561|FG002|Overall Study|Death|4|||
27964517|NCT02323126|81701559|FG000|Overall Study|Adverse Event|3|||
27964518|NCT02323126|81701560|FG001|Overall Study|Adverse Event|5|||
27964519|NCT02323126|81701561|FG002|Overall Study|Adverse Event|7|||
27964520|NCT01709110|81701563|FG000|Overall Study|Adverse Event|56|||
27964521|NCT01709110|81701564|FG001|Overall Study|Adverse Event|48|||
27964522|NCT01709110|81701563|FG000|Overall Study|Death|14|||
27964523|NCT01709110|81701564|FG001|Overall Study|Death|6|||
27964524|NCT01709110|81701563|FG000|Overall Study|Lost to Follow-up|7|||
27964525|NCT01709110|81701564|FG001|Overall Study|Lost to Follow-up|5|||
27964526|NCT01709110|81701563|FG000|Overall Study|Protocol Violation|4|||
27964527|NCT01709110|81701564|FG001|Overall Study|Protocol Violation|6|||
27964528|NCT01709110|81701563|FG000|Overall Study|Withdrawal by Subject|96|||
27964529|NCT01709110|81701564|FG001|Overall Study|Withdrawal by Subject|89|||
27964530|NCT01709110|81701563|FG000|Overall Study|Physician Decision|4|||
27964531|NCT01709110|81701564|FG001|Overall Study|Physician Decision|10|||
27964532|NCT01709110|81701563|FG000|Overall Study|Sponsor Decision|2|||
27964533|NCT01709110|81701564|FG001|Overall Study|Sponsor Decision|2|||
27964534|NCT01709110|81701563|FG000|Overall Study|Lack of Efficacy|1|||
27770914|NCT01685203|80988683|FG004|Overall Study|Lost to Follow-up|0|||
27770915|NCT01685203|80988684|FG005|Overall Study|Lost to Follow-up|0|||
27569018|NCT02658890|80271473|FG003|Treatment Phase|Other Reasons|0|||
27569019|NCT02658890|80271474|FG004|Treatment Phase|Other Reasons|0|||
27569020|NCT02658890|80271475|FG005|Treatment Phase|Other Reasons|0|||
27770916|NCT01685203|80988685|FG006|Overall Study|Lost to Follow-up|0|||
27770917|NCT01685203|80988679|FG000|Overall Study|Adverse Event|0|||
27770918|NCT01685203|80988680|FG001|Overall Study|Adverse Event|0|||
27770919|NCT01685203|80988681|FG002|Overall Study|Adverse Event|0|||
27770920|NCT01685203|80988682|FG003|Overall Study|Adverse Event|0|||
27770921|NCT01685203|80988683|FG004|Overall Study|Adverse Event|0|||
27770922|NCT01685203|80988684|FG005|Overall Study|Adverse Event|2|||
27770923|NCT01685203|80988685|FG006|Overall Study|Adverse Event|0|||
27770924|NCT01685203|80988679|FG000|Overall Study|Adverse event and withdrew consent|1|||
27770925|NCT01685203|80988680|FG001|Overall Study|Adverse event and withdrew consent|0|||
27770926|NCT01685203|80988681|FG002|Overall Study|Adverse event and withdrew consent|0|||
27770927|NCT01685203|80988682|FG003|Overall Study|Adverse event and withdrew consent|0|||
27770928|NCT01685203|80988683|FG004|Overall Study|Adverse event and withdrew consent|0|||
27770929|NCT01685203|80988684|FG005|Overall Study|Adverse event and withdrew consent|0|||
27770930|NCT01685203|80988685|FG006|Overall Study|Adverse event and withdrew consent|0|||
27770931|NCT01685203|80988679|FG000|Overall Study|Patient's decision|0|||
27770932|NCT01685203|80988680|FG001|Overall Study|Patient's decision|0|||
27770933|NCT01685203|80988681|FG002|Overall Study|Patient's decision|0|||
27770934|NCT01685203|80988682|FG003|Overall Study|Patient's decision|0|||
27770935|NCT01685203|80988683|FG004|Overall Study|Patient's decision|0|||
27770936|NCT01685203|80988684|FG005|Overall Study|Patient's decision|1|||
27770937|NCT01685203|80988685|FG006|Overall Study|Patient's decision|0|||
27770938|NCT00688623|80988686|FG000|Overall Study|Adverse Event|22|||
27770939|NCT00688623|80988686|FG000|Overall Study|abnormal lab value|1|||
27770940|NCT00688623|80988686|FG000|Overall Study|Withdrawal by Subject|4|||
27770941|NCT00688623|80988686|FG000|Overall Study|Death|3|||
27770942|NCT00688623|80988686|FG000|Overall Study|disease progression|23|||
27770943|NCT00688623|80988686|FG000|Overall Study|Protocol Violation|2|||
27770944|NCT00981682|80988687|FG000|Overall Study|Adverse Event|48|||
27770945|NCT00981682|80988687|FG000|Overall Study|Withdrawal by Subject|52|||
27770946|NCT00981682|80988687|FG000|Overall Study|Lost to Follow-up|14|||
27770947|NCT00981682|80988687|FG000|Overall Study|Lack of Efficacy|13|||
27770948|NCT00981682|80988687|FG000|Overall Study|Protocol Violation|6|||
27964535|NCT01709110|81701564|FG001|Overall Study|Lack of Efficacy|1|||
27964536|NCT01709110|81701563|FG000|Overall Study|Caregiver Decision|1|||
27964537|NCT01709110|81701564|FG001|Overall Study|Caregiver Decision|1|||
27770949|NCT00981682|80988687|FG000|Overall Study|administrative|9|||
27770950|NCT01553591|80988688|FG000|Overall Study|Voluntarily withdrew|94|||
27770951|NCT01553591|80988689|FG001|Overall Study|Voluntarily withdrew|79|||
27770952|NCT01553591|80988690|FG002|Overall Study|Voluntarily withdrew|96|||
27770953|NCT01553591|80988688|FG000|Overall Study|Adverse Event|36|||
27964538|NCT02120781|81701565|FG000|Overall Study|Physician Decision|2|||
27569021|NCT02658890|80271476|FG006|Treatment Phase|Other Reasons|1|||
27770954|NCT01553591|80988689|FG001|Overall Study|Adverse Event|45|||
27770955|NCT01553591|80988690|FG002|Overall Study|Adverse Event|16|||
27770956|NCT01553591|80988688|FG000|Overall Study|Lost to Follow-up|25|||
27964539|NCT02120781|81701566|FG001|Overall Study|Physician Decision|0|||
27770957|NCT01553591|80988689|FG001|Overall Study|Lost to Follow-up|23|||
27964540|NCT02120781|81701565|FG000|Overall Study|Completion not documented|2|||
27770958|NCT01553591|80988690|FG002|Overall Study|Lost to Follow-up|16|||
27770959|NCT01553591|80988688|FG000|Overall Study|Physician decision: other|11|||
27770960|NCT01553591|80988689|FG001|Overall Study|Physician decision: other|14|||
27770961|NCT01553591|80988690|FG002|Overall Study|Physician decision: other|16|||
27770962|NCT01553591|80988688|FG000|Overall Study|Physician decision: lack of efficacy|2|||
27770963|NCT01553591|80988689|FG001|Overall Study|Physician decision: lack of efficacy|3|||
27770964|NCT01553591|80988690|FG002|Overall Study|Physician decision: lack of efficacy|7|||
27770965|NCT01553591|80988688|FG000|Overall Study|Protocol Violation|3|||
27770966|NCT01553591|80988689|FG001|Overall Study|Protocol Violation|4|||
27770967|NCT01553591|80988690|FG002|Overall Study|Protocol Violation|4|||
27770968|NCT01553591|80988688|FG000|Overall Study|Sponsor decision|1|||
27770969|NCT01553591|80988689|FG001|Overall Study|Sponsor decision|0|||
27770970|NCT01553591|80988690|FG002|Overall Study|Sponsor decision|3|||
27770971|NCT01553591|80988688|FG000|Overall Study|Randomized and never dispensed drug|0|||
27770972|NCT01553591|80988689|FG001|Overall Study|Randomized and never dispensed drug|1|||
27770973|NCT01553591|80988690|FG002|Overall Study|Randomized and never dispensed drug|0|||
27770974|NCT00367341|80988692|FG000|Overall Study|Physician Decision|1|||
27770975|NCT00367341|80988693|FG001|Overall Study|Physician Decision|0|||
27770976|NCT00367341|80988692|FG000|Overall Study|Protocol Violation|1|||
27770977|NCT00367341|80988693|FG001|Overall Study|Protocol Violation|0|||
27770978|NCT00432562|80992799|FG000|Overall Study|Death|3|||
27770979|NCT00432562|80992800|FG001|Overall Study|Death|0|||
27770980|NCT02177812|80992801|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27770981|NCT02177812|80992802|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27770982|NCT02177812|80992803|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27770983|NCT02177812|80992804|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27770984|NCT02177812|80992805|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27770985|NCT02177812|80992806|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
27770986|NCT02177812|80992807|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
27770987|NCT02177812|80992808|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
27770988|NCT02177812|80992809|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
27770989|NCT02177812|80992801|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770990|NCT02177812|80992802|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770991|NCT02177812|80992803|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770992|NCT02177812|80992804|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770993|NCT02177812|80992805|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770994|NCT02177812|80992806|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
27770995|NCT02177812|80992807|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
27770996|NCT02177812|80992808|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770997|NCT02177812|80992809|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
27770998|NCT02177812|80992801|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27770999|NCT02177812|80992802|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27771000|NCT02177812|80992803|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27771001|NCT02177812|80992804|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27771002|NCT02177812|80992805|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27771003|NCT02177812|80992806|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27771004|NCT02177812|80992807|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
27771005|NCT02177812|80992808|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
27771006|NCT02177812|80992809|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
27771007|NCT00285649|80992812|FG000|Overall Study|Lost to Follow-up|6|||
27771008|NCT00285649|80992813|FG001|Overall Study|Lost to Follow-up|4|||
27771009|NCT00285649|80992814|FG002|Overall Study|Lost to Follow-up|4|||
27771010|NCT00285649|80992812|FG000|Overall Study|Withdrawal by Subject|3|||
27771011|NCT00285649|80992813|FG001|Overall Study|Withdrawal by Subject|2|||
27771012|NCT00285649|80992814|FG002|Overall Study|Withdrawal by Subject|2|||
27771013|NCT01057862|80992815|FG000|Overall Study|Withdrawal by Subject|1|||
27771014|NCT01057862|80992816|FG001|Overall Study|Withdrawal by Subject|2|||
27771015|NCT00398138|80992817|FG000|Overall Study|Adverse Event|2|||
27771016|NCT00615459|80992818|FG000|Period I|Adverse Event|2|||
27771017|NCT00615459|80992819|FG001|Period I|Adverse Event|0|||
27771018|NCT00615459|80992820|FG002|Period I|Adverse Event|1|||
27771019|NCT00615459|80992821|FG003|Period I|Adverse Event|0|||
27771020|NCT00615459|80992818|FG000|Period I|Subject withdrew consent|1|||
27771021|NCT00615459|80992819|FG001|Period I|Subject withdrew consent|0|||
27771022|NCT00615459|80992820|FG002|Period I|Subject withdrew consent|0|||
27771023|NCT00615459|80992821|FG003|Period I|Subject withdrew consent|1|||
27771024|NCT00615459|80992818|FG000|Period I|Abnormal test procedure results|1|||
27771025|NCT00615459|80992819|FG001|Period I|Abnormal test procedure results|1|||
27771026|NCT00615459|80992820|FG002|Period I|Abnormal test procedure results|1|||
27771027|NCT00615459|80992821|FG003|Period I|Abnormal test procedure results|0|||
27771028|NCT00615459|80992818|FG000|Period II|Adverse Event|1|||
27771029|NCT00615459|80992819|FG001|Period II|Adverse Event|0|||
27771030|NCT00615459|80992820|FG002|Period II|Adverse Event|0|||
27771031|NCT00615459|80992821|FG003|Period II|Adverse Event|0|||
27771032|NCT00615459|80992818|FG000|Period II|Lost to Follow-up|0|||
27964541|NCT02120781|81701566|FG001|Overall Study|Completion not documented|1|||
27771033|NCT00615459|80992819|FG001|Period II|Lost to Follow-up|0|||
27771034|NCT00615459|80992820|FG002|Period II|Lost to Follow-up|0|||
27771035|NCT00615459|80992821|FG003|Period II|Lost to Follow-up|1|||
27771036|NCT00615459|80992818|FG000|Period III|Adverse Event|0|||
27771037|NCT00615459|80992819|FG001|Period III|Adverse Event|1|||
27771038|NCT00615459|80992820|FG002|Period III|Adverse Event|0|||
27771039|NCT00615459|80992821|FG003|Period III|Adverse Event|0|||
27771040|NCT00615459|80992818|FG000|Period III|Administrative problems|0|||
27771041|NCT00615459|80992819|FG001|Period III|Administrative problems|1|||
27771042|NCT00615459|80992820|FG002|Period III|Administrative problems|1|||
27771043|NCT00615459|80992821|FG003|Period III|Administrative problems|0|||
27771044|NCT00615459|80992818|FG000|Period III|Unsatisfactory therapeutic effect|0|||
27771045|NCT00615459|80992819|FG001|Period III|Unsatisfactory therapeutic effect|1|||
27771046|NCT00615459|80992820|FG002|Period III|Unsatisfactory therapeutic effect|0|||
27771047|NCT00615459|80992821|FG003|Period III|Unsatisfactory therapeutic effect|0|||
27771048|NCT03383614|80992828|FG000|Overall Study|Withdrawal by Subject|0|||
27771049|NCT03383614|80992829|FG001|Overall Study|Withdrawal by Subject|1|||
27771050|NCT03383614|80992830|FG002|Overall Study|Withdrawal by Subject|0|||
27771051|NCT03383614|80992831|FG003|Overall Study|Withdrawal by Subject|0|||
27771052|NCT00688545|80992832|FG000|Overall Study|Lost to Follow-up|1|||
27771053|NCT00688545|80992833|FG001|Overall Study|Lost to Follow-up|4|||
27771054|NCT00688545|80992832|FG000|Overall Study|Insurance/cost of drug|0|||
27771055|NCT00688545|80992833|FG001|Overall Study|Insurance/cost of drug|1|||
27771056|NCT00688545|80992832|FG000|Overall Study|Withdrawal by Subject|2|||
27771057|NCT00688545|80992833|FG001|Overall Study|Withdrawal by Subject|3|||
27771058|NCT00688545|80992832|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
27771059|NCT00688545|80992833|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
27771060|NCT05166603|80992834|FG000|Overall Study|Withdrawal by Subject|68|||
27771061|NCT05166603|80992835|FG001|Overall Study|Withdrawal by Subject|0|||
27771062|NCT02580591|80992836|FG000|Overall Study|Adverse Event|0|||
27771063|NCT02580591|80992837|FG001|Overall Study|Adverse Event|1|||
27771064|NCT02580591|80992838|FG002|Overall Study|Adverse Event|2|||
27771065|NCT02580591|80992839|FG003|Overall Study|Adverse Event|5|||
27771066|NCT02580591|80992836|FG000|Overall Study|Protocol Violation|3|||
27771067|NCT02580591|80992837|FG001|Overall Study|Protocol Violation|2|||
27771068|NCT02580591|80992838|FG002|Overall Study|Protocol Violation|1|||
27771069|NCT02580591|80992839|FG003|Overall Study|Protocol Violation|1|||
27771070|NCT02580591|80992836|FG000|Overall Study|Lost to Follow-up|5|||
27771071|NCT02580591|80992837|FG001|Overall Study|Lost to Follow-up|3|||
27771072|NCT02580591|80992838|FG002|Overall Study|Lost to Follow-up|3|||
27771073|NCT02580591|80992839|FG003|Overall Study|Lost to Follow-up|1|||
27771074|NCT02580591|80992836|FG000|Overall Study|Withdrawal by Subject|6|||
27771075|NCT02580591|80992837|FG001|Overall Study|Withdrawal by Subject|1|||
27771076|NCT02580591|80992838|FG002|Overall Study|Withdrawal by Subject|2|||
27771077|NCT02580591|80992839|FG003|Overall Study|Withdrawal by Subject|3|||
27771078|NCT02580591|80992836|FG000|Overall Study|Not treated|1|||
27771079|NCT02580591|80992837|FG001|Overall Study|Not treated|1|||
27771080|NCT02580591|80992838|FG002|Overall Study|Not treated|0|||
27771081|NCT02580591|80992839|FG003|Overall Study|Not treated|0|||
27771082|NCT02580591|80992836|FG000|Overall Study|Other than specified|3|||
27771083|NCT02580591|80992837|FG001|Overall Study|Other than specified|2|||
27771084|NCT02580591|80992838|FG002|Overall Study|Other than specified|5|||
27771085|NCT02580591|80992839|FG003|Overall Study|Other than specified|2|||
27771086|NCT00552344|80992842|FG000|Overall Study|Lack of Efficacy|55|||
27771087|NCT00552344|80992842|FG000|Overall Study|Loss of efficacy|75|||
27771088|NCT00552344|80992842|FG000|Overall Study|Lost to Follow-up|8|||
27771089|NCT00552344|80992842|FG000|Overall Study|Withdrawal by Subject|48|||
27771090|NCT00552344|80992842|FG000|Overall Study|SAE, non-fatal|6|||
27771091|NCT00552344|80992842|FG000|Overall Study|AE, non-serious non-fatal|38|||
27771092|NCT00552344|80992842|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
27771093|NCT00552344|80992842|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
27771094|NCT00552344|80992842|FG000|Overall Study|Other Reason|22|||
27771095|NCT04362189|80992845|FG000|Overall Study|Lost to Follow-up|0|||
27771096|NCT04362189|80992846|FG001|Overall Study|Lost to Follow-up|1|||
27771097|NCT04362189|80992845|FG000|Overall Study|Withdrawal by Subject|1|||
27771098|NCT04362189|80992846|FG001|Overall Study|Withdrawal by Subject|0|||
27771099|NCT04362189|80992845|FG000|Overall Study|FDA Clinical Hold|7|||
27771100|NCT04362189|80992846|FG001|Overall Study|FDA Clinical Hold|2|||
27771101|NCT04362189|80992845|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
27771102|NCT04362189|80992846|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
27569022|NCT02658890|80271477|FG007|Treatment Phase|Other Reasons|0|||
27771103|NCT04362189|80992845|FG000|Overall Study|Adverse Event|0|||
27771104|NCT04362189|80992846|FG001|Overall Study|Adverse Event|2|||
27771105|NCT04362189|80992845|FG000|Overall Study|Death|4|||
27771106|NCT04362189|80992846|FG001|Overall Study|Death|1|||
27771107|NCT00560794|80992849|FG000|Overall Study|Adverse Event|2|||
27771108|NCT00560794|80992849|FG000|Overall Study|Patient was not Compliant|1|||
27771109|NCT00560794|80992849|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
27771110|NCT00560794|80992849|FG000|Overall Study|Hematological Relapse|1|||
27771111|NCT00560794|80992849|FG000|Overall Study|Received Bone Marrow Transplant|6|||
27771112|NCT02688153|80992850|FG000|Overall Study|Death|7|||
27771113|NCT02688153|80992851|FG001|Overall Study|Death|5|||
27771114|NCT02688153|80992850|FG000|Overall Study|Withdrawal by Subject|4|||
27771115|NCT02688153|80992851|FG001|Overall Study|Withdrawal by Subject|2|||
27771116|NCT02688153|80992850|FG000|Overall Study|Valve Explant|1|||
27771117|NCT02688153|80992851|FG001|Overall Study|Valve Explant|0|||
27771118|NCT02688153|80992850|FG000|Overall Study|Conversion to Commercial Valve|3|||
27771119|NCT02688153|80992851|FG001|Overall Study|Conversion to Commercial Valve|0|||
27771120|NCT01843205|80992852|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
27771121|NCT01843205|80992853|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
27771122|NCT00810043|80992856|FG000|Overall Study|Withdrawal by Subject|1|||
27771123|NCT00810043|80992857|FG001|Overall Study|Withdrawal by Subject|0|||
27771124|NCT00810043|80992858|FG002|Overall Study|Withdrawal by Subject|2|||
27771125|NCT00810043|80992856|FG000|Overall Study|Lost to Follow-up|1|||
27771126|NCT00810043|80992857|FG001|Overall Study|Lost to Follow-up|0|||
27771127|NCT00810043|80992858|FG002|Overall Study|Lost to Follow-up|0|||
27771128|NCT00810043|80992856|FG000|Overall Study|Physician Decision|0|||
27771129|NCT00810043|80992857|FG001|Overall Study|Physician Decision|0|||
27771130|NCT00810043|80992858|FG002|Overall Study|Physician Decision|2|||
27771131|NCT00810043|80992856|FG000|Overall Study|Death|2|||
27771132|NCT00810043|80992857|FG001|Overall Study|Death|0|||
27771133|NCT00810043|80992858|FG002|Overall Study|Death|0|||
27771134|NCT00810043|80992856|FG000|Overall Study|Unrelated medical problem|0|||
27771135|NCT00810043|80992857|FG001|Overall Study|Unrelated medical problem|1|||
27771136|NCT00810043|80992858|FG002|Overall Study|Unrelated medical problem|0|||
27771137|NCT00810043|80992856|FG000|Overall Study|Non-medical problem|0|||
27771138|NCT00810043|80992857|FG001|Overall Study|Non-medical problem|0|||
27771139|NCT00810043|80992858|FG002|Overall Study|Non-medical problem|1|||
27771140|NCT00810043|80992856|FG000|Overall Study|No longer met enrollment criteria|0|||
27771141|NCT00810043|80992857|FG001|Overall Study|No longer met enrollment criteria|0|||
27771142|NCT00810043|80992858|FG002|Overall Study|No longer met enrollment criteria|3|||
27771143|NCT02977507|80992859|FG000|Overall Study|Protocol Deviation|1|||
27771144|NCT02977507|80992860|FG001|Overall Study|Protocol Deviation|0|||
27771145|NCT02977507|80992859|FG000|Overall Study|Lost to Follow-up|1|||
27771146|NCT02977507|80992860|FG001|Overall Study|Lost to Follow-up|0|||
27771147|NCT00324740|80992861|FG000|Overall Study|Withdrawal by Subject|1|||
27771148|NCT00324740|80992862|FG001|Overall Study|Withdrawal by Subject|0|||
27771149|NCT00324740|80992863|FG002|Overall Study|Withdrawal by Subject|1|||
27771150|NCT00928512|80992864|FG000|Overall Study|Adverse Event|4|||
27771151|NCT00928512|80992865|FG001|Overall Study|Adverse Event|3|||
27771152|NCT00928512|80992866|FG002|Overall Study|Adverse Event|2|||
27771153|NCT00928512|80992867|FG003|Overall Study|Adverse Event|8|||
27771154|NCT00928512|80992868|FG004|Overall Study|Adverse Event|6|||
27771155|NCT00928512|80992864|FG000|Overall Study|Lack of Efficacy|2|||
27771156|NCT00928512|80992865|FG001|Overall Study|Lack of Efficacy|0|||
27771157|NCT00928512|80992866|FG002|Overall Study|Lack of Efficacy|4|||
27771158|NCT00928512|80992867|FG003|Overall Study|Lack of Efficacy|7|||
27771159|NCT00928512|80992868|FG004|Overall Study|Lack of Efficacy|3|||
27771160|NCT00928512|80992864|FG000|Overall Study|Protocol Violation|0|||
27771161|NCT00928512|80992865|FG001|Overall Study|Protocol Violation|1|||
27771162|NCT00928512|80992866|FG002|Overall Study|Protocol Violation|0|||
27771163|NCT00928512|80992867|FG003|Overall Study|Protocol Violation|1|||
27771164|NCT00928512|80992868|FG004|Overall Study|Protocol Violation|3|||
27771165|NCT00928512|80992864|FG000|Overall Study|Withdrawal by Subject|3|||
27771166|NCT00928512|80992865|FG001|Overall Study|Withdrawal by Subject|0|||
27771167|NCT00928512|80992866|FG002|Overall Study|Withdrawal by Subject|3|||
27771168|NCT00928512|80992867|FG003|Overall Study|Withdrawal by Subject|4|||
27771169|NCT00928512|80992868|FG004|Overall Study|Withdrawal by Subject|0|||
27771170|NCT00928512|80992864|FG000|Overall Study|Lost to Follow-up|1|||
27771171|NCT00928512|80992865|FG001|Overall Study|Lost to Follow-up|1|||
27771172|NCT00928512|80992866|FG002|Overall Study|Lost to Follow-up|2|||
27771173|NCT00928512|80992867|FG003|Overall Study|Lost to Follow-up|1|||
27771174|NCT00928512|80992868|FG004|Overall Study|Lost to Follow-up|3|||
27771175|NCT00928512|80992864|FG000|Overall Study|Administrative Problems|0|||
27771176|NCT00928512|80992865|FG001|Overall Study|Administrative Problems|1|||
27771177|NCT00928512|80992866|FG002|Overall Study|Administrative Problems|0|||
27771178|NCT00928512|80992867|FG003|Overall Study|Administrative Problems|0|||
27771179|NCT00928512|80992868|FG004|Overall Study|Administrative Problems|0|||
27771180|NCT02658968|80992869|FG000|Received Rituximab|Adverse Event|0|||
27771181|NCT02658968|80992870|FG001|Received Rituximab|Adverse Event|0|||
27771182|NCT02658968|80992871|FG002|Received Rituximab|Adverse Event|0|||
27771183|NCT02658968|80992872|FG003|Received Rituximab|Adverse Event|0|||
27771184|NCT02658968|80992873|FG004|Received Rituximab|Adverse Event|1|||
27771185|NCT02658968|80992869|FG000|Received Rituximab|Progressive disease|0|||
27771186|NCT02658968|80992870|FG001|Received Rituximab|Progressive disease|0|||
27771187|NCT02658968|80992871|FG002|Received Rituximab|Progressive disease|0|||
27771188|NCT02658968|80992872|FG003|Received Rituximab|Progressive disease|0|||
27771189|NCT02658968|80992873|FG004|Received Rituximab|Progressive disease|1|||
27771190|NCT02658968|80992869|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
27771191|NCT02658968|80992870|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
27771192|NCT02658968|80992871|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
27771193|NCT02658968|80992872|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
27771194|NCT02658968|80992873|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
27771195|NCT02658968|80992869|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
27771196|NCT02658968|80992870|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
27771197|NCT02658968|80992871|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
27771198|NCT02658968|80992872|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
27771199|NCT02658968|80992873|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
27771200|NCT02658968|80992869|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
27771201|NCT02658968|80992870|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
27771202|NCT02658968|80992871|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
27771203|NCT02658968|80992872|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
27771204|NCT02658968|80992873|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
27771205|NCT02658968|80992869|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
27771206|NCT02658968|80992870|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
27771207|NCT02658968|80992871|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
27771208|NCT02658968|80992872|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
27771209|NCT02658968|80992873|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
27771210|NCT02658968|80992869|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
27771211|NCT02658968|80992870|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
27771212|NCT02658968|80992871|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
27771213|NCT02658968|80992872|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
27771214|NCT02658968|80992873|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
27771215|NCT01190020|80992874|FG000|Overall Study|Adverse Event|2|||
27771216|NCT01190020|80992875|FG001|Overall Study|Adverse Event|0|||
27771217|NCT01190020|80992874|FG000|Overall Study|Lost to Follow-up|2|||
27771218|NCT01190020|80992875|FG001|Overall Study|Lost to Follow-up|0|||
27771219|NCT01190020|80992874|FG000|Overall Study|Withdrawal by Subject|3|||
27771220|NCT01190020|80992875|FG001|Overall Study|Withdrawal by Subject|0|||
27771221|NCT01175590|80992876|FG000|Overall Study|Lost to Follow-up|1|||
27771222|NCT01175590|80992877|FG001|Overall Study|Lost to Follow-up|0|||
27771223|NCT01175590|80992876|FG000|Overall Study|Withdrawal by Subject|0|||
27771224|NCT01175590|80992877|FG001|Overall Study|Withdrawal by Subject|2|||
27771225|NCT01175590|80992876|FG000|Overall Study|Adverse Event|4|||
27771226|NCT01175590|80992877|FG001|Overall Study|Adverse Event|0|||
27771227|NCT01175590|80992876|FG000|Overall Study|Physician Decision|1|||
27771228|NCT01175590|80992877|FG001|Overall Study|Physician Decision|4|||
27771229|NCT01175590|80992876|FG000|Overall Study|Lack of Efficacy|1|||
27771230|NCT01175590|80992877|FG001|Overall Study|Lack of Efficacy|1|||
27771231|NCT01175590|80992876|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
27771232|NCT01175590|80992877|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
27771233|NCT01175590|80992876|FG000|Overall Study|Treated not as randomized|3|||
27771234|NCT01175590|80992877|FG001|Overall Study|Treated not as randomized|2|||
27771235|NCT01175590|80992876|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
27771236|NCT01175590|80992877|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
27771237|NCT01175590|80992876|FG000|Overall Study|Protocol Violation|0|||
27771238|NCT01175590|80992877|FG001|Overall Study|Protocol Violation|1|||
27771239|NCT02583711|80992878|FG000|Overall Study|Withdrawal by Subject|0|||
27771240|NCT02583711|80992879|FG001|Overall Study|Withdrawal by Subject|10|||
27771241|NCT02583711|80992880|FG002|Overall Study|Withdrawal by Subject|0|||
27771242|NCT00493467|80992886|FG000|Overall Study|Death|1|||
27771243|NCT01963780|80992887|FG000|Overall Study|Death|7|||
27771244|NCT01770145|80992888|FG000|Baseline|Adverse Event|20|||
27771245|NCT01770145|80992888|FG000|Baseline|Withdrawal by Subject|1|||
27771246|NCT01770145|80992888|FG000|Baseline|Lost to Follow-up|1|||
27771247|NCT01770145|80992888|FG000|Baseline|Unable to define optimal dose|4|||
27771248|NCT01770145|80992888|FG000|Treatment|Adverse Event|3|||
27771249|NCT01770145|80992888|FG000|Treatment|Withdrawal by Subject|1|||
27771250|NCT00010803|80992889|FG000|Overall Study|Withdrawal by Subject|97|||
27771251|NCT00010803|80992890|FG001|Overall Study|Withdrawal by Subject|98|||
27771252|NCT00422240|80992896|FG000|Overall Study|Lack of Efficacy|1|||
27771253|NCT00422240|80992897|FG001|Overall Study|Lack of Efficacy|2|||
27771254|NCT00422240|80992898|FG002|Overall Study|Lack of Efficacy|0|||
27771255|NCT00422240|80992899|FG003|Overall Study|Lack of Efficacy|1|||
27771256|NCT00422240|80992896|FG000|Overall Study|Adverse Event|11|||
27771257|NCT00422240|80992897|FG001|Overall Study|Adverse Event|4|||
27771258|NCT00422240|80992898|FG002|Overall Study|Adverse Event|5|||
27771259|NCT00422240|80992899|FG003|Overall Study|Adverse Event|2|||
27771260|NCT00422240|80992896|FG000|Overall Study|Subject request|21|||
27771261|NCT00422240|80992897|FG001|Overall Study|Subject request|17|||
27771262|NCT00422240|80992898|FG002|Overall Study|Subject request|18|||
27771263|NCT00422240|80992899|FG003|Overall Study|Subject request|30|||
27771264|NCT00422240|80992896|FG000|Overall Study|Protocol Violation|0|||
27771265|NCT00422240|80992897|FG001|Overall Study|Protocol Violation|1|||
27771266|NCT00422240|80992898|FG002|Overall Study|Protocol Violation|0|||
27771267|NCT00422240|80992899|FG003|Overall Study|Protocol Violation|1|||
27771268|NCT00422240|80992896|FG000|Overall Study|Lost to Follow-up|31|||
27771269|NCT00422240|80992897|FG001|Overall Study|Lost to Follow-up|32|||
27771270|NCT00422240|80992898|FG002|Overall Study|Lost to Follow-up|19|||
27771271|NCT00422240|80992899|FG003|Overall Study|Lost to Follow-up|34|||
27771272|NCT00422240|80992896|FG000|Overall Study|Other|1|||
27771273|NCT00422240|80992897|FG001|Overall Study|Other|0|||
27771274|NCT00422240|80992898|FG002|Overall Study|Other|0|||
27771275|NCT00422240|80992899|FG003|Overall Study|Other|1|||
27771276|NCT00422240|80992896|FG000|Overall Study|Pregnancy|3|||
27771277|NCT00422240|80992897|FG001|Overall Study|Pregnancy|1|||
27771278|NCT00422240|80992898|FG002|Overall Study|Pregnancy|1|||
27771279|NCT00422240|80992899|FG003|Overall Study|Pregnancy|2|||
27771280|NCT01448707|80992900|FG000|Overall Study|Adverse Event|3|||
27771281|NCT01448707|80992901|FG001|Overall Study|Adverse Event|1|||
27771282|NCT01448707|80992900|FG000|Overall Study|Lost to Follow-up|2|||
27771283|NCT01448707|80992901|FG001|Overall Study|Lost to Follow-up|6|||
27771284|NCT01448707|80992900|FG000|Overall Study|Withdrawal by Subject|6|||
27771285|NCT01448707|80992901|FG001|Overall Study|Withdrawal by Subject|7|||
27771286|NCT01448707|80992900|FG000|Overall Study|Other|7|||
27771287|NCT01448707|80992901|FG001|Overall Study|Other|4|||
27771288|NCT02475629|80992903|FG000|Overall Study|Adverse Event|1|||
27771289|NCT02475629|80992903|FG000|Overall Study|Death|4|||
27771290|NCT02475629|80992903|FG000|Overall Study|Physician Decision|1|||
27771291|NCT02475629|80992903|FG000|Overall Study|Withdrawal by Subject|1|||
27771292|NCT02475629|80992903|FG000|Overall Study|Lost to Follow-up|1|||
27771293|NCT02475629|80992903|FG000|Overall Study|Subject non-compliance|1|||
27771294|NCT01039428|80992906|FG000|Overall Study|Protocol Violation|1|||
27771295|NCT01039428|80992907|FG001|Overall Study|Protocol Violation|0|||
27771296|NCT01039428|80992906|FG000|Overall Study|Withdrawal by Subject|1|||
27771297|NCT01039428|80992907|FG001|Overall Study|Withdrawal by Subject|0|||
27771298|NCT04728815|80992914|FG000|Overall Study|Lost to Follow-up|3|||
27771299|NCT04728815|80992915|FG001|Overall Study|Lost to Follow-up|0|||
27771300|NCT04728815|80992916|FG002|Overall Study|Lost to Follow-up|0|||
27771301|NCT04728815|80992917|FG003|Overall Study|Lost to Follow-up|1|||
27771302|NCT04728815|80992918|FG004|Overall Study|Lost to Follow-up|1|||
27771303|NCT04728815|80992919|FG005|Overall Study|Lost to Follow-up|0|||
27771304|NCT04728815|80992920|FG006|Overall Study|Lost to Follow-up|2|||
27771305|NCT04728815|80992921|FG007|Overall Study|Lost to Follow-up|0|||
27771306|NCT04728815|80992914|FG000|Overall Study|Physician Decision|0|||
27771307|NCT04728815|80992915|FG001|Overall Study|Physician Decision|0|||
27771308|NCT04728815|80992916|FG002|Overall Study|Physician Decision|1|||
27771309|NCT04728815|80992917|FG003|Overall Study|Physician Decision|0|||
27771310|NCT04728815|80992918|FG004|Overall Study|Physician Decision|0|||
27771311|NCT04728815|80992919|FG005|Overall Study|Physician Decision|0|||
27771312|NCT04728815|80992920|FG006|Overall Study|Physician Decision|0|||
27771313|NCT04728815|80992921|FG007|Overall Study|Physician Decision|0|||
27771314|NCT04728815|80992914|FG000|Overall Study|Treatment drop|0|||
27771315|NCT04728815|80992915|FG001|Overall Study|Treatment drop|2|||
27771316|NCT04728815|80992916|FG002|Overall Study|Treatment drop|1|||
27771317|NCT04728815|80992917|FG003|Overall Study|Treatment drop|0|||
27964542|NCT04470050|81701567|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27964543|NCT04470050|81701568|FG001|Double-blind Treatment Phase|Adverse Event|0|||
27771318|NCT04728815|80992918|FG004|Overall Study|Treatment drop|3|||
27771319|NCT04728815|80992919|FG005|Overall Study|Treatment drop|1|||
27771320|NCT04728815|80992920|FG006|Overall Study|Treatment drop|3|||
27771321|NCT04728815|80992921|FG007|Overall Study|Treatment drop|0|||
27771322|NCT04728815|80992914|FG000|Overall Study|Study drop|0|||
27771323|NCT04728815|80992915|FG001|Overall Study|Study drop|3|||
27771324|NCT04728815|80992916|FG002|Overall Study|Study drop|3|||
27771325|NCT04728815|80992917|FG003|Overall Study|Study drop|0|||
27771326|NCT04728815|80992918|FG004|Overall Study|Study drop|0|||
27771327|NCT04728815|80992919|FG005|Overall Study|Study drop|0|||
27771328|NCT04728815|80992920|FG006|Overall Study|Study drop|7|||
27771329|NCT04728815|80992921|FG007|Overall Study|Study drop|0|||
27771330|NCT04737759|80992922|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
27771331|NCT04737759|80992923|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
27771332|NCT04737759|80992922|FG000|Overall Study|Death|2|||
27771333|NCT04737759|80992923|FG001|Overall Study|Death|0|||
27771334|NCT04737759|80992922|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
27771335|NCT04737759|80992923|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
27771336|NCT04737759|80992922|FG000|Overall Study|Lost to Follow-up|4|||
27771337|NCT04737759|80992923|FG001|Overall Study|Lost to Follow-up|12|||
27771338|NCT02120469|80992924|FG000|Overall Study|HER-2/neu-amplified|1|||
27771339|NCT02120469|80992925|FG001|Overall Study|HER-2/neu-amplified|0|||
27771340|NCT02120469|80992926|FG002|Overall Study|HER-2/neu-amplified|1|||
27771341|NCT01047436|80992927|FG000|Overall Study|Protocol Violation|1|||
27771342|NCT01047436|80992928|FG001|Overall Study|Protocol Violation|0|||
27771343|NCT01010776|80992929|FG000|Main Phase|Withdrawal by Subject|14|||
27771344|NCT01010776|80992929|FG000|Main Phase|Lack of Efficacy|8|||
27771345|NCT01010776|80992929|FG000|Main Phase|Adverse Event|7|||
27771346|NCT01010776|80992929|FG000|Main Phase|Lost to Follow-up|6|||
27771347|NCT01010776|80992929|FG000|Main Phase|Non-compliance to study medication|5|||
27771348|NCT01010776|80992929|FG000|Main Phase|Selection failure|2|||
27771349|NCT01010776|80992929|FG000|Main Phase|Inform consent withdrawal|1|||
27771350|NCT01010776|80992929|FG000|Main Phase|Other|1|||
27771351|NCT01010776|80992929|FG000|Main Phase|Did not received study medication|5|||
27771352|NCT01010776|80992929|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
27771353|NCT01010776|80992929|FG000|Extension Phase|Other|3|||
27771354|NCT00618813|80992939|FG000|Overall Study|Lack of Efficacy|1|||
27771355|NCT00618813|80992939|FG000|Overall Study|Physician Decision|2|||
27771356|NCT00618813|80992939|FG000|Overall Study|Withdrawal by Subject|1|||
27771357|NCT00701441|80992940|FG000|Overall Study|failure in cpap compliance|0|||
27771358|NCT00701441|80992941|FG001|Overall Study|failure in cpap compliance|4|||
27771359|NCT02017704|80992946|FG000|Overall Study|Withdrawal by Subject|2|||
27771360|NCT02017704|80992947|FG001|Overall Study|Withdrawal by Subject|0|||
27771361|NCT01392742|80992950|FG000|Overall Study|Premature study termination|42|||
27771362|NCT01392742|80992950|FG000|Overall Study|Failure to return|35|||
27771363|NCT01392742|80992950|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
27771364|NCT01392742|80992950|FG000|Overall Study|Lost to Follow-up|34|||
27771365|NCT01392742|80992950|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
27771366|NCT01392742|80992950|FG000|Overall Study|ITR and Protocol deviation|1|||
27771367|NCT01392742|80992950|FG000|Overall Study|Adverse event/intercurrent illness|17|||
27771368|NCT01392742|80992950|FG000|Overall Study|Protocol Violation|14|||
27771369|NCT01392742|80992950|FG000|Overall Study|Other|3|||
27771370|NCT01392742|80992950|FG000|Overall Study|Missing information|13|||
27771371|NCT00595868|80992960|FG000|Overall Study|Lost to Follow-up|45|||
27771372|NCT00595868|80992961|FG001|Overall Study|Lost to Follow-up|50|||
27771373|NCT01235507|80992964|FG000|Overall Study|Adverse Event|1|||
27771374|NCT01235507|80992964|FG000|Overall Study|Withdrawal by Subject|1|||
27771375|NCT05041062|80992967|FG000|Overall Study|Adverse Event|2|||
27771376|NCT01415908|80992968|FG000|Overall Study|Withdrawal by Subject|1|||
27771377|NCT01415908|80992969|FG001|Overall Study|Withdrawal by Subject|0|||
27771378|NCT00106249|80992974|FG000|Overall Study|Lost to Follow-up|3|||
27771379|NCT00106249|80992975|FG001|Overall Study|Lost to Follow-up|2|||
27771380|NCT01405027|80992984|FG000|Overall Study|Withdrawn consent|3|||
27771381|NCT01405027|80992985|FG001|Overall Study|Withdrawn consent|0|||
27771382|NCT01405027|80992984|FG000|Overall Study|Lost to Follow-up|16|||
27771383|NCT01405027|80992985|FG001|Overall Study|Lost to Follow-up|24|||
27771384|NCT01405027|80992984|FG000|Overall Study|Investigator judgement|0|||
27771385|NCT01405027|80992985|FG001|Overall Study|Investigator judgement|2|||
27771386|NCT01405027|80992984|FG000|Overall Study|Death|1|||
27771387|NCT01405027|80992985|FG001|Overall Study|Death|0|||
27771388|NCT01405027|80992984|FG000|Overall Study|Other or Unknown|12|||
27771389|NCT01405027|80992985|FG001|Overall Study|Other or Unknown|25|||
27771390|NCT00796224|80992990|FG000|Overall Study|Adverse Event|1|||
27771391|NCT00796224|80992991|FG001|Overall Study|Adverse Event|0|||
27771392|NCT00796224|80992990|FG000|Overall Study|Protocol Violation|0|||
27771393|NCT00796224|80992991|FG001|Overall Study|Protocol Violation|1|||
27771394|NCT00643448|80992992|FG000|Overall Study|Lack of Efficacy|2|||
27771395|NCT00643448|80992993|FG001|Overall Study|Lack of Efficacy|0|||
27771396|NCT00643448|80992994|FG002|Overall Study|Lack of Efficacy|4|||
27771397|NCT00643448|80992992|FG000|Overall Study|Adverse Event|2|||
27771398|NCT00643448|80992993|FG001|Overall Study|Adverse Event|2|||
27771399|NCT00643448|80992994|FG002|Overall Study|Adverse Event|2|||
27771400|NCT00643448|80992992|FG000|Overall Study|QTcF>550 ms|0|||
27771401|NCT00643448|80992993|FG001|Overall Study|QTcF>550 ms|3|||
27771402|NCT00643448|80992994|FG002|Overall Study|QTcF>550 ms|0|||
27771403|NCT00693693|80992998|FG000|Overall Study|Lost to Follow-up|1|||
27771404|NCT00693693|80992999|FG001|Overall Study|Lost to Follow-up|1|||
27771405|NCT00693693|80993000|FG002|Overall Study|Lost to Follow-up|2|||
27771406|NCT01849562|80993003|FG000|Overall Study|Lost to Follow-up|1|||
27771407|NCT01849562|80993004|FG001|Overall Study|Lost to Follow-up|0|||
27771408|NCT01849562|80993005|FG002|Overall Study|Lost to Follow-up|0|||
27771409|NCT01849562|80993003|FG000|Overall Study|Non-compliance with Study Drug|1|||
27771410|NCT01849562|80993004|FG001|Overall Study|Non-compliance with Study Drug|0|||
27771411|NCT01849562|80993005|FG002|Overall Study|Non-compliance with Study Drug|0|||
27771412|NCT01197794|80993006|FG000|Overall Study|Adverse Event|3|||
27771413|NCT01197794|80993007|FG001|Overall Study|Adverse Event|2|||
27771414|NCT01197794|80993008|FG002|Overall Study|Adverse Event|4|||
27771415|NCT01197794|80993009|FG003|Overall Study|Adverse Event|4|||
27771416|NCT01197794|80993010|FG004|Overall Study|Adverse Event|4|||
27569023|NCT02658890|80271478|FG008|Treatment Phase|Other Reasons|1|||
27569024|NCT02658890|80271479|FG009|Treatment Phase|Other Reasons|0|||
27771417|NCT01197794|80993011|FG005|Overall Study|Adverse Event|2|||
27771418|NCT01197794|80993012|FG006|Overall Study|Adverse Event|3|||
27771419|NCT01197794|80993006|FG000|Overall Study|Protocol Violation|0|||
27771420|NCT01197794|80993007|FG001|Overall Study|Protocol Violation|0|||
27569025|NCT02658890|80271480|FG010|Treatment Phase|Other Reasons|0|||
27569026|NCT02658890|80271481|FG011|Treatment Phase|Other Reasons|0|||
27569027|NCT02658890|80271482|FG012|Treatment Phase|Other Reasons|0|||
27569028|NCT02658890|80271483|FG013|Treatment Phase|Other Reasons|2|||
27569029|NCT02658890|80271484|FG014|Treatment Phase|Other Reasons|0|||
27771421|NCT01197794|80993008|FG002|Overall Study|Protocol Violation|0|||
27771422|NCT01197794|80993009|FG003|Overall Study|Protocol Violation|0|||
27771423|NCT01197794|80993010|FG004|Overall Study|Protocol Violation|2|||
27569030|NCT02658890|80271485|FG015|Treatment Phase|Other Reasons|0|||
27569031|NCT02658890|80271486|FG016|Treatment Phase|Other Reasons|0|||
27569032|NCT02658890|80271487|FG017|Treatment Phase|Other Reasons|0|||
27569033|NCT02658890|80271488|FG018|Treatment Phase|Other Reasons|1|||
27569034|NCT02658890|80271489|FG019|Treatment Phase|Other Reasons|0|||
27569035|NCT02658890|80271490|FG020|Treatment Phase|Other Reasons|0|||
27569036|NCT02658890|80271491|FG021|Treatment Phase|Other Reasons|0|||
27569037|NCT02658890|80271492|FG022|Treatment Phase|Other Reasons|0|||
27569038|NCT02658890|80271493|FG023|Treatment Phase|Other Reasons|0|||
27569039|NCT02658890|80271494|FG024|Treatment Phase|Other Reasons|1|||
27569040|NCT02658890|80271495|FG025|Treatment Phase|Other Reasons|0|||
27771424|NCT01197794|80993011|FG005|Overall Study|Protocol Violation|0|||
27771425|NCT01197794|80993012|FG006|Overall Study|Protocol Violation|1|||
27771426|NCT01197794|80993006|FG000|Overall Study|Development of study withdrawal criteria|3|||
27771427|NCT01197794|80993007|FG001|Overall Study|Development of study withdrawal criteria|0|||
27771428|NCT01197794|80993008|FG002|Overall Study|Development of study withdrawal criteria|0|||
27771429|NCT01197794|80993009|FG003|Overall Study|Development of study withdrawal criteria|1|||
27771430|NCT01197794|80993010|FG004|Overall Study|Development of study withdrawal criteria|0|||
27771431|NCT01197794|80993011|FG005|Overall Study|Development of study withdrawal criteria|0|||
27771432|NCT01197794|80993012|FG006|Overall Study|Development of study withdrawal criteria|1|||
27771433|NCT01197794|80993006|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
27771434|NCT01197794|80993007|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
27771435|NCT01197794|80993008|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
27771436|NCT01197794|80993009|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
27771437|NCT01197794|80993010|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
27771438|NCT01197794|80993011|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
27771439|NCT01197794|80993012|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
27771440|NCT01197794|80993006|FG000|Overall Study|Withdrawal by Subject|3|||
27771441|NCT01197794|80993007|FG001|Overall Study|Withdrawal by Subject|3|||
27771442|NCT01197794|80993008|FG002|Overall Study|Withdrawal by Subject|4|||
27771443|NCT01197794|80993009|FG003|Overall Study|Withdrawal by Subject|1|||
27771444|NCT01197794|80993010|FG004|Overall Study|Withdrawal by Subject|1|||
27771445|NCT01197794|80993011|FG005|Overall Study|Withdrawal by Subject|5|||
27771446|NCT01197794|80993012|FG006|Overall Study|Withdrawal by Subject|6|||
27771447|NCT01197794|80993006|FG000|Overall Study|Lost to Follow-up|1|||
27771448|NCT01197794|80993007|FG001|Overall Study|Lost to Follow-up|1|||
27771449|NCT01197794|80993008|FG002|Overall Study|Lost to Follow-up|0|||
27771450|NCT01197794|80993009|FG003|Overall Study|Lost to Follow-up|1|||
27771451|NCT01197794|80993010|FG004|Overall Study|Lost to Follow-up|0|||
27771452|NCT01197794|80993011|FG005|Overall Study|Lost to Follow-up|1|||
27771453|NCT01197794|80993012|FG006|Overall Study|Lost to Follow-up|0|||
27771454|NCT01197794|80993006|FG000|Overall Study|Other|1|||
27771455|NCT01197794|80993007|FG001|Overall Study|Other|1|||
27771456|NCT01197794|80993008|FG002|Overall Study|Other|3|||
27771457|NCT01197794|80993009|FG003|Overall Study|Other|0|||
27771458|NCT01197794|80993010|FG004|Overall Study|Other|2|||
27771459|NCT01197794|80993011|FG005|Overall Study|Other|2|||
27771460|NCT01197794|80993012|FG006|Overall Study|Other|4|||
27663922|NCT02162771|80606570|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
27569041|NCT02658890|80271496|FG026|Treatment Phase|Other Reasons|1|||
27569042|NCT02658890|80271470|FG000|Treatment Phase|Progressive Disease|6|||
27569043|NCT02658890|80271471|FG001|Treatment Phase|Progressive Disease|7|||
27569044|NCT02658890|80271472|FG002|Treatment Phase|Progressive Disease|6|||
27569045|NCT02658890|80271473|FG003|Treatment Phase|Progressive Disease|12|||
27569046|NCT02658890|80271474|FG004|Treatment Phase|Progressive Disease|6|||
27569047|NCT02658890|80271475|FG005|Treatment Phase|Progressive Disease|18|||
27569048|NCT02658890|80271476|FG006|Treatment Phase|Progressive Disease|12|||
27569049|NCT02658890|80271477|FG007|Treatment Phase|Progressive Disease|19|||
27569050|NCT02658890|80271478|FG008|Treatment Phase|Progressive Disease|26|||
27569051|NCT02658890|80271479|FG009|Treatment Phase|Progressive Disease|8|||
27569052|NCT02658890|80271480|FG010|Treatment Phase|Progressive Disease|7|||
27569053|NCT02658890|80271481|FG011|Treatment Phase|Progressive Disease|9|||
27569054|NCT02658890|80271482|FG012|Treatment Phase|Progressive Disease|8|||
27569055|NCT02658890|80271483|FG013|Treatment Phase|Progressive Disease|29|||
27569056|NCT02658890|80271484|FG014|Treatment Phase|Progressive Disease|6|||
27569057|NCT02658890|80271485|FG015|Treatment Phase|Progressive Disease|2|||
27569058|NCT02658890|80271486|FG016|Treatment Phase|Progressive Disease|32|||
27569059|NCT02658890|80271487|FG017|Treatment Phase|Progressive Disease|14|||
27569060|NCT02658890|80271488|FG018|Treatment Phase|Progressive Disease|40|||
27964544|NCT04470050|81701569|FG002|Double-blind Treatment Phase|Adverse Event|0|||
27964545|NCT04470050|81701570|FG003|Double-blind Treatment Phase|Adverse Event|1|||
27964546|NCT04470050|81701571|FG004|Double-blind Treatment Phase|Adverse Event|0|||
27964547|NCT04470050|81701572|FG005|Double-blind Treatment Phase|Adverse Event|0|||
27964548|NCT04470050|81701573|FG006|Double-blind Treatment Phase|Adverse Event|0|||
27964549|NCT04470050|81701567|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27964550|NCT04470050|81701568|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
27964551|NCT04470050|81701569|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
27771461|NCT01993667|80993013|FG000|Overall Study|Insufficient data to analyze|16|||
27771462|NCT01993667|80993014|FG001|Overall Study|Insufficient data to analyze|16|||
27771463|NCT01993667|80993013|FG000|Overall Study|Insufficient altitude reached|3|||
27964552|NCT04470050|81701570|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
27964553|NCT04470050|81701571|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
27964554|NCT04470050|81701572|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
27569061|NCT02658890|80271489|FG019|Treatment Phase|Progressive Disease|32|||
27569062|NCT02658890|80271490|FG020|Treatment Phase|Progressive Disease|19|||
27569063|NCT02658890|80271491|FG021|Treatment Phase|Progressive Disease|30|||
27569064|NCT02658890|80271492|FG022|Treatment Phase|Progressive Disease|15|||
27569065|NCT02658890|80271493|FG023|Treatment Phase|Progressive Disease|0|||
27569066|NCT02658890|80271494|FG024|Treatment Phase|Progressive Disease|0|||
27771464|NCT01993667|80993014|FG001|Overall Study|Insufficient altitude reached|1|||
27771465|NCT01993667|80993013|FG000|Overall Study|Lost to Follow-up|2|||
27771466|NCT01993667|80993014|FG001|Overall Study|Lost to Follow-up|2|||
27771467|NCT04159701|80993015|FG000|Period 1: Treatment Period|Pregnancy|1|||
27771468|NCT04159701|80993016|FG001|Period 1: Treatment Period|Pregnancy|0|||
27771469|NCT04159701|80993015|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
27771470|NCT04159701|80993016|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
27771471|NCT04159701|80993015|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
27771472|NCT04159701|80993016|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
27964555|NCT04470050|81701573|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
27569067|NCT02658890|80271495|FG025|Treatment Phase|Progressive Disease|14|||
27569068|NCT02658890|80271496|FG026|Treatment Phase|Progressive Disease|11|||
27663923|NCT02162771|80606569|FG000|Core Study Period (Part 2)|Physician Decision|0|||
27663924|NCT02162771|80606570|FG001|Core Study Period (Part 2)|Physician Decision|2|||
27663925|NCT02162771|80606569|FG000|Core Study Period (Part 2)|Death|1|||
27663926|NCT02162771|80606570|FG001|Core Study Period (Part 2)|Death|0|||
27663927|NCT02162771|80606569|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
27663928|NCT02162771|80606570|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
27663929|NCT02162771|80606569|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
27663930|NCT02162771|80606570|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
27663931|NCT02162771|80606569|FG000|Maintenance Study Period (Part 2)|Death|2|||
27663932|NCT02162771|80606570|FG001|Maintenance Study Period (Part 2)|Death|1|||
27663933|NCT02162771|80606569|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
27663934|NCT02162771|80606570|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
27663935|NCT02162771|80606569|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
27663936|NCT02162771|80606570|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
27663937|NCT02162771|80606569|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
27663938|NCT02162771|80606570|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
27663939|NCT00553605|80606572|FG000|Overall Study|Did not meet entrance criteria|1|||
27771473|NCT04159701|80993015|FG000|Washout Period|site terminated by sponsor|0|||
27771474|NCT04159701|80993016|FG001|Washout Period|site terminated by sponsor|1|||
27569069|NCT02658890|80271470|FG000|Treatment Phase|Study Drug Toxicity|0|||
27569070|NCT02658890|80271471|FG001|Treatment Phase|Study Drug Toxicity|0|||
27771475|NCT04159701|80993015|FG000|Washout Period|study terminated by sponsor|10|||
27771476|NCT04159701|80993016|FG001|Washout Period|study terminated by sponsor|3|||
27771477|NCT04159701|80993015|FG000|Washout Period|Withdrawal by Subject|1|||
27771478|NCT04159701|80993016|FG001|Washout Period|Withdrawal by Subject|0|||
27771479|NCT04159701|80993015|FG000|Washout Period|Inadvertent Enrollment|1|||
27771480|NCT04159701|80993016|FG001|Washout Period|Inadvertent Enrollment|0|||
27771481|NCT04159701|80993015|FG000|Washout Period|Miscellaneous|1|||
27771482|NCT04159701|80993016|FG001|Washout Period|Miscellaneous|0|||
27771483|NCT04159701|80993015|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
27771484|NCT04159701|80993016|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
27771485|NCT04159701|80993015|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
27771486|NCT04159701|80993016|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
27569071|NCT02658890|80271472|FG002|Treatment Phase|Study Drug Toxicity|2|||
27569072|NCT02658890|80271473|FG003|Treatment Phase|Study Drug Toxicity|0|||
27569073|NCT02658890|80271474|FG004|Treatment Phase|Study Drug Toxicity|0|||
27569074|NCT02658890|80271475|FG005|Treatment Phase|Study Drug Toxicity|0|||
27569075|NCT02658890|80271476|FG006|Treatment Phase|Study Drug Toxicity|0|||
27569076|NCT02658890|80271477|FG007|Treatment Phase|Study Drug Toxicity|0|||
27569077|NCT02658890|80271478|FG008|Treatment Phase|Study Drug Toxicity|3|||
27569078|NCT02658890|80271479|FG009|Treatment Phase|Study Drug Toxicity|0|||
27569079|NCT02658890|80271480|FG010|Treatment Phase|Study Drug Toxicity|1|||
27569080|NCT02658890|80271481|FG011|Treatment Phase|Study Drug Toxicity|1|||
27569081|NCT02658890|80271482|FG012|Treatment Phase|Study Drug Toxicity|2|||
27569082|NCT02658890|80271483|FG013|Treatment Phase|Study Drug Toxicity|9|||
27569083|NCT02658890|80271484|FG014|Treatment Phase|Study Drug Toxicity|0|||
27569084|NCT02658890|80271485|FG015|Treatment Phase|Study Drug Toxicity|1|||
27569085|NCT02658890|80271486|FG016|Treatment Phase|Study Drug Toxicity|1|||
27569086|NCT02658890|80271487|FG017|Treatment Phase|Study Drug Toxicity|0|||
27771487|NCT04159701|80993015|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
27771488|NCT04159701|80993016|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
27771489|NCT04159701|80993015|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
27771490|NCT04159701|80993016|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
27771491|NCT04159701|80993015|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
27569087|NCT02658890|80271488|FG018|Treatment Phase|Study Drug Toxicity|8|||
27569088|NCT02658890|80271489|FG019|Treatment Phase|Study Drug Toxicity|3|||
27569089|NCT02658890|80271490|FG020|Treatment Phase|Study Drug Toxicity|2|||
27569090|NCT02658890|80271491|FG021|Treatment Phase|Study Drug Toxicity|0|||
27569091|NCT02658890|80271492|FG022|Treatment Phase|Study Drug Toxicity|8|||
27569092|NCT02658890|80271493|FG023|Treatment Phase|Study Drug Toxicity|0|||
27569093|NCT02658890|80271494|FG024|Treatment Phase|Study Drug Toxicity|0|||
27569094|NCT02658890|80271495|FG025|Treatment Phase|Study Drug Toxicity|2|||
27569095|NCT02658890|80271496|FG026|Treatment Phase|Study Drug Toxicity|0|||
27569096|NCT02658890|80271470|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569097|NCT02658890|80271471|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569098|NCT02658890|80271472|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569099|NCT02658890|80271473|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
27569100|NCT02658890|80271474|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569101|NCT02658890|80271475|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569102|NCT02658890|80271476|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569103|NCT02658890|80271477|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569104|NCT02658890|80271478|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569105|NCT02658890|80271479|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
27569106|NCT02658890|80271480|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569107|NCT02658890|80271481|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569108|NCT02658890|80271482|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569109|NCT02658890|80271483|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569110|NCT02658890|80271484|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569111|NCT02658890|80271485|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569112|NCT02658890|80271486|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569113|NCT02658890|80271487|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569114|NCT02658890|80271488|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
27569115|NCT02658890|80271489|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569116|NCT02658890|80271490|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569117|NCT02658890|80271491|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569118|NCT02658890|80271492|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
27569119|NCT02658890|80271493|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569120|NCT02658890|80271494|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27771492|NCT04159701|80993016|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
27771493|NCT03565991|80993019|FG000|Overall Study|Other|11|||
27771494|NCT03565991|80993020|FG001|Overall Study|Other|0|||
27771495|NCT03565991|80993019|FG000|Overall Study|Global deterioration of health status|14|||
27771496|NCT03565991|80993020|FG001|Overall Study|Global deterioration of health status|4|||
27771497|NCT03565991|80993019|FG000|Overall Study|Withdrawal by Subject|2|||
27771498|NCT03565991|80993020|FG001|Overall Study|Withdrawal by Subject|6|||
27771499|NCT03565991|80993019|FG000|Overall Study|Progressive disease|121|||
27771500|NCT03565991|80993020|FG001|Overall Study|Progressive disease|29|||
27771501|NCT03565991|80993019|FG000|Overall Study|Death|3|||
27771502|NCT03565991|80993020|FG001|Overall Study|Death|0|||
27771503|NCT03565991|80993019|FG000|Overall Study|Adverse Event|7|||
27771504|NCT03565991|80993020|FG001|Overall Study|Adverse Event|2|||
27771505|NCT02741310|80993021|FG000|Overall Study|Sponsor Decision|2|||
27771506|NCT02741310|80993022|FG001|Overall Study|Sponsor Decision|2|||
27771507|NCT00225212|80993023|FG000|Overall Study|Disease progression|2|||
27771508|NCT00225212|80993023|FG000|Overall Study|Death|1|||
27569121|NCT02658890|80271495|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569122|NCT02658890|80271496|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
27569123|NCT02658890|80271470|FG000|Treatment Phase|Withdrawal by Subject|0|||
27569124|NCT02658890|80271471|FG001|Treatment Phase|Withdrawal by Subject|1|||
27569125|NCT02658890|80271472|FG002|Treatment Phase|Withdrawal by Subject|0|||
27569126|NCT02658890|80271473|FG003|Treatment Phase|Withdrawal by Subject|0|||
27569127|NCT02658890|80271474|FG004|Treatment Phase|Withdrawal by Subject|0|||
27771509|NCT00225212|80993023|FG000|Overall Study|Adverse Event|2|||
27771510|NCT00225212|80993023|FG000|Overall Study|Intercurrent illness|1|||
27771511|NCT01055457|80993024|FG000|Overall Study|Lost to Follow-up|0|||
27771512|NCT01055457|80993025|FG001|Overall Study|Lost to Follow-up|1|||
27771513|NCT01055457|80993026|FG002|Overall Study|Lost to Follow-up|0|||
27964556|NCT04470050|81701567|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
27964557|NCT04470050|81701568|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
27964558|NCT04470050|81701569|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
27964559|NCT04470050|81701570|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
27964560|NCT04470050|81701571|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
27964561|NCT04470050|81701572|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
27964562|NCT04470050|81701573|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
27964563|NCT00553436|81701578|FG000|Overall Study|Conversion to another procedure|1|||
27964564|NCT00958360|81701579|FG000|Overall Study|Withdrawal by Subject|3|||
27964565|NCT00958360|81701580|FG001|Overall Study|Withdrawal by Subject|1|||
27964566|NCT00958360|81701579|FG000|Overall Study|Death|6|||
27964567|NCT00958360|81701580|FG001|Overall Study|Death|7|||
27964568|NCT00958360|81701579|FG000|Overall Study|Physician Decision|2|||
27964569|NCT00958360|81701580|FG001|Overall Study|Physician Decision|1|||
27964570|NCT00958360|81701579|FG000|Overall Study|Lost to Follow-up|0|||
27964571|NCT00958360|81701580|FG001|Overall Study|Lost to Follow-up|1|||
27964572|NCT02097719|81701581|FG000|Overall Study|Subject Withdrew Consent|1|||
27964573|NCT02097719|81701582|FG001|Overall Study|Subject Withdrew Consent|0|||
27964574|NCT02097719|81701581|FG000|Overall Study|Lost to Follow-up|0|||
27964575|NCT02097719|81701582|FG001|Overall Study|Lost to Follow-up|1|||
27964576|NCT02097719|81701581|FG000|Overall Study|Adverse Event|2|||
27964577|NCT02097719|81701582|FG001|Overall Study|Adverse Event|0|||
27964578|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
27964579|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27964580|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27964581|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27964582|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27771514|NCT01055457|80993027|FG003|Overall Study|Lost to Follow-up|0|||
27771515|NCT01055457|80993028|FG004|Overall Study|Lost to Follow-up|0|||
27771516|NCT01055457|80993029|FG005|Overall Study|Lost to Follow-up|1|||
27771517|NCT01055457|80993030|FG006|Overall Study|Lost to Follow-up|0|||
27771518|NCT01055457|80993031|FG007|Overall Study|Lost to Follow-up|0|||
27771519|NCT01055457|80993032|FG008|Overall Study|Lost to Follow-up|0|||
27771520|NCT01055457|80993033|FG009|Overall Study|Lost to Follow-up|0|||
27964583|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27964584|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
27964585|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
27964586|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27964587|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27964588|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27964589|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27569128|NCT02658890|80271475|FG005|Treatment Phase|Withdrawal by Subject|0|||
27771521|NCT01055457|80993024|FG000|Overall Study|Protocol Violation|0|||
27771522|NCT01055457|80993025|FG001|Overall Study|Protocol Violation|0|||
27771523|NCT01055457|80993026|FG002|Overall Study|Protocol Violation|1|||
27771524|NCT01055457|80993027|FG003|Overall Study|Protocol Violation|1|||
27964590|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
27771525|NCT01055457|80993028|FG004|Overall Study|Protocol Violation|1|||
27771526|NCT01055457|80993029|FG005|Overall Study|Protocol Violation|2|||
27771527|NCT01055457|80993030|FG006|Overall Study|Protocol Violation|1|||
27771528|NCT01055457|80993031|FG007|Overall Study|Protocol Violation|0|||
27771529|NCT01055457|80993032|FG008|Overall Study|Protocol Violation|0|||
27771530|NCT01055457|80993033|FG009|Overall Study|Protocol Violation|1|||
27771531|NCT01055457|80993024|FG000|Overall Study|Subject Disinterest|0|||
27771532|NCT01055457|80993025|FG001|Overall Study|Subject Disinterest|0|||
27771533|NCT01055457|80993026|FG002|Overall Study|Subject Disinterest|0|||
27771534|NCT01055457|80993027|FG003|Overall Study|Subject Disinterest|0|||
27771535|NCT01055457|80993028|FG004|Overall Study|Subject Disinterest|0|||
27771536|NCT01055457|80993029|FG005|Overall Study|Subject Disinterest|0|||
27771537|NCT01055457|80993030|FG006|Overall Study|Subject Disinterest|0|||
27964591|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
27964592|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
27964593|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
27964594|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
27964595|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
27964596|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
27964597|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
27964598|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27964599|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27964600|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27964601|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27964602|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
27964603|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
27964604|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
27771538|NCT01055457|80993031|FG007|Overall Study|Subject Disinterest|1|||
27771539|NCT01055457|80993032|FG008|Overall Study|Subject Disinterest|0|||
27771540|NCT01055457|80993033|FG009|Overall Study|Subject Disinterest|0|||
27771541|NCT01055457|80993024|FG000|Overall Study|Subject Ineligible|1|||
27771542|NCT01055457|80993025|FG001|Overall Study|Subject Ineligible|0|||
27771543|NCT01055457|80993026|FG002|Overall Study|Subject Ineligible|1|||
27771544|NCT01055457|80993027|FG003|Overall Study|Subject Ineligible|0|||
27771545|NCT01055457|80993028|FG004|Overall Study|Subject Ineligible|1|||
27771546|NCT01055457|80993029|FG005|Overall Study|Subject Ineligible|0|||
27771547|NCT01055457|80993030|FG006|Overall Study|Subject Ineligible|0|||
27771548|NCT01055457|80993031|FG007|Overall Study|Subject Ineligible|0|||
27771549|NCT01055457|80993032|FG008|Overall Study|Subject Ineligible|0|||
27771550|NCT01055457|80993033|FG009|Overall Study|Subject Ineligible|0|||
27771551|NCT01055457|80993024|FG000|Overall Study|Discomfort|0|||
27771552|NCT01055457|80993025|FG001|Overall Study|Discomfort|0|||
27771553|NCT01055457|80993026|FG002|Overall Study|Discomfort|0|||
27771554|NCT01055457|80993027|FG003|Overall Study|Discomfort|0|||
27771555|NCT01055457|80993028|FG004|Overall Study|Discomfort|1|||
27771556|NCT01055457|80993029|FG005|Overall Study|Discomfort|0|||
27771557|NCT01055457|80993030|FG006|Overall Study|Discomfort|0|||
27771558|NCT01055457|80993031|FG007|Overall Study|Discomfort|0|||
27771559|NCT01055457|80993032|FG008|Overall Study|Discomfort|0|||
27771560|NCT01055457|80993033|FG009|Overall Study|Discomfort|0|||
27771561|NCT01055457|80993024|FG000|Overall Study|Pregnancy|0|||
27771562|NCT01055457|80993025|FG001|Overall Study|Pregnancy|0|||
27771563|NCT01055457|80993026|FG002|Overall Study|Pregnancy|0|||
27771564|NCT01055457|80993027|FG003|Overall Study|Pregnancy|1|||
27771565|NCT01055457|80993028|FG004|Overall Study|Pregnancy|0|||
27771566|NCT01055457|80993029|FG005|Overall Study|Pregnancy|0|||
27771567|NCT01055457|80993030|FG006|Overall Study|Pregnancy|0|||
27771568|NCT01055457|80993031|FG007|Overall Study|Pregnancy|0|||
27771569|NCT01055457|80993032|FG008|Overall Study|Pregnancy|0|||
27771570|NCT01055457|80993033|FG009|Overall Study|Pregnancy|0|||
27771571|NCT01055457|80993024|FG000|Overall Study|Adverse Event|0|||
27771572|NCT01055457|80993025|FG001|Overall Study|Adverse Event|0|||
27771573|NCT01055457|80993026|FG002|Overall Study|Adverse Event|0|||
27964605|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
27964606|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
27771574|NCT01055457|80993027|FG003|Overall Study|Adverse Event|1|||
27771575|NCT01055457|80993028|FG004|Overall Study|Adverse Event|0|||
27771576|NCT01055457|80993029|FG005|Overall Study|Adverse Event|0|||
27771577|NCT01055457|80993030|FG006|Overall Study|Adverse Event|0|||
27771578|NCT01055457|80993031|FG007|Overall Study|Adverse Event|0|||
27771579|NCT01055457|80993032|FG008|Overall Study|Adverse Event|0|||
27771580|NCT01055457|80993033|FG009|Overall Study|Adverse Event|0|||
27771581|NCT03417505|80993034|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
27771582|NCT03417505|80993035|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
27771583|NCT00959894|80993036|FG000|Overall Study|Lost to Follow-up|10|||
27771584|NCT00959894|80993036|FG000|Overall Study|Adverse Event|3|||
27771585|NCT00959894|80993036|FG000|Overall Study|Withdrawal by Subject|1|||
27964607|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
27964608|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
27964609|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
27964610|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
27964611|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
27964612|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
27964613|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
27964614|NCT03989349|81701585|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
27663940|NCT00553605|80606573|FG001|Overall Study|Did not meet entrance criteria|3|||
27663941|NCT00553605|80606572|FG000|Overall Study|Did not receive full dose|1|||
27663942|NCT00553605|80606573|FG001|Overall Study|Did not receive full dose|0|||
27663943|NCT00553605|80606572|FG000|Overall Study|Randomized but not treated|2|||
27663944|NCT00553605|80606573|FG001|Overall Study|Randomized but not treated|0|||
27663945|NCT02402465|80606574|FG000|Overall Study|Withdrawal by Subject|0|||
27663946|NCT02402465|80606575|FG001|Overall Study|Withdrawal by Subject|0|||
27663947|NCT02402465|80606576|FG002|Overall Study|Withdrawal by Subject|0|||
27663948|NCT02402465|80606577|FG003|Overall Study|Withdrawal by Subject|0|||
27663949|NCT02402465|80606578|FG004|Overall Study|Withdrawal by Subject|0|||
27663950|NCT02402465|80606579|FG005|Overall Study|Withdrawal by Subject|1|||
27663951|NCT02402465|80606574|FG000|Overall Study|Lost to Follow-up|0|||
27663952|NCT02402465|80606575|FG001|Overall Study|Lost to Follow-up|1|||
27663953|NCT02402465|80606576|FG002|Overall Study|Lost to Follow-up|0|||
27663954|NCT02402465|80606577|FG003|Overall Study|Lost to Follow-up|0|||
27663955|NCT02402465|80606578|FG004|Overall Study|Lost to Follow-up|1|||
27663956|NCT02402465|80606579|FG005|Overall Study|Lost to Follow-up|0|||
27663957|NCT01560585|80606584|FG000|Overall Study|Physician Decision|3|||
27663958|NCT00451555|80606587|FG000|Overall Study|Protocol Violation|2|||
27663959|NCT00451555|80606588|FG001|Overall Study|Protocol Violation|2|||
27663960|NCT00451555|80606587|FG000|Overall Study|Adverse Event|3|||
27663961|NCT00451555|80606588|FG001|Overall Study|Adverse Event|1|||
27663962|NCT00451555|80606587|FG000|Overall Study|Withdrawal by Subject|6|||
27663963|NCT00451555|80606588|FG001|Overall Study|Withdrawal by Subject|0|||
27663964|NCT00451555|80606587|FG000|Overall Study|Physician Decision|2|||
27663965|NCT00451555|80606588|FG001|Overall Study|Physician Decision|1|||
27663966|NCT02675998|80606591|FG000|8-Week Treatment Period|Adverse Event|6|||
27663967|NCT02675998|80606592|FG001|8-Week Treatment Period|Adverse Event|5|||
27663968|NCT02675998|80606593|FG002|8-Week Treatment Period|Adverse Event|6|||
27663969|NCT02675998|80606594|FG003|8-Week Treatment Period|Adverse Event|0|||
27663970|NCT02675998|80606591|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
27663971|NCT02675998|80606592|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
27663972|NCT02675998|80606593|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
27663973|NCT02675998|80606594|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
27663974|NCT02675998|80606591|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
27663975|NCT02675998|80606592|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
27663976|NCT02675998|80606593|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
27663977|NCT02675998|80606594|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
27663978|NCT02675998|80606591|FG000|8-Week Treatment Period|Physician Decision|1|||
27663979|NCT02675998|80606592|FG001|8-Week Treatment Period|Physician Decision|0|||
27663980|NCT02675998|80606593|FG002|8-Week Treatment Period|Physician Decision|2|||
27771586|NCT00959894|80993036|FG000|Overall Study|Need for contraindicated medication|1|||
27771587|NCT00959894|80993036|FG000|Overall Study|Subject moved out of town|1|||
27771588|NCT03954704|80993041|FG000|Overall Study|Death|1|||
27964615|NCT03989349|81701586|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
27964616|NCT03989349|81701587|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
27663981|NCT02675998|80606594|FG003|8-Week Treatment Period|Physician Decision|0|||
27663982|NCT02675998|80606591|FG000|8-Week Treatment Period|GI side Effects|1|||
27663983|NCT02675998|80606592|FG001|8-Week Treatment Period|GI side Effects|4|||
27663984|NCT02675998|80606593|FG002|8-Week Treatment Period|GI side Effects|2|||
27663985|NCT02675998|80606594|FG003|8-Week Treatment Period|GI side Effects|0|||
27663986|NCT02675998|80606591|FG000|8-Week Treatment Period|Protocol Violation|1|||
27663987|NCT02675998|80606592|FG001|8-Week Treatment Period|Protocol Violation|1|||
27663988|NCT02675998|80606593|FG002|8-Week Treatment Period|Protocol Violation|1|||
27663989|NCT02675998|80606594|FG003|8-Week Treatment Period|Protocol Violation|0|||
27663990|NCT02675998|80606591|FG000|8-Week Treatment Period|Other|3|||
27663991|NCT02675998|80606592|FG001|8-Week Treatment Period|Other|1|||
27663992|NCT02675998|80606593|FG002|8-Week Treatment Period|Other|2|||
27663993|NCT02675998|80606594|FG003|8-Week Treatment Period|Other|0|||
27771589|NCT03954704|80993042|FG001|Overall Study|Death|1|||
27771590|NCT03954704|80993043|FG002|Overall Study|Death|1|||
27663994|NCT02675998|80606591|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
27663995|NCT02675998|80606592|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
27663996|NCT02675998|80606593|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
27663997|NCT02675998|80606594|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
27663998|NCT02675998|80606591|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
27663999|NCT02675998|80606592|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
27664000|NCT02675998|80606593|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
27664001|NCT02675998|80606594|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
27664002|NCT02675998|80606591|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
27664003|NCT02675998|80606592|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
27664004|NCT02675998|80606593|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
27664005|NCT02675998|80606594|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
27664006|NCT02675998|80606591|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
27664007|NCT02675998|80606592|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
27664008|NCT02675998|80606593|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
27664009|NCT02675998|80606594|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
27664010|NCT02675998|80606591|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
27664011|NCT02675998|80606592|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
27664012|NCT02675998|80606593|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
27664013|NCT02675998|80606594|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
27664014|NCT04491006|80606598|FG000|Overall Study|Adverse Event|0|||
27664015|NCT04491006|80606599|FG001|Overall Study|Adverse Event|3|||
27664016|NCT04491006|80606600|FG002|Overall Study|Adverse Event|5|||
27664017|NCT04491006|80606598|FG000|Overall Study|Withdrawal by Subject|1|||
27664018|NCT04491006|80606599|FG001|Overall Study|Withdrawal by Subject|0|||
27664019|NCT04491006|80606600|FG002|Overall Study|Withdrawal by Subject|2|||
27664020|NCT03927222|80606603|FG000|Overall Study|Progression|3|||
27664021|NCT03927222|80606603|FG000|Overall Study|CMV testing results inconclusive|1|||
27664022|NCT03927222|80606603|FG000|Overall Study|Unable to generate enough vaccines|1|||
27664023|NCT03927222|80606603|FG000|Overall Study|Early study termination|1|||
27664024|NCT04414397|80606606|FG000|Control Period|Withdrawal by Subject|2|||
27664025|NCT04414397|80606607|FG001|Control Period|Withdrawal by Subject|2|||
27664026|NCT04414397|80606606|FG000|Control Period|Lost to Follow-up|0|||
27664027|NCT04414397|80606607|FG001|Control Period|Lost to Follow-up|4|||
27664028|NCT04414397|80606606|FG000|Control Period|Protocol deviation|0|||
27664029|NCT04414397|80606607|FG001|Control Period|Protocol deviation|1|||
27664030|NCT04414397|80606606|FG000|Post-Control Period|Withdrawal by Subject|3|||
27664031|NCT04414397|80606607|FG001|Post-Control Period|Withdrawal by Subject|6|||
27664032|NCT04414397|80606606|FG000|Post-Control Period|Lost to Follow-up|4|||
27664033|NCT04414397|80606607|FG001|Post-Control Period|Lost to Follow-up|9|||
27664034|NCT04414397|80606606|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
27664035|NCT04414397|80606607|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
27664036|NCT04414397|80606606|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
27664037|NCT04414397|80606607|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
27664038|NCT00125853|80606608|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
27664039|NCT00125853|80606609|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
27664040|NCT02720081|80606610|FG000|Overall Study|Adverse Event|0|||
27664041|NCT02720081|80606611|FG001|Overall Study|Adverse Event|3|||
27664042|NCT02720081|80606610|FG000|Overall Study|Protocol Violation|4|||
27664043|NCT02720081|80606611|FG001|Overall Study|Protocol Violation|1|||
27664044|NCT01702519|80606615|FG000|Washout Period|Lost to Follow-up|1|||
27664045|NCT01702519|80606616|FG001|Washout Period|Lost to Follow-up|0|||
27664046|NCT01702519|80606615|FG000|Washout Period|Withdrawal by Subject|0|||
27664047|NCT01702519|80606616|FG001|Washout Period|Withdrawal by Subject|2|||
27664048|NCT02435381|80606617|FG000|Overall Study|Lost to Follow-up|2|||
27771591|NCT03954704|80993044|FG003|Overall Study|Death|3|||
27771592|NCT03954704|80993045|FG004|Overall Study|Death|2|||
27771593|NCT03954704|80993046|FG005|Overall Study|Death|2|||
27771594|NCT03954704|80993047|FG006|Overall Study|Death|0|||
27771595|NCT03954704|80993041|FG000|Overall Study|Withdrew Consent|0|||
27771596|NCT03954704|80993042|FG001|Overall Study|Withdrew Consent|0|||
27771597|NCT03954704|80993043|FG002|Overall Study|Withdrew Consent|1|||
27569129|NCT02658890|80271476|FG006|Treatment Phase|Withdrawal by Subject|1|||
27664049|NCT02435381|80606618|FG001|Overall Study|Lost to Follow-up|1|||
27664050|NCT01251887|80606619|FG000|Overall Study|Scheduling conflict|1|||
27664051|NCT01251887|80606620|FG001|Overall Study|Scheduling conflict|2|||
27664052|NCT01251887|80606621|FG002|Overall Study|Scheduling conflict|2|||
27664053|NCT01251887|80606619|FG000|Overall Study|Physician Decision|0|||
27664054|NCT01251887|80606620|FG001|Overall Study|Physician Decision|1|||
27771598|NCT03954704|80993044|FG003|Overall Study|Withdrew Consent|0|||
27771599|NCT03954704|80993045|FG004|Overall Study|Withdrew Consent|0|||
27771600|NCT03954704|80993046|FG005|Overall Study|Withdrew Consent|1|||
27771601|NCT03954704|80993047|FG006|Overall Study|Withdrew Consent|0|||
27771602|NCT03954704|80993041|FG000|Overall Study|Lost to Follow-up|0|||
27664055|NCT01251887|80606621|FG002|Overall Study|Physician Decision|0|||
27664056|NCT03681353|80606622|FG000|Overall Study|Lost to Follow-up|2|||
27664057|NCT03681353|80606622|FG000|Overall Study|Withdrawal by Subject|3|||
27664058|NCT03681353|80606622|FG000|Overall Study|withdrawn by PI|2|||
27664059|NCT03605368|80606627|FG000|Overall Study|Lost to Follow-up|2|||
27664060|NCT03605368|80606628|FG001|Overall Study|Lost to Follow-up|1|||
27664061|NCT03605368|80606629|FG002|Overall Study|Lost to Follow-up|3|||
27664062|NCT03605368|80606630|FG003|Overall Study|Lost to Follow-up|2|||
27964617|NCT03989349|81701588|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
27964618|NCT03989349|81701589|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
27964619|NCT03989349|81701590|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
27964620|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27964621|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27964622|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
27964623|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
27964624|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
27964625|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
27964626|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27964627|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27964628|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
27964629|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
27964630|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
27964631|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
27664063|NCT03605368|80606627|FG000|Overall Study|Withdrawal by Subject|0|||
27664064|NCT03605368|80606628|FG001|Overall Study|Withdrawal by Subject|0|||
27664065|NCT03605368|80606629|FG002|Overall Study|Withdrawal by Subject|4|||
27664066|NCT03605368|80606630|FG003|Overall Study|Withdrawal by Subject|3|||
27664067|NCT01704547|80606631|FG000|Overall Study|Physician Decision|4|||
27664068|NCT01704547|80606631|FG000|Overall Study|Withdrawal by Subject|1|||
27664069|NCT02661490|80606634|FG000|Overall Study|Lost to Follow-up|0|||
27664070|NCT02661490|80606635|FG001|Overall Study|Lost to Follow-up|1|||
27664071|NCT02661490|80606636|FG002|Overall Study|Lost to Follow-up|0|||
27664072|NCT02661490|80606637|FG003|Overall Study|Lost to Follow-up|0|||
27664073|NCT02661490|80606638|FG004|Overall Study|Lost to Follow-up|2|||
27664074|NCT02661490|80606634|FG000|Overall Study|Withdrawal by Subject|2|||
27664075|NCT02661490|80606635|FG001|Overall Study|Withdrawal by Subject|0|||
27664076|NCT02661490|80606636|FG002|Overall Study|Withdrawal by Subject|2|||
27664077|NCT02661490|80606637|FG003|Overall Study|Withdrawal by Subject|0|||
27664078|NCT02661490|80606638|FG004|Overall Study|Withdrawal by Subject|0|||
27664079|NCT02661490|80606634|FG000|Overall Study|Death|1|||
27664080|NCT02661490|80606635|FG001|Overall Study|Death|1|||
27664081|NCT02661490|80606636|FG002|Overall Study|Death|0|||
27664082|NCT02661490|80606637|FG003|Overall Study|Death|1|||
27664083|NCT02661490|80606638|FG004|Overall Study|Death|0|||
27664084|NCT02661490|80606634|FG000|Overall Study|Reason not Specified|0|||
27664085|NCT02661490|80606635|FG001|Overall Study|Reason not Specified|0|||
27664086|NCT02661490|80606636|FG002|Overall Study|Reason not Specified|0|||
27664087|NCT02661490|80606637|FG003|Overall Study|Reason not Specified|0|||
27664088|NCT02661490|80606638|FG004|Overall Study|Reason not Specified|1|||
27664089|NCT03214250|80606639|FG000|Overall Study|Death|5|||
27664090|NCT03214250|80606640|FG001|Overall Study|Death|5|||
27664091|NCT03214250|80606641|FG002|Overall Study|Death|7|||
27664092|NCT03214250|80606642|FG003|Overall Study|Death|4|||
27664093|NCT03214250|80606643|FG004|Overall Study|Death|23|||
27664094|NCT03214250|80606644|FG005|Overall Study|Death|23|||
27771603|NCT03954704|80993042|FG001|Overall Study|Lost to Follow-up|0|||
27964632|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27964633|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27964634|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
27964635|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
27664095|NCT03214250|80606645|FG006|Overall Study|Death|24|||
27664096|NCT03214250|80606639|FG000|Overall Study|Lost to Follow-up|0|||
27664097|NCT03214250|80606640|FG001|Overall Study|Lost to Follow-up|0|||
27664098|NCT03214250|80606641|FG002|Overall Study|Lost to Follow-up|0|||
27664099|NCT03214250|80606642|FG003|Overall Study|Lost to Follow-up|1|||
27771604|NCT03954704|80993043|FG002|Overall Study|Lost to Follow-up|0|||
27964636|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
27664100|NCT03214250|80606643|FG004|Overall Study|Lost to Follow-up|1|||
27771605|NCT03954704|80993044|FG003|Overall Study|Lost to Follow-up|0|||
27664101|NCT03214250|80606644|FG005|Overall Study|Lost to Follow-up|2|||
27664102|NCT03214250|80606645|FG006|Overall Study|Lost to Follow-up|0|||
27664103|NCT03214250|80606639|FG000|Overall Study|Other|0|||
27664104|NCT03214250|80606640|FG001|Overall Study|Other|0|||
27664105|NCT03214250|80606641|FG002|Overall Study|Other|0|||
27664106|NCT03214250|80606642|FG003|Overall Study|Other|0|||
27664107|NCT03214250|80606643|FG004|Overall Study|Other|1|||
27664108|NCT03214250|80606644|FG005|Overall Study|Other|1|||
27664109|NCT03214250|80606645|FG006|Overall Study|Other|2|||
27664110|NCT03214250|80606639|FG000|Overall Study|Remains on Study|2|||
27664111|NCT03214250|80606640|FG001|Overall Study|Remains on Study|2|||
27664112|NCT03214250|80606641|FG002|Overall Study|Remains on Study|0|||
27664113|NCT03214250|80606642|FG003|Overall Study|Remains on Study|1|||
27664114|NCT03214250|80606643|FG004|Overall Study|Remains on Study|7|||
27664115|NCT03214250|80606644|FG005|Overall Study|Remains on Study|5|||
27664116|NCT03214250|80606645|FG006|Overall Study|Remains on Study|3|||
27664117|NCT03214250|80606639|FG000|Overall Study|Withdrawal by Subject|0|||
27664118|NCT03214250|80606640|FG001|Overall Study|Withdrawal by Subject|0|||
27664119|NCT03214250|80606641|FG002|Overall Study|Withdrawal by Subject|1|||
27664120|NCT03214250|80606642|FG003|Overall Study|Withdrawal by Subject|2|||
27664121|NCT03214250|80606643|FG004|Overall Study|Withdrawal by Subject|5|||
27664122|NCT03214250|80606644|FG005|Overall Study|Withdrawal by Subject|0|||
27664123|NCT03214250|80606645|FG006|Overall Study|Withdrawal by Subject|2|||
27664124|NCT01002547|80606646|FG000|Overall Study|Withdrawal by Subject|4|||
27664125|NCT01002547|80606647|FG001|Overall Study|Withdrawal by Subject|0|||
27664126|NCT01002547|80606648|FG002|Overall Study|Withdrawal by Subject|5|||
27664127|NCT01002547|80606646|FG000|Overall Study|Lost to Follow-up|2|||
27664128|NCT01002547|80606647|FG001|Overall Study|Lost to Follow-up|1|||
27664129|NCT01002547|80606648|FG002|Overall Study|Lost to Follow-up|1|||
27664130|NCT01002547|80606646|FG000|Overall Study|Physician Decision|1|||
27664131|NCT01002547|80606647|FG001|Overall Study|Physician Decision|0|||
27664132|NCT01002547|80606648|FG002|Overall Study|Physician Decision|0|||
27664133|NCT01002547|80606646|FG000|Overall Study|Death|0|||
27664134|NCT01002547|80606647|FG001|Overall Study|Death|2|||
27964637|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
27964638|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27964639|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27964640|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
27964641|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27664135|NCT01002547|80606648|FG002|Overall Study|Death|2|||
27664136|NCT01002547|80606646|FG000|Overall Study|Adverse Event|1|||
27664137|NCT01002547|80606647|FG001|Overall Study|Adverse Event|0|||
27664138|NCT01002547|80606648|FG002|Overall Study|Adverse Event|0|||
27664139|NCT03723915|80606649|FG000|Screening|Failed to meet screening requirements.|2|||
27664140|NCT03723915|80606649|FG000|On Treatment|Failed to meet treatment requirements|2|||
27664141|NCT00740597|80606650|FG000|Overall Study|insurance would not cover treatment|1|||
27664142|NCT00690378|80606651|FG000|Overall Study|Adverse Event|1|||
27664143|NCT00690378|80606652|FG001|Overall Study|Adverse Event|0|||
27664144|NCT00690378|80606651|FG000|Overall Study|Withdrawal by Subject|2|||
27664145|NCT00690378|80606652|FG001|Overall Study|Withdrawal by Subject|0|||
27664146|NCT00690378|80606651|FG000|Overall Study|Protocol Violation|1|||
27664147|NCT00690378|80606652|FG001|Overall Study|Protocol Violation|0|||
27664148|NCT00690378|80606651|FG000|Overall Study|Lost to Follow-up|2|||
27664149|NCT00690378|80606652|FG001|Overall Study|Lost to Follow-up|3|||
27664150|NCT00690378|80606651|FG000|Overall Study|Did not meet inc/exc criteria|13|||
27664151|NCT00690378|80606652|FG001|Overall Study|Did not meet inc/exc criteria|11|||
27664152|NCT00690378|80606651|FG000|Overall Study|Social problem|1|||
27664153|NCT00690378|80606652|FG001|Overall Study|Social problem|0|||
27664154|NCT00655668|80606653|FG000|Overall Study|Adverse Event|6|||
27664155|NCT00655668|80606653|FG000|Overall Study|Death|5|||
27664156|NCT00655668|80606653|FG000|Overall Study|Disease Progression|27|||
27664157|NCT00655668|80606653|FG000|Overall Study|Study Terminated|9|||
27664158|NCT00655668|80606653|FG000|Overall Study|Other|1|||
27664159|NCT00655668|80606653|FG000|Overall Study|New Lymphoma Treatment Started|4|||
27664160|NCT00655668|80606653|FG000|Overall Study|Withdrawal by Subject|2|||
27771606|NCT03954704|80993045|FG004|Overall Study|Lost to Follow-up|0|||
27771607|NCT03954704|80993046|FG005|Overall Study|Lost to Follow-up|0|||
27771608|NCT03954704|80993047|FG006|Overall Study|Lost to Follow-up|1|||
27771609|NCT03954704|80993041|FG000|Overall Study|Study Terminated by Sponsor|0|||
27664161|NCT00985621|80606654|FG000|Overall Study|Adverse Event|2|||
27664162|NCT00985621|80606655|FG001|Overall Study|Adverse Event|3|||
27664163|NCT00985621|80606656|FG002|Overall Study|Adverse Event|4|||
27664164|NCT00985621|80606657|FG003|Overall Study|Adverse Event|16|||
27771610|NCT03954704|80993042|FG001|Overall Study|Study Terminated by Sponsor|0|||
27964642|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
27964643|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27664165|NCT00985621|80606654|FG000|Overall Study|Lack of Efficacy|10|||
27664166|NCT00985621|80606655|FG001|Overall Study|Lack of Efficacy|6|||
27664167|NCT00985621|80606656|FG002|Overall Study|Lack of Efficacy|5|||
27664168|NCT00985621|80606657|FG003|Overall Study|Lack of Efficacy|12|||
27664169|NCT00985621|80606654|FG000|Overall Study|Lost to Follow-up|2|||
27664170|NCT00985621|80606655|FG001|Overall Study|Lost to Follow-up|3|||
27664171|NCT00985621|80606656|FG002|Overall Study|Lost to Follow-up|4|||
27664172|NCT00985621|80606657|FG003|Overall Study|Lost to Follow-up|4|||
27664173|NCT00985621|80606654|FG000|Overall Study|Study Terminated by Sponsor|89|||
27664174|NCT00985621|80606655|FG001|Overall Study|Study Terminated by Sponsor|108|||
27664175|NCT00985621|80606656|FG002|Overall Study|Study Terminated by Sponsor|99|||
27664176|NCT00985621|80606657|FG003|Overall Study|Study Terminated by Sponsor|92|||
27664177|NCT00985621|80606654|FG000|Overall Study|Protocol Violation|1|||
27664178|NCT00985621|80606655|FG001|Overall Study|Protocol Violation|1|||
27664179|NCT00985621|80606656|FG002|Overall Study|Protocol Violation|1|||
27964644|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27771611|NCT03954704|80993043|FG002|Overall Study|Study Terminated by Sponsor|1|||
27771612|NCT03954704|80993044|FG003|Overall Study|Study Terminated by Sponsor|0|||
27771613|NCT03954704|80993045|FG004|Overall Study|Study Terminated by Sponsor|1|||
27771614|NCT03954704|80993046|FG005|Overall Study|Study Terminated by Sponsor|4|||
27771615|NCT03954704|80993047|FG006|Overall Study|Study Terminated by Sponsor|2|||
27771616|NCT03954704|80993041|FG000|Overall Study|Enrolled but not Treated|0|||
27771617|NCT03954704|80993042|FG001|Overall Study|Enrolled but not Treated|0|||
27771618|NCT03954704|80993043|FG002|Overall Study|Enrolled but not Treated|0|||
27771619|NCT03954704|80993044|FG003|Overall Study|Enrolled but not Treated|0|||
27771620|NCT03954704|80993045|FG004|Overall Study|Enrolled but not Treated|0|||
27771621|NCT03954704|80993046|FG005|Overall Study|Enrolled but not Treated|1|||
27771622|NCT03954704|80993047|FG006|Overall Study|Enrolled but not Treated|0|||
27771623|NCT00320190|80993048|FG000|First 12 Months|Completed but did not enter extension|5|||
27771624|NCT00320190|80993049|FG001|First 12 Months|Completed but did not enter extension|3|||
27771625|NCT00320190|80993048|FG000|First 12 Months|Sponsor terminated study|2|||
27771626|NCT00320190|80993049|FG001|First 12 Months|Sponsor terminated study|2|||
27771627|NCT00320190|80993048|FG000|First 12 Months|Lost to Follow-up|0|||
27771628|NCT00320190|80993049|FG001|First 12 Months|Lost to Follow-up|1|||
27771629|NCT00320190|80993048|FG000|First 12 Months|Enrollment failure|0|||
27771630|NCT00320190|80993049|FG001|First 12 Months|Enrollment failure|1|||
27771631|NCT00320190|80993048|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
27771632|NCT00320190|80993049|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
27771633|NCT00320190|80993048|FG000|First 12 Months|Investigator request|0|||
27771634|NCT00320190|80993049|FG001|First 12 Months|Investigator request|1|||
27771635|NCT00320190|80993048|FG000|First 12 Months|Study drug toxicity|0|||
27771636|NCT00320190|80993049|FG001|First 12 Months|Study drug toxicity|1|||
27771637|NCT00320190|80993048|FG000|First 12 Months|Withdrawal by Subject|0|||
27771638|NCT00320190|80993049|FG001|First 12 Months|Withdrawal by Subject|1|||
27771639|NCT00320190|80993048|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
27771640|NCT00320190|80993049|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
27771641|NCT00320190|80993048|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
27964645|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27964646|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
27964647|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
27664180|NCT00985621|80606657|FG003|Overall Study|Protocol Violation|0|||
27664181|NCT00985621|80606654|FG000|Overall Study|Withdrawal by Subject|8|||
27664182|NCT00985621|80606655|FG001|Overall Study|Withdrawal by Subject|10|||
27664183|NCT00985621|80606656|FG002|Overall Study|Withdrawal by Subject|8|||
27664184|NCT00985621|80606657|FG003|Overall Study|Withdrawal by Subject|12|||
27664185|NCT00985621|80606654|FG000|Overall Study|Other|1|||
27664186|NCT00985621|80606655|FG001|Overall Study|Other|0|||
27664187|NCT00985621|80606656|FG002|Overall Study|Other|0|||
27664188|NCT00985621|80606657|FG003|Overall Study|Other|0|||
27664189|NCT00985621|80606654|FG000|Overall Study|Randomized but not Treated|1|||
27664190|NCT00985621|80606655|FG001|Overall Study|Randomized but not Treated|0|||
27664191|NCT00985621|80606656|FG002|Overall Study|Randomized but not Treated|2|||
27664192|NCT00985621|80606657|FG003|Overall Study|Randomized but not Treated|1|||
27664193|NCT04167085|80606658|FG000|Baseline|Withdrawal by Subject|2|||
27664194|NCT04167085|80606659|FG001|Baseline|Withdrawal by Subject|1|||
27664195|NCT04167085|80606658|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
27664196|NCT04167085|80606659|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
27664197|NCT00582114|80606670|FG000|Overall Study|Death|4|||
27664198|NCT00582114|80606671|FG001|Overall Study|Death|4|||
27664199|NCT00582114|80606670|FG000|Overall Study|Kidney Transplant|3|||
27664200|NCT00582114|80606671|FG001|Overall Study|Kidney Transplant|1|||
27664201|NCT00582114|80606670|FG000|Overall Study|Lost to Follow-up|7|||
27664202|NCT00582114|80606671|FG001|Overall Study|Lost to Follow-up|6|||
27569130|NCT02658890|80271477|FG007|Treatment Phase|Withdrawal by Subject|0|||
27664203|NCT00582114|80606670|FG000|Overall Study|Withdrawal by Subject|8|||
27664204|NCT00582114|80606671|FG001|Overall Study|Withdrawal by Subject|16|||
27664205|NCT00582114|80606670|FG000|Overall Study|Adverse Event|1|||
27664206|NCT00582114|80606671|FG001|Overall Study|Adverse Event|1|||
27664207|NCT00582114|80606670|FG000|Overall Study|Physician Decision|0|||
27664208|NCT00582114|80606671|FG001|Overall Study|Physician Decision|6|||
27771642|NCT00320190|80993049|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
27771643|NCT00320190|80993048|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
27771644|NCT00320190|80993049|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
27771645|NCT03924427|80993050|FG000|Overall Study|Adverse Event|4|||
27771646|NCT03924427|80993050|FG000|Overall Study|Lack of Efficacy|1|||
27771647|NCT03924427|80993050|FG000|Overall Study|Withdrawal by Subject|1|||
27771648|NCT02143141|80993051|FG000|Overall Study|pain scores at 24 hours not collected|1|||
27771649|NCT02143141|80993052|FG001|Overall Study|pain scores at 24 hours not collected|0|||
27771650|NCT02996500|80993055|FG000|Overall Study|Adverse Event|1|||
27771651|NCT02996500|80993056|FG001|Overall Study|Adverse Event|1|||
27771652|NCT02996500|80993057|FG002|Overall Study|Adverse Event|4|||
27771653|NCT02996500|80993058|FG003|Overall Study|Adverse Event|3|||
27771654|NCT02996500|80993059|FG004|Overall Study|Adverse Event|1|||
27771655|NCT02996500|80993060|FG005|Overall Study|Adverse Event|2|||
27771656|NCT02996500|80993055|FG000|Overall Study|Lack of Efficacy|0|||
27771657|NCT02996500|80993056|FG001|Overall Study|Lack of Efficacy|0|||
27771658|NCT02996500|80993057|FG002|Overall Study|Lack of Efficacy|0|||
27771659|NCT02996500|80993058|FG003|Overall Study|Lack of Efficacy|0|||
27771660|NCT02996500|80993059|FG004|Overall Study|Lack of Efficacy|2|||
27771661|NCT02996500|80993060|FG005|Overall Study|Lack of Efficacy|0|||
27771662|NCT02996500|80993055|FG000|Overall Study|Lost to Follow-up|1|||
27771663|NCT02996500|80993056|FG001|Overall Study|Lost to Follow-up|0|||
27771664|NCT02996500|80993057|FG002|Overall Study|Lost to Follow-up|0|||
27771665|NCT02996500|80993058|FG003|Overall Study|Lost to Follow-up|0|||
27771666|NCT02996500|80993059|FG004|Overall Study|Lost to Follow-up|0|||
27771667|NCT02996500|80993060|FG005|Overall Study|Lost to Follow-up|1|||
27771668|NCT02996500|80993055|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27771669|NCT02996500|80993056|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27771670|NCT02996500|80993057|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
27771671|NCT02996500|80993058|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
27771672|NCT02996500|80993059|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
27771673|NCT02996500|80993060|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27771674|NCT02996500|80993055|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27771675|NCT02996500|80993056|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27771676|NCT02996500|80993057|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27771677|NCT02996500|80993058|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27771678|NCT02996500|80993059|FG004|Overall Study|Non-Compliance With Study Drug|0|||
27771679|NCT02996500|80993060|FG005|Overall Study|Non-Compliance With Study Drug|1|||
27771680|NCT02996500|80993055|FG000|Overall Study|Progressive Disease|1|||
27771681|NCT02996500|80993056|FG001|Overall Study|Progressive Disease|0|||
27771682|NCT02996500|80993057|FG002|Overall Study|Progressive Disease|0|||
27771683|NCT02996500|80993058|FG003|Overall Study|Progressive Disease|0|||
27771684|NCT02996500|80993059|FG004|Overall Study|Progressive Disease|0|||
27771685|NCT02996500|80993060|FG005|Overall Study|Progressive Disease|0|||
27771686|NCT02996500|80993055|FG000|Overall Study|Other|2|||
27771687|NCT02996500|80993056|FG001|Overall Study|Other|0|||
27771688|NCT02996500|80993057|FG002|Overall Study|Other|2|||
27771689|NCT02996500|80993058|FG003|Overall Study|Other|0|||
27771690|NCT02996500|80993059|FG004|Overall Study|Other|0|||
27771691|NCT02996500|80993060|FG005|Overall Study|Other|0|||
27771692|NCT02996500|80993055|FG000|Overall Study|Protocol Violation|0|||
27771693|NCT02996500|80993056|FG001|Overall Study|Protocol Violation|0|||
27771694|NCT02996500|80993057|FG002|Overall Study|Protocol Violation|0|||
27771695|NCT02996500|80993058|FG003|Overall Study|Protocol Violation|1|||
27771696|NCT02996500|80993059|FG004|Overall Study|Protocol Violation|0|||
27771697|NCT02996500|80993060|FG005|Overall Study|Protocol Violation|0|||
27771698|NCT02996500|80993055|FG000|Overall Study|Withdrawal by Subject|3|||
27771699|NCT02996500|80993056|FG001|Overall Study|Withdrawal by Subject|0|||
27771700|NCT02996500|80993057|FG002|Overall Study|Withdrawal by Subject|3|||
27771701|NCT02996500|80993058|FG003|Overall Study|Withdrawal by Subject|0|||
27771702|NCT02996500|80993059|FG004|Overall Study|Withdrawal by Subject|2|||
27771703|NCT02996500|80993060|FG005|Overall Study|Withdrawal by Subject|0|||
27771704|NCT02903368|80993061|FG000|Part 1|Adverse Event|3|||
27771705|NCT02903368|80993062|FG001|Part 1|Adverse Event|0|||
27964648|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27964649|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
27964650|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
27771706|NCT02903368|80993063|FG002|Part 1|Adverse Event|0|||
27964651|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
27569131|NCT02658890|80271478|FG008|Treatment Phase|Withdrawal by Subject|0|||
27771707|NCT02903368|80993064|FG003|Part 1|Adverse Event|0|||
27771708|NCT02903368|80993061|FG000|Part 1|Withdrawal by Subject|1|||
27771709|NCT02903368|80993062|FG001|Part 1|Withdrawal by Subject|0|||
27964652|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
27771710|NCT02903368|80993063|FG002|Part 1|Withdrawal by Subject|0|||
27771711|NCT02903368|80993064|FG003|Part 1|Withdrawal by Subject|0|||
27771712|NCT02903368|80993061|FG000|Part 2|Adverse Event|0|||
27771713|NCT02903368|80993062|FG001|Part 2|Adverse Event|0|||
27771714|NCT02903368|80993063|FG002|Part 2|Adverse Event|5|||
27771715|NCT02903368|80993064|FG003|Part 2|Adverse Event|0|||
27964653|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
27964654|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
27964655|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
27964656|NCT03989349|81701585|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
27964657|NCT03989349|81701586|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
27964658|NCT03989349|81701587|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
27964659|NCT03989349|81701588|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
27964660|NCT03989349|81701589|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
27964661|NCT03989349|81701590|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
27964662|NCT02298868|81701591|FG000|Overall Study|Adverse Event|1|||
27771716|NCT02903368|80993061|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
27771717|NCT02903368|80993062|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
27771718|NCT02903368|80993063|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
27771719|NCT02903368|80993064|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
27771720|NCT02903368|80993061|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
27771721|NCT02903368|80993062|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
27771722|NCT02903368|80993063|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
27771723|NCT02903368|80993064|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
27771724|NCT02903368|80993061|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
27771725|NCT02903368|80993062|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
27771726|NCT02903368|80993063|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
27771727|NCT02903368|80993064|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
27771728|NCT02000219|80993065|FG000|14-Week Study Period|Physician Decision|1|||
27771729|NCT02000219|80993065|FG000|14-Week Study Period|Adverse Event|1|||
27771730|NCT02000219|80993065|FG000|14-Week Study Period|Underwent transplantation|1|||
27771731|NCT02000219|80993065|FG000|Continuation Period|Withdrawal by Subject|1|||
27771732|NCT02000219|80993065|FG000|Continuation Period|Had liver transplant|2|||
27771733|NCT02000219|80993065|FG000|Continuation Period|Non-compliance with study drug|2|||
27771734|NCT01305941|80993074|FG000|Overall Study|Adverse Event|6|||
27771735|NCT01305941|80993074|FG000|Overall Study|Clinical decline|2|||
27771736|NCT01305941|80993074|FG000|Overall Study|Withdrawal by Subject|1|||
27771737|NCT01305941|80993074|FG000|Overall Study|Death|1|||
27771738|NCT01060124|80993076|FG000|Overall Study|Other|16|||
27771739|NCT01060124|80993076|FG000|Overall Study|Adverse Event|14|||
27771740|NCT01060124|80993076|FG000|Overall Study|Withdrawal by Subject|7|||
27771741|NCT02975349|80993082|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27771742|NCT02975349|80993083|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27771743|NCT02975349|80993084|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
27771744|NCT02975349|80993085|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
27771745|NCT02975349|80993086|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27771746|NCT02975349|80993087|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27771747|NCT02975349|80993082|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27771748|NCT02975349|80993083|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27771749|NCT02975349|80993084|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27771750|NCT02975349|80993085|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27771751|NCT02975349|80993086|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27771752|NCT02975349|80993087|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27771753|NCT02975349|80993082|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
27771754|NCT02975349|80993083|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
27771755|NCT02975349|80993084|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
27771756|NCT02975349|80993085|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
27771757|NCT02975349|80993086|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
27771758|NCT02975349|80993087|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
27771759|NCT02975349|80993082|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
27964663|NCT02298868|81701591|FG000|Overall Study|Death|1|||
27964664|NCT02298868|81701591|FG000|Overall Study|Patient underwent transplant|1|||
27964665|NCT02013778|81701592|FG000|Overall Study|Death|4|||
27964666|NCT02013778|81701592|FG000|Overall Study|Withdrawal by Subject|1|||
27964667|NCT02013778|81701592|FG000|Overall Study|Physician Decision|1|||
27964668|NCT02013778|81701592|FG000|Overall Study|Adverse Event|1|||
27964669|NCT03299244|81701596|FG000|Overall Study|Withdrawal by Subject|34|||
27964670|NCT03299244|81701597|FG001|Overall Study|Withdrawal by Subject|29|||
27964671|NCT03299244|81701596|FG000|Overall Study|Decision by Sponsor|4|||
27964672|NCT03299244|81701597|FG001|Overall Study|Decision by Sponsor|5|||
27964673|NCT03299244|81701596|FG000|Overall Study|Death|9|||
27964674|NCT03299244|81701597|FG001|Overall Study|Death|4|||
27664209|NCT00582114|80606670|FG000|Overall Study|Stopped by data safety monitoring board|19|||
27771760|NCT02975349|80993083|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
27771761|NCT02975349|80993084|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
27771762|NCT02975349|80993085|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
27771763|NCT02975349|80993086|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
27771764|NCT02975349|80993087|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
27771765|NCT02975349|80993082|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
27771766|NCT02975349|80993083|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
27771767|NCT02975349|80993084|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
27771768|NCT02975349|80993085|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
27771769|NCT02975349|80993086|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
27771770|NCT02975349|80993087|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
27964675|NCT02702609|81701598|FG000|Overall Study|Lost to Follow-up|8|||
27964676|NCT02702609|81701599|FG001|Overall Study|Lost to Follow-up|4|||
27964677|NCT02702609|81701598|FG000|Overall Study|Physician Decision|1|||
27964678|NCT02702609|81701599|FG001|Overall Study|Physician Decision|0|||
27964679|NCT00635349|81701600|FG000|Overall Study|Other|8|||
27964680|NCT00635349|81701601|FG001|Overall Study|Other|6|||
27964681|NCT00635349|81701600|FG000|Overall Study|Protocol Violation|18|||
27964682|NCT00635349|81701601|FG001|Overall Study|Protocol Violation|22|||
27964683|NCT00635349|81701600|FG000|Overall Study|Withdrawal by Subject|3|||
27964684|NCT00635349|81701601|FG001|Overall Study|Withdrawal by Subject|8|||
27771771|NCT02975349|80993082|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
27771772|NCT02975349|80993083|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
27771773|NCT02975349|80993084|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
27771774|NCT02975349|80993085|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
27771775|NCT02975349|80993086|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
27771776|NCT02975349|80993087|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
27771777|NCT02975349|80993082|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27771778|NCT02975349|80993083|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27771779|NCT02975349|80993084|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
27771780|NCT02975349|80993085|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27771781|NCT02975349|80993086|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27771782|NCT02975349|80993087|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
27771783|NCT02975349|80993082|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27771784|NCT02975349|80993083|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
27771785|NCT02975349|80993084|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27771786|NCT02975349|80993085|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27771787|NCT02975349|80993086|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27771788|NCT02975349|80993087|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
27771789|NCT02975349|80993082|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27771790|NCT02975349|80993083|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27771791|NCT02975349|80993084|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27771792|NCT02975349|80993085|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
27771793|NCT02975349|80993086|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27771794|NCT02975349|80993087|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
27771795|NCT00633893|80993090|FG000|Overall Study|Death|1|||
27964685|NCT00635349|81701600|FG000|Overall Study|Lost to Follow-up|4|||
27964686|NCT00635349|81701601|FG001|Overall Study|Lost to Follow-up|3|||
27964687|NCT00635349|81701600|FG000|Overall Study|Adverse Event|11|||
27964688|NCT00635349|81701601|FG001|Overall Study|Adverse Event|9|||
27964689|NCT00224120|81701602|FG000|Overall Study|Adverse Event|10|||
27964690|NCT00224120|81701603|FG001|Overall Study|Adverse Event|4|||
27964691|NCT00224120|81701602|FG000|Overall Study|Protocol Violation|1|||
27964692|NCT00224120|81701603|FG001|Overall Study|Protocol Violation|0|||
27964693|NCT00224120|81701602|FG000|Overall Study|Withdrawal by Subject|5|||
27964694|NCT00224120|81701603|FG001|Overall Study|Withdrawal by Subject|10|||
27964695|NCT00224120|81701602|FG000|Overall Study|Lack of Efficacy|0|||
27964696|NCT00224120|81701603|FG001|Overall Study|Lack of Efficacy|2|||
27964697|NCT00224120|81701602|FG000|Overall Study|Lost to Follow-up|2|||
27964698|NCT00224120|81701603|FG001|Overall Study|Lost to Follow-up|3|||
27964699|NCT00224120|81701602|FG000|Overall Study|Other|4|||
27964700|NCT00224120|81701603|FG001|Overall Study|Other|5|||
27964701|NCT00005947|81701604|FG000|Overall Study|Death|54|||
27964702|NCT00005947|81701605|FG001|Overall Study|Death|40|||
27964703|NCT00005947|81701604|FG000|Overall Study|Patient Refused to Continue|2|||
27964704|NCT00005947|81701605|FG001|Overall Study|Patient Refused to Continue|1|||
27964705|NCT00005947|81701604|FG000|Overall Study|Site Closure|1|||
27771796|NCT00633893|80993091|FG001|Overall Study|Death|3|||
27771797|NCT00633893|80993092|FG002|Overall Study|Death|9|||
27771798|NCT00633893|80993090|FG000|Overall Study|Adverse Event|65|||
27964706|NCT00005947|81701605|FG001|Overall Study|Site Closure|0|||
27964707|NCT00564733|81701608|FG000|Overall Study|Withdrawal by Subject|4|||
27964708|NCT00564733|81701608|FG000|Overall Study|Ineligible|5|||
27964709|NCT00583752|81701609|FG000|Overall Study|Lost to Follow-up|5|||
27964710|NCT00583752|81701610|FG001|Overall Study|Lost to Follow-up|5|||
27964711|NCT01534351|81701614|FG000|Overall Study|Study Terminated Early|1|||
27964712|NCT01534351|81701615|FG001|Overall Study|Study Terminated Early|0|||
27964713|NCT01534351|81701616|FG002|Overall Study|Study Terminated Early|0|||
27964714|NCT00780143|81701619|FG000|Overall Study|Progressive disease|1|||
27964715|NCT00780143|81701619|FG000|Overall Study|Toxicity|1|||
27771799|NCT00633893|80993091|FG001|Overall Study|Adverse Event|58|||
27771800|NCT00633893|80993092|FG002|Overall Study|Adverse Event|126|||
27771801|NCT00633893|80993090|FG000|Overall Study|Withdrawal by Subject|7|||
27771802|NCT00633893|80993091|FG001|Overall Study|Withdrawal by Subject|12|||
27964716|NCT00780143|81701619|FG000|Overall Study|Adverse Event|1|||
27771803|NCT00633893|80993092|FG002|Overall Study|Withdrawal by Subject|6|||
27771804|NCT00633893|80993090|FG000|Overall Study|Lost to Follow-up|2|||
27964717|NCT03640507|81701620|FG000|Overall Study|Withdrawal by Subject|0|||
27964718|NCT03640507|81701621|FG001|Overall Study|Withdrawal by Subject|0|||
27964719|NCT03640507|81701622|FG002|Overall Study|Withdrawal by Subject|1|||
27964720|NCT03248167|81701623|FG000|Overall Study|Withdrawal by Subject|2|||
27964721|NCT03248167|81701624|FG001|Overall Study|Withdrawal by Subject|2|||
27964722|NCT03248167|81701623|FG000|Overall Study|Physician Decision|0|||
27964723|NCT03248167|81701624|FG001|Overall Study|Physician Decision|1|||
27964724|NCT03248167|81701623|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
27964725|NCT03248167|81701624|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
27964726|NCT03248167|81701623|FG000|Overall Study|Lost to Follow-up|1|||
27964727|NCT03248167|81701624|FG001|Overall Study|Lost to Follow-up|0|||
27964728|NCT01700959|81701627|FG000|Overall Study|Adverse Event|0|||
27964729|NCT01700959|81701628|FG001|Overall Study|Adverse Event|1|||
27964730|NCT01700959|81701629|FG002|Overall Study|Adverse Event|1|||
27964731|NCT01700959|81701630|FG003|Overall Study|Adverse Event|2|||
27964732|NCT01700959|81701631|FG004|Overall Study|Adverse Event|0|||
27964733|NCT01700959|81701632|FG005|Overall Study|Adverse Event|2|||
27964734|NCT01700959|81701627|FG000|Overall Study|Withdrawal by Subject|15|||
27964735|NCT01700959|81701628|FG001|Overall Study|Withdrawal by Subject|9|||
27964736|NCT01700959|81701629|FG002|Overall Study|Withdrawal by Subject|12|||
27964737|NCT01700959|81701630|FG003|Overall Study|Withdrawal by Subject|11|||
27964738|NCT01700959|81701631|FG004|Overall Study|Withdrawal by Subject|8|||
27964739|NCT01700959|81701632|FG005|Overall Study|Withdrawal by Subject|12|||
27964740|NCT01700959|81701627|FG000|Overall Study|Ineligible|2|||
27964741|NCT01700959|81701628|FG001|Overall Study|Ineligible|1|||
27964742|NCT01700959|81701629|FG002|Overall Study|Ineligible|2|||
27964743|NCT01700959|81701630|FG003|Overall Study|Ineligible|0|||
27771805|NCT00633893|80993091|FG001|Overall Study|Lost to Follow-up|4|||
27771806|NCT00633893|80993092|FG002|Overall Study|Lost to Follow-up|8|||
27771807|NCT00633893|80993090|FG000|Overall Study|Poor/non-compliance|5|||
27771808|NCT00633893|80993091|FG001|Overall Study|Poor/non-compliance|12|||
27771809|NCT00633893|80993092|FG002|Overall Study|Poor/non-compliance|3|||
27771810|NCT00633893|80993090|FG000|Overall Study|Pregnancy|2|||
27771811|NCT00633893|80993091|FG001|Overall Study|Pregnancy|1|||
27771812|NCT00633893|80993092|FG002|Overall Study|Pregnancy|1|||
27771813|NCT00633893|80993090|FG000|Overall Study|Not meet/no longer meets criteria|4|||
27771814|NCT00633893|80993091|FG001|Overall Study|Not meet/no longer meets criteria|6|||
27771815|NCT00633893|80993092|FG002|Overall Study|Not meet/no longer meets criteria|4|||
27964744|NCT01700959|81701631|FG004|Overall Study|Ineligible|0|||
27964745|NCT01700959|81701632|FG005|Overall Study|Ineligible|1|||
27664210|NCT00582114|80606671|FG001|Overall Study|Stopped by data safety monitoring board|20|||
27664211|NCT01260142|80606674|FG000|Treatment Period 1|Study on hold|1|||
27664212|NCT01260142|80606675|FG001|Treatment Period 1|Study on hold|1|||
27664213|NCT01260142|80606676|FG002|Treatment Period 1|Study on hold|0|||
27664214|NCT01260142|80606677|FG003|Treatment Period 1|Study on hold|0|||
27664215|NCT01260142|80606678|FG004|Treatment Period 1|Study on hold|1|||
27664216|NCT01260142|80606679|FG005|Treatment Period 1|Study on hold|2|||
27664217|NCT01260142|80606674|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
27664218|NCT01260142|80606675|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
27664219|NCT01260142|80606676|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
27664220|NCT01260142|80606677|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
27664221|NCT01260142|80606678|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
27664222|NCT01260142|80606679|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
27664223|NCT01260142|80606674|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27664224|NCT01260142|80606675|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27664225|NCT01260142|80606676|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27664226|NCT01260142|80606677|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27964746|NCT01700959|81701627|FG000|Overall Study|Noncompliant|9|||
27964747|NCT01700959|81701628|FG001|Overall Study|Noncompliant|9|||
27964748|NCT01700959|81701629|FG002|Overall Study|Noncompliant|17|||
27964749|NCT01700959|81701630|FG003|Overall Study|Noncompliant|18|||
27964750|NCT01700959|81701631|FG004|Overall Study|Noncompliant|15|||
27771816|NCT00633893|80993090|FG000|Overall Study|Other|28|||
27964751|NCT01700959|81701632|FG005|Overall Study|Noncompliant|9|||
27964752|NCT01700959|81701627|FG000|Overall Study|Side effects|1|||
27964753|NCT01700959|81701628|FG001|Overall Study|Side effects|4|||
27771817|NCT00633893|80993091|FG001|Overall Study|Other|33|||
27771818|NCT00633893|80993092|FG002|Overall Study|Other|31|||
27771819|NCT00479167|80993093|FG000|Overall Study|Withdrawal by Subject|1|||
27771820|NCT00373880|80993099|FG000|Overall Study|Physician Decision|3|||
27771821|NCT00373880|80993099|FG000|Overall Study|Arrested|1|||
27771822|NCT00373880|80993099|FG000|Overall Study|Protocol Violation|14|||
27771823|NCT02972593|80993100|FG000|Overall Study|Lost to Follow-up|19|||
27771824|NCT02972593|80993101|FG001|Overall Study|Lost to Follow-up|15|||
27771825|NCT02972593|80993100|FG000|Overall Study|Protocol Violation|1|||
27771826|NCT02972593|80993101|FG001|Overall Study|Protocol Violation|0|||
27771827|NCT02443155|80993102|FG000|Overall Study|Adverse Event|3|||
27771828|NCT02443155|80993103|FG001|Overall Study|Adverse Event|4|||
27771829|NCT02443155|80993104|FG002|Overall Study|Adverse Event|1|||
27771830|NCT02443155|80993105|FG003|Overall Study|Adverse Event|2|||
27771831|NCT02443155|80993102|FG000|Overall Study|Unclassified|0|||
27771832|NCT02443155|80993103|FG001|Overall Study|Unclassified|0|||
27771833|NCT02443155|80993104|FG002|Overall Study|Unclassified|2|||
27771834|NCT02443155|80993105|FG003|Overall Study|Unclassified|1|||
27771835|NCT02443155|80993102|FG000|Overall Study|Withdrawal by Subject|4|||
27771836|NCT02443155|80993103|FG001|Overall Study|Withdrawal by Subject|7|||
27771837|NCT02443155|80993104|FG002|Overall Study|Withdrawal by Subject|3|||
27771838|NCT02443155|80993105|FG003|Overall Study|Withdrawal by Subject|9|||
27771839|NCT02443155|80993102|FG000|Overall Study|Pregnancy|3|||
27771840|NCT02443155|80993103|FG001|Overall Study|Pregnancy|1|||
27771841|NCT02443155|80993104|FG002|Overall Study|Pregnancy|1|||
27771842|NCT02443155|80993105|FG003|Overall Study|Pregnancy|2|||
27771843|NCT02443155|80993102|FG000|Overall Study|Lost to Follow-up|1|||
27771844|NCT02443155|80993103|FG001|Overall Study|Lost to Follow-up|2|||
27964754|NCT01700959|81701629|FG002|Overall Study|Side effects|8|||
27964755|NCT01700959|81701630|FG003|Overall Study|Side effects|4|||
27964756|NCT01700959|81701631|FG004|Overall Study|Side effects|4|||
27964757|NCT01700959|81701632|FG005|Overall Study|Side effects|1|||
27964758|NCT00700882|81701633|FG000|Overall Study|Never received treatment|6|||
27964759|NCT00700882|81701633|FG000|Overall Study|Ineligible|2|||
27964760|NCT00700882|81701633|FG000|Overall Study|No KIT mutation|51|||
27964761|NCT04153981|81701640|FG000|Overall Study|Death|1|||
27964762|NCT04153981|81701640|FG000|Overall Study|Withdrawal by Subject|24|||
27964763|NCT04153981|81701640|FG000|Overall Study|Lost to Follow-up|1|||
27964764|NCT04153981|81701640|FG000|Overall Study|Physician Decision|1|||
27964765|NCT04153981|81701640|FG000|Overall Study|Due to Unavailable Glucometer|1|||
27964766|NCT04153981|81701640|FG000|Overall Study|Covid 19|52|||
27964767|NCT04153981|81701640|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
27964768|NCT04153981|81701640|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
27964769|NCT00107900|81701641|FG000|Overall Study|Adverse Event|3|||
27964770|NCT00107900|81701642|FG001|Overall Study|Adverse Event|2|||
27964771|NCT00107900|81701643|FG002|Overall Study|Adverse Event|10|||
27964772|NCT00107900|81701644|FG003|Overall Study|Adverse Event|3|||
27964773|NCT00107900|81701645|FG004|Overall Study|Adverse Event|5|||
27964774|NCT00107900|81701646|FG005|Overall Study|Adverse Event|3|||
27964775|NCT00107900|81701641|FG000|Overall Study|Death|0|||
27964776|NCT00107900|81701642|FG001|Overall Study|Death|0|||
27964777|NCT00107900|81701643|FG002|Overall Study|Death|0|||
27964778|NCT00107900|81701644|FG003|Overall Study|Death|0|||
27964779|NCT00107900|81701645|FG004|Overall Study|Death|1|||
27964780|NCT00107900|81701646|FG005|Overall Study|Death|0|||
27964781|NCT00107900|81701641|FG000|Overall Study|Lost to Follow-up|4|||
27964782|NCT00107900|81701642|FG001|Overall Study|Lost to Follow-up|1|||
27964783|NCT00107900|81701643|FG002|Overall Study|Lost to Follow-up|3|||
27771845|NCT02443155|80993104|FG002|Overall Study|Lost to Follow-up|0|||
27771846|NCT02443155|80993105|FG003|Overall Study|Lost to Follow-up|1|||
27771847|NCT02443155|80993102|FG000|Overall Study|Protocol Violation|1|||
27964784|NCT00107900|81701644|FG003|Overall Study|Lost to Follow-up|2|||
27964785|NCT00107900|81701645|FG004|Overall Study|Lost to Follow-up|5|||
27964786|NCT00107900|81701646|FG005|Overall Study|Lost to Follow-up|5|||
27771848|NCT02443155|80993103|FG001|Overall Study|Protocol Violation|0|||
27771849|NCT02443155|80993104|FG002|Overall Study|Protocol Violation|1|||
27771850|NCT02443155|80993105|FG003|Overall Study|Protocol Violation|1|||
27964787|NCT00107900|81701641|FG000|Overall Study|Protocol Violation|1|||
27964788|NCT00107900|81701642|FG001|Overall Study|Protocol Violation|0|||
27964789|NCT00107900|81701643|FG002|Overall Study|Protocol Violation|5|||
27964790|NCT00107900|81701644|FG003|Overall Study|Protocol Violation|5|||
27964791|NCT00107900|81701645|FG004|Overall Study|Protocol Violation|7|||
27964792|NCT00107900|81701646|FG005|Overall Study|Protocol Violation|0|||
27771851|NCT02443155|80993102|FG000|Overall Study|Death|0|||
27771852|NCT02443155|80993103|FG001|Overall Study|Death|0|||
27771853|NCT02443155|80993104|FG002|Overall Study|Death|1|||
27964793|NCT00107900|81701641|FG000|Overall Study|Withdrawal by Subject|1|||
27964794|NCT00107900|81701642|FG001|Overall Study|Withdrawal by Subject|0|||
27964795|NCT00107900|81701643|FG002|Overall Study|Withdrawal by Subject|5|||
27771854|NCT02443155|80993105|FG003|Overall Study|Death|0|||
27771855|NCT02182999|80993106|FG000|Overall Study|Adverse Event|4|||
27771856|NCT02182999|80993107|FG001|Overall Study|Adverse Event|3|||
27771857|NCT02182999|80993106|FG000|Overall Study|Physician Decision|1|||
27771858|NCT02182999|80993107|FG001|Overall Study|Physician Decision|0|||
27771859|NCT00561340|80993108|FG000|Overall Study|refused to drink pediasure|6|||
27771860|NCT00561340|80993109|FG001|Overall Study|refused to drink pediasure|0|||
27771861|NCT01624467|80993110|FG000|Overall Study|Withdrawal by Subject|2|||
27771862|NCT01624467|80993110|FG000|Overall Study|Lost to Follow-up|1|||
27771863|NCT01624467|80993110|FG000|Overall Study|Adverse Event|7|||
27771864|NCT01624467|80993110|FG000|Overall Study|Progressive Disease|19|||
27771865|NCT01624467|80993110|FG000|Overall Study|Per Sponsor Requirement|1|||
27771866|NCT01624467|80993110|FG000|Overall Study|Subject Withdrew from Treatment|1|||
27771873|NCT01156363|80993113|FG000|Overall Study|Adverse Event|6|||
27771874|NCT01156363|80993113|FG000|Overall Study|Insufficient Therapeutic Response|5|||
27771875|NCT01156363|80993113|FG000|Overall Study|Failure to Return|1|||
27771876|NCT01156363|80993113|FG000|Overall Study|Refused Treatment|4|||
27771877|NCT01156363|80993113|FG000|Overall Study|Other|6|||
27771878|NCT02903966|80993116|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
27771879|NCT02903966|80993117|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
27771880|NCT02903966|80993116|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
27771881|NCT02903966|80993117|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
27771882|NCT02903966|80993116|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
27771883|NCT02903966|80993117|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
27771884|NCT01628393|80993120|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
27771885|NCT01628393|80993121|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27771886|NCT01628393|80993122|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27771887|NCT01628393|80993123|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27771888|NCT01628393|80993124|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27964796|NCT00107900|81701644|FG003|Overall Study|Withdrawal by Subject|0|||
27771889|NCT01628393|80993120|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
27771890|NCT01628393|80993121|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
27771891|NCT01628393|80993122|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
27771892|NCT01628393|80993123|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
27771893|NCT01628393|80993124|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
27964797|NCT00107900|81701645|FG004|Overall Study|Withdrawal by Subject|1|||
27964798|NCT00107900|81701646|FG005|Overall Study|Withdrawal by Subject|1|||
27964799|NCT00107900|81701641|FG000|Overall Study|Administrative Reasons|1|||
27964800|NCT00107900|81701642|FG001|Overall Study|Administrative Reasons|0|||
27964801|NCT00107900|81701643|FG002|Overall Study|Administrative Reasons|2|||
27964802|NCT00107900|81701644|FG003|Overall Study|Administrative Reasons|2|||
27964803|NCT00107900|81701645|FG004|Overall Study|Administrative Reasons|2|||
27964804|NCT00107900|81701646|FG005|Overall Study|Administrative Reasons|0|||
27964805|NCT04245449|81701653|FG000|Overall Study|COVID shutdown|7|||
27964806|NCT01309997|81701654|FG000|Overall Study|Adverse Event|1|||
27964807|NCT01309997|81701655|FG001|Overall Study|Adverse Event|0|||
27964808|NCT01309997|81701654|FG000|Overall Study|Death|1|||
27964809|NCT01309997|81701655|FG001|Overall Study|Death|3|||
27964810|NCT01309997|81701654|FG000|Overall Study|Lack of Efficacy|2|||
27964811|NCT01309997|81701655|FG001|Overall Study|Lack of Efficacy|2|||
27964812|NCT01309997|81701654|FG000|Overall Study|Withdrawal by Subject|1|||
27964813|NCT01309997|81701655|FG001|Overall Study|Withdrawal by Subject|1|||
27964814|NCT03711370|81701658|FG000|Overall Study|Lost to Follow-up|16|||
27964815|NCT03711370|81701659|FG001|Overall Study|Lost to Follow-up|10|||
27964816|NCT03711370|81701658|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
27964817|NCT03711370|81701659|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
27569132|NCT02658890|80271479|FG009|Treatment Phase|Withdrawal by Subject|1|||
27664227|NCT01260142|80606678|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27664228|NCT01260142|80606679|FG005|Treatment Period 1|Withdrawal by Subject|1|||
27964818|NCT03818607|81701660|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
27964819|NCT03818607|81701661|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
27964820|NCT03818607|81701660|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
27771894|NCT01628393|80993120|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
27771895|NCT01628393|80993121|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
27964821|NCT03818607|81701661|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
27964822|NCT03818607|81701660|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
27964823|NCT03818607|81701661|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
27964824|NCT02752633|81701677|FG000|Overall Study|Withdrawal by Subject|1|||
27964825|NCT02248649|81701683|FG000|Overall Study|Death|7|||
27964826|NCT02248649|81701684|FG001|Overall Study|Death|11|||
27964827|NCT02248649|81701683|FG000|Overall Study|Lost to Follow-up|14|||
27964828|NCT02248649|81701684|FG001|Overall Study|Lost to Follow-up|10|||
27964829|NCT03951766|81701687|FG000|Treatment Phase|Lost to Follow-up|1|||
27964830|NCT03951766|81701687|FG000|Follow-up Phase|Lost to Follow-up|10|||
27964831|NCT00289289|81701688|FG000|Overall Study|Withdrawal by Subject|5|||
27964832|NCT00289289|81701689|FG001|Overall Study|Withdrawal by Subject|3|||
27964833|NCT00289289|81701690|FG002|Overall Study|Withdrawal by Subject|15|||
27964834|NCT00289289|81701688|FG000|Overall Study|Lost to Follow-up|1|||
27964835|NCT00289289|81701689|FG001|Overall Study|Lost to Follow-up|0|||
27964836|NCT00289289|81701690|FG002|Overall Study|Lost to Follow-up|1|||
27964837|NCT00289289|81701688|FG000|Overall Study|Death|4|||
27964838|NCT00289289|81701689|FG001|Overall Study|Death|2|||
27964839|NCT00289289|81701690|FG002|Overall Study|Death|5|||
27964840|NCT00289289|81701688|FG000|Overall Study|No implant attempted|0|||
27964841|NCT00289289|81701689|FG001|Overall Study|No implant attempted|0|||
27964842|NCT00289289|81701690|FG002|Overall Study|No implant attempted|1|||
27964843|NCT00289289|81701688|FG000|Overall Study|Physician Decision|1|||
27964844|NCT00289289|81701689|FG001|Overall Study|Physician Decision|0|||
27964845|NCT00289289|81701690|FG002|Overall Study|Physician Decision|6|||
27964846|NCT00289289|81701688|FG000|Overall Study|Non-study device implanted|2|||
27964847|NCT00289289|81701689|FG001|Overall Study|Non-study device implanted|1|||
27964848|NCT00289289|81701690|FG002|Overall Study|Non-study device implanted|3|||
27964849|NCT00289289|81701688|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
27964850|NCT00289289|81701689|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
27964851|NCT00289289|81701690|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
27771896|NCT01628393|80993122|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
27771897|NCT01628393|80993123|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
27771898|NCT01628393|80993124|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
27771899|NCT01628393|80993120|FG000|Blinded Active Extension Period|Adverse Event|0|||
27964852|NCT00289289|81701688|FG000|Overall Study|Other Exit Reason|6|||
27964853|NCT00289289|81701689|FG001|Overall Study|Other Exit Reason|4|||
27964854|NCT00289289|81701690|FG002|Overall Study|Other Exit Reason|12|||
27964855|NCT00526656|81701691|FG000|Overall Study|Death|1|||
27964856|NCT00526656|81701691|FG000|Overall Study|Refused surgery|1|||
27964857|NCT02482298|81701692|FG000|Overall Study|Withdrawal by Subject|2|||
27964858|NCT02482298|81701693|FG001|Overall Study|Withdrawal by Subject|1|||
27964859|NCT02482298|81701694|FG002|Overall Study|Withdrawal by Subject|2|||
27964860|NCT02482298|81701692|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
27964861|NCT02482298|81701693|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
27964862|NCT02482298|81701694|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
27964863|NCT02482298|81701692|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
27964864|NCT02482298|81701693|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
27964865|NCT02482298|81701694|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
27964866|NCT02482298|81701692|FG000|Overall Study|Lost to Follow-up|0|||
27964867|NCT02482298|81701693|FG001|Overall Study|Lost to Follow-up|1|||
27964868|NCT02482298|81701694|FG002|Overall Study|Lost to Follow-up|0|||
27964869|NCT01140867|81701695|FG000|Overall Study|Adverse Event|22|||
27964870|NCT01140867|81701695|FG000|Overall Study|Lack of Efficacy|3|||
27964871|NCT01140867|81701695|FG000|Overall Study|Lost to Follow-up|2|||
27964872|NCT01140867|81701695|FG000|Overall Study|Withdrawal by Subject|1|||
27569133|NCT02658890|80271480|FG010|Treatment Phase|Withdrawal by Subject|0|||
27964873|NCT01140867|81701695|FG000|Overall Study|Protocol Violation|1|||
27964874|NCT01140867|81701695|FG000|Overall Study|Uncooperative patient|2|||
27964875|NCT01140867|81701695|FG000|Overall Study|Medication Noncompliance|2|||
27964876|NCT01390298|81701698|FG000|Overall Study|Death|1|||
27964877|NCT01390298|81701698|FG000|Overall Study|long term ICU admission|1|||
27964878|NCT01390298|81701698|FG000|Overall Study|Withdrawal by Subject|14|||
27964879|NCT01390298|81701698|FG000|Overall Study|Lost to Follow-up|7|||
27964880|NCT01390298|81701698|FG000|Overall Study|Surgery cancelled|1|||
27964881|NCT01220401|81701701|FG000|Overall Study|Withdrawal by Subject|2|||
27964882|NCT01220401|81701701|FG000|Overall Study|Protocol Violation|1|||
27964883|NCT03098433|81701702|FG000|Overall Study|Withdrawal by Subject|10|||
27964884|NCT00632827|81701705|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
27964885|NCT00632827|81701705|FG000|Overall Study|Death|2|||
27964886|NCT00632827|81701705|FG000|Overall Study|Adverse Event|5|||
27964887|NCT00632827|81701705|FG000|Overall Study|Lost to Follow-up|1|||
27964888|NCT00342628|81701706|FG000|Overall Study|Withdrawal by Subject|19|||
27964889|NCT00342628|81701707|FG001|Overall Study|Withdrawal by Subject|19|||
27964890|NCT00342628|81701708|FG002|Overall Study|Withdrawal by Subject|18|||
27964891|NCT00342628|81701706|FG000|Overall Study|Death|1|||
27964892|NCT00342628|81701707|FG001|Overall Study|Death|1|||
27964893|NCT00342628|81701708|FG002|Overall Study|Death|0|||
27964894|NCT00342628|81701706|FG000|Overall Study|moved residence|0|||
27964895|NCT00342628|81701707|FG001|Overall Study|moved residence|1|||
27964896|NCT00342628|81701708|FG002|Overall Study|moved residence|1|||
27964897|NCT02547038|81701709|FG000|Overall Study|Lost to Follow-up|3|||
27964898|NCT02547038|81701710|FG001|Overall Study|Lost to Follow-up|2|||
27964899|NCT04599803|81701718|FG000|Overall Study|Withdrawal by Subject|5|||
27771900|NCT01628393|80993121|FG001|Blinded Active Extension Period|Adverse Event|1|||
27771901|NCT01628393|80993122|FG002|Blinded Active Extension Period|Adverse Event|0|||
27964900|NCT04599803|81701718|FG000|Overall Study|Lost to Follow-up|26|||
27964901|NCT03248531|81701723|FG000|Overall Study|Adverse Event|0|||
27964902|NCT03248531|81701724|FG001|Overall Study|Adverse Event|0|||
27964903|NCT03248531|81701725|FG002|Overall Study|Adverse Event|1|||
27964904|NCT03248531|81701723|FG000|Overall Study|Lost to Follow-up|1|||
27964905|NCT03248531|81701724|FG001|Overall Study|Lost to Follow-up|0|||
27964906|NCT03248531|81701725|FG002|Overall Study|Lost to Follow-up|5|||
27771902|NCT01628393|80993123|FG003|Blinded Active Extension Period|Adverse Event|2|||
27771903|NCT01628393|80993124|FG004|Blinded Active Extension Period|Adverse Event|2|||
27771904|NCT01628393|80993120|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
27771905|NCT01628393|80993121|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
27771906|NCT01628393|80993122|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
27771907|NCT01628393|80993123|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
27771908|NCT01628393|80993124|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
27771909|NCT01628393|80993120|FG000|Blinded Active Extension Period|Physician Decision|0|||
27771910|NCT01628393|80993121|FG001|Blinded Active Extension Period|Physician Decision|3|||
27771911|NCT01628393|80993122|FG002|Blinded Active Extension Period|Physician Decision|0|||
27771912|NCT01628393|80993123|FG003|Blinded Active Extension Period|Physician Decision|1|||
27771913|NCT01628393|80993124|FG004|Blinded Active Extension Period|Physician Decision|0|||
27771914|NCT01628393|80993120|FG000|Blinded Active Extension Period|Protocol Violation|0|||
27771915|NCT01628393|80993121|FG001|Blinded Active Extension Period|Protocol Violation|0|||
27771916|NCT01628393|80993122|FG002|Blinded Active Extension Period|Protocol Violation|2|||
27771917|NCT01628393|80993123|FG003|Blinded Active Extension Period|Protocol Violation|1|||
27771918|NCT01628393|80993124|FG004|Blinded Active Extension Period|Protocol Violation|0|||
27771919|NCT01628393|80993120|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
27771920|NCT01628393|80993121|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
27771921|NCT01628393|80993122|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
27771922|NCT01628393|80993123|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
27771923|NCT01628393|80993124|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
27771924|NCT03807778|80993125|FG000|Overall Study|Adverse Event|0|||
27771925|NCT03807778|80993126|FG001|Overall Study|Adverse Event|0|||
27771926|NCT03807778|80993127|FG002|Overall Study|Adverse Event|3|||
27771927|NCT03807778|80993128|FG003|Overall Study|Adverse Event|5|||
27771928|NCT03807778|80993125|FG000|Overall Study|Progressive Disease|4|||
27771929|NCT03807778|80993126|FG001|Overall Study|Progressive Disease|2|||
27771930|NCT03807778|80993127|FG002|Overall Study|Progressive Disease|8|||
27771931|NCT03807778|80993128|FG003|Overall Study|Progressive Disease|15|||
27771932|NCT03807778|80993125|FG000|Overall Study|Symptomatic Deterioration|0|||
27771933|NCT03807778|80993126|FG001|Overall Study|Symptomatic Deterioration|1|||
27771934|NCT03807778|80993127|FG002|Overall Study|Symptomatic Deterioration|0|||
27771935|NCT03807778|80993128|FG003|Overall Study|Symptomatic Deterioration|1|||
27771936|NCT03807778|80993125|FG000|Overall Study|Withdrawal by Subject|0|||
27771937|NCT03807778|80993126|FG001|Overall Study|Withdrawal by Subject|1|||
27771938|NCT03807778|80993127|FG002|Overall Study|Withdrawal by Subject|0|||
27771939|NCT03807778|80993128|FG003|Overall Study|Withdrawal by Subject|1|||
27771940|NCT03807778|80993125|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
27771941|NCT03807778|80993126|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
27771942|NCT03807778|80993127|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
27771943|NCT03807778|80993128|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
27771944|NCT00437203|80993129|FG000|Overall Study|Death|0|||
27771945|NCT00437203|80993130|FG001|Overall Study|Death|0|||
27964907|NCT03248531|81701723|FG000|Overall Study|Withdrawal by Subject|3|||
27964908|NCT03248531|81701724|FG001|Overall Study|Withdrawal by Subject|3|||
27771946|NCT00437203|80993131|FG002|Overall Study|Death|1|||
27964909|NCT03248531|81701725|FG002|Overall Study|Withdrawal by Subject|2|||
27964910|NCT03248531|81701723|FG000|Overall Study|Sponsor Request|0|||
27964911|NCT03248531|81701724|FG001|Overall Study|Sponsor Request|2|||
27964912|NCT03248531|81701725|FG002|Overall Study|Sponsor Request|0|||
27964913|NCT01001767|81701726|FG000|Overall Study|no baseline study performed|1|||
27964914|NCT01001767|81701727|FG001|Overall Study|no baseline study performed|0|||
27964915|NCT01001767|81701726|FG000|Overall Study|Protocol Violation|1|||
27964916|NCT01001767|81701727|FG001|Overall Study|Protocol Violation|0|||
27964917|NCT01001767|81701726|FG000|Overall Study|Lost to Follow-up|1|||
27964918|NCT01001767|81701727|FG001|Overall Study|Lost to Follow-up|0|||
27964919|NCT01001767|81701726|FG000|Overall Study|Physician Decision|1|||
27964920|NCT01001767|81701727|FG001|Overall Study|Physician Decision|0|||
27964921|NCT01318135|81701731|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
27964922|NCT01318135|81701732|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964923|NCT01318135|81701733|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964924|NCT01318135|81701734|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964925|NCT01318135|81701735|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964926|NCT01318135|81701736|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964927|NCT01318135|81701737|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964928|NCT01318135|81701738|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27964929|NCT01318135|81701731|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
27964930|NCT01318135|81701732|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964931|NCT01318135|81701733|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964932|NCT01318135|81701734|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964933|NCT01318135|81701735|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964934|NCT01318135|81701736|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964935|NCT01318135|81701737|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964936|NCT01318135|81701738|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
27964937|NCT01318135|81701731|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
27964938|NCT01318135|81701732|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
27964939|NCT01318135|81701733|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
27964940|NCT01318135|81701734|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
27964941|NCT01318135|81701735|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
27964942|NCT01318135|81701736|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
27964943|NCT01318135|81701737|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
27964944|NCT01318135|81701738|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
27964945|NCT01318135|81701731|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
27771947|NCT00437203|80993132|FG003|Overall Study|Death|0|||
27771948|NCT00437203|80993133|FG004|Overall Study|Death|0|||
27771949|NCT00437203|80993134|FG005|Overall Study|Death|0|||
27771950|NCT00437203|80993135|FG006|Overall Study|Death|0|||
27771951|NCT00437203|80993136|FG007|Overall Study|Death|1|||
27964946|NCT01318135|81701732|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
27964947|NCT01318135|81701733|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
27964948|NCT01318135|81701734|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
27964949|NCT01318135|81701735|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
27964950|NCT01318135|81701736|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
27964951|NCT01318135|81701737|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
27964952|NCT01318135|81701738|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
27964953|NCT01318135|81701731|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27964954|NCT01318135|81701732|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27964955|NCT01318135|81701733|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27964956|NCT01318135|81701734|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27964957|NCT01318135|81701735|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27964958|NCT01318135|81701736|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27964959|NCT01318135|81701737|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27964960|NCT01318135|81701738|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27771952|NCT00437203|80993137|FG008|Overall Study|Death|0|||
27771953|NCT00437203|80993138|FG009|Overall Study|Death|1|||
27771954|NCT00437203|80993129|FG000|Overall Study|Adverse Event|1|||
27771955|NCT00437203|80993130|FG001|Overall Study|Adverse Event|1|||
27771956|NCT00437203|80993131|FG002|Overall Study|Adverse Event|0|||
27771957|NCT00437203|80993132|FG003|Overall Study|Adverse Event|0|||
27771958|NCT00437203|80993133|FG004|Overall Study|Adverse Event|0|||
27771959|NCT00437203|80993134|FG005|Overall Study|Adverse Event|0|||
27771960|NCT00437203|80993135|FG006|Overall Study|Adverse Event|0|||
27771961|NCT00437203|80993136|FG007|Overall Study|Adverse Event|1|||
27771962|NCT00437203|80993137|FG008|Overall Study|Adverse Event|0|||
27771963|NCT00437203|80993138|FG009|Overall Study|Adverse Event|1|||
27771964|NCT00437203|80993129|FG000|Overall Study|Study terminated by sponsor|0|||
27771965|NCT00437203|80993130|FG001|Overall Study|Study terminated by sponsor|0|||
27771966|NCT00437203|80993131|FG002|Overall Study|Study terminated by sponsor|0|||
27771967|NCT00437203|80993132|FG003|Overall Study|Study terminated by sponsor|0|||
27771968|NCT00437203|80993133|FG004|Overall Study|Study terminated by sponsor|0|||
27569134|NCT02658890|80271481|FG011|Treatment Phase|Withdrawal by Subject|0|||
27569135|NCT02658890|80271482|FG012|Treatment Phase|Withdrawal by Subject|1|||
27569136|NCT02658890|80271483|FG013|Treatment Phase|Withdrawal by Subject|3|||
27569137|NCT02658890|80271484|FG014|Treatment Phase|Withdrawal by Subject|0|||
27771969|NCT00437203|80993134|FG005|Overall Study|Study terminated by sponsor|0|||
27771970|NCT00437203|80993135|FG006|Overall Study|Study terminated by sponsor|0|||
27771971|NCT00437203|80993136|FG007|Overall Study|Study terminated by sponsor|0|||
27771972|NCT00437203|80993137|FG008|Overall Study|Study terminated by sponsor|1|||
27771973|NCT00437203|80993138|FG009|Overall Study|Study terminated by sponsor|0|||
27771974|NCT00437203|80993129|FG000|Overall Study|Objective progression or relapse|5|||
27771975|NCT00437203|80993130|FG001|Overall Study|Objective progression or relapse|6|||
27771976|NCT00437203|80993131|FG002|Overall Study|Objective progression or relapse|2|||
27771977|NCT00437203|80993132|FG003|Overall Study|Objective progression or relapse|3|||
27771978|NCT00437203|80993133|FG004|Overall Study|Objective progression or relapse|3|||
27771979|NCT00437203|80993134|FG005|Overall Study|Objective progression or relapse|3|||
27771980|NCT00437203|80993135|FG006|Overall Study|Objective progression or relapse|6|||
27771981|NCT00437203|80993136|FG007|Overall Study|Objective progression or relapse|1|||
27771982|NCT00437203|80993137|FG008|Overall Study|Objective progression or relapse|2|||
27771983|NCT00437203|80993138|FG009|Overall Study|Objective progression or relapse|2|||
27771984|NCT00437203|80993129|FG000|Overall Study|Other|0|||
27771985|NCT00437203|80993130|FG001|Overall Study|Other|1|||
27771986|NCT00437203|80993131|FG002|Overall Study|Other|0|||
27771987|NCT00437203|80993132|FG003|Overall Study|Other|0|||
27771988|NCT00437203|80993133|FG004|Overall Study|Other|0|||
27771989|NCT00437203|80993134|FG005|Overall Study|Other|0|||
27771990|NCT00437203|80993135|FG006|Overall Study|Other|1|||
27771991|NCT00437203|80993136|FG007|Overall Study|Other|0|||
27771992|NCT00437203|80993137|FG008|Overall Study|Other|0|||
27771993|NCT00437203|80993138|FG009|Overall Study|Other|0|||
27771994|NCT01782885|80995648|FG000|Overall Study|Lost to Follow-up|4|||
27771995|NCT01782885|80995649|FG001|Overall Study|Lost to Follow-up|6|||
27771996|NCT03325010|80995657|FG000|Overall Study|Adverse Event|3|||
27771997|NCT03325010|80995658|FG001|Overall Study|Adverse Event|8|||
27771998|NCT03325010|80995657|FG000|Overall Study|Protocol Violation|1|||
27771999|NCT03325010|80995658|FG001|Overall Study|Protocol Violation|8|||
27772000|NCT03325010|80995657|FG000|Overall Study|Withdrawal by Subject|1|||
27772001|NCT03325010|80995658|FG001|Overall Study|Withdrawal by Subject|3|||
27772002|NCT03325010|80995657|FG000|Overall Study|Lost to Follow-up|1|||
27772003|NCT03325010|80995658|FG001|Overall Study|Lost to Follow-up|0|||
27772004|NCT03325010|80995657|FG000|Overall Study|Physician Decision|1|||
27772005|NCT03325010|80995658|FG001|Overall Study|Physician Decision|1|||
27772006|NCT03325010|80995657|FG000|Overall Study|Lack of Efficacy|2|||
27772007|NCT03325010|80995658|FG001|Overall Study|Lack of Efficacy|0|||
27772008|NCT04063865|80995659|FG000|Overall Study|Physician Decision|1|||
27772009|NCT04063865|80995660|FG001|Overall Study|Physician Decision|3|||
27772010|NCT04063865|80995659|FG000|Overall Study|Study Closed Prior to Completion|4|||
27772011|NCT04063865|80995660|FG001|Overall Study|Study Closed Prior to Completion|4|||
27772012|NCT04063865|80995659|FG000|Overall Study|Withdrawal by Subject|1|||
27569138|NCT02658890|80271485|FG015|Treatment Phase|Withdrawal by Subject|0|||
27772013|NCT04063865|80995660|FG001|Overall Study|Withdrawal by Subject|1|||
27772014|NCT02963766|80995661|FG000|Double-Blind Period|Adverse Event|1|||
27772015|NCT02963766|80995662|FG001|Double-Blind Period|Adverse Event|0|||
27772016|NCT02963766|80995663|FG002|Double-Blind Period|Adverse Event|1|||
27772017|NCT02963766|80995661|FG000|Double-Blind Period|Physician Decision|1|||
27772018|NCT02963766|80995662|FG001|Double-Blind Period|Physician Decision|0|||
27772019|NCT02963766|80995663|FG002|Double-Blind Period|Physician Decision|0|||
27772020|NCT02963766|80995661|FG000|Double-Blind Period|Withdrawal by Subject|1|||
27772021|NCT02963766|80995662|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27772022|NCT02963766|80995663|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27772023|NCT02963766|80995661|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
27772024|NCT02963766|80995662|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
27772025|NCT02963766|80995663|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
27772026|NCT02963766|80995661|FG000|Double-Blind Period|Protocol Violation|1|||
27772027|NCT02963766|80995662|FG001|Double-Blind Period|Protocol Violation|0|||
27772028|NCT02963766|80995663|FG002|Double-Blind Period|Protocol Violation|0|||
27772029|NCT02963766|80995661|FG000|Double-Blind Period|Lost to Follow-up|0|||
27772030|NCT02963766|80995662|FG001|Double-Blind Period|Lost to Follow-up|1|||
27772031|NCT02963766|80995663|FG002|Double-Blind Period|Lost to Follow-up|0|||
27772032|NCT02963766|80995661|FG000|Open Label Extension (OLE)|Physician Decision|1|||
27772033|NCT02963766|80995662|FG001|Open Label Extension (OLE)|Physician Decision|2|||
27569139|NCT02658890|80271486|FG016|Treatment Phase|Withdrawal by Subject|1|||
27569140|NCT02658890|80271487|FG017|Treatment Phase|Withdrawal by Subject|0|||
27569141|NCT02658890|80271488|FG018|Treatment Phase|Withdrawal by Subject|4|||
27772034|NCT02963766|80995663|FG002|Open Label Extension (OLE)|Physician Decision|2|||
27772035|NCT02963766|80995661|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
27772036|NCT02963766|80995662|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
27772037|NCT02963766|80995663|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
27772038|NCT02971007|80995664|FG000|Overall Study|Adverse Event|1|||
27772039|NCT02971007|80995665|FG001|Overall Study|Adverse Event|0|||
27772040|NCT02971007|80995666|FG002|Overall Study|Adverse Event|0|||
27772041|NCT02971007|80995664|FG000|Overall Study|Lost to Follow-up|0|||
27772042|NCT02971007|80995665|FG001|Overall Study|Lost to Follow-up|1|||
27772043|NCT02971007|80995666|FG002|Overall Study|Lost to Follow-up|1|||
27772044|NCT02971007|80995664|FG000|Overall Study|Withdrawal by Subject|0|||
27772045|NCT02971007|80995665|FG001|Overall Study|Withdrawal by Subject|1|||
27772046|NCT02971007|80995666|FG002|Overall Study|Withdrawal by Subject|0|||
27772047|NCT02971007|80995664|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
27772048|NCT02971007|80995665|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
27772049|NCT02971007|80995666|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
27772050|NCT02971007|80995664|FG000|Overall Study|Patient discontinued study drug|0|||
27772051|NCT02971007|80995665|FG001|Overall Study|Patient discontinued study drug|1|||
27772052|NCT02971007|80995666|FG002|Overall Study|Patient discontinued study drug|0|||
27772053|NCT01838213|80995668|FG000|Overall Study|Ineligible|166|||
27772054|NCT01838213|80995669|FG001|Overall Study|Ineligible|191|||
27772055|NCT00136357|80995675|FG000|Overall Study|Withdrawal by Subject|3|||
27772056|NCT00136357|80995676|FG001|Overall Study|Withdrawal by Subject|2|||
27772057|NCT01201967|80995678|FG000|Overall Study|Lost to Follow-up|6|||
27772058|NCT01201967|80995679|FG001|Overall Study|Lost to Follow-up|5|||
27772059|NCT02327078|80995680|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
27772060|NCT02327078|80995681|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
27772061|NCT02327078|80995682|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
27772062|NCT02327078|80995683|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
27772063|NCT02327078|80995684|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
27772064|NCT02327078|80995685|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
27772065|NCT02327078|80995686|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
27964961|NCT01318135|81701731|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
27964962|NCT01318135|81701732|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
27964963|NCT01318135|81701733|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
27964964|NCT01318135|81701734|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
27964965|NCT01318135|81701735|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
27964966|NCT01318135|81701736|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
27964967|NCT01318135|81701737|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27964968|NCT01318135|81701738|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27964969|NCT01318135|81701731|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27772066|NCT02327078|80995687|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
27569142|NCT02658890|80271489|FG019|Treatment Phase|Withdrawal by Subject|3|||
27569143|NCT02658890|80271490|FG020|Treatment Phase|Withdrawal by Subject|0|||
27772067|NCT02327078|80995688|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
27772068|NCT02327078|80995680|FG000|Overall Study|Death|2|||
27772069|NCT02327078|80995681|FG001|Overall Study|Death|4|||
27772070|NCT02327078|80995682|FG002|Overall Study|Death|10|||
27772071|NCT02327078|80995683|FG003|Overall Study|Death|6|||
27772072|NCT02327078|80995684|FG004|Overall Study|Death|4|||
27772073|NCT02327078|80995685|FG005|Overall Study|Death|3|||
27772074|NCT02327078|80995686|FG006|Overall Study|Death|2|||
27772075|NCT02327078|80995687|FG007|Overall Study|Death|51|||
27772076|NCT02327078|80995688|FG008|Overall Study|Death|97|||
27772077|NCT02327078|80995680|FG000|Overall Study|Lost to Follow-up|0|||
27772078|NCT02327078|80995681|FG001|Overall Study|Lost to Follow-up|1|||
27772079|NCT02327078|80995682|FG002|Overall Study|Lost to Follow-up|1|||
27772080|NCT02327078|80995683|FG003|Overall Study|Lost to Follow-up|0|||
27772081|NCT02327078|80995684|FG004|Overall Study|Lost to Follow-up|0|||
27772082|NCT02327078|80995685|FG005|Overall Study|Lost to Follow-up|0|||
27772083|NCT02327078|80995686|FG006|Overall Study|Lost to Follow-up|0|||
27772084|NCT02327078|80995687|FG007|Overall Study|Lost to Follow-up|2|||
27772085|NCT02327078|80995688|FG008|Overall Study|Lost to Follow-up|5|||
27772086|NCT02327078|80995680|FG000|Overall Study|Site Terminated by Sponsor|1|||
27772087|NCT02327078|80995681|FG001|Overall Study|Site Terminated by Sponsor|0|||
27772088|NCT02327078|80995682|FG002|Overall Study|Site Terminated by Sponsor|1|||
27772089|NCT02327078|80995683|FG003|Overall Study|Site Terminated by Sponsor|4|||
27772090|NCT02327078|80995684|FG004|Overall Study|Site Terminated by Sponsor|0|||
27772091|NCT02327078|80995685|FG005|Overall Study|Site Terminated by Sponsor|0|||
27772092|NCT02327078|80995686|FG006|Overall Study|Site Terminated by Sponsor|0|||
27772093|NCT02327078|80995687|FG007|Overall Study|Site Terminated by Sponsor|11|||
27772094|NCT02327078|80995688|FG008|Overall Study|Site Terminated by Sponsor|25|||
27772095|NCT02327078|80995680|FG000|Overall Study|Physician Decision|0|||
27772096|NCT02327078|80995681|FG001|Overall Study|Physician Decision|0|||
27772097|NCT02327078|80995682|FG002|Overall Study|Physician Decision|0|||
27772098|NCT02327078|80995683|FG003|Overall Study|Physician Decision|1|||
27772099|NCT02327078|80995684|FG004|Overall Study|Physician Decision|0|||
27772100|NCT02327078|80995685|FG005|Overall Study|Physician Decision|0|||
27772101|NCT02327078|80995686|FG006|Overall Study|Physician Decision|0|||
27772102|NCT02327078|80995687|FG007|Overall Study|Physician Decision|0|||
27772103|NCT02327078|80995688|FG008|Overall Study|Physician Decision|1|||
27772104|NCT02327078|80995680|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27772105|NCT02327078|80995681|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27772106|NCT02327078|80995682|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27772107|NCT02327078|80995683|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
27772108|NCT02327078|80995684|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
27772109|NCT02327078|80995685|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
27772110|NCT02327078|80995686|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
27772111|NCT02327078|80995687|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
27772112|NCT02327078|80995688|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
27772113|NCT02327078|80995680|FG000|Overall Study|Reason not Specified|0|||
27772114|NCT02327078|80995681|FG001|Overall Study|Reason not Specified|0|||
27772115|NCT02327078|80995682|FG002|Overall Study|Reason not Specified|0|||
27772116|NCT02327078|80995683|FG003|Overall Study|Reason not Specified|0|||
27772117|NCT02327078|80995684|FG004|Overall Study|Reason not Specified|0|||
27772118|NCT02327078|80995685|FG005|Overall Study|Reason not Specified|0|||
27772119|NCT02327078|80995686|FG006|Overall Study|Reason not Specified|0|||
27772120|NCT02327078|80995687|FG007|Overall Study|Reason not Specified|5|||
27772121|NCT02327078|80995688|FG008|Overall Study|Reason not Specified|12|||
27772122|NCT02201472|80995691|FG000|Overall Study|Lack of Efficacy|2|||
27772123|NCT03964493|80995693|FG000|Overall Study|Withdrawal by Subject|4|||
27772124|NCT03964493|80995694|FG001|Overall Study|Withdrawal by Subject|1|||
27772125|NCT03964493|80995693|FG000|Overall Study|Lost to Follow-up|13|||
27772126|NCT03964493|80995694|FG001|Overall Study|Lost to Follow-up|4|||
27772127|NCT02910089|80995698|FG000|Overall Study|Lost insurance eligibility|22|||
27772128|NCT02910089|80995699|FG001|Overall Study|Lost insurance eligibility|16|||
27772129|NCT03077711|80995700|FG000|Overall Study|Lost to Follow-up|2|||
27772130|NCT03077711|80995701|FG001|Overall Study|Lost to Follow-up|2|||
27772131|NCT03077711|80995700|FG000|Overall Study|noncompliant taking medication|2|||
27772132|NCT03077711|80995701|FG001|Overall Study|noncompliant taking medication|0|||
27772133|NCT01131078|80995704|FG000|Overall Study|Adverse Event|22|||
27772134|NCT01131078|80995705|FG001|Overall Study|Adverse Event|12|||
27772135|NCT01131078|80995706|FG002|Overall Study|Adverse Event|17|||
27569144|NCT02658890|80271491|FG021|Treatment Phase|Withdrawal by Subject|4|||
27772136|NCT01131078|80995704|FG000|Overall Study|Progressive Disease|58|||
27772137|NCT01131078|80995705|FG001|Overall Study|Progressive Disease|77|||
27772138|NCT01131078|80995706|FG002|Overall Study|Progressive Disease|71|||
27772139|NCT01131078|80995704|FG000|Overall Study|Protocol Violation|1|||
27772140|NCT01131078|80995705|FG001|Overall Study|Protocol Violation|0|||
27772141|NCT01131078|80995706|FG002|Overall Study|Protocol Violation|0|||
27772142|NCT01131078|80995704|FG000|Overall Study|Lost to Follow-up|1|||
27772143|NCT01131078|80995705|FG001|Overall Study|Lost to Follow-up|1|||
27772144|NCT01131078|80995706|FG002|Overall Study|Lost to Follow-up|1|||
27772145|NCT01131078|80995704|FG000|Overall Study|Withdrawal by Subject|2|||
27772146|NCT01131078|80995705|FG001|Overall Study|Withdrawal by Subject|4|||
27772147|NCT01131078|80995706|FG002|Overall Study|Withdrawal by Subject|3|||
27772148|NCT01131078|80995704|FG000|Overall Study|Non-compliance|3|||
27772149|NCT01131078|80995705|FG001|Overall Study|Non-compliance|0|||
27772150|NCT01131078|80995706|FG002|Overall Study|Non-compliance|0|||
27772151|NCT01131078|80995704|FG000|Overall Study|Physician Decision|10|||
27772152|NCT01131078|80995705|FG001|Overall Study|Physician Decision|6|||
27772153|NCT01131078|80995706|FG002|Overall Study|Physician Decision|8|||
27772154|NCT01131078|80995704|FG000|Overall Study|Death|4|||
27772155|NCT01131078|80995705|FG001|Overall Study|Death|0|||
27772156|NCT01131078|80995706|FG002|Overall Study|Death|2|||
27772157|NCT01131078|80995704|FG000|Overall Study|Other|0|||
27772158|NCT01131078|80995705|FG001|Overall Study|Other|1|||
27772159|NCT01131078|80995706|FG002|Overall Study|Other|0|||
27772160|NCT00126672|80995710|FG000|Overall Study|Adverse Event|4|||
27772161|NCT00126672|80995710|FG000|Overall Study|Lost to Follow-up|4|||
27772162|NCT03418376|80995711|FG000|Overall Study|Musculoskeletal injury|1|||
27772163|NCT03418376|80995712|FG001|Overall Study|Musculoskeletal injury|2|||
27772164|NCT03418376|80995713|FG002|Overall Study|Musculoskeletal injury|1|||
27772165|NCT03418376|80995714|FG003|Overall Study|Musculoskeletal injury|0|||
27772166|NCT03418376|80995711|FG000|Overall Study|Personal reasons|0|||
27772167|NCT03418376|80995712|FG001|Overall Study|Personal reasons|2|||
27772168|NCT03418376|80995713|FG002|Overall Study|Personal reasons|2|||
27772169|NCT03418376|80995714|FG003|Overall Study|Personal reasons|1|||
27772170|NCT03418376|80995711|FG000|Overall Study|Exacerbation|0|||
27772171|NCT03418376|80995712|FG001|Overall Study|Exacerbation|1|||
27772172|NCT03418376|80995713|FG002|Overall Study|Exacerbation|0|||
27772173|NCT03418376|80995714|FG003|Overall Study|Exacerbation|0|||
27772174|NCT00707486|80995715|FG000|Overall Study|Withdrawal by Subject|1|||
27772175|NCT01080625|80995716|FG000|Overall Study|Physician Decision|0|||
27772176|NCT01080625|80995717|FG001|Overall Study|Physician Decision|2|||
27772177|NCT01080625|80995718|FG002|Overall Study|Physician Decision|1|||
27772178|NCT00880100|80995719|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
27772179|NCT00880100|80995719|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
27772180|NCT00880100|80995719|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
27772181|NCT03238352|80995720|FG000|Overall Study|Lost to Follow-up|0|||
27772182|NCT03238352|80995721|FG001|Overall Study|Lost to Follow-up|2|||
27772183|NCT03238352|80995722|FG002|Overall Study|Lost to Follow-up|1|||
27772184|NCT03238352|80995720|FG000|Overall Study|Withdrawal by Subject|0|||
27772185|NCT03238352|80995721|FG001|Overall Study|Withdrawal by Subject|1|||
27772186|NCT03238352|80995722|FG002|Overall Study|Withdrawal by Subject|0|||
27772187|NCT01600105|80995725|FG000|Total Participants|Withdrawal by Subject|1|||
27772188|NCT01600105|80995726|FG001|Total Participants|Withdrawal by Subject|0|||
27772189|NCT01600105|80995725|FG000|Total Participants|No images in PACS|10|||
27772190|NCT01600105|80995726|FG001|Total Participants|No images in PACS|0|||
27772191|NCT01600105|80995725|FG000|Total Participants|Insufficient image quality|30|||
27772192|NCT01600105|80995726|FG001|Total Participants|Insufficient image quality|10|||
27772193|NCT01600105|80995725|FG000|Sub Study I|Insufficient image quality|0|||
27772194|NCT01600105|80995726|FG001|Sub Study I|Insufficient image quality|10|||
27772195|NCT01600105|80995725|FG000|Sub Study II|Withdrawal by Subject|1|||
27862249|NCT02359994|81326288|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
27772196|NCT01600105|80995726|FG001|Sub Study II|Withdrawal by Subject|0|||
27772197|NCT01600105|80995725|FG000|Sub Study II|No images in PACS|1|||
27772198|NCT01600105|80995726|FG001|Sub Study II|No images in PACS|0|||
27772199|NCT01600105|80995725|FG000|Sub Study II|Insufficient image quality|3|||
27772200|NCT01600105|80995726|FG001|Sub Study II|Insufficient image quality|0|||
27886623|NCT00619892|81418125|FG000|Overall Study|Intercurrent illness|0|||
27569145|NCT02658890|80271492|FG022|Treatment Phase|Withdrawal by Subject|1|||
27772201|NCT01600105|80995725|FG000|Sub Study III|Insufficient image quality|5|||
27772202|NCT01600105|80995726|FG001|Sub Study III|Insufficient image quality|0|||
27772203|NCT01600105|80995725|FG000|Sub Study V|Poor Image Quality|2|||
27772204|NCT01600105|80995726|FG001|Sub Study V|Poor Image Quality|0|||
27772205|NCT02392468|80995731|FG000|Overall Study|Adverse Event|0|||
27772206|NCT02392468|80995732|FG001|Overall Study|Adverse Event|1|||
27772207|NCT02392468|80995733|FG002|Overall Study|Adverse Event|0|||
27772208|NCT02392468|80995734|FG003|Overall Study|Adverse Event|0|||
27772209|NCT02392468|80995735|FG004|Overall Study|Adverse Event|0|||
27772210|NCT02392468|80995736|FG005|Overall Study|Adverse Event|1|||
27772211|NCT02985684|80995740|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
27772212|NCT02985684|80995740|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
27772213|NCT02985684|80995740|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
27772214|NCT01826448|80995741|FG000|Overall Study|Adverse Event|1|||
27772215|NCT01826448|80995742|FG001|Overall Study|Adverse Event|3|||
27772216|NCT01826448|80995741|FG000|Overall Study|Disease progression|2|||
27772217|NCT01826448|80995742|FG001|Overall Study|Disease progression|4|||
27772218|NCT01826448|80995741|FG000|Overall Study|Withdrawal by Subject|1|||
27772219|NCT01826448|80995742|FG001|Overall Study|Withdrawal by Subject|0|||
27772220|NCT01826448|80995741|FG000|Overall Study|Physician Decision|0|||
27772221|NCT01826448|80995742|FG001|Overall Study|Physician Decision|1|||
27772222|NCT01826448|80995741|FG000|Overall Study|2 active cancers|0|||
27772223|NCT01826448|80995742|FG001|Overall Study|2 active cancers|1|||
27772224|NCT02707601|80995745|FG000|Overall Study|Death|0|||
27772225|NCT02707601|80995746|FG001|Overall Study|Death|1|||
27772226|NCT02707601|80995745|FG000|Overall Study|Lack of Efficacy|0|||
27772227|NCT02707601|80995746|FG001|Overall Study|Lack of Efficacy|1|||
27772228|NCT02707601|80995745|FG000|Overall Study|Investigator's Discretion|1|||
27772229|NCT02707601|80995746|FG001|Overall Study|Investigator's Discretion|0|||
27772230|NCT02707601|80995745|FG000|Overall Study|Withdrew Consent|0|||
27772231|NCT02707601|80995746|FG001|Overall Study|Withdrew Consent|1|||
27772232|NCT02707601|80995745|FG000|Overall Study|Lost to Follow-up|1|||
27772233|NCT02707601|80995746|FG001|Overall Study|Lost to Follow-up|1|||
27772234|NCT02707601|80995745|FG000|Overall Study|Participants Randomized but Not Treated|2|||
27772235|NCT02707601|80995746|FG001|Overall Study|Participants Randomized but Not Treated|0|||
27772236|NCT02756845|80995747|FG000|Overall Study|Death|12|||
27772237|NCT02756845|80995748|FG001|Overall Study|Death|2|||
27772238|NCT02756845|80995747|FG000|Overall Study|Withdrawal by Subject|1|||
27964970|NCT01318135|81701732|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27964971|NCT01318135|81701733|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27964972|NCT01318135|81701734|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27964973|NCT01318135|81701735|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27964974|NCT01318135|81701736|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27964975|NCT01318135|81701737|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
27964976|NCT01318135|81701738|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
27964977|NCT01202188|81701741|FG000|Overall Study|Protocol deviation|14|||
27964978|NCT01202188|81701742|FG001|Overall Study|Protocol deviation|8|||
27964979|NCT01202188|81701743|FG002|Overall Study|Protocol deviation|12|||
27964980|NCT01202188|81701744|FG003|Overall Study|Protocol deviation|10|||
27964981|NCT01202188|81701745|FG004|Overall Study|Protocol deviation|11|||
27964982|NCT01202188|81701741|FG000|Overall Study|Subject withdrew consent|12|||
27964983|NCT01202188|81701742|FG001|Overall Study|Subject withdrew consent|13|||
27964984|NCT01202188|81701743|FG002|Overall Study|Subject withdrew consent|22|||
27964985|NCT01202188|81701744|FG003|Overall Study|Subject withdrew consent|11|||
27964986|NCT01202188|81701745|FG004|Overall Study|Subject withdrew consent|13|||
27964987|NCT01202188|81701741|FG000|Overall Study|Adverse Event|5|||
27964988|NCT01202188|81701742|FG001|Overall Study|Adverse Event|23|||
27964989|NCT01202188|81701743|FG002|Overall Study|Adverse Event|13|||
27964990|NCT01202188|81701744|FG003|Overall Study|Adverse Event|10|||
27964991|NCT01202188|81701745|FG004|Overall Study|Adverse Event|10|||
27964992|NCT01202188|81701741|FG000|Overall Study|Administrative problems|3|||
27964993|NCT01202188|81701742|FG001|Overall Study|Administrative problems|2|||
27964994|NCT01202188|81701743|FG002|Overall Study|Administrative problems|1|||
27772239|NCT02756845|80995748|FG001|Overall Study|Withdrawal by Subject|0|||
27772240|NCT03472040|80995749|FG000|Overall Study|Physician Decision|0|||
27772241|NCT03472040|80995750|FG001|Overall Study|Physician Decision|3|||
27964995|NCT01202188|81701744|FG003|Overall Study|Administrative problems|1|||
27772242|NCT03472040|80995749|FG000|Overall Study|Withdrawal by Subject|10|||
27772243|NCT03472040|80995750|FG001|Overall Study|Withdrawal by Subject|23|||
27772244|NCT03472040|80995749|FG000|Overall Study|Perceived Lack of Efficacy|29|||
27772245|NCT03472040|80995750|FG001|Overall Study|Perceived Lack of Efficacy|30|||
27772246|NCT03472040|80995749|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
27772247|NCT03472040|80995750|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
27772248|NCT03472040|80995749|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
27772249|NCT03472040|80995750|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
27772250|NCT03472040|80995749|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
27772251|NCT03472040|80995750|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
27772252|NCT03472040|80995749|FG000|Overall Study|Subject Non-compliance|2|||
27772253|NCT03472040|80995750|FG001|Overall Study|Subject Non-compliance|5|||
27772254|NCT03472040|80995749|FG000|Overall Study|Discontinuation due to Rash|0|||
27772255|NCT03472040|80995750|FG001|Overall Study|Discontinuation due to Rash|1|||
27772256|NCT03472040|80995749|FG000|Overall Study|Subsequent Ineligibility|0|||
27772257|NCT03472040|80995750|FG001|Overall Study|Subsequent Ineligibility|2|||
27772258|NCT03472040|80995749|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
27772259|NCT03472040|80995750|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
27772260|NCT03630016|80995752|FG000|Overall Study|Poor Sensor Placement|1|||
27772261|NCT04350372|80995753|FG000|Overall Study|Death|1|||
27772262|NCT02667236|80995754|FG000|Overall Study|Adverse Event|1|||
27772263|NCT02667236|80995755|FG001|Overall Study|Adverse Event|1|||
27772264|NCT02667236|80995754|FG000|Overall Study|Withdrawal by Subject|2|||
27772265|NCT02667236|80995755|FG001|Overall Study|Withdrawal by Subject|0|||
27772266|NCT01249157|80995760|FG000|Overall Study|Withdrawal by Subject|1|||
27772267|NCT00415623|80995761|FG000|Overall Study|Adverse Event|3|||
27772268|NCT00415623|80995762|FG001|Overall Study|Adverse Event|4|||
27772269|NCT00415623|80995761|FG000|Overall Study|Death|1|||
27772270|NCT00415623|80995762|FG001|Overall Study|Death|0|||
27772271|NCT00415623|80995761|FG000|Overall Study|Withdrawal by Subject|1|||
27772272|NCT00415623|80995762|FG001|Overall Study|Withdrawal by Subject|1|||
27772273|NCT04095793|80995763|FG000|Overall Study|Adverse Event|3|||
27772274|NCT04095793|80995763|FG000|Overall Study|Study Terminated by Sponsor|103|||
27772275|NCT04095793|80995763|FG000|Overall Study|Withdrawal by Subject|4|||
27772276|NCT01680991|80995767|FG000|Overall Study|Adverse Event|1|||
27772277|NCT01680991|80995768|FG001|Overall Study|Adverse Event|0|||
27772278|NCT01680991|80995769|FG002|Overall Study|Adverse Event|0|||
27772279|NCT01680991|80995767|FG000|Overall Study|Death|1|||
27772280|NCT01680991|80995768|FG001|Overall Study|Death|0|||
27772281|NCT01680991|80995769|FG002|Overall Study|Death|1|||
27772282|NCT01680991|80995767|FG000|Overall Study|Protocol Violation|0|||
27772283|NCT01680991|80995768|FG001|Overall Study|Protocol Violation|1|||
27772284|NCT01680991|80995769|FG002|Overall Study|Protocol Violation|0|||
27772285|NCT01680991|80995767|FG000|Overall Study|Withdrawal by Subject|5|||
27772286|NCT01680991|80995768|FG001|Overall Study|Withdrawal by Subject|1|||
27772287|NCT01680991|80995769|FG002|Overall Study|Withdrawal by Subject|0|||
27772288|NCT01680991|80995767|FG000|Overall Study|Progressive disease (PD)|0|||
27569146|NCT02658890|80271493|FG023|Treatment Phase|Withdrawal by Subject|1|||
27569147|NCT02658890|80271494|FG024|Treatment Phase|Withdrawal by Subject|0|||
27772289|NCT01680991|80995768|FG001|Overall Study|Progressive disease (PD)|10|||
27772290|NCT01680991|80995769|FG002|Overall Study|Progressive disease (PD)|0|||
27772291|NCT01680991|80995767|FG000|Overall Study|Physician Decision|0|||
27772292|NCT01680991|80995768|FG001|Overall Study|Physician Decision|7|||
27772293|NCT01680991|80995769|FG002|Overall Study|Physician Decision|2|||
27772294|NCT01680991|80995767|FG000|Overall Study|Bad physical condition|0|||
27772295|NCT01680991|80995768|FG001|Overall Study|Bad physical condition|0|||
27772296|NCT01680991|80995769|FG002|Overall Study|Bad physical condition|1|||
27772297|NCT01680991|80995767|FG000|Overall Study|PD confirmed in other hospital|1|||
27772298|NCT01680991|80995768|FG001|Overall Study|PD confirmed in other hospital|0|||
27772299|NCT01680991|80995769|FG002|Overall Study|PD confirmed in other hospital|0|||
27772300|NCT01678313|80995777|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
27772301|NCT01678313|80995778|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
27772302|NCT01678313|80995777|FG000|Completed the 3-month Therapy|Physician Decision|3|||
27772303|NCT01678313|80995778|FG001|Completed the 3-month Therapy|Physician Decision|4|||
27772304|NCT01678313|80995777|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
27772305|NCT01678313|80995778|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
27772306|NCT01678313|80995777|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
27772307|NCT01678313|80995778|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
27772308|NCT00369278|80995779|FG000|Overall Study|Adverse Event|14|||
27772309|NCT00369278|80995780|FG001|Overall Study|Adverse Event|11|||
27772310|NCT00369278|80995779|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27772311|NCT00369278|80995780|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
27569148|NCT02658890|80271495|FG025|Treatment Phase|Withdrawal by Subject|0|||
27772312|NCT00369278|80995779|FG000|Overall Study|Protocol Violation|2|||
27772313|NCT00369278|80995780|FG001|Overall Study|Protocol Violation|1|||
27772314|NCT00369278|80995779|FG000|Overall Study|Withdrawal by Subject|2|||
27964996|NCT01202188|81701745|FG004|Overall Study|Administrative problems|2|||
27964997|NCT01202188|81701741|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27964998|NCT01202188|81701742|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27964999|NCT01202188|81701743|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27965000|NCT01202188|81701744|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
27965001|NCT01202188|81701745|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
27965002|NCT01202188|81701741|FG000|Overall Study|Lost to Follow-up|1|||
27965003|NCT01202188|81701742|FG001|Overall Study|Lost to Follow-up|1|||
27965004|NCT01202188|81701743|FG002|Overall Study|Lost to Follow-up|0|||
27965005|NCT01202188|81701744|FG003|Overall Study|Lost to Follow-up|4|||
27965006|NCT01202188|81701745|FG004|Overall Study|Lost to Follow-up|1|||
27965007|NCT01202188|81701741|FG000|Overall Study|Death|1|||
27965008|NCT01202188|81701742|FG001|Overall Study|Death|1|||
27965009|NCT01202188|81701743|FG002|Overall Study|Death|1|||
27965010|NCT01202188|81701744|FG003|Overall Study|Death|1|||
27965011|NCT01202188|81701745|FG004|Overall Study|Death|0|||
27965012|NCT01202188|81701741|FG000|Overall Study|Abnormal test procedure result (s)|0|||
27965013|NCT01202188|81701742|FG001|Overall Study|Abnormal test procedure result (s)|0|||
27965014|NCT01202188|81701743|FG002|Overall Study|Abnormal test procedure result (s)|2|||
27965015|NCT01202188|81701744|FG003|Overall Study|Abnormal test procedure result (s)|0|||
27965016|NCT01202188|81701745|FG004|Overall Study|Abnormal test procedure result (s)|0|||
27965017|NCT02952313|81701746|FG000|Primary Endpoint|Lost to Follow-up|4|||
27965018|NCT02952313|81701746|FG000|Primary Endpoint|Withdrawal by Subject|1|||
27965019|NCT02952313|81701746|FG000|Primary Endpoint|Lack of Efficacy|1|||
27965020|NCT02952313|81701746|FG000|Primary Endpoint|Missed visit|1|||
27965021|NCT02952313|81701746|FG000|Long-term Follow-up|Lost to Follow-up|12|||
27965022|NCT02952313|81701746|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
27965023|NCT02952313|81701746|FG000|Long-term Follow-up|Lack of Efficacy|6|||
27965024|NCT02952313|81701746|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
27965025|NCT02952313|81701746|FG000|Long-term Follow-up|Physician Decision|1|||
27965026|NCT02952313|81701746|FG000|Long-term Follow-up|Death|1|||
27965027|NCT00191945|81701747|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
27965028|NCT00191945|81701748|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
27965029|NCT00191945|81701747|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
27965030|NCT00191945|81701748|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
27965031|NCT00191945|81701747|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
27965032|NCT00191945|81701748|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
27965033|NCT00191945|81701747|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
27965034|NCT00191945|81701748|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
27965035|NCT03562975|81701749|FG000|Overall Study|Death|1|||
27965036|NCT03562975|81701749|FG000|Overall Study|Lost to Follow-up|1|||
27965037|NCT03562975|81701749|FG000|Overall Study|Withdrawal by Subject|1|||
27965038|NCT04209634|81701750|FG000|Overall Study|Ongoing|10|||
27569149|NCT02658890|80271496|FG026|Treatment Phase|Withdrawal by Subject|0|||
27569150|NCT00637195|80271502|FG000|Overall Study|Lost to Follow-up|1|||
27569151|NCT00637195|80271503|FG001|Overall Study|Lost to Follow-up|0|||
27569152|NCT00637195|80271502|FG000|Overall Study|Other|2|||
27569153|NCT00637195|80271503|FG001|Overall Study|Other|0|||
27569154|NCT00637195|80271502|FG000|Overall Study|Withdrawal by Subject|0|||
27569155|NCT00637195|80271503|FG001|Overall Study|Withdrawal by Subject|1|||
27965039|NCT00269087|81701751|FG000|Overall Study|Adverse Event|20|||
27772315|NCT00369278|80995780|FG001|Overall Study|Withdrawal by Subject|2|||
27772316|NCT00369278|80995779|FG000|Overall Study|Lost to Follow-up|1|||
27772317|NCT00369278|80995780|FG001|Overall Study|Lost to Follow-up|0|||
27772318|NCT00369278|80995779|FG000|Overall Study|Graft loss|1|||
27772319|NCT00369278|80995780|FG001|Overall Study|Graft loss|2|||
27569156|NCT00735371|80271504|FG000|Overall Study|Adverse Event|3|||
27569157|NCT00735371|80271505|FG001|Overall Study|Adverse Event|3|||
27772320|NCT00654420|80995784|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
27965040|NCT00269087|81701751|FG000|Overall Study|Withdrawal by Subject|1|||
27965041|NCT00269087|81701751|FG000|Overall Study|Exacerbation of COPD|13|||
27965042|NCT04154293|81701759|FG000|Overall Study|Withdrawal by Subject|2|||
27965043|NCT04154293|81701760|FG001|Overall Study|Withdrawal by Subject|3|||
27965044|NCT04154293|81701761|FG002|Overall Study|Withdrawal by Subject|1|||
27965045|NCT04154293|81701759|FG000|Overall Study|Physician Decision|0|||
27569158|NCT00735371|80271506|FG002|Overall Study|Adverse Event|4|||
27965046|NCT04154293|81701760|FG001|Overall Study|Physician Decision|0|||
27965047|NCT04154293|81701761|FG002|Overall Study|Physician Decision|1|||
27965048|NCT01681186|81701762|FG000|Washout Period From Second Intervention|Adverse Event|0|||
27965049|NCT01681186|81701763|FG001|Washout Period From Second Intervention|Adverse Event|0|||
27965050|NCT01681186|81701764|FG002|Washout Period From Second Intervention|Adverse Event|0|||
27569159|NCT00735371|80271507|FG003|Overall Study|Adverse Event|1|||
27772321|NCT00654420|80995785|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
27569160|NCT00735371|80271504|FG000|Overall Study|Protocol Violation|2|||
27965051|NCT01681186|81701765|FG003|Washout Period From Second Intervention|Adverse Event|0|||
27965052|NCT01681186|81701766|FG004|Washout Period From Second Intervention|Adverse Event|0|||
27965053|NCT01681186|81701767|FG005|Washout Period From Second Intervention|Adverse Event|0|||
27965054|NCT01681186|81701768|FG006|Washout Period From Second Intervention|Adverse Event|1|||
27965055|NCT01681186|81701769|FG007|Washout Period From Second Intervention|Adverse Event|0|||
27965056|NCT01681186|81701762|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
27965057|NCT01681186|81701763|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
27965058|NCT01681186|81701764|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
27965059|NCT01681186|81701765|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
27965060|NCT01681186|81701766|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
27965061|NCT01681186|81701767|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
27965062|NCT01681186|81701768|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
27965063|NCT01681186|81701769|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
27965064|NCT01681186|81701762|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965065|NCT01681186|81701763|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965066|NCT01681186|81701764|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965067|NCT01681186|81701765|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965068|NCT01681186|81701766|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965069|NCT01681186|81701767|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965070|NCT01681186|81701768|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
27965071|NCT01681186|81701769|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
27965072|NCT01681186|81701762|FG000|Fourth Intervention|Protocol Violation|0|||
27965073|NCT01681186|81701763|FG001|Fourth Intervention|Protocol Violation|0|||
27965074|NCT01681186|81701764|FG002|Fourth Intervention|Protocol Violation|0|||
27965075|NCT01681186|81701765|FG003|Fourth Intervention|Protocol Violation|0|||
27965076|NCT01681186|81701766|FG004|Fourth Intervention|Protocol Violation|0|||
27965077|NCT01681186|81701767|FG005|Fourth Intervention|Protocol Violation|0|||
27965078|NCT01681186|81701768|FG006|Fourth Intervention|Protocol Violation|0|||
27965079|NCT01681186|81701769|FG007|Fourth Intervention|Protocol Violation|1|||
27965080|NCT02798315|81701770|FG000|Overall Study|Failure to return|1|||
27772322|NCT00654420|80995786|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
27965081|NCT03370419|81701771|FG000|Overall Study|Lost to Follow-up|16|||
27965082|NCT00688467|81701779|FG000|Treatment Period 1|Adverse Event|2|||
27965083|NCT00688467|81701780|FG001|Treatment Period 1|Adverse Event|1|||
27965084|NCT00688467|81701779|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
27965085|NCT00688467|81701780|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
27965086|NCT00688467|81701779|FG000|Treatment Period 2|Protocol Violation|0|||
27965087|NCT00688467|81701780|FG001|Treatment Period 2|Protocol Violation|1|||
27965088|NCT00688467|81701779|FG000|Treatment Period 2|Adverse Event|0|||
27965089|NCT00688467|81701780|FG001|Treatment Period 2|Adverse Event|1|||
27965090|NCT01832493|81701781|FG000|Overall Study|Physician Decision|2|||
27965091|NCT01832493|81701781|FG000|Overall Study|Protocol Violation|4|||
27965092|NCT01832493|81701781|FG000|Overall Study|Unable to place LV lead|2|||
27965093|NCT03206970|81701782|FG000|Overall Study|Death|21|||
27965094|NCT03206970|81701782|FG000|Overall Study|Withdrawal by Subject|13|||
27965095|NCT03206970|81701782|FG000|Overall Study|Lost to Follow-up|3|||
27965096|NCT03206970|81701782|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
27965097|NCT02982772|81701783|FG000|Intervention|Lost to Follow-up|19|||
27965098|NCT02982772|81701784|FG001|Intervention|Lost to Follow-up|13|||
27965099|NCT02982772|81701783|FG000|1M Follow-Up|Lost to Follow-up|21|||
27965100|NCT02982772|81701784|FG001|1M Follow-Up|Lost to Follow-up|18|||
27965101|NCT02982772|81701783|FG000|3M Follow-Up|Lost to Follow-up|17|||
27965102|NCT02982772|81701784|FG001|3M Follow-Up|Lost to Follow-up|11|||
27965103|NCT02982772|81701783|FG000|6M Follow-Up|Lost to Follow-up|11|||
27965104|NCT02982772|81701784|FG001|6M Follow-Up|Lost to Follow-up|9|||
27965105|NCT02982772|81701783|FG000|12M Follow-Up|Lost to Follow-up|11|||
27965106|NCT02982772|81701784|FG001|12M Follow-Up|Lost to Follow-up|5|||
27965107|NCT01701362|81701785|FG000|Overall Study|Adverse events not related to study drug|1|||
27965108|NCT01701362|81701786|FG001|Overall Study|Adverse events not related to study drug|6|||
27965109|NCT01701362|81701785|FG000|Overall Study|Adverse events related to study drug|12|||
27965110|NCT01701362|81701786|FG001|Overall Study|Adverse events related to study drug|10|||
27965111|NCT01701362|81701785|FG000|Overall Study|Protocol Violation|5|||
27965112|NCT01701362|81701786|FG001|Overall Study|Protocol Violation|3|||
27965113|NCT01701362|81701785|FG000|Overall Study|No longer willing to participate|8|||
27965114|NCT01701362|81701786|FG001|Overall Study|No longer willing to participate|14|||
27965115|NCT01701362|81701785|FG000|Overall Study|Lost to Follow-up|6|||
27965116|NCT01701362|81701786|FG001|Overall Study|Lost to Follow-up|9|||
27965117|NCT01701362|81701785|FG000|Overall Study|Insufficient clinical response|6|||
27772323|NCT00654420|80995787|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
27965118|NCT01701362|81701786|FG001|Overall Study|Insufficient clinical response|6|||
27965119|NCT01701362|81701785|FG000|Overall Study|Death|0|||
27965120|NCT01701362|81701786|FG001|Overall Study|Death|1|||
27965121|NCT01701362|81701785|FG000|Overall Study|Randomized but not treated|1|||
27965122|NCT01701362|81701786|FG001|Overall Study|Randomized but not treated|2|||
27965123|NCT01701362|81701785|FG000|Overall Study|Reasons other than those mentioned above|3|||
27965124|NCT01701362|81701786|FG001|Overall Study|Reasons other than those mentioned above|5|||
27965125|NCT03846427|81701787|FG000|Overall Study|Death|13|||
27965126|NCT03846427|81701787|FG000|Overall Study|Withdrawal by Subject|3|||
27965127|NCT03846427|81701787|FG000|Overall Study|Physician Decision|1|||
27965128|NCT03292640|81701790|FG000|Overall Study|Withdrawal by Subject|17|||
27965129|NCT03292640|81701791|FG001|Overall Study|Withdrawal by Subject|16|||
27965130|NCT03292640|81701790|FG000|Overall Study|Adverse Event|20|||
27965131|NCT03292640|81701791|FG001|Overall Study|Adverse Event|2|||
27965132|NCT03292640|81701790|FG000|Overall Study|Lost to Follow-up|24|||
27965133|NCT03292640|81701791|FG001|Overall Study|Lost to Follow-up|24|||
27965134|NCT00624468|81704483|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
27965135|NCT00624468|81704484|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
27965136|NCT00624468|81704485|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
27965137|NCT00624468|81704486|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
27965138|NCT00624468|81704483|FG000|Double-blind Period|Withdrew Prematurely|1|||
27965139|NCT00624468|81704484|FG001|Double-blind Period|Withdrew Prematurely|1|||
27965140|NCT00624468|81704485|FG002|Double-blind Period|Withdrew Prematurely|0|||
27965141|NCT00624468|81704486|FG003|Double-blind Period|Withdrew Prematurely|0|||
27965142|NCT00624468|81704483|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
27965143|NCT00624468|81704484|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
27965144|NCT00624468|81704485|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
27965145|NCT00624468|81704486|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
27965146|NCT00624468|81704483|FG000|Safety Follow-up (SFU) Period|Other|0|||
27965147|NCT00624468|81704484|FG001|Safety Follow-up (SFU) Period|Other|0|||
27965148|NCT00624468|81704485|FG002|Safety Follow-up (SFU) Period|Other|1|||
27965149|NCT00624468|81704486|FG003|Safety Follow-up (SFU) Period|Other|1|||
27965150|NCT02241733|81704487|FG000|Overall Study|Lost to Follow-up|9|||
27965151|NCT02241733|81704488|FG001|Overall Study|Lost to Follow-up|4|||
27965152|NCT02241733|81704487|FG000|Overall Study|Physician Decision|6|||
27965153|NCT02241733|81704488|FG001|Overall Study|Physician Decision|2|||
27965154|NCT02241733|81704487|FG000|Overall Study|Withdrawal by Subject|0|||
27965155|NCT02241733|81704488|FG001|Overall Study|Withdrawal by Subject|2|||
27965156|NCT02241733|81704487|FG000|Overall Study|Death|0|||
27965157|NCT02241733|81704488|FG001|Overall Study|Death|2|||
27965158|NCT04493424|81704490|FG000|Overall Study|Termination of the trial by the sponsor|89|||
27965159|NCT04493424|81704490|FG000|Overall Study|Withdrawal by Subject|9|||
27965160|NCT04493424|81704490|FG000|Overall Study|Lost to Follow-up|2|||
27569161|NCT00735371|80271505|FG001|Overall Study|Protocol Violation|2|||
27569162|NCT00735371|80271506|FG002|Overall Study|Protocol Violation|0|||
27569163|NCT00735371|80271507|FG003|Overall Study|Protocol Violation|3|||
27569164|NCT00735371|80271504|FG000|Overall Study|Withdrawal by Subject|0|||
27569165|NCT00735371|80271505|FG001|Overall Study|Withdrawal by Subject|2|||
27772324|NCT00654420|80995784|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
27965161|NCT04493424|81704490|FG000|Overall Study|Lack of Efficacy|3|||
27965162|NCT04493424|81704490|FG000|Overall Study|Adverse Event|5|||
27965163|NCT01221753|81704493|FG000|Overall Study|Adverse Event|1|||
27965164|NCT01905943|81704494|FG000|Overall Study|Withdrawal of consent|90|||
27965165|NCT01905943|81704494|FG000|Overall Study|Lost to Follow-up|16|||
27965166|NCT01905943|81704494|FG000|Overall Study|Investigator discretion|7|||
27772325|NCT00654420|80995785|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
27772326|NCT00654420|80995786|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
27772327|NCT00654420|80995787|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
27772328|NCT00654420|80995784|FG000|Phase II|Adverse Event|0|||
27772329|NCT00654420|80995785|FG001|Phase II|Adverse Event|0|||
27772330|NCT00654420|80995786|FG002|Phase II|Adverse Event|3|||
27772331|NCT00654420|80995787|FG003|Phase II|Adverse Event|3|||
27772332|NCT00654420|80995784|FG000|Phase II|Lost to Follow-up|0|||
27772333|NCT00654420|80995785|FG001|Phase II|Lost to Follow-up|0|||
27772334|NCT00654420|80995786|FG002|Phase II|Lost to Follow-up|0|||
27772335|NCT00654420|80995787|FG003|Phase II|Lost to Follow-up|1|||
27772336|NCT00654420|80995784|FG000|Phase II|Physician Decision|0|||
27772337|NCT00654420|80995785|FG001|Phase II|Physician Decision|0|||
27772338|NCT00654420|80995786|FG002|Phase II|Physician Decision|0|||
27965167|NCT01905943|81704494|FG000|Overall Study|Death|186|||
27569166|NCT00735371|80271506|FG002|Overall Study|Withdrawal by Subject|2|||
27965168|NCT01905943|81704494|FG000|Overall Study|Adverse Event|3|||
27965169|NCT01905943|81704494|FG000|Overall Study|Other|12|||
27965170|NCT02582814|81704497|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27965171|NCT02582814|81704498|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27965172|NCT02582814|81704497|FG000|Overall Study|Withdrawal by Subject|4|||
27965173|NCT02582814|81704498|FG001|Overall Study|Withdrawal by Subject|3|||
27965174|NCT02582814|81704497|FG000|Overall Study|Adverse Event|4|||
27965175|NCT02582814|81704498|FG001|Overall Study|Adverse Event|4|||
27772339|NCT00654420|80995787|FG003|Phase II|Physician Decision|4|||
27772340|NCT00654420|80995784|FG000|Phase II|Progressive Disease|0|||
27772341|NCT00654420|80995785|FG001|Phase II|Progressive Disease|0|||
27965176|NCT02920528|81704499|FG000|Overall Study|Incomplete Data|1|||
27965177|NCT02920528|81704500|FG001|Overall Study|Incomplete Data|1|||
27965178|NCT02920528|81704501|FG002|Overall Study|Incomplete Data|1|||
27965179|NCT02920528|81704499|FG000|Overall Study|Adverse Event|0|||
27965180|NCT02920528|81704500|FG001|Overall Study|Adverse Event|0|||
27965181|NCT02920528|81704501|FG002|Overall Study|Adverse Event|3|||
27965182|NCT02920528|81704499|FG000|Overall Study|Did not meet inclusion criteria|2|||
27965183|NCT02920528|81704500|FG001|Overall Study|Did not meet inclusion criteria|0|||
27965184|NCT02920528|81704501|FG002|Overall Study|Did not meet inclusion criteria|1|||
27965185|NCT00577707|81704510|FG000|Overall Study|Withdrawal by Subject|3|||
27965186|NCT00412958|81704513|FG000|Overall Study|Withdrawal by Subject|3|||
27965187|NCT00412958|81704514|FG001|Overall Study|Withdrawal by Subject|0|||
27965188|NCT00412958|81704515|FG002|Overall Study|Withdrawal by Subject|0|||
27965189|NCT00412958|81704516|FG003|Overall Study|Withdrawal by Subject|1|||
27965190|NCT00412958|81704513|FG000|Overall Study|Adverse Event|0|||
27965191|NCT00412958|81704514|FG001|Overall Study|Adverse Event|1|||
27965192|NCT00412958|81704515|FG002|Overall Study|Adverse Event|0|||
27965193|NCT00412958|81704516|FG003|Overall Study|Adverse Event|0|||
27965194|NCT00412958|81704513|FG000|Overall Study|Lost to Follow-up|0|||
27965195|NCT00412958|81704514|FG001|Overall Study|Lost to Follow-up|1|||
27965196|NCT00412958|81704515|FG002|Overall Study|Lost to Follow-up|0|||
27965197|NCT00412958|81704516|FG003|Overall Study|Lost to Follow-up|0|||
27965198|NCT00412958|81704513|FG000|Overall Study|Death|0|||
27965199|NCT00412958|81704514|FG001|Overall Study|Death|1|||
27965200|NCT00412958|81704515|FG002|Overall Study|Death|0|||
27965201|NCT00412958|81704516|FG003|Overall Study|Death|0|||
27965202|NCT00412958|81704513|FG000|Overall Study|Transport issue|0|||
27965203|NCT00412958|81704514|FG001|Overall Study|Transport issue|1|||
27965204|NCT00412958|81704515|FG002|Overall Study|Transport issue|0|||
27965205|NCT00412958|81704516|FG003|Overall Study|Transport issue|0|||
27965206|NCT05040971|81704517|FG000|Overall Study|Withdrawal by Subject|0|||
27965207|NCT05040971|81704518|FG001|Overall Study|Withdrawal by Subject|2|||
27965208|NCT05040971|81704517|FG000|Overall Study|Lost to Follow-up|8|||
27965209|NCT05040971|81704518|FG001|Overall Study|Lost to Follow-up|3|||
27965210|NCT05040971|81704517|FG000|Overall Study|Death|2|||
27965211|NCT05040971|81704518|FG001|Overall Study|Death|0|||
27965212|NCT01581021|81704528|FG000|Overall Study|Lost to Follow-up|4|||
27965213|NCT01581021|81704529|FG001|Overall Study|Lost to Follow-up|6|||
27965214|NCT01581021|81704528|FG000|Overall Study|More than 2 hooks in thoracic|3|||
27965215|NCT01581021|81704529|FG001|Overall Study|More than 2 hooks in thoracic|0|||
27965216|NCT01581021|81704528|FG000|Overall Study|Neuromuscular|2|||
27965217|NCT01581021|81704529|FG001|Overall Study|Neuromuscular|1|||
27965218|NCT01581021|81704528|FG000|Overall Study|Not Randomized|1|||
27965219|NCT01581021|81704529|FG001|Overall Study|Not Randomized|2|||
27965220|NCT01581021|81704528|FG000|Overall Study|Lenke 6 Classification|0|||
27965221|NCT01581021|81704529|FG001|Overall Study|Lenke 6 Classification|1|||
27965222|NCT01581021|81704528|FG000|Overall Study|Lack of Efficacy|0|||
27965223|NCT01581021|81704529|FG001|Overall Study|Lack of Efficacy|1|||
27965224|NCT02249091|81704530|FG000|Overall Study|Lack of Efficacy|8|||
27965225|NCT02249091|81704531|FG001|Overall Study|Lack of Efficacy|3|||
27965226|NCT02249091|81704530|FG000|Overall Study|Physician Decision|4|||
27965227|NCT02249091|81704531|FG001|Overall Study|Physician Decision|1|||
27965228|NCT02249091|81704530|FG000|Overall Study|Withdrawal by Subject|2|||
27965229|NCT02249091|81704531|FG001|Overall Study|Withdrawal by Subject|2|||
27965230|NCT02249091|81704530|FG000|Overall Study|Death|3|||
27965231|NCT02249091|81704531|FG001|Overall Study|Death|4|||
27965232|NCT02249091|81704530|FG000|Overall Study|Adverse Event|1|||
27965233|NCT02249091|81704531|FG001|Overall Study|Adverse Event|0|||
27965234|NCT02249091|81704530|FG000|Overall Study|Stable disease with following SCT|0|||
27965235|NCT02249091|81704531|FG001|Overall Study|Stable disease with following SCT|1|||
27965236|NCT02249091|81704530|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
27965237|NCT02249091|81704531|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
27965238|NCT02249091|81704530|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
27965239|NCT02249091|81704531|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
27965240|NCT02249091|81704530|FG000|Overall Study|Refractory AML|1|||
27965241|NCT02249091|81704531|FG001|Overall Study|Refractory AML|1|||
27965242|NCT03490292|81704532|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
27965243|NCT03490292|81704533|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
27965244|NCT03490292|81704532|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
27965245|NCT03490292|81704533|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
27965246|NCT03490292|81704532|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
27965247|NCT03490292|81704533|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
27965248|NCT03490292|81704532|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
27965249|NCT03490292|81704533|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
27965250|NCT03490292|81704532|FG000|1 Year Follow Up Post Last Dose|Death|1|||
27569167|NCT00735371|80271507|FG003|Overall Study|Withdrawal by Subject|0|||
27569168|NCT00735371|80271504|FG000|Overall Study|Lost to Follow-up|1|||
27569169|NCT00735371|80271505|FG001|Overall Study|Lost to Follow-up|1|||
27569170|NCT00735371|80271506|FG002|Overall Study|Lost to Follow-up|3|||
27772342|NCT00654420|80995786|FG002|Phase II|Progressive Disease|29|||
27772343|NCT00654420|80995787|FG003|Phase II|Progressive Disease|29|||
27772344|NCT00654420|80995784|FG000|Phase II|Withdrawal by Subject|0|||
27772345|NCT00654420|80995785|FG001|Phase II|Withdrawal by Subject|0|||
27772346|NCT00654420|80995786|FG002|Phase II|Withdrawal by Subject|4|||
27772347|NCT00654420|80995787|FG003|Phase II|Withdrawal by Subject|1|||
27965251|NCT03490292|81704533|FG001|1 Year Follow Up Post Last Dose|Death|1|||
27965252|NCT03718884|81704534|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
27772348|NCT00654420|80995784|FG000|Phase II|Missing Disposition Record|0|||
27772349|NCT00654420|80995785|FG001|Phase II|Missing Disposition Record|0|||
27772350|NCT00654420|80995786|FG002|Phase II|Missing Disposition Record|1|||
27772351|NCT00654420|80995787|FG003|Phase II|Missing Disposition Record|0|||
27772352|NCT01976624|80995792|FG000|Overall Study|Participants contraindicated|2|||
27772353|NCT01976624|80995792|FG000|Overall Study|Participants age less than 19 years|12|||
27772354|NCT01756833|80995798|FG000|Overall Study|Withdrawal by Subject|4|||
27772355|NCT01756833|80995799|FG001|Overall Study|Withdrawal by Subject|3|||
27772356|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Death|3|||
27772357|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Death|0|||
27772358|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Death|0|||
27772359|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Death|0|||
27772360|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Death|0|||
27772361|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
27772362|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
27772363|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
27772364|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
27772365|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
27772366|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27772367|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
27772368|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
27772369|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27772370|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
27772371|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Other|0|||
27772372|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Other|0|||
27772373|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Other|1|||
27772374|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Other|0|||
27772375|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Other|0|||
27772376|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
27772377|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
27772378|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
27772379|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
27772380|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
27772381|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
27772382|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
27772383|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
27772384|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
27772385|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
27772386|NCT01224106|80995800|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27772387|NCT01224106|80995801|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27772388|NCT01224106|80995802|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27772389|NCT01224106|80995803|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27772390|NCT01224106|80995804|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27772391|NCT01224106|80995800|FG000|Open-Label Extension (OLE) Phase|Death|0|||
27772392|NCT01224106|80995801|FG001|Open-Label Extension (OLE) Phase|Death|0|||
27772393|NCT01224106|80995802|FG002|Open-Label Extension (OLE) Phase|Death|0|||
27772394|NCT01224106|80995803|FG003|Open-Label Extension (OLE) Phase|Death|1|||
27772395|NCT01224106|80995804|FG004|Open-Label Extension (OLE) Phase|Death|3|||
27772396|NCT01224106|80995800|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
27772397|NCT01224106|80995801|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
27772398|NCT01224106|80995802|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
27772399|NCT01224106|80995803|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
27772400|NCT01224106|80995804|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
27772401|NCT01224106|80995800|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
27772402|NCT01224106|80995801|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
27772403|NCT01224106|80995802|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
27772404|NCT01224106|80995803|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
27772405|NCT01224106|80995804|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
27965253|NCT03718884|81704535|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
27772406|NCT01224106|80995800|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
27772407|NCT01224106|80995801|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
27772408|NCT01224106|80995802|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
27772409|NCT01224106|80995803|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
27965254|NCT03718884|81704534|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
27965255|NCT03718884|81704535|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
27772410|NCT01224106|80995804|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
27772411|NCT01224106|80995800|FG000|Open-Label Extension (OLE) Phase|Other|0|||
27772412|NCT01224106|80995801|FG001|Open-Label Extension (OLE) Phase|Other|0|||
27772413|NCT01224106|80995802|FG002|Open-Label Extension (OLE) Phase|Other|0|||
27772414|NCT01224106|80995803|FG003|Open-Label Extension (OLE) Phase|Other|5|||
27772415|NCT01224106|80995804|FG004|Open-Label Extension (OLE) Phase|Other|3|||
27772416|NCT00107172|80995808|FG000|Overall Study|Withdrawal by Subject|1|||
27772417|NCT00107172|80995809|FG001|Overall Study|Withdrawal by Subject|0|||
27772418|NCT00107172|80995808|FG000|Overall Study|Death|0|||
27772419|NCT00107172|80995809|FG001|Overall Study|Death|2|||
27772420|NCT00107172|80995808|FG000|Overall Study|Other Reason|4|||
27772421|NCT00107172|80995809|FG001|Overall Study|Other Reason|3|||
27772422|NCT00420342|80995812|FG000|Overall Study|Lost to Follow-up|1|||
27772423|NCT00420342|80995813|FG001|Overall Study|Lost to Follow-up|0|||
27772424|NCT00420342|80995814|FG002|Overall Study|Lost to Follow-up|1|||
27772425|NCT00420342|80995812|FG000|Overall Study|Withdrawal by Subject|0|||
27772426|NCT00420342|80995813|FG001|Overall Study|Withdrawal by Subject|2|||
27772427|NCT00420342|80995814|FG002|Overall Study|Withdrawal by Subject|0|||
27772428|NCT01468701|80995816|FG000|Overall Study|Not eligible|91|||
27772429|NCT01468701|80995817|FG001|Overall Study|Not eligible|140|||
27772430|NCT01468701|80995818|FG002|Overall Study|Not eligible|29|||
27772431|NCT01468701|80995819|FG003|Overall Study|Not eligible|12|||
27772432|NCT01468701|80995820|FG004|Overall Study|Not eligible|22|||
27772433|NCT01468701|80995821|FG005|Overall Study|Not eligible|2|||
27772434|NCT01468701|80995822|FG006|Overall Study|Not eligible|39|||
27772435|NCT01468701|80995823|FG007|Overall Study|Not eligible|1|||
27772436|NCT01468701|80995824|FG008|Overall Study|Not eligible|40|||
27772437|NCT01468701|80995825|FG009|Overall Study|Not eligible|126|||
27772438|NCT01468701|80995826|FG010|Overall Study|Not eligible|39|||
27772439|NCT01468701|80995827|FG011|Overall Study|Not eligible|33|||
27772440|NCT01468701|80995828|FG012|Overall Study|Not eligible|1|||
27772441|NCT01468701|80995829|FG013|Overall Study|Not eligible|19|||
27772442|NCT01468701|80995830|FG014|Overall Study|Not eligible|1|||
27772443|NCT01468701|80995831|FG015|Overall Study|Not eligible|32|||
27772444|NCT01468701|80995832|FG016|Overall Study|Not eligible|0|||
27772445|NCT01468701|80995816|FG000|Overall Study|Lost to Follow-up|306|||
27772446|NCT01468701|80995817|FG001|Overall Study|Lost to Follow-up|0|||
27772447|NCT01468701|80995818|FG002|Overall Study|Lost to Follow-up|0|||
27772448|NCT01468701|80995819|FG003|Overall Study|Lost to Follow-up|0|||
27772449|NCT01468701|80995820|FG004|Overall Study|Lost to Follow-up|0|||
27772450|NCT01468701|80995821|FG005|Overall Study|Lost to Follow-up|0|||
27772451|NCT01468701|80995822|FG006|Overall Study|Lost to Follow-up|0|||
27772452|NCT01468701|80995823|FG007|Overall Study|Lost to Follow-up|0|||
27772453|NCT01468701|80995824|FG008|Overall Study|Lost to Follow-up|215|||
27772454|NCT01468701|80995825|FG009|Overall Study|Lost to Follow-up|309|||
27772455|NCT01468701|80995826|FG010|Overall Study|Lost to Follow-up|224|||
27772456|NCT01468701|80995827|FG011|Overall Study|Lost to Follow-up|212|||
27772457|NCT01468701|80995828|FG012|Overall Study|Lost to Follow-up|11|||
27772458|NCT01468701|80995829|FG013|Overall Study|Lost to Follow-up|164|||
27772459|NCT01468701|80995830|FG014|Overall Study|Lost to Follow-up|17|||
27772460|NCT01468701|80995831|FG015|Overall Study|Lost to Follow-up|127|||
27772461|NCT01468701|80995832|FG016|Overall Study|Lost to Follow-up|1|||
27772462|NCT01468701|80995816|FG000|Overall Study|Withdrawal by Subject|165|||
27772463|NCT01468701|80995817|FG001|Overall Study|Withdrawal by Subject|0|||
27772464|NCT01468701|80995818|FG002|Overall Study|Withdrawal by Subject|0|||
27772465|NCT01468701|80995819|FG003|Overall Study|Withdrawal by Subject|0|||
27772466|NCT01468701|80995820|FG004|Overall Study|Withdrawal by Subject|0|||
27772467|NCT01468701|80995821|FG005|Overall Study|Withdrawal by Subject|0|||
27772468|NCT01468701|80995822|FG006|Overall Study|Withdrawal by Subject|0|||
27965256|NCT01521923|81704538|FG000|Overall Study|AE, serious fatal|1|||
27965257|NCT01521923|81704539|FG001|Overall Study|AE, serious fatal|0|||
27965258|NCT01521923|81704540|FG002|Overall Study|AE, serious fatal|0|||
27965259|NCT01521923|81704541|FG003|Overall Study|AE, serious fatal|0|||
27772469|NCT01468701|80995823|FG007|Overall Study|Withdrawal by Subject|0|||
27772470|NCT01468701|80995824|FG008|Overall Study|Withdrawal by Subject|83|||
27772471|NCT01468701|80995825|FG009|Overall Study|Withdrawal by Subject|88|||
27772472|NCT01468701|80995826|FG010|Overall Study|Withdrawal by Subject|100|||
27965260|NCT01521923|81704538|FG000|Overall Study|SAE, non-fatal|0|||
27772473|NCT01468701|80995827|FG011|Overall Study|Withdrawal by Subject|114|||
27965261|NCT01521923|81704539|FG001|Overall Study|SAE, non-fatal|2|||
27772474|NCT01468701|80995828|FG012|Overall Study|Withdrawal by Subject|9|||
27772475|NCT01468701|80995829|FG013|Overall Study|Withdrawal by Subject|47|||
27664229|NCT03675308|80606680|FG000|Overall Study|Adverse Event|3|||
27664230|NCT03675308|80606681|FG001|Overall Study|Adverse Event|2|||
27664231|NCT03675308|80606680|FG000|Overall Study|Withdrawal by Subject|6|||
27664232|NCT03675308|80606681|FG001|Overall Study|Withdrawal by Subject|4|||
27664233|NCT03675308|80606680|FG000|Overall Study|Lost to Follow-up|3|||
27664234|NCT03675308|80606681|FG001|Overall Study|Lost to Follow-up|0|||
27664235|NCT03675308|80606680|FG000|Overall Study|Lack of Efficacy|1|||
27664236|NCT03675308|80606681|FG001|Overall Study|Lack of Efficacy|1|||
27664237|NCT03675308|80606680|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
27664238|NCT03675308|80606681|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
27664239|NCT03675308|80606680|FG000|Overall Study|Other|0|||
27664240|NCT03675308|80606681|FG001|Overall Study|Other|1|||
27664241|NCT04362176|80606682|FG000|Overall Study|Lost to Follow-up|5|||
27664242|NCT04362176|80606683|FG001|Overall Study|Lost to Follow-up|8|||
27664243|NCT04362176|80606682|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
27664244|NCT04362176|80606683|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
27772476|NCT01468701|80995830|FG014|Overall Study|Withdrawal by Subject|6|||
27772477|NCT01468701|80995831|FG015|Overall Study|Withdrawal by Subject|31|||
27772478|NCT01468701|80995832|FG016|Overall Study|Withdrawal by Subject|0|||
27772479|NCT01468701|80995816|FG000|Overall Study|Other reasons than listed|437|||
27772480|NCT01468701|80995817|FG001|Overall Study|Other reasons than listed|0|||
27772481|NCT01468701|80995818|FG002|Overall Study|Other reasons than listed|0|||
27772482|NCT01468701|80995819|FG003|Overall Study|Other reasons than listed|0|||
27772483|NCT01468701|80995820|FG004|Overall Study|Other reasons than listed|0|||
27772484|NCT01468701|80995821|FG005|Overall Study|Other reasons than listed|0|||
27772485|NCT01468701|80995822|FG006|Overall Study|Other reasons than listed|0|||
27772486|NCT01468701|80995823|FG007|Overall Study|Other reasons than listed|0|||
27772487|NCT01468701|80995824|FG008|Overall Study|Other reasons than listed|318|||
27664245|NCT01157377|80606686|FG000|Overall Study|Lost to Follow-up|0|||
27664246|NCT01157377|80606687|FG001|Overall Study|Lost to Follow-up|0|||
27664247|NCT01157377|80606688|FG002|Overall Study|Lost to Follow-up|1|||
27664248|NCT01157377|80606689|FG003|Overall Study|Lost to Follow-up|0|||
27664249|NCT01157377|80606690|FG004|Overall Study|Lost to Follow-up|1|||
27664250|NCT01157377|80606691|FG005|Overall Study|Lost to Follow-up|1|||
27772488|NCT01468701|80995825|FG009|Overall Study|Other reasons than listed|658|||
27772489|NCT01468701|80995826|FG010|Overall Study|Other reasons than listed|433|||
27772490|NCT01468701|80995827|FG011|Overall Study|Other reasons than listed|504|||
27772491|NCT01468701|80995828|FG012|Overall Study|Other reasons than listed|28|||
27772492|NCT01468701|80995829|FG013|Overall Study|Other reasons than listed|239|||
27772493|NCT01468701|80995830|FG014|Overall Study|Other reasons than listed|39|||
27772494|NCT01468701|80995831|FG015|Overall Study|Other reasons than listed|172|||
27772495|NCT01468701|80995832|FG016|Overall Study|Other reasons than listed|0|||
27772496|NCT01468701|80995816|FG000|Overall Study|No end of study case report form|0|||
27772497|NCT01468701|80995817|FG001|Overall Study|No end of study case report form|0|||
27772498|NCT01468701|80995818|FG002|Overall Study|No end of study case report form|0|||
27772499|NCT01468701|80995819|FG003|Overall Study|No end of study case report form|0|||
27772500|NCT01468701|80995820|FG004|Overall Study|No end of study case report form|0|||
27772501|NCT01468701|80995821|FG005|Overall Study|No end of study case report form|0|||
27772502|NCT01468701|80995822|FG006|Overall Study|No end of study case report form|0|||
27772503|NCT01468701|80995823|FG007|Overall Study|No end of study case report form|0|||
27772504|NCT01468701|80995824|FG008|Overall Study|No end of study case report form|4|||
27772505|NCT01468701|80995825|FG009|Overall Study|No end of study case report form|1|||
27772506|NCT01468701|80995826|FG010|Overall Study|No end of study case report form|2|||
27772507|NCT01468701|80995827|FG011|Overall Study|No end of study case report form|3|||
27772508|NCT01468701|80995828|FG012|Overall Study|No end of study case report form|0|||
27772509|NCT01468701|80995829|FG013|Overall Study|No end of study case report form|1|||
27772510|NCT01468701|80995830|FG014|Overall Study|No end of study case report form|0|||
27772511|NCT01468701|80995831|FG015|Overall Study|No end of study case report form|0|||
27772512|NCT01468701|80995832|FG016|Overall Study|No end of study case report form|0|||
27772513|NCT01468701|80995816|FG000|Overall Study|Not being followed up|0|||
27772514|NCT01468701|80995817|FG001|Overall Study|Not being followed up|4963|||
27772515|NCT01468701|80995818|FG002|Overall Study|Not being followed up|1755|||
27772516|NCT01468701|80995819|FG003|Overall Study|Not being followed up|703|||
27965262|NCT01521923|81704540|FG002|Overall Study|SAE, non-fatal|2|||
27965263|NCT01521923|81704541|FG003|Overall Study|SAE, non-fatal|0|||
27772517|NCT01468701|80995820|FG004|Overall Study|Not being followed up|1714|||
27772518|NCT01468701|80995821|FG005|Overall Study|Not being followed up|126|||
27772519|NCT01468701|80995822|FG006|Overall Study|Not being followed up|1170|||
27664251|NCT01157377|80606692|FG006|Overall Study|Lost to Follow-up|0|||
27772520|NCT01468701|80995823|FG007|Overall Study|Not being followed up|4|||
27965264|NCT01521923|81704538|FG000|Overall Study|AE, non-serious, non-fatal|1|||
27965265|NCT01521923|81704539|FG001|Overall Study|AE, non-serious, non-fatal|3|||
27664252|NCT01157377|80606686|FG000|Overall Study|Personal Reasons|2|||
27664253|NCT01157377|80606687|FG001|Overall Study|Personal Reasons|1|||
27664254|NCT01157377|80606688|FG002|Overall Study|Personal Reasons|0|||
27664255|NCT01157377|80606689|FG003|Overall Study|Personal Reasons|1|||
27664256|NCT01157377|80606690|FG004|Overall Study|Personal Reasons|0|||
27664257|NCT01157377|80606691|FG005|Overall Study|Personal Reasons|0|||
27664258|NCT01157377|80606692|FG006|Overall Study|Personal Reasons|0|||
27664259|NCT01157377|80606686|FG000|Overall Study|Protocol Violation|0|||
27664260|NCT01157377|80606687|FG001|Overall Study|Protocol Violation|0|||
27664261|NCT01157377|80606688|FG002|Overall Study|Protocol Violation|0|||
27664262|NCT01157377|80606689|FG003|Overall Study|Protocol Violation|0|||
27664263|NCT01157377|80606690|FG004|Overall Study|Protocol Violation|0|||
27664264|NCT01157377|80606691|FG005|Overall Study|Protocol Violation|1|||
27664265|NCT01157377|80606692|FG006|Overall Study|Protocol Violation|0|||
27664266|NCT01157377|80606686|FG000|Overall Study|Lack of Efficacy|0|||
27664267|NCT01157377|80606687|FG001|Overall Study|Lack of Efficacy|0|||
27664268|NCT01157377|80606688|FG002|Overall Study|Lack of Efficacy|0|||
27664269|NCT01157377|80606689|FG003|Overall Study|Lack of Efficacy|0|||
27664270|NCT01157377|80606690|FG004|Overall Study|Lack of Efficacy|0|||
27664271|NCT01157377|80606691|FG005|Overall Study|Lack of Efficacy|0|||
27664272|NCT01157377|80606692|FG006|Overall Study|Lack of Efficacy|1|||
27664273|NCT01157377|80606686|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27664274|NCT01157377|80606687|FG001|Overall Study|Other Miscellaneous Reasons|2|||
27664275|NCT01157377|80606688|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27664276|NCT01157377|80606689|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27664277|NCT01157377|80606690|FG004|Overall Study|Other Miscellaneous Reasons|1|||
27664278|NCT01157377|80606691|FG005|Overall Study|Other Miscellaneous Reasons|1|||
27664279|NCT01157377|80606692|FG006|Overall Study|Other Miscellaneous Reasons|1|||
27664280|NCT00817336|80606693|FG000|Overall Study|Withdrawal by Subject|1|||
27664281|NCT00817336|80606694|FG001|Overall Study|Withdrawal by Subject|1|||
27664282|NCT01649297|80609394|FG000|Overall Study|Adverse Event|5|||
27664283|NCT01649297|80609395|FG001|Overall Study|Adverse Event|5|||
27664284|NCT01649297|80609396|FG002|Overall Study|Adverse Event|4|||
27664285|NCT01649297|80609397|FG003|Overall Study|Adverse Event|13|||
27664286|NCT01649297|80609398|FG004|Overall Study|Adverse Event|1|||
27664287|NCT01649297|80609394|FG000|Overall Study|Lack of Efficacy|0|||
27664288|NCT01649297|80609395|FG001|Overall Study|Lack of Efficacy|0|||
27965266|NCT01521923|81704540|FG002|Overall Study|AE, non-serious, non-fatal|6|||
27965267|NCT01521923|81704541|FG003|Overall Study|AE, non-serious, non-fatal|2|||
27965268|NCT01521923|81704538|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
27965269|NCT01521923|81704539|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
27664289|NCT01649297|80609396|FG002|Overall Study|Lack of Efficacy|0|||
27664290|NCT01649297|80609397|FG003|Overall Study|Lack of Efficacy|0|||
27664291|NCT01649297|80609398|FG004|Overall Study|Lack of Efficacy|1|||
27664292|NCT01649297|80609394|FG000|Overall Study|Non compliant with Protocol|1|||
27664293|NCT01649297|80609395|FG001|Overall Study|Non compliant with Protocol|0|||
27664294|NCT01649297|80609396|FG002|Overall Study|Non compliant with Protocol|3|||
27664295|NCT01649297|80609397|FG003|Overall Study|Non compliant with Protocol|2|||
27664296|NCT01649297|80609398|FG004|Overall Study|Non compliant with Protocol|1|||
27664297|NCT01649297|80609394|FG000|Overall Study|Lost to Follow-up|1|||
27664298|NCT01649297|80609395|FG001|Overall Study|Lost to Follow-up|1|||
27664299|NCT01649297|80609396|FG002|Overall Study|Lost to Follow-up|4|||
27664300|NCT01649297|80609397|FG003|Overall Study|Lost to Follow-up|3|||
27664301|NCT01649297|80609398|FG004|Overall Study|Lost to Follow-up|0|||
27664302|NCT01649297|80609394|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
27664303|NCT01649297|80609395|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
27664304|NCT01649297|80609396|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
27965270|NCT01521923|81704540|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
27965271|NCT01521923|81704541|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
27965272|NCT01521923|81704538|FG000|Overall Study|Lack of Efficacy|1|||
27965273|NCT01521923|81704539|FG001|Overall Study|Lack of Efficacy|1|||
27965274|NCT01521923|81704540|FG002|Overall Study|Lack of Efficacy|0|||
27965275|NCT01521923|81704541|FG003|Overall Study|Lack of Efficacy|0|||
27965276|NCT01521923|81704538|FG000|Overall Study|Protocol Violation|0|||
27965277|NCT01521923|81704539|FG001|Overall Study|Protocol Violation|0|||
27965278|NCT01521923|81704540|FG002|Overall Study|Protocol Violation|1|||
27965279|NCT01521923|81704541|FG003|Overall Study|Protocol Violation|0|||
27965280|NCT01521923|81704538|FG000|Overall Study|Lost to Follow-up|1|||
27664305|NCT01649297|80609397|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
27664306|NCT01649297|80609398|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
27664307|NCT01649297|80609394|FG000|Overall Study|For other reason|4|||
27664308|NCT01649297|80609395|FG001|Overall Study|For other reason|1|||
27664309|NCT01649297|80609396|FG002|Overall Study|For other reason|2|||
27664310|NCT01649297|80609397|FG003|Overall Study|For other reason|0|||
27664311|NCT01649297|80609398|FG004|Overall Study|For other reason|0|||
27664312|NCT01747629|80609400|FG000|Overall Study|Adverse Event|1|||
27965281|NCT01521923|81704539|FG001|Overall Study|Lost to Follow-up|0|||
27664313|NCT01747629|80609401|FG001|Overall Study|Adverse Event|2|||
27965282|NCT01521923|81704540|FG002|Overall Study|Lost to Follow-up|2|||
27965283|NCT01521923|81704541|FG003|Overall Study|Lost to Follow-up|1|||
27965284|NCT01521923|81704538|FG000|Overall Study|Withdrawal by Subject|1|||
27965285|NCT01521923|81704539|FG001|Overall Study|Withdrawal by Subject|1|||
27965286|NCT01521923|81704540|FG002|Overall Study|Withdrawal by Subject|1|||
27965287|NCT01521923|81704541|FG003|Overall Study|Withdrawal by Subject|2|||
27965288|NCT01521923|81704538|FG000|Overall Study|Other|2|||
27965289|NCT01521923|81704539|FG001|Overall Study|Other|1|||
27965290|NCT01521923|81704540|FG002|Overall Study|Other|3|||
27664314|NCT01747629|80609400|FG000|Overall Study|Withdrawal by Subject|2|||
27664315|NCT01747629|80609401|FG001|Overall Study|Withdrawal by Subject|2|||
27664316|NCT01747629|80609400|FG000|Overall Study|Noncompliance|1|||
27772521|NCT01468701|80995824|FG008|Overall Study|Not being followed up|0|||
27772522|NCT01468701|80995825|FG009|Overall Study|Not being followed up|0|||
27965291|NCT01521923|81704541|FG003|Overall Study|Other|6|||
27664317|NCT01747629|80609401|FG001|Overall Study|Noncompliance|1|||
27664318|NCT01747629|80609400|FG000|Overall Study|Inclusion criteria not met|1|||
27965292|NCT01521923|81704538|FG000|Overall Study|AE, captured in Period 1|0|||
27965293|NCT01521923|81704539|FG001|Overall Study|AE, captured in Period 1|1|||
27664319|NCT01747629|80609401|FG001|Overall Study|Inclusion criteria not met|0|||
27664320|NCT01747629|80609400|FG000|Overall Study|Not treated|1|||
27664321|NCT01747629|80609401|FG001|Overall Study|Not treated|0|||
27664322|NCT01747629|80609400|FG000|Overall Study|Other|2|||
27664323|NCT01747629|80609401|FG001|Overall Study|Other|1|||
27664324|NCT00578318|80609411|FG000|Overall Study|Lost to Follow-up|2|||
27664325|NCT00578318|80609412|FG001|Overall Study|Lost to Follow-up|0|||
27772523|NCT01468701|80995826|FG010|Overall Study|Not being followed up|0|||
27772524|NCT01468701|80995827|FG011|Overall Study|Not being followed up|0|||
27664326|NCT00578318|80609411|FG000|Overall Study|Physician Decision|1|||
27664327|NCT00578318|80609412|FG001|Overall Study|Physician Decision|0|||
27664328|NCT03334695|80609413|FG000|Overall Study|Lost to Follow-up|3|||
27664329|NCT03334695|80609414|FG001|Overall Study|Lost to Follow-up|3|||
27664330|NCT03334695|80609413|FG000|Overall Study|Physician Decision|1|||
27664331|NCT03334695|80609414|FG001|Overall Study|Physician Decision|2|||
27664332|NCT03334695|80609413|FG000|Overall Study|Protocol Violation|0|||
27664333|NCT03334695|80609414|FG001|Overall Study|Protocol Violation|1|||
27664334|NCT02859558|80609415|FG000|Step 1|Not Eligible|0|||
27664335|NCT02859558|80609416|FG001|Step 1|Not Eligible|0|||
27664336|NCT02859558|80609417|FG002|Step 1|Not Eligible|0|||
27664337|NCT02859558|80609418|FG003|Step 1|Not Eligible|0|||
27664338|NCT02859558|80609419|FG004|Step 1|Not Eligible|3|||
27664339|NCT02859558|80609415|FG000|Step 1|Lost to Follow-up|1|||
27664340|NCT02859558|80609416|FG001|Step 1|Lost to Follow-up|3|||
27664341|NCT02859558|80609417|FG002|Step 1|Lost to Follow-up|3|||
27664342|NCT02859558|80609418|FG003|Step 1|Lost to Follow-up|0|||
27664343|NCT02859558|80609419|FG004|Step 1|Lost to Follow-up|0|||
27664344|NCT02859558|80609415|FG000|Step 1|Did Not Return to Clinic|2|||
27664345|NCT02859558|80609416|FG001|Step 1|Did Not Return to Clinic|3|||
27664346|NCT02859558|80609417|FG002|Step 1|Did Not Return to Clinic|4|||
27664347|NCT02859558|80609418|FG003|Step 1|Did Not Return to Clinic|0|||
27664348|NCT02859558|80609419|FG004|Step 1|Did Not Return to Clinic|0|||
27664349|NCT02859558|80609415|FG000|Step 1|Moved|0|||
27664350|NCT02859558|80609416|FG001|Step 1|Moved|1|||
27664351|NCT02859558|80609417|FG002|Step 1|Moved|1|||
27664352|NCT02859558|80609418|FG003|Step 1|Moved|0|||
27664353|NCT02859558|80609419|FG004|Step 1|Moved|0|||
27664354|NCT02859558|80609415|FG000|Step 1|Withdrawal By Participant|1|||
27664355|NCT02859558|80609416|FG001|Step 1|Withdrawal By Participant|2|||
27664356|NCT02859558|80609417|FG002|Step 1|Withdrawal By Participant|1|||
27664357|NCT02859558|80609418|FG003|Step 1|Withdrawal By Participant|0|||
27772525|NCT01468701|80995828|FG012|Overall Study|Not being followed up|0|||
27772526|NCT01468701|80995829|FG013|Overall Study|Not being followed up|0|||
27772527|NCT01468701|80995830|FG014|Overall Study|Not being followed up|0|||
27772528|NCT01468701|80995831|FG015|Overall Study|Not being followed up|0|||
27772529|NCT01468701|80995832|FG016|Overall Study|Not being followed up|0|||
27664358|NCT02859558|80609419|FG004|Step 1|Withdrawal By Participant|0|||
27772530|NCT02289833|80995833|FG000|Overall Study|Study discontinuation|0|||
27965294|NCT01521923|81704540|FG002|Overall Study|AE, captured in Period 1|0|||
27664359|NCT02859558|80609415|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
27664360|NCT02859558|80609416|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
27772531|NCT02289833|80995834|FG001|Overall Study|Study discontinuation|1|||
27965295|NCT01521923|81704541|FG003|Overall Study|AE, captured in Period 1|1|||
27965296|NCT01891396|81704546|FG000|Overall Study|Withdrawal by Subject|4|||
27664361|NCT02859558|80609417|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
27664362|NCT02859558|80609418|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
27664363|NCT02859558|80609419|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
27965297|NCT01891396|81704547|FG001|Overall Study|Withdrawal by Subject|4|||
27965298|NCT01891396|81704548|FG002|Overall Study|Withdrawal by Subject|3|||
27664364|NCT02859558|80609415|FG000|Step 1|Incarceration|0|||
27664365|NCT02859558|80609416|FG001|Step 1|Incarceration|1|||
27664366|NCT02859558|80609417|FG002|Step 1|Incarceration|0|||
27664367|NCT02859558|80609418|FG003|Step 1|Incarceration|0|||
27772532|NCT02289833|80995833|FG000|Overall Study|Lost to Follow-up|4|||
27772533|NCT02289833|80995834|FG001|Overall Study|Lost to Follow-up|0|||
27772534|NCT02289833|80995833|FG000|Overall Study|Death|23|||
27772535|NCT02289833|80995834|FG001|Overall Study|Death|16|||
27772536|NCT01474889|80995836|FG000|Overall Study|Physician Decision|1|||
27772537|NCT01474889|80995837|FG001|Overall Study|Physician Decision|0|||
27772538|NCT01474889|80995838|FG002|Overall Study|Physician Decision|0|||
27772539|NCT01474889|80995836|FG000|Overall Study|Did not meet inclusion|1|||
27772540|NCT01474889|80995837|FG001|Overall Study|Did not meet inclusion|0|||
27772541|NCT01474889|80995838|FG002|Overall Study|Did not meet inclusion|0|||
27772542|NCT01474889|80995836|FG000|Overall Study|Withdrawal by Subject|0|||
27772543|NCT01474889|80995837|FG001|Overall Study|Withdrawal by Subject|1|||
27772544|NCT01474889|80995838|FG002|Overall Study|Withdrawal by Subject|0|||
27772545|NCT00608881|80995839|FG000|Overall Study|Death|22|||
27772546|NCT00608881|80995840|FG001|Overall Study|Death|13|||
27772547|NCT00608881|80995839|FG000|Overall Study|Adverse Event|5|||
27772548|NCT00608881|80995840|FG001|Overall Study|Adverse Event|3|||
27772549|NCT00608881|80995839|FG000|Overall Study|Lost to Follow-up|28|||
27772550|NCT00608881|80995840|FG001|Overall Study|Lost to Follow-up|14|||
27772551|NCT00608881|80995839|FG000|Overall Study|Withdrawal by Subject|18|||
27772552|NCT00608881|80995840|FG001|Overall Study|Withdrawal by Subject|29|||
27772553|NCT00608881|80995839|FG000|Overall Study|Physician Decision|5|||
27965299|NCT01891396|81704546|FG000|Overall Study|Lost to Follow-up|0|||
27965300|NCT01891396|81704547|FG001|Overall Study|Lost to Follow-up|1|||
27965301|NCT01891396|81704548|FG002|Overall Study|Lost to Follow-up|0|||
27965302|NCT02957747|81704549|FG000|Overall Study|Withdrawal by Subject|0|||
27965303|NCT02957747|81704550|FG001|Overall Study|Withdrawal by Subject|3|||
27965304|NCT02957747|81704549|FG000|Overall Study|Lost to Follow-up|10|||
27965305|NCT02957747|81704550|FG001|Overall Study|Lost to Follow-up|5|||
27965306|NCT03594747|81704551|FG000|Overall Study|Death|78|||
27965307|NCT03594747|81704552|FG001|Overall Study|Death|86|||
27965308|NCT03594747|81704553|FG002|Overall Study|Death|87|||
27965309|NCT03594747|81704551|FG000|Overall Study|Withdrawal by Subject|5|||
27965310|NCT03594747|81704552|FG001|Overall Study|Withdrawal by Subject|2|||
27965311|NCT03594747|81704553|FG002|Overall Study|Withdrawal by Subject|11|||
27965312|NCT03594747|81704551|FG000|Overall Study|Lost to Follow-up|4|||
27965313|NCT03594747|81704552|FG001|Overall Study|Lost to Follow-up|1|||
27965314|NCT03594747|81704553|FG002|Overall Study|Lost to Follow-up|1|||
27664368|NCT02859558|80609419|FG004|Step 1|Incarceration|0|||
27664369|NCT02859558|80609415|FG000|Step 1|Non-Adherence to Study Drug|2|||
27664370|NCT02859558|80609416|FG001|Step 1|Non-Adherence to Study Drug|0|||
27664371|NCT02859558|80609417|FG002|Step 1|Non-Adherence to Study Drug|1|||
27664372|NCT02859558|80609418|FG003|Step 1|Non-Adherence to Study Drug|0|||
27664373|NCT02859558|80609419|FG004|Step 1|Non-Adherence to Study Drug|0|||
27664374|NCT02859558|80609415|FG000|Step 1|Non-Adherence to Study Requirements|3|||
27664375|NCT02859558|80609416|FG001|Step 1|Non-Adherence to Study Requirements|1|||
27664376|NCT02859558|80609417|FG002|Step 1|Non-Adherence to Study Requirements|0|||
27664377|NCT02859558|80609418|FG003|Step 1|Non-Adherence to Study Requirements|0|||
27664378|NCT02859558|80609419|FG004|Step 1|Non-Adherence to Study Requirements|0|||
27664379|NCT02859558|80609415|FG000|Step 1|Virologic Failure|2|||
27664380|NCT02859558|80609416|FG001|Step 1|Virologic Failure|1|||
27664381|NCT02859558|80609417|FG002|Step 1|Virologic Failure|1|||
27664382|NCT02859558|80609418|FG003|Step 1|Virologic Failure|0|||
27664383|NCT02859558|80609419|FG004|Step 1|Virologic Failure|0|||
27664384|NCT02859558|80609415|FG000|Step 2|Active On Study|23|||
27664385|NCT02859558|80609416|FG001|Step 2|Active On Study|38|||
27664386|NCT02859558|80609417|FG002|Step 2|Active On Study|20|||
27664387|NCT02859558|80609418|FG003|Step 2|Active On Study|0|||
27664388|NCT02859558|80609419|FG004|Step 2|Active On Study|0|||
27664389|NCT02859558|80609415|FG000|Step 2|Did Not Return to Clinic|2|||
27664390|NCT02859558|80609416|FG001|Step 2|Did Not Return to Clinic|0|||
27664391|NCT02859558|80609417|FG002|Step 2|Did Not Return to Clinic|0|||
27664392|NCT02859558|80609418|FG003|Step 2|Did Not Return to Clinic|0|||
27664393|NCT02859558|80609419|FG004|Step 2|Did Not Return to Clinic|0|||
27664394|NCT02859558|80609415|FG000|Step 2|Unexpected Closure of Site|0|||
27664395|NCT02859558|80609416|FG001|Step 2|Unexpected Closure of Site|1|||
27664396|NCT02859558|80609417|FG002|Step 2|Unexpected Closure of Site|1|||
27664397|NCT02859558|80609418|FG003|Step 2|Unexpected Closure of Site|0|||
27664398|NCT02859558|80609419|FG004|Step 2|Unexpected Closure of Site|0|||
27664399|NCT00922441|80609420|FG000|Overall Study|Protocol Violation|0|||
27664400|NCT00922441|80609421|FG001|Overall Study|Protocol Violation|0|||
27664401|NCT00922441|80609422|FG002|Overall Study|Protocol Violation|2|||
27664402|NCT00922441|80609420|FG000|Overall Study|Withdrawal by Subject|0|||
27664403|NCT00922441|80609421|FG001|Overall Study|Withdrawal by Subject|0|||
27664404|NCT00922441|80609422|FG002|Overall Study|Withdrawal by Subject|1|||
27664405|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
27664406|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27664407|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27772554|NCT00608881|80995840|FG001|Overall Study|Physician Decision|5|||
27965315|NCT03594747|81704551|FG000|Overall Study|Physician Decision|0|||
27965316|NCT03594747|81704552|FG001|Overall Study|Physician Decision|1|||
27965317|NCT03594747|81704553|FG002|Overall Study|Physician Decision|0|||
27965318|NCT03594747|81704551|FG000|Overall Study|Sponsor decision|23|||
27965319|NCT03594747|81704552|FG001|Overall Study|Sponsor decision|17|||
27965320|NCT03594747|81704553|FG002|Overall Study|Sponsor decision|16|||
27965321|NCT03594747|81704551|FG000|Overall Study|Did not meet inclusion criteria|0|||
27965322|NCT03594747|81704552|FG001|Overall Study|Did not meet inclusion criteria|0|||
27965323|NCT03594747|81704553|FG002|Overall Study|Did not meet inclusion criteria|1|||
27965324|NCT03594747|81704551|FG000|Overall Study|Transfer to long term extension study|10|||
27965325|NCT03594747|81704552|FG001|Overall Study|Transfer to long term extension study|12|||
27965326|NCT03594747|81704553|FG002|Overall Study|Transfer to long term extension study|5|||
27965327|NCT03145064|81704556|FG000|Overall Study|Death|24|||
27965328|NCT03145064|81704556|FG000|Overall Study|Lost to Follow-up|3|||
27965329|NCT03145064|81704556|FG000|Overall Study|Withdrawal by Subject|6|||
27965330|NCT03145064|81704556|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
27965331|NCT03145064|81704556|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
27965332|NCT00904670|81704557|FG000|Open Label Phase|Withdrawal by Subject|2|||
27772555|NCT00608881|80995839|FG000|Overall Study|Institutionalized|1|||
27772556|NCT00608881|80995840|FG001|Overall Study|Institutionalized|2|||
27772557|NCT01712490|80995843|FG000|Overall Study|Ongoing|601|||
27772558|NCT01712490|80995844|FG001|Overall Study|Ongoing|586|||
27772559|NCT01712490|80995843|FG000|Overall Study|Other|11|||
27772560|NCT01712490|80995844|FG001|Overall Study|Other|11|||
27772561|NCT01712490|80995843|FG000|Overall Study|Withdrawal by Subject|36|||
27772562|NCT01712490|80995844|FG001|Overall Study|Withdrawal by Subject|44|||
27772563|NCT01712490|80995843|FG000|Overall Study|Lost to Follow-up|16|||
27772564|NCT01712490|80995844|FG001|Overall Study|Lost to Follow-up|29|||
27772565|NCT00247273|80995846|FG000|Overall Study|Adverse Event|85|||
27772566|NCT00247273|80995847|FG001|Overall Study|Adverse Event|80|||
27772567|NCT00247273|80995846|FG000|Overall Study|Physician Decision|6|||
27772568|NCT00247273|80995847|FG001|Overall Study|Physician Decision|3|||
27772569|NCT00247273|80995846|FG000|Overall Study|Lost to Follow-up|7|||
27772570|NCT00247273|80995847|FG001|Overall Study|Lost to Follow-up|7|||
27772571|NCT00247273|80995846|FG000|Overall Study|Withdrawal by Subject|46|||
27772572|NCT00247273|80995847|FG001|Overall Study|Withdrawal by Subject|47|||
27772573|NCT00247273|80995846|FG000|Overall Study|Did not take any study drug|2|||
27772574|NCT00247273|80995847|FG001|Overall Study|Did not take any study drug|0|||
27772575|NCT02603172|80995851|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27965333|NCT00904670|81704558|FG001|Open Label Phase|Withdrawal by Subject|0|||
27965334|NCT00904670|81704557|FG000|Open Label Phase|Adverse Event|2|||
27965335|NCT00904670|81704558|FG001|Open Label Phase|Adverse Event|0|||
27772576|NCT02603172|80995852|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27772577|NCT02603172|80995853|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
27772578|NCT02603172|80995854|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27772579|NCT02603172|80995855|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27772580|NCT02603172|80995856|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27772581|NCT02603172|80995857|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27772582|NCT02603172|80995858|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
27772583|NCT02109744|80995861|FG000|Overall Study|Death|1|||
27772584|NCT02109744|80995862|FG001|Overall Study|Death|1|||
27772585|NCT02109744|80995861|FG000|Overall Study|no marrow exam|1|||
27772586|NCT02109744|80995862|FG001|Overall Study|no marrow exam|0|||
27772587|NCT02499575|80995863|FG000|Overall Study|Protocol Violation|0|||
27772588|NCT02499575|80995864|FG001|Overall Study|Protocol Violation|1|||
27772589|NCT01098032|80995868|FG000|Overall Study|Withdrawal by Subject|1|||
27772590|NCT01098032|80995869|FG001|Overall Study|Withdrawal by Subject|1|||
27772591|NCT01641081|80995870|FG000|Period 1|Sponsor request (potential unblinding)|0|||
27772592|NCT01641081|80995871|FG001|Period 1|Sponsor request (potential unblinding)|0|||
27772593|NCT01641081|80995872|FG002|Period 1|Sponsor request (potential unblinding)|0|||
27772594|NCT01641081|80995873|FG003|Period 1|Sponsor request (potential unblinding)|0|||
27772595|NCT01641081|80995874|FG004|Period 1|Sponsor request (potential unblinding)|0|||
27772596|NCT01641081|80995875|FG005|Period 1|Sponsor request (potential unblinding)|0|||
27772597|NCT01641081|80995876|FG006|Period 1|Sponsor request (potential unblinding)|1|||
27772598|NCT01641081|80995877|FG007|Period 1|Sponsor request (potential unblinding)|0|||
27772599|NCT01641081|80995878|FG008|Period 1|Sponsor request (potential unblinding)|0|||
27772600|NCT01641081|80995879|FG009|Period 1|Sponsor request (potential unblinding)|0|||
27772601|NCT01641081|80995870|FG000|Period 1|Protocol Violation|0|||
27772602|NCT01641081|80995871|FG001|Period 1|Protocol Violation|0|||
27772603|NCT01641081|80995872|FG002|Period 1|Protocol Violation|0|||
27965336|NCT00904670|81704557|FG000|Open Label Phase|Lack of Efficacy|1|||
27772604|NCT01641081|80995873|FG003|Period 1|Protocol Violation|0|||
27772605|NCT01641081|80995874|FG004|Period 1|Protocol Violation|1|||
27965337|NCT00904670|81704558|FG001|Open Label Phase|Lack of Efficacy|0|||
27965338|NCT00904670|81704557|FG000|Open Label Phase|Lost to Follow-up|1|||
27772606|NCT01641081|80995875|FG005|Period 1|Protocol Violation|0|||
27965339|NCT00904670|81704558|FG001|Open Label Phase|Lost to Follow-up|0|||
27965340|NCT04075513|81704559|FG000|Overall Study|Withdrawal by Subject|2|||
27965341|NCT04075513|81704560|FG001|Overall Study|Withdrawal by Subject|2|||
27965342|NCT04075513|81704559|FG000|Overall Study|Lack of Efficacy|1|||
27965343|NCT04075513|81704560|FG001|Overall Study|Lack of Efficacy|0|||
27965344|NCT04075513|81704559|FG000|Overall Study|Lost to Follow-up|4|||
27965345|NCT04075513|81704560|FG001|Overall Study|Lost to Follow-up|2|||
27965346|NCT04075513|81704559|FG000|Overall Study|Switch to insulin pump|1|||
27965347|NCT04075513|81704560|FG001|Overall Study|Switch to insulin pump|0|||
27965348|NCT02470585|81704561|FG000|Overall Study|Death|224|||
27965349|NCT02470585|81704562|FG001|Overall Study|Death|227|||
27965350|NCT02470585|81704563|FG002|Overall Study|Death|199|||
27965351|NCT02470585|81704561|FG000|Overall Study|Withdrew consent|21|||
27965352|NCT02470585|81704562|FG001|Overall Study|Withdrew consent|22|||
27965353|NCT02470585|81704563|FG002|Overall Study|Withdrew consent|31|||
27965354|NCT02470585|81704561|FG000|Overall Study|Lost to Follow-up|8|||
27965355|NCT02470585|81704562|FG001|Overall Study|Lost to Follow-up|15|||
27965356|NCT02470585|81704563|FG002|Overall Study|Lost to Follow-up|13|||
27965357|NCT02470585|81704561|FG000|Overall Study|Sponsor discontinued study|117|||
27664408|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27664409|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27664410|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
27664411|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27664412|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27664413|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27664414|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27664415|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
27664416|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27664417|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27664418|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27664419|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27664420|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
27664421|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27664422|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27664423|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27664424|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27664425|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
27664426|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27965358|NCT02470585|81704562|FG001|Overall Study|Sponsor discontinued study|110|||
27664427|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27664428|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27664429|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27664430|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
27664431|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27664432|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27664433|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27664434|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27664435|NCT01187407|80609425|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
27664436|NCT01187407|80609426|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27664437|NCT01187407|80609427|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27664438|NCT01187407|80609428|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27664439|NCT01187407|80609429|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27664440|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
27772607|NCT01641081|80995876|FG006|Period 1|Protocol Violation|0|||
27772608|NCT01641081|80995877|FG007|Period 1|Protocol Violation|1|||
27772609|NCT01641081|80995878|FG008|Period 1|Protocol Violation|0|||
27772610|NCT01641081|80995879|FG009|Period 1|Protocol Violation|0|||
27772611|NCT01641081|80995870|FG000|Period 1|Adverse Event|1|||
27772612|NCT01641081|80995871|FG001|Period 1|Adverse Event|0|||
27772613|NCT01641081|80995872|FG002|Period 1|Adverse Event|0|||
27772614|NCT01641081|80995873|FG003|Period 1|Adverse Event|0|||
27772615|NCT01641081|80995874|FG004|Period 1|Adverse Event|0|||
27772616|NCT01641081|80995875|FG005|Period 1|Adverse Event|0|||
27965359|NCT02470585|81704563|FG002|Overall Study|Sponsor discontinued study|122|||
27965360|NCT02470585|81704561|FG000|Overall Study|Other, not specified|5|||
27772617|NCT01641081|80995876|FG006|Period 1|Adverse Event|0|||
27772618|NCT01641081|80995877|FG007|Period 1|Adverse Event|2|||
27772619|NCT01641081|80995878|FG008|Period 1|Adverse Event|0|||
27965361|NCT02470585|81704562|FG001|Overall Study|Other, not specified|7|||
27965362|NCT02470585|81704563|FG002|Overall Study|Other, not specified|14|||
27965363|NCT02470585|81704561|FG000|Overall Study|Missing due to site non-compliance|0|||
27965364|NCT02470585|81704562|FG001|Overall Study|Missing due to site non-compliance|2|||
27965365|NCT02470585|81704563|FG002|Overall Study|Missing due to site non-compliance|3|||
27772620|NCT01641081|80995879|FG009|Period 1|Adverse Event|0|||
27772621|NCT01641081|80995870|FG000|Period 2|Adverse Event|0|||
27772622|NCT01641081|80995871|FG001|Period 2|Adverse Event|0|||
27772623|NCT01641081|80995872|FG002|Period 2|Adverse Event|0|||
27772624|NCT01641081|80995873|FG003|Period 2|Adverse Event|0|||
27772625|NCT01641081|80995874|FG004|Period 2|Adverse Event|0|||
27772626|NCT01641081|80995875|FG005|Period 2|Adverse Event|1|||
27772627|NCT01641081|80995876|FG006|Period 2|Adverse Event|0|||
27772628|NCT01641081|80995877|FG007|Period 2|Adverse Event|0|||
27772629|NCT01641081|80995878|FG008|Period 2|Adverse Event|0|||
27772630|NCT01641081|80995879|FG009|Period 2|Adverse Event|0|||
27772631|NCT01641081|80995870|FG000|Period 2|Withdrawal by Subject|0|||
27772632|NCT01641081|80995871|FG001|Period 2|Withdrawal by Subject|0|||
27772633|NCT01641081|80995872|FG002|Period 2|Withdrawal by Subject|0|||
27772634|NCT01641081|80995873|FG003|Period 2|Withdrawal by Subject|1|||
27772635|NCT01641081|80995874|FG004|Period 2|Withdrawal by Subject|0|||
27772636|NCT01641081|80995875|FG005|Period 2|Withdrawal by Subject|0|||
27772637|NCT01641081|80995876|FG006|Period 2|Withdrawal by Subject|2|||
27772638|NCT01641081|80995877|FG007|Period 2|Withdrawal by Subject|0|||
27772639|NCT01641081|80995878|FG008|Period 2|Withdrawal by Subject|0|||
27772640|NCT01641081|80995879|FG009|Period 2|Withdrawal by Subject|0|||
27772641|NCT01641081|80995870|FG000|Period 2|Protocol Violation|1|||
27772642|NCT01641081|80995871|FG001|Period 2|Protocol Violation|0|||
27772643|NCT01641081|80995872|FG002|Period 2|Protocol Violation|0|||
27772644|NCT01641081|80995873|FG003|Period 2|Protocol Violation|0|||
27772645|NCT01641081|80995874|FG004|Period 2|Protocol Violation|0|||
27772646|NCT01641081|80995875|FG005|Period 2|Protocol Violation|0|||
27772647|NCT01641081|80995876|FG006|Period 2|Protocol Violation|0|||
27772648|NCT01641081|80995877|FG007|Period 2|Protocol Violation|0|||
27772649|NCT01641081|80995878|FG008|Period 2|Protocol Violation|0|||
27965366|NCT00617084|81704564|FG000|Overall Study|Withdrawal by Subject|5|||
27965367|NCT00617084|81704565|FG001|Overall Study|Withdrawal by Subject|7|||
27965368|NCT00617084|81704564|FG000|Overall Study|Missed 12 Months visit|16|||
27772650|NCT01641081|80995879|FG009|Period 2|Protocol Violation|0|||
27965369|NCT00617084|81704565|FG001|Overall Study|Missed 12 Months visit|19|||
27772651|NCT01641081|80995870|FG000|Period 3|Adverse Event|0|||
27772652|NCT01641081|80995871|FG001|Period 3|Adverse Event|0|||
27772653|NCT01641081|80995872|FG002|Period 3|Adverse Event|1|||
27772654|NCT01641081|80995873|FG003|Period 3|Adverse Event|0|||
27772655|NCT01641081|80995874|FG004|Period 3|Adverse Event|0|||
27772656|NCT01641081|80995875|FG005|Period 3|Adverse Event|0|||
27772657|NCT01641081|80995876|FG006|Period 3|Adverse Event|0|||
27772658|NCT01641081|80995877|FG007|Period 3|Adverse Event|0|||
27772659|NCT01641081|80995878|FG008|Period 3|Adverse Event|0|||
27772660|NCT01641081|80995879|FG009|Period 3|Adverse Event|0|||
27965370|NCT00967694|81704566|FG000|Overall Study|Withdrawal by Subject|6|||
27965371|NCT01071252|81704567|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
27965372|NCT01071252|81704568|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
27965373|NCT01071252|81704569|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
27965374|NCT01071252|81704570|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
27965375|NCT01071252|81704571|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
27965376|NCT01071252|81704567|FG000|Overall Study|Withdrawal by Subject|8|||
27965377|NCT01071252|81704568|FG001|Overall Study|Withdrawal by Subject|2|||
27965378|NCT01071252|81704569|FG002|Overall Study|Withdrawal by Subject|1|||
27965379|NCT01071252|81704570|FG003|Overall Study|Withdrawal by Subject|2|||
27965380|NCT01071252|81704571|FG004|Overall Study|Withdrawal by Subject|3|||
27965381|NCT01071252|81704567|FG000|Overall Study|administrative problems|1|||
27965382|NCT01071252|81704568|FG001|Overall Study|administrative problems|1|||
27965383|NCT01071252|81704569|FG002|Overall Study|administrative problems|0|||
27965384|NCT01071252|81704570|FG003|Overall Study|administrative problems|2|||
27965385|NCT01071252|81704571|FG004|Overall Study|administrative problems|1|||
27965386|NCT01071252|81704567|FG000|Overall Study|Lost to Follow-up|1|||
27965387|NCT01071252|81704568|FG001|Overall Study|Lost to Follow-up|0|||
27965388|NCT01071252|81704569|FG002|Overall Study|Lost to Follow-up|1|||
27965389|NCT01071252|81704570|FG003|Overall Study|Lost to Follow-up|2|||
27965390|NCT01071252|81704571|FG004|Overall Study|Lost to Follow-up|0|||
27965391|NCT01071252|81704567|FG000|Overall Study|Adverse Event|1|||
27965392|NCT01071252|81704568|FG001|Overall Study|Adverse Event|1|||
27965393|NCT01071252|81704569|FG002|Overall Study|Adverse Event|0|||
27569171|NCT00735371|80271507|FG003|Overall Study|Lost to Follow-up|1|||
27772661|NCT01641081|80995870|FG000|Period 3|Withdrawal by Subject|0|||
27772662|NCT01641081|80995871|FG001|Period 3|Withdrawal by Subject|0|||
27965394|NCT01071252|81704570|FG003|Overall Study|Adverse Event|1|||
27965395|NCT01071252|81704571|FG004|Overall Study|Adverse Event|0|||
27772663|NCT01641081|80995872|FG002|Period 3|Withdrawal by Subject|0|||
27772664|NCT01641081|80995873|FG003|Period 3|Withdrawal by Subject|0|||
27965396|NCT01071252|81704567|FG000|Overall Study|Death|0|||
27772665|NCT01641081|80995874|FG004|Period 3|Withdrawal by Subject|0|||
27772666|NCT01641081|80995875|FG005|Period 3|Withdrawal by Subject|0|||
27772667|NCT01641081|80995876|FG006|Period 3|Withdrawal by Subject|0|||
27772668|NCT01641081|80995877|FG007|Period 3|Withdrawal by Subject|0|||
27772669|NCT01641081|80995878|FG008|Period 3|Withdrawal by Subject|1|||
27772670|NCT01641081|80995879|FG009|Period 3|Withdrawal by Subject|0|||
27772671|NCT01641081|80995870|FG000|Period 4|Adverse Event|0|||
27772672|NCT01641081|80995871|FG001|Period 4|Adverse Event|1|||
27772673|NCT01641081|80995872|FG002|Period 4|Adverse Event|0|||
27772674|NCT01641081|80995873|FG003|Period 4|Adverse Event|1|||
27772675|NCT01641081|80995874|FG004|Period 4|Adverse Event|0|||
27772676|NCT01641081|80995875|FG005|Period 4|Adverse Event|0|||
27772677|NCT01641081|80995876|FG006|Period 4|Adverse Event|0|||
27772678|NCT01641081|80995877|FG007|Period 4|Adverse Event|0|||
27772679|NCT01641081|80995878|FG008|Period 4|Adverse Event|0|||
27772680|NCT01641081|80995879|FG009|Period 4|Adverse Event|0|||
27772681|NCT01641081|80995870|FG000|Period 5|Adverse Event|0|||
27772682|NCT01641081|80995871|FG001|Period 5|Adverse Event|0|||
27772683|NCT01641081|80995872|FG002|Period 5|Adverse Event|2|||
27772684|NCT01641081|80995873|FG003|Period 5|Adverse Event|0|||
27772685|NCT01641081|80995874|FG004|Period 5|Adverse Event|0|||
27772686|NCT01641081|80995875|FG005|Period 5|Adverse Event|0|||
27772687|NCT01641081|80995876|FG006|Period 5|Adverse Event|0|||
27965397|NCT01071252|81704568|FG001|Overall Study|Death|0|||
27965398|NCT01071252|81704569|FG002|Overall Study|Death|0|||
27965399|NCT01071252|81704570|FG003|Overall Study|Death|0|||
27569172|NCT00735371|80271504|FG000|Overall Study|Lack of Efficacy|4|||
27772688|NCT01641081|80995877|FG007|Period 5|Adverse Event|0|||
27772689|NCT01641081|80995878|FG008|Period 5|Adverse Event|0|||
27772690|NCT01641081|80995879|FG009|Period 5|Adverse Event|0|||
27772691|NCT02762708|80995880|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
27772692|NCT02762708|80995881|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
27772693|NCT02762708|80995882|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
27772694|NCT02762708|80995883|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
27965400|NCT01071252|81704571|FG004|Overall Study|Death|1|||
27965401|NCT01555073|81704572|FG000|Overall Study|Lost to Follow-up|1|||
27965402|NCT01555073|81704573|FG001|Overall Study|Lost to Follow-up|2|||
27569173|NCT00735371|80271505|FG001|Overall Study|Lack of Efficacy|2|||
27569174|NCT00735371|80271506|FG002|Overall Study|Lack of Efficacy|0|||
27569175|NCT00735371|80271507|FG003|Overall Study|Lack of Efficacy|4|||
27569176|NCT00735371|80271504|FG000|Overall Study|Sponsor Decision|3|||
27965403|NCT01555073|81704574|FG002|Overall Study|Lost to Follow-up|0|||
27965404|NCT01555073|81704575|FG003|Overall Study|Lost to Follow-up|5|||
27965405|NCT00759876|81704578|FG000|Overall Study|Sponsor terminated study early|36|||
27569177|NCT00735371|80271505|FG001|Overall Study|Sponsor Decision|1|||
27569178|NCT00735371|80271506|FG002|Overall Study|Sponsor Decision|0|||
27569179|NCT00735371|80271507|FG003|Overall Study|Sponsor Decision|1|||
27569180|NCT00735371|80271504|FG000|Overall Study|Protocol Violation|0|||
27569181|NCT00735371|80271505|FG001|Overall Study|Protocol Violation|1|||
27569182|NCT00735371|80271506|FG002|Overall Study|Protocol Violation|2|||
27772695|NCT04973085|80995886|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
27772696|NCT04973085|80995887|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
27965406|NCT01939977|81704579|FG000|Overall Study|Adverse Event|4|||
27965407|NCT01939977|81704580|FG001|Overall Study|Adverse Event|3|||
27569183|NCT00735371|80271507|FG003|Overall Study|Protocol Violation|0|||
27569184|NCT00735371|80271504|FG000|Overall Study|Prior Vyvanse Exposure|1|||
27772697|NCT00839436|80995889|FG000|Overall Study|Developed exclusionary condition|1|||
27772698|NCT00839436|80995890|FG001|Overall Study|Developed exclusionary condition|0|||
27965408|NCT01939977|81704579|FG000|Overall Study|Lack of Efficacy|3|||
27569185|NCT00735371|80271505|FG001|Overall Study|Prior Vyvanse Exposure|1|||
27772699|NCT00839436|80995891|FG002|Overall Study|Developed exclusionary condition|0|||
27569186|NCT00735371|80271506|FG002|Overall Study|Prior Vyvanse Exposure|0|||
27569187|NCT00735371|80271507|FG003|Overall Study|Prior Vyvanse Exposure|0|||
27569188|NCT00735371|80271504|FG000|Overall Study|Exclusion criteria|1|||
27772700|NCT00839436|80995889|FG000|Overall Study|Withdrawal by Subject|0|||
27772701|NCT00839436|80995890|FG001|Overall Study|Withdrawal by Subject|1|||
27772702|NCT00839436|80995891|FG002|Overall Study|Withdrawal by Subject|0|||
27772703|NCT00839436|80995889|FG000|Overall Study|Study drug no longer available|0|||
27772704|NCT00839436|80995890|FG001|Overall Study|Study drug no longer available|0|||
27772705|NCT00839436|80995891|FG002|Overall Study|Study drug no longer available|1|||
27772706|NCT02332798|80995893|FG000|Overall Study|Unwilling to Participate in Study|0|||
27772707|NCT02332798|80995894|FG001|Overall Study|Unwilling to Participate in Study|1|||
27772708|NCT02332798|80995895|FG002|Overall Study|Unwilling to Participate in Study|1|||
27772709|NCT02332798|80995893|FG000|Overall Study|Positive Urine Drug Test|0|||
27772710|NCT02332798|80995894|FG001|Overall Study|Positive Urine Drug Test|1|||
27772711|NCT02332798|80995895|FG002|Overall Study|Positive Urine Drug Test|0|||
27772712|NCT02332798|80995893|FG000|Overall Study|Abnormal Laboratory Findings|1|||
27772713|NCT02332798|80995894|FG001|Overall Study|Abnormal Laboratory Findings|0|||
27772714|NCT02332798|80995895|FG002|Overall Study|Abnormal Laboratory Findings|0|||
27772715|NCT01462045|80995896|FG000|Overall Study|Family matter|0|||
27772716|NCT01462045|80995897|FG001|Overall Study|Family matter|1|||
27772717|NCT01462045|80995898|FG002|Overall Study|Family matter|0|||
27772718|NCT02408484|80995899|FG000|Overall Study|Withdrawal by Subject|3|||
27772719|NCT02408484|80995899|FG000|Overall Study|Not treated during study period|1|||
27772720|NCT02244619|80995900|FG000|Overall Study|Did not receive study intervention|8|||
27772721|NCT02244619|80995901|FG001|Overall Study|Did not receive study intervention|21|||
27772722|NCT02724111|80995903|FG000|Overall Study|Protocol Violation|2|||
27772723|NCT02724111|80995904|FG001|Overall Study|Protocol Violation|5|||
27772724|NCT03074318|80995905|FG000|Overall Study|Adverse Event|0|||
27772725|NCT03074318|80995906|FG001|Overall Study|Adverse Event|1|||
27772726|NCT03074318|80995907|FG002|Overall Study|Adverse Event|1|||
27772727|NCT03074318|80995908|FG003|Overall Study|Adverse Event|1|||
27772728|NCT03074318|80995905|FG000|Overall Study|Death|1|||
27772729|NCT03074318|80995906|FG001|Overall Study|Death|0|||
27772730|NCT03074318|80995907|FG002|Overall Study|Death|0|||
27772731|NCT03074318|80995908|FG003|Overall Study|Death|0|||
27772732|NCT03074318|80995905|FG000|Overall Study|Withdrawal by Subject|1|||
27772733|NCT03074318|80995906|FG001|Overall Study|Withdrawal by Subject|2|||
27772734|NCT03074318|80995907|FG002|Overall Study|Withdrawal by Subject|2|||
27772735|NCT03074318|80995908|FG003|Overall Study|Withdrawal by Subject|4|||
27772736|NCT03074318|80995905|FG000|Overall Study|Trial Closure|2|||
27772737|NCT03074318|80995906|FG001|Overall Study|Trial Closure|2|||
27772738|NCT03074318|80995907|FG002|Overall Study|Trial Closure|3|||
27772739|NCT03074318|80995908|FG003|Overall Study|Trial Closure|11|||
27772740|NCT02224274|80995909|FG000|Overall Study|Death|1|||
27772741|NCT02224274|80995910|FG001|Overall Study|Death|0|||
27772742|NCT03512275|80995911|FG000|Overall Study|Withdrawal by Subject|1|||
27772743|NCT03512275|80995912|FG001|Overall Study|Withdrawal by Subject|3|||
27772744|NCT03512275|80995911|FG000|Overall Study|Physician Decision|0|||
27772745|NCT03512275|80995912|FG001|Overall Study|Physician Decision|1|||
27772746|NCT03512275|80995911|FG000|Overall Study|Lost to Follow-up|0|||
27772747|NCT03512275|80995912|FG001|Overall Study|Lost to Follow-up|3|||
27772748|NCT03512275|80995911|FG000|Overall Study|Other|1|||
27772749|NCT03512275|80995912|FG001|Overall Study|Other|0|||
27772750|NCT03573804|80995913|FG000|Overall Study|claustrophobia or MRI table problems|10|||
27772751|NCT04228445|80995916|FG000|Overall Study|Lost to Follow-up|1|||
27772752|NCT04228445|80995917|FG001|Overall Study|Lost to Follow-up|1|||
27772753|NCT04228445|80995916|FG000|Overall Study|Physician Decision|1|||
27772754|NCT04228445|80995917|FG001|Overall Study|Physician Decision|2|||
27772755|NCT04228445|80995916|FG000|Overall Study|Withdrawal by Subject|0|||
27772756|NCT04228445|80995917|FG001|Overall Study|Withdrawal by Subject|1|||
27772757|NCT04228445|80995916|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
27772758|NCT04228445|80995917|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
27772759|NCT02348840|80995918|FG000|Overall Study|Withdrawal by Subject|2|||
27772760|NCT02348840|80995919|FG001|Overall Study|Withdrawal by Subject|1|||
27965409|NCT01939977|81704580|FG001|Overall Study|Lack of Efficacy|0|||
27965410|NCT01939977|81704579|FG000|Overall Study|Physician Decision|1|||
27965411|NCT01939977|81704580|FG001|Overall Study|Physician Decision|1|||
27965412|NCT01939977|81704579|FG000|Overall Study|Withdrawal by Subject|0|||
27965413|NCT01939977|81704580|FG001|Overall Study|Withdrawal by Subject|2|||
27965414|NCT01939977|81704579|FG000|Overall Study|Did not meet inclusion criteria|1|||
27965415|NCT01939977|81704580|FG001|Overall Study|Did not meet inclusion criteria|0|||
27965416|NCT01939977|81704579|FG000|Overall Study|Did not receive study medication|0|||
27965417|NCT01939977|81704580|FG001|Overall Study|Did not receive study medication|1|||
27965418|NCT00705250|81704581|FG000|Overall Study|Withdrawal by Subject|1|||
27965419|NCT00705250|81704581|FG000|Overall Study|Patient died in car accident|1|||
27965420|NCT03650413|81704582|FG000|Overall Study|Adverse Event|1|||
27965421|NCT03650413|81704582|FG000|Overall Study|Lack of Efficacy|17|||
27965422|NCT03650413|81704582|FG000|Overall Study|Other|9|||
27965423|NCT03650413|81704582|FG000|Overall Study|Physician Decision|2|||
27965424|NCT03650413|81704582|FG000|Overall Study|Study Terminated By Sponsor|16|||
27965425|NCT03650413|81704582|FG000|Overall Study|Withdrawal by Subject|16|||
27965426|NCT01734785|81704587|FG000|Open-Label Period|Adverse Event|0|||
27965427|NCT01734785|81704588|FG001|Open-Label Period|Adverse Event|0|||
27965428|NCT01734785|81704589|FG002|Open-Label Period|Adverse Event|0|||
27965429|NCT01734785|81704590|FG003|Open-Label Period|Adverse Event|9|||
27965430|NCT01734785|81704587|FG000|Open-Label Period|Lack of Efficacy|0|||
27965431|NCT01734785|81704588|FG001|Open-Label Period|Lack of Efficacy|0|||
27965432|NCT01734785|81704589|FG002|Open-Label Period|Lack of Efficacy|0|||
27965433|NCT01734785|81704590|FG003|Open-Label Period|Lack of Efficacy|1|||
27965434|NCT01734785|81704587|FG000|Open-Label Period|Protocol Violation|0|||
27965435|NCT01734785|81704588|FG001|Open-Label Period|Protocol Violation|0|||
27772761|NCT02348840|80995920|FG002|Overall Study|Withdrawal by Subject|0|||
27772762|NCT02348840|80995921|FG003|Overall Study|Withdrawal by Subject|0|||
27965436|NCT01734785|81704589|FG002|Open-Label Period|Protocol Violation|0|||
27965437|NCT01734785|81704590|FG003|Open-Label Period|Protocol Violation|13|||
27664441|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
27664442|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
27664443|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
27664444|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
27772763|NCT01355497|80995923|FG000|Overall Study|Death|19|||
27965438|NCT01734785|81704587|FG000|Open-Label Period|Lost to Follow-up|0|||
27965439|NCT01734785|81704588|FG001|Open-Label Period|Lost to Follow-up|0|||
27965440|NCT01734785|81704589|FG002|Open-Label Period|Lost to Follow-up|0|||
27965441|NCT01734785|81704590|FG003|Open-Label Period|Lost to Follow-up|14|||
27965442|NCT01734785|81704587|FG000|Open-Label Period|Withdrawal by Subject|0|||
27965443|NCT01734785|81704588|FG001|Open-Label Period|Withdrawal by Subject|0|||
27965444|NCT01734785|81704589|FG002|Open-Label Period|Withdrawal by Subject|0|||
27965445|NCT01734785|81704590|FG003|Open-Label Period|Withdrawal by Subject|12|||
27965446|NCT01734785|81704587|FG000|Open-Label Period|Other Reasons|0|||
27965447|NCT01734785|81704588|FG001|Open-Label Period|Other Reasons|0|||
27965448|NCT01734785|81704589|FG002|Open-Label Period|Other Reasons|0|||
27965449|NCT01734785|81704590|FG003|Open-Label Period|Other Reasons|224|||
27965450|NCT01734785|81704587|FG000|Double-Blind Period|Adverse Event|0|||
27965451|NCT01734785|81704588|FG001|Double-Blind Period|Adverse Event|3|||
27965452|NCT01734785|81704589|FG002|Double-Blind Period|Adverse Event|2|||
27569189|NCT00735371|80271505|FG001|Overall Study|Exclusion criteria|0|||
27569190|NCT00735371|80271506|FG002|Overall Study|Exclusion criteria|0|||
27569191|NCT00735371|80271507|FG003|Overall Study|Exclusion criteria|0|||
27965453|NCT01734785|81704590|FG003|Double-Blind Period|Adverse Event|0|||
27965454|NCT01734785|81704587|FG000|Double-Blind Period|Lack of Efficacy|0|||
27965455|NCT01734785|81704588|FG001|Double-Blind Period|Lack of Efficacy|1|||
27965456|NCT01734785|81704589|FG002|Double-Blind Period|Lack of Efficacy|0|||
27965457|NCT01734785|81704590|FG003|Double-Blind Period|Lack of Efficacy|0|||
27965458|NCT01734785|81704587|FG000|Double-Blind Period|Protocol Violation|0|||
27664445|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
27664446|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
27664447|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
27664448|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
27664449|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
27664450|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
27664451|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
27664452|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
27664453|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
27664454|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
27664455|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27664456|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27664457|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27664458|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27772764|NCT01355497|80995924|FG001|Overall Study|Death|18|||
27772765|NCT01355497|80995923|FG000|Overall Study|Lost to Follow-up|3|||
27965459|NCT01734785|81704588|FG001|Double-Blind Period|Protocol Violation|1|||
27965460|NCT01734785|81704589|FG002|Double-Blind Period|Protocol Violation|1|||
27965461|NCT01734785|81704590|FG003|Double-Blind Period|Protocol Violation|0|||
27965462|NCT01734785|81704587|FG000|Double-Blind Period|Lost to Follow-up|2|||
27965463|NCT01734785|81704588|FG001|Double-Blind Period|Lost to Follow-up|4|||
27965464|NCT01734785|81704589|FG002|Double-Blind Period|Lost to Follow-up|2|||
27965465|NCT01734785|81704590|FG003|Double-Blind Period|Lost to Follow-up|0|||
27965466|NCT01734785|81704587|FG000|Double-Blind Period|Withdrawal by Subject|2|||
27772766|NCT01355497|80995924|FG001|Overall Study|Lost to Follow-up|0|||
27772767|NCT01355497|80995923|FG000|Overall Study|Protocol Violation|0|||
27772768|NCT01355497|80995924|FG001|Overall Study|Protocol Violation|1|||
27772769|NCT01355497|80995923|FG000|Overall Study|other-not provided|9|||
27772770|NCT01355497|80995924|FG001|Overall Study|other-not provided|4|||
27772771|NCT01355497|80995923|FG000|Overall Study|Withdrawal by Subject|12|||
27772772|NCT01355497|80995924|FG001|Overall Study|Withdrawal by Subject|20|||
27772773|NCT01355497|80995923|FG000|Overall Study|noncompliance|1|||
27772774|NCT01355497|80995924|FG001|Overall Study|noncompliance|2|||
27772775|NCT01355497|80995923|FG000|Overall Study|progressive disease|11|||
27772776|NCT01355497|80995924|FG001|Overall Study|progressive disease|8|||
27772777|NCT01355497|80995923|FG000|Overall Study|Adverse Event|11|||
27772778|NCT01355497|80995924|FG001|Overall Study|Adverse Event|10|||
27772779|NCT01831804|80995933|FG000|Overall Study|Adverse Event|0|||
27772780|NCT01831804|80995934|FG001|Overall Study|Adverse Event|0|||
27772781|NCT01831804|80995935|FG002|Overall Study|Adverse Event|0|||
27772782|NCT01831804|80995936|FG003|Overall Study|Adverse Event|0|||
27772783|NCT01831804|80995937|FG004|Overall Study|Adverse Event|0|||
27772784|NCT01831804|80995938|FG005|Overall Study|Adverse Event|0|||
27772785|NCT01831804|80995939|FG006|Overall Study|Adverse Event|1|||
27772786|NCT01831804|80995940|FG007|Overall Study|Adverse Event|0|||
27772787|NCT01831804|80995941|FG008|Overall Study|Adverse Event|1|||
27772788|NCT01831804|80995933|FG000|Overall Study|Protocol Violation|0|||
27965467|NCT01734785|81704588|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27772789|NCT01831804|80995934|FG001|Overall Study|Protocol Violation|0|||
27965468|NCT01734785|81704589|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27569192|NCT00500370|80271508|FG000|Overall Study|Adverse Event|9|||
27569193|NCT00500370|80271509|FG001|Overall Study|Adverse Event|3|||
27569194|NCT00500370|80271508|FG000|Overall Study|Lost to Follow-up|10|||
27569195|NCT00500370|80271509|FG001|Overall Study|Lost to Follow-up|10|||
27569196|NCT00500370|80271508|FG000|Overall Study|Protocol Violation|2|||
27569197|NCT00500370|80271509|FG001|Overall Study|Protocol Violation|4|||
27569198|NCT00500370|80271508|FG000|Overall Study|Sponsor Decision|2|||
27772790|NCT01831804|80995935|FG002|Overall Study|Protocol Violation|2|||
27772791|NCT01831804|80995936|FG003|Overall Study|Protocol Violation|0|||
27772792|NCT01831804|80995937|FG004|Overall Study|Protocol Violation|0|||
27772793|NCT01831804|80995938|FG005|Overall Study|Protocol Violation|0|||
27772794|NCT01831804|80995939|FG006|Overall Study|Protocol Violation|0|||
27772795|NCT01831804|80995940|FG007|Overall Study|Protocol Violation|0|||
27772796|NCT01831804|80995941|FG008|Overall Study|Protocol Violation|0|||
27772797|NCT01831804|80995933|FG000|Overall Study|Protocol defined stopping criteria|1|||
27772798|NCT01831804|80995934|FG001|Overall Study|Protocol defined stopping criteria|1|||
27772799|NCT01831804|80995935|FG002|Overall Study|Protocol defined stopping criteria|3|||
27772800|NCT01831804|80995936|FG003|Overall Study|Protocol defined stopping criteria|0|||
27772801|NCT01831804|80995937|FG004|Overall Study|Protocol defined stopping criteria|1|||
27772802|NCT01831804|80995938|FG005|Overall Study|Protocol defined stopping criteria|0|||
27772803|NCT01831804|80995939|FG006|Overall Study|Protocol defined stopping criteria|0|||
27772804|NCT01831804|80995940|FG007|Overall Study|Protocol defined stopping criteria|0|||
27772805|NCT01831804|80995941|FG008|Overall Study|Protocol defined stopping criteria|0|||
27772806|NCT01831804|80995933|FG000|Overall Study|Lost to Follow-up|0|||
27772807|NCT01831804|80995934|FG001|Overall Study|Lost to Follow-up|0|||
27772808|NCT01831804|80995935|FG002|Overall Study|Lost to Follow-up|1|||
27772809|NCT01831804|80995936|FG003|Overall Study|Lost to Follow-up|0|||
27772810|NCT01831804|80995937|FG004|Overall Study|Lost to Follow-up|0|||
27772811|NCT01831804|80995938|FG005|Overall Study|Lost to Follow-up|0|||
27772812|NCT01831804|80995939|FG006|Overall Study|Lost to Follow-up|0|||
27772813|NCT01831804|80995940|FG007|Overall Study|Lost to Follow-up|0|||
27772814|NCT01831804|80995941|FG008|Overall Study|Lost to Follow-up|1|||
27772815|NCT01831804|80995933|FG000|Overall Study|Investigator discretion|0|||
27772816|NCT01831804|80995934|FG001|Overall Study|Investigator discretion|0|||
27772817|NCT01831804|80995935|FG002|Overall Study|Investigator discretion|0|||
27664459|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
27664460|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
27664461|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
27664462|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27664463|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
27664464|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
27664465|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
27664466|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
27664467|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
27664468|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
27664469|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
27664470|NCT01187407|80609425|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27664471|NCT01187407|80609426|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27664472|NCT01187407|80609427|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27664473|NCT01187407|80609428|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
27664474|NCT01187407|80609429|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
27664475|NCT02299427|80609430|FG000|Overall Study|Withdrawal by Subject|1|||
27664476|NCT02299427|80609431|FG001|Overall Study|Withdrawal by Subject|0|||
27664477|NCT02299427|80609430|FG000|Overall Study|Lost to Follow-up|1|||
27664478|NCT02299427|80609431|FG001|Overall Study|Lost to Follow-up|3|||
27664479|NCT02299427|80609430|FG000|Overall Study|not adherent to dog website use|21|||
27664480|NCT02299427|80609431|FG001|Overall Study|not adherent to dog website use|0|||
27664481|NCT00332488|80609432|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
27664482|NCT00332488|80609433|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
27664483|NCT00332488|80609434|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
27664484|NCT00332488|80609432|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
27664485|NCT00332488|80609433|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
27664486|NCT00332488|80609434|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
27664487|NCT00332488|80609432|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
27664488|NCT00332488|80609433|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
27664489|NCT00332488|80609434|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
27664490|NCT00332488|80609432|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
27664491|NCT00332488|80609433|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
27664492|NCT00332488|80609434|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
27772818|NCT01831804|80995936|FG003|Overall Study|Investigator discretion|0|||
27772819|NCT01831804|80995937|FG004|Overall Study|Investigator discretion|1|||
27772820|NCT01831804|80995938|FG005|Overall Study|Investigator discretion|0|||
27772821|NCT01831804|80995939|FG006|Overall Study|Investigator discretion|0|||
27772822|NCT01831804|80995940|FG007|Overall Study|Investigator discretion|1|||
27772823|NCT01831804|80995941|FG008|Overall Study|Investigator discretion|0|||
27772824|NCT01831804|80995933|FG000|Overall Study|Withdrew Consent|0|||
27772825|NCT01831804|80995934|FG001|Overall Study|Withdrew Consent|1|||
27772826|NCT01831804|80995935|FG002|Overall Study|Withdrew Consent|0|||
27772827|NCT01831804|80995936|FG003|Overall Study|Withdrew Consent|0|||
27772828|NCT01831804|80995937|FG004|Overall Study|Withdrew Consent|0|||
27772829|NCT01831804|80995938|FG005|Overall Study|Withdrew Consent|0|||
27772830|NCT01831804|80995939|FG006|Overall Study|Withdrew Consent|0|||
27772831|NCT01831804|80995940|FG007|Overall Study|Withdrew Consent|2|||
27772832|NCT01831804|80995941|FG008|Overall Study|Withdrew Consent|0|||
27772833|NCT00859573|80999233|FG000|Overall Study|Withdrawal by Subject|4|||
27772834|NCT00859573|80999234|FG001|Overall Study|Withdrawal by Subject|1|||
27772835|NCT00859573|80999233|FG000|Overall Study|Physician Decision|1|||
27772836|NCT00859573|80999234|FG001|Overall Study|Physician Decision|1|||
27772837|NCT01899768|80999235|FG000|Part A|Adverse Event|2|||
27772838|NCT01899768|80999235|FG000|Part A|Withdrawal by Subject|1|||
27772839|NCT01899768|80999235|FG000|Part B|Adverse Event|1|||
27772840|NCT01899768|80999235|FG000|Part B|Withdrawal by Subject|1|||
27772841|NCT01431521|80999240|FG000|Overall Study|Withdrawal by Subject|0|||
27772842|NCT01431521|80999241|FG001|Overall Study|Withdrawal by Subject|0|||
27772843|NCT01431521|80999242|FG002|Overall Study|Withdrawal by Subject|1|||
27772844|NCT01431521|80999243|FG003|Overall Study|Withdrawal by Subject|0|||
27772845|NCT01192100|80999248|FG000|Overall Study|Withdrawal by Subject|0|||
27772846|NCT01192100|80999249|FG001|Overall Study|Withdrawal by Subject|0|||
27772847|NCT01192100|80999250|FG002|Overall Study|Withdrawal by Subject|0|||
27772848|NCT01192100|80999251|FG003|Overall Study|Withdrawal by Subject|0|||
27772849|NCT01192100|80999252|FG004|Overall Study|Withdrawal by Subject|1|||
27772850|NCT01192100|80999253|FG005|Overall Study|Withdrawal by Subject|0|||
27772851|NCT01192100|80999248|FG000|Overall Study|Protocol Violation|0|||
27772852|NCT01192100|80999249|FG001|Overall Study|Protocol Violation|0|||
27772853|NCT01192100|80999250|FG002|Overall Study|Protocol Violation|0|||
27772854|NCT01192100|80999251|FG003|Overall Study|Protocol Violation|1|||
27772855|NCT01192100|80999252|FG004|Overall Study|Protocol Violation|0|||
27772856|NCT01192100|80999253|FG005|Overall Study|Protocol Violation|0|||
27772857|NCT00654368|80999255|FG000|Overall Study|Ineligibility determined|6|||
27772858|NCT00654368|80999256|FG001|Overall Study|Ineligibility determined|0|||
27772859|NCT00654368|80999257|FG002|Overall Study|Ineligibility determined|0|||
27772860|NCT00654368|80999255|FG000|Overall Study|Protocol deviation|3|||
27772861|NCT00654368|80999256|FG001|Overall Study|Protocol deviation|2|||
27772862|NCT00654368|80999257|FG002|Overall Study|Protocol deviation|1|||
27772863|NCT00654368|80999255|FG000|Overall Study|Non-compliance|2|||
27772864|NCT00654368|80999256|FG001|Overall Study|Non-compliance|1|||
27772865|NCT00654368|80999257|FG002|Overall Study|Non-compliance|2|||
27772866|NCT00654368|80999255|FG000|Overall Study|Withdrawal by Subject|5|||
27772867|NCT00654368|80999256|FG001|Overall Study|Withdrawal by Subject|2|||
27772868|NCT00654368|80999257|FG002|Overall Study|Withdrawal by Subject|2|||
27772869|NCT00654368|80999255|FG000|Overall Study|Disease progression|21|||
27772870|NCT00654368|80999256|FG001|Overall Study|Disease progression|31|||
27772871|NCT00654368|80999257|FG002|Overall Study|Disease progression|13|||
27772872|NCT00654368|80999255|FG000|Overall Study|Requirement for alternative therapy|1|||
27772873|NCT00654368|80999256|FG001|Overall Study|Requirement for alternative therapy|1|||
27772874|NCT00654368|80999257|FG002|Overall Study|Requirement for alternative therapy|1|||
27772875|NCT00654368|80999255|FG000|Overall Study|Physician Decision|0|||
27664493|NCT00332488|80609432|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
27664494|NCT00332488|80609433|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
27664495|NCT00332488|80609434|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
27664496|NCT00332488|80609432|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
27664497|NCT00332488|80609433|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
27664498|NCT00332488|80609434|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
27664499|NCT00332488|80609432|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
27664500|NCT00332488|80609433|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
27664501|NCT00332488|80609434|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
27664502|NCT00332488|80609432|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
27664503|NCT00332488|80609433|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
27772876|NCT00654368|80999256|FG001|Overall Study|Physician Decision|0|||
27772877|NCT00654368|80999257|FG002|Overall Study|Physician Decision|2|||
27772878|NCT00654368|80999255|FG000|Overall Study|Death|1|||
27772879|NCT00654368|80999256|FG001|Overall Study|Death|0|||
27664504|NCT00332488|80609434|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
27664505|NCT00332488|80609432|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
27664506|NCT00332488|80609433|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
27772880|NCT00654368|80999257|FG002|Overall Study|Death|0|||
27772881|NCT00654368|80999255|FG000|Overall Study|Pregnancy|0|||
27772882|NCT00654368|80999256|FG001|Overall Study|Pregnancy|0|||
27772883|NCT00654368|80999257|FG002|Overall Study|Pregnancy|2|||
27772884|NCT00654368|80999255|FG000|Overall Study|Other|0|||
27772885|NCT00654368|80999256|FG001|Overall Study|Other|2|||
27772886|NCT00654368|80999257|FG002|Overall Study|Other|3|||
27772887|NCT00654368|80999255|FG000|Overall Study|Adverse Event|14|||
27772888|NCT00654368|80999256|FG001|Overall Study|Adverse Event|9|||
27772889|NCT00654368|80999257|FG002|Overall Study|Adverse Event|6|||
27772890|NCT00430027|80999260|FG000|Overall Study|Study terminated|8|||
27772891|NCT01678560|80999261|FG000|Overall Study|Physician Decision|4|||
27772892|NCT01678560|80999262|FG001|Overall Study|Physician Decision|4|||
27772893|NCT01678560|80999261|FG000|Overall Study|Death|0|||
27772894|NCT01678560|80999262|FG001|Overall Study|Death|1|||
27772895|NCT01678560|80999261|FG000|Overall Study|Withdrawal by Subject|0|||
27772896|NCT01678560|80999262|FG001|Overall Study|Withdrawal by Subject|1|||
27772897|NCT01117181|80999266|FG000|Overall Study|Lost to Follow-up|1|||
27772898|NCT01117181|80999267|FG001|Overall Study|Lost to Follow-up|0|||
27772899|NCT01117181|80999266|FG000|Overall Study|Withdrawal by Subject|0|||
27772900|NCT01117181|80999267|FG001|Overall Study|Withdrawal by Subject|2|||
27772901|NCT02940860|80999269|FG000|Overall Study|Non-serious AE|1|||
27772902|NCT02940860|80999270|FG001|Overall Study|Non-serious AE|2|||
27772903|NCT02940860|80999269|FG000|Overall Study|Serious AE|7|||
27772904|NCT02940860|80999270|FG001|Overall Study|Serious AE|3|||
27772905|NCT02940860|80999269|FG000|Overall Study|Withdrawal by Subject|19|||
27772906|NCT02940860|80999270|FG001|Overall Study|Withdrawal by Subject|9|||
27772907|NCT02940860|80999269|FG000|Overall Study|Lost to Follow-up|13|||
27772908|NCT02940860|80999270|FG001|Overall Study|Lost to Follow-up|7|||
27772909|NCT02940860|80999269|FG000|Overall Study|Physician Decision|5|||
27772910|NCT02940860|80999270|FG001|Overall Study|Physician Decision|3|||
27772911|NCT02940860|80999269|FG000|Overall Study|Sponsor Decision|0|||
27965469|NCT01734785|81704590|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27965470|NCT01734785|81704587|FG000|Double-Blind Period|Not treated|1|||
27965471|NCT01734785|81704588|FG001|Double-Blind Period|Not treated|0|||
27965472|NCT01734785|81704589|FG002|Double-Blind Period|Not treated|0|||
27965473|NCT01734785|81704590|FG003|Double-Blind Period|Not treated|0|||
27965474|NCT02516982|81704591|FG000|Overall Study|Called in to antenatal appointment|32|||
27965475|NCT02516982|81704592|FG001|Overall Study|Called in to antenatal appointment|35|||
27965476|NCT02516982|81704593|FG002|Overall Study|Called in to antenatal appointment|0|||
27965477|NCT02516982|81704594|FG003|Overall Study|Called in to antenatal appointment|0|||
27965478|NCT02516982|81704591|FG000|Overall Study|Withdrawal by Subject|0|||
27965479|NCT02516982|81704592|FG001|Overall Study|Withdrawal by Subject|0|||
27965480|NCT02516982|81704593|FG002|Overall Study|Withdrawal by Subject|1|||
27965481|NCT02516982|81704594|FG003|Overall Study|Withdrawal by Subject|2|||
27965482|NCT02516982|81704591|FG000|Overall Study|Protocol Violation|0|||
27965483|NCT02516982|81704592|FG001|Overall Study|Protocol Violation|0|||
27772912|NCT02940860|80999270|FG001|Overall Study|Sponsor Decision|1|||
27772913|NCT02940860|80999269|FG000|Overall Study|Protocol Violation|0|||
27772914|NCT02940860|80999270|FG001|Overall Study|Protocol Violation|2|||
27772915|NCT02940860|80999269|FG000|Overall Study|Death|3|||
27772916|NCT02940860|80999270|FG001|Overall Study|Death|2|||
27772917|NCT02940860|80999269|FG000|Overall Study|Moved, poor venous access, transport|6|||
27772918|NCT02940860|80999270|FG001|Overall Study|Moved, poor venous access, transport|4|||
27772919|NCT02940860|80999269|FG000|Overall Study|Not treated|2|||
27772920|NCT02940860|80999270|FG001|Overall Study|Not treated|2|||
27965484|NCT02516982|81704593|FG002|Overall Study|Protocol Violation|1|||
27965485|NCT02516982|81704594|FG003|Overall Study|Protocol Violation|1|||
27965486|NCT02516982|81704591|FG000|Overall Study|Did not install the app|0|||
27965487|NCT02516982|81704592|FG001|Overall Study|Did not install the app|0|||
27965488|NCT02516982|81704593|FG002|Overall Study|Did not install the app|46|||
27965489|NCT02516982|81704594|FG003|Overall Study|Did not install the app|47|||
27965490|NCT03520920|81704596|FG000|Overall Study|Death|13|||
27965491|NCT03520920|81704597|FG001|Overall Study|Death|1|||
27772921|NCT02723019|80999271|FG000|Overall Study|Death|17|||
27772922|NCT02723019|80999272|FG001|Overall Study|Death|13|||
27772923|NCT02723019|80999271|FG000|Overall Study|Withdrawal by Subject|11|||
27772924|NCT02723019|80999272|FG001|Overall Study|Withdrawal by Subject|7|||
27772925|NCT02723019|80999271|FG000|Overall Study|Lost to Follow-up|57|||
27772926|NCT02723019|80999272|FG001|Overall Study|Lost to Follow-up|70|||
27772927|NCT01833806|80999273|FG000|Overall Study|Alternative treatment|2|||
27772928|NCT01833806|80999273|FG000|Overall Study|Death|5|||
27772929|NCT01833806|80999273|FG000|Overall Study|Physician Decision|1|||
27772930|NCT01833806|80999273|FG000|Overall Study|Lost to Follow-up|1|||
27772931|NCT04897594|80999274|FG000|Overall Study|Lost to Follow-up|0|||
27772932|NCT04897594|80999275|FG001|Overall Study|Lost to Follow-up|1|||
27772933|NCT04897594|80999276|FG002|Overall Study|Lost to Follow-up|1|||
27772934|NCT04897594|80999274|FG000|Overall Study|Sponsor Decision|0|||
27772935|NCT04897594|80999275|FG001|Overall Study|Sponsor Decision|0|||
27772936|NCT04897594|80999276|FG002|Overall Study|Sponsor Decision|1|||
27772937|NCT04897594|80999274|FG000|Overall Study|Withdrawal by Subject|1|||
27772938|NCT04897594|80999275|FG001|Overall Study|Withdrawal by Subject|0|||
27772939|NCT04897594|80999276|FG002|Overall Study|Withdrawal by Subject|1|||
27772940|NCT01828567|80999277|FG000|Overall Study|Lost to Follow-up|27|||
27772941|NCT01828567|80999278|FG001|Overall Study|Lost to Follow-up|9|||
27772942|NCT01828567|80999277|FG000|Overall Study|Excluded - did not meet criteria|4|||
27772943|NCT01828567|80999278|FG001|Overall Study|Excluded - did not meet criteria|1|||
27772944|NCT02736929|80999279|FG000|Main Study|Lost to Follow-up|7|||
27772945|NCT02736929|80999280|FG001|Main Study|Lost to Follow-up|1|||
27772946|NCT02736929|80999281|FG002|Main Study|Lost to Follow-up|0|||
27772947|NCT02736929|80999279|FG000|Main Study|Withdrawal by Subject|1|||
27772948|NCT02736929|80999280|FG001|Main Study|Withdrawal by Subject|1|||
27772949|NCT02736929|80999281|FG002|Main Study|Withdrawal by Subject|0|||
27772950|NCT02736929|80999279|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
27772951|NCT02736929|80999280|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
27772952|NCT02736929|80999281|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
27772953|NCT02280096|80999284|FG000|Overall Study|Pregnancy|1|||
27772954|NCT02280096|80999285|FG001|Overall Study|Pregnancy|0|||
27772955|NCT02280096|80999284|FG000|Overall Study|Functional neurological disorder|1|||
27772956|NCT02280096|80999285|FG001|Overall Study|Functional neurological disorder|0|||
27772957|NCT02280096|80999284|FG000|Overall Study|Lack of attachment|0|||
27772958|NCT02280096|80999285|FG001|Overall Study|Lack of attachment|1|||
27772959|NCT00729560|80999288|FG000|Overall Study|Withdrawal by Subject|3|||
27772960|NCT02705755|80999289|FG000|Part A (6 Days)|Adverse Event|1|||
27772961|NCT02705755|80999290|FG001|Part A (6 Days)|Adverse Event|0|||
27772962|NCT02705755|80999291|FG002|Part A (6 Days)|Adverse Event|0|||
27772963|NCT02705755|80999292|FG003|Part A (6 Days)|Adverse Event|0|||
27772964|NCT02705755|80999289|FG000|Part A (6 Days)|Physician Decision|3|||
27772965|NCT02705755|80999290|FG001|Part A (6 Days)|Physician Decision|0|||
27772966|NCT02705755|80999291|FG002|Part A (6 Days)|Physician Decision|0|||
27772967|NCT02705755|80999292|FG003|Part A (6 Days)|Physician Decision|0|||
27772968|NCT02705755|80999289|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
27772969|NCT02705755|80999290|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
27772970|NCT02705755|80999291|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
27772971|NCT02705755|80999292|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
27772972|NCT02705755|80999289|FG000|Part C (20 Weeks)|Physician Decision|0|||
27772973|NCT02705755|80999290|FG001|Part C (20 Weeks)|Physician Decision|0|||
27772974|NCT02705755|80999291|FG002|Part C (20 Weeks)|Physician Decision|0|||
27772975|NCT02705755|80999292|FG003|Part C (20 Weeks)|Physician Decision|2|||
27772976|NCT02705755|80999289|FG000|Part C (20 Weeks)|Adverse Event|0|||
27772977|NCT02705755|80999290|FG001|Part C (20 Weeks)|Adverse Event|0|||
27965492|NCT03520920|81704598|FG002|Overall Study|Death|0|||
27965493|NCT03520920|81704596|FG000|Overall Study|Withdrawal by Subject|2|||
27772978|NCT02705755|80999291|FG002|Part C (20 Weeks)|Adverse Event|0|||
27772979|NCT02705755|80999292|FG003|Part C (20 Weeks)|Adverse Event|6|||
27772980|NCT02705755|80999289|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
27772981|NCT02705755|80999290|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
27772982|NCT02705755|80999291|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
27772983|NCT02705755|80999292|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
27772984|NCT00863317|80999296|FG000|Overall Study|Lost to Follow-up|8|||
27772985|NCT00863317|80999297|FG001|Overall Study|Lost to Follow-up|9|||
27772986|NCT00592072|80999299|FG000|Wash Out Period|Lost to Follow-up|1|||
27965494|NCT03520920|81704597|FG001|Overall Study|Withdrawal by Subject|1|||
27965495|NCT03520920|81704598|FG002|Overall Study|Withdrawal by Subject|0|||
27772987|NCT00592072|80999300|FG001|Wash Out Period|Lost to Follow-up|1|||
27772988|NCT01819194|80999301|FG000|Overall Study|Loss of study articles|2|||
27772989|NCT02635867|80999304|FG000|Overall Study|Lost to Follow-up|4|||
27772990|NCT02635867|80999305|FG001|Overall Study|Lost to Follow-up|3|||
27772991|NCT02635867|80999306|FG002|Overall Study|Lost to Follow-up|3|||
27772992|NCT02635867|80999307|FG003|Overall Study|Lost to Follow-up|4|||
27772993|NCT02635867|80999308|FG004|Overall Study|Lost to Follow-up|1|||
27772994|NCT00102804|80999313|FG000|Overall Study|Progressive Disease (PD)|307|||
27772995|NCT00102804|80999314|FG001|Overall Study|Progressive Disease (PD)|196|||
27772996|NCT00102804|80999313|FG000|Overall Study|Withdrawal by Subject|46|||
27772997|NCT00102804|80999314|FG001|Overall Study|Withdrawal by Subject|7|||
27772998|NCT00102804|80999313|FG000|Overall Study|Adverse Event|37|||
27772999|NCT00102804|80999314|FG001|Overall Study|Adverse Event|3|||
27773000|NCT00102804|80999313|FG000|Overall Study|Physician Decision|24|||
27773001|NCT00102804|80999314|FG001|Overall Study|Physician Decision|6|||
27773002|NCT00102804|80999313|FG000|Overall Study|Death|5|||
27773003|NCT00102804|80999314|FG001|Overall Study|Death|6|||
27773004|NCT00102804|80999313|FG000|Overall Study|Enrollment Criteria Not Met|6|||
27773005|NCT00102804|80999314|FG001|Overall Study|Enrollment Criteria Not Met|0|||
27773006|NCT00102804|80999313|FG000|Overall Study|Lost to Follow-up|4|||
27965496|NCT03520920|81704596|FG000|Overall Study|Study Terminated by the Sponsor|5|||
27965497|NCT03520920|81704597|FG001|Overall Study|Study Terminated by the Sponsor|14|||
27965498|NCT03520920|81704598|FG002|Overall Study|Study Terminated by the Sponsor|5|||
27965499|NCT01932372|81704602|FG000|Overall Study|Not meeting eligibility criteria|33|||
27965500|NCT01932372|81704603|FG001|Overall Study|Not meeting eligibility criteria|179|||
27773007|NCT00102804|80999314|FG001|Overall Study|Lost to Follow-up|1|||
27773008|NCT00102804|80999313|FG000|Overall Study|Protocol Violation|2|||
27773009|NCT00102804|80999314|FG001|Overall Study|Protocol Violation|1|||
27773010|NCT00102804|80999313|FG000|Overall Study|Satisfactory Response|2|||
27773011|NCT00102804|80999314|FG001|Overall Study|Satisfactory Response|0|||
27773012|NCT00102804|80999313|FG000|Overall Study|Sponsor Decision|1|||
27773013|NCT00102804|80999314|FG001|Overall Study|Sponsor Decision|0|||
27773014|NCT00102804|80999313|FG000|Overall Study|Alive, Receiving Treatment|7|||
27773015|NCT00102804|80999314|FG001|Overall Study|Alive, Receiving Treatment|2|||
27773016|NCT01868594|80999315|FG000|Overall Study|Do not meet inclusion criteria|4|||
27773017|NCT01868594|80999316|FG001|Overall Study|Do not meet inclusion criteria|3|||
27773018|NCT00741260|80999319|FG000|Overall Study|Disease Progression|3|||
27773019|NCT00741260|80999320|FG001|Overall Study|Disease Progression|5|||
27773020|NCT00741260|80999321|FG002|Overall Study|Disease Progression|3|||
27773021|NCT00741260|80999322|FG003|Overall Study|Disease Progression|3|||
27773022|NCT00741260|80999323|FG004|Overall Study|Disease Progression|5|||
27773023|NCT00741260|80999324|FG005|Overall Study|Disease Progression|37|||
27773024|NCT00741260|80999325|FG006|Overall Study|Disease Progression|4|||
27773025|NCT00741260|80999319|FG000|Overall Study|Death|0|||
27965501|NCT01013649|81704605|FG000|First Step|Withdrawal by Subject|36|||
27965502|NCT01013649|81704606|FG001|First Step|Withdrawal by Subject|19|||
27965503|NCT01013649|81704607|FG002|First Step|Withdrawal by Subject|0|||
27965504|NCT01013649|81704608|FG003|First Step|Withdrawal by Subject|0|||
27965505|NCT01013649|81704605|FG000|First Step|Progression|58|||
27965506|NCT01013649|81704606|FG001|First Step|Progression|23|||
27965507|NCT01013649|81704607|FG002|First Step|Progression|0|||
27965508|NCT01013649|81704608|FG003|First Step|Progression|0|||
27965509|NCT01013649|81704605|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
27965510|NCT01013649|81704606|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
27773026|NCT00741260|80999320|FG001|Overall Study|Death|1|||
27773027|NCT00741260|80999321|FG002|Overall Study|Death|0|||
27773028|NCT00741260|80999322|FG003|Overall Study|Death|1|||
27773029|NCT00741260|80999323|FG004|Overall Study|Death|2|||
27773030|NCT00741260|80999324|FG005|Overall Study|Death|2|||
27773031|NCT00741260|80999325|FG006|Overall Study|Death|1|||
27773032|NCT00741260|80999319|FG000|Overall Study|Withdrawal by Subject|0|||
27965511|NCT01013649|81704607|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
27965512|NCT01013649|81704608|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
27965513|NCT01013649|81704605|FG000|First Step|Death|3|||
27965514|NCT01013649|81704606|FG001|First Step|Death|4|||
27773033|NCT00741260|80999320|FG001|Overall Study|Withdrawal by Subject|0|||
27773034|NCT00741260|80999321|FG002|Overall Study|Withdrawal by Subject|0|||
27773035|NCT00741260|80999322|FG003|Overall Study|Withdrawal by Subject|0|||
27773036|NCT00741260|80999323|FG004|Overall Study|Withdrawal by Subject|1|||
27773037|NCT00741260|80999324|FG005|Overall Study|Withdrawal by Subject|3|||
27773038|NCT00741260|80999325|FG006|Overall Study|Withdrawal by Subject|1|||
27773039|NCT00741260|80999319|FG000|Overall Study|Physician Decision|1|||
27965515|NCT01013649|81704607|FG002|First Step|Death|0|||
27773040|NCT00741260|80999320|FG001|Overall Study|Physician Decision|1|||
27773041|NCT00741260|80999321|FG002|Overall Study|Physician Decision|0|||
27773042|NCT00741260|80999322|FG003|Overall Study|Physician Decision|0|||
27773043|NCT00741260|80999323|FG004|Overall Study|Physician Decision|0|||
27773044|NCT00741260|80999324|FG005|Overall Study|Physician Decision|0|||
27773045|NCT00741260|80999325|FG006|Overall Study|Physician Decision|0|||
27773046|NCT00741260|80999319|FG000|Overall Study|Other|2|||
27773047|NCT00741260|80999320|FG001|Overall Study|Other|1|||
27773048|NCT00741260|80999321|FG002|Overall Study|Other|1|||
27773049|NCT00741260|80999322|FG003|Overall Study|Other|2|||
27773050|NCT00741260|80999323|FG004|Overall Study|Other|1|||
27773051|NCT00741260|80999324|FG005|Overall Study|Other|3|||
27773052|NCT00741260|80999325|FG006|Overall Study|Other|1|||
27773053|NCT04847141|80999331|FG000|Overall Study|Adverse Event|1|||
27773054|NCT04847141|80999332|FG001|Overall Study|Adverse Event|0|||
27773055|NCT04847141|80999333|FG002|Overall Study|Adverse Event|1|||
27773056|NCT04847141|80999331|FG000|Overall Study|Withdrawal by Subject|2|||
27773057|NCT04847141|80999332|FG001|Overall Study|Withdrawal by Subject|4|||
27773058|NCT04847141|80999333|FG002|Overall Study|Withdrawal by Subject|3|||
27773059|NCT04847141|80999331|FG000|Overall Study|Lost to Follow-up|7|||
27773060|NCT04847141|80999332|FG001|Overall Study|Lost to Follow-up|5|||
27773061|NCT04847141|80999333|FG002|Overall Study|Lost to Follow-up|7|||
27773062|NCT04847141|80999331|FG000|Overall Study|Reason not Specified|0|||
27773063|NCT04847141|80999332|FG001|Overall Study|Reason not Specified|1|||
27773064|NCT04847141|80999333|FG002|Overall Study|Reason not Specified|0|||
27773065|NCT01510028|80999334|FG000|Overall Study|Lack of Efficacy|1|||
27773066|NCT01510028|80999335|FG001|Overall Study|Lack of Efficacy|0|||
27773067|NCT01510028|80999336|FG002|Overall Study|Lack of Efficacy|0|||
27773068|NCT01510028|80999337|FG003|Overall Study|Lack of Efficacy|0|||
27773069|NCT04055844|80999338|FG000|Overall Study|Adverse Event|12|||
27773070|NCT04055844|80999338|FG000|Overall Study|Poor Performance|1|||
27773071|NCT04055844|80999338|FG000|Overall Study|Death|1|||
27773072|NCT02774291|80999339|FG000|Overall Study|Lost to Follow-up|1|||
27773073|NCT00486889|80999340|FG000|Overall Study|Death|3|||
27773074|NCT00486889|80999340|FG000|Overall Study|Non-compliant|2|||
27773075|NCT00486889|80999340|FG000|Overall Study|Withdrawal by Subject|6|||
27773076|NCT00636155|80999344|FG000|Overall Study|Adverse Event|8|||
27773077|NCT00636155|80999344|FG000|Overall Study|Lack of Efficacy|1|||
27773078|NCT00636155|80999344|FG000|Overall Study|Withdrawal by Subject|3|||
27773079|NCT00636155|80999344|FG000|Overall Study|Stem cell transplant|1|||
27773080|NCT00636155|80999344|FG000|Overall Study|Physician Decision|5|||
27773081|NCT01436357|80999345|FG000|Overall Study|Death|5|||
27773082|NCT01436357|80999346|FG001|Overall Study|Death|1|||
27773083|NCT01436357|80999345|FG000|Overall Study|Enrolled but not vaccinated|1|||
27773084|NCT01436357|80999346|FG001|Overall Study|Enrolled but not vaccinated|1|||
27773085|NCT01436357|80999345|FG000|Overall Study|Incarceration|18|||
27773086|NCT01436357|80999346|FG001|Overall Study|Incarceration|20|||
27773087|NCT01436357|80999345|FG000|Overall Study|Lost to Follow-up|67|||
27773088|NCT01436357|80999346|FG001|Overall Study|Lost to Follow-up|61|||
27773089|NCT01436357|80999345|FG000|Overall Study|Protocol Violation|1|||
27773090|NCT01436357|80999346|FG001|Overall Study|Protocol Violation|0|||
27773091|NCT01436357|80999345|FG000|Overall Study|Withdrawal by Subject|26|||
27773092|NCT01436357|80999346|FG001|Overall Study|Withdrawal by Subject|38|||
27965516|NCT01013649|81704608|FG003|First Step|Death|0|||
27965517|NCT01013649|81704605|FG000|First Step|Adverse Event|9|||
27965518|NCT01013649|81704606|FG001|First Step|Adverse Event|5|||
27965519|NCT01013649|81704607|FG002|First Step|Adverse Event|0|||
27965520|NCT01013649|81704608|FG003|First Step|Adverse Event|0|||
27965521|NCT01013649|81704605|FG000|First Step|Other|4|||
27965522|NCT01013649|81704606|FG001|First Step|Other|6|||
27965523|NCT01013649|81704607|FG002|First Step|Other|0|||
27965524|NCT01013649|81704608|FG003|First Step|Other|0|||
27773093|NCT01436357|80999345|FG000|Overall Study|Physician Decision|3|||
27773094|NCT01436357|80999346|FG001|Overall Study|Physician Decision|4|||
27773095|NCT01436357|80999345|FG000|Overall Study|Moved out of area|1|||
27773096|NCT01436357|80999346|FG001|Overall Study|Moved out of area|2|||
27773097|NCT01436357|80999345|FG000|Overall Study|Subject in rehab|0|||
27773098|NCT01436357|80999346|FG001|Overall Study|Subject in rehab|1|||
27773099|NCT02465489|80999347|FG000|Overall Study|Adverse Event|5|||
27773100|NCT00948428|80999355|FG000|Overall Study|Withdrawal by Subject|6|||
27773101|NCT00948428|80999356|FG001|Overall Study|Withdrawal by Subject|12|||
27773102|NCT00948428|80999357|FG002|Overall Study|Withdrawal by Subject|7|||
27773103|NCT00948428|80999355|FG000|Overall Study|Adverse Event|6|||
27773104|NCT00948428|80999356|FG001|Overall Study|Adverse Event|3|||
27773105|NCT00948428|80999357|FG002|Overall Study|Adverse Event|0|||
27773106|NCT00948428|80999355|FG000|Overall Study|Lost to Follow-up|2|||
27773107|NCT00948428|80999356|FG001|Overall Study|Lost to Follow-up|1|||
27773108|NCT00948428|80999357|FG002|Overall Study|Lost to Follow-up|1|||
27773109|NCT00948428|80999355|FG000|Overall Study|Death|2|||
27773110|NCT00948428|80999356|FG001|Overall Study|Death|0|||
27773111|NCT00948428|80999357|FG002|Overall Study|Death|0|||
27773112|NCT00948428|80999355|FG000|Overall Study|Intercurrent Illness|1|||
27773113|NCT00948428|80999356|FG001|Overall Study|Intercurrent Illness|0|||
27965525|NCT04222699|81704609|FG000|Overall Study|Lost to Follow-up|2|||
27773114|NCT00948428|80999357|FG002|Overall Study|Intercurrent Illness|0|||
27773115|NCT00948428|80999355|FG000|Overall Study|Non-compliance|1|||
27773116|NCT00948428|80999356|FG001|Overall Study|Non-compliance|2|||
27773117|NCT00948428|80999357|FG002|Overall Study|Non-compliance|0|||
27773118|NCT03860844|80999366|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
27773119|NCT03860844|80999367|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
27773120|NCT03860844|80999368|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
27773121|NCT03860844|80999366|FG000|Overall Study|Progressive disease|5|||
27773122|NCT03860844|80999367|FG001|Overall Study|Progressive disease|3|||
27773123|NCT03860844|80999368|FG002|Overall Study|Progressive disease|4|||
27773124|NCT03860844|80999366|FG000|Overall Study|Other, Not related to COVID-19|0|||
27773125|NCT03860844|80999367|FG001|Overall Study|Other, Not related to COVID-19|1|||
27773126|NCT03860844|80999368|FG002|Overall Study|Other, Not related to COVID-19|0|||
27773127|NCT03748420|80999369|FG000|Overall Study|No 12 month medication adherence data available|0|||
27773128|NCT03748420|80999370|FG001|Overall Study|No 12 month medication adherence data available|1|||
27773129|NCT03748420|80999369|FG000|Overall Study|Death|24|||
27773130|NCT03748420|80999370|FG001|Overall Study|Death|28|||
27773131|NCT03748420|80999369|FG000|Overall Study|Lost to Follow-up|231|||
27773132|NCT03748420|80999370|FG001|Overall Study|Lost to Follow-up|230|||
27773133|NCT00712270|80999371|FG000|Overall Study|Withdrawal by Subject|11|||
27773134|NCT00712270|80999371|FG000|Overall Study|Screen Failure|3|||
27773135|NCT00518336|80999372|FG000|Year 7|Lost to Follow-up|2|||
27773136|NCT00518336|80999373|FG001|Year 7|Lost to Follow-up|0|||
27773137|NCT00518336|80999372|FG000|Year 7|Could not attend in time|0|||
27773138|NCT00518336|80999373|FG001|Year 7|Could not attend in time|3|||
27773139|NCT00518336|80999372|FG000|Year 8|Lost to Follow-up|1|||
27773140|NCT00518336|80999373|FG001|Year 8|Lost to Follow-up|1|||
27773141|NCT00518336|80999372|FG000|Year 8|Could not attend in time|0|||
27773142|NCT00518336|80999373|FG001|Year 8|Could not attend in time|1|||
27773143|NCT00518336|80999372|FG000|Year 9|Migrated/moved from study area|1|||
27773144|NCT00518336|80999373|FG001|Year 9|Migrated/moved from study area|1|||
27773145|NCT00518336|80999372|FG000|Year 9|Lost to Follow-up|3|||
27773146|NCT00518336|80999373|FG001|Year 9|Lost to Follow-up|0|||
27773147|NCT00518336|80999372|FG000|Year 9|Personal reasons|1|||
27773148|NCT00518336|80999373|FG001|Year 9|Personal reasons|0|||
27773149|NCT01237223|80999379|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
27773150|NCT01237223|80999380|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27773151|NCT01237223|80999381|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27773152|NCT01237223|80999382|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27773153|NCT01237223|80999383|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27773154|NCT01237223|80999384|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
27773155|NCT01237223|80999379|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
27773156|NCT01237223|80999380|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27773157|NCT01237223|80999381|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27773158|NCT01237223|80999382|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27773159|NCT01237223|80999383|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27773160|NCT01237223|80999384|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
27773161|NCT01237223|80999379|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
27773162|NCT01237223|80999380|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27773163|NCT01237223|80999381|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27773164|NCT01237223|80999382|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27773165|NCT01237223|80999383|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27773166|NCT01237223|80999384|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
27773167|NCT01237223|80999379|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
27773168|NCT01237223|80999380|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27773169|NCT01237223|80999381|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27773170|NCT01237223|80999382|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27773171|NCT01237223|80999383|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27773172|NCT01237223|80999384|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
27773173|NCT01237223|80999379|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
27773174|NCT01237223|80999380|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27773175|NCT01237223|80999381|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27773176|NCT01237223|80999382|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27773177|NCT01237223|80999383|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27773178|NCT01237223|80999384|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
27773179|NCT01237223|80999379|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
27773180|NCT01237223|80999380|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
27664507|NCT00332488|80609434|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
27965526|NCT00889603|81704612|FG000|Overall Study|Adverse Event|7|||
27773181|NCT01237223|80999381|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
27773182|NCT01237223|80999382|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
27773183|NCT01237223|80999383|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
27773184|NCT01237223|80999384|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
27773185|NCT01237223|80999379|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
27773186|NCT01237223|80999380|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
27773187|NCT01237223|80999381|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
27773188|NCT01237223|80999382|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
27773189|NCT01237223|80999383|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
27773190|NCT01237223|80999384|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
27773191|NCT01237223|80999379|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
27773192|NCT01237223|80999380|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
27773193|NCT01237223|80999381|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
27773194|NCT01237223|80999382|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
27773195|NCT01237223|80999383|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
27773196|NCT01237223|80999384|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
27773197|NCT01237223|80999379|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27773198|NCT01237223|80999380|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27773199|NCT01237223|80999381|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27773200|NCT01237223|80999382|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27773201|NCT01237223|80999383|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
27773202|NCT01237223|80999384|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
27773203|NCT01237223|80999379|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
27773204|NCT01237223|80999380|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27773205|NCT01237223|80999381|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27773206|NCT01237223|80999382|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
27773207|NCT01237223|80999383|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27773208|NCT01237223|80999384|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
27773209|NCT00887068|80999389|FG000|Overall Study|Withdrawal by Subject|2|||
27773210|NCT00887068|80999390|FG001|Overall Study|Withdrawal by Subject|0|||
27773211|NCT00887068|80999389|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
27773212|NCT00887068|80999390|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
27773213|NCT02865928|80999391|FG000|Overall Study|Withdrawal by Subject|1|||
27773214|NCT02865928|80999392|FG001|Overall Study|Withdrawal by Subject|0|||
27773215|NCT02865928|80999391|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
27773216|NCT02865928|80999392|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
27773217|NCT02865928|80999391|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
27773218|NCT02865928|80999392|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
27773219|NCT02187224|80999393|FG000|Overall Study|Did not show up for test day|1|||
27773220|NCT02187224|80999394|FG001|Overall Study|Did not show up for test day|0|||
27773221|NCT00246376|80999395|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
27773222|NCT00246376|80999396|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
27773223|NCT00246376|80999397|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
27773224|NCT00246376|80999398|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
27773225|NCT00246376|80999399|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
27773226|NCT00246376|80999395|FG000|Overall Study|Adverse Event|2|||
27773227|NCT00246376|80999396|FG001|Overall Study|Adverse Event|3|||
27773228|NCT00246376|80999397|FG002|Overall Study|Adverse Event|1|||
27773229|NCT00246376|80999398|FG003|Overall Study|Adverse Event|3|||
27773230|NCT00246376|80999399|FG004|Overall Study|Adverse Event|1|||
27773231|NCT00246376|80999395|FG000|Overall Study|Lost to Follow-up|2|||
27773232|NCT00246376|80999396|FG001|Overall Study|Lost to Follow-up|11|||
27773233|NCT00246376|80999397|FG002|Overall Study|Lost to Follow-up|11|||
27773234|NCT00246376|80999398|FG003|Overall Study|Lost to Follow-up|16|||
27773235|NCT00246376|80999399|FG004|Overall Study|Lost to Follow-up|13|||
27773236|NCT00126425|80999400|FG000|Overall Study|Withdrawal by Subject|17|||
27773237|NCT00126425|80999401|FG001|Overall Study|Withdrawal by Subject|1|||
27773238|NCT00126425|80999400|FG000|Overall Study|Lost to Follow-up|8|||
27773239|NCT00126425|80999401|FG001|Overall Study|Lost to Follow-up|4|||
27773240|NCT00126425|80999400|FG000|Overall Study|Protocol Violation|9|||
27773241|NCT00126425|80999401|FG001|Overall Study|Protocol Violation|6|||
27773242|NCT00126425|80999400|FG000|Overall Study|Adverse Event|1|||
27773243|NCT00126425|80999401|FG001|Overall Study|Adverse Event|0|||
27773244|NCT00126425|80999400|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
27773245|NCT00126425|80999401|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
27965527|NCT00889603|81704612|FG000|Overall Study|Death|3|||
27965528|NCT00889603|81704612|FG000|Overall Study|Lost to Follow-up|19|||
27773246|NCT00126425|80999400|FG000|Overall Study|Other|5|||
27773247|NCT00126425|80999401|FG001|Overall Study|Other|0|||
27773248|NCT02043509|80999403|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
27773249|NCT02043509|80999404|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
27965529|NCT00889603|81704612|FG000|Overall Study|No longer willing to participant in stud|4|||
27965530|NCT00889603|81704612|FG000|Overall Study|Other|4|||
27965531|NCT01951586|81704615|FG000|Overall Study|Death|61|||
27965532|NCT01951586|81704616|FG001|Overall Study|Death|120|||
27965533|NCT01951586|81704615|FG000|Overall Study|Withdrawal by Subject|8|||
27965534|NCT01951586|81704616|FG001|Overall Study|Withdrawal by Subject|17|||
27965535|NCT01951586|81704615|FG000|Overall Study|Lost to Follow-up|0|||
27965536|NCT01951586|81704616|FG001|Overall Study|Lost to Follow-up|1|||
27965537|NCT01951586|81704615|FG000|Overall Study|Sponsor Decision|9|||
27965538|NCT01951586|81704616|FG001|Overall Study|Sponsor Decision|10|||
27965539|NCT04295681|81704617|FG000|Overall Study|Eligibility error|1|||
27965540|NCT04295681|81704618|FG001|Overall Study|Eligibility error|3|||
27965541|NCT01703091|81704621|FG000|Overall Study|Adverse Event|5|||
27965542|NCT01703091|81704622|FG001|Overall Study|Adverse Event|3|||
27569199|NCT00500370|80271509|FG001|Overall Study|Sponsor Decision|0|||
27773250|NCT02043509|80999403|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
27773251|NCT02043509|80999404|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
27773252|NCT02043509|80999403|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
27773253|NCT02043509|80999404|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
27773254|NCT02043509|80999403|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
27773255|NCT02043509|80999404|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
27773256|NCT03518034|80999416|FG000|Overall Study|Not Treated|5|||
27773257|NCT03518034|80999417|FG001|Overall Study|Not Treated|1|||
27773258|NCT03518034|80999416|FG000|Overall Study|Withdrawal by Subject|309|||
27773259|NCT03518034|80999417|FG001|Overall Study|Withdrawal by Subject|351|||
27773260|NCT03518034|80999416|FG000|Overall Study|Lost to Follow-up|446|||
27773261|NCT03518034|80999417|FG001|Overall Study|Lost to Follow-up|458|||
27773262|NCT03518034|80999416|FG000|Overall Study|Adverse Event|138|||
27773263|NCT03518034|80999417|FG001|Overall Study|Adverse Event|130|||
27773264|NCT03518034|80999416|FG000|Overall Study|Lack of Efficacy|11|||
27773265|NCT03518034|80999417|FG001|Overall Study|Lack of Efficacy|23|||
27773266|NCT03518034|80999416|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
27773267|NCT03518034|80999417|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
27773268|NCT03518034|80999416|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
27773269|NCT03518034|80999417|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
27773270|NCT03518034|80999416|FG000|Overall Study|Other, Not Specified|84|||
27773271|NCT03518034|80999417|FG001|Overall Study|Other, Not Specified|53|||
27773272|NCT03518034|80999416|FG000|Overall Study|Reason Missing|2|||
27773273|NCT03518034|80999417|FG001|Overall Study|Reason Missing|3|||
27773274|NCT00744991|80999418|FG000|Overall Study|Progressive Disease|11|||
27773275|NCT00744991|80999418|FG000|Overall Study|Withdrawal by Subject|8|||
27773276|NCT00744991|80999418|FG000|Overall Study|Physician Decision|3|||
27773277|NCT00744991|80999418|FG000|Overall Study|Adverse Event|2|||
27773278|NCT00744991|80999418|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
27773279|NCT01473355|80999420|FG000|Overall Study|Protocol Violation|2|||
27773280|NCT01473355|80999420|FG000|Overall Study|Adverse Event|2|||
27773281|NCT01473355|80999420|FG000|Overall Study|Lost to Follow-up|2|||
27773282|NCT00255008|80999422|FG000|Overall Study|Adverse Event|1|||
27773283|NCT00255008|80999423|FG001|Overall Study|Adverse Event|1|||
27773284|NCT00255008|80999424|FG002|Overall Study|Adverse Event|2|||
27773285|NCT00255008|80999425|FG003|Overall Study|Adverse Event|0|||
27773286|NCT00255008|80999422|FG000|Overall Study|Lost to Follow-up|1|||
27773287|NCT00255008|80999423|FG001|Overall Study|Lost to Follow-up|0|||
27773288|NCT00255008|80999424|FG002|Overall Study|Lost to Follow-up|1|||
27773289|NCT00255008|80999425|FG003|Overall Study|Lost to Follow-up|2|||
27773290|NCT00255008|80999422|FG000|Overall Study|Did not meet viral reduction criteria|4|||
27773291|NCT00255008|80999423|FG001|Overall Study|Did not meet viral reduction criteria|5|||
27773292|NCT00255008|80999424|FG002|Overall Study|Did not meet viral reduction criteria|0|||
27773293|NCT00255008|80999425|FG003|Overall Study|Did not meet viral reduction criteria|1|||
27773294|NCT00255008|80999422|FG000|Overall Study|Withdrew consent|0|||
27773295|NCT00255008|80999423|FG001|Overall Study|Withdrew consent|0|||
27773296|NCT00255008|80999424|FG002|Overall Study|Withdrew consent|2|||
27773297|NCT00255008|80999425|FG003|Overall Study|Withdrew consent|0|||
27773298|NCT00255008|80999422|FG000|Overall Study|Sponsor request|18|||
27773299|NCT00255008|80999423|FG001|Overall Study|Sponsor request|3|||
27773300|NCT00255008|80999424|FG002|Overall Study|Sponsor request|8|||
27773301|NCT00255008|80999425|FG003|Overall Study|Sponsor request|17|||
27773302|NCT00255008|80999422|FG000|Overall Study|Adverse lab experience|1|||
27965543|NCT01703091|81704621|FG000|Overall Study|Physician Decision|2|||
27965544|NCT01703091|81704622|FG001|Overall Study|Physician Decision|1|||
27773303|NCT00255008|80999423|FG001|Overall Study|Adverse lab experience|0|||
27965545|NCT01703091|81704621|FG000|Overall Study|Withdrawal by Subject|1|||
27965546|NCT01703091|81704622|FG001|Overall Study|Withdrawal by Subject|0|||
27965547|NCT01703091|81704621|FG000|Overall Study|Sponsor Decision|1|||
27965548|NCT01703091|81704622|FG001|Overall Study|Sponsor Decision|0|||
27965549|NCT01523743|81704625|FG000|Period 1|Adverse Event|1|||
27965550|NCT01523743|81704626|FG001|Period 1|Adverse Event|0|||
27965551|NCT01523743|81704625|FG000|Period 1|Withdrawal by Subject|6|||
27965552|NCT01523743|81704626|FG001|Period 1|Withdrawal by Subject|2|||
27965553|NCT01523743|81704625|FG000|Period 1|Lost to Follow-up|1|||
27965554|NCT01523743|81704626|FG001|Period 1|Lost to Follow-up|0|||
27965555|NCT01523743|81704625|FG000|Period 1|Lack of Efficacy|1|||
27965556|NCT01523743|81704626|FG001|Period 1|Lack of Efficacy|0|||
27965557|NCT01523743|81704625|FG000|Period 1|Felt unable to empty bladder|1|||
27773304|NCT00255008|80999424|FG002|Overall Study|Adverse lab experience|0|||
27773305|NCT00255008|80999425|FG003|Overall Study|Adverse lab experience|0|||
27773306|NCT00255008|80999422|FG000|Overall Study|Other|7|||
27773307|NCT00255008|80999423|FG001|Overall Study|Other|0|||
27773308|NCT00255008|80999424|FG002|Overall Study|Other|3|||
27773309|NCT00255008|80999425|FG003|Overall Study|Other|2|||
27773310|NCT02668692|80999427|FG000|Overall Study|Adverse Event|1|||
27773311|NCT02668692|80999428|FG001|Overall Study|Adverse Event|0|||
27773312|NCT00446797|80999429|FG000|Overall Study|Lack of Efficacy|0|||
27773313|NCT00446797|80999430|FG001|Overall Study|Lack of Efficacy|2|||
27773314|NCT00446797|80999429|FG000|Overall Study|Lost to Follow-up|5|||
27773315|NCT00446797|80999430|FG001|Overall Study|Lost to Follow-up|3|||
27773316|NCT00446797|80999429|FG000|Overall Study|Withdrawal by Subject|2|||
27773317|NCT00446797|80999430|FG001|Overall Study|Withdrawal by Subject|2|||
27773318|NCT00446797|80999429|FG000|Overall Study|Protocol Violation|1|||
27965558|NCT01523743|81704626|FG001|Period 1|Felt unable to empty bladder|0|||
27965559|NCT01523743|81704625|FG000|Period 2|Withdrawal by Subject|0|||
27965560|NCT01523743|81704626|FG001|Period 2|Withdrawal by Subject|2|||
27965561|NCT01523743|81704625|FG000|Period 2|Adverse Event|1|||
27965562|NCT01523743|81704626|FG001|Period 2|Adverse Event|0|||
27773319|NCT00446797|80999430|FG001|Overall Study|Protocol Violation|3|||
27773320|NCT00446797|80999429|FG000|Overall Study|subject entered at another site|0|||
27773321|NCT00446797|80999430|FG001|Overall Study|subject entered at another site|1|||
27773322|NCT00446797|80999429|FG000|Overall Study|did not meet entrance criteria|0|||
27965563|NCT02096952|81704627|FG000|Overall Study|Adverse Event|1|||
27965564|NCT02482428|81704628|FG000|Overall Study|Lost to Follow-up|4|||
27965565|NCT02482428|81704629|FG001|Overall Study|Lost to Follow-up|9|||
27965566|NCT02482428|81704630|FG002|Overall Study|Lost to Follow-up|1|||
27773323|NCT00446797|80999430|FG001|Overall Study|did not meet entrance criteria|1|||
27773324|NCT05307523|80999435|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
27965567|NCT02482428|81704631|FG003|Overall Study|Lost to Follow-up|2|||
27773325|NCT05307523|80999436|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
27773326|NCT05307523|80999435|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
27773327|NCT05307523|80999436|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
27773328|NCT00666536|80999437|FG000|Overall Study|Adverse Event|9|||
27773329|NCT00666536|80999438|FG001|Overall Study|Adverse Event|19|||
27773330|NCT00666536|80999437|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27773331|NCT00666536|80999438|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27773332|NCT00666536|80999437|FG000|Overall Study|Protocol deviation(s)|8|||
27773333|NCT00666536|80999438|FG001|Overall Study|Protocol deviation(s)|6|||
27773334|NCT00666536|80999437|FG000|Overall Study|Withdrawal by Subject|10|||
27773335|NCT00666536|80999438|FG001|Overall Study|Withdrawal by Subject|9|||
27773336|NCT00666536|80999437|FG000|Overall Study|Lost to Follow-up|4|||
27773337|NCT00666536|80999438|FG001|Overall Study|Lost to Follow-up|3|||
27773338|NCT01681836|80999439|FG000|Second Intervention|Withdrawal by Subject|0|||
27773339|NCT01681836|80999440|FG001|Second Intervention|Withdrawal by Subject|1|||
27773340|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
27773341|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
27773342|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
27773343|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
27773344|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
27773345|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
27773346|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
27773347|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
27773348|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
27773349|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
27773350|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
27773351|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
27773352|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
27773353|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
27773354|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
27773355|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
27773356|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
27773357|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
27773358|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
27773359|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
27773360|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
27773361|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
27773362|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
27773363|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
27773364|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Other|0|||
27773365|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Other|1|||
27773366|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Other|0|||
27773367|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Other|0|||
27773368|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
27773369|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
27773370|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
27773371|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
27773372|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
27773373|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
27773374|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
27773375|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
27773376|NCT01194414|80999443|FG000|24 Weeks Double Blind Period|Death|0|||
27773377|NCT01194414|80999444|FG001|24 Weeks Double Blind Period|Death|1|||
27773378|NCT01194414|80999445|FG002|24 Weeks Double Blind Period|Death|0|||
27773379|NCT01194414|80999446|FG003|24 Weeks Double Blind Period|Death|0|||
27773380|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
27773381|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
27773382|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
27773383|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
27773384|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
27773385|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
27773386|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
27773387|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
27773388|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
27773389|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
27773390|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
27773391|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
27773392|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
27965568|NCT02482428|81704632|FG004|Overall Study|Lost to Follow-up|4|||
27965569|NCT02482428|81704628|FG000|Overall Study|Physician Decision|0|||
27965570|NCT02482428|81704629|FG001|Overall Study|Physician Decision|0|||
27965571|NCT02482428|81704630|FG002|Overall Study|Physician Decision|0|||
27965572|NCT02482428|81704631|FG003|Overall Study|Physician Decision|0|||
27965573|NCT02482428|81704632|FG004|Overall Study|Physician Decision|1|||
27965574|NCT02482428|81704628|FG000|Overall Study|protocol deviation|1|||
27965575|NCT02482428|81704629|FG001|Overall Study|protocol deviation|1|||
27965576|NCT02482428|81704630|FG002|Overall Study|protocol deviation|0|||
27965577|NCT02482428|81704631|FG003|Overall Study|protocol deviation|0|||
27965578|NCT02482428|81704632|FG004|Overall Study|protocol deviation|0|||
27965579|NCT02482428|81704628|FG000|Overall Study|subject/guardian decision|4|||
27965580|NCT02482428|81704629|FG001|Overall Study|subject/guardian decision|2|||
27965581|NCT02482428|81704630|FG002|Overall Study|subject/guardian decision|0|||
27965582|NCT02482428|81704631|FG003|Overall Study|subject/guardian decision|0|||
27965583|NCT02482428|81704632|FG004|Overall Study|subject/guardian decision|2|||
27965584|NCT02397915|81704633|FG000|Period 1|Protocol Violation|0|||
27965585|NCT02397915|81704634|FG001|Period 1|Protocol Violation|1|||
27965586|NCT02397915|81704635|FG002|Period 1|Protocol Violation|0|||
27965587|NCT02397915|81704636|FG003|Period 1|Protocol Violation|0|||
27965588|NCT02397915|81704633|FG000|Period 1|Physician Decision|1|||
27965589|NCT02397915|81704634|FG001|Period 1|Physician Decision|0|||
27965590|NCT02397915|81704635|FG002|Period 1|Physician Decision|0|||
27965591|NCT02397915|81704636|FG003|Period 1|Physician Decision|0|||
27965592|NCT03070223|81704640|FG000|Overall Study|Lost to Follow-up|34|||
27965593|NCT03070223|81704641|FG001|Overall Study|Lost to Follow-up|27|||
27965594|NCT03070223|81704640|FG000|Overall Study|Withdrawal by Subject|12|||
27965595|NCT03070223|81704641|FG001|Overall Study|Withdrawal by Subject|22|||
27965596|NCT03070223|81704640|FG000|Overall Study|Protocol Violation|0|||
27965597|NCT03070223|81704641|FG001|Overall Study|Protocol Violation|1|||
27965598|NCT02584452|81704642|FG000|Overall Study|Physician Decision|1|||
27965599|NCT02584452|81704643|FG001|Overall Study|Physician Decision|1|||
27965600|NCT02584452|81704642|FG000|Overall Study|Lost to Follow-up|1|||
27965601|NCT02584452|81704643|FG001|Overall Study|Lost to Follow-up|1|||
27965602|NCT03994211|81704646|FG000|Core Phase|Adverse Event|0|||
27965603|NCT03994211|81704647|FG001|Core Phase|Adverse Event|1|||
27965604|NCT03994211|81704648|FG002|Core Phase|Adverse Event|0|||
27965605|NCT03994211|81704646|FG000|Extension Phase|Adverse Event|0|||
27965606|NCT03994211|81704647|FG001|Extension Phase|Adverse Event|0|||
27965607|NCT03994211|81704648|FG002|Extension Phase|Adverse Event|1|||
27965608|NCT03994211|81704646|FG000|Extension Phase|Physician Decision|0|||
27965609|NCT03994211|81704647|FG001|Extension Phase|Physician Decision|0|||
27965610|NCT03994211|81704648|FG002|Extension Phase|Physician Decision|1|||
27965611|NCT03994211|81704646|FG000|Extension Phase|Progressive Disease|0|||
27965612|NCT03994211|81704647|FG001|Extension Phase|Progressive Disease|0|||
27965613|NCT03994211|81704648|FG002|Extension Phase|Progressive Disease|20|||
27965614|NCT03994211|81704646|FG000|Extension Phase|Withdrawal by Subject|0|||
27965615|NCT03994211|81704647|FG001|Extension Phase|Withdrawal by Subject|0|||
27965616|NCT03994211|81704648|FG002|Extension Phase|Withdrawal by Subject|2|||
27965617|NCT04860869|81704649|FG000|Overall Study|Withdrawal by Subject|1|||
27965618|NCT04860869|81704650|FG001|Overall Study|Withdrawal by Subject|0|||
27965619|NCT05479097|81704653|FG000|Overall Study|Withdrawal by Subject|2|||
27965620|NCT03783442|81704654|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
27965621|NCT03783442|81704655|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
27965622|NCT03783442|81704654|FG000|Overall Study|Death|196|||
27965623|NCT03783442|81704655|FG001|Overall Study|Death|226|||
27965624|NCT03783442|81704654|FG000|Overall Study|Withdrawal by Subject|14|||
27569200|NCT00500370|80271508|FG000|Overall Study|Subject Decision|10|||
27965625|NCT03783442|81704655|FG001|Overall Study|Withdrawal by Subject|17|||
27965626|NCT03783442|81704654|FG000|Overall Study|Lost to Follow-up|2|||
27965627|NCT03783442|81704655|FG001|Overall Study|Lost to Follow-up|3|||
27965628|NCT00249808|81704664|FG000|Overall Study|Other|27|||
27965629|NCT00249808|81704664|FG000|Overall Study|Protocol Violation|3|||
27965630|NCT00249808|81704664|FG000|Overall Study|Lost to Follow-up|8|||
27965631|NCT00249808|81704664|FG000|Overall Study|Adverse Event|81|||
27965632|NCT00249808|81704664|FG000|Overall Study|Lack of Efficacy|52|||
27965633|NCT00249808|81704664|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
27965634|NCT00576628|81704665|FG000|Overall Study|Adverse Event|11|||
27965635|NCT00576628|81704665|FG000|Overall Study|Death|2|||
27965636|NCT00576628|81704665|FG000|Overall Study|Failure to return|1|||
27965637|NCT00576628|81704665|FG000|Overall Study|Refused Treatment|8|||
27965638|NCT00576628|81704665|FG000|Overall Study|Pregnancy|1|||
27773393|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
27773394|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
27773395|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
27773396|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
27773397|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
27773398|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
27773399|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
27773400|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
27773401|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
27773402|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
27773403|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
27773404|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Other|2|||
27773405|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Other|1|||
27773406|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Other|0|||
27773407|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Other|0|||
27773408|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
27773409|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
27773410|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
27773411|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
27773412|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
27773413|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
27773414|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
27773415|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
27773416|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
27773417|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
27773418|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
27773419|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
27773420|NCT01194414|80999443|FG000|72 Weeks Open Label Extension|Death|1|||
27773421|NCT01194414|80999444|FG001|72 Weeks Open Label Extension|Death|2|||
27773422|NCT01194414|80999445|FG002|72 Weeks Open Label Extension|Death|0|||
27773423|NCT01194414|80999446|FG003|72 Weeks Open Label Extension|Death|2|||
27773424|NCT01226472|80999447|FG000|Overall Study|Progressive Disease|1|||
27773425|NCT03342404|80999451|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
27773426|NCT03342404|80999452|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
27773427|NCT03342404|80999451|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
27773428|NCT03342404|80999452|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
27773429|NCT03342404|80999451|FG000|Blinded Treatment Phase|Adverse Event|5|||
27773430|NCT03342404|80999452|FG001|Blinded Treatment Phase|Adverse Event|4|||
27773431|NCT03342404|80999451|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
27773432|NCT03342404|80999452|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
27773433|NCT03342404|80999451|FG000|Blinded Treatment Phase|Other reasons|1|||
27773434|NCT03342404|80999452|FG001|Blinded Treatment Phase|Other reasons|0|||
27773435|NCT03342404|80999451|FG000|Blinded Treatment Phase|Physician Decision|1|||
27773436|NCT03342404|80999452|FG001|Blinded Treatment Phase|Physician Decision|0|||
27773437|NCT03342404|80999451|FG000|Blinded Treatment Phase|Death|1|||
27773438|NCT03342404|80999452|FG001|Blinded Treatment Phase|Death|0|||
27773439|NCT03342404|80999451|FG000|Open-Label Phase|Lost to Follow-up|0|||
27773440|NCT03342404|80999452|FG001|Open-Label Phase|Lost to Follow-up|1|||
27773441|NCT03342404|80999451|FG000|Open-Label Phase|Other reasons|0|||
27773442|NCT03342404|80999452|FG001|Open-Label Phase|Other reasons|1|||
27773443|NCT03342404|80999451|FG000|Open-Label Phase|Adverse Event|0|||
27773444|NCT03342404|80999452|FG001|Open-Label Phase|Adverse Event|3|||
27773445|NCT03342404|80999451|FG000|Open-Label Phase|Withdrawal by Subject|0|||
27773446|NCT03342404|80999452|FG001|Open-Label Phase|Withdrawal by Subject|6|||
27773447|NCT03424044|80999455|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773448|NCT03424044|80999456|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773449|NCT03424044|80999457|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
27773450|NCT03424044|80999458|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773451|NCT03424044|80999459|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773452|NCT03424044|80999460|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773453|NCT03424044|80999461|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773454|NCT03424044|80999462|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773455|NCT03424044|80999463|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
27773456|NCT03424044|80999455|FG000|First Intervention (76 Hours)|Adverse Event|0|||
27773457|NCT03424044|80999456|FG001|First Intervention (76 Hours)|Adverse Event|0|||
27773458|NCT03424044|80999457|FG002|First Intervention (76 Hours)|Adverse Event|0|||
27773459|NCT03424044|80999458|FG003|First Intervention (76 Hours)|Adverse Event|0|||
27773460|NCT03424044|80999459|FG004|First Intervention (76 Hours)|Adverse Event|1|||
27773461|NCT03424044|80999460|FG005|First Intervention (76 Hours)|Adverse Event|0|||
27773462|NCT03424044|80999461|FG006|First Intervention (76 Hours)|Adverse Event|0|||
27965639|NCT00576628|81704665|FG000|Overall Study|RBC transfusion|1|||
27965640|NCT00576628|81704665|FG000|Overall Study|Progression of Kidney Disease|1|||
27965641|NCT00576628|81704665|FG000|Overall Study|Progression of Renal Failure|1|||
27965642|NCT00576628|81704665|FG000|Overall Study|The patient move into other town|1|||
27965643|NCT00576628|81704665|FG000|Overall Study|Transplantation|1|||
27965644|NCT00576628|81704665|FG000|Overall Study|Dialysis|15|||
27965645|NCT00933608|81704666|FG000|Overall Study|Adverse Event|4|||
27965646|NCT00933608|81704667|FG001|Overall Study|Adverse Event|2|||
27569201|NCT00500370|80271509|FG001|Overall Study|Subject Decision|17|||
27569202|NCT02382016|80271510|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
27569203|NCT02382016|80271511|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
27569204|NCT02382016|80271510|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
27569205|NCT02382016|80271511|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
27773463|NCT03424044|80999462|FG007|First Intervention (76 Hours)|Adverse Event|0|||
27773464|NCT03424044|80999463|FG008|First Intervention (76 Hours)|Adverse Event|0|||
27773465|NCT03424044|80999455|FG000|First Intervention (76 Hours)|device issues|0|||
27773466|NCT03424044|80999456|FG001|First Intervention (76 Hours)|device issues|0|||
27965647|NCT00933608|81704666|FG000|Overall Study|Physician Decision|1|||
27569206|NCT02382016|80271510|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
27965648|NCT00933608|81704667|FG001|Overall Study|Physician Decision|0|||
27965649|NCT02993822|81704668|FG000|Overall Study|Lack of Efficacy|1|||
27569207|NCT02382016|80271511|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
27569208|NCT02382016|80271510|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
27569209|NCT02382016|80271511|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
27569210|NCT02382016|80271510|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
27569211|NCT02382016|80271511|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
27569212|NCT02382016|80271510|FG000|Open-label (OL) Treatment Period|Death|4|||
27569213|NCT02382016|80271511|FG001|Open-label (OL) Treatment Period|Death|0|||
27569214|NCT02382016|80271510|FG000|OL Extension Period|Physician Decision|3|||
27569215|NCT02382016|80271511|FG001|OL Extension Period|Physician Decision|0|||
27569216|NCT02382016|80271510|FG000|OL Extension Period|Death|2|||
27569217|NCT02382016|80271511|FG001|OL Extension Period|Death|0|||
27569218|NCT02382016|80271510|FG000|OL Extension Period|Withdrawal by Subject|1|||
27569219|NCT02382016|80271511|FG001|OL Extension Period|Withdrawal by Subject|0|||
27569220|NCT04847674|80271512|FG000|Overall Study|Withdrawal by Subject|0|||
27569221|NCT04847674|80271513|FG001|Overall Study|Withdrawal by Subject|1|||
27569222|NCT04847674|80271514|FG002|Overall Study|Withdrawal by Subject|0|||
27773467|NCT03424044|80999457|FG002|First Intervention (76 Hours)|device issues|0|||
27773468|NCT03424044|80999458|FG003|First Intervention (76 Hours)|device issues|0|||
27773469|NCT03424044|80999459|FG004|First Intervention (76 Hours)|device issues|0|||
27773470|NCT03424044|80999460|FG005|First Intervention (76 Hours)|device issues|0|||
27773471|NCT03424044|80999461|FG006|First Intervention (76 Hours)|device issues|1|||
27773472|NCT03424044|80999462|FG007|First Intervention (76 Hours)|device issues|1|||
27773473|NCT03424044|80999463|FG008|First Intervention (76 Hours)|device issues|1|||
27773474|NCT03424044|80999455|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
27773475|NCT03424044|80999456|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
27773476|NCT03424044|80999457|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
27773477|NCT03424044|80999458|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
27773478|NCT03424044|80999459|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
27773479|NCT03424044|80999460|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
27773480|NCT03424044|80999461|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
27773481|NCT03424044|80999462|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
27773482|NCT03424044|80999463|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
27773483|NCT03424044|80999455|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773484|NCT03424044|80999456|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773485|NCT03424044|80999457|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773486|NCT03424044|80999458|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
27862250|NCT02359994|81326289|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
27569223|NCT04847674|80271512|FG000|Overall Study|Lost to Follow-up|0|||
27569224|NCT04847674|80271513|FG001|Overall Study|Lost to Follow-up|0|||
27569225|NCT04847674|80271514|FG002|Overall Study|Lost to Follow-up|2|||
27569226|NCT04847674|80271512|FG000|Overall Study|Other than specified|21|||
27773487|NCT03424044|80999459|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773488|NCT03424044|80999460|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773489|NCT03424044|80999461|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773490|NCT03424044|80999462|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773491|NCT03424044|80999463|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
27773492|NCT01432938|80999464|FG000|First Intervention|Protocol Violation|1|||
27773493|NCT01432938|80999465|FG001|First Intervention|Protocol Violation|0|||
27773494|NCT01432938|80999464|FG000|First Intervention|Physician Decision|1|||
27773495|NCT01432938|80999465|FG001|First Intervention|Physician Decision|0|||
27773496|NCT01432938|80999464|FG000|Second Intervention|Adverse Event|1|||
27773497|NCT01432938|80999465|FG001|Second Intervention|Adverse Event|0|||
27773498|NCT02809118|80999471|FG000|Overall Study|Withdrawal by Subject|0|||
27773499|NCT02809118|80999472|FG001|Overall Study|Withdrawal by Subject|1|||
27773500|NCT02809118|80999473|FG002|Overall Study|Withdrawal by Subject|1|||
27773501|NCT01347073|80999475|FG000|Overall Study|Adverse Event|1|||
27773502|NCT01347073|80999475|FG000|Overall Study|Liver Transplant|1|||
27773503|NCT03938636|80999476|FG000|Overall Study|Protocol Violation|0|||
27773504|NCT03938636|80999477|FG001|Overall Study|Protocol Violation|1|||
27773505|NCT03938636|80999478|FG002|Overall Study|Protocol Violation|1|||
27773506|NCT03938636|80999476|FG000|Overall Study|Subject withdrew due to death in family|0|||
27773507|NCT03938636|80999477|FG001|Overall Study|Subject withdrew due to death in family|1|||
27773508|NCT03938636|80999478|FG002|Overall Study|Subject withdrew due to death in family|0|||
27773509|NCT03938636|80999476|FG000|Overall Study|Missed visit|0|||
27773510|NCT03938636|80999477|FG001|Overall Study|Missed visit|1|||
27773511|NCT03938636|80999478|FG002|Overall Study|Missed visit|0|||
27773512|NCT03938636|80999476|FG000|Overall Study|Adverse Event|0|||
27773513|NCT03938636|80999477|FG001|Overall Study|Adverse Event|0|||
27773514|NCT03938636|80999478|FG002|Overall Study|Adverse Event|1|||
27773515|NCT03938636|80999476|FG000|Overall Study|Lost to Follow-up|0|||
27773516|NCT03938636|80999477|FG001|Overall Study|Lost to Follow-up|0|||
27773517|NCT03938636|80999478|FG002|Overall Study|Lost to Follow-up|1|||
27773518|NCT03878160|80999479|FG000|Overall Study|Lost to Follow-up|1|||
27773519|NCT03878160|80999480|FG001|Overall Study|Lost to Follow-up|1|||
27773520|NCT03878160|80999481|FG002|Overall Study|Lost to Follow-up|1|||
27773521|NCT03878160|80999479|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
27773522|NCT03878160|80999480|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
27773523|NCT03878160|80999481|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
27773524|NCT00002981|80999482|FG000|Overall Study|Inevaluable|6|||
27773525|NCT03127852|80999489|FG000|Overall Study|Withdrawal by Subject|4|||
27773526|NCT03127852|80999490|FG001|Overall Study|Withdrawal by Subject|1|||
27773527|NCT03127852|80999489|FG000|Overall Study|Death|1|||
27773528|NCT03127852|80999490|FG001|Overall Study|Death|1|||
27773529|NCT01365091|80999493|FG000|Period 1|Adverse Event|1|||
27773530|NCT01365091|80999494|FG001|Period 1|Adverse Event|0|||
27773531|NCT01365091|80999495|FG002|Period 1|Adverse Event|2|||
27773532|NCT01365091|80999496|FG003|Period 1|Adverse Event|3|||
27773533|NCT01365091|80999493|FG000|Period 1|Positive test result for drugs of abuse|1|||
27773534|NCT01365091|80999494|FG001|Period 1|Positive test result for drugs of abuse|0|||
27773535|NCT01365091|80999495|FG002|Period 1|Positive test result for drugs of abuse|0|||
27773536|NCT01365091|80999496|FG003|Period 1|Positive test result for drugs of abuse|0|||
27773537|NCT01365091|80999493|FG000|Period 1|No longer met study criteria|0|||
27773538|NCT01365091|80999494|FG001|Period 1|No longer met study criteria|1|||
27773539|NCT01365091|80999495|FG002|Period 1|No longer met study criteria|0|||
27773540|NCT01365091|80999496|FG003|Period 1|No longer met study criteria|0|||
27773541|NCT01365091|80999493|FG000|Period 1|Withdrawal by Subject|0|||
27773542|NCT01365091|80999494|FG001|Period 1|Withdrawal by Subject|1|||
27773543|NCT01365091|80999495|FG002|Period 1|Withdrawal by Subject|0|||
27773544|NCT01365091|80999496|FG003|Period 1|Withdrawal by Subject|0|||
27773545|NCT01365091|80999493|FG000|Period 1|Personal reasons|0|||
27773546|NCT01365091|80999494|FG001|Period 1|Personal reasons|0|||
27773547|NCT01365091|80999495|FG002|Period 1|Personal reasons|1|||
27773548|NCT01365091|80999496|FG003|Period 1|Personal reasons|0|||
27773549|NCT01365091|80999493|FG000|Period 2|Withdrawal by Subject|1|||
27773550|NCT01365091|80999494|FG001|Period 2|Withdrawal by Subject|0|||
27773551|NCT01365091|80999495|FG002|Period 2|Withdrawal by Subject|0|||
27773552|NCT01365091|80999496|FG003|Period 2|Withdrawal by Subject|0|||
27773553|NCT01365091|80999493|FG000|Period 2|Adverse Event|0|||
27773554|NCT01365091|80999494|FG001|Period 2|Adverse Event|0|||
27773555|NCT01365091|80999495|FG002|Period 2|Adverse Event|1|||
27773556|NCT01365091|80999496|FG003|Period 2|Adverse Event|0|||
27773557|NCT04539262|80999497|FG000|Overall Study|Adverse Event|0|||
27773558|NCT04539262|80999498|FG001|Overall Study|Adverse Event|0|||
27773559|NCT04539262|80999499|FG002|Overall Study|Adverse Event|1|||
27773560|NCT04539262|80999500|FG003|Overall Study|Adverse Event|0|||
27773561|NCT04539262|80999501|FG004|Overall Study|Adverse Event|0|||
27773562|NCT04539262|80999502|FG005|Overall Study|Adverse Event|0|||
27773563|NCT04539262|80999503|FG006|Overall Study|Adverse Event|0|||
27773564|NCT04539262|80999504|FG007|Overall Study|Adverse Event|0|||
27965650|NCT02993822|81704669|FG001|Overall Study|Lack of Efficacy|1|||
27965651|NCT02993822|81704670|FG002|Overall Study|Lack of Efficacy|0|||
27965652|NCT02993822|81704671|FG003|Overall Study|Lack of Efficacy|0|||
27965653|NCT02993822|81704668|FG000|Overall Study|Protocol Violation|1|||
27965654|NCT02993822|81704669|FG001|Overall Study|Protocol Violation|0|||
27965655|NCT02993822|81704670|FG002|Overall Study|Protocol Violation|0|||
27965656|NCT02993822|81704671|FG003|Overall Study|Protocol Violation|0|||
27965657|NCT02993822|81704668|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
27965658|NCT02993822|81704669|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
27965659|NCT02993822|81704670|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
27965660|NCT02993822|81704671|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
27965661|NCT02993822|81704668|FG000|Overall Study|Adverse Event|3|||
27965662|NCT02993822|81704669|FG001|Overall Study|Adverse Event|1|||
27965663|NCT02993822|81704670|FG002|Overall Study|Adverse Event|7|||
27965664|NCT02993822|81704671|FG003|Overall Study|Adverse Event|0|||
27965665|NCT02993822|81704668|FG000|Overall Study|Withdrawal by Subject|4|||
27965666|NCT02993822|81704669|FG001|Overall Study|Withdrawal by Subject|2|||
27965667|NCT02993822|81704670|FG002|Overall Study|Withdrawal by Subject|2|||
27965668|NCT02993822|81704671|FG003|Overall Study|Withdrawal by Subject|3|||
27965669|NCT02993822|81704668|FG000|Overall Study|Lost to Follow-up|1|||
27569227|NCT04847674|80271513|FG001|Overall Study|Other than specified|20|||
27569228|NCT04847674|80271514|FG002|Overall Study|Other than specified|20|||
27569229|NCT01231581|80271516|FG000|Overall Study|Lost to Follow-up|2|||
27569230|NCT01231581|80271517|FG001|Overall Study|Lost to Follow-up|2|||
27569231|NCT01231581|80271516|FG000|Overall Study|Withdrawal by Subject|6|||
27569232|NCT01231581|80271517|FG001|Overall Study|Withdrawal by Subject|9|||
27569233|NCT01231581|80271516|FG000|Overall Study|Study Closed/Terminated|6|||
27569234|NCT01231581|80271517|FG001|Overall Study|Study Closed/Terminated|5|||
27569235|NCT01231581|80271516|FG000|Overall Study|Death|65|||
27569236|NCT01231581|80271517|FG001|Overall Study|Death|64|||
27569237|NCT01231581|80271516|FG000|Overall Study|Ongoing|1|||
27569238|NCT01231581|80271517|FG001|Overall Study|Ongoing|0|||
27569239|NCT00405548|80271518|FG000|Overall Study|Cognitive Memory problems on study day|1|||
27569240|NCT00405548|80271519|FG001|Overall Study|Cognitive Memory problems on study day|0|||
27569241|NCT00405548|80271518|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
27569242|NCT00405548|80271519|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
27569243|NCT00405548|80271518|FG000|Overall Study|Unable to self-administer shots|1|||
27569244|NCT00405548|80271519|FG001|Overall Study|Unable to self-administer shots|0|||
27569245|NCT00405548|80271518|FG000|Overall Study|Venous access failed during study day|1|||
27569246|NCT00405548|80271519|FG001|Overall Study|Venous access failed during study day|0|||
27569247|NCT00405548|80271518|FG000|Overall Study|Withdrawal by Subject|1|||
27569248|NCT00405548|80271519|FG001|Overall Study|Withdrawal by Subject|0|||
27569249|NCT01418937|80271523|FG000|Overall Study|Lost to Follow-up|5|||
27569250|NCT01418937|80271523|FG000|Overall Study|Protocol Violation|1|||
27569251|NCT01418937|80271523|FG000|Overall Study|Pregnancy|1|||
27569252|NCT01418937|80271523|FG000|Overall Study|Withdrawal by Subject|1|||
27569253|NCT01354496|80271524|FG000|Period 1|Adverse Event|0|||
27569254|NCT01354496|80271525|FG001|Period 1|Adverse Event|0|||
27569255|NCT01354496|80271526|FG002|Period 1|Adverse Event|1|||
27569256|NCT01354496|80271527|FG003|Period 1|Adverse Event|0|||
27569257|NCT01354496|80271528|FG004|Period 1|Adverse Event|0|||
27569258|NCT01354496|80271529|FG005|Period 1|Adverse Event|0|||
27569259|NCT01354496|80271524|FG000|Period 1|Physician Decision|0|||
27965670|NCT02993822|81704669|FG001|Overall Study|Lost to Follow-up|0|||
27965671|NCT02993822|81704670|FG002|Overall Study|Lost to Follow-up|1|||
27569260|NCT01354496|80271525|FG001|Period 1|Physician Decision|0|||
27569261|NCT01354496|80271526|FG002|Period 1|Physician Decision|1|||
27569262|NCT01354496|80271527|FG003|Period 1|Physician Decision|0|||
27569263|NCT01354496|80271528|FG004|Period 1|Physician Decision|0|||
27569264|NCT01354496|80271529|FG005|Period 1|Physician Decision|0|||
27569265|NCT01354496|80271524|FG000|Period 2|Adverse Event|0|||
27569266|NCT01354496|80271525|FG001|Period 2|Adverse Event|0|||
27569267|NCT01354496|80271526|FG002|Period 2|Adverse Event|0|||
27965672|NCT02993822|81704671|FG003|Overall Study|Lost to Follow-up|0|||
27965673|NCT03300024|81704672|FG000|Overall Study|Physician Decision|4|||
27965674|NCT03300024|81704673|FG001|Overall Study|Physician Decision|6|||
27965675|NCT05784129|81704681|FG000|Overall Study|Study terminated by sponsor|2|||
27569268|NCT01354496|80271527|FG003|Period 2|Adverse Event|1|||
27569269|NCT01354496|80271528|FG004|Period 2|Adverse Event|0|||
27569270|NCT01354496|80271529|FG005|Period 2|Adverse Event|0|||
27569271|NCT01354496|80271524|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
27569272|NCT01354496|80271525|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
27569273|NCT01354496|80271526|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
27569274|NCT01354496|80271527|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
27569275|NCT01354496|80271528|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
27569276|NCT01354496|80271529|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
27569277|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
27569278|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
27569279|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
27569280|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
27569281|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
27569282|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
27569283|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
27569284|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
27569285|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
27569286|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
27569287|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
27569288|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
27569289|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
27569290|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
27569291|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
27569292|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
27569293|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
27569294|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
27569295|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
27569296|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
27569297|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
27569298|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
27569299|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
27569300|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
27965676|NCT05784129|81704682|FG001|Overall Study|Study terminated by sponsor|2|||
27965677|NCT02921230|81704683|FG000|Overall Study|Withdrawal by Subject|20|||
27569301|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
27569302|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
27569303|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
27569304|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
27569305|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
27569306|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
27569307|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
27569308|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
27569309|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
27569310|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
27569311|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
27569312|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
27569313|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
27569314|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
27569315|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
27569316|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
27569317|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
27569318|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
27569319|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
27569320|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
27569321|NCT01218516|80271530|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
27569322|NCT01218516|80271531|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
27569323|NCT01218516|80271532|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
27664508|NCT00332488|80609432|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
27965678|NCT02921230|81704684|FG001|Overall Study|Withdrawal by Subject|8|||
27965679|NCT02921230|81704683|FG000|Overall Study|Death|12|||
27569324|NCT01218516|80271533|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
27569325|NCT00082433|80271534|FG000|Overall Study|Adverse Event|12|||
27569326|NCT00082433|80271535|FG001|Overall Study|Adverse Event|17|||
27569327|NCT00082433|80271534|FG000|Overall Study|Death|8|||
27569328|NCT00082433|80271535|FG001|Overall Study|Death|18|||
27569329|NCT00082433|80271534|FG000|Overall Study|Disease Progression/Relapse|270|||
27569330|NCT00082433|80271535|FG001|Overall Study|Disease Progression/Relapse|388|||
27569331|NCT00082433|80271534|FG000|Overall Study|Physician Decision|50|||
27569332|NCT00082433|80271535|FG001|Overall Study|Physician Decision|61|||
27569333|NCT00082433|80271534|FG000|Overall Study|Lost to Follow-up|1|||
27569334|NCT00082433|80271535|FG001|Overall Study|Lost to Follow-up|2|||
27569335|NCT00082433|80271534|FG000|Overall Study|Study Drug Toxicity|179|||
27569336|NCT00082433|80271535|FG001|Overall Study|Study Drug Toxicity|66|||
27569337|NCT00082433|80271534|FG000|Overall Study|Withdrawal by Subject|55|||
27569338|NCT00082433|80271535|FG001|Overall Study|Withdrawal by Subject|30|||
27569339|NCT00082433|80271534|FG000|Overall Study|Still On Treatment|2|||
27569340|NCT00082433|80271535|FG001|Overall Study|Still On Treatment|1|||
27773565|NCT04539262|80999497|FG000|Overall Study|Withdrew Consent|0|||
27773566|NCT04539262|80999498|FG001|Overall Study|Withdrew Consent|0|||
27773567|NCT04539262|80999499|FG002|Overall Study|Withdrew Consent|0|||
27773568|NCT04539262|80999500|FG003|Overall Study|Withdrew Consent|1|||
27773569|NCT04539262|80999501|FG004|Overall Study|Withdrew Consent|0|||
27773570|NCT04539262|80999502|FG005|Overall Study|Withdrew Consent|0|||
27773571|NCT04539262|80999503|FG006|Overall Study|Withdrew Consent|0|||
27773572|NCT04539262|80999504|FG007|Overall Study|Withdrew Consent|0|||
27773573|NCT04539262|80999497|FG000|Overall Study|Randomized, Not treated|0|||
27773574|NCT04539262|80999498|FG001|Overall Study|Randomized, Not treated|1|||
27569341|NCT00082433|80271534|FG000|Overall Study|Not Treated|12|||
27569342|NCT00082433|80271535|FG001|Overall Study|Not Treated|11|||
27569343|NCT00082433|80271534|FG000|Overall Study|Ineligible|2|||
27569344|NCT00082433|80271535|FG001|Overall Study|Ineligible|1|||
27569345|NCT00082433|80271534|FG000|Overall Study|Noncompliance|2|||
27569346|NCT00082433|80271535|FG001|Overall Study|Noncompliance|1|||
27569347|NCT00082433|80271534|FG000|Overall Study|New primary cancer|1|||
27569348|NCT00082433|80271535|FG001|Overall Study|New primary cancer|0|||
27569349|NCT00082433|80271534|FG000|Overall Study|Impending surgery|0|||
27569350|NCT00082433|80271535|FG001|Overall Study|Impending surgery|1|||
27569351|NCT04907032|80271537|FG000|Overall Study|Withdrawal by Subject|7|||
27569352|NCT04907032|80271538|FG001|Overall Study|Withdrawal by Subject|1|||
27569353|NCT03090100|80271539|FG000|Overall Study|Adverse Event|9|||
27569354|NCT03090100|80271540|FG001|Overall Study|Adverse Event|11|||
27569355|NCT03090100|80271539|FG000|Overall Study|Pregnancy|1|||
27569356|NCT03090100|80271540|FG001|Overall Study|Pregnancy|1|||
27569357|NCT03090100|80271539|FG000|Overall Study|Lack of Efficacy|2|||
27569358|NCT03090100|80271540|FG001|Overall Study|Lack of Efficacy|7|||
27569359|NCT03090100|80271539|FG000|Overall Study|Lost to Follow-up|2|||
27569360|NCT03090100|80271540|FG001|Overall Study|Lost to Follow-up|2|||
27569361|NCT03090100|80271539|FG000|Overall Study|Withdrawal by Subject|7|||
27569362|NCT03090100|80271540|FG001|Overall Study|Withdrawal by Subject|19|||
27569363|NCT03090100|80271539|FG000|Overall Study|Protocol Violation|2|||
27569364|NCT03090100|80271540|FG001|Overall Study|Protocol Violation|6|||
27569365|NCT03090100|80271539|FG000|Overall Study|Non-compliance|2|||
27569366|NCT03090100|80271540|FG001|Overall Study|Non-compliance|0|||
27569367|NCT03090100|80271539|FG000|Overall Study|Other|2|||
27569368|NCT03090100|80271540|FG001|Overall Study|Other|2|||
27569369|NCT02552316|80271543|FG000|Overall Study|Withdrawal by Subject|1|||
27569370|NCT02552316|80271543|FG000|Overall Study|Withdrawal due to non-compliance|1|||
27569371|NCT00096044|80275125|FG000|Overall Study|Withdrawal by Subject|9|||
27569372|NCT00096044|80275125|FG000|Overall Study|Adverse Event|21|||
27569373|NCT00096044|80275125|FG000|Overall Study|Disease Progression|4|||
27569374|NCT01600586|80275136|FG000|Overall Study|Physician Decision|3|||
27569375|NCT01600586|80275137|FG001|Overall Study|Physician Decision|3|||
27569376|NCT00964392|80275138|FG000|Overall Study|Withdrawal by Subject|4|||
27569377|NCT00964392|80275139|FG001|Overall Study|Withdrawal by Subject|6|||
27569378|NCT00964392|80275138|FG000|Overall Study|Lost to Follow-up|4|||
27569379|NCT00964392|80275139|FG001|Overall Study|Lost to Follow-up|10|||
27569380|NCT00964392|80275138|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
27569381|NCT00964392|80275139|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
27569382|NCT00964392|80275138|FG000|Overall Study|Not completed|44|||
27569383|NCT00964392|80275139|FG001|Overall Study|Not completed|168|||
27569384|NCT00159588|80275140|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
27569385|NCT00159588|80275141|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
27773575|NCT04539262|80999499|FG002|Overall Study|Randomized, Not treated|0|||
27773576|NCT04539262|80999500|FG003|Overall Study|Randomized, Not treated|0|||
27773577|NCT04539262|80999501|FG004|Overall Study|Randomized, Not treated|0|||
27886624|NCT00619892|81418126|FG001|Overall Study|Intercurrent illness|1|||
27569386|NCT00159588|80275142|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
27569387|NCT00508742|80275143|FG000|Period 1: Infant Series|Adverse Event|5|||
27773578|NCT04539262|80999502|FG005|Overall Study|Randomized, Not treated|0|||
27773579|NCT04539262|80999503|FG006|Overall Study|Randomized, Not treated|1|||
27965680|NCT02921230|81704684|FG001|Overall Study|Death|3|||
27965681|NCT02921230|81704683|FG000|Overall Study|Protocol Violation|17|||
27965682|NCT02921230|81704684|FG001|Overall Study|Protocol Violation|6|||
27773580|NCT04539262|80999504|FG007|Overall Study|Randomized, Not treated|0|||
27773581|NCT01764022|80999505|FG000|Overall Study|Death|3|||
27773582|NCT01764022|80999506|FG001|Overall Study|Death|5|||
27773583|NCT01764022|80999505|FG000|Overall Study|Withdrawal by Subject|2|||
27773584|NCT01764022|80999506|FG001|Overall Study|Withdrawal by Subject|6|||
27773585|NCT01764022|80999505|FG000|Overall Study|Lack of Efficacy|0|||
27773586|NCT01764022|80999506|FG001|Overall Study|Lack of Efficacy|1|||
27773587|NCT01764022|80999505|FG000|Overall Study|Physician Decision|0|||
27773588|NCT01764022|80999506|FG001|Overall Study|Physician Decision|2|||
27773589|NCT01764022|80999505|FG000|Overall Study|Lost to Follow-up|2|||
27773590|NCT01764022|80999506|FG001|Overall Study|Lost to Follow-up|0|||
27773591|NCT01764022|80999505|FG000|Overall Study|Protocol Violation|1|||
27773592|NCT01764022|80999506|FG001|Overall Study|Protocol Violation|0|||
27773593|NCT05104749|80999509|FG000|Overall Study|Lost to Follow-up|2|||
27773594|NCT05104749|80999510|FG001|Overall Study|Lost to Follow-up|3|||
27773595|NCT01268514|80999511|FG000|Overall Study|Adverse Event|20|||
27773596|NCT01268514|80999511|FG000|Overall Study|Death|8|||
27773597|NCT01268514|80999511|FG000|Overall Study|Lost to Follow-up|5|||
27773598|NCT01268514|80999511|FG000|Overall Study|Withdrawal by Subject|3|||
27773599|NCT01268514|80999511|FG000|Overall Study|Withdrawal by Surgeon|5|||
27773600|NCT01929018|80999514|FG000|Overall Study|Lost to Follow-up|1|||
27773601|NCT01929018|80999515|FG001|Overall Study|Lost to Follow-up|0|||
27773602|NCT01929018|80999514|FG000|Overall Study|Hospitalization|0|||
27773603|NCT01929018|80999515|FG001|Overall Study|Hospitalization|1|||
27773604|NCT02728206|80999518|FG000|Overall Study|Death|1|||
27773605|NCT00441012|80999519|FG000|Overall Study|Adverse Event|0|||
27773606|NCT00441012|80999520|FG001|Overall Study|Adverse Event|1|||
27773607|NCT00441012|80999519|FG000|Overall Study|Lost to Follow-up|3|||
27773608|NCT00441012|80999520|FG001|Overall Study|Lost to Follow-up|3|||
27773609|NCT00441012|80999519|FG000|Overall Study|Protocol Violation|10|||
27773610|NCT00441012|80999520|FG001|Overall Study|Protocol Violation|9|||
27773611|NCT00441012|80999519|FG000|Overall Study|Withdrawal by Subject|4|||
27773612|NCT00441012|80999520|FG001|Overall Study|Withdrawal by Subject|0|||
27773613|NCT00441012|80999519|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
27773614|NCT00441012|80999520|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
27773615|NCT03099304|80999521|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
27773616|NCT03099304|80999522|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
27773617|NCT03099304|80999523|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
27773618|NCT03099304|80999524|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
27773619|NCT03099304|80999525|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
27773620|NCT03099304|80999526|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
27773621|NCT03099304|80999521|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
27773622|NCT03099304|80999522|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
27773623|NCT03099304|80999523|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
27773624|NCT03099304|80999524|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
27773625|NCT03099304|80999525|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
27773626|NCT03099304|80999526|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
27773627|NCT03099304|80999521|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
27773628|NCT03099304|80999522|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
27773629|NCT03099304|80999523|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
27773630|NCT03099304|80999524|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
27773631|NCT03099304|80999525|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
27773632|NCT03099304|80999526|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
27773633|NCT03099304|80999521|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
27773634|NCT03099304|80999522|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
27773635|NCT03099304|80999523|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
27773636|NCT03099304|80999524|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
27773637|NCT03099304|80999525|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
27773638|NCT03099304|80999526|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
27773639|NCT03099304|80999521|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
27773640|NCT03099304|80999522|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
27773641|NCT03099304|80999523|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
27773642|NCT03099304|80999524|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
27773643|NCT03099304|80999525|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
27773644|NCT03099304|80999526|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
27773645|NCT03099304|80999521|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
27773646|NCT03099304|80999522|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
27773647|NCT03099304|80999523|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
27773648|NCT03099304|80999524|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
27965683|NCT02921230|81704683|FG000|Overall Study|Early completion|5|||
27965684|NCT02921230|81704684|FG001|Overall Study|Early completion|1|||
27773649|NCT03099304|80999525|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
27773650|NCT03099304|80999526|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
27773651|NCT03099304|80999521|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
27773652|NCT03099304|80999522|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
27773653|NCT03099304|80999523|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
27773654|NCT03099304|80999524|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
27773655|NCT03099304|80999525|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
27773656|NCT03099304|80999526|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
27773657|NCT03099304|80999521|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
27773658|NCT03099304|80999522|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
27773659|NCT03099304|80999523|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
27773660|NCT03099304|80999524|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
27773661|NCT03099304|80999525|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
27773662|NCT03099304|80999526|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
27773663|NCT03099304|80999521|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
27773664|NCT03099304|80999522|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
27773665|NCT03099304|80999523|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
27773666|NCT03099304|80999524|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
27773667|NCT03099304|80999525|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
27773668|NCT03099304|80999526|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
27773669|NCT03099304|80999521|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
27773670|NCT03099304|80999522|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
27773671|NCT03099304|80999523|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
27773672|NCT03099304|80999524|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
27773673|NCT03099304|80999525|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
27773674|NCT03099304|80999526|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
27773675|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
27773676|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
27773677|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
27773678|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
27773679|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
27773680|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
27773681|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
27773682|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
27773683|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
27773684|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
27773685|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
27773686|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
27773687|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
27773688|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
27773689|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
27773690|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
27773691|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
27773692|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
27773693|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
27773694|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
27773695|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
27773696|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
27773697|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
27773698|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
27773699|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
27773700|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
27773701|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
27773702|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
27773703|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
27773704|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
27773705|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
27773706|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
27773707|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
27773708|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
27773709|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
27773710|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
27773711|NCT03099304|80999521|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
27773712|NCT03099304|80999522|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
27773713|NCT03099304|80999523|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
27569388|NCT00508742|80275144|FG001|Period 1: Infant Series|Adverse Event|4|||
27773714|NCT03099304|80999524|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
27965685|NCT02921230|81704683|FG000|Overall Study|Pending data entry|1|||
27664509|NCT00332488|80609433|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
27664510|NCT00332488|80609434|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
27664511|NCT00332488|80609432|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
27664512|NCT00332488|80609433|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
27664513|NCT00332488|80609434|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
27664514|NCT00332488|80609432|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
27664515|NCT00332488|80609433|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
27664516|NCT00332488|80609434|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
27664517|NCT01705145|80609435|FG000|Part B|Adverse Event|1|||
27664518|NCT00468858|80609438|FG000|Overall Study|Adverse Event|0|||
27664519|NCT00468858|80609439|FG001|Overall Study|Adverse Event|1|||
27773715|NCT03099304|80999525|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
27773716|NCT03099304|80999526|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
27773717|NCT01235338|80999527|FG000|Overall Study|Adverse Event|3|||
27773718|NCT01235338|80999528|FG001|Overall Study|Adverse Event|2|||
27773719|NCT01235338|80999527|FG000|Overall Study|Protocol Violation|1|||
27773720|NCT01235338|80999528|FG001|Overall Study|Protocol Violation|1|||
27773721|NCT01235338|80999527|FG000|Overall Study|Withdrawal by Subject|5|||
27664520|NCT00468858|80609440|FG002|Overall Study|Adverse Event|0|||
27664521|NCT00468858|80609438|FG000|Overall Study|Withdrawal by Subject|7|||
27664522|NCT00468858|80609439|FG001|Overall Study|Withdrawal by Subject|4|||
27664523|NCT00468858|80609440|FG002|Overall Study|Withdrawal by Subject|5|||
27664524|NCT00468858|80609438|FG000|Overall Study|Relocation|1|||
27664525|NCT00468858|80609439|FG001|Overall Study|Relocation|3|||
27664526|NCT00468858|80609440|FG002|Overall Study|Relocation|3|||
27664527|NCT00468858|80609438|FG000|Overall Study|Lost to Follow-up|1|||
27664528|NCT00468858|80609439|FG001|Overall Study|Lost to Follow-up|2|||
27664529|NCT00468858|80609440|FG002|Overall Study|Lost to Follow-up|5|||
27664530|NCT00468858|80609438|FG000|Overall Study|Other|0|||
27664531|NCT00468858|80609439|FG001|Overall Study|Other|0|||
27664532|NCT00468858|80609440|FG002|Overall Study|Other|1|||
27664533|NCT00802438|80609443|FG000|Overall Study|Screen Failure|20|||
27664534|NCT00802438|80609443|FG000|Overall Study|Withdrawal by Subject|7|||
27664535|NCT00802438|80609443|FG000|Overall Study|Physician Decision|1|||
27664536|NCT05600036|80609444|FG000|Overall Study|Adverse Event|0|||
27664537|NCT05600036|80609445|FG001|Overall Study|Adverse Event|2|||
27664538|NCT05600036|80609446|FG002|Overall Study|Adverse Event|1|||
27664539|NCT05600036|80609447|FG003|Overall Study|Adverse Event|0|||
27664540|NCT05600036|80609448|FG004|Overall Study|Adverse Event|1|||
27664541|NCT05600036|80609449|FG005|Overall Study|Adverse Event|0|||
27664542|NCT05600036|80609444|FG000|Overall Study|Lost to Follow-up|0|||
27664543|NCT05600036|80609445|FG001|Overall Study|Lost to Follow-up|2|||
27664544|NCT05600036|80609446|FG002|Overall Study|Lost to Follow-up|1|||
27664545|NCT05600036|80609447|FG003|Overall Study|Lost to Follow-up|1|||
27664546|NCT05600036|80609448|FG004|Overall Study|Lost to Follow-up|0|||
27664547|NCT05600036|80609449|FG005|Overall Study|Lost to Follow-up|0|||
27664548|NCT05600036|80609444|FG000|Overall Study|Protocol Violation|0|||
27664549|NCT05600036|80609445|FG001|Overall Study|Protocol Violation|0|||
27664550|NCT05600036|80609446|FG002|Overall Study|Protocol Violation|2|||
27664551|NCT05600036|80609447|FG003|Overall Study|Protocol Violation|0|||
27664552|NCT05600036|80609448|FG004|Overall Study|Protocol Violation|0|||
27664553|NCT05600036|80609449|FG005|Overall Study|Protocol Violation|0|||
27664554|NCT05600036|80609444|FG000|Overall Study|Withdrawal by Subject|0|||
27664555|NCT05600036|80609445|FG001|Overall Study|Withdrawal by Subject|1|||
27664556|NCT05600036|80609446|FG002|Overall Study|Withdrawal by Subject|2|||
27664557|NCT05600036|80609447|FG003|Overall Study|Withdrawal by Subject|0|||
27664558|NCT05600036|80609448|FG004|Overall Study|Withdrawal by Subject|3|||
27664559|NCT05600036|80609449|FG005|Overall Study|Withdrawal by Subject|5|||
27773722|NCT01235338|80999528|FG001|Overall Study|Withdrawal by Subject|0|||
27773723|NCT01235338|80999527|FG000|Overall Study|Exclusion criteria violations|1|||
27886625|NCT01938430|81418136|FG000|Overall Study|Randomized but Not Treated|0|||
27965686|NCT02921230|81704684|FG001|Overall Study|Pending data entry|0|||
27664560|NCT05600036|80609444|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
27664561|NCT05600036|80609445|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
27664562|NCT05600036|80609446|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
27664563|NCT05600036|80609447|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
27664564|NCT05600036|80609448|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
27773724|NCT01235338|80999528|FG001|Overall Study|Exclusion criteria violations|1|||
27773725|NCT01235338|80999527|FG000|Overall Study|Positive drug screen|0|||
27773726|NCT01235338|80999528|FG001|Overall Study|Positive drug screen|1|||
27664565|NCT05600036|80609449|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
27773727|NCT01235338|80999527|FG000|Overall Study|Prohibited meds|1|||
27773728|NCT01235338|80999528|FG001|Overall Study|Prohibited meds|0|||
27664566|NCT05600036|80609444|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
27773729|NCT01867580|80999529|FG000|Overall Study|Withdrawal by Subject|2|||
27773730|NCT01867580|80999530|FG001|Overall Study|Withdrawal by Subject|3|||
27773731|NCT01867580|80999529|FG000|Overall Study|Physician Decision|17|||
27773732|NCT01867580|80999530|FG001|Overall Study|Physician Decision|12|||
27773733|NCT01867580|80999529|FG000|Overall Study|Lost to Follow-up|3|||
27773734|NCT01867580|80999530|FG001|Overall Study|Lost to Follow-up|5|||
27773735|NCT01867580|80999529|FG000|Overall Study|Sponsor terminated study|1|||
27773736|NCT01867580|80999530|FG001|Overall Study|Sponsor terminated study|0|||
27773737|NCT01867580|80999529|FG000|Overall Study|Missed follow-up assessment|2|||
27773738|NCT01867580|80999530|FG001|Overall Study|Missed follow-up assessment|1|||
27773739|NCT01867580|80999529|FG000|Overall Study|Interruption to therapy|3|||
27773740|NCT01867580|80999530|FG001|Overall Study|Interruption to therapy|0|||
27773741|NCT01867580|80999529|FG000|Overall Study|Osteomyelitis|0|||
27773742|NCT01867580|80999530|FG001|Overall Study|Osteomyelitis|1|||
27773743|NCT01867580|80999529|FG000|Overall Study|Continuation of therapy|0|||
27773744|NCT01867580|80999530|FG001|Overall Study|Continuation of therapy|1|||
27773745|NCT01867580|80999529|FG000|Overall Study|Wound recurrence|0|||
27773746|NCT01867580|80999530|FG001|Overall Study|Wound recurrence|1|||
27773747|NCT00832091|81002824|FG000|Overall Study|Adverse Event|1|||
27773748|NCT00832091|81002825|FG001|Overall Study|Adverse Event|1|||
27773749|NCT00832091|81002824|FG000|Overall Study|Protocol Violation|1|||
27773750|NCT00832091|81002825|FG001|Overall Study|Protocol Violation|0|||
27773751|NCT00832091|81002824|FG000|Overall Study|Withdrawal by Subject|2|||
27773752|NCT00832091|81002825|FG001|Overall Study|Withdrawal by Subject|1|||
27773753|NCT00832091|81002824|FG000|Overall Study|Prohibited Medication|1|||
27773754|NCT00832091|81002825|FG001|Overall Study|Prohibited Medication|0|||
27773755|NCT03152110|81002826|FG000|Overall Study|Withdrawal by Subject|3|||
27773756|NCT02623699|81002828|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773757|NCT02623699|81002829|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
27773758|NCT02623699|81002830|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773759|NCT02623699|81002831|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773760|NCT02623699|81002832|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773761|NCT02623699|81002833|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773762|NCT02623699|81002834|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773763|NCT02623699|81002835|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773764|NCT02623699|81002836|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773765|NCT02623699|81002837|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773766|NCT02623699|81002838|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773767|NCT02623699|81002839|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
27773768|NCT02623699|81002828|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773769|NCT02623699|81002829|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773770|NCT02623699|81002830|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773771|NCT02623699|81002831|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773772|NCT02623699|81002832|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773773|NCT02623699|81002833|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773774|NCT02623699|81002834|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
27773775|NCT02623699|81002835|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773776|NCT02623699|81002836|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773777|NCT02623699|81002837|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773778|NCT02623699|81002838|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773779|NCT02623699|81002839|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
27773780|NCT02623699|81002828|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773781|NCT02623699|81002829|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773782|NCT02623699|81002830|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773783|NCT02623699|81002831|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773784|NCT02623699|81002832|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773785|NCT02623699|81002833|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
27773786|NCT02623699|81002834|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773787|NCT02623699|81002835|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773788|NCT02623699|81002836|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773789|NCT02623699|81002837|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773790|NCT02623699|81002838|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773791|NCT02623699|81002839|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
27773792|NCT02623699|81002828|FG000|Part B (Up to 289 Days)|Death|0|||
27773793|NCT02623699|81002829|FG001|Part B (Up to 289 Days)|Death|0|||
27773794|NCT02623699|81002830|FG002|Part B (Up to 289 Days)|Death|0|||
27773795|NCT02623699|81002831|FG003|Part B (Up to 289 Days)|Death|0|||
27773796|NCT02623699|81002832|FG004|Part B (Up to 289 Days)|Death|0|||
27773797|NCT02623699|81002833|FG005|Part B (Up to 289 Days)|Death|1|||
27773798|NCT02623699|81002834|FG006|Part B (Up to 289 Days)|Death|1|||
27773799|NCT02623699|81002835|FG007|Part B (Up to 289 Days)|Death|0|||
27773800|NCT02623699|81002836|FG008|Part B (Up to 289 Days)|Death|1|||
27773801|NCT02623699|81002837|FG009|Part B (Up to 289 Days)|Death|0|||
27773802|NCT02623699|81002838|FG010|Part B (Up to 289 Days)|Death|0|||
27773803|NCT02623699|81002839|FG011|Part B (Up to 289 Days)|Death|0|||
27773804|NCT02623699|81002828|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
27773805|NCT02623699|81002829|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
27773806|NCT02623699|81002830|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
27773807|NCT02623699|81002831|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
27773808|NCT02623699|81002832|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
27773809|NCT02623699|81002833|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
27773810|NCT02623699|81002834|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
27773811|NCT02623699|81002835|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
27773812|NCT02623699|81002836|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
27773813|NCT02623699|81002837|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
27773814|NCT02623699|81002838|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
27773815|NCT02623699|81002839|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
27773816|NCT02623699|81002828|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773817|NCT02623699|81002829|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773818|NCT02623699|81002830|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773819|NCT02623699|81002831|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773820|NCT02623699|81002832|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773821|NCT02623699|81002833|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773822|NCT02623699|81002834|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27965687|NCT04551898|81704685|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
27965688|NCT04551898|81704686|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
27965689|NCT04551898|81704687|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
27965690|NCT04551898|81704688|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
27965691|NCT04551898|81704685|FG000|Overall Study|Withdrawal by Subject|5|||
27965692|NCT04551898|81704686|FG001|Overall Study|Withdrawal by Subject|1|||
27965693|NCT04551898|81704687|FG002|Overall Study|Withdrawal by Subject|2|||
27965694|NCT04551898|81704688|FG003|Overall Study|Withdrawal by Subject|2|||
27965695|NCT04551898|81704685|FG000|Overall Study|Lost to Follow-up|2|||
27965696|NCT04551898|81704686|FG001|Overall Study|Lost to Follow-up|1|||
27965697|NCT04551898|81704687|FG002|Overall Study|Lost to Follow-up|2|||
27773823|NCT02623699|81002835|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773824|NCT02623699|81002836|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773825|NCT02623699|81002837|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
27773826|NCT02623699|81002838|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
27773827|NCT02623699|81002839|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
27773828|NCT02623699|81002828|FG000|Part C (Up to 236 Days)|Death|0|||
27773829|NCT02623699|81002829|FG001|Part C (Up to 236 Days)|Death|0|||
27773830|NCT02623699|81002830|FG002|Part C (Up to 236 Days)|Death|0|||
27773831|NCT02623699|81002831|FG003|Part C (Up to 236 Days)|Death|0|||
27773832|NCT02623699|81002832|FG004|Part C (Up to 236 Days)|Death|0|||
27773833|NCT02623699|81002833|FG005|Part C (Up to 236 Days)|Death|0|||
27773834|NCT02623699|81002834|FG006|Part C (Up to 236 Days)|Death|0|||
27773835|NCT02623699|81002835|FG007|Part C (Up to 236 Days)|Death|0|||
27773836|NCT02623699|81002836|FG008|Part C (Up to 236 Days)|Death|0|||
27773837|NCT02623699|81002837|FG009|Part C (Up to 236 Days)|Death|0|||
27773838|NCT02623699|81002838|FG010|Part C (Up to 236 Days)|Death|0|||
27773839|NCT02623699|81002839|FG011|Part C (Up to 236 Days)|Death|1|||
27773840|NCT02623699|81002828|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
27773841|NCT02623699|81002829|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
27773842|NCT02623699|81002830|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
27773843|NCT02623699|81002831|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
27773844|NCT02623699|81002832|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
27773845|NCT02623699|81002833|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
27773846|NCT02623699|81002834|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
27773847|NCT02623699|81002835|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
27773848|NCT02623699|81002836|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
27773849|NCT02623699|81002837|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
27773850|NCT02623699|81002838|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
27773851|NCT02623699|81002839|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
27965698|NCT04551898|81704688|FG003|Overall Study|Lost to Follow-up|2|||
27965699|NCT04551898|81704685|FG000|Overall Study|Death|1|||
27773852|NCT01983683|81002841|FG000|Overall Study|Withdrawal by Subject|14|||
27773853|NCT01983683|81002842|FG001|Overall Study|Withdrawal by Subject|18|||
27773854|NCT01983683|81002841|FG000|Overall Study|Death|11|||
27773855|NCT01983683|81002842|FG001|Overall Study|Death|15|||
27773856|NCT01983683|81002841|FG000|Overall Study|Physician Decision|8|||
27773857|NCT01983683|81002842|FG001|Overall Study|Physician Decision|9|||
27773858|NCT01983683|81002841|FG000|Overall Study|Lost to Follow-up|4|||
27773859|NCT01983683|81002842|FG001|Overall Study|Lost to Follow-up|8|||
27773860|NCT01983683|81002841|FG000|Overall Study|Sponsor Decision|1|||
27773861|NCT01983683|81002842|FG001|Overall Study|Sponsor Decision|1|||
27965700|NCT04551898|81704686|FG001|Overall Study|Death|0|||
27965701|NCT04551898|81704687|FG002|Overall Study|Death|0|||
27773862|NCT04624672|81002845|FG000|Overall Study|Early Study Closure|2|||
27773863|NCT04624672|81002846|FG001|Overall Study|Early Study Closure|1|||
27773864|NCT02415595|81002849|FG000|Overall Study|Administrative reason by sponsor|39|||
27773865|NCT02415595|81002850|FG001|Overall Study|Administrative reason by sponsor|40|||
27773866|NCT02415595|81002851|FG002|Overall Study|Administrative reason by sponsor|41|||
27773867|NCT02415595|81002852|FG003|Overall Study|Administrative reason by sponsor|39|||
27773868|NCT02415595|81002849|FG000|Overall Study|Adverse Event|1|||
27773869|NCT02415595|81002850|FG001|Overall Study|Adverse Event|3|||
27773870|NCT02415595|81002851|FG002|Overall Study|Adverse Event|5|||
27773871|NCT02415595|81002852|FG003|Overall Study|Adverse Event|10|||
27773872|NCT02415595|81002849|FG000|Overall Study|Lack of Efficacy|4|||
27773873|NCT02415595|81002850|FG001|Overall Study|Lack of Efficacy|4|||
27773874|NCT02415595|81002851|FG002|Overall Study|Lack of Efficacy|0|||
27773875|NCT02415595|81002852|FG003|Overall Study|Lack of Efficacy|0|||
27773876|NCT02415595|81002849|FG000|Overall Study|Lost to Follow-up|1|||
27773877|NCT02415595|81002850|FG001|Overall Study|Lost to Follow-up|3|||
27773878|NCT02415595|81002851|FG002|Overall Study|Lost to Follow-up|1|||
27773879|NCT02415595|81002852|FG003|Overall Study|Lost to Follow-up|1|||
27773880|NCT02415595|81002849|FG000|Overall Study|Poor/Non-compliance|1|||
27773881|NCT02415595|81002850|FG001|Overall Study|Poor/Non-compliance|0|||
27773882|NCT02415595|81002851|FG002|Overall Study|Poor/Non-compliance|1|||
27773883|NCT02415595|81002852|FG003|Overall Study|Poor/Non-compliance|0|||
27773884|NCT02415595|81002849|FG000|Overall Study|Reached stopping criteria|0|||
27773885|NCT02415595|81002850|FG001|Overall Study|Reached stopping criteria|1|||
27773886|NCT02415595|81002851|FG002|Overall Study|Reached stopping criteria|1|||
27773887|NCT02415595|81002852|FG003|Overall Study|Reached stopping criteria|0|||
27773888|NCT02415595|81002849|FG000|Overall Study|Withdrawal by Subject|4|||
27773889|NCT02415595|81002850|FG001|Overall Study|Withdrawal by Subject|0|||
27773890|NCT02415595|81002851|FG002|Overall Study|Withdrawal by Subject|1|||
27773891|NCT02415595|81002852|FG003|Overall Study|Withdrawal by Subject|3|||
27773892|NCT02415595|81002849|FG000|Overall Study|Other|0|||
27773893|NCT02415595|81002850|FG001|Overall Study|Other|1|||
27773894|NCT02415595|81002851|FG002|Overall Study|Other|1|||
27773895|NCT02415595|81002852|FG003|Overall Study|Other|0|||
27773896|NCT04432376|81002853|FG000|Double-blind Treatment Period|Adverse Event|2|||
27773897|NCT04432376|81002854|FG001|Double-blind Treatment Period|Adverse Event|6|||
27773898|NCT04432376|81002855|FG002|Double-blind Treatment Period|Adverse Event|0|||
27773899|NCT04432376|81002853|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
27773900|NCT04432376|81002854|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27773901|NCT04432376|81002855|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27773902|NCT04432376|81002853|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27773903|NCT04432376|81002854|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27773904|NCT04432376|81002855|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27773905|NCT04432376|81002853|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27773906|NCT04432376|81002854|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27773907|NCT04432376|81002855|FG002|Double-blind Treatment Period|Protocol Violation|0|||
27773908|NCT04432376|81002853|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
27773909|NCT04432376|81002854|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
27773910|NCT04432376|81002855|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
27773911|NCT01518309|81002858|FG000|Overall Study|Adverse Event|6|||
27773912|NCT01518309|81002858|FG000|Overall Study|Death|6|||
27773913|NCT01518309|81002858|FG000|Overall Study|Lack of Efficacy|7|||
27773914|NCT01518309|81002858|FG000|Overall Study|Withdrawal by Subject|6|||
27773915|NCT01518309|81002858|FG000|Overall Study|Physician Decision|3|||
27773916|NCT01518309|81002858|FG000|Overall Study|Sponsor Decision|2|||
27773917|NCT01518309|81002858|FG000|Overall Study|Not in Predefined Categories|9|||
27773918|NCT00149890|81002859|FG000|Overall Study|Adverse Event|1|||
27773919|NCT00149890|81002860|FG001|Overall Study|Adverse Event|8|||
27773920|NCT00149890|81002859|FG000|Overall Study|Lack of Efficacy|8|||
27773921|NCT00149890|81002860|FG001|Overall Study|Lack of Efficacy|9|||
27773922|NCT00149890|81002859|FG000|Overall Study|Protocol Violation|1|||
27773923|NCT00149890|81002860|FG001|Overall Study|Protocol Violation|0|||
27773924|NCT00149890|81002859|FG000|Overall Study|Lost to Follow-up|1|||
27965702|NCT04551898|81704688|FG003|Overall Study|Death|0|||
27773925|NCT00149890|81002860|FG001|Overall Study|Lost to Follow-up|0|||
27773926|NCT00149890|81002859|FG000|Overall Study|Graft Loss|2|||
27773927|NCT00149890|81002860|FG001|Overall Study|Graft Loss|1|||
27773928|NCT00402285|81002862|FG000|Overall Study|insufficient RNA quality|7|||
27773929|NCT00402285|81002863|FG001|Overall Study|insufficient RNA quality|6|||
27773930|NCT00402285|81002864|FG002|Overall Study|insufficient RNA quality|2|||
27773931|NCT00063986|81002865|FG000|Overall Study|Withdrawal by Subject|1|||
27773932|NCT00063986|81002865|FG000|Overall Study|Ineligible|1|||
27773933|NCT00063986|81002865|FG000|Overall Study|Intra-operatively ineligible|4|||
27773934|NCT01387074|81002874|FG000|Overall Study|Lost to Follow-up|7|||
27773935|NCT01387074|81002874|FG000|Overall Study|Lack of Efficacy|1|||
27773936|NCT03073200|81002877|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27773937|NCT03073200|81002878|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27773938|NCT03073200|81002879|FG002|Double Blind Treatment Period|Protocol Violation|0|||
27773939|NCT03073200|81002880|FG003|Double Blind Treatment Period|Protocol Violation|0|||
27773940|NCT03073200|81002881|FG004|Double Blind Treatment Period|Protocol Violation|0|||
27773941|NCT03073200|81002882|FG005|Double Blind Treatment Period|Protocol Violation|0|||
27773942|NCT03073200|81002883|FG006|Double Blind Treatment Period|Protocol Violation|0|||
27773943|NCT03073200|81002884|FG007|Double Blind Treatment Period|Protocol Violation|0|||
27773944|NCT03073200|81002885|FG008|Double Blind Treatment Period|Protocol Violation|0|||
27773945|NCT03073200|81002886|FG009|Double Blind Treatment Period|Protocol Violation|0|||
27773946|NCT03073200|81002887|FG010|Double Blind Treatment Period|Protocol Violation|0|||
27773947|NCT03073200|81002888|FG011|Double Blind Treatment Period|Protocol Violation|0|||
27773948|NCT03073200|81002889|FG012|Double Blind Treatment Period|Protocol Violation|0|||
27773949|NCT03073200|81002890|FG013|Double Blind Treatment Period|Protocol Violation|0|||
27773950|NCT03073200|81002891|FG014|Double Blind Treatment Period|Protocol Violation|0|||
27773951|NCT03073200|81002877|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773952|NCT03073200|81002878|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
27773953|NCT03073200|81002879|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773954|NCT03073200|81002880|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773955|NCT03073200|81002881|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773956|NCT03073200|81002882|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773957|NCT03073200|81002883|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773958|NCT03073200|81002884|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773959|NCT03073200|81002885|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773960|NCT03073200|81002886|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773961|NCT03073200|81002887|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773962|NCT03073200|81002888|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773963|NCT03073200|81002889|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773964|NCT03073200|81002890|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773965|NCT03073200|81002891|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
27773966|NCT03073200|81002877|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
27773967|NCT03073200|81002878|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773968|NCT03073200|81002879|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773969|NCT03073200|81002880|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773970|NCT03073200|81002881|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773971|NCT03073200|81002882|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773972|NCT03073200|81002883|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773973|NCT03073200|81002884|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773974|NCT03073200|81002885|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773975|NCT03073200|81002886|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773976|NCT03073200|81002887|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773977|NCT03073200|81002888|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773978|NCT03073200|81002889|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773979|NCT03073200|81002890|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773980|NCT03073200|81002891|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
27773981|NCT03073200|81002877|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773982|NCT03073200|81002878|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773983|NCT03073200|81002879|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773984|NCT03073200|81002880|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
27773985|NCT03073200|81002881|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
27773986|NCT03073200|81002882|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773987|NCT03073200|81002883|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773988|NCT03073200|81002884|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773989|NCT03073200|81002885|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773990|NCT03073200|81002886|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773991|NCT03073200|81002887|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
27569389|NCT00508742|80275143|FG000|Period 1: Infant Series|Protocol Violation|1|||
27569390|NCT00508742|80275144|FG001|Period 1: Infant Series|Protocol Violation|0|||
27773992|NCT03073200|81002888|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773993|NCT03073200|81002889|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773994|NCT03073200|81002890|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773995|NCT03073200|81002891|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
27773996|NCT03073200|81002877|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
27773997|NCT03073200|81002878|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
27773998|NCT03073200|81002879|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
27773999|NCT03073200|81002880|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
27774000|NCT03073200|81002881|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
27774001|NCT03073200|81002882|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
27774002|NCT03073200|81002883|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
27774003|NCT03073200|81002884|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
27774004|NCT03073200|81002885|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
27774005|NCT03073200|81002886|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
27774006|NCT03073200|81002887|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
27774007|NCT03073200|81002888|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
27774008|NCT03073200|81002889|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
27774009|NCT03073200|81002890|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
27774010|NCT03073200|81002891|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
27774011|NCT03073200|81002877|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774012|NCT03073200|81002878|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774013|NCT03073200|81002879|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774014|NCT03073200|81002880|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774015|NCT03073200|81002881|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
27774016|NCT03073200|81002882|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774017|NCT03073200|81002883|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774018|NCT03073200|81002884|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774019|NCT03073200|81002885|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774020|NCT03073200|81002886|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774021|NCT03073200|81002887|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774022|NCT03073200|81002888|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774023|NCT03073200|81002889|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774024|NCT03073200|81002890|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774025|NCT03073200|81002891|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
27774026|NCT03073200|81002877|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774027|NCT03073200|81002878|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774028|NCT03073200|81002879|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774029|NCT03073200|81002880|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
27774030|NCT03073200|81002881|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
27774031|NCT03073200|81002882|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774032|NCT03073200|81002883|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774033|NCT03073200|81002884|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774034|NCT03073200|81002885|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774035|NCT03073200|81002886|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774036|NCT03073200|81002887|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774037|NCT03073200|81002888|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774038|NCT03073200|81002889|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27664567|NCT05600036|80609445|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
27664568|NCT05600036|80609446|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
27664569|NCT05600036|80609447|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
27664570|NCT05600036|80609448|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
27664571|NCT05600036|80609449|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
27664572|NCT05600036|80609444|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
27774039|NCT03073200|81002890|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774040|NCT03073200|81002891|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
27774041|NCT03073200|81002877|FG000|Extension Period|Lost to Follow-up|0|||
27774042|NCT03073200|81002878|FG001|Extension Period|Lost to Follow-up|0|||
27569391|NCT00508742|80275143|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
27569392|NCT00508742|80275144|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
27569393|NCT00508742|80275143|FG000|Period 1: Infant Series|Physician Decision|1|||
27774043|NCT03073200|81002879|FG002|Extension Period|Lost to Follow-up|0|||
27774044|NCT03073200|81002880|FG003|Extension Period|Lost to Follow-up|0|||
27569394|NCT00508742|80275144|FG001|Period 1: Infant Series|Physician Decision|0|||
27569395|NCT00508742|80275143|FG000|Period 1: Infant Series|Other|4|||
27569396|NCT00508742|80275144|FG001|Period 1: Infant Series|Other|1|||
27569397|NCT00508742|80275143|FG000|Period 2: After Infant Series|Adverse Event|2|||
27569398|NCT00508742|80275144|FG001|Period 2: After Infant Series|Adverse Event|6|||
27569399|NCT00508742|80275143|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
27569400|NCT00508742|80275144|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
27569401|NCT00508742|80275143|FG000|Period 2: After Infant Series|Protocol Violation|1|||
27569402|NCT00508742|80275144|FG001|Period 2: After Infant Series|Protocol Violation|0|||
27569403|NCT00508742|80275143|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
27965703|NCT04551898|81704685|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
27965704|NCT04551898|81704686|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
27965705|NCT04551898|81704687|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
27965706|NCT04551898|81704688|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
27965707|NCT02675751|81704691|FG000|Overall Study|Lost to Follow-up|16|||
27965708|NCT03332173|81704692|FG000|Overall Study|Death|7|||
27965709|NCT03332173|81704692|FG000|Overall Study|Withdrawal by Subject|6|||
27965710|NCT03332173|81704692|FG000|Overall Study|Lost to Follow-up|2|||
27965711|NCT03332173|81704692|FG000|Overall Study|Transferred to long-term extension study|29|||
27965712|NCT04556591|81704693|FG000|Overall Study|Lost to Follow-up|1|||
27965713|NCT04556591|81704694|FG001|Overall Study|Lost to Follow-up|0|||
27569404|NCT00508742|80275144|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
27569405|NCT00508742|80275143|FG000|Period 2: After Infant Series|Failed to Return|1|||
27569406|NCT00508742|80275144|FG001|Period 2: After Infant Series|Failed to Return|0|||
27569407|NCT00508742|80275143|FG000|Period 2: After Infant Series|Other|2|||
27569408|NCT00508742|80275144|FG001|Period 2: After Infant Series|Other|1|||
27569409|NCT00508742|80275143|FG000|Period 3: Toddler Dose|Adverse Event|1|||
27569410|NCT00508742|80275144|FG001|Period 3: Toddler Dose|Adverse Event|0|||
27965714|NCT04556591|81704693|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
27965715|NCT04556591|81704694|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
27965716|NCT00372619|81704695|FG000|Overall Study|Ineligible|0|||
27965717|NCT00372619|81704696|FG001|Overall Study|Ineligible|0|||
27569411|NCT00508742|80275143|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
27569412|NCT00508742|80275144|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
27569413|NCT00508742|80275143|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
27569414|NCT00508742|80275144|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
27569415|NCT00508742|80275143|FG000|Period 3: Toddler Dose|Other|5|||
27569416|NCT00508742|80275144|FG001|Period 3: Toddler Dose|Other|4|||
27569417|NCT04382911|80275145|FG000|Overall Study|unable to be imaged prior to surgery|2|||
27569418|NCT00579826|80275151|FG000|Overall Study|Withdrawal by Subject|5|||
27569419|NCT00579826|80275152|FG001|Overall Study|Withdrawal by Subject|3|||
27569420|NCT00380393|80275154|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
27569421|NCT00380393|80275155|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
27569422|NCT00380393|80275154|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
27569423|NCT00380393|80275155|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
27569424|NCT00380393|80275154|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
27569425|NCT00380393|80275155|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
27569426|NCT00380393|80275154|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
27569427|NCT00380393|80275155|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
27569428|NCT00380393|80275154|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
27569429|NCT00380393|80275155|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
27569430|NCT00380393|80275154|FG000|Month 14|Withdrawal by Subject|9|||
27774045|NCT03073200|81002881|FG004|Extension Period|Lost to Follow-up|0|||
27774046|NCT03073200|81002882|FG005|Extension Period|Lost to Follow-up|0|||
27774047|NCT03073200|81002883|FG006|Extension Period|Lost to Follow-up|1|||
27774048|NCT03073200|81002884|FG007|Extension Period|Lost to Follow-up|1|||
27774049|NCT03073200|81002885|FG008|Extension Period|Lost to Follow-up|0|||
27774050|NCT03073200|81002886|FG009|Extension Period|Lost to Follow-up|0|||
27774051|NCT03073200|81002887|FG010|Extension Period|Lost to Follow-up|0|||
27965718|NCT00372619|81704697|FG002|Overall Study|Ineligible|0|||
27965719|NCT00372619|81704698|FG003|Overall Study|Ineligible|0|||
27965720|NCT00372619|81704699|FG004|Overall Study|Ineligible|0|||
27965721|NCT00372619|81704700|FG005|Overall Study|Ineligible|2|||
27569431|NCT00380393|80275155|FG001|Month 14|Withdrawal by Subject|7|||
27569432|NCT00380393|80275154|FG000|Month 14|Death|1|||
27774052|NCT03073200|81002888|FG011|Extension Period|Lost to Follow-up|0|||
27774053|NCT03073200|81002889|FG012|Extension Period|Lost to Follow-up|0|||
27965722|NCT00372619|81704701|FG006|Overall Study|Ineligible|0|||
27965723|NCT00372619|81704695|FG000|Overall Study|Inevaluable|0|||
27965724|NCT00372619|81704696|FG001|Overall Study|Inevaluable|0|||
27965725|NCT00372619|81704697|FG002|Overall Study|Inevaluable|0|||
27965726|NCT00372619|81704698|FG003|Overall Study|Inevaluable|0|||
27569433|NCT00380393|80275155|FG001|Month 14|Death|0|||
27569434|NCT00380393|80275154|FG000|Month 14|Lost to Follow-up|0|||
27569435|NCT00380393|80275155|FG001|Month 14|Lost to Follow-up|1|||
27569436|NCT00380393|80275154|FG000|Month 14|Migrated/moved from study area|39|||
27569437|NCT00380393|80275155|FG001|Month 14|Migrated/moved from study area|42|||
27569438|NCT00380393|80275154|FG000|Month 14|Protocol Violation|2|||
27569439|NCT00380393|80275155|FG001|Month 14|Protocol Violation|0|||
27569440|NCT00380393|80275154|FG000|Month 14|Others|6|||
27569441|NCT00380393|80275155|FG001|Month 14|Others|6|||
27569442|NCT01339390|80275156|FG000|Overall Study|Death|32|||
27569443|NCT01339390|80275157|FG001|Overall Study|Death|29|||
27569444|NCT01339390|80275156|FG000|Overall Study|Lost to Follow-up|125|||
27569445|NCT01339390|80275157|FG001|Overall Study|Lost to Follow-up|127|||
27569446|NCT01071512|80275161|FG000|Overall Study|Adverse Event|1|||
27569447|NCT01071512|80275161|FG000|Overall Study|Development of antibodies to drug|2|||
27569448|NCT01071512|80275161|FG000|Overall Study|positive anti-JC virus antibody test|2|||
27569449|NCT00983580|80275162|FG000|Overall Study|Cancel Prior to treatment|1|||
27569450|NCT00983580|80275163|FG001|Overall Study|Cancel Prior to treatment|3|||
27569451|NCT00983580|80275162|FG000|Overall Study|Protocol Violation|1|||
27569452|NCT00983580|80275163|FG001|Overall Study|Protocol Violation|1|||
27569453|NCT00983580|80275162|FG000|Overall Study|Ineligible|3|||
27569454|NCT00983580|80275163|FG001|Overall Study|Ineligible|0|||
27569455|NCT02272413|80275164|FG000|Randomized Through Treatment Start|Not treated|3|||
27569456|NCT02272413|80275165|FG001|Randomized Through Treatment Start|Not treated|5|||
27569457|NCT02272413|80275164|FG000|Pre-switch Period|Adverse Event|38|||
27569458|NCT02272413|80275165|FG001|Pre-switch Period|Adverse Event|37|||
27569459|NCT02272413|80275164|FG000|Pre-switch Period|Death|26|||
27569460|NCT02272413|80275165|FG001|Pre-switch Period|Death|26|||
27569461|NCT02272413|80275164|FG000|Pre-switch Period|Withdrawal by Subject|27|||
27569462|NCT02272413|80275165|FG001|Pre-switch Period|Withdrawal by Subject|15|||
27569463|NCT02272413|80275164|FG000|Pre-switch Period|Physician Decision|6|||
27569464|NCT02272413|80275165|FG001|Pre-switch Period|Physician Decision|18|||
27569465|NCT02272413|80275164|FG000|Pre-switch Period|Progressive disease|185|||
27569466|NCT02272413|80275165|FG001|Pre-switch Period|Progressive disease|173|||
27965727|NCT00372619|81704699|FG004|Overall Study|Inevaluable|0|||
27569467|NCT02272413|80275164|FG000|Pre-switch Period|Lost to Follow-up|0|||
27569468|NCT02272413|80275165|FG001|Pre-switch Period|Lost to Follow-up|2|||
27569469|NCT02272413|80275164|FG000|Pre-switch Period|Protocol Violation|1|||
27569470|NCT02272413|80275165|FG001|Pre-switch Period|Protocol Violation|0|||
27569471|NCT02272413|80275164|FG000|Pre-switch Period|Other than listed|10|||
27774054|NCT03073200|81002890|FG013|Extension Period|Lost to Follow-up|0|||
27774055|NCT03073200|81002891|FG014|Extension Period|Lost to Follow-up|0|||
27965728|NCT00372619|81704700|FG005|Overall Study|Inevaluable|1|||
27965729|NCT00372619|81704701|FG006|Overall Study|Inevaluable|0|||
27965730|NCT00964002|81704702|FG000|Overall Study|Protocol Violation|8|||
27965731|NCT03832322|81704703|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
27965732|NCT03832322|81704704|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
27965733|NCT03028415|81704705|FG000|Overall Study|Lost to Follow-up|6|||
27569472|NCT02272413|80275165|FG001|Pre-switch Period|Other than listed|11|||
27886626|NCT01938430|81418137|FG001|Overall Study|Randomized but Not Treated|0|||
27965734|NCT03028415|81704706|FG001|Overall Study|Lost to Follow-up|3|||
27569473|NCT02272413|80275164|FG000|Post-switch Period|Adverse Event|4|||
27569474|NCT02272413|80275165|FG001|Post-switch Period|Adverse Event|4|||
27569475|NCT02272413|80275164|FG000|Post-switch Period|Death|3|||
27569476|NCT02272413|80275165|FG001|Post-switch Period|Death|2|||
27965735|NCT03028415|81704705|FG000|Overall Study|Withdrawal by Subject|1|||
27965736|NCT03028415|81704706|FG001|Overall Study|Withdrawal by Subject|0|||
27965737|NCT03028415|81704705|FG000|Overall Study|Discontinued due to COVID-19|1|||
27965738|NCT03028415|81704706|FG001|Overall Study|Discontinued due to COVID-19|0|||
27569477|NCT02272413|80275164|FG000|Post-switch Period|Withdrawal by Subject|1|||
27569478|NCT02272413|80275165|FG001|Post-switch Period|Withdrawal by Subject|2|||
27569479|NCT02272413|80275164|FG000|Post-switch Period|Physician Decision|1|||
27569480|NCT02272413|80275165|FG001|Post-switch Period|Physician Decision|1|||
27569481|NCT02272413|80275164|FG000|Post-switch Period|Progressive disease|21|||
27569482|NCT02272413|80275165|FG001|Post-switch Period|Progressive disease|21|||
27965739|NCT03015363|81704707|FG000|Overall Study|Physician Decision|14|||
27965740|NCT03015363|81704707|FG000|Overall Study|Withdrawal by Subject|3|||
27965741|NCT00090779|81704708|FG000|Step 1|Withdrawal by Subject|4|||
27569483|NCT02272413|80275164|FG000|Post-switch Period|Study terminated by sponsor|8|||
27569484|NCT02272413|80275165|FG001|Post-switch Period|Study terminated by sponsor|11|||
27569485|NCT02272413|80275164|FG000|Post-switch Period|Other than listed|4|||
27569486|NCT02272413|80275165|FG001|Post-switch Period|Other than listed|5|||
27569487|NCT02356783|80275166|FG000|Overall Study|Lost to Follow-up|1|||
27569488|NCT02356783|80275167|FG001|Overall Study|Lost to Follow-up|3|||
27569489|NCT01907828|80275168|FG000|Overall Study|Exclusion criteria not met|0|||
27569490|NCT01907828|80275169|FG001|Overall Study|Exclusion criteria not met|1|||
27569491|NCT01907828|80275168|FG000|Overall Study|Withdrawal by Subject|3|||
27569492|NCT01907828|80275169|FG001|Overall Study|Withdrawal by Subject|4|||
27569493|NCT01907828|80275168|FG000|Overall Study|Lost to Follow-up|3|||
27569494|NCT01907828|80275169|FG001|Overall Study|Lost to Follow-up|0|||
27569495|NCT01907828|80275168|FG000|Overall Study|Participant refused 24-month follow-up|1|||
27569496|NCT01907828|80275169|FG001|Overall Study|Participant refused 24-month follow-up|0|||
27569497|NCT01907828|80275168|FG000|Overall Study|Participant met exclusion criteria|0|||
27569498|NCT01907828|80275169|FG001|Overall Study|Participant met exclusion criteria|1|||
27569499|NCT03216850|80275170|FG000|Overall Study|Pre-analytical error|6|||
27569500|NCT00419562|80275171|FG000|Overall Study|Lost to Follow-up|12|||
27569501|NCT00419562|80275172|FG001|Overall Study|Lost to Follow-up|13|||
27569502|NCT00419562|80275171|FG000|Overall Study|Withdrawal by Subject|20|||
27569503|NCT00419562|80275172|FG001|Overall Study|Withdrawal by Subject|18|||
27569504|NCT00419562|80275171|FG000|Overall Study|Participant Institutionalized|1|||
27569505|NCT00419562|80275172|FG001|Overall Study|Participant Institutionalized|0|||
27569506|NCT01709695|80275175|FG000|Overall Study|Withdrawal by Subject|1|||
27569507|NCT01709695|80275176|FG001|Overall Study|Withdrawal by Subject|1|||
27569508|NCT00600756|80275180|FG000|Analysis After 6 Months|Adverse Event|43|||
27569509|NCT00600756|80275181|FG001|Analysis After 6 Months|Adverse Event|33|||
27569510|NCT00600756|80275180|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
27569511|NCT00600756|80275181|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
27569512|NCT00600756|80275180|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
27569513|NCT00600756|80275181|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
27965742|NCT00090779|81704709|FG001|Step 1|Withdrawal by Subject|2|||
27965743|NCT00090779|81704708|FG000|Step 1|Lost to Follow-up|3|||
27569514|NCT00600756|80275180|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
27569515|NCT00600756|80275181|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
27569516|NCT00600756|80275180|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
27664573|NCT05600036|80609445|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
27664574|NCT05600036|80609446|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
27664575|NCT05600036|80609447|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
27664576|NCT05600036|80609448|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
27664577|NCT05600036|80609449|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
27664578|NCT02986659|80609452|FG000|First Intervention Period|Adverse Event|3|||
27664579|NCT02986659|80609453|FG001|First Intervention Period|Adverse Event|1|||
27664580|NCT02986659|80609452|FG000|First Intervention Period|Lost to Follow-up|1|||
27664581|NCT02986659|80609453|FG001|First Intervention Period|Lost to Follow-up|0|||
27664582|NCT02986659|80609452|FG000|First Intervention Period|Withdrawal by Subject|0|||
27664583|NCT02986659|80609453|FG001|First Intervention Period|Withdrawal by Subject|1|||
27886627|NCT01938430|81418138|FG002|Overall Study|Randomized but Not Treated|0|||
27569517|NCT00600756|80275181|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
27569518|NCT00600756|80275180|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
27569519|NCT00600756|80275181|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
27569520|NCT00600756|80275180|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
27569521|NCT00600756|80275181|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
27965744|NCT00090779|81704709|FG001|Step 1|Lost to Follow-up|2|||
27965745|NCT00090779|81704708|FG000|Step 1|Death|0|||
27664584|NCT02986659|80609452|FG000|Second Intervention Period|Adverse Event|0|||
27664585|NCT02986659|80609453|FG001|Second Intervention Period|Adverse Event|6|||
27664586|NCT00496834|80609457|FG000|Overall Study|Withdrawal by Subject|4|||
27664587|NCT00496834|80609458|FG001|Overall Study|Withdrawal by Subject|6|||
27664588|NCT00496834|80609457|FG000|Overall Study|Contraindicated medication administered|0|||
27664589|NCT00496834|80609458|FG001|Overall Study|Contraindicated medication administered|1|||
27664590|NCT00496834|80609457|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
27664591|NCT00496834|80609458|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
27664592|NCT00496834|80609457|FG000|Overall Study|Adverse Event|5|||
27664593|NCT00496834|80609458|FG001|Overall Study|Adverse Event|3|||
27664594|NCT00496834|80609457|FG000|Overall Study|IP administration violation|2|||
27664595|NCT00496834|80609458|FG001|Overall Study|IP administration violation|0|||
27774056|NCT03073200|81002877|FG000|Extension Period|Sponsor Decision|0|||
27774057|NCT03073200|81002878|FG001|Extension Period|Sponsor Decision|0|||
27774058|NCT03073200|81002879|FG002|Extension Period|Sponsor Decision|0|||
27664596|NCT00496834|80609457|FG000|Overall Study|Lost to Follow-up|2|||
27569522|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
27569523|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
27569524|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
27569525|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
27569526|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
27569527|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
27569528|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
27569529|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
27569530|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
27569531|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
27569532|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
27569533|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
27569534|NCT00600756|80275180|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
27569535|NCT00600756|80275181|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
27569536|NCT03670810|80275182|FG000|Main Study|Adverse Event|37|||
27569537|NCT03670810|80275183|FG001|Main Study|Adverse Event|38|||
27569538|NCT03670810|80275184|FG002|Main Study|Adverse Event|3|||
27569539|NCT03670810|80275185|FG003|Main Study|Adverse Event|4|||
27569540|NCT03670810|80275186|FG004|Main Study|Adverse Event|4|||
27569541|NCT03670810|80275187|FG005|Main Study|Adverse Event|5|||
27569542|NCT03670810|80275188|FG006|Main Study|Adverse Event|0|||
27569543|NCT03670810|80275189|FG007|Main Study|Adverse Event|0|||
27569544|NCT03670810|80275190|FG008|Main Study|Adverse Event|0|||
27569545|NCT03670810|80275182|FG000|Main Study|Lack of Efficacy|8|||
27569546|NCT03670810|80275183|FG001|Main Study|Lack of Efficacy|9|||
27569547|NCT03670810|80275184|FG002|Main Study|Lack of Efficacy|3|||
27569548|NCT03670810|80275185|FG003|Main Study|Lack of Efficacy|4|||
27569549|NCT03670810|80275186|FG004|Main Study|Lack of Efficacy|0|||
27569550|NCT03670810|80275187|FG005|Main Study|Lack of Efficacy|0|||
27569551|NCT03670810|80275188|FG006|Main Study|Lack of Efficacy|0|||
27569552|NCT03670810|80275189|FG007|Main Study|Lack of Efficacy|0|||
27569553|NCT03670810|80275190|FG008|Main Study|Lack of Efficacy|0|||
27569554|NCT03670810|80275182|FG000|Main Study|Lost to Follow-up|9|||
27569555|NCT03670810|80275183|FG001|Main Study|Lost to Follow-up|7|||
27569556|NCT03670810|80275184|FG002|Main Study|Lost to Follow-up|4|||
27569557|NCT03670810|80275185|FG003|Main Study|Lost to Follow-up|6|||
27664597|NCT00496834|80609458|FG001|Overall Study|Lost to Follow-up|0|||
27664598|NCT00496834|80609457|FG000|Overall Study|Blood Pressure control failure|2|||
27664599|NCT00496834|80609458|FG001|Overall Study|Blood Pressure control failure|1|||
27664600|NCT00084747|80609459|FG000|Overall Study|Relapsed|8|||
27774059|NCT03073200|81002880|FG003|Extension Period|Sponsor Decision|0|||
27774060|NCT03073200|81002881|FG004|Extension Period|Sponsor Decision|0|||
27774061|NCT03073200|81002882|FG005|Extension Period|Sponsor Decision|0|||
27774062|NCT03073200|81002883|FG006|Extension Period|Sponsor Decision|0|||
27569558|NCT03670810|80275186|FG004|Main Study|Lost to Follow-up|1|||
27569559|NCT03670810|80275187|FG005|Main Study|Lost to Follow-up|0|||
27569560|NCT03670810|80275188|FG006|Main Study|Lost to Follow-up|0|||
27569561|NCT03670810|80275189|FG007|Main Study|Lost to Follow-up|0|||
27569562|NCT03670810|80275190|FG008|Main Study|Lost to Follow-up|0|||
27569563|NCT03670810|80275182|FG000|Main Study|Non-compliance with Study Drug|0|||
27569564|NCT03670810|80275183|FG001|Main Study|Non-compliance with Study Drug|2|||
27569565|NCT03670810|80275184|FG002|Main Study|Non-compliance with Study Drug|3|||
27664601|NCT00084747|80609459|FG000|Overall Study|Death|3|||
27664602|NCT00084747|80609459|FG000|Overall Study|Withdrawal by Subject|2|||
27664603|NCT00424177|80609460|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
27664604|NCT00424177|80609460|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
27774063|NCT03073200|81002884|FG007|Extension Period|Sponsor Decision|0|||
27774064|NCT03073200|81002885|FG008|Extension Period|Sponsor Decision|1|||
27774065|NCT03073200|81002886|FG009|Extension Period|Sponsor Decision|0|||
27774066|NCT03073200|81002887|FG010|Extension Period|Sponsor Decision|0|||
27774067|NCT03073200|81002888|FG011|Extension Period|Sponsor Decision|0|||
27774068|NCT03073200|81002889|FG012|Extension Period|Sponsor Decision|0|||
27774069|NCT03073200|81002890|FG013|Extension Period|Sponsor Decision|0|||
27774070|NCT03073200|81002891|FG014|Extension Period|Sponsor Decision|0|||
27774071|NCT03073200|81002877|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
27774072|NCT03073200|81002878|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
27965746|NCT00090779|81704709|FG001|Step 1|Death|2|||
27965747|NCT00090779|81704708|FG000|Step 1|Physician Decision|1|||
27965748|NCT00090779|81704709|FG001|Step 1|Physician Decision|0|||
27965749|NCT00090779|81704708|FG000|Step 1|Pregnancy|1|||
27965750|NCT00090779|81704709|FG001|Step 1|Pregnancy|0|||
27965751|NCT00090779|81704708|FG000|Step 1|Non-compliance to study requirements|0|||
27965752|NCT00090779|81704709|FG001|Step 1|Non-compliance to study requirements|1|||
27965753|NCT00090779|81704708|FG000|Step 1|Subject relocated|2|||
27965754|NCT00090779|81704709|FG001|Step 1|Subject relocated|8|||
27965755|NCT00090779|81704708|FG000|Step 2|Off study per study closure|6|||
27569566|NCT03670810|80275185|FG003|Main Study|Non-compliance with Study Drug|0|||
27569567|NCT03670810|80275186|FG004|Main Study|Non-compliance with Study Drug|0|||
27569568|NCT03670810|80275187|FG005|Main Study|Non-compliance with Study Drug|0|||
27569569|NCT03670810|80275188|FG006|Main Study|Non-compliance with Study Drug|0|||
27569570|NCT03670810|80275189|FG007|Main Study|Non-compliance with Study Drug|1|||
27965756|NCT00090779|81704709|FG001|Step 2|Off study per study closure|16|||
27965757|NCT00090779|81704708|FG000|Step 2|Subject relocated|0|||
27965758|NCT00090779|81704709|FG001|Step 2|Subject relocated|1|||
27965759|NCT00090779|81704708|FG000|Step 2|Non-compliance to study requirements|0|||
27965760|NCT00090779|81704709|FG001|Step 2|Non-compliance to study requirements|1|||
27965761|NCT00090779|81704708|FG000|Step 3|Initiation of ART and off extended study|3|||
27965762|NCT00090779|81704709|FG001|Step 3|Initiation of ART and off extended study|2|||
27965763|NCT00090779|81704708|FG000|Step 3|Off extended study due to study closure|4|||
27965764|NCT00090779|81704709|FG001|Step 3|Off extended study due to study closure|3|||
27965765|NCT01108731|81704712|FG000|Overall Study|Withdrawal by Subject|1|||
27965766|NCT01108731|81704713|FG001|Overall Study|Withdrawal by Subject|1|||
27965767|NCT01108731|81704712|FG000|Overall Study|Adverse Event|3|||
27965768|NCT01108731|81704713|FG001|Overall Study|Adverse Event|3|||
27569571|NCT03670810|80275190|FG008|Main Study|Non-compliance with Study Drug|0|||
27569572|NCT03670810|80275182|FG000|Main Study|Physician Decision|3|||
27774073|NCT03073200|81002879|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
27774074|NCT03073200|81002880|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
27774075|NCT03073200|81002881|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
27774076|NCT03073200|81002882|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
27774077|NCT03073200|81002883|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
27774078|NCT03073200|81002884|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
27965769|NCT03286543|81704714|FG000|Consented|Screen failure before randomization|2|||
27965770|NCT03286543|81704715|FG001|Consented|Screen failure before randomization|0|||
27965771|NCT03286543|81704716|FG002|Consented|Screen failure before randomization|0|||
27965772|NCT03286543|81704714|FG000|Consented|Screen failure before enrollment|4|||
27965773|NCT03286543|81704715|FG001|Consented|Screen failure before enrollment|0|||
27965774|NCT03286543|81704716|FG002|Consented|Screen failure before enrollment|0|||
27965775|NCT03286543|81704714|FG000|Consented|TKA cancelled after enrollment|1|||
27965776|NCT03286543|81704715|FG001|Consented|TKA cancelled after enrollment|0|||
27965777|NCT03286543|81704716|FG002|Consented|TKA cancelled after enrollment|0|||
27965778|NCT03286543|81704714|FG000|Consented|Withdrawn from study|12|||
27965779|NCT03286543|81704715|FG001|Consented|Withdrawn from study|0|||
27965780|NCT03286543|81704716|FG002|Consented|Withdrawn from study|0|||
27965781|NCT03286543|81704714|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
27965782|NCT03286543|81704715|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
27965783|NCT03286543|81704716|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
27965784|NCT03286543|81704714|FG000|Study Enrollment|Withdrawn from study|0|||
27965785|NCT03286543|81704715|FG001|Study Enrollment|Withdrawn from study|6|||
27965786|NCT03286543|81704716|FG002|Study Enrollment|Withdrawn from study|6|||
27965787|NCT02791516|81704721|FG000|Overall Study|Withdrawal by Subject|1|||
27965788|NCT02791516|81704722|FG001|Overall Study|Withdrawal by Subject|1|||
27965789|NCT02680041|81704725|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
27965790|NCT02680041|81704725|FG000|Overall Study|Lost to Follow-up|2|||
27965791|NCT04382586|81704726|FG000|Overall Study|Death|3|||
27965792|NCT04382586|81704727|FG001|Overall Study|Death|4|||
27965793|NCT04382586|81704726|FG000|Overall Study|Lost to Follow-up|11|||
27965794|NCT04382586|81704727|FG001|Overall Study|Lost to Follow-up|8|||
27965795|NCT04382586|81704726|FG000|Overall Study|Withdrawal by Subject|3|||
27965796|NCT04382586|81704727|FG001|Overall Study|Withdrawal by Subject|1|||
27965797|NCT04382586|81704726|FG000|Overall Study|Physician Decision|0|||
27965798|NCT04382586|81704727|FG001|Overall Study|Physician Decision|3|||
27965799|NCT00395486|81704728|FG000|Overall Study|Adverse Event|1|||
27965800|NCT00395486|81704729|FG001|Overall Study|Adverse Event|2|||
27965801|NCT00395486|81704728|FG000|Overall Study|Withdrawal by Subject|5|||
27965802|NCT00395486|81704729|FG001|Overall Study|Withdrawal by Subject|2|||
27965803|NCT00395486|81704728|FG000|Overall Study|Lost to Follow-up|0|||
27965804|NCT00395486|81704729|FG001|Overall Study|Lost to Follow-up|1|||
27774079|NCT03073200|81002885|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
27774080|NCT03073200|81002886|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
27774081|NCT03073200|81002887|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
27774082|NCT03073200|81002888|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
27774083|NCT03073200|81002889|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
27774084|NCT03073200|81002890|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
27774085|NCT03073200|81002891|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
27774086|NCT03073200|81002877|FG000|Extension Period|Withdrawal by Subject|0|||
27774087|NCT03073200|81002878|FG001|Extension Period|Withdrawal by Subject|0|||
27774088|NCT03073200|81002879|FG002|Extension Period|Withdrawal by Subject|0|||
27774089|NCT03073200|81002880|FG003|Extension Period|Withdrawal by Subject|0|||
27774090|NCT03073200|81002881|FG004|Extension Period|Withdrawal by Subject|0|||
27774091|NCT03073200|81002882|FG005|Extension Period|Withdrawal by Subject|0|||
27774092|NCT03073200|81002883|FG006|Extension Period|Withdrawal by Subject|1|||
27774093|NCT03073200|81002884|FG007|Extension Period|Withdrawal by Subject|2|||
27774094|NCT03073200|81002885|FG008|Extension Period|Withdrawal by Subject|0|||
27774095|NCT03073200|81002886|FG009|Extension Period|Withdrawal by Subject|0|||
27774096|NCT03073200|81002887|FG010|Extension Period|Withdrawal by Subject|0|||
27774097|NCT03073200|81002888|FG011|Extension Period|Withdrawal by Subject|0|||
27774098|NCT03073200|81002889|FG012|Extension Period|Withdrawal by Subject|0|||
27774099|NCT03073200|81002890|FG013|Extension Period|Withdrawal by Subject|0|||
27774100|NCT03073200|81002891|FG014|Extension Period|Withdrawal by Subject|0|||
27774101|NCT03073200|81002877|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774102|NCT03073200|81002878|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774103|NCT03073200|81002879|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
27965805|NCT00361231|81704730|FG000|Overall Study|Physician Decision|3|||
27965806|NCT00361231|81704730|FG000|Overall Study|Symptomatic deterioration|5|||
27965807|NCT00361231|81704730|FG000|Overall Study|Radiographic disease progression|16|||
27965808|NCT00361231|81704730|FG000|Overall Study|Withdrawal by Subject|4|||
27965809|NCT00361231|81704730|FG000|Overall Study|Adverse Event|6|||
27965810|NCT02308163|81704731|FG000|Overall Study|Not fulfill eligible criteria|1|||
27965811|NCT02308163|81704732|FG001|Overall Study|Not fulfill eligible criteria|2|||
27965812|NCT02308163|81704733|FG002|Overall Study|Not fulfill eligible criteria|0|||
27965813|NCT02308163|81704734|FG003|Overall Study|Not fulfill eligible criteria|1|||
27965814|NCT02308163|81704735|FG004|Overall Study|Not fulfill eligible criteria|1|||
27965815|NCT02308163|81704731|FG000|Overall Study|Adverse Event|9|||
27965816|NCT02308163|81704732|FG001|Overall Study|Adverse Event|5|||
27965817|NCT02308163|81704733|FG002|Overall Study|Adverse Event|2|||
27965818|NCT02308163|81704734|FG003|Overall Study|Adverse Event|2|||
27965819|NCT02308163|81704735|FG004|Overall Study|Adverse Event|11|||
27774104|NCT03073200|81002880|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774105|NCT03073200|81002881|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774106|NCT03073200|81002882|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774107|NCT03073200|81002883|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774108|NCT03073200|81002884|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774109|NCT03073200|81002885|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774110|NCT03073200|81002886|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774111|NCT03073200|81002887|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774112|NCT03073200|81002888|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
27774113|NCT03073200|81002889|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774114|NCT03073200|81002890|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774115|NCT03073200|81002891|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
27774116|NCT03073200|81002877|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774117|NCT03073200|81002878|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774118|NCT03073200|81002879|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774119|NCT03073200|81002880|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27965820|NCT02308163|81704731|FG000|Overall Study|Lack of Efficacy|11|||
27965821|NCT02308163|81704732|FG001|Overall Study|Lack of Efficacy|3|||
27965822|NCT02308163|81704733|FG002|Overall Study|Lack of Efficacy|8|||
27965823|NCT02308163|81704734|FG003|Overall Study|Lack of Efficacy|4|||
27965824|NCT02308163|81704735|FG004|Overall Study|Lack of Efficacy|6|||
27965825|NCT02308163|81704731|FG000|Overall Study|Withdrawal of consent|2|||
27965826|NCT02308163|81704732|FG001|Overall Study|Withdrawal of consent|3|||
27965827|NCT02308163|81704733|FG002|Overall Study|Withdrawal of consent|0|||
27965828|NCT02308163|81704734|FG003|Overall Study|Withdrawal of consent|2|||
27965829|NCT02308163|81704735|FG004|Overall Study|Withdrawal of consent|6|||
27965830|NCT02308163|81704731|FG000|Overall Study|Protocol Violation|3|||
27965831|NCT02308163|81704732|FG001|Overall Study|Protocol Violation|3|||
27965832|NCT02308163|81704733|FG002|Overall Study|Protocol Violation|3|||
27965833|NCT02308163|81704734|FG003|Overall Study|Protocol Violation|2|||
27965834|NCT02308163|81704735|FG004|Overall Study|Protocol Violation|5|||
27965835|NCT02308163|81704731|FG000|Overall Study|Lab data met discontinuation criteria|3|||
27965836|NCT02308163|81704732|FG001|Overall Study|Lab data met discontinuation criteria|0|||
27569573|NCT03670810|80275183|FG001|Main Study|Physician Decision|0|||
27569574|NCT03670810|80275184|FG002|Main Study|Physician Decision|1|||
27569575|NCT03670810|80275185|FG003|Main Study|Physician Decision|0|||
27569576|NCT03670810|80275186|FG004|Main Study|Physician Decision|0|||
27569577|NCT03670810|80275187|FG005|Main Study|Physician Decision|0|||
27569578|NCT03670810|80275188|FG006|Main Study|Physician Decision|1|||
27569579|NCT03670810|80275189|FG007|Main Study|Physician Decision|1|||
27569580|NCT03670810|80275190|FG008|Main Study|Physician Decision|0|||
27569581|NCT03670810|80275182|FG000|Main Study|Pregnancy|1|||
27569582|NCT03670810|80275183|FG001|Main Study|Pregnancy|2|||
27569583|NCT03670810|80275184|FG002|Main Study|Pregnancy|0|||
27569584|NCT03670810|80275185|FG003|Main Study|Pregnancy|0|||
27569585|NCT03670810|80275186|FG004|Main Study|Pregnancy|0|||
27569586|NCT03670810|80275187|FG005|Main Study|Pregnancy|0|||
27569587|NCT03670810|80275188|FG006|Main Study|Pregnancy|0|||
27569588|NCT03670810|80275189|FG007|Main Study|Pregnancy|0|||
27569589|NCT03670810|80275190|FG008|Main Study|Pregnancy|0|||
27569590|NCT03670810|80275182|FG000|Main Study|Protocol Deviation|2|||
27569591|NCT03670810|80275183|FG001|Main Study|Protocol Deviation|12|||
27569592|NCT03670810|80275184|FG002|Main Study|Protocol Deviation|8|||
27569593|NCT03670810|80275185|FG003|Main Study|Protocol Deviation|4|||
27569594|NCT03670810|80275186|FG004|Main Study|Protocol Deviation|0|||
27569595|NCT03670810|80275187|FG005|Main Study|Protocol Deviation|0|||
27569596|NCT03670810|80275188|FG006|Main Study|Protocol Deviation|0|||
27965837|NCT02308163|81704733|FG002|Overall Study|Lab data met discontinuation criteria|0|||
27965838|NCT02308163|81704734|FG003|Overall Study|Lab data met discontinuation criteria|2|||
27965839|NCT02308163|81704735|FG004|Overall Study|Lab data met discontinuation criteria|0|||
27569597|NCT03670810|80275189|FG007|Main Study|Protocol Deviation|0|||
27569598|NCT03670810|80275190|FG008|Main Study|Protocol Deviation|0|||
27569599|NCT03670810|80275182|FG000|Main Study|Withdrawal by Subject|21|||
27569600|NCT03670810|80275183|FG001|Main Study|Withdrawal by Subject|21|||
27569601|NCT03670810|80275184|FG002|Main Study|Withdrawal by Subject|8|||
27569602|NCT03670810|80275185|FG003|Main Study|Withdrawal by Subject|9|||
27569603|NCT03670810|80275186|FG004|Main Study|Withdrawal by Subject|5|||
27569604|NCT03670810|80275187|FG005|Main Study|Withdrawal by Subject|2|||
27569605|NCT03670810|80275188|FG006|Main Study|Withdrawal by Subject|1|||
27569606|NCT03670810|80275189|FG007|Main Study|Withdrawal by Subject|1|||
27569607|NCT03670810|80275190|FG008|Main Study|Withdrawal by Subject|0|||
27569608|NCT03670810|80275182|FG000|Main Study|Participant did not want to take the three other treatments|1|||
27569609|NCT03670810|80275183|FG001|Main Study|Participant did not want to take the three other treatments|0|||
27569610|NCT03670810|80275184|FG002|Main Study|Participant did not want to take the three other treatments|0|||
27569611|NCT03670810|80275185|FG003|Main Study|Participant did not want to take the three other treatments|0|||
27774120|NCT03073200|81002881|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774121|NCT03073200|81002882|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774122|NCT03073200|81002883|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774123|NCT03073200|81002884|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774124|NCT03073200|81002885|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774125|NCT03073200|81002886|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774126|NCT03073200|81002887|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774127|NCT03073200|81002888|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
27965840|NCT02308163|81704731|FG000|Overall Study|Miscellaneous|2|||
27965841|NCT02308163|81704732|FG001|Overall Study|Miscellaneous|2|||
27965842|NCT02308163|81704733|FG002|Overall Study|Miscellaneous|1|||
27965843|NCT02308163|81704734|FG003|Overall Study|Miscellaneous|0|||
27965844|NCT02308163|81704735|FG004|Overall Study|Miscellaneous|5|||
27965845|NCT02489318|81707918|FG000|Randomized|Withdrawal by Subject|0|||
27569612|NCT03670810|80275186|FG004|Main Study|Participant did not want to take the three other treatments|0|||
27569613|NCT03670810|80275187|FG005|Main Study|Participant did not want to take the three other treatments|0|||
27569614|NCT03670810|80275188|FG006|Main Study|Participant did not want to take the three other treatments|0|||
27569615|NCT03670810|80275189|FG007|Main Study|Participant did not want to take the three other treatments|0|||
27965846|NCT02489318|81707919|FG001|Randomized|Withdrawal by Subject|1|||
27965847|NCT02489318|81707918|FG000|Treated|Adverse Event|19|||
27965848|NCT02489318|81707919|FG001|Treated|Adverse Event|62|||
27774128|NCT03073200|81002889|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774129|NCT03073200|81002890|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774130|NCT03073200|81002891|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
27774131|NCT03073200|81002877|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27965849|NCT02489318|81707918|FG000|Treated|Death|13|||
27965850|NCT02489318|81707919|FG001|Treated|Death|11|||
27965851|NCT02489318|81707918|FG000|Treated|Physician Decision|4|||
27965852|NCT02489318|81707919|FG001|Treated|Physician Decision|6|||
27965853|NCT02489318|81707918|FG000|Treated|Protocol Violation|1|||
27965854|NCT02489318|81707919|FG001|Treated|Protocol Violation|2|||
27965855|NCT02489318|81707918|FG000|Treated|Withdrawal by Subject|37|||
27965856|NCT02489318|81707919|FG001|Treated|Withdrawal by Subject|36|||
27965857|NCT02489318|81707918|FG000|Treated|Other: Progressive Disease|245|||
27965858|NCT02489318|81707919|FG001|Treated|Other: Progressive Disease|138|||
27965859|NCT02489318|81707918|FG000|Treated|Other|0|||
27965860|NCT02489318|81707919|FG001|Treated|Other|2|||
27965861|NCT02489318|81707918|FG000|Treated|Ongoing|0|||
27965862|NCT02489318|81707919|FG001|Treated|Ongoing|267|||
27965863|NCT00177294|81707920|FG000|Overall Study|Withdrawal by Subject|7|||
27965864|NCT00177294|81707921|FG001|Overall Study|Withdrawal by Subject|5|||
27965865|NCT04003207|81707922|FG000|Overall Study|Protocol Violation|1|||
27965866|NCT02712983|81707923|FG000|Treatment Phase|Adverse Event|3|||
27965867|NCT02712983|81707924|FG001|Treatment Phase|Adverse Event|1|||
27965868|NCT02712983|81707925|FG002|Treatment Phase|Adverse Event|1|||
27965869|NCT02712983|81707926|FG003|Treatment Phase|Adverse Event|4|||
27965870|NCT02712983|81707927|FG004|Treatment Phase|Adverse Event|3|||
27965871|NCT02712983|81707928|FG005|Treatment Phase|Adverse Event|0|||
27965872|NCT02712983|81707929|FG006|Treatment Phase|Adverse Event|6|||
27965873|NCT02712983|81707930|FG007|Treatment Phase|Adverse Event|6|||
27965874|NCT02712983|81707931|FG008|Treatment Phase|Adverse Event|1|||
27965875|NCT02712983|81707923|FG000|Treatment Phase|Protocol Deviation|0|||
27965876|NCT02712983|81707924|FG001|Treatment Phase|Protocol Deviation|0|||
27774132|NCT03073200|81002878|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774133|NCT03073200|81002879|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774134|NCT03073200|81002880|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27965877|NCT02712983|81707925|FG002|Treatment Phase|Protocol Deviation|0|||
27965878|NCT02712983|81707926|FG003|Treatment Phase|Protocol Deviation|2|||
27965879|NCT02712983|81707927|FG004|Treatment Phase|Protocol Deviation|0|||
27965880|NCT02712983|81707928|FG005|Treatment Phase|Protocol Deviation|0|||
27965881|NCT02712983|81707929|FG006|Treatment Phase|Protocol Deviation|1|||
27965882|NCT02712983|81707930|FG007|Treatment Phase|Protocol Deviation|0|||
27965883|NCT02712983|81707931|FG008|Treatment Phase|Protocol Deviation|0|||
27965884|NCT02712983|81707923|FG000|Treatment Phase|Technical Problems|0|||
27965885|NCT02712983|81707924|FG001|Treatment Phase|Technical Problems|0|||
27965886|NCT02712983|81707925|FG002|Treatment Phase|Technical Problems|0|||
27965887|NCT02712983|81707926|FG003|Treatment Phase|Technical Problems|0|||
27965888|NCT02712983|81707927|FG004|Treatment Phase|Technical Problems|0|||
27774135|NCT03073200|81002881|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774136|NCT03073200|81002882|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27569616|NCT03670810|80275190|FG008|Main Study|Participant did not want to take the three other treatments|0|||
27664605|NCT00424177|80609460|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
27664606|NCT00424177|80609460|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
27664607|NCT00424177|80609460|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
27664608|NCT00424177|80609460|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
27664609|NCT00424177|80609460|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
27664610|NCT00424177|80609460|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
27664611|NCT00424177|80609460|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
27664612|NCT00424177|80609460|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
27664613|NCT00819013|80609461|FG000|Overall Study|Not meeting continuing study eligibility|2|||
27664614|NCT00819013|80609462|FG001|Overall Study|Not meeting continuing study eligibility|1|||
27664615|NCT00819013|80609463|FG002|Overall Study|Not meeting continuing study eligibility|2|||
27664616|NCT00819013|80609464|FG003|Overall Study|Not meeting continuing study eligibility|1|||
27664617|NCT00819013|80609461|FG000|Overall Study|Adverse Event|0|||
27664618|NCT00819013|80609462|FG001|Overall Study|Adverse Event|0|||
27664619|NCT00819013|80609463|FG002|Overall Study|Adverse Event|1|||
27664620|NCT00819013|80609464|FG003|Overall Study|Adverse Event|0|||
27664621|NCT00819013|80609461|FG000|Overall Study|Withdrawal by Subject|1|||
27664622|NCT00819013|80609462|FG001|Overall Study|Withdrawal by Subject|0|||
27664623|NCT00819013|80609463|FG002|Overall Study|Withdrawal by Subject|1|||
27664624|NCT00819013|80609464|FG003|Overall Study|Withdrawal by Subject|0|||
27664625|NCT00819013|80609461|FG000|Overall Study|Lost to Follow-up|0|||
27664626|NCT00819013|80609462|FG001|Overall Study|Lost to Follow-up|0|||
27664627|NCT00819013|80609463|FG002|Overall Study|Lost to Follow-up|1|||
27664628|NCT00819013|80609464|FG003|Overall Study|Lost to Follow-up|2|||
27774137|NCT03073200|81002883|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774138|NCT03073200|81002884|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774139|NCT03073200|81002885|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774140|NCT03073200|81002886|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774141|NCT03073200|81002887|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
27774142|NCT03073200|81002888|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
27774143|NCT03073200|81002889|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774144|NCT03073200|81002890|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774145|NCT03073200|81002891|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27774146|NCT03073200|81002877|FG000|Randomized Withdrawal Period|Adverse Event|0|||
27774147|NCT03073200|81002878|FG001|Randomized Withdrawal Period|Adverse Event|0|||
27774148|NCT03073200|81002879|FG002|Randomized Withdrawal Period|Adverse Event|0|||
27774149|NCT03073200|81002880|FG003|Randomized Withdrawal Period|Adverse Event|0|||
27774150|NCT03073200|81002881|FG004|Randomized Withdrawal Period|Adverse Event|0|||
27774151|NCT03073200|81002882|FG005|Randomized Withdrawal Period|Adverse Event|0|||
27965889|NCT02712983|81707928|FG005|Treatment Phase|Technical Problems|0|||
27965890|NCT02712983|81707929|FG006|Treatment Phase|Technical Problems|1|||
27965891|NCT02712983|81707930|FG007|Treatment Phase|Technical Problems|0|||
27965892|NCT02712983|81707931|FG008|Treatment Phase|Technical Problems|0|||
27965893|NCT02712983|81707923|FG000|Treatment Phase|Physician Decision|0|||
27965894|NCT02712983|81707924|FG001|Treatment Phase|Physician Decision|0|||
27965895|NCT02712983|81707925|FG002|Treatment Phase|Physician Decision|0|||
27965896|NCT02712983|81707926|FG003|Treatment Phase|Physician Decision|0|||
27965897|NCT02712983|81707927|FG004|Treatment Phase|Physician Decision|0|||
27965898|NCT02712983|81707928|FG005|Treatment Phase|Physician Decision|0|||
27965899|NCT02712983|81707929|FG006|Treatment Phase|Physician Decision|0|||
27569617|NCT03670810|80275182|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27664629|NCT00819013|80609461|FG000|Overall Study|Death|0|||
27664630|NCT00819013|80609462|FG001|Overall Study|Death|0|||
27664631|NCT00819013|80609463|FG002|Overall Study|Death|0|||
27664632|NCT00819013|80609464|FG003|Overall Study|Death|1|||
27664633|NCT01780545|80609465|FG000|Overall Study|Withdrawal by Subject|3|||
27664634|NCT01780545|80609466|FG001|Overall Study|Withdrawal by Subject|1|||
27774152|NCT03073200|81002883|FG006|Randomized Withdrawal Period|Adverse Event|0|||
27774153|NCT03073200|81002884|FG007|Randomized Withdrawal Period|Adverse Event|0|||
27774154|NCT03073200|81002885|FG008|Randomized Withdrawal Period|Adverse Event|0|||
27774155|NCT03073200|81002886|FG009|Randomized Withdrawal Period|Adverse Event|0|||
27965900|NCT02712983|81707930|FG007|Treatment Phase|Physician Decision|1|||
27664635|NCT01780545|80609465|FG000|Overall Study|Lost to Follow-up|1|||
27774156|NCT03073200|81002887|FG010|Randomized Withdrawal Period|Adverse Event|1|||
27774157|NCT03073200|81002888|FG011|Randomized Withdrawal Period|Adverse Event|0|||
27774158|NCT03073200|81002889|FG012|Randomized Withdrawal Period|Adverse Event|0|||
27774159|NCT03073200|81002890|FG013|Randomized Withdrawal Period|Adverse Event|0|||
27774160|NCT03073200|81002891|FG014|Randomized Withdrawal Period|Adverse Event|0|||
27774161|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774162|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774163|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774164|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774165|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774166|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774167|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774168|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774169|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774170|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774171|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774172|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774173|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774174|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
27774175|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
27774176|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774177|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774178|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774179|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774180|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774181|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774182|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774183|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774184|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27965901|NCT02712983|81707931|FG008|Treatment Phase|Physician Decision|1|||
27965902|NCT02712983|81707923|FG000|Treatment Phase|Subject Decision|2|||
27965903|NCT02712983|81707924|FG001|Treatment Phase|Subject Decision|0|||
27965904|NCT02712983|81707925|FG002|Treatment Phase|Subject Decision|0|||
27965905|NCT02712983|81707926|FG003|Treatment Phase|Subject Decision|2|||
27965906|NCT02712983|81707927|FG004|Treatment Phase|Subject Decision|1|||
27965907|NCT02712983|81707928|FG005|Treatment Phase|Subject Decision|0|||
27965908|NCT02712983|81707929|FG006|Treatment Phase|Subject Decision|1|||
27965909|NCT02712983|81707930|FG007|Treatment Phase|Subject Decision|2|||
27965910|NCT02712983|81707931|FG008|Treatment Phase|Subject Decision|0|||
27774185|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774186|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774187|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774188|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27774189|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
27774190|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27965911|NCT02712983|81707923|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27965912|NCT02712983|81707924|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
27965913|NCT02712983|81707925|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27774191|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774192|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774193|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774194|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774195|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774196|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774197|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774198|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774199|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774200|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774201|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774202|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774203|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774204|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
27774205|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
27774206|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27965914|NCT02712983|81707926|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27965915|NCT02712983|81707927|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27965916|NCT02712983|81707928|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27862251|NCT02359994|81326288|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
27774207|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774208|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774209|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774210|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774211|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27664636|NCT01780545|80609466|FG001|Overall Study|Lost to Follow-up|1|||
27664637|NCT02165397|80609467|FG000|Overall Study|Death|7|||
27664638|NCT02165397|80609468|FG001|Overall Study|Death|10|||
27664639|NCT02165397|80609469|FG002|Overall Study|Death|8|||
27664640|NCT02165397|80609467|FG000|Overall Study|Lost to Follow-up|1|||
27664641|NCT02165397|80609468|FG001|Overall Study|Lost to Follow-up|3|||
27664642|NCT02165397|80609469|FG002|Overall Study|Lost to Follow-up|0|||
27664643|NCT02165397|80609467|FG000|Overall Study|Withdrawal by Subject|6|||
27664644|NCT02165397|80609468|FG001|Overall Study|Withdrawal by Subject|6|||
27664645|NCT02165397|80609469|FG002|Overall Study|Withdrawal by Subject|1|||
27664646|NCT02165397|80609467|FG000|Overall Study|Other, Not Specified|0|||
27664647|NCT02165397|80609468|FG001|Overall Study|Other, Not Specified|0|||
27664648|NCT02165397|80609469|FG002|Overall Study|Other, Not Specified|1|||
27664649|NCT00352053|80609470|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
27664650|NCT00352053|80609471|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
27664651|NCT00352053|80609470|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
27664652|NCT00352053|80609471|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
27664653|NCT00352053|80609470|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
27664654|NCT00352053|80609471|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
27664655|NCT00352053|80609470|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
27664656|NCT00352053|80609471|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
27664657|NCT00352053|80609470|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
27664658|NCT00352053|80609471|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
27664659|NCT00352053|80609470|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
27664660|NCT00352053|80609471|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
27664661|NCT00352053|80609470|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
27664662|NCT00352053|80609471|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
27664663|NCT00352053|80609470|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
27664664|NCT00352053|80609471|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
27664665|NCT00352053|80609470|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
27664666|NCT00352053|80609471|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
27664667|NCT00352053|80609470|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
27664668|NCT00352053|80609471|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
27664669|NCT00352053|80609470|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
27664670|NCT00352053|80609471|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
27664671|NCT00352053|80609470|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
27664672|NCT00352053|80609471|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
27664673|NCT00352053|80609470|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
27664674|NCT00352053|80609471|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
27774212|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27569618|NCT03670810|80275183|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
27569619|NCT03670810|80275184|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569620|NCT03670810|80275185|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569621|NCT03670810|80275186|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569622|NCT03670810|80275187|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569623|NCT03670810|80275188|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569624|NCT03670810|80275189|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569625|NCT03670810|80275190|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
27569626|NCT03670810|80275182|FG000|Main Study|Travel and Coronavirus issues|0|||
27569627|NCT03670810|80275183|FG001|Main Study|Travel and Coronavirus issues|0|||
27569628|NCT03670810|80275184|FG002|Main Study|Travel and Coronavirus issues|0|||
27569629|NCT03670810|80275185|FG003|Main Study|Travel and Coronavirus issues|1|||
27569630|NCT03670810|80275186|FG004|Main Study|Travel and Coronavirus issues|0|||
27569631|NCT03670810|80275187|FG005|Main Study|Travel and Coronavirus issues|0|||
27569632|NCT03670810|80275188|FG006|Main Study|Travel and Coronavirus issues|0|||
27569633|NCT03670810|80275189|FG007|Main Study|Travel and Coronavirus issues|0|||
27569634|NCT03670810|80275190|FG008|Main Study|Travel and Coronavirus issues|0|||
27569635|NCT03670810|80275182|FG000|Open Label Extension|Protocol Deviation|0|||
27774213|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774214|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774215|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774216|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774217|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774218|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27965917|NCT02712983|81707929|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
27965918|NCT02712983|81707930|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
27965919|NCT02712983|81707931|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27965920|NCT02712983|81707923|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965921|NCT02712983|81707924|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965922|NCT02712983|81707925|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965923|NCT02712983|81707926|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
27965924|NCT02712983|81707927|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965925|NCT02712983|81707928|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965926|NCT02712983|81707929|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965927|NCT02712983|81707930|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965928|NCT02712983|81707931|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
27965929|NCT02712983|81707923|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27965930|NCT02712983|81707924|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27965931|NCT02712983|81707925|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27965932|NCT02712983|81707926|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27664675|NCT01831726|80609476|FG000|Overall Study|Adverse Event|16|||
27664676|NCT01831726|80609476|FG000|Overall Study|Death|7|||
27664677|NCT01831726|80609476|FG000|Overall Study|Disease Progression|49|||
27664678|NCT01831726|80609476|FG000|Overall Study|Physician Decision|1|||
27664679|NCT01831726|80609476|FG000|Overall Study|Subject/guardian decision|7|||
27664680|NCT00463580|80609493|FG000|Overall Study|Lost to Follow-up|1|||
27664681|NCT00463580|80609494|FG001|Overall Study|Lost to Follow-up|0|||
27664682|NCT00463580|80609493|FG000|Overall Study|Schedule conflict|2|||
27664683|NCT00463580|80609494|FG001|Overall Study|Schedule conflict|0|||
27664684|NCT00463580|80609493|FG000|Overall Study|Medical/psychiatric complications|0|||
27664685|NCT00463580|80609494|FG001|Overall Study|Medical/psychiatric complications|2|||
27965933|NCT02712983|81707927|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
27965934|NCT02712983|81707928|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
27965935|NCT02712983|81707929|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
27965936|NCT02712983|81707930|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
27664686|NCT02413593|80609500|FG000|Overall Study|Lost to Follow-up|3|||
27664687|NCT02413593|80609500|FG000|Overall Study|Adverse Event|1|||
27664688|NCT00815919|80609503|FG000|Overall Study|Unrelated Fungal Infection|1|||
27664689|NCT00815919|80609503|FG000|Overall Study|AML Relapse|1|||
27664690|NCT00815919|80609503|FG000|Overall Study|Lack of Efficacy|2|||
27664691|NCT01978236|80609506|FG000|Overall Study|Discontinued due to study close|2|||
27664692|NCT00361842|80609509|FG000|Overall Study|Withdrawal by Subject|2|||
27664693|NCT00361842|80609510|FG001|Overall Study|Withdrawal by Subject|3|||
27664694|NCT00361842|80609509|FG000|Overall Study|Death|2|||
27664695|NCT00361842|80609510|FG001|Overall Study|Death|1|||
27664696|NCT00361842|80609509|FG000|Overall Study|Disease progression|19|||
27664697|NCT00361842|80609510|FG001|Overall Study|Disease progression|20|||
27664698|NCT00361842|80609509|FG000|Overall Study|Adverse Event|2|||
27664699|NCT00361842|80609510|FG001|Overall Study|Adverse Event|3|||
27664700|NCT00361842|80609509|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
27664701|NCT00361842|80609510|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
27664702|NCT00361842|80609509|FG000|Overall Study|Other|1|||
27664703|NCT00361842|80609510|FG001|Overall Study|Other|0|||
27664704|NCT00361842|80609509|FG000|Overall Study|Other|0|||
27664705|NCT00361842|80609510|FG001|Overall Study|Other|2|||
27664706|NCT00875615|80609511|FG000|Overall Study|Withdrawal by Subject|1|||
27664707|NCT02172950|80609512|FG000|Overall Study|Physician Decision|3|||
27664708|NCT02172950|80609513|FG001|Overall Study|Physician Decision|3|||
27664709|NCT02172950|80609512|FG000|Overall Study|Lack of Efficacy|1|||
27664710|NCT02172950|80609513|FG001|Overall Study|Lack of Efficacy|0|||
27664711|NCT02172950|80609512|FG000|Overall Study|Adverse Event|4|||
27664712|NCT02172950|80609513|FG001|Overall Study|Adverse Event|1|||
27664713|NCT02172950|80609512|FG000|Overall Study|Withdrawal by Subject|10|||
27664714|NCT02172950|80609513|FG001|Overall Study|Withdrawal by Subject|0|||
27664715|NCT02172950|80609512|FG000|Overall Study|Protocol Violation|1|||
27664716|NCT02172950|80609513|FG001|Overall Study|Protocol Violation|0|||
27664717|NCT02172950|80609512|FG000|Overall Study|Lost to Follow-up|1|||
27664718|NCT02172950|80609513|FG001|Overall Study|Lost to Follow-up|0|||
27664719|NCT02172950|80609512|FG000|Overall Study|Death|1|||
27664720|NCT02172950|80609513|FG001|Overall Study|Death|0|||
27664721|NCT02172950|80609512|FG000|Overall Study|Patient traveling|1|||
27664722|NCT02172950|80609513|FG001|Overall Study|Patient traveling|0|||
27774219|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
27774220|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27774221|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774222|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774223|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774224|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774225|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774226|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774227|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774228|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774229|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774230|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774231|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774232|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774233|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774234|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
27774235|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
27774236|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774237|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774238|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774239|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774240|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774241|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774242|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774243|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774244|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774245|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774246|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774247|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774248|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774249|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
27774250|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
27774251|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774252|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774253|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774254|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774255|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774256|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774257|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774258|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774259|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774260|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774261|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774262|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27664723|NCT02172950|80609512|FG000|Overall Study|Patient went to other country|1|||
27664724|NCT02172950|80609513|FG001|Overall Study|Patient went to other country|0|||
27664725|NCT02172950|80609512|FG000|Overall Study|Patient relocated overseas|1|||
27664726|NCT02172950|80609513|FG001|Overall Study|Patient relocated overseas|1|||
27664727|NCT02172950|80609512|FG000|Overall Study|Patient moving|1|||
27664728|NCT02172950|80609513|FG001|Overall Study|Patient moving|0|||
27664729|NCT01820637|80609518|FG000|Overall Study|Death|2|||
27664730|NCT01820637|80609518|FG000|Overall Study|Withdrawal by Subject|1|||
27664731|NCT01746108|80609519|FG000|Overall Study|Migrated /moved from study area|0|||
27664732|NCT01746108|80609520|FG001|Overall Study|Migrated /moved from study area|1|||
27664733|NCT01746108|80609521|FG002|Overall Study|Migrated /moved from study area|0|||
27664734|NCT01746108|80609519|FG000|Overall Study|Adverse event, non-fatal|0|||
27664735|NCT01746108|80609520|FG001|Overall Study|Adverse event, non-fatal|1|||
27664736|NCT01746108|80609521|FG002|Overall Study|Adverse event, non-fatal|0|||
27664737|NCT01746108|80609519|FG000|Overall Study|Withdrawal by Subject|0|||
27664738|NCT01746108|80609520|FG001|Overall Study|Withdrawal by Subject|1|||
27664739|NCT01746108|80609521|FG002|Overall Study|Withdrawal by Subject|0|||
27664740|NCT01746108|80609519|FG000|Overall Study|Lost to Follow-up|0|||
27664741|NCT01746108|80609520|FG001|Overall Study|Lost to Follow-up|1|||
27664742|NCT01746108|80609521|FG002|Overall Study|Lost to Follow-up|0|||
27664743|NCT02158247|80609530|FG000|Overall Study|Invisible vocal cords|5|||
27664744|NCT04358068|80609531|FG000|Overall Study|Did not initiate study treatment|2|||
27774263|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774264|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
27774265|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27774266|NCT03073200|81002877|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774267|NCT03073200|81002878|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774268|NCT03073200|81002879|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774269|NCT03073200|81002880|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774270|NCT03073200|81002881|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774271|NCT03073200|81002882|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774272|NCT03073200|81002883|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774273|NCT03073200|81002884|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774274|NCT03073200|81002885|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774275|NCT03073200|81002886|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774276|NCT03073200|81002887|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774277|NCT03073200|81002888|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774278|NCT03073200|81002889|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774279|NCT03073200|81002890|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
27774280|NCT03073200|81002891|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
27774281|NCT03051217|81002892|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
27774282|NCT03051217|81002893|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27774283|NCT03051217|81002894|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
27774284|NCT03051217|81002895|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27774285|NCT03051217|81002896|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27774286|NCT03051217|81002897|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27774287|NCT03051217|81002898|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27774288|NCT03051217|81002892|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
27774289|NCT03051217|81002893|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
27774290|NCT03051217|81002894|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
27774291|NCT03051217|81002895|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
27774292|NCT03051217|81002896|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
27774293|NCT03051217|81002897|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
27774294|NCT03051217|81002898|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
27774295|NCT03051217|81002892|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
27774296|NCT03051217|81002893|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
27774297|NCT03051217|81002894|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
27774298|NCT03051217|81002895|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27774299|NCT03051217|81002896|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27774300|NCT03051217|81002897|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27774301|NCT03051217|81002898|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27774302|NCT03051217|81002892|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
27774303|NCT03051217|81002893|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
27774304|NCT03051217|81002894|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
27774305|NCT03051217|81002895|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
27774306|NCT03051217|81002896|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
27774307|NCT03051217|81002897|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
27774308|NCT03051217|81002898|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
27774309|NCT03051217|81002892|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27774310|NCT03051217|81002893|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27774311|NCT03051217|81002894|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27774312|NCT03051217|81002895|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
27774313|NCT03051217|81002896|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27774314|NCT03051217|81002897|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27774315|NCT03051217|81002898|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
27774316|NCT03051217|81002892|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
27774317|NCT03051217|81002893|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
27774318|NCT03051217|81002894|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
27774319|NCT03051217|81002895|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
27774320|NCT03051217|81002896|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
27774321|NCT03051217|81002897|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
27774322|NCT03051217|81002898|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
27774323|NCT03051217|81002892|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
27774324|NCT03051217|81002893|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
27774325|NCT03051217|81002894|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
27862252|NCT02359994|81326289|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
27774326|NCT03051217|81002895|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
27774327|NCT03051217|81002896|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
27774328|NCT03051217|81002897|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
27774329|NCT03051217|81002898|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
27774330|NCT03051217|81002892|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27774331|NCT03051217|81002893|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27774332|NCT03051217|81002894|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27774333|NCT03051217|81002895|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27774334|NCT03051217|81002896|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27774335|NCT03051217|81002897|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
27774336|NCT03051217|81002898|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
27774337|NCT00959699|81002902|FG000|Treatment Period|Adverse Event|3|||
27774338|NCT00959699|81002903|FG001|Treatment Period|Adverse Event|13|||
27774339|NCT00959699|81002902|FG000|Treatment Period|Lack of Efficacy|15|||
27774340|NCT00959699|81002903|FG001|Treatment Period|Lack of Efficacy|6|||
27774341|NCT00959699|81002902|FG000|Treatment Period|Lost to Follow-up|0|||
27774342|NCT00959699|81002903|FG001|Treatment Period|Lost to Follow-up|1|||
27774343|NCT00959699|81002902|FG000|Treatment Period|Withdrawal by Subject|1|||
27774344|NCT00959699|81002903|FG001|Treatment Period|Withdrawal by Subject|3|||
27774345|NCT00959699|81002902|FG000|Treatment Period|Non-Compliance with Protocol|0|||
27774346|NCT00959699|81002903|FG001|Treatment Period|Non-Compliance with Protocol|1|||
27774347|NCT00959699|81002902|FG000|Treatment Period|Did not receive treatment|0|||
27774348|NCT00959699|81002903|FG001|Treatment Period|Did not receive treatment|1|||
27774349|NCT00959699|81002902|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
27774350|NCT00959699|81002903|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
27774351|NCT00959699|81002902|FG000|Follow-up Period|Lost to Follow-up|3|||
27774352|NCT00959699|81002903|FG001|Follow-up Period|Lost to Follow-up|2|||
27774353|NCT00959699|81002902|FG000|Follow-up Period|Withdrawal by Subject|3|||
27774354|NCT00959699|81002903|FG001|Follow-up Period|Withdrawal by Subject|4|||
27774355|NCT05116683|81002904|FG000|Overall Study|Physician Decision|4|||
27774356|NCT00633360|81002908|FG000|Overall Study|Lost to Follow-up|1|||
27774357|NCT00633360|81002909|FG001|Overall Study|Lost to Follow-up|1|||
27774358|NCT00633360|81002908|FG000|Overall Study|Adverse Event|3|||
27774359|NCT00633360|81002909|FG001|Overall Study|Adverse Event|1|||
27774360|NCT00633360|81002908|FG000|Overall Study|Protocol Violation|0|||
27774361|NCT00633360|81002909|FG001|Overall Study|Protocol Violation|1|||
27774362|NCT02252588|81002914|FG000|Overall Study|Withdrawal by Subject|4|||
27774363|NCT02252588|81002915|FG001|Overall Study|Withdrawal by Subject|0|||
27774364|NCT00638690|81002922|FG000|Overall Study|Death|655|||
27774365|NCT00638690|81002923|FG001|Overall Study|Death|335|||
27774366|NCT00638690|81002922|FG000|Overall Study|Withdrawal by Subject|22|||
27774367|NCT00638690|81002923|FG001|Overall Study|Withdrawal by Subject|5|||
27774368|NCT00638690|81002922|FG000|Overall Study|Lost to Follow-up|4|||
27774369|NCT00638690|81002923|FG001|Overall Study|Lost to Follow-up|2|||
27774370|NCT03858686|81002924|FG000|Period 1|Adverse Event|1|||
27774371|NCT03858686|81002925|FG001|Period 1|Adverse Event|1|||
27774372|NCT03858686|81002924|FG000|Period 1|Lack of compliance|0|||
27774373|NCT03858686|81002925|FG001|Period 1|Lack of compliance|1|||
27774374|NCT03858686|81002924|FG000|Period 1|Adverse Event|0|||
27774375|NCT03858686|81002925|FG001|Period 1|Adverse Event|1|||
27774376|NCT03858686|81002924|FG000|Period 2|Adverse Event|0|||
27774377|NCT03858686|81002925|FG001|Period 2|Adverse Event|1|||
27774378|NCT01466062|81002939|FG000|Overall Study|Adverse Event|1|||
27774379|NCT01466062|81002939|FG000|Overall Study|Withdrawal by Subject|1|||
27774380|NCT00117572|81002940|FG000|Overall Study|Site withdrew before starting treatment|2|||
27774381|NCT00117572|81002941|FG001|Overall Study|Site withdrew before starting treatment|3|||
27774382|NCT00117572|81002940|FG000|Overall Study|Withdrawal by Subject|3|||
27774383|NCT00117572|81002941|FG001|Overall Study|Withdrawal by Subject|3|||
27774384|NCT00117572|81002940|FG000|Overall Study|Protocol Violation|1|||
27774385|NCT00117572|81002941|FG001|Overall Study|Protocol Violation|0|||
27774386|NCT00844415|81002943|FG000|Overall Study|Withdrawal by Subject|1|||
27774387|NCT00777257|81002945|FG000|Overall Study|Adverse Event|3|||
27774388|NCT00777257|81002946|FG001|Overall Study|Adverse Event|1|||
27774389|NCT00777257|81002947|FG002|Overall Study|Adverse Event|0|||
27774390|NCT00777257|81002945|FG000|Overall Study|Lost to Follow-up|3|||
27774391|NCT00777257|81002946|FG001|Overall Study|Lost to Follow-up|3|||
27774392|NCT00777257|81002947|FG002|Overall Study|Lost to Follow-up|2|||
27774393|NCT00777257|81002945|FG000|Overall Study|Protocol Violation|2|||
27774394|NCT00777257|81002946|FG001|Overall Study|Protocol Violation|2|||
27774395|NCT00777257|81002947|FG002|Overall Study|Protocol Violation|2|||
27774396|NCT00777257|81002945|FG000|Overall Study|Withdrawal by Subject|3|||
27774397|NCT00777257|81002946|FG001|Overall Study|Withdrawal by Subject|6|||
27774398|NCT00777257|81002947|FG002|Overall Study|Withdrawal by Subject|5|||
27774399|NCT01188811|81002951|FG000|Overall Study|Withdrawal by Subject|0|||
27774400|NCT01188811|81002952|FG001|Overall Study|Withdrawal by Subject|2|||
27774401|NCT01188811|81002951|FG000|Overall Study|Adverse Event|6|||
27774402|NCT01188811|81002952|FG001|Overall Study|Adverse Event|0|||
27774403|NCT00446641|81002953|FG000|Overall Study|Withdrawal by Subject|8|||
27774404|NCT00446641|81002954|FG001|Overall Study|Withdrawal by Subject|3|||
27774405|NCT00446641|81002953|FG000|Overall Study|poor compliance|8|||
27774406|NCT00446641|81002954|FG001|Overall Study|poor compliance|6|||
27774407|NCT00446641|81002953|FG000|Overall Study|Lost to Follow-up|1|||
27774408|NCT00446641|81002954|FG001|Overall Study|Lost to Follow-up|1|||
27774409|NCT01366534|81002955|FG000|Overall Study|Lost to Follow-up|1|||
27774410|NCT01366534|81002956|FG001|Overall Study|Lost to Follow-up|0|||
27569636|NCT03670810|80275183|FG001|Open Label Extension|Protocol Deviation|0|||
27569637|NCT03670810|80275184|FG002|Open Label Extension|Protocol Deviation|0|||
27774411|NCT01366534|81002957|FG002|Overall Study|Lost to Follow-up|0|||
27774412|NCT01366534|81002955|FG000|Overall Study|Migrated|1|||
27774413|NCT01366534|81002956|FG001|Overall Study|Migrated|1|||
27774414|NCT01366534|81002957|FG002|Overall Study|Migrated|0|||
27774415|NCT01366534|81002955|FG000|Overall Study|Declined challenged|0|||
27774416|NCT01366534|81002956|FG001|Overall Study|Declined challenged|1|||
27774417|NCT01366534|81002957|FG002|Overall Study|Declined challenged|0|||
27774418|NCT00085644|81002958|FG000|Double-Blind Period|Adverse Event|5|||
27774419|NCT00085644|81002959|FG001|Double-Blind Period|Adverse Event|2|||
27774420|NCT00085644|81002960|FG002|Double-Blind Period|Adverse Event|0|||
27774421|NCT00085644|81002958|FG000|Double-Blind Period|Withdrawal by Subject|3|||
27774422|NCT00085644|81002959|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27774423|NCT00085644|81002960|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27774424|NCT00085644|81002958|FG000|Double-Blind Period|Lost to Follow-up|2|||
27774425|NCT00085644|81002959|FG001|Double-Blind Period|Lost to Follow-up|1|||
27965937|NCT02712983|81707931|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
27965938|NCT03629223|81707935|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
27965939|NCT03629223|81707936|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
27774426|NCT00085644|81002960|FG002|Double-Blind Period|Lost to Follow-up|0|||
27774427|NCT00085644|81002958|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
27774428|NCT00085644|81002959|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
27774429|NCT00085644|81002960|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
27774430|NCT00085644|81002958|FG000|Double-Blind Period|Contemplating pregnancy|1|||
27774431|NCT00085644|81002959|FG001|Double-Blind Period|Contemplating pregnancy|0|||
27774432|NCT00085644|81002960|FG002|Double-Blind Period|Contemplating pregnancy|0|||
27774433|NCT00085644|81002958|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
27774434|NCT00085644|81002959|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
27774435|NCT00085644|81002960|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
27774436|NCT00085644|81002958|FG000|Open-Label Period|Adverse Event|0|||
27774437|NCT00085644|81002959|FG001|Open-Label Period|Adverse Event|0|||
27774438|NCT00085644|81002960|FG002|Open-Label Period|Adverse Event|38|||
27774439|NCT00085644|81002958|FG000|Open-Label Period|Withdrawal by Subject|0|||
27774440|NCT00085644|81002959|FG001|Open-Label Period|Withdrawal by Subject|0|||
27965940|NCT03629223|81707937|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
27774441|NCT00085644|81002960|FG002|Open-Label Period|Withdrawal by Subject|29|||
27774442|NCT00085644|81002958|FG000|Open-Label Period|Lost to Follow-up|0|||
27774443|NCT00085644|81002959|FG001|Open-Label Period|Lost to Follow-up|0|||
27774444|NCT00085644|81002960|FG002|Open-Label Period|Lost to Follow-up|13|||
27774445|NCT00085644|81002958|FG000|Open-Label Period|Lack of Efficacy|0|||
27774446|NCT00085644|81002959|FG001|Open-Label Period|Lack of Efficacy|0|||
27774447|NCT00085644|81002960|FG002|Open-Label Period|Lack of Efficacy|15|||
27774448|NCT00085644|81002958|FG000|Open-Label Period|Pregnancy|0|||
27774449|NCT00085644|81002959|FG001|Open-Label Period|Pregnancy|0|||
27965941|NCT03629223|81707938|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
27965942|NCT03629223|81707939|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
27965943|NCT03629223|81707940|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
27965944|NCT03629223|81707935|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
27965945|NCT03629223|81707936|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
27569638|NCT03670810|80275185|FG003|Open Label Extension|Protocol Deviation|0|||
27965946|NCT03629223|81707937|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
27965947|NCT03629223|81707938|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
27965948|NCT03629223|81707939|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
27965949|NCT03629223|81707940|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
27965950|NCT03629223|81707935|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
27965951|NCT03629223|81707936|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
27569639|NCT03670810|80275186|FG004|Open Label Extension|Protocol Deviation|0|||
27569640|NCT03670810|80275187|FG005|Open Label Extension|Protocol Deviation|0|||
27569641|NCT03670810|80275188|FG006|Open Label Extension|Protocol Deviation|0|||
27965952|NCT03629223|81707937|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
27965953|NCT03629223|81707938|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
27965954|NCT03629223|81707939|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
27965955|NCT03629223|81707940|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
27965956|NCT03629223|81707935|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
27965957|NCT03629223|81707936|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
27965958|NCT03629223|81707937|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
27569642|NCT03670810|80275189|FG007|Open Label Extension|Protocol Deviation|0|||
27965959|NCT03629223|81707938|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
27965960|NCT03629223|81707939|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
27965961|NCT03629223|81707940|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
27965962|NCT03629223|81707935|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
27965963|NCT03629223|81707936|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
27965964|NCT03629223|81707937|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
27965965|NCT03629223|81707938|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
27965966|NCT03629223|81707939|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
27965967|NCT03629223|81707940|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
27965968|NCT03941873|81707941|FG000|Overall Study|Death|0|||
27965969|NCT03941873|81707942|FG001|Overall Study|Death|12|||
27965970|NCT03941873|81707943|FG002|Overall Study|Death|2|||
27774450|NCT00085644|81002960|FG002|Open-Label Period|Pregnancy|3|||
27774451|NCT00085644|81002958|FG000|Open-Label Period|Contemplating pregnancy|0|||
27774452|NCT00085644|81002959|FG001|Open-Label Period|Contemplating pregnancy|0|||
27774453|NCT00085644|81002960|FG002|Open-Label Period|Contemplating pregnancy|3|||
27774454|NCT00085644|81002958|FG000|Open-Label Period|Protocol Violation|0|||
27774455|NCT00085644|81002959|FG001|Open-Label Period|Protocol Violation|0|||
27774456|NCT00085644|81002960|FG002|Open-Label Period|Protocol Violation|4|||
27774457|NCT00085644|81002958|FG000|Open-Label Period|Personal reason|0|||
27774458|NCT00085644|81002959|FG001|Open-Label Period|Personal reason|0|||
27774459|NCT00085644|81002960|FG002|Open-Label Period|Personal reason|4|||
27774460|NCT00623766|81002967|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
27774461|NCT00623766|81002968|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
27774462|NCT00623766|81002967|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
27774463|NCT00623766|81002968|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
27774464|NCT00623766|81002967|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
27774465|NCT00623766|81002968|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
27774466|NCT00623766|81002967|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
27774467|NCT00623766|81002968|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
27774468|NCT00623766|81002967|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
27774469|NCT00623766|81002968|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
27774470|NCT03344562|81002976|FG000|Overall Study|Withdrawal by Subject|2|||
27965971|NCT03941873|81707944|FG003|Overall Study|Death|53|||
27965972|NCT03941873|81707941|FG000|Overall Study|Withdrawal by Subject|1|||
27965973|NCT03941873|81707942|FG001|Overall Study|Withdrawal by Subject|1|||
27965974|NCT03941873|81707943|FG002|Overall Study|Withdrawal by Subject|0|||
27569643|NCT03670810|80275190|FG008|Open Label Extension|Protocol Deviation|5|||
27569644|NCT03670810|80275182|FG000|Open Label Extension|Death|0|||
27569645|NCT03670810|80275183|FG001|Open Label Extension|Death|0|||
27569646|NCT03670810|80275184|FG002|Open Label Extension|Death|0|||
27569647|NCT03670810|80275185|FG003|Open Label Extension|Death|0|||
27569648|NCT03670810|80275186|FG004|Open Label Extension|Death|0|||
27569649|NCT03670810|80275187|FG005|Open Label Extension|Death|0|||
27569650|NCT03670810|80275188|FG006|Open Label Extension|Death|0|||
27569651|NCT03670810|80275189|FG007|Open Label Extension|Death|0|||
27569652|NCT03670810|80275190|FG008|Open Label Extension|Death|1|||
27569653|NCT03670810|80275182|FG000|Open Label Extension|COVID-19|0|||
27569654|NCT03670810|80275183|FG001|Open Label Extension|COVID-19|0|||
27569655|NCT03670810|80275184|FG002|Open Label Extension|COVID-19|0|||
27569656|NCT03670810|80275185|FG003|Open Label Extension|COVID-19|0|||
27569657|NCT03670810|80275186|FG004|Open Label Extension|COVID-19|0|||
27569658|NCT03670810|80275187|FG005|Open Label Extension|COVID-19|0|||
27569659|NCT03670810|80275188|FG006|Open Label Extension|COVID-19|0|||
27569660|NCT03670810|80275189|FG007|Open Label Extension|COVID-19|0|||
27569661|NCT03670810|80275190|FG008|Open Label Extension|COVID-19|1|||
27569662|NCT03670810|80275182|FG000|Open Label Extension|Lack of Efficacy|0|||
27569663|NCT03670810|80275183|FG001|Open Label Extension|Lack of Efficacy|0|||
27569664|NCT03670810|80275184|FG002|Open Label Extension|Lack of Efficacy|0|||
27569665|NCT03670810|80275185|FG003|Open Label Extension|Lack of Efficacy|0|||
27774471|NCT03344562|81002977|FG001|Overall Study|Withdrawal by Subject|0|||
27774472|NCT02996110|81002978|FG000|Pre-Treatment|Other Reasons|0|||
27774473|NCT02996110|81002979|FG001|Pre-Treatment|Other Reasons|1|||
27774474|NCT02996110|81002980|FG002|Pre-Treatment|Other Reasons|0|||
27965975|NCT03941873|81707944|FG003|Overall Study|Withdrawal by Subject|5|||
27965976|NCT03941873|81707941|FG000|Overall Study|Lost to Follow-up|1|||
27569666|NCT03670810|80275186|FG004|Open Label Extension|Lack of Efficacy|0|||
27569667|NCT03670810|80275187|FG005|Open Label Extension|Lack of Efficacy|0|||
27569668|NCT03670810|80275188|FG006|Open Label Extension|Lack of Efficacy|0|||
27569669|NCT03670810|80275189|FG007|Open Label Extension|Lack of Efficacy|0|||
27774475|NCT02996110|81002981|FG003|Pre-Treatment|Other Reasons|0|||
27774476|NCT02996110|81002982|FG004|Pre-Treatment|Other Reasons|1|||
27774477|NCT02996110|81002978|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
27965977|NCT03941873|81707942|FG001|Overall Study|Lost to Follow-up|2|||
27774478|NCT02996110|81002979|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
27774479|NCT02996110|81002980|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
27774480|NCT02996110|81002981|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
27774481|NCT02996110|81002982|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
27774482|NCT02996110|81002978|FG000|Track 1|Disease Progression|15|||
27774483|NCT02996110|81002979|FG001|Track 1|Disease Progression|17|||
27774484|NCT02996110|81002980|FG002|Track 1|Disease Progression|0|||
27774485|NCT02996110|81002981|FG003|Track 1|Disease Progression|0|||
27774486|NCT02996110|81002982|FG004|Track 1|Disease Progression|0|||
27774487|NCT02996110|81002978|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
27965978|NCT03941873|81707943|FG002|Overall Study|Lost to Follow-up|0|||
27569670|NCT03670810|80275190|FG008|Open Label Extension|Lack of Efficacy|39|||
27569671|NCT03670810|80275182|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
27569672|NCT03670810|80275183|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
27569673|NCT03670810|80275184|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
27569674|NCT03670810|80275185|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
27569675|NCT03670810|80275186|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
27569676|NCT03670810|80275187|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
27569677|NCT03670810|80275188|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
27569678|NCT03670810|80275189|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
27569679|NCT03670810|80275190|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
27569680|NCT03670810|80275182|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27965979|NCT03941873|81707944|FG003|Overall Study|Lost to Follow-up|0|||
27965980|NCT03941873|81707941|FG000|Overall Study|Sponsor Decision|0|||
27965981|NCT03941873|81707942|FG001|Overall Study|Sponsor Decision|6|||
27965982|NCT03941873|81707943|FG002|Overall Study|Sponsor Decision|0|||
27965983|NCT03941873|81707944|FG003|Overall Study|Sponsor Decision|15|||
27965984|NCT04723355|81707945|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
27965985|NCT04723355|81707945|FG000|Overall Study|Errors in the informed consent form|2|||
27965986|NCT01562314|81707952|FG000|Overall Study|Adverse Event|10|||
27569681|NCT03670810|80275183|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569682|NCT03670810|80275184|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569683|NCT03670810|80275185|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569684|NCT03670810|80275186|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569685|NCT03670810|80275187|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569686|NCT03670810|80275188|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569687|NCT03670810|80275189|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
27569688|NCT03670810|80275190|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
27569689|NCT03670810|80275182|FG000|Open Label Extension|Withdrawal by Subject|0|||
27569690|NCT03670810|80275183|FG001|Open Label Extension|Withdrawal by Subject|0|||
27569691|NCT03670810|80275184|FG002|Open Label Extension|Withdrawal by Subject|0|||
27569692|NCT03670810|80275185|FG003|Open Label Extension|Withdrawal by Subject|0|||
27569693|NCT03670810|80275186|FG004|Open Label Extension|Withdrawal by Subject|0|||
27569694|NCT03670810|80275187|FG005|Open Label Extension|Withdrawal by Subject|0|||
27569695|NCT03670810|80275188|FG006|Open Label Extension|Withdrawal by Subject|0|||
27569696|NCT03670810|80275189|FG007|Open Label Extension|Withdrawal by Subject|0|||
27569697|NCT03670810|80275190|FG008|Open Label Extension|Withdrawal by Subject|46|||
27569698|NCT03670810|80275182|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569699|NCT03670810|80275183|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569700|NCT03670810|80275184|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569701|NCT03670810|80275185|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569702|NCT03670810|80275186|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569703|NCT03670810|80275187|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569704|NCT03670810|80275188|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569705|NCT03670810|80275189|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
27569706|NCT03670810|80275190|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
27569707|NCT03670810|80275182|FG000|Open Label Extension|Physician Decision|0|||
27569708|NCT03670810|80275183|FG001|Open Label Extension|Physician Decision|0|||
27569709|NCT03670810|80275184|FG002|Open Label Extension|Physician Decision|0|||
27569710|NCT03670810|80275185|FG003|Open Label Extension|Physician Decision|0|||
27569711|NCT03670810|80275186|FG004|Open Label Extension|Physician Decision|0|||
27774488|NCT02996110|81002979|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
27774489|NCT02996110|81002980|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
27965987|NCT01562314|81707953|FG001|Overall Study|Adverse Event|5|||
27965988|NCT01562314|81707952|FG000|Overall Study|Met Withdrawal Criteria|3|||
27965989|NCT01562314|81707953|FG001|Overall Study|Met Withdrawal Criteria|2|||
27965990|NCT01562314|81707952|FG000|Overall Study|Withdrawal by Subject|0|||
27965991|NCT01562314|81707953|FG001|Overall Study|Withdrawal by Subject|1|||
27965992|NCT00316706|81707954|FG000|Overall Study|Lost to Follow-up|38|||
27965993|NCT00316706|81707955|FG001|Overall Study|Lost to Follow-up|48|||
27965994|NCT01691105|81707956|FG000|1 Month Follow-up|Lost to Follow-up|41|||
27965995|NCT01691105|81707957|FG001|1 Month Follow-up|Lost to Follow-up|38|||
27965996|NCT01691105|81707956|FG000|1 Month Follow-up|Death|2|||
27965997|NCT01691105|81707957|FG001|1 Month Follow-up|Death|3|||
27965998|NCT01691105|81707956|FG000|6 Month Follow-up|Lost to Follow-up|39|||
27965999|NCT01691105|81707957|FG001|6 Month Follow-up|Lost to Follow-up|58|||
27966000|NCT01691105|81707956|FG000|6 Month Follow-up|Death|13|||
27966001|NCT01691105|81707957|FG001|6 Month Follow-up|Death|13|||
27966002|NCT01691105|81707956|FG000|12 Month Follow-up|Lost to Follow-up|50|||
27966003|NCT01691105|81707957|FG001|12 Month Follow-up|Lost to Follow-up|71|||
27966004|NCT01691105|81707956|FG000|12 Month Follow-up|Death|22|||
27966005|NCT01691105|81707957|FG001|12 Month Follow-up|Death|30|||
27966006|NCT01691105|81707956|FG000|12 Month Biochemical Verification|Death|22|||
27966007|NCT01691105|81707957|FG001|12 Month Biochemical Verification|Death|30|||
27966008|NCT01691105|81707956|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
27966009|NCT01691105|81707957|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
27966010|NCT01691105|81707956|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
27966011|NCT01691105|81707957|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
27966012|NCT01606176|81707958|FG000|Overall Study|Adverse Event|2|||
27966013|NCT01606176|81707959|FG001|Overall Study|Adverse Event|3|||
27966014|NCT01606176|81707958|FG000|Overall Study|Disease progression|1|||
27966015|NCT01606176|81707959|FG001|Overall Study|Disease progression|0|||
27966016|NCT01606176|81707958|FG000|Overall Study|Withdrawal by Subject|1|||
27966017|NCT01606176|81707959|FG001|Overall Study|Withdrawal by Subject|0|||
27966018|NCT00344318|81707960|FG000|Overall Study|Adverse Event|0|||
27966019|NCT00344318|81707961|FG001|Overall Study|Adverse Event|3|||
27966020|NCT00344318|81707962|FG002|Overall Study|Adverse Event|0|||
27966021|NCT00344318|81707963|FG003|Overall Study|Adverse Event|1|||
27966022|NCT00344318|81707960|FG000|Overall Study|Withdrawal by Subject|2|||
27664745|NCT04358068|80609532|FG001|Overall Study|Did not initiate study treatment|2|||
27664746|NCT00520403|80609533|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
27664747|NCT00520403|80609533|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
27664748|NCT00520403|80609533|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
27569712|NCT03670810|80275187|FG005|Open Label Extension|Physician Decision|0|||
27664749|NCT00520403|80609533|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
27774490|NCT02996110|81002981|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
27774491|NCT02996110|81002982|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
27569713|NCT03670810|80275188|FG006|Open Label Extension|Physician Decision|0|||
27569714|NCT03670810|80275189|FG007|Open Label Extension|Physician Decision|0|||
27569715|NCT03670810|80275190|FG008|Open Label Extension|Physician Decision|2|||
27774492|NCT02996110|81002978|FG000|Track 1|Study Drug Toxicity|5|||
27774493|NCT02996110|81002979|FG001|Track 1|Study Drug Toxicity|3|||
27569716|NCT03670810|80275182|FG000|Open Label Extension|Non-compliance with study drug|0|||
27664750|NCT00520403|80609533|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
27966023|NCT00344318|81707961|FG001|Overall Study|Withdrawal by Subject|2|||
27966024|NCT00344318|81707962|FG002|Overall Study|Withdrawal by Subject|0|||
27966025|NCT00344318|81707963|FG003|Overall Study|Withdrawal by Subject|2|||
27966026|NCT00344318|81707960|FG000|Overall Study|Lost to Follow-up|2|||
27966027|NCT00344318|81707961|FG001|Overall Study|Lost to Follow-up|0|||
27966028|NCT00344318|81707962|FG002|Overall Study|Lost to Follow-up|1|||
27966029|NCT00344318|81707963|FG003|Overall Study|Lost to Follow-up|0|||
27966030|NCT03427814|81707968|FG000|Overall Study|Withdrawal by Subject|4|||
27774494|NCT02996110|81002980|FG002|Track 1|Study Drug Toxicity|0|||
27774495|NCT02996110|81002981|FG003|Track 1|Study Drug Toxicity|0|||
27774496|NCT02996110|81002982|FG004|Track 1|Study Drug Toxicity|0|||
27774497|NCT02996110|81002978|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
27774498|NCT02996110|81002979|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27774499|NCT02996110|81002980|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27774500|NCT02996110|81002981|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27774501|NCT02996110|81002982|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
27774502|NCT02996110|81002978|FG000|Track 1|Administrative Reason by Sponsor|0|||
27774503|NCT02996110|81002979|FG001|Track 1|Administrative Reason by Sponsor|1|||
27774504|NCT02996110|81002980|FG002|Track 1|Administrative Reason by Sponsor|0|||
27774505|NCT02996110|81002981|FG003|Track 1|Administrative Reason by Sponsor|0|||
27774506|NCT02996110|81002982|FG004|Track 1|Administrative Reason by Sponsor|0|||
27774507|NCT02996110|81002978|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
27774508|NCT02996110|81002979|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
27774509|NCT02996110|81002980|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
27774510|NCT02996110|81002981|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
27774511|NCT02996110|81002982|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
27774512|NCT02996110|81002978|FG000|Track 2|Disease Progression|33|||
27774513|NCT02996110|81002979|FG001|Track 2|Disease Progression|26|||
27774514|NCT02996110|81002980|FG002|Track 2|Disease Progression|19|||
27774515|NCT02996110|81002981|FG003|Track 2|Disease Progression|16|||
27774516|NCT02996110|81002982|FG004|Track 2|Disease Progression|15|||
27774517|NCT02996110|81002978|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
27774518|NCT02996110|81002979|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
27774519|NCT02996110|81002980|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
27774520|NCT02996110|81002981|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
27774521|NCT02996110|81002982|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
27966031|NCT03427814|81707969|FG001|Overall Study|Withdrawal by Subject|4|||
27966032|NCT03427814|81707968|FG000|Overall Study|Lost to Follow-up|0|||
27966033|NCT03427814|81707969|FG001|Overall Study|Lost to Follow-up|2|||
27966034|NCT03427814|81707968|FG000|Overall Study|Death|42|||
27774522|NCT02996110|81002978|FG000|Track 2|Death|0|||
27774523|NCT02996110|81002979|FG001|Track 2|Death|0|||
27774524|NCT02996110|81002980|FG002|Track 2|Death|1|||
27774525|NCT02996110|81002981|FG003|Track 2|Death|0|||
27966035|NCT03427814|81707969|FG001|Overall Study|Death|31|||
27966036|NCT03427814|81707968|FG000|Overall Study|Sponsor's Decision|1|||
27966037|NCT03427814|81707969|FG001|Overall Study|Sponsor's Decision|0|||
27966038|NCT03427814|81707968|FG000|Overall Study|Investigator's Decision|1|||
27966039|NCT03427814|81707969|FG001|Overall Study|Investigator's Decision|2|||
27966040|NCT03427814|81707968|FG000|Overall Study|Disease progression|1|||
27966041|NCT03427814|81707969|FG001|Overall Study|Disease progression|0|||
27966042|NCT03427814|81707968|FG000|Overall Study|Treatment Completed|0|||
27966043|NCT03427814|81707969|FG001|Overall Study|Treatment Completed|1|||
27966044|NCT03427814|81707968|FG000|Overall Study|Sponsor's Decision to End study|21|||
27966045|NCT03427814|81707969|FG001|Overall Study|Sponsor's Decision to End study|25|||
27966046|NCT03427814|81707968|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
27966047|NCT03427814|81707969|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
27774526|NCT02996110|81002982|FG004|Track 2|Death|1|||
27774527|NCT02996110|81002978|FG000|Track 2|Study Drug Toxicity|4|||
27774528|NCT02996110|81002979|FG001|Track 2|Study Drug Toxicity|1|||
27774529|NCT02996110|81002980|FG002|Track 2|Study Drug Toxicity|4|||
27774530|NCT02996110|81002981|FG003|Track 2|Study Drug Toxicity|1|||
27774531|NCT02996110|81002982|FG004|Track 2|Study Drug Toxicity|0|||
27774532|NCT02996110|81002978|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
27774533|NCT02996110|81002979|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
27774534|NCT02996110|81002980|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
27774535|NCT02996110|81002981|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
27774536|NCT02996110|81002982|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
27774537|NCT02996110|81002978|FG000|Track 2|Participant Withdrew Consent|1|||
27774538|NCT02996110|81002979|FG001|Track 2|Participant Withdrew Consent|2|||
27774539|NCT02996110|81002980|FG002|Track 2|Participant Withdrew Consent|3|||
27774540|NCT02996110|81002981|FG003|Track 2|Participant Withdrew Consent|1|||
27774541|NCT02996110|81002982|FG004|Track 2|Participant Withdrew Consent|1|||
27966048|NCT04908384|81707970|FG000|Overall Study|Lost to Follow-up|4|||
27774542|NCT02996110|81002978|FG000|Track 2|Other Reasons|0|||
27966049|NCT04908384|81707971|FG001|Overall Study|Lost to Follow-up|4|||
27966050|NCT04908384|81707972|FG002|Overall Study|Lost to Follow-up|0|||
27966051|NCT04908384|81707973|FG003|Overall Study|Lost to Follow-up|0|||
27966052|NCT03053440|81707974|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
27966053|NCT03053440|81707975|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
27966054|NCT03053440|81707974|FG000|Overall Study|Death|18|||
27774543|NCT02996110|81002979|FG001|Track 2|Other Reasons|0|||
27966055|NCT03053440|81707975|FG001|Overall Study|Death|14|||
27774544|NCT02996110|81002980|FG002|Track 2|Other Reasons|1|||
27774545|NCT02996110|81002981|FG003|Track 2|Other Reasons|0|||
27774546|NCT02996110|81002982|FG004|Track 2|Other Reasons|1|||
27774547|NCT03887052|81002983|FG000|Overall Study|Adverse Event|2|||
27774548|NCT03887052|81002983|FG000|Overall Study|Physician Decision|2|||
27774549|NCT03887052|81002983|FG000|Overall Study|Withdrawal by Subject|3|||
27774550|NCT03887052|81002983|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
27774551|NCT03887052|81002983|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
27774552|NCT00209092|81002984|FG000|Overall Study|Progression of disease|7|||
27774553|NCT00209092|81002985|FG001|Overall Study|Progression of disease|1|||
27774554|NCT00209092|81002984|FG000|Overall Study|Adverse Event|0|||
27774555|NCT00209092|81002985|FG001|Overall Study|Adverse Event|1|||
27774556|NCT00209092|81002984|FG000|Overall Study|Withdrawal by Subject|1|||
27774557|NCT00209092|81002985|FG001|Overall Study|Withdrawal by Subject|0|||
27774558|NCT02579863|81002986|FG000|Overall Study|Final Disposition Unknown|2|||
27774559|NCT02579863|81002987|FG001|Overall Study|Final Disposition Unknown|1|||
27774560|NCT02579863|81002986|FG000|Overall Study|Adverse Event|18|||
27774561|NCT02579863|81002987|FG001|Overall Study|Adverse Event|11|||
27774562|NCT02579863|81002986|FG000|Overall Study|Death|31|||
27774563|NCT02579863|81002987|FG001|Overall Study|Death|29|||
27774564|NCT02579863|81002986|FG000|Overall Study|Lost to Follow-up|2|||
27774565|NCT02579863|81002987|FG001|Overall Study|Lost to Follow-up|1|||
27774566|NCT02579863|81002986|FG000|Overall Study|Physician Decision|1|||
27774567|NCT02579863|81002987|FG001|Overall Study|Physician Decision|2|||
27774568|NCT02579863|81002986|FG000|Overall Study|Screen Failure|0|||
27774569|NCT02579863|81002987|FG001|Overall Study|Screen Failure|2|||
27774570|NCT02579863|81002986|FG000|Overall Study|Study Terminated at Selected Sites|82|||
27774571|NCT02579863|81002987|FG001|Overall Study|Study Terminated at Selected Sites|88|||
27774572|NCT02579863|81002986|FG000|Overall Study|Withdrawal by Subject|20|||
27774573|NCT02579863|81002987|FG001|Overall Study|Withdrawal by Subject|20|||
27774574|NCT02177786|81002992|FG000|Overall Study|Withdrew Consent|2|||
27774575|NCT02177786|81002993|FG001|Overall Study|Withdrew Consent|6|||
27774576|NCT02177786|81002994|FG002|Overall Study|Withdrew Consent|9|||
27774577|NCT02177786|81002995|FG003|Overall Study|Withdrew Consent|5|||
27774578|NCT02177786|81002992|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
27774579|NCT02177786|81002993|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
27774580|NCT02177786|81002994|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
27774581|NCT02177786|81002995|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
27774582|NCT02177786|81002992|FG000|Overall Study|Adverse Event|1|||
27774583|NCT02177786|81002993|FG001|Overall Study|Adverse Event|1|||
27774584|NCT02177786|81002994|FG002|Overall Study|Adverse Event|2|||
27774585|NCT02177786|81002995|FG003|Overall Study|Adverse Event|3|||
27774586|NCT02177786|81002992|FG000|Overall Study|Death|1|||
27774587|NCT02177786|81002993|FG001|Overall Study|Death|1|||
27774588|NCT02177786|81002994|FG002|Overall Study|Death|1|||
27774589|NCT02177786|81002995|FG003|Overall Study|Death|1|||
27774590|NCT02177786|81002992|FG000|Overall Study|Lost to Follow-up|0|||
27774591|NCT02177786|81002993|FG001|Overall Study|Lost to Follow-up|0|||
27774592|NCT02177786|81002994|FG002|Overall Study|Lost to Follow-up|2|||
27774593|NCT02177786|81002995|FG003|Overall Study|Lost to Follow-up|2|||
27774594|NCT02177786|81002992|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27774595|NCT02177786|81002993|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27774596|NCT02177786|81002994|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27774597|NCT02177786|81002995|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27774598|NCT02177786|81002992|FG000|Overall Study|Protocol Violation|0|||
27774599|NCT02177786|81002993|FG001|Overall Study|Protocol Violation|0|||
27774600|NCT02177786|81002994|FG002|Overall Study|Protocol Violation|2|||
27966056|NCT03053440|81707974|FG000|Overall Study|Withdrawal by Subject|9|||
27966057|NCT03053440|81707975|FG001|Overall Study|Withdrawal by Subject|8|||
27966058|NCT03053440|81707974|FG000|Overall Study|Lost to Follow-up|1|||
27966059|NCT03053440|81707975|FG001|Overall Study|Lost to Follow-up|0|||
27569717|NCT03670810|80275183|FG001|Open Label Extension|Non-compliance with study drug|0|||
27569718|NCT03670810|80275184|FG002|Open Label Extension|Non-compliance with study drug|0|||
27569719|NCT03670810|80275185|FG003|Open Label Extension|Non-compliance with study drug|0|||
27569720|NCT03670810|80275186|FG004|Open Label Extension|Non-compliance with study drug|0|||
27569721|NCT03670810|80275187|FG005|Open Label Extension|Non-compliance with study drug|0|||
27966060|NCT03053440|81707974|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
27966061|NCT03053440|81707975|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
27774601|NCT02177786|81002995|FG003|Overall Study|Protocol Violation|0|||
27774602|NCT02177786|81002992|FG000|Overall Study|Progressive Disease|0|||
27774603|NCT02177786|81002993|FG001|Overall Study|Progressive Disease|1|||
27774604|NCT02177786|81002994|FG002|Overall Study|Progressive Disease|0|||
27774605|NCT02177786|81002995|FG003|Overall Study|Progressive Disease|0|||
27774606|NCT02177786|81002992|FG000|Overall Study|Missing study completion status|0|||
27774607|NCT02177786|81002993|FG001|Overall Study|Missing study completion status|1|||
27774608|NCT02177786|81002994|FG002|Overall Study|Missing study completion status|0|||
27774609|NCT02177786|81002995|FG003|Overall Study|Missing study completion status|0|||
27774610|NCT00790218|81002996|FG000|Overall Study|Death|1|||
27774611|NCT00790218|81002997|FG001|Overall Study|Death|0|||
27774612|NCT00790218|81002998|FG002|Overall Study|Death|0|||
27774613|NCT00118040|81003000|FG000|Overall Study|Adverse Event|0|||
27774614|NCT00118040|81003001|FG001|Overall Study|Adverse Event|1|||
27774615|NCT00118040|81003002|FG002|Overall Study|Adverse Event|0|||
27774616|NCT00118040|81003000|FG000|Overall Study|Withdrawal by Subject|0|||
27774617|NCT00118040|81003001|FG001|Overall Study|Withdrawal by Subject|0|||
27774618|NCT00118040|81003002|FG002|Overall Study|Withdrawal by Subject|2|||
27774619|NCT00118040|81003000|FG000|Overall Study|Medical Contraindication|0|||
27774620|NCT00118040|81003001|FG001|Overall Study|Medical Contraindication|0|||
27774621|NCT00118040|81003002|FG002|Overall Study|Medical Contraindication|1|||
27774622|NCT00118040|81003000|FG000|Overall Study|Non-Compliant Participant|1|||
27774623|NCT00118040|81003001|FG001|Overall Study|Non-Compliant Participant|1|||
27774624|NCT00118040|81003002|FG002|Overall Study|Non-Compliant Participant|2|||
27774625|NCT00118040|81003000|FG000|Overall Study|Other|0|||
27774626|NCT00118040|81003001|FG001|Overall Study|Other|0|||
27774627|NCT00118040|81003002|FG002|Overall Study|Other|1|||
27774628|NCT04259346|81003003|FG000|Overall Study|Lost to Follow-up|1|||
27774629|NCT04259346|81003004|FG001|Overall Study|Lost to Follow-up|3|||
27774630|NCT04259346|81003003|FG000|Overall Study|Protocol Violation|1|||
27774631|NCT04259346|81003004|FG001|Overall Study|Protocol Violation|0|||
27774632|NCT04259346|81003003|FG000|Overall Study|Withdrawal by Subject|1|||
27774633|NCT04259346|81003004|FG001|Overall Study|Withdrawal by Subject|0|||
27774634|NCT04259346|81003003|FG000|Overall Study|Adverse Event|1|||
27774635|NCT04259346|81003004|FG001|Overall Study|Adverse Event|1|||
27774636|NCT03050307|81003005|FG000|Overall Study|Adverse Event|4|||
27774637|NCT03050307|81003006|FG001|Overall Study|Adverse Event|2|||
27774638|NCT03050307|81003005|FG000|Overall Study|Significant Protocol Deviation|0|||
27774639|NCT03050307|81003006|FG001|Overall Study|Significant Protocol Deviation|1|||
27774640|NCT03050307|81003005|FG000|Overall Study|Lost to Follow-up|0|||
27774641|NCT03050307|81003006|FG001|Overall Study|Lost to Follow-up|1|||
27774642|NCT03050307|81003005|FG000|Overall Study|Voluntary Withdrawal|3|||
27774643|NCT03050307|81003006|FG001|Overall Study|Voluntary Withdrawal|4|||
27774644|NCT03050307|81003005|FG000|Overall Study|Reason not Specified|1|||
27774645|NCT03050307|81003006|FG001|Overall Study|Reason not Specified|1|||
27774646|NCT00464620|81003007|FG000|Overall Study|Physician Decision|1|||
27774647|NCT00464620|81003008|FG001|Overall Study|Physician Decision|0|||
27774648|NCT00464620|81003009|FG002|Overall Study|Physician Decision|0|||
27774649|NCT00464620|81003007|FG000|Overall Study|Withdrawal by Subject|1|||
27774650|NCT00464620|81003008|FG001|Overall Study|Withdrawal by Subject|0|||
27774651|NCT00464620|81003009|FG002|Overall Study|Withdrawal by Subject|3|||
27774652|NCT00464620|81003007|FG000|Overall Study|Ineligible sarcoma subtype|0|||
27774653|NCT00464620|81003008|FG001|Overall Study|Ineligible sarcoma subtype|2|||
27774654|NCT00464620|81003009|FG002|Overall Study|Ineligible sarcoma subtype|2|||
27774655|NCT00464620|81003007|FG000|Overall Study|Use of prohibited concomitant medication|0|||
27774656|NCT00464620|81003008|FG001|Overall Study|Use of prohibited concomitant medication|0|||
27774657|NCT00464620|81003009|FG002|Overall Study|Use of prohibited concomitant medication|2|||
27774658|NCT02691468|81003010|FG000|Overall Study|Bronchial blocker use|2|||
27774659|NCT02691468|81003011|FG001|Overall Study|Bronchial blocker use|1|||
27774660|NCT02691468|81003010|FG000|Overall Study|Lost to Follow-up|2|||
27774661|NCT02691468|81003011|FG001|Overall Study|Lost to Follow-up|1|||
27774662|NCT02691468|81003010|FG000|Overall Study|Failure to advance FOB|2|||
27774663|NCT02691468|81003011|FG001|Overall Study|Failure to advance FOB|0|||
27774664|NCT00732238|81003012|FG000|Overall Study|Bacteremia|4|||
27774665|NCT00732238|81003013|FG001|Overall Study|Bacteremia|1|||
27774666|NCT00732238|81003012|FG000|Overall Study|Asymptomatic bacteriuria|1|||
27774667|NCT00732238|81003013|FG001|Overall Study|Asymptomatic bacteriuria|0|||
27774668|NCT00537771|81003014|FG000|Overall Study|Withdrawal by Subject|6|||
27774669|NCT00537771|81003015|FG001|Overall Study|Withdrawal by Subject|23|||
27774670|NCT00537771|81003014|FG000|Overall Study|Adverse Event|8|||
27774671|NCT00537771|81003015|FG001|Overall Study|Adverse Event|15|||
27966062|NCT03053440|81707974|FG000|Overall Study|Physician Decision|2|||
27966063|NCT03053440|81707975|FG001|Overall Study|Physician Decision|1|||
27774672|NCT00537771|81003014|FG000|Overall Study|Lost to Follow-up|9|||
27774673|NCT00537771|81003015|FG001|Overall Study|Lost to Follow-up|15|||
27774674|NCT00537771|81003014|FG000|Overall Study|Protocol Violation|2|||
27774675|NCT00537771|81003015|FG001|Overall Study|Protocol Violation|6|||
27774676|NCT00537771|81003014|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
27774677|NCT00537771|81003015|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27774678|NCT04067011|81003018|FG000|Overall Study|Not Treated|8|||
27774679|NCT04067011|81003019|FG001|Overall Study|Not Treated|7|||
27774680|NCT04067011|81003020|FG002|Overall Study|Not Treated|5|||
27774681|NCT04067011|81003018|FG000|Overall Study|Adverse Event|2|||
27774682|NCT04067011|81003019|FG001|Overall Study|Adverse Event|1|||
27966064|NCT03053440|81707974|FG000|Overall Study|Participant Randomized but died before dosing|1|||
27966065|NCT03053440|81707975|FG001|Overall Study|Participant Randomized but died before dosing|0|||
27966066|NCT02701283|81707976|FG000|Overall Study|Death|25|||
27966067|NCT02701283|81707977|FG001|Overall Study|Death|29|||
27966068|NCT02701283|81707978|FG002|Overall Study|Death|19|||
27966069|NCT02701283|81707976|FG000|Overall Study|Lost to Follow-up|3|||
27966070|NCT02701283|81707977|FG001|Overall Study|Lost to Follow-up|8|||
27966071|NCT02701283|81707978|FG002|Overall Study|Lost to Follow-up|1|||
27966072|NCT02701283|81707976|FG000|Overall Study|Withdrawal by Subject|12|||
27966073|NCT02701283|81707977|FG001|Overall Study|Withdrawal by Subject|41|||
27966074|NCT02701283|81707978|FG002|Overall Study|Withdrawal by Subject|1|||
27966075|NCT02701283|81707976|FG000|Overall Study|Missed 2-year visit|22|||
27966076|NCT02701283|81707977|FG001|Overall Study|Missed 2-year visit|27|||
27966077|NCT02701283|81707978|FG002|Overall Study|Missed 2-year visit|0|||
27966078|NCT02701283|81707976|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
27966079|NCT02701283|81707977|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
27966080|NCT02701283|81707978|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
27966081|NCT02438683|81707980|FG000|Overall Study|Adverse Event|1|||
27966082|NCT02438683|81707981|FG001|Overall Study|Adverse Event|0|||
27966083|NCT02438683|81707982|FG002|Overall Study|Adverse Event|0|||
27966084|NCT02438683|81707983|FG003|Overall Study|Adverse Event|0|||
27966085|NCT02438683|81707984|FG004|Overall Study|Adverse Event|0|||
27966086|NCT02438683|81707985|FG005|Overall Study|Adverse Event|0|||
27966087|NCT05425732|81707986|FG000|Overall Study|Death|4|||
27966088|NCT05425732|81707987|FG001|Overall Study|Death|2|||
27966089|NCT05425732|81707988|FG002|Overall Study|Death|0|||
27966090|NCT05425732|81707989|FG003|Overall Study|Death|0|||
27966091|NCT05425732|81707986|FG000|Overall Study|Lost to Follow-up|10|||
27966092|NCT05425732|81707987|FG001|Overall Study|Lost to Follow-up|15|||
27966093|NCT05425732|81707988|FG002|Overall Study|Lost to Follow-up|5|||
27966094|NCT05425732|81707989|FG003|Overall Study|Lost to Follow-up|3|||
27966095|NCT05425732|81707986|FG000|Overall Study|Physician Decision|0|||
27966096|NCT05425732|81707987|FG001|Overall Study|Physician Decision|2|||
27966097|NCT05425732|81707988|FG002|Overall Study|Physician Decision|0|||
27966098|NCT05425732|81707989|FG003|Overall Study|Physician Decision|0|||
27966099|NCT05425732|81707986|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
27966100|NCT05425732|81707987|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
27774683|NCT04067011|81003020|FG002|Overall Study|Adverse Event|0|||
27774684|NCT04067011|81003018|FG000|Overall Study|Withdrawal by Subject|6|||
27774685|NCT04067011|81003019|FG001|Overall Study|Withdrawal by Subject|2|||
27774686|NCT04067011|81003020|FG002|Overall Study|Withdrawal by Subject|1|||
27774687|NCT04067011|81003018|FG000|Overall Study|Lost to Follow-up|0|||
27774688|NCT04067011|81003019|FG001|Overall Study|Lost to Follow-up|0|||
27774689|NCT04067011|81003020|FG002|Overall Study|Lost to Follow-up|1|||
27774690|NCT04067011|81003018|FG000|Overall Study|Physician Decision|1|||
27774691|NCT04067011|81003019|FG001|Overall Study|Physician Decision|1|||
27774692|NCT04067011|81003020|FG002|Overall Study|Physician Decision|0|||
27774693|NCT04067011|81003018|FG000|Overall Study|Other Reasons|2|||
27774694|NCT04067011|81003019|FG001|Overall Study|Other Reasons|0|||
27774695|NCT04067011|81003020|FG002|Overall Study|Other Reasons|1|||
27774696|NCT04067011|81003018|FG000|Overall Study|Missing|0|||
27774697|NCT04067011|81003019|FG001|Overall Study|Missing|2|||
27774698|NCT04067011|81003020|FG002|Overall Study|Missing|0|||
27774699|NCT00985738|81003021|FG000|Overall Study|Study closed prematurely|8|||
27774700|NCT00985738|81003022|FG001|Overall Study|Study closed prematurely|8|||
27774701|NCT01135394|81003023|FG000|Screening|Lost to Follow-up|2|||
27774702|NCT01135394|81003023|FG000|Screening|Withdrawal by Subject|10|||
27774703|NCT01135394|81003023|FG000|Screening|Screening failure|16|||
27966101|NCT05425732|81707988|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27774704|NCT01135394|81003023|FG000|Screening|Physician Decision|5|||
27966102|NCT05425732|81707989|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27966103|NCT05425732|81707986|FG000|Overall Study|Withdrawal by Subject|4|||
27966104|NCT05425732|81707987|FG001|Overall Study|Withdrawal by Subject|8|||
27966105|NCT05425732|81707988|FG002|Overall Study|Withdrawal by Subject|1|||
27966106|NCT05425732|81707989|FG003|Overall Study|Withdrawal by Subject|1|||
27774705|NCT01135394|81003023|FG000|Baseline Assessment|Withdrawal by Subject|9|||
27774706|NCT01135394|81003023|FG000|Baseline Assessment|Physician Decision|3|||
27774707|NCT01135394|81003023|FG000|Baseline Assessment|Lost to Follow-up|2|||
27966107|NCT05425732|81707986|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
27966108|NCT05425732|81707987|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
27966109|NCT05425732|81707988|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
27966110|NCT05425732|81707989|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
27966111|NCT01450696|81707991|FG000|Overall Study|Never Treated|1|||
27966112|NCT01450696|81707992|FG001|Overall Study|Never Treated|1|||
27966113|NCT01450696|81707991|FG000|Overall Study|Death|77|||
27966114|NCT01450696|81707992|FG001|Overall Study|Death|84|||
27966115|NCT01450696|81707991|FG000|Overall Study|Lost to Follow-up|3|||
27966116|NCT01450696|81707992|FG001|Overall Study|Lost to Follow-up|3|||
27966117|NCT01450696|81707991|FG000|Overall Study|Non-Compliance|1|||
27966118|NCT01450696|81707992|FG001|Overall Study|Non-Compliance|0|||
27966119|NCT01450696|81707991|FG000|Overall Study|Withdrawal by Subject|13|||
27966120|NCT01450696|81707992|FG001|Overall Study|Withdrawal by Subject|2|||
27966121|NCT01450696|81707991|FG000|Overall Study|Study Terminated by Sponsor|53|||
27966122|NCT01450696|81707992|FG001|Overall Study|Study Terminated by Sponsor|58|||
27966123|NCT01096368|81707995|FG000|Overall Study|Death|0|||
27966124|NCT01096368|81707996|FG001|Overall Study|Death|1|||
27774708|NCT01135394|81003023|FG000|Baseline Assessment|Adverse Event|1|||
27966125|NCT01096368|81707997|FG002|Overall Study|Death|0|||
27966126|NCT01096368|81707998|FG003|Overall Study|Death|0|||
27966127|NCT01096368|81707999|FG004|Overall Study|Death|0|||
27966128|NCT01096368|81707995|FG000|Overall Study|Physician Decision|0|||
27966129|NCT01096368|81707996|FG001|Overall Study|Physician Decision|13|||
27966130|NCT01096368|81707997|FG002|Overall Study|Physician Decision|2|||
27966131|NCT01096368|81707998|FG003|Overall Study|Physician Decision|4|||
27966132|NCT01096368|81707999|FG004|Overall Study|Physician Decision|6|||
27966133|NCT01096368|81707995|FG000|Overall Study|Withdrawal by Subject|0|||
27966134|NCT01096368|81707996|FG001|Overall Study|Withdrawal by Subject|52|||
27966135|NCT01096368|81707997|FG002|Overall Study|Withdrawal by Subject|0|||
27966136|NCT01096368|81707998|FG003|Overall Study|Withdrawal by Subject|10|||
27966137|NCT01096368|81707999|FG004|Overall Study|Withdrawal by Subject|14|||
27966138|NCT01096368|81707995|FG000|Overall Study|Ineligible|0|||
27966139|NCT01096368|81707996|FG001|Overall Study|Ineligible|3|||
27966140|NCT01096368|81707997|FG002|Overall Study|Ineligible|2|||
27966141|NCT01096368|81707998|FG003|Overall Study|Ineligible|0|||
27966142|NCT01096368|81707999|FG004|Overall Study|Ineligible|25|||
27966143|NCT01096368|81707995|FG000|Overall Study|Did not start treatment|0|||
27966144|NCT01096368|81707996|FG001|Overall Study|Did not start treatment|4|||
27966145|NCT01096368|81707997|FG002|Overall Study|Did not start treatment|4|||
27966146|NCT01096368|81707998|FG003|Overall Study|Did not start treatment|0|||
27966147|NCT01096368|81707999|FG004|Overall Study|Did not start treatment|0|||
27966148|NCT01096368|81707995|FG000|Overall Study|Progressive disease|0|||
27966149|NCT01096368|81707996|FG001|Overall Study|Progressive disease|6|||
27966150|NCT01096368|81707997|FG002|Overall Study|Progressive disease|0|||
27966151|NCT01096368|81707998|FG003|Overall Study|Progressive disease|10|||
27966152|NCT01096368|81707999|FG004|Overall Study|Progressive disease|3|||
27966153|NCT01096368|81707995|FG000|Overall Study|Other|0|||
27966154|NCT01096368|81707996|FG001|Overall Study|Other|0|||
27966155|NCT01096368|81707997|FG002|Overall Study|Other|1|||
27966156|NCT01096368|81707998|FG003|Overall Study|Other|0|||
27966157|NCT01096368|81707999|FG004|Overall Study|Other|0|||
27966158|NCT01096368|81707995|FG000|Overall Study|Treated with institutional review|0|||
27966159|NCT01096368|81707996|FG001|Overall Study|Treated with institutional review|0|||
27966160|NCT01096368|81707997|FG002|Overall Study|Treated with institutional review|0|||
27966161|NCT01096368|81707998|FG003|Overall Study|Treated with institutional review|0|||
27966162|NCT01096368|81707999|FG004|Overall Study|Treated with institutional review|1|||
27966163|NCT01814046|81708000|FG000|Drug Administration|Death due to complications of RSV|1|||
27966164|NCT01814046|81708001|FG001|Drug Administration|Death due to complications of RSV|0|||
27966165|NCT01814046|81708002|FG002|Drug Administration|Death due to complications of RSV|0|||
27966166|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
27966167|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
27966168|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
27966169|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
27966170|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
27966171|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
27966172|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
27966173|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
27966174|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27966175|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27966176|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27966177|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
27966178|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
27966179|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
27966180|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27569722|NCT03670810|80275188|FG006|Open Label Extension|Non-compliance with study drug|0|||
27569723|NCT03670810|80275189|FG007|Open Label Extension|Non-compliance with study drug|0|||
27569724|NCT03670810|80275190|FG008|Open Label Extension|Non-compliance with study drug|5|||
27569725|NCT03670810|80275182|FG000|Open Label Extension|Pregnancy|0|||
27569726|NCT03670810|80275183|FG001|Open Label Extension|Pregnancy|0|||
27569727|NCT03670810|80275184|FG002|Open Label Extension|Pregnancy|0|||
27569728|NCT03670810|80275185|FG003|Open Label Extension|Pregnancy|0|||
27774709|NCT01135394|81003023|FG000|Study Treatment|Withdrawal by Subject|1|||
27966181|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27966182|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27966183|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
27966184|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
27966185|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
27966186|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
27966187|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
27966188|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
27966189|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
27966190|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27966191|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
27966192|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27966193|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27966194|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27966195|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
27966196|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
27966197|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
27966198|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
27966199|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
27966200|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
27966201|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
27966202|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
27966203|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
27966204|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
27966205|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
27966206|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
27966207|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
27569729|NCT03670810|80275186|FG004|Open Label Extension|Pregnancy|0|||
27569730|NCT03670810|80275187|FG005|Open Label Extension|Pregnancy|0|||
27569731|NCT03670810|80275188|FG006|Open Label Extension|Pregnancy|0|||
27569732|NCT03670810|80275189|FG007|Open Label Extension|Pregnancy|0|||
27569733|NCT03670810|80275190|FG008|Open Label Extension|Pregnancy|3|||
27569734|NCT03670810|80275182|FG000|Open Label Extension|Adverse Event|0|||
27569735|NCT03670810|80275183|FG001|Open Label Extension|Adverse Event|0|||
27966208|NCT03985943|81708003|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
27966209|NCT03985943|81708004|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
27966210|NCT03985943|81708005|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
27966211|NCT03985943|81708006|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
27966212|NCT03985943|81708007|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
27966213|NCT03985943|81708008|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
27966214|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27966215|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27966216|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
27774710|NCT01135394|81003023|FG000|Study Treatment|Physician Decision|1|||
27774711|NCT01135394|81003023|FG000|Study Treatment|Adverse Event|2|||
27966217|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
27966218|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
27966219|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
27966220|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27966221|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27966222|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
27966223|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
27966224|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
27774712|NCT00498368|81003026|FG000|Overall Study|Withdrawal by Subject|3|||
27774713|NCT00498368|81003027|FG001|Overall Study|Withdrawal by Subject|2|||
27966225|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
27966226|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
27966227|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
27966228|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
27966229|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
27966230|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
27966231|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
27966232|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27966233|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27966234|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27966235|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
27966236|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
27966237|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
27966238|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
27966239|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
27966240|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
27966241|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
27966242|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
27966243|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
27966244|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
27966245|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
27966246|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
27966247|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
27966248|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
27569736|NCT03670810|80275184|FG002|Open Label Extension|Adverse Event|0|||
27569737|NCT03670810|80275185|FG003|Open Label Extension|Adverse Event|0|||
27774714|NCT01974440|81003028|FG000|Overall Study|Lost to Follow-up|7|||
27966249|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
27966250|NCT03985943|81708003|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
27966251|NCT03985943|81708004|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
27966252|NCT03985943|81708005|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
27966253|NCT03985943|81708006|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
27966254|NCT03985943|81708007|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
27966255|NCT03985943|81708008|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
27966256|NCT04952597|81708009|FG000|Overall Study|Death|12|||
27966257|NCT04952597|81708010|FG001|Overall Study|Death|13|||
27966258|NCT04952597|81708011|FG002|Overall Study|Death|14|||
27966259|NCT04952597|81708009|FG000|Overall Study|Withdrawal by Subject|1|||
27966260|NCT04952597|81708010|FG001|Overall Study|Withdrawal by Subject|0|||
27966261|NCT04952597|81708011|FG002|Overall Study|Withdrawal by Subject|3|||
27966262|NCT04952597|81708009|FG000|Overall Study|Lost to Follow-up|0|||
27966263|NCT04952597|81708010|FG001|Overall Study|Lost to Follow-up|1|||
27966264|NCT04952597|81708011|FG002|Overall Study|Lost to Follow-up|1|||
27966265|NCT01436656|81708016|FG000|Dose Escalation|Death|1|||
27966266|NCT01436656|81708017|FG001|Dose Escalation|Death|3|||
27966267|NCT01436656|81708018|FG002|Dose Escalation|Death|1|||
27966268|NCT01436656|81708019|FG003|Dose Escalation|Death|0|||
27966269|NCT01436656|81708020|FG004|Dose Escalation|Death|2|||
27966270|NCT01436656|81708021|FG005|Dose Escalation|Death|1|||
27966271|NCT01436656|81708022|FG006|Dose Escalation|Death|1|||
27966272|NCT01436656|81708023|FG007|Dose Escalation|Death|1|||
27966273|NCT01436656|81708024|FG008|Dose Escalation|Death|1|||
27966274|NCT01436656|81708025|FG009|Dose Escalation|Death|0|||
27966275|NCT01436656|81708026|FG010|Dose Escalation|Death|0|||
27966276|NCT01436656|81708027|FG011|Dose Escalation|Death|0|||
27966277|NCT01436656|81708028|FG012|Dose Escalation|Death|0|||
27966278|NCT01436656|81708029|FG013|Dose Escalation|Death|0|||
27966279|NCT01436656|81708030|FG014|Dose Escalation|Death|0|||
27966280|NCT01436656|81708031|FG015|Dose Escalation|Death|0|||
27966281|NCT01436656|81708032|FG016|Dose Escalation|Death|0|||
27966282|NCT01436656|81708033|FG017|Dose Escalation|Death|0|||
27966283|NCT01436656|81708016|FG000|Dose Escalation|Protocol Violation|0|||
27966284|NCT01436656|81708017|FG001|Dose Escalation|Protocol Violation|0|||
27966285|NCT01436656|81708018|FG002|Dose Escalation|Protocol Violation|0|||
27966286|NCT01436656|81708019|FG003|Dose Escalation|Protocol Violation|0|||
27966287|NCT01436656|81708020|FG004|Dose Escalation|Protocol Violation|0|||
27966288|NCT01436656|81708021|FG005|Dose Escalation|Protocol Violation|1|||
27966289|NCT01436656|81708022|FG006|Dose Escalation|Protocol Violation|0|||
27966290|NCT01436656|81708023|FG007|Dose Escalation|Protocol Violation|0|||
27966291|NCT01436656|81708024|FG008|Dose Escalation|Protocol Violation|0|||
27966292|NCT01436656|81708025|FG009|Dose Escalation|Protocol Violation|0|||
27966293|NCT01436656|81708026|FG010|Dose Escalation|Protocol Violation|0|||
27966294|NCT01436656|81708027|FG011|Dose Escalation|Protocol Violation|0|||
27966295|NCT01436656|81708028|FG012|Dose Escalation|Protocol Violation|0|||
27966296|NCT01436656|81708029|FG013|Dose Escalation|Protocol Violation|0|||
27966297|NCT01436656|81708030|FG014|Dose Escalation|Protocol Violation|0|||
27966298|NCT01436656|81708031|FG015|Dose Escalation|Protocol Violation|0|||
27966299|NCT01436656|81708032|FG016|Dose Escalation|Protocol Violation|0|||
27966300|NCT01436656|81708033|FG017|Dose Escalation|Protocol Violation|0|||
27966301|NCT01436656|81708016|FG000|Dose Escalation|Withdrawal by Subject|0|||
27966302|NCT01436656|81708017|FG001|Dose Escalation|Withdrawal by Subject|0|||
27966303|NCT01436656|81708018|FG002|Dose Escalation|Withdrawal by Subject|0|||
27966304|NCT01436656|81708019|FG003|Dose Escalation|Withdrawal by Subject|0|||
27966305|NCT01436656|81708020|FG004|Dose Escalation|Withdrawal by Subject|1|||
27966306|NCT01436656|81708021|FG005|Dose Escalation|Withdrawal by Subject|0|||
27862253|NCT02359994|81326288|FG000|Extended Oncology 24-Month Survival|Death|19|||
27966307|NCT01436656|81708022|FG006|Dose Escalation|Withdrawal by Subject|0|||
27966308|NCT01436656|81708023|FG007|Dose Escalation|Withdrawal by Subject|2|||
27966309|NCT01436656|81708024|FG008|Dose Escalation|Withdrawal by Subject|0|||
27966310|NCT01436656|81708025|FG009|Dose Escalation|Withdrawal by Subject|1|||
27966311|NCT01436656|81708026|FG010|Dose Escalation|Withdrawal by Subject|1|||
27966312|NCT01436656|81708027|FG011|Dose Escalation|Withdrawal by Subject|0|||
27966313|NCT01436656|81708028|FG012|Dose Escalation|Withdrawal by Subject|0|||
27966314|NCT01436656|81708029|FG013|Dose Escalation|Withdrawal by Subject|0|||
27966315|NCT01436656|81708030|FG014|Dose Escalation|Withdrawal by Subject|0|||
27966316|NCT01436656|81708031|FG015|Dose Escalation|Withdrawal by Subject|0|||
27966317|NCT01436656|81708032|FG016|Dose Escalation|Withdrawal by Subject|0|||
27966318|NCT01436656|81708033|FG017|Dose Escalation|Withdrawal by Subject|0|||
27966319|NCT01436656|81708016|FG000|Dose Escalation|Administrative problems|0|||
27966320|NCT01436656|81708017|FG001|Dose Escalation|Administrative problems|1|||
27966321|NCT01436656|81708018|FG002|Dose Escalation|Administrative problems|0|||
27966322|NCT01436656|81708019|FG003|Dose Escalation|Administrative problems|0|||
27966323|NCT01436656|81708020|FG004|Dose Escalation|Administrative problems|0|||
27966324|NCT01436656|81708021|FG005|Dose Escalation|Administrative problems|0|||
27966325|NCT01436656|81708022|FG006|Dose Escalation|Administrative problems|0|||
27966326|NCT01436656|81708023|FG007|Dose Escalation|Administrative problems|0|||
27966327|NCT01436656|81708024|FG008|Dose Escalation|Administrative problems|0|||
27966328|NCT01436656|81708025|FG009|Dose Escalation|Administrative problems|0|||
27966329|NCT01436656|81708026|FG010|Dose Escalation|Administrative problems|0|||
27664751|NCT00520403|80609533|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
27664752|NCT00520403|80609533|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
27664753|NCT00520403|80609533|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
27664754|NCT02396758|80609536|FG000|Overall Study|Withdrawal by Subject|2|||
27664755|NCT02396758|80609537|FG001|Overall Study|Withdrawal by Subject|0|||
27664756|NCT02396758|80609538|FG002|Overall Study|Withdrawal by Subject|0|||
27664757|NCT02396758|80609539|FG003|Overall Study|Withdrawal by Subject|1|||
27664758|NCT02396758|80609536|FG000|Overall Study|Lost to Follow-up|8|||
27664759|NCT02396758|80609537|FG001|Overall Study|Lost to Follow-up|5|||
27664760|NCT02396758|80609538|FG002|Overall Study|Lost to Follow-up|3|||
27664761|NCT02396758|80609539|FG003|Overall Study|Lost to Follow-up|3|||
27664762|NCT02396758|80609536|FG000|Overall Study|Death|1|||
27664763|NCT02396758|80609537|FG001|Overall Study|Death|1|||
27664764|NCT02396758|80609538|FG002|Overall Study|Death|0|||
27664765|NCT02396758|80609539|FG003|Overall Study|Death|1|||
27664766|NCT02396758|80609536|FG000|Overall Study|Randomized but not treated|1|||
27664767|NCT02396758|80609537|FG001|Overall Study|Randomized but not treated|0|||
27664768|NCT02396758|80609538|FG002|Overall Study|Randomized but not treated|1|||
27664769|NCT02396758|80609539|FG003|Overall Study|Randomized but not treated|0|||
27664770|NCT02427958|80609540|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
27664771|NCT02427958|80609540|FG000|Overall Study|Lost to Follow-up|6|||
27664772|NCT02427958|80609540|FG000|Overall Study|Withdrawal by Subject|14|||
27966330|NCT01436656|81708027|FG011|Dose Escalation|Administrative problems|0|||
27966331|NCT01436656|81708028|FG012|Dose Escalation|Administrative problems|0|||
27664773|NCT02427958|80609540|FG000|Overall Study|Lack of Efficacy|1|||
27664774|NCT03821064|80609550|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
27664775|NCT02253147|80609551|FG000|Overall Study|Protocol Violation|30|||
27664776|NCT02253147|80609551|FG000|Overall Study|Did not consent to study extension|9|||
27664777|NCT02253147|80609551|FG000|Overall Study|Conditional re-treatment at W52|5|||
27664778|NCT02253147|80609551|FG000|Overall Study|Lost to Follow-up|2|||
27664779|NCT02253147|80609551|FG000|Overall Study|Withdrawal by Subject|1|||
27664780|NCT03721978|80609555|FG000|Overall Study|Withdrawal by Subject|6|||
27664781|NCT03721978|80609556|FG001|Overall Study|Withdrawal by Subject|1|||
27664782|NCT03721978|80609555|FG000|Overall Study|Adverse Event|1|||
27664783|NCT03721978|80609556|FG001|Overall Study|Adverse Event|1|||
27664784|NCT03721978|80609555|FG000|Overall Study|Progressive Disease|1|||
27774715|NCT01974440|81003029|FG001|Overall Study|Lost to Follow-up|7|||
27774716|NCT01974440|81003028|FG000|Overall Study|Withdrawal by Subject|24|||
27774717|NCT01974440|81003029|FG001|Overall Study|Withdrawal by Subject|20|||
27774718|NCT01974440|81003028|FG000|Overall Study|Sponsor decision|109|||
27774719|NCT01974440|81003029|FG001|Overall Study|Sponsor decision|110|||
27774720|NCT02692560|81003030|FG000|Overall Study|Withdrawal by Subject|0|||
27966332|NCT01436656|81708029|FG013|Dose Escalation|Administrative problems|0|||
27664785|NCT03721978|80609556|FG001|Overall Study|Progressive Disease|0|||
27774721|NCT02692560|81003031|FG001|Overall Study|Withdrawal by Subject|6|||
27966333|NCT01436656|81708030|FG014|Dose Escalation|Administrative problems|0|||
27966334|NCT01436656|81708031|FG015|Dose Escalation|Administrative problems|0|||
27966335|NCT01436656|81708032|FG016|Dose Escalation|Administrative problems|0|||
27966336|NCT01436656|81708033|FG017|Dose Escalation|Administrative problems|0|||
27664786|NCT03721978|80609555|FG000|Overall Study|Lost to Follow-up|5|||
27664787|NCT03721978|80609556|FG001|Overall Study|Lost to Follow-up|1|||
27664788|NCT03721978|80609555|FG000|Overall Study|Reason not Specified|0|||
27664789|NCT03721978|80609556|FG001|Overall Study|Reason not Specified|2|||
27664790|NCT02383927|80609560|FG000|Overall Study|Disease Progression|8|||
27664791|NCT02383927|80609561|FG001|Overall Study|Disease Progression|8|||
27664792|NCT02383927|80609562|FG002|Overall Study|Disease Progression|15|||
27664793|NCT02383927|80609563|FG003|Overall Study|Disease Progression|4|||
27664794|NCT02383927|80609560|FG000|Overall Study|Physician Decision|0|||
27966337|NCT01436656|81708016|FG000|Dose Escalation|Lost to Follow-up|1|||
27966338|NCT01436656|81708017|FG001|Dose Escalation|Lost to Follow-up|0|||
27966339|NCT01436656|81708018|FG002|Dose Escalation|Lost to Follow-up|0|||
27966340|NCT01436656|81708019|FG003|Dose Escalation|Lost to Follow-up|0|||
27966341|NCT01436656|81708020|FG004|Dose Escalation|Lost to Follow-up|1|||
27966342|NCT01436656|81708021|FG005|Dose Escalation|Lost to Follow-up|0|||
27966343|NCT01436656|81708022|FG006|Dose Escalation|Lost to Follow-up|0|||
27966344|NCT01436656|81708023|FG007|Dose Escalation|Lost to Follow-up|0|||
27966345|NCT01436656|81708024|FG008|Dose Escalation|Lost to Follow-up|0|||
27966346|NCT01436656|81708025|FG009|Dose Escalation|Lost to Follow-up|0|||
27664795|NCT02383927|80609561|FG001|Overall Study|Physician Decision|0|||
27664796|NCT02383927|80609562|FG002|Overall Study|Physician Decision|2|||
27664797|NCT02383927|80609563|FG003|Overall Study|Physician Decision|0|||
27664798|NCT02383927|80609560|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
27664799|NCT02383927|80609561|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
27664800|NCT02383927|80609562|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
27664801|NCT02383927|80609563|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
27664802|NCT02383927|80609560|FG000|Overall Study|Adverse Event|4|||
27664803|NCT02383927|80609561|FG001|Overall Study|Adverse Event|1|||
27664804|NCT02383927|80609562|FG002|Overall Study|Adverse Event|3|||
27664805|NCT02383927|80609563|FG003|Overall Study|Adverse Event|5|||
27664806|NCT02383927|80609560|FG000|Overall Study|Miscellaneous|1|||
27664807|NCT02383927|80609561|FG001|Overall Study|Miscellaneous|0|||
27664808|NCT02383927|80609562|FG002|Overall Study|Miscellaneous|0|||
27664809|NCT02383927|80609563|FG003|Overall Study|Miscellaneous|1|||
27664810|NCT02383927|80609560|FG000|Overall Study|Withdrawal by Subject|0|||
27664811|NCT02383927|80609561|FG001|Overall Study|Withdrawal by Subject|1|||
27664812|NCT02383927|80609562|FG002|Overall Study|Withdrawal by Subject|4|||
27664813|NCT02383927|80609563|FG003|Overall Study|Withdrawal by Subject|0|||
27664814|NCT04357964|80609571|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
27664815|NCT04357964|80609572|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
27664816|NCT04357964|80609571|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
27664817|NCT04357964|80609572|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
27664818|NCT04357964|80609571|FG000|Overall Study|Adipose sample was insufficient quality|0|||
27664819|NCT04357964|80609572|FG001|Overall Study|Adipose sample was insufficient quality|1|||
27664820|NCT01209286|80609573|FG000|Overall Study|Adverse Event|4|||
27664821|NCT01209286|80609574|FG001|Overall Study|Adverse Event|3|||
27664822|NCT01209286|80609575|FG002|Overall Study|Adverse Event|1|||
27664823|NCT01209286|80609573|FG000|Overall Study|Hematological Relapse After Remission|0|||
27664824|NCT01209286|80609574|FG001|Overall Study|Hematological Relapse After Remission|1|||
27664825|NCT01209286|80609575|FG002|Overall Study|Hematological Relapse After Remission|1|||
27664826|NCT01209286|80609573|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
27664827|NCT01209286|80609574|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
27664828|NCT01209286|80609575|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
27664829|NCT01209286|80609573|FG000|Overall Study|Physician Decision|0|||
27664830|NCT01209286|80609574|FG001|Overall Study|Physician Decision|2|||
27664831|NCT01209286|80609575|FG002|Overall Study|Physician Decision|0|||
27664832|NCT01209286|80609573|FG000|Overall Study|Other|0|||
27664833|NCT01209286|80609574|FG001|Overall Study|Other|1|||
27664834|NCT01209286|80609575|FG002|Overall Study|Other|0|||
27664835|NCT03811834|80609579|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
27664836|NCT02143063|80609580|FG000|Overall Study|Lost to Follow-up|16|||
27664837|NCT02143063|80609581|FG001|Overall Study|Lost to Follow-up|28|||
27664838|NCT02143063|80609582|FG002|Overall Study|Lost to Follow-up|29|||
27664839|NCT02143063|80609580|FG000|Overall Study|Withdrawal by Subject|0|||
27664840|NCT02143063|80609581|FG001|Overall Study|Withdrawal by Subject|1|||
27664841|NCT02143063|80609582|FG002|Overall Study|Withdrawal by Subject|0|||
27664842|NCT02143063|80609580|FG000|Overall Study|Death|0|||
27664843|NCT02143063|80609581|FG001|Overall Study|Death|1|||
27664844|NCT02143063|80609582|FG002|Overall Study|Death|1|||
27664845|NCT02845375|80609583|FG000|Overall Study|upper airway obstruction|1|||
27664846|NCT02845375|80609584|FG001|Overall Study|upper airway obstruction|2|||
27966347|NCT01436656|81708026|FG010|Dose Escalation|Lost to Follow-up|0|||
27966348|NCT01436656|81708027|FG011|Dose Escalation|Lost to Follow-up|0|||
27966349|NCT01436656|81708028|FG012|Dose Escalation|Lost to Follow-up|0|||
27966350|NCT01436656|81708029|FG013|Dose Escalation|Lost to Follow-up|0|||
27966351|NCT01436656|81708030|FG014|Dose Escalation|Lost to Follow-up|0|||
27664847|NCT02845375|80609585|FG002|Overall Study|upper airway obstruction|1|||
27664848|NCT01732588|80609587|FG000|First Intervention (7 Days)|Adverse Event|0|||
27664849|NCT01732588|80609588|FG001|First Intervention (7 Days)|Adverse Event|1|||
27664850|NCT01732588|80609589|FG002|First Intervention (7 Days)|Adverse Event|0|||
27664851|NCT00225277|80609590|FG000|Overall Study|Adverse Event|30|||
27774722|NCT01818765|81003032|FG000|Overall Study|Death|2|||
27774723|NCT02736474|81003033|FG000|Overall Study|Lost to Follow-up|0|||
27966352|NCT01436656|81708031|FG015|Dose Escalation|Lost to Follow-up|0|||
27664852|NCT00225277|80609591|FG001|Overall Study|Adverse Event|34|||
27664853|NCT00225277|80609590|FG000|Overall Study|Lack of Efficacy|4|||
27664854|NCT00225277|80609591|FG001|Overall Study|Lack of Efficacy|1|||
27664855|NCT00225277|80609590|FG000|Overall Study|Lost to Follow-up|4|||
27664856|NCT00225277|80609591|FG001|Overall Study|Lost to Follow-up|6|||
27664857|NCT00225277|80609590|FG000|Overall Study|Physician Decision|6|||
27664858|NCT00225277|80609591|FG001|Overall Study|Physician Decision|8|||
27664859|NCT00225277|80609590|FG000|Overall Study|Protocol Violation|6|||
27664860|NCT00225277|80609591|FG001|Overall Study|Protocol Violation|3|||
27664861|NCT00225277|80609590|FG000|Overall Study|Withdrawal by Subject|40|||
27664862|NCT00225277|80609591|FG001|Overall Study|Withdrawal by Subject|34|||
27664863|NCT00225277|80609590|FG000|Overall Study|Other|7|||
27664864|NCT00225277|80609591|FG001|Overall Study|Other|9|||
27664865|NCT01874665|80609592|FG000|Overall Study|Adverse Event|6|||
27664866|NCT01874665|80609593|FG001|Overall Study|Adverse Event|2|||
27664867|NCT01874665|80609592|FG000|Overall Study|Withdrawal by Subject|4|||
27664868|NCT01874665|80609593|FG001|Overall Study|Withdrawal by Subject|1|||
27664869|NCT01874665|80609592|FG000|Overall Study|Physician Decision|3|||
27966353|NCT01436656|81708032|FG016|Dose Escalation|Lost to Follow-up|0|||
27966354|NCT01436656|81708033|FG017|Dose Escalation|Lost to Follow-up|0|||
27966355|NCT01436656|81708016|FG000|Dose Escalation|New anti-cancer therapy|1|||
27966356|NCT01436656|81708017|FG001|Dose Escalation|New anti-cancer therapy|0|||
27966357|NCT01436656|81708018|FG002|Dose Escalation|New anti-cancer therapy|0|||
27966358|NCT01436656|81708019|FG003|Dose Escalation|New anti-cancer therapy|0|||
27966359|NCT01436656|81708020|FG004|Dose Escalation|New anti-cancer therapy|0|||
27966360|NCT01436656|81708021|FG005|Dose Escalation|New anti-cancer therapy|0|||
27966361|NCT01436656|81708022|FG006|Dose Escalation|New anti-cancer therapy|0|||
27966362|NCT01436656|81708023|FG007|Dose Escalation|New anti-cancer therapy|0|||
27966363|NCT01436656|81708024|FG008|Dose Escalation|New anti-cancer therapy|1|||
27966364|NCT01436656|81708025|FG009|Dose Escalation|New anti-cancer therapy|1|||
27966365|NCT01436656|81708026|FG010|Dose Escalation|New anti-cancer therapy|0|||
27966366|NCT01436656|81708027|FG011|Dose Escalation|New anti-cancer therapy|0|||
27966367|NCT01436656|81708028|FG012|Dose Escalation|New anti-cancer therapy|0|||
27966368|NCT01436656|81708029|FG013|Dose Escalation|New anti-cancer therapy|0|||
27664870|NCT01874665|80609593|FG001|Overall Study|Physician Decision|0|||
27664871|NCT01874665|80609592|FG000|Overall Study|Clinical Progressive Disease|4|||
27664872|NCT01874665|80609593|FG001|Overall Study|Clinical Progressive Disease|3|||
27966369|NCT01436656|81708030|FG014|Dose Escalation|New anti-cancer therapy|0|||
27966370|NCT01436656|81708031|FG015|Dose Escalation|New anti-cancer therapy|0|||
27966371|NCT01436656|81708032|FG016|Dose Escalation|New anti-cancer therapy|0|||
27664873|NCT01874665|80609592|FG000|Overall Study|Study Terminated by Sponsor|0|||
27966372|NCT01436656|81708033|FG017|Dose Escalation|New anti-cancer therapy|0|||
27966373|NCT01436656|81708016|FG000|Dose Expansion|Adverse Event|0|||
27664874|NCT01874665|80609593|FG001|Overall Study|Study Terminated by Sponsor|2|||
27664875|NCT01874665|80609592|FG000|Overall Study|Documented Progressive Disease|11|||
27664876|NCT01874665|80609593|FG001|Overall Study|Documented Progressive Disease|7|||
27569738|NCT03670810|80275186|FG004|Open Label Extension|Adverse Event|0|||
27569739|NCT03670810|80275187|FG005|Open Label Extension|Adverse Event|0|||
27664877|NCT01874665|80609592|FG000|Overall Study|Other|2|||
27664878|NCT01874665|80609593|FG001|Overall Study|Other|0|||
27774724|NCT02736474|81003034|FG001|Overall Study|Lost to Follow-up|1|||
27774725|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
27774726|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27774727|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
27774728|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27774729|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
27774730|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27774731|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27774732|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27774733|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
27774734|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
27774735|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27774736|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27774737|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
27774738|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
27774739|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
27774740|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
27774741|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
27774742|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
27774743|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
27774744|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
27774745|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
27774746|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
27774747|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
27774748|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
27774749|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Screen failure|0|||
27774750|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Screen failure|1|||
27774751|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Screen failure|2|||
27774752|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Screen failure|0|||
27774753|NCT02614261|81003035|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
27774754|NCT02614261|81003036|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
27774755|NCT02614261|81003037|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
27774756|NCT02614261|81003038|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27774757|NCT02614261|81003035|FG000|Open-Label Extension Phase|Adverse Event|23|||
27774758|NCT02614261|81003036|FG001|Open-Label Extension Phase|Adverse Event|12|||
27774759|NCT02614261|81003037|FG002|Open-Label Extension Phase|Adverse Event|11|||
27774760|NCT02614261|81003038|FG003|Open-Label Extension Phase|Adverse Event|0|||
27664879|NCT00745121|80609594|FG000|Overall Study|Death|3|||
27664880|NCT00745121|80609595|FG001|Overall Study|Death|0|||
27664881|NCT00745121|80609594|FG000|Overall Study|Adverse Event|1|||
27664882|NCT00745121|80609595|FG001|Overall Study|Adverse Event|0|||
27664883|NCT00745121|80609594|FG000|Overall Study|Lost to Follow-up|1|||
27664884|NCT00745121|80609595|FG001|Overall Study|Lost to Follow-up|0|||
27664885|NCT00745121|80609594|FG000|Overall Study|Withdrawal by Subject|4|||
27664886|NCT00745121|80609595|FG001|Overall Study|Withdrawal by Subject|2|||
27774761|NCT02614261|81003035|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
27774762|NCT02614261|81003036|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
27774763|NCT02614261|81003037|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
27774764|NCT02614261|81003038|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
27774765|NCT02614261|81003035|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
27774766|NCT02614261|81003036|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
27664887|NCT00857233|80609596|FG000|Overall Study|Adverse Event|24|||
27774767|NCT02614261|81003037|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
27774768|NCT02614261|81003038|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
27774769|NCT02614261|81003035|FG000|Open-Label Extension Phase|Physician Decision|2|||
27774770|NCT02614261|81003036|FG001|Open-Label Extension Phase|Physician Decision|0|||
27774771|NCT02614261|81003037|FG002|Open-Label Extension Phase|Physician Decision|0|||
27774772|NCT02614261|81003038|FG003|Open-Label Extension Phase|Physician Decision|0|||
27774773|NCT02614261|81003035|FG000|Open-Label Extension Phase|Pregnancy|1|||
27774774|NCT02614261|81003036|FG001|Open-Label Extension Phase|Pregnancy|2|||
27774775|NCT02614261|81003037|FG002|Open-Label Extension Phase|Pregnancy|1|||
27774776|NCT02614261|81003038|FG003|Open-Label Extension Phase|Pregnancy|0|||
27774777|NCT02614261|81003035|FG000|Open-Label Extension Phase|Protocol Violation|3|||
27774778|NCT02614261|81003036|FG001|Open-Label Extension Phase|Protocol Violation|4|||
27774779|NCT02614261|81003037|FG002|Open-Label Extension Phase|Protocol Violation|1|||
27774780|NCT02614261|81003038|FG003|Open-Label Extension Phase|Protocol Violation|0|||
27966374|NCT01436656|81708017|FG001|Dose Expansion|Adverse Event|0|||
27966375|NCT01436656|81708018|FG002|Dose Expansion|Adverse Event|0|||
27966376|NCT01436656|81708019|FG003|Dose Expansion|Adverse Event|0|||
27966377|NCT01436656|81708020|FG004|Dose Expansion|Adverse Event|0|||
27966378|NCT01436656|81708021|FG005|Dose Expansion|Adverse Event|0|||
27966379|NCT01436656|81708022|FG006|Dose Expansion|Adverse Event|0|||
27966380|NCT01436656|81708023|FG007|Dose Expansion|Adverse Event|0|||
27966381|NCT01436656|81708024|FG008|Dose Expansion|Adverse Event|0|||
27966382|NCT01436656|81708025|FG009|Dose Expansion|Adverse Event|0|||
27966383|NCT01436656|81708026|FG010|Dose Expansion|Adverse Event|0|||
27966384|NCT01436656|81708027|FG011|Dose Expansion|Adverse Event|1|||
27966385|NCT01436656|81708028|FG012|Dose Expansion|Adverse Event|0|||
27966386|NCT01436656|81708029|FG013|Dose Expansion|Adverse Event|0|||
27774781|NCT02614261|81003035|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
27774782|NCT02614261|81003036|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
27774783|NCT02614261|81003037|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
27966387|NCT01436656|81708030|FG014|Dose Expansion|Adverse Event|0|||
27966388|NCT01436656|81708031|FG015|Dose Expansion|Adverse Event|0|||
27966389|NCT01436656|81708032|FG016|Dose Expansion|Adverse Event|0|||
27966390|NCT01436656|81708033|FG017|Dose Expansion|Adverse Event|0|||
27774784|NCT02614261|81003038|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
27774785|NCT02614261|81003035|FG000|Follow-up Phase|Adverse Event|2|||
27774786|NCT02614261|81003036|FG001|Follow-up Phase|Adverse Event|0|||
27966391|NCT01436656|81708016|FG000|Dose Expansion|Withdrawal by Subject|0|||
27966392|NCT01436656|81708017|FG001|Dose Expansion|Withdrawal by Subject|0|||
27966393|NCT01436656|81708018|FG002|Dose Expansion|Withdrawal by Subject|0|||
27774787|NCT02614261|81003037|FG002|Follow-up Phase|Adverse Event|1|||
27774788|NCT02614261|81003038|FG003|Follow-up Phase|Adverse Event|0|||
27774789|NCT02614261|81003035|FG000|Follow-up Phase|Lost to Follow-up|12|||
27774790|NCT02614261|81003036|FG001|Follow-up Phase|Lost to Follow-up|5|||
27774791|NCT02614261|81003037|FG002|Follow-up Phase|Lost to Follow-up|2|||
27774792|NCT02614261|81003038|FG003|Follow-up Phase|Lost to Follow-up|0|||
27774793|NCT02614261|81003035|FG000|Follow-up Phase|Physician Decision|5|||
27774794|NCT02614261|81003036|FG001|Follow-up Phase|Physician Decision|1|||
27774795|NCT02614261|81003037|FG002|Follow-up Phase|Physician Decision|0|||
27774796|NCT02614261|81003038|FG003|Follow-up Phase|Physician Decision|0|||
27774797|NCT02614261|81003035|FG000|Follow-up Phase|Pregnancy|0|||
27774798|NCT02614261|81003036|FG001|Follow-up Phase|Pregnancy|1|||
27774799|NCT02614261|81003037|FG002|Follow-up Phase|Pregnancy|0|||
27774800|NCT02614261|81003038|FG003|Follow-up Phase|Pregnancy|0|||
27774801|NCT02614261|81003035|FG000|Follow-up Phase|Protocol Violation|1|||
27774802|NCT02614261|81003036|FG001|Follow-up Phase|Protocol Violation|0|||
27774803|NCT02614261|81003037|FG002|Follow-up Phase|Protocol Violation|0|||
27966394|NCT01436656|81708019|FG003|Dose Expansion|Withdrawal by Subject|0|||
27966395|NCT01436656|81708020|FG004|Dose Expansion|Withdrawal by Subject|0|||
27966396|NCT01436656|81708021|FG005|Dose Expansion|Withdrawal by Subject|0|||
27966397|NCT01436656|81708022|FG006|Dose Expansion|Withdrawal by Subject|0|||
27966398|NCT01436656|81708023|FG007|Dose Expansion|Withdrawal by Subject|0|||
27966399|NCT01436656|81708024|FG008|Dose Expansion|Withdrawal by Subject|0|||
27966400|NCT01436656|81708025|FG009|Dose Expansion|Withdrawal by Subject|0|||
27966401|NCT01436656|81708026|FG010|Dose Expansion|Withdrawal by Subject|0|||
27966402|NCT01436656|81708027|FG011|Dose Expansion|Withdrawal by Subject|1|||
27774804|NCT02614261|81003038|FG003|Follow-up Phase|Protocol Violation|0|||
27774805|NCT02614261|81003035|FG000|Follow-up Phase|Withdrawal by Subject|12|||
27774806|NCT02614261|81003036|FG001|Follow-up Phase|Withdrawal by Subject|4|||
27774807|NCT02614261|81003037|FG002|Follow-up Phase|Withdrawal by Subject|11|||
27774808|NCT02614261|81003038|FG003|Follow-up Phase|Withdrawal by Subject|0|||
27774809|NCT02614261|81003035|FG000|Israel Addendum|Withdrawal by Subject|0|||
27774810|NCT02614261|81003036|FG001|Israel Addendum|Withdrawal by Subject|0|||
27774811|NCT02614261|81003037|FG002|Israel Addendum|Withdrawal by Subject|0|||
27966403|NCT01436656|81708028|FG012|Dose Expansion|Withdrawal by Subject|3|||
27774812|NCT02614261|81003038|FG003|Israel Addendum|Withdrawal by Subject|4|||
27774813|NCT00608244|81003039|FG000|Overall Study|Adverse Event|1|||
27774814|NCT00608244|81003039|FG000|Overall Study|Low trough levels|1|||
27774815|NCT03458234|81003041|FG000|Overall Study|Withdrawal by Subject|1|||
27774816|NCT00893763|81003043|FG000|Overall Study|extubated|110|||
27774817|NCT00893763|81003044|FG001|Overall Study|extubated|110|||
27774818|NCT02100813|81003045|FG000|Overall Study|Adverse Event|0|||
27774819|NCT02100813|81003046|FG001|Overall Study|Adverse Event|0|||
27774820|NCT02100813|81003047|FG002|Overall Study|Adverse Event|0|||
27774821|NCT02100813|81003048|FG003|Overall Study|Adverse Event|0|||
27774822|NCT02100813|81003049|FG004|Overall Study|Adverse Event|0|||
27774823|NCT02100813|81003050|FG005|Overall Study|Adverse Event|0|||
27774824|NCT02100813|81003051|FG006|Overall Study|Adverse Event|0|||
27774825|NCT02100813|81003052|FG007|Overall Study|Adverse Event|1|||
27774826|NCT04007367|81003053|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
27774827|NCT04007367|81003054|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
27774828|NCT04007367|81003055|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
27774829|NCT04007367|81003053|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
27774830|NCT04007367|81003054|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
27774831|NCT04007367|81003055|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
27774832|NCT04007367|81003053|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
27774833|NCT04007367|81003054|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
27774834|NCT04007367|81003055|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
27774835|NCT04007367|81003053|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
27774836|NCT04007367|81003054|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
27774837|NCT04007367|81003055|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
27774838|NCT04007367|81003053|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
27774839|NCT04007367|81003054|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
27774840|NCT04007367|81003055|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
27774841|NCT01040728|81003058|FG000|Overall Study|Adverse Event|4|||
27774842|NCT01040728|81003059|FG001|Overall Study|Adverse Event|8|||
27774843|NCT01040728|81003060|FG002|Overall Study|Adverse Event|0|||
27774844|NCT01040728|81003061|FG003|Overall Study|Adverse Event|4|||
27774845|NCT01040728|81003058|FG000|Overall Study|Withdrawal by Subject|0|||
27569740|NCT03670810|80275188|FG006|Open Label Extension|Adverse Event|0|||
27569741|NCT03670810|80275189|FG007|Open Label Extension|Adverse Event|0|||
27569742|NCT03670810|80275190|FG008|Open Label Extension|Adverse Event|24|||
27774846|NCT01040728|81003059|FG001|Overall Study|Withdrawal by Subject|1|||
27774847|NCT01040728|81003060|FG002|Overall Study|Withdrawal by Subject|1|||
27774848|NCT01040728|81003061|FG003|Overall Study|Withdrawal by Subject|0|||
27774849|NCT01040728|81003058|FG000|Overall Study|Protocol Violation|0|||
27774850|NCT01040728|81003059|FG001|Overall Study|Protocol Violation|0|||
27774851|NCT01040728|81003060|FG002|Overall Study|Protocol Violation|0|||
27774852|NCT01040728|81003061|FG003|Overall Study|Protocol Violation|1|||
27774853|NCT01040728|81003058|FG000|Overall Study|Lack of Efficacy|0|||
27774854|NCT01040728|81003059|FG001|Overall Study|Lack of Efficacy|1|||
27774855|NCT01040728|81003060|FG002|Overall Study|Lack of Efficacy|0|||
27774856|NCT01040728|81003061|FG003|Overall Study|Lack of Efficacy|1|||
27774857|NCT01040728|81003058|FG000|Overall Study|Other reasons not listed above|0|||
27774858|NCT01040728|81003059|FG001|Overall Study|Other reasons not listed above|1|||
27774859|NCT01040728|81003060|FG002|Overall Study|Other reasons not listed above|0|||
27774860|NCT01040728|81003061|FG003|Overall Study|Other reasons not listed above|0|||
27774861|NCT02147691|81003070|FG000|Overall Study|Withdrawal by Subject|2|||
27774862|NCT02147691|81003071|FG001|Overall Study|Withdrawal by Subject|0|||
27774863|NCT02147691|81003070|FG000|Overall Study|Adverse Event|2|||
27774864|NCT02147691|81003071|FG001|Overall Study|Adverse Event|0|||
27966404|NCT01436656|81708029|FG013|Dose Expansion|Withdrawal by Subject|1|||
27966405|NCT01436656|81708030|FG014|Dose Expansion|Withdrawal by Subject|2|||
27966406|NCT01436656|81708031|FG015|Dose Expansion|Withdrawal by Subject|0|||
27966407|NCT01436656|81708032|FG016|Dose Expansion|Withdrawal by Subject|1|||
27966408|NCT01436656|81708033|FG017|Dose Expansion|Withdrawal by Subject|1|||
27774865|NCT02147691|81003070|FG000|Overall Study|Lost to Follow-up|0|||
27774866|NCT02147691|81003071|FG001|Overall Study|Lost to Follow-up|1|||
27966409|NCT01436656|81708016|FG000|Dose Expansion|Death|0|||
27966410|NCT01436656|81708017|FG001|Dose Expansion|Death|0|||
27774867|NCT03745989|81003072|FG000|Overall Study|Death|3|||
27774868|NCT03745989|81003073|FG001|Overall Study|Death|7|||
27966411|NCT01436656|81708018|FG002|Dose Expansion|Death|0|||
27966412|NCT01436656|81708019|FG003|Dose Expansion|Death|0|||
27774869|NCT03745989|81003074|FG002|Overall Study|Death|4|||
27774870|NCT03745989|81003072|FG000|Overall Study|Lost to Follow-up|0|||
27774871|NCT03745989|81003073|FG001|Overall Study|Lost to Follow-up|2|||
27774872|NCT03745989|81003074|FG002|Overall Study|Lost to Follow-up|0|||
27966413|NCT01436656|81708020|FG004|Dose Expansion|Death|0|||
27774873|NCT03745989|81003072|FG000|Overall Study|Sponsor Decision|0|||
27774874|NCT03745989|81003073|FG001|Overall Study|Sponsor Decision|2|||
27774875|NCT03745989|81003074|FG002|Overall Study|Sponsor Decision|8|||
27774876|NCT03745989|81003072|FG000|Overall Study|Withdrawal by Subject|0|||
27774877|NCT03745989|81003073|FG001|Overall Study|Withdrawal by Subject|1|||
27774878|NCT03745989|81003074|FG002|Overall Study|Withdrawal by Subject|3|||
27774879|NCT00441727|81003077|FG000|Overall Study|Protocol Violation|19|||
27774880|NCT00441727|81003078|FG001|Overall Study|Protocol Violation|28|||
27774881|NCT00441727|81003079|FG002|Overall Study|Protocol Violation|32|||
27774882|NCT00441727|81003077|FG000|Overall Study|Adverse Event|26|||
27774883|NCT00441727|81003078|FG001|Overall Study|Adverse Event|33|||
27774884|NCT00441727|81003079|FG002|Overall Study|Adverse Event|28|||
27774885|NCT00441727|81003077|FG000|Overall Study|Lack of Efficacy|7|||
27774886|NCT00441727|81003078|FG001|Overall Study|Lack of Efficacy|8|||
27774887|NCT00441727|81003079|FG002|Overall Study|Lack of Efficacy|48|||
27774888|NCT00441727|81003077|FG000|Overall Study|Withdrawal by Subject|40|||
27774889|NCT00441727|81003078|FG001|Overall Study|Withdrawal by Subject|34|||
27774890|NCT00441727|81003079|FG002|Overall Study|Withdrawal by Subject|47|||
27774891|NCT00441727|81003077|FG000|Overall Study|Lost to Follow-up|5|||
27774892|NCT00441727|81003078|FG001|Overall Study|Lost to Follow-up|6|||
27774893|NCT00441727|81003079|FG002|Overall Study|Lost to Follow-up|5|||
27774894|NCT00441727|81003077|FG000|Overall Study|Safety Reasons|3|||
27774895|NCT00441727|81003078|FG001|Overall Study|Safety Reasons|1|||
27774896|NCT00441727|81003079|FG002|Overall Study|Safety Reasons|3|||
27774897|NCT00441727|81003077|FG000|Overall Study|Various reason specified|6|||
27774898|NCT00441727|81003078|FG001|Overall Study|Various reason specified|8|||
27774899|NCT00441727|81003079|FG002|Overall Study|Various reason specified|5|||
27774900|NCT01634100|81003080|FG000|Overall Study|Withdrawal by Subject|1|||
27774901|NCT01634100|81003081|FG001|Overall Study|Withdrawal by Subject|0|||
27774902|NCT01634100|81003082|FG002|Overall Study|Withdrawal by Subject|1|||
27774903|NCT01634100|81003083|FG003|Overall Study|Withdrawal by Subject|0|||
27774904|NCT01634100|81003084|FG004|Overall Study|Withdrawal by Subject|0|||
27774905|NCT01634100|81003085|FG005|Overall Study|Withdrawal by Subject|0|||
27774906|NCT00122317|81003096|FG000|Overall Study|Death|3|||
27774907|NCT00122317|81003096|FG000|Overall Study|Adverse Event|4|||
27774908|NCT00122317|81003096|FG000|Overall Study|Physician Decision|2|||
27774909|NCT00122317|81003096|FG000|Overall Study|patient non-compliance|1|||
27774910|NCT00122317|81003096|FG000|Overall Study|Withdrawal by Subject|1|||
27774911|NCT02967562|81003100|FG000|Overall Study|Consent not obtained|1|||
27774912|NCT02967562|81003101|FG001|Overall Study|Consent not obtained|0|||
27774913|NCT02967562|81003100|FG000|Overall Study|High leak precluding analysis|1|||
27774914|NCT02967562|81003101|FG001|Overall Study|High leak precluding analysis|1|||
27774915|NCT00609167|81003107|FG000|Overall Study|Withdrawal by Subject|1|||
27774916|NCT00609167|81003108|FG001|Overall Study|Withdrawal by Subject|0|||
27774917|NCT00609167|81003107|FG000|Overall Study|Lack of Efficacy|1|||
27774918|NCT00609167|81003108|FG001|Overall Study|Lack of Efficacy|0|||
27774919|NCT00609167|81003107|FG000|Overall Study|Adverse Event|5|||
27774920|NCT00609167|81003108|FG001|Overall Study|Adverse Event|1|||
27774921|NCT00609167|81003107|FG000|Overall Study|Disease Progression|1|||
27774922|NCT00609167|81003108|FG001|Overall Study|Disease Progression|0|||
27774923|NCT00609167|81003107|FG000|Overall Study|Stem Cell Transplant|0|||
27774924|NCT00609167|81003108|FG001|Overall Study|Stem Cell Transplant|6|||
27774925|NCT00673816|81003109|FG000|Overall Study|Adverse Event|1|||
27774926|NCT00673816|81003109|FG000|Overall Study|Withdrawal by Subject|1|||
27774927|NCT00068822|81003110|FG000|First Randomized Intervention|Lost to Follow-up|1|||
27774928|NCT00068822|81003111|FG001|First Randomized Intervention|Lost to Follow-up|2|||
27774929|NCT02640755|81003117|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
27774930|NCT02640755|81003118|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
27774931|NCT02640755|81003117|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
27774932|NCT02640755|81003118|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
27774933|NCT02640755|81003117|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
27774934|NCT02640755|81003118|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
27774935|NCT02015104|81003119|FG000|Overall Study|Withdrew consent after first dose drug|1|||
27774936|NCT02015104|81003120|FG001|Overall Study|Withdrew consent after first dose drug|0|||
27774937|NCT02015104|81003119|FG000|Overall Study|Withdrew consent prior to treatment|0|||
27774938|NCT02015104|81003120|FG001|Overall Study|Withdrew consent prior to treatment|1|||
27774939|NCT01700140|81003121|FG000|Overall Study|Use of rescue drugs|3|||
27774940|NCT01700140|81003122|FG001|Overall Study|Use of rescue drugs|3|||
27774941|NCT01700140|81003123|FG002|Overall Study|Use of rescue drugs|1|||
27774942|NCT01700140|81003121|FG000|Overall Study|Discontinuation of radiotherapy|1|||
27966414|NCT01436656|81708021|FG005|Dose Expansion|Death|0|||
27966415|NCT01436656|81708022|FG006|Dose Expansion|Death|0|||
27774943|NCT01700140|81003122|FG001|Overall Study|Discontinuation of radiotherapy|0|||
27774944|NCT01700140|81003123|FG002|Overall Study|Discontinuation of radiotherapy|0|||
27774945|NCT01700140|81003121|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
27774946|NCT01700140|81003122|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
27774947|NCT01700140|81003123|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
27774948|NCT01700140|81003121|FG000|Overall Study|Aggravation of symptoms|1|||
27774949|NCT01700140|81003122|FG001|Overall Study|Aggravation of symptoms|0|||
27774950|NCT01700140|81003123|FG002|Overall Study|Aggravation of symptoms|0|||
27774951|NCT01700140|81003121|FG000|Overall Study|Adverse Event|0|||
27774952|NCT01700140|81003122|FG001|Overall Study|Adverse Event|1|||
27774953|NCT01700140|81003123|FG002|Overall Study|Adverse Event|0|||
27774954|NCT01700140|81003121|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
27774955|NCT01700140|81003122|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
27774956|NCT01700140|81003123|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
27774957|NCT00333970|81003124|FG000|Overall Study|Withdrawal by Subject|13|||
27774958|NCT00333970|81003125|FG001|Overall Study|Withdrawal by Subject|7|||
27774959|NCT02708966|81003129|FG000|Overall Study|Lost to Follow-up|2|||
27774960|NCT02708966|81003130|FG001|Overall Study|Lost to Follow-up|2|||
27774961|NCT04157751|81003133|FG000|Overall Study|Withdrawal by Subject|12|||
27774962|NCT04157751|81003134|FG001|Overall Study|Withdrawal by Subject|17|||
27774963|NCT04157751|81003133|FG000|Overall Study|Lost to Follow-up|6|||
27774964|NCT04157751|81003134|FG001|Overall Study|Lost to Follow-up|2|||
27774965|NCT04157751|81003133|FG000|Overall Study|Adverse Event|34|||
27774966|NCT04157751|81003134|FG001|Overall Study|Adverse Event|23|||
27774967|NCT04157751|81003133|FG000|Overall Study|Not treated|1|||
27774968|NCT04157751|81003134|FG001|Overall Study|Not treated|5|||
27774969|NCT04157751|81003133|FG000|Overall Study|Other reason not stated above|10|||
27774970|NCT04157751|81003134|FG001|Overall Study|Other reason not stated above|10|||
27774971|NCT02142712|81003138|FG000|Overall Study|Lost to Follow-up|1|||
27774972|NCT02142712|81003139|FG001|Overall Study|Lost to Follow-up|1|||
27774973|NCT02142712|81003140|FG002|Overall Study|Lost to Follow-up|1|||
27774974|NCT02142712|81003141|FG003|Overall Study|Lost to Follow-up|0|||
27774975|NCT00511108|81003142|FG000|Overall Study|Adverse Event|2|||
27774976|NCT00511108|81003143|FG001|Overall Study|Adverse Event|0|||
27774977|NCT00511108|81003144|FG002|Overall Study|Adverse Event|1|||
27774978|NCT00511108|81003145|FG003|Overall Study|Adverse Event|2|||
27774979|NCT00511108|81003142|FG000|Overall Study|Lost to Follow-up|0|||
27774980|NCT00511108|81003143|FG001|Overall Study|Lost to Follow-up|2|||
27774981|NCT00511108|81003144|FG002|Overall Study|Lost to Follow-up|1|||
27774982|NCT00511108|81003145|FG003|Overall Study|Lost to Follow-up|0|||
27774983|NCT00511108|81003142|FG000|Overall Study|Physician Decision|0|||
27774984|NCT00511108|81003143|FG001|Overall Study|Physician Decision|0|||
27774985|NCT00511108|81003144|FG002|Overall Study|Physician Decision|0|||
27774986|NCT00511108|81003145|FG003|Overall Study|Physician Decision|1|||
27774987|NCT00511108|81003142|FG000|Overall Study|Withdrawal by Subject|4|||
27774988|NCT00511108|81003143|FG001|Overall Study|Withdrawal by Subject|0|||
27774989|NCT00511108|81003144|FG002|Overall Study|Withdrawal by Subject|3|||
27774990|NCT00511108|81003145|FG003|Overall Study|Withdrawal by Subject|2|||
27774991|NCT04402385|81003155|FG000|Overall Study|Withdrawal by Subject|4|||
27774992|NCT04402385|81003156|FG001|Overall Study|Withdrawal by Subject|4|||
27774993|NCT04402385|81003155|FG000|Overall Study|Lost to Follow-up|1|||
27774994|NCT04402385|81003156|FG001|Overall Study|Lost to Follow-up|1|||
27774995|NCT04402385|81003155|FG000|Overall Study|Physician Decision|0|||
27774996|NCT04402385|81003156|FG001|Overall Study|Physician Decision|1|||
27774997|NCT02332876|81003157|FG000|Overall Study|Lost to Follow-up|1|||
27774998|NCT02332876|81003158|FG001|Overall Study|Lost to Follow-up|1|||
27774999|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Adverse Event|30|||
27775000|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Adverse Event|25|||
27775001|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Adverse Event|23|||
27775002|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Adverse Event|14|||
27775003|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Death|0|||
27775004|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Death|0|||
27775005|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Death|1|||
27775006|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Death|0|||
27775007|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Physician Decision|0|||
27775008|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Physician Decision|1|||
27775009|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Physician Decision|0|||
27775010|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Physician Decision|1|||
27775011|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
27775012|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
27775013|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
27966416|NCT01436656|81708023|FG007|Dose Expansion|Death|0|||
27775014|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
27775015|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Other|6|||
27775016|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Other|1|||
27775017|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Other|0|||
27966417|NCT01436656|81708024|FG008|Dose Expansion|Death|0|||
27775018|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Other|2|||
27775019|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
27966418|NCT01436656|81708025|FG009|Dose Expansion|Death|0|||
27775020|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
27775021|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
27775022|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
27775023|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
27664888|NCT00857233|80609596|FG000|Overall Study|Lack of Efficacy|1|||
27664889|NCT00857233|80609596|FG000|Overall Study|Non-compliance|1|||
27775024|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
27775025|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
27775026|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
27775027|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
27775028|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
27775029|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
27775030|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
27775031|NCT00242710|81003159|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
27775032|NCT00242710|81003160|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
27775033|NCT00242710|81003161|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
27775034|NCT00242710|81003162|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
27775035|NCT00242710|81003159|FG000|Period Between Core Study and Extension|Adverse Event|2|||
27775036|NCT00242710|81003160|FG001|Period Between Core Study and Extension|Adverse Event|3|||
27775037|NCT00242710|81003161|FG002|Period Between Core Study and Extension|Adverse Event|5|||
27775038|NCT00242710|81003162|FG003|Period Between Core Study and Extension|Adverse Event|2|||
27775039|NCT00242710|81003159|FG000|Period Between Core Study and Extension|Physician Decision|1|||
27775040|NCT00242710|81003160|FG001|Period Between Core Study and Extension|Physician Decision|1|||
27775041|NCT00242710|81003161|FG002|Period Between Core Study and Extension|Physician Decision|0|||
27775042|NCT00242710|81003162|FG003|Period Between Core Study and Extension|Physician Decision|0|||
27775043|NCT00242710|81003159|FG000|Period Between Core Study and Extension|Other|24|||
27775044|NCT00242710|81003160|FG001|Period Between Core Study and Extension|Other|24|||
27775045|NCT00242710|81003161|FG002|Period Between Core Study and Extension|Other|9|||
27775046|NCT00242710|81003162|FG003|Period Between Core Study and Extension|Other|11|||
27775047|NCT00242710|81003159|FG000|Period Between Core Study and Extension|Extension not Available|17|||
27775048|NCT00242710|81003160|FG001|Period Between Core Study and Extension|Extension not Available|21|||
27775049|NCT00242710|81003161|FG002|Period Between Core Study and Extension|Extension not Available|8|||
27775050|NCT00242710|81003162|FG003|Period Between Core Study and Extension|Extension not Available|7|||
27775051|NCT00242710|81003159|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
27775052|NCT00242710|81003160|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
27775053|NCT00242710|81003161|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
27775054|NCT00242710|81003162|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
27775055|NCT00242710|81003159|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
27775056|NCT00242710|81003160|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
27775057|NCT00242710|81003161|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
27775058|NCT00242710|81003162|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
27775059|NCT00242710|81003159|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
27775060|NCT00242710|81003160|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
27775061|NCT00242710|81003161|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
27775062|NCT00242710|81003162|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
27775063|NCT00242710|81003159|FG000|Study Extension (up to Year 2)|Death|0|||
27775064|NCT00242710|81003160|FG001|Study Extension (up to Year 2)|Death|0|||
27775065|NCT00242710|81003161|FG002|Study Extension (up to Year 2)|Death|0|||
27775066|NCT00242710|81003162|FG003|Study Extension (up to Year 2)|Death|1|||
27775067|NCT00242710|81003159|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
27775068|NCT00242710|81003160|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
27775069|NCT00242710|81003161|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
27775070|NCT00242710|81003162|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
27775071|NCT00242710|81003159|FG000|Study Extension (up to Year 2)|Other|3|||
27775072|NCT00242710|81003160|FG001|Study Extension (up to Year 2)|Other|5|||
27775073|NCT00242710|81003161|FG002|Study Extension (up to Year 2)|Other|4|||
27775074|NCT00242710|81003162|FG003|Study Extension (up to Year 2)|Other|3|||
27664890|NCT00857233|80609596|FG000|Overall Study|Withdrawal of Consent|9|||
27775075|NCT00242710|81003159|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
27775076|NCT00242710|81003160|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
27775077|NCT00242710|81003161|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
27775078|NCT00242710|81003162|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
27775079|NCT00242710|81003159|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
27775080|NCT00242710|81003160|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
27775081|NCT00242710|81003161|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
27775082|NCT00242710|81003162|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
27775083|NCT05179057|81003163|FG000|Overall Study|Adverse Event|3|||
27775084|NCT05179057|81003164|FG001|Overall Study|Adverse Event|2|||
27775085|NCT05179057|81003163|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
27775086|NCT05179057|81003164|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
27775087|NCT05179057|81003163|FG000|Overall Study|Study terminated|13|||
27775088|NCT05179057|81003164|FG001|Overall Study|Study terminated|7|||
27775089|NCT05179057|81003163|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
27775090|NCT05179057|81003164|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
27775091|NCT05179057|81003163|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
27966419|NCT01436656|81708026|FG010|Dose Expansion|Death|0|||
27966420|NCT01436656|81708027|FG011|Dose Expansion|Death|0|||
27966421|NCT01436656|81708028|FG012|Dose Expansion|Death|1|||
27966422|NCT01436656|81708029|FG013|Dose Expansion|Death|0|||
27966423|NCT01436656|81708030|FG014|Dose Expansion|Death|3|||
27966424|NCT01436656|81708031|FG015|Dose Expansion|Death|0|||
27966425|NCT01436656|81708032|FG016|Dose Expansion|Death|3|||
27966426|NCT01436656|81708033|FG017|Dose Expansion|Death|3|||
27966427|NCT01436656|81708016|FG000|Dose Expansion|Lost to Follow-up|0|||
27966428|NCT01436656|81708017|FG001|Dose Expansion|Lost to Follow-up|0|||
27966429|NCT01436656|81708018|FG002|Dose Expansion|Lost to Follow-up|0|||
27966430|NCT01436656|81708019|FG003|Dose Expansion|Lost to Follow-up|0|||
27966431|NCT01436656|81708020|FG004|Dose Expansion|Lost to Follow-up|0|||
27966432|NCT01436656|81708021|FG005|Dose Expansion|Lost to Follow-up|0|||
27966433|NCT01436656|81708022|FG006|Dose Expansion|Lost to Follow-up|0|||
27966434|NCT01436656|81708023|FG007|Dose Expansion|Lost to Follow-up|0|||
27966435|NCT01436656|81708024|FG008|Dose Expansion|Lost to Follow-up|0|||
27966436|NCT01436656|81708025|FG009|Dose Expansion|Lost to Follow-up|0|||
27966437|NCT01436656|81708026|FG010|Dose Expansion|Lost to Follow-up|0|||
27966438|NCT01436656|81708027|FG011|Dose Expansion|Lost to Follow-up|0|||
27966439|NCT01436656|81708028|FG012|Dose Expansion|Lost to Follow-up|0|||
27966440|NCT01436656|81708029|FG013|Dose Expansion|Lost to Follow-up|0|||
27966441|NCT01436656|81708030|FG014|Dose Expansion|Lost to Follow-up|0|||
27966442|NCT01436656|81708031|FG015|Dose Expansion|Lost to Follow-up|0|||
27966443|NCT01436656|81708032|FG016|Dose Expansion|Lost to Follow-up|0|||
27966444|NCT01436656|81708033|FG017|Dose Expansion|Lost to Follow-up|3|||
27966445|NCT01436656|81708016|FG000|Dose Expansion|Disease progression|0|||
27966446|NCT01436656|81708017|FG001|Dose Expansion|Disease progression|0|||
27775092|NCT05179057|81003164|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
27775093|NCT00472043|81003165|FG000|Overall Study|Withdrawal by Subject|1|||
27966447|NCT01436656|81708018|FG002|Dose Expansion|Disease progression|0|||
27966448|NCT01436656|81708019|FG003|Dose Expansion|Disease progression|0|||
27966449|NCT01436656|81708020|FG004|Dose Expansion|Disease progression|0|||
27966450|NCT01436656|81708021|FG005|Dose Expansion|Disease progression|0|||
27966451|NCT01436656|81708022|FG006|Dose Expansion|Disease progression|0|||
27966452|NCT01436656|81708023|FG007|Dose Expansion|Disease progression|0|||
27966453|NCT01436656|81708024|FG008|Dose Expansion|Disease progression|0|||
27966454|NCT01436656|81708025|FG009|Dose Expansion|Disease progression|0|||
27966455|NCT01436656|81708026|FG010|Dose Expansion|Disease progression|0|||
27966456|NCT01436656|81708027|FG011|Dose Expansion|Disease progression|3|||
27966457|NCT01436656|81708028|FG012|Dose Expansion|Disease progression|1|||
27966458|NCT01436656|81708029|FG013|Dose Expansion|Disease progression|0|||
27966459|NCT01436656|81708030|FG014|Dose Expansion|Disease progression|1|||
27966460|NCT01436656|81708031|FG015|Dose Expansion|Disease progression|0|||
27966461|NCT01436656|81708032|FG016|Dose Expansion|Disease progression|0|||
27966462|NCT01436656|81708033|FG017|Dose Expansion|Disease progression|1|||
27966463|NCT01436656|81708016|FG000|Dose Expansion|New cancer therapy|0|||
27966464|NCT01436656|81708017|FG001|Dose Expansion|New cancer therapy|0|||
27966465|NCT01436656|81708018|FG002|Dose Expansion|New cancer therapy|0|||
27966466|NCT01436656|81708019|FG003|Dose Expansion|New cancer therapy|0|||
27966467|NCT01436656|81708020|FG004|Dose Expansion|New cancer therapy|0|||
27966468|NCT01436656|81708021|FG005|Dose Expansion|New cancer therapy|0|||
27966469|NCT01436656|81708022|FG006|Dose Expansion|New cancer therapy|0|||
27966470|NCT01436656|81708023|FG007|Dose Expansion|New cancer therapy|0|||
27966471|NCT01436656|81708024|FG008|Dose Expansion|New cancer therapy|0|||
27966472|NCT01436656|81708025|FG009|Dose Expansion|New cancer therapy|0|||
27966473|NCT01436656|81708026|FG010|Dose Expansion|New cancer therapy|0|||
27966474|NCT01436656|81708027|FG011|Dose Expansion|New cancer therapy|1|||
27966475|NCT01436656|81708028|FG012|Dose Expansion|New cancer therapy|1|||
27966476|NCT01436656|81708029|FG013|Dose Expansion|New cancer therapy|0|||
27966477|NCT01436656|81708030|FG014|Dose Expansion|New cancer therapy|2|||
27966478|NCT01436656|81708031|FG015|Dose Expansion|New cancer therapy|0|||
27966479|NCT01436656|81708032|FG016|Dose Expansion|New cancer therapy|0|||
27966480|NCT01436656|81708033|FG017|Dose Expansion|New cancer therapy|0|||
27966481|NCT03143153|81708034|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
27966482|NCT03143153|81708035|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
27966483|NCT03143153|81708036|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
27966484|NCT03143153|81708034|FG000|Pre-Treatment|Participant withdrew consent|0|||
27966485|NCT03143153|81708035|FG001|Pre-Treatment|Participant withdrew consent|1|||
27966486|NCT03143153|81708036|FG002|Pre-Treatment|Participant withdrew consent|12|||
27966487|NCT03143153|81708034|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
27966488|NCT03143153|81708035|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
27966489|NCT03143153|81708036|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
27966490|NCT03143153|81708034|FG000|Pre-Treatment|Other Reasons|1|||
27966491|NCT03143153|81708035|FG001|Pre-Treatment|Other Reasons|2|||
27966492|NCT03143153|81708036|FG002|Pre-Treatment|Other Reasons|1|||
27966493|NCT03143153|81708034|FG000|Pre-Treatment|Disease Progression|1|||
27966494|NCT03143153|81708035|FG001|Pre-Treatment|Disease Progression|1|||
27966495|NCT03143153|81708036|FG002|Pre-Treatment|Disease Progression|2|||
27966496|NCT03143153|81708034|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
27966497|NCT03143153|81708035|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
27966498|NCT03143153|81708036|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
27966499|NCT03143153|81708034|FG000|Treatment|Disease progression|174|||
27966500|NCT03143153|81708035|FG001|Treatment|Disease progression|184|||
27966501|NCT03143153|81708036|FG002|Treatment|Disease progression|193|||
27966502|NCT03143153|81708034|FG000|Treatment|Study drug toxicity|59|||
27966503|NCT03143153|81708035|FG001|Treatment|Study drug toxicity|33|||
27966504|NCT03143153|81708036|FG002|Treatment|Study drug toxicity|40|||
27966505|NCT03143153|81708034|FG000|Treatment|Death|5|||
27966506|NCT03143153|81708035|FG001|Treatment|Death|3|||
27966507|NCT03143153|81708036|FG002|Treatment|Death|4|||
27966508|NCT03143153|81708034|FG000|Treatment|Adverse event unrelated to study drug|19|||
27966509|NCT03143153|81708035|FG001|Treatment|Adverse event unrelated to study drug|28|||
27966510|NCT03143153|81708036|FG002|Treatment|Adverse event unrelated to study drug|12|||
27966511|NCT03143153|81708034|FG000|Treatment|Participant request to discontinue study treatment|13|||
27966512|NCT03143153|81708035|FG001|Treatment|Participant request to discontinue study treatment|15|||
27966513|NCT03143153|81708036|FG002|Treatment|Participant request to discontinue study treatment|20|||
27966514|NCT03143153|81708034|FG000|Treatment|Participant withdrew consent|3|||
27966515|NCT03143153|81708035|FG001|Treatment|Participant withdrew consent|4|||
27966516|NCT03143153|81708036|FG002|Treatment|Participant withdrew consent|12|||
27966517|NCT03143153|81708034|FG000|Treatment|Pregnancy|1|||
27966518|NCT03143153|81708035|FG001|Treatment|Pregnancy|0|||
27966519|NCT03143153|81708036|FG002|Treatment|Pregnancy|0|||
27966520|NCT03143153|81708034|FG000|Treatment|Maximum clinical benefit|1|||
27966521|NCT03143153|81708035|FG001|Treatment|Maximum clinical benefit|3|||
27966522|NCT03143153|81708036|FG002|Treatment|Maximum clinical benefit|4|||
27966523|NCT03143153|81708034|FG000|Treatment|Completed treatment as per Protocol|13|||
27966524|NCT03143153|81708035|FG001|Treatment|Completed treatment as per Protocol|8|||
27966525|NCT03143153|81708036|FG002|Treatment|Completed treatment as per Protocol|0|||
27966526|NCT03143153|81708034|FG000|Treatment|Other reasons|12|||
27966527|NCT03143153|81708035|FG001|Treatment|Other reasons|7|||
27966528|NCT03143153|81708036|FG002|Treatment|Other reasons|15|||
27966529|NCT03143153|81708034|FG000|Treatment|Not reported|1|||
27966530|NCT03143153|81708035|FG001|Treatment|Not reported|0|||
27966531|NCT03143153|81708036|FG002|Treatment|Not reported|0|||
27966532|NCT00425698|81708037|FG000|Overall Study|Adverse Event|3|||
27966533|NCT00425698|81708038|FG001|Overall Study|Adverse Event|1|||
27966534|NCT00425698|81708037|FG000|Overall Study|Withdrawal by Subject|0|||
27569743|NCT03670810|80275182|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
27569744|NCT03670810|80275183|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
27569745|NCT03670810|80275184|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
27862254|NCT02359994|81326289|FG001|Extended Oncology 24-Month Survival|Death|21|||
27966535|NCT00425698|81708038|FG001|Overall Study|Withdrawal by Subject|1|||
27966536|NCT00313144|81708041|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
27966537|NCT00313144|81708041|FG000|Overall Study|Death|7|||
27966538|NCT00313144|81708041|FG000|Overall Study|Lost to Follow-up|5|||
27966539|NCT00313144|81708041|FG000|Overall Study|Withdrawal by Subject|4|||
27966540|NCT00313144|81708041|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
27966541|NCT00313144|81708041|FG000|Overall Study|Physician Decision|4|||
27966542|NCT00313144|81708041|FG000|Overall Study|Adverse event - transient|5|||
27569746|NCT03670810|80275185|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
27966543|NCT00313144|81708041|FG000|Overall Study|Liver transplant|1|||
27966544|NCT00313144|81708041|FG000|Overall Study|Insurance (homecare provider) change|1|||
27966545|NCT00313144|81708041|FG000|Overall Study|Change to different product|1|||
27966546|NCT00313144|81708041|FG000|Overall Study|Due to termination of the study|66|||
27966547|NCT02231892|81708044|FG000|Overall Study|Lost to Follow-up|1|||
27966548|NCT02231892|81708045|FG001|Overall Study|Lost to Follow-up|0|||
27966549|NCT02231892|81708046|FG002|Overall Study|Lost to Follow-up|3|||
27966550|NCT02231892|81708044|FG000|Overall Study|Withdrawal by Subject|4|||
27966551|NCT02231892|81708045|FG001|Overall Study|Withdrawal by Subject|3|||
27966552|NCT02231892|81708046|FG002|Overall Study|Withdrawal by Subject|15|||
27966553|NCT02231892|81708044|FG000|Overall Study|Physician Decision|0|||
27966554|NCT02231892|81708045|FG001|Overall Study|Physician Decision|2|||
27966555|NCT02231892|81708046|FG002|Overall Study|Physician Decision|4|||
27966556|NCT02231892|81708044|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
27966557|NCT02231892|81708045|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
27966558|NCT02231892|81708046|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
27966559|NCT02231892|81708044|FG000|Overall Study|Participant motor threshold was >83%|0|||
27966560|NCT02231892|81708045|FG001|Overall Study|Participant motor threshold was >83%|0|||
27966561|NCT02231892|81708046|FG002|Overall Study|Participant motor threshold was >83%|9|||
27966562|NCT02231892|81708044|FG000|Overall Study|Could not find motor threshold|2|||
27966563|NCT02231892|81708045|FG001|Overall Study|Could not find motor threshold|0|||
27966564|NCT02231892|81708046|FG002|Overall Study|Could not find motor threshold|1|||
27966565|NCT02231892|81708044|FG000|Overall Study|Could not find reliable motor hotspot|0|||
27966566|NCT02231892|81708045|FG001|Overall Study|Could not find reliable motor hotspot|0|||
27966567|NCT02231892|81708046|FG002|Overall Study|Could not find reliable motor hotspot|1|||
27966568|NCT01463696|81708048|FG000|Overall Study|Adverse Event|0|||
27966569|NCT01463696|81708049|FG001|Overall Study|Adverse Event|1|||
27966570|NCT01463696|81708050|FG002|Overall Study|Adverse Event|0|||
27966571|NCT01463696|81708051|FG003|Overall Study|Adverse Event|2|||
27966572|NCT01463696|81708052|FG004|Overall Study|Adverse Event|0|||
27966573|NCT01463696|81708053|FG005|Overall Study|Adverse Event|1|||
27966574|NCT01463696|81708054|FG006|Overall Study|Adverse Event|3|||
27966575|NCT01463696|81708055|FG007|Overall Study|Adverse Event|2|||
27966576|NCT01463696|81708048|FG000|Overall Study|Lost to Follow-up|0|||
27966577|NCT01463696|81708049|FG001|Overall Study|Lost to Follow-up|0|||
27966578|NCT01463696|81708050|FG002|Overall Study|Lost to Follow-up|1|||
27966579|NCT01463696|81708051|FG003|Overall Study|Lost to Follow-up|0|||
27966580|NCT01463696|81708052|FG004|Overall Study|Lost to Follow-up|0|||
27966581|NCT01463696|81708053|FG005|Overall Study|Lost to Follow-up|0|||
27966582|NCT01463696|81708054|FG006|Overall Study|Lost to Follow-up|0|||
27966583|NCT01463696|81708055|FG007|Overall Study|Lost to Follow-up|0|||
27966584|NCT01463696|81708048|FG000|Overall Study|Progressive Disease|0|||
27966585|NCT01463696|81708049|FG001|Overall Study|Progressive Disease|1|||
27966586|NCT01463696|81708050|FG002|Overall Study|Progressive Disease|0|||
27966587|NCT01463696|81708051|FG003|Overall Study|Progressive Disease|1|||
27966588|NCT01463696|81708052|FG004|Overall Study|Progressive Disease|0|||
27966589|NCT01463696|81708053|FG005|Overall Study|Progressive Disease|1|||
27966590|NCT01463696|81708054|FG006|Overall Study|Progressive Disease|4|||
27966591|NCT01463696|81708055|FG007|Overall Study|Progressive Disease|2|||
27966592|NCT01463696|81708048|FG000|Overall Study|Withdrawal by Subject|0|||
27966593|NCT01463696|81708049|FG001|Overall Study|Withdrawal by Subject|0|||
27966594|NCT01463696|81708050|FG002|Overall Study|Withdrawal by Subject|0|||
27966595|NCT01463696|81708051|FG003|Overall Study|Withdrawal by Subject|1|||
27966596|NCT01463696|81708052|FG004|Overall Study|Withdrawal by Subject|1|||
27966597|NCT01463696|81708053|FG005|Overall Study|Withdrawal by Subject|1|||
27966598|NCT01463696|81708054|FG006|Overall Study|Withdrawal by Subject|2|||
27966599|NCT01463696|81708055|FG007|Overall Study|Withdrawal by Subject|0|||
27966600|NCT01463696|81708048|FG000|Overall Study|Not Treated|0|||
27966601|NCT01463696|81708049|FG001|Overall Study|Not Treated|0|||
27966602|NCT01463696|81708050|FG002|Overall Study|Not Treated|0|||
27966603|NCT01463696|81708051|FG003|Overall Study|Not Treated|0|||
27966604|NCT01463696|81708052|FG004|Overall Study|Not Treated|0|||
27966605|NCT01463696|81708053|FG005|Overall Study|Not Treated|0|||
27966606|NCT01463696|81708054|FG006|Overall Study|Not Treated|1|||
27966607|NCT01463696|81708055|FG007|Overall Study|Not Treated|0|||
27966608|NCT00104416|81708056|FG000|Double-Blind Phase|Adverse Event|2|||
27966609|NCT00104416|81708057|FG001|Double-Blind Phase|Adverse Event|1|||
27966610|NCT00104416|81708058|FG002|Double-Blind Phase|Adverse Event|0|||
27966611|NCT00104416|81708059|FG003|Double-Blind Phase|Adverse Event|0|||
27775094|NCT00472043|81003166|FG001|Overall Study|Withdrawal by Subject|0|||
27966612|NCT00104416|81708060|FG004|Double-Blind Phase|Adverse Event|0|||
27966613|NCT00104416|81708056|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27966614|NCT00104416|81708057|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27966615|NCT00104416|81708058|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27966616|NCT00104416|81708059|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27966617|NCT00104416|81708060|FG004|Double-Blind Phase|Lost to Follow-up|0|||
27966618|NCT00104416|81708056|FG000|Double-Blind Phase|Protocol Violation|0|||
27966619|NCT00104416|81708057|FG001|Double-Blind Phase|Protocol Violation|1|||
27966620|NCT00104416|81708058|FG002|Double-Blind Phase|Protocol Violation|0|||
27966621|NCT00104416|81708059|FG003|Double-Blind Phase|Protocol Violation|0|||
27966622|NCT00104416|81708060|FG004|Double-Blind Phase|Protocol Violation|0|||
27966623|NCT00104416|81708056|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
27966624|NCT00104416|81708057|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
27966625|NCT00104416|81708058|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27966626|NCT00104416|81708059|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27966627|NCT00104416|81708060|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
27966628|NCT00104416|81708056|FG000|Double-Blind Phase|Pregnancy|1|||
27966629|NCT00104416|81708057|FG001|Double-Blind Phase|Pregnancy|0|||
27966630|NCT00104416|81708058|FG002|Double-Blind Phase|Pregnancy|0|||
27966631|NCT00104416|81708059|FG003|Double-Blind Phase|Pregnancy|0|||
27966632|NCT00104416|81708060|FG004|Double-Blind Phase|Pregnancy|0|||
27966633|NCT00104416|81708056|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
27966634|NCT00104416|81708057|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
27966635|NCT00104416|81708058|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
27966636|NCT00104416|81708059|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
27966637|NCT00104416|81708060|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
27966638|NCT00104416|81708056|FG000|Continuation Phase|Adverse Event|0|||
27966639|NCT00104416|81708057|FG001|Continuation Phase|Adverse Event|0|||
27966640|NCT00104416|81708058|FG002|Continuation Phase|Adverse Event|2|||
27966641|NCT00104416|81708059|FG003|Continuation Phase|Adverse Event|0|||
27966642|NCT00104416|81708060|FG004|Continuation Phase|Adverse Event|2|||
27966643|NCT00104416|81708056|FG000|Continuation Phase|Lost to Follow-up|0|||
27966644|NCT00104416|81708057|FG001|Continuation Phase|Lost to Follow-up|0|||
27966645|NCT00104416|81708058|FG002|Continuation Phase|Lost to Follow-up|1|||
27966646|NCT00104416|81708059|FG003|Continuation Phase|Lost to Follow-up|0|||
27966647|NCT00104416|81708060|FG004|Continuation Phase|Lost to Follow-up|1|||
27966648|NCT00104416|81708056|FG000|Continuation Phase|Withdrawal by Subject|0|||
27966649|NCT00104416|81708057|FG001|Continuation Phase|Withdrawal by Subject|0|||
27966650|NCT00104416|81708058|FG002|Continuation Phase|Withdrawal by Subject|2|||
27966651|NCT00104416|81708059|FG003|Continuation Phase|Withdrawal by Subject|1|||
27966652|NCT00104416|81708060|FG004|Continuation Phase|Withdrawal by Subject|1|||
27966653|NCT00104416|81708056|FG000|Continuation Phase|Pregnancy|0|||
27966654|NCT00104416|81708057|FG001|Continuation Phase|Pregnancy|0|||
27966655|NCT00104416|81708058|FG002|Continuation Phase|Pregnancy|1|||
27966656|NCT00104416|81708059|FG003|Continuation Phase|Pregnancy|1|||
27966657|NCT00104416|81708060|FG004|Continuation Phase|Pregnancy|0|||
27966658|NCT00104416|81708056|FG000|Continuation Phase|Non-compliance|0|||
27966659|NCT00104416|81708057|FG001|Continuation Phase|Non-compliance|0|||
27966660|NCT00104416|81708058|FG002|Continuation Phase|Non-compliance|0|||
27966661|NCT00104416|81708059|FG003|Continuation Phase|Non-compliance|0|||
27966662|NCT00104416|81708060|FG004|Continuation Phase|Non-compliance|1|||
27966663|NCT00958347|81708062|FG000|Overall Study|Death|43|||
27966664|NCT00958347|81708062|FG000|Overall Study|Withdrawal by Subject|23|||
27775095|NCT00472043|81003165|FG000|Overall Study|Death|1|||
27775096|NCT00472043|81003166|FG001|Overall Study|Death|0|||
27775097|NCT02352090|81003167|FG000|Overall Study|general malaise|1|||
27775098|NCT02352090|81003168|FG001|Overall Study|general malaise|0|||
27775099|NCT02352090|81003169|FG002|Overall Study|general malaise|0|||
27775100|NCT02352090|81003167|FG000|Overall Study|non-specified mild side-effects|0|||
27775101|NCT02352090|81003168|FG001|Overall Study|non-specified mild side-effects|0|||
27775102|NCT02352090|81003169|FG002|Overall Study|non-specified mild side-effects|2|||
27775103|NCT00515099|81003170|FG000|Overall Study|Lost to Follow-up|0|||
27775104|NCT00515099|81003171|FG001|Overall Study|Lost to Follow-up|4|||
27775105|NCT00515099|81003170|FG000|Overall Study|Withdrawal by Subject|2|||
27775106|NCT00515099|81003171|FG001|Overall Study|Withdrawal by Subject|0|||
27775107|NCT00515099|81003170|FG000|Overall Study|IRB Recommendation|1|||
27775108|NCT00515099|81003171|FG001|Overall Study|IRB Recommendation|0|||
27775109|NCT02431793|81003172|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
27775110|NCT02431793|81003173|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
27775111|NCT02431793|81003174|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
27775112|NCT02431793|81003172|FG000|Overall Study|Withdrawal by Subject|7|||
27775113|NCT02431793|81003173|FG001|Overall Study|Withdrawal by Subject|5|||
27775114|NCT02431793|81003174|FG002|Overall Study|Withdrawal by Subject|5|||
27775115|NCT02431793|81003172|FG000|Overall Study|Lost to Follow-up|101|||
27775116|NCT02431793|81003173|FG001|Overall Study|Lost to Follow-up|122|||
27966665|NCT00958347|81708062|FG000|Overall Study|Lost to Follow-up|15|||
27966666|NCT00958347|81708062|FG000|Overall Study|revision/removal|10|||
27966667|NCT00958347|81708062|FG000|Overall Study|study termination|135|||
27966668|NCT02222688|81708063|FG000|Overall Study|Withdrawal by Subject|0|||
27775117|NCT02431793|81003174|FG002|Overall Study|Lost to Follow-up|104|||
27966669|NCT02222688|81708064|FG001|Overall Study|Withdrawal by Subject|0|||
27966670|NCT02222688|81708065|FG002|Overall Study|Withdrawal by Subject|0|||
27966671|NCT02222688|81708066|FG003|Overall Study|Withdrawal by Subject|2|||
27775118|NCT00952419|81003175|FG000|Overall Study|Adverse Event|2|||
27966672|NCT02222688|81708067|FG004|Overall Study|Withdrawal by Subject|1|||
27966673|NCT02222688|81708068|FG005|Overall Study|Withdrawal by Subject|0|||
27966674|NCT02222688|81708069|FG006|Overall Study|Withdrawal by Subject|1|||
27966675|NCT02222688|81708063|FG000|Overall Study|Disease progression|1|||
27966676|NCT02222688|81708064|FG001|Overall Study|Disease progression|0|||
27966677|NCT02222688|81708065|FG002|Overall Study|Disease progression|0|||
27966678|NCT02222688|81708066|FG003|Overall Study|Disease progression|0|||
27966679|NCT02222688|81708067|FG004|Overall Study|Disease progression|0|||
27966680|NCT02222688|81708068|FG005|Overall Study|Disease progression|0|||
27966681|NCT02222688|81708069|FG006|Overall Study|Disease progression|0|||
27966682|NCT00559104|81708070|FG000|Overall Study|Lack of Efficacy|9|||
27966683|NCT00559104|81708071|FG001|Overall Study|Lack of Efficacy|0|||
27966684|NCT02907216|81708072|FG000|Overall Study|No benefit to be obtained by continuing|0|||
27966685|NCT02907216|81708073|FG001|Overall Study|No benefit to be obtained by continuing|1|||
27966686|NCT02907216|81708072|FG000|Overall Study|Withdrawal by Subject|1|||
27966687|NCT02907216|81708073|FG001|Overall Study|Withdrawal by Subject|0|||
27966688|NCT01133756|81708075|FG000|Overall Study|Adverse Event|1|||
27966689|NCT01133756|81708076|FG001|Overall Study|Adverse Event|2|||
27966690|NCT01133756|81708077|FG002|Overall Study|Adverse Event|1|||
27966691|NCT01133756|81708075|FG000|Overall Study|Investigator Decision|1|||
27966692|NCT01133756|81708076|FG001|Overall Study|Investigator Decision|0|||
27966693|NCT01133756|81708077|FG002|Overall Study|Investigator Decision|0|||
27966694|NCT01133756|81708075|FG000|Overall Study|Withdrawal by Subject|0|||
27966695|NCT01133756|81708076|FG001|Overall Study|Withdrawal by Subject|1|||
27966696|NCT01133756|81708077|FG002|Overall Study|Withdrawal by Subject|0|||
27966697|NCT01133756|81708075|FG000|Overall Study|Progression of Disease|0|||
27966698|NCT01133756|81708076|FG001|Overall Study|Progression of Disease|0|||
27664891|NCT00857233|80609596|FG000|Overall Study|Lost to Follow-up|4|||
27664892|NCT00857233|80609596|FG000|Overall Study|Nursing Home Placement|14|||
27664893|NCT00857233|80609596|FG000|Overall Study|Other Reasons|2|||
27664894|NCT00363649|80609597|FG000|Overall Study|Withdrawal by Subject|1|||
27664895|NCT00363649|80609598|FG001|Overall Study|Withdrawal by Subject|1|||
27664896|NCT00363649|80609597|FG000|Overall Study|Adverse Event|6|||
27664897|NCT00363649|80609598|FG001|Overall Study|Adverse Event|0|||
27664898|NCT00583115|80609599|FG000|Overall Study|Death|1|||
27664899|NCT01121913|80609600|FG000|First Intervention Period|Adverse Event|0|||
27664900|NCT01121913|80609601|FG001|First Intervention Period|Adverse Event|0|||
27664901|NCT01121913|80609602|FG002|First Intervention Period|Adverse Event|1|||
27664902|NCT01121913|80609603|FG003|First Intervention Period|Adverse Event|0|||
27664903|NCT01121913|80609600|FG000|First Washout Period|Withdrawal by Subject|1|||
27664904|NCT01121913|80609601|FG001|First Washout Period|Withdrawal by Subject|0|||
27664905|NCT01121913|80609602|FG002|First Washout Period|Withdrawal by Subject|0|||
27664906|NCT01121913|80609603|FG003|First Washout Period|Withdrawal by Subject|0|||
27664907|NCT01121913|80609600|FG000|Second Intervention Period|Adverse Event|0|||
27664908|NCT01121913|80609601|FG001|Second Intervention Period|Adverse Event|0|||
27664909|NCT01121913|80609602|FG002|Second Intervention Period|Adverse Event|1|||
27664910|NCT01121913|80609603|FG003|Second Intervention Period|Adverse Event|0|||
27664911|NCT01121913|80609600|FG000|Second Washout Period|Withdrawal by Subject|0|||
27664912|NCT01121913|80609601|FG001|Second Washout Period|Withdrawal by Subject|0|||
27664913|NCT01121913|80609602|FG002|Second Washout Period|Withdrawal by Subject|1|||
27664914|NCT01121913|80609603|FG003|Second Washout Period|Withdrawal by Subject|0|||
27664915|NCT01121913|80609600|FG000|Third Washout Period|Adverse Event|1|||
27664916|NCT01121913|80609601|FG001|Third Washout Period|Adverse Event|0|||
27664917|NCT01121913|80609602|FG002|Third Washout Period|Adverse Event|0|||
27664918|NCT01121913|80609603|FG003|Third Washout Period|Adverse Event|0|||
27664919|NCT00726388|80609614|FG000|Overall Study|Withdrawal by Subject|5|||
27664920|NCT00726388|80609614|FG000|Overall Study|Adverse Event|3|||
27664921|NCT00726388|80609614|FG000|Overall Study|Lost to Follow-up|10|||
27664922|NCT00726388|80609614|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
27664923|NCT00726388|80609614|FG000|Overall Study|Other|5|||
27664924|NCT00726388|80609614|FG000|Overall Study|Enrolled, Not Treated|79|||
27664925|NCT02720198|80609619|FG000|Overall Study|Withdrawal by Subject|0|||
27664926|NCT02720198|80609620|FG001|Overall Study|Withdrawal by Subject|1|||
27664927|NCT01201915|80609621|FG000|Overall Study|Adverse Event|2|||
27664928|NCT01201915|80609622|FG001|Overall Study|Adverse Event|1|||
27664929|NCT01201915|80609623|FG002|Overall Study|Adverse Event|1|||
27664930|NCT01201915|80609621|FG000|Overall Study|Lost to Follow-up|0|||
27664931|NCT01201915|80609622|FG001|Overall Study|Lost to Follow-up|4|||
27664932|NCT01201915|80609623|FG002|Overall Study|Lost to Follow-up|0|||
27664933|NCT01201915|80609621|FG000|Overall Study|Physician Decision|3|||
27664934|NCT01201915|80609622|FG001|Overall Study|Physician Decision|0|||
27966699|NCT01133756|81708077|FG002|Overall Study|Progression of Disease|1|||
27966700|NCT00443053|81708078|FG000|Overall Study|Adverse Event|2|||
27966701|NCT00443053|81708079|FG001|Overall Study|Adverse Event|1|||
27664935|NCT01201915|80609623|FG002|Overall Study|Physician Decision|0|||
27664936|NCT01201915|80609621|FG000|Overall Study|Subject Decision|3|||
27664937|NCT01201915|80609622|FG001|Overall Study|Subject Decision|3|||
27664938|NCT01201915|80609623|FG002|Overall Study|Subject Decision|5|||
27664939|NCT01201915|80609621|FG000|Overall Study|Target Lesion Progression|0|||
27862255|NCT02359994|81326288|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
27664940|NCT01201915|80609622|FG001|Overall Study|Target Lesion Progression|3|||
27664941|NCT01201915|80609623|FG002|Overall Study|Target Lesion Progression|0|||
27664942|NCT01885936|80609626|FG000|Overall Study|Withdrawal by Subject|1|||
27664943|NCT01885936|80609627|FG001|Overall Study|Withdrawal by Subject|0|||
27664944|NCT00961298|80609628|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
27664945|NCT00961298|80609628|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
27664946|NCT00961298|80609628|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
27664947|NCT01713998|80609629|FG000|Overall Study|Lost to Follow-up|2|||
27664948|NCT01713998|80609630|FG001|Overall Study|Lost to Follow-up|0|||
27664949|NCT01713998|80609631|FG002|Overall Study|Lost to Follow-up|2|||
27664950|NCT01713998|80609629|FG000|Overall Study|Withdrawal by Subject|1|||
27664951|NCT01713998|80609630|FG001|Overall Study|Withdrawal by Subject|0|||
27664952|NCT01713998|80609631|FG002|Overall Study|Withdrawal by Subject|0|||
27664953|NCT00053352|80609639|FG000|Overall Study|Lost to Follow-up|0|||
27664954|NCT00053352|80609640|FG001|Overall Study|Lost to Follow-up|1|||
27664955|NCT00053352|80609639|FG000|Overall Study|Physician Decision|11|||
27664956|NCT00053352|80609640|FG001|Overall Study|Physician Decision|1|||
27664957|NCT00053352|80609639|FG000|Overall Study|Withdrawal by Subject|1|||
27664958|NCT00053352|80609640|FG001|Overall Study|Withdrawal by Subject|0|||
27664959|NCT00053352|80609639|FG000|Overall Study|Ineligible|8|||
27664960|NCT00053352|80609640|FG001|Overall Study|Ineligible|8|||
27664961|NCT00053352|80609639|FG000|Overall Study|Disease at new site|1|||
27664962|NCT00053352|80609640|FG001|Overall Study|Disease at new site|0|||
27664963|NCT04159805|80609643|FG000|Overall Study|Withdrawal by Subject|0|||
27664964|NCT04159805|80609644|FG001|Overall Study|Withdrawal by Subject|2|||
27664965|NCT04159805|80609645|FG002|Overall Study|Withdrawal by Subject|2|||
27664966|NCT02512861|80609646|FG000|Overall Study|Protocol Violation|3|||
27664967|NCT02512861|80609647|FG001|Overall Study|Protocol Violation|7|||
27664968|NCT02512861|80609646|FG000|Overall Study|Physician Decision|3|||
27664969|NCT02512861|80609647|FG001|Overall Study|Physician Decision|1|||
27664970|NCT02512861|80609646|FG000|Overall Study|Withdrawal by Subject|0|||
27664971|NCT02512861|80609647|FG001|Overall Study|Withdrawal by Subject|1|||
27664972|NCT00514813|80609648|FG000|Overall Study|Study terminated|14|||
27664973|NCT00514813|80609649|FG001|Overall Study|Study terminated|74|||
27664974|NCT00514813|80609650|FG002|Overall Study|Study terminated|40|||
27664975|NCT00514813|80609651|FG003|Overall Study|Study terminated|2|||
27664976|NCT00514813|80609648|FG000|Overall Study|Adverse Event|0|||
27664977|NCT00514813|80609649|FG001|Overall Study|Adverse Event|2|||
27664978|NCT00514813|80609650|FG002|Overall Study|Adverse Event|2|||
27664979|NCT00514813|80609651|FG003|Overall Study|Adverse Event|0|||
27664980|NCT00514813|80609648|FG000|Overall Study|Protocol Violation|1|||
27664981|NCT00514813|80609649|FG001|Overall Study|Protocol Violation|0|||
27664982|NCT00514813|80609650|FG002|Overall Study|Protocol Violation|0|||
27664983|NCT00514813|80609651|FG003|Overall Study|Protocol Violation|0|||
27664984|NCT00514813|80609648|FG000|Overall Study|Withdrawal by Subject|0|||
27664985|NCT00514813|80609649|FG001|Overall Study|Withdrawal by Subject|1|||
27664986|NCT00514813|80609650|FG002|Overall Study|Withdrawal by Subject|0|||
27664987|NCT00514813|80609651|FG003|Overall Study|Withdrawal by Subject|0|||
27664988|NCT00514813|80609648|FG000|Overall Study|Lack of Efficacy|0|||
27664989|NCT00514813|80609649|FG001|Overall Study|Lack of Efficacy|1|||
27664990|NCT00514813|80609650|FG002|Overall Study|Lack of Efficacy|0|||
27664991|NCT00514813|80609651|FG003|Overall Study|Lack of Efficacy|0|||
27664992|NCT00514813|80609648|FG000|Overall Study|Kidney transplant|0|||
27664993|NCT00514813|80609649|FG001|Overall Study|Kidney transplant|6|||
27664994|NCT00514813|80609650|FG002|Overall Study|Kidney transplant|2|||
27664995|NCT00514813|80609651|FG003|Overall Study|Kidney transplant|0|||
27664996|NCT00514813|80609648|FG000|Overall Study|Death|0|||
27664997|NCT00514813|80609649|FG001|Overall Study|Death|2|||
27664998|NCT00514813|80609650|FG002|Overall Study|Death|3|||
27664999|NCT00514813|80609651|FG003|Overall Study|Death|2|||
27665000|NCT01208870|80609652|FG000|Overall Study|Lost to Follow-up|2|||
27665001|NCT01208870|80609653|FG001|Overall Study|Lost to Follow-up|8|||
27665002|NCT00961896|80609656|FG000|Overall Study|Abnormal laboratory value|0|||
27665003|NCT00961896|80609657|FG001|Overall Study|Abnormal laboratory value|0|||
27665004|NCT00961896|80609658|FG002|Overall Study|Abnormal laboratory value|1|||
27665005|NCT03294941|80609661|FG000|Overall Study|Withdrawal by Subject|0|||
27665006|NCT03294941|80609662|FG001|Overall Study|Withdrawal by Subject|2|||
27665007|NCT05896696|80611999|FG000|Overall Study|Screening Failure|7|||
27665008|NCT05896696|80611999|FG000|Overall Study|Withdrawal by Subject|2|||
27665009|NCT00866918|80612000|FG000|Overall Study|Death|1|||
27665010|NCT00866918|80612001|FG001|Overall Study|Death|5|||
27665011|NCT00866918|80612000|FG000|Overall Study|Lack of Efficacy|1|||
27665012|NCT00866918|80612001|FG001|Overall Study|Lack of Efficacy|1|||
27665013|NCT00866918|80612000|FG000|Overall Study|Physician Decision|10|||
27665014|NCT00866918|80612001|FG001|Overall Study|Physician Decision|2|||
27665015|NCT00866918|80612000|FG000|Overall Study|Ineligible|2|||
27665016|NCT00866918|80612001|FG001|Overall Study|Ineligible|4|||
27665017|NCT00866918|80612000|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
27665018|NCT00866918|80612001|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
27665019|NCT00866918|80612000|FG000|Overall Study|Secondary malignancy|1|||
27665020|NCT00866918|80612001|FG001|Overall Study|Secondary malignancy|0|||
27665021|NCT01121185|80612005|FG000|Overall Study|Not infused|0|||
27665022|NCT01121185|80612006|FG001|Overall Study|Not infused|1|||
27665023|NCT01121185|80612005|FG000|Overall Study|Not transplanted|1|||
27665024|NCT01121185|80612006|FG001|Overall Study|Not transplanted|0|||
27665025|NCT00546078|80612008|FG000|Overall Study|Lost to Follow-up|1|||
27665026|NCT00546078|80612009|FG001|Overall Study|Lost to Follow-up|3|||
27665027|NCT00546078|80612008|FG000|Overall Study|Withdrawal by Subject|2|||
27665028|NCT00546078|80612009|FG001|Overall Study|Withdrawal by Subject|3|||
27665029|NCT00546078|80612008|FG000|Overall Study|Other reason|1|||
27665030|NCT00546078|80612009|FG001|Overall Study|Other reason|1|||
27665031|NCT01837797|80612010|FG000|Period 1|Adverse Event|9|||
27665032|NCT01837797|80612011|FG001|Period 1|Adverse Event|0|||
27665033|NCT01837797|80612012|FG002|Period 1|Adverse Event|0|||
27665034|NCT01837797|80612013|FG003|Period 1|Adverse Event|0|||
27665035|NCT01837797|80612014|FG004|Period 1|Adverse Event|0|||
27665036|NCT01837797|80612010|FG000|Period 1|Withdrawal by Subject|6|||
27665037|NCT01837797|80612011|FG001|Period 1|Withdrawal by Subject|0|||
27665038|NCT01837797|80612012|FG002|Period 1|Withdrawal by Subject|0|||
27665039|NCT01837797|80612013|FG003|Period 1|Withdrawal by Subject|0|||
27665040|NCT01837797|80612014|FG004|Period 1|Withdrawal by Subject|0|||
27665041|NCT01837797|80612010|FG000|Period 1|Administrative reasons|76|||
27665042|NCT01837797|80612011|FG001|Period 1|Administrative reasons|0|||
27665043|NCT01837797|80612012|FG002|Period 1|Administrative reasons|0|||
27665044|NCT01837797|80612013|FG003|Period 1|Administrative reasons|0|||
27665045|NCT01837797|80612014|FG004|Period 1|Administrative reasons|0|||
27665046|NCT01837797|80612010|FG000|Period 1|Withdrawal of consent before treatment|1|||
27665047|NCT01837797|80612011|FG001|Period 1|Withdrawal of consent before treatment|0|||
27665048|NCT01837797|80612012|FG002|Period 1|Withdrawal of consent before treatment|0|||
27665049|NCT01837797|80612013|FG003|Period 1|Withdrawal of consent before treatment|0|||
27665050|NCT01837797|80612014|FG004|Period 1|Withdrawal of consent before treatment|0|||
27665051|NCT01837797|80612010|FG000|Period 1|Other|10|||
27665052|NCT01837797|80612011|FG001|Period 1|Other|0|||
27665053|NCT01837797|80612012|FG002|Period 1|Other|0|||
27665054|NCT01837797|80612013|FG003|Period 1|Other|0|||
27665055|NCT01837797|80612014|FG004|Period 1|Other|0|||
27665056|NCT01837797|80612010|FG000|Period 2|Administrative or other reasons|0|||
27665057|NCT01837797|80612011|FG001|Period 2|Administrative or other reasons|5|||
27665058|NCT01837797|80612012|FG002|Period 2|Administrative or other reasons|2|||
27966702|NCT00443053|81708078|FG000|Overall Study|Withdrawal by Subject|9|||
27966703|NCT00443053|81708079|FG001|Overall Study|Withdrawal by Subject|18|||
27966704|NCT00443053|81708078|FG000|Overall Study|Lost to Follow-up|4|||
27966705|NCT00443053|81708079|FG001|Overall Study|Lost to Follow-up|5|||
27966706|NCT00443053|81708078|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27966707|NCT00443053|81708079|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
27966708|NCT00443053|81708078|FG000|Overall Study|Noncompliance|2|||
27966709|NCT00443053|81708079|FG001|Overall Study|Noncompliance|1|||
27966710|NCT00443053|81708078|FG000|Overall Study|Other|3|||
27966711|NCT00443053|81708079|FG001|Overall Study|Other|4|||
27966712|NCT00443053|81708078|FG000|Overall Study|Physician Decision|0|||
27966713|NCT00443053|81708079|FG001|Overall Study|Physician Decision|4|||
27966714|NCT02265536|81708080|FG000|Overall Study|Adverse Event|1|||
27966715|NCT02265536|81708081|FG001|Overall Study|Adverse Event|0|||
27966716|NCT02265536|81708082|FG002|Overall Study|Adverse Event|0|||
27966717|NCT02265536|81708083|FG003|Overall Study|Adverse Event|0|||
27966718|NCT02265536|81708084|FG004|Overall Study|Adverse Event|1|||
27966719|NCT02265536|81708085|FG005|Overall Study|Adverse Event|0|||
27665059|NCT01837797|80612013|FG003|Period 2|Administrative or other reasons|4|||
27665060|NCT01837797|80612014|FG004|Period 2|Administrative or other reasons|0|||
27966720|NCT02265536|81708080|FG000|Overall Study|Physician Decision|0|||
27966721|NCT02265536|81708081|FG001|Overall Study|Physician Decision|0|||
27665061|NCT01837797|80612010|FG000|Period 2|Adverse Event|0|||
27665062|NCT01837797|80612011|FG001|Period 2|Adverse Event|0|||
27665063|NCT01837797|80612012|FG002|Period 2|Adverse Event|0|||
27966722|NCT02265536|81708082|FG002|Overall Study|Physician Decision|0|||
27966723|NCT02265536|81708083|FG003|Overall Study|Physician Decision|0|||
27966724|NCT02265536|81708084|FG004|Overall Study|Physician Decision|2|||
27665064|NCT01837797|80612013|FG003|Period 2|Adverse Event|1|||
27665065|NCT01837797|80612014|FG004|Period 2|Adverse Event|0|||
27665066|NCT01837797|80612010|FG000|Period 3|Adverse Event|0|||
27665067|NCT01837797|80612011|FG001|Period 3|Adverse Event|0|||
27665068|NCT01837797|80612012|FG002|Period 3|Adverse Event|0|||
27665069|NCT01837797|80612013|FG003|Period 3|Adverse Event|0|||
27665070|NCT01837797|80612014|FG004|Period 3|Adverse Event|1|||
27966725|NCT02265536|81708085|FG005|Overall Study|Physician Decision|0|||
27966726|NCT02265536|81708080|FG000|Overall Study|Withdrawal by Subject|0|||
27966727|NCT02265536|81708081|FG001|Overall Study|Withdrawal by Subject|3|||
27966728|NCT02265536|81708082|FG002|Overall Study|Withdrawal by Subject|0|||
27966729|NCT02265536|81708083|FG003|Overall Study|Withdrawal by Subject|0|||
27966730|NCT02265536|81708084|FG004|Overall Study|Withdrawal by Subject|0|||
27966731|NCT02265536|81708085|FG005|Overall Study|Withdrawal by Subject|0|||
27966732|NCT03249909|81708088|FG000|Overall Study|Withdrawal by Subject|3|||
27966733|NCT03249909|81708089|FG001|Overall Study|Withdrawal by Subject|0|||
27966734|NCT03249909|81708090|FG002|Overall Study|Withdrawal by Subject|0|||
27966735|NCT03249909|81708088|FG000|Overall Study|Adverse Event|3|||
27665071|NCT01837797|80612010|FG000|Period 3|Administrative reasons|0|||
27665072|NCT01837797|80612011|FG001|Period 3|Administrative reasons|0|||
27665073|NCT01837797|80612012|FG002|Period 3|Administrative reasons|0|||
27665074|NCT01837797|80612013|FG003|Period 3|Administrative reasons|0|||
27665075|NCT01837797|80612014|FG004|Period 3|Administrative reasons|20|||
27665076|NCT01837797|80612010|FG000|Period 3|Other|0|||
27665077|NCT01837797|80612011|FG001|Period 3|Other|0|||
27665078|NCT01837797|80612012|FG002|Period 3|Other|0|||
27665079|NCT01837797|80612013|FG003|Period 3|Other|0|||
27665080|NCT01837797|80612014|FG004|Period 3|Other|2|||
27665081|NCT00496626|80612015|FG000|Overall Study|Lost to Follow-up|0|||
27665082|NCT00496626|80612016|FG001|Overall Study|Lost to Follow-up|1|||
27775119|NCT00952419|81003176|FG001|Overall Study|Adverse Event|0|||
27775120|NCT00952419|81003177|FG002|Overall Study|Adverse Event|0|||
27775121|NCT00952419|81003175|FG000|Overall Study|Protocol Violation|3|||
27775122|NCT00952419|81003176|FG001|Overall Study|Protocol Violation|7|||
27775123|NCT00952419|81003177|FG002|Overall Study|Protocol Violation|0|||
27775124|NCT00952419|81003175|FG000|Overall Study|Withdrawal by Subject|1|||
27775125|NCT00952419|81003176|FG001|Overall Study|Withdrawal by Subject|3|||
27775126|NCT00952419|81003177|FG002|Overall Study|Withdrawal by Subject|0|||
27775127|NCT01846208|81003178|FG000|Overall Study|Withdrew prior to treatment|1|||
27775128|NCT01846208|81003179|FG001|Overall Study|Withdrew prior to treatment|1|||
27775129|NCT01846208|81003180|FG002|Overall Study|Withdrew prior to treatment|1|||
27775130|NCT01846208|81003178|FG000|Overall Study|Dosing Symptoms|1|||
27775131|NCT01846208|81003179|FG001|Overall Study|Dosing Symptoms|2|||
27775132|NCT01846208|81003180|FG002|Overall Study|Dosing Symptoms|6|||
27775133|NCT01846208|81003178|FG000|Overall Study|Withdrawal by Subject|5|||
27775134|NCT01846208|81003179|FG001|Overall Study|Withdrawal by Subject|0|||
27775135|NCT01846208|81003180|FG002|Overall Study|Withdrawal by Subject|0|||
27775136|NCT01846208|81003178|FG000|Overall Study|Non-compliance|1|||
27775137|NCT01846208|81003179|FG001|Overall Study|Non-compliance|1|||
27775138|NCT01846208|81003180|FG002|Overall Study|Non-compliance|0|||
27775139|NCT01846208|81003178|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
27775140|NCT01846208|81003179|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
27775141|NCT01846208|81003180|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
27775142|NCT01846208|81003178|FG000|Overall Study|Refused SU OFC|0|||
27775143|NCT01846208|81003179|FG001|Overall Study|Refused SU OFC|0|||
27775144|NCT01846208|81003180|FG002|Overall Study|Refused SU OFC|1|||
27775145|NCT00976963|81003186|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
27775146|NCT00976963|81003187|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
27775147|NCT00976963|81003186|FG000|Overall Study|administrative error|1|||
27775148|NCT00976963|81003187|FG001|Overall Study|administrative error|0|||
27775149|NCT00976963|81003186|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
27775150|NCT00976963|81003187|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
27775151|NCT01975376|81003188|FG000|Overall Study|Adverse Event|5|||
27775152|NCT01975376|81003189|FG001|Overall Study|Adverse Event|5|||
27775153|NCT01975376|81003188|FG000|Overall Study|Death|65|||
27775154|NCT01975376|81003189|FG001|Overall Study|Death|72|||
27775155|NCT01975376|81003188|FG000|Overall Study|Lost to Follow-up|70|||
27775156|NCT01975376|81003189|FG001|Overall Study|Lost to Follow-up|66|||
27775157|NCT01975376|81003188|FG000|Overall Study|Withdrew consent|68|||
27775158|NCT01975376|81003189|FG001|Overall Study|Withdrew consent|62|||
27775159|NCT01975376|81003188|FG000|Overall Study|Other|2|||
27966736|NCT03249909|81708089|FG001|Overall Study|Adverse Event|0|||
27665083|NCT00496626|80612015|FG000|Overall Study|Protocol Violation|1|||
27665084|NCT00496626|80612016|FG001|Overall Study|Protocol Violation|0|||
27665085|NCT00496626|80612015|FG000|Overall Study|Withdrawal by Subject|5|||
27665086|NCT00496626|80612016|FG001|Overall Study|Withdrawal by Subject|4|||
27665087|NCT00496626|80612015|FG000|Overall Study|Relocated|0|||
27665088|NCT00496626|80612016|FG001|Overall Study|Relocated|1|||
27665089|NCT03318783|80612017|FG000|Overall Study|Withdrawal by Subject|0|||
27665090|NCT03318783|80612018|FG001|Overall Study|Withdrawal by Subject|1|||
27665091|NCT03318783|80612017|FG000|Overall Study|Death|0|||
27665092|NCT03318783|80612018|FG001|Overall Study|Death|1|||
27665093|NCT02257918|80612019|FG000|Overall Study|Lost to Follow-up|4|||
27665094|NCT02257918|80612020|FG001|Overall Study|Lost to Follow-up|1|||
27665095|NCT02257918|80612021|FG002|Overall Study|Lost to Follow-up|0|||
27966737|NCT03249909|81708090|FG002|Overall Study|Adverse Event|0|||
27775160|NCT01975376|81003189|FG001|Overall Study|Other|4|||
27775161|NCT01975376|81003188|FG000|Overall Study|Randomized, Not Treated|16|||
27775162|NCT01975376|81003189|FG001|Overall Study|Randomized, Not Treated|8|||
27775163|NCT01387594|81003190|FG000|Overall Study|Withdrawal by Subject|0|||
27775164|NCT01387594|81003191|FG001|Overall Study|Withdrawal by Subject|2|||
27775165|NCT01387594|81003190|FG000|Overall Study|Lost to Follow-up|0|||
27775166|NCT01387594|81003191|FG001|Overall Study|Lost to Follow-up|1|||
27775167|NCT00378534|81006010|FG000|Overall Study|Participants did not receive transplant|3|||
27775168|NCT00378534|81006011|FG001|Overall Study|Participants did not receive transplant|0|||
27775169|NCT02853123|81006014|FG000|Treatment Period 1|Adverse Event|0|||
27775170|NCT02853123|81006015|FG001|Treatment Period 1|Adverse Event|3|||
27775171|NCT02853123|81006014|FG000|Washout Period|Worsening of COPD|0|||
27775172|NCT02853123|81006015|FG001|Washout Period|Worsening of COPD|3|||
27775173|NCT02853123|81006014|FG000|Washout Period|Adverse Event|1|||
27775174|NCT02853123|81006015|FG001|Washout Period|Adverse Event|0|||
27775175|NCT03277794|81006016|FG000|Overall Study|Lost to Follow-up|2|||
27775176|NCT03277794|81006017|FG001|Overall Study|Lost to Follow-up|4|||
27775177|NCT03277794|81006016|FG000|Overall Study|Withdrew due to high acuity|1|||
27775178|NCT03277794|81006017|FG001|Overall Study|Withdrew due to high acuity|0|||
27775179|NCT01408732|81006019|FG000|Overall Study|Withdrawal by Subject|2|||
27775180|NCT01408732|81006020|FG001|Overall Study|Withdrawal by Subject|2|||
27775181|NCT03733249|81006021|FG000|Overall Study|Death|7|||
27775182|NCT03733249|81006021|FG000|Overall Study|Disease relapse|16|||
27775183|NCT03733249|81006021|FG000|Overall Study|Lost to Follow-up|4|||
27775184|NCT03733249|81006021|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
27775185|NCT03733249|81006021|FG000|Overall Study|Withdrawal by Subject|1|||
27775186|NCT03369704|81006022|FG000|Treatment Epoch|technical problems|1|||
27775187|NCT03369704|81006023|FG001|Treatment Epoch|technical problems|0|||
27775188|NCT03369704|81006022|FG000|Treatment Epoch|Protocol Violation|1|||
27775189|NCT03369704|81006023|FG001|Treatment Epoch|Protocol Violation|0|||
27775190|NCT03369704|81006022|FG000|Treatment Epoch|Lost to Follow-up|0|||
27775191|NCT03369704|81006023|FG001|Treatment Epoch|Lost to Follow-up|1|||
27775192|NCT03369704|81006022|FG000|Treatment Epoch|Lack of Efficacy|0|||
27775193|NCT03369704|81006023|FG001|Treatment Epoch|Lack of Efficacy|2|||
27775194|NCT03369704|81006022|FG000|Treatment Epoch|Adverse Event|2|||
27775195|NCT03369704|81006023|FG001|Treatment Epoch|Adverse Event|0|||
27775196|NCT03369704|81006022|FG000|Follow-up Epoch|Lost to Follow-up|1|||
27775197|NCT03369704|81006023|FG001|Follow-up Epoch|Lost to Follow-up|0|||
27775198|NCT01585168|81006024|FG000|Overall Study|Lost to Follow-up|3|||
27775199|NCT01585168|81006025|FG001|Overall Study|Lost to Follow-up|1|||
27775200|NCT01585168|81006026|FG002|Overall Study|Lost to Follow-up|1|||
27775201|NCT01585168|81006027|FG003|Overall Study|Lost to Follow-up|1|||
27775202|NCT01642004|81006028|FG000|Randomization|Adverse Event unrelated to study drug|1|||
27775203|NCT01642004|81006029|FG001|Randomization|Adverse Event unrelated to study drug|0|||
27775204|NCT01642004|81006028|FG000|Randomization|Participant withdrew consent|1|||
27966738|NCT03249909|81708088|FG000|Overall Study|Lost to Follow-up|0|||
27966739|NCT03249909|81708089|FG001|Overall Study|Lost to Follow-up|1|||
27775205|NCT01642004|81006029|FG001|Randomization|Participant withdrew consent|6|||
27775206|NCT01642004|81006028|FG000|Randomization|No longer meets study criteria|2|||
27775207|NCT01642004|81006029|FG001|Randomization|No longer meets study criteria|2|||
27775208|NCT01642004|81006028|FG000|Treatment|Disease progression|95|||
27775209|NCT01642004|81006029|FG001|Treatment|Disease progression|79|||
27775210|NCT01642004|81006028|FG000|Treatment|Study drug toxicity|10|||
27775211|NCT01642004|81006029|FG001|Treatment|Study drug toxicity|13|||
27775212|NCT01642004|81006028|FG000|Treatment|Death|1|||
27775213|NCT01642004|81006029|FG001|Treatment|Death|1|||
27775214|NCT01642004|81006028|FG000|Treatment|Adverse event unrelated to study drug|9|||
27775215|NCT01642004|81006029|FG001|Treatment|Adverse event unrelated to study drug|13|||
27775216|NCT01642004|81006028|FG000|Treatment|Maximum clinical benefit|1|||
27775217|NCT01642004|81006029|FG001|Treatment|Maximum clinical benefit|9|||
27775218|NCT01642004|81006028|FG000|Treatment|Poor/non-compliance|1|||
27775219|NCT01642004|81006029|FG001|Treatment|Poor/non-compliance|0|||
27775220|NCT01642004|81006028|FG000|Treatment|No longer meets study criteria|1|||
27775221|NCT01642004|81006029|FG001|Treatment|No longer meets study criteria|2|||
27775222|NCT01642004|81006028|FG000|Treatment|Other reasons|2|||
27775223|NCT01642004|81006029|FG001|Treatment|Other reasons|0|||
27775224|NCT01642004|81006028|FG000|Treatment|Not reported|0|||
27775225|NCT01642004|81006029|FG001|Treatment|Not reported|3|||
27966740|NCT03249909|81708090|FG002|Overall Study|Lost to Follow-up|0|||
27966741|NCT00485758|81708096|FG000|Overall Study|Adverse Event|102|||
27775226|NCT01642004|81006028|FG000|Treatment|Participant request to discontinue study treatment|6|||
27775227|NCT01642004|81006029|FG001|Treatment|Participant request to discontinue study treatment|4|||
27775228|NCT01642004|81006028|FG000|Treatment|Participant withdrew consent|5|||
27775229|NCT01642004|81006029|FG001|Treatment|Participant withdrew consent|5|||
27775230|NCT04247828|81006031|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
27775231|NCT01809691|81006044|FG000|Overall Study|Currently on Treatment|192|||
27775232|NCT01809691|81006045|FG001|Overall Study|Currently on Treatment|100|||
27775233|NCT01809691|81006044|FG000|Overall Study|No Protocol Treatment|10|||
27775234|NCT01809691|81006045|FG001|Overall Study|No Protocol Treatment|11|||
27775235|NCT01809691|81006044|FG000|Overall Study|Adverse Event|80|||
27775236|NCT01809691|81006045|FG001|Overall Study|Adverse Event|21|||
27775237|NCT01809691|81006044|FG000|Overall Study|Disease Progression|226|||
27775238|NCT01809691|81006045|FG001|Overall Study|Disease Progression|372|||
27775239|NCT01809691|81006044|FG000|Overall Study|Death|26|||
27775240|NCT01809691|81006045|FG001|Overall Study|Death|13|||
27775241|NCT01809691|81006044|FG000|Overall Study|Participant Refusal|70|||
27775242|NCT01809691|81006045|FG001|Overall Study|Participant Refusal|72|||
27775243|NCT01809691|81006044|FG000|Overall Study|Other, Not Specified|34|||
27775244|NCT01809691|81006045|FG001|Overall Study|Other, Not Specified|52|||
27775245|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
27775246|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
27775247|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
27775248|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
27775249|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
27775250|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
27775251|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
27775252|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
27775253|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
27775254|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
27775255|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
27775256|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
27775257|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
27775258|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
27775259|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
27775260|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
27775261|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
27775262|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
27966742|NCT00485758|81708097|FG001|Overall Study|Adverse Event|31|||
27966743|NCT00485758|81708096|FG000|Overall Study|Death|0|||
27966744|NCT00485758|81708097|FG001|Overall Study|Death|1|||
27966745|NCT00485758|81708096|FG000|Overall Study|Lost to Follow-up|5|||
27966746|NCT00485758|81708097|FG001|Overall Study|Lost to Follow-up|1|||
27966747|NCT00485758|81708096|FG000|Overall Study|Physician Decision|3|||
27966748|NCT00485758|81708097|FG001|Overall Study|Physician Decision|3|||
27966749|NCT00485758|81708096|FG000|Overall Study|Protocol Violation|11|||
27966750|NCT00485758|81708097|FG001|Overall Study|Protocol Violation|2|||
27966751|NCT00485758|81708096|FG000|Overall Study|Withdrawal by Subject|32|||
27966752|NCT00485758|81708097|FG001|Overall Study|Withdrawal by Subject|27|||
27966753|NCT00485758|81708096|FG000|Overall Study|Study Terminated by Sponsor|3|||
27966754|NCT00485758|81708097|FG001|Overall Study|Study Terminated by Sponsor|0|||
27966755|NCT00405392|81708098|FG000|Overall Study|Adverse Event|15|||
27966756|NCT00405392|81708099|FG001|Overall Study|Adverse Event|14|||
27966757|NCT00405392|81708098|FG000|Overall Study|Did not meet Eligibility criteria|7|||
27966758|NCT00405392|81708099|FG001|Overall Study|Did not meet Eligibility criteria|2|||
27966759|NCT00405392|81708098|FG000|Overall Study|Withdrawal by Subject|4|||
27966760|NCT00405392|81708099|FG001|Overall Study|Withdrawal by Subject|3|||
27966761|NCT00405392|81708098|FG000|Overall Study|Lost to Follow-up|1|||
27966762|NCT00405392|81708099|FG001|Overall Study|Lost to Follow-up|2|||
27966763|NCT00405392|81708098|FG000|Overall Study|Data missing|2|||
27775263|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
27775264|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
27775265|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
27775266|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
27775267|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
27775268|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
27966764|NCT00405392|81708099|FG001|Overall Study|Data missing|0|||
27966765|NCT00405392|81708098|FG000|Overall Study|Non-compliance|0|||
27966766|NCT00405392|81708099|FG001|Overall Study|Non-compliance|1|||
27966767|NCT00405392|81708098|FG000|Overall Study|Other|1|||
27775269|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
27775270|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
27775271|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
27775272|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
27966768|NCT00405392|81708099|FG001|Overall Study|Other|5|||
27569747|NCT03670810|80275186|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
27966769|NCT02091362|81708100|FG000|Period 1|Protocol Violation|1|||
27966770|NCT02091362|81708101|FG001|Period 1|Protocol Violation|0|||
27966771|NCT02091362|81708100|FG000|Period 1|Withdrawal by Subject|2|||
27966772|NCT02091362|81708101|FG001|Period 1|Withdrawal by Subject|3|||
27966773|NCT02091362|81708100|FG000|Period 1|Lost to Follow-up|0|||
27966774|NCT02091362|81708101|FG001|Period 1|Lost to Follow-up|1|||
27966775|NCT02091362|81708100|FG000|Period 1|Adverse Event|2|||
27966776|NCT02091362|81708101|FG001|Period 1|Adverse Event|0|||
27966777|NCT02091362|81708100|FG000|Wash-out|Lost to Follow-up|1|||
27966778|NCT02091362|81708101|FG001|Wash-out|Lost to Follow-up|1|||
27966779|NCT02091362|81708100|FG000|Wash-out|Withdrawal by Subject|0|||
27966780|NCT02091362|81708101|FG001|Wash-out|Withdrawal by Subject|2|||
27966781|NCT02091362|81708100|FG000|Period 2|Adverse Event|1|||
27966782|NCT02091362|81708101|FG001|Period 2|Adverse Event|0|||
27966783|NCT02091362|81708100|FG000|Period 2|Lost to Follow-up|0|||
27966784|NCT02091362|81708101|FG001|Period 2|Lost to Follow-up|1|||
27966785|NCT02091362|81708100|FG000|Period 2|Withdrawal by Subject|1|||
27966786|NCT02091362|81708101|FG001|Period 2|Withdrawal by Subject|1|||
27966787|NCT03530995|81708106|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
27966788|NCT03530995|81708107|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
27966789|NCT03530995|81708106|FG000|Part 1 Period 3|Protocol Violation|1|||
27966790|NCT03530995|81708107|FG001|Part 1 Period 3|Protocol Violation|0|||
27966791|NCT03530995|81708106|FG000|Part 1 Period 4|Physician Decision|1|||
27966792|NCT03530995|81708107|FG001|Part 1 Period 4|Physician Decision|0|||
27966793|NCT03530995|81708106|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
27966794|NCT03530995|81708107|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
27966795|NCT01054560|81708108|FG000|Overall Study|Death|10|||
27966796|NCT01054560|81708109|FG001|Overall Study|Death|21|||
27966797|NCT01054560|81708108|FG000|Overall Study|Lost to Follow-up|2|||
27966798|NCT01054560|81708109|FG001|Overall Study|Lost to Follow-up|5|||
27966799|NCT01054560|81708108|FG000|Overall Study|Withdrawal by Subject|0|||
27966800|NCT01054560|81708109|FG001|Overall Study|Withdrawal by Subject|2|||
27966801|NCT01054560|81708108|FG000|Overall Study|Physician Decision|1|||
27966802|NCT01054560|81708109|FG001|Overall Study|Physician Decision|0|||
27966803|NCT01681069|81708110|FG000|Overall Study|Withdrawal by Subject|4|||
27966804|NCT01681069|81708111|FG001|Overall Study|Withdrawal by Subject|5|||
27966805|NCT01681069|81708110|FG000|Overall Study|Protocol Violation|1|||
27966806|NCT01681069|81708111|FG001|Overall Study|Protocol Violation|1|||
27966807|NCT01681069|81708110|FG000|Overall Study|Adverse Event|0|||
27966808|NCT01681069|81708111|FG001|Overall Study|Adverse Event|1|||
27966809|NCT05111002|81708112|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
27966810|NCT05111002|81708113|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
27966811|NCT05111002|81708112|FG000|Secondary Outcome|Lost to Follow-up|1|||
27966812|NCT05111002|81708113|FG001|Secondary Outcome|Lost to Follow-up|0|||
27966813|NCT04091581|81708116|FG000|Overall Study|Lost to Follow-up|0|||
27966814|NCT04091581|81708117|FG001|Overall Study|Lost to Follow-up|1|||
27966815|NCT00956007|81708118|FG000|Overall Study|Protocol Violation|27|||
27966816|NCT00956007|81708119|FG001|Overall Study|Protocol Violation|23|||
27966817|NCT01524224|81708120|FG000|Overall Study|Progressive Disease|1|||
27966818|NCT01524224|81708121|FG001|Overall Study|Progressive Disease|0|||
27966819|NCT01524224|81708122|FG002|Overall Study|Progressive Disease|2|||
27966820|NCT01524224|81708123|FG003|Overall Study|Progressive Disease|1|||
27966821|NCT01524224|81708124|FG004|Overall Study|Progressive Disease|2|||
27966822|NCT01524224|81708125|FG005|Overall Study|Progressive Disease|1|||
27966823|NCT01524224|81708126|FG006|Overall Study|Progressive Disease|1|||
27966824|NCT01524224|81708127|FG007|Overall Study|Progressive Disease|5|||
27966825|NCT01524224|81708120|FG000|Overall Study|Withdrawal by Subject|2|||
27966826|NCT01524224|81708121|FG001|Overall Study|Withdrawal by Subject|0|||
27966827|NCT01524224|81708122|FG002|Overall Study|Withdrawal by Subject|0|||
27966828|NCT01524224|81708123|FG003|Overall Study|Withdrawal by Subject|0|||
27966829|NCT01524224|81708124|FG004|Overall Study|Withdrawal by Subject|0|||
27966830|NCT01524224|81708125|FG005|Overall Study|Withdrawal by Subject|0|||
27966831|NCT01524224|81708126|FG006|Overall Study|Withdrawal by Subject|2|||
27966832|NCT01524224|81708127|FG007|Overall Study|Withdrawal by Subject|0|||
27966833|NCT01524224|81708120|FG000|Overall Study|Adverse Event|0|||
27966834|NCT01524224|81708121|FG001|Overall Study|Adverse Event|1|||
27966835|NCT01524224|81708122|FG002|Overall Study|Adverse Event|0|||
27966836|NCT01524224|81708123|FG003|Overall Study|Adverse Event|0|||
27966837|NCT01524224|81708124|FG004|Overall Study|Adverse Event|0|||
27966838|NCT01524224|81708125|FG005|Overall Study|Adverse Event|1|||
27966839|NCT01524224|81708126|FG006|Overall Study|Adverse Event|0|||
27966840|NCT01524224|81708127|FG007|Overall Study|Adverse Event|0|||
27966841|NCT01524224|81708120|FG000|Overall Study|Physician Decision|0|||
27966842|NCT01524224|81708121|FG001|Overall Study|Physician Decision|0|||
27966843|NCT01524224|81708122|FG002|Overall Study|Physician Decision|0|||
27966844|NCT01524224|81708123|FG003|Overall Study|Physician Decision|1|||
27966845|NCT01524224|81708124|FG004|Overall Study|Physician Decision|1|||
27966846|NCT01524224|81708125|FG005|Overall Study|Physician Decision|0|||
27966847|NCT01524224|81708126|FG006|Overall Study|Physician Decision|0|||
27966848|NCT01524224|81708127|FG007|Overall Study|Physician Decision|1|||
27966849|NCT01524224|81708120|FG000|Overall Study|Sponsor Decision|0|||
27966850|NCT01524224|81708121|FG001|Overall Study|Sponsor Decision|0|||
27966851|NCT01524224|81708122|FG002|Overall Study|Sponsor Decision|0|||
27665096|NCT02257918|80612019|FG000|Overall Study|Withdrawal by Subject|0|||
27665097|NCT02257918|80612020|FG001|Overall Study|Withdrawal by Subject|0|||
27665098|NCT02257918|80612021|FG002|Overall Study|Withdrawal by Subject|1|||
27665099|NCT02257918|80612019|FG000|Overall Study|Pregnancy|0|||
27665100|NCT02257918|80612020|FG001|Overall Study|Pregnancy|0|||
27665101|NCT02257918|80612021|FG002|Overall Study|Pregnancy|1|||
27665102|NCT03924947|80612027|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
27665103|NCT03924947|80612028|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
27775273|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
27775274|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
27775275|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
27775276|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
27775277|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
27775278|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
27775279|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
27775280|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
27966852|NCT01524224|81708123|FG003|Overall Study|Sponsor Decision|0|||
27966853|NCT01524224|81708124|FG004|Overall Study|Sponsor Decision|1|||
27665104|NCT03924947|80612029|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
27665105|NCT03924947|80612030|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
27665106|NCT03924947|80612031|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
27665107|NCT03924947|80612032|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
27665108|NCT03028012|80612035|FG000|Overall Study|Lost to Follow-up|2|||
27665109|NCT03028012|80612036|FG001|Overall Study|Lost to Follow-up|3|||
27665110|NCT03028012|80612037|FG002|Overall Study|Lost to Follow-up|3|||
27665111|NCT01145417|80612038|FG000|Overall Study|Death|1|||
27665112|NCT01145417|80612039|FG001|Overall Study|Death|0|||
27665113|NCT01145417|80612038|FG000|Overall Study|Lost to Follow-up|2|||
27665114|NCT01145417|80612039|FG001|Overall Study|Lost to Follow-up|1|||
27665115|NCT01145417|80612038|FG000|Overall Study|Withdrawal by Subject|1|||
27665116|NCT01145417|80612039|FG001|Overall Study|Withdrawal by Subject|2|||
27665117|NCT01145417|80612038|FG000|Overall Study|Pregnancy|1|||
27665118|NCT01145417|80612039|FG001|Overall Study|Pregnancy|0|||
27665119|NCT01145417|80612038|FG000|Overall Study|Adverse Event|0|||
27665120|NCT01145417|80612039|FG001|Overall Study|Adverse Event|1|||
27665121|NCT01145417|80612038|FG000|Overall Study|Study terminated by sponsor|35|||
27665122|NCT01145417|80612039|FG001|Overall Study|Study terminated by sponsor|43|||
27665123|NCT01145417|80612038|FG000|Overall Study|Other|1|||
27665124|NCT01145417|80612039|FG001|Overall Study|Other|0|||
27665125|NCT01772147|80612044|FG000|Overall Study|Adverse Event|13|||
27665126|NCT01772147|80612045|FG001|Overall Study|Adverse Event|10|||
27665127|NCT01772147|80612046|FG002|Overall Study|Adverse Event|6|||
27665128|NCT01772147|80612044|FG000|Overall Study|Withdrew Consent|7|||
27966854|NCT01524224|81708125|FG005|Overall Study|Sponsor Decision|0|||
27966855|NCT01524224|81708126|FG006|Overall Study|Sponsor Decision|0|||
27569748|NCT03670810|80275187|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
27569749|NCT03670810|80275188|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
27966856|NCT01524224|81708127|FG007|Overall Study|Sponsor Decision|0|||
27966857|NCT00623233|81708128|FG000|Overall Study|Adverse Event|10|||
27966858|NCT00623233|81708128|FG000|Overall Study|Physician Decision|10|||
27966859|NCT00623233|81708128|FG000|Overall Study|Lost to Follow-up|1|||
27665129|NCT01772147|80612045|FG001|Overall Study|Withdrew Consent|8|||
27665130|NCT01772147|80612046|FG002|Overall Study|Withdrew Consent|4|||
27665131|NCT01772147|80612044|FG000|Overall Study|Lost to Follow-up|1|||
27665132|NCT01772147|80612045|FG001|Overall Study|Lost to Follow-up|0|||
27665133|NCT01772147|80612046|FG002|Overall Study|Lost to Follow-up|1|||
27966860|NCT00623233|81708128|FG000|Overall Study|Withdrawal by Subject|3|||
27966861|NCT02923830|81708129|FG000|Overall Study|Physician Decision|13|||
27966862|NCT02923830|81708130|FG001|Overall Study|Physician Decision|15|||
27569750|NCT03670810|80275189|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
27569751|NCT03670810|80275190|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
27569752|NCT03670810|80275182|FG000|Open Label Extension|Lost to Follow-up|0|||
27569753|NCT03670810|80275183|FG001|Open Label Extension|Lost to Follow-up|0|||
27966863|NCT03006458|81708131|FG000|First Intervention|Unsatisfied Vision|0|||
27966864|NCT03006458|81708132|FG001|First Intervention|Unsatisfied Vision|3|||
27966865|NCT04730635|81708137|FG000|Overall Study|Lost to Follow-up|1|||
27966866|NCT04730635|81708138|FG001|Overall Study|Lost to Follow-up|0|||
27966867|NCT04730635|81708137|FG000|Overall Study|Withdrawal by Subject|0|||
27966868|NCT04730635|81708138|FG001|Overall Study|Withdrawal by Subject|1|||
27966869|NCT03332017|81708145|FG000|Overall Study|Lost to Follow-up|1|||
27966870|NCT03332017|81708146|FG001|Overall Study|Lost to Follow-up|2|||
27966871|NCT03332017|81708145|FG000|Overall Study|Death|17|||
27966872|NCT03332017|81708146|FG001|Overall Study|Death|16|||
27966873|NCT03332017|81708145|FG000|Overall Study|Withdrawal by Subject|6|||
27966874|NCT03332017|81708146|FG001|Overall Study|Withdrawal by Subject|14|||
27966875|NCT03332017|81708145|FG000|Overall Study|Other|1|||
27966876|NCT03332017|81708146|FG001|Overall Study|Other|3|||
27966877|NCT03332017|81708145|FG000|Overall Study|Remained in Study (Ongoing)|47|||
27966878|NCT03332017|81708146|FG001|Overall Study|Remained in Study (Ongoing)|110|||
27966879|NCT01814397|81708150|FG000|Overall Study|Adverse Event|7|||
27775281|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
27775282|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
27775283|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
27966880|NCT01814397|81708150|FG000|Overall Study|Withdrawal by Subject|7|||
27966881|NCT03983382|81708156|FG000|Overall Study|Death|1|||
27569754|NCT03670810|80275184|FG002|Open Label Extension|Lost to Follow-up|0|||
27569755|NCT03670810|80275185|FG003|Open Label Extension|Lost to Follow-up|0|||
27569756|NCT03670810|80275186|FG004|Open Label Extension|Lost to Follow-up|0|||
27569757|NCT03670810|80275187|FG005|Open Label Extension|Lost to Follow-up|0|||
27569758|NCT03670810|80275188|FG006|Open Label Extension|Lost to Follow-up|0|||
27665134|NCT01772147|80612044|FG000|Overall Study|Protocol Deviation|2|||
27775284|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
27775285|NCT03605836|81006046|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
27775286|NCT03605836|81006047|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
27775287|NCT03605836|81006048|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
27775288|NCT03605836|81006049|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
27775289|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
27775290|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
27775291|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
27775292|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
27775293|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
27775294|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
27775295|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
27775296|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
27775297|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
27775298|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
27775299|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
27775300|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
27775301|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
27775302|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
27775303|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
27775304|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
27775305|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
27775306|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
27775307|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
27775308|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
27775309|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
27966882|NCT03983382|81708156|FG000|Overall Study|Lost to Follow-up|3|||
27966883|NCT03983382|81708156|FG000|Overall Study|Physician Decision|2|||
27966884|NCT03983382|81708156|FG000|Overall Study|Withdrawal by Subject|10|||
27966885|NCT03983382|81708156|FG000|Overall Study|Change in cancer treatment|2|||
27966886|NCT04472650|81708157|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
27966887|NCT04472650|81708158|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
27966888|NCT00113399|81708159|FG000|Overall Study|Death|1|||
27966889|NCT00113399|81708160|FG001|Overall Study|Death|1|||
27966890|NCT00113399|81708159|FG000|Overall Study|Withdrawal by Subject|1|||
27966891|NCT00113399|81708160|FG001|Overall Study|Withdrawal by Subject|2|||
27966892|NCT00113399|81708159|FG000|Overall Study|Complete Response|0|||
27966893|NCT00113399|81708160|FG001|Overall Study|Complete Response|1|||
27966894|NCT00113399|81708159|FG000|Overall Study|Other|0|||
27966895|NCT00113399|81708160|FG001|Overall Study|Other|1|||
27966896|NCT01132651|81708163|FG000|Overall Study|Lost to Follow-up|1|||
27966897|NCT01132651|81708164|FG001|Overall Study|Lost to Follow-up|1|||
27966898|NCT01986231|81708165|FG000|Overall Study|Adverse Event|1|||
27966899|NCT00431444|81708166|FG000|Overall Study|Protocol Violation|1|||
27569759|NCT03670810|80275189|FG007|Open Label Extension|Lost to Follow-up|0|||
27569760|NCT03670810|80275190|FG008|Open Label Extension|Lost to Follow-up|23|||
27569761|NCT04019041|80275191|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
27569762|NCT04019041|80275192|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
27966900|NCT00431444|81708167|FG001|Overall Study|Protocol Violation|4|||
27966901|NCT00431444|81708166|FG000|Overall Study|Adverse Event|2|||
27966902|NCT00431444|81708167|FG001|Overall Study|Adverse Event|1|||
27966903|NCT00431444|81708166|FG000|Overall Study|Withdrawal by Subject|1|||
27966904|NCT00431444|81708167|FG001|Overall Study|Withdrawal by Subject|1|||
27569763|NCT04019041|80275193|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
27569764|NCT04019041|80275194|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27569765|NCT04019041|80275195|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27775310|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
27775311|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
27775312|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
27775313|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
27966905|NCT00431444|81708166|FG000|Overall Study|Lost to Follow-up|1|||
27966906|NCT00431444|81708167|FG001|Overall Study|Lost to Follow-up|0|||
27966907|NCT00431444|81708166|FG000|Overall Study|Administrative Problems|0|||
27966908|NCT00431444|81708167|FG001|Overall Study|Administrative Problems|1|||
27966909|NCT03062280|81708168|FG000|Overall Study|Adverse Event|1|||
27966910|NCT03062280|81708168|FG000|Overall Study|Death|1|||
27966911|NCT03062280|81708168|FG000|Overall Study|Fertility Treatment|2|||
27966912|NCT03062280|81708168|FG000|Overall Study|Physician Decision|2|||
27966913|NCT03062280|81708168|FG000|Overall Study|Pregnancy|5|||
27966914|NCT03062280|81708168|FG000|Overall Study|Withdrawal by Subject|11|||
27966915|NCT02851797|81708169|FG000|Overall Study|Withdrawal by Subject|4|||
27966916|NCT02851797|81708170|FG001|Overall Study|Withdrawal by Subject|2|||
27966917|NCT02851797|81708169|FG000|Overall Study|Adverse Event|3|||
27966918|NCT02851797|81708170|FG001|Overall Study|Adverse Event|0|||
27966919|NCT03763656|81708171|FG000|Overall Study|Physician Decision|1|||
27966920|NCT03763656|81708171|FG000|Overall Study|Protocol Violation|1|||
27966921|NCT03763656|81708171|FG000|Overall Study|Withdrawal by Subject|7|||
27966922|NCT01811485|81708174|FG000|Overall Study|Adverse Event|1|||
27966923|NCT01811485|81708175|FG001|Overall Study|Adverse Event|3|||
27966924|NCT01811485|81708176|FG002|Overall Study|Adverse Event|2|||
27966925|NCT01811485|81708174|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27966926|NCT01811485|81708175|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27966927|NCT01811485|81708176|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
27966928|NCT01811485|81708174|FG000|Overall Study|Administrative problems|1|||
27966929|NCT01811485|81708175|FG001|Overall Study|Administrative problems|0|||
27966930|NCT01811485|81708176|FG002|Overall Study|Administrative problems|0|||
27966931|NCT01811485|81708174|FG000|Overall Study|Protocol Deviation|0|||
27966932|NCT01811485|81708175|FG001|Overall Study|Protocol Deviation|1|||
27966933|NCT01811485|81708176|FG002|Overall Study|Protocol Deviation|0|||
27966934|NCT03640325|81708178|FG000|Overall Study|Withdrawal by Subject|4|||
27966935|NCT03640325|81708179|FG001|Overall Study|Withdrawal by Subject|1|||
27966936|NCT03640325|81708180|FG002|Overall Study|Withdrawal by Subject|0|||
27966937|NCT03640325|81708178|FG000|Overall Study|Lost to Follow-up|4|||
27966938|NCT03640325|81708179|FG001|Overall Study|Lost to Follow-up|5|||
27966939|NCT03640325|81708180|FG002|Overall Study|Lost to Follow-up|21|||
27966940|NCT03640325|81708178|FG000|Overall Study|Death|5|||
27966941|NCT03640325|81708179|FG001|Overall Study|Death|5|||
27775314|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
27966942|NCT03640325|81708180|FG002|Overall Study|Death|0|||
27966943|NCT03379259|81708191|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
27966944|NCT03379259|81708192|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
27966945|NCT03379259|81708193|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
27966946|NCT03379259|81708194|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
27966947|NCT03379259|81708195|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
27966948|NCT03379259|81708196|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
27966949|NCT03379259|81708191|FG000|Overall Study|Death|0|||
27966950|NCT03379259|81708192|FG001|Overall Study|Death|1|||
27966951|NCT03379259|81708193|FG002|Overall Study|Death|2|||
27966952|NCT03379259|81708194|FG003|Overall Study|Death|1|||
27966953|NCT03379259|81708195|FG004|Overall Study|Death|4|||
27966954|NCT03379259|81708196|FG005|Overall Study|Death|2|||
27966955|NCT03379259|81708191|FG000|Overall Study|Withdrawal by Subject|0|||
27966956|NCT03379259|81708192|FG001|Overall Study|Withdrawal by Subject|0|||
27966957|NCT03379259|81708193|FG002|Overall Study|Withdrawal by Subject|1|||
27966958|NCT03379259|81708194|FG003|Overall Study|Withdrawal by Subject|0|||
27966959|NCT03379259|81708195|FG004|Overall Study|Withdrawal by Subject|2|||
27966960|NCT03379259|81708196|FG005|Overall Study|Withdrawal by Subject|0|||
27966961|NCT03379259|81708191|FG000|Overall Study|Study terminated by sponsor|0|||
27966962|NCT03379259|81708192|FG001|Overall Study|Study terminated by sponsor|0|||
27966963|NCT03379259|81708193|FG002|Overall Study|Study terminated by sponsor|0|||
27966964|NCT03379259|81708194|FG003|Overall Study|Study terminated by sponsor|1|||
27966965|NCT03379259|81708195|FG004|Overall Study|Study terminated by sponsor|1|||
27569766|NCT04019041|80275196|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27569767|NCT04019041|80275191|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27569768|NCT04019041|80275192|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27665135|NCT01772147|80612045|FG001|Overall Study|Protocol Deviation|1|||
27665136|NCT01772147|80612046|FG002|Overall Study|Protocol Deviation|1|||
27665137|NCT01772147|80612044|FG000|Overall Study|Lack of Efficacy|8|||
27665138|NCT01772147|80612045|FG001|Overall Study|Lack of Efficacy|6|||
27665139|NCT01772147|80612046|FG002|Overall Study|Lack of Efficacy|6|||
27665140|NCT00796614|80612047|FG000|Overall Study|Adverse Event|1|||
27665141|NCT00796614|80612048|FG001|Overall Study|Adverse Event|2|||
27665142|NCT00796614|80612049|FG002|Overall Study|Adverse Event|0|||
27665143|NCT00796614|80612050|FG003|Overall Study|Adverse Event|0|||
27665144|NCT00796614|80612047|FG000|Overall Study|Protocol Violation|0|||
27665145|NCT00796614|80612048|FG001|Overall Study|Protocol Violation|0|||
27665146|NCT00796614|80612049|FG002|Overall Study|Protocol Violation|2|||
27665147|NCT00796614|80612050|FG003|Overall Study|Protocol Violation|0|||
27665148|NCT00796614|80612047|FG000|Overall Study|Lost to Follow-up|2|||
27665149|NCT00796614|80612048|FG001|Overall Study|Lost to Follow-up|2|||
27665150|NCT00796614|80612049|FG002|Overall Study|Lost to Follow-up|1|||
27665151|NCT00796614|80612050|FG003|Overall Study|Lost to Follow-up|0|||
27665152|NCT00796614|80612047|FG000|Overall Study|Withdrawal by Subject|1|||
27665153|NCT00796614|80612048|FG001|Overall Study|Withdrawal by Subject|0|||
27665154|NCT00796614|80612049|FG002|Overall Study|Withdrawal by Subject|0|||
27665155|NCT00796614|80612050|FG003|Overall Study|Withdrawal by Subject|1|||
27665156|NCT00796614|80612047|FG000|Overall Study|Other than stated|1|||
27665157|NCT00796614|80612048|FG001|Overall Study|Other than stated|0|||
27665158|NCT00796614|80612049|FG002|Overall Study|Other than stated|0|||
27665159|NCT00796614|80612050|FG003|Overall Study|Other than stated|0|||
27665160|NCT01077622|80612051|FG000|Overall Study|Physician Decision|2|||
27665161|NCT01077622|80612051|FG000|Overall Study|Withdrawal by Subject|1|||
27775315|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
27775316|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
27775317|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
27775318|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
27775319|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
27775320|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
27775321|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
27966966|NCT03379259|81708196|FG005|Overall Study|Study terminated by sponsor|4|||
27966967|NCT03379259|81708191|FG000|Overall Study|Disease progression|0|||
27665162|NCT04270747|80612054|FG000|Through Week 16|Adverse Event|1|||
27665163|NCT04270747|80612055|FG001|Through Week 16|Adverse Event|2|||
27665164|NCT04270747|80612056|FG002|Through Week 16|Adverse Event|0|||
27665165|NCT04270747|80612054|FG000|Through Week 16|Death|0|||
27665166|NCT04270747|80612055|FG001|Through Week 16|Death|2|||
27966968|NCT03379259|81708192|FG001|Overall Study|Disease progression|0|||
27966969|NCT03379259|81708193|FG002|Overall Study|Disease progression|0|||
27966970|NCT03379259|81708194|FG003|Overall Study|Disease progression|1|||
27966971|NCT03379259|81708195|FG004|Overall Study|Disease progression|0|||
27966972|NCT03379259|81708196|FG005|Overall Study|Disease progression|1|||
27665167|NCT04270747|80612056|FG002|Through Week 16|Death|0|||
27665168|NCT04270747|80612054|FG000|Through Week 16|Consent Withdrawn|3|||
27665169|NCT04270747|80612055|FG001|Through Week 16|Consent Withdrawn|3|||
27665170|NCT04270747|80612056|FG002|Through Week 16|Consent Withdrawn|0|||
27665171|NCT04270747|80612054|FG000|Through Week 16|Physician Decision|1|||
27665172|NCT04270747|80612055|FG001|Through Week 16|Physician Decision|1|||
27966973|NCT03379259|81708191|FG000|Overall Study|Lost to Follow-up|0|||
27966974|NCT03379259|81708192|FG001|Overall Study|Lost to Follow-up|0|||
27665173|NCT04270747|80612056|FG002|Through Week 16|Physician Decision|0|||
27665174|NCT04270747|80612054|FG000|Through Week 16|Lost to Follow-up|2|||
27665175|NCT04270747|80612055|FG001|Through Week 16|Lost to Follow-up|0|||
27665176|NCT04270747|80612056|FG002|Through Week 16|Lost to Follow-up|0|||
27665177|NCT04270747|80612054|FG000|Through Week 16|Protocol Violation|1|||
27665178|NCT04270747|80612055|FG001|Through Week 16|Protocol Violation|2|||
27665179|NCT04270747|80612056|FG002|Through Week 16|Protocol Violation|0|||
27665180|NCT04270747|80612054|FG000|Through Week 16|Protocol Specified Criteria|6|||
27665181|NCT04270747|80612055|FG001|Through Week 16|Protocol Specified Criteria|7|||
27665182|NCT04270747|80612056|FG002|Through Week 16|Protocol Specified Criteria|0|||
27665183|NCT04270747|80612054|FG000|Through Week 16|Miscellaneous|1|||
27665184|NCT04270747|80612055|FG001|Through Week 16|Miscellaneous|1|||
27665185|NCT04270747|80612056|FG002|Through Week 16|Miscellaneous|0|||
27665186|NCT04270747|80612054|FG000|Post Week 16|Adverse Event|7|||
27665187|NCT04270747|80612055|FG001|Post Week 16|Adverse Event|5|||
27665188|NCT04270747|80612056|FG002|Post Week 16|Adverse Event|1|||
27665189|NCT04270747|80612054|FG000|Post Week 16|Death|2|||
27665190|NCT04270747|80612055|FG001|Post Week 16|Death|0|||
27665191|NCT04270747|80612056|FG002|Post Week 16|Death|2|||
27665192|NCT04270747|80612054|FG000|Post Week 16|Consent Withdrawn|4|||
27665193|NCT04270747|80612055|FG001|Post Week 16|Consent Withdrawn|3|||
27665194|NCT04270747|80612056|FG002|Post Week 16|Consent Withdrawn|6|||
27665195|NCT04270747|80612054|FG000|Post Week 16|Physician Decision|3|||
27665196|NCT04270747|80612055|FG001|Post Week 16|Physician Decision|1|||
27665197|NCT04270747|80612056|FG002|Post Week 16|Physician Decision|1|||
27665198|NCT04270747|80612054|FG000|Post Week 16|Lost to Follow-up|2|||
27665199|NCT04270747|80612055|FG001|Post Week 16|Lost to Follow-up|1|||
27665200|NCT04270747|80612056|FG002|Post Week 16|Lost to Follow-up|0|||
27665201|NCT04270747|80612054|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
27665202|NCT04270747|80612055|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
27665203|NCT04270747|80612056|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
27665204|NCT04270747|80612054|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
27665205|NCT04270747|80612055|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
27665206|NCT04270747|80612056|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
27665207|NCT04270747|80612054|FG000|Post Week 16|Miscellaneous|1|||
27665208|NCT04270747|80612055|FG001|Post Week 16|Miscellaneous|0|||
27665209|NCT04270747|80612056|FG002|Post Week 16|Miscellaneous|1|||
27665210|NCT00439647|80612062|FG000|Overall Study|Withdrawal by Subject|25|||
27665211|NCT00439647|80612063|FG001|Overall Study|Withdrawal by Subject|22|||
27665212|NCT00439647|80612062|FG000|Overall Study|Death|15|||
27665213|NCT00439647|80612063|FG001|Overall Study|Death|18|||
27665214|NCT00439647|80612062|FG000|Overall Study|Adverse Event|11|||
27665215|NCT00439647|80612063|FG001|Overall Study|Adverse Event|11|||
27665216|NCT00439647|80612062|FG000|Overall Study|Lost to Follow-up|4|||
27665217|NCT00439647|80612063|FG001|Overall Study|Lost to Follow-up|12|||
27665218|NCT00439647|80612062|FG000|Overall Study|Protocol Violation|3|||
27665219|NCT00439647|80612063|FG001|Overall Study|Protocol Violation|4|||
27665220|NCT00439647|80612062|FG000|Overall Study|Lack of Efficacy|0|||
27665221|NCT00439647|80612063|FG001|Overall Study|Lack of Efficacy|4|||
27665222|NCT00487552|80612066|FG000|Overall Study|Unsuccessful magnet placements|3|||
27665223|NCT00487552|80612066|FG000|Overall Study|Death due to progressive malignancy|2|||
27665224|NCT00487552|80612066|FG000|Overall Study|Stent not placed|1|||
27665225|NCT00427778|80612068|FG000|First Intervention (4 Weeks)|no longer interested|1|||
27665226|NCT00427778|80612069|FG001|First Intervention (4 Weeks)|no longer interested|0|||
27665227|NCT00427778|80612068|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
27665228|NCT00427778|80612069|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
27665229|NCT00427778|80612068|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
27665230|NCT00427778|80612069|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
27665231|NCT00427778|80612068|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
27665232|NCT00427778|80612069|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
27665233|NCT02388932|80612070|FG000|Overall Study|Death|1|||
27665234|NCT01059526|80612071|FG000|Overall Study|Patient enrolled but not treated|20|||
27665235|NCT01059526|80612072|FG001|Overall Study|Patient enrolled but not treated|17|||
27665236|NCT01059526|80612071|FG000|Overall Study|Adverse Event|2|||
27966975|NCT03379259|81708193|FG002|Overall Study|Lost to Follow-up|0|||
27966976|NCT03379259|81708194|FG003|Overall Study|Lost to Follow-up|0|||
27966977|NCT03379259|81708195|FG004|Overall Study|Lost to Follow-up|1|||
27665237|NCT01059526|80612072|FG001|Overall Study|Adverse Event|2|||
27665238|NCT01059526|80612071|FG000|Overall Study|Protocol Violation|0|||
27665239|NCT01059526|80612072|FG001|Overall Study|Protocol Violation|1|||
27665240|NCT01059526|80612071|FG000|Overall Study|Withdrawal by Subject|3|||
27665241|NCT01059526|80612072|FG001|Overall Study|Withdrawal by Subject|1|||
27665242|NCT01059526|80612071|FG000|Overall Study|Lost to Follow-up|4|||
27665243|NCT01059526|80612072|FG001|Overall Study|Lost to Follow-up|1|||
27665244|NCT01059526|80612071|FG000|Overall Study|Patient found to be dermatographic|1|||
27665245|NCT01059526|80612072|FG001|Overall Study|Patient found to be dermatographic|0|||
27665246|NCT01274559|80612073|FG000|Overall Study|Adverse Event|57|||
27665247|NCT01274559|80612074|FG001|Overall Study|Adverse Event|13|||
27665248|NCT01274559|80612073|FG000|Overall Study|Death|1|||
27665249|NCT01274559|80612074|FG001|Overall Study|Death|1|||
27665250|NCT01274559|80612073|FG000|Overall Study|Lost to Follow-up|3|||
27665251|NCT01274559|80612074|FG001|Overall Study|Lost to Follow-up|3|||
27665252|NCT01274559|80612073|FG000|Overall Study|Non-compliance with Study Drug|2|||
27665253|NCT01274559|80612074|FG001|Overall Study|Non-compliance with Study Drug|4|||
27665254|NCT01274559|80612073|FG000|Overall Study|Physician Decision|2|||
27665255|NCT01274559|80612074|FG001|Overall Study|Physician Decision|1|||
27665256|NCT01274559|80612073|FG000|Overall Study|Protocol Violation|28|||
27665257|NCT01274559|80612074|FG001|Overall Study|Protocol Violation|23|||
27665258|NCT01274559|80612073|FG000|Overall Study|Study Terminated by Sponsor|79|||
27665259|NCT01274559|80612074|FG001|Overall Study|Study Terminated by Sponsor|87|||
27665260|NCT01274559|80612073|FG000|Overall Study|Withdrawal by Subject|25|||
27665261|NCT01274559|80612074|FG001|Overall Study|Withdrawal by Subject|13|||
27665262|NCT01904019|80612075|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
27665263|NCT01904019|80612075|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
27665264|NCT01904019|80612075|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
27665265|NCT01904019|80612075|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
27665266|NCT01904019|80612075|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
27665267|NCT01904019|80612075|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
27665268|NCT01878383|80612080|FG000|Overall Study|Lost to Follow-up|0|||
27665269|NCT01878383|80612081|FG001|Overall Study|Lost to Follow-up|1499|||
27665270|NCT00679549|80612082|FG000|Overall Study|dropout|2|||
27665271|NCT00679549|80612083|FG001|Overall Study|dropout|4|||
27569769|NCT04019041|80275193|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
27665272|NCT00679549|80612082|FG000|Overall Study|missing outcome echocardiograms|4|||
27665273|NCT00679549|80612083|FG001|Overall Study|missing outcome echocardiograms|5|||
27665274|NCT01774019|80612084|FG000|Overall Study|No longer meets protocol criteria|2|||
27665275|NCT01774019|80612085|FG001|Overall Study|No longer meets protocol criteria|0|||
27665276|NCT01774019|80612084|FG000|Overall Study|Withdrawal by Subject|1|||
27665277|NCT01774019|80612085|FG001|Overall Study|Withdrawal by Subject|0|||
27665278|NCT01774019|80612084|FG000|Overall Study|Surgery delayed > 120 days|1|||
27665279|NCT01774019|80612085|FG001|Overall Study|Surgery delayed > 120 days|0|||
27665280|NCT01774019|80612084|FG000|Overall Study|Patient refused surgery|1|||
27665281|NCT01774019|80612085|FG001|Overall Study|Patient refused surgery|1|||
27665282|NCT01774019|80612084|FG000|Overall Study|Unable to implant study device|1|||
27665283|NCT01774019|80612085|FG001|Overall Study|Unable to implant study device|0|||
27665284|NCT01774019|80612084|FG000|Overall Study|Lost to Follow-up|0|||
27665285|NCT01774019|80612085|FG001|Overall Study|Lost to Follow-up|3|||
27665286|NCT00634049|80612087|FG000|Overall Study|Never received study drug|1|||
27665287|NCT00634049|80612087|FG000|Overall Study|Died prior to receiving study drug|1|||
27665288|NCT00634049|80612087|FG000|Overall Study|Screening failure|1|||
27775322|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
27775323|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
27775324|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
27775325|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
27775326|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
27775327|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
27775328|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
27775329|NCT03605836|81006046|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
27775330|NCT03605836|81006047|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
27775331|NCT03605836|81006048|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
27775332|NCT03605836|81006049|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
27775333|NCT02735044|81006050|FG000|Overall Study|Adverse Event|3|||
27775334|NCT02735044|81006051|FG001|Overall Study|Adverse Event|3|||
27775335|NCT02735044|81006050|FG000|Overall Study|Lack of Efficacy|1|||
27775336|NCT02735044|81006051|FG001|Overall Study|Lack of Efficacy|0|||
27775337|NCT02735044|81006050|FG000|Overall Study|Poor compliance to protocol|7|||
27775338|NCT02735044|81006051|FG001|Overall Study|Poor compliance to protocol|7|||
27775339|NCT02735044|81006050|FG000|Overall Study|Randomized and not treated|0|||
27775340|NCT02735044|81006051|FG001|Overall Study|Randomized and not treated|2|||
27775341|NCT02735044|81006050|FG000|Overall Study|Other, not specified above|5|||
27775342|NCT02735044|81006051|FG001|Overall Study|Other, not specified above|11|||
27665289|NCT03511378|80612088|FG000|Overall Study|Withdrawal by Subject|2|||
27665290|NCT03511378|80612089|FG001|Overall Study|Withdrawal by Subject|2|||
27665291|NCT03511378|80612088|FG000|Overall Study|Patient not coming or schedule visit|1|||
27665292|NCT03511378|80612089|FG001|Overall Study|Patient not coming or schedule visit|0|||
27665293|NCT00957996|80612092|FG000|Overall Study|Death|4|||
27665294|NCT00957996|80612093|FG001|Overall Study|Death|10|||
27665295|NCT00957996|80612092|FG000|Overall Study|Lost to Follow-up|4|||
27665296|NCT00957996|80612093|FG001|Overall Study|Lost to Follow-up|7|||
27665297|NCT00957996|80612092|FG000|Overall Study|Withdrawal by Subject|9|||
27665298|NCT00957996|80612093|FG001|Overall Study|Withdrawal by Subject|2|||
27665299|NCT00957996|80612092|FG000|Overall Study|Adverse Event|2|||
27665300|NCT00957996|80612093|FG001|Overall Study|Adverse Event|1|||
27665301|NCT00957996|80612092|FG000|Overall Study|Physician Decision|1|||
27665302|NCT00957996|80612093|FG001|Overall Study|Physician Decision|1|||
27665303|NCT00957996|80612092|FG000|Overall Study|Influenza-related complication|0|||
27665304|NCT00957996|80612093|FG001|Overall Study|Influenza-related complication|1|||
27665305|NCT00957996|80612092|FG000|Overall Study|Missing|1|||
27966978|NCT03379259|81708196|FG005|Overall Study|Lost to Follow-up|0|||
27966979|NCT03379259|81708191|FG000|Overall Study|Deteriorating condition|0|||
27966980|NCT03379259|81708192|FG001|Overall Study|Deteriorating condition|0|||
27966981|NCT03379259|81708193|FG002|Overall Study|Deteriorating condition|0|||
27966982|NCT03379259|81708194|FG003|Overall Study|Deteriorating condition|0|||
27966983|NCT03379259|81708195|FG004|Overall Study|Deteriorating condition|1|||
27966984|NCT03379259|81708196|FG005|Overall Study|Deteriorating condition|0|||
27966985|NCT01238991|81708199|FG000|Overall Study|Adverse Event|1|||
27966986|NCT01238991|81708200|FG001|Overall Study|Adverse Event|0|||
27775343|NCT02253992|81006052|FG000|Overall Study|Study drug toxicity|1|||
27665306|NCT00957996|80612093|FG001|Overall Study|Missing|0|||
27665307|NCT00957996|80612092|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
27775344|NCT02253992|81006053|FG001|Overall Study|Study drug toxicity|0|||
27775345|NCT02253992|81006054|FG002|Overall Study|Study drug toxicity|10|||
27775346|NCT02253992|81006052|FG000|Overall Study|Disease progression|4|||
27775347|NCT02253992|81006053|FG001|Overall Study|Disease progression|3|||
27775348|NCT02253992|81006054|FG002|Overall Study|Disease progression|98|||
27775349|NCT02253992|81006052|FG000|Overall Study|Withdrawal by Subject|0|||
27775350|NCT02253992|81006053|FG001|Overall Study|Withdrawal by Subject|0|||
27775351|NCT02253992|81006054|FG002|Overall Study|Withdrawal by Subject|3|||
27775352|NCT02253992|81006052|FG000|Overall Study|Adverse Event|0|||
27775353|NCT02253992|81006053|FG001|Overall Study|Adverse Event|0|||
27775354|NCT02253992|81006054|FG002|Overall Study|Adverse Event|8|||
27775355|NCT02253992|81006052|FG000|Overall Study|Death|0|||
27775356|NCT02253992|81006053|FG001|Overall Study|Death|0|||
27775357|NCT02253992|81006054|FG002|Overall Study|Death|1|||
27775358|NCT02253992|81006052|FG000|Overall Study|Subject discontinued study drug|1|||
27775359|NCT02253992|81006053|FG001|Overall Study|Subject discontinued study drug|0|||
27775360|NCT02253992|81006054|FG002|Overall Study|Subject discontinued study drug|1|||
27775361|NCT02253992|81006052|FG000|Overall Study|Completed treatment as per protocol|0|||
27775362|NCT02253992|81006053|FG001|Overall Study|Completed treatment as per protocol|1|||
27775363|NCT02253992|81006054|FG002|Overall Study|Completed treatment as per protocol|22|||
27775364|NCT02253992|81006052|FG000|Overall Study|Other|0|||
27665308|NCT00957996|80612093|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
27665309|NCT00264498|80612097|FG000|Randomized Treatment|Death|0|||
27665310|NCT00264498|80612098|FG001|Randomized Treatment|Death|3|||
27665311|NCT00264498|80612097|FG000|Randomized Treatment|Withdrawal by Subject|0|||
27665312|NCT00264498|80612098|FG001|Randomized Treatment|Withdrawal by Subject|1|||
27665313|NCT00264498|80612097|FG000|Randomized Treatment|Objective disease Progression|13|||
27665314|NCT00264498|80612098|FG001|Randomized Treatment|Objective disease Progression|14|||
27775365|NCT02253992|81006053|FG001|Overall Study|Other|0|||
27775366|NCT02253992|81006054|FG002|Overall Study|Other|1|||
27775367|NCT02520141|81006055|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
27775368|NCT00290355|81006060|FG000|Overall Study|Serious adverse event|7|||
27775369|NCT00290355|81006061|FG001|Overall Study|Serious adverse event|4|||
27775370|NCT00290355|81006060|FG000|Overall Study|Study product reactogenicity|1|||
27775371|NCT00290355|81006061|FG001|Overall Study|Study product reactogenicity|0|||
27775372|NCT00290355|81006060|FG000|Overall Study|Protocol Violation|1|||
27775373|NCT00290355|81006061|FG001|Overall Study|Protocol Violation|0|||
27775374|NCT00290355|81006060|FG000|Overall Study|Withdrawal by Subject|2|||
27775375|NCT00290355|81006061|FG001|Overall Study|Withdrawal by Subject|0|||
27775376|NCT00290355|81006060|FG000|Overall Study|Migrated / moved from the study area|1|||
27775377|NCT00290355|81006061|FG001|Overall Study|Migrated / moved from the study area|0|||
27775378|NCT00290355|81006060|FG000|Overall Study|Lost to Follow-up|3|||
27775379|NCT00290355|81006061|FG001|Overall Study|Lost to Follow-up|1|||
27665315|NCT00264498|80612097|FG000|Randomized Treatment|Physician Decision|1|||
27665316|NCT00264498|80612098|FG001|Randomized Treatment|Physician Decision|0|||
27665317|NCT00264498|80612097|FG000|Randomized Treatment|Incorrectly randomized|1|||
27665318|NCT00264498|80612098|FG001|Randomized Treatment|Incorrectly randomized|0|||
27665319|NCT00264498|80612097|FG000|Randomized Treatment|Study Closure|1|||
27665320|NCT00264498|80612098|FG001|Randomized Treatment|Study Closure|0|||
27665321|NCT00264498|80612097|FG000|Randomized Treatment|Protocol Violation|1|||
27775380|NCT00290355|81006060|FG000|Overall Study|Other|2|||
27775381|NCT00290355|81006061|FG001|Overall Study|Other|0|||
27775382|NCT00509028|81006062|FG000|Overall Study|Adverse Event|2|||
27775383|NCT00509028|81006063|FG001|Overall Study|Adverse Event|0|||
27775384|NCT00509028|81006062|FG000|Overall Study|Withdrawal by Subject|4|||
27966987|NCT01238991|81708201|FG002|Overall Study|Adverse Event|3|||
27966988|NCT01238991|81708202|FG003|Overall Study|Adverse Event|1|||
27775385|NCT00509028|81006063|FG001|Overall Study|Withdrawal by Subject|3|||
27775386|NCT00509028|81006062|FG000|Overall Study|Lost to Follow-up|0|||
27775387|NCT00509028|81006063|FG001|Overall Study|Lost to Follow-up|1|||
27775388|NCT00509028|81006062|FG000|Overall Study|Protocol Violation|4|||
27775389|NCT00509028|81006063|FG001|Overall Study|Protocol Violation|2|||
27775390|NCT00509028|81006062|FG000|Overall Study|Non-compliance|2|||
27775391|NCT00509028|81006063|FG001|Overall Study|Non-compliance|1|||
27775392|NCT02243306|81006064|FG000|Overall Study|Adverse Event|0|||
27775393|NCT02243306|81006065|FG001|Overall Study|Adverse Event|1|||
27775394|NCT02243306|81006064|FG000|Overall Study|Other: Reached stopping criteria|0|||
27775395|NCT02243306|81006065|FG001|Overall Study|Other: Reached stopping criteria|1|||
27569770|NCT04019041|80275194|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27569771|NCT04019041|80275195|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27569772|NCT04019041|80275196|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
27569773|NCT04019041|80275191|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
27569774|NCT04019041|80275192|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
27569775|NCT04019041|80275193|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
27569776|NCT04019041|80275194|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27665322|NCT00264498|80612098|FG001|Randomized Treatment|Protocol Violation|0|||
27569777|NCT04019041|80275195|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27569778|NCT04019041|80275196|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27665323|NCT00264498|80612097|FG000|Crossover Treatment|Death|1|||
27665324|NCT00264498|80612098|FG001|Crossover Treatment|Death|3|||
27665325|NCT00264498|80612097|FG000|Crossover Treatment|Objective disease progression|4|||
27665326|NCT00264498|80612098|FG001|Crossover Treatment|Objective disease progression|5|||
27665327|NCT00264498|80612097|FG000|Crossover Treatment|Study closure|0|||
27665328|NCT00264498|80612098|FG001|Crossover Treatment|Study closure|1|||
27665329|NCT00264498|80612097|FG000|Crossover Treatment|Withdrawal by Subject|1|||
27665330|NCT00264498|80612098|FG001|Crossover Treatment|Withdrawal by Subject|0|||
27665331|NCT02592707|80612099|FG000|Overall Study|Consent Withdrawn|0|||
27665332|NCT02592707|80612100|FG001|Overall Study|Consent Withdrawn|1|||
27665333|NCT02592707|80612101|FG002|Overall Study|Consent Withdrawn|2|||
27665334|NCT02592707|80612102|FG003|Overall Study|Consent Withdrawn|0|||
27665335|NCT02592707|80612099|FG000|Overall Study|Death|1|||
27665336|NCT02592707|80612100|FG001|Overall Study|Death|0|||
27665337|NCT02592707|80612101|FG002|Overall Study|Death|0|||
27665338|NCT02592707|80612102|FG003|Overall Study|Death|0|||
27665339|NCT02592707|80612099|FG000|Overall Study|Progressive Disease|4|||
27665340|NCT02592707|80612100|FG001|Overall Study|Progressive Disease|4|||
27665341|NCT02592707|80612101|FG002|Overall Study|Progressive Disease|3|||
27665342|NCT02592707|80612102|FG003|Overall Study|Progressive Disease|3|||
27665343|NCT02592707|80612099|FG000|Overall Study|Other|0|||
27665344|NCT02592707|80612100|FG001|Overall Study|Other|0|||
27665345|NCT02592707|80612101|FG002|Overall Study|Other|1|||
27665346|NCT02592707|80612102|FG003|Overall Study|Other|2|||
27665347|NCT02592707|80612099|FG000|Overall Study|Never entered LTFU period|1|||
27665348|NCT02592707|80612100|FG001|Overall Study|Never entered LTFU period|0|||
27665349|NCT02592707|80612101|FG002|Overall Study|Never entered LTFU period|0|||
27665350|NCT02592707|80612102|FG003|Overall Study|Never entered LTFU period|2|||
27665351|NCT00797511|80612104|FG000|Overall Study|Withdrawal by Subject|1|||
27665352|NCT01202409|80612108|FG000|Overall Study|Adverse Event|1|||
27665353|NCT01202409|80612108|FG000|Overall Study|Ineligible - KRAS mutants|7|||
27665354|NCT00396097|80612110|FG000|Overall Study|Withdrawal by Subject|17|||
27665355|NCT00396097|80612111|FG001|Overall Study|Withdrawal by Subject|17|||
27665356|NCT00396097|80612110|FG000|Overall Study|Lost to Follow-up|4|||
27665357|NCT00396097|80612111|FG001|Overall Study|Lost to Follow-up|9|||
27665358|NCT00396097|80612110|FG000|Overall Study|Other|3|||
27665359|NCT00396097|80612111|FG001|Overall Study|Other|5|||
27665360|NCT00396097|80612110|FG000|Overall Study|Protocol Violation|0|||
27665361|NCT00396097|80612111|FG001|Overall Study|Protocol Violation|6|||
27665362|NCT00396097|80612110|FG000|Overall Study|Adverse Event|1|||
27665363|NCT00396097|80612111|FG001|Overall Study|Adverse Event|5|||
27775396|NCT02243306|81006064|FG000|Overall Study|Physician Decision|0|||
27665364|NCT00396097|80612110|FG000|Overall Study|Insufficient Clinical Response|1|||
27665365|NCT00396097|80612111|FG001|Overall Study|Insufficient Clinical Response|4|||
27665366|NCT00730847|80612112|FG000|Overall Study|Adverse Event|1|||
27665367|NCT00730847|80612112|FG000|Overall Study|Protocol Violation|2|||
27665368|NCT00730847|80612112|FG000|Overall Study|Withdrawal by Subject|16|||
27665369|NCT00730847|80612112|FG000|Overall Study|Lost to Follow-up|67|||
27665370|NCT00730847|80612112|FG000|Overall Study|Unknown completion status|21|||
27665371|NCT00730847|80612112|FG000|Overall Study|Other|24|||
27665372|NCT03918447|80612117|FG000|Overall Study|Death|1|||
27665373|NCT03918447|80612118|FG001|Overall Study|Death|0|||
27665374|NCT03918447|80612117|FG000|Overall Study|Lost to Follow-up|13|||
27665375|NCT03918447|80612118|FG001|Overall Study|Lost to Follow-up|6|||
27665376|NCT03918447|80612117|FG000|Overall Study|Withdrawal by Subject|19|||
27665377|NCT03918447|80612118|FG001|Overall Study|Withdrawal by Subject|17|||
27569779|NCT04019041|80275191|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27569780|NCT04019041|80275192|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27569781|NCT04019041|80275193|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
27569782|NCT04019041|80275194|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27569783|NCT04019041|80275195|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27569784|NCT04019041|80275196|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
27569785|NCT04019041|80275191|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27569786|NCT04019041|80275192|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27569787|NCT04019041|80275193|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27665378|NCT03918447|80612117|FG000|Overall Study|Study Terminated by Sponsor|195|||
27665379|NCT03918447|80612118|FG001|Overall Study|Study Terminated by Sponsor|197|||
27665380|NCT03918447|80612117|FG000|Overall Study|Reason not Specified|0|||
27665381|NCT03918447|80612118|FG001|Overall Study|Reason not Specified|1|||
27665382|NCT01062971|80612122|FG000|Overall Study|Protocol Violation|1|||
27665383|NCT01062971|80612123|FG001|Overall Study|Protocol Violation|3|||
27665384|NCT01062971|80612122|FG000|Overall Study|Lost to Follow-up|3|||
27665385|NCT01062971|80612123|FG001|Overall Study|Lost to Follow-up|4|||
27665386|NCT01393613|80612128|FG000|Overall Study|Adverse Event|11|||
27665387|NCT01393613|80612129|FG001|Overall Study|Adverse Event|11|||
27665388|NCT01393613|80612130|FG002|Overall Study|Adverse Event|13|||
27665389|NCT01393613|80612131|FG003|Overall Study|Adverse Event|22|||
27665390|NCT01393613|80612128|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
27775397|NCT02243306|81006065|FG001|Overall Study|Physician Decision|1|||
27775398|NCT02485860|81006067|FG000|Overall Study|Lost to Follow-up|4|||
27775399|NCT02485860|81006068|FG001|Overall Study|Lost to Follow-up|1|||
27775400|NCT02485860|81006067|FG000|Overall Study|Physician Decision|1|||
27775401|NCT02485860|81006068|FG001|Overall Study|Physician Decision|2|||
27775402|NCT02485860|81006067|FG000|Overall Study|Health context (COVID-19)|1|||
27775403|NCT02485860|81006068|FG001|Overall Study|Health context (COVID-19)|0|||
27775404|NCT03742271|81006069|FG000|Overall Study|Unsatisfactory Visual Response|1|||
27775405|NCT03742271|81006069|FG000|Overall Study|Withdrawal by Subject|3|||
27775406|NCT03742271|81006069|FG000|Overall Study|Lost to Follow-up|4|||
27775407|NCT03742271|81006069|FG000|Overall Study|Failed Insertion & removal|3|||
27775408|NCT03742271|81006069|FG000|Overall Study|Protocol Violation|1|||
27775409|NCT00683774|81006070|FG000|Overall Study|Withdrawal by Subject|0|||
27775410|NCT00683774|81006071|FG001|Overall Study|Withdrawal by Subject|1|||
27775411|NCT00683774|81006070|FG000|Overall Study|Physician Decision|3|||
27775412|NCT00683774|81006071|FG001|Overall Study|Physician Decision|0|||
27775413|NCT01998906|81006076|FG000|Overall Study|Participants ongoing in follow-up|77|||
27775414|NCT01998906|81006077|FG001|Overall Study|Participants ongoing in follow-up|60|||
27775415|NCT01998906|81006078|FG002|Overall Study|Participants ongoing in follow-up|58|||
27775416|NCT01998906|81006076|FG000|Overall Study|Death|21|||
27775417|NCT01998906|81006077|FG001|Overall Study|Death|30|||
27775418|NCT01998906|81006078|FG002|Overall Study|Death|17|||
27775419|NCT01998906|81006076|FG000|Overall Study|Lack of Efficacy|10|||
27775420|NCT01998906|81006077|FG001|Overall Study|Lack of Efficacy|9|||
27775421|NCT01998906|81006078|FG002|Overall Study|Lack of Efficacy|8|||
27775422|NCT01998906|81006076|FG000|Overall Study|Failure to return|0|||
27775423|NCT01998906|81006077|FG001|Overall Study|Failure to return|2|||
27775424|NCT01998906|81006078|FG002|Overall Study|Failure to return|4|||
27775425|NCT01998906|81006076|FG000|Overall Study|Violation of Selection Criteria|0|||
27775426|NCT01998906|81006077|FG001|Overall Study|Violation of Selection Criteria|0|||
27775427|NCT01998906|81006078|FG002|Overall Study|Violation of Selection Criteria|1|||
27775428|NCT01998906|81006076|FG000|Overall Study|Withdrawal by Subject|1|||
27775429|NCT01998906|81006077|FG001|Overall Study|Withdrawal by Subject|4|||
27775430|NCT01998906|81006078|FG002|Overall Study|Withdrawal by Subject|3|||
27775431|NCT01998906|81006076|FG000|Overall Study|Administrative/Other|2|||
27775432|NCT01998906|81006077|FG001|Overall Study|Administrative/Other|1|||
27775433|NCT01998906|81006078|FG002|Overall Study|Administrative/Other|3|||
27775434|NCT01998906|81006076|FG000|Overall Study|Other|3|||
27775435|NCT01998906|81006077|FG001|Overall Study|Other|8|||
27775436|NCT01998906|81006078|FG002|Overall Study|Other|4|||
27569788|NCT04019041|80275194|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
27665391|NCT01393613|80612129|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
27665392|NCT01393613|80612130|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
27665393|NCT01393613|80612131|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
27775437|NCT00981292|81006079|FG000|Day 1|Protocol Violation|1|||
27775438|NCT00981292|81006080|FG001|Day 1|Protocol Violation|0|||
27775439|NCT00981292|81006081|FG002|Day 1|Protocol Violation|0|||
27665394|NCT01393613|80612128|FG000|Overall Study|Physician Decision|2|||
27775440|NCT00981292|81006082|FG003|Day 1|Protocol Violation|0|||
27775441|NCT00981292|81006083|FG004|Day 1|Protocol Violation|0|||
27775442|NCT00981292|81006084|FG005|Day 1|Protocol Violation|2|||
27775443|NCT00981292|81006079|FG000|Day 2|Protocol Violation|2|||
27775444|NCT00981292|81006080|FG001|Day 2|Protocol Violation|0|||
27775445|NCT00981292|81006081|FG002|Day 2|Protocol Violation|0|||
27775446|NCT00981292|81006082|FG003|Day 2|Protocol Violation|0|||
27775447|NCT00981292|81006083|FG004|Day 2|Protocol Violation|0|||
27775448|NCT00981292|81006084|FG005|Day 2|Protocol Violation|0|||
27775449|NCT00981292|81006079|FG000|Day 3|Protocol Violation|0|||
27775450|NCT00981292|81006080|FG001|Day 3|Protocol Violation|0|||
27775451|NCT00981292|81006081|FG002|Day 3|Protocol Violation|0|||
27775452|NCT00981292|81006082|FG003|Day 3|Protocol Violation|0|||
27775453|NCT00981292|81006083|FG004|Day 3|Protocol Violation|0|||
27775454|NCT00981292|81006084|FG005|Day 3|Protocol Violation|1|||
27775455|NCT02343952|81006085|FG000|Study Treatment|Disease Progression|23|||
27775456|NCT02343952|81006085|FG000|Study Treatment|Death|3|||
27775457|NCT02343952|81006085|FG000|Study Treatment|Adverse Event|19|||
27775458|NCT02343952|81006085|FG000|Study Treatment|Withdrawal by Subject|7|||
27775459|NCT02343952|81006085|FG000|Study Treatment|other complicating Diseases|1|||
27775460|NCT02343952|81006085|FG000|Follow up|Withdrawal by Subject|3|||
27775461|NCT02343952|81006085|FG000|Follow up|Death|33|||
27775462|NCT02343952|81006085|FG000|Follow up|Patient does not meet eligibility for study.|1|||
27775463|NCT02343952|81006085|FG000|Follow up|Research department closed by the practice.|5|||
27775464|NCT02343952|81006085|FG000|Follow up|Patient went home to Russia|1|||
27775465|NCT02343952|81006085|FG000|Follow up|Disease Progression|1|||
27775466|NCT02343952|81006085|FG000|Follow up|study terminated|1|||
27775467|NCT02148952|81006087|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
27775468|NCT02148952|81006088|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
27775469|NCT02148952|81006087|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
27775470|NCT02148952|81006088|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
27775471|NCT02148952|81006087|FG000|Follow-Up|Lost to Follow-up|219|||
27775472|NCT02148952|81006088|FG001|Follow-Up|Lost to Follow-up|231|||
27775473|NCT02148952|81006087|FG000|Follow-Up|Withdrawal by Subject|46|||
27775474|NCT02148952|81006088|FG001|Follow-Up|Withdrawal by Subject|48|||
27775475|NCT04005755|81006089|FG000|Overall Study|Adverse Event|6|||
27775476|NCT04005755|81006089|FG000|Overall Study|Physician Decision|3|||
27775477|NCT04005755|81006089|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
27775478|NCT04005755|81006089|FG000|Overall Study|Withdrawal by Subject|3|||
27775479|NCT04005755|81006089|FG000|Overall Study|Lost to Follow-up|1|||
27775480|NCT02044822|81006096|FG000|Overall Study|Study Terminated by Sponsor|77|||
27569789|NCT04019041|80275195|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
27775481|NCT02044822|81006096|FG000|Overall Study|Investigator's Discretion|10|||
27775482|NCT02044822|81006096|FG000|Overall Study|Withdrew Consent|3|||
27775483|NCT02044822|81006096|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
27775484|NCT02044822|81006096|FG000|Overall Study|Lost to Follow-up|1|||
27775485|NCT01023516|81006108|FG000|Overall Study|Voluntary discontinuation|7|||
27775486|NCT01023516|81006109|FG001|Overall Study|Voluntary discontinuation|5|||
27775487|NCT01023516|81006108|FG000|Overall Study|Adverse Event|9|||
27775488|NCT01023516|81006109|FG001|Overall Study|Adverse Event|6|||
27775489|NCT01023516|81006108|FG000|Overall Study|Safety reason|0|||
27775490|NCT01023516|81006109|FG001|Overall Study|Safety reason|3|||
27775491|NCT01023516|81006108|FG000|Overall Study|Study-specific criteria|4|||
27775492|NCT01023516|81006109|FG001|Overall Study|Study-specific criteria|2|||
27775493|NCT01023516|81006108|FG000|Overall Study|Incorrect enrolment|4|||
27775494|NCT01023516|81006109|FG001|Overall Study|Incorrect enrolment|2|||
27775495|NCT00398086|81006112|FG000|Overall Study|Unacceptable Toxicity|2|||
27775496|NCT00398086|81006113|FG001|Overall Study|Unacceptable Toxicity|8|||
27775497|NCT00398086|81006114|FG002|Overall Study|Unacceptable Toxicity|2|||
27775498|NCT00398086|81006112|FG000|Overall Study|Adverse Event|1|||
27775499|NCT00398086|81006113|FG001|Overall Study|Adverse Event|4|||
27775500|NCT00398086|81006114|FG002|Overall Study|Adverse Event|0|||
27775501|NCT00398086|81006112|FG000|Overall Study|Physician Decision|1|||
27775502|NCT00398086|81006113|FG001|Overall Study|Physician Decision|4|||
27775503|NCT00398086|81006114|FG002|Overall Study|Physician Decision|0|||
27775504|NCT00398086|81006112|FG000|Overall Study|Withdrawal by Subject|5|||
27775505|NCT00398086|81006113|FG001|Overall Study|Withdrawal by Subject|7|||
27775506|NCT00398086|81006114|FG002|Overall Study|Withdrawal by Subject|0|||
27775507|NCT00693420|81006115|FG000|Overall Study|Adverse Event|4|||
27775508|NCT00693420|81006116|FG001|Overall Study|Adverse Event|4|||
27775509|NCT00693420|81006115|FG000|Overall Study|Lost to Follow-up|0|||
27775510|NCT00693420|81006116|FG001|Overall Study|Lost to Follow-up|3|||
27775511|NCT00693420|81006115|FG000|Overall Study|Withdrawal by Subject|1|||
27775512|NCT00693420|81006116|FG001|Overall Study|Withdrawal by Subject|0|||
27775513|NCT00693420|81006115|FG000|Overall Study|Protocol Violation|0|||
27775514|NCT00693420|81006116|FG001|Overall Study|Protocol Violation|2|||
27775515|NCT00693420|81006115|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
27775516|NCT00693420|81006116|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
27775517|NCT00693420|81006115|FG000|Overall Study|Personal Reasons|1|||
27775518|NCT00693420|81006116|FG001|Overall Study|Personal Reasons|4|||
27775519|NCT03135262|81006119|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
27775520|NCT03135262|81006120|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
27775521|NCT03135262|81006121|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
27775522|NCT03135262|81006122|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
27775523|NCT03135262|81006123|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
27775524|NCT03135262|81006119|FG000|Overall Study|Progression of disease|0|||
27775525|NCT03135262|81006120|FG001|Overall Study|Progression of disease|0|||
27775526|NCT03135262|81006121|FG002|Overall Study|Progression of disease|0|||
27775527|NCT03135262|81006122|FG003|Overall Study|Progression of disease|1|||
27775528|NCT03135262|81006123|FG004|Overall Study|Progression of disease|0|||
27775529|NCT03135262|81006119|FG000|Overall Study|Death|6|||
27775530|NCT03135262|81006120|FG001|Overall Study|Death|2|||
27775531|NCT03135262|81006121|FG002|Overall Study|Death|2|||
27775532|NCT03135262|81006122|FG003|Overall Study|Death|2|||
27775533|NCT03135262|81006123|FG004|Overall Study|Death|0|||
27775534|NCT03135262|81006119|FG000|Overall Study|Withdrawal by Subject|0|||
27775535|NCT03135262|81006120|FG001|Overall Study|Withdrawal by Subject|0|||
27775536|NCT03135262|81006121|FG002|Overall Study|Withdrawal by Subject|1|||
27775537|NCT03135262|81006122|FG003|Overall Study|Withdrawal by Subject|0|||
27775538|NCT03135262|81006123|FG004|Overall Study|Withdrawal by Subject|1|||
27775539|NCT03135262|81006119|FG000|Overall Study|Study terminated by sponsor|2|||
27966989|NCT01238991|81708203|FG004|Overall Study|Adverse Event|1|||
27966990|NCT01238991|81708204|FG005|Overall Study|Adverse Event|0|||
27569790|NCT04019041|80275196|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
27569791|NCT04019041|80275191|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27966991|NCT01238991|81708205|FG006|Overall Study|Adverse Event|1|||
27966992|NCT01238991|81708206|FG007|Overall Study|Adverse Event|1|||
27966993|NCT01238991|81708207|FG008|Overall Study|Adverse Event|0|||
27966994|NCT01238991|81708208|FG009|Overall Study|Adverse Event|0|||
27966995|NCT01238991|81708199|FG000|Overall Study|Death|0|||
27966996|NCT01238991|81708200|FG001|Overall Study|Death|0|||
27966997|NCT01238991|81708201|FG002|Overall Study|Death|0|||
27966998|NCT01238991|81708202|FG003|Overall Study|Death|1|||
27966999|NCT01238991|81708203|FG004|Overall Study|Death|0|||
27569792|NCT04019041|80275192|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27569793|NCT04019041|80275193|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27569794|NCT04019041|80275194|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
27569795|NCT04019041|80275195|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27569796|NCT04019041|80275196|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
27569797|NCT04019041|80275191|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27569798|NCT04019041|80275192|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27569799|NCT04019041|80275193|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27967000|NCT01238991|81708204|FG005|Overall Study|Death|0|||
27967001|NCT01238991|81708205|FG006|Overall Study|Death|0|||
27569800|NCT04019041|80275194|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27569801|NCT04019041|80275195|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
27569802|NCT04019041|80275196|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
27569803|NCT04019041|80275191|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27569804|NCT04019041|80275192|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27569805|NCT04019041|80275193|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27569806|NCT04019041|80275194|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
27569807|NCT04019041|80275195|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
27569808|NCT04019041|80275196|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
27665395|NCT01393613|80612129|FG001|Overall Study|Physician Decision|0|||
27665396|NCT01393613|80612130|FG002|Overall Study|Physician Decision|0|||
27775540|NCT03135262|81006120|FG001|Overall Study|Study terminated by sponsor|4|||
27967002|NCT01238991|81708206|FG007|Overall Study|Death|0|||
27967003|NCT01238991|81708207|FG008|Overall Study|Death|0|||
27775541|NCT03135262|81006121|FG002|Overall Study|Study terminated by sponsor|4|||
27775542|NCT03135262|81006122|FG003|Overall Study|Study terminated by sponsor|3|||
27775543|NCT03135262|81006123|FG004|Overall Study|Study terminated by sponsor|0|||
27967004|NCT01238991|81708208|FG009|Overall Study|Death|0|||
27967005|NCT01238991|81708199|FG000|Overall Study|Lack of Efficacy|0|||
27967006|NCT01238991|81708200|FG001|Overall Study|Lack of Efficacy|0|||
27967007|NCT01238991|81708201|FG002|Overall Study|Lack of Efficacy|1|||
27775544|NCT00621244|81006128|FG000|Overall Study|Withdrawal by Subject|7|||
27967008|NCT01238991|81708202|FG003|Overall Study|Lack of Efficacy|0|||
27967009|NCT01238991|81708203|FG004|Overall Study|Lack of Efficacy|0|||
27967010|NCT01238991|81708204|FG005|Overall Study|Lack of Efficacy|0|||
27967011|NCT01238991|81708205|FG006|Overall Study|Lack of Efficacy|0|||
27967012|NCT01238991|81708206|FG007|Overall Study|Lack of Efficacy|0|||
27967013|NCT01238991|81708207|FG008|Overall Study|Lack of Efficacy|1|||
27967014|NCT01238991|81708208|FG009|Overall Study|Lack of Efficacy|0|||
27967015|NCT01238991|81708199|FG000|Overall Study|Withdrawal by Subject|0|||
27967016|NCT01238991|81708200|FG001|Overall Study|Withdrawal by Subject|0|||
27967017|NCT01238991|81708201|FG002|Overall Study|Withdrawal by Subject|1|||
27967018|NCT01238991|81708202|FG003|Overall Study|Withdrawal by Subject|0|||
27967019|NCT01238991|81708203|FG004|Overall Study|Withdrawal by Subject|0|||
27967020|NCT01238991|81708204|FG005|Overall Study|Withdrawal by Subject|0|||
27967021|NCT01238991|81708205|FG006|Overall Study|Withdrawal by Subject|0|||
27967022|NCT01238991|81708206|FG007|Overall Study|Withdrawal by Subject|0|||
27967023|NCT01238991|81708207|FG008|Overall Study|Withdrawal by Subject|0|||
27967024|NCT01238991|81708208|FG009|Overall Study|Withdrawal by Subject|0|||
27967025|NCT01238991|81708199|FG000|Overall Study|Study Terminated by Sponsor|0|||
27967026|NCT01238991|81708200|FG001|Overall Study|Study Terminated by Sponsor|0|||
27967027|NCT01238991|81708201|FG002|Overall Study|Study Terminated by Sponsor|0|||
27967028|NCT01238991|81708202|FG003|Overall Study|Study Terminated by Sponsor|0|||
27967029|NCT01238991|81708203|FG004|Overall Study|Study Terminated by Sponsor|1|||
27967030|NCT01238991|81708204|FG005|Overall Study|Study Terminated by Sponsor|0|||
27967031|NCT01238991|81708205|FG006|Overall Study|Study Terminated by Sponsor|7|||
27967032|NCT01238991|81708206|FG007|Overall Study|Study Terminated by Sponsor|4|||
27967033|NCT01238991|81708207|FG008|Overall Study|Study Terminated by Sponsor|2|||
27967034|NCT01238991|81708208|FG009|Overall Study|Study Terminated by Sponsor|2|||
27967035|NCT01238991|81708199|FG000|Overall Study|Caregiver's request|0|||
27967036|NCT01238991|81708200|FG001|Overall Study|Caregiver's request|0|||
27967037|NCT01238991|81708201|FG002|Overall Study|Caregiver's request|0|||
27967038|NCT01238991|81708202|FG003|Overall Study|Caregiver's request|0|||
27967039|NCT01238991|81708203|FG004|Overall Study|Caregiver's request|0|||
27967040|NCT01238991|81708204|FG005|Overall Study|Caregiver's request|0|||
27967041|NCT01238991|81708205|FG006|Overall Study|Caregiver's request|0|||
27967042|NCT01238991|81708206|FG007|Overall Study|Caregiver's request|0|||
27967043|NCT01238991|81708207|FG008|Overall Study|Caregiver's request|1|||
27967044|NCT01238991|81708208|FG009|Overall Study|Caregiver's request|0|||
27967045|NCT01238991|81708199|FG000|Overall Study|Admission to a nursing home|1|||
27967046|NCT01238991|81708200|FG001|Overall Study|Admission to a nursing home|0|||
27967047|NCT01238991|81708201|FG002|Overall Study|Admission to a nursing home|1|||
27967048|NCT01238991|81708202|FG003|Overall Study|Admission to a nursing home|0|||
27967049|NCT01238991|81708203|FG004|Overall Study|Admission to a nursing home|0|||
27967050|NCT01238991|81708204|FG005|Overall Study|Admission to a nursing home|0|||
27967051|NCT01238991|81708205|FG006|Overall Study|Admission to a nursing home|0|||
27967052|NCT01238991|81708206|FG007|Overall Study|Admission to a nursing home|0|||
27967053|NCT01238991|81708207|FG008|Overall Study|Admission to a nursing home|0|||
27967054|NCT01238991|81708208|FG009|Overall Study|Admission to a nursing home|0|||
27967055|NCT00309985|81708213|FG000|Overall Study|Disease progression|12|||
27967056|NCT00309985|81708214|FG001|Overall Study|Disease progression|0|||
27967057|NCT00309985|81708213|FG000|Overall Study|Adverse Event|30|||
27967058|NCT00309985|81708214|FG001|Overall Study|Adverse Event|0|||
27967059|NCT00309985|81708213|FG000|Overall Study|Death|2|||
27967060|NCT00309985|81708214|FG001|Overall Study|Death|0|||
27967061|NCT00309985|81708213|FG000|Overall Study|Withdrawal by Subject|5|||
27967062|NCT00309985|81708214|FG001|Overall Study|Withdrawal by Subject|1|||
27967063|NCT00309985|81708213|FG000|Overall Study|Physician Decision|3|||
27665397|NCT01393613|80612131|FG003|Overall Study|Physician Decision|1|||
27665398|NCT01393613|80612128|FG000|Overall Study|Withdrawal by Subject|15|||
27665399|NCT01393613|80612129|FG001|Overall Study|Withdrawal by Subject|25|||
27665400|NCT01393613|80612130|FG002|Overall Study|Withdrawal by Subject|23|||
27665401|NCT01393613|80612131|FG003|Overall Study|Withdrawal by Subject|21|||
27665402|NCT01393613|80612128|FG000|Overall Study|Protocol Deviation|2|||
27665403|NCT01393613|80612129|FG001|Overall Study|Protocol Deviation|1|||
27775545|NCT00621244|81006129|FG001|Overall Study|Withdrawal by Subject|3|||
27775546|NCT00621244|81006130|FG002|Overall Study|Withdrawal by Subject|3|||
27775547|NCT00621244|81006131|FG003|Overall Study|Withdrawal by Subject|3|||
27967064|NCT00309985|81708214|FG001|Overall Study|Physician Decision|0|||
27967065|NCT00309985|81708213|FG000|Overall Study|Never started treatment|7|||
27665404|NCT01393613|80612130|FG002|Overall Study|Protocol Deviation|0|||
27775548|NCT00621244|81006128|FG000|Overall Study|Disease progression|44|||
27967066|NCT00309985|81708214|FG001|Overall Study|Never started treatment|0|||
27967067|NCT00309985|81708213|FG000|Overall Study|Complicating disease|1|||
27967068|NCT00309985|81708214|FG001|Overall Study|Complicating disease|0|||
27967069|NCT00309985|81708213|FG000|Overall Study|Non-compliance|1|||
27967070|NCT00309985|81708214|FG001|Overall Study|Non-compliance|0|||
27967071|NCT00309985|81708213|FG000|Overall Study|Chemotherapy discontinued only|1|||
27967072|NCT00309985|81708214|FG001|Overall Study|Chemotherapy discontinued only|0|||
27775549|NCT00621244|81006129|FG001|Overall Study|Disease progression|20|||
27775550|NCT00621244|81006130|FG002|Overall Study|Disease progression|20|||
27775551|NCT00621244|81006131|FG003|Overall Study|Disease progression|15|||
27775552|NCT00621244|81006128|FG000|Overall Study|Death|3|||
27775553|NCT00621244|81006129|FG001|Overall Study|Death|3|||
27775554|NCT00621244|81006130|FG002|Overall Study|Death|1|||
27775555|NCT00621244|81006131|FG003|Overall Study|Death|1|||
27775556|NCT00621244|81006128|FG000|Overall Study|Adverse Event|27|||
27775557|NCT00621244|81006129|FG001|Overall Study|Adverse Event|7|||
27665405|NCT01393613|80612131|FG003|Overall Study|Protocol Deviation|0|||
27665406|NCT01393613|80612128|FG000|Overall Study|Lack of Efficacy|9|||
27665407|NCT01393613|80612129|FG001|Overall Study|Lack of Efficacy|20|||
27665408|NCT01393613|80612130|FG002|Overall Study|Lack of Efficacy|16|||
27665409|NCT01393613|80612131|FG003|Overall Study|Lack of Efficacy|21|||
27665410|NCT02973477|80612132|FG000|First Intervention|Lost to Follow-up|0|||
27665411|NCT02973477|80612133|FG001|First Intervention|Lost to Follow-up|2|||
27665412|NCT02973477|80612132|FG000|Washout|Withdrawal by Subject|1|||
27665413|NCT02973477|80612133|FG001|Washout|Withdrawal by Subject|0|||
27665414|NCT02973477|80612132|FG000|Second Intervention|Lost to Follow-up|1|||
27665415|NCT02973477|80612133|FG001|Second Intervention|Lost to Follow-up|0|||
27665416|NCT00853021|80612134|FG000|Overall Study|Adverse Event|2|||
27665417|NCT00853021|80612134|FG000|Overall Study|Withdrawal by Subject|2|||
27665418|NCT00853021|80612134|FG000|Overall Study|Death|1|||
27775558|NCT00621244|81006130|FG002|Overall Study|Adverse Event|9|||
27775559|NCT00621244|81006131|FG003|Overall Study|Adverse Event|2|||
27775560|NCT00621244|81006128|FG000|Overall Study|Administrative problems|5|||
27967073|NCT03802630|81708217|FG000|Overall Study|Study terminated by sponsor|130|||
27967074|NCT03802630|81708218|FG001|Overall Study|Study terminated by sponsor|134|||
27967075|NCT03802630|81708217|FG000|Overall Study|Subject decision|16|||
27967076|NCT03802630|81708218|FG001|Overall Study|Subject decision|9|||
27967077|NCT03802630|81708217|FG000|Overall Study|Adverse Event|3|||
27967078|NCT03802630|81708218|FG001|Overall Study|Adverse Event|1|||
27967079|NCT03802630|81708217|FG000|Overall Study|Lost to Follow-up|2|||
27967080|NCT03802630|81708218|FG001|Overall Study|Lost to Follow-up|2|||
27967081|NCT03802630|81708217|FG000|Overall Study|Physician Decision|2|||
27967082|NCT03802630|81708218|FG001|Overall Study|Physician Decision|0|||
27967083|NCT03802630|81708217|FG000|Overall Study|Death|0|||
27967084|NCT03802630|81708218|FG001|Overall Study|Death|2|||
27967085|NCT04097028|81708219|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
27967086|NCT04097028|81708219|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
27775561|NCT00621244|81006129|FG001|Overall Study|Administrative problems|1|||
27775562|NCT00621244|81006130|FG002|Overall Study|Administrative problems|0|||
27775563|NCT00621244|81006131|FG003|Overall Study|Administrative problems|2|||
27775564|NCT01199198|81006132|FG000|Overall Study|Adverse Event|3|||
27967087|NCT04097028|81708219|FG000|Overall Study|Disease Progression prior to Surgery|2|||
27665419|NCT02282059|80612135|FG000|Overall Study|Other|15|||
27665420|NCT02282059|80612136|FG001|Overall Study|Other|3|||
27665421|NCT02282059|80612135|FG000|Overall Study|Participant refused further follow-up|8|||
27775565|NCT01199198|81006133|FG001|Overall Study|Adverse Event|0|||
27775566|NCT01199198|81006132|FG000|Overall Study|Lost to Follow-up|1|||
27967088|NCT04097028|81708219|FG000|Overall Study|Adverse Event prior to Surgery|1|||
27967089|NCT05145322|81708221|FG000|Overall Study|Lost to Follow-up|4|||
27967090|NCT05145322|81708222|FG001|Overall Study|Lost to Follow-up|5|||
27775567|NCT01199198|81006133|FG001|Overall Study|Lost to Follow-up|5|||
27775568|NCT01199198|81006132|FG000|Overall Study|Withdrawal by Subject|1|||
27775569|NCT01199198|81006133|FG001|Overall Study|Withdrawal by Subject|2|||
27775570|NCT01199198|81006132|FG000|Overall Study|ICU Transfer|1|||
27967091|NCT01301066|81708223|FG000|Overall Study|Lost to Follow-up|5|||
27967092|NCT01301066|81708224|FG001|Overall Study|Lost to Follow-up|11|||
27967093|NCT01301066|81708223|FG000|Overall Study|Protocol Violation|8|||
27967094|NCT01301066|81708224|FG001|Overall Study|Protocol Violation|7|||
27967095|NCT01301066|81708223|FG000|Overall Study|Withdrawal by Subject|4|||
27967096|NCT01301066|81708224|FG001|Overall Study|Withdrawal by Subject|9|||
27967097|NCT01301066|81708223|FG000|Overall Study|Adverse Event|6|||
27967098|NCT01301066|81708224|FG001|Overall Study|Adverse Event|6|||
27967099|NCT01301066|81708223|FG000|Overall Study|Sponsor Decision|2|||
27967100|NCT01301066|81708224|FG001|Overall Study|Sponsor Decision|1|||
27967101|NCT01301066|81708223|FG000|Overall Study|Physician Decision|0|||
27967102|NCT01301066|81708224|FG001|Overall Study|Physician Decision|1|||
27967103|NCT01301066|81708223|FG000|Overall Study|Other|2|||
27967104|NCT01301066|81708224|FG001|Overall Study|Other|0|||
27967105|NCT00841776|81708225|FG000|Overall Study|Lack of Efficacy|0|||
27967106|NCT00841776|81708226|FG001|Overall Study|Lack of Efficacy|1|||
27967107|NCT00841776|81708225|FG000|Overall Study|Lost to Follow-up|2|||
27967108|NCT00841776|81708226|FG001|Overall Study|Lost to Follow-up|1|||
27775571|NCT01199198|81006133|FG001|Overall Study|ICU Transfer|2|||
27775572|NCT01199198|81006132|FG000|Overall Study|Hospice-care transfer|1|||
27775573|NCT01199198|81006133|FG001|Overall Study|Hospice-care transfer|2|||
27775574|NCT01440972|81006138|FG000|Overall Study|Withdrawal by Subject|3|||
27775575|NCT01440972|81006139|FG001|Overall Study|Withdrawal by Subject|2|||
27775576|NCT02449915|81006140|FG000|Overall Study|Exclusion criteria - drug use|1|||
27775577|NCT02449915|81006141|FG001|Overall Study|Exclusion criteria - drug use|0|||
27775578|NCT02449915|81006140|FG000|Overall Study|Withdrawal by Subject|0|||
27775579|NCT02449915|81006141|FG001|Overall Study|Withdrawal by Subject|2|||
27775580|NCT02449915|81006140|FG000|Overall Study|Intraoperative surgical findings|1|||
27775581|NCT02449915|81006141|FG001|Overall Study|Intraoperative surgical findings|1|||
27775582|NCT02449915|81006140|FG000|Overall Study|Abnormal preop lab|0|||
27775583|NCT02449915|81006141|FG001|Overall Study|Abnormal preop lab|1|||
27967109|NCT00841776|81708225|FG000|Overall Study|Withdrawal by Subject|0|||
27967110|NCT00841776|81708226|FG001|Overall Study|Withdrawal by Subject|1|||
27967111|NCT00810277|81708227|FG000|Overall Study|Adverse Event|1|||
27967112|NCT04659174|81710736|FG000|Overall Study|Sponsor decision to discontinue study|0|||
27967113|NCT04659174|81710737|FG001|Overall Study|Sponsor decision to discontinue study|2|||
27665422|NCT02282059|80612136|FG001|Overall Study|Participant refused further follow-up|4|||
27967114|NCT04659174|81710736|FG000|Overall Study|Lost to Follow-up|9|||
27967115|NCT04659174|81710737|FG001|Overall Study|Lost to Follow-up|11|||
27967116|NCT04659174|81710736|FG000|Overall Study|Adverse Event|8|||
27665423|NCT02282059|80612135|FG000|Overall Study|Lost to Follow-up|19|||
27665424|NCT02282059|80612136|FG001|Overall Study|Lost to Follow-up|3|||
27665425|NCT02282059|80612135|FG000|Overall Study|Death|40|||
27665426|NCT02282059|80612136|FG001|Overall Study|Death|8|||
27665427|NCT00001941|80612137|FG000|Overall Study|not treated- rapidly progressing disease|0|||
27665428|NCT00001941|80612138|FG001|Overall Study|not treated- rapidly progressing disease|0|||
27665429|NCT00001941|80612139|FG002|Overall Study|not treated- rapidly progressing disease|0|||
27665430|NCT00001941|80612140|FG003|Overall Study|not treated- rapidly progressing disease|0|||
27665431|NCT00001941|80612141|FG004|Overall Study|not treated- rapidly progressing disease|1|||
27665432|NCT02024750|80612142|FG000|Overall Study|Withdrawal by Subject|2|||
27665433|NCT02024750|80612143|FG001|Overall Study|Withdrawal by Subject|1|||
27665434|NCT01220856|80612144|FG000|Overall Study|graft loss|3|||
27665435|NCT01220856|80612145|FG001|Overall Study|graft loss|3|||
27665436|NCT01220856|80612144|FG000|Overall Study|Lost to Follow-up|1|||
27665437|NCT01220856|80612145|FG001|Overall Study|Lost to Follow-up|0|||
27775584|NCT02886338|81006142|FG000|Overall Study|Withdrawal by Subject|1|||
27775585|NCT01347840|81006143|FG000|Overall Study|Withdrawal by Subject|1|||
27967117|NCT04659174|81710737|FG001|Overall Study|Adverse Event|5|||
27967118|NCT04659174|81710736|FG000|Overall Study|Withdrawal by Subject|17|||
27665438|NCT01091519|80612148|FG000|Overall Study|Adverse Event|12|||
27665439|NCT01091519|80612149|FG001|Overall Study|Adverse Event|16|||
27665440|NCT01091519|80612148|FG000|Overall Study|Death|1|||
27665441|NCT01091519|80612149|FG001|Overall Study|Death|0|||
27775586|NCT01131130|81006144|FG000|Period 1 - Baseline|Pregnancy|1|||
27775587|NCT01131130|81006144|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
27967119|NCT04659174|81710737|FG001|Overall Study|Withdrawal by Subject|33|||
27967120|NCT04659174|81710736|FG000|Overall Study|Progressive disease|0|||
27967121|NCT04659174|81710737|FG001|Overall Study|Progressive disease|2|||
27967122|NCT04659174|81710736|FG000|Overall Study|Other reasons|0|||
27967123|NCT04659174|81710737|FG001|Overall Study|Other reasons|2|||
27967124|NCT04659174|81710736|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
27967125|NCT04659174|81710737|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
27967126|NCT04659174|81710736|FG000|Overall Study|Alcohol or illegal drug use|0|||
27967127|NCT04659174|81710737|FG001|Overall Study|Alcohol or illegal drug use|3|||
27967128|NCT04659174|81710736|FG000|Overall Study|Violation of entry criteria|1|||
27967129|NCT04659174|81710737|FG001|Overall Study|Violation of entry criteria|0|||
27967130|NCT04659174|81710736|FG000|Overall Study|Death|0|||
27967131|NCT04659174|81710737|FG001|Overall Study|Death|1|||
27967132|NCT00211757|81710742|FG000|Overall Study|Withdrawal by Subject|1|||
27967133|NCT00211757|81710743|FG001|Overall Study|Withdrawal by Subject|1|||
27967134|NCT00211757|81710742|FG000|Overall Study|Lack of Efficacy|0|||
27967135|NCT00211757|81710743|FG001|Overall Study|Lack of Efficacy|1|||
27967136|NCT00098748|81710749|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
27967137|NCT00098748|81710750|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
27967138|NCT00098748|81710751|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
27967139|NCT00098748|81710749|FG000|Received Study Treatment|Death|2|||
27967140|NCT00098748|81710750|FG001|Received Study Treatment|Death|1|||
27967141|NCT00098748|81710751|FG002|Received Study Treatment|Death|2|||
27967142|NCT00098748|81710749|FG000|Received Study Treatment|Adverse Event|1|||
27967143|NCT00098748|81710750|FG001|Received Study Treatment|Adverse Event|2|||
27967144|NCT00098748|81710751|FG002|Received Study Treatment|Adverse Event|5|||
27967145|NCT00098748|81710749|FG000|Received Study Treatment|Lack of Efficacy|40|||
27967146|NCT00098748|81710750|FG001|Received Study Treatment|Lack of Efficacy|27|||
27967147|NCT00098748|81710751|FG002|Received Study Treatment|Lack of Efficacy|27|||
27967148|NCT00098748|81710749|FG000|Received Study Treatment|Other|2|||
27967149|NCT00098748|81710750|FG001|Received Study Treatment|Other|2|||
27967150|NCT00098748|81710751|FG002|Received Study Treatment|Other|6|||
27967151|NCT00098748|81710749|FG000|Received Study Treatment|Subject defaulted|3|||
27967152|NCT00098748|81710750|FG001|Received Study Treatment|Subject defaulted|4|||
27967153|NCT00098748|81710751|FG002|Received Study Treatment|Subject defaulted|4|||
27967154|NCT00098748|81710749|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
27967155|NCT00098748|81710750|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
27967156|NCT00098748|81710751|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
27967157|NCT00098748|81710749|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
27967158|NCT00098748|81710750|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
27775588|NCT00998985|81006145|FG000|Overall Study|Withdrawal by Subject|0|||
27775589|NCT00998985|81006146|FG001|Overall Study|Withdrawal by Subject|0|||
27775590|NCT00998985|81006147|FG002|Overall Study|Withdrawal by Subject|0|||
27775591|NCT00998985|81006148|FG003|Overall Study|Withdrawal by Subject|0|||
27775592|NCT00998985|81006149|FG004|Overall Study|Withdrawal by Subject|0|||
27775593|NCT00998985|81006150|FG005|Overall Study|Withdrawal by Subject|0|||
27775594|NCT00998985|81006151|FG006|Overall Study|Withdrawal by Subject|0|||
27775595|NCT00998985|81006152|FG007|Overall Study|Withdrawal by Subject|0|||
27775596|NCT00998985|81006153|FG008|Overall Study|Withdrawal by Subject|1|||
27775597|NCT00998985|81006154|FG009|Overall Study|Withdrawal by Subject|0|||
27775598|NCT00998985|81006155|FG010|Overall Study|Withdrawal by Subject|0|||
27775599|NCT00998985|81006156|FG011|Overall Study|Withdrawal by Subject|0|||
27775600|NCT00998985|81006157|FG012|Overall Study|Withdrawal by Subject|0|||
27775601|NCT00998985|81006158|FG013|Overall Study|Withdrawal by Subject|0|||
27775602|NCT00998985|81006145|FG000|Overall Study|Protocol Violation|0|||
27775603|NCT00998985|81006146|FG001|Overall Study|Protocol Violation|0|||
27775604|NCT00998985|81006147|FG002|Overall Study|Protocol Violation|0|||
27775605|NCT00998985|81006148|FG003|Overall Study|Protocol Violation|0|||
27775606|NCT00998985|81006149|FG004|Overall Study|Protocol Violation|0|||
27775607|NCT00998985|81006150|FG005|Overall Study|Protocol Violation|1|||
27775608|NCT00998985|81006151|FG006|Overall Study|Protocol Violation|0|||
27775609|NCT00998985|81006152|FG007|Overall Study|Protocol Violation|0|||
27775610|NCT00998985|81006153|FG008|Overall Study|Protocol Violation|0|||
27775611|NCT00998985|81006154|FG009|Overall Study|Protocol Violation|0|||
27775612|NCT00998985|81006155|FG010|Overall Study|Protocol Violation|0|||
27775613|NCT00998985|81006156|FG011|Overall Study|Protocol Violation|0|||
27775614|NCT00998985|81006157|FG012|Overall Study|Protocol Violation|0|||
27775615|NCT00998985|81006158|FG013|Overall Study|Protocol Violation|0|||
27775616|NCT03607994|81006159|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
27775617|NCT03607994|81006160|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
27775618|NCT01685372|81006161|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
27775619|NCT01685372|81006162|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
27775620|NCT00410514|81006163|FG000|Overall Study|Adverse Event|2|||
27775621|NCT00410514|81006164|FG001|Overall Study|Adverse Event|2|||
27775622|NCT00410514|81006165|FG002|Overall Study|Adverse Event|2|||
27967159|NCT00098748|81710751|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
27967160|NCT00098748|81710749|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
27967161|NCT00098748|81710750|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
27967162|NCT00098748|81710751|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
27967163|NCT00098748|81710749|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
27967164|NCT00098748|81710750|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
27967165|NCT00098748|81710751|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
27775623|NCT00410514|81006163|FG000|Overall Study|Protocol Violation|0|||
27775624|NCT00410514|81006164|FG001|Overall Study|Protocol Violation|1|||
27775625|NCT00410514|81006165|FG002|Overall Study|Protocol Violation|1|||
27775626|NCT00410514|81006163|FG000|Overall Study|Lost to Follow-up|0|||
27775627|NCT00410514|81006164|FG001|Overall Study|Lost to Follow-up|0|||
27775628|NCT00410514|81006165|FG002|Overall Study|Lost to Follow-up|2|||
27665442|NCT01091519|80612148|FG000|Overall Study|Lack of Efficacy|16|||
27665443|NCT01091519|80612149|FG001|Overall Study|Lack of Efficacy|19|||
27665444|NCT01091519|80612148|FG000|Overall Study|Lost to Follow-up|14|||
27665445|NCT01091519|80612149|FG001|Overall Study|Lost to Follow-up|24|||
27665446|NCT01091519|80612148|FG000|Overall Study|Withdrawal by Subject|2|||
27665447|NCT01091519|80612149|FG001|Overall Study|Withdrawal by Subject|2|||
27665448|NCT01091519|80612148|FG000|Overall Study|Other|6|||
27665449|NCT01091519|80612149|FG001|Overall Study|Other|8|||
27665450|NCT01091519|80612148|FG000|Overall Study|Randomized not treated|4|||
27665451|NCT01091519|80612149|FG001|Overall Study|Randomized not treated|4|||
27665452|NCT01990664|80612152|FG000|Overall Study|Lost to Follow-up|2|||
27665453|NCT01990664|80612153|FG001|Overall Study|Lost to Follow-up|6|||
27665454|NCT01990664|80612152|FG000|Overall Study|Withdrawal by Subject|2|||
27665455|NCT01990664|80612153|FG001|Overall Study|Withdrawal by Subject|3|||
27665456|NCT01990664|80612152|FG000|Overall Study|Protocol Violation|1|||
27665457|NCT01990664|80612153|FG001|Overall Study|Protocol Violation|0|||
27665458|NCT01990664|80612152|FG000|Overall Study|Lens Discomfort|1|||
27665459|NCT01990664|80612153|FG001|Overall Study|Lens Discomfort|1|||
27665460|NCT01990664|80612152|FG000|Overall Study|Lens Handling Difficulties|1|||
27665461|NCT01990664|80612153|FG001|Overall Study|Lens Handling Difficulties|0|||
27665462|NCT01990664|80612152|FG000|Overall Study|Unsatisfactory Visual Response|0|||
27665463|NCT01990664|80612153|FG001|Overall Study|Unsatisfactory Visual Response|1|||
27665464|NCT00233389|80612154|FG000|Overall Study|Adverse Event|5|||
27665465|NCT00233389|80612155|FG001|Overall Study|Adverse Event|5|||
27665466|NCT00233389|80612154|FG000|Overall Study|Lack of Efficacy|11|||
27665467|NCT00233389|80612155|FG001|Overall Study|Lack of Efficacy|8|||
27665468|NCT00233389|80612154|FG000|Overall Study|Lost to Follow-up|1|||
27665469|NCT00233389|80612155|FG001|Overall Study|Lost to Follow-up|1|||
27665470|NCT00233389|80612154|FG000|Overall Study|Physician Decision|1|||
27967166|NCT00098748|81710749|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
27967167|NCT00098748|81710750|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
27967168|NCT00098748|81710751|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
27967169|NCT01597908|81710758|FG000|Randomized Phase|Death|217|||
27967170|NCT01597908|81710759|FG001|Randomized Phase|Death|238|||
27967171|NCT01597908|81710760|FG002|Randomized Phase|Death|0|||
27967172|NCT01597908|81710758|FG000|Randomized Phase|Sponsor Decision|93|||
27665471|NCT00233389|80612155|FG001|Overall Study|Physician Decision|0|||
27665472|NCT00233389|80612154|FG000|Overall Study|Protocol Violation|0|||
27665473|NCT00233389|80612155|FG001|Overall Study|Protocol Violation|1|||
27665474|NCT00233389|80612154|FG000|Overall Study|Withdrawal by Subject|0|||
27665475|NCT00233389|80612155|FG001|Overall Study|Withdrawal by Subject|1|||
27665476|NCT02316847|80612156|FG000|Overall Study|Adverse Event|0|||
27665477|NCT02316847|80612157|FG001|Overall Study|Adverse Event|3|||
27967173|NCT01597908|81710759|FG001|Randomized Phase|Sponsor Decision|39|||
27967174|NCT01597908|81710760|FG002|Randomized Phase|Sponsor Decision|0|||
27967175|NCT01597908|81710758|FG000|Randomized Phase|Lost to Follow-up|9|||
27967176|NCT01597908|81710759|FG001|Randomized Phase|Lost to Follow-up|16|||
27967177|NCT01597908|81710760|FG002|Randomized Phase|Lost to Follow-up|0|||
27967178|NCT01597908|81710758|FG000|Randomized Phase|Physician Decision|6|||
27775629|NCT00410514|81006163|FG000|Overall Study|Non-compliant with study procedures|0|||
27775630|NCT00410514|81006164|FG001|Overall Study|Non-compliant with study procedures|0|||
27775631|NCT00410514|81006165|FG002|Overall Study|Non-compliant with study procedures|2|||
27775632|NCT03006926|81006166|FG000|Overall Study|Adverse Event|0|||
27967179|NCT01597908|81710759|FG001|Randomized Phase|Physician Decision|3|||
27967180|NCT01597908|81710760|FG002|Randomized Phase|Physician Decision|0|||
27775633|NCT03006926|81006167|FG001|Overall Study|Adverse Event|27|||
27775634|NCT03006926|81006166|FG000|Overall Study|Withdrawal by Subject|0|||
27775635|NCT03006926|81006167|FG001|Overall Study|Withdrawal by Subject|1|||
27967181|NCT01597908|81710758|FG000|Randomized Phase|Withdrawal by Subject|26|||
27967182|NCT01597908|81710759|FG001|Randomized Phase|Withdrawal by Subject|22|||
27967183|NCT01597908|81710760|FG002|Randomized Phase|Withdrawal by Subject|0|||
27967184|NCT01597908|81710758|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
27967185|NCT01597908|81710759|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
27967186|NCT01597908|81710760|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
27967187|NCT01597908|81710758|FG000|Crossover Phase|Death|0|||
27967188|NCT01597908|81710759|FG001|Crossover Phase|Death|0|||
27967189|NCT01597908|81710760|FG002|Crossover Phase|Death|11|||
27967190|NCT01597908|81710758|FG000|Crossover Phase|Withdrawal by Subject|0|||
27967191|NCT01597908|81710759|FG001|Crossover Phase|Withdrawal by Subject|0|||
27967192|NCT01597908|81710760|FG002|Crossover Phase|Withdrawal by Subject|3|||
27967193|NCT01597908|81710758|FG000|Crossover Phase|Sponsor Decision|0|||
27967194|NCT01597908|81710759|FG001|Crossover Phase|Sponsor Decision|0|||
27967195|NCT01597908|81710760|FG002|Crossover Phase|Sponsor Decision|20|||
27967196|NCT01974206|81710769|FG000|Overall Study|Did Not Take Study Drug|0|||
27967197|NCT01974206|81710770|FG001|Overall Study|Did Not Take Study Drug|1|||
27967198|NCT01974206|81710769|FG000|Overall Study|Physician Decision|1|||
27967199|NCT01974206|81710770|FG001|Overall Study|Physician Decision|0|||
27967200|NCT01974206|81710769|FG000|Overall Study|Withdrawal by Subject|3|||
27967201|NCT01974206|81710770|FG001|Overall Study|Withdrawal by Subject|0|||
27967202|NCT01974206|81710769|FG000|Overall Study|Lost to Follow-up|1|||
27967203|NCT01974206|81710770|FG001|Overall Study|Lost to Follow-up|0|||
27967204|NCT01974206|81710769|FG000|Overall Study|Death|1|||
27967205|NCT01974206|81710770|FG001|Overall Study|Death|0|||
27967206|NCT03493451|81710778|FG000|Overall Study|Death|11|||
27967207|NCT03493451|81710779|FG001|Overall Study|Death|26|||
27967208|NCT03493451|81710780|FG002|Overall Study|Death|3|||
27967209|NCT03493451|81710778|FG000|Overall Study|Lost to Follow-up|1|||
27967210|NCT03493451|81710779|FG001|Overall Study|Lost to Follow-up|4|||
27967211|NCT03493451|81710780|FG002|Overall Study|Lost to Follow-up|1|||
27967212|NCT03493451|81710778|FG000|Overall Study|Withdrawal by Subject|1|||
27967213|NCT03493451|81710779|FG001|Overall Study|Withdrawal by Subject|1|||
27967214|NCT03493451|81710780|FG002|Overall Study|Withdrawal by Subject|2|||
27967215|NCT03493451|81710778|FG000|Overall Study|Progressive Disease|1|||
27967216|NCT03493451|81710779|FG001|Overall Study|Progressive Disease|0|||
27967217|NCT03493451|81710780|FG002|Overall Study|Progressive Disease|0|||
27967218|NCT03493451|81710778|FG000|Overall Study|Transferred to long term extension study|8|||
27967219|NCT03493451|81710779|FG001|Overall Study|Transferred to long term extension study|13|||
27967220|NCT03493451|81710780|FG002|Overall Study|Transferred to long term extension study|5|||
27967221|NCT03419897|81710781|FG000|Overall Study|Death|180|||
27967222|NCT03419897|81710781|FG000|Overall Study|Lost to Follow-up|1|||
27967223|NCT03419897|81710781|FG000|Overall Study|Withdrawal by Subject|6|||
27967224|NCT03419897|81710781|FG000|Overall Study|Sponsor Decision|61|||
27967225|NCT03419897|81710781|FG000|Overall Study|Physician Decision|1|||
27967226|NCT03734016|81710784|FG000|Overall Study|Participants Remaining in the Study|260|||
27967227|NCT03734016|81710785|FG001|Overall Study|Participants Remaining in the Study|240|||
27967228|NCT03734016|81710784|FG000|Overall Study|Death|48|||
27967229|NCT03734016|81710785|FG001|Overall Study|Death|60|||
27967230|NCT03734016|81710784|FG000|Overall Study|Withdrawal by Subject|14|||
27967231|NCT03734016|81710785|FG001|Overall Study|Withdrawal by Subject|16|||
27967232|NCT03734016|81710784|FG000|Overall Study|Physician Decision|0|||
27967233|NCT03734016|81710785|FG001|Overall Study|Physician Decision|7|||
27967234|NCT03734016|81710784|FG000|Overall Study|Lost to Follow-up|3|||
27967235|NCT03734016|81710785|FG001|Overall Study|Lost to Follow-up|1|||
27967236|NCT03734016|81710784|FG000|Overall Study|Adverse Event|2|||
27967237|NCT03734016|81710785|FG001|Overall Study|Adverse Event|1|||
27967238|NCT00716482|81710786|FG000|Overall Study|Lost to Follow-up|6|||
27967239|NCT00716482|81710786|FG000|Overall Study|Inadequate acquisition or analysis|50|||
27967240|NCT00716482|81710786|FG000|Overall Study|no pathology obtained|10|||
27967241|NCT00716482|81710786|FG000|Overall Study|technical/machine error|28|||
27775636|NCT03006926|81006166|FG000|Overall Study|Radiological Disease Progression|0|||
27775637|NCT03006926|81006167|FG001|Overall Study|Radiological Disease Progression|52|||
27775638|NCT03006926|81006166|FG000|Overall Study|Clinical Disease Progression|0|||
27775639|NCT03006926|81006167|FG001|Overall Study|Clinical Disease Progression|10|||
27775640|NCT03006926|81006166|FG000|Overall Study|Other|0|||
27775641|NCT03006926|81006167|FG001|Overall Study|Other|8|||
27775642|NCT00809614|81006168|FG000|Overall Study|Lack of Efficacy|2|||
27775643|NCT00809614|81006169|FG001|Overall Study|Lack of Efficacy|3|||
27775644|NCT00809614|81006168|FG000|Overall Study|Withdrawal by Subject|1|||
27775645|NCT00809614|81006169|FG001|Overall Study|Withdrawal by Subject|1|||
27775646|NCT00374127|81006170|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
27775647|NCT00374127|81006170|FG000|Overall Study|Blood could not be drawn.|2|||
27775648|NCT00374127|81006170|FG000|Overall Study|Protocol Violation|5|||
27775649|NCT00374127|81006170|FG000|Overall Study|Pregnancy|1|||
27775650|NCT00796549|81006171|FG000|Overall Study|Adverse Event|11|||
27775651|NCT00796549|81006171|FG000|Overall Study|not entered|149|||
27775652|NCT00796549|81006171|FG000|Overall Study|Other|2|||
27775653|NCT00796549|81006171|FG000|Overall Study|Progressive disease|56|||
27775654|NCT04280081|81006172|FG000|Overall Study|Adverse Event|4|||
27775655|NCT04280081|81006172|FG000|Overall Study|Death|2|||
27967242|NCT00716482|81710786|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
27967243|NCT00324805|81710789|FG000|Overall Study|Adverse Event|62|||
27967244|NCT00324805|81710790|FG001|Overall Study|Adverse Event|203|||
27967245|NCT00324805|81710789|FG000|Overall Study|Progression|7|||
27967246|NCT00324805|81710790|FG001|Overall Study|Progression|35|||
27967247|NCT00324805|81710789|FG000|Overall Study|Withdrawal by Subject|51|||
27967248|NCT00324805|81710790|FG001|Overall Study|Withdrawal by Subject|174|||
27967249|NCT00324805|81710789|FG000|Overall Study|Death|6|||
27967250|NCT00324805|81710790|FG001|Overall Study|Death|9|||
27967251|NCT00324805|81710789|FG000|Overall Study|Alternative therapy|4|||
27967252|NCT00324805|81710790|FG001|Overall Study|Alternative therapy|8|||
27967253|NCT00324805|81710789|FG000|Overall Study|Other complicating disease|1|||
27967254|NCT00324805|81710790|FG001|Overall Study|Other complicating disease|9|||
27967255|NCT00324805|81710789|FG000|Overall Study|Other reasons|7|||
27967256|NCT00324805|81710790|FG001|Overall Study|Other reasons|26|||
27967257|NCT00324805|81710789|FG000|Overall Study|Other|0|||
27967258|NCT00324805|81710790|FG001|Overall Study|Other|2|||
27967259|NCT00324805|81710789|FG000|Overall Study|Did not start therapy|12|||
27967260|NCT00324805|81710790|FG001|Overall Study|Did not start therapy|17|||
27967261|NCT02254278|81710793|FG000|Overall Study|Protocol Violation|1|||
27967262|NCT02254278|81710794|FG001|Overall Study|Protocol Violation|1|||
27775656|NCT04280081|81006172|FG000|Overall Study|Progressive Disease|6|||
27775657|NCT03864627|81006179|FG000|Overall Study|Adverse Event|0|||
27775658|NCT03864627|81006180|FG001|Overall Study|Adverse Event|1|||
27775659|NCT03864627|81006179|FG000|Overall Study|Lack of Efficacy|0|||
27775660|NCT03864627|81006180|FG001|Overall Study|Lack of Efficacy|1|||
27775661|NCT03864627|81006179|FG000|Overall Study|Lost to Follow-up|0|||
27775662|NCT03864627|81006180|FG001|Overall Study|Lost to Follow-up|1|||
27775663|NCT03864627|81006179|FG000|Overall Study|Withdrawal by Subject|4|||
27775664|NCT03864627|81006180|FG001|Overall Study|Withdrawal by Subject|8|||
27775665|NCT03864627|81006179|FG000|Overall Study|Study terminated by sponsor|0|||
27775666|NCT03864627|81006180|FG001|Overall Study|Study terminated by sponsor|1|||
27775667|NCT03285490|81006181|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
27775668|NCT03285490|81006182|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
27775669|NCT03285490|81006181|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
27775670|NCT03285490|81006182|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
27775671|NCT03032523|81006183|FG000|Overall Study|Withdrawal by Subject|2|||
27775672|NCT03032523|81006184|FG001|Overall Study|Withdrawal by Subject|2|||
27775673|NCT03032523|81006183|FG000|Overall Study|Physician Decision|1|||
27775674|NCT03032523|81006184|FG001|Overall Study|Physician Decision|0|||
27775675|NCT00471315|81006185|FG000|Overall Study|Adverse Event|7|||
27775676|NCT00471315|81006185|FG000|Overall Study|Withdrawal by Subject|1|||
27775677|NCT01012037|81006193|FG000|Overall Study|Adverse Event|0|||
27775678|NCT01012037|81006194|FG001|Overall Study|Adverse Event|8|||
27775679|NCT01012037|81006195|FG002|Overall Study|Adverse Event|3|||
27775680|NCT01012037|81006193|FG000|Overall Study|Protocol Violation|0|||
27775681|NCT01012037|81006194|FG001|Overall Study|Protocol Violation|3|||
27775682|NCT01012037|81006195|FG002|Overall Study|Protocol Violation|5|||
27775683|NCT01012037|81006193|FG000|Overall Study|Withdrawal by Subject|0|||
27775684|NCT01012037|81006194|FG001|Overall Study|Withdrawal by Subject|4|||
27775685|NCT01012037|81006195|FG002|Overall Study|Withdrawal by Subject|1|||
27775686|NCT01012037|81006193|FG000|Overall Study|Other reason (not specified)|1|||
27775687|NCT01012037|81006194|FG001|Overall Study|Other reason (not specified)|1|||
27967263|NCT03350035|81710796|FG000|Overall Study|Lack of Efficacy|2|||
27967264|NCT03350035|81710797|FG001|Overall Study|Lack of Efficacy|0|||
27967265|NCT03350035|81710798|FG002|Overall Study|Lack of Efficacy|0|||
27665478|NCT02316847|80612156|FG000|Overall Study|Lost to Follow-up|0|||
27775688|NCT01012037|81006195|FG002|Overall Study|Other reason (not specified)|1|||
27967266|NCT03350035|81710796|FG000|Overall Study|Subject discharged to hospice|0|||
27775689|NCT01894776|81006196|FG000|Overall Study|Withdrawal by Subject|1|||
27775690|NCT02559115|81006200|FG000|Overall Study|Withdrawal by Subject|3|||
27775691|NCT03922711|81006201|FG000|Overall Study|Adverse Event|3|||
27775692|NCT03922711|81006202|FG001|Overall Study|Adverse Event|2|||
27775693|NCT03922711|81006203|FG002|Overall Study|Adverse Event|2|||
27775694|NCT03922711|81006201|FG000|Overall Study|Protocol Violation|1|||
27775695|NCT03922711|81006202|FG001|Overall Study|Protocol Violation|0|||
27775696|NCT03922711|81006203|FG002|Overall Study|Protocol Violation|0|||
27569809|NCT04019041|80275191|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27569810|NCT04019041|80275192|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27569811|NCT04019041|80275193|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27569812|NCT04019041|80275194|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27569813|NCT04019041|80275195|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
27775697|NCT03922711|81006201|FG000|Overall Study|Withdrawal by Subject|0|||
27775698|NCT03922711|81006202|FG001|Overall Study|Withdrawal by Subject|3|||
27775699|NCT03922711|81006203|FG002|Overall Study|Withdrawal by Subject|1|||
27775700|NCT03922711|81006201|FG000|Overall Study|Not further specified|0|||
27775701|NCT03922711|81006202|FG001|Overall Study|Not further specified|0|||
27775702|NCT03922711|81006203|FG002|Overall Study|Not further specified|1|||
27775703|NCT02096471|81006214|FG000|Overall Study|Adverse Event|1|||
27775704|NCT02096471|81006214|FG000|Overall Study|Lack of Efficacy|7|||
27775705|NCT02096471|81006214|FG000|Overall Study|Withdrawal by Subject|3|||
27775706|NCT02096471|81006214|FG000|Overall Study|Non-Compliant|2|||
27775707|NCT02718625|81006219|FG000|Overall Study|Adverse Event|0|||
27775708|NCT02718625|81006220|FG001|Overall Study|Adverse Event|1|||
27775709|NCT02718625|81006219|FG000|Overall Study|Termination of Study by Sponsor|0|||
27775710|NCT02718625|81006220|FG001|Overall Study|Termination of Study by Sponsor|1|||
27775711|NCT02365506|81006226|FG000|Overall Study|Investigator's Discretion|0|||
27775712|NCT02365506|81006227|FG001|Overall Study|Investigator's Discretion|0|||
27775713|NCT02365506|81006228|FG002|Overall Study|Investigator's Discretion|1|||
27775714|NCT00420212|81006229|FG000|Overall Study|Adverse Event|22|||
27775715|NCT00420212|81006230|FG001|Overall Study|Adverse Event|40|||
27775716|NCT00420212|81006231|FG002|Overall Study|Adverse Event|36|||
27775717|NCT00420212|81006229|FG000|Overall Study|Lost to Follow-up|9|||
27775718|NCT00420212|81006230|FG001|Overall Study|Lost to Follow-up|11|||
27775719|NCT00420212|81006231|FG002|Overall Study|Lost to Follow-up|11|||
27775720|NCT00420212|81006229|FG000|Overall Study|Withdrawal by Subject|31|||
27775721|NCT00420212|81006230|FG001|Overall Study|Withdrawal by Subject|22|||
27775722|NCT00420212|81006231|FG002|Overall Study|Withdrawal by Subject|19|||
27775723|NCT00420212|81006229|FG000|Overall Study|Physician Decision|4|||
27775724|NCT00420212|81006230|FG001|Overall Study|Physician Decision|4|||
27775725|NCT00420212|81006231|FG002|Overall Study|Physician Decision|3|||
27775726|NCT00420212|81006229|FG000|Overall Study|Protocol Violation|4|||
27775727|NCT00420212|81006230|FG001|Overall Study|Protocol Violation|4|||
27775728|NCT00420212|81006231|FG002|Overall Study|Protocol Violation|8|||
27775729|NCT00420212|81006229|FG000|Overall Study|Death|0|||
27775730|NCT00420212|81006230|FG001|Overall Study|Death|0|||
27775731|NCT00420212|81006231|FG002|Overall Study|Death|1|||
27775732|NCT00420212|81006229|FG000|Overall Study|Other-Unspecified|21|||
27775733|NCT00420212|81006230|FG001|Overall Study|Other-Unspecified|14|||
27775734|NCT00420212|81006231|FG002|Overall Study|Other-Unspecified|18|||
27775735|NCT03442595|81006232|FG000|Overall Study|Lost to Follow-up|94|||
27775736|NCT03442595|81006233|FG001|Overall Study|Lost to Follow-up|0|||
27775737|NCT02038790|81006236|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
27775738|NCT02038790|81006237|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
27775739|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
27665479|NCT02316847|80612157|FG001|Overall Study|Lost to Follow-up|2|||
27665480|NCT02316847|80612156|FG000|Overall Study|Physician Decision|0|||
27665481|NCT02316847|80612157|FG001|Overall Study|Physician Decision|1|||
27665482|NCT02316847|80612156|FG000|Overall Study|Pregnancy|0|||
27665483|NCT02316847|80612157|FG001|Overall Study|Pregnancy|1|||
27665484|NCT02316847|80612156|FG000|Overall Study|Withdrawal by Subject|2|||
27665485|NCT02316847|80612157|FG001|Overall Study|Withdrawal by Subject|9|||
27665486|NCT02316847|80612156|FG000|Overall Study|Noncompliance with study drug|0|||
27665487|NCT02316847|80612157|FG001|Overall Study|Noncompliance with study drug|3|||
27665488|NCT02316847|80612156|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
27665489|NCT02316847|80612157|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
27665490|NCT01525641|80612158|FG000|Overall Study|Case report form not collected|25|||
27775740|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
27775741|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
27775742|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
27775743|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
27775744|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
27775745|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
27775746|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
27665491|NCT01525641|80612158|FG000|Overall Study|No visit since the first visit|16|||
27665492|NCT01525641|80612158|FG000|Overall Study|Adverse Event|73|||
27665493|NCT01525641|80612158|FG000|Overall Study|Lack of Efficacy|24|||
27665494|NCT01525641|80612158|FG000|Overall Study|Improvement|5|||
27665495|NCT01525641|80612158|FG000|Overall Study|Lost to follow-up (relocation)|1|||
27665496|NCT01525641|80612158|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
27665497|NCT01525641|80612158|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
27665498|NCT01525641|80612158|FG000|Overall Study|Other than stated above|7|||
27665499|NCT01435798|80612159|FG000|Overall Study|Withdrawal by Subject|1|||
27665500|NCT01967719|80612160|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
27665501|NCT01967719|80612161|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
27665502|NCT01967719|80612162|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27665503|NCT01967719|80612163|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
27665504|NCT01967719|80612160|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
27665505|NCT01967719|80612161|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
27665506|NCT01967719|80612162|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
27665507|NCT01967719|80612163|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
27665508|NCT01183013|80612164|FG000|Overall Study|Adverse Event|6|||
27665509|NCT01183013|80612165|FG001|Overall Study|Adverse Event|8|||
27665510|NCT01183013|80612166|FG002|Overall Study|Adverse Event|5|||
27665511|NCT01183013|80612167|FG003|Overall Study|Adverse Event|5|||
27665512|NCT01183013|80612168|FG004|Overall Study|Adverse Event|10|||
27665513|NCT01183013|80612169|FG005|Overall Study|Adverse Event|10|||
27665514|NCT01183013|80612170|FG006|Overall Study|Adverse Event|6|||
27665515|NCT01183013|80612164|FG000|Overall Study|Lack of Efficacy|3|||
27665516|NCT01183013|80612165|FG001|Overall Study|Lack of Efficacy|2|||
27665517|NCT01183013|80612166|FG002|Overall Study|Lack of Efficacy|1|||
27665518|NCT01183013|80612167|FG003|Overall Study|Lack of Efficacy|2|||
27665519|NCT01183013|80612168|FG004|Overall Study|Lack of Efficacy|1|||
27665520|NCT01183013|80612169|FG005|Overall Study|Lack of Efficacy|2|||
27665521|NCT01183013|80612170|FG006|Overall Study|Lack of Efficacy|0|||
27665522|NCT01183013|80612164|FG000|Overall Study|Protocol Violation|5|||
27665523|NCT01183013|80612165|FG001|Overall Study|Protocol Violation|2|||
27665524|NCT01183013|80612166|FG002|Overall Study|Protocol Violation|4|||
27775747|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
27775748|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
27775749|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
27569814|NCT04019041|80275196|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
27569815|NCT01256593|80275197|FG000|Overall Study|Protocol Violation|26|||
27569816|NCT01256593|80275197|FG000|Overall Study|No Drug Administration Information|2|||
27569817|NCT01256593|80275197|FG000|Overall Study|No Visit After Treatment|186|||
27569818|NCT03548584|80275198|FG000|Overall Study|Lost to Follow-up|0|||
27569819|NCT03548584|80275199|FG001|Overall Study|Lost to Follow-up|0|||
27569820|NCT03548584|80275200|FG002|Overall Study|Lost to Follow-up|1|||
27569821|NCT03548584|80275198|FG000|Overall Study|Adverse Event|1|||
27569822|NCT03548584|80275199|FG001|Overall Study|Adverse Event|11|||
27569823|NCT03548584|80275200|FG002|Overall Study|Adverse Event|5|||
27569824|NCT03548584|80275198|FG000|Overall Study|Site Terminated by Sponsor|1|||
27569825|NCT03548584|80275199|FG001|Overall Study|Site Terminated by Sponsor|3|||
27775750|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
27775751|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
27775752|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
27775753|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
27775754|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
27775755|NCT01291511|81006238|FG000|Cross-Titration and Stabilization Phase|Death|1|||
27775756|NCT01291511|81006239|FG001|Cross-Titration and Stabilization Phase|Death|0|||
27569826|NCT03548584|80275200|FG002|Overall Study|Site Terminated by Sponsor|2|||
27569827|NCT03548584|80275198|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
27569828|NCT03548584|80275199|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
27775757|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
27775758|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
27665525|NCT01183013|80612167|FG003|Overall Study|Protocol Violation|0|||
27665526|NCT01183013|80612168|FG004|Overall Study|Protocol Violation|4|||
27775759|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
27775760|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
27569829|NCT03548584|80275200|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
27775761|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
27775762|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
27775763|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
27775764|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
27775765|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
27775766|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
27775767|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
27775768|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
27775769|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
27775770|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
27775771|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
27775772|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
27775773|NCT01291511|81006238|FG000|Double-blind Relapse Prevention Phase|Death|1|||
27775774|NCT01291511|81006239|FG001|Double-blind Relapse Prevention Phase|Death|0|||
27569830|NCT03548584|80275198|FG000|Overall Study|Lack of Efficacy|0|||
27569831|NCT03548584|80275199|FG001|Overall Study|Lack of Efficacy|1|||
27569832|NCT03548584|80275200|FG002|Overall Study|Lack of Efficacy|0|||
27569833|NCT03548584|80275198|FG000|Overall Study|Non-compliance with Study Drug|0|||
27569834|NCT03548584|80275199|FG001|Overall Study|Non-compliance with Study Drug|1|||
27569835|NCT03548584|80275200|FG002|Overall Study|Non-compliance with Study Drug|0|||
27569836|NCT03548584|80275198|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
27665527|NCT01183013|80612169|FG005|Overall Study|Protocol Violation|3|||
27665528|NCT01183013|80612170|FG006|Overall Study|Protocol Violation|3|||
27665529|NCT01183013|80612164|FG000|Overall Study|Lost to Follow-up|7|||
27665530|NCT01183013|80612165|FG001|Overall Study|Lost to Follow-up|3|||
27665531|NCT01183013|80612166|FG002|Overall Study|Lost to Follow-up|4|||
27665532|NCT01183013|80612167|FG003|Overall Study|Lost to Follow-up|3|||
27665533|NCT01183013|80612168|FG004|Overall Study|Lost to Follow-up|2|||
27665534|NCT01183013|80612169|FG005|Overall Study|Lost to Follow-up|6|||
27665535|NCT01183013|80612170|FG006|Overall Study|Lost to Follow-up|5|||
27665536|NCT01183013|80612164|FG000|Overall Study|Withdrawal by Subject|9|||
27665537|NCT01183013|80612165|FG001|Overall Study|Withdrawal by Subject|13|||
27665538|NCT01183013|80612166|FG002|Overall Study|Withdrawal by Subject|10|||
27665539|NCT01183013|80612167|FG003|Overall Study|Withdrawal by Subject|8|||
27665540|NCT01183013|80612168|FG004|Overall Study|Withdrawal by Subject|7|||
27775775|NCT00191386|81006240|FG000|Overall Study|Adverse Event|16|||
27775776|NCT00191386|81006240|FG000|Overall Study|Lost to Follow-up|1|||
27775777|NCT00191386|81006240|FG000|Overall Study|Entry Criteria Exclusion|3|||
27775778|NCT00191386|81006240|FG000|Overall Study|Protocol Violation|18|||
27775779|NCT00191386|81006240|FG000|Overall Study|Withdrawal by Subject|96|||
27775780|NCT00191386|81006240|FG000|Overall Study|Physician Decision|11|||
27775781|NCT00191386|81006240|FG000|Overall Study|Lack of Efficacy|15|||
27775782|NCT00081263|81006243|FG000|Overall Study|clerical error|1|||
27775783|NCT00081263|81006244|FG001|Overall Study|clerical error|0|||
27775784|NCT00081263|81006243|FG000|Overall Study|wrong cell type|7|||
27775785|NCT00081263|81006244|FG001|Overall Study|wrong cell type|5|||
27775786|NCT00081263|81006243|FG000|Overall Study|improper pre-protocol therapy|0|||
27775787|NCT00081263|81006244|FG001|Overall Study|improper pre-protocol therapy|1|||
27775788|NCT00081263|81006243|FG000|Overall Study|Inadequate pathology|0|||
27775789|NCT00081263|81006244|FG001|Overall Study|Inadequate pathology|1|||
27775790|NCT00081263|81006243|FG000|Overall Study|Never treated|4|||
27775791|NCT00081263|81006244|FG001|Overall Study|Never treated|5|||
27775792|NCT00081263|81006243|FG000|Overall Study|Inadequate data|5|||
27775793|NCT00081263|81006244|FG001|Overall Study|Inadequate data|10|||
27775794|NCT01708915|81006245|FG000|Overall Study|Adverse Event|1|||
27775795|NCT01708915|81006246|FG001|Overall Study|Adverse Event|0|||
27775796|NCT01708915|81006247|FG002|Overall Study|Adverse Event|9|||
27775797|NCT01708915|81006248|FG003|Overall Study|Adverse Event|13|||
27775798|NCT01708915|81006245|FG000|Overall Study|Lack of Efficacy|84|||
27775799|NCT01708915|81006246|FG001|Overall Study|Lack of Efficacy|60|||
27775800|NCT01708915|81006247|FG002|Overall Study|Lack of Efficacy|35|||
27775801|NCT01708915|81006248|FG003|Overall Study|Lack of Efficacy|15|||
27775802|NCT01708915|81006245|FG000|Overall Study|Protocol Violation|0|||
27775803|NCT01708915|81006246|FG001|Overall Study|Protocol Violation|0|||
27569837|NCT03548584|80275199|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
27569838|NCT03548584|80275200|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
27569839|NCT01944059|80275214|FG000|Overall Study|Lost to Follow-up|1|||
27775804|NCT01708915|81006247|FG002|Overall Study|Protocol Violation|0|||
27775805|NCT01708915|81006248|FG003|Overall Study|Protocol Violation|1|||
27775806|NCT01708915|81006245|FG000|Overall Study|Withdrawal by Subject|0|||
27665541|NCT01183013|80612169|FG005|Overall Study|Withdrawal by Subject|9|||
27775807|NCT01708915|81006246|FG001|Overall Study|Withdrawal by Subject|1|||
27775808|NCT01708915|81006247|FG002|Overall Study|Withdrawal by Subject|2|||
27775809|NCT01708915|81006248|FG003|Overall Study|Withdrawal by Subject|2|||
27775810|NCT01708915|81006245|FG000|Overall Study|Other reasons than stated above|1|||
27775811|NCT01708915|81006246|FG001|Overall Study|Other reasons than stated above|1|||
27775812|NCT01708915|81006247|FG002|Overall Study|Other reasons than stated above|0|||
27775813|NCT01708915|81006248|FG003|Overall Study|Other reasons than stated above|2|||
27775814|NCT03399786|81006258|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27775815|NCT03399786|81006259|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27775816|NCT03399786|81006260|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27775817|NCT03399786|81006261|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27775818|NCT03399786|81006258|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
27775819|NCT03399786|81006259|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
27775820|NCT03399786|81006260|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
27775821|NCT03399786|81006261|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
27775822|NCT03399786|81006258|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
27775823|NCT03399786|81006259|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
27775824|NCT03399786|81006260|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
27775825|NCT03399786|81006261|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
27775826|NCT02181504|81006276|FG000|Overall Study|Adverse Event|1|||
27775827|NCT02181504|81006277|FG001|Overall Study|Adverse Event|1|||
27775828|NCT02181504|81006278|FG002|Overall Study|Adverse Event|1|||
27775829|NCT02045979|81006281|FG000|Overall Study|Informed Consent Withdrawn|2|||
27775830|NCT02045979|81006282|FG001|Overall Study|Informed Consent Withdrawn|0|||
27775831|NCT02045979|81006283|FG002|Overall Study|Informed Consent Withdrawn|1|||
27775832|NCT02045979|81006281|FG000|Overall Study|not specified above|0|||
27775833|NCT02045979|81006282|FG001|Overall Study|not specified above|1|||
27775834|NCT02045979|81006283|FG002|Overall Study|not specified above|0|||
27775835|NCT02447952|81006284|FG000|Overall Study|Adverse Event|2|||
27775836|NCT02447952|81006284|FG000|Overall Study|Physician Decision|1|||
27775837|NCT02447952|81006284|FG000|Overall Study|Withdrawal by Subject|4|||
27775838|NCT03462030|81009474|FG000|Overall Study|Withdrawal by Subject|1|||
27775839|NCT03462030|81009475|FG001|Overall Study|Withdrawal by Subject|1|||
27775840|NCT01602744|81009486|FG000|Overall Study|Death|17|||
27775841|NCT01602744|81009487|FG001|Overall Study|Death|15|||
27775842|NCT01602744|81009486|FG000|Overall Study|Lost to Follow-up|13|||
27775843|NCT01602744|81009487|FG001|Overall Study|Lost to Follow-up|8|||
27665542|NCT01183013|80612170|FG006|Overall Study|Withdrawal by Subject|10|||
27665543|NCT01183013|80612164|FG000|Overall Study|Reasons other than stated above|15|||
27665544|NCT01183013|80612165|FG001|Overall Study|Reasons other than stated above|11|||
27775844|NCT00364832|81009488|FG000|Core Period|Early Withdrawals|2|||
27775845|NCT00364832|81009489|FG001|Core Period|Early Withdrawals|2|||
27775846|NCT00364832|81009490|FG002|Core Period|Early Withdrawals|1|||
27775847|NCT00364832|81009491|FG003|Core Period|Early Withdrawals|1|||
27775848|NCT00364832|81009492|FG004|Core Period|Early Withdrawals|0|||
27775849|NCT00364832|81009493|FG005|Core Period|Early Withdrawals|0|||
27775850|NCT00364832|81009494|FG006|Core Period|Early Withdrawals|4|||
27775851|NCT00364832|81009495|FG007|Core Period|Early Withdrawals|1|||
27775852|NCT00364832|81009496|FG008|Core Period|Early Withdrawals|0|||
27775853|NCT00364832|81009497|FG009|Core Period|Early Withdrawals|0|||
27775854|NCT00364832|81009498|FG010|Core Period|Early Withdrawals|0|||
27775855|NCT00364832|81009499|FG011|Core Period|Early Withdrawals|0|||
27775856|NCT00364832|81009488|FG000|Extension Year 1|Early Withdrawals|0|||
27775857|NCT00364832|81009489|FG001|Extension Year 1|Early Withdrawals|0|||
27775858|NCT00364832|81009490|FG002|Extension Year 1|Early Withdrawals|0|||
27775859|NCT00364832|81009491|FG003|Extension Year 1|Early Withdrawals|0|||
27775860|NCT00364832|81009492|FG004|Extension Year 1|Early Withdrawals|0|||
27775861|NCT00364832|81009493|FG005|Extension Year 1|Early Withdrawals|0|||
27775862|NCT00364832|81009494|FG006|Extension Year 1|Early Withdrawals|0|||
27775863|NCT00364832|81009495|FG007|Extension Year 1|Early Withdrawals|0|||
27775864|NCT00364832|81009496|FG008|Extension Year 1|Early Withdrawals|0|||
27775865|NCT00364832|81009497|FG009|Extension Year 1|Early Withdrawals|4|||
27775866|NCT00364832|81009498|FG010|Extension Year 1|Early Withdrawals|2|||
27775867|NCT00364832|81009499|FG011|Extension Year 1|Early Withdrawals|10|||
27775868|NCT00364832|81009488|FG000|Extension Year 2|Early Withdrawals|0|||
27775869|NCT00364832|81009489|FG001|Extension Year 2|Early Withdrawals|0|||
27775870|NCT00364832|81009490|FG002|Extension Year 2|Early Withdrawals|0|||
27775871|NCT00364832|81009491|FG003|Extension Year 2|Early Withdrawals|0|||
27775872|NCT00364832|81009492|FG004|Extension Year 2|Early Withdrawals|0|||
27775873|NCT00364832|81009493|FG005|Extension Year 2|Early Withdrawals|0|||
27775874|NCT00364832|81009494|FG006|Extension Year 2|Early Withdrawals|0|||
27775875|NCT00364832|81009495|FG007|Extension Year 2|Early Withdrawals|0|||
27775876|NCT00364832|81009496|FG008|Extension Year 2|Early Withdrawals|0|||
27775877|NCT00364832|81009497|FG009|Extension Year 2|Early Withdrawals|5|||
27967267|NCT03350035|81710797|FG001|Overall Study|Subject discharged to hospice|0|||
27967268|NCT03350035|81710798|FG002|Overall Study|Subject discharged to hospice|1|||
27967269|NCT05507567|81710799|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
27569840|NCT01944059|80275214|FG000|Overall Study|Physician Decision|3|||
27569841|NCT01944059|80275214|FG000|Overall Study|Withdrawal by Subject|1|||
27569842|NCT01944059|80275214|FG000|Overall Study|Adverse Event|2|||
27569843|NCT01232296|80275215|FG000|Overall Study|Adverse Event|24|||
27569844|NCT01232296|80275216|FG001|Overall Study|Adverse Event|12|||
27569845|NCT01232296|80275215|FG000|Overall Study|Physician Decision|1|||
27569846|NCT01232296|80275216|FG001|Overall Study|Physician Decision|1|||
27569847|NCT01232296|80275215|FG000|Overall Study|Progressive disease|43|||
27569848|NCT01232296|80275216|FG001|Overall Study|Progressive disease|61|||
27569849|NCT01232296|80275215|FG000|Overall Study|Study terminated by sponsor|0|||
27569850|NCT01232296|80275216|FG001|Overall Study|Study terminated by sponsor|1|||
27569851|NCT01232296|80275215|FG000|Overall Study|Technical problems|3|||
27569852|NCT01232296|80275216|FG001|Overall Study|Technical problems|0|||
27569853|NCT01232296|80275215|FG000|Overall Study|Subject/guardian decision|10|||
27569854|NCT01232296|80275216|FG001|Overall Study|Subject/guardian decision|2|||
27569855|NCT01232296|80275215|FG000|Overall Study|Death|1|||
27569856|NCT01232296|80275216|FG001|Overall Study|Death|6|||
27569857|NCT00715793|80275217|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
27967270|NCT05507567|81710800|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
27967271|NCT05507567|81710801|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
27967272|NCT05507567|81710799|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
27967273|NCT05507567|81710800|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
27967274|NCT05507567|81710801|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
27775878|NCT00364832|81009498|FG010|Extension Year 2|Early Withdrawals|5|||
27775879|NCT00364832|81009499|FG011|Extension Year 2|Early Withdrawals|3|||
27775880|NCT01601873|81009500|FG000|Overall Study|Lost to Follow-up|2|||
27775881|NCT01601873|81009501|FG001|Overall Study|Lost to Follow-up|3|||
27775882|NCT01166386|81009503|FG000|Overall Study|Withdrawal by Subject|3|||
27775883|NCT01166386|81009504|FG001|Overall Study|Withdrawal by Subject|5|||
27775884|NCT00948194|81009505|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
27775885|NCT00948194|81009506|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
27775886|NCT02513394|81009509|FG000|Overall Study|Withdrawal by Subject|11|||
27775887|NCT02513394|81009510|FG001|Overall Study|Withdrawal by Subject|23|||
27775888|NCT02513394|81009509|FG000|Overall Study|Ineligible|1|||
27775889|NCT02513394|81009510|FG001|Overall Study|Ineligible|0|||
27775890|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
27775891|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
27569858|NCT00715793|80275218|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
27569859|NCT00715793|80275217|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
27569860|NCT00715793|80275218|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
27775892|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
27775893|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
27775894|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
27775895|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
27775896|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
27775897|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
27775898|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27775899|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27775900|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27775901|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27775902|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27775903|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27775904|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
27775905|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
27775906|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
27775907|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27775908|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27775909|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27967275|NCT05507567|81710799|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
27967276|NCT05507567|81710800|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
27967277|NCT05507567|81710801|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
27569861|NCT00308711|80275221|FG000|Overall Study|Withdrawal by Subject|1|||
27569862|NCT00308711|80275222|FG001|Overall Study|Withdrawal by Subject|0|||
27775910|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27775911|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
27775912|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
27775913|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
27569863|NCT00308711|80275223|FG002|Overall Study|Withdrawal by Subject|1|||
27569864|NCT00308711|80275221|FG000|Overall Study|Protocol Violation|0|||
27569865|NCT00308711|80275222|FG001|Overall Study|Protocol Violation|1|||
27569866|NCT00308711|80275223|FG002|Overall Study|Protocol Violation|1|||
27569867|NCT00308711|80275221|FG000|Overall Study|Lost to Follow-up|0|||
27569868|NCT00308711|80275222|FG001|Overall Study|Lost to Follow-up|1|||
27569869|NCT00308711|80275223|FG002|Overall Study|Lost to Follow-up|0|||
27569870|NCT00308711|80275221|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
27569871|NCT00308711|80275222|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
27569872|NCT00308711|80275223|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
27569873|NCT00308711|80275221|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
27569874|NCT00308711|80275222|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
27569875|NCT00308711|80275223|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
27569876|NCT04074317|80275237|FG000|Third Period|Withdrawal by Subject|0|||
27569877|NCT04074317|80275238|FG001|Third Period|Withdrawal by Subject|0|||
27569878|NCT04074317|80275239|FG002|Third Period|Withdrawal by Subject|0|||
27569879|NCT04074317|80275240|FG003|Third Period|Withdrawal by Subject|1|||
27569880|NCT04074317|80275241|FG004|Third Period|Withdrawal by Subject|0|||
27569881|NCT04074317|80275242|FG005|Third Period|Withdrawal by Subject|0|||
27569882|NCT00323414|80275243|FG000|Overall Study|Withdrawal by Subject|0|||
27569883|NCT00323414|80275244|FG001|Overall Study|Withdrawal by Subject|1|||
27569884|NCT03848845|80275245|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
27569885|NCT03848845|80275246|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
27569886|NCT03848845|80275247|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
27569887|NCT03848845|80275248|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
27569888|NCT03848845|80275245|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
27569889|NCT03848845|80275246|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
27569890|NCT03848845|80275247|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
27569891|NCT03848845|80275248|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
27569892|NCT03848845|80275245|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
27569893|NCT03848845|80275246|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
27569894|NCT03848845|80275247|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
27569895|NCT03848845|80275248|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
27569896|NCT03848845|80275245|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
27569897|NCT03848845|80275246|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
27569898|NCT03848845|80275247|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
27569899|NCT03848845|80275248|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
27569900|NCT03554291|80275249|FG000|Overall Study|Death|2|||
27569901|NCT03554291|80275250|FG001|Overall Study|Death|1|||
27569902|NCT03554291|80275249|FG000|Overall Study|Lost to Follow-up|1|||
27775914|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
27775915|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
27775916|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
27775917|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
27569903|NCT03554291|80275250|FG001|Overall Study|Lost to Follow-up|0|||
27569904|NCT03554291|80275249|FG000|Overall Study|Withdrawal by Subject|1|||
27569905|NCT03554291|80275250|FG001|Overall Study|Withdrawal by Subject|0|||
27569906|NCT03554291|80275249|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
27569907|NCT03554291|80275250|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
27569908|NCT04587193|80275252|FG000|Overall Study|Screen failure after consent|3|||
27569909|NCT04587193|80275253|FG001|Overall Study|Screen failure after consent|0|||
27569910|NCT04587193|80275252|FG000|Overall Study|Device broke during study|3|||
27569911|NCT04587193|80275253|FG001|Overall Study|Device broke during study|2|||
27569912|NCT04334460|80275259|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
27569913|NCT04334460|80275260|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
27594091|NCT00802074|80352430|FG003|Overall Study|Withdrawal by Subject|0|||
27594092|NCT00802074|80352431|FG004|Overall Study|Withdrawal by Subject|0|||
27594093|NCT00802074|80352432|FG005|Overall Study|Withdrawal by Subject|0|||
27594094|NCT00489970|80352433|FG000|Persistence Year 9|Lost to Follow-up|2|||
27594095|NCT00489970|80352434|FG001|Persistence Year 9|Lost to Follow-up|2|||
27594096|NCT00489970|80352435|FG002|Persistence Year 9|Lost to Follow-up|3|||
27594097|NCT00489970|80352433|FG000|Persistence Year 9|Other|1|||
27594098|NCT00489970|80352434|FG001|Persistence Year 9|Other|0|||
27665545|NCT01183013|80612166|FG002|Overall Study|Reasons other than stated above|17|||
27665546|NCT01183013|80612167|FG003|Overall Study|Reasons other than stated above|12|||
27665547|NCT01183013|80612168|FG004|Overall Study|Reasons other than stated above|12|||
27665548|NCT01183013|80612169|FG005|Overall Study|Reasons other than stated above|15|||
27665549|NCT01183013|80612170|FG006|Overall Study|Reasons other than stated above|13|||
27665550|NCT02201771|80612177|FG000|Overall Study|Death|3|||
27665551|NCT02201771|80612178|FG001|Overall Study|Death|2|||
27665552|NCT02201771|80612179|FG002|Overall Study|Death|0|||
27665553|NCT02201771|80612177|FG000|Overall Study|Protocol Violation|10|||
27665554|NCT02201771|80612178|FG001|Overall Study|Protocol Violation|8|||
27775918|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
27775919|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
27775920|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
27775921|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
27862256|NCT02359994|81326289|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
27569914|NCT04334460|80275259|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
27569915|NCT04334460|80275260|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
27569916|NCT00430092|80275263|FG000|Overall Study|Adverse Event|0|||
27569917|NCT00430092|80275264|FG001|Overall Study|Adverse Event|0|||
27569918|NCT00430092|80275265|FG002|Overall Study|Adverse Event|1|||
27569919|NCT00430092|80275263|FG000|Overall Study|Lack of Efficacy|5|||
27569920|NCT00430092|80275264|FG001|Overall Study|Lack of Efficacy|2|||
27569921|NCT00430092|80275265|FG002|Overall Study|Lack of Efficacy|54|||
27569922|NCT00430092|80275263|FG000|Overall Study|Lost to Follow-up|1|||
27569923|NCT00430092|80275264|FG001|Overall Study|Lost to Follow-up|0|||
27569924|NCT00430092|80275265|FG002|Overall Study|Lost to Follow-up|0|||
27569925|NCT00430092|80275263|FG000|Overall Study|Protocol Violation|0|||
27569926|NCT00430092|80275264|FG001|Overall Study|Protocol Violation|1|||
27569927|NCT00430092|80275265|FG002|Overall Study|Protocol Violation|1|||
27569928|NCT00430092|80275263|FG000|Overall Study|Withdrawal by Subject|0|||
27569929|NCT00430092|80275264|FG001|Overall Study|Withdrawal by Subject|1|||
27569930|NCT00430092|80275265|FG002|Overall Study|Withdrawal by Subject|1|||
27569931|NCT02774681|80275266|FG000|Treatment on Study|Progressive Disease|7|||
27569932|NCT02774681|80275266|FG000|Follow-Up for 3 Years|Death|11|||
27569933|NCT02774681|80275266|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
27569934|NCT00838201|80275267|FG000|Overall Study|Investigator decision, or other reasons|2|||
27569935|NCT00838201|80275268|FG001|Overall Study|Investigator decision, or other reasons|3|||
27569936|NCT00838201|80275267|FG000|Overall Study|Noncompliance|0|||
27569937|NCT00838201|80275268|FG001|Overall Study|Noncompliance|1|||
27569938|NCT00838201|80275267|FG000|Overall Study|Administrative decision|1|||
27569939|NCT00838201|80275268|FG001|Overall Study|Administrative decision|2|||
27569940|NCT00838201|80275267|FG000|Overall Study|Disease progression|3|||
27569941|NCT00838201|80275268|FG001|Overall Study|Disease progression|3|||
27569942|NCT00838201|80275267|FG000|Overall Study|Consent withdrawn|16|||
27569943|NCT00838201|80275268|FG001|Overall Study|Consent withdrawn|19|||
27569944|NCT00838201|80275267|FG000|Overall Study|Lost to Follow-up|4|||
27569945|NCT00838201|80275268|FG001|Overall Study|Lost to Follow-up|3|||
27569946|NCT00838201|80275267|FG000|Overall Study|Adverse Event|5|||
27569947|NCT00838201|80275268|FG001|Overall Study|Adverse Event|9|||
27569948|NCT00838201|80275267|FG000|Overall Study|Death|11|||
27569949|NCT00838201|80275268|FG001|Overall Study|Death|13|||
27569950|NCT01302392|80275269|FG000|Overall Study|Lost to Follow-up|1|||
27569951|NCT01302392|80275270|FG001|Overall Study|Lost to Follow-up|0|||
27569952|NCT01302392|80275269|FG000|Overall Study|Withdrawal by Subject|6|||
27569953|NCT01302392|80275270|FG001|Overall Study|Withdrawal by Subject|1|||
27569954|NCT01190254|80275271|FG000|Overall Study|Adverse Event|3|||
27569955|NCT01190254|80275272|FG001|Overall Study|Adverse Event|6|||
27569956|NCT01190254|80275273|FG002|Overall Study|Adverse Event|8|||
27569957|NCT01190254|80275271|FG000|Overall Study|Lack of Efficacy|7|||
27569958|NCT01190254|80275272|FG001|Overall Study|Lack of Efficacy|4|||
27569959|NCT01190254|80275273|FG002|Overall Study|Lack of Efficacy|5|||
27569960|NCT01190254|80275271|FG000|Overall Study|Lost to Follow-up|4|||
27569961|NCT01190254|80275272|FG001|Overall Study|Lost to Follow-up|2|||
27569962|NCT01190254|80275273|FG002|Overall Study|Lost to Follow-up|0|||
27569963|NCT01190254|80275271|FG000|Overall Study|Withdrawal by Subject|4|||
27569964|NCT01190254|80275272|FG001|Overall Study|Withdrawal by Subject|5|||
27569965|NCT01190254|80275273|FG002|Overall Study|Withdrawal by Subject|7|||
27569966|NCT01190254|80275271|FG000|Overall Study|Protocol Violation|2|||
27569967|NCT01190254|80275272|FG001|Overall Study|Protocol Violation|0|||
27569968|NCT01190254|80275273|FG002|Overall Study|Protocol Violation|2|||
27569969|NCT01190254|80275271|FG000|Overall Study|Did not meet protocol eligibility|1|||
27569970|NCT01190254|80275272|FG001|Overall Study|Did not meet protocol eligibility|0|||
27569971|NCT01190254|80275273|FG002|Overall Study|Did not meet protocol eligibility|0|||
27775922|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
27775923|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
27775924|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
27775925|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
27775926|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
27775927|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
27775928|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27775929|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27775930|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27775931|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27775932|NCT04921969|81009511|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
27775933|NCT04921969|81009512|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
27775934|NCT04921969|81009513|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
27775935|NCT04921969|81009514|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
27775936|NCT04921969|81009515|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
27775937|NCT04921969|81009516|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
27569972|NCT00582933|80275277|FG000|Overall Study|Physician Decision|3|||
27569973|NCT01572038|80275278|FG000|Overall Study|Death|648|||
27569974|NCT01572038|80275278|FG000|Overall Study|Withdrawal by Subject|204|||
27569975|NCT01572038|80275278|FG000|Overall Study|Lost to Follow-up|81|||
27569976|NCT01572038|80275278|FG000|Overall Study|Physician Decision|20|||
27569977|NCT01572038|80275278|FG000|Overall Study|Patient Decision|14|||
27569978|NCT01572038|80275278|FG000|Overall Study|Progressive Disease|8|||
27569979|NCT01572038|80275278|FG000|Overall Study|Site Closed Before Completing Form|6|||
27569980|NCT01572038|80275278|FG000|Overall Study|Enrolled into Another Trial|3|||
27569981|NCT01572038|80275278|FG000|Overall Study|Participated in Another Trial|3|||
27569982|NCT01572038|80275278|FG000|Overall Study|Termination by Sponsor|2|||
27569983|NCT01572038|80275278|FG000|Overall Study|Patient Deterioration|1|||
27569984|NCT01572038|80275278|FG000|Overall Study|Sponsor Decision|1|||
27569985|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569986|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
27569987|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
27569988|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
27569989|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569990|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569991|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569992|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569993|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569994|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569995|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569996|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27569997|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27594099|NCT00489970|80352435|FG002|Persistence Year 9|Other|2|||
27594100|NCT00818753|80352436|FG000|Overall Study|Protocol Violation|1|||
27594101|NCT00818753|80352437|FG001|Overall Study|Protocol Violation|0|||
27594102|NCT00818753|80352438|FG002|Overall Study|Protocol Violation|0|||
27594103|NCT00818753|80352436|FG000|Overall Study|Other reason (not specified)|0|||
27594104|NCT00818753|80352437|FG001|Overall Study|Other reason (not specified)|0|||
27594105|NCT00818753|80352438|FG002|Overall Study|Other reason (not specified)|1|||
27594106|NCT00818753|80352436|FG000|Overall Study|Randomised and not treated|2|||
27594107|NCT00818753|80352437|FG001|Overall Study|Randomised and not treated|0|||
27594108|NCT00818753|80352438|FG002|Overall Study|Randomised and not treated|0|||
27594109|NCT00674986|80352441|FG000|Overall Study|Adverse Event|2|||
27594110|NCT00674986|80352442|FG001|Overall Study|Adverse Event|1|||
27594111|NCT00674986|80352441|FG000|Overall Study|Subject withdrew consent|12|||
27594112|NCT00674986|80352442|FG001|Overall Study|Subject withdrew consent|19|||
27594113|NCT00674986|80352441|FG000|Overall Study|Lost to Follow-up|25|||
27594114|NCT00674986|80352442|FG001|Overall Study|Lost to Follow-up|53|||
27594115|NCT00674986|80352441|FG000|Overall Study|Other reasons|4|||
27594116|NCT00674986|80352442|FG001|Overall Study|Other reasons|8|||
27594117|NCT02492100|80352443|FG000|Overall Study|Death|1|||
27594118|NCT01587651|80352446|FG000|Overall Study|Adverse Event|0|||
27594119|NCT01587651|80352447|FG001|Overall Study|Adverse Event|1|||
27594120|NCT01587651|80352448|FG002|Overall Study|Adverse Event|0|||
27594121|NCT01587651|80352446|FG000|Overall Study|Protocol Violation|0|||
27594122|NCT01587651|80352447|FG001|Overall Study|Protocol Violation|1|||
27594123|NCT01587651|80352448|FG002|Overall Study|Protocol Violation|1|||
27594124|NCT01587651|80352446|FG000|Overall Study|Withdrawal by Subject|0|||
27594125|NCT01587651|80352447|FG001|Overall Study|Withdrawal by Subject|1|||
27594126|NCT01587651|80352448|FG002|Overall Study|Withdrawal by Subject|0|||
27775938|NCT04921969|81009517|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
27775939|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
27775940|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
27775941|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
27775942|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
27775943|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
27775944|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
27775945|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
27775946|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27775947|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27775948|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27775949|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
27775950|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27775951|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
27775952|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
27775953|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27775954|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27775955|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27775956|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
27775957|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
27775958|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
27775959|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
27775960|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
27775961|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
27775962|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
27775963|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
27775964|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
27775965|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
27775966|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
27775967|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27775968|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27775969|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27775970|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
27775971|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
27775972|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
27775973|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
27775974|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
27775975|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
27775976|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
27775977|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
27775978|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
27775979|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
27775980|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
27775981|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
27775982|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
27775983|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
27775984|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
27775985|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
27775986|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
27775987|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
27775988|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
27775989|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
27775990|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
27775991|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
27775992|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
27775993|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
27775994|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
27775995|NCT04921969|81009511|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
27775996|NCT04921969|81009512|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
27775997|NCT04921969|81009513|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
27775998|NCT04921969|81009514|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
27775999|NCT04921969|81009515|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
27862257|NCT00426361|81326290|FG000|Overall Study|Lost to Follow-up|3|||
27862258|NCT00426361|81326291|FG001|Overall Study|Lost to Follow-up|2|||
27862259|NCT00426361|81326292|FG002|Overall Study|Lost to Follow-up|5|||
27569998|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27862260|NCT00426361|81326290|FG000|Overall Study|Withdrawal by Subject|1|||
27569999|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27776000|NCT04921969|81009516|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
27776001|NCT04921969|81009517|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
27776002|NCT00528840|81009518|FG000|Overall Study|Lost to Follow-up|10|||
27776003|NCT00528840|81009518|FG000|Overall Study|Adverse Event|1|||
27776004|NCT00528840|81009518|FG000|Overall Study|Withdrawal by Subject|17|||
27776005|NCT00528840|81009518|FG000|Overall Study|Death|2|||
27776006|NCT00528840|81009518|FG000|Overall Study|Administrative Reasons|1|||
27776007|NCT00528840|81009518|FG000|Overall Study|Other|2|||
27776008|NCT02943668|81009519|FG000|Overall Study|Disease Progression|1|||
27776009|NCT01100658|81009526|FG000|Overall Study|Withdrawal by Subject|1|||
27776010|NCT02750501|81009533|FG000|Overall Study|Adverse Event|4|||
27776011|NCT02750501|81009533|FG000|Overall Study|Physician Decision|1|||
27776012|NCT02750501|81009533|FG000|Overall Study|Protocol Violation|1|||
27776013|NCT02750501|81009533|FG000|Overall Study|G-tube came out|1|||
27776014|NCT02750501|81009533|FG000|Overall Study|Non-compliant use of PERT|1|||
27776015|NCT04476108|81009534|FG000|Overall Study|Adverse Event|4|||
27776016|NCT04476108|81009535|FG001|Overall Study|Adverse Event|1|||
27776017|NCT04476108|81009534|FG000|Overall Study|Lost to Follow-up|1|||
27776018|NCT04476108|81009535|FG001|Overall Study|Lost to Follow-up|0|||
27776019|NCT04476108|81009534|FG000|Overall Study|Inadvertent Enrollment|1|||
27776020|NCT04476108|81009535|FG001|Overall Study|Inadvertent Enrollment|0|||
27776021|NCT04476108|81009534|FG000|Overall Study|Protocol Violation|1|||
27776022|NCT04476108|81009535|FG001|Overall Study|Protocol Violation|1|||
27776023|NCT04476108|81009534|FG000|Overall Study|Withdrawal by Subject|1|||
27776024|NCT04476108|81009535|FG001|Overall Study|Withdrawal by Subject|1|||
27776025|NCT00589602|81009536|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
27776026|NCT03303625|81009539|FG000|Overall Study|Withdrawal by Subject|2|||
27776027|NCT03303625|81009540|FG001|Overall Study|Withdrawal by Subject|0|||
27776028|NCT03303625|81009541|FG002|Overall Study|Withdrawal by Subject|0|||
27776029|NCT03303625|81009542|FG003|Overall Study|Withdrawal by Subject|0|||
27776030|NCT04124952|81009543|FG000|Overall Study|Lost to Follow-up|1|||
27776031|NCT04785144|81009544|FG000|Overall Study|Withdrawal by Subject|4|||
27776032|NCT04785144|81009545|FG001|Overall Study|Withdrawal by Subject|1|||
27776033|NCT04785144|81009546|FG002|Overall Study|Withdrawal by Subject|0|||
27776034|NCT04785144|81009547|FG003|Overall Study|Withdrawal by Subject|0|||
27776035|NCT04785144|81009548|FG004|Overall Study|Withdrawal by Subject|0|||
27776036|NCT04785144|81009549|FG005|Overall Study|Withdrawal by Subject|2|||
27776037|NCT04785144|81009550|FG006|Overall Study|Withdrawal by Subject|2|||
27776038|NCT04785144|81009551|FG007|Overall Study|Withdrawal by Subject|0|||
27776039|NCT04785144|81009552|FG008|Overall Study|Withdrawal by Subject|1|||
27776040|NCT04785144|81009553|FG009|Overall Study|Withdrawal by Subject|0|||
27776041|NCT04785144|81009544|FG000|Overall Study|Lost to Follow-up|1|||
27776042|NCT04785144|81009545|FG001|Overall Study|Lost to Follow-up|0|||
27776043|NCT04785144|81009546|FG002|Overall Study|Lost to Follow-up|0|||
27776044|NCT04785144|81009547|FG003|Overall Study|Lost to Follow-up|0|||
27776045|NCT04785144|81009548|FG004|Overall Study|Lost to Follow-up|1|||
27776046|NCT04785144|81009549|FG005|Overall Study|Lost to Follow-up|2|||
27776047|NCT04785144|81009550|FG006|Overall Study|Lost to Follow-up|1|||
27776048|NCT04785144|81009551|FG007|Overall Study|Lost to Follow-up|2|||
27776049|NCT04785144|81009552|FG008|Overall Study|Lost to Follow-up|4|||
27776050|NCT04785144|81009553|FG009|Overall Study|Lost to Follow-up|1|||
27776051|NCT04785144|81009544|FG000|Overall Study|Protocol Violation|0|||
27776052|NCT04785144|81009545|FG001|Overall Study|Protocol Violation|0|||
27776053|NCT04785144|81009546|FG002|Overall Study|Protocol Violation|0|||
27776054|NCT04785144|81009547|FG003|Overall Study|Protocol Violation|0|||
27776055|NCT04785144|81009548|FG004|Overall Study|Protocol Violation|0|||
27776056|NCT04785144|81009549|FG005|Overall Study|Protocol Violation|0|||
27776057|NCT04785144|81009550|FG006|Overall Study|Protocol Violation|1|||
27776058|NCT04785144|81009551|FG007|Overall Study|Protocol Violation|0|||
27776059|NCT04785144|81009552|FG008|Overall Study|Protocol Violation|0|||
27776060|NCT04785144|81009553|FG009|Overall Study|Protocol Violation|0|||
27776061|NCT04785144|81009544|FG000|Overall Study|Physician Decision|0|||
27776062|NCT04785144|81009545|FG001|Overall Study|Physician Decision|0|||
27776063|NCT04785144|81009546|FG002|Overall Study|Physician Decision|0|||
27776064|NCT04785144|81009547|FG003|Overall Study|Physician Decision|0|||
27776065|NCT04785144|81009548|FG004|Overall Study|Physician Decision|0|||
27776066|NCT04785144|81009549|FG005|Overall Study|Physician Decision|0|||
27776067|NCT04785144|81009550|FG006|Overall Study|Physician Decision|0|||
27776068|NCT04785144|81009551|FG007|Overall Study|Physician Decision|0|||
27776069|NCT04785144|81009552|FG008|Overall Study|Physician Decision|0|||
27776070|NCT04785144|81009553|FG009|Overall Study|Physician Decision|1|||
27776071|NCT04785144|81009544|FG000|Overall Study|Unable to continue due to work schedule|0|||
27776072|NCT04785144|81009545|FG001|Overall Study|Unable to continue due to work schedule|0|||
27776073|NCT04785144|81009546|FG002|Overall Study|Unable to continue due to work schedule|0|||
27776074|NCT04785144|81009547|FG003|Overall Study|Unable to continue due to work schedule|0|||
27776075|NCT04785144|81009548|FG004|Overall Study|Unable to continue due to work schedule|0|||
27776076|NCT04785144|81009549|FG005|Overall Study|Unable to continue due to work schedule|0|||
27776077|NCT04785144|81009550|FG006|Overall Study|Unable to continue due to work schedule|0|||
27776078|NCT04785144|81009551|FG007|Overall Study|Unable to continue due to work schedule|0|||
27776079|NCT04785144|81009552|FG008|Overall Study|Unable to continue due to work schedule|0|||
27776080|NCT04785144|81009553|FG009|Overall Study|Unable to continue due to work schedule|1|||
27776081|NCT00376675|81009554|FG000|Overall Study|Withdrawal by Subject|9|||
27776082|NCT00376675|81009555|FG001|Overall Study|Withdrawal by Subject|2|||
27776083|NCT00376675|81009554|FG000|Overall Study|Adverse Event|10|||
27776084|NCT00376675|81009555|FG001|Overall Study|Adverse Event|5|||
27776085|NCT00376675|81009554|FG000|Overall Study|Other Reason|1|||
27776086|NCT00376675|81009555|FG001|Overall Study|Other Reason|7|||
27776087|NCT03644173|81009556|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
27776088|NCT03644173|81009556|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
27776089|NCT03644173|81009556|FG000|Participants at the 1-month Follow up|Death|2|||
27776090|NCT03644173|81009556|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
27776091|NCT00846027|81009557|FG000|Overall Study|Death|3|||
27776092|NCT00846027|81009557|FG000|Overall Study|Disease Progression|30|||
27776093|NCT00846027|81009557|FG000|Overall Study|Toxicity|12|||
27776094|NCT00846027|81009557|FG000|Overall Study|Patient Decision|7|||
27776095|NCT00846027|81009557|FG000|Overall Study|Investigator Discretion|29|||
27776096|NCT00846027|81009557|FG000|Overall Study|Protocol Violation|2|||
27776097|NCT00846027|81009557|FG000|Overall Study|Subject Not Treated|7|||
27776098|NCT03083470|81009558|FG000|Overall Study|Lost to Follow-up|0|||
27776099|NCT03083470|81009559|FG001|Overall Study|Lost to Follow-up|0|||
27776100|NCT03083470|81009560|FG002|Overall Study|Lost to Follow-up|0|||
27776101|NCT03083470|81009561|FG003|Overall Study|Lost to Follow-up|0|||
27776102|NCT03083470|81009562|FG004|Overall Study|Lost to Follow-up|1|||
27776103|NCT03083470|81009558|FG000|Overall Study|Withdrawal by Subject|0|||
27776104|NCT03083470|81009559|FG001|Overall Study|Withdrawal by Subject|0|||
27776105|NCT03083470|81009560|FG002|Overall Study|Withdrawal by Subject|0|||
27776106|NCT03083470|81009561|FG003|Overall Study|Withdrawal by Subject|0|||
27776107|NCT03083470|81009562|FG004|Overall Study|Withdrawal by Subject|1|||
27776108|NCT04489940|81009563|FG000|Overall Study|Other|2|||
27776109|NCT04489940|81009563|FG000|Overall Study|Withdrawal by Subject|2|||
27776110|NCT04489940|81009563|FG000|Overall Study|Death|5|||
27776111|NCT04489940|81009563|FG000|Overall Study|Lost to Follow-up|1|||
27776112|NCT01388491|81009573|FG000|Overall Study|Adverse Event|10|||
27776113|NCT01388491|81009574|FG001|Overall Study|Adverse Event|9|||
27776114|NCT01388491|81009573|FG000|Overall Study|Sponsor Request|9|||
27776115|NCT01388491|81009574|FG001|Overall Study|Sponsor Request|7|||
27776116|NCT01388491|81009573|FG000|Overall Study|Withdrawal by Subject|6|||
27776117|NCT01388491|81009574|FG001|Overall Study|Withdrawal by Subject|10|||
27776118|NCT01388491|81009573|FG000|Overall Study|Lost to Follow-up|4|||
27776119|NCT01388491|81009574|FG001|Overall Study|Lost to Follow-up|3|||
27776120|NCT01388491|81009573|FG000|Overall Study|Protocol Violation|2|||
27776121|NCT01388491|81009574|FG001|Overall Study|Protocol Violation|0|||
27776122|NCT01388491|81009573|FG000|Overall Study|Noncompliance|2|||
27776123|NCT01388491|81009574|FG001|Overall Study|Noncompliance|0|||
27776124|NCT01388491|81009573|FG000|Overall Study|Pregnancy|1|||
27776125|NCT01388491|81009574|FG001|Overall Study|Pregnancy|0|||
27776126|NCT01878175|81009575|FG000|Overall Study|Developed contraindicated health problem|2|||
27776127|NCT01646255|81009576|FG000|Overall Study|Adverse Event|7|||
27776128|NCT01646255|81009577|FG001|Overall Study|Adverse Event|8|||
27776129|NCT01646255|81009576|FG000|Overall Study|Lack of Efficacy|2|||
27776130|NCT01646255|81009577|FG001|Overall Study|Lack of Efficacy|0|||
27776131|NCT01646255|81009576|FG000|Overall Study|Withdrawal by Subject|10|||
27776132|NCT01646255|81009577|FG001|Overall Study|Withdrawal by Subject|6|||
27776133|NCT01646255|81009576|FG000|Overall Study|Compliance is not well|1|||
27776134|NCT01646255|81009577|FG001|Overall Study|Compliance is not well|0|||
27776135|NCT01646255|81009576|FG000|Overall Study|Inclusion Criteria Deviation|1|||
27776136|NCT01646255|81009577|FG001|Overall Study|Inclusion Criteria Deviation|0|||
27776137|NCT00958191|81009590|FG000|Overall Study|Death|4|||
27776138|NCT00958191|81009590|FG000|Overall Study|Lost to Follow-up|5|||
27776139|NCT00958191|81009590|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
27776140|NCT00958191|81009590|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
27776141|NCT00958191|81009590|FG000|Overall Study|Revision of study device|4|||
27776142|NCT00958191|81009590|FG000|Overall Study|Site termination|11|||
27776143|NCT00958191|81009590|FG000|Overall Study|No 5 yr x-rays|56|||
27776144|NCT01957215|81009591|FG000|Overall Study|Adverse Event|2|||
27776145|NCT01957215|81009592|FG001|Overall Study|Adverse Event|2|||
27776146|NCT01957215|81009591|FG000|Overall Study|Lost to Follow-up|3|||
27776147|NCT01957215|81009592|FG001|Overall Study|Lost to Follow-up|3|||
27862261|NCT00426361|81326291|FG001|Overall Study|Withdrawal by Subject|3|||
27862262|NCT00426361|81326292|FG002|Overall Study|Withdrawal by Subject|0|||
27862263|NCT03456453|81326295|FG000|Overall Study|Withdrawal by Subject|2|||
27862264|NCT03456453|81326296|FG001|Overall Study|Withdrawal by Subject|0|||
27862265|NCT03456453|81326295|FG000|Overall Study|Not released to community|1|||
27862266|NCT03456453|81326296|FG001|Overall Study|Not released to community|5|||
27776148|NCT01957215|81009591|FG000|Overall Study|Protocol Violation|1|||
27776149|NCT01957215|81009592|FG001|Overall Study|Protocol Violation|2|||
27776150|NCT01957215|81009591|FG000|Overall Study|Withdrawal by Subject|7|||
27776151|NCT01957215|81009592|FG001|Overall Study|Withdrawal by Subject|5|||
27776152|NCT00939055|81009595|FG000|Overall Study|Discontinuation prior to procedure|4|||
27776153|NCT00939055|81009596|FG001|Overall Study|Discontinuation prior to procedure|0|||
27776154|NCT01222416|81009599|FG000|Overall Study|ineligible;metastasis|3|||
27862267|NCT03456453|81326295|FG000|Overall Study|Lost to Follow-up|0|||
27862268|NCT03456453|81326296|FG001|Overall Study|Lost to Follow-up|2|||
27862269|NCT02121392|81329452|FG000|Prior to Intervention|Protocol Violation|40|||
27862270|NCT02121392|81329453|FG001|Prior to Intervention|Protocol Violation|35|||
27862271|NCT02121392|81329452|FG000|Prior to Intervention|Withdrawal by Subject|8|||
27862272|NCT02121392|81329453|FG001|Prior to Intervention|Withdrawal by Subject|6|||
27862273|NCT02121392|81329452|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
27862274|NCT02121392|81329453|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
27862275|NCT02121392|81329452|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
27862276|NCT02121392|81329453|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
27862277|NCT02212379|81329454|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
27862278|NCT02212379|81329454|FG000|From Baseline to Week 48|Adverse Event|7|||
27862279|NCT02212379|81329454|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
27862280|NCT02212379|81329454|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
27862281|NCT02212379|81329454|FG000|From Week 48 to Week 96|Adverse Event|1|||
27776155|NCT01222416|81009600|FG001|Overall Study|ineligible;metastasis|0|||
27776156|NCT01222416|81009599|FG000|Overall Study|Adverse Event|4|||
27776157|NCT01222416|81009600|FG001|Overall Study|Adverse Event|0|||
27776158|NCT01222416|81009599|FG000|Overall Study|Withdrawal by Subject|5|||
27776159|NCT01222416|81009600|FG001|Overall Study|Withdrawal by Subject|0|||
27776160|NCT01222416|81009599|FG000|Overall Study|scheduling|6|||
27776161|NCT01222416|81009600|FG001|Overall Study|scheduling|0|||
27776162|NCT01222416|81009599|FG000|Overall Study|missed view/scan|1|||
27776163|NCT01222416|81009600|FG001|Overall Study|missed view/scan|0|||
27776164|NCT01222416|81009599|FG000|Overall Study|Death|1|||
27776165|NCT01222416|81009600|FG001|Overall Study|Death|0|||
27776168|NCT02993783|81009605|FG000|Overall Study|Reason not Specified|6|||
27862282|NCT02212379|81329454|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
27862283|NCT00813800|81329455|FG000|Overall Study|Screen Failure after Consent|2|||
27862284|NCT00813800|81329455|FG000|Overall Study|Adverse Event|1|||
27862285|NCT00813800|81329455|FG000|Overall Study|Worsening of depression|2|||
27862286|NCT00813800|81329455|FG000|Overall Study|Physician Decision|1|||
27862287|NCT00143390|81329458|FG000|Overall Study|Death|2|||
27862288|NCT00143390|81329459|FG001|Overall Study|Death|0|||
27862289|NCT00143390|81329458|FG000|Overall Study|Not meeting entry criteria|2|||
27862290|NCT00143390|81329459|FG001|Overall Study|Not meeting entry criteria|5|||
27862291|NCT00143390|81329458|FG000|Overall Study|Withdrawal by Subject|4|||
27862292|NCT00143390|81329459|FG001|Overall Study|Withdrawal by Subject|4|||
27862293|NCT00143390|81329458|FG000|Overall Study|Progressive disease|119|||
27862294|NCT00143390|81329459|FG001|Overall Study|Progressive disease|115|||
27862295|NCT00143390|81329458|FG000|Overall Study|Protocol Violation|2|||
27862296|NCT00143390|81329459|FG001|Overall Study|Protocol Violation|0|||
27862297|NCT00143390|81329458|FG000|Overall Study|Study termination|10|||
27862298|NCT00143390|81329459|FG001|Overall Study|Study termination|15|||
27862299|NCT00143390|81329458|FG000|Overall Study|Adverse Event|9|||
27862300|NCT00143390|81329459|FG001|Overall Study|Adverse Event|8|||
27862301|NCT00143390|81329458|FG000|Overall Study|Other|1|||
27862302|NCT00143390|81329459|FG001|Overall Study|Other|2|||
27862303|NCT00976911|81329460|FG000|Overall Study|Withdrawal by Subject|4|||
27862304|NCT00976911|81329461|FG001|Overall Study|Withdrawal by Subject|6|||
27862305|NCT00976911|81329460|FG000|Overall Study|Death|138|||
27862306|NCT00976911|81329461|FG001|Overall Study|Death|126|||
27862307|NCT00976911|81329460|FG000|Overall Study|Adverse Event|0|||
27967278|NCT05507567|81710799|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
27776169|NCT02993783|81009606|FG001|Overall Study|Reason not Specified|9|||
27776170|NCT01369069|81009607|FG000|Overall Study|Lost to Follow-up|8|||
27776171|NCT01369069|81009608|FG001|Overall Study|Lost to Follow-up|9|||
27862308|NCT00976911|81329461|FG001|Overall Study|Adverse Event|1|||
27862309|NCT00976911|81329460|FG000|Overall Study|Protocol Violation|2|||
27862310|NCT00976911|81329461|FG001|Overall Study|Protocol Violation|0|||
27776172|NCT01369069|81009607|FG000|Overall Study|Withdrawal by Subject|9|||
27776173|NCT01369069|81009608|FG001|Overall Study|Withdrawal by Subject|7|||
27776174|NCT02870348|81009613|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
27862311|NCT00976911|81329460|FG000|Overall Study|Other|8|||
27862312|NCT00976911|81329461|FG001|Overall Study|Other|9|||
27862313|NCT00976911|81329460|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
27862314|NCT00976911|81329461|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
27862315|NCT02640690|81329462|FG000|Overall Study|Lost to Follow-up|7|||
27862316|NCT02640690|81329463|FG001|Overall Study|Lost to Follow-up|7|||
27862317|NCT02640690|81329462|FG000|Overall Study|Withdrawal by Subject|16|||
27862318|NCT02640690|81329463|FG001|Overall Study|Withdrawal by Subject|20|||
27862319|NCT02640690|81329462|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
27862320|NCT02640690|81329463|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
27862321|NCT00603837|81329464|FG000|Overall Study|Physician Decision|3|||
27862322|NCT00603837|81329465|FG001|Overall Study|Physician Decision|0|||
27862323|NCT02759692|81329466|FG000|Period 1|Test article no longer available|1|||
27862324|NCT02759692|81329467|FG001|Period 1|Test article no longer available|1|||
27862325|NCT02759692|81329466|FG000|Period 1|No longer meets eligibility criteria.|1|||
27862326|NCT02759692|81329467|FG001|Period 1|No longer meets eligibility criteria.|0|||
27862327|NCT02759692|81329466|FG000|Period 1|Miss-Randomized|1|||
27862328|NCT02759692|81329467|FG001|Period 1|Miss-Randomized|1|||
27862329|NCT02759692|81329466|FG000|Period 2|Lost to Follow-up|1|||
27862330|NCT02759692|81329467|FG001|Period 2|Lost to Follow-up|0|||
27862331|NCT02759692|81329466|FG000|Period 2|Test article no longer available|0|||
27862332|NCT02759692|81329467|FG001|Period 2|Test article no longer available|1|||
27862333|NCT04562155|81329468|FG000|Overall Study|COVID-19 pandemic|0|||
27862334|NCT04562155|81329469|FG001|Overall Study|COVID-19 pandemic|0|||
27862335|NCT04562155|81329470|FG002|Overall Study|COVID-19 pandemic|0|||
27862336|NCT04562155|81329471|FG003|Overall Study|COVID-19 pandemic|1|||
27862337|NCT04562155|81329468|FG000|Overall Study|Adverse Event|7|||
27862338|NCT04562155|81329469|FG001|Overall Study|Adverse Event|3|||
27862339|NCT04562155|81329470|FG002|Overall Study|Adverse Event|8|||
27862340|NCT04562155|81329471|FG003|Overall Study|Adverse Event|1|||
27862341|NCT04562155|81329468|FG000|Overall Study|Withdrawal by Subject|3|||
27776175|NCT03898323|81009614|FG000|Overall Study|Physician Decision|1|||
27776176|NCT01662986|81009615|FG000|Overall Study|Adverse Event|5|||
27862342|NCT04562155|81329469|FG001|Overall Study|Withdrawal by Subject|6|||
27570000|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27776177|NCT01662986|81009616|FG001|Overall Study|Adverse Event|4|||
27776178|NCT01662986|81009615|FG000|Overall Study|Protocol Violation|2|||
27776179|NCT01662986|81009616|FG001|Overall Study|Protocol Violation|3|||
27776180|NCT01662986|81009615|FG000|Overall Study|Lost to Follow-up|5|||
27776181|NCT01662986|81009616|FG001|Overall Study|Lost to Follow-up|4|||
27776182|NCT01662986|81009615|FG000|Overall Study|Withdrawal by Subject|2|||
27776183|NCT01662986|81009616|FG001|Overall Study|Withdrawal by Subject|2|||
27776184|NCT01662986|81009615|FG000|Overall Study|Not Treated|1|||
27776185|NCT01662986|81009616|FG001|Overall Study|Not Treated|0|||
27776186|NCT01662986|81009615|FG000|Overall Study|Other than stated above|3|||
27776187|NCT01662986|81009616|FG001|Overall Study|Other than stated above|0|||
27776188|NCT00952588|81009624|FG000|Overall Study|Death|28|||
27776189|NCT00952588|81009625|FG001|Overall Study|Death|13|||
27776190|NCT00952588|81009624|FG000|Overall Study|Withdrawal by Subject|2|||
27776191|NCT00952588|81009625|FG001|Overall Study|Withdrawal by Subject|5|||
27776192|NCT00952588|81009624|FG000|Overall Study|Adverse Event|2|||
27776193|NCT00952588|81009625|FG001|Overall Study|Adverse Event|3|||
27776194|NCT00952588|81009624|FG000|Overall Study|Lost to Follow-up|2|||
27776195|NCT00952588|81009625|FG001|Overall Study|Lost to Follow-up|0|||
27776196|NCT00952588|81009624|FG000|Overall Study|Physician Decision|0|||
27776197|NCT00952588|81009625|FG001|Overall Study|Physician Decision|1|||
27776198|NCT00952588|81009624|FG000|Overall Study|Lack of Efficacy|2|||
27776199|NCT00952588|81009625|FG001|Overall Study|Lack of Efficacy|2|||
27776200|NCT02274766|81009626|FG000|Overall Study|Withdrawal by Subject|3|||
27776201|NCT02274766|81009627|FG001|Overall Study|Withdrawal by Subject|6|||
27776202|NCT02274766|81009626|FG000|Overall Study|Did Not Receive Study Drug|1|||
27776203|NCT02274766|81009627|FG001|Overall Study|Did Not Receive Study Drug|1|||
27862343|NCT04562155|81329470|FG002|Overall Study|Withdrawal by Subject|3|||
27862344|NCT04562155|81329471|FG003|Overall Study|Withdrawal by Subject|3|||
27862345|NCT04562155|81329468|FG000|Overall Study|Participant personal reason|1|||
27862346|NCT04562155|81329469|FG001|Overall Study|Participant personal reason|0|||
27862347|NCT04562155|81329470|FG002|Overall Study|Participant personal reason|2|||
27862348|NCT04562155|81329471|FG003|Overall Study|Participant personal reason|1|||
27862349|NCT02643355|81329474|FG000|Overall Study|Withdrawal by Subject|1|||
27776204|NCT02274766|81009626|FG000|Overall Study|Subject Unwilling to Proceed|0|||
27776205|NCT02274766|81009627|FG001|Overall Study|Subject Unwilling to Proceed|1|||
27776206|NCT02274766|81009626|FG000|Overall Study|Adverse Event|0|||
27776207|NCT02274766|81009627|FG001|Overall Study|Adverse Event|1|||
27776208|NCT03950440|81009629|FG000|Overall Study|Death|8|||
27862350|NCT02643355|81329475|FG001|Overall Study|Withdrawal by Subject|3|||
27862351|NCT02643355|81329474|FG000|Overall Study|Protocol Violation|0|||
27862352|NCT02643355|81329475|FG001|Overall Study|Protocol Violation|2|||
27776209|NCT03950440|81009630|FG001|Overall Study|Death|2|||
27776210|NCT03950440|81009631|FG002|Overall Study|Death|1|||
27776211|NCT00444951|81009636|FG000|Overall Study|Lost to Follow-up|1|||
27776212|NCT00444951|81009637|FG001|Overall Study|Lost to Follow-up|1|||
27776213|NCT00444951|81009638|FG002|Overall Study|Lost to Follow-up|0|||
27776214|NCT00444951|81009636|FG000|Overall Study|Withdrawal by Subject|4|||
27776215|NCT00444951|81009637|FG001|Overall Study|Withdrawal by Subject|5|||
27776216|NCT00444951|81009638|FG002|Overall Study|Withdrawal by Subject|3|||
27776217|NCT01594411|81009639|FG000|Overall Study|Lost to Follow-up|2|||
27776218|NCT00584987|81009640|FG000|Overall Study|Protocol Violation|1|||
27776219|NCT00584987|81009641|FG001|Overall Study|Protocol Violation|1|||
27776220|NCT00584987|81009642|FG002|Overall Study|Protocol Violation|1|||
27776221|NCT00584987|81009643|FG003|Overall Study|Protocol Violation|0|||
27776222|NCT00584987|81009640|FG000|Overall Study|Adverse Event|0|||
27776223|NCT00584987|81009641|FG001|Overall Study|Adverse Event|0|||
27776224|NCT00584987|81009642|FG002|Overall Study|Adverse Event|0|||
27776225|NCT00584987|81009643|FG003|Overall Study|Adverse Event|1|||
27776226|NCT01376908|81009644|FG000|Overall Study|Protocol Violation|1|||
27776227|NCT01376908|81009645|FG001|Overall Study|Protocol Violation|1|||
27776228|NCT01376908|81009644|FG000|Overall Study|Withdrawal by Subject|1|||
27776229|NCT01376908|81009645|FG001|Overall Study|Withdrawal by Subject|2|||
27776230|NCT00772889|81009646|FG000|Overall Study|Adverse Event|7|||
27776231|NCT00772889|81009647|FG001|Overall Study|Adverse Event|4|||
27776232|NCT00772889|81009648|FG002|Overall Study|Adverse Event|0|||
27776233|NCT00772889|81009646|FG000|Overall Study|Withdrawal by Subject|9|||
27776234|NCT00772889|81009647|FG001|Overall Study|Withdrawal by Subject|8|||
27776235|NCT00772889|81009648|FG002|Overall Study|Withdrawal by Subject|9|||
27776236|NCT00772889|81009646|FG000|Overall Study|Lost to Follow-up|6|||
27776237|NCT00772889|81009647|FG001|Overall Study|Lost to Follow-up|6|||
27776238|NCT00772889|81009648|FG002|Overall Study|Lost to Follow-up|7|||
27776239|NCT00610714|81009651|FG000|Overall Study|Adverse Event|3|||
27776240|NCT00610714|81009652|FG001|Overall Study|Adverse Event|1|||
27776241|NCT00610714|81009651|FG000|Overall Study|Death|12|||
27776242|NCT00610714|81009652|FG001|Overall Study|Death|18|||
27776243|NCT00610714|81009651|FG000|Overall Study|Withdrawal by Subject|9|||
27776244|NCT00610714|81009652|FG001|Overall Study|Withdrawal by Subject|3|||
27776245|NCT00610714|81009651|FG000|Overall Study|Study completion at 120 PFS events|2|||
27776246|NCT00610714|81009652|FG001|Overall Study|Study completion at 120 PFS events|2|||
27776247|NCT01469637|81009653|FG000|First Intervention|Unacceptable behavior|0|||
27862353|NCT05422625|81329476|FG000|Overall Study|Withdrawal by Subject|1|||
27862354|NCT05422625|81329477|FG001|Overall Study|Withdrawal by Subject|0|||
27862355|NCT00985491|81329478|FG000|Overall Study|Adverse Event|8|||
27862356|NCT00985491|81329478|FG000|Overall Study|device migration|7|||
27862357|NCT00985491|81329478|FG000|Overall Study|Withdrawal by Subject|1|||
27862358|NCT00985491|81329478|FG000|Overall Study|implant failure|3|||
27862359|NCT03201445|81329487|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
27862360|NCT03201445|81329488|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
27862361|NCT03201445|81329487|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
27862362|NCT03201445|81329488|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
27862363|NCT03201445|81329487|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
27862364|NCT03201445|81329488|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
27862365|NCT03201445|81329487|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
27862366|NCT03201445|81329488|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
27862367|NCT03201445|81329487|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
27862368|NCT03201445|81329488|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
27862369|NCT03201445|81329487|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
27862370|NCT03201445|81329488|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
27862371|NCT03201445|81329487|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
27862372|NCT03201445|81329488|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
27862373|NCT03201445|81329487|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
27862374|NCT03201445|81329488|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
27862375|NCT03201445|81329487|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
27776248|NCT01469637|81009654|FG001|First Intervention|Unacceptable behavior|1|||
27776249|NCT01469637|81009653|FG000|Second Intervention|Incarcerated|1|||
27776250|NCT01469637|81009654|FG001|Second Intervention|Incarcerated|0|||
27776251|NCT03687827|81009655|FG000|Treatment Period 1|Death|0|||
27776252|NCT03687827|81009656|FG001|Treatment Period 1|Death|1|||
27776253|NCT03687827|81009655|FG000|Treatment Period 1|Lost to Follow-up|2|||
27776254|NCT03687827|81009656|FG001|Treatment Period 1|Lost to Follow-up|2|||
27862376|NCT03201445|81329488|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
27862377|NCT03201445|81329487|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
27776255|NCT03687827|81009655|FG000|Treatment Period 1|Physician Decision|5|||
27776256|NCT03687827|81009656|FG001|Treatment Period 1|Physician Decision|2|||
27862378|NCT03201445|81329488|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
27776257|NCT03687827|81009655|FG000|Treatment Period 1|Withdrawal by Subject|7|||
27776258|NCT03687827|81009656|FG001|Treatment Period 1|Withdrawal by Subject|3|||
27776259|NCT03687827|81009655|FG000|Treatment Period 2|Physician Decision|4|||
27776260|NCT03687827|81009656|FG001|Treatment Period 2|Physician Decision|1|||
27776261|NCT03687827|81009655|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27776262|NCT03687827|81009656|FG001|Treatment Period 2|Withdrawal by Subject|2|||
27776263|NCT00038142|81009659|FG000|Overall Study|Ineligible|1|||
27776264|NCT00038142|81009660|FG001|Overall Study|Ineligible|0|||
27776265|NCT00038142|81009659|FG000|Overall Study|Progressive Disease|11|||
27776266|NCT00038142|81009660|FG001|Overall Study|Progressive Disease|7|||
27776267|NCT00038142|81009659|FG000|Overall Study|Death|1|||
27776268|NCT00038142|81009660|FG001|Overall Study|Death|0|||
27776269|NCT00038142|81009659|FG000|Overall Study|Adverse Event|1|||
27776270|NCT00038142|81009660|FG001|Overall Study|Adverse Event|0|||
27776271|NCT00038142|81009659|FG000|Overall Study|Unknown Reason|8|||
27776272|NCT00038142|81009660|FG001|Overall Study|Unknown Reason|0|||
27776273|NCT04412668|81009661|FG000|Overall Study|Death - multiple comorbidities|2|||
27776274|NCT04412668|81009662|FG001|Overall Study|Death - multiple comorbidities|0|||
27776275|NCT04412668|81009663|FG002|Overall Study|Death - multiple comorbidities|0|||
27776276|NCT04412668|81009661|FG000|Overall Study|Withdrawal by Subject|3|||
27776277|NCT04412668|81009662|FG001|Overall Study|Withdrawal by Subject|0|||
27776278|NCT04412668|81009663|FG002|Overall Study|Withdrawal by Subject|0|||
27776279|NCT04412668|81009661|FG000|Overall Study|Other than Specified|2|||
27776280|NCT04412668|81009662|FG001|Overall Study|Other than Specified|0|||
27776281|NCT04412668|81009663|FG002|Overall Study|Other than Specified|0|||
27776282|NCT00090766|81009664|FG000|Overall Study|Nephrectomy Planned|0|||
27776283|NCT00090766|81009665|FG001|Overall Study|Nephrectomy Planned|0|||
27776284|NCT00090766|81009666|FG002|Overall Study|Nephrectomy Planned|1|||
27776285|NCT00090766|81009664|FG000|Overall Study|Death|1|||
27776286|NCT00090766|81009665|FG001|Overall Study|Death|0|||
27776287|NCT00090766|81009666|FG002|Overall Study|Death|0|||
27776288|NCT00090766|81009664|FG000|Overall Study|Admin|0|||
27776289|NCT00090766|81009665|FG001|Overall Study|Admin|2|||
27776290|NCT00090766|81009666|FG002|Overall Study|Admin|0|||
27776291|NCT00090766|81009664|FG000|Overall Study|Lost to Follow-up|2|||
27776292|NCT00090766|81009665|FG001|Overall Study|Lost to Follow-up|0|||
27776293|NCT00090766|81009666|FG002|Overall Study|Lost to Follow-up|2|||
27776294|NCT02892734|81009667|FG000|Treatment on Study|Progressive Disease|2|||
27776295|NCT02892734|81009667|FG000|Follow up for 2 Years|Death|2|||
27776296|NCT02892734|81009667|FG000|Follow up for 2 Years|Study closed early|1|||
27776297|NCT01266070|81009668|FG000|Overall Study|Adverse Event|3|||
27776298|NCT01266070|81009668|FG000|Overall Study|Protocol Violation|1|||
27776299|NCT00372489|81009671|FG000|Overall Study|Adverse Event|18|||
27776300|NCT00372489|81009671|FG000|Overall Study|Lack of Efficacy|1|||
27776301|NCT00372489|81009671|FG000|Overall Study|Lost to Follow-up|3|||
27776302|NCT00372489|81009671|FG000|Overall Study|Physician Decision|3|||
27776303|NCT00372489|81009671|FG000|Overall Study|Withdrawal by Subject|5|||
27776304|NCT00372489|81009671|FG000|Overall Study|Patient Relocation|2|||
27776305|NCT00372489|81009671|FG000|Overall Study|Renal transplant|6|||
27776306|NCT00372489|81009671|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
27776307|NCT03236506|81009672|FG000|Overall Study|Death|1|||
27776308|NCT03236506|81009673|FG001|Overall Study|Death|1|||
27776309|NCT03236506|81009674|FG002|Overall Study|Death|1|||
27776310|NCT03236506|81009672|FG000|Overall Study|Withdrawal by Subject|3|||
27776311|NCT03236506|81009673|FG001|Overall Study|Withdrawal by Subject|3|||
27776312|NCT03236506|81009674|FG002|Overall Study|Withdrawal by Subject|4|||
27776313|NCT03236506|81009672|FG000|Overall Study|Did not initiate treatment|2|||
27776314|NCT03236506|81009673|FG001|Overall Study|Did not initiate treatment|1|||
27776315|NCT03236506|81009674|FG002|Overall Study|Did not initiate treatment|2|||
27776316|NCT00403390|81009677|FG000|Overall Study|Withdrawal by Subject|1|||
27776317|NCT00403390|81009678|FG001|Overall Study|Withdrawal by Subject|0|||
27776318|NCT00403390|81009677|FG000|Overall Study|samples lost|1|||
27776319|NCT00403390|81009678|FG001|Overall Study|samples lost|0|||
27776320|NCT00403390|81009677|FG000|Overall Study|non-compliant|1|||
27776321|NCT00403390|81009678|FG001|Overall Study|non-compliant|0|||
27776322|NCT00853112|81009679|FG000|Overall Study|Randomized but not treated|0|||
27776323|NCT00853112|81009680|FG001|Overall Study|Randomized but not treated|1|||
27776324|NCT00853112|81009681|FG002|Overall Study|Randomized but not treated|0|||
27776325|NCT00853112|81009682|FG003|Overall Study|Randomized but not treated|2|||
27776326|NCT00853112|81009683|FG004|Overall Study|Randomized but not treated|0|||
27776327|NCT00853112|81009684|FG005|Overall Study|Randomized but not treated|0|||
27776328|NCT00853112|81009685|FG006|Overall Study|Randomized but not treated|1|||
27776329|NCT01424306|81009686|FG000|Overall Study|Protocol Violation|0|||
27776330|NCT01424306|81009687|FG001|Overall Study|Protocol Violation|0|||
27776331|NCT01424306|81009688|FG002|Overall Study|Protocol Violation|0|||
27776332|NCT01424306|81009689|FG003|Overall Study|Protocol Violation|0|||
27776333|NCT01424306|81009690|FG004|Overall Study|Protocol Violation|1|||
27776334|NCT01424306|81009691|FG005|Overall Study|Protocol Violation|0|||
27776335|NCT01307046|81009692|FG000|Overall Study|Adverse Event|3|||
27776336|NCT01307046|81009693|FG001|Overall Study|Adverse Event|3|||
27776337|NCT01307046|81009692|FG000|Overall Study|Lack of Efficacy|0|||
27776338|NCT01307046|81009693|FG001|Overall Study|Lack of Efficacy|2|||
27776339|NCT01307046|81009692|FG000|Overall Study|Physician Decision|2|||
27776340|NCT01307046|81009693|FG001|Overall Study|Physician Decision|0|||
27776341|NCT01307046|81009692|FG000|Overall Study|Withdrawal by Subject|1|||
27776342|NCT01307046|81009693|FG001|Overall Study|Withdrawal by Subject|1|||
27776343|NCT01307046|81009692|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
27776344|NCT01307046|81009693|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
27776345|NCT01307046|81009692|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
27776346|NCT01307046|81009693|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
27776347|NCT00606229|81009702|FG000|Overall Study|Adverse Event|11|||
27776348|NCT00606229|81009702|FG000|Overall Study|Lack of Efficacy|1|||
27776349|NCT00606229|81009702|FG000|Overall Study|Withdrawal by Subject|4|||
27776350|NCT00606229|81009702|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
27776351|NCT00606229|81009702|FG000|Overall Study|change of residence or other commitments|2|||
27776352|NCT04009824|81009703|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
27776353|NCT04009824|81009704|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
27776354|NCT04009824|81009705|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
27776355|NCT04009824|81009706|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
27776356|NCT04009824|81009707|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
27776357|NCT01836549|81009708|FG000|Overall Study|Did not receive study drug|0|||
27776358|NCT01836549|81009709|FG001|Overall Study|Did not receive study drug|0|||
27776359|NCT01836549|81009710|FG002|Overall Study|Did not receive study drug|1|||
27776360|NCT01836549|81009711|FG003|Overall Study|Did not receive study drug|0|||
27776361|NCT01836549|81009712|FG004|Overall Study|Did not receive study drug|0|||
27776362|NCT01836549|81009713|FG005|Overall Study|Did not receive study drug|0|||
27776363|NCT01836549|81009714|FG006|Overall Study|Did not receive study drug|0|||
27776364|NCT01836549|81009708|FG000|Overall Study|Patient declared ineligible|0|||
27776365|NCT01836549|81009709|FG001|Overall Study|Patient declared ineligible|0|||
27776366|NCT01836549|81009710|FG002|Overall Study|Patient declared ineligible|0|||
27776367|NCT01836549|81009711|FG003|Overall Study|Patient declared ineligible|1|||
27776368|NCT01836549|81009712|FG004|Overall Study|Patient declared ineligible|0|||
27776369|NCT01836549|81009713|FG005|Overall Study|Patient declared ineligible|0|||
27776370|NCT01836549|81009714|FG006|Overall Study|Patient declared ineligible|0|||
27776371|NCT01836549|81009708|FG000|Overall Study|Patient inevaluable to start therapy|0|||
27776372|NCT01836549|81009709|FG001|Overall Study|Patient inevaluable to start therapy|0|||
27776373|NCT01836549|81009710|FG002|Overall Study|Patient inevaluable to start therapy|0|||
27776374|NCT01836549|81009711|FG003|Overall Study|Patient inevaluable to start therapy|0|||
27776375|NCT01836549|81009712|FG004|Overall Study|Patient inevaluable to start therapy|0|||
27776376|NCT01836549|81009713|FG005|Overall Study|Patient inevaluable to start therapy|0|||
27776377|NCT01836549|81009714|FG006|Overall Study|Patient inevaluable to start therapy|1|||
27776378|NCT03227692|81009715|FG000|Overall Study|Protocol Violation|1|||
27776379|NCT03227692|81009716|FG001|Overall Study|Protocol Violation|1|||
27776380|NCT03227692|81009715|FG000|Overall Study|Lost to Follow-up|4|||
27776381|NCT03227692|81009716|FG001|Overall Study|Lost to Follow-up|2|||
27776382|NCT03227692|81009715|FG000|Overall Study|Adverse Event|0|||
27776383|NCT03227692|81009716|FG001|Overall Study|Adverse Event|2|||
27776384|NCT04315298|81009717|FG000|Overall Study|Withdrawal by Subject|0|||
27776385|NCT04315298|81009718|FG001|Overall Study|Withdrawal by Subject|0|||
27776386|NCT04315298|81009719|FG002|Overall Study|Withdrawal by Subject|0|||
27776387|NCT04315298|81009720|FG003|Overall Study|Withdrawal by Subject|2|||
27776388|NCT04315298|81009721|FG004|Overall Study|Withdrawal by Subject|2|||
27776389|NCT04315298|81009722|FG005|Overall Study|Withdrawal by Subject|2|||
27776390|NCT04315298|81009723|FG006|Overall Study|Withdrawal by Subject|0|||
27776391|NCT04315298|81009724|FG007|Overall Study|Withdrawal by Subject|1|||
27776392|NCT04315298|81009725|FG008|Overall Study|Withdrawal by Subject|1|||
27776393|NCT04315298|81009726|FG009|Overall Study|Withdrawal by Subject|1|||
27776394|NCT04315298|81009727|FG010|Overall Study|Withdrawal by Subject|0|||
27776395|NCT04315298|81009728|FG011|Overall Study|Withdrawal by Subject|0|||
27776396|NCT04315298|81009729|FG012|Overall Study|Withdrawal by Subject|0|||
27665555|NCT02201771|80612179|FG002|Overall Study|Protocol Violation|10|||
27776397|NCT04315298|81009730|FG013|Overall Study|Withdrawal by Subject|0|||
27776398|NCT04315298|81009731|FG014|Overall Study|Withdrawal by Subject|0|||
27776399|NCT04315298|81009732|FG015|Overall Study|Withdrawal by Subject|0|||
27776400|NCT04315298|81009733|FG016|Overall Study|Withdrawal by Subject|0|||
27776401|NCT04315298|81009734|FG017|Overall Study|Withdrawal by Subject|0|||
27776402|NCT04315298|81009735|FG018|Overall Study|Withdrawal by Subject|0|||
27776403|NCT04315298|81009717|FG000|Overall Study|Physician Decision|0|||
27776404|NCT04315298|81009718|FG001|Overall Study|Physician Decision|0|||
27776405|NCT04315298|81009719|FG002|Overall Study|Physician Decision|0|||
27776406|NCT04315298|81009720|FG003|Overall Study|Physician Decision|0|||
27776407|NCT04315298|81009721|FG004|Overall Study|Physician Decision|1|||
27776408|NCT04315298|81009722|FG005|Overall Study|Physician Decision|0|||
27776409|NCT04315298|81009723|FG006|Overall Study|Physician Decision|0|||
27776410|NCT04315298|81009724|FG007|Overall Study|Physician Decision|0|||
27776411|NCT04315298|81009725|FG008|Overall Study|Physician Decision|0|||
27776412|NCT04315298|81009726|FG009|Overall Study|Physician Decision|0|||
27776413|NCT04315298|81009727|FG010|Overall Study|Physician Decision|0|||
27776414|NCT04315298|81009728|FG011|Overall Study|Physician Decision|0|||
27776415|NCT04315298|81009729|FG012|Overall Study|Physician Decision|0|||
27776416|NCT04315298|81009730|FG013|Overall Study|Physician Decision|0|||
27776417|NCT04315298|81009731|FG014|Overall Study|Physician Decision|0|||
27776418|NCT04315298|81009732|FG015|Overall Study|Physician Decision|0|||
27776419|NCT04315298|81009733|FG016|Overall Study|Physician Decision|0|||
27776420|NCT04315298|81009734|FG017|Overall Study|Physician Decision|0|||
27776421|NCT04315298|81009735|FG018|Overall Study|Physician Decision|0|||
27776422|NCT04315298|81009717|FG000|Overall Study|Lost to Follow-up|5|||
27776423|NCT04315298|81009718|FG001|Overall Study|Lost to Follow-up|10|||
27776424|NCT04315298|81009719|FG002|Overall Study|Lost to Follow-up|6|||
27776425|NCT04315298|81009720|FG003|Overall Study|Lost to Follow-up|8|||
27776426|NCT04315298|81009721|FG004|Overall Study|Lost to Follow-up|12|||
27776427|NCT04315298|81009722|FG005|Overall Study|Lost to Follow-up|13|||
27776428|NCT04315298|81009723|FG006|Overall Study|Lost to Follow-up|9|||
27776429|NCT04315298|81009724|FG007|Overall Study|Lost to Follow-up|16|||
27776430|NCT04315298|81009725|FG008|Overall Study|Lost to Follow-up|14|||
27776431|NCT04315298|81009726|FG009|Overall Study|Lost to Follow-up|0|||
27776432|NCT04315298|81009727|FG010|Overall Study|Lost to Follow-up|2|||
27776433|NCT04315298|81009728|FG011|Overall Study|Lost to Follow-up|1|||
27776434|NCT04315298|81009729|FG012|Overall Study|Lost to Follow-up|0|||
27776435|NCT04315298|81009730|FG013|Overall Study|Lost to Follow-up|0|||
27776436|NCT04315298|81009731|FG014|Overall Study|Lost to Follow-up|0|||
27776437|NCT04315298|81009732|FG015|Overall Study|Lost to Follow-up|2|||
27776438|NCT04315298|81009733|FG016|Overall Study|Lost to Follow-up|0|||
27776439|NCT04315298|81009734|FG017|Overall Study|Lost to Follow-up|0|||
27776440|NCT04315298|81009735|FG018|Overall Study|Lost to Follow-up|0|||
27776441|NCT04315298|81009717|FG000|Overall Study|Death|24|||
27776442|NCT04315298|81009718|FG001|Overall Study|Death|60|||
27776443|NCT04315298|81009719|FG002|Overall Study|Death|49|||
27776444|NCT04315298|81009720|FG003|Overall Study|Death|59|||
27776445|NCT04315298|81009721|FG004|Overall Study|Death|70|||
27776446|NCT04315298|81009722|FG005|Overall Study|Death|114|||
27776447|NCT04315298|81009723|FG006|Overall Study|Death|9|||
27776448|NCT04315298|81009724|FG007|Overall Study|Death|12|||
27776449|NCT04315298|81009725|FG008|Overall Study|Death|21|||
27776450|NCT04315298|81009726|FG009|Overall Study|Death|16|||
27776451|NCT04315298|81009727|FG010|Overall Study|Death|40|||
27776452|NCT04315298|81009728|FG011|Overall Study|Death|40|||
27776453|NCT04315298|81009729|FG012|Overall Study|Death|3|||
27776454|NCT04315298|81009730|FG013|Overall Study|Death|4|||
27776455|NCT04315298|81009731|FG014|Overall Study|Death|6|||
27776456|NCT04315298|81009732|FG015|Overall Study|Death|4|||
27776457|NCT04315298|81009733|FG016|Overall Study|Death|3|||
27776458|NCT04315298|81009734|FG017|Overall Study|Death|1|||
27776459|NCT04315298|81009735|FG018|Overall Study|Death|0|||
27776460|NCT00397631|81009742|FG000|Overall Study|Adverse Event|5|||
27776461|NCT00397631|81009743|FG001|Overall Study|Adverse Event|6|||
27776462|NCT00397631|81009742|FG000|Overall Study|Lack of Efficacy|7|||
27776463|NCT00397631|81009743|FG001|Overall Study|Lack of Efficacy|10|||
27776464|NCT00397631|81009742|FG000|Overall Study|Lost to Follow-up|8|||
27776465|NCT00397631|81009743|FG001|Overall Study|Lost to Follow-up|9|||
27776466|NCT00397631|81009742|FG000|Overall Study|Physician Decision|2|||
27776467|NCT00397631|81009743|FG001|Overall Study|Physician Decision|0|||
27776468|NCT00397631|81009742|FG000|Overall Study|Protocol Violation|0|||
27776469|NCT00397631|81009743|FG001|Overall Study|Protocol Violation|1|||
27776470|NCT00397631|81009742|FG000|Overall Study|Withdrawal by Subject|7|||
27776471|NCT00397631|81009743|FG001|Overall Study|Withdrawal by Subject|14|||
27776472|NCT00397631|81009742|FG000|Overall Study|protocol discontinuation criteria|1|||
27776473|NCT00397631|81009743|FG001|Overall Study|protocol discontinuation criteria|4|||
27776474|NCT01081951|81009744|FG000|Overall Study|Death|54|||
27776475|NCT01081951|81009745|FG001|Overall Study|Death|47|||
27776476|NCT01081951|81009744|FG000|Overall Study|Withdrawal by Subject|2|||
27776477|NCT01081951|81009745|FG001|Overall Study|Withdrawal by Subject|6|||
27776478|NCT01081951|81009744|FG000|Overall Study|Allocated treatment but did not take it|0|||
27776479|NCT01081951|81009745|FG001|Overall Study|Allocated treatment but did not take it|1|||
27776480|NCT01081951|81009744|FG000|Overall Study|Lost to Follow-up|0|||
27776481|NCT01081951|81009745|FG001|Overall Study|Lost to Follow-up|1|||
27776482|NCT03935594|81009746|FG000|Overall Study|Physician Decision|3|||
27776483|NCT00634751|81009747|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
27776484|NCT00634751|81009748|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
27776485|NCT00634751|81009749|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
27665556|NCT01194271|80612180|FG000|Overall Study|Withdrawal by Subject|1|||
27665557|NCT01194271|80612180|FG000|Overall Study|Ineligible, Screen Failure|1|||
27665558|NCT01194271|80612180|FG000|Overall Study|Death|1|||
27665559|NCT02176356|80612181|FG000|Overall Study|Screen Failure|14|||
27665560|NCT02176356|80612181|FG000|Overall Study|Lost to Follow-up|4|||
27665561|NCT02176356|80612181|FG000|Overall Study|Personal Reasons|3|||
27665562|NCT02176356|80612181|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27665563|NCT04772313|80612182|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
27665564|NCT04772313|80612182|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
27665565|NCT00594178|80612183|FG000|Overall Study|Physician Decision|5|||
27665566|NCT01845649|80612184|FG000|Overall Study|Adverse Event|7|||
27665567|NCT01845649|80612185|FG001|Overall Study|Adverse Event|10|||
27665568|NCT01845649|80612184|FG000|Overall Study|Lack of Efficacy|1|||
27665569|NCT01845649|80612185|FG001|Overall Study|Lack of Efficacy|1|||
27665570|NCT01845649|80612184|FG000|Overall Study|Lost to Follow-up|2|||
27665571|NCT01845649|80612185|FG001|Overall Study|Lost to Follow-up|2|||
27665572|NCT01845649|80612184|FG000|Overall Study|Withdrew Consent|12|||
27665573|NCT01845649|80612185|FG001|Overall Study|Withdrew Consent|4|||
27665574|NCT01845649|80612184|FG000|Overall Study|Protocol Deviation|7|||
27665575|NCT01845649|80612185|FG001|Overall Study|Protocol Deviation|4|||
27665576|NCT01845649|80612184|FG000|Overall Study|Reason not Specified|2|||
27665577|NCT01845649|80612185|FG001|Overall Study|Reason not Specified|1|||
27665578|NCT03503162|80612190|FG000|Overall Study|did not meet eligibility|1|||
27665579|NCT01431950|80612191|FG000|Overall Study|Study Site Closed/Terminated|7|||
27665580|NCT01431950|80612192|FG001|Overall Study|Study Site Closed/Terminated|3|||
27665581|NCT01431950|80612191|FG000|Overall Study|Withdrawal by Subject|4|||
27665582|NCT01431950|80612192|FG001|Overall Study|Withdrawal by Subject|3|||
27665583|NCT01431950|80612191|FG000|Overall Study|Protocol Violation|2|||
27665584|NCT01431950|80612192|FG001|Overall Study|Protocol Violation|3|||
27665585|NCT01431950|80612191|FG000|Overall Study|Adverse Event|2|||
27665586|NCT01431950|80612192|FG001|Overall Study|Adverse Event|2|||
27665587|NCT01431950|80612191|FG000|Overall Study|Physician Decision|2|||
27665588|NCT01431950|80612192|FG001|Overall Study|Physician Decision|1|||
27665589|NCT01431950|80612191|FG000|Overall Study|Lack of Efficacy|2|||
27665590|NCT01431950|80612192|FG001|Overall Study|Lack of Efficacy|1|||
27665591|NCT01431950|80612191|FG000|Overall Study|Lost to Follow-up|0|||
27665592|NCT01431950|80612192|FG001|Overall Study|Lost to Follow-up|1|||
27665593|NCT01431950|80612191|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27665594|NCT01431950|80612192|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27665595|NCT04545476|80612193|FG000|Overall Study|Lost to Follow-up|1|||
27665596|NCT04545476|80612194|FG001|Overall Study|Lost to Follow-up|1|||
27665597|NCT04545476|80612195|FG002|Overall Study|Lost to Follow-up|0|||
27665598|NCT04545476|80612196|FG003|Overall Study|Lost to Follow-up|0|||
27665599|NCT02168478|80612197|FG000|Overall Study|Withdrawal by Subject|1|||
27665600|NCT02168478|80612197|FG000|Overall Study|Did Not Consent to Participation|2|||
27665601|NCT02168478|80612197|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
27665602|NCT02151643|80612198|FG000|Overall Study|Adverse Event|2|||
27665603|NCT02151643|80612199|FG001|Overall Study|Adverse Event|0|||
27665604|NCT02151643|80612200|FG002|Overall Study|Adverse Event|1|||
27665605|NCT02151643|80612201|FG003|Overall Study|Adverse Event|4|||
27665606|NCT02151643|80612202|FG004|Overall Study|Adverse Event|0|||
27665607|NCT02151643|80612198|FG000|Overall Study|Withdrawal by Subject|0|||
27665608|NCT02151643|80612199|FG001|Overall Study|Withdrawal by Subject|1|||
27665609|NCT02151643|80612200|FG002|Overall Study|Withdrawal by Subject|1|||
27665610|NCT02151643|80612201|FG003|Overall Study|Withdrawal by Subject|1|||
27665611|NCT02151643|80612202|FG004|Overall Study|Withdrawal by Subject|1|||
27665612|NCT02151643|80612198|FG000|Overall Study|Hyperphosphataemia|1|||
27665613|NCT02151643|80612199|FG001|Overall Study|Hyperphosphataemia|0|||
27665614|NCT02151643|80612200|FG002|Overall Study|Hyperphosphataemia|0|||
27665615|NCT02151643|80612201|FG003|Overall Study|Hyperphosphataemia|0|||
27665616|NCT02151643|80612202|FG004|Overall Study|Hyperphosphataemia|1|||
27665617|NCT02151643|80612198|FG000|Overall Study|High Ferritin levels|3|||
27665618|NCT02151643|80612199|FG001|Overall Study|High Ferritin levels|3|||
27665619|NCT02151643|80612200|FG002|Overall Study|High Ferritin levels|2|||
27665620|NCT02151643|80612201|FG003|Overall Study|High Ferritin levels|2|||
27665621|NCT02151643|80612202|FG004|Overall Study|High Ferritin levels|1|||
27665622|NCT01182207|80612203|FG000|First Intervention|Positive Hepatitis Results|0|||
27665623|NCT01182207|80612204|FG001|First Intervention|Positive Hepatitis Results|1|||
27665624|NCT01182207|80612203|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
27665625|NCT01182207|80612204|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
27665626|NCT04225039|80612205|FG000|Overall Study|Withdrawal by Subject|1|||
27665627|NCT04225039|80612206|FG001|Overall Study|Withdrawal by Subject|0|||
27665628|NCT04225039|80612207|FG002|Overall Study|Withdrawal by Subject|0|||
27665629|NCT04225039|80612208|FG003|Overall Study|Withdrawal by Subject|1|||
27665630|NCT04225039|80612205|FG000|Overall Study|Currently active on study treatment|0|||
27665631|NCT04225039|80612206|FG001|Overall Study|Currently active on study treatment|1|||
27665632|NCT04225039|80612207|FG002|Overall Study|Currently active on study treatment|0|||
27862379|NCT03201445|81329487|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
27862380|NCT03201445|81329488|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
27862381|NCT03201445|81329487|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
27862382|NCT03201445|81329488|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
27862383|NCT03201445|81329487|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
27862384|NCT03201445|81329488|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
27862385|NCT03201445|81329487|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
27862386|NCT03201445|81329488|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
27862387|NCT03201445|81329487|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
27862388|NCT03201445|81329488|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
27862389|NCT03201445|81329487|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
27862390|NCT03201445|81329488|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
27862391|NCT03201445|81329487|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
27862392|NCT03201445|81329488|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
27862393|NCT03201445|81329487|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
27862394|NCT03201445|81329488|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
27862395|NCT03201445|81329487|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
27862396|NCT03201445|81329488|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
27862397|NCT03201445|81329487|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
27862398|NCT03201445|81329488|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
27862399|NCT03201445|81329487|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
27862400|NCT03201445|81329488|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
27862401|NCT01520870|81329489|FG000|Overall Study|Withdrawal by Subject|2|||
27862402|NCT03485365|81329490|FG000|Overall Study|Protocol Violation|0|||
27862403|NCT03485365|81329491|FG001|Overall Study|Protocol Violation|0|||
27862404|NCT03485365|81329492|FG002|Overall Study|Protocol Violation|0|||
27862405|NCT03485365|81329493|FG003|Overall Study|Protocol Violation|1|||
27862406|NCT03485365|81329494|FG004|Overall Study|Protocol Violation|0|||
27862407|NCT03485365|81329495|FG005|Overall Study|Protocol Violation|0|||
27862408|NCT03485365|81329496|FG006|Overall Study|Protocol Violation|1|||
27862409|NCT03485365|81329497|FG007|Overall Study|Protocol Violation|0|||
27862410|NCT03485365|81329498|FG008|Overall Study|Protocol Violation|0|||
27862411|NCT00282919|81329499|FG000|Overall Study|Lack of Efficacy|4|||
27862412|NCT00282919|81329499|FG000|Overall Study|Withdrawal by Subject|1|||
27862413|NCT00282919|81329499|FG000|Overall Study|Asymptomatic Parasitemia|2|||
27862414|NCT01464931|81329500|FG000|Overall Study|Withdrawal by Subject|1|||
27862415|NCT01464931|81329501|FG001|Overall Study|Withdrawal by Subject|0|||
27862416|NCT01145508|81329502|FG000|Overall Study|Adverse Event|1|||
27776486|NCT00634751|81009750|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
27776487|NCT00634751|81009747|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
27776488|NCT00634751|81009748|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
27776489|NCT00634751|81009749|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
27776490|NCT00634751|81009750|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
27776491|NCT00634751|81009747|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
27776492|NCT00634751|81009748|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
27776493|NCT00634751|81009749|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
27776494|NCT00634751|81009750|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
27776495|NCT02094612|81009751|FG000|Overall Study|Lost to Follow-up|47|||
27776496|NCT02094612|81009752|FG001|Overall Study|Lost to Follow-up|47|||
27776497|NCT02094612|81009751|FG000|Overall Study|Never started ADHD medication|32|||
27776498|NCT02094612|81009752|FG001|Overall Study|Never started ADHD medication|23|||
27776499|NCT00113555|81009753|FG000|Overall Study|Baseline Failure|59|||
27776500|NCT00113555|81009753|FG000|Overall Study|Permanently Explanted|7|||
27776501|NCT00113555|81009753|FG000|Overall Study|Death|1|||
27776502|NCT00113555|81009753|FG000|Overall Study|Missed Followup|4|||
27776503|NCT00113555|81009753|FG000|Overall Study|Lost to Follow-up|8|||
27776504|NCT01263470|81009754|FG000|Overall Study|Adverse Event|2|||
27776505|NCT01263470|81009755|FG001|Overall Study|Adverse Event|2|||
27776506|NCT01263470|81009756|FG002|Overall Study|Adverse Event|1|||
27776507|NCT01263470|81009757|FG003|Overall Study|Adverse Event|1|||
27776508|NCT01263470|81009758|FG004|Overall Study|Adverse Event|2|||
27776509|NCT01263470|81009759|FG005|Overall Study|Adverse Event|2|||
27776510|NCT01263470|81009754|FG000|Overall Study|Protocol Violation|0|||
27776511|NCT01263470|81009755|FG001|Overall Study|Protocol Violation|1|||
27776512|NCT01263470|81009756|FG002|Overall Study|Protocol Violation|0|||
27776513|NCT01263470|81009757|FG003|Overall Study|Protocol Violation|0|||
27776514|NCT01263470|81009758|FG004|Overall Study|Protocol Violation|0|||
27776515|NCT01263470|81009759|FG005|Overall Study|Protocol Violation|1|||
27776516|NCT01263470|81009754|FG000|Overall Study|Withdrawal by Subject|0|||
27776517|NCT01263470|81009755|FG001|Overall Study|Withdrawal by Subject|1|||
27776518|NCT01263470|81009756|FG002|Overall Study|Withdrawal by Subject|1|||
27776519|NCT01263470|81009757|FG003|Overall Study|Withdrawal by Subject|2|||
27967279|NCT05507567|81710800|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
27967280|NCT05507567|81710801|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
27967281|NCT03575065|81710802|FG000|Overall Study|Death|31|||
27570001|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570002|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570003|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570004|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570005|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570006|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570007|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27776520|NCT01263470|81009758|FG004|Overall Study|Withdrawal by Subject|0|||
27776521|NCT01263470|81009759|FG005|Overall Study|Withdrawal by Subject|2|||
27570008|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
27570009|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570010|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
27570011|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570012|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570013|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570014|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570015|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570016|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570017|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570018|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570019|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570020|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570021|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570022|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27665633|NCT04225039|80612208|FG003|Overall Study|Currently active on study treatment|0|||
27665634|NCT04225039|80612205|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
27665635|NCT04225039|80612206|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
27665636|NCT04225039|80612207|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
27665637|NCT04225039|80612208|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
27665638|NCT04225039|80612205|FG000|Overall Study|Ineligible for treatment|0|||
27665639|NCT04225039|80612206|FG001|Overall Study|Ineligible for treatment|0|||
27665640|NCT04225039|80612207|FG002|Overall Study|Ineligible for treatment|0|||
27665641|NCT04225039|80612208|FG003|Overall Study|Ineligible for treatment|4|||
27665642|NCT02246218|80612209|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27665643|NCT02246218|80612210|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27665644|NCT02246218|80612209|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
27665645|NCT02246218|80612210|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
27665646|NCT02246218|80612209|FG000|Overall Study|Adverse Event|1|||
27665647|NCT02246218|80612210|FG001|Overall Study|Adverse Event|1|||
27776522|NCT01263470|81009754|FG000|Overall Study|Lack of Efficacy|0|||
27776523|NCT01263470|81009755|FG001|Overall Study|Lack of Efficacy|0|||
27776524|NCT01263470|81009756|FG002|Overall Study|Lack of Efficacy|2|||
27776525|NCT01263470|81009757|FG003|Overall Study|Lack of Efficacy|0|||
27776526|NCT01263470|81009758|FG004|Overall Study|Lack of Efficacy|0|||
27776527|NCT01263470|81009759|FG005|Overall Study|Lack of Efficacy|0|||
27776528|NCT01263470|81009754|FG000|Overall Study|Participant Unavailability|0|||
27776529|NCT01263470|81009755|FG001|Overall Study|Participant Unavailability|1|||
27776530|NCT01263470|81009756|FG002|Overall Study|Participant Unavailability|0|||
27776531|NCT01263470|81009757|FG003|Overall Study|Participant Unavailability|0|||
27776532|NCT01263470|81009758|FG004|Overall Study|Participant Unavailability|0|||
27776533|NCT01263470|81009759|FG005|Overall Study|Participant Unavailability|0|||
27776534|NCT01263470|81009754|FG000|Overall Study|Study Drug Non-compliance|0|||
27776535|NCT01263470|81009755|FG001|Overall Study|Study Drug Non-compliance|0|||
27967282|NCT03575065|81710803|FG001|Overall Study|Death|12|||
27967283|NCT03575065|81710802|FG000|Overall Study|Sponsor's Decision|28|||
27570023|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570024|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570025|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570026|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27665648|NCT02246218|80612209|FG000|Overall Study|Lost to Follow-up|1|||
27665649|NCT02246218|80612210|FG001|Overall Study|Lost to Follow-up|0|||
27665650|NCT01370018|80612211|FG000|Overall Study|Did not meet criteria for analysis|1|||
27776536|NCT01263470|81009756|FG002|Overall Study|Study Drug Non-compliance|0|||
27776537|NCT01263470|81009757|FG003|Overall Study|Study Drug Non-compliance|0|||
27967284|NCT03575065|81710803|FG001|Overall Study|Sponsor's Decision|13|||
27776538|NCT01263470|81009758|FG004|Overall Study|Study Drug Non-compliance|1|||
27776539|NCT01263470|81009759|FG005|Overall Study|Study Drug Non-compliance|0|||
27776540|NCT00882362|81009760|FG000|Overall Study|Adverse Event|13|||
27665651|NCT00702650|80612212|FG000|Overall Study|Withdrawal by Subject|9|||
27665652|NCT00702650|80612212|FG000|Overall Study|Non-Compliance of Study Drug|3|||
27665653|NCT00702650|80612212|FG000|Overall Study|Lost to Follow-up|2|||
27776541|NCT00882362|81009761|FG001|Overall Study|Adverse Event|10|||
27776542|NCT00882362|81009760|FG000|Overall Study|Withdrawal by Subject|13|||
27776543|NCT00882362|81009761|FG001|Overall Study|Withdrawal by Subject|10|||
27776544|NCT00882362|81009760|FG000|Overall Study|Lack of Efficacy|3|||
27776545|NCT00882362|81009761|FG001|Overall Study|Lack of Efficacy|0|||
27665654|NCT00702650|80612212|FG000|Overall Study|Non-Compliance with Site Directives|1|||
27665655|NCT00702650|80612212|FG000|Overall Study|Sponsor Request|1|||
27665656|NCT00702650|80612212|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
27665657|NCT00702650|80612212|FG000|Overall Study|Adverse Event|3|||
27665658|NCT00925288|80612213|FG000|Overall Study|Lost to Follow-up|9|||
27665659|NCT00925288|80612214|FG001|Overall Study|Lost to Follow-up|7|||
27665660|NCT03891641|80612215|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
27665661|NCT03891641|80612216|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
27665662|NCT00814632|80612217|FG000|Overall Study|Lack of Efficacy|2|||
27665663|NCT02971228|80612218|FG000|Overall Study|Withdrawal by Subject|1|||
27776546|NCT00882362|81009760|FG000|Overall Study|Protocol Violation|7|||
27776547|NCT00882362|81009761|FG001|Overall Study|Protocol Violation|2|||
27776548|NCT00882362|81009760|FG000|Overall Study|Pregnancy|1|||
27776549|NCT00882362|81009761|FG001|Overall Study|Pregnancy|0|||
27776550|NCT00882362|81009760|FG000|Overall Study|Physician Decision|5|||
27776551|NCT00882362|81009761|FG001|Overall Study|Physician Decision|1|||
27776552|NCT00882362|81009760|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
27776553|NCT00882362|81009761|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
27776554|NCT00882362|81009760|FG000|Overall Study|change of residence or other commitments|5|||
27776555|NCT00882362|81009761|FG001|Overall Study|change of residence or other commitments|0|||
27862417|NCT01145508|81329503|FG001|Overall Study|Adverse Event|0|||
27862418|NCT01145508|81329502|FG000|Overall Study|Death|1|||
27862419|NCT01145508|81329503|FG001|Overall Study|Death|0|||
27862420|NCT01145508|81329502|FG000|Overall Study|Physician Decision|2|||
27862421|NCT01145508|81329503|FG001|Overall Study|Physician Decision|1|||
27862422|NCT01145508|81329502|FG000|Overall Study|Never started treatment|1|||
27862423|NCT01145508|81329503|FG001|Overall Study|Never started treatment|1|||
27862424|NCT02383810|81329504|FG000|Overall Study|Physician Decision|1|||
27862425|NCT02383810|81329505|FG001|Overall Study|Physician Decision|1|||
27776556|NCT00691054|81009764|FG000|Overall Study|Withdrawal by Subject|1|||
27967285|NCT03575065|81710802|FG000|Overall Study|Withdrawal by Subject|2|||
27776557|NCT01625611|81009768|FG000|Overall Study|No adlib drinks Lab 1|3|||
27776558|NCT01625611|81009769|FG001|Overall Study|No adlib drinks Lab 1|0|||
27862426|NCT02383810|81329506|FG002|Overall Study|Physician Decision|0|||
27862427|NCT02383810|81329507|FG003|Overall Study|Physician Decision|0|||
27862428|NCT02383810|81329508|FG004|Overall Study|Physician Decision|0|||
27862429|NCT02383810|81329509|FG005|Overall Study|Physician Decision|0|||
27862430|NCT02383810|81329510|FG006|Overall Study|Physician Decision|0|||
27862431|NCT02383810|81329511|FG007|Overall Study|Physician Decision|0|||
27862432|NCT02383810|81329504|FG000|Overall Study|Withdrawal by Subject|2|||
27862433|NCT02383810|81329505|FG001|Overall Study|Withdrawal by Subject|3|||
27862434|NCT02383810|81329506|FG002|Overall Study|Withdrawal by Subject|3|||
27862435|NCT02383810|81329507|FG003|Overall Study|Withdrawal by Subject|3|||
27967286|NCT03575065|81710803|FG001|Overall Study|Withdrawal by Subject|1|||
27967287|NCT03575065|81710802|FG000|Overall Study|Lost to Follow-up|1|||
27967288|NCT03575065|81710803|FG001|Overall Study|Lost to Follow-up|0|||
27967289|NCT03333252|81710806|FG000|Overall Study|Adverse Event|10|||
27967290|NCT03333252|81710807|FG001|Overall Study|Adverse Event|6|||
27967291|NCT03333252|81710808|FG002|Overall Study|Adverse Event|5|||
27967292|NCT03333252|81710809|FG003|Overall Study|Adverse Event|2|||
27665664|NCT02971228|80612219|FG001|Overall Study|Withdrawal by Subject|1|||
27665665|NCT02971228|80612220|FG002|Overall Study|Withdrawal by Subject|0|||
27665666|NCT02971228|80612221|FG003|Overall Study|Withdrawal by Subject|0|||
27776559|NCT01625611|81009768|FG000|Overall Study|Technical issues with PET|1|||
27862436|NCT02383810|81329508|FG004|Overall Study|Withdrawal by Subject|0|||
27665667|NCT02971228|80612222|FG004|Overall Study|Withdrawal by Subject|0|||
27665668|NCT02971228|80612218|FG000|Overall Study|Logistical challenges|0|||
27776560|NCT01625611|81009769|FG001|Overall Study|Technical issues with PET|0|||
27862437|NCT02383810|81329509|FG005|Overall Study|Withdrawal by Subject|0|||
27862438|NCT02383810|81329510|FG006|Overall Study|Withdrawal by Subject|0|||
27862439|NCT02383810|81329511|FG007|Overall Study|Withdrawal by Subject|0|||
27862440|NCT02383810|81329504|FG000|Overall Study|Adverse Event|0|||
27862441|NCT02383810|81329505|FG001|Overall Study|Adverse Event|2|||
27967293|NCT03333252|81710806|FG000|Overall Study|Death|1|||
27862442|NCT02383810|81329506|FG002|Overall Study|Adverse Event|4|||
27862443|NCT02383810|81329507|FG003|Overall Study|Adverse Event|5|||
27862444|NCT02383810|81329508|FG004|Overall Study|Adverse Event|0|||
27967294|NCT03333252|81710807|FG001|Overall Study|Death|3|||
27967295|NCT03333252|81710808|FG002|Overall Study|Death|0|||
27967296|NCT03333252|81710809|FG003|Overall Study|Death|0|||
27665669|NCT02971228|80612219|FG001|Overall Study|Logistical challenges|1|||
27665670|NCT02971228|80612220|FG002|Overall Study|Logistical challenges|0|||
27665671|NCT02971228|80612221|FG003|Overall Study|Logistical challenges|0|||
27665672|NCT02971228|80612222|FG004|Overall Study|Logistical challenges|0|||
27665673|NCT01222078|80612223|FG000|Overall Study|Early termination of the study|1|||
27665674|NCT02482935|80612226|FG000|Period 1|Withdrawal by Subject|1|||
27665675|NCT02482935|80612227|FG001|Period 1|Withdrawal by Subject|0|||
27665676|NCT03449134|80612228|FG000|52-Week Treatment Period|Death|2|||
27665677|NCT03449134|80612229|FG001|52-Week Treatment Period|Death|1|||
27665678|NCT03449134|80612230|FG002|52-Week Treatment Period|Death|0|||
27665679|NCT03449134|80612228|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
27665680|NCT03449134|80612229|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
27665681|NCT03449134|80612230|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
27665682|NCT03449134|80612228|FG000|52-Week Treatment Period|Physician Decision|2|||
27665683|NCT03449134|80612229|FG001|52-Week Treatment Period|Physician Decision|3|||
27665684|NCT03449134|80612230|FG002|52-Week Treatment Period|Physician Decision|3|||
27665685|NCT03449134|80612228|FG000|52-Week Treatment Period|Screen Failure|1|||
27665686|NCT03449134|80612229|FG001|52-Week Treatment Period|Screen Failure|0|||
27665687|NCT03449134|80612230|FG002|52-Week Treatment Period|Screen Failure|1|||
27665688|NCT03449134|80612228|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
27665689|NCT03449134|80612229|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
27665690|NCT03449134|80612230|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
27665691|NCT03449134|80612228|FG000|52-Week Treatment Period|Site Closure|1|||
27776561|NCT01625611|81009768|FG000|Overall Study|Unable to complete study procedures|1|||
27776562|NCT01625611|81009769|FG001|Overall Study|Unable to complete study procedures|0|||
27776563|NCT01625611|81009768|FG000|Overall Study|Withdrawal by Subject|3|||
27776564|NCT01625611|81009769|FG001|Overall Study|Withdrawal by Subject|0|||
27776565|NCT00636506|81009775|FG000|Overall Study|Lost to Follow-up|8|||
27776566|NCT00636506|81009775|FG000|Overall Study|Explanted|1|||
27776567|NCT00636506|81009775|FG000|Overall Study|Withdrawal by Subject|6|||
27776568|NCT00636506|81009775|FG000|Overall Study|Procedure aborted|1|||
27776569|NCT00711412|81009776|FG000|Induction Treatment|Death|2|||
27776570|NCT00711412|81009776|FG000|Induction Treatment|Adverse Event|1|||
27776571|NCT00711412|81009776|FG000|Induction Treatment|Other|1|||
27776572|NCT00711412|81009776|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
27776573|NCT00711412|81009776|FG000|Evaluated for Combination Treatment|Death|1|||
27776574|NCT00711412|81009776|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
27776575|NCT00711412|81009776|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
27776576|NCT00711412|81009776|FG000|Combination Treatment|Progressive Disease|1|||
27776577|NCT00711412|81009776|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
27776578|NCT00711412|81009776|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
27776579|NCT00711412|81009776|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
27776580|NCT00711412|81009776|FG000|Evaluation for Response and Surgery|Death|1|||
27776581|NCT00711412|81009776|FG000|Survival Follow up Until Death|Other|12|||
27776582|NCT01512693|81009779|FG000|Overall Study|Withdrawal by Subject|0|||
27776583|NCT01512693|81009780|FG001|Overall Study|Withdrawal by Subject|1|||
27776584|NCT02005211|81009781|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27776585|NCT02005211|81009782|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27776586|NCT02005211|81009783|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27776587|NCT02005211|81009784|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27776588|NCT02005211|81009785|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
27776589|NCT02005211|81009786|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27776590|NCT02005211|81009787|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
27776591|NCT01512108|81009790|FG000|Overall Study|Adverse Event|9|||
27776592|NCT01512108|81009791|FG001|Overall Study|Adverse Event|4|||
27776593|NCT01512108|81009790|FG000|Overall Study|Protocol Violation|1|||
27776594|NCT01512108|81009791|FG001|Overall Study|Protocol Violation|2|||
27776595|NCT01512108|81009790|FG000|Overall Study|Withdrawal Criteria|1|||
27776596|NCT01512108|81009791|FG001|Overall Study|Withdrawal Criteria|0|||
27776597|NCT01512108|81009790|FG000|Overall Study|Unclassified|11|||
27776598|NCT01512108|81009791|FG001|Overall Study|Unclassified|3|||
27776599|NCT03030261|81013385|FG000|Overall Study|Still receiving continuation therapy|5|||
27776600|NCT00732472|81013386|FG000|Overall Study|Adverse Event|0|||
27776601|NCT00732472|81013387|FG001|Overall Study|Adverse Event|1|||
27776602|NCT00732472|81013388|FG002|Overall Study|Adverse Event|1|||
27776603|NCT00732472|81013389|FG003|Overall Study|Adverse Event|1|||
27776604|NCT00732472|81013386|FG000|Overall Study|Protocol Violation|0|||
27776605|NCT00732472|81013387|FG001|Overall Study|Protocol Violation|0|||
27776606|NCT00732472|81013388|FG002|Overall Study|Protocol Violation|0|||
27776607|NCT00732472|81013389|FG003|Overall Study|Protocol Violation|1|||
27665692|NCT03449134|80612229|FG001|52-Week Treatment Period|Site Closure|0|||
27665693|NCT03449134|80612230|FG002|52-Week Treatment Period|Site Closure|0|||
27665694|NCT03807700|80612234|FG000|Overall Study|Withdrawal by Subject|2|||
27665695|NCT03807700|80612235|FG001|Overall Study|Withdrawal by Subject|1|||
27776608|NCT00732472|81013386|FG000|Overall Study|Withdrawal by Subject|0|||
27776609|NCT00732472|81013387|FG001|Overall Study|Withdrawal by Subject|2|||
27776610|NCT00732472|81013388|FG002|Overall Study|Withdrawal by Subject|0|||
27776611|NCT00732472|81013389|FG003|Overall Study|Withdrawal by Subject|1|||
27776612|NCT03261037|81013391|FG000|Overall Study|Withdrawal by Subject|2|||
27776613|NCT03261037|81013392|FG001|Overall Study|Withdrawal by Subject|13|||
27776614|NCT03261037|81013393|FG002|Overall Study|Withdrawal by Subject|0|||
27776615|NCT03261037|81013394|FG003|Overall Study|Withdrawal by Subject|18|||
27776616|NCT03261037|81013391|FG000|Overall Study|Non-compliance with study procedures|0|||
27776617|NCT03261037|81013392|FG001|Overall Study|Non-compliance with study procedures|2|||
27776618|NCT03261037|81013393|FG002|Overall Study|Non-compliance with study procedures|0|||
27776619|NCT03261037|81013394|FG003|Overall Study|Non-compliance with study procedures|6|||
27776620|NCT03261037|81013391|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
27776621|NCT03261037|81013392|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
27776622|NCT03261037|81013393|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
27776623|NCT03261037|81013394|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
27776624|NCT03261037|81013391|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
27776625|NCT03261037|81013392|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
27776626|NCT03261037|81013393|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
27776627|NCT03261037|81013394|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
27776628|NCT03261037|81013391|FG000|Overall Study|Diagnosed but protocol deviation|1|||
27776629|NCT03261037|81013392|FG001|Overall Study|Diagnosed but protocol deviation|0|||
27776630|NCT03261037|81013393|FG002|Overall Study|Diagnosed but protocol deviation|0|||
27776631|NCT03261037|81013394|FG003|Overall Study|Diagnosed but protocol deviation|0|||
27776632|NCT03261037|81013391|FG000|Overall Study|Participant did not want to continue the study|0|||
27776633|NCT03261037|81013392|FG001|Overall Study|Participant did not want to continue the study|1|||
27776634|NCT03261037|81013393|FG002|Overall Study|Participant did not want to continue the study|0|||
27776635|NCT03261037|81013394|FG003|Overall Study|Participant did not want to continue the study|0|||
27776636|NCT03261037|81013391|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
27776637|NCT03261037|81013392|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
27776638|NCT03261037|81013393|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
27776639|NCT03261037|81013394|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
27776640|NCT03261037|81013391|FG000|Overall Study|Participant presented clinical improvement|0|||
27776641|NCT03261037|81013392|FG001|Overall Study|Participant presented clinical improvement|2|||
27776642|NCT03261037|81013393|FG002|Overall Study|Participant presented clinical improvement|0|||
27776643|NCT03261037|81013394|FG003|Overall Study|Participant presented clinical improvement|0|||
27776644|NCT03261037|81013391|FG000|Overall Study|Technical difficulties|0|||
27776645|NCT03261037|81013392|FG001|Overall Study|Technical difficulties|0|||
27776646|NCT03261037|81013393|FG002|Overall Study|Technical difficulties|0|||
27776647|NCT03261037|81013394|FG003|Overall Study|Technical difficulties|1|||
27776648|NCT03261037|81013391|FG000|Overall Study|Equipment failed to work|0|||
27776649|NCT03261037|81013392|FG001|Overall Study|Equipment failed to work|0|||
27776650|NCT03261037|81013393|FG002|Overall Study|Equipment failed to work|0|||
27776651|NCT03261037|81013394|FG003|Overall Study|Equipment failed to work|1|||
27776652|NCT03261037|81013391|FG000|Overall Study|End of study for participant and no follow up|0|||
27776653|NCT03261037|81013392|FG001|Overall Study|End of study for participant and no follow up|0|||
27776654|NCT03261037|81013393|FG002|Overall Study|End of study for participant and no follow up|0|||
27776655|NCT03261037|81013394|FG003|Overall Study|End of study for participant and no follow up|1|||
27776656|NCT03261037|81013391|FG000|Overall Study|Participant was too weak to continue in study|1|||
27776657|NCT03261037|81013392|FG001|Overall Study|Participant was too weak to continue in study|0|||
27776658|NCT03261037|81013393|FG002|Overall Study|Participant was too weak to continue in study|0|||
27776659|NCT03261037|81013394|FG003|Overall Study|Participant was too weak to continue in study|0|||
27776660|NCT00364611|81013395|FG000|Overall Study|Did not receive study medication|0|||
27776661|NCT00364611|81013396|FG001|Overall Study|Did not receive study medication|1|||
27776662|NCT00364611|81013395|FG000|Overall Study|Adverse Event|7|||
27776663|NCT00364611|81013396|FG001|Overall Study|Adverse Event|4|||
27776664|NCT00364611|81013395|FG000|Overall Study|Participant's Request|3|||
27776665|NCT00364611|81013396|FG001|Overall Study|Participant's Request|4|||
27776666|NCT00364611|81013395|FG000|Overall Study|Disease Progression|38|||
27862445|NCT02383810|81329509|FG005|Overall Study|Adverse Event|1|||
27862446|NCT02383810|81329510|FG006|Overall Study|Adverse Event|1|||
27862447|NCT02383810|81329511|FG007|Overall Study|Adverse Event|0|||
27862448|NCT02383810|81329504|FG000|Overall Study|Lost to Follow-up|0|||
27665696|NCT00115336|80612240|FG000|Overall Study|Hospital discharge before study drug|0|||
27776667|NCT00364611|81013396|FG001|Overall Study|Disease Progression|8|||
27776668|NCT00364611|81013395|FG000|Overall Study|Investigator decision|2|||
27862449|NCT02383810|81329505|FG001|Overall Study|Lost to Follow-up|1|||
27862450|NCT02383810|81329506|FG002|Overall Study|Lost to Follow-up|0|||
27862451|NCT02383810|81329507|FG003|Overall Study|Lost to Follow-up|1|||
27862452|NCT02383810|81329508|FG004|Overall Study|Lost to Follow-up|0|||
27862453|NCT02383810|81329509|FG005|Overall Study|Lost to Follow-up|0|||
27776669|NCT00364611|81013396|FG001|Overall Study|Investigator decision|2|||
27776670|NCT00364611|81013395|FG000|Overall Study|Found Ineligible|1|||
27776671|NCT00364611|81013396|FG001|Overall Study|Found Ineligible|0|||
27776672|NCT00364611|81013395|FG000|Overall Study|Presumed CR on Study|0|||
27776673|NCT00364611|81013396|FG001|Overall Study|Presumed CR on Study|1|||
27776674|NCT00364611|81013395|FG000|Overall Study|Receiving Liver Ablation|0|||
27776675|NCT00364611|81013396|FG001|Overall Study|Receiving Liver Ablation|1|||
27776676|NCT05091918|81013397|FG000|Overall Study|Adverse Event|1|||
27776677|NCT05091918|81013397|FG000|Overall Study|Withdrawal by Subject|81|||
27776678|NCT01308853|81013398|FG000|Overall Study|Adverse Event|1|||
27776679|NCT01308853|81013398|FG000|Overall Study|Lost to Follow-up|2|||
27776680|NCT01308853|81013398|FG000|Overall Study|Insertion of permanent implants|1|||
27776681|NCT00088595|81013402|FG000|Overall Study|Adverse Event|11|||
27776682|NCT00088595|81013402|FG000|Overall Study|Withdrawal by Subject|8|||
27776683|NCT00088595|81013402|FG000|Overall Study|Ongoing (After Core)|7|||
27776684|NCT00088595|81013402|FG000|Overall Study|New Cancer Therapy|2|||
27776685|NCT02274311|81013403|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
27776686|NCT02565576|81013406|FG000|Overall Study|abnormal lab value|2|||
27776687|NCT02565576|81013407|FG001|Overall Study|abnormal lab value|0|||
27776688|NCT02565576|81013406|FG000|Overall Study|subject / guardian decision|1|||
27776689|NCT02565576|81013407|FG001|Overall Study|subject / guardian decision|3|||
27776690|NCT02565576|81013406|FG000|Overall Study|Lost to Follow-up|1|||
27776691|NCT02565576|81013407|FG001|Overall Study|Lost to Follow-up|0|||
27776692|NCT02565576|81013406|FG000|Overall Study|Death|0|||
27776693|NCT02565576|81013407|FG001|Overall Study|Death|2|||
27776694|NCT02565576|81013406|FG000|Overall Study|Adverse Event|1|||
27776695|NCT02565576|81013407|FG001|Overall Study|Adverse Event|0|||
27776696|NCT00338806|81013408|FG000|Acute Phase|Withdrawal by Subject|0|||
27776697|NCT00338806|81013409|FG001|Acute Phase|Withdrawal by Subject|1|||
27776698|NCT00338806|81013408|FG000|Follow-up|Lost to Follow-up|1|||
27776699|NCT00338806|81013409|FG001|Follow-up|Lost to Follow-up|3|||
27776700|NCT00742391|81013410|FG000|Overall Study|Adverse Event|2|||
27776701|NCT00742391|81013411|FG001|Overall Study|Adverse Event|1|||
27776702|NCT00742391|81013410|FG000|Overall Study|Lost to Follow-up|1|||
27776703|NCT00742391|81013411|FG001|Overall Study|Lost to Follow-up|0|||
27776704|NCT00742391|81013410|FG000|Overall Study|Protocol Violation|1|||
27776705|NCT00742391|81013411|FG001|Overall Study|Protocol Violation|0|||
27776706|NCT03685643|81013412|FG000|Overall Study|Lost to Follow-up|14|||
27776707|NCT03685643|81013413|FG001|Overall Study|Lost to Follow-up|22|||
27776708|NCT01021293|81013414|FG000|Overall Study|Serious Adverse Event|2|||
27776709|NCT01021293|81013415|FG001|Overall Study|Serious Adverse Event|1|||
27776710|NCT01021293|81013414|FG000|Overall Study|Adverse Event|2|||
27776711|NCT01021293|81013415|FG001|Overall Study|Adverse Event|1|||
27776712|NCT01021293|81013414|FG000|Overall Study|Withdrawal by Subject|1|||
27776713|NCT01021293|81013415|FG001|Overall Study|Withdrawal by Subject|3|||
27776714|NCT01021293|81013414|FG000|Overall Study|Migrated/moved from study area|6|||
27776715|NCT01021293|81013415|FG001|Overall Study|Migrated/moved from study area|18|||
27776716|NCT01021293|81013414|FG000|Overall Study|Lost to Follow-up|1|||
27776717|NCT01021293|81013415|FG001|Overall Study|Lost to Follow-up|1|||
27776718|NCT00471276|81013416|FG000|Overall Study|Death|2|||
27776719|NCT00471276|81013416|FG000|Overall Study|Adverse Event|16|||
27776720|NCT00471276|81013416|FG000|Overall Study|Protocol Violation|1|||
27776721|NCT00471276|81013416|FG000|Overall Study|Objective progression or relapse|54|||
27776722|NCT00471276|81013416|FG000|Overall Study|Global deterioration of health status|1|||
27776723|NCT00471276|81013416|FG000|Overall Study|Other|3|||
27776724|NCT00471276|81013416|FG000|Overall Study|Refused treatment|6|||
27776725|NCT01017549|81013417|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
27776726|NCT01017549|81013417|FG000|One-year Follow-up|Lost to Follow-up|2|||
27776727|NCT01017549|81013417|FG000|One-year Follow-up|Withdrawal by Subject|5|||
27776728|NCT01017549|81013417|FG000|5 Year Follow-up|Lost to Follow-up|9|||
27776729|NCT01017549|81013417|FG000|5 Year Follow-up|Mastectomy|3|||
27776730|NCT01426009|81013420|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
27776731|NCT01426009|81013420|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
27776732|NCT01426009|81013420|FG000|Washout 1|Withdrawal by Subject|1|||
27776733|NCT01426009|81013420|FG000|Washout 1|Personal Reasons|1|||
27776734|NCT01426009|81013420|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
27776735|NCT01426009|81013420|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
27776736|NCT01426009|81013420|FG000|Washout 2|electrive surgery|1|||
27862454|NCT02383810|81329510|FG006|Overall Study|Lost to Follow-up|0|||
27862455|NCT02383810|81329511|FG007|Overall Study|Lost to Follow-up|0|||
27776737|NCT01426009|81013420|FG000|Washout 3|personal reasons|1|||
27862456|NCT02383810|81329504|FG000|Overall Study|other|0|||
27665697|NCT00115336|80612241|FG001|Overall Study|Hospital discharge before study drug|1|||
27862457|NCT02383810|81329505|FG001|Overall Study|other|0|||
27862458|NCT02383810|81329506|FG002|Overall Study|other|0|||
27862459|NCT02383810|81329507|FG003|Overall Study|other|2|||
27862460|NCT02383810|81329508|FG004|Overall Study|other|0|||
27862461|NCT02383810|81329509|FG005|Overall Study|other|0|||
27776738|NCT01426009|81013420|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
27776739|NCT01426009|81013420|FG000|Washout 4|Lost to Follow-up|1|||
27776740|NCT02060903|81013421|FG000|Overall Study|Lost to Follow-up|4|||
27776741|NCT02060903|81013422|FG001|Overall Study|Lost to Follow-up|0|||
27776742|NCT02060903|81013421|FG000|Overall Study|Withdrawal by Subject|0|||
27776743|NCT02060903|81013422|FG001|Overall Study|Withdrawal by Subject|7|||
27776744|NCT03196973|81013423|FG000|Overall Study|Adverse Event|1|||
27776745|NCT03196973|81013424|FG001|Overall Study|Adverse Event|1|||
27776746|NCT03196973|81013425|FG002|Overall Study|Adverse Event|2|||
27776747|NCT03196973|81013423|FG000|Overall Study|Lack of Efficacy|2|||
27862462|NCT02383810|81329510|FG006|Overall Study|other|0|||
27862463|NCT02383810|81329511|FG007|Overall Study|other|0|||
27862464|NCT02383810|81329504|FG000|Overall Study|subject did not receive study treatment|0|||
27862465|NCT02383810|81329505|FG001|Overall Study|subject did not receive study treatment|1|||
27862466|NCT02383810|81329506|FG002|Overall Study|subject did not receive study treatment|0|||
27862467|NCT02383810|81329507|FG003|Overall Study|subject did not receive study treatment|0|||
27862468|NCT02383810|81329508|FG004|Overall Study|subject did not receive study treatment|0|||
27862469|NCT02383810|81329509|FG005|Overall Study|subject did not receive study treatment|0|||
27862470|NCT02383810|81329510|FG006|Overall Study|subject did not receive study treatment|0|||
27862471|NCT02383810|81329511|FG007|Overall Study|subject did not receive study treatment|0|||
27862472|NCT01422187|81329513|FG000|Overall Study|Personal reason|1|||
27862473|NCT01422187|81329514|FG001|Overall Study|Personal reason|0|||
27862474|NCT01422187|81329515|FG002|Overall Study|Personal reason|0|||
27862475|NCT01422187|81329513|FG000|Overall Study|Lost to Follow-up|0|||
27862476|NCT01422187|81329514|FG001|Overall Study|Lost to Follow-up|1|||
27862477|NCT01422187|81329515|FG002|Overall Study|Lost to Follow-up|0|||
27862478|NCT02242045|81329516|FG000|Overall Study|Investigator's Discretion|1|||
27862479|NCT02242045|81329516|FG000|Overall Study|Progressive Disease|2|||
27862480|NCT02242045|81329516|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
27862481|NCT02242045|81329516|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
27862482|NCT00384930|81329517|FG000|Overall Study|Adverse Event|5|||
27862483|NCT00384930|81329518|FG001|Overall Study|Adverse Event|4|||
27862484|NCT00384930|81329519|FG002|Overall Study|Adverse Event|12|||
27862485|NCT00384930|81329520|FG003|Overall Study|Adverse Event|11|||
27862486|NCT00384930|81329521|FG004|Overall Study|Adverse Event|14|||
27862487|NCT00384930|81329517|FG000|Overall Study|Entry Criteria Not Met|2|||
27862488|NCT00384930|81329518|FG001|Overall Study|Entry Criteria Not Met|6|||
27862489|NCT00384930|81329519|FG002|Overall Study|Entry Criteria Not Met|7|||
27862490|NCT00384930|81329520|FG003|Overall Study|Entry Criteria Not Met|8|||
27862491|NCT00384930|81329521|FG004|Overall Study|Entry Criteria Not Met|4|||
27776748|NCT03196973|81013424|FG001|Overall Study|Lack of Efficacy|6|||
27776749|NCT03196973|81013425|FG002|Overall Study|Lack of Efficacy|1|||
27776750|NCT03196973|81013423|FG000|Overall Study|Lost to Follow-up|4|||
27776751|NCT03196973|81013424|FG001|Overall Study|Lost to Follow-up|3|||
27776752|NCT03196973|81013425|FG002|Overall Study|Lost to Follow-up|2|||
27776753|NCT03196973|81013423|FG000|Overall Study|Consent withdrawn|2|||
27776754|NCT03196973|81013424|FG001|Overall Study|Consent withdrawn|1|||
27776755|NCT03196973|81013425|FG002|Overall Study|Consent withdrawn|0|||
27776756|NCT03196973|81013423|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
27776757|NCT03196973|81013424|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
27776758|NCT03196973|81013425|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
27776759|NCT01875874|81013426|FG000|Overall Study|Death|3|||
27776760|NCT02092324|81013427|FG000|Overall Study|Adverse Event|1|||
27776761|NCT02092324|81013427|FG000|Overall Study|Lack of Efficacy|6|||
27776762|NCT02092324|81013427|FG000|Overall Study|Proceed to Transplant|3|||
27776763|NCT02092324|81013427|FG000|Overall Study|Physician Decision|7|||
27776764|NCT02092324|81013427|FG000|Overall Study|Misdiagnosis|2|||
27776765|NCT02590406|81013428|FG000|Overall Study|Adverse Event|1|||
27776766|NCT02590406|81013429|FG001|Overall Study|Adverse Event|0|||
27776767|NCT02590406|81013428|FG000|Overall Study|Saturometer malfunction|0|||
27776768|NCT02590406|81013429|FG001|Overall Study|Saturometer malfunction|1|||
27776769|NCT02139280|81013430|FG000|Overall Study|No longer eligible|2|||
27776770|NCT02139280|81013431|FG001|Overall Study|No longer eligible|0|||
27776771|NCT03702166|81013434|FG000|Overall Study|Lost to Follow-up|1|||
27862492|NCT00384930|81329517|FG000|Overall Study|Lack of Efficacy|1|||
27862493|NCT00384930|81329518|FG001|Overall Study|Lack of Efficacy|1|||
27862494|NCT00384930|81329519|FG002|Overall Study|Lack of Efficacy|2|||
27862495|NCT00384930|81329520|FG003|Overall Study|Lack of Efficacy|1|||
27862496|NCT00384930|81329521|FG004|Overall Study|Lack of Efficacy|2|||
27862497|NCT00384930|81329517|FG000|Overall Study|Lost to Follow-up|5|||
27862498|NCT00384930|81329518|FG001|Overall Study|Lost to Follow-up|3|||
27776772|NCT03702166|81013434|FG000|Overall Study|Withdrawal by Subject|1|||
27862499|NCT00384930|81329519|FG002|Overall Study|Lost to Follow-up|0|||
27776773|NCT00537810|81013445|FG000|Overall Study|Withdrawal by Subject|4|||
27776774|NCT00537810|81013446|FG001|Overall Study|Withdrawal by Subject|11|||
27776775|NCT00537810|81013447|FG002|Overall Study|Withdrawal by Subject|4|||
27776776|NCT00537810|81013448|FG003|Overall Study|Withdrawal by Subject|3|||
27776777|NCT00537810|81013445|FG000|Overall Study|Medically withdrawn|2|||
27776778|NCT00537810|81013446|FG001|Overall Study|Medically withdrawn|2|||
27862500|NCT00384930|81329520|FG003|Overall Study|Lost to Follow-up|4|||
27862501|NCT00384930|81329521|FG004|Overall Study|Lost to Follow-up|6|||
27862502|NCT00384930|81329517|FG000|Overall Study|Physician Decision|0|||
27862503|NCT00384930|81329518|FG001|Overall Study|Physician Decision|1|||
27862504|NCT00384930|81329519|FG002|Overall Study|Physician Decision|1|||
27862505|NCT00384930|81329520|FG003|Overall Study|Physician Decision|0|||
27862506|NCT00384930|81329521|FG004|Overall Study|Physician Decision|1|||
27862507|NCT00384930|81329517|FG000|Overall Study|Protocol Violation|1|||
27862508|NCT00384930|81329518|FG001|Overall Study|Protocol Violation|0|||
27862509|NCT00384930|81329519|FG002|Overall Study|Protocol Violation|1|||
27862510|NCT00384930|81329520|FG003|Overall Study|Protocol Violation|6|||
27862511|NCT00384930|81329521|FG004|Overall Study|Protocol Violation|4|||
27862512|NCT00384930|81329517|FG000|Overall Study|Sponsor Decision|3|||
27862513|NCT00384930|81329518|FG001|Overall Study|Sponsor Decision|4|||
27862514|NCT00384930|81329519|FG002|Overall Study|Sponsor Decision|0|||
27862515|NCT00384930|81329520|FG003|Overall Study|Sponsor Decision|5|||
27862516|NCT00384930|81329521|FG004|Overall Study|Sponsor Decision|0|||
27862517|NCT00384930|81329517|FG000|Overall Study|Withdrawal by Subject|9|||
27862518|NCT00384930|81329518|FG001|Overall Study|Withdrawal by Subject|7|||
27862519|NCT00384930|81329519|FG002|Overall Study|Withdrawal by Subject|7|||
27862520|NCT00384930|81329520|FG003|Overall Study|Withdrawal by Subject|6|||
27862521|NCT00384930|81329521|FG004|Overall Study|Withdrawal by Subject|16|||
27862522|NCT00384930|81329517|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
27862523|NCT00384930|81329518|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
27862524|NCT00384930|81329519|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
27862525|NCT00384930|81329520|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
27862526|NCT00384930|81329521|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
27862527|NCT02437903|81329522|FG000|Overall Study|Adverse Event|1|||
27862528|NCT02437903|81329522|FG000|Overall Study|Withdrawal by Subject|1|||
27862529|NCT02437903|81329522|FG000|Overall Study|Lost to Follow-up|3|||
27862530|NCT02648932|81329523|FG000|Overall Study|No transplant|3|||
27862531|NCT02648932|81329524|FG001|Overall Study|No transplant|1|||
27862532|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
27862533|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
27862534|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
27665698|NCT01388478|80612243|FG000|Overall Study|Adverse Event|4|||
27776779|NCT00537810|81013447|FG002|Overall Study|Medically withdrawn|0|||
27776780|NCT00537810|81013448|FG003|Overall Study|Medically withdrawn|1|||
27776781|NCT00806494|81013449|FG000|Overall Study|Adverse Event|29|||
27776782|NCT00806494|81013449|FG000|Overall Study|Lack of Efficacy|6|||
27776783|NCT00806494|81013449|FG000|Overall Study|Lost to Follow-up|10|||
27862535|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
27862536|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
27862537|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
27862538|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
27862539|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
27862540|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
27862541|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27967297|NCT03333252|81710806|FG000|Overall Study|Lack of Efficacy|8|||
27967298|NCT03333252|81710807|FG001|Overall Study|Lack of Efficacy|4|||
27776784|NCT00806494|81013449|FG000|Overall Study|Other|30|||
27776785|NCT00806494|81013449|FG000|Overall Study|Withdrawal by Subject|5|||
27862542|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
27862543|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27862544|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27862545|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27967299|NCT03333252|81710808|FG002|Overall Study|Lack of Efficacy|0|||
27967300|NCT03333252|81710809|FG003|Overall Study|Lack of Efficacy|7|||
27967301|NCT03333252|81710806|FG000|Overall Study|Lost to Follow-up|0|||
27967302|NCT03333252|81710807|FG001|Overall Study|Lost to Follow-up|5|||
27967303|NCT03333252|81710808|FG002|Overall Study|Lost to Follow-up|9|||
27967304|NCT03333252|81710809|FG003|Overall Study|Lost to Follow-up|3|||
27967305|NCT03333252|81710806|FG000|Overall Study|Withdrawal by Subject|14|||
27967306|NCT03333252|81710807|FG001|Overall Study|Withdrawal by Subject|24|||
27967307|NCT03333252|81710808|FG002|Overall Study|Withdrawal by Subject|11|||
27967308|NCT03333252|81710809|FG003|Overall Study|Withdrawal by Subject|17|||
27776786|NCT01572480|81013451|FG000|Participants Enrolled|Withdrawal by Subject|1|||
27967309|NCT02379988|81710819|FG000|Overall Study|Not eligible|1|||
27967310|NCT00765037|81710822|FG000|Overall Study|Lost to Follow-up|5|||
27862546|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27862547|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27862548|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27862549|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
27862550|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862551|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
27862552|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862553|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
27862554|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862555|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862556|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862557|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862558|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862559|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862560|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
27862561|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862562|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
27862563|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862564|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862565|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862566|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862567|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
27862568|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
27862569|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
27862570|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
27862571|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862572|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
27862573|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862574|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862575|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862576|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862577|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862578|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
27862579|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862580|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862581|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862582|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862583|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862584|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862585|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
27862586|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862587|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862588|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862589|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
27665699|NCT01388478|80612243|FG000|Overall Study|Withdrawal by Subject|1|||
27665700|NCT01161628|80612245|FG000|Overall Study|Death|6|||
27862590|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862591|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862592|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862593|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862594|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862595|NCT03893565|81329525|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27862596|NCT03893565|81329526|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
27862597|NCT03893565|81329527|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
27862598|NCT03893565|81329528|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
27665701|NCT01161628|80612245|FG000|Overall Study|Lack of Efficacy|2|||
27665702|NCT00337285|80612253|FG000|Overall Study|Withdrawal by Subject|42|||
27665703|NCT00337285|80612253|FG000|Overall Study|Lost to Follow-up|41|||
27665704|NCT00337285|80612253|FG000|Overall Study|Adverse Event|28|||
27665705|NCT00337285|80612253|FG000|Overall Study|Protocol Violation|27|||
27665706|NCT00337285|80612253|FG000|Overall Study|Lack of Efficacy|11|||
27776787|NCT01572480|81013451|FG000|Drug Administration|Discontinued drug/Off Study|1|||
27776788|NCT01572480|81013451|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
27776789|NCT01572480|81013451|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
27776790|NCT02116582|81013452|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
27776791|NCT02116582|81013452|FG000|Overall Study|Adverse Event|22|||
27776792|NCT02116582|81013452|FG000|Overall Study|Death|9|||
27776793|NCT02116582|81013452|FG000|Overall Study|Progressive Disease|148|||
27776794|NCT02116582|81013452|FG000|Overall Study|Protocol Violation|3|||
27776795|NCT02116582|81013452|FG000|Overall Study|Withdrawal by Subject|8|||
27776796|NCT02116582|81013452|FG000|Overall Study|Other: Miscellaneous|11|||
27776797|NCT02116582|81013452|FG000|Overall Study|Lost to Follow-up|1|||
27776798|NCT02116582|81013452|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
27862599|NCT03893565|81329529|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27776799|NCT00424099|81013455|FG000|Overall Study|Adverse Event|0|||
27776800|NCT00424099|81013456|FG001|Overall Study|Adverse Event|1|||
27776801|NCT00424099|81013457|FG002|Overall Study|Adverse Event|1|||
27776802|NCT00424099|81013458|FG003|Overall Study|Adverse Event|0|||
27776803|NCT00424099|81013455|FG000|Overall Study|Death|0|||
27776804|NCT00424099|81013456|FG001|Overall Study|Death|1|||
27776805|NCT00424099|81013457|FG002|Overall Study|Death|0|||
27776806|NCT00424099|81013458|FG003|Overall Study|Death|0|||
27776807|NCT00424099|81013455|FG000|Overall Study|Illness|2|||
27776808|NCT00424099|81013456|FG001|Overall Study|Illness|0|||
27776809|NCT00424099|81013457|FG002|Overall Study|Illness|1|||
27776810|NCT00424099|81013458|FG003|Overall Study|Illness|4|||
27776811|NCT00424099|81013455|FG000|Overall Study|Lost to Follow-up|0|||
27776812|NCT00424099|81013456|FG001|Overall Study|Lost to Follow-up|0|||
27776813|NCT00424099|81013457|FG002|Overall Study|Lost to Follow-up|3|||
27776814|NCT00424099|81013458|FG003|Overall Study|Lost to Follow-up|0|||
27776815|NCT00424099|81013455|FG000|Overall Study|Hospitalized|1|||
27776816|NCT00424099|81013456|FG001|Overall Study|Hospitalized|2|||
27776817|NCT00424099|81013457|FG002|Overall Study|Hospitalized|1|||
27776818|NCT00424099|81013458|FG003|Overall Study|Hospitalized|3|||
27776819|NCT00424099|81013455|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
27776820|NCT00424099|81013456|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
27776821|NCT00424099|81013457|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
27776822|NCT00424099|81013458|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
27776823|NCT00424099|81013455|FG000|Overall Study|Withdrawal by Subject|1|||
27776824|NCT00424099|81013456|FG001|Overall Study|Withdrawal by Subject|9|||
27776825|NCT00424099|81013457|FG002|Overall Study|Withdrawal by Subject|4|||
27776826|NCT00424099|81013458|FG003|Overall Study|Withdrawal by Subject|6|||
27776827|NCT00424099|81013455|FG000|Overall Study|Physician Decision|0|||
27776828|NCT00424099|81013456|FG001|Overall Study|Physician Decision|0|||
27776829|NCT00424099|81013457|FG002|Overall Study|Physician Decision|1|||
27776830|NCT00424099|81013458|FG003|Overall Study|Physician Decision|0|||
27776831|NCT00424099|81013455|FG000|Overall Study|Missing|0|||
27776832|NCT00424099|81013456|FG001|Overall Study|Missing|0|||
27776833|NCT00424099|81013457|FG002|Overall Study|Missing|1|||
27776834|NCT00424099|81013458|FG003|Overall Study|Missing|0|||
27776835|NCT03523715|81013459|FG000|Overall Study|Lost to Follow-up|11|||
27776836|NCT03523715|81013460|FG001|Overall Study|Lost to Follow-up|14|||
27776837|NCT03523715|81013459|FG000|Overall Study|Did not meet inclusion criteria|1|||
27776838|NCT03523715|81013460|FG001|Overall Study|Did not meet inclusion criteria|0|||
27776839|NCT03523715|81013459|FG000|Overall Study|Internally inconsistent reporting|0|||
27776840|NCT03523715|81013460|FG001|Overall Study|Internally inconsistent reporting|2|||
27776841|NCT02954952|81013461|FG000|Overall Study|Withdrawal by Subject|1|||
27776842|NCT02954952|81013462|FG001|Overall Study|Withdrawal by Subject|0|||
27776843|NCT02954952|81013463|FG002|Overall Study|Withdrawal by Subject|0|||
27862600|NCT03893565|81329530|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27862601|NCT03893565|81329531|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27570027|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27776844|NCT02954952|81013461|FG000|Overall Study|No data collected|0|||
27776845|NCT02954952|81013462|FG001|Overall Study|No data collected|1|||
27776846|NCT02954952|81013463|FG002|Overall Study|No data collected|0|||
27776847|NCT02355665|81013464|FG000|Overall Study|Adverse Event|16|||
27776848|NCT02355665|81013465|FG001|Overall Study|Adverse Event|24|||
27776849|NCT02355665|81013464|FG000|Overall Study|Protocol Violation|2|||
27776850|NCT02355665|81013465|FG001|Overall Study|Protocol Violation|0|||
27776851|NCT02355665|81013464|FG000|Overall Study|Withdrawal by Subject|90|||
27862602|NCT03893565|81329532|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27776852|NCT02355665|81013465|FG001|Overall Study|Withdrawal by Subject|100|||
27776853|NCT02355665|81013464|FG000|Overall Study|Lost to Follow-up|131|||
27776854|NCT02355665|81013465|FG001|Overall Study|Lost to Follow-up|103|||
27776855|NCT02355665|81013464|FG000|Overall Study|Death|4|||
27776856|NCT02355665|81013465|FG001|Overall Study|Death|2|||
27776857|NCT02355665|81013464|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
27862603|NCT03893565|81329533|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
27862604|NCT03893565|81329525|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
27862605|NCT03893565|81329526|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
27862606|NCT03893565|81329527|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
27776858|NCT02355665|81013465|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
27776859|NCT01057394|81013466|FG000|Overall Study|Not eligible|0|||
27776860|NCT01057394|81013467|FG001|Overall Study|Not eligible|2|||
27776861|NCT00957723|81013468|FG000|Overall Study|Death|3|||
27776862|NCT00957723|81013468|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
27776863|NCT00957723|81013468|FG000|Overall Study|Lost to Follow-up|8|||
27776864|NCT00957723|81013468|FG000|Overall Study|Withdrawal by Subject|24|||
27776865|NCT00957723|81013468|FG000|Overall Study|Investigative Site Terminated|61|||
27776866|NCT00957723|81013468|FG000|Overall Study|Intercurrent Illness|2|||
27776867|NCT00957723|81013468|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
27776868|NCT01997892|81013469|FG000|Overall Study|Physician Decision|2|||
27776869|NCT01997892|81013469|FG000|Overall Study|Lost to Follow-up|6|||
27776870|NCT01997892|81013469|FG000|Overall Study|Death|14|||
27776871|NCT01997892|81013469|FG000|Overall Study|Renal transplant|8|||
27776872|NCT01997892|81013469|FG000|Overall Study|Other|3|||
27776873|NCT01997892|81013469|FG000|Overall Study|Study completion data not recorded|35|||
27776874|NCT02574520|81013470|FG000|Overall Study|Not dosed|2|||
27776875|NCT02574520|81013471|FG001|Overall Study|Not dosed|0|||
27776876|NCT02574520|81013472|FG002|Overall Study|Not dosed|5|||
27776877|NCT02574520|81013473|FG003|Overall Study|Not dosed|4|||
27776878|NCT02574520|81013470|FG000|Overall Study|Adverse Event|0|||
27776879|NCT02574520|81013471|FG001|Overall Study|Adverse Event|0|||
27776880|NCT02574520|81013472|FG002|Overall Study|Adverse Event|0|||
27776881|NCT02574520|81013473|FG003|Overall Study|Adverse Event|1|||
27776882|NCT02574520|81013470|FG000|Overall Study|Withdrawal by Subject|0|||
27776883|NCT02574520|81013471|FG001|Overall Study|Withdrawal by Subject|0|||
27776884|NCT02574520|81013472|FG002|Overall Study|Withdrawal by Subject|0|||
27776885|NCT02574520|81013473|FG003|Overall Study|Withdrawal by Subject|1|||
27776886|NCT02574520|81013470|FG000|Overall Study|Other|0|||
27776887|NCT02574520|81013471|FG001|Overall Study|Other|0|||
27776888|NCT02574520|81013472|FG002|Overall Study|Other|0|||
27776889|NCT02574520|81013473|FG003|Overall Study|Other|2|||
27776890|NCT02158728|81013476|FG000|Overall Study|no procedure according to CIP done|3|||
27776891|NCT02158728|81013476|FG000|Overall Study|no qualified dataset|24|||
27776892|NCT00517634|81013477|FG000|Second Treatment Period|Withdrawal by Subject|0|||
27776893|NCT00517634|81013478|FG001|Second Treatment Period|Withdrawal by Subject|0|||
27776894|NCT00517634|81013479|FG002|Second Treatment Period|Withdrawal by Subject|0|||
27776895|NCT00517634|81013480|FG003|Second Treatment Period|Withdrawal by Subject|0|||
27776896|NCT00517634|81013481|FG004|Second Treatment Period|Withdrawal by Subject|1|||
27776897|NCT00517634|81013482|FG005|Second Treatment Period|Withdrawal by Subject|0|||
27776898|NCT03345849|81013486|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
27776899|NCT03345849|81013487|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
27776900|NCT03345849|81013488|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
27776901|NCT03345849|81013489|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
27776902|NCT03345849|81013486|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
27776903|NCT03345849|81013487|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
27776904|NCT03345849|81013488|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
27776905|NCT03345849|81013489|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
27776906|NCT03345849|81013486|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
27776907|NCT03345849|81013487|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
27776908|NCT03345849|81013488|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
27776909|NCT03345849|81013489|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
27776910|NCT03345849|81013486|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
27776911|NCT03345849|81013487|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
27776912|NCT03345849|81013488|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
27776913|NCT03345849|81013489|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
27776914|NCT03345849|81013486|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
27776915|NCT03345849|81013487|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
27776916|NCT03345849|81013488|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
27776917|NCT03345849|81013489|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
27776918|NCT03345849|81013486|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
27776919|NCT03345849|81013487|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
27776920|NCT03345849|81013488|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
27776921|NCT03345849|81013489|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
27776922|NCT03345849|81013486|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
27776923|NCT03345849|81013487|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
27776924|NCT03345849|81013488|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
27862607|NCT03893565|81329528|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
27862608|NCT03893565|81329529|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
27862609|NCT03893565|81329530|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
27862610|NCT03893565|81329531|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
27862611|NCT03893565|81329532|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
27862612|NCT03893565|81329533|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
27862613|NCT03893565|81329525|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862614|NCT03893565|81329526|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862615|NCT03893565|81329527|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862616|NCT03893565|81329528|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862617|NCT03893565|81329529|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862618|NCT03893565|81329530|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862619|NCT03893565|81329531|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
27862620|NCT03893565|81329532|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862621|NCT03893565|81329533|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
27862622|NCT03893565|81329525|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862623|NCT03893565|81329526|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862624|NCT03893565|81329527|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862625|NCT03893565|81329528|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862626|NCT03893565|81329529|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862627|NCT03893565|81329530|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
27862628|NCT03893565|81329531|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
27862629|NCT03893565|81329532|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862630|NCT03893565|81329533|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
27862631|NCT03893565|81329525|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
27862632|NCT03893565|81329526|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
27862633|NCT03893565|81329527|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
27967311|NCT00765037|81710822|FG000|Overall Study|Adverse Event|1|||
27570028|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570029|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570030|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570031|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570032|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
27570033|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570034|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
27570035|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570036|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570037|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570038|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570039|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570040|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570041|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570042|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570043|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570044|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570045|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570046|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570047|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570048|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570049|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27776925|NCT03345849|81013489|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
27776926|NCT03345849|81013486|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
27776927|NCT03345849|81013487|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
27776928|NCT03345849|81013488|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
27776929|NCT03345849|81013489|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
27776930|NCT03345849|81013486|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27776931|NCT03345849|81013487|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27776932|NCT03345849|81013488|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27776933|NCT03345849|81013489|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
27862634|NCT03893565|81329528|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
27862635|NCT03893565|81329529|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
27570050|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570051|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570052|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570053|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570054|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27967312|NCT03655054|81710831|FG000|Overall Study|Lost to Follow-up|1|||
27967313|NCT03928418|81710836|FG000|Overall Study|Lost to Follow-up|5|||
27967314|NCT03928418|81710837|FG001|Overall Study|Lost to Follow-up|3|||
27967315|NCT03928418|81710838|FG002|Overall Study|Lost to Follow-up|5|||
27967316|NCT03928418|81710836|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
27967317|NCT03928418|81710837|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
27967318|NCT03928418|81710838|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
27967319|NCT03931382|81710841|FG000|Overall Study|Equipment malfunction|2|||
27967320|NCT03931382|81710842|FG001|Overall Study|Equipment malfunction|0|||
27967321|NCT03931382|81710843|FG002|Overall Study|Equipment malfunction|2|||
27967322|NCT03931382|81710841|FG000|Overall Study|Withdrawal by Subject|0|||
27967323|NCT03931382|81710842|FG001|Overall Study|Withdrawal by Subject|1|||
27967324|NCT03931382|81710843|FG002|Overall Study|Withdrawal by Subject|0|||
27967325|NCT03473743|81710844|FG000|Overall Study|Withdrawal by Subject|0|||
27967326|NCT03473743|81710845|FG001|Overall Study|Withdrawal by Subject|0|||
27967327|NCT03473743|81710846|FG002|Overall Study|Withdrawal by Subject|0|||
27967328|NCT03473743|81710847|FG003|Overall Study|Withdrawal by Subject|0|||
27967329|NCT03473743|81710848|FG004|Overall Study|Withdrawal by Subject|0|||
27967330|NCT03473743|81710849|FG005|Overall Study|Withdrawal by Subject|0|||
27967331|NCT03473743|81710850|FG006|Overall Study|Withdrawal by Subject|0|||
27967332|NCT03473743|81710851|FG007|Overall Study|Withdrawal by Subject|3|||
27967333|NCT03473743|81710844|FG000|Overall Study|Other|0|||
27967334|NCT03473743|81710845|FG001|Overall Study|Other|0|||
27967335|NCT03473743|81710846|FG002|Overall Study|Other|0|||
27967336|NCT03473743|81710847|FG003|Overall Study|Other|1|||
27967337|NCT03473743|81710848|FG004|Overall Study|Other|0|||
27967338|NCT03473743|81710849|FG005|Overall Study|Other|0|||
27967339|NCT03473743|81710850|FG006|Overall Study|Other|0|||
27570055|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570056|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
27570057|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
27967340|NCT03473743|81710851|FG007|Overall Study|Other|0|||
27967341|NCT03473743|81710844|FG000|Overall Study|Ongoing|0|||
27570058|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
27570059|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
27570060|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
27570061|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570062|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570063|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570064|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570065|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570066|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570067|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570068|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570069|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570070|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570071|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570072|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570073|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570074|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570075|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570076|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570077|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570078|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570079|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570080|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
27570081|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
27570082|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
27570083|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
27776934|NCT03345849|81013486|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
27967342|NCT03473743|81710845|FG001|Overall Study|Ongoing|0|||
27967343|NCT03473743|81710846|FG002|Overall Study|Ongoing|6|||
27967344|NCT03473743|81710847|FG003|Overall Study|Ongoing|8|||
27967345|NCT03473743|81710848|FG004|Overall Study|Ongoing|1|||
27967346|NCT03473743|81710849|FG005|Overall Study|Ongoing|1|||
27967347|NCT03473743|81710850|FG006|Overall Study|Ongoing|22|||
27967348|NCT03473743|81710851|FG007|Overall Study|Ongoing|24|||
27967349|NCT03473743|81710844|FG000|Overall Study|Randomized but not treated|0|||
27967350|NCT03473743|81710845|FG001|Overall Study|Randomized but not treated|0|||
27967351|NCT03473743|81710846|FG002|Overall Study|Randomized but not treated|0|||
27594127|NCT01816594|80352449|FG000|Overall Study|Local Progress|0|||
27776935|NCT03345849|81013487|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
27594128|NCT01816594|80352450|FG001|Overall Study|Local Progress|2|||
27594129|NCT01816594|80352449|FG000|Overall Study|Adverse Event|9|||
27594130|NCT01816594|80352450|FG001|Overall Study|Adverse Event|0|||
27594131|NCT01816594|80352449|FG000|Overall Study|Withdrawal by Subject|1|||
27665707|NCT00337285|80612253|FG000|Overall Study|Death|1|||
27665708|NCT00337285|80612253|FG000|Overall Study|Physician Decision|1|||
27665709|NCT00337285|80612253|FG000|Overall Study|Lack of protocol compliance|7|||
27665710|NCT00706914|80612254|FG000|Overall Study|Lack of Efficacy|0|||
27665711|NCT00706914|80612255|FG001|Overall Study|Lack of Efficacy|1|||
27665712|NCT00706914|80612256|FG002|Overall Study|Lack of Efficacy|0|||
27665713|NCT00706914|80612254|FG000|Overall Study|Lost to Follow-up|1|||
27665714|NCT00706914|80612255|FG001|Overall Study|Lost to Follow-up|0|||
27665715|NCT00706914|80612256|FG002|Overall Study|Lost to Follow-up|0|||
27665716|NCT00706914|80612254|FG000|Overall Study|Adverse Event|2|||
27665717|NCT00706914|80612255|FG001|Overall Study|Adverse Event|2|||
27665718|NCT00706914|80612256|FG002|Overall Study|Adverse Event|0|||
27665719|NCT00706914|80612254|FG000|Overall Study|Protocol Violation|3|||
27665720|NCT00706914|80612255|FG001|Overall Study|Protocol Violation|1|||
27665721|NCT00706914|80612256|FG002|Overall Study|Protocol Violation|1|||
27665722|NCT03098797|80612257|FG000|Part 2 Open Label Extension|Adverse Event|2|||
27665723|NCT03098797|80612258|FG001|Part 2 Open Label Extension|Adverse Event|0|||
27665724|NCT04816708|80612259|FG000|Overall Study|Lost to Follow-up|10|||
27665725|NCT04816708|80612260|FG001|Overall Study|Lost to Follow-up|4|||
27665726|NCT00297778|80612264|FG000|Overall Study|Adverse Event|16|||
27665727|NCT00297778|80612265|FG001|Overall Study|Adverse Event|10|||
27665728|NCT00297778|80612264|FG000|Overall Study|Withdrawal by Subject|1|||
27665729|NCT00297778|80612265|FG001|Overall Study|Withdrawal by Subject|5|||
27665730|NCT00297778|80612264|FG000|Overall Study|Lack of Efficacy|2|||
27665731|NCT00297778|80612265|FG001|Overall Study|Lack of Efficacy|1|||
27665732|NCT00297778|80612264|FG000|Overall Study|Non-compliant with trial protocol|0|||
27665733|NCT00297778|80612265|FG001|Overall Study|Non-compliant with trial protocol|3|||
27665734|NCT00297778|80612264|FG000|Overall Study|Other|0|||
27665735|NCT00297778|80612265|FG001|Overall Study|Other|1|||
27665736|NCT00695136|80612266|FG000|Overall Study|Withdrawal by Subject|1|||
27665737|NCT00695136|80612266|FG000|Overall Study|unrelated adverse event|1|||
27665738|NCT02878590|80612267|FG000|Overall Study|Withdrawal by Subject|2|||
27665739|NCT01020747|80612271|FG000|Overall Study|Withdrawal by Subject|1|||
27665740|NCT03082612|80612272|FG000|Overall Study|Lost to Follow-up|2|||
27665741|NCT03082612|80612273|FG001|Overall Study|Lost to Follow-up|0|||
27665742|NCT04052997|80615377|FG000|Overall Study|Withdrawal by Subject|17|||
27665743|NCT04052997|80615377|FG000|Overall Study|Physician Decision|50|||
27665744|NCT04052997|80615377|FG000|Overall Study|Death|43|||
27665745|NCT04052997|80615377|FG000|Overall Study|Lost to Follow-up|5|||
27665746|NCT04052997|80615377|FG000|Overall Study|Progression of Disease|1|||
27665747|NCT00474383|80615378|FG000|Main Study|Adverse Event|11|||
27665748|NCT00474383|80615379|FG001|Main Study|Adverse Event|0|||
27665749|NCT00474383|80615378|FG000|Main Study|Symptomatic Deterioration|1|||
27665750|NCT00474383|80615379|FG001|Main Study|Symptomatic Deterioration|0|||
27776936|NCT03345849|81013488|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
27776937|NCT03345849|81013489|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
27862636|NCT03893565|81329530|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
27862637|NCT03893565|81329531|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
27570084|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
27570085|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570086|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570087|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570088|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570089|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570090|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570091|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570092|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570093|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570094|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570095|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570096|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570097|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570098|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570099|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570100|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570101|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570102|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570103|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570104|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
27570105|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570106|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
27665751|NCT00474383|80615378|FG000|Main Study|Progressive Disease|23|||
27665752|NCT00474383|80615379|FG001|Main Study|Progressive Disease|0|||
27665753|NCT00474383|80615378|FG000|Main Study|Other|1|||
27665754|NCT00474383|80615379|FG001|Main Study|Other|0|||
27665755|NCT00474383|80615378|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
27665756|NCT00474383|80615379|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
27665757|NCT00474383|80615378|FG000|Extension|Progressive Disease|0|||
27665758|NCT00474383|80615379|FG001|Extension|Progressive Disease|5|||
27665759|NCT00461123|80615380|FG000|Overall Study|Adverse Event|1|||
27665760|NCT00461123|80615381|FG001|Overall Study|Adverse Event|0|||
27665761|NCT00461123|80615380|FG000|Overall Study|Lost to Follow-up|1|||
27665762|NCT00461123|80615381|FG001|Overall Study|Lost to Follow-up|1|||
27665763|NCT00461123|80615380|FG000|Overall Study|Protocol Violation|3|||
27665764|NCT00461123|80615381|FG001|Overall Study|Protocol Violation|2|||
27665765|NCT00461123|80615380|FG000|Overall Study|Withdrawal by Subject|1|||
27665766|NCT00461123|80615381|FG001|Overall Study|Withdrawal by Subject|3|||
27665767|NCT00511797|80615382|FG000|Overall Study|Adverse Event|1|||
27665768|NCT00511797|80615383|FG001|Overall Study|Adverse Event|2|||
27665769|NCT00511797|80615384|FG002|Overall Study|Adverse Event|2|||
27665770|NCT00511797|80615385|FG003|Overall Study|Adverse Event|2|||
27665771|NCT00511797|80615382|FG000|Overall Study|Lost to Follow-up|1|||
27665772|NCT00511797|80615383|FG001|Overall Study|Lost to Follow-up|0|||
27665773|NCT00511797|80615384|FG002|Overall Study|Lost to Follow-up|0|||
27665774|NCT00511797|80615385|FG003|Overall Study|Lost to Follow-up|1|||
27665775|NCT00511797|80615382|FG000|Overall Study|Pregnancy|0|||
27665776|NCT00511797|80615383|FG001|Overall Study|Pregnancy|0|||
27665777|NCT00511797|80615384|FG002|Overall Study|Pregnancy|0|||
27665778|NCT00511797|80615385|FG003|Overall Study|Pregnancy|1|||
27665779|NCT00511797|80615382|FG000|Overall Study|Protocol Violation|0|||
27665780|NCT00511797|80615383|FG001|Overall Study|Protocol Violation|2|||
27665781|NCT00511797|80615384|FG002|Overall Study|Protocol Violation|2|||
27665782|NCT00511797|80615385|FG003|Overall Study|Protocol Violation|3|||
27665783|NCT00511797|80615382|FG000|Overall Study|Withdrawal by Subject|3|||
27665784|NCT00511797|80615383|FG001|Overall Study|Withdrawal by Subject|3|||
27665785|NCT00511797|80615384|FG002|Overall Study|Withdrawal by Subject|4|||
27665786|NCT00511797|80615385|FG003|Overall Study|Withdrawal by Subject|2|||
27665787|NCT00511797|80615382|FG000|Overall Study|Never dispensed|1|||
27665788|NCT00511797|80615383|FG001|Overall Study|Never dispensed|0|||
27665789|NCT00511797|80615384|FG002|Overall Study|Never dispensed|1|||
27665790|NCT00511797|80615385|FG003|Overall Study|Never dispensed|3|||
27665791|NCT00511797|80615382|FG000|Overall Study|Study drug not taken|0|||
27665792|NCT00511797|80615383|FG001|Overall Study|Study drug not taken|1|||
27665793|NCT00511797|80615384|FG002|Overall Study|Study drug not taken|0|||
27665794|NCT00511797|80615385|FG003|Overall Study|Study drug not taken|1|||
27665795|NCT00511797|80615382|FG000|Overall Study|Partially missing diary|0|||
27665796|NCT00511797|80615383|FG001|Overall Study|Partially missing diary|0|||
27665797|NCT00511797|80615384|FG002|Overall Study|Partially missing diary|1|||
27665798|NCT00511797|80615385|FG003|Overall Study|Partially missing diary|0|||
27665799|NCT00511797|80615382|FG000|Overall Study|Other (moving etc)|1|||
27665800|NCT00511797|80615383|FG001|Overall Study|Other (moving etc)|0|||
27665801|NCT00511797|80615384|FG002|Overall Study|Other (moving etc)|1|||
27665802|NCT00511797|80615385|FG003|Overall Study|Other (moving etc)|2|||
27665803|NCT01087814|80615386|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
27665804|NCT01087814|80615387|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
27665805|NCT01087814|80615386|FG000|Second Intervention (5 Days)|Physician Decision|1|||
27665806|NCT01087814|80615387|FG001|Second Intervention (5 Days)|Physician Decision|0|||
27665807|NCT04191148|80615390|FG000|Overall Study|Withdrawal by Subject|1|||
27665808|NCT04191148|80615391|FG001|Overall Study|Withdrawal by Subject|0|||
27665809|NCT04191148|80615390|FG000|Overall Study|Adverse Event|1|||
27665810|NCT04191148|80615391|FG001|Overall Study|Adverse Event|0|||
27665811|NCT00087555|80615392|FG000|Overall Study|Adverse Event|3|||
27665812|NCT00087555|80615393|FG001|Overall Study|Adverse Event|6|||
27665813|NCT00087555|80615394|FG002|Overall Study|Adverse Event|14|||
27665814|NCT00087555|80615392|FG000|Overall Study|Lost to Follow-up|0|||
27665815|NCT00087555|80615393|FG001|Overall Study|Lost to Follow-up|1|||
27665816|NCT00087555|80615394|FG002|Overall Study|Lost to Follow-up|1|||
27665817|NCT00087555|80615392|FG000|Overall Study|Non - Compliance|1|||
27665818|NCT00087555|80615393|FG001|Overall Study|Non - Compliance|0|||
27665819|NCT00087555|80615394|FG002|Overall Study|Non - Compliance|0|||
27776938|NCT03345849|81013486|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
27665820|NCT00087555|80615392|FG000|Overall Study|Protocol Violation|0|||
27665821|NCT00087555|80615393|FG001|Overall Study|Protocol Violation|0|||
27665822|NCT00087555|80615394|FG002|Overall Study|Protocol Violation|2|||
27665823|NCT00087555|80615392|FG000|Overall Study|Screen Failure|1|||
27665824|NCT00087555|80615393|FG001|Overall Study|Screen Failure|1|||
27665825|NCT00087555|80615394|FG002|Overall Study|Screen Failure|0|||
27665826|NCT00087555|80615392|FG000|Overall Study|Pregnancy|0|||
27665827|NCT00087555|80615393|FG001|Overall Study|Pregnancy|1|||
27665828|NCT00087555|80615394|FG002|Overall Study|Pregnancy|1|||
27665829|NCT00087555|80615392|FG000|Overall Study|Withdrawal by Subject|3|||
27665830|NCT00087555|80615393|FG001|Overall Study|Withdrawal by Subject|2|||
27665831|NCT00087555|80615394|FG002|Overall Study|Withdrawal by Subject|1|||
27665832|NCT00087555|80615392|FG000|Overall Study|Lack of Efficacy|2|||
27665833|NCT00087555|80615393|FG001|Overall Study|Lack of Efficacy|0|||
27665834|NCT00087555|80615394|FG002|Overall Study|Lack of Efficacy|1|||
27665835|NCT00087555|80615392|FG000|Overall Study|Non Compliance|0|||
27776939|NCT03345849|81013487|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
27776940|NCT03345849|81013488|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
27776941|NCT03345849|81013489|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
27776942|NCT02463331|81013490|FG000|Overall Study|Adverse Event|4|||
27776943|NCT02463331|81013491|FG001|Overall Study|Adverse Event|2|||
27776944|NCT02463331|81013490|FG000|Overall Study|Lost to Follow-up|1|||
27776945|NCT02463331|81013491|FG001|Overall Study|Lost to Follow-up|1|||
27776946|NCT02463331|81013490|FG000|Overall Study|Pregnancy|2|||
27776947|NCT02463331|81013491|FG001|Overall Study|Pregnancy|3|||
27776948|NCT02463331|81013490|FG000|Overall Study|Lack of Efficacy|6|||
27776949|NCT02463331|81013491|FG001|Overall Study|Lack of Efficacy|0|||
27776950|NCT02463331|81013490|FG000|Overall Study|Physician Decision|3|||
27862638|NCT03893565|81329532|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
27862639|NCT03893565|81329533|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
27862640|NCT03893565|81329525|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862641|NCT03893565|81329526|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862642|NCT03893565|81329527|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862643|NCT03893565|81329528|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27776951|NCT02463331|81013491|FG001|Overall Study|Physician Decision|0|||
27776952|NCT00994890|81013492|FG000|Overall Study|Adverse Event|13|||
27776953|NCT00994890|81013493|FG001|Overall Study|Adverse Event|9|||
27862644|NCT03893565|81329529|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862645|NCT03893565|81329530|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862646|NCT03893565|81329531|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862647|NCT03893565|81329532|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
27862648|NCT03893565|81329533|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
27862649|NCT03893565|81329525|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862650|NCT03893565|81329526|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862651|NCT03893565|81329527|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862652|NCT03893565|81329528|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862653|NCT03893565|81329529|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862654|NCT03893565|81329530|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862655|NCT03893565|81329531|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862656|NCT03893565|81329532|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
27862657|NCT03893565|81329533|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
27862658|NCT03893565|81329525|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862659|NCT03893565|81329526|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862660|NCT03893565|81329527|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862661|NCT03893565|81329528|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862662|NCT03893565|81329529|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862663|NCT03893565|81329530|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862664|NCT03893565|81329531|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862665|NCT03893565|81329532|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
27862666|NCT03893565|81329533|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
27862667|NCT03893565|81329525|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862668|NCT03893565|81329526|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862669|NCT03893565|81329527|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862670|NCT03893565|81329528|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862671|NCT03893565|81329529|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862672|NCT03893565|81329530|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862673|NCT03893565|81329531|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27862674|NCT03893565|81329532|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
27665836|NCT00087555|80615393|FG001|Overall Study|Non Compliance|0|||
27776954|NCT00994890|81013494|FG002|Overall Study|Adverse Event|11|||
27776955|NCT00994890|81013492|FG000|Overall Study|Lack of Efficacy|0|||
27776956|NCT00994890|81013493|FG001|Overall Study|Lack of Efficacy|0|||
27776957|NCT00994890|81013494|FG002|Overall Study|Lack of Efficacy|1|||
27776958|NCT00994890|81013492|FG000|Overall Study|Lost to Follow-up|6|||
27776959|NCT00994890|81013493|FG001|Overall Study|Lost to Follow-up|1|||
27665837|NCT00087555|80615394|FG002|Overall Study|Non Compliance|1|||
27776960|NCT00994890|81013494|FG002|Overall Study|Lost to Follow-up|3|||
27776961|NCT00994890|81013492|FG000|Overall Study|No longer willing to participate|8|||
27862675|NCT03893565|81329533|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
27862676|NCT02752087|81329534|FG000|Washout|Physician Decision|1|||
27862677|NCT02752087|81329535|FG001|Washout|Physician Decision|0|||
27862678|NCT04893018|81329537|FG000|Overall Study|Lost to Follow-up|1|||
27862679|NCT04893018|81329538|FG001|Overall Study|Lost to Follow-up|0|||
27862680|NCT04893018|81329537|FG000|Overall Study|Withdrawal by Subject|2|||
27862681|NCT04893018|81329538|FG001|Overall Study|Withdrawal by Subject|0|||
27862682|NCT04893018|81329537|FG000|Overall Study|Study Terminated|1|||
27862683|NCT04893018|81329538|FG001|Overall Study|Study Terminated|2|||
27862684|NCT01716715|81329541|FG000|Overall Study|Never Treated|2|||
27862685|NCT01716715|81329542|FG001|Overall Study|Never Treated|4|||
27862686|NCT02996487|81329543|FG000|Overall Study|Lost to Follow-up|1|||
27862687|NCT02996487|81329544|FG001|Overall Study|Lost to Follow-up|1|||
27862688|NCT02996487|81329545|FG002|Overall Study|Lost to Follow-up|0|||
27862689|NCT02996487|81329543|FG000|Overall Study|Death|0|||
27862690|NCT02996487|81329544|FG001|Overall Study|Death|1|||
27862691|NCT02996487|81329545|FG002|Overall Study|Death|0|||
27862692|NCT02996487|81329543|FG000|Overall Study|Withdrawal by Subject|2|||
27862693|NCT02996487|81329544|FG001|Overall Study|Withdrawal by Subject|3|||
27862694|NCT02996487|81329545|FG002|Overall Study|Withdrawal by Subject|0|||
27862695|NCT01352416|81329547|FG000|Overall Study|Physician Decision|1|||
27862696|NCT01352416|81329548|FG001|Overall Study|Physician Decision|2|||
27862697|NCT01352416|81329549|FG002|Overall Study|Physician Decision|2|||
27862698|NCT01352416|81329550|FG003|Overall Study|Physician Decision|1|||
27862699|NCT00191165|81329551|FG000|Overall Study|Adverse Event|2|||
27862700|NCT00191165|81329552|FG001|Overall Study|Adverse Event|0|||
27862701|NCT00191165|81329551|FG000|Overall Study|Protocol Violation|0|||
27862702|NCT00191165|81329552|FG001|Overall Study|Protocol Violation|1|||
27862703|NCT00191165|81329551|FG000|Overall Study|Participant Moved Away|0|||
27862704|NCT00191165|81329552|FG001|Overall Study|Participant Moved Away|1|||
27862705|NCT03390426|81329553|FG000|Overall Study|Protocol Violation|0|||
27862706|NCT03390426|81329554|FG001|Overall Study|Protocol Violation|1|||
27862707|NCT00879411|81329557|FG000|Overall Study|lost to follow-up (non-AE)|162|||
27862708|NCT00507130|81329559|FG000|Overall Study|Lost to Follow-up|0|||
27862709|NCT00507130|81329560|FG001|Overall Study|Lost to Follow-up|0|||
27862710|NCT00507130|81329561|FG002|Overall Study|Lost to Follow-up|1|||
27862711|NCT00507130|81329562|FG003|Overall Study|Lost to Follow-up|1|||
27862712|NCT00507130|81329559|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
27862713|NCT00507130|81329560|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
27862714|NCT00507130|81329561|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
27862715|NCT00507130|81329562|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
27862716|NCT01814553|81329565|FG000|Overall Study|PD per clinical progression|6|||
27862717|NCT01814553|81329566|FG001|Overall Study|PD per clinical progression|8|||
27862718|NCT01814553|81329565|FG000|Overall Study|Other Adverse Event|4|||
27862719|NCT01814553|81329566|FG001|Overall Study|Other Adverse Event|5|||
27862720|NCT01814553|81329565|FG000|Overall Study|Withdrawal by Subject|1|||
27862721|NCT01814553|81329566|FG001|Overall Study|Withdrawal by Subject|1|||
27862722|NCT01814553|81329565|FG000|Overall Study|Other than stated|7|||
27862723|NCT01814553|81329566|FG001|Overall Study|Other than stated|8|||
27862724|NCT04480021|81329567|FG000|Overall Study|Lost to Follow-up|3|||
27862725|NCT04480021|81329568|FG001|Overall Study|Lost to Follow-up|4|||
27862726|NCT05297578|81329569|FG000|Overall Study|Lost to Follow-up|1|||
27862727|NCT05297578|81329570|FG001|Overall Study|Lost to Follow-up|1|||
27862728|NCT05297578|81329571|FG002|Overall Study|Lost to Follow-up|2|||
27862729|NCT05297578|81329572|FG003|Overall Study|Lost to Follow-up|1|||
27862730|NCT05297578|81329569|FG000|Overall Study|Death|0|||
27862731|NCT05297578|81329570|FG001|Overall Study|Death|1|||
27862732|NCT05297578|81329571|FG002|Overall Study|Death|0|||
27570107|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27862733|NCT05297578|81329572|FG003|Overall Study|Death|0|||
27862734|NCT05297578|81329569|FG000|Overall Study|Withdrawal by Subject|0|||
27862735|NCT05297578|81329570|FG001|Overall Study|Withdrawal by Subject|0|||
27862736|NCT05297578|81329571|FG002|Overall Study|Withdrawal by Subject|1|||
27862737|NCT05297578|81329572|FG003|Overall Study|Withdrawal by Subject|0|||
27862738|NCT02552303|81329574|FG000|Allocation|Withdrawal by Subject|2|||
27862739|NCT02552303|81329575|FG001|Allocation|Withdrawal by Subject|1|||
27862740|NCT02552303|81329576|FG002|Allocation|Withdrawal by Subject|1|||
27862741|NCT02552303|81329577|FG003|Allocation|Withdrawal by Subject|1|||
27862742|NCT02552303|81329574|FG000|Allocation|ineligible|1|||
27862743|NCT02552303|81329575|FG001|Allocation|ineligible|1|||
27862744|NCT02552303|81329576|FG002|Allocation|ineligible|0|||
27862745|NCT02552303|81329577|FG003|Allocation|ineligible|0|||
27862746|NCT02552303|81329574|FG000|Follow-Up|Lost to Follow-up|0|||
27862747|NCT02552303|81329575|FG001|Follow-Up|Lost to Follow-up|0|||
27862748|NCT02552303|81329576|FG002|Follow-Up|Lost to Follow-up|1|||
27862749|NCT02552303|81329577|FG003|Follow-Up|Lost to Follow-up|0|||
27862750|NCT02552303|81329574|FG000|Follow-Up|ineligible|0|||
27862751|NCT02552303|81329575|FG001|Follow-Up|ineligible|2|||
27862752|NCT02552303|81329576|FG002|Follow-Up|ineligible|0|||
27862753|NCT02552303|81329577|FG003|Follow-Up|ineligible|0|||
27862754|NCT02335983|81329578|FG000|Overall Study|Sponsor Decision|0|||
27862755|NCT02335983|81329579|FG001|Overall Study|Sponsor Decision|0|||
27862756|NCT02335983|81329580|FG002|Overall Study|Sponsor Decision|1|||
27862757|NCT02335983|81329581|FG003|Overall Study|Sponsor Decision|1|||
27862758|NCT02335983|81329582|FG004|Overall Study|Sponsor Decision|0|||
27862759|NCT02335983|81329583|FG005|Overall Study|Sponsor Decision|1|||
27862760|NCT02335983|81329578|FG000|Overall Study|Withdrawal by Subject|3|||
27862761|NCT02335983|81329579|FG001|Overall Study|Withdrawal by Subject|2|||
27862762|NCT02335983|81329580|FG002|Overall Study|Withdrawal by Subject|2|||
27862763|NCT02335983|81329581|FG003|Overall Study|Withdrawal by Subject|1|||
27862764|NCT02335983|81329582|FG004|Overall Study|Withdrawal by Subject|3|||
27862765|NCT02335983|81329583|FG005|Overall Study|Withdrawal by Subject|9|||
27862766|NCT02335983|81329578|FG000|Overall Study|Death|0|||
27862767|NCT02335983|81329579|FG001|Overall Study|Death|0|||
27862768|NCT02335983|81329580|FG002|Overall Study|Death|2|||
27862769|NCT02335983|81329581|FG003|Overall Study|Death|0|||
27862770|NCT02335983|81329582|FG004|Overall Study|Death|0|||
27862771|NCT02335983|81329583|FG005|Overall Study|Death|0|||
27862772|NCT02335983|81329578|FG000|Overall Study|Lost to Follow-up|0|||
27862773|NCT02335983|81329579|FG001|Overall Study|Lost to Follow-up|0|||
27862774|NCT02335983|81329580|FG002|Overall Study|Lost to Follow-up|0|||
27967352|NCT03473743|81710847|FG003|Overall Study|Randomized but not treated|0|||
27967353|NCT03473743|81710848|FG004|Overall Study|Randomized but not treated|0|||
27967354|NCT03473743|81710849|FG005|Overall Study|Randomized but not treated|0|||
27967355|NCT03473743|81710850|FG006|Overall Study|Randomized but not treated|1|||
27967356|NCT03473743|81710851|FG007|Overall Study|Randomized but not treated|1|||
27967357|NCT04731298|81710853|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
27967358|NCT04731298|81710854|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
27967359|NCT03327220|81710859|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
27967360|NCT03327220|81710860|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
27967361|NCT03327220|81710859|FG000|Overall Study|Investigator Decision|2|||
27967362|NCT03327220|81710860|FG001|Overall Study|Investigator Decision|0|||
27967363|NCT03327220|81710859|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
27967364|NCT03327220|81710860|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
27967365|NCT03327220|81710859|FG000|Overall Study|Fungal infection|1|||
27967366|NCT03327220|81710860|FG001|Overall Study|Fungal infection|0|||
27967367|NCT03327220|81710859|FG000|Overall Study|Discharged to Rehabilitation|0|||
27967368|NCT03327220|81710860|FG001|Overall Study|Discharged to Rehabilitation|1|||
27967369|NCT03327220|81710859|FG000|Overall Study|Missing|1|||
27967370|NCT03327220|81710860|FG001|Overall Study|Missing|0|||
27967371|NCT03037476|81710864|FG000|Overall Study|Lost to Follow-up|63|||
27967372|NCT03037476|81710865|FG001|Overall Study|Lost to Follow-up|46|||
27967373|NCT00391430|81710866|FG000|Overall Study|Withdrawal by Subject|3|||
27967374|NCT00391430|81710867|FG001|Overall Study|Withdrawal by Subject|0|||
27967375|NCT00391430|81710868|FG002|Overall Study|Withdrawal by Subject|12|||
27967376|NCT01576146|81710869|FG000|Extension Period 1|Adverse Event|2|||
27967377|NCT01576146|81710869|FG000|Extension Period 1|Death|2|||
27967378|NCT01576146|81710869|FG000|Extension Period 1|Physician Decision|2|||
27967379|NCT01576146|81710869|FG000|Extension Period 1|Withdrawal by Subject|1|||
27967380|NCT01576146|81710869|FG000|Extension Period 1|Lost to Follow-up|1|||
27967381|NCT01576146|81710869|FG000|Extension Period 1|Parathyroidectomy|1|||
27967382|NCT01576146|81710869|FG000|Extension Period 1|Renal Transplant|1|||
27862775|NCT02335983|81329581|FG003|Overall Study|Lost to Follow-up|0|||
27862776|NCT02335983|81329582|FG004|Overall Study|Lost to Follow-up|0|||
27570108|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
27967383|NCT01576146|81710869|FG000|Extension Period 2|Sponsor Decision|13|||
27967384|NCT01576146|81710869|FG000|Extension Period 2|Death|1|||
27967385|NCT01576146|81710869|FG000|Extension Period 2|Adverse Event|1|||
27967386|NCT01576146|81710869|FG000|Extension Period 2|Renal Transplant|1|||
27862777|NCT02335983|81329583|FG005|Overall Study|Lost to Follow-up|1|||
27862778|NCT02335983|81329578|FG000|Overall Study|Protocol Specified Criteria|5|||
27862779|NCT02335983|81329579|FG001|Overall Study|Protocol Specified Criteria|7|||
27967387|NCT01576146|81710869|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
27967388|NCT01468233|81710876|FG000|Treatment Period 1|Adverse Event|5|||
27862780|NCT02335983|81329580|FG002|Overall Study|Protocol Specified Criteria|27|||
27862781|NCT02335983|81329581|FG003|Overall Study|Protocol Specified Criteria|7|||
27967389|NCT01468233|81710877|FG001|Treatment Period 1|Adverse Event|3|||
27967390|NCT01468233|81710878|FG002|Treatment Period 1|Adverse Event|0|||
27967391|NCT01468233|81710879|FG003|Treatment Period 1|Adverse Event|0|||
27967392|NCT01468233|81710880|FG004|Treatment Period 1|Adverse Event|0|||
27967393|NCT01468233|81710881|FG005|Treatment Period 1|Adverse Event|0|||
27776962|NCT00994890|81013493|FG001|Overall Study|No longer willing to participate|5|||
27776963|NCT00994890|81013494|FG002|Overall Study|No longer willing to participate|13|||
27776964|NCT00994890|81013492|FG000|Overall Study|Protocol Violation|2|||
27776965|NCT00994890|81013493|FG001|Overall Study|Protocol Violation|4|||
27776966|NCT00994890|81013494|FG002|Overall Study|Protocol Violation|0|||
27776967|NCT00994890|81013492|FG000|Overall Study|Study terminated by sponsor|199|||
27776968|NCT00994890|81013493|FG001|Overall Study|Study terminated by sponsor|201|||
27967394|NCT01468233|81710876|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27967395|NCT01468233|81710877|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27967396|NCT01468233|81710878|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27967397|NCT01468233|81710879|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27862782|NCT02335983|81329582|FG004|Overall Study|Protocol Specified Criteria|5|||
27862783|NCT02335983|81329583|FG005|Overall Study|Protocol Specified Criteria|21|||
27862784|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
27862785|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
27862786|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
27862787|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
27862788|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
27862789|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
27862790|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
27862791|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
27862792|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
27862793|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
27967398|NCT01468233|81710880|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27967399|NCT01468233|81710881|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27967400|NCT01468233|81710876|FG000|Treatment Period 1|Lost to Follow-up|3|||
27967401|NCT01468233|81710877|FG001|Treatment Period 1|Lost to Follow-up|0|||
27967402|NCT01468233|81710878|FG002|Treatment Period 1|Lost to Follow-up|0|||
27967403|NCT01468233|81710879|FG003|Treatment Period 1|Lost to Follow-up|0|||
27967404|NCT01468233|81710880|FG004|Treatment Period 1|Lost to Follow-up|0|||
27967405|NCT01468233|81710881|FG005|Treatment Period 1|Lost to Follow-up|0|||
27967406|NCT01468233|81710876|FG000|Treatment Period 1|Other|1|||
27967407|NCT01468233|81710877|FG001|Treatment Period 1|Other|1|||
27665838|NCT00087555|80615392|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
27967408|NCT01468233|81710878|FG002|Treatment Period 1|Other|0|||
27967409|NCT01468233|81710879|FG003|Treatment Period 1|Other|0|||
27665839|NCT00087555|80615393|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
27665840|NCT00087555|80615394|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
27967410|NCT01468233|81710880|FG004|Treatment Period 1|Other|0|||
27967411|NCT01468233|81710881|FG005|Treatment Period 1|Other|0|||
27665841|NCT00087555|80615392|FG000|Overall Study|Patient wanted to go back on Med|1|||
27665842|NCT00087555|80615393|FG001|Overall Study|Patient wanted to go back on Med|0|||
27665843|NCT00087555|80615394|FG002|Overall Study|Patient wanted to go back on Med|0|||
27665844|NCT01101997|80615395|FG000|Overall Study|Withdrawal by Subject|2|||
27665845|NCT01182181|80615396|FG000|First Intervention|Adverse Event|1|||
27665846|NCT01182181|80615397|FG001|First Intervention|Adverse Event|0|||
27665847|NCT01182181|80615396|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
27665848|NCT01182181|80615397|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
27665849|NCT02154347|80615400|FG000|Double-blind Period|Adverse Event|1|||
27665850|NCT02154347|80615401|FG001|Double-blind Period|Adverse Event|2|||
27665851|NCT02154347|80615400|FG000|Double-blind Period|Lack of Efficacy|1|||
27665852|NCT02154347|80615401|FG001|Double-blind Period|Lack of Efficacy|0|||
27665853|NCT02154347|80615400|FG000|Double-blind Period|Physician Decision|0|||
27665854|NCT02154347|80615401|FG001|Double-blind Period|Physician Decision|1|||
27665855|NCT02154347|80615400|FG000|Double-blind Period|Withdrawal by Subject|1|||
27862794|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
27862795|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
27967412|NCT01468233|81710876|FG000|Treatment Period 2|Adverse Event|0|||
27967413|NCT01468233|81710877|FG001|Treatment Period 2|Adverse Event|0|||
27665856|NCT02154347|80615401|FG001|Double-blind Period|Withdrawal by Subject|1|||
27967414|NCT01468233|81710878|FG002|Treatment Period 2|Adverse Event|3|||
27967415|NCT01468233|81710879|FG003|Treatment Period 2|Adverse Event|0|||
27967416|NCT01468233|81710880|FG004|Treatment Period 2|Adverse Event|2|||
27967417|NCT01468233|81710881|FG005|Treatment Period 2|Adverse Event|1|||
27967418|NCT01468233|81710876|FG000|Treatment Period 2|Lack of Efficacy|0|||
27665857|NCT02154347|80615400|FG000|Open-label Period|Adverse Event|3|||
27665858|NCT02154347|80615401|FG001|Open-label Period|Adverse Event|4|||
27665859|NCT02154347|80615400|FG000|Open-label Period|Lack of Efficacy|4|||
27665860|NCT02154347|80615401|FG001|Open-label Period|Lack of Efficacy|19|||
27776969|NCT00994890|81013494|FG002|Overall Study|Study terminated by sponsor|197|||
27776970|NCT00994890|81013492|FG000|Overall Study|Randomized, but not treated|1|||
27776971|NCT00994890|81013493|FG001|Overall Study|Randomized, but not treated|0|||
27776972|NCT00994890|81013494|FG002|Overall Study|Randomized, but not treated|0|||
27776973|NCT00994890|81013492|FG000|Overall Study|Other|2|||
27776974|NCT00994890|81013493|FG001|Overall Study|Other|2|||
27776975|NCT00994890|81013494|FG002|Overall Study|Other|1|||
27776976|NCT02607865|81013497|FG000|Overall Study|Lost to Follow-up|9|||
27776977|NCT02607865|81013498|FG001|Overall Study|Lost to Follow-up|7|||
27776978|NCT02607865|81013499|FG002|Overall Study|Lost to Follow-up|7|||
27776979|NCT02607865|81013500|FG003|Overall Study|Lost to Follow-up|5|||
27776980|NCT02607865|81013497|FG000|Overall Study|Withdrawal by Subject|18|||
27776981|NCT02607865|81013498|FG001|Overall Study|Withdrawal by Subject|18|||
27776982|NCT02607865|81013499|FG002|Overall Study|Withdrawal by Subject|17|||
27776983|NCT02607865|81013500|FG003|Overall Study|Withdrawal by Subject|8|||
27776984|NCT02607865|81013497|FG000|Overall Study|Death|5|||
27776985|NCT02607865|81013498|FG001|Overall Study|Death|4|||
27776986|NCT02607865|81013499|FG002|Overall Study|Death|1|||
27776987|NCT02607865|81013500|FG003|Overall Study|Death|3|||
27776988|NCT02607865|81013497|FG000|Overall Study|Unclassified|1|||
27776989|NCT02607865|81013498|FG001|Overall Study|Unclassified|1|||
27776990|NCT02607865|81013499|FG002|Overall Study|Unclassified|2|||
27776991|NCT02607865|81013500|FG003|Overall Study|Unclassified|0|||
27776992|NCT05333289|81013508|FG000|Overall Study|Other|1|||
27776993|NCT05333289|81013509|FG001|Overall Study|Other|0|||
27776994|NCT05333289|81013510|FG002|Overall Study|Other|0|||
27776995|NCT05333289|81013511|FG003|Overall Study|Other|1|||
27776996|NCT05333289|81013512|FG004|Overall Study|Other|1|||
27776997|NCT05333289|81013513|FG005|Overall Study|Other|2|||
27776998|NCT05333289|81013514|FG006|Overall Study|Other|2|||
27776999|NCT05333289|81013515|FG007|Overall Study|Other|0|||
27777000|NCT05333289|81013508|FG000|Overall Study|Withdrawal by Subject|1|||
27777001|NCT05333289|81013509|FG001|Overall Study|Withdrawal by Subject|2|||
27777002|NCT05333289|81013510|FG002|Overall Study|Withdrawal by Subject|2|||
27777003|NCT05333289|81013511|FG003|Overall Study|Withdrawal by Subject|1|||
27777004|NCT05333289|81013512|FG004|Overall Study|Withdrawal by Subject|1|||
27777005|NCT05333289|81013513|FG005|Overall Study|Withdrawal by Subject|2|||
27777006|NCT05333289|81013514|FG006|Overall Study|Withdrawal by Subject|1|||
27777007|NCT05333289|81013515|FG007|Overall Study|Withdrawal by Subject|3|||
27777008|NCT05333289|81013508|FG000|Overall Study|Protocol Violation|1|||
27777009|NCT05333289|81013509|FG001|Overall Study|Protocol Violation|0|||
27777010|NCT05333289|81013510|FG002|Overall Study|Protocol Violation|0|||
27777011|NCT05333289|81013511|FG003|Overall Study|Protocol Violation|0|||
27777012|NCT05333289|81013512|FG004|Overall Study|Protocol Violation|0|||
27777013|NCT05333289|81013513|FG005|Overall Study|Protocol Violation|0|||
27777014|NCT05333289|81013514|FG006|Overall Study|Protocol Violation|0|||
27777015|NCT05333289|81013515|FG007|Overall Study|Protocol Violation|0|||
27777016|NCT05333289|81013508|FG000|Overall Study|Physician Decision|0|||
27777017|NCT05333289|81013509|FG001|Overall Study|Physician Decision|0|||
27777018|NCT05333289|81013510|FG002|Overall Study|Physician Decision|1|||
27777019|NCT05333289|81013511|FG003|Overall Study|Physician Decision|0|||
27777020|NCT05333289|81013512|FG004|Overall Study|Physician Decision|0|||
27777021|NCT05333289|81013513|FG005|Overall Study|Physician Decision|2|||
27777022|NCT05333289|81013514|FG006|Overall Study|Physician Decision|0|||
27777023|NCT05333289|81013515|FG007|Overall Study|Physician Decision|0|||
27777024|NCT05333289|81013508|FG000|Overall Study|Lost to Follow-up|6|||
27777025|NCT05333289|81013509|FG001|Overall Study|Lost to Follow-up|0|||
27777026|NCT05333289|81013510|FG002|Overall Study|Lost to Follow-up|1|||
27777027|NCT05333289|81013511|FG003|Overall Study|Lost to Follow-up|6|||
27777028|NCT05333289|81013512|FG004|Overall Study|Lost to Follow-up|3|||
27777029|NCT05333289|81013513|FG005|Overall Study|Lost to Follow-up|3|||
27777030|NCT05333289|81013514|FG006|Overall Study|Lost to Follow-up|2|||
27777031|NCT05333289|81013515|FG007|Overall Study|Lost to Follow-up|1|||
27777032|NCT05333289|81013508|FG000|Overall Study|Death|1|||
27777033|NCT05333289|81013509|FG001|Overall Study|Death|0|||
27777034|NCT05333289|81013510|FG002|Overall Study|Death|0|||
27777035|NCT05333289|81013511|FG003|Overall Study|Death|0|||
27777036|NCT05333289|81013512|FG004|Overall Study|Death|0|||
27777037|NCT05333289|81013513|FG005|Overall Study|Death|0|||
27777038|NCT05333289|81013514|FG006|Overall Study|Death|0|||
27777039|NCT05333289|81013515|FG007|Overall Study|Death|0|||
27777040|NCT01327573|81013516|FG000|Overall Study|Physician Decision|3|||
27777041|NCT01327573|81013517|FG001|Overall Study|Physician Decision|1|||
27777042|NCT02608892|81013526|FG000|Overall Study|Lost to Follow-up|1|||
27777043|NCT02608892|81013527|FG001|Overall Study|Lost to Follow-up|0|||
27777044|NCT01657253|81013530|FG000|Overall Study|Lost to Follow-up|6|||
27777045|NCT01657253|81013531|FG001|Overall Study|Lost to Follow-up|5|||
27777046|NCT01657253|81013530|FG000|Overall Study|Withdrawal by Subject|11|||
27777047|NCT01657253|81013531|FG001|Overall Study|Withdrawal by Subject|12|||
27777048|NCT01657253|81013530|FG000|Overall Study|Adverse Event|0|||
27777049|NCT01657253|81013531|FG001|Overall Study|Adverse Event|1|||
27777050|NCT01984294|81013534|FG000|Overall Study|Randomized but Never Treated|0|||
27777051|NCT01984294|81013535|FG001|Overall Study|Randomized but Never Treated|0|||
27777052|NCT01984294|81013536|FG002|Overall Study|Randomized but Never Treated|1|||
27777053|NCT01984294|81013534|FG000|Overall Study|Lack of Efficacy|4|||
27777054|NCT01984294|81013535|FG001|Overall Study|Lack of Efficacy|2|||
27777055|NCT01984294|81013536|FG002|Overall Study|Lack of Efficacy|6|||
27777056|NCT01984294|81013534|FG000|Overall Study|Adverse Event|0|||
27570109|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570110|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570111|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570112|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570113|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27777057|NCT01984294|81013535|FG001|Overall Study|Adverse Event|1|||
27777058|NCT01984294|81013536|FG002|Overall Study|Adverse Event|0|||
27777059|NCT00957034|81013537|FG000|Overall Study|Adverse Event|0|||
27777060|NCT00957034|81013538|FG001|Overall Study|Adverse Event|1|||
27777061|NCT00957034|81013539|FG002|Overall Study|Adverse Event|1|||
27777062|NCT00957034|81013537|FG000|Overall Study|Sponsor Terminated Study|6|||
27777063|NCT00957034|81013538|FG001|Overall Study|Sponsor Terminated Study|1|||
27777064|NCT00957034|81013539|FG002|Overall Study|Sponsor Terminated Study|5|||
27777065|NCT00957034|81013537|FG000|Overall Study|Withdrawal by Subject|0|||
27777066|NCT00957034|81013538|FG001|Overall Study|Withdrawal by Subject|2|||
27777067|NCT00957034|81013539|FG002|Overall Study|Withdrawal by Subject|0|||
27777068|NCT01326910|81013540|FG000|Overall Study|Withdrawal by Subject|3|||
27777069|NCT01326910|81013541|FG001|Overall Study|Withdrawal by Subject|2|||
27777070|NCT01326910|81013540|FG000|Overall Study|Protocol Violation|1|||
27777071|NCT01326910|81013541|FG001|Overall Study|Protocol Violation|1|||
27777072|NCT00112840|81013545|FG000|Overall Study|Physician Decision|1|||
27777073|NCT00112840|81013546|FG001|Overall Study|Physician Decision|0|||
27777074|NCT00112840|81013547|FG002|Overall Study|Physician Decision|0|||
27777075|NCT00112840|81013545|FG000|Overall Study|Withdrawal by Subject|1|||
27777076|NCT00112840|81013546|FG001|Overall Study|Withdrawal by Subject|0|||
27777077|NCT00112840|81013547|FG002|Overall Study|Withdrawal by Subject|1|||
27777078|NCT00112840|81013545|FG000|Overall Study|Protocol Violation|0|||
27777079|NCT00112840|81013546|FG001|Overall Study|Protocol Violation|0|||
27777080|NCT00112840|81013547|FG002|Overall Study|Protocol Violation|5|||
27777081|NCT03228836|81013550|FG000|Overall Study|Adverse Event|3|||
27777082|NCT03228836|81013550|FG000|Overall Study|Withdrawal by Subject|1|||
27777083|NCT03228836|81013550|FG000|Overall Study|Death|1|||
27777084|NCT03228836|81013550|FG000|Overall Study|Physician Decision|1|||
27777085|NCT03228836|81013550|FG000|Overall Study|Disease Progression|7|||
27777086|NCT03228836|81013550|FG000|Overall Study|Other|4|||
27777087|NCT02531633|81013551|FG000|Part A (52 Weeks)|Sponsor request|24|||
27777088|NCT02531633|81013552|FG001|Part A (52 Weeks)|Sponsor request|24|||
27777089|NCT02531633|81013553|FG002|Part A (52 Weeks)|Sponsor request|18|||
27777090|NCT02531633|81013554|FG003|Part A (52 Weeks)|Sponsor request|18|||
27777091|NCT02531633|81013555|FG004|Part A (52 Weeks)|Sponsor request|19|||
27777092|NCT02531633|81013556|FG005|Part A (52 Weeks)|Sponsor request|0|||
27777093|NCT02531633|81013557|FG006|Part A (52 Weeks)|Sponsor request|0|||
27777094|NCT02531633|81013558|FG007|Part A (52 Weeks)|Sponsor request|0|||
27777095|NCT02531633|81013559|FG008|Part A (52 Weeks)|Sponsor request|0|||
27777096|NCT02531633|81013560|FG009|Part A (52 Weeks)|Sponsor request|0|||
27777097|NCT02531633|81013551|FG000|Part A (52 Weeks)|Protocol Violation|1|||
27777098|NCT02531633|81013552|FG001|Part A (52 Weeks)|Protocol Violation|0|||
27777099|NCT02531633|81013553|FG002|Part A (52 Weeks)|Protocol Violation|0|||
27777100|NCT02531633|81013554|FG003|Part A (52 Weeks)|Protocol Violation|0|||
27777101|NCT02531633|81013555|FG004|Part A (52 Weeks)|Protocol Violation|0|||
27777102|NCT02531633|81013556|FG005|Part A (52 Weeks)|Protocol Violation|0|||
27777103|NCT02531633|81013557|FG006|Part A (52 Weeks)|Protocol Violation|0|||
27777104|NCT02531633|81013558|FG007|Part A (52 Weeks)|Protocol Violation|0|||
27777105|NCT02531633|81013559|FG008|Part A (52 Weeks)|Protocol Violation|0|||
27777106|NCT02531633|81013560|FG009|Part A (52 Weeks)|Protocol Violation|0|||
27570114|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570115|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27777107|NCT02531633|81013551|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
27777108|NCT02531633|81013552|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
27777109|NCT02531633|81013553|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
27777110|NCT02531633|81013554|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
27777111|NCT02531633|81013555|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
27777112|NCT02531633|81013556|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
27777113|NCT02531633|81013557|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
27777114|NCT02531633|81013558|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
27777115|NCT02531633|81013559|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
27777116|NCT02531633|81013560|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
27777117|NCT02531633|81013551|FG000|Part A (52 Weeks)|Physician Decision|1|||
27777118|NCT02531633|81013552|FG001|Part A (52 Weeks)|Physician Decision|4|||
27777119|NCT02531633|81013553|FG002|Part A (52 Weeks)|Physician Decision|3|||
27777120|NCT02531633|81013554|FG003|Part A (52 Weeks)|Physician Decision|1|||
27777121|NCT02531633|81013555|FG004|Part A (52 Weeks)|Physician Decision|0|||
27777122|NCT02531633|81013556|FG005|Part A (52 Weeks)|Physician Decision|0|||
27777123|NCT02531633|81013557|FG006|Part A (52 Weeks)|Physician Decision|0|||
27777124|NCT02531633|81013558|FG007|Part A (52 Weeks)|Physician Decision|0|||
27777125|NCT02531633|81013559|FG008|Part A (52 Weeks)|Physician Decision|0|||
27777126|NCT02531633|81013560|FG009|Part A (52 Weeks)|Physician Decision|0|||
27777127|NCT02531633|81013551|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
27777128|NCT02531633|81013552|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
27777129|NCT02531633|81013553|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
27777130|NCT02531633|81013554|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
27777131|NCT02531633|81013555|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
27777132|NCT02531633|81013556|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
27777133|NCT02531633|81013557|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
27777134|NCT02531633|81013558|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
27777135|NCT02531633|81013559|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
27777136|NCT02531633|81013560|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
27777137|NCT02531633|81013551|FG000|Part A (52 Weeks)|Other|2|||
27777138|NCT02531633|81013552|FG001|Part A (52 Weeks)|Other|0|||
27777139|NCT02531633|81013553|FG002|Part A (52 Weeks)|Other|0|||
27777140|NCT02531633|81013554|FG003|Part A (52 Weeks)|Other|0|||
27777141|NCT02531633|81013555|FG004|Part A (52 Weeks)|Other|0|||
27777142|NCT02531633|81013556|FG005|Part A (52 Weeks)|Other|0|||
27777143|NCT02531633|81013557|FG006|Part A (52 Weeks)|Other|0|||
27777144|NCT02531633|81013558|FG007|Part A (52 Weeks)|Other|0|||
27777145|NCT02531633|81013559|FG008|Part A (52 Weeks)|Other|0|||
27777146|NCT02531633|81013560|FG009|Part A (52 Weeks)|Other|0|||
27777147|NCT02531633|81013551|FG000|Part B (104 Weeks)|Sponsor request|0|||
27777148|NCT02531633|81013552|FG001|Part B (104 Weeks)|Sponsor request|0|||
27967419|NCT01468233|81710877|FG001|Treatment Period 2|Lack of Efficacy|0|||
27967420|NCT01468233|81710878|FG002|Treatment Period 2|Lack of Efficacy|9|||
27967421|NCT01468233|81710879|FG003|Treatment Period 2|Lack of Efficacy|2|||
27967422|NCT01468233|81710880|FG004|Treatment Period 2|Lack of Efficacy|0|||
27967423|NCT01468233|81710881|FG005|Treatment Period 2|Lack of Efficacy|1|||
27967424|NCT01468233|81710876|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27967425|NCT01468233|81710877|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27967426|NCT01468233|81710878|FG002|Treatment Period 2|Withdrawal by Subject|9|||
27967427|NCT01468233|81710879|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27777149|NCT02531633|81013553|FG002|Part B (104 Weeks)|Sponsor request|0|||
27777150|NCT02531633|81013554|FG003|Part B (104 Weeks)|Sponsor request|0|||
27777151|NCT02531633|81013555|FG004|Part B (104 Weeks)|Sponsor request|0|||
27967428|NCT01468233|81710880|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27967429|NCT01468233|81710881|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27967430|NCT01468233|81710876|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
27967431|NCT01468233|81710877|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
27967432|NCT01468233|81710878|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
27967433|NCT01468233|81710879|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
27967434|NCT01468233|81710880|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
27967435|NCT01468233|81710881|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
27967436|NCT01468233|81710876|FG000|Treatment Period 2|Lost to Follow-up|0|||
27967437|NCT01468233|81710877|FG001|Treatment Period 2|Lost to Follow-up|0|||
27967438|NCT01468233|81710878|FG002|Treatment Period 2|Lost to Follow-up|3|||
27967439|NCT01468233|81710879|FG003|Treatment Period 2|Lost to Follow-up|0|||
27967440|NCT01468233|81710880|FG004|Treatment Period 2|Lost to Follow-up|2|||
27777152|NCT02531633|81013556|FG005|Part B (104 Weeks)|Sponsor request|8|||
27777153|NCT02531633|81013557|FG006|Part B (104 Weeks)|Sponsor request|5|||
27967441|NCT01468233|81710881|FG005|Treatment Period 2|Lost to Follow-up|0|||
27967442|NCT01468233|81710876|FG000|Treatment Period 2|Other|0|||
27967443|NCT01468233|81710877|FG001|Treatment Period 2|Other|0|||
27967444|NCT01468233|81710878|FG002|Treatment Period 2|Other|3|||
27777154|NCT02531633|81013558|FG007|Part B (104 Weeks)|Sponsor request|3|||
27777155|NCT02531633|81013559|FG008|Part B (104 Weeks)|Sponsor request|5|||
27777156|NCT02531633|81013560|FG009|Part B (104 Weeks)|Sponsor request|4|||
27777157|NCT02531633|81013551|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
27777158|NCT02531633|81013552|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
27777159|NCT02531633|81013553|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
27967445|NCT01468233|81710879|FG003|Treatment Period 2|Other|0|||
27967446|NCT01468233|81710880|FG004|Treatment Period 2|Other|1|||
27967447|NCT01468233|81710881|FG005|Treatment Period 2|Other|0|||
27967448|NCT03988621|81710888|FG000|Overall Study|Lost to Follow-up|16|||
27777160|NCT02531633|81013554|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
27777161|NCT02531633|81013555|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
27777162|NCT02531633|81013556|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
27777163|NCT02531633|81013557|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
27777164|NCT02531633|81013558|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
27777165|NCT02531633|81013559|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
27777166|NCT02531633|81013560|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
27777167|NCT01624974|81013561|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
27777168|NCT01624974|81013562|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
27777169|NCT01624974|81013561|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
27777170|NCT01624974|81013562|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
27777171|NCT01624974|81013561|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
27777172|NCT01624974|81013562|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
27777173|NCT01624974|81013561|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
27777174|NCT01624974|81013562|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
27777175|NCT01624974|81013561|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
27777176|NCT01624974|81013562|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
27777177|NCT01624974|81013561|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
27777178|NCT01624974|81013562|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
27777179|NCT01624974|81013561|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
27777180|NCT01624974|81013562|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
27777181|NCT01624974|81013561|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
27777182|NCT01624974|81013562|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
27777183|NCT01624974|81013561|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
27777184|NCT01624974|81013562|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
27777185|NCT01624974|81013561|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
27777186|NCT01624974|81013562|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
27777187|NCT01624974|81013561|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
27777188|NCT01624974|81013562|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
27777189|NCT01624974|81013561|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
27777190|NCT01624974|81013562|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
27777191|NCT02299206|81013566|FG000|Overall Study|Lost to Follow-up|1|||
27777192|NCT02299206|81013566|FG000|Overall Study|Withdrawal by Subject|1|||
27777193|NCT02203916|81013567|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27777194|NCT02203916|81013568|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
27777195|NCT02203916|81013569|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
27777196|NCT02203916|81013567|FG000|Overall Study|Major Protocol Deviation|1|||
27777197|NCT02203916|81013568|FG001|Overall Study|Major Protocol Deviation|1|||
27777198|NCT02203916|81013569|FG002|Overall Study|Major Protocol Deviation|0|||
27777199|NCT02203916|81013567|FG000|Overall Study|Lost to Follow-up|0|||
27777200|NCT02203916|81013568|FG001|Overall Study|Lost to Follow-up|1|||
27777201|NCT02203916|81013569|FG002|Overall Study|Lost to Follow-up|0|||
27777202|NCT02203916|81013567|FG000|Overall Study|Voluntary Withdrawal|3|||
27777203|NCT02203916|81013568|FG001|Overall Study|Voluntary Withdrawal|3|||
27777204|NCT02203916|81013569|FG002|Overall Study|Voluntary Withdrawal|8|||
27777205|NCT02203916|81013567|FG000|Overall Study|Lack of Efficacy|3|||
27777206|NCT02203916|81013568|FG001|Overall Study|Lack of Efficacy|0|||
27777207|NCT02203916|81013569|FG002|Overall Study|Lack of Efficacy|0|||
27777208|NCT02203916|81013567|FG000|Overall Study|Reason Not Specified|0|||
27777209|NCT02203916|81013568|FG001|Overall Study|Reason Not Specified|2|||
27777210|NCT02203916|81013569|FG002|Overall Study|Reason Not Specified|1|||
27777211|NCT01034709|81013575|FG000|Overall Study|Protocol Violation|9|||
27777212|NCT01034709|81013576|FG001|Overall Study|Protocol Violation|16|||
27777213|NCT03662789|81013578|FG000|Overall Study|Lost to Follow-up|1|||
27777214|NCT03662789|81013579|FG001|Overall Study|Lost to Follow-up|2|||
27862796|NCT02294461|81329584|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
27862797|NCT02294461|81329585|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
27862798|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
27777215|NCT03662789|81013578|FG000|Overall Study|Could not perform treadmill test|4|||
27777216|NCT03662789|81013579|FG001|Overall Study|Could not perform treadmill test|4|||
27777217|NCT03662789|81013578|FG000|Overall Study|Death|0|||
27777218|NCT03662789|81013579|FG001|Overall Study|Death|1|||
27862799|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
27777219|NCT00686699|81013580|FG000|Treatment Period 1|Adverse Event|0|||
27777220|NCT00686699|81013581|FG001|Treatment Period 1|Adverse Event|2|||
27777221|NCT03231228|81013584|FG000|Overall Study|Lost to Follow-up|2|||
27777222|NCT03231228|81013585|FG001|Overall Study|Lost to Follow-up|0|||
27777223|NCT03231228|81013584|FG000|Overall Study|Physician Decision|1|||
27777224|NCT03231228|81013585|FG001|Overall Study|Physician Decision|0|||
27777225|NCT05013385|81013587|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
27862800|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
27862801|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
27862802|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
27862803|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
27862804|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
27862805|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
27862806|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
27862807|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
27862808|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
27777226|NCT04043416|81013588|FG000|Washout|Change in health condition|0|||
27777227|NCT04043416|81013589|FG001|Washout|Change in health condition|1|||
27777228|NCT00443534|81013590|FG000|Overall Study|Lack of Efficacy|67|||
27777229|NCT00443534|81013590|FG000|Overall Study|Adverse Event|16|||
27777230|NCT00443534|81013590|FG000|Overall Study|Death|9|||
27777231|NCT00443534|81013590|FG000|Overall Study|Withdrawal by Subject|8|||
27777232|NCT00443534|81013590|FG000|Overall Study|Study Terminated by Sponsor|12|||
27777233|NCT00443534|81013590|FG000|Overall Study|Other|10|||
27777234|NCT00443534|81013590|FG000|Overall Study|Enrolled, Not Treated|1|||
27777235|NCT02545049|81013591|FG000|Overall Study|Withdrawal by Subject|1|||
27777236|NCT02545049|81013592|FG001|Overall Study|Withdrawal by Subject|7|||
27777237|NCT02545049|81013591|FG000|Overall Study|Lost to Follow-up|4|||
27777238|NCT02545049|81013592|FG001|Overall Study|Lost to Follow-up|6|||
27777239|NCT02545049|81013591|FG000|Overall Study|GCP violations|37|||
27777240|NCT02545049|81013592|FG001|Overall Study|GCP violations|48|||
27777241|NCT00939094|81013593|FG000|Overall Study|Adverse Event|9|||
27777242|NCT00939094|81013594|FG001|Overall Study|Adverse Event|0|||
27777243|NCT00939094|81013593|FG000|Overall Study|Withdrawal by Subject|1|||
27777244|NCT00939094|81013594|FG001|Overall Study|Withdrawal by Subject|6|||
27777245|NCT00939094|81013593|FG000|Overall Study|Lost to Follow-up|1|||
27777246|NCT00939094|81013594|FG001|Overall Study|Lost to Follow-up|1|||
27777247|NCT00939094|81013593|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27777248|NCT00939094|81013594|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27777249|NCT00939094|81013593|FG000|Overall Study|Severe non-compliance to protocol|0|||
27777250|NCT00939094|81013594|FG001|Overall Study|Severe non-compliance to protocol|1|||
27777251|NCT00939094|81013593|FG000|Overall Study|Study stopped by sponsor|0|||
27777252|NCT00939094|81013594|FG001|Overall Study|Study stopped by sponsor|2|||
27777253|NCT00939094|81013593|FG000|Overall Study|Abnormal ECG findings|1|||
27777254|NCT00939094|81013594|FG001|Overall Study|Abnormal ECG findings|0|||
27777255|NCT00086385|81013599|FG000|Overall Study|Death|2|||
27777256|NCT00086385|81013600|FG001|Overall Study|Death|2|||
27777257|NCT00086385|81013601|FG002|Overall Study|Death|1|||
27777258|NCT00086385|81013602|FG003|Overall Study|Death|1|||
27777259|NCT01435122|81013603|FG000|Overall Study|Early withdrawal due to toxicity|8|||
27777260|NCT03198728|81013610|FG000|Overall Study|Adverse Event|10|||
27777261|NCT03198728|81013611|FG001|Overall Study|Adverse Event|5|||
27777262|NCT03198728|81013610|FG000|Overall Study|Lost to Follow-up|21|||
27777263|NCT03198728|81013611|FG001|Overall Study|Lost to Follow-up|7|||
27777264|NCT03198728|81013610|FG000|Overall Study|Physician Decision|7|||
27777265|NCT03198728|81013611|FG001|Overall Study|Physician Decision|2|||
27777266|NCT03198728|81013610|FG000|Overall Study|Withdrawal by Subject|14|||
27777267|NCT03198728|81013611|FG001|Overall Study|Withdrawal by Subject|10|||
27777268|NCT01610414|81013612|FG000|Study Start - Month 13|Serious Adverse Event|65|||
27777269|NCT01610414|81013613|FG001|Study Start - Month 13|Serious Adverse Event|67|||
27777270|NCT01610414|81013612|FG000|Study Start - Month 13|Adverse Event|14|||
27777271|NCT01610414|81013613|FG001|Study Start - Month 13|Adverse Event|14|||
27777272|NCT01610414|81013612|FG000|Study Start - Month 13|Protocol Violation|3|||
27777273|NCT01610414|81013613|FG001|Study Start - Month 13|Protocol Violation|1|||
27777274|NCT01610414|81013612|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
27777275|NCT01610414|81013613|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
27777276|NCT01610414|81013612|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
27777277|NCT01610414|81013613|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
27862809|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
27862810|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
27777278|NCT01610414|81013612|FG000|Study Start - Month 13|Lost to Follow-up|4|||
27777279|NCT01610414|81013613|FG001|Study Start - Month 13|Lost to Follow-up|6|||
27777280|NCT01610414|81013612|FG000|Study Start - Month 13|Suspected HZ episode|1|||
27777281|NCT01610414|81013613|FG001|Study Start - Month 13|Suspected HZ episode|3|||
27777282|NCT01610414|81013612|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
27777283|NCT01610414|81013613|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
27777284|NCT01610414|81013612|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
27777285|NCT01610414|81013613|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
27777286|NCT01610414|81013612|FG000|Month 13 - Month 25|Adverse Event|8|||
27777287|NCT01610414|81013613|FG001|Month 13 - Month 25|Adverse Event|4|||
27777288|NCT01610414|81013612|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
27777289|NCT01610414|81013613|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
27777290|NCT01610414|81013612|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
27777291|NCT01610414|81013613|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
27777292|NCT01610414|81013612|FG000|Month 13 - Month 25|Protocol Violation|0|||
27777293|NCT01610414|81013613|FG001|Month 13 - Month 25|Protocol Violation|2|||
27777294|NCT01610414|81013612|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
27777295|NCT01610414|81013613|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
27777296|NCT01610414|81013612|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
27967449|NCT03988621|81710889|FG001|Overall Study|Lost to Follow-up|17|||
27967450|NCT03988621|81710888|FG000|Overall Study|Withdrawal by Subject|14|||
27967451|NCT03988621|81710889|FG001|Overall Study|Withdrawal by Subject|7|||
27967452|NCT03988621|81710888|FG000|Overall Study|Patient Lost to Follow Up|1|||
27967453|NCT03988621|81710889|FG001|Overall Study|Patient Lost to Follow Up|8|||
27967454|NCT03988621|81710888|FG000|Overall Study|Patient death|15|||
27967455|NCT03988621|81710889|FG001|Overall Study|Patient death|12|||
27967456|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
27967457|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
27967458|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
27967459|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
27967460|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
27777297|NCT01610414|81013613|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
27777298|NCT01610414|81013612|FG000|After Month 25|Study end not reached|48|||
27777299|NCT01610414|81013613|FG001|After Month 25|Study end not reached|53|||
27777300|NCT00901394|81013614|FG000|Overall Study|Physician Decision|1|||
27777301|NCT00901394|81013615|FG001|Overall Study|Physician Decision|1|||
27777302|NCT00901394|81013616|FG002|Overall Study|Physician Decision|2|||
27777303|NCT02573012|81013617|FG000|Overall Study|Adverse Event|5|||
27777304|NCT02573012|81013618|FG001|Overall Study|Adverse Event|5|||
27777305|NCT02573012|81013617|FG000|Overall Study|Lack of Efficacy|5|||
27967461|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
27967462|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
27967463|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
27967464|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
27967465|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
27967466|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
27967467|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
27967468|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
27967469|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
27967470|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
27967471|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
27967472|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
27967473|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
27967474|NCT03308968|81710890|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
27967475|NCT03308968|81710891|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
27967476|NCT03308968|81710892|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
27967477|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
27967478|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
27967479|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
27967480|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
27967481|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
27967482|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
27967483|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
27967484|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
27967485|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
27967486|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
27967487|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
27967488|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
27967489|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
27967490|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
27967491|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
27967492|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
27777306|NCT02573012|81013618|FG001|Overall Study|Lack of Efficacy|4|||
27967493|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
27967494|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
27777307|NCT02573012|81013617|FG000|Overall Study|Non-compliance|1|||
27777308|NCT02573012|81013618|FG001|Overall Study|Non-compliance|2|||
27777309|NCT02573012|81013617|FG000|Overall Study|Withdrawal by Subject|2|||
27777310|NCT02573012|81013618|FG001|Overall Study|Withdrawal by Subject|2|||
27967495|NCT03308968|81710890|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
27967496|NCT03308968|81710891|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
27967497|NCT03308968|81710892|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
27967498|NCT00791479|81710893|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27967499|NCT00791479|81710894|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27967500|NCT00791479|81710895|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27967501|NCT00791479|81710896|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27967502|NCT00791479|81710897|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
27967503|NCT00791479|81710898|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
27967504|NCT00791479|81710893|FG000|Overall Study|Adverse Event|0|||
27967505|NCT00791479|81710894|FG001|Overall Study|Adverse Event|1|||
27967506|NCT00791479|81710895|FG002|Overall Study|Adverse Event|0|||
27967507|NCT00791479|81710896|FG003|Overall Study|Adverse Event|2|||
27967508|NCT00791479|81710897|FG004|Overall Study|Adverse Event|0|||
27967509|NCT00791479|81710898|FG005|Overall Study|Adverse Event|1|||
27967510|NCT00791479|81710893|FG000|Overall Study|Lost to Follow-up|0|||
27967511|NCT00791479|81710894|FG001|Overall Study|Lost to Follow-up|1|||
27967512|NCT00791479|81710895|FG002|Overall Study|Lost to Follow-up|0|||
27777311|NCT02573012|81013617|FG000|Overall Study|Study Ended per Protocol|1|||
27777312|NCT02573012|81013618|FG001|Overall Study|Study Ended per Protocol|0|||
27967513|NCT00791479|81710896|FG003|Overall Study|Lost to Follow-up|0|||
27967514|NCT00791479|81710897|FG004|Overall Study|Lost to Follow-up|0|||
27967515|NCT00791479|81710898|FG005|Overall Study|Lost to Follow-up|1|||
27967516|NCT00791479|81710893|FG000|Overall Study|Protocol Violation|2|||
27967517|NCT00791479|81710894|FG001|Overall Study|Protocol Violation|1|||
27967518|NCT00791479|81710895|FG002|Overall Study|Protocol Violation|0|||
27777313|NCT02573012|81013617|FG000|Overall Study|Physician Decision|1|||
27967519|NCT00791479|81710896|FG003|Overall Study|Protocol Violation|1|||
27967520|NCT00791479|81710897|FG004|Overall Study|Protocol Violation|0|||
27967521|NCT00791479|81710898|FG005|Overall Study|Protocol Violation|0|||
27967522|NCT00791479|81710893|FG000|Overall Study|Withdrawal by Subject|0|||
27967523|NCT00791479|81710894|FG001|Overall Study|Withdrawal by Subject|0|||
27967524|NCT00791479|81710895|FG002|Overall Study|Withdrawal by Subject|0|||
27967525|NCT00791479|81710896|FG003|Overall Study|Withdrawal by Subject|1|||
27777314|NCT02573012|81013618|FG001|Overall Study|Physician Decision|2|||
27777315|NCT00233324|81013619|FG000|Main Study|Death|68|||
27777316|NCT00233324|81013620|FG001|Main Study|Death|60|||
27777317|NCT00233324|81013621|FG002|Main Study|Death|62|||
27777318|NCT00233324|81013622|FG003|Main Study|Death|47|||
27777319|NCT00233324|81013619|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
27777320|NCT00233324|81013620|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
27777321|NCT00233324|81013621|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
27777322|NCT00233324|81013622|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
27777323|NCT00233324|81013619|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
27777324|NCT00233324|81013620|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
27777325|NCT00233324|81013621|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
27777326|NCT00233324|81013622|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
27777327|NCT03756285|81013623|FG000|Overall Study|Lost to Follow-up|0|||
27777328|NCT03756285|81013624|FG001|Overall Study|Lost to Follow-up|1|||
27777329|NCT03756285|81013623|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
27777330|NCT03756285|81013624|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
27777331|NCT03756285|81013623|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
27777332|NCT03756285|81013624|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
27777333|NCT01981096|81013627|FG000|Overall Study|Parent illness|1|||
27777334|NCT01981096|81013628|FG001|Overall Study|Parent illness|0|||
27777335|NCT01981096|81013627|FG000|Overall Study|Withdrawal by Subject|0|||
27777336|NCT01981096|81013628|FG001|Overall Study|Withdrawal by Subject|1|||
27862811|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
27862812|NCT02294461|81329584|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
27862813|NCT02294461|81329585|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
27862814|NCT01893346|81329586|FG000|Overall Study|Lost to Follow-up|0|||
27862815|NCT01893346|81329587|FG001|Overall Study|Lost to Follow-up|1|||
27967526|NCT00791479|81710897|FG004|Overall Study|Withdrawal by Subject|0|||
27967527|NCT00791479|81710898|FG005|Overall Study|Withdrawal by Subject|1|||
27967528|NCT03268954|81710914|FG000|Overall Study|Ongoing|23|||
27967529|NCT03268954|81710915|FG001|Overall Study|Ongoing|31|||
27777337|NCT01981096|81013627|FG000|Overall Study|Lost to Follow-up|2|||
27777338|NCT01981096|81013628|FG001|Overall Study|Lost to Follow-up|0|||
27777339|NCT04474366|81013629|FG000|Overall Study|Lost to Follow-up|2|||
27777340|NCT04474366|81013630|FG001|Overall Study|Lost to Follow-up|5|||
27862816|NCT01893346|81329588|FG002|Overall Study|Lost to Follow-up|0|||
27862817|NCT01893346|81329589|FG003|Overall Study|Lost to Follow-up|0|||
27862818|NCT01893346|81329586|FG000|Overall Study|Protocol Violation|1|||
27967530|NCT03268954|81710914|FG000|Overall Study|Adverse Event|53|||
27967531|NCT03268954|81710915|FG001|Overall Study|Adverse Event|62|||
27777341|NCT05283499|81013631|FG000|Overall Study|Did not receive intervention|1|||
27862819|NCT01893346|81329587|FG001|Overall Study|Protocol Violation|0|||
27862820|NCT01893346|81329588|FG002|Overall Study|Protocol Violation|0|||
27862821|NCT01893346|81329589|FG003|Overall Study|Protocol Violation|0|||
27862822|NCT01893346|81329586|FG000|Overall Study|Withdrawal by Subject|2|||
27862823|NCT01893346|81329587|FG001|Overall Study|Withdrawal by Subject|0|||
27862824|NCT01893346|81329588|FG002|Overall Study|Withdrawal by Subject|0|||
27862825|NCT01893346|81329589|FG003|Overall Study|Withdrawal by Subject|0|||
27862826|NCT01860677|81329595|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
27862827|NCT01860677|81329596|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
27862828|NCT04746794|81329597|FG000|Overall Study|Did not complete any study assessment|50303|||
27862829|NCT04746794|81329598|FG001|Overall Study|Did not complete any study assessment|44997|||
27862830|NCT00025259|81329599|FG000|Overall Study|Death|1|||
27862831|NCT00025259|81329600|FG001|Overall Study|Death|3|||
27862832|NCT00025259|81329601|FG002|Overall Study|Death|0|||
27862833|NCT00025259|81329602|FG003|Overall Study|Death|3|||
27862834|NCT00025259|81329603|FG004|Overall Study|Death|0|||
27862835|NCT00025259|81329604|FG005|Overall Study|Death|1|||
27862836|NCT00025259|81329605|FG006|Overall Study|Death|2|||
27862837|NCT00025259|81329599|FG000|Overall Study|Lack of Efficacy|2|||
27862838|NCT00025259|81329600|FG001|Overall Study|Lack of Efficacy|46|||
27862839|NCT00025259|81329601|FG002|Overall Study|Lack of Efficacy|60|||
27862840|NCT00025259|81329602|FG003|Overall Study|Lack of Efficacy|78|||
27862841|NCT00025259|81329603|FG004|Overall Study|Lack of Efficacy|11|||
27862842|NCT00025259|81329604|FG005|Overall Study|Lack of Efficacy|30|||
27862843|NCT00025259|81329605|FG006|Overall Study|Lack of Efficacy|38|||
27862844|NCT00025259|81329599|FG000|Overall Study|Lost to Follow-up|2|||
27862845|NCT00025259|81329600|FG001|Overall Study|Lost to Follow-up|9|||
27777342|NCT05283499|81013632|FG001|Overall Study|Did not receive intervention|2|||
27777343|NCT01332851|81013635|FG000|Overall Study|Withdrawal by Subject|4|||
27777344|NCT01332851|81013636|FG001|Overall Study|Withdrawal by Subject|2|||
27777345|NCT01332851|81013635|FG000|Overall Study|Lost to Follow-up|7|||
27777346|NCT01332851|81013636|FG001|Overall Study|Lost to Follow-up|11|||
27777347|NCT00414973|81013637|FG000|Overall Study|Withdrawal by Subject|14|||
27777348|NCT00414973|81013638|FG001|Overall Study|Withdrawal by Subject|4|||
27777349|NCT00414973|81013639|FG002|Overall Study|Withdrawal by Subject|1|||
27777350|NCT00414973|81013640|FG003|Overall Study|Withdrawal by Subject|0|||
27777351|NCT00414973|81013637|FG000|Overall Study|Adverse Event|10|||
27777352|NCT00414973|81013638|FG001|Overall Study|Adverse Event|0|||
27777353|NCT00414973|81013639|FG002|Overall Study|Adverse Event|1|||
27777354|NCT00414973|81013640|FG003|Overall Study|Adverse Event|0|||
27777355|NCT00414973|81013637|FG000|Overall Study|Protocol Violation|3|||
27777356|NCT00414973|81013638|FG001|Overall Study|Protocol Violation|4|||
27777357|NCT00414973|81013639|FG002|Overall Study|Protocol Violation|0|||
27777358|NCT00414973|81013640|FG003|Overall Study|Protocol Violation|0|||
27777359|NCT00414973|81013637|FG000|Overall Study|Lost to Follow-up|0|||
27777360|NCT00414973|81013638|FG001|Overall Study|Lost to Follow-up|2|||
27777361|NCT00414973|81013639|FG002|Overall Study|Lost to Follow-up|0|||
27777362|NCT00414973|81013640|FG003|Overall Study|Lost to Follow-up|0|||
27777363|NCT00414973|81013637|FG000|Overall Study|Sponsor Decision|1|||
27777364|NCT00414973|81013638|FG001|Overall Study|Sponsor Decision|0|||
27777365|NCT00414973|81013639|FG002|Overall Study|Sponsor Decision|0|||
27777366|NCT00414973|81013640|FG003|Overall Study|Sponsor Decision|0|||
27862846|NCT00025259|81329601|FG002|Overall Study|Lost to Follow-up|13|||
27862847|NCT00025259|81329602|FG003|Overall Study|Lost to Follow-up|13|||
27862848|NCT00025259|81329603|FG004|Overall Study|Lost to Follow-up|1|||
27862849|NCT00025259|81329604|FG005|Overall Study|Lost to Follow-up|3|||
27862850|NCT00025259|81329605|FG006|Overall Study|Lost to Follow-up|1|||
27862851|NCT00025259|81329599|FG000|Overall Study|Physician Decision|12|||
27862852|NCT00025259|81329600|FG001|Overall Study|Physician Decision|1|||
27862853|NCT00025259|81329601|FG002|Overall Study|Physician Decision|0|||
27862854|NCT00025259|81329602|FG003|Overall Study|Physician Decision|5|||
27862855|NCT00025259|81329603|FG004|Overall Study|Physician Decision|4|||
27862856|NCT00025259|81329604|FG005|Overall Study|Physician Decision|2|||
27967532|NCT03268954|81710914|FG000|Overall Study|Withdrawal by Subject|25|||
27777367|NCT00414973|81013637|FG000|Overall Study|Death|0|||
27777368|NCT00414973|81013638|FG001|Overall Study|Death|0|||
27777369|NCT00414973|81013639|FG002|Overall Study|Death|1|||
27777370|NCT00414973|81013640|FG003|Overall Study|Death|0|||
27777371|NCT02875366|81013641|FG000|Overall Study|Adverse Event|0|||
27777372|NCT02875366|81013642|FG001|Overall Study|Adverse Event|2|||
27777373|NCT02875366|81013641|FG000|Overall Study|Noncompliance|0|||
27777374|NCT02875366|81013642|FG001|Overall Study|Noncompliance|1|||
27862857|NCT00025259|81329605|FG006|Overall Study|Physician Decision|1|||
27862858|NCT00025259|81329599|FG000|Overall Study|Protocol Violation|3|||
27862859|NCT00025259|81329600|FG001|Overall Study|Protocol Violation|2|||
27862860|NCT00025259|81329601|FG002|Overall Study|Protocol Violation|2|||
27862861|NCT00025259|81329602|FG003|Overall Study|Protocol Violation|1|||
27862862|NCT00025259|81329603|FG004|Overall Study|Protocol Violation|2|||
27777375|NCT02309372|81013643|FG000|Overall Study|Lost to Follow-up|3|||
27862863|NCT00025259|81329604|FG005|Overall Study|Protocol Violation|1|||
27862864|NCT00025259|81329605|FG006|Overall Study|Protocol Violation|3|||
27862865|NCT00025259|81329599|FG000|Overall Study|Withdrawal by Subject|9|||
27862866|NCT00025259|81329600|FG001|Overall Study|Withdrawal by Subject|27|||
27862867|NCT00025259|81329601|FG002|Overall Study|Withdrawal by Subject|6|||
27862868|NCT00025259|81329602|FG003|Overall Study|Withdrawal by Subject|14|||
27862869|NCT00025259|81329603|FG004|Overall Study|Withdrawal by Subject|11|||
27862870|NCT00025259|81329604|FG005|Overall Study|Withdrawal by Subject|8|||
27862871|NCT00025259|81329605|FG006|Overall Study|Withdrawal by Subject|3|||
27862872|NCT00025259|81329599|FG000|Overall Study|Ineligible|14|||
27862873|NCT00025259|81329600|FG001|Overall Study|Ineligible|1|||
27862874|NCT00025259|81329601|FG002|Overall Study|Ineligible|0|||
27862875|NCT00025259|81329602|FG003|Overall Study|Ineligible|0|||
27862876|NCT00025259|81329603|FG004|Overall Study|Ineligible|6|||
27862877|NCT00025259|81329604|FG005|Overall Study|Ineligible|0|||
27862878|NCT00025259|81329605|FG006|Overall Study|Ineligible|1|||
27862879|NCT00025259|81329599|FG000|Overall Study|Randomization error|1|||
27862880|NCT00025259|81329600|FG001|Overall Study|Randomization error|0|||
27862881|NCT00025259|81329601|FG002|Overall Study|Randomization error|0|||
27862882|NCT00025259|81329602|FG003|Overall Study|Randomization error|0|||
27967533|NCT03268954|81710915|FG001|Overall Study|Withdrawal by Subject|16|||
27967534|NCT03268954|81710914|FG000|Overall Study|Progressive Disease|61|||
27777376|NCT02309372|81013644|FG001|Overall Study|Lost to Follow-up|2|||
27777377|NCT01888965|81013645|FG000|Overall Study|Adverse Event|5|||
27777378|NCT01888965|81013645|FG000|Overall Study|Lack of Efficacy|4|||
27777379|NCT05375838|81013646|FG000|Overall Study|Other|0|||
27777380|NCT05375838|81013647|FG001|Overall Study|Other|0|||
27777381|NCT05375838|81013648|FG002|Overall Study|Other|0|||
27777382|NCT05375838|81013649|FG003|Overall Study|Other|1|||
27777383|NCT05375838|81013650|FG004|Overall Study|Other|1|||
27777384|NCT05375838|81013651|FG005|Overall Study|Other|0|||
27777385|NCT05375838|81013646|FG000|Overall Study|Withdrawal by Subject|2|||
27777386|NCT05375838|81013647|FG001|Overall Study|Withdrawal by Subject|1|||
27777387|NCT05375838|81013648|FG002|Overall Study|Withdrawal by Subject|3|||
27777388|NCT05375838|81013649|FG003|Overall Study|Withdrawal by Subject|2|||
27777389|NCT05375838|81013650|FG004|Overall Study|Withdrawal by Subject|2|||
27777390|NCT05375838|81013651|FG005|Overall Study|Withdrawal by Subject|0|||
27777391|NCT05375838|81013646|FG000|Overall Study|Protocol Violation|0|||
27777392|NCT05375838|81013647|FG001|Overall Study|Protocol Violation|0|||
27777393|NCT05375838|81013648|FG002|Overall Study|Protocol Violation|0|||
27777394|NCT05375838|81013649|FG003|Overall Study|Protocol Violation|0|||
27777395|NCT05375838|81013650|FG004|Overall Study|Protocol Violation|1|||
27777396|NCT05375838|81013651|FG005|Overall Study|Protocol Violation|0|||
27777397|NCT05375838|81013646|FG000|Overall Study|Physician Decision|0|||
27777398|NCT05375838|81013647|FG001|Overall Study|Physician Decision|1|||
27777399|NCT05375838|81013648|FG002|Overall Study|Physician Decision|0|||
27777400|NCT05375838|81013649|FG003|Overall Study|Physician Decision|0|||
27777401|NCT05375838|81013650|FG004|Overall Study|Physician Decision|0|||
27777402|NCT05375838|81013651|FG005|Overall Study|Physician Decision|1|||
27777403|NCT05375838|81013646|FG000|Overall Study|Lost to Follow-up|2|||
27777404|NCT05375838|81013647|FG001|Overall Study|Lost to Follow-up|7|||
27777405|NCT05375838|81013648|FG002|Overall Study|Lost to Follow-up|0|||
27777406|NCT05375838|81013649|FG003|Overall Study|Lost to Follow-up|4|||
27777407|NCT05375838|81013650|FG004|Overall Study|Lost to Follow-up|2|||
27777408|NCT05375838|81013651|FG005|Overall Study|Lost to Follow-up|3|||
27777409|NCT02881151|81013652|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
27777410|NCT01950364|81013655|FG000|Overall Study|Adverse Event|3|||
27777411|NCT01950364|81013656|FG001|Overall Study|Adverse Event|0|||
27777412|NCT01950364|81013655|FG000|Overall Study|Stem Cell Transplant|2|||
27777413|NCT01950364|81013656|FG001|Overall Study|Stem Cell Transplant|6|||
27777414|NCT01950364|81013655|FG000|Overall Study|Disease Progression|5|||
27862883|NCT00025259|81329603|FG004|Overall Study|Randomization error|1|||
27862884|NCT00025259|81329604|FG005|Overall Study|Randomization error|7|||
27777415|NCT01950364|81013656|FG001|Overall Study|Disease Progression|2|||
27777416|NCT01950364|81013655|FG000|Overall Study|Withdrawal by Subject|0|||
27777417|NCT01950364|81013656|FG001|Overall Study|Withdrawal by Subject|1|||
27777418|NCT01950364|81013655|FG000|Overall Study|Protocol Violation|0|||
27777419|NCT01950364|81013656|FG001|Overall Study|Protocol Violation|1|||
27777420|NCT03323086|81013657|FG000|Overall Study|Lost to Follow-up|3|||
27777421|NCT03323086|81013658|FG001|Overall Study|Lost to Follow-up|2|||
27777422|NCT00462488|81016708|FG000|Overall Study|Protocol Violation|1|||
27777423|NCT00462488|81016709|FG001|Overall Study|Protocol Violation|0|||
27777424|NCT00462488|81016708|FG000|Overall Study|Lack of Efficacy|19|||
27777425|NCT00462488|81016709|FG001|Overall Study|Lack of Efficacy|17|||
27777426|NCT01142791|81016710|FG000|Overall Study|Alternative Treatment|1|||
27777427|NCT01142791|81016711|FG001|Overall Study|Alternative Treatment|0|||
27862885|NCT00025259|81329605|FG006|Overall Study|Randomization error|2|||
27862886|NCT00025259|81329599|FG000|Overall Study|Adverse Event|1|||
27862887|NCT00025259|81329600|FG001|Overall Study|Adverse Event|0|||
27862888|NCT00025259|81329601|FG002|Overall Study|Adverse Event|0|||
27862889|NCT00025259|81329602|FG003|Overall Study|Adverse Event|0|||
27777428|NCT01142791|81016710|FG000|Overall Study|Lost to Follow-up|1|||
27777429|NCT01142791|81016711|FG001|Overall Study|Lost to Follow-up|0|||
27777430|NCT01142791|81016710|FG000|Overall Study|Withdrawal by Subject|5|||
27777431|NCT01142791|81016711|FG001|Overall Study|Withdrawal by Subject|0|||
27777432|NCT01142791|81016710|FG000|Overall Study|Received only 1 sonication|0|||
27777433|NCT01142791|81016711|FG001|Overall Study|Received only 1 sonication|6|||
27777434|NCT01108263|81016719|FG000|Overall Study|Adverse Event|0|||
27777435|NCT01108263|81016720|FG001|Overall Study|Adverse Event|1|||
27777436|NCT00281528|81016724|FG000|Overall Study|Progressive Disease|28|||
27777437|NCT00281528|81016725|FG001|Overall Study|Progressive Disease|18|||
27777438|NCT00281528|81016726|FG002|Overall Study|Progressive Disease|27|||
27777439|NCT00281528|81016724|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
27777440|NCT00281528|81016725|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
27777441|NCT00281528|81016726|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
27777442|NCT00281528|81016724|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
27777443|NCT00281528|81016725|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
27777444|NCT00281528|81016726|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
27777445|NCT00281528|81016724|FG000|Overall Study|Physician Decision|11|||
27777446|NCT00281528|81016725|FG001|Overall Study|Physician Decision|4|||
27777447|NCT00281528|81016726|FG002|Overall Study|Physician Decision|5|||
27777448|NCT00281528|81016724|FG000|Overall Study|Protocol Violation|1|||
27777449|NCT00281528|81016725|FG001|Overall Study|Protocol Violation|0|||
27777450|NCT00281528|81016726|FG002|Overall Study|Protocol Violation|1|||
27777451|NCT00281528|81016724|FG000|Overall Study|Withdrawal by Subject|5|||
27777452|NCT00281528|81016725|FG001|Overall Study|Withdrawal by Subject|5|||
27777453|NCT00281528|81016726|FG002|Overall Study|Withdrawal by Subject|7|||
27777454|NCT00281528|81016724|FG000|Overall Study|Other|6|||
27777455|NCT00281528|81016725|FG001|Overall Study|Other|3|||
27777456|NCT00281528|81016726|FG002|Overall Study|Other|5|||
27777457|NCT01682759|81016736|FG000|Overall Study|Death|2|||
27777458|NCT01682759|81016737|FG001|Overall Study|Death|1|||
27777459|NCT01682759|81016736|FG000|Overall Study|Lost to Follow-up|10|||
27777460|NCT01682759|81016737|FG001|Overall Study|Lost to Follow-up|13|||
27777461|NCT01682759|81016736|FG000|Overall Study|Physician Decision|1|||
27777462|NCT01682759|81016737|FG001|Overall Study|Physician Decision|1|||
27777463|NCT01682759|81016736|FG000|Overall Study|Withdrawal by Subject|56|||
27777464|NCT01682759|81016737|FG001|Overall Study|Withdrawal by Subject|55|||
27777465|NCT00811395|81016738|FG000|Extension Treatment|Adverse Event|1|||
27777466|NCT00811395|81016739|FG001|Extension Treatment|Adverse Event|2|||
27777467|NCT00811395|81016740|FG002|Extension Treatment|Adverse Event|2|||
27777468|NCT00811395|81016741|FG003|Extension Treatment|Adverse Event|2|||
27777469|NCT00811395|81016742|FG004|Extension Treatment|Adverse Event|0|||
27777470|NCT00811395|81016743|FG005|Extension Treatment|Adverse Event|1|||
27777471|NCT00811395|81016738|FG000|Extension Treatment|Progressive disease|1|||
27777472|NCT00811395|81016739|FG001|Extension Treatment|Progressive disease|1|||
27777473|NCT00811395|81016740|FG002|Extension Treatment|Progressive disease|0|||
27777474|NCT00811395|81016741|FG003|Extension Treatment|Progressive disease|0|||
27777475|NCT00811395|81016742|FG004|Extension Treatment|Progressive disease|0|||
27777476|NCT00811395|81016743|FG005|Extension Treatment|Progressive disease|0|||
27777477|NCT00811395|81016738|FG000|Extension Treatment|Participant did not wish to continue|0|||
27777478|NCT00811395|81016739|FG001|Extension Treatment|Participant did not wish to continue|3|||
27777479|NCT00811395|81016740|FG002|Extension Treatment|Participant did not wish to continue|0|||
27777480|NCT00811395|81016741|FG003|Extension Treatment|Participant did not wish to continue|1|||
27777481|NCT00811395|81016742|FG004|Extension Treatment|Participant did not wish to continue|0|||
27777482|NCT00811395|81016743|FG005|Extension Treatment|Participant did not wish to continue|1|||
27777483|NCT00811395|81016738|FG000|Extension Treatment|Other than above|0|||
27777484|NCT00811395|81016739|FG001|Extension Treatment|Other than above|0|||
27665861|NCT02154347|80615400|FG000|Open-label Period|Protocol Violation|0|||
27665862|NCT02154347|80615401|FG001|Open-label Period|Protocol Violation|1|||
27777485|NCT00811395|81016740|FG002|Extension Treatment|Other than above|1|||
27777486|NCT00811395|81016741|FG003|Extension Treatment|Other than above|0|||
27777487|NCT00811395|81016742|FG004|Extension Treatment|Other than above|0|||
27777488|NCT00811395|81016743|FG005|Extension Treatment|Other than above|0|||
27967535|NCT03268954|81710915|FG001|Overall Study|Progressive Disease|48|||
27777489|NCT04411472|81016753|FG000|Overall Study|Adverse Event|5|||
27777490|NCT04411472|81016754|FG001|Overall Study|Adverse Event|10|||
27777491|NCT04411472|81016755|FG002|Overall Study|Adverse Event|1|||
27777492|NCT04411472|81016756|FG003|Overall Study|Adverse Event|0|||
27777493|NCT04411472|81016757|FG004|Overall Study|Adverse Event|0|||
27777494|NCT04411472|81016758|FG005|Overall Study|Adverse Event|0|||
27777495|NCT04411472|81016753|FG000|Overall Study|Protocol Violation|1|||
27777496|NCT04411472|81016754|FG001|Overall Study|Protocol Violation|0|||
27777497|NCT04411472|81016755|FG002|Overall Study|Protocol Violation|0|||
27777498|NCT04411472|81016756|FG003|Overall Study|Protocol Violation|0|||
27777499|NCT04411472|81016757|FG004|Overall Study|Protocol Violation|0|||
27777500|NCT04411472|81016758|FG005|Overall Study|Protocol Violation|0|||
27777501|NCT04411472|81016753|FG000|Overall Study|Withdrawal by Subject|0|||
27862890|NCT00025259|81329603|FG004|Overall Study|Adverse Event|0|||
27862891|NCT00025259|81329604|FG005|Overall Study|Adverse Event|0|||
27862892|NCT00025259|81329605|FG006|Overall Study|Adverse Event|0|||
27862893|NCT01582152|81329608|FG000|Overall Study|Disease Progression|4|||
27862894|NCT01582152|81329609|FG001|Overall Study|Disease Progression|5|||
27862895|NCT01582152|81329608|FG000|Overall Study|Adverse Event|2|||
27862896|NCT01582152|81329609|FG001|Overall Study|Adverse Event|1|||
27862897|NCT02388906|81329610|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
27862898|NCT02388906|81329611|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27862899|NCT02388906|81329610|FG000|Treatment Period|Disease progression|121|||
27862900|NCT02388906|81329611|FG001|Treatment Period|Disease progression|101|||
27862901|NCT02388906|81329610|FG000|Treatment Period|Study drug toxicity|41|||
27862902|NCT02388906|81329611|FG001|Treatment Period|Study drug toxicity|208|||
27862903|NCT02388906|81329610|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
27862904|NCT02388906|81329611|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
27862905|NCT02388906|81329610|FG000|Treatment Period|Participant request to stop treatment|5|||
27862906|NCT02388906|81329611|FG001|Treatment Period|Participant request to stop treatment|9|||
27862907|NCT02388906|81329610|FG000|Treatment Period|Participant withdrew consent|2|||
27862908|NCT02388906|81329611|FG001|Treatment Period|Participant withdrew consent|3|||
27862909|NCT02388906|81329610|FG000|Treatment Period|Poor/non-compliance|0|||
27862910|NCT02388906|81329611|FG001|Treatment Period|Poor/non-compliance|1|||
27862911|NCT02388906|81329610|FG000|Treatment Period|Participant no longer meets study criteria|0|||
27862912|NCT02388906|81329611|FG001|Treatment Period|Participant no longer meets study criteria|1|||
27862913|NCT02388906|81329610|FG000|Treatment Period|Other reasons|3|||
27862914|NCT02388906|81329611|FG001|Treatment Period|Other reasons|3|||
27862915|NCT01130597|81329614|FG000|Overall Study|Protocol-specified (High K+)|1|||
27862916|NCT01130597|81329614|FG000|Overall Study|Adverse Event|4|||
27862917|NCT01130597|81329614|FG000|Overall Study|Death|1|||
27862918|NCT01130597|81329614|FG000|Overall Study|Protocol Violation|1|||
27862919|NCT03172494|81329615|FG000|Overall Study|Adverse Event|5|||
27862920|NCT03172494|81329616|FG001|Overall Study|Adverse Event|1|||
27862921|NCT03172494|81329617|FG002|Overall Study|Adverse Event|15|||
27862922|NCT03172494|81329615|FG000|Overall Study|Protocol Violation|3|||
27862923|NCT03172494|81329616|FG001|Overall Study|Protocol Violation|2|||
27862924|NCT03172494|81329617|FG002|Overall Study|Protocol Violation|1|||
27862925|NCT03172494|81329615|FG000|Overall Study|Lack of Efficacy|0|||
27862926|NCT03172494|81329616|FG001|Overall Study|Lack of Efficacy|0|||
27862927|NCT03172494|81329617|FG002|Overall Study|Lack of Efficacy|4|||
27862928|NCT03172494|81329615|FG000|Overall Study|Pregnancy|0|||
27862929|NCT03172494|81329616|FG001|Overall Study|Pregnancy|1|||
27862930|NCT03172494|81329617|FG002|Overall Study|Pregnancy|0|||
27777502|NCT04411472|81016754|FG001|Overall Study|Withdrawal by Subject|1|||
27777503|NCT04411472|81016755|FG002|Overall Study|Withdrawal by Subject|0|||
27862931|NCT03172494|81329615|FG000|Overall Study|Withdrawal by Subject|10|||
27862932|NCT03172494|81329616|FG001|Overall Study|Withdrawal by Subject|8|||
27862933|NCT03172494|81329617|FG002|Overall Study|Withdrawal by Subject|8|||
27862934|NCT03172494|81329615|FG000|Overall Study|Severe hypoglycaemic episode|0|||
27862935|NCT03172494|81329616|FG001|Overall Study|Severe hypoglycaemic episode|0|||
27967536|NCT03268954|81710914|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
27967537|NCT03268954|81710915|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
27967538|NCT03268954|81710914|FG000|Overall Study|Reason not Specified|40|||
27967539|NCT03268954|81710915|FG001|Overall Study|Reason not Specified|40|||
27967540|NCT01638013|81710916|FG000|Overall Study|Adverse Event|36|||
27967541|NCT01638013|81710917|FG001|Overall Study|Adverse Event|29|||
27967542|NCT01638013|81710918|FG002|Overall Study|Adverse Event|48|||
27967543|NCT01638013|81710916|FG000|Overall Study|Lack of Efficacy|39|||
27967544|NCT01638013|81710917|FG001|Overall Study|Lack of Efficacy|11|||
27967545|NCT01638013|81710918|FG002|Overall Study|Lack of Efficacy|14|||
27967546|NCT01638013|81710916|FG000|Overall Study|Protocol Violation|10|||
27967547|NCT01638013|81710917|FG001|Overall Study|Protocol Violation|7|||
27967548|NCT01638013|81710918|FG002|Overall Study|Protocol Violation|11|||
27967549|NCT01638013|81710916|FG000|Overall Study|Met discontinuation criteria|4|||
27967550|NCT01638013|81710917|FG001|Overall Study|Met discontinuation criteria|0|||
27967551|NCT01638013|81710918|FG002|Overall Study|Met discontinuation criteria|7|||
27777504|NCT04411472|81016756|FG003|Overall Study|Withdrawal by Subject|1|||
27862936|NCT03172494|81329617|FG002|Overall Study|Severe hypoglycaemic episode|1|||
27862937|NCT03172494|81329615|FG000|Overall Study|Non-compliance towards treatment|2|||
27862938|NCT03172494|81329616|FG001|Overall Study|Non-compliance towards treatment|0|||
27862939|NCT03172494|81329617|FG002|Overall Study|Non-compliance towards treatment|0|||
27862940|NCT00843635|81329618|FG000|Overall Study|Adverse Event|2|||
27967552|NCT01638013|81710916|FG000|Overall Study|Subject Lost to Follow up|1|||
27967553|NCT01638013|81710917|FG001|Overall Study|Subject Lost to Follow up|0|||
27967554|NCT01638013|81710918|FG002|Overall Study|Subject Lost to Follow up|1|||
27967555|NCT01638013|81710916|FG000|Overall Study|Miscellaneous|25|||
27967556|NCT01638013|81710917|FG001|Overall Study|Miscellaneous|19|||
27967557|NCT01638013|81710918|FG002|Overall Study|Miscellaneous|23|||
27967558|NCT01638013|81710916|FG000|Overall Study|Withdrawal of Consent|16|||
27967559|NCT01638013|81710917|FG001|Overall Study|Withdrawal of Consent|12|||
27967560|NCT01638013|81710918|FG002|Overall Study|Withdrawal of Consent|16|||
27967561|NCT01638013|81710916|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
27967562|NCT01638013|81710917|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
27967563|NCT01638013|81710918|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
27967564|NCT04551963|81710919|FG000|Overall Study|Physician Decision|1|||
27967565|NCT04551963|81710920|FG001|Overall Study|Physician Decision|1|||
27967566|NCT04551963|81710919|FG000|Overall Study|Death|1|||
27777505|NCT04411472|81016757|FG004|Overall Study|Withdrawal by Subject|0|||
27777506|NCT04411472|81016758|FG005|Overall Study|Withdrawal by Subject|0|||
27777507|NCT04411472|81016753|FG000|Overall Study|Physician Decision|1|||
27777508|NCT04411472|81016754|FG001|Overall Study|Physician Decision|0|||
27777509|NCT04411472|81016755|FG002|Overall Study|Physician Decision|0|||
27777510|NCT04411472|81016756|FG003|Overall Study|Physician Decision|0|||
27777511|NCT04411472|81016757|FG004|Overall Study|Physician Decision|0|||
27777512|NCT04411472|81016758|FG005|Overall Study|Physician Decision|0|||
27777513|NCT04411472|81016753|FG000|Overall Study|Study terminated by sponsor|17|||
27777514|NCT04411472|81016754|FG001|Overall Study|Study terminated by sponsor|20|||
27777515|NCT04411472|81016755|FG002|Overall Study|Study terminated by sponsor|3|||
27777516|NCT04411472|81016756|FG003|Overall Study|Study terminated by sponsor|0|||
27777517|NCT04411472|81016757|FG004|Overall Study|Study terminated by sponsor|0|||
27777518|NCT04411472|81016758|FG005|Overall Study|Study terminated by sponsor|0|||
27777519|NCT00826540|81016759|FG000|Overall Study|ineligible|3|||
27777520|NCT00826540|81016759|FG000|Overall Study|Withdrawal by Subject|1|||
27777521|NCT02087241|81016762|FG000|Overall Study|Death|2|||
27777522|NCT02087241|81016763|FG001|Overall Study|Death|1|||
27777523|NCT02087241|81016764|FG002|Overall Study|Death|1|||
27777524|NCT02087241|81016765|FG003|Overall Study|Death|1|||
27777525|NCT02087241|81016762|FG000|Overall Study|Withdrawal by Subject|1|||
27777526|NCT02087241|81016763|FG001|Overall Study|Withdrawal by Subject|0|||
27777527|NCT02087241|81016764|FG002|Overall Study|Withdrawal by Subject|0|||
27777528|NCT02087241|81016765|FG003|Overall Study|Withdrawal by Subject|1|||
27777529|NCT02087241|81016762|FG000|Overall Study|Progressive Disease|0|||
27777530|NCT02087241|81016763|FG001|Overall Study|Progressive Disease|0|||
27777531|NCT02087241|81016764|FG002|Overall Study|Progressive Disease|0|||
27777532|NCT02087241|81016765|FG003|Overall Study|Progressive Disease|1|||
27777533|NCT02087241|81016762|FG000|Overall Study|Study Terminated by Sponsor|0|||
27777534|NCT02087241|81016763|FG001|Overall Study|Study Terminated by Sponsor|2|||
27777535|NCT02087241|81016764|FG002|Overall Study|Study Terminated by Sponsor|0|||
27777536|NCT02087241|81016765|FG003|Overall Study|Study Terminated by Sponsor|4|||
27777537|NCT02140762|81016768|FG000|Overall Study|Adverse Event|1|||
27777538|NCT02140762|81016769|FG001|Overall Study|Adverse Event|1|||
27777539|NCT02140762|81016768|FG000|Overall Study|Lost to Follow-up|9|||
27777540|NCT02140762|81016769|FG001|Overall Study|Lost to Follow-up|5|||
27777541|NCT02140762|81016768|FG000|Overall Study|Protocol Violation|1|||
27777542|NCT02140762|81016769|FG001|Overall Study|Protocol Violation|1|||
27777543|NCT02140762|81016768|FG000|Overall Study|Withdrawal by Subject|6|||
27777544|NCT02140762|81016769|FG001|Overall Study|Withdrawal by Subject|4|||
27777545|NCT02140762|81016768|FG000|Overall Study|Other|0|||
27777546|NCT02140762|81016769|FG001|Overall Study|Other|1|||
27777547|NCT03661983|81016770|FG000|Open Label Stabilization Phase|Adverse Event|5|||
27777548|NCT03661983|81016771|FG001|Open Label Stabilization Phase|Adverse Event|0|||
27777549|NCT03661983|81016772|FG002|Open Label Stabilization Phase|Adverse Event|0|||
27777550|NCT03661983|81016773|FG003|Open Label Stabilization Phase|Adverse Event|0|||
27777551|NCT03661983|81016770|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
27862941|NCT00843635|81329619|FG001|Overall Study|Adverse Event|2|||
27967567|NCT04551963|81710920|FG001|Overall Study|Death|0|||
27967568|NCT02569476|81710923|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
27967569|NCT02569476|81710923|FG000|Overall Study|Death|33|||
27967570|NCT02569476|81710923|FG000|Overall Study|Withdrawal by Subject|9|||
27967571|NCT02569476|81710923|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
27777552|NCT03661983|81016771|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
27777553|NCT03661983|81016772|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
27777554|NCT03661983|81016773|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
27777555|NCT03661983|81016770|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
27777556|NCT03661983|81016771|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
27777557|NCT03661983|81016772|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
27777558|NCT03661983|81016773|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
27777559|NCT03661983|81016770|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
27862942|NCT00843635|81329620|FG002|Overall Study|Adverse Event|0|||
27862943|NCT04974749|81329621|FG000|Overall Study|Withdrawal by Subject|2|||
27862944|NCT04974749|81329621|FG000|Overall Study|Gestation|1|||
27777560|NCT03661983|81016771|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
27777561|NCT03661983|81016772|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
27777562|NCT03661983|81016773|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
27777563|NCT03661983|81016770|FG000|Double-blind Randomized Phase|Adverse Event|0|||
27777564|NCT03661983|81016771|FG001|Double-blind Randomized Phase|Adverse Event|1|||
27862945|NCT01243775|81329626|FG000|Overall Study|Withdrawal by Subject|2|||
27862946|NCT01775189|81329633|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27862947|NCT01775189|81329634|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
27862948|NCT01775189|81329635|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27862949|NCT01775189|81329636|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27862950|NCT01775189|81329637|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27862951|NCT01775189|81329638|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27862952|NCT01775189|81329639|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27862953|NCT01775189|81329633|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27570116|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27862954|NCT01775189|81329634|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
27862955|NCT01775189|81329635|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27862956|NCT01775189|81329636|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27862957|NCT01775189|81329637|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27862958|NCT01775189|81329638|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27862959|NCT01775189|81329639|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27862960|NCT01775189|81329633|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27777565|NCT03661983|81016772|FG002|Double-blind Randomized Phase|Adverse Event|0|||
27862961|NCT01775189|81329634|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
27862962|NCT01775189|81329635|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
27862963|NCT01775189|81329636|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27862964|NCT01775189|81329637|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27862965|NCT01775189|81329638|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27862966|NCT01775189|81329639|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
27862967|NCT01775189|81329633|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27862968|NCT01775189|81329634|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27862969|NCT01775189|81329635|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27862970|NCT01775189|81329636|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27862971|NCT01775189|81329637|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27862972|NCT01775189|81329638|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
27967572|NCT02569476|81710923|FG000|Overall Study|Palliative care|1|||
27570117|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27777566|NCT03661983|81016773|FG003|Double-blind Randomized Phase|Adverse Event|0|||
27777567|NCT03661983|81016770|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
27777568|NCT03661983|81016771|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
27777569|NCT03661983|81016772|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
27777570|NCT03661983|81016773|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
27777571|NCT03661983|81016770|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
27777572|NCT03661983|81016771|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
27777573|NCT03661983|81016772|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
27777574|NCT03661983|81016773|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
27777575|NCT03661983|81016770|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
27777576|NCT03661983|81016771|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
27777577|NCT03661983|81016772|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
27777578|NCT03661983|81016773|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
27777579|NCT01051856|81016774|FG000|Overall Study|Withdrawal by Subject|1|||
27777580|NCT01051856|81016775|FG001|Overall Study|Withdrawal by Subject|0|||
27777581|NCT01969565|81016776|FG000|Overall Study|Withdrawal by Subject|1|||
27777582|NCT00836953|81016778|FG000|Overall Study|Withdrawal by Subject|1|||
27777583|NCT00836953|81016778|FG000|Overall Study|Lost to Follow-up|1|||
27777584|NCT02483611|81016779|FG000|Overall Study|Protocol Violation|0|||
27777585|NCT02483611|81016780|FG001|Overall Study|Protocol Violation|0|||
27777586|NCT02483611|81016781|FG002|Overall Study|Protocol Violation|1|||
27777587|NCT01225211|81016782|FG000|Overall Study|Adverse Event|0|||
27777588|NCT01225211|81016783|FG001|Overall Study|Adverse Event|0|||
27777589|NCT01225211|81016784|FG002|Overall Study|Adverse Event|1|||
27862973|NCT01775189|81329639|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
27862974|NCT01775189|81329633|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27777590|NCT01225211|81016785|FG003|Overall Study|Adverse Event|0|||
27777591|NCT01225211|81016786|FG004|Overall Study|Adverse Event|0|||
27777592|NCT01225211|81016787|FG005|Overall Study|Adverse Event|0|||
27967573|NCT02569476|81710923|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
27967574|NCT02569476|81710923|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
27967575|NCT00778375|81710926|FG000|Overall Study|Ineligible|3|||
27967576|NCT01252186|81710929|FG000|Overall Study|Adverse Event|9|||
27967577|NCT01252186|81710930|FG001|Overall Study|Adverse Event|6|||
27967578|NCT01252186|81710931|FG002|Overall Study|Adverse Event|8|||
27967579|NCT01252186|81710929|FG000|Overall Study|Withdrawal by Subject|2|||
27967580|NCT01252186|81710930|FG001|Overall Study|Withdrawal by Subject|5|||
27967581|NCT01252186|81710931|FG002|Overall Study|Withdrawal by Subject|2|||
27967582|NCT01252186|81710929|FG000|Overall Study|Physician Decision|0|||
27570118|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27665863|NCT02154347|80615400|FG000|Open-label Period|Withdrawal by Subject|0|||
27665864|NCT02154347|80615401|FG001|Open-label Period|Withdrawal by Subject|1|||
27665865|NCT02108652|80615403|FG000|Overall Study|Death|253|||
27777593|NCT01225211|81016788|FG006|Overall Study|Adverse Event|0|||
27777594|NCT01225211|81016789|FG007|Overall Study|Adverse Event|0|||
27777595|NCT01225211|81016790|FG008|Overall Study|Adverse Event|0|||
27777596|NCT01225211|81016791|FG009|Overall Study|Adverse Event|1|||
27665866|NCT02108652|80615403|FG000|Overall Study|Lost to Follow-up|2|||
27665867|NCT02108652|80615403|FG000|Overall Study|Withdrawal by Subject|16|||
27665868|NCT02108652|80615403|FG000|Overall Study|Study Terminated By Sponsor|31|||
27665869|NCT02108652|80615403|FG000|Overall Study|Non-Compliance|1|||
27665870|NCT02108652|80615403|FG000|Overall Study|Physician Decision|6|||
27665871|NCT02108652|80615403|FG000|Overall Study|Progression Of Disease|1|||
27665872|NCT01085812|80615404|FG000|Open-Label Period|Adverse Event|0|||
27665873|NCT01085812|80615405|FG001|Open-Label Period|Adverse Event|80|||
27665874|NCT01085812|80615404|FG000|Open-Label Period|Lack of Efficacy|0|||
27665875|NCT01085812|80615405|FG001|Open-Label Period|Lack of Efficacy|26|||
27665876|NCT01085812|80615404|FG000|Open-Label Period|Protocol Violation|0|||
27665877|NCT01085812|80615405|FG001|Open-Label Period|Protocol Violation|39|||
27665878|NCT01085812|80615404|FG000|Open-Label Period|Withdrawal by Subject|0|||
27665879|NCT01085812|80615405|FG001|Open-Label Period|Withdrawal by Subject|53|||
27665880|NCT01085812|80615404|FG000|Open-Label Period|Lost to Follow-up|0|||
27665881|NCT01085812|80615405|FG001|Open-Label Period|Lost to Follow-up|42|||
27665882|NCT01085812|80615404|FG000|Double-Blind Period|Adverse Event|3|||
27665883|NCT01085812|80615405|FG001|Double-Blind Period|Adverse Event|8|||
27665884|NCT01085812|80615404|FG000|Double-Blind Period|Protocol Violation|2|||
27665885|NCT01085812|80615405|FG001|Double-Blind Period|Protocol Violation|7|||
27665886|NCT01085812|80615404|FG000|Double-Blind Period|Withdrawal by Subject|11|||
27665887|NCT01085812|80615405|FG001|Double-Blind Period|Withdrawal by Subject|24|||
27665888|NCT01085812|80615404|FG000|Double-Blind Period|Lost to Follow-up|5|||
27665889|NCT01085812|80615405|FG001|Double-Blind Period|Lost to Follow-up|17|||
27665890|NCT01085812|80615404|FG000|Double-Blind Period|Other Reasons|0|||
27665891|NCT01085812|80615405|FG001|Double-Blind Period|Other Reasons|2|||
27665892|NCT01085812|80615404|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
27665893|NCT01085812|80615405|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
27665894|NCT01085812|80615404|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
27665895|NCT01085812|80615405|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
27665896|NCT01085812|80615404|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
27777597|NCT01225211|81016782|FG000|Overall Study|Withdrawal by Subject|0|||
27777598|NCT01225211|81016783|FG001|Overall Study|Withdrawal by Subject|0|||
27777599|NCT01225211|81016784|FG002|Overall Study|Withdrawal by Subject|0|||
27777600|NCT01225211|81016785|FG003|Overall Study|Withdrawal by Subject|0|||
27777601|NCT01225211|81016786|FG004|Overall Study|Withdrawal by Subject|0|||
27777602|NCT01225211|81016787|FG005|Overall Study|Withdrawal by Subject|0|||
27777603|NCT01225211|81016788|FG006|Overall Study|Withdrawal by Subject|1|||
27777604|NCT01225211|81016789|FG007|Overall Study|Withdrawal by Subject|0|||
27777605|NCT01225211|81016790|FG008|Overall Study|Withdrawal by Subject|1|||
27967583|NCT01252186|81710930|FG001|Overall Study|Physician Decision|0|||
27665897|NCT01085812|80615405|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
27665898|NCT01085812|80615404|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
27665899|NCT01085812|80615405|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
27665900|NCT01085812|80615404|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
27665901|NCT01085812|80615405|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
27777606|NCT01225211|81016791|FG009|Overall Study|Withdrawal by Subject|3|||
27777607|NCT01225211|81016782|FG000|Overall Study|Other|0|||
27967584|NCT01252186|81710931|FG002|Overall Study|Physician Decision|1|||
27665902|NCT00560313|80615408|FG000|Overall Study|Adverse Events or Death|2|||
27665903|NCT00560313|80615408|FG000|Overall Study|Withdrawal by Subject|2|||
27665904|NCT00560313|80615408|FG000|Overall Study|Lost to Follow-up|1|||
27665905|NCT00560313|80615408|FG000|Overall Study|Protocol Violation|1|||
27665906|NCT01232569|80615410|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
27777608|NCT01225211|81016783|FG001|Overall Study|Other|0|||
27777609|NCT01225211|81016784|FG002|Overall Study|Other|0|||
27777610|NCT01225211|81016785|FG003|Overall Study|Other|0|||
27665907|NCT01232569|80615411|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27665908|NCT01232569|80615412|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27665909|NCT01232569|80615413|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
27665910|NCT01232569|80615410|FG000|Double-blind Treatment Period|Escape|2|||
27665911|NCT01232569|80615411|FG001|Double-blind Treatment Period|Escape|2|||
27665912|NCT01232569|80615412|FG002|Double-blind Treatment Period|Escape|0|||
27665913|NCT01232569|80615413|FG003|Double-blind Treatment Period|Escape|0|||
27777611|NCT01225211|81016786|FG004|Overall Study|Other|0|||
27777612|NCT01225211|81016787|FG005|Overall Study|Other|0|||
27777613|NCT01225211|81016788|FG006|Overall Study|Other|0|||
27777614|NCT01225211|81016789|FG007|Overall Study|Other|0|||
27777615|NCT01225211|81016790|FG008|Overall Study|Other|0|||
27777616|NCT01225211|81016791|FG009|Overall Study|Other|1|||
27777617|NCT02710422|81016792|FG000|Overall Study|Termination of study|9|||
27967585|NCT01252186|81710929|FG000|Overall Study|Non-compliance|0|||
27967586|NCT01252186|81710930|FG001|Overall Study|Non-compliance|3|||
27777618|NCT02710422|81016793|FG001|Overall Study|Termination of study|9|||
27777619|NCT03147495|81016794|FG000|Overall Study|Physician Decision|0|||
27777620|NCT03147495|81016795|FG001|Overall Study|Physician Decision|6|||
27777621|NCT01590810|81016796|FG000|Overall Study|Physician Decision|0|||
27777622|NCT01590810|81016797|FG001|Overall Study|Physician Decision|1|||
27777623|NCT01590810|81016798|FG002|Overall Study|Physician Decision|1|||
27777624|NCT01590810|81016799|FG003|Overall Study|Physician Decision|0|||
27777625|NCT01590810|81016800|FG004|Overall Study|Physician Decision|0|||
27777626|NCT01947127|81016801|FG000|Overall Study|Protocol Violation|18|||
27777627|NCT01947127|81016802|FG001|Overall Study|Protocol Violation|38|||
27777628|NCT01947127|81016801|FG000|Overall Study|Withdrawal by Subject|1|||
27777629|NCT01947127|81016802|FG001|Overall Study|Withdrawal by Subject|1|||
27777630|NCT01947127|81016801|FG000|Overall Study|Data loss|4|||
27777631|NCT01947127|81016802|FG001|Overall Study|Data loss|4|||
27777632|NCT03018340|81016803|FG000|Overall Study|Adverse Event|1|||
27777633|NCT03018340|81016804|FG001|Overall Study|Adverse Event|2|||
27777634|NCT03018340|81016803|FG000|Overall Study|Withdrawal by Subject|0|||
27777635|NCT03018340|81016804|FG001|Overall Study|Withdrawal by Subject|8|||
27777636|NCT03018340|81016803|FG000|Overall Study|Lack of Efficacy|0|||
27777637|NCT03018340|81016804|FG001|Overall Study|Lack of Efficacy|1|||
27777638|NCT03018340|81016803|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
27777639|NCT03018340|81016804|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
27777640|NCT03018340|81016803|FG000|Overall Study|Lost to Follow-up|1|||
27777641|NCT03018340|81016804|FG001|Overall Study|Lost to Follow-up|7|||
27777642|NCT03018340|81016803|FG000|Overall Study|Protocol Violation|3|||
27777643|NCT03018340|81016804|FG001|Overall Study|Protocol Violation|7|||
27777644|NCT03018340|81016803|FG000|Overall Study|Not further specified|0|||
27777645|NCT03018340|81016804|FG001|Overall Study|Not further specified|1|||
27777646|NCT00911144|81016810|FG000|Overall Study|Withdrawal by Subject|16|||
27777647|NCT00911144|81016811|FG001|Overall Study|Withdrawal by Subject|5|||
27777648|NCT01572844|81016819|FG000|Overall Study|Physician Decision|1|||
27777649|NCT01572844|81016820|FG001|Overall Study|Physician Decision|1|||
27777650|NCT02178592|81016824|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
27777651|NCT02178592|81016825|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
27777652|NCT02178592|81016824|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
27777653|NCT02178592|81016825|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
27777654|NCT02178592|81016824|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
27777655|NCT02178592|81016825|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
27777656|NCT02178592|81016824|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
27777657|NCT02178592|81016825|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
27777658|NCT02178592|81016824|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
27777659|NCT02178592|81016825|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
27777660|NCT02178592|81016824|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
27777661|NCT02178592|81016825|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
27777662|NCT02178592|81016824|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
27777663|NCT02178592|81016825|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
27967587|NCT01252186|81710931|FG002|Overall Study|Non-compliance|4|||
27777664|NCT02178592|81016824|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
27777665|NCT02178592|81016825|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
27777666|NCT02178592|81016824|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
27665914|NCT01232569|80615410|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
27777667|NCT02178592|81016825|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
27777668|NCT02178592|81016824|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
27777669|NCT02178592|81016825|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
27777670|NCT02178592|81016824|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
27777671|NCT02178592|81016825|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
27777672|NCT02178592|81016824|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
27967588|NCT01252186|81710929|FG000|Overall Study|Protocol Violation|0|||
27862975|NCT01775189|81329634|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27777673|NCT02178592|81016825|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
27777674|NCT02380703|81016826|FG000|Overall Study|Withdrawal by Subject|12|||
27777675|NCT02380703|81016827|FG001|Overall Study|Withdrawal by Subject|9|||
27777676|NCT02380703|81016826|FG000|Overall Study|Lost to Follow-up|12|||
27777677|NCT02380703|81016827|FG001|Overall Study|Lost to Follow-up|12|||
27777678|NCT02380703|81016826|FG000|Overall Study|Caregiver death|1|||
27777679|NCT02380703|81016827|FG001|Overall Study|Caregiver death|0|||
27777680|NCT02380703|81016826|FG000|Overall Study|Person with dementia (PWD) death|7|||
27777681|NCT02380703|81016827|FG001|Overall Study|Person with dementia (PWD) death|8|||
27777682|NCT02380703|81016826|FG000|Overall Study|Entered Long-term Care|4|||
27777683|NCT02380703|81016827|FG001|Overall Study|Entered Long-term Care|7|||
27862976|NCT01775189|81329635|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27862977|NCT01775189|81329636|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
27862978|NCT01775189|81329637|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27862979|NCT01775189|81329638|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27862980|NCT01775189|81329639|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
27862981|NCT01775189|81329633|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27862982|NCT01775189|81329634|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27862983|NCT01775189|81329635|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27862984|NCT01775189|81329636|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
27862985|NCT01775189|81329637|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27862986|NCT01775189|81329638|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
27862987|NCT01775189|81329639|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
27862988|NCT00721227|81329642|FG000|Overall Study|Lost to Follow-up|3|||
27862989|NCT00721227|81329643|FG001|Overall Study|Lost to Follow-up|0|||
27862990|NCT00721227|81329642|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
27862991|NCT00721227|81329643|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
27862992|NCT04988087|81329646|FG000|Overall Study|Adverse Event|4|||
27862993|NCT04988087|81329647|FG001|Overall Study|Adverse Event|0|||
27862994|NCT04988087|81329648|FG002|Overall Study|Adverse Event|0|||
27862995|NCT04988087|81329649|FG003|Overall Study|Adverse Event|0|||
27862996|NCT04988087|81329646|FG000|Overall Study|Withdrawal by Subject|1|||
27862997|NCT04988087|81329647|FG001|Overall Study|Withdrawal by Subject|1|||
27862998|NCT04988087|81329648|FG002|Overall Study|Withdrawal by Subject|0|||
27862999|NCT04988087|81329649|FG003|Overall Study|Withdrawal by Subject|0|||
27863000|NCT04988087|81329646|FG000|Overall Study|Technical problems|7|||
27863001|NCT04988087|81329647|FG001|Overall Study|Technical problems|9|||
27863002|NCT04988087|81329648|FG002|Overall Study|Technical problems|1|||
27863003|NCT04988087|81329649|FG003|Overall Study|Technical problems|2|||
27863004|NCT04388553|81329650|FG000|Overall Study|Protocol Violation|1|||
27863005|NCT04388553|81329651|FG001|Overall Study|Protocol Violation|0|||
27967589|NCT01252186|81710930|FG001|Overall Study|Protocol Violation|0|||
27570119|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27777684|NCT01425528|81016829|FG000|Overall Study|Withdrawal by Subject|1|||
27777685|NCT01425528|81016830|FG001|Overall Study|Withdrawal by Subject|1|||
27777686|NCT00886587|81016831|FG000|Overall Study|Adverse Event|2|||
27777687|NCT00886587|81016832|FG001|Overall Study|Adverse Event|1|||
27777688|NCT00886587|81016831|FG000|Overall Study|Protocol Violation|2|||
27777689|NCT00886587|81016832|FG001|Overall Study|Protocol Violation|0|||
27777690|NCT00886587|81016831|FG000|Overall Study|Withdrawal by Subject|0|||
27777691|NCT00886587|81016832|FG001|Overall Study|Withdrawal by Subject|1|||
27777692|NCT01536418|81016833|FG000|Overall Study|Protocol Violation|2|||
27777693|NCT01536418|81016834|FG001|Overall Study|Protocol Violation|3|||
27863006|NCT02901548|81329652|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
27967590|NCT01252186|81710931|FG002|Overall Study|Protocol Violation|1|||
27967591|NCT01252186|81710929|FG000|Overall Study|Pregnancy|2|||
27967592|NCT01252186|81710930|FG001|Overall Study|Pregnancy|2|||
27967593|NCT01252186|81710931|FG002|Overall Study|Pregnancy|0|||
27967594|NCT01252186|81710929|FG000|Overall Study|Sponsor Request|2|||
27967595|NCT01252186|81710930|FG001|Overall Study|Sponsor Request|1|||
27967596|NCT01252186|81710931|FG002|Overall Study|Sponsor Request|0|||
27967597|NCT01252186|81710929|FG000|Overall Study|Lost to Follow-up|10|||
27967598|NCT01252186|81710930|FG001|Overall Study|Lost to Follow-up|10|||
27967599|NCT01252186|81710931|FG002|Overall Study|Lost to Follow-up|11|||
27777694|NCT01536418|81016833|FG000|Overall Study|Physician Decision|1|||
27777695|NCT01536418|81016834|FG001|Overall Study|Physician Decision|3|||
27863007|NCT00577395|81329653|FG000|Overall Study|Study was terminated early by Sponsor|7|||
27863008|NCT00577395|81329654|FG001|Overall Study|Study was terminated early by Sponsor|6|||
27863009|NCT02052011|81329655|FG000|Overall Study|Lost to Follow-up|3|||
27863010|NCT02052011|81329656|FG001|Overall Study|Lost to Follow-up|0|||
27967600|NCT01252186|81710929|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
27777696|NCT01536418|81016833|FG000|Overall Study|Study closed/terminated|41|||
27777697|NCT01536418|81016834|FG001|Overall Study|Study closed/terminated|37|||
27777698|NCT01536418|81016833|FG000|Overall Study|Lack of Efficacy|10|||
27863011|NCT02052011|81329655|FG000|Overall Study|Withdrawal by Subject|1|||
27863012|NCT02052011|81329656|FG001|Overall Study|Withdrawal by Subject|2|||
27863013|NCT02552732|81329657|FG000|Overall Study|Lost to Follow-up|2|||
27863014|NCT02552732|81329657|FG000|Overall Study|Physician Decision|1|||
27967601|NCT01252186|81710930|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
27967602|NCT01252186|81710931|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
27967603|NCT00564902|81710934|FG000|Overall Study|Withdrawal by Subject|0|||
27967604|NCT00564902|81710935|FG001|Overall Study|Withdrawal by Subject|3|||
27777699|NCT01536418|81016834|FG001|Overall Study|Lack of Efficacy|16|||
27777700|NCT01536418|81016833|FG000|Overall Study|Adverse Event|9|||
27777701|NCT01536418|81016834|FG001|Overall Study|Adverse Event|4|||
27777702|NCT01536418|81016833|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
27777703|NCT01536418|81016834|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
27777704|NCT01536418|81016833|FG000|Overall Study|Withdrawal by Subject|5|||
27777705|NCT01536418|81016834|FG001|Overall Study|Withdrawal by Subject|3|||
27777706|NCT01495689|81016837|FG000|Overall Study|Death|0|||
27967605|NCT00564902|81710936|FG002|Overall Study|Withdrawal by Subject|4|||
27967606|NCT00564902|81710934|FG000|Overall Study|Death|1|||
27863015|NCT02552732|81329657|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
27777707|NCT01495689|81016838|FG001|Overall Study|Death|1|||
27777708|NCT01495689|81016837|FG000|Overall Study|Withdrawal by Subject|3|||
27863016|NCT02552732|81329657|FG000|Overall Study|Withdrawal by Subject|6|||
27863017|NCT00626392|81329660|FG000|Run-in Period|Adverse Event|0|||
27863018|NCT00626392|81329661|FG001|Run-in Period|Adverse Event|0|||
27967607|NCT00564902|81710935|FG001|Overall Study|Death|1|||
27967608|NCT00564902|81710936|FG002|Overall Study|Death|0|||
27967609|NCT00748618|81710937|FG000|Overall Study|Adverse Event|1|||
27967610|NCT00748618|81710938|FG001|Overall Study|Adverse Event|0|||
27967611|NCT03462719|81710939|FG000|Overall Study|Withdrawal by Subject|4|||
27967612|NCT03462719|81710940|FG001|Overall Study|Withdrawal by Subject|3|||
27967613|NCT03462719|81710939|FG000|Overall Study|Ongoing|87|||
27967614|NCT03462719|81710940|FG001|Overall Study|Ongoing|72|||
27967615|NCT02321319|81710941|FG000|Overall Study|Product discontinued|5|||
27967616|NCT02003638|81710942|FG000|Overall Study|Withdrawal by Subject|1|||
27967617|NCT02003638|81710943|FG001|Overall Study|Withdrawal by Subject|0|||
27967618|NCT03206918|81710944|FG000|Overall Study|Death|11|||
27967619|NCT03206918|81710944|FG000|Overall Study|Withdrawal by Subject|5|||
27967620|NCT03206918|81710944|FG000|Overall Study|Study terminated by sponsor|12|||
27967621|NCT03206918|81710944|FG000|Overall Study|Lost to Follow-up|3|||
27967622|NCT03206918|81710944|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
27967623|NCT03654040|81710945|FG000|Overall Study|Death|1|||
27967624|NCT03654040|81710946|FG001|Overall Study|Death|0|||
27967625|NCT03654040|81710945|FG000|Overall Study|Withdrawal by Subject|1|||
27967626|NCT03654040|81710946|FG001|Overall Study|Withdrawal by Subject|0|||
27967627|NCT03654040|81710945|FG000|Overall Study|Study terminated by sponsor|8|||
27967628|NCT03654040|81710946|FG001|Overall Study|Study terminated by sponsor|2|||
27777709|NCT01495689|81016838|FG001|Overall Study|Withdrawal by Subject|0|||
27777710|NCT01495689|81016837|FG000|Overall Study|Lost to Follow-up|7|||
27967629|NCT03654040|81710945|FG000|Overall Study|Failure to initiate study therapy|2|||
27967630|NCT03654040|81710946|FG001|Overall Study|Failure to initiate study therapy|0|||
27777711|NCT01495689|81016838|FG001|Overall Study|Lost to Follow-up|6|||
27777712|NCT01885104|81016843|FG000|Overall Study|Withdrawal of Consent|1|||
27777713|NCT01885104|81016844|FG001|Overall Study|Withdrawal of Consent|0|||
27777714|NCT01885104|81016843|FG000|Overall Study|Lost to Follow-up|0|||
27777715|NCT01885104|81016844|FG001|Overall Study|Lost to Follow-up|1|||
27777716|NCT01885104|81016843|FG000|Overall Study|Physician Decision|1|||
27777717|NCT01885104|81016844|FG001|Overall Study|Physician Decision|0|||
27777718|NCT00703781|81016845|FG000|Overall Study|Withdrawal by Subject|1|||
27777719|NCT00703781|81016846|FG001|Overall Study|Withdrawal by Subject|2|||
27777720|NCT00703781|81016845|FG000|Overall Study|Cancelled surgery|1|||
27777721|NCT00703781|81016846|FG001|Overall Study|Cancelled surgery|0|||
27777722|NCT03595176|81016847|FG000|Overall Study|Death|0|||
27967631|NCT03654040|81710945|FG000|Overall Study|Transplanted at another center|2|||
27967632|NCT03654040|81710946|FG001|Overall Study|Transplanted at another center|0|||
27967633|NCT03654040|81710945|FG000|Overall Study|Failure to meet eligibility criteria|14|||
27967634|NCT03654040|81710946|FG001|Overall Study|Failure to meet eligibility criteria|2|||
27967635|NCT03654040|81710945|FG000|Overall Study|No longer transplant candidate|1|||
27570120|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570121|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27777723|NCT03595176|81016848|FG001|Overall Study|Death|2|||
27777724|NCT03595176|81016847|FG000|Overall Study|Lost to Follow-up|0|||
27777725|NCT03595176|81016848|FG001|Overall Study|Lost to Follow-up|1|||
27863019|NCT00626392|81329662|FG002|Run-in Period|Adverse Event|1|||
27967636|NCT03654040|81710946|FG001|Overall Study|No longer transplant candidate|0|||
27777726|NCT01362049|81016849|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
27777727|NCT01362049|81016850|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
27863020|NCT00626392|81329663|FG003|Run-in Period|Adverse Event|0|||
27777728|NCT01362049|81016851|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
27777729|NCT01362049|81016852|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
27777730|NCT01362049|81016849|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
27777731|NCT01362049|81016850|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
27777732|NCT01362049|81016851|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
27777733|NCT01362049|81016852|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
27777734|NCT02202161|81016853|FG000|Overall Study|Adverse Event|1|||
27777735|NCT02202161|81016854|FG001|Overall Study|Adverse Event|1|||
27777736|NCT02202161|81016855|FG002|Overall Study|Adverse Event|0|||
27777737|NCT02202161|81016856|FG003|Overall Study|Adverse Event|0|||
27777738|NCT02202161|81016857|FG004|Overall Study|Adverse Event|0|||
27777739|NCT02202161|81016858|FG005|Overall Study|Adverse Event|1|||
27777740|NCT02202161|81016859|FG006|Overall Study|Adverse Event|0|||
27777741|NCT02202161|81016860|FG007|Overall Study|Adverse Event|0|||
27777742|NCT02202161|81016853|FG000|Overall Study|Did not meet continuation criteria|0|||
27777743|NCT02202161|81016854|FG001|Overall Study|Did not meet continuation criteria|0|||
27777744|NCT02202161|81016855|FG002|Overall Study|Did not meet continuation criteria|0|||
27777745|NCT02202161|81016856|FG003|Overall Study|Did not meet continuation criteria|0|||
27777746|NCT02202161|81016857|FG004|Overall Study|Did not meet continuation criteria|0|||
27777747|NCT02202161|81016858|FG005|Overall Study|Did not meet continuation criteria|0|||
27777748|NCT02202161|81016859|FG006|Overall Study|Did not meet continuation criteria|0|||
27777749|NCT02202161|81016860|FG007|Overall Study|Did not meet continuation criteria|3|||
27570122|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570123|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27777750|NCT02202161|81016853|FG000|Overall Study|Physician Decision|0|||
27777751|NCT02202161|81016854|FG001|Overall Study|Physician Decision|0|||
27777752|NCT02202161|81016855|FG002|Overall Study|Physician Decision|0|||
27777753|NCT02202161|81016856|FG003|Overall Study|Physician Decision|0|||
27777754|NCT02202161|81016857|FG004|Overall Study|Physician Decision|0|||
27777755|NCT02202161|81016858|FG005|Overall Study|Physician Decision|0|||
27777756|NCT02202161|81016859|FG006|Overall Study|Physician Decision|0|||
27777757|NCT02202161|81016860|FG007|Overall Study|Physician Decision|3|||
27777758|NCT02202161|81016853|FG000|Overall Study|Withdrawal by Subject|0|||
27777759|NCT02202161|81016854|FG001|Overall Study|Withdrawal by Subject|0|||
27777760|NCT02202161|81016855|FG002|Overall Study|Withdrawal by Subject|0|||
27777761|NCT02202161|81016856|FG003|Overall Study|Withdrawal by Subject|0|||
27777762|NCT02202161|81016857|FG004|Overall Study|Withdrawal by Subject|1|||
27777763|NCT02202161|81016858|FG005|Overall Study|Withdrawal by Subject|0|||
27777764|NCT02202161|81016859|FG006|Overall Study|Withdrawal by Subject|0|||
27777765|NCT02202161|81016860|FG007|Overall Study|Withdrawal by Subject|0|||
27777766|NCT02516306|81016870|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
27777767|NCT02516306|81016871|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
27777768|NCT00731666|81016874|FG000|Overall Study|Adverse Event|2|||
27777769|NCT00731666|81016874|FG000|Overall Study|Lost to Follow-up|8|||
27777770|NCT00731666|81016874|FG000|Overall Study|Withdrawal by Subject|2|||
27777771|NCT02254304|81016876|FG000|Overall Study|Adverse Event|2|||
27777772|NCT02254304|81016877|FG001|Overall Study|Adverse Event|1|||
27777773|NCT02254304|81016876|FG000|Overall Study|Lost to Follow-up|2|||
27777774|NCT02254304|81016877|FG001|Overall Study|Lost to Follow-up|2|||
27777775|NCT02254304|81016876|FG000|Overall Study|Protocol Violation|1|||
27967637|NCT03654040|81710945|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
27967638|NCT03654040|81710946|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
27967639|NCT03654040|81710945|FG000|Overall Study|Recipient ineligible|0|||
27967640|NCT03654040|81710946|FG001|Overall Study|Recipient ineligible|2|||
27967641|NCT03654040|81710945|FG000|Overall Study|Received deceased liver|0|||
27967642|NCT03654040|81710946|FG001|Overall Study|Received deceased liver|1|||
27967643|NCT04776720|81710949|FG000|Overall Study|COVID Related|4|||
27967644|NCT04776720|81710950|FG001|Overall Study|COVID Related|2|||
27967645|NCT04776720|81710949|FG000|Overall Study|Adverse Event|2|||
27967646|NCT04776720|81710950|FG001|Overall Study|Adverse Event|0|||
27777776|NCT02254304|81016877|FG001|Overall Study|Protocol Violation|0|||
27777777|NCT02254304|81016876|FG000|Overall Study|Withdrawal by Subject|3|||
27777778|NCT02254304|81016877|FG001|Overall Study|Withdrawal by Subject|0|||
27777779|NCT02254304|81016876|FG000|Overall Study|Injection site pain and Injection fear|1|||
27777780|NCT02254304|81016877|FG001|Overall Study|Injection site pain and Injection fear|0|||
27777781|NCT02254304|81016876|FG000|Overall Study|Personal causes|4|||
27777782|NCT02254304|81016877|FG001|Overall Study|Personal causes|1|||
27777783|NCT02254304|81016876|FG000|Overall Study|Personal decision|1|||
27967647|NCT04776720|81710949|FG000|Overall Study|Serious Adverse Event|0|||
27777784|NCT02254304|81016877|FG001|Overall Study|Personal decision|0|||
27777785|NCT03137173|81016878|FG000|Overall Study|Withdrawal by Subject|8|||
27967648|NCT04776720|81710950|FG001|Overall Study|Serious Adverse Event|1|||
27777786|NCT03137173|81016879|FG001|Overall Study|Withdrawal by Subject|13|||
27777787|NCT03137173|81016878|FG000|Overall Study|Death|1|||
27777788|NCT03137173|81016879|FG001|Overall Study|Death|3|||
27665915|NCT01232569|80615411|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27665916|NCT01232569|80615412|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27665917|NCT01232569|80615413|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27665918|NCT01232569|80615410|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
27665919|NCT01232569|80615411|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
27665920|NCT01232569|80615412|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27665921|NCT01232569|80615413|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
27665922|NCT01232569|80615410|FG000|Double-blind Treatment Period|Physician Decision|1|||
27665923|NCT01232569|80615411|FG001|Double-blind Treatment Period|Physician Decision|0|||
27665924|NCT01232569|80615412|FG002|Double-blind Treatment Period|Physician Decision|0|||
27665925|NCT01232569|80615413|FG003|Double-blind Treatment Period|Physician Decision|0|||
27665926|NCT01232569|80615410|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
27665927|NCT01232569|80615411|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
27665928|NCT01232569|80615412|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
27665929|NCT01232569|80615413|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
27665930|NCT01232569|80615410|FG000|Double-blind Treatment Period|Death|2|||
27665931|NCT01232569|80615411|FG001|Double-blind Treatment Period|Death|0|||
27665932|NCT01232569|80615412|FG002|Double-blind Treatment Period|Death|0|||
27665933|NCT01232569|80615413|FG003|Double-blind Treatment Period|Death|0|||
27665934|NCT00630552|80615414|FG000|Overall Study|Adverse Event|0|||
27665935|NCT00630552|80615415|FG001|Overall Study|Adverse Event|1|||
27665936|NCT00630552|80615416|FG002|Overall Study|Adverse Event|5|||
27665937|NCT00630552|80615417|FG003|Overall Study|Adverse Event|4|||
27665938|NCT00630552|80615418|FG004|Overall Study|Adverse Event|2|||
27665939|NCT00630552|80615414|FG000|Overall Study|Disease progression|5|||
27665940|NCT00630552|80615415|FG001|Overall Study|Disease progression|6|||
27665941|NCT00630552|80615416|FG002|Overall Study|Disease progression|27|||
27665942|NCT00630552|80615417|FG003|Overall Study|Disease progression|22|||
27665943|NCT00630552|80615418|FG004|Overall Study|Disease progression|31|||
27665944|NCT00630552|80615414|FG000|Overall Study|Never received IP|0|||
27665945|NCT00630552|80615415|FG001|Overall Study|Never received IP|0|||
27665946|NCT00630552|80615416|FG002|Overall Study|Never received IP|0|||
27665947|NCT00630552|80615417|FG003|Overall Study|Never received IP|2|||
27665948|NCT00630552|80615418|FG004|Overall Study|Never received IP|2|||
27665949|NCT00630552|80615414|FG000|Overall Study|Ineligibility determined|0|||
27665950|NCT00630552|80615415|FG001|Overall Study|Ineligibility determined|0|||
27665951|NCT00630552|80615416|FG002|Overall Study|Ineligibility determined|0|||
27665952|NCT00630552|80615417|FG003|Overall Study|Ineligibility determined|0|||
27665953|NCT00630552|80615418|FG004|Overall Study|Ineligibility determined|1|||
27665954|NCT00630552|80615414|FG000|Overall Study|Protocol Violation|0|||
27665955|NCT00630552|80615415|FG001|Overall Study|Protocol Violation|0|||
27665956|NCT00630552|80615416|FG002|Overall Study|Protocol Violation|0|||
27665957|NCT00630552|80615417|FG003|Overall Study|Protocol Violation|1|||
27665958|NCT00630552|80615418|FG004|Overall Study|Protocol Violation|0|||
27665959|NCT00630552|80615414|FG000|Overall Study|Physician Decision|0|||
27665960|NCT00630552|80615415|FG001|Overall Study|Physician Decision|0|||
27665961|NCT00630552|80615416|FG002|Overall Study|Physician Decision|0|||
27665962|NCT00630552|80615417|FG003|Overall Study|Physician Decision|0|||
27665963|NCT00630552|80615418|FG004|Overall Study|Physician Decision|1|||
27665964|NCT00630552|80615414|FG000|Overall Study|Death|0|||
27665965|NCT00630552|80615415|FG001|Overall Study|Death|0|||
27665966|NCT00630552|80615416|FG002|Overall Study|Death|1|||
27665967|NCT00630552|80615417|FG003|Overall Study|Death|2|||
27665968|NCT00630552|80615418|FG004|Overall Study|Death|2|||
27665969|NCT00630552|80615414|FG000|Overall Study|Withdrawal by Subject|0|||
27665970|NCT00630552|80615415|FG001|Overall Study|Withdrawal by Subject|0|||
27665971|NCT00630552|80615416|FG002|Overall Study|Withdrawal by Subject|0|||
27665972|NCT00630552|80615417|FG003|Overall Study|Withdrawal by Subject|1|||
27665973|NCT00630552|80615418|FG004|Overall Study|Withdrawal by Subject|0|||
27665974|NCT00630552|80615414|FG000|Overall Study|Other|0|||
27665975|NCT00630552|80615415|FG001|Overall Study|Other|0|||
27665976|NCT00630552|80615416|FG002|Overall Study|Other|4|||
27665977|NCT00630552|80615417|FG003|Overall Study|Other|2|||
27665978|NCT00630552|80615418|FG004|Overall Study|Other|0|||
27665979|NCT00143598|80615419|FG000|Overall Study|Lost to Follow-up|23|||
27665980|NCT00143598|80615420|FG001|Overall Study|Lost to Follow-up|21|||
27665981|NCT00143598|80615419|FG000|Overall Study|Withdrawal by Subject|33|||
27665982|NCT00143598|80615420|FG001|Overall Study|Withdrawal by Subject|37|||
27665983|NCT00143598|80615419|FG000|Overall Study|Death|36|||
27665984|NCT00143598|80615420|FG001|Overall Study|Death|36|||
27665985|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
27665986|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
27665987|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
27665988|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
27665989|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
27665990|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
27777789|NCT03137173|81016878|FG000|Overall Study|Physician Decision|1|||
27777790|NCT03137173|81016879|FG001|Overall Study|Physician Decision|0|||
27777791|NCT03137173|81016878|FG000|Overall Study|Lost to Follow-up|13|||
27777792|NCT03137173|81016879|FG001|Overall Study|Lost to Follow-up|18|||
27967649|NCT04776720|81710949|FG000|Overall Study|Too Busy|3|||
27967650|NCT04776720|81710950|FG001|Overall Study|Too Busy|1|||
27777793|NCT03137173|81016878|FG000|Overall Study|Other reasons|3|||
27777794|NCT03137173|81016879|FG001|Overall Study|Other reasons|2|||
27777795|NCT01183104|81016880|FG000|Overall Study|Adverse Event|8|||
27777796|NCT01183104|81016881|FG001|Overall Study|Adverse Event|6|||
27777797|NCT01183104|81016880|FG000|Overall Study|Death|0|||
27777798|NCT01183104|81016881|FG001|Overall Study|Death|1|||
27777799|NCT01183104|81016880|FG000|Overall Study|Lost to Follow-up|14|||
27777800|NCT01183104|81016881|FG001|Overall Study|Lost to Follow-up|7|||
27777801|NCT01183104|81016880|FG000|Overall Study|Physician Decision|5|||
27777802|NCT01183104|81016881|FG001|Overall Study|Physician Decision|8|||
27777803|NCT01183104|81016880|FG000|Overall Study|Withdrawal by Subject|6|||
27777804|NCT01183104|81016881|FG001|Overall Study|Withdrawal by Subject|11|||
27777805|NCT01183104|81016880|FG000|Overall Study|Nonparticipation in Extension Study|39|||
27777806|NCT01183104|81016881|FG001|Overall Study|Nonparticipation in Extension Study|50|||
27777807|NCT01183104|81016880|FG000|Overall Study|Did not receive study drug|5|||
27777808|NCT01183104|81016881|FG001|Overall Study|Did not receive study drug|9|||
27777809|NCT00098865|81016882|FG000|Overall Study|Progressive Disease|6|||
27777810|NCT00098865|81016882|FG000|Overall Study|Adverse Event|2|||
27777811|NCT00098865|81016882|FG000|Overall Study|Alternative Therapy|1|||
27777812|NCT00083616|81016883|FG000|Overall Study|Disease Progression|16|||
27777813|NCT00083616|81016883|FG000|Overall Study|Lost to Follow-up|1|||
27777814|NCT00083616|81016883|FG000|Overall Study|Physician Decision|2|||
27777815|NCT00083616|81016883|FG000|Overall Study|Withdrawal by Subject|3|||
27777816|NCT00083616|81016883|FG000|Overall Study|Ineligibility determined|2|||
27777817|NCT00083616|81016883|FG000|Overall Study|Non-compliance|1|||
27777818|NCT00083616|81016883|FG000|Overall Study|Other|6|||
27777819|NCT01241318|81016886|FG000|Overall Study|Woman: false pregnancies|27|||
27777820|NCT01241318|81016887|FG001|Overall Study|Woman: false pregnancies|15|||
27777821|NCT01241318|81016886|FG000|Overall Study|Woman: miscarriage/abortion|46|||
27777822|NCT01241318|81016887|FG001|Overall Study|Woman: miscarriage/abortion|38|||
27777823|NCT01241318|81016886|FG000|Overall Study|Withdrawal by Subject|175|||
27863021|NCT00626392|81329664|FG004|Run-in Period|Adverse Event|1|||
27863022|NCT00626392|81329665|FG005|Run-in Period|Adverse Event|0|||
27863023|NCT00626392|81329660|FG000|Run-in Period|Withdrawal by Subject|0|||
27863024|NCT00626392|81329661|FG001|Run-in Period|Withdrawal by Subject|1|||
27863025|NCT00626392|81329662|FG002|Run-in Period|Withdrawal by Subject|1|||
27863026|NCT00626392|81329663|FG003|Run-in Period|Withdrawal by Subject|1|||
27863027|NCT00626392|81329664|FG004|Run-in Period|Withdrawal by Subject|3|||
27777824|NCT01241318|81016887|FG001|Overall Study|Withdrawal by Subject|46|||
27777825|NCT01241318|81016886|FG000|Overall Study|Lost to Follow-up|740|||
27863028|NCT00626392|81329665|FG005|Run-in Period|Withdrawal by Subject|1|||
27777826|NCT01241318|81016887|FG001|Overall Study|Lost to Follow-up|455|||
27777827|NCT01241318|81016886|FG000|Overall Study|Death|2|||
27777828|NCT01241318|81016887|FG001|Overall Study|Death|4|||
27777829|NCT01241318|81016886|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
27777830|NCT01241318|81016887|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
27777831|NCT01241318|81016886|FG000|Overall Study|Woman: Stillborn infant|129|||
27777832|NCT01241318|81016887|FG001|Overall Study|Woman: Stillborn infant|146|||
27777833|NCT00355615|81016888|FG000|Randomized Double Blind Period|Adverse Event|1|||
27777834|NCT00355615|81016889|FG001|Randomized Double Blind Period|Adverse Event|0|||
27777835|NCT00355615|81016890|FG002|Randomized Double Blind Period|Adverse Event|0|||
27777836|NCT00355615|81016891|FG003|Randomized Double Blind Period|Adverse Event|0|||
27777837|NCT00355615|81016892|FG004|Randomized Double Blind Period|Adverse Event|0|||
27777838|NCT00355615|81016888|FG000|Randomized Double Blind Period|Protocol Violation|0|||
27777839|NCT00355615|81016889|FG001|Randomized Double Blind Period|Protocol Violation|0|||
27863029|NCT00626392|81329660|FG000|Run-in Period|Noncompliance|1|||
27863030|NCT00626392|81329661|FG001|Run-in Period|Noncompliance|0|||
27967651|NCT04776720|81710949|FG000|Overall Study|Lost to Follow-up|1|||
27967652|NCT04776720|81710950|FG001|Overall Study|Lost to Follow-up|2|||
27967653|NCT04776720|81710949|FG000|Overall Study|Family|2|||
27967654|NCT04776720|81710950|FG001|Overall Study|Family|2|||
27967655|NCT04776720|81710949|FG000|Overall Study|No remote technology access|0|||
27967656|NCT04776720|81710950|FG001|Overall Study|No remote technology access|1|||
27967657|NCT04776720|81710949|FG000|Overall Study|Withdrawal by Subject|1|||
27777840|NCT00355615|81016890|FG002|Randomized Double Blind Period|Protocol Violation|1|||
27777841|NCT00355615|81016891|FG003|Randomized Double Blind Period|Protocol Violation|1|||
27777842|NCT00355615|81016892|FG004|Randomized Double Blind Period|Protocol Violation|0|||
27777843|NCT00355615|81016888|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
27777844|NCT00355615|81016889|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
27777845|NCT00355615|81016890|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
27967658|NCT04776720|81710950|FG001|Overall Study|Withdrawal by Subject|0|||
27967659|NCT04776720|81710949|FG000|Overall Study|Cannot tolerate intervention|1|||
27570124|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570125|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570126|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570127|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570128|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
27570129|NCT02346240|80275284|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570130|NCT02346240|80275285|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570131|NCT02346240|80275286|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
27570132|NCT02346240|80275287|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570133|NCT02346240|80275288|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570134|NCT02346240|80275289|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570135|NCT02346240|80275290|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570136|NCT02346240|80275291|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570137|NCT02346240|80275292|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570138|NCT02346240|80275293|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570139|NCT02346240|80275294|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570140|NCT02346240|80275295|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570141|NCT02346240|80275296|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570142|NCT02346240|80275297|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570143|NCT02346240|80275298|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570144|NCT02346240|80275299|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570145|NCT02346240|80275300|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570146|NCT02346240|80275301|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570147|NCT02346240|80275302|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570148|NCT02346240|80275303|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27777846|NCT00355615|81016891|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
27777847|NCT00355615|81016892|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
27777848|NCT00355615|81016888|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
27777849|NCT00355615|81016889|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
27777850|NCT00355615|81016890|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
27777851|NCT00355615|81016891|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
27777852|NCT00355615|81016892|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
27777853|NCT00355615|81016888|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
27777854|NCT00355615|81016889|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
27777855|NCT00355615|81016890|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
27777856|NCT00355615|81016891|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
27777857|NCT00355615|81016892|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
27777858|NCT00355615|81016888|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
27777859|NCT00355615|81016889|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
27777860|NCT00355615|81016890|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
27777861|NCT00355615|81016891|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
27777862|NCT00355615|81016892|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
27777863|NCT03797144|81016893|FG000|Enrollment|Protocol Violation|4|||
27777864|NCT03797144|81016894|FG001|Enrollment|Protocol Violation|1|||
27777865|NCT03797144|81016893|FG000|Surgery|Protocol Violation|1|||
27777866|NCT03797144|81016894|FG001|Surgery|Protocol Violation|0|||
27777867|NCT03797144|81016893|FG000|3 Month|Early termination cut-off date|2|||
27777868|NCT03797144|81016894|FG001|3 Month|Early termination cut-off date|0|||
27777869|NCT03797144|81016893|FG000|12 Month|Early termination cut-off date|8|||
27777870|NCT03797144|81016894|FG001|12 Month|Early termination cut-off date|9|||
27777871|NCT03797144|81016893|FG000|24 Month|Early termination cut-off date|1|||
27777872|NCT03797144|81016894|FG001|24 Month|Early termination cut-off date|1|||
27777873|NCT01784211|81016899|FG000|Part A (Days 1-15)|Adverse Event|1|||
27777874|NCT01784211|81016900|FG001|Part A (Days 1-15)|Adverse Event|1|||
27777875|NCT01784211|81016901|FG002|Part A (Days 1-15)|Adverse Event|0|||
27777876|NCT01784211|81016902|FG003|Part A (Days 1-15)|Adverse Event|0|||
27777877|NCT01784211|81016903|FG004|Part A (Days 1-15)|Adverse Event|0|||
27777878|NCT01784211|81016904|FG005|Part A (Days 1-15)|Adverse Event|0|||
27777879|NCT01784211|81016899|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
27777880|NCT01784211|81016900|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
27777881|NCT01784211|81016901|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
27777882|NCT01784211|81016902|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
27777883|NCT01784211|81016903|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
27777884|NCT01784211|81016904|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
27777885|NCT02828644|81016907|FG000|Overall Study|Lost to Follow-up|23|||
27863031|NCT00626392|81329662|FG002|Run-in Period|Noncompliance|1|||
27863032|NCT00626392|81329663|FG003|Run-in Period|Noncompliance|0|||
27863033|NCT00626392|81329664|FG004|Run-in Period|Noncompliance|0|||
27863034|NCT00626392|81329665|FG005|Run-in Period|Noncompliance|0|||
27863035|NCT00626392|81329660|FG000|Coadministration Period|Adverse Event|3|||
27863036|NCT00626392|81329661|FG001|Coadministration Period|Adverse Event|1|||
27863037|NCT00626392|81329662|FG002|Coadministration Period|Adverse Event|7|||
27863038|NCT00626392|81329663|FG003|Coadministration Period|Adverse Event|4|||
27863039|NCT00626392|81329664|FG004|Coadministration Period|Adverse Event|3|||
27863040|NCT00626392|81329665|FG005|Coadministration Period|Adverse Event|4|||
27863041|NCT00626392|81329660|FG000|Coadministration Period|Withdrawal by Subject|1|||
27863042|NCT00626392|81329661|FG001|Coadministration Period|Withdrawal by Subject|1|||
27863043|NCT00626392|81329662|FG002|Coadministration Period|Withdrawal by Subject|0|||
27863044|NCT00626392|81329663|FG003|Coadministration Period|Withdrawal by Subject|1|||
27863045|NCT00626392|81329664|FG004|Coadministration Period|Withdrawal by Subject|0|||
27863046|NCT00626392|81329665|FG005|Coadministration Period|Withdrawal by Subject|1|||
27863047|NCT00626392|81329660|FG000|Coadministration Period|Protocol Violation|0|||
27863048|NCT00626392|81329661|FG001|Coadministration Period|Protocol Violation|1|||
27863049|NCT00626392|81329662|FG002|Coadministration Period|Protocol Violation|0|||
27863050|NCT00626392|81329663|FG003|Coadministration Period|Protocol Violation|1|||
27863051|NCT00626392|81329664|FG004|Coadministration Period|Protocol Violation|1|||
27863052|NCT00626392|81329665|FG005|Coadministration Period|Protocol Violation|0|||
27863053|NCT00626392|81329660|FG000|Coadministration Period|Other|0|||
27863054|NCT00626392|81329661|FG001|Coadministration Period|Other|2|||
27863055|NCT00626392|81329662|FG002|Coadministration Period|Other|3|||
27863056|NCT00626392|81329663|FG003|Coadministration Period|Other|1|||
27863057|NCT00626392|81329664|FG004|Coadministration Period|Other|1|||
27863058|NCT00626392|81329665|FG005|Coadministration Period|Other|1|||
27863059|NCT00528411|81329666|FG000|Overall Study|Adverse Event|4|||
27863060|NCT00528411|81329667|FG001|Overall Study|Adverse Event|0|||
27863061|NCT00528411|81329668|FG002|Overall Study|Adverse Event|1|||
27777886|NCT02828644|81016908|FG001|Overall Study|Lost to Follow-up|22|||
27777887|NCT02477800|81016909|FG000|Placebo-Controlled Period|Adverse Event|16|||
27665991|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
27665992|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
27665993|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
27665994|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
27665995|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
27665996|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
27665997|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
27665998|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
27665999|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
27666000|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
27666001|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
27666002|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
27666003|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
27666004|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
27666005|NCT02637856|80615422|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
27666006|NCT02637856|80615423|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
27666007|NCT02637856|80615422|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
27666008|NCT02637856|80615423|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
27666009|NCT02637856|80615422|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
27777888|NCT02477800|81016910|FG001|Placebo-Controlled Period|Adverse Event|25|||
27777889|NCT02477800|81016911|FG002|Placebo-Controlled Period|Adverse Event|28|||
27777890|NCT02477800|81016912|FG003|Placebo-Controlled Period|Adverse Event|0|||
27777891|NCT02477800|81016913|FG004|Placebo-Controlled Period|Adverse Event|0|||
27777892|NCT02477800|81016914|FG005|Placebo-Controlled Period|Adverse Event|0|||
27777893|NCT02477800|81016915|FG006|Placebo-Controlled Period|Adverse Event|0|||
27777894|NCT02477800|81016909|FG000|Placebo-Controlled Period|Change of Treatment|1|||
27777895|NCT02477800|81016910|FG001|Placebo-Controlled Period|Change of Treatment|2|||
27777896|NCT02477800|81016911|FG002|Placebo-Controlled Period|Change of Treatment|1|||
27777897|NCT02477800|81016912|FG003|Placebo-Controlled Period|Change of Treatment|0|||
27777898|NCT02477800|81016913|FG004|Placebo-Controlled Period|Change of Treatment|0|||
27863062|NCT00528411|81329666|FG000|Overall Study|Incorrect Enrolment|1|||
27863063|NCT00528411|81329667|FG001|Overall Study|Incorrect Enrolment|1|||
27863064|NCT00528411|81329668|FG002|Overall Study|Incorrect Enrolment|0|||
27863065|NCT00528411|81329666|FG000|Overall Study|Severe non-compliance to protocol|0|||
27863066|NCT00528411|81329667|FG001|Overall Study|Severe non-compliance to protocol|1|||
27863067|NCT00528411|81329668|FG002|Overall Study|Severe non-compliance to protocol|0|||
27777899|NCT02477800|81016914|FG005|Placebo-Controlled Period|Change of Treatment|0|||
27777900|NCT02477800|81016915|FG006|Placebo-Controlled Period|Change of Treatment|0|||
27777901|NCT02477800|81016909|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
27777902|NCT02477800|81016910|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
27863068|NCT00528411|81329666|FG000|Overall Study|Prior commitment medication|0|||
27666010|NCT02637856|80615423|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
27666011|NCT00591409|80615424|FG000|Overall Study|Not Treated|0|||
27666012|NCT00591409|80615425|FG001|Overall Study|Not Treated|0|||
27666013|NCT00591409|80615426|FG002|Overall Study|Not Treated|0|||
27666014|NCT00591409|80615427|FG003|Overall Study|Not Treated|0|||
27666015|NCT00591409|80615428|FG004|Overall Study|Not Treated|1|||
27666016|NCT00591409|80615429|FG005|Overall Study|Not Treated|0|||
27666017|NCT00591409|80615430|FG006|Overall Study|Not Treated|0|||
27666018|NCT00591409|80615431|FG007|Overall Study|Not Treated|0|||
27666019|NCT00591409|80615432|FG008|Overall Study|Not Treated|0|||
27666020|NCT00591409|80615433|FG009|Overall Study|Not Treated|1|||
27666021|NCT05523219|80615436|FG000|Overall Study|Wrong inclusion|1|||
27666022|NCT05523219|80615436|FG000|Overall Study|Lost to Follow-up|7|||
27666023|NCT02514577|80615437|FG000|Overall Study|Lost to Follow-up|6|||
27666024|NCT02514577|80615438|FG001|Overall Study|Lost to Follow-up|6|||
27666025|NCT02514577|80615437|FG000|Overall Study|Protocol Violation|1|||
27666026|NCT02514577|80615438|FG001|Overall Study|Protocol Violation|0|||
27666027|NCT02514577|80615437|FG000|Overall Study|Withdrawal by Subject|6|||
27666028|NCT02514577|80615438|FG001|Overall Study|Withdrawal by Subject|6|||
27666029|NCT02514577|80615437|FG000|Overall Study|Adverse Event|1|||
27666030|NCT02514577|80615438|FG001|Overall Study|Adverse Event|1|||
27666031|NCT00551135|80615441|FG000|Overall Study|Adverse Event|1|||
27666032|NCT00551135|80615442|FG001|Overall Study|Adverse Event|0|||
27666033|NCT00551135|80615443|FG002|Overall Study|Adverse Event|1|||
27666034|NCT00551135|80615444|FG003|Overall Study|Adverse Event|1|||
27666035|NCT00551135|80615441|FG000|Overall Study|Lost to Follow-up|0|||
27666036|NCT00551135|80615442|FG001|Overall Study|Lost to Follow-up|0|||
27666037|NCT00551135|80615443|FG002|Overall Study|Lost to Follow-up|0|||
27666038|NCT00551135|80615444|FG003|Overall Study|Lost to Follow-up|1|||
27666039|NCT00551135|80615441|FG000|Overall Study|Other|3|||
27666040|NCT00551135|80615442|FG001|Overall Study|Other|2|||
27666041|NCT00551135|80615443|FG002|Overall Study|Other|1|||
27666042|NCT00551135|80615444|FG003|Overall Study|Other|2|||
27666043|NCT00551135|80615441|FG000|Overall Study|Withdrawal by Subject|1|||
27666044|NCT00551135|80615442|FG001|Overall Study|Withdrawal by Subject|0|||
27777903|NCT02477800|81016911|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
27777904|NCT02477800|81016912|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
27777905|NCT02477800|81016913|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
27777906|NCT02477800|81016914|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
27777907|NCT02477800|81016915|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
27777908|NCT02477800|81016909|FG000|Placebo-Controlled Period|Death|0|||
27777909|NCT02477800|81016910|FG001|Placebo-Controlled Period|Death|3|||
27777910|NCT02477800|81016911|FG002|Placebo-Controlled Period|Death|2|||
27777911|NCT02477800|81016912|FG003|Placebo-Controlled Period|Death|0|||
27777912|NCT02477800|81016913|FG004|Placebo-Controlled Period|Death|0|||
27666045|NCT00551135|80615443|FG002|Overall Study|Withdrawal by Subject|3|||
27777913|NCT02477800|81016914|FG005|Placebo-Controlled Period|Death|0|||
27777914|NCT02477800|81016915|FG006|Placebo-Controlled Period|Death|0|||
27777915|NCT02477800|81016909|FG000|Placebo-Controlled Period|Disease Progression|1|||
27777916|NCT02477800|81016910|FG001|Placebo-Controlled Period|Disease Progression|0|||
27777917|NCT02477800|81016911|FG002|Placebo-Controlled Period|Disease Progression|1|||
27777918|NCT02477800|81016912|FG003|Placebo-Controlled Period|Disease Progression|0|||
27777919|NCT02477800|81016913|FG004|Placebo-Controlled Period|Disease Progression|0|||
27777920|NCT02477800|81016914|FG005|Placebo-Controlled Period|Disease Progression|0|||
27777921|NCT02477800|81016915|FG006|Placebo-Controlled Period|Disease Progression|0|||
27666046|NCT00551135|80615444|FG003|Overall Study|Withdrawal by Subject|1|||
27666047|NCT00988117|80615448|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
27666048|NCT00988117|80615448|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
27666049|NCT02624869|80615455|FG000|Overall Study|Lost to Follow-up|0|||
27666050|NCT02624869|80615456|FG001|Overall Study|Lost to Follow-up|0|||
27666051|NCT02624869|80615457|FG002|Overall Study|Lost to Follow-up|1|||
27777922|NCT02477800|81016909|FG000|Placebo-Controlled Period|Investigator Decision|3|||
27666052|NCT02624869|80615455|FG000|Overall Study|Withdrawal by Subject|1|||
27666053|NCT02624869|80615456|FG001|Overall Study|Withdrawal by Subject|3|||
27666054|NCT02624869|80615457|FG002|Overall Study|Withdrawal by Subject|1|||
27777923|NCT02477800|81016910|FG001|Placebo-Controlled Period|Investigator Decision|2|||
27777924|NCT02477800|81016911|FG002|Placebo-Controlled Period|Investigator Decision|1|||
27666055|NCT02564718|80615458|FG000|Overall Study|Withdrew from treatment|0|||
27666056|NCT02564718|80615459|FG001|Overall Study|Withdrew from treatment|1|||
27666057|NCT03041701|80615460|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
27666058|NCT03041701|80615461|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
27666059|NCT03041701|80615462|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
27666060|NCT03041701|80615460|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
27777925|NCT02477800|81016912|FG003|Placebo-Controlled Period|Investigator Decision|0|||
27777926|NCT02477800|81016913|FG004|Placebo-Controlled Period|Investigator Decision|0|||
27777927|NCT02477800|81016914|FG005|Placebo-Controlled Period|Investigator Decision|0|||
27777928|NCT02477800|81016915|FG006|Placebo-Controlled Period|Investigator Decision|0|||
27777929|NCT02477800|81016909|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
27777930|NCT02477800|81016910|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
27777931|NCT02477800|81016911|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
27777932|NCT02477800|81016912|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
27777933|NCT02477800|81016913|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
27777934|NCT02477800|81016914|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
27777935|NCT02477800|81016915|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
27777936|NCT02477800|81016909|FG000|Placebo-Controlled Period|Relocation|2|||
27777937|NCT02477800|81016910|FG001|Placebo-Controlled Period|Relocation|0|||
27777938|NCT02477800|81016911|FG002|Placebo-Controlled Period|Relocation|0|||
27666061|NCT03041701|80615461|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
27666062|NCT03041701|80615462|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
27666063|NCT02725008|80615471|FG000|Overall Study|Lost to Follow-up|7|||
27666064|NCT02725008|80615472|FG001|Overall Study|Lost to Follow-up|9|||
27666065|NCT02725008|80615471|FG000|Overall Study|Withdrawal by Subject|2|||
27666066|NCT02725008|80615472|FG001|Overall Study|Withdrawal by Subject|2|||
27666067|NCT02725008|80615471|FG000|Overall Study|Admitted to hospital|0|||
27666068|NCT02725008|80615472|FG001|Overall Study|Admitted to hospital|1|||
27666069|NCT01180790|80615475|FG000|Overall Study|Adverse Event|1|||
27666070|NCT01180790|80615476|FG001|Overall Study|Adverse Event|1|||
27666071|NCT01180790|80615477|FG002|Overall Study|Adverse Event|2|||
27777939|NCT02477800|81016912|FG003|Placebo-Controlled Period|Relocation|0|||
27777940|NCT02477800|81016913|FG004|Placebo-Controlled Period|Relocation|0|||
27777941|NCT02477800|81016914|FG005|Placebo-Controlled Period|Relocation|0|||
27777942|NCT02477800|81016915|FG006|Placebo-Controlled Period|Relocation|0|||
27777943|NCT02477800|81016909|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
27777944|NCT02477800|81016910|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
27777945|NCT02477800|81016911|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
27777946|NCT02477800|81016912|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
27777947|NCT02477800|81016913|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
27777948|NCT02477800|81016914|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
27777949|NCT02477800|81016915|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
27777950|NCT02477800|81016909|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
27777951|NCT02477800|81016910|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
27777952|NCT02477800|81016911|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
27777953|NCT02477800|81016912|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
27777954|NCT02477800|81016913|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
27777955|NCT02477800|81016914|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
27666072|NCT01180790|80615478|FG003|Overall Study|Adverse Event|0|||
27666073|NCT01180790|80615479|FG004|Overall Study|Adverse Event|1|||
27666074|NCT01180790|80615480|FG005|Overall Study|Adverse Event|3|||
27666075|NCT01180790|80615481|FG006|Overall Study|Adverse Event|0|||
27666076|NCT01180790|80615475|FG000|Overall Study|Withdrawal by Subject|3|||
27777956|NCT02477800|81016915|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
27777957|NCT02477800|81016909|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
27777958|NCT02477800|81016910|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
27666077|NCT01180790|80615476|FG001|Overall Study|Withdrawal by Subject|0|||
27777959|NCT02477800|81016911|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
27777960|NCT02477800|81016912|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
27777961|NCT02477800|81016913|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
27777962|NCT02477800|81016914|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
27777963|NCT02477800|81016915|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
27777964|NCT02477800|81016909|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
27777965|NCT02477800|81016910|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
27777966|NCT02477800|81016911|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
27777967|NCT02477800|81016912|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27777968|NCT02477800|81016913|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27777969|NCT02477800|81016914|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27777970|NCT02477800|81016915|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27666078|NCT01180790|80615477|FG002|Overall Study|Withdrawal by Subject|5|||
27666079|NCT01180790|80615478|FG003|Overall Study|Withdrawal by Subject|0|||
27666080|NCT01180790|80615479|FG004|Overall Study|Withdrawal by Subject|2|||
27666081|NCT01180790|80615480|FG005|Overall Study|Withdrawal by Subject|1|||
27666082|NCT01180790|80615481|FG006|Overall Study|Withdrawal by Subject|0|||
27777971|NCT02477800|81016909|FG000|Placebo-Controlled Period|Reason not Specified|161|||
27777972|NCT02477800|81016910|FG001|Placebo-Controlled Period|Reason not Specified|161|||
27777973|NCT02477800|81016911|FG002|Placebo-Controlled Period|Reason not Specified|189|||
27666083|NCT01180790|80615475|FG000|Overall Study|Lost to Follow-up|3|||
27666084|NCT01180790|80615476|FG001|Overall Study|Lost to Follow-up|1|||
27666085|NCT01180790|80615477|FG002|Overall Study|Lost to Follow-up|0|||
27666086|NCT01180790|80615478|FG003|Overall Study|Lost to Follow-up|2|||
27666087|NCT01180790|80615479|FG004|Overall Study|Lost to Follow-up|1|||
27666088|NCT01180790|80615480|FG005|Overall Study|Lost to Follow-up|0|||
27666089|NCT01180790|80615481|FG006|Overall Study|Lost to Follow-up|1|||
27666090|NCT01180790|80615475|FG000|Overall Study|Physician Decision|1|||
27666091|NCT01180790|80615476|FG001|Overall Study|Physician Decision|0|||
27777974|NCT02477800|81016912|FG003|Placebo-Controlled Period|Reason not Specified|0|||
27777975|NCT02477800|81016913|FG004|Placebo-Controlled Period|Reason not Specified|0|||
27777976|NCT02477800|81016914|FG005|Placebo-Controlled Period|Reason not Specified|0|||
27777977|NCT02477800|81016915|FG006|Placebo-Controlled Period|Reason not Specified|0|||
27777978|NCT02477800|81016909|FG000|Long Term Extension Period|Adverse Event|0|||
27777979|NCT02477800|81016910|FG001|Long Term Extension Period|Adverse Event|0|||
27777980|NCT02477800|81016911|FG002|Long Term Extension Period|Adverse Event|0|||
27777981|NCT02477800|81016912|FG003|Long Term Extension Period|Adverse Event|6|||
27777982|NCT02477800|81016913|FG004|Long Term Extension Period|Adverse Event|2|||
27967660|NCT04776720|81710950|FG001|Overall Study|Cannot tolerate intervention|0|||
27967661|NCT04776720|81710949|FG000|Overall Study|Incomplete outcome data|6|||
27967662|NCT04776720|81710950|FG001|Overall Study|Incomplete outcome data|1|||
27967663|NCT01813058|81710956|FG000|Overall Study|Withdrawal by Subject|5|||
27967664|NCT01813058|81710957|FG001|Overall Study|Withdrawal by Subject|4|||
27967665|NCT04644237|81714021|FG000|Overall Study|Death|3|||
27967666|NCT04644237|81714022|FG001|Overall Study|Death|2|||
27967667|NCT04644237|81714021|FG000|Overall Study|Adverse Event|15|||
27967668|NCT04644237|81714022|FG001|Overall Study|Adverse Event|12|||
27967669|NCT04644237|81714021|FG000|Overall Study|Progressive Disease|47|||
27967670|NCT04644237|81714022|FG001|Overall Study|Progressive Disease|19|||
27967671|NCT04644237|81714021|FG000|Overall Study|Clinical Progression|4|||
27967672|NCT04644237|81714022|FG001|Overall Study|Clinical Progression|1|||
27967673|NCT04644237|81714021|FG000|Overall Study|Withdrawal by Subject|1|||
27967674|NCT04644237|81714022|FG001|Overall Study|Withdrawal by Subject|2|||
27967675|NCT04644237|81714021|FG000|Overall Study|Physician Decision|3|||
27967676|NCT04644237|81714022|FG001|Overall Study|Physician Decision|0|||
27967677|NCT04644237|81714021|FG000|Overall Study|Other|1|||
27967678|NCT04644237|81714022|FG001|Overall Study|Other|0|||
27967679|NCT04644237|81714021|FG000|Overall Study|Randomized but not Treated|1|||
27967680|NCT04644237|81714022|FG001|Overall Study|Randomized but not Treated|0|||
27967681|NCT00616018|81714023|FG000|Overall Study|Protocol Violation|3|||
27967682|NCT01942161|81714026|FG000|Overall Study|Adverse Event|1|||
27967683|NCT01942161|81714027|FG001|Overall Study|Adverse Event|2|||
27967684|NCT01942161|81714028|FG002|Overall Study|Adverse Event|5|||
27967685|NCT01942161|81714026|FG000|Overall Study|Physician Decision|3|||
27967686|NCT01942161|81714027|FG001|Overall Study|Physician Decision|1|||
27967687|NCT01942161|81714028|FG002|Overall Study|Physician Decision|0|||
27967688|NCT01942161|81714026|FG000|Overall Study|Protocol Violation|1|||
27967689|NCT01942161|81714027|FG001|Overall Study|Protocol Violation|0|||
27967690|NCT01942161|81714028|FG002|Overall Study|Protocol Violation|0|||
27967691|NCT01942161|81714026|FG000|Overall Study|Withdrawal by Subject|3|||
27967692|NCT01942161|81714027|FG001|Overall Study|Withdrawal by Subject|3|||
27967693|NCT01942161|81714028|FG002|Overall Study|Withdrawal by Subject|1|||
27967694|NCT04550832|81714029|FG000|Overall Study|Adverse Event|0|||
27967695|NCT04550832|81714030|FG001|Overall Study|Adverse Event|0|||
27967696|NCT04550832|81714031|FG002|Overall Study|Adverse Event|2|||
27967697|NCT04550832|81714032|FG003|Overall Study|Adverse Event|0|||
27967698|NCT04550832|81714033|FG004|Overall Study|Adverse Event|1|||
27967699|NCT02543281|81714038|FG000|Overall Study|Lost to Follow-up|0|||
27967700|NCT02543281|81714039|FG001|Overall Study|Lost to Follow-up|0|||
27967701|NCT02543281|81714040|FG002|Overall Study|Lost to Follow-up|1|||
27967702|NCT02218697|81714047|FG000|Overall Study|Adverse Event|0|||
27967703|NCT02218697|81714048|FG001|Overall Study|Adverse Event|2|||
27967704|NCT02218697|81714047|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
27967705|NCT02218697|81714048|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
27967706|NCT02218697|81714047|FG000|Overall Study|Withdrawal by Subject|2|||
27967707|NCT02218697|81714048|FG001|Overall Study|Withdrawal by Subject|3|||
27967708|NCT04308239|81714049|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
27666092|NCT01180790|80615477|FG002|Overall Study|Physician Decision|0|||
27666093|NCT01180790|80615478|FG003|Overall Study|Physician Decision|1|||
27666094|NCT01180790|80615479|FG004|Overall Study|Physician Decision|0|||
27666095|NCT01180790|80615480|FG005|Overall Study|Physician Decision|0|||
27666096|NCT01180790|80615481|FG006|Overall Study|Physician Decision|0|||
27666097|NCT01180790|80615475|FG000|Overall Study|Lack of Efficacy|1|||
27666098|NCT01180790|80615476|FG001|Overall Study|Lack of Efficacy|2|||
27967709|NCT04308239|81714050|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
27967710|NCT04308239|81714049|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
27967711|NCT04308239|81714050|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
27967712|NCT04308239|81714049|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
27967713|NCT04308239|81714050|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
27967714|NCT04308239|81714049|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
27967715|NCT04308239|81714050|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
27967716|NCT05151445|81714051|FG000|Overall Study|Withdrawal by Subject|3|||
27967717|NCT00157196|81714054|FG000|Overall Study|Ongoing at data cut-off|9|||
27967718|NCT01164891|81714055|FG000|Overall Study|Disease Progression|5|||
27967719|NCT01164891|81714055|FG000|Overall Study|Adverse Event|1|||
27967720|NCT02499900|81714061|FG000|Core Study Period|Other|1|||
27967721|NCT02499900|81714062|FG001|Core Study Period|Other|4|||
27967722|NCT02499900|81714061|FG000|Core Study Period|Lost to Follow-up|1|||
27967723|NCT02499900|81714062|FG001|Core Study Period|Lost to Follow-up|2|||
27967724|NCT02499900|81714061|FG000|Core Study Period|Per sponsor request|0|||
27967725|NCT02499900|81714062|FG001|Core Study Period|Per sponsor request|1|||
27967726|NCT02499900|81714061|FG000|Core Study Period|Pregnancy|1|||
27967727|NCT02499900|81714062|FG001|Core Study Period|Pregnancy|0|||
27967728|NCT02499900|81714061|FG000|Core Study Period|Protocol Violation|3|||
27967729|NCT02499900|81714062|FG001|Core Study Period|Protocol Violation|0|||
27967730|NCT02499900|81714061|FG000|Core Study Period|Withdrawal by Subject|11|||
27967731|NCT02499900|81714062|FG001|Core Study Period|Withdrawal by Subject|10|||
27967732|NCT02499900|81714061|FG000|Core Study Period|Adverse Event|18|||
27967733|NCT02499900|81714062|FG001|Core Study Period|Adverse Event|14|||
27967734|NCT02499900|81714061|FG000|Core Study Period|Death|0|||
27967735|NCT02499900|81714062|FG001|Core Study Period|Death|1|||
27967736|NCT02499900|81714061|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
27967737|NCT02499900|81714062|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
27967738|NCT02499900|81714061|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
27967739|NCT02499900|81714062|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
27967740|NCT02499900|81714061|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
27967741|NCT02499900|81714062|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
27967742|NCT02499900|81714061|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
27967743|NCT02499900|81714062|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
27967744|NCT02499900|81714061|FG000|Extension Study Period|Adverse Event|2|||
27967745|NCT02499900|81714062|FG001|Extension Study Period|Adverse Event|4|||
27967746|NCT02499900|81714061|FG000|Extension Study Period|Withdrawal by Subject|5|||
27967747|NCT02499900|81714062|FG001|Extension Study Period|Withdrawal by Subject|2|||
27967748|NCT02499900|81714061|FG000|Extension Study Period|Physician Decision|2|||
27967749|NCT02499900|81714062|FG001|Extension Study Period|Physician Decision|5|||
27967750|NCT02499900|81714061|FG000|Extension Study Period|Pregnancy|1|||
27967751|NCT02499900|81714062|FG001|Extension Study Period|Pregnancy|2|||
27967752|NCT02499900|81714061|FG000|Extension Study Period|Lost to Follow-up|2|||
27967753|NCT02499900|81714062|FG001|Extension Study Period|Lost to Follow-up|5|||
27967754|NCT02499900|81714061|FG000|Extension Study Period|Other|0|||
27967755|NCT02499900|81714062|FG001|Extension Study Period|Other|2|||
27967756|NCT00580034|81714065|FG000|Overall Study|Toxicity|10|||
27967757|NCT00580034|81714066|FG001|Overall Study|Toxicity|0|||
27967758|NCT04790279|81714067|FG000|Overall Study|Did not meet medication start criteria|27|||
27967759|NCT04790279|81714068|FG001|Overall Study|Did not meet medication start criteria|15|||
27967760|NCT04790279|81714067|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
27967761|NCT04790279|81714068|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
27967762|NCT04790279|81714067|FG000|Overall Study|Protocol Violation|8|||
27967763|NCT04790279|81714068|FG001|Overall Study|Protocol Violation|3|||
27967764|NCT04790279|81714067|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
27967765|NCT04790279|81714068|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
27967766|NCT03505788|81714069|FG000|Overall Study|Lost to Follow-up|2|||
27967767|NCT03505788|81714070|FG001|Overall Study|Lost to Follow-up|1|||
27967768|NCT03505788|81714069|FG000|Overall Study|Withdrawal by Subject|1|||
27967769|NCT03505788|81714070|FG001|Overall Study|Withdrawal by Subject|3|||
27967770|NCT03505788|81714069|FG000|Overall Study|Physician Decision|0|||
27777983|NCT02477800|81016914|FG005|Long Term Extension Period|Adverse Event|4|||
27967771|NCT03505788|81714070|FG001|Overall Study|Physician Decision|1|||
27967772|NCT00118846|81714077|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
27967773|NCT00118846|81714078|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
27967774|NCT00118846|81714077|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
27967775|NCT00118846|81714078|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
27967776|NCT00118846|81714077|FG000|Overall Study|Physician Decision|1|||
27967777|NCT00118846|81714078|FG001|Overall Study|Physician Decision|0|||
27967778|NCT00118846|81714077|FG000|Overall Study|Medical condition|2|||
27967779|NCT00118846|81714078|FG001|Overall Study|Medical condition|2|||
27967780|NCT00118846|81714077|FG000|Overall Study|Lost to Follow-up|0|||
27967781|NCT00118846|81714078|FG001|Overall Study|Lost to Follow-up|2|||
27967782|NCT00118846|81714077|FG000|Overall Study|Personal reason|4|||
27967783|NCT00118846|81714078|FG001|Overall Study|Personal reason|5|||
27967784|NCT02301546|81714080|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
27967785|NCT02301546|81714081|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
27666099|NCT01180790|80615477|FG002|Overall Study|Lack of Efficacy|5|||
27666100|NCT01180790|80615478|FG003|Overall Study|Lack of Efficacy|6|||
27666101|NCT01180790|80615479|FG004|Overall Study|Lack of Efficacy|1|||
27666102|NCT01180790|80615480|FG005|Overall Study|Lack of Efficacy|3|||
27967786|NCT02301546|81714080|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
27967787|NCT02301546|81714081|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
27666103|NCT01180790|80615481|FG006|Overall Study|Lack of Efficacy|0|||
27666104|NCT01180790|80615475|FG000|Overall Study|compliance|0|||
27666105|NCT01180790|80615476|FG001|Overall Study|compliance|1|||
27666106|NCT01180790|80615477|FG002|Overall Study|compliance|0|||
27666107|NCT01180790|80615478|FG003|Overall Study|compliance|0|||
27777984|NCT02477800|81016915|FG006|Long Term Extension Period|Adverse Event|3|||
27967788|NCT02301546|81714080|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
27967789|NCT02301546|81714081|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
27967790|NCT02301546|81714080|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
27967791|NCT02301546|81714081|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
27967792|NCT02301546|81714080|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
27967793|NCT02301546|81714081|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
27967794|NCT02301546|81714080|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
27777985|NCT02477800|81016909|FG000|Long Term Extension Period|Death|0|||
27777986|NCT02477800|81016910|FG001|Long Term Extension Period|Death|0|||
27777987|NCT02477800|81016911|FG002|Long Term Extension Period|Death|0|||
27777988|NCT02477800|81016912|FG003|Long Term Extension Period|Death|1|||
27777989|NCT02477800|81016913|FG004|Long Term Extension Period|Death|1|||
27777990|NCT02477800|81016914|FG005|Long Term Extension Period|Death|1|||
27777991|NCT02477800|81016915|FG006|Long Term Extension Period|Death|2|||
27777992|NCT02477800|81016909|FG000|Long Term Extension Period|Consent Withdrawn|0|||
27777993|NCT02477800|81016910|FG001|Long Term Extension Period|Consent Withdrawn|0|||
27777994|NCT02477800|81016911|FG002|Long Term Extension Period|Consent Withdrawn|0|||
27777995|NCT02477800|81016912|FG003|Long Term Extension Period|Consent Withdrawn|10|||
27777996|NCT02477800|81016913|FG004|Long Term Extension Period|Consent Withdrawn|4|||
27777997|NCT02477800|81016914|FG005|Long Term Extension Period|Consent Withdrawn|13|||
27777998|NCT02477800|81016915|FG006|Long Term Extension Period|Consent Withdrawn|16|||
27777999|NCT02477800|81016909|FG000|Long Term Extension Period|Disease Progression|0|||
27778000|NCT02477800|81016910|FG001|Long Term Extension Period|Disease Progression|0|||
27778001|NCT02477800|81016911|FG002|Long Term Extension Period|Disease Progression|0|||
27778002|NCT02477800|81016912|FG003|Long Term Extension Period|Disease Progression|3|||
27778003|NCT02477800|81016913|FG004|Long Term Extension Period|Disease Progression|1|||
27778004|NCT02477800|81016914|FG005|Long Term Extension Period|Disease Progression|1|||
27778005|NCT02477800|81016915|FG006|Long Term Extension Period|Disease Progression|0|||
27778006|NCT02477800|81016909|FG000|Long Term Extension Period|Investigator Decision|0|||
27778007|NCT02477800|81016910|FG001|Long Term Extension Period|Investigator Decision|0|||
27778008|NCT02477800|81016911|FG002|Long Term Extension Period|Investigator Decision|0|||
27778009|NCT02477800|81016912|FG003|Long Term Extension Period|Investigator Decision|0|||
27778010|NCT02477800|81016913|FG004|Long Term Extension Period|Investigator Decision|0|||
27778011|NCT02477800|81016914|FG005|Long Term Extension Period|Investigator Decision|0|||
27778012|NCT02477800|81016915|FG006|Long Term Extension Period|Investigator Decision|2|||
27778013|NCT02477800|81016909|FG000|Long Term Extension Period|Lost to Follow-up|0|||
27778014|NCT02477800|81016910|FG001|Long Term Extension Period|Lost to Follow-up|0|||
27778015|NCT02477800|81016911|FG002|Long Term Extension Period|Lost to Follow-up|0|||
27967795|NCT02301546|81714081|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
27967796|NCT02301546|81714080|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
27666108|NCT01180790|80615479|FG004|Overall Study|compliance|0|||
27666109|NCT01180790|80615480|FG005|Overall Study|compliance|0|||
27666110|NCT01180790|80615481|FG006|Overall Study|compliance|0|||
27666111|NCT01180790|80615475|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
27666112|NCT01180790|80615476|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
27778016|NCT02477800|81016912|FG003|Long Term Extension Period|Lost to Follow-up|0|||
27967797|NCT02301546|81714081|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
27967798|NCT00441142|81714082|FG000|Overall Study|Adverse Event|2|||
27967799|NCT00441142|81714083|FG001|Overall Study|Adverse Event|3|||
27967800|NCT00441142|81714084|FG002|Overall Study|Adverse Event|3|||
27967801|NCT00441142|81714085|FG003|Overall Study|Adverse Event|22|||
27967802|NCT00441142|81714082|FG000|Overall Study|Lack of Efficacy|3|||
27778017|NCT02477800|81016913|FG004|Long Term Extension Period|Lost to Follow-up|1|||
27778018|NCT02477800|81016914|FG005|Long Term Extension Period|Lost to Follow-up|3|||
27778019|NCT02477800|81016915|FG006|Long Term Extension Period|Lost to Follow-up|0|||
27778020|NCT02477800|81016909|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
27778021|NCT02477800|81016910|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
27778022|NCT02477800|81016911|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
27778023|NCT02477800|81016912|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
27778024|NCT02477800|81016913|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
27778025|NCT02477800|81016914|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
27778026|NCT02477800|81016915|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
27778027|NCT02477800|81016909|FG000|Long Term Extension Period|Study Visit Burden|0|||
27778028|NCT02477800|81016910|FG001|Long Term Extension Period|Study Visit Burden|0|||
27778029|NCT02477800|81016911|FG002|Long Term Extension Period|Study Visit Burden|0|||
27778030|NCT02477800|81016912|FG003|Long Term Extension Period|Study Visit Burden|3|||
27778031|NCT02477800|81016913|FG004|Long Term Extension Period|Study Visit Burden|0|||
27778032|NCT02477800|81016914|FG005|Long Term Extension Period|Study Visit Burden|2|||
27778033|NCT02477800|81016915|FG006|Long Term Extension Period|Study Visit Burden|2|||
27778034|NCT02477800|81016909|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
27778035|NCT02477800|81016910|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
27778036|NCT02477800|81016911|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
27778037|NCT02477800|81016912|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
27778038|NCT02477800|81016913|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
27778039|NCT02477800|81016914|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
27778040|NCT02477800|81016915|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
27778041|NCT02477800|81016909|FG000|Long Term Extension Period|Reason not Specified|0|||
27778042|NCT02477800|81016910|FG001|Long Term Extension Period|Reason not Specified|0|||
27778043|NCT02477800|81016911|FG002|Long Term Extension Period|Reason not Specified|0|||
27778044|NCT02477800|81016912|FG003|Long Term Extension Period|Reason not Specified|126|||
27778045|NCT02477800|81016913|FG004|Long Term Extension Period|Reason not Specified|140|||
27778046|NCT02477800|81016914|FG005|Long Term Extension Period|Reason not Specified|270|||
27778047|NCT02477800|81016915|FG006|Long Term Extension Period|Reason not Specified|224|||
27778048|NCT00736450|81016917|FG000|Overall Study|Not ABC gene eligible|19|||
27778049|NCT00736450|81016917|FG000|Overall Study|Withdrawal by Subject|5|||
27778050|NCT00736450|81016917|FG000|Overall Study|Physician Decision|1|||
27778051|NCT02390362|81016918|FG000|Overall Study|Withdrawal by Subject|0|||
27778052|NCT02390362|81016919|FG001|Overall Study|Withdrawal by Subject|1|||
27778053|NCT00608894|81016922|FG000|Overall Study|Withdrawal by Subject|0|||
27778054|NCT00608894|81016923|FG001|Overall Study|Withdrawal by Subject|2|||
27778055|NCT01948791|81016924|FG000|Overall Study|Adverse Event|12|||
27778056|NCT01948791|81016924|FG000|Overall Study|Lack of Efficacy|3|||
27778057|NCT01948791|81016924|FG000|Overall Study|Protocol Violation|2|||
27778058|NCT01948791|81016924|FG000|Overall Study|Withdrawal by Subject|5|||
27778059|NCT01948791|81016924|FG000|Overall Study|Lost to Follow-up|6|||
27778060|NCT01948791|81016924|FG000|Overall Study|Management issues|1|||
27967803|NCT00441142|81714083|FG001|Overall Study|Lack of Efficacy|3|||
27967804|NCT00441142|81714084|FG002|Overall Study|Lack of Efficacy|17|||
27967805|NCT00441142|81714085|FG003|Overall Study|Lack of Efficacy|32|||
27967806|NCT00441142|81714082|FG000|Overall Study|Withdrawal by Subject|0|||
27967807|NCT00441142|81714083|FG001|Overall Study|Withdrawal by Subject|0|||
27967808|NCT00441142|81714084|FG002|Overall Study|Withdrawal by Subject|2|||
27967809|NCT00441142|81714085|FG003|Overall Study|Withdrawal by Subject|10|||
27967810|NCT00441142|81714082|FG000|Overall Study|Patient still receiving active study tx|1|||
27967811|NCT00441142|81714083|FG001|Overall Study|Patient still receiving active study tx|0|||
27778061|NCT01948791|81016924|FG000|Overall Study|Others|7|||
27778062|NCT01948791|81016924|FG000|Overall Study|Screening failure|35|||
27778063|NCT02811640|81016925|FG000|Overall Study|Technology malfunction|2|||
27778064|NCT01738594|81016926|FG000|Registration and Treatment Start|Adverse Event|0|||
27778065|NCT01738594|81016927|FG001|Registration and Treatment Start|Adverse Event|1|||
27778066|NCT01738594|81016928|FG002|Registration and Treatment Start|Adverse Event|0|||
27778067|NCT01738594|81016929|FG003|Registration and Treatment Start|Adverse Event|0|||
27778068|NCT01738594|81016930|FG004|Registration and Treatment Start|Adverse Event|0|||
27778069|NCT01738594|81016931|FG005|Registration and Treatment Start|Adverse Event|0|||
27778070|NCT01738594|81016932|FG006|Registration and Treatment Start|Adverse Event|0|||
27778071|NCT01738594|81016933|FG007|Registration and Treatment Start|Adverse Event|0|||
27967812|NCT00441142|81714084|FG002|Overall Study|Patient still receiving active study tx|0|||
27778072|NCT01738594|81016926|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778073|NCT01738594|81016927|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778074|NCT01738594|81016928|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778075|NCT01738594|81016929|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778076|NCT01738594|81016930|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778077|NCT01738594|81016931|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
27778078|NCT01738594|81016932|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778079|NCT01738594|81016933|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
27778080|NCT01738594|81016926|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
27778081|NCT01738594|81016927|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
27863069|NCT00528411|81329667|FG001|Overall Study|Prior commitment medication|1|||
27863070|NCT00528411|81329668|FG002|Overall Study|Prior commitment medication|0|||
27863071|NCT00086281|81329669|FG000|Phase 1|Adverse Event|0|||
27863072|NCT00086281|81329670|FG001|Phase 1|Adverse Event|0|||
27863073|NCT00086281|81329671|FG002|Phase 1|Adverse Event|0|||
27863074|NCT00086281|81329672|FG003|Phase 1|Adverse Event|0|||
27863075|NCT00086281|81329673|FG004|Phase 1|Adverse Event|0|||
27863076|NCT00086281|81329674|FG005|Phase 1|Adverse Event|0|||
27863077|NCT00086281|81329675|FG006|Phase 1|Adverse Event|0|||
27863078|NCT00086281|81329676|FG007|Phase 1|Adverse Event|0|||
27863079|NCT00086281|81329677|FG008|Phase 1|Adverse Event|0|||
27863080|NCT00086281|81329678|FG009|Phase 1|Adverse Event|1|||
27863081|NCT00086281|81329679|FG010|Phase 1|Adverse Event|2|||
27863082|NCT00086281|81329680|FG011|Phase 1|Adverse Event|1|||
27863083|NCT00086281|81329681|FG012|Phase 1|Adverse Event|1|||
27863084|NCT00086281|81329682|FG013|Phase 1|Adverse Event|1|||
27863085|NCT00086281|81329683|FG014|Phase 1|Adverse Event|2|||
27863086|NCT00086281|81329669|FG000|Phase 1|Protocol Violation|0|||
27863087|NCT00086281|81329670|FG001|Phase 1|Protocol Violation|0|||
27863088|NCT00086281|81329671|FG002|Phase 1|Protocol Violation|0|||
27863089|NCT00086281|81329672|FG003|Phase 1|Protocol Violation|0|||
27863090|NCT00086281|81329673|FG004|Phase 1|Protocol Violation|0|||
27863091|NCT00086281|81329674|FG005|Phase 1|Protocol Violation|0|||
27863092|NCT00086281|81329675|FG006|Phase 1|Protocol Violation|0|||
27863093|NCT00086281|81329676|FG007|Phase 1|Protocol Violation|0|||
27863094|NCT00086281|81329677|FG008|Phase 1|Protocol Violation|0|||
27863095|NCT00086281|81329678|FG009|Phase 1|Protocol Violation|0|||
27863096|NCT00086281|81329679|FG010|Phase 1|Protocol Violation|1|||
27863097|NCT00086281|81329680|FG011|Phase 1|Protocol Violation|0|||
27863098|NCT00086281|81329681|FG012|Phase 1|Protocol Violation|0|||
27863099|NCT00086281|81329682|FG013|Phase 1|Protocol Violation|0|||
27863100|NCT00086281|81329683|FG014|Phase 1|Protocol Violation|0|||
27863101|NCT00086281|81329669|FG000|Phase 1|Serious Adverse Event|0|||
27863102|NCT00086281|81329670|FG001|Phase 1|Serious Adverse Event|0|||
27863103|NCT00086281|81329671|FG002|Phase 1|Serious Adverse Event|0|||
27863104|NCT00086281|81329672|FG003|Phase 1|Serious Adverse Event|0|||
27863105|NCT00086281|81329673|FG004|Phase 1|Serious Adverse Event|0|||
27863106|NCT00086281|81329674|FG005|Phase 1|Serious Adverse Event|0|||
27863107|NCT00086281|81329675|FG006|Phase 1|Serious Adverse Event|0|||
27778082|NCT01738594|81016928|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
27778083|NCT01738594|81016929|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
27778084|NCT01738594|81016930|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
27778085|NCT01738594|81016931|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
27863108|NCT00086281|81329676|FG007|Phase 1|Serious Adverse Event|0|||
27863109|NCT00086281|81329677|FG008|Phase 1|Serious Adverse Event|0|||
27863110|NCT00086281|81329678|FG009|Phase 1|Serious Adverse Event|0|||
27863111|NCT00086281|81329679|FG010|Phase 1|Serious Adverse Event|0|||
27863112|NCT00086281|81329680|FG011|Phase 1|Serious Adverse Event|0|||
27863113|NCT00086281|81329681|FG012|Phase 1|Serious Adverse Event|0|||
27778086|NCT01738594|81016932|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
27863114|NCT00086281|81329682|FG013|Phase 1|Serious Adverse Event|0|||
27863115|NCT00086281|81329683|FG014|Phase 1|Serious Adverse Event|1|||
27863116|NCT00086281|81329669|FG000|Phase 2|Adverse Event|0|||
27863117|NCT00086281|81329670|FG001|Phase 2|Adverse Event|0|||
27863118|NCT00086281|81329671|FG002|Phase 2|Adverse Event|0|||
27863119|NCT00086281|81329672|FG003|Phase 2|Adverse Event|0|||
27863120|NCT00086281|81329673|FG004|Phase 2|Adverse Event|0|||
27863121|NCT00086281|81329674|FG005|Phase 2|Adverse Event|0|||
27863122|NCT00086281|81329675|FG006|Phase 2|Adverse Event|0|||
27863123|NCT00086281|81329676|FG007|Phase 2|Adverse Event|0|||
27863124|NCT00086281|81329677|FG008|Phase 2|Adverse Event|0|||
27863125|NCT00086281|81329678|FG009|Phase 2|Adverse Event|0|||
27778087|NCT01738594|81016933|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
27778088|NCT01738594|81016926|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778089|NCT01738594|81016927|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778090|NCT01738594|81016928|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778091|NCT01738594|81016929|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778092|NCT01738594|81016930|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778093|NCT01738594|81016931|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
27778094|NCT01738594|81016932|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778095|NCT01738594|81016933|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
27778096|NCT01738594|81016926|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778097|NCT01738594|81016927|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778098|NCT01738594|81016928|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778099|NCT01738594|81016929|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778100|NCT01738594|81016930|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778101|NCT01738594|81016931|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
27778102|NCT01738594|81016932|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778103|NCT01738594|81016933|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
27778104|NCT01738594|81016926|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27863126|NCT00086281|81329679|FG010|Phase 2|Adverse Event|0|||
27863127|NCT00086281|81329680|FG011|Phase 2|Adverse Event|0|||
27863128|NCT00086281|81329681|FG012|Phase 2|Adverse Event|1|||
27863129|NCT00086281|81329682|FG013|Phase 2|Adverse Event|1|||
27863130|NCT00086281|81329683|FG014|Phase 2|Adverse Event|0|||
27863131|NCT01994291|81329684|FG000|Overall Study|Adverse Event|4|||
27863132|NCT01994291|81329685|FG001|Overall Study|Adverse Event|1|||
27863133|NCT01994291|81329686|FG002|Overall Study|Adverse Event|3|||
27863134|NCT01994291|81329684|FG000|Overall Study|Lost to Follow-up|1|||
27863135|NCT01994291|81329685|FG001|Overall Study|Lost to Follow-up|1|||
27863136|NCT01994291|81329686|FG002|Overall Study|Lost to Follow-up|0|||
27863137|NCT01994291|81329684|FG000|Overall Study|Does not meet entrance criteria|1|||
27863138|NCT01994291|81329685|FG001|Overall Study|Does not meet entrance criteria|0|||
27863139|NCT01994291|81329686|FG002|Overall Study|Does not meet entrance criteria|0|||
27863140|NCT01994291|81329684|FG000|Overall Study|Medication error without associated AE|1|||
27863141|NCT01994291|81329685|FG001|Overall Study|Medication error without associated AE|0|||
27863142|NCT01994291|81329686|FG002|Overall Study|Medication error without associated AE|1|||
27863143|NCT01994291|81329684|FG000|Overall Study|Protocol Violation|1|||
27863144|NCT01994291|81329685|FG001|Overall Study|Protocol Violation|0|||
27863145|NCT01994291|81329686|FG002|Overall Study|Protocol Violation|0|||
27863146|NCT01994291|81329684|FG000|Overall Study|Withdrawal by Subject|6|||
27863147|NCT01994291|81329685|FG001|Overall Study|Withdrawal by Subject|3|||
27863148|NCT01994291|81329686|FG002|Overall Study|Withdrawal by Subject|5|||
27863149|NCT01994291|81329684|FG000|Overall Study|Other|1|||
27863150|NCT01994291|81329685|FG001|Overall Study|Other|2|||
27863151|NCT01994291|81329686|FG002|Overall Study|Other|0|||
27863152|NCT01696058|81329695|FG000|Overall Study|Adverse Event|21|||
27863153|NCT01696058|81329696|FG001|Overall Study|Adverse Event|11|||
27863154|NCT01696058|81329695|FG000|Overall Study|Lack of Efficacy|2|||
27863155|NCT01696058|81329696|FG001|Overall Study|Lack of Efficacy|3|||
27570149|NCT02346240|80275304|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27863156|NCT01696058|81329695|FG000|Overall Study|Protocol Violation|9|||
27863157|NCT01696058|81329696|FG001|Overall Study|Protocol Violation|3|||
27863158|NCT01696058|81329695|FG000|Overall Study|Lost to Follow-up|2|||
27863159|NCT01696058|81329696|FG001|Overall Study|Lost to Follow-up|5|||
27863160|NCT01696058|81329695|FG000|Overall Study|Withdrawal by Subject|4|||
27778105|NCT01738594|81016927|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27778106|NCT01738594|81016928|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27778107|NCT01738594|81016929|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27778108|NCT01738594|81016930|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
27778109|NCT01738594|81016931|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27778110|NCT01738594|81016932|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27778111|NCT01738594|81016933|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
27778112|NCT01738594|81016926|FG000|Follow up for 1 Year|Death|0|||
27778113|NCT01738594|81016927|FG001|Follow up for 1 Year|Death|0|||
27863161|NCT01696058|81329696|FG001|Overall Study|Withdrawal by Subject|6|||
27967813|NCT00441142|81714085|FG003|Overall Study|Patient still receiving active study tx|2|||
27967814|NCT00441142|81714082|FG000|Overall Study|Physician Decision|0|||
27863162|NCT01696058|81329695|FG000|Overall Study|Other reason prematurely discontinued|5|||
27863163|NCT01696058|81329696|FG001|Overall Study|Other reason prematurely discontinued|3|||
27863164|NCT02787408|81329697|FG000|Overall Study|Death|16|||
27863165|NCT02787408|81329697|FG000|Overall Study|Withdrawal by Subject|1|||
27863166|NCT02787408|81329697|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
27863167|NCT01544179|81329699|FG000|Overall Study|Death|50|||
27863168|NCT01544179|81329700|FG001|Overall Study|Death|37|||
27863169|NCT01544179|81329699|FG000|Overall Study|Lost to Follow-up|0|||
27863170|NCT01544179|81329700|FG001|Overall Study|Lost to Follow-up|1|||
27863171|NCT01544179|81329699|FG000|Overall Study|Adverse Event|0|||
27863172|NCT01544179|81329700|FG001|Overall Study|Adverse Event|1|||
27863173|NCT01544179|81329699|FG000|Overall Study|Withdrawal by Subject|12|||
27863174|NCT01544179|81329700|FG001|Overall Study|Withdrawal by Subject|7|||
27863175|NCT01544179|81329699|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
27863176|NCT01544179|81329700|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27863177|NCT00631657|81329701|FG000|6-Month Treatment Period|Adverse Event|47|||
27863178|NCT00631657|81329702|FG001|6-Month Treatment Period|Adverse Event|0|||
27863179|NCT00631657|81329703|FG002|6-Month Treatment Period|Adverse Event|7|||
27863180|NCT00631657|81329701|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
27863181|NCT00631657|81329702|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
27863182|NCT00631657|81329703|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
27863183|NCT00631657|81329701|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
27863184|NCT00631657|81329702|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
27863185|NCT00631657|81329703|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
27863186|NCT00631657|81329701|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
27863187|NCT00631657|81329702|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
27863188|NCT00631657|81329703|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
27863189|NCT00631657|81329701|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
27863190|NCT00631657|81329702|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
27863191|NCT00631657|81329703|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
27863192|NCT00631657|81329701|FG000|6-Month Treatment Period|Other|16|||
27863193|NCT00631657|81329702|FG001|6-Month Treatment Period|Other|0|||
27863194|NCT00631657|81329703|FG002|6-Month Treatment Period|Other|4|||
27863195|NCT00631657|81329701|FG000|6-Month Treatment Period|Not Treated|2|||
27863196|NCT00631657|81329702|FG001|6-Month Treatment Period|Not Treated|0|||
27863197|NCT00631657|81329703|FG002|6-Month Treatment Period|Not Treated|1|||
27863198|NCT00631657|81329701|FG000|7-Day Discontinuation Period|Not Treated|1|||
27863199|NCT00631657|81329702|FG001|7-Day Discontinuation Period|Not Treated|1|||
27863200|NCT00631657|81329703|FG002|7-Day Discontinuation Period|Not Treated|1|||
27863201|NCT00631657|81329701|FG000|7-Day Discontinuation Period|Other|1|||
27863202|NCT00631657|81329702|FG001|7-Day Discontinuation Period|Other|0|||
27863203|NCT00631657|81329703|FG002|7-Day Discontinuation Period|Other|0|||
27863204|NCT01199016|81329707|FG000|Overall Study|No longer meets eligibility criteria|4|||
27863205|NCT01199016|81329707|FG000|Overall Study|Entrance criteria|5|||
27863206|NCT01199016|81329707|FG000|Overall Study|Protocol Violation|9|||
27863207|NCT01199016|81329707|FG000|Overall Study|Other|13|||
27863208|NCT01199016|81329707|FG000|Overall Study|Withdrawal by Subject|21|||
27863209|NCT01199016|81329707|FG000|Overall Study|Lost to Follow-up|25|||
27863210|NCT03597529|81329709|FG000|Overall Study|Lost to Follow-up|10|||
27967815|NCT00441142|81714083|FG001|Overall Study|Physician Decision|1|||
27967816|NCT00441142|81714084|FG002|Overall Study|Physician Decision|0|||
27967817|NCT00441142|81714085|FG003|Overall Study|Physician Decision|1|||
27863211|NCT03597529|81329710|FG001|Overall Study|Lost to Follow-up|12|||
27863212|NCT03597529|81329709|FG000|Overall Study|Physician Decision|3|||
27863213|NCT03597529|81329710|FG001|Overall Study|Physician Decision|1|||
27863214|NCT03597529|81329709|FG000|Overall Study|Withdrawal by Subject|6|||
27863215|NCT03597529|81329710|FG001|Overall Study|Withdrawal by Subject|3|||
27863216|NCT03597529|81329709|FG000|Overall Study|Non-compliant with study activities|1|||
27863217|NCT03597529|81329710|FG001|Overall Study|Non-compliant with study activities|2|||
27863218|NCT04380961|81329711|FG000|Overall Study|Lost to Follow-up|17|||
27863219|NCT04380961|81329712|FG001|Overall Study|Lost to Follow-up|11|||
27967818|NCT00441142|81714082|FG000|Overall Study|Death|0|||
27863220|NCT04380961|81329711|FG000|Overall Study|Withdrawal by Subject|3|||
27570150|NCT02346240|80275305|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570151|NCT02346240|80275306|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570152|NCT02346240|80275307|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
27570153|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570154|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570155|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570156|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570157|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570158|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570159|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570160|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27570161|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27570162|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27778114|NCT01738594|81016928|FG002|Follow up for 1 Year|Death|0|||
27778115|NCT01738594|81016929|FG003|Follow up for 1 Year|Death|0|||
27778116|NCT01738594|81016930|FG004|Follow up for 1 Year|Death|0|||
27967819|NCT00441142|81714083|FG001|Overall Study|Death|0|||
27967820|NCT00441142|81714084|FG002|Overall Study|Death|0|||
27967821|NCT00441142|81714085|FG003|Overall Study|Death|1|||
27967822|NCT03006848|81714086|FG000|Overall Study|Adverse Event|1|||
27967823|NCT03006848|81714086|FG000|Overall Study|Physician Decision|1|||
27967824|NCT03006848|81714086|FG000|Overall Study|Lack of Efficacy|16|||
27967825|NCT01893411|81714087|FG000|Overall Study|Protocol Violation|1|||
27778117|NCT01738594|81016931|FG005|Follow up for 1 Year|Death|1|||
27778118|NCT01738594|81016932|FG006|Follow up for 1 Year|Death|0|||
27778119|NCT01738594|81016933|FG007|Follow up for 1 Year|Death|0|||
27778120|NCT01738594|81016926|FG000|Follow up for 1 Year|Other|0|||
27778121|NCT01738594|81016927|FG001|Follow up for 1 Year|Other|0|||
27778122|NCT01738594|81016928|FG002|Follow up for 1 Year|Other|0|||
27778123|NCT01738594|81016929|FG003|Follow up for 1 Year|Other|0|||
27778124|NCT01738594|81016930|FG004|Follow up for 1 Year|Other|0|||
27778125|NCT01738594|81016931|FG005|Follow up for 1 Year|Other|2|||
27778126|NCT01738594|81016932|FG006|Follow up for 1 Year|Other|0|||
27778127|NCT01738594|81016933|FG007|Follow up for 1 Year|Other|0|||
27778128|NCT00735072|81016934|FG000|Overall Study|interrupted study med during ARV change|1|||
27778129|NCT00735072|81016935|FG001|Overall Study|interrupted study med during ARV change|0|||
27967826|NCT01893411|81714088|FG001|Overall Study|Protocol Violation|0|||
27967827|NCT01893411|81714089|FG002|Overall Study|Protocol Violation|0|||
27967828|NCT01893411|81714087|FG000|Overall Study|Physician Decision|1|||
27967829|NCT01893411|81714088|FG001|Overall Study|Physician Decision|1|||
27778130|NCT00735072|81016934|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
27778131|NCT00735072|81016935|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
27778132|NCT00715949|81016945|FG000|Overall Study|could not finish first test|4|||
27778133|NCT01693562|81016946|FG000|Escalation Phase|Withdrawal by Subject|0|||
27778134|NCT01693562|81016947|FG001|Escalation Phase|Withdrawal by Subject|1|||
27778135|NCT01693562|81016948|FG002|Escalation Phase|Withdrawal by Subject|0|||
27778136|NCT01693562|81016949|FG003|Escalation Phase|Withdrawal by Subject|0|||
27778137|NCT01693562|81016950|FG004|Escalation Phase|Withdrawal by Subject|0|||
27778138|NCT01693562|81016951|FG005|Escalation Phase|Withdrawal by Subject|2|||
27778139|NCT01693562|81016952|FG006|Escalation Phase|Withdrawal by Subject|0|||
27778140|NCT01693562|81016953|FG007|Escalation Phase|Withdrawal by Subject|0|||
27778141|NCT01693562|81016954|FG008|Escalation Phase|Withdrawal by Subject|0|||
27778142|NCT01693562|81016955|FG009|Escalation Phase|Withdrawal by Subject|0|||
27778143|NCT01693562|81016956|FG010|Escalation Phase|Withdrawal by Subject|0|||
27778144|NCT01693562|81016957|FG011|Escalation Phase|Withdrawal by Subject|0|||
27778145|NCT01693562|81016958|FG012|Escalation Phase|Withdrawal by Subject|0|||
27778146|NCT01693562|81016959|FG013|Escalation Phase|Withdrawal by Subject|0|||
27778147|NCT01693562|81016960|FG014|Escalation Phase|Withdrawal by Subject|0|||
27778148|NCT01693562|81016961|FG015|Escalation Phase|Withdrawal by Subject|0|||
27778149|NCT01693562|81016962|FG016|Escalation Phase|Withdrawal by Subject|0|||
27778150|NCT01693562|81016963|FG017|Escalation Phase|Withdrawal by Subject|0|||
27778151|NCT01693562|81016964|FG018|Escalation Phase|Withdrawal by Subject|0|||
27778152|NCT01693562|81016965|FG019|Escalation Phase|Withdrawal by Subject|0|||
27778153|NCT01693562|81016966|FG020|Escalation Phase|Withdrawal by Subject|0|||
27778154|NCT01693562|81016967|FG021|Escalation Phase|Withdrawal by Subject|0|||
27778155|NCT01693562|81016968|FG022|Escalation Phase|Withdrawal by Subject|0|||
27863221|NCT04380961|81329712|FG001|Overall Study|Withdrawal by Subject|0|||
27967830|NCT01893411|81714089|FG002|Overall Study|Physician Decision|2|||
27967831|NCT01893411|81714087|FG000|Overall Study|Lack of Efficacy|2|||
27967832|NCT01893411|81714088|FG001|Overall Study|Lack of Efficacy|1|||
27967833|NCT01893411|81714089|FG002|Overall Study|Lack of Efficacy|0|||
27778156|NCT01693562|81016946|FG000|Escalation Phase|Death|4|||
27778157|NCT01693562|81016947|FG001|Escalation Phase|Death|2|||
27778158|NCT01693562|81016948|FG002|Escalation Phase|Death|0|||
27778159|NCT01693562|81016949|FG003|Escalation Phase|Death|3|||
27778160|NCT01693562|81016950|FG004|Escalation Phase|Death|6|||
27778161|NCT01693562|81016951|FG005|Escalation Phase|Death|4|||
27863222|NCT04380961|81329711|FG000|Overall Study|Death|22|||
27863223|NCT04380961|81329712|FG001|Overall Study|Death|16|||
27863224|NCT04380961|81329711|FG000|Overall Study|Other|1|||
27863225|NCT04380961|81329712|FG001|Overall Study|Other|0|||
27863226|NCT04380961|81329711|FG000|Overall Study|Randomized but Not Treated|1|||
27863227|NCT04380961|81329712|FG001|Overall Study|Randomized but Not Treated|2|||
27967834|NCT01893411|81714087|FG000|Overall Study|Other|3|||
27967835|NCT01893411|81714088|FG001|Overall Study|Other|1|||
27967836|NCT01893411|81714089|FG002|Overall Study|Other|3|||
27967837|NCT01893411|81714087|FG000|Overall Study|Adverse Event|1|||
27967838|NCT01893411|81714088|FG001|Overall Study|Adverse Event|0|||
27967839|NCT01893411|81714089|FG002|Overall Study|Adverse Event|0|||
27967840|NCT01893411|81714087|FG000|Overall Study|Withdrawal by Subject|7|||
27778162|NCT01693562|81016952|FG006|Escalation Phase|Death|0|||
27778163|NCT01693562|81016953|FG007|Escalation Phase|Death|0|||
27778164|NCT01693562|81016954|FG008|Escalation Phase|Death|0|||
27863228|NCT00264550|81329714|FG000|Overall Study|Death|0|||
27863229|NCT00264550|81329715|FG001|Overall Study|Death|3|||
27863230|NCT00264550|81329716|FG002|Overall Study|Death|0|||
27863231|NCT00264550|81329717|FG003|Overall Study|Death|0|||
27863232|NCT00264550|81329714|FG000|Overall Study|Lost to Follow-up|3|||
27863233|NCT00264550|81329715|FG001|Overall Study|Lost to Follow-up|1|||
27863234|NCT00264550|81329716|FG002|Overall Study|Lost to Follow-up|1|||
27863235|NCT00264550|81329717|FG003|Overall Study|Lost to Follow-up|1|||
27863236|NCT00264550|81329714|FG000|Overall Study|Adverse Event|23|||
27863237|NCT00264550|81329715|FG001|Overall Study|Adverse Event|18|||
27863238|NCT00264550|81329716|FG002|Overall Study|Adverse Event|9|||
27863239|NCT00264550|81329717|FG003|Overall Study|Adverse Event|14|||
27863240|NCT00264550|81329714|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27863241|NCT00264550|81329715|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
27863242|NCT00264550|81329716|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
27863243|NCT00264550|81329717|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
27863244|NCT00264550|81329714|FG000|Overall Study|Discontinued oral study agent|0|||
27863245|NCT00264550|81329715|FG001|Overall Study|Discontinued oral study agent|1|||
27863246|NCT00264550|81329716|FG002|Overall Study|Discontinued oral study agent|0|||
27863247|NCT00264550|81329717|FG003|Overall Study|Discontinued oral study agent|0|||
27863248|NCT00264550|81329714|FG000|Overall Study|Other|13|||
27863249|NCT00264550|81329715|FG001|Overall Study|Other|7|||
27863250|NCT00264550|81329716|FG002|Overall Study|Other|3|||
27863251|NCT00264550|81329717|FG003|Overall Study|Other|9|||
27863252|NCT02129608|81329718|FG000|Overall Study|Lost to Follow-up|0|||
27863253|NCT02129608|81329719|FG001|Overall Study|Lost to Follow-up|1|||
27967841|NCT01893411|81714088|FG001|Overall Study|Withdrawal by Subject|4|||
27967842|NCT01893411|81714089|FG002|Overall Study|Withdrawal by Subject|3|||
27778165|NCT01693562|81016955|FG009|Escalation Phase|Death|0|||
27778166|NCT01693562|81016956|FG010|Escalation Phase|Death|0|||
27778167|NCT01693562|81016957|FG011|Escalation Phase|Death|0|||
27967843|NCT01893411|81714087|FG000|Overall Study|Lost to Follow-up|2|||
27666113|NCT01180790|80615477|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
27778168|NCT01693562|81016958|FG012|Escalation Phase|Death|0|||
27863254|NCT02129608|81329720|FG002|Overall Study|Lost to Follow-up|1|||
27863255|NCT02129608|81329718|FG000|Overall Study|Withdrawal by Subject|0|||
27863256|NCT02129608|81329719|FG001|Overall Study|Withdrawal by Subject|0|||
27778169|NCT01693562|81016959|FG013|Escalation Phase|Death|0|||
27778170|NCT01693562|81016960|FG014|Escalation Phase|Death|0|||
27863257|NCT02129608|81329720|FG002|Overall Study|Withdrawal by Subject|2|||
27863258|NCT00789737|81329721|FG000|Overall Study|Withdrawal by Subject|13|||
27967844|NCT01893411|81714088|FG001|Overall Study|Lost to Follow-up|0|||
27967845|NCT01893411|81714089|FG002|Overall Study|Lost to Follow-up|1|||
27778171|NCT01693562|81016961|FG015|Escalation Phase|Death|0|||
27778172|NCT01693562|81016962|FG016|Escalation Phase|Death|0|||
27778173|NCT01693562|81016963|FG017|Escalation Phase|Death|0|||
27778174|NCT01693562|81016964|FG018|Escalation Phase|Death|0|||
27778175|NCT01693562|81016965|FG019|Escalation Phase|Death|0|||
27778176|NCT01693562|81016966|FG020|Escalation Phase|Death|0|||
27778177|NCT01693562|81016967|FG021|Escalation Phase|Death|0|||
27778178|NCT01693562|81016968|FG022|Escalation Phase|Death|0|||
27778179|NCT01693562|81016946|FG000|Escalation Phase|Lost to Follow-up|0|||
27778180|NCT01693562|81016947|FG001|Escalation Phase|Lost to Follow-up|1|||
27778181|NCT01693562|81016948|FG002|Escalation Phase|Lost to Follow-up|1|||
27863259|NCT00789737|81329722|FG001|Overall Study|Withdrawal by Subject|22|||
27863260|NCT00789737|81329721|FG000|Overall Study|Lost to Follow-up|10|||
27863261|NCT00789737|81329722|FG001|Overall Study|Lost to Follow-up|14|||
27863262|NCT00789737|81329721|FG000|Overall Study|Adverse Event|8|||
27863263|NCT00789737|81329722|FG001|Overall Study|Adverse Event|8|||
27863264|NCT00789737|81329721|FG000|Overall Study|Protocol Violation|3|||
27863265|NCT00789737|81329722|FG001|Overall Study|Protocol Violation|0|||
27863266|NCT00789737|81329721|FG000|Overall Study|Lack of Efficacy|3|||
27863267|NCT00789737|81329722|FG001|Overall Study|Lack of Efficacy|0|||
27863268|NCT00789737|81329721|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
27863269|NCT00789737|81329722|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
27863270|NCT00789737|81329721|FG000|Overall Study|Other|11|||
27863271|NCT00789737|81329722|FG001|Overall Study|Other|7|||
27863272|NCT04239027|81329723|FG000|Overall Study|Adverse Event|4|||
27863273|NCT04239027|81329723|FG000|Overall Study|Withdrawal by Subject|9|||
27863274|NCT04239027|81329723|FG000|Overall Study|Death|1|||
27863275|NCT04239027|81329723|FG000|Overall Study|Physician Decision|9|||
27863276|NCT04239027|81329723|FG000|Overall Study|Lost to Follow-up|2|||
27863277|NCT04239027|81329723|FG000|Overall Study|Lack of Efficacy|1|||
27863278|NCT00952731|81329727|FG000|Overall Study|Drug supply expired|1|||
27863279|NCT00952731|81329728|FG001|Overall Study|Drug supply expired|0|||
27863280|NCT03656744|81329731|FG000|Overall Study|Adverse Event|1|||
27863281|NCT03656744|81329732|FG001|Overall Study|Adverse Event|4|||
27967846|NCT00316225|81714090|FG000|Overall Study|Adverse Event|2|||
27967847|NCT00316225|81714090|FG000|Overall Study|Physician Decision|3|||
27967848|NCT00316225|81714090|FG000|Overall Study|Progressive Disease|15|||
27967849|NCT00316225|81714090|FG000|Overall Study|Withdrawal by Subject|3|||
27967850|NCT00316225|81714090|FG000|Overall Study|Death|2|||
27967851|NCT02256384|81714091|FG000|Overall Study|Withdrawal by Subject|12|||
27967852|NCT02256384|81714091|FG000|Overall Study|Equipment not capturing data|2|||
27778182|NCT01693562|81016949|FG003|Escalation Phase|Lost to Follow-up|0|||
27778183|NCT01693562|81016950|FG004|Escalation Phase|Lost to Follow-up|0|||
27778184|NCT01693562|81016951|FG005|Escalation Phase|Lost to Follow-up|0|||
27778185|NCT01693562|81016952|FG006|Escalation Phase|Lost to Follow-up|0|||
27778186|NCT01693562|81016953|FG007|Escalation Phase|Lost to Follow-up|0|||
27778187|NCT01693562|81016954|FG008|Escalation Phase|Lost to Follow-up|0|||
27778188|NCT01693562|81016955|FG009|Escalation Phase|Lost to Follow-up|0|||
27778189|NCT01693562|81016956|FG010|Escalation Phase|Lost to Follow-up|0|||
27778190|NCT01693562|81016957|FG011|Escalation Phase|Lost to Follow-up|0|||
27778191|NCT01693562|81016958|FG012|Escalation Phase|Lost to Follow-up|0|||
27778192|NCT01693562|81016959|FG013|Escalation Phase|Lost to Follow-up|0|||
27778193|NCT01693562|81016960|FG014|Escalation Phase|Lost to Follow-up|0|||
27778194|NCT01693562|81016961|FG015|Escalation Phase|Lost to Follow-up|0|||
27778195|NCT01693562|81016962|FG016|Escalation Phase|Lost to Follow-up|0|||
27863282|NCT03656744|81329733|FG002|Overall Study|Adverse Event|1|||
27863283|NCT03656744|81329731|FG000|Overall Study|Protocol Violation|1|||
27863284|NCT03656744|81329732|FG001|Overall Study|Protocol Violation|0|||
27863285|NCT03656744|81329733|FG002|Overall Study|Protocol Violation|0|||
27863286|NCT03656744|81329731|FG000|Overall Study|Lost to Follow-up|2|||
27863287|NCT03656744|81329732|FG001|Overall Study|Lost to Follow-up|2|||
27863288|NCT03656744|81329733|FG002|Overall Study|Lost to Follow-up|0|||
27863289|NCT03656744|81329731|FG000|Overall Study|Withdrawal by Subject|0|||
27967853|NCT00566982|81714094|FG000|Overall Study|Adverse Event|6|||
27778196|NCT01693562|81016963|FG017|Escalation Phase|Lost to Follow-up|0|||
27778197|NCT01693562|81016964|FG018|Escalation Phase|Lost to Follow-up|0|||
27863290|NCT03656744|81329732|FG001|Overall Study|Withdrawal by Subject|1|||
27967854|NCT00566982|81714095|FG001|Overall Study|Adverse Event|48|||
27778198|NCT01693562|81016965|FG019|Escalation Phase|Lost to Follow-up|0|||
27778199|NCT01693562|81016966|FG020|Escalation Phase|Lost to Follow-up|0|||
27778200|NCT01693562|81016967|FG021|Escalation Phase|Lost to Follow-up|0|||
27778201|NCT01693562|81016968|FG022|Escalation Phase|Lost to Follow-up|0|||
27778202|NCT01693562|81016946|FG000|Escalation Phase|Other|0|||
27778203|NCT01693562|81016947|FG001|Escalation Phase|Other|0|||
27967855|NCT00566982|81714094|FG000|Overall Study|Withdrawal by Subject|1|||
27967856|NCT00566982|81714095|FG001|Overall Study|Withdrawal by Subject|14|||
27967857|NCT00566982|81714094|FG000|Overall Study|Protocol Violation|1|||
27967858|NCT00566982|81714095|FG001|Overall Study|Protocol Violation|4|||
27967859|NCT00566982|81714094|FG000|Overall Study|Lost to Follow-up|0|||
27967860|NCT00566982|81714095|FG001|Overall Study|Lost to Follow-up|1|||
27967861|NCT00566982|81714094|FG000|Overall Study|Other-family problems & doctor's request|0|||
27967862|NCT00566982|81714095|FG001|Overall Study|Other-family problems & doctor's request|2|||
27967863|NCT01659996|81714097|FG000|Overall Study|Protocol Violation|3|||
27967864|NCT01659996|81714098|FG001|Overall Study|Protocol Violation|3|||
27570163|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570164|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570165|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570166|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27570167|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
27570168|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27570169|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27570170|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27967865|NCT01659996|81714099|FG002|Overall Study|Protocol Violation|3|||
27570171|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570172|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570173|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570174|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570175|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570176|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27570177|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570178|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570179|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27967866|NCT01659996|81714097|FG000|Overall Study|Lost to Follow-up|1|||
27967867|NCT01659996|81714098|FG001|Overall Study|Lost to Follow-up|3|||
27967868|NCT01659996|81714099|FG002|Overall Study|Lost to Follow-up|2|||
27967869|NCT01659996|81714097|FG000|Overall Study|Adverse Event|0|||
27967870|NCT01659996|81714098|FG001|Overall Study|Adverse Event|0|||
27967871|NCT01659996|81714099|FG002|Overall Study|Adverse Event|1|||
27967872|NCT01659996|81714097|FG000|Overall Study|Withdrawal by Subject|4|||
27967873|NCT01659996|81714098|FG001|Overall Study|Withdrawal by Subject|1|||
27967874|NCT01659996|81714099|FG002|Overall Study|Withdrawal by Subject|5|||
27967875|NCT00957944|81714108|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
27967876|NCT00957944|81714109|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
27967877|NCT01208961|81714110|FG000|High-Fat Period III|Protocol Violation|1|||
27967878|NCT01208961|81714111|FG001|High-Fat Period III|Protocol Violation|0|||
27967879|NCT01355679|81714112|FG000|Overall Study|benign tumor types found at biopsy|2|||
27967880|NCT04238481|81714113|FG000|Overall Study|Miscellaneous|0|||
27967881|NCT04238481|81714114|FG001|Overall Study|Miscellaneous|1|||
27967882|NCT04238481|81714115|FG002|Overall Study|Miscellaneous|0|||
27967883|NCT04238481|81714116|FG003|Overall Study|Miscellaneous|0|||
27967884|NCT01302834|81714119|FG000|Overall Study|Protocol Violation|17|||
27967885|NCT01302834|81714120|FG001|Overall Study|Protocol Violation|23|||
27570180|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570181|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570182|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570183|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570184|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27778204|NCT01693562|81016948|FG002|Escalation Phase|Other|2|||
27778205|NCT01693562|81016949|FG003|Escalation Phase|Other|0|||
27778206|NCT01693562|81016950|FG004|Escalation Phase|Other|0|||
27778207|NCT01693562|81016951|FG005|Escalation Phase|Other|1|||
27778208|NCT01693562|81016952|FG006|Escalation Phase|Other|0|||
27967886|NCT01302834|81714119|FG000|Overall Study|HIV positive|1|||
27778209|NCT01693562|81016953|FG007|Escalation Phase|Other|0|||
27778210|NCT01693562|81016954|FG008|Escalation Phase|Other|0|||
27778211|NCT01693562|81016955|FG009|Escalation Phase|Other|0|||
27967887|NCT01302834|81714120|FG001|Overall Study|HIV positive|3|||
27967888|NCT00606034|81714121|FG000|Overall Study|incarceration|1|||
27967889|NCT05243745|81714124|FG000|Overall Study|Withdrawal by Subject|0|||
27967890|NCT05243745|81714125|FG001|Overall Study|Withdrawal by Subject|0|||
27778212|NCT01693562|81016956|FG010|Escalation Phase|Other|0|||
27778213|NCT01693562|81016957|FG011|Escalation Phase|Other|0|||
27778214|NCT01693562|81016958|FG012|Escalation Phase|Other|0|||
27778215|NCT01693562|81016959|FG013|Escalation Phase|Other|0|||
27778216|NCT01693562|81016960|FG014|Escalation Phase|Other|0|||
27778217|NCT01693562|81016961|FG015|Escalation Phase|Other|0|||
27778218|NCT01693562|81016962|FG016|Escalation Phase|Other|0|||
27778219|NCT01693562|81016963|FG017|Escalation Phase|Other|0|||
27778220|NCT01693562|81016964|FG018|Escalation Phase|Other|0|||
27778221|NCT01693562|81016965|FG019|Escalation Phase|Other|0|||
27778222|NCT01693562|81016966|FG020|Escalation Phase|Other|0|||
27778223|NCT01693562|81016967|FG021|Escalation Phase|Other|0|||
27778224|NCT01693562|81016968|FG022|Escalation Phase|Other|0|||
27778225|NCT01693562|81016946|FG000|Exploration Phase|Withdrawal by Subject|0|||
27778226|NCT01693562|81016947|FG001|Exploration Phase|Withdrawal by Subject|0|||
27778227|NCT01693562|81016948|FG002|Exploration Phase|Withdrawal by Subject|0|||
27570185|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570186|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570187|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570188|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570189|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570190|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27570191|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570192|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
27570193|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570194|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570195|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570196|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570197|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570198|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570199|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570200|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27570201|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570202|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570203|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570204|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570205|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570206|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570207|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570208|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570209|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570210|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570211|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570212|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570213|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570214|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570215|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
27570216|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570217|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570218|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570219|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570220|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570221|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570222|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570223|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570224|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27570225|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570226|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570227|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570228|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570229|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570230|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27778228|NCT01693562|81016949|FG003|Exploration Phase|Withdrawal by Subject|0|||
27778229|NCT01693562|81016950|FG004|Exploration Phase|Withdrawal by Subject|0|||
27778230|NCT01693562|81016951|FG005|Exploration Phase|Withdrawal by Subject|0|||
27778231|NCT01693562|81016952|FG006|Exploration Phase|Withdrawal by Subject|2|||
27778232|NCT01693562|81016953|FG007|Exploration Phase|Withdrawal by Subject|0|||
27778233|NCT01693562|81016954|FG008|Exploration Phase|Withdrawal by Subject|0|||
27778234|NCT01693562|81016955|FG009|Exploration Phase|Withdrawal by Subject|0|||
27778235|NCT01693562|81016956|FG010|Exploration Phase|Withdrawal by Subject|0|||
27778236|NCT01693562|81016957|FG011|Exploration Phase|Withdrawal by Subject|0|||
27666114|NCT01180790|80615478|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
27666115|NCT01180790|80615479|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
27666116|NCT01180790|80615480|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
27666117|NCT01180790|80615481|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
27666118|NCT00088452|80615482|FG000|Overall Study|Did not receive intervention|1|||
27666119|NCT00088452|80615483|FG001|Overall Study|Did not receive intervention|0|||
27666120|NCT00088452|80615484|FG002|Overall Study|Did not receive intervention|1|||
27666121|NCT02720185|80615486|FG000|Overall Study|Lost to Follow-up|1|||
27666122|NCT00635570|80615492|FG000|Overall Study|Lost to Follow-up|8|||
27666123|NCT00635570|80615493|FG001|Overall Study|Lost to Follow-up|8|||
27778237|NCT01693562|81016958|FG012|Exploration Phase|Withdrawal by Subject|0|||
27778238|NCT01693562|81016959|FG013|Exploration Phase|Withdrawal by Subject|0|||
27778239|NCT01693562|81016960|FG014|Exploration Phase|Withdrawal by Subject|0|||
27778240|NCT01693562|81016961|FG015|Exploration Phase|Withdrawal by Subject|0|||
27778241|NCT01693562|81016962|FG016|Exploration Phase|Withdrawal by Subject|0|||
27778242|NCT01693562|81016963|FG017|Exploration Phase|Withdrawal by Subject|0|||
27778243|NCT01693562|81016964|FG018|Exploration Phase|Withdrawal by Subject|0|||
27778244|NCT01693562|81016965|FG019|Exploration Phase|Withdrawal by Subject|0|||
27778245|NCT01693562|81016966|FG020|Exploration Phase|Withdrawal by Subject|0|||
27778246|NCT01693562|81016967|FG021|Exploration Phase|Withdrawal by Subject|0|||
27778247|NCT01693562|81016968|FG022|Exploration Phase|Withdrawal by Subject|0|||
27778248|NCT01693562|81016946|FG000|Exploration Phase|Death|0|||
27778249|NCT01693562|81016947|FG001|Exploration Phase|Death|0|||
27778250|NCT01693562|81016948|FG002|Exploration Phase|Death|0|||
27778251|NCT01693562|81016949|FG003|Exploration Phase|Death|0|||
27778252|NCT01693562|81016950|FG004|Exploration Phase|Death|0|||
27778253|NCT01693562|81016951|FG005|Exploration Phase|Death|0|||
27778254|NCT01693562|81016952|FG006|Exploration Phase|Death|17|||
27778255|NCT01693562|81016953|FG007|Exploration Phase|Death|0|||
27778256|NCT01693562|81016954|FG008|Exploration Phase|Death|0|||
27778257|NCT01693562|81016955|FG009|Exploration Phase|Death|0|||
27778258|NCT01693562|81016956|FG010|Exploration Phase|Death|0|||
27778259|NCT01693562|81016957|FG011|Exploration Phase|Death|0|||
27778260|NCT01693562|81016958|FG012|Exploration Phase|Death|0|||
27778261|NCT01693562|81016959|FG013|Exploration Phase|Death|0|||
27778262|NCT01693562|81016960|FG014|Exploration Phase|Death|0|||
27778263|NCT01693562|81016961|FG015|Exploration Phase|Death|0|||
27778264|NCT01693562|81016962|FG016|Exploration Phase|Death|0|||
27778265|NCT01693562|81016963|FG017|Exploration Phase|Death|0|||
27778266|NCT01693562|81016964|FG018|Exploration Phase|Death|0|||
27778267|NCT01693562|81016965|FG019|Exploration Phase|Death|0|||
27778268|NCT01693562|81016966|FG020|Exploration Phase|Death|0|||
27778269|NCT01693562|81016967|FG021|Exploration Phase|Death|0|||
27778270|NCT01693562|81016968|FG022|Exploration Phase|Death|0|||
27778271|NCT01693562|81016946|FG000|Exploration Phase|Other|0|||
27778272|NCT01693562|81016947|FG001|Exploration Phase|Other|0|||
27778273|NCT01693562|81016948|FG002|Exploration Phase|Other|0|||
27778274|NCT01693562|81016949|FG003|Exploration Phase|Other|0|||
27778275|NCT01693562|81016950|FG004|Exploration Phase|Other|0|||
27778276|NCT01693562|81016951|FG005|Exploration Phase|Other|0|||
27778277|NCT01693562|81016952|FG006|Exploration Phase|Other|2|||
27778278|NCT01693562|81016953|FG007|Exploration Phase|Other|0|||
27778279|NCT01693562|81016954|FG008|Exploration Phase|Other|0|||
27778280|NCT01693562|81016955|FG009|Exploration Phase|Other|0|||
27778281|NCT01693562|81016956|FG010|Exploration Phase|Other|0|||
27778282|NCT01693562|81016957|FG011|Exploration Phase|Other|0|||
27778283|NCT01693562|81016958|FG012|Exploration Phase|Other|0|||
27778284|NCT01693562|81016959|FG013|Exploration Phase|Other|0|||
27778285|NCT01693562|81016960|FG014|Exploration Phase|Other|0|||
27778286|NCT01693562|81016961|FG015|Exploration Phase|Other|0|||
27778287|NCT01693562|81016962|FG016|Exploration Phase|Other|0|||
27778288|NCT01693562|81016963|FG017|Exploration Phase|Other|0|||
27778289|NCT01693562|81016964|FG018|Exploration Phase|Other|0|||
27778290|NCT01693562|81016965|FG019|Exploration Phase|Other|0|||
27778291|NCT01693562|81016966|FG020|Exploration Phase|Other|0|||
27778292|NCT01693562|81016967|FG021|Exploration Phase|Other|0|||
27570231|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27666124|NCT00635570|80615492|FG000|Overall Study|Withdrawal by Subject|1|||
27666125|NCT00635570|80615493|FG001|Overall Study|Withdrawal by Subject|1|||
27666126|NCT00635570|80615492|FG000|Overall Study|Adverse Event|2|||
27666127|NCT00635570|80615493|FG001|Overall Study|Adverse Event|0|||
27778293|NCT01693562|81016968|FG022|Exploration Phase|Other|0|||
27778294|NCT01693562|81016946|FG000|Expansion Phase|Withdrawal by Subject|0|||
27778295|NCT01693562|81016947|FG001|Expansion Phase|Withdrawal by Subject|0|||
27778296|NCT01693562|81016948|FG002|Expansion Phase|Withdrawal by Subject|0|||
27778297|NCT01693562|81016949|FG003|Expansion Phase|Withdrawal by Subject|0|||
27778298|NCT01693562|81016950|FG004|Expansion Phase|Withdrawal by Subject|0|||
27778299|NCT01693562|81016951|FG005|Expansion Phase|Withdrawal by Subject|0|||
27778300|NCT01693562|81016952|FG006|Expansion Phase|Withdrawal by Subject|0|||
27778301|NCT01693562|81016953|FG007|Expansion Phase|Withdrawal by Subject|16|||
27778302|NCT01693562|81016954|FG008|Expansion Phase|Withdrawal by Subject|2|||
27666128|NCT00635570|80615492|FG000|Overall Study|Physician Decision|1|||
27666129|NCT00635570|80615493|FG001|Overall Study|Physician Decision|0|||
27666130|NCT00635570|80615492|FG000|Overall Study|Did not complete survey|2|||
27666131|NCT00635570|80615493|FG001|Overall Study|Did not complete survey|1|||
27666132|NCT00635570|80615492|FG000|Overall Study|Early termination(No sexual activity)|1|||
27666133|NCT00635570|80615493|FG001|Overall Study|Early termination(No sexual activity)|1|||
27666134|NCT00002597|80615494|FG000|Overall Study|Protocol Violation|19|||
27666135|NCT00002597|80615495|FG001|Overall Study|Protocol Violation|17|||
27666136|NCT00002597|80615494|FG000|Overall Study|Withdrawal by Subject|7|||
27666137|NCT00002597|80615495|FG001|Overall Study|Withdrawal by Subject|6|||
27666138|NCT02853305|80615498|FG000|Overall Study|Death|287|||
27666139|NCT02853305|80615499|FG001|Overall Study|Death|249|||
27666140|NCT02853305|80615500|FG002|Overall Study|Death|300|||
27666141|NCT02853305|80615498|FG000|Overall Study|Withdrawal by Subject|2|||
27666142|NCT02853305|80615499|FG001|Overall Study|Withdrawal by Subject|8|||
27666143|NCT02853305|80615500|FG002|Overall Study|Withdrawal by Subject|3|||
27666144|NCT02853305|80615498|FG000|Overall Study|Transferred to Extension Study|46|||
27666145|NCT02853305|80615499|FG001|Overall Study|Transferred to Extension Study|30|||
27666146|NCT02853305|80615500|FG002|Overall Study|Transferred to Extension Study|25|||
27666147|NCT02853305|80615498|FG000|Overall Study|Did Not Continue on Extension Study|16|||
27666148|NCT02853305|80615499|FG001|Overall Study|Did Not Continue on Extension Study|20|||
27666149|NCT02853305|80615500|FG002|Overall Study|Did Not Continue on Extension Study|24|||
27666150|NCT02037256|80615505|FG000|Overall Study|Protocol Violation|0|||
27666151|NCT02037256|80615506|FG001|Overall Study|Protocol Violation|1|||
27666152|NCT02037256|80615505|FG000|Overall Study|Withdrawn prior to Velcade|0|||
27666153|NCT02037256|80615506|FG001|Overall Study|Withdrawn prior to Velcade|2|||
27666154|NCT00853229|80615507|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
27666155|NCT00853229|80615508|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
27666156|NCT01084239|80615509|FG000|28-Day Follow-up|Lost to Follow-up|4|||
27666157|NCT01084239|80615510|FG001|28-Day Follow-up|Lost to Follow-up|9|||
27666158|NCT00118703|80615511|FG000|Overall Study|Protocol Violation|1|||
27666159|NCT00118703|80615512|FG001|Overall Study|Protocol Violation|0|||
27666160|NCT00118703|80615511|FG000|Overall Study|Adverse Event|1|||
27666161|NCT00118703|80615512|FG001|Overall Study|Adverse Event|1|||
27666162|NCT00118703|80615511|FG000|Overall Study|Participant took two different treatment|0|||
27666163|NCT00118703|80615512|FG001|Overall Study|Participant took two different treatment|1|||
27666164|NCT00118703|80615511|FG000|Overall Study|Withdrawal by Subject|2|||
27666165|NCT00118703|80615512|FG001|Overall Study|Withdrawal by Subject|5|||
27666166|NCT00118703|80615511|FG000|Overall Study|Lost to Follow-up|1|||
27666167|NCT00118703|80615512|FG001|Overall Study|Lost to Follow-up|2|||
27666168|NCT02647645|80615513|FG000|Overall Study|Lost to Follow-up|2|||
27666169|NCT02647645|80615514|FG001|Overall Study|Lost to Follow-up|1|||
27666170|NCT01171183|80615515|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
27666171|NCT01171183|80615516|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
27666172|NCT01171183|80615515|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
27666173|NCT01171183|80615516|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
27666174|NCT01171183|80615515|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
27666175|NCT01171183|80615516|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
27666176|NCT01171183|80615515|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
27666177|NCT01171183|80615516|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
27666178|NCT01171183|80615515|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
27666179|NCT01171183|80615516|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
27666180|NCT01171183|80615515|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
27666181|NCT01171183|80615516|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
27666182|NCT00523549|80615519|FG000|Overall Study|Adverse Event|6|||
27666183|NCT00523549|80615520|FG001|Overall Study|Adverse Event|3|||
27666184|NCT00523549|80615519|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27666185|NCT00523549|80615520|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27666186|NCT00523549|80615519|FG000|Overall Study|Protocol Deviation|3|||
27666187|NCT00523549|80615520|FG001|Overall Study|Protocol Deviation|1|||
27666188|NCT00523549|80615519|FG000|Overall Study|Patient withdrew consent|7|||
27666189|NCT00523549|80615520|FG001|Overall Study|Patient withdrew consent|6|||
27666190|NCT00523549|80615519|FG000|Overall Study|Lost to Follow-up|3|||
27666191|NCT00523549|80615520|FG001|Overall Study|Lost to Follow-up|5|||
27666192|NCT04124471|80615521|FG000|Overall Study|screen failure|1|||
27666193|NCT00605566|80615526|FG000|Overall Study|Adverse Event|1|||
27666194|NCT00605566|80615526|FG000|Overall Study|Clinical deterioration|1|||
27666195|NCT00605566|80615526|FG000|Overall Study|Poor compliance in run-in period|1|||
27666196|NCT03772613|80615529|FG000|Overall Study|Lost to Follow-up|0|||
27666197|NCT03772613|80615530|FG001|Overall Study|Lost to Follow-up|1|||
27666198|NCT03772613|80615531|FG002|Overall Study|Lost to Follow-up|1|||
27666199|NCT01530087|80615532|FG000|Overall Study|Physician Decision|2|||
27666200|NCT00766142|80615535|FG000|Overall Study|Protocol Violation|4|||
27778303|NCT01693562|81016955|FG009|Expansion Phase|Withdrawal by Subject|54|||
27778304|NCT01693562|81016956|FG010|Expansion Phase|Withdrawal by Subject|2|||
27778305|NCT01693562|81016957|FG011|Expansion Phase|Withdrawal by Subject|2|||
27778306|NCT01693562|81016958|FG012|Expansion Phase|Withdrawal by Subject|3|||
27778307|NCT01693562|81016959|FG013|Expansion Phase|Withdrawal by Subject|5|||
27778308|NCT01693562|81016960|FG014|Expansion Phase|Withdrawal by Subject|16|||
27778309|NCT01693562|81016961|FG015|Expansion Phase|Withdrawal by Subject|7|||
27778310|NCT01693562|81016962|FG016|Expansion Phase|Withdrawal by Subject|40|||
27778311|NCT01693562|81016963|FG017|Expansion Phase|Withdrawal by Subject|4|||
27778312|NCT01693562|81016964|FG018|Expansion Phase|Withdrawal by Subject|8|||
27778313|NCT01693562|81016965|FG019|Expansion Phase|Withdrawal by Subject|3|||
27778314|NCT01693562|81016966|FG020|Expansion Phase|Withdrawal by Subject|1|||
27778315|NCT01693562|81016967|FG021|Expansion Phase|Withdrawal by Subject|8|||
27778316|NCT01693562|81016968|FG022|Expansion Phase|Withdrawal by Subject|1|||
27778317|NCT01693562|81016946|FG000|Expansion Phase|Death|0|||
27778318|NCT01693562|81016947|FG001|Expansion Phase|Death|0|||
27778319|NCT01693562|81016948|FG002|Expansion Phase|Death|0|||
27778320|NCT01693562|81016949|FG003|Expansion Phase|Death|0|||
27778321|NCT01693562|81016950|FG004|Expansion Phase|Death|0|||
27778322|NCT01693562|81016951|FG005|Expansion Phase|Death|0|||
27778323|NCT01693562|81016952|FG006|Expansion Phase|Death|0|||
27778324|NCT01693562|81016953|FG007|Expansion Phase|Death|42|||
27778325|NCT01693562|81016954|FG008|Expansion Phase|Death|17|||
27778326|NCT01693562|81016955|FG009|Expansion Phase|Death|208|||
27778327|NCT01693562|81016956|FG010|Expansion Phase|Death|30|||
27778328|NCT01693562|81016957|FG011|Expansion Phase|Death|8|||
27778329|NCT01693562|81016958|FG012|Expansion Phase|Death|19|||
27778330|NCT01693562|81016959|FG013|Expansion Phase|Death|42|||
27778331|NCT01693562|81016960|FG014|Expansion Phase|Death|23|||
27778332|NCT01693562|81016961|FG015|Expansion Phase|Death|23|||
27778333|NCT01693562|81016962|FG016|Expansion Phase|Death|128|||
27778334|NCT01693562|81016963|FG017|Expansion Phase|Death|16|||
27778335|NCT01693562|81016964|FG018|Expansion Phase|Death|36|||
27778336|NCT01693562|81016965|FG019|Expansion Phase|Death|16|||
27778337|NCT01693562|81016966|FG020|Expansion Phase|Death|17|||
27778338|NCT01693562|81016967|FG021|Expansion Phase|Death|35|||
27778339|NCT01693562|81016968|FG022|Expansion Phase|Death|7|||
27778340|NCT01693562|81016946|FG000|Expansion Phase|Lost to Follow-up|0|||
27778341|NCT01693562|81016947|FG001|Expansion Phase|Lost to Follow-up|0|||
27778342|NCT01693562|81016948|FG002|Expansion Phase|Lost to Follow-up|0|||
27778343|NCT01693562|81016949|FG003|Expansion Phase|Lost to Follow-up|0|||
27778344|NCT01693562|81016950|FG004|Expansion Phase|Lost to Follow-up|0|||
27778345|NCT01693562|81016951|FG005|Expansion Phase|Lost to Follow-up|0|||
27778346|NCT01693562|81016952|FG006|Expansion Phase|Lost to Follow-up|0|||
27778347|NCT01693562|81016953|FG007|Expansion Phase|Lost to Follow-up|1|||
27778348|NCT01693562|81016954|FG008|Expansion Phase|Lost to Follow-up|2|||
27778349|NCT01693562|81016955|FG009|Expansion Phase|Lost to Follow-up|10|||
27778350|NCT01693562|81016956|FG010|Expansion Phase|Lost to Follow-up|4|||
27778351|NCT01693562|81016957|FG011|Expansion Phase|Lost to Follow-up|4|||
27778352|NCT01693562|81016958|FG012|Expansion Phase|Lost to Follow-up|1|||
27778353|NCT01693562|81016959|FG013|Expansion Phase|Lost to Follow-up|3|||
27778354|NCT01693562|81016960|FG014|Expansion Phase|Lost to Follow-up|0|||
27778355|NCT01693562|81016961|FG015|Expansion Phase|Lost to Follow-up|1|||
27778356|NCT01693562|81016962|FG016|Expansion Phase|Lost to Follow-up|1|||
27778357|NCT01693562|81016963|FG017|Expansion Phase|Lost to Follow-up|0|||
27778358|NCT01693562|81016964|FG018|Expansion Phase|Lost to Follow-up|2|||
27778359|NCT01693562|81016965|FG019|Expansion Phase|Lost to Follow-up|1|||
27778360|NCT01693562|81016966|FG020|Expansion Phase|Lost to Follow-up|2|||
27778361|NCT01693562|81016967|FG021|Expansion Phase|Lost to Follow-up|2|||
27778362|NCT01693562|81016968|FG022|Expansion Phase|Lost to Follow-up|1|||
27778363|NCT01693562|81016946|FG000|Expansion Phase|Other|0|||
27778364|NCT01693562|81016947|FG001|Expansion Phase|Other|0|||
27778365|NCT01693562|81016948|FG002|Expansion Phase|Other|0|||
27778366|NCT01693562|81016949|FG003|Expansion Phase|Other|0|||
27778367|NCT01693562|81016950|FG004|Expansion Phase|Other|0|||
27778368|NCT01693562|81016951|FG005|Expansion Phase|Other|0|||
27778369|NCT01693562|81016952|FG006|Expansion Phase|Other|0|||
27778370|NCT01693562|81016953|FG007|Expansion Phase|Other|3|||
27778371|NCT01693562|81016954|FG008|Expansion Phase|Other|1|||
27778372|NCT01693562|81016955|FG009|Expansion Phase|Other|28|||
27778373|NCT01693562|81016956|FG010|Expansion Phase|Other|4|||
27778374|NCT01693562|81016957|FG011|Expansion Phase|Other|7|||
27778375|NCT01693562|81016958|FG012|Expansion Phase|Other|0|||
27778376|NCT01693562|81016959|FG013|Expansion Phase|Other|1|||
27778377|NCT01693562|81016960|FG014|Expansion Phase|Other|1|||
27778378|NCT01693562|81016961|FG015|Expansion Phase|Other|0|||
27778379|NCT01693562|81016962|FG016|Expansion Phase|Other|28|||
27778380|NCT01693562|81016963|FG017|Expansion Phase|Other|0|||
27778381|NCT01693562|81016964|FG018|Expansion Phase|Other|1|||
27778382|NCT01693562|81016965|FG019|Expansion Phase|Other|0|||
27778383|NCT01693562|81016966|FG020|Expansion Phase|Other|1|||
27778384|NCT01693562|81016967|FG021|Expansion Phase|Other|17|||
27778385|NCT01693562|81016968|FG022|Expansion Phase|Other|1|||
27778386|NCT00819052|81016975|FG000|Overall Study|Adverse Event|0|||
27666201|NCT02705625|80615536|FG000|Overall Study|Protocol Violation|1|||
27666202|NCT02705625|80615537|FG001|Overall Study|Protocol Violation|0|||
27666203|NCT02705625|80615538|FG002|Overall Study|Protocol Violation|0|||
27666204|NCT02705625|80615536|FG000|Overall Study|Adverse Event|6|||
27666205|NCT02705625|80615537|FG001|Overall Study|Adverse Event|5|||
27666206|NCT02705625|80615538|FG002|Overall Study|Adverse Event|2|||
27666207|NCT02705625|80615536|FG000|Overall Study|Death|0|||
27666208|NCT02705625|80615537|FG001|Overall Study|Death|0|||
27666209|NCT02705625|80615538|FG002|Overall Study|Death|1|||
27666210|NCT02705625|80615536|FG000|Overall Study|Withdrawal by Subject|1|||
27666211|NCT02705625|80615537|FG001|Overall Study|Withdrawal by Subject|4|||
27666212|NCT02705625|80615538|FG002|Overall Study|Withdrawal by Subject|5|||
27666213|NCT02705625|80615536|FG000|Overall Study|Lost to Follow-up|0|||
27666214|NCT02705625|80615537|FG001|Overall Study|Lost to Follow-up|0|||
27666215|NCT02705625|80615538|FG002|Overall Study|Lost to Follow-up|1|||
27666216|NCT02705625|80615536|FG000|Overall Study|Non-compliance|0|||
27666217|NCT02705625|80615537|FG001|Overall Study|Non-compliance|1|||
27666218|NCT02705625|80615538|FG002|Overall Study|Non-compliance|1|||
27666219|NCT02705625|80615536|FG000|Overall Study|Overdosing|0|||
27666220|NCT02705625|80615537|FG001|Overall Study|Overdosing|0|||
27666221|NCT02705625|80615538|FG002|Overall Study|Overdosing|1|||
27666222|NCT00349622|80615539|FG000|Overall Study|Death|168|||
27666223|NCT00349622|80615540|FG001|Overall Study|Death|86|||
27666224|NCT00349622|80615539|FG000|Overall Study|Lost to Follow-up|5|||
27666225|NCT00349622|80615540|FG001|Overall Study|Lost to Follow-up|1|||
27666226|NCT00349622|80615539|FG000|Overall Study|Withdrawal by Subject|5|||
27666227|NCT00349622|80615540|FG001|Overall Study|Withdrawal by Subject|9|||
27666228|NCT01037413|80615541|FG000|Part A: Skin Testing|Adverse Event|1|||
27666229|NCT01037413|80615542|FG001|Part A: Skin Testing|Adverse Event|0|||
27666230|NCT01037413|80615541|FG000|Part A: Skin Testing|Protocol Violation|1|||
27666231|NCT01037413|80615542|FG001|Part A: Skin Testing|Protocol Violation|0|||
27666232|NCT01037413|80615541|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
27666233|NCT01037413|80615542|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
27666234|NCT01037413|80615541|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
27666235|NCT01037413|80615542|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
27666236|NCT02016690|80615543|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
27666237|NCT02016690|80615543|FG000|Overall Study|Excluded from SAS: Duplication|2|||
27666238|NCT02016690|80615543|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
27666239|NCT02016690|80615543|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
27666240|NCT02016690|80615543|FG000|Overall Study|Did not meet inclusion criteria|13|||
27666241|NCT02016690|80615543|FG000|Overall Study|Hospitalized for RSV at study start|3|||
27666242|NCT01011049|80615544|FG000|Overall Study|Protocol Violation|0|||
27666243|NCT01011049|80615545|FG001|Overall Study|Protocol Violation|0|||
27666244|NCT01011049|80615546|FG002|Overall Study|Protocol Violation|2|||
27666245|NCT01011049|80615547|FG003|Overall Study|Protocol Violation|0|||
27666246|NCT01011049|80615544|FG000|Overall Study|Lost to Follow-up|1|||
27967891|NCT05243745|81714126|FG002|Overall Study|Withdrawal by Subject|0|||
27967892|NCT05243745|81714127|FG003|Overall Study|Withdrawal by Subject|1|||
27967893|NCT05243745|81714124|FG000|Overall Study|Unable to Attend Visit 6|0|||
27967894|NCT05243745|81714125|FG001|Overall Study|Unable to Attend Visit 6|0|||
27967895|NCT05243745|81714126|FG002|Overall Study|Unable to Attend Visit 6|1|||
27967896|NCT05243745|81714127|FG003|Overall Study|Unable to Attend Visit 6|0|||
27967897|NCT02550288|81714129|FG000|Overall Study|Adverse Event|0|||
27967898|NCT02550288|81714130|FG001|Overall Study|Adverse Event|1|||
27967899|NCT02550288|81714131|FG002|Overall Study|Adverse Event|0|||
27967900|NCT02550288|81714132|FG003|Overall Study|Adverse Event|0|||
27967901|NCT02550288|81714133|FG004|Overall Study|Adverse Event|0|||
27967902|NCT02550288|81714129|FG000|Overall Study|Physician Decision|0|||
27967903|NCT02550288|81714130|FG001|Overall Study|Physician Decision|0|||
27967904|NCT02550288|81714131|FG002|Overall Study|Physician Decision|0|||
27967905|NCT02550288|81714132|FG003|Overall Study|Physician Decision|1|||
27967906|NCT02550288|81714133|FG004|Overall Study|Physician Decision|0|||
27967907|NCT02550288|81714129|FG000|Overall Study|Protocol Violation|2|||
27967908|NCT02550288|81714130|FG001|Overall Study|Protocol Violation|2|||
27967909|NCT02550288|81714131|FG002|Overall Study|Protocol Violation|1|||
27967910|NCT02550288|81714132|FG003|Overall Study|Protocol Violation|0|||
27967911|NCT02550288|81714133|FG004|Overall Study|Protocol Violation|3|||
27967912|NCT02550288|81714129|FG000|Overall Study|Participant moved|0|||
27967913|NCT02550288|81714130|FG001|Overall Study|Participant moved|0|||
27967914|NCT02550288|81714131|FG002|Overall Study|Participant moved|0|||
27967915|NCT02550288|81714132|FG003|Overall Study|Participant moved|1|||
27967916|NCT02550288|81714133|FG004|Overall Study|Participant moved|0|||
27967917|NCT02550288|81714129|FG000|Overall Study|Withdrawal by Subject|0|||
27967918|NCT02550288|81714130|FG001|Overall Study|Withdrawal by Subject|0|||
27967919|NCT02550288|81714131|FG002|Overall Study|Withdrawal by Subject|0|||
27967920|NCT02550288|81714132|FG003|Overall Study|Withdrawal by Subject|1|||
27967921|NCT02550288|81714133|FG004|Overall Study|Withdrawal by Subject|0|||
27967922|NCT02719691|81714138|FG000|Overall Study|Physician Decision|0|||
27967923|NCT02719691|81714139|FG001|Overall Study|Physician Decision|0|||
27967924|NCT02719691|81714140|FG002|Overall Study|Physician Decision|1|||
27967925|NCT02719691|81714141|FG003|Overall Study|Physician Decision|0|||
27967926|NCT02719691|81714142|FG004|Overall Study|Physician Decision|0|||
27967927|NCT02719691|81714143|FG005|Overall Study|Physician Decision|0|||
27666247|NCT01011049|80615545|FG001|Overall Study|Lost to Follow-up|2|||
27666248|NCT01011049|80615546|FG002|Overall Study|Lost to Follow-up|1|||
27666249|NCT01011049|80615547|FG003|Overall Study|Lost to Follow-up|0|||
27666250|NCT01011049|80615544|FG000|Overall Study|Withdrawal by Subject|0|||
27967928|NCT02719691|81714144|FG006|Overall Study|Physician Decision|0|||
27967929|NCT02719691|81714138|FG000|Overall Study|Withdrawal by Subject|0|||
27967930|NCT02719691|81714139|FG001|Overall Study|Withdrawal by Subject|0|||
27967931|NCT02719691|81714140|FG002|Overall Study|Withdrawal by Subject|0|||
27967932|NCT02719691|81714141|FG003|Overall Study|Withdrawal by Subject|0|||
27967933|NCT02719691|81714142|FG004|Overall Study|Withdrawal by Subject|0|||
27967934|NCT02719691|81714143|FG005|Overall Study|Withdrawal by Subject|1|||
27666251|NCT01011049|80615545|FG001|Overall Study|Withdrawal by Subject|0|||
27666252|NCT01011049|80615546|FG002|Overall Study|Withdrawal by Subject|1|||
27666253|NCT01011049|80615547|FG003|Overall Study|Withdrawal by Subject|0|||
27666254|NCT03463577|80615548|FG000|Overall Study|Lost to Follow-up|238|||
27666255|NCT03463577|80615549|FG001|Overall Study|Lost to Follow-up|435|||
27666256|NCT03463577|80615550|FG002|Overall Study|Lost to Follow-up|0|||
27666257|NCT03463577|80615551|FG003|Overall Study|Lost to Follow-up|0|||
27666258|NCT03463577|80615552|FG004|Overall Study|Lost to Follow-up|0|||
27666259|NCT03463577|80615553|FG005|Overall Study|Lost to Follow-up|0|||
27666260|NCT03463577|80615548|FG000|Overall Study|With unknown pregnancy outcome|0|||
27666261|NCT03463577|80615549|FG001|Overall Study|With unknown pregnancy outcome|5|||
27666262|NCT03463577|80615550|FG002|Overall Study|With unknown pregnancy outcome|0|||
27666263|NCT03463577|80615551|FG003|Overall Study|With unknown pregnancy outcome|0|||
27666264|NCT03463577|80615552|FG004|Overall Study|With unknown pregnancy outcome|0|||
27666265|NCT03463577|80615553|FG005|Overall Study|With unknown pregnancy outcome|0|||
27666266|NCT03463577|80615548|FG000|Overall Study|Maternal death|2|||
27666267|NCT03463577|80615549|FG001|Overall Study|Maternal death|0|||
27666268|NCT03463577|80615550|FG002|Overall Study|Maternal death|0|||
27666269|NCT03463577|80615551|FG003|Overall Study|Maternal death|0|||
27666270|NCT03463577|80615552|FG004|Overall Study|Maternal death|0|||
27778387|NCT00819052|81016976|FG001|Overall Study|Adverse Event|5|||
27778388|NCT00819052|81016975|FG000|Overall Study|Protocol Violation|1|||
27778389|NCT00819052|81016976|FG001|Overall Study|Protocol Violation|2|||
27778390|NCT00819052|81016975|FG000|Overall Study|Lost to Follow-up|1|||
27778391|NCT00819052|81016976|FG001|Overall Study|Lost to Follow-up|2|||
27778392|NCT00819052|81016975|FG000|Overall Study|Withdrawal by Subject|1|||
27778393|NCT00819052|81016976|FG001|Overall Study|Withdrawal by Subject|2|||
27778394|NCT00819052|81016975|FG000|Overall Study|Lack of Efficacy|1|||
27666271|NCT03463577|80615553|FG005|Overall Study|Maternal death|0|||
27666272|NCT03463577|80615548|FG000|Overall Study|Neonatal death|0|||
27666273|NCT03463577|80615549|FG001|Overall Study|Neonatal death|0|||
27666274|NCT03463577|80615550|FG002|Overall Study|Neonatal death|0|||
27666275|NCT03463577|80615551|FG003|Overall Study|Neonatal death|15|||
27778395|NCT00819052|81016976|FG001|Overall Study|Lack of Efficacy|1|||
27778396|NCT00819052|81016975|FG000|Overall Study|Pregnancy|1|||
27778397|NCT00819052|81016976|FG001|Overall Study|Pregnancy|2|||
27778398|NCT00819052|81016975|FG000|Overall Study|Death or events leading to death|1|||
27778399|NCT00819052|81016976|FG001|Overall Study|Death or events leading to death|0|||
27778400|NCT00362297|81016977|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
27778401|NCT00362297|81016978|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
27778402|NCT02471586|81016979|FG000|Overall Study|Lost to Follow-up|3|||
27778403|NCT02471586|81016980|FG001|Overall Study|Lost to Follow-up|8|||
27778404|NCT02471586|81016981|FG002|Overall Study|Lost to Follow-up|4|||
27778405|NCT02471586|81016979|FG000|Overall Study|Death|2|||
27778406|NCT02471586|81016980|FG001|Overall Study|Death|2|||
27778407|NCT02471586|81016981|FG002|Overall Study|Death|0|||
27778408|NCT03483012|81016982|FG000|Overall Study|Lack of Efficacy|6|||
27778409|NCT03245840|81016983|FG000|Overall Study|Adverse Event|6|||
27778410|NCT03245840|81016984|FG001|Overall Study|Adverse Event|0|||
27778411|NCT03245840|81016983|FG000|Overall Study|Death|2|||
27778412|NCT03245840|81016984|FG001|Overall Study|Death|0|||
27778413|NCT03245840|81016983|FG000|Overall Study|Withdrawal by Subject|31|||
27778414|NCT03245840|81016984|FG001|Overall Study|Withdrawal by Subject|1|||
27778415|NCT03245840|81016983|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27778416|NCT03245840|81016984|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27778417|NCT03245840|81016983|FG000|Overall Study|Physician Decision|4|||
27778418|NCT03245840|81016984|FG001|Overall Study|Physician Decision|1|||
27778419|NCT03245840|81016983|FG000|Overall Study|Study Terminated by Sponsor|56|||
27778420|NCT03245840|81016984|FG001|Overall Study|Study Terminated by Sponsor|6|||
27778421|NCT03245840|81016983|FG000|Overall Study|Site Terminated by Sponsor|4|||
27778422|NCT03245840|81016984|FG001|Overall Study|Site Terminated by Sponsor|0|||
27778423|NCT03245840|81016983|FG000|Overall Study|Lost to Follow-up|12|||
27666276|NCT03463577|80615552|FG004|Overall Study|Neonatal death|17|||
27666277|NCT03463577|80615553|FG005|Overall Study|Neonatal death|0|||
27666278|NCT00676195|80615557|FG000|Overall Study|Lost to Follow-up|1|||
27666279|NCT00676195|80615557|FG000|Overall Study|Adverse Event|1|||
27778424|NCT03245840|81016984|FG001|Overall Study|Lost to Follow-up|2|||
27778425|NCT03245840|81016983|FG000|Overall Study|Pregnancy|2|||
27778426|NCT03245840|81016984|FG001|Overall Study|Pregnancy|0|||
27778427|NCT03245840|81016983|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27778428|NCT03245840|81016984|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27778429|NCT03245840|81016983|FG000|Overall Study|Not treated|1|||
27778430|NCT03245840|81016984|FG001|Overall Study|Not treated|1|||
27778431|NCT01675141|81016985|FG000|Overall Study|Lenalidomide outside NIH|3|||
27778432|NCT01675141|81016985|FG000|Overall Study|Withdrawal by Subject|3|||
27778433|NCT01675141|81016985|FG000|Overall Study|Physician Decision|4|||
27778434|NCT01675141|81016985|FG000|Overall Study|No treatment, per protocol|1|||
27666280|NCT00676195|80615557|FG000|Overall Study|Physician Decision|1|||
27778435|NCT01603615|81016986|FG000|Overall Study|Did not Receive Treatment|7|||
27778436|NCT01603615|81016986|FG000|Overall Study|Lost to Follow-up|9|||
27778437|NCT01603615|81016986|FG000|Overall Study|Personal Reasons|17|||
27778438|NCT01603615|81016986|FG000|Overall Study|Other Miscellaneous|1|||
27778439|NCT00394654|81016991|FG000|Overall Study|Lost to Follow-up|1|||
27778440|NCT00394654|81016992|FG001|Overall Study|Lost to Follow-up|0|||
27778441|NCT00394654|81016991|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
27863291|NCT03656744|81329733|FG002|Overall Study|Withdrawal by Subject|0|||
27863292|NCT03656744|81329731|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
27863293|NCT03656744|81329732|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
27863294|NCT03656744|81329733|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
27863295|NCT01954745|81329737|FG000|Overall Study|Radiological Progression|11|||
27863296|NCT01954745|81329737|FG000|Overall Study|Clinical Progression|5|||
27863297|NCT01954745|81329737|FG000|Overall Study|Adverse Event|2|||
27863298|NCT01954745|81329737|FG000|Overall Study|Death|1|||
27863299|NCT03136965|81329740|FG000|Overall Study|Lost to Follow-up|0|||
27863300|NCT03136965|81329741|FG001|Overall Study|Lost to Follow-up|1|||
27863301|NCT03136965|81329742|FG002|Overall Study|Lost to Follow-up|0|||
27863302|NCT00576316|81329743|FG000|Overall Study|Adverse Event|9|||
27863303|NCT00576316|81329743|FG000|Overall Study|Withdrawal by Subject|2|||
27863304|NCT00576316|81329743|FG000|Overall Study|Protocol Violation|9|||
27863305|NCT00338455|81329744|FG000|Overall Study|Death|2|||
27863306|NCT00338455|81329745|FG001|Overall Study|Death|1|||
27863307|NCT00338455|81329744|FG000|Overall Study|Physician Decision|1|||
27863308|NCT00338455|81329745|FG001|Overall Study|Physician Decision|0|||
27863309|NCT02027428|81329746|FG000|Induction|Never treated|7|||
27863310|NCT02027428|81329747|FG001|Induction|Never treated|0|||
27863311|NCT02027428|81329748|FG002|Induction|Never treated|0|||
27863312|NCT02027428|81329746|FG000|Induction|Progressive disease|77|||
27863313|NCT02027428|81329747|FG001|Induction|Progressive disease|0|||
27863314|NCT02027428|81329748|FG002|Induction|Progressive disease|0|||
27863315|NCT02027428|81329746|FG000|Induction|Adverse Event|51|||
27863316|NCT02027428|81329747|FG001|Induction|Adverse Event|0|||
27863317|NCT02027428|81329748|FG002|Induction|Adverse Event|0|||
27863318|NCT02027428|81329746|FG000|Induction|Withdrawal by Subject|22|||
27863319|NCT02027428|81329747|FG001|Induction|Withdrawal by Subject|0|||
27863320|NCT02027428|81329748|FG002|Induction|Withdrawal by Subject|0|||
27863321|NCT02027428|81329746|FG000|Induction|Death|21|||
27863322|NCT02027428|81329747|FG001|Induction|Death|0|||
27863323|NCT02027428|81329748|FG002|Induction|Death|0|||
27863324|NCT02027428|81329746|FG000|Induction|Symptomatic deterioration|16|||
27863325|NCT02027428|81329747|FG001|Induction|Symptomatic deterioration|0|||
27863326|NCT02027428|81329748|FG002|Induction|Symptomatic deterioration|0|||
27778442|NCT00394654|81016992|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
27778443|NCT00908895|81016993|FG000|Overall Study|Lost to Follow-up|1|||
27863327|NCT02027428|81329746|FG000|Induction|Study terminated by sponsor|12|||
27778444|NCT00908895|81016994|FG001|Overall Study|Lost to Follow-up|3|||
27778445|NCT00908895|81016993|FG000|Overall Study|algodystrophy|2|||
27778446|NCT00908895|81016994|FG001|Overall Study|algodystrophy|2|||
27863328|NCT02027428|81329747|FG001|Induction|Study terminated by sponsor|0|||
27863329|NCT02027428|81329748|FG002|Induction|Study terminated by sponsor|0|||
27967935|NCT02719691|81714144|FG006|Overall Study|Withdrawal by Subject|0|||
27967936|NCT01639339|81714145|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
27967937|NCT01639339|81714146|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
27967938|NCT01639339|81714145|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
27778447|NCT00908895|81016993|FG000|Overall Study|Adverse Event|1|||
27778448|NCT00908895|81016994|FG001|Overall Study|Adverse Event|1|||
27778449|NCT02850276|81016995|FG000|Overall Study|screen failure|43|||
27778450|NCT02850276|81016995|FG000|Overall Study|Withdrawal by Subject|14|||
27778451|NCT02850276|81016995|FG000|Overall Study|Physician Decision|2|||
27778452|NCT02850276|81016995|FG000|Overall Study|Lost to Follow-up|2|||
27863330|NCT02027428|81329746|FG000|Induction|Protocol Violation|1|||
27863331|NCT02027428|81329747|FG001|Induction|Protocol Violation|0|||
27967939|NCT01639339|81714146|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
27863332|NCT02027428|81329748|FG002|Induction|Protocol Violation|0|||
27967940|NCT01639339|81714145|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
27778453|NCT00784459|81016996|FG000|Overall Study|Adverse Event|0|||
27778454|NCT00784459|81016997|FG001|Overall Study|Adverse Event|2|||
27778455|NCT03035409|81017001|FG000|Overall Study|Adverse Event|5|||
27778456|NCT03035409|81017001|FG000|Overall Study|Death|2|||
27778457|NCT03035409|81017001|FG000|Overall Study|Withdrawal by Subject|2|||
27778458|NCT03035409|81017001|FG000|Overall Study|Non compliance|4|||
27778459|NCT03035409|81017001|FG000|Overall Study|Patient was jittery|1|||
27778460|NCT03035409|81017001|FG000|Overall Study|Did not like Questionnaire|1|||
27863333|NCT02027428|81329746|FG000|Induction|Miscellaneous|14|||
27863334|NCT02027428|81329747|FG001|Induction|Miscellaneous|0|||
27967941|NCT01639339|81714146|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
27570232|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27570233|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27570234|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27778461|NCT03035409|81017001|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
27778462|NCT03035409|81017001|FG000|Overall Study|Did not like taking drugs|1|||
27778463|NCT00474539|81017002|FG000|Infant Series|Withdrawal by Subject|3|||
27778464|NCT00474539|81017003|FG001|Infant Series|Withdrawal by Subject|4|||
27778465|NCT00474539|81017002|FG000|Infant Series|Randomization error|5|||
27778466|NCT00474539|81017003|FG001|Infant Series|Randomization error|0|||
27778467|NCT00474539|81017002|FG000|Infant Series|Lost to Follow-up|2|||
27778468|NCT00474539|81017003|FG001|Infant Series|Lost to Follow-up|1|||
27778469|NCT00474539|81017002|FG000|Infant Series|Protocol Violation|0|||
27778470|NCT00474539|81017003|FG001|Infant Series|Protocol Violation|1|||
27778471|NCT00474539|81017002|FG000|After Infant Series|Lost to Follow-up|3|||
27778472|NCT00474539|81017003|FG001|After Infant Series|Lost to Follow-up|0|||
27778473|NCT00474539|81017002|FG000|After Infant Series|Withdrawal by Subject|1|||
27778474|NCT00474539|81017003|FG001|After Infant Series|Withdrawal by Subject|0|||
27778475|NCT00474539|81017002|FG000|Toddler Dose|Protocol Violation|1|||
27778476|NCT00474539|81017003|FG001|Toddler Dose|Protocol Violation|0|||
27778477|NCT01234337|81017005|FG000|Overall Study|Adverse Event|58|||
27778478|NCT01234337|81017006|FG001|Overall Study|Adverse Event|21|||
27570235|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27570236|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
27570237|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570238|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
27570239|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
27570240|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
27778479|NCT01234337|81017005|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
27778480|NCT01234337|81017006|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
27778481|NCT01234337|81017005|FG000|Overall Study|Investi. decision not protocol driven|5|||
27778482|NCT01234337|81017006|FG001|Overall Study|Investi. decision not protocol driven|6|||
27778483|NCT01234337|81017005|FG000|Overall Study|Non-compliant with study medication|3|||
27778484|NCT01234337|81017006|FG001|Overall Study|Non-compliant with study medication|2|||
27778485|NCT01234337|81017005|FG000|Overall Study|Randomized but not treated|6|||
27778486|NCT01234337|81017006|FG001|Overall Study|Randomized but not treated|4|||
27778487|NCT01234337|81017005|FG000|Overall Study|Lost to Follow-up|0|||
27778488|NCT01234337|81017006|FG001|Overall Study|Lost to Follow-up|1|||
27778489|NCT01234337|81017005|FG000|Overall Study|Protocol Violation|2|||
27778490|NCT01234337|81017006|FG001|Overall Study|Protocol Violation|3|||
27778491|NCT01234337|81017005|FG000|Overall Study|Withdrawal by Subject|11|||
27778492|NCT01234337|81017006|FG001|Overall Study|Withdrawal by Subject|9|||
27778493|NCT01234337|81017005|FG000|Overall Study|Death|0|||
27778494|NCT01234337|81017006|FG001|Overall Study|Death|1|||
27778495|NCT01234337|81017005|FG000|Overall Study|Switch to commercial drug|0|||
27967942|NCT01639339|81714145|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
27967943|NCT01639339|81714146|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
27967944|NCT01639339|81714145|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
27967945|NCT01639339|81714146|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
27967946|NCT01639339|81714145|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
27967947|NCT01639339|81714146|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
27967948|NCT01639339|81714145|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
27967949|NCT01639339|81714146|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
27967950|NCT01639339|81714145|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
27967951|NCT01639339|81714146|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
27778496|NCT01234337|81017006|FG001|Overall Study|Switch to commercial drug|1|||
27778497|NCT02159365|81017007|FG000|Overall Study|Disease Progression|23|||
27778498|NCT02159365|81017007|FG000|Overall Study|Other reasons|11|||
27778499|NCT02159365|81017007|FG000|Overall Study|Administrative reason by Sponsor|9|||
27778500|NCT02159365|81017007|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
27778501|NCT02159365|81017007|FG000|Overall Study|Study drug toxicity|7|||
27778502|NCT02159365|81017007|FG000|Overall Study|Maximum clinical benefit|3|||
27778503|NCT02159365|81017007|FG000|Overall Study|Subject request to discontinue treatment|3|||
27778504|NCT02159365|81017007|FG000|Overall Study|Subject withdrew consent|3|||
27778505|NCT02159365|81017007|FG000|Overall Study|Death|1|||
27778506|NCT02159365|81017007|FG000|Overall Study|Lost to Follow-up|1|||
27778507|NCT00129376|81017008|FG000|Overall Study|Adverse Event|1|||
27778508|NCT00129376|81017008|FG000|Overall Study|Lack of Efficacy|1|||
27778509|NCT00508820|81017020|FG000|Overall Study|Adverse Event|6|||
27778510|NCT00508820|81017021|FG001|Overall Study|Adverse Event|10|||
27570241|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27778511|NCT00508820|81017020|FG000|Overall Study|Death|6|||
27778512|NCT00508820|81017021|FG001|Overall Study|Death|8|||
27778513|NCT00508820|81017020|FG000|Overall Study|Lost to Follow-up|1|||
27778514|NCT00508820|81017021|FG001|Overall Study|Lost to Follow-up|1|||
27778515|NCT00508820|81017020|FG000|Overall Study|Physician Decision|8|||
27778516|NCT00508820|81017021|FG001|Overall Study|Physician Decision|2|||
27778517|NCT00508820|81017020|FG000|Overall Study|Pregnancy|0|||
27778518|NCT00508820|81017021|FG001|Overall Study|Pregnancy|2|||
27778519|NCT00508820|81017020|FG000|Overall Study|Protocol Violation|2|||
27778520|NCT00508820|81017021|FG001|Overall Study|Protocol Violation|0|||
27778521|NCT00508820|81017020|FG000|Overall Study|Withdrawal by Subject|10|||
27778522|NCT00508820|81017021|FG001|Overall Study|Withdrawal by Subject|12|||
27778523|NCT00508820|81017020|FG000|Overall Study|Other|11|||
27778524|NCT00508820|81017021|FG001|Overall Study|Other|2|||
27778525|NCT00508820|81017020|FG000|Overall Study|Noncompliance|1|||
27778526|NCT00508820|81017021|FG001|Overall Study|Noncompliance|0|||
27778527|NCT00508820|81017020|FG000|Overall Study|Requirement for alternative therapy|7|||
27778528|NCT00508820|81017021|FG001|Overall Study|Requirement for alternative therapy|15|||
27778529|NCT00508820|81017020|FG000|Overall Study|Protocol-specified Criteria|3|||
27778530|NCT00508820|81017021|FG001|Overall Study|Protocol-specified Criteria|12|||
27778531|NCT02394028|81021090|FG000|Induction Phase|Adverse Event|2|||
27778532|NCT02394028|81021091|FG001|Induction Phase|Adverse Event|4|||
27778533|NCT02394028|81021092|FG002|Induction Phase|Adverse Event|1|||
27778534|NCT02394028|81021093|FG003|Induction Phase|Adverse Event|2|||
27778535|NCT02394028|81021094|FG004|Induction Phase|Adverse Event|5|||
27778536|NCT02394028|81021095|FG005|Induction Phase|Adverse Event|2|||
27778537|NCT02394028|81021096|FG006|Induction Phase|Adverse Event|0|||
27778538|NCT02394028|81021097|FG007|Induction Phase|Adverse Event|0|||
27778539|NCT02394028|81021098|FG008|Induction Phase|Adverse Event|0|||
27778540|NCT02394028|81021099|FG009|Induction Phase|Adverse Event|0|||
27778541|NCT02394028|81021100|FG010|Induction Phase|Adverse Event|0|||
27778542|NCT02394028|81021090|FG000|Induction Phase|Lack of Efficacy|3|||
27778543|NCT02394028|81021091|FG001|Induction Phase|Lack of Efficacy|6|||
27778544|NCT02394028|81021092|FG002|Induction Phase|Lack of Efficacy|2|||
27778545|NCT02394028|81021093|FG003|Induction Phase|Lack of Efficacy|17|||
27778546|NCT02394028|81021094|FG004|Induction Phase|Lack of Efficacy|14|||
27778547|NCT02394028|81021095|FG005|Induction Phase|Lack of Efficacy|8|||
27778548|NCT02394028|81021096|FG006|Induction Phase|Lack of Efficacy|17|||
27778549|NCT02394028|81021097|FG007|Induction Phase|Lack of Efficacy|23|||
27570242|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570243|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570244|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570245|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570246|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27778550|NCT02394028|81021098|FG008|Induction Phase|Lack of Efficacy|0|||
27778551|NCT02394028|81021099|FG009|Induction Phase|Lack of Efficacy|0|||
27778552|NCT02394028|81021100|FG010|Induction Phase|Lack of Efficacy|0|||
27778553|NCT02394028|81021090|FG000|Induction Phase|Lost to Follow-up|1|||
27778554|NCT02394028|81021091|FG001|Induction Phase|Lost to Follow-up|0|||
27778555|NCT02394028|81021092|FG002|Induction Phase|Lost to Follow-up|0|||
27778556|NCT02394028|81021093|FG003|Induction Phase|Lost to Follow-up|1|||
27778557|NCT02394028|81021094|FG004|Induction Phase|Lost to Follow-up|0|||
27778558|NCT02394028|81021095|FG005|Induction Phase|Lost to Follow-up|0|||
27778559|NCT02394028|81021096|FG006|Induction Phase|Lost to Follow-up|1|||
27778560|NCT02394028|81021097|FG007|Induction Phase|Lost to Follow-up|0|||
27778561|NCT02394028|81021098|FG008|Induction Phase|Lost to Follow-up|0|||
27778562|NCT02394028|81021099|FG009|Induction Phase|Lost to Follow-up|0|||
27778563|NCT02394028|81021100|FG010|Induction Phase|Lost to Follow-up|0|||
27778564|NCT02394028|81021090|FG000|Induction Phase|Non-compliance|0|||
27778565|NCT02394028|81021091|FG001|Induction Phase|Non-compliance|1|||
27778566|NCT02394028|81021092|FG002|Induction Phase|Non-compliance|3|||
27778567|NCT02394028|81021093|FG003|Induction Phase|Non-compliance|1|||
27778568|NCT02394028|81021094|FG004|Induction Phase|Non-compliance|3|||
27778569|NCT02394028|81021095|FG005|Induction Phase|Non-compliance|0|||
27778570|NCT02394028|81021096|FG006|Induction Phase|Non-compliance|1|||
27778571|NCT02394028|81021097|FG007|Induction Phase|Non-compliance|1|||
27778572|NCT02394028|81021098|FG008|Induction Phase|Non-compliance|0|||
27967952|NCT01639339|81714145|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
27778573|NCT02394028|81021099|FG009|Induction Phase|Non-compliance|0|||
27778574|NCT02394028|81021100|FG010|Induction Phase|Non-compliance|0|||
27778575|NCT02394028|81021090|FG000|Induction Phase|Physician Decision|0|||
27778576|NCT02394028|81021091|FG001|Induction Phase|Physician Decision|0|||
27778577|NCT02394028|81021092|FG002|Induction Phase|Physician Decision|1|||
27778578|NCT02394028|81021093|FG003|Induction Phase|Physician Decision|4|||
27778579|NCT02394028|81021094|FG004|Induction Phase|Physician Decision|0|||
27778580|NCT02394028|81021095|FG005|Induction Phase|Physician Decision|2|||
27778581|NCT02394028|81021096|FG006|Induction Phase|Physician Decision|1|||
27778582|NCT02394028|81021097|FG007|Induction Phase|Physician Decision|0|||
27778583|NCT02394028|81021098|FG008|Induction Phase|Physician Decision|0|||
27778584|NCT02394028|81021099|FG009|Induction Phase|Physician Decision|0|||
27778585|NCT02394028|81021100|FG010|Induction Phase|Physician Decision|0|||
27778586|NCT02394028|81021090|FG000|Induction Phase|Protocol Violation|0|||
27778587|NCT02394028|81021091|FG001|Induction Phase|Protocol Violation|2|||
27778588|NCT02394028|81021092|FG002|Induction Phase|Protocol Violation|0|||
27778589|NCT02394028|81021093|FG003|Induction Phase|Protocol Violation|3|||
27778590|NCT02394028|81021094|FG004|Induction Phase|Protocol Violation|0|||
27778591|NCT02394028|81021095|FG005|Induction Phase|Protocol Violation|1|||
27778592|NCT02394028|81021096|FG006|Induction Phase|Protocol Violation|1|||
27778593|NCT02394028|81021097|FG007|Induction Phase|Protocol Violation|0|||
27778594|NCT02394028|81021098|FG008|Induction Phase|Protocol Violation|0|||
27778595|NCT02394028|81021099|FG009|Induction Phase|Protocol Violation|0|||
27778596|NCT02394028|81021100|FG010|Induction Phase|Protocol Violation|0|||
27778597|NCT02394028|81021090|FG000|Induction Phase|Withdrawal by Subject|1|||
27778598|NCT02394028|81021091|FG001|Induction Phase|Withdrawal by Subject|2|||
27778599|NCT02394028|81021092|FG002|Induction Phase|Withdrawal by Subject|4|||
27778600|NCT02394028|81021093|FG003|Induction Phase|Withdrawal by Subject|6|||
27778601|NCT02394028|81021094|FG004|Induction Phase|Withdrawal by Subject|7|||
27778602|NCT02394028|81021095|FG005|Induction Phase|Withdrawal by Subject|4|||
27778603|NCT02394028|81021096|FG006|Induction Phase|Withdrawal by Subject|3|||
27778604|NCT02394028|81021097|FG007|Induction Phase|Withdrawal by Subject|6|||
27778605|NCT02394028|81021098|FG008|Induction Phase|Withdrawal by Subject|0|||
27778606|NCT02394028|81021099|FG009|Induction Phase|Withdrawal by Subject|0|||
27778607|NCT02394028|81021100|FG010|Induction Phase|Withdrawal by Subject|0|||
27778608|NCT02394028|81021090|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778609|NCT02394028|81021091|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778610|NCT02394028|81021092|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778611|NCT02394028|81021093|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778612|NCT02394028|81021094|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778613|NCT02394028|81021095|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778614|NCT02394028|81021096|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
27778615|NCT02394028|81021097|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778616|NCT02394028|81021098|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778617|NCT02394028|81021099|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
27832924|NCT04583423|81219403|FG002|Overall Study|Withdrawal by Subject|2|||
27832925|NCT04583423|81219404|FG003|Overall Study|Withdrawal by Subject|1|||
27832926|NCT00354159|81219405|FG000|Randomized Study Period|Withdrawal by Subject|5|||
27832927|NCT00354159|81219406|FG001|Randomized Study Period|Withdrawal by Subject|3|||
27832928|NCT00354159|81219405|FG000|Randomized Study Period|Physician Decision|6|||
27832929|NCT00354159|81219406|FG001|Randomized Study Period|Physician Decision|10|||
27832930|NCT00354159|81219405|FG000|Randomized Study Period|Lost to Follow-up|4|||
27832931|NCT00354159|81219406|FG001|Randomized Study Period|Lost to Follow-up|0|||
27832932|NCT00354159|81219405|FG000|Randomized Study Period|Death|7|||
27832933|NCT00354159|81219406|FG001|Randomized Study Period|Death|9|||
27832934|NCT00354159|81219405|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
27832935|NCT00354159|81219406|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
27832936|NCT00354159|81219405|FG000|Long-term Follow-up|Physician Decision|127|||
27832937|NCT00354159|81219406|FG001|Long-term Follow-up|Physician Decision|122|||
27832938|NCT00354159|81219405|FG000|Long-term Follow-up|Lost to Follow-up|1|||
27832939|NCT00354159|81219406|FG001|Long-term Follow-up|Lost to Follow-up|0|||
27832940|NCT00354159|81219405|FG000|Long-term Follow-up|Death|14|||
27832941|NCT00354159|81219406|FG001|Long-term Follow-up|Death|11|||
27832942|NCT00354159|81219405|FG000|Long-term Follow-up|Study Closed|29|||
27832943|NCT00354159|81219406|FG001|Long-term Follow-up|Study Closed|34|||
27832944|NCT03193021|81219407|FG000|Overall Study|Lost to Follow-up|1|||
27832945|NCT03193021|81219408|FG001|Overall Study|Lost to Follow-up|1|||
27832946|NCT02452463|81219409|FG000|Overall Study|Death|1|||
27832947|NCT02452463|81219410|FG001|Overall Study|Death|0|||
27832948|NCT02452463|81219411|FG002|Overall Study|Death|0|||
27832949|NCT02452463|81219409|FG000|Overall Study|Study Suspended|1|||
27778618|NCT02394028|81021100|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
27778619|NCT02394028|81021090|FG000|Induction Phase|Sponsor decision|0|||
27778620|NCT02394028|81021091|FG001|Induction Phase|Sponsor decision|1|||
27778621|NCT02394028|81021092|FG002|Induction Phase|Sponsor decision|2|||
27778622|NCT02394028|81021093|FG003|Induction Phase|Sponsor decision|0|||
27778623|NCT02394028|81021094|FG004|Induction Phase|Sponsor decision|0|||
27778624|NCT02394028|81021095|FG005|Induction Phase|Sponsor decision|0|||
27967953|NCT01639339|81714146|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
27967954|NCT01639339|81714145|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
27967955|NCT01639339|81714146|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
27967956|NCT03255967|81714147|FG000|Overall Study|Adverse Event|26|||
27967957|NCT03255967|81714148|FG001|Overall Study|Adverse Event|30|||
27967958|NCT03255967|81714147|FG000|Overall Study|Withdrawal by Subject|6|||
27967959|NCT03255967|81714148|FG001|Overall Study|Withdrawal by Subject|6|||
27570247|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570248|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27570249|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570250|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570251|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27666281|NCT01589523|80615558|FG000|Overall Study|Withdrawal by Subject|1|||
27666282|NCT02956278|80615559|FG000|Overall Study|Withdrawal by Subject|6|||
27666283|NCT02956278|80615560|FG001|Overall Study|Withdrawal by Subject|2|||
27666284|NCT02956278|80615561|FG002|Overall Study|Withdrawal by Subject|0|||
27778625|NCT02394028|81021096|FG006|Induction Phase|Sponsor decision|0|||
27778626|NCT02394028|81021097|FG007|Induction Phase|Sponsor decision|0|||
27778627|NCT02394028|81021098|FG008|Induction Phase|Sponsor decision|0|||
27778628|NCT02394028|81021099|FG009|Induction Phase|Sponsor decision|0|||
27778629|NCT02394028|81021100|FG010|Induction Phase|Sponsor decision|0|||
27778630|NCT02394028|81021090|FG000|Induction Phase|Technical reason|0|||
27778631|NCT02394028|81021091|FG001|Induction Phase|Technical reason|0|||
27778632|NCT02394028|81021092|FG002|Induction Phase|Technical reason|0|||
27778633|NCT02394028|81021093|FG003|Induction Phase|Technical reason|1|||
27778634|NCT02394028|81021094|FG004|Induction Phase|Technical reason|0|||
27778635|NCT02394028|81021095|FG005|Induction Phase|Technical reason|0|||
27778636|NCT02394028|81021096|FG006|Induction Phase|Technical reason|0|||
27778637|NCT02394028|81021097|FG007|Induction Phase|Technical reason|0|||
27778638|NCT02394028|81021098|FG008|Induction Phase|Technical reason|0|||
27778639|NCT02394028|81021099|FG009|Induction Phase|Technical reason|0|||
27778640|NCT02394028|81021100|FG010|Induction Phase|Technical reason|0|||
27778641|NCT02394028|81021090|FG000|Induction Phase|:ack of calculation|0|||
27778642|NCT02394028|81021091|FG001|Induction Phase|:ack of calculation|0|||
27778643|NCT02394028|81021092|FG002|Induction Phase|:ack of calculation|0|||
27778644|NCT02394028|81021093|FG003|Induction Phase|:ack of calculation|0|||
27778645|NCT02394028|81021094|FG004|Induction Phase|:ack of calculation|0|||
27778646|NCT02394028|81021095|FG005|Induction Phase|:ack of calculation|0|||
27778647|NCT02394028|81021096|FG006|Induction Phase|:ack of calculation|0|||
27778648|NCT02394028|81021097|FG007|Induction Phase|:ack of calculation|1|||
27666285|NCT01904136|80615567|FG000|Overall Study|Physician Decision|0|||
27666286|NCT01904136|80615568|FG001|Overall Study|Physician Decision|0|||
27666287|NCT01904136|80615569|FG002|Overall Study|Physician Decision|0|||
27666288|NCT01904136|80615570|FG003|Overall Study|Physician Decision|0|||
27666289|NCT01904136|80615571|FG004|Overall Study|Physician Decision|0|||
27666290|NCT01904136|80615572|FG005|Overall Study|Physician Decision|1|||
27666291|NCT01904136|80615573|FG006|Overall Study|Physician Decision|0|||
27666292|NCT01904136|80615574|FG007|Overall Study|Physician Decision|0|||
27666293|NCT01904136|80615575|FG008|Overall Study|Physician Decision|0|||
27666294|NCT02412111|80615576|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
27666295|NCT02412111|80615577|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
27666296|NCT02412111|80615578|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
27666297|NCT02412111|80615576|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
27778649|NCT02394028|81021098|FG008|Induction Phase|:ack of calculation|0|||
27778650|NCT02394028|81021099|FG009|Induction Phase|:ack of calculation|0|||
27967960|NCT03255967|81714147|FG000|Overall Study|Schedule conflict|6|||
27967961|NCT03255967|81714148|FG001|Overall Study|Schedule conflict|4|||
27967962|NCT03255967|81714147|FG000|Overall Study|POA did not sign consent form|2|||
27570252|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27666298|NCT02412111|80615577|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
27666299|NCT02412111|80615578|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
27778651|NCT02394028|81021100|FG010|Induction Phase|:ack of calculation|0|||
27778652|NCT02394028|81021090|FG000|Maintenance Phase|Protocol Violation|0|||
27778653|NCT02394028|81021091|FG001|Maintenance Phase|Protocol Violation|0|||
27778654|NCT02394028|81021092|FG002|Maintenance Phase|Protocol Violation|0|||
27778655|NCT02394028|81021093|FG003|Maintenance Phase|Protocol Violation|0|||
27778656|NCT02394028|81021094|FG004|Maintenance Phase|Protocol Violation|0|||
27570253|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570254|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570255|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570256|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570257|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570258|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570259|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570260|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570261|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570262|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
27570263|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
27570264|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
27570265|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
27570266|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570267|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570268|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570269|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570270|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570271|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570272|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27570273|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27666300|NCT02412111|80615576|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
27863335|NCT02027428|81329748|FG002|Induction|Miscellaneous|0|||
27967963|NCT03255967|81714148|FG001|Overall Study|POA did not sign consent form|0|||
27967964|NCT00721578|81714152|FG000|Overall Study|Death|1|||
27863336|NCT02027428|81329746|FG000|Induction|Induction Treatment Ongoing|4|||
27967965|NCT00721578|81714153|FG001|Overall Study|Death|1|||
27967966|NCT00721578|81714152|FG000|Overall Study|Withdrawal by Subject|1|||
27967967|NCT00721578|81714153|FG001|Overall Study|Withdrawal by Subject|1|||
27967968|NCT03430843|81714154|FG000|Overall Study|Death|233|||
27967969|NCT03430843|81714155|FG001|Overall Study|Death|233|||
27967970|NCT03430843|81714154|FG000|Overall Study|Sponsor Decision|17|||
27967971|NCT03430843|81714155|FG001|Overall Study|Sponsor Decision|6|||
27967972|NCT03430843|81714154|FG000|Overall Study|Withdrawal by Subject|5|||
27967973|NCT03430843|81714155|FG001|Overall Study|Withdrawal by Subject|14|||
27967974|NCT03430843|81714154|FG000|Overall Study|Lost to Follow-up|1|||
27967975|NCT03430843|81714155|FG001|Overall Study|Lost to Follow-up|3|||
27967976|NCT00516906|81714157|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
27967977|NCT00516906|81714158|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
27967978|NCT02684058|81714159|FG000|Treatment Period|Progressive disease|4|||
27967979|NCT02684058|81714160|FG001|Treatment Period|Progressive disease|10|||
27967980|NCT02684058|81714161|FG002|Treatment Period|Progressive disease|19|||
27967981|NCT02684058|81714159|FG000|Treatment Period|Adverse Event|3|||
27967982|NCT02684058|81714160|FG001|Treatment Period|Adverse Event|8|||
27967983|NCT02684058|81714161|FG002|Treatment Period|Adverse Event|1|||
27967984|NCT02684058|81714159|FG000|Treatment Period|Physician Decision|5|||
27967985|NCT02684058|81714160|FG001|Treatment Period|Physician Decision|1|||
27967986|NCT02684058|81714161|FG002|Treatment Period|Physician Decision|2|||
27967987|NCT02684058|81714159|FG000|Treatment Period|New therapy for study indication|1|||
27967988|NCT02684058|81714160|FG001|Treatment Period|New therapy for study indication|0|||
27967989|NCT02684058|81714161|FG002|Treatment Period|New therapy for study indication|0|||
27967990|NCT02684058|81714159|FG000|Treatment Period|Protocol deviation|0|||
27967991|NCT02684058|81714160|FG001|Treatment Period|Protocol deviation|1|||
27967992|NCT02684058|81714161|FG002|Treatment Period|Protocol deviation|0|||
27967993|NCT02684058|81714159|FG000|Treatment Period|Subject/guardian decision|4|||
27967994|NCT02684058|81714160|FG001|Treatment Period|Subject/guardian decision|3|||
27967995|NCT02684058|81714161|FG002|Treatment Period|Subject/guardian decision|0|||
27967996|NCT02684058|81714159|FG000|Treatment Period|Death|0|||
27967997|NCT02684058|81714160|FG001|Treatment Period|Death|0|||
27967998|NCT02684058|81714161|FG002|Treatment Period|Death|2|||
27967999|NCT02684058|81714159|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27968000|NCT02684058|81714160|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
27968001|NCT02684058|81714161|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27968002|NCT02684058|81714159|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
27968003|NCT02684058|81714160|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
27968004|NCT02684058|81714161|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
27968005|NCT02684058|81714159|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
27968006|NCT02684058|81714160|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
27968007|NCT02684058|81714161|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
27968008|NCT02684058|81714159|FG000|Post-treatment Efficacy Follow-up|Death|0|||
27666301|NCT02412111|80615577|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
27666302|NCT02412111|80615578|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
27666303|NCT02412111|80615576|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
27666304|NCT02412111|80615577|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
27666305|NCT02412111|80615578|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
27666306|NCT02412111|80615576|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
27666307|NCT02412111|80615577|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
27666308|NCT02412111|80615578|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
27666309|NCT02412111|80615576|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
27666310|NCT02412111|80615577|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
27666311|NCT02412111|80615578|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
27666312|NCT02412111|80615576|FG000|Active Comparator Period (8 Weeks)|Other|0|||
27666313|NCT02412111|80615577|FG001|Active Comparator Period (8 Weeks)|Other|0|||
27666314|NCT02412111|80615578|FG002|Active Comparator Period (8 Weeks)|Other|2|||
27666315|NCT01349036|80615581|FG000|Overall Study|Disease progression|13|||
27666316|NCT01349036|80615582|FG001|Overall Study|Disease progression|22|||
27666317|NCT01349036|80615581|FG000|Overall Study|Other|1|||
27666318|NCT01349036|80615582|FG001|Overall Study|Other|0|||
27666319|NCT01349036|80615581|FG000|Overall Study|Withdrawal by Subject|0|||
27666320|NCT01349036|80615582|FG001|Overall Study|Withdrawal by Subject|2|||
27666321|NCT02507687|80615583|FG000|Overall Study|Adverse Event|3|||
27666322|NCT02507687|80615584|FG001|Overall Study|Adverse Event|2|||
27666323|NCT02507687|80615585|FG002|Overall Study|Adverse Event|2|||
27666324|NCT02507687|80615586|FG003|Overall Study|Adverse Event|2|||
27666325|NCT02507687|80615583|FG000|Overall Study|Withdrawal by Subject|1|||
27666326|NCT02507687|80615584|FG001|Overall Study|Withdrawal by Subject|4|||
27666327|NCT02507687|80615585|FG002|Overall Study|Withdrawal by Subject|6|||
27666328|NCT02507687|80615586|FG003|Overall Study|Withdrawal by Subject|6|||
27666329|NCT02507687|80615583|FG000|Overall Study|Protocol Violation|1|||
27666330|NCT02507687|80615584|FG001|Overall Study|Protocol Violation|0|||
27666331|NCT02507687|80615585|FG002|Overall Study|Protocol Violation|2|||
27666332|NCT02507687|80615586|FG003|Overall Study|Protocol Violation|0|||
27666333|NCT02507687|80615583|FG000|Overall Study|Lost to Follow-up|0|||
27666334|NCT02507687|80615584|FG001|Overall Study|Lost to Follow-up|0|||
27666335|NCT02507687|80615585|FG002|Overall Study|Lost to Follow-up|2|||
27666336|NCT02507687|80615586|FG003|Overall Study|Lost to Follow-up|1|||
27666337|NCT02507687|80615583|FG000|Overall Study|Screen Failure|0|||
27666338|NCT02507687|80615584|FG001|Overall Study|Screen Failure|0|||
27666339|NCT02507687|80615585|FG002|Overall Study|Screen Failure|1|||
27666340|NCT02507687|80615586|FG003|Overall Study|Screen Failure|0|||
27666341|NCT02507687|80615583|FG000|Overall Study|Other, Not Specified|0|||
27666342|NCT02507687|80615584|FG001|Overall Study|Other, Not Specified|0|||
27666343|NCT02507687|80615585|FG002|Overall Study|Other, Not Specified|2|||
27666344|NCT02507687|80615586|FG003|Overall Study|Other, Not Specified|4|||
27666345|NCT01880437|80615588|FG000|Overall Study|Death|12|||
27968009|NCT02684058|81714160|FG001|Post-treatment Efficacy Follow-up|Death|0|||
27968010|NCT02684058|81714161|FG002|Post-treatment Efficacy Follow-up|Death|3|||
27968011|NCT02684058|81714159|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
27968012|NCT02684058|81714160|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
27968013|NCT02684058|81714161|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
27968014|NCT02684058|81714159|FG000|Post-treatment Survival Follow-up|Death|0|||
27968015|NCT02684058|81714160|FG001|Post-treatment Survival Follow-up|Death|0|||
27968016|NCT02684058|81714161|FG002|Post-treatment Survival Follow-up|Death|7|||
27968017|NCT02684058|81714159|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
27968018|NCT02684058|81714160|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
27666346|NCT01880437|80615589|FG001|Overall Study|Death|4|||
27666347|NCT01880437|80615590|FG002|Overall Study|Death|17|||
27666348|NCT01880437|80615588|FG000|Overall Study|Study terminated by Sponsor|3|||
27666349|NCT01880437|80615589|FG001|Overall Study|Study terminated by Sponsor|0|||
27666350|NCT01880437|80615590|FG002|Overall Study|Study terminated by Sponsor|2|||
27666351|NCT00733226|80615591|FG000|Overall Study|Withdrawal by Subject|1|||
27666352|NCT00733226|80615592|FG001|Overall Study|Withdrawal by Subject|0|||
27666353|NCT00733226|80615591|FG000|Overall Study|Lost to Follow-up|2|||
27666354|NCT00733226|80615592|FG001|Overall Study|Lost to Follow-up|0|||
27666355|NCT00733226|80615591|FG000|Overall Study|moved to another place|2|||
27666356|NCT00733226|80615592|FG001|Overall Study|moved to another place|0|||
27666357|NCT00570921|80615593|FG000|Overall Study|Protocol Violation|1|||
27666358|NCT00570921|80615593|FG000|Overall Study|Physician Decision|1|||
27666359|NCT00275301|80615594|FG000|Overall Study|Adverse Event|5|||
27666360|NCT01841112|80615595|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
27666361|NCT01841112|80615596|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
27666362|NCT01841112|80615597|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
27666363|NCT01841112|80615598|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
27666364|NCT01841112|80615599|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
27968019|NCT02684058|81714161|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
27968020|NCT02684058|81714159|FG000|Crossover Treatment Period|Progressive disease|0|||
27968021|NCT02684058|81714160|FG001|Crossover Treatment Period|Progressive disease|1|||
27968022|NCT02684058|81714161|FG002|Crossover Treatment Period|Progressive disease|0|||
27968023|NCT00675441|81714162|FG000|Overall Study|Withdrawal by Subject|2|||
27968024|NCT00675441|81714162|FG000|Overall Study|Death|1|||
27968025|NCT02910401|81714163|FG000|Overall Study|Study closure Study closure|0|||
27968026|NCT02910401|81714164|FG001|Overall Study|Study closure Study closure|0|||
27968027|NCT02910401|81714165|FG002|Overall Study|Study closure Study closure|2|||
27968028|NCT02910401|81714163|FG000|Overall Study|Physician Decision|1|||
27968029|NCT02910401|81714164|FG001|Overall Study|Physician Decision|0|||
27968030|NCT02910401|81714165|FG002|Overall Study|Physician Decision|0|||
27968031|NCT00271856|81714166|FG000|Overall Study|Withdrawal by Subject|1|||
27968032|NCT00271856|81714167|FG001|Overall Study|Withdrawal by Subject|7|||
27968033|NCT00271856|81714166|FG000|Overall Study|Lost to Follow-up|10|||
27968034|NCT00271856|81714167|FG001|Overall Study|Lost to Follow-up|11|||
27968035|NCT00152477|81714172|FG000|Chemotherapy Period|Adverse Event|9|||
27968036|NCT00152477|81714173|FG001|Chemotherapy Period|Adverse Event|4|||
27968037|NCT00152477|81714174|FG002|Chemotherapy Period|Adverse Event|5|||
27968038|NCT00152477|81714172|FG000|Chemotherapy Period|Death|1|||
27968039|NCT00152477|81714173|FG001|Chemotherapy Period|Death|3|||
27968040|NCT00152477|81714174|FG002|Chemotherapy Period|Death|3|||
27968041|NCT00152477|81714172|FG000|Chemotherapy Period|Lack of Efficacy|4|||
27968042|NCT00152477|81714173|FG001|Chemotherapy Period|Lack of Efficacy|5|||
27968043|NCT00152477|81714174|FG002|Chemotherapy Period|Lack of Efficacy|6|||
27968044|NCT00152477|81714172|FG000|Chemotherapy Period|Lost to Follow-up|1|||
27968045|NCT00152477|81714173|FG001|Chemotherapy Period|Lost to Follow-up|0|||
27968046|NCT00152477|81714174|FG002|Chemotherapy Period|Lost to Follow-up|1|||
27666365|NCT00808899|80615600|FG000|Overall Study|Death|1|||
27968047|NCT00152477|81714172|FG000|Chemotherapy Period|Protocol Violation|1|||
27968048|NCT00152477|81714173|FG001|Chemotherapy Period|Protocol Violation|1|||
27968049|NCT00152477|81714174|FG002|Chemotherapy Period|Protocol Violation|0|||
27968050|NCT00152477|81714172|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
27968051|NCT00152477|81714173|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
27666366|NCT00808899|80615600|FG000|Overall Study|Physician Decision|3|||
27666367|NCT02204319|80615603|FG000|Overall Study|Pregnancy|1|||
27666368|NCT02204319|80615603|FG000|Overall Study|Withdrawal by Subject|2|||
27666369|NCT03269695|80615604|FG000|Overall Study|Adverse Event|2|||
27666370|NCT03269695|80615605|FG001|Overall Study|Adverse Event|1|||
27666371|NCT03269695|80615604|FG000|Overall Study|Lack of Efficacy|0|||
27666372|NCT03269695|80615605|FG001|Overall Study|Lack of Efficacy|1|||
27666373|NCT03269695|80615604|FG000|Overall Study|Withdrawal by Subject|0|||
27778657|NCT02394028|81021095|FG005|Maintenance Phase|Protocol Violation|0|||
27666374|NCT03269695|80615605|FG001|Overall Study|Withdrawal by Subject|1|||
27666375|NCT03188536|80615610|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
27778658|NCT02394028|81021096|FG006|Maintenance Phase|Protocol Violation|0|||
27778659|NCT02394028|81021097|FG007|Maintenance Phase|Protocol Violation|0|||
27778660|NCT02394028|81021098|FG008|Maintenance Phase|Protocol Violation|0|||
27778661|NCT02394028|81021099|FG009|Maintenance Phase|Protocol Violation|0|||
27778662|NCT02394028|81021100|FG010|Maintenance Phase|Protocol Violation|1|||
27778663|NCT02394028|81021090|FG000|Maintenance Phase|Physician Decision|0|||
27778664|NCT02394028|81021091|FG001|Maintenance Phase|Physician Decision|0|||
27778665|NCT02394028|81021092|FG002|Maintenance Phase|Physician Decision|0|||
27778666|NCT02394028|81021093|FG003|Maintenance Phase|Physician Decision|0|||
27778667|NCT02394028|81021094|FG004|Maintenance Phase|Physician Decision|0|||
27968052|NCT00152477|81714174|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
27666376|NCT03188536|80615610|FG000|Overall Study|Not participated/met inclusion criteria|1|||
27666377|NCT03371485|80615612|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
27666378|NCT03371485|80615612|FG000|2-year Follow-up|Death|5|||
27666379|NCT00576823|80615613|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
27666380|NCT00576823|80615614|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
27778668|NCT02394028|81021095|FG005|Maintenance Phase|Physician Decision|0|||
27778669|NCT02394028|81021096|FG006|Maintenance Phase|Physician Decision|0|||
27968053|NCT00152477|81714172|FG000|Chemotherapy Period|Progression of Disease|6|||
27968054|NCT00152477|81714173|FG001|Chemotherapy Period|Progression of Disease|8|||
27968055|NCT00152477|81714174|FG002|Chemotherapy Period|Progression of Disease|4|||
27968056|NCT00152477|81714172|FG000|Chemotherapy Period|Investigator decision|0|||
27968057|NCT00152477|81714173|FG001|Chemotherapy Period|Investigator decision|0|||
27968058|NCT00152477|81714174|FG002|Chemotherapy Period|Investigator decision|1|||
27863337|NCT02027428|81329747|FG001|Induction|Induction Treatment Ongoing|0|||
27863338|NCT02027428|81329748|FG002|Induction|Induction Treatment Ongoing|0|||
27863339|NCT02027428|81329746|FG000|Maintenance|Death|0|||
27863340|NCT02027428|81329747|FG001|Maintenance|Death|3|||
27863341|NCT02027428|81329748|FG002|Maintenance|Death|2|||
27863342|NCT02027428|81329746|FG000|Maintenance|Adverse Event|0|||
27863343|NCT02027428|81329747|FG001|Maintenance|Adverse Event|21|||
27863344|NCT02027428|81329748|FG002|Maintenance|Adverse Event|1|||
27863345|NCT02027428|81329746|FG000|Maintenance|Progressive disease|0|||
27863346|NCT02027428|81329747|FG001|Maintenance|Progressive disease|84|||
27863347|NCT02027428|81329748|FG002|Maintenance|Progressive disease|47|||
27863348|NCT02027428|81329746|FG000|Maintenance|Symptomatic deterioration|0|||
27863349|NCT02027428|81329747|FG001|Maintenance|Symptomatic deterioration|4|||
27863350|NCT02027428|81329748|FG002|Maintenance|Symptomatic deterioration|1|||
27863351|NCT02027428|81329746|FG000|Maintenance|Withdrawal by Subject|0|||
27570274|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27778670|NCT02394028|81021097|FG007|Maintenance Phase|Physician Decision|0|||
27778671|NCT02394028|81021098|FG008|Maintenance Phase|Physician Decision|1|||
27778672|NCT02394028|81021099|FG009|Maintenance Phase|Physician Decision|3|||
27778673|NCT02394028|81021100|FG010|Maintenance Phase|Physician Decision|2|||
27778674|NCT02394028|81021090|FG000|Maintenance Phase|Lack of Efficacy|0|||
27778675|NCT02394028|81021091|FG001|Maintenance Phase|Lack of Efficacy|0|||
27778676|NCT02394028|81021092|FG002|Maintenance Phase|Lack of Efficacy|0|||
27778677|NCT02394028|81021093|FG003|Maintenance Phase|Lack of Efficacy|0|||
27778678|NCT02394028|81021094|FG004|Maintenance Phase|Lack of Efficacy|0|||
27778679|NCT02394028|81021095|FG005|Maintenance Phase|Lack of Efficacy|0|||
27778680|NCT02394028|81021096|FG006|Maintenance Phase|Lack of Efficacy|0|||
27778681|NCT02394028|81021097|FG007|Maintenance Phase|Lack of Efficacy|0|||
27778682|NCT02394028|81021098|FG008|Maintenance Phase|Lack of Efficacy|7|||
27778683|NCT02394028|81021099|FG009|Maintenance Phase|Lack of Efficacy|25|||
27778684|NCT02394028|81021100|FG010|Maintenance Phase|Lack of Efficacy|33|||
27778685|NCT02394028|81021090|FG000|Maintenance Phase|Death|0|||
27778686|NCT02394028|81021091|FG001|Maintenance Phase|Death|0|||
27778687|NCT02394028|81021092|FG002|Maintenance Phase|Death|0|||
27778688|NCT02394028|81021093|FG003|Maintenance Phase|Death|0|||
27778689|NCT02394028|81021094|FG004|Maintenance Phase|Death|0|||
27778690|NCT02394028|81021095|FG005|Maintenance Phase|Death|0|||
27778691|NCT02394028|81021096|FG006|Maintenance Phase|Death|0|||
27778692|NCT02394028|81021097|FG007|Maintenance Phase|Death|0|||
27778693|NCT02394028|81021098|FG008|Maintenance Phase|Death|0|||
27778694|NCT02394028|81021099|FG009|Maintenance Phase|Death|0|||
27778695|NCT02394028|81021100|FG010|Maintenance Phase|Death|1|||
27778696|NCT02394028|81021090|FG000|Maintenance Phase|Adverse Event|0|||
27778697|NCT02394028|81021091|FG001|Maintenance Phase|Adverse Event|0|||
27778698|NCT02394028|81021092|FG002|Maintenance Phase|Adverse Event|0|||
27778699|NCT02394028|81021093|FG003|Maintenance Phase|Adverse Event|0|||
27778700|NCT02394028|81021094|FG004|Maintenance Phase|Adverse Event|0|||
27778701|NCT02394028|81021095|FG005|Maintenance Phase|Adverse Event|0|||
27778702|NCT02394028|81021096|FG006|Maintenance Phase|Adverse Event|0|||
27778703|NCT02394028|81021097|FG007|Maintenance Phase|Adverse Event|0|||
27778704|NCT02394028|81021098|FG008|Maintenance Phase|Adverse Event|1|||
27778705|NCT02394028|81021099|FG009|Maintenance Phase|Adverse Event|1|||
27778706|NCT02394028|81021100|FG010|Maintenance Phase|Adverse Event|3|||
27778707|NCT02394028|81021090|FG000|Maintenance Phase|Site closure|0|||
27778708|NCT02394028|81021091|FG001|Maintenance Phase|Site closure|0|||
27778709|NCT02394028|81021092|FG002|Maintenance Phase|Site closure|0|||
27778710|NCT02394028|81021093|FG003|Maintenance Phase|Site closure|0|||
27778711|NCT02394028|81021094|FG004|Maintenance Phase|Site closure|0|||
27778712|NCT02394028|81021095|FG005|Maintenance Phase|Site closure|0|||
27778713|NCT02394028|81021096|FG006|Maintenance Phase|Site closure|0|||
27778714|NCT02394028|81021097|FG007|Maintenance Phase|Site closure|0|||
27778715|NCT02394028|81021098|FG008|Maintenance Phase|Site closure|0|||
27778716|NCT02394028|81021099|FG009|Maintenance Phase|Site closure|1|||
27863352|NCT02027428|81329747|FG001|Maintenance|Withdrawal by Subject|6|||
27863353|NCT02027428|81329748|FG002|Maintenance|Withdrawal by Subject|5|||
27863354|NCT02027428|81329746|FG000|Maintenance|Protocol Violation|0|||
27863355|NCT02027428|81329747|FG001|Maintenance|Protocol Violation|0|||
27863356|NCT02027428|81329748|FG002|Maintenance|Protocol Violation|1|||
27863357|NCT02027428|81329746|FG000|Maintenance|Other|0|||
27863358|NCT02027428|81329747|FG001|Maintenance|Other|6|||
27778717|NCT02394028|81021100|FG010|Maintenance Phase|Site closure|0|||
27778718|NCT02394028|81021090|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27778719|NCT02394028|81021091|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27778720|NCT02394028|81021092|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27778721|NCT02394028|81021093|FG003|Maintenance Phase|Withdrawal by Subject|0|||
27778722|NCT02394028|81021094|FG004|Maintenance Phase|Withdrawal by Subject|0|||
27778723|NCT02394028|81021095|FG005|Maintenance Phase|Withdrawal by Subject|0|||
27778724|NCT02394028|81021096|FG006|Maintenance Phase|Withdrawal by Subject|0|||
27778725|NCT02394028|81021097|FG007|Maintenance Phase|Withdrawal by Subject|0|||
27778726|NCT02394028|81021098|FG008|Maintenance Phase|Withdrawal by Subject|3|||
27863359|NCT02027428|81329748|FG002|Maintenance|Other|3|||
27863360|NCT02027428|81329746|FG000|Survival Follow-up|Death|0|||
27863361|NCT02027428|81329747|FG001|Survival Follow-up|Death|78|||
27863362|NCT02027428|81329748|FG002|Survival Follow-up|Death|45|||
27863363|NCT02027428|81329746|FG000|Survival Follow-up|Lost to Follow-up|0|||
27863364|NCT02027428|81329747|FG001|Survival Follow-up|Lost to Follow-up|1|||
27863365|NCT02027428|81329748|FG002|Survival Follow-up|Lost to Follow-up|1|||
27863366|NCT00340678|81329749|FG000|Overall Study|Lost to Follow-up|1|||
27863367|NCT00340678|81329750|FG001|Overall Study|Lost to Follow-up|0|||
27863368|NCT00340678|81329751|FG002|Overall Study|Lost to Follow-up|0|||
27863369|NCT00340678|81329752|FG003|Overall Study|Lost to Follow-up|0|||
27863370|NCT01059344|81329753|FG000|Overall Study|Adverse Event|12|||
27863371|NCT01059344|81329754|FG001|Overall Study|Adverse Event|30|||
27863372|NCT01059344|81329753|FG000|Overall Study|Withdrawal by Subject|6|||
27863373|NCT01059344|81329754|FG001|Overall Study|Withdrawal by Subject|9|||
27863374|NCT01059344|81329753|FG000|Overall Study|Lost to Follow-up|1|||
27863375|NCT01059344|81329754|FG001|Overall Study|Lost to Follow-up|1|||
27863376|NCT01059344|81329753|FG000|Overall Study|Other|3|||
27863377|NCT01059344|81329754|FG001|Overall Study|Other|6|||
27863378|NCT03138655|81329766|FG000|Overall Study|Adverse Event|2|||
27863379|NCT03138655|81329767|FG001|Overall Study|Adverse Event|1|||
27863380|NCT03138655|81329768|FG002|Overall Study|Adverse Event|2|||
27863381|NCT03138655|81329769|FG003|Overall Study|Adverse Event|1|||
27863382|NCT03138655|81329770|FG004|Overall Study|Adverse Event|1|||
27863383|NCT03138655|81329771|FG005|Overall Study|Adverse Event|4|||
27863384|NCT03138655|81329772|FG006|Overall Study|Adverse Event|2|||
27863385|NCT03138655|81329773|FG007|Overall Study|Adverse Event|2|||
27863386|NCT03138655|81329766|FG000|Overall Study|Withdrawal by Subject|0|||
27863387|NCT03138655|81329767|FG001|Overall Study|Withdrawal by Subject|1|||
27863388|NCT03138655|81329768|FG002|Overall Study|Withdrawal by Subject|0|||
27863389|NCT03138655|81329769|FG003|Overall Study|Withdrawal by Subject|0|||
27863390|NCT03138655|81329770|FG004|Overall Study|Withdrawal by Subject|0|||
27863391|NCT03138655|81329771|FG005|Overall Study|Withdrawal by Subject|0|||
27863392|NCT03138655|81329772|FG006|Overall Study|Withdrawal by Subject|1|||
27863393|NCT03138655|81329773|FG007|Overall Study|Withdrawal by Subject|0|||
27863394|NCT03138655|81329766|FG000|Overall Study|Reason not Specified|1|||
27778727|NCT02394028|81021099|FG009|Maintenance Phase|Withdrawal by Subject|12|||
27778728|NCT02394028|81021100|FG010|Maintenance Phase|Withdrawal by Subject|12|||
27778729|NCT02994927|81021101|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27778730|NCT02994927|81021102|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27778731|NCT02994927|81021101|FG000|Overall Study|Did not meet eligibility criteria|0|||
27778732|NCT02994927|81021102|FG001|Overall Study|Did not meet eligibility criteria|1|||
27778733|NCT02994927|81021101|FG000|Overall Study|Physician Decision|4|||
27778734|NCT02994927|81021102|FG001|Overall Study|Physician Decision|3|||
27778735|NCT02994927|81021101|FG000|Overall Study|Death|4|||
27778736|NCT02994927|81021102|FG001|Overall Study|Death|2|||
27778737|NCT02994927|81021101|FG000|Overall Study|Adverse Event|2|||
27778738|NCT02994927|81021102|FG001|Overall Study|Adverse Event|1|||
27778739|NCT02994927|81021101|FG000|Overall Study|Withdrawal by Subject|3|||
27778740|NCT02994927|81021102|FG001|Overall Study|Withdrawal by Subject|6|||
27778741|NCT02994927|81021101|FG000|Overall Study|Lost to Follow-up|2|||
27778742|NCT02994927|81021102|FG001|Overall Study|Lost to Follow-up|1|||
27778743|NCT02382276|81021103|FG000|Overall Study|Withdrawal by Subject|4|||
27778744|NCT02382276|81021104|FG001|Overall Study|Withdrawal by Subject|8|||
27778745|NCT02382276|81021105|FG002|Overall Study|Withdrawal by Subject|5|||
27778746|NCT02382276|81021103|FG000|Overall Study|Adverse Event|7|||
27778747|NCT02382276|81021104|FG001|Overall Study|Adverse Event|2|||
27778748|NCT02382276|81021105|FG002|Overall Study|Adverse Event|32|||
27778749|NCT02382276|81021103|FG000|Overall Study|Physician Decision|0|||
27778750|NCT02382276|81021104|FG001|Overall Study|Physician Decision|0|||
27778751|NCT02382276|81021105|FG002|Overall Study|Physician Decision|2|||
27778752|NCT04490499|81021108|FG000|Overall Study|Withdrawal by Subject|2|||
27778753|NCT00989664|81021109|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
27778754|NCT00989664|81021109|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
27778755|NCT00989664|81021109|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
27778756|NCT00989664|81021109|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
27778757|NCT00989664|81021109|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
27863395|NCT03138655|81329767|FG001|Overall Study|Reason not Specified|0|||
27863396|NCT03138655|81329768|FG002|Overall Study|Reason not Specified|0|||
27863397|NCT03138655|81329769|FG003|Overall Study|Reason not Specified|2|||
27863398|NCT03138655|81329770|FG004|Overall Study|Reason not Specified|1|||
27863399|NCT03138655|81329771|FG005|Overall Study|Reason not Specified|1|||
27778758|NCT00989664|81021109|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
27778759|NCT00989664|81021109|FG000|Long-Term Follow-Up|Death|3|||
27778760|NCT01078974|81021112|FG000|Overall Study|Adverse Event|3|||
27778761|NCT03590613|81021115|FG000|Period 2, 4 Days|Physician Decision|0|||
27863400|NCT03138655|81329772|FG006|Overall Study|Reason not Specified|0|||
27863401|NCT03138655|81329773|FG007|Overall Study|Reason not Specified|0|||
27778762|NCT03590613|81021116|FG001|Period 2, 4 Days|Physician Decision|0|||
27778763|NCT03590613|81021117|FG002|Period 2, 4 Days|Physician Decision|0|||
27778764|NCT03590613|81021118|FG003|Period 2, 4 Days|Physician Decision|1|||
27778765|NCT02871791|81021119|FG000|Phase 1b|Death|0|||
27778766|NCT02871791|81021120|FG001|Phase 1b|Death|1|||
27778767|NCT02871791|81021119|FG000|Phase 1b|progressive disease|6|||
27778768|NCT02871791|81021120|FG001|Phase 1b|progressive disease|2|||
27778769|NCT02871791|81021119|FG000|Phase 2|Death|1|||
27778770|NCT02871791|81021120|FG001|Phase 2|Death|0|||
27778771|NCT02871791|81021119|FG000|Phase 2|Lost to Follow-up|2|||
27778772|NCT02871791|81021120|FG001|Phase 2|Lost to Follow-up|0|||
27778773|NCT04035473|81021121|FG000|Screening/Baseline|Death|0|||
27778774|NCT04035473|81021122|FG001|Screening/Baseline|Death|1|||
27778775|NCT04035473|81021121|FG000|Screening/Baseline|Adverse Event|0|||
27778776|NCT04035473|81021122|FG001|Screening/Baseline|Adverse Event|1|||
27778777|NCT04035473|81021121|FG000|Follow-up Period|Adverse Event|2|||
27778778|NCT04035473|81021122|FG001|Follow-up Period|Adverse Event|0|||
27778779|NCT02773849|81021132|FG000|Overall Study|Lost to Follow-up|11|||
27968059|NCT00152477|81714172|FG000|Chemotherapy Period|Patient condition worsened|1|||
27968060|NCT00152477|81714173|FG001|Chemotherapy Period|Patient condition worsened|0|||
27968061|NCT00152477|81714174|FG002|Chemotherapy Period|Patient condition worsened|0|||
27968062|NCT00152477|81714172|FG000|Monotherapy Period|Adverse Event|1|||
27968063|NCT00152477|81714173|FG001|Monotherapy Period|Adverse Event|0|||
27968064|NCT00152477|81714174|FG002|Monotherapy Period|Adverse Event|5|||
27968065|NCT00152477|81714172|FG000|Monotherapy Period|Death|2|||
27968066|NCT00152477|81714173|FG001|Monotherapy Period|Death|0|||
27968067|NCT00152477|81714174|FG002|Monotherapy Period|Death|1|||
27968068|NCT00152477|81714172|FG000|Monotherapy Period|Lack of Efficacy|7|||
27968069|NCT00152477|81714173|FG001|Monotherapy Period|Lack of Efficacy|16|||
27968070|NCT00152477|81714174|FG002|Monotherapy Period|Lack of Efficacy|10|||
27968071|NCT00152477|81714172|FG000|Monotherapy Period|Protocol Violation|0|||
27968072|NCT00152477|81714173|FG001|Monotherapy Period|Protocol Violation|1|||
27968073|NCT00152477|81714174|FG002|Monotherapy Period|Protocol Violation|0|||
27968074|NCT00152477|81714172|FG000|Monotherapy Period|Withdrawal by Subject|0|||
27968075|NCT00152477|81714173|FG001|Monotherapy Period|Withdrawal by Subject|0|||
27968076|NCT00152477|81714174|FG002|Monotherapy Period|Withdrawal by Subject|4|||
27968077|NCT00152477|81714172|FG000|Monotherapy Period|Progression of Disease|5|||
27968078|NCT00152477|81714173|FG001|Monotherapy Period|Progression of Disease|11|||
27968079|NCT00152477|81714174|FG002|Monotherapy Period|Progression of Disease|12|||
27968080|NCT00152477|81714172|FG000|Monotherapy Period|Patient decision|0|||
27968081|NCT00152477|81714173|FG001|Monotherapy Period|Patient decision|1|||
27968082|NCT00152477|81714174|FG002|Monotherapy Period|Patient decision|1|||
27968083|NCT00152477|81714172|FG000|Monotherapy Period|Study personel decision|0|||
27968084|NCT00152477|81714173|FG001|Monotherapy Period|Study personel decision|0|||
27968085|NCT00152477|81714174|FG002|Monotherapy Period|Study personel decision|1|||
27570275|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570276|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570277|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570278|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570279|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
27570280|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570281|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570282|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570283|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570284|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570285|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570286|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570287|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570288|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570289|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570290|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570291|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27778780|NCT02773849|81021132|FG000|Overall Study|Death|26|||
27778781|NCT02773849|81021132|FG000|Overall Study|Withdrawal by Subject|5|||
27778782|NCT02773849|81021132|FG000|Overall Study|Withdrawal of Consent|9|||
27778783|NCT02773849|81021132|FG000|Overall Study|Other: not due to lack of tolerability|11|||
27778784|NCT00942422|81021133|FG000|Overall Study|Withdrawal by Subject|1|||
27778785|NCT00942422|81021133|FG000|Overall Study|Death|1|||
27778786|NCT00942422|81021133|FG000|Overall Study|Progressive diease|1|||
27968086|NCT00654745|81714178|FG000|Overall Study|Adverse Event|12|||
27968087|NCT00654745|81714178|FG000|Overall Study|Lost to Follow-up|7|||
27968088|NCT00654745|81714178|FG000|Overall Study|Protocol Violation|11|||
27968089|NCT00654745|81714178|FG000|Overall Study|Withdrawal by Subject|10|||
27968090|NCT00654745|81714178|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
27570292|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570293|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570294|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570295|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570296|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
27570297|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570298|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570299|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570300|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570301|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570302|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570303|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570304|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570305|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27570306|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570307|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570308|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27570309|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570310|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27570311|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
27570312|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570313|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570314|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570315|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570316|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27968091|NCT04537208|81714179|FG000|Overall Study|Adverse Event|0|||
27968092|NCT04537208|81714180|FG001|Overall Study|Adverse Event|0|||
27968093|NCT04537208|81714181|FG002|Overall Study|Adverse Event|0|||
27570317|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570318|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570319|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570320|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
27570321|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570322|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27778787|NCT00606931|81021136|FG000|Overall Study|Withdrawal by Subject|3|||
27778788|NCT00626795|81021137|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
27778789|NCT00626795|81021138|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
27778790|NCT00626795|81021139|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
27778791|NCT00626795|81021137|FG000|Blinded Treatment|Lack of Efficacy|2|||
27778792|NCT00626795|81021138|FG001|Blinded Treatment|Lack of Efficacy|0|||
27778793|NCT00626795|81021139|FG002|Blinded Treatment|Lack of Efficacy|0|||
27778794|NCT00626795|81021137|FG000|Blinded Treatment|Unacceptable adverse event|0|||
27778795|NCT00626795|81021138|FG001|Blinded Treatment|Unacceptable adverse event|0|||
27778796|NCT00626795|81021139|FG002|Blinded Treatment|Unacceptable adverse event|1|||
27778797|NCT00626795|81021137|FG000|Blinded Treatment|Protocol Violation|0|||
27778798|NCT00626795|81021138|FG001|Blinded Treatment|Protocol Violation|1|||
27778799|NCT00626795|81021139|FG002|Blinded Treatment|Protocol Violation|1|||
27778800|NCT00626795|81021137|FG000|Blinded Treatment|Withdrawal by Subject|1|||
27778801|NCT00626795|81021138|FG001|Blinded Treatment|Withdrawal by Subject|1|||
27778802|NCT00626795|81021139|FG002|Blinded Treatment|Withdrawal by Subject|0|||
27778803|NCT00626795|81021137|FG000|Blinded Treatment|Other reasons|2|||
27778804|NCT00626795|81021138|FG001|Blinded Treatment|Other reasons|0|||
27778805|NCT00626795|81021139|FG002|Blinded Treatment|Other reasons|2|||
27778806|NCT00626795|81021137|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
27778807|NCT00626795|81021138|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
27778808|NCT00626795|81021139|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
27778809|NCT04397757|81021140|FG000|Overall Study|Death|3|||
27778810|NCT04397757|81021141|FG001|Overall Study|Death|11|||
27778811|NCT04397757|81021140|FG000|Overall Study|Withdrawal by Subject|2|||
27778812|NCT04397757|81021141|FG001|Overall Study|Withdrawal by Subject|0|||
27778813|NCT04397757|81021140|FG000|Overall Study|Lost to Follow-up|4|||
27778814|NCT04397757|81021141|FG001|Overall Study|Lost to Follow-up|3|||
27778815|NCT01320033|81021142|FG000|Overall Study|Lack of Efficacy|0|||
27778816|NCT01320033|81021143|FG001|Overall Study|Lack of Efficacy|0|||
27968094|NCT04537208|81714182|FG003|Overall Study|Adverse Event|0|||
27778817|NCT01320033|81021144|FG002|Overall Study|Lack of Efficacy|1|||
27778818|NCT01320033|81021142|FG000|Overall Study|Adverse Event|9|||
27778819|NCT01320033|81021143|FG001|Overall Study|Adverse Event|7|||
27778820|NCT01320033|81021144|FG002|Overall Study|Adverse Event|8|||
27778821|NCT01320033|81021142|FG000|Overall Study|Withdrawal by Subject|22|||
27863402|NCT04877457|81332980|FG000|Overall Study|Early termination of study due to low enrollment|2|||
27863403|NCT04877457|81332981|FG001|Overall Study|Early termination of study due to low enrollment|1|||
27863404|NCT04623086|81332984|FG000|Overall Study|Withdrawal by Subject|0|||
27863405|NCT04623086|81332985|FG001|Overall Study|Withdrawal by Subject|0|||
27863406|NCT04623086|81332986|FG002|Overall Study|Withdrawal by Subject|10|||
27863407|NCT03276078|81332987|FG000|Overall Study|Adverse Event|1|||
27863408|NCT00447993|81332992|FG000|Overall Study|Lost to Follow-up|0|||
27863409|NCT00447993|81332993|FG001|Overall Study|Lost to Follow-up|0|||
27863410|NCT00447993|81332994|FG002|Overall Study|Lost to Follow-up|2|||
27863411|NCT00447993|81332995|FG003|Overall Study|Lost to Follow-up|2|||
27863412|NCT00447993|81332992|FG000|Overall Study|Withdrawal by Subject|0|||
27863413|NCT00447993|81332993|FG001|Overall Study|Withdrawal by Subject|0|||
27863414|NCT00447993|81332994|FG002|Overall Study|Withdrawal by Subject|2|||
27863415|NCT00447993|81332995|FG003|Overall Study|Withdrawal by Subject|2|||
27863416|NCT04895982|81332999|FG000|Overall Study|Withdrawal by Subject|0|||
27863417|NCT04895982|81333000|FG001|Overall Study|Withdrawal by Subject|0|||
27863418|NCT04895982|81333001|FG002|Overall Study|Withdrawal by Subject|0|||
27863419|NCT04895982|81333002|FG003|Overall Study|Withdrawal by Subject|0|||
27863420|NCT04895982|81333003|FG004|Overall Study|Withdrawal by Subject|0|||
27863421|NCT04895982|81333004|FG005|Overall Study|Withdrawal by Subject|1|||
27863422|NCT04895982|81333005|FG006|Overall Study|Withdrawal by Subject|1|||
27968095|NCT04537208|81714183|FG004|Overall Study|Adverse Event|0|||
27778822|NCT01320033|81021143|FG001|Overall Study|Withdrawal by Subject|23|||
27778823|NCT01320033|81021144|FG002|Overall Study|Withdrawal by Subject|23|||
27778824|NCT01320033|81021142|FG000|Overall Study|Protocol Violation|3|||
27778825|NCT01320033|81021143|FG001|Overall Study|Protocol Violation|5|||
27778826|NCT01320033|81021144|FG002|Overall Study|Protocol Violation|3|||
27778827|NCT01320033|81021142|FG000|Overall Study|Lost to Follow-up|22|||
27778828|NCT01320033|81021143|FG001|Overall Study|Lost to Follow-up|26|||
27778829|NCT01320033|81021144|FG002|Overall Study|Lost to Follow-up|17|||
27778830|NCT01320033|81021142|FG000|Overall Study|Other|2|||
27778831|NCT01320033|81021143|FG001|Overall Study|Other|3|||
27863423|NCT04895982|81333006|FG007|Overall Study|Withdrawal by Subject|0|||
27863424|NCT04895982|81333007|FG008|Overall Study|Withdrawal by Subject|0|||
27863425|NCT04895982|81333008|FG009|Overall Study|Withdrawal by Subject|1|||
27863426|NCT04895982|81333009|FG010|Overall Study|Withdrawal by Subject|0|||
27863427|NCT04895982|81333010|FG011|Overall Study|Withdrawal by Subject|1|||
27863428|NCT04895982|81332999|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27863429|NCT04895982|81333000|FG001|Overall Study|Withdrawal by parent/guardian|3|||
27863430|NCT04895982|81333001|FG002|Overall Study|Withdrawal by parent/guardian|3|||
27863431|NCT04895982|81333002|FG003|Overall Study|Withdrawal by parent/guardian|1|||
27863432|NCT04895982|81333003|FG004|Overall Study|Withdrawal by parent/guardian|3|||
27863433|NCT04895982|81333004|FG005|Overall Study|Withdrawal by parent/guardian|2|||
27863434|NCT04895982|81333005|FG006|Overall Study|Withdrawal by parent/guardian|1|||
27863435|NCT04895982|81333006|FG007|Overall Study|Withdrawal by parent/guardian|0|||
27863436|NCT04895982|81333007|FG008|Overall Study|Withdrawal by parent/guardian|3|||
27863437|NCT04895982|81333008|FG009|Overall Study|Withdrawal by parent/guardian|0|||
27778832|NCT01320033|81021144|FG002|Overall Study|Other|1|||
27778833|NCT00397891|81021145|FG000|Overall Study|Withdrawal by Subject|1|||
27778834|NCT00397891|81021146|FG001|Overall Study|Withdrawal by Subject|0|||
27778835|NCT00397891|81021147|FG002|Overall Study|Withdrawal by Subject|0|||
27778836|NCT00397891|81021148|FG003|Overall Study|Withdrawal by Subject|0|||
27778837|NCT00397891|81021149|FG004|Overall Study|Withdrawal by Subject|1|||
27863438|NCT04895982|81333009|FG010|Overall Study|Withdrawal by parent/guardian|0|||
27863439|NCT04895982|81333010|FG011|Overall Study|Withdrawal by parent/guardian|0|||
27863440|NCT04895982|81332999|FG000|Overall Study|Other|0|||
27778838|NCT01038635|81021150|FG000|Overall Study|Disease Progression|2|||
27968096|NCT04537208|81714184|FG005|Overall Study|Adverse Event|0|||
27968097|NCT04537208|81714185|FG006|Overall Study|Adverse Event|0|||
27863441|NCT04895982|81333000|FG001|Overall Study|Other|0|||
27863442|NCT04895982|81333001|FG002|Overall Study|Other|1|||
27968098|NCT04537208|81714186|FG007|Overall Study|Adverse Event|0|||
27863443|NCT04895982|81333002|FG003|Overall Study|Other|1|||
27863444|NCT04895982|81333003|FG004|Overall Study|Other|0|||
27863445|NCT04895982|81333004|FG005|Overall Study|Other|0|||
27863446|NCT04895982|81333005|FG006|Overall Study|Other|0|||
27968099|NCT04537208|81714187|FG008|Overall Study|Adverse Event|1|||
27968100|NCT04537208|81714188|FG009|Overall Study|Adverse Event|0|||
27778839|NCT01038635|81021151|FG001|Overall Study|Disease Progression|0|||
27778840|NCT01038635|81021152|FG002|Overall Study|Disease Progression|0|||
27778841|NCT01038635|81021153|FG003|Overall Study|Disease Progression|0|||
27778842|NCT01038635|81021154|FG004|Overall Study|Disease Progression|0|||
27778843|NCT01038635|81021155|FG005|Overall Study|Disease Progression|0|||
27778844|NCT01038635|81021156|FG006|Overall Study|Disease Progression|1|||
27778845|NCT01038635|81021157|FG007|Overall Study|Disease Progression|4|||
27778846|NCT01038635|81021158|FG008|Overall Study|Disease Progression|0|||
27778847|NCT01038635|81021150|FG000|Overall Study|Death|0|||
27778848|NCT01038635|81021151|FG001|Overall Study|Death|0|||
27778849|NCT01038635|81021152|FG002|Overall Study|Death|0|||
27778850|NCT01038635|81021153|FG003|Overall Study|Death|0|||
27778851|NCT01038635|81021154|FG004|Overall Study|Death|1|||
27778852|NCT01038635|81021155|FG005|Overall Study|Death|0|||
27778853|NCT01038635|81021156|FG006|Overall Study|Death|1|||
27778854|NCT01038635|81021157|FG007|Overall Study|Death|1|||
27778855|NCT01038635|81021158|FG008|Overall Study|Death|2|||
27778856|NCT00934791|81021159|FG000|Overall Study|Withdrawal by Subject|1|||
27778857|NCT00934791|81021160|FG001|Overall Study|Withdrawal by Subject|0|||
27778858|NCT02407236|81021161|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
27778859|NCT02407236|81021162|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
27778860|NCT02407236|81021163|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
27778861|NCT02407236|81021164|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
27778862|NCT02407236|81021165|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
27778863|NCT02407236|81021166|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
27778864|NCT02407236|81021167|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
27778865|NCT02407236|81021168|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
27778866|NCT02407236|81021169|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
27778867|NCT02407236|81021170|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
27778868|NCT02407236|81021171|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
27778869|NCT02407236|81021172|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
27778870|NCT02407236|81021173|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
27778871|NCT02407236|81021161|FG000|Induction Study (8 Weeks)|Death|0|||
27778872|NCT02407236|81021162|FG001|Induction Study (8 Weeks)|Death|0|||
27778873|NCT02407236|81021163|FG002|Induction Study (8 Weeks)|Death|1|||
27778874|NCT02407236|81021164|FG003|Induction Study (8 Weeks)|Death|0|||
27778875|NCT02407236|81021165|FG004|Induction Study (8 Weeks)|Death|0|||
27778876|NCT02407236|81021166|FG005|Induction Study (8 Weeks)|Death|0|||
27778877|NCT02407236|81021167|FG006|Induction Study (8 Weeks)|Death|0|||
27778878|NCT02407236|81021168|FG007|Induction Study (8 Weeks)|Death|0|||
27778879|NCT02407236|81021169|FG008|Induction Study (8 Weeks)|Death|0|||
27778880|NCT02407236|81021170|FG009|Induction Study (8 Weeks)|Death|0|||
27778881|NCT02407236|81021171|FG010|Induction Study (8 Weeks)|Death|0|||
27778882|NCT02407236|81021172|FG011|Induction Study (8 Weeks)|Death|0|||
27778883|NCT02407236|81021173|FG012|Induction Study (8 Weeks)|Death|0|||
27778884|NCT02407236|81021161|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
27778885|NCT02407236|81021162|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
27778886|NCT02407236|81021163|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
27778887|NCT02407236|81021164|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778888|NCT02407236|81021165|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778889|NCT02407236|81021166|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778890|NCT02407236|81021167|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778891|NCT02407236|81021168|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778892|NCT02407236|81021169|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778893|NCT02407236|81021170|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778894|NCT02407236|81021171|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778895|NCT02407236|81021172|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778896|NCT02407236|81021173|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
27778897|NCT02407236|81021161|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778898|NCT02407236|81021162|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778899|NCT02407236|81021163|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
27778900|NCT02407236|81021164|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778901|NCT02407236|81021165|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778902|NCT02407236|81021166|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778903|NCT02407236|81021167|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778904|NCT02407236|81021168|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778905|NCT02407236|81021169|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778906|NCT02407236|81021170|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778907|NCT02407236|81021171|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778908|NCT02407236|81021172|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778909|NCT02407236|81021173|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
27778910|NCT02407236|81021161|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
27778911|NCT02407236|81021162|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
27778912|NCT02407236|81021163|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
27778913|NCT02407236|81021164|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
27778914|NCT02407236|81021165|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
27778915|NCT02407236|81021166|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
27778916|NCT02407236|81021167|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
27778917|NCT02407236|81021168|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
27968101|NCT04537208|81714189|FG010|Overall Study|Adverse Event|0|||
27968102|NCT04537208|81714179|FG000|Overall Study|Protocol deviation|0|||
27968103|NCT04537208|81714180|FG001|Overall Study|Protocol deviation|0|||
27968104|NCT04537208|81714181|FG002|Overall Study|Protocol deviation|2|||
27968105|NCT04537208|81714182|FG003|Overall Study|Protocol deviation|0|||
27778918|NCT02407236|81021169|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
27968106|NCT04537208|81714183|FG004|Overall Study|Protocol deviation|0|||
27778919|NCT02407236|81021170|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
27778920|NCT02407236|81021171|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
27778921|NCT02407236|81021172|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
27778922|NCT02407236|81021173|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
27778923|NCT02407236|81021161|FG000|Induction Study (8 Weeks)|Other|2|||
27778924|NCT02407236|81021162|FG001|Induction Study (8 Weeks)|Other|1|||
27778925|NCT02407236|81021163|FG002|Induction Study (8 Weeks)|Other|5|||
27968107|NCT04537208|81714184|FG005|Overall Study|Protocol deviation|2|||
27778926|NCT02407236|81021164|FG003|Induction Study (8 Weeks)|Other|0|||
27778927|NCT02407236|81021165|FG004|Induction Study (8 Weeks)|Other|0|||
27778928|NCT02407236|81021166|FG005|Induction Study (8 Weeks)|Other|0|||
27778929|NCT02407236|81021167|FG006|Induction Study (8 Weeks)|Other|0|||
27778930|NCT02407236|81021168|FG007|Induction Study (8 Weeks)|Other|0|||
27778931|NCT02407236|81021169|FG008|Induction Study (8 Weeks)|Other|0|||
27778932|NCT02407236|81021170|FG009|Induction Study (8 Weeks)|Other|0|||
27778933|NCT02407236|81021171|FG010|Induction Study (8 Weeks)|Other|0|||
27778934|NCT02407236|81021172|FG011|Induction Study (8 Weeks)|Other|0|||
27778935|NCT02407236|81021173|FG012|Induction Study (8 Weeks)|Other|0|||
27778936|NCT02407236|81021161|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778937|NCT02407236|81021162|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778938|NCT02407236|81021163|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778939|NCT02407236|81021164|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
27778940|NCT02407236|81021165|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
27778941|NCT02407236|81021166|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
27778942|NCT02407236|81021167|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
27778943|NCT02407236|81021168|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
27778944|NCT02407236|81021169|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778945|NCT02407236|81021170|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778946|NCT02407236|81021171|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778947|NCT02407236|81021172|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778948|NCT02407236|81021173|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
27778949|NCT02407236|81021161|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778950|NCT02407236|81021162|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778951|NCT02407236|81021163|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778952|NCT02407236|81021164|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
27778953|NCT02407236|81021165|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
27778954|NCT02407236|81021166|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
27778955|NCT02407236|81021167|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
27778956|NCT02407236|81021168|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
27778957|NCT02407236|81021169|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778958|NCT02407236|81021170|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778959|NCT02407236|81021171|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778960|NCT02407236|81021172|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778961|NCT02407236|81021173|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
27778962|NCT02407236|81021161|FG000|Maintenance Study (44 Weeks)|Other|0|||
27778963|NCT02407236|81021162|FG001|Maintenance Study (44 Weeks)|Other|0|||
27778964|NCT02407236|81021163|FG002|Maintenance Study (44 Weeks)|Other|0|||
27778965|NCT02407236|81021164|FG003|Maintenance Study (44 Weeks)|Other|5|||
27778966|NCT02407236|81021165|FG004|Maintenance Study (44 Weeks)|Other|7|||
27968108|NCT04537208|81714185|FG006|Overall Study|Protocol deviation|4|||
27778967|NCT02407236|81021166|FG005|Maintenance Study (44 Weeks)|Other|8|||
27778968|NCT02407236|81021167|FG006|Maintenance Study (44 Weeks)|Other|4|||
27778969|NCT02407236|81021168|FG007|Maintenance Study (44 Weeks)|Other|6|||
27778970|NCT02407236|81021169|FG008|Maintenance Study (44 Weeks)|Other|0|||
27778971|NCT02407236|81021170|FG009|Maintenance Study (44 Weeks)|Other|0|||
27778972|NCT02407236|81021171|FG010|Maintenance Study (44 Weeks)|Other|0|||
27778973|NCT02407236|81021172|FG011|Maintenance Study (44 Weeks)|Other|0|||
27778974|NCT02407236|81021173|FG012|Maintenance Study (44 Weeks)|Other|0|||
27778975|NCT02407236|81021161|FG000|Maintenance Study (44 Weeks)|Death|0|||
27778976|NCT02407236|81021162|FG001|Maintenance Study (44 Weeks)|Death|0|||
27778977|NCT02407236|81021163|FG002|Maintenance Study (44 Weeks)|Death|0|||
27778978|NCT02407236|81021164|FG003|Maintenance Study (44 Weeks)|Death|0|||
27778979|NCT02407236|81021165|FG004|Maintenance Study (44 Weeks)|Death|0|||
27778980|NCT02407236|81021166|FG005|Maintenance Study (44 Weeks)|Death|0|||
27968109|NCT04537208|81714186|FG007|Overall Study|Protocol deviation|0|||
27968110|NCT04537208|81714187|FG008|Overall Study|Protocol deviation|1|||
27968111|NCT04537208|81714188|FG009|Overall Study|Protocol deviation|0|||
27778981|NCT02407236|81021167|FG006|Maintenance Study (44 Weeks)|Death|0|||
27778982|NCT02407236|81021168|FG007|Maintenance Study (44 Weeks)|Death|1|||
27968112|NCT04537208|81714189|FG010|Overall Study|Protocol deviation|2|||
27968113|NCT04537208|81714179|FG000|Overall Study|Withdrawal by Subject|4|||
27968114|NCT04537208|81714180|FG001|Overall Study|Withdrawal by Subject|2|||
27968115|NCT04537208|81714181|FG002|Overall Study|Withdrawal by Subject|1|||
27968116|NCT04537208|81714182|FG003|Overall Study|Withdrawal by Subject|3|||
27968117|NCT04537208|81714183|FG004|Overall Study|Withdrawal by Subject|5|||
27968118|NCT04537208|81714184|FG005|Overall Study|Withdrawal by Subject|1|||
27968119|NCT04537208|81714185|FG006|Overall Study|Withdrawal by Subject|6|||
27968120|NCT04537208|81714186|FG007|Overall Study|Withdrawal by Subject|1|||
27968121|NCT04537208|81714187|FG008|Overall Study|Withdrawal by Subject|7|||
27968122|NCT04537208|81714188|FG009|Overall Study|Withdrawal by Subject|2|||
27968123|NCT04537208|81714189|FG010|Overall Study|Withdrawal by Subject|4|||
27968124|NCT04537208|81714179|FG000|Overall Study|Lost to Follow-up|4|||
27968125|NCT04537208|81714180|FG001|Overall Study|Lost to Follow-up|1|||
27968126|NCT04537208|81714181|FG002|Overall Study|Lost to Follow-up|3|||
27968127|NCT04537208|81714182|FG003|Overall Study|Lost to Follow-up|4|||
27968128|NCT04537208|81714183|FG004|Overall Study|Lost to Follow-up|3|||
27968129|NCT04537208|81714184|FG005|Overall Study|Lost to Follow-up|2|||
27968130|NCT04537208|81714185|FG006|Overall Study|Lost to Follow-up|3|||
27968131|NCT04537208|81714186|FG007|Overall Study|Lost to Follow-up|2|||
27968132|NCT04537208|81714187|FG008|Overall Study|Lost to Follow-up|7|||
27968133|NCT04537208|81714188|FG009|Overall Study|Lost to Follow-up|2|||
27968134|NCT04537208|81714189|FG010|Overall Study|Lost to Follow-up|2|||
27968135|NCT01961297|81714192|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
27968136|NCT01961297|81714193|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
27968137|NCT04004221|81714194|FG000|Overall Study|Death|89|||
27968138|NCT04004221|81714194|FG000|Overall Study|Withdrawal by Subject|5|||
27968139|NCT04004221|81714194|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
27968140|NCT04004221|81714194|FG000|Overall Study|Sponsor Decision|9|||
27968141|NCT04004221|81714194|FG000|Overall Study|Participant refused to enter LTE|1|||
27968142|NCT00443872|81714196|FG000|Overall Study|Protocol Violation|7|||
27968143|NCT00443872|81714196|FG000|Overall Study|Lost to Follow-up|2|||
27968144|NCT00443872|81714196|FG000|Overall Study|Adverse Event|8|||
27968145|NCT00244933|81714197|FG000|Overall Study|Not response evaluable|2|||
27968146|NCT03077438|81714198|FG000|Overall Study|Protocol Violation|3|||
27968147|NCT03077438|81714199|FG001|Overall Study|Protocol Violation|5|||
27968148|NCT03077438|81714198|FG000|Overall Study|Withdrawal by Subject|3|||
27968149|NCT03077438|81714199|FG001|Overall Study|Withdrawal by Subject|6|||
27968150|NCT03077438|81714198|FG000|Overall Study|Lost to Follow-up|6|||
27968151|NCT03077438|81714199|FG001|Overall Study|Lost to Follow-up|3|||
27968152|NCT00853242|81714200|FG000|Overall Study|Adverse Event|0|||
27778983|NCT02407236|81021169|FG008|Maintenance Study (44 Weeks)|Death|0|||
27778984|NCT02407236|81021170|FG009|Maintenance Study (44 Weeks)|Death|0|||
27968153|NCT00853242|81714201|FG001|Overall Study|Adverse Event|1|||
27968154|NCT00853242|81714202|FG002|Overall Study|Adverse Event|1|||
27832950|NCT02452463|81219410|FG001|Overall Study|Study Suspended|0|||
27832951|NCT02452463|81219411|FG002|Overall Study|Study Suspended|0|||
27968155|NCT00853242|81714203|FG003|Overall Study|Adverse Event|0|||
27968156|NCT00853242|81714204|FG004|Overall Study|Adverse Event|3|||
27968157|NCT00853242|81714205|FG005|Overall Study|Adverse Event|1|||
27968158|NCT00853242|81714206|FG006|Overall Study|Adverse Event|1|||
27968159|NCT00853242|81714200|FG000|Overall Study|Noncompliant|0|||
27968160|NCT00853242|81714201|FG001|Overall Study|Noncompliant|0|||
27968161|NCT00853242|81714202|FG002|Overall Study|Noncompliant|0|||
27778985|NCT02407236|81021171|FG010|Maintenance Study (44 Weeks)|Death|0|||
27778986|NCT02407236|81021172|FG011|Maintenance Study (44 Weeks)|Death|0|||
27778987|NCT02407236|81021173|FG012|Maintenance Study (44 Weeks)|Death|0|||
27778988|NCT02407236|81021161|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778989|NCT02407236|81021162|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778990|NCT02407236|81021163|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778991|NCT02407236|81021164|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778992|NCT02407236|81021165|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778993|NCT02407236|81021166|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778994|NCT02407236|81021167|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778995|NCT02407236|81021168|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
27778996|NCT02407236|81021169|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
27778997|NCT02407236|81021170|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
27778998|NCT02407236|81021171|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
27778999|NCT02407236|81021172|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
27779000|NCT02407236|81021173|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
27779001|NCT02407236|81021161|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779002|NCT02407236|81021162|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779003|NCT02407236|81021163|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779004|NCT02407236|81021164|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779005|NCT02407236|81021165|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779006|NCT02407236|81021166|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779007|NCT02407236|81021167|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779008|NCT02407236|81021168|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779009|NCT02407236|81021169|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779010|NCT02407236|81021170|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779011|NCT02407236|81021171|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
27779012|NCT02407236|81021172|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779013|NCT02407236|81021173|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
27779014|NCT02407236|81021161|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779015|NCT02407236|81021162|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779016|NCT02407236|81021163|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779017|NCT02407236|81021164|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779018|NCT02407236|81021165|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779019|NCT02407236|81021166|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779020|NCT02407236|81021167|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779021|NCT02407236|81021168|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
27779022|NCT02407236|81021169|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
27779023|NCT02407236|81021170|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
27779024|NCT02407236|81021171|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
27779025|NCT02407236|81021172|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
27779026|NCT02407236|81021173|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
27779027|NCT02407236|81021161|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
27779028|NCT02407236|81021162|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
27666381|NCT00576823|80615615|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
27666382|NCT00576823|80615613|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
27666383|NCT00576823|80615614|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
27666384|NCT00576823|80615615|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
27666385|NCT01281917|80615616|FG000|Overall Study|Withdrawal by Subject|1|||
27666386|NCT02230306|80615634|FG000|Overall Study|Did not receive study treatment|1|||
27666387|NCT01751165|80615635|FG000|Overall Study|Adverse event, serious fatal|1|||
27779029|NCT02407236|81021163|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
27779030|NCT02407236|81021164|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
27968162|NCT00853242|81714203|FG003|Overall Study|Noncompliant|0|||
27968163|NCT00853242|81714204|FG004|Overall Study|Noncompliant|1|||
27968164|NCT00853242|81714205|FG005|Overall Study|Noncompliant|0|||
27968165|NCT00853242|81714206|FG006|Overall Study|Noncompliant|0|||
27779031|NCT02407236|81021165|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
27779032|NCT02407236|81021166|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
27779033|NCT02407236|81021167|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
27779034|NCT02407236|81021168|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
27779035|NCT02407236|81021169|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
27779036|NCT02407236|81021170|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
27863447|NCT04895982|81333006|FG007|Overall Study|Other|0|||
27968166|NCT00853242|81714200|FG000|Overall Study|Withdrawal by Subject|1|||
27968167|NCT00853242|81714201|FG001|Overall Study|Withdrawal by Subject|2|||
27666388|NCT01751165|80615636|FG001|Overall Study|Adverse event, serious fatal|0|||
27666389|NCT01751165|80615637|FG002|Overall Study|Adverse event, serious fatal|1|||
27968168|NCT00853242|81714202|FG002|Overall Study|Withdrawal by Subject|0|||
27968169|NCT00853242|81714203|FG003|Overall Study|Withdrawal by Subject|4|||
27968170|NCT00853242|81714204|FG004|Overall Study|Withdrawal by Subject|0|||
27968171|NCT00853242|81714205|FG005|Overall Study|Withdrawal by Subject|0|||
27968172|NCT00853242|81714206|FG006|Overall Study|Withdrawal by Subject|2|||
27968173|NCT00853242|81714200|FG000|Overall Study|Other|2|||
27968174|NCT00853242|81714201|FG001|Overall Study|Other|0|||
27968175|NCT00853242|81714202|FG002|Overall Study|Other|2|||
27968176|NCT00853242|81714203|FG003|Overall Study|Other|0|||
27968177|NCT00853242|81714204|FG004|Overall Study|Other|0|||
27968178|NCT00853242|81714205|FG005|Overall Study|Other|1|||
27968179|NCT00853242|81714206|FG006|Overall Study|Other|2|||
27968180|NCT01439971|81714207|FG000|Overall Study|Required number in cohort dosed|0|||
27968181|NCT01439971|81714208|FG001|Overall Study|Required number in cohort dosed|1|||
27968182|NCT01439971|81714209|FG002|Overall Study|Required number in cohort dosed|2|||
27968183|NCT01439971|81714210|FG003|Overall Study|Required number in cohort dosed|0|||
27968184|NCT01439971|81714211|FG004|Overall Study|Required number in cohort dosed|1|||
27779037|NCT02407236|81021171|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
27779038|NCT02407236|81021172|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
27968185|NCT00281099|81714214|FG000|Overall Study|Death|46|||
27968186|NCT00281099|81714215|FG001|Overall Study|Death|57|||
27968187|NCT00281099|81714214|FG000|Overall Study|Lost to Follow-up|10|||
27968188|NCT00281099|81714215|FG001|Overall Study|Lost to Follow-up|19|||
27968189|NCT00281099|81714214|FG000|Overall Study|Withdrawal by Subject|65|||
27968190|NCT00281099|81714215|FG001|Overall Study|Withdrawal by Subject|70|||
27968191|NCT00281099|81714214|FG000|Overall Study|Physician Decision|79|||
27779039|NCT02407236|81021173|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
27968192|NCT00281099|81714215|FG001|Overall Study|Physician Decision|72|||
27968193|NCT00281099|81714214|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
27968194|NCT00281099|81714215|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
27968195|NCT01271712|81714216|FG000|Double Blind Treatment|Death|2|||
27968196|NCT01271712|81714217|FG001|Double Blind Treatment|Death|0|||
27570323|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27968197|NCT01271712|81714216|FG000|Double Blind Treatment|Lack of Efficacy|1|||
27968198|NCT01271712|81714217|FG001|Double Blind Treatment|Lack of Efficacy|0|||
27968199|NCT01271712|81714216|FG000|Double Blind Treatment|Adverse Event|9|||
27968200|NCT01271712|81714217|FG001|Double Blind Treatment|Adverse Event|4|||
27968201|NCT01271712|81714216|FG000|Double Blind Treatment|Progressive disease|23|||
27968202|NCT01271712|81714217|FG001|Double Blind Treatment|Progressive disease|3|||
27968203|NCT01271712|81714216|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
27968204|NCT01271712|81714217|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
27968205|NCT01271712|81714216|FG000|Double Blind Treatment|Non compliance with study drug|2|||
27779040|NCT01843933|81021174|FG000|Overall Study|Data lost|6|||
27779041|NCT01843933|81021175|FG001|Overall Study|Data lost|4|||
27779042|NCT00866606|81021176|FG000|Overall Study|Lost to Follow-up|3|||
27779043|NCT00866606|81021176|FG000|Overall Study|Adverse Event|1|||
27779044|NCT01731600|81021180|FG000|Overall Study|Adverse Event|2|||
27779045|NCT01731600|81021181|FG001|Overall Study|Adverse Event|0|||
27779046|NCT01731600|81021180|FG000|Overall Study|Withdrawal criteria|1|||
27779047|NCT01731600|81021181|FG001|Overall Study|Withdrawal criteria|0|||
27779048|NCT01731600|81021180|FG000|Overall Study|Other reasons|3|||
27779049|NCT01731600|81021181|FG001|Overall Study|Other reasons|0|||
27779050|NCT00366444|81021182|FG000|Overall Study|Withdrawal by Subject|1|||
27779051|NCT00366444|81021183|FG001|Overall Study|Withdrawal by Subject|1|||
27779052|NCT00366444|81021182|FG000|Overall Study|Lack of Efficacy|0|||
27666390|NCT01751165|80615635|FG000|Overall Study|Withdrawal by Subject|0|||
27666391|NCT01751165|80615636|FG001|Overall Study|Withdrawal by Subject|0|||
27666392|NCT01751165|80615637|FG002|Overall Study|Withdrawal by Subject|1|||
27666393|NCT01751165|80615635|FG000|Overall Study|Serious adverse event|0|||
27666394|NCT01751165|80615636|FG001|Overall Study|Serious adverse event|2|||
27666395|NCT01751165|80615637|FG002|Overall Study|Serious adverse event|0|||
27666396|NCT01751165|80615635|FG000|Overall Study|Lost to Follow-up|1|||
27666397|NCT01751165|80615636|FG001|Overall Study|Lost to Follow-up|1|||
27666398|NCT01751165|80615637|FG002|Overall Study|Lost to Follow-up|1|||
27666399|NCT02396953|80615638|FG000|Overall Study|Withdrawal by Subject|0|||
27666400|NCT02396953|80615639|FG001|Overall Study|Withdrawal by Subject|0|||
27666401|NCT02396953|80615640|FG002|Overall Study|Withdrawal by Subject|1|||
27666402|NCT02396953|80615638|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
27666403|NCT02396953|80615639|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
27666404|NCT02396953|80615640|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
27666405|NCT02396953|80615638|FG000|Overall Study|Personal Reasons|1|||
27666406|NCT02396953|80615639|FG001|Overall Study|Personal Reasons|1|||
27666407|NCT02396953|80615640|FG002|Overall Study|Personal Reasons|0|||
27666408|NCT00848393|80615650|FG000|Overall Study|Protocol Violation|0|||
27666409|NCT00848393|80615651|FG001|Overall Study|Protocol Violation|0|||
27666410|NCT00848393|80615652|FG002|Overall Study|Protocol Violation|1|||
27666411|NCT00848393|80615650|FG000|Overall Study|surgical complications unrelated to stud|0|||
27666412|NCT00848393|80615651|FG001|Overall Study|surgical complications unrelated to stud|0|||
27666413|NCT00848393|80615652|FG002|Overall Study|surgical complications unrelated to stud|2|||
27666414|NCT01379703|80615657|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
27666415|NCT01379703|80615658|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
27666416|NCT01379703|80615659|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
27666417|NCT01379703|80615657|FG000|Study Start Through 9 Months|Adverse Event|0|||
27666418|NCT01379703|80615658|FG001|Study Start Through 9 Months|Adverse Event|14|||
27666419|NCT01379703|80615659|FG002|Study Start Through 9 Months|Adverse Event|10|||
27666420|NCT01379703|80615657|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
27779053|NCT00366444|81021183|FG001|Overall Study|Lack of Efficacy|1|||
27779054|NCT02436915|81021185|FG000|Overall Study|Withdrawal by Subject|0|||
27779055|NCT02436915|81021186|FG001|Overall Study|Withdrawal by Subject|1|||
27779056|NCT02646891|81021187|FG000|Overall Study|Adverse Event|0|||
27779057|NCT02646891|81021188|FG001|Overall Study|Adverse Event|1|||
27779058|NCT02646891|81021189|FG002|Overall Study|Adverse Event|0|||
27779059|NCT02646891|81021190|FG003|Overall Study|Adverse Event|0|||
27779060|NCT02646891|81021191|FG004|Overall Study|Adverse Event|0|||
27779061|NCT02646891|81021192|FG005|Overall Study|Adverse Event|0|||
27779062|NCT02646891|81021193|FG006|Overall Study|Adverse Event|0|||
27779063|NCT02646891|81021194|FG007|Overall Study|Adverse Event|0|||
27779064|NCT02646891|81021195|FG008|Overall Study|Adverse Event|0|||
27779065|NCT02646891|81021196|FG009|Overall Study|Adverse Event|0|||
27779066|NCT02646891|81021187|FG000|Overall Study|Lost to Follow-up|0|||
27863448|NCT04895982|81333007|FG008|Overall Study|Other|0|||
27968206|NCT01271712|81714217|FG001|Double Blind Treatment|Non compliance with study drug|0|||
27968207|NCT01271712|81714216|FG000|Double Blind Treatment|receive no study drug|1|||
27666421|NCT01379703|80615658|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
27666422|NCT01379703|80615659|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
27666423|NCT01379703|80615657|FG000|Study Start Through 9 Months|Treatment Failure|0|||
27666424|NCT01379703|80615658|FG001|Study Start Through 9 Months|Treatment Failure|2|||
27666425|NCT01379703|80615659|FG002|Study Start Through 9 Months|Treatment Failure|2|||
27666426|NCT01379703|80615657|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
27666427|NCT01379703|80615658|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
27779067|NCT02646891|81021188|FG001|Overall Study|Lost to Follow-up|0|||
27779068|NCT02646891|81021189|FG002|Overall Study|Lost to Follow-up|0|||
27779069|NCT02646891|81021190|FG003|Overall Study|Lost to Follow-up|0|||
27779070|NCT02646891|81021191|FG004|Overall Study|Lost to Follow-up|0|||
27779071|NCT02646891|81021192|FG005|Overall Study|Lost to Follow-up|0|||
27779072|NCT02646891|81021193|FG006|Overall Study|Lost to Follow-up|2|||
27779073|NCT02646891|81021194|FG007|Overall Study|Lost to Follow-up|2|||
27779074|NCT02646891|81021195|FG008|Overall Study|Lost to Follow-up|2|||
27666428|NCT01379703|80615659|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
27666429|NCT01379703|80615657|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
27666430|NCT01379703|80615658|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
27666431|NCT01379703|80615659|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
27666432|NCT01379703|80615657|FG000|Study Start Through 9 Months|Medication not available|0|||
27666433|NCT01379703|80615658|FG001|Study Start Through 9 Months|Medication not available|2|||
27779075|NCT02646891|81021196|FG009|Overall Study|Lost to Follow-up|2|||
27666434|NCT01379703|80615659|FG002|Study Start Through 9 Months|Medication not available|1|||
27666435|NCT01379703|80615657|FG000|Study Start Through 9 Months|Poor general condition|0|||
27666436|NCT01379703|80615658|FG001|Study Start Through 9 Months|Poor general condition|1|||
27666437|NCT01379703|80615659|FG002|Study Start Through 9 Months|Poor general condition|0|||
27779076|NCT02646891|81021187|FG000|Overall Study|Protocol Violation|0|||
27779077|NCT02646891|81021188|FG001|Overall Study|Protocol Violation|0|||
27779078|NCT02646891|81021189|FG002|Overall Study|Protocol Violation|0|||
27779079|NCT02646891|81021190|FG003|Overall Study|Protocol Violation|0|||
27779080|NCT02646891|81021191|FG004|Overall Study|Protocol Violation|0|||
27779081|NCT02646891|81021192|FG005|Overall Study|Protocol Violation|0|||
27666438|NCT01379703|80615657|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
27666439|NCT01379703|80615658|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
27666440|NCT01379703|80615659|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
27666441|NCT01379703|80615657|FG000|Study Start Through 9 Months|Reason unknown|2|||
27666442|NCT01379703|80615658|FG001|Study Start Through 9 Months|Reason unknown|31|||
27666443|NCT01379703|80615659|FG002|Study Start Through 9 Months|Reason unknown|24|||
27666444|NCT01379703|80615657|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
27666445|NCT01379703|80615658|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
27666446|NCT01379703|80615659|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
27666447|NCT01379703|80615657|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
27666448|NCT01379703|80615658|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
27666449|NCT01379703|80615659|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
27666450|NCT01379703|80615657|FG000|9 Months Through 18 Months|Adverse Event|0|||
27666451|NCT01379703|80615658|FG001|9 Months Through 18 Months|Adverse Event|6|||
27666452|NCT01379703|80615659|FG002|9 Months Through 18 Months|Adverse Event|0|||
27666453|NCT01379703|80615657|FG000|9 Months Through 18 Months|Treatment failure|0|||
27666454|NCT01379703|80615658|FG001|9 Months Through 18 Months|Treatment failure|5|||
27666455|NCT01379703|80615659|FG002|9 Months Through 18 Months|Treatment failure|0|||
27666456|NCT01379703|80615657|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
27666457|NCT01379703|80615658|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
27666458|NCT01379703|80615659|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
27666459|NCT01379703|80615657|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
27666460|NCT01379703|80615658|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
27666461|NCT01379703|80615659|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
27666462|NCT01379703|80615657|FG000|9 Months Through 18 Months|Fatigue|0|||
27666463|NCT01379703|80615658|FG001|9 Months Through 18 Months|Fatigue|1|||
27666464|NCT01379703|80615659|FG002|9 Months Through 18 Months|Fatigue|0|||
27666465|NCT01379703|80615657|FG000|9 Months Through 18 Months|Reason Unknown|0|||
27666466|NCT01379703|80615658|FG001|9 Months Through 18 Months|Reason Unknown|23|||
27666467|NCT01379703|80615659|FG002|9 Months Through 18 Months|Reason Unknown|0|||
27666468|NCT01960348|80615660|FG000|Overall Study|Adverse event, not serious|2|||
27666469|NCT01960348|80615661|FG001|Overall Study|Adverse event, not serious|2|||
27666470|NCT01960348|80615660|FG000|Overall Study|Adverse event, serious fatal|6|||
27666471|NCT01960348|80615661|FG001|Overall Study|Adverse event, serious fatal|5|||
27666472|NCT01960348|80615660|FG000|Overall Study|Adverse event, serious non-fatal|0|||
27666473|NCT01960348|80615661|FG001|Overall Study|Adverse event, serious non-fatal|3|||
27779082|NCT02646891|81021193|FG006|Overall Study|Protocol Violation|1|||
27779083|NCT02646891|81021194|FG007|Overall Study|Protocol Violation|1|||
27666474|NCT01960348|80615660|FG000|Overall Study|Withdrawal by Subject|1|||
27666475|NCT01960348|80615661|FG001|Overall Study|Withdrawal by Subject|11|||
27666476|NCT01960348|80615660|FG000|Overall Study|Physician Decision|0|||
27666477|NCT01960348|80615661|FG001|Overall Study|Physician Decision|1|||
27666478|NCT01960348|80615660|FG000|Overall Study|Protocol Violation|1|||
27666479|NCT01960348|80615661|FG001|Overall Study|Protocol Violation|0|||
27666480|NCT00506922|80615662|FG000|Overall Study|Physician Decision|0|||
27666481|NCT00506922|80615663|FG001|Overall Study|Physician Decision|0|||
27666482|NCT00506922|80615664|FG002|Overall Study|Physician Decision|0|||
27666483|NCT00506922|80615665|FG003|Overall Study|Physician Decision|2|||
27779084|NCT02646891|81021195|FG008|Overall Study|Protocol Violation|0|||
27779085|NCT02646891|81021196|FG009|Overall Study|Protocol Violation|0|||
27666484|NCT00506922|80615666|FG004|Overall Study|Physician Decision|0|||
27666485|NCT00506922|80615662|FG000|Overall Study|Withdrawal by Subject|0|||
27666486|NCT00506922|80615663|FG001|Overall Study|Withdrawal by Subject|0|||
27666487|NCT00506922|80615664|FG002|Overall Study|Withdrawal by Subject|0|||
27779086|NCT02646891|81021187|FG000|Overall Study|Withdrawal by Subject|2|||
27779087|NCT02646891|81021188|FG001|Overall Study|Withdrawal by Subject|0|||
27779088|NCT02646891|81021189|FG002|Overall Study|Withdrawal by Subject|1|||
27779089|NCT02646891|81021190|FG003|Overall Study|Withdrawal by Subject|0|||
27779090|NCT02646891|81021191|FG004|Overall Study|Withdrawal by Subject|0|||
27779091|NCT02646891|81021192|FG005|Overall Study|Withdrawal by Subject|0|||
27779092|NCT02646891|81021193|FG006|Overall Study|Withdrawal by Subject|5|||
27779093|NCT02646891|81021194|FG007|Overall Study|Withdrawal by Subject|9|||
27779094|NCT02646891|81021195|FG008|Overall Study|Withdrawal by Subject|7|||
27666488|NCT00506922|80615665|FG003|Overall Study|Withdrawal by Subject|0|||
27666489|NCT00506922|80615666|FG004|Overall Study|Withdrawal by Subject|1|||
27666490|NCT04150341|80615671|FG000|Overall Study|Physician Decision|0|||
27666491|NCT04150341|80615672|FG001|Overall Study|Physician Decision|0|||
27666492|NCT04150341|80615673|FG002|Overall Study|Physician Decision|1|||
27666493|NCT04150341|80615674|FG003|Overall Study|Physician Decision|0|||
27666494|NCT04150341|80615675|FG004|Overall Study|Physician Decision|0|||
27666495|NCT04150341|80615676|FG005|Overall Study|Physician Decision|0|||
27666496|NCT04150341|80615671|FG000|Overall Study|Adverse Event|0|||
27666497|NCT04150341|80615672|FG001|Overall Study|Adverse Event|0|||
27666498|NCT04150341|80615673|FG002|Overall Study|Adverse Event|0|||
27666499|NCT04150341|80615674|FG003|Overall Study|Adverse Event|0|||
27666500|NCT04150341|80615675|FG004|Overall Study|Adverse Event|1|||
27666501|NCT04150341|80615676|FG005|Overall Study|Adverse Event|0|||
27666502|NCT02633397|80615677|FG000|Overall Study|Adverse Event|8|||
27666503|NCT02633397|80615678|FG001|Overall Study|Adverse Event|8|||
27666504|NCT02633397|80615677|FG000|Overall Study|Study Burden|4|||
27666505|NCT02633397|80615678|FG001|Overall Study|Study Burden|1|||
27666506|NCT02633397|80615677|FG000|Overall Study|Treatment interruption|2|||
27666507|NCT02633397|80615678|FG001|Overall Study|Treatment interruption|5|||
27666508|NCT02633397|80615677|FG000|Overall Study|Death|2|||
27666509|NCT02633397|80615678|FG001|Overall Study|Death|2|||
27666510|NCT02633397|80615677|FG000|Overall Study|Physician Decision|0|||
27666511|NCT02633397|80615678|FG001|Overall Study|Physician Decision|1|||
27666512|NCT01726517|80615679|FG000|Overall Study|Withdrawal by Subject|0|||
27666513|NCT01726517|80615680|FG001|Overall Study|Withdrawal by Subject|0|||
27666514|NCT01726517|80615681|FG002|Overall Study|Withdrawal by Subject|1|||
27666515|NCT01726517|80615682|FG003|Overall Study|Withdrawal by Subject|0|||
27666516|NCT01726517|80615683|FG004|Overall Study|Withdrawal by Subject|0|||
27666517|NCT00691678|80615689|FG000|Overall Study|Adverse Event|5|||
27666518|NCT00691678|80615689|FG000|Overall Study|life events, pain|11|||
27666519|NCT00721214|80615690|FG000|Overall Study|Chose another center for transplant|1|||
27666520|NCT00721214|80615690|FG000|Overall Study|Death|3|||
27666521|NCT03187353|80615695|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
27666522|NCT03187353|80615696|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
27666523|NCT03187353|80615695|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
27666524|NCT03187353|80615696|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27779095|NCT02646891|81021196|FG009|Overall Study|Withdrawal by Subject|3|||
27779096|NCT02646891|81021187|FG000|Overall Study|Death|0|||
27779097|NCT02646891|81021188|FG001|Overall Study|Death|0|||
27779098|NCT02646891|81021189|FG002|Overall Study|Death|0|||
27779099|NCT02646891|81021190|FG003|Overall Study|Death|0|||
27779100|NCT02646891|81021191|FG004|Overall Study|Death|0|||
27779101|NCT02646891|81021192|FG005|Overall Study|Death|0|||
27779102|NCT02646891|81021193|FG006|Overall Study|Death|1|||
27779103|NCT02646891|81021194|FG007|Overall Study|Death|1|||
27779104|NCT02646891|81021195|FG008|Overall Study|Death|1|||
27779105|NCT02646891|81021196|FG009|Overall Study|Death|0|||
27779106|NCT00170846|81021197|FG000|Overall Study|Subject withdrew Informed Consent|5|||
27968208|NCT01271712|81714217|FG001|Double Blind Treatment|receive no study drug|0|||
27968209|NCT01271712|81714216|FG000|Open Label Treatment|Death|6|||
27666525|NCT03187353|80615695|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
27666526|NCT03187353|80615696|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
27666527|NCT03187353|80615695|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
27666528|NCT03187353|80615696|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
27968210|NCT01271712|81714217|FG001|Open Label Treatment|Death|5|||
27666529|NCT03187353|80615695|FG000|Washout (2 Weeks)|Adverse Event|2|||
27666530|NCT03187353|80615696|FG001|Washout (2 Weeks)|Adverse Event|0|||
27666531|NCT03187353|80615695|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
27666532|NCT03187353|80615696|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
27666533|NCT01951378|80615699|FG000|Overall Study|Study Terminated-Not completed|23|||
27779107|NCT00170846|81021198|FG001|Overall Study|Subject withdrew Informed Consent|12|||
27779108|NCT00170846|81021199|FG002|Overall Study|Subject withdrew Informed Consent|8|||
27779109|NCT00170846|81021197|FG000|Overall Study|Lost to Follow-up|6|||
27779110|NCT00170846|81021198|FG001|Overall Study|Lost to Follow-up|3|||
27779111|NCT00170846|81021199|FG002|Overall Study|Lost to Follow-up|2|||
27779112|NCT00170846|81021197|FG000|Overall Study|Death|0|||
27779113|NCT00170846|81021198|FG001|Overall Study|Death|3|||
27779114|NCT00170846|81021199|FG002|Overall Study|Death|3|||
27779115|NCT00170846|81021197|FG000|Overall Study|Reason Missing|0|||
27779116|NCT00170846|81021198|FG001|Overall Study|Reason Missing|1|||
27968211|NCT01271712|81714216|FG000|Open Label Treatment|Withdrawal by Subject|6|||
27779117|NCT00170846|81021199|FG002|Overall Study|Reason Missing|0|||
27779118|NCT03619902|81021201|FG000|Overall Study|Termination of Study by Investigator|1|||
27779119|NCT03619902|81021201|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
27779120|NCT02658149|81021203|FG000|Overall Study|Physician Decision|1|||
27779121|NCT02658149|81021204|FG001|Overall Study|Physician Decision|0|||
27779122|NCT05466240|81021207|FG000|Overall Study|Adverse Event|1|||
27779123|NCT05466240|81021208|FG001|Overall Study|Adverse Event|0|||
27779124|NCT05466240|81021207|FG000|Overall Study|Withdrawal by Subject|1|||
27779125|NCT05466240|81021208|FG001|Overall Study|Withdrawal by Subject|0|||
27779126|NCT03258762|81021209|FG000|Overall Study|Lost to Follow-up|0|||
27779127|NCT03258762|81021210|FG001|Overall Study|Lost to Follow-up|1|||
27779128|NCT01594749|81021211|FG000|Overall Study|Adverse Event|2|||
27779129|NCT01594749|81021212|FG001|Overall Study|Adverse Event|1|||
27779130|NCT01594749|81021211|FG000|Overall Study|Withdrawal by Subject|2|||
27779131|NCT01594749|81021212|FG001|Overall Study|Withdrawal by Subject|2|||
27779132|NCT01594749|81021211|FG000|Overall Study|Protocol Violation|2|||
27779133|NCT01594749|81021212|FG001|Overall Study|Protocol Violation|0|||
27779134|NCT01594749|81021211|FG000|Overall Study|Physician Decision|1|||
27863449|NCT04895982|81333008|FG009|Overall Study|Other|1|||
27863450|NCT04895982|81333009|FG010|Overall Study|Other|0|||
27863451|NCT04895982|81333010|FG011|Overall Study|Other|0|||
27863452|NCT04895982|81332999|FG000|Overall Study|Protocol Violation|0|||
27863453|NCT04895982|81333000|FG001|Overall Study|Protocol Violation|0|||
27863454|NCT04895982|81333001|FG002|Overall Study|Protocol Violation|1|||
27863455|NCT04895982|81333002|FG003|Overall Study|Protocol Violation|1|||
27863456|NCT04895982|81333003|FG004|Overall Study|Protocol Violation|1|||
27863457|NCT04895982|81333004|FG005|Overall Study|Protocol Violation|0|||
27863458|NCT04895982|81333005|FG006|Overall Study|Protocol Violation|0|||
27968212|NCT01271712|81714217|FG001|Open Label Treatment|Withdrawal by Subject|11|||
27968213|NCT01271712|81714216|FG000|Open Label Treatment|Physician Decision|2|||
27968214|NCT01271712|81714217|FG001|Open Label Treatment|Physician Decision|0|||
27968215|NCT01271712|81714216|FG000|Open Label Treatment|Adverse Event|14|||
27968216|NCT01271712|81714217|FG001|Open Label Treatment|Adverse Event|8|||
27968217|NCT01271712|81714216|FG000|Open Label Treatment|Progressive disease|59|||
27968218|NCT01271712|81714217|FG001|Open Label Treatment|Progressive disease|32|||
27968219|NCT01271712|81714216|FG000|Open Label Treatment|transferred to rollover study|1|||
27968220|NCT01271712|81714217|FG001|Open Label Treatment|transferred to rollover study|0|||
27779135|NCT01594749|81021212|FG001|Overall Study|Physician Decision|1|||
27779136|NCT01594749|81021211|FG000|Overall Study|Non-compliance with Protocol|0|||
27779137|NCT01594749|81021212|FG001|Overall Study|Non-compliance with Protocol|1|||
27779138|NCT01594749|81021211|FG000|Overall Study|Lost to Follow-up|1|||
27779139|NCT01594749|81021212|FG001|Overall Study|Lost to Follow-up|0|||
27779140|NCT01594749|81021211|FG000|Overall Study|Death|9|||
27779141|NCT01594749|81021212|FG001|Overall Study|Death|3|||
27779142|NCT01594749|81021211|FG000|Overall Study|Not Treated|4|||
27779143|NCT01594749|81021212|FG001|Overall Study|Not Treated|10|||
27968221|NCT01271712|81714216|FG000|Open Label Treatment|Non-compliance with study drug|1|||
27968222|NCT01271712|81714217|FG001|Open Label Treatment|Non-compliance with study drug|0|||
27968223|NCT01271712|81714216|FG000|Open Label Treatment|Protocol Violation|0|||
27968224|NCT01271712|81714217|FG001|Open Label Treatment|Protocol Violation|1|||
27968225|NCT01271712|81714216|FG000|Open Label Treatment|Switching to other therapy|2|||
27968226|NCT01271712|81714217|FG001|Open Label Treatment|Switching to other therapy|1|||
27968227|NCT01271712|81714216|FG000|Safety Follow-up|Death|11|||
27968228|NCT01271712|81714217|FG001|Safety Follow-up|Death|7|||
27968229|NCT01271712|81714216|FG000|Safety Follow-up|Withdrawal by Subject|4|||
27968230|NCT01271712|81714217|FG001|Safety Follow-up|Withdrawal by Subject|2|||
27968231|NCT01271712|81714216|FG000|Safety Follow-up|Protocol Violation|1|||
27968232|NCT01271712|81714217|FG001|Safety Follow-up|Protocol Violation|1|||
27968233|NCT01271712|81714216|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
27779144|NCT01594749|81021211|FG000|Overall Study|Lost Source Documentation|1|||
27779145|NCT01594749|81021212|FG001|Overall Study|Lost Source Documentation|0|||
27863459|NCT04895982|81333006|FG007|Overall Study|Protocol Violation|1|||
27863460|NCT04895982|81333007|FG008|Overall Study|Protocol Violation|0|||
27863461|NCT04895982|81333008|FG009|Overall Study|Protocol Violation|0|||
27968234|NCT01271712|81714217|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
27968235|NCT01271712|81714216|FG000|Safety Follow-up|No follow-up|1|||
27779146|NCT01809327|81021213|FG000|Overall Study|Lost to Follow-up|5|||
27968236|NCT01271712|81714217|FG001|Safety Follow-up|No follow-up|1|||
27779147|NCT01809327|81021214|FG001|Overall Study|Lost to Follow-up|2|||
27863462|NCT04895982|81333009|FG010|Overall Study|Protocol Violation|0|||
27863463|NCT04895982|81333010|FG011|Overall Study|Protocol Violation|0|||
27779148|NCT01809327|81021215|FG002|Overall Study|Lost to Follow-up|4|||
27863464|NCT04895982|81332999|FG000|Overall Study|Lost to Follow-up|0|||
27863465|NCT04895982|81333000|FG001|Overall Study|Lost to Follow-up|0|||
27779149|NCT01809327|81021216|FG003|Overall Study|Lost to Follow-up|2|||
27863466|NCT04895982|81333001|FG002|Overall Study|Lost to Follow-up|1|||
27968237|NCT01271712|81714216|FG000|Safety Follow-up|Progressive disease|1|||
27968238|NCT01271712|81714217|FG001|Safety Follow-up|Progressive disease|0|||
27968239|NCT01271712|81714216|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
27968240|NCT01271712|81714217|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
27968241|NCT04026009|81714219|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27968242|NCT04026009|81714220|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27968243|NCT04026009|81714221|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27968244|NCT04026009|81714222|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27968245|NCT04026009|81714223|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
27968246|NCT04026009|81714219|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
27968247|NCT04026009|81714220|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
27968248|NCT04026009|81714221|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
27779150|NCT01809327|81021217|FG004|Overall Study|Lost to Follow-up|3|||
27779151|NCT01809327|81021213|FG000|Overall Study|Withdrawal by Subject|6|||
27779152|NCT01809327|81021214|FG001|Overall Study|Withdrawal by Subject|4|||
27779153|NCT01809327|81021215|FG002|Overall Study|Withdrawal by Subject|4|||
27779154|NCT01809327|81021216|FG003|Overall Study|Withdrawal by Subject|2|||
27779155|NCT01809327|81021217|FG004|Overall Study|Withdrawal by Subject|5|||
27779156|NCT01809327|81021213|FG000|Overall Study|Adverse Event|4|||
27779157|NCT01809327|81021214|FG001|Overall Study|Adverse Event|3|||
27779158|NCT01809327|81021215|FG002|Overall Study|Adverse Event|7|||
27779159|NCT01809327|81021216|FG003|Overall Study|Adverse Event|4|||
27779160|NCT01809327|81021217|FG004|Overall Study|Adverse Event|8|||
27779161|NCT01809327|81021213|FG000|Overall Study|Death|1|||
27779162|NCT01809327|81021214|FG001|Overall Study|Death|0|||
27779163|NCT01809327|81021215|FG002|Overall Study|Death|0|||
27779164|NCT01809327|81021216|FG003|Overall Study|Death|0|||
27779165|NCT01809327|81021217|FG004|Overall Study|Death|0|||
27779166|NCT01809327|81021213|FG000|Overall Study|Protocol Violation|0|||
27779167|NCT01809327|81021214|FG001|Overall Study|Protocol Violation|1|||
27779168|NCT01809327|81021215|FG002|Overall Study|Protocol Violation|0|||
27779169|NCT01809327|81021216|FG003|Overall Study|Protocol Violation|0|||
27779170|NCT01809327|81021217|FG004|Overall Study|Protocol Violation|0|||
27779171|NCT01809327|81021213|FG000|Overall Study|Physician Decision|1|||
27779172|NCT01809327|81021214|FG001|Overall Study|Physician Decision|1|||
27779173|NCT01809327|81021215|FG002|Overall Study|Physician Decision|0|||
27779174|NCT01809327|81021216|FG003|Overall Study|Physician Decision|0|||
27779175|NCT01809327|81021217|FG004|Overall Study|Physician Decision|0|||
27779176|NCT01809327|81021213|FG000|Overall Study|Pregnancy|1|||
27779177|NCT01809327|81021214|FG001|Overall Study|Pregnancy|0|||
27779178|NCT01809327|81021215|FG002|Overall Study|Pregnancy|0|||
27779179|NCT01809327|81021216|FG003|Overall Study|Pregnancy|0|||
27779180|NCT01809327|81021217|FG004|Overall Study|Pregnancy|0|||
27779181|NCT01809327|81021213|FG000|Overall Study|Other|14|||
27779182|NCT01809327|81021214|FG001|Overall Study|Other|15|||
27779183|NCT01809327|81021215|FG002|Overall Study|Other|7|||
27779184|NCT01809327|81021216|FG003|Overall Study|Other|4|||
27779185|NCT01809327|81021217|FG004|Overall Study|Other|9|||
27779186|NCT01925014|81021218|FG000|Overall Study|Inappropriate enrollment|4|||
27779187|NCT01925014|81021219|FG001|Overall Study|Inappropriate enrollment|6|||
27779188|NCT01925014|81021218|FG000|Overall Study|Withdrawal by Subject|5|||
27779189|NCT01925014|81021219|FG001|Overall Study|Withdrawal by Subject|13|||
27779190|NCT02177942|81021220|FG000|Overall Study|Adverse Event|1|||
27779191|NCT02177942|81021221|FG001|Overall Study|Adverse Event|0|||
27779192|NCT02177942|81021220|FG000|Overall Study|Lost to Follow-up|1|||
27779193|NCT02177942|81021221|FG001|Overall Study|Lost to Follow-up|1|||
27779194|NCT02177942|81021220|FG000|Overall Study|Protocol Violation|4|||
27779195|NCT02177942|81021221|FG001|Overall Study|Protocol Violation|6|||
27779196|NCT02177942|81021220|FG000|Overall Study|Withdrawal by Subject|71|||
27570324|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27779197|NCT02177942|81021221|FG001|Overall Study|Withdrawal by Subject|81|||
27779198|NCT00764322|81021225|FG000|Overall Study|Withdrawal by Subject|11|||
27779199|NCT00764322|81021225|FG000|Overall Study|No CYP2D6 genotyping|9|||
27779200|NCT01566981|81021226|FG000|Overall Study|Lost to Follow-up|5|||
27779201|NCT01566981|81021227|FG001|Overall Study|Lost to Follow-up|8|||
27779202|NCT05049122|81021229|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
27779203|NCT05049122|81021229|FG000|Overall Study|Participant moved|1|||
27779204|NCT05049122|81021229|FG000|Overall Study|At the direction of the doctor|1|||
27779205|NCT04905563|81021234|FG000|Overall Study|Withdrawal by Subject|1|||
27779206|NCT04905563|81021235|FG001|Overall Study|Withdrawal by Subject|0|||
27779207|NCT04905563|81021234|FG000|Overall Study|Standard of care orders entered by resident|1|||
27779208|NCT04905563|81021235|FG001|Overall Study|Standard of care orders entered by resident|0|||
27832952|NCT02452463|81219409|FG000|Overall Study|Recommended by DSMB|0|||
27779209|NCT04905563|81021234|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
27779210|NCT04905563|81021235|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
27779211|NCT04905563|81021234|FG000|Overall Study|Withdrawal by Subject|0|||
27779212|NCT04905563|81021235|FG001|Overall Study|Withdrawal by Subject|1|||
27779213|NCT00542425|81021236|FG000|Initial 24 Weeks|Administrative reasons|0|||
27779214|NCT00542425|81021237|FG001|Initial 24 Weeks|Administrative reasons|0|||
27779215|NCT00542425|81021238|FG002|Initial 24 Weeks|Administrative reasons|1|||
27779216|NCT00542425|81021239|FG003|Initial 24 Weeks|Administrative reasons|1|||
27779217|NCT00542425|81021240|FG004|Initial 24 Weeks|Administrative reasons|0|||
27779218|NCT00542425|81021236|FG000|Initial 24 Weeks|Adverse Event|0|||
27779219|NCT00542425|81021237|FG001|Initial 24 Weeks|Adverse Event|1|||
27779220|NCT00542425|81021238|FG002|Initial 24 Weeks|Adverse Event|1|||
27779221|NCT00542425|81021239|FG003|Initial 24 Weeks|Adverse Event|3|||
27779222|NCT00542425|81021240|FG004|Initial 24 Weeks|Adverse Event|2|||
27779223|NCT00542425|81021236|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
27779224|NCT00542425|81021237|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
27779225|NCT00542425|81021238|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
27779226|NCT00542425|81021239|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
27779227|NCT00542425|81021240|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
27779228|NCT00542425|81021236|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
27779229|NCT00542425|81021237|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
27779230|NCT00542425|81021238|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
27779231|NCT00542425|81021239|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
27779232|NCT00542425|81021240|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
27779233|NCT00542425|81021236|FG000|Initial 24 Weeks|Non-compliance|0|||
27779234|NCT00542425|81021237|FG001|Initial 24 Weeks|Non-compliance|0|||
27779235|NCT00542425|81021238|FG002|Initial 24 Weeks|Non-compliance|0|||
27779236|NCT00542425|81021239|FG003|Initial 24 Weeks|Non-compliance|1|||
27779237|NCT00542425|81021240|FG004|Initial 24 Weeks|Non-compliance|1|||
27779238|NCT00542425|81021236|FG000|Initial 24 Weeks|Protocol Violation|0|||
27779239|NCT00542425|81021237|FG001|Initial 24 Weeks|Protocol Violation|0|||
27779240|NCT00542425|81021238|FG002|Initial 24 Weeks|Protocol Violation|0|||
27779241|NCT00542425|81021239|FG003|Initial 24 Weeks|Protocol Violation|1|||
27779242|NCT00542425|81021240|FG004|Initial 24 Weeks|Protocol Violation|0|||
27779243|NCT00542425|81021236|FG000|Initial 24 Weeks|Refusal of treatment|2|||
27779244|NCT00542425|81021237|FG001|Initial 24 Weeks|Refusal of treatment|2|||
27779245|NCT00542425|81021238|FG002|Initial 24 Weeks|Refusal of treatment|1|||
27779246|NCT00542425|81021239|FG003|Initial 24 Weeks|Refusal of treatment|4|||
27779247|NCT00542425|81021240|FG004|Initial 24 Weeks|Refusal of treatment|1|||
27779248|NCT00542425|81021236|FG000|Initial 24 Weeks|Other|0|||
27779249|NCT00542425|81021237|FG001|Initial 24 Weeks|Other|2|||
27779250|NCT00542425|81021238|FG002|Initial 24 Weeks|Other|1|||
27779251|NCT00542425|81021239|FG003|Initial 24 Weeks|Other|0|||
27779252|NCT00542425|81021240|FG004|Initial 24 Weeks|Other|0|||
27779253|NCT00542425|81021236|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
27779254|NCT00542425|81021237|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
27779255|NCT00542425|81021238|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
27779256|NCT00542425|81021239|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
27779257|NCT00542425|81021240|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
27779258|NCT00542425|81021236|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27779259|NCT00542425|81021237|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27779260|NCT00542425|81021238|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
27779261|NCT00542425|81021239|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27779262|NCT00542425|81021240|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
27779263|NCT00542425|81021236|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27779264|NCT00542425|81021237|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
27779265|NCT00542425|81021238|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27779266|NCT00542425|81021239|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27779267|NCT00542425|81021240|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
27779268|NCT00542425|81021236|FG000|Extended 24 Weeks of Treatment|Other|1|||
27779269|NCT00542425|81021237|FG001|Extended 24 Weeks of Treatment|Other|1|||
27779270|NCT00542425|81021238|FG002|Extended 24 Weeks of Treatment|Other|0|||
27779271|NCT00542425|81021239|FG003|Extended 24 Weeks of Treatment|Other|0|||
27779272|NCT00542425|81021240|FG004|Extended 24 Weeks of Treatment|Other|1|||
27779273|NCT01815099|81021243|FG000|Overall Study|Lack of Efficacy|1|||
27779274|NCT01815099|81021243|FG000|Overall Study|unable to attend study visits|1|||
27779275|NCT00423267|81021246|FG000|Period A|Withdrawal by Subject|0|||
27779276|NCT00423267|81021247|FG001|Period A|Withdrawal by Subject|1|||
27779277|NCT00423267|81021246|FG000|Period A|Non-compliance with protocol|1|||
27779278|NCT00423267|81021247|FG001|Period A|Non-compliance with protocol|0|||
27779279|NCT00423267|81021246|FG000|Period A|Administrative|1|||
27779280|NCT00423267|81021247|FG001|Period A|Administrative|0|||
27779281|NCT01882439|81021248|FG000|Overall Study|Adverse event related to study drug|3|||
27779282|NCT01882439|81021249|FG001|Overall Study|Adverse event related to study drug|8|||
27832953|NCT02452463|81219410|FG001|Overall Study|Recommended by DSMB|1|||
27968249|NCT04026009|81714222|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
27968250|NCT04026009|81714223|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
27968251|NCT01106651|81714224|FG000|Overall Study|Adverse Event|17|||
27968252|NCT01106651|81714225|FG001|Overall Study|Adverse Event|9|||
27779283|NCT01882439|81021250|FG002|Overall Study|Adverse event related to study drug|1|||
27779284|NCT01882439|81021251|FG003|Overall Study|Adverse event related to study drug|2|||
27779285|NCT01882439|81021248|FG000|Overall Study|Pregnancy|0|||
27779286|NCT01882439|81021249|FG001|Overall Study|Pregnancy|1|||
27968253|NCT01106651|81714226|FG002|Overall Study|Adverse Event|23|||
27968254|NCT01106651|81714224|FG000|Overall Study|Lost to Follow-up|8|||
27968255|NCT01106651|81714225|FG001|Overall Study|Lost to Follow-up|2|||
27968256|NCT01106651|81714226|FG002|Overall Study|Lost to Follow-up|6|||
27968257|NCT01106651|81714224|FG000|Overall Study|Physician Decision|4|||
27968258|NCT01106651|81714225|FG001|Overall Study|Physician Decision|3|||
27968259|NCT01106651|81714226|FG002|Overall Study|Physician Decision|1|||
27968260|NCT01106651|81714224|FG000|Overall Study|Protocol Violation|1|||
27968261|NCT01106651|81714225|FG001|Overall Study|Protocol Violation|2|||
27968262|NCT01106651|81714226|FG002|Overall Study|Protocol Violation|1|||
27968263|NCT01106651|81714224|FG000|Overall Study|Withdrawal by Subject|14|||
27968264|NCT01106651|81714225|FG001|Overall Study|Withdrawal by Subject|7|||
27968265|NCT01106651|81714226|FG002|Overall Study|Withdrawal by Subject|4|||
27968266|NCT01106651|81714224|FG000|Overall Study|Noncompliance with study drug|1|||
27968267|NCT01106651|81714225|FG001|Overall Study|Noncompliance with study drug|0|||
27968268|NCT01106651|81714226|FG002|Overall Study|Noncompliance with study drug|2|||
27968269|NCT01106651|81714224|FG000|Overall Study|Other|34|||
27968270|NCT01106651|81714225|FG001|Overall Study|Other|31|||
27968271|NCT01106651|81714226|FG002|Overall Study|Other|21|||
27968272|NCT01106651|81714224|FG000|Overall Study|Death|0|||
27968273|NCT01106651|81714225|FG001|Overall Study|Death|3|||
27968274|NCT01106651|81714226|FG002|Overall Study|Death|0|||
27968275|NCT02461290|81714228|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
27968276|NCT02461290|81714228|FG000|Overall Study|Lost to Follow-up|3|||
27968277|NCT00624585|81714229|FG000|Overall Study|Death|3|||
27968278|NCT00624585|81714229|FG000|Overall Study|Disease Progression|6|||
27968279|NCT00624585|81714229|FG000|Overall Study|Adverse Event|3|||
27968280|NCT00218634|81714230|FG000|Overall Study|Lost to Follow-up|8|||
27968281|NCT00218634|81714231|FG001|Overall Study|Lost to Follow-up|15|||
27968282|NCT00855933|81714234|FG000|Overall Study|Withdrawal by Subject|0|||
27968283|NCT00855933|81714235|FG001|Overall Study|Withdrawal by Subject|1|||
27779287|NCT01882439|81021250|FG002|Overall Study|Pregnancy|0|||
27779288|NCT01882439|81021251|FG003|Overall Study|Pregnancy|0|||
27779289|NCT01882439|81021248|FG000|Overall Study|Protocol Violation|2|||
27779290|NCT01882439|81021249|FG001|Overall Study|Protocol Violation|2|||
27779291|NCT01882439|81021250|FG002|Overall Study|Protocol Violation|0|||
27779292|NCT01882439|81021251|FG003|Overall Study|Protocol Violation|1|||
27779293|NCT01882439|81021248|FG000|Overall Study|No longer willing to participate|1|||
27779294|NCT01882439|81021249|FG001|Overall Study|No longer willing to participate|4|||
27779295|NCT01882439|81021250|FG002|Overall Study|No longer willing to participate|2|||
27779296|NCT01882439|81021251|FG003|Overall Study|No longer willing to participate|3|||
27779297|NCT01882439|81021248|FG000|Overall Study|Medication error with no associated AE|0|||
27779298|NCT01882439|81021249|FG001|Overall Study|Medication error with no associated AE|0|||
27779299|NCT01882439|81021250|FG002|Overall Study|Medication error with no associated AE|2|||
27779300|NCT01882439|81021251|FG003|Overall Study|Medication error with no associated AE|0|||
27779301|NCT01882439|81021248|FG000|Overall Study|Insufficient clinical response|1|||
27779302|NCT01882439|81021249|FG001|Overall Study|Insufficient clinical response|4|||
27968284|NCT01545934|81714237|FG000|Overall Study|Withdrawal by Subject|4|||
27968285|NCT01545934|81714238|FG001|Overall Study|Withdrawal by Subject|3|||
27779303|NCT01882439|81021250|FG002|Overall Study|Insufficient clinical response|4|||
27779304|NCT01882439|81021251|FG003|Overall Study|Insufficient clinical response|2|||
27779305|NCT01882439|81021248|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27779306|NCT01882439|81021249|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27779307|NCT01882439|81021250|FG002|Overall Study|Adverse event unrelated to study drug|1|||
27779308|NCT01882439|81021251|FG003|Overall Study|Adverse event unrelated to study drug|1|||
27779309|NCT03377452|81021252|FG000|Overall Study|Refused assessment|0|||
27779310|NCT03377452|81021253|FG001|Overall Study|Refused assessment|2|||
27863467|NCT04895982|81333002|FG003|Overall Study|Lost to Follow-up|0|||
27968286|NCT01545934|81714237|FG000|Overall Study|Lost to Follow-up|1|||
27968287|NCT01545934|81714238|FG001|Overall Study|Lost to Follow-up|0|||
27968288|NCT01092780|81714239|FG000|Washout Period 1|Adverse Event|0|||
27968289|NCT01092780|81714240|FG001|Washout Period 1|Adverse Event|1|||
27968290|NCT01092780|81714241|FG002|Washout Period 1|Adverse Event|0|||
27968291|NCT01092780|81714242|FG003|Washout Period 1|Adverse Event|0|||
27863468|NCT04895982|81333003|FG004|Overall Study|Lost to Follow-up|0|||
27968292|NCT01092780|81714239|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
27968293|NCT01092780|81714240|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
27968294|NCT01092780|81714241|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
27968295|NCT01092780|81714242|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
27968296|NCT01092780|81714239|FG000|Washout Period 2|Adverse Event|0|||
27968297|NCT01092780|81714240|FG001|Washout Period 2|Adverse Event|1|||
27968298|NCT01092780|81714241|FG002|Washout Period 2|Adverse Event|1|||
27968299|NCT01092780|81714242|FG003|Washout Period 2|Adverse Event|0|||
27968300|NCT00338286|81714245|FG000|Overall Study|Withdrawal by Subject|50|||
27968301|NCT00338286|81714246|FG001|Overall Study|Withdrawal by Subject|54|||
27779311|NCT03377452|81021252|FG000|Overall Study|Lost to Follow-up|5|||
27779312|NCT03377452|81021253|FG001|Overall Study|Lost to Follow-up|4|||
27779313|NCT02067104|81021254|FG000|Overall Study|Study termination due to low accrual|4|||
27779314|NCT02067104|81021255|FG001|Overall Study|Study termination due to low accrual|5|||
27779315|NCT00413777|81021256|FG000|Fixed-dose Period|Lost to Follow-up|1|||
27779316|NCT00413777|81021257|FG001|Fixed-dose Period|Lost to Follow-up|1|||
27779317|NCT00413777|81021256|FG000|Fixed-dose Period|Adverse Event|2|||
27779318|NCT00413777|81021257|FG001|Fixed-dose Period|Adverse Event|1|||
27779319|NCT00413777|81021256|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
27779320|NCT00413777|81021257|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
27779321|NCT00413777|81021256|FG000|Fixed-dose Period|Withdrew Consent|0|||
27779322|NCT00413777|81021257|FG001|Fixed-dose Period|Withdrew Consent|1|||
27968302|NCT00338286|81714245|FG000|Overall Study|Lost to Follow-up|80|||
27968303|NCT00338286|81714246|FG001|Overall Study|Lost to Follow-up|66|||
27779323|NCT04815291|81021260|FG000|Overall Study|Lost to Follow-up|1|||
27779324|NCT04815291|81021260|FG000|Overall Study|Physician Decision|4|||
27968304|NCT00338286|81714245|FG000|Overall Study|Other|103|||
27968305|NCT00338286|81714246|FG001|Overall Study|Other|93|||
27968306|NCT00578877|81714254|FG000|Overall Study|Lost to Follow-up|8|||
27968307|NCT00578877|81714255|FG001|Overall Study|Lost to Follow-up|10|||
27968308|NCT00578877|81714254|FG000|Overall Study|early discontinue|61|||
27968309|NCT00578877|81714255|FG001|Overall Study|early discontinue|101|||
27968310|NCT00578877|81714254|FG000|Overall Study|did not provide follow-up data|12|||
27968311|NCT00578877|81714255|FG001|Overall Study|did not provide follow-up data|17|||
27968312|NCT01694121|81714258|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
27968313|NCT01694121|81714259|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
27968314|NCT00322452|81714261|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27968315|NCT00322452|81714262|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27968316|NCT00322452|81714261|FG000|Overall Study|Lost to Follow-up|5|||
27968317|NCT00322452|81714262|FG001|Overall Study|Lost to Follow-up|2|||
27968318|NCT00322452|81714261|FG000|Overall Study|Withdrawal by Subject|19|||
27968319|NCT00322452|81714262|FG001|Overall Study|Withdrawal by Subject|46|||
27968320|NCT00322452|81714261|FG000|Overall Study|Death|223|||
27968321|NCT00322452|81714262|FG001|Overall Study|Death|227|||
27968322|NCT00066222|81714263|FG000|Overall Study|No protocol treatment received|1|||
27968323|NCT04115748|81714268|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
27968324|NCT04115748|81714269|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
27968325|NCT04115748|81714270|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
27968326|NCT04115748|81714271|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
27968327|NCT04115748|81714272|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27968328|NCT04115748|81714273|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27968329|NCT04115748|81714274|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27968330|NCT04115748|81714275|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27968331|NCT04115748|81714276|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27968332|NCT04115748|81714277|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
27968333|NCT04115748|81714268|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968334|NCT04115748|81714269|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968335|NCT04115748|81714270|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968336|NCT04115748|81714271|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
27968337|NCT04115748|81714272|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968338|NCT04115748|81714273|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968339|NCT04115748|81714274|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968340|NCT04115748|81714275|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968341|NCT04115748|81714276|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968342|NCT04115748|81714277|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
27968343|NCT04115748|81714268|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27968344|NCT04115748|81714269|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27968345|NCT04115748|81714270|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27968346|NCT04115748|81714271|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
27968347|NCT04115748|81714272|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
27666534|NCT01951378|80615700|FG001|Overall Study|Study Terminated-Not completed|17|||
27666535|NCT01066936|80615701|FG000|Overall Study|Death|2|||
27666536|NCT01066936|80615701|FG000|Overall Study|Device revised/removed|1|||
27779325|NCT04815291|81021260|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
27666537|NCT01066936|80615701|FG000|Overall Study|Lost to Follow-up|3|||
27968348|NCT04115748|81714273|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
27968349|NCT04115748|81714274|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
27968350|NCT04115748|81714275|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
27968351|NCT04115748|81714276|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
27968352|NCT04115748|81714277|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
27968353|NCT04115748|81714268|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968354|NCT04115748|81714269|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968355|NCT04115748|81714270|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968356|NCT04115748|81714271|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968357|NCT04115748|81714272|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968358|NCT04115748|81714273|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968359|NCT04115748|81714274|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968360|NCT04115748|81714275|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968361|NCT04115748|81714276|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
27968362|NCT04115748|81714277|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
27968363|NCT03201965|81718641|FG000|Overall Study|Death|5|||
27968364|NCT03201965|81718642|FG001|Overall Study|Death|27|||
27968365|NCT03201965|81718643|FG002|Overall Study|Death|27|||
27968366|NCT03201965|81718641|FG000|Overall Study|Lost to Follow-up|0|||
27779326|NCT02709889|81021261|FG000|Overall Study|Withdrawal by Subject|11|||
27779327|NCT02709889|81021262|FG001|Overall Study|Withdrawal by Subject|10|||
27779328|NCT02709889|81021263|FG002|Overall Study|Withdrawal by Subject|2|||
27779329|NCT02709889|81021264|FG003|Overall Study|Withdrawal by Subject|12|||
27779330|NCT02709889|81021261|FG000|Overall Study|Death|25|||
27779331|NCT02709889|81021262|FG001|Overall Study|Death|38|||
27779332|NCT02709889|81021263|FG002|Overall Study|Death|4|||
27779333|NCT02709889|81021264|FG003|Overall Study|Death|44|||
27779334|NCT02709889|81021261|FG000|Overall Study|Physician Decision|1|||
27779335|NCT02709889|81021262|FG001|Overall Study|Physician Decision|2|||
27779336|NCT02709889|81021263|FG002|Overall Study|Physician Decision|3|||
27779337|NCT02709889|81021264|FG003|Overall Study|Physician Decision|5|||
27779338|NCT02709889|81021261|FG000|Overall Study|Lost to Follow-up|2|||
27968367|NCT03201965|81718642|FG001|Overall Study|Lost to Follow-up|1|||
27968368|NCT03201965|81718643|FG002|Overall Study|Lost to Follow-up|0|||
27968369|NCT03201965|81718641|FG000|Overall Study|Withdrawal by Subject|3|||
27968370|NCT03201965|81718642|FG001|Overall Study|Withdrawal by Subject|13|||
27968371|NCT03201965|81718643|FG002|Overall Study|Withdrawal by Subject|4|||
27968372|NCT03201965|81718641|FG000|Overall Study|Ongoing|20|||
27968373|NCT03201965|81718642|FG001|Overall Study|Ongoing|152|||
27968374|NCT03201965|81718643|FG002|Overall Study|Ongoing|164|||
27968375|NCT03219034|81718644|FG000|Overall Study|Lost to Follow-up|9|||
27968376|NCT03219034|81718645|FG001|Overall Study|Lost to Follow-up|13|||
27968377|NCT03219034|81718644|FG000|Overall Study|Additional dental work needed|1|||
27968378|NCT03219034|81718645|FG001|Overall Study|Additional dental work needed|0|||
27968379|NCT03219034|81718644|FG000|Overall Study|UPPP Surgery|1|||
27968380|NCT03219034|81718645|FG001|Overall Study|UPPP Surgery|0|||
27968381|NCT03219034|81718644|FG000|Overall Study|Dental sensitivity|0|||
27968382|NCT03219034|81718645|FG001|Overall Study|Dental sensitivity|1|||
27968383|NCT03219034|81718644|FG000|Overall Study|Death in family|0|||
27968384|NCT03219034|81718645|FG001|Overall Study|Death in family|1|||
27968385|NCT04068519|81718646|FG000|Dose Verification|Death|15|||
27968386|NCT04068519|81718646|FG000|Dose Verification|Withdrawal by Subject|1|||
27968387|NCT04068519|81718646|FG000|Pharmacokinetic Sub-study|Death|35|||
27968388|NCT04068519|81718646|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
27968389|NCT04068519|81718646|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
27968390|NCT04068519|81718646|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
27968391|NCT04068519|81718646|FG000|Indication Expansion|Death|152|||
27968392|NCT04068519|81718646|FG000|Indication Expansion|Withdrawal by Subject|10|||
27968393|NCT04068519|81718646|FG000|Indication Expansion|Lost to Follow-up|7|||
27968394|NCT00734604|81718649|FG000|Overall Study|Adverse Event|0|||
27968395|NCT00734604|81718650|FG001|Overall Study|Adverse Event|2|||
27968396|NCT00734604|81718651|FG002|Overall Study|Adverse Event|0|||
27968397|NCT00734604|81718652|FG003|Overall Study|Adverse Event|2|||
27968398|NCT00734604|81718653|FG004|Overall Study|Adverse Event|1|||
27968399|NCT00734604|81718654|FG005|Overall Study|Adverse Event|1|||
27968400|NCT00734604|81718649|FG000|Overall Study|Serious Adverse Event|1|||
27779339|NCT02709889|81021262|FG001|Overall Study|Lost to Follow-up|0|||
27779340|NCT02709889|81021263|FG002|Overall Study|Lost to Follow-up|0|||
27779341|NCT02709889|81021264|FG003|Overall Study|Lost to Follow-up|4|||
27779342|NCT02709889|81021261|FG000|Overall Study|Study Terminated by Sponsor|4|||
27779343|NCT02709889|81021262|FG001|Overall Study|Study Terminated by Sponsor|6|||
27779344|NCT02709889|81021263|FG002|Overall Study|Study Terminated by Sponsor|2|||
27779345|NCT02709889|81021264|FG003|Overall Study|Study Terminated by Sponsor|17|||
27779346|NCT02709889|81021261|FG000|Overall Study|Other, Not Specified|0|||
27779347|NCT02709889|81021262|FG001|Overall Study|Other, Not Specified|1|||
27779348|NCT02709889|81021263|FG002|Overall Study|Other, Not Specified|1|||
27779349|NCT02709889|81021264|FG003|Overall Study|Other, Not Specified|6|||
27779350|NCT01542632|81021267|FG000|Overall Study|Withdrawal of Consent|0|||
27779351|NCT01542632|81021268|FG001|Overall Study|Withdrawal of Consent|0|||
27779352|NCT01542632|81021269|FG002|Overall Study|Withdrawal of Consent|0|||
27779353|NCT01542632|81021270|FG003|Overall Study|Withdrawal of Consent|2|||
27779354|NCT01542632|81021271|FG004|Overall Study|Withdrawal of Consent|3|||
27779355|NCT01542632|81021272|FG005|Overall Study|Withdrawal of Consent|0|||
27779356|NCT01542632|81021267|FG000|Overall Study|Adverse Event|0|||
27779357|NCT01542632|81021268|FG001|Overall Study|Adverse Event|0|||
27779358|NCT01542632|81021269|FG002|Overall Study|Adverse Event|1|||
27779359|NCT01542632|81021270|FG003|Overall Study|Adverse Event|0|||
27779360|NCT01542632|81021271|FG004|Overall Study|Adverse Event|0|||
27779361|NCT01542632|81021272|FG005|Overall Study|Adverse Event|0|||
27779362|NCT01542632|81021267|FG000|Overall Study|Lost to Follow-up|0|||
27779363|NCT01542632|81021268|FG001|Overall Study|Lost to Follow-up|1|||
27779364|NCT01542632|81021269|FG002|Overall Study|Lost to Follow-up|0|||
27779365|NCT01542632|81021270|FG003|Overall Study|Lost to Follow-up|0|||
27779366|NCT01542632|81021271|FG004|Overall Study|Lost to Follow-up|0|||
27779367|NCT01542632|81021272|FG005|Overall Study|Lost to Follow-up|0|||
27779368|NCT01542632|81021267|FG000|Overall Study|Sponsor/Investigator Decision|0|||
27779369|NCT01542632|81021268|FG001|Overall Study|Sponsor/Investigator Decision|0|||
27779370|NCT01542632|81021269|FG002|Overall Study|Sponsor/Investigator Decision|0|||
27779371|NCT01542632|81021270|FG003|Overall Study|Sponsor/Investigator Decision|0|||
27779372|NCT01542632|81021271|FG004|Overall Study|Sponsor/Investigator Decision|1|||
27779373|NCT01542632|81021272|FG005|Overall Study|Sponsor/Investigator Decision|0|||
27779374|NCT01987609|81021273|FG000|Overall Study|Adverse Event|1|||
27779375|NCT00939341|81021274|FG000|Overall Study|Adverse Event|15|||
27779376|NCT00939341|81021274|FG000|Overall Study|Pregnancy|1|||
27779377|NCT00939341|81021274|FG000|Overall Study|Lost to Follow-up|23|||
27779378|NCT00939341|81021274|FG000|Overall Study|Withdrawal by Subject|13|||
27779379|NCT00939341|81021274|FG000|Overall Study|Protocol Violation|6|||
27779380|NCT00939341|81021274|FG000|Overall Study|Incorrect enrolment|8|||
27779381|NCT00392210|81021275|FG000|First Voiding Trial|Physician Decision|2|||
27779382|NCT00392210|81021276|FG001|First Voiding Trial|Physician Decision|2|||
27779383|NCT02417935|81021277|FG000|Treatment Period|Adverse Event|12|||
27779384|NCT02417935|81021278|FG001|Treatment Period|Adverse Event|10|||
27779385|NCT02417935|81021277|FG000|Treatment Period|Lost to Follow-up|1|||
27779386|NCT02417935|81021278|FG001|Treatment Period|Lost to Follow-up|0|||
27779387|NCT02417935|81021277|FG000|Treatment Period|Entry Criteria not met|0|||
27779388|NCT02417935|81021278|FG001|Treatment Period|Entry Criteria not met|1|||
27779389|NCT02417935|81021277|FG000|Treatment Period|Protocol Violation|2|||
27779390|NCT02417935|81021278|FG001|Treatment Period|Protocol Violation|1|||
27779391|NCT02417935|81021277|FG000|Treatment Period|Withdrawal by Subject|3|||
27779392|NCT02417935|81021278|FG001|Treatment Period|Withdrawal by Subject|3|||
27779393|NCT02417935|81021277|FG000|Treatment Period|Physician Decision|3|||
27779394|NCT02417935|81021278|FG001|Treatment Period|Physician Decision|1|||
27779395|NCT00405275|81021279|FG000|Overall Study|Death|1|||
27779396|NCT00405275|81021280|FG001|Overall Study|Death|0|||
27779397|NCT00405275|81021279|FG000|Overall Study|Lost to Follow-up|5|||
27779398|NCT00405275|81021280|FG001|Overall Study|Lost to Follow-up|1|||
27779399|NCT00405275|81021279|FG000|Overall Study|Withdrawal by Subject|7|||
27779400|NCT00405275|81021280|FG001|Overall Study|Withdrawal by Subject|9|||
27779401|NCT00405275|81021279|FG000|Overall Study|Unwilling to continue|10|||
27779402|NCT00405275|81021280|FG001|Overall Study|Unwilling to continue|9|||
27779403|NCT01970540|81021281|FG000|Overall Study|Non-treatment-related AE|0|||
27779404|NCT01970540|81021282|FG001|Overall Study|Non-treatment-related AE|0|||
27779405|NCT01970540|81021283|FG002|Overall Study|Non-treatment-related AE|1|||
27779406|NCT01970540|81021281|FG000|Overall Study|Progressive disease|55|||
27779407|NCT01970540|81021282|FG001|Overall Study|Progressive disease|23|||
27779408|NCT01970540|81021283|FG002|Overall Study|Progressive disease|10|||
27779409|NCT01970540|81021281|FG000|Overall Study|Treatment delay over protocol|0|||
27779410|NCT01970540|81021282|FG001|Overall Study|Treatment delay over protocol|0|||
27779411|NCT01970540|81021283|FG002|Overall Study|Treatment delay over protocol|1|||
27779412|NCT01970540|81021281|FG000|Overall Study|Physician Decision|7|||
27779413|NCT01970540|81021282|FG001|Overall Study|Physician Decision|2|||
27779414|NCT01970540|81021283|FG002|Overall Study|Physician Decision|0|||
27779415|NCT01970540|81021281|FG000|Overall Study|Clinical progression|0|||
27779416|NCT01970540|81021282|FG001|Overall Study|Clinical progression|1|||
27779417|NCT01970540|81021283|FG002|Overall Study|Clinical progression|1|||
27779418|NCT01970540|81021281|FG000|Overall Study|End of study|2|||
27968401|NCT00734604|81718650|FG001|Overall Study|Serious Adverse Event|0|||
27968402|NCT00734604|81718651|FG002|Overall Study|Serious Adverse Event|1|||
27968403|NCT00734604|81718652|FG003|Overall Study|Serious Adverse Event|2|||
27968404|NCT00734604|81718653|FG004|Overall Study|Serious Adverse Event|0|||
27968405|NCT00734604|81718654|FG005|Overall Study|Serious Adverse Event|1|||
27968406|NCT00734604|81718649|FG000|Overall Study|Lost to Follow-up|1|||
27968407|NCT00734604|81718650|FG001|Overall Study|Lost to Follow-up|2|||
27968408|NCT00734604|81718651|FG002|Overall Study|Lost to Follow-up|2|||
27968409|NCT00734604|81718652|FG003|Overall Study|Lost to Follow-up|4|||
27968410|NCT00734604|81718653|FG004|Overall Study|Lost to Follow-up|2|||
27968411|NCT00734604|81718654|FG005|Overall Study|Lost to Follow-up|3|||
27779419|NCT01970540|81021282|FG001|Overall Study|End of study|0|||
27779420|NCT01970540|81021283|FG002|Overall Study|End of study|2|||
27779421|NCT01970540|81021281|FG000|Overall Study|Adverse Event|0|||
27779422|NCT01970540|81021282|FG001|Overall Study|Adverse Event|2|||
27779423|NCT01970540|81021283|FG002|Overall Study|Adverse Event|1|||
27779424|NCT01970540|81021281|FG000|Overall Study|Treatment-related AE|4|||
27779425|NCT01970540|81021282|FG001|Overall Study|Treatment-related AE|0|||
27779426|NCT01970540|81021283|FG002|Overall Study|Treatment-related AE|2|||
27779427|NCT01970540|81021281|FG000|Overall Study|Withdrawal by Subject|4|||
27779428|NCT01970540|81021282|FG001|Overall Study|Withdrawal by Subject|0|||
27779429|NCT01970540|81021283|FG002|Overall Study|Withdrawal by Subject|1|||
27779430|NCT01970540|81021281|FG000|Overall Study|Clinical deterioration|1|||
27779431|NCT01970540|81021282|FG001|Overall Study|Clinical deterioration|0|||
27779432|NCT01970540|81021283|FG002|Overall Study|Clinical deterioration|0|||
27779433|NCT03049852|81021284|FG000|Overall Study|Lost to Follow-up|0|||
27779434|NCT03049852|81021285|FG001|Overall Study|Lost to Follow-up|1|||
27779435|NCT03049852|81021286|FG002|Overall Study|Lost to Follow-up|0|||
27779436|NCT02306148|81021287|FG000|Overall Study|Adverse Event|12|||
27779437|NCT02306148|81021288|FG001|Overall Study|Adverse Event|6|||
27779438|NCT02306148|81021287|FG000|Overall Study|Lost to Follow-up|1|||
27779439|NCT02306148|81021288|FG001|Overall Study|Lost to Follow-up|4|||
27779440|NCT00545740|81021289|FG000|Overall Study|Lack of Efficacy|34|||
27779441|NCT00545740|81021290|FG001|Overall Study|Lack of Efficacy|35|||
27779442|NCT00545740|81021291|FG002|Overall Study|Lack of Efficacy|47|||
27779443|NCT00545740|81021292|FG003|Overall Study|Lack of Efficacy|36|||
27779444|NCT00545740|81021289|FG000|Overall Study|Withdrawal by Subject|17|||
27779445|NCT00545740|81021290|FG001|Overall Study|Withdrawal by Subject|15|||
27779446|NCT00545740|81021291|FG002|Overall Study|Withdrawal by Subject|16|||
27779447|NCT00545740|81021292|FG003|Overall Study|Withdrawal by Subject|18|||
27779448|NCT00545740|81021289|FG000|Overall Study|Adverse Event|10|||
27779449|NCT00545740|81021290|FG001|Overall Study|Adverse Event|18|||
27779450|NCT00545740|81021291|FG002|Overall Study|Adverse Event|19|||
27779451|NCT00545740|81021292|FG003|Overall Study|Adverse Event|9|||
27779452|NCT00545740|81021289|FG000|Overall Study|Lost to Follow-up|7|||
27779453|NCT00545740|81021290|FG001|Overall Study|Lost to Follow-up|5|||
27779454|NCT00545740|81021291|FG002|Overall Study|Lost to Follow-up|5|||
27779455|NCT00545740|81021292|FG003|Overall Study|Lost to Follow-up|6|||
27779456|NCT00545740|81021289|FG000|Overall Study|Protocol Violation|1|||
27779457|NCT00545740|81021290|FG001|Overall Study|Protocol Violation|3|||
27779458|NCT00545740|81021291|FG002|Overall Study|Protocol Violation|1|||
27779459|NCT00545740|81021292|FG003|Overall Study|Protocol Violation|0|||
27779460|NCT00545740|81021289|FG000|Overall Study|Non-compliance|0|||
27779461|NCT00545740|81021290|FG001|Overall Study|Non-compliance|2|||
27779462|NCT00545740|81021291|FG002|Overall Study|Non-compliance|1|||
27779463|NCT00545740|81021292|FG003|Overall Study|Non-compliance|0|||
27779464|NCT00545740|81021289|FG000|Overall Study|Moved|2|||
27779465|NCT00545740|81021290|FG001|Overall Study|Moved|0|||
27779466|NCT00545740|81021291|FG002|Overall Study|Moved|1|||
27779467|NCT00545740|81021292|FG003|Overall Study|Moved|0|||
27779468|NCT00545740|81021289|FG000|Overall Study|Diverticulitis attack|0|||
27779469|NCT00545740|81021290|FG001|Overall Study|Diverticulitis attack|0|||
27779470|NCT00545740|81021291|FG002|Overall Study|Diverticulitis attack|1|||
27779471|NCT00545740|81021292|FG003|Overall Study|Diverticulitis attack|1|||
27779472|NCT00545740|81021289|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
27779473|NCT00545740|81021290|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
27779474|NCT00545740|81021291|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
27779475|NCT00545740|81021292|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
27779476|NCT00545740|81021289|FG000|Overall Study|Site closure|1|||
27779477|NCT00545740|81021290|FG001|Overall Study|Site closure|0|||
27779478|NCT00545740|81021291|FG002|Overall Study|Site closure|0|||
27779479|NCT00545740|81021292|FG003|Overall Study|Site closure|0|||
27863469|NCT04895982|81333004|FG005|Overall Study|Lost to Follow-up|1|||
27968412|NCT00734604|81718649|FG000|Overall Study|Physician Decision|0|||
27968413|NCT00734604|81718650|FG001|Overall Study|Physician Decision|1|||
27779480|NCT00545740|81021289|FG000|Overall Study|Missed visit|1|||
27779481|NCT00545740|81021290|FG001|Overall Study|Missed visit|0|||
27779482|NCT00545740|81021291|FG002|Overall Study|Missed visit|0|||
27968414|NCT00734604|81718651|FG002|Overall Study|Physician Decision|1|||
27779483|NCT00545740|81021292|FG003|Overall Study|Missed visit|0|||
27779484|NCT00545740|81021289|FG000|Overall Study|Physician Decision|0|||
27779485|NCT00545740|81021290|FG001|Overall Study|Physician Decision|0|||
27779486|NCT00545740|81021291|FG002|Overall Study|Physician Decision|3|||
27779487|NCT00545740|81021292|FG003|Overall Study|Physician Decision|0|||
27779488|NCT00545740|81021289|FG000|Overall Study|Accepted only monthly telephone calls|1|||
27779489|NCT00545740|81021290|FG001|Overall Study|Accepted only monthly telephone calls|0|||
27779490|NCT00545740|81021291|FG002|Overall Study|Accepted only monthly telephone calls|0|||
27779491|NCT00545740|81021292|FG003|Overall Study|Accepted only monthly telephone calls|0|||
27779492|NCT00545740|81021289|FG000|Overall Study|Sponsor decision|0|||
27779493|NCT00545740|81021290|FG001|Overall Study|Sponsor decision|1|||
27779494|NCT00545740|81021291|FG002|Overall Study|Sponsor decision|0|||
27779495|NCT00545740|81021292|FG003|Overall Study|Sponsor decision|0|||
27779496|NCT00545740|81021289|FG000|Overall Study|Lack of time|0|||
27779497|NCT00545740|81021290|FG001|Overall Study|Lack of time|1|||
27779498|NCT00545740|81021291|FG002|Overall Study|Lack of time|0|||
27779499|NCT00545740|81021292|FG003|Overall Study|Lack of time|0|||
27779500|NCT00545740|81021289|FG000|Overall Study|Non-adherence to visits|0|||
27779501|NCT00545740|81021290|FG001|Overall Study|Non-adherence to visits|1|||
27779502|NCT00545740|81021291|FG002|Overall Study|Non-adherence to visits|0|||
27779503|NCT00545740|81021292|FG003|Overall Study|Non-adherence to visits|0|||
27779504|NCT00545740|81021289|FG000|Overall Study|Patient difficulties|0|||
27779505|NCT00545740|81021290|FG001|Overall Study|Patient difficulties|1|||
27779506|NCT00545740|81021291|FG002|Overall Study|Patient difficulties|0|||
27779507|NCT00545740|81021292|FG003|Overall Study|Patient difficulties|0|||
27779508|NCT00545740|81021289|FG000|Overall Study|Husband against study|0|||
27779509|NCT00545740|81021290|FG001|Overall Study|Husband against study|0|||
27779510|NCT00545740|81021291|FG002|Overall Study|Husband against study|1|||
27779511|NCT00545740|81021292|FG003|Overall Study|Husband against study|0|||
27779512|NCT01938391|81021299|FG000|6 Month Follow up|Withdrawal by Subject|1|||
27779513|NCT01938391|81021299|FG000|12 Month Follow up|Physician Decision|1|||
27779514|NCT01938391|81021299|FG000|12 Month Follow up|Withdrawal by Subject|1|||
27779515|NCT02543801|81021300|FG000|Overall Study|Protocol Violation|1|||
27779516|NCT02543801|81021301|FG001|Overall Study|Protocol Violation|2|||
27779517|NCT02543801|81021302|FG002|Overall Study|Protocol Violation|0|||
27779518|NCT02543801|81021303|FG003|Overall Study|Protocol Violation|0|||
27779519|NCT00672139|81021304|FG000|Overall Study|Death|14|||
27779520|NCT00672139|81021305|FG001|Overall Study|Death|23|||
27779521|NCT00672139|81021304|FG000|Overall Study|Withdrawal by Subject|2|||
27779522|NCT00672139|81021305|FG001|Overall Study|Withdrawal by Subject|11|||
27779523|NCT00672139|81021304|FG000|Overall Study|Adverse Event|4|||
27779524|NCT00672139|81021305|FG001|Overall Study|Adverse Event|7|||
27779525|NCT00672139|81021304|FG000|Overall Study|Physician Decision|2|||
27779526|NCT00672139|81021305|FG001|Overall Study|Physician Decision|0|||
27779527|NCT00672139|81021304|FG000|Overall Study|Lack of Efficacy|4|||
27779528|NCT00672139|81021305|FG001|Overall Study|Lack of Efficacy|1|||
27779529|NCT00672139|81021304|FG000|Overall Study|Protocol Violation|1|||
27779530|NCT00672139|81021305|FG001|Overall Study|Protocol Violation|1|||
27779531|NCT00672139|81021304|FG000|Overall Study|hospice discharge, caregiver requests|3|||
27779532|NCT00672139|81021305|FG001|Overall Study|hospice discharge, caregiver requests|2|||
27779533|NCT03330106|81021309|FG000|Part A|Withdrawal by Subject|1|||
27779534|NCT03330106|81021310|FG001|Part A|Withdrawal by Subject|1|||
27779535|NCT03330106|81021311|FG002|Part A|Withdrawal by Subject|0|||
27779536|NCT03330106|81021312|FG003|Part A|Withdrawal by Subject|0|||
27779537|NCT03330106|81021309|FG000|Part A|Death|2|||
27779538|NCT03330106|81021310|FG001|Part A|Death|1|||
27779539|NCT03330106|81021311|FG002|Part A|Death|0|||
27779540|NCT03330106|81021312|FG003|Part A|Death|0|||
27779541|NCT03330106|81021309|FG000|Part A|Adverse Event|0|||
27779542|NCT03330106|81021310|FG001|Part A|Adverse Event|1|||
27666538|NCT01066936|80615701|FG000|Overall Study|Withdrawal by Subject|4|||
27779543|NCT03330106|81021311|FG002|Part A|Adverse Event|0|||
27779544|NCT03330106|81021312|FG003|Part A|Adverse Event|0|||
27968415|NCT00734604|81718652|FG003|Overall Study|Physician Decision|0|||
27666539|NCT01920178|80615702|FG000|Overall Study|Lost to Follow-up|2|||
27666540|NCT01920178|80615703|FG001|Overall Study|Lost to Follow-up|1|||
27779545|NCT03330106|81021309|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
27779546|NCT03330106|81021310|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
27779547|NCT03330106|81021311|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
27779548|NCT03330106|81021312|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
27779549|NCT03330106|81021309|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
27779550|NCT03330106|81021310|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
27779551|NCT03330106|81021311|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
27779552|NCT03330106|81021312|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
27779553|NCT03330106|81021309|FG000|Part A|Progressive Disease|0|||
27779554|NCT03330106|81021310|FG001|Part A|Progressive Disease|1|||
27863470|NCT04895982|81333005|FG006|Overall Study|Lost to Follow-up|0|||
27863471|NCT04895982|81333006|FG007|Overall Study|Lost to Follow-up|0|||
27863472|NCT04895982|81333007|FG008|Overall Study|Lost to Follow-up|1|||
27863473|NCT04895982|81333008|FG009|Overall Study|Lost to Follow-up|0|||
27863474|NCT04895982|81333009|FG010|Overall Study|Lost to Follow-up|0|||
27863475|NCT04895982|81333010|FG011|Overall Study|Lost to Follow-up|0|||
27863476|NCT04895982|81332999|FG000|Overall Study|Refused further study procedures|0|||
27863477|NCT04895982|81333000|FG001|Overall Study|Refused further study procedures|0|||
27863478|NCT04895982|81333001|FG002|Overall Study|Refused further study procedures|1|||
27863479|NCT04895982|81333002|FG003|Overall Study|Refused further study procedures|0|||
27570325|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27863480|NCT04895982|81333003|FG004|Overall Study|Refused further study procedures|0|||
27779555|NCT03330106|81021311|FG002|Part A|Progressive Disease|0|||
27779556|NCT03330106|81021312|FG003|Part A|Progressive Disease|0|||
27779557|NCT03330106|81021309|FG000|Part B|Lost to Follow-up|0|||
27779558|NCT03330106|81021310|FG001|Part B|Lost to Follow-up|0|||
27779559|NCT03330106|81021311|FG002|Part B|Lost to Follow-up|0|||
27779560|NCT03330106|81021312|FG003|Part B|Lost to Follow-up|1|||
27779561|NCT03330106|81021309|FG000|Part B|Withdrawal by Subject|0|||
27779562|NCT03330106|81021310|FG001|Part B|Withdrawal by Subject|0|||
27779563|NCT03330106|81021311|FG002|Part B|Withdrawal by Subject|4|||
27779564|NCT03330106|81021312|FG003|Part B|Withdrawal by Subject|0|||
27779565|NCT03330106|81021309|FG000|Part B|Death|0|||
27779566|NCT03330106|81021310|FG001|Part B|Death|0|||
27779567|NCT03330106|81021311|FG002|Part B|Death|2|||
27779568|NCT03330106|81021312|FG003|Part B|Death|0|||
27779569|NCT03330106|81021309|FG000|Part B|Clinical Progression|0|||
27779570|NCT03330106|81021310|FG001|Part B|Clinical Progression|0|||
27779571|NCT03330106|81021311|FG002|Part B|Clinical Progression|1|||
27779572|NCT03330106|81021312|FG003|Part B|Clinical Progression|1|||
27779573|NCT03330106|81021309|FG000|Part B|Symptomatic Deterioration|0|||
27779574|NCT03330106|81021310|FG001|Part B|Symptomatic Deterioration|0|||
27779575|NCT03330106|81021311|FG002|Part B|Symptomatic Deterioration|0|||
27779576|NCT03330106|81021312|FG003|Part B|Symptomatic Deterioration|1|||
27779577|NCT03330106|81021309|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
27779578|NCT03330106|81021310|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
27779579|NCT03330106|81021311|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
27779580|NCT03330106|81021312|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
27779581|NCT03330106|81021309|FG000|Part B|Progressive Disease|0|||
27779582|NCT03330106|81021310|FG001|Part B|Progressive Disease|0|||
27779583|NCT03330106|81021311|FG002|Part B|Progressive Disease|11|||
27779584|NCT03330106|81021312|FG003|Part B|Progressive Disease|4|||
27779585|NCT00631969|81021315|FG000|Overall Study|Adverse Event|3|||
27779586|NCT00631969|81021316|FG001|Overall Study|Adverse Event|1|||
27779587|NCT00631969|81021315|FG000|Overall Study|Lack of Efficacy|2|||
27779588|NCT00631969|81021316|FG001|Overall Study|Lack of Efficacy|8|||
27779589|NCT00631969|81021315|FG000|Overall Study|Lost to Follow-up|2|||
27779590|NCT00631969|81021316|FG001|Overall Study|Lost to Follow-up|1|||
27779591|NCT00631969|81021315|FG000|Overall Study|Protocol Violation|1|||
27779592|NCT00631969|81021316|FG001|Overall Study|Protocol Violation|1|||
27779593|NCT00631969|81021315|FG000|Overall Study|Consent Withdrawn|5|||
27779594|NCT00631969|81021316|FG001|Overall Study|Consent Withdrawn|7|||
27779595|NCT00631969|81021315|FG000|Overall Study|Noncompliant With Study Medication|0|||
27779596|NCT00631969|81021316|FG001|Overall Study|Noncompliant With Study Medication|1|||
27779597|NCT00631969|81021315|FG000|Overall Study|No Drug Exposure|2|||
27779598|NCT00631969|81021316|FG001|Overall Study|No Drug Exposure|2|||
27779599|NCT00697255|81021321|FG000|Stage 1a|Insufficient ovarian response|1|||
27779600|NCT00697255|81021322|FG001|Stage 1a|Insufficient ovarian response|0|||
27779601|NCT00697255|81021321|FG000|Stage 1a|Multifollicular growth|1|||
27779602|NCT00697255|81021322|FG001|Stage 1a|Multifollicular growth|0|||
27779603|NCT00697255|81021321|FG000|Stage 1a|Not growing of dominant follicle|1|||
27779604|NCT00697255|81021322|FG001|Stage 1a|Not growing of dominant follicle|0|||
27779605|NCT00697255|81021321|FG000|Stage 1b|Not growing of dominant follicle|0|||
27779606|NCT00697255|81021322|FG001|Stage 1b|Not growing of dominant follicle|1|||
27779607|NCT00697255|81021321|FG000|Stage 1b|Insufficient ovarian response|0|||
27779608|NCT00697255|81021322|FG001|Stage 1b|Insufficient ovarian response|1|||
27779609|NCT04048876|81021328|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
27779610|NCT04048876|81021329|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
27779611|NCT04048876|81021330|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
27779612|NCT04048876|81021331|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
27779613|NCT04048876|81021328|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
27779614|NCT04048876|81021329|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
27779615|NCT04048876|81021330|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
27779616|NCT04048876|81021331|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
27779617|NCT04048876|81021328|FG000|Placebo Controlled Phase|Adverse Event|0|||
27779618|NCT04048876|81021329|FG001|Placebo Controlled Phase|Adverse Event|1|||
27779619|NCT04048876|81021330|FG002|Placebo Controlled Phase|Adverse Event|0|||
27779620|NCT04048876|81021331|FG003|Placebo Controlled Phase|Adverse Event|0|||
27779621|NCT04048876|81021328|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
27779622|NCT04048876|81021329|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
27779623|NCT04048876|81021330|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
27779624|NCT04048876|81021331|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
27779625|NCT01058395|81021335|FG000|Overall Study|Death|2|||
27779626|NCT01058395|81021336|FG001|Overall Study|Death|1|||
27779627|NCT01058395|81021335|FG000|Overall Study|Lost to Follow-up|1|||
27779628|NCT01058395|81021336|FG001|Overall Study|Lost to Follow-up|0|||
27779629|NCT03480841|81021342|FG000|Overall Study|Lost to Follow-up|2|||
27779630|NCT02630459|81021343|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27779631|NCT02630459|81021344|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
27779632|NCT02630459|81021345|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27779633|NCT02630459|81021346|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
27779634|NCT02630459|81021347|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27779635|NCT02630459|81021348|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27779636|NCT02630459|81021349|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27779637|NCT02630459|81021350|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
27779638|NCT02630459|81021343|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779639|NCT02630459|81021344|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779640|NCT02630459|81021345|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
27779641|NCT02630459|81021346|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779642|NCT02630459|81021347|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779643|NCT02630459|81021348|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779644|NCT02630459|81021349|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779645|NCT02630459|81021350|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
27779646|NCT02630459|81021343|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
27779647|NCT02630459|81021344|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
27779648|NCT02630459|81021345|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
27779649|NCT02630459|81021346|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
27779650|NCT02630459|81021347|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27779651|NCT02630459|81021348|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27779652|NCT02630459|81021349|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27779653|NCT02630459|81021350|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
27779654|NCT02630459|81021343|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
27779655|NCT02630459|81021344|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779656|NCT02630459|81021345|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779657|NCT02630459|81021346|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779658|NCT02630459|81021347|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779659|NCT02630459|81021348|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779660|NCT02630459|81021349|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779661|NCT02630459|81021350|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
27779662|NCT02630459|81021343|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27779663|NCT02630459|81021344|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27779664|NCT02630459|81021345|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27779665|NCT02630459|81021346|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27779666|NCT02630459|81021347|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
27779667|NCT02630459|81021348|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
27779668|NCT02630459|81021349|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27779669|NCT02630459|81021350|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
27779670|NCT02630459|81021343|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27779671|NCT02630459|81021344|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27779672|NCT02630459|81021345|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27779673|NCT02630459|81021346|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27779674|NCT02630459|81021347|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
27779675|NCT02630459|81021348|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
27779676|NCT02630459|81021349|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27779677|NCT02630459|81021350|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
27779678|NCT02630459|81021343|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27779679|NCT02630459|81021344|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27779680|NCT02630459|81021345|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27779681|NCT02630459|81021346|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27779682|NCT02630459|81021347|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
27779683|NCT02630459|81021348|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27779684|NCT02630459|81021349|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27570326|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570327|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570328|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570329|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570330|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
27570331|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27666541|NCT01891890|80615706|FG000|Overall Study|Lost to Follow-up|0|||
27666542|NCT01891890|80615707|FG001|Overall Study|Lost to Follow-up|0|||
27666543|NCT01891890|80615708|FG002|Overall Study|Lost to Follow-up|1|||
27779685|NCT02630459|81021350|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
27779686|NCT00303329|81021351|FG000|Overall Study|Adverse Event|7|||
27570332|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570333|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570334|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570335|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570336|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570337|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570338|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570339|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570340|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570341|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570342|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570343|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570344|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
27570345|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570346|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570347|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570348|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570349|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570350|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570351|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570352|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570353|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570354|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570355|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
27570356|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570357|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570358|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570359|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570360|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570361|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570362|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570363|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570364|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570365|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570366|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570367|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570368|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
27570369|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570370|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570371|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570372|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570373|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570374|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570375|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570376|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570377|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570378|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570379|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570380|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570381|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570382|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570383|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
27570384|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570385|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570386|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27666544|NCT01891890|80615706|FG000|Overall Study|Study ended before endpoint reached|7|||
27666545|NCT01891890|80615707|FG001|Overall Study|Study ended before endpoint reached|3|||
27779687|NCT00303329|81021352|FG001|Overall Study|Adverse Event|14|||
27570387|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570388|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570389|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570390|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570391|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570392|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
27570393|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570394|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570395|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570396|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570397|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570398|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570399|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570400|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570401|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570402|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570403|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570404|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570405|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570406|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570407|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
27570408|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570409|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570410|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570411|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570412|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570413|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570414|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570415|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570416|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
27570417|NCT02346240|80275284|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570418|NCT02346240|80275285|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570419|NCT02346240|80275286|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570420|NCT02346240|80275287|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570421|NCT02346240|80275288|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570422|NCT02346240|80275289|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570423|NCT02346240|80275290|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570424|NCT02346240|80275291|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570425|NCT02346240|80275292|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570426|NCT02346240|80275293|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570427|NCT02346240|80275294|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570428|NCT02346240|80275295|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570429|NCT02346240|80275296|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570430|NCT02346240|80275297|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570431|NCT02346240|80275298|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
27779688|NCT00303329|81021351|FG000|Overall Study|Abnormal Laboratory Values|0|||
27779689|NCT00303329|81021352|FG001|Overall Study|Abnormal Laboratory Values|1|||
27779690|NCT00303329|81021351|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
27779691|NCT00303329|81021352|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27779692|NCT00303329|81021351|FG000|Overall Study|Condition no longer requires study drug|0|||
27779693|NCT00303329|81021352|FG001|Overall Study|Condition no longer requires study drug|8|||
27779694|NCT00303329|81021351|FG000|Overall Study|Protocol Violation|3|||
27779695|NCT00303329|81021352|FG001|Overall Study|Protocol Violation|0|||
27779696|NCT00303329|81021351|FG000|Overall Study|Withdrawal by Subject|9|||
27779697|NCT00303329|81021352|FG001|Overall Study|Withdrawal by Subject|15|||
27779698|NCT00303329|81021351|FG000|Overall Study|Lost to Follow-up|0|||
27779699|NCT00303329|81021352|FG001|Overall Study|Lost to Follow-up|1|||
27968416|NCT00734604|81718653|FG004|Overall Study|Physician Decision|0|||
27779700|NCT00303329|81021351|FG000|Overall Study|Administrative problems|1|||
27779701|NCT00303329|81021352|FG001|Overall Study|Administrative problems|0|||
27968417|NCT00734604|81718654|FG005|Overall Study|Physician Decision|0|||
27968418|NCT00734604|81718649|FG000|Overall Study|Protocol Violation|0|||
27779702|NCT00303329|81021351|FG000|Overall Study|Death|2|||
27779703|NCT00303329|81021352|FG001|Overall Study|Death|12|||
27779704|NCT00303329|81021351|FG000|Overall Study|Stopped at end of core|3|||
27779705|NCT00303329|81021352|FG001|Overall Study|Stopped at end of core|9|||
27779706|NCT00303329|81021351|FG000|Overall Study|Stopped at end of extension 1|1|||
27779707|NCT00303329|81021352|FG001|Overall Study|Stopped at end of extension 1|0|||
27779708|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
27779709|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
27779710|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
27779711|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
27779712|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
27779713|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
27779714|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
27779715|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
27779716|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Death|0|||
27779717|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Death|0|||
27779718|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Death|0|||
27779719|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Death|1|||
27666546|NCT01891890|80615708|FG002|Overall Study|Study ended before endpoint reached|6|||
27666547|NCT04522778|80615711|FG000|Overall Study|Patient did not want to wear the device|1|||
27666548|NCT04522778|80615712|FG001|Overall Study|Patient did not want to wear the device|0|||
27666549|NCT04522778|80615711|FG000|Overall Study|Lost to Follow-up|0|||
27666550|NCT04522778|80615712|FG001|Overall Study|Lost to Follow-up|1|||
27666551|NCT00338949|80615713|FG000|Subject Screening|Screen failures|11|||
27666552|NCT00338949|80615714|FG001|Subject Screening|Screen failures|11|||
27666553|NCT00338949|80615713|FG000|Randomization|Withdrawal by Subject|1|||
27779720|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Death|1|||
27666554|NCT00338949|80615714|FG001|Randomization|Withdrawal by Subject|0|||
27666555|NCT00338949|80615713|FG000|Randomization|Adverse Event|0|||
27666556|NCT00338949|80615714|FG001|Randomization|Adverse Event|5|||
27779721|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Death|0|||
27779722|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Death|2|||
27779723|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Death|0|||
27666557|NCT03440047|80619489|FG000|Overall Study|Withdrawal by Subject|2|||
27666558|NCT00874497|80619491|FG000|Overall Study|Lost to Follow-up|2|||
27666559|NCT00874497|80619492|FG001|Overall Study|Lost to Follow-up|4|||
27666560|NCT00874497|80619491|FG000|Overall Study|Adverse Event|9|||
27666561|NCT00874497|80619492|FG001|Overall Study|Adverse Event|4|||
27666562|NCT00874497|80619491|FG000|Overall Study|Sponsor Discontinued Trial|7|||
27666563|NCT00874497|80619492|FG001|Overall Study|Sponsor Discontinued Trial|3|||
27968419|NCT00734604|81718650|FG001|Overall Study|Protocol Violation|2|||
27968420|NCT00734604|81718651|FG002|Overall Study|Protocol Violation|0|||
27968421|NCT00734604|81718652|FG003|Overall Study|Protocol Violation|0|||
27968422|NCT00734604|81718653|FG004|Overall Study|Protocol Violation|1|||
27968423|NCT00734604|81718654|FG005|Overall Study|Protocol Violation|0|||
27968424|NCT00734604|81718649|FG000|Overall Study|Sponsor Decision|1|||
27968425|NCT00734604|81718650|FG001|Overall Study|Sponsor Decision|2|||
27968426|NCT00734604|81718651|FG002|Overall Study|Sponsor Decision|1|||
27968427|NCT00734604|81718652|FG003|Overall Study|Sponsor Decision|0|||
27968428|NCT00734604|81718653|FG004|Overall Study|Sponsor Decision|2|||
27968429|NCT00734604|81718654|FG005|Overall Study|Sponsor Decision|0|||
27968430|NCT00734604|81718649|FG000|Overall Study|Withdrawal by Subject|0|||
27968431|NCT00734604|81718650|FG001|Overall Study|Withdrawal by Subject|2|||
27968432|NCT00734604|81718651|FG002|Overall Study|Withdrawal by Subject|0|||
27968433|NCT00734604|81718652|FG003|Overall Study|Withdrawal by Subject|1|||
27666564|NCT00874497|80619491|FG000|Overall Study|Met Withdrawal Criteria|4|||
27666565|NCT00874497|80619492|FG001|Overall Study|Met Withdrawal Criteria|2|||
27666566|NCT00874497|80619491|FG000|Overall Study|Physician Decision|1|||
27666567|NCT00874497|80619492|FG001|Overall Study|Physician Decision|1|||
27666568|NCT00874497|80619491|FG000|Overall Study|Withdrawal by Subject|5|||
27666569|NCT00874497|80619492|FG001|Overall Study|Withdrawal by Subject|4|||
27666570|NCT00460564|80619493|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
27666571|NCT00460564|80619494|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
27666572|NCT00460564|80619495|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27666573|NCT00460564|80619496|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27666574|NCT00460564|80619497|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27666575|NCT00460564|80619498|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27666576|NCT00460564|80619499|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27666577|NCT00460564|80619500|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
27666578|NCT00460564|80619493|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
27666579|NCT00460564|80619494|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27779724|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27779725|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27779726|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27666580|NCT00460564|80619495|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27666581|NCT00460564|80619496|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27666582|NCT00460564|80619497|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27666583|NCT00460564|80619498|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27666584|NCT00460564|80619499|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27666585|NCT00460564|80619500|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
27666586|NCT00460564|80619493|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27666587|NCT00460564|80619494|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27666588|NCT00460564|80619495|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27666589|NCT00460564|80619496|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27666590|NCT00460564|80619497|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
27666591|NCT00460564|80619498|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
27666592|NCT00460564|80619499|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
27666593|NCT00460564|80619500|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
27666594|NCT00460564|80619493|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27666595|NCT00460564|80619494|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27666596|NCT00460564|80619495|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27666597|NCT00460564|80619496|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27666598|NCT00460564|80619497|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
27666599|NCT00460564|80619498|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
27666600|NCT00460564|80619499|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27779727|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
27666601|NCT00460564|80619500|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
27666602|NCT00460564|80619493|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27666603|NCT00460564|80619494|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27968434|NCT00734604|81718653|FG004|Overall Study|Withdrawal by Subject|2|||
27968435|NCT00734604|81718654|FG005|Overall Study|Withdrawal by Subject|1|||
27968436|NCT00734604|81718649|FG000|Overall Study|Lack of Efficacy|0|||
27968437|NCT00734604|81718650|FG001|Overall Study|Lack of Efficacy|1|||
27666604|NCT00460564|80619495|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27666605|NCT00460564|80619496|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27666606|NCT00460564|80619497|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
27666607|NCT00460564|80619498|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27666608|NCT00460564|80619499|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27666609|NCT00460564|80619500|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
27666610|NCT01222533|80619503|FG000|Overall Study|Adverse Event|5|||
27666611|NCT01222533|80619503|FG000|Overall Study|Withdrawal by Subject|5|||
27666612|NCT01222533|80619503|FG000|Overall Study|Other|4|||
27666613|NCT00904722|80619507|FG000|Overall Study|Physician Decision|1|||
27666614|NCT00329550|80619510|FG000|Overall Study|Adverse Event|3|||
27666615|NCT00329550|80619511|FG001|Overall Study|Adverse Event|4|||
27666616|NCT00329550|80619512|FG002|Overall Study|Adverse Event|2|||
27666617|NCT00329550|80619510|FG000|Overall Study|Withdrawal of Consent|1|||
27666618|NCT00329550|80619511|FG001|Overall Study|Withdrawal of Consent|0|||
27666619|NCT00329550|80619512|FG002|Overall Study|Withdrawal of Consent|1|||
27666620|NCT00329550|80619510|FG000|Overall Study|Due to Relocation|0|||
27666621|NCT00329550|80619511|FG001|Overall Study|Due to Relocation|0|||
27666622|NCT00329550|80619512|FG002|Overall Study|Due to Relocation|1|||
27666623|NCT03023423|80619513|FG000|Overall Study|Death|5|||
27666624|NCT03023423|80619514|FG001|Overall Study|Death|12|||
27666625|NCT03023423|80619515|FG002|Overall Study|Death|20|||
27666626|NCT03023423|80619513|FG000|Overall Study|Other|0|||
27666627|NCT03023423|80619514|FG001|Overall Study|Other|2|||
27666628|NCT03023423|80619515|FG002|Overall Study|Other|2|||
27666629|NCT03023423|80619513|FG000|Overall Study|Ongoing|2|||
27666630|NCT03023423|80619514|FG001|Overall Study|Ongoing|32|||
27666631|NCT03023423|80619515|FG002|Overall Study|Ongoing|24|||
27666632|NCT04969276|80619516|FG000|Overall Study|Protocol Deviation|0|||
27666633|NCT04969276|80619517|FG001|Overall Study|Protocol Deviation|1|||
27666634|NCT04969276|80619518|FG002|Overall Study|Protocol Deviation|0|||
27666635|NCT04969276|80619516|FG000|Overall Study|Withdrawal by Subject|1|||
27666636|NCT04969276|80619517|FG001|Overall Study|Withdrawal by Subject|10|||
27666637|NCT04969276|80619518|FG002|Overall Study|Withdrawal by Subject|0|||
27666638|NCT04969276|80619516|FG000|Overall Study|Lost to Follow-up|0|||
27666639|NCT04969276|80619517|FG001|Overall Study|Lost to Follow-up|1|||
27666640|NCT04969276|80619518|FG002|Overall Study|Lost to Follow-up|0|||
27666641|NCT04599907|80619519|FG000|Overall Study|Withdrawal by Subject|1|||
27666642|NCT04599907|80619520|FG001|Overall Study|Withdrawal by Subject|7|||
27666643|NCT04599907|80619521|FG002|Overall Study|Withdrawal by Subject|6|||
27666644|NCT04599907|80619519|FG000|Overall Study|Lost to Follow-up|0|||
27666645|NCT04599907|80619520|FG001|Overall Study|Lost to Follow-up|1|||
27666646|NCT04599907|80619521|FG002|Overall Study|Lost to Follow-up|0|||
27666647|NCT00405912|80619522|FG000|Overall Study|Withdrawal by Subject|12|||
27666648|NCT00405912|80619523|FG001|Overall Study|Withdrawal by Subject|11|||
27666649|NCT00405912|80619524|FG002|Overall Study|Withdrawal by Subject|12|||
27666650|NCT00405912|80619522|FG000|Overall Study|Lost to Follow-up|4|||
27666651|NCT00405912|80619523|FG001|Overall Study|Lost to Follow-up|8|||
27666652|NCT00405912|80619524|FG002|Overall Study|Lost to Follow-up|4|||
27666653|NCT02554383|80619525|FG000|Overall Study|Ineligible|3|||
27666654|NCT02554383|80619526|FG001|Overall Study|Ineligible|2|||
27666655|NCT02554383|80619525|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
27666656|NCT02554383|80619526|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
27666657|NCT02554383|80619525|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
27666658|NCT02554383|80619526|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
27666659|NCT02554383|80619525|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
27666660|NCT02554383|80619526|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
27666661|NCT02330562|80619527|FG000|Overall Study|Adverse Event|0|||
27666662|NCT02330562|80619528|FG001|Overall Study|Adverse Event|0|||
27666663|NCT02330562|80619529|FG002|Overall Study|Adverse Event|3|||
27666664|NCT02330562|80619530|FG003|Overall Study|Adverse Event|0|||
27666665|NCT02330562|80619531|FG004|Overall Study|Adverse Event|3|||
27666666|NCT02330562|80619532|FG005|Overall Study|Adverse Event|1|||
27779728|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27666667|NCT02330562|80619533|FG006|Overall Study|Adverse Event|0|||
27666668|NCT02330562|80619534|FG007|Overall Study|Adverse Event|0|||
27666669|NCT02330562|80619535|FG008|Overall Study|Adverse Event|0|||
27666670|NCT02330562|80619536|FG009|Overall Study|Adverse Event|1|||
27666671|NCT02330562|80619537|FG010|Overall Study|Adverse Event|1|||
27666672|NCT02330562|80619527|FG000|Overall Study|Participant decision|1|||
27666673|NCT02330562|80619528|FG001|Overall Study|Participant decision|0|||
27666674|NCT02330562|80619529|FG002|Overall Study|Participant decision|4|||
27666675|NCT02330562|80619530|FG003|Overall Study|Participant decision|1|||
27666676|NCT02330562|80619531|FG004|Overall Study|Participant decision|5|||
27779729|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27779730|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27666677|NCT02330562|80619532|FG005|Overall Study|Participant decision|2|||
27666678|NCT02330562|80619533|FG006|Overall Study|Participant decision|0|||
27666679|NCT02330562|80619534|FG007|Overall Study|Participant decision|0|||
27666680|NCT02330562|80619535|FG008|Overall Study|Participant decision|0|||
27666681|NCT02330562|80619536|FG009|Overall Study|Participant decision|3|||
27666682|NCT02330562|80619537|FG010|Overall Study|Participant decision|0|||
27666683|NCT02330562|80619527|FG000|Overall Study|Disease progression|5|||
27666684|NCT02330562|80619528|FG001|Overall Study|Disease progression|3|||
27666685|NCT02330562|80619529|FG002|Overall Study|Disease progression|20|||
27968438|NCT00734604|81718651|FG002|Overall Study|Lack of Efficacy|1|||
27666686|NCT02330562|80619530|FG003|Overall Study|Disease progression|28|||
27666687|NCT02330562|80619531|FG004|Overall Study|Disease progression|23|||
27666688|NCT02330562|80619532|FG005|Overall Study|Disease progression|7|||
27666689|NCT02330562|80619533|FG006|Overall Study|Disease progression|1|||
27666690|NCT02330562|80619534|FG007|Overall Study|Disease progression|1|||
27666691|NCT02330562|80619535|FG008|Overall Study|Disease progression|1|||
27666692|NCT02330562|80619536|FG009|Overall Study|Disease progression|0|||
27666693|NCT02330562|80619537|FG010|Overall Study|Disease progression|5|||
27666694|NCT02330562|80619527|FG000|Overall Study|Other reasons|0|||
27666695|NCT02330562|80619528|FG001|Overall Study|Other reasons|0|||
27666696|NCT02330562|80619529|FG002|Overall Study|Other reasons|0|||
27666697|NCT02330562|80619530|FG003|Overall Study|Other reasons|1|||
27666698|NCT02330562|80619531|FG004|Overall Study|Other reasons|0|||
27666699|NCT02330562|80619532|FG005|Overall Study|Other reasons|0|||
27666700|NCT02330562|80619533|FG006|Overall Study|Other reasons|0|||
27666701|NCT02330562|80619534|FG007|Overall Study|Other reasons|0|||
27666702|NCT02330562|80619535|FG008|Overall Study|Other reasons|0|||
27666703|NCT02330562|80619536|FG009|Overall Study|Other reasons|0|||
27666704|NCT02330562|80619537|FG010|Overall Study|Other reasons|0|||
27666705|NCT02330562|80619527|FG000|Overall Study|Withdrawal by Subject|0|||
27666706|NCT02330562|80619528|FG001|Overall Study|Withdrawal by Subject|0|||
27666707|NCT02330562|80619529|FG002|Overall Study|Withdrawal by Subject|0|||
27666708|NCT02330562|80619530|FG003|Overall Study|Withdrawal by Subject|0|||
27968439|NCT00734604|81718652|FG003|Overall Study|Lack of Efficacy|0|||
27968440|NCT00734604|81718653|FG004|Overall Study|Lack of Efficacy|0|||
27968441|NCT00734604|81718654|FG005|Overall Study|Lack of Efficacy|0|||
27968442|NCT00962741|81718655|FG000|Overall Study|Failed to return|3|||
27968443|NCT00962741|81718655|FG000|Overall Study|Lost to Follow-up|2|||
27968444|NCT00962741|81718655|FG000|Overall Study|Withdrawal by Subject|1|||
27968445|NCT00962741|81718655|FG000|Overall Study|Lack of Efficacy|1|||
27968446|NCT00962741|81718655|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
27968447|NCT02516098|81718661|FG000|Period 1|Protocol Violation|1|||
27968448|NCT02516098|81718662|FG001|Period 1|Protocol Violation|0|||
27968449|NCT02516098|81718661|FG000|Washout After Period 1|Adverse Event|0|||
27968450|NCT02516098|81718662|FG001|Washout After Period 1|Adverse Event|1|||
27968451|NCT02516098|81718661|FG000|Period 2|Withdrawal by Subject|0|||
27968452|NCT02516098|81718662|FG001|Period 2|Withdrawal by Subject|1|||
27968453|NCT01066104|81718663|FG000|Overall Study|Adverse Event|1|||
27968454|NCT01066104|81718664|FG001|Overall Study|Adverse Event|1|||
27968455|NCT01066104|81718663|FG000|Overall Study|Protocol Violation|1|||
27968456|NCT01066104|81718664|FG001|Overall Study|Protocol Violation|0|||
27968457|NCT00327015|81718667|FG000|Overall Study|Lack of Efficacy|18|||
27968458|NCT00327015|81718668|FG001|Overall Study|Lack of Efficacy|18|||
27968459|NCT00327015|81718669|FG002|Overall Study|Lack of Efficacy|35|||
27968460|NCT00327015|81718670|FG003|Overall Study|Lack of Efficacy|29|||
27968461|NCT00327015|81718667|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
27968462|NCT00327015|81718668|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
27968463|NCT00327015|81718669|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
27968464|NCT00327015|81718670|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
27968465|NCT00327015|81718667|FG000|Overall Study|Lost to Follow-up|22|||
27968466|NCT00327015|81718668|FG001|Overall Study|Lost to Follow-up|23|||
27968467|NCT00327015|81718669|FG002|Overall Study|Lost to Follow-up|29|||
27968468|NCT00327015|81718670|FG003|Overall Study|Lost to Follow-up|22|||
27666709|NCT02330562|80619531|FG004|Overall Study|Withdrawal by Subject|0|||
27666710|NCT02330562|80619532|FG005|Overall Study|Withdrawal by Subject|0|||
27968469|NCT00327015|81718667|FG000|Overall Study|Adverse Event|14|||
27968470|NCT00327015|81718668|FG001|Overall Study|Adverse Event|10|||
27666711|NCT02330562|80619533|FG006|Overall Study|Withdrawal by Subject|0|||
27863481|NCT04895982|81333004|FG005|Overall Study|Refused further study procedures|0|||
27968471|NCT00327015|81718669|FG002|Overall Study|Adverse Event|14|||
27968472|NCT00327015|81718670|FG003|Overall Study|Adverse Event|14|||
27968473|NCT00327015|81718667|FG000|Overall Study|Subject no longer meets study criteria|4|||
27570432|NCT02346240|80275299|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27666712|NCT02330562|80619534|FG007|Overall Study|Withdrawal by Subject|0|||
27666713|NCT02330562|80619535|FG008|Overall Study|Withdrawal by Subject|0|||
27666714|NCT02330562|80619536|FG009|Overall Study|Withdrawal by Subject|1|||
27968474|NCT00327015|81718668|FG001|Overall Study|Subject no longer meets study criteria|2|||
27968475|NCT00327015|81718669|FG002|Overall Study|Subject no longer meets study criteria|8|||
27968476|NCT00327015|81718670|FG003|Overall Study|Subject no longer meets study criteria|7|||
27968477|NCT00327015|81718667|FG000|Overall Study|Poor/Noncompliance|11|||
27968478|NCT00327015|81718668|FG001|Overall Study|Poor/Noncompliance|8|||
27968479|NCT00327015|81718669|FG002|Overall Study|Poor/Noncompliance|4|||
27968480|NCT00327015|81718670|FG003|Overall Study|Poor/Noncompliance|5|||
27968481|NCT00327015|81718667|FG000|Overall Study|Physician Decision|0|||
27968482|NCT00327015|81718668|FG001|Overall Study|Physician Decision|1|||
27968483|NCT00327015|81718669|FG002|Overall Study|Physician Decision|3|||
27968484|NCT00327015|81718670|FG003|Overall Study|Physician Decision|2|||
27968485|NCT00327015|81718667|FG000|Overall Study|Death|1|||
27968486|NCT00327015|81718668|FG001|Overall Study|Death|2|||
27968487|NCT00327015|81718669|FG002|Overall Study|Death|2|||
27968488|NCT00327015|81718670|FG003|Overall Study|Death|3|||
27968489|NCT00327015|81718667|FG000|Overall Study|Pregnancy|0|||
27968490|NCT00327015|81718668|FG001|Overall Study|Pregnancy|2|||
27968491|NCT00327015|81718669|FG002|Overall Study|Pregnancy|1|||
27968492|NCT00327015|81718670|FG003|Overall Study|Pregnancy|1|||
27968493|NCT00327015|81718667|FG000|Overall Study|Administrative Reason by Sponsor|1|||
27968494|NCT00327015|81718668|FG001|Overall Study|Administrative Reason by Sponsor|2|||
27968495|NCT00327015|81718669|FG002|Overall Study|Administrative Reason by Sponsor|2|||
27968496|NCT00327015|81718670|FG003|Overall Study|Administrative Reason by Sponsor|1|||
27968497|NCT02305849|81718671|FG000|Overall Study|Adverse Event|10|||
27968498|NCT02305849|81718672|FG001|Overall Study|Adverse Event|12|||
27968499|NCT02305849|81718673|FG002|Overall Study|Adverse Event|7|||
27968500|NCT02305849|81718674|FG003|Overall Study|Adverse Event|3|||
27968501|NCT02305849|81718671|FG000|Overall Study|Lack of Efficacy|10|||
27968502|NCT02305849|81718672|FG001|Overall Study|Lack of Efficacy|6|||
27968503|NCT02305849|81718673|FG002|Overall Study|Lack of Efficacy|3|||
27968504|NCT02305849|81718674|FG003|Overall Study|Lack of Efficacy|9|||
27968505|NCT02305849|81718671|FG000|Overall Study|Withdrawal by Subject|2|||
27968506|NCT02305849|81718672|FG001|Overall Study|Withdrawal by Subject|2|||
27968507|NCT02305849|81718673|FG002|Overall Study|Withdrawal by Subject|1|||
27968508|NCT02305849|81718674|FG003|Overall Study|Withdrawal by Subject|4|||
27968509|NCT02305849|81718671|FG000|Overall Study|Lost to Follow-up|0|||
27968510|NCT02305849|81718672|FG001|Overall Study|Lost to Follow-up|2|||
27968511|NCT02305849|81718673|FG002|Overall Study|Lost to Follow-up|0|||
27968512|NCT02305849|81718674|FG003|Overall Study|Lost to Follow-up|0|||
27968513|NCT02305849|81718671|FG000|Overall Study|Protocol Violation|3|||
27968514|NCT02305849|81718672|FG001|Overall Study|Protocol Violation|2|||
27968515|NCT02305849|81718673|FG002|Overall Study|Protocol Violation|1|||
27968516|NCT02305849|81718674|FG003|Overall Study|Protocol Violation|1|||
27968517|NCT02305849|81718671|FG000|Overall Study|Lab data met discontinuation criteria|0|||
27779731|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
27779732|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27779733|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27779734|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27779735|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
27779736|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27779737|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27779738|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27968518|NCT02305849|81718672|FG001|Overall Study|Lab data met discontinuation criteria|1|||
27968519|NCT02305849|81718673|FG002|Overall Study|Lab data met discontinuation criteria|2|||
27968520|NCT02305849|81718674|FG003|Overall Study|Lab data met discontinuation criteria|1|||
27968521|NCT02305849|81718671|FG000|Overall Study|Miscellaneous|1|||
27779739|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
27968522|NCT02305849|81718672|FG001|Overall Study|Miscellaneous|2|||
27968523|NCT02305849|81718673|FG002|Overall Study|Miscellaneous|4|||
27832954|NCT02452463|81219411|FG002|Overall Study|Recommended by DSMB|0|||
27968524|NCT02305849|81718674|FG003|Overall Study|Miscellaneous|1|||
27968525|NCT02305849|81718671|FG000|Overall Study|Not fulfill eligibility criteria|1|||
27968526|NCT02305849|81718672|FG001|Overall Study|Not fulfill eligibility criteria|1|||
27968527|NCT02305849|81718673|FG002|Overall Study|Not fulfill eligibility criteria|0|||
27968528|NCT02305849|81718674|FG003|Overall Study|Not fulfill eligibility criteria|0|||
27968529|NCT00245050|81718676|FG000|Overall Study|Adverse Event|3|||
27968530|NCT00245050|81718677|FG001|Overall Study|Adverse Event|2|||
27968531|NCT03403361|81718680|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
27968532|NCT02839720|81718681|FG000|Overall Study|Adverse Event|2|||
27968533|NCT02839720|81718681|FG000|Overall Study|Non-compliance|2|||
27968534|NCT02839720|81718681|FG000|Overall Study|Intercurrent Illness|1|||
27666715|NCT02330562|80619537|FG010|Overall Study|Withdrawal by Subject|0|||
27968535|NCT02839720|81718681|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
27968536|NCT00487942|81718684|FG000|Overall Study|Adverse Event|1|||
27968537|NCT00487942|81718685|FG001|Overall Study|Adverse Event|1|||
27968538|NCT00487942|81718686|FG002|Overall Study|Adverse Event|1|||
27968539|NCT00487942|81718687|FG003|Overall Study|Adverse Event|1|||
27968540|NCT00487942|81718684|FG000|Overall Study|Lost to Follow-up|1|||
27968541|NCT00487942|81718685|FG001|Overall Study|Lost to Follow-up|0|||
27968542|NCT00487942|81718686|FG002|Overall Study|Lost to Follow-up|0|||
27968543|NCT00487942|81718687|FG003|Overall Study|Lost to Follow-up|1|||
27968544|NCT00487942|81718684|FG000|Overall Study|Protocol Violation|1|||
27968545|NCT00487942|81718685|FG001|Overall Study|Protocol Violation|1|||
27968546|NCT00487942|81718686|FG002|Overall Study|Protocol Violation|0|||
27968547|NCT00487942|81718687|FG003|Overall Study|Protocol Violation|0|||
27968548|NCT00487942|81718684|FG000|Overall Study|Withdrawal by Subject|0|||
27968549|NCT00487942|81718685|FG001|Overall Study|Withdrawal by Subject|1|||
27968550|NCT00487942|81718686|FG002|Overall Study|Withdrawal by Subject|2|||
27968551|NCT00487942|81718687|FG003|Overall Study|Withdrawal by Subject|0|||
27968552|NCT03635424|81718688|FG000|Overall Study|Adverse Event|1|||
27968553|NCT03635424|81718688|FG000|Overall Study|Death|1|||
27968554|NCT03635424|81718688|FG000|Overall Study|Device not implanted|1|||
27968555|NCT00433966|81718689|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
27968556|NCT00433966|81718690|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
27968557|NCT00433966|81718691|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
27968558|NCT00433966|81718692|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
27968559|NCT00433966|81718689|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
27968560|NCT00433966|81718690|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
27968561|NCT00433966|81718691|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
27968562|NCT00433966|81718692|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
27968563|NCT00433966|81718689|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
27968564|NCT00433966|81718690|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
27968565|NCT00433966|81718691|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
27968566|NCT00433966|81718692|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
27968567|NCT00433966|81718689|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
27968568|NCT00433966|81718690|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
27968569|NCT00433966|81718691|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
27968570|NCT00433966|81718692|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
27968571|NCT00433966|81718689|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
27968572|NCT00433966|81718690|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
27968573|NCT00433966|81718691|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
27968574|NCT00433966|81718692|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
27968575|NCT00054327|81718693|FG000|Overall Study|Engraftment failure|1|||
27968576|NCT00054327|81718694|FG001|Overall Study|Engraftment failure|0|||
27968577|NCT00054327|81718695|FG002|Overall Study|Engraftment failure|0|||
27968578|NCT00054327|81718696|FG003|Overall Study|Engraftment failure|0|||
27968579|NCT00054327|81718697|FG004|Overall Study|Engraftment failure|0|||
27968580|NCT00054327|81718698|FG005|Overall Study|Engraftment failure|0|||
27666716|NCT00719212|80619538|FG000|Overall Study|Death|41|||
27666717|NCT00719212|80619538|FG000|Overall Study|Lost to Follow-up|2|||
27666718|NCT00719212|80619538|FG000|Overall Study|Withdrawal by Subject|1|||
27666719|NCT02101983|80619539|FG000|Overall Study|Physician Decision|1|||
27666720|NCT02101983|80619540|FG001|Overall Study|Physician Decision|0|||
27968581|NCT00306293|81718699|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
27968582|NCT00306293|81718700|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
27968583|NCT00306293|81718699|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
27968584|NCT00306293|81718700|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
27968585|NCT00306293|81718699|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
27968586|NCT00306293|81718700|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
27666721|NCT00634920|80619541|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
27666722|NCT00634920|80619542|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
27968587|NCT00306293|81718699|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
27666723|NCT00634920|80619543|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
27666724|NCT00634920|80619541|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
27968588|NCT00306293|81718700|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
27968589|NCT00306293|81718699|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
27968590|NCT00306293|81718700|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
27968591|NCT00306293|81718699|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
27968592|NCT00306293|81718700|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
27968593|NCT00306293|81718699|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
27968594|NCT00306293|81718700|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
27968595|NCT00306293|81718699|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
27968596|NCT00306293|81718700|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
27968597|NCT03654404|81718701|FG000|Overall Study|Death|1|||
27968598|NCT03654404|81718701|FG000|Overall Study|Lost to Follow-up|2|||
27968599|NCT03654404|81718701|FG000|Overall Study|Withdrawal by Subject|5|||
27968600|NCT01667224|81718702|FG000|Overall Study|Withdrawal by Subject|3|||
27968601|NCT01667224|81718703|FG001|Overall Study|Withdrawal by Subject|1|||
27968602|NCT01667224|81718702|FG000|Overall Study|Protocol Violation|1|||
27968603|NCT01667224|81718703|FG001|Overall Study|Protocol Violation|1|||
27968604|NCT01005316|81718708|FG000|Overall Study|Adverse Event|0|||
27968605|NCT01005316|81718709|FG001|Overall Study|Adverse Event|0|||
27968606|NCT01005316|81718710|FG002|Overall Study|Adverse Event|0|||
27968607|NCT01005316|81718711|FG003|Overall Study|Adverse Event|1|||
27968608|NCT01005316|81718708|FG000|Overall Study|Death|20|||
27779740|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
27779741|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
27779742|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
27779743|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
27779744|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
27779745|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
27779746|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
27779747|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
27779748|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
27779749|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
27779750|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
27779751|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
27779752|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
27779753|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
27779754|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
27779755|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
27968609|NCT01005316|81718709|FG001|Overall Study|Death|5|||
27968610|NCT01005316|81718710|FG002|Overall Study|Death|1|||
27968611|NCT01005316|81718711|FG003|Overall Study|Death|15|||
27968612|NCT01005316|81718708|FG000|Overall Study|Study Termination|5|||
27968613|NCT01005316|81718709|FG001|Overall Study|Study Termination|63|||
27968614|NCT01005316|81718710|FG002|Overall Study|Study Termination|9|||
27968615|NCT01005316|81718711|FG003|Overall Study|Study Termination|85|||
27968616|NCT01005316|81718708|FG000|Overall Study|Lost to Follow-up|1|||
27968617|NCT01005316|81718709|FG001|Overall Study|Lost to Follow-up|3|||
27968618|NCT01005316|81718710|FG002|Overall Study|Lost to Follow-up|0|||
27968619|NCT01005316|81718711|FG003|Overall Study|Lost to Follow-up|2|||
27968620|NCT01005316|81718708|FG000|Overall Study|Physician Decision|6|||
27968621|NCT01005316|81718709|FG001|Overall Study|Physician Decision|0|||
27968622|NCT01005316|81718710|FG002|Overall Study|Physician Decision|0|||
27968623|NCT01005316|81718711|FG003|Overall Study|Physician Decision|0|||
27968624|NCT01005316|81718708|FG000|Overall Study|Sponsor Decision|6|||
27968625|NCT01005316|81718709|FG001|Overall Study|Sponsor Decision|3|||
27968626|NCT01005316|81718710|FG002|Overall Study|Sponsor Decision|0|||
27666725|NCT00634920|80619542|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
27666726|NCT00634920|80619543|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
27666727|NCT00634920|80619541|FG000|Period 1 - Pre-Randomization|Rejections|0|||
27666728|NCT00634920|80619542|FG001|Period 1 - Pre-Randomization|Rejections|0|||
27666729|NCT00634920|80619543|FG002|Period 1 - Pre-Randomization|Rejections|55|||
27666730|NCT00634920|80619541|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
27968627|NCT01005316|81718711|FG003|Overall Study|Sponsor Decision|0|||
27968628|NCT01005316|81718708|FG000|Overall Study|Withdrawal by Subject|1|||
27968629|NCT01005316|81718709|FG001|Overall Study|Withdrawal by Subject|1|||
27968630|NCT01005316|81718710|FG002|Overall Study|Withdrawal by Subject|0|||
27968631|NCT01005316|81718711|FG003|Overall Study|Withdrawal by Subject|2|||
27968632|NCT01005316|81718708|FG000|Overall Study|Consented to Another Study|2|||
27968633|NCT01005316|81718709|FG001|Overall Study|Consented to Another Study|0|||
27968634|NCT01005316|81718710|FG002|Overall Study|Consented to Another Study|0|||
27968635|NCT01005316|81718711|FG003|Overall Study|Consented to Another Study|0|||
27968636|NCT01005316|81718708|FG000|Overall Study|Delisted|8|||
27968637|NCT01005316|81718709|FG001|Overall Study|Delisted|0|||
27968638|NCT01005316|81718710|FG002|Overall Study|Delisted|0|||
27666731|NCT00634920|80619542|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
27779756|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
27779757|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
27779758|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
27779759|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
27779760|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
27779761|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
27779762|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
27779763|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
27779764|NCT02442765|81021353|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
27779765|NCT02442765|81021354|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
27779766|NCT02442765|81021355|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
27779767|NCT02442765|81021356|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
27779768|NCT02442765|81021357|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
27779769|NCT02442765|81021358|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
27779770|NCT02442765|81021359|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
27779771|NCT02442765|81021360|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
27779772|NCT03322540|81021361|FG000|Overall Study|Death|21|||
27779773|NCT03322540|81021362|FG001|Overall Study|Death|28|||
27779774|NCT03322540|81021361|FG000|Overall Study|Lost to Follow-up|0|||
27968639|NCT01005316|81718711|FG003|Overall Study|Delisted|0|||
27968640|NCT01005316|81718708|FG000|Overall Study|Transferred Care|1|||
27968641|NCT01005316|81718709|FG001|Overall Study|Transferred Care|0|||
27968642|NCT01005316|81718710|FG002|Overall Study|Transferred Care|1|||
27968643|NCT01005316|81718711|FG003|Overall Study|Transferred Care|3|||
27968644|NCT01005316|81718708|FG000|Overall Study|Retransplanted|0|||
27968645|NCT01005316|81718709|FG001|Overall Study|Retransplanted|1|||
27968646|NCT01005316|81718710|FG002|Overall Study|Retransplanted|0|||
27968647|NCT01005316|81718711|FG003|Overall Study|Retransplanted|0|||
27968648|NCT00290771|81718716|FG000|Overall Study|Disease progression|95|||
27968649|NCT00290771|81718717|FG001|Overall Study|Disease progression|73|||
27666732|NCT00634920|80619543|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
27666733|NCT00634920|80619541|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
27666734|NCT00634920|80619542|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
27666735|NCT00634920|80619543|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
27666736|NCT00634920|80619541|FG000|Period 1 - Pre-Randomization|Other issues|0|||
27666737|NCT00634920|80619542|FG001|Period 1 - Pre-Randomization|Other issues|0|||
27666738|NCT00634920|80619543|FG002|Period 1 - Pre-Randomization|Other issues|6|||
27666739|NCT00634920|80619541|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
27666740|NCT00634920|80619542|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
27666741|NCT00634920|80619543|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
27666742|NCT00634920|80619541|FG000|Period 2 - Post-Randomization|Rejection|11|||
27666743|NCT00634920|80619542|FG001|Period 2 - Post-Randomization|Rejection|5|||
27666744|NCT00634920|80619543|FG002|Period 2 - Post-Randomization|Rejection|0|||
27666745|NCT00634920|80619541|FG000|Period 2 - Post-Randomization|Death|2|||
27666746|NCT00634920|80619542|FG001|Period 2 - Post-Randomization|Death|5|||
27666747|NCT00634920|80619543|FG002|Period 2 - Post-Randomization|Death|0|||
27666748|NCT00634920|80619541|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
27666749|NCT00634920|80619542|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
27666750|NCT00634920|80619543|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
27666751|NCT00634920|80619541|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
27666752|NCT00634920|80619542|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
27666753|NCT00634920|80619543|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
27666754|NCT02138253|80619549|FG000|Overall Study|Adverse Event|3|||
27666755|NCT02138253|80619550|FG001|Overall Study|Adverse Event|3|||
27666756|NCT02138253|80619549|FG000|Overall Study|Lost to Follow-up|2|||
27666757|NCT02138253|80619550|FG001|Overall Study|Lost to Follow-up|1|||
27666758|NCT02138253|80619549|FG000|Overall Study|Physician Decision|2|||
27666759|NCT02138253|80619550|FG001|Overall Study|Physician Decision|0|||
27666760|NCT02138253|80619549|FG000|Overall Study|Non compliance|1|||
27666761|NCT02138253|80619550|FG001|Overall Study|Non compliance|0|||
27666762|NCT02138253|80619549|FG000|Overall Study|Withdrawal by Subject|1|||
27666763|NCT02138253|80619550|FG001|Overall Study|Withdrawal by Subject|0|||
27666764|NCT03245619|80619551|FG000|Part A (Up to Day 22)|Physician Decision|4|||
27666765|NCT03245619|80619552|FG001|Part A (Up to Day 22)|Physician Decision|6|||
27968650|NCT00290771|81718716|FG000|Overall Study|Death|11|||
27863482|NCT04895982|81333005|FG006|Overall Study|Refused further study procedures|0|||
27968651|NCT00290771|81718717|FG001|Overall Study|Death|10|||
27968652|NCT00290771|81718716|FG000|Overall Study|Adverse Event|12|||
27666766|NCT03245619|80619553|FG002|Part A (Up to Day 22)|Physician Decision|6|||
27666767|NCT03245619|80619554|FG003|Part A (Up to Day 22)|Physician Decision|0|||
27666768|NCT03245619|80619555|FG004|Part A (Up to Day 22)|Physician Decision|0|||
27779775|NCT03322540|81021362|FG001|Overall Study|Lost to Follow-up|1|||
27779776|NCT03322540|81021361|FG000|Overall Study|Physician Decision|7|||
27968653|NCT00290771|81718717|FG001|Overall Study|Adverse Event|6|||
27968654|NCT00290771|81718716|FG000|Overall Study|Withdrawal by Subject|5|||
27968655|NCT00290771|81718717|FG001|Overall Study|Withdrawal by Subject|6|||
27968656|NCT00290771|81718716|FG000|Overall Study|Administrative problems|2|||
27968657|NCT00290771|81718717|FG001|Overall Study|Administrative problems|1|||
27968658|NCT00290771|81718716|FG000|Overall Study|Protocol Violation|2|||
27968659|NCT00290771|81718717|FG001|Overall Study|Protocol Violation|0|||
27968660|NCT00290771|81718716|FG000|Overall Study|Lost to Follow-up|0|||
27968661|NCT00290771|81718717|FG001|Overall Study|Lost to Follow-up|1|||
27968662|NCT01885208|81718718|FG000|Overall Study|Unclassified|32|||
27968663|NCT01885208|81718719|FG001|Overall Study|Unclassified|38|||
27968664|NCT00882583|81718722|FG000|Overall Study|Physician Decision|1|||
27968665|NCT00882583|81718723|FG001|Overall Study|Physician Decision|0|||
27968666|NCT00882583|81718722|FG000|Overall Study|Adverse Event|0|||
27968667|NCT00882583|81718723|FG001|Overall Study|Adverse Event|1|||
27968668|NCT02141633|81718724|FG000|Overall Study|Physician Decision|1|||
27968669|NCT02141633|81718725|FG001|Overall Study|Physician Decision|0|||
27968670|NCT00730041|81718726|FG000|Overall Study|Lost to Follow-up|0|||
27968671|NCT00730041|81718727|FG001|Overall Study|Lost to Follow-up|2|||
27968672|NCT01406938|81718728|FG000|Induction Period|Subject/guardian decision|6|||
27968673|NCT01406938|81718729|FG001|Induction Period|Subject/guardian decision|8|||
27968674|NCT01406938|81718730|FG002|Induction Period|Subject/guardian decision|0|||
27968675|NCT01406938|81718731|FG003|Induction Period|Subject/guardian decision|0|||
27968676|NCT01406938|81718732|FG004|Induction Period|Subject/guardian decision|0|||
27968677|NCT01406938|81718733|FG005|Induction Period|Subject/guardian decision|0|||
27968678|NCT01406938|81718728|FG000|Induction Period|Protocol deviation|1|||
27968679|NCT01406938|81718729|FG001|Induction Period|Protocol deviation|0|||
27968680|NCT01406938|81718730|FG002|Induction Period|Protocol deviation|0|||
27968681|NCT01406938|81718731|FG003|Induction Period|Protocol deviation|0|||
27968682|NCT01406938|81718732|FG004|Induction Period|Protocol deviation|0|||
27968683|NCT01406938|81718733|FG005|Induction Period|Protocol deviation|0|||
27968684|NCT01406938|81718728|FG000|Induction Period|Adverse Event|8|||
27968685|NCT01406938|81718729|FG001|Induction Period|Adverse Event|9|||
27968686|NCT01406938|81718730|FG002|Induction Period|Adverse Event|0|||
27968687|NCT01406938|81718731|FG003|Induction Period|Adverse Event|0|||
27968688|NCT01406938|81718732|FG004|Induction Period|Adverse Event|0|||
27968689|NCT01406938|81718733|FG005|Induction Period|Adverse Event|0|||
27968690|NCT01406938|81718728|FG000|Induction Period|Lack of Efficacy|1|||
27968691|NCT01406938|81718729|FG001|Induction Period|Lack of Efficacy|0|||
27968692|NCT01406938|81718730|FG002|Induction Period|Lack of Efficacy|0|||
27968693|NCT01406938|81718731|FG003|Induction Period|Lack of Efficacy|0|||
27968694|NCT01406938|81718732|FG004|Induction Period|Lack of Efficacy|0|||
27968695|NCT01406938|81718733|FG005|Induction Period|Lack of Efficacy|0|||
27968696|NCT01406938|81718728|FG000|Induction Period|Lost to Follow-up|2|||
27968697|NCT01406938|81718729|FG001|Induction Period|Lost to Follow-up|3|||
27968698|NCT01406938|81718730|FG002|Induction Period|Lost to Follow-up|0|||
27968699|NCT01406938|81718731|FG003|Induction Period|Lost to Follow-up|0|||
27968700|NCT01406938|81718732|FG004|Induction Period|Lost to Follow-up|0|||
27968701|NCT01406938|81718733|FG005|Induction Period|Lost to Follow-up|0|||
27968702|NCT01406938|81718728|FG000|Maintenance Period|Adverse Event|0|||
27968703|NCT01406938|81718729|FG001|Maintenance Period|Adverse Event|0|||
27968704|NCT01406938|81718730|FG002|Maintenance Period|Adverse Event|2|||
27968705|NCT01406938|81718731|FG003|Maintenance Period|Adverse Event|8|||
27968706|NCT01406938|81718732|FG004|Maintenance Period|Adverse Event|4|||
27968707|NCT01406938|81718733|FG005|Maintenance Period|Adverse Event|2|||
27968708|NCT01406938|81718728|FG000|Maintenance Period|Death|0|||
27968709|NCT01406938|81718729|FG001|Maintenance Period|Death|0|||
27968710|NCT01406938|81718730|FG002|Maintenance Period|Death|0|||
27968711|NCT01406938|81718731|FG003|Maintenance Period|Death|0|||
27968712|NCT01406938|81718732|FG004|Maintenance Period|Death|1|||
27968713|NCT01406938|81718733|FG005|Maintenance Period|Death|0|||
27968714|NCT01406938|81718728|FG000|Maintenance Period|Subject/guardian decision|0|||
27968715|NCT01406938|81718729|FG001|Maintenance Period|Subject/guardian decision|0|||
27666769|NCT03245619|80619556|FG005|Part A (Up to Day 22)|Physician Decision|0|||
27968716|NCT01406938|81718730|FG002|Maintenance Period|Subject/guardian decision|11|||
27968717|NCT01406938|81718731|FG003|Maintenance Period|Subject/guardian decision|7|||
27968718|NCT01406938|81718732|FG004|Maintenance Period|Subject/guardian decision|10|||
27968719|NCT01406938|81718733|FG005|Maintenance Period|Subject/guardian decision|7|||
27968720|NCT01406938|81718728|FG000|Maintenance Period|Protocol Violation|0|||
27968721|NCT01406938|81718729|FG001|Maintenance Period|Protocol Violation|0|||
27666770|NCT03245619|80619557|FG006|Part A (Up to Day 22)|Physician Decision|0|||
27968722|NCT01406938|81718730|FG002|Maintenance Period|Protocol Violation|2|||
27968723|NCT01406938|81718731|FG003|Maintenance Period|Protocol Violation|2|||
27968724|NCT01406938|81718732|FG004|Maintenance Period|Protocol Violation|2|||
27968725|NCT01406938|81718733|FG005|Maintenance Period|Protocol Violation|2|||
27968726|NCT01406938|81718728|FG000|Maintenance Period|Pregnancy|0|||
27968727|NCT01406938|81718729|FG001|Maintenance Period|Pregnancy|0|||
27968728|NCT01406938|81718730|FG002|Maintenance Period|Pregnancy|0|||
27968729|NCT01406938|81718731|FG003|Maintenance Period|Pregnancy|0|||
27968730|NCT01406938|81718732|FG004|Maintenance Period|Pregnancy|1|||
27968731|NCT01406938|81718733|FG005|Maintenance Period|Pregnancy|0|||
27968732|NCT01406938|81718728|FG000|Maintenance Period|Lost to Follow-up|0|||
27968733|NCT01406938|81718729|FG001|Maintenance Period|Lost to Follow-up|0|||
27968734|NCT01406938|81718730|FG002|Maintenance Period|Lost to Follow-up|0|||
27968735|NCT01406938|81718731|FG003|Maintenance Period|Lost to Follow-up|0|||
27968736|NCT01406938|81718732|FG004|Maintenance Period|Lost to Follow-up|4|||
27968737|NCT01406938|81718733|FG005|Maintenance Period|Lost to Follow-up|0|||
27968738|NCT01406938|81718728|FG000|Maintenance Period|Lack of Efficacy|0|||
27968739|NCT01406938|81718729|FG001|Maintenance Period|Lack of Efficacy|0|||
27968740|NCT01406938|81718730|FG002|Maintenance Period|Lack of Efficacy|2|||
27968741|NCT01406938|81718731|FG003|Maintenance Period|Lack of Efficacy|1|||
27968742|NCT01406938|81718732|FG004|Maintenance Period|Lack of Efficacy|3|||
27968743|NCT01406938|81718733|FG005|Maintenance Period|Lack of Efficacy|5|||
27968744|NCT01406938|81718728|FG000|Follow up|Lack of Efficacy|3|||
27968745|NCT01406938|81718729|FG001|Follow up|Lack of Efficacy|2|||
27968746|NCT01406938|81718730|FG002|Follow up|Lack of Efficacy|1|||
27968747|NCT01406938|81718731|FG003|Follow up|Lack of Efficacy|0|||
27968748|NCT01406938|81718732|FG004|Follow up|Lack of Efficacy|0|||
27968749|NCT01406938|81718733|FG005|Follow up|Lack of Efficacy|0|||
27968750|NCT01406938|81718728|FG000|Follow up|Patient/guardian decision|4|||
27968751|NCT01406938|81718729|FG001|Follow up|Patient/guardian decision|2|||
27968752|NCT01406938|81718730|FG002|Follow up|Patient/guardian decision|4|||
27968753|NCT01406938|81718731|FG003|Follow up|Patient/guardian decision|2|||
27968754|NCT01406938|81718732|FG004|Follow up|Patient/guardian decision|4|||
27968755|NCT01406938|81718733|FG005|Follow up|Patient/guardian decision|1|||
27968756|NCT01406938|81718728|FG000|Follow up|Protocol Violation|0|||
27968757|NCT01406938|81718729|FG001|Follow up|Protocol Violation|0|||
27968758|NCT01406938|81718730|FG002|Follow up|Protocol Violation|1|||
27968759|NCT01406938|81718731|FG003|Follow up|Protocol Violation|0|||
27968760|NCT01406938|81718732|FG004|Follow up|Protocol Violation|0|||
27968761|NCT01406938|81718733|FG005|Follow up|Protocol Violation|0|||
27968762|NCT01406938|81718728|FG000|Follow up|Physician Decision|0|||
27968763|NCT01406938|81718729|FG001|Follow up|Physician Decision|0|||
27968764|NCT01406938|81718730|FG002|Follow up|Physician Decision|2|||
27968765|NCT01406938|81718731|FG003|Follow up|Physician Decision|0|||
27968766|NCT01406938|81718732|FG004|Follow up|Physician Decision|3|||
27968767|NCT01406938|81718733|FG005|Follow up|Physician Decision|1|||
27968768|NCT01406938|81718728|FG000|Follow up|Lost to Follow-up|1|||
27968769|NCT01406938|81718729|FG001|Follow up|Lost to Follow-up|1|||
27968770|NCT01406938|81718730|FG002|Follow up|Lost to Follow-up|0|||
27968771|NCT01406938|81718731|FG003|Follow up|Lost to Follow-up|1|||
27968772|NCT01406938|81718732|FG004|Follow up|Lost to Follow-up|2|||
27968773|NCT01406938|81718733|FG005|Follow up|Lost to Follow-up|1|||
27968774|NCT00413894|81718736|FG000|Overall Study|Withdrawal by Subject|10|||
27968775|NCT00413894|81718736|FG000|Overall Study|Administrative Reasons|1|||
27968776|NCT00413894|81718736|FG000|Overall Study|Hb <10 grams/deciliter|12|||
27968777|NCT00413894|81718736|FG000|Overall Study|Adverse Event|28|||
27968778|NCT00413894|81718736|FG000|Overall Study|Protocol Violation|11|||
27968779|NCT00413894|81718736|FG000|Overall Study|Other|18|||
27968780|NCT03315793|81718738|FG000|Overall Study|Adverse Event|4|||
27968781|NCT03315793|81718739|FG001|Overall Study|Adverse Event|2|||
27968782|NCT03315793|81718738|FG000|Overall Study|Protocol Deviation|1|||
27968783|NCT03315793|81718739|FG001|Overall Study|Protocol Deviation|0|||
27968784|NCT03315793|81718738|FG000|Overall Study|Difficult for regular visit|0|||
27968785|NCT03315793|81718739|FG001|Overall Study|Difficult for regular visit|1|||
27968786|NCT00873041|81718741|FG000|Core Study|Adverse Event|2|||
27968787|NCT00873041|81718742|FG001|Core Study|Adverse Event|3|||
27968788|NCT00873041|81718743|FG002|Core Study|Adverse Event|1|||
27968789|NCT00873041|81718741|FG000|Core Study|Withdrawal by Subject|1|||
27968790|NCT00873041|81718742|FG001|Core Study|Withdrawal by Subject|2|||
27968791|NCT00873041|81718743|FG002|Core Study|Withdrawal by Subject|2|||
27968792|NCT00873041|81718741|FG000|Core Study|Lost to Follow-up|3|||
27968793|NCT00873041|81718742|FG001|Core Study|Lost to Follow-up|1|||
27968794|NCT00873041|81718743|FG002|Core Study|Lost to Follow-up|0|||
27968795|NCT00873041|81718741|FG000|Core Study|Abnormal laboratory value|0|||
27968796|NCT00873041|81718742|FG001|Core Study|Abnormal laboratory value|0|||
27968797|NCT00873041|81718743|FG002|Core Study|Abnormal laboratory value|1|||
27968798|NCT00873041|81718741|FG000|Core Study|Protocol deviation|1|||
27968799|NCT00873041|81718742|FG001|Core Study|Protocol deviation|0|||
27968800|NCT00873041|81718743|FG002|Core Study|Protocol deviation|1|||
27968801|NCT00873041|81718741|FG000|Extension Study|Adverse Event|1|||
27968802|NCT00873041|81718742|FG001|Extension Study|Adverse Event|0|||
27968803|NCT00873041|81718743|FG002|Extension Study|Adverse Event|1|||
27968804|NCT00873041|81718741|FG000|Extension Study|Administrative reasons|0|||
27968805|NCT00873041|81718742|FG001|Extension Study|Administrative reasons|0|||
27968806|NCT00873041|81718743|FG002|Extension Study|Administrative reasons|1|||
27968807|NCT00733291|81718744|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
27968808|NCT00733291|81718745|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
27968809|NCT00733291|81718746|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
27968810|NCT00733291|81718747|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
27968811|NCT01257568|81718748|FG000|Overall Study|Lost to Follow-up|2|||
27968812|NCT01257568|81718748|FG000|Overall Study|Withdrawal by Subject|6|||
27968813|NCT01257568|81718748|FG000|Overall Study|Terminated|1|||
27968814|NCT01257568|81718748|FG000|Overall Study|Component Revision|24|||
27968815|NCT00503776|81718749|FG000|Overall Study|Withdrawal by Subject|1|||
27968816|NCT00503776|81718750|FG001|Overall Study|Withdrawal by Subject|0|||
27968817|NCT00503776|81718751|FG002|Overall Study|Withdrawal by Subject|1|||
27968818|NCT00503776|81718752|FG003|Overall Study|Withdrawal by Subject|1|||
27968819|NCT00503776|81718749|FG000|Overall Study|Physician Decision|0|||
27968820|NCT00503776|81718750|FG001|Overall Study|Physician Decision|0|||
27968821|NCT00503776|81718751|FG002|Overall Study|Physician Decision|1|||
27968822|NCT00503776|81718752|FG003|Overall Study|Physician Decision|1|||
27968823|NCT01190475|81718753|FG000|Overall Study|Withdrawal by Subject|0|||
27968824|NCT01190475|81718754|FG001|Overall Study|Withdrawal by Subject|0|||
27968825|NCT01190475|81718755|FG002|Overall Study|Withdrawal by Subject|1|||
27968826|NCT01126437|81718756|FG000|Overall Study|Not treated|11|||
27968827|NCT01126437|81718757|FG001|Overall Study|Not treated|18|||
27968828|NCT01126437|81718758|FG002|Overall Study|Not treated|19|||
27968829|NCT01126437|81718756|FG000|Overall Study|Sites with data irregularities/fraud|6|||
27968830|NCT01126437|81718757|FG001|Overall Study|Sites with data irregularities/fraud|6|||
27968831|NCT01126437|81718758|FG002|Overall Study|Sites with data irregularities/fraud|7|||
27968832|NCT01126437|81718756|FG000|Overall Study|Adverse Event|602|||
27968833|NCT01126437|81718757|FG001|Overall Study|Adverse Event|606|||
27968834|NCT01126437|81718758|FG002|Overall Study|Adverse Event|635|||
27968835|NCT01126437|81718756|FG000|Overall Study|Lack of Efficacy|65|||
27968836|NCT01126437|81718757|FG001|Overall Study|Lack of Efficacy|60|||
27968837|NCT01126437|81718758|FG002|Overall Study|Lack of Efficacy|59|||
27968838|NCT01126437|81718756|FG000|Overall Study|Protocol Violation|64|||
27968839|NCT01126437|81718757|FG001|Overall Study|Protocol Violation|66|||
27968840|NCT01126437|81718758|FG002|Overall Study|Protocol Violation|41|||
27968841|NCT01126437|81718756|FG000|Overall Study|Lost to Follow-up|52|||
27968842|NCT01126437|81718757|FG001|Overall Study|Lost to Follow-up|63|||
27968843|NCT01126437|81718758|FG002|Overall Study|Lost to Follow-up|55|||
27968844|NCT01126437|81718756|FG000|Overall Study|Withdrawal by Subject|331|||
27968845|NCT01126437|81718757|FG001|Overall Study|Withdrawal by Subject|335|||
27968846|NCT01126437|81718758|FG002|Overall Study|Withdrawal by Subject|319|||
27968847|NCT01126437|81718756|FG000|Overall Study|Other reason not specified|210|||
27968848|NCT01126437|81718757|FG001|Overall Study|Other reason not specified|176|||
27968849|NCT01126437|81718758|FG002|Overall Study|Other reason not specified|178|||
27968850|NCT04848220|81718759|FG000|Overall Study|Unable to proceed to study procedure|0|||
27968851|NCT04848220|81718760|FG001|Overall Study|Unable to proceed to study procedure|1|||
27968852|NCT04848220|81718761|FG002|Overall Study|Unable to proceed to study procedure|0|||
27968853|NCT04848220|81718759|FG000|Overall Study|Fractional flow not significant|0|||
27779777|NCT03322540|81021362|FG001|Overall Study|Physician Decision|6|||
27779778|NCT03322540|81021361|FG000|Overall Study|Withdrawal by Subject|3|||
27779779|NCT03322540|81021362|FG001|Overall Study|Withdrawal by Subject|1|||
27779780|NCT03322540|81021361|FG000|Overall Study|Study terminated by sponsor|0|||
27779781|NCT03322540|81021362|FG001|Overall Study|Study terminated by sponsor|1|||
27779782|NCT04430036|81021365|FG000|Safety Run in Phase|Progression of disease|2|||
27779783|NCT00252499|81021366|FG000|Overall Study|Lost to Follow-up|1|||
27779784|NCT00252499|81021367|FG001|Overall Study|Lost to Follow-up|0|||
27779785|NCT00252499|81021368|FG002|Overall Study|Lost to Follow-up|0|||
27779786|NCT00887913|81021372|FG000|Overall Study|Withdrawal by Subject|6|||
27779787|NCT01021553|81021373|FG000|Overall Study|Adverse Event|1|||
27968854|NCT04848220|81718760|FG001|Overall Study|Fractional flow not significant|1|||
27779788|NCT01021553|81021374|FG001|Overall Study|Adverse Event|0|||
27779789|NCT01021553|81021375|FG002|Overall Study|Adverse Event|0|||
27779790|NCT01021553|81021373|FG000|Overall Study|Lack of Efficacy|2|||
27779791|NCT01021553|81021374|FG001|Overall Study|Lack of Efficacy|2|||
27968855|NCT04848220|81718761|FG002|Overall Study|Fractional flow not significant|0|||
27968856|NCT00951080|81718763|FG000|Overall Study|Adverse Event|3|||
27968857|NCT00951080|81718764|FG001|Overall Study|Adverse Event|3|||
27968858|NCT00951080|81718763|FG000|Overall Study|Lost to Follow-up|0|||
27968859|NCT00951080|81718764|FG001|Overall Study|Lost to Follow-up|1|||
27968860|NCT00951080|81718763|FG000|Overall Study|Physician Decision|4|||
27968861|NCT00951080|81718764|FG001|Overall Study|Physician Decision|1|||
27968862|NCT00951080|81718763|FG000|Overall Study|Other|19|||
27779792|NCT01021553|81021375|FG002|Overall Study|Lack of Efficacy|0|||
27779793|NCT01021553|81021373|FG000|Overall Study|Protocol Violation|0|||
27779794|NCT01021553|81021374|FG001|Overall Study|Protocol Violation|2|||
27779795|NCT01021553|81021375|FG002|Overall Study|Protocol Violation|2|||
27779796|NCT01021553|81021373|FG000|Overall Study|Lost to Follow-up|0|||
27779797|NCT01021553|81021374|FG001|Overall Study|Lost to Follow-up|0|||
27779798|NCT01021553|81021375|FG002|Overall Study|Lost to Follow-up|1|||
27779799|NCT01021553|81021373|FG000|Overall Study|Withdrawal by Subject|1|||
27779800|NCT01021553|81021374|FG001|Overall Study|Withdrawal by Subject|1|||
27779801|NCT01021553|81021375|FG002|Overall Study|Withdrawal by Subject|0|||
27779802|NCT01997333|81021379|FG000|Randomization and Treatment|Disease Progression|70|||
27779803|NCT01997333|81021380|FG001|Randomization and Treatment|Disease Progression|159|||
27779804|NCT01997333|81021379|FG000|Randomization and Treatment|Adverse Event|10|||
27779805|NCT01997333|81021380|FG001|Randomization and Treatment|Adverse Event|32|||
27779806|NCT01997333|81021379|FG000|Randomization and Treatment|Physician Decision|0|||
27779807|NCT01997333|81021380|FG001|Randomization and Treatment|Physician Decision|4|||
27779808|NCT01997333|81021379|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
27779809|NCT01997333|81021380|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
27779810|NCT01997333|81021379|FG000|Randomization and Treatment|Did not receive treatment|17|||
27779811|NCT01997333|81021380|FG001|Randomization and Treatment|Did not receive treatment|5|||
27779812|NCT01997333|81021379|FG000|Survival Follow up|Withdrawal by Subject|15|||
27779813|NCT01997333|81021380|FG001|Survival Follow up|Withdrawal by Subject|6|||
27779814|NCT01997333|81021379|FG000|Survival Follow up|Lost to Follow-up|0|||
27779815|NCT01997333|81021380|FG001|Survival Follow up|Lost to Follow-up|6|||
27779816|NCT01997333|81021379|FG000|Survival Follow up|Various|1|||
27779817|NCT01997333|81021380|FG001|Survival Follow up|Various|2|||
27779818|NCT03452397|81021381|FG000|Overall Study|Adverse Event|1|||
27779819|NCT03452397|81021382|FG001|Overall Study|Adverse Event|0|||
27779820|NCT03452397|81021383|FG002|Overall Study|Adverse Event|0|||
27968863|NCT00951080|81718764|FG001|Overall Study|Other|22|||
27968864|NCT00347438|81718765|FG000|Overall Study|Withdrawal by Subject|1|||
27968865|NCT00347438|81718765|FG000|Overall Study|Physician Decision|1|||
27968866|NCT00984165|81718770|FG000|Overall Study|Death on study|2|||
27968867|NCT00984165|81718771|FG001|Overall Study|Death on study|0|||
27968868|NCT00984165|81718772|FG002|Overall Study|Death on study|0|||
27968869|NCT00984165|81718773|FG003|Overall Study|Death on study|0|||
27968870|NCT00984165|81718770|FG000|Overall Study|Disease progression on study|5|||
27968871|NCT00984165|81718771|FG001|Overall Study|Disease progression on study|1|||
27968872|NCT00984165|81718772|FG002|Overall Study|Disease progression on study|0|||
27968873|NCT00984165|81718773|FG003|Overall Study|Disease progression on study|0|||
27968874|NCT00984165|81718770|FG000|Overall Study|Death of recipient|0|||
27968875|NCT00984165|81718771|FG001|Overall Study|Death of recipient|0|||
27968876|NCT00984165|81718772|FG002|Overall Study|Death of recipient|0|||
27968877|NCT00984165|81718773|FG003|Overall Study|Death of recipient|1|||
27968878|NCT00984165|81718770|FG000|Overall Study|New protocol|0|||
27968879|NCT00984165|81718771|FG001|Overall Study|New protocol|0|||
27968880|NCT00984165|81718772|FG002|Overall Study|New protocol|0|||
27968881|NCT00984165|81718773|FG003|Overall Study|New protocol|1|||
27968882|NCT00984165|81718770|FG000|Overall Study|P+/donor pair removed from protocol|0|||
27968883|NCT00984165|81718771|FG001|Overall Study|P+/donor pair removed from protocol|0|||
27968884|NCT00984165|81718772|FG002|Overall Study|P+/donor pair removed from protocol|0|||
27968885|NCT00984165|81718773|FG003|Overall Study|P+/donor pair removed from protocol|1|||
27968886|NCT00984165|81718770|FG000|Overall Study|removed with a pair recipient|0|||
27968887|NCT00984165|81718771|FG001|Overall Study|removed with a pair recipient|0|||
27968888|NCT00984165|81718772|FG002|Overall Study|removed with a pair recipient|0|||
27968889|NCT00984165|81718773|FG003|Overall Study|removed with a pair recipient|1|||
27968890|NCT00920218|81718777|FG000|Overall Study|Serious Adverse Event|2|||
27968891|NCT00920218|81718778|FG001|Overall Study|Serious Adverse Event|0|||
27968892|NCT00920218|81718779|FG002|Overall Study|Serious Adverse Event|2|||
27968893|NCT00920218|81718780|FG003|Overall Study|Serious Adverse Event|1|||
27968894|NCT00920218|81718777|FG000|Overall Study|Withdrawal by Subject|0|||
27968895|NCT00920218|81718778|FG001|Overall Study|Withdrawal by Subject|3|||
27968896|NCT00920218|81718779|FG002|Overall Study|Withdrawal by Subject|2|||
27779821|NCT03452397|81021384|FG003|Overall Study|Adverse Event|0|||
27779822|NCT03452397|81021381|FG000|Overall Study|Administrative reason|0|||
27968897|NCT00920218|81718780|FG003|Overall Study|Withdrawal by Subject|0|||
27968898|NCT00920218|81718777|FG000|Overall Study|Migrated/moved from study area|0|||
27968899|NCT00920218|81718778|FG001|Overall Study|Migrated/moved from study area|0|||
27968900|NCT00920218|81718779|FG002|Overall Study|Migrated/moved from study area|1|||
27968901|NCT00920218|81718780|FG003|Overall Study|Migrated/moved from study area|0|||
27968902|NCT00920218|81718777|FG000|Overall Study|Lost to Follow-up|0|||
27968903|NCT00920218|81718778|FG001|Overall Study|Lost to Follow-up|1|||
27779823|NCT03452397|81021382|FG001|Overall Study|Administrative reason|0|||
27779824|NCT03452397|81021383|FG002|Overall Study|Administrative reason|1|||
27779825|NCT03452397|81021384|FG003|Overall Study|Administrative reason|1|||
27968904|NCT00920218|81718779|FG002|Overall Study|Lost to Follow-up|0|||
27968905|NCT00920218|81718780|FG003|Overall Study|Lost to Follow-up|3|||
27968906|NCT00920218|81718777|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
27968907|NCT00920218|81718778|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
27968908|NCT00920218|81718779|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
27968909|NCT00920218|81718780|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
27968910|NCT00920218|81718777|FG000|Overall Study|Other|0|||
27968911|NCT00920218|81718778|FG001|Overall Study|Other|0|||
27968912|NCT00920218|81718779|FG002|Overall Study|Other|1|||
27968913|NCT00920218|81718780|FG003|Overall Study|Other|0|||
27968914|NCT01779856|81718781|FG000|Overall Study|Withdrawal by Subject|15|||
27968915|NCT01779856|81718781|FG000|Overall Study|Death|3|||
27968916|NCT01779856|81718781|FG000|Overall Study|Physician Decision|1|||
27968917|NCT01779856|81718781|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
27968918|NCT01779856|81718781|FG000|Overall Study|Delays in scheduling implant|1|||
27968919|NCT01779856|81718781|FG000|Overall Study|Subject ineligible for Implant|2|||
27968920|NCT01471028|81718782|FG000|VTI-208|Adverse Event|39|||
27968921|NCT01471028|81718783|FG001|VTI-208|Adverse Event|41|||
27968922|NCT01471028|81718782|FG000|VTI-208|Withdrawal by Subject|0|||
27968923|NCT01471028|81718783|FG001|VTI-208|Withdrawal by Subject|2|||
27968924|NCT01471028|81718782|FG000|VTI-208|Lost to Follow-up|1|||
27968925|NCT01471028|81718783|FG001|VTI-208|Lost to Follow-up|1|||
27968926|NCT01471028|81718782|FG000|VTI-208E|Death|7|||
27968927|NCT01471028|81718783|FG001|VTI-208E|Death|10|||
27968928|NCT01471028|81718782|FG000|VTI-208E|Withdrawal by Subject|1|||
27968929|NCT01471028|81718783|FG001|VTI-208E|Withdrawal by Subject|0|||
27968930|NCT01471028|81718782|FG000|VTI-208E|Lost to Follow-up|0|||
27968931|NCT01471028|81718783|FG001|VTI-208E|Lost to Follow-up|2|||
27968932|NCT01200407|81718786|FG000|Overall Study|Lost to Follow-up|56|||
27968933|NCT01200407|81718786|FG000|Overall Study|Adverse Event|3|||
27968934|NCT01200407|81718786|FG000|Overall Study|Withdrawal by Subject|4|||
27968935|NCT01200407|81718786|FG000|Overall Study|Other|19|||
27968936|NCT02524275|81718791|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
27968937|NCT00227344|81718792|FG000|Overall Study|study terminated early|12|||
27968938|NCT00227344|81718793|FG001|Overall Study|study terminated early|5|||
27968939|NCT00960011|81718795|FG000|Overall Study|Death|5|||
27968940|NCT00960011|81718796|FG001|Overall Study|Death|0|||
27968941|NCT00960011|81718795|FG000|Overall Study|Lost to Follow-up|6|||
27968942|NCT00960011|81718796|FG001|Overall Study|Lost to Follow-up|2|||
27968943|NCT03276026|81718797|FG000|Overall Study|Protocol Violation|1|||
27968944|NCT03276026|81718798|FG001|Overall Study|Protocol Violation|0|||
27968945|NCT00473668|81718800|FG000|Overall Study|Withdrawal by Subject|0|||
27968946|NCT00473668|81718801|FG001|Overall Study|Withdrawal by Subject|2|||
27863483|NCT04895982|81333006|FG007|Overall Study|Refused further study procedures|0|||
27863484|NCT04895982|81333007|FG008|Overall Study|Refused further study procedures|0|||
27863485|NCT04895982|81333008|FG009|Overall Study|Refused further study procedures|0|||
27863486|NCT04895982|81333009|FG010|Overall Study|Refused further study procedures|0|||
27863487|NCT04895982|81333010|FG011|Overall Study|Refused further study procedures|0|||
27968947|NCT00473668|81718802|FG002|Overall Study|Withdrawal by Subject|0|||
27968948|NCT00473668|81718800|FG000|Overall Study|Migrated/moved from study area|3|||
27968949|NCT00473668|81718801|FG001|Overall Study|Migrated/moved from study area|2|||
27570433|NCT02346240|80275300|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570434|NCT02346240|80275301|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570435|NCT02346240|80275302|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27863488|NCT01982448|81333017|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
27863489|NCT01982448|81333018|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
27863490|NCT01982448|81333017|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
27863491|NCT01982448|81333018|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
27863492|NCT01982448|81333017|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
27968950|NCT00473668|81718802|FG002|Overall Study|Migrated/moved from study area|0|||
27968951|NCT00473668|81718800|FG000|Overall Study|Lost to Follow-up|0|||
27968952|NCT00473668|81718801|FG001|Overall Study|Lost to Follow-up|4|||
27968953|NCT00473668|81718802|FG002|Overall Study|Lost to Follow-up|6|||
27863493|NCT01982448|81333018|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
27863494|NCT01982448|81333017|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
27863495|NCT01982448|81333018|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
27968954|NCT00473668|81718800|FG000|Overall Study|Other|2|||
27968955|NCT00473668|81718801|FG001|Overall Study|Other|3|||
27968956|NCT00473668|81718802|FG002|Overall Study|Other|4|||
27968957|NCT00185380|81718803|FG000|Overall Study|Adverse Event|41|||
27968958|NCT00185380|81718804|FG001|Overall Study|Adverse Event|43|||
27968959|NCT00185380|81718805|FG002|Overall Study|Adverse Event|48|||
27968960|NCT00185380|81718803|FG000|Overall Study|Lost to Follow-up|0|||
27968961|NCT00185380|81718804|FG001|Overall Study|Lost to Follow-up|4|||
27968962|NCT00185380|81718805|FG002|Overall Study|Lost to Follow-up|3|||
27666771|NCT03245619|80619558|FG007|Part A (Up to Day 22)|Physician Decision|0|||
27666772|NCT03245619|80619559|FG008|Part A (Up to Day 22)|Physician Decision|0|||
27666773|NCT03245619|80619560|FG009|Part A (Up to Day 22)|Physician Decision|0|||
27666774|NCT03245619|80619561|FG010|Part A (Up to Day 22)|Physician Decision|0|||
27666775|NCT03245619|80619562|FG011|Part A (Up to Day 22)|Physician Decision|0|||
27666776|NCT03245619|80619563|FG012|Part A (Up to Day 22)|Physician Decision|0|||
27666777|NCT03245619|80619564|FG013|Part A (Up to Day 22)|Physician Decision|0|||
27666778|NCT03245619|80619565|FG014|Part A (Up to Day 22)|Physician Decision|0|||
27666779|NCT03245619|80619566|FG015|Part A (Up to Day 22)|Physician Decision|0|||
27666780|NCT03245619|80619567|FG016|Part A (Up to Day 22)|Physician Decision|0|||
27666781|NCT01722045|80619569|FG000|Overall Study|Adverse Event|8|||
27666782|NCT01722045|80619569|FG000|Overall Study|Death|3|||
27666783|NCT01722045|80619569|FG000|Overall Study|Withdrawal by Subject|8|||
27666784|NCT01722045|80619569|FG000|Overall Study|Lost to Follow-up|4|||
27666785|NCT01722045|80619569|FG000|Overall Study|Protocol Deviation|1|||
27666786|NCT01722045|80619569|FG000|Overall Study|Physician Decision|3|||
27666787|NCT01722045|80619569|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
27968963|NCT00185380|81718803|FG000|Overall Study|Pregnancy|1|||
27968964|NCT00185380|81718804|FG001|Overall Study|Pregnancy|4|||
27968965|NCT00185380|81718805|FG002|Overall Study|Pregnancy|0|||
27968966|NCT00185380|81718803|FG000|Overall Study|Protocol Violation|2|||
27968967|NCT00185380|81718804|FG001|Overall Study|Protocol Violation|2|||
27968968|NCT00185380|81718805|FG002|Overall Study|Protocol Violation|1|||
27968969|NCT00185380|81718803|FG000|Overall Study|Withdrawal by Subject|1|||
27968970|NCT00185380|81718804|FG001|Overall Study|Withdrawal by Subject|2|||
27968971|NCT00185380|81718805|FG002|Overall Study|Withdrawal by Subject|0|||
27968972|NCT00185380|81718803|FG000|Overall Study|Failed insertion|1|||
27968973|NCT00185380|81718804|FG001|Overall Study|Failed insertion|1|||
27968974|NCT00185380|81718805|FG002|Overall Study|Failed insertion|2|||
27968975|NCT00185380|81718803|FG000|Overall Study|Planned pregnancy|9|||
27968976|NCT00185380|81718804|FG001|Overall Study|Planned pregnancy|12|||
27968977|NCT00185380|81718805|FG002|Overall Study|Planned pregnancy|12|||
27968978|NCT00185380|81718803|FG000|Overall Study|No need for contraception|3|||
27968979|NCT00185380|81718804|FG001|Overall Study|No need for contraception|3|||
27968980|NCT00185380|81718805|FG002|Overall Study|No need for contraception|3|||
27570436|NCT02346240|80275303|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570437|NCT02346240|80275304|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570438|NCT02346240|80275305|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27570439|NCT02346240|80275306|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27666788|NCT01797562|80619570|FG000|Overall Study|Protocol Violation|5|||
27666789|NCT00292981|80619571|FG000|Overall Study|Adverse Event|1|||
27666790|NCT00292981|80619571|FG000|Overall Study|Lost to Follow-up|13|||
27666791|NCT00292981|80619571|FG000|Overall Study|Withdrawal by Subject|22|||
27666792|NCT00292981|80619571|FG000|Overall Study|Other|3|||
27666793|NCT00217022|80619578|FG000|Overall Study|Withdrawal by Subject|1|||
27666794|NCT00217022|80619579|FG001|Overall Study|Withdrawal by Subject|1|||
27863496|NCT02794870|81333019|FG000|Overall Study|Withdrawal by Subject|2|||
27968981|NCT00185380|81718803|FG000|Overall Study|Could not attend visits|2|||
27968982|NCT00185380|81718804|FG001|Overall Study|Could not attend visits|0|||
27968983|NCT00185380|81718805|FG002|Overall Study|Could not attend visits|4|||
27968984|NCT00185380|81718803|FG000|Overall Study|personal reason|6|||
27968985|NCT00185380|81718804|FG001|Overall Study|personal reason|1|||
27968986|NCT00185380|81718805|FG002|Overall Study|personal reason|1|||
27968987|NCT01357161|81718806|FG000|Part 1 (Open Label Run-in)|Death|5|||
27666795|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
27666796|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
27666797|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
27666798|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
27666799|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
27666800|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
27666801|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
27666802|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
27666803|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
27666804|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
27666805|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
27666806|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
27666807|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
27666808|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
27666809|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
27666810|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
27666811|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
27666812|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
27666813|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
27666814|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
27666815|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
27666816|NCT01125566|80619583|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
27666817|NCT01125566|80619584|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
27666818|NCT01125566|80619585|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
27968988|NCT01357161|81718807|FG001|Part 1 (Open Label Run-in)|Death|0|||
27968989|NCT01357161|81718808|FG002|Part 1 (Open Label Run-in)|Death|0|||
27968990|NCT01357161|81718806|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
27968991|NCT01357161|81718807|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
27968992|NCT01357161|81718808|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
27968993|NCT01357161|81718806|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
27968994|NCT01357161|81718807|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
27968995|NCT01357161|81718808|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
27968996|NCT01357161|81718806|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
27968997|NCT01357161|81718807|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
27968998|NCT01357161|81718808|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
27968999|NCT01357161|81718806|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
27969000|NCT01357161|81718807|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
27969001|NCT01357161|81718808|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
27969002|NCT01357161|81718806|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
27969003|NCT01357161|81718807|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
27969004|NCT01357161|81718808|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
27969005|NCT01357161|81718806|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
27969006|NCT01357161|81718807|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
27969007|NCT01357161|81718808|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
27969008|NCT01357161|81718806|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
27969009|NCT01357161|81718807|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
27969010|NCT01357161|81718808|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
27969011|NCT01357161|81718806|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
27969012|NCT01357161|81718807|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
27969013|NCT01357161|81718808|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
27969014|NCT01357161|81718806|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
27570440|NCT02346240|80275307|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
27666819|NCT01125566|80619583|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
27666820|NCT01125566|80619584|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
27666821|NCT01125566|80619585|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
27666822|NCT01125566|80619583|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
27969015|NCT01357161|81718807|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
27969016|NCT01357161|81718808|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
27969017|NCT01357161|81718806|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
27969018|NCT01357161|81718807|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
27969019|NCT01357161|81718808|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
27969020|NCT01110330|81718809|FG000|Overall Study|Adverse Event|0|||
27969021|NCT01110330|81718810|FG001|Overall Study|Adverse Event|4|||
27969022|NCT01110330|81718811|FG002|Overall Study|Adverse Event|3|||
27969023|NCT01110330|81718809|FG000|Overall Study|Lack of Efficacy|3|||
27969024|NCT01110330|81718810|FG001|Overall Study|Lack of Efficacy|1|||
27969025|NCT01110330|81718811|FG002|Overall Study|Lack of Efficacy|1|||
27969026|NCT01110330|81718809|FG000|Overall Study|Lost to Follow-up|9|||
27666823|NCT01125566|80619584|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
27666824|NCT01125566|80619585|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
27666825|NCT01125566|80619583|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
27666826|NCT01125566|80619584|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
27666827|NCT01125566|80619585|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
27666828|NCT01125566|80619583|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
27666829|NCT01125566|80619584|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
27666830|NCT01125566|80619585|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
27666831|NCT03481556|80619586|FG000|Overall Study|Adverse Event|1|||
27666832|NCT03481556|80619587|FG001|Overall Study|Adverse Event|0|||
27666833|NCT03481556|80619588|FG002|Overall Study|Adverse Event|0|||
27666834|NCT03481556|80619589|FG003|Overall Study|Adverse Event|0|||
27666835|NCT03481556|80619586|FG000|Overall Study|Death|4|||
27666836|NCT03481556|80619587|FG001|Overall Study|Death|2|||
27666837|NCT03481556|80619588|FG002|Overall Study|Death|3|||
27666838|NCT03481556|80619589|FG003|Overall Study|Death|16|||
27779826|NCT03452397|81021381|FG000|Overall Study|Withdrawal by Subject|0|||
27779827|NCT03452397|81021382|FG001|Overall Study|Withdrawal by Subject|0|||
27863497|NCT02794870|81333020|FG001|Overall Study|Withdrawal by Subject|0|||
27863498|NCT01121562|81333021|FG000|Overall Study|Objective progression or relapse|8|||
27863499|NCT01121562|81333021|FG000|Overall Study|Withdrawal by Subject|1|||
27863500|NCT01121562|81333021|FG000|Overall Study|Adverse Event|1|||
27863501|NCT01121562|81333021|FG000|Overall Study|Sponsor Decision|1|||
27863502|NCT01121562|81333021|FG000|Overall Study|Met study discontinuation criteria|1|||
27666839|NCT03481556|80619586|FG000|Overall Study|Study Terminated by Sponsor|10|||
27666840|NCT03481556|80619587|FG001|Overall Study|Study Terminated by Sponsor|5|||
27666841|NCT03481556|80619588|FG002|Overall Study|Study Terminated by Sponsor|2|||
27779828|NCT03452397|81021383|FG002|Overall Study|Withdrawal by Subject|1|||
27779829|NCT03452397|81021384|FG003|Overall Study|Withdrawal by Subject|0|||
27779830|NCT00089505|81021388|FG000|Overall Study|Death|4|||
27779831|NCT00089505|81021389|FG001|Overall Study|Death|1|||
27779832|NCT00089505|81021390|FG002|Overall Study|Death|5|||
27779833|NCT00089505|81021391|FG003|Overall Study|Death|8|||
27779834|NCT00089505|81021388|FG000|Overall Study|Withdrawal by Subject|3|||
27779835|NCT00089505|81021389|FG001|Overall Study|Withdrawal by Subject|0|||
27779836|NCT00089505|81021390|FG002|Overall Study|Withdrawal by Subject|6|||
27779837|NCT00089505|81021391|FG003|Overall Study|Withdrawal by Subject|6|||
27779838|NCT00089505|81021388|FG000|Overall Study|Lost to Follow-up|1|||
27779839|NCT00089505|81021389|FG001|Overall Study|Lost to Follow-up|1|||
27779840|NCT00089505|81021390|FG002|Overall Study|Lost to Follow-up|9|||
27779841|NCT00089505|81021391|FG003|Overall Study|Lost to Follow-up|7|||
27779842|NCT00089505|81021388|FG000|Overall Study|Physician Decision|1|||
27779843|NCT00089505|81021389|FG001|Overall Study|Physician Decision|0|||
27779844|NCT00089505|81021390|FG002|Overall Study|Physician Decision|0|||
27779845|NCT00089505|81021391|FG003|Overall Study|Physician Decision|0|||
27779846|NCT00089505|81021388|FG000|Overall Study|Protocol Violation|0|||
27779847|NCT00089505|81021389|FG001|Overall Study|Protocol Violation|0|||
27779848|NCT00089505|81021390|FG002|Overall Study|Protocol Violation|1|||
27779849|NCT00089505|81021391|FG003|Overall Study|Protocol Violation|0|||
27779850|NCT03512028|81021392|FG000|Overall Study|Withdrawal by Subject|2|||
27779851|NCT03512028|81021393|FG001|Overall Study|Withdrawal by Subject|0|||
27779852|NCT03512028|81021392|FG000|Overall Study|Protocol Violation|2|||
27779853|NCT03512028|81021393|FG001|Overall Study|Protocol Violation|0|||
27779854|NCT04062240|81021414|FG000|Overall Study|equipment malfunction|1|||
27863503|NCT02022748|81333022|FG000|Overall Study|Adverse Event|1|||
27863504|NCT02022748|81333023|FG001|Overall Study|Adverse Event|1|||
27863505|NCT02022748|81333024|FG002|Overall Study|Adverse Event|0|||
27969027|NCT01110330|81718810|FG001|Overall Study|Lost to Follow-up|10|||
27969028|NCT01110330|81718811|FG002|Overall Study|Lost to Follow-up|15|||
27969029|NCT01110330|81718809|FG000|Overall Study|Physician Decision|0|||
27666842|NCT03481556|80619589|FG003|Overall Study|Study Terminated by Sponsor|9|||
27666843|NCT00619983|80619590|FG000|Test Drug Alone|Withdrawal by Subject|1|||
27666844|NCT00619983|80619591|FG001|Test Drug Alone|Withdrawal by Subject|0|||
27666845|NCT00619983|80619592|FG002|Test Drug Alone|Withdrawal by Subject|0|||
27666846|NCT00619983|80619593|FG003|Test Drug Alone|Withdrawal by Subject|1|||
27666847|NCT00619983|80619590|FG000|Test Drug Alone|Failure of daily diary device|1|||
27666848|NCT00619983|80619591|FG001|Test Drug Alone|Failure of daily diary device|1|||
27666849|NCT00619983|80619592|FG002|Test Drug Alone|Failure of daily diary device|2|||
27666850|NCT00619983|80619593|FG003|Test Drug Alone|Failure of daily diary device|2|||
27666851|NCT02381652|80619595|FG000|Overall Study|Withdrawal by Subject|0|||
27666852|NCT02381652|80619596|FG001|Overall Study|Withdrawal by Subject|0|||
27666853|NCT02381652|80619597|FG002|Overall Study|Withdrawal by Subject|1|||
27779855|NCT04554394|81021415|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
27779856|NCT04554394|81021416|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
27779857|NCT04554394|81021415|FG000|Overall Study|Withdrawal by Subject|2|||
27779858|NCT04554394|81021416|FG001|Overall Study|Withdrawal by Subject|2|||
27779859|NCT04554394|81021415|FG000|Overall Study|Lost to Follow-up|2|||
27779860|NCT04554394|81021416|FG001|Overall Study|Lost to Follow-up|2|||
27779861|NCT04554394|81021415|FG000|Overall Study|Physician Decision|1|||
27779862|NCT04554394|81021416|FG001|Overall Study|Physician Decision|1|||
27779863|NCT02499172|81021419|FG000|Overall Study|Financial reason|0|||
27779864|NCT02499172|81021420|FG001|Overall Study|Financial reason|0|||
27779865|NCT02499172|81021421|FG002|Overall Study|Financial reason|523|||
27779866|NCT02499172|81021422|FG003|Overall Study|Financial reason|436|||
27779867|NCT02499172|81021419|FG000|Overall Study|Lost to Follow-up|65|||
27779868|NCT02499172|81021420|FG001|Overall Study|Lost to Follow-up|64|||
27779869|NCT02499172|81021421|FG002|Overall Study|Lost to Follow-up|0|||
27779870|NCT02499172|81021422|FG003|Overall Study|Lost to Follow-up|0|||
27779871|NCT01289028|81021425|FG000|Overall Study|Progressive Disease|49|||
27779872|NCT01289028|81021425|FG000|Overall Study|Adverse Event|14|||
27779873|NCT01289028|81021425|FG000|Overall Study|Withdrawal by Subject|6|||
27779874|NCT01289028|81021425|FG000|Overall Study|Death|4|||
27779875|NCT01289028|81021425|FG000|Overall Study|Lack of Efficacy|2|||
27779876|NCT01289028|81021425|FG000|Overall Study|No longer required|2|||
27779877|NCT01289028|81021425|FG000|Overall Study|Lost to Follow-up|2|||
27779878|NCT01289028|81021425|FG000|Overall Study|New Cancer Therapy|2|||
27779879|NCT01289028|81021425|FG000|Overall Study|Abnormal Lab Value|1|||
27779880|NCT01289028|81021425|FG000|Overall Study|Missing reason for discon|1|||
27779881|NCT00266695|81021428|FG000|Overall Study|Adverse Event|1|||
27779882|NCT00266695|81021428|FG000|Overall Study|Death|9|||
27779883|NCT00266695|81021428|FG000|Overall Study|Physician Decision|1|||
27969030|NCT01110330|81718810|FG001|Overall Study|Physician Decision|1|||
27969031|NCT01110330|81718811|FG002|Overall Study|Physician Decision|0|||
27969032|NCT01110330|81718809|FG000|Overall Study|Protocol Violation|2|||
27779884|NCT00266695|81021428|FG000|Overall Study|Lost to Follow-up|3|||
27779885|NCT00266695|81021428|FG000|Overall Study|Withdrawal by Subject|15|||
27779886|NCT04652102|81021429|FG000|Overall Study|Adverse Event|14|||
27779887|NCT04652102|81021430|FG001|Overall Study|Adverse Event|13|||
27779888|NCT04652102|81021429|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
27779889|NCT04652102|81021430|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
27779890|NCT04652102|81021429|FG000|Overall Study|Physician Decision|78|||
27779891|NCT04652102|81021430|FG001|Overall Study|Physician Decision|40|||
27779892|NCT04652102|81021429|FG000|Overall Study|Study Ended by Sponsor|64|||
27779893|NCT04652102|81021430|FG001|Overall Study|Study Ended by Sponsor|17|||
27779894|NCT04652102|81021429|FG000|Overall Study|Withdrawal by Subject|4625|||
27779895|NCT04652102|81021430|FG001|Overall Study|Withdrawal by Subject|5594|||
27779896|NCT04652102|81021429|FG000|Overall Study|Lost to Follow-up|2019|||
27779897|NCT04652102|81021430|FG001|Overall Study|Lost to Follow-up|1082|||
27779898|NCT04652102|81021429|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
27779899|NCT04652102|81021430|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
27779900|NCT04652102|81021429|FG000|Overall Study|Miscellaneous|80|||
27779901|NCT04652102|81021430|FG001|Overall Study|Miscellaneous|64|||
27969033|NCT01110330|81718810|FG001|Overall Study|Protocol Violation|0|||
27969034|NCT01110330|81718811|FG002|Overall Study|Protocol Violation|4|||
27666854|NCT02109107|80619603|FG000|Overall Study|Lost to Follow-up|2|||
27666855|NCT01776008|80619604|FG000|Overall Study|ineligible|2|||
27666856|NCT04680637|80619609|FG000|Overall Study|Lost to Follow-up|0|||
27666857|NCT04680637|80619610|FG001|Overall Study|Lost to Follow-up|1|||
27779902|NCT00808028|81021434|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
27570441|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27779903|NCT00808028|81021435|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
27779904|NCT00808028|81021436|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
27779905|NCT00808028|81021437|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
27779906|NCT00808028|81021434|FG000|Stage 1 (6 Months)|Other|1|||
27779907|NCT00808028|81021435|FG001|Stage 1 (6 Months)|Other|0|||
27779908|NCT00808028|81021436|FG002|Stage 1 (6 Months)|Other|2|||
27779909|NCT00808028|81021437|FG003|Stage 1 (6 Months)|Other|4|||
27969035|NCT01110330|81718809|FG000|Overall Study|Withdrawal by Subject|0|||
27969036|NCT01110330|81718810|FG001|Overall Study|Withdrawal by Subject|6|||
27969037|NCT01110330|81718811|FG002|Overall Study|Withdrawal by Subject|2|||
27969038|NCT01110330|81718809|FG000|Overall Study|Other|1|||
27969039|NCT01110330|81718810|FG001|Overall Study|Other|1|||
27969040|NCT01110330|81718811|FG002|Overall Study|Other|1|||
27969041|NCT00948857|81718812|FG000|Overall Study|Lost to Follow-up|1|||
27969042|NCT00948857|81718813|FG001|Overall Study|Lost to Follow-up|0|||
27969043|NCT02141399|81718814|FG000|Overall Study|Adverse Event|158|||
27969044|NCT02141399|81718814|FG000|Overall Study|Lack of Efficacy|62|||
27666858|NCT04680637|80619611|FG002|Overall Study|Lost to Follow-up|0|||
27969045|NCT02141399|81718814|FG000|Overall Study|Lost to Follow-up|151|||
27969046|NCT02141399|81718814|FG000|Overall Study|Non-compliance with study drug|18|||
27969047|NCT02141399|81718814|FG000|Overall Study|Other|45|||
27969048|NCT02141399|81718814|FG000|Overall Study|Physician Decision|17|||
27969049|NCT02141399|81718814|FG000|Overall Study|Pregnancy|3|||
27969050|NCT02141399|81718814|FG000|Overall Study|Protocol Violation|38|||
27969051|NCT02141399|81718814|FG000|Overall Study|Withdrawal by Subject|238|||
27969052|NCT02141399|81718814|FG000|Overall Study|Failure to meet eligibility criteria|14|||
27969053|NCT00313313|81718815|FG000|Overall Study|Lack of Efficacy|14|||
27969054|NCT00313313|81718816|FG001|Overall Study|Lack of Efficacy|9|||
27969055|NCT00313313|81718817|FG002|Overall Study|Lack of Efficacy|20|||
27969056|NCT00313313|81718815|FG000|Overall Study|Withdrawal of consent by subject|18|||
27969057|NCT00313313|81718816|FG001|Overall Study|Withdrawal of consent by subject|17|||
27969058|NCT00313313|81718817|FG002|Overall Study|Withdrawal of consent by subject|31|||
27969059|NCT00313313|81718815|FG000|Overall Study|Lost to Follow-up|10|||
27969060|NCT00313313|81718816|FG001|Overall Study|Lost to Follow-up|7|||
27969061|NCT00313313|81718817|FG002|Overall Study|Lost to Follow-up|9|||
27969062|NCT00313313|81718815|FG000|Overall Study|Adverse Event|15|||
27969063|NCT00313313|81718816|FG001|Overall Study|Adverse Event|16|||
27969064|NCT00313313|81718817|FG002|Overall Study|Adverse Event|12|||
27969065|NCT00313313|81718815|FG000|Overall Study|Physician Decision|2|||
27969066|NCT00313313|81718816|FG001|Overall Study|Physician Decision|6|||
27969067|NCT00313313|81718817|FG002|Overall Study|Physician Decision|4|||
27969068|NCT00313313|81718815|FG000|Overall Study|Poor/Noncompliance|3|||
27969069|NCT00313313|81718816|FG001|Overall Study|Poor/Noncompliance|6|||
27969070|NCT00313313|81718817|FG002|Overall Study|Poor/Noncompliance|2|||
27969071|NCT00313313|81718815|FG000|Overall Study|Pregnancy|1|||
27969072|NCT00313313|81718816|FG001|Overall Study|Pregnancy|2|||
27969073|NCT00313313|81718817|FG002|Overall Study|Pregnancy|0|||
27969074|NCT00313313|81718815|FG000|Overall Study|Death|0|||
27666859|NCT04680637|80619612|FG003|Overall Study|Lost to Follow-up|1|||
27666860|NCT04680637|80619609|FG000|Overall Study|Death|1|||
27666861|NCT04680637|80619610|FG001|Overall Study|Death|0|||
27666862|NCT04680637|80619611|FG002|Overall Study|Death|0|||
27666863|NCT04680637|80619612|FG003|Overall Study|Death|0|||
27666864|NCT04680637|80619609|FG000|Overall Study|Withdrawal by Subject|7|||
27666865|NCT04680637|80619610|FG001|Overall Study|Withdrawal by Subject|10|||
27666866|NCT04680637|80619611|FG002|Overall Study|Withdrawal by Subject|17|||
27666867|NCT04680637|80619612|FG003|Overall Study|Withdrawal by Subject|15|||
27666868|NCT04680637|80619609|FG000|Overall Study|Decision by Sponsor|21|||
27666869|NCT04680637|80619610|FG001|Overall Study|Decision by Sponsor|15|||
27666870|NCT04680637|80619611|FG002|Overall Study|Decision by Sponsor|7|||
27666871|NCT04680637|80619612|FG003|Overall Study|Decision by Sponsor|32|||
27666872|NCT01172639|80619613|FG000|Overall Study|Death|1|||
27666873|NCT01172639|80619614|FG001|Overall Study|Death|1|||
27666874|NCT01172639|80619615|FG002|Overall Study|Death|0|||
27969075|NCT00313313|81718816|FG001|Overall Study|Death|0|||
27969076|NCT00313313|81718817|FG002|Overall Study|Death|2|||
27969077|NCT00313313|81718815|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
27969078|NCT00313313|81718816|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
27969079|NCT00313313|81718817|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
27666875|NCT01172639|80619616|FG003|Overall Study|Death|0|||
27666876|NCT01172639|80619617|FG004|Overall Study|Death|0|||
27666877|NCT01172639|80619613|FG000|Overall Study|Lost to Follow-up|9|||
27666878|NCT01172639|80619614|FG001|Overall Study|Lost to Follow-up|7|||
27666879|NCT01172639|80619615|FG002|Overall Study|Lost to Follow-up|11|||
27666880|NCT01172639|80619616|FG003|Overall Study|Lost to Follow-up|6|||
27666881|NCT01172639|80619617|FG004|Overall Study|Lost to Follow-up|6|||
27666882|NCT01172639|80619613|FG000|Overall Study|Withdrawal by Subject|3|||
27666883|NCT01172639|80619614|FG001|Overall Study|Withdrawal by Subject|3|||
27969080|NCT02039219|81718818|FG000|Treatment|Withdrawal by Subject|1|||
27969081|NCT02039219|81718819|FG001|Treatment|Withdrawal by Subject|0|||
27969082|NCT02039219|81718818|FG000|Treatment|Adverse Event|0|||
27969083|NCT02039219|81718819|FG001|Treatment|Adverse Event|1|||
27666884|NCT01172639|80619615|FG002|Overall Study|Withdrawal by Subject|5|||
27666885|NCT01172639|80619616|FG003|Overall Study|Withdrawal by Subject|5|||
27666886|NCT01172639|80619617|FG004|Overall Study|Withdrawal by Subject|0|||
27666887|NCT03544229|80619618|FG000|Overall Study|Adverse Event|1|||
27969084|NCT02039219|81718818|FG000|Treatment|Physician Decision|1|||
27969085|NCT02039219|81718819|FG001|Treatment|Physician Decision|0|||
27969086|NCT02039219|81718818|FG000|Treatment|Lost to Follow-up|0|||
27969087|NCT02039219|81718819|FG001|Treatment|Lost to Follow-up|1|||
27969088|NCT02039219|81718818|FG000|Treatment|Protocol Violation|1|||
27969089|NCT02039219|81718819|FG001|Treatment|Protocol Violation|0|||
27969090|NCT02039219|81718818|FG000|Treatment|Death|1|||
27969091|NCT02039219|81718819|FG001|Treatment|Death|0|||
27969092|NCT02039219|81718818|FG000|Follow up|Adverse Event|0|||
27969093|NCT02039219|81718819|FG001|Follow up|Adverse Event|1|||
27969094|NCT02247011|81718823|FG000|Overall Study|Poor quality of radiological results|125|||
27969095|NCT03116828|81718824|FG000|Overall Study|Adverse Event|1|||
27969096|NCT03116828|81718825|FG001|Overall Study|Adverse Event|10|||
27969097|NCT03116828|81718824|FG000|Overall Study|Withdrawal by Subject|4|||
27969098|NCT03116828|81718825|FG001|Overall Study|Withdrawal by Subject|8|||
27969099|NCT03116828|81718824|FG000|Overall Study|OTHER|3|||
27779910|NCT00808028|81021434|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
27779911|NCT00808028|81021435|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
27779912|NCT00808028|81021436|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
27779913|NCT00808028|81021437|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
27779914|NCT00808028|81021434|FG000|Stage 1 (6 Months)|Adverse Event|0|||
27779915|NCT00808028|81021435|FG001|Stage 1 (6 Months)|Adverse Event|0|||
27779916|NCT00808028|81021436|FG002|Stage 1 (6 Months)|Adverse Event|1|||
27779917|NCT00808028|81021437|FG003|Stage 1 (6 Months)|Adverse Event|2|||
27779918|NCT00808028|81021434|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
27779919|NCT00808028|81021435|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
27779920|NCT00808028|81021436|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
27779921|NCT00808028|81021437|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
27779922|NCT00808028|81021434|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
27779923|NCT00808028|81021435|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
27779924|NCT00808028|81021436|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
27779925|NCT00808028|81021437|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
27779926|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
27779927|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
27779928|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
27779929|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
27779930|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
27779931|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
27779932|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
27779933|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
27779934|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
27779935|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
27779936|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
27969100|NCT03116828|81718825|FG001|Overall Study|OTHER|3|||
27969101|NCT01529515|81718826|FG000|TRANSITION PHASE|Adverse Event|16|||
27969102|NCT01529515|81718827|FG001|TRANSITION PHASE|Adverse Event|0|||
27969103|NCT01529515|81718828|FG002|TRANSITION PHASE|Adverse Event|0|||
27969104|NCT01529515|81718829|FG003|TRANSITION PHASE|Adverse Event|0|||
27969105|NCT01529515|81718826|FG000|TRANSITION PHASE|Death|1|||
27969106|NCT01529515|81718827|FG001|TRANSITION PHASE|Death|0|||
27969107|NCT01529515|81718828|FG002|TRANSITION PHASE|Death|0|||
27969108|NCT01529515|81718829|FG003|TRANSITION PHASE|Death|0|||
27863506|NCT02022748|81333022|FG000|Overall Study|Withdrawal by Subject|0|||
27863507|NCT02022748|81333023|FG001|Overall Study|Withdrawal by Subject|1|||
27863508|NCT02022748|81333024|FG002|Overall Study|Withdrawal by Subject|0|||
27863509|NCT04839692|81333029|FG000|Overall Study|Withdrawal by Subject|0|||
27863510|NCT04839692|81333030|FG001|Overall Study|Withdrawal by Subject|3|||
27863511|NCT04839692|81333029|FG000|Overall Study|Physician Decision|1|||
27863512|NCT04839692|81333030|FG001|Overall Study|Physician Decision|0|||
27863513|NCT04058067|81333032|FG000|Overall Study|Adverse Event|2|||
27863514|NCT04058067|81333033|FG001|Overall Study|Adverse Event|0|||
27863515|NCT04058067|81333032|FG000|Overall Study|Death|0|||
27863516|NCT04058067|81333033|FG001|Overall Study|Death|1|||
27863517|NCT04058067|81333032|FG000|Overall Study|Physician Decision|3|||
27863518|NCT04058067|81333033|FG001|Overall Study|Physician Decision|1|||
27863519|NCT04058067|81333032|FG000|Overall Study|Protocol Violation|0|||
27863520|NCT04058067|81333033|FG001|Overall Study|Protocol Violation|1|||
27863521|NCT04058067|81333032|FG000|Overall Study|Withdrawal by Subject|7|||
27863522|NCT04058067|81333033|FG001|Overall Study|Withdrawal by Subject|8|||
27969109|NCT01529515|81718826|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
27969110|NCT01529515|81718827|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
27969111|NCT01529515|81718828|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
27969112|NCT01529515|81718829|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
27969113|NCT01529515|81718826|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
27969114|NCT01529515|81718827|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
27969115|NCT01529515|81718828|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
27969116|NCT01529515|81718829|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
27969117|NCT01529515|81718826|FG000|TRANSITION PHASE|Protocol Violation|4|||
27969118|NCT01529515|81718827|FG001|TRANSITION PHASE|Protocol Violation|0|||
27969119|NCT01529515|81718828|FG002|TRANSITION PHASE|Protocol Violation|0|||
27969120|NCT01529515|81718829|FG003|TRANSITION PHASE|Protocol Violation|0|||
27969121|NCT01529515|81718826|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
27969122|NCT01529515|81718827|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
27969123|NCT01529515|81718828|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
27969124|NCT01529515|81718829|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
27969125|NCT01529515|81718826|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
27969126|NCT01529515|81718827|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
27969127|NCT01529515|81718828|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
27969128|NCT01529515|81718829|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
27969129|NCT01529515|81718826|FG000|TRANSITION PHASE|Other|9|||
27969130|NCT01529515|81718827|FG001|TRANSITION PHASE|Other|0|||
27969131|NCT01529515|81718828|FG002|TRANSITION PHASE|Other|0|||
27969132|NCT01529515|81718829|FG003|TRANSITION PHASE|Other|0|||
27969133|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Adverse Event|0|||
27969134|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Adverse Event|10|||
27969135|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Adverse Event|0|||
27969136|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Adverse Event|0|||
27969137|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
27969138|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
27969139|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
27969140|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
27969141|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
27969142|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
27969143|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
27969144|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
27969145|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
27779937|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
27779938|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
27779939|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
27779940|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
27779941|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
27779942|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
27779943|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
27779944|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
27779945|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
27863523|NCT01874353|81333034|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
27863524|NCT01874353|81333035|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
27666888|NCT03544229|80619619|FG001|Overall Study|Adverse Event|0|||
27863525|NCT01874353|81333036|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
27969146|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
27969147|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
27969148|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
27969149|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
27969150|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
27969151|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
27969152|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
27969153|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
27969154|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
27779946|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
27779947|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
27779948|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
27779949|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
27779950|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
27779951|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
27779952|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
27779953|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
27779954|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
27779955|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
27779956|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
27779957|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
27779958|NCT00808028|81021434|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
27779959|NCT00808028|81021435|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
27779960|NCT00808028|81021436|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
27779961|NCT00808028|81021437|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
27863526|NCT01874353|81333037|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
27863527|NCT01874353|81333034|FG000|Overall Study|Lost to Follow-up|2|||
27863528|NCT01874353|81333035|FG001|Overall Study|Lost to Follow-up|2|||
27863529|NCT01874353|81333036|FG002|Overall Study|Lost to Follow-up|2|||
27863530|NCT01874353|81333037|FG003|Overall Study|Lost to Follow-up|0|||
27863531|NCT01874353|81333034|FG000|Overall Study|Death|110|||
27779962|NCT00827112|81021438|FG000|Overall Study|Adverse Event|2|||
27779963|NCT00827112|81021439|FG001|Overall Study|Adverse Event|0|||
27779964|NCT00827112|81021438|FG000|Overall Study|Lack of Efficacy|2|||
27779965|NCT00827112|81021439|FG001|Overall Study|Lack of Efficacy|0|||
27779966|NCT00827112|81021438|FG000|Overall Study|Lost to Follow-up|3|||
27779967|NCT00827112|81021439|FG001|Overall Study|Lost to Follow-up|2|||
27779968|NCT00827112|81021438|FG000|Overall Study|Pregnancy|0|||
27863532|NCT01874353|81333035|FG001|Overall Study|Death|60|||
27779969|NCT00827112|81021439|FG001|Overall Study|Pregnancy|1|||
27863533|NCT01874353|81333036|FG002|Overall Study|Death|13|||
27863534|NCT01874353|81333037|FG003|Overall Study|Death|7|||
27863535|NCT01874353|81333034|FG000|Overall Study|Withdrawal by Subject|13|||
27863536|NCT01874353|81333035|FG001|Overall Study|Withdrawal by Subject|11|||
27863537|NCT01874353|81333036|FG002|Overall Study|Withdrawal by Subject|0|||
27863538|NCT01874353|81333037|FG003|Overall Study|Withdrawal by Subject|0|||
27863539|NCT02593110|81333038|FG000|Overall Study|Withdrawal by Subject|0|||
27863540|NCT02593110|81333039|FG001|Overall Study|Withdrawal by Subject|3|||
27863541|NCT02593110|81333040|FG002|Overall Study|Withdrawal by Subject|3|||
27863542|NCT02593110|81333041|FG003|Overall Study|Withdrawal by Subject|2|||
27863543|NCT02593110|81333038|FG000|Overall Study|Death|0|||
27863544|NCT02593110|81333039|FG001|Overall Study|Death|0|||
27863545|NCT02593110|81333040|FG002|Overall Study|Death|1|||
27863546|NCT02593110|81333041|FG003|Overall Study|Death|0|||
27863547|NCT02455518|81333042|FG000|Overall Study|Protocol Violation|0|||
27863548|NCT02455518|81333043|FG001|Overall Study|Protocol Violation|1|||
27863549|NCT02455518|81333044|FG002|Overall Study|Protocol Violation|1|||
27863550|NCT02455518|81333045|FG003|Overall Study|Protocol Violation|3|||
27863551|NCT04138823|81333046|FG000|Overall Study|Clinical disease progression|0|||
27863552|NCT04138823|81333047|FG001|Overall Study|Clinical disease progression|0|||
27863553|NCT04138823|81333048|FG002|Overall Study|Clinical disease progression|1|||
27863554|NCT04138823|81333046|FG000|Overall Study|Objective disease progression|3|||
27863555|NCT04138823|81333047|FG001|Overall Study|Objective disease progression|2|||
27863556|NCT04138823|81333048|FG002|Overall Study|Objective disease progression|5|||
27863557|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
27863558|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
27969155|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
27969156|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
27969157|NCT01529515|81718826|FG000|MAINTENANCE PHASE|Other|0|||
27666889|NCT03544229|80619620|FG002|Overall Study|Adverse Event|1|||
27666890|NCT03544229|80619621|FG003|Overall Study|Adverse Event|0|||
27779970|NCT00827112|81021438|FG000|Overall Study|Protocol Violation|0|||
27863559|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
27969158|NCT01529515|81718827|FG001|MAINTENANCE PHASE|Other|10|||
27969159|NCT01529515|81718828|FG002|MAINTENANCE PHASE|Other|0|||
27863560|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
27863561|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
27969160|NCT01529515|81718829|FG003|MAINTENANCE PHASE|Other|0|||
27969161|NCT01529515|81718826|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
27969162|NCT01529515|81718827|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
27969163|NCT01529515|81718828|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
27969164|NCT01529515|81718829|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
27969165|NCT01529515|81718826|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
27969166|NCT01529515|81718827|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
27969167|NCT01529515|81718828|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
27969168|NCT01529515|81718829|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
27969169|NCT01529515|81718826|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
27969170|NCT01529515|81718827|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
27969171|NCT01529515|81718828|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
27969172|NCT01529515|81718829|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
27969173|NCT01529515|81718826|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
27969174|NCT01529515|81718827|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
27969175|NCT01529515|81718828|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
27969176|NCT01529515|81718829|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
27969177|NCT01529515|81718826|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
27969178|NCT01529515|81718827|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
27969179|NCT01529515|81718828|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
27969180|NCT01529515|81718829|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
27969181|NCT01529515|81718826|FG000|DOUBLE BLIND PHASE|Other|0|||
27969182|NCT01529515|81718827|FG001|DOUBLE BLIND PHASE|Other|0|||
27969183|NCT01529515|81718828|FG002|DOUBLE BLIND PHASE|Other|9|||
27969184|NCT01529515|81718829|FG003|DOUBLE BLIND PHASE|Other|2|||
27969185|NCT00790647|81718839|FG000|Overall Study|Adverse Event|1|||
27969186|NCT00176488|81718840|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
27969187|NCT03172325|81718845|FG000|Overall Study|Adverse Event|2|||
27969188|NCT03172325|81718846|FG001|Overall Study|Adverse Event|3|||
27969189|NCT03172325|81718845|FG000|Overall Study|Positive PPD|1|||
27779971|NCT00827112|81021439|FG001|Overall Study|Protocol Violation|2|||
27779972|NCT00827112|81021438|FG000|Overall Study|Withdrawal by Subject|2|||
27779973|NCT00827112|81021439|FG001|Overall Study|Withdrawal by Subject|1|||
27779974|NCT00827112|81021438|FG000|Overall Study|Randomized but not treated|5|||
27779975|NCT00827112|81021439|FG001|Overall Study|Randomized but not treated|3|||
27779976|NCT00827112|81021438|FG000|Overall Study|Other|1|||
27779977|NCT00827112|81021439|FG001|Overall Study|Other|3|||
27779978|NCT02176226|81021442|FG000|Overall Study|Lost to Follow-up|3|||
27779979|NCT02176226|81021442|FG000|Overall Study|Withdrew prior to treatment|6|||
27779980|NCT00783263|81021443|FG000|Overall Study|Adverse Event|3|||
27779981|NCT00783263|81021444|FG001|Overall Study|Adverse Event|0|||
27779982|NCT00783263|81021445|FG002|Overall Study|Adverse Event|2|||
27779983|NCT00783263|81021446|FG003|Overall Study|Adverse Event|1|||
27779984|NCT00783263|81021443|FG000|Overall Study|Lost to Follow-up|1|||
27779985|NCT00783263|81021444|FG001|Overall Study|Lost to Follow-up|1|||
27779986|NCT00783263|81021445|FG002|Overall Study|Lost to Follow-up|0|||
27779987|NCT00783263|81021446|FG003|Overall Study|Lost to Follow-up|0|||
27779988|NCT00783263|81021443|FG000|Overall Study|Withdrawal by Subject|0|||
27779989|NCT00783263|81021444|FG001|Overall Study|Withdrawal by Subject|1|||
27779990|NCT00783263|81021445|FG002|Overall Study|Withdrawal by Subject|1|||
27779991|NCT00783263|81021446|FG003|Overall Study|Withdrawal by Subject|2|||
27779992|NCT00554840|81021447|FG000|Overall Study|Physician Decision|0|||
27779993|NCT00554840|81021448|FG001|Overall Study|Physician Decision|1|||
27779994|NCT01487863|81021450|FG000|Overall Study|Death|19|||
27779995|NCT01487863|81021451|FG001|Overall Study|Death|19|||
27779996|NCT01685060|81021454|FG000|Overall Study|Rollover patients|16|||
27779997|NCT01685060|81021454|FG000|Overall Study|Adverse Event|12|||
27779998|NCT01685060|81021454|FG000|Overall Study|Progressive disease|69|||
27779999|NCT01685060|81021454|FG000|Overall Study|Physician Decision|14|||
27780000|NCT01685060|81021454|FG000|Overall Study|Subject/guardian decision|20|||
27780001|NCT01685060|81021454|FG000|Overall Study|Lost to Follow-up|1|||
27780002|NCT01685060|81021454|FG000|Overall Study|Death|8|||
27780003|NCT02010567|81021455|FG000|Overall Study|Adverse Event|0|||
27780004|NCT02010567|81021456|FG001|Overall Study|Adverse Event|0|||
27780005|NCT02010567|81021457|FG002|Overall Study|Adverse Event|1|||
27780006|NCT02010567|81021458|FG003|Overall Study|Adverse Event|0|||
27969190|NCT03172325|81718846|FG001|Overall Study|Positive PPD|0|||
27969191|NCT03172325|81718845|FG000|Overall Study|Poor Compliance|1|||
27570442|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27780007|NCT02010567|81021459|FG004|Overall Study|Adverse Event|1|||
27780008|NCT00312728|81021463|FG000|Overall Study|Progressive disease|53|||
27780009|NCT00312728|81021463|FG000|Overall Study|Adverse Event|32|||
27969192|NCT03172325|81718846|FG001|Overall Study|Poor Compliance|1|||
27969193|NCT02449889|81718847|FG000|Overall Study|Adverse Event|1|||
27969194|NCT02449889|81718848|FG001|Overall Study|Adverse Event|2|||
27666891|NCT03544229|80619618|FG000|Overall Study|Protocol Deviation|0|||
27780010|NCT00312728|81021463|FG000|Overall Study|Withdrawal by Subject|10|||
27969195|NCT02449889|81718849|FG002|Overall Study|Adverse Event|0|||
27969196|NCT02449889|81718847|FG000|Overall Study|Protocol Violation|0|||
27969197|NCT02449889|81718848|FG001|Overall Study|Protocol Violation|4|||
27969198|NCT02449889|81718849|FG002|Overall Study|Protocol Violation|1|||
27969199|NCT04621240|81718850|FG000|Overall Study|Withdrawal by Subject|36|||
27969200|NCT03632993|81718853|FG000|Overall Study|Withdrawal by Subject|1|||
27969201|NCT03632993|81718854|FG001|Overall Study|Withdrawal by Subject|0|||
27969202|NCT03632993|81718855|FG002|Overall Study|Withdrawal by Subject|0|||
27969203|NCT03632993|81718856|FG003|Overall Study|Withdrawal by Subject|0|||
27969204|NCT03632993|81718857|FG004|Overall Study|Withdrawal by Subject|0|||
27969205|NCT03632993|81718858|FG005|Overall Study|Withdrawal by Subject|0|||
27969206|NCT03632993|81718859|FG006|Overall Study|Withdrawal by Subject|0|||
27969207|NCT03632993|81718860|FG007|Overall Study|Withdrawal by Subject|0|||
27969208|NCT03632993|81718861|FG008|Overall Study|Withdrawal by Subject|0|||
27969209|NCT03632993|81718862|FG009|Overall Study|Withdrawal by Subject|1|||
27969210|NCT03632993|81718853|FG000|Overall Study|Protocol Non-compliance|0|||
27969211|NCT03632993|81718854|FG001|Overall Study|Protocol Non-compliance|1|||
27969212|NCT03632993|81718855|FG002|Overall Study|Protocol Non-compliance|0|||
27969213|NCT03632993|81718856|FG003|Overall Study|Protocol Non-compliance|0|||
27969214|NCT03632993|81718857|FG004|Overall Study|Protocol Non-compliance|0|||
27969215|NCT03632993|81718858|FG005|Overall Study|Protocol Non-compliance|0|||
27969216|NCT03632993|81718859|FG006|Overall Study|Protocol Non-compliance|0|||
27969217|NCT03632993|81718860|FG007|Overall Study|Protocol Non-compliance|0|||
27969218|NCT03632993|81718861|FG008|Overall Study|Protocol Non-compliance|0|||
27969219|NCT03632993|81718862|FG009|Overall Study|Protocol Non-compliance|0|||
27969220|NCT03632993|81718853|FG000|Overall Study|Lost to Follow-up|0|||
27969221|NCT03632993|81718854|FG001|Overall Study|Lost to Follow-up|0|||
27969222|NCT03632993|81718855|FG002|Overall Study|Lost to Follow-up|0|||
27969223|NCT03632993|81718856|FG003|Overall Study|Lost to Follow-up|0|||
27969224|NCT03632993|81718857|FG004|Overall Study|Lost to Follow-up|0|||
27969225|NCT03632993|81718858|FG005|Overall Study|Lost to Follow-up|1|||
27969226|NCT03632993|81718859|FG006|Overall Study|Lost to Follow-up|0|||
27969227|NCT03632993|81718860|FG007|Overall Study|Lost to Follow-up|1|||
27969228|NCT03632993|81718861|FG008|Overall Study|Lost to Follow-up|0|||
27570443|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570444|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570445|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570446|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570447|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570448|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27780011|NCT00312728|81021463|FG000|Overall Study|Required non-protocol cancer treatment|2|||
27780012|NCT00312728|81021463|FG000|Overall Study|Protocol Violation|2|||
27969229|NCT03632993|81718862|FG009|Overall Study|Lost to Follow-up|0|||
27570449|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570450|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570451|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570452|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570453|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570454|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570455|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27780013|NCT00312728|81021463|FG000|Overall Study|Other|10|||
27780014|NCT00312728|81021463|FG000|Overall Study|Other|1|||
27969230|NCT03632993|81718853|FG000|Overall Study|Adverse Event|0|||
27969231|NCT03632993|81718854|FG001|Overall Study|Adverse Event|0|||
27969232|NCT03632993|81718855|FG002|Overall Study|Adverse Event|0|||
27969233|NCT03632993|81718856|FG003|Overall Study|Adverse Event|0|||
27969234|NCT03632993|81718857|FG004|Overall Study|Adverse Event|0|||
27969235|NCT03632993|81718858|FG005|Overall Study|Adverse Event|1|||
27969236|NCT03632993|81718859|FG006|Overall Study|Adverse Event|0|||
27969237|NCT03632993|81718860|FG007|Overall Study|Adverse Event|1|||
27969238|NCT03632993|81718861|FG008|Overall Study|Adverse Event|0|||
27969239|NCT03632993|81718862|FG009|Overall Study|Adverse Event|0|||
27969240|NCT01482169|81718863|FG000|Overall Study|Physician Decision|2|||
27969241|NCT00557310|81718864|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
27969242|NCT00557310|81718864|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
27969243|NCT00557310|81718864|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
27570456|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27969244|NCT00557310|81718864|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
27969245|NCT00557310|81718864|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
27666892|NCT03544229|80619619|FG001|Overall Study|Protocol Deviation|0|||
27666893|NCT03544229|80619620|FG002|Overall Study|Protocol Deviation|1|||
27780015|NCT01468844|81021468|FG000|Overall Study|Adverse Event|1|||
27969246|NCT00557310|81718864|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
27969247|NCT02998203|81718866|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
27969248|NCT02998203|81718867|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
27969249|NCT02998203|81718866|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
27780016|NCT01468844|81021469|FG001|Overall Study|Adverse Event|0|||
27969250|NCT02998203|81718867|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
27570457|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
27570458|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
27570459|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
27570460|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
27570461|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
27570462|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
27570463|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
27570464|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
27570465|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570466|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570467|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570468|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570469|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570470|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570471|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570472|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570473|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570474|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570475|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570476|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
27969251|NCT04065074|81718875|FG000|Overall Study|Adverse Event|1|||
27570477|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570478|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570479|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570480|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570481|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570482|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570483|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
27570484|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
27570485|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570486|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
27570487|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570488|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
27570489|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570490|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570491|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570492|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570493|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570494|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27780017|NCT01468844|81021468|FG000|Overall Study|Withdrawal by Subject|1|||
27780018|NCT01468844|81021469|FG001|Overall Study|Withdrawal by Subject|0|||
27780019|NCT00775138|81024127|FG000|Overall Study|Withdrawal by Subject|0|||
27780020|NCT00775138|81024128|FG001|Overall Study|Withdrawal by Subject|0|||
27780021|NCT00775138|81024129|FG002|Overall Study|Withdrawal by Subject|2|||
27780022|NCT00775138|81024130|FG003|Overall Study|Withdrawal by Subject|2|||
27780023|NCT00775138|81024127|FG000|Overall Study|Adverse Event|0|||
27780024|NCT00775138|81024128|FG001|Overall Study|Adverse Event|0|||
27780025|NCT00775138|81024129|FG002|Overall Study|Adverse Event|1|||
27780026|NCT00775138|81024130|FG003|Overall Study|Adverse Event|0|||
27780027|NCT01156012|81024131|FG000|Overall Study|Adverse Event|3|||
27780028|NCT01156012|81024132|FG001|Overall Study|Adverse Event|1|||
27969252|NCT04065074|81718875|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
27780029|NCT01156012|81024131|FG000|Overall Study|Lost to Follow-up|1|||
27780030|NCT01156012|81024132|FG001|Overall Study|Lost to Follow-up|0|||
27780031|NCT01156012|81024131|FG000|Overall Study|Withdrawal by Subject|1|||
27780032|NCT01156012|81024132|FG001|Overall Study|Withdrawal by Subject|0|||
27969253|NCT04669262|81718879|FG000|Overall Study|Withdrawal by Subject|0|||
27969254|NCT04669262|81718880|FG001|Overall Study|Withdrawal by Subject|0|||
27969255|NCT04669262|81718881|FG002|Overall Study|Withdrawal by Subject|0|||
27969256|NCT04669262|81718882|FG003|Overall Study|Withdrawal by Subject|1|||
27969257|NCT04669262|81718879|FG000|Overall Study|Randomized but Not Treated|0|||
27969258|NCT04669262|81718880|FG001|Overall Study|Randomized but Not Treated|1|||
27969259|NCT04669262|81718881|FG002|Overall Study|Randomized but Not Treated|0|||
27969260|NCT04669262|81718882|FG003|Overall Study|Randomized but Not Treated|0|||
27969261|NCT04470908|81718886|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
27969262|NCT01127607|81718888|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
27969263|NCT01127607|81718889|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
27969264|NCT01127607|81718888|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
27969265|NCT01127607|81718889|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
27969266|NCT01923363|81718890|FG000|Overall Study|Protocol Violation|1|||
27969267|NCT03213938|81718891|FG000|Overall Study|Lost to Follow-up|4|||
27969268|NCT03213938|81718892|FG001|Overall Study|Lost to Follow-up|3|||
27969269|NCT03213938|81718891|FG000|Overall Study|Lack of Efficacy|1|||
27969270|NCT03213938|81718892|FG001|Overall Study|Lack of Efficacy|0|||
27969271|NCT03213938|81718891|FG000|Overall Study|Decline to participate|5|||
27969272|NCT03213938|81718892|FG001|Overall Study|Decline to participate|4|||
27969273|NCT03213938|81718891|FG000|Overall Study|Without reason|4|||
27969274|NCT03213938|81718892|FG001|Overall Study|Without reason|5|||
27969275|NCT01519791|81718893|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
27969276|NCT01519791|81718894|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
27969277|NCT01519791|81718893|FG000|Overall Study|Protocol Violation|6|||
27969278|NCT01519791|81718894|FG001|Overall Study|Protocol Violation|19|||
27969279|NCT01519791|81718893|FG000|Overall Study|Other Reason|87|||
27969280|NCT01519791|81718894|FG001|Overall Study|Other Reason|222|||
27969281|NCT01519791|81718893|FG000|Overall Study|subjects randomized in error|2|||
27969282|NCT01519791|81718894|FG001|Overall Study|subjects randomized in error|0|||
27969283|NCT01519791|81718893|FG000|Overall Study|Lack of Efficacy|16|||
27969284|NCT01519791|81718894|FG001|Overall Study|Lack of Efficacy|20|||
27969285|NCT01519791|81718893|FG000|Overall Study|SAE, non-fatal|6|||
27969286|NCT01519791|81718894|FG001|Overall Study|SAE, non-fatal|22|||
27969287|NCT01519791|81718893|FG000|Overall Study|AE, serious fatal|0|||
27969288|NCT01519791|81718894|FG001|Overall Study|AE, serious fatal|1|||
27969289|NCT01519791|81718893|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
27969290|NCT01519791|81718894|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
27969291|NCT01519791|81718893|FG000|Overall Study|AE, non-serious non-fatal|12|||
27570495|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570496|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27863562|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
27863563|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
27863564|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
27863565|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
27863566|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
27863567|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
27863568|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
27863569|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
27863570|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
27969292|NCT01519791|81718894|FG001|Overall Study|AE, non-serious non-fatal|31|||
27969293|NCT01519791|81718893|FG000|Overall Study|Withdrawal by Subject|15|||
27969294|NCT01519791|81718894|FG001|Overall Study|Withdrawal by Subject|37|||
27969295|NCT01519791|81718893|FG000|Overall Study|Lost to Follow-up|6|||
27969296|NCT01519791|81718894|FG001|Overall Study|Lost to Follow-up|14|||
27863571|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
27863572|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
27863573|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
27863574|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
27863575|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
27863576|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
27863577|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
27863578|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27863579|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
27863580|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27863581|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
27863582|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
27863583|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
27863584|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
27863585|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
27863586|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
27863587|NCT03713632|81333049|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
27863588|NCT03713632|81333050|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
27863589|NCT03713632|81333051|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
27863590|NCT03713632|81333052|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
27863591|NCT03713632|81333053|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
27863592|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
27863593|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
27863594|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
27863595|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
27863596|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
27863597|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
27863598|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
27863599|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
27969297|NCT02778555|81718895|FG000|Overall Study|Withdrawal by Subject|55|||
27969298|NCT02778555|81718896|FG001|Overall Study|Withdrawal by Subject|32|||
27969299|NCT02778555|81718897|FG002|Overall Study|Withdrawal by Subject|107|||
27969300|NCT00079391|81718898|FG000|Overall Study|Withdrawal by Subject|1|||
27969301|NCT02589665|81718899|FG000|Induction Period|Did not receive drug|0|||
27969302|NCT02589665|81718900|FG001|Induction Period|Did not receive drug|0|||
27969303|NCT02589665|81718901|FG002|Induction Period|Did not receive drug|0|||
27969304|NCT02589665|81718902|FG003|Induction Period|Did not receive drug|1|||
27969305|NCT02589665|81718903|FG004|Induction Period|Did not receive drug|0|||
27969306|NCT02589665|81718904|FG005|Induction Period|Did not receive drug|0|||
27969307|NCT02589665|81718905|FG006|Induction Period|Did not receive drug|0|||
27969308|NCT02589665|81718906|FG007|Induction Period|Did not receive drug|0|||
27969309|NCT02589665|81718907|FG008|Induction Period|Did not receive drug|0|||
27969310|NCT02589665|81718908|FG009|Induction Period|Did not receive drug|0|||
27969311|NCT02589665|81718899|FG000|Induction Period|Adverse Event|3|||
27969312|NCT02589665|81718900|FG001|Induction Period|Adverse Event|0|||
27969313|NCT02589665|81718901|FG002|Induction Period|Adverse Event|2|||
27969314|NCT02589665|81718902|FG003|Induction Period|Adverse Event|2|||
27863600|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
27863601|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
27969315|NCT02589665|81718903|FG004|Induction Period|Adverse Event|0|||
27969316|NCT02589665|81718904|FG005|Induction Period|Adverse Event|0|||
27666894|NCT03544229|80619621|FG003|Overall Study|Protocol Deviation|0|||
27666895|NCT03544229|80619618|FG000|Overall Study|Lost to Follow-up|3|||
27666896|NCT03544229|80619619|FG001|Overall Study|Lost to Follow-up|0|||
27666897|NCT03544229|80619620|FG002|Overall Study|Lost to Follow-up|0|||
27666898|NCT03544229|80619621|FG003|Overall Study|Lost to Follow-up|2|||
27666899|NCT03544229|80619618|FG000|Overall Study|Voluntary Withdrawal|2|||
27666900|NCT03544229|80619619|FG001|Overall Study|Voluntary Withdrawal|1|||
27666901|NCT03544229|80619620|FG002|Overall Study|Voluntary Withdrawal|3|||
27666902|NCT03544229|80619621|FG003|Overall Study|Voluntary Withdrawal|0|||
27666903|NCT03544229|80619618|FG000|Overall Study|Lack of Efficacy|0|||
27666904|NCT03544229|80619619|FG001|Overall Study|Lack of Efficacy|1|||
27666905|NCT03544229|80619620|FG002|Overall Study|Lack of Efficacy|0|||
27666906|NCT03544229|80619621|FG003|Overall Study|Lack of Efficacy|0|||
27666907|NCT01665599|80619622|FG000|Overall Study|Adverse Event|1|||
27666908|NCT01665599|80619622|FG000|Overall Study|Consent Withdrawn|1|||
27666909|NCT01665599|80619622|FG000|Overall Study|Investigator/Sponsor decision|1|||
27666910|NCT01665599|80619622|FG000|Overall Study|Death|1|||
27666911|NCT01665599|80619622|FG000|Overall Study|Lost to Follow-up|2|||
27666912|NCT01665599|80619622|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
27666913|NCT01665599|80619622|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
27666914|NCT01193218|80619623|FG000|0-12 Weeks|Adverse Event|6|||
27666915|NCT01193218|80619624|FG001|0-12 Weeks|Adverse Event|0|||
27666916|NCT01193218|80619625|FG002|0-12 Weeks|Adverse Event|1|||
27666917|NCT01193218|80619626|FG003|0-12 Weeks|Adverse Event|0|||
27666918|NCT01193218|80619627|FG004|0-12 Weeks|Adverse Event|0|||
27666919|NCT01193218|80619628|FG005|0-12 Weeks|Adverse Event|2|||
27666920|NCT01193218|80619629|FG006|0-12 Weeks|Adverse Event|2|||
27666921|NCT01193218|80619630|FG007|0-12 Weeks|Adverse Event|0|||
27666922|NCT01193218|80619623|FG000|0-12 Weeks|Protocol Violation|0|||
27666923|NCT01193218|80619624|FG001|0-12 Weeks|Protocol Violation|0|||
27666924|NCT01193218|80619625|FG002|0-12 Weeks|Protocol Violation|0|||
27666925|NCT01193218|80619626|FG003|0-12 Weeks|Protocol Violation|0|||
27666926|NCT01193218|80619627|FG004|0-12 Weeks|Protocol Violation|1|||
27666927|NCT01193218|80619628|FG005|0-12 Weeks|Protocol Violation|1|||
27666928|NCT01193218|80619629|FG006|0-12 Weeks|Protocol Violation|0|||
27570497|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570498|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570499|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570500|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570501|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570502|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27666929|NCT01193218|80619630|FG007|0-12 Weeks|Protocol Violation|0|||
27666930|NCT01193218|80619623|FG000|0-12 Weeks|Withdrawal by Subject|3|||
27666931|NCT01193218|80619624|FG001|0-12 Weeks|Withdrawal by Subject|0|||
27666932|NCT01193218|80619625|FG002|0-12 Weeks|Withdrawal by Subject|2|||
27666933|NCT01193218|80619626|FG003|0-12 Weeks|Withdrawal by Subject|0|||
27666934|NCT01193218|80619627|FG004|0-12 Weeks|Withdrawal by Subject|0|||
27666935|NCT01193218|80619628|FG005|0-12 Weeks|Withdrawal by Subject|0|||
27666936|NCT01193218|80619629|FG006|0-12 Weeks|Withdrawal by Subject|1|||
27666937|NCT01193218|80619630|FG007|0-12 Weeks|Withdrawal by Subject|0|||
27666938|NCT01193218|80619623|FG000|12-52 Weeks|Adverse Event|1|||
27666939|NCT01193218|80619624|FG001|12-52 Weeks|Adverse Event|0|||
27666940|NCT01193218|80619625|FG002|12-52 Weeks|Adverse Event|1|||
27666941|NCT01193218|80619626|FG003|12-52 Weeks|Adverse Event|2|||
27666942|NCT01193218|80619627|FG004|12-52 Weeks|Adverse Event|3|||
27666943|NCT01193218|80619628|FG005|12-52 Weeks|Adverse Event|3|||
27666944|NCT01193218|80619629|FG006|12-52 Weeks|Adverse Event|1|||
27666945|NCT01193218|80619630|FG007|12-52 Weeks|Adverse Event|2|||
27666946|NCT01193218|80619623|FG000|12-52 Weeks|Lack of Efficacy|0|||
27666947|NCT01193218|80619624|FG001|12-52 Weeks|Lack of Efficacy|0|||
27666948|NCT01193218|80619625|FG002|12-52 Weeks|Lack of Efficacy|0|||
27666949|NCT01193218|80619626|FG003|12-52 Weeks|Lack of Efficacy|0|||
27666950|NCT01193218|80619627|FG004|12-52 Weeks|Lack of Efficacy|0|||
27666951|NCT01193218|80619628|FG005|12-52 Weeks|Lack of Efficacy|0|||
27666952|NCT01193218|80619629|FG006|12-52 Weeks|Lack of Efficacy|1|||
27666953|NCT01193218|80619630|FG007|12-52 Weeks|Lack of Efficacy|0|||
27666954|NCT01193218|80619623|FG000|12-52 Weeks|Withdrawal by Subject|3|||
27666955|NCT01193218|80619624|FG001|12-52 Weeks|Withdrawal by Subject|0|||
27666956|NCT01193218|80619625|FG002|12-52 Weeks|Withdrawal by Subject|3|||
27969317|NCT02589665|81718905|FG006|Induction Period|Adverse Event|0|||
27666957|NCT01193218|80619626|FG003|12-52 Weeks|Withdrawal by Subject|0|||
27666958|NCT01193218|80619627|FG004|12-52 Weeks|Withdrawal by Subject|0|||
27666959|NCT01193218|80619628|FG005|12-52 Weeks|Withdrawal by Subject|2|||
27666960|NCT01193218|80619629|FG006|12-52 Weeks|Withdrawal by Subject|1|||
27969318|NCT02589665|81718906|FG007|Induction Period|Adverse Event|0|||
27666961|NCT01193218|80619630|FG007|12-52 Weeks|Withdrawal by Subject|2|||
27666962|NCT01193218|80619623|FG000|12-52 Weeks|Other reason than above|1|||
27666963|NCT01193218|80619624|FG001|12-52 Weeks|Other reason than above|0|||
27666964|NCT01193218|80619625|FG002|12-52 Weeks|Other reason than above|0|||
27666965|NCT01193218|80619626|FG003|12-52 Weeks|Other reason than above|1|||
27666966|NCT01193218|80619627|FG004|12-52 Weeks|Other reason than above|1|||
27666967|NCT01193218|80619628|FG005|12-52 Weeks|Other reason than above|0|||
27666968|NCT01193218|80619629|FG006|12-52 Weeks|Other reason than above|0|||
27780033|NCT01156012|81024131|FG000|Overall Study|use of commercial drug instead of study|0|||
27780034|NCT01156012|81024132|FG001|Overall Study|use of commercial drug instead of study|1|||
27780035|NCT01156012|81024131|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
27780036|NCT01156012|81024132|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
27780037|NCT02802735|81024133|FG000|Overall Study|Withdrawal by Subject|0|||
27780038|NCT02802735|81024134|FG001|Overall Study|Withdrawal by Subject|1|||
27780039|NCT02802735|81024135|FG002|Overall Study|Withdrawal by Subject|0|||
27780040|NCT02802735|81024136|FG003|Overall Study|Withdrawal by Subject|0|||
27780041|NCT02802735|81024137|FG004|Overall Study|Withdrawal by Subject|0|||
27780042|NCT02324049|81024138|FG000|Part C|Study terminated|11|||
27780043|NCT03125902|81024139|FG000|Overall Study|Adverse Event|0|||
27780044|NCT03125902|81024140|FG001|Overall Study|Adverse Event|1|||
27780045|NCT03125902|81024139|FG000|Overall Study|Death|119|||
27780046|NCT03125902|81024140|FG001|Overall Study|Death|229|||
27780047|NCT03125902|81024139|FG000|Overall Study|Lost to Follow-up|4|||
27780048|NCT03125902|81024140|FG001|Overall Study|Lost to Follow-up|13|||
27780049|NCT03125902|81024139|FG000|Overall Study|Other|0|||
27780050|NCT03125902|81024140|FG001|Overall Study|Other|4|||
27780051|NCT03125902|81024139|FG000|Overall Study|Physician Decision|2|||
27780052|NCT03125902|81024140|FG001|Overall Study|Physician Decision|1|||
27780053|NCT03125902|81024139|FG000|Overall Study|Progressive Disease|0|||
27780054|NCT03125902|81024140|FG001|Overall Study|Progressive Disease|3|||
27666969|NCT01193218|80619630|FG007|12-52 Weeks|Other reason than above|0|||
27666970|NCT00843115|80619636|FG000|Overall Study|Death|4|||
27666971|NCT00843115|80619636|FG000|Overall Study|Adverse Event|30|||
27666972|NCT00843115|80619636|FG000|Overall Study|Lost to Follow-up|4|||
27666973|NCT00843115|80619636|FG000|Overall Study|Withdrawal by Subject|17|||
27780055|NCT03125902|81024139|FG000|Overall Study|Study Terminated By Sponsor|74|||
27780056|NCT03125902|81024140|FG001|Overall Study|Study Terminated By Sponsor|143|||
27780057|NCT03125902|81024139|FG000|Overall Study|Withdrawal by Subject|21|||
27969319|NCT02589665|81718907|FG008|Induction Period|Adverse Event|0|||
27969320|NCT02589665|81718908|FG009|Induction Period|Adverse Event|0|||
27969321|NCT02589665|81718899|FG000|Induction Period|Withdrawal by Subject|0|||
27969322|NCT02589665|81718900|FG001|Induction Period|Withdrawal by Subject|1|||
27969323|NCT02589665|81718901|FG002|Induction Period|Withdrawal by Subject|0|||
27969324|NCT02589665|81718902|FG003|Induction Period|Withdrawal by Subject|1|||
27969325|NCT02589665|81718903|FG004|Induction Period|Withdrawal by Subject|0|||
27969326|NCT02589665|81718904|FG005|Induction Period|Withdrawal by Subject|0|||
27969327|NCT02589665|81718905|FG006|Induction Period|Withdrawal by Subject|0|||
27969328|NCT02589665|81718906|FG007|Induction Period|Withdrawal by Subject|0|||
27570503|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27780058|NCT03125902|81024140|FG001|Overall Study|Withdrawal by Subject|37|||
27780059|NCT01227252|81024150|FG000|Overall Study|Sponsor Decision|0|||
27780060|NCT01227252|81024151|FG001|Overall Study|Sponsor Decision|1|||
27780061|NCT01227252|81024152|FG002|Overall Study|Sponsor Decision|0|||
27780062|NCT01227252|81024153|FG003|Overall Study|Sponsor Decision|0|||
27780063|NCT01227252|81024150|FG000|Overall Study|Lost to Follow-up|0|||
27780064|NCT01227252|81024151|FG001|Overall Study|Lost to Follow-up|1|||
27780065|NCT01227252|81024152|FG002|Overall Study|Lost to Follow-up|0|||
27780066|NCT01227252|81024153|FG003|Overall Study|Lost to Follow-up|0|||
27780067|NCT01227252|81024150|FG000|Overall Study|Withdrawal by Subject|0|||
27780068|NCT01227252|81024151|FG001|Overall Study|Withdrawal by Subject|1|||
27780069|NCT01227252|81024152|FG002|Overall Study|Withdrawal by Subject|0|||
27780070|NCT01227252|81024153|FG003|Overall Study|Withdrawal by Subject|0|||
27969329|NCT02589665|81718907|FG008|Induction Period|Withdrawal by Subject|0|||
27570504|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570505|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27780071|NCT00550615|81024154|FG000|Overall Study|Withdrawal by Subject|0|||
27780072|NCT00550615|81024155|FG001|Overall Study|Withdrawal by Subject|0|||
27780073|NCT00550615|81024156|FG002|Overall Study|Withdrawal by Subject|2|||
27780074|NCT00550615|81024157|FG003|Overall Study|Withdrawal by Subject|3|||
27969330|NCT02589665|81718908|FG009|Induction Period|Withdrawal by Subject|0|||
27969331|NCT02589665|81718899|FG000|Induction Period|Protocol Violation|0|||
27780075|NCT00550615|81024154|FG000|Overall Study|Not evaluable|0|||
27780076|NCT00550615|81024155|FG001|Overall Study|Not evaluable|0|||
27780077|NCT00550615|81024156|FG002|Overall Study|Not evaluable|2|||
27780078|NCT00550615|81024157|FG003|Overall Study|Not evaluable|7|||
27780079|NCT03267576|81024158|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
27969332|NCT02589665|81718900|FG001|Induction Period|Protocol Violation|1|||
27969333|NCT02589665|81718901|FG002|Induction Period|Protocol Violation|0|||
27969334|NCT02589665|81718902|FG003|Induction Period|Protocol Violation|0|||
27969335|NCT02589665|81718903|FG004|Induction Period|Protocol Violation|0|||
27969336|NCT02589665|81718904|FG005|Induction Period|Protocol Violation|0|||
27969337|NCT02589665|81718905|FG006|Induction Period|Protocol Violation|0|||
27969338|NCT02589665|81718906|FG007|Induction Period|Protocol Violation|0|||
27969339|NCT02589665|81718907|FG008|Induction Period|Protocol Violation|0|||
27969340|NCT02589665|81718908|FG009|Induction Period|Protocol Violation|0|||
27969341|NCT02589665|81718899|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969342|NCT02589665|81718900|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969343|NCT02589665|81718901|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969344|NCT02589665|81718902|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969345|NCT02589665|81718903|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
27969346|NCT02589665|81718904|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
27666974|NCT00843115|80619636|FG000|Overall Study|Family wanted meds stopped|1|||
27666975|NCT00843115|80619636|FG000|Overall Study|Family does not want continuation|1|||
27666976|NCT00843115|80619636|FG000|Overall Study|Patient forgot to take meds|1|||
27666977|NCT00843115|80619636|FG000|Overall Study|Does not meet entrance criteria|1|||
27666978|NCT00843115|80619636|FG000|Overall Study|Physician Decision|1|||
27666979|NCT00843115|80619636|FG000|Overall Study|Family discontinued meds|1|||
27666980|NCT00843115|80619636|FG000|Overall Study|patient took for 2 days then stopped|1|||
27666981|NCT00843115|80619636|FG000|Overall Study|patient never took the medication|1|||
27666982|NCT00843115|80619636|FG000|Overall Study|hospitalized due to deterioration|1|||
27780080|NCT03267576|81024159|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
27780081|NCT03267576|81024158|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
27780082|NCT03267576|81024159|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
27780083|NCT00439309|81024161|FG000|Follow-Up|Death|1|||
27780084|NCT00439309|81024162|FG001|Follow-Up|Death|0|||
27780085|NCT00439309|81024161|FG000|Follow-Up|Lost to Follow-up|2|||
27780086|NCT00439309|81024162|FG001|Follow-Up|Lost to Follow-up|0|||
27780087|NCT00439309|81024161|FG000|Follow-Up|Withdrawal by Subject|0|||
27780088|NCT00439309|81024162|FG001|Follow-Up|Withdrawal by Subject|1|||
27780089|NCT00439309|81024161|FG000|Follow-Up|Late response by subject|0|||
27780090|NCT00439309|81024162|FG001|Follow-Up|Late response by subject|1|||
27780091|NCT03267511|81024163|FG000|Overall Study|Lost to Follow-up|0|||
27780092|NCT03267511|81024164|FG001|Overall Study|Lost to Follow-up|0|||
27780093|NCT03267511|81024165|FG002|Overall Study|Lost to Follow-up|0|||
27780094|NCT03267511|81024166|FG003|Overall Study|Lost to Follow-up|1|||
27780095|NCT02576652|81024168|FG000|Overall Study|Withdrawal by Subject|2|||
27780096|NCT01775995|81024169|FG000|Overall Study|Lost to Follow-up|1|||
27780097|NCT01775995|81024170|FG001|Overall Study|Lost to Follow-up|1|||
27780098|NCT03323385|81024174|FG000|Overall Study|Withdrawal by Subject|1|||
27780099|NCT03323385|81024175|FG001|Overall Study|Withdrawal by Subject|2|||
27780100|NCT03323385|81024174|FG000|Overall Study|Noncompliance|0|||
27780101|NCT03323385|81024175|FG001|Overall Study|Noncompliance|1|||
27780102|NCT03598140|81024177|FG000|Overall Study|enrolled but didn't start|1|||
27780103|NCT03598140|81024178|FG001|Overall Study|enrolled but didn't start|0|||
27780104|NCT04129242|81024179|FG000|Overall Study|Physician Decision|1|||
27780105|NCT04129242|81024180|FG001|Overall Study|Physician Decision|1|||
27780106|NCT04129242|81024179|FG000|Overall Study|Protocol Violation|0|||
27780107|NCT04129242|81024180|FG001|Overall Study|Protocol Violation|1|||
27780108|NCT05643170|81024186|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
27780109|NCT05643170|81024186|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
27780110|NCT02405091|81024187|FG000|Overall Study|Adverse Event|16|||
27780111|NCT02405091|81024188|FG001|Overall Study|Adverse Event|10|||
27780112|NCT02405091|81024189|FG002|Overall Study|Adverse Event|0|||
27780113|NCT02405091|81024187|FG000|Overall Study|Protocol Violation|1|||
27780114|NCT02405091|81024188|FG001|Overall Study|Protocol Violation|0|||
27780115|NCT02405091|81024189|FG002|Overall Study|Protocol Violation|0|||
27666983|NCT00843115|80619636|FG000|Overall Study|week 12 not done|1|||
27666984|NCT00843115|80619636|FG000|Overall Study|Syndrome De Glissement|1|||
27666985|NCT00833898|80619639|FG000|Overall Study|Withdrawal by Subject|33|||
27780116|NCT02405091|81024187|FG000|Overall Study|Noncompliance|1|||
27780117|NCT02405091|81024188|FG001|Overall Study|Noncompliance|6|||
27780118|NCT02405091|81024189|FG002|Overall Study|Noncompliance|2|||
27666986|NCT00833898|80619640|FG001|Overall Study|Withdrawal by Subject|27|||
27780119|NCT02405091|81024187|FG000|Overall Study|Withdrawal by Subject|4|||
27780120|NCT02405091|81024188|FG001|Overall Study|Withdrawal by Subject|8|||
27780121|NCT02405091|81024189|FG002|Overall Study|Withdrawal by Subject|0|||
27863602|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
27863603|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
27863604|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
27863605|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
27863606|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
27863607|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
27863608|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
27863609|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
27863610|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
27863611|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
27863612|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
27863613|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
27863614|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
27863615|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
27863616|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
27863617|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
27863618|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
27863619|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
27863620|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
27863621|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
27863622|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Death|0|||
27863623|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Death|1|||
27863624|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Death|0|||
27863625|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Death|0|||
27863626|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Death|0|||
27863627|NCT03713632|81333049|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27863628|NCT03713632|81333050|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
27863629|NCT03713632|81333051|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27863630|NCT03713632|81333052|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27863631|NCT03713632|81333053|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
27863632|NCT01959295|81333054|FG000|Overall Study|Adverse Event|2|||
27863633|NCT01959295|81333055|FG001|Overall Study|Adverse Event|0|||
27863634|NCT01959295|81333054|FG000|Overall Study|Lost to Follow-up|0|||
27863635|NCT01959295|81333055|FG001|Overall Study|Lost to Follow-up|2|||
27863636|NCT01959295|81333054|FG000|Overall Study|Physician Decision|2|||
27863637|NCT01959295|81333055|FG001|Overall Study|Physician Decision|3|||
27863638|NCT01959295|81333054|FG000|Overall Study|Protocol Violation|16|||
27863639|NCT01959295|81333055|FG001|Overall Study|Protocol Violation|5|||
27863640|NCT01959295|81333054|FG000|Overall Study|Withdrawal by Subject|3|||
27863641|NCT01959295|81333055|FG001|Overall Study|Withdrawal by Subject|1|||
27863642|NCT01959295|81333054|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
27863643|NCT01959295|81333055|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
27863644|NCT01769456|81333056|FG000|Overall Study|Lost to Follow-up|19|||
27863645|NCT01769456|81333056|FG000|Overall Study|Withdrawal by Subject|3|||
27863646|NCT01769456|81333056|FG000|Overall Study|Did not receive PCC intervention|6|||
27863647|NCT01769456|81333056|FG000|Overall Study|Moved out of the area|3|||
27863648|NCT01769456|81333056|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
27863649|NCT01769456|81333056|FG000|Overall Study|Parental request to youth to withdraw|1|||
27863650|NCT03496610|81333057|FG000|Overall Study|Lost to Follow-up|3|||
27969347|NCT02589665|81718905|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
27780122|NCT02405091|81024187|FG000|Overall Study|Death|0|||
27780123|NCT02405091|81024188|FG001|Overall Study|Death|1|||
27780124|NCT02405091|81024189|FG002|Overall Study|Death|0|||
27780125|NCT02405091|81024187|FG000|Overall Study|Lost to Follow-up|5|||
27780126|NCT02405091|81024188|FG001|Overall Study|Lost to Follow-up|6|||
27780127|NCT02405091|81024189|FG002|Overall Study|Lost to Follow-up|0|||
27780128|NCT02405091|81024187|FG000|Overall Study|Physician Decision|2|||
27780129|NCT02405091|81024188|FG001|Overall Study|Physician Decision|2|||
27780130|NCT02405091|81024189|FG002|Overall Study|Physician Decision|0|||
27780131|NCT01599585|81024192|FG000|Overall Study|Withdrawal by Subject|16|||
27780132|NCT01599585|81024193|FG001|Overall Study|Withdrawal by Subject|9|||
27780133|NCT01599585|81024192|FG000|Overall Study|Lost to Follow-up|3|||
27780134|NCT01599585|81024193|FG001|Overall Study|Lost to Follow-up|5|||
27780135|NCT01599585|81024192|FG000|Overall Study|randomized did not start treatment|3|||
27780136|NCT01599585|81024193|FG001|Overall Study|randomized did not start treatment|3|||
27780137|NCT01196091|81024194|FG000|Overall Study|Adverse Event|22|||
27863651|NCT03496610|81333058|FG001|Overall Study|Lost to Follow-up|2|||
27863652|NCT03496610|81333057|FG000|Overall Study|Physician Decision|1|||
27969348|NCT02589665|81718906|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27570506|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27780138|NCT01196091|81024195|FG001|Overall Study|Adverse Event|27|||
27780139|NCT01196091|81024196|FG002|Overall Study|Adverse Event|26|||
27780140|NCT01196091|81024194|FG000|Overall Study|Death|3|||
27780141|NCT01196091|81024195|FG001|Overall Study|Death|2|||
27780142|NCT01196091|81024196|FG002|Overall Study|Death|2|||
27780143|NCT01196091|81024194|FG000|Overall Study|Entry Criteria Not Met|11|||
27780144|NCT01196091|81024195|FG001|Overall Study|Entry Criteria Not Met|11|||
27780145|NCT01196091|81024196|FG002|Overall Study|Entry Criteria Not Met|10|||
27780146|NCT01196091|81024194|FG000|Overall Study|Lack of Efficacy|15|||
27780147|NCT01196091|81024195|FG001|Overall Study|Lack of Efficacy|12|||
27780148|NCT01196091|81024196|FG002|Overall Study|Lack of Efficacy|17|||
27780149|NCT01196091|81024194|FG000|Overall Study|Lost to Follow-up|5|||
27780150|NCT01196091|81024195|FG001|Overall Study|Lost to Follow-up|5|||
27780151|NCT01196091|81024196|FG002|Overall Study|Lost to Follow-up|6|||
27780152|NCT01196091|81024194|FG000|Overall Study|Parent/Caregiver Decision|0|||
27780153|NCT01196091|81024195|FG001|Overall Study|Parent/Caregiver Decision|0|||
27780154|NCT01196091|81024196|FG002|Overall Study|Parent/Caregiver Decision|1|||
27780155|NCT01196091|81024194|FG000|Overall Study|Withdrawal by Subject|16|||
27780156|NCT01196091|81024195|FG001|Overall Study|Withdrawal by Subject|19|||
27780157|NCT01196091|81024196|FG002|Overall Study|Withdrawal by Subject|22|||
27780158|NCT01196091|81024194|FG000|Overall Study|Physician Decision|3|||
27780159|NCT01196091|81024195|FG001|Overall Study|Physician Decision|3|||
27780160|NCT01196091|81024196|FG002|Overall Study|Physician Decision|4|||
27780161|NCT01196091|81024194|FG000|Overall Study|Protocol Violation|1|||
27780162|NCT01196091|81024195|FG001|Overall Study|Protocol Violation|3|||
27780163|NCT01196091|81024196|FG002|Overall Study|Protocol Violation|3|||
27780164|NCT01196091|81024194|FG000|Overall Study|Sponsor Decision|6|||
27780165|NCT01196091|81024195|FG001|Overall Study|Sponsor Decision|5|||
27780166|NCT01196091|81024196|FG002|Overall Study|Sponsor Decision|4|||
27780167|NCT01196091|81024194|FG000|Overall Study|Excluded Site|5|||
27780168|NCT01196091|81024195|FG001|Overall Study|Excluded Site|11|||
27780169|NCT01196091|81024196|FG002|Overall Study|Excluded Site|8|||
27780170|NCT01196091|81024194|FG000|Overall Study|Randomized, No Study Drug Received|1|||
27780171|NCT01196091|81024195|FG001|Overall Study|Randomized, No Study Drug Received|0|||
27780172|NCT01196091|81024196|FG002|Overall Study|Randomized, No Study Drug Received|1|||
27780173|NCT02061540|81024197|FG000|Overall Study|Adverse Event|2|||
27780174|NCT02061540|81024197|FG000|Overall Study|Withdrawal by Subject|2|||
27780175|NCT02933489|81024198|FG000|Overall Study|Ineligible|3|||
27780176|NCT02933489|81024199|FG001|Overall Study|Ineligible|3|||
27780177|NCT02933489|81024198|FG000|Overall Study|Withdrawal by Subject|27|||
27780178|NCT02933489|81024199|FG001|Overall Study|Withdrawal by Subject|18|||
27780179|NCT02933489|81024198|FG000|Overall Study|Unable to complete exams (other)|14|||
27780180|NCT02933489|81024199|FG001|Overall Study|Unable to complete exams (other)|7|||
27780181|NCT04735432|81024200|FG000|Overall Study|Other - due to personal reason|1|||
27780182|NCT04735432|81024201|FG001|Overall Study|Other - due to personal reason|0|||
27780183|NCT04735432|81024200|FG000|Overall Study|Adverse Event|2|||
27780184|NCT04735432|81024201|FG001|Overall Study|Adverse Event|0|||
27780185|NCT01058356|81024202|FG000|Overall Study|Adverse Event|5|||
27780186|NCT01058356|81024202|FG000|Overall Study|Administration of contraindicated drugs|12|||
27780187|NCT01058356|81024202|FG000|Overall Study|Withdrawal by Subject|21|||
27780188|NCT01058356|81024202|FG000|Overall Study|Lost to Follow-up|4|||
27780189|NCT04051944|81024203|FG000|Overall Study|Study ending|1|||
27780190|NCT04051944|81024204|FG001|Overall Study|Study ending|1|||
27780191|NCT04051944|81024203|FG000|Overall Study|Early study termination by participant|1|||
27780192|NCT04051944|81024204|FG001|Overall Study|Early study termination by participant|0|||
27780193|NCT04051944|81024203|FG000|Overall Study|Withdrawal by Subject|2|||
27780194|NCT04051944|81024204|FG001|Overall Study|Withdrawal by Subject|2|||
27780195|NCT04051944|81024203|FG000|Overall Study|Lack of Efficacy|3|||
27780196|NCT04051944|81024204|FG001|Overall Study|Lack of Efficacy|0|||
27780197|NCT04051944|81024203|FG000|Overall Study|Adverse event, non- fatal|1|||
27780198|NCT04051944|81024204|FG001|Overall Study|Adverse event, non- fatal|1|||
27780199|NCT00033293|81024209|FG000|Overall Study|Death|0|||
27780200|NCT00033293|81024210|FG001|Overall Study|Death|1|||
27780201|NCT00033293|81024209|FG000|Overall Study|Lack of Efficacy|5|||
27780202|NCT00033293|81024210|FG001|Overall Study|Lack of Efficacy|8|||
27863653|NCT03496610|81333058|FG001|Overall Study|Physician Decision|0|||
27863654|NCT03496610|81333057|FG000|Overall Study|Withdrawal by Subject|1|||
27780203|NCT00033293|81024209|FG000|Overall Study|Lost to Follow-up|0|||
27780204|NCT00033293|81024210|FG001|Overall Study|Lost to Follow-up|1|||
27780205|NCT00033293|81024209|FG000|Overall Study|Physician Decision|3|||
27780206|NCT00033293|81024210|FG001|Overall Study|Physician Decision|1|||
27780207|NCT00033293|81024209|FG000|Overall Study|Withdrawal by Subject|1|||
27780208|NCT00033293|81024210|FG001|Overall Study|Withdrawal by Subject|0|||
27780209|NCT00033293|81024209|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
27780210|NCT00033293|81024210|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
27780211|NCT00033293|81024209|FG000|Overall Study|Treatment refused|0|||
27780212|NCT00033293|81024210|FG001|Overall Study|Treatment refused|6|||
27780213|NCT01412333|81024212|FG000|Overall Study|Adverse Event|40|||
27780214|NCT01412333|81024213|FG001|Overall Study|Adverse Event|42|||
27780215|NCT01412333|81024212|FG000|Overall Study|Death|5|||
27780216|NCT01412333|81024213|FG001|Overall Study|Death|6|||
27780217|NCT01412333|81024212|FG000|Overall Study|Lack of Efficacy|22|||
27780218|NCT01412333|81024213|FG001|Overall Study|Lack of Efficacy|10|||
27780219|NCT01412333|81024212|FG000|Overall Study|Lost to Follow-up|15|||
27780220|NCT01412333|81024213|FG001|Overall Study|Lost to Follow-up|12|||
27780221|NCT01412333|81024212|FG000|Overall Study|Non-Compliance|3|||
27780222|NCT01412333|81024213|FG001|Overall Study|Non-Compliance|7|||
27780223|NCT01412333|81024212|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27780224|NCT01412333|81024213|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27780225|NCT01412333|81024212|FG000|Overall Study|Other|30|||
27780226|NCT01412333|81024213|FG001|Overall Study|Other|33|||
27780227|NCT01412333|81024212|FG000|Overall Study|Physician Decision|11|||
27780228|NCT01412333|81024213|FG001|Overall Study|Physician Decision|16|||
27780229|NCT01412333|81024212|FG000|Overall Study|Pregnancy|6|||
27780230|NCT01412333|81024213|FG001|Overall Study|Pregnancy|4|||
27780231|NCT01412333|81024212|FG000|Overall Study|Protocol Violation|1|||
27780232|NCT01412333|81024213|FG001|Overall Study|Protocol Violation|2|||
27780233|NCT01412333|81024212|FG000|Overall Study|Study Terminated By Sponsor|3|||
27780234|NCT01412333|81024213|FG001|Overall Study|Study Terminated By Sponsor|2|||
27780235|NCT01412333|81024212|FG000|Overall Study|Withdrawal by Subject|51|||
27780236|NCT01412333|81024213|FG001|Overall Study|Withdrawal by Subject|54|||
27780237|NCT01412333|81024212|FG000|Overall Study|Missing|1|||
27780238|NCT01412333|81024213|FG001|Overall Study|Missing|3|||
27780239|NCT00850135|81024214|FG000|Overall Study|Physician Decision|1|||
27780240|NCT03500419|81024215|FG000|Overall Study|Withdrawal by Subject|2|||
27780241|NCT03500419|81024216|FG001|Overall Study|Withdrawal by Subject|25|||
27780242|NCT00877890|81024219|FG000|Overall Study|Adverse Event|6|||
27780243|NCT00877890|81024220|FG001|Overall Study|Adverse Event|6|||
27780244|NCT00877890|81024219|FG000|Overall Study|Lost to Follow-up|5|||
27780245|NCT00877890|81024220|FG001|Overall Study|Lost to Follow-up|5|||
27780246|NCT00877890|81024219|FG000|Overall Study|Protocol Violation|0|||
27780247|NCT00877890|81024220|FG001|Overall Study|Protocol Violation|1|||
27780248|NCT00877890|81024219|FG000|Overall Study|Withdrawal of Consent|6|||
27780249|NCT00877890|81024220|FG001|Overall Study|Withdrawal of Consent|12|||
27780250|NCT00877890|81024219|FG000|Overall Study|Investigator Decision|0|||
27780251|NCT00877890|81024220|FG001|Overall Study|Investigator Decision|2|||
27780252|NCT00877890|81024219|FG000|Overall Study|Loss of Glucose Control|3|||
27780253|NCT00877890|81024220|FG001|Overall Study|Loss of Glucose Control|4|||
27780254|NCT00638989|81024223|FG000|Overall Study|Lost to Follow-up|0|||
27780255|NCT00638989|81024224|FG001|Overall Study|Lost to Follow-up|0|||
27780256|NCT00638989|81024225|FG002|Overall Study|Lost to Follow-up|1|||
27780257|NCT00679354|81024235|FG000|Overall Study|Death|3|||
27780258|NCT00679354|81024235|FG000|Overall Study|Lack of Efficacy|22|||
27780259|NCT00679354|81024235|FG000|Overall Study|Physician Decision|4|||
27780260|NCT00679354|81024235|FG000|Overall Study|Ineligible|1|||
27780261|NCT00656799|81024238|FG000|Overall Study|Death|2|||
27780262|NCT00661362|81024241|FG000|Overall Study|Adverse Event|5|||
27780263|NCT00661362|81024242|FG001|Overall Study|Adverse Event|4|||
27780264|NCT00661362|81024241|FG000|Overall Study|Incorrect enrollment|2|||
27780265|NCT00661362|81024242|FG001|Overall Study|Incorrect enrollment|0|||
27780266|NCT00661362|81024241|FG000|Overall Study|Study specific discontinuation criteria|4|||
27780267|NCT00661362|81024242|FG001|Overall Study|Study specific discontinuation criteria|11|||
27780268|NCT00661362|81024241|FG000|Overall Study|Withdrawal by Subject|13|||
27780269|NCT00661362|81024242|FG001|Overall Study|Withdrawal by Subject|23|||
27780270|NCT00661362|81024241|FG000|Overall Study|Lost to Follow-up|3|||
27780271|NCT00661362|81024242|FG001|Overall Study|Lost to Follow-up|1|||
27780272|NCT00661362|81024241|FG000|Overall Study|Severe non-compliance to protocol|0|||
27780273|NCT00661362|81024242|FG001|Overall Study|Severe non-compliance to protocol|1|||
27780274|NCT00661362|81024241|FG000|Overall Study|Safety reasons|1|||
27780275|NCT00661362|81024242|FG001|Overall Study|Safety reasons|0|||
27780276|NCT00661362|81024241|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
27780277|NCT00661362|81024242|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
27780278|NCT00440232|81024243|FG000|Overall Study|Lost to Follow-up|1|||
27780279|NCT00440232|81024244|FG001|Overall Study|Lost to Follow-up|1|||
27780280|NCT00440232|81024243|FG000|Overall Study|Unable to treat within allowed time|0|||
27780281|NCT00440232|81024244|FG001|Overall Study|Unable to treat within allowed time|1|||
27780282|NCT00440232|81024243|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
27780283|NCT00440232|81024244|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
27780284|NCT00381706|81024245|FG000|Overall Study|Never treated|7|||
27780285|NCT00381706|81024246|FG001|Overall Study|Never treated|2|||
27780286|NCT00381706|81024247|FG002|Overall Study|Never treated|1|||
27780287|NCT00125268|81024248|FG000|Overall Study|Withdrawal by Subject|1|||
27780288|NCT00125268|81024249|FG001|Overall Study|Withdrawal by Subject|1|||
27780289|NCT03557801|81024252|FG000|Overall Study|Protocol Violation|1|||
27780290|NCT03557801|81024253|FG001|Overall Study|Protocol Violation|0|||
27863655|NCT03496610|81333058|FG001|Overall Study|Withdrawal by Subject|0|||
27780291|NCT03557801|81024254|FG002|Overall Study|Protocol Violation|0|||
27780292|NCT03557801|81024252|FG000|Overall Study|Withdrawal by Subject|1|||
27780293|NCT03557801|81024253|FG001|Overall Study|Withdrawal by Subject|0|||
27780294|NCT03557801|81024254|FG002|Overall Study|Withdrawal by Subject|3|||
27780295|NCT03557801|81024252|FG000|Overall Study|Lost to Follow-up|0|||
27780296|NCT03557801|81024253|FG001|Overall Study|Lost to Follow-up|1|||
27780297|NCT03557801|81024254|FG002|Overall Study|Lost to Follow-up|0|||
27780298|NCT03961529|81024256|FG000|Overall Study|Adverse Event|13|||
27780299|NCT03961529|81024257|FG001|Overall Study|Adverse Event|5|||
27780300|NCT03961529|81024258|FG002|Overall Study|Adverse Event|2|||
27780301|NCT03961529|81024256|FG000|Overall Study|Withdrawal by Subject|17|||
27780302|NCT03961529|81024257|FG001|Overall Study|Withdrawal by Subject|2|||
27780303|NCT03961529|81024258|FG002|Overall Study|Withdrawal by Subject|1|||
27780304|NCT03961529|81024256|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27780305|NCT03961529|81024257|FG001|Overall Study|Withdrawal by parent/guardian|7|||
27780306|NCT03961529|81024258|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27780307|NCT03961529|81024256|FG000|Overall Study|Physician Decision|2|||
27780308|NCT03961529|81024257|FG001|Overall Study|Physician Decision|1|||
27780309|NCT03961529|81024258|FG002|Overall Study|Physician Decision|1|||
27780310|NCT03961529|81024256|FG000|Overall Study|Lost to Follow-up|2|||
27780311|NCT03961529|81024257|FG001|Overall Study|Lost to Follow-up|1|||
27780312|NCT03961529|81024258|FG002|Overall Study|Lost to Follow-up|0|||
27780313|NCT03961529|81024256|FG000|Overall Study|Lack of Efficacy|2|||
27780314|NCT03961529|81024257|FG001|Overall Study|Lack of Efficacy|0|||
27780315|NCT03961529|81024258|FG002|Overall Study|Lack of Efficacy|1|||
27780316|NCT03961529|81024256|FG000|Overall Study|Other|6|||
27780317|NCT03961529|81024257|FG001|Overall Study|Other|1|||
27780318|NCT03961529|81024258|FG002|Overall Study|Other|0|||
27780319|NCT00829010|81024259|FG000|Overall Study|Adverse Event|1|||
27780320|NCT00829010|81024260|FG001|Overall Study|Adverse Event|0|||
27780321|NCT00829010|81024261|FG002|Overall Study|Adverse Event|0|||
27780322|NCT00829010|81024262|FG003|Overall Study|Adverse Event|0|||
27780323|NCT00829010|81024263|FG004|Overall Study|Adverse Event|0|||
27780324|NCT00829010|81024259|FG000|Overall Study|Withdrawal by Subject|0|||
27780325|NCT00829010|81024260|FG001|Overall Study|Withdrawal by Subject|1|||
27780326|NCT00829010|81024261|FG002|Overall Study|Withdrawal by Subject|1|||
27780327|NCT00829010|81024262|FG003|Overall Study|Withdrawal by Subject|0|||
27780328|NCT00829010|81024263|FG004|Overall Study|Withdrawal by Subject|2|||
27780329|NCT00829010|81024259|FG000|Overall Study|Lost to Follow-up|1|||
27780330|NCT00829010|81024260|FG001|Overall Study|Lost to Follow-up|0|||
27780331|NCT00829010|81024261|FG002|Overall Study|Lost to Follow-up|2|||
27780332|NCT00829010|81024262|FG003|Overall Study|Lost to Follow-up|0|||
27863656|NCT04971187|81333059|FG000|Overall Study|Screen failures|2|||
27863657|NCT02540850|81333060|FG000|Overall Study|Lost to Follow-up|69|||
27863658|NCT02540850|81333061|FG001|Overall Study|Lost to Follow-up|66|||
27863659|NCT02540850|81333062|FG002|Overall Study|Lost to Follow-up|34|||
27863660|NCT02461160|81333063|FG000|Overall Study|Lost to Follow-up|0|||
27863661|NCT02461160|81333064|FG001|Overall Study|Lost to Follow-up|0|||
27863662|NCT02461160|81333065|FG002|Overall Study|Lost to Follow-up|0|||
27863663|NCT02461160|81333066|FG003|Overall Study|Lost to Follow-up|0|||
27863664|NCT02461160|81333067|FG004|Overall Study|Lost to Follow-up|0|||
27863665|NCT02461160|81333068|FG005|Overall Study|Lost to Follow-up|0|||
27863666|NCT02461160|81333069|FG006|Overall Study|Lost to Follow-up|0|||
27863667|NCT02461160|81333070|FG007|Overall Study|Lost to Follow-up|1|||
27863668|NCT02461160|81333071|FG008|Overall Study|Lost to Follow-up|0|||
27863669|NCT02461160|81333072|FG009|Overall Study|Lost to Follow-up|0|||
27863670|NCT02461160|81333073|FG010|Overall Study|Lost to Follow-up|0|||
27780333|NCT00829010|81024263|FG004|Overall Study|Lost to Follow-up|0|||
27780334|NCT00829010|81024259|FG000|Overall Study|Fatality|5|||
27780335|NCT00829010|81024260|FG001|Overall Study|Fatality|4|||
27780336|NCT00829010|81024261|FG002|Overall Study|Fatality|0|||
27780337|NCT00829010|81024262|FG003|Overall Study|Fatality|3|||
27780338|NCT00829010|81024263|FG004|Overall Study|Fatality|0|||
27780339|NCT00829010|81024259|FG000|Overall Study|Migrated/Moved from study area|3|||
27780340|NCT00829010|81024260|FG001|Overall Study|Migrated/Moved from study area|4|||
27863671|NCT02461160|81333074|FG011|Overall Study|Lost to Follow-up|0|||
27863672|NCT02461160|81333075|FG012|Overall Study|Lost to Follow-up|0|||
27863673|NCT04874155|81333083|FG000|Overall Study|Lost to Follow-up|1|||
27780341|NCT00829010|81024261|FG002|Overall Study|Migrated/Moved from study area|0|||
27780342|NCT00829010|81024262|FG003|Overall Study|Migrated/Moved from study area|5|||
27780343|NCT00829010|81024263|FG004|Overall Study|Migrated/Moved from study area|0|||
27780344|NCT00529152|81024264|FG000|Overall Study|Adverse Event|2|||
27780345|NCT00529152|81024264|FG000|Overall Study|Withdrawal by Subject|2|||
27780346|NCT00529152|81024264|FG000|Overall Study|Lost to Follow-up|1|||
27863674|NCT04874155|81333084|FG001|Overall Study|Lost to Follow-up|1|||
27863675|NCT04874155|81333083|FG000|Overall Study|Withdrawal by Subject|2|||
27780347|NCT00323479|81024265|FG000|Overall Study|Adverse Event|2|||
27863676|NCT04874155|81333084|FG001|Overall Study|Withdrawal by Subject|2|||
27969349|NCT02589665|81718907|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969350|NCT02589665|81718908|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27666987|NCT00833898|80619639|FG000|Overall Study|Lost to Follow-up|7|||
27666988|NCT00833898|80619640|FG001|Overall Study|Lost to Follow-up|7|||
27666989|NCT00833898|80619639|FG000|Overall Study|Patient did not receive transplant|0|||
27780348|NCT00323479|81024265|FG000|Overall Study|Withdrawal by Subject|2|||
27780349|NCT00323479|81024265|FG000|Overall Study|Protocol Violation|3|||
27780350|NCT00323479|81024265|FG000|Overall Study|house moving|1|||
27780351|NCT03818399|81024267|FG000|Overall Study|Lost to Follow-up|11|||
27780352|NCT03818399|81024267|FG000|Overall Study|Withdrawal by Subject|1|||
27780353|NCT03818399|81024267|FG000|Overall Study|Protocol Violation|2|||
27780354|NCT04005885|81024270|FG000|First Intervention|Withdrawal by Subject|1|||
27780355|NCT04005885|81024271|FG001|First Intervention|Withdrawal by Subject|1|||
27780356|NCT04005885|81024270|FG000|Second Intervention|Withdrawal by Subject|0|||
27780357|NCT04005885|81024271|FG001|Second Intervention|Withdrawal by Subject|2|||
27780358|NCT02354690|81024274|FG000|Overall Study|Physician Decision|1|||
27780359|NCT00216086|81024281|FG000|Overall Study|Protocol Violation|1|||
27780360|NCT00216086|81024281|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
27780361|NCT00216086|81024281|FG000|Overall Study|Social Reasons|2|||
27780362|NCT02607735|81024290|FG000|Primary Study|Randomized but Never Treated|1|||
27780363|NCT02607735|81024291|FG001|Primary Study|Randomized but Never Treated|0|||
27780364|NCT02607735|81024292|FG002|Primary Study|Randomized but Never Treated|0|||
27780365|NCT02607735|81024290|FG000|Primary Study|Lost to Follow-up|4|||
27780366|NCT02607735|81024291|FG001|Primary Study|Lost to Follow-up|0|||
27666990|NCT00833898|80619640|FG001|Overall Study|Patient did not receive transplant|2|||
27666991|NCT00239681|80619646|FG000|Overall Study|Adverse Event|100|||
27666992|NCT00239681|80619647|FG001|Overall Study|Adverse Event|99|||
27666993|NCT00239681|80619646|FG000|Overall Study|Withdrawal by Subject|458|||
27666994|NCT00239681|80619647|FG001|Overall Study|Withdrawal by Subject|489|||
27666995|NCT00239681|80619646|FG000|Overall Study|Lost to Follow-up|28|||
27666996|NCT00239681|80619647|FG001|Overall Study|Lost to Follow-up|22|||
27666997|NCT00239681|80619646|FG000|Overall Study|Protocol Violation|4|||
27666998|NCT00239681|80619647|FG001|Overall Study|Protocol Violation|4|||
27666999|NCT00239681|80619646|FG000|Overall Study|Physician Decision|13|||
27667000|NCT00239681|80619647|FG001|Overall Study|Physician Decision|17|||
27667001|NCT00239681|80619646|FG000|Overall Study|No information chacked on CaseReportForm|90|||
27667002|NCT00239681|80619647|FG001|Overall Study|No information chacked on CaseReportForm|84|||
27780367|NCT02607735|81024292|FG002|Primary Study|Lost to Follow-up|0|||
27780368|NCT02607735|81024290|FG000|Primary Study|Withdrew Consent|2|||
27780369|NCT02607735|81024291|FG001|Primary Study|Withdrew Consent|0|||
27780370|NCT02607735|81024292|FG002|Primary Study|Withdrew Consent|0|||
27780371|NCT02607735|81024290|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
27780372|NCT02607735|81024291|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
27780373|NCT02607735|81024292|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
27780374|NCT02607735|81024290|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
27780375|NCT02607735|81024291|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
27780376|NCT02607735|81024292|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
27780377|NCT03137433|81024296|FG000|Overall Study|Withdrawal by Subject|11|||
27780378|NCT03137433|81024297|FG001|Overall Study|Withdrawal by Subject|11|||
27780379|NCT03137433|81024296|FG000|Overall Study|Lost to Follow-up|5|||
27780380|NCT03137433|81024297|FG001|Overall Study|Lost to Follow-up|6|||
27780381|NCT03137433|81024296|FG000|Overall Study|Physician Decision|2|||
27780382|NCT03137433|81024297|FG001|Overall Study|Physician Decision|0|||
27780383|NCT03137433|81024296|FG000|Overall Study|Moved out of study area|1|||
27780384|NCT03137433|81024297|FG001|Overall Study|Moved out of study area|0|||
27780385|NCT03137433|81024296|FG000|Overall Study|Too far out of window due to COVID|0|||
27780386|NCT03137433|81024297|FG001|Overall Study|Too far out of window due to COVID|1|||
27780387|NCT01899729|81024304|FG000|Overall Study|Adverse Event|1|||
27780388|NCT01899729|81024305|FG001|Overall Study|Adverse Event|0|||
27863677|NCT02045147|81333094|FG000|Overall Study|Withdrawal by Subject|2|||
27863678|NCT02045147|81333095|FG001|Overall Study|Withdrawal by Subject|0|||
27863679|NCT02045147|81333096|FG002|Overall Study|Withdrawal by Subject|0|||
27863680|NCT02045147|81333097|FG003|Overall Study|Withdrawal by Subject|0|||
27667003|NCT04969224|80619649|FG000|Overall Study|Adverse Event|1|||
27667004|NCT04969224|80619649|FG000|Overall Study|Enrolled but never dosed|1|||
27667005|NCT04531813|80619658|FG000|Overall Study|Protocol Violation|1|||
27667006|NCT04531813|80619658|FG000|Overall Study|Withdrawal by Subject|1|||
27667007|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
27780389|NCT01899729|81024306|FG002|Overall Study|Adverse Event|0|||
27780390|NCT01899729|81024307|FG003|Overall Study|Adverse Event|0|||
27780391|NCT01899729|81024308|FG004|Overall Study|Adverse Event|1|||
27780392|NCT01899729|81024304|FG000|Overall Study|Withdrawal by Subject|1|||
27780393|NCT01899729|81024305|FG001|Overall Study|Withdrawal by Subject|2|||
27863681|NCT02045147|81333098|FG004|Overall Study|Withdrawal by Subject|0|||
27863682|NCT02045147|81333099|FG005|Overall Study|Withdrawal by Subject|0|||
27780394|NCT01899729|81024306|FG002|Overall Study|Withdrawal by Subject|0|||
27780395|NCT01899729|81024307|FG003|Overall Study|Withdrawal by Subject|0|||
27780396|NCT01899729|81024308|FG004|Overall Study|Withdrawal by Subject|0|||
27780397|NCT01899729|81024304|FG000|Overall Study|Lack of Efficacy|0|||
27780398|NCT01899729|81024305|FG001|Overall Study|Lack of Efficacy|0|||
27780399|NCT01899729|81024306|FG002|Overall Study|Lack of Efficacy|2|||
27780400|NCT01899729|81024307|FG003|Overall Study|Lack of Efficacy|0|||
27780401|NCT01899729|81024308|FG004|Overall Study|Lack of Efficacy|1|||
27780402|NCT02364999|81024309|FG000|Overall Study|Death|136|||
27780403|NCT02364999|81024310|FG001|Overall Study|Death|138|||
27780404|NCT02364999|81024309|FG000|Overall Study|Lost to Follow-up|10|||
27780405|NCT02364999|81024310|FG001|Overall Study|Lost to Follow-up|15|||
27780406|NCT02364999|81024309|FG000|Overall Study|Protocol Violation|3|||
27570507|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27570508|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570509|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570510|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27570511|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570512|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27570513|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570514|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570515|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570516|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570517|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570518|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570519|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27667008|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
27780407|NCT02364999|81024310|FG001|Overall Study|Protocol Violation|2|||
27780408|NCT02364999|81024309|FG000|Overall Study|Withdrawal by Subject|14|||
27863683|NCT02045147|81333100|FG006|Overall Study|Withdrawal by Subject|0|||
27863684|NCT02045147|81333101|FG007|Overall Study|Withdrawal by Subject|1|||
27863685|NCT02045147|81333094|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
27863686|NCT02045147|81333095|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
27863687|NCT02045147|81333096|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
27863688|NCT02045147|81333097|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
27863689|NCT02045147|81333098|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
27863690|NCT02045147|81333099|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
27863691|NCT02045147|81333100|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
27863692|NCT02045147|81333101|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
27863693|NCT00143247|81333102|FG000|Overall Study|Death|8|||
27863694|NCT00143247|81333102|FG000|Overall Study|Adverse Event|19|||
27863695|NCT00143247|81333102|FG000|Overall Study|Lack of Efficacy|3|||
27863696|NCT00143247|81333102|FG000|Overall Study|Withdrawal by Subject|55|||
27863697|NCT00143247|81333102|FG000|Overall Study|Study terminated by sponsor|31|||
27863698|NCT00143247|81333102|FG000|Overall Study|Protocol Violation|15|||
27863699|NCT00143247|81333102|FG000|Overall Study|Lost to Follow-up|12|||
27863700|NCT00143247|81333102|FG000|Overall Study|following inaccurate lab adverse event|1|||
27863701|NCT00143247|81333102|FG000|Overall Study|Other|12|||
27863702|NCT03583086|81333104|FG000|Overall Study|Death|2|||
27863703|NCT03583086|81333105|FG001|Overall Study|Death|6|||
27863704|NCT03583086|81333106|FG002|Overall Study|Death|12|||
27863705|NCT03583086|81333107|FG003|Overall Study|Death|10|||
27863706|NCT03583086|81333108|FG004|Overall Study|Death|14|||
27863707|NCT03583086|81333109|FG005|Overall Study|Death|14|||
27863708|NCT03583086|81333110|FG006|Overall Study|Death|4|||
27863709|NCT03583086|81333104|FG000|Overall Study|Withdrawal by Subject|0|||
27863710|NCT03583086|81333105|FG001|Overall Study|Withdrawal by Subject|0|||
27863711|NCT03583086|81333106|FG002|Overall Study|Withdrawal by Subject|1|||
27863712|NCT03583086|81333107|FG003|Overall Study|Withdrawal by Subject|0|||
27863713|NCT03583086|81333108|FG004|Overall Study|Withdrawal by Subject|0|||
27863714|NCT03583086|81333109|FG005|Overall Study|Withdrawal by Subject|0|||
27863715|NCT03583086|81333110|FG006|Overall Study|Withdrawal by Subject|1|||
27863716|NCT03583086|81333104|FG000|Overall Study|Refused follow-up|0|||
27863717|NCT03583086|81333105|FG001|Overall Study|Refused follow-up|0|||
27863718|NCT03583086|81333106|FG002|Overall Study|Refused follow-up|1|||
27863719|NCT03583086|81333107|FG003|Overall Study|Refused follow-up|0|||
27863720|NCT03583086|81333108|FG004|Overall Study|Refused follow-up|1|||
27863721|NCT03583086|81333109|FG005|Overall Study|Refused follow-up|0|||
27780409|NCT02364999|81024310|FG001|Overall Study|Withdrawal by Subject|14|||
27780410|NCT02364999|81024309|FG000|Overall Study|Other|0|||
27863722|NCT03583086|81333110|FG006|Overall Study|Refused follow-up|0|||
27863723|NCT03583086|81333104|FG000|Overall Study|Declining Performance Status|0|||
27780411|NCT02364999|81024310|FG001|Overall Study|Other|1|||
27570520|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570521|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570522|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570523|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570524|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570525|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570526|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570527|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570528|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570529|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570530|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570531|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570532|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570533|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570534|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
27969351|NCT02589665|81718899|FG000|Maintenance Period|Withdrawal by Subject|0|||
27969352|NCT02589665|81718900|FG001|Maintenance Period|Withdrawal by Subject|0|||
27969353|NCT02589665|81718901|FG002|Maintenance Period|Withdrawal by Subject|0|||
27969354|NCT02589665|81718902|FG003|Maintenance Period|Withdrawal by Subject|0|||
27969355|NCT02589665|81718903|FG004|Maintenance Period|Withdrawal by Subject|4|||
27969356|NCT02589665|81718904|FG005|Maintenance Period|Withdrawal by Subject|2|||
27969357|NCT02589665|81718905|FG006|Maintenance Period|Withdrawal by Subject|4|||
27969358|NCT02589665|81718906|FG007|Maintenance Period|Withdrawal by Subject|0|||
27969359|NCT02589665|81718907|FG008|Maintenance Period|Withdrawal by Subject|0|||
27969360|NCT02589665|81718908|FG009|Maintenance Period|Withdrawal by Subject|0|||
27969361|NCT02589665|81718899|FG000|Maintenance Period|Lack of Efficacy|0|||
27969362|NCT02589665|81718900|FG001|Maintenance Period|Lack of Efficacy|0|||
27969363|NCT02589665|81718901|FG002|Maintenance Period|Lack of Efficacy|0|||
27969364|NCT02589665|81718902|FG003|Maintenance Period|Lack of Efficacy|0|||
27969365|NCT02589665|81718903|FG004|Maintenance Period|Lack of Efficacy|2|||
27969366|NCT02589665|81718904|FG005|Maintenance Period|Lack of Efficacy|1|||
27969367|NCT02589665|81718905|FG006|Maintenance Period|Lack of Efficacy|0|||
27570535|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27969368|NCT02589665|81718906|FG007|Maintenance Period|Lack of Efficacy|0|||
27969369|NCT02589665|81718907|FG008|Maintenance Period|Lack of Efficacy|0|||
27969370|NCT02589665|81718908|FG009|Maintenance Period|Lack of Efficacy|0|||
27570536|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
27570537|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570538|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570539|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570540|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570541|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570542|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570543|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27667009|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
27667010|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
27667011|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
27667012|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
27667013|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
27667014|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
27667015|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
27667016|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
27667017|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
27667018|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
27667019|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
27667020|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
27667021|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
27667022|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
27667023|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
27667024|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
27667025|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
27570544|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570545|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570546|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570547|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570548|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570549|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570550|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570551|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570552|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570553|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570554|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
27570555|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
27570556|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
27570557|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27570558|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27570559|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27969371|NCT02589665|81718899|FG000|Maintenance Period|Adverse Event|0|||
27969372|NCT02589665|81718900|FG001|Maintenance Period|Adverse Event|0|||
27570560|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27570561|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570562|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570563|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570564|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570565|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570566|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570567|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570568|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570569|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570570|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570571|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570572|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570573|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570574|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570575|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27969373|NCT02589665|81718901|FG002|Maintenance Period|Adverse Event|0|||
27969374|NCT02589665|81718902|FG003|Maintenance Period|Adverse Event|0|||
27969375|NCT02589665|81718903|FG004|Maintenance Period|Adverse Event|0|||
27969376|NCT02589665|81718904|FG005|Maintenance Period|Adverse Event|0|||
27969377|NCT02589665|81718905|FG006|Maintenance Period|Adverse Event|2|||
27969378|NCT02589665|81718906|FG007|Maintenance Period|Adverse Event|0|||
27969379|NCT02589665|81718907|FG008|Maintenance Period|Adverse Event|0|||
27969380|NCT02589665|81718908|FG009|Maintenance Period|Adverse Event|0|||
27969381|NCT02589665|81718899|FG000|Maintenance Period|Lost to Follow-up|0|||
27969382|NCT02589665|81718900|FG001|Maintenance Period|Lost to Follow-up|0|||
27969383|NCT02589665|81718901|FG002|Maintenance Period|Lost to Follow-up|0|||
27969384|NCT02589665|81718902|FG003|Maintenance Period|Lost to Follow-up|0|||
27969385|NCT02589665|81718903|FG004|Maintenance Period|Lost to Follow-up|0|||
27969386|NCT02589665|81718904|FG005|Maintenance Period|Lost to Follow-up|1|||
27969387|NCT02589665|81718905|FG006|Maintenance Period|Lost to Follow-up|0|||
27969388|NCT02589665|81718906|FG007|Maintenance Period|Lost to Follow-up|0|||
27969389|NCT02589665|81718907|FG008|Maintenance Period|Lost to Follow-up|0|||
27969390|NCT02589665|81718908|FG009|Maintenance Period|Lost to Follow-up|0|||
27969391|NCT02589665|81718899|FG000|Maintenance Period|Physician Decision|0|||
27969392|NCT02589665|81718900|FG001|Maintenance Period|Physician Decision|0|||
27969393|NCT02589665|81718901|FG002|Maintenance Period|Physician Decision|0|||
27969394|NCT02589665|81718902|FG003|Maintenance Period|Physician Decision|0|||
27969395|NCT02589665|81718903|FG004|Maintenance Period|Physician Decision|0|||
27969396|NCT02589665|81718904|FG005|Maintenance Period|Physician Decision|1|||
27969397|NCT02589665|81718905|FG006|Maintenance Period|Physician Decision|0|||
27969398|NCT02589665|81718906|FG007|Maintenance Period|Physician Decision|0|||
27969399|NCT02589665|81718907|FG008|Maintenance Period|Physician Decision|0|||
27570576|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570577|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570578|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570579|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
27969400|NCT02589665|81718908|FG009|Maintenance Period|Physician Decision|0|||
27969401|NCT02589665|81718899|FG000|Maintenance Period|Reason Not Collected|0|||
27969402|NCT02589665|81718900|FG001|Maintenance Period|Reason Not Collected|0|||
27969403|NCT02589665|81718901|FG002|Maintenance Period|Reason Not Collected|0|||
27780412|NCT02364999|81024309|FG000|Overall Study|Randomized but did not receive treatment|2|||
27780413|NCT02364999|81024310|FG001|Overall Study|Randomized but did not receive treatment|3|||
27780414|NCT01195636|81024311|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
27780415|NCT01195636|81024312|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
27780416|NCT01195636|81024311|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
27780417|NCT01195636|81024312|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
27780418|NCT01195636|81024311|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27780419|NCT01195636|81024312|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
27780420|NCT01195636|81024311|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
27780421|NCT01195636|81024312|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
27780422|NCT01195636|81024311|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
27780423|NCT01195636|81024312|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
27780424|NCT01195636|81024311|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
27780425|NCT01195636|81024312|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
27780426|NCT01195636|81024311|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
27780427|NCT01195636|81024312|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
27780428|NCT01195636|81024311|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27780429|NCT01195636|81024312|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
27780430|NCT02975206|81024320|FG000|Overall Study|Withdrawal by Subject|14|||
27780431|NCT02975206|81024321|FG001|Overall Study|Withdrawal by Subject|11|||
27780432|NCT02975206|81024322|FG002|Overall Study|Withdrawal by Subject|11|||
27780433|NCT02975206|81024320|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
27780434|NCT02975206|81024321|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
27863724|NCT03583086|81333105|FG001|Overall Study|Declining Performance Status|0|||
27863725|NCT03583086|81333106|FG002|Overall Study|Declining Performance Status|1|||
27863726|NCT03583086|81333107|FG003|Overall Study|Declining Performance Status|0|||
27863727|NCT03583086|81333108|FG004|Overall Study|Declining Performance Status|0|||
27863728|NCT03583086|81333109|FG005|Overall Study|Declining Performance Status|0|||
27863729|NCT03583086|81333110|FG006|Overall Study|Declining Performance Status|0|||
27863730|NCT03583086|81333104|FG000|Overall Study|Still on study|0|||
27863731|NCT03583086|81333105|FG001|Overall Study|Still on study|0|||
27863732|NCT03583086|81333106|FG002|Overall Study|Still on study|0|||
27863733|NCT03583086|81333107|FG003|Overall Study|Still on study|1|||
27969404|NCT02589665|81718902|FG003|Maintenance Period|Reason Not Collected|0|||
27969405|NCT02589665|81718903|FG004|Maintenance Period|Reason Not Collected|0|||
27969406|NCT02589665|81718904|FG005|Maintenance Period|Reason Not Collected|1|||
27969407|NCT02589665|81718905|FG006|Maintenance Period|Reason Not Collected|1|||
27969408|NCT02589665|81718906|FG007|Maintenance Period|Reason Not Collected|0|||
27570580|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27570581|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27570582|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
27570583|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27863734|NCT03583086|81333108|FG004|Overall Study|Still on study|0|||
27863735|NCT03583086|81333109|FG005|Overall Study|Still on study|0|||
27863736|NCT03583086|81333110|FG006|Overall Study|Still on study|1|||
27863737|NCT03583086|81333104|FG000|Overall Study|Disease progression|0|||
27863738|NCT03583086|81333105|FG001|Overall Study|Disease progression|0|||
27863739|NCT03583086|81333106|FG002|Overall Study|Disease progression|0|||
27863740|NCT03583086|81333107|FG003|Overall Study|Disease progression|0|||
27863741|NCT03583086|81333108|FG004|Overall Study|Disease progression|0|||
27863742|NCT03583086|81333109|FG005|Overall Study|Disease progression|0|||
27863743|NCT03583086|81333110|FG006|Overall Study|Disease progression|1|||
27863744|NCT03583086|81333104|FG000|Overall Study|Undergoing radiation therapy|0|||
27863745|NCT03583086|81333105|FG001|Overall Study|Undergoing radiation therapy|0|||
27863746|NCT03583086|81333106|FG002|Overall Study|Undergoing radiation therapy|0|||
27863747|NCT03583086|81333107|FG003|Overall Study|Undergoing radiation therapy|0|||
27863748|NCT03583086|81333108|FG004|Overall Study|Undergoing radiation therapy|0|||
27863749|NCT03583086|81333109|FG005|Overall Study|Undergoing radiation therapy|0|||
27863750|NCT03583086|81333110|FG006|Overall Study|Undergoing radiation therapy|1|||
27863751|NCT03583086|81333104|FG000|Overall Study|Lost to Follow-up|0|||
27863752|NCT03583086|81333105|FG001|Overall Study|Lost to Follow-up|0|||
27863753|NCT03583086|81333106|FG002|Overall Study|Lost to Follow-up|0|||
27780435|NCT02975206|81024322|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
27863754|NCT03583086|81333107|FG003|Overall Study|Lost to Follow-up|0|||
27863755|NCT03583086|81333108|FG004|Overall Study|Lost to Follow-up|0|||
27863756|NCT03583086|81333109|FG005|Overall Study|Lost to Follow-up|1|||
27863757|NCT03583086|81333110|FG006|Overall Study|Lost to Follow-up|0|||
27863758|NCT03583086|81333104|FG000|Overall Study|Adverse Event|0|||
27780436|NCT00736385|81024323|FG000|Overall Study|Withdrawal by Subject|2|||
27780437|NCT00736385|81024324|FG001|Overall Study|Withdrawal by Subject|2|||
27780438|NCT00736385|81024323|FG000|Overall Study|Adverse Event|0|||
27780439|NCT00736385|81024324|FG001|Overall Study|Adverse Event|1|||
27863759|NCT03583086|81333105|FG001|Overall Study|Adverse Event|0|||
27969409|NCT02589665|81718907|FG008|Maintenance Period|Reason Not Collected|0|||
27969410|NCT02589665|81718908|FG009|Maintenance Period|Reason Not Collected|0|||
27969411|NCT02589665|81718899|FG000|Induction Extension Period|Adverse Event|0|||
27969412|NCT02589665|81718900|FG001|Induction Extension Period|Adverse Event|0|||
27969413|NCT02589665|81718901|FG002|Induction Extension Period|Adverse Event|0|||
27969414|NCT02589665|81718902|FG003|Induction Extension Period|Adverse Event|0|||
27969415|NCT02589665|81718903|FG004|Induction Extension Period|Adverse Event|0|||
27969416|NCT02589665|81718904|FG005|Induction Extension Period|Adverse Event|0|||
27969417|NCT02589665|81718905|FG006|Induction Extension Period|Adverse Event|0|||
27969418|NCT02589665|81718906|FG007|Induction Extension Period|Adverse Event|0|||
27969419|NCT02589665|81718907|FG008|Induction Extension Period|Adverse Event|4|||
27969420|NCT02589665|81718908|FG009|Induction Extension Period|Adverse Event|0|||
27969421|NCT02589665|81718899|FG000|Induction Extension Period|Lack of Efficacy|0|||
27969422|NCT02589665|81718900|FG001|Induction Extension Period|Lack of Efficacy|0|||
27969423|NCT02589665|81718901|FG002|Induction Extension Period|Lack of Efficacy|0|||
27969424|NCT02589665|81718902|FG003|Induction Extension Period|Lack of Efficacy|0|||
27969425|NCT02589665|81718903|FG004|Induction Extension Period|Lack of Efficacy|0|||
27969426|NCT02589665|81718904|FG005|Induction Extension Period|Lack of Efficacy|0|||
27969427|NCT02589665|81718905|FG006|Induction Extension Period|Lack of Efficacy|0|||
27969428|NCT02589665|81718906|FG007|Induction Extension Period|Lack of Efficacy|0|||
27969429|NCT02589665|81718907|FG008|Induction Extension Period|Lack of Efficacy|3|||
27969430|NCT02589665|81718908|FG009|Induction Extension Period|Lack of Efficacy|0|||
27969431|NCT02589665|81718899|FG000|Induction Extension Period|Withdrawal by Subject|0|||
27969432|NCT02589665|81718900|FG001|Induction Extension Period|Withdrawal by Subject|0|||
27969433|NCT02589665|81718901|FG002|Induction Extension Period|Withdrawal by Subject|0|||
27969434|NCT02589665|81718902|FG003|Induction Extension Period|Withdrawal by Subject|0|||
27969435|NCT02589665|81718903|FG004|Induction Extension Period|Withdrawal by Subject|0|||
27969436|NCT02589665|81718904|FG005|Induction Extension Period|Withdrawal by Subject|0|||
27969437|NCT02589665|81718905|FG006|Induction Extension Period|Withdrawal by Subject|0|||
27969438|NCT02589665|81718906|FG007|Induction Extension Period|Withdrawal by Subject|2|||
27969439|NCT02589665|81718907|FG008|Induction Extension Period|Withdrawal by Subject|3|||
27969440|NCT02589665|81718908|FG009|Induction Extension Period|Withdrawal by Subject|0|||
27969441|NCT02589665|81718899|FG000|Induction Extension Period|Physician Decision|0|||
27969442|NCT02589665|81718900|FG001|Induction Extension Period|Physician Decision|0|||
27969443|NCT02589665|81718901|FG002|Induction Extension Period|Physician Decision|0|||
27969444|NCT02589665|81718902|FG003|Induction Extension Period|Physician Decision|0|||
27969445|NCT02589665|81718903|FG004|Induction Extension Period|Physician Decision|0|||
27969446|NCT02589665|81718904|FG005|Induction Extension Period|Physician Decision|0|||
27969447|NCT02589665|81718905|FG006|Induction Extension Period|Physician Decision|0|||
27969448|NCT02589665|81718906|FG007|Induction Extension Period|Physician Decision|0|||
27969449|NCT02589665|81718907|FG008|Induction Extension Period|Physician Decision|1|||
27969450|NCT02589665|81718908|FG009|Induction Extension Period|Physician Decision|0|||
27969451|NCT02589665|81718899|FG000|Induction Extension Period|Reason Not Collected|0|||
27969452|NCT02589665|81718900|FG001|Induction Extension Period|Reason Not Collected|0|||
27969453|NCT02589665|81718901|FG002|Induction Extension Period|Reason Not Collected|0|||
27969454|NCT02589665|81718902|FG003|Induction Extension Period|Reason Not Collected|0|||
27969455|NCT02589665|81718903|FG004|Induction Extension Period|Reason Not Collected|0|||
27969456|NCT02589665|81718904|FG005|Induction Extension Period|Reason Not Collected|0|||
27969457|NCT02589665|81718905|FG006|Induction Extension Period|Reason Not Collected|0|||
27969458|NCT02589665|81718906|FG007|Induction Extension Period|Reason Not Collected|0|||
27969459|NCT02589665|81718907|FG008|Induction Extension Period|Reason Not Collected|1|||
27969460|NCT02589665|81718908|FG009|Induction Extension Period|Reason Not Collected|0|||
27969461|NCT02589665|81718899|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969462|NCT02589665|81718900|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969463|NCT02589665|81718901|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969464|NCT02589665|81718902|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969465|NCT02589665|81718903|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969466|NCT02589665|81718904|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969467|NCT02589665|81718905|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969468|NCT02589665|81718906|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27863760|NCT03583086|81333106|FG002|Overall Study|Adverse Event|0|||
27969469|NCT02589665|81718907|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
27969470|NCT02589665|81718908|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
27969471|NCT02589665|81718899|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
27667026|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
27667027|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
27667028|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
27667029|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
27667030|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
27667031|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
27667032|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
27667033|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
27667034|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
27667035|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
27667036|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
27667037|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
27667038|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
27667039|NCT00092521|80619663|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
27667040|NCT00092521|80619664|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
27667041|NCT00092521|80619665|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
27667042|NCT00092521|80619666|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
27667043|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
27667044|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
27667045|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
27667046|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
27667047|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
27667048|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
27667049|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
27667050|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
27667051|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
27667052|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
27667053|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
27667054|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
27667055|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Death|2|||
27667056|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Death|0|||
27667057|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Death|1|||
27667058|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Death|0|||
27667059|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
27667060|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
27667061|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
27667062|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
27667063|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
27969472|NCT02589665|81718900|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
27969473|NCT02589665|81718901|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
27969474|NCT02589665|81718902|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
27667064|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
27667065|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
27667066|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
27667067|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
27667068|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
27667069|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
27667070|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
27667071|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Moved|32|||
27667072|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Moved|2|||
27667073|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Moved|28|||
27667074|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Moved|0|||
27667075|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
27863761|NCT03583086|81333107|FG003|Overall Study|Adverse Event|0|||
27969475|NCT02589665|81718903|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
27667076|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
27667077|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
27667078|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
27667079|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Travel|2|||
27667080|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Travel|0|||
27667081|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Travel|0|||
27667082|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Travel|0|||
27667083|NCT00092521|80619663|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
27667084|NCT00092521|80619664|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
27667085|NCT00092521|80619665|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
27667086|NCT00092521|80619666|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
27667087|NCT00092521|80619663|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
27667088|NCT00092521|80619664|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
27667089|NCT00092521|80619665|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
27667090|NCT00092521|80619666|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
27780440|NCT00256204|81024325|FG000|Overall Study|Adverse Event|10|||
27667091|NCT00092521|80619663|FG000|Extension Study (Group 4)|Adverse Event|0|||
27969476|NCT02589665|81718904|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
27969477|NCT02589665|81718905|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
27969478|NCT02589665|81718906|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
27780441|NCT00256204|81024326|FG001|Overall Study|Adverse Event|14|||
27780442|NCT00256204|81024327|FG002|Overall Study|Adverse Event|16|||
27780443|NCT00256204|81024328|FG003|Overall Study|Adverse Event|14|||
27780444|NCT00256204|81024325|FG000|Overall Study|Death|0|||
27667092|NCT00092521|80619664|FG001|Extension Study (Group 4)|Adverse Event|0|||
27667093|NCT00092521|80619665|FG002|Extension Study (Group 4)|Adverse Event|0|||
27667094|NCT00092521|80619666|FG003|Extension Study (Group 4)|Adverse Event|2|||
27969479|NCT02589665|81718907|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
27969480|NCT02589665|81718908|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
27969481|NCT02589665|81718899|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
27667095|NCT00092521|80619663|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
27667096|NCT00092521|80619664|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
27780445|NCT00256204|81024326|FG001|Overall Study|Death|1|||
27780446|NCT00256204|81024327|FG002|Overall Study|Death|0|||
27780447|NCT00256204|81024328|FG003|Overall Study|Death|0|||
27780448|NCT00256204|81024325|FG000|Overall Study|Lost to Follow-up|1|||
27780449|NCT00256204|81024326|FG001|Overall Study|Lost to Follow-up|1|||
27780450|NCT00256204|81024327|FG002|Overall Study|Lost to Follow-up|1|||
27780451|NCT00256204|81024328|FG003|Overall Study|Lost to Follow-up|2|||
27780452|NCT00256204|81024325|FG000|Overall Study|Protocol Violation|1|||
27780453|NCT00256204|81024326|FG001|Overall Study|Protocol Violation|0|||
27780454|NCT00256204|81024327|FG002|Overall Study|Protocol Violation|2|||
27780455|NCT00256204|81024328|FG003|Overall Study|Protocol Violation|1|||
27780456|NCT00256204|81024325|FG000|Overall Study|Physician Decision|0|||
27780457|NCT00256204|81024326|FG001|Overall Study|Physician Decision|0|||
27780458|NCT00256204|81024327|FG002|Overall Study|Physician Decision|1|||
27780459|NCT00256204|81024328|FG003|Overall Study|Physician Decision|2|||
27863762|NCT03583086|81333108|FG004|Overall Study|Adverse Event|0|||
27863763|NCT03583086|81333109|FG005|Overall Study|Adverse Event|1|||
27969482|NCT02589665|81718900|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
27969483|NCT02589665|81718901|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
27969484|NCT02589665|81718902|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
27969485|NCT02589665|81718903|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
27969486|NCT02589665|81718904|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
27969487|NCT02589665|81718905|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
27969488|NCT02589665|81718906|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
27969489|NCT02589665|81718907|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
27969490|NCT02589665|81718908|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
27969491|NCT02589665|81718899|FG000|Maintenance Extension Period|Adverse Event|0|||
27969492|NCT02589665|81718900|FG001|Maintenance Extension Period|Adverse Event|0|||
27969493|NCT02589665|81718901|FG002|Maintenance Extension Period|Adverse Event|0|||
27969494|NCT02589665|81718902|FG003|Maintenance Extension Period|Adverse Event|0|||
27969495|NCT02589665|81718903|FG004|Maintenance Extension Period|Adverse Event|0|||
27969496|NCT02589665|81718904|FG005|Maintenance Extension Period|Adverse Event|0|||
27969497|NCT02589665|81718905|FG006|Maintenance Extension Period|Adverse Event|0|||
27667097|NCT00092521|80619665|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
27667098|NCT00092521|80619666|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
27667099|NCT00092521|80619663|FG000|Extension Study (Group 4)|Pregnancy|0|||
27667100|NCT00092521|80619664|FG001|Extension Study (Group 4)|Pregnancy|0|||
27667101|NCT00092521|80619665|FG002|Extension Study (Group 4)|Pregnancy|0|||
27667102|NCT00092521|80619666|FG003|Extension Study (Group 4)|Pregnancy|4|||
27667103|NCT00092521|80619663|FG000|Extension Study (Group 4)|Protocol Violation|0|||
27667104|NCT00092521|80619664|FG001|Extension Study (Group 4)|Protocol Violation|0|||
27667105|NCT00092521|80619665|FG002|Extension Study (Group 4)|Protocol Violation|0|||
27667106|NCT00092521|80619666|FG003|Extension Study (Group 4)|Protocol Violation|2|||
27667107|NCT00092521|80619663|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
27667108|NCT00092521|80619664|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
27667109|NCT00092521|80619665|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
27667110|NCT00092521|80619666|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
27667111|NCT00092521|80619663|FG000|Extension Study (Group 4)|Moved|0|||
27667112|NCT00092521|80619664|FG001|Extension Study (Group 4)|Moved|0|||
27667113|NCT00092521|80619665|FG002|Extension Study (Group 4)|Moved|0|||
27667114|NCT00092521|80619666|FG003|Extension Study (Group 4)|Moved|16|||
27780460|NCT00256204|81024325|FG000|Overall Study|Withdrawal by Subject|17|||
27780461|NCT00256204|81024326|FG001|Overall Study|Withdrawal by Subject|6|||
27780462|NCT00256204|81024327|FG002|Overall Study|Withdrawal by Subject|7|||
27780463|NCT00256204|81024328|FG003|Overall Study|Withdrawal by Subject|5|||
27667115|NCT00092521|80619663|FG000|Extension Study (Group 4)|Site Terminated|0|||
27780464|NCT00256204|81024325|FG000|Overall Study|Need for additional prohibited treatment|38|||
27863764|NCT03583086|81333110|FG006|Overall Study|Adverse Event|0|||
27780465|NCT00256204|81024326|FG001|Overall Study|Need for additional prohibited treatment|28|||
27780466|NCT00256204|81024327|FG002|Overall Study|Need for additional prohibited treatment|27|||
27780467|NCT00256204|81024328|FG003|Overall Study|Need for additional prohibited treatment|25|||
27780468|NCT00305773|81024331|FG000|Overall Study|Death|3|||
27780469|NCT00305773|81024332|FG001|Overall Study|Death|2|||
27780470|NCT00305773|81024331|FG000|Overall Study|Adverse Event|1|||
27780471|NCT00305773|81024332|FG001|Overall Study|Adverse Event|2|||
27780472|NCT00305773|81024331|FG000|Overall Study|Alternative Treatment|4|||
27780473|NCT00305773|81024332|FG001|Overall Study|Alternative Treatment|4|||
27863765|NCT00243412|81333117|FG000|Overall Study|Death|0|||
27863766|NCT00243412|81333118|FG001|Overall Study|Death|1|||
27863767|NCT00243412|81333117|FG000|Overall Study|Adverse Event|4|||
27863768|NCT00243412|81333118|FG001|Overall Study|Adverse Event|2|||
27863769|NCT00243412|81333117|FG000|Overall Study|Lost to Follow-up|0|||
27863770|NCT00243412|81333118|FG001|Overall Study|Lost to Follow-up|1|||
27863771|NCT00243412|81333117|FG000|Overall Study|Physician Decision|1|||
27863772|NCT00243412|81333118|FG001|Overall Study|Physician Decision|1|||
27863773|NCT00243412|81333117|FG000|Overall Study|Withdrawal by Subject|4|||
27863774|NCT00243412|81333118|FG001|Overall Study|Withdrawal by Subject|5|||
27863775|NCT00243412|81333117|FG000|Overall Study|Other|1|||
27863776|NCT00243412|81333118|FG001|Overall Study|Other|1|||
27863777|NCT03485352|81333119|FG000|Overall Study|Lost to Follow-up|9|||
27863778|NCT04683029|81333120|FG000|Overall Study|Withdrawal by Subject|1|||
27863779|NCT04683029|81333121|FG001|Overall Study|Withdrawal by Subject|0|||
27863780|NCT04759768|81333123|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
27863781|NCT04759768|81333124|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
27863782|NCT04759768|81333123|FG000|Washout (7 Days)|Physician Decision|0|||
27863783|NCT04759768|81333124|FG001|Washout (7 Days)|Physician Decision|1|||
27863784|NCT00195338|81333125|FG000|Overall Study|Lost to Follow-up|2|||
27969498|NCT02589665|81718906|FG007|Maintenance Extension Period|Adverse Event|0|||
27969499|NCT02589665|81718907|FG008|Maintenance Extension Period|Adverse Event|0|||
27969500|NCT02589665|81718908|FG009|Maintenance Extension Period|Adverse Event|2|||
27969501|NCT02589665|81718899|FG000|Maintenance Extension Period|Non-responder|0|||
27969502|NCT02589665|81718900|FG001|Maintenance Extension Period|Non-responder|0|||
27969503|NCT02589665|81718901|FG002|Maintenance Extension Period|Non-responder|0|||
27969504|NCT02589665|81718902|FG003|Maintenance Extension Period|Non-responder|0|||
27969505|NCT02589665|81718903|FG004|Maintenance Extension Period|Non-responder|0|||
27969506|NCT02589665|81718904|FG005|Maintenance Extension Period|Non-responder|0|||
27969507|NCT02589665|81718905|FG006|Maintenance Extension Period|Non-responder|0|||
27969508|NCT02589665|81718906|FG007|Maintenance Extension Period|Non-responder|0|||
27969509|NCT02589665|81718907|FG008|Maintenance Extension Period|Non-responder|0|||
27969510|NCT02589665|81718908|FG009|Maintenance Extension Period|Non-responder|1|||
27969511|NCT02789345|81718909|FG000|Overall Study|Adverse Event|0|||
27969512|NCT02789345|81718910|FG001|Overall Study|Adverse Event|0|||
27969513|NCT02789345|81718911|FG002|Overall Study|Adverse Event|1|||
27969514|NCT02789345|81718909|FG000|Overall Study|Death|0|||
27969515|NCT02789345|81718910|FG001|Overall Study|Death|0|||
27969516|NCT02789345|81718911|FG002|Overall Study|Death|1|||
27969517|NCT02789345|81718909|FG000|Overall Study|Physician Decision|2|||
27969518|NCT02789345|81718910|FG001|Overall Study|Physician Decision|0|||
27969519|NCT02789345|81718911|FG002|Overall Study|Physician Decision|1|||
27969520|NCT02789345|81718909|FG000|Overall Study|Progressive Disease|1|||
27969521|NCT02789345|81718910|FG001|Overall Study|Progressive Disease|3|||
27969522|NCT02789345|81718911|FG002|Overall Study|Progressive Disease|14|||
27969523|NCT01369641|81718912|FG000|Overall Study|Withdrawal by Subject|1|||
27969524|NCT00939029|81718913|FG000|Overall Study|Withdrawal by Subject|3|||
27969525|NCT00939029|81718914|FG001|Overall Study|Withdrawal by Subject|7|||
27969526|NCT00939029|81718913|FG000|Overall Study|Lost to Follow-up|3|||
27969527|NCT00939029|81718914|FG001|Overall Study|Lost to Follow-up|4|||
27969528|NCT00939029|81718913|FG000|Overall Study|Adverse Event|0|||
27969529|NCT00939029|81718914|FG001|Overall Study|Adverse Event|1|||
27969530|NCT01453205|81718915|FG000|Overall Study|Lost to Follow-up|3|||
27969531|NCT01453205|81718916|FG001|Overall Study|Lost to Follow-up|0|||
27969532|NCT01453205|81718917|FG002|Overall Study|Lost to Follow-up|1|||
27969533|NCT01453205|81718915|FG000|Overall Study|Withdrawal by Subject|8|||
27969534|NCT01453205|81718916|FG001|Overall Study|Withdrawal by Subject|3|||
27969535|NCT01453205|81718917|FG002|Overall Study|Withdrawal by Subject|0|||
27570584|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27780474|NCT00305773|81024331|FG000|Overall Study|Physician Decision|1|||
27780475|NCT00305773|81024332|FG001|Overall Study|Physician Decision|1|||
27780476|NCT00305773|81024331|FG000|Overall Study|Withdrawal by Subject|1|||
27780477|NCT00305773|81024332|FG001|Overall Study|Withdrawal by Subject|4|||
27780478|NCT00305773|81024331|FG000|Overall Study|Disease Progression|1|||
27780479|NCT00305773|81024332|FG001|Overall Study|Disease Progression|3|||
27863785|NCT00195338|81333125|FG000|Overall Study|Adverse Event|5|||
27969536|NCT01453205|81718915|FG000|Overall Study|Death|24|||
27863786|NCT00195338|81333125|FG000|Overall Study|Lack of Efficacy|1|||
27863787|NCT00195338|81333125|FG000|Overall Study|Early closure of the site|4|||
27863788|NCT05299528|81333126|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
27863789|NCT05299528|81333127|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
27863790|NCT05299528|81333128|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
27863791|NCT05299528|81333129|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
27863792|NCT05299528|81333130|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
27863793|NCT05299528|81333131|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
27863794|NCT05299528|81333132|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
27863795|NCT05299528|81333126|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
27863796|NCT05299528|81333127|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
27863797|NCT05299528|81333128|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
27863798|NCT05299528|81333129|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
27863799|NCT05299528|81333130|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
27863800|NCT05299528|81333131|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
27863801|NCT05299528|81333132|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
27863802|NCT05299528|81333126|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
27863803|NCT05299528|81333127|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
27863804|NCT05299528|81333128|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
27863805|NCT05299528|81333129|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
27863806|NCT05299528|81333130|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
27863807|NCT05299528|81333131|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
27863808|NCT05299528|81333132|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
27863809|NCT02374346|81333136|FG000|Overall Study|operated or discharged during weekend|48|||
27863810|NCT01590277|81333137|FG000|Overall Study|Withdrawal by Subject|3|||
27863811|NCT01590277|81333137|FG000|Overall Study|Withdrawal by Subject|2|||
27780480|NCT00305773|81024331|FG000|Overall Study|All other reasons|3|||
27780481|NCT00305773|81024332|FG001|Overall Study|All other reasons|2|||
27780482|NCT00554229|81024333|FG000|Overall Study|Lost to Follow-up|3|||
27780483|NCT00554229|81024334|FG001|Overall Study|Lost to Follow-up|6|||
27780484|NCT00554229|81024333|FG000|Overall Study|Withdrawal by Subject|29|||
27780485|NCT00554229|81024334|FG001|Overall Study|Withdrawal by Subject|37|||
27780486|NCT00554229|81024333|FG000|Overall Study|Adverse Event|71|||
27780487|NCT00554229|81024334|FG001|Overall Study|Adverse Event|39|||
27780488|NCT00554229|81024333|FG000|Overall Study|Protocol Violation|3|||
27780489|NCT00554229|81024334|FG001|Overall Study|Protocol Violation|3|||
27667116|NCT00092521|80619664|FG001|Extension Study (Group 4)|Site Terminated|0|||
27780490|NCT00554229|81024333|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
27780491|NCT00554229|81024334|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
27780492|NCT00554229|81024333|FG000|Overall Study|Randomised but no treatment received|1|||
27863812|NCT01590277|81333137|FG000|Overall Study|Withdrawal by Subject|1|||
27863813|NCT01590277|81333137|FG000|Overall Study|Withdrawal by Subject|1|||
27863814|NCT00799825|81333138|FG000|Overall Study|Adverse Event|1|||
27863815|NCT00799825|81333138|FG000|Overall Study|Withdrawal by Subject|6|||
27863816|NCT00799825|81333138|FG000|Overall Study|Lost to Follow-up|38|||
27863817|NCT00799825|81333138|FG000|Overall Study|Pregnancy|3|||
27863818|NCT01377012|81333139|FG000|Core Study|Study terminated by Sponsor|47|||
27863819|NCT01377012|81333140|FG001|Core Study|Study terminated by Sponsor|54|||
27863820|NCT01377012|81333141|FG002|Core Study|Study terminated by Sponsor|46|||
27863821|NCT01377012|81333139|FG000|Core Study|Technical problems|1|||
27863822|NCT01377012|81333140|FG001|Core Study|Technical problems|0|||
27969537|NCT01453205|81718916|FG001|Overall Study|Death|22|||
27969538|NCT01453205|81718917|FG002|Overall Study|Death|18|||
27969539|NCT01453205|81718915|FG000|Overall Study|Other|45|||
27969540|NCT01453205|81718916|FG001|Overall Study|Other|27|||
27969541|NCT01453205|81718917|FG002|Overall Study|Other|35|||
27969542|NCT03070171|81718926|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
27969543|NCT03070171|81718927|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
27969544|NCT03070171|81718926|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
27969545|NCT03070171|81718927|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
27780493|NCT00554229|81024334|FG001|Overall Study|Randomised but no treatment received|0|||
27780494|NCT03481634|81024337|FG000|Overall Study|Withdrawal by Subject|16|||
27780495|NCT03481634|81024338|FG001|Overall Study|Withdrawal by Subject|19|||
27780496|NCT03481634|81024339|FG002|Overall Study|Withdrawal by Subject|14|||
27863823|NCT01377012|81333141|FG002|Core Study|Technical problems|0|||
27969546|NCT03305081|81718928|FG000|Overall Study|Lost to Follow-up|10|||
27969547|NCT03305081|81718929|FG001|Overall Study|Lost to Follow-up|15|||
27780497|NCT03481634|81024337|FG000|Overall Study|Protocol Violation|1|||
27780498|NCT03481634|81024338|FG001|Overall Study|Protocol Violation|0|||
27780499|NCT03481634|81024339|FG002|Overall Study|Protocol Violation|1|||
27780500|NCT03481634|81024337|FG000|Overall Study|Progressive disease|0|||
27780501|NCT03481634|81024338|FG001|Overall Study|Progressive disease|1|||
27780502|NCT03481634|81024339|FG002|Overall Study|Progressive disease|0|||
27780503|NCT03481634|81024337|FG000|Overall Study|Physician Decision|3|||
27780504|NCT03481634|81024338|FG001|Overall Study|Physician Decision|0|||
27780505|NCT03481634|81024339|FG002|Overall Study|Physician Decision|1|||
27780506|NCT03481634|81024337|FG000|Overall Study|Lost to Follow-up|3|||
27780507|NCT03481634|81024338|FG001|Overall Study|Lost to Follow-up|4|||
27780508|NCT03481634|81024339|FG002|Overall Study|Lost to Follow-up|4|||
27780509|NCT03481634|81024337|FG000|Overall Study|Death|4|||
27780510|NCT03481634|81024338|FG001|Overall Study|Death|8|||
27780511|NCT03481634|81024339|FG002|Overall Study|Death|7|||
27780512|NCT03481634|81024337|FG000|Overall Study|Adverse Event|6|||
27780513|NCT03481634|81024338|FG001|Overall Study|Adverse Event|3|||
27780514|NCT03481634|81024339|FG002|Overall Study|Adverse Event|7|||
27780515|NCT00286156|81024340|FG000|Overall Study|Missed 12 month visit|0|||
27780516|NCT00286156|81024341|FG001|Overall Study|Missed 12 month visit|0|||
27780517|NCT00286156|81024342|FG002|Overall Study|Missed 12 month visit|1|||
27780518|NCT00286156|81024340|FG000|Overall Study|AE: pulmonary embolus|0|||
27780519|NCT00286156|81024341|FG001|Overall Study|AE: pulmonary embolus|1|||
27780520|NCT00286156|81024342|FG002|Overall Study|AE: pulmonary embolus|0|||
27780521|NCT00286156|81024340|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
27780522|NCT00286156|81024341|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
27780523|NCT00286156|81024342|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
27780524|NCT00286156|81024340|FG000|Overall Study|AE: pneumonia|1|||
27780525|NCT00286156|81024341|FG001|Overall Study|AE: pneumonia|0|||
27780526|NCT00286156|81024342|FG002|Overall Study|AE: pneumonia|0|||
27780527|NCT02909504|81024343|FG000|Overall Study|Adverse Event|2|||
27780528|NCT02909504|81024343|FG000|Overall Study|Lack of Efficacy|3|||
27780529|NCT02909504|81024343|FG000|Overall Study|Withdrawal by Subject|4|||
27780530|NCT02909504|81024343|FG000|Overall Study|Pregnancy|1|||
27780531|NCT02909504|81024343|FG000|Overall Study|Subject moved|1|||
27780532|NCT02909504|81024343|FG000|Overall Study|Lost to Follow-up|1|||
27780533|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
27780534|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27780535|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27780536|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27969548|NCT01944098|81718930|FG000|Overall Study|Physician Decision|1|||
27969549|NCT01944098|81718931|FG001|Overall Study|Physician Decision|0|||
27969550|NCT00920387|81718932|FG000|Stage 1|Adverse Event|1|||
27969551|NCT00920387|81718933|FG001|Stage 1|Adverse Event|0|||
27969552|NCT00920387|81718934|FG002|Stage 1|Adverse Event|0|||
27570585|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570586|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27667117|NCT00092521|80619665|FG002|Extension Study (Group 4)|Site Terminated|0|||
27667118|NCT00092521|80619666|FG003|Extension Study (Group 4)|Site Terminated|4|||
27667119|NCT00092521|80619663|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
27780537|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27780538|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27780539|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
27780540|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27780541|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27780542|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27780543|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27780544|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27780545|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
27780546|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27780547|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27863824|NCT01377012|81333139|FG000|Core Study|Withdrawal by Subject|15|||
27780548|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27780549|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27780550|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27780551|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Other|14|||
27780552|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Other|0|||
27780553|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Other|0|||
27780554|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Other|0|||
27780555|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Other|0|||
27969553|NCT03199053|81722603|FG000|ST Period|Withdrawal by Subject|2|||
27780556|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Other|0|||
27780557|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
27780558|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
27780559|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
27780560|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
27780561|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
27780562|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
27780563|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
27780564|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27780565|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27780566|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27780567|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27780568|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27780569|NCT02141854|81024347|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
27780570|NCT02141854|81024348|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27780571|NCT02141854|81024349|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27780572|NCT02141854|81024350|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27780573|NCT02141854|81024351|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27780574|NCT02141854|81024352|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27780575|NCT02141854|81024347|FG000|Treatment Period|Protocol Violation|0|||
27780576|NCT02141854|81024348|FG001|Treatment Period|Protocol Violation|1|||
27780577|NCT02141854|81024349|FG002|Treatment Period|Protocol Violation|0|||
27780578|NCT02141854|81024350|FG003|Treatment Period|Protocol Violation|2|||
27780579|NCT02141854|81024351|FG004|Treatment Period|Protocol Violation|2|||
27780580|NCT02141854|81024352|FG005|Treatment Period|Protocol Violation|1|||
27780581|NCT02141854|81024347|FG000|Treatment Period|Noncompliance|0|||
27780582|NCT02141854|81024348|FG001|Treatment Period|Noncompliance|0|||
27780583|NCT02141854|81024349|FG002|Treatment Period|Noncompliance|0|||
27780584|NCT02141854|81024350|FG003|Treatment Period|Noncompliance|1|||
27780585|NCT02141854|81024351|FG004|Treatment Period|Noncompliance|0|||
27780586|NCT02141854|81024352|FG005|Treatment Period|Noncompliance|0|||
27780587|NCT02141854|81024347|FG000|Treatment Period|Lack of Efficacy|0|||
27780588|NCT02141854|81024348|FG001|Treatment Period|Lack of Efficacy|0|||
27780589|NCT02141854|81024349|FG002|Treatment Period|Lack of Efficacy|0|||
27780590|NCT02141854|81024350|FG003|Treatment Period|Lack of Efficacy|1|||
27780591|NCT02141854|81024351|FG004|Treatment Period|Lack of Efficacy|1|||
27780592|NCT02141854|81024352|FG005|Treatment Period|Lack of Efficacy|7|||
27780593|NCT02141854|81024347|FG000|Treatment Period|Pregnancy|0|||
27780594|NCT02141854|81024348|FG001|Treatment Period|Pregnancy|1|||
27780595|NCT02141854|81024349|FG002|Treatment Period|Pregnancy|0|||
27780596|NCT02141854|81024350|FG003|Treatment Period|Pregnancy|0|||
27780597|NCT02141854|81024351|FG004|Treatment Period|Pregnancy|0|||
27969554|NCT03199053|81722604|FG001|ST Period|Withdrawal by Subject|4|||
27969555|NCT03199053|81722605|FG002|ST Period|Withdrawal by Subject|6|||
27969556|NCT03199053|81722603|FG000|ST Period|Withdrawal by parent/guardian|1|||
27969557|NCT03199053|81722604|FG001|ST Period|Withdrawal by parent/guardian|1|||
27969558|NCT03199053|81722605|FG002|ST Period|Withdrawal by parent/guardian|1|||
27969559|NCT03199053|81722603|FG000|ST Period|Lost to Follow-up|2|||
27969560|NCT03199053|81722604|FG001|ST Period|Lost to Follow-up|0|||
27969561|NCT03199053|81722605|FG002|ST Period|Lost to Follow-up|1|||
27969562|NCT03199053|81722603|FG000|LT Period|Withdrawal by Subject|1|||
27969563|NCT03199053|81722604|FG001|LT Period|Withdrawal by Subject|3|||
27969564|NCT03199053|81722605|FG002|LT Period|Withdrawal by Subject|3|||
27780598|NCT02141854|81024352|FG005|Treatment Period|Pregnancy|0|||
27780599|NCT02141854|81024347|FG000|Treatment Period|Other|0|||
27780600|NCT02141854|81024348|FG001|Treatment Period|Other|1|||
27780601|NCT02141854|81024349|FG002|Treatment Period|Other|2|||
27780602|NCT02141854|81024350|FG003|Treatment Period|Other|0|||
27780603|NCT02141854|81024351|FG004|Treatment Period|Other|1|||
27780604|NCT02141854|81024352|FG005|Treatment Period|Other|2|||
27780605|NCT02141854|81024347|FG000|Treatment Period|Adverse Event|0|||
27780606|NCT02141854|81024348|FG001|Treatment Period|Adverse Event|2|||
27780607|NCT02141854|81024349|FG002|Treatment Period|Adverse Event|2|||
27780608|NCT02141854|81024350|FG003|Treatment Period|Adverse Event|0|||
27780609|NCT02141854|81024351|FG004|Treatment Period|Adverse Event|2|||
27780610|NCT02141854|81024352|FG005|Treatment Period|Adverse Event|2|||
27780611|NCT02141854|81024347|FG000|Treatment Period|Withdrawal by Subject|0|||
27969565|NCT03199053|81722603|FG000|LT Period|Withdrawal by parent/guardian|0|||
27969566|NCT03199053|81722604|FG001|LT Period|Withdrawal by parent/guardian|0|||
27969567|NCT03199053|81722605|FG002|LT Period|Withdrawal by parent/guardian|1|||
27969568|NCT03199053|81722603|FG000|LT Period|Lost to Follow-up|0|||
27570587|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27780612|NCT02141854|81024348|FG001|Treatment Period|Withdrawal by Subject|2|||
27780613|NCT02141854|81024349|FG002|Treatment Period|Withdrawal by Subject|3|||
27780614|NCT02141854|81024350|FG003|Treatment Period|Withdrawal by Subject|3|||
27969569|NCT03199053|81722604|FG001|LT Period|Lost to Follow-up|1|||
27570588|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27780615|NCT02141854|81024351|FG004|Treatment Period|Withdrawal by Subject|4|||
27780616|NCT02141854|81024352|FG005|Treatment Period|Withdrawal by Subject|7|||
27780617|NCT02141854|81024347|FG000|Treatment Period|Disease progression|0|||
27780618|NCT02141854|81024348|FG001|Treatment Period|Disease progression|2|||
27780619|NCT02141854|81024349|FG002|Treatment Period|Disease progression|1|||
27780620|NCT02141854|81024350|FG003|Treatment Period|Disease progression|3|||
27780621|NCT02141854|81024351|FG004|Treatment Period|Disease progression|0|||
27780622|NCT02141854|81024352|FG005|Treatment Period|Disease progression|18|||
27780623|NCT02141854|81024347|FG000|Treatment Period|Lost to Follow-up|0|||
27780624|NCT02141854|81024348|FG001|Treatment Period|Lost to Follow-up|1|||
27780625|NCT02141854|81024349|FG002|Treatment Period|Lost to Follow-up|1|||
27780626|NCT02141854|81024350|FG003|Treatment Period|Lost to Follow-up|1|||
27780627|NCT02141854|81024351|FG004|Treatment Period|Lost to Follow-up|0|||
27780628|NCT02141854|81024352|FG005|Treatment Period|Lost to Follow-up|1|||
27780629|NCT00890201|81024353|FG000|Overall Study|Protocol Violation|5|||
27780630|NCT00890201|81024354|FG001|Overall Study|Protocol Violation|56|||
27780631|NCT02098733|81024356|FG000|Overall Study|Data Not Available|5|||
27780632|NCT02098733|81024356|FG000|Overall Study|Lost to Follow-up|5|||
27780633|NCT01657903|81027458|FG000|Overall Study|Lost to Follow-up|1|||
27780634|NCT01657903|81027458|FG000|Overall Study|Withdrawal by Subject|1|||
27780635|NCT00591786|81027459|FG000|Overall Study|Withdrawal of Informed Consent|0|||
27780636|NCT00591786|81027460|FG001|Overall Study|Withdrawal of Informed Consent|0|||
27780637|NCT00591786|81027461|FG002|Overall Study|Withdrawal of Informed Consent|1|||
27780638|NCT00591786|81027462|FG003|Overall Study|Withdrawal of Informed Consent|0|||
27780639|NCT00591786|81027463|FG004|Overall Study|Withdrawal of Informed Consent|0|||
27780640|NCT00591786|81027464|FG005|Overall Study|Withdrawal of Informed Consent|0|||
27780641|NCT00591786|81027465|FG006|Overall Study|Withdrawal of Informed Consent|0|||
27780642|NCT00591786|81027466|FG007|Overall Study|Withdrawal of Informed Consent|0|||
27780643|NCT00591786|81027467|FG008|Overall Study|Withdrawal of Informed Consent|0|||
27780644|NCT00591786|81027468|FG009|Overall Study|Withdrawal of Informed Consent|0|||
27780645|NCT00750867|81027471|FG000|Overall Study|Adverse Event|2|||
27780646|NCT04109066|81027472|FG000|Pre-treatment|Participant withdrew consent|2|||
27780647|NCT04109066|81027473|FG001|Pre-treatment|Participant withdrew consent|0|||
27780648|NCT04109066|81027472|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
27780649|NCT04109066|81027473|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
27780650|NCT04109066|81027472|FG000|Treatment|Lack of Efficacy|2|||
27780651|NCT04109066|81027473|FG001|Treatment|Lack of Efficacy|3|||
27780652|NCT04109066|81027472|FG000|Treatment|Adverse Event|19|||
27780653|NCT04109066|81027473|FG001|Treatment|Adverse Event|6|||
27780654|NCT04109066|81027472|FG000|Treatment|Participant request to discontinue Study treatment|12|||
27780655|NCT04109066|81027473|FG001|Treatment|Participant request to discontinue Study treatment|14|||
27780656|NCT04109066|81027472|FG000|Treatment|Withdrawal by Subject|7|||
27780657|NCT04109066|81027473|FG001|Treatment|Withdrawal by Subject|8|||
27780658|NCT04109066|81027472|FG000|Treatment|Death|3|||
27780659|NCT04109066|81027473|FG001|Treatment|Death|0|||
27780660|NCT04109066|81027472|FG000|Treatment|Participant no longer meets study criteria|3|||
27780661|NCT04109066|81027473|FG001|Treatment|Participant no longer meets study criteria|1|||
27780662|NCT04109066|81027472|FG000|Treatment|Administrative reasons by sponsor|2|||
27780663|NCT04109066|81027473|FG001|Treatment|Administrative reasons by sponsor|3|||
27780664|NCT04109066|81027472|FG000|Treatment|Other reasons|17|||
27780665|NCT04109066|81027473|FG001|Treatment|Other reasons|23|||
27780666|NCT04109066|81027472|FG000|Treatment|Disease Progression|4|||
27780667|NCT04109066|81027473|FG001|Treatment|Disease Progression|7|||
27780668|NCT04109066|81027472|FG000|Treatment|Study drug toxicity|13|||
27780669|NCT04109066|81027473|FG001|Treatment|Study drug toxicity|5|||
27780670|NCT04109066|81027472|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
27780671|NCT04109066|81027473|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
27780672|NCT04109066|81027472|FG000|Treatment|Disease Recurrence|0|||
27780673|NCT04109066|81027473|FG001|Treatment|Disease Recurrence|2|||
27780674|NCT04109066|81027472|FG000|Treatment|Not reported|6|||
27780675|NCT04109066|81027473|FG001|Treatment|Not reported|8|||
27780676|NCT04109066|81027472|FG000|Treatment|On-going treatment|48|||
27780677|NCT04109066|81027473|FG001|Treatment|On-going treatment|52|||
27780678|NCT01562327|81027474|FG000|Overall Study|Adverse Event|2|||
27780679|NCT01562327|81027474|FG000|Overall Study|Lack of Efficacy|1|||
27780680|NCT01562327|81027474|FG000|Overall Study|Participant drop-out|1|||
27780681|NCT01562327|81027474|FG000|Overall Study|Infusion not received at 6 month window|4|||
27780682|NCT02358863|81027475|FG000|Overall Study|Physician Decision|3|||
27780683|NCT01957111|81027478|FG000|Overall Study|Withdrawal by Subject|1|||
27780684|NCT01957111|81027479|FG001|Overall Study|Withdrawal by Subject|1|||
27780685|NCT01977040|81027484|FG000|Overall Study|Vasa previa not confirmed|2|||
27780686|NCT00434876|81027490|FG000|Overall Study|Lost to Follow-up|1|||
27780687|NCT00434876|81027491|FG001|Overall Study|Lost to Follow-up|1|||
27780688|NCT02155660|81027492|FG000|Overall Study|Other Reason|8|||
27780689|NCT02155660|81027493|FG001|Overall Study|Other Reason|6|||
27780690|NCT02155660|81027494|FG002|Overall Study|Other Reason|10|||
27780691|NCT02155660|81027495|FG003|Overall Study|Other Reason|10|||
27780692|NCT02155660|81027492|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27780693|NCT02155660|81027493|FG001|Overall Study|Study-specific withdrawal criteria|1|||
27780694|NCT02155660|81027494|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27780695|NCT02155660|81027495|FG003|Overall Study|Study-specific withdrawal criteria|1|||
27780696|NCT02155660|81027492|FG000|Overall Study|Severe non-compliance|0|||
27780697|NCT02155660|81027493|FG001|Overall Study|Severe non-compliance|4|||
27780698|NCT02155660|81027494|FG002|Overall Study|Severe non-compliance|0|||
27780699|NCT02155660|81027495|FG003|Overall Study|Severe non-compliance|1|||
27780700|NCT02155660|81027492|FG000|Overall Study|Adverse Event|2|||
27780701|NCT02155660|81027493|FG001|Overall Study|Adverse Event|6|||
27780702|NCT02155660|81027494|FG002|Overall Study|Adverse Event|3|||
27780703|NCT02155660|81027495|FG003|Overall Study|Adverse Event|1|||
27780704|NCT02155660|81027492|FG000|Overall Study|Lost to Follow-up|3|||
27780705|NCT02155660|81027493|FG001|Overall Study|Lost to Follow-up|6|||
27780706|NCT02155660|81027494|FG002|Overall Study|Lost to Follow-up|5|||
27780707|NCT02155660|81027495|FG003|Overall Study|Lost to Follow-up|8|||
27780708|NCT02155660|81027492|FG000|Overall Study|Death|17|||
27780709|NCT02155660|81027493|FG001|Overall Study|Death|19|||
27780710|NCT02155660|81027494|FG002|Overall Study|Death|17|||
27780711|NCT02155660|81027495|FG003|Overall Study|Death|19|||
27780712|NCT02155660|81027492|FG000|Overall Study|Withdrawal by Subject|28|||
27780713|NCT02155660|81027493|FG001|Overall Study|Withdrawal by Subject|31|||
27780714|NCT02155660|81027494|FG002|Overall Study|Withdrawal by Subject|24|||
27780715|NCT02155660|81027495|FG003|Overall Study|Withdrawal by Subject|21|||
27780716|NCT00095836|81027496|FG000|Overall Study|Lost to Follow-up|1|||
27780717|NCT00095836|81027496|FG000|Overall Study|Adverse Event|1|||
27780718|NCT00095836|81027496|FG000|Overall Study|Death|2|||
27570589|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27780719|NCT02795182|81027497|FG000|Overall Study|Death|5|||
27780720|NCT02795182|81027498|FG001|Overall Study|Death|4|||
27780721|NCT02795182|81027499|FG002|Overall Study|Death|4|||
27780722|NCT02795182|81027500|FG003|Overall Study|Death|18|||
27832955|NCT02452463|81219409|FG000|Overall Study|Withdrawal by Subject|0|||
27832956|NCT02452463|81219410|FG001|Overall Study|Withdrawal by Subject|1|||
27832957|NCT02452463|81219411|FG002|Overall Study|Withdrawal by Subject|0|||
27832958|NCT00924638|81219412|FG000|Overall Study|Death|3|||
27832959|NCT00924638|81219413|FG001|Overall Study|Death|2|||
27832960|NCT00924638|81219412|FG000|Overall Study|Lost to Follow-up|1|||
27832961|NCT00924638|81219413|FG001|Overall Study|Lost to Follow-up|1|||
27832962|NCT00924638|81219412|FG000|Overall Study|Withdrawal by Subject|5|||
27832963|NCT00924638|81219413|FG001|Overall Study|Withdrawal by Subject|7|||
27832964|NCT00924638|81219412|FG000|Overall Study|Physician Decision|3|||
27832965|NCT00924638|81219413|FG001|Overall Study|Physician Decision|3|||
27832966|NCT05098743|81219414|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
27832967|NCT05098743|81219415|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
27832968|NCT05098743|81219414|FG000|Overall Study|Lost to Follow-up|1|||
27832969|NCT05098743|81219415|FG001|Overall Study|Lost to Follow-up|2|||
27832970|NCT01083693|81219416|FG000|Overall Study|Adverse Event|1|||
27832971|NCT01083693|81219417|FG001|Overall Study|Adverse Event|1|||
27832972|NCT01083693|81219418|FG002|Overall Study|Adverse Event|0|||
27832973|NCT01083693|81219416|FG000|Overall Study|Lost to Follow-up|2|||
27832974|NCT01083693|81219417|FG001|Overall Study|Lost to Follow-up|0|||
27832975|NCT01083693|81219418|FG002|Overall Study|Lost to Follow-up|2|||
27832976|NCT01083693|81219416|FG000|Overall Study|Lack of effectiveness|13|||
27832977|NCT01083693|81219417|FG001|Overall Study|Lack of effectiveness|2|||
27832978|NCT01083693|81219418|FG002|Overall Study|Lack of effectiveness|2|||
27832979|NCT01083693|81219416|FG000|Overall Study|Patient Moved|0|||
27832980|NCT01083693|81219417|FG001|Overall Study|Patient Moved|1|||
27832981|NCT01083693|81219418|FG002|Overall Study|Patient Moved|0|||
27832982|NCT01083693|81219416|FG000|Overall Study|Complete remission|0|||
27832983|NCT01083693|81219417|FG001|Overall Study|Complete remission|1|||
27832984|NCT01083693|81219418|FG002|Overall Study|Complete remission|0|||
27832985|NCT01083693|81219416|FG000|Overall Study|Other medical condition/surgery|1|||
27832986|NCT01083693|81219417|FG001|Overall Study|Other medical condition/surgery|1|||
27863825|NCT01377012|81333140|FG001|Core Study|Withdrawal by Subject|23|||
27863826|NCT01377012|81333141|FG002|Core Study|Withdrawal by Subject|18|||
27780723|NCT02795182|81027497|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
27863827|NCT01377012|81333139|FG000|Core Study|Protocol Violation|7|||
27863828|NCT01377012|81333140|FG001|Core Study|Protocol Violation|3|||
27570590|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570591|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570592|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570593|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570594|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570595|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27780724|NCT02795182|81027498|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
27863829|NCT01377012|81333141|FG002|Core Study|Protocol Violation|2|||
27863830|NCT01377012|81333139|FG000|Core Study|Pregnancy|0|||
27863831|NCT01377012|81333140|FG001|Core Study|Pregnancy|0|||
27863832|NCT01377012|81333141|FG002|Core Study|Pregnancy|1|||
27863833|NCT01377012|81333139|FG000|Core Study|Physician Decision|5|||
27863834|NCT01377012|81333140|FG001|Core Study|Physician Decision|4|||
27863835|NCT01377012|81333141|FG002|Core Study|Physician Decision|10|||
27863836|NCT01377012|81333139|FG000|Core Study|Non-Compliant with study treatment|0|||
27863837|NCT01377012|81333140|FG001|Core Study|Non-Compliant with study treatment|0|||
27863838|NCT01377012|81333141|FG002|Core Study|Non-Compliant with study treatment|1|||
27863839|NCT01377012|81333139|FG000|Core Study|No Longer require treatment|0|||
27863840|NCT01377012|81333140|FG001|Core Study|No Longer require treatment|0|||
27863841|NCT01377012|81333141|FG002|Core Study|No Longer require treatment|1|||
27863842|NCT01377012|81333139|FG000|Core Study|Lost to Follow-up|7|||
27863843|NCT01377012|81333140|FG001|Core Study|Lost to Follow-up|5|||
27863844|NCT01377012|81333141|FG002|Core Study|Lost to Follow-up|4|||
27863845|NCT01377012|81333139|FG000|Core Study|Lack of Efficacy|41|||
27863846|NCT01377012|81333140|FG001|Core Study|Lack of Efficacy|28|||
27863847|NCT01377012|81333141|FG002|Core Study|Lack of Efficacy|37|||
27863848|NCT01377012|81333139|FG000|Core Study|Death|1|||
27863849|NCT01377012|81333140|FG001|Core Study|Death|1|||
27863850|NCT01377012|81333141|FG002|Core Study|Death|1|||
27863851|NCT01377012|81333139|FG000|Core Study|Adverse Event|10|||
27863852|NCT01377012|81333140|FG001|Core Study|Adverse Event|14|||
27863853|NCT01377012|81333141|FG002|Core Study|Adverse Event|13|||
27780725|NCT02795182|81027499|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
27780726|NCT02795182|81027500|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
27780727|NCT02795182|81027497|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
27780728|NCT02795182|81027498|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
27780729|NCT02795182|81027499|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
27780730|NCT02795182|81027500|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
27780731|NCT02795182|81027497|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
27780732|NCT02795182|81027498|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
27780733|NCT02795182|81027499|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
27780734|NCT02795182|81027500|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
27780735|NCT02795182|81027497|FG000|Overall Study|Withdrawal by Subject|4|||
27780736|NCT02795182|81027498|FG001|Overall Study|Withdrawal by Subject|0|||
27780737|NCT02795182|81027499|FG002|Overall Study|Withdrawal by Subject|0|||
27780738|NCT02795182|81027500|FG003|Overall Study|Withdrawal by Subject|3|||
27780739|NCT02795182|81027497|FG000|Overall Study|Lost to Follow-up|0|||
27780740|NCT02795182|81027498|FG001|Overall Study|Lost to Follow-up|0|||
27780741|NCT02795182|81027499|FG002|Overall Study|Lost to Follow-up|1|||
27780742|NCT02795182|81027500|FG003|Overall Study|Lost to Follow-up|1|||
27863854|NCT01377012|81333139|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
27863855|NCT01377012|81333140|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
27863856|NCT01377012|81333141|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
27863857|NCT01377012|81333139|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
27863858|NCT01377012|81333140|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
27863859|NCT01377012|81333141|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
27863860|NCT01377012|81333139|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
27863861|NCT01377012|81333140|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
27863862|NCT01377012|81333141|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
27863863|NCT01377012|81333139|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
27863864|NCT01377012|81333140|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
27863865|NCT01377012|81333141|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
27863866|NCT01377012|81333139|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
27863867|NCT01377012|81333140|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
27863868|NCT01377012|81333141|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
27863869|NCT01377012|81333139|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
27863870|NCT01377012|81333140|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
27863871|NCT01377012|81333141|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
27863872|NCT02865460|81333142|FG000|Overall Study|Adverse Event|1|||
27863873|NCT02865460|81333143|FG001|Overall Study|Adverse Event|0|||
27863874|NCT02865460|81333142|FG000|Overall Study|Withdrawal by Subject|1|||
27863875|NCT02865460|81333143|FG001|Overall Study|Withdrawal by Subject|1|||
27863876|NCT02865460|81333142|FG000|Overall Study|Lost to Follow-up|7|||
27863877|NCT02865460|81333143|FG001|Overall Study|Lost to Follow-up|4|||
27863878|NCT02865460|81333142|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
27863879|NCT02865460|81333143|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
27863880|NCT04338269|81333147|FG000|Overall Study|Death|86|||
27863881|NCT04338269|81333148|FG001|Overall Study|Death|89|||
27863882|NCT04338269|81333147|FG000|Overall Study|Lost to Follow-up|1|||
27863883|NCT04338269|81333148|FG001|Overall Study|Lost to Follow-up|2|||
27863884|NCT04338269|81333147|FG000|Overall Study|Physician Decision|1|||
27863885|NCT04338269|81333148|FG001|Overall Study|Physician Decision|0|||
27863886|NCT04338269|81333147|FG000|Overall Study|Withdrawal by Subject|14|||
27780743|NCT02795182|81027497|FG000|Overall Study|Roll Over to Long Term Extension|3|||
27780744|NCT02795182|81027498|FG001|Overall Study|Roll Over to Long Term Extension|3|||
27780745|NCT02795182|81027499|FG002|Overall Study|Roll Over to Long Term Extension|2|||
27780746|NCT02795182|81027500|FG003|Overall Study|Roll Over to Long Term Extension|5|||
27780747|NCT02795182|81027497|FG000|Overall Study|Progressive Disease|0|||
27780748|NCT02795182|81027498|FG001|Overall Study|Progressive Disease|1|||
27780749|NCT02795182|81027499|FG002|Overall Study|Progressive Disease|0|||
27780750|NCT02795182|81027500|FG003|Overall Study|Progressive Disease|4|||
27780751|NCT02795182|81027497|FG000|Overall Study|Physician Decision|0|||
27863887|NCT04338269|81333148|FG001|Overall Study|Withdrawal by Subject|11|||
27863888|NCT05478252|81333153|FG000|Overall Study|Withdrawal by Subject|2|||
27863889|NCT05478252|81333154|FG001|Overall Study|Withdrawal by Subject|3|||
27863890|NCT05478252|81333153|FG000|Overall Study|Lost to Follow-up|4|||
27863891|NCT05478252|81333154|FG001|Overall Study|Lost to Follow-up|2|||
27863892|NCT05478252|81333153|FG000|Overall Study|Physician Decision|1|||
27863893|NCT05478252|81333154|FG001|Overall Study|Physician Decision|1|||
27863894|NCT05478252|81333153|FG000|Overall Study|Death|1|||
27863895|NCT05478252|81333154|FG001|Overall Study|Death|0|||
27863896|NCT00397514|81333157|FG000|Overall Study|Withdrawal by Subject|1|||
27863897|NCT00397514|81333157|FG000|Overall Study|Pacing wire malfunction|1|||
27863898|NCT00397514|81333157|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
27969570|NCT03199053|81722605|FG002|LT Period|Lost to Follow-up|1|||
27969571|NCT03199053|81722603|FG000|LT Period|Miscellaneous|0|||
27780752|NCT02795182|81027498|FG001|Overall Study|Physician Decision|0|||
27780753|NCT02795182|81027499|FG002|Overall Study|Physician Decision|0|||
27863899|NCT00397514|81333157|FG000|Overall Study|early extubation|2|||
27969572|NCT03199053|81722604|FG001|LT Period|Miscellaneous|0|||
27969573|NCT03199053|81722605|FG002|LT Period|Miscellaneous|2|||
27969574|NCT03199053|81722603|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
27969575|NCT03199053|81722604|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
27969576|NCT03199053|81722605|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
27969577|NCT03199053|81722603|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
27969578|NCT03199053|81722604|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
27667120|NCT00092521|80619664|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
27780754|NCT02795182|81027500|FG003|Overall Study|Physician Decision|1|||
27863900|NCT00397514|81333157|FG000|Overall Study|poor echocardiographic windows|1|||
27863901|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
27863902|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
27863903|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
27863904|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
27863905|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
27969579|NCT03199053|81722605|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
27780755|NCT00758394|81027501|FG000|2nd Intervention Order|Lost to Follow-up|0|||
27969580|NCT03199053|81722603|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
27969581|NCT03199053|81722604|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
27969582|NCT03199053|81722605|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
27969583|NCT03199053|81722603|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
27969584|NCT03199053|81722604|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
27969585|NCT03199053|81722605|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
27969586|NCT04493333|81722606|FG000|Overall Study|Withdrawal by Subject|1|||
27969587|NCT04493333|81722607|FG001|Overall Study|Withdrawal by Subject|1|||
27969588|NCT04493333|81722606|FG000|Overall Study|Ineligible|0|||
27969589|NCT04493333|81722607|FG001|Overall Study|Ineligible|1|||
27969590|NCT04493333|81722606|FG000|Overall Study|Noncompliance|2|||
27969591|NCT04493333|81722607|FG001|Overall Study|Noncompliance|1|||
27969592|NCT01331837|81722613|FG000|Overall Study|Death|30|||
27969593|NCT01331837|81722614|FG001|Overall Study|Death|34|||
27667121|NCT00092521|80619665|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
27667122|NCT00092521|80619666|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
27667123|NCT05006417|80619667|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
27667124|NCT00381888|80619668|FG000|Overall Study|Death|1|||
27780756|NCT00758394|81027502|FG001|2nd Intervention Order|Lost to Follow-up|1|||
27780757|NCT00758394|81027503|FG002|2nd Intervention Order|Lost to Follow-up|0|||
27780758|NCT00758394|81027504|FG003|2nd Intervention Order|Lost to Follow-up|0|||
27780759|NCT00758394|81027501|FG000|3rd Intervention|Lost to Follow-up|1|||
27780760|NCT00758394|81027502|FG001|3rd Intervention|Lost to Follow-up|0|||
27780761|NCT00758394|81027503|FG002|3rd Intervention|Lost to Follow-up|0|||
27780762|NCT00758394|81027504|FG003|3rd Intervention|Lost to Follow-up|1|||
27780763|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
27780764|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
27780765|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
27780766|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
27780767|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
27780768|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
27780769|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
27780770|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
27780771|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
27780772|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
27780773|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
27780774|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
27780775|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
27780776|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
27780777|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
27780778|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|Other|6|||
27780779|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|Other|6|||
27780780|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|Other|7|||
27863906|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
27863907|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
27863908|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
27863909|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
27863910|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
27863911|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
27780781|NCT02681094|81027505|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
27780782|NCT02681094|81027506|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
27780783|NCT02681094|81027507|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
27780784|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|Participant decision|7|||
27780785|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|Participant decision|10|||
27780786|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|Participant decision|9|||
27780787|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
27780788|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
27863912|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
27863913|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
27863914|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
27863915|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
27863916|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
27969594|NCT01331837|81722613|FG000|Overall Study|Lost to Follow-up|3|||
27969595|NCT01331837|81722614|FG001|Overall Study|Lost to Follow-up|1|||
27969596|NCT01331837|81722613|FG000|Overall Study|Info not recorded|10|||
27969597|NCT01331837|81722614|FG001|Overall Study|Info not recorded|16|||
27667125|NCT00381888|80619668|FG000|Overall Study|Withdrawal by Subject|1|||
27667126|NCT00381888|80619668|FG000|Overall Study|Physician Decision|1|||
27969598|NCT01331837|81722613|FG000|Overall Study|Withdrawal by Subject|13|||
27667127|NCT00381888|80619668|FG000|Overall Study|Protocol Violation|9|||
27667128|NCT00381888|80619668|FG000|Overall Study|Had laparoscopic surgery|2|||
27969599|NCT01331837|81722614|FG001|Overall Study|Withdrawal by Subject|16|||
27969600|NCT01814878|81722615|FG000|Overall Study|Adverse Event|16|||
27969601|NCT01814878|81722616|FG001|Overall Study|Adverse Event|5|||
27969602|NCT01814878|81722615|FG000|Overall Study|Withdrawal by Subject|20|||
27969603|NCT01814878|81722616|FG001|Overall Study|Withdrawal by Subject|16|||
27969604|NCT01814878|81722615|FG000|Overall Study|Protocol Violation|5|||
27969605|NCT01814878|81722616|FG001|Overall Study|Protocol Violation|5|||
27969606|NCT01814878|81722615|FG000|Overall Study|Physician Decision|3|||
27969607|NCT01814878|81722616|FG001|Overall Study|Physician Decision|1|||
27969608|NCT01814878|81722615|FG000|Overall Study|Screening failure (drop-out)|0|||
27969609|NCT01814878|81722616|FG001|Overall Study|Screening failure (drop-out)|3|||
27969610|NCT01814878|81722615|FG000|Overall Study|Other|2|||
27969611|NCT01814878|81722616|FG001|Overall Study|Other|0|||
27969612|NCT04098367|81722619|FG000|Overall Study|Adverse Event|0|||
27570596|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570597|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570598|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570599|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27969613|NCT04098367|81722620|FG001|Overall Study|Adverse Event|0|||
27969614|NCT04098367|81722621|FG002|Overall Study|Adverse Event|1|||
27969615|NCT04098367|81722619|FG000|Overall Study|Lost to Follow-up|1|||
27969616|NCT04098367|81722620|FG001|Overall Study|Lost to Follow-up|5|||
27969617|NCT04098367|81722621|FG002|Overall Study|Lost to Follow-up|2|||
27969618|NCT04098367|81722619|FG000|Overall Study|Withdrawal by Subject|0|||
27969619|NCT04098367|81722620|FG001|Overall Study|Withdrawal by Subject|0|||
27969620|NCT04098367|81722621|FG002|Overall Study|Withdrawal by Subject|1|||
27969621|NCT04098367|81722619|FG000|Overall Study|Sick . Could not attend visit|1|||
27969622|NCT04098367|81722620|FG001|Overall Study|Sick . Could not attend visit|0|||
27969623|NCT04098367|81722621|FG002|Overall Study|Sick . Could not attend visit|0|||
27969624|NCT02120300|81722627|FG000|Overall Study|Enrolled but Never Treated|2|||
27969625|NCT02120300|81722628|FG001|Overall Study|Enrolled but Never Treated|0|||
27969626|NCT02120300|81722629|FG002|Overall Study|Enrolled but Never Treated|0|||
27969627|NCT02120300|81722630|FG003|Overall Study|Enrolled but Never Treated|0|||
27969628|NCT02120300|81722627|FG000|Overall Study|Lack of Efficacy|0|||
27969629|NCT02120300|81722628|FG001|Overall Study|Lack of Efficacy|0|||
27969630|NCT02120300|81722629|FG002|Overall Study|Lack of Efficacy|0|||
27969631|NCT02120300|81722630|FG003|Overall Study|Lack of Efficacy|1|||
27969632|NCT02120300|81722627|FG000|Overall Study|Lost to Follow-up|1|||
27969633|NCT02120300|81722628|FG001|Overall Study|Lost to Follow-up|0|||
27969634|NCT02120300|81722629|FG002|Overall Study|Lost to Follow-up|0|||
27969635|NCT02120300|81722630|FG003|Overall Study|Lost to Follow-up|0|||
27969636|NCT02954406|81722634|FG000|Overall Study|Adverse Event|0|||
27969637|NCT02954406|81722635|FG001|Overall Study|Adverse Event|1|||
27969638|NCT02954406|81722636|FG002|Overall Study|Adverse Event|0|||
27570600|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570601|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570602|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570603|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
27570604|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570605|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
27570606|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
27570607|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
27570608|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
27570609|NCT02346240|80275284|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570610|NCT02346240|80275285|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570611|NCT02346240|80275286|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27667129|NCT00381888|80619668|FG000|Overall Study|Surgery was cancelled|2|||
27667130|NCT00381888|80619668|FG000|Overall Study|Adverse Event|1|||
27667131|NCT02175745|80619669|FG000|Overall Study|Not Eligible|1|||
27969639|NCT02954406|81722637|FG003|Overall Study|Adverse Event|0|||
27969640|NCT02954406|81722638|FG004|Overall Study|Adverse Event|1|||
27969641|NCT02954406|81722639|FG005|Overall Study|Adverse Event|0|||
27969642|NCT02954406|81722640|FG006|Overall Study|Adverse Event|0|||
27969643|NCT02954406|81722641|FG007|Overall Study|Adverse Event|0|||
27969644|NCT02954406|81722642|FG008|Overall Study|Adverse Event|1|||
27969645|NCT02954406|81722643|FG009|Overall Study|Adverse Event|1|||
27969646|NCT02954406|81722644|FG010|Overall Study|Adverse Event|0|||
27969647|NCT02954406|81722634|FG000|Overall Study|Progressive Disease|3|||
27969648|NCT02954406|81722635|FG001|Overall Study|Progressive Disease|4|||
27969649|NCT02954406|81722636|FG002|Overall Study|Progressive Disease|3|||
27969650|NCT02954406|81722637|FG003|Overall Study|Progressive Disease|4|||
27969651|NCT02954406|81722638|FG004|Overall Study|Progressive Disease|3|||
27570612|NCT02346240|80275287|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570613|NCT02346240|80275288|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570614|NCT02346240|80275289|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570615|NCT02346240|80275290|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570616|NCT02346240|80275291|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570617|NCT02346240|80275292|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570618|NCT02346240|80275293|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570619|NCT02346240|80275294|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570620|NCT02346240|80275295|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570621|NCT02346240|80275296|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570622|NCT02346240|80275297|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570623|NCT02346240|80275298|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570624|NCT02346240|80275299|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570625|NCT02346240|80275300|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570626|NCT02346240|80275301|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570627|NCT02346240|80275302|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
27570628|NCT02346240|80275303|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570629|NCT02346240|80275304|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570630|NCT02346240|80275305|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570631|NCT02346240|80275306|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570632|NCT02346240|80275307|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
27570633|NCT00094653|80275308|FG000|Overall Study|Death|306|||
27570634|NCT00094653|80275309|FG001|Overall Study|Death|100|||
27570635|NCT00094653|80275310|FG002|Overall Study|Death|119|||
27570636|NCT00094653|80275308|FG000|Overall Study|Subject Withdrew Consent|10|||
27570637|NCT00094653|80275309|FG001|Overall Study|Subject Withdrew Consent|2|||
27570638|NCT00094653|80275310|FG002|Overall Study|Subject Withdrew Consent|3|||
27570639|NCT00094653|80275308|FG000|Overall Study|Other|2|||
27570640|NCT00094653|80275309|FG001|Overall Study|Other|2|||
27570641|NCT00094653|80275310|FG002|Overall Study|Other|2|||
27570642|NCT00094653|80275308|FG000|Overall Study|Lost to Follow-up|3|||
27570643|NCT00094653|80275309|FG001|Overall Study|Lost to Follow-up|2|||
27570644|NCT00094653|80275310|FG002|Overall Study|Lost to Follow-up|1|||
27570645|NCT00094653|80275308|FG000|Overall Study|Protocol Violation|0|||
27570646|NCT00094653|80275309|FG001|Overall Study|Protocol Violation|0|||
27570647|NCT00094653|80275310|FG002|Overall Study|Protocol Violation|1|||
27570648|NCT02821962|80275311|FG000|Overall Study|Lost to Follow-up|2|||
27570649|NCT02821962|80275312|FG001|Overall Study|Lost to Follow-up|0|||
27570650|NCT01428193|80275313|FG000|Overall Study|Physician Decision|1|||
27570651|NCT01428193|80275313|FG000|Overall Study|Elevated screening liver enzymes|1|||
27570652|NCT03925727|80275314|FG000|Overall Study|Adverse Event|4|||
27570653|NCT03925727|80275315|FG001|Overall Study|Adverse Event|0|||
27570654|NCT03925727|80275316|FG002|Overall Study|Adverse Event|3|||
27570655|NCT03925727|80275314|FG000|Overall Study|Protocol Violation|1|||
27570656|NCT03925727|80275315|FG001|Overall Study|Protocol Violation|2|||
27570657|NCT03925727|80275316|FG002|Overall Study|Protocol Violation|2|||
27570658|NCT03925727|80275314|FG000|Overall Study|Withdrawal by Subject|3|||
27570659|NCT03925727|80275315|FG001|Overall Study|Withdrawal by Subject|2|||
27570660|NCT03925727|80275316|FG002|Overall Study|Withdrawal by Subject|4|||
27570661|NCT03925727|80275314|FG000|Overall Study|Administrative Reasons|3|||
27570662|NCT03925727|80275315|FG001|Overall Study|Administrative Reasons|1|||
27570663|NCT03925727|80275316|FG002|Overall Study|Administrative Reasons|2|||
27570664|NCT03925727|80275314|FG000|Overall Study|Randomized in error or Disqualified|8|||
27570665|NCT03925727|80275315|FG001|Overall Study|Randomized in error or Disqualified|1|||
27570666|NCT03925727|80275316|FG002|Overall Study|Randomized in error or Disqualified|7|||
27570667|NCT00855309|80275317|FG000|Overall Study|patient never recieved drug|1|||
27570668|NCT00855309|80275318|FG001|Overall Study|patient never recieved drug|0|||
27570669|NCT04206293|80275321|FG000|Overall Study|Consent withdrawal|1|||
27570670|NCT00578942|80275323|FG000|Overall Study|Lost to Follow-up|1|||
27969652|NCT02954406|81722639|FG005|Overall Study|Progressive Disease|3|||
27969653|NCT02954406|81722640|FG006|Overall Study|Progressive Disease|2|||
27969654|NCT02954406|81722641|FG007|Overall Study|Progressive Disease|2|||
27969655|NCT02954406|81722642|FG008|Overall Study|Progressive Disease|1|||
27969656|NCT02954406|81722643|FG009|Overall Study|Progressive Disease|1|||
27969657|NCT02954406|81722644|FG010|Overall Study|Progressive Disease|0|||
27969658|NCT02954406|81722634|FG000|Overall Study|Symptomatic Deterioration|0|||
27969659|NCT02954406|81722635|FG001|Overall Study|Symptomatic Deterioration|1|||
27969660|NCT02954406|81722636|FG002|Overall Study|Symptomatic Deterioration|0|||
27969661|NCT02954406|81722637|FG003|Overall Study|Symptomatic Deterioration|0|||
27570671|NCT03029624|80275328|FG000|Overall Study|Adverse Event|1|||
27969662|NCT02954406|81722638|FG004|Overall Study|Symptomatic Deterioration|0|||
27969663|NCT02954406|81722639|FG005|Overall Study|Symptomatic Deterioration|0|||
27969664|NCT02954406|81722640|FG006|Overall Study|Symptomatic Deterioration|0|||
27969665|NCT02954406|81722641|FG007|Overall Study|Symptomatic Deterioration|0|||
27969666|NCT02954406|81722642|FG008|Overall Study|Symptomatic Deterioration|0|||
27969667|NCT02954406|81722643|FG009|Overall Study|Symptomatic Deterioration|0|||
27969668|NCT02954406|81722644|FG010|Overall Study|Symptomatic Deterioration|0|||
27969669|NCT02954406|81722634|FG000|Overall Study|Death|0|||
27969670|NCT02954406|81722635|FG001|Overall Study|Death|0|||
27969671|NCT02954406|81722636|FG002|Overall Study|Death|0|||
27969672|NCT02954406|81722637|FG003|Overall Study|Death|0|||
27969673|NCT02954406|81722638|FG004|Overall Study|Death|1|||
27969674|NCT02954406|81722639|FG005|Overall Study|Death|0|||
27969675|NCT02954406|81722640|FG006|Overall Study|Death|0|||
27969676|NCT02954406|81722641|FG007|Overall Study|Death|0|||
27969677|NCT02954406|81722642|FG008|Overall Study|Death|1|||
27969678|NCT02954406|81722643|FG009|Overall Study|Death|1|||
27969679|NCT02954406|81722644|FG010|Overall Study|Death|0|||
27969680|NCT02954406|81722634|FG000|Overall Study|Reason Not Specified|0|||
27969681|NCT02954406|81722635|FG001|Overall Study|Reason Not Specified|0|||
27969682|NCT02954406|81722636|FG002|Overall Study|Reason Not Specified|3|||
27969683|NCT02954406|81722637|FG003|Overall Study|Reason Not Specified|2|||
27969684|NCT02954406|81722638|FG004|Overall Study|Reason Not Specified|2|||
27969685|NCT02954406|81722639|FG005|Overall Study|Reason Not Specified|0|||
27570672|NCT03029624|80275328|FG000|Overall Study|Withdrawal by Subject|1|||
27570673|NCT03029624|80275328|FG000|Overall Study|Lack of Efficacy|1|||
27570674|NCT03029624|80275328|FG000|Overall Study|MRI need|2|||
27570675|NCT02449239|80275329|FG000|Induction Phase|Lack of Efficacy|64|||
27667132|NCT00826228|80619670|FG000|Overall Study|Withdrawal by Subject|1|||
27969686|NCT02954406|81722640|FG006|Overall Study|Reason Not Specified|1|||
27667133|NCT00905359|80619674|FG000|Overall Study|Lost to Follow-up|17|||
27667134|NCT00905359|80619675|FG001|Overall Study|Lost to Follow-up|10|||
27667135|NCT00905359|80619674|FG000|Overall Study|Death|2|||
27780789|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
27780790|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
27780791|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
27667136|NCT00905359|80619675|FG001|Overall Study|Death|0|||
27780792|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
27780793|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
27780794|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
27780795|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
27667137|NCT00905359|80619674|FG000|Overall Study|Withdrawal consent|5|||
27667138|NCT00905359|80619675|FG001|Overall Study|Withdrawal consent|6|||
27667139|NCT04353817|80619676|FG000|Overall Study|Adverse Event|0|||
27667140|NCT04353817|80619677|FG001|Overall Study|Adverse Event|1|||
27667141|NCT02803593|80619678|FG000|Overall Study|Lost to Follow-up|17|||
27667142|NCT02803593|80619679|FG001|Overall Study|Lost to Follow-up|35|||
27667143|NCT03279978|80619684|FG000|Overall Study|Withdrawal by Subject|0|||
27667144|NCT03279978|80619685|FG001|Overall Study|Withdrawal by Subject|1|||
27667145|NCT03279978|80619686|FG002|Overall Study|Withdrawal by Subject|0|||
27667146|NCT03279978|80619687|FG003|Overall Study|Withdrawal by Subject|0|||
27667147|NCT03279978|80619688|FG004|Overall Study|Withdrawal by Subject|0|||
27780796|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
27780797|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
27780798|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
27969687|NCT02954406|81722641|FG007|Overall Study|Reason Not Specified|0|||
27969688|NCT02954406|81722642|FG008|Overall Study|Reason Not Specified|1|||
27570676|NCT02449239|80275329|FG000|Induction Phase|Adverse Event|1|||
27570677|NCT02449239|80275329|FG000|Induction Phase|Lost to Follow-up|1|||
27667148|NCT03279978|80619689|FG005|Overall Study|Withdrawal by Subject|0|||
27969689|NCT02954406|81722643|FG009|Overall Study|Reason Not Specified|0|||
27969690|NCT02954406|81722644|FG010|Overall Study|Reason Not Specified|0|||
27780799|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|Other|6|||
27780800|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|Other|6|||
27780801|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|Other|7|||
27780802|NCT02681094|81027505|FG000|2 - Enrolled Participants Set|No treatment given|0|||
27780803|NCT02681094|81027506|FG001|2 - Enrolled Participants Set|No treatment given|1|||
27780804|NCT02681094|81027507|FG002|2 - Enrolled Participants Set|No treatment given|1|||
27780805|NCT02987205|81027508|FG000|Overall Study|Adverse Event|1|||
27780806|NCT02987205|81027508|FG000|Overall Study|Withdrawal by Subject|3|||
27780807|NCT03289676|81027525|FG000|Overall Study|Withdrawal by Subject|2|||
27969691|NCT03905265|81722645|FG000|Overall Study|Withdrawal by Subject|1|||
27969692|NCT03905265|81722646|FG001|Overall Study|Withdrawal by Subject|1|||
27570678|NCT02449239|80275329|FG000|Induction Phase|Protocol Violation|1|||
27570679|NCT02449239|80275329|FG000|Induction Phase|Physician Decision|1|||
27570680|NCT02449239|80275329|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
27570681|NCT02449239|80275329|FG000|Induction Phase|Withdrawal by Subject|1|||
27570682|NCT02449239|80275329|FG000|Maintenance Month 3|Lack of Efficacy|14|||
27570683|NCT02449239|80275329|FG000|Maintenance Month 6|Lack of Efficacy|10|||
27570684|NCT02449239|80275329|FG000|Maintenance Month 6|Adverse Event|2|||
27570685|NCT02449239|80275329|FG000|Maintenance Month 6|Physician Decision|1|||
27570686|NCT02449239|80275329|FG000|Maintenance Month 9|Lack of Efficacy|2|||
27570687|NCT02449239|80275329|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
27570688|NCT02449239|80275329|FG000|Maintenance Month 12|Lack of Efficacy|5|||
27570689|NCT02449239|80275329|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
27570690|NCT02449239|80275329|FG000|Maintenance Month 12|Subject moved from area|1|||
27570691|NCT02449239|80275329|FG000|Maintenance Month 15|Lack of Efficacy|1|||
27570692|NCT02449239|80275329|FG000|Maintenance Month 21|Lack of Efficacy|1|||
27570693|NCT02449239|80275329|FG000|Maintenance Month 21|Sponsor decision|1|||
27570694|NCT01921829|80275336|FG000|Overall Study|Withdrawal by Subject|0|||
27570695|NCT01921829|80275337|FG001|Overall Study|Withdrawal by Subject|1|||
27570696|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
27570697|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
27570698|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
27570699|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
27570700|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
27570701|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
27570702|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
27570703|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
27570704|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
27570705|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
27570706|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
27570707|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
27570708|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
27570709|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
27570710|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
27570711|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
27570712|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
27570713|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
27570714|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Death|0|||
27570715|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Death|0|||
27570716|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Death|1|||
27570717|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Death|0|||
27570718|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Death|0|||
27570719|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Death|0|||
27570720|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Death|0|||
27570721|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Death|0|||
27570722|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Death|0|||
27570723|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
27570724|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
27570725|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
27780808|NCT03289676|81027526|FG001|Overall Study|Withdrawal by Subject|0|||
27780809|NCT03289676|81027525|FG000|Overall Study|Protocol Violation|2|||
27780810|NCT03289676|81027526|FG001|Overall Study|Protocol Violation|0|||
27780811|NCT03289676|81027525|FG000|Overall Study|Lost to Follow-up|0|||
27969693|NCT03905265|81722647|FG002|Overall Study|Withdrawal by Subject|0|||
27570726|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
27570727|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
27570728|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
27570729|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
27570730|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
27780812|NCT03289676|81027526|FG001|Overall Study|Lost to Follow-up|1|||
27780813|NCT03696576|81027531|FG000|Overall Study|Soreness of throat after therapy|1|||
27780814|NCT03696576|81027532|FG001|Overall Study|Soreness of throat after therapy|1|||
27570731|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
27570732|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
27570733|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
27570734|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
27570735|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
27570736|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
27570737|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
27570738|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
27570739|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
27570740|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
27570741|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
27570742|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
27570743|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
27570744|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
27570745|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
27570746|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
27570747|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
27570748|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
27570749|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
27570750|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
27570751|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
27570752|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
27570753|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
27570754|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
27570755|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
27570756|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
27570757|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
27570758|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
27570759|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
27570760|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
27570761|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
27570762|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27570763|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27570764|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27969694|NCT03905265|81722648|FG003|Overall Study|Withdrawal by Subject|0|||
27969695|NCT03842969|81722649|FG000|Overall Study|Participant declined follow-up visit|0|||
27969696|NCT03842969|81722650|FG001|Overall Study|Participant declined follow-up visit|1|||
27969697|NCT03842969|81722651|FG002|Overall Study|Participant declined follow-up visit|0|||
27570765|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27570766|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27570767|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
27570768|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570769|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
27570770|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570771|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570772|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570773|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570774|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570775|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570776|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
27570777|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
27570778|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
27570779|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
27570780|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
27570781|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
27667149|NCT03279978|80619690|FG006|Overall Study|Withdrawal by Subject|0|||
27667150|NCT03279978|80619691|FG007|Overall Study|Withdrawal by Subject|0|||
27667151|NCT03279978|80619692|FG008|Overall Study|Withdrawal by Subject|0|||
27667152|NCT03279978|80619693|FG009|Overall Study|Withdrawal by Subject|1|||
27667153|NCT03279978|80619684|FG000|Overall Study|Lost to Follow-up|1|||
27667154|NCT03279978|80619685|FG001|Overall Study|Lost to Follow-up|0|||
27969698|NCT03842969|81722649|FG000|Overall Study|Sponsor's decision|12|||
27969699|NCT03842969|81722650|FG001|Overall Study|Sponsor's decision|99|||
27969700|NCT03842969|81722651|FG002|Overall Study|Sponsor's decision|61|||
27969701|NCT03842969|81722649|FG000|Overall Study|Pregnancy|0|||
27570782|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
27667155|NCT03279978|80619686|FG002|Overall Study|Lost to Follow-up|1|||
27570783|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
27667156|NCT03279978|80619687|FG003|Overall Study|Lost to Follow-up|0|||
27667157|NCT03279978|80619688|FG004|Overall Study|Lost to Follow-up|0|||
27667158|NCT03279978|80619689|FG005|Overall Study|Lost to Follow-up|0|||
27667159|NCT03279978|80619690|FG006|Overall Study|Lost to Follow-up|0|||
27667160|NCT03279978|80619691|FG007|Overall Study|Lost to Follow-up|0|||
27667161|NCT03279978|80619692|FG008|Overall Study|Lost to Follow-up|0|||
27667162|NCT03279978|80619693|FG009|Overall Study|Lost to Follow-up|0|||
27667163|NCT03279978|80619684|FG000|Overall Study|Other than stated above|0|||
27667164|NCT03279978|80619685|FG001|Overall Study|Other than stated above|0|||
27667165|NCT03279978|80619686|FG002|Overall Study|Other than stated above|0|||
27667166|NCT03279978|80619687|FG003|Overall Study|Other than stated above|0|||
27667167|NCT03279978|80619688|FG004|Overall Study|Other than stated above|0|||
27667168|NCT03279978|80619689|FG005|Overall Study|Other than stated above|0|||
27667169|NCT03279978|80619690|FG006|Overall Study|Other than stated above|1|||
27667170|NCT03279978|80619691|FG007|Overall Study|Other than stated above|0|||
27667171|NCT03279978|80619692|FG008|Overall Study|Other than stated above|0|||
27667172|NCT03279978|80619693|FG009|Overall Study|Other than stated above|0|||
27667173|NCT00526097|80619694|FG000|Overall Study|Adverse Event|6|||
27780815|NCT03696576|81027531|FG000|Overall Study|Lost to Follow-up|2|||
27780816|NCT03696576|81027532|FG001|Overall Study|Lost to Follow-up|4|||
27780817|NCT00606021|81027533|FG000|Induction Phase|Death|73|||
27780818|NCT00606021|81027534|FG001|Induction Phase|Death|0|||
27780819|NCT00606021|81027535|FG002|Induction Phase|Death|0|||
27780820|NCT00606021|81027533|FG000|Induction Phase|Physician Decision|2|||
27780821|NCT00606021|81027534|FG001|Induction Phase|Physician Decision|0|||
27780822|NCT00606021|81027535|FG002|Induction Phase|Physician Decision|0|||
27780823|NCT00606021|81027533|FG000|Induction Phase|Withdrawal by Subject|2|||
27780824|NCT00606021|81027534|FG001|Induction Phase|Withdrawal by Subject|0|||
27780825|NCT00606021|81027535|FG002|Induction Phase|Withdrawal by Subject|0|||
27780826|NCT00606021|81027533|FG000|Induction Phase|Lost to Follow-up|10|||
27780827|NCT00606021|81027534|FG001|Induction Phase|Lost to Follow-up|0|||
27780828|NCT00606021|81027535|FG002|Induction Phase|Lost to Follow-up|0|||
27780829|NCT00606021|81027533|FG000|Maintenance Phase|Death|0|||
27780830|NCT00606021|81027534|FG001|Maintenance Phase|Death|17|||
27780831|NCT00606021|81027535|FG002|Maintenance Phase|Death|15|||
27780832|NCT00606021|81027533|FG000|Maintenance Phase|Physician Decision|0|||
27780833|NCT00606021|81027534|FG001|Maintenance Phase|Physician Decision|1|||
27780834|NCT00606021|81027535|FG002|Maintenance Phase|Physician Decision|0|||
27780835|NCT00606021|81027533|FG000|Maintenance Phase|Lost to Follow-up|0|||
27780836|NCT00606021|81027534|FG001|Maintenance Phase|Lost to Follow-up|5|||
27863917|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
27863918|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
27863919|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
27863920|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
27863921|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
27863922|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
27780837|NCT00606021|81027535|FG002|Maintenance Phase|Lost to Follow-up|2|||
27780838|NCT01072500|81027536|FG000|Overall Study|Death|2|||
27780839|NCT01072500|81027537|FG001|Overall Study|Death|2|||
27780840|NCT01072500|81027536|FG000|Overall Study|Lost to Follow-up|5|||
27780841|NCT01072500|81027537|FG001|Overall Study|Lost to Follow-up|2|||
27780842|NCT01072500|81027536|FG000|Overall Study|Withdrawal by Subject|17|||
27780843|NCT01072500|81027537|FG001|Overall Study|Withdrawal by Subject|10|||
27780844|NCT00413231|81027538|FG000|0 to 30-day Post Treatment|Death|5|||
27780845|NCT00413231|81027538|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
27780846|NCT00413231|81027538|FG000|30-day to 365-day Post Treatment|Death|13|||
27780847|NCT00413231|81027538|FG000|365-day to 60-month Post Treatment|Death|36|||
27780848|NCT00413231|81027538|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
27780849|NCT00413231|81027538|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
27780850|NCT00413231|81027538|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
27780851|NCT00298766|81027539|FG000|Overall Study|Adverse Event|18|||
27780852|NCT00298766|81027539|FG000|Overall Study|Death|2|||
27780853|NCT00298766|81027539|FG000|Overall Study|Withdrawal by Subject|9|||
27780854|NCT00298766|81027539|FG000|Overall Study|Treatment ongoing|4|||
27780855|NCT00298766|81027539|FG000|Overall Study|Progression of amyloid markers|4|||
27863923|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
27863924|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
27667174|NCT00526097|80619695|FG001|Overall Study|Adverse Event|44|||
27667175|NCT00526097|80619694|FG000|Overall Study|Protocol Violation|4|||
27667176|NCT00526097|80619695|FG001|Overall Study|Protocol Violation|10|||
27667177|NCT00526097|80619694|FG000|Overall Study|Withdrawal by Subject|3|||
27780856|NCT00298766|81027539|FG000|Overall Study|Deterioration in KPS and organ function|1|||
27780857|NCT00298766|81027539|FG000|Overall Study|Subjects overall condition deterioration|4|||
27780858|NCT00298766|81027539|FG000|Overall Study|Other|4|||
27780859|NCT02200510|81027540|FG000|Overall Study|Death|1|||
27780860|NCT02200510|81027541|FG001|Overall Study|Death|1|||
27780861|NCT02200510|81027540|FG000|Overall Study|Protocol Violation|0|||
27780862|NCT02200510|81027541|FG001|Overall Study|Protocol Violation|1|||
27780863|NCT02200510|81027540|FG000|Overall Study|Lost to Follow-up|7|||
27780864|NCT02200510|81027541|FG001|Overall Study|Lost to Follow-up|1|||
27780865|NCT02200510|81027540|FG000|Overall Study|potential COI - joined study team|1|||
27780866|NCT02200510|81027541|FG001|Overall Study|potential COI - joined study team|0|||
27780867|NCT03824704|81027542|FG000|Overall Study|Study Terminated by Sponsor|1|||
27780868|NCT01279954|81027543|FG000|Overall Study|Lack of Efficacy|3|||
27780869|NCT01279954|81027544|FG001|Overall Study|Lack of Efficacy|4|||
27780870|NCT02918006|81027545|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
27780871|NCT02918006|81027546|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
27780872|NCT02918006|81027547|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
27780873|NCT02918006|81027545|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
27780874|NCT02918006|81027546|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
27780875|NCT02918006|81027547|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
27780876|NCT02918006|81027545|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
27780877|NCT02918006|81027546|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
27780878|NCT02918006|81027547|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
27780879|NCT02918006|81027545|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
27780880|NCT02918006|81027546|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
27780881|NCT02918006|81027547|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
27780882|NCT02918006|81027545|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
27780883|NCT02918006|81027546|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
27780884|NCT02918006|81027547|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
27780885|NCT02918006|81027545|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
27780886|NCT02918006|81027546|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
27780887|NCT02918006|81027547|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
27780888|NCT02918006|81027545|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
27780889|NCT02918006|81027546|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
27780890|NCT02918006|81027547|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
27780891|NCT02918006|81027545|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
27780892|NCT02918006|81027546|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
27780893|NCT02918006|81027547|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
27780894|NCT02918006|81027545|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
27780895|NCT02918006|81027546|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
27780896|NCT02918006|81027547|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
27780897|NCT01432756|81027548|FG000|Overall Study|Lost to Follow-up|1|||
27780898|NCT01432756|81027549|FG001|Overall Study|Lost to Follow-up|0|||
27780899|NCT01432756|81027550|FG002|Overall Study|Lost to Follow-up|2|||
27780900|NCT01432756|81027551|FG003|Overall Study|Lost to Follow-up|1|||
27780901|NCT02500706|81027552|FG000|Overall Study|Adverse Event|0|||
27780902|NCT02500706|81027553|FG001|Overall Study|Adverse Event|0|||
27780903|NCT02500706|81027554|FG002|Overall Study|Adverse Event|1|||
27780904|NCT02500706|81027552|FG000|Overall Study|Lost to Follow-up|0|||
27780905|NCT02500706|81027553|FG001|Overall Study|Lost to Follow-up|1|||
27780906|NCT02500706|81027554|FG002|Overall Study|Lost to Follow-up|1|||
27780907|NCT02500706|81027552|FG000|Overall Study|Withdrawal by Subject|4|||
27780908|NCT02500706|81027553|FG001|Overall Study|Withdrawal by Subject|6|||
27780909|NCT02500706|81027554|FG002|Overall Study|Withdrawal by Subject|4|||
27780910|NCT02500706|81027552|FG000|Overall Study|Unclassified|0|||
27969702|NCT03842969|81722650|FG001|Overall Study|Pregnancy|0|||
27969703|NCT03842969|81722651|FG002|Overall Study|Pregnancy|1|||
27969704|NCT03842969|81722649|FG000|Overall Study|Death|1|||
27969705|NCT03842969|81722650|FG001|Overall Study|Death|0|||
27969706|NCT03842969|81722651|FG002|Overall Study|Death|1|||
27969707|NCT03842969|81722649|FG000|Overall Study|Withdrawal by Subject|3|||
27969708|NCT03842969|81722650|FG001|Overall Study|Withdrawal by Subject|30|||
27969709|NCT03842969|81722651|FG002|Overall Study|Withdrawal by Subject|18|||
27969710|NCT03842969|81722649|FG000|Overall Study|Protocol Violation|1|||
27969711|NCT03842969|81722650|FG001|Overall Study|Protocol Violation|1|||
27969712|NCT03842969|81722651|FG002|Overall Study|Protocol Violation|0|||
27969713|NCT03842969|81722649|FG000|Overall Study|Physician Decision|0|||
27969714|NCT03842969|81722650|FG001|Overall Study|Physician Decision|3|||
27969715|NCT03842969|81722651|FG002|Overall Study|Physician Decision|0|||
27780911|NCT02500706|81027553|FG001|Overall Study|Unclassified|0|||
27780912|NCT02500706|81027554|FG002|Overall Study|Unclassified|1|||
27780913|NCT01277666|81027557|FG000|Overall Study|Adverse Event|26|||
27780914|NCT01277666|81027558|FG001|Overall Study|Adverse Event|25|||
27780915|NCT01277666|81027559|FG002|Overall Study|Adverse Event|20|||
27780916|NCT01277666|81027557|FG000|Overall Study|Lack of Efficacy|8|||
27780917|NCT01277666|81027558|FG001|Overall Study|Lack of Efficacy|20|||
27780918|NCT01277666|81027559|FG002|Overall Study|Lack of Efficacy|12|||
27969716|NCT03842969|81722649|FG000|Overall Study|Lost to Follow-up|0|||
27969717|NCT03842969|81722650|FG001|Overall Study|Lost to Follow-up|2|||
27969718|NCT03842969|81722651|FG002|Overall Study|Lost to Follow-up|0|||
27969719|NCT03842969|81722649|FG000|Overall Study|Adverse Event|0|||
27969720|NCT03842969|81722650|FG001|Overall Study|Adverse Event|2|||
27969721|NCT03842969|81722651|FG002|Overall Study|Adverse Event|0|||
27969722|NCT03319953|81722652|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
27969723|NCT03319953|81722653|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
27969724|NCT03319953|81722654|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
27969725|NCT03319953|81722655|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
27969726|NCT03319953|81722652|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
27969727|NCT03319953|81722653|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
27969728|NCT03319953|81722654|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
27969729|NCT03319953|81722655|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
27969730|NCT01035463|81722664|FG000|Overall Study|Adverse Event|0|||
27969731|NCT01035463|81722665|FG001|Overall Study|Adverse Event|0|||
27969732|NCT01035463|81722666|FG002|Overall Study|Adverse Event|4|||
27969733|NCT01035463|81722667|FG003|Overall Study|Adverse Event|1|||
27969734|NCT01035463|81722668|FG004|Overall Study|Adverse Event|5|||
27969735|NCT01035463|81722669|FG005|Overall Study|Adverse Event|7|||
27969736|NCT01035463|81722664|FG000|Overall Study|Withdrawal by Subject|0|||
27969737|NCT01035463|81722665|FG001|Overall Study|Withdrawal by Subject|2|||
27969738|NCT01035463|81722666|FG002|Overall Study|Withdrawal by Subject|1|||
27969739|NCT01035463|81722667|FG003|Overall Study|Withdrawal by Subject|0|||
27969740|NCT01035463|81722668|FG004|Overall Study|Withdrawal by Subject|1|||
27969741|NCT01035463|81722669|FG005|Overall Study|Withdrawal by Subject|4|||
27969742|NCT01035463|81722664|FG000|Overall Study|Disease progression|0|||
27780919|NCT01277666|81027557|FG000|Overall Study|Protocol Violation|2|||
27780920|NCT01277666|81027558|FG001|Overall Study|Protocol Violation|3|||
27780921|NCT01277666|81027559|FG002|Overall Study|Protocol Violation|2|||
27780922|NCT01277666|81027557|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
27780923|NCT01277666|81027558|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
27780924|NCT01277666|81027559|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
27780925|NCT01277666|81027557|FG000|Overall Study|Lost to Follow-up|1|||
27780926|NCT01277666|81027558|FG001|Overall Study|Lost to Follow-up|1|||
27780927|NCT01277666|81027559|FG002|Overall Study|Lost to Follow-up|2|||
27780928|NCT01277666|81027557|FG000|Overall Study|Withdrawal by Subject|7|||
27780929|NCT01277666|81027558|FG001|Overall Study|Withdrawal by Subject|8|||
27780930|NCT01277666|81027559|FG002|Overall Study|Withdrawal by Subject|6|||
27780931|NCT01277666|81027557|FG000|Overall Study|Death|0|||
27780932|NCT01277666|81027558|FG001|Overall Study|Death|0|||
27780933|NCT01277666|81027559|FG002|Overall Study|Death|1|||
27780934|NCT02129192|81027560|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
27780935|NCT02129192|81027561|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
27780936|NCT01497899|81027562|FG000|Double-Blind Phase|Randomized but not Treated|1|||
27780937|NCT01497899|81027563|FG001|Double-Blind Phase|Randomized but not Treated|0|||
27780938|NCT01497899|81027564|FG002|Double-Blind Phase|Randomized but not Treated|0|||
27780939|NCT01497899|81027565|FG003|Double-Blind Phase|Randomized but not Treated|0|||
27780940|NCT01497899|81027562|FG000|Double-Blind Phase|Adverse Event|1|||
27780941|NCT01497899|81027563|FG001|Double-Blind Phase|Adverse Event|0|||
27780942|NCT01497899|81027564|FG002|Double-Blind Phase|Adverse Event|0|||
27780943|NCT01497899|81027565|FG003|Double-Blind Phase|Adverse Event|0|||
27780944|NCT01497899|81027562|FG000|Double-Blind Phase|Lack of Efficacy|0|||
27780945|NCT01497899|81027563|FG001|Double-Blind Phase|Lack of Efficacy|1|||
27780946|NCT01497899|81027564|FG002|Double-Blind Phase|Lack of Efficacy|0|||
27780947|NCT01497899|81027565|FG003|Double-Blind Phase|Lack of Efficacy|0|||
27780948|NCT01497899|81027562|FG000|Double-Blind Phase|Investigator's Discretion|1|||
27780949|NCT01497899|81027563|FG001|Double-Blind Phase|Investigator's Discretion|0|||
27780950|NCT01497899|81027564|FG002|Double-Blind Phase|Investigator's Discretion|0|||
27780951|NCT01497899|81027565|FG003|Double-Blind Phase|Investigator's Discretion|0|||
27969743|NCT01035463|81722665|FG001|Overall Study|Disease progression|0|||
27969744|NCT01035463|81722666|FG002|Overall Study|Disease progression|0|||
27969745|NCT01035463|81722667|FG003|Overall Study|Disease progression|0|||
27969746|NCT01035463|81722668|FG004|Overall Study|Disease progression|0|||
27780952|NCT01497899|81027562|FG000|Double-Blind Phase|Withdrew Consent|0|||
27780953|NCT01497899|81027563|FG001|Double-Blind Phase|Withdrew Consent|1|||
27780954|NCT01497899|81027564|FG002|Double-Blind Phase|Withdrew Consent|0|||
27780955|NCT01497899|81027565|FG003|Double-Blind Phase|Withdrew Consent|0|||
27780956|NCT01497899|81027562|FG000|Double-Blind Phase|Lost to Follow-up|3|||
27780957|NCT01497899|81027563|FG001|Double-Blind Phase|Lost to Follow-up|2|||
27780958|NCT01497899|81027564|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27863925|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
27969747|NCT01035463|81722669|FG005|Overall Study|Disease progression|3|||
27969748|NCT01035463|81722664|FG000|Overall Study|Other Malignancy|0|||
27969749|NCT01035463|81722665|FG001|Overall Study|Other Malignancy|0|||
27969750|NCT01035463|81722666|FG002|Overall Study|Other Malignancy|0|||
27780959|NCT01497899|81027565|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27780960|NCT01497899|81027562|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
27780961|NCT01497899|81027563|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
27780962|NCT01497899|81027564|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
27780963|NCT01497899|81027565|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
27780964|NCT01497899|81027562|FG000|Open-Label Extension Phase|Adverse Event|1|||
27780965|NCT01497899|81027563|FG001|Open-Label Extension Phase|Adverse Event|0|||
27780966|NCT01497899|81027564|FG002|Open-Label Extension Phase|Adverse Event|0|||
27780967|NCT01497899|81027565|FG003|Open-Label Extension Phase|Adverse Event|0|||
27780968|NCT01497899|81027562|FG000|Open-Label Extension Phase|Death|1|||
27780969|NCT01497899|81027563|FG001|Open-Label Extension Phase|Death|0|||
27780970|NCT01497899|81027564|FG002|Open-Label Extension Phase|Death|0|||
27780971|NCT01497899|81027565|FG003|Open-Label Extension Phase|Death|0|||
27969751|NCT01035463|81722667|FG003|Overall Study|Other Malignancy|0|||
27969752|NCT01035463|81722668|FG004|Overall Study|Other Malignancy|0|||
27667178|NCT00526097|80619695|FG001|Overall Study|Withdrawal by Subject|1|||
27667179|NCT00526097|80619694|FG000|Overall Study|Other|2|||
27667180|NCT00526097|80619695|FG001|Overall Study|Other|1|||
27667181|NCT01482429|80619696|FG000|Care Usual|Protocol Violation|0|||
27667182|NCT01482429|80619697|FG001|Care Usual|Protocol Violation|172|||
27667183|NCT01482429|80619696|FG000|Care Usual|Lost to Follow-up|0|||
27667184|NCT01482429|80619697|FG001|Care Usual|Lost to Follow-up|1|||
27667185|NCT01482429|80619696|FG000|Protocol|Protocol Violation|275|||
27667186|NCT01482429|80619697|FG001|Protocol|Protocol Violation|0|||
27667187|NCT02972242|80619700|FG000|Overall Study|Withdrawal by Subject|1|||
27667188|NCT02972242|80619701|FG001|Overall Study|Withdrawal by Subject|0|||
27667189|NCT00935259|80619704|FG000|Period 1|Administrative (scheduling conflict)|1|||
27667190|NCT00935259|80619705|FG001|Period 1|Administrative (scheduling conflict)|1|||
27667191|NCT00632931|80619706|FG000|Part 1, Period 1|Protocol Violation|1|||
27667192|NCT00632931|80619707|FG001|Part 1, Period 1|Protocol Violation|0|||
27667193|NCT00632931|80619708|FG002|Part 1, Period 1|Protocol Violation|0|||
27969753|NCT01035463|81722669|FG005|Overall Study|Other Malignancy|2|||
27969754|NCT01035463|81722664|FG000|Overall Study|Other|0|||
27969755|NCT01035463|81722665|FG001|Overall Study|Other|0|||
27969756|NCT01035463|81722666|FG002|Overall Study|Other|0|||
27969757|NCT01035463|81722667|FG003|Overall Study|Other|1|||
27969758|NCT01035463|81722668|FG004|Overall Study|Other|0|||
27969759|NCT01035463|81722669|FG005|Overall Study|Other|2|||
27969760|NCT01895543|81722670|FG000|Overall Study|Withdrawal by Subject|43|||
27969761|NCT01895543|81722670|FG000|Overall Study|Lost to Follow-up|25|||
27969762|NCT01895543|81722670|FG000|Overall Study|Adverse Event|28|||
27969763|NCT01895543|81722670|FG000|Overall Study|Subject's substantial non-compliance|6|||
27969764|NCT01895543|81722670|FG000|Overall Study|Protocol Violation|1|||
27969765|NCT01895543|81722670|FG000|Overall Study|Physician Decision|2|||
27969766|NCT01895543|81722670|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
27969767|NCT00075725|81722679|FG000|Overall Study|Adverse Event|6|||
27969768|NCT00075725|81722680|FG001|Overall Study|Adverse Event|6|||
27969769|NCT00075725|81722681|FG002|Overall Study|Adverse Event|20|||
27969770|NCT00075725|81722682|FG003|Overall Study|Adverse Event|8|||
27969771|NCT00075725|81722683|FG004|Overall Study|Adverse Event|4|||
27969772|NCT00075725|81722684|FG005|Overall Study|Adverse Event|38|||
27969773|NCT00075725|81722685|FG006|Overall Study|Adverse Event|3|||
27969774|NCT00075725|81722686|FG007|Overall Study|Adverse Event|51|||
27969775|NCT00075725|81722687|FG008|Overall Study|Adverse Event|15|||
27969776|NCT00075725|81722688|FG009|Overall Study|Adverse Event|4|||
27969777|NCT00075725|81722689|FG010|Overall Study|Adverse Event|2|||
27969778|NCT00075725|81722690|FG011|Overall Study|Adverse Event|2|||
27969779|NCT00075725|81722679|FG000|Overall Study|Death|3|||
27969780|NCT00075725|81722680|FG001|Overall Study|Death|5|||
27969781|NCT00075725|81722681|FG002|Overall Study|Death|10|||
27969782|NCT00075725|81722682|FG003|Overall Study|Death|2|||
27969783|NCT00075725|81722683|FG004|Overall Study|Death|3|||
27667194|NCT00632931|80619706|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
27667195|NCT00632931|80619707|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
27667196|NCT00632931|80619708|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
27667197|NCT00632931|80619706|FG000|Part 2|Adverse Event|0|||
27667198|NCT00632931|80619707|FG001|Part 2|Adverse Event|0|||
27780972|NCT01497899|81027562|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
27780973|NCT01497899|81027563|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
27969784|NCT00075725|81722684|FG005|Overall Study|Death|25|||
27969785|NCT00075725|81722685|FG006|Overall Study|Death|4|||
27969786|NCT00075725|81722686|FG007|Overall Study|Death|22|||
27969787|NCT00075725|81722687|FG008|Overall Study|Death|14|||
27969788|NCT00075725|81722688|FG009|Overall Study|Death|4|||
27969789|NCT00075725|81722689|FG010|Overall Study|Death|3|||
27969790|NCT00075725|81722690|FG011|Overall Study|Death|0|||
27969791|NCT00075725|81722679|FG000|Overall Study|Lost to Follow-up|1|||
27969792|NCT00075725|81722680|FG001|Overall Study|Lost to Follow-up|1|||
27969793|NCT00075725|81722681|FG002|Overall Study|Lost to Follow-up|4|||
27969794|NCT00075725|81722682|FG003|Overall Study|Lost to Follow-up|1|||
27969795|NCT00075725|81722683|FG004|Overall Study|Lost to Follow-up|0|||
27969796|NCT00075725|81722684|FG005|Overall Study|Lost to Follow-up|13|||
27969797|NCT00075725|81722685|FG006|Overall Study|Lost to Follow-up|2|||
27969798|NCT00075725|81722686|FG007|Overall Study|Lost to Follow-up|4|||
27969799|NCT00075725|81722687|FG008|Overall Study|Lost to Follow-up|1|||
27969800|NCT00075725|81722688|FG009|Overall Study|Lost to Follow-up|0|||
27969801|NCT00075725|81722689|FG010|Overall Study|Lost to Follow-up|0|||
27969802|NCT00075725|81722690|FG011|Overall Study|Lost to Follow-up|0|||
27969803|NCT00075725|81722679|FG000|Overall Study|Physician Decision|2|||
27969804|NCT00075725|81722680|FG001|Overall Study|Physician Decision|6|||
27969805|NCT00075725|81722681|FG002|Overall Study|Physician Decision|5|||
27969806|NCT00075725|81722682|FG003|Overall Study|Physician Decision|8|||
27969807|NCT00075725|81722683|FG004|Overall Study|Physician Decision|4|||
27969808|NCT00075725|81722684|FG005|Overall Study|Physician Decision|19|||
27969809|NCT00075725|81722685|FG006|Overall Study|Physician Decision|3|||
27969810|NCT00075725|81722686|FG007|Overall Study|Physician Decision|17|||
27969811|NCT00075725|81722687|FG008|Overall Study|Physician Decision|5|||
27969812|NCT00075725|81722688|FG009|Overall Study|Physician Decision|0|||
27969813|NCT00075725|81722689|FG010|Overall Study|Physician Decision|1|||
27969814|NCT00075725|81722690|FG011|Overall Study|Physician Decision|0|||
27969815|NCT00075725|81722679|FG000|Overall Study|Pregnancy|0|||
27969816|NCT00075725|81722680|FG001|Overall Study|Pregnancy|0|||
27969817|NCT00075725|81722681|FG002|Overall Study|Pregnancy|0|||
27969818|NCT00075725|81722682|FG003|Overall Study|Pregnancy|0|||
27969819|NCT00075725|81722683|FG004|Overall Study|Pregnancy|0|||
27969820|NCT00075725|81722684|FG005|Overall Study|Pregnancy|1|||
27969821|NCT00075725|81722685|FG006|Overall Study|Pregnancy|0|||
27969822|NCT00075725|81722686|FG007|Overall Study|Pregnancy|1|||
27969823|NCT00075725|81722687|FG008|Overall Study|Pregnancy|0|||
27969824|NCT00075725|81722688|FG009|Overall Study|Pregnancy|0|||
27969825|NCT00075725|81722689|FG010|Overall Study|Pregnancy|0|||
27969826|NCT00075725|81722690|FG011|Overall Study|Pregnancy|0|||
27969827|NCT00075725|81722679|FG000|Overall Study|Protocol Violation|1|||
27969828|NCT00075725|81722680|FG001|Overall Study|Protocol Violation|1|||
27969829|NCT00075725|81722681|FG002|Overall Study|Protocol Violation|0|||
27969830|NCT00075725|81722682|FG003|Overall Study|Protocol Violation|3|||
27969831|NCT00075725|81722683|FG004|Overall Study|Protocol Violation|3|||
27969832|NCT00075725|81722684|FG005|Overall Study|Protocol Violation|2|||
27969833|NCT00075725|81722685|FG006|Overall Study|Protocol Violation|1|||
27969834|NCT00075725|81722686|FG007|Overall Study|Protocol Violation|2|||
27969835|NCT00075725|81722687|FG008|Overall Study|Protocol Violation|3|||
27969836|NCT00075725|81722688|FG009|Overall Study|Protocol Violation|0|||
27969837|NCT00075725|81722689|FG010|Overall Study|Protocol Violation|0|||
27863926|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
27863927|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
27863928|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
27863929|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
27863930|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
27863931|NCT04614948|81333158|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
27863932|NCT04614948|81333159|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
27969838|NCT00075725|81722690|FG011|Overall Study|Protocol Violation|1|||
27969839|NCT00075725|81722679|FG000|Overall Study|Withdrawal by Subject|12|||
27969840|NCT00075725|81722680|FG001|Overall Study|Withdrawal by Subject|3|||
27969841|NCT00075725|81722681|FG002|Overall Study|Withdrawal by Subject|6|||
27969842|NCT00075725|81722682|FG003|Overall Study|Withdrawal by Subject|10|||
27969843|NCT00075725|81722683|FG004|Overall Study|Withdrawal by Subject|6|||
27780974|NCT01497899|81027564|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
27780975|NCT01497899|81027565|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
27780976|NCT01497899|81027562|FG000|Open-Label Extension Phase|Pregnancy|0|||
27780977|NCT01497899|81027563|FG001|Open-Label Extension Phase|Pregnancy|1|||
27780978|NCT01497899|81027564|FG002|Open-Label Extension Phase|Pregnancy|1|||
27780979|NCT01497899|81027565|FG003|Open-Label Extension Phase|Pregnancy|0|||
27780980|NCT01497899|81027562|FG000|Open-Label Extension Phase|Protocol Violation|0|||
27969844|NCT00075725|81722684|FG005|Overall Study|Withdrawal by Subject|27|||
27780981|NCT01497899|81027563|FG001|Open-Label Extension Phase|Protocol Violation|0|||
27780982|NCT01497899|81027564|FG002|Open-Label Extension Phase|Protocol Violation|1|||
27780983|NCT01497899|81027565|FG003|Open-Label Extension Phase|Protocol Violation|0|||
27780984|NCT01497899|81027562|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
27969845|NCT00075725|81722685|FG006|Overall Study|Withdrawal by Subject|7|||
27969846|NCT00075725|81722686|FG007|Overall Study|Withdrawal by Subject|31|||
27969847|NCT00075725|81722687|FG008|Overall Study|Withdrawal by Subject|10|||
27969848|NCT00075725|81722688|FG009|Overall Study|Withdrawal by Subject|2|||
27969849|NCT00075725|81722689|FG010|Overall Study|Withdrawal by Subject|0|||
27969850|NCT00075725|81722690|FG011|Overall Study|Withdrawal by Subject|0|||
27969851|NCT00075725|81722679|FG000|Overall Study|Disease Progression, all other reasons|17|||
27969852|NCT00075725|81722680|FG001|Overall Study|Disease Progression, all other reasons|5|||
27969853|NCT00075725|81722681|FG002|Overall Study|Disease Progression, all other reasons|33|||
27969854|NCT00075725|81722682|FG003|Overall Study|Disease Progression, all other reasons|6|||
27969855|NCT00075725|81722683|FG004|Overall Study|Disease Progression, all other reasons|21|||
27969856|NCT00075725|81722684|FG005|Overall Study|Disease Progression, all other reasons|59|||
27969857|NCT00075725|81722685|FG006|Overall Study|Disease Progression, all other reasons|20|||
27969858|NCT00075725|81722686|FG007|Overall Study|Disease Progression, all other reasons|46|||
27969859|NCT00075725|81722687|FG008|Overall Study|Disease Progression, all other reasons|21|||
27969860|NCT00075725|81722688|FG009|Overall Study|Disease Progression, all other reasons|4|||
27969861|NCT00075725|81722689|FG010|Overall Study|Disease Progression, all other reasons|0|||
27969862|NCT00075725|81722690|FG011|Overall Study|Disease Progression, all other reasons|5|||
27969863|NCT00075725|81722679|FG000|Overall Study|Patient off treatment|0|||
27969864|NCT00075725|81722680|FG001|Overall Study|Patient off treatment|0|||
27969865|NCT00075725|81722681|FG002|Overall Study|Patient off treatment|1|||
27969866|NCT00075725|81722682|FG003|Overall Study|Patient off treatment|2|||
27969867|NCT00075725|81722683|FG004|Overall Study|Patient off treatment|1|||
27969868|NCT00075725|81722684|FG005|Overall Study|Patient off treatment|0|||
27969869|NCT00075725|81722685|FG006|Overall Study|Patient off treatment|0|||
27969870|NCT00075725|81722686|FG007|Overall Study|Patient off treatment|2|||
27969871|NCT00075725|81722687|FG008|Overall Study|Patient off treatment|1|||
27969872|NCT00075725|81722688|FG009|Overall Study|Patient off treatment|0|||
27969873|NCT00075725|81722689|FG010|Overall Study|Patient off treatment|0|||
27969874|NCT00075725|81722690|FG011|Overall Study|Patient off treatment|0|||
27969875|NCT00075725|81722679|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
27969876|NCT00075725|81722680|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
27969877|NCT00075725|81722681|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
27969878|NCT00075725|81722682|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
27969879|NCT00075725|81722683|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
27969880|NCT00075725|81722684|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
27969881|NCT00075725|81722685|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
27969882|NCT00075725|81722686|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
27969883|NCT00075725|81722687|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
27969884|NCT00075725|81722688|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
27969885|NCT00075725|81722689|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
27969886|NCT00075725|81722690|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
27969887|NCT00075725|81722679|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
27969888|NCT00075725|81722680|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
27969889|NCT00075725|81722681|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
27780985|NCT01497899|81027563|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
27780986|NCT01497899|81027564|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
27780987|NCT01497899|81027565|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
27969890|NCT00075725|81722682|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
27969891|NCT00075725|81722683|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
27969892|NCT00075725|81722684|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
27969893|NCT00075725|81722685|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
27969894|NCT00075725|81722686|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
27969895|NCT00075725|81722687|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
27969896|NCT00075725|81722688|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
27969897|NCT00075725|81722689|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
27969898|NCT00075725|81722690|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
27969899|NCT00075725|81722679|FG000|Overall Study|Pt non compliant with therapy|2|||
27969900|NCT00075725|81722680|FG001|Overall Study|Pt non compliant with therapy|1|||
27969901|NCT00075725|81722681|FG002|Overall Study|Pt non compliant with therapy|1|||
27969902|NCT00075725|81722682|FG003|Overall Study|Pt non compliant with therapy|0|||
27969903|NCT00075725|81722683|FG004|Overall Study|Pt non compliant with therapy|2|||
27969904|NCT00075725|81722684|FG005|Overall Study|Pt non compliant with therapy|14|||
27969905|NCT00075725|81722685|FG006|Overall Study|Pt non compliant with therapy|2|||
27969906|NCT00075725|81722686|FG007|Overall Study|Pt non compliant with therapy|5|||
27969907|NCT00075725|81722687|FG008|Overall Study|Pt non compliant with therapy|3|||
27969908|NCT00075725|81722688|FG009|Overall Study|Pt non compliant with therapy|0|||
27969909|NCT00075725|81722689|FG010|Overall Study|Pt non compliant with therapy|0|||
27969910|NCT00075725|81722690|FG011|Overall Study|Pt non compliant with therapy|0|||
27780988|NCT04610827|81027566|FG000|Overall Study|Withdrawal by Subject|1|||
27969911|NCT00075725|81722679|FG000|Overall Study|Pt age out of range for treatment|0|||
27969912|NCT00075725|81722680|FG001|Overall Study|Pt age out of range for treatment|1|||
27969913|NCT00075725|81722681|FG002|Overall Study|Pt age out of range for treatment|0|||
27969914|NCT00075725|81722682|FG003|Overall Study|Pt age out of range for treatment|0|||
27780989|NCT04610827|81027567|FG001|Overall Study|Withdrawal by Subject|1|||
27969915|NCT00075725|81722683|FG004|Overall Study|Pt age out of range for treatment|0|||
27780990|NCT04610827|81027568|FG002|Overall Study|Withdrawal by Subject|0|||
27969916|NCT00075725|81722684|FG005|Overall Study|Pt age out of range for treatment|1|||
27969917|NCT00075725|81722685|FG006|Overall Study|Pt age out of range for treatment|0|||
27969918|NCT00075725|81722686|FG007|Overall Study|Pt age out of range for treatment|1|||
27969919|NCT00075725|81722687|FG008|Overall Study|Pt age out of range for treatment|0|||
27969920|NCT00075725|81722688|FG009|Overall Study|Pt age out of range for treatment|0|||
27969921|NCT00075725|81722689|FG010|Overall Study|Pt age out of range for treatment|0|||
27969922|NCT00075725|81722690|FG011|Overall Study|Pt age out of range for treatment|0|||
27969923|NCT00075725|81722679|FG000|Overall Study|Insurance issues|0|||
27969924|NCT00075725|81722680|FG001|Overall Study|Insurance issues|1|||
27969925|NCT00075725|81722681|FG002|Overall Study|Insurance issues|0|||
27969926|NCT00075725|81722682|FG003|Overall Study|Insurance issues|1|||
27969927|NCT00075725|81722683|FG004|Overall Study|Insurance issues|1|||
27969928|NCT00075725|81722684|FG005|Overall Study|Insurance issues|1|||
27969929|NCT00075725|81722685|FG006|Overall Study|Insurance issues|0|||
27969930|NCT00075725|81722686|FG007|Overall Study|Insurance issues|1|||
27969931|NCT00075725|81722687|FG008|Overall Study|Insurance issues|0|||
27969932|NCT00075725|81722688|FG009|Overall Study|Insurance issues|0|||
27969933|NCT00075725|81722689|FG010|Overall Study|Insurance issues|0|||
27969934|NCT00075725|81722690|FG011|Overall Study|Insurance issues|0|||
27969935|NCT00075725|81722679|FG000|Overall Study|MRD positive after extended ind|0|||
27969936|NCT00075725|81722680|FG001|Overall Study|MRD positive after extended ind|1|||
27969937|NCT00075725|81722681|FG002|Overall Study|MRD positive after extended ind|1|||
27969938|NCT00075725|81722682|FG003|Overall Study|MRD positive after extended ind|0|||
27780991|NCT03812224|81027569|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
27780992|NCT03812224|81027570|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27780993|NCT03812224|81027569|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
27780994|NCT03812224|81027570|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
27780995|NCT03812224|81027569|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
27780996|NCT03812224|81027570|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
27780997|NCT03812224|81027569|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
27780998|NCT03812224|81027570|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
27780999|NCT00590031|81027571|FG000|Overall Study|Adverse Event|3|||
27781000|NCT00590031|81027571|FG000|Overall Study|Withdrawal by Subject|1|||
27781001|NCT00590031|81027571|FG000|Overall Study|Metastatic Disease|1|||
27781002|NCT00590031|81027571|FG000|Overall Study|Admin Hold|1|||
27781003|NCT02371980|81027572|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
27781004|NCT02371980|81027573|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
27781005|NCT02371980|81027574|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
27781006|NCT02371980|81027575|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
27781007|NCT02371980|81027576|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
27781008|NCT02371980|81027572|FG000|Open-label Period|Significant Protocol Deviation|19|||
27781009|NCT02371980|81027573|FG001|Open-label Period|Significant Protocol Deviation|0|||
27781010|NCT02371980|81027574|FG002|Open-label Period|Significant Protocol Deviation|0|||
27781011|NCT02371980|81027575|FG003|Open-label Period|Significant Protocol Deviation|0|||
27781012|NCT02371980|81027576|FG004|Open-label Period|Significant Protocol Deviation|0|||
27781013|NCT02371980|81027572|FG000|Open-label Period|Noncompliance with Study Drug|10|||
27781014|NCT02371980|81027573|FG001|Open-label Period|Noncompliance with Study Drug|0|||
27781015|NCT02371980|81027574|FG002|Open-label Period|Noncompliance with Study Drug|0|||
27781016|NCT02371980|81027575|FG003|Open-label Period|Noncompliance with Study Drug|0|||
27781017|NCT02371980|81027576|FG004|Open-label Period|Noncompliance with Study Drug|0|||
27781018|NCT02371980|81027572|FG000|Open-label Period|Lost to Follow-up|55|||
27781019|NCT02371980|81027573|FG001|Open-label Period|Lost to Follow-up|0|||
27781020|NCT02371980|81027574|FG002|Open-label Period|Lost to Follow-up|0|||
27969939|NCT00075725|81722683|FG004|Overall Study|MRD positive after extended ind|1|||
27969940|NCT00075725|81722684|FG005|Overall Study|MRD positive after extended ind|2|||
27969941|NCT00075725|81722685|FG006|Overall Study|MRD positive after extended ind|0|||
27969942|NCT00075725|81722686|FG007|Overall Study|MRD positive after extended ind|1|||
27667199|NCT00632931|80619708|FG002|Part 2|Adverse Event|3|||
27667200|NCT00632931|80619706|FG000|Part 2|Death|0|||
27667201|NCT00632931|80619707|FG001|Part 2|Death|0|||
27781021|NCT02371980|81027575|FG003|Open-label Period|Lost to Follow-up|0|||
27781022|NCT02371980|81027576|FG004|Open-label Period|Lost to Follow-up|0|||
27781023|NCT02371980|81027572|FG000|Open-label Period|Voluntary Withdrawal|91|||
27781024|NCT02371980|81027573|FG001|Open-label Period|Voluntary Withdrawal|0|||
27781025|NCT02371980|81027574|FG002|Open-label Period|Voluntary Withdrawal|0|||
27781026|NCT02371980|81027575|FG003|Open-label Period|Voluntary Withdrawal|0|||
27781027|NCT02371980|81027576|FG004|Open-label Period|Voluntary Withdrawal|0|||
27969943|NCT00075725|81722687|FG008|Overall Study|MRD positive after extended ind|0|||
27969944|NCT00075725|81722688|FG009|Overall Study|MRD positive after extended ind|0|||
27969945|NCT00075725|81722689|FG010|Overall Study|MRD positive after extended ind|0|||
27667202|NCT00632931|80619708|FG002|Part 2|Death|1|||
27969946|NCT00075725|81722690|FG011|Overall Study|MRD positive after extended ind|0|||
27969947|NCT00075725|81722679|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
27969948|NCT00075725|81722680|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
27969949|NCT00075725|81722681|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
27969950|NCT00075725|81722682|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
27969951|NCT00075725|81722683|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
27969952|NCT00075725|81722684|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
27969953|NCT00075725|81722685|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
27969954|NCT00075725|81722686|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
27969955|NCT00075725|81722687|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
27969956|NCT00075725|81722688|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
27863933|NCT04614948|81333160|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
27863934|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
27863935|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
27863936|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
27781028|NCT02371980|81027572|FG000|Open-label Period|Pregnancy|1|||
27781029|NCT02371980|81027573|FG001|Open-label Period|Pregnancy|0|||
27781030|NCT02371980|81027574|FG002|Open-label Period|Pregnancy|0|||
27781031|NCT02371980|81027575|FG003|Open-label Period|Pregnancy|0|||
27781032|NCT02371980|81027576|FG004|Open-label Period|Pregnancy|0|||
27781033|NCT02371980|81027572|FG000|Open-label Period|Lack of Efficacy|116|||
27781034|NCT02371980|81027573|FG001|Open-label Period|Lack of Efficacy|0|||
27781035|NCT02371980|81027574|FG002|Open-label Period|Lack of Efficacy|0|||
27781036|NCT02371980|81027575|FG003|Open-label Period|Lack of Efficacy|0|||
27781037|NCT02371980|81027576|FG004|Open-label Period|Lack of Efficacy|0|||
27781038|NCT02371980|81027572|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
27781039|NCT02371980|81027573|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
27781040|NCT02371980|81027574|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
27781041|NCT02371980|81027575|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
27781042|NCT02371980|81027576|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
27781043|NCT02371980|81027572|FG000|Open-label Period|Reason not Specified|9|||
27781044|NCT02371980|81027573|FG001|Open-label Period|Reason not Specified|0|||
27863937|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
27781045|NCT02371980|81027574|FG002|Open-label Period|Reason not Specified|0|||
27781046|NCT02371980|81027575|FG003|Open-label Period|Reason not Specified|0|||
27781047|NCT02371980|81027576|FG004|Open-label Period|Reason not Specified|0|||
27781048|NCT02371980|81027572|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
27863938|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
27863939|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
27570784|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
27863940|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
27863941|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
27863942|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
27863943|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
27863944|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
27863945|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
27863946|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
27863947|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
27863948|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
27863949|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
27863950|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
27863951|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
27863952|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
27863953|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
27863954|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
27863955|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
27863956|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
27863957|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
27863958|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
27863959|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
27863960|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
27863961|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
27863962|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
27863963|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
27863964|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
27863965|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
27863966|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
27863967|NCT04614948|81333158|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
27863968|NCT04614948|81333159|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
27863969|NCT04614948|81333160|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
27863970|NCT03765788|81333161|FG000|Overall Study|Subject decision|2|||
27863971|NCT03765788|81333162|FG001|Overall Study|Subject decision|3|||
27863972|NCT03765788|81333161|FG000|Overall Study|Physician Decision|2|||
27863973|NCT03765788|81333162|FG001|Overall Study|Physician Decision|4|||
27863974|NCT03765788|81333161|FG000|Overall Study|Death|0|||
27863975|NCT03765788|81333162|FG001|Overall Study|Death|1|||
27863976|NCT03765788|81333161|FG000|Overall Study|Lost to Follow-up|1|||
27863977|NCT03765788|81333162|FG001|Overall Study|Lost to Follow-up|0|||
27863978|NCT03516513|81333163|FG000|Overall Study|Withdrawal by Subject|2|||
27863979|NCT03516513|81333164|FG001|Overall Study|Withdrawal by Subject|2|||
27863980|NCT03516513|81333165|FG002|Overall Study|Withdrawal by Subject|0|||
27969957|NCT00075725|81722689|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
27969958|NCT00075725|81722690|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
27969959|NCT00075725|81722679|FG000|Overall Study|Inevaluable|1|||
27969960|NCT00075725|81722680|FG001|Overall Study|Inevaluable|1|||
27969961|NCT00075725|81722681|FG002|Overall Study|Inevaluable|4|||
27969962|NCT00075725|81722682|FG003|Overall Study|Inevaluable|2|||
27969963|NCT00075725|81722683|FG004|Overall Study|Inevaluable|2|||
27969964|NCT00075725|81722684|FG005|Overall Study|Inevaluable|9|||
27969965|NCT00075725|81722685|FG006|Overall Study|Inevaluable|1|||
27969966|NCT00075725|81722686|FG007|Overall Study|Inevaluable|11|||
27969967|NCT00075725|81722687|FG008|Overall Study|Inevaluable|2|||
27969968|NCT00075725|81722688|FG009|Overall Study|Inevaluable|0|||
27969969|NCT00075725|81722689|FG010|Overall Study|Inevaluable|1|||
27969970|NCT00075725|81722690|FG011|Overall Study|Inevaluable|0|||
27969971|NCT00075725|81722679|FG000|Overall Study|Other|4|||
27863981|NCT03516513|81333166|FG003|Overall Study|Withdrawal by Subject|0|||
27863982|NCT03047330|81333169|FG000|Sleep Block 1|Withdrawal by Subject|3|||
27863983|NCT03597464|81333170|FG000|Overall Study|Withdrawal by Subject|4|||
27969972|NCT00075725|81722680|FG001|Overall Study|Other|2|||
27969973|NCT00075725|81722681|FG002|Overall Study|Other|1|||
27969974|NCT00075725|81722682|FG003|Overall Study|Other|1|||
27969975|NCT00075725|81722683|FG004|Overall Study|Other|1|||
27863984|NCT03597464|81333171|FG001|Overall Study|Withdrawal by Subject|5|||
27863985|NCT03597464|81333170|FG000|Overall Study|Lost to Follow-up|3|||
27863986|NCT03597464|81333171|FG001|Overall Study|Lost to Follow-up|1|||
27863987|NCT03597464|81333170|FG000|Overall Study|Pregnancy|3|||
27863988|NCT03597464|81333171|FG001|Overall Study|Pregnancy|1|||
27863989|NCT03597464|81333170|FG000|Overall Study|Lack of Efficacy|2|||
27863990|NCT03597464|81333171|FG001|Overall Study|Lack of Efficacy|0|||
27863991|NCT03597464|81333170|FG000|Overall Study|Physician Decision|2|||
27863992|NCT03597464|81333171|FG001|Overall Study|Physician Decision|2|||
27863993|NCT03597464|81333170|FG000|Overall Study|Protocol Violation|1|||
27863994|NCT03597464|81333171|FG001|Overall Study|Protocol Violation|1|||
27863995|NCT03597464|81333170|FG000|Overall Study|Adverse Event|0|||
27863996|NCT03597464|81333171|FG001|Overall Study|Adverse Event|2|||
27863997|NCT03597464|81333170|FG000|Overall Study|Death|0|||
27863998|NCT03597464|81333171|FG001|Overall Study|Death|3|||
27863999|NCT05101343|81333172|FG000|Overall Study|Withdrawal by Subject|2|||
27864000|NCT05101343|81333173|FG001|Overall Study|Withdrawal by Subject|1|||
27864001|NCT03760185|81333177|FG000|Overall Study|Lost to Follow-up|1|||
27864002|NCT03760185|81333178|FG001|Overall Study|Lost to Follow-up|1|||
27864003|NCT01884337|81333179|FG000|Treatment|Adverse Event|2|||
27864004|NCT01884337|81333180|FG001|Treatment|Adverse Event|2|||
27864005|NCT01884337|81333179|FG000|Treatment|Subj. request to discont. treatment|2|||
27864006|NCT01884337|81333180|FG001|Treatment|Subj. request to discont. treatment|0|||
27864007|NCT01884337|81333179|FG000|Follow-up Period|Lost to Follow-up|1|||
27864008|NCT01884337|81333180|FG001|Follow-up Period|Lost to Follow-up|1|||
27969976|NCT00075725|81722684|FG005|Overall Study|Other|4|||
27969977|NCT00075725|81722685|FG006|Overall Study|Other|2|||
27969978|NCT00075725|81722686|FG007|Overall Study|Other|9|||
27969979|NCT00075725|81722687|FG008|Overall Study|Other|2|||
27969980|NCT00075725|81722688|FG009|Overall Study|Other|1|||
27969981|NCT00075725|81722689|FG010|Overall Study|Other|0|||
27969982|NCT00075725|81722690|FG011|Overall Study|Other|3|||
27969983|NCT00075725|81722679|FG000|Overall Study|Pt trying to find a BM donor|0|||
27969984|NCT00075725|81722680|FG001|Overall Study|Pt trying to find a BM donor|1|||
27969985|NCT00075725|81722681|FG002|Overall Study|Pt trying to find a BM donor|0|||
27969986|NCT00075725|81722682|FG003|Overall Study|Pt trying to find a BM donor|0|||
27969987|NCT00075725|81722683|FG004|Overall Study|Pt trying to find a BM donor|0|||
27969988|NCT00075725|81722684|FG005|Overall Study|Pt trying to find a BM donor|0|||
27969989|NCT00075725|81722685|FG006|Overall Study|Pt trying to find a BM donor|0|||
27969990|NCT00075725|81722686|FG007|Overall Study|Pt trying to find a BM donor|0|||
27969991|NCT00075725|81722687|FG008|Overall Study|Pt trying to find a BM donor|0|||
27969992|NCT00075725|81722688|FG009|Overall Study|Pt trying to find a BM donor|0|||
27969993|NCT00075725|81722689|FG010|Overall Study|Pt trying to find a BM donor|0|||
27781049|NCT02371980|81027573|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
27781050|NCT02371980|81027574|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
27781051|NCT02371980|81027575|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
27781052|NCT02371980|81027576|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
27781053|NCT02371980|81027572|FG000|Double-blind Period|Significant Protocol Deviation|0|||
27781054|NCT02371980|81027573|FG001|Double-blind Period|Significant Protocol Deviation|2|||
27781055|NCT02371980|81027574|FG002|Double-blind Period|Significant Protocol Deviation|7|||
27864009|NCT01661062|81333241|FG000|Overall Study|Completed Treatment Off Study|3|||
27864010|NCT01661062|81333241|FG000|Overall Study|Withdrawal by Subject|2|||
27864011|NCT02224157|81333242|FG000|Overall Study|Severe non-compliance to protocol|2|||
27969994|NCT00075725|81722690|FG011|Overall Study|Pt trying to find a BM donor|0|||
27969995|NCT00075725|81722679|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
27969996|NCT00075725|81722680|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
27969997|NCT00075725|81722681|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
27969998|NCT00075725|81722682|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
27864012|NCT02224157|81333243|FG001|Overall Study|Severe non-compliance to protocol|2|||
27864013|NCT02224157|81333242|FG000|Overall Study|Other|13|||
27864014|NCT02224157|81333243|FG001|Overall Study|Other|10|||
27864015|NCT02224157|81333242|FG000|Overall Study|Subject decision|58|||
27969999|NCT00075725|81722683|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
27970000|NCT00075725|81722684|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
27864016|NCT02224157|81333243|FG001|Overall Study|Subject decision|50|||
27864017|NCT02224157|81333242|FG000|Overall Study|Prematurely closed site|4|||
27970001|NCT00075725|81722685|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
27970002|NCT00075725|81722686|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
27970003|NCT00075725|81722687|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
27970004|NCT00075725|81722688|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
27970005|NCT00075725|81722689|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
27970006|NCT00075725|81722690|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
27970007|NCT00075725|81722679|FG000|Overall Study|Unsuccessful institutional transfer|0|||
27970008|NCT00075725|81722680|FG001|Overall Study|Unsuccessful institutional transfer|0|||
27970009|NCT00075725|81722681|FG002|Overall Study|Unsuccessful institutional transfer|2|||
27970010|NCT00075725|81722682|FG003|Overall Study|Unsuccessful institutional transfer|0|||
27970011|NCT00075725|81722683|FG004|Overall Study|Unsuccessful institutional transfer|0|||
27970012|NCT00075725|81722684|FG005|Overall Study|Unsuccessful institutional transfer|0|||
27970013|NCT00075725|81722685|FG006|Overall Study|Unsuccessful institutional transfer|0|||
27970014|NCT00075725|81722686|FG007|Overall Study|Unsuccessful institutional transfer|0|||
27970015|NCT00075725|81722687|FG008|Overall Study|Unsuccessful institutional transfer|0|||
27970016|NCT00075725|81722688|FG009|Overall Study|Unsuccessful institutional transfer|1|||
27970017|NCT00075725|81722689|FG010|Overall Study|Unsuccessful institutional transfer|0|||
27970018|NCT00075725|81722690|FG011|Overall Study|Unsuccessful institutional transfer|0|||
27970019|NCT00075725|81722679|FG000|Overall Study|specimen(s) not submitted|0|||
27970020|NCT00075725|81722680|FG001|Overall Study|specimen(s) not submitted|0|||
27970021|NCT00075725|81722681|FG002|Overall Study|specimen(s) not submitted|2|||
27970022|NCT00075725|81722682|FG003|Overall Study|specimen(s) not submitted|0|||
27970023|NCT00075725|81722683|FG004|Overall Study|specimen(s) not submitted|0|||
27970024|NCT00075725|81722684|FG005|Overall Study|specimen(s) not submitted|0|||
27970025|NCT00075725|81722685|FG006|Overall Study|specimen(s) not submitted|0|||
27970026|NCT00075725|81722686|FG007|Overall Study|specimen(s) not submitted|0|||
27970027|NCT00075725|81722687|FG008|Overall Study|specimen(s) not submitted|0|||
27970028|NCT00075725|81722688|FG009|Overall Study|specimen(s) not submitted|0|||
27970029|NCT00075725|81722689|FG010|Overall Study|specimen(s) not submitted|0|||
27970030|NCT00075725|81722690|FG011|Overall Study|specimen(s) not submitted|0|||
27970031|NCT00075725|81722679|FG000|Overall Study|Pt went to transplant|0|||
27970032|NCT00075725|81722680|FG001|Overall Study|Pt went to transplant|0|||
27970033|NCT00075725|81722681|FG002|Overall Study|Pt went to transplant|0|||
27970034|NCT00075725|81722682|FG003|Overall Study|Pt went to transplant|1|||
27781056|NCT02371980|81027575|FG003|Double-blind Period|Significant Protocol Deviation|3|||
27781057|NCT02371980|81027576|FG004|Double-blind Period|Significant Protocol Deviation|3|||
27781058|NCT02371980|81027572|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
27781059|NCT02371980|81027573|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
27781060|NCT02371980|81027574|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
27781061|NCT02371980|81027575|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
27781062|NCT02371980|81027576|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
27781063|NCT02371980|81027572|FG000|Double-blind Period|Lost to Follow-up|0|||
27781064|NCT02371980|81027573|FG001|Double-blind Period|Lost to Follow-up|8|||
27781065|NCT02371980|81027574|FG002|Double-blind Period|Lost to Follow-up|8|||
27781066|NCT02371980|81027575|FG003|Double-blind Period|Lost to Follow-up|6|||
27781067|NCT02371980|81027576|FG004|Double-blind Period|Lost to Follow-up|5|||
27781068|NCT02371980|81027572|FG000|Double-blind Period|Voluntary Withdrawal|0|||
27781069|NCT02371980|81027573|FG001|Double-blind Period|Voluntary Withdrawal|12|||
27781070|NCT02371980|81027574|FG002|Double-blind Period|Voluntary Withdrawal|8|||
27781071|NCT02371980|81027575|FG003|Double-blind Period|Voluntary Withdrawal|9|||
27781072|NCT02371980|81027576|FG004|Double-blind Period|Voluntary Withdrawal|11|||
27781073|NCT02371980|81027572|FG000|Double-blind Period|Relapse|0|||
27781074|NCT02371980|81027573|FG001|Double-blind Period|Relapse|50|||
27781075|NCT02371980|81027574|FG002|Double-blind Period|Relapse|25|||
27781076|NCT02371980|81027575|FG003|Double-blind Period|Relapse|25|||
27781077|NCT02371980|81027576|FG004|Double-blind Period|Relapse|26|||
27781078|NCT02371980|81027572|FG000|Double-blind Period|Reason not Specified|0|||
27781079|NCT02371980|81027573|FG001|Double-blind Period|Reason not Specified|3|||
27781080|NCT02371980|81027574|FG002|Double-blind Period|Reason not Specified|3|||
27781081|NCT02371980|81027575|FG003|Double-blind Period|Reason not Specified|2|||
27781082|NCT02371980|81027576|FG004|Double-blind Period|Reason not Specified|1|||
27781083|NCT02371980|81027572|FG000|Double-blind Period|Missing|0|||
27781084|NCT02371980|81027573|FG001|Double-blind Period|Missing|1|||
27781085|NCT02371980|81027574|FG002|Double-blind Period|Missing|0|||
27781086|NCT02371980|81027575|FG003|Double-blind Period|Missing|0|||
27781087|NCT02371980|81027576|FG004|Double-blind Period|Missing|0|||
27970035|NCT00075725|81722683|FG004|Overall Study|Pt went to transplant|0|||
27970036|NCT00075725|81722684|FG005|Overall Study|Pt went to transplant|1|||
27970037|NCT00075725|81722685|FG006|Overall Study|Pt went to transplant|0|||
27667203|NCT00632931|80619706|FG000|Part 2|Lack of Efficacy|0|||
27781088|NCT02425891|81027577|FG000|Overall Study|Death|333|||
27781089|NCT02425891|81027578|FG001|Overall Study|Death|314|||
27781090|NCT02425891|81027577|FG000|Overall Study|Lost to Follow-up|4|||
27781091|NCT02425891|81027578|FG001|Overall Study|Lost to Follow-up|6|||
27970038|NCT00075725|81722686|FG007|Overall Study|Pt went to transplant|0|||
27970039|NCT00075725|81722687|FG008|Overall Study|Pt went to transplant|0|||
27970040|NCT00075725|81722688|FG009|Overall Study|Pt went to transplant|0|||
27970041|NCT00075725|81722689|FG010|Overall Study|Pt went to transplant|0|||
27970042|NCT00075725|81722690|FG011|Overall Study|Pt went to transplant|0|||
27970043|NCT00075725|81722679|FG000|Overall Study|Pt received additional steroids|0|||
27970044|NCT00075725|81722680|FG001|Overall Study|Pt received additional steroids|0|||
27970045|NCT00075725|81722681|FG002|Overall Study|Pt received additional steroids|0|||
27970046|NCT00075725|81722682|FG003|Overall Study|Pt received additional steroids|1|||
27970047|NCT00075725|81722683|FG004|Overall Study|Pt received additional steroids|0|||
27970048|NCT00075725|81722684|FG005|Overall Study|Pt received additional steroids|0|||
27970049|NCT00075725|81722685|FG006|Overall Study|Pt received additional steroids|0|||
27970050|NCT00075725|81722686|FG007|Overall Study|Pt received additional steroids|0|||
27970051|NCT00075725|81722687|FG008|Overall Study|Pt received additional steroids|0|||
27970052|NCT00075725|81722688|FG009|Overall Study|Pt received additional steroids|0|||
27970053|NCT00075725|81722689|FG010|Overall Study|Pt received additional steroids|0|||
27970054|NCT00075725|81722690|FG011|Overall Study|Pt received additional steroids|0|||
27970055|NCT00075725|81722679|FG000|Overall Study|Pt relocated|0|||
27570785|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
27570786|NCT00404352|80275344|FG000|Double Blind (up to 24 Month)|Other|0|||
27570787|NCT00404352|80275345|FG001|Double Blind (up to 24 Month)|Other|1|||
27570788|NCT00404352|80275346|FG002|Double Blind (up to 24 Month)|Other|0|||
27570789|NCT00404352|80275347|FG003|Double Blind (up to 24 Month)|Other|0|||
27570790|NCT00404352|80275348|FG004|Double Blind (up to 24 Month)|Other|0|||
27667204|NCT00632931|80619707|FG001|Part 2|Lack of Efficacy|0|||
27781092|NCT02425891|81027577|FG000|Overall Study|Non-Compliance|1|||
27781093|NCT02425891|81027578|FG001|Overall Study|Non-Compliance|1|||
27781094|NCT02425891|81027577|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
27781095|NCT02425891|81027578|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
27781096|NCT02425891|81027577|FG000|Overall Study|Physician Decision|0|||
27781097|NCT02425891|81027578|FG001|Overall Study|Physician Decision|1|||
27781098|NCT02425891|81027577|FG000|Overall Study|Protocol Violation|1|||
27781099|NCT02425891|81027578|FG001|Overall Study|Protocol Violation|1|||
27781100|NCT02425891|81027577|FG000|Overall Study|Study Terminated By Sponsor|85|||
27781101|NCT02425891|81027578|FG001|Overall Study|Study Terminated By Sponsor|95|||
27781102|NCT02425891|81027577|FG000|Overall Study|Withdrawal by Subject|27|||
27781103|NCT02425891|81027578|FG001|Overall Study|Withdrawal by Subject|32|||
27781104|NCT03575975|81027582|FG000|Overall Study|Lost to Follow-up|1|||
27864018|NCT02224157|81333243|FG001|Overall Study|Prematurely closed site|2|||
27864019|NCT02224157|81333242|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
27970056|NCT00075725|81722680|FG001|Overall Study|Pt relocated|0|||
27781105|NCT03575975|81027583|FG001|Overall Study|Lost to Follow-up|0|||
27781106|NCT03575975|81027584|FG002|Overall Study|Lost to Follow-up|0|||
27781107|NCT02712008|81027590|FG000|Baseline (Day 1) up to Week 12|Death|3|||
27781108|NCT02712008|81027591|FG001|Baseline (Day 1) up to Week 12|Death|0|||
27781109|NCT02712008|81027592|FG002|Baseline (Day 1) up to Week 12|Death|0|||
27781110|NCT02712008|81027593|FG003|Baseline (Day 1) up to Week 12|Death|0|||
27781111|NCT02712008|81027594|FG004|Baseline (Day 1) up to Week 12|Death|0|||
27781112|NCT02712008|81027595|FG005|Baseline (Day 1) up to Week 12|Death|0|||
27781113|NCT02712008|81027596|FG006|Baseline (Day 1) up to Week 12|Death|0|||
27781114|NCT02712008|81027597|FG007|Baseline (Day 1) up to Week 12|Death|0|||
27781115|NCT02712008|81027590|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27781116|NCT02712008|81027591|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
27781117|NCT02712008|81027592|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
27781118|NCT02712008|81027593|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27781119|NCT02712008|81027594|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27970057|NCT00075725|81722681|FG002|Overall Study|Pt relocated|0|||
27970058|NCT00075725|81722682|FG003|Overall Study|Pt relocated|2|||
27970059|NCT00075725|81722683|FG004|Overall Study|Pt relocated|0|||
27970060|NCT00075725|81722684|FG005|Overall Study|Pt relocated|1|||
27970061|NCT00075725|81722685|FG006|Overall Study|Pt relocated|1|||
27970062|NCT00075725|81722686|FG007|Overall Study|Pt relocated|2|||
27970063|NCT00075725|81722687|FG008|Overall Study|Pt relocated|1|||
27970064|NCT00075725|81722688|FG009|Overall Study|Pt relocated|0|||
27970065|NCT00075725|81722689|FG010|Overall Study|Pt relocated|0|||
27970066|NCT00075725|81722690|FG011|Overall Study|Pt relocated|0|||
27970067|NCT00075725|81722679|FG000|Overall Study|Institution Terminated|0|||
27970068|NCT00075725|81722680|FG001|Overall Study|Institution Terminated|0|||
27970069|NCT00075725|81722681|FG002|Overall Study|Institution Terminated|0|||
27970070|NCT00075725|81722682|FG003|Overall Study|Institution Terminated|0|||
27970071|NCT00075725|81722683|FG004|Overall Study|Institution Terminated|1|||
27970072|NCT00075725|81722684|FG005|Overall Study|Institution Terminated|0|||
27970073|NCT00075725|81722685|FG006|Overall Study|Institution Terminated|0|||
27970074|NCT00075725|81722686|FG007|Overall Study|Institution Terminated|3|||
27970075|NCT00075725|81722687|FG008|Overall Study|Institution Terminated|0|||
27970076|NCT00075725|81722688|FG009|Overall Study|Institution Terminated|0|||
27667205|NCT00632931|80619708|FG002|Part 2|Lack of Efficacy|17|||
27781120|NCT02712008|81027595|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27781121|NCT02712008|81027596|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27781122|NCT02712008|81027597|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27781123|NCT02712008|81027590|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
27781124|NCT02712008|81027591|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27781125|NCT02712008|81027592|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
27781126|NCT02712008|81027593|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27781127|NCT02712008|81027594|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27970077|NCT00075725|81722689|FG010|Overall Study|Institution Terminated|0|||
27970078|NCT00075725|81722690|FG011|Overall Study|Institution Terminated|0|||
27970079|NCT00075725|81722679|FG000|Overall Study|Study Closure|1|||
27970080|NCT00075725|81722680|FG001|Overall Study|Study Closure|0|||
27970081|NCT00075725|81722681|FG002|Overall Study|Study Closure|0|||
27970082|NCT00075725|81722682|FG003|Overall Study|Study Closure|0|||
27970083|NCT00075725|81722683|FG004|Overall Study|Study Closure|1|||
27970084|NCT00075725|81722684|FG005|Overall Study|Study Closure|3|||
27970085|NCT00075725|81722685|FG006|Overall Study|Study Closure|0|||
27970086|NCT00075725|81722686|FG007|Overall Study|Study Closure|1|||
27970087|NCT00075725|81722687|FG008|Overall Study|Study Closure|0|||
27970088|NCT00075725|81722688|FG009|Overall Study|Study Closure|0|||
27970089|NCT00075725|81722689|FG010|Overall Study|Study Closure|0|||
27970090|NCT00075725|81722690|FG011|Overall Study|Study Closure|0|||
27970091|NCT00075725|81722679|FG000|Overall Study|Other complications|0|||
27970092|NCT00075725|81722680|FG001|Overall Study|Other complications|0|||
27970093|NCT00075725|81722681|FG002|Overall Study|Other complications|0|||
27970094|NCT00075725|81722682|FG003|Overall Study|Other complications|0|||
27970095|NCT00075725|81722683|FG004|Overall Study|Other complications|0|||
27970096|NCT00075725|81722684|FG005|Overall Study|Other complications|1|||
27970097|NCT00075725|81722685|FG006|Overall Study|Other complications|0|||
27970098|NCT00075725|81722686|FG007|Overall Study|Other complications|0|||
27970099|NCT00075725|81722687|FG008|Overall Study|Other complications|0|||
27970100|NCT00075725|81722688|FG009|Overall Study|Other complications|0|||
27970101|NCT00075725|81722689|FG010|Overall Study|Other complications|0|||
27970102|NCT00075725|81722690|FG011|Overall Study|Other complications|0|||
27970103|NCT00075725|81722679|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
27970104|NCT00075725|81722680|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
27970105|NCT00075725|81722681|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
27970106|NCT00075725|81722682|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
27970107|NCT00075725|81722683|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
27970108|NCT00075725|81722684|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
27970109|NCT00075725|81722685|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
27970110|NCT00075725|81722686|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
27970111|NCT00075725|81722687|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
27970112|NCT00075725|81722688|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
27970113|NCT00075725|81722689|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
27970114|NCT00075725|81722690|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
27970115|NCT00075725|81722679|FG000|Overall Study|Pt incarcerated|0|||
27970116|NCT00075725|81722680|FG001|Overall Study|Pt incarcerated|0|||
27970117|NCT00075725|81722681|FG002|Overall Study|Pt incarcerated|0|||
27970118|NCT00075725|81722682|FG003|Overall Study|Pt incarcerated|0|||
27970119|NCT00075725|81722683|FG004|Overall Study|Pt incarcerated|0|||
27970120|NCT00075725|81722684|FG005|Overall Study|Pt incarcerated|0|||
27970121|NCT00075725|81722685|FG006|Overall Study|Pt incarcerated|0|||
27970122|NCT00075725|81722686|FG007|Overall Study|Pt incarcerated|1|||
27570791|NCT00404352|80275349|FG005|Double Blind (up to 24 Month)|Other|0|||
27667206|NCT00632931|80619706|FG000|Part 2|Withdrawal by Subject|0|||
27667207|NCT00632931|80619707|FG001|Part 2|Withdrawal by Subject|0|||
27667208|NCT00632931|80619708|FG002|Part 2|Withdrawal by Subject|3|||
27667209|NCT01167192|80619714|FG000|Overall Study|Adverse Event|1|||
27667210|NCT01167192|80619714|FG000|Overall Study|Death|1|||
27667211|NCT01167192|80619714|FG000|Overall Study|Withdrawal by Subject|1|||
27667212|NCT01167192|80619714|FG000|Overall Study|Insurance denial|1|||
27667213|NCT00677092|80619723|FG000|Overall Study|Adverse Event|1|||
27781128|NCT02712008|81027595|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27864020|NCT02224157|81333243|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
27864021|NCT02224157|81333242|FG000|Overall Study|Lost to Follow-up|27|||
27970123|NCT00075725|81722687|FG008|Overall Study|Pt incarcerated|0|||
27970124|NCT00075725|81722688|FG009|Overall Study|Pt incarcerated|0|||
27970125|NCT00075725|81722689|FG010|Overall Study|Pt incarcerated|0|||
27970126|NCT00075725|81722690|FG011|Overall Study|Pt incarcerated|0|||
27970127|NCT00336284|81722691|FG000|Overall Study|Death|52|||
27970128|NCT00336284|81722692|FG001|Overall Study|Death|26|||
27970129|NCT00336284|81722691|FG000|Overall Study|Lost to Follow-up|82|||
27970130|NCT00336284|81722692|FG001|Overall Study|Lost to Follow-up|61|||
27970131|NCT00336284|81722691|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
27570792|NCT00404352|80275350|FG006|Double Blind (up to 24 Month)|Other|0|||
27570793|NCT00404352|80275351|FG007|Double Blind (up to 24 Month)|Other|0|||
27570794|NCT00404352|80275352|FG008|Double Blind (up to 24 Month)|Other|0|||
27570795|NCT00404352|80275344|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
27570796|NCT00404352|80275345|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
27570797|NCT00404352|80275346|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
27570798|NCT00404352|80275347|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
27970132|NCT00336284|81722692|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
27970133|NCT02438384|81722695|FG000|Overall Study|Lost to Follow-up|8|||
27970134|NCT02438384|81722696|FG001|Overall Study|Lost to Follow-up|6|||
27970135|NCT02438384|81722697|FG002|Overall Study|Lost to Follow-up|4|||
27970136|NCT01795495|81722698|FG000|Overall Study|Protocol Violation|1|||
27970137|NCT01795495|81722699|FG001|Overall Study|Protocol Violation|0|||
27970138|NCT01795495|81722700|FG002|Overall Study|Protocol Violation|1|||
27970139|NCT01795495|81722698|FG000|Overall Study|Physician Decision|0|||
27970140|NCT01795495|81722699|FG001|Overall Study|Physician Decision|0|||
27970141|NCT01795495|81722700|FG002|Overall Study|Physician Decision|1|||
27970142|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
27970143|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
27970144|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
27570799|NCT00404352|80275348|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
27570800|NCT00404352|80275349|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
27570801|NCT00404352|80275350|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
27570802|NCT00404352|80275351|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
27570803|NCT00404352|80275352|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
27570804|NCT00404352|80275344|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
27570805|NCT00404352|80275345|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
27570806|NCT00404352|80275346|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
27570807|NCT00404352|80275347|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
27570808|NCT00404352|80275348|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
27570809|NCT00404352|80275349|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
27570810|NCT00404352|80275350|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
27570811|NCT00404352|80275351|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
27570812|NCT00404352|80275352|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
27570813|NCT00404352|80275344|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27781129|NCT02712008|81027596|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27970145|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
27970146|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
27970147|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
27570814|NCT00404352|80275345|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570815|NCT00404352|80275346|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570816|NCT00404352|80275347|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570817|NCT00404352|80275348|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
27781130|NCT02712008|81027597|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27970148|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
27970149|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
27970150|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
27970151|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
27970152|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
27970153|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
27970154|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
27970155|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
27970156|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
27970157|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
27781131|NCT02712008|81027590|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27970158|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
27667214|NCT00677092|80619723|FG000|Overall Study|Lost to Follow-up|1|||
27970159|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970160|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970161|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970162|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970163|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970164|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970165|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970166|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970167|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970168|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970169|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970170|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970171|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27970172|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
27970173|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
27970174|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
27970175|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
27970176|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
27970177|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
27970178|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
27970179|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
27970180|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
27970181|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
27570818|NCT00404352|80275349|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570819|NCT00404352|80275350|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570820|NCT00404352|80275351|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570821|NCT00404352|80275352|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
27570822|NCT00404352|80275344|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570823|NCT00404352|80275345|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570824|NCT00404352|80275346|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570825|NCT00404352|80275347|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570826|NCT00404352|80275348|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570827|NCT00404352|80275349|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
27570828|NCT00404352|80275350|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570829|NCT00404352|80275351|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570830|NCT00404352|80275352|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
27570831|NCT00404352|80275344|FG000|Open Label (up to 24 Month)|Disease progression|0|||
27570832|NCT00404352|80275345|FG001|Open Label (up to 24 Month)|Disease progression|0|||
27570833|NCT00404352|80275346|FG002|Open Label (up to 24 Month)|Disease progression|0|||
27570834|NCT00404352|80275347|FG003|Open Label (up to 24 Month)|Disease progression|1|||
27570835|NCT00404352|80275348|FG004|Open Label (up to 24 Month)|Disease progression|0|||
27570836|NCT00404352|80275349|FG005|Open Label (up to 24 Month)|Disease progression|0|||
27570837|NCT00404352|80275350|FG006|Open Label (up to 24 Month)|Disease progression|0|||
27570838|NCT00404352|80275351|FG007|Open Label (up to 24 Month)|Disease progression|0|||
27570839|NCT00404352|80275352|FG008|Open Label (up to 24 Month)|Disease progression|0|||
27570840|NCT00404352|80275344|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570841|NCT00404352|80275345|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570842|NCT00404352|80275346|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570843|NCT00404352|80275347|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570844|NCT00404352|80275348|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570845|NCT00404352|80275349|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570846|NCT00404352|80275350|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
27570847|NCT00404352|80275351|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
27570848|NCT00404352|80275352|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
27570849|NCT00404352|80275344|FG000|Open Label Extension (up to 36 Months)|Other|0|||
27570850|NCT00404352|80275345|FG001|Open Label Extension (up to 36 Months)|Other|0|||
27570851|NCT00404352|80275346|FG002|Open Label Extension (up to 36 Months)|Other|0|||
27864022|NCT02224157|81333243|FG001|Overall Study|Lost to Follow-up|35|||
27970182|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
27970183|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
27970184|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
27970185|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
27970186|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
27570852|NCT00404352|80275347|FG003|Open Label Extension (up to 36 Months)|Other|0|||
27570853|NCT00404352|80275348|FG004|Open Label Extension (up to 36 Months)|Other|0|||
27570854|NCT00404352|80275349|FG005|Open Label Extension (up to 36 Months)|Other|0|||
27570855|NCT00404352|80275350|FG006|Open Label Extension (up to 36 Months)|Other|0|||
27864023|NCT02224157|81333242|FG000|Overall Study|Death|1|||
27864024|NCT02224157|81333243|FG001|Overall Study|Death|1|||
27864025|NCT02224157|81333242|FG000|Overall Study|Adverse Event|1|||
27864026|NCT02224157|81333243|FG001|Overall Study|Adverse Event|3|||
27970187|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
27970188|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
27970189|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
27970190|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
27970191|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
27970192|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
27970193|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
27970194|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
27970195|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
27970196|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
27970197|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
27970198|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
27970199|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
27970200|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
27970201|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
27970202|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
27970203|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
27970204|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
27970205|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
27970206|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970207|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970208|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970209|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970210|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970211|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970212|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970213|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27781132|NCT02712008|81027591|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27781133|NCT02712008|81027592|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
27781134|NCT02712008|81027593|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27781135|NCT02712008|81027594|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27781136|NCT02712008|81027595|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27781137|NCT02712008|81027596|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27970214|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970215|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970216|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27970217|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
27970218|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
27970219|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
27970220|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
27970221|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970222|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970223|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970224|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970225|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970226|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970227|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970228|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970229|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970230|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970231|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
27970232|NCT03831191|81722701|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970233|NCT03831191|81722702|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970234|NCT03831191|81722703|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970235|NCT03831191|81722704|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
27970236|NCT03831191|81722705|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970237|NCT03831191|81722706|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970238|NCT03831191|81722707|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970239|NCT03831191|81722708|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970240|NCT03831191|81722709|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
27864027|NCT01559389|81333249|FG000|Overall Study|Withdrawal by Subject|20|||
27970241|NCT03831191|81722710|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
27570856|NCT00404352|80275351|FG007|Open Label Extension (up to 36 Months)|Other|0|||
27781138|NCT02712008|81027597|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
27781139|NCT02712008|81027590|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27864028|NCT01559389|81333250|FG001|Overall Study|Withdrawal by Subject|20|||
27864029|NCT02954991|81333256|FG000|Overall Study|Death|92|||
27864030|NCT02954991|81333257|FG001|Overall Study|Death|11|||
27667215|NCT00677092|80619723|FG000|Overall Study|Withdrawal by Subject|3|||
27667216|NCT00677092|80619723|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
27667217|NCT00727415|80619728|FG000|Phase I|Dose Limiting Toxicity|2|||
27667218|NCT04811339|80619730|FG000|Overall Study|lack of transportation not wanting to return|4|||
27667219|NCT04811339|80619731|FG001|Overall Study|lack of transportation not wanting to return|8|||
27667220|NCT04811339|80619732|FG002|Overall Study|lack of transportation not wanting to return|0|||
27667221|NCT04811339|80619730|FG000|Overall Study|Adverse Event|3|||
27667222|NCT04811339|80619731|FG001|Overall Study|Adverse Event|0|||
27667223|NCT04811339|80619732|FG002|Overall Study|Adverse Event|0|||
27667224|NCT04811339|80619730|FG000|Overall Study|Lost to Follow-up|1|||
27667225|NCT04811339|80619731|FG001|Overall Study|Lost to Follow-up|0|||
27667226|NCT04811339|80619732|FG002|Overall Study|Lost to Follow-up|0|||
27667227|NCT04811339|80619730|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
27667228|NCT04811339|80619731|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
27667229|NCT04811339|80619732|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
27781140|NCT02712008|81027591|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
27781141|NCT02712008|81027592|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27781142|NCT02712008|81027593|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27781143|NCT02712008|81027594|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27781144|NCT02712008|81027595|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27781145|NCT02712008|81027596|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27781146|NCT02712008|81027597|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
27781147|NCT02712008|81027590|FG000|From Week 12 up to Week 36|Adverse Event|0|||
27781148|NCT02712008|81027591|FG001|From Week 12 up to Week 36|Adverse Event|0|||
27781149|NCT02712008|81027592|FG002|From Week 12 up to Week 36|Adverse Event|0|||
27781150|NCT02712008|81027593|FG003|From Week 12 up to Week 36|Adverse Event|0|||
27781151|NCT02712008|81027594|FG004|From Week 12 up to Week 36|Adverse Event|1|||
27781152|NCT02712008|81027595|FG005|From Week 12 up to Week 36|Adverse Event|0|||
27781153|NCT02712008|81027596|FG006|From Week 12 up to Week 36|Adverse Event|0|||
27781154|NCT02712008|81027597|FG007|From Week 12 up to Week 36|Adverse Event|2|||
27781155|NCT02712008|81027590|FG000|From Week 12 up to Week 36|Death|1|||
27781156|NCT02712008|81027591|FG001|From Week 12 up to Week 36|Death|0|||
27781157|NCT02712008|81027592|FG002|From Week 12 up to Week 36|Death|0|||
27781158|NCT02712008|81027593|FG003|From Week 12 up to Week 36|Death|0|||
27781159|NCT02712008|81027594|FG004|From Week 12 up to Week 36|Death|0|||
27781160|NCT02712008|81027595|FG005|From Week 12 up to Week 36|Death|0|||
27781161|NCT02712008|81027596|FG006|From Week 12 up to Week 36|Death|1|||
27781162|NCT02712008|81027597|FG007|From Week 12 up to Week 36|Death|0|||
27781163|NCT02712008|81027590|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
27781164|NCT02712008|81027591|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
27781165|NCT02712008|81027592|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
27781166|NCT02712008|81027593|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
27781167|NCT02712008|81027594|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
27781168|NCT02712008|81027595|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
27781169|NCT02712008|81027596|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
27781170|NCT02712008|81027597|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
27781171|NCT02712008|81027590|FG000|From Week 12 up to Week 36|Physician Decision|0|||
27781172|NCT02712008|81027591|FG001|From Week 12 up to Week 36|Physician Decision|0|||
27781173|NCT02712008|81027592|FG002|From Week 12 up to Week 36|Physician Decision|0|||
27781174|NCT02712008|81027593|FG003|From Week 12 up to Week 36|Physician Decision|1|||
27781175|NCT02712008|81027594|FG004|From Week 12 up to Week 36|Physician Decision|1|||
27781176|NCT02712008|81027595|FG005|From Week 12 up to Week 36|Physician Decision|0|||
27781177|NCT02712008|81027596|FG006|From Week 12 up to Week 36|Physician Decision|0|||
27781178|NCT02712008|81027597|FG007|From Week 12 up to Week 36|Physician Decision|0|||
27781179|NCT02712008|81027590|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27781180|NCT02712008|81027591|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27781181|NCT02712008|81027592|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27781182|NCT02712008|81027593|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27781183|NCT02712008|81027594|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27781184|NCT02712008|81027595|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
27781185|NCT02712008|81027596|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
27781186|NCT02712008|81027597|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
27667230|NCT04811339|80619730|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
27781187|NCT00504595|81027598|FG000|Overall Study|Lack of Efficacy|1|||
27781188|NCT00504595|81027599|FG001|Overall Study|Lack of Efficacy|0|||
27781189|NCT00504595|81027600|FG002|Overall Study|Lack of Efficacy|0|||
27781190|NCT00504595|81027601|FG003|Overall Study|Lack of Efficacy|0|||
27781191|NCT00504595|81027598|FG000|Overall Study|Other|0|||
27781192|NCT00504595|81027599|FG001|Overall Study|Other|0|||
27781193|NCT00504595|81027600|FG002|Overall Study|Other|2|||
27781194|NCT00504595|81027601|FG003|Overall Study|Other|0|||
27970242|NCT03831191|81722711|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970243|NCT03831191|81722712|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
27864031|NCT02954991|81333258|FG002|Overall Study|Death|2|||
27864032|NCT02954991|81333256|FG000|Overall Study|Lost to Follow-up|3|||
27864033|NCT02954991|81333257|FG001|Overall Study|Lost to Follow-up|2|||
27864034|NCT02954991|81333258|FG002|Overall Study|Lost to Follow-up|0|||
27864035|NCT02954991|81333256|FG000|Overall Study|Withdrawal by Subject|9|||
27864036|NCT02954991|81333257|FG001|Overall Study|Withdrawal by Subject|8|||
27864037|NCT02954991|81333258|FG002|Overall Study|Withdrawal by Subject|1|||
27864038|NCT02954991|81333256|FG000|Overall Study|Study Terminated by Sponsor|18|||
27864039|NCT02954991|81333257|FG001|Overall Study|Study Terminated by Sponsor|10|||
27864040|NCT02954991|81333258|FG002|Overall Study|Study Terminated by Sponsor|1|||
27864041|NCT02954991|81333256|FG000|Overall Study|Miscellaneous|2|||
27864042|NCT02954991|81333257|FG001|Overall Study|Miscellaneous|1|||
27864043|NCT02954991|81333258|FG002|Overall Study|Miscellaneous|1|||
27864044|NCT02806024|81333262|FG000|Overall Study|Night Delivery|1|||
27864045|NCT02806024|81333263|FG001|Overall Study|Night Delivery|1|||
27864046|NCT02806024|81333262|FG000|Overall Study|DVT during antepartum admission|0|||
27864047|NCT02806024|81333263|FG001|Overall Study|DVT during antepartum admission|1|||
27864048|NCT04003896|81333264|FG000|Overall Study|Withdrawal by Subject|3|||
27864049|NCT04003896|81333264|FG000|Overall Study|Physician Decision|1|||
27864050|NCT02538965|81333265|FG000|Treatment Period|Other = Death due to disease progression|1|||
27864051|NCT02538965|81333265|FG000|Treatment Period|Adverse Event|2|||
27781195|NCT01024946|81027623|FG000|Overall Study|Screen Failure|3|||
27781196|NCT01024946|81027623|FG000|Overall Study|Withdrawal by Subject|1|||
27781197|NCT01024946|81027623|FG000|Overall Study|Adverse Event|1|||
27781198|NCT00137267|81027624|FG000|Overall Study|Lost to Follow-up|15|||
27781199|NCT00137267|81027625|FG001|Overall Study|Lost to Follow-up|21|||
27781200|NCT05158244|81027626|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
27781201|NCT05158244|81027627|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
27781202|NCT05158244|81027628|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
27781203|NCT05158244|81027629|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
27781204|NCT05158244|81027630|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
27781205|NCT05158244|81027626|FG000|Overall Study|Withdrawal by Subject|0|||
27781206|NCT05158244|81027627|FG001|Overall Study|Withdrawal by Subject|0|||
27781207|NCT05158244|81027628|FG002|Overall Study|Withdrawal by Subject|1|||
27864052|NCT02538965|81333265|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
27864053|NCT02538965|81333265|FG000|Treatment Period|Treatment Failure|9|||
27667231|NCT04811339|80619731|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
27864054|NCT02538965|81333265|FG000|Treatment Period|Disease Progression|1|||
27864055|NCT02538965|81333265|FG000|Treatment Period|Physician Decision|2|||
27864056|NCT02538965|81333265|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
27667232|NCT04811339|80619732|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
27667233|NCT04811339|80619730|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
27667234|NCT04811339|80619731|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
27667235|NCT04811339|80619732|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
27667236|NCT04811339|80619730|FG000|Overall Study|Withdrawal by Subject|0|||
27667237|NCT04811339|80619731|FG001|Overall Study|Withdrawal by Subject|3|||
27667238|NCT04811339|80619732|FG002|Overall Study|Withdrawal by Subject|0|||
27667239|NCT04811339|80619730|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
27667240|NCT04811339|80619731|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
27667241|NCT04811339|80619732|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
27667242|NCT04811339|80619730|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
27667243|NCT04811339|80619731|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
27667244|NCT04811339|80619732|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
27667245|NCT02104505|80619733|FG000|First Intervention (14 Days)|Adverse Event|2|||
27667246|NCT02104505|80619734|FG001|First Intervention (14 Days)|Adverse Event|0|||
27667247|NCT02104505|80619733|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
27667248|NCT02104505|80619734|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
27667249|NCT02104505|80619733|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
27667250|NCT02104505|80619734|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
27667251|NCT02104505|80619733|FG000|First Intervention (14 Days)|exclusionary condition|0|||
27781208|NCT05158244|81027629|FG003|Overall Study|Withdrawal by Subject|0|||
27781209|NCT05158244|81027630|FG004|Overall Study|Withdrawal by Subject|0|||
27864057|NCT02538965|81333265|FG000|Follow-Up Period|Withdrawal by Parent|4|||
27864058|NCT04208750|81333266|FG000|Overall Study|Lost to Follow-up|16|||
27864059|NCT04208750|81333267|FG001|Overall Study|Lost to Follow-up|15|||
27864060|NCT01547130|81333270|FG000|Overall Study|Lost to Follow-up|9|||
27864061|NCT01547130|81333271|FG001|Overall Study|Lost to Follow-up|5|||
27781210|NCT01333865|81027631|FG000|Overall Study|Adverse Event|2|||
27781211|NCT03287830|81027632|FG000|Overall Study|Withdrawal by Subject|1|||
27781212|NCT03287830|81027633|FG001|Overall Study|Withdrawal by Subject|1|||
27781213|NCT03287830|81027632|FG000|Overall Study|not meeting inclusion criteria|5|||
27781214|NCT03287830|81027633|FG001|Overall Study|not meeting inclusion criteria|12|||
27781215|NCT00643851|81027635|FG000|Overall Study|Death|0|||
27781216|NCT00643851|81027636|FG001|Overall Study|Death|1|||
27781217|NCT00643851|81027637|FG002|Overall Study|Death|0|||
27781218|NCT00643851|81027635|FG000|Overall Study|Lack of Efficacy|0|||
27781219|NCT00643851|81027636|FG001|Overall Study|Lack of Efficacy|1|||
27781220|NCT00643851|81027637|FG002|Overall Study|Lack of Efficacy|0|||
27781221|NCT00643851|81027635|FG000|Overall Study|Adverse Event|2|||
27781222|NCT00643851|81027636|FG001|Overall Study|Adverse Event|6|||
27781223|NCT00643851|81027637|FG002|Overall Study|Adverse Event|6|||
27781224|NCT00643851|81027635|FG000|Overall Study|Lost to Follow-up|4|||
27781225|NCT00643851|81027636|FG001|Overall Study|Lost to Follow-up|6|||
27781226|NCT00643851|81027637|FG002|Overall Study|Lost to Follow-up|9|||
27781227|NCT00643851|81027635|FG000|Overall Study|Withdrawal by Subject|8|||
27781228|NCT00643851|81027636|FG001|Overall Study|Withdrawal by Subject|15|||
27781229|NCT00643851|81027637|FG002|Overall Study|Withdrawal by Subject|9|||
27781230|NCT00643851|81027635|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
27781231|NCT00643851|81027636|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
27781232|NCT00643851|81027637|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
27781233|NCT02504424|81027646|FG000|Overall Study|Withdrawal by Subject|2|||
27781234|NCT00352027|81027647|FG000|Overall Study|Progressive disease|3|||
27781235|NCT02036476|81027651|FG000|Overall Study|Withdrawal by Subject|2|||
27781236|NCT02036476|81027651|FG000|Overall Study|Progressive Disease|4|||
27781237|NCT02036476|81027651|FG000|Overall Study|Unacceptable Toxicity|2|||
27781238|NCT01526928|81027652|FG000|Overall Study|Progressive Disease|35|||
27781239|NCT01526928|81027653|FG001|Overall Study|Progressive Disease|17|||
27781240|NCT01526928|81027654|FG002|Overall Study|Progressive Disease|150|||
27781241|NCT01526928|81027655|FG003|Overall Study|Progressive Disease|182|||
27781242|NCT01526928|81027656|FG004|Overall Study|Progressive Disease|76|||
27781243|NCT01526928|81027657|FG005|Overall Study|Progressive Disease|4|||
27781244|NCT01526928|81027652|FG000|Overall Study|Adverse Event|2|||
27781245|NCT01526928|81027653|FG001|Overall Study|Adverse Event|1|||
27781246|NCT01526928|81027654|FG002|Overall Study|Adverse Event|29|||
27781247|NCT01526928|81027655|FG003|Overall Study|Adverse Event|40|||
27781248|NCT01526928|81027656|FG004|Overall Study|Adverse Event|13|||
27781249|NCT01526928|81027657|FG005|Overall Study|Adverse Event|2|||
27781250|NCT01526928|81027652|FG000|Overall Study|Death|0|||
27781251|NCT01526928|81027653|FG001|Overall Study|Death|0|||
27781252|NCT01526928|81027654|FG002|Overall Study|Death|3|||
27781253|NCT01526928|81027655|FG003|Overall Study|Death|0|||
27781254|NCT01526928|81027656|FG004|Overall Study|Death|0|||
27781255|NCT01526928|81027657|FG005|Overall Study|Death|0|||
27781256|NCT01526928|81027652|FG000|Overall Study|Withdrawal by Subject|1|||
27781257|NCT01526928|81027653|FG001|Overall Study|Withdrawal by Subject|0|||
27781258|NCT01526928|81027654|FG002|Overall Study|Withdrawal by Subject|13|||
27781259|NCT01526928|81027655|FG003|Overall Study|Withdrawal by Subject|11|||
27781260|NCT01526928|81027656|FG004|Overall Study|Withdrawal by Subject|3|||
27781261|NCT01526928|81027657|FG005|Overall Study|Withdrawal by Subject|0|||
27781262|NCT01526928|81027652|FG000|Overall Study|Physician Decision|0|||
27781263|NCT01526928|81027653|FG001|Overall Study|Physician Decision|0|||
27781264|NCT01526928|81027654|FG002|Overall Study|Physician Decision|2|||
27781265|NCT01526928|81027655|FG003|Overall Study|Physician Decision|5|||
27781266|NCT01526928|81027656|FG004|Overall Study|Physician Decision|0|||
27781267|NCT01526928|81027657|FG005|Overall Study|Physician Decision|0|||
27781268|NCT01526928|81027652|FG000|Overall Study|Other Reason|0|||
27781269|NCT01526928|81027653|FG001|Overall Study|Other Reason|1|||
27781270|NCT01526928|81027654|FG002|Overall Study|Other Reason|11|||
27781271|NCT01526928|81027655|FG003|Overall Study|Other Reason|4|||
27781272|NCT01526928|81027656|FG004|Overall Study|Other Reason|1|||
27781273|NCT01526928|81027657|FG005|Overall Study|Other Reason|0|||
27781274|NCT01526928|81027652|FG000|Overall Study|Lost to Follow-up|0|||
27781275|NCT01526928|81027653|FG001|Overall Study|Lost to Follow-up|0|||
27781276|NCT01526928|81027654|FG002|Overall Study|Lost to Follow-up|0|||
27781277|NCT01526928|81027655|FG003|Overall Study|Lost to Follow-up|1|||
27781278|NCT01526928|81027656|FG004|Overall Study|Lost to Follow-up|0|||
27781279|NCT01526928|81027657|FG005|Overall Study|Lost to Follow-up|0|||
27781280|NCT01526928|81027652|FG000|Overall Study|Protocol Deviation|0|||
27781281|NCT01526928|81027653|FG001|Overall Study|Protocol Deviation|0|||
27781282|NCT01526928|81027654|FG002|Overall Study|Protocol Deviation|0|||
27781283|NCT01526928|81027655|FG003|Overall Study|Protocol Deviation|2|||
27781284|NCT01526928|81027656|FG004|Overall Study|Protocol Deviation|0|||
27970244|NCT03831191|81722713|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
27781285|NCT01526928|81027657|FG005|Overall Study|Protocol Deviation|0|||
27781286|NCT01526928|81027652|FG000|Overall Study|Missing|0|||
27781287|NCT01526928|81027653|FG001|Overall Study|Missing|0|||
27781288|NCT01526928|81027654|FG002|Overall Study|Missing|1|||
27781289|NCT01526928|81027655|FG003|Overall Study|Missing|0|||
27864062|NCT04660331|81333272|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
27864063|NCT04660331|81333273|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
27864064|NCT04660331|81333274|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
27864065|NCT00660907|81333275|FG000|Overall Study|Incorrect Enrollment|1|||
27864066|NCT00660907|81333276|FG001|Overall Study|Incorrect Enrollment|1|||
27864067|NCT00660907|81333275|FG000|Overall Study|Adverse Event|33|||
27864068|NCT00660907|81333276|FG001|Overall Study|Adverse Event|19|||
27864069|NCT00660907|81333275|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
27864070|NCT00660907|81333276|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
27864071|NCT00660907|81333275|FG000|Overall Study|Withdrawal by Subject|23|||
27864072|NCT00660907|81333276|FG001|Overall Study|Withdrawal by Subject|32|||
27781290|NCT01526928|81027656|FG004|Overall Study|Missing|2|||
27781291|NCT01526928|81027657|FG005|Overall Study|Missing|0|||
27781292|NCT04107935|81027658|FG000|Overall Study|Death|1|||
27781293|NCT04107935|81027659|FG001|Overall Study|Death|0|||
27781294|NCT04021706|81027660|FG000|Overall Study|Adverse Event|2|||
27781295|NCT04021706|81027661|FG001|Overall Study|Adverse Event|0|||
27781296|NCT04021706|81027660|FG000|Overall Study|Withdrawal by Subject|1|||
27781297|NCT04021706|81027661|FG001|Overall Study|Withdrawal by Subject|2|||
27781298|NCT04021706|81027660|FG000|Overall Study|Physician Decision|1|||
27781299|NCT04021706|81027661|FG001|Overall Study|Physician Decision|0|||
27781300|NCT03419741|81027662|FG000|Overall Study|Adverse Event|1|||
27781301|NCT03419741|81027663|FG001|Overall Study|Adverse Event|0|||
27781302|NCT03419741|81027662|FG000|Overall Study|Withdrawal by Subject|1|||
27781303|NCT03419741|81027663|FG001|Overall Study|Withdrawal by Subject|2|||
27781304|NCT01326481|81027664|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
27864073|NCT00660907|81333275|FG000|Overall Study|Lost to Follow-up|3|||
27864074|NCT00660907|81333276|FG001|Overall Study|Lost to Follow-up|3|||
27864075|NCT00660907|81333275|FG000|Overall Study|Poor/Non-Compliance|5|||
27864076|NCT00660907|81333276|FG001|Overall Study|Poor/Non-Compliance|1|||
27864077|NCT00660907|81333275|FG000|Overall Study|Safety|1|||
27864078|NCT00660907|81333276|FG001|Overall Study|Safety|0|||
27864079|NCT00660907|81333275|FG000|Overall Study|Death|1|||
27864080|NCT00660907|81333276|FG001|Overall Study|Death|3|||
27864081|NCT00660907|81333275|FG000|Overall Study|Various|11|||
27864082|NCT00660907|81333276|FG001|Overall Study|Various|8|||
27864083|NCT04005352|81333284|FG000|Overall Study|Adverse Event|4|||
27864084|NCT04005352|81333285|FG001|Overall Study|Adverse Event|5|||
27864085|NCT04005352|81333284|FG000|Overall Study|Death|4|||
27864086|NCT04005352|81333285|FG001|Overall Study|Death|2|||
27864087|NCT04005352|81333284|FG000|Overall Study|Lost to Follow-up|6|||
27864088|NCT04005352|81333285|FG001|Overall Study|Lost to Follow-up|2|||
27864089|NCT04005352|81333284|FG000|Overall Study|Physician Decision|7|||
27864090|NCT04005352|81333285|FG001|Overall Study|Physician Decision|13|||
27864091|NCT04005352|81333284|FG000|Overall Study|Protocol Violation|0|||
27864092|NCT04005352|81333285|FG001|Overall Study|Protocol Violation|1|||
27864093|NCT04005352|81333284|FG000|Overall Study|Withdrawal by Subject|28|||
27864094|NCT04005352|81333285|FG001|Overall Study|Withdrawal by Subject|38|||
27864095|NCT01305044|81333286|FG000|Overall Study|Withdrawal by Subject|3|||
27864096|NCT01305044|81333287|FG001|Overall Study|Withdrawal by Subject|6|||
27864097|NCT01184079|81333290|FG000|Overall Study|Lost to Follow-up|14|||
27864098|NCT01184079|81333291|FG001|Overall Study|Lost to Follow-up|2|||
27864099|NCT04693416|81333294|FG000|Overall Study|Lost to Follow-up|13|||
27864100|NCT04693416|81333295|FG001|Overall Study|Lost to Follow-up|0|||
27864101|NCT04015908|81333297|FG000|Overall Study|Lost to Follow-up|0|||
27864102|NCT04015908|81333298|FG001|Overall Study|Lost to Follow-up|1|||
27864103|NCT00708227|81333299|FG000|Overall Study|Physician Decision|0|||
27864104|NCT00708227|81333300|FG001|Overall Study|Physician Decision|3|||
27864105|NCT00708227|81333301|FG002|Overall Study|Physician Decision|1|||
27864106|NCT00708227|81333302|FG003|Overall Study|Physician Decision|2|||
27864107|NCT00708227|81333299|FG000|Overall Study|Withdrawal by Subject|1|||
27864108|NCT00708227|81333300|FG001|Overall Study|Withdrawal by Subject|2|||
27781305|NCT00935701|81027667|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
27781306|NCT01351415|81027668|FG000|Overall Study|Withdrawal by Subject|15|||
27781307|NCT01351415|81027669|FG001|Overall Study|Withdrawal by Subject|17|||
27864109|NCT00708227|81333301|FG002|Overall Study|Withdrawal by Subject|0|||
27864110|NCT00708227|81333302|FG003|Overall Study|Withdrawal by Subject|1|||
27864111|NCT00875797|81333303|FG000|Overall Study|Protocol Violation|6|||
27781308|NCT01351415|81027668|FG000|Overall Study|Trial termination by the Sponsor|28|||
27864112|NCT00875797|81333304|FG001|Overall Study|Protocol Violation|3|||
27864113|NCT02764151|81333305|FG000|Overall Study|Subject refused further follow-up|0|||
27781309|NCT01351415|81027669|FG001|Overall Study|Trial termination by the Sponsor|19|||
27781310|NCT01351415|81027668|FG000|Overall Study|Lost to Follow-up|5|||
27781311|NCT01351415|81027669|FG001|Overall Study|Lost to Follow-up|7|||
27864114|NCT02764151|81333306|FG001|Overall Study|Subject refused further follow-up|0|||
27864115|NCT02764151|81333307|FG002|Overall Study|Subject refused further follow-up|0|||
27864116|NCT02764151|81333308|FG003|Overall Study|Subject refused further follow-up|1|||
27864117|NCT02764151|81333305|FG000|Overall Study|Other|0|||
27864118|NCT02764151|81333306|FG001|Overall Study|Other|0|||
27864119|NCT02764151|81333307|FG002|Overall Study|Other|0|||
27864120|NCT02764151|81333308|FG003|Overall Study|Other|2|||
27864121|NCT01085357|81333311|FG000|Overall Study|Adverse Event|1|||
27864122|NCT01085357|81333312|FG001|Overall Study|Adverse Event|1|||
27864123|NCT01085357|81333311|FG000|Overall Study|Subject Decision|4|||
27864124|NCT01085357|81333312|FG001|Overall Study|Subject Decision|3|||
27864125|NCT01085357|81333311|FG000|Overall Study|Investigator Decision|1|||
27864126|NCT01085357|81333312|FG001|Overall Study|Investigator Decision|1|||
27864127|NCT01085357|81333311|FG000|Overall Study|Death|11|||
27864128|NCT01085357|81333312|FG001|Overall Study|Death|1|||
27864129|NCT01085357|81333311|FG000|Overall Study|Lost to Follow-up|2|||
27864130|NCT01085357|81333312|FG001|Overall Study|Lost to Follow-up|0|||
27864131|NCT00811928|81333315|FG000|Overall Study|AEs and SAEs Including Death|7|||
27864132|NCT00811928|81333316|FG001|Overall Study|AEs and SAEs Including Death|11|||
27864133|NCT00811928|81333315|FG000|Overall Study|Withdrawal by Subject|18|||
27864134|NCT00811928|81333316|FG001|Overall Study|Withdrawal by Subject|12|||
27864135|NCT00811928|81333315|FG000|Overall Study|Did Not Take Study Drug|3|||
27864136|NCT00811928|81333316|FG001|Overall Study|Did Not Take Study Drug|0|||
27864137|NCT00811928|81333315|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
27864138|NCT00811928|81333316|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
27864139|NCT00811928|81333315|FG000|Overall Study|Investigator Decision|2|||
27864140|NCT00811928|81333316|FG001|Overall Study|Investigator Decision|1|||
27864141|NCT00811928|81333315|FG000|Overall Study|Poor Compliance|2|||
27864142|NCT00811928|81333316|FG001|Overall Study|Poor Compliance|5|||
27864143|NCT00920790|81333322|FG000|Overall Study|aggravation of general condition|14|||
27864144|NCT03999749|81333323|FG000|Overall Study|Toxicity|16|||
27864145|NCT03999749|81333323|FG000|Overall Study|Withdrawal by Subject|3|||
27864146|NCT03999749|81333323|FG000|Overall Study|Disease progression|26|||
27864147|NCT03999749|81333323|FG000|Overall Study|Physician Decision|4|||
27864148|NCT03999749|81333323|FG000|Overall Study|Death|5|||
27864149|NCT03999749|81333323|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
27864150|NCT00000620|81333327|FG000|Overall Study|Death|86|||
27864151|NCT00000620|81333328|FG001|Overall Study|Death|67|||
27864152|NCT00000620|81333329|FG002|Overall Study|Death|112|||
27864153|NCT00000620|81333330|FG003|Overall Study|Death|126|||
27864154|NCT00000620|81333331|FG004|Overall Study|Death|64|||
27864155|NCT00000620|81333332|FG005|Overall Study|Death|77|||
27970245|NCT03831191|81722714|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
27781312|NCT01351415|81027668|FG000|Overall Study|Death|190|||
27781313|NCT01351415|81027669|FG001|Overall Study|Death|187|||
27781314|NCT01351415|81027668|FG000|Overall Study|Physician Decision|2|||
27781315|NCT01351415|81027669|FG001|Overall Study|Physician Decision|3|||
27781316|NCT01351415|81027668|FG000|Overall Study|Reason unknown|0|||
27781317|NCT01351415|81027669|FG001|Overall Study|Reason unknown|2|||
27781318|NCT01351415|81027668|FG000|Overall Study|Never Started|5|||
27781319|NCT01351415|81027669|FG001|Overall Study|Never Started|5|||
27781320|NCT00303719|81027674|FG000|Overall Study|Not evaluable, prior therapies|0|||
27781321|NCT00303719|81027675|FG001|Overall Study|Not evaluable, prior therapies|30|||
27781322|NCT00303719|81027674|FG000|Overall Study|Lost to Follow-up|0|||
27781323|NCT00303719|81027675|FG001|Overall Study|Lost to Follow-up|7|||
27781324|NCT01796106|81027676|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
27781325|NCT01796106|81027677|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
27781326|NCT01888367|81027681|FG000|Overall Study|Physician Decision|3|||
27781327|NCT01888367|81027682|FG001|Overall Study|Physician Decision|4|||
27781328|NCT01888367|81027683|FG002|Overall Study|Physician Decision|2|||
27781329|NCT01888367|81027681|FG000|Overall Study|Death|2|||
27781330|NCT01888367|81027682|FG001|Overall Study|Death|0|||
27781331|NCT01888367|81027683|FG002|Overall Study|Death|1|||
27781332|NCT01888367|81027681|FG000|Overall Study|Withdrawal by Subject|1|||
27781333|NCT01888367|81027682|FG001|Overall Study|Withdrawal by Subject|0|||
27781334|NCT01888367|81027683|FG002|Overall Study|Withdrawal by Subject|1|||
27781335|NCT01888367|81027681|FG000|Overall Study|Lost to Follow-up|1|||
27781336|NCT01888367|81027682|FG001|Overall Study|Lost to Follow-up|1|||
27781337|NCT01888367|81027683|FG002|Overall Study|Lost to Follow-up|0|||
27781338|NCT01888367|81027681|FG000|Overall Study|Protocol Violation|0|||
27781339|NCT01888367|81027682|FG001|Overall Study|Protocol Violation|0|||
27781340|NCT01888367|81027683|FG002|Overall Study|Protocol Violation|1|||
27781341|NCT01888367|81027681|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
27781342|NCT01888367|81027682|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
27781343|NCT01888367|81027683|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
27781344|NCT01365468|81027684|FG000|Overall Study|Physician Decision|1|||
27781345|NCT01365468|81027685|FG001|Overall Study|Physician Decision|0|||
27781346|NCT01365468|81027684|FG000|Overall Study|Disease progression|1|||
27781347|NCT01365468|81027685|FG001|Overall Study|Disease progression|0|||
27781348|NCT01365468|81027684|FG000|Overall Study|Lost to Follow-up|2|||
27781349|NCT01365468|81027685|FG001|Overall Study|Lost to Follow-up|0|||
27864156|NCT00000620|81333333|FG006|Overall Study|Death|91|||
27570857|NCT00404352|80275352|FG008|Open Label Extension (up to 36 Months)|Other|2|||
27570858|NCT01344369|80275353|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
27570859|NCT01344369|80275354|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
27570860|NCT01344369|80275353|FG000|Washout of 28 Days|Physician Decision|0|||
27570861|NCT01344369|80275354|FG001|Washout of 28 Days|Physician Decision|1|||
27570862|NCT01344369|80275353|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
27570863|NCT01344369|80275354|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
27570864|NCT02702401|80275355|FG000|Overall Study|Death|242|||
27970246|NCT03831191|81722715|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
27970247|NCT03831191|81722701|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
27970248|NCT03831191|81722702|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
27970249|NCT03831191|81722703|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
27970250|NCT03831191|81722704|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
27970251|NCT03831191|81722705|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
27970252|NCT03831191|81722706|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
27970253|NCT03831191|81722707|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
27970254|NCT03831191|81722708|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
27970255|NCT03831191|81722709|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
27970256|NCT03831191|81722710|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
27970257|NCT03831191|81722711|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
27970258|NCT03831191|81722712|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
27970259|NCT03831191|81722713|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
27970260|NCT03831191|81722714|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
27970261|NCT03831191|81722715|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
27970262|NCT03831191|81722701|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970263|NCT03831191|81722702|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970264|NCT03831191|81722703|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970265|NCT03831191|81722704|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970266|NCT03831191|81722705|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970267|NCT03831191|81722706|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970268|NCT03831191|81722707|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970269|NCT03831191|81722708|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970270|NCT03831191|81722709|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970271|NCT03831191|81722710|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970272|NCT03831191|81722711|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970273|NCT03831191|81722712|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970274|NCT03831191|81722713|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970275|NCT03831191|81722714|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27970276|NCT03831191|81722715|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
27970277|NCT03831191|81722701|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27570865|NCT02702401|80275356|FG001|Overall Study|Death|125|||
27570866|NCT02702401|80275355|FG000|Overall Study|Withdrawal by Subject|15|||
27570867|NCT02702401|80275356|FG001|Overall Study|Withdrawal by Subject|5|||
27570868|NCT02702401|80275355|FG000|Overall Study|Sponsor Decision|19|||
27570869|NCT02702401|80275356|FG001|Overall Study|Sponsor Decision|3|||
27570870|NCT02702401|80275355|FG000|Overall Study|Physician Decision|1|||
27570871|NCT02702401|80275356|FG001|Overall Study|Physician Decision|2|||
27570872|NCT02702401|80275355|FG000|Overall Study|Lost to Follow-up|1|||
27570873|NCT02702401|80275356|FG001|Overall Study|Lost to Follow-up|0|||
27570874|NCT00245765|80275357|FG000|Overall Study|Adverse Event|1|||
27570875|NCT00245765|80275358|FG001|Overall Study|Adverse Event|1|||
27570876|NCT00245765|80275359|FG002|Overall Study|Adverse Event|0|||
27570877|NCT00245765|80275357|FG000|Overall Study|Lack of Efficacy|14|||
27570878|NCT00245765|80275358|FG001|Overall Study|Lack of Efficacy|7|||
27570879|NCT00245765|80275359|FG002|Overall Study|Lack of Efficacy|0|||
27570880|NCT00245765|80275357|FG000|Overall Study|Lost to Follow-up|1|||
27570881|NCT00245765|80275358|FG001|Overall Study|Lost to Follow-up|2|||
27570882|NCT00245765|80275359|FG002|Overall Study|Lost to Follow-up|0|||
27570883|NCT00245765|80275357|FG000|Overall Study|Withdrawal by Subject|1|||
27570884|NCT00245765|80275358|FG001|Overall Study|Withdrawal by Subject|0|||
27570885|NCT00245765|80275359|FG002|Overall Study|Withdrawal by Subject|3|||
27570886|NCT00245765|80275357|FG000|Overall Study|Other reason|2|||
27570887|NCT00245765|80275358|FG001|Overall Study|Other reason|0|||
27570888|NCT00245765|80275359|FG002|Overall Study|Other reason|1|||
27570889|NCT00245765|80275357|FG000|Overall Study|Other|13|||
27570890|NCT00245765|80275358|FG001|Overall Study|Other|4|||
27570891|NCT00245765|80275359|FG002|Overall Study|Other|4|||
27570892|NCT01393743|80275360|FG000|Core Study|Adverse Event|5|||
27570893|NCT01393743|80275361|FG001|Core Study|Adverse Event|9|||
27570894|NCT01393743|80275362|FG002|Core Study|Adverse Event|0|||
27570895|NCT01393743|80275360|FG000|Core Study|Lost to Follow-up|1|||
27570896|NCT01393743|80275361|FG001|Core Study|Lost to Follow-up|1|||
27570897|NCT01393743|80275362|FG002|Core Study|Lost to Follow-up|0|||
27667252|NCT02104505|80619734|FG001|First Intervention (14 Days)|exclusionary condition|1|||
27667253|NCT02104505|80619733|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27667254|NCT02104505|80619734|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27667255|NCT02104505|80619733|FG000|Second Intervention (14 Days)|Adverse Event|2|||
27667256|NCT02104505|80619734|FG001|Second Intervention (14 Days)|Adverse Event|0|||
27667257|NCT01402063|80619735|FG000|Overall Study|Withdrawal by Subject|3|||
27667258|NCT01402063|80619736|FG001|Overall Study|Withdrawal by Subject|3|||
27667259|NCT02418845|80619741|FG000|Overall Study|Lost to Follow-up|7|||
27667260|NCT02418845|80619742|FG001|Overall Study|Lost to Follow-up|2|||
27667261|NCT02418845|80619741|FG000|Overall Study|Lack of Efficacy|0|||
27667262|NCT02418845|80619742|FG001|Overall Study|Lack of Efficacy|3|||
27667263|NCT02418845|80619741|FG000|Overall Study|Physician Decision|5|||
27667264|NCT02418845|80619742|FG001|Overall Study|Physician Decision|5|||
27667265|NCT02418845|80619741|FG000|Overall Study|Protocol Violation|1|||
27667266|NCT02418845|80619742|FG001|Overall Study|Protocol Violation|0|||
27667267|NCT02418845|80619741|FG000|Overall Study|Withdrawal by Subject|3|||
27667268|NCT02418845|80619742|FG001|Overall Study|Withdrawal by Subject|2|||
27667269|NCT01703845|80619743|FG000|Overall Study|Adverse Event|1|||
27667270|NCT01703845|80619744|FG001|Overall Study|Adverse Event|0|||
27667271|NCT01703845|80619743|FG000|Overall Study|Protocol Violation|1|||
27667272|NCT01703845|80619744|FG001|Overall Study|Protocol Violation|0|||
27667273|NCT01703845|80619743|FG000|Overall Study|other than stated above|1|||
27667274|NCT01703845|80619744|FG001|Overall Study|other than stated above|0|||
27667275|NCT01919398|80619745|FG000|Overall Study|Progressive Disease|0|||
27667276|NCT01919398|80619746|FG001|Overall Study|Progressive Disease|0|||
27667277|NCT01919398|80619747|FG002|Overall Study|Progressive Disease|4|||
27667278|NCT00607997|80619748|FG000|Overall Study|Lack of Efficacy|6|||
27667279|NCT00607997|80619749|FG001|Overall Study|Lack of Efficacy|20|||
27667280|NCT00607997|80619750|FG002|Overall Study|Lack of Efficacy|14|||
27667281|NCT00607997|80619751|FG003|Overall Study|Lack of Efficacy|10|||
27667282|NCT00607997|80619748|FG000|Overall Study|Death|8|||
27667283|NCT00607997|80619749|FG001|Overall Study|Death|5|||
27667284|NCT00607997|80619750|FG002|Overall Study|Death|2|||
27667285|NCT00607997|80619751|FG003|Overall Study|Death|5|||
27667286|NCT00607997|80619748|FG000|Overall Study|Adverse Event|3|||
27667287|NCT00607997|80619749|FG001|Overall Study|Adverse Event|1|||
27667288|NCT00607997|80619750|FG002|Overall Study|Adverse Event|2|||
27667289|NCT00607997|80619751|FG003|Overall Study|Adverse Event|0|||
27667290|NCT00607997|80619748|FG000|Overall Study|Physician Decision|4|||
27667291|NCT00607997|80619749|FG001|Overall Study|Physician Decision|1|||
27667292|NCT00607997|80619750|FG002|Overall Study|Physician Decision|0|||
27667293|NCT00607997|80619751|FG003|Overall Study|Physician Decision|0|||
27667294|NCT00607997|80619748|FG000|Overall Study|Relapse, recurrent illness|4|||
27667295|NCT00607997|80619749|FG001|Overall Study|Relapse, recurrent illness|0|||
27667296|NCT00607997|80619750|FG002|Overall Study|Relapse, recurrent illness|2|||
27667297|NCT00607997|80619751|FG003|Overall Study|Relapse, recurrent illness|0|||
27667298|NCT00607997|80619748|FG000|Overall Study|Other without explanation|2|||
27667299|NCT00607997|80619749|FG001|Overall Study|Other without explanation|0|||
27667300|NCT00607997|80619750|FG002|Overall Study|Other without explanation|4|||
27667301|NCT00607997|80619751|FG003|Overall Study|Other without explanation|1|||
27667302|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
27667303|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
27667304|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
27667305|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
27667306|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
27667307|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
27667308|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
27667309|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
27667310|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Death|6|||
27667311|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Death|2|||
27667312|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Death|2|||
27667313|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Death|9|||
27667314|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
27667315|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27667316|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27667317|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
27667318|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
27667319|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
27667320|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
27667321|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
27667322|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
27781350|NCT03018028|81027688|FG000|Overall Study|Withdrawal by Subject|3|||
27781351|NCT03018028|81027689|FG001|Overall Study|Withdrawal by Subject|0|||
27970278|NCT03831191|81722702|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27667323|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
27667324|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
27667325|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
27667326|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
27667327|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
27667328|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
27667329|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
27667330|NCT03730662|80619752|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
27667331|NCT03730662|80619753|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
27667332|NCT03730662|80619754|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
27781352|NCT03018028|81027690|FG002|Overall Study|Withdrawal by Subject|1|||
27781353|NCT03018028|81027691|FG003|Overall Study|Withdrawal by Subject|2|||
27781354|NCT03018028|81027692|FG004|Overall Study|Withdrawal by Subject|0|||
27781355|NCT00963469|81027694|FG000|Overall Study|Adverse Event|15|||
27781356|NCT00963469|81027695|FG001|Overall Study|Adverse Event|11|||
27781357|NCT00963469|81027696|FG002|Overall Study|Adverse Event|1|||
27781358|NCT00963469|81027694|FG000|Overall Study|Lack of Efficacy|10|||
27781359|NCT00963469|81027695|FG001|Overall Study|Lack of Efficacy|7|||
27781360|NCT00963469|81027696|FG002|Overall Study|Lack of Efficacy|2|||
27781361|NCT00963469|81027694|FG000|Overall Study|Lost to Follow-up|1|||
27781362|NCT00963469|81027695|FG001|Overall Study|Lost to Follow-up|1|||
27781363|NCT00963469|81027696|FG002|Overall Study|Lost to Follow-up|0|||
27781364|NCT00963469|81027694|FG000|Overall Study|Protocol Violation|5|||
27781365|NCT00963469|81027695|FG001|Overall Study|Protocol Violation|5|||
27781366|NCT00963469|81027696|FG002|Overall Study|Protocol Violation|3|||
27781367|NCT00963469|81027694|FG000|Overall Study|Withdrawal by Subject|4|||
27781368|NCT00963469|81027695|FG001|Overall Study|Withdrawal by Subject|1|||
27781369|NCT00963469|81027696|FG002|Overall Study|Withdrawal by Subject|1|||
27781370|NCT00963469|81027694|FG000|Overall Study|Pre-randomization Adverse Event|1|||
27781371|NCT00963469|81027695|FG001|Overall Study|Pre-randomization Adverse Event|2|||
27781372|NCT00963469|81027696|FG002|Overall Study|Pre-randomization Adverse Event|0|||
27667333|NCT03730662|80619755|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
27667334|NCT03730662|80619752|FG000|Variable Treatment Period|Adverse Event|1|||
27667335|NCT03730662|80619753|FG001|Variable Treatment Period|Adverse Event|2|||
27667336|NCT03730662|80619754|FG002|Variable Treatment Period|Adverse Event|0|||
27667337|NCT03730662|80619755|FG003|Variable Treatment Period|Adverse Event|7|||
27667338|NCT03730662|80619752|FG000|Variable Treatment Period|Death|9|||
27667339|NCT03730662|80619753|FG001|Variable Treatment Period|Death|0|||
27667340|NCT03730662|80619754|FG002|Variable Treatment Period|Death|6|||
27667341|NCT03730662|80619755|FG003|Variable Treatment Period|Death|26|||
27667342|NCT03730662|80619752|FG000|Variable Treatment Period|Lost to Follow-up|2|||
27667343|NCT03730662|80619753|FG001|Variable Treatment Period|Lost to Follow-up|1|||
27667344|NCT03730662|80619754|FG002|Variable Treatment Period|Lost to Follow-up|4|||
27781373|NCT00963469|81027694|FG000|Overall Study|Moved|1|||
27781374|NCT00963469|81027695|FG001|Overall Study|Moved|0|||
27781375|NCT00963469|81027696|FG002|Overall Study|Moved|0|||
27781376|NCT00963469|81027694|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
27781377|NCT00963469|81027695|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
27781378|NCT00963469|81027696|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
27570898|NCT01393743|80275360|FG000|Core Study|Participant's Choice|2|||
27570899|NCT01393743|80275361|FG001|Core Study|Participant's Choice|3|||
27570900|NCT01393743|80275362|FG002|Core Study|Participant's Choice|0|||
27570901|NCT01393743|80275360|FG000|Core Study|Inadequate therapeutic effect|2|||
27570902|NCT01393743|80275361|FG001|Core Study|Inadequate therapeutic effect|0|||
27570903|NCT01393743|80275362|FG002|Core Study|Inadequate therapeutic effect|0|||
27570904|NCT01393743|80275360|FG000|Extension Phase|Adverse Event|0|||
27570905|NCT01393743|80275361|FG001|Extension Phase|Adverse Event|0|||
27570906|NCT01393743|80275362|FG002|Extension Phase|Adverse Event|12|||
27570907|NCT01393743|80275360|FG000|Extension Phase|Lost to Follow-up|0|||
27570908|NCT01393743|80275361|FG001|Extension Phase|Lost to Follow-up|0|||
27570909|NCT01393743|80275362|FG002|Extension Phase|Lost to Follow-up|2|||
27570910|NCT01393743|80275360|FG000|Extension Phase|Participant choice|0|||
27570911|NCT01393743|80275361|FG001|Extension Phase|Participant choice|0|||
27570912|NCT01393743|80275362|FG002|Extension Phase|Participant choice|16|||
27570913|NCT01393743|80275360|FG000|Extension Phase|Inadequate therapeutic effect|0|||
27570914|NCT01393743|80275361|FG001|Extension Phase|Inadequate therapeutic effect|0|||
27570915|NCT01393743|80275362|FG002|Extension Phase|Inadequate therapeutic effect|7|||
27570916|NCT01393743|80275360|FG000|Extension Phase|Withdrawal by Subject|0|||
27570917|NCT01393743|80275361|FG001|Extension Phase|Withdrawal by Subject|0|||
27570918|NCT01393743|80275362|FG002|Extension Phase|Withdrawal by Subject|8|||
27570919|NCT01393743|80275360|FG000|Extension Phase|Pregnancy|0|||
27570920|NCT01393743|80275361|FG001|Extension Phase|Pregnancy|0|||
27570921|NCT01393743|80275362|FG002|Extension Phase|Pregnancy|1|||
27570922|NCT01393743|80275360|FG000|Extension Phase|Other|0|||
27570923|NCT01393743|80275361|FG001|Extension Phase|Other|0|||
27570924|NCT01393743|80275362|FG002|Extension Phase|Other|14|||
27570925|NCT01537783|80275363|FG000|Overall Study|Lost to Follow-up|11|||
27570926|NCT01537783|80275364|FG001|Overall Study|Lost to Follow-up|2|||
27667345|NCT03730662|80619755|FG003|Variable Treatment Period|Lost to Follow-up|11|||
27667346|NCT03730662|80619752|FG000|Variable Treatment Period|Personal Reason|0|||
27667347|NCT03730662|80619753|FG001|Variable Treatment Period|Personal Reason|2|||
27667348|NCT03730662|80619754|FG002|Variable Treatment Period|Personal Reason|1|||
27667349|NCT03730662|80619755|FG003|Variable Treatment Period|Personal Reason|6|||
27667350|NCT03730662|80619752|FG000|Variable Treatment Period|Physician Decision|0|||
27667351|NCT03730662|80619753|FG001|Variable Treatment Period|Physician Decision|0|||
27667352|NCT03730662|80619754|FG002|Variable Treatment Period|Physician Decision|0|||
27667353|NCT03730662|80619755|FG003|Variable Treatment Period|Physician Decision|3|||
27667354|NCT03730662|80619752|FG000|Variable Treatment Period|Protocol Violation|0|||
27667355|NCT03730662|80619753|FG001|Variable Treatment Period|Protocol Violation|1|||
27667356|NCT03730662|80619754|FG002|Variable Treatment Period|Protocol Violation|1|||
27667357|NCT03730662|80619755|FG003|Variable Treatment Period|Protocol Violation|1|||
27667358|NCT03730662|80619752|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
27667359|NCT03730662|80619753|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
27667360|NCT03730662|80619754|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
27667361|NCT03730662|80619755|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
27667362|NCT01264887|80619761|FG000|Overall Study|Adverse Event|5|||
27667363|NCT01264887|80619761|FG000|Overall Study|Death|7|||
27667364|NCT01264887|80619761|FG000|Overall Study|Lack of Efficacy|5|||
27667365|NCT01264887|80619761|FG000|Overall Study|Physician Decision|4|||
27667366|NCT01264887|80619761|FG000|Overall Study|Withdrawal by Subject|6|||
27667367|NCT01264887|80619761|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
27667368|NCT01264887|80619761|FG000|Overall Study|Other|2|||
27667369|NCT02506881|80619771|FG000|First Intervention (Day 1)|Protocol Violation|0|||
27667370|NCT02506881|80619772|FG001|First Intervention (Day 1)|Protocol Violation|0|||
27667371|NCT02506881|80619773|FG002|First Intervention (Day 1)|Protocol Violation|1|||
27667372|NCT02506881|80619774|FG003|First Intervention (Day 1)|Protocol Violation|0|||
27667373|NCT02506881|80619771|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
27667374|NCT02506881|80619772|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
27667375|NCT02506881|80619773|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27667376|NCT02506881|80619774|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
27667377|NCT02506881|80619771|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
27667378|NCT02506881|80619772|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
27667379|NCT02506881|80619773|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
27667380|NCT02506881|80619774|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
27667381|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
27667382|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
27667383|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
27667384|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
27667385|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
27667386|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
27667387|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
27667388|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
27667389|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
27667390|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
27667391|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
27667392|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
27667393|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
27667394|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
27667395|NCT01664923|80619775|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
27667396|NCT01664923|80619776|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
27667397|NCT01664923|80619775|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
27667398|NCT01664923|80619776|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
27667399|NCT01664923|80619775|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
27667400|NCT01664923|80619776|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
27667401|NCT01664923|80619775|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
27667402|NCT01664923|80619776|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
27667403|NCT01664923|80619775|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
27667404|NCT01664923|80619776|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
27667405|NCT01664923|80619775|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
27667406|NCT01664923|80619776|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
27667407|NCT01664923|80619775|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
27667408|NCT01664923|80619776|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
27667409|NCT03561597|80619777|FG000|Overall Study|Lost to Follow-up|20|||
27667410|NCT01185171|80619778|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
27667411|NCT01185171|80619778|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
27667412|NCT01185171|80619778|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
27970279|NCT03831191|81722703|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27667413|NCT01185171|80619778|FG000|Maintenance|Elevated liver transaminases|3|||
27667414|NCT01185171|80619778|FG000|Maintenance|Rush|2|||
27667415|NCT01185171|80619778|FG000|Maintenance|Diarrhea|1|||
27667416|NCT01185171|80619778|FG000|Maintenance|Xerostomia|1|||
27667417|NCT01185171|80619778|FG000|Maintenance|Nausea|1|||
27667418|NCT01185171|80619778|FG000|Maintenance|Comorbid Illness|2|||
27667419|NCT01185171|80619778|FG000|Maintenance|Withdrawal by Subject|1|||
27667420|NCT01185171|80619778|FG000|Maintenance|Disease Recurrence|1|||
27667421|NCT01726049|80619780|FG000|Overall Study|Death|1|||
27667422|NCT01726049|80619781|FG001|Overall Study|Death|1|||
27667423|NCT01726049|80619780|FG000|Overall Study|Adverse Event|4|||
27667424|NCT01726049|80619781|FG001|Overall Study|Adverse Event|1|||
27667425|NCT01726049|80619780|FG000|Overall Study|refused second HC|0|||
27667426|NCT01726049|80619781|FG001|Overall Study|refused second HC|2|||
27667427|NCT03772041|80619782|FG000|Overall Study|Adverse Event|8|||
27667428|NCT03772041|80619783|FG001|Overall Study|Adverse Event|3|||
27667429|NCT03772041|80619782|FG000|Overall Study|Withdrawal by Subject|0|||
27667430|NCT03772041|80619783|FG001|Overall Study|Withdrawal by Subject|2|||
27667431|NCT03772041|80619782|FG000|Overall Study|Protocol Violation|4|||
27667432|NCT03772041|80619783|FG001|Overall Study|Protocol Violation|2|||
27667433|NCT03772041|80619782|FG000|Overall Study|Physician Decision|2|||
27667434|NCT03772041|80619783|FG001|Overall Study|Physician Decision|3|||
27667435|NCT01101334|80619784|FG000|Overall Study|Adverse Event|9|||
27667436|NCT01101334|80619785|FG001|Overall Study|Adverse Event|4|||
27667437|NCT01101334|80619784|FG000|Overall Study|Death|7|||
27667438|NCT01101334|80619785|FG001|Overall Study|Death|1|||
27667439|NCT01101334|80619784|FG000|Overall Study|Withdrawal by Subject|4|||
27667440|NCT01101334|80619785|FG001|Overall Study|Withdrawal by Subject|3|||
27667441|NCT01101334|80619784|FG000|Overall Study|Withdrawal by Sponsor|1|||
27667442|NCT01101334|80619785|FG001|Overall Study|Withdrawal by Sponsor|1|||
27667443|NCT01101334|80619784|FG000|Overall Study|Progressive Disease|22|||
27667444|NCT01101334|80619785|FG001|Overall Study|Progressive Disease|35|||
27667445|NCT01101334|80619784|FG000|Overall Study|Other|2|||
27667446|NCT01101334|80619785|FG001|Overall Study|Other|1|||
27667447|NCT02741713|80619786|FG000|Overall Study|Surgery type changed intra-operatively|2|||
27667448|NCT02741713|80619787|FG001|Overall Study|Surgery type changed intra-operatively|1|||
27667449|NCT00505414|80619791|FG000|Titration Phase|Adverse Event|0|||
27667450|NCT00505414|80619792|FG001|Titration Phase|Adverse Event|0|||
27667451|NCT00505414|80619793|FG002|Titration Phase|Adverse Event|0|||
27667452|NCT00505414|80619794|FG003|Titration Phase|Adverse Event|8|||
27667453|NCT00505414|80619795|FG004|Titration Phase|Adverse Event|3|||
27667454|NCT00505414|80619791|FG000|Titration Phase|Death|0|||
27667455|NCT00505414|80619792|FG001|Titration Phase|Death|0|||
27667456|NCT00505414|80619793|FG002|Titration Phase|Death|0|||
27667457|NCT00505414|80619794|FG003|Titration Phase|Death|2|||
27667458|NCT00505414|80619795|FG004|Titration Phase|Death|0|||
27667459|NCT00505414|80619791|FG000|Titration Phase|Lack of Efficacy|0|||
27667460|NCT00505414|80619792|FG001|Titration Phase|Lack of Efficacy|0|||
27667461|NCT00505414|80619793|FG002|Titration Phase|Lack of Efficacy|0|||
27667462|NCT00505414|80619794|FG003|Titration Phase|Lack of Efficacy|10|||
27667463|NCT00505414|80619795|FG004|Titration Phase|Lack of Efficacy|1|||
27667464|NCT00505414|80619791|FG000|Titration Phase|Protocol Violation|0|||
27667465|NCT00505414|80619792|FG001|Titration Phase|Protocol Violation|0|||
27667466|NCT00505414|80619793|FG002|Titration Phase|Protocol Violation|0|||
27667467|NCT00505414|80619794|FG003|Titration Phase|Protocol Violation|0|||
27667468|NCT00505414|80619795|FG004|Titration Phase|Protocol Violation|1|||
27667469|NCT00505414|80619791|FG000|Titration Phase|Withdrawal by Subject|0|||
27667470|NCT00505414|80619792|FG001|Titration Phase|Withdrawal by Subject|0|||
27667471|NCT00505414|80619793|FG002|Titration Phase|Withdrawal by Subject|0|||
27667472|NCT00505414|80619794|FG003|Titration Phase|Withdrawal by Subject|3|||
27667473|NCT00505414|80619795|FG004|Titration Phase|Withdrawal by Subject|4|||
27667474|NCT00505414|80619791|FG000|Titration Phase|Underlying disease and therapy required|0|||
27667475|NCT00505414|80619792|FG001|Titration Phase|Underlying disease and therapy required|0|||
27667476|NCT00505414|80619793|FG002|Titration Phase|Underlying disease and therapy required|0|||
27667477|NCT00505414|80619794|FG003|Titration Phase|Underlying disease and therapy required|7|||
27864157|NCT00000620|81333334|FG007|Overall Study|Death|95|||
27667478|NCT00505414|80619795|FG004|Titration Phase|Underlying disease and therapy required|3|||
27667479|NCT00505414|80619791|FG000|Maintenance Phase|Adverse Event|2|||
27781379|NCT02646332|81027697|FG000|Overall Study|Lost to Follow-up|0|||
27864158|NCT00000620|81333327|FG000|Overall Study|Lost to Follow-up|14|||
27667480|NCT00505414|80619792|FG001|Maintenance Phase|Adverse Event|2|||
27667481|NCT00505414|80619793|FG002|Maintenance Phase|Adverse Event|3|||
27667482|NCT00505414|80619794|FG003|Maintenance Phase|Adverse Event|0|||
27667483|NCT00505414|80619795|FG004|Maintenance Phase|Adverse Event|0|||
27667484|NCT00505414|80619791|FG000|Maintenance Phase|Death|2|||
27667485|NCT00505414|80619792|FG001|Maintenance Phase|Death|0|||
27667486|NCT00505414|80619793|FG002|Maintenance Phase|Death|1|||
27667487|NCT00505414|80619794|FG003|Maintenance Phase|Death|0|||
27667488|NCT00505414|80619795|FG004|Maintenance Phase|Death|0|||
27781380|NCT02646332|81027698|FG001|Overall Study|Lost to Follow-up|3|||
27667489|NCT00505414|80619791|FG000|Maintenance Phase|Lack of Efficacy|2|||
27667490|NCT00505414|80619792|FG001|Maintenance Phase|Lack of Efficacy|1|||
27667491|NCT00505414|80619793|FG002|Maintenance Phase|Lack of Efficacy|1|||
27667492|NCT00505414|80619794|FG003|Maintenance Phase|Lack of Efficacy|0|||
27667493|NCT00505414|80619795|FG004|Maintenance Phase|Lack of Efficacy|0|||
27667494|NCT00505414|80619791|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27667495|NCT00505414|80619792|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27667496|NCT00505414|80619793|FG002|Maintenance Phase|Withdrawal by Subject|1|||
27667497|NCT00505414|80619794|FG003|Maintenance Phase|Withdrawal by Subject|0|||
27667498|NCT00505414|80619795|FG004|Maintenance Phase|Withdrawal by Subject|0|||
27667499|NCT00505414|80619791|FG000|Maintenance Phase|underlying disease and therapy required|0|||
27667500|NCT00505414|80619792|FG001|Maintenance Phase|underlying disease and therapy required|2|||
27667501|NCT00505414|80619793|FG002|Maintenance Phase|underlying disease and therapy required|2|||
27667502|NCT00505414|80619794|FG003|Maintenance Phase|underlying disease and therapy required|0|||
27667503|NCT00505414|80619795|FG004|Maintenance Phase|underlying disease and therapy required|0|||
27667504|NCT01461005|80619796|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
27667505|NCT01340300|80619797|FG000|Overall Study|Lost to Follow-up|3|||
27667506|NCT01340300|80619798|FG001|Overall Study|Lost to Follow-up|0|||
27667507|NCT01340300|80619799|FG002|Overall Study|Lost to Follow-up|5|||
27667508|NCT01340300|80619800|FG003|Overall Study|Lost to Follow-up|10|||
27667509|NCT01340300|80619797|FG000|Overall Study|Withdrawal by Subject|5|||
27667510|NCT01340300|80619798|FG001|Overall Study|Withdrawal by Subject|6|||
27667511|NCT01340300|80619799|FG002|Overall Study|Withdrawal by Subject|6|||
27667512|NCT01340300|80619800|FG003|Overall Study|Withdrawal by Subject|3|||
27667513|NCT01340300|80619797|FG000|Overall Study|Adverse Event|1|||
27667514|NCT01340300|80619798|FG001|Overall Study|Adverse Event|0|||
27667515|NCT01340300|80619799|FG002|Overall Study|Adverse Event|4|||
27667516|NCT01340300|80619800|FG003|Overall Study|Adverse Event|0|||
27667517|NCT01340300|80619797|FG000|Overall Study|Physician Decision|0|||
27667518|NCT01340300|80619798|FG001|Overall Study|Physician Decision|1|||
27667519|NCT01340300|80619799|FG002|Overall Study|Physician Decision|0|||
27667520|NCT01340300|80619800|FG003|Overall Study|Physician Decision|0|||
27667521|NCT01340300|80619797|FG000|Overall Study|Unrelated sickness|0|||
27667522|NCT01340300|80619798|FG001|Overall Study|Unrelated sickness|2|||
27781381|NCT01535638|81027704|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
27781382|NCT01535638|81027705|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
27667523|NCT01340300|80619799|FG002|Overall Study|Unrelated sickness|0|||
27667524|NCT01340300|80619800|FG003|Overall Study|Unrelated sickness|1|||
27667525|NCT01227928|80619803|FG000|Overall Study|Lost to Follow-up|4|||
27667526|NCT01227928|80619804|FG001|Overall Study|Lost to Follow-up|2|||
27667527|NCT01227928|80619803|FG000|Overall Study|Withdrawal by Subject|4|||
27667528|NCT01227928|80619804|FG001|Overall Study|Withdrawal by Subject|3|||
27667529|NCT01227928|80619803|FG000|Overall Study|Death|14|||
27667530|NCT01227928|80619804|FG001|Overall Study|Death|12|||
27667531|NCT01836198|80619805|FG000|Part A, Period 2|Protocol Violation|0|||
27667532|NCT01836198|80619806|FG001|Part A, Period 2|Protocol Violation|1|||
27667533|NCT01836198|80619807|FG002|Part A, Period 2|Protocol Violation|0|||
27667534|NCT03599622|80619808|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
27667535|NCT03599622|80619809|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
27667536|NCT03599622|80619810|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
27667537|NCT03599622|80619811|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
27667538|NCT03599622|80619808|FG000|Pre-Treatment Period|Other reasons|1|||
27667539|NCT03599622|80619809|FG001|Pre-Treatment Period|Other reasons|1|||
27667540|NCT03599622|80619810|FG002|Pre-Treatment Period|Other reasons|1|||
27667541|NCT03599622|80619811|FG003|Pre-Treatment Period|Other reasons|0|||
27667542|NCT03599622|80619808|FG000|Treatment Period|Adverse Event|11|||
27667543|NCT03599622|80619809|FG001|Treatment Period|Adverse Event|20|||
27667544|NCT03599622|80619810|FG002|Treatment Period|Adverse Event|18|||
27667545|NCT03599622|80619811|FG003|Treatment Period|Adverse Event|2|||
27667546|NCT03599622|80619808|FG000|Treatment Period|Lack of Efficacy|18|||
27667547|NCT03599622|80619809|FG001|Treatment Period|Lack of Efficacy|12|||
27667548|NCT03599622|80619810|FG002|Treatment Period|Lack of Efficacy|13|||
27667549|NCT03599622|80619811|FG003|Treatment Period|Lack of Efficacy|2|||
27667550|NCT03599622|80619808|FG000|Treatment Period|Withdrawal by Subject|5|||
27667551|NCT03599622|80619809|FG001|Treatment Period|Withdrawal by Subject|11|||
27667552|NCT03599622|80619810|FG002|Treatment Period|Withdrawal by Subject|16|||
27667553|NCT03599622|80619811|FG003|Treatment Period|Withdrawal by Subject|1|||
27667554|NCT03599622|80619808|FG000|Treatment Period|Other reasons|4|||
27667555|NCT03599622|80619809|FG001|Treatment Period|Other reasons|6|||
27667556|NCT03599622|80619810|FG002|Treatment Period|Other reasons|7|||
27667557|NCT03599622|80619811|FG003|Treatment Period|Other reasons|0|||
27781383|NCT01535638|81027706|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
27781384|NCT01535638|81027707|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
27781385|NCT01535638|81027708|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
27781386|NCT01535638|81027709|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
27781387|NCT01535638|81027704|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
27781388|NCT01535638|81027705|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
27781389|NCT01535638|81027706|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
27781390|NCT01535638|81027707|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
27781391|NCT01535638|81027708|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
27781392|NCT01535638|81027709|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
27781393|NCT03091920|81027710|FG000|Overall Study|Adverse Event|0|||
27781394|NCT03091920|81027711|FG001|Overall Study|Adverse Event|1|||
27781395|NCT03091920|81027712|FG002|Overall Study|Adverse Event|0|||
27781396|NCT01728454|81027713|FG000|Stage 1 and 2|Pregnancy|1|||
27781397|NCT01728454|81027714|FG001|Stage 1 and 2|Pregnancy|0|||
27781398|NCT01728454|81027715|FG002|Stage 1 and 2|Pregnancy|0|||
27781399|NCT01728454|81027713|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
27781400|NCT01728454|81027714|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
27781401|NCT01728454|81027715|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
27781402|NCT01728454|81027713|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
27781403|NCT01728454|81027714|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
27781404|NCT01728454|81027715|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
27781405|NCT01728454|81027713|FG000|Stage 1 and 2|Lost to Follow-up|1|||
27781406|NCT01728454|81027714|FG001|Stage 1 and 2|Lost to Follow-up|1|||
27781407|NCT01728454|81027715|FG002|Stage 1 and 2|Lost to Follow-up|0|||
27781408|NCT01728454|81027713|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
27781409|NCT01728454|81027714|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
27781410|NCT01728454|81027715|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
27781411|NCT01728454|81027713|FG000|Stage 3|Reason Missing|0|||
27781412|NCT01728454|81027714|FG001|Stage 3|Reason Missing|0|||
27781413|NCT01728454|81027715|FG002|Stage 3|Reason Missing|1|||
27781414|NCT01728454|81027713|FG000|Stage 3|Subject Required Other Treatment|0|||
27781415|NCT01728454|81027714|FG001|Stage 3|Subject Required Other Treatment|1|||
27781416|NCT01728454|81027715|FG002|Stage 3|Subject Required Other Treatment|0|||
27781417|NCT01728454|81027713|FG000|Stage 3|Pregnancy|1|||
27781418|NCT01728454|81027714|FG001|Stage 3|Pregnancy|0|||
27781419|NCT01728454|81027715|FG002|Stage 3|Pregnancy|0|||
27781420|NCT01728454|81027713|FG000|Stage 3|Withdrew Consent|1|||
27781421|NCT01728454|81027714|FG001|Stage 3|Withdrew Consent|0|||
27781422|NCT01728454|81027715|FG002|Stage 3|Withdrew Consent|1|||
27781423|NCT01728454|81027713|FG000|Stage 3|Non-compliance with Protocol|0|||
27781424|NCT01728454|81027714|FG001|Stage 3|Non-compliance with Protocol|0|||
27781425|NCT01728454|81027715|FG002|Stage 3|Non-compliance with Protocol|1|||
27781426|NCT01728454|81027713|FG000|Stage 3|Lost to Follow-up|0|||
27781427|NCT01728454|81027714|FG001|Stage 3|Lost to Follow-up|3|||
27781428|NCT01728454|81027715|FG002|Stage 3|Lost to Follow-up|1|||
27781429|NCT01728454|81027713|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
27970280|NCT03831191|81722704|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970281|NCT03831191|81722705|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970282|NCT03831191|81722706|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970283|NCT03831191|81722707|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970284|NCT03831191|81722708|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970285|NCT03831191|81722709|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970286|NCT03831191|81722710|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970287|NCT03831191|81722711|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970288|NCT03831191|81722712|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970289|NCT03831191|81722713|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970290|NCT03831191|81722714|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27970291|NCT03831191|81722715|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
27970292|NCT02545517|81722717|FG000|Overall Study|Death|2|||
27864159|NCT00000620|81333328|FG001|Overall Study|Lost to Follow-up|14|||
27864160|NCT00000620|81333329|FG002|Overall Study|Lost to Follow-up|14|||
27970293|NCT02545517|81722718|FG001|Overall Study|Death|2|||
27781430|NCT01728454|81027714|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
27864161|NCT00000620|81333330|FG003|Overall Study|Lost to Follow-up|14|||
27864162|NCT00000620|81333331|FG004|Overall Study|Lost to Follow-up|15|||
27970294|NCT02545517|81722719|FG002|Overall Study|Death|1|||
27970295|NCT02545517|81722717|FG000|Overall Study|Lost to Follow-up|14|||
27781431|NCT01728454|81027715|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
27781432|NCT03347279|81027717|FG000|Overall Study|Withdrawal by Subject|8|||
27781433|NCT03347279|81027718|FG001|Overall Study|Withdrawal by Subject|15|||
27781434|NCT03347279|81027717|FG000|Overall Study|Death|0|||
27781435|NCT03347279|81027718|FG001|Overall Study|Death|2|||
27781436|NCT03347279|81027717|FG000|Overall Study|Lost to Follow-up|5|||
27781437|NCT03347279|81027718|FG001|Overall Study|Lost to Follow-up|2|||
27781438|NCT03347279|81027717|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
27864163|NCT00000620|81333332|FG005|Overall Study|Lost to Follow-up|15|||
27864164|NCT00000620|81333333|FG006|Overall Study|Lost to Follow-up|13|||
27864165|NCT00000620|81333334|FG007|Overall Study|Lost to Follow-up|14|||
27864166|NCT00000620|81333327|FG000|Overall Study|Withdrawal by Subject|40|||
27864167|NCT00000620|81333328|FG001|Overall Study|Withdrawal by Subject|27|||
27864168|NCT00000620|81333329|FG002|Overall Study|Withdrawal by Subject|28|||
27864169|NCT00000620|81333330|FG003|Overall Study|Withdrawal by Subject|27|||
27864170|NCT00000620|81333331|FG004|Overall Study|Withdrawal by Subject|30|||
27864171|NCT00000620|81333332|FG005|Overall Study|Withdrawal by Subject|32|||
27864172|NCT00000620|81333333|FG006|Overall Study|Withdrawal by Subject|32|||
27781439|NCT03347279|81027718|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
27781440|NCT00984009|81027726|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
27781441|NCT00982111|81027734|FG000|Overall Study|Adverse Event|1|||
27781442|NCT00982111|81027735|FG001|Overall Study|Adverse Event|1|||
27781443|NCT00982111|81027734|FG000|Overall Study|Progressive Disease|46|||
27781444|NCT00982111|81027735|FG001|Overall Study|Progressive Disease|39|||
27781445|NCT00982111|81027734|FG000|Overall Study|Lost to Follow-up|9|||
27781446|NCT00982111|81027735|FG001|Overall Study|Lost to Follow-up|6|||
27781447|NCT00982111|81027734|FG000|Overall Study|New Anti-Cancer Therapy|5|||
27781448|NCT00982111|81027735|FG001|Overall Study|New Anti-Cancer Therapy|5|||
27781449|NCT00982111|81027734|FG000|Overall Study|Medical Decision|1|||
27781450|NCT00982111|81027735|FG001|Overall Study|Medical Decision|0|||
27781451|NCT00982111|81027734|FG000|Overall Study|Withdrawal by Subject|17|||
27781452|NCT00982111|81027735|FG001|Overall Study|Withdrawal by Subject|19|||
27781453|NCT00982111|81027734|FG000|Overall Study|Global Study End|0|||
27781454|NCT00982111|81027735|FG001|Overall Study|Global Study End|1|||
27781455|NCT00982111|81027734|FG000|Overall Study|Sponsor's Decision|0|||
27781456|NCT00982111|81027735|FG001|Overall Study|Sponsor's Decision|1|||
27864173|NCT00000620|81333334|FG007|Overall Study|Withdrawal by Subject|21|||
27864174|NCT00000620|81333327|FG000|Overall Study|missed closeout visit|22|||
27864175|NCT00000620|81333328|FG001|Overall Study|missed closeout visit|28|||
27864176|NCT00000620|81333329|FG002|Overall Study|missed closeout visit|16|||
27864177|NCT00000620|81333330|FG003|Overall Study|missed closeout visit|11|||
27864178|NCT00000620|81333331|FG004|Overall Study|missed closeout visit|26|||
27864179|NCT00000620|81333332|FG005|Overall Study|missed closeout visit|28|||
27864180|NCT00000620|81333333|FG006|Overall Study|missed closeout visit|13|||
27864181|NCT00000620|81333334|FG007|Overall Study|missed closeout visit|16|||
27864182|NCT00710866|81333335|FG000|Overall Study|Protocol Violation|5|||
27864183|NCT00710866|81333336|FG001|Overall Study|Protocol Violation|4|||
27864184|NCT00710866|81333335|FG000|Overall Study|Withdrawal by Subject|2|||
27864185|NCT00710866|81333336|FG001|Overall Study|Withdrawal by Subject|1|||
27864186|NCT00710866|81333335|FG000|Overall Study|Lost to Follow-up|1|||
27864187|NCT00710866|81333336|FG001|Overall Study|Lost to Follow-up|0|||
27864188|NCT00710866|81333335|FG000|Overall Study|Failed to meet eligibility|1|||
27864189|NCT00710866|81333336|FG001|Overall Study|Failed to meet eligibility|1|||
27864190|NCT02227446|81333337|FG000|Overall Study|not eligible post randomization|18|||
27864191|NCT02227446|81333338|FG001|Overall Study|not eligible post randomization|29|||
27864192|NCT02227446|81333337|FG000|Overall Study|Withdrawal by Subject|4|||
27864193|NCT02227446|81333338|FG001|Overall Study|Withdrawal by Subject|5|||
27864194|NCT02754856|81333339|FG000|Overall Study|Withdrawal by Subject|1|||
27864195|NCT02296931|81333340|FG000|Overall Study|Protocol Violation|0|||
27864196|NCT02296931|81333341|FG001|Overall Study|Protocol Violation|2|||
27864197|NCT02252406|81333355|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
27864198|NCT02252406|81333356|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
27864199|NCT02252406|81333355|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
27864200|NCT02252406|81333356|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
27667558|NCT03599622|80619808|FG000|Treatment Period|Lost to Follow-up|1|||
27667559|NCT03599622|80619809|FG001|Treatment Period|Lost to Follow-up|0|||
27667560|NCT03599622|80619810|FG002|Treatment Period|Lost to Follow-up|0|||
27667561|NCT03599622|80619811|FG003|Treatment Period|Lost to Follow-up|0|||
27667562|NCT03599622|80619808|FG000|Treatment Period|Study terminated by sponsor|7|||
27667563|NCT03599622|80619809|FG001|Treatment Period|Study terminated by sponsor|20|||
27667564|NCT03599622|80619810|FG002|Treatment Period|Study terminated by sponsor|15|||
27667565|NCT03599622|80619811|FG003|Treatment Period|Study terminated by sponsor|0|||
27667566|NCT03599622|80619808|FG000|Treatment Period|Site terminated by sponsor|0|||
27667567|NCT03599622|80619809|FG001|Treatment Period|Site terminated by sponsor|1|||
27781457|NCT00621764|81027741|FG000|Overall Study|Protocol Violation|0|||
27864201|NCT02252406|81333355|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
27667568|NCT03599622|80619810|FG002|Treatment Period|Site terminated by sponsor|0|||
27781458|NCT00621764|81027742|FG001|Overall Study|Protocol Violation|0|||
27781459|NCT00621764|81027743|FG002|Overall Study|Protocol Violation|0|||
27781460|NCT00621764|81027744|FG003|Overall Study|Protocol Violation|1|||
27864202|NCT02252406|81333356|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
27864203|NCT02252406|81333355|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
27970296|NCT02545517|81722718|FG001|Overall Study|Lost to Follow-up|13|||
27864204|NCT02252406|81333356|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
27864205|NCT02252406|81333355|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
27864206|NCT02252406|81333356|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
27864207|NCT02125877|81333357|FG000|Overall Study|Physician Decision|1|||
27864208|NCT02125877|81333358|FG001|Overall Study|Physician Decision|0|||
27864209|NCT02125877|81333357|FG000|Overall Study|Death|0|||
27864210|NCT02125877|81333358|FG001|Overall Study|Death|1|||
27864211|NCT02125877|81333357|FG000|Overall Study|Administrative problems|0|||
27864212|NCT02125877|81333358|FG001|Overall Study|Administrative problems|1|||
27864213|NCT02125877|81333357|FG000|Overall Study|Participant/guardian decision|0|||
27864214|NCT02125877|81333358|FG001|Overall Study|Participant/guardian decision|2|||
27864215|NCT02125877|81333357|FG000|Overall Study|Withdrawal by Subject|2|||
27864216|NCT02125877|81333358|FG001|Overall Study|Withdrawal by Subject|1|||
27864217|NCT02125877|81333357|FG000|Overall Study|Protocol deviation|4|||
27864218|NCT02125877|81333358|FG001|Overall Study|Protocol deviation|1|||
27864219|NCT02125877|81333357|FG000|Overall Study|Adverse Event|6|||
27864220|NCT02125877|81333358|FG001|Overall Study|Adverse Event|4|||
27864221|NCT04191499|81333359|FG000|Overall Study|Adverse Event|1|||
27864222|NCT04191499|81333360|FG001|Overall Study|Adverse Event|0|||
27864223|NCT04191499|81333359|FG000|Overall Study|Death|42|||
27864224|NCT04191499|81333360|FG001|Overall Study|Death|55|||
27864225|NCT04191499|81333359|FG000|Overall Study|Lost to Follow-up|4|||
27864226|NCT04191499|81333360|FG001|Overall Study|Lost to Follow-up|1|||
27864227|NCT04191499|81333359|FG000|Overall Study|Physician Decision|1|||
27864228|NCT04191499|81333360|FG001|Overall Study|Physician Decision|0|||
27570927|NCT01574703|80275365|FG000|Overall Study|Adverse Event|0|||
27570928|NCT01574703|80275366|FG001|Overall Study|Adverse Event|2|||
27570929|NCT01574703|80275367|FG002|Overall Study|Adverse Event|1|||
27570930|NCT01574703|80275368|FG003|Overall Study|Adverse Event|1|||
27781461|NCT04880642|81027747|FG000|Randomization|Withdrawal by Subject|2|||
27781462|NCT04880642|81027748|FG001|Randomization|Withdrawal by Subject|3|||
27781463|NCT04880642|81027747|FG000|Treatment Period|Adverse Event|0|||
27781464|NCT04880642|81027748|FG001|Treatment Period|Adverse Event|1|||
27781465|NCT04880642|81027747|FG000|Treatment Period|Death|6|||
27781466|NCT04880642|81027748|FG001|Treatment Period|Death|6|||
27781467|NCT04880642|81027747|FG000|Treatment Period|Lost to Follow-up|1|||
27781468|NCT04880642|81027748|FG001|Treatment Period|Lost to Follow-up|0|||
27781469|NCT04880642|81027747|FG000|Treatment Period|Protocol Violation|0|||
27781470|NCT04880642|81027748|FG001|Treatment Period|Protocol Violation|1|||
27781471|NCT04880642|81027747|FG000|Treatment Period|Withdrawal by Subject|5|||
27781472|NCT04880642|81027748|FG001|Treatment Period|Withdrawal by Subject|3|||
27781473|NCT04880642|81027747|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
27781474|NCT04880642|81027748|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
27781475|NCT04880642|81027747|FG000|Follow-up|Death|4|||
27781476|NCT04880642|81027748|FG001|Follow-up|Death|3|||
27781477|NCT04880642|81027747|FG000|Follow-up|Withdrawal by Subject|1|||
27781478|NCT04880642|81027748|FG001|Follow-up|Withdrawal by Subject|0|||
27781479|NCT00951912|81027749|FG000|Overall Study|Lack of Efficacy|1|||
27570931|NCT01574703|80275365|FG000|Overall Study|Protocol Violation|0|||
27570932|NCT01574703|80275366|FG001|Overall Study|Protocol Violation|0|||
27570933|NCT01574703|80275367|FG002|Overall Study|Protocol Violation|0|||
27570934|NCT01574703|80275368|FG003|Overall Study|Protocol Violation|1|||
27570935|NCT01574703|80275365|FG000|Overall Study|Unspecified Reason|27|||
27570936|NCT01574703|80275366|FG001|Overall Study|Unspecified Reason|15|||
27570937|NCT01574703|80275367|FG002|Overall Study|Unspecified Reason|20|||
27570938|NCT01574703|80275368|FG003|Overall Study|Unspecified Reason|16|||
27570939|NCT01574703|80275365|FG000|Overall Study|Withdrawal by Subject|53|||
27864229|NCT04191499|81333359|FG000|Overall Study|Progressive Disease|1|||
27970297|NCT02545517|81722719|FG002|Overall Study|Lost to Follow-up|17|||
27970298|NCT02545517|81722717|FG000|Overall Study|Protocol Violation|0|||
27570940|NCT01574703|80275366|FG001|Overall Study|Withdrawal by Subject|52|||
27781480|NCT00951912|81027750|FG001|Overall Study|Lack of Efficacy|0|||
27781481|NCT00951912|81027751|FG002|Overall Study|Lack of Efficacy|0|||
27781482|NCT00951912|81027749|FG000|Overall Study|Adverse Event|0|||
27781483|NCT00951912|81027750|FG001|Overall Study|Adverse Event|1|||
27781484|NCT00951912|81027751|FG002|Overall Study|Adverse Event|1|||
27864230|NCT04191499|81333360|FG001|Overall Study|Progressive Disease|0|||
27864231|NCT04191499|81333359|FG000|Overall Study|Symptomatic Deterioration|1|||
27864232|NCT04191499|81333360|FG001|Overall Study|Symptomatic Deterioration|0|||
27970299|NCT02545517|81722718|FG001|Overall Study|Protocol Violation|1|||
27970300|NCT02545517|81722719|FG002|Overall Study|Protocol Violation|1|||
27970301|NCT02545517|81722717|FG000|Overall Study|Withdrawal by Subject|5|||
27970302|NCT02545517|81722718|FG001|Overall Study|Withdrawal by Subject|8|||
27970303|NCT02545517|81722719|FG002|Overall Study|Withdrawal by Subject|9|||
27970304|NCT02545517|81722717|FG000|Overall Study|Administrative reason|5|||
27970305|NCT02545517|81722718|FG001|Overall Study|Administrative reason|6|||
27970306|NCT02545517|81722719|FG002|Overall Study|Administrative reason|10|||
27970307|NCT02545517|81722717|FG000|Overall Study|Other|2|||
27864233|NCT04191499|81333359|FG000|Overall Study|Withdrawal by Subject|7|||
27570941|NCT01574703|80275367|FG002|Overall Study|Withdrawal by Subject|36|||
27570942|NCT01574703|80275368|FG003|Overall Study|Withdrawal by Subject|61|||
27570943|NCT01574703|80275365|FG000|Overall Study|Met Withdrawal Criteria|0|||
27570944|NCT01574703|80275366|FG001|Overall Study|Met Withdrawal Criteria|1|||
27570945|NCT01574703|80275367|FG002|Overall Study|Met Withdrawal Criteria|1|||
27570946|NCT01574703|80275368|FG003|Overall Study|Met Withdrawal Criteria|0|||
27570947|NCT01574703|80275365|FG000|Overall Study|Lost to Follow-up|43|||
27570948|NCT01574703|80275366|FG001|Overall Study|Lost to Follow-up|41|||
27570949|NCT01574703|80275367|FG002|Overall Study|Lost to Follow-up|46|||
27570950|NCT01574703|80275368|FG003|Overall Study|Lost to Follow-up|35|||
27570951|NCT01574703|80275365|FG000|Overall Study|Death|2|||
27570952|NCT01574703|80275366|FG001|Overall Study|Death|1|||
27570953|NCT01574703|80275367|FG002|Overall Study|Death|1|||
27570954|NCT01574703|80275368|FG003|Overall Study|Death|0|||
27570955|NCT00829296|80275369|FG000|Overall Study|Adverse Event|5|||
27570956|NCT00829296|80275370|FG001|Overall Study|Adverse Event|4|||
27570957|NCT04292730|80275372|FG000|Overall Study|Lost to Follow-up|8|||
27570958|NCT04292730|80275373|FG001|Overall Study|Lost to Follow-up|12|||
27570959|NCT04292730|80275374|FG002|Overall Study|Lost to Follow-up|12|||
27570960|NCT04292730|80275375|FG003|Overall Study|Lost to Follow-up|48|||
27570961|NCT04292730|80275372|FG000|Overall Study|Death|2|||
27570962|NCT04292730|80275373|FG001|Overall Study|Death|2|||
27570963|NCT04292730|80275374|FG002|Overall Study|Death|4|||
27570964|NCT04292730|80275375|FG003|Overall Study|Death|12|||
27570965|NCT04292730|80275372|FG000|Overall Study|Withdrew Consent|2|||
27970308|NCT02545517|81722718|FG001|Overall Study|Other|4|||
27970309|NCT02545517|81722719|FG002|Overall Study|Other|3|||
27970310|NCT01239381|81722720|FG000|Overall Study|Protocol Violation|1|||
27970311|NCT01239381|81722720|FG000|Overall Study|Withdrawal by Subject|1|||
27570966|NCT04292730|80275373|FG001|Overall Study|Withdrew Consent|2|||
27570967|NCT04292730|80275374|FG002|Overall Study|Withdrew Consent|5|||
27570968|NCT04292730|80275375|FG003|Overall Study|Withdrew Consent|6|||
27570969|NCT04292730|80275372|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27570970|NCT04292730|80275373|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27570971|NCT04292730|80275374|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27570972|NCT04292730|80275375|FG003|Overall Study|Non-Compliance with Study Drug|0|||
27570973|NCT04292730|80275372|FG000|Overall Study|Protocol Violation|0|||
27570974|NCT04292730|80275373|FG001|Overall Study|Protocol Violation|0|||
27570975|NCT04292730|80275374|FG002|Overall Study|Protocol Violation|1|||
27570976|NCT04292730|80275375|FG003|Overall Study|Protocol Violation|0|||
27570977|NCT04292730|80275372|FG000|Overall Study|Randomized but not Treated|8|||
27570978|NCT04292730|80275373|FG001|Overall Study|Randomized but not Treated|4|||
27570979|NCT04292730|80275374|FG002|Overall Study|Randomized but not Treated|0|||
27570980|NCT04292730|80275375|FG003|Overall Study|Randomized but not Treated|14|||
27570981|NCT00337103|80275378|FG000|Overall Study|Progressive Disease|414|||
27570982|NCT00337103|80275379|FG001|Overall Study|Progressive Disease|410|||
27570983|NCT00337103|80275378|FG000|Overall Study|Adverse Event|45|||
27570984|NCT00337103|80275379|FG001|Overall Study|Adverse Event|59|||
27570985|NCT00337103|80275378|FG000|Overall Study|Subject Choice|34|||
27570986|NCT00337103|80275379|FG001|Overall Study|Subject Choice|27|||
27570987|NCT00337103|80275378|FG000|Overall Study|Clinical Progression|27|||
27570988|NCT00337103|80275379|FG001|Overall Study|Clinical Progression|24|||
27570989|NCT00337103|80275378|FG000|Overall Study|Physician Decision|15|||
27570990|NCT00337103|80275379|FG001|Overall Study|Physician Decision|14|||
27570991|NCT00337103|80275378|FG000|Overall Study|Withdrawal by Subject|8|||
27570992|NCT00337103|80275379|FG001|Overall Study|Withdrawal by Subject|5|||
27570993|NCT00337103|80275378|FG000|Overall Study|Other|5|||
27570994|NCT00337103|80275379|FG001|Overall Study|Other|6|||
27570995|NCT00337103|80275378|FG000|Overall Study|Entry Criteria Not Met|4|||
27570996|NCT00337103|80275379|FG001|Overall Study|Entry Criteria Not Met|1|||
27864234|NCT04191499|81333360|FG001|Overall Study|Withdrawal by Subject|11|||
27864235|NCT04191499|81333359|FG000|Overall Study|Ongoing in the study|104|||
27570997|NCT00337103|80275378|FG000|Overall Study|Lost to Follow-up|1|||
27570998|NCT00337103|80275379|FG001|Overall Study|Lost to Follow-up|2|||
27570999|NCT00337103|80275378|FG000|Overall Study|Death|1|||
27571000|NCT00337103|80275379|FG001|Overall Study|Death|0|||
27571001|NCT00235989|80275382|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
27571002|NCT00235989|80275383|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
27571003|NCT00235989|80275384|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
27864236|NCT04191499|81333360|FG001|Overall Study|Ongoing in the study|97|||
27970312|NCT04187144|81722724|FG000|Overall Study|Lost to Follow-up|12|||
27571004|NCT00235989|80275385|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
27667569|NCT03599622|80619811|FG003|Treatment Period|Site terminated by sponsor|0|||
27571005|NCT00235989|80275386|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
27571006|NCT00235989|80275387|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
27864237|NCT03086551|81333361|FG000|First Intervention|Failure to meet inclusion criterion|1|||
27970313|NCT04187144|81722725|FG001|Overall Study|Lost to Follow-up|11|||
27571007|NCT00235989|80275382|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
27571008|NCT00235989|80275383|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
27571009|NCT00235989|80275384|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
27571010|NCT00235989|80275385|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
27571011|NCT00235989|80275386|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
27571012|NCT00235989|80275387|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
27571013|NCT00235989|80275382|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
27571014|NCT00235989|80275383|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
27571015|NCT00235989|80275384|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
27571016|NCT00235989|80275385|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
27571017|NCT00235989|80275386|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
27571018|NCT00235989|80275387|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
27571019|NCT00235989|80275382|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
27571020|NCT00235989|80275383|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
27571021|NCT00235989|80275384|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
27571022|NCT00235989|80275385|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
27571023|NCT00235989|80275386|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
27571024|NCT00235989|80275387|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
27571025|NCT00235989|80275382|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
27571026|NCT00235989|80275383|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
27571027|NCT00235989|80275384|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
27571028|NCT00235989|80275385|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
27571029|NCT00235989|80275386|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
27571030|NCT00235989|80275387|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
27571031|NCT00378703|80275388|FG000|Overall Study|Disease progression|59|||
27571032|NCT00378703|80275389|FG001|Overall Study|Disease progression|43|||
27571033|NCT00378703|80275390|FG002|Overall Study|Disease progression|48|||
27571034|NCT00378703|80275391|FG003|Overall Study|Disease progression|49|||
27571035|NCT00378703|80275388|FG000|Overall Study|Adverse Event|11|||
27571036|NCT00378703|80275389|FG001|Overall Study|Adverse Event|17|||
27571037|NCT00378703|80275390|FG002|Overall Study|Adverse Event|20|||
27571038|NCT00378703|80275391|FG003|Overall Study|Adverse Event|18|||
27571039|NCT00378703|80275388|FG000|Overall Study|Death|2|||
27571040|NCT00378703|80275389|FG001|Overall Study|Death|2|||
27571041|NCT00378703|80275390|FG002|Overall Study|Death|4|||
27571042|NCT00378703|80275391|FG003|Overall Study|Death|3|||
27571043|NCT00378703|80275388|FG000|Overall Study|Withdrawal by Subject|4|||
27571044|NCT00378703|80275389|FG001|Overall Study|Withdrawal by Subject|8|||
27781485|NCT00951912|81027749|FG000|Overall Study|Lost to Follow-up|2|||
27781486|NCT00951912|81027750|FG001|Overall Study|Lost to Follow-up|2|||
27781487|NCT00951912|81027751|FG002|Overall Study|Lost to Follow-up|0|||
27970314|NCT04187144|81722724|FG000|Overall Study|Withdrawal by Subject|20|||
27970315|NCT04187144|81722725|FG001|Overall Study|Withdrawal by Subject|18|||
27970316|NCT04187144|81722724|FG000|Overall Study|Adverse Event|19|||
27970317|NCT04187144|81722725|FG001|Overall Study|Adverse Event|4|||
27970318|NCT04187144|81722724|FG000|Overall Study|Physician Decision|5|||
27970319|NCT04187144|81722725|FG001|Overall Study|Physician Decision|3|||
27970320|NCT04187144|81722724|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
27970321|NCT04187144|81722725|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
27970322|NCT04187144|81722724|FG000|Overall Study|Protocol Deviation|1|||
27970323|NCT04187144|81722725|FG001|Overall Study|Protocol Deviation|4|||
27970324|NCT02290691|81722726|FG000|Overall Study|Noncompliance|0|||
27970325|NCT02290691|81722727|FG001|Overall Study|Noncompliance|1|||
27571045|NCT00378703|80275390|FG002|Overall Study|Withdrawal by Subject|5|||
27571046|NCT00378703|80275391|FG003|Overall Study|Withdrawal by Subject|7|||
27781488|NCT00951912|81027749|FG000|Overall Study|Physician Decision|1|||
27970326|NCT02290691|81722726|FG000|Overall Study|Withdrawal by Subject|1|||
27970327|NCT02290691|81722727|FG001|Overall Study|Withdrawal by Subject|1|||
27970328|NCT02290691|81722726|FG000|Overall Study|Lost to Follow-up|7|||
27970329|NCT02290691|81722727|FG001|Overall Study|Lost to Follow-up|7|||
27970330|NCT01352221|81722740|FG000|Double-blind Phase|Adverse Event|6|||
27970331|NCT01352221|81722741|FG001|Double-blind Phase|Adverse Event|4|||
27970332|NCT01352221|81722742|FG002|Double-blind Phase|Adverse Event|0|||
27970333|NCT01352221|81722743|FG003|Double-blind Phase|Adverse Event|0|||
27970334|NCT01352221|81722740|FG000|Double-blind Phase|Withdrawal by Subject|3|||
27970335|NCT01352221|81722741|FG001|Double-blind Phase|Withdrawal by Subject|5|||
27970336|NCT01352221|81722742|FG002|Double-blind Phase|Withdrawal by Subject|0|||
27970337|NCT01352221|81722743|FG003|Double-blind Phase|Withdrawal by Subject|0|||
27970338|NCT01352221|81722740|FG000|Double-blind Phase|Lost to Follow-up|0|||
27970339|NCT01352221|81722741|FG001|Double-blind Phase|Lost to Follow-up|1|||
27970340|NCT01352221|81722742|FG002|Double-blind Phase|Lost to Follow-up|0|||
27970341|NCT01352221|81722743|FG003|Double-blind Phase|Lost to Follow-up|0|||
27970342|NCT01352221|81722740|FG000|Double-blind Phase|Protocol Violation|0|||
27970343|NCT01352221|81722741|FG001|Double-blind Phase|Protocol Violation|1|||
27970344|NCT01352221|81722742|FG002|Double-blind Phase|Protocol Violation|0|||
27970345|NCT01352221|81722743|FG003|Double-blind Phase|Protocol Violation|0|||
27970346|NCT01352221|81722740|FG000|Open-label Phase|Physician Decision|0|||
27970347|NCT01352221|81722741|FG001|Open-label Phase|Physician Decision|0|||
27970348|NCT01352221|81722742|FG002|Open-label Phase|Physician Decision|2|||
27970349|NCT01352221|81722743|FG003|Open-label Phase|Physician Decision|1|||
27970350|NCT01352221|81722740|FG000|Open-label Phase|Pregnancy|0|||
27970351|NCT01352221|81722741|FG001|Open-label Phase|Pregnancy|0|||
27970352|NCT01352221|81722742|FG002|Open-label Phase|Pregnancy|1|||
27970353|NCT01352221|81722743|FG003|Open-label Phase|Pregnancy|0|||
27970354|NCT01352221|81722740|FG000|Open-label Phase|Adverse Event|0|||
27970355|NCT01352221|81722741|FG001|Open-label Phase|Adverse Event|0|||
27970356|NCT01352221|81722742|FG002|Open-label Phase|Adverse Event|8|||
27970357|NCT01352221|81722743|FG003|Open-label Phase|Adverse Event|4|||
27970358|NCT01352221|81722740|FG000|Open-label Phase|Withdrawal by Subject|0|||
27970359|NCT01352221|81722741|FG001|Open-label Phase|Withdrawal by Subject|0|||
27970360|NCT01352221|81722742|FG002|Open-label Phase|Withdrawal by Subject|1|||
27970361|NCT01352221|81722743|FG003|Open-label Phase|Withdrawal by Subject|6|||
27970362|NCT01352221|81722740|FG000|Open-label Phase|Worsening of IBD|0|||
27970363|NCT01352221|81722741|FG001|Open-label Phase|Worsening of IBD|0|||
27970364|NCT01352221|81722742|FG002|Open-label Phase|Worsening of IBD|1|||
27970365|NCT01352221|81722743|FG003|Open-label Phase|Worsening of IBD|0|||
27970366|NCT01443364|81722744|FG000|Overall Study|Lack of Efficacy|14|||
27970367|NCT01443364|81722744|FG000|Overall Study|Lost to Follow-up|3|||
27970368|NCT01443364|81722744|FG000|Overall Study|Withdrawal by Subject|5|||
27970369|NCT01443364|81722744|FG000|Overall Study|Other Reason|4|||
27970370|NCT01443364|81722744|FG000|Overall Study|SAE, non-fatal|6|||
27970371|NCT01443364|81722744|FG000|Overall Study|AE, non-serious non-fatal|8|||
27970372|NCT01443364|81722744|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27970373|NCT00688324|81722745|FG000|Overall Study|Withdrawal by Subject|2|||
27970374|NCT00688324|81722745|FG000|Overall Study|Physician Decision|5|||
27970375|NCT00688324|81722745|FG000|Overall Study|Lost to Follow-up|1|||
27970376|NCT03362502|81722746|FG000|Overall Study|Death|0|||
27970377|NCT03362502|81722747|FG001|Overall Study|Death|0|||
27970378|NCT03362502|81722748|FG002|Overall Study|Death|1|||
27970379|NCT04123093|81722756|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
27970380|NCT04123093|81722757|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
27970381|NCT04123093|81722756|FG000|Phase 2|Physician Decision|0|||
27970382|NCT04123093|81722757|FG001|Phase 2|Physician Decision|1|||
27970383|NCT04123093|81722756|FG000|Phase 2|Withdrawal by Subject|0|||
27970384|NCT04123093|81722757|FG001|Phase 2|Withdrawal by Subject|1|||
27970385|NCT00022763|81722764|FG000|Overall Study|Adverse Event|1|||
27970386|NCT00022763|81722765|FG001|Overall Study|Adverse Event|2|||
27970387|NCT00022763|81722764|FG000|Overall Study|Injection Site Reactions|0|||
27970388|NCT00022763|81722765|FG001|Overall Study|Injection Site Reactions|2|||
27970389|NCT00022763|81722764|FG000|Overall Study|Death|0|||
27970390|NCT00022763|81722765|FG001|Overall Study|Death|1|||
27970391|NCT00022763|81722764|FG000|Overall Study|Lost to Follow-up|0|||
27970392|NCT00022763|81722765|FG001|Overall Study|Lost to Follow-up|3|||
27970393|NCT00022763|81722764|FG000|Overall Study|Withdrawal by Subject|4|||
27571047|NCT00378703|80275388|FG000|Overall Study|Physician Decision|1|||
27970394|NCT00022763|81722765|FG001|Overall Study|Withdrawal by Subject|7|||
27970395|NCT00022763|81722764|FG000|Overall Study|Insufficient Therapy|1|||
27970396|NCT00022763|81722765|FG001|Overall Study|Insufficient Therapy|0|||
27970397|NCT00022763|81722764|FG000|Overall Study|Admin|3|||
27970398|NCT00022763|81722765|FG001|Overall Study|Admin|2|||
27970399|NCT01089413|81722767|FG000|Overall Study|Lost to Follow-up|1|||
27970400|NCT01089413|81722767|FG000|Overall Study|Progressive Disease|93|||
27970401|NCT01089413|81722767|FG000|Overall Study|Participant Withdrew Consent|1|||
27970402|NCT01089413|81722767|FG000|Overall Study|Unacceptable Toxicity|12|||
27970403|NCT01089413|81722767|FG000|Overall Study|Death|10|||
27970404|NCT01089413|81722767|FG000|Overall Study|Metastasectomy|13|||
27970405|NCT01089413|81722767|FG000|Overall Study|Other|71|||
27970406|NCT01549886|81722770|FG000|Overall Study|Sponsor's decision|2|||
27970407|NCT01549886|81722771|FG001|Overall Study|Sponsor's decision|3|||
27970408|NCT02743949|81722772|FG000|Overall Study|Adverse Event|0|||
27970409|NCT02743949|81722773|FG001|Overall Study|Adverse Event|0|||
27970410|NCT02743949|81722774|FG002|Overall Study|Adverse Event|2|||
27667570|NCT02447432|80619815|FG000|Epoch 001|Adverse Event|1|||
27667571|NCT02447432|80619816|FG001|Epoch 001|Adverse Event|1|||
27667572|NCT02447432|80619815|FG000|Epoch 001|Withdrawal by Subject|0|||
27667573|NCT02447432|80619816|FG001|Epoch 001|Withdrawal by Subject|4|||
27667574|NCT02447432|80619815|FG000|Epoch 001|Migrated/moved from study area|3|||
27667575|NCT02447432|80619816|FG001|Epoch 001|Migrated/moved from study area|5|||
27667576|NCT02447432|80619815|FG000|Epoch 001|Lost to Follow-up|1|||
27667577|NCT02447432|80619816|FG001|Epoch 001|Lost to Follow-up|3|||
27667578|NCT00519285|80619817|FG000|Overall Study|Adverse Event|127|||
27667579|NCT00519285|80619818|FG001|Overall Study|Adverse Event|266|||
27667580|NCT00519285|80619817|FG000|Overall Study|Disease progression|334|||
27667581|NCT00519285|80619818|FG001|Overall Study|Disease progression|186|||
27667582|NCT00519285|80619817|FG000|Overall Study|Physician Decision|75|||
27667583|NCT00519285|80619818|FG001|Overall Study|Physician Decision|47|||
27667584|NCT00519285|80619817|FG000|Overall Study|Participant's request|53|||
27667585|NCT00519285|80619818|FG001|Overall Study|Participant's request|84|||
27667586|NCT00519285|80619817|FG000|Overall Study|Consent withdrawn|4|||
27667587|NCT00519285|80619818|FG001|Overall Study|Consent withdrawn|5|||
27667588|NCT00519285|80619817|FG000|Overall Study|Poor compliance to protocol|5|||
27667589|NCT00519285|80619818|FG001|Overall Study|Poor compliance to protocol|7|||
27667590|NCT00519285|80619817|FG000|Overall Study|Reason unspecified|5|||
27667591|NCT00519285|80619818|FG001|Overall Study|Reason unspecified|8|||
27667592|NCT00519285|80619817|FG000|Overall Study|Not treated|8|||
27667593|NCT00519285|80619818|FG001|Overall Study|Not treated|7|||
27667594|NCT00519285|80619817|FG000|Overall Study|Treatment ongoing|1|||
27667595|NCT00519285|80619818|FG001|Overall Study|Treatment ongoing|2|||
27667596|NCT00792259|80619820|FG000|Overall Study|Poor Quality Scans|1|||
27667597|NCT00792259|80619821|FG001|Overall Study|Poor Quality Scans|0|||
27667598|NCT00792259|80619822|FG002|Overall Study|Poor Quality Scans|0|||
27667599|NCT00436956|80619823|FG000|Overall Study|Not evaluable|1|||
27667600|NCT00436956|80619824|FG001|Overall Study|Not evaluable|0|||
27667601|NCT02049515|80619825|FG000|Overall Study|Adverse Event|46|||
27667602|NCT02049515|80619826|FG001|Overall Study|Adverse Event|2|||
27667603|NCT02049515|80619825|FG000|Overall Study|Protocol-specified Disease Progression|23|||
27667604|NCT02049515|80619826|FG001|Overall Study|Protocol-specified Disease Progression|2|||
27667605|NCT02049515|80619825|FG000|Overall Study|Death|6|||
27667606|NCT02049515|80619826|FG001|Overall Study|Death|0|||
27667607|NCT02049515|80619825|FG000|Overall Study|Physician Decision|5|||
27667608|NCT02049515|80619826|FG001|Overall Study|Physician Decision|1|||
27667609|NCT02049515|80619825|FG000|Overall Study|Withdrawal by Subject|3|||
27667610|NCT02049515|80619826|FG001|Overall Study|Withdrawal by Subject|0|||
27667611|NCT02049515|80619825|FG000|Overall Study|Termination of the Study by Sponsor|2|||
27667612|NCT02049515|80619826|FG001|Overall Study|Termination of the Study by Sponsor|0|||
27667613|NCT02049515|80619825|FG000|Overall Study|Protocol Violation|1|||
27667614|NCT02049515|80619826|FG001|Overall Study|Protocol Violation|1|||
27667615|NCT02049515|80619825|FG000|Overall Study|Clinical Deterioration|1|||
27667616|NCT02049515|80619826|FG001|Overall Study|Clinical Deterioration|0|||
27667617|NCT02049515|80619825|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
27667618|NCT02049515|80619826|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
27667619|NCT02049515|80619825|FG000|Overall Study|Treatment Interruption >42 Days|1|||
27970411|NCT02743949|81722772|FG000|Overall Study|Significant Protocol Deviation|2|||
27970412|NCT02743949|81722773|FG001|Overall Study|Significant Protocol Deviation|0|||
27667620|NCT02049515|80619826|FG001|Overall Study|Treatment Interruption >42 Days|0|||
27667621|NCT02049515|80619825|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
27667622|NCT02049515|80619826|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
27667623|NCT01580995|80619829|FG000|Overall Study|Lost to Follow-up|2|||
27667624|NCT01580995|80619830|FG001|Overall Study|Lost to Follow-up|2|||
27667625|NCT02959177|80623373|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
27667626|NCT02959177|80623374|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
27667627|NCT02959177|80623375|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
27970413|NCT02743949|81722774|FG002|Overall Study|Significant Protocol Deviation|1|||
27667628|NCT02959177|80623373|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
27970414|NCT02743949|81722772|FG000|Overall Study|Voluntary Withdrawal|2|||
27970415|NCT02743949|81722773|FG001|Overall Study|Voluntary Withdrawal|1|||
27970416|NCT02743949|81722774|FG002|Overall Study|Voluntary Withdrawal|0|||
27970417|NCT00404755|81722775|FG000|Phase I (Bupropion)|Adverse Event|3|||
27970418|NCT00404755|81722775|FG000|Phase I (Bupropion)|Other|1|||
27970419|NCT00404755|81722775|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
27970420|NCT01340625|81722776|FG000|First Intervention|Adverse Event|1|||
27970421|NCT01340625|81722777|FG001|First Intervention|Adverse Event|0|||
27970422|NCT01340625|81722776|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
27970423|NCT01340625|81722777|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
27970424|NCT05286658|81722784|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
27970425|NCT05286658|81722784|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
27970426|NCT01560637|81722788|FG000|Overall Study|Adverse Event|63|||
27970427|NCT01560637|81722788|FG000|Overall Study|Death|69|||
27970428|NCT01560637|81722788|FG000|Overall Study|Lost to Follow-up|8|||
27667629|NCT02959177|80623374|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
27667630|NCT02959177|80623375|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
27667631|NCT02959177|80623373|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
27667632|NCT02959177|80623374|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
27667633|NCT02959177|80623375|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
27667634|NCT02959177|80623373|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
27667635|NCT02959177|80623374|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27667636|NCT02959177|80623375|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
27667637|NCT02959177|80623373|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
27667638|NCT02959177|80623374|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
27667639|NCT02959177|80623375|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
27667640|NCT02959177|80623373|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
27667641|NCT02959177|80623374|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
27667642|NCT02959177|80623375|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
27667643|NCT02959177|80623373|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
27667644|NCT02959177|80623374|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
27667645|NCT02959177|80623375|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
27667646|NCT01426113|80623378|FG000|Overall Study|Study Discontinued|1|||
27667647|NCT01426113|80623379|FG001|Overall Study|Study Discontinued|1|||
27667648|NCT01426113|80623378|FG000|Overall Study|Adverse Event|0|||
27667649|NCT01426113|80623379|FG001|Overall Study|Adverse Event|1|||
27667650|NCT00878553|80623380|FG000|Sleep Study|Withdrawal by Subject|2|||
27667651|NCT00878553|80623381|FG001|Sleep Study|Withdrawal by Subject|0|||
27667652|NCT00878553|80623382|FG002|Sleep Study|Withdrawal by Subject|0|||
27667653|NCT00878553|80623383|FG003|Sleep Study|Withdrawal by Subject|0|||
27667654|NCT00878553|80623384|FG004|Sleep Study|Withdrawal by Subject|0|||
27667655|NCT00878553|80623380|FG000|Sleep Study|Lost to Follow-up|1|||
27667656|NCT00878553|80623381|FG001|Sleep Study|Lost to Follow-up|0|||
27667657|NCT00878553|80623382|FG002|Sleep Study|Lost to Follow-up|0|||
27667658|NCT00878553|80623383|FG003|Sleep Study|Lost to Follow-up|0|||
27667659|NCT00878553|80623384|FG004|Sleep Study|Lost to Follow-up|0|||
27667660|NCT00878553|80623380|FG000|Sleep Study|car accident|1|||
27667661|NCT00878553|80623381|FG001|Sleep Study|car accident|0|||
27667662|NCT00878553|80623382|FG002|Sleep Study|car accident|0|||
27667663|NCT00878553|80623383|FG003|Sleep Study|car accident|0|||
27667664|NCT00878553|80623384|FG004|Sleep Study|car accident|0|||
27667665|NCT00878553|80623380|FG000|Sleep Study|family emergency|1|||
27667666|NCT00878553|80623381|FG001|Sleep Study|family emergency|0|||
27667667|NCT00878553|80623382|FG002|Sleep Study|family emergency|0|||
27667668|NCT00878553|80623383|FG003|Sleep Study|family emergency|0|||
27667669|NCT00878553|80623384|FG004|Sleep Study|family emergency|0|||
27667670|NCT00878553|80623380|FG000|PK Study|Withdrawal by Subject|0|||
27667671|NCT00878553|80623381|FG001|PK Study|Withdrawal by Subject|0|||
27667672|NCT00878553|80623382|FG002|PK Study|Withdrawal by Subject|0|||
27970429|NCT01560637|81722788|FG000|Overall Study|Protocol Violation|8|||
27970430|NCT01560637|81722788|FG000|Overall Study|Withdrawal by Subject|24|||
27970431|NCT01560637|81722788|FG000|Overall Study|Progressive Disease|20|||
27970432|NCT01560637|81722788|FG000|Overall Study|Other Reason Not Specified|6|||
27970433|NCT01566149|81722789|FG000|Overall Study|Adverse Event|0|||
27970434|NCT01566149|81722790|FG001|Overall Study|Adverse Event|1|||
27970435|NCT01566149|81722789|FG000|Overall Study|Non-compliance with study medication|2|||
27667673|NCT00878553|80623383|FG003|PK Study|Withdrawal by Subject|1|||
27667674|NCT00878553|80623384|FG004|PK Study|Withdrawal by Subject|0|||
27667675|NCT01503164|80623385|FG000|Overall Study|Withdrawal by Subject|2|||
27667676|NCT01503164|80623386|FG001|Overall Study|Withdrawal by Subject|1|||
27667677|NCT00371462|80623387|FG000|Overall Study|Withdrawal by Subject|1|||
27667678|NCT00371462|80623388|FG001|Overall Study|Withdrawal by Subject|0|||
27667679|NCT00371462|80623387|FG000|Overall Study|Other|7|||
27970436|NCT01566149|81722790|FG001|Overall Study|Non-compliance with study medication|0|||
27667680|NCT00371462|80623388|FG001|Overall Study|Other|8|||
27970437|NCT01566149|81722789|FG000|Overall Study|Protocol Violation|0|||
27970438|NCT01566149|81722790|FG001|Overall Study|Protocol Violation|1|||
27970439|NCT01566149|81722789|FG000|Overall Study|Withdrawal by Subject|1|||
27970440|NCT01566149|81722790|FG001|Overall Study|Withdrawal by Subject|0|||
27970441|NCT02403817|81722791|FG000|Overall Study|Withdrawal by Subject|5|||
27970442|NCT02403817|81722792|FG001|Overall Study|Withdrawal by Subject|0|||
27970443|NCT01296711|81722794|FG000|Overall Study|Adverse Event|3|||
27970444|NCT01296711|81722795|FG001|Overall Study|Adverse Event|1|||
27667681|NCT00591591|80623394|FG000|Overall Study|Withdrawal by Subject|1|||
27667682|NCT00591591|80623395|FG001|Overall Study|Withdrawal by Subject|37|||
27667683|NCT00591591|80623394|FG000|Overall Study|Lack of Efficacy|10|||
27667684|NCT00591591|80623395|FG001|Overall Study|Lack of Efficacy|2|||
27970445|NCT01296711|81722796|FG002|Overall Study|Adverse Event|4|||
27970446|NCT01296711|81722797|FG003|Overall Study|Adverse Event|3|||
27970447|NCT01296711|81722798|FG004|Overall Study|Adverse Event|1|||
27970448|NCT01296711|81722799|FG005|Overall Study|Adverse Event|6|||
27970449|NCT01296711|81722800|FG006|Overall Study|Adverse Event|11|||
27970450|NCT01296711|81722801|FG007|Overall Study|Adverse Event|3|||
27970451|NCT01296711|81722794|FG000|Overall Study|Lack of Efficacy|1|||
27970452|NCT01296711|81722795|FG001|Overall Study|Lack of Efficacy|4|||
27970453|NCT01296711|81722796|FG002|Overall Study|Lack of Efficacy|1|||
27970454|NCT01296711|81722797|FG003|Overall Study|Lack of Efficacy|1|||
27970455|NCT01296711|81722798|FG004|Overall Study|Lack of Efficacy|1|||
27970456|NCT01296711|81722799|FG005|Overall Study|Lack of Efficacy|0|||
27667685|NCT00745498|80623403|FG000|Overall Study|Lost to Follow-up|1|||
27667686|NCT00745498|80623404|FG001|Overall Study|Lost to Follow-up|1|||
27667687|NCT00745498|80623405|FG002|Overall Study|Lost to Follow-up|3|||
27667688|NCT00745498|80623403|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
27667689|NCT00745498|80623404|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
27667690|NCT00745498|80623405|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
27667691|NCT00745498|80623403|FG000|Overall Study|Non-PDR related VH|0|||
27667692|NCT00745498|80623404|FG001|Overall Study|Non-PDR related VH|1|||
27667693|NCT00745498|80623405|FG002|Overall Study|Non-PDR related VH|1|||
27667694|NCT00745498|80623403|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
27667695|NCT00745498|80623404|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
27667696|NCT00745498|80623405|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
27667697|NCT02918292|80623407|FG000|Study Enrollment Prior to Transplant|Death|1|||
27667698|NCT02918292|80623407|FG000|Study Follow up After Transplant|Death|6|||
27667699|NCT01036165|80623408|FG000|Overall Study|Adverse Event|6|||
27667700|NCT01036165|80623408|FG000|Overall Study|Lost to Follow-up|2|||
27667701|NCT01036165|80623408|FG000|Overall Study|Withdrawal by Subject|3|||
27667702|NCT01036165|80623408|FG000|Overall Study|Device Related Issues|3|||
27667703|NCT01036165|80623408|FG000|Overall Study|Problems finding proper area to inject|1|||
27667704|NCT02210208|80623409|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
27667705|NCT02210208|80623409|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
27667706|NCT02210208|80623409|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
27667707|NCT00350298|80623413|FG000|Overall Study|Death|7|||
27667708|NCT00350298|80623414|FG001|Overall Study|Death|8|||
27667709|NCT00350298|80623413|FG000|Overall Study|Lost to Follow-up|1|||
27667710|NCT00350298|80623414|FG001|Overall Study|Lost to Follow-up|2|||
27667711|NCT00350298|80623413|FG000|Overall Study|Withdrawal by Subject|1|||
27667712|NCT00350298|80623414|FG001|Overall Study|Withdrawal by Subject|3|||
27667713|NCT03991988|80623415|FG000|Overall Study|Withdrawal by Subject|2|||
27667714|NCT03991988|80623416|FG001|Overall Study|Withdrawal by Subject|2|||
27667715|NCT02980705|80623417|FG000|Overall Study|Adverse Event|0|||
27667716|NCT02980705|80623418|FG001|Overall Study|Adverse Event|1|||
27970457|NCT01296711|81722800|FG006|Overall Study|Lack of Efficacy|2|||
27970458|NCT01296711|81722801|FG007|Overall Study|Lack of Efficacy|3|||
27970459|NCT01296711|81722794|FG000|Overall Study|Lost to Follow-up|0|||
27970460|NCT01296711|81722795|FG001|Overall Study|Lost to Follow-up|0|||
27970461|NCT01296711|81722796|FG002|Overall Study|Lost to Follow-up|1|||
27970462|NCT01296711|81722797|FG003|Overall Study|Lost to Follow-up|1|||
27970463|NCT01296711|81722798|FG004|Overall Study|Lost to Follow-up|2|||
27970464|NCT01296711|81722799|FG005|Overall Study|Lost to Follow-up|0|||
27970465|NCT01296711|81722800|FG006|Overall Study|Lost to Follow-up|4|||
27970466|NCT01296711|81722801|FG007|Overall Study|Lost to Follow-up|2|||
27970467|NCT01296711|81722794|FG000|Overall Study|Protocol Violation|0|||
27970468|NCT01296711|81722795|FG001|Overall Study|Protocol Violation|0|||
27970469|NCT01296711|81722796|FG002|Overall Study|Protocol Violation|0|||
27970470|NCT01296711|81722797|FG003|Overall Study|Protocol Violation|1|||
27970471|NCT01296711|81722798|FG004|Overall Study|Protocol Violation|1|||
27970472|NCT01296711|81722799|FG005|Overall Study|Protocol Violation|0|||
27970473|NCT01296711|81722800|FG006|Overall Study|Protocol Violation|0|||
27970474|NCT01296711|81722801|FG007|Overall Study|Protocol Violation|0|||
27970475|NCT01296711|81722794|FG000|Overall Study|Withdrawal by Subject|4|||
27571048|NCT00378703|80275389|FG001|Overall Study|Physician Decision|4|||
27667717|NCT02980705|80623417|FG000|Overall Study|Withdrawal by Subject|6|||
27667718|NCT02980705|80623418|FG001|Overall Study|Withdrawal by Subject|9|||
27781489|NCT00951912|81027750|FG001|Overall Study|Physician Decision|0|||
27970476|NCT01296711|81722795|FG001|Overall Study|Withdrawal by Subject|2|||
27970477|NCT01296711|81722796|FG002|Overall Study|Withdrawal by Subject|2|||
27970478|NCT01296711|81722797|FG003|Overall Study|Withdrawal by Subject|1|||
27864238|NCT03086551|81333362|FG001|First Intervention|Failure to meet inclusion criterion|0|||
27864239|NCT03086551|81333361|FG000|First Intervention|Lost to Follow-up|0|||
27970479|NCT01296711|81722798|FG004|Overall Study|Withdrawal by Subject|1|||
27970480|NCT01296711|81722799|FG005|Overall Study|Withdrawal by Subject|1|||
27970481|NCT01296711|81722800|FG006|Overall Study|Withdrawal by Subject|2|||
27970482|NCT01296711|81722801|FG007|Overall Study|Withdrawal by Subject|1|||
27970483|NCT01296711|81722794|FG000|Overall Study|Study termination|8|||
27970484|NCT01296711|81722795|FG001|Overall Study|Study termination|1|||
27970485|NCT01296711|81722796|FG002|Overall Study|Study termination|5|||
27970486|NCT01296711|81722797|FG003|Overall Study|Study termination|4|||
27970487|NCT01296711|81722798|FG004|Overall Study|Study termination|4|||
27864240|NCT03086551|81333362|FG001|First Intervention|Lost to Follow-up|1|||
27864241|NCT03086551|81333361|FG000|Washout|Lost to Follow-up|1|||
27864242|NCT03086551|81333362|FG001|Washout|Lost to Follow-up|2|||
27864243|NCT03086551|81333361|FG000|Washout|Withdrawal by Subject|2|||
27864244|NCT03086551|81333362|FG001|Washout|Withdrawal by Subject|1|||
27864245|NCT04611529|81337017|FG000|2-day Follow up|Lost to Follow-up|5|||
27864246|NCT04611529|81337018|FG001|2-day Follow up|Lost to Follow-up|6|||
27864247|NCT04611529|81337019|FG002|2-day Follow up|Lost to Follow-up|3|||
27864248|NCT01475097|81337020|FG000|Overall Study|Protocol Violation|1|||
27864249|NCT01475097|81337021|FG001|Overall Study|Protocol Violation|1|||
27864250|NCT01590797|81337022|FG000|Overall Study|Adverse Event|4|||
27864251|NCT01590797|81337023|FG001|Overall Study|Adverse Event|3|||
27864252|NCT01590797|81337022|FG000|Overall Study|Lack of Efficacy|0|||
27864253|NCT01590797|81337023|FG001|Overall Study|Lack of Efficacy|2|||
27864254|NCT01590797|81337022|FG000|Overall Study|Lost to Follow-up|0|||
27864255|NCT01590797|81337023|FG001|Overall Study|Lost to Follow-up|1|||
27864256|NCT01590797|81337022|FG000|Overall Study|Protocol Violation|4|||
27864257|NCT01590797|81337023|FG001|Overall Study|Protocol Violation|1|||
27864258|NCT01590797|81337022|FG000|Overall Study|Withdrawal by Subject|7|||
27864259|NCT01590797|81337023|FG001|Overall Study|Withdrawal by Subject|5|||
27864260|NCT01590797|81337022|FG000|Overall Study|Other Protocol Specified Criteria|2|||
27864261|NCT01590797|81337023|FG001|Overall Study|Other Protocol Specified Criteria|4|||
27864262|NCT00805961|81337032|FG000|Modality Therapy|Withdrawal by Subject|1|||
27864263|NCT00805961|81337032|FG000|Modality Therapy|Adverse Event|1|||
27864264|NCT00805961|81337032|FG000|Modality Therapy|Disease Progression|2|||
27864265|NCT00805961|81337032|FG000|Treatment-Free Interval|Adverse Event|3|||
27864266|NCT00805961|81337032|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
27864267|NCT00805961|81337032|FG000|Treatment-Free Interval|Physician Decision|1|||
27864268|NCT00805961|81337032|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
27864269|NCT00805961|81337032|FG000|Maintenance Treatment|Lack of Efficacy|13|||
27864270|NCT00805961|81337032|FG000|Maintenance Treatment|Intercurrent Illness|7|||
27864271|NCT00805961|81337032|FG000|Maintenance Treatment|Adverse Event|6|||
27864272|NCT00805961|81337032|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
27864273|NCT00805961|81337032|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
27864274|NCT00805961|81337032|FG000|Maintenance Treatment|Withdrawn Consent|1|||
27864275|NCT04036110|81337033|FG000|Overall Study|Lost to Follow-up|3|||
27864276|NCT04036110|81337034|FG001|Overall Study|Lost to Follow-up|2|||
27864277|NCT04036110|81337035|FG002|Overall Study|Lost to Follow-up|1|||
27864278|NCT04036110|81337033|FG000|Overall Study|Study Suspended|4|||
27864279|NCT04036110|81337034|FG001|Overall Study|Study Suspended|5|||
27864280|NCT04036110|81337035|FG002|Overall Study|Study Suspended|1|||
27864281|NCT00530218|81337036|FG000|Overall Study|CMV Not Detected|13|||
27864282|NCT00530218|81337036|FG000|Overall Study|Death|12|||
27864283|NCT00786409|81337041|FG000|Overall Study|Withdrawal by Subject|2|||
27864284|NCT00786409|81337041|FG000|Overall Study|Adverse Event|2|||
27864285|NCT00786409|81337041|FG000|Overall Study|Pregnancy|2|||
27864286|NCT00786409|81337041|FG000|Overall Study|Lost to Follow-up|1|||
27864287|NCT03340974|81337045|FG000|Completion of Study -Long Term Follow up|Death|8|||
27864288|NCT03340974|81337046|FG001|Completion of Study -Long Term Follow up|Death|5|||
27864289|NCT03340974|81337047|FG002|Completion of Study -Long Term Follow up|Death|5|||
27571049|NCT00378703|80275390|FG002|Overall Study|Physician Decision|1|||
27571050|NCT00378703|80275391|FG003|Overall Study|Physician Decision|0|||
27571051|NCT00378703|80275388|FG000|Overall Study|Alternative therapy|4|||
27571052|NCT00378703|80275389|FG001|Overall Study|Alternative therapy|2|||
27864290|NCT03340974|81337048|FG003|Completion of Study -Long Term Follow up|Death|7|||
27864291|NCT03340974|81337045|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
27864292|NCT03340974|81337046|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
27864293|NCT03340974|81337047|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
27970488|NCT01296711|81722799|FG005|Overall Study|Study termination|4|||
27970489|NCT01296711|81722800|FG006|Overall Study|Study termination|8|||
27864294|NCT03340974|81337048|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
27864295|NCT03340974|81337045|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
27864296|NCT03340974|81337046|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
27864297|NCT03340974|81337047|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
27970490|NCT01296711|81722801|FG007|Overall Study|Study termination|10|||
27970491|NCT01296711|81722794|FG000|Overall Study|Continued elevated liver enzymes|0|||
27970492|NCT01296711|81722795|FG001|Overall Study|Continued elevated liver enzymes|0|||
27781490|NCT00951912|81027751|FG002|Overall Study|Physician Decision|1|||
27781491|NCT00951912|81027749|FG000|Overall Study|Withdrawal by Subject|1|||
27781492|NCT00951912|81027750|FG001|Overall Study|Withdrawal by Subject|1|||
27781493|NCT00951912|81027751|FG002|Overall Study|Withdrawal by Subject|0|||
27781494|NCT00951912|81027749|FG000|Overall Study|Other:Depression|1|||
27781495|NCT00951912|81027750|FG001|Overall Study|Other:Depression|0|||
27781496|NCT00951912|81027751|FG002|Overall Study|Other:Depression|0|||
27781497|NCT00951912|81027749|FG000|Overall Study|Other: Colon cancer|1|||
27781498|NCT00951912|81027750|FG001|Overall Study|Other: Colon cancer|0|||
27781499|NCT00951912|81027751|FG002|Overall Study|Other: Colon cancer|0|||
27781500|NCT00951912|81027749|FG000|Overall Study|Other: Stroke|0|||
27781501|NCT00951912|81027750|FG001|Overall Study|Other: Stroke|1|||
27781502|NCT00951912|81027751|FG002|Overall Study|Other: Stroke|0|||
27781503|NCT03529162|81027754|FG000|Overall Study|Lost to Follow-up|2|||
27781504|NCT03529162|81027755|FG001|Overall Study|Lost to Follow-up|2|||
27781505|NCT00684073|81027756|FG000|Selection|Selection/non-selection criteria|3|||
27781506|NCT00684073|81027756|FG000|Selection|Death|1|||
27781507|NCT00684073|81027756|FG000|Selection|noncompliance|1|||
27781508|NCT00684073|81027756|FG000|Selection|Lost to Follow-up|1|||
27781509|NCT00684073|81027756|FG000|Selection|request of the sponsor|1|||
27781510|NCT00684073|81027756|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
27781511|NCT02155712|81027757|FG000|Overall Study|Death|12|||
27781512|NCT02155712|81027758|FG001|Overall Study|Death|0|||
27970493|NCT01296711|81722796|FG002|Overall Study|Continued elevated liver enzymes|0|||
27970494|NCT01296711|81722797|FG003|Overall Study|Continued elevated liver enzymes|1|||
27970495|NCT01296711|81722798|FG004|Overall Study|Continued elevated liver enzymes|0|||
27970496|NCT01296711|81722799|FG005|Overall Study|Continued elevated liver enzymes|0|||
27970497|NCT01296711|81722800|FG006|Overall Study|Continued elevated liver enzymes|0|||
27970498|NCT01296711|81722801|FG007|Overall Study|Continued elevated liver enzymes|0|||
27970499|NCT01296711|81722794|FG000|Overall Study|Methotrexate discontinued|0|||
27970500|NCT01296711|81722795|FG001|Overall Study|Methotrexate discontinued|0|||
27970501|NCT01296711|81722796|FG002|Overall Study|Methotrexate discontinued|0|||
27970502|NCT01296711|81722797|FG003|Overall Study|Methotrexate discontinued|1|||
27970503|NCT01296711|81722798|FG004|Overall Study|Methotrexate discontinued|0|||
27970504|NCT01296711|81722799|FG005|Overall Study|Methotrexate discontinued|0|||
27970505|NCT01296711|81722800|FG006|Overall Study|Methotrexate discontinued|0|||
27970506|NCT01296711|81722801|FG007|Overall Study|Methotrexate discontinued|0|||
27970507|NCT01296711|81722794|FG000|Overall Study|Investigator discretion|0|||
27970508|NCT01296711|81722795|FG001|Overall Study|Investigator discretion|0|||
27970509|NCT01296711|81722796|FG002|Overall Study|Investigator discretion|0|||
27970510|NCT01296711|81722797|FG003|Overall Study|Investigator discretion|0|||
27970511|NCT01296711|81722798|FG004|Overall Study|Investigator discretion|0|||
27970512|NCT01296711|81722799|FG005|Overall Study|Investigator discretion|0|||
27970513|NCT01296711|81722800|FG006|Overall Study|Investigator discretion|1|||
27970514|NCT01296711|81722801|FG007|Overall Study|Investigator discretion|0|||
27970515|NCT01296711|81722794|FG000|Overall Study|Other|0|||
27970516|NCT01296711|81722795|FG001|Overall Study|Other|0|||
27970517|NCT01296711|81722796|FG002|Overall Study|Other|0|||
27970518|NCT01296711|81722797|FG003|Overall Study|Other|0|||
27970519|NCT01296711|81722798|FG004|Overall Study|Other|0|||
27781513|NCT02155712|81027757|FG000|Overall Study|Lost to Follow-up|37|||
27781514|NCT02155712|81027758|FG001|Overall Study|Lost to Follow-up|22|||
27781515|NCT02155712|81027757|FG000|Overall Study|Revision of device|4|||
27781516|NCT02155712|81027758|FG001|Overall Study|Revision of device|3|||
27781517|NCT02155712|81027757|FG000|Overall Study|Withdrawal by Subject|39|||
27781518|NCT02155712|81027758|FG001|Overall Study|Withdrawal by Subject|21|||
27864298|NCT03340974|81337048|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
27864299|NCT03340974|81337045|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
27864300|NCT03340974|81337046|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
27781519|NCT02155712|81027757|FG000|Overall Study|Site termination|77|||
27781520|NCT02155712|81027758|FG001|Overall Study|Site termination|19|||
27781521|NCT02155712|81027757|FG000|Overall Study|Sponsor terminated study early|150|||
27781522|NCT02155712|81027758|FG001|Overall Study|Sponsor terminated study early|0|||
27781523|NCT02155712|81027757|FG000|Overall Study|Missed final 5-year protocol visit|0|||
27781524|NCT02155712|81027758|FG001|Overall Study|Missed final 5-year protocol visit|32|||
27781525|NCT02155712|81027757|FG000|Overall Study|Censored because surgery cancelled|6|||
27781526|NCT02155712|81027758|FG001|Overall Study|Censored because surgery cancelled|10|||
27781527|NCT02155712|81027757|FG000|Overall Study|Censored because study device was not implanted|61|||
27781528|NCT02155712|81027758|FG001|Overall Study|Censored because study device was not implanted|66|||
27781529|NCT02155712|81027757|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
27781530|NCT02155712|81027758|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
27781531|NCT00424463|81027764|FG000|Overall Study|Adverse Event|2|||
27781532|NCT00424463|81027765|FG001|Overall Study|Adverse Event|3|||
27781533|NCT00424463|81027766|FG002|Overall Study|Adverse Event|2|||
27864301|NCT03340974|81337047|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
27864302|NCT03340974|81337048|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
27864303|NCT00352417|81337049|FG000|Overall Study|Adverse Event|1|||
27864304|NCT00352417|81337050|FG001|Overall Study|Adverse Event|0|||
27864305|NCT00352417|81337049|FG000|Overall Study|Protocol Violation|0|||
27864306|NCT00352417|81337050|FG001|Overall Study|Protocol Violation|2|||
27864307|NCT00352417|81337049|FG000|Overall Study|Withdrawal by Subject|1|||
27864308|NCT00352417|81337050|FG001|Overall Study|Withdrawal by Subject|2|||
27864309|NCT00352417|81337049|FG000|Overall Study|Lost to Follow-up|1|||
27864310|NCT00352417|81337050|FG001|Overall Study|Lost to Follow-up|0|||
27864311|NCT00352417|81337049|FG000|Overall Study|Schedule Change|2|||
27864312|NCT00352417|81337050|FG001|Overall Study|Schedule Change|1|||
27864313|NCT01137071|81337051|FG000|Overall Study|Disease Progression|11|||
27864314|NCT01137071|81337051|FG000|Overall Study|Withdrawal by Subject|2|||
27864315|NCT01137071|81337051|FG000|Overall Study|Wrongly Included|1|||
27864316|NCT04233073|81337060|FG000|Overall Study|Death|5|||
27864317|NCT04303780|81337061|FG000|Overall Study|Death|104|||
27864318|NCT04303780|81337062|FG001|Overall Study|Death|85|||
27864319|NCT04303780|81337061|FG000|Overall Study|Lost to Follow-up|5|||
27864320|NCT04303780|81337062|FG001|Overall Study|Lost to Follow-up|2|||
27864321|NCT04303780|81337061|FG000|Overall Study|Withdrawal by Subject|12|||
27864322|NCT04303780|81337062|FG001|Overall Study|Withdrawal by Subject|39|||
27864323|NCT04303780|81337061|FG000|Overall Study|Ongoing in study|50|||
27864324|NCT04303780|81337062|FG001|Overall Study|Ongoing in study|45|||
27864325|NCT01987479|81337063|FG000|Overall Study|Protocol Violation|1|||
27864326|NCT01987479|81337063|FG000|Overall Study|Physician Decision|2|||
27864327|NCT01987479|81337063|FG000|Overall Study|Participant/legal guardian decision|1|||
27864328|NCT01987479|81337063|FG000|Overall Study|Other|5|||
27970520|NCT01296711|81722799|FG005|Overall Study|Other|0|||
27970521|NCT01296711|81722800|FG006|Overall Study|Other|1|||
27970522|NCT01296711|81722801|FG007|Overall Study|Other|0|||
27970523|NCT01296711|81722794|FG000|Overall Study|Required restricted steroid injections|0|||
27970524|NCT01296711|81722795|FG001|Overall Study|Required restricted steroid injections|0|||
27970525|NCT01296711|81722796|FG002|Overall Study|Required restricted steroid injections|0|||
27970526|NCT01296711|81722797|FG003|Overall Study|Required restricted steroid injections|0|||
27970527|NCT01296711|81722798|FG004|Overall Study|Required restricted steroid injections|0|||
27970528|NCT01296711|81722799|FG005|Overall Study|Required restricted steroid injections|0|||
27970529|NCT01296711|81722800|FG006|Overall Study|Required restricted steroid injections|1|||
27970530|NCT01296711|81722801|FG007|Overall Study|Required restricted steroid injections|0|||
27970531|NCT01296711|81722794|FG000|Overall Study|Ongoing missed appointments|0|||
27970532|NCT01296711|81722795|FG001|Overall Study|Ongoing missed appointments|0|||
27970533|NCT01296711|81722796|FG002|Overall Study|Ongoing missed appointments|0|||
27970534|NCT01296711|81722797|FG003|Overall Study|Ongoing missed appointments|0|||
27970535|NCT01296711|81722798|FG004|Overall Study|Ongoing missed appointments|0|||
27970536|NCT01296711|81722799|FG005|Overall Study|Ongoing missed appointments|0|||
27970537|NCT01296711|81722800|FG006|Overall Study|Ongoing missed appointments|1|||
27970538|NCT01296711|81722801|FG007|Overall Study|Ongoing missed appointments|0|||
27864329|NCT01987479|81337063|FG000|Overall Study|Lost to Follow-up|1|||
27864330|NCT01987479|81337063|FG000|Overall Study|Adverse Event|7|||
27864331|NCT02201277|81337064|FG000|Overall Study|Death|3|||
27781534|NCT00424463|81027764|FG000|Overall Study|Physician Decision|0|||
27781535|NCT00424463|81027765|FG001|Overall Study|Physician Decision|2|||
27781536|NCT00424463|81027766|FG002|Overall Study|Physician Decision|2|||
27864332|NCT02201277|81337065|FG001|Overall Study|Death|4|||
27864333|NCT02201277|81337064|FG000|Overall Study|Lost to Follow-up|2|||
27864334|NCT02201277|81337065|FG001|Overall Study|Lost to Follow-up|1|||
27864335|NCT02201277|81337064|FG000|Overall Study|Failed retrieval|1|||
27864336|NCT02201277|81337065|FG001|Overall Study|Failed retrieval|0|||
27864337|NCT02201277|81337064|FG000|Overall Study|Physician Decision|1|||
27864338|NCT02201277|81337065|FG001|Overall Study|Physician Decision|0|||
27864339|NCT01111825|81337066|FG000|Overall Study|Withdrawal by Subject|0|||
27864340|NCT01111825|81337067|FG001|Overall Study|Withdrawal by Subject|0|||
27781537|NCT00424463|81027764|FG000|Overall Study|Withdrawal by Subject|4|||
27781538|NCT00424463|81027765|FG001|Overall Study|Withdrawal by Subject|2|||
27781539|NCT00424463|81027766|FG002|Overall Study|Withdrawal by Subject|5|||
27781540|NCT00424463|81027764|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
27781541|NCT00424463|81027765|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
27781542|NCT00424463|81027766|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
27781543|NCT00424463|81027764|FG000|Overall Study|Patient's convenience|0|||
27781544|NCT00424463|81027765|FG001|Overall Study|Patient's convenience|0|||
27781545|NCT00424463|81027766|FG002|Overall Study|Patient's convenience|1|||
27781546|NCT00917553|81027768|FG000|Overall Study|Lost to Follow-up|2|||
27781547|NCT00917553|81027769|FG001|Overall Study|Lost to Follow-up|1|||
27781548|NCT03395704|81027773|FG000|Overall Study|Adverse Event|2|||
27781549|NCT03395704|81027774|FG001|Overall Study|Adverse Event|1|||
27781550|NCT03395704|81027773|FG000|Overall Study|Withdrawal by Subject|2|||
27781551|NCT03395704|81027774|FG001|Overall Study|Withdrawal by Subject|1|||
27781552|NCT03395704|81027773|FG000|Overall Study|Physician Decision|0|||
27781553|NCT03395704|81027774|FG001|Overall Study|Physician Decision|1|||
27781554|NCT01077193|81027775|FG000|Overall Study|Lost to Follow-up|1|||
27781555|NCT01077193|81027775|FG000|Overall Study|Withdrawal by Subject|2|||
27781556|NCT01077193|81027775|FG000|Overall Study|Lack of Efficacy|1|||
27781557|NCT01077193|81027775|FG000|Overall Study|Study Terminated by Sponsor|40|||
27781558|NCT00286234|81027776|FG000|Overall Study|Protocol Violation|1|||
27781559|NCT00286234|81027777|FG001|Overall Study|Protocol Violation|2|||
27781560|NCT00286234|81027778|FG002|Overall Study|Protocol Violation|0|||
27781561|NCT00286234|81027779|FG003|Overall Study|Protocol Violation|1|||
27781562|NCT00286234|81027776|FG000|Overall Study|Physician Decision|1|||
27781563|NCT00286234|81027777|FG001|Overall Study|Physician Decision|0|||
27781564|NCT00286234|81027778|FG002|Overall Study|Physician Decision|0|||
27781565|NCT00286234|81027779|FG003|Overall Study|Physician Decision|1|||
27781566|NCT00286234|81027776|FG000|Overall Study|Adverse Event|0|||
27781567|NCT00286234|81027777|FG001|Overall Study|Adverse Event|0|||
27781568|NCT00286234|81027778|FG002|Overall Study|Adverse Event|0|||
27781569|NCT00286234|81027779|FG003|Overall Study|Adverse Event|1|||
27781570|NCT00286234|81027776|FG000|Overall Study|Adverse Event|0|||
27781571|NCT00286234|81027777|FG001|Overall Study|Adverse Event|0|||
27781572|NCT00286234|81027778|FG002|Overall Study|Adverse Event|0|||
27781573|NCT00286234|81027779|FG003|Overall Study|Adverse Event|1|||
27781574|NCT03233308|81027782|FG000|Overall Study|Adverse Event|1|||
27781575|NCT03233308|81027782|FG000|Overall Study|Protocol Violation|1|||
27781576|NCT01904760|81027783|FG000|Overall Study|Protocol Violation|1|||
27781577|NCT01904760|81027784|FG001|Overall Study|Protocol Violation|0|||
27781578|NCT01029691|81032031|FG000|Continued APAP to Delivery|Death|0|||
27781579|NCT01029691|81032032|FG001|Continued APAP to Delivery|Death|0|||
27781580|NCT01029691|81032033|FG002|Continued APAP to Delivery|Death|1|||
27781581|NCT00696774|81032034|FG000|Period II|Adverse Event|0|||
27781582|NCT00696774|81032035|FG001|Period II|Adverse Event|0|||
27781583|NCT00696774|81032036|FG002|Period II|Adverse Event|15|||
27781584|NCT00696774|81032034|FG000|Period II|Lost to Follow-up|0|||
27781585|NCT00696774|81032035|FG001|Period II|Lost to Follow-up|0|||
27781586|NCT00696774|81032036|FG002|Period II|Lost to Follow-up|4|||
27781587|NCT00696774|81032034|FG000|Period II|Protocol Violation|0|||
27864341|NCT01111825|81337068|FG002|Overall Study|Withdrawal by Subject|1|||
27864342|NCT01111825|81337069|FG003|Overall Study|Withdrawal by Subject|0|||
27864343|NCT01111825|81337066|FG000|Overall Study|Lost to Follow-up|0|||
27864344|NCT01111825|81337067|FG001|Overall Study|Lost to Follow-up|0|||
27864345|NCT01111825|81337068|FG002|Overall Study|Lost to Follow-up|3|||
27571053|NCT00378703|80275390|FG002|Overall Study|Alternative therapy|0|||
27571054|NCT00378703|80275391|FG003|Overall Study|Alternative therapy|0|||
27781588|NCT00696774|81032035|FG001|Period II|Protocol Violation|0|||
27781589|NCT00696774|81032036|FG002|Period II|Protocol Violation|11|||
27781590|NCT00696774|81032034|FG000|Period II|Withdrawal by Subject|0|||
27781591|NCT00696774|81032035|FG001|Period II|Withdrawal by Subject|0|||
27781592|NCT00696774|81032036|FG002|Period II|Withdrawal by Subject|4|||
27781593|NCT00696774|81032034|FG000|Period II|Sponsor Decision|0|||
27781594|NCT00696774|81032035|FG001|Period II|Sponsor Decision|0|||
27781595|NCT00696774|81032036|FG002|Period II|Sponsor Decision|0|||
27781596|NCT00696774|81032034|FG000|Period II|Lack of Efficacy|0|||
27781597|NCT00696774|81032035|FG001|Period II|Lack of Efficacy|0|||
27781598|NCT00696774|81032036|FG002|Period II|Lack of Efficacy|2|||
27781599|NCT00696774|81032034|FG000|Period III|Adverse Event|1|||
27781600|NCT00696774|81032035|FG001|Period III|Adverse Event|1|||
27781601|NCT00696774|81032036|FG002|Period III|Adverse Event|0|||
27781602|NCT00696774|81032034|FG000|Period III|Lost to Follow-up|2|||
27781603|NCT00696774|81032035|FG001|Period III|Lost to Follow-up|1|||
27864346|NCT01111825|81337069|FG003|Overall Study|Lost to Follow-up|1|||
27781604|NCT00696774|81032036|FG002|Period III|Lost to Follow-up|0|||
27781605|NCT00696774|81032034|FG000|Period III|Protocol Violation|1|||
27781606|NCT00696774|81032035|FG001|Period III|Protocol Violation|1|||
27781607|NCT00696774|81032036|FG002|Period III|Protocol Violation|0|||
27781608|NCT00696774|81032034|FG000|Period III|Withdrawal by Subject|1|||
27781609|NCT00696774|81032035|FG001|Period III|Withdrawal by Subject|2|||
27970539|NCT01296711|81722794|FG000|Overall Study|Failure to comply with visits|0|||
27970540|NCT01296711|81722795|FG001|Overall Study|Failure to comply with visits|0|||
27970541|NCT01296711|81722796|FG002|Overall Study|Failure to comply with visits|0|||
27970542|NCT01296711|81722797|FG003|Overall Study|Failure to comply with visits|0|||
27970543|NCT01296711|81722798|FG004|Overall Study|Failure to comply with visits|0|||
27970544|NCT01296711|81722799|FG005|Overall Study|Failure to comply with visits|0|||
27970545|NCT01296711|81722800|FG006|Overall Study|Failure to comply with visits|0|||
27970546|NCT01296711|81722801|FG007|Overall Study|Failure to comply with visits|1|||
27970547|NCT01296711|81722794|FG000|Overall Study|Patient decision due to transport|0|||
27970548|NCT01296711|81722795|FG001|Overall Study|Patient decision due to transport|0|||
27970549|NCT01296711|81722796|FG002|Overall Study|Patient decision due to transport|0|||
27970550|NCT01296711|81722797|FG003|Overall Study|Patient decision due to transport|0|||
27970551|NCT01296711|81722798|FG004|Overall Study|Patient decision due to transport|0|||
27970552|NCT01296711|81722799|FG005|Overall Study|Patient decision due to transport|0|||
27970553|NCT01296711|81722800|FG006|Overall Study|Patient decision due to transport|0|||
27970554|NCT01296711|81722801|FG007|Overall Study|Patient decision due to transport|1|||
27970555|NCT00459875|81722802|FG000|Overall Study|Ineligible participant|1|||
27970556|NCT00459875|81722802|FG000|Overall Study|Adverse Event|2|||
27970557|NCT05312632|81722803|FG000|Overall Study|Adverse Event|12|||
27970558|NCT05312632|81722803|FG000|Overall Study|Withdrawal by Subject|10|||
27970559|NCT05312632|81722803|FG000|Overall Study|Lack of Efficacy|4|||
27970560|NCT05312632|81722803|FG000|Overall Study|Non-compliance with study procedures|9|||
27970561|NCT05312632|81722803|FG000|Overall Study|Other|4|||
27970562|NCT00724854|81722804|FG000|Overall Study|Lack of Efficacy|187|||
27970563|NCT00724854|81722805|FG001|Overall Study|Lack of Efficacy|13|||
27970564|NCT00724854|81722804|FG000|Overall Study|Lost to Follow-up|87|||
27970565|NCT00724854|81722805|FG001|Overall Study|Lost to Follow-up|10|||
27970566|NCT00724854|81722804|FG000|Overall Study|Adverse Event|62|||
27970567|NCT00724854|81722805|FG001|Overall Study|Adverse Event|4|||
27970568|NCT00724854|81722804|FG000|Overall Study|Other|42|||
27781610|NCT00696774|81032036|FG002|Period III|Withdrawal by Subject|0|||
27781611|NCT00696774|81032034|FG000|Period III|Sponsor Decision|2|||
27781612|NCT00696774|81032035|FG001|Period III|Sponsor Decision|0|||
27781613|NCT00696774|81032036|FG002|Period III|Sponsor Decision|0|||
27781614|NCT00696774|81032034|FG000|Period III|Lack of Efficacy|0|||
27781615|NCT00696774|81032035|FG001|Period III|Lack of Efficacy|2|||
27970569|NCT00724854|81722805|FG001|Overall Study|Other|3|||
27970570|NCT00724854|81722804|FG000|Overall Study|Death|11|||
27970571|NCT00724854|81722805|FG001|Overall Study|Death|0|||
27970572|NCT00724854|81722804|FG000|Overall Study|Change of treatment|7|||
27970573|NCT00724854|81722805|FG001|Overall Study|Change of treatment|0|||
27970574|NCT00724854|81722804|FG000|Overall Study|Withdrawal by Subject|5|||
27970575|NCT00724854|81722805|FG001|Overall Study|Withdrawal by Subject|0|||
27970576|NCT00724854|81722804|FG000|Overall Study|Adverse event + lack of efficacy|2|||
27970577|NCT00724854|81722805|FG001|Overall Study|Adverse event + lack of efficacy|1|||
27970578|NCT00842153|81722811|FG000|Overall Study|Adverse Event|0|||
27970579|NCT00842153|81722812|FG001|Overall Study|Adverse Event|1|||
27970580|NCT00842153|81722811|FG000|Overall Study|Lost to Follow-up|1|||
27970581|NCT00842153|81722812|FG001|Overall Study|Lost to Follow-up|2|||
27970582|NCT01631747|81722814|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
27970583|NCT01631747|81722815|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
27970584|NCT01631747|81722814|FG000|Live Birth|Pregnancy Termination|1|||
27970585|NCT01631747|81722815|FG001|Live Birth|Pregnancy Termination|0|||
27970586|NCT01631747|81722814|FG000|Live Birth|MIscarriage|2|||
27970587|NCT01631747|81722815|FG001|Live Birth|MIscarriage|0|||
27571055|NCT00378703|80275388|FG000|Overall Study|Other complicated disease|0|||
27970588|NCT01631747|81722814|FG000|Live Birth|Stillbirth|1|||
27970589|NCT01631747|81722815|FG001|Live Birth|Stillbirth|1|||
27571056|NCT00378703|80275389|FG001|Overall Study|Other complicated disease|2|||
27571057|NCT00378703|80275390|FG002|Overall Study|Other complicated disease|2|||
27781616|NCT00696774|81032036|FG002|Period III|Lack of Efficacy|0|||
27781617|NCT01797302|81032037|FG000|Overall Study|Lost to Follow-up|16|||
27781618|NCT01797302|81032038|FG001|Overall Study|Lost to Follow-up|23|||
27970590|NCT01631747|81722814|FG000|One Year Infant Outcomes|Patient Refused|13|||
27970591|NCT01631747|81722815|FG001|One Year Infant Outcomes|Patient Refused|9|||
27970592|NCT03650803|81722816|FG000|Overall Study|Lost to Follow-up|6|||
27781619|NCT01797302|81032039|FG002|Overall Study|Lost to Follow-up|22|||
27781620|NCT01797302|81032037|FG000|Overall Study|Withdrawal by Subject|1|||
27781621|NCT01797302|81032038|FG001|Overall Study|Withdrawal by Subject|3|||
27781622|NCT01797302|81032039|FG002|Overall Study|Withdrawal by Subject|4|||
27781623|NCT01906489|81032040|FG000|Overall Study|Adverse Event|10|||
27970593|NCT00737568|81722819|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
27970594|NCT00737568|81722820|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
27970595|NCT00737568|81722819|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
27970596|NCT00737568|81722820|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
27970597|NCT00737568|81722819|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
27970598|NCT00737568|81722820|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
27970599|NCT00737568|81722819|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
27970600|NCT00737568|81722820|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
27781624|NCT01906489|81032041|FG001|Overall Study|Adverse Event|3|||
27781625|NCT01906489|81032040|FG000|Overall Study|Worsening of CKD|6|||
27781626|NCT01906489|81032041|FG001|Overall Study|Worsening of CKD|4|||
27781627|NCT01906489|81032040|FG000|Overall Study|Withdrawal by Subject|5|||
27781628|NCT01906489|81032041|FG001|Overall Study|Withdrawal by Subject|0|||
27781629|NCT01906489|81032040|FG000|Overall Study|Worsening of Anemia|1|||
27781630|NCT01906489|81032041|FG001|Overall Study|Worsening of Anemia|0|||
27781631|NCT01906489|81032040|FG000|Overall Study|Protocol Violation|0|||
27781632|NCT01906489|81032041|FG001|Overall Study|Protocol Violation|1|||
27781633|NCT01906489|81032040|FG000|Overall Study|Non- Compliance|1|||
27781634|NCT01906489|81032041|FG001|Overall Study|Non- Compliance|0|||
27781635|NCT01906489|81032040|FG000|Overall Study|Sponsor Decision|1|||
27781636|NCT01906489|81032041|FG001|Overall Study|Sponsor Decision|0|||
27781637|NCT01906489|81032040|FG000|Overall Study|Lost to Follow-up|1|||
27781638|NCT01906489|81032041|FG001|Overall Study|Lost to Follow-up|1|||
27781639|NCT01906489|81032040|FG000|Overall Study|Other|1|||
27781640|NCT01906489|81032041|FG001|Overall Study|Other|0|||
27781641|NCT01191190|81032042|FG000|Overall Study|Withdrawal by Subject|1|||
27781642|NCT00842829|81032043|FG000|Dose Titration Period|Adverse Event|11|||
27781643|NCT00842829|81032044|FG001|Dose Titration Period|Adverse Event|10|||
27781644|NCT00842829|81032045|FG002|Dose Titration Period|Adverse Event|0|||
27781645|NCT00842829|81032043|FG000|Dose Titration Period|Lack of Efficacy|4|||
27781646|NCT00842829|81032044|FG001|Dose Titration Period|Lack of Efficacy|1|||
27781647|NCT00842829|81032045|FG002|Dose Titration Period|Lack of Efficacy|0|||
27864347|NCT01111825|81337066|FG000|Overall Study|Adverse Event|2|||
27864348|NCT01111825|81337067|FG001|Overall Study|Adverse Event|1|||
27864349|NCT01111825|81337068|FG002|Overall Study|Adverse Event|4|||
27864350|NCT01111825|81337069|FG003|Overall Study|Adverse Event|0|||
27970601|NCT00737568|81722819|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
27970602|NCT00737568|81722820|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
27970603|NCT00737568|81722819|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
27970604|NCT00737568|81722820|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
27970605|NCT00737568|81722819|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
27970606|NCT00737568|81722820|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
27970607|NCT00737568|81722819|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
27970608|NCT00737568|81722820|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
27970609|NCT00737568|81722819|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
27970610|NCT00737568|81722820|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
27970611|NCT02901054|81722821|FG000|Overall Study|Physician Decision|1|||
27970612|NCT02901054|81722821|FG000|Overall Study|Withdrawal by Subject|3|||
27970613|NCT00252694|81722824|FG000|Overall Study|Withdrawal by Subject|83|||
27970614|NCT00252694|81722825|FG001|Overall Study|Withdrawal by Subject|91|||
27970615|NCT00252694|81722824|FG000|Overall Study|Death|36|||
27970616|NCT00252694|81722825|FG001|Overall Study|Death|34|||
27970617|NCT00252694|81722824|FG000|Overall Study|Mostly Lost to Follow Up|8|||
27970618|NCT00252694|81722825|FG001|Overall Study|Mostly Lost to Follow Up|13|||
27970619|NCT00252694|81722824|FG000|Overall Study|Patient Moving|17|||
27970620|NCT00252694|81722825|FG001|Overall Study|Patient Moving|16|||
27970621|NCT03136497|81722826|FG000|Overall Study|Screen Failure|1|||
27970622|NCT03136497|81722827|FG001|Overall Study|Screen Failure|0|||
27970623|NCT03136497|81722828|FG002|Overall Study|Screen Failure|0|||
27970624|NCT01257230|81722829|FG000|Overall Study|Not Treated|0|||
27970625|NCT01257230|81722830|FG001|Overall Study|Not Treated|0|||
27970626|NCT01257230|81722831|FG002|Overall Study|Not Treated|1|||
27970627|NCT01257230|81722829|FG000|Overall Study|Adverse Event|2|||
27970628|NCT01257230|81722830|FG001|Overall Study|Adverse Event|0|||
27781648|NCT00842829|81032043|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
27781649|NCT00842829|81032044|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
27781650|NCT00842829|81032045|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
27781651|NCT00842829|81032043|FG000|Dose Titration Period|Withdrawal by Subject|2|||
27781652|NCT00842829|81032044|FG001|Dose Titration Period|Withdrawal by Subject|6|||
27781653|NCT00842829|81032045|FG002|Dose Titration Period|Withdrawal by Subject|0|||
27781654|NCT00842829|81032043|FG000|Dose Titration Period|Other|5|||
27864351|NCT01111825|81337066|FG000|Overall Study|Disease Progression|1|||
27970629|NCT01257230|81722831|FG002|Overall Study|Adverse Event|0|||
27970630|NCT01257230|81722829|FG000|Overall Study|Lack of Efficacy|0|||
27970631|NCT01257230|81722830|FG001|Overall Study|Lack of Efficacy|1|||
27970632|NCT01257230|81722831|FG002|Overall Study|Lack of Efficacy|0|||
27970633|NCT01257230|81722829|FG000|Overall Study|Protocol Violation|3|||
27970634|NCT01257230|81722830|FG001|Overall Study|Protocol Violation|0|||
27970635|NCT01257230|81722831|FG002|Overall Study|Protocol Violation|1|||
27970636|NCT01257230|81722829|FG000|Overall Study|Withdrawal by Subject|0|||
27970637|NCT01257230|81722830|FG001|Overall Study|Withdrawal by Subject|4|||
27781655|NCT00842829|81032044|FG001|Dose Titration Period|Other|4|||
27781656|NCT00842829|81032045|FG002|Dose Titration Period|Other|0|||
27781657|NCT00842829|81032043|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
27781658|NCT00842829|81032044|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
27781659|NCT00842829|81032045|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
27781660|NCT00842829|81032043|FG000|Dose Titration Period|Non-compliance to study drug|2|||
27781661|NCT00842829|81032044|FG001|Dose Titration Period|Non-compliance to study drug|1|||
27781662|NCT00842829|81032045|FG002|Dose Titration Period|Non-compliance to study drug|0|||
27970638|NCT01257230|81722831|FG002|Overall Study|Withdrawal by Subject|1|||
27781663|NCT00842829|81032043|FG000|Treatment Period|Adverse Event|0|||
27781664|NCT00842829|81032044|FG001|Treatment Period|Adverse Event|0|||
27781665|NCT00842829|81032045|FG002|Treatment Period|Adverse Event|15|||
27781666|NCT00842829|81032043|FG000|Treatment Period|Lack of Efficacy|0|||
27781667|NCT00842829|81032044|FG001|Treatment Period|Lack of Efficacy|0|||
27781668|NCT00842829|81032045|FG002|Treatment Period|Lack of Efficacy|6|||
27781669|NCT00842829|81032043|FG000|Treatment Period|Unstable persistent cancer pain|0|||
27781670|NCT00842829|81032044|FG001|Treatment Period|Unstable persistent cancer pain|0|||
27781671|NCT00842829|81032045|FG002|Treatment Period|Unstable persistent cancer pain|5|||
27864352|NCT01111825|81337067|FG001|Overall Study|Disease Progression|0|||
27970639|NCT01257230|81722829|FG000|Overall Study|Other reason not defined above|1|||
27781672|NCT00842829|81032043|FG000|Treatment Period|Withdrawal by Subject|0|||
27781673|NCT00842829|81032044|FG001|Treatment Period|Withdrawal by Subject|0|||
27781674|NCT00842829|81032045|FG002|Treatment Period|Withdrawal by Subject|11|||
27864353|NCT01111825|81337068|FG002|Overall Study|Disease Progression|0|||
27781675|NCT00842829|81032043|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
27781676|NCT00842829|81032044|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
27781677|NCT00842829|81032045|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
27781678|NCT00842829|81032043|FG000|Treatment Period|Protocol Violation|0|||
27781679|NCT00842829|81032044|FG001|Treatment Period|Protocol Violation|0|||
27781680|NCT00842829|81032045|FG002|Treatment Period|Protocol Violation|2|||
27781681|NCT00842829|81032043|FG000|Treatment Period|Other|0|||
27781682|NCT00842829|81032044|FG001|Treatment Period|Other|0|||
27781683|NCT00842829|81032045|FG002|Treatment Period|Other|18|||
27781684|NCT00842829|81032043|FG000|Treatment Period|Non-compliance to study procedures|0|||
27781685|NCT00842829|81032044|FG001|Treatment Period|Non-compliance to study procedures|0|||
27970640|NCT01257230|81722830|FG001|Overall Study|Other reason not defined above|5|||
27970641|NCT01257230|81722831|FG002|Overall Study|Other reason not defined above|3|||
27970642|NCT00328562|81722833|FG000|Overall Study|Disease progression|1|||
27970643|NCT00812006|81722834|FG000|Overall Study|Lost to Follow-up|0|||
27970644|NCT00812006|81722835|FG001|Overall Study|Lost to Follow-up|0|||
27970645|NCT00812006|81722836|FG002|Overall Study|Lost to Follow-up|2|||
27970646|NCT00812006|81722834|FG000|Overall Study|Physician Decision|0|||
27970647|NCT00812006|81722835|FG001|Overall Study|Physician Decision|0|||
27781686|NCT00842829|81032045|FG002|Treatment Period|Non-compliance to study procedures|4|||
27781687|NCT00842829|81032043|FG000|Treatment Period|Unclear completion status|0|||
27781688|NCT00842829|81032044|FG001|Treatment Period|Unclear completion status|0|||
27781689|NCT00842829|81032045|FG002|Treatment Period|Unclear completion status|1|||
27781690|NCT00842829|81032043|FG000|Continuation Period|Adverse Event|0|||
27781691|NCT00842829|81032044|FG001|Continuation Period|Adverse Event|0|||
27781692|NCT00842829|81032045|FG002|Continuation Period|Adverse Event|32|||
27781693|NCT00842829|81032043|FG000|Continuation Period|Lack of Efficacy|0|||
27781694|NCT00842829|81032044|FG001|Continuation Period|Lack of Efficacy|0|||
27781695|NCT00842829|81032045|FG002|Continuation Period|Lack of Efficacy|6|||
27781696|NCT00842829|81032043|FG000|Continuation Period|Unstable persistent cancer pain|0|||
27781697|NCT00842829|81032044|FG001|Continuation Period|Unstable persistent cancer pain|0|||
27781698|NCT00842829|81032045|FG002|Continuation Period|Unstable persistent cancer pain|3|||
27781699|NCT00842829|81032043|FG000|Continuation Period|Withdrawal by Subject|0|||
27781700|NCT00842829|81032044|FG001|Continuation Period|Withdrawal by Subject|0|||
27781701|NCT00842829|81032045|FG002|Continuation Period|Withdrawal by Subject|10|||
27781702|NCT00842829|81032043|FG000|Continuation Period|Other|0|||
27970648|NCT00812006|81722836|FG002|Overall Study|Physician Decision|1|||
27781703|NCT00842829|81032044|FG001|Continuation Period|Other|0|||
27781704|NCT00842829|81032045|FG002|Continuation Period|Other|7|||
27781705|NCT00842829|81032043|FG000|Continuation Period|Non-compliance to study procedures|0|||
27781706|NCT00842829|81032044|FG001|Continuation Period|Non-compliance to study procedures|0|||
27970649|NCT00812006|81722834|FG000|Overall Study|Withdrawal by Subject|2|||
27970650|NCT00812006|81722835|FG001|Overall Study|Withdrawal by Subject|1|||
27970651|NCT00812006|81722836|FG002|Overall Study|Withdrawal by Subject|1|||
27970652|NCT00812006|81722834|FG000|Overall Study|Lack of Qualifying Event|4|||
27970653|NCT00812006|81722835|FG001|Overall Study|Lack of Qualifying Event|2|||
27970654|NCT00812006|81722836|FG002|Overall Study|Lack of Qualifying Event|2|||
27970655|NCT00875485|81722837|FG000|Challenge Dose Epoch|Pregnancy|1|||
27970656|NCT00875485|81722838|FG001|Challenge Dose Epoch|Pregnancy|0|||
27970657|NCT00759356|81722843|FG000|Overall Study|Adverse Event|0|||
27970658|NCT00759356|81722844|FG001|Overall Study|Adverse Event|1|||
27970659|NCT00759356|81722843|FG000|Overall Study|Withdrawal by Subject|0|||
27781707|NCT00842829|81032045|FG002|Continuation Period|Non-compliance to study procedures|2|||
27781708|NCT00842829|81032043|FG000|Continuation Period|Non-compliance to study drug|0|||
27781709|NCT00842829|81032044|FG001|Continuation Period|Non-compliance to study drug|0|||
27781710|NCT00842829|81032045|FG002|Continuation Period|Non-compliance to study drug|1|||
27781711|NCT00417248|81032046|FG000|Overall Study|Study Terminated|6|||
27781712|NCT00417248|81032046|FG000|Overall Study|Death|1|||
27781713|NCT00417248|81032046|FG000|Overall Study|Lack of Efficacy|1|||
27781714|NCT00808132|81032047|FG000|Overall Study|Adverse Event|34|||
27781715|NCT00808132|81032048|FG001|Overall Study|Adverse Event|33|||
27781716|NCT00808132|81032049|FG002|Overall Study|Adverse Event|16|||
27864354|NCT01111825|81337069|FG003|Overall Study|Disease Progression|0|||
27864355|NCT01111825|81337066|FG000|Overall Study|Discontinuation by Sponsor|0|||
27970660|NCT00759356|81722844|FG001|Overall Study|Withdrawal by Subject|2|||
27970661|NCT00759356|81722843|FG000|Overall Study|Subject was unable to return|1|||
27781717|NCT00808132|81032050|FG003|Overall Study|Adverse Event|31|||
27781718|NCT00808132|81032051|FG004|Overall Study|Adverse Event|33|||
27781719|NCT00808132|81032047|FG000|Overall Study|Death|0|||
27781720|NCT00808132|81032048|FG001|Overall Study|Death|0|||
27781721|NCT00808132|81032049|FG002|Overall Study|Death|0|||
27781722|NCT00808132|81032050|FG003|Overall Study|Death|0|||
27781723|NCT00808132|81032051|FG004|Overall Study|Death|1|||
27781724|NCT00808132|81032047|FG000|Overall Study|Physician Decision|0|||
27970662|NCT00759356|81722844|FG001|Overall Study|Subject was unable to return|0|||
27970663|NCT02324205|81722854|FG000|Overall Study|Withdrawal by Subject|37|||
27970664|NCT00666588|81722856|FG000|Overall Study|ineligible|2|||
27970665|NCT00666588|81722857|FG001|Overall Study|ineligible|0|||
27781725|NCT00808132|81032048|FG001|Overall Study|Physician Decision|1|||
27781726|NCT00808132|81032049|FG002|Overall Study|Physician Decision|0|||
27781727|NCT00808132|81032050|FG003|Overall Study|Physician Decision|0|||
27781728|NCT00808132|81032051|FG004|Overall Study|Physician Decision|0|||
27781729|NCT00808132|81032047|FG000|Overall Study|Lost to Follow-up|8|||
27781730|NCT00808132|81032048|FG001|Overall Study|Lost to Follow-up|10|||
27970666|NCT00666588|81722858|FG002|Overall Study|ineligible|0|||
27970667|NCT00666588|81722859|FG003|Overall Study|ineligible|2|||
27970668|NCT00666588|81722856|FG000|Overall Study|inevaluable|2|||
27970669|NCT00666588|81722857|FG001|Overall Study|inevaluable|0|||
27571058|NCT00378703|80275391|FG003|Overall Study|Other complicated disease|0|||
27571059|NCT00378703|80275388|FG000|Overall Study|Symptomatic deterioration|0|||
27571060|NCT00378703|80275389|FG001|Overall Study|Symptomatic deterioration|1|||
27571061|NCT00378703|80275390|FG002|Overall Study|Symptomatic deterioration|0|||
27571062|NCT00378703|80275391|FG003|Overall Study|Symptomatic deterioration|2|||
27781731|NCT00808132|81032049|FG002|Overall Study|Lost to Follow-up|11|||
27970670|NCT00666588|81722858|FG002|Overall Study|inevaluable|0|||
27970671|NCT00666588|81722859|FG003|Overall Study|inevaluable|0|||
27970672|NCT00522418|81722860|FG000|Overall Study|Local IRB Consent Violation|5|||
27970673|NCT00522418|81722861|FG001|Overall Study|Local IRB Consent Violation|5|||
27970674|NCT00522418|81722860|FG000|Overall Study|Early Study Termination|46|||
27970675|NCT00522418|81722861|FG001|Overall Study|Early Study Termination|47|||
27970676|NCT00522418|81722860|FG000|Overall Study|Noncompliance|2|||
27970677|NCT00522418|81722861|FG001|Overall Study|Noncompliance|2|||
27970678|NCT00522418|81722860|FG000|Overall Study|Reason Not Specified|3|||
27970679|NCT00522418|81722861|FG001|Overall Study|Reason Not Specified|1|||
27970680|NCT00522418|81722860|FG000|Overall Study|Consent Withdraw|1|||
27970681|NCT00522418|81722861|FG001|Overall Study|Consent Withdraw|2|||
27970682|NCT00522418|81722860|FG000|Overall Study|Lack of Efficacy|0|||
27970683|NCT00522418|81722861|FG001|Overall Study|Lack of Efficacy|1|||
27970684|NCT01610557|81722864|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27970685|NCT01610557|81722865|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
27970686|NCT01610557|81722866|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27970687|NCT01610557|81722867|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27970688|NCT01610557|81722868|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
27970689|NCT01610557|81722864|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27970690|NCT01610557|81722865|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27970691|NCT01610557|81722866|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27970692|NCT01610557|81722867|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
27970693|NCT01610557|81722868|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
27970694|NCT00510718|81722870|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
27970695|NCT00510718|81722871|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
27970696|NCT00510718|81722870|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
27970697|NCT00510718|81722871|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
27970698|NCT00510718|81722870|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
27970699|NCT00510718|81722871|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
27970700|NCT00510718|81722870|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
27970701|NCT00510718|81722871|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
27970702|NCT00510718|81722870|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
27970703|NCT00510718|81722871|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
27970704|NCT00510718|81722870|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
27970705|NCT00510718|81722871|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
27970706|NCT02135029|81722872|FG000|Overall Study|Adverse Event|2|||
27970707|NCT02135029|81722873|FG001|Overall Study|Adverse Event|2|||
27970708|NCT02135029|81722874|FG002|Overall Study|Adverse Event|2|||
27970709|NCT02135029|81722872|FG000|Overall Study|Lost to Follow-up|0|||
27970710|NCT02135029|81722873|FG001|Overall Study|Lost to Follow-up|1|||
27970711|NCT02135029|81722874|FG002|Overall Study|Lost to Follow-up|0|||
27970712|NCT02135029|81722872|FG000|Overall Study|Withdrawal by Subject|2|||
27970713|NCT02135029|81722873|FG001|Overall Study|Withdrawal by Subject|0|||
27970714|NCT02135029|81722874|FG002|Overall Study|Withdrawal by Subject|1|||
27781732|NCT00808132|81032050|FG003|Overall Study|Lost to Follow-up|8|||
27970715|NCT02135029|81722872|FG000|Overall Study|Other|0|||
27970716|NCT02135029|81722873|FG001|Overall Study|Other|1|||
27970717|NCT02135029|81722874|FG002|Overall Study|Other|0|||
27970718|NCT02135029|81722872|FG000|Overall Study|Death|0|||
27970719|NCT02135029|81722873|FG001|Overall Study|Death|1|||
27970720|NCT02135029|81722874|FG002|Overall Study|Death|0|||
27571063|NCT00378703|80275388|FG000|Overall Study|Surgery|1|||
27970721|NCT00633074|81722880|FG000|Overall Study|Adverse Event|1|||
27970722|NCT00633074|81722881|FG001|Overall Study|Adverse Event|0|||
27970723|NCT01126268|81722884|FG000|Overall Study|Adverse Event|1|||
27781733|NCT00808132|81032051|FG004|Overall Study|Lost to Follow-up|9|||
27781734|NCT00808132|81032047|FG000|Overall Study|Protocol Violation|8|||
27970724|NCT03299881|81722886|FG000|Overall Study|Study Termination|17|||
27970725|NCT03299881|81722887|FG001|Overall Study|Study Termination|13|||
27970726|NCT01468207|81722888|FG000|Treatment Period 1|Adverse Event|1|||
27970727|NCT01468207|81722889|FG001|Treatment Period 1|Adverse Event|0|||
27970728|NCT01468207|81722890|FG002|Treatment Period 1|Adverse Event|0|||
27970729|NCT01468207|81722891|FG003|Treatment Period 1|Adverse Event|0|||
27970730|NCT01468207|81722892|FG004|Treatment Period 1|Adverse Event|0|||
27970731|NCT01468207|81722893|FG005|Treatment Period 1|Adverse Event|0|||
27970732|NCT01468207|81722888|FG000|Treatment Period 1|Protocol Violation|1|||
27970733|NCT01468207|81722889|FG001|Treatment Period 1|Protocol Violation|1|||
27667719|NCT02980705|80623417|FG000|Overall Study|withdrew participation|0|||
27667720|NCT02980705|80623418|FG001|Overall Study|withdrew participation|1|||
27667721|NCT02980705|80623417|FG000|Overall Study|Lost to Follow-up|2|||
27667722|NCT02980705|80623418|FG001|Overall Study|Lost to Follow-up|0|||
27667723|NCT02835092|80623419|FG000|Overall Study|Withdrawal by Subject|3|||
27667724|NCT02835092|80623420|FG001|Overall Study|Withdrawal by Subject|6|||
27667725|NCT02835092|80623421|FG002|Overall Study|Withdrawal by Subject|3|||
27667726|NCT02835092|80623419|FG000|Overall Study|Lost to Follow-up|0|||
27667727|NCT02835092|80623420|FG001|Overall Study|Lost to Follow-up|2|||
27781735|NCT00808132|81032048|FG001|Overall Study|Protocol Violation|9|||
27970734|NCT01468207|81722890|FG002|Treatment Period 1|Protocol Violation|0|||
27667728|NCT02835092|80623421|FG002|Overall Study|Lost to Follow-up|0|||
27667729|NCT00661713|80623426|FG000|Overall Study|Death|1|||
27781736|NCT00808132|81032049|FG002|Overall Study|Protocol Violation|4|||
27970735|NCT01468207|81722891|FG003|Treatment Period 1|Protocol Violation|0|||
27970736|NCT01468207|81722892|FG004|Treatment Period 1|Protocol Violation|0|||
27667730|NCT00661713|80623427|FG001|Overall Study|Death|0|||
27667731|NCT00661713|80623428|FG002|Overall Study|Death|0|||
27970737|NCT01468207|81722893|FG005|Treatment Period 1|Protocol Violation|0|||
27970738|NCT01468207|81722888|FG000|Treatment Period 1|Withdrawal by Subject|5|||
27970739|NCT01468207|81722889|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27970740|NCT01468207|81722890|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27667732|NCT00661713|80623429|FG003|Overall Study|Death|0|||
27667733|NCT00661713|80623430|FG004|Overall Study|Death|1|||
27667734|NCT00661713|80623431|FG005|Overall Study|Death|0|||
27667735|NCT00661713|80623432|FG006|Overall Study|Death|0|||
27667736|NCT00661713|80623433|FG007|Overall Study|Death|0|||
27667737|NCT00661713|80623426|FG000|Overall Study|Unable to Classify|1|||
27667738|NCT00661713|80623427|FG001|Overall Study|Unable to Classify|0|||
27667739|NCT00661713|80623428|FG002|Overall Study|Unable to Classify|0|||
27667740|NCT00661713|80623429|FG003|Overall Study|Unable to Classify|0|||
27667741|NCT00661713|80623430|FG004|Overall Study|Unable to Classify|0|||
27667742|NCT00661713|80623431|FG005|Overall Study|Unable to Classify|0|||
27667743|NCT00661713|80623432|FG006|Overall Study|Unable to Classify|0|||
27667744|NCT00661713|80623433|FG007|Overall Study|Unable to Classify|0|||
27667745|NCT00661713|80623426|FG000|Overall Study|Protocol Violation|1|||
27667746|NCT00661713|80623427|FG001|Overall Study|Protocol Violation|6|||
27667747|NCT00661713|80623428|FG002|Overall Study|Protocol Violation|3|||
27667748|NCT00661713|80623429|FG003|Overall Study|Protocol Violation|3|||
27667749|NCT00661713|80623430|FG004|Overall Study|Protocol Violation|0|||
27667750|NCT00661713|80623431|FG005|Overall Study|Protocol Violation|2|||
27667751|NCT00661713|80623432|FG006|Overall Study|Protocol Violation|2|||
27667752|NCT00661713|80623433|FG007|Overall Study|Protocol Violation|1|||
27667753|NCT00661713|80623426|FG000|Overall Study|Withdrawal by Subject|11|||
27667754|NCT00661713|80623427|FG001|Overall Study|Withdrawal by Subject|25|||
27781737|NCT00808132|81032050|FG003|Overall Study|Protocol Violation|9|||
27970741|NCT01468207|81722891|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27970742|NCT01468207|81722892|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27970743|NCT01468207|81722893|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27970744|NCT01468207|81722888|FG000|Treatment Period 1|Lost to Follow-up|2|||
27970745|NCT01468207|81722889|FG001|Treatment Period 1|Lost to Follow-up|1|||
27970746|NCT01468207|81722890|FG002|Treatment Period 1|Lost to Follow-up|0|||
27970747|NCT01468207|81722891|FG003|Treatment Period 1|Lost to Follow-up|0|||
27970748|NCT01468207|81722892|FG004|Treatment Period 1|Lost to Follow-up|0|||
27970749|NCT01468207|81722893|FG005|Treatment Period 1|Lost to Follow-up|0|||
27970750|NCT01468207|81722888|FG000|Treatment Period 1|Other|0|||
27970751|NCT01468207|81722889|FG001|Treatment Period 1|Other|2|||
27970752|NCT01468207|81722890|FG002|Treatment Period 1|Other|0|||
27970753|NCT01468207|81722891|FG003|Treatment Period 1|Other|0|||
27970754|NCT01468207|81722892|FG004|Treatment Period 1|Other|0|||
27970755|NCT01468207|81722893|FG005|Treatment Period 1|Other|0|||
27970756|NCT01468207|81722888|FG000|Treatment Period 2|Adverse Event|0|||
27970757|NCT01468207|81722889|FG001|Treatment Period 2|Adverse Event|0|||
27970758|NCT01468207|81722890|FG002|Treatment Period 2|Adverse Event|6|||
27970759|NCT01468207|81722891|FG003|Treatment Period 2|Adverse Event|1|||
27970760|NCT01468207|81722892|FG004|Treatment Period 2|Adverse Event|2|||
27970761|NCT01468207|81722893|FG005|Treatment Period 2|Adverse Event|1|||
27970762|NCT01468207|81722888|FG000|Treatment Period 2|Lack of Efficacy|0|||
27970763|NCT01468207|81722889|FG001|Treatment Period 2|Lack of Efficacy|0|||
27970764|NCT01468207|81722890|FG002|Treatment Period 2|Lack of Efficacy|1|||
27970765|NCT01468207|81722891|FG003|Treatment Period 2|Lack of Efficacy|1|||
27970766|NCT01468207|81722892|FG004|Treatment Period 2|Lack of Efficacy|0|||
27970767|NCT01468207|81722893|FG005|Treatment Period 2|Lack of Efficacy|2|||
27970768|NCT01468207|81722888|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27970769|NCT01468207|81722889|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27970770|NCT01468207|81722890|FG002|Treatment Period 2|Withdrawal by Subject|5|||
27970771|NCT01468207|81722891|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27970772|NCT01468207|81722892|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27970773|NCT01468207|81722893|FG005|Treatment Period 2|Withdrawal by Subject|2|||
27970774|NCT01468207|81722888|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
27970775|NCT01468207|81722889|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
27970776|NCT01468207|81722890|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
27970777|NCT01468207|81722891|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
27970778|NCT01468207|81722892|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
27970779|NCT01468207|81722893|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
27970780|NCT01468207|81722888|FG000|Treatment Period 2|Lost to Follow-up|0|||
27667755|NCT00661713|80623428|FG002|Overall Study|Withdrawal by Subject|12|||
27970781|NCT01468207|81722889|FG001|Treatment Period 2|Lost to Follow-up|0|||
27667756|NCT00661713|80623429|FG003|Overall Study|Withdrawal by Subject|21|||
27667757|NCT00661713|80623430|FG004|Overall Study|Withdrawal by Subject|12|||
27667758|NCT00661713|80623431|FG005|Overall Study|Withdrawal by Subject|26|||
27970782|NCT01468207|81722890|FG002|Treatment Period 2|Lost to Follow-up|5|||
27970783|NCT01468207|81722891|FG003|Treatment Period 2|Lost to Follow-up|1|||
27970784|NCT01468207|81722892|FG004|Treatment Period 2|Lost to Follow-up|0|||
27970785|NCT01468207|81722893|FG005|Treatment Period 2|Lost to Follow-up|0|||
27970786|NCT01468207|81722888|FG000|Treatment Period 2|Other|0|||
27970787|NCT01468207|81722889|FG001|Treatment Period 2|Other|0|||
27970788|NCT01468207|81722890|FG002|Treatment Period 2|Other|5|||
27970789|NCT01468207|81722891|FG003|Treatment Period 2|Other|1|||
27970790|NCT01468207|81722892|FG004|Treatment Period 2|Other|1|||
27970791|NCT01468207|81722893|FG005|Treatment Period 2|Other|2|||
27970792|NCT05791565|81722898|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
27970793|NCT05791565|81722899|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
27970794|NCT01205061|81722902|FG000|Overall Study|Adverse Event|4|||
27970795|NCT01205061|81722902|FG000|Overall Study|Withdrawal by Subject|11|||
27970796|NCT01205061|81722902|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
27970797|NCT01205061|81722902|FG000|Overall Study|Lost to Follow-up|9|||
27970798|NCT01205061|81722902|FG000|Overall Study|Other|1|||
27970799|NCT01265563|81722903|FG000|Overall Study|Withdrawal by Subject|0|||
27970800|NCT01265563|81722904|FG001|Overall Study|Withdrawal by Subject|1|||
27970801|NCT01265563|81722905|FG002|Overall Study|Withdrawal by Subject|1|||
27970802|NCT01265563|81722906|FG003|Overall Study|Withdrawal by Subject|0|||
27970803|NCT01265563|81722907|FG004|Overall Study|Withdrawal by Subject|2|||
27970804|NCT00132691|81722912|FG000|Overall Study|Lost to Follow-up|5|||
27970805|NCT00132691|81722913|FG001|Overall Study|Lost to Follow-up|8|||
27970806|NCT00132691|81722912|FG000|Overall Study|Missed 2-year visit|4|||
27970807|NCT00132691|81722913|FG001|Overall Study|Missed 2-year visit|4|||
27970808|NCT00132691|81722912|FG000|Overall Study|Death|2|||
27970809|NCT00132691|81722913|FG001|Overall Study|Death|0|||
27970810|NCT04173260|81722915|FG000|Overall Study|Early termination|4|||
27970811|NCT02557100|81722918|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
27667759|NCT00661713|80623432|FG006|Overall Study|Withdrawal by Subject|45|||
27667760|NCT00661713|80623433|FG007|Overall Study|Withdrawal by Subject|9|||
27667761|NCT00661713|80623426|FG000|Overall Study|Lost to Follow-up|2|||
27667762|NCT00661713|80623427|FG001|Overall Study|Lost to Follow-up|7|||
27667763|NCT00661713|80623428|FG002|Overall Study|Lost to Follow-up|2|||
27667764|NCT00661713|80623429|FG003|Overall Study|Lost to Follow-up|2|||
27667765|NCT00661713|80623430|FG004|Overall Study|Lost to Follow-up|5|||
27667766|NCT00661713|80623431|FG005|Overall Study|Lost to Follow-up|7|||
27667767|NCT00661713|80623432|FG006|Overall Study|Lost to Follow-up|14|||
27667768|NCT00661713|80623433|FG007|Overall Study|Lost to Follow-up|1|||
27667769|NCT00661713|80623426|FG000|Overall Study|Administrative Reason|0|||
27667770|NCT00661713|80623427|FG001|Overall Study|Administrative Reason|1|||
27667771|NCT00661713|80623428|FG002|Overall Study|Administrative Reason|0|||
27667772|NCT00661713|80623429|FG003|Overall Study|Administrative Reason|2|||
27667773|NCT00661713|80623430|FG004|Overall Study|Administrative Reason|2|||
27667774|NCT00661713|80623431|FG005|Overall Study|Administrative Reason|2|||
27667775|NCT00661713|80623432|FG006|Overall Study|Administrative Reason|1|||
27667776|NCT00661713|80623433|FG007|Overall Study|Administrative Reason|0|||
27667777|NCT00661713|80623426|FG000|Overall Study|Adverse Event|0|||
27667778|NCT00661713|80623427|FG001|Overall Study|Adverse Event|0|||
27667779|NCT00661713|80623428|FG002|Overall Study|Adverse Event|0|||
27781738|NCT00808132|81032051|FG004|Overall Study|Protocol Violation|5|||
27781739|NCT00808132|81032047|FG000|Overall Study|Withdrawal by Subject|27|||
27571064|NCT00378703|80275389|FG001|Overall Study|Surgery|0|||
27781740|NCT00808132|81032048|FG001|Overall Study|Withdrawal by Subject|18|||
27781741|NCT00808132|81032049|FG002|Overall Study|Withdrawal by Subject|2|||
27970812|NCT02557100|81722919|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
27571065|NCT00378703|80275390|FG002|Overall Study|Surgery|0|||
27571066|NCT00378703|80275391|FG003|Overall Study|Surgery|1|||
27667780|NCT00661713|80623429|FG003|Overall Study|Adverse Event|0|||
27667781|NCT00661713|80623430|FG004|Overall Study|Adverse Event|0|||
27667782|NCT00661713|80623431|FG005|Overall Study|Adverse Event|0|||
27667783|NCT00661713|80623432|FG006|Overall Study|Adverse Event|1|||
27667784|NCT00661713|80623433|FG007|Overall Study|Adverse Event|0|||
27667785|NCT00661713|80623426|FG000|Overall Study|Inappropriate Enrollment|0|||
27667786|NCT00661713|80623427|FG001|Overall Study|Inappropriate Enrollment|0|||
27781742|NCT00808132|81032050|FG003|Overall Study|Withdrawal by Subject|7|||
27970813|NCT02557100|81722920|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
27667787|NCT00661713|80623428|FG002|Overall Study|Inappropriate Enrollment|0|||
27667788|NCT00661713|80623429|FG003|Overall Study|Inappropriate Enrollment|0|||
27667789|NCT00661713|80623430|FG004|Overall Study|Inappropriate Enrollment|0|||
27667790|NCT00661713|80623431|FG005|Overall Study|Inappropriate Enrollment|0|||
27667791|NCT00661713|80623432|FG006|Overall Study|Inappropriate Enrollment|1|||
27667792|NCT00661713|80623433|FG007|Overall Study|Inappropriate Enrollment|0|||
27667793|NCT03458728|80623434|FG000|Overall Study|Adverse Event|1|||
27667794|NCT03458728|80623435|FG001|Overall Study|Adverse Event|0|||
27667795|NCT03458728|80623434|FG000|Overall Study|Physician Decision|1|||
27667796|NCT03458728|80623435|FG001|Overall Study|Physician Decision|0|||
27667797|NCT03458728|80623434|FG000|Overall Study|Progressive disease - clinical assessment|1|||
27667798|NCT03458728|80623435|FG001|Overall Study|Progressive disease - clinical assessment|0|||
27667799|NCT03458728|80623434|FG000|Overall Study|Progressive disease - radiological progression|21|||
27667800|NCT03458728|80623435|FG001|Overall Study|Progressive disease - radiological progression|6|||
27667801|NCT03458728|80623434|FG000|Overall Study|Withdrawal by Subject|0|||
27667802|NCT03458728|80623435|FG001|Overall Study|Withdrawal by Subject|1|||
27667803|NCT00951171|80623440|FG000|Overall Study|Adverse Event|2|||
27667804|NCT00951171|80623441|FG001|Overall Study|Adverse Event|0|||
27667805|NCT02196077|80623447|FG000|Overall Study|Adverse Event|4|||
27667806|NCT02196077|80623447|FG000|Overall Study|Lack of Efficacy|1|||
27667807|NCT02196077|80623447|FG000|Overall Study|Withdrawal by Subject|14|||
27667808|NCT02196077|80623447|FG000|Overall Study|Physician Decision|1|||
27667809|NCT02196077|80623447|FG000|Overall Study|Lost to Follow-up|3|||
27667810|NCT02196077|80623447|FG000|Overall Study|Protocol Violation|24|||
27667811|NCT00469859|80623452|FG000|Overall Study|Inevaluable|0|||
27667812|NCT00469859|80623453|FG001|Overall Study|Inevaluable|2|||
27667813|NCT00585975|80623454|FG000|Overall Study|Withdrawal by Subject|3|||
27667814|NCT00585975|80623455|FG001|Overall Study|Withdrawal by Subject|3|||
27667815|NCT00585975|80623454|FG000|Overall Study|Lost to Follow-up|2|||
27667816|NCT00585975|80623455|FG001|Overall Study|Lost to Follow-up|1|||
27667817|NCT00585975|80623454|FG000|Overall Study|Enrollment met/over-enrolled|10|||
27667818|NCT00585975|80623455|FG001|Overall Study|Enrollment met/over-enrolled|9|||
27667819|NCT00604188|80623456|FG000|Overall Study|Adverse Event|1|||
27667820|NCT00604188|80623457|FG001|Overall Study|Adverse Event|4|||
27667821|NCT00604188|80623456|FG000|Overall Study|Lost to Follow-up|17|||
27667822|NCT00604188|80623457|FG001|Overall Study|Lost to Follow-up|15|||
27667823|NCT00604188|80623456|FG000|Overall Study|Withdrawal by Subject|5|||
27667824|NCT00604188|80623457|FG001|Overall Study|Withdrawal by Subject|1|||
27667825|NCT00604188|80623456|FG000|Overall Study|Non-compliance with protocol|4|||
27667826|NCT00604188|80623457|FG001|Overall Study|Non-compliance with protocol|4|||
27667827|NCT00604188|80623456|FG000|Overall Study|Did not receive study drug|0|||
27667828|NCT00604188|80623457|FG001|Overall Study|Did not receive study drug|1|||
27667829|NCT01231464|80623458|FG000|Overall Study|Adverse Event|0|||
27667830|NCT01231464|80623459|FG001|Overall Study|Adverse Event|1|||
27667831|NCT01231464|80623458|FG000|Overall Study|Protocol Violation|1|||
27667832|NCT01231464|80623459|FG001|Overall Study|Protocol Violation|2|||
27667833|NCT01231464|80623458|FG000|Overall Study|Lost to Follow-up|1|||
27667834|NCT01231464|80623459|FG001|Overall Study|Lost to Follow-up|2|||
27667835|NCT01231464|80623458|FG000|Overall Study|Withdrawal by Subject|3|||
27667836|NCT01231464|80623459|FG001|Overall Study|Withdrawal by Subject|2|||
27667837|NCT02561078|80623460|FG000|Overall Study|Adverse Event|5|||
27667838|NCT02561078|80623461|FG001|Overall Study|Adverse Event|2|||
27667839|NCT02561078|80623460|FG000|Overall Study|Death|2|||
27667840|NCT02561078|80623461|FG001|Overall Study|Death|1|||
27667841|NCT02561078|80623460|FG000|Overall Study|Lost to Follow-up|2|||
27667842|NCT02561078|80623461|FG001|Overall Study|Lost to Follow-up|6|||
27667843|NCT02561078|80623460|FG000|Overall Study|Non-Compliance with Study Drug|6|||
27667844|NCT02561078|80623461|FG001|Overall Study|Non-Compliance with Study Drug|3|||
27667845|NCT02561078|80623460|FG000|Overall Study|Physician Decision|2|||
27667846|NCT02561078|80623461|FG001|Overall Study|Physician Decision|3|||
27667847|NCT02561078|80623460|FG000|Overall Study|Withdrawal by Subject|13|||
27667848|NCT02561078|80623461|FG001|Overall Study|Withdrawal by Subject|10|||
27667849|NCT04706793|80623462|FG000|Treatment|Disease worsening|10|||
27667850|NCT04706793|80623463|FG001|Treatment|Disease worsening|10|||
27571067|NCT00378703|80275388|FG000|Overall Study|Joint decision of physician and patient|1|||
27667851|NCT04706793|80623462|FG000|Follow-up|Lack of Efficacy|1|||
27667852|NCT04706793|80623463|FG001|Follow-up|Lack of Efficacy|0|||
27667853|NCT04706793|80623462|FG000|Follow-up|Disease worsening|8|||
27667854|NCT04706793|80623463|FG001|Follow-up|Disease worsening|10|||
27667855|NCT04706793|80623462|FG000|Follow-up|Adverse Event|1|||
27667856|NCT04706793|80623463|FG001|Follow-up|Adverse Event|0|||
27667857|NCT03845023|80623464|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
27667858|NCT03845023|80623465|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
27667859|NCT03845023|80623466|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
27667860|NCT03845023|80623467|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
27667861|NCT03845023|80623464|FG000|Follow-Up (14 Days)|Adverse Event|0|||
27667862|NCT03845023|80623465|FG001|Follow-Up (14 Days)|Adverse Event|0|||
27667863|NCT03845023|80623466|FG002|Follow-Up (14 Days)|Adverse Event|1|||
27667864|NCT03845023|80623467|FG003|Follow-Up (14 Days)|Adverse Event|1|||
27667865|NCT04696146|80623468|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
27667866|NCT04696146|80623469|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
27667867|NCT04696146|80623468|FG000|Overall Study|Off hours issue with product|1|||
27667868|NCT04696146|80623469|FG001|Overall Study|Off hours issue with product|0|||
27667869|NCT01268098|80623470|FG000|Overall Study|Adverse Event|1|||
27667870|NCT01268098|80623471|FG001|Overall Study|Adverse Event|0|||
27781743|NCT00808132|81032051|FG004|Overall Study|Withdrawal by Subject|16|||
27781744|NCT00808132|81032047|FG000|Overall Study|Other|6|||
27864356|NCT01111825|81337067|FG001|Overall Study|Discontinuation by Sponsor|0|||
27864357|NCT01111825|81337068|FG002|Overall Study|Discontinuation by Sponsor|0|||
27781745|NCT00808132|81032048|FG001|Overall Study|Other|4|||
27781746|NCT00808132|81032049|FG002|Overall Study|Other|6|||
27781747|NCT00808132|81032050|FG003|Overall Study|Other|2|||
27781748|NCT00808132|81032051|FG004|Overall Study|Other|15|||
27781749|NCT00808132|81032047|FG000|Overall Study|Randomized, but not treated|10|||
27781750|NCT00808132|81032048|FG001|Overall Study|Randomized, but not treated|7|||
27781751|NCT00808132|81032049|FG002|Overall Study|Randomized, but not treated|9|||
27781752|NCT00808132|81032050|FG003|Overall Study|Randomized, but not treated|8|||
27781753|NCT00808132|81032051|FG004|Overall Study|Randomized, but not treated|9|||
27781754|NCT00808132|81032047|FG000|Overall Study|Unsatisfactory response|5|||
27781755|NCT00808132|81032048|FG001|Overall Study|Unsatisfactory response|6|||
27781756|NCT00808132|81032049|FG002|Overall Study|Unsatisfactory response|6|||
27781757|NCT00808132|81032050|FG003|Overall Study|Unsatisfactory response|4|||
27781758|NCT00808132|81032051|FG004|Overall Study|Unsatisfactory response|12|||
27781759|NCT02612194|81032057|FG000|Overall Study|Death|5|||
27781760|NCT02612194|81032058|FG001|Overall Study|Death|0|||
27781761|NCT02612194|81032059|FG002|Overall Study|Death|2|||
27781762|NCT02612194|81032057|FG000|Overall Study|Early Study Termination|1|||
27781763|NCT02612194|81032058|FG001|Overall Study|Early Study Termination|0|||
27781764|NCT02612194|81032059|FG002|Overall Study|Early Study Termination|0|||
27781765|NCT02059174|81032060|FG000|Period 1|Withdrawal by Subject|0|||
27781766|NCT02059174|81032061|FG001|Period 1|Withdrawal by Subject|2|||
27781767|NCT02059174|81032060|FG000|Period 2|Withdrawal by Subject|0|||
27864358|NCT01111825|81337069|FG003|Overall Study|Discontinuation by Sponsor|20|||
27864359|NCT00281957|81337072|FG000|Overall Study|Adverse Event|7|||
27864360|NCT00281957|81337073|FG001|Overall Study|Adverse Event|2|||
27864361|NCT00281957|81337072|FG000|Overall Study|Death|1|||
27864362|NCT00281957|81337073|FG001|Overall Study|Death|0|||
27864363|NCT00281957|81337072|FG000|Overall Study|Progression/relapse|47|||
27864364|NCT00281957|81337073|FG001|Overall Study|Progression/relapse|35|||
27864365|NCT00281957|81337072|FG000|Overall Study|Not protocol specified|8|||
27864366|NCT00281957|81337073|FG001|Overall Study|Not protocol specified|1|||
27864367|NCT00281957|81337072|FG000|Overall Study|Not eligible|1|||
27864368|NCT00281957|81337073|FG001|Overall Study|Not eligible|2|||
27864369|NCT00281957|81337072|FG000|Overall Study|Did not start treatment|3|||
27781768|NCT02059174|81032061|FG001|Period 2|Withdrawal by Subject|2|||
27781769|NCT02059174|81032060|FG000|Period 2|Protocol Violation|1|||
27781770|NCT02059174|81032061|FG001|Period 2|Protocol Violation|0|||
27864370|NCT00281957|81337073|FG001|Overall Study|Did not start treatment|1|||
27864371|NCT00281957|81337072|FG000|Overall Study|Refusal unrelated to adverse events|0|||
27864372|NCT00281957|81337073|FG001|Overall Study|Refusal unrelated to adverse events|1|||
27864373|NCT03247816|81337082|FG000|Overall Study|Adverse Event|12|||
27864374|NCT03247816|81337082|FG000|Overall Study|Physician Decision|3|||
27864375|NCT03247816|81337082|FG000|Overall Study|Lack of Efficacy|1|||
27864376|NCT03247816|81337082|FG000|Overall Study|Lost to Follow-up|10|||
27864377|NCT03247816|81337082|FG000|Overall Study|Missing Feraccru stop date|3|||
27864378|NCT00810511|81337083|FG000|Overall Study|Protocol Violation|0|||
27864379|NCT00810511|81337084|FG001|Overall Study|Protocol Violation|1|||
27864380|NCT00810511|81337083|FG000|Overall Study|Lack of Efficacy|9|||
27864381|NCT00810511|81337084|FG001|Overall Study|Lack of Efficacy|1|||
27864382|NCT00810511|81337083|FG000|Overall Study|death in the family|0|||
27864383|NCT00810511|81337084|FG001|Overall Study|death in the family|1|||
27864384|NCT00810511|81337083|FG000|Overall Study|Lost to Follow-up|1|||
27864385|NCT00810511|81337084|FG001|Overall Study|Lost to Follow-up|0|||
27970814|NCT02557100|81722918|FG000|Single Blind Treatment Period|Death|0|||
27781771|NCT02059174|81032060|FG000|Period 3|Physician Decision|1|||
27781772|NCT02059174|81032061|FG001|Period 3|Physician Decision|0|||
27781773|NCT02807376|81032062|FG000|Overall Study|Intra-operative exclusion criteria|3|||
27781774|NCT02807376|81032063|FG001|Overall Study|Intra-operative exclusion criteria|0|||
27781775|NCT02807376|81032062|FG000|Overall Study|Lost to Follow-up|0|||
27781776|NCT02807376|81032063|FG001|Overall Study|Lost to Follow-up|1|||
27781777|NCT01266876|81032066|FG000|Overall Study|Adverse Event|0|||
27864386|NCT00810511|81337083|FG000|Overall Study|deposits on contact lens|0|||
27864387|NCT00810511|81337084|FG001|Overall Study|deposits on contact lens|1|||
27864388|NCT05794503|81337086|FG000|Overall Study|Operation Cancelled|2|||
27864389|NCT05794503|81337087|FG001|Overall Study|Operation Cancelled|0|||
27864390|NCT05794503|81337086|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
27864391|NCT05794503|81337087|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
27864392|NCT05794503|81337086|FG000|Overall Study|Protocol Violation|1|||
27864393|NCT05794503|81337087|FG001|Overall Study|Protocol Violation|0|||
27864394|NCT01908907|81337091|FG000|Overall Study|Physician Decision|1|||
27864395|NCT01908907|81337092|FG001|Overall Study|Physician Decision|0|||
27864396|NCT01908907|81337091|FG000|Overall Study|Protocol Violation|1|||
27864397|NCT01908907|81337092|FG001|Overall Study|Protocol Violation|0|||
27864398|NCT01338870|81337093|FG000|Overall Study|Lost to Follow-up|0|||
27864399|NCT01338870|81337094|FG001|Overall Study|Lost to Follow-up|0|||
27864400|NCT01338870|81337095|FG002|Overall Study|Lost to Follow-up|1|||
27864401|NCT01338870|81337096|FG003|Overall Study|Lost to Follow-up|0|||
27864402|NCT01338870|81337097|FG004|Overall Study|Lost to Follow-up|1|||
27864403|NCT01338870|81337098|FG005|Overall Study|Lost to Follow-up|0|||
27864404|NCT01338870|81337093|FG000|Overall Study|Withdrawal by Subject|2|||
27864405|NCT01338870|81337094|FG001|Overall Study|Withdrawal by Subject|3|||
27864406|NCT01338870|81337095|FG002|Overall Study|Withdrawal by Subject|4|||
27864407|NCT01338870|81337096|FG003|Overall Study|Withdrawal by Subject|0|||
27864408|NCT01338870|81337097|FG004|Overall Study|Withdrawal by Subject|0|||
27864409|NCT01338870|81337098|FG005|Overall Study|Withdrawal by Subject|2|||
27864410|NCT01338870|81337093|FG000|Overall Study|Other|3|||
27864411|NCT01338870|81337094|FG001|Overall Study|Other|3|||
27864412|NCT01338870|81337095|FG002|Overall Study|Other|3|||
27864413|NCT01338870|81337096|FG003|Overall Study|Other|2|||
27864414|NCT01338870|81337097|FG004|Overall Study|Other|0|||
27864415|NCT01338870|81337098|FG005|Overall Study|Other|2|||
27864416|NCT01338870|81337093|FG000|Overall Study|Protocol Violation|0|||
27864417|NCT01338870|81337094|FG001|Overall Study|Protocol Violation|2|||
27864418|NCT01338870|81337095|FG002|Overall Study|Protocol Violation|2|||
27864419|NCT01338870|81337096|FG003|Overall Study|Protocol Violation|2|||
27864420|NCT01338870|81337097|FG004|Overall Study|Protocol Violation|1|||
27864421|NCT01338870|81337098|FG005|Overall Study|Protocol Violation|1|||
27864422|NCT01338870|81337093|FG000|Overall Study|Adverse Event|4|||
27864423|NCT01338870|81337094|FG001|Overall Study|Adverse Event|4|||
27864424|NCT01338870|81337095|FG002|Overall Study|Adverse Event|1|||
27864425|NCT01338870|81337096|FG003|Overall Study|Adverse Event|5|||
27864426|NCT01338870|81337097|FG004|Overall Study|Adverse Event|4|||
27864427|NCT01338870|81337098|FG005|Overall Study|Adverse Event|1|||
27864428|NCT00863772|81337101|FG000|Overall Study|Adverse Event|1|||
27864429|NCT00863772|81337102|FG001|Overall Study|Adverse Event|4|||
27864430|NCT00863772|81337103|FG002|Overall Study|Adverse Event|0|||
27864431|NCT00863772|81337101|FG000|Overall Study|Lack of Efficacy|4|||
27864432|NCT00863772|81337102|FG001|Overall Study|Lack of Efficacy|2|||
27864433|NCT00863772|81337103|FG002|Overall Study|Lack of Efficacy|4|||
27864434|NCT00863772|81337101|FG000|Overall Study|Lost to Follow-up|5|||
27864435|NCT00863772|81337102|FG001|Overall Study|Lost to Follow-up|1|||
27864436|NCT00863772|81337103|FG002|Overall Study|Lost to Follow-up|1|||
27864437|NCT00863772|81337101|FG000|Overall Study|Protocol Violation|2|||
27864438|NCT00863772|81337102|FG001|Overall Study|Protocol Violation|0|||
27864439|NCT00863772|81337103|FG002|Overall Study|Protocol Violation|2|||
27864440|NCT00863772|81337101|FG000|Overall Study|Withdrawal by Subject|4|||
27864441|NCT00863772|81337102|FG001|Overall Study|Withdrawal by Subject|7|||
27864442|NCT00863772|81337103|FG002|Overall Study|Withdrawal by Subject|5|||
27864443|NCT00863772|81337101|FG000|Overall Study|Study terminated by sponsor|44|||
27864444|NCT00863772|81337102|FG001|Overall Study|Study terminated by sponsor|45|||
27864445|NCT00863772|81337103|FG002|Overall Study|Study terminated by sponsor|36|||
27864446|NCT00863772|81337101|FG000|Overall Study|Entered extension study|6|||
27864447|NCT00863772|81337102|FG001|Overall Study|Entered extension study|4|||
27864448|NCT00863772|81337103|FG002|Overall Study|Entered extension study|9|||
27864449|NCT00863772|81337101|FG000|Overall Study|Other|1|||
27864450|NCT00863772|81337102|FG001|Overall Study|Other|2|||
27864451|NCT00863772|81337103|FG002|Overall Study|Other|4|||
27864452|NCT00863772|81337101|FG000|Overall Study|Randomized but not Treated|1|||
27864453|NCT00863772|81337102|FG001|Overall Study|Randomized but not Treated|0|||
27864454|NCT00863772|81337103|FG002|Overall Study|Randomized but not Treated|0|||
27864455|NCT02047734|81337104|FG000|Overall Study|Adverse Event|18|||
27864456|NCT02047734|81337105|FG001|Overall Study|Adverse Event|13|||
27864457|NCT02047734|81337106|FG002|Overall Study|Adverse Event|13|||
27864458|NCT02047734|81337104|FG000|Overall Study|Lack of Efficacy|4|||
27864459|NCT02047734|81337105|FG001|Overall Study|Lack of Efficacy|5|||
27864460|NCT02047734|81337106|FG002|Overall Study|Lack of Efficacy|1|||
27864461|NCT02047734|81337104|FG000|Overall Study|Protocol Violation|3|||
27864462|NCT02047734|81337105|FG001|Overall Study|Protocol Violation|1|||
27864463|NCT02047734|81337106|FG002|Overall Study|Protocol Violation|1|||
27864464|NCT02047734|81337104|FG000|Overall Study|Lost to Follow-up|1|||
27864465|NCT02047734|81337105|FG001|Overall Study|Lost to Follow-up|4|||
27864466|NCT02047734|81337106|FG002|Overall Study|Lost to Follow-up|0|||
27864467|NCT02047734|81337104|FG000|Overall Study|Death|0|||
27864468|NCT02047734|81337105|FG001|Overall Study|Death|1|||
27864469|NCT02047734|81337106|FG002|Overall Study|Death|0|||
27864470|NCT02047734|81337104|FG000|Overall Study|Withdrawal by Subject|30|||
27864471|NCT02047734|81337105|FG001|Overall Study|Withdrawal by Subject|31|||
27864472|NCT02047734|81337106|FG002|Overall Study|Withdrawal by Subject|19|||
27864473|NCT02047734|81337104|FG000|Overall Study|Physician Decision|7|||
27864474|NCT02047734|81337105|FG001|Overall Study|Physician Decision|6|||
27864475|NCT02047734|81337106|FG002|Overall Study|Physician Decision|5|||
27864476|NCT02047734|81337104|FG000|Overall Study|Miscellaneous|2|||
27864477|NCT02047734|81337105|FG001|Overall Study|Miscellaneous|4|||
27864478|NCT02047734|81337106|FG002|Overall Study|Miscellaneous|6|||
27864479|NCT02047734|81337104|FG000|Overall Study|Did Not Receive Study Drug|2|||
27864480|NCT02047734|81337105|FG001|Overall Study|Did Not Receive Study Drug|4|||
27864481|NCT02047734|81337106|FG002|Overall Study|Did Not Receive Study Drug|1|||
27864482|NCT00396565|81337107|FG000|Overall Study|Physician Decision|3|||
27864483|NCT00396565|81337108|FG001|Overall Study|Physician Decision|1|||
27864484|NCT00396565|81337109|FG002|Overall Study|Physician Decision|2|||
27864485|NCT00396565|81337107|FG000|Overall Study|Adverse Event|5|||
27864486|NCT00396565|81337108|FG001|Overall Study|Adverse Event|13|||
27864487|NCT00396565|81337109|FG002|Overall Study|Adverse Event|3|||
27864488|NCT00396565|81337107|FG000|Overall Study|Withdrawal by Subject|8|||
27864489|NCT00396565|81337108|FG001|Overall Study|Withdrawal by Subject|13|||
27864490|NCT00396565|81337109|FG002|Overall Study|Withdrawal by Subject|1|||
27864491|NCT00396565|81337107|FG000|Overall Study|Lack of Efficacy|32|||
27864492|NCT00396565|81337108|FG001|Overall Study|Lack of Efficacy|64|||
27864493|NCT00396565|81337109|FG002|Overall Study|Lack of Efficacy|11|||
27864494|NCT00796107|81337112|FG000|Overall Study|Lack of Efficacy|1|||
27864495|NCT00796107|81337112|FG000|Overall Study|Progressive Disease|5|||
27864496|NCT02859142|81337118|FG000|Overall Study|Adverse Event|1|||
27864497|NCT02859142|81337119|FG001|Overall Study|Adverse Event|2|||
27864498|NCT02859142|81337118|FG000|Overall Study|Lost to Follow-up|1|||
27864499|NCT02859142|81337119|FG001|Overall Study|Lost to Follow-up|4|||
27864500|NCT02859142|81337118|FG000|Overall Study|Withdrawal by Subject|2|||
27864501|NCT02859142|81337119|FG001|Overall Study|Withdrawal by Subject|0|||
27571068|NCT00378703|80275389|FG001|Overall Study|Joint decision of physician and patient|0|||
27571069|NCT00378703|80275390|FG002|Overall Study|Joint decision of physician and patient|0|||
27571070|NCT00378703|80275391|FG003|Overall Study|Joint decision of physician and patient|0|||
27781778|NCT01266876|81032067|FG001|Overall Study|Adverse Event|0|||
27781779|NCT01266876|81032068|FG002|Overall Study|Adverse Event|0|||
27781780|NCT01266876|81032069|FG003|Overall Study|Adverse Event|1|||
27781781|NCT01266876|81032070|FG004|Overall Study|Adverse Event|0|||
27781782|NCT05060003|81032077|FG000|Overall Study|ctDNA negative|7|||
27781783|NCT02993731|81032081|FG000|Overall Study|Study Termination|101|||
27781784|NCT02993731|81032082|FG001|Overall Study|Study Termination|105|||
27781785|NCT00760994|81032083|FG000|Overall Study|Lost to Follow-up|4|||
27781786|NCT00760994|81032084|FG001|Overall Study|Lost to Follow-up|4|||
27781787|NCT00760994|81032085|FG002|Overall Study|Lost to Follow-up|3|||
27781788|NCT02475564|81032089|FG000|Overall Study|Withdrawal by Subject|1|||
27781789|NCT02475564|81032090|FG001|Overall Study|Withdrawal by Subject|0|||
27781790|NCT02475564|81032089|FG000|Overall Study|Lost to Follow-up|2|||
27781791|NCT02475564|81032090|FG001|Overall Study|Lost to Follow-up|1|||
27781792|NCT02475564|81032089|FG000|Overall Study|Intense Menstrual bleeding|1|||
27781793|NCT02475564|81032090|FG001|Overall Study|Intense Menstrual bleeding|0|||
27781794|NCT01990339|81032091|FG000|Overall Study|Data Not Available|49|||
27781795|NCT01990339|81032091|FG000|Overall Study|Voluntary Withdrawal|1402|||
27781796|NCT01990339|81032091|FG000|Overall Study|Lost to Follow-up|861|||
27781797|NCT01853397|81032092|FG000|Overall Study|Withdrawal by Subject|0|||
27781798|NCT01853397|81032093|FG001|Overall Study|Withdrawal by Subject|0|||
27781799|NCT01853397|81032094|FG002|Overall Study|Withdrawal by Subject|0|||
27781800|NCT01853397|81032095|FG003|Overall Study|Withdrawal by Subject|1|||
27781801|NCT01853397|81032092|FG000|Overall Study|Subject Noncompliance|0|||
27781802|NCT01853397|81032093|FG001|Overall Study|Subject Noncompliance|0|||
27781803|NCT01853397|81032094|FG002|Overall Study|Subject Noncompliance|0|||
27781804|NCT01853397|81032095|FG003|Overall Study|Subject Noncompliance|1|||
27864502|NCT02859142|81337118|FG000|Overall Study|Scheduling difficulties|0|||
27864503|NCT02859142|81337119|FG001|Overall Study|Scheduling difficulties|3|||
27864504|NCT04602546|81337120|FG000|Overall Study|Training|2|||
27864505|NCT04602546|81337121|FG001|Overall Study|Training|2|||
27864506|NCT04602546|81337122|FG002|Overall Study|Training|1|||
27864507|NCT04602546|81337123|FG003|Overall Study|Training|2|||
27781805|NCT02561273|81032096|FG000|Overall Study|Protocol Violation|1|||
27781806|NCT02561273|81032097|FG001|Overall Study|Protocol Violation|0|||
27781807|NCT00967343|81032099|FG000|Overall Study|Study termination by sponsor|12|||
27781808|NCT00967343|81032099|FG000|Overall Study|Death|24|||
27781809|NCT00967343|81032099|FG000|Overall Study|Relapse|1|||
27781810|NCT00967343|81032099|FG000|Overall Study|Lost to Follow-up|1|||
27864508|NCT04602546|81337124|FG004|Overall Study|Training|0|||
27864509|NCT04602546|81337120|FG000|Overall Study|Randomized with disqualified data|2|||
27864510|NCT04602546|81337121|FG001|Overall Study|Randomized with disqualified data|0|||
27864511|NCT04602546|81337122|FG002|Overall Study|Randomized with disqualified data|2|||
27781811|NCT03969589|81032108|FG000|Overall Study|Lost to Follow-up|3|||
27571071|NCT00378703|80275388|FG000|Overall Study|Adverse events and progressive disease|0|||
27781812|NCT03969589|81032109|FG001|Overall Study|Lost to Follow-up|2|||
27781813|NCT03969589|81032108|FG000|Overall Study|Declined Follow-Up|0|||
27781814|NCT03969589|81032109|FG001|Overall Study|Declined Follow-Up|1|||
27781815|NCT04369742|81032110|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
27781816|NCT04369742|81032111|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
27781817|NCT04369742|81032110|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
27970815|NCT02557100|81722919|FG001|Single Blind Treatment Period|Death|1|||
27667871|NCT00488319|80623472|FG000|Overall Study|Adverse Event|1|||
27781818|NCT04369742|81032111|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
27781819|NCT00702949|81032112|FG000|Overall Study|Refusal|3|||
27781820|NCT00702949|81032113|FG001|Overall Study|Refusal|2|||
27781821|NCT00702949|81032114|FG002|Overall Study|Refusal|2|||
27781822|NCT00702949|81032112|FG000|Overall Study|Adverse Event|1|||
27781823|NCT00702949|81032113|FG001|Overall Study|Adverse Event|6|||
27781824|NCT00702949|81032114|FG002|Overall Study|Adverse Event|3|||
27781825|NCT00702949|81032112|FG000|Overall Study|Other Medical Reason/unknown|1|||
27781826|NCT00702949|81032113|FG001|Overall Study|Other Medical Reason/unknown|1|||
27781827|NCT00702949|81032114|FG002|Overall Study|Other Medical Reason/unknown|3|||
27781828|NCT01284127|81032118|FG000|Overall Study|Adverse Event|2|||
27781829|NCT01284127|81032118|FG000|Overall Study|Withdrawal by Subject|4|||
27781830|NCT01284127|81032118|FG000|Overall Study|Physician Decision|1|||
27781831|NCT03432819|81032132|FG000|Overall Study|Lost to Follow-up|2|||
27781832|NCT03432819|81032133|FG001|Overall Study|Lost to Follow-up|2|||
27864512|NCT04602546|81337123|FG003|Overall Study|Randomized with disqualified data|5|||
27864513|NCT04602546|81337124|FG004|Overall Study|Randomized with disqualified data|3|||
27864514|NCT00338728|81337125|FG000|Overall Study|Screen Failure|14|||
27864515|NCT00735397|81337134|FG000|Overall Study|Adverse Event|194|||
27864516|NCT00735397|81337134|FG000|Overall Study|Lost to Follow-up|33|||
27864517|NCT00735397|81337134|FG000|Overall Study|Participant choice|252|||
27864518|NCT00735397|81337134|FG000|Overall Study|Inadequate therapeutic effect|202|||
27864519|NCT00735397|81337134|FG000|Overall Study|Administrative/Other|502|||
27864520|NCT02068092|81337137|FG000|Overall Study|Physician Decision|2|||
27864521|NCT02068092|81337137|FG000|Overall Study|Adverse Event|2|||
27864522|NCT02068092|81337137|FG000|Overall Study|Lost to Follow-up|4|||
27864523|NCT02068092|81337137|FG000|Overall Study|Withdrawal by Subject|2|||
27864524|NCT00554190|81337144|FG000|Overall Study|Termination forms not completed|10|||
27864525|NCT01128179|81337145|FG000|Overall Study|Death|1|||
27864526|NCT01128179|81337146|FG001|Overall Study|Death|0|||
27864527|NCT01128179|81337145|FG000|Overall Study|Protocol Violation|1|||
27864528|NCT01128179|81337146|FG001|Overall Study|Protocol Violation|0|||
27970816|NCT02557100|81722920|FG002|Single Blind Treatment Period|Death|0|||
27970817|NCT02557100|81722918|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
27970818|NCT02557100|81722919|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
27970819|NCT02557100|81722920|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
27970820|NCT02557100|81722918|FG000|Single Blind Treatment Period|Adverse Event|0|||
27970821|NCT02557100|81722919|FG001|Single Blind Treatment Period|Adverse Event|1|||
27970822|NCT02557100|81722920|FG002|Single Blind Treatment Period|Adverse Event|0|||
27970823|NCT02557100|81722918|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
27970824|NCT02557100|81722919|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
27970825|NCT02557100|81722920|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
27970826|NCT02557100|81722918|FG000|Cumulative Abatacept Period|Other Reasons|0|||
27970827|NCT02557100|81722919|FG001|Cumulative Abatacept Period|Other Reasons|0|||
27970828|NCT02557100|81722920|FG002|Cumulative Abatacept Period|Other Reasons|1|||
27970829|NCT02557100|81722918|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
27970830|NCT02557100|81722919|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
27970831|NCT02557100|81722920|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
27970832|NCT02557100|81722918|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
27970833|NCT02557100|81722919|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
27970834|NCT02557100|81722920|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
27970835|NCT02566785|81722923|FG000|Overall Study|Lost to Follow-up|0|||
27970836|NCT02566785|81722924|FG001|Overall Study|Lost to Follow-up|2|||
27970837|NCT02566785|81722923|FG000|Overall Study|Worsening condition|1|||
27970838|NCT02566785|81722924|FG001|Overall Study|Worsening condition|1|||
27781833|NCT03432819|81032132|FG000|Overall Study|Withdrawal by Subject|5|||
27781834|NCT03432819|81032133|FG001|Overall Study|Withdrawal by Subject|3|||
27781835|NCT00962780|81032134|FG000|Overall Study|Death|0|||
27864529|NCT02766283|81337149|FG000|Overall Study|Lost to Follow-up|27|||
27864530|NCT01141205|81337152|FG000|Overall Study|Physician Decision|1|||
27864531|NCT01141205|81337153|FG001|Overall Study|Physician Decision|1|||
27864532|NCT01141205|81337152|FG000|Overall Study|Lost to Follow-up|1|||
27864533|NCT01141205|81337153|FG001|Overall Study|Lost to Follow-up|0|||
27781836|NCT00962780|81032135|FG001|Overall Study|Death|1|||
27781837|NCT00962780|81032134|FG000|Overall Study|Protocol Violation|9|||
27781838|NCT00962780|81032135|FG001|Overall Study|Protocol Violation|4|||
27864534|NCT01141205|81337152|FG000|Overall Study|Withdrawal by Subject|1|||
27864535|NCT01141205|81337153|FG001|Overall Study|Withdrawal by Subject|1|||
27781839|NCT00962780|81032134|FG000|Overall Study|Withdrawal by Subject|1|||
27864536|NCT00459043|81337154|FG000|Overall Study|Withdrawal by Subject|1|||
27864537|NCT00459043|81337155|FG001|Overall Study|Withdrawal by Subject|0|||
27864538|NCT01332292|81337158|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27864539|NCT01332292|81337159|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27864540|NCT01332292|81337158|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27864541|NCT01332292|81337159|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27864542|NCT01332292|81337158|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
27864543|NCT01332292|81337159|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
27864544|NCT03696953|81337170|FG000|Overall Study|Withdrawal by Subject|6|||
27864545|NCT03696953|81337171|FG001|Overall Study|Withdrawal by Subject|1|||
27864546|NCT03696953|81337170|FG000|Overall Study|missed GBS swabs|2|||
27864547|NCT03696953|81337171|FG001|Overall Study|missed GBS swabs|2|||
27864548|NCT03696953|81337170|FG000|Overall Study|lost study bottle containing capsules|2|||
27864549|NCT03696953|81337171|FG001|Overall Study|lost study bottle containing capsules|0|||
27864550|NCT03696953|81337170|FG000|Overall Study|Premature birth|1|||
27864551|NCT03696953|81337171|FG001|Overall Study|Premature birth|4|||
27781840|NCT00962780|81032135|FG001|Overall Study|Withdrawal by Subject|8|||
27781841|NCT00962780|81032134|FG000|Overall Study|Other|0|||
27781842|NCT00962780|81032135|FG001|Overall Study|Other|1|||
27781843|NCT02584660|81032136|FG000|Overall Study|Adverse Event|4|||
27781844|NCT02584660|81032137|FG001|Overall Study|Adverse Event|0|||
27781845|NCT02584660|81032136|FG000|Overall Study|Lost to Follow-up|3|||
27781846|NCT02584660|81032137|FG001|Overall Study|Lost to Follow-up|4|||
27781847|NCT02584660|81032136|FG000|Overall Study|Protocol Violation|0|||
27781848|NCT02584660|81032137|FG001|Overall Study|Protocol Violation|1|||
27781849|NCT02584660|81032136|FG000|Overall Study|Withdrawal by Subject|0|||
27781850|NCT02584660|81032137|FG001|Overall Study|Withdrawal by Subject|2|||
27781851|NCT02584660|81032136|FG000|Overall Study|Other|0|||
27781852|NCT02584660|81032137|FG001|Overall Study|Other|1|||
27781853|NCT00307736|81032138|FG000|Overall Study|Adverse Event|0|||
27781854|NCT00307736|81032139|FG001|Overall Study|Adverse Event|0|||
27864552|NCT03696953|81337170|FG000|Overall Study|Gestational hypertension|1|||
27864553|NCT03696953|81337171|FG001|Overall Study|Gestational hypertension|1|||
27864554|NCT03696953|81337170|FG000|Overall Study|Gestational diabetes|2|||
27864555|NCT03696953|81337171|FG001|Overall Study|Gestational diabetes|1|||
27864556|NCT03696953|81337170|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
27864557|NCT03696953|81337171|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
27864558|NCT03696953|81337170|FG000|Overall Study|Changed prenatal provider|1|||
27864559|NCT03696953|81337171|FG001|Overall Study|Changed prenatal provider|1|||
27864560|NCT00303459|81337172|FG000|Overall Study|Death|33|||
27864561|NCT00303459|81337173|FG001|Overall Study|Death|44|||
27864562|NCT00303459|81337172|FG000|Overall Study|Withdrawal of consent|32|||
27864563|NCT00303459|81337173|FG001|Overall Study|Withdrawal of consent|26|||
27864564|NCT00303459|81337172|FG000|Overall Study|Lost to Follow-up|5|||
27864565|NCT00303459|81337173|FG001|Overall Study|Lost to Follow-up|4|||
27864566|NCT00303459|81337172|FG000|Overall Study|Administrative reason|7|||
27864567|NCT00303459|81337173|FG001|Overall Study|Administrative reason|7|||
27864568|NCT00303459|81337172|FG000|Overall Study|Decision by the investigator|5|||
27864569|NCT00303459|81337173|FG001|Overall Study|Decision by the investigator|7|||
27864570|NCT00303459|81337172|FG000|Overall Study|Lung transplantation|1|||
27864571|NCT00303459|81337173|FG001|Overall Study|Lung transplantation|1|||
27864572|NCT00478244|81337177|FG000|Overall Study|Did not receive transplant|1|||
27864573|NCT04803305|81337181|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
27864574|NCT04803305|81337182|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
27864575|NCT04803305|81337181|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
27781855|NCT00307736|81032140|FG002|Overall Study|Adverse Event|1|||
27864576|NCT04803305|81337182|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
27864577|NCT04803305|81337181|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
27781856|NCT00307736|81032141|FG003|Overall Study|Adverse Event|3|||
27781857|NCT00307736|81032138|FG000|Overall Study|Withdrawal by Subject|0|||
27781858|NCT00307736|81032139|FG001|Overall Study|Withdrawal by Subject|0|||
27781859|NCT00307736|81032140|FG002|Overall Study|Withdrawal by Subject|2|||
27864578|NCT04803305|81337182|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
27864579|NCT04803305|81337181|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
27864580|NCT04803305|81337182|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
27864581|NCT04803305|81337181|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
27864582|NCT04803305|81337182|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
27864583|NCT04803305|81337181|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
27864584|NCT04803305|81337182|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
27864585|NCT04803305|81337181|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
27864586|NCT04803305|81337182|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
27864587|NCT04803305|81337181|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
27864588|NCT04803305|81337182|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
27864589|NCT04975191|81337183|FG000|Overall Study|Protocol Violation|1|||
27864590|NCT04975191|81337184|FG001|Overall Study|Protocol Violation|2|||
27864591|NCT04975191|81337185|FG002|Overall Study|Protocol Violation|2|||
27864592|NCT04975191|81337186|FG003|Overall Study|Protocol Violation|2|||
27864593|NCT04975191|81337183|FG000|Overall Study|Lost to Follow-up|13|||
27864594|NCT04975191|81337184|FG001|Overall Study|Lost to Follow-up|3|||
27864595|NCT04975191|81337185|FG002|Overall Study|Lost to Follow-up|8|||
27864596|NCT04975191|81337186|FG003|Overall Study|Lost to Follow-up|8|||
27864597|NCT03414684|81337188|FG000|First-course Treatment|Complete response|0|||
27864598|NCT03414684|81337189|FG001|First-course Treatment|Complete response|1|||
27864599|NCT03414684|81337188|FG000|First-course Treatment|Intercurrent illness|1|||
27864600|NCT03414684|81337189|FG001|First-course Treatment|Intercurrent illness|0|||
27864601|NCT03414684|81337188|FG000|First-course Treatment|Progressive Disease|31|||
27864602|NCT03414684|81337189|FG001|First-course Treatment|Progressive Disease|32|||
27864603|NCT03414684|81337188|FG000|First-course Treatment|Adverse Event|1|||
27864604|NCT03414684|81337189|FG001|First-course Treatment|Adverse Event|2|||
27864605|NCT03414684|81337188|FG000|First-course Treatment|Physician Decision|0|||
27864606|NCT03414684|81337189|FG001|First-course Treatment|Physician Decision|1|||
27864607|NCT03414684|81337188|FG000|First-course Treatment|Withdrawal by Subject|0|||
27864608|NCT03414684|81337189|FG001|First-course Treatment|Withdrawal by Subject|1|||
27864609|NCT03414684|81337188|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
27864610|NCT03414684|81337189|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
27864611|NCT03414684|81337188|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
27864612|NCT03414684|81337189|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
27864613|NCT03414684|81337188|FG000|First-course Treatment|Still on treatment|3|||
27864614|NCT03414684|81337189|FG001|First-course Treatment|Still on treatment|0|||
27864615|NCT03414684|81337188|FG000|First-course Treatment|Never started protocol therapy|2|||
27864616|NCT03414684|81337189|FG001|First-course Treatment|Never started protocol therapy|1|||
27864617|NCT03414684|81337188|FG000|Crossover Treatment|Progressive disease|0|||
27864618|NCT03414684|81337189|FG001|Crossover Treatment|Progressive disease|12|||
27864619|NCT03414684|81337188|FG000|Crossover Treatment|Adverse Event|0|||
27864620|NCT03414684|81337189|FG001|Crossover Treatment|Adverse Event|3|||
27864621|NCT03414684|81337188|FG000|Crossover Treatment|Physician Decision|0|||
27864622|NCT03414684|81337189|FG001|Crossover Treatment|Physician Decision|1|||
27781860|NCT00307736|81032141|FG003|Overall Study|Withdrawal by Subject|0|||
27781861|NCT00732199|81032144|FG000|Overall Study|Withdrawal by Subject|25|||
27781862|NCT00732199|81032145|FG001|Overall Study|Withdrawal by Subject|18|||
27781863|NCT00732199|81032144|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
27781864|NCT00732199|81032145|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
27781865|NCT04604015|81032146|FG000|Overall Study|Incomplete Data Collection|33|||
27781866|NCT02611037|81032147|FG000|Overall Study|Withdrawal prior to treatment|2|||
27781867|NCT02611037|81032148|FG001|Overall Study|Withdrawal prior to treatment|0|||
27781868|NCT02853318|81032156|FG000|Overall Study|Withdrawal by Subject|1|||
27864623|NCT03414684|81337188|FG000|Crossover Treatment|Still on treatment|0|||
27864624|NCT03414684|81337189|FG001|Crossover Treatment|Still on treatment|2|||
27864625|NCT01068262|81337190|FG000|Overall Study|Adverse Event|2|||
27864626|NCT01068262|81337191|FG001|Overall Study|Adverse Event|0|||
27571072|NCT00378703|80275389|FG001|Overall Study|Adverse events and progressive disease|0|||
27571073|NCT00378703|80275390|FG002|Overall Study|Adverse events and progressive disease|0|||
27571074|NCT00378703|80275391|FG003|Overall Study|Adverse events and progressive disease|1|||
27571075|NCT00378703|80275388|FG000|Overall Study|Relocation|0|||
27571076|NCT00378703|80275389|FG001|Overall Study|Relocation|0|||
27781869|NCT01521494|81032157|FG000|Overall Study|Adverse Event|1|||
27864627|NCT01068262|81337192|FG002|Overall Study|Adverse Event|1|||
27864628|NCT01068262|81337193|FG003|Overall Study|Adverse Event|0|||
27864629|NCT01068262|81337190|FG000|Overall Study|Protocol Violation|1|||
27864630|NCT01068262|81337191|FG001|Overall Study|Protocol Violation|0|||
27864631|NCT01068262|81337192|FG002|Overall Study|Protocol Violation|0|||
27864632|NCT01068262|81337193|FG003|Overall Study|Protocol Violation|0|||
27864633|NCT01068262|81337190|FG000|Overall Study|Withdrawal by Subject|0|||
27864634|NCT01068262|81337191|FG001|Overall Study|Withdrawal by Subject|1|||
27864635|NCT01068262|81337192|FG002|Overall Study|Withdrawal by Subject|0|||
27970839|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Death|1|||
27781870|NCT01521494|81032158|FG001|Overall Study|Adverse Event|2|||
27781871|NCT01521494|81032159|FG002|Overall Study|Adverse Event|9|||
27781872|NCT01521494|81032160|FG003|Overall Study|Adverse Event|6|||
27781873|NCT01521494|81032161|FG004|Overall Study|Adverse Event|2|||
27781874|NCT01521494|81032157|FG000|Overall Study|Lack of Efficacy|0|||
27781875|NCT01521494|81032158|FG001|Overall Study|Lack of Efficacy|0|||
27781876|NCT01521494|81032159|FG002|Overall Study|Lack of Efficacy|0|||
27781877|NCT01521494|81032160|FG003|Overall Study|Lack of Efficacy|0|||
27781878|NCT01521494|81032161|FG004|Overall Study|Lack of Efficacy|2|||
27781879|NCT01521494|81032157|FG000|Overall Study|Withdrawal by Subject|1|||
27781880|NCT01521494|81032158|FG001|Overall Study|Withdrawal by Subject|1|||
27781881|NCT01521494|81032159|FG002|Overall Study|Withdrawal by Subject|0|||
27781882|NCT01521494|81032160|FG003|Overall Study|Withdrawal by Subject|2|||
27781883|NCT01521494|81032161|FG004|Overall Study|Withdrawal by Subject|0|||
27781884|NCT01521494|81032157|FG000|Overall Study|Decrease in serum phosphate|0|||
27781885|NCT01521494|81032158|FG001|Overall Study|Decrease in serum phosphate|2|||
27781886|NCT01521494|81032159|FG002|Overall Study|Decrease in serum phosphate|3|||
27781887|NCT01521494|81032160|FG003|Overall Study|Decrease in serum phosphate|12|||
27781888|NCT01521494|81032161|FG004|Overall Study|Decrease in serum phosphate|0|||
27781889|NCT01521494|81032157|FG000|Overall Study|Decrease in serum calcium|0|||
27781890|NCT01521494|81032158|FG001|Overall Study|Decrease in serum calcium|0|||
27781891|NCT01521494|81032159|FG002|Overall Study|Decrease in serum calcium|0|||
27781892|NCT01521494|81032160|FG003|Overall Study|Decrease in serum calcium|1|||
27781893|NCT01521494|81032161|FG004|Overall Study|Decrease in serum calcium|1|||
27781894|NCT01521494|81032157|FG000|Overall Study|Physician Decision|0|||
27781895|NCT01521494|81032158|FG001|Overall Study|Physician Decision|0|||
27781896|NCT01521494|81032159|FG002|Overall Study|Physician Decision|0|||
27781897|NCT01521494|81032160|FG003|Overall Study|Physician Decision|0|||
27781898|NCT01521494|81032161|FG004|Overall Study|Physician Decision|2|||
27781899|NCT01728194|81032162|FG000|Overall Study|Lost to Follow-up|4|||
27781900|NCT01728194|81032163|FG001|Overall Study|Lost to Follow-up|3|||
27781901|NCT01728194|81032162|FG000|Overall Study|Physician Decision|4|||
27781902|NCT01728194|81032163|FG001|Overall Study|Physician Decision|0|||
27781903|NCT01728194|81032162|FG000|Overall Study|Withdrawal by Subject|7|||
27781904|NCT01728194|81032163|FG001|Overall Study|Withdrawal by Subject|3|||
27781905|NCT01728194|81032162|FG000|Overall Study|Perceived Medication Side Effects|4|||
27781906|NCT01728194|81032163|FG001|Overall Study|Perceived Medication Side Effects|0|||
27781907|NCT01728194|81032162|FG000|Overall Study|Family Member Request|1|||
27781908|NCT01728194|81032163|FG001|Overall Study|Family Member Request|0|||
27781909|NCT00082628|81032164|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27781910|NCT00082628|81032165|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
27781911|NCT00082628|81032166|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27781912|NCT00082628|81032167|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27781913|NCT00082628|81032168|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
27781914|NCT00082628|81032164|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
27781915|NCT00082628|81032165|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
27781916|NCT00082628|81032166|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
27781917|NCT00082628|81032167|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
27781918|NCT00082628|81032168|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
27781919|NCT00082628|81032164|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
27781920|NCT00082628|81032165|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
27781921|NCT00082628|81032166|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
27781922|NCT00082628|81032167|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
27781923|NCT00082628|81032168|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
27781924|NCT00082628|81032164|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
27781925|NCT00082628|81032165|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
27781926|NCT00082628|81032166|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
27781927|NCT00082628|81032167|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
27781928|NCT00082628|81032168|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
27781929|NCT00082628|81032164|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27781930|NCT00082628|81032165|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27781931|NCT00082628|81032166|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27781932|NCT00082628|81032167|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
27781933|NCT00082628|81032168|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
27781934|NCT00082628|81032164|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27781935|NCT00082628|81032165|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27781936|NCT00082628|81032166|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27864636|NCT01068262|81337193|FG003|Overall Study|Withdrawal by Subject|0|||
27864637|NCT03907878|81337196|FG000|Treatment Period|Withdrawal by Subject|5|||
27970840|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Death|1|||
27781937|NCT00082628|81032167|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
27781938|NCT00082628|81032168|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
27781939|NCT00082628|81032164|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
27781940|NCT00082628|81032165|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
27781941|NCT00082628|81032166|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
27781942|NCT00082628|81032167|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
27781943|NCT00082628|81032168|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
27781944|NCT03793010|81032173|FG000|Overall Study|Withdrawal by Subject|5|||
27781945|NCT03793010|81032174|FG001|Overall Study|Withdrawal by Subject|7|||
27781946|NCT03793010|81032173|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
27781947|NCT03793010|81032174|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
27781948|NCT03793010|81032173|FG000|Overall Study|Lost to Follow-up|1|||
27781949|NCT03793010|81032174|FG001|Overall Study|Lost to Follow-up|2|||
27781950|NCT03793010|81032173|FG000|Overall Study|Patient couldn't sit still for injection|1|||
27781951|NCT03793010|81032174|FG001|Overall Study|Patient couldn't sit still for injection|0|||
27781952|NCT03793010|81032173|FG000|Overall Study|Withdrew to pursue other treatment|1|||
27781953|NCT03793010|81032174|FG001|Overall Study|Withdrew to pursue other treatment|0|||
27781954|NCT03793010|81032173|FG000|Overall Study|Did not meet eligibility criteria|1|||
27781955|NCT03793010|81032174|FG001|Overall Study|Did not meet eligibility criteria|0|||
27781956|NCT01603628|81032175|FG000|Overall Study|Personal Reasons|1|||
27781957|NCT01603628|81032176|FG001|Overall Study|Personal Reasons|1|||
27781958|NCT01603628|81032177|FG002|Overall Study|Personal Reasons|2|||
27781959|NCT01603628|81032175|FG000|Overall Study|Protocol Violation|1|||
27781960|NCT01603628|81032176|FG001|Overall Study|Protocol Violation|1|||
27781961|NCT01603628|81032177|FG002|Overall Study|Protocol Violation|0|||
27781962|NCT01603628|81032175|FG000|Overall Study|Lost to Follow-up|0|||
27781963|NCT01603628|81032176|FG001|Overall Study|Lost to Follow-up|1|||
27781964|NCT01603628|81032177|FG002|Overall Study|Lost to Follow-up|0|||
27781965|NCT01603628|81032175|FG000|Overall Study|Other Miscellaneous Reason|1|||
27781966|NCT01603628|81032176|FG001|Overall Study|Other Miscellaneous Reason|0|||
27781967|NCT01603628|81032177|FG002|Overall Study|Other Miscellaneous Reason|0|||
27781968|NCT03055806|81032182|FG000|Overall Study|Adverse Event|0|||
27781969|NCT03055806|81032183|FG001|Overall Study|Adverse Event|0|||
27781970|NCT03055806|81032184|FG002|Overall Study|Adverse Event|1|||
27781971|NCT03055806|81032185|FG003|Overall Study|Adverse Event|1|||
27781972|NCT03055806|81032182|FG000|Overall Study|Lost to Follow-up|0|||
27781973|NCT03055806|81032183|FG001|Overall Study|Lost to Follow-up|3|||
27781974|NCT03055806|81032184|FG002|Overall Study|Lost to Follow-up|6|||
27781975|NCT03055806|81032185|FG003|Overall Study|Lost to Follow-up|7|||
27781976|NCT03055806|81032182|FG000|Overall Study|Physician Decision|1|||
27781977|NCT03055806|81032183|FG001|Overall Study|Physician Decision|0|||
27781978|NCT03055806|81032184|FG002|Overall Study|Physician Decision|0|||
27781979|NCT03055806|81032185|FG003|Overall Study|Physician Decision|1|||
27781980|NCT03055806|81032182|FG000|Overall Study|Protocol Violation|1|||
27781981|NCT03055806|81032183|FG001|Overall Study|Protocol Violation|0|||
27781982|NCT03055806|81032184|FG002|Overall Study|Protocol Violation|0|||
27781983|NCT03055806|81032185|FG003|Overall Study|Protocol Violation|0|||
27781984|NCT03055806|81032182|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
27781985|NCT03055806|81032183|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
27781986|NCT03055806|81032184|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
27781987|NCT03055806|81032185|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
27970841|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Death|0|||
27970842|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Death|0|||
27970843|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Death|1|||
27970844|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Death|0|||
27970845|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Death|0|||
27970846|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Death|0|||
27970847|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Death|0|||
27970848|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Death|0|||
27970849|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
27970850|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
27970851|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
27970852|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
27970853|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
27970854|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
27781988|NCT03055806|81032182|FG000|Overall Study|Withdrawal of consent to continue study|2|||
27781989|NCT03055806|81032183|FG001|Overall Study|Withdrawal of consent to continue study|3|||
27781990|NCT03055806|81032184|FG002|Overall Study|Withdrawal of consent to continue study|4|||
27781991|NCT03055806|81032185|FG003|Overall Study|Withdrawal of consent to continue study|6|||
27781992|NCT03055806|81032182|FG000|Overall Study|Partner not willing to try intercourse|1|||
27781993|NCT03055806|81032183|FG001|Overall Study|Partner not willing to try intercourse|0|||
27864638|NCT03907878|81337196|FG000|Treatment Period|Adverse Event|4|||
27970855|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
27571077|NCT00378703|80275390|FG002|Overall Study|Relocation|1|||
27571078|NCT00378703|80275391|FG003|Overall Study|Relocation|0|||
27571079|NCT00378703|80275388|FG000|Overall Study|Ineligible|4|||
27571080|NCT00378703|80275389|FG001|Overall Study|Ineligible|7|||
27571081|NCT00378703|80275390|FG002|Overall Study|Ineligible|7|||
27571082|NCT00378703|80275391|FG003|Overall Study|Ineligible|7|||
27571083|NCT00378703|80275388|FG000|Overall Study|Never started treatment|1|||
27571084|NCT00378703|80275389|FG001|Overall Study|Never started treatment|4|||
27571085|NCT00378703|80275390|FG002|Overall Study|Never started treatment|0|||
27571086|NCT00378703|80275391|FG003|Overall Study|Never started treatment|0|||
27571087|NCT00378703|80275388|FG000|Overall Study|Other|1|||
27571088|NCT00378703|80275389|FG001|Overall Study|Other|1|||
27571089|NCT00378703|80275390|FG002|Overall Study|Other|2|||
27571090|NCT00378703|80275391|FG003|Overall Study|Other|3|||
27571091|NCT01344447|80275392|FG000|Overall Study|Adverse Event|1|||
27571092|NCT01344447|80275392|FG000|Overall Study|Protocol Violation|1|||
27571093|NCT01344447|80275392|FG000|Overall Study|Withdrawal by Subject|1|||
27571094|NCT01344447|80275392|FG000|Overall Study|The contrast was not seen|1|||
27571095|NCT01344447|80275392|FG000|Overall Study|Physician Decision|1|||
27571096|NCT01344447|80275392|FG000|Overall Study|MRA unsuccessful|1|||
27571097|NCT01344447|80275392|FG000|Overall Study|Bolus tracking failed|1|||
27571098|NCT01344447|80275392|FG000|Overall Study|Error of power injector|1|||
27571099|NCT01541826|80275397|FG000|Overall Study|Lost to Follow-up|2|||
27571100|NCT01541826|80275398|FG001|Overall Study|Lost to Follow-up|3|||
27667872|NCT00488319|80623473|FG001|Overall Study|Adverse Event|2|||
27667873|NCT00488319|80623474|FG002|Overall Study|Adverse Event|23|||
27667874|NCT00488319|80623472|FG000|Overall Study|Lack of Efficacy|6|||
27667875|NCT00488319|80623473|FG001|Overall Study|Lack of Efficacy|12|||
27667876|NCT00488319|80623474|FG002|Overall Study|Lack of Efficacy|27|||
27667877|NCT00488319|80623472|FG000|Overall Study|Lost to Follow-up|3|||
27667878|NCT00488319|80623473|FG001|Overall Study|Lost to Follow-up|5|||
27667879|NCT00488319|80623474|FG002|Overall Study|Lost to Follow-up|16|||
27667880|NCT00488319|80623472|FG000|Overall Study|Withdrawal by Subject|5|||
27667881|NCT00488319|80623473|FG001|Overall Study|Withdrawal by Subject|20|||
27571101|NCT01541826|80275399|FG002|Overall Study|Lost to Follow-up|0|||
27571102|NCT01541826|80275397|FG000|Overall Study|Withdrawal by Subject|2|||
27571103|NCT01541826|80275398|FG001|Overall Study|Withdrawal by Subject|0|||
27571104|NCT01541826|80275399|FG002|Overall Study|Withdrawal by Subject|0|||
27571105|NCT01828034|80275400|FG000|Overall Study|Withdrawal by Subject|0|||
27571106|NCT01828034|80275401|FG001|Overall Study|Withdrawal by Subject|0|||
27571107|NCT01828034|80275402|FG002|Overall Study|Withdrawal by Subject|0|||
27571108|NCT01828034|80275403|FG003|Overall Study|Withdrawal by Subject|1|||
27571109|NCT00205712|80275404|FG000|Overall Study|Lost to Follow-up|0|||
27571110|NCT00205712|80275405|FG001|Overall Study|Lost to Follow-up|1|||
27571111|NCT01524770|80275406|FG000|First Intervention|Withdrawal by Subject|1|||
27571112|NCT01524770|80275407|FG001|First Intervention|Withdrawal by Subject|0|||
27667882|NCT00488319|80623474|FG002|Overall Study|Withdrawal by Subject|44|||
27864639|NCT03907878|81337196|FG000|Treatment Period|Lack of Efficacy|1|||
27864640|NCT03907878|81337196|FG000|Treatment Period|Protocol Violation|1|||
27864641|NCT03907878|81337196|FG000|Follow-up Period|Adverse Event|3|||
27864642|NCT03907878|81337196|FG000|Follow-up Period|Withdrawal by Subject|3|||
27864643|NCT04435184|81337197|FG000|Overall Study|follow-up blood draws missing|3|||
27864644|NCT04435184|81337198|FG001|Overall Study|follow-up blood draws missing|5|||
27864645|NCT00720382|81337201|FG000|Overall Study|Adverse Event|54|||
27864646|NCT00720382|81337202|FG001|Overall Study|Adverse Event|17|||
27864647|NCT00720382|81337201|FG000|Overall Study|Lack of Efficacy|18|||
27864648|NCT00720382|81337202|FG001|Overall Study|Lack of Efficacy|7|||
27864649|NCT00720382|81337201|FG000|Overall Study|Non-Compliance|15|||
27864650|NCT00720382|81337202|FG001|Overall Study|Non-Compliance|5|||
27864651|NCT00720382|81337201|FG000|Overall Study|Withdrawal by Subject|47|||
27864652|NCT00720382|81337202|FG001|Overall Study|Withdrawal by Subject|11|||
27864653|NCT00720382|81337201|FG000|Overall Study|Lost to Follow-up|28|||
27864654|NCT00720382|81337202|FG001|Overall Study|Lost to Follow-up|14|||
27864655|NCT00720382|81337201|FG000|Overall Study|administrative|14|||
27864656|NCT00720382|81337202|FG001|Overall Study|administrative|5|||
27864657|NCT01308424|81337209|FG000|Baseline Eligibility|Screen Failures|71|||
27864658|NCT01308424|81337210|FG001|Baseline Eligibility|Screen Failures|0|||
27864659|NCT01308424|81337211|FG002|Baseline Eligibility|Screen Failures|0|||
27864660|NCT01308424|81337209|FG000|Randomization|Adverse Event|0|||
27864661|NCT01308424|81337210|FG001|Randomization|Adverse Event|1|||
27864662|NCT01308424|81337211|FG002|Randomization|Adverse Event|1|||
27864663|NCT01308424|81337209|FG000|Randomization|Lost to Follow-up|0|||
27571113|NCT01524770|80275406|FG000|First Intervention|Adverse Event|1|||
27571114|NCT01524770|80275407|FG001|First Intervention|Adverse Event|1|||
27571115|NCT01524770|80275406|FG000|First Intervention|Protocol Violation|1|||
27864664|NCT01308424|81337210|FG001|Randomization|Lost to Follow-up|1|||
27864665|NCT01308424|81337211|FG002|Randomization|Lost to Follow-up|0|||
27667883|NCT00488319|80623472|FG000|Overall Study|Other reasons for withdrawal|0|||
27864666|NCT01308424|81337209|FG000|Randomization|Physician Decision|0|||
27571116|NCT01524770|80275407|FG001|First Intervention|Protocol Violation|0|||
27571117|NCT03254134|80275409|FG000|Overall Study|Not eligible patients|599|||
27571118|NCT03254134|80275410|FG001|Overall Study|Not eligible patients|3630|||
27571119|NCT02214121|80275411|FG000|Part A|Patient decision|2|||
27571120|NCT02214121|80275412|FG001|Part A|Patient decision|0|||
27571121|NCT02214121|80275413|FG002|Part A|Patient decision|0|||
27571122|NCT02214121|80275411|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
27571123|NCT02214121|80275412|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
27571124|NCT02214121|80275413|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
27571125|NCT02214121|80275411|FG000|Part A|Other|1|||
27571126|NCT02214121|80275412|FG001|Part A|Other|0|||
27571127|NCT02214121|80275413|FG002|Part A|Other|0|||
27571128|NCT02214121|80275411|FG000|Part B|Patient decision|0|||
27571129|NCT02214121|80275412|FG001|Part B|Patient decision|1|||
27571130|NCT02214121|80275413|FG002|Part B|Patient decision|0|||
27571131|NCT02214121|80275411|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
27571132|NCT02214121|80275412|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
27571133|NCT02214121|80275413|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
27571134|NCT02214121|80275411|FG000|Part B|Lost to Follow-up|0|||
27571135|NCT02214121|80275412|FG001|Part B|Lost to Follow-up|0|||
27571136|NCT02214121|80275413|FG002|Part B|Lost to Follow-up|1|||
27571137|NCT03385239|80275414|FG000|Overall Study|Voluntary Withdrawal|2|||
27571138|NCT03385239|80275415|FG001|Overall Study|Voluntary Withdrawal|3|||
27571139|NCT03385239|80275416|FG002|Overall Study|Voluntary Withdrawal|2|||
27571140|NCT03385239|80275417|FG003|Overall Study|Voluntary Withdrawal|3|||
27571141|NCT03385239|80275418|FG004|Overall Study|Voluntary Withdrawal|0|||
27571142|NCT03385239|80275414|FG000|Overall Study|Adverse Event|0|||
27571143|NCT03385239|80275415|FG001|Overall Study|Adverse Event|0|||
27571144|NCT03385239|80275416|FG002|Overall Study|Adverse Event|1|||
27571145|NCT03385239|80275417|FG003|Overall Study|Adverse Event|0|||
27571146|NCT03385239|80275418|FG004|Overall Study|Adverse Event|0|||
27571147|NCT03385239|80275414|FG000|Overall Study|Other|0|||
27571148|NCT03385239|80275415|FG001|Overall Study|Other|0|||
27571149|NCT03385239|80275416|FG002|Overall Study|Other|0|||
27571150|NCT03385239|80275417|FG003|Overall Study|Other|1|||
27864667|NCT01308424|81337210|FG001|Randomization|Physician Decision|1|||
27571151|NCT03385239|80275418|FG004|Overall Study|Other|0|||
27571152|NCT00974571|80275423|FG000|Overall Study|Adverse Event|31|||
27571153|NCT00974571|80275424|FG001|Overall Study|Adverse Event|4|||
27571154|NCT00974571|80275425|FG002|Overall Study|Adverse Event|27|||
27571155|NCT00974571|80275423|FG000|Overall Study|Lack of Efficacy|3|||
27571156|NCT00974571|80275424|FG001|Overall Study|Lack of Efficacy|2|||
27571157|NCT00974571|80275425|FG002|Overall Study|Lack of Efficacy|9|||
27571158|NCT00974571|80275423|FG000|Overall Study|Lost to Follow-up|2|||
27571159|NCT00974571|80275424|FG001|Overall Study|Lost to Follow-up|1|||
27571160|NCT00974571|80275425|FG002|Overall Study|Lost to Follow-up|2|||
27571161|NCT00974571|80275423|FG000|Overall Study|Protocol Violation|13|||
27571162|NCT00974571|80275424|FG001|Overall Study|Protocol Violation|4|||
27667884|NCT00488319|80623473|FG001|Overall Study|Other reasons for withdrawal|4|||
27864668|NCT01308424|81337211|FG002|Randomization|Physician Decision|1|||
27864669|NCT02800642|81337212|FG000|Overall Study|Death|3|||
27864670|NCT02800642|81337212|FG000|Overall Study|Other|10|||
27864671|NCT02800642|81337212|FG000|Overall Study|Physician Decision|2|||
27864672|NCT02800642|81337212|FG000|Overall Study|Adverse Event|6|||
27864673|NCT02800642|81337212|FG000|Overall Study|Withdrawal by Subject|3|||
27864674|NCT02800642|81337212|FG000|Overall Study|Lost to Follow-up|1|||
27864675|NCT01555671|81337214|FG000|Overall Study|Physician Decision|20|||
27864676|NCT01555671|81337215|FG001|Overall Study|Physician Decision|25|||
27864677|NCT03106987|81337216|FG000|Overall Study|Death|37|||
27864678|NCT03106987|81337217|FG001|Overall Study|Death|22|||
27864679|NCT03106987|81337218|FG002|Overall Study|Death|12|||
27864680|NCT03106987|81337219|FG003|Overall Study|Death|8|||
27864681|NCT03106987|81337216|FG000|Overall Study|Lost to Follow-up|2|||
27864682|NCT03106987|81337217|FG001|Overall Study|Lost to Follow-up|0|||
27864683|NCT03106987|81337218|FG002|Overall Study|Lost to Follow-up|2|||
27970856|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
27970857|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
27970858|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
27970859|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970860|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970861|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970862|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970863|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
27970864|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970865|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970866|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970867|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27571163|NCT00974571|80275425|FG002|Overall Study|Protocol Violation|18|||
27571164|NCT00974571|80275423|FG000|Overall Study|Withdrawal by Subject|14|||
27864684|NCT03106987|81337219|FG003|Overall Study|Lost to Follow-up|2|||
27970868|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
27970869|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
27970870|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970871|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970872|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970873|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970874|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27571165|NCT00974571|80275424|FG001|Overall Study|Withdrawal by Subject|5|||
27571166|NCT00974571|80275425|FG002|Overall Study|Withdrawal by Subject|16|||
27571167|NCT00974571|80275423|FG000|Overall Study|Patient Moved|1|||
27571168|NCT00974571|80275424|FG001|Overall Study|Patient Moved|0|||
27571169|NCT00974571|80275425|FG002|Overall Study|Patient Moved|1|||
27571170|NCT00974571|80275423|FG000|Overall Study|Other|4|||
27571171|NCT00974571|80275424|FG001|Overall Study|Other|0|||
27667885|NCT00488319|80623474|FG002|Overall Study|Other reasons for withdrawal|12|||
27667886|NCT01588366|80623475|FG000|Overall Study|Adverse Event|0|||
27667887|NCT01588366|80623476|FG001|Overall Study|Adverse Event|1|||
27667888|NCT01588366|80623477|FG002|Overall Study|Adverse Event|0|||
27667889|NCT01588366|80623478|FG003|Overall Study|Adverse Event|1|||
27667890|NCT01588366|80623479|FG004|Overall Study|Adverse Event|0|||
27667891|NCT01588366|80623480|FG005|Overall Study|Adverse Event|2|||
27667892|NCT00365547|80623481|FG000|Overall Study|Insurance did not cover Avastin|1|||
27667893|NCT00365547|80623481|FG000|Overall Study|Screen failure|1|||
27667894|NCT00365547|80623481|FG000|Overall Study|Withdrawal by Subject|1|||
27667895|NCT00937521|80623483|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27667896|NCT00937521|80623484|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27667897|NCT00937521|80623485|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
27667898|NCT00937521|80623486|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27667899|NCT00937521|80623487|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27667900|NCT00937521|80623488|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27667901|NCT00937521|80623489|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
27667902|NCT00937521|80623490|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
27667903|NCT00937521|80623483|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
27667904|NCT00937521|80623484|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
27667905|NCT00937521|80623485|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
27667906|NCT00937521|80623486|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
27667907|NCT00937521|80623487|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
27667908|NCT00937521|80623488|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
27667909|NCT00937521|80623489|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
27667910|NCT00937521|80623490|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
27667911|NCT00937521|80623483|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27667912|NCT00937521|80623484|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27864685|NCT03106987|81337216|FG000|Overall Study|Withdrawal by Subject|5|||
27864686|NCT03106987|81337217|FG001|Overall Study|Withdrawal by Subject|1|||
27864687|NCT03106987|81337218|FG002|Overall Study|Withdrawal by Subject|4|||
27864688|NCT03106987|81337219|FG003|Overall Study|Withdrawal by Subject|1|||
27864689|NCT04546724|81337224|FG000|Overall Study|Withdrawal by Subject|145|||
27864690|NCT04546724|81337225|FG001|Overall Study|Withdrawal by Subject|41|||
27864691|NCT04546724|81337224|FG000|Overall Study|Adverse Event|1|||
27864692|NCT04546724|81337225|FG001|Overall Study|Adverse Event|1|||
27864693|NCT04546724|81337224|FG000|Overall Study|Lost to Follow-up|186|||
27864694|NCT04546724|81337225|FG001|Overall Study|Lost to Follow-up|63|||
27864695|NCT04546724|81337224|FG000|Overall Study|Physician Decision|8|||
27864696|NCT04546724|81337225|FG001|Overall Study|Physician Decision|2|||
27864697|NCT04546724|81337224|FG000|Overall Study|Death|2|||
27864698|NCT04546724|81337225|FG001|Overall Study|Death|1|||
27864699|NCT04546724|81337224|FG000|Overall Study|subject has been out of town|1|||
27864700|NCT04546724|81337225|FG001|Overall Study|subject has been out of town|0|||
27864701|NCT04546724|81337224|FG000|Overall Study|subject is incarcerated|2|||
27864702|NCT04546724|81337225|FG001|Overall Study|subject is incarcerated|0|||
27864703|NCT04546724|81337224|FG000|Overall Study|subject is relocating|12|||
27864704|NCT04546724|81337225|FG001|Overall Study|subject is relocating|4|||
27864705|NCT04546724|81337224|FG000|Overall Study|Subject in another study|1|||
27864706|NCT04546724|81337225|FG001|Overall Study|Subject in another study|1|||
27864707|NCT01589497|81337226|FG000|Overall Study|Withdrawal by Subject|0|||
27864708|NCT01589497|81337227|FG001|Overall Study|Withdrawal by Subject|1|||
27864709|NCT01589497|81337228|FG002|Overall Study|Withdrawal by Subject|0|||
27864710|NCT01589497|81337229|FG003|Overall Study|Withdrawal by Subject|1|||
27864711|NCT01589497|81337226|FG000|Overall Study|Death|1|||
27864712|NCT01589497|81337227|FG001|Overall Study|Death|0|||
27970875|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27571172|NCT00974571|80275425|FG002|Overall Study|Other|10|||
27571173|NCT04116710|80275429|FG000|Overall Study|Death|4|||
27667913|NCT00937521|80623485|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
27667914|NCT00937521|80623486|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
27667915|NCT00937521|80623487|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27667916|NCT00937521|80623488|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27667917|NCT00937521|80623489|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27667918|NCT00937521|80623490|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
27667919|NCT00937521|80623483|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27667920|NCT00937521|80623484|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
27667921|NCT00937521|80623485|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27667922|NCT00937521|80623486|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27667923|NCT00937521|80623487|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
27667924|NCT00937521|80623488|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
27667925|NCT00937521|80623489|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
27667926|NCT00937521|80623490|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
27667927|NCT00937521|80623483|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
27667928|NCT00937521|80623484|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27667929|NCT00937521|80623485|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27667930|NCT00937521|80623486|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27667931|NCT00937521|80623487|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27667932|NCT00937521|80623488|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27667933|NCT00937521|80623489|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
27667934|NCT00937521|80623490|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
27667935|NCT00937521|80623483|FG000|Booster Phase|Adverse Event|0|||
27667936|NCT00937521|80623484|FG001|Booster Phase|Adverse Event|0|||
27667937|NCT00937521|80623485|FG002|Booster Phase|Adverse Event|0|||
27667938|NCT00937521|80623486|FG003|Booster Phase|Adverse Event|0|||
27667939|NCT00937521|80623487|FG004|Booster Phase|Adverse Event|0|||
27667940|NCT00937521|80623488|FG005|Booster Phase|Adverse Event|0|||
27667941|NCT00937521|80623489|FG006|Booster Phase|Adverse Event|1|||
27667942|NCT00937521|80623490|FG007|Booster Phase|Adverse Event|0|||
27667943|NCT00937521|80623483|FG000|Booster Phase|Withdrawal by Subject|1|||
27667944|NCT00937521|80623484|FG001|Booster Phase|Withdrawal by Subject|0|||
27667945|NCT00937521|80623485|FG002|Booster Phase|Withdrawal by Subject|0|||
27667946|NCT00937521|80623486|FG003|Booster Phase|Withdrawal by Subject|1|||
27667947|NCT00937521|80623487|FG004|Booster Phase|Withdrawal by Subject|0|||
27667948|NCT00937521|80623488|FG005|Booster Phase|Withdrawal by Subject|0|||
27667949|NCT00937521|80623489|FG006|Booster Phase|Withdrawal by Subject|0|||
27667950|NCT00937521|80623490|FG007|Booster Phase|Withdrawal by Subject|2|||
27667951|NCT00937521|80623483|FG000|Booster Phase|Lost to Follow-up|2|||
27667952|NCT00937521|80623484|FG001|Booster Phase|Lost to Follow-up|2|||
27667953|NCT00937521|80623485|FG002|Booster Phase|Lost to Follow-up|4|||
27667954|NCT00937521|80623486|FG003|Booster Phase|Lost to Follow-up|2|||
27667955|NCT00937521|80623487|FG004|Booster Phase|Lost to Follow-up|4|||
27667956|NCT00937521|80623488|FG005|Booster Phase|Lost to Follow-up|4|||
27667957|NCT00937521|80623489|FG006|Booster Phase|Lost to Follow-up|3|||
27667958|NCT00937521|80623490|FG007|Booster Phase|Lost to Follow-up|0|||
27667959|NCT00937521|80623483|FG000|Booster Phase|Administrative Reason|0|||
27667960|NCT00937521|80623484|FG001|Booster Phase|Administrative Reason|0|||
27667961|NCT00937521|80623485|FG002|Booster Phase|Administrative Reason|1|||
27667962|NCT00937521|80623486|FG003|Booster Phase|Administrative Reason|0|||
27667963|NCT00937521|80623487|FG004|Booster Phase|Administrative Reason|1|||
27667964|NCT00937521|80623488|FG005|Booster Phase|Administrative Reason|1|||
27667965|NCT00937521|80623489|FG006|Booster Phase|Administrative Reason|0|||
27667966|NCT00937521|80623490|FG007|Booster Phase|Administrative Reason|0|||
27781994|NCT03055806|81032184|FG002|Overall Study|Partner not willing to try intercourse|0|||
27781995|NCT03055806|81032185|FG003|Overall Study|Partner not willing to try intercourse|0|||
27781996|NCT00141297|81032188|FG000|Overall Study|Adverse Event|0|||
27781997|NCT00141297|81032189|FG001|Overall Study|Adverse Event|0|||
27781998|NCT00141297|81032190|FG002|Overall Study|Adverse Event|1|||
27781999|NCT00141297|81032191|FG003|Overall Study|Adverse Event|0|||
27782000|NCT00141297|81032192|FG004|Overall Study|Adverse Event|1|||
27782001|NCT00141297|81032193|FG005|Overall Study|Adverse Event|1|||
27667967|NCT00937521|80623483|FG000|Booster Phase|Protocol Deviation|0|||
27667968|NCT00937521|80623484|FG001|Booster Phase|Protocol Deviation|0|||
27667969|NCT00937521|80623485|FG002|Booster Phase|Protocol Deviation|0|||
27667970|NCT00937521|80623486|FG003|Booster Phase|Protocol Deviation|0|||
27667971|NCT00937521|80623487|FG004|Booster Phase|Protocol Deviation|0|||
27667972|NCT00937521|80623488|FG005|Booster Phase|Protocol Deviation|0|||
27667973|NCT00937521|80623489|FG006|Booster Phase|Protocol Deviation|1|||
27667974|NCT00937521|80623490|FG007|Booster Phase|Protocol Deviation|0|||
27667975|NCT01990313|80623491|FG000|Overall Study|Lost to Follow-up|1|||
27667976|NCT00611715|80623492|FG000|Overall Study|Disease Progression|24|||
27782002|NCT00141297|81032194|FG006|Overall Study|Adverse Event|0|||
27782003|NCT00141297|81032195|FG007|Overall Study|Adverse Event|1|||
27864713|NCT01589497|81337228|FG002|Overall Study|Death|0|||
27864714|NCT01589497|81337229|FG003|Overall Study|Death|0|||
27864715|NCT01589497|81337226|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
27864716|NCT01589497|81337227|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
27864717|NCT01589497|81337228|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
27864718|NCT01589497|81337229|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
27864719|NCT02694328|81337232|FG000|Overall Study|Adverse Event|27|||
27864720|NCT02694328|81337233|FG001|Overall Study|Adverse Event|33|||
27864721|NCT02694328|81337232|FG000|Overall Study|Withdrawal by Subject|27|||
27864722|NCT02694328|81337233|FG001|Overall Study|Withdrawal by Subject|23|||
27864723|NCT02694328|81337232|FG000|Overall Study|Lost to Follow-up|26|||
27864724|NCT02694328|81337233|FG001|Overall Study|Lost to Follow-up|22|||
27970876|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970877|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970878|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
27970879|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
27970880|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970881|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970882|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
27970883|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
27970884|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970885|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970886|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970887|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970888|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
27970889|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
27970890|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970891|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970892|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
27970893|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970894|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970895|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970896|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970897|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970898|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
27970899|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
27970900|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
27970901|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
27970902|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
27970903|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
27970904|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
27970905|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
27970906|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
27970907|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
27571174|NCT04116710|80275430|FG001|Overall Study|Death|6|||
27571175|NCT04116710|80275431|FG002|Overall Study|Death|3|||
27571176|NCT04116710|80275432|FG003|Overall Study|Death|1|||
27667977|NCT00611715|80623493|FG001|Overall Study|Disease Progression|4|||
27970908|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
27782004|NCT00141297|81032196|FG008|Overall Study|Adverse Event|1|||
27782005|NCT00141297|81032197|FG009|Overall Study|Adverse Event|0|||
27782006|NCT00141297|81032188|FG000|Overall Study|Death|1|||
27782007|NCT00141297|81032189|FG001|Overall Study|Death|0|||
27782008|NCT00141297|81032190|FG002|Overall Study|Death|0|||
27782009|NCT00141297|81032191|FG003|Overall Study|Death|0|||
27782010|NCT00141297|81032192|FG004|Overall Study|Death|0|||
27782011|NCT00141297|81032193|FG005|Overall Study|Death|0|||
27782012|NCT00141297|81032194|FG006|Overall Study|Death|0|||
27782013|NCT00141297|81032195|FG007|Overall Study|Death|0|||
27782014|NCT00141297|81032196|FG008|Overall Study|Death|1|||
27782015|NCT00141297|81032197|FG009|Overall Study|Death|0|||
27782016|NCT00141297|81032188|FG000|Overall Study|Withdrawal by Subject|0|||
27782017|NCT00141297|81032189|FG001|Overall Study|Withdrawal by Subject|0|||
27782018|NCT00141297|81032190|FG002|Overall Study|Withdrawal by Subject|0|||
27782019|NCT00141297|81032191|FG003|Overall Study|Withdrawal by Subject|0|||
27782020|NCT00141297|81032192|FG004|Overall Study|Withdrawal by Subject|0|||
27782021|NCT00141297|81032193|FG005|Overall Study|Withdrawal by Subject|0|||
27782022|NCT00141297|81032194|FG006|Overall Study|Withdrawal by Subject|0|||
27782023|NCT00141297|81032195|FG007|Overall Study|Withdrawal by Subject|0|||
27782024|NCT00141297|81032196|FG008|Overall Study|Withdrawal by Subject|1|||
27782025|NCT00141297|81032197|FG009|Overall Study|Withdrawal by Subject|0|||
27782026|NCT00141297|81032188|FG000|Overall Study|Other|0|||
27782027|NCT00141297|81032189|FG001|Overall Study|Other|0|||
27782028|NCT00141297|81032190|FG002|Overall Study|Other|0|||
27970909|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
27970910|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
27970911|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
27970912|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27970913|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
27970914|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27970915|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27970916|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27970917|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27970918|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27970919|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
27970920|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970921|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970922|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
27970923|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
27970924|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970925|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970926|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970927|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970928|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
27970929|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27970930|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27970931|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27667978|NCT00611715|80623492|FG000|Overall Study|Withdrawal by Subject|5|||
27970932|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27970933|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27970934|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27970935|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27970936|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27970937|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27667979|NCT00611715|80623493|FG001|Overall Study|Withdrawal by Subject|1|||
27667980|NCT00611715|80623492|FG000|Overall Study|Adverse Event|9|||
27782029|NCT00141297|81032191|FG003|Overall Study|Other|1|||
27782030|NCT00141297|81032192|FG004|Overall Study|Other|5|||
27782031|NCT00141297|81032193|FG005|Overall Study|Other|0|||
27782032|NCT00141297|81032194|FG006|Overall Study|Other|0|||
27782033|NCT00141297|81032195|FG007|Overall Study|Other|0|||
27782034|NCT00141297|81032196|FG008|Overall Study|Other|2|||
27782035|NCT00141297|81032197|FG009|Overall Study|Other|0|||
27782036|NCT00141297|81032188|FG000|Overall Study|Progressive Disease|2|||
27782037|NCT00141297|81032189|FG001|Overall Study|Progressive Disease|3|||
27782038|NCT00141297|81032190|FG002|Overall Study|Progressive Disease|6|||
27782039|NCT00141297|81032191|FG003|Overall Study|Progressive Disease|2|||
27782040|NCT00141297|81032192|FG004|Overall Study|Progressive Disease|15|||
27782041|NCT00141297|81032193|FG005|Overall Study|Progressive Disease|2|||
27782042|NCT00141297|81032194|FG006|Overall Study|Progressive Disease|3|||
27782043|NCT00141297|81032195|FG007|Overall Study|Progressive Disease|3|||
27782044|NCT00141297|81032196|FG008|Overall Study|Progressive Disease|15|||
27782045|NCT00141297|81032197|FG009|Overall Study|Progressive Disease|6|||
27782046|NCT00141297|81032188|FG000|Overall Study|Transitioned|0|||
27782047|NCT00141297|81032189|FG001|Overall Study|Transitioned|0|||
27782048|NCT00141297|81032190|FG002|Overall Study|Transitioned|0|||
27864725|NCT02694328|81337232|FG000|Overall Study|Noncompliant with study drug|11|||
27864726|NCT02694328|81337233|FG001|Overall Study|Noncompliant with study drug|8|||
27864727|NCT02694328|81337232|FG000|Overall Study|Incarceration|1|||
27864728|NCT02694328|81337233|FG001|Overall Study|Incarceration|1|||
27782049|NCT00141297|81032191|FG003|Overall Study|Transitioned|0|||
27782050|NCT00141297|81032192|FG004|Overall Study|Transitioned|1|||
27782051|NCT00141297|81032193|FG005|Overall Study|Transitioned|0|||
27571177|NCT04116710|80275429|FG000|Overall Study|Withdrawal by Subject|0|||
27571178|NCT04116710|80275430|FG001|Overall Study|Withdrawal by Subject|0|||
27571179|NCT04116710|80275431|FG002|Overall Study|Withdrawal by Subject|0|||
27782052|NCT00141297|81032194|FG006|Overall Study|Transitioned|0|||
27782053|NCT00141297|81032195|FG007|Overall Study|Transitioned|0|||
27782054|NCT00141297|81032196|FG008|Overall Study|Transitioned|0|||
27782055|NCT00141297|81032197|FG009|Overall Study|Transitioned|0|||
27782056|NCT01849289|81032199|FG000|Overall Study|Adverse Event|3|||
27970938|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27970939|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970940|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970941|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
27970942|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970943|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
27970944|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970945|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970946|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970947|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970948|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970949|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
27970950|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
27571180|NCT04116710|80275432|FG003|Overall Study|Withdrawal by Subject|1|||
27571181|NCT04889625|80275433|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
27571182|NCT04889625|80275434|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
27571183|NCT04889625|80275433|FG000|Period 1|Subject out of window|0|||
27571184|NCT04889625|80275434|FG001|Period 1|Subject out of window|1|||
27571185|NCT04889625|80275433|FG000|Period 1|Wrong add power dispensed|0|||
27571186|NCT04889625|80275434|FG001|Period 1|Wrong add power dispensed|1|||
27782057|NCT01849289|81032200|FG001|Overall Study|Adverse Event|3|||
27782058|NCT01849289|81032199|FG000|Overall Study|Protocol Violation|3|||
27782059|NCT01849289|81032200|FG001|Overall Study|Protocol Violation|3|||
27782060|NCT01849289|81032199|FG000|Overall Study|Withdrawal criteria|1|||
27782061|NCT01849289|81032200|FG001|Overall Study|Withdrawal criteria|0|||
27782062|NCT01849289|81032199|FG000|Overall Study|Unclassified|25|||
27864729|NCT02694328|81337232|FG000|Overall Study|Lack of Efficacy|1|||
27864730|NCT02694328|81337233|FG001|Overall Study|Lack of Efficacy|2|||
27864731|NCT02694328|81337232|FG000|Overall Study|Pregnancy|1|||
27864732|NCT02694328|81337233|FG001|Overall Study|Pregnancy|1|||
27864733|NCT02694328|81337232|FG000|Overall Study|Protocol Violation|6|||
27864734|NCT02694328|81337233|FG001|Overall Study|Protocol Violation|5|||
27864735|NCT02694328|81337232|FG000|Overall Study|Abnormal Laboratory Value|0|||
27864736|NCT02694328|81337233|FG001|Overall Study|Abnormal Laboratory Value|3|||
27864737|NCT02564887|81337234|FG000|Overall Study|Lost to Follow-up|6|||
27864738|NCT02564887|81337235|FG001|Overall Study|Lost to Follow-up|0|||
27864739|NCT01038297|81337237|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
27864740|NCT01038297|81337238|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
27864741|NCT01038297|81337239|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
27864742|NCT04052620|81337244|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
27864743|NCT04052620|81337245|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
27864744|NCT04052620|81337244|FG000|Overall Study|Withdrawal by Subject|1|||
27864745|NCT04052620|81337245|FG001|Overall Study|Withdrawal by Subject|0|||
27864746|NCT04052620|81337244|FG000|Overall Study|Lost to Follow-up|1|||
27864747|NCT04052620|81337245|FG001|Overall Study|Lost to Follow-up|1|||
27864748|NCT04052620|81337244|FG000|Overall Study|Adverse Event|1|||
27864749|NCT04052620|81337245|FG001|Overall Study|Adverse Event|0|||
27864750|NCT04052620|81337244|FG000|Overall Study|Subject did not meet study Criteria|0|||
27864751|NCT04052620|81337245|FG001|Overall Study|Subject did not meet study Criteria|1|||
27864752|NCT04052620|81337244|FG000|Overall Study|Screened failure, randomized by mistake|0|||
27864753|NCT04052620|81337245|FG001|Overall Study|Screened failure, randomized by mistake|1|||
27864754|NCT04052620|81337244|FG000|Overall Study|Personal reasons|2|||
27864755|NCT04052620|81337245|FG001|Overall Study|Personal reasons|4|||
27864756|NCT04052620|81337244|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
27864757|NCT04052620|81337245|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
27864758|NCT05320887|81337248|FG000|Overall Study|Lost to Follow-up|0|||
27864759|NCT05320887|81337249|FG001|Overall Study|Lost to Follow-up|3|||
27864760|NCT05320887|81337250|FG002|Overall Study|Lost to Follow-up|0|||
27782063|NCT01849289|81032200|FG001|Overall Study|Unclassified|18|||
27782064|NCT01097057|81032201|FG000|Overall Study|Physician Decision|3|||
27782065|NCT01454531|81032202|FG000|Overall Study|Adverse Event|14|||
27782066|NCT01454531|81032202|FG000|Overall Study|Withdrawal by Subject|5|||
27782067|NCT01454531|81032202|FG000|Overall Study|Lost to Follow-up|1|||
27782068|NCT01454531|81032202|FG000|Overall Study|Physician Decision|1|||
27782069|NCT01454531|81032202|FG000|Overall Study|Delay in IMP administration|1|||
27782070|NCT01454531|81032202|FG000|Overall Study|Other|1|||
27782071|NCT01385098|81032203|FG000|Overall Study|Adverse Event|10|||
27782072|NCT01385098|81032203|FG000|Overall Study|Lost to Follow-up|4|||
27782073|NCT00087594|81032204|FG000|Overall Study|Adverse Event|2|||
27782074|NCT00087594|81032205|FG001|Overall Study|Adverse Event|3|||
27782075|NCT00087594|81032204|FG000|Overall Study|Lost to Follow-up|0|||
27782076|NCT00087594|81032205|FG001|Overall Study|Lost to Follow-up|2|||
27782077|NCT00087594|81032204|FG000|Overall Study|Withdrawal by Subject|4|||
27782078|NCT00087594|81032205|FG001|Overall Study|Withdrawal by Subject|2|||
27782079|NCT00087594|81032204|FG000|Overall Study|Lack of Efficacy|2|||
27782080|NCT00087594|81032205|FG001|Overall Study|Lack of Efficacy|5|||
27782081|NCT02381795|81032206|FG000|Overall Study|Withdrawal by Subject|1|||
27782082|NCT02381795|81032206|FG000|Overall Study|Study Terminated|2|||
27782083|NCT01108068|81032207|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
27782084|NCT01108068|81032208|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
27782085|NCT00523744|81032210|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
27782086|NCT00523744|81032210|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
27782087|NCT00523744|81032210|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
27782088|NCT00523744|81032210|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
27782089|NCT00523744|81032210|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
27782090|NCT00523744|81032210|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
27782091|NCT02555722|81032211|FG000|Week 2|Adverse Event|0|||
27782092|NCT02555722|81032212|FG001|Week 2|Adverse Event|1|||
27782093|NCT02555722|81032211|FG000|Week 2|Withdrawal by Subject|1|||
27970951|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
27970952|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
27970953|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
27970954|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
27970955|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
27782094|NCT02555722|81032212|FG001|Week 2|Withdrawal by Subject|0|||
27782095|NCT02555722|81032211|FG000|Month 1|Lens Discomfort|1|||
27782096|NCT02555722|81032212|FG001|Month 1|Lens Discomfort|0|||
27782097|NCT02555722|81032211|FG000|Month 2|Withdrawal by Subject|3|||
27782098|NCT02555722|81032212|FG001|Month 2|Withdrawal by Subject|0|||
27782099|NCT02555722|81032211|FG000|Month 2|Lost to Follow-up|1|||
27782100|NCT02555722|81032212|FG001|Month 2|Lost to Follow-up|0|||
27782101|NCT02679222|81032213|FG000|Overall Study|No time for project|1|||
27782102|NCT01314261|81032214|FG000|Overall Study|Adverse Event|1|||
27782103|NCT01314261|81032215|FG001|Overall Study|Adverse Event|0|||
27864761|NCT05320887|81337251|FG003|Overall Study|Lost to Follow-up|0|||
27864762|NCT02886624|81337252|FG000|12-week Post Treatment Follow-up|Death|1|||
27864763|NCT02886624|81337252|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
27864764|NCT02695537|81337256|FG000|Overall Study|Adverse Event|3|||
27864765|NCT02695537|81337256|FG000|Overall Study|Lack of Efficacy|28|||
27864766|NCT02695537|81337256|FG000|Overall Study|Withdrawal by Subject|4|||
27864767|NCT02695537|81337256|FG000|Overall Study|Protocol Violation|3|||
27864768|NCT03700385|81337261|FG000|Overall Study|Lost to Follow-up|1|||
27864769|NCT03316547|81337262|FG000|Overall Study|Death|3|||
27864770|NCT03316547|81337263|FG001|Overall Study|Death|1|||
27864771|NCT03316547|81337262|FG000|Overall Study|Lost to Follow-up|6|||
27864772|NCT03316547|81337263|FG001|Overall Study|Lost to Follow-up|6|||
27864773|NCT03316547|81337262|FG000|Overall Study|Withdrawal by Subject|3|||
27864774|NCT03316547|81337263|FG001|Overall Study|Withdrawal by Subject|2|||
27864775|NCT03316547|81337262|FG000|Overall Study|Transfer to another hospital|6|||
27864776|NCT03316547|81337263|FG001|Overall Study|Transfer to another hospital|4|||
27864777|NCT03203850|81337264|FG000|Overall Study|Subject/guardian decision|4|||
27864778|NCT03203850|81337265|FG001|Overall Study|Subject/guardian decision|3|||
27864779|NCT03203850|81337264|FG000|Overall Study|Adverse Event|3|||
27864780|NCT03203850|81337265|FG001|Overall Study|Adverse Event|0|||
27864781|NCT03203850|81337264|FG000|Overall Study|Death|1|||
27864782|NCT03203850|81337265|FG001|Overall Study|Death|0|||
27864783|NCT02111603|81337267|FG000|Overall Study|Withdrawal by Subject|1|||
27864784|NCT01374269|81337270|FG000|Overall Study|Withdrawal by Subject|4|||
27864785|NCT01374269|81337271|FG001|Overall Study|Withdrawal by Subject|0|||
27864786|NCT01374269|81337270|FG000|Overall Study|Lost to Follow-up|1|||
27970956|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
27782104|NCT01314261|81032216|FG002|Overall Study|Adverse Event|0|||
27864787|NCT01374269|81337271|FG001|Overall Study|Lost to Follow-up|3|||
27864788|NCT01374269|81337270|FG000|Overall Study|closed research|1|||
27864789|NCT01374269|81337271|FG001|Overall Study|closed research|2|||
27782105|NCT01314261|81032217|FG003|Overall Study|Adverse Event|0|||
27782106|NCT01314261|81032214|FG000|Overall Study|Withdrawal by Subject|0|||
27782107|NCT01314261|81032215|FG001|Overall Study|Withdrawal by Subject|3|||
27782108|NCT01314261|81032216|FG002|Overall Study|Withdrawal by Subject|1|||
27782109|NCT01314261|81032217|FG003|Overall Study|Withdrawal by Subject|0|||
27782110|NCT01314261|81032214|FG000|Overall Study|Lost to Follow-up|1|||
27782111|NCT01314261|81032215|FG001|Overall Study|Lost to Follow-up|0|||
27782112|NCT01314261|81032216|FG002|Overall Study|Lost to Follow-up|2|||
27782113|NCT01314261|81032217|FG003|Overall Study|Lost to Follow-up|2|||
27782114|NCT01314261|81032214|FG000|Overall Study|Virologic Failure|0|||
27782115|NCT01314261|81032215|FG001|Overall Study|Virologic Failure|1|||
27782116|NCT01314261|81032216|FG002|Overall Study|Virologic Failure|0|||
27782117|NCT01314261|81032217|FG003|Overall Study|Virologic Failure|1|||
27782118|NCT00805142|81032219|FG000|Titration Period|Adverse Event|3|||
27782119|NCT00805142|81032220|FG001|Titration Period|Adverse Event|3|||
27782120|NCT00805142|81032219|FG000|Titration Period|Lack of Efficacy|1|||
27782121|NCT00805142|81032220|FG001|Titration Period|Lack of Efficacy|1|||
27782122|NCT00805142|81032219|FG000|Titration Period|Lost to Follow-up|0|||
27782123|NCT00805142|81032220|FG001|Titration Period|Lost to Follow-up|1|||
27782124|NCT00805142|81032219|FG000|Titration Period|Disease Progression|2|||
27782125|NCT00805142|81032220|FG001|Titration Period|Disease Progression|1|||
27782126|NCT00805142|81032219|FG000|Titration Period|Withdrawal of consent|0|||
27782127|NCT00805142|81032220|FG001|Titration Period|Withdrawal of consent|1|||
27864790|NCT03645863|81337275|FG000|Overall Study|Withdrawal by Subject|1|||
27864791|NCT03645863|81337276|FG001|Overall Study|Withdrawal by Subject|0|||
27864792|NCT03645863|81337277|FG002|Overall Study|Withdrawal by Subject|0|||
27864793|NCT00948155|81337278|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
27864794|NCT00948155|81337279|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
27864795|NCT00948155|81337278|FG000|Washout 14 Days|Lost to Follow-up|1|||
27864796|NCT00948155|81337279|FG001|Washout 14 Days|Lost to Follow-up|2|||
27864797|NCT01449370|81337280|FG000|Overall Study|Disease Progression|5|||
27864798|NCT01449370|81337281|FG001|Overall Study|Disease Progression|4|||
27864799|NCT01449370|81337282|FG002|Overall Study|Disease Progression|8|||
27970957|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
27970958|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
27970959|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970960|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970961|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970962|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
27970963|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
27970964|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970965|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970966|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970967|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970968|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27970969|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
27667981|NCT00611715|80623493|FG001|Overall Study|Adverse Event|1|||
27667982|NCT00611715|80623492|FG000|Overall Study|Death|1|||
27782128|NCT00805142|81032219|FG000|Titration Period|Other|0|||
27782129|NCT00805142|81032220|FG001|Titration Period|Other|3|||
27782130|NCT00805142|81032219|FG000|Maintenance Period|Adverse Event|0|||
27782131|NCT00805142|81032220|FG001|Maintenance Period|Adverse Event|1|||
27782132|NCT00805142|81032219|FG000|Maintenance Period|Other|0|||
27782133|NCT00805142|81032220|FG001|Maintenance Period|Other|1|||
27864800|NCT01449370|81337283|FG003|Overall Study|Disease Progression|3|||
27864801|NCT01449370|81337284|FG004|Overall Study|Disease Progression|3|||
27864802|NCT01449370|81337285|FG005|Overall Study|Disease Progression|3|||
27970970|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27970971|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
27970972|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
27970973|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
27970974|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27970975|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27970976|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27970977|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27970978|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27970979|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
27970980|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970981|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970982|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970983|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
27970984|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970985|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970986|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970987|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970988|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
27970989|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970990|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27571187|NCT04889625|80275433|FG000|Period 1|Discontinued due to fitting guide error|1|||
27571188|NCT04889625|80275434|FG001|Period 1|Discontinued due to fitting guide error|1|||
27571189|NCT04889625|80275433|FG000|Period 2|Test article no longer available|1|||
27571190|NCT04889625|80275434|FG001|Period 2|Test article no longer available|0|||
27571191|NCT04889625|80275433|FG000|Period 2|Incorrect lens dispensed|1|||
27571192|NCT04889625|80275434|FG001|Period 2|Incorrect lens dispensed|0|||
27571193|NCT04889625|80275433|FG000|Period 2|Wrong add power dispensed|0|||
27571194|NCT04889625|80275434|FG001|Period 2|Wrong add power dispensed|1|||
27864803|NCT01449370|81337286|FG006|Overall Study|Disease Progression|3|||
27864804|NCT01449370|81337287|FG007|Overall Study|Disease Progression|2|||
27970991|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970992|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970993|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
27970994|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27864805|NCT01449370|81337288|FG008|Overall Study|Disease Progression|9|||
27864806|NCT01449370|81337289|FG009|Overall Study|Disease Progression|1|||
27864807|NCT01449370|81337290|FG010|Overall Study|Disease Progression|3|||
27864808|NCT01449370|81337291|FG011|Overall Study|Disease Progression|3|||
27864809|NCT01449370|81337292|FG012|Overall Study|Disease Progression|2|||
27864810|NCT01449370|81337293|FG013|Overall Study|Disease Progression|8|||
27970995|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970996|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970997|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970998|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27970999|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971000|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
27971001|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971002|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971003|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
27971004|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971005|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971006|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971007|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27571195|NCT00701129|80275435|FG000|Overall Study|Death|2|||
27571196|NCT01940120|80275436|FG000|Overall Study|Death|40|||
27571197|NCT01940120|80275436|FG000|Overall Study|Withdrawal by Subject|8|||
27571198|NCT02188485|80275437|FG000|Overall Study|Withdrawal by Subject|2|||
27864811|NCT01449370|81337294|FG014|Overall Study|Disease Progression|3|||
27864812|NCT01449370|81337295|FG015|Overall Study|Disease Progression|1|||
27864813|NCT01449370|81337296|FG016|Overall Study|Disease Progression|4|||
27864814|NCT01449370|81337297|FG017|Overall Study|Disease Progression|3|||
27864815|NCT01449370|81337298|FG018|Overall Study|Disease Progression|1|||
27864816|NCT01449370|81337299|FG019|Overall Study|Disease Progression|2|||
27971008|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
27971009|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
27971010|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971011|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971012|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971013|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
27971014|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971015|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971016|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971017|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971018|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
27971019|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
27971020|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27971021|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
27971022|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27971023|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
27971024|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27971025|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27971026|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27971027|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27971028|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
27667983|NCT00611715|80623493|FG001|Overall Study|Death|0|||
27667984|NCT00611715|80623492|FG000|Overall Study|two patients are still on treatment|2|||
27667985|NCT00611715|80623493|FG001|Overall Study|two patients are still on treatment|0|||
27667986|NCT01560871|80623494|FG000|Overall Study|transportation issues|2|||
27667987|NCT01560871|80623495|FG001|Overall Study|transportation issues|1|||
27667988|NCT01560871|80623494|FG000|Overall Study|relocation|1|||
27667989|NCT01560871|80623495|FG001|Overall Study|relocation|0|||
27667990|NCT01560871|80623494|FG000|Overall Study|readmission to a hospital|2|||
27667991|NCT01560871|80623495|FG001|Overall Study|readmission to a hospital|1|||
27667992|NCT01560871|80623494|FG000|Overall Study|Lost to Follow-up|1|||
27667993|NCT01560871|80623495|FG001|Overall Study|Lost to Follow-up|0|||
27667994|NCT01821729|80623500|FG000|Overall Study|Withdrawal by Subject|1|||
27667995|NCT00263575|80623505|FG000|Titration Period|Adverse Event|14|||
27667996|NCT00263575|80623505|FG000|Titration Period|Withdrawal by Subject|10|||
27667997|NCT00263575|80623505|FG000|Titration Period|Protocol Violation|9|||
27667998|NCT00263575|80623505|FG000|Titration Period|Sponsor Decision|2|||
27667999|NCT00263575|80623505|FG000|Titration Period|Other|2|||
27668000|NCT00263575|80623505|FG000|Titration Period|Lack of Efficacy|6|||
27668001|NCT00263575|80623505|FG000|Maintence Period|Adverse Event|23|||
27668002|NCT00263575|80623505|FG000|Maintence Period|Withdrawal by Subject|8|||
27782134|NCT01488994|81032230|FG000|Overall Study|Withdrawal by Subject|0|||
27971029|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Other|5|||
27668003|NCT00263575|80623505|FG000|Maintence Period|Protocol Violation|4|||
27668004|NCT00263575|80623505|FG000|Maintence Period|Lack of Efficacy|4|||
27668005|NCT00263575|80623505|FG000|Maintence Period|Physician Decision|6|||
27668006|NCT00263575|80623505|FG000|Maintence Period|Lost to Follow-up|1|||
27668007|NCT00263575|80623505|FG000|Maintence Period|Sponsor Decision|24|||
27668008|NCT00263575|80623505|FG000|Maintence Period|Other|7|||
27668009|NCT01721746|80623506|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
27864817|NCT01449370|81337300|FG020|Overall Study|Disease Progression|5|||
27668010|NCT01721746|80623507|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
27668011|NCT01721746|80623506|FG000|Pre-Treatment|Withdrawal by Subject|1|||
27668012|NCT01721746|80623507|FG001|Pre-Treatment|Withdrawal by Subject|16|||
27668013|NCT01721746|80623506|FG000|Pre-Treatment|Poor/Non-compliance|1|||
27668014|NCT01721746|80623507|FG001|Pre-Treatment|Poor/Non-compliance|0|||
27668015|NCT01721746|80623506|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
27668016|NCT01721746|80623507|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
27668017|NCT01721746|80623506|FG000|Treatment|Disease Progression|192|||
27668018|NCT01721746|80623507|FG001|Treatment|Disease Progression|74|||
27668019|NCT01721746|80623506|FG000|Treatment|Study Drug Toxicity|19|||
27668020|NCT01721746|80623507|FG001|Treatment|Study Drug Toxicity|11|||
27668021|NCT01721746|80623506|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
27668022|NCT01721746|80623507|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
27668023|NCT01721746|80623506|FG000|Treatment|Participant request to discontinue Study treatment|26|||
27668024|NCT01721746|80623507|FG001|Treatment|Participant request to discontinue Study treatment|7|||
27668025|NCT01721746|80623506|FG000|Treatment|Participant withdrew consent|4|||
27668026|NCT01721746|80623507|FG001|Treatment|Participant withdrew consent|2|||
27668027|NCT01721746|80623506|FG000|Treatment|Maximum Clinical Benefit|9|||
27668028|NCT01721746|80623507|FG001|Treatment|Maximum Clinical Benefit|3|||
27668029|NCT01721746|80623506|FG000|Treatment|Poor/Non-compliance|2|||
27668030|NCT01721746|80623507|FG001|Treatment|Poor/Non-compliance|0|||
27668031|NCT01721746|80623506|FG000|Treatment|Participant no longer met Study criteria|4|||
27668032|NCT01721746|80623507|FG001|Treatment|Participant no longer met Study criteria|0|||
27668033|NCT01721746|80623506|FG000|Treatment|Other reasons|6|||
27668034|NCT01721746|80623507|FG001|Treatment|Other reasons|2|||
27668035|NCT01644188|80623508|FG000|Overall Study|Adverse Event|44|||
27668036|NCT01644188|80623509|FG001|Overall Study|Adverse Event|20|||
27668037|NCT01644188|80623508|FG000|Overall Study|Poor compliance to protocol|26|||
27668038|NCT01644188|80623509|FG001|Overall Study|Poor compliance to protocol|14|||
27668039|NCT01644188|80623508|FG000|Overall Study|Physician Decision|1|||
27668040|NCT01644188|80623509|FG001|Overall Study|Physician Decision|3|||
27668041|NCT01644188|80623508|FG000|Overall Study|Participant moved|7|||
27668042|NCT01644188|80623509|FG001|Overall Study|Participant moved|2|||
27668043|NCT01644188|80623508|FG000|Overall Study|Related to auto-injector administration|2|||
27668044|NCT01644188|80623509|FG001|Overall Study|Related to auto-injector administration|2|||
27668045|NCT01644188|80623508|FG000|Overall Study|Consent withdrawn by participant|14|||
27668046|NCT01644188|80623509|FG001|Overall Study|Consent withdrawn by participant|7|||
27864818|NCT01449370|81337301|FG021|Overall Study|Disease Progression|2|||
27864819|NCT01449370|81337302|FG022|Overall Study|Disease Progression|3|||
27864820|NCT01449370|81337303|FG023|Overall Study|Disease Progression|7|||
27864821|NCT01449370|81337304|FG024|Overall Study|Disease Progression|3|||
27864822|NCT01449370|81337280|FG000|Overall Study|Adverse Event|1|||
27864823|NCT01449370|81337281|FG001|Overall Study|Adverse Event|2|||
27864824|NCT01449370|81337282|FG002|Overall Study|Adverse Event|0|||
27864825|NCT01449370|81337283|FG003|Overall Study|Adverse Event|1|||
27864826|NCT01449370|81337284|FG004|Overall Study|Adverse Event|0|||
27864827|NCT01449370|81337285|FG005|Overall Study|Adverse Event|0|||
27864828|NCT01449370|81337286|FG006|Overall Study|Adverse Event|0|||
27864829|NCT01449370|81337287|FG007|Overall Study|Adverse Event|0|||
27864830|NCT01449370|81337288|FG008|Overall Study|Adverse Event|1|||
27864831|NCT01449370|81337289|FG009|Overall Study|Adverse Event|1|||
27864832|NCT01449370|81337290|FG010|Overall Study|Adverse Event|0|||
27864833|NCT01449370|81337291|FG011|Overall Study|Adverse Event|0|||
27864834|NCT01449370|81337292|FG012|Overall Study|Adverse Event|0|||
27864835|NCT01449370|81337293|FG013|Overall Study|Adverse Event|2|||
27864836|NCT01449370|81337294|FG014|Overall Study|Adverse Event|0|||
27864837|NCT01449370|81337295|FG015|Overall Study|Adverse Event|1|||
27864838|NCT01449370|81337296|FG016|Overall Study|Adverse Event|0|||
27864839|NCT01449370|81337297|FG017|Overall Study|Adverse Event|0|||
27864840|NCT01449370|81337298|FG018|Overall Study|Adverse Event|1|||
27864841|NCT01449370|81337299|FG019|Overall Study|Adverse Event|1|||
27864842|NCT01449370|81337300|FG020|Overall Study|Adverse Event|0|||
27971030|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Other|1|||
27971031|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Other|0|||
27668047|NCT01644188|80623508|FG000|Overall Study|Selection criteria finally not met|2|||
27668048|NCT01644188|80623509|FG001|Overall Study|Selection criteria finally not met|0|||
27668049|NCT01644188|80623508|FG000|Overall Study|Lost to Follow-up|1|||
27864843|NCT01449370|81337301|FG021|Overall Study|Adverse Event|1|||
27864844|NCT01449370|81337302|FG022|Overall Study|Adverse Event|0|||
27864845|NCT01449370|81337303|FG023|Overall Study|Adverse Event|1|||
27864846|NCT01449370|81337304|FG024|Overall Study|Adverse Event|3|||
27864847|NCT01449370|81337280|FG000|Overall Study|Participant Decision|0|||
27971032|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Other|3|||
27971033|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Other|0|||
27864848|NCT01449370|81337281|FG001|Overall Study|Participant Decision|0|||
27668050|NCT01644188|80623509|FG001|Overall Study|Lost to Follow-up|0|||
27668051|NCT01644188|80623508|FG000|Overall Study|Death|4|||
27668052|NCT01644188|80623509|FG001|Overall Study|Death|3|||
27668053|NCT01644188|80623508|FG000|Overall Study|Last visit outside protocol visit window|14|||
27668054|NCT01644188|80623509|FG001|Overall Study|Last visit outside protocol visit window|16|||
27668055|NCT01644188|80623508|FG000|Overall Study|Site closure|1|||
27668056|NCT01644188|80623509|FG001|Overall Study|Site closure|1|||
27971034|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Other|0|||
27971035|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Other|0|||
27971036|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Other|0|||
27971037|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Other|0|||
27971038|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Other|0|||
27971039|NCT03352557|81722931|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971040|NCT03352557|81722932|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971041|NCT03352557|81722933|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971042|NCT03352557|81722934|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971043|NCT03352557|81722935|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
27971044|NCT03352557|81722936|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971045|NCT03352557|81722937|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
27668057|NCT01644188|80623508|FG000|Overall Study|Other than specified above|6|||
27971046|NCT03352557|81722938|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
27668058|NCT01644188|80623509|FG001|Overall Study|Other than specified above|7|||
27668059|NCT01006889|80623510|FG000|Overall Study|Withdrawal by Subject|3|||
27668060|NCT03464383|80623515|FG000|Overall Study|Lost to Follow-up|1|||
27668061|NCT03464383|80623516|FG001|Overall Study|Lost to Follow-up|0|||
27668062|NCT03464383|80623517|FG002|Overall Study|Lost to Follow-up|0|||
27971047|NCT03352557|81722939|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971048|NCT03352557|81722940|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
27971049|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Death|0|||
27971050|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Death|0|||
27971051|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Death|0|||
27971052|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Death|0|||
27971053|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Death|0|||
27971054|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Death|1|||
27971055|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Death|0|||
27971056|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Death|1|||
27668063|NCT03464383|80623515|FG000|Overall Study|Withdrawal by Subject|0|||
27668064|NCT03464383|80623516|FG001|Overall Study|Withdrawal by Subject|1|||
27668065|NCT03464383|80623517|FG002|Overall Study|Withdrawal by Subject|0|||
27668066|NCT01255761|80623518|FG000|Overall Study|Adverse Event|29|||
27668067|NCT01255761|80623519|FG001|Overall Study|Adverse Event|43|||
27668068|NCT01255761|80623518|FG000|Overall Study|Lack of Efficacy|86|||
27668069|NCT01255761|80623519|FG001|Overall Study|Lack of Efficacy|74|||
27668070|NCT01255761|80623518|FG000|Overall Study|Protocol Violation|9|||
27668071|NCT01255761|80623519|FG001|Overall Study|Protocol Violation|5|||
27668072|NCT01255761|80623518|FG000|Overall Study|Lost to Follow-up|10|||
27668073|NCT01255761|80623519|FG001|Overall Study|Lost to Follow-up|8|||
27668074|NCT01255761|80623518|FG000|Overall Study|Withdrawal by Subject|11|||
27668075|NCT01255761|80623519|FG001|Overall Study|Withdrawal by Subject|27|||
27668076|NCT01255761|80623518|FG000|Overall Study|Other Reasons|37|||
27668077|NCT01255761|80623519|FG001|Overall Study|Other Reasons|18|||
27668078|NCT00280683|80623528|FG000|Overall Study|Withdrawal by Subject|1|||
27668079|NCT00280683|80623529|FG001|Overall Study|Withdrawal by Subject|2|||
27668080|NCT00280683|80623528|FG000|Overall Study|Adverse Event|1|||
27668081|NCT00280683|80623529|FG001|Overall Study|Adverse Event|1|||
27668082|NCT01161446|80623532|FG000|Overall Study|Lost to Follow-up|18|||
27571199|NCT02188485|80275438|FG001|Overall Study|Withdrawal by Subject|1|||
27571200|NCT02188485|80275437|FG000|Overall Study|PI withdrew, lack of capacity|0|||
27668083|NCT01161446|80623533|FG001|Overall Study|Lost to Follow-up|14|||
27971057|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Death|1|||
27971058|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Death|1|||
27971059|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27571201|NCT02188485|80275438|FG001|Overall Study|PI withdrew, lack of capacity|2|||
27571202|NCT04033003|80275439|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
27668084|NCT01161446|80623532|FG000|Overall Study|Withdrawal by Subject|0|||
27668085|NCT01161446|80623533|FG001|Overall Study|Withdrawal by Subject|1|||
27668086|NCT02560389|80623534|FG000|Overall Study|Lost to Follow-up|1|||
27971060|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971061|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971062|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971063|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971064|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
27971065|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971066|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971067|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971068|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
27971069|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27971070|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27971071|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27971072|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27668087|NCT02560389|80623535|FG001|Overall Study|Lost to Follow-up|2|||
27668088|NCT02560389|80623536|FG002|Overall Study|Lost to Follow-up|2|||
27668089|NCT02560389|80623534|FG000|Overall Study|Tested positive for illicit substance|0|||
27668090|NCT02560389|80623535|FG001|Overall Study|Tested positive for illicit substance|1|||
27668091|NCT02560389|80623536|FG002|Overall Study|Tested positive for illicit substance|0|||
27668092|NCT00552513|80623537|FG000|Overall Study|Lost to Follow-up|5|||
27668093|NCT00552513|80623538|FG001|Overall Study|Lost to Follow-up|1|||
27668094|NCT00510198|80623539|FG000|Overall Study|Withdrawal by Subject|5|||
27668095|NCT00510198|80623540|FG001|Overall Study|Withdrawal by Subject|4|||
27668096|NCT01253447|80623541|FG000|Overall Study|Adverse Event|2|||
27668097|NCT01200485|80623542|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
27668098|NCT01200485|80623543|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
27668099|NCT01200485|80623544|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
27668100|NCT01200485|80623542|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
27668101|NCT01200485|80623543|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
27668102|NCT01200485|80623544|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
27668103|NCT00644878|80623545|FG000|Overall Study|Adverse Event|2|||
27668104|NCT00644878|80623545|FG000|Overall Study|Abnormal laboratory value|3|||
27971073|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27668105|NCT00644878|80623545|FG000|Overall Study|Protocol deviation|2|||
27782135|NCT01488994|81032231|FG001|Overall Study|Withdrawal by Subject|1|||
27782136|NCT04450394|81032232|FG000|Overall Study|Adverse Event|2|||
27782137|NCT04450394|81032233|FG001|Overall Study|Adverse Event|0|||
27782138|NCT04450394|81032234|FG002|Overall Study|Adverse Event|0|||
27782139|NCT04450394|81032232|FG000|Overall Study|Death|0|||
27782140|NCT04450394|81032233|FG001|Overall Study|Death|1|||
27782141|NCT04450394|81032234|FG002|Overall Study|Death|0|||
27971074|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27571203|NCT04033003|80275440|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
27571204|NCT04033003|80275439|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
27571205|NCT04033003|80275440|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
27571206|NCT04033003|80275439|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
27571207|NCT04033003|80275440|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
27571208|NCT04033003|80275439|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
27571209|NCT04033003|80275440|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
27571210|NCT04033003|80275439|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
27571211|NCT04033003|80275440|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
27782142|NCT04450394|81032232|FG000|Overall Study|Lost to Follow-up|0|||
27782143|NCT04450394|81032233|FG001|Overall Study|Lost to Follow-up|3|||
27782144|NCT04450394|81032234|FG002|Overall Study|Lost to Follow-up|0|||
27782145|NCT04450394|81032232|FG000|Overall Study|Physician Decision|0|||
27782146|NCT04450394|81032233|FG001|Overall Study|Physician Decision|1|||
27782147|NCT04450394|81032234|FG002|Overall Study|Physician Decision|0|||
27782148|NCT04450394|81032232|FG000|Overall Study|Protocol Violation|2|||
27864849|NCT01449370|81337282|FG002|Overall Study|Participant Decision|0|||
27864850|NCT01449370|81337283|FG003|Overall Study|Participant Decision|0|||
27864851|NCT01449370|81337284|FG004|Overall Study|Participant Decision|0|||
27864852|NCT01449370|81337285|FG005|Overall Study|Participant Decision|0|||
27864853|NCT01449370|81337286|FG006|Overall Study|Participant Decision|0|||
27864854|NCT01449370|81337287|FG007|Overall Study|Participant Decision|1|||
27971075|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27971076|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27864855|NCT01449370|81337288|FG008|Overall Study|Participant Decision|1|||
27864856|NCT01449370|81337289|FG009|Overall Study|Participant Decision|0|||
27864857|NCT01449370|81337290|FG010|Overall Study|Participant Decision|0|||
27971077|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
27971078|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
27971079|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
27971080|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
27971081|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
27971082|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
27971083|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
27971084|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
27971085|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
27971086|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
27971087|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
27571212|NCT04033003|80275439|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
27782149|NCT04450394|81032233|FG001|Overall Study|Protocol Violation|0|||
27782150|NCT04450394|81032234|FG002|Overall Study|Protocol Violation|0|||
27782151|NCT04450394|81032232|FG000|Overall Study|Withdrawal by Subject|6|||
27782152|NCT04450394|81032233|FG001|Overall Study|Withdrawal by Subject|9|||
27782153|NCT04450394|81032234|FG002|Overall Study|Withdrawal by Subject|0|||
27782154|NCT01790633|81032237|FG000|Overall Study|Protocol Violation|1|||
27782155|NCT01790633|81032238|FG001|Overall Study|Protocol Violation|2|||
27782156|NCT01790633|81032237|FG000|Overall Study|Did not have serology performed|47|||
27782157|NCT01790633|81032238|FG001|Overall Study|Did not have serology performed|0|||
27782158|NCT01790633|81032237|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
27782159|NCT01790633|81032238|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
27782160|NCT03524664|81032239|FG000|Overall Study|Withdrawal by Subject|1|||
27782161|NCT03524664|81032240|FG001|Overall Study|Withdrawal by Subject|2|||
27782162|NCT03524664|81032239|FG000|Overall Study|Lost to Follow-up|4|||
27782163|NCT03524664|81032240|FG001|Overall Study|Lost to Follow-up|13|||
27782164|NCT00372905|81032241|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
27782165|NCT00372905|81032242|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
27782166|NCT00372905|81032243|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
27782167|NCT00372905|81032244|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
27782168|NCT00372905|81032241|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
27782169|NCT00372905|81032242|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
27782170|NCT00372905|81032243|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
27782171|NCT00372905|81032244|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
27782172|NCT00372905|81032241|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
27864858|NCT01449370|81337291|FG011|Overall Study|Participant Decision|0|||
27864859|NCT01449370|81337292|FG012|Overall Study|Participant Decision|1|||
27971088|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
27971089|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27971090|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27971091|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27571213|NCT04033003|80275440|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
27571214|NCT04033003|80275439|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
27571215|NCT04033003|80275440|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
27571216|NCT04033003|80275439|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
27571217|NCT04033003|80275440|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
27571218|NCT04033003|80275439|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
27571219|NCT04033003|80275440|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
27571220|NCT04033003|80275439|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
27571221|NCT04033003|80275440|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
27571222|NCT04033003|80275439|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
27571223|NCT04033003|80275440|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
27571224|NCT04033003|80275439|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
27571225|NCT04033003|80275440|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
27571226|NCT04033003|80275439|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
27571227|NCT04033003|80275440|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
27571228|NCT03907683|80275442|FG000|Overall Study|Pregnancy|1|||
27571229|NCT03907683|80275442|FG000|Overall Study|Withdrawal by Subject|1|||
27571230|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
27571231|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
27571232|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
27571233|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
27571234|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
27571235|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
27571236|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
27571237|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
27571238|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
27571239|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
27782173|NCT00372905|81032242|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
27782174|NCT00372905|81032243|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
27782175|NCT00372905|81032244|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
27782176|NCT00372905|81032241|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
27782177|NCT00372905|81032242|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
27782178|NCT00372905|81032243|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
27782179|NCT00372905|81032244|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
27782180|NCT00372905|81032241|FG000|Follow up Until Relapse or Progression|Study closed|0|||
27864860|NCT01449370|81337293|FG013|Overall Study|Participant Decision|1|||
27864861|NCT01449370|81337294|FG014|Overall Study|Participant Decision|0|||
27864862|NCT01449370|81337295|FG015|Overall Study|Participant Decision|1|||
27864863|NCT01449370|81337296|FG016|Overall Study|Participant Decision|3|||
27864864|NCT01449370|81337297|FG017|Overall Study|Participant Decision|0|||
27864865|NCT01449370|81337298|FG018|Overall Study|Participant Decision|1|||
27864866|NCT01449370|81337299|FG019|Overall Study|Participant Decision|0|||
27864867|NCT01449370|81337300|FG020|Overall Study|Participant Decision|0|||
27864868|NCT01449370|81337301|FG021|Overall Study|Participant Decision|1|||
27864869|NCT01449370|81337302|FG022|Overall Study|Participant Decision|0|||
27864870|NCT01449370|81337303|FG023|Overall Study|Participant Decision|0|||
27864871|NCT01449370|81337304|FG024|Overall Study|Participant Decision|1|||
27864872|NCT01449370|81337280|FG000|Overall Study|Lost to Follow-up|0|||
27864873|NCT01449370|81337281|FG001|Overall Study|Lost to Follow-up|0|||
27864874|NCT01449370|81337282|FG002|Overall Study|Lost to Follow-up|0|||
27864875|NCT01449370|81337283|FG003|Overall Study|Lost to Follow-up|0|||
27864876|NCT01449370|81337284|FG004|Overall Study|Lost to Follow-up|0|||
27864877|NCT01449370|81337285|FG005|Overall Study|Lost to Follow-up|0|||
27864878|NCT01449370|81337286|FG006|Overall Study|Lost to Follow-up|0|||
27864879|NCT01449370|81337287|FG007|Overall Study|Lost to Follow-up|0|||
27864880|NCT01449370|81337288|FG008|Overall Study|Lost to Follow-up|0|||
27864881|NCT01449370|81337289|FG009|Overall Study|Lost to Follow-up|0|||
27782181|NCT00372905|81032242|FG001|Follow up Until Relapse or Progression|Study closed|0|||
27782182|NCT00372905|81032243|FG002|Follow up Until Relapse or Progression|Study closed|0|||
27782183|NCT00372905|81032244|FG003|Follow up Until Relapse or Progression|Study closed|3|||
27782184|NCT00372905|81032241|FG000|Follow up Until Relapse or Progression|Other|0|||
27782185|NCT00372905|81032242|FG001|Follow up Until Relapse or Progression|Other|1|||
27782186|NCT00372905|81032243|FG002|Follow up Until Relapse or Progression|Other|0|||
27864882|NCT01449370|81337290|FG010|Overall Study|Lost to Follow-up|0|||
27864883|NCT01449370|81337291|FG011|Overall Study|Lost to Follow-up|0|||
27864884|NCT01449370|81337292|FG012|Overall Study|Lost to Follow-up|0|||
27864885|NCT01449370|81337293|FG013|Overall Study|Lost to Follow-up|0|||
27864886|NCT01449370|81337294|FG014|Overall Study|Lost to Follow-up|0|||
27571240|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
27571241|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
27571242|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
27864887|NCT01449370|81337295|FG015|Overall Study|Lost to Follow-up|0|||
27864888|NCT01449370|81337296|FG016|Overall Study|Lost to Follow-up|0|||
27864889|NCT01449370|81337297|FG017|Overall Study|Lost to Follow-up|0|||
27864890|NCT01449370|81337298|FG018|Overall Study|Lost to Follow-up|0|||
27864891|NCT01449370|81337299|FG019|Overall Study|Lost to Follow-up|0|||
27864892|NCT01449370|81337300|FG020|Overall Study|Lost to Follow-up|1|||
27864893|NCT01449370|81337301|FG021|Overall Study|Lost to Follow-up|0|||
27864894|NCT01449370|81337302|FG022|Overall Study|Lost to Follow-up|0|||
27864895|NCT01449370|81337303|FG023|Overall Study|Lost to Follow-up|0|||
27864896|NCT01449370|81337304|FG024|Overall Study|Lost to Follow-up|0|||
27864897|NCT01449370|81337280|FG000|Overall Study|Other|0|||
27864898|NCT01449370|81337281|FG001|Overall Study|Other|0|||
27864899|NCT01449370|81337282|FG002|Overall Study|Other|0|||
27864900|NCT01449370|81337283|FG003|Overall Study|Other|0|||
27864901|NCT01449370|81337284|FG004|Overall Study|Other|0|||
27864902|NCT01449370|81337285|FG005|Overall Study|Other|0|||
27864903|NCT01449370|81337286|FG006|Overall Study|Other|0|||
27864904|NCT01449370|81337287|FG007|Overall Study|Other|0|||
27864905|NCT01449370|81337288|FG008|Overall Study|Other|1|||
27864906|NCT01449370|81337289|FG009|Overall Study|Other|1|||
27864907|NCT01449370|81337290|FG010|Overall Study|Other|0|||
27864908|NCT01449370|81337291|FG011|Overall Study|Other|0|||
27864909|NCT01449370|81337292|FG012|Overall Study|Other|0|||
27864910|NCT01449370|81337293|FG013|Overall Study|Other|0|||
27864911|NCT01449370|81337294|FG014|Overall Study|Other|0|||
27864912|NCT01449370|81337295|FG015|Overall Study|Other|0|||
27864913|NCT01449370|81337296|FG016|Overall Study|Other|0|||
27864914|NCT01449370|81337297|FG017|Overall Study|Other|0|||
27864915|NCT01449370|81337298|FG018|Overall Study|Other|0|||
27864916|NCT01449370|81337299|FG019|Overall Study|Other|0|||
27864917|NCT01449370|81337300|FG020|Overall Study|Other|0|||
27864918|NCT01449370|81337301|FG021|Overall Study|Other|0|||
27864919|NCT01449370|81337302|FG022|Overall Study|Other|1|||
27864920|NCT01449370|81337303|FG023|Overall Study|Other|1|||
27864921|NCT01449370|81337304|FG024|Overall Study|Other|0|||
27864922|NCT01449370|81337280|FG000|Overall Study|Medication Prohibited by Protocol|0|||
27864923|NCT01449370|81337281|FG001|Overall Study|Medication Prohibited by Protocol|0|||
27864924|NCT01449370|81337282|FG002|Overall Study|Medication Prohibited by Protocol|0|||
27864925|NCT01449370|81337283|FG003|Overall Study|Medication Prohibited by Protocol|0|||
27864926|NCT01449370|81337284|FG004|Overall Study|Medication Prohibited by Protocol|0|||
27864927|NCT01449370|81337285|FG005|Overall Study|Medication Prohibited by Protocol|0|||
27864928|NCT01449370|81337286|FG006|Overall Study|Medication Prohibited by Protocol|0|||
27864929|NCT01449370|81337287|FG007|Overall Study|Medication Prohibited by Protocol|0|||
27864930|NCT01449370|81337288|FG008|Overall Study|Medication Prohibited by Protocol|0|||
27864931|NCT01449370|81337289|FG009|Overall Study|Medication Prohibited by Protocol|0|||
27864932|NCT01449370|81337290|FG010|Overall Study|Medication Prohibited by Protocol|0|||
27864933|NCT01449370|81337291|FG011|Overall Study|Medication Prohibited by Protocol|0|||
27864934|NCT01449370|81337292|FG012|Overall Study|Medication Prohibited by Protocol|0|||
27864935|NCT01449370|81337293|FG013|Overall Study|Medication Prohibited by Protocol|0|||
27864936|NCT01449370|81337294|FG014|Overall Study|Medication Prohibited by Protocol|0|||
27864937|NCT01449370|81337295|FG015|Overall Study|Medication Prohibited by Protocol|0|||
27864938|NCT01449370|81337296|FG016|Overall Study|Medication Prohibited by Protocol|0|||
27864939|NCT01449370|81337297|FG017|Overall Study|Medication Prohibited by Protocol|0|||
27864940|NCT01449370|81337298|FG018|Overall Study|Medication Prohibited by Protocol|0|||
27864941|NCT01449370|81337299|FG019|Overall Study|Medication Prohibited by Protocol|0|||
27864942|NCT01449370|81337300|FG020|Overall Study|Medication Prohibited by Protocol|0|||
27864943|NCT01449370|81337301|FG021|Overall Study|Medication Prohibited by Protocol|0|||
27864944|NCT01449370|81337302|FG022|Overall Study|Medication Prohibited by Protocol|0|||
27864945|NCT01449370|81337303|FG023|Overall Study|Medication Prohibited by Protocol|1|||
27864946|NCT01449370|81337304|FG024|Overall Study|Medication Prohibited by Protocol|0|||
27864947|NCT01449370|81337280|FG000|Overall Study|Death|0|||
27864948|NCT01449370|81337281|FG001|Overall Study|Death|0|||
27864949|NCT01449370|81337282|FG002|Overall Study|Death|0|||
27864950|NCT01449370|81337283|FG003|Overall Study|Death|0|||
27864951|NCT01449370|81337284|FG004|Overall Study|Death|0|||
27864952|NCT01449370|81337285|FG005|Overall Study|Death|0|||
27864953|NCT01449370|81337286|FG006|Overall Study|Death|0|||
27864954|NCT01449370|81337287|FG007|Overall Study|Death|0|||
27864955|NCT01449370|81337288|FG008|Overall Study|Death|0|||
27864956|NCT01449370|81337289|FG009|Overall Study|Death|0|||
27864957|NCT01449370|81337290|FG010|Overall Study|Death|0|||
27864958|NCT01449370|81337291|FG011|Overall Study|Death|0|||
27864959|NCT01449370|81337292|FG012|Overall Study|Death|0|||
27864960|NCT01449370|81337293|FG013|Overall Study|Death|0|||
27864961|NCT01449370|81337294|FG014|Overall Study|Death|0|||
27864962|NCT01449370|81337295|FG015|Overall Study|Death|0|||
27864963|NCT01449370|81337296|FG016|Overall Study|Death|0|||
27864964|NCT01449370|81337297|FG017|Overall Study|Death|0|||
27864965|NCT01449370|81337298|FG018|Overall Study|Death|0|||
27864966|NCT01449370|81337299|FG019|Overall Study|Death|0|||
27864967|NCT01449370|81337300|FG020|Overall Study|Death|0|||
27864968|NCT01449370|81337301|FG021|Overall Study|Death|0|||
27864969|NCT01449370|81337302|FG022|Overall Study|Death|0|||
27864970|NCT01449370|81337303|FG023|Overall Study|Death|0|||
27864971|NCT01449370|81337304|FG024|Overall Study|Death|1|||
27864972|NCT04102189|81337308|FG000|Overall Study|Withdrawal by Subject|1|||
27864973|NCT04102189|81337309|FG001|Overall Study|Withdrawal by Subject|2|||
27864974|NCT04102189|81337308|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27864975|NCT04102189|81337309|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27864976|NCT04102189|81337308|FG000|Overall Study|Lost to Follow-up|1|||
27864977|NCT04102189|81337309|FG001|Overall Study|Lost to Follow-up|0|||
27864978|NCT04194645|81337310|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864979|NCT04194645|81337311|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864980|NCT04194645|81337312|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864981|NCT04194645|81337313|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864982|NCT04194645|81337314|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864983|NCT04194645|81337315|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864984|NCT04194645|81337316|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864985|NCT04194645|81337317|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864986|NCT04194645|81337318|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864987|NCT04194645|81337319|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
27864988|NCT04194645|81337320|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864989|NCT04194645|81337321|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864990|NCT04194645|81337322|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864991|NCT04194645|81337323|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864992|NCT04194645|81337324|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
27864993|NCT01862484|81337325|FG000|Overall Study|Lack of Efficacy|1|||
27864994|NCT01862484|81337326|FG001|Overall Study|Lack of Efficacy|1|||
27864995|NCT01862484|81337325|FG000|Overall Study|Lost to Follow-up|1|||
27864996|NCT01862484|81337326|FG001|Overall Study|Lost to Follow-up|2|||
27864997|NCT01862484|81337325|FG000|Overall Study|Protocol Violation|0|||
27971092|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27971093|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27782187|NCT00372905|81032244|FG003|Follow up Until Relapse or Progression|Other|0|||
27782188|NCT01524900|81032245|FG000|Overall Study|Lost to Follow-up|3|||
27782189|NCT01524900|81032246|FG001|Overall Study|Lost to Follow-up|12|||
27782190|NCT01524900|81032247|FG002|Overall Study|Lost to Follow-up|1|||
27782191|NCT01524900|81032248|FG003|Overall Study|Lost to Follow-up|0|||
27782192|NCT01524900|81032249|FG004|Overall Study|Lost to Follow-up|0|||
27782193|NCT01524900|81032245|FG000|Overall Study|Other reason than stated above|1|||
27782194|NCT01524900|81032246|FG001|Overall Study|Other reason than stated above|1|||
27782195|NCT01524900|81032247|FG002|Overall Study|Other reason than stated above|0|||
27782196|NCT01524900|81032248|FG003|Overall Study|Other reason than stated above|0|||
27782197|NCT01524900|81032249|FG004|Overall Study|Other reason than stated above|0|||
27782198|NCT01524900|81032245|FG000|Overall Study|No reason documented|2|||
27782199|NCT01524900|81032246|FG001|Overall Study|No reason documented|1|||
27782200|NCT01524900|81032247|FG002|Overall Study|No reason documented|0|||
27782201|NCT01524900|81032248|FG003|Overall Study|No reason documented|1|||
27782202|NCT01524900|81032249|FG004|Overall Study|No reason documented|0|||
27782203|NCT00104299|81032259|FG000|Overall Study|Adverse Event|3|||
27782204|NCT00104299|81032260|FG001|Overall Study|Adverse Event|1|||
27782205|NCT00104299|81032259|FG000|Overall Study|Death|2|||
27782206|NCT00104299|81032260|FG001|Overall Study|Death|2|||
27782207|NCT00104299|81032259|FG000|Overall Study|Withdrawal by Subject|2|||
27782208|NCT00104299|81032260|FG001|Overall Study|Withdrawal by Subject|6|||
27782209|NCT00104299|81032259|FG000|Overall Study|Physician Decision|1|||
27782210|NCT00104299|81032260|FG001|Overall Study|Physician Decision|1|||
27864998|NCT01862484|81337326|FG001|Overall Study|Protocol Violation|2|||
27864999|NCT01862484|81337325|FG000|Overall Study|Withdrawal by Subject|0|||
27865000|NCT01862484|81337326|FG001|Overall Study|Withdrawal by Subject|3|||
27782211|NCT00104299|81032259|FG000|Overall Study|To have renal transplant|1|||
27782212|NCT00104299|81032260|FG001|Overall Study|To have renal transplant|0|||
27782213|NCT01231620|81032263|FG000|Overall Study|Physician Decision|3|||
27782214|NCT01231620|81032264|FG001|Overall Study|Physician Decision|5|||
27782215|NCT01231620|81032265|FG002|Overall Study|Physician Decision|10|||
27865001|NCT05513391|81337327|FG000|Overall Study|Adverse Event|1|||
27865002|NCT05513391|81337328|FG001|Overall Study|Adverse Event|0|||
27865003|NCT05513391|81337327|FG000|Overall Study|Protocol Deviation|0|||
27865004|NCT05513391|81337328|FG001|Overall Study|Protocol Deviation|1|||
27865005|NCT05513391|81337327|FG000|Overall Study|Withdrawal by Subject|3|||
27782216|NCT01231620|81032263|FG000|Overall Study|Death|12|||
27782217|NCT01231620|81032264|FG001|Overall Study|Death|14|||
27782218|NCT01231620|81032265|FG002|Overall Study|Death|11|||
27782219|NCT01231620|81032263|FG000|Overall Study|Adverse Event|2|||
27782220|NCT01231620|81032264|FG001|Overall Study|Adverse Event|2|||
27782221|NCT01231620|81032265|FG002|Overall Study|Adverse Event|1|||
27782222|NCT01231620|81032263|FG000|Overall Study|Withdrawal by Subject|6|||
27782223|NCT01231620|81032264|FG001|Overall Study|Withdrawal by Subject|6|||
27782224|NCT01231620|81032265|FG002|Overall Study|Withdrawal by Subject|8|||
27782225|NCT01231620|81032263|FG000|Overall Study|Lost to Follow-up|3|||
27782226|NCT01231620|81032264|FG001|Overall Study|Lost to Follow-up|4|||
27782227|NCT01231620|81032265|FG002|Overall Study|Lost to Follow-up|9|||
27782228|NCT02363322|81032268|FG000|Overall Study|Lost to Follow-up|1|||
27782229|NCT02363322|81032269|FG001|Overall Study|Lost to Follow-up|0|||
27782230|NCT02117024|81032270|FG000|Overall Study|Progressive Disease|26|||
27782231|NCT02117024|81032271|FG001|Overall Study|Progressive Disease|9|||
27782232|NCT02117024|81032270|FG000|Overall Study|Significant Clinical Progression|7|||
27782233|NCT02117024|81032271|FG001|Overall Study|Significant Clinical Progression|4|||
27782234|NCT02117024|81032270|FG000|Overall Study|Death|5|||
27782235|NCT02117024|81032271|FG001|Overall Study|Death|0|||
27782236|NCT02117024|81032270|FG000|Overall Study|Withdrawal by Subject|3|||
27782237|NCT02117024|81032271|FG001|Overall Study|Withdrawal by Subject|1|||
27782238|NCT02117024|81032270|FG000|Overall Study|Protocol Violation|1|||
27782239|NCT02117024|81032271|FG001|Overall Study|Protocol Violation|0|||
27782240|NCT02117024|81032270|FG000|Overall Study|Adverse Event|1|||
27782241|NCT02117024|81032271|FG001|Overall Study|Adverse Event|2|||
27782242|NCT02117024|81032270|FG000|Overall Study|Randomized in Error|1|||
27782243|NCT02117024|81032271|FG001|Overall Study|Randomized in Error|0|||
27782244|NCT02117024|81032270|FG000|Overall Study|Patient returned to primary oncologist|0|||
27782245|NCT02117024|81032271|FG001|Overall Study|Patient returned to primary oncologist|1|||
27782246|NCT02117024|81032270|FG000|Overall Study|Patient took treatment break|0|||
27782247|NCT02117024|81032271|FG001|Overall Study|Patient took treatment break|1|||
27782248|NCT02117024|81032270|FG000|Overall Study|Physician Decision|0|||
27782249|NCT02117024|81032271|FG001|Overall Study|Physician Decision|2|||
27782250|NCT00805194|81032274|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
27782251|NCT00805194|81032275|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
27782252|NCT00805194|81032274|FG000|Overall Study|Worsening or AE of underlying disease|64|||
27782253|NCT00805194|81032275|FG001|Overall Study|Worsening or AE of underlying disease|70|||
27782254|NCT00805194|81032274|FG000|Overall Study|Other AE|84|||
27782255|NCT00805194|81032275|FG001|Overall Study|Other AE|73|||
27782256|NCT00805194|81032274|FG000|Overall Study|Protocol Violation|9|||
27782257|NCT00805194|81032275|FG001|Overall Study|Protocol Violation|9|||
27782258|NCT00805194|81032274|FG000|Overall Study|Lost to Follow-up|5|||
27782259|NCT00805194|81032275|FG001|Overall Study|Lost to Follow-up|5|||
27782260|NCT00805194|81032274|FG000|Overall Study|Withdrawal by Subject|60|||
27782261|NCT00805194|81032275|FG001|Overall Study|Withdrawal by Subject|42|||
27782262|NCT00805194|81032274|FG000|Overall Study|Not treated|3|||
27782263|NCT00805194|81032275|FG001|Overall Study|Not treated|4|||
27782264|NCT00805194|81032274|FG000|Overall Study|Reasons other than stated above|20|||
27782265|NCT00805194|81032275|FG001|Overall Study|Reasons other than stated above|16|||
27782266|NCT03558503|81032280|FG000|Overall Study|Adverse Event|1|||
27782267|NCT03558503|81032280|FG000|Overall Study|Death|1|||
27782268|NCT03558503|81032280|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
27782269|NCT01060150|81032283|FG000|Overall Study|Adverse Event|6|||
27782270|NCT01060150|81032283|FG000|Overall Study|Lost to Follow-up|1|||
27782271|NCT01060150|81032283|FG000|Overall Study|Protocol Violation|6|||
27782272|NCT01060150|81032283|FG000|Overall Study|Withdrawal by Subject|8|||
27571243|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
27571244|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
27571245|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
27571246|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
27782273|NCT01060150|81032283|FG000|Overall Study|Enrolled, but not treated|2|||
27782274|NCT02041533|81032287|FG000|Pre-Treatment Period|Disease Progression|1|||
27782275|NCT02041533|81032288|FG001|Pre-Treatment Period|Disease Progression|1|||
27571247|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
27782276|NCT02041533|81032287|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
27782277|NCT02041533|81032288|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
27782278|NCT02041533|81032287|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
27782279|NCT02041533|81032288|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
27782280|NCT02041533|81032287|FG000|Treatment Period|Disease progression|189|||
27782281|NCT02041533|81032288|FG001|Treatment Period|Disease progression|146|||
27782282|NCT02041533|81032287|FG000|Treatment Period|Study drug toxicity|30|||
27782283|NCT02041533|81032288|FG001|Treatment Period|Study drug toxicity|34|||
27782284|NCT02041533|81032287|FG000|Treatment Period|Death|1|||
27782285|NCT02041533|81032288|FG001|Treatment Period|Death|0|||
27782286|NCT02041533|81032287|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
27782287|NCT02041533|81032288|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
27782288|NCT02041533|81032287|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
27782289|NCT02041533|81032288|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
27782290|NCT02041533|81032287|FG000|Treatment Period|Participant withdrew consent|2|||
27782291|NCT02041533|81032288|FG001|Treatment Period|Participant withdrew consent|2|||
27782292|NCT02041533|81032287|FG000|Treatment Period|Maximum clinical benefit|0|||
27782293|NCT02041533|81032288|FG001|Treatment Period|Maximum clinical benefit|18|||
27782294|NCT02041533|81032287|FG000|Treatment Period|Poor/Non-compliance|1|||
27782295|NCT02041533|81032288|FG001|Treatment Period|Poor/Non-compliance|0|||
27782296|NCT02041533|81032287|FG000|Treatment Period|Administrative reason by sponsor|1|||
27782297|NCT02041533|81032288|FG001|Treatment Period|Administrative reason by sponsor|0|||
27782298|NCT02041533|81032287|FG000|Treatment Period|Other reasons|9|||
27782299|NCT02041533|81032288|FG001|Treatment Period|Other reasons|2|||
27782300|NCT02041533|81032287|FG000|Treatment Period|Not Reported|0|||
27782301|NCT02041533|81032288|FG001|Treatment Period|Not Reported|1|||
27782302|NCT02260791|81032297|FG000|Overall Study|Lost to Follow-up|4|||
27782303|NCT02260791|81032298|FG001|Overall Study|Lost to Follow-up|4|||
27782304|NCT02260791|81032297|FG000|Overall Study|Lack of Efficacy|2|||
27782305|NCT02260791|81032298|FG001|Overall Study|Lack of Efficacy|1|||
27782306|NCT02260791|81032297|FG000|Overall Study|Adverse Event|13|||
27782307|NCT02260791|81032298|FG001|Overall Study|Adverse Event|9|||
27782308|NCT02260791|81032297|FG000|Overall Study|Death|1|||
27782309|NCT02260791|81032298|FG001|Overall Study|Death|0|||
27782310|NCT02260791|81032297|FG000|Overall Study|Withdrawal by Subject|11|||
27782311|NCT02260791|81032298|FG001|Overall Study|Withdrawal by Subject|16|||
27782312|NCT02260791|81032297|FG000|Overall Study|Screen failure|0|||
27782313|NCT02260791|81032298|FG001|Overall Study|Screen failure|1|||
27782314|NCT02260791|81032297|FG000|Overall Study|Protocol deviation|2|||
27782315|NCT02260791|81032298|FG001|Overall Study|Protocol deviation|3|||
27782316|NCT01696396|81032299|FG000|Overall Study|Withdrawal by Subject|19|||
27782317|NCT01696396|81032300|FG001|Overall Study|Withdrawal by Subject|5|||
27782318|NCT01696396|81032301|FG002|Overall Study|Withdrawal by Subject|19|||
27782319|NCT01696396|81032302|FG003|Overall Study|Withdrawal by Subject|11|||
27782320|NCT01696396|81032299|FG000|Overall Study|Decision by Sponsor|3|||
27782321|NCT01696396|81032300|FG001|Overall Study|Decision by Sponsor|1|||
27782322|NCT01696396|81032301|FG002|Overall Study|Decision by Sponsor|2|||
27971094|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
27971095|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
27971096|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
27971097|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
27971098|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
27971099|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27971100|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27971101|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27971102|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27971103|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27971104|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27971105|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27782323|NCT01696396|81032302|FG003|Overall Study|Decision by Sponsor|2|||
27782324|NCT01696396|81032299|FG000|Overall Study|Lost to Follow-up|9|||
27782325|NCT01696396|81032300|FG001|Overall Study|Lost to Follow-up|1|||
27782326|NCT01696396|81032301|FG002|Overall Study|Lost to Follow-up|4|||
27782327|NCT01696396|81032302|FG003|Overall Study|Lost to Follow-up|1|||
27782328|NCT01696396|81032299|FG000|Overall Study|Death|0|||
27782329|NCT01696396|81032300|FG001|Overall Study|Death|0|||
27782330|NCT01696396|81032301|FG002|Overall Study|Death|1|||
27782331|NCT01696396|81032302|FG003|Overall Study|Death|0|||
27782332|NCT01766401|81032303|FG000|Overall Study|Adverse Event|7|||
27782333|NCT01766401|81032304|FG001|Overall Study|Adverse Event|22|||
27782334|NCT01766401|81032303|FG000|Overall Study|Lack of Efficacy|1|||
27782335|NCT01766401|81032304|FG001|Overall Study|Lack of Efficacy|2|||
27782336|NCT01766401|81032303|FG000|Overall Study|Protocol Violation|3|||
27782337|NCT01766401|81032304|FG001|Overall Study|Protocol Violation|8|||
27782338|NCT01766401|81032303|FG000|Overall Study|Withdrawal by Subject|15|||
27782339|NCT01766401|81032304|FG001|Overall Study|Withdrawal by Subject|12|||
27782340|NCT01766401|81032303|FG000|Overall Study|Lost to Follow-up|10|||
27782341|NCT01766401|81032304|FG001|Overall Study|Lost to Follow-up|11|||
27782342|NCT01766401|81032303|FG000|Overall Study|Pregnancy|1|||
27782343|NCT01766401|81032304|FG001|Overall Study|Pregnancy|1|||
27865006|NCT05513391|81337328|FG001|Overall Study|Withdrawal by Subject|1|||
27865007|NCT05513391|81337327|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27865008|NCT05513391|81337328|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27865009|NCT05513391|81337327|FG000|Overall Study|Lost to Follow-up|0|||
27971106|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27971107|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
27971108|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
27971109|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
27971110|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
27971111|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
27971112|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
27971113|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
27971114|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
27971115|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
27971116|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
27971117|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
27971118|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
27971119|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971120|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971121|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971122|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971123|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971124|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971125|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971126|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
27971127|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
27971128|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
27971129|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971130|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971131|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971132|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971133|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971134|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971135|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971136|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
27971137|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971138|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
27971139|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971140|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971141|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971142|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971143|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971144|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971145|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971146|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
27971147|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971148|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
27971149|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971150|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971151|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971152|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27865010|NCT05513391|81337328|FG001|Overall Study|Lost to Follow-up|2|||
27865011|NCT01442688|81337329|FG000|First Intervention|Withdrawal by Subject|1|||
27865012|NCT01442688|81337330|FG001|First Intervention|Withdrawal by Subject|0|||
27865013|NCT01442688|81337329|FG000|First Intervention|subject incarcerated|1|||
27865014|NCT01442688|81337330|FG001|First Intervention|subject incarcerated|0|||
27971153|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971154|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971155|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971156|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
27971157|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
27971158|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
27971159|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971160|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971161|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971162|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971163|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971164|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
27971165|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971166|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971167|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
27971168|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
27971169|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971170|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971171|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971172|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971173|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971174|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971175|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971176|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971177|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
27971178|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
27971179|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971180|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971181|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971182|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971183|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971184|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971185|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971186|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
27971187|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
27971188|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
27971189|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971190|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971191|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971192|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971193|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971194|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971195|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971196|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
27971197|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
27971198|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
27971199|NCT03352557|81722931|FG000|LTE Period: Week 80 to Week 173|Other|0|||
27971200|NCT03352557|81722932|FG001|LTE Period: Week 80 to Week 173|Other|0|||
27971201|NCT03352557|81722933|FG002|LTE Period: Week 80 to Week 173|Other|0|||
27971202|NCT03352557|81722934|FG003|LTE Period: Week 80 to Week 173|Other|0|||
27971203|NCT03352557|81722935|FG004|LTE Period: Week 80 to Week 173|Other|0|||
27971204|NCT03352557|81722936|FG005|LTE Period: Week 80 to Week 173|Other|0|||
27971205|NCT03352557|81722937|FG006|LTE Period: Week 80 to Week 173|Other|0|||
27971206|NCT03352557|81722938|FG007|LTE Period: Week 80 to Week 173|Other|1|||
27971207|NCT03352557|81722939|FG008|LTE Period: Week 80 to Week 173|Other|0|||
27971208|NCT03352557|81722940|FG009|LTE Period: Week 80 to Week 173|Other|0|||
27971209|NCT01892436|81722941|FG000|Overall Study|Withdrawal by Subject|8|||
27971210|NCT01892436|81722942|FG001|Overall Study|Withdrawal by Subject|15|||
27971211|NCT01892436|81722943|FG002|Overall Study|Withdrawal by Subject|4|||
27971212|NCT01892436|81722944|FG003|Overall Study|Withdrawal by Subject|4|||
27571248|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
27571249|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
27571250|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
27571251|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
27571252|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
27971213|NCT01892436|81722941|FG000|Overall Study|Death|1|||
27971214|NCT01892436|81722942|FG001|Overall Study|Death|1|||
27971215|NCT01892436|81722943|FG002|Overall Study|Death|0|||
27971216|NCT01892436|81722944|FG003|Overall Study|Death|0|||
27971217|NCT01892436|81722941|FG000|Overall Study|Physician Decision|2|||
27971218|NCT01892436|81722942|FG001|Overall Study|Physician Decision|1|||
27971219|NCT01892436|81722943|FG002|Overall Study|Physician Decision|0|||
27971220|NCT01892436|81722944|FG003|Overall Study|Physician Decision|1|||
27971221|NCT01892436|81722941|FG000|Overall Study|Pregnancy|0|||
27971222|NCT01892436|81722942|FG001|Overall Study|Pregnancy|2|||
27971223|NCT01892436|81722943|FG002|Overall Study|Pregnancy|1|||
27971224|NCT01892436|81722944|FG003|Overall Study|Pregnancy|0|||
27971225|NCT01892436|81722941|FG000|Overall Study|Technical problems|2|||
27971226|NCT01892436|81722942|FG001|Overall Study|Technical problems|1|||
27782344|NCT00540228|81032309|FG000|Overall Study|Adverse Event|2|||
27782345|NCT00540228|81032310|FG001|Overall Study|Adverse Event|0|||
27782346|NCT00540228|81032311|FG002|Overall Study|Adverse Event|0|||
27782347|NCT00540228|81032312|FG003|Overall Study|Adverse Event|0|||
27782348|NCT00540228|81032313|FG004|Overall Study|Adverse Event|0|||
27782349|NCT00540228|81032309|FG000|Overall Study|Lost to Follow-up|1|||
27782350|NCT00540228|81032310|FG001|Overall Study|Lost to Follow-up|1|||
27782351|NCT00540228|81032311|FG002|Overall Study|Lost to Follow-up|0|||
27782352|NCT00540228|81032312|FG003|Overall Study|Lost to Follow-up|0|||
27782353|NCT00540228|81032313|FG004|Overall Study|Lost to Follow-up|0|||
27782354|NCT00959192|81032315|FG000|Overall Study|Adverse Event|1|||
27782355|NCT00959192|81032316|FG001|Overall Study|Adverse Event|1|||
27782356|NCT00959192|81032317|FG002|Overall Study|Adverse Event|1|||
27782357|NCT00959192|81032318|FG003|Overall Study|Adverse Event|0|||
27782358|NCT00959192|81032315|FG000|Overall Study|Investigator Request|1|||
27782359|NCT00959192|81032316|FG001|Overall Study|Investigator Request|0|||
27782360|NCT00959192|81032317|FG002|Overall Study|Investigator Request|0|||
27782361|NCT00959192|81032318|FG003|Overall Study|Investigator Request|0|||
27782362|NCT00959192|81032315|FG000|Overall Study|Caregiver Request|0|||
27782363|NCT00959192|81032316|FG001|Overall Study|Caregiver Request|0|||
27782364|NCT00959192|81032317|FG002|Overall Study|Caregiver Request|2|||
27782365|NCT00959192|81032318|FG003|Overall Study|Caregiver Request|1|||
27782366|NCT01944462|81032319|FG000|PPPP Educational Program|Lost to Follow-up|60|||
27782367|NCT01373294|81032320|FG000|Overall Study|Adverse Event|1|||
27782368|NCT01373294|81032321|FG001|Overall Study|Adverse Event|0|||
27782369|NCT02269709|81032324|FG000|Time of Enrollment|Withdrawal by Subject|3|||
27782370|NCT02269709|81032324|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
27782371|NCT02269709|81032324|FG000|Six Month Follow-up|Lost to Follow-up|12|||
27782372|NCT01539720|81032325|FG000|Overall Study|Screen Fail|15|||
27782373|NCT01539720|81032326|FG001|Overall Study|Screen Fail|3|||
27782374|NCT01539720|81032325|FG000|Overall Study|Lost to Follow-up|14|||
27782375|NCT01539720|81032326|FG001|Overall Study|Lost to Follow-up|7|||
27782376|NCT00426842|81032327|FG000|Overall Study|Lost to Follow-up|1|||
27782377|NCT02087085|81032328|FG000|Overall Study|Adverse Event|10|||
27782378|NCT02087085|81032329|FG001|Overall Study|Adverse Event|14|||
27782379|NCT02087085|81032328|FG000|Overall Study|Lack of Efficacy|4|||
27782380|NCT02087085|81032329|FG001|Overall Study|Lack of Efficacy|3|||
27782381|NCT02087085|81032328|FG000|Overall Study|Lost to Follow-up|6|||
27782382|NCT02087085|81032329|FG001|Overall Study|Lost to Follow-up|4|||
27782383|NCT02087085|81032328|FG000|Overall Study|Withdrawal by Subject|9|||
27782384|NCT02087085|81032329|FG001|Overall Study|Withdrawal by Subject|11|||
27782385|NCT02087085|81032328|FG000|Overall Study|Protocol Violation|1|||
27782386|NCT02087085|81032329|FG001|Overall Study|Protocol Violation|0|||
27782387|NCT02087085|81032328|FG000|Overall Study|Study Terminated by Sponsor|87|||
27782388|NCT02087085|81032329|FG001|Overall Study|Study Terminated by Sponsor|80|||
27782389|NCT02087085|81032328|FG000|Overall Study|Other Miscellaneous Reasons|3|||
27782390|NCT02087085|81032329|FG001|Overall Study|Other Miscellaneous Reasons|4|||
27782391|NCT01852591|81032331|FG000|Overall Study|Withdrawal by Subject|2|||
27782392|NCT01852591|81032331|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
27782393|NCT00963820|81032334|FG000|Dose Escalation Phase|Progressive Disease|3|||
27782394|NCT00963820|81032335|FG001|Dose Escalation Phase|Progressive Disease|3|||
27971227|NCT01892436|81722943|FG002|Overall Study|Technical problems|1|||
27971228|NCT01892436|81722944|FG003|Overall Study|Technical problems|1|||
27971229|NCT01892436|81722941|FG000|Overall Study|Lack of Efficacy|1|||
27971230|NCT01892436|81722942|FG001|Overall Study|Lack of Efficacy|2|||
27782395|NCT00963820|81032336|FG002|Dose Escalation Phase|Progressive Disease|3|||
27782396|NCT00963820|81032337|FG003|Dose Escalation Phase|Progressive Disease|3|||
27782397|NCT00963820|81032338|FG004|Dose Escalation Phase|Progressive Disease|4|||
27782398|NCT00963820|81032339|FG005|Dose Escalation Phase|Progressive Disease|3|||
27782399|NCT00963820|81032340|FG006|Dose Escalation Phase|Progressive Disease|3|||
27782400|NCT00963820|81032341|FG007|Dose Escalation Phase|Progressive Disease|2|||
27782401|NCT00963820|81032342|FG008|Dose Escalation Phase|Progressive Disease|0|||
27782402|NCT00963820|81032343|FG009|Dose Escalation Phase|Progressive Disease|0|||
27782403|NCT00963820|81032344|FG010|Dose Escalation Phase|Progressive Disease|0|||
27782404|NCT00963820|81032345|FG011|Dose Escalation Phase|Progressive Disease|0|||
27971231|NCT01892436|81722943|FG002|Overall Study|Lack of Efficacy|2|||
27971232|NCT01892436|81722944|FG003|Overall Study|Lack of Efficacy|2|||
27971233|NCT01892436|81722941|FG000|Overall Study|Lost to Follow-up|1|||
27971234|NCT01892436|81722942|FG001|Overall Study|Lost to Follow-up|1|||
27971235|NCT01892436|81722943|FG002|Overall Study|Lost to Follow-up|1|||
27971236|NCT01892436|81722944|FG003|Overall Study|Lost to Follow-up|3|||
27971237|NCT01892436|81722941|FG000|Overall Study|non-compliance with treatment|1|||
27971238|NCT01892436|81722942|FG001|Overall Study|non-compliance with treatment|0|||
27971239|NCT01892436|81722943|FG002|Overall Study|non-compliance with treatment|0|||
27971240|NCT01892436|81722944|FG003|Overall Study|non-compliance with treatment|0|||
27971241|NCT01892436|81722941|FG000|Overall Study|Adverse Event|7|||
27971242|NCT01892436|81722942|FG001|Overall Study|Adverse Event|6|||
27971243|NCT01892436|81722943|FG002|Overall Study|Adverse Event|2|||
27971244|NCT01892436|81722944|FG003|Overall Study|Adverse Event|3|||
27971245|NCT02109432|81722945|FG000|Overall Study|Withdrawal by Subject|1|||
27971246|NCT02447250|81722946|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
27971247|NCT02447250|81722946|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
27971248|NCT02447250|81722946|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
27971249|NCT00978380|81722947|FG000|Overall Study|Protocol Violation|2|||
27971250|NCT00978380|81722947|FG000|Overall Study|Withdrawal criteria|9|||
27971251|NCT00978380|81722947|FG000|Overall Study|Unclassified|8|||
27971252|NCT00090142|81722951|FG000|Treatment Period I|Lost to Follow-up|1|||
27971253|NCT00090142|81722952|FG001|Treatment Period I|Lost to Follow-up|2|||
27971254|NCT00090142|81722951|FG000|Treatment Period I|Protocol Violation|2|||
27971255|NCT00090142|81722952|FG001|Treatment Period I|Protocol Violation|0|||
27971256|NCT00090142|81722951|FG000|Treatment Period I|Withdrawal by Subject|2|||
27971257|NCT00090142|81722952|FG001|Treatment Period I|Withdrawal by Subject|0|||
27971258|NCT00090142|81722951|FG000|Treatment Period I|Other|0|||
27971259|NCT00090142|81722952|FG001|Treatment Period I|Other|1|||
27971260|NCT00090142|81722951|FG000|Treatment Period II|Other|1|||
27971261|NCT00090142|81722952|FG001|Treatment Period II|Other|0|||
27971262|NCT00072293|81722953|FG000|Overall Study|Lost to Follow-up|1|||
27971263|NCT00072293|81722954|FG001|Overall Study|Lost to Follow-up|1|||
27971264|NCT00072293|81722953|FG000|Overall Study|Withdrawal by Subject|0|||
27971265|NCT00072293|81722954|FG001|Overall Study|Withdrawal by Subject|1|||
27971266|NCT00283803|81722955|FG000|Overall Study|Physician Decision|9|||
27971267|NCT00283803|81722955|FG000|Overall Study|Withdrawal by Subject|4|||
27971268|NCT04600076|81722959|FG000|Overall Study|Lost to Follow-up|3|||
27971269|NCT03576066|81726423|FG000|Overall Study|Noncompliance with study drug|0|||
27971270|NCT03576066|81726424|FG001|Overall Study|Noncompliance with study drug|1|||
27971271|NCT01166373|81726439|FG000|Overall Study|Lost to Follow-up|3|||
27971272|NCT01166373|81726440|FG001|Overall Study|Lost to Follow-up|2|||
27971273|NCT01166373|81726441|FG002|Overall Study|Lost to Follow-up|2|||
27971274|NCT01166373|81726442|FG003|Overall Study|Lost to Follow-up|2|||
27971275|NCT01166373|81726439|FG000|Overall Study|Withdrawal by Subject|1|||
27971276|NCT01166373|81726440|FG001|Overall Study|Withdrawal by Subject|2|||
27971277|NCT01166373|81726441|FG002|Overall Study|Withdrawal by Subject|2|||
27971278|NCT01166373|81726442|FG003|Overall Study|Withdrawal by Subject|3|||
27971279|NCT01166373|81726439|FG000|Overall Study|Physician Decision|1|||
27971280|NCT01166373|81726440|FG001|Overall Study|Physician Decision|0|||
27971281|NCT01166373|81726441|FG002|Overall Study|Physician Decision|0|||
27971282|NCT01166373|81726442|FG003|Overall Study|Physician Decision|0|||
27971283|NCT05260073|81726448|FG000|Overall Study|Physician Decision|1|||
27971284|NCT05260073|81726448|FG000|Overall Study|Withdrawal by Subject|6|||
27971285|NCT05260073|81726448|FG000|Overall Study|Lost to Follow-up|14|||
27971286|NCT02152371|81726449|FG000|Overall Study|Adverse Event|6|||
27971287|NCT02152371|81726450|FG001|Overall Study|Adverse Event|2|||
27971288|NCT02152371|81726449|FG000|Overall Study|Withdrawal by Subject|3|||
27971289|NCT02152371|81726450|FG001|Overall Study|Withdrawal by Subject|7|||
27971290|NCT02152371|81726449|FG000|Overall Study|Protocol Violation|2|||
27971291|NCT02152371|81726450|FG001|Overall Study|Protocol Violation|3|||
27971292|NCT02152371|81726449|FG000|Overall Study|Lost to Follow-up|1|||
27971293|NCT02152371|81726450|FG001|Overall Study|Lost to Follow-up|0|||
27971294|NCT02152371|81726449|FG000|Overall Study|Lack of Efficacy|0|||
27865015|NCT01442688|81337329|FG000|Second Intervention|Adverse Event|1|||
27971295|NCT02152371|81726450|FG001|Overall Study|Lack of Efficacy|1|||
27971296|NCT02152371|81726449|FG000|Overall Study|Physician Decision|0|||
27971297|NCT02152371|81726450|FG001|Overall Study|Physician Decision|2|||
27971298|NCT02152371|81726449|FG000|Overall Study|Reason Not Given|0|||
27971299|NCT02152371|81726450|FG001|Overall Study|Reason Not Given|1|||
27971300|NCT00368836|81726453|FG000|Phase II|Screen Failure|1|||
27971301|NCT00368836|81726453|FG000|Phase II|Withdrawal by Subject|1|||
27971302|NCT00368836|81726453|FG000|Phase II|unable to collect blood and/or breath|17|||
27971303|NCT00368836|81726453|FG000|Phase II|Protocol Violation|2|||
27971304|NCT00365105|81726454|FG000|Overall Study|Protocol Violation|5|||
27971305|NCT00365105|81726455|FG001|Overall Study|Protocol Violation|8|||
27971306|NCT01960998|81726456|FG000|Overall Study|Lost to Follow-up|3|||
27971307|NCT01960998|81726457|FG001|Overall Study|Lost to Follow-up|7|||
27971308|NCT01960998|81726456|FG000|Overall Study|Death|0|||
27971309|NCT01960998|81726457|FG001|Overall Study|Death|1|||
27865016|NCT01442688|81337330|FG001|Second Intervention|Adverse Event|0|||
27971310|NCT01960998|81726456|FG000|Overall Study|Withdrawal by Subject|8|||
27971311|NCT01960998|81726457|FG001|Overall Study|Withdrawal by Subject|2|||
27971312|NCT01960998|81726456|FG000|Overall Study|lost computer access|0|||
27971313|NCT01960998|81726457|FG001|Overall Study|lost computer access|1|||
27971314|NCT00813865|81726458|FG000|Overall Study|Failure to Respond|3|||
27971315|NCT00813865|81726458|FG000|Overall Study|Lost to Follow-up|3|||
27971316|NCT00813865|81726458|FG000|Overall Study|Withdrawal by Subject|1|||
27971317|NCT02080481|81726463|FG000|Overall Study|Never received a block.|1|||
27971318|NCT02080481|81726464|FG001|Overall Study|Never received a block.|0|||
27971319|NCT01774097|81726465|FG000|Overall Study|Withdrawal by Subject|1|||
27971320|NCT01774097|81726466|FG001|Overall Study|Withdrawal by Subject|1|||
27971321|NCT01774097|81726465|FG000|Overall Study|Adverse Event|1|||
27971322|NCT01774097|81726466|FG001|Overall Study|Adverse Event|1|||
27971323|NCT01818258|81726475|FG000|Overall Study|Death|3|||
27971324|NCT01818258|81726476|FG001|Overall Study|Death|0|||
27971325|NCT01818258|81726475|FG000|Overall Study|Withdrawal by Subject|0|||
27971326|NCT01818258|81726476|FG001|Overall Study|Withdrawal by Subject|1|||
27571253|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
27571254|NCT04542070|80275446|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
27571255|NCT04542070|80275447|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
27571256|NCT04542070|80275448|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
27571257|NCT04542070|80275449|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
27571258|NCT04542070|80275446|FG000|Maintenance + Extension Period|Adverse Event|10|||
27571259|NCT04542070|80275447|FG001|Maintenance + Extension Period|Adverse Event|2|||
27571260|NCT04542070|80275448|FG002|Maintenance + Extension Period|Adverse Event|0|||
27571261|NCT04542070|80275449|FG003|Maintenance + Extension Period|Adverse Event|0|||
27571262|NCT04542070|80275446|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
27571263|NCT04542070|80275447|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
27571264|NCT04542070|80275448|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
27571265|NCT04542070|80275449|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
27571266|NCT04542070|80275446|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
27571267|NCT04542070|80275447|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
27571268|NCT04542070|80275448|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
27571269|NCT04542070|80275449|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
27571270|NCT04542070|80275446|FG000|Maintenance + Extension Period|Physician Decision|1|||
27571271|NCT04542070|80275447|FG001|Maintenance + Extension Period|Physician Decision|1|||
27571272|NCT04542070|80275448|FG002|Maintenance + Extension Period|Physician Decision|0|||
27571273|NCT04542070|80275449|FG003|Maintenance + Extension Period|Physician Decision|0|||
27571274|NCT04542070|80275446|FG000|Maintenance + Extension Period|Protocol Violation|2|||
27571275|NCT04542070|80275447|FG001|Maintenance + Extension Period|Protocol Violation|5|||
27571276|NCT04542070|80275448|FG002|Maintenance + Extension Period|Protocol Violation|0|||
27571277|NCT04542070|80275449|FG003|Maintenance + Extension Period|Protocol Violation|0|||
27865017|NCT04604795|81337331|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
27971327|NCT01818258|81726475|FG000|Overall Study|Lost to Follow-up|0|||
27971328|NCT01818258|81726476|FG001|Overall Study|Lost to Follow-up|1|||
27971329|NCT01818258|81726475|FG000|Overall Study|Unable to Travel to Clinic|0|||
27571278|NCT04542070|80275446|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
27571279|NCT04542070|80275447|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
27594132|NCT01816594|80352450|FG001|Overall Study|Withdrawal by Subject|0|||
27594133|NCT01816594|80352449|FG000|Overall Study|Physician Decision|1|||
27594134|NCT01816594|80352450|FG001|Overall Study|Physician Decision|0|||
27594135|NCT02962908|80352451|FG000|Overall Study|Lost to Follow-up|0|||
27594136|NCT02962908|80352452|FG001|Overall Study|Lost to Follow-up|3|||
27594137|NCT02962908|80352453|FG002|Overall Study|Lost to Follow-up|0|||
27594138|NCT02962908|80352454|FG003|Overall Study|Lost to Follow-up|1|||
27571280|NCT04542070|80275448|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
27571281|NCT04542070|80275449|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
27571282|NCT04542070|80275446|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
27571283|NCT04542070|80275447|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
27571284|NCT04542070|80275448|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
27571285|NCT04542070|80275449|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
27571286|NCT04542070|80275446|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
27571287|NCT04542070|80275447|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
27571288|NCT04542070|80275448|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
27571289|NCT04542070|80275449|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
27571290|NCT04542070|80275446|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
27571291|NCT04542070|80275447|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
27571292|NCT04542070|80275448|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
27571293|NCT04542070|80275449|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
27571294|NCT04542070|80275446|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
27571295|NCT04542070|80275447|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
27571296|NCT04542070|80275448|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
27571297|NCT04542070|80275449|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
27571298|NCT04542070|80275446|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
27571299|NCT04542070|80275447|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
27571300|NCT04542070|80275448|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
27571301|NCT04542070|80275449|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
27571302|NCT04542070|80275446|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
27571303|NCT04542070|80275447|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
27571304|NCT04542070|80275448|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
27571305|NCT04542070|80275449|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
27571306|NCT00086580|80275456|FG000|Treatment Period|Disease progression|9|||
27571307|NCT00086580|80275457|FG001|Treatment Period|Disease progression|8|||
27571308|NCT00086580|80275456|FG000|Treatment Period|Unable to comply with protocol|3|||
27571309|NCT00086580|80275457|FG001|Treatment Period|Unable to comply with protocol|1|||
27571310|NCT00086580|80275456|FG000|Treatment Period|Withdrawal by Subject|7|||
27571311|NCT00086580|80275457|FG001|Treatment Period|Withdrawal by Subject|8|||
27571312|NCT00086580|80275456|FG000|Treatment Period|Physician Decision|13|||
27571313|NCT00086580|80275457|FG001|Treatment Period|Physician Decision|7|||
27571314|NCT00086580|80275456|FG000|Treatment Period|AE - not treatment related|7|||
27571315|NCT00086580|80275457|FG001|Treatment Period|AE - not treatment related|7|||
27571316|NCT00086580|80275456|FG000|Treatment Period|Toxicity - treatment related|15|||
27571317|NCT00086580|80275457|FG001|Treatment Period|Toxicity - treatment related|15|||
27571318|NCT00086580|80275456|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
27571319|NCT00086580|80275457|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
27571320|NCT00086580|80275456|FG000|Treatment Period|Death|5|||
27571321|NCT00086580|80275457|FG001|Treatment Period|Death|7|||
27571322|NCT00086580|80275456|FG000|Treatment Period|Other|5|||
27571323|NCT00086580|80275457|FG001|Treatment Period|Other|3|||
27571324|NCT00086580|80275456|FG000|Follow-up Period|Disease progression|72|||
27571325|NCT00086580|80275457|FG001|Follow-up Period|Disease progression|99|||
27571326|NCT00086580|80275456|FG000|Follow-up Period|Unable to comply with protocol|5|||
27571327|NCT00086580|80275457|FG001|Follow-up Period|Unable to comply with protocol|0|||
27571328|NCT00086580|80275456|FG000|Follow-up Period|Withdrawal by Subject|6|||
27571329|NCT00086580|80275457|FG001|Follow-up Period|Withdrawal by Subject|6|||
27571330|NCT00086580|80275456|FG000|Follow-up Period|Physician Decision|0|||
27571331|NCT00086580|80275457|FG001|Follow-up Period|Physician Decision|1|||
27571332|NCT00086580|80275456|FG000|Follow-up Period|AE - not related|1|||
27571333|NCT00086580|80275457|FG001|Follow-up Period|AE - not related|0|||
27571334|NCT00086580|80275456|FG000|Follow-up Period|Death|13|||
27571335|NCT00086580|80275457|FG001|Follow-up Period|Death|7|||
27571336|NCT00086580|80275456|FG000|Follow-up Period|Other|7|||
27571337|NCT00086580|80275457|FG001|Follow-up Period|Other|6|||
27571338|NCT00086580|80275456|FG000|Observation Period|Unable to comply with protocol|1|||
27571339|NCT00086580|80275457|FG001|Observation Period|Unable to comply with protocol|1|||
27571340|NCT00086580|80275456|FG000|Observation Period|Withdrawal by Subject|4|||
27571341|NCT00086580|80275457|FG001|Observation Period|Withdrawal by Subject|2|||
27571342|NCT00086580|80275456|FG000|Observation Period|Death|33|||
27571343|NCT00086580|80275457|FG001|Observation Period|Death|55|||
27571344|NCT00086580|80275456|FG000|Observation Period|Other|8|||
27668106|NCT00644878|80623545|FG000|Overall Study|Treatment duration completed as per protocol|11|||
27668107|NCT05239598|80623551|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
27668108|NCT05239598|80623552|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
27668109|NCT05239598|80623551|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
27668110|NCT05239598|80623552|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
27668111|NCT03305809|80623555|FG000|Overall Study|Adverse Event|2|||
27668112|NCT03305809|80623556|FG001|Overall Study|Adverse Event|2|||
27668113|NCT03305809|80623557|FG002|Overall Study|Adverse Event|6|||
27668114|NCT03305809|80623558|FG003|Overall Study|Adverse Event|6|||
27971330|NCT01818258|81726476|FG001|Overall Study|Unable to Travel to Clinic|1|||
27971331|NCT00782171|81726477|FG000|Overall Study|Lost to Follow-up|2|||
27971332|NCT00782171|81726478|FG001|Overall Study|Lost to Follow-up|2|||
27971333|NCT00782171|81726477|FG000|Overall Study|Withdrawal by Subject|2|||
27971334|NCT00782171|81726478|FG001|Overall Study|Withdrawal by Subject|1|||
27971335|NCT00782171|81726477|FG000|Overall Study|complications|3|||
27971336|NCT00782171|81726478|FG001|Overall Study|complications|1|||
27971337|NCT00782171|81726477|FG000|Overall Study|others|7|||
27971338|NCT00782171|81726478|FG001|Overall Study|others|9|||
27971339|NCT00782171|81726477|FG000|Overall Study|not eligible|8|||
27971340|NCT00782171|81726478|FG001|Overall Study|not eligible|6|||
27971341|NCT03350256|81726479|FG000|Overall Study|Inclusion/exclusion violation|4|||
27971342|NCT03350256|81726479|FG000|Overall Study|Recommended for other therapies|2|||
27971343|NCT03350256|81726479|FG000|Overall Study|Protocol Violation|3|||
27971344|NCT03350256|81726479|FG000|Overall Study|Non compliance|2|||
27971345|NCT03350256|81726479|FG000|Overall Study|Denial by insurance|1|||
27971346|NCT03350256|81726479|FG000|Overall Study|Adverse Event|2|||
27971347|NCT03350256|81726479|FG000|Overall Study|Trial failure|12|||
27971348|NCT03350256|81726479|FG000|Overall Study|Did not proceed to permanent implant|3|||
27971349|NCT03350256|81726479|FG000|Overall Study|Withdrawal by Subject|3|||
27971350|NCT03350256|81726479|FG000|Overall Study|Subject moving out of state|1|||
27971351|NCT03350256|81726479|FG000|Overall Study|Lost to Follow-up|1|||
27971352|NCT03350256|81726479|FG000|Overall Study|Lack of Efficacy|2|||
27971353|NCT03645421|81726483|FG000|Overall Study|Adverse Event|0|||
27971354|NCT03645421|81726484|FG001|Overall Study|Adverse Event|0|||
27971355|NCT03645421|81726485|FG002|Overall Study|Adverse Event|4|||
27971356|NCT03645421|81726486|FG003|Overall Study|Adverse Event|1|||
27971357|NCT03645421|81726483|FG000|Overall Study|Withdrawal by patient|0|||
27971358|NCT03645421|81726484|FG001|Overall Study|Withdrawal by patient|0|||
27971359|NCT03645421|81726485|FG002|Overall Study|Withdrawal by patient|0|||
27971360|NCT03645421|81726486|FG003|Overall Study|Withdrawal by patient|3|||
27971361|NCT03645421|81726483|FG000|Overall Study|Study specific withdrawal criteria|0|||
27971362|NCT03645421|81726484|FG001|Overall Study|Study specific withdrawal criteria|0|||
27971363|NCT03645421|81726485|FG002|Overall Study|Study specific withdrawal criteria|1|||
27971364|NCT03645421|81726486|FG003|Overall Study|Study specific withdrawal criteria|0|||
27971365|NCT01920568|81726491|FG000|Overall Study|Adverse Event|27|||
27971366|NCT01920568|81726492|FG001|Overall Study|Adverse Event|8|||
27971367|NCT01920568|81726491|FG000|Overall Study|Protocol Violation|5|||
27971368|NCT01920568|81726492|FG001|Overall Study|Protocol Violation|3|||
27971369|NCT01920568|81726491|FG000|Overall Study|Lost to Follow-up|2|||
27971370|NCT01920568|81726492|FG001|Overall Study|Lost to Follow-up|2|||
27971371|NCT01920568|81726491|FG000|Overall Study|Physician Decision|13|||
27971372|NCT01920568|81726492|FG001|Overall Study|Physician Decision|4|||
27971373|NCT01920568|81726491|FG000|Overall Study|Withdrawal by Subject|79|||
27971374|NCT01920568|81726492|FG001|Overall Study|Withdrawal by Subject|55|||
27971375|NCT01920568|81726491|FG000|Overall Study|Death due to disease progression|25|||
27971376|NCT01920568|81726492|FG001|Overall Study|Death due to disease progression|12|||
27971377|NCT00712725|81726493|FG000|Overall Study|Adverse Event|1|||
27971378|NCT00712725|81726494|FG001|Overall Study|Adverse Event|0|||
27971379|NCT00712725|81726495|FG002|Overall Study|Adverse Event|0|||
27971380|NCT00712725|81726496|FG003|Overall Study|Adverse Event|1|||
27971381|NCT00712725|81726497|FG004|Overall Study|Adverse Event|0|||
27668115|NCT03305809|80623555|FG000|Overall Study|Death|0|||
27971382|NCT00712725|81726498|FG005|Overall Study|Adverse Event|0|||
27971383|NCT00712725|81726499|FG006|Overall Study|Adverse Event|0|||
27971384|NCT00712725|81726500|FG007|Overall Study|Adverse Event|0|||
27971385|NCT00712725|81726493|FG000|Overall Study|Lost to Follow-up|3|||
27971386|NCT00712725|81726494|FG001|Overall Study|Lost to Follow-up|2|||
27971387|NCT00712725|81726495|FG002|Overall Study|Lost to Follow-up|1|||
27971388|NCT00712725|81726496|FG003|Overall Study|Lost to Follow-up|1|||
27971389|NCT00712725|81726497|FG004|Overall Study|Lost to Follow-up|2|||
27971390|NCT00712725|81726498|FG005|Overall Study|Lost to Follow-up|2|||
27971391|NCT00712725|81726499|FG006|Overall Study|Lost to Follow-up|3|||
27971392|NCT00712725|81726500|FG007|Overall Study|Lost to Follow-up|1|||
27971393|NCT00712725|81726493|FG000|Overall Study|Physician Decision|2|||
27971394|NCT00712725|81726494|FG001|Overall Study|Physician Decision|0|||
27971395|NCT00712725|81726495|FG002|Overall Study|Physician Decision|0|||
27971396|NCT00712725|81726496|FG003|Overall Study|Physician Decision|0|||
27971397|NCT00712725|81726497|FG004|Overall Study|Physician Decision|1|||
27971398|NCT00712725|81726498|FG005|Overall Study|Physician Decision|0|||
27971399|NCT00712725|81726499|FG006|Overall Study|Physician Decision|2|||
27971400|NCT00712725|81726500|FG007|Overall Study|Physician Decision|0|||
27971401|NCT00712725|81726493|FG000|Overall Study|Pregnancy|0|||
27971402|NCT00712725|81726494|FG001|Overall Study|Pregnancy|1|||
27971403|NCT00712725|81726495|FG002|Overall Study|Pregnancy|0|||
27971404|NCT00712725|81726496|FG003|Overall Study|Pregnancy|0|||
27971405|NCT00712725|81726497|FG004|Overall Study|Pregnancy|1|||
27971406|NCT00712725|81726498|FG005|Overall Study|Pregnancy|0|||
27971407|NCT00712725|81726499|FG006|Overall Study|Pregnancy|2|||
27971408|NCT00712725|81726500|FG007|Overall Study|Pregnancy|0|||
27971409|NCT00712725|81726493|FG000|Overall Study|Protocol Violation|2|||
27971410|NCT00712725|81726494|FG001|Overall Study|Protocol Violation|0|||
27971411|NCT00712725|81726495|FG002|Overall Study|Protocol Violation|1|||
27971412|NCT00712725|81726496|FG003|Overall Study|Protocol Violation|3|||
27971413|NCT00712725|81726497|FG004|Overall Study|Protocol Violation|2|||
27971414|NCT00712725|81726498|FG005|Overall Study|Protocol Violation|0|||
27971415|NCT00712725|81726499|FG006|Overall Study|Protocol Violation|1|||
27971416|NCT00712725|81726500|FG007|Overall Study|Protocol Violation|1|||
27971417|NCT00712725|81726493|FG000|Overall Study|Withdrawal by Subject|2|||
27971418|NCT00712725|81726494|FG001|Overall Study|Withdrawal by Subject|1|||
27971419|NCT00712725|81726495|FG002|Overall Study|Withdrawal by Subject|1|||
27971420|NCT00712725|81726496|FG003|Overall Study|Withdrawal by Subject|2|||
27971421|NCT00712725|81726497|FG004|Overall Study|Withdrawal by Subject|1|||
27971422|NCT00712725|81726498|FG005|Overall Study|Withdrawal by Subject|1|||
27971423|NCT00712725|81726499|FG006|Overall Study|Withdrawal by Subject|1|||
27668116|NCT03305809|80623556|FG001|Overall Study|Death|0|||
27668117|NCT03305809|80623557|FG002|Overall Study|Death|1|||
27571345|NCT00086580|80275457|FG001|Observation Period|Other|7|||
27571346|NCT04568122|80275461|FG000|Overall Study|Lost to Follow-up|48|||
27571347|NCT04568122|80275462|FG001|Overall Study|Lost to Follow-up|44|||
27571348|NCT04568122|80275463|FG002|Overall Study|Lost to Follow-up|4|||
27571349|NCT04568122|80275464|FG003|Overall Study|Lost to Follow-up|0|||
27571350|NCT04568122|80275465|FG004|Overall Study|Lost to Follow-up|0|||
27571351|NCT02365636|80275466|FG000|Overall Study|Adverse Event|3|||
27571352|NCT02365636|80275467|FG001|Overall Study|Adverse Event|3|||
27571353|NCT02365636|80275468|FG002|Overall Study|Adverse Event|2|||
27571354|NCT02365636|80275466|FG000|Overall Study|Protocol Violation|1|||
27571355|NCT02365636|80275467|FG001|Overall Study|Protocol Violation|4|||
27571356|NCT02365636|80275468|FG002|Overall Study|Protocol Violation|0|||
27571357|NCT02365636|80275466|FG000|Overall Study|Lost to Follow-up|0|||
27571358|NCT02365636|80275467|FG001|Overall Study|Lost to Follow-up|0|||
27571359|NCT02365636|80275468|FG002|Overall Study|Lost to Follow-up|1|||
27571360|NCT02365636|80275466|FG000|Overall Study|Other|2|||
27571361|NCT02365636|80275467|FG001|Overall Study|Other|0|||
27571362|NCT02365636|80275468|FG002|Overall Study|Other|0|||
27571363|NCT02296112|80275469|FG000|Overall Study|Disease progression|7|||
27571364|NCT02296112|80275469|FG000|Overall Study|Toxicity|1|||
27571365|NCT02296112|80275469|FG000|Overall Study|Began an alternate therapy|1|||
27571366|NCT02722928|80275470|FG000|Overall Study|Standard CT was not as required per prot|5|||
27571367|NCT02722928|80275471|FG001|Overall Study|Standard CT was not as required per prot|13|||
27571368|NCT02722928|80275470|FG000|Overall Study|Required Intraoperative MRI|5|||
27571369|NCT02722928|80275471|FG001|Overall Study|Required Intraoperative MRI|7|||
27571370|NCT01640366|80275472|FG000|Overall Study|Withdrawal by Subject|1|||
27571371|NCT01640366|80275472|FG000|Overall Study|Protocol Violation|16|||
27571372|NCT01640366|80275472|FG000|Overall Study|Lost to Follow-up|5|||
27571373|NCT01466192|80275475|FG000|Overall Study|Physician Decision|1|||
27571374|NCT01466192|80275475|FG000|Overall Study|Withdrawal by Subject|3|||
27571375|NCT03643562|80278806|FG000|Overall Study|Adverse Event|1|||
27571376|NCT03643562|80278807|FG001|Overall Study|Adverse Event|0|||
27571377|NCT03643562|80278806|FG000|Overall Study|Lack of Efficacy|0|||
27571378|NCT03643562|80278807|FG001|Overall Study|Lack of Efficacy|1|||
27571379|NCT03643562|80278806|FG000|Overall Study|Physician Decision|0|||
27571380|NCT03643562|80278807|FG001|Overall Study|Physician Decision|1|||
27571381|NCT03643562|80278806|FG000|Overall Study|Study Terminated by Sponsor|2|||
27571382|NCT03643562|80278807|FG001|Overall Study|Study Terminated by Sponsor|10|||
27571383|NCT03643562|80278806|FG000|Overall Study|Withdrawal by Subject|2|||
27571384|NCT03643562|80278807|FG001|Overall Study|Withdrawal by Subject|2|||
27571385|NCT03643562|80278806|FG000|Overall Study|Other than specified|3|||
27571386|NCT03643562|80278807|FG001|Overall Study|Other than specified|2|||
27571387|NCT01227512|80278810|FG000|Overall Study|Physician Decision|6|||
27571388|NCT01227512|80278811|FG001|Overall Study|Physician Decision|6|||
27571389|NCT01227512|80278810|FG000|Overall Study|Adverse Event|4|||
27571390|NCT01227512|80278811|FG001|Overall Study|Adverse Event|3|||
27571391|NCT01227512|80278810|FG000|Overall Study|Withdrawal by Subject|3|||
27571392|NCT01227512|80278811|FG001|Overall Study|Withdrawal by Subject|0|||
27571393|NCT01227512|80278810|FG000|Overall Study|Participant met withdrawal criteria|0|||
27571394|NCT01227512|80278811|FG001|Overall Study|Participant met withdrawal criteria|1|||
27571395|NCT00842348|80278816|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
27571396|NCT00842348|80278817|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
27571397|NCT00842348|80278816|FG000|Study 729|Disease progression/death|19|||
27571398|NCT00842348|80278817|FG001|Study 729|Disease progression/death|30|||
27571399|NCT00842348|80278816|FG000|Study 729|Adverse Event|1|||
27571400|NCT00842348|80278817|FG001|Study 729|Adverse Event|1|||
27571401|NCT00842348|80278816|FG000|Study 729|Protocol Violation|1|||
27571402|NCT00842348|80278817|FG001|Study 729|Protocol Violation|1|||
27571403|NCT00842348|80278816|FG000|Study 729|Withdrawal by Subject|2|||
27571404|NCT00842348|80278817|FG001|Study 729|Withdrawal by Subject|4|||
27571405|NCT00842348|80278816|FG000|Study 729|Due to Sponsor stopping the study|1|||
27571406|NCT00842348|80278817|FG001|Study 729|Due to Sponsor stopping the study|1|||
27571407|NCT00842348|80278816|FG000|Study 729|Due to non-availability of IP|0|||
27571408|NCT00842348|80278817|FG001|Study 729|Due to non-availability of IP|1|||
27571409|NCT00842348|80278816|FG000|Study 729|Sponsor's decision|1|||
27571410|NCT00842348|80278817|FG001|Study 729|Sponsor's decision|0|||
27571411|NCT00842348|80278816|FG000|Study 729|Surgical resection|1|||
27571412|NCT00842348|80278817|FG001|Study 729|Surgical resection|0|||
27571413|NCT02739269|80278819|FG000|Overall Study|Protocol Violation|5|||
27571414|NCT02739269|80278820|FG001|Overall Study|Protocol Violation|0|||
27571415|NCT02739269|80278819|FG000|Overall Study|Cycle cancellation|2|||
27571416|NCT02739269|80278820|FG001|Overall Study|Cycle cancellation|2|||
27571417|NCT02739269|80278819|FG000|Overall Study|Withdrawal by Subject|0|||
27571418|NCT02739269|80278820|FG001|Overall Study|Withdrawal by Subject|2|||
27571419|NCT01577758|80278821|FG000|Dose Escalation Phase|Adverse Event|0|||
27668118|NCT03305809|80623558|FG003|Overall Study|Death|1|||
27668119|NCT03305809|80623555|FG000|Overall Study|Lost to Follow-up|1|||
27571420|NCT01577758|80278822|FG001|Dose Escalation Phase|Adverse Event|0|||
27971424|NCT00712725|81726500|FG007|Overall Study|Withdrawal by Subject|2|||
27971425|NCT00712725|81726493|FG000|Overall Study|Lack of Qualifying Event|16|||
27971426|NCT00712725|81726494|FG001|Overall Study|Lack of Qualifying Event|2|||
27971427|NCT00712725|81726495|FG002|Overall Study|Lack of Qualifying Event|6|||
27971428|NCT00712725|81726496|FG003|Overall Study|Lack of Qualifying Event|8|||
27971429|NCT00712725|81726497|FG004|Overall Study|Lack of Qualifying Event|11|||
27782405|NCT00963820|81032334|FG000|Dose Escalation Phase|Adverse Event|0|||
27782406|NCT00963820|81032335|FG001|Dose Escalation Phase|Adverse Event|0|||
27782407|NCT00963820|81032336|FG002|Dose Escalation Phase|Adverse Event|0|||
27782408|NCT00963820|81032337|FG003|Dose Escalation Phase|Adverse Event|0|||
27782409|NCT00963820|81032338|FG004|Dose Escalation Phase|Adverse Event|0|||
27782410|NCT00963820|81032339|FG005|Dose Escalation Phase|Adverse Event|0|||
27782411|NCT00963820|81032340|FG006|Dose Escalation Phase|Adverse Event|3|||
27782412|NCT00963820|81032341|FG007|Dose Escalation Phase|Adverse Event|1|||
27782413|NCT00963820|81032342|FG008|Dose Escalation Phase|Adverse Event|0|||
27782414|NCT00963820|81032343|FG009|Dose Escalation Phase|Adverse Event|0|||
27668120|NCT03305809|80623556|FG001|Overall Study|Lost to Follow-up|2|||
27668121|NCT03305809|80623557|FG002|Overall Study|Lost to Follow-up|0|||
27668122|NCT03305809|80623558|FG003|Overall Study|Lost to Follow-up|0|||
27668123|NCT03305809|80623555|FG000|Overall Study|Sponsor Decision|1|||
27668124|NCT03305809|80623556|FG001|Overall Study|Sponsor Decision|0|||
27668125|NCT03305809|80623557|FG002|Overall Study|Sponsor Decision|1|||
27668126|NCT03305809|80623558|FG003|Overall Study|Sponsor Decision|8|||
27668127|NCT03305809|80623555|FG000|Overall Study|Physician Decision|0|||
27668128|NCT03305809|80623556|FG001|Overall Study|Physician Decision|0|||
27668129|NCT03305809|80623557|FG002|Overall Study|Physician Decision|2|||
27668130|NCT03305809|80623558|FG003|Overall Study|Physician Decision|4|||
27668131|NCT03305809|80623555|FG000|Overall Study|Progressive Disease|0|||
27668132|NCT03305809|80623556|FG001|Overall Study|Progressive Disease|0|||
27668133|NCT03305809|80623557|FG002|Overall Study|Progressive Disease|1|||
27668134|NCT03305809|80623558|FG003|Overall Study|Progressive Disease|0|||
27668135|NCT03305809|80623555|FG000|Overall Study|Protocol Violation|1|||
27668136|NCT03305809|80623556|FG001|Overall Study|Protocol Violation|0|||
27668137|NCT03305809|80623557|FG002|Overall Study|Protocol Violation|2|||
27668138|NCT03305809|80623558|FG003|Overall Study|Protocol Violation|3|||
27668139|NCT03305809|80623555|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
27668140|NCT03305809|80623556|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
27668141|NCT03305809|80623557|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
27668142|NCT03305809|80623558|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
27668143|NCT03305809|80623555|FG000|Overall Study|Withdrawal by Subject|2|||
27668144|NCT03305809|80623556|FG001|Overall Study|Withdrawal by Subject|4|||
27668145|NCT03305809|80623557|FG002|Overall Study|Withdrawal by Subject|5|||
27668146|NCT03305809|80623558|FG003|Overall Study|Withdrawal by Subject|2|||
27668147|NCT03305809|80623555|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
27668148|NCT03305809|80623556|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
27668149|NCT03305809|80623557|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
27668150|NCT03305809|80623558|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
27668151|NCT04334278|80623559|FG000|Overall Study|Lost to Follow-up|0|||
27668152|NCT04334278|80623560|FG001|Overall Study|Lost to Follow-up|3|||
27668153|NCT04334278|80623559|FG000|Overall Study|Withdrawal by Subject|4|||
27668154|NCT04334278|80623560|FG001|Overall Study|Withdrawal by Subject|2|||
27668155|NCT00713206|80623561|FG000|Overall Study|Lost to Follow-up|4|||
27668156|NCT00713206|80623562|FG001|Overall Study|Lost to Follow-up|4|||
27668157|NCT00713206|80623561|FG000|Overall Study|Death|1|||
27668158|NCT00713206|80623562|FG001|Overall Study|Death|0|||
27668159|NCT03022578|80623563|FG000|Overall Study|Adverse Event|1|||
27668160|NCT03022578|80623563|FG000|Overall Study|Lack of Efficacy|2|||
27668161|NCT03022578|80623563|FG000|Overall Study|Withdrawal by Subject|1|||
27668162|NCT01313624|80623565|FG000|Double-Blind Phase|Adverse Event|27|||
27782415|NCT00963820|81032344|FG010|Dose Escalation Phase|Adverse Event|0|||
27782416|NCT00963820|81032345|FG011|Dose Escalation Phase|Adverse Event|0|||
27865018|NCT04604795|81337332|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
27571421|NCT01577758|80278823|FG002|Dose Escalation Phase|Adverse Event|0|||
27571422|NCT01577758|80278824|FG003|Dose Escalation Phase|Adverse Event|0|||
27571423|NCT01577758|80278825|FG004|Dose Escalation Phase|Adverse Event|0|||
27571424|NCT01577758|80278826|FG005|Dose Escalation Phase|Adverse Event|2|||
27571425|NCT01577758|80278827|FG006|Dose Escalation Phase|Adverse Event|1|||
27571426|NCT01577758|80278828|FG007|Dose Escalation Phase|Adverse Event|0|||
27571427|NCT01577758|80278821|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
27571428|NCT01577758|80278822|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
27571429|NCT01577758|80278823|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
27571430|NCT01577758|80278824|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
27571431|NCT01577758|80278825|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
27668163|NCT01313624|80623566|FG001|Double-Blind Phase|Adverse Event|4|||
27668164|NCT01313624|80623565|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
27668165|NCT01313624|80623566|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
27668166|NCT01313624|80623565|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27971430|NCT00712725|81726498|FG005|Overall Study|Lack of Qualifying Event|13|||
27971431|NCT00712725|81726499|FG006|Overall Study|Lack of Qualifying Event|11|||
27971432|NCT00712725|81726500|FG007|Overall Study|Lack of Qualifying Event|6|||
27971433|NCT00712725|81726493|FG000|Overall Study|Protocol Specified Criteria|3|||
27971434|NCT00712725|81726494|FG001|Overall Study|Protocol Specified Criteria|0|||
27971435|NCT00712725|81726495|FG002|Overall Study|Protocol Specified Criteria|1|||
27971436|NCT00712725|81726496|FG003|Overall Study|Protocol Specified Criteria|2|||
27668167|NCT01313624|80623566|FG001|Double-Blind Phase|Lost to Follow-up|2|||
27668168|NCT01313624|80623565|FG000|Double-Blind Phase|Physician Decision|1|||
27668169|NCT01313624|80623566|FG001|Double-Blind Phase|Physician Decision|0|||
27668170|NCT01313624|80623565|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27668171|NCT01313624|80623566|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27668172|NCT01313624|80623565|FG000|Open-Label Phase|Adverse Event|1|||
27668173|NCT01313624|80623566|FG001|Open-Label Phase|Adverse Event|10|||
27668174|NCT01313624|80623565|FG000|Open-Label Phase|Withdrawal by Subject|2|||
27668175|NCT01313624|80623566|FG001|Open-Label Phase|Withdrawal by Subject|2|||
27668176|NCT01313624|80623565|FG000|Open-Label Phase|Lost to Follow-up|1|||
27668177|NCT01313624|80623566|FG001|Open-Label Phase|Lost to Follow-up|1|||
27668178|NCT03029819|80623567|FG000|Overall Study|Lost to Follow-up|3|||
27668179|NCT03029819|80623568|FG001|Overall Study|Lost to Follow-up|5|||
27668180|NCT03029819|80623567|FG000|Overall Study|Removed due to disruptive behavior|0|||
27668181|NCT03029819|80623568|FG001|Overall Study|Removed due to disruptive behavior|1|||
27668182|NCT01816685|80623569|FG000|Overall Study|Lost to Follow-up|7|||
27668183|NCT01816685|80623570|FG001|Overall Study|Lost to Follow-up|9|||
27668184|NCT01816685|80623569|FG000|Overall Study|Surgery Cancelled|3|||
27668185|NCT01816685|80623570|FG001|Overall Study|Surgery Cancelled|2|||
27668186|NCT01340014|80623580|FG000|Period 1, First 7 Days|Adverse Event|1|||
27668187|NCT01340014|80623581|FG001|Period 1, First 7 Days|Adverse Event|0|||
27668188|NCT01340014|80623580|FG000|Period 1, First 7 Days|Personal Reasons|1|||
27668189|NCT01340014|80623581|FG001|Period 1, First 7 Days|Personal Reasons|0|||
27668190|NCT01340014|80623580|FG000|Period 2, Second 7 Days|Adverse Event|0|||
27668191|NCT01340014|80623581|FG001|Period 2, Second 7 Days|Adverse Event|1|||
27668192|NCT02970305|80623582|FG000|Overall Study|Adverse Event|10|||
27668193|NCT02970305|80623583|FG001|Overall Study|Adverse Event|6|||
27668194|NCT02970305|80623582|FG000|Overall Study|Lack of Efficacy|1|||
27668195|NCT02970305|80623583|FG001|Overall Study|Lack of Efficacy|1|||
27668196|NCT02970305|80623582|FG000|Overall Study|Noncompliance with study drug|2|||
27668197|NCT02970305|80623583|FG001|Overall Study|Noncompliance with study drug|4|||
27971437|NCT00712725|81726497|FG004|Overall Study|Protocol Specified Criteria|1|||
27971438|NCT00712725|81726498|FG005|Overall Study|Protocol Specified Criteria|0|||
27971439|NCT00712725|81726499|FG006|Overall Study|Protocol Specified Criteria|2|||
27971440|NCT00712725|81726500|FG007|Overall Study|Protocol Specified Criteria|1|||
27971441|NCT00695955|81726501|FG000|Cohort 1|Adverse Event|26|||
27971442|NCT00695955|81726501|FG000|Cohort 1|Protocol Violation|2|||
27971443|NCT00695955|81726501|FG000|Cohort 1|Lost to Follow-up|30|||
27971444|NCT00695955|81726501|FG000|Cohort 1|Withdrawal by Subject|25|||
27668198|NCT02970305|80623582|FG000|Overall Study|Protocol Violation|2|||
27668199|NCT02970305|80623583|FG001|Overall Study|Protocol Violation|2|||
27668200|NCT02970305|80623582|FG000|Overall Study|Withdrawal by Subject|12|||
27668201|NCT02970305|80623583|FG001|Overall Study|Withdrawal by Subject|11|||
27668202|NCT02970305|80623582|FG000|Overall Study|Not further specified|1|||
27668203|NCT02970305|80623583|FG001|Overall Study|Not further specified|2|||
27971445|NCT00695955|81726501|FG000|Cohort 1|Lack of Efficacy|3|||
27971446|NCT00695955|81726501|FG000|Cohort 1|Other|16|||
27971447|NCT00695955|81726501|FG000|Cohort 2|Adverse Event|24|||
27668204|NCT02970305|80623582|FG000|Overall Study|Lost to Follow-up|1|||
27668205|NCT02970305|80623583|FG001|Overall Study|Lost to Follow-up|2|||
27668206|NCT00816556|80623584|FG000|Overall Study|Adverse Event|1|||
27668207|NCT00816556|80623585|FG001|Overall Study|Adverse Event|1|||
27668208|NCT00816556|80623586|FG002|Overall Study|Adverse Event|1|||
27668209|NCT00816556|80623584|FG000|Overall Study|Withdrawal by Subject|1|||
27865019|NCT04604795|81337333|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27865020|NCT04604795|81337334|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27971448|NCT00695955|81726501|FG000|Cohort 2|Protocol Violation|5|||
27668210|NCT00816556|80623585|FG001|Overall Study|Withdrawal by Subject|1|||
27668211|NCT00816556|80623586|FG002|Overall Study|Withdrawal by Subject|1|||
27668212|NCT00816556|80623584|FG000|Overall Study|Lost to Follow-up|0|||
27668213|NCT00816556|80623585|FG001|Overall Study|Lost to Follow-up|0|||
27971449|NCT00695955|81726501|FG000|Cohort 2|Lost to Follow-up|38|||
27865021|NCT04604795|81337335|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27971450|NCT00695955|81726501|FG000|Cohort 2|Withdrawal by Subject|28|||
27971451|NCT00695955|81726501|FG000|Cohort 2|Lack of Efficacy|4|||
27668214|NCT00816556|80623586|FG002|Overall Study|Lost to Follow-up|1|||
27971452|NCT00695955|81726501|FG000|Cohort 2|Other|5|||
27668215|NCT04035577|80623589|FG000|Overall Study|Lost to Follow-up|1|||
27668216|NCT04035577|80623589|FG000|Overall Study|Withdrawal by Subject|1|||
27668217|NCT02517528|80623594|FG000|Overall Study|Withdrawal by Subject|1|||
27668218|NCT00443898|80623595|FG000|Overall Study|Adverse Event|0|||
27668219|NCT00443898|80623596|FG001|Overall Study|Adverse Event|0|||
27668220|NCT00443898|80623597|FG002|Overall Study|Adverse Event|1|||
27668221|NCT00443898|80623598|FG003|Overall Study|Adverse Event|1|||
27668222|NCT00443898|80623595|FG000|Overall Study|Lack of Efficacy|2|||
27668223|NCT00443898|80623596|FG001|Overall Study|Lack of Efficacy|3|||
27668224|NCT00443898|80623597|FG002|Overall Study|Lack of Efficacy|3|||
27668225|NCT00443898|80623598|FG003|Overall Study|Lack of Efficacy|1|||
27668226|NCT00443898|80623595|FG000|Overall Study|Protocol Violation|1|||
27668227|NCT00443898|80623596|FG001|Overall Study|Protocol Violation|1|||
27668228|NCT00443898|80623597|FG002|Overall Study|Protocol Violation|1|||
27668229|NCT00443898|80623598|FG003|Overall Study|Protocol Violation|0|||
27668230|NCT00443898|80623595|FG000|Overall Study|Withdrawal by Subject|11|||
27668231|NCT00443898|80623596|FG001|Overall Study|Withdrawal by Subject|10|||
27668232|NCT00443898|80623597|FG002|Overall Study|Withdrawal by Subject|10|||
27668233|NCT00443898|80623598|FG003|Overall Study|Withdrawal by Subject|6|||
27971453|NCT01229254|81726502|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
27971454|NCT01229254|81726503|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
27971455|NCT01229254|81726504|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
27971456|NCT01229254|81726502|FG000|Overall Study|Adverse Event|4|||
27971457|NCT01229254|81726503|FG001|Overall Study|Adverse Event|5|||
27971458|NCT01229254|81726504|FG002|Overall Study|Adverse Event|3|||
27971459|NCT01229254|81726502|FG000|Overall Study|Lost to Follow-up|3|||
27971460|NCT01229254|81726503|FG001|Overall Study|Lost to Follow-up|0|||
27971461|NCT01229254|81726504|FG002|Overall Study|Lost to Follow-up|1|||
27971462|NCT01229254|81726502|FG000|Overall Study|Physician Decision|0|||
27668234|NCT00443898|80623595|FG000|Overall Study|Lost to Follow-up|10|||
27668235|NCT00443898|80623596|FG001|Overall Study|Lost to Follow-up|10|||
27668236|NCT00443898|80623597|FG002|Overall Study|Lost to Follow-up|14|||
27668237|NCT00443898|80623598|FG003|Overall Study|Lost to Follow-up|10|||
27668238|NCT00443898|80623595|FG000|Overall Study|Death|0|||
27668239|NCT00443898|80623596|FG001|Overall Study|Death|1|||
27668240|NCT00443898|80623597|FG002|Overall Study|Death|0|||
27668241|NCT00443898|80623598|FG003|Overall Study|Death|0|||
27668242|NCT02804399|80623599|FG000|Period 2|Adverse Event|0|||
27668243|NCT02804399|80623600|FG001|Period 2|Adverse Event|1|||
27668244|NCT01056263|80623601|FG000|Overall Study|Adverse Event|12|||
27668245|NCT01056263|80623601|FG000|Overall Study|Death|1|||
27668246|NCT01056263|80623601|FG000|Overall Study|Withdrawal by Subject|1|||
27668247|NCT01056263|80623601|FG000|Overall Study|Lack of Efficacy|29|||
27668248|NCT01056263|80623601|FG000|Overall Study|Progressive disease|2|||
27668249|NCT01056263|80623601|FG000|Overall Study|Neoplasm progression|1|||
27668250|NCT01056263|80623601|FG000|Overall Study|Objective progression or relapse|1|||
27668251|NCT01056263|80623601|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
27668252|NCT01321723|80623604|FG000|Overall Study|Adverse Event|3|||
27668253|NCT01321723|80623605|FG001|Overall Study|Adverse Event|5|||
27782417|NCT00963820|81032334|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27782418|NCT00963820|81032335|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27782419|NCT00963820|81032336|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27782420|NCT00963820|81032337|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27782421|NCT00963820|81032338|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
27782422|NCT00963820|81032339|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
27782423|NCT00963820|81032340|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
27782424|NCT00963820|81032341|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
27782425|NCT00963820|81032342|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
27782426|NCT00963820|81032343|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
27782427|NCT00963820|81032344|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
27782428|NCT00963820|81032345|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
27782429|NCT00963820|81032334|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27971463|NCT01229254|81726503|FG001|Overall Study|Physician Decision|3|||
27782430|NCT00963820|81032335|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782431|NCT00963820|81032336|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27971464|NCT01229254|81726504|FG002|Overall Study|Physician Decision|0|||
27971465|NCT01229254|81726502|FG000|Overall Study|Protocol Violation|4|||
27668254|NCT01321723|80623606|FG002|Overall Study|Adverse Event|2|||
27668255|NCT01321723|80623604|FG000|Overall Study|Withdrawal by Subject|2|||
27668256|NCT01321723|80623605|FG001|Overall Study|Withdrawal by Subject|0|||
27668257|NCT01321723|80623606|FG002|Overall Study|Withdrawal by Subject|2|||
27668258|NCT00917462|80623607|FG000|Overall Study|Clinical Deterioration|1|||
27668259|NCT01086384|80623608|FG000|2-week Run-in Period|Adverse Event|1|||
27668260|NCT01086384|80623609|FG001|2-week Run-in Period|Adverse Event|0|||
27668261|NCT01086384|80623610|FG002|2-week Run-in Period|Adverse Event|0|||
27668262|NCT01086384|80623608|FG000|2-week Run-in Period|Protocol Violation|1|||
27668263|NCT01086384|80623609|FG001|2-week Run-in Period|Protocol Violation|0|||
27668264|NCT01086384|80623610|FG002|2-week Run-in Period|Protocol Violation|0|||
27668265|NCT01086384|80623608|FG000|2-week Run-in Period|Lost to Follow-up|1|||
27668266|NCT01086384|80623609|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27668267|NCT01086384|80623610|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27668268|NCT01086384|80623608|FG000|2-week Run-in Period|Physician Decision|6|||
27668269|NCT01086384|80623609|FG001|2-week Run-in Period|Physician Decision|0|||
27668270|NCT01086384|80623610|FG002|2-week Run-in Period|Physician Decision|0|||
27668271|NCT01086384|80623608|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
27668272|NCT01086384|80623609|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27668273|NCT01086384|80623610|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27668274|NCT01086384|80623608|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
27668275|NCT01086384|80623609|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
27668276|NCT01086384|80623610|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
27668277|NCT01086384|80623608|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
27668278|NCT01086384|80623609|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
27971466|NCT01229254|81726503|FG001|Overall Study|Protocol Violation|6|||
27971467|NCT01229254|81726504|FG002|Overall Study|Protocol Violation|5|||
27971468|NCT01229254|81726502|FG000|Overall Study|Withdrawal by Subject|1|||
27668279|NCT01086384|80623610|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
27668280|NCT01086384|80623608|FG000|2-week Run-in Period|Randomized in Error|1|||
27668281|NCT01086384|80623609|FG001|2-week Run-in Period|Randomized in Error|0|||
27668282|NCT01086384|80623610|FG002|2-week Run-in Period|Randomized in Error|0|||
27668283|NCT01086384|80623608|FG000|Treatment Period|Withdrawal by Subject|0|||
27668284|NCT01086384|80623609|FG001|Treatment Period|Withdrawal by Subject|53|||
27668285|NCT01086384|80623610|FG002|Treatment Period|Withdrawal by Subject|55|||
27668286|NCT01086384|80623608|FG000|Treatment Period|Protocol Violation|0|||
27668287|NCT01086384|80623609|FG001|Treatment Period|Protocol Violation|26|||
27668288|NCT01086384|80623610|FG002|Treatment Period|Protocol Violation|17|||
27668289|NCT01086384|80623608|FG000|Treatment Period|Lack of Efficacy|0|||
27668290|NCT01086384|80623609|FG001|Treatment Period|Lack of Efficacy|22|||
27668291|NCT01086384|80623610|FG002|Treatment Period|Lack of Efficacy|13|||
27668292|NCT01086384|80623608|FG000|Treatment Period|Adverse Event|0|||
27668293|NCT01086384|80623609|FG001|Treatment Period|Adverse Event|19|||
27668294|NCT01086384|80623610|FG002|Treatment Period|Adverse Event|15|||
27668295|NCT01086384|80623608|FG000|Treatment Period|Lost to Follow-up|0|||
27668296|NCT01086384|80623609|FG001|Treatment Period|Lost to Follow-up|11|||
27668297|NCT01086384|80623610|FG002|Treatment Period|Lost to Follow-up|9|||
27668298|NCT01086384|80623608|FG000|Treatment Period|Physician Decision|0|||
27668299|NCT01086384|80623609|FG001|Treatment Period|Physician Decision|9|||
27668300|NCT01086384|80623610|FG002|Treatment Period|Physician Decision|6|||
27668301|NCT01086384|80623608|FG000|Treatment Period|Study Closed/Terminated|0|||
27668302|NCT01086384|80623609|FG001|Treatment Period|Study Closed/Terminated|7|||
27668303|NCT01086384|80623610|FG002|Treatment Period|Study Closed/Terminated|8|||
27668304|NCT01086384|80623608|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
27668305|NCT01086384|80623609|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
27668306|NCT01086384|80623610|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
27668307|NCT01086384|80623608|FG000|Treatment Period|Received Treatment in Error|0|||
27668308|NCT01086384|80623609|FG001|Treatment Period|Received Treatment in Error|1|||
27668309|NCT01086384|80623610|FG002|Treatment Period|Received Treatment in Error|0|||
27668310|NCT00195442|80623611|FG000|Overall Study|Less than expected therapeutic effect|38|||
27668311|NCT00195442|80623611|FG000|Overall Study|Lost to Follow-up|27|||
27668312|NCT00195442|80623611|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
27668313|NCT00195442|80623611|FG000|Overall Study|Intermittent product shortage|21|||
27668314|NCT00195442|80623611|FG000|Overall Study|Death|7|||
27668315|NCT00195442|80623611|FG000|Overall Study|No reason specified|4|||
27668316|NCT00195442|80623611|FG000|Overall Study|Poor cooperation|2|||
27668317|NCT00195442|80623611|FG000|Overall Study|Other|14|||
27668318|NCT01263925|80623612|FG000|Overall Study|Protocol Violation|1|||
27668319|NCT01263925|80623613|FG001|Overall Study|Protocol Violation|0|||
27668320|NCT01263925|80623612|FG000|Overall Study|Lack of Efficacy|0|||
27668321|NCT01263925|80623613|FG001|Overall Study|Lack of Efficacy|1|||
27668322|NCT01263925|80623612|FG000|Overall Study|Adverse Event|23|||
27668323|NCT01263925|80623613|FG001|Overall Study|Adverse Event|22|||
27668324|NCT01263925|80623612|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
27668325|NCT01263925|80623613|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
27668326|NCT01263925|80623612|FG000|Overall Study|Withdrawal by Subject|6|||
27865022|NCT04604795|81337336|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27668327|NCT01263925|80623613|FG001|Overall Study|Withdrawal by Subject|8|||
27668328|NCT01263925|80623612|FG000|Overall Study|Other|4|||
27668329|NCT01263925|80623613|FG001|Overall Study|Other|4|||
27668330|NCT01263925|80623612|FG000|Overall Study|Lost to Follow-up|3|||
27668331|NCT01263925|80623613|FG001|Overall Study|Lost to Follow-up|1|||
27668332|NCT01263925|80623612|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
27668333|NCT01263925|80623613|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
27668334|NCT01263925|80623612|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
27668335|NCT01263925|80623613|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
27668336|NCT01263925|80623612|FG000|Overall Study|AE/ Withdrawal|1|||
27668337|NCT01263925|80623613|FG001|Overall Study|AE/ Withdrawal|4|||
27668338|NCT01263925|80623612|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
27668339|NCT01263925|80623613|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
27668340|NCT01263925|80623612|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
27668341|NCT01263925|80623613|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
27668342|NCT01263925|80623612|FG000|Overall Study|Withdrawal/ Not specified|0|||
27971469|NCT01229254|81726503|FG001|Overall Study|Withdrawal by Subject|0|||
27971470|NCT01229254|81726504|FG002|Overall Study|Withdrawal by Subject|1|||
27668343|NCT01263925|80623613|FG001|Overall Study|Withdrawal/ Not specified|1|||
27668344|NCT00537329|80623615|FG000|Overall Study|Death|10|||
27668345|NCT00537329|80623615|FG000|Overall Study|Adverse Event|3|||
27668346|NCT00537329|80623615|FG000|Overall Study|Lack of Efficacy|2|||
27668347|NCT00537329|80623615|FG000|Overall Study|Lost to Follow-up|6|||
27668348|NCT00537329|80623615|FG000|Overall Study|Withdrawal by Subject|4|||
27668349|NCT00537329|80623615|FG000|Overall Study|Other|1|||
27668350|NCT01093599|80623616|FG000|Overall Study|Lost to Follow-up|32|||
27668351|NCT01093599|80623617|FG001|Overall Study|Lost to Follow-up|46|||
27668352|NCT02215954|80623623|FG000|Overall Study|Adverse Event|0|||
27668353|NCT02215954|80623624|FG001|Overall Study|Adverse Event|0|||
27782432|NCT00963820|81032337|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782433|NCT00963820|81032338|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782434|NCT00963820|81032339|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782435|NCT00963820|81032340|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27782436|NCT00963820|81032341|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782437|NCT00963820|81032342|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782438|NCT00963820|81032343|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782439|NCT00963820|81032344|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782440|NCT00963820|81032345|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27782441|NCT00963820|81032334|FG000|Expansion Phase|Progressive Disease|0|||
27782442|NCT00963820|81032335|FG001|Expansion Phase|Progressive Disease|0|||
27971471|NCT01229254|81726502|FG000|Overall Study|Non-compliance with Study Drug|0|||
27971472|NCT01229254|81726503|FG001|Overall Study|Non-compliance with Study Drug|1|||
27971473|NCT01229254|81726504|FG002|Overall Study|Non-compliance with Study Drug|1|||
27971474|NCT00778258|81726507|FG000|Overall Study|Adverse Event|1|||
27971475|NCT00778258|81726508|FG001|Overall Study|Adverse Event|0|||
27971476|NCT00778258|81726509|FG002|Overall Study|Adverse Event|0|||
27971477|NCT00778258|81726510|FG003|Overall Study|Adverse Event|0|||
27971478|NCT00778258|81726511|FG004|Overall Study|Adverse Event|0|||
27971479|NCT00778258|81726512|FG005|Overall Study|Adverse Event|1|||
27971480|NCT00778258|81726513|FG006|Overall Study|Adverse Event|0|||
27971481|NCT00778258|81726514|FG007|Overall Study|Adverse Event|0|||
27782443|NCT00963820|81032336|FG002|Expansion Phase|Progressive Disease|0|||
27971482|NCT00778258|81726515|FG008|Overall Study|Adverse Event|0|||
27971483|NCT00778258|81726507|FG000|Overall Study|Lost to Follow-up|0|||
27668354|NCT02215954|80623625|FG002|Overall Study|Adverse Event|1|||
27668355|NCT02215954|80623623|FG000|Overall Study|Withdrawal by Subject|0|||
27782444|NCT00963820|81032337|FG003|Expansion Phase|Progressive Disease|0|||
27971484|NCT00778258|81726508|FG001|Overall Study|Lost to Follow-up|0|||
27971485|NCT00778258|81726509|FG002|Overall Study|Lost to Follow-up|2|||
27971486|NCT00778258|81726510|FG003|Overall Study|Lost to Follow-up|0|||
27971487|NCT00778258|81726511|FG004|Overall Study|Lost to Follow-up|0|||
27971488|NCT00778258|81726512|FG005|Overall Study|Lost to Follow-up|3|||
27971489|NCT00778258|81726513|FG006|Overall Study|Lost to Follow-up|2|||
27971490|NCT00778258|81726514|FG007|Overall Study|Lost to Follow-up|2|||
27971491|NCT00778258|81726515|FG008|Overall Study|Lost to Follow-up|0|||
27971492|NCT00778258|81726507|FG000|Overall Study|Withdrawal by Subject|6|||
27971493|NCT00778258|81726508|FG001|Overall Study|Withdrawal by Subject|2|||
27971494|NCT00778258|81726509|FG002|Overall Study|Withdrawal by Subject|8|||
27971495|NCT00778258|81726510|FG003|Overall Study|Withdrawal by Subject|2|||
27971496|NCT00778258|81726511|FG004|Overall Study|Withdrawal by Subject|0|||
27971497|NCT00778258|81726512|FG005|Overall Study|Withdrawal by Subject|6|||
27971498|NCT00778258|81726513|FG006|Overall Study|Withdrawal by Subject|12|||
27971499|NCT00778258|81726514|FG007|Overall Study|Withdrawal by Subject|12|||
27971500|NCT00778258|81726515|FG008|Overall Study|Withdrawal by Subject|4|||
27971501|NCT00778258|81726507|FG000|Overall Study|New Contraindication|0|||
27971502|NCT00778258|81726508|FG001|Overall Study|New Contraindication|0|||
27971503|NCT00778258|81726509|FG002|Overall Study|New Contraindication|0|||
27971504|NCT00778258|81726510|FG003|Overall Study|New Contraindication|0|||
27971505|NCT00778258|81726511|FG004|Overall Study|New Contraindication|0|||
27971506|NCT00778258|81726512|FG005|Overall Study|New Contraindication|0|||
27971507|NCT00778258|81726513|FG006|Overall Study|New Contraindication|0|||
27971508|NCT00778258|81726514|FG007|Overall Study|New Contraindication|1|||
27971509|NCT00778258|81726515|FG008|Overall Study|New Contraindication|0|||
27971510|NCT00778258|81726507|FG000|Overall Study|Non-compliance|0|||
27971511|NCT00778258|81726508|FG001|Overall Study|Non-compliance|0|||
27971512|NCT00778258|81726509|FG002|Overall Study|Non-compliance|0|||
27971513|NCT00778258|81726510|FG003|Overall Study|Non-compliance|1|||
27971514|NCT00778258|81726511|FG004|Overall Study|Non-compliance|0|||
27971515|NCT00778258|81726512|FG005|Overall Study|Non-compliance|0|||
27971516|NCT00778258|81726513|FG006|Overall Study|Non-compliance|0|||
27971517|NCT00778258|81726514|FG007|Overall Study|Non-compliance|0|||
27971518|NCT00778258|81726515|FG008|Overall Study|Non-compliance|0|||
27971519|NCT00778258|81726507|FG000|Overall Study|Other|0|||
27971520|NCT00778258|81726508|FG001|Overall Study|Other|0|||
27971521|NCT00778258|81726509|FG002|Overall Study|Other|0|||
27971522|NCT00778258|81726510|FG003|Overall Study|Other|0|||
27971523|NCT00778258|81726511|FG004|Overall Study|Other|0|||
27971524|NCT00778258|81726512|FG005|Overall Study|Other|0|||
27971525|NCT00778258|81726513|FG006|Overall Study|Other|1|||
27971526|NCT00778258|81726514|FG007|Overall Study|Other|0|||
27971527|NCT00778258|81726515|FG008|Overall Study|Other|0|||
27971528|NCT00090233|81726516|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
27971529|NCT00090233|81726517|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
27971530|NCT00090233|81726516|FG000|Overall Study|Adverse Event|214|||
27971531|NCT00090233|81726517|FG001|Overall Study|Adverse Event|198|||
27971532|NCT00090233|81726516|FG000|Overall Study|Lost to Follow-up|68|||
27971533|NCT00090233|81726517|FG001|Overall Study|Lost to Follow-up|95|||
27971534|NCT00090233|81726516|FG000|Overall Study|Protocol Violation|960|||
27971535|NCT00090233|81726517|FG001|Overall Study|Protocol Violation|1022|||
27971536|NCT00090233|81726516|FG000|Overall Study|Withdrawal by Subject|182|||
27971537|NCT00090233|81726517|FG001|Overall Study|Withdrawal by Subject|211|||
27971538|NCT00090233|81726516|FG000|Overall Study|Moved|203|||
27971539|NCT00090233|81726517|FG001|Overall Study|Moved|189|||
27971540|NCT00090233|81726516|FG000|Overall Study|Other|1211|||
27971541|NCT00090233|81726517|FG001|Overall Study|Other|1160|||
27971542|NCT00090233|81726516|FG000|Overall Study|Data not available at data cut-off point|1552|||
27971543|NCT00090233|81726517|FG001|Overall Study|Data not available at data cut-off point|1563|||
27971544|NCT04027049|81726518|FG000|Overall Study|Withdrawn by family|1|||
27971545|NCT04027049|81726519|FG001|Overall Study|Withdrawn by family|0|||
27971546|NCT04027049|81726518|FG000|Overall Study|Participant safety|1|||
27971547|NCT04027049|81726519|FG001|Overall Study|Participant safety|0|||
27971548|NCT01535599|81726525|FG000|Overall Study|Adverse Event|6|||
27971549|NCT01535599|81726526|FG001|Overall Study|Adverse Event|15|||
27971550|NCT01535599|81726525|FG000|Overall Study|Lost to Follow-up|3|||
27971551|NCT01535599|81726526|FG001|Overall Study|Lost to Follow-up|4|||
27971552|NCT01535599|81726525|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
27971553|NCT01535599|81726526|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
27971554|NCT01535599|81726525|FG000|Overall Study|Treatment Failure|33|||
27571432|NCT01577758|80278826|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
27971555|NCT01535599|81726526|FG001|Overall Study|Treatment Failure|66|||
27971556|NCT01535599|81726525|FG000|Overall Study|BL Culture + for Group A Strep|0|||
27971557|NCT01535599|81726526|FG001|Overall Study|BL Culture + for Group A Strep|1|||
27971558|NCT01535599|81726525|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
27971559|NCT01535599|81726526|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
27971560|NCT01535599|81726525|FG000|Overall Study|Randomized in Error|2|||
27971561|NCT01535599|81726526|FG001|Overall Study|Randomized in Error|4|||
27971562|NCT01535599|81726525|FG000|Overall Study|Did not use product|1|||
27971563|NCT01535599|81726526|FG001|Overall Study|Did not use product|0|||
27971564|NCT01535599|81726525|FG000|Overall Study|Other|1|||
27971565|NCT01535599|81726526|FG001|Overall Study|Other|0|||
27971566|NCT01535599|81726525|FG000|Overall Study|Stopped medication|0|||
27971567|NCT01535599|81726526|FG001|Overall Study|Stopped medication|1|||
27971568|NCT01535599|81726525|FG000|Overall Study|Noncompliance|0|||
27971569|NCT01535599|81726526|FG001|Overall Study|Noncompliance|1|||
27971570|NCT00570037|81726527|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
27971571|NCT00570037|81726528|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
27971572|NCT01703208|81726529|FG000|Overall Study|Death|61|||
27971573|NCT01703208|81726530|FG001|Overall Study|Death|48|||
27971574|NCT01703208|81726529|FG000|Overall Study|Lack of Efficacy|1|||
27971575|NCT01703208|81726530|FG001|Overall Study|Lack of Efficacy|2|||
27971576|NCT01703208|81726529|FG000|Overall Study|Lost to Follow-up|68|||
27971577|NCT01703208|81726530|FG001|Overall Study|Lost to Follow-up|62|||
27971578|NCT01703208|81726529|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27971579|NCT01703208|81726530|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27971580|NCT01703208|81726529|FG000|Overall Study|Excluded Medication|1|||
27971581|NCT01703208|81726530|FG001|Overall Study|Excluded Medication|2|||
27971582|NCT01703208|81726529|FG000|Overall Study|Site Discontinued Study Participation|23|||
27971583|NCT01703208|81726530|FG001|Overall Study|Site Discontinued Study Participation|27|||
27971584|NCT01703208|81726529|FG000|Overall Study|Physician Decision|11|||
27971585|NCT01703208|81726530|FG001|Overall Study|Physician Decision|13|||
27865023|NCT04604795|81337337|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27865024|NCT04604795|81337338|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27865025|NCT04604795|81337339|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27971586|NCT01703208|81726529|FG000|Overall Study|Progressive disease|2|||
27971587|NCT01703208|81726530|FG001|Overall Study|Progressive disease|2|||
27971588|NCT01703208|81726529|FG000|Overall Study|Protocol Violation|1|||
27971589|NCT01703208|81726530|FG001|Overall Study|Protocol Violation|1|||
27971590|NCT01703208|81726529|FG000|Overall Study|Study Terminated by Sponsor|1710|||
27971591|NCT01703208|81726530|FG001|Overall Study|Study Terminated by Sponsor|1716|||
27971592|NCT01703208|81726529|FG000|Overall Study|Withdrawal by Subject|205|||
27971593|NCT01703208|81726530|FG001|Overall Study|Withdrawal by Subject|209|||
27971594|NCT01703208|81726529|FG000|Overall Study|Adverse Event|14|||
27865026|NCT04604795|81337340|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
27865027|NCT04604795|81337331|FG000|Part B: Up to Day 14|Adverse Event|0|||
27865028|NCT04604795|81337332|FG001|Part B: Up to Day 14|Adverse Event|0|||
27865029|NCT04604795|81337333|FG002|Part B: Up to Day 14|Adverse Event|0|||
27865030|NCT04604795|81337334|FG003|Part B: Up to Day 14|Adverse Event|0|||
27865031|NCT04604795|81337335|FG004|Part B: Up to Day 14|Adverse Event|2|||
27865032|NCT04604795|81337336|FG005|Part B: Up to Day 14|Adverse Event|1|||
27865033|NCT04604795|81337337|FG006|Part B: Up to Day 14|Adverse Event|0|||
27865034|NCT04604795|81337338|FG007|Part B: Up to Day 14|Adverse Event|0|||
27865035|NCT04604795|81337339|FG008|Part B: Up to Day 14|Adverse Event|0|||
27865036|NCT04604795|81337340|FG009|Part B: Up to Day 14|Adverse Event|0|||
27865037|NCT04604795|81337331|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865038|NCT04604795|81337332|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865039|NCT04604795|81337333|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865040|NCT04604795|81337334|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865041|NCT04604795|81337335|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865042|NCT04604795|81337336|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865043|NCT04604795|81337337|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865044|NCT04604795|81337338|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865045|NCT04604795|81337339|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
27865046|NCT04604795|81337340|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
27865047|NCT04604795|81337331|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865048|NCT04604795|81337332|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865049|NCT04604795|81337333|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865050|NCT04604795|81337334|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865051|NCT04604795|81337335|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865052|NCT04604795|81337336|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27971595|NCT01703208|81726530|FG001|Overall Study|Adverse Event|19|||
27865053|NCT04604795|81337337|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865054|NCT04604795|81337338|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27971596|NCT01703208|81726529|FG000|Overall Study|Technical Problems|0|||
27971597|NCT01703208|81726530|FG001|Overall Study|Technical Problems|1|||
27971598|NCT01703208|81726529|FG000|Overall Study|Protocol Deviation|2|||
27971599|NCT01703208|81726530|FG001|Overall Study|Protocol Deviation|0|||
27971600|NCT04686084|81726542|FG000|Overall Study|Lost to Follow-up|1|||
27971601|NCT01421303|81726544|FG000|Overall Study|Lost to Follow-up|13|||
27971602|NCT01421303|81726544|FG000|Overall Study|Non compliance with study procedure|1|||
27971603|NCT01421303|81726544|FG000|Overall Study|Other|7|||
27971604|NCT01421303|81726544|FG000|Overall Study|Withdrawal by Subject|1|||
27971605|NCT02199314|81726549|FG000|Overall Study|Withdrawal by Subject|6|||
27971606|NCT02199314|81726549|FG000|Overall Study|Physician Decision|10|||
27971607|NCT02359045|81726550|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
27971608|NCT02359045|81726551|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27971609|NCT02359045|81726550|FG000|Overall Study|Lost to Follow-up|1|||
27971610|NCT02359045|81726551|FG001|Overall Study|Lost to Follow-up|1|||
27865055|NCT04604795|81337339|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
27865056|NCT04604795|81337340|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
27865057|NCT04604795|81337331|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865058|NCT04604795|81337332|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27668356|NCT02215954|80623624|FG001|Overall Study|Withdrawal by Subject|0|||
27668357|NCT02215954|80623625|FG002|Overall Study|Withdrawal by Subject|2|||
27668358|NCT02215954|80623623|FG000|Overall Study|Not exposed|1|||
27668359|NCT02215954|80623624|FG001|Overall Study|Not exposed|1|||
27668360|NCT02215954|80623625|FG002|Overall Study|Not exposed|3|||
27668361|NCT02654132|80623626|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
27668362|NCT02654132|80623627|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
27668363|NCT02654132|80623626|FG000|Treatment Period|Disease progression|43|||
27668364|NCT02654132|80623627|FG001|Treatment Period|Disease progression|38|||
27668365|NCT02654132|80623626|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
27668366|NCT02654132|80623627|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
27668367|NCT02654132|80623626|FG000|Treatment Period|Other reasons|4|||
27668368|NCT02654132|80623627|FG001|Treatment Period|Other reasons|2|||
27668369|NCT02654132|80623626|FG000|Treatment Period|Study drug toxicity|2|||
27668370|NCT02654132|80623627|FG001|Treatment Period|Study drug toxicity|2|||
27668371|NCT02654132|80623626|FG000|Treatment Period|Withdrawal by Subject|2|||
27668372|NCT02654132|80623627|FG001|Treatment Period|Withdrawal by Subject|1|||
27668373|NCT02654132|80623626|FG000|Treatment Period|Maximum Clinical Benefit|0|||
27865059|NCT04604795|81337333|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865060|NCT04604795|81337334|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865061|NCT04604795|81337335|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865062|NCT04604795|81337336|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865063|NCT04604795|81337337|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27971611|NCT02359045|81726550|FG000|Overall Study|Adverse Event|0|||
27971612|NCT02359045|81726551|FG001|Overall Study|Adverse Event|1|||
27971613|NCT03260894|81726552|FG000|Overall Study|Death|6|||
27971614|NCT03260894|81726553|FG001|Overall Study|Death|8|||
27971615|NCT03260894|81726552|FG000|Overall Study|Withdrawal by Subject|4|||
27971616|NCT03260894|81726553|FG001|Overall Study|Withdrawal by Subject|11|||
27971617|NCT03260894|81726552|FG000|Overall Study|On-going at clinical cut off date|36|||
27971618|NCT03260894|81726553|FG001|Overall Study|On-going at clinical cut off date|31|||
27971619|NCT01734395|81726554|FG000|Overall Study|Other|65|||
27971620|NCT01734395|81726554|FG000|Overall Study|Lost to Follow-up|287|||
27971621|NCT01734395|81726554|FG000|Overall Study|Lack of Efficacy|5|||
27971622|NCT01734395|81726554|FG000|Overall Study|Adverse Event|40|||
27971623|NCT01734395|81726554|FG000|Overall Study|Withdrawal by Subject|10|||
27971624|NCT01734395|81726554|FG000|Overall Study|Missing the reasons for not completed|3|||
27971625|NCT01380535|81726558|FG000|Overall Study|Adverse Event|3|||
27971626|NCT01380535|81726559|FG001|Overall Study|Adverse Event|3|||
27971627|NCT01380535|81726558|FG000|Overall Study|Death|3|||
27971628|NCT01380535|81726559|FG001|Overall Study|Death|0|||
27971629|NCT01380535|81726558|FG000|Overall Study|Study site closed|0|||
27971630|NCT01380535|81726559|FG001|Overall Study|Study site closed|5|||
27971631|NCT01380535|81726558|FG000|Overall Study|Withdrawal by Subject|1|||
27971632|NCT01380535|81726559|FG001|Overall Study|Withdrawal by Subject|2|||
27971633|NCT01380535|81726558|FG000|Overall Study|Protocol Violation|0|||
27971634|NCT01380535|81726559|FG001|Overall Study|Protocol Violation|2|||
27971635|NCT01380535|81726558|FG000|Overall Study|Lack of Efficacy|0|||
27971636|NCT01380535|81726559|FG001|Overall Study|Lack of Efficacy|3|||
27971637|NCT01457014|81726560|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
27971638|NCT01457014|81726561|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
27971639|NCT01457014|81726562|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
27971640|NCT01457014|81726563|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
27971641|NCT01457014|81726560|FG000|First Night|Withdrawal by Subject|3|||
27668374|NCT02654132|80623627|FG001|Treatment Period|Maximum Clinical Benefit|2|||
27668375|NCT02654132|80623626|FG000|Treatment Period|Participant request to discontinue|2|||
27668376|NCT02654132|80623627|FG001|Treatment Period|Participant request to discontinue|0|||
27971642|NCT01457014|81726561|FG001|First Night|Withdrawal by Subject|0|||
27971643|NCT01457014|81726562|FG002|First Night|Withdrawal by Subject|0|||
27971644|NCT01457014|81726563|FG003|First Night|Withdrawal by Subject|0|||
27971645|NCT04049266|81726564|FG000|Overall Study|Adverse Event|16|||
27971646|NCT04049266|81726565|FG001|Overall Study|Adverse Event|9|||
27971647|NCT04049266|81726564|FG000|Overall Study|Non-compliance with study drug|0|||
27971648|NCT04049266|81726565|FG001|Overall Study|Non-compliance with study drug|3|||
27971649|NCT04049266|81726564|FG000|Overall Study|Withdrawal by Subject|6|||
27971650|NCT04049266|81726565|FG001|Overall Study|Withdrawal by Subject|10|||
27971651|NCT04049266|81726564|FG000|Overall Study|Lost to Follow-up|2|||
27971652|NCT04049266|81726565|FG001|Overall Study|Lost to Follow-up|2|||
27971653|NCT04049266|81726564|FG000|Overall Study|Progressive disease|11|||
27971654|NCT04049266|81726565|FG001|Overall Study|Progressive disease|2|||
27971655|NCT04049266|81726564|FG000|Overall Study|Physician Decision|1|||
27971656|NCT04049266|81726565|FG001|Overall Study|Physician Decision|0|||
27971657|NCT04049266|81726564|FG000|Overall Study|Patient moved out of state|1|||
27971658|NCT04049266|81726565|FG001|Overall Study|Patient moved out of state|0|||
27971659|NCT02750345|81726567|FG000|Intervention 1|Adverse Event|0|||
27971660|NCT02750345|81726568|FG001|Intervention 1|Adverse Event|0|||
27971661|NCT02750345|81726569|FG002|Intervention 1|Adverse Event|0|||
27971662|NCT02750345|81726570|FG003|Intervention 1|Adverse Event|0|||
27971663|NCT02750345|81726571|FG004|Intervention 1|Adverse Event|1|||
27971664|NCT02750345|81726572|FG005|Intervention 1|Adverse Event|0|||
27971665|NCT05426031|81726575|FG000|Overall Study|Circulatory Arrest|3|||
27971666|NCT05426031|81726576|FG001|Overall Study|Circulatory Arrest|2|||
27971667|NCT02300558|81726579|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
27971668|NCT02300558|81726579|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
27971669|NCT02300558|81726579|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
27971670|NCT02300558|81726579|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
27971671|NCT02585830|81726581|FG000|Overall Study|Withdrawal by Subject|3|||
27971672|NCT02509052|81726582|FG000|Overall Study|Non compliance|0|||
27971673|NCT02509052|81726583|FG001|Overall Study|Non compliance|0|||
27971674|NCT02509052|81726584|FG002|Overall Study|Non compliance|1|||
27971675|NCT01032291|81726587|FG000|Safety Lead-in|Adverse Event|1|||
27971676|NCT01032291|81726588|FG001|Safety Lead-in|Adverse Event|0|||
27971677|NCT01032291|81726589|FG002|Safety Lead-in|Adverse Event|0|||
27971678|NCT01032291|81726587|FG000|Safety Lead-in|Death|1|||
27971679|NCT01032291|81726588|FG001|Safety Lead-in|Death|0|||
27971680|NCT01032291|81726589|FG002|Safety Lead-in|Death|0|||
27971681|NCT01032291|81726587|FG000|Proof of Concept|Adverse Event|0|||
27971682|NCT01032291|81726588|FG001|Proof of Concept|Adverse Event|5|||
27971683|NCT01032291|81726589|FG002|Proof of Concept|Adverse Event|1|||
27971684|NCT01032291|81726587|FG000|Proof of Concept|Death|0|||
27971685|NCT01032291|81726588|FG001|Proof of Concept|Death|1|||
27971686|NCT01032291|81726589|FG002|Proof of Concept|Death|2|||
27971687|NCT01032291|81726587|FG000|Proof of Concept|Lack of Efficacy|0|||
27668377|NCT02654132|80623626|FG000|Treatment Period|Administrative reasons by sponsor|0|||
27668378|NCT02654132|80623627|FG001|Treatment Period|Administrative reasons by sponsor|1|||
27668379|NCT02654132|80623626|FG000|Treatment Period|Death|1|||
27668380|NCT02654132|80623627|FG001|Treatment Period|Death|0|||
27668381|NCT00104637|80623628|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
27782445|NCT00963820|81032338|FG004|Expansion Phase|Progressive Disease|0|||
27782446|NCT00963820|81032339|FG005|Expansion Phase|Progressive Disease|0|||
27782447|NCT00963820|81032340|FG006|Expansion Phase|Progressive Disease|0|||
27782448|NCT00963820|81032341|FG007|Expansion Phase|Progressive Disease|0|||
27782449|NCT00963820|81032342|FG008|Expansion Phase|Progressive Disease|8|||
27782450|NCT00963820|81032343|FG009|Expansion Phase|Progressive Disease|6|||
27782451|NCT00963820|81032344|FG010|Expansion Phase|Progressive Disease|4|||
27782452|NCT00963820|81032345|FG011|Expansion Phase|Progressive Disease|2|||
27782453|NCT00963820|81032334|FG000|Expansion Phase|Adverse Event|0|||
27782454|NCT00963820|81032335|FG001|Expansion Phase|Adverse Event|0|||
27782455|NCT00963820|81032336|FG002|Expansion Phase|Adverse Event|0|||
27782456|NCT00963820|81032337|FG003|Expansion Phase|Adverse Event|0|||
27782457|NCT00963820|81032338|FG004|Expansion Phase|Adverse Event|0|||
27782458|NCT00963820|81032339|FG005|Expansion Phase|Adverse Event|0|||
27782459|NCT00963820|81032340|FG006|Expansion Phase|Adverse Event|0|||
27782460|NCT00963820|81032341|FG007|Expansion Phase|Adverse Event|0|||
27782461|NCT00963820|81032342|FG008|Expansion Phase|Adverse Event|1|||
27782462|NCT00963820|81032343|FG009|Expansion Phase|Adverse Event|3|||
27668382|NCT00104637|80623629|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
27782463|NCT00963820|81032344|FG010|Expansion Phase|Adverse Event|0|||
27782464|NCT00963820|81032345|FG011|Expansion Phase|Adverse Event|0|||
27782465|NCT00963820|81032334|FG000|Expansion Phase|Withdrawal by Subject|0|||
27971688|NCT01032291|81726588|FG001|Proof of Concept|Lack of Efficacy|1|||
27971689|NCT01032291|81726589|FG002|Proof of Concept|Lack of Efficacy|0|||
27668383|NCT03475056|80623630|FG000|Overall Study|Lost to Follow-up|0|||
27971690|NCT01032291|81726587|FG000|Proof of Concept|Never Received Study Drug|0|||
27971691|NCT01032291|81726588|FG001|Proof of Concept|Never Received Study Drug|1|||
27971692|NCT01032291|81726589|FG002|Proof of Concept|Never Received Study Drug|0|||
27668384|NCT03475056|80623631|FG001|Overall Study|Lost to Follow-up|1|||
27668385|NCT03475056|80623630|FG000|Overall Study|Moved from Area|0|||
27668386|NCT03475056|80623631|FG001|Overall Study|Moved from Area|2|||
27668387|NCT00847132|80623632|FG000|Overall Study|Death|1|||
27668388|NCT00847132|80623633|FG001|Overall Study|Death|1|||
27668389|NCT00129649|80623634|FG000|Overall Study|Withdrawal by Subject|76|||
27668390|NCT00129649|80623635|FG001|Overall Study|Withdrawal by Subject|65|||
27668391|NCT01917006|80623636|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
27668392|NCT01917006|80623637|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
27668393|NCT01917006|80623638|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
27668394|NCT01917006|80623639|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
27668395|NCT01917006|80623640|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
27668396|NCT01917006|80623641|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
27668397|NCT01917006|80623642|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
27668398|NCT01917006|80623643|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
27668399|NCT01917006|80623636|FG000|Randomized-treatment Period|Personal Reasons|0|||
27668400|NCT01917006|80623637|FG001|Randomized-treatment Period|Personal Reasons|0|||
27668401|NCT01917006|80623638|FG002|Randomized-treatment Period|Personal Reasons|0|||
27668402|NCT01917006|80623639|FG003|Randomized-treatment Period|Personal Reasons|0|||
27668403|NCT01917006|80623640|FG004|Randomized-treatment Period|Personal Reasons|0|||
27668404|NCT01917006|80623641|FG005|Randomized-treatment Period|Personal Reasons|1|||
27668405|NCT01917006|80623642|FG006|Randomized-treatment Period|Personal Reasons|0|||
27668406|NCT01917006|80623643|FG007|Randomized-treatment Period|Personal Reasons|0|||
27668407|NCT01917006|80623636|FG000|Randomized-treatment Period|Protocol Violation|1|||
27668408|NCT01917006|80623637|FG001|Randomized-treatment Period|Protocol Violation|0|||
27668409|NCT01917006|80623638|FG002|Randomized-treatment Period|Protocol Violation|0|||
27668410|NCT01917006|80623639|FG003|Randomized-treatment Period|Protocol Violation|0|||
27668411|NCT01917006|80623640|FG004|Randomized-treatment Period|Protocol Violation|0|||
27668412|NCT01917006|80623641|FG005|Randomized-treatment Period|Protocol Violation|0|||
27668413|NCT01917006|80623642|FG006|Randomized-treatment Period|Protocol Violation|0|||
27668414|NCT01917006|80623643|FG007|Randomized-treatment Period|Protocol Violation|0|||
27668415|NCT01917006|80623636|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668416|NCT01917006|80623637|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668417|NCT01917006|80623638|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668418|NCT01917006|80623639|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668419|NCT01917006|80623640|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668420|NCT01917006|80623641|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668421|NCT01917006|80623642|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
27668422|NCT01917006|80623643|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
27668423|NCT01917006|80623636|FG000|Open-label Period|Adverse Event|0|||
27668424|NCT01917006|80623637|FG001|Open-label Period|Adverse Event|0|||
27668425|NCT01917006|80623638|FG002|Open-label Period|Adverse Event|0|||
27668426|NCT01917006|80623639|FG003|Open-label Period|Adverse Event|0|||
27668427|NCT01917006|80623640|FG004|Open-label Period|Adverse Event|0|||
27668428|NCT01917006|80623641|FG005|Open-label Period|Adverse Event|0|||
27668429|NCT01917006|80623642|FG006|Open-label Period|Adverse Event|0|||
27668430|NCT01917006|80623643|FG007|Open-label Period|Adverse Event|1|||
27668431|NCT01917006|80623636|FG000|Open-label Period|Lost to Follow-up|0|||
27668432|NCT01917006|80623637|FG001|Open-label Period|Lost to Follow-up|0|||
27668433|NCT01917006|80623638|FG002|Open-label Period|Lost to Follow-up|0|||
27668434|NCT01917006|80623639|FG003|Open-label Period|Lost to Follow-up|0|||
27971693|NCT01939002|81726592|FG000|Overall Study|Adverse Event|13|||
27668435|NCT01917006|80623640|FG004|Open-label Period|Lost to Follow-up|0|||
27668436|NCT01917006|80623641|FG005|Open-label Period|Lost to Follow-up|0|||
27971694|NCT01939002|81726593|FG001|Overall Study|Adverse Event|13|||
27971695|NCT01939002|81726592|FG000|Overall Study|Withdrawal by Subject|5|||
27971696|NCT01939002|81726593|FG001|Overall Study|Withdrawal by Subject|3|||
27971697|NCT01939002|81726592|FG000|Overall Study|Other|1|||
27971698|NCT01939002|81726593|FG001|Overall Study|Other|2|||
27971699|NCT04437511|81726594|FG000|Overall Study|Adverse Event|50|||
27971700|NCT04437511|81726595|FG001|Overall Study|Adverse Event|21|||
27971701|NCT04437511|81726594|FG000|Overall Study|Death|15|||
27971702|NCT04437511|81726595|FG001|Overall Study|Death|10|||
27971703|NCT04437511|81726594|FG000|Overall Study|Lost to Follow-up|11|||
27971704|NCT04437511|81726595|FG001|Overall Study|Lost to Follow-up|11|||
27971705|NCT04437511|81726594|FG000|Overall Study|Physician Decision|19|||
27971706|NCT04437511|81726595|FG001|Overall Study|Physician Decision|10|||
27668437|NCT01917006|80623642|FG006|Open-label Period|Lost to Follow-up|0|||
27971707|NCT04437511|81726594|FG000|Overall Study|Progressive Disease|4|||
27668438|NCT01917006|80623643|FG007|Open-label Period|Lost to Follow-up|1|||
27668439|NCT00043186|80623644|FG000|Overall Study|Physician Decision|0|||
27971708|NCT04437511|81726595|FG001|Overall Study|Progressive Disease|7|||
27971709|NCT04437511|81726594|FG000|Overall Study|Withdrawal by Subject|111|||
27971710|NCT04437511|81726595|FG001|Overall Study|Withdrawal by Subject|94|||
27971711|NCT04437511|81726594|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
27668440|NCT00043186|80623645|FG001|Overall Study|Physician Decision|0|||
27668441|NCT00043186|80623646|FG002|Overall Study|Physician Decision|3|||
27668442|NCT00043186|80623647|FG003|Overall Study|Physician Decision|0|||
27668443|NCT00043186|80623648|FG004|Overall Study|Physician Decision|1|||
27668444|NCT00043186|80623649|FG005|Overall Study|Physician Decision|0|||
27668445|NCT00043186|80623650|FG006|Overall Study|Physician Decision|0|||
27668446|NCT00043186|80623651|FG007|Overall Study|Physician Decision|1|||
27668447|NCT00043186|80623652|FG008|Overall Study|Physician Decision|1|||
27668448|NCT00043186|80623644|FG000|Overall Study|Adverse Event|2|||
27668449|NCT00043186|80623645|FG001|Overall Study|Adverse Event|2|||
27668450|NCT00043186|80623646|FG002|Overall Study|Adverse Event|2|||
27668451|NCT00043186|80623647|FG003|Overall Study|Adverse Event|3|||
27971712|NCT04437511|81726595|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
27971713|NCT04437511|81726594|FG000|Overall Study|Continuing Study|7|||
27668452|NCT00043186|80623648|FG004|Overall Study|Adverse Event|2|||
27668453|NCT00043186|80623649|FG005|Overall Study|Adverse Event|1|||
27668454|NCT00043186|80623650|FG006|Overall Study|Adverse Event|2|||
27668455|NCT00043186|80623651|FG007|Overall Study|Adverse Event|1|||
27668456|NCT00043186|80623652|FG008|Overall Study|Adverse Event|3|||
27668457|NCT00043186|80623644|FG000|Overall Study|Withdrawal by Subject|11|||
27668458|NCT00043186|80623645|FG001|Overall Study|Withdrawal by Subject|8|||
27668459|NCT00043186|80623646|FG002|Overall Study|Withdrawal by Subject|11|||
27668460|NCT00043186|80623647|FG003|Overall Study|Withdrawal by Subject|13|||
27668461|NCT00043186|80623648|FG004|Overall Study|Withdrawal by Subject|14|||
27668462|NCT00043186|80623649|FG005|Overall Study|Withdrawal by Subject|6|||
27668463|NCT00043186|80623650|FG006|Overall Study|Withdrawal by Subject|12|||
27668464|NCT00043186|80623651|FG007|Overall Study|Withdrawal by Subject|9|||
27668465|NCT00043186|80623652|FG008|Overall Study|Withdrawal by Subject|10|||
27668466|NCT00043186|80623644|FG000|Overall Study|Death|0|||
27668467|NCT00043186|80623645|FG001|Overall Study|Death|0|||
27668468|NCT00043186|80623646|FG002|Overall Study|Death|1|||
27668469|NCT00043186|80623647|FG003|Overall Study|Death|0|||
27668470|NCT00043186|80623648|FG004|Overall Study|Death|0|||
27668471|NCT00043186|80623649|FG005|Overall Study|Death|0|||
27668472|NCT00043186|80623650|FG006|Overall Study|Death|2|||
27668473|NCT00043186|80623651|FG007|Overall Study|Death|0|||
27668474|NCT00043186|80623652|FG008|Overall Study|Death|0|||
27668475|NCT00043186|80623644|FG000|Overall Study|Disease progression|1|||
27668476|NCT00043186|80623645|FG001|Overall Study|Disease progression|0|||
27668477|NCT00043186|80623646|FG002|Overall Study|Disease progression|0|||
27668478|NCT00043186|80623647|FG003|Overall Study|Disease progression|3|||
27668479|NCT00043186|80623648|FG004|Overall Study|Disease progression|0|||
27668480|NCT00043186|80623649|FG005|Overall Study|Disease progression|0|||
27668481|NCT00043186|80623650|FG006|Overall Study|Disease progression|0|||
27782466|NCT00963820|81032335|FG001|Expansion Phase|Withdrawal by Subject|0|||
27782467|NCT00963820|81032336|FG002|Expansion Phase|Withdrawal by Subject|0|||
27782468|NCT00963820|81032337|FG003|Expansion Phase|Withdrawal by Subject|0|||
27782469|NCT00963820|81032338|FG004|Expansion Phase|Withdrawal by Subject|0|||
27782470|NCT00963820|81032339|FG005|Expansion Phase|Withdrawal by Subject|0|||
27782471|NCT00963820|81032340|FG006|Expansion Phase|Withdrawal by Subject|0|||
27782472|NCT00963820|81032341|FG007|Expansion Phase|Withdrawal by Subject|0|||
27782473|NCT00963820|81032342|FG008|Expansion Phase|Withdrawal by Subject|1|||
27782474|NCT00963820|81032343|FG009|Expansion Phase|Withdrawal by Subject|0|||
27782475|NCT00963820|81032344|FG010|Expansion Phase|Withdrawal by Subject|1|||
27782476|NCT00963820|81032345|FG011|Expansion Phase|Withdrawal by Subject|1|||
27782477|NCT00963820|81032334|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27971714|NCT04437511|81726595|FG001|Overall Study|Continuing Study|5|||
27971715|NCT02487654|81726598|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
27668482|NCT00043186|80623651|FG007|Overall Study|Disease progression|4|||
27668483|NCT00043186|80623652|FG008|Overall Study|Disease progression|0|||
27668484|NCT00043186|80623644|FG000|Overall Study|Ineligibility determined|0|||
27668485|NCT00043186|80623645|FG001|Overall Study|Ineligibility determined|0|||
27668486|NCT00043186|80623646|FG002|Overall Study|Ineligibility determined|0|||
27668487|NCT00043186|80623647|FG003|Overall Study|Ineligibility determined|0|||
27782478|NCT00963820|81032335|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782479|NCT00963820|81032336|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782480|NCT00963820|81032337|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27668488|NCT00043186|80623648|FG004|Overall Study|Ineligibility determined|0|||
27782481|NCT00963820|81032338|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27668489|NCT00043186|80623649|FG005|Overall Study|Ineligibility determined|0|||
27668490|NCT00043186|80623650|FG006|Overall Study|Ineligibility determined|0|||
27668491|NCT00043186|80623651|FG007|Overall Study|Ineligibility determined|0|||
27668492|NCT00043186|80623652|FG008|Overall Study|Ineligibility determined|1|||
27668493|NCT00043186|80623644|FG000|Overall Study|Lost to Follow-up|3|||
27668494|NCT00043186|80623645|FG001|Overall Study|Lost to Follow-up|5|||
27782482|NCT00963820|81032339|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782483|NCT00963820|81032340|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782484|NCT00963820|81032341|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782485|NCT00963820|81032342|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782486|NCT00963820|81032343|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782487|NCT00963820|81032344|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27782488|NCT00963820|81032345|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
27782489|NCT02354599|81032353|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27782490|NCT02354599|81032354|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27782491|NCT02354599|81032355|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27971716|NCT02487654|81726599|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
27971717|NCT02487654|81726598|FG000|Overall Study|Withdrawal by Subject|3|||
27971718|NCT02487654|81726599|FG001|Overall Study|Withdrawal by Subject|7|||
27971719|NCT02095873|81726600|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
27971720|NCT02095873|81726601|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27971721|NCT02095873|81726600|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
27971722|NCT02095873|81726601|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27971723|NCT02095873|81726600|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
27971724|NCT02095873|81726601|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
27971725|NCT02310230|81726602|FG000|Overall Study|Physician Decision|1|||
27971726|NCT02310230|81726603|FG001|Overall Study|Physician Decision|3|||
27971727|NCT02310230|81726602|FG000|Overall Study|monitor baseline taken after induction|2|||
27971728|NCT02310230|81726603|FG001|Overall Study|monitor baseline taken after induction|7|||
27971729|NCT02310230|81726602|FG000|Overall Study|Poor signal quality|5|||
27971730|NCT02310230|81726603|FG001|Overall Study|Poor signal quality|8|||
27971731|NCT02310230|81726602|FG000|Overall Study|Case cancelled|1|||
27971732|NCT02310230|81726603|FG001|Overall Study|Case cancelled|0|||
27971733|NCT00559845|81726604|FG000|Overall Study|Withdrew Consent|1|||
27971734|NCT00559845|81726604|FG000|Overall Study|Disease Progression|1|||
27971735|NCT00559845|81726604|FG000|Overall Study|Adverse Event|3|||
27971736|NCT00559845|81726604|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
27971737|NCT00559845|81726604|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
27971738|NCT00676520|81726605|FG000|Overall Study|Withdrawal by Subject|163|||
27971739|NCT00676520|81726605|FG000|Overall Study|Lost to Follow-up|162|||
27971740|NCT00676520|81726605|FG000|Overall Study|Death|159|||
27971741|NCT00676520|81726605|FG000|Overall Study|Physician Decision|20|||
27971742|NCT00676520|81726605|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
27971743|NCT00676520|81726605|FG000|Overall Study|Other Reason|18|||
27971744|NCT05032690|81726606|FG000|Period 1|Adverse Event|0|||
27971745|NCT05032690|81726607|FG001|Period 1|Adverse Event|1|||
27971746|NCT05032690|81726608|FG002|Period 1|Adverse Event|0|||
27971747|NCT05032690|81726609|FG003|Period 1|Adverse Event|0|||
27971748|NCT05032690|81726606|FG000|Period 1|Withdrawal by Subject|1|||
27971749|NCT05032690|81726607|FG001|Period 1|Withdrawal by Subject|0|||
27971750|NCT05032690|81726608|FG002|Period 1|Withdrawal by Subject|0|||
27782492|NCT02354599|81032356|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
27668495|NCT00043186|80623646|FG002|Overall Study|Lost to Follow-up|1|||
27971751|NCT05032690|81726609|FG003|Period 1|Withdrawal by Subject|0|||
27971752|NCT05032690|81726606|FG000|Period 1|No longer meets eligibility criteria|0|||
27971753|NCT05032690|81726607|FG001|Period 1|No longer meets eligibility criteria|1|||
27971754|NCT05032690|81726608|FG002|Period 1|No longer meets eligibility criteria|0|||
27971755|NCT05032690|81726609|FG003|Period 1|No longer meets eligibility criteria|0|||
27782493|NCT02354599|81032357|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27782494|NCT02354599|81032358|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
27782495|NCT02354599|81032353|FG000|Overall Study|Withdrawal by Subject|1|||
27782496|NCT02354599|81032354|FG001|Overall Study|Withdrawal by Subject|1|||
27782497|NCT02354599|81032355|FG002|Overall Study|Withdrawal by Subject|0|||
27782498|NCT02354599|81032356|FG003|Overall Study|Withdrawal by Subject|0|||
27782499|NCT02354599|81032357|FG004|Overall Study|Withdrawal by Subject|0|||
27782500|NCT02354599|81032358|FG005|Overall Study|Withdrawal by Subject|0|||
27782501|NCT01952041|81032362|FG000|Overall Study|Lost to Follow-up|9|||
27782502|NCT01952041|81032363|FG001|Overall Study|Lost to Follow-up|16|||
27782503|NCT01952041|81032362|FG000|Overall Study|Withdrawal by Subject|7|||
27782504|NCT01952041|81032363|FG001|Overall Study|Withdrawal by Subject|5|||
27782505|NCT01952041|81032362|FG000|Overall Study|Death|1|||
27782506|NCT01952041|81032363|FG001|Overall Study|Death|0|||
27782507|NCT01552408|81032364|FG000|Overall Study|Lost to Follow-up|2|||
27782508|NCT01552408|81032365|FG001|Overall Study|Lost to Follow-up|0|||
27782509|NCT01552408|81032364|FG000|Overall Study|Relocation|0|||
27782510|NCT01552408|81032365|FG001|Overall Study|Relocation|1|||
27782511|NCT01552408|81032364|FG000|Overall Study|Withdrawal by Subject|2|||
27782512|NCT01552408|81032365|FG001|Overall Study|Withdrawal by Subject|1|||
27782513|NCT02500901|81032368|FG000|Overall Study|Disease ProgressionDD|2|||
27782514|NCT01140646|81032372|FG000|Overall Study|Adverse Event|4|||
27782515|NCT01140646|81032372|FG000|Overall Study|Refused Further Treatment|5|||
27782516|NCT02194699|81032373|FG000|Randomised|Did not receive treatment|1|||
27782517|NCT02194699|81032374|FG001|Randomised|Did not receive treatment|5|||
27782518|NCT02194699|81032373|FG000|Randomised|Without potential for 52 weeks of IP|5|||
27782519|NCT02194699|81032374|FG001|Randomised|Without potential for 52 weeks of IP|5|||
27782520|NCT02194699|81032373|FG000|Randomised|Duplicate patient|2|||
27782521|NCT02194699|81032374|FG001|Randomised|Duplicate patient|1|||
27782522|NCT02194699|81032373|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
27782523|NCT02194699|81032374|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
27782524|NCT02194699|81032373|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
27782525|NCT02194699|81032374|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
27782526|NCT02194699|81032373|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
27782527|NCT02194699|81032374|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
27782528|NCT02194699|81032373|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
27782529|NCT02194699|81032374|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
27782530|NCT02194699|81032373|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
27782531|NCT02194699|81032374|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
27782532|NCT02194699|81032373|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
27782533|NCT02194699|81032374|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
27782534|NCT01066819|81032378|FG000|Overall Study|Adverse Event|18|||
27782535|NCT01066819|81032379|FG001|Overall Study|Adverse Event|1|||
27865064|NCT04604795|81337338|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865065|NCT04604795|81337339|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
27865066|NCT04604795|81337340|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
27865067|NCT04604795|81337331|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865068|NCT04604795|81337332|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865069|NCT04604795|81337333|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865070|NCT04604795|81337334|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865071|NCT04604795|81337335|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865072|NCT04604795|81337336|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865073|NCT04604795|81337337|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865074|NCT04604795|81337338|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865075|NCT04604795|81337339|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
27865076|NCT04604795|81337340|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
27865077|NCT04646005|81337345|FG000|Overall Study|Adverse Event|1|||
27782536|NCT01066819|81032380|FG002|Overall Study|Adverse Event|6|||
27782537|NCT01066819|81032381|FG003|Overall Study|Adverse Event|0|||
27782538|NCT01066819|81032382|FG004|Overall Study|Adverse Event|0|||
27782539|NCT01066819|81032383|FG005|Overall Study|Adverse Event|0|||
27782540|NCT01066819|81032378|FG000|Overall Study|Death|5|||
27782541|NCT01066819|81032379|FG001|Overall Study|Death|0|||
27865078|NCT04646005|81337345|FG000|Overall Study|Progressive Disease|60|||
27865079|NCT04646005|81337345|FG000|Overall Study|Death|19|||
27865080|NCT04646005|81337345|FG000|Overall Study|Withdrawal by Subject|9|||
27865081|NCT04646005|81337345|FG000|Overall Study|Study Ongoing|24|||
27865082|NCT01191944|81337346|FG000|Overall Study|Adverse Event|11|||
27865083|NCT01191944|81337347|FG001|Overall Study|Adverse Event|12|||
27865084|NCT01191944|81337346|FG000|Overall Study|Protocol Violation|1|||
27865085|NCT01191944|81337347|FG001|Overall Study|Protocol Violation|2|||
27865086|NCT01191944|81337346|FG000|Overall Study|Withdrawal by Subject|4|||
27865087|NCT01191944|81337347|FG001|Overall Study|Withdrawal by Subject|2|||
27971756|NCT05032690|81726606|FG000|Period 2|Adverse Event|1|||
27971757|NCT05032690|81726607|FG001|Period 2|Adverse Event|0|||
27971758|NCT05032690|81726608|FG002|Period 2|Adverse Event|0|||
27971759|NCT05032690|81726609|FG003|Period 2|Adverse Event|0|||
27971760|NCT05032690|81726606|FG000|Period 2|Withdrawal by Subject|0|||
27971761|NCT05032690|81726607|FG001|Period 2|Withdrawal by Subject|1|||
27971762|NCT05032690|81726608|FG002|Period 2|Withdrawal by Subject|0|||
27971763|NCT05032690|81726609|FG003|Period 2|Withdrawal by Subject|0|||
27668496|NCT00043186|80623647|FG003|Overall Study|Lost to Follow-up|1|||
27782542|NCT01066819|81032380|FG002|Overall Study|Death|1|||
27782543|NCT01066819|81032381|FG003|Overall Study|Death|0|||
27782544|NCT01066819|81032382|FG004|Overall Study|Death|0|||
27782545|NCT01066819|81032383|FG005|Overall Study|Death|0|||
27782546|NCT01066819|81032378|FG000|Overall Study|Lack of Efficacy|22|||
27782547|NCT01066819|81032379|FG001|Overall Study|Lack of Efficacy|1|||
27782548|NCT01066819|81032380|FG002|Overall Study|Lack of Efficacy|2|||
27782549|NCT01066819|81032381|FG003|Overall Study|Lack of Efficacy|1|||
27782550|NCT01066819|81032382|FG004|Overall Study|Lack of Efficacy|0|||
27782551|NCT01066819|81032383|FG005|Overall Study|Lack of Efficacy|0|||
27782552|NCT01066819|81032378|FG000|Overall Study|Physician Decision|6|||
27782553|NCT01066819|81032379|FG001|Overall Study|Physician Decision|2|||
27782554|NCT01066819|81032380|FG002|Overall Study|Physician Decision|3|||
27782555|NCT01066819|81032381|FG003|Overall Study|Physician Decision|0|||
27782556|NCT01066819|81032382|FG004|Overall Study|Physician Decision|0|||
27782557|NCT01066819|81032383|FG005|Overall Study|Physician Decision|0|||
27782558|NCT01066819|81032378|FG000|Overall Study|Protocol Violation|12|||
27782559|NCT01066819|81032379|FG001|Overall Study|Protocol Violation|6|||
27782560|NCT01066819|81032380|FG002|Overall Study|Protocol Violation|0|||
27782561|NCT01066819|81032381|FG003|Overall Study|Protocol Violation|0|||
27865088|NCT01191944|81337346|FG000|Overall Study|Other|1|||
27865089|NCT01191944|81337347|FG001|Overall Study|Other|3|||
27782562|NCT01066819|81032382|FG004|Overall Study|Protocol Violation|0|||
27782563|NCT01066819|81032383|FG005|Overall Study|Protocol Violation|0|||
27865090|NCT00456300|81341791|FG000|Overall Study|Adverse Event|1|||
27782564|NCT01066819|81032378|FG000|Overall Study|Withdrawal by Subject|29|||
27782565|NCT01066819|81032379|FG001|Overall Study|Withdrawal by Subject|11|||
27782566|NCT01066819|81032380|FG002|Overall Study|Withdrawal by Subject|6|||
27782567|NCT01066819|81032381|FG003|Overall Study|Withdrawal by Subject|0|||
27865091|NCT00456300|81341792|FG001|Overall Study|Adverse Event|0|||
27971764|NCT05032690|81726606|FG000|Period 2|No longer meets eligibility criteria|0|||
27971765|NCT05032690|81726607|FG001|Period 2|No longer meets eligibility criteria|1|||
27971766|NCT05032690|81726608|FG002|Period 2|No longer meets eligibility criteria|0|||
27971767|NCT05032690|81726609|FG003|Period 2|No longer meets eligibility criteria|0|||
27971768|NCT05032690|81726606|FG000|Period 3|Adverse Event|0|||
27971769|NCT05032690|81726607|FG001|Period 3|Adverse Event|1|||
27971770|NCT05032690|81726608|FG002|Period 3|Adverse Event|0|||
27971771|NCT05032690|81726609|FG003|Period 3|Adverse Event|0|||
27971772|NCT01988662|81726610|FG000|Overall Study|Subject/guardian decision|1|||
27971773|NCT01988662|81726611|FG001|Overall Study|Subject/guardian decision|1|||
27971774|NCT01988662|81726610|FG000|Overall Study|Adverse Event|3|||
27971775|NCT01988662|81726611|FG001|Overall Study|Adverse Event|1|||
27971776|NCT02374814|81726623|FG000|Overall Study|Lost to Follow-up|1|||
27971777|NCT02374814|81726624|FG001|Overall Study|Lost to Follow-up|1|||
27971778|NCT02374814|81726625|FG002|Overall Study|Lost to Follow-up|0|||
27971779|NCT02374814|81726626|FG003|Overall Study|Lost to Follow-up|1|||
27971780|NCT02374814|81726627|FG004|Overall Study|Lost to Follow-up|0|||
27971781|NCT02374814|81726628|FG005|Overall Study|Lost to Follow-up|0|||
27971782|NCT02374814|81726623|FG000|Overall Study|Withdrawal by Subject|0|||
27865092|NCT01783886|81341793|FG000|Overall Study|Lost to Follow-up|0|||
27865093|NCT01783886|81341794|FG001|Overall Study|Lost to Follow-up|3|||
27865094|NCT01783886|81341795|FG002|Overall Study|Lost to Follow-up|0|||
27865095|NCT01783886|81341793|FG000|Overall Study|Protocol deviation|0|||
27865096|NCT01783886|81341794|FG001|Overall Study|Protocol deviation|0|||
27865097|NCT01783886|81341795|FG002|Overall Study|Protocol deviation|2|||
27865098|NCT01783886|81341793|FG000|Overall Study|Withdrawal of consent by participant|1|||
27865099|NCT01783886|81341794|FG001|Overall Study|Withdrawal of consent by participant|3|||
27865100|NCT01783886|81341795|FG002|Overall Study|Withdrawal of consent by participant|4|||
27865101|NCT01783886|81341793|FG000|Overall Study|Adverse Event|4|||
27865102|NCT01783886|81341794|FG001|Overall Study|Adverse Event|5|||
27865103|NCT01783886|81341795|FG002|Overall Study|Adverse Event|4|||
27865104|NCT03132155|81341796|FG000|Overall Study|Lack of Efficacy|6|||
27865105|NCT03132155|81341796|FG000|Overall Study|Lost to Follow-up|1|||
27865106|NCT03132155|81341796|FG000|Overall Study|Withdrawal by Subject|1|||
27865107|NCT00640315|81341797|FG000|Overall Study|Withdrawal by Subject|0|||
27865108|NCT00640315|81341798|FG001|Overall Study|Withdrawal by Subject|1|||
27865109|NCT01851330|81341805|FG000|Overall Study|Lack of Efficacy|10|||
27865110|NCT01851330|81341806|FG001|Overall Study|Lack of Efficacy|9|||
27865111|NCT01851330|81341807|FG002|Overall Study|Lack of Efficacy|2|||
27865112|NCT01851330|81341805|FG000|Overall Study|Lost to Follow-up|1|||
27865113|NCT01851330|81341806|FG001|Overall Study|Lost to Follow-up|6|||
27865114|NCT01851330|81341807|FG002|Overall Study|Lost to Follow-up|9|||
27865115|NCT01851330|81341805|FG000|Overall Study|Withdrew Consent|2|||
27865116|NCT01851330|81341806|FG001|Overall Study|Withdrew Consent|1|||
27865117|NCT01851330|81341807|FG002|Overall Study|Withdrew Consent|0|||
27865118|NCT01851330|81341805|FG000|Overall Study|Investigator's Discretion|0|||
27865119|NCT01851330|81341806|FG001|Overall Study|Investigator's Discretion|0|||
27865120|NCT01851330|81341807|FG002|Overall Study|Investigator's Discretion|1|||
27865121|NCT03097991|81341810|FG000|Overall Study|Didn't meet study criteria|8|||
27865122|NCT03097991|81341811|FG001|Overall Study|Didn't meet study criteria|0|||
27865123|NCT03097991|81341810|FG000|Overall Study|Withdrawal by Subject|12|||
27865124|NCT03097991|81341811|FG001|Overall Study|Withdrawal by Subject|6|||
27865125|NCT03097991|81341810|FG000|Overall Study|Death of Baby|3|||
27865126|NCT03097991|81341811|FG001|Overall Study|Death of Baby|1|||
27865127|NCT03097991|81341810|FG000|Overall Study|Lost to Follow-up|24|||
27865128|NCT03097991|81341811|FG001|Overall Study|Lost to Follow-up|38|||
27865129|NCT03097991|81341810|FG000|Overall Study|Adverse Event|3|||
27971783|NCT02374814|81726624|FG001|Overall Study|Withdrawal by Subject|0|||
27865130|NCT03097991|81341811|FG001|Overall Study|Adverse Event|5|||
27865131|NCT00534404|81341814|FG000|Overall Study|Death|0|||
27865132|NCT00534404|81341815|FG001|Overall Study|Death|0|||
27865133|NCT00534404|81341816|FG002|Overall Study|Death|2|||
27865134|NCT00534404|81341814|FG000|Overall Study|Withdrawal by Subject|8|||
27865135|NCT00534404|81341815|FG001|Overall Study|Withdrawal by Subject|2|||
27865136|NCT00534404|81341816|FG002|Overall Study|Withdrawal by Subject|38|||
27865137|NCT00534404|81341814|FG000|Overall Study|Removed by study staff|2|||
27865138|NCT00534404|81341815|FG001|Overall Study|Removed by study staff|3|||
27865139|NCT00534404|81341816|FG002|Overall Study|Removed by study staff|1|||
27865140|NCT00534404|81341814|FG000|Overall Study|Lost to Follow-up|170|||
27971784|NCT02374814|81726625|FG002|Overall Study|Withdrawal by Subject|1|||
27782568|NCT01066819|81032382|FG004|Overall Study|Withdrawal by Subject|0|||
27782569|NCT01066819|81032383|FG005|Overall Study|Withdrawal by Subject|0|||
27782570|NCT01066819|81032378|FG000|Overall Study|Administrative|6|||
27782571|NCT01066819|81032379|FG001|Overall Study|Administrative|4|||
27668497|NCT00043186|80623648|FG004|Overall Study|Lost to Follow-up|1|||
27668498|NCT00043186|80623649|FG005|Overall Study|Lost to Follow-up|1|||
27668499|NCT00043186|80623650|FG006|Overall Study|Lost to Follow-up|1|||
27668500|NCT00043186|80623651|FG007|Overall Study|Lost to Follow-up|1|||
27668501|NCT00043186|80623652|FG008|Overall Study|Lost to Follow-up|2|||
27668502|NCT00043186|80623644|FG000|Overall Study|Noncompliance|0|||
27668503|NCT00043186|80623645|FG001|Overall Study|Noncompliance|0|||
27668504|NCT00043186|80623646|FG002|Overall Study|Noncompliance|1|||
27668505|NCT00043186|80623647|FG003|Overall Study|Noncompliance|1|||
27668506|NCT00043186|80623648|FG004|Overall Study|Noncompliance|0|||
27668507|NCT00043186|80623649|FG005|Overall Study|Noncompliance|0|||
27782572|NCT01066819|81032380|FG002|Overall Study|Administrative|2|||
27782573|NCT01066819|81032381|FG003|Overall Study|Administrative|0|||
27782574|NCT01066819|81032382|FG004|Overall Study|Administrative|0|||
27782575|NCT01066819|81032383|FG005|Overall Study|Administrative|0|||
27782576|NCT01066819|81032378|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
27782577|NCT01066819|81032379|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
27782578|NCT01066819|81032380|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
27782579|NCT01066819|81032381|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
27668508|NCT00043186|80623650|FG006|Overall Study|Noncompliance|0|||
27782580|NCT01066819|81032382|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
27782581|NCT01066819|81032383|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
27782582|NCT01066819|81032378|FG000|Overall Study|Early termination|2|||
27782583|NCT01066819|81032379|FG001|Overall Study|Early termination|0|||
27782584|NCT01066819|81032380|FG002|Overall Study|Early termination|0|||
27782585|NCT01066819|81032381|FG003|Overall Study|Early termination|0|||
27782586|NCT01066819|81032382|FG004|Overall Study|Early termination|0|||
27782587|NCT01066819|81032383|FG005|Overall Study|Early termination|0|||
27782588|NCT01066819|81032378|FG000|Overall Study|Failed to return|298|||
27782589|NCT01066819|81032379|FG001|Overall Study|Failed to return|107|||
27782590|NCT01066819|81032380|FG002|Overall Study|Failed to return|68|||
27782591|NCT01066819|81032381|FG003|Overall Study|Failed to return|7|||
27782592|NCT01066819|81032382|FG004|Overall Study|Failed to return|2|||
27782593|NCT01066819|81032383|FG005|Overall Study|Failed to return|3|||
27668509|NCT00043186|80623651|FG007|Overall Study|Noncompliance|0|||
27668510|NCT00043186|80623652|FG008|Overall Study|Noncompliance|0|||
27668511|NCT00043186|80623644|FG000|Overall Study|Other|0|||
27782594|NCT01066819|81032378|FG000|Overall Study|Lab test not done|9|||
27782595|NCT01066819|81032379|FG001|Overall Study|Lab test not done|0|||
27782596|NCT01066819|81032380|FG002|Overall Study|Lab test not done|2|||
27782597|NCT01066819|81032381|FG003|Overall Study|Lab test not done|1|||
27782598|NCT01066819|81032382|FG004|Overall Study|Lab test not done|0|||
27782599|NCT01066819|81032383|FG005|Overall Study|Lab test not done|0|||
27782600|NCT01066819|81032378|FG000|Overall Study|Miscellaneous|28|||
27782601|NCT01066819|81032379|FG001|Overall Study|Miscellaneous|10|||
27782602|NCT01066819|81032380|FG002|Overall Study|Miscellaneous|18|||
27782603|NCT01066819|81032381|FG003|Overall Study|Miscellaneous|1|||
27782604|NCT01066819|81032382|FG004|Overall Study|Miscellaneous|0|||
27782605|NCT01066819|81032383|FG005|Overall Study|Miscellaneous|0|||
27668512|NCT00043186|80623645|FG001|Overall Study|Other|0|||
27782606|NCT01066819|81032378|FG000|Overall Study|Non responders|123|||
27782607|NCT01066819|81032379|FG001|Overall Study|Non responders|2|||
27782608|NCT01066819|81032380|FG002|Overall Study|Non responders|7|||
27782609|NCT01066819|81032381|FG003|Overall Study|Non responders|2|||
27782610|NCT01066819|81032382|FG004|Overall Study|Non responders|0|||
27782611|NCT01066819|81032383|FG005|Overall Study|Non responders|1|||
27782612|NCT01066819|81032378|FG000|Overall Study|Not categorised|9|||
27782613|NCT01066819|81032379|FG001|Overall Study|Not categorised|2|||
27782614|NCT01066819|81032380|FG002|Overall Study|Not categorised|6|||
27971785|NCT02374814|81726626|FG003|Overall Study|Withdrawal by Subject|1|||
27782615|NCT01066819|81032381|FG003|Overall Study|Not categorised|1|||
27668513|NCT00043186|80623646|FG002|Overall Study|Other|1|||
27668514|NCT00043186|80623647|FG003|Overall Study|Other|1|||
27782616|NCT01066819|81032382|FG004|Overall Study|Not categorised|0|||
27782617|NCT01066819|81032383|FG005|Overall Study|Not categorised|0|||
27668515|NCT00043186|80623648|FG004|Overall Study|Other|0|||
27668516|NCT00043186|80623649|FG005|Overall Study|Other|0|||
27668517|NCT00043186|80623650|FG006|Overall Study|Other|0|||
27668518|NCT00043186|80623651|FG007|Overall Study|Other|0|||
27668519|NCT00043186|80623652|FG008|Overall Study|Other|0|||
27971786|NCT02374814|81726627|FG004|Overall Study|Withdrawal by Subject|0|||
27971787|NCT02374814|81726628|FG005|Overall Study|Withdrawal by Subject|0|||
27971788|NCT03359785|81726630|FG000|Overall Study|Protocol Violation|0|||
27971789|NCT03359785|81726631|FG001|Overall Study|Protocol Violation|1|||
27971790|NCT03359785|81726632|FG002|Overall Study|Protocol Violation|0|||
27971791|NCT03359785|81726633|FG003|Overall Study|Protocol Violation|0|||
27971792|NCT03359785|81726630|FG000|Overall Study|Early study termination due to study pause|0|||
27971793|NCT03359785|81726631|FG001|Overall Study|Early study termination due to study pause|0|||
27971794|NCT03359785|81726632|FG002|Overall Study|Early study termination due to study pause|2|||
27971795|NCT03359785|81726633|FG003|Overall Study|Early study termination due to study pause|0|||
27971796|NCT03359785|81726630|FG000|Overall Study|Withdrawal by Subject|2|||
27971797|NCT03359785|81726631|FG001|Overall Study|Withdrawal by Subject|2|||
27971798|NCT03359785|81726632|FG002|Overall Study|Withdrawal by Subject|0|||
27971799|NCT03359785|81726633|FG003|Overall Study|Withdrawal by Subject|0|||
27971800|NCT01972308|81726634|FG000|Overall Study|Withdrawal by Subject|0|||
27971801|NCT01972308|81726635|FG001|Overall Study|Withdrawal by Subject|1|||
27971802|NCT01972308|81726634|FG000|Overall Study|Lost to Follow-up|4|||
27971803|NCT01972308|81726635|FG001|Overall Study|Lost to Follow-up|6|||
27971804|NCT01972308|81726634|FG000|Overall Study|Death|4|||
27971805|NCT01972308|81726635|FG001|Overall Study|Death|1|||
27571433|NCT01577758|80278827|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
27571434|NCT01577758|80278828|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
27571435|NCT01577758|80278821|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27571436|NCT01577758|80278822|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27571437|NCT01577758|80278823|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27571438|NCT01577758|80278824|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27571439|NCT01577758|80278825|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
27571440|NCT01577758|80278826|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
27668520|NCT02101268|80623655|FG000|Randomized Treatment Phase|Subject Decision|8|||
27668521|NCT02101268|80623656|FG001|Randomized Treatment Phase|Subject Decision|4|||
27971806|NCT03447314|81726636|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
27668522|NCT02101268|80623657|FG002|Randomized Treatment Phase|Subject Decision|0|||
27668523|NCT02101268|80623658|FG003|Randomized Treatment Phase|Subject Decision|0|||
27668524|NCT02101268|80623655|FG000|Randomized Treatment Phase|Physician Decision|4|||
27668525|NCT02101268|80623656|FG001|Randomized Treatment Phase|Physician Decision|1|||
27668526|NCT02101268|80623657|FG002|Randomized Treatment Phase|Physician Decision|0|||
27668527|NCT02101268|80623658|FG003|Randomized Treatment Phase|Physician Decision|0|||
27668528|NCT02101268|80623655|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
27668529|NCT02101268|80623656|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
27668530|NCT02101268|80623657|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
27668531|NCT02101268|80623658|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
27668532|NCT02101268|80623655|FG000|Randomized Treatment Phase|Adverse Event|6|||
27668533|NCT02101268|80623656|FG001|Randomized Treatment Phase|Adverse Event|0|||
27668534|NCT02101268|80623657|FG002|Randomized Treatment Phase|Adverse Event|0|||
27668535|NCT02101268|80623658|FG003|Randomized Treatment Phase|Adverse Event|0|||
27668536|NCT02101268|80623655|FG000|Randomized Treatment Phase|Death|5|||
27668537|NCT02101268|80623656|FG001|Randomized Treatment Phase|Death|4|||
27668538|NCT02101268|80623657|FG002|Randomized Treatment Phase|Death|0|||
27668539|NCT02101268|80623658|FG003|Randomized Treatment Phase|Death|0|||
27668540|NCT02101268|80623655|FG000|Randomized Treatment Phase|Disease Progression|4|||
27668541|NCT02101268|80623656|FG001|Randomized Treatment Phase|Disease Progression|1|||
27668542|NCT02101268|80623657|FG002|Randomized Treatment Phase|Disease Progression|0|||
27668543|NCT02101268|80623658|FG003|Randomized Treatment Phase|Disease Progression|0|||
27668544|NCT02101268|80623655|FG000|Extended Treatment Phase|Subject Decision|0|||
27668545|NCT02101268|80623656|FG001|Extended Treatment Phase|Subject Decision|0|||
27668546|NCT02101268|80623657|FG002|Extended Treatment Phase|Subject Decision|3|||
27668547|NCT02101268|80623658|FG003|Extended Treatment Phase|Subject Decision|2|||
27668548|NCT02101268|80623655|FG000|Extended Treatment Phase|Physician Decision|0|||
27668549|NCT02101268|80623656|FG001|Extended Treatment Phase|Physician Decision|0|||
27571441|NCT01577758|80278827|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
27668550|NCT02101268|80623657|FG002|Extended Treatment Phase|Physician Decision|5|||
27668551|NCT02101268|80623658|FG003|Extended Treatment Phase|Physician Decision|2|||
27668552|NCT02101268|80623655|FG000|Extended Treatment Phase|Adverse Event|0|||
27668553|NCT02101268|80623656|FG001|Extended Treatment Phase|Adverse Event|0|||
27668554|NCT02101268|80623657|FG002|Extended Treatment Phase|Adverse Event|14|||
27668555|NCT02101268|80623658|FG003|Extended Treatment Phase|Adverse Event|18|||
27668556|NCT02101268|80623655|FG000|Extended Treatment Phase|Death|0|||
27971807|NCT03447314|81726637|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
27971808|NCT03447314|81726638|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
27668557|NCT02101268|80623656|FG001|Extended Treatment Phase|Death|0|||
27668558|NCT02101268|80623657|FG002|Extended Treatment Phase|Death|5|||
27668559|NCT02101268|80623658|FG003|Extended Treatment Phase|Death|1|||
27668560|NCT02101268|80623655|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
27668561|NCT02101268|80623656|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
27668562|NCT02101268|80623657|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
27668563|NCT02101268|80623658|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
27668564|NCT02101268|80623655|FG000|Extended Treatment Phase|Disease Progression|0|||
27668565|NCT02101268|80623656|FG001|Extended Treatment Phase|Disease Progression|0|||
27668566|NCT02101268|80623657|FG002|Extended Treatment Phase|Disease Progression|13|||
27668567|NCT02101268|80623658|FG003|Extended Treatment Phase|Disease Progression|6|||
27668568|NCT02101268|80623655|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
27782618|NCT01066819|81032378|FG000|Overall Study|Relapse|16|||
27782619|NCT01066819|81032379|FG001|Overall Study|Relapse|4|||
27782620|NCT01066819|81032380|FG002|Overall Study|Relapse|3|||
27782621|NCT01066819|81032381|FG003|Overall Study|Relapse|0|||
27782622|NCT01066819|81032382|FG004|Overall Study|Relapse|0|||
27782623|NCT01066819|81032383|FG005|Overall Study|Relapse|0|||
27782624|NCT01066819|81032378|FG000|Overall Study|Results not available|1|||
27668569|NCT02101268|80623656|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
27668570|NCT02101268|80623657|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
27668571|NCT02101268|80623658|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
27668572|NCT02669407|80623659|FG000|Overall Study|Physician Decision|3|||
27668573|NCT02057575|80623660|FG000|Overall Study|Adverse Event|0|||
27668574|NCT02057575|80623661|FG001|Overall Study|Adverse Event|2|||
27668575|NCT02057575|80623662|FG002|Overall Study|Adverse Event|0|||
27668576|NCT02057575|80623663|FG003|Overall Study|Adverse Event|1|||
27668577|NCT02057575|80623660|FG000|Overall Study|Withdrawal by Subject|1|||
27668578|NCT02057575|80623661|FG001|Overall Study|Withdrawal by Subject|0|||
27668579|NCT02057575|80623662|FG002|Overall Study|Withdrawal by Subject|0|||
27668580|NCT02057575|80623663|FG003|Overall Study|Withdrawal by Subject|0|||
27668581|NCT02057575|80623660|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
27668582|NCT02057575|80623661|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
27668583|NCT02057575|80623662|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
27668584|NCT02057575|80623663|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
27668585|NCT02057575|80623660|FG000|Overall Study|Protocol Violation|0|||
27668586|NCT02057575|80623661|FG001|Overall Study|Protocol Violation|1|||
27668587|NCT02057575|80623662|FG002|Overall Study|Protocol Violation|0|||
27668588|NCT02057575|80623663|FG003|Overall Study|Protocol Violation|0|||
27668589|NCT00715117|80623665|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
27668590|NCT00715117|80623666|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
27668591|NCT01004185|80623669|FG000|Overall Study|Adverse Event|1|||
27668592|NCT01004185|80623670|FG001|Overall Study|Adverse Event|1|||
27668593|NCT01004185|80623669|FG000|Overall Study|Lost to Follow-up|0|||
27668594|NCT01004185|80623670|FG001|Overall Study|Lost to Follow-up|1|||
27668595|NCT01004185|80623669|FG000|Overall Study|Lack of Efficacy|2|||
27668596|NCT01004185|80623670|FG001|Overall Study|Lack of Efficacy|1|||
27668597|NCT01004185|80623669|FG000|Overall Study|Sponsor Terminated Study|4|||
27668598|NCT01004185|80623670|FG001|Overall Study|Sponsor Terminated Study|5|||
27668599|NCT01004185|80623669|FG000|Overall Study|Withdrawal by Subject|2|||
27668600|NCT01004185|80623670|FG001|Overall Study|Withdrawal by Subject|1|||
27668601|NCT01157351|80623671|FG000|Overall Study|Adverse Event|5|||
27668602|NCT01157351|80623672|FG001|Overall Study|Adverse Event|4|||
27668603|NCT01157351|80623671|FG000|Overall Study|Death|1|||
27668604|NCT01157351|80623672|FG001|Overall Study|Death|0|||
27668605|NCT01157351|80623671|FG000|Overall Study|Lost to Follow-up|53|||
27668606|NCT01157351|80623672|FG001|Overall Study|Lost to Follow-up|55|||
27668607|NCT01157351|80623671|FG000|Overall Study|Withdrawal by Subject|37|||
27668608|NCT01157351|80623672|FG001|Overall Study|Withdrawal by Subject|27|||
27668609|NCT01157351|80623671|FG000|Overall Study|Physician Decision|5|||
27668610|NCT01157351|80623672|FG001|Overall Study|Physician Decision|4|||
27668611|NCT01157351|80623671|FG000|Overall Study|Protocol Violation|0|||
27668612|NCT01157351|80623672|FG001|Overall Study|Protocol Violation|1|||
27668613|NCT01157351|80623671|FG000|Overall Study|Other|32|||
27782625|NCT01066819|81032379|FG001|Overall Study|Results not available|0|||
27782626|NCT01066819|81032380|FG002|Overall Study|Results not available|0|||
27782627|NCT01066819|81032381|FG003|Overall Study|Results not available|0|||
27782628|NCT01066819|81032382|FG004|Overall Study|Results not available|0|||
27782629|NCT01066819|81032383|FG005|Overall Study|Results not available|0|||
27668614|NCT01157351|80623672|FG001|Overall Study|Other|36|||
27668615|NCT01157351|80623671|FG000|Overall Study|Noncompliance with Study Drug|0|||
27668616|NCT01157351|80623672|FG001|Overall Study|Noncompliance with Study Drug|3|||
27668617|NCT01157351|80623671|FG000|Overall Study|Randomized but not Treated|4|||
27668618|NCT01157351|80623672|FG001|Overall Study|Randomized but not Treated|2|||
27668619|NCT01947517|80623673|FG000|Overall Study|Withdrawal by Subject|1|||
27668620|NCT01947517|80623674|FG001|Overall Study|Withdrawal by Subject|1|||
27782630|NCT01066819|81032378|FG000|Overall Study|Screen failure|1|||
27668621|NCT04333147|80623675|FG000|Overall Study|Adverse Event|43|||
27668622|NCT04333147|80623676|FG001|Overall Study|Adverse Event|40|||
27668623|NCT04333147|80623675|FG000|Overall Study|Lack of Efficacy|49|||
27668624|NCT04333147|80623676|FG001|Overall Study|Lack of Efficacy|48|||
27668625|NCT04333147|80623675|FG000|Overall Study|Lost to Follow-up|19|||
27668626|NCT04333147|80623676|FG001|Overall Study|Lost to Follow-up|16|||
27668627|NCT04333147|80623675|FG000|Overall Study|Physician Decision|17|||
27668628|NCT04333147|80623676|FG001|Overall Study|Physician Decision|20|||
27668629|NCT04333147|80623675|FG000|Overall Study|Withdrawal by Subject|65|||
27668630|NCT04333147|80623676|FG001|Overall Study|Withdrawal by Subject|68|||
27668631|NCT04333147|80623675|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
27668632|NCT04333147|80623676|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
27668633|NCT04333147|80623675|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
27668634|NCT04333147|80623676|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
27668635|NCT04333147|80623675|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
27668636|NCT04333147|80623676|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
27668637|NCT00809341|80623677|FG000|Overall Study|Physician Decision|0|||
27668638|NCT00809341|80623678|FG001|Overall Study|Physician Decision|1|||
27668639|NCT03517111|80623680|FG000|Enrolled|Withdrawal by Subject|0|||
27668640|NCT03517111|80623681|FG001|Enrolled|Withdrawal by Subject|1|||
27668641|NCT03517111|80623682|FG002|Enrolled|Withdrawal by Subject|0|||
27668642|NCT03517111|80623680|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
27668643|NCT03517111|80623681|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
27668644|NCT03517111|80623682|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
27668645|NCT03517111|80623680|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
27668646|NCT03517111|80623681|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
27668647|NCT03517111|80623682|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
27668648|NCT03517111|80623680|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
27668649|NCT03517111|80623681|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
27668650|NCT03517111|80623682|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
27668651|NCT03517111|80623680|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
27668652|NCT03517111|80623681|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
27668653|NCT03517111|80623682|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
27668654|NCT02353871|80623683|FG000|Overall Study|Protocol deviation|0|||
27668655|NCT02353871|80623684|FG001|Overall Study|Protocol deviation|1|||
27668656|NCT02353871|80623683|FG000|Overall Study|Consent withdrawn|1|||
27668657|NCT02353871|80623684|FG001|Overall Study|Consent withdrawn|8|||
27668658|NCT02353871|80623683|FG000|Overall Study|Lost to Follow-up|2|||
27668659|NCT02353871|80623684|FG001|Overall Study|Lost to Follow-up|0|||
27668660|NCT01657877|80623685|FG000|Overall Study|Withdrawal by Subject|4|||
27668661|NCT01657877|80623685|FG000|Overall Study|Protocol Violation|6|||
27668662|NCT01657877|80623685|FG000|Overall Study|Adverse Event|2|||
27668663|NCT01657877|80623685|FG000|Overall Study|Other Reason|2|||
27668664|NCT01128114|80627321|FG000|Overall Study|Treatment Withdrawn|6|||
27668665|NCT01128114|80627321|FG000|Overall Study|Screening Failed|2|||
27668666|NCT00478647|80627322|FG000|Overall Study|Adverse Event|1|||
27668667|NCT00478647|80627322|FG000|Overall Study|Withdrawal by Subject|1|||
27668668|NCT00107978|80627323|FG000|Overall Study|Adverse Event|1|||
27668669|NCT00107978|80627324|FG001|Overall Study|Adverse Event|5|||
27668670|NCT00107978|80627323|FG000|Overall Study|Death|3|||
27668671|NCT00107978|80627324|FG001|Overall Study|Death|3|||
27668672|NCT00107978|80627323|FG000|Overall Study|Lost to Follow-up|20|||
27668673|NCT00107978|80627324|FG001|Overall Study|Lost to Follow-up|28|||
27668674|NCT00107978|80627323|FG000|Overall Study|Withdrawal by Subject|4|||
27668675|NCT00107978|80627324|FG001|Overall Study|Withdrawal by Subject|9|||
27668676|NCT00107978|80627323|FG000|Overall Study|Protocol Violation|0|||
27668677|NCT00107978|80627324|FG001|Overall Study|Protocol Violation|1|||
27668678|NCT00107978|80627323|FG000|Overall Study|Other|5|||
27668679|NCT00107978|80627324|FG001|Overall Study|Other|4|||
27668680|NCT03842436|80627325|FG000|Overall Study|Lost to Follow-up|1|||
27668681|NCT00863798|80627326|FG000|Overall Study|Adverse Event|5|||
27668682|NCT00863798|80627327|FG001|Overall Study|Adverse Event|2|||
27668683|NCT00863798|80627328|FG002|Overall Study|Adverse Event|4|||
27668684|NCT00863798|80627326|FG000|Overall Study|Participant failed to return|2|||
27668685|NCT00863798|80627327|FG001|Overall Study|Participant failed to return|1|||
27668686|NCT00863798|80627328|FG002|Overall Study|Participant failed to return|0|||
27668687|NCT00863798|80627326|FG000|Overall Study|Investigator request|1|||
27668688|NCT00863798|80627327|FG001|Overall Study|Investigator request|2|||
27668689|NCT00863798|80627328|FG002|Overall Study|Investigator request|1|||
27668690|NCT00863798|80627326|FG000|Overall Study|Lack of Efficacy|4|||
27668691|NCT00863798|80627327|FG001|Overall Study|Lack of Efficacy|3|||
27668692|NCT00863798|80627328|FG002|Overall Study|Lack of Efficacy|6|||
27668693|NCT00863798|80627326|FG000|Overall Study|Lost to Follow-up|6|||
27668694|NCT00863798|80627327|FG001|Overall Study|Lost to Follow-up|9|||
27668695|NCT00863798|80627328|FG002|Overall Study|Lost to Follow-up|5|||
27668696|NCT00863798|80627326|FG000|Overall Study|Other|2|||
27668697|NCT00863798|80627327|FG001|Overall Study|Other|3|||
27668698|NCT00863798|80627328|FG002|Overall Study|Other|1|||
27668699|NCT00863798|80627326|FG000|Overall Study|Protocol Violation|0|||
27668700|NCT00863798|80627327|FG001|Overall Study|Protocol Violation|1|||
27668701|NCT00863798|80627328|FG002|Overall Study|Protocol Violation|1|||
27668702|NCT00863798|80627326|FG000|Overall Study|Withdrawal by Subject|8|||
27668703|NCT00863798|80627327|FG001|Overall Study|Withdrawal by Subject|7|||
27668704|NCT00863798|80627328|FG002|Overall Study|Withdrawal by Subject|4|||
27668705|NCT00863798|80627326|FG000|Overall Study|Randomized not treated|4|||
27668706|NCT00863798|80627327|FG001|Overall Study|Randomized not treated|2|||
27668707|NCT00863798|80627328|FG002|Overall Study|Randomized not treated|3|||
27668708|NCT00746356|80627331|FG000|Overall Study|Withdrawal by Subject|2|||
27668709|NCT00746356|80627332|FG001|Overall Study|Withdrawal by Subject|3|||
27668710|NCT00746356|80627331|FG000|Overall Study|Death|7|||
27668711|NCT00746356|80627332|FG001|Overall Study|Death|3|||
27668712|NCT00746356|80627331|FG000|Overall Study|Lost to Follow-up|1|||
27668713|NCT00746356|80627332|FG001|Overall Study|Lost to Follow-up|0|||
27668714|NCT00746356|80627331|FG000|Overall Study|Removal of Device|0|||
27668715|NCT00746356|80627332|FG001|Overall Study|Removal of Device|1|||
27668716|NCT00746356|80627331|FG000|Overall Study|Patient relocated|1|||
27668717|NCT00746356|80627332|FG001|Overall Study|Patient relocated|0|||
27668718|NCT04947436|80627333|FG000|Overall Study|Lost to Follow-up|3|||
27668719|NCT04947436|80627334|FG001|Overall Study|Lost to Follow-up|7|||
27668720|NCT04947436|80627335|FG002|Overall Study|Lost to Follow-up|5|||
27668721|NCT04947436|80627333|FG000|Overall Study|Death|1|||
27668722|NCT04947436|80627334|FG001|Overall Study|Death|1|||
27668723|NCT04947436|80627335|FG002|Overall Study|Death|1|||
27668724|NCT03296566|80627338|FG000|Overall Study|Lost to Follow-up|19|||
27668725|NCT03296566|80627339|FG001|Overall Study|Lost to Follow-up|46|||
27668726|NCT03296566|80627338|FG000|Overall Study|Withdrawal by Subject|0|||
27668727|NCT03296566|80627339|FG001|Overall Study|Withdrawal by Subject|3|||
27668728|NCT00468130|80627340|FG000|Overall Study|Adverse Event|2|||
27668729|NCT00468130|80627341|FG001|Overall Study|Adverse Event|1|||
27668730|NCT00468130|80627340|FG000|Overall Study|Withdrawal by Subject|0|||
27668731|NCT00468130|80627341|FG001|Overall Study|Withdrawal by Subject|1|||
27668732|NCT02916706|80627342|FG000|Overall Study|Adverse Event|0|||
27668733|NCT02916706|80627343|FG001|Overall Study|Adverse Event|1|||
27668734|NCT02916706|80627342|FG000|Overall Study|Lost to Follow-up|0|||
27668735|NCT02916706|80627343|FG001|Overall Study|Lost to Follow-up|1|||
27668736|NCT02916706|80627342|FG000|Overall Study|Physician Decision|1|||
27668737|NCT02916706|80627343|FG001|Overall Study|Physician Decision|0|||
27668738|NCT02916706|80627342|FG000|Overall Study|Protocol Violation|3|||
27668739|NCT02916706|80627343|FG001|Overall Study|Protocol Violation|1|||
27668740|NCT02916706|80627342|FG000|Overall Study|Withdrawal by Subject|6|||
27668741|NCT02916706|80627343|FG001|Overall Study|Withdrawal by Subject|9|||
27668742|NCT02916706|80627342|FG000|Overall Study|Other|5|||
27668743|NCT02916706|80627343|FG001|Overall Study|Other|19|||
27668744|NCT02973802|80627344|FG000|Overall Study|Lost to Follow-up|1|||
27668745|NCT02973802|80627344|FG000|Overall Study|Withdrawal by Subject|1|||
27668746|NCT00805285|80627345|FG000|Overall Study|Lack of Efficacy|1|||
27668747|NCT01587118|80627347|FG000|Overall Study|Adverse Event|3|||
27668748|NCT01587118|80627347|FG000|Overall Study|Lost to Follow-up|2|||
27668749|NCT01587118|80627347|FG000|Overall Study|Relocation|1|||
27668750|NCT01587118|80627347|FG000|Overall Study|nonresponse|1|||
27668751|NCT02194829|80627360|FG000|Overall Study|Adverse Event|2|||
27668752|NCT02194829|80627361|FG001|Overall Study|Adverse Event|2|||
27668753|NCT02194829|80627360|FG000|Overall Study|Death|0|||
27668754|NCT02194829|80627361|FG001|Overall Study|Death|1|||
27668755|NCT02194829|80627360|FG000|Overall Study|Disease progression|0|||
27668756|NCT02194829|80627361|FG001|Overall Study|Disease progression|1|||
27668757|NCT02194829|80627360|FG000|Overall Study|Withdrawal by Subject|0|||
27668758|NCT02194829|80627361|FG001|Overall Study|Withdrawal by Subject|1|||
27971809|NCT03447314|81726639|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
27971810|NCT03447314|81726640|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
27668759|NCT02194829|80627360|FG000|Overall Study|Never started protocol therapy|0|||
27668760|NCT02194829|80627361|FG001|Overall Study|Never started protocol therapy|1|||
27668761|NCT00409409|80627368|FG000|Overall Study|Adverse Event|7|||
27668762|NCT00409409|80627369|FG001|Overall Study|Adverse Event|2|||
27668763|NCT00409409|80627368|FG000|Overall Study|Withdrawal by Subject|1|||
27971811|NCT03447314|81726641|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
27971812|NCT03447314|81726642|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
27971813|NCT03447314|81726643|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27668764|NCT00409409|80627369|FG001|Overall Study|Withdrawal by Subject|1|||
27668765|NCT00409409|80627368|FG000|Overall Study|Any other reason not above-mentioned|0|||
27668766|NCT00409409|80627369|FG001|Overall Study|Any other reason not above-mentioned|1|||
27668767|NCT01114139|80627370|FG000|Overall Study|Adverse Event|3|||
27668768|NCT01114139|80627371|FG001|Overall Study|Adverse Event|2|||
27668769|NCT01114139|80627370|FG000|Overall Study|Lost to Follow-up|15|||
27668770|NCT01114139|80627371|FG001|Overall Study|Lost to Follow-up|3|||
27668771|NCT01114139|80627370|FG000|Overall Study|Withdrawal by Subject|17|||
27668772|NCT01114139|80627371|FG001|Overall Study|Withdrawal by Subject|6|||
27668773|NCT01114139|80627370|FG000|Overall Study|Other-Missed 1 visit|1|||
27668774|NCT01114139|80627371|FG001|Overall Study|Other-Missed 1 visit|0|||
27668775|NCT01114139|80627370|FG000|Overall Study|Other-Protocol Violation|1|||
27668776|NCT01114139|80627371|FG001|Overall Study|Other-Protocol Violation|0|||
27668777|NCT01114139|80627370|FG000|Overall Study|Other-Out of window for study drug dose|1|||
27668778|NCT01114139|80627371|FG001|Overall Study|Other-Out of window for study drug dose|0|||
27668779|NCT01114139|80627370|FG000|Overall Study|Other-Participant falsified records|0|||
27668780|NCT01114139|80627371|FG001|Overall Study|Other-Participant falsified records|1|||
27668781|NCT01114139|80627370|FG000|Overall Study|Other-Participant went on hospice|0|||
27668782|NCT01114139|80627371|FG001|Overall Study|Other-Participant went on hospice|1|||
27668783|NCT01114139|80627370|FG000|Overall Study|Other-Physician changed treatment|1|||
27668784|NCT01114139|80627371|FG001|Overall Study|Other-Physician changed treatment|0|||
27668785|NCT01114139|80627370|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
27668786|NCT01114139|80627371|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
27668787|NCT01841697|80627390|FG000|Overall Study|Death|0|||
27668788|NCT01841697|80627391|FG001|Overall Study|Death|1|||
27668789|NCT01841697|80627390|FG000|Overall Study|Lost to Follow-up|4|||
27668790|NCT01841697|80627391|FG001|Overall Study|Lost to Follow-up|1|||
27668791|NCT01841697|80627390|FG000|Overall Study|Withdrawal by Subject|16|||
27668792|NCT01841697|80627391|FG001|Overall Study|Withdrawal by Subject|16|||
27668793|NCT02859064|80627392|FG000|Overall Study|Progressive Disease|3|||
27668794|NCT02859064|80627392|FG000|Overall Study|Physician Decision|1|||
27668795|NCT02859064|80627392|FG000|Overall Study|Withdrawal by Subject|1|||
27668796|NCT02859064|80627392|FG000|Overall Study|Death|1|||
27668797|NCT02635386|80627393|FG000|Overall Study|Pregnancy|2|||
27668798|NCT02635386|80627394|FG001|Overall Study|Pregnancy|0|||
27668799|NCT02635386|80627395|FG002|Overall Study|Pregnancy|0|||
27668800|NCT02635386|80627396|FG003|Overall Study|Pregnancy|0|||
27668801|NCT02635386|80627397|FG004|Overall Study|Pregnancy|2|||
27668802|NCT02635386|80627393|FG000|Overall Study|Withdrawal by Subject|1|||
27668803|NCT02635386|80627394|FG001|Overall Study|Withdrawal by Subject|1|||
27668804|NCT02635386|80627395|FG002|Overall Study|Withdrawal by Subject|0|||
27668805|NCT02635386|80627396|FG003|Overall Study|Withdrawal by Subject|1|||
27668806|NCT02635386|80627397|FG004|Overall Study|Withdrawal by Subject|0|||
27668807|NCT02635386|80627393|FG000|Overall Study|Physician Decision|0|||
27668808|NCT02635386|80627394|FG001|Overall Study|Physician Decision|1|||
27668809|NCT02635386|80627395|FG002|Overall Study|Physician Decision|0|||
27668810|NCT02635386|80627396|FG003|Overall Study|Physician Decision|0|||
27668811|NCT02635386|80627397|FG004|Overall Study|Physician Decision|0|||
27668812|NCT02635386|80627393|FG000|Overall Study|Moved Out of State|0|||
27668813|NCT02635386|80627394|FG001|Overall Study|Moved Out of State|1|||
27668814|NCT02635386|80627395|FG002|Overall Study|Moved Out of State|0|||
27668815|NCT02635386|80627396|FG003|Overall Study|Moved Out of State|0|||
27668816|NCT02635386|80627397|FG004|Overall Study|Moved Out of State|0|||
27668817|NCT02635386|80627393|FG000|Overall Study|Noncompliant|0|||
27668818|NCT02635386|80627394|FG001|Overall Study|Noncompliant|2|||
27668819|NCT02635386|80627395|FG002|Overall Study|Noncompliant|1|||
27668820|NCT02635386|80627396|FG003|Overall Study|Noncompliant|1|||
27668821|NCT02635386|80627397|FG004|Overall Study|Noncompliant|1|||
27668822|NCT02635386|80627393|FG000|Overall Study|side effects|0|||
27668823|NCT02635386|80627394|FG001|Overall Study|side effects|0|||
27668824|NCT02635386|80627395|FG002|Overall Study|side effects|1|||
27668825|NCT02635386|80627396|FG003|Overall Study|side effects|4|||
27668826|NCT02635386|80627397|FG004|Overall Study|side effects|6|||
27668827|NCT02635386|80627393|FG000|Overall Study|needed other major surgery|0|||
27668828|NCT02635386|80627394|FG001|Overall Study|needed other major surgery|1|||
27668829|NCT02635386|80627395|FG002|Overall Study|needed other major surgery|0|||
27668830|NCT02635386|80627396|FG003|Overall Study|needed other major surgery|0|||
27571442|NCT01577758|80278828|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
27668831|NCT02635386|80627397|FG004|Overall Study|needed other major surgery|0|||
27668832|NCT02635386|80627393|FG000|Overall Study|Other medical problems not drug related|0|||
27668833|NCT02635386|80627394|FG001|Overall Study|Other medical problems not drug related|0|||
27668834|NCT02635386|80627395|FG002|Overall Study|Other medical problems not drug related|0|||
27668835|NCT02635386|80627396|FG003|Overall Study|Other medical problems not drug related|1|||
27668836|NCT02635386|80627397|FG004|Overall Study|Other medical problems not drug related|0|||
27668837|NCT00598871|80627398|FG000|Overall Study|Adverse Event|0|||
27668838|NCT00598871|80627399|FG001|Overall Study|Adverse Event|1|||
27668839|NCT00727506|80627400|FG000|Overall Study|Adverse Event|0|||
27668840|NCT00727506|80627401|FG001|Overall Study|Adverse Event|0|||
27668841|NCT00727506|80627402|FG002|Overall Study|Adverse Event|4|||
27668842|NCT00727506|80627403|FG003|Overall Study|Adverse Event|4|||
27668843|NCT00727506|80627404|FG004|Overall Study|Adverse Event|1|||
27668844|NCT00727506|80627405|FG005|Overall Study|Adverse Event|8|||
27668845|NCT00727506|80627400|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27668846|NCT00727506|80627401|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27668847|NCT00727506|80627402|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27668848|NCT00727506|80627403|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27668849|NCT00727506|80627404|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27668850|NCT00727506|80627405|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27668851|NCT00727506|80627400|FG000|Overall Study|Progressive disease|4|||
27668852|NCT00727506|80627401|FG001|Overall Study|Progressive disease|7|||
27668853|NCT00727506|80627402|FG002|Overall Study|Progressive disease|9|||
27668854|NCT00727506|80627403|FG003|Overall Study|Progressive disease|28|||
27668855|NCT00727506|80627404|FG004|Overall Study|Progressive disease|38|||
27668856|NCT00727506|80627405|FG005|Overall Study|Progressive disease|28|||
27668857|NCT00727506|80627400|FG000|Overall Study|Refused to continue medication|0|||
27668858|NCT00727506|80627401|FG001|Overall Study|Refused to continue medication|1|||
27668859|NCT00727506|80627402|FG002|Overall Study|Refused to continue medication|2|||
27668860|NCT00727506|80627403|FG003|Overall Study|Refused to continue medication|3|||
27668861|NCT00727506|80627404|FG004|Overall Study|Refused to continue medication|1|||
27668862|NCT00727506|80627405|FG005|Overall Study|Refused to continue medication|2|||
27668863|NCT00727506|80627400|FG000|Overall Study|Other reason not described above|0|||
27668864|NCT00727506|80627401|FG001|Overall Study|Other reason not described above|0|||
27668865|NCT00727506|80627402|FG002|Overall Study|Other reason not described above|1|||
27668866|NCT00727506|80627403|FG003|Overall Study|Other reason not described above|4|||
27668867|NCT00727506|80627404|FG004|Overall Study|Other reason not described above|1|||
27668868|NCT00727506|80627405|FG005|Overall Study|Other reason not described above|1|||
27668869|NCT03765164|80627408|FG000|Pre-intervention|Withdrawal by Subject|5|||
27668870|NCT03765164|80627409|FG001|Pre-intervention|Withdrawal by Subject|6|||
27668871|NCT03856047|80627410|FG000|Overall Study|Withdrawal by Subject|0|||
27668872|NCT03856047|80627411|FG001|Overall Study|Withdrawal by Subject|1|||
27668873|NCT03856047|80627412|FG002|Overall Study|Withdrawal by Subject|1|||
27668874|NCT03856047|80627413|FG003|Overall Study|Withdrawal by Subject|0|||
27668875|NCT03856047|80627414|FG004|Overall Study|Withdrawal by Subject|3|||
27668876|NCT03856047|80627415|FG005|Overall Study|Withdrawal by Subject|0|||
27668877|NCT03856047|80627416|FG006|Overall Study|Withdrawal by Subject|2|||
27668878|NCT03856047|80627410|FG000|Overall Study|Lost to Follow-up|4|||
27668879|NCT03856047|80627411|FG001|Overall Study|Lost to Follow-up|2|||
27668880|NCT03856047|80627412|FG002|Overall Study|Lost to Follow-up|3|||
27668881|NCT03856047|80627413|FG003|Overall Study|Lost to Follow-up|1|||
27668882|NCT03856047|80627414|FG004|Overall Study|Lost to Follow-up|4|||
27668883|NCT03856047|80627415|FG005|Overall Study|Lost to Follow-up|4|||
27668884|NCT03856047|80627416|FG006|Overall Study|Lost to Follow-up|4|||
27668885|NCT02647788|80627417|FG000|Overall Study|Lost to Follow-up|13|||
27668886|NCT02647788|80627418|FG001|Overall Study|Lost to Follow-up|11|||
27668887|NCT02647788|80627417|FG000|Overall Study|Did not want opiate|0|||
27668888|NCT02647788|80627418|FG001|Overall Study|Did not want opiate|1|||
27668889|NCT02647788|80627417|FG000|Overall Study|Withdrawal by Subject|1|||
27668890|NCT02647788|80627418|FG001|Overall Study|Withdrawal by Subject|0|||
27668891|NCT02647788|80627417|FG000|Overall Study|Felt itchy with assigned medication|1|||
27668892|NCT02647788|80627418|FG001|Overall Study|Felt itchy with assigned medication|0|||
27668893|NCT02647788|80627417|FG000|Overall Study|Felt nauseous with assigned medication|1|||
27668894|NCT02647788|80627418|FG001|Overall Study|Felt nauseous with assigned medication|1|||
27668895|NCT01316887|80627423|FG000|Overall Study|Adverse Event|13|||
27668896|NCT01316887|80627424|FG001|Overall Study|Adverse Event|21|||
27668897|NCT01316887|80627425|FG002|Overall Study|Adverse Event|17|||
27668898|NCT01316887|80627423|FG000|Overall Study|Lack of Efficacy|9|||
27668899|NCT01316887|80627424|FG001|Overall Study|Lack of Efficacy|3|||
27668900|NCT01316887|80627425|FG002|Overall Study|Lack of Efficacy|1|||
27668901|NCT01316887|80627423|FG000|Overall Study|Protocol Violation|2|||
27668902|NCT01316887|80627424|FG001|Overall Study|Protocol Violation|6|||
27668903|NCT01316887|80627425|FG002|Overall Study|Protocol Violation|6|||
27668904|NCT01316887|80627423|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
27668905|NCT01316887|80627424|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
27668906|NCT01316887|80627425|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
27668907|NCT01316887|80627423|FG000|Overall Study|Study Closed/Terminated|2|||
27668908|NCT01316887|80627424|FG001|Overall Study|Study Closed/Terminated|4|||
27668909|NCT01316887|80627425|FG002|Overall Study|Study Closed/Terminated|3|||
27668910|NCT01316887|80627423|FG000|Overall Study|Lost to Follow-up|1|||
27668911|NCT01316887|80627424|FG001|Overall Study|Lost to Follow-up|7|||
27668912|NCT01316887|80627425|FG002|Overall Study|Lost to Follow-up|5|||
27668913|NCT01316887|80627423|FG000|Overall Study|Withdrawal by Subject|8|||
27668914|NCT01316887|80627424|FG001|Overall Study|Withdrawal by Subject|16|||
27668915|NCT01316887|80627425|FG002|Overall Study|Withdrawal by Subject|15|||
27668916|NCT03845075|80627428|FG000|Part 1 - DB|Withdrawal by Subject|1|||
27668917|NCT03845075|80627429|FG001|Part 1 - DB|Withdrawal by Subject|1|||
27668918|NCT03845075|80627430|FG002|Part 1 - DB|Withdrawal by Subject|0|||
27668919|NCT03845075|80627431|FG003|Part 1 - DB|Withdrawal by Subject|0|||
27668920|NCT03845075|80627428|FG000|Part 1 - DB|Adverse Event|0|||
27668921|NCT03845075|80627429|FG001|Part 1 - DB|Adverse Event|1|||
27668922|NCT03845075|80627430|FG002|Part 1 - DB|Adverse Event|0|||
27782631|NCT01066819|81032379|FG001|Overall Study|Screen failure|0|||
27971814|NCT03447314|81726644|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971815|NCT03447314|81726645|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971816|NCT03447314|81726646|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
27971817|NCT03447314|81726647|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
27971818|NCT03447314|81726648|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971819|NCT03447314|81726649|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971820|NCT03447314|81726650|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971821|NCT03447314|81726651|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971822|NCT03447314|81726652|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27971823|NCT03447314|81726653|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
27865141|NCT00534404|81341815|FG001|Overall Study|Lost to Follow-up|138|||
27865142|NCT00534404|81341816|FG002|Overall Study|Lost to Follow-up|201|||
27865143|NCT04172597|81341817|FG000|Overall Study|Disease Progression|0|||
27865144|NCT04172597|81341818|FG001|Overall Study|Disease Progression|0|||
27865145|NCT04172597|81341819|FG002|Overall Study|Disease Progression|0|||
27865146|NCT04172597|81341820|FG003|Overall Study|Disease Progression|0|||
27865147|NCT04172597|81341821|FG004|Overall Study|Disease Progression|1|||
27865148|NCT01609023|81341828|FG000|Overall Study|Lack of Efficacy|3|||
27865149|NCT01609023|81341828|FG000|Overall Study|Withdrawal by Subject|4|||
27865150|NCT01609023|81341828|FG000|Overall Study|Lost to Follow-up|8|||
27865151|NCT01609023|81341828|FG000|Overall Study|Toxicity|3|||
27971824|NCT03447314|81726636|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
27971825|NCT03447314|81726637|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971826|NCT03447314|81726638|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
27971827|NCT03447314|81726639|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971828|NCT03447314|81726640|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971829|NCT03447314|81726641|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
27971830|NCT03447314|81726642|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
27782632|NCT01066819|81032380|FG002|Overall Study|Screen failure|0|||
27782633|NCT01066819|81032381|FG003|Overall Study|Screen failure|0|||
27782634|NCT01066819|81032382|FG004|Overall Study|Screen failure|0|||
27782635|NCT01066819|81032383|FG005|Overall Study|Screen failure|0|||
27782636|NCT01066819|81032378|FG000|Overall Study|Spontaneous cure|1|||
27782637|NCT01066819|81032379|FG001|Overall Study|Spontaneous cure|0|||
27782638|NCT01066819|81032380|FG002|Overall Study|Spontaneous cure|0|||
27782639|NCT01066819|81032381|FG003|Overall Study|Spontaneous cure|0|||
27782640|NCT01066819|81032382|FG004|Overall Study|Spontaneous cure|0|||
27782641|NCT01066819|81032383|FG005|Overall Study|Spontaneous cure|0|||
27782642|NCT01066819|81032378|FG000|Overall Study|Treatment never started|85|||
27782643|NCT01066819|81032379|FG001|Overall Study|Treatment never started|19|||
27782644|NCT01066819|81032380|FG002|Overall Study|Treatment never started|19|||
27782645|NCT01066819|81032381|FG003|Overall Study|Treatment never started|3|||
27782646|NCT01066819|81032382|FG004|Overall Study|Treatment never started|2|||
27782647|NCT01066819|81032383|FG005|Overall Study|Treatment never started|2|||
27782648|NCT01066819|81032378|FG000|Overall Study|Treatment stopped|12|||
27782649|NCT01066819|81032379|FG001|Overall Study|Treatment stopped|1|||
27782650|NCT01066819|81032380|FG002|Overall Study|Treatment stopped|2|||
27782651|NCT01066819|81032381|FG003|Overall Study|Treatment stopped|1|||
27782652|NCT01066819|81032382|FG004|Overall Study|Treatment stopped|0|||
27782653|NCT01066819|81032383|FG005|Overall Study|Treatment stopped|0|||
27782654|NCT01066819|81032378|FG000|Overall Study|Other|5|||
27782655|NCT01066819|81032379|FG001|Overall Study|Other|1|||
27782656|NCT01066819|81032380|FG002|Overall Study|Other|1|||
27782657|NCT01066819|81032381|FG003|Overall Study|Other|0|||
27782658|NCT01066819|81032382|FG004|Overall Study|Other|0|||
27782659|NCT01066819|81032383|FG005|Overall Study|Other|0|||
27782660|NCT01611558|81032384|FG000|Induction Phase|Study drug toxicity|15|||
27782661|NCT01611558|81032384|FG000|Induction Phase|Disease progression|18|||
27782662|NCT01611558|81032384|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
27782663|NCT01611558|81032384|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
27971831|NCT03447314|81726643|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971832|NCT03447314|81726644|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971833|NCT03447314|81726645|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27668923|NCT03845075|80627431|FG003|Part 1 - DB|Adverse Event|0|||
27782664|NCT01611558|81032384|FG000|Induction Phase|Death|1|||
27782665|NCT01611558|81032384|FG000|Maintenance Phase|Withdrawal by Subject|1|||
27782666|NCT01611558|81032384|FG000|Maintenance Phase|Elevated Uric acid|1|||
27782667|NCT02192190|81032386|FG000|Overall Study|Adverse Event|1|||
27782668|NCT02192190|81032387|FG001|Overall Study|Adverse Event|1|||
27782669|NCT02192190|81032388|FG002|Overall Study|Adverse Event|0|||
27782670|NCT02192190|81032389|FG003|Overall Study|Adverse Event|0|||
27865152|NCT01609023|81341828|FG000|Overall Study|Disease progression|10|||
27865153|NCT01609023|81341828|FG000|Overall Study|Physician Decision|2|||
27865154|NCT01609023|81341828|FG000|Overall Study|Death|2|||
27971834|NCT03447314|81726646|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27782671|NCT02192190|81032390|FG004|Overall Study|Adverse Event|0|||
27782672|NCT02192190|81032391|FG005|Overall Study|Adverse Event|0|||
27782673|NCT02192190|81032386|FG000|Overall Study|Lost to Follow-up|3|||
27782674|NCT02192190|81032387|FG001|Overall Study|Lost to Follow-up|3|||
27782675|NCT02192190|81032388|FG002|Overall Study|Lost to Follow-up|2|||
27782676|NCT02192190|81032389|FG003|Overall Study|Lost to Follow-up|1|||
27782677|NCT02192190|81032390|FG004|Overall Study|Lost to Follow-up|4|||
27782678|NCT02192190|81032391|FG005|Overall Study|Lost to Follow-up|3|||
27782679|NCT02192190|81032386|FG000|Overall Study|Physician Decision|2|||
27782680|NCT02192190|81032387|FG001|Overall Study|Physician Decision|0|||
27782681|NCT02192190|81032388|FG002|Overall Study|Physician Decision|0|||
27782682|NCT02192190|81032389|FG003|Overall Study|Physician Decision|0|||
27782683|NCT02192190|81032390|FG004|Overall Study|Physician Decision|0|||
27782684|NCT02192190|81032391|FG005|Overall Study|Physician Decision|0|||
27782685|NCT02192190|81032386|FG000|Overall Study|Terminated by Sponsor|43|||
27782686|NCT02192190|81032387|FG001|Overall Study|Terminated by Sponsor|23|||
27782687|NCT02192190|81032388|FG002|Overall Study|Terminated by Sponsor|20|||
27782688|NCT02192190|81032389|FG003|Overall Study|Terminated by Sponsor|23|||
27782689|NCT02192190|81032390|FG004|Overall Study|Terminated by Sponsor|21|||
27782690|NCT02192190|81032391|FG005|Overall Study|Terminated by Sponsor|23|||
27782691|NCT02192190|81032386|FG000|Overall Study|Withdrawal by Subject|4|||
27782692|NCT02192190|81032387|FG001|Overall Study|Withdrawal by Subject|1|||
27782693|NCT02192190|81032388|FG002|Overall Study|Withdrawal by Subject|2|||
27782694|NCT02192190|81032389|FG003|Overall Study|Withdrawal by Subject|1|||
27782695|NCT02192190|81032390|FG004|Overall Study|Withdrawal by Subject|5|||
27782696|NCT02192190|81032391|FG005|Overall Study|Withdrawal by Subject|3|||
27782697|NCT02192190|81032386|FG000|Overall Study|Could not Keep Visit Schedule|1|||
27782698|NCT02192190|81032387|FG001|Overall Study|Could not Keep Visit Schedule|0|||
27782699|NCT02192190|81032388|FG002|Overall Study|Could not Keep Visit Schedule|0|||
27782700|NCT02192190|81032389|FG003|Overall Study|Could not Keep Visit Schedule|0|||
27782701|NCT02192190|81032390|FG004|Overall Study|Could not Keep Visit Schedule|0|||
27782702|NCT02192190|81032391|FG005|Overall Study|Could not Keep Visit Schedule|0|||
27782703|NCT02192190|81032386|FG000|Overall Study|Positive Drug Screen|0|||
27782704|NCT02192190|81032387|FG001|Overall Study|Positive Drug Screen|0|||
27782705|NCT02192190|81032388|FG002|Overall Study|Positive Drug Screen|0|||
27782706|NCT02192190|81032389|FG003|Overall Study|Positive Drug Screen|1|||
27782707|NCT02192190|81032390|FG004|Overall Study|Positive Drug Screen|0|||
27782708|NCT02192190|81032391|FG005|Overall Study|Positive Drug Screen|0|||
27782709|NCT02192190|81032386|FG000|Overall Study|Inadequate Pain Relief|0|||
27782710|NCT02192190|81032387|FG001|Overall Study|Inadequate Pain Relief|1|||
27782711|NCT02192190|81032388|FG002|Overall Study|Inadequate Pain Relief|1|||
27782712|NCT02192190|81032389|FG003|Overall Study|Inadequate Pain Relief|0|||
27782713|NCT02192190|81032390|FG004|Overall Study|Inadequate Pain Relief|0|||
27782714|NCT02192190|81032391|FG005|Overall Study|Inadequate Pain Relief|0|||
27782715|NCT00106626|81032392|FG000|Overall Study|Adverse Event|5|||
27782716|NCT00106626|81032393|FG001|Overall Study|Adverse Event|4|||
27782717|NCT00106626|81032394|FG002|Overall Study|Adverse Event|3|||
27782718|NCT00106626|81032395|FG003|Overall Study|Adverse Event|3|||
27782719|NCT00106626|81032392|FG000|Overall Study|Progressive Disease|4|||
27782720|NCT00106626|81032393|FG001|Overall Study|Progressive Disease|1|||
27782721|NCT00106626|81032394|FG002|Overall Study|Progressive Disease|9|||
27782722|NCT00106626|81032395|FG003|Overall Study|Progressive Disease|10|||
27782723|NCT00106626|81032392|FG000|Overall Study|Received radiation on new therapy|1|||
27782724|NCT00106626|81032393|FG001|Overall Study|Received radiation on new therapy|0|||
27782725|NCT00106626|81032394|FG002|Overall Study|Received radiation on new therapy|0|||
27782726|NCT00106626|81032395|FG003|Overall Study|Received radiation on new therapy|0|||
27782727|NCT00106626|81032392|FG000|Overall Study|> 14 day delay in therapy start|0|||
27782728|NCT00106626|81032393|FG001|Overall Study|> 14 day delay in therapy start|1|||
27782729|NCT00106626|81032394|FG002|Overall Study|> 14 day delay in therapy start|0|||
27782730|NCT00106626|81032395|FG003|Overall Study|> 14 day delay in therapy start|0|||
27782731|NCT02610231|81032396|FG000|Overall Study|Withdrawal by Subject|27|||
27971835|NCT03447314|81726647|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27782732|NCT02610231|81032396|FG000|Overall Study|Adverse Event|20|||
27782733|NCT02610231|81032396|FG000|Overall Study|Death|5|||
27782734|NCT02610231|81032396|FG000|Overall Study|Surgery|2|||
27782735|NCT02610231|81032396|FG000|Overall Study|Physician Decision|1|||
27782736|NCT02610231|81032396|FG000|Overall Study|Non Compliance|2|||
27782737|NCT02610231|81032396|FG000|Overall Study|Other|3|||
27832987|NCT01083693|81219418|FG002|Overall Study|Other medical condition/surgery|0|||
27832988|NCT01083693|81219416|FG000|Overall Study|Withdrawal by Subject|3|||
27832989|NCT01083693|81219417|FG001|Overall Study|Withdrawal by Subject|0|||
27832990|NCT01083693|81219418|FG002|Overall Study|Withdrawal by Subject|2|||
27832991|NCT01083693|81219416|FG000|Overall Study|Reason unknown|0|||
27832992|NCT01083693|81219417|FG001|Overall Study|Reason unknown|0|||
27782738|NCT02168816|81036281|FG000|Overall Study|Lost to Follow-up|2|||
27782739|NCT02168816|81036282|FG001|Overall Study|Lost to Follow-up|2|||
27782740|NCT03604159|81036284|FG000|Overall Study|Lost to Follow-up|6|||
27782741|NCT03604159|81036285|FG001|Overall Study|Lost to Follow-up|7|||
27782742|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Adverse Event|6|||
27782743|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Adverse Event|6|||
27782744|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Death|14|||
27782745|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Death|11|||
27782746|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
27782747|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
27782748|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
27782749|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
27782750|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
27782751|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
27782752|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Disease Progression|1|||
27782753|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Disease Progression|0|||
27782754|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
27971836|NCT03447314|81726648|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971837|NCT03447314|81726649|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971838|NCT03447314|81726650|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971839|NCT03447314|81726651|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27782755|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
27782756|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
27782757|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
27782758|NCT04419558|81036288|FG000|DB Period (48 Weeks)|Participant Decision|4|||
27782759|NCT04419558|81036289|FG001|DB Period (48 Weeks)|Participant Decision|3|||
27782760|NCT04419558|81036288|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
27782761|NCT04419558|81036289|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
27782762|NCT04419558|81036288|FG000|OLE Period (48 Weeks)|Death|4|||
27782763|NCT04419558|81036289|FG001|OLE Period (48 Weeks)|Death|6|||
27782764|NCT04419558|81036288|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
27782765|NCT04419558|81036289|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
27782766|NCT04419558|81036288|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
27782767|NCT04419558|81036289|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
27782768|NCT05047601|81036292|FG000|Overall Study|Lost to Follow-up|9|||
27782769|NCT05047601|81036293|FG001|Overall Study|Lost to Follow-up|11|||
27782770|NCT05047601|81036294|FG002|Overall Study|Lost to Follow-up|7|||
27782771|NCT05047601|81036292|FG000|Overall Study|Withdrawal by Subject|25|||
27782772|NCT05047601|81036293|FG001|Overall Study|Withdrawal by Subject|36|||
27971840|NCT03447314|81726652|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971841|NCT03447314|81726653|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
27971842|NCT03447314|81726636|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971843|NCT03447314|81726637|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971844|NCT03447314|81726638|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
27971845|NCT03447314|81726639|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971846|NCT03447314|81726640|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971847|NCT03447314|81726641|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971848|NCT03447314|81726642|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971849|NCT03447314|81726643|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971850|NCT03447314|81726644|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27782773|NCT05047601|81036294|FG002|Overall Study|Withdrawal by Subject|23|||
27782774|NCT05047601|81036292|FG000|Overall Study|Other|10|||
27782775|NCT05047601|81036293|FG001|Overall Study|Other|6|||
27782776|NCT05047601|81036294|FG002|Overall Study|Other|5|||
27782777|NCT01667731|81036299|FG000|Overall Study|Enrolled but not treated|0|||
27782778|NCT01667731|81036300|FG001|Overall Study|Enrolled but not treated|0|||
27782779|NCT01667731|81036301|FG002|Overall Study|Enrolled but not treated|0|||
27782780|NCT01667731|81036302|FG003|Overall Study|Enrolled but not treated|0|||
27782781|NCT01667731|81036303|FG004|Overall Study|Enrolled but not treated|1|||
27782782|NCT01667731|81036299|FG000|Overall Study|Efficacy Failure|1|||
27782783|NCT01667731|81036300|FG001|Overall Study|Efficacy Failure|12|||
27782784|NCT01667731|81036301|FG002|Overall Study|Efficacy Failure|0|||
27782785|NCT01667731|81036302|FG003|Overall Study|Efficacy Failure|1|||
27782786|NCT01667731|81036303|FG004|Overall Study|Efficacy Failure|24|||
27782787|NCT01667731|81036299|FG000|Overall Study|Lost to Follow-up|2|||
27782788|NCT01667731|81036300|FG001|Overall Study|Lost to Follow-up|3|||
27865155|NCT01609023|81341828|FG000|Overall Study|Personal reasons|1|||
27782789|NCT01667731|81036301|FG002|Overall Study|Lost to Follow-up|1|||
27782790|NCT01667731|81036302|FG003|Overall Study|Lost to Follow-up|1|||
27782791|NCT01667731|81036303|FG004|Overall Study|Lost to Follow-up|2|||
27782792|NCT01667731|81036299|FG000|Overall Study|Subject Withdrew Consent|2|||
27865156|NCT02290223|81341829|FG000|6 Months|Lost to Follow-up|9|||
27782793|NCT01667731|81036300|FG001|Overall Study|Subject Withdrew Consent|0|||
27865157|NCT02290223|81341830|FG001|6 Months|Lost to Follow-up|6|||
27865158|NCT02290223|81341829|FG000|6 Months|Withdrawal by Subject|5|||
27865159|NCT02290223|81341830|FG001|6 Months|Withdrawal by Subject|0|||
27865160|NCT02290223|81341829|FG000|6 Months|deceased (not related to study)|2|||
27865161|NCT02290223|81341830|FG001|6 Months|deceased (not related to study)|0|||
27865162|NCT02290223|81341829|FG000|12 Months|Lost to Follow-up|16|||
27865163|NCT02290223|81341830|FG001|12 Months|Lost to Follow-up|10|||
27865164|NCT02290223|81341829|FG000|12 Months|Refusal|0|||
27865165|NCT02290223|81341830|FG001|12 Months|Refusal|1|||
27865166|NCT03016975|81341831|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
27865167|NCT03016975|81341832|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
27865168|NCT03016975|81341833|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
27865169|NCT03016975|81341831|FG000|At 6 Months Follow-up|Death|2|||
27865170|NCT03016975|81341832|FG001|At 6 Months Follow-up|Death|0|||
27865171|NCT03016975|81341833|FG002|At 6 Months Follow-up|Death|0|||
27865172|NCT03016975|81341831|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
27865173|NCT03016975|81341832|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
27668924|NCT03845075|80627428|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
27865174|NCT03016975|81341833|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
27865175|NCT03016975|81341831|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
27865176|NCT03016975|81341832|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
27865177|NCT03016975|81341833|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
27865178|NCT03016975|81341831|FG000|At 6 Months Follow-up|Aborted implant|1|||
27865179|NCT03016975|81341832|FG001|At 6 Months Follow-up|Aborted implant|0|||
27865180|NCT03016975|81341833|FG002|At 6 Months Follow-up|Aborted implant|0|||
27865181|NCT03016975|81341831|FG000|At 2 Year Follow-up|Death|1|||
27865182|NCT03016975|81341832|FG001|At 2 Year Follow-up|Death|0|||
27865183|NCT03016975|81341833|FG002|At 2 Year Follow-up|Death|0|||
27865184|NCT03016975|81341831|FG000|At 3 Year Follow-up|Death|1|||
27865185|NCT03016975|81341832|FG001|At 3 Year Follow-up|Death|0|||
27865186|NCT03016975|81341833|FG002|At 3 Year Follow-up|Death|0|||
27865187|NCT03016975|81341831|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
27865188|NCT03016975|81341832|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
27865189|NCT03016975|81341833|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
27865190|NCT03016975|81341831|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
27865191|NCT03016975|81341832|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
27865192|NCT03016975|81341833|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
27865193|NCT01890434|81341834|FG000|Overall Study|Adverse Event|8|||
27865194|NCT01890434|81341834|FG000|Overall Study|PCI at external hospital|1|||
27865195|NCT01890434|81341834|FG000|Overall Study|Assessment discrepancy|1|||
27865196|NCT01890434|81341834|FG000|Overall Study|CRC didn't contact participant for FU|1|||
27865197|NCT01890434|81341834|FG000|Overall Study|Could not get whole set of images|1|||
27865198|NCT01890434|81341834|FG000|Overall Study|Decline to return for GSPECT|1|||
27865199|NCT01890434|81341834|FG000|Overall Study|GSPECT at rest was not done|1|||
27865200|NCT01890434|81341834|FG000|Overall Study|Participant didn't complete MRI|1|||
27865201|NCT01890434|81341834|FG000|Overall Study|Uncontactable by phone|1|||
27865202|NCT01890434|81341834|FG000|Overall Study|Moved out of position|1|||
27865203|NCT01890434|81341834|FG000|Overall Study|Unable to contact|1|||
27865204|NCT01890434|81341834|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
27865205|NCT01721317|81341835|FG000|Overall Study|Study Closed / Terminated|2|||
27865206|NCT01721317|81341836|FG001|Overall Study|Study Closed / Terminated|2|||
27865207|NCT01721317|81341835|FG000|Overall Study|Physician Decision|0|||
27865208|NCT01721317|81341836|FG001|Overall Study|Physician Decision|1|||
27865209|NCT01721317|81341835|FG000|Overall Study|Withdrawal by Subject|0|||
27865210|NCT01721317|81341836|FG001|Overall Study|Withdrawal by Subject|1|||
27865211|NCT01855828|81341837|FG000|Overall Study|Adverse Event|1|||
27865212|NCT01855828|81341837|FG000|Overall Study|Withdrawal by Subject|1|||
27865213|NCT00230178|81341840|FG000|Overall Study|Adverse Event|1|||
27865214|NCT00230178|81341841|FG001|Overall Study|Adverse Event|5|||
27782794|NCT01667731|81036301|FG002|Overall Study|Subject Withdrew Consent|1|||
27782795|NCT01667731|81036302|FG003|Overall Study|Subject Withdrew Consent|0|||
27865215|NCT00230178|81341842|FG002|Overall Study|Adverse Event|2|||
27865216|NCT00230178|81341840|FG000|Overall Study|Withdrawal by Subject|0|||
27865217|NCT00230178|81341841|FG001|Overall Study|Withdrawal by Subject|0|||
27782796|NCT01667731|81036303|FG004|Overall Study|Subject Withdrew Consent|1|||
27782797|NCT01667731|81036299|FG000|Overall Study|Death|0|||
27782798|NCT01667731|81036300|FG001|Overall Study|Death|1|||
27782799|NCT01667731|81036301|FG002|Overall Study|Death|0|||
27782800|NCT01667731|81036302|FG003|Overall Study|Death|0|||
27782801|NCT01667731|81036303|FG004|Overall Study|Death|0|||
27782802|NCT02698176|81036304|FG000|Overall Study|Progressive disease|4|||
27782803|NCT02698176|81036305|FG001|Overall Study|Progressive disease|3|||
27782804|NCT02698176|81036306|FG002|Overall Study|Progressive disease|1|||
27782805|NCT02698176|81036307|FG003|Overall Study|Progressive disease|0|||
27782806|NCT02698176|81036304|FG000|Overall Study|Adverse Event|2|||
27782807|NCT02698176|81036305|FG001|Overall Study|Adverse Event|0|||
27782808|NCT02698176|81036306|FG002|Overall Study|Adverse Event|0|||
27782809|NCT02698176|81036307|FG003|Overall Study|Adverse Event|0|||
27782810|NCT02698176|81036304|FG000|Overall Study|Clinical progression|3|||
27782811|NCT02698176|81036305|FG001|Overall Study|Clinical progression|0|||
27782812|NCT02698176|81036306|FG002|Overall Study|Clinical progression|0|||
27782813|NCT02698176|81036307|FG003|Overall Study|Clinical progression|0|||
27782814|NCT02185040|81036319|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
27782815|NCT02185040|81036320|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
27782816|NCT02185040|81036321|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
27782817|NCT02185040|81036322|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
27782818|NCT02185040|81036323|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
27782819|NCT02185040|81036324|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
27782820|NCT02185040|81036325|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
27782821|NCT02185040|81036319|FG000|Part 1 Treatment Phase|Adverse Event|1|||
27782822|NCT02185040|81036320|FG001|Part 1 Treatment Phase|Adverse Event|0|||
27782823|NCT02185040|81036321|FG002|Part 1 Treatment Phase|Adverse Event|0|||
27782824|NCT02185040|81036322|FG003|Part 1 Treatment Phase|Adverse Event|2|||
27782825|NCT02185040|81036323|FG004|Part 1 Treatment Phase|Adverse Event|3|||
27782826|NCT02185040|81036324|FG005|Part 1 Treatment Phase|Adverse Event|0|||
27782827|NCT02185040|81036325|FG006|Part 1 Treatment Phase|Adverse Event|0|||
27782828|NCT02185040|81036319|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27782829|NCT02185040|81036320|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
27782830|NCT02185040|81036321|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27782831|NCT02185040|81036322|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27782832|NCT02185040|81036323|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27971851|NCT03447314|81726645|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971852|NCT03447314|81726646|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971853|NCT03447314|81726647|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971854|NCT03447314|81726648|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971855|NCT03447314|81726649|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971856|NCT03447314|81726650|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971857|NCT03447314|81726651|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971858|NCT03447314|81726652|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971859|NCT03447314|81726653|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
27971860|NCT03447314|81726636|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971861|NCT03447314|81726637|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971862|NCT03447314|81726638|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
27865218|NCT00230178|81341842|FG002|Overall Study|Withdrawal by Subject|1|||
27865219|NCT00230178|81341840|FG000|Overall Study|Various other reasons|3|||
27865220|NCT00230178|81341841|FG001|Overall Study|Various other reasons|2|||
27865221|NCT00230178|81341842|FG002|Overall Study|Various other reasons|4|||
27865222|NCT01808573|81341848|FG000|Overall Study|Death|212|||
27668925|NCT03845075|80627429|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
27668926|NCT03845075|80627430|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
27782833|NCT02185040|81036324|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27782834|NCT02185040|81036325|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
27782835|NCT02185040|81036319|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
27782836|NCT02185040|81036320|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
27782837|NCT02185040|81036321|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
27782838|NCT02185040|81036322|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
27782839|NCT02185040|81036323|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
27782840|NCT02185040|81036324|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
27782841|NCT02185040|81036325|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
27782842|NCT02185040|81036319|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
27782843|NCT02185040|81036320|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
27782844|NCT02185040|81036321|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
27865223|NCT01808573|81341849|FG001|Overall Study|Death|240|||
27782845|NCT02185040|81036322|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
27865224|NCT01808573|81341848|FG000|Overall Study|Withdrawal by Subject|12|||
27782846|NCT02185040|81036323|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
27865225|NCT01808573|81341849|FG001|Overall Study|Withdrawal by Subject|10|||
27971863|NCT03447314|81726639|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27782847|NCT02185040|81036324|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
27782848|NCT02185040|81036325|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
27782849|NCT02185040|81036319|FG000|Active Treatment Extension Phase|Adverse Event|0|||
27782850|NCT02185040|81036320|FG001|Active Treatment Extension Phase|Adverse Event|0|||
27782851|NCT02185040|81036321|FG002|Active Treatment Extension Phase|Adverse Event|0|||
27782852|NCT02185040|81036322|FG003|Active Treatment Extension Phase|Adverse Event|0|||
27782853|NCT02185040|81036323|FG004|Active Treatment Extension Phase|Adverse Event|0|||
27782854|NCT02185040|81036324|FG005|Active Treatment Extension Phase|Adverse Event|1|||
27782855|NCT02185040|81036325|FG006|Active Treatment Extension Phase|Adverse Event|4|||
27782856|NCT02185040|81036319|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27782857|NCT02185040|81036320|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27782858|NCT02185040|81036321|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27782859|NCT02185040|81036322|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27782860|NCT02185040|81036323|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
27971864|NCT03447314|81726640|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971865|NCT03447314|81726641|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971866|NCT03447314|81726642|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971867|NCT03447314|81726643|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27782861|NCT02185040|81036324|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
27865226|NCT01808573|81341848|FG000|Overall Study|Lost to Follow-up|3|||
27971868|NCT03447314|81726644|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971869|NCT03447314|81726645|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971870|NCT03447314|81726646|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971871|NCT03447314|81726647|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971872|NCT03447314|81726648|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971873|NCT03447314|81726649|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971874|NCT03447314|81726650|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971875|NCT03447314|81726651|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971876|NCT03447314|81726652|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971877|NCT03447314|81726653|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
27971878|NCT03447314|81726636|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971879|NCT03447314|81726637|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971880|NCT03447314|81726638|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971881|NCT03447314|81726639|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971882|NCT03447314|81726640|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27571443|NCT01577758|80278821|FG000|Dose Escalation Phase|Progression Disease|2|||
27971883|NCT03447314|81726641|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971884|NCT03447314|81726642|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971885|NCT03447314|81726643|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971886|NCT03447314|81726644|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971887|NCT03447314|81726645|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971888|NCT03447314|81726646|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
27971889|NCT03447314|81726647|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971890|NCT03447314|81726648|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971891|NCT03447314|81726649|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971892|NCT03447314|81726650|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971893|NCT03447314|81726651|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971894|NCT03447314|81726652|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971895|NCT03447314|81726653|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
27971896|NCT03447314|81726636|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971897|NCT03447314|81726637|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971898|NCT03447314|81726638|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971899|NCT03447314|81726639|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
27971900|NCT03447314|81726640|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27782862|NCT02185040|81036325|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
27971901|NCT03447314|81726641|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
27971902|NCT03447314|81726642|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971903|NCT03447314|81726643|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971904|NCT03447314|81726644|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971905|NCT03447314|81726645|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971906|NCT03447314|81726646|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971907|NCT03447314|81726647|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971908|NCT03447314|81726648|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971909|NCT03447314|81726649|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971910|NCT03447314|81726650|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971911|NCT03447314|81726651|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971912|NCT03447314|81726652|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971913|NCT03447314|81726653|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
27971914|NCT00585221|81726662|FG000|Overall Study|Protocol Violation|8|||
27971915|NCT05289271|81726663|FG000|Overall Study|Mistakenly allocated, untreated|1|||
27971916|NCT05289271|81726664|FG001|Overall Study|Mistakenly allocated, untreated|0|||
27971917|NCT01534260|81726668|FG000|Overall Study|Adverse Event|1|||
27782863|NCT02185040|81036319|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
27782864|NCT02185040|81036320|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
27782865|NCT02185040|81036321|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
27782866|NCT02185040|81036322|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
27782867|NCT02185040|81036323|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
27782868|NCT02185040|81036324|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
27782869|NCT02185040|81036325|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
27782870|NCT02728804|81036326|FG000|Overall Study|Ineligible|3|||
27782871|NCT02728804|81036326|FG000|Overall Study|Did not complete baseline questionnaire|9|||
27971918|NCT01534260|81726669|FG001|Overall Study|Adverse Event|8|||
27971919|NCT01534260|81726668|FG000|Overall Study|Death|2|||
27971920|NCT01534260|81726669|FG001|Overall Study|Death|0|||
27971921|NCT01534260|81726668|FG000|Overall Study|Lack of Efficacy|1|||
27971922|NCT01534260|81726669|FG001|Overall Study|Lack of Efficacy|1|||
27971923|NCT01534260|81726668|FG000|Overall Study|Withdrawal by Subject|1|||
27971924|NCT01534260|81726669|FG001|Overall Study|Withdrawal by Subject|3|||
27971925|NCT01534260|81726668|FG000|Overall Study|Disease Progression|8|||
27971926|NCT01534260|81726669|FG001|Overall Study|Disease Progression|6|||
27971927|NCT01534260|81726668|FG000|Overall Study|Physician Decision|3|||
27971928|NCT01534260|81726669|FG001|Overall Study|Physician Decision|1|||
27782872|NCT02728804|81036326|FG000|Overall Study|Death|99|||
27971929|NCT01534260|81726668|FG000|Overall Study|No treatment, per protocol|0|||
27971930|NCT01534260|81726669|FG001|Overall Study|No treatment, per protocol|1|||
27782873|NCT01222767|81036327|FG000|Overall Study|Progressive disease|13|||
27782874|NCT01222767|81036327|FG000|Overall Study|Adverse Event|2|||
27782875|NCT01222767|81036327|FG000|Overall Study|Surgical resection|1|||
27782876|NCT01222767|81036327|FG000|Overall Study|Never treated|1|||
27782877|NCT01362062|81036344|FG000|Overall Study|Adverse Event|1|||
27782878|NCT01362062|81036345|FG001|Overall Study|Adverse Event|0|||
27782879|NCT01362062|81036344|FG000|Overall Study|Lost to Follow-up|11|||
27782880|NCT01362062|81036345|FG001|Overall Study|Lost to Follow-up|0|||
27782881|NCT01362062|81036344|FG000|Overall Study|Withdrawal by Subject|2|||
27782882|NCT01362062|81036345|FG001|Overall Study|Withdrawal by Subject|0|||
27782883|NCT01362062|81036344|FG000|Overall Study|Non-compliant participant|2|||
27782884|NCT01362062|81036345|FG001|Overall Study|Non-compliant participant|0|||
27782885|NCT01362062|81036344|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
27782886|NCT01362062|81036345|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
27782887|NCT01362062|81036344|FG000|Overall Study|Had significant improvement|9|||
27782888|NCT01362062|81036345|FG001|Overall Study|Had significant improvement|0|||
27782889|NCT02058966|81036346|FG000|Open-Label Methamphetamine|Adverse Event|1|||
27782890|NCT02058966|81036346|FG000|First Intervention|Withdrawal by Subject|1|||
27782891|NCT04657003|81036347|FG000|Overall Study|Adverse Event|5|||
27782892|NCT04657003|81036348|FG001|Overall Study|Adverse Event|1|||
27782893|NCT04657003|81036349|FG002|Overall Study|Adverse Event|5|||
27782894|NCT04657003|81036347|FG000|Overall Study|Death|0|||
27782895|NCT04657003|81036348|FG001|Overall Study|Death|2|||
27782896|NCT04657003|81036349|FG002|Overall Study|Death|0|||
27782897|NCT04657003|81036347|FG000|Overall Study|Lost to Follow-up|8|||
27782898|NCT04657003|81036348|FG001|Overall Study|Lost to Follow-up|4|||
27782899|NCT04657003|81036349|FG002|Overall Study|Lost to Follow-up|10|||
27782900|NCT04657003|81036347|FG000|Overall Study|Other - As Reported by Investigator|3|||
27832993|NCT01083693|81219418|FG002|Overall Study|Reason unknown|1|||
27832994|NCT03676634|81219419|FG000|Overall Study|Red blood cell loss|1|||
27782901|NCT04657003|81036348|FG001|Overall Study|Other - As Reported by Investigator|2|||
27782902|NCT04657003|81036349|FG002|Overall Study|Other - As Reported by Investigator|2|||
27782903|NCT04657003|81036347|FG000|Overall Study|Pregnancy|2|||
27782904|NCT04657003|81036348|FG001|Overall Study|Pregnancy|0|||
27782905|NCT04657003|81036349|FG002|Overall Study|Pregnancy|2|||
27782906|NCT04657003|81036347|FG000|Overall Study|Withdrawal by Subject|16|||
27782907|NCT04657003|81036348|FG001|Overall Study|Withdrawal by Subject|7|||
27782908|NCT04657003|81036349|FG002|Overall Study|Withdrawal by Subject|10|||
27782909|NCT01736176|81036352|FG000|Overall Study|Adverse Event|3|||
27782910|NCT01736176|81036352|FG000|Overall Study|Withdrawal by Subject|4|||
27782911|NCT01736176|81036352|FG000|Overall Study|Lack of Efficacy|3|||
27782912|NCT01736176|81036352|FG000|Overall Study|Unable to Complete PEG Placement|1|||
27782913|NCT00129220|81036353|FG000|Study Period II|Adverse Event|9|||
27782914|NCT00129220|81036354|FG001|Study Period II|Adverse Event|5|||
27782915|NCT00129220|81036355|FG002|Study Period II|Adverse Event|7|||
27782916|NCT00129220|81036353|FG000|Study Period II|Lack of Efficacy|15|||
27782917|NCT00129220|81036354|FG001|Study Period II|Lack of Efficacy|1|||
27782918|NCT00129220|81036355|FG002|Study Period II|Lack of Efficacy|28|||
27782919|NCT00129220|81036353|FG000|Study Period II|Entry Criteria Not Met|2|||
27782920|NCT00129220|81036354|FG001|Study Period II|Entry Criteria Not Met|0|||
27782921|NCT00129220|81036355|FG002|Study Period II|Entry Criteria Not Met|2|||
27782922|NCT00129220|81036353|FG000|Study Period II|Protocol Violation|4|||
27782923|NCT00129220|81036354|FG001|Study Period II|Protocol Violation|2|||
27782924|NCT00129220|81036355|FG002|Study Period II|Protocol Violation|1|||
27782925|NCT00129220|81036353|FG000|Study Period II|Physician Decision|0|||
27782926|NCT00129220|81036354|FG001|Study Period II|Physician Decision|1|||
27782927|NCT00129220|81036355|FG002|Study Period II|Physician Decision|0|||
27782928|NCT00129220|81036353|FG000|Study Period II|Withdrawal by Subject|1|||
27782929|NCT00129220|81036354|FG001|Study Period II|Withdrawal by Subject|3|||
27782930|NCT00129220|81036355|FG002|Study Period II|Withdrawal by Subject|4|||
27971931|NCT03194568|81726670|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
27971932|NCT01082874|81726671|FG000|Overall Study|Lost to Follow-up|10|||
27971933|NCT01082874|81726672|FG001|Overall Study|Lost to Follow-up|10|||
27971934|NCT01082874|81726673|FG002|Overall Study|Lost to Follow-up|6|||
27971935|NCT01082874|81726674|FG003|Overall Study|Lost to Follow-up|10|||
27971936|NCT01082874|81726671|FG000|Overall Study|Withdrawal by Subject|1|||
27971937|NCT01082874|81726672|FG001|Overall Study|Withdrawal by Subject|2|||
27971938|NCT01082874|81726673|FG002|Overall Study|Withdrawal by Subject|5|||
27571444|NCT01577758|80278822|FG001|Dose Escalation Phase|Progression Disease|2|||
27571445|NCT01577758|80278823|FG002|Dose Escalation Phase|Progression Disease|1|||
27571446|NCT01577758|80278824|FG003|Dose Escalation Phase|Progression Disease|2|||
27571447|NCT01577758|80278825|FG004|Dose Escalation Phase|Progression Disease|5|||
27571448|NCT01577758|80278826|FG005|Dose Escalation Phase|Progression Disease|0|||
27971939|NCT01082874|81726674|FG003|Overall Study|Withdrawal by Subject|3|||
27971940|NCT04085458|81726675|FG000|Overall Study|Other|1|||
27971941|NCT04085458|81726675|FG000|Overall Study|Withdrawal by Subject|2|||
27971942|NCT04085458|81726675|FG000|Overall Study|Adverse Event|2|||
27971943|NCT00420004|81726678|FG000|Overall Study|Adverse Event|4|||
27971944|NCT00420004|81726679|FG001|Overall Study|Adverse Event|1|||
27971945|NCT00420004|81726680|FG002|Overall Study|Adverse Event|1|||
27971946|NCT00420004|81726678|FG000|Overall Study|Lack of Efficacy|5|||
27971947|NCT00420004|81726679|FG001|Overall Study|Lack of Efficacy|4|||
27971948|NCT00420004|81726680|FG002|Overall Study|Lack of Efficacy|1|||
27971949|NCT00420004|81726678|FG000|Overall Study|Lost to Follow-up|31|||
27971950|NCT00420004|81726679|FG001|Overall Study|Lost to Follow-up|12|||
27971951|NCT00420004|81726680|FG002|Overall Study|Lost to Follow-up|10|||
27971952|NCT00420004|81726678|FG000|Overall Study|Entry Criteria Not Met|0|||
27971953|NCT00420004|81726679|FG001|Overall Study|Entry Criteria Not Met|1|||
27971954|NCT00420004|81726680|FG002|Overall Study|Entry Criteria Not Met|0|||
27971955|NCT00420004|81726678|FG000|Overall Study|Physician Decision|14|||
27971956|NCT00420004|81726679|FG001|Overall Study|Physician Decision|4|||
27971957|NCT00420004|81726680|FG002|Overall Study|Physician Decision|2|||
27971958|NCT00420004|81726678|FG000|Overall Study|Protocol Violation|5|||
27571449|NCT01577758|80278827|FG006|Dose Escalation Phase|Progression Disease|0|||
27571450|NCT01577758|80278828|FG007|Dose Escalation Phase|Progression Disease|0|||
27571451|NCT01577758|80278821|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27782931|NCT00129220|81036353|FG000|Study Period II|Reason Not Specified|2|||
27782932|NCT00129220|81036354|FG001|Study Period II|Reason Not Specified|0|||
27782933|NCT00129220|81036355|FG002|Study Period II|Reason Not Specified|5|||
27782934|NCT00129220|81036353|FG000|Study Period III|Adverse Event|1|||
27782935|NCT00129220|81036354|FG001|Study Period III|Adverse Event|0|||
27782936|NCT00129220|81036355|FG002|Study Period III|Adverse Event|3|||
27782937|NCT00129220|81036353|FG000|Study Period III|Protocol Violation|1|||
27782938|NCT00129220|81036354|FG001|Study Period III|Protocol Violation|1|||
27782939|NCT00129220|81036355|FG002|Study Period III|Protocol Violation|2|||
27971959|NCT00420004|81726679|FG001|Overall Study|Protocol Violation|4|||
27971960|NCT00420004|81726680|FG002|Overall Study|Protocol Violation|3|||
27971961|NCT00420004|81726678|FG000|Overall Study|Withdrawal by Subject|67|||
27971962|NCT00420004|81726679|FG001|Overall Study|Withdrawal by Subject|42|||
27971963|NCT00420004|81726680|FG002|Overall Study|Withdrawal by Subject|14|||
27971964|NCT00420004|81726678|FG000|Overall Study|Sponsor Decision|3|||
27971965|NCT00420004|81726679|FG001|Overall Study|Sponsor Decision|3|||
27971966|NCT00420004|81726680|FG002|Overall Study|Sponsor Decision|1|||
27971967|NCT05935878|81726681|FG000|Overall Study|Death|1|||
27571452|NCT01577758|80278822|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27571453|NCT01577758|80278823|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27971968|NCT05935878|81726682|FG001|Overall Study|Death|2|||
27971969|NCT05935878|81726681|FG000|Overall Study|Withdrawal by Subject|5|||
27971970|NCT05935878|81726682|FG001|Overall Study|Withdrawal by Subject|5|||
27971971|NCT05935878|81726681|FG000|Overall Study|Revision of implant|1|||
27971972|NCT05935878|81726682|FG001|Overall Study|Revision of implant|1|||
27971973|NCT05935878|81726681|FG000|Overall Study|Mobile bearing dislocation|0|||
27971974|NCT05935878|81726682|FG001|Overall Study|Mobile bearing dislocation|1|||
27971975|NCT03596047|81726685|FG000|Overall Study|Withdrawal by Subject|7|||
27971976|NCT03596047|81726686|FG001|Overall Study|Withdrawal by Subject|4|||
27971977|NCT03596047|81726685|FG000|Overall Study|Lost to Follow-up|0|||
27971978|NCT03596047|81726686|FG001|Overall Study|Lost to Follow-up|2|||
27971979|NCT02379221|81726687|FG000|Overall Study|Lost to Follow-up|1|||
27971980|NCT00294645|81726690|FG000|Overall Study|Death|10|||
27971981|NCT00294645|81726691|FG001|Overall Study|Death|18|||
27971982|NCT00294645|81726690|FG000|Overall Study|Lost to Follow-up|1|||
27971983|NCT00294645|81726691|FG001|Overall Study|Lost to Follow-up|10|||
27971984|NCT00294645|81726690|FG000|Overall Study|Withdrawal by Subject|18|||
27971985|NCT00294645|81726691|FG001|Overall Study|Withdrawal by Subject|34|||
27971986|NCT00294645|81726690|FG000|Overall Study|Physician Decision|15|||
27971987|NCT00294645|81726691|FG001|Overall Study|Physician Decision|20|||
27971988|NCT00294645|81726690|FG000|Overall Study|Other|4|||
27971989|NCT00294645|81726691|FG001|Overall Study|Other|10|||
27971990|NCT00064259|81726692|FG000|Overall Study|Adverse Event|1|||
27971991|NCT00064259|81726693|FG001|Overall Study|Adverse Event|0|||
27971992|NCT00064259|81726694|FG002|Overall Study|Adverse Event|0|||
27971993|NCT00064259|81726695|FG003|Overall Study|Adverse Event|1|||
27571454|NCT01577758|80278824|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27571455|NCT01577758|80278825|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27571456|NCT01577758|80278826|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27571457|NCT01577758|80278827|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
27571458|NCT01577758|80278828|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
27571459|NCT01577758|80278821|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571460|NCT01577758|80278822|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571461|NCT01577758|80278823|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571462|NCT01577758|80278824|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571463|NCT01577758|80278825|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571464|NCT01577758|80278826|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571465|NCT01577758|80278827|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
27571466|NCT01577758|80278828|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
27571467|NCT01577758|80278821|FG000|mCRC Expansion Phase|Progression Disease|0|||
27571468|NCT01577758|80278822|FG001|mCRC Expansion Phase|Progression Disease|0|||
27571469|NCT01577758|80278823|FG002|mCRC Expansion Phase|Progression Disease|0|||
27571470|NCT01577758|80278824|FG003|mCRC Expansion Phase|Progression Disease|0|||
27571471|NCT01577758|80278825|FG004|mCRC Expansion Phase|Progression Disease|0|||
27571472|NCT01577758|80278826|FG005|mCRC Expansion Phase|Progression Disease|0|||
27571473|NCT01577758|80278827|FG006|mCRC Expansion Phase|Progression Disease|0|||
27832995|NCT03676634|81219419|FG000|Overall Study|Out-of-limit pulse|2|||
27832996|NCT02105272|81219420|FG000|Overall Study|Adverse Event|1|||
27832997|NCT02105272|81219421|FG001|Overall Study|Adverse Event|2|||
27832998|NCT02105272|81219420|FG000|Overall Study|Physician Decision|0|||
27832999|NCT02105272|81219421|FG001|Overall Study|Physician Decision|1|||
27833000|NCT02105272|81219420|FG000|Overall Study|Protocol Violation|2|||
27833001|NCT02105272|81219421|FG001|Overall Study|Protocol Violation|0|||
27833002|NCT02105272|81219420|FG000|Overall Study|Withdrawal by Subject|2|||
27833003|NCT02105272|81219421|FG001|Overall Study|Withdrawal by Subject|0|||
27833004|NCT01149057|81219422|FG000|Overall Study|Lack of Efficacy|16|||
27833005|NCT01149057|81219422|FG000|Overall Study|Adverse Event|13|||
27833006|NCT01149057|81219422|FG000|Overall Study|Withdrawal by Subject|9|||
27833007|NCT01149057|81219422|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
27833008|NCT01149057|81219422|FG000|Overall Study|B Cell Depletion|4|||
27833009|NCT01149057|81219422|FG000|Overall Study|Participant Non-Compliance|2|||
27833010|NCT01149057|81219422|FG000|Overall Study|Lost to Follow-up|1|||
27833011|NCT01149057|81219422|FG000|Overall Study|High Parathyroid Hormone Value|1|||
27833012|NCT01149057|81219422|FG000|Overall Study|Other|6|||
27833013|NCT00700739|81219432|FG000|Overall Study|Lost to Follow-up|4|||
27833014|NCT00700739|81219433|FG001|Overall Study|Lost to Follow-up|4|||
27833015|NCT02658487|81219436|FG000|Overall Study|Death|2|||
27833016|NCT02658487|81219436|FG000|Overall Study|Disease progression|10|||
27971994|NCT00349921|81726696|FG000|First Spinal Injection|Physician Decision|1|||
27971995|NCT00349921|81726697|FG001|First Spinal Injection|Physician Decision|0|||
27971996|NCT00349921|81726698|FG002|First Spinal Injection|Physician Decision|0|||
27971997|NCT00349921|81726699|FG003|First Spinal Injection|Physician Decision|0|||
27971998|NCT00349921|81726696|FG000|First Spinal Injection|Adverse Event|0|||
27971999|NCT00349921|81726697|FG001|First Spinal Injection|Adverse Event|0|||
27972000|NCT00349921|81726698|FG002|First Spinal Injection|Adverse Event|1|||
27972001|NCT00349921|81726699|FG003|First Spinal Injection|Adverse Event|0|||
27972002|NCT02513485|81726700|FG000|Overall Study|Adverse Event|1|||
27972003|NCT02513485|81726701|FG001|Overall Study|Adverse Event|0|||
27972004|NCT02013206|81726702|FG000|Overall Study|Progressive disease (PD)|14|||
27972005|NCT02013206|81726703|FG001|Overall Study|Progressive disease (PD)|17|||
27972006|NCT02013206|81726702|FG000|Overall Study|Symptomatic deterioration|3|||
27972007|NCT02013206|81726703|FG001|Overall Study|Symptomatic deterioration|1|||
27972008|NCT02013206|81726702|FG000|Overall Study|Adverse Event|1|||
27972009|NCT02013206|81726703|FG001|Overall Study|Adverse Event|0|||
27972010|NCT02013206|81726702|FG000|Overall Study|Patient refusal|2|||
27972011|NCT02013206|81726703|FG001|Overall Study|Patient refusal|0|||
27972012|NCT02013206|81726702|FG000|Overall Study|Patient non-compliance|1|||
27972013|NCT02013206|81726703|FG001|Overall Study|Patient non-compliance|0|||
27972014|NCT02013206|81726702|FG000|Overall Study|Death|1|||
27972015|NCT02013206|81726703|FG001|Overall Study|Death|2|||
27972016|NCT02013206|81726702|FG000|Overall Study|Other reasons off treatment|5|||
27972017|NCT02013206|81726703|FG001|Overall Study|Other reasons off treatment|2|||
27972018|NCT01685801|81726708|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
27972019|NCT01685801|81726709|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
27972020|NCT01685801|81726710|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
27865227|NCT01808573|81341849|FG001|Overall Study|Lost to Follow-up|0|||
27865228|NCT01808573|81341848|FG000|Overall Study|Discontinuation of study by sponsor|79|||
27865229|NCT01808573|81341849|FG001|Overall Study|Discontinuation of study by sponsor|64|||
27865230|NCT01808573|81341848|FG000|Overall Study|Randomized in Error|1|||
27972021|NCT01685801|81726711|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
27865231|NCT01808573|81341849|FG001|Overall Study|Randomized in Error|0|||
27972022|NCT01685801|81726708|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
27972023|NCT01685801|81726709|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
27972024|NCT01685801|81726710|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
27972025|NCT01685801|81726711|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
27571474|NCT01577758|80278828|FG007|mCRC Expansion Phase|Progression Disease|19|||
27571475|NCT02510794|80278836|FG000|Overall Study|Adverse Event|0|||
27972026|NCT00923975|81726712|FG000|Overall Study|Did not meet inclusion criteria|1|||
27972027|NCT03555981|81726716|FG000|Overall Study|Lost to Follow-up|0|||
27972028|NCT03555981|81726717|FG001|Overall Study|Lost to Follow-up|2|||
27972029|NCT02220855|81726719|FG000|Overall Study|Adverse Event|8|||
27972030|NCT02220855|81726719|FG000|Overall Study|Disease Progression|5|||
27972031|NCT02220855|81726719|FG000|Overall Study|Withdrawal by Subject|1|||
27972032|NCT03215758|81726720|FG000|Overall Study|Technical Problems|1|||
27972033|NCT03215758|81726721|FG001|Overall Study|Technical Problems|0|||
27972034|NCT03215758|81726720|FG000|Overall Study|Protocol deviation|0|||
27972035|NCT03215758|81726721|FG001|Overall Study|Protocol deviation|1|||
27972036|NCT03215758|81726720|FG000|Overall Study|Physician Decision|0|||
27972037|NCT03215758|81726721|FG001|Overall Study|Physician Decision|1|||
27972038|NCT03215758|81726720|FG000|Overall Study|Death|0|||
27972039|NCT03215758|81726721|FG001|Overall Study|Death|1|||
27972040|NCT03215758|81726720|FG000|Overall Study|Adverse Event|1|||
27972041|NCT03215758|81726721|FG001|Overall Study|Adverse Event|2|||
27972042|NCT03215758|81726720|FG000|Overall Study|Subject/Guardian Decision|3|||
27972043|NCT03215758|81726721|FG001|Overall Study|Subject/Guardian Decision|3|||
27972044|NCT01330628|81726722|FG000|Overall Study|Death|2|||
27972045|NCT01330628|81726723|FG001|Overall Study|Death|3|||
27972046|NCT01330628|81726722|FG000|Overall Study|Lost to Follow-up|5|||
27972047|NCT01330628|81726723|FG001|Overall Study|Lost to Follow-up|6|||
27972048|NCT01330628|81726722|FG000|Overall Study|Adverse Event|44|||
27972049|NCT01330628|81726723|FG001|Overall Study|Adverse Event|25|||
27571476|NCT02510794|80278837|FG001|Overall Study|Adverse Event|1|||
27571477|NCT02510794|80278838|FG002|Overall Study|Adverse Event|0|||
27571478|NCT02510794|80278839|FG003|Overall Study|Adverse Event|0|||
27571479|NCT02510794|80278836|FG000|Overall Study|Death|1|||
27571480|NCT02510794|80278837|FG001|Overall Study|Death|2|||
27571481|NCT02510794|80278838|FG002|Overall Study|Death|1|||
27972050|NCT01330628|81726722|FG000|Overall Study|Withdrawn|18|||
27972051|NCT01330628|81726723|FG001|Overall Study|Withdrawn|6|||
27972052|NCT01330628|81726722|FG000|Overall Study|Didn't receive study treatment|1|||
27972053|NCT01330628|81726723|FG001|Overall Study|Didn't receive study treatment|0|||
27972054|NCT01579565|81726724|FG000|Randomized|Adverse Event|1|||
27972055|NCT01579565|81726725|FG001|Randomized|Adverse Event|3|||
27571482|NCT02510794|80278839|FG003|Overall Study|Death|1|||
27571483|NCT02510794|80278836|FG000|Overall Study|Lack of Efficacy|3|||
27571484|NCT02510794|80278837|FG001|Overall Study|Lack of Efficacy|1|||
27571485|NCT02510794|80278838|FG002|Overall Study|Lack of Efficacy|1|||
27571486|NCT02510794|80278839|FG003|Overall Study|Lack of Efficacy|0|||
27571487|NCT02510794|80278836|FG000|Overall Study|Participant moved out of the area|0|||
27571488|NCT02510794|80278837|FG001|Overall Study|Participant moved out of the area|0|||
27571489|NCT02510794|80278838|FG002|Overall Study|Participant moved out of the area|0|||
27571490|NCT02510794|80278839|FG003|Overall Study|Participant moved out of the area|1|||
27571491|NCT02510794|80278836|FG000|Overall Study|Physician Decision|3|||
27571492|NCT02510794|80278837|FG001|Overall Study|Physician Decision|0|||
27571493|NCT02510794|80278838|FG002|Overall Study|Physician Decision|0|||
27571494|NCT02510794|80278839|FG003|Overall Study|Physician Decision|0|||
27571495|NCT02510794|80278836|FG000|Overall Study|Protocol Violation|0|||
27571496|NCT02510794|80278837|FG001|Overall Study|Protocol Violation|0|||
27571497|NCT02510794|80278838|FG002|Overall Study|Protocol Violation|1|||
27571498|NCT02510794|80278839|FG003|Overall Study|Protocol Violation|0|||
27571499|NCT02510794|80278836|FG000|Overall Study|Withdrawal by Subject|1|||
27571500|NCT02510794|80278837|FG001|Overall Study|Withdrawal by Subject|2|||
27571501|NCT02510794|80278838|FG002|Overall Study|Withdrawal by Subject|4|||
27972056|NCT01579565|81726724|FG000|Randomized|Withdrawal by Subject|3|||
27972057|NCT01579565|81726725|FG001|Randomized|Withdrawal by Subject|0|||
27972058|NCT01579565|81726724|FG000|Randomized|inadequate preoperative pupil dilation|0|||
27972059|NCT01579565|81726725|FG001|Randomized|inadequate preoperative pupil dilation|1|||
27972060|NCT01579565|81726724|FG000|Randomized|prohibited preoperative eating|1|||
27972061|NCT01579565|81726725|FG001|Randomized|prohibited preoperative eating|0|||
27972062|NCT01579565|81726724|FG000|Randomized|prohibited preoperative medication|0|||
27972063|NCT01579565|81726725|FG001|Randomized|prohibited preoperative medication|1|||
27571502|NCT02510794|80278839|FG003|Overall Study|Withdrawal by Subject|3|||
27571503|NCT03350503|80278840|FG000|Overall Study|Adverse Event|5|||
27571504|NCT03350503|80278840|FG000|Overall Study|Withdrawal by Subject|5|||
27571505|NCT03350503|80278840|FG000|Overall Study|Continuation impossible due to move|4|||
27571506|NCT03350503|80278840|FG000|Overall Study|Physician Decision|3|||
27571507|NCT01252290|80278843|FG000|Overall Study|Withdrawal by Subject|1|||
27972064|NCT01579565|81726724|FG000|Treated|Physician Decision|0|||
27972065|NCT01579565|81726725|FG001|Treated|Physician Decision|1|||
27972066|NCT01579565|81726724|FG000|Treated|Lost to Follow-up|2|||
27972067|NCT01579565|81726725|FG001|Treated|Lost to Follow-up|1|||
27972068|NCT01579565|81726724|FG000|Treated|declined to return for final visit|0|||
27972069|NCT01579565|81726725|FG001|Treated|declined to return for final visit|1|||
27972070|NCT00503581|81726726|FG000|Overall Study|Study closed|3|||
27972071|NCT00503581|81726727|FG001|Overall Study|Study closed|4|||
27972072|NCT00503581|81726728|FG002|Overall Study|Study closed|2|||
27972073|NCT04225676|81726731|FG000|Overall Study|Physician Decision|1|||
27972074|NCT04225676|81726731|FG000|Overall Study|Lack of Efficacy|1|||
27972075|NCT04225676|81726731|FG000|Overall Study|Study terminated by sponsor|3|||
27972076|NCT04376684|81726736|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
27972077|NCT04376684|81726737|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
27571508|NCT01481116|80278846|FG000|Overall Study|Adverse Event|26|||
27571509|NCT01481116|80278847|FG001|Overall Study|Adverse Event|26|||
27571510|NCT01481116|80278848|FG002|Overall Study|Adverse Event|42|||
27571511|NCT01481116|80278846|FG000|Overall Study|Major Protocol Deviation|3|||
27571512|NCT01481116|80278847|FG001|Overall Study|Major Protocol Deviation|7|||
27571513|NCT01481116|80278848|FG002|Overall Study|Major Protocol Deviation|1|||
27571514|NCT01481116|80278846|FG000|Overall Study|Lost to Follow-up|8|||
27571515|NCT01481116|80278847|FG001|Overall Study|Lost to Follow-up|12|||
27571516|NCT01481116|80278848|FG002|Overall Study|Lost to Follow-up|11|||
27571517|NCT01481116|80278846|FG000|Overall Study|Withdrawal by Subject|37|||
27571518|NCT01481116|80278847|FG001|Overall Study|Withdrawal by Subject|33|||
27571519|NCT01481116|80278848|FG002|Overall Study|Withdrawal by Subject|37|||
27571520|NCT01481116|80278846|FG000|Overall Study|Study Termination|730|||
27571521|NCT01481116|80278847|FG001|Overall Study|Study Termination|729|||
27571522|NCT01481116|80278848|FG002|Overall Study|Study Termination|713|||
27571523|NCT01481116|80278846|FG000|Overall Study|Pregnancy|0|||
27571524|NCT01481116|80278847|FG001|Overall Study|Pregnancy|0|||
27571525|NCT01481116|80278848|FG002|Overall Study|Pregnancy|1|||
27571526|NCT01481116|80278846|FG000|Overall Study|Lack of Efficacy|3|||
27571527|NCT01481116|80278847|FG001|Overall Study|Lack of Efficacy|3|||
27668927|NCT03845075|80627431|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
27668928|NCT03246347|80627435|FG000|Overall Study|On Study|23|||
27668929|NCT00236184|80627436|FG000|Overall Study|Adverse Event|5|||
27668930|NCT00236184|80627437|FG001|Overall Study|Adverse Event|2|||
27668931|NCT00236184|80627436|FG000|Overall Study|Lack of Efficacy|0|||
27972078|NCT04376684|81726738|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
27972079|NCT04376684|81726739|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
27972080|NCT04376684|81726736|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
27972081|NCT04376684|81726737|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
27972082|NCT04376684|81726738|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
27972083|NCT04376684|81726739|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
27972084|NCT04376684|81726736|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
27972085|NCT04376684|81726737|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
27571528|NCT01481116|80278848|FG002|Overall Study|Lack of Efficacy|1|||
27668932|NCT00236184|80627437|FG001|Overall Study|Lack of Efficacy|1|||
27668933|NCT00236184|80627436|FG000|Overall Study|Lost to Follow-up|3|||
27668934|NCT00236184|80627437|FG001|Overall Study|Lost to Follow-up|4|||
27782940|NCT00129220|81036353|FG000|Study Period III|Withdrawal by Subject|1|||
27782941|NCT00129220|81036354|FG001|Study Period III|Withdrawal by Subject|0|||
27782942|NCT00129220|81036355|FG002|Study Period III|Withdrawal by Subject|3|||
27782943|NCT00129220|81036353|FG000|Study Period III|Sponsor Decision|1|||
27782944|NCT00129220|81036354|FG001|Study Period III|Sponsor Decision|0|||
27782945|NCT00129220|81036355|FG002|Study Period III|Sponsor Decision|0|||
27782946|NCT00129220|81036353|FG000|Study Period III|Reason Not Specified|9|||
27782947|NCT00129220|81036354|FG001|Study Period III|Reason Not Specified|0|||
27782948|NCT00129220|81036355|FG002|Study Period III|Reason Not Specified|2|||
27782949|NCT00686894|81036356|FG000|Overall Study|Relapse|2|||
27782950|NCT00686894|81036356|FG000|Overall Study|Protocol Violation|4|||
27782951|NCT00579527|81036357|FG000|Overall Study|Death|4|||
27782952|NCT02908841|81036360|FG000|Overall Study|Physician Decision|4|||
27782953|NCT02908841|81036361|FG001|Overall Study|Physician Decision|0|||
27782954|NCT00695318|81036362|FG000|Overall Study|Lost to Follow-up|1|||
27865232|NCT05093829|81341850|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
27972086|NCT04376684|81726738|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
27972087|NCT04376684|81726739|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
27972088|NCT04376684|81726736|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
27972089|NCT04376684|81726737|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
27972090|NCT04376684|81726738|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
27972091|NCT04376684|81726739|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
27571529|NCT01481116|80278846|FG000|Overall Study|Contraindications|1|||
27668935|NCT00236184|80627436|FG000|Overall Study|Physician Decision|1|||
27668936|NCT00236184|80627437|FG001|Overall Study|Physician Decision|1|||
27668937|NCT00236184|80627436|FG000|Overall Study|Withdrawal by Subject|3|||
27782955|NCT00695318|81036363|FG001|Overall Study|Lost to Follow-up|0|||
27972092|NCT04376684|81726736|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
27972093|NCT04376684|81726737|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
27972094|NCT04376684|81726738|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
27972095|NCT04376684|81726739|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
27972096|NCT04376684|81726736|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
27972097|NCT04376684|81726737|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
27972098|NCT04376684|81726738|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
27972099|NCT04376684|81726739|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
27972100|NCT04376684|81726736|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
27972101|NCT04376684|81726737|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
27972102|NCT04376684|81726738|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
27972103|NCT04376684|81726739|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
27972104|NCT00394251|81726740|FG000|Overall Study|Adverse Event|7|||
27972105|NCT00394251|81726741|FG001|Overall Study|Adverse Event|5|||
27972106|NCT00394251|81726740|FG000|Overall Study|Unacceptable Toxicity|20|||
27972107|NCT00394251|81726741|FG001|Overall Study|Unacceptable Toxicity|18|||
27972108|NCT00394251|81726740|FG000|Overall Study|Physician Decision|1|||
27972109|NCT00394251|81726741|FG001|Overall Study|Physician Decision|1|||
27972110|NCT00394251|81726740|FG000|Overall Study|Protocol Violation|0|||
27972111|NCT00394251|81726741|FG001|Overall Study|Protocol Violation|1|||
27972112|NCT00394251|81726740|FG000|Overall Study|Withdrawal by Subject|7|||
27972113|NCT00394251|81726741|FG001|Overall Study|Withdrawal by Subject|11|||
27668938|NCT00236184|80627437|FG001|Overall Study|Withdrawal by Subject|0|||
27668939|NCT00236184|80627436|FG000|Overall Study|Protocol Violation|3|||
27668940|NCT00236184|80627437|FG001|Overall Study|Protocol Violation|0|||
27668941|NCT00236184|80627436|FG000|Overall Study|non-compliance with study drug|2|||
27668942|NCT00236184|80627437|FG001|Overall Study|non-compliance with study drug|1|||
27668943|NCT00236184|80627436|FG000|Overall Study|other|1|||
27668944|NCT00236184|80627437|FG001|Overall Study|other|2|||
27668945|NCT05043883|80627438|FG000|Overall Study|Minimum required measurements could not be taken|4|||
27668946|NCT01427738|80627439|FG000|Overall Study|Death|12|||
27668947|NCT01427738|80627440|FG001|Overall Study|Death|9|||
27668948|NCT01427738|80627439|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27668949|NCT01427738|80627440|FG001|Overall Study|Severe debilitation, unable to continue|1|||
27668950|NCT01427738|80627439|FG000|Overall Study|Subject unable to get to clinic|5|||
27668951|NCT01427738|80627440|FG001|Overall Study|Subject unable to get to clinic|2|||
27668952|NCT01427738|80627439|FG000|Overall Study|Withdrawal by Subject|0|||
27668953|NCT01427738|80627440|FG001|Overall Study|Withdrawal by Subject|2|||
27668954|NCT01427738|80627439|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
27668955|NCT01427738|80627440|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
27668956|NCT01427738|80627439|FG000|Overall Study|Lost to Follow-up|1|||
27668957|NCT01427738|80627440|FG001|Overall Study|Lost to Follow-up|5|||
27668958|NCT04081389|80627445|FG000|Overall Study|Withdrawal by Subject|0|||
27668959|NCT04081389|80627446|FG001|Overall Study|Withdrawal by Subject|0|||
27668960|NCT04081389|80627447|FG002|Overall Study|Withdrawal by Subject|1|||
27668961|NCT04081389|80627448|FG003|Overall Study|Withdrawal by Subject|0|||
27668962|NCT01124838|80627449|FG000|Overall Study|Miscellaneous|4|||
27668963|NCT01124838|80627450|FG001|Overall Study|Miscellaneous|2|||
27668964|NCT01124838|80627449|FG000|Overall Study|Adverse Event|7|||
27668965|NCT01124838|80627450|FG001|Overall Study|Adverse Event|11|||
27668966|NCT01124838|80627449|FG000|Overall Study|Lack of Efficacy|2|||
27668967|NCT01124838|80627450|FG001|Overall Study|Lack of Efficacy|0|||
27668968|NCT01124838|80627449|FG000|Overall Study|Withdrawal by Subject|3|||
27668969|NCT01124838|80627450|FG001|Overall Study|Withdrawal by Subject|2|||
27668970|NCT01124838|80627449|FG000|Overall Study|Lost to Follow-up|2|||
27668971|NCT01124838|80627450|FG001|Overall Study|Lost to Follow-up|0|||
27668972|NCT02826798|80627451|FG000|Overall Study|Withdrawal by Subject|0|||
27668973|NCT02826798|80627452|FG001|Overall Study|Withdrawal by Subject|1|||
27668974|NCT02826798|80627453|FG002|Overall Study|Withdrawal by Subject|0|||
27668975|NCT02826798|80627454|FG003|Overall Study|Withdrawal by Subject|1|||
27668976|NCT02826798|80627455|FG004|Overall Study|Withdrawal by Subject|0|||
27782956|NCT00695318|81036362|FG000|Overall Study|Withdrawal by Subject|2|||
27782957|NCT00695318|81036363|FG001|Overall Study|Withdrawal by Subject|0|||
27782958|NCT00695318|81036362|FG000|Overall Study|Death|1|||
27972114|NCT00394251|81726740|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
27972115|NCT00394251|81726741|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
27972116|NCT00096174|81726742|FG000|Overall Study|Lack of Efficacy|9|||
27972117|NCT00096174|81726742|FG000|Overall Study|Adverse Event|15|||
27668977|NCT00887198|80627471|FG000|Randomized Period|Ongoing|42|||
27668978|NCT00887198|80627472|FG001|Randomized Period|Ongoing|0|||
27668979|NCT00887198|80627473|FG002|Randomized Period|Ongoing|0|||
27668980|NCT00887198|80627471|FG000|Randomized Period|Adverse Event|50|||
27668981|NCT00887198|80627472|FG001|Randomized Period|Adverse Event|33|||
27668982|NCT00887198|80627473|FG002|Randomized Period|Adverse Event|0|||
27668983|NCT00887198|80627471|FG000|Randomized Period|Lost to Follow-up|1|||
27668984|NCT00887198|80627472|FG001|Randomized Period|Lost to Follow-up|0|||
27972118|NCT00096174|81726742|FG000|Overall Study|Death|6|||
27972119|NCT00096174|81726742|FG000|Overall Study|Withdrawal by Subject|15|||
27972120|NCT00096174|81726742|FG000|Overall Study|Not started protocol therapy|3|||
27972121|NCT00096174|81726742|FG000|Overall Study|Ineligible|6|||
27972122|NCT00096174|81726742|FG000|Overall Study|other reason|8|||
27972123|NCT01610713|81729953|FG000|Overall Study|Adverse Event|3|||
27972124|NCT01610713|81729954|FG001|Overall Study|Adverse Event|0|||
27972125|NCT01610713|81729953|FG000|Overall Study|Lack of Efficacy|1|||
27972126|NCT01610713|81729954|FG001|Overall Study|Lack of Efficacy|0|||
27972127|NCT01610713|81729953|FG000|Overall Study|low mood and poor motivation|1|||
27972128|NCT01610713|81729954|FG001|Overall Study|low mood and poor motivation|0|||
27972129|NCT01610713|81729953|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
27972130|NCT01610713|81729954|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
27972131|NCT01610713|81729953|FG000|Overall Study|Lost to Follow-up|0|||
27972132|NCT01610713|81729954|FG001|Overall Study|Lost to Follow-up|1|||
27972133|NCT00516893|81729955|FG000|Overall Study|Lost to Follow-up|4|||
27972134|NCT00516893|81729955|FG000|Overall Study|Adverse Event|3|||
27972135|NCT00516893|81729955|FG000|Overall Study|Withdrawal by Subject|2|||
27972136|NCT00516893|81729955|FG000|Overall Study|Noncompliance|2|||
27782959|NCT00695318|81036363|FG001|Overall Study|Death|1|||
27782960|NCT00695318|81036362|FG000|Overall Study|Study Terminated|1|||
27782961|NCT00695318|81036363|FG001|Overall Study|Study Terminated|0|||
27782962|NCT00925522|81036366|FG000|Overall Study|study closed -- business decision|20|||
27782963|NCT04097925|81036367|FG000|Overall Study|Withdrawal by Subject|1|||
27668985|NCT00887198|80627473|FG002|Randomized Period|Lost to Follow-up|0|||
27782964|NCT02400281|81036368|FG000|Overall Study|Adverse Event|0|||
27782965|NCT02400281|81036369|FG001|Overall Study|Adverse Event|0|||
27782966|NCT02400281|81036370|FG002|Overall Study|Adverse Event|1|||
27782967|NCT02400281|81036371|FG003|Overall Study|Adverse Event|0|||
27782968|NCT02400281|81036372|FG004|Overall Study|Adverse Event|1|||
27782969|NCT02400281|81036373|FG005|Overall Study|Adverse Event|0|||
27782970|NCT02400281|81036368|FG000|Overall Study|Physician Decision|0|||
27782971|NCT02400281|81036369|FG001|Overall Study|Physician Decision|0|||
27782972|NCT02400281|81036370|FG002|Overall Study|Physician Decision|1|||
27782973|NCT02400281|81036371|FG003|Overall Study|Physician Decision|0|||
27782974|NCT02400281|81036372|FG004|Overall Study|Physician Decision|0|||
27782975|NCT02400281|81036373|FG005|Overall Study|Physician Decision|0|||
27782976|NCT03037489|81036374|FG000|Overall Study|Adverse Event|4|||
27782977|NCT03037489|81036375|FG001|Overall Study|Adverse Event|0|||
27782978|NCT03037489|81036374|FG000|Overall Study|Withdrawal by Subject|3|||
27782979|NCT03037489|81036375|FG001|Overall Study|Withdrawal by Subject|0|||
27865233|NCT05093829|81341851|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
27782980|NCT01513460|81036376|FG000|Overall Study|Death|0|||
27782981|NCT01513460|81036377|FG001|Overall Study|Death|0|||
27782982|NCT01513460|81036378|FG002|Overall Study|Death|1|||
27782983|NCT01513460|81036376|FG000|Overall Study|Lost to Follow-up|0|||
27782984|NCT01513460|81036377|FG001|Overall Study|Lost to Follow-up|0|||
27782985|NCT01513460|81036378|FG002|Overall Study|Lost to Follow-up|2|||
27782986|NCT01513460|81036376|FG000|Overall Study|Abnormal laboratory value|1|||
27782987|NCT01513460|81036377|FG001|Overall Study|Abnormal laboratory value|0|||
27782988|NCT01513460|81036378|FG002|Overall Study|Abnormal laboratory value|1|||
27782989|NCT01513460|81036376|FG000|Overall Study|Lack of Efficacy|1|||
27782990|NCT01513460|81036377|FG001|Overall Study|Lack of Efficacy|2|||
27782991|NCT01513460|81036378|FG002|Overall Study|Lack of Efficacy|5|||
27782992|NCT01513460|81036376|FG000|Overall Study|Protocol deviations|3|||
27782993|NCT01513460|81036377|FG001|Overall Study|Protocol deviations|4|||
27865234|NCT05093829|81341852|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
27865235|NCT05093829|81341853|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
27865236|NCT05093829|81341854|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
27865237|NCT01408043|81341855|FG000|Overall Study|unable to collect cells|1|||
27865238|NCT01000961|81341856|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
27865239|NCT01000961|81341857|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27865240|NCT01000961|81341856|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
27865241|NCT01000961|81341857|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
27865242|NCT00663026|81341859|FG000|Overall Study|Lost to Follow-up|1|||
27865243|NCT00663026|81341860|FG001|Overall Study|Lost to Follow-up|0|||
27865244|NCT00663026|81341861|FG002|Overall Study|Lost to Follow-up|0|||
27865245|NCT00663026|81341859|FG000|Overall Study|Other|1|||
27865246|NCT00663026|81341860|FG001|Overall Study|Other|2|||
27865247|NCT00663026|81341861|FG002|Overall Study|Other|0|||
27865248|NCT00663026|81341859|FG000|Overall Study|Adverse Event|0|||
27865249|NCT00663026|81341860|FG001|Overall Study|Adverse Event|2|||
27865250|NCT00663026|81341861|FG002|Overall Study|Adverse Event|3|||
27865251|NCT00663026|81341859|FG000|Overall Study|Caregiver Request|0|||
27865252|NCT00663026|81341860|FG001|Overall Study|Caregiver Request|2|||
27972137|NCT00516893|81729955|FG000|Overall Study|Death|1|||
27972138|NCT00516893|81729955|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
27972139|NCT00516893|81729955|FG000|Overall Study|Relocated|1|||
27782994|NCT01513460|81036378|FG002|Overall Study|Protocol deviations|3|||
27782995|NCT01513460|81036376|FG000|Overall Study|Withdrawal by Subject|7|||
27782996|NCT01513460|81036377|FG001|Overall Study|Withdrawal by Subject|8|||
27972140|NCT00516893|81729955|FG000|Overall Study|Pregnancy|1|||
27972141|NCT00516893|81729955|FG000|Overall Study|Received Medication From Another Study|1|||
27972142|NCT01451931|81729956|FG000|Overall Study|Lost to Follow-up|17|||
27972143|NCT01451931|81729957|FG001|Overall Study|Lost to Follow-up|36|||
27972144|NCT01451931|81729958|FG002|Overall Study|Lost to Follow-up|21|||
27972145|NCT01451931|81729956|FG000|Overall Study|Withdrawal by Subject|16|||
27972146|NCT01451931|81729957|FG001|Overall Study|Withdrawal by Subject|22|||
27972147|NCT01451931|81729958|FG002|Overall Study|Withdrawal by Subject|22|||
27972148|NCT00713349|81729959|FG000|Overall Study|Protocol Violation|1|||
27972149|NCT02576535|81729960|FG000|Overall Study|Withdrawal by Subject|2|||
27972150|NCT01973387|81729961|FG000|Overall Study|Adverse Event|14|||
27972151|NCT01973387|81729962|FG001|Overall Study|Adverse Event|4|||
27972152|NCT01973387|81729961|FG000|Overall Study|Withdrawal by Subject|7|||
27972153|NCT01973387|81729962|FG001|Overall Study|Withdrawal by Subject|4|||
27972154|NCT01973387|81729961|FG000|Overall Study|Study terminated by sponsor|63|||
27972155|NCT01973387|81729962|FG001|Overall Study|Study terminated by sponsor|0|||
27668986|NCT00887198|80627471|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
27668987|NCT00887198|80627472|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
27668988|NCT00887198|80627473|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
27668989|NCT00887198|80627471|FG000|Randomized Period|Withdrawal by Subject|41|||
27668990|NCT00887198|80627472|FG001|Randomized Period|Withdrawal by Subject|56|||
27668991|NCT00887198|80627473|FG002|Randomized Period|Withdrawal by Subject|0|||
27865253|NCT00663026|81341861|FG002|Overall Study|Caregiver Request|0|||
27668992|NCT00887198|80627471|FG000|Randomized Period|Progressive disease|366|||
27668993|NCT00887198|80627472|FG001|Randomized Period|Progressive disease|370|||
27668994|NCT00887198|80627473|FG002|Randomized Period|Progressive disease|0|||
27782997|NCT01513460|81036378|FG002|Overall Study|Withdrawal by Subject|21|||
27782998|NCT01513460|81036376|FG000|Overall Study|Adverse Event|16|||
27782999|NCT01513460|81036377|FG001|Overall Study|Adverse Event|18|||
27783000|NCT01513460|81036378|FG002|Overall Study|Adverse Event|23|||
27783001|NCT01513460|81036376|FG000|Overall Study|Abnormal test procedure|1|||
27783002|NCT01513460|81036377|FG001|Overall Study|Abnormal test procedure|0|||
27783003|NCT01513460|81036378|FG002|Overall Study|Abnormal test procedure|0|||
27783004|NCT01982942|81036379|FG000|Overall Study|Adverse Event|10|||
27783005|NCT01982942|81036380|FG001|Overall Study|Adverse Event|5|||
27783006|NCT01982942|81036379|FG000|Overall Study|Lost to Follow-up|4|||
27783007|NCT01982942|81036380|FG001|Overall Study|Lost to Follow-up|3|||
27783008|NCT01982942|81036379|FG000|Overall Study|Multiple sclerosis progression|3|||
27783009|NCT01982942|81036380|FG001|Overall Study|Multiple sclerosis progression|2|||
27783010|NCT01982942|81036379|FG000|Overall Study|Wanted to try therapy not permitted|1|||
27783011|NCT01982942|81036380|FG001|Overall Study|Wanted to try therapy not permitted|0|||
27783012|NCT01982942|81036379|FG000|Overall Study|Subject declined future visits|0|||
27783013|NCT01982942|81036380|FG001|Overall Study|Subject declined future visits|1|||
27783014|NCT01982942|81036379|FG000|Overall Study|Left geographical area|2|||
27783015|NCT01982942|81036380|FG001|Overall Study|Left geographical area|0|||
27783016|NCT01982942|81036379|FG000|Overall Study|Too many pills|1|||
27783017|NCT01982942|81036380|FG001|Overall Study|Too many pills|0|||
27783018|NCT01982942|81036379|FG000|Overall Study|MS Relapse|0|||
27865254|NCT00663026|81341859|FG000|Overall Study|Withdrawal by Subject|0|||
27668995|NCT00887198|80627471|FG000|Randomized Period|Other|42|||
27668996|NCT00887198|80627472|FG001|Randomized Period|Other|30|||
27668997|NCT00887198|80627473|FG002|Randomized Period|Other|0|||
27668998|NCT00887198|80627471|FG000|Randomized Period|Randomized, Not treated|4|||
27668999|NCT00887198|80627472|FG001|Randomized Period|Randomized, Not treated|2|||
27669000|NCT00887198|80627473|FG002|Randomized Period|Randomized, Not treated|0|||
27669001|NCT00887198|80627471|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
27669002|NCT00887198|80627472|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
27669003|NCT00887198|80627473|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
27669004|NCT00887198|80627471|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
27669005|NCT00887198|80627472|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
27669006|NCT00887198|80627473|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
27669007|NCT00887198|80627471|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
27669008|NCT00887198|80627472|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
27783019|NCT01982942|81036380|FG001|Overall Study|MS Relapse|1|||
27783020|NCT01982942|81036379|FG000|Overall Study|Chose to join a stem cell trial|0|||
27972156|NCT01973387|81729961|FG000|Overall Study|Progressive disease or relapse|16|||
27669009|NCT00887198|80627473|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
27783021|NCT01982942|81036380|FG001|Overall Study|Chose to join a stem cell trial|1|||
27783022|NCT01982942|81036379|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
27783023|NCT01982942|81036380|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
27865255|NCT00663026|81341860|FG001|Overall Study|Withdrawal by Subject|0|||
27972157|NCT01973387|81729962|FG001|Overall Study|Progressive disease or relapse|5|||
27972158|NCT01973387|81729961|FG000|Overall Study|Death|4|||
27972159|NCT01973387|81729962|FG001|Overall Study|Death|3|||
27972160|NCT01973387|81729961|FG000|Overall Study|Randomized, not treated|2|||
27783024|NCT02813681|81036390|FG000|Overall Study|Physician Decision|5|||
27783025|NCT02813681|81036391|FG001|Overall Study|Physician Decision|5|||
27865256|NCT00663026|81341861|FG002|Overall Study|Withdrawal by Subject|1|||
27865257|NCT01523002|81341865|FG000|Period 1|Withdrawal by Subject|1|||
27865258|NCT01523002|81341866|FG001|Period 1|Withdrawal by Subject|3|||
27865259|NCT01523002|81341865|FG000|Period 1|Lost to Follow-up|1|||
27865260|NCT01523002|81341866|FG001|Period 1|Lost to Follow-up|0|||
27865261|NCT01523002|81341865|FG000|Period 1|Adverse Event|0|||
27865262|NCT01523002|81341866|FG001|Period 1|Adverse Event|8|||
27865263|NCT01523002|81341865|FG000|Period 2|Withdrawal by Subject|4|||
27865264|NCT01523002|81341866|FG001|Period 2|Withdrawal by Subject|1|||
27865265|NCT01523002|81341865|FG000|Period 2|Adverse Event|2|||
27865266|NCT01523002|81341866|FG001|Period 2|Adverse Event|5|||
27865267|NCT01523002|81341865|FG000|Period 3|Withdrawal by Subject|1|||
27865268|NCT01523002|81341866|FG001|Period 3|Withdrawal by Subject|0|||
27865269|NCT01523002|81341865|FG000|Period 3|Adverse Event|3|||
27865270|NCT01523002|81341866|FG001|Period 3|Adverse Event|0|||
27783026|NCT02813681|81036392|FG002|Overall Study|Physician Decision|0|||
27783027|NCT02813681|81036390|FG000|Overall Study|Lost to Follow-up|0|||
27783028|NCT02813681|81036391|FG001|Overall Study|Lost to Follow-up|1|||
27783029|NCT02813681|81036392|FG002|Overall Study|Lost to Follow-up|0|||
27783030|NCT01842334|81036395|FG000|Overall Study|Withdrawal by Subject|3|||
27783031|NCT01842334|81036396|FG001|Overall Study|Withdrawal by Subject|3|||
27783032|NCT01842334|81036395|FG000|Overall Study|Moved away mid-study|0|||
27783033|NCT01842334|81036396|FG001|Overall Study|Moved away mid-study|1|||
27783034|NCT04524507|81036397|FG000|Overall Study|Lost to Follow-up|2|||
27865271|NCT00749892|81341868|FG000|Overall Study|Withdrawal by Subject|3|||
27865272|NCT02246114|81341869|FG000|Overall Study|miscarriage|1|||
27865273|NCT02246114|81341870|FG001|Overall Study|miscarriage|0|||
27865274|NCT02075515|81341871|FG000|Overall Study|Serious Adverse Event|1|||
27669010|NCT00887198|80627471|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
27783035|NCT04524507|81036398|FG001|Overall Study|Lost to Follow-up|4|||
27783036|NCT04524507|81036397|FG000|Overall Study|Withdrawal by Subject|2|||
27783037|NCT04524507|81036398|FG001|Overall Study|Withdrawal by Subject|9|||
27783038|NCT04524507|81036397|FG000|Overall Study|Death|2|||
27783039|NCT04524507|81036398|FG001|Overall Study|Death|10|||
27783040|NCT01005875|81036403|FG000|Overall Study|Death|3|||
27783041|NCT04806334|81036405|FG000|Overall Study|Withdrawal by Subject|1|||
27865275|NCT02075515|81341872|FG001|Overall Study|Serious Adverse Event|1|||
27865276|NCT02075515|81341873|FG002|Overall Study|Serious Adverse Event|1|||
27865277|NCT02075515|81341871|FG000|Overall Study|Non-Serious Adverse Event|0|||
27865278|NCT02075515|81341872|FG001|Overall Study|Non-Serious Adverse Event|1|||
27865279|NCT02075515|81341873|FG002|Overall Study|Non-Serious Adverse Event|0|||
27783042|NCT00535236|81036406|FG000|Overall Study|Adverse Event|1|||
27865280|NCT02075515|81341871|FG000|Overall Study|Withdrawal by Subject|2|||
27783043|NCT00535236|81036407|FG001|Overall Study|Adverse Event|0|||
27783044|NCT00535236|81036408|FG002|Overall Study|Adverse Event|9|||
27783045|NCT00535236|81036409|FG003|Overall Study|Adverse Event|3|||
27783046|NCT00535236|81036410|FG004|Overall Study|Adverse Event|3|||
27783047|NCT00535236|81036411|FG005|Overall Study|Adverse Event|0|||
27783048|NCT00535236|81036412|FG006|Overall Study|Adverse Event|5|||
27783049|NCT00535236|81036413|FG007|Overall Study|Adverse Event|1|||
27783050|NCT00535236|81036414|FG008|Overall Study|Adverse Event|2|||
27783051|NCT00535236|81036415|FG009|Overall Study|Adverse Event|1|||
27783052|NCT00535236|81036406|FG000|Overall Study|Lost to Follow-up|1|||
27783053|NCT00535236|81036407|FG001|Overall Study|Lost to Follow-up|2|||
27783054|NCT00535236|81036408|FG002|Overall Study|Lost to Follow-up|0|||
27783055|NCT00535236|81036409|FG003|Overall Study|Lost to Follow-up|0|||
27783056|NCT00535236|81036410|FG004|Overall Study|Lost to Follow-up|2|||
27783057|NCT00535236|81036411|FG005|Overall Study|Lost to Follow-up|0|||
27783058|NCT00535236|81036412|FG006|Overall Study|Lost to Follow-up|0|||
27783059|NCT00535236|81036413|FG007|Overall Study|Lost to Follow-up|0|||
27783060|NCT00535236|81036414|FG008|Overall Study|Lost to Follow-up|6|||
27783061|NCT00535236|81036415|FG009|Overall Study|Lost to Follow-up|1|||
27783062|NCT00535236|81036406|FG000|Overall Study|Physician Decision|0|||
27783063|NCT00535236|81036407|FG001|Overall Study|Physician Decision|0|||
27783064|NCT00535236|81036408|FG002|Overall Study|Physician Decision|0|||
27783065|NCT00535236|81036409|FG003|Overall Study|Physician Decision|0|||
27783066|NCT00535236|81036410|FG004|Overall Study|Physician Decision|1|||
27669011|NCT00887198|80627472|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
27669012|NCT00887198|80627473|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
27669013|NCT00887198|80627471|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
27669014|NCT00887198|80627472|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
27669015|NCT00887198|80627473|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
27669016|NCT00887198|80627471|FG000|Cross Over (Placebo to AA)|Other|0|||
27669017|NCT00887198|80627472|FG001|Cross Over (Placebo to AA)|Other|0|||
27669018|NCT00887198|80627473|FG002|Cross Over (Placebo to AA)|Other|19|||
27669019|NCT02670122|80627474|FG000|Overall Study|Lost to Follow-up|4|||
27669020|NCT00545571|80627475|FG000|Overall Study|Administrative Reasons|1|||
27669021|NCT00545571|80627475|FG000|Overall Study|Adverse Event|2|||
27669022|NCT00545571|80627475|FG000|Overall Study|Death|5|||
27669023|NCT00545571|80627475|FG000|Overall Study|Lack of Efficacy|1|||
27669024|NCT00545571|80627475|FG000|Overall Study|Protocol Violation|2|||
27669025|NCT00545571|80627475|FG000|Overall Study|Refused Treatment|1|||
27669026|NCT00545571|80627475|FG000|Overall Study|Screen Failure|16|||
27669027|NCT00545571|80627475|FG000|Overall Study|Transfusion|12|||
27669028|NCT00545571|80627475|FG000|Overall Study|Early Termination of Study|24|||
27669029|NCT00545571|80627475|FG000|Overall Study|Kidney Transplantation|3|||
27669030|NCT00746785|80627476|FG000|Overall Study|Lost to Follow-up|29|||
27669031|NCT00746785|80627477|FG001|Overall Study|Lost to Follow-up|25|||
27669032|NCT00746785|80627478|FG002|Overall Study|Lost to Follow-up|27|||
27669033|NCT00494026|80627480|FG000|Overall Study|Sponsor Decision|4|||
27669034|NCT01013740|80627481|FG000|Overall Study|Lost to Follow-up|3|||
27669035|NCT01013740|80627482|FG001|Overall Study|Lost to Follow-up|5|||
27669036|NCT01013740|80627481|FG000|Overall Study|Physician Decision|2|||
27669037|NCT01013740|80627482|FG001|Overall Study|Physician Decision|0|||
27669038|NCT01013740|80627481|FG000|Overall Study|Withdrawal by Subject|2|||
27669039|NCT01013740|80627482|FG001|Overall Study|Withdrawal by Subject|10|||
27669040|NCT01013740|80627481|FG000|Overall Study|study close / terminated : done in error|2|||
27669041|NCT01013740|80627482|FG001|Overall Study|study close / terminated : done in error|1|||
27669042|NCT01013740|80627481|FG000|Overall Study|Missing|2|||
27669043|NCT01013740|80627482|FG001|Overall Study|Missing|1|||
27669044|NCT01013740|80627481|FG000|Overall Study|Ongoing: Study records not completed|0|||
27669045|NCT01013740|80627482|FG001|Overall Study|Ongoing: Study records not completed|2|||
27669046|NCT01801982|80627483|FG000|Overall Study|Lost to Follow-up|1|||
27669047|NCT03834623|80627484|FG000|Overall Study|Progression|0|||
27669048|NCT03834623|80627485|FG001|Overall Study|Progression|1|||
27669049|NCT00704171|80627489|FG000|Overall Study|Withdrawal by Subject|1|||
27669050|NCT00704171|80627490|FG001|Overall Study|Withdrawal by Subject|0|||
27669051|NCT00665223|80627491|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
27669052|NCT00665223|80627492|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
27783067|NCT00535236|81036411|FG005|Overall Study|Physician Decision|0|||
27783068|NCT00535236|81036412|FG006|Overall Study|Physician Decision|1|||
27669053|NCT00665223|80627493|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
27783069|NCT00535236|81036413|FG007|Overall Study|Physician Decision|0|||
27865281|NCT02075515|81341872|FG001|Overall Study|Withdrawal by Subject|0|||
27669054|NCT00665223|80627491|FG000|Randomized Phase (26 Weeks)|Death|0|||
27669055|NCT00665223|80627492|FG001|Randomized Phase (26 Weeks)|Death|0|||
27669056|NCT00665223|80627493|FG002|Randomized Phase (26 Weeks)|Death|1|||
27669057|NCT00665223|80627491|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
27669058|NCT00665223|80627492|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
27669059|NCT00665223|80627493|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
27669060|NCT00665223|80627491|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
27783070|NCT00535236|81036414|FG008|Overall Study|Physician Decision|0|||
27783071|NCT00535236|81036415|FG009|Overall Study|Physician Decision|0|||
27865282|NCT02075515|81341873|FG002|Overall Study|Withdrawal by Subject|1|||
27865283|NCT02075515|81341871|FG000|Overall Study|Lost to Follow-up|1|||
27865284|NCT02075515|81341872|FG001|Overall Study|Lost to Follow-up|3|||
27865285|NCT02075515|81341873|FG002|Overall Study|Lost to Follow-up|6|||
27865286|NCT01941498|81341874|FG000|Overall Study|Relocated out of state|1|||
27865287|NCT00061932|81341875|FG000|Overall Study|Withdrawal by Subject|13|||
27783072|NCT00535236|81036406|FG000|Overall Study|Protocol Violation|2|||
27783073|NCT00535236|81036407|FG001|Overall Study|Protocol Violation|0|||
27783074|NCT00535236|81036408|FG002|Overall Study|Protocol Violation|1|||
27783075|NCT00535236|81036409|FG003|Overall Study|Protocol Violation|0|||
27783076|NCT00535236|81036410|FG004|Overall Study|Protocol Violation|0|||
27783077|NCT00535236|81036411|FG005|Overall Study|Protocol Violation|0|||
27783078|NCT00535236|81036412|FG006|Overall Study|Protocol Violation|0|||
27783079|NCT00535236|81036413|FG007|Overall Study|Protocol Violation|0|||
27783080|NCT00535236|81036414|FG008|Overall Study|Protocol Violation|1|||
27783081|NCT00535236|81036415|FG009|Overall Study|Protocol Violation|0|||
27783082|NCT00535236|81036406|FG000|Overall Study|Withdrawal by Subject|3|||
27783083|NCT00535236|81036407|FG001|Overall Study|Withdrawal by Subject|0|||
27783084|NCT00535236|81036408|FG002|Overall Study|Withdrawal by Subject|2|||
27783085|NCT00535236|81036409|FG003|Overall Study|Withdrawal by Subject|1|||
27783086|NCT00535236|81036410|FG004|Overall Study|Withdrawal by Subject|6|||
27783087|NCT00535236|81036411|FG005|Overall Study|Withdrawal by Subject|1|||
27783088|NCT00535236|81036412|FG006|Overall Study|Withdrawal by Subject|5|||
27783089|NCT00535236|81036413|FG007|Overall Study|Withdrawal by Subject|0|||
27783090|NCT00535236|81036414|FG008|Overall Study|Withdrawal by Subject|4|||
27783091|NCT00535236|81036415|FG009|Overall Study|Withdrawal by Subject|2|||
27783092|NCT00612456|81036420|FG000|Overall Study|Adverse Event|1|||
27783093|NCT00612456|81036421|FG001|Overall Study|Adverse Event|0|||
27783094|NCT00612456|81036422|FG002|Overall Study|Adverse Event|0|||
27783095|NCT00612456|81036420|FG000|Overall Study|Lack of Efficacy|1|||
27865288|NCT00061932|81341876|FG001|Overall Study|Withdrawal by Subject|4|||
27783096|NCT00612456|81036421|FG001|Overall Study|Lack of Efficacy|1|||
27783097|NCT00612456|81036422|FG002|Overall Study|Lack of Efficacy|0|||
27783098|NCT00612456|81036420|FG000|Overall Study|Withdrawal by Subject|0|||
27783099|NCT00612456|81036421|FG001|Overall Study|Withdrawal by Subject|1|||
27783100|NCT00612456|81036422|FG002|Overall Study|Withdrawal by Subject|0|||
27783101|NCT00526227|81036425|FG000|Overall Study|Device not implanted|1|||
27783102|NCT00526227|81036425|FG000|Overall Study|Death|1|||
27783103|NCT02608099|81036427|FG000|Overall Study|Ablation procedure not initiated|3|||
27783104|NCT02608099|81036428|FG001|Overall Study|Ablation procedure not initiated|2|||
27783105|NCT01920061|81036429|FG000|Overall Study|Death|1|||
27783106|NCT01920061|81036430|FG001|Overall Study|Death|1|||
27865289|NCT00233402|81341877|FG000|Overall Study|No pathology data|12|||
27865290|NCT00233402|81341878|FG001|Overall Study|No pathology data|9|||
27865291|NCT00233402|81341877|FG000|Overall Study|No Ta/T1|89|||
27669061|NCT00665223|80627492|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
27865292|NCT00233402|81341878|FG001|Overall Study|No Ta/T1|94|||
27669062|NCT00665223|80627493|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
27865293|NCT00233402|81341877|FG000|Overall Study|Lost to follow up etc|3|||
27783107|NCT01920061|81036431|FG002|Overall Study|Death|0|||
27783108|NCT01920061|81036432|FG003|Overall Study|Death|1|||
27783109|NCT01920061|81036433|FG004|Overall Study|Death|1|||
27783110|NCT01920061|81036434|FG005|Overall Study|Death|0|||
27783111|NCT01920061|81036435|FG006|Overall Study|Death|0|||
27783112|NCT01920061|81036436|FG007|Overall Study|Death|1|||
27783113|NCT01920061|81036437|FG008|Overall Study|Death|0|||
27783114|NCT01920061|81036438|FG009|Overall Study|Death|1|||
27783115|NCT01920061|81036439|FG010|Overall Study|Death|0|||
27783116|NCT01920061|81036440|FG011|Overall Study|Death|1|||
27783117|NCT01920061|81036441|FG012|Overall Study|Death|0|||
27783118|NCT01920061|81036442|FG013|Overall Study|Death|2|||
27783119|NCT01920061|81036443|FG014|Overall Study|Death|0|||
27783120|NCT01920061|81036444|FG015|Overall Study|Death|0|||
27783121|NCT01920061|81036445|FG016|Overall Study|Death|0|||
27783122|NCT01920061|81036446|FG017|Overall Study|Death|0|||
27783123|NCT01920061|81036447|FG018|Overall Study|Death|1|||
27783124|NCT01920061|81036448|FG019|Overall Study|Death|0|||
27783125|NCT01920061|81036429|FG000|Overall Study|Lost to Follow-up|0|||
27783126|NCT01920061|81036430|FG001|Overall Study|Lost to Follow-up|2|||
27783127|NCT01920061|81036431|FG002|Overall Study|Lost to Follow-up|0|||
27783128|NCT01920061|81036432|FG003|Overall Study|Lost to Follow-up|0|||
27783129|NCT01920061|81036433|FG004|Overall Study|Lost to Follow-up|0|||
27783130|NCT01920061|81036434|FG005|Overall Study|Lost to Follow-up|0|||
27783131|NCT01920061|81036435|FG006|Overall Study|Lost to Follow-up|1|||
27783132|NCT01920061|81036436|FG007|Overall Study|Lost to Follow-up|0|||
27783133|NCT01920061|81036437|FG008|Overall Study|Lost to Follow-up|0|||
27783134|NCT01920061|81036438|FG009|Overall Study|Lost to Follow-up|0|||
27783135|NCT01920061|81036439|FG010|Overall Study|Lost to Follow-up|3|||
27783136|NCT01920061|81036440|FG011|Overall Study|Lost to Follow-up|0|||
27783137|NCT01920061|81036441|FG012|Overall Study|Lost to Follow-up|0|||
27783138|NCT01920061|81036442|FG013|Overall Study|Lost to Follow-up|0|||
27783139|NCT01920061|81036443|FG014|Overall Study|Lost to Follow-up|0|||
27783140|NCT01920061|81036444|FG015|Overall Study|Lost to Follow-up|0|||
27783141|NCT01920061|81036445|FG016|Overall Study|Lost to Follow-up|0|||
27783142|NCT01920061|81036446|FG017|Overall Study|Lost to Follow-up|1|||
27783143|NCT01920061|81036447|FG018|Overall Study|Lost to Follow-up|4|||
27783144|NCT01920061|81036448|FG019|Overall Study|Lost to Follow-up|3|||
27783145|NCT01920061|81036429|FG000|Overall Study|Other|1|||
27783146|NCT01920061|81036430|FG001|Overall Study|Other|1|||
27783147|NCT01920061|81036431|FG002|Overall Study|Other|2|||
27783148|NCT01920061|81036432|FG003|Overall Study|Other|1|||
27783149|NCT01920061|81036433|FG004|Overall Study|Other|0|||
27783150|NCT01920061|81036434|FG005|Overall Study|Other|1|||
27783151|NCT01920061|81036435|FG006|Overall Study|Other|0|||
27783152|NCT01920061|81036436|FG007|Overall Study|Other|0|||
27783153|NCT01920061|81036437|FG008|Overall Study|Other|0|||
27783154|NCT01920061|81036438|FG009|Overall Study|Other|1|||
27783155|NCT01920061|81036439|FG010|Overall Study|Other|1|||
27783156|NCT01920061|81036440|FG011|Overall Study|Other|2|||
27783157|NCT01920061|81036441|FG012|Overall Study|Other|1|||
27865294|NCT00233402|81341878|FG001|Overall Study|Lost to follow up etc|21|||
27865295|NCT02445963|81341879|FG000|Overall Study|Lost to Follow-up|1|||
27865296|NCT02445963|81341880|FG001|Overall Study|Lost to Follow-up|0|||
27865297|NCT02445963|81341881|FG002|Overall Study|Lost to Follow-up|0|||
27865298|NCT02445963|81341882|FG003|Overall Study|Lost to Follow-up|0|||
27865299|NCT02445963|81341879|FG000|Overall Study|Change in employment|1|||
27865300|NCT02445963|81341880|FG001|Overall Study|Change in employment|0|||
27865301|NCT02445963|81341881|FG002|Overall Study|Change in employment|0|||
27865302|NCT02445963|81341882|FG003|Overall Study|Change in employment|0|||
27865303|NCT02445963|81341879|FG000|Overall Study|Symptoms post-vaccination|0|||
27865304|NCT02445963|81341880|FG001|Overall Study|Symptoms post-vaccination|0|||
27865305|NCT02445963|81341881|FG002|Overall Study|Symptoms post-vaccination|1|||
27865306|NCT02445963|81341882|FG003|Overall Study|Symptoms post-vaccination|0|||
27865307|NCT01644617|81341883|FG000|Overall Study|Withdrawal by Subject|3|||
27865308|NCT01644617|81341884|FG001|Overall Study|Withdrawal by Subject|4|||
27865309|NCT01644617|81341885|FG002|Overall Study|Withdrawal by Subject|1|||
27865310|NCT01644617|81341883|FG000|Overall Study|Lost to Follow-up|0|||
27865311|NCT01644617|81341884|FG001|Overall Study|Lost to Follow-up|1|||
27865312|NCT01644617|81341885|FG002|Overall Study|Lost to Follow-up|0|||
27865313|NCT01644617|81341883|FG000|Overall Study|Adverse Event|3|||
27783158|NCT01920061|81036442|FG013|Overall Study|Other|4|||
27783159|NCT01920061|81036443|FG014|Overall Study|Other|0|||
27865314|NCT01644617|81341884|FG001|Overall Study|Adverse Event|0|||
27865315|NCT01644617|81341885|FG002|Overall Study|Adverse Event|6|||
27865316|NCT01998841|81341886|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
27865317|NCT01998841|81341887|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
27783160|NCT01920061|81036444|FG015|Overall Study|Other|1|||
27783161|NCT01920061|81036445|FG016|Overall Study|Other|1|||
27783162|NCT01920061|81036446|FG017|Overall Study|Other|0|||
27783163|NCT01920061|81036447|FG018|Overall Study|Other|1|||
27783164|NCT01920061|81036448|FG019|Overall Study|Other|1|||
27783165|NCT01920061|81036429|FG000|Overall Study|Participant refused further follow-up|0|||
27783166|NCT01920061|81036430|FG001|Overall Study|Participant refused further follow-up|0|||
27783167|NCT01920061|81036431|FG002|Overall Study|Participant refused further follow-up|0|||
27783168|NCT01920061|81036432|FG003|Overall Study|Participant refused further follow-up|0|||
27783169|NCT01920061|81036433|FG004|Overall Study|Participant refused further follow-up|1|||
27783170|NCT01920061|81036434|FG005|Overall Study|Participant refused further follow-up|1|||
27783171|NCT01920061|81036435|FG006|Overall Study|Participant refused further follow-up|0|||
27783172|NCT01920061|81036436|FG007|Overall Study|Participant refused further follow-up|0|||
27783173|NCT01920061|81036437|FG008|Overall Study|Participant refused further follow-up|1|||
27783174|NCT01920061|81036438|FG009|Overall Study|Participant refused further follow-up|0|||
27783175|NCT01920061|81036439|FG010|Overall Study|Participant refused further follow-up|1|||
27783176|NCT01920061|81036440|FG011|Overall Study|Participant refused further follow-up|0|||
27783177|NCT01920061|81036441|FG012|Overall Study|Participant refused further follow-up|1|||
27783178|NCT01920061|81036442|FG013|Overall Study|Participant refused further follow-up|0|||
27783179|NCT01920061|81036443|FG014|Overall Study|Participant refused further follow-up|1|||
27783180|NCT01920061|81036444|FG015|Overall Study|Participant refused further follow-up|2|||
27783181|NCT01920061|81036445|FG016|Overall Study|Participant refused further follow-up|1|||
27783182|NCT01920061|81036446|FG017|Overall Study|Participant refused further follow-up|1|||
27783183|NCT01920061|81036447|FG018|Overall Study|Participant refused further follow-up|0|||
27783184|NCT01920061|81036448|FG019|Overall Study|Participant refused further follow-up|0|||
27783185|NCT01218477|81036450|FG000|Overall Study|Disease progression|2|||
27783186|NCT01218477|81036451|FG001|Overall Study|Disease progression|3|||
27783187|NCT01218477|81036452|FG002|Overall Study|Disease progression|6|||
27783188|NCT01218477|81036453|FG003|Overall Study|Disease progression|2|||
27783189|NCT01218477|81036450|FG000|Overall Study|Study drug toxicity|0|||
27783190|NCT01218477|81036451|FG001|Overall Study|Study drug toxicity|2|||
27783191|NCT01218477|81036452|FG002|Overall Study|Study drug toxicity|5|||
27783192|NCT01218477|81036453|FG003|Overall Study|Study drug toxicity|0|||
27783193|NCT01218477|81036450|FG000|Overall Study|No longer meets study criteria|1|||
27783194|NCT01218477|81036451|FG001|Overall Study|No longer meets study criteria|0|||
27783195|NCT01218477|81036452|FG002|Overall Study|No longer meets study criteria|0|||
27783196|NCT01218477|81036453|FG003|Overall Study|No longer meets study criteria|0|||
27783197|NCT01218477|81036450|FG000|Overall Study|Withdrawal by Subject|0|||
27783198|NCT01218477|81036451|FG001|Overall Study|Withdrawal by Subject|0|||
27783199|NCT01218477|81036452|FG002|Overall Study|Withdrawal by Subject|1|||
27783200|NCT01218477|81036453|FG003|Overall Study|Withdrawal by Subject|0|||
27783201|NCT01218477|81036450|FG000|Overall Study|Prepared for cell transplantation|0|||
27783202|NCT01218477|81036451|FG001|Overall Study|Prepared for cell transplantation|1|||
27783203|NCT01218477|81036452|FG002|Overall Study|Prepared for cell transplantation|1|||
27783204|NCT01218477|81036453|FG003|Overall Study|Prepared for cell transplantation|0|||
27783205|NCT01218477|81036450|FG000|Overall Study|Administrative reason by sponsor|0|||
27783206|NCT01218477|81036451|FG001|Overall Study|Administrative reason by sponsor|0|||
27783207|NCT01218477|81036452|FG002|Overall Study|Administrative reason by sponsor|1|||
27783208|NCT01218477|81036453|FG003|Overall Study|Administrative reason by sponsor|0|||
27783209|NCT01218477|81036450|FG000|Overall Study|Maximum clinical benefit|0|||
27783210|NCT01218477|81036451|FG001|Overall Study|Maximum clinical benefit|2|||
27783211|NCT01218477|81036452|FG002|Overall Study|Maximum clinical benefit|0|||
27783212|NCT01218477|81036453|FG003|Overall Study|Maximum clinical benefit|0|||
27783213|NCT03225833|81036457|FG000|Overall Study|Adverse Event|0|||
27783214|NCT03225833|81036458|FG001|Overall Study|Adverse Event|1|||
27783215|NCT03225833|81036459|FG002|Overall Study|Adverse Event|2|||
27783216|NCT03225833|81036460|FG003|Overall Study|Adverse Event|0|||
27783217|NCT03225833|81036461|FG004|Overall Study|Adverse Event|0|||
27783218|NCT03225833|81036462|FG005|Overall Study|Adverse Event|2|||
27783219|NCT03225833|81036457|FG000|Overall Study|Withdrawal by Subject|1|||
27783220|NCT03225833|81036458|FG001|Overall Study|Withdrawal by Subject|0|||
27783221|NCT03225833|81036459|FG002|Overall Study|Withdrawal by Subject|0|||
27783222|NCT03225833|81036460|FG003|Overall Study|Withdrawal by Subject|0|||
27783223|NCT03225833|81036461|FG004|Overall Study|Withdrawal by Subject|1|||
27783224|NCT03225833|81036462|FG005|Overall Study|Withdrawal by Subject|0|||
27783225|NCT03225833|81036457|FG000|Overall Study|Termination of Study by Sponsor|4|||
27783226|NCT03225833|81036458|FG001|Overall Study|Termination of Study by Sponsor|0|||
27783227|NCT03225833|81036459|FG002|Overall Study|Termination of Study by Sponsor|0|||
27783228|NCT03225833|81036460|FG003|Overall Study|Termination of Study by Sponsor|0|||
27669063|NCT00665223|80627491|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
27783229|NCT03225833|81036461|FG004|Overall Study|Termination of Study by Sponsor|0|||
27783230|NCT03225833|81036462|FG005|Overall Study|Termination of Study by Sponsor|7|||
27783231|NCT03225833|81036457|FG000|Overall Study|Sponsor Decision|0|||
27783232|NCT03225833|81036458|FG001|Overall Study|Sponsor Decision|0|||
27783233|NCT03225833|81036459|FG002|Overall Study|Sponsor Decision|0|||
27783234|NCT03225833|81036460|FG003|Overall Study|Sponsor Decision|0|||
27783235|NCT03225833|81036461|FG004|Overall Study|Sponsor Decision|0|||
27783236|NCT03225833|81036462|FG005|Overall Study|Sponsor Decision|1|||
27783237|NCT01673373|81036463|FG000|Overall Study|Death|2|||
27783238|NCT00784836|81036464|FG000|Overall Study|Early Study Termination|3|||
27783239|NCT03143855|81036467|FG000|Overall Study|Withdrawal by Subject|4|||
27783240|NCT03143855|81036468|FG001|Overall Study|Withdrawal by Subject|3|||
27783241|NCT03143855|81036467|FG000|Overall Study|Protocol Violation|1|||
27783242|NCT03143855|81036468|FG001|Overall Study|Protocol Violation|0|||
27783243|NCT03143855|81036467|FG000|Overall Study|Participant experienced withdrawal|0|||
27783244|NCT03143855|81036468|FG001|Overall Study|Participant experienced withdrawal|1|||
27783245|NCT01117428|81036469|FG000|Overall Study|Lack of Efficacy|1|||
27783246|NCT01117428|81036470|FG001|Overall Study|Lack of Efficacy|0|||
27783247|NCT01117428|81036471|FG002|Overall Study|Lack of Efficacy|0|||
27783248|NCT01117428|81036472|FG003|Overall Study|Lack of Efficacy|0|||
27783249|NCT01117428|81036473|FG004|Overall Study|Lack of Efficacy|0|||
27783250|NCT01117428|81036474|FG005|Overall Study|Lack of Efficacy|0|||
27783251|NCT01117428|81036469|FG000|Overall Study|Adverse Event|4|||
27783252|NCT01117428|81036470|FG001|Overall Study|Adverse Event|0|||
27783253|NCT01117428|81036471|FG002|Overall Study|Adverse Event|0|||
27783254|NCT01117428|81036472|FG003|Overall Study|Adverse Event|0|||
27783255|NCT01117428|81036473|FG004|Overall Study|Adverse Event|1|||
27783256|NCT01117428|81036474|FG005|Overall Study|Adverse Event|2|||
27783257|NCT01117428|81036469|FG000|Overall Study|Death|0|||
27783258|NCT01117428|81036470|FG001|Overall Study|Death|1|||
27783259|NCT01117428|81036471|FG002|Overall Study|Death|2|||
27783260|NCT01117428|81036472|FG003|Overall Study|Death|0|||
27783261|NCT01117428|81036473|FG004|Overall Study|Death|0|||
27783262|NCT01117428|81036474|FG005|Overall Study|Death|1|||
27783263|NCT01117428|81036469|FG000|Overall Study|Physician Decision|0|||
27783264|NCT01117428|81036470|FG001|Overall Study|Physician Decision|1|||
27783265|NCT01117428|81036471|FG002|Overall Study|Physician Decision|0|||
27783266|NCT01117428|81036472|FG003|Overall Study|Physician Decision|0|||
27783267|NCT01117428|81036473|FG004|Overall Study|Physician Decision|0|||
27783268|NCT01117428|81036474|FG005|Overall Study|Physician Decision|0|||
27783269|NCT01117428|81036469|FG000|Overall Study|Withdrawal by Subject|0|||
27783270|NCT01117428|81036470|FG001|Overall Study|Withdrawal by Subject|0|||
27783271|NCT01117428|81036471|FG002|Overall Study|Withdrawal by Subject|1|||
27783272|NCT01117428|81036472|FG003|Overall Study|Withdrawal by Subject|0|||
27783273|NCT01117428|81036473|FG004|Overall Study|Withdrawal by Subject|0|||
27783274|NCT01117428|81036474|FG005|Overall Study|Withdrawal by Subject|0|||
27783275|NCT01117428|81036469|FG000|Overall Study|Progressive disease|15|||
27783276|NCT01117428|81036470|FG001|Overall Study|Progressive disease|27|||
27783277|NCT01117428|81036471|FG002|Overall Study|Progressive disease|10|||
27783278|NCT01117428|81036472|FG003|Overall Study|Progressive disease|12|||
27783279|NCT01117428|81036473|FG004|Overall Study|Progressive disease|16|||
27783280|NCT01117428|81036474|FG005|Overall Study|Progressive disease|17|||
27783281|NCT01875731|81036475|FG000|Overall Study|Fail to obtain lab sample|1|||
27783282|NCT01875731|81036476|FG001|Overall Study|Fail to obtain lab sample|0|||
27783283|NCT01724021|81036477|FG000|Overall Study|Adverse Event|11|||
27783284|NCT01724021|81036478|FG001|Overall Study|Adverse Event|6|||
27783285|NCT01724021|81036477|FG000|Overall Study|Death|46|||
27783286|NCT01724021|81036478|FG001|Overall Study|Death|58|||
27783287|NCT01724021|81036477|FG000|Overall Study|Participant request/ Withdrew consent|18|||
27783288|NCT01724021|81036478|FG001|Overall Study|Participant request/ Withdrew consent|14|||
27783289|NCT01724021|81036477|FG000|Overall Study|Lost to Follow-up|15|||
27783290|NCT01724021|81036478|FG001|Overall Study|Lost to Follow-up|15|||
27783291|NCT01724021|81036477|FG000|Overall Study|Reason Not Specified|36|||
27783292|NCT01724021|81036478|FG001|Overall Study|Reason Not Specified|39|||
27783293|NCT01724021|81036477|FG000|Overall Study|Missing|1|||
27783294|NCT01724021|81036478|FG001|Overall Study|Missing|1|||
27783295|NCT04249076|81036479|FG000|Overall Study|Adverse Event|1|||
27783296|NCT04249076|81036480|FG001|Overall Study|Adverse Event|1|||
27783297|NCT04249076|81036479|FG000|Overall Study|Protocol Violation|1|||
27783298|NCT04249076|81036480|FG001|Overall Study|Protocol Violation|2|||
27783299|NCT04249076|81036479|FG000|Overall Study|Lack of Efficacy|0|||
27783300|NCT04249076|81036480|FG001|Overall Study|Lack of Efficacy|1|||
27783301|NCT04249076|81036479|FG000|Overall Study|Withdrawal by Subject|0|||
27783302|NCT04249076|81036480|FG001|Overall Study|Withdrawal by Subject|1|||
27783303|NCT01049360|81036486|FG000|Period 1|Adverse Event|0|||
27783304|NCT01049360|81036487|FG001|Period 1|Adverse Event|1|||
27783305|NCT01049360|81036488|FG002|Period 1|Adverse Event|0|||
27783306|NCT01049360|81036489|FG003|Period 1|Adverse Event|1|||
27783307|NCT01049360|81036490|FG004|Period 1|Adverse Event|0|||
27783308|NCT01049360|81036491|FG005|Period 1|Adverse Event|0|||
27783309|NCT01049360|81036492|FG006|Period 1|Adverse Event|0|||
27783310|NCT01049360|81036493|FG007|Period 1|Adverse Event|1|||
27783311|NCT01049360|81036494|FG008|Period 1|Adverse Event|0|||
27783312|NCT01049360|81036495|FG009|Period 1|Adverse Event|0|||
27783313|NCT01049360|81036496|FG010|Period 1|Adverse Event|0|||
27783314|NCT01049360|81036497|FG011|Period 1|Adverse Event|0|||
27783315|NCT01049360|81036498|FG012|Period 1|Adverse Event|1|||
27783316|NCT01049360|81036499|FG013|Period 1|Adverse Event|1|||
27783317|NCT01049360|81036500|FG014|Period 1|Adverse Event|0|||
27783318|NCT01049360|81036501|FG015|Period 1|Adverse Event|0|||
27783319|NCT01049360|81036502|FG016|Period 1|Adverse Event|1|||
27783320|NCT01049360|81036503|FG017|Period 1|Adverse Event|0|||
27783321|NCT01049360|81036504|FG018|Period 1|Adverse Event|1|||
27783322|NCT01049360|81036505|FG019|Period 1|Adverse Event|0|||
27783323|NCT01049360|81036486|FG000|Period 1|Did not meet inc/exc criteria|0|||
27783324|NCT01049360|81036487|FG001|Period 1|Did not meet inc/exc criteria|0|||
27783325|NCT01049360|81036488|FG002|Period 1|Did not meet inc/exc criteria|0|||
27783326|NCT01049360|81036489|FG003|Period 1|Did not meet inc/exc criteria|0|||
27783327|NCT01049360|81036490|FG004|Period 1|Did not meet inc/exc criteria|0|||
27783328|NCT01049360|81036491|FG005|Period 1|Did not meet inc/exc criteria|0|||
27783329|NCT01049360|81036492|FG006|Period 1|Did not meet inc/exc criteria|0|||
27783330|NCT01049360|81036493|FG007|Period 1|Did not meet inc/exc criteria|1|||
27783331|NCT01049360|81036494|FG008|Period 1|Did not meet inc/exc criteria|1|||
27783332|NCT01049360|81036495|FG009|Period 1|Did not meet inc/exc criteria|0|||
27783333|NCT01049360|81036496|FG010|Period 1|Did not meet inc/exc criteria|0|||
27783334|NCT01049360|81036497|FG011|Period 1|Did not meet inc/exc criteria|0|||
27783335|NCT01049360|81036498|FG012|Period 1|Did not meet inc/exc criteria|0|||
27783336|NCT01049360|81036499|FG013|Period 1|Did not meet inc/exc criteria|0|||
27783337|NCT01049360|81036500|FG014|Period 1|Did not meet inc/exc criteria|0|||
27783338|NCT01049360|81036501|FG015|Period 1|Did not meet inc/exc criteria|0|||
27783339|NCT01049360|81036502|FG016|Period 1|Did not meet inc/exc criteria|0|||
27783340|NCT01049360|81036503|FG017|Period 1|Did not meet inc/exc criteria|0|||
27783341|NCT01049360|81036504|FG018|Period 1|Did not meet inc/exc criteria|0|||
27783342|NCT01049360|81036505|FG019|Period 1|Did not meet inc/exc criteria|0|||
27783343|NCT01049360|81036486|FG000|Period 1|Withdrawal by Subject|0|||
27783344|NCT01049360|81036487|FG001|Period 1|Withdrawal by Subject|0|||
27783345|NCT01049360|81036488|FG002|Period 1|Withdrawal by Subject|0|||
27783346|NCT01049360|81036489|FG003|Period 1|Withdrawal by Subject|0|||
27783347|NCT01049360|81036490|FG004|Period 1|Withdrawal by Subject|0|||
27783348|NCT01049360|81036491|FG005|Period 1|Withdrawal by Subject|0|||
27783349|NCT01049360|81036492|FG006|Period 1|Withdrawal by Subject|0|||
27783350|NCT01049360|81036493|FG007|Period 1|Withdrawal by Subject|0|||
27783351|NCT01049360|81036494|FG008|Period 1|Withdrawal by Subject|1|||
27783352|NCT01049360|81036495|FG009|Period 1|Withdrawal by Subject|0|||
27783353|NCT01049360|81036496|FG010|Period 1|Withdrawal by Subject|1|||
27783354|NCT01049360|81036497|FG011|Period 1|Withdrawal by Subject|0|||
27783355|NCT01049360|81036498|FG012|Period 1|Withdrawal by Subject|1|||
27783356|NCT01049360|81036499|FG013|Period 1|Withdrawal by Subject|0|||
27783357|NCT01049360|81036500|FG014|Period 1|Withdrawal by Subject|0|||
27783358|NCT01049360|81036501|FG015|Period 1|Withdrawal by Subject|0|||
27783359|NCT01049360|81036502|FG016|Period 1|Withdrawal by Subject|0|||
27783360|NCT01049360|81036503|FG017|Period 1|Withdrawal by Subject|0|||
27783361|NCT01049360|81036504|FG018|Period 1|Withdrawal by Subject|0|||
27783362|NCT01049360|81036505|FG019|Period 1|Withdrawal by Subject|0|||
27783363|NCT01049360|81036486|FG000|Period 2|Protocol Violation|0|||
27783364|NCT01049360|81036487|FG001|Period 2|Protocol Violation|0|||
27783365|NCT01049360|81036488|FG002|Period 2|Protocol Violation|0|||
27783366|NCT01049360|81036489|FG003|Period 2|Protocol Violation|1|||
27783367|NCT01049360|81036490|FG004|Period 2|Protocol Violation|0|||
27783368|NCT01049360|81036491|FG005|Period 2|Protocol Violation|0|||
27783369|NCT01049360|81036492|FG006|Period 2|Protocol Violation|0|||
27783370|NCT01049360|81036493|FG007|Period 2|Protocol Violation|0|||
27783371|NCT01049360|81036494|FG008|Period 2|Protocol Violation|0|||
27783372|NCT01049360|81036495|FG009|Period 2|Protocol Violation|0|||
27783373|NCT01049360|81036496|FG010|Period 2|Protocol Violation|0|||
27783374|NCT01049360|81036497|FG011|Period 2|Protocol Violation|0|||
27783375|NCT01049360|81036498|FG012|Period 2|Protocol Violation|0|||
27783376|NCT01049360|81036499|FG013|Period 2|Protocol Violation|0|||
27783377|NCT01049360|81036500|FG014|Period 2|Protocol Violation|1|||
27783378|NCT01049360|81036501|FG015|Period 2|Protocol Violation|1|||
27783379|NCT01049360|81036502|FG016|Period 2|Protocol Violation|0|||
27783380|NCT01049360|81036503|FG017|Period 2|Protocol Violation|0|||
27783381|NCT01049360|81036504|FG018|Period 2|Protocol Violation|0|||
27783382|NCT01049360|81036505|FG019|Period 2|Protocol Violation|0|||
27783383|NCT01049360|81036486|FG000|Period 2|Adverse Event|0|||
27783384|NCT01049360|81036487|FG001|Period 2|Adverse Event|1|||
27783385|NCT01049360|81036488|FG002|Period 2|Adverse Event|0|||
27783386|NCT01049360|81036489|FG003|Period 2|Adverse Event|0|||
27783387|NCT01049360|81036490|FG004|Period 2|Adverse Event|0|||
27783388|NCT01049360|81036491|FG005|Period 2|Adverse Event|0|||
27783389|NCT01049360|81036492|FG006|Period 2|Adverse Event|0|||
27783390|NCT01049360|81036493|FG007|Period 2|Adverse Event|0|||
27783391|NCT01049360|81036494|FG008|Period 2|Adverse Event|1|||
27783392|NCT01049360|81036495|FG009|Period 2|Adverse Event|0|||
27783393|NCT01049360|81036496|FG010|Period 2|Adverse Event|0|||
27783394|NCT01049360|81036497|FG011|Period 2|Adverse Event|0|||
27783395|NCT01049360|81036498|FG012|Period 2|Adverse Event|0|||
27783396|NCT01049360|81036499|FG013|Period 2|Adverse Event|0|||
27783397|NCT01049360|81036500|FG014|Period 2|Adverse Event|0|||
27783398|NCT01049360|81036501|FG015|Period 2|Adverse Event|0|||
27783399|NCT01049360|81036502|FG016|Period 2|Adverse Event|0|||
27783400|NCT01049360|81036503|FG017|Period 2|Adverse Event|0|||
27783401|NCT01049360|81036504|FG018|Period 2|Adverse Event|0|||
27783402|NCT01049360|81036505|FG019|Period 2|Adverse Event|1|||
27783403|NCT01049360|81036486|FG000|Period 2|Withdrawal by Subject|0|||
27783404|NCT01049360|81036487|FG001|Period 2|Withdrawal by Subject|0|||
27783405|NCT01049360|81036488|FG002|Period 2|Withdrawal by Subject|0|||
27783406|NCT01049360|81036489|FG003|Period 2|Withdrawal by Subject|1|||
27783407|NCT01049360|81036490|FG004|Period 2|Withdrawal by Subject|0|||
27783408|NCT01049360|81036491|FG005|Period 2|Withdrawal by Subject|0|||
27783409|NCT01049360|81036492|FG006|Period 2|Withdrawal by Subject|0|||
27783410|NCT01049360|81036493|FG007|Period 2|Withdrawal by Subject|0|||
27783411|NCT01049360|81036494|FG008|Period 2|Withdrawal by Subject|0|||
27783412|NCT01049360|81036495|FG009|Period 2|Withdrawal by Subject|0|||
27783413|NCT01049360|81036496|FG010|Period 2|Withdrawal by Subject|0|||
27783414|NCT01049360|81036497|FG011|Period 2|Withdrawal by Subject|0|||
27783415|NCT01049360|81036498|FG012|Period 2|Withdrawal by Subject|0|||
27783416|NCT01049360|81036499|FG013|Period 2|Withdrawal by Subject|0|||
27783417|NCT01049360|81036500|FG014|Period 2|Withdrawal by Subject|1|||
27783418|NCT01049360|81036501|FG015|Period 2|Withdrawal by Subject|0|||
27783419|NCT01049360|81036502|FG016|Period 2|Withdrawal by Subject|0|||
27783420|NCT01049360|81036503|FG017|Period 2|Withdrawal by Subject|0|||
27783421|NCT01049360|81036504|FG018|Period 2|Withdrawal by Subject|0|||
27783422|NCT01049360|81036505|FG019|Period 2|Withdrawal by Subject|1|||
27783423|NCT01049360|81036486|FG000|Period 2|Lack of Efficacy|0|||
27783424|NCT01049360|81036487|FG001|Period 2|Lack of Efficacy|0|||
27783425|NCT01049360|81036488|FG002|Period 2|Lack of Efficacy|0|||
27783426|NCT01049360|81036489|FG003|Period 2|Lack of Efficacy|0|||
27783427|NCT01049360|81036490|FG004|Period 2|Lack of Efficacy|0|||
27783428|NCT01049360|81036491|FG005|Period 2|Lack of Efficacy|1|||
27783429|NCT01049360|81036492|FG006|Period 2|Lack of Efficacy|0|||
27783430|NCT01049360|81036493|FG007|Period 2|Lack of Efficacy|0|||
27783431|NCT01049360|81036494|FG008|Period 2|Lack of Efficacy|0|||
27783432|NCT01049360|81036495|FG009|Period 2|Lack of Efficacy|0|||
27783433|NCT01049360|81036496|FG010|Period 2|Lack of Efficacy|0|||
27783434|NCT01049360|81036497|FG011|Period 2|Lack of Efficacy|0|||
27783435|NCT01049360|81036498|FG012|Period 2|Lack of Efficacy|0|||
27783436|NCT01049360|81036499|FG013|Period 2|Lack of Efficacy|0|||
27783437|NCT01049360|81036500|FG014|Period 2|Lack of Efficacy|0|||
27783438|NCT01049360|81036501|FG015|Period 2|Lack of Efficacy|0|||
27783439|NCT01049360|81036502|FG016|Period 2|Lack of Efficacy|0|||
27783440|NCT01049360|81036503|FG017|Period 2|Lack of Efficacy|0|||
27783441|NCT01049360|81036504|FG018|Period 2|Lack of Efficacy|0|||
27783442|NCT01049360|81036505|FG019|Period 2|Lack of Efficacy|0|||
27783443|NCT01049360|81036486|FG000|Period 4|Protocol Violation|0|||
27783444|NCT01049360|81036487|FG001|Period 4|Protocol Violation|0|||
27783445|NCT01049360|81036488|FG002|Period 4|Protocol Violation|0|||
27783446|NCT01049360|81036489|FG003|Period 4|Protocol Violation|0|||
27783447|NCT01049360|81036490|FG004|Period 4|Protocol Violation|0|||
27783448|NCT01049360|81036491|FG005|Period 4|Protocol Violation|0|||
27783449|NCT01049360|81036492|FG006|Period 4|Protocol Violation|0|||
27783450|NCT01049360|81036493|FG007|Period 4|Protocol Violation|0|||
27783451|NCT01049360|81036494|FG008|Period 4|Protocol Violation|0|||
27783452|NCT01049360|81036495|FG009|Period 4|Protocol Violation|0|||
27783453|NCT01049360|81036496|FG010|Period 4|Protocol Violation|0|||
27783454|NCT01049360|81036497|FG011|Period 4|Protocol Violation|0|||
27783455|NCT01049360|81036498|FG012|Period 4|Protocol Violation|0|||
27783456|NCT01049360|81036499|FG013|Period 4|Protocol Violation|0|||
27783457|NCT01049360|81036500|FG014|Period 4|Protocol Violation|0|||
27783458|NCT01049360|81036501|FG015|Period 4|Protocol Violation|0|||
27783459|NCT01049360|81036502|FG016|Period 4|Protocol Violation|0|||
27783460|NCT01049360|81036503|FG017|Period 4|Protocol Violation|1|||
27783461|NCT01049360|81036504|FG018|Period 4|Protocol Violation|0|||
27783462|NCT01049360|81036505|FG019|Period 4|Protocol Violation|0|||
27783463|NCT01049360|81036486|FG000|Period 4|Withdrawal by Subject|0|||
27783464|NCT01049360|81036487|FG001|Period 4|Withdrawal by Subject|0|||
27783465|NCT01049360|81036488|FG002|Period 4|Withdrawal by Subject|0|||
27783466|NCT01049360|81036489|FG003|Period 4|Withdrawal by Subject|1|||
27783467|NCT01049360|81036490|FG004|Period 4|Withdrawal by Subject|0|||
27783468|NCT01049360|81036491|FG005|Period 4|Withdrawal by Subject|0|||
27783469|NCT01049360|81036492|FG006|Period 4|Withdrawal by Subject|0|||
27783470|NCT01049360|81036493|FG007|Period 4|Withdrawal by Subject|0|||
27783471|NCT01049360|81036494|FG008|Period 4|Withdrawal by Subject|0|||
27783472|NCT01049360|81036495|FG009|Period 4|Withdrawal by Subject|0|||
27783473|NCT01049360|81036496|FG010|Period 4|Withdrawal by Subject|0|||
27783474|NCT01049360|81036497|FG011|Period 4|Withdrawal by Subject|0|||
27783475|NCT01049360|81036498|FG012|Period 4|Withdrawal by Subject|0|||
27783476|NCT01049360|81036499|FG013|Period 4|Withdrawal by Subject|0|||
27783477|NCT01049360|81036500|FG014|Period 4|Withdrawal by Subject|0|||
27783478|NCT01049360|81036501|FG015|Period 4|Withdrawal by Subject|0|||
27783479|NCT01049360|81036502|FG016|Period 4|Withdrawal by Subject|0|||
27783480|NCT01049360|81036503|FG017|Period 4|Withdrawal by Subject|0|||
27783481|NCT01049360|81036504|FG018|Period 4|Withdrawal by Subject|0|||
27783482|NCT01049360|81036505|FG019|Period 4|Withdrawal by Subject|0|||
27783483|NCT03958149|81036506|FG000|Overall Study|Withdrawal by Subject|0|||
27783484|NCT03958149|81036507|FG001|Overall Study|Withdrawal by Subject|1|||
27783485|NCT00568399|81036508|FG000|Overall Study|Death|2|||
27783486|NCT00568399|81036508|FG000|Overall Study|Adverse Event|5|||
27783487|NCT00568399|81036508|FG000|Overall Study|Withdrawal by Subject|8|||
27783488|NCT02719028|81036511|FG000|Overall Study|Adverse Event|2|||
27783489|NCT02719028|81036512|FG001|Overall Study|Adverse Event|1|||
27783490|NCT02719028|81036513|FG002|Overall Study|Adverse Event|4|||
27783491|NCT02719028|81036514|FG003|Overall Study|Adverse Event|8|||
27783492|NCT02719028|81036511|FG000|Overall Study|Physician Decision|0|||
27783493|NCT02719028|81036512|FG001|Overall Study|Physician Decision|1|||
27783494|NCT02719028|81036513|FG002|Overall Study|Physician Decision|1|||
27783495|NCT02719028|81036514|FG003|Overall Study|Physician Decision|1|||
27783496|NCT02719028|81036511|FG000|Overall Study|Use of prohibited medication|0|||
27783497|NCT02719028|81036512|FG001|Overall Study|Use of prohibited medication|0|||
27783498|NCT02719028|81036513|FG002|Overall Study|Use of prohibited medication|1|||
27783499|NCT02719028|81036514|FG003|Overall Study|Use of prohibited medication|0|||
27783500|NCT02719028|81036511|FG000|Overall Study|Protocol Violation|0|||
27783501|NCT02719028|81036512|FG001|Overall Study|Protocol Violation|0|||
27783502|NCT02719028|81036513|FG002|Overall Study|Protocol Violation|0|||
27783503|NCT02719028|81036514|FG003|Overall Study|Protocol Violation|1|||
27783504|NCT00620815|81036515|FG000|Overall Study|Adverse Event|1|||
27783505|NCT00620815|81036516|FG001|Overall Study|Adverse Event|1|||
27783506|NCT00620815|81036517|FG002|Overall Study|Adverse Event|2|||
27783507|NCT00620815|81036515|FG000|Overall Study|Withdrawal by Subject|1|||
27783508|NCT00620815|81036516|FG001|Overall Study|Withdrawal by Subject|2|||
27783509|NCT00620815|81036517|FG002|Overall Study|Withdrawal by Subject|0|||
27783510|NCT00620815|81036515|FG000|Overall Study|Lost to Follow-up|1|||
27783511|NCT00620815|81036516|FG001|Overall Study|Lost to Follow-up|6|||
27783512|NCT00620815|81036517|FG002|Overall Study|Lost to Follow-up|3|||
27783513|NCT00620815|81036515|FG000|Overall Study|Inappropriate enrolment|0|||
27783514|NCT00620815|81036516|FG001|Overall Study|Inappropriate enrolment|0|||
27783515|NCT00620815|81036517|FG002|Overall Study|Inappropriate enrolment|1|||
27783516|NCT00620815|81036515|FG000|Overall Study|Protocol Violation|1|||
27783517|NCT00620815|81036516|FG001|Overall Study|Protocol Violation|2|||
27783518|NCT00620815|81036517|FG002|Overall Study|Protocol Violation|1|||
27783519|NCT02828982|81036518|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27783520|NCT02828982|81036519|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27783521|NCT02583399|81036520|FG000|Overall Study|Able to be discharged|3|||
27783522|NCT02583399|81036520|FG000|Overall Study|Wanted to use a restricted medication|3|||
27783523|NCT01977573|81036521|FG000|Overall Study|Adverse Event|7|||
27783524|NCT01977573|81036522|FG001|Overall Study|Adverse Event|0|||
27783525|NCT01977573|81036523|FG002|Overall Study|Adverse Event|2|||
27783526|NCT01977573|81036524|FG003|Overall Study|Adverse Event|1|||
27783527|NCT01977573|81036521|FG000|Overall Study|Lost to Follow-up|1|||
27783528|NCT01977573|81036522|FG001|Overall Study|Lost to Follow-up|0|||
27783529|NCT01977573|81036523|FG002|Overall Study|Lost to Follow-up|0|||
27783530|NCT01977573|81036524|FG003|Overall Study|Lost to Follow-up|1|||
27783531|NCT01977573|81036521|FG000|Overall Study|Physician Decision|1|||
27783532|NCT01977573|81036522|FG001|Overall Study|Physician Decision|0|||
27783533|NCT01977573|81036523|FG002|Overall Study|Physician Decision|0|||
27783534|NCT01977573|81036524|FG003|Overall Study|Physician Decision|0|||
27783535|NCT01977573|81036521|FG000|Overall Study|Protocol Violation|3|||
27783536|NCT01977573|81036522|FG001|Overall Study|Protocol Violation|1|||
27783537|NCT01977573|81036523|FG002|Overall Study|Protocol Violation|0|||
27783538|NCT01977573|81036524|FG003|Overall Study|Protocol Violation|0|||
27783539|NCT01977573|81036521|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
27783540|NCT01977573|81036522|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
27783541|NCT01977573|81036523|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
27783542|NCT01977573|81036524|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
27783543|NCT01977573|81036521|FG000|Overall Study|Withdrawal by Subject|6|||
27783544|NCT01977573|81036522|FG001|Overall Study|Withdrawal by Subject|1|||
27783545|NCT01977573|81036523|FG002|Overall Study|Withdrawal by Subject|1|||
27865318|NCT01998841|81341888|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
27865319|NCT01998841|81341889|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
27865320|NCT01998841|81341890|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
27865321|NCT01998841|81341886|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
27865322|NCT01998841|81341887|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
27865323|NCT01998841|81341888|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
27865324|NCT01998841|81341889|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
27865325|NCT01998841|81341890|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
27865326|NCT00970593|81341893|FG000|Overall Study|Adverse Event|1|||
27865327|NCT00970593|81341894|FG001|Overall Study|Adverse Event|1|||
27865328|NCT00970593|81341895|FG002|Overall Study|Adverse Event|0|||
27865329|NCT00970593|81341896|FG003|Overall Study|Adverse Event|0|||
27865330|NCT00970593|81341897|FG004|Overall Study|Adverse Event|0|||
27865331|NCT00970593|81341898|FG005|Overall Study|Adverse Event|0|||
27865332|NCT00970593|81341899|FG006|Overall Study|Adverse Event|0|||
27865333|NCT00970593|81341893|FG000|Overall Study|Discontinuation of study by sponsor|0|||
27865334|NCT00970593|81341894|FG001|Overall Study|Discontinuation of study by sponsor|0|||
27865335|NCT00970593|81341895|FG002|Overall Study|Discontinuation of study by sponsor|5|||
27865336|NCT00970593|81341896|FG003|Overall Study|Discontinuation of study by sponsor|0|||
27865337|NCT00970593|81341897|FG004|Overall Study|Discontinuation of study by sponsor|0|||
27865338|NCT00970593|81341898|FG005|Overall Study|Discontinuation of study by sponsor|0|||
27865339|NCT00970593|81341899|FG006|Overall Study|Discontinuation of study by sponsor|2|||
27865340|NCT00970593|81341893|FG000|Overall Study|Withdrawal by Subject|0|||
27865341|NCT00970593|81341894|FG001|Overall Study|Withdrawal by Subject|0|||
27865342|NCT00970593|81341895|FG002|Overall Study|Withdrawal by Subject|1|||
27865343|NCT00970593|81341896|FG003|Overall Study|Withdrawal by Subject|0|||
27865344|NCT00970593|81341897|FG004|Overall Study|Withdrawal by Subject|0|||
27865345|NCT00970593|81341898|FG005|Overall Study|Withdrawal by Subject|0|||
27865346|NCT00970593|81341899|FG006|Overall Study|Withdrawal by Subject|0|||
27865347|NCT00993421|81341900|FG000|Overall Study|Adverse Event|2|||
27865348|NCT00993421|81341901|FG001|Overall Study|Adverse Event|7|||
27865349|NCT00993421|81341902|FG002|Overall Study|Adverse Event|6|||
27865350|NCT00993421|81341903|FG003|Overall Study|Adverse Event|9|||
27865351|NCT00993421|81341904|FG004|Overall Study|Adverse Event|5|||
27865352|NCT00993421|81341905|FG005|Overall Study|Adverse Event|7|||
27865353|NCT00993421|81341906|FG006|Overall Study|Adverse Event|1|||
27865354|NCT00993421|81341900|FG000|Overall Study|Sponsor Decision|36|||
27865355|NCT00993421|81341901|FG001|Overall Study|Sponsor Decision|31|||
27865356|NCT00993421|81341902|FG002|Overall Study|Sponsor Decision|28|||
27865357|NCT00993421|81341903|FG003|Overall Study|Sponsor Decision|30|||
27865358|NCT00993421|81341904|FG004|Overall Study|Sponsor Decision|38|||
27865359|NCT00993421|81341905|FG005|Overall Study|Sponsor Decision|30|||
27865360|NCT00993421|81341906|FG006|Overall Study|Sponsor Decision|29|||
27865361|NCT00993421|81341900|FG000|Overall Study|Lost to Follow-up|3|||
27865362|NCT00993421|81341901|FG001|Overall Study|Lost to Follow-up|5|||
27865363|NCT00993421|81341902|FG002|Overall Study|Lost to Follow-up|5|||
27865364|NCT00993421|81341903|FG003|Overall Study|Lost to Follow-up|0|||
27865365|NCT00993421|81341904|FG004|Overall Study|Lost to Follow-up|0|||
27865366|NCT00993421|81341905|FG005|Overall Study|Lost to Follow-up|0|||
27865367|NCT00993421|81341906|FG006|Overall Study|Lost to Follow-up|6|||
27865368|NCT00993421|81341900|FG000|Overall Study|Withdrawal by Subject|3|||
27865369|NCT00993421|81341901|FG001|Overall Study|Withdrawal by Subject|2|||
27865370|NCT00993421|81341902|FG002|Overall Study|Withdrawal by Subject|3|||
27865371|NCT00993421|81341903|FG003|Overall Study|Withdrawal by Subject|3|||
27865372|NCT00993421|81341904|FG004|Overall Study|Withdrawal by Subject|3|||
27865373|NCT00993421|81341905|FG005|Overall Study|Withdrawal by Subject|5|||
27865374|NCT00993421|81341906|FG006|Overall Study|Withdrawal by Subject|3|||
27865375|NCT00993421|81341900|FG000|Overall Study|Death|0|||
27865376|NCT00993421|81341901|FG001|Overall Study|Death|0|||
27865377|NCT00993421|81341902|FG002|Overall Study|Death|0|||
27865378|NCT00993421|81341903|FG003|Overall Study|Death|0|||
27865379|NCT00993421|81341904|FG004|Overall Study|Death|0|||
27865380|NCT00993421|81341905|FG005|Overall Study|Death|0|||
27865381|NCT00993421|81341906|FG006|Overall Study|Death|1|||
27865382|NCT00993421|81341900|FG000|Overall Study|Entry Criteria Exclusion|0|||
27865383|NCT00993421|81341901|FG001|Overall Study|Entry Criteria Exclusion|0|||
27865384|NCT00993421|81341902|FG002|Overall Study|Entry Criteria Exclusion|1|||
27865385|NCT00993421|81341903|FG003|Overall Study|Entry Criteria Exclusion|3|||
27865386|NCT00993421|81341904|FG004|Overall Study|Entry Criteria Exclusion|0|||
27865387|NCT00993421|81341905|FG005|Overall Study|Entry Criteria Exclusion|1|||
27865388|NCT00993421|81341906|FG006|Overall Study|Entry Criteria Exclusion|0|||
27865389|NCT00993421|81341900|FG000|Overall Study|Physician Decision|0|||
27865390|NCT00993421|81341901|FG001|Overall Study|Physician Decision|0|||
27865391|NCT00993421|81341902|FG002|Overall Study|Physician Decision|0|||
27865392|NCT00993421|81341903|FG003|Overall Study|Physician Decision|0|||
27865393|NCT00993421|81341904|FG004|Overall Study|Physician Decision|0|||
27783546|NCT01977573|81036524|FG003|Overall Study|Withdrawal by Subject|1|||
27783547|NCT00931515|81036528|FG000|Overall Study|Lost to Follow-up|2|||
27783548|NCT00931515|81036529|FG001|Overall Study|Lost to Follow-up|5|||
27783549|NCT01371721|81036530|FG000|Overall Study|Adverse Event|5|||
27783550|NCT01371721|81036531|FG001|Overall Study|Adverse Event|4|||
27783551|NCT01371721|81036532|FG002|Overall Study|Adverse Event|5|||
27783552|NCT01371721|81036530|FG000|Overall Study|Protocol Violation|6|||
27783553|NCT01371721|81036531|FG001|Overall Study|Protocol Violation|4|||
27783554|NCT01371721|81036532|FG002|Overall Study|Protocol Violation|5|||
27783555|NCT01371721|81036530|FG000|Overall Study|Lost to Follow-up|8|||
27783556|NCT01371721|81036531|FG001|Overall Study|Lost to Follow-up|2|||
27783557|NCT01371721|81036532|FG002|Overall Study|Lost to Follow-up|6|||
27783558|NCT01371721|81036530|FG000|Overall Study|Withdrawal by Subject|5|||
27783559|NCT01371721|81036531|FG001|Overall Study|Withdrawal by Subject|7|||
27783560|NCT01371721|81036532|FG002|Overall Study|Withdrawal by Subject|11|||
27783561|NCT01371721|81036530|FG000|Overall Study|Other|2|||
27783562|NCT01371721|81036531|FG001|Overall Study|Other|3|||
27783563|NCT01371721|81036532|FG002|Overall Study|Other|0|||
27783564|NCT01371721|81036530|FG000|Overall Study|Lack of Efficacy|2|||
27783565|NCT01371721|81036531|FG001|Overall Study|Lack of Efficacy|4|||
27783566|NCT01371721|81036532|FG002|Overall Study|Lack of Efficacy|3|||
27783567|NCT01371721|81036530|FG000|Overall Study|Randomized but not treated|1|||
27783568|NCT01371721|81036531|FG001|Overall Study|Randomized but not treated|0|||
27783569|NCT01371721|81036532|FG002|Overall Study|Randomized but not treated|0|||
27783570|NCT00718887|81036535|FG000|Overall Study|Withdrawal by Subject|3|||
27783571|NCT00718887|81036536|FG001|Overall Study|Withdrawal by Subject|2|||
27783572|NCT00718887|81036535|FG000|Overall Study|Not identified|2|||
27783573|NCT00718887|81036536|FG001|Overall Study|Not identified|7|||
27783574|NCT00412360|81036537|FG000|Overall Study|Lost to Follow-up|0|||
27783575|NCT00412360|81036538|FG001|Overall Study|Lost to Follow-up|1|||
27783576|NCT00412360|81036537|FG000|Overall Study|Not Transplanted|1|||
27783577|NCT00412360|81036538|FG001|Overall Study|Not Transplanted|2|||
27783578|NCT02519777|81036539|FG000|Overall Study|Death|1|||
27783579|NCT02519777|81036540|FG001|Overall Study|Death|0|||
27783580|NCT02519777|81036541|FG002|Overall Study|Death|0|||
27783581|NCT02519777|81036539|FG000|Overall Study|Lost to Follow-up|0|||
27783582|NCT02519777|81036540|FG001|Overall Study|Lost to Follow-up|4|||
27783583|NCT02519777|81036541|FG002|Overall Study|Lost to Follow-up|2|||
27783584|NCT02519777|81036539|FG000|Overall Study|Withdrawal by Subject|3|||
27783585|NCT02519777|81036540|FG001|Overall Study|Withdrawal by Subject|1|||
27783586|NCT02519777|81036541|FG002|Overall Study|Withdrawal by Subject|0|||
27783587|NCT02519777|81036539|FG000|Overall Study|Severe Debilitation|1|||
27972161|NCT01973387|81729962|FG001|Overall Study|Randomized, not treated|2|||
27972162|NCT00396136|81729963|FG000|Overall Study|Death|43|||
27972163|NCT00396136|81729963|FG000|Overall Study|Withdrawal by Subject|59|||
27972164|NCT00396136|81729963|FG000|Overall Study|Lost to Follow-up|15|||
27972165|NCT00396136|81729963|FG000|Overall Study|Study device explanted|8|||
27972166|NCT00907803|81729981|FG000|Overall Study|Withdrawal of consent - long commute|1|||
27972167|NCT00907803|81729982|FG001|Overall Study|Withdrawal of consent - long commute|0|||
27972168|NCT00907803|81729983|FG002|Overall Study|Withdrawal of consent - long commute|0|||
27783588|NCT02519777|81036540|FG001|Overall Study|Severe Debilitation|1|||
27783589|NCT02519777|81036541|FG002|Overall Study|Severe Debilitation|1|||
27783590|NCT02519777|81036539|FG000|Overall Study|Not able to get to clinic|1|||
27783591|NCT02519777|81036540|FG001|Overall Study|Not able to get to clinic|2|||
27783592|NCT02519777|81036541|FG002|Overall Study|Not able to get to clinic|1|||
27783593|NCT02694562|81036546|FG000|Overall Study|Death|8|||
27783594|NCT02694562|81036546|FG000|Overall Study|Protocol Violation|4|||
27783595|NCT02694562|81036546|FG000|Overall Study|Lost to Follow-up|3|||
27783596|NCT02694562|81036546|FG000|Overall Study|Screen Failure|2|||
27783597|NCT02694562|81036546|FG000|Overall Study|Physician Decision|1|||
27783598|NCT00465894|81036547|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
27783599|NCT00465894|81036548|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
27783600|NCT00465894|81036547|FG000|Treatment For 12 Weeks|Family Issues|1|||
27783601|NCT00465894|81036548|FG001|Treatment For 12 Weeks|Family Issues|1|||
27783602|NCT00465894|81036547|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
27783603|NCT00465894|81036548|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
27783604|NCT01265511|81036549|FG000|Overall Study|Lack of Efficacy|2|||
27783605|NCT01265511|81036550|FG001|Overall Study|Lack of Efficacy|1|||
27783606|NCT01265511|81036549|FG000|Overall Study|Met stopping rules|0|||
27972169|NCT00907803|81729981|FG000|Overall Study|Adverse Event|2|||
27783607|NCT01265511|81036550|FG001|Overall Study|Met stopping rules|2|||
27783608|NCT01293123|81036552|FG000|Overall Study|Lost to Follow-up|0|||
27783609|NCT01293123|81036553|FG001|Overall Study|Lost to Follow-up|1|||
27783610|NCT01683058|81036556|FG000|Overall Study|Lost to Follow-up|9|||
27783611|NCT01683058|81036556|FG000|Overall Study|Adverse Event|6|||
27972170|NCT00907803|81729982|FG001|Overall Study|Adverse Event|0|||
27972171|NCT00907803|81729983|FG002|Overall Study|Adverse Event|0|||
27783612|NCT01683058|81036556|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
27783613|NCT01683058|81036556|FG000|Overall Study|Withdrawal by Subject|7|||
27783614|NCT01683058|81036556|FG000|Overall Study|Lack of Efficacy|2|||
27783615|NCT03907072|81036557|FG000|Overall Study|Study Terminated by Sponsor|2|||
27783616|NCT03907072|81036558|FG001|Overall Study|Study Terminated by Sponsor|2|||
27783617|NCT03907072|81036559|FG002|Overall Study|Study Terminated by Sponsor|2|||
27783618|NCT04118127|81036572|FG000|Overall Study|Trial terminated by sponsor|0|||
27783619|NCT04118127|81036573|FG001|Overall Study|Trial terminated by sponsor|12|||
27783620|NCT04118127|81036572|FG000|Overall Study|Adverse Event|1|||
27783621|NCT04118127|81036573|FG001|Overall Study|Adverse Event|2|||
27783622|NCT04118127|81036572|FG000|Overall Study|Physician Decision|0|||
27783623|NCT04118127|81036573|FG001|Overall Study|Physician Decision|1|||
27783624|NCT04118127|81036572|FG000|Overall Study|Withdrawal by Subject|2|||
27783625|NCT04118127|81036573|FG001|Overall Study|Withdrawal by Subject|1|||
27783626|NCT00453349|81036576|FG000|Randomized|Adverse Event|12|||
27783627|NCT00453349|81036577|FG001|Randomized|Adverse Event|11|||
27783628|NCT00453349|81036576|FG000|Randomized|Lack of Efficacy|2|||
27783629|NCT00453349|81036577|FG001|Randomized|Lack of Efficacy|1|||
27783630|NCT00453349|81036576|FG000|Randomized|Lost to Follow-up|7|||
27783631|NCT00453349|81036577|FG001|Randomized|Lost to Follow-up|5|||
27783632|NCT00453349|81036576|FG000|Randomized|Protocol Violation|1|||
27783633|NCT00453349|81036577|FG001|Randomized|Protocol Violation|1|||
27783634|NCT00453349|81036576|FG000|Randomized|Withdrawal by Subject|3|||
27783635|NCT00453349|81036577|FG001|Randomized|Withdrawal by Subject|5|||
27783636|NCT00453349|81036576|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
27783637|NCT00453349|81036577|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
27783638|NCT00453349|81036576|FG000|Completed Study|Adverse Event|12|||
27783639|NCT00453349|81036577|FG001|Completed Study|Adverse Event|11|||
27783640|NCT00453349|81036576|FG000|Completed Study|Lack of Efficacy|2|||
27783641|NCT00453349|81036577|FG001|Completed Study|Lack of Efficacy|1|||
27783642|NCT00453349|81036576|FG000|Completed Study|Lost to Follow-up|7|||
27783643|NCT00453349|81036577|FG001|Completed Study|Lost to Follow-up|5|||
27783644|NCT00453349|81036576|FG000|Completed Study|Protocol Violation|1|||
27783645|NCT00453349|81036577|FG001|Completed Study|Protocol Violation|1|||
27783646|NCT00453349|81036576|FG000|Completed Study|Withdrawal by Subject|3|||
27783647|NCT00453349|81036577|FG001|Completed Study|Withdrawal by Subject|5|||
27972172|NCT00907803|81729981|FG000|Overall Study|Withdrawal by Subject|0|||
27972173|NCT00907803|81729982|FG001|Overall Study|Withdrawal by Subject|1|||
27783648|NCT00453349|81036576|FG000|Completed Study|Lost to follow up after study treatment|2|||
27783649|NCT00453349|81036577|FG001|Completed Study|Lost to follow up after study treatment|11|||
27783650|NCT03384316|81036578|FG000|Overall Study|Screen failure|0|||
27783651|NCT03384316|81036579|FG001|Overall Study|Screen failure|1|||
27783652|NCT01731951|81036580|FG000|Overall Study|Documented Disease Progression|1|||
27783653|NCT01731951|81036581|FG001|Overall Study|Documented Disease Progression|0|||
27783654|NCT01731951|81036582|FG002|Overall Study|Documented Disease Progression|0|||
27783655|NCT01731951|81036583|FG003|Overall Study|Documented Disease Progression|0|||
27783656|NCT01731951|81036584|FG004|Overall Study|Documented Disease Progression|0|||
27783657|NCT01731951|81036585|FG005|Overall Study|Documented Disease Progression|0|||
27783658|NCT01731951|81036580|FG000|Overall Study|Lost to Follow-up|2|||
27783659|NCT01731951|81036581|FG001|Overall Study|Lost to Follow-up|0|||
27783660|NCT01731951|81036582|FG002|Overall Study|Lost to Follow-up|0|||
27783661|NCT01731951|81036583|FG003|Overall Study|Lost to Follow-up|1|||
27783662|NCT01731951|81036584|FG004|Overall Study|Lost to Follow-up|3|||
27783663|NCT01731951|81036585|FG005|Overall Study|Lost to Follow-up|1|||
27783664|NCT01731951|81036580|FG000|Overall Study|Withdrawal of Consent|1|||
27783665|NCT01731951|81036581|FG001|Overall Study|Withdrawal of Consent|0|||
27783666|NCT01731951|81036582|FG002|Overall Study|Withdrawal of Consent|0|||
27783667|NCT01731951|81036583|FG003|Overall Study|Withdrawal of Consent|0|||
27783668|NCT01731951|81036584|FG004|Overall Study|Withdrawal of Consent|0|||
27783669|NCT01731951|81036585|FG005|Overall Study|Withdrawal of Consent|2|||
27783670|NCT01731951|81036580|FG000|Overall Study|Death|13|||
27972174|NCT00907803|81729983|FG002|Overall Study|Withdrawal by Subject|0|||
27783671|NCT01731951|81036581|FG001|Overall Study|Death|15|||
27972175|NCT00907803|81729981|FG000|Overall Study|Lost to Follow-up|0|||
27972176|NCT00907803|81729982|FG001|Overall Study|Lost to Follow-up|1|||
27783672|NCT01731951|81036582|FG002|Overall Study|Death|9|||
27783673|NCT01731951|81036583|FG003|Overall Study|Death|8|||
27783674|NCT01731951|81036584|FG004|Overall Study|Death|9|||
27783675|NCT01731951|81036585|FG005|Overall Study|Death|6|||
27783676|NCT04601194|81036590|FG000|Overall Study|Lost to Follow-up|7|||
27783677|NCT01632345|81036591|FG000|Treatment: Part I|Adverse Event|1|||
27783678|NCT01632345|81036592|FG001|Treatment: Part I|Adverse Event|4|||
27783679|NCT01632345|81036593|FG002|Treatment: Part I|Adverse Event|2|||
27783680|NCT01632345|81036594|FG003|Treatment: Part I|Adverse Event|1|||
27783681|NCT01632345|81036595|FG004|Treatment: Part I|Adverse Event|3|||
27972177|NCT00907803|81729983|FG002|Overall Study|Lost to Follow-up|0|||
27783682|NCT01632345|81036596|FG005|Treatment: Part I|Adverse Event|0|||
27783683|NCT01632345|81036597|FG006|Treatment: Part I|Adverse Event|0|||
27783684|NCT01632345|81036591|FG000|Treatment: Part I|Lack of Efficacy|0|||
27783685|NCT01632345|81036592|FG001|Treatment: Part I|Lack of Efficacy|1|||
27783686|NCT01632345|81036593|FG002|Treatment: Part I|Lack of Efficacy|0|||
27783687|NCT01632345|81036594|FG003|Treatment: Part I|Lack of Efficacy|1|||
27783688|NCT01632345|81036595|FG004|Treatment: Part I|Lack of Efficacy|1|||
27783689|NCT01632345|81036596|FG005|Treatment: Part I|Lack of Efficacy|0|||
27783690|NCT01632345|81036597|FG006|Treatment: Part I|Lack of Efficacy|0|||
27783691|NCT01632345|81036591|FG000|Treatment: Part I|Lost to Follow-up|3|||
27783692|NCT01632345|81036592|FG001|Treatment: Part I|Lost to Follow-up|2|||
27783693|NCT01632345|81036593|FG002|Treatment: Part I|Lost to Follow-up|1|||
27783694|NCT01632345|81036594|FG003|Treatment: Part I|Lost to Follow-up|3|||
27783695|NCT01632345|81036595|FG004|Treatment: Part I|Lost to Follow-up|4|||
27783696|NCT01632345|81036596|FG005|Treatment: Part I|Lost to Follow-up|0|||
27783697|NCT01632345|81036597|FG006|Treatment: Part I|Lost to Follow-up|0|||
27783698|NCT01632345|81036591|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
27865394|NCT00993421|81341905|FG005|Overall Study|Physician Decision|1|||
27865395|NCT00993421|81341906|FG006|Overall Study|Physician Decision|1|||
27865396|NCT00993421|81341900|FG000|Overall Study|Protocol Violation|0|||
27865397|NCT00993421|81341901|FG001|Overall Study|Protocol Violation|0|||
27865398|NCT00993421|81341902|FG002|Overall Study|Protocol Violation|0|||
27865399|NCT00993421|81341903|FG003|Overall Study|Protocol Violation|0|||
27865400|NCT00993421|81341904|FG004|Overall Study|Protocol Violation|0|||
27865401|NCT00993421|81341905|FG005|Overall Study|Protocol Violation|2|||
27865402|NCT00993421|81341906|FG006|Overall Study|Protocol Violation|1|||
27865403|NCT00306995|81341917|FG000|Study Part I|Withdrawal by Subject|0|||
27865404|NCT00306995|81341918|FG001|Study Part I|Withdrawal by Subject|0|||
27865405|NCT00306995|81341919|FG002|Study Part I|Withdrawal by Subject|0|||
27865406|NCT00306995|81341920|FG003|Study Part I|Withdrawal by Subject|0|||
27865407|NCT00306995|81341921|FG004|Study Part I|Withdrawal by Subject|0|||
27865408|NCT00306995|81341922|FG005|Study Part I|Withdrawal by Subject|0|||
27865409|NCT00306995|81341923|FG006|Study Part I|Withdrawal by Subject|1|||
27865410|NCT00306995|81341917|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
27865411|NCT00306995|81341918|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
27865412|NCT00306995|81341919|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
27865413|NCT00306995|81341920|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
27865414|NCT00306995|81341921|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
27865415|NCT00306995|81341922|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
27865416|NCT00306995|81341923|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
27865417|NCT00582010|81341926|FG000|Overall Study|Death|0|||
27865418|NCT00582010|81341927|FG001|Overall Study|Death|1|||
27865419|NCT00901576|81341928|FG000|Second Intervention|Withdrawal by Subject|0|||
27865420|NCT00901576|81341929|FG001|Second Intervention|Withdrawal by Subject|0|||
27865421|NCT00901576|81341930|FG002|Second Intervention|Withdrawal by Subject|0|||
27865422|NCT00901576|81341931|FG003|Second Intervention|Withdrawal by Subject|1|||
27865423|NCT00901576|81341932|FG004|Second Intervention|Withdrawal by Subject|0|||
27865424|NCT00901576|81341933|FG005|Second Intervention|Withdrawal by Subject|1|||
27865425|NCT00901576|81341928|FG000|Second Intervention|Physician Decision|1|||
27865426|NCT00901576|81341929|FG001|Second Intervention|Physician Decision|0|||
27865427|NCT00901576|81341930|FG002|Second Intervention|Physician Decision|0|||
27865428|NCT00901576|81341931|FG003|Second Intervention|Physician Decision|0|||
27865429|NCT00901576|81341932|FG004|Second Intervention|Physician Decision|0|||
27865430|NCT00901576|81341933|FG005|Second Intervention|Physician Decision|0|||
27865431|NCT00794339|81341934|FG000|Overall Study|Withdrawal by Subject|3|||
27865432|NCT00794339|81341934|FG000|Overall Study|Ineligible|4|||
27865433|NCT00794339|81341934|FG000|Overall Study|Tx prior to ATSM|3|||
27865434|NCT00794339|81341934|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
27865435|NCT00794339|81341934|FG000|Overall Study|Tx not per protocol|1|||
27865436|NCT00696787|81341935|FG000|Overall Study|Adverse Event|1|||
27865437|NCT00696787|81341936|FG001|Overall Study|Adverse Event|0|||
27865438|NCT00696787|81341937|FG002|Overall Study|Adverse Event|6|||
27865439|NCT00696787|81341935|FG000|Overall Study|Discontinuation by Sponsor|9|||
27865440|NCT00696787|81341936|FG001|Overall Study|Discontinuation by Sponsor|13|||
27865441|NCT00696787|81341937|FG002|Overall Study|Discontinuation by Sponsor|14|||
27865442|NCT00696787|81341935|FG000|Overall Study|Lack of Efficacy|0|||
27865443|NCT00696787|81341936|FG001|Overall Study|Lack of Efficacy|1|||
27783699|NCT01632345|81036592|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
27783700|NCT01632345|81036593|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
27783701|NCT01632345|81036594|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
27865444|NCT00696787|81341937|FG002|Overall Study|Lack of Efficacy|0|||
27865445|NCT00696787|81341935|FG000|Overall Study|Lost to Follow-up|4|||
27865446|NCT00696787|81341936|FG001|Overall Study|Lost to Follow-up|0|||
27669064|NCT00665223|80627492|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
27783702|NCT01632345|81036595|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
27865447|NCT00696787|81341937|FG002|Overall Study|Lost to Follow-up|3|||
27865448|NCT00696787|81341935|FG000|Overall Study|Withdrawal by Subject|0|||
27865449|NCT00696787|81341936|FG001|Overall Study|Withdrawal by Subject|3|||
27865450|NCT00696787|81341937|FG002|Overall Study|Withdrawal by Subject|2|||
27865451|NCT00696787|81341935|FG000|Overall Study|Failed to return|1|||
27865452|NCT00696787|81341936|FG001|Overall Study|Failed to return|3|||
27865453|NCT00696787|81341937|FG002|Overall Study|Failed to return|1|||
27865454|NCT01715571|81341938|FG000|Overall Study|Lost to Follow-up|8|||
27865455|NCT04807400|81341941|FG000|Overall Study|Adverse Event|2|||
27865456|NCT04807400|81341942|FG001|Overall Study|Adverse Event|3|||
27865457|NCT04807400|81341943|FG002|Overall Study|Adverse Event|3|||
27865458|NCT04807400|81341941|FG000|Overall Study|Death|2|||
27865459|NCT04807400|81341942|FG001|Overall Study|Death|0|||
27865460|NCT04807400|81341943|FG002|Overall Study|Death|0|||
27865461|NCT04807400|81341941|FG000|Overall Study|Lost to Follow-up|8|||
27865462|NCT04807400|81341942|FG001|Overall Study|Lost to Follow-up|6|||
27865463|NCT04807400|81341943|FG002|Overall Study|Lost to Follow-up|6|||
27865464|NCT04807400|81341941|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27865465|NCT04807400|81341942|FG001|Overall Study|Non-Compliance With Study Drug|4|||
27865466|NCT04807400|81341943|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27972178|NCT00907803|81729981|FG000|Overall Study|Protocol Violation|0|||
27972179|NCT00907803|81729982|FG001|Overall Study|Protocol Violation|1|||
27972180|NCT00907803|81729983|FG002|Overall Study|Protocol Violation|0|||
27972181|NCT03457142|81729984|FG000|Overall Study|Death|1|||
27972182|NCT04240457|81729985|FG000|Overall Study|Lost to Follow-up|5|||
27972183|NCT04240457|81729986|FG001|Overall Study|Lost to Follow-up|1|||
27972184|NCT02439450|81729993|FG000|Overall Study|Adverse Event|4|||
27972185|NCT02439450|81729994|FG001|Overall Study|Adverse Event|1|||
27972186|NCT02439450|81729995|FG002|Overall Study|Adverse Event|0|||
27972187|NCT02439450|81729996|FG003|Overall Study|Adverse Event|0|||
27972188|NCT02439450|81729993|FG000|Overall Study|Withdrawal by Subject|1|||
27972189|NCT02439450|81729994|FG001|Overall Study|Withdrawal by Subject|2|||
27972190|NCT02439450|81729995|FG002|Overall Study|Withdrawal by Subject|0|||
27972191|NCT02439450|81729996|FG003|Overall Study|Withdrawal by Subject|0|||
27972192|NCT02439450|81729993|FG000|Overall Study|Death|3|||
27865467|NCT04807400|81341941|FG000|Overall Study|Participant Decision|20|||
27865468|NCT04807400|81341942|FG001|Overall Study|Participant Decision|19|||
27865469|NCT04807400|81341943|FG002|Overall Study|Participant Decision|26|||
27865470|NCT04807400|81341941|FG000|Overall Study|Physician Decision|0|||
27865471|NCT04807400|81341942|FG001|Overall Study|Physician Decision|1|||
27865472|NCT04807400|81341943|FG002|Overall Study|Physician Decision|0|||
27865473|NCT04807400|81341941|FG000|Overall Study|Protocol Violation|4|||
27865474|NCT04807400|81341942|FG001|Overall Study|Protocol Violation|3|||
27865475|NCT04807400|81341943|FG002|Overall Study|Protocol Violation|7|||
27865476|NCT04807400|81341941|FG000|Overall Study|Withdrawal by Subject|13|||
27865477|NCT04807400|81341942|FG001|Overall Study|Withdrawal by Subject|9|||
27865478|NCT04807400|81341943|FG002|Overall Study|Withdrawal by Subject|20|||
27865479|NCT04807400|81341941|FG000|Overall Study|Mis-randomized|1|||
27865480|NCT04807400|81341942|FG001|Overall Study|Mis-randomized|0|||
27865481|NCT04807400|81341943|FG002|Overall Study|Mis-randomized|0|||
27865482|NCT01876446|81341944|FG000|Overall Study|Death|0|||
27865483|NCT01876446|81341945|FG001|Overall Study|Death|1|||
27865484|NCT01876446|81341944|FG000|Overall Study|Withdrawal by Subject|1|||
27865485|NCT01876446|81341945|FG001|Overall Study|Withdrawal by Subject|2|||
27865486|NCT01876446|81341944|FG000|Overall Study|Physician Decision|1|||
27972193|NCT02439450|81729994|FG001|Overall Study|Death|0|||
27972194|NCT02439450|81729995|FG002|Overall Study|Death|0|||
27972195|NCT02439450|81729996|FG003|Overall Study|Death|1|||
27972196|NCT02439450|81729993|FG000|Overall Study|Progressive Disease|18|||
27972197|NCT02439450|81729994|FG001|Overall Study|Progressive Disease|41|||
27972198|NCT02439450|81729995|FG002|Overall Study|Progressive Disease|2|||
27972199|NCT02439450|81729996|FG003|Overall Study|Progressive Disease|3|||
27972200|NCT01751906|81730001|FG000|Overall Study|Lost to Follow-up|151|||
27972201|NCT01751906|81730002|FG001|Overall Study|Lost to Follow-up|68|||
27972202|NCT01751906|81730001|FG000|Overall Study|Withdrawal by Subject|22|||
27972203|NCT01751906|81730002|FG001|Overall Study|Withdrawal by Subject|18|||
27865487|NCT01876446|81341945|FG001|Overall Study|Physician Decision|3|||
27865488|NCT02613182|81341948|FG000|Overall Study|Death|6|||
27972204|NCT01751906|81730001|FG000|Overall Study|Physician Decision|5|||
27972205|NCT01751906|81730002|FG001|Overall Study|Physician Decision|2|||
27865489|NCT02613182|81341948|FG000|Overall Study|Physician Decision|1|||
27865490|NCT02613182|81341948|FG000|Overall Study|Study Terminated by Sponsor|21|||
27865491|NCT02613182|81341948|FG000|Overall Study|Withdrawal by Subject|6|||
27972206|NCT01751906|81730001|FG000|Overall Study|Death|84|||
27972207|NCT01751906|81730002|FG001|Overall Study|Death|43|||
27865492|NCT01822366|81341951|FG000|Overall Study|Lost to Follow-up|5|||
27865493|NCT01822366|81341952|FG001|Overall Study|Lost to Follow-up|1|||
27865494|NCT01822366|81341953|FG002|Overall Study|Lost to Follow-up|5|||
27865495|NCT01822366|81341954|FG003|Overall Study|Lost to Follow-up|1|||
27865496|NCT01822366|81341951|FG000|Overall Study|Withdrawal by Subject|0|||
27972208|NCT01751906|81730001|FG000|Overall Study|Denied on premises for follow-up by law|1|||
27972209|NCT01751906|81730002|FG001|Overall Study|Denied on premises for follow-up by law|0|||
27972210|NCT02185014|81730003|FG000|Overall Study|Adverse Event|18|||
27783703|NCT01632345|81036596|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
27972211|NCT02185014|81730003|FG000|Overall Study|Withdrew Consent|8|||
27972212|NCT02185014|81730003|FG000|Overall Study|Lost to Follow-up|4|||
27972213|NCT02185014|81730003|FG000|Overall Study|Lack of Efficacy|14|||
27972214|NCT02185014|81730003|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
27972215|NCT02185014|81730003|FG000|Overall Study|Subject Noncompliance|1|||
27972216|NCT02185014|81730003|FG000|Overall Study|Other|4|||
27972217|NCT00737711|81730004|FG000|Overall Study|Adverse Event|2|||
27972218|NCT00737711|81730004|FG000|Overall Study|Death|8|||
27972219|NCT00737711|81730004|FG000|Overall Study|Failure to return|4|||
27972220|NCT00737711|81730004|FG000|Overall Study|Protocol Violation|1|||
27972221|NCT00737711|81730004|FG000|Overall Study|Withdrawal by Subject|5|||
27972222|NCT00737711|81730004|FG000|Overall Study|Blood transfusion|6|||
27972223|NCT00737711|81730004|FG000|Overall Study|Other|5|||
27972224|NCT00519376|81730005|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972225|NCT00519376|81730006|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972226|NCT00519376|81730007|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972227|NCT00519376|81730008|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972228|NCT00519376|81730009|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972229|NCT00519376|81730010|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972230|NCT00519376|81730011|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972231|NCT00519376|81730012|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972232|NCT00519376|81730013|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972233|NCT00519376|81730014|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972234|NCT00519376|81730015|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972235|NCT00519376|81730016|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972236|NCT00519376|81730017|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
27972237|NCT00519376|81730018|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972238|NCT00519376|81730019|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972239|NCT00519376|81730020|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
27972240|NCT00519376|81730005|FG000|Treatment Period 4|Lost to Follow-up|0|||
27972241|NCT00519376|81730006|FG001|Treatment Period 4|Lost to Follow-up|0|||
27972242|NCT00519376|81730007|FG002|Treatment Period 4|Lost to Follow-up|1|||
27972243|NCT00519376|81730008|FG003|Treatment Period 4|Lost to Follow-up|0|||
27972244|NCT00519376|81730009|FG004|Treatment Period 4|Lost to Follow-up|0|||
27972245|NCT00519376|81730010|FG005|Treatment Period 4|Lost to Follow-up|0|||
27972246|NCT00519376|81730011|FG006|Treatment Period 4|Lost to Follow-up|0|||
27972247|NCT00519376|81730012|FG007|Treatment Period 4|Lost to Follow-up|0|||
27972248|NCT00519376|81730013|FG008|Treatment Period 4|Lost to Follow-up|0|||
27972249|NCT00519376|81730014|FG009|Treatment Period 4|Lost to Follow-up|0|||
27972250|NCT00519376|81730015|FG010|Treatment Period 4|Lost to Follow-up|0|||
27972251|NCT00519376|81730016|FG011|Treatment Period 4|Lost to Follow-up|0|||
27972252|NCT00519376|81730017|FG012|Treatment Period 4|Lost to Follow-up|0|||
27972253|NCT00519376|81730018|FG013|Treatment Period 4|Lost to Follow-up|0|||
27972254|NCT00519376|81730019|FG014|Treatment Period 4|Lost to Follow-up|0|||
27972255|NCT00519376|81730020|FG015|Treatment Period 4|Lost to Follow-up|0|||
27972256|NCT00837265|81730021|FG000|Pilot Phase|Withdrawal by Subject|0|||
27972257|NCT00837265|81730022|FG001|Pilot Phase|Withdrawal by Subject|2|||
27972258|NCT00837265|81730023|FG002|Pilot Phase|Withdrawal by Subject|3|||
27972259|NCT00837265|81730024|FG003|Pilot Phase|Withdrawal by Subject|2|||
27972260|NCT00837265|81730025|FG004|Pilot Phase|Withdrawal by Subject|0|||
27972261|NCT00837265|81730026|FG005|Pilot Phase|Withdrawal by Subject|0|||
27972262|NCT00837265|81730027|FG006|Pilot Phase|Withdrawal by Subject|0|||
27972263|NCT00837265|81730021|FG000|Pilot Phase|Decision of the investigator|2|||
27972264|NCT00837265|81730022|FG001|Pilot Phase|Decision of the investigator|1|||
27972265|NCT00837265|81730023|FG002|Pilot Phase|Decision of the investigator|0|||
27972266|NCT00837265|81730024|FG003|Pilot Phase|Decision of the investigator|0|||
27972267|NCT00837265|81730025|FG004|Pilot Phase|Decision of the investigator|0|||
27972268|NCT00837265|81730026|FG005|Pilot Phase|Decision of the investigator|0|||
27972269|NCT00837265|81730027|FG006|Pilot Phase|Decision of the investigator|0|||
27972270|NCT00837265|81730021|FG000|Pilot Phase|Adverse Event|1|||
27972271|NCT00837265|81730022|FG001|Pilot Phase|Adverse Event|0|||
27972272|NCT00837265|81730023|FG002|Pilot Phase|Adverse Event|0|||
27972273|NCT00837265|81730024|FG003|Pilot Phase|Adverse Event|0|||
27972274|NCT00837265|81730025|FG004|Pilot Phase|Adverse Event|0|||
27972275|NCT00837265|81730026|FG005|Pilot Phase|Adverse Event|0|||
27972276|NCT00837265|81730027|FG006|Pilot Phase|Adverse Event|0|||
27972277|NCT00837265|81730021|FG000|Pilot Phase|Disease progression|0|||
27972278|NCT00837265|81730022|FG001|Pilot Phase|Disease progression|0|||
27972279|NCT00837265|81730023|FG002|Pilot Phase|Disease progression|0|||
27972280|NCT00837265|81730024|FG003|Pilot Phase|Disease progression|1|||
27972281|NCT00837265|81730025|FG004|Pilot Phase|Disease progression|0|||
27972282|NCT00837265|81730026|FG005|Pilot Phase|Disease progression|0|||
27972283|NCT00837265|81730027|FG006|Pilot Phase|Disease progression|0|||
27972284|NCT00837265|81730021|FG000|Pilot Phase|Participant left the city|0|||
27972285|NCT00837265|81730022|FG001|Pilot Phase|Participant left the city|0|||
27972286|NCT00837265|81730023|FG002|Pilot Phase|Participant left the city|0|||
27972287|NCT00837265|81730024|FG003|Pilot Phase|Participant left the city|1|||
27972288|NCT00837265|81730025|FG004|Pilot Phase|Participant left the city|0|||
27972289|NCT00837265|81730026|FG005|Pilot Phase|Participant left the city|0|||
27972290|NCT00837265|81730027|FG006|Pilot Phase|Participant left the city|0|||
27972291|NCT00837265|81730021|FG000|Main Phase|Withdrawal by Subject|0|||
27972292|NCT00837265|81730022|FG001|Main Phase|Withdrawal by Subject|0|||
27972293|NCT00837265|81730023|FG002|Main Phase|Withdrawal by Subject|0|||
27972294|NCT00837265|81730024|FG003|Main Phase|Withdrawal by Subject|0|||
27972295|NCT00837265|81730025|FG004|Main Phase|Withdrawal by Subject|4|||
27972296|NCT00837265|81730026|FG005|Main Phase|Withdrawal by Subject|2|||
27972297|NCT00837265|81730027|FG006|Main Phase|Withdrawal by Subject|1|||
27972298|NCT00837265|81730021|FG000|Main Phase|Decision of the investigator|0|||
27972299|NCT00837265|81730022|FG001|Main Phase|Decision of the investigator|0|||
27972300|NCT00837265|81730023|FG002|Main Phase|Decision of the investigator|0|||
27669065|NCT00665223|80627493|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
27669066|NCT00665223|80627491|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
27669067|NCT00665223|80627492|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
27669068|NCT00665223|80627493|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
27669069|NCT00665223|80627491|FG000|Open-Label Period (26 Weeks)|Death|0|||
27669070|NCT00665223|80627492|FG001|Open-Label Period (26 Weeks)|Death|1|||
27669071|NCT00665223|80627493|FG002|Open-Label Period (26 Weeks)|Death|0|||
27669072|NCT00665223|80627491|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
27669073|NCT00665223|80627492|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
27669074|NCT00665223|80627493|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
27669075|NCT00665223|80627491|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
27669076|NCT00665223|80627492|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
27669077|NCT00665223|80627493|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
27669078|NCT00665223|80627491|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
27669079|NCT00665223|80627492|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
27669080|NCT00665223|80627493|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
27669081|NCT00665223|80627491|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
27669082|NCT00665223|80627492|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
27669083|NCT00665223|80627493|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
27669084|NCT02250534|80627495|FG000|Overall Study|Lost to Follow-up|18|||
27669085|NCT02250534|80627496|FG001|Overall Study|Lost to Follow-up|28|||
27669086|NCT02250534|80627497|FG002|Overall Study|Lost to Follow-up|33|||
27669087|NCT02250534|80627495|FG000|Overall Study|Personal reasons|7|||
27669088|NCT02250534|80627496|FG001|Overall Study|Personal reasons|8|||
27669089|NCT02250534|80627497|FG002|Overall Study|Personal reasons|14|||
27669090|NCT02250534|80627495|FG000|Overall Study|Adverse Event|6|||
27972301|NCT00837265|81730024|FG003|Main Phase|Decision of the investigator|0|||
27669091|NCT02250534|80627496|FG001|Overall Study|Adverse Event|3|||
27669092|NCT02250534|80627497|FG002|Overall Study|Adverse Event|8|||
27669093|NCT02250534|80627495|FG000|Overall Study|incarcerated|2|||
27669094|NCT02250534|80627496|FG001|Overall Study|incarcerated|1|||
27669095|NCT02250534|80627497|FG002|Overall Study|incarcerated|2|||
27669096|NCT02250534|80627495|FG000|Overall Study|Withdrawal by Subject|0|||
27669097|NCT02250534|80627496|FG001|Overall Study|Withdrawal by Subject|1|||
27669098|NCT02250534|80627497|FG002|Overall Study|Withdrawal by Subject|2|||
27669099|NCT02250534|80627495|FG000|Overall Study|Death|0|||
27972302|NCT00837265|81730025|FG004|Main Phase|Decision of the investigator|0|||
27972303|NCT00837265|81730026|FG005|Main Phase|Decision of the investigator|2|||
27972304|NCT00837265|81730027|FG006|Main Phase|Decision of the investigator|1|||
27972305|NCT00837265|81730021|FG000|Main Phase|Adverse Event|0|||
27669100|NCT02250534|80627496|FG001|Overall Study|Death|1|||
27669101|NCT02250534|80627497|FG002|Overall Study|Death|1|||
27972306|NCT00837265|81730022|FG001|Main Phase|Adverse Event|0|||
27972307|NCT00837265|81730023|FG002|Main Phase|Adverse Event|0|||
27972308|NCT00837265|81730024|FG003|Main Phase|Adverse Event|0|||
27972309|NCT00837265|81730025|FG004|Main Phase|Adverse Event|0|||
27972310|NCT00837265|81730026|FG005|Main Phase|Adverse Event|1|||
27669102|NCT02250534|80627495|FG000|Overall Study|Physician Decision|1|||
27669103|NCT02250534|80627496|FG001|Overall Study|Physician Decision|3|||
27669104|NCT02250534|80627497|FG002|Overall Study|Physician Decision|1|||
27669105|NCT02250534|80627495|FG000|Overall Study|Protocol Violation|1|||
27669106|NCT02250534|80627496|FG001|Overall Study|Protocol Violation|0|||
27669107|NCT02250534|80627497|FG002|Overall Study|Protocol Violation|1|||
27669108|NCT02250534|80627495|FG000|Overall Study|Reason unknown|1|||
27669109|NCT02250534|80627496|FG001|Overall Study|Reason unknown|0|||
27669110|NCT02250534|80627497|FG002|Overall Study|Reason unknown|0|||
27669111|NCT00776659|80627498|FG000|Overall Study|Lost to Follow-up|15|||
27783704|NCT01632345|81036597|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
27783705|NCT01632345|81036591|FG000|Treatment: Part I|Physician Decision|2|||
27783706|NCT01632345|81036592|FG001|Treatment: Part I|Physician Decision|1|||
27783707|NCT01632345|81036593|FG002|Treatment: Part I|Physician Decision|0|||
27783708|NCT01632345|81036594|FG003|Treatment: Part I|Physician Decision|0|||
27783709|NCT01632345|81036595|FG004|Treatment: Part I|Physician Decision|1|||
27783710|NCT01632345|81036596|FG005|Treatment: Part I|Physician Decision|0|||
27783711|NCT01632345|81036597|FG006|Treatment: Part I|Physician Decision|0|||
27783712|NCT01632345|81036591|FG000|Treatment: Part I|Pregnancy|0|||
27783713|NCT01632345|81036592|FG001|Treatment: Part I|Pregnancy|1|||
27783714|NCT01632345|81036593|FG002|Treatment: Part I|Pregnancy|0|||
27783715|NCT01632345|81036594|FG003|Treatment: Part I|Pregnancy|0|||
27783716|NCT01632345|81036595|FG004|Treatment: Part I|Pregnancy|0|||
27783717|NCT01632345|81036596|FG005|Treatment: Part I|Pregnancy|0|||
27783718|NCT01632345|81036597|FG006|Treatment: Part I|Pregnancy|0|||
27783719|NCT01632345|81036591|FG000|Treatment: Part I|Protocol Deviation|0|||
27783720|NCT01632345|81036592|FG001|Treatment: Part I|Protocol Deviation|0|||
27783721|NCT01632345|81036593|FG002|Treatment: Part I|Protocol Deviation|1|||
27783722|NCT01632345|81036594|FG003|Treatment: Part I|Protocol Deviation|1|||
27783723|NCT01632345|81036595|FG004|Treatment: Part I|Protocol Deviation|0|||
27783724|NCT01632345|81036596|FG005|Treatment: Part I|Protocol Deviation|0|||
27783725|NCT01632345|81036597|FG006|Treatment: Part I|Protocol Deviation|0|||
27783726|NCT01632345|81036591|FG000|Treatment: Part I|Withdrawal by Subject|3|||
27783727|NCT01632345|81036592|FG001|Treatment: Part I|Withdrawal by Subject|4|||
27783728|NCT01632345|81036593|FG002|Treatment: Part I|Withdrawal by Subject|4|||
27783729|NCT01632345|81036594|FG003|Treatment: Part I|Withdrawal by Subject|1|||
27783730|NCT01632345|81036595|FG004|Treatment: Part I|Withdrawal by Subject|4|||
27783731|NCT01632345|81036596|FG005|Treatment: Part I|Withdrawal by Subject|0|||
27783732|NCT01632345|81036597|FG006|Treatment: Part I|Withdrawal by Subject|0|||
27783733|NCT01632345|81036591|FG000|Treatment: Part II|Adverse Event|0|||
27783734|NCT01632345|81036592|FG001|Treatment: Part II|Adverse Event|0|||
27783735|NCT01632345|81036593|FG002|Treatment: Part II|Adverse Event|0|||
27865497|NCT01822366|81341952|FG001|Overall Study|Withdrawal by Subject|6|||
27865498|NCT01822366|81341953|FG002|Overall Study|Withdrawal by Subject|0|||
27865499|NCT01822366|81341954|FG003|Overall Study|Withdrawal by Subject|6|||
27865500|NCT01822366|81341951|FG000|Overall Study|Partial Intervention Completion|0|||
27865501|NCT01822366|81341952|FG001|Overall Study|Partial Intervention Completion|15|||
27865502|NCT01822366|81341953|FG002|Overall Study|Partial Intervention Completion|0|||
27865503|NCT01822366|81341954|FG003|Overall Study|Partial Intervention Completion|15|||
27865504|NCT02198963|81341958|FG000|Overall Study|Adverse Event|1|||
27865505|NCT02198963|81341958|FG000|Overall Study|Withdrawal by Subject|6|||
27865506|NCT00796757|81341963|FG000|Overall Study|Withdrawal by Subject|14|||
27669112|NCT00776659|80627498|FG000|Overall Study|Withdrawal by Subject|10|||
27783736|NCT01632345|81036594|FG003|Treatment: Part II|Adverse Event|0|||
27783737|NCT01632345|81036595|FG004|Treatment: Part II|Adverse Event|0|||
27783738|NCT01632345|81036596|FG005|Treatment: Part II|Adverse Event|3|||
27783739|NCT01632345|81036597|FG006|Treatment: Part II|Adverse Event|8|||
27783740|NCT01632345|81036591|FG000|Treatment: Part II|Lost to Follow-up|0|||
27783741|NCT01632345|81036592|FG001|Treatment: Part II|Lost to Follow-up|0|||
27783742|NCT01632345|81036593|FG002|Treatment: Part II|Lost to Follow-up|0|||
27972311|NCT00837265|81730027|FG006|Main Phase|Adverse Event|0|||
27972312|NCT00837265|81730021|FG000|Main Phase|Death|0|||
27669113|NCT00776659|80627498|FG000|Overall Study|Study Terminated by Sponsor|1|||
27669114|NCT01278615|80627499|FG000|Overall Study|Withdrawal by Subject|2|||
27783743|NCT01632345|81036594|FG003|Treatment: Part II|Lost to Follow-up|0|||
27669115|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
27783744|NCT01632345|81036595|FG004|Treatment: Part II|Lost to Follow-up|0|||
27783745|NCT01632345|81036596|FG005|Treatment: Part II|Lost to Follow-up|3|||
27972313|NCT00837265|81730022|FG001|Main Phase|Death|0|||
27669116|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
27783746|NCT01632345|81036597|FG006|Treatment: Part II|Lost to Follow-up|1|||
27783747|NCT01632345|81036591|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
27783748|NCT01632345|81036592|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
27783749|NCT01632345|81036593|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
27783750|NCT01632345|81036594|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
27783751|NCT01632345|81036595|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
27783752|NCT01632345|81036596|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
27783753|NCT01632345|81036597|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
27783754|NCT01632345|81036591|FG000|Treatment: Part II|Withdrawal by Subject|0|||
27783755|NCT01632345|81036592|FG001|Treatment: Part II|Withdrawal by Subject|0|||
27783756|NCT01632345|81036593|FG002|Treatment: Part II|Withdrawal by Subject|0|||
27783757|NCT01632345|81036594|FG003|Treatment: Part II|Withdrawal by Subject|0|||
27783758|NCT01632345|81036595|FG004|Treatment: Part II|Withdrawal by Subject|0|||
27783759|NCT01632345|81036596|FG005|Treatment: Part II|Withdrawal by Subject|2|||
27783760|NCT01632345|81036597|FG006|Treatment: Part II|Withdrawal by Subject|2|||
27783761|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
27783762|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
27783763|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
27783764|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
27783765|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
27783766|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Death|1|||
27783767|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Death|0|||
27783768|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Death|0|||
27783769|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Death|0|||
27783770|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Death|0|||
27783771|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
27783772|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
27783773|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
27783774|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
27783775|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
27783776|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
27783777|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
27783778|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
27783779|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
27783780|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
27783781|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
27783782|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
27865507|NCT00796757|81341963|FG000|Overall Study|Death|61|||
27865508|NCT00796757|81341963|FG000|Overall Study|Protocol Violation|1|||
27972314|NCT00837265|81730023|FG002|Main Phase|Death|0|||
27972315|NCT00837265|81730024|FG003|Main Phase|Death|0|||
27972316|NCT00837265|81730025|FG004|Main Phase|Death|2|||
27865509|NCT00796757|81341963|FG000|Overall Study|Participant noncompliance|1|||
27865510|NCT00796757|81341963|FG000|Overall Study|Investigator's decision|2|||
27865511|NCT00796757|81341963|FG000|Overall Study|Other|7|||
27783783|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
27783784|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
27783785|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
27865512|NCT04414618|81341970|FG000|Overall Study|Death|3|||
27865513|NCT04414618|81341971|FG001|Overall Study|Death|3|||
27865514|NCT04414618|81341970|FG000|Overall Study|Withdrawal by Subject|2|||
27865515|NCT04414618|81341971|FG001|Overall Study|Withdrawal by Subject|1|||
27865516|NCT04414618|81341970|FG000|Overall Study|Lost to Follow-up|2|||
27865517|NCT04414618|81341971|FG001|Overall Study|Lost to Follow-up|3|||
27865518|NCT04414618|81341970|FG000|Overall Study|Physician Decision|1|||
27865519|NCT04414618|81341971|FG001|Overall Study|Physician Decision|0|||
27865520|NCT02213510|81341972|FG000|Overall Study|Death|0|||
27865521|NCT02213510|81341973|FG001|Overall Study|Death|1|||
27865522|NCT02213510|81341972|FG000|Overall Study|Lost to Follow-up|1|||
27865523|NCT02213510|81341973|FG001|Overall Study|Lost to Follow-up|0|||
27865524|NCT03452137|81341974|FG000|Overall Study|Death|67|||
27865525|NCT03452137|81341975|FG001|Overall Study|Death|70|||
27865526|NCT03452137|81341974|FG000|Overall Study|Lost to Follow-up|4|||
27972317|NCT00837265|81730026|FG005|Main Phase|Death|0|||
27972318|NCT00837265|81730027|FG006|Main Phase|Death|1|||
27783786|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
27783787|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
27783788|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
27865527|NCT03452137|81341975|FG001|Overall Study|Lost to Follow-up|2|||
27865528|NCT03452137|81341974|FG000|Overall Study|Physician Decision|0|||
27865529|NCT03452137|81341975|FG001|Overall Study|Physician Decision|1|||
27865530|NCT03452137|81341974|FG000|Overall Study|Study Terminated by Sponsor|120|||
27972319|NCT00837265|81730021|FG000|Main Phase|Lost to Follow-up|0|||
27972320|NCT00837265|81730022|FG001|Main Phase|Lost to Follow-up|0|||
27865531|NCT03452137|81341975|FG001|Overall Study|Study Terminated by Sponsor|121|||
27865532|NCT03452137|81341974|FG000|Overall Study|Withdrawal by Subject|12|||
27972321|NCT00837265|81730023|FG002|Main Phase|Lost to Follow-up|0|||
27972322|NCT00837265|81730024|FG003|Main Phase|Lost to Follow-up|0|||
27783789|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
27783790|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
27865533|NCT03452137|81341975|FG001|Overall Study|Withdrawal by Subject|9|||
27865534|NCT02017015|81341978|FG000|Overall Study|Adverse Event|9|||
27865535|NCT02017015|81341978|FG000|Overall Study|Withdrawal by Subject|21|||
27865536|NCT02017015|81341978|FG000|Overall Study|Death|4|||
27865537|NCT02017015|81341978|FG000|Overall Study|Progressive Disease|31|||
27865538|NCT02017015|81341978|FG000|Overall Study|Non-compliance with study drug|2|||
27865539|NCT02017015|81341978|FG000|Overall Study|Physician Decision|2|||
27865540|NCT01611857|81341981|FG000|Overall Study|Withdrawal by Subject|0|||
27865541|NCT01611857|81341982|FG001|Overall Study|Withdrawal by Subject|2|||
27865542|NCT00258960|81341983|FG000|Overall Study|Death|2|||
27865543|NCT00258960|81341983|FG000|Overall Study|Disease Progression|7|||
27865544|NCT00258960|81341983|FG000|Overall Study|Adverse Event|4|||
27865545|NCT00258960|81341983|FG000|Overall Study|Physician Decision|1|||
27865546|NCT00258960|81341983|FG000|Overall Study|Withdrawal by Subject|1|||
27865547|NCT00258960|81341983|FG000|Overall Study|Mistake|2|||
27865548|NCT02960490|81341985|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
27865549|NCT02960490|81341986|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
27865550|NCT02960490|81341987|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865551|NCT02960490|81341988|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865552|NCT02960490|81341989|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865553|NCT02960490|81341990|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865554|NCT02960490|81341991|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865555|NCT02960490|81341992|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865556|NCT02960490|81341993|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865557|NCT02960490|81341994|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
27865558|NCT02960490|81341985|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865559|NCT02960490|81341986|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
27865560|NCT02960490|81341987|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865561|NCT02960490|81341988|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865562|NCT02960490|81341989|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865563|NCT02960490|81341990|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865564|NCT02960490|81341991|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865565|NCT02960490|81341992|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865566|NCT02960490|81341993|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865567|NCT02960490|81341994|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
27865568|NCT02960490|81341985|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
27865569|NCT02960490|81341986|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
27865570|NCT02960490|81341987|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865571|NCT02960490|81341988|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865572|NCT02960490|81341989|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865573|NCT02960490|81341990|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865574|NCT02960490|81341991|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865575|NCT02960490|81341992|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865576|NCT02960490|81341993|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865577|NCT02960490|81341994|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
27865578|NCT02960490|81341985|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
27865579|NCT02960490|81341986|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
27865580|NCT02960490|81341987|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27865581|NCT02960490|81341988|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27783791|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
27783792|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
27783793|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
27783794|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
27783795|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
27783796|NCT00634933|81036598|FG000|Part A: Baseline to Week 24|Other|1|||
27783797|NCT00634933|81036599|FG001|Part A: Baseline to Week 24|Other|8|||
27783798|NCT00634933|81036600|FG002|Part A: Baseline to Week 24|Other|5|||
27783799|NCT00634933|81036601|FG003|Part A: Baseline to Week 24|Other|0|||
27783800|NCT00634933|81036602|FG004|Part A: Baseline to Week 24|Other|0|||
27783801|NCT00634933|81036598|FG000|Between Part A and Part B|Physician Decision|0|||
27783802|NCT00634933|81036599|FG001|Between Part A and Part B|Physician Decision|1|||
27783803|NCT00634933|81036600|FG002|Between Part A and Part B|Physician Decision|0|||
27783804|NCT00634933|81036601|FG003|Between Part A and Part B|Physician Decision|0|||
27865582|NCT02960490|81341989|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27865583|NCT02960490|81341990|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27865584|NCT02960490|81341991|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27783805|NCT00634933|81036602|FG004|Between Part A and Part B|Physician Decision|0|||
27865585|NCT02960490|81341992|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27783806|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
27783807|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
27783808|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
27783809|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
27865586|NCT02960490|81341993|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27865587|NCT02960490|81341994|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
27865588|NCT02960490|81341985|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865589|NCT02960490|81341986|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865590|NCT02960490|81341987|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
27865591|NCT02960490|81341988|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
27865592|NCT02960490|81341989|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865593|NCT02960490|81341990|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
27865594|NCT02960490|81341991|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865595|NCT02960490|81341992|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865596|NCT02960490|81341993|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865597|NCT02960490|81341994|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
27865598|NCT02960490|81341985|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865599|NCT02960490|81341986|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865600|NCT02960490|81341987|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
27865601|NCT02960490|81341988|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865602|NCT02960490|81341989|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
27865603|NCT02960490|81341990|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27783810|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
27783811|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
27783812|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
27783813|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
27783814|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
27783815|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
27783816|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
27783817|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
27783818|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
27783819|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
27783820|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
27783821|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
27783822|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
27783823|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
27783824|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
27783825|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
27783826|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
27783827|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
27783828|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
27783829|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
27783830|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
27865604|NCT02960490|81341991|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865605|NCT02960490|81341992|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865606|NCT02960490|81341993|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865607|NCT02960490|81341994|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
27865608|NCT02960490|81341985|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
27783831|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
27865609|NCT02960490|81341986|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
27865610|NCT02960490|81341987|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
27865611|NCT02960490|81341988|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
27865612|NCT02960490|81341989|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
27865613|NCT02960490|81341990|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
27865614|NCT02960490|81341991|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
27865615|NCT02960490|81341992|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
27865616|NCT02960490|81341993|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
27865617|NCT02960490|81341994|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
27865618|NCT02960490|81341985|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865619|NCT02960490|81341986|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865620|NCT02960490|81341987|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865621|NCT02960490|81341988|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865622|NCT02960490|81341989|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865623|NCT02960490|81341990|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865624|NCT02960490|81341991|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
27865625|NCT02960490|81341992|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
27865626|NCT02960490|81341993|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
27865627|NCT02960490|81341994|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
27865628|NCT02960490|81341985|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865629|NCT02960490|81341986|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865630|NCT02960490|81341987|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865631|NCT02960490|81341988|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865632|NCT02960490|81341989|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865633|NCT02960490|81341990|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865634|NCT02960490|81341991|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865635|NCT02960490|81341992|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
27865636|NCT02960490|81341993|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865637|NCT02960490|81341994|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
27865638|NCT02960490|81341985|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
27865639|NCT02960490|81341986|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
27865640|NCT02960490|81341987|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
27865641|NCT02960490|81341988|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
27865642|NCT02960490|81341989|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
27865643|NCT02960490|81341990|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
27865644|NCT02960490|81341991|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
27865645|NCT02960490|81341992|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
27865646|NCT02960490|81341993|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
27865647|NCT02960490|81341994|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
27865648|NCT02960490|81341985|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865649|NCT02960490|81341986|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865650|NCT02960490|81341987|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865651|NCT02960490|81341988|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27972323|NCT00837265|81730025|FG004|Main Phase|Lost to Follow-up|1|||
27571530|NCT01481116|80278847|FG001|Overall Study|Contraindications|1|||
27571531|NCT01481116|80278848|FG002|Overall Study|Contraindications|0|||
27571532|NCT01481116|80278846|FG000|Overall Study|Other|1|||
27783832|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
27783833|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
27783834|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
27783835|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
27783836|NCT00634933|81036598|FG000|Part B: Week 24 to Week 52|Other|0|||
27783837|NCT00634933|81036599|FG001|Part B: Week 24 to Week 52|Other|0|||
27783838|NCT00634933|81036600|FG002|Part B: Week 24 to Week 52|Other|5|||
27783839|NCT00634933|81036601|FG003|Part B: Week 24 to Week 52|Other|0|||
27783840|NCT00634933|81036602|FG004|Part B: Week 24 to Week 52|Other|1|||
27783841|NCT03490734|81036603|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
27783842|NCT03490734|81036604|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
27783843|NCT03490734|81036605|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
27783844|NCT03490734|81036606|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
27783845|NCT03490734|81036603|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
27783846|NCT03490734|81036604|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
27783847|NCT03490734|81036605|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
27783848|NCT03490734|81036606|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
27783849|NCT03490734|81036603|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
27783850|NCT03490734|81036604|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
27783851|NCT03490734|81036605|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
27783852|NCT03490734|81036606|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
27783853|NCT03490734|81036603|FG000|Post-intervention Scan Visit|Adverse Event|2|||
27865652|NCT02960490|81341989|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865653|NCT02960490|81341990|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865654|NCT02960490|81341991|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
27865655|NCT02960490|81341992|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865656|NCT02960490|81341993|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865657|NCT02960490|81341994|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
27865658|NCT02960490|81341985|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865659|NCT02960490|81341986|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865660|NCT02960490|81341987|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865661|NCT02960490|81341988|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865662|NCT02960490|81341989|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865663|NCT02960490|81341990|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865664|NCT02960490|81341991|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865665|NCT02960490|81341992|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
27865666|NCT02960490|81341993|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865667|NCT02960490|81341994|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
27865668|NCT00996892|81341995|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
27865669|NCT00996892|81341996|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
27865670|NCT00996892|81341997|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
27865671|NCT00996892|81341998|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
27865672|NCT00996892|81341999|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
27865673|NCT00996892|81342000|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
27865674|NCT00996892|81342001|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
27865675|NCT00996892|81342002|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
27865676|NCT00996892|81342003|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
27865677|NCT00996892|81342004|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
27865678|NCT00996892|81342005|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
27865679|NCT00996892|81342006|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
27865680|NCT00996892|81342007|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
27865681|NCT00996892|81342008|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
27865682|NCT00996892|81342009|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
27865683|NCT00996892|81342010|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
27865684|NCT00996892|81342011|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
27865685|NCT00996892|81342012|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
27865686|NCT00996892|81342013|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
27783854|NCT03490734|81036604|FG001|Post-intervention Scan Visit|Adverse Event|0|||
27783855|NCT03490734|81036605|FG002|Post-intervention Scan Visit|Adverse Event|0|||
27783856|NCT03490734|81036606|FG003|Post-intervention Scan Visit|Adverse Event|0|||
27783857|NCT03490734|81036603|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
27783858|NCT03490734|81036604|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
27783859|NCT03490734|81036605|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
27865687|NCT00996892|81342014|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
27783860|NCT03490734|81036606|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
27783861|NCT03490734|81036603|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
27783862|NCT03490734|81036604|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
27783863|NCT03490734|81036605|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
27783864|NCT03490734|81036606|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
27865688|NCT00996892|81341995|FG000|Dose-Escalation Stage 1|Death|1|||
27972324|NCT00837265|81730026|FG005|Main Phase|Lost to Follow-up|0|||
27972325|NCT00837265|81730027|FG006|Main Phase|Lost to Follow-up|0|||
27972326|NCT00837265|81730021|FG000|Main Phase|Principal investigator resignation|0|||
27972327|NCT00837265|81730022|FG001|Main Phase|Principal investigator resignation|0|||
27972328|NCT00837265|81730023|FG002|Main Phase|Principal investigator resignation|0|||
27972329|NCT00837265|81730024|FG003|Main Phase|Principal investigator resignation|0|||
27972330|NCT00837265|81730025|FG004|Main Phase|Principal investigator resignation|2|||
27972331|NCT00837265|81730026|FG005|Main Phase|Principal investigator resignation|0|||
27972332|NCT00837265|81730027|FG006|Main Phase|Principal investigator resignation|0|||
27972333|NCT00837265|81730021|FG000|Main Phase|Participant's personal reason|0|||
27972334|NCT00837265|81730022|FG001|Main Phase|Participant's personal reason|0|||
27972335|NCT00837265|81730023|FG002|Main Phase|Participant's personal reason|0|||
27783865|NCT01747655|81036611|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
27783866|NCT01747655|81036612|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
27783867|NCT01747655|81036611|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
27865689|NCT00996892|81341996|FG001|Dose-Escalation Stage 1|Death|0|||
27865690|NCT00996892|81341997|FG002|Dose-Escalation Stage 1|Death|0|||
27865691|NCT00996892|81341998|FG003|Dose-Escalation Stage 1|Death|0|||
27972336|NCT00837265|81730024|FG003|Main Phase|Participant's personal reason|0|||
27972337|NCT00837265|81730025|FG004|Main Phase|Participant's personal reason|1|||
27783868|NCT01747655|81036612|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
27783869|NCT01747655|81036611|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
27972338|NCT00837265|81730026|FG005|Main Phase|Participant's personal reason|0|||
27571533|NCT01481116|80278847|FG001|Overall Study|Other|1|||
27571534|NCT01481116|80278848|FG002|Overall Study|Other|0|||
27571535|NCT01481116|80278846|FG000|Overall Study|Participant Started Taking Glipizide|1|||
27571536|NCT01481116|80278847|FG001|Overall Study|Participant Started Taking Glipizide|0|||
27571537|NCT01481116|80278848|FG002|Overall Study|Participant Started Taking Glipizide|0|||
27571538|NCT01481116|80278846|FG000|Overall Study|Participant Moved Out of Area|2|||
27571539|NCT01481116|80278847|FG001|Overall Study|Participant Moved Out of Area|0|||
27571540|NCT01481116|80278848|FG002|Overall Study|Participant Moved Out of Area|1|||
27571541|NCT01481116|80278846|FG000|Overall Study|Participant Moved Out of Country|1|||
27571542|NCT01481116|80278847|FG001|Overall Study|Participant Moved Out of Country|0|||
27972339|NCT00837265|81730027|FG006|Main Phase|Participant's personal reason|0|||
27972340|NCT02534935|81730028|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
27972341|NCT02534935|81730029|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
27972342|NCT02534935|81730030|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
27972343|NCT02534935|81730028|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
27972344|NCT02534935|81730029|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
27972345|NCT02534935|81730030|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
27972346|NCT02534935|81730028|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
27972347|NCT02534935|81730029|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
27972348|NCT02534935|81730030|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
27972349|NCT02534935|81730028|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
27972350|NCT02534935|81730029|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
27972351|NCT02534935|81730030|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
27972352|NCT02534935|81730028|FG000|Stage 1: 24 Months|Adverse Event|0|||
27669117|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
27669118|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
27669119|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Death|0|||
27669120|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Death|1|||
27669121|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
27669122|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
27669123|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
27669124|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
27783870|NCT01747655|81036612|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
27972353|NCT02534935|81730029|FG001|Stage 1: 24 Months|Adverse Event|2|||
27972354|NCT02534935|81730030|FG002|Stage 1: 24 Months|Adverse Event|0|||
27972355|NCT02534935|81730028|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
27972356|NCT02534935|81730029|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
27972357|NCT02534935|81730030|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
27972358|NCT02534935|81730028|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
27972359|NCT02534935|81730029|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
27972360|NCT02534935|81730030|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
27972361|NCT04043234|81730031|FG000|Overall Study|Lost to Follow-up|1|||
27972362|NCT04043234|81730031|FG000|Overall Study|Withdrawal by Subject|1|||
27972363|NCT02570152|81730032|FG000|Overall Study|Protocol Violation|2|||
27972364|NCT02570152|81730032|FG000|Overall Study|Migrated/moved from study area|13|||
27972365|NCT02019108|81730033|FG000|Overall Study|Lost to Follow-up|5|||
27972366|NCT02019108|81730034|FG001|Overall Study|Lost to Follow-up|7|||
27972367|NCT00191724|81730035|FG000|Overall Study|Adverse Event|0|||
27972368|NCT00191724|81730036|FG001|Overall Study|Adverse Event|0|||
27972369|NCT00191724|81730037|FG002|Overall Study|Adverse Event|1|||
27972370|NCT00191724|81730038|FG003|Overall Study|Adverse Event|0|||
27972371|NCT00191724|81730039|FG004|Overall Study|Adverse Event|0|||
27972372|NCT00191724|81730035|FG000|Overall Study|Lost to Follow-up|1|||
27972373|NCT00191724|81730036|FG001|Overall Study|Lost to Follow-up|1|||
27972374|NCT00191724|81730037|FG002|Overall Study|Lost to Follow-up|0|||
27972375|NCT00191724|81730038|FG003|Overall Study|Lost to Follow-up|2|||
27972376|NCT00191724|81730039|FG004|Overall Study|Lost to Follow-up|3|||
27972377|NCT00191724|81730035|FG000|Overall Study|Withdrawal by Subject|0|||
27571543|NCT01481116|80278848|FG002|Overall Study|Participant Moved Out of Country|1|||
27833017|NCT02658487|81219436|FG000|Overall Study|Alternative therapy|1|||
27571544|NCT01481116|80278846|FG000|Overall Study|Investigator Decision|3|||
27972378|NCT00191724|81730036|FG001|Overall Study|Withdrawal by Subject|0|||
27972379|NCT00191724|81730037|FG002|Overall Study|Withdrawal by Subject|0|||
27972380|NCT00191724|81730038|FG003|Overall Study|Withdrawal by Subject|1|||
27972381|NCT00191724|81730039|FG004|Overall Study|Withdrawal by Subject|0|||
27972382|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Adverse Event|76|||
27669125|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
27669126|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
27669127|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
27972383|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Adverse Event|0|||
27972384|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Adverse Event|0|||
27972385|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Death|3|||
27972386|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Death|0|||
27972387|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Death|0|||
27972388|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
27972389|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
27972390|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
27972391|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Physician Decision|9|||
27972392|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Physician Decision|0|||
27972393|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Physician Decision|0|||
27972394|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
27972395|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
27972396|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
27972397|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Disease progression|45|||
27972398|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Disease progression|0|||
27972399|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Disease progression|0|||
27972400|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
27972401|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
27972402|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
27972403|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
27972404|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
27972405|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
27972406|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
27972407|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
27783871|NCT02242305|81036616|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
27783872|NCT02242305|81036617|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
27783873|NCT02242305|81036616|FG000|Overall Study|Adverse Event|1|||
27972408|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
27972409|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
27972410|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
27972411|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
27972412|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
27669128|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
27669129|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
27669130|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
27669131|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
27669132|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
27669133|NCT01309243|80627500|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
27669134|NCT01309243|80627501|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
27669135|NCT01309243|80627500|FG000|Extension Phase|Lost to Follow-up|6|||
27669136|NCT01309243|80627501|FG001|Extension Phase|Lost to Follow-up|0|||
27669137|NCT00934700|80627502|FG000|Overall Study|missing scan|5|||
27669138|NCT00934700|80627503|FG001|Overall Study|missing scan|9|||
27669139|NCT00934700|80627502|FG000|Overall Study|Death|8|||
27669140|NCT00934700|80627503|FG001|Overall Study|Death|3|||
27972413|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
27669141|NCT04486313|80627504|FG000|Overall Study|Lost to Follow-up|7|||
27669142|NCT04486313|80627505|FG001|Overall Study|Lost to Follow-up|9|||
27669143|NCT04486313|80627504|FG000|Overall Study|Withdrawal by Subject|8|||
27669144|NCT04486313|80627505|FG001|Overall Study|Withdrawal by Subject|6|||
27669145|NCT04486313|80627504|FG000|Overall Study|Physician Decision|1|||
27669146|NCT04486313|80627505|FG001|Overall Study|Physician Decision|1|||
27669147|NCT04486313|80627504|FG000|Overall Study|Death|2|||
27783874|NCT02242305|81036617|FG001|Overall Study|Adverse Event|0|||
27783875|NCT02242305|81036616|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
27972414|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
27972415|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
27669148|NCT04486313|80627505|FG001|Overall Study|Death|0|||
27783876|NCT02242305|81036617|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
27783877|NCT02242305|81036616|FG000|Overall Study|Subject withdraws inform consent|0|||
27783878|NCT02242305|81036617|FG001|Overall Study|Subject withdraws inform consent|4|||
27783879|NCT02242305|81036616|FG000|Overall Study|Lost to Follow-up|2|||
27783880|NCT02242305|81036617|FG001|Overall Study|Lost to Follow-up|0|||
27783881|NCT00348686|81036618|FG000|Overall Study|Withdrawal by Subject|45|||
27783882|NCT00348686|81036618|FG000|Overall Study|Adverse Event|5|||
27783883|NCT00348686|81036618|FG000|Overall Study|Protocol Violation|6|||
27783884|NCT00348686|81036618|FG000|Overall Study|Lost to Follow-up|2|||
27783885|NCT00348686|81036618|FG000|Overall Study|Multiple Reasons|8|||
27783886|NCT02924129|81036619|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
27783887|NCT02924129|81036620|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
27783888|NCT02924129|81036619|FG000|Overall Study|Withdrawal by Subject|2|||
27783889|NCT02924129|81036620|FG001|Overall Study|Withdrawal by Subject|2|||
27783890|NCT02924129|81036619|FG000|Overall Study|Physician Decision|1|||
27783891|NCT02924129|81036620|FG001|Overall Study|Physician Decision|0|||
27783892|NCT02924129|81036619|FG000|Overall Study|Missed Visit|0|||
27783893|NCT02924129|81036620|FG001|Overall Study|Missed Visit|1|||
27783894|NCT00665002|81036624|FG000|Overall Study|Progression/relapse during treatment|11|||
27783895|NCT00665002|81036624|FG000|Overall Study|Cytogenetic resistance|1|||
27783896|NCT00955682|81036625|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
27783897|NCT00955682|81036626|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
27783898|NCT01354964|81036627|FG000|Overall Study|Lost to Follow-up|2|||
27783899|NCT01354964|81036628|FG001|Overall Study|Lost to Follow-up|0|||
27783900|NCT01354964|81036627|FG000|Overall Study|IV access issues|1|||
27783901|NCT01354964|81036628|FG001|Overall Study|IV access issues|1|||
27783902|NCT01354964|81036627|FG000|Overall Study|Physician Decision|1|||
27783903|NCT01354964|81036628|FG001|Overall Study|Physician Decision|0|||
27783904|NCT00626327|81036629|FG000|Overall Study|Withdrawal by Subject|21|||
27783905|NCT00626327|81036630|FG001|Overall Study|Withdrawal by Subject|29|||
27783906|NCT00626327|81036631|FG002|Overall Study|Withdrawal by Subject|30|||
27783907|NCT00626327|81036629|FG000|Overall Study|Adverse Event|1|||
27783908|NCT00626327|81036630|FG001|Overall Study|Adverse Event|0|||
27783909|NCT00626327|81036631|FG002|Overall Study|Adverse Event|0|||
27783910|NCT00626327|81036629|FG000|Overall Study|Lost to Follow-up|24|||
27783911|NCT00626327|81036630|FG001|Overall Study|Lost to Follow-up|21|||
27783912|NCT00626327|81036631|FG002|Overall Study|Lost to Follow-up|23|||
27972416|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
27972417|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
27972418|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
27972419|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
27972420|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
27972421|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
27669149|NCT04486313|80627504|FG000|Overall Study|Protocol Violation|1|||
27669150|NCT04486313|80627505|FG001|Overall Study|Protocol Violation|1|||
27669151|NCT00846768|80627506|FG000|Overall Study|Adverse Event|0|||
27669152|NCT00846768|80627507|FG001|Overall Study|Adverse Event|1|||
27669153|NCT00846768|80627508|FG002|Overall Study|Adverse Event|0|||
27669154|NCT00846768|80627509|FG003|Overall Study|Adverse Event|0|||
27669155|NCT00983892|80627515|FG000|Overall Study|Withdrawal by Subject|10|||
27669156|NCT00983892|80627516|FG001|Overall Study|Withdrawal by Subject|12|||
27669157|NCT01192776|80627517|FG000|Overall Study|Death|8|||
27669158|NCT01192776|80627518|FG001|Overall Study|Death|15|||
27669159|NCT01192776|80627519|FG002|Overall Study|Death|18|||
27669160|NCT01192776|80627520|FG003|Overall Study|Death|15|||
27669161|NCT01192776|80627517|FG000|Overall Study|Lost to Follow-up|3|||
27783913|NCT00626327|81036629|FG000|Overall Study|Inappropriate enrollment|4|||
27783914|NCT00626327|81036630|FG001|Overall Study|Inappropriate enrollment|5|||
27972422|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
27972423|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
27972424|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
27783915|NCT00626327|81036631|FG002|Overall Study|Inappropriate enrollment|3|||
27972425|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
27669162|NCT01192776|80627518|FG001|Overall Study|Lost to Follow-up|6|||
27669163|NCT01192776|80627519|FG002|Overall Study|Lost to Follow-up|3|||
27669164|NCT01192776|80627520|FG003|Overall Study|Lost to Follow-up|5|||
27669165|NCT04016805|80627521|FG000|Overall Study|Sponsor's Discretion|30|||
27669166|NCT04016805|80627522|FG001|Overall Study|Sponsor's Discretion|6|||
27783916|NCT00626327|81036629|FG000|Overall Study|Administrative Reason|2|||
27783917|NCT00626327|81036630|FG001|Overall Study|Administrative Reason|0|||
27783918|NCT00626327|81036631|FG002|Overall Study|Administrative Reason|6|||
27783919|NCT00626327|81036629|FG000|Overall Study|Protocol Violation|26|||
27972426|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
27669167|NCT04016805|80627523|FG002|Overall Study|Sponsor's Discretion|5|||
27669168|NCT01101061|80627524|FG000|Overall Study|Adverse Event|0|||
27669169|NCT01101061|80627525|FG001|Overall Study|Adverse Event|0|||
27669170|NCT01101061|80627526|FG002|Overall Study|Adverse Event|1|||
27972427|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Promotor request|1|||
27972428|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Promotor request|0|||
27669171|NCT01101061|80627527|FG003|Overall Study|Adverse Event|0|||
27669172|NCT01101061|80627528|FG004|Overall Study|Adverse Event|0|||
27669173|NCT01101061|80627529|FG005|Overall Study|Adverse Event|0|||
27669174|NCT03796208|80627530|FG000|Overall Study|Withdrawal by Subject|3|||
27669175|NCT03796208|80627531|FG001|Overall Study|Withdrawal by Subject|0|||
27669176|NCT03796208|80627530|FG000|Overall Study|Loss of pregnancy|1|||
27669177|NCT03796208|80627531|FG001|Overall Study|Loss of pregnancy|1|||
27669178|NCT03796208|80627530|FG000|Overall Study|Changed prenatal clinics|0|||
27669179|NCT03796208|80627531|FG001|Overall Study|Changed prenatal clinics|5|||
27669180|NCT03796208|80627530|FG000|Overall Study|Lost to Follow-up|20|||
27669181|NCT03796208|80627531|FG001|Overall Study|Lost to Follow-up|16|||
27669182|NCT00927901|80627532|FG000|Treatment Period 1|Subject withdrew consent|0|||
27669183|NCT00927901|80627533|FG001|Treatment Period 1|Subject withdrew consent|0|||
27669184|NCT00927901|80627534|FG002|Treatment Period 1|Subject withdrew consent|1|||
27669185|NCT00927901|80627535|FG003|Treatment Period 1|Subject withdrew consent|0|||
27669186|NCT00927901|80627532|FG000|Treatment Period 4|Adverse Event|0|||
27669187|NCT00927901|80627533|FG001|Treatment Period 4|Adverse Event|0|||
27669188|NCT00927901|80627534|FG002|Treatment Period 4|Adverse Event|0|||
27669189|NCT00927901|80627535|FG003|Treatment Period 4|Adverse Event|1|||
27669190|NCT00927901|80627532|FG000|Treatment Period 4|Subject withdrew consent|0|||
27669191|NCT00927901|80627533|FG001|Treatment Period 4|Subject withdrew consent|0|||
27669192|NCT00927901|80627534|FG002|Treatment Period 4|Subject withdrew consent|1|||
27669193|NCT00927901|80627535|FG003|Treatment Period 4|Subject withdrew consent|0|||
27669194|NCT04629443|80627543|FG000|Overall Study|Adverse Event|2|||
27669195|NCT04629443|80627544|FG001|Overall Study|Adverse Event|1|||
27669196|NCT04629443|80627545|FG002|Overall Study|Adverse Event|2|||
27669197|NCT04629443|80627543|FG000|Overall Study|Progressive Disease|2|||
27669198|NCT04629443|80627544|FG001|Overall Study|Progressive Disease|3|||
27669199|NCT04629443|80627545|FG002|Overall Study|Progressive Disease|3|||
27669200|NCT04629443|80627543|FG000|Overall Study|Physician Decision|1|||
27669201|NCT04629443|80627544|FG001|Overall Study|Physician Decision|3|||
27669202|NCT04629443|80627545|FG002|Overall Study|Physician Decision|0|||
27669203|NCT02520310|80627549|FG000|At 6 Months Clinical Follow-up|Death|1|||
27669204|NCT02520310|80627549|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
27669205|NCT02520310|80627549|FG000|AT 3 Year Clinical Follow-up|Death|2|||
27669206|NCT02520310|80627549|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
27669207|NCT02520310|80627549|FG000|AT 4 Year Clinical Follow-up|Death|1|||
27669208|NCT02520310|80627549|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
27669209|NCT02561806|80627550|FG000|Induction Period|Adverse Event|0|||
27669210|NCT02561806|80627551|FG001|Induction Period|Adverse Event|2|||
27669211|NCT02561806|80627550|FG000|Induction Period|Lack of Efficacy|1|||
27669212|NCT02561806|80627551|FG001|Induction Period|Lack of Efficacy|0|||
27669213|NCT02561806|80627550|FG000|Induction Period|Withdrawal by Subject|0|||
27669214|NCT02561806|80627551|FG001|Induction Period|Withdrawal by Subject|2|||
27669215|NCT02561806|80627550|FG000|Induction Period|Site staff became unblinded|1|||
27669216|NCT02561806|80627551|FG001|Induction Period|Site staff became unblinded|0|||
27783920|NCT00626327|81036630|FG001|Overall Study|Protocol Violation|4|||
27783921|NCT00626327|81036631|FG002|Overall Study|Protocol Violation|26|||
27783922|NCT01711359|81036635|FG000|Treatment Period|Withdrawal by Subject|18|||
27783923|NCT01711359|81036636|FG001|Treatment Period|Withdrawal by Subject|7|||
27972429|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Promotor request|0|||
27669217|NCT02561806|80627550|FG000|Induction Period|Randomized but not treated|0|||
27669218|NCT02561806|80627551|FG001|Induction Period|Randomized but not treated|1|||
27669219|NCT02561806|80627550|FG000|Maintenance Period|Adverse Event|2|||
27669220|NCT02561806|80627551|FG001|Maintenance Period|Adverse Event|1|||
27669221|NCT02561806|80627550|FG000|Maintenance Period|Lack of Efficacy|3|||
27972430|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
27669222|NCT02561806|80627551|FG001|Maintenance Period|Lack of Efficacy|1|||
27669223|NCT02561806|80627550|FG000|Maintenance Period|Lost to Follow-up|2|||
27972431|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
27669224|NCT02561806|80627551|FG001|Maintenance Period|Lost to Follow-up|2|||
27669225|NCT02561806|80627550|FG000|Maintenance Period|Protocol Violation|1|||
27972432|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
27972433|NCT01461928|81730040|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
27669226|NCT02561806|80627551|FG001|Maintenance Period|Protocol Violation|0|||
27669227|NCT02561806|80627550|FG000|Maintenance Period|Withdrawal by Subject|5|||
27669228|NCT02561806|80627551|FG001|Maintenance Period|Withdrawal by Subject|3|||
27783924|NCT01711359|81036637|FG002|Treatment Period|Withdrawal by Subject|13|||
27783925|NCT01711359|81036635|FG000|Treatment Period|Lack of Efficacy|13|||
27783926|NCT01711359|81036636|FG001|Treatment Period|Lack of Efficacy|2|||
27783927|NCT01711359|81036637|FG002|Treatment Period|Lack of Efficacy|2|||
27783928|NCT01711359|81036635|FG000|Treatment Period|Adverse Event|8|||
27972434|NCT01461928|81730041|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
27972435|NCT01461928|81730042|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
27972436|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Death|3|||
27972437|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Death|0|||
27972438|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Death|0|||
27972439|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
27783929|NCT01711359|81036636|FG001|Treatment Period|Adverse Event|10|||
27783930|NCT01711359|81036637|FG002|Treatment Period|Adverse Event|24|||
27783931|NCT01711359|81036635|FG000|Treatment Period|Physician Decision|4|||
27783932|NCT01711359|81036636|FG001|Treatment Period|Physician Decision|3|||
27972440|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
27972441|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
27972442|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
27972443|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
27972444|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
27972445|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Diseases progression|91|||
27972446|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Diseases progression|0|||
27972447|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Diseases progression|0|||
27972448|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Adverse Event|70|||
27972449|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Adverse Event|0|||
27972450|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Adverse Event|0|||
27972451|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Physician Decision|9|||
27972452|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Physician Decision|0|||
27972453|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Physician Decision|0|||
27972454|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
27972455|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
27972456|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
27972457|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
27972458|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
27972459|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
27972460|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
27972461|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
27972462|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
27972463|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Not compliant|1|||
27972464|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Not compliant|0|||
27972465|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Not compliant|0|||
27972466|NCT01461928|81730040|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
27972467|NCT01461928|81730041|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
27972468|NCT01461928|81730042|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
27972469|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Adverse Event|0|||
27972470|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Adverse Event|2|||
27669229|NCT02561806|80627550|FG000|Maintenance Period|Site staff became unblinded|0|||
27669230|NCT02561806|80627551|FG001|Maintenance Period|Site staff became unblinded|1|||
27669231|NCT02561806|80627550|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
27669232|NCT02561806|80627551|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
27669233|NCT02561806|80627550|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
27669234|NCT02561806|80627551|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
27669235|NCT02438371|80627556|FG000|Overall Study|Lost to Follow-up|3|||
27669236|NCT02438371|80627557|FG001|Overall Study|Lost to Follow-up|2|||
27669237|NCT02438371|80627556|FG000|Overall Study|Withdrawal by Subject|1|||
27669238|NCT02438371|80627557|FG001|Overall Study|Withdrawal by Subject|1|||
27669239|NCT03589300|80627560|FG000|Overall Study|Adverse Event|2|||
27669240|NCT03589300|80627560|FG000|Overall Study|Death|4|||
27972471|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Adverse Event|0|||
27972472|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Death|0|||
27972473|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Death|10|||
27972474|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Death|8|||
27972475|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Physician Decision|0|||
27972476|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Physician Decision|0|||
27972477|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Physician Decision|4|||
27972478|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
27972479|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
27972480|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
27972481|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Moved to another town|0|||
27669241|NCT03589300|80627560|FG000|Overall Study|Lost to Follow-up|12|||
27669242|NCT03589300|80627560|FG000|Overall Study|Withdrawal by Subject|5|||
27669243|NCT00944229|80627561|FG000|Overall Study|Withdrawal by Subject|11|||
27783933|NCT01711359|81036637|FG002|Treatment Period|Physician Decision|2|||
27783934|NCT01711359|81036635|FG000|Treatment Period|Death|3|||
27783935|NCT01711359|81036636|FG001|Treatment Period|Death|0|||
27783936|NCT01711359|81036637|FG002|Treatment Period|Death|0|||
27783937|NCT01711359|81036635|FG000|Treatment Period|Entry Criteria Not Met|1|||
27669244|NCT00944229|80627561|FG000|Overall Study|Physician Decision|14|||
27669245|NCT02171130|80627562|FG000|Overall Study|Death|1|||
27669246|NCT02171130|80627562|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
27669247|NCT02171130|80627562|FG000|Overall Study|Discontinued; Site Termination|5|||
27669248|NCT02171130|80627562|FG000|Overall Study|Withdrawal by Subject|3|||
27669249|NCT02171130|80627562|FG000|Overall Study|Physician Decision|1|||
27669250|NCT02171130|80627562|FG000|Overall Study|Lost to Follow-up|1|||
27669251|NCT02171130|80627562|FG000|Overall Study|Met Exclusion Criteria|1|||
27669252|NCT03864341|80627563|FG000|Overall Study|Withdrawal by Subject|1|||
27669253|NCT00025662|80627564|FG000|Overall Study|Withdrawal by Subject|2|||
27669254|NCT00025662|80627564|FG000|Overall Study|Technical failure of manipulation|1|||
27669255|NCT00983905|80627565|FG000|Theophylline Alone|Adverse Event|1|||
27669256|NCT00983905|80627565|FG000|Colchicine Alone|Adverse Event|2|||
27669257|NCT03927690|80627567|FG000|Overall Study|Withdrawal by Subject|3|||
27669258|NCT03927690|80627568|FG001|Overall Study|Withdrawal by Subject|1|||
27669259|NCT03927690|80627569|FG002|Overall Study|Withdrawal by Subject|1|||
27669260|NCT03927690|80627567|FG000|Overall Study|Adverse Event|1|||
27669261|NCT03927690|80627568|FG001|Overall Study|Adverse Event|0|||
27669262|NCT03927690|80627569|FG002|Overall Study|Adverse Event|0|||
27669263|NCT03927690|80627567|FG000|Overall Study|Death|1|||
27669264|NCT03927690|80627568|FG001|Overall Study|Death|0|||
27669265|NCT03927690|80627569|FG002|Overall Study|Death|0|||
27669266|NCT03927690|80627567|FG000|Overall Study|Lost to Follow-up|2|||
27669267|NCT03927690|80627568|FG001|Overall Study|Lost to Follow-up|2|||
27669268|NCT03927690|80627569|FG002|Overall Study|Lost to Follow-up|1|||
27669269|NCT02509312|80627570|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
27669270|NCT02509312|80627571|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
27669271|NCT02509312|80627570|FG000|Overall Study|Obstetrician refusal|0|||
27669272|NCT02509312|80627571|FG001|Overall Study|Obstetrician refusal|1|||
27669273|NCT02509312|80627570|FG000|Overall Study|Patient elected for TOLAC|1|||
27669274|NCT02509312|80627571|FG001|Overall Study|Patient elected for TOLAC|0|||
27669275|NCT02509312|80627570|FG000|Overall Study|Cesarean deemed stat|1|||
27669276|NCT02509312|80627571|FG001|Overall Study|Cesarean deemed stat|0|||
27669277|NCT02509312|80627570|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
27669278|NCT02509312|80627571|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
27669279|NCT01018732|80627572|FG000|Overall Study|Lost to Follow-up|0|||
27669280|NCT01018732|80627573|FG001|Overall Study|Lost to Follow-up|0|||
27669281|NCT01018732|80627574|FG002|Overall Study|Lost to Follow-up|3|||
27669282|NCT01018732|80627572|FG000|Overall Study|Protocol Violation|1|||
27669283|NCT01018732|80627573|FG001|Overall Study|Protocol Violation|1|||
27669284|NCT01018732|80627574|FG002|Overall Study|Protocol Violation|0|||
27669285|NCT01018732|80627572|FG000|Overall Study|Inappropriate Enrollment|0|||
27669286|NCT01018732|80627573|FG001|Overall Study|Inappropriate Enrollment|1|||
27669287|NCT01018732|80627574|FG002|Overall Study|Inappropriate Enrollment|0|||
27669288|NCT01018732|80627572|FG000|Overall Study|Unable to Classify|0|||
27669289|NCT01018732|80627573|FG001|Overall Study|Unable to Classify|0|||
27669290|NCT01018732|80627574|FG002|Overall Study|Unable to Classify|1|||
27669291|NCT00548847|80627577|FG000|Overall Study|Disease progression|7|||
27669292|NCT00827775|80627580|FG000|Overall Study|Withdrawal by Subject|0|||
27669293|NCT00827775|80627581|FG001|Overall Study|Withdrawal by Subject|5|||
27669294|NCT00004445|80627582|FG000|Overall Study|Physician Decision|2|||
27669295|NCT00004445|80627582|FG000|Overall Study|Withdrawal by Subject|1|||
27669296|NCT04582669|80627583|FG000|Overall Study|Subject missed appointment(s).|1|||
27669297|NCT04582669|80627584|FG001|Overall Study|Subject missed appointment(s).|0|||
27669298|NCT04582669|80627585|FG002|Overall Study|Subject missed appointment(s).|1|||
27669299|NCT04582669|80627586|FG003|Overall Study|Subject missed appointment(s).|2|||
27783938|NCT01711359|81036636|FG001|Treatment Period|Entry Criteria Not Met|0|||
27669300|NCT04582669|80627583|FG000|Overall Study|Protocol Violation|0|||
27669301|NCT04582669|80627584|FG001|Overall Study|Protocol Violation|1|||
27669302|NCT04582669|80627585|FG002|Overall Study|Protocol Violation|1|||
27783939|NCT01711359|81036637|FG002|Treatment Period|Entry Criteria Not Met|0|||
27783940|NCT01711359|81036635|FG000|Treatment Period|Sponsor Decision|1|||
27669303|NCT04582669|80627586|FG003|Overall Study|Protocol Violation|0|||
27669304|NCT00243022|80627588|FG000|Overall Study|Withdrawal by Subject|1|||
27669305|NCT00243022|80627589|FG001|Overall Study|Withdrawal by Subject|0|||
27669306|NCT00243022|80627588|FG000|Overall Study|Death|1|||
27669307|NCT00243022|80627589|FG001|Overall Study|Death|0|||
27669308|NCT00243022|80627588|FG000|Overall Study|Difficult Travel Distance|0|||
27669309|NCT00243022|80627589|FG001|Overall Study|Difficult Travel Distance|1|||
27669310|NCT00197106|80627593|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
27669311|NCT00197106|80627594|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
27783941|NCT01711359|81036636|FG001|Treatment Period|Sponsor Decision|0|||
27669312|NCT00197106|80627595|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
27669313|NCT00197106|80627593|FG000|Overall Treatment Period|Lack of Efficacy|0|||
27669314|NCT00197106|80627594|FG001|Overall Treatment Period|Lack of Efficacy|1|||
27669315|NCT00197106|80627595|FG002|Overall Treatment Period|Lack of Efficacy|0|||
27669316|NCT00197106|80627593|FG000|Overall Treatment Period|Lost to Follow-up|0|||
27669317|NCT00197106|80627594|FG001|Overall Treatment Period|Lost to Follow-up|0|||
27669318|NCT00197106|80627595|FG002|Overall Treatment Period|Lost to Follow-up|2|||
27669319|NCT00197106|80627593|FG000|Overall Treatment Period|Protocol Violation|0|||
27669320|NCT00197106|80627594|FG001|Overall Treatment Period|Protocol Violation|0|||
27669321|NCT00197106|80627595|FG002|Overall Treatment Period|Protocol Violation|2|||
27669322|NCT00197106|80627593|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
27669323|NCT00197106|80627594|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
27669324|NCT00197106|80627595|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
27783942|NCT01711359|81036637|FG002|Treatment Period|Sponsor Decision|0|||
27783943|NCT01711359|81036635|FG000|Treatment Period|Lost to Follow-up|1|||
27783944|NCT01711359|81036636|FG001|Treatment Period|Lost to Follow-up|1|||
27783945|NCT01711359|81036637|FG002|Treatment Period|Lost to Follow-up|1|||
27783946|NCT01711359|81036635|FG000|Treatment Period|Randomized, Not Treated|3|||
27783947|NCT01711359|81036636|FG001|Treatment Period|Randomized, Not Treated|1|||
27783948|NCT01711359|81036637|FG002|Treatment Period|Randomized, Not Treated|0|||
27783949|NCT02718131|81036640|FG000|Overall Study|Withdrawal by Subject|1|||
27783950|NCT02718131|81036641|FG001|Overall Study|Withdrawal by Subject|0|||
27783951|NCT02718131|81036640|FG000|Overall Study|Adverse Event|1|||
27783952|NCT02718131|81036641|FG001|Overall Study|Adverse Event|0|||
27783953|NCT02718131|81036640|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
27972482|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Moved to another town|1|||
27972483|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Moved to another town|0|||
27972484|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Disease progression|0|||
27972485|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Disease progression|0|||
27972486|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Disease progression|3|||
27972487|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
27972488|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
27972489|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
27972490|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
27972491|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
27972492|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
27972493|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
27972494|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
27972495|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
27972496|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
27972497|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
27972498|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
27972499|NCT01461928|81730040|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
27972500|NCT01461928|81730041|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
27972501|NCT01461928|81730042|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
27972502|NCT03344549|81730043|FG000|Overall Study|Withdrawal by Subject|3|||
27972503|NCT03344549|81730044|FG001|Overall Study|Withdrawal by Subject|2|||
27972504|NCT03344549|81730043|FG000|Overall Study|Dialysis|2|||
27972505|NCT03344549|81730044|FG001|Overall Study|Dialysis|0|||
27972506|NCT03344549|81730043|FG000|Overall Study|Cancer|1|||
27972507|NCT03344549|81730044|FG001|Overall Study|Cancer|0|||
27972508|NCT03344549|81730043|FG000|Overall Study|Lack of electronic device|1|||
27972509|NCT03344549|81730044|FG001|Overall Study|Lack of electronic device|0|||
27972510|NCT03344549|81730043|FG000|Overall Study|Transportation difficulty|0|||
27972511|NCT03344549|81730044|FG001|Overall Study|Transportation difficulty|13|||
27972512|NCT03195660|81730045|FG000|Overall Study|The study was terminated|2|||
27972513|NCT02242435|81730052|FG000|Overall Study|Lost to Follow-up|3|||
27972514|NCT02242435|81730053|FG001|Overall Study|Lost to Follow-up|4|||
27972515|NCT02242435|81730052|FG000|Overall Study|Adverse Event|3|||
27972516|NCT02242435|81730053|FG001|Overall Study|Adverse Event|2|||
27972517|NCT02242435|81730052|FG000|Overall Study|Withdrawal by Subject|13|||
27972518|NCT02242435|81730053|FG001|Overall Study|Withdrawal by Subject|8|||
27972519|NCT02242435|81730052|FG000|Overall Study|Death|0|||
27972520|NCT02242435|81730053|FG001|Overall Study|Death|1|||
27972521|NCT02242435|81730052|FG000|Overall Study|Protocol Violation|1|||
27972522|NCT02242435|81730053|FG001|Overall Study|Protocol Violation|0|||
27669325|NCT01918371|80627596|FG000|Overall Study|Missing Data|1|||
27972523|NCT02242435|81730052|FG000|Overall Study|Physician Decision|0|||
27972524|NCT02242435|81730053|FG001|Overall Study|Physician Decision|1|||
27669326|NCT01918371|80627597|FG001|Overall Study|Missing Data|1|||
27783954|NCT02718131|81036641|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
27669327|NCT00510146|80627598|FG000|Double-Blind Treatment|Adverse Event|30|||
27669328|NCT00510146|80627599|FG001|Double-Blind Treatment|Adverse Event|13|||
27972525|NCT03222973|81730054|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
27972526|NCT03222973|81730055|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
27865692|NCT00996892|81341999|FG004|Dose-Escalation Stage 1|Death|0|||
27865693|NCT00996892|81342000|FG005|Dose-Escalation Stage 1|Death|1|||
27972527|NCT03222973|81730056|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
27972528|NCT03222973|81730057|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
27972529|NCT03222973|81730054|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
27972530|NCT03222973|81730055|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
27972531|NCT03222973|81730056|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
27972532|NCT03222973|81730057|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
27972533|NCT03222973|81730054|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
27972534|NCT03222973|81730055|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
27972535|NCT03222973|81730056|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
27972536|NCT03222973|81730057|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
27972537|NCT03222973|81730054|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
27972538|NCT03222973|81730055|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
27972539|NCT03222973|81730056|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
27972540|NCT03222973|81730057|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
27972541|NCT03222973|81730054|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
27972542|NCT03222973|81730055|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
27972543|NCT03222973|81730056|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
27972544|NCT03222973|81730057|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
27972545|NCT03222973|81730054|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
27972546|NCT03222973|81730055|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
27972547|NCT03222973|81730056|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
27972548|NCT03222973|81730057|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
27972549|NCT03222973|81730054|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
27972550|NCT03222973|81730055|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
27972551|NCT03222973|81730056|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
27972552|NCT03222973|81730057|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
27972553|NCT03222973|81730054|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
27972554|NCT03222973|81730055|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
27972555|NCT03222973|81730056|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
27972556|NCT03222973|81730057|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
27972557|NCT03222973|81730054|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
27972558|NCT03222973|81730055|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
27972559|NCT03222973|81730056|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
27972560|NCT03222973|81730057|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
27972561|NCT03222973|81730054|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
27972562|NCT03222973|81730055|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
27972563|NCT03222973|81730056|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
27972564|NCT03222973|81730057|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
27972565|NCT03222973|81730054|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
27972566|NCT03222973|81730055|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
27972567|NCT03222973|81730056|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
27972568|NCT03222973|81730057|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
27972569|NCT03222973|81730054|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
27972570|NCT03222973|81730055|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
27972571|NCT03222973|81730056|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
27972572|NCT03222973|81730057|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
27972573|NCT01062841|81730059|FG000|Overall Study|Indwelling Device Removed|41|||
27972574|NCT01062841|81730060|FG001|Overall Study|Indwelling Device Removed|48|||
27972575|NCT01062841|81730059|FG000|Overall Study|Death|3|||
27972576|NCT01062841|81730060|FG001|Overall Study|Death|5|||
27972577|NCT01062841|81730059|FG000|Overall Study|Withdrawal by Subject|2|||
27972578|NCT01062841|81730060|FG001|Overall Study|Withdrawal by Subject|0|||
27972579|NCT01062841|81730059|FG000|Overall Study|Withdrawal by Study|3|||
27972580|NCT01062841|81730060|FG001|Overall Study|Withdrawal by Study|0|||
27972581|NCT03466099|81730063|FG000|Overall Study|Adverse Event|1|||
27972582|NCT03466099|81730064|FG001|Overall Study|Adverse Event|1|||
27669329|NCT00510146|80627598|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
27972583|NCT03466099|81730065|FG002|Overall Study|Adverse Event|1|||
27972584|NCT03466099|81730063|FG000|Overall Study|Withdrawal by Subject|2|||
27972585|NCT03466099|81730064|FG001|Overall Study|Withdrawal by Subject|3|||
27783955|NCT00027846|81036642|FG000|Overall Study|Lost to Follow-up|0|||
27783956|NCT00027846|81036643|FG001|Overall Study|Lost to Follow-up|41|||
27783957|NCT00027846|81036644|FG002|Overall Study|Lost to Follow-up|9|||
27783958|NCT00027846|81036642|FG000|Overall Study|Withdrawal by Subject|0|||
27783959|NCT00027846|81036643|FG001|Overall Study|Withdrawal by Subject|14|||
27783960|NCT00027846|81036644|FG002|Overall Study|Withdrawal by Subject|7|||
27783961|NCT00027846|81036642|FG000|Overall Study|Ineligible for study|2|||
27783962|NCT00027846|81036643|FG001|Overall Study|Ineligible for study|6|||
27783963|NCT00027846|81036644|FG002|Overall Study|Ineligible for study|14|||
27783964|NCT00027846|81036642|FG000|Overall Study|Entry into another COG therapeutic study|0|||
27972586|NCT03466099|81730065|FG002|Overall Study|Withdrawal by Subject|1|||
27972587|NCT03466099|81730063|FG000|Overall Study|Use of rescue medication|8|||
27972588|NCT03466099|81730064|FG001|Overall Study|Use of rescue medication|9|||
27972589|NCT03466099|81730065|FG002|Overall Study|Use of rescue medication|13|||
27972590|NCT03466099|81730063|FG000|Overall Study|Rescued without meeting criteria|4|||
27972591|NCT03466099|81730064|FG001|Overall Study|Rescued without meeting criteria|1|||
27972592|NCT03466099|81730065|FG002|Overall Study|Rescued without meeting criteria|1|||
27972593|NCT03466099|81730063|FG000|Overall Study|Subject compliance|2|||
27972594|NCT03466099|81730064|FG001|Overall Study|Subject compliance|0|||
27972595|NCT03466099|81730065|FG002|Overall Study|Subject compliance|0|||
27972596|NCT03466099|81730063|FG000|Overall Study|Worsening disease|0|||
27972597|NCT03466099|81730064|FG001|Overall Study|Worsening disease|0|||
27972598|NCT03466099|81730065|FG002|Overall Study|Worsening disease|1|||
27972599|NCT03703817|81730066|FG000|Overall Study|Not meeting eligibility criteria|7|||
27972600|NCT03703817|81730067|FG001|Overall Study|Not meeting eligibility criteria|4|||
27972601|NCT00385944|81730068|FG000|1st Maintenance Dose Period|Physician Decision|1|||
27865694|NCT00996892|81342001|FG006|Dose-Escalation Stage 1|Death|0|||
27865695|NCT00996892|81342002|FG007|Dose-Escalation Stage 1|Death|0|||
27865696|NCT00996892|81342003|FG008|Dose-Escalation Stage 1|Death|0|||
27865697|NCT00996892|81342004|FG009|Dose-Escalation Stage 1|Death|0|||
27865698|NCT00996892|81342005|FG010|Dose-Escalation Stage 1|Death|0|||
27865699|NCT00996892|81342006|FG011|Dose-Escalation Stage 1|Death|0|||
27865700|NCT00996892|81342007|FG012|Dose-Escalation Stage 1|Death|0|||
27865701|NCT00996892|81342008|FG013|Dose-Escalation Stage 1|Death|0|||
27865702|NCT00996892|81342009|FG014|Dose-Escalation Stage 1|Death|0|||
27865703|NCT00996892|81342010|FG015|Dose-Escalation Stage 1|Death|0|||
27865704|NCT00996892|81342011|FG016|Dose-Escalation Stage 1|Death|0|||
27865705|NCT00996892|81342012|FG017|Dose-Escalation Stage 1|Death|0|||
27865706|NCT00996892|81342013|FG018|Dose-Escalation Stage 1|Death|0|||
27865707|NCT00996892|81342014|FG019|Dose-Escalation Stage 1|Death|0|||
27865708|NCT00996892|81341995|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
27865709|NCT00996892|81341996|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
27865710|NCT00996892|81341997|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
27865711|NCT00996892|81341998|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
27865712|NCT00996892|81341999|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
27865713|NCT00996892|81342000|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
27865714|NCT00996892|81342001|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
27865715|NCT00996892|81342002|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
27865716|NCT00996892|81342003|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
27865717|NCT00996892|81342004|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
27865718|NCT00996892|81342005|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
27865719|NCT00996892|81342006|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
27865720|NCT00996892|81342007|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
27865721|NCT00996892|81342008|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
27865722|NCT00996892|81342009|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
27865723|NCT00996892|81342010|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
27972602|NCT00385944|81730069|FG001|1st Maintenance Dose Period|Physician Decision|0|||
27972603|NCT00385944|81730070|FG002|1st Maintenance Dose Period|Physician Decision|0|||
27972604|NCT00385944|81730068|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
27972605|NCT00385944|81730069|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
27972606|NCT00385944|81730070|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
27783965|NCT00027846|81036643|FG001|Overall Study|Entry into another COG therapeutic study|5|||
27783966|NCT00027846|81036644|FG002|Overall Study|Entry into another COG therapeutic study|2|||
27783967|NCT00027846|81036642|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
27783968|NCT00027846|81036643|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
27783969|NCT00027846|81036644|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
27783970|NCT01259388|81036645|FG000|Overall Study|Adverse Event|3|||
27783971|NCT01259388|81036646|FG001|Overall Study|Adverse Event|0|||
27783972|NCT01259388|81036645|FG000|Overall Study|Withdrawal by Subject|1|||
27783973|NCT01259388|81036646|FG001|Overall Study|Withdrawal by Subject|1|||
27783974|NCT01259388|81036645|FG000|Overall Study|Physician Decision|1|||
27865724|NCT00996892|81342011|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
27865725|NCT00996892|81342012|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
27865726|NCT00996892|81342013|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
27972607|NCT00385944|81730068|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
27972608|NCT00385944|81730069|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
27972609|NCT00385944|81730070|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
27972610|NCT00385944|81730068|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
27783975|NCT01259388|81036646|FG001|Overall Study|Physician Decision|0|||
27865727|NCT00996892|81342014|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
27865728|NCT00996892|81341995|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865729|NCT00996892|81341996|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27865730|NCT00996892|81341997|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27972611|NCT00385944|81730069|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
27972612|NCT00385944|81730070|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
27972613|NCT00549900|81730071|FG000|Overall Study|Adverse Event|1|||
27972614|NCT01425359|81730072|FG000|Overall Study|Randomized but Not Treated|2|||
27972615|NCT01425359|81730073|FG001|Overall Study|Randomized but Not Treated|3|||
27972616|NCT01425359|81730072|FG000|Overall Study|Adverse Event|9|||
27972617|NCT01425359|81730073|FG001|Overall Study|Adverse Event|8|||
27972618|NCT01425359|81730072|FG000|Overall Study|Revascularization|0|||
27972619|NCT01425359|81730073|FG001|Overall Study|Revascularization|1|||
27972620|NCT01425359|81730072|FG000|Overall Study|Death|0|||
27783976|NCT02943577|81036649|FG000|Overall Study|Protocol Violation|0|||
27783977|NCT02943577|81036650|FG001|Overall Study|Protocol Violation|1|||
27783978|NCT02943577|81036649|FG000|Overall Study|Adverse Event|3|||
27783979|NCT02943577|81036650|FG001|Overall Study|Adverse Event|2|||
27783980|NCT02943577|81036649|FG000|Overall Study|Lost to Follow-up|0|||
27783981|NCT02943577|81036650|FG001|Overall Study|Lost to Follow-up|1|||
27783982|NCT02943577|81036649|FG000|Overall Study|Withdrawal by Subject|1|||
27783983|NCT02943577|81036650|FG001|Overall Study|Withdrawal by Subject|1|||
27783984|NCT02943577|81036649|FG000|Overall Study|Pregnancy|1|||
27865731|NCT00996892|81341998|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
27972621|NCT01425359|81730073|FG001|Overall Study|Death|1|||
27972622|NCT01425359|81730072|FG000|Overall Study|Unsatisfactory Response|1|||
27972623|NCT01425359|81730073|FG001|Overall Study|Unsatisfactory Response|0|||
27972624|NCT01425359|81730072|FG000|Overall Study|Protocol Violation|1|||
27972625|NCT01425359|81730073|FG001|Overall Study|Protocol Violation|2|||
27972626|NCT01425359|81730072|FG000|Overall Study|Subject Withdrew Consent|1|||
27972627|NCT01425359|81730073|FG001|Overall Study|Subject Withdrew Consent|2|||
27972628|NCT01425359|81730072|FG000|Overall Study|Investigator's Discretion|2|||
27972629|NCT01425359|81730073|FG001|Overall Study|Investigator's Discretion|0|||
27972630|NCT01425359|81730072|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
27972631|NCT01425359|81730073|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
27972632|NCT03781323|81730076|FG000|Overall Study|Withdrawal by Subject|1|||
27972633|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
27972634|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
27972635|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Death|0|||
27972636|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Death|0|||
27972637|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
27972638|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
27865732|NCT00996892|81341999|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27865733|NCT00996892|81342000|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27865734|NCT00996892|81342001|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
27865735|NCT00996892|81342002|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865736|NCT00996892|81342003|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865737|NCT00996892|81342004|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865738|NCT00996892|81342005|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865739|NCT00996892|81342006|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865740|NCT00996892|81342007|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865741|NCT00996892|81342008|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865742|NCT00996892|81342009|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865743|NCT00996892|81342010|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865744|NCT00996892|81342011|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865745|NCT00996892|81342012|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27972639|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
27972640|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
27972641|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
27972642|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
27972643|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
27972644|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
27972645|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
27972646|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
27972647|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
27972648|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
27783985|NCT02943577|81036650|FG001|Overall Study|Pregnancy|0|||
27783986|NCT01716585|81036651|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
27783987|NCT01716585|81036652|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
27865746|NCT00996892|81342013|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27972649|NCT00433160|81730079|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
27783988|NCT01716585|81036651|FG000|Double-blind Treatment|Adverse Event|2|||
27783989|NCT01716585|81036652|FG001|Double-blind Treatment|Adverse Event|1|||
27972650|NCT00433160|81730080|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
27972651|NCT00433160|81730079|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
27972652|NCT00433160|81730080|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
27972653|NCT00433160|81730079|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
27972654|NCT00433160|81730080|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
27972655|NCT00433160|81730079|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
27972656|NCT00433160|81730080|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
27972657|NCT00433160|81730079|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
27972658|NCT00433160|81730080|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
27972659|NCT00433160|81730079|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
27972660|NCT00433160|81730080|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
27972661|NCT00433160|81730079|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
27972662|NCT00433160|81730080|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
27972663|NCT00433160|81730079|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
27972664|NCT00433160|81730080|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
27972665|NCT03764631|81730083|FG000|Overall Study|Personal Reasons|3|||
27571545|NCT01481116|80278847|FG001|Overall Study|Investigator Decision|2|||
27571546|NCT01481116|80278848|FG002|Overall Study|Investigator Decision|1|||
27571547|NCT01481116|80278846|FG000|Overall Study|Sponsor Decision|0|||
27571548|NCT01481116|80278847|FG001|Overall Study|Sponsor Decision|1|||
27571549|NCT01481116|80278848|FG002|Overall Study|Sponsor Decision|3|||
27571550|NCT01481116|80278846|FG000|Overall Study|Non-Compliant With Study Drug|0|||
27571551|NCT01481116|80278847|FG001|Overall Study|Non-Compliant With Study Drug|1|||
27571552|NCT01481116|80278848|FG002|Overall Study|Non-Compliant With Study Drug|1|||
27571553|NCT01481116|80278846|FG000|Overall Study|Investigator's Discretion|2|||
27571554|NCT01481116|80278847|FG001|Overall Study|Investigator's Discretion|0|||
27571555|NCT01481116|80278848|FG002|Overall Study|Investigator's Discretion|0|||
27571556|NCT01481116|80278846|FG000|Overall Study|Death|2|||
27571557|NCT01481116|80278847|FG001|Overall Study|Death|1|||
27571558|NCT01481116|80278848|FG002|Overall Study|Death|0|||
27571559|NCT01481116|80278846|FG000|Overall Study|Hypoglycemic Event|4|||
27571560|NCT01481116|80278847|FG001|Overall Study|Hypoglycemic Event|0|||
27571561|NCT01481116|80278848|FG002|Overall Study|Hypoglycemic Event|0|||
27972666|NCT03764631|81730084|FG001|Overall Study|Personal Reasons|2|||
27972667|NCT03764631|81730083|FG000|Overall Study|Switching Therapy|3|||
27972668|NCT03764631|81730084|FG001|Overall Study|Switching Therapy|3|||
27972669|NCT03764631|81730083|FG000|Overall Study|Adverse Event|0|||
27972670|NCT03764631|81730084|FG001|Overall Study|Adverse Event|1|||
27972671|NCT03764631|81730083|FG000|Overall Study|Lost to Follow-up|33|||
27972672|NCT03764631|81730084|FG001|Overall Study|Lost to Follow-up|41|||
27972673|NCT03764631|81730083|FG000|Overall Study|No data as study site was closed|2|||
27972674|NCT03764631|81730084|FG001|Overall Study|No data as study site was closed|6|||
27972675|NCT01801436|81730089|FG000|Overall Study|Withdrawal by Subject|3|||
27571562|NCT04765358|80278849|FG000|Overall Study|Withdrawal by Subject|1|||
27571563|NCT01077960|80278855|FG000|Overall Study|Adverse Event|6|||
27571564|NCT01077960|80278855|FG000|Overall Study|Protocol Violation|3|||
27571565|NCT01077960|80278855|FG000|Overall Study|Lost to Follow-up|5|||
27571566|NCT01077960|80278855|FG000|Overall Study|Subject decision|1|||
27571567|NCT01077960|80278855|FG000|Overall Study|Reason unspecified|1|||
27571568|NCT01762943|80278856|FG000|Overall Study|Physician Decision|1|||
27571569|NCT01762943|80278857|FG001|Overall Study|Physician Decision|1|||
27571570|NCT01762943|80278856|FG000|Overall Study|Protocol Violation|1|||
27571571|NCT01762943|80278857|FG001|Overall Study|Protocol Violation|0|||
27571572|NCT01762943|80278856|FG000|Overall Study|Withdrawal by Subject|2|||
27571573|NCT01762943|80278857|FG001|Overall Study|Withdrawal by Subject|1|||
27571574|NCT00539838|80278860|FG000|Overall Study|Fail to return|2|||
27571575|NCT00539838|80278861|FG001|Overall Study|Fail to return|0|||
27571576|NCT00539838|80278862|FG002|Overall Study|Fail to return|0|||
27571577|NCT00539838|80278860|FG000|Overall Study|Withdrawal by Subject|0|||
27571578|NCT00539838|80278861|FG001|Overall Study|Withdrawal by Subject|4|||
27571579|NCT00539838|80278862|FG002|Overall Study|Withdrawal by Subject|0|||
27571580|NCT00539838|80278860|FG000|Overall Study|Death|0|||
27571581|NCT00539838|80278861|FG001|Overall Study|Death|2|||
27571582|NCT00539838|80278862|FG002|Overall Study|Death|0|||
27571583|NCT00539838|80278860|FG000|Overall Study|Did not cooperate|1|||
27972676|NCT01801436|81730089|FG000|Overall Study|Adverse Event|2|||
27571584|NCT00539838|80278861|FG001|Overall Study|Did not cooperate|0|||
27571585|NCT00539838|80278862|FG002|Overall Study|Did not cooperate|1|||
27571586|NCT00539838|80278860|FG000|Overall Study|Administrative|4|||
27571587|NCT00539838|80278861|FG001|Overall Study|Administrative|0|||
27972677|NCT01801436|81730089|FG000|Overall Study|Progressive disease|4|||
27571588|NCT00539838|80278862|FG002|Overall Study|Administrative|8|||
27571589|NCT04999111|80278868|FG000|Overall Study|Lost to Follow-up|21|||
27571590|NCT04999111|80278869|FG001|Overall Study|Lost to Follow-up|16|||
27571591|NCT04999111|80278870|FG002|Overall Study|Lost to Follow-up|2|||
27571592|NCT04999111|80278871|FG003|Overall Study|Lost to Follow-up|26|||
27972678|NCT00790868|81730092|FG000|Overall Study|Withdrawal by Subject|4|||
27972679|NCT00790868|81730093|FG001|Overall Study|Withdrawal by Subject|5|||
27972680|NCT00790868|81730092|FG000|Overall Study|Lost to Follow-up|2|||
27571593|NCT04999111|80278872|FG004|Overall Study|Lost to Follow-up|30|||
27571594|NCT04999111|80278873|FG005|Overall Study|Lost to Follow-up|6|||
27571595|NCT04999111|80278868|FG000|Overall Study|Physician Decision|1|||
27571596|NCT04999111|80278869|FG001|Overall Study|Physician Decision|3|||
27972681|NCT00790868|81730093|FG001|Overall Study|Lost to Follow-up|12|||
27972682|NCT01044745|81730094|FG000|Overall Study|Ineiligible|2|||
27972683|NCT01007435|81730095|FG000|Overall Study|Adverse Event|16|||
27972684|NCT01007435|81730096|FG001|Overall Study|Adverse Event|25|||
27972685|NCT01007435|81730097|FG002|Overall Study|Adverse Event|47|||
27972686|NCT01007435|81730098|FG003|Overall Study|Adverse Event|31|||
27972687|NCT01007435|81730095|FG000|Overall Study|Death|2|||
27972688|NCT01007435|81730096|FG001|Overall Study|Death|4|||
27972689|NCT01007435|81730097|FG002|Overall Study|Death|2|||
27972690|NCT01007435|81730098|FG003|Overall Study|Death|1|||
27972691|NCT01007435|81730095|FG000|Overall Study|Insufficient Therapeutic Response|21|||
27972692|NCT01007435|81730096|FG001|Overall Study|Insufficient Therapeutic Response|7|||
27972693|NCT01007435|81730097|FG002|Overall Study|Insufficient Therapeutic Response|2|||
27972694|NCT01007435|81730098|FG003|Overall Study|Insufficient Therapeutic Response|9|||
27972695|NCT01007435|81730095|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
27972696|NCT01007435|81730096|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
27972697|NCT01007435|81730097|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
27571597|NCT04999111|80278870|FG002|Overall Study|Physician Decision|0|||
27571598|NCT04999111|80278871|FG003|Overall Study|Physician Decision|1|||
27571599|NCT04999111|80278872|FG004|Overall Study|Physician Decision|2|||
27571600|NCT04999111|80278873|FG005|Overall Study|Physician Decision|0|||
27571601|NCT04999111|80278868|FG000|Overall Study|Withdrawal by Subject|23|||
27571602|NCT04999111|80278869|FG001|Overall Study|Withdrawal by Subject|29|||
27571603|NCT04999111|80278870|FG002|Overall Study|Withdrawal by Subject|15|||
27571604|NCT04999111|80278871|FG003|Overall Study|Withdrawal by Subject|30|||
27571605|NCT04999111|80278872|FG004|Overall Study|Withdrawal by Subject|35|||
27571606|NCT04999111|80278873|FG005|Overall Study|Withdrawal by Subject|10|||
27972698|NCT01007435|81730098|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
27972699|NCT01007435|81730095|FG000|Overall Study|Other Protocol Violation|2|||
27972700|NCT01007435|81730096|FG001|Overall Study|Other Protocol Violation|0|||
27972701|NCT01007435|81730097|FG002|Overall Study|Other Protocol Violation|1|||
27972702|NCT01007435|81730098|FG003|Overall Study|Other Protocol Violation|0|||
27972703|NCT01007435|81730095|FG000|Overall Study|Refused Treatment|13|||
27972704|NCT01007435|81730096|FG001|Overall Study|Refused Treatment|13|||
27972705|NCT01007435|81730097|FG002|Overall Study|Refused Treatment|5|||
27972706|NCT01007435|81730098|FG003|Overall Study|Refused Treatment|8|||
27972707|NCT01007435|81730095|FG000|Overall Study|Failure to Return|5|||
27972708|NCT01007435|81730096|FG001|Overall Study|Failure to Return|4|||
27972709|NCT01007435|81730097|FG002|Overall Study|Failure to Return|3|||
27972710|NCT01007435|81730098|FG003|Overall Study|Failure to Return|6|||
27972711|NCT01007435|81730095|FG000|Overall Study|Reason not Specified|1|||
27972712|NCT01007435|81730096|FG001|Overall Study|Reason not Specified|1|||
27972713|NCT01007435|81730097|FG002|Overall Study|Reason not Specified|2|||
27972714|NCT01007435|81730098|FG003|Overall Study|Reason not Specified|1|||
27972715|NCT00096226|81730099|FG000|Overall Study|Ineligible|2|||
27972716|NCT00096226|81730099|FG000|Overall Study|Protocol treatment not started|1|||
27972717|NCT01626118|81730100|FG000|Overall Study|Lack of Efficacy|1|||
27972718|NCT01626118|81730101|FG001|Overall Study|Lack of Efficacy|0|||
27972719|NCT01626118|81730102|FG002|Overall Study|Lack of Efficacy|1|||
27972720|NCT01626118|81730103|FG003|Overall Study|Lack of Efficacy|3|||
27972721|NCT01626118|81730100|FG000|Overall Study|Lost to Follow-up|1|||
27571607|NCT04999111|80278868|FG000|Overall Study|Other|6|||
27571608|NCT04999111|80278869|FG001|Overall Study|Other|6|||
27571609|NCT04999111|80278870|FG002|Overall Study|Other|3|||
27571610|NCT04999111|80278871|FG003|Overall Study|Other|8|||
27571611|NCT04999111|80278872|FG004|Overall Study|Other|8|||
27571612|NCT04999111|80278873|FG005|Overall Study|Other|5|||
27571613|NCT04999111|80278868|FG000|Overall Study|Non-compliance with study schedule|1|||
27571614|NCT04999111|80278869|FG001|Overall Study|Non-compliance with study schedule|0|||
27571615|NCT04999111|80278870|FG002|Overall Study|Non-compliance with study schedule|0|||
27571616|NCT04999111|80278871|FG003|Overall Study|Non-compliance with study schedule|1|||
27571617|NCT04999111|80278872|FG004|Overall Study|Non-compliance with study schedule|1|||
27571618|NCT04999111|80278873|FG005|Overall Study|Non-compliance with study schedule|1|||
27972722|NCT01626118|81730101|FG001|Overall Study|Lost to Follow-up|0|||
27972723|NCT01626118|81730102|FG002|Overall Study|Lost to Follow-up|0|||
27972724|NCT01626118|81730103|FG003|Overall Study|Lost to Follow-up|0|||
27972725|NCT01626118|81730100|FG000|Overall Study|Adverse Event|0|||
27972726|NCT01626118|81730101|FG001|Overall Study|Adverse Event|1|||
27972727|NCT01626118|81730102|FG002|Overall Study|Adverse Event|1|||
27972728|NCT01626118|81730103|FG003|Overall Study|Adverse Event|0|||
27972729|NCT01626118|81730100|FG000|Overall Study|Investigator Decision|0|||
27972730|NCT01626118|81730101|FG001|Overall Study|Investigator Decision|1|||
27972731|NCT01626118|81730102|FG002|Overall Study|Investigator Decision|0|||
27972732|NCT01626118|81730103|FG003|Overall Study|Investigator Decision|0|||
27972733|NCT01691885|81730104|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
27571619|NCT04999111|80278868|FG000|Overall Study|Randomized but not vaccinated|1|||
27972734|NCT01691885|81730105|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
27972735|NCT01691885|81730104|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
27972736|NCT01691885|81730105|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
27972737|NCT02759107|81730106|FG000|Overall Study|Adverse Event|0|||
27972738|NCT02759107|81730107|FG001|Overall Study|Adverse Event|0|||
27972739|NCT02759107|81730108|FG002|Overall Study|Adverse Event|0|||
27972740|NCT02759107|81730109|FG003|Overall Study|Adverse Event|0|||
27972741|NCT02759107|81730110|FG004|Overall Study|Adverse Event|0|||
27972742|NCT02759107|81730111|FG005|Overall Study|Adverse Event|0|||
27972743|NCT02759107|81730112|FG006|Overall Study|Adverse Event|0|||
27972744|NCT02759107|81730113|FG007|Overall Study|Adverse Event|0|||
27972745|NCT02759107|81730114|FG008|Overall Study|Adverse Event|0|||
27972746|NCT02759107|81730115|FG009|Overall Study|Adverse Event|0|||
27972747|NCT02759107|81730116|FG010|Overall Study|Adverse Event|0|||
27783990|NCT01716585|81036651|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
27783991|NCT01716585|81036652|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
27783992|NCT01716585|81036651|FG000|Double-blind Treatment|Lost to Follow-up|2|||
27783993|NCT01716585|81036652|FG001|Double-blind Treatment|Lost to Follow-up|0|||
27783994|NCT01716585|81036651|FG000|Double-blind Treatment|Subject Noncompliant|1|||
27783995|NCT01716585|81036652|FG001|Double-blind Treatment|Subject Noncompliant|0|||
27865747|NCT00996892|81342014|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
27865748|NCT00996892|81341995|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
27865749|NCT00996892|81341996|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
27865750|NCT00996892|81341997|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
27571620|NCT04999111|80278869|FG001|Overall Study|Randomized but not vaccinated|2|||
27571621|NCT04999111|80278870|FG002|Overall Study|Randomized but not vaccinated|0|||
27571622|NCT04999111|80278871|FG003|Overall Study|Randomized but not vaccinated|3|||
27571623|NCT04999111|80278872|FG004|Overall Study|Randomized but not vaccinated|3|||
27571624|NCT04999111|80278873|FG005|Overall Study|Randomized but not vaccinated|0|||
27571625|NCT04999111|80278868|FG000|Overall Study|Adverse Event|1|||
27972748|NCT02759107|81730117|FG011|Overall Study|Adverse Event|0|||
27972749|NCT02759107|81730118|FG012|Overall Study|Adverse Event|2|||
27972750|NCT02759107|81730119|FG013|Overall Study|Adverse Event|0|||
27972751|NCT02759107|81730120|FG014|Overall Study|Adverse Event|0|||
27571626|NCT04999111|80278869|FG001|Overall Study|Adverse Event|1|||
27571627|NCT04999111|80278870|FG002|Overall Study|Adverse Event|0|||
27571628|NCT04999111|80278871|FG003|Overall Study|Adverse Event|0|||
27571629|NCT04999111|80278872|FG004|Overall Study|Adverse Event|0|||
27571630|NCT04999111|80278873|FG005|Overall Study|Adverse Event|0|||
27571631|NCT04999111|80278868|FG000|Overall Study|Initiated prohibited medication|0|||
27571632|NCT04999111|80278869|FG001|Overall Study|Initiated prohibited medication|0|||
27571633|NCT04999111|80278870|FG002|Overall Study|Initiated prohibited medication|0|||
27571634|NCT04999111|80278871|FG003|Overall Study|Initiated prohibited medication|0|||
27571635|NCT04999111|80278872|FG004|Overall Study|Initiated prohibited medication|1|||
27571636|NCT04999111|80278873|FG005|Overall Study|Initiated prohibited medication|0|||
27783996|NCT01716585|81036651|FG000|Double-blind Treatment|Other|1|||
27783997|NCT01716585|81036652|FG001|Double-blind Treatment|Other|0|||
27783998|NCT01716585|81036651|FG000|Open-label Treatment|Adverse Event|0|||
27783999|NCT01716585|81036652|FG001|Open-label Treatment|Adverse Event|2|||
27865751|NCT00996892|81341998|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
27865752|NCT00996892|81341999|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
27865753|NCT00996892|81342000|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
27865754|NCT00996892|81342001|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
27865755|NCT00996892|81342002|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
27865756|NCT00996892|81342003|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
27865757|NCT00996892|81342004|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
27865758|NCT00996892|81342005|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
27865759|NCT00996892|81342006|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
27865760|NCT00996892|81342007|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
27865761|NCT00996892|81342008|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
27865762|NCT00996892|81342009|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
27865763|NCT00996892|81342010|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
27784000|NCT01716585|81036651|FG000|Open-label Treatment|Virologic Failure|0|||
27784001|NCT01716585|81036652|FG001|Open-label Treatment|Virologic Failure|2|||
27784002|NCT01716585|81036651|FG000|Open-label Treatment|Withdrawal by Subject|0|||
27784003|NCT01716585|81036652|FG001|Open-label Treatment|Withdrawal by Subject|3|||
27865764|NCT00996892|81342011|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
27972752|NCT02759107|81730121|FG015|Overall Study|Adverse Event|1|||
27972753|NCT02759107|81730122|FG016|Overall Study|Adverse Event|0|||
27972754|NCT02759107|81730123|FG017|Overall Study|Adverse Event|2|||
27972755|NCT02759107|81730106|FG000|Overall Study|Scheduling Conflict|0|||
27972756|NCT02759107|81730107|FG001|Overall Study|Scheduling Conflict|0|||
27972757|NCT02759107|81730108|FG002|Overall Study|Scheduling Conflict|0|||
27972758|NCT02759107|81730109|FG003|Overall Study|Scheduling Conflict|0|||
27972759|NCT02759107|81730110|FG004|Overall Study|Scheduling Conflict|0|||
27972760|NCT02759107|81730111|FG005|Overall Study|Scheduling Conflict|0|||
27972761|NCT02759107|81730112|FG006|Overall Study|Scheduling Conflict|0|||
27972762|NCT02759107|81730113|FG007|Overall Study|Scheduling Conflict|0|||
27972763|NCT02759107|81730114|FG008|Overall Study|Scheduling Conflict|0|||
27972764|NCT02759107|81730115|FG009|Overall Study|Scheduling Conflict|1|||
27972765|NCT02759107|81730116|FG010|Overall Study|Scheduling Conflict|0|||
27972766|NCT02759107|81730117|FG011|Overall Study|Scheduling Conflict|0|||
27972767|NCT02759107|81730118|FG012|Overall Study|Scheduling Conflict|0|||
27972768|NCT02759107|81730119|FG013|Overall Study|Scheduling Conflict|0|||
27972769|NCT02759107|81730120|FG014|Overall Study|Scheduling Conflict|0|||
27972770|NCT02759107|81730121|FG015|Overall Study|Scheduling Conflict|0|||
27972771|NCT02759107|81730122|FG016|Overall Study|Scheduling Conflict|0|||
27972772|NCT02759107|81730123|FG017|Overall Study|Scheduling Conflict|0|||
27972773|NCT02370537|81730124|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
27972774|NCT02370537|81730125|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
27972775|NCT02370537|81730126|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
27972776|NCT02370537|81730124|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
27972777|NCT02370537|81730125|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
27972778|NCT02370537|81730126|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
27972779|NCT02370537|81730124|FG000|Part B|Not randomised to receive treatment|1|||
27972780|NCT02370537|81730125|FG001|Part B|Not randomised to receive treatment|2|||
27972781|NCT02370537|81730126|FG002|Part B|Not randomised to receive treatment|259|||
27571637|NCT01559311|80278876|FG000|Overall Study|Protocol Violation|0|||
27571638|NCT01559311|80278877|FG001|Overall Study|Protocol Violation|0|||
27571639|NCT01559311|80278878|FG002|Overall Study|Protocol Violation|2|||
27571640|NCT01559311|80278876|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
27571641|NCT01559311|80278877|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
27571642|NCT01559311|80278878|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
27571643|NCT01559311|80278876|FG000|Overall Study|Withdrawal by Subject|2|||
27571644|NCT01559311|80278877|FG001|Overall Study|Withdrawal by Subject|1|||
27571645|NCT01559311|80278878|FG002|Overall Study|Withdrawal by Subject|0|||
27571646|NCT01559311|80278876|FG000|Overall Study|Death|0|||
27571647|NCT01559311|80278877|FG001|Overall Study|Death|2|||
27571648|NCT01559311|80278878|FG002|Overall Study|Death|3|||
27571649|NCT01559311|80278876|FG000|Overall Study|Lost to Follow-up|0|||
27571650|NCT01559311|80278877|FG001|Overall Study|Lost to Follow-up|3|||
27571651|NCT01559311|80278878|FG002|Overall Study|Lost to Follow-up|2|||
27571652|NCT01559311|80278876|FG000|Overall Study|Adverse Event|0|||
27571653|NCT01559311|80278877|FG001|Overall Study|Adverse Event|0|||
27571654|NCT01559311|80278878|FG002|Overall Study|Adverse Event|1|||
27571655|NCT03616912|80278879|FG000|Overall Study|Adverse Event|17|||
27571656|NCT03616912|80278880|FG001|Overall Study|Adverse Event|21|||
27571657|NCT03616912|80278881|FG002|Overall Study|Adverse Event|9|||
27571658|NCT03616912|80278882|FG003|Overall Study|Adverse Event|0|||
27669330|NCT00510146|80627599|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
27669331|NCT00510146|80627598|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
27669332|NCT00510146|80627599|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
27669333|NCT00510146|80627598|FG000|Double-Blind Treatment|Physician Decision|6|||
27669334|NCT00510146|80627599|FG001|Double-Blind Treatment|Physician Decision|0|||
27669335|NCT00510146|80627598|FG000|Double-Blind Treatment|Protocol Violation|1|||
27669336|NCT00510146|80627599|FG001|Double-Blind Treatment|Protocol Violation|2|||
27669337|NCT00510146|80627598|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
27669338|NCT00510146|80627599|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
27669339|NCT00510146|80627598|FG000|Double-Blind Treatment|Clinical Relapse|0|||
27669340|NCT00510146|80627599|FG001|Double-Blind Treatment|Clinical Relapse|1|||
27669341|NCT00510146|80627598|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
27669342|NCT00510146|80627599|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
27669343|NCT00510146|80627598|FG000|Open-Label Treatment|Adverse Event|22|||
27669344|NCT00510146|80627599|FG001|Open-Label Treatment|Adverse Event|8|||
27669345|NCT00510146|80627598|FG000|Open-Label Treatment|Death|1|||
27669346|NCT00510146|80627599|FG001|Open-Label Treatment|Death|1|||
27669347|NCT00510146|80627598|FG000|Open-Label Treatment|Lack of Efficacy|4|||
27669348|NCT00510146|80627599|FG001|Open-Label Treatment|Lack of Efficacy|0|||
27669349|NCT00510146|80627598|FG000|Open-Label Treatment|Lost to Follow-up|10|||
27669350|NCT00510146|80627599|FG001|Open-Label Treatment|Lost to Follow-up|1|||
27669351|NCT00510146|80627598|FG000|Open-Label Treatment|Physician Decision|3|||
27669352|NCT00510146|80627599|FG001|Open-Label Treatment|Physician Decision|1|||
27669353|NCT00510146|80627598|FG000|Open-Label Treatment|Protocol Violation|4|||
27669354|NCT00510146|80627599|FG001|Open-Label Treatment|Protocol Violation|2|||
27669355|NCT00510146|80627598|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
27669356|NCT00510146|80627599|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
27669357|NCT00510146|80627598|FG000|Open-Label Treatment|Clinical Relapse|1|||
27669358|NCT00510146|80627599|FG001|Open-Label Treatment|Clinical Relapse|1|||
27669359|NCT00510146|80627598|FG000|Open-Label Treatment|Sponsor Decision|2|||
27669360|NCT00510146|80627599|FG001|Open-Label Treatment|Sponsor Decision|0|||
27669361|NCT02202109|80627603|FG000|Overall Study|Lost to Follow-up|88|||
27669362|NCT02202109|80627604|FG001|Overall Study|Lost to Follow-up|87|||
27669363|NCT02202109|80627603|FG000|Overall Study|Withdrawal by Subject|2|||
27669364|NCT02202109|80627604|FG001|Overall Study|Withdrawal by Subject|0|||
27669365|NCT03020069|80627607|FG000|Overall Study|Lost to Follow-up|0|||
27669366|NCT03020069|80627608|FG001|Overall Study|Lost to Follow-up|1|||
27669367|NCT00639769|80627611|FG000|Overall Study|Death|2|||
27669368|NCT00639769|80627611|FG000|Overall Study|Adverse Event|7|||
27669369|NCT00639769|80627611|FG000|Overall Study|Lack of Efficacy|1|||
27669370|NCT00639769|80627611|FG000|Overall Study|Disease progression|26|||
27669371|NCT00639769|80627611|FG000|Overall Study|Withdrawal by Subject|4|||
27669372|NCT03638258|80627615|FG000|Overall Study|Adverse Event|1|||
27669373|NCT03638258|80627616|FG001|Overall Study|Adverse Event|0|||
27669374|NCT03638258|80627617|FG002|Overall Study|Adverse Event|2|||
27669375|NCT03638258|80627615|FG000|Overall Study|Lost to Follow-up|2|||
27669376|NCT03638258|80627616|FG001|Overall Study|Lost to Follow-up|4|||
27669377|NCT03638258|80627617|FG002|Overall Study|Lost to Follow-up|5|||
27669378|NCT03638258|80627615|FG000|Overall Study|Pregnancy|0|||
27571659|NCT03616912|80278883|FG004|Overall Study|Adverse Event|0|||
27571660|NCT03616912|80278884|FG005|Overall Study|Adverse Event|0|||
27571661|NCT03616912|80278879|FG000|Overall Study|Death|1|||
27571662|NCT03616912|80278880|FG001|Overall Study|Death|1|||
27571663|NCT03616912|80278881|FG002|Overall Study|Death|0|||
27669379|NCT03638258|80627616|FG001|Overall Study|Pregnancy|0|||
27669380|NCT03638258|80627617|FG002|Overall Study|Pregnancy|1|||
27669381|NCT03638258|80627615|FG000|Overall Study|Protocol Violation|0|||
27669382|NCT03638258|80627616|FG001|Overall Study|Protocol Violation|0|||
27669383|NCT03638258|80627617|FG002|Overall Study|Protocol Violation|1|||
27669384|NCT03638258|80627615|FG000|Overall Study|Withdrawal by Subject|4|||
27669385|NCT03638258|80627616|FG001|Overall Study|Withdrawal by Subject|5|||
27669386|NCT03638258|80627617|FG002|Overall Study|Withdrawal by Subject|12|||
27669387|NCT03638258|80627615|FG000|Overall Study|Lack of Efficacy|0|||
27669388|NCT03638258|80627616|FG001|Overall Study|Lack of Efficacy|0|||
27669389|NCT03638258|80627617|FG002|Overall Study|Lack of Efficacy|2|||
27669390|NCT02062645|80627620|FG000|Overall Study|Adverse Event|2|||
27669391|NCT02062645|80627620|FG000|Overall Study|Protocol Violation|8|||
27669392|NCT02062645|80627620|FG000|Overall Study|Lost to Follow-up|5|||
27669393|NCT02725528|80627625|FG000|Overall Study|Lost to Follow-up|1|||
27669394|NCT02725528|80627626|FG001|Overall Study|Lost to Follow-up|4|||
27669395|NCT02725528|80627625|FG000|Overall Study|Withdrawal by Subject|0|||
27669396|NCT02725528|80627626|FG001|Overall Study|Withdrawal by Subject|1|||
27669397|NCT00632021|80627631|FG000|Overall Study|Withdrawal/death|4|||
27669398|NCT00632021|80627632|FG001|Overall Study|Withdrawal/death|7|||
27669399|NCT01114672|80627635|FG000|Overall Study|Death|0|||
27669400|NCT01114672|80627636|FG001|Overall Study|Death|1|||
27669401|NCT01114672|80627635|FG000|Overall Study|Withdrawal by Subject|2|||
27669402|NCT01114672|80627636|FG001|Overall Study|Withdrawal by Subject|1|||
27669403|NCT01114672|80627635|FG000|Overall Study|Lost to Follow-up|1|||
27669404|NCT01114672|80627636|FG001|Overall Study|Lost to Follow-up|0|||
27669405|NCT01114672|80627635|FG000|Overall Study|transplanted|1|||
27669406|NCT01114672|80627636|FG001|Overall Study|transplanted|0|||
27669407|NCT00621192|80630780|FG000|Overall Study|Withdrawal by Subject|0|||
27669408|NCT00621192|80630781|FG001|Overall Study|Withdrawal by Subject|0|||
27669409|NCT00621192|80630782|FG002|Overall Study|Withdrawal by Subject|2|||
27669410|NCT00621192|80630783|FG003|Overall Study|Withdrawal by Subject|0|||
27669411|NCT00621192|80630780|FG000|Overall Study|Physician Decision|1|||
27669412|NCT00621192|80630781|FG001|Overall Study|Physician Decision|3|||
27669413|NCT00621192|80630782|FG002|Overall Study|Physician Decision|0|||
27669414|NCT00621192|80630783|FG003|Overall Study|Physician Decision|0|||
27669415|NCT00621192|80630780|FG000|Overall Study|Protocol Violation|1|||
27669416|NCT00621192|80630781|FG001|Overall Study|Protocol Violation|0|||
27669417|NCT00621192|80630782|FG002|Overall Study|Protocol Violation|0|||
27669418|NCT00621192|80630783|FG003|Overall Study|Protocol Violation|1|||
27669419|NCT00621192|80630780|FG000|Overall Study|Adverse Event|0|||
27669420|NCT00621192|80630781|FG001|Overall Study|Adverse Event|1|||
27669421|NCT00621192|80630782|FG002|Overall Study|Adverse Event|0|||
27669422|NCT00621192|80630783|FG003|Overall Study|Adverse Event|1|||
27669423|NCT00621192|80630780|FG000|Overall Study|Death|2|||
27669424|NCT00621192|80630781|FG001|Overall Study|Death|5|||
27669425|NCT00621192|80630782|FG002|Overall Study|Death|0|||
27669426|NCT00621192|80630783|FG003|Overall Study|Death|0|||
27669427|NCT00621192|80630780|FG000|Overall Study|Final Assessments not Completed|0|||
27669428|NCT00621192|80630781|FG001|Overall Study|Final Assessments not Completed|0|||
27669429|NCT00621192|80630782|FG002|Overall Study|Final Assessments not Completed|3|||
27669430|NCT00621192|80630783|FG003|Overall Study|Final Assessments not Completed|1|||
27669431|NCT01181609|80630785|FG000|Overall Study|Adverse Event|1|||
27669432|NCT01181609|80630785|FG000|Overall Study|Withdrawal by Subject|1|||
27669433|NCT01181609|80630785|FG000|Overall Study|Lost to Follow-up|1|||
27669434|NCT01181609|80630785|FG000|Overall Study|Death|50|||
27669435|NCT04014790|80630786|FG000|Overall Study|Death|4|||
27669436|NCT04014790|80630786|FG000|Overall Study|Adverse Event|1|||
27669437|NCT04014790|80630786|FG000|Overall Study|Withdrawal by Subject|1|||
27669438|NCT01710800|80630787|FG000|Overall Study|Withdrawal by Subject|21|||
27669439|NCT01710800|80630787|FG000|Overall Study|Protocol Violation|1|||
27784004|NCT01230489|81036653|FG000|Overall Study|Death|2|||
27784005|NCT01230489|81036653|FG000|Overall Study|Adverse Event|2|||
27784006|NCT01230489|81036653|FG000|Overall Study|Treatment modality changed|1|||
27669440|NCT01103232|80630791|FG000|Overall Study|Withdrawal by Subject|1|||
27669441|NCT01103232|80630792|FG001|Overall Study|Withdrawal by Subject|1|||
27669442|NCT01103232|80630791|FG000|Overall Study|Protocol Violation|0|||
27669443|NCT01103232|80630792|FG001|Overall Study|Protocol Violation|1|||
27669444|NCT01434680|80630793|FG000|Overall Study|Withdrawal by Subject|1|||
27669445|NCT01434680|80630794|FG001|Overall Study|Withdrawal by Subject|0|||
27669446|NCT01434680|80630795|FG002|Overall Study|Withdrawal by Subject|2|||
27669447|NCT01434680|80630796|FG003|Overall Study|Withdrawal by Subject|0|||
27669448|NCT01434680|80630793|FG000|Overall Study|Lost to Follow-up|1|||
27669449|NCT01434680|80630794|FG001|Overall Study|Lost to Follow-up|1|||
27669450|NCT01434680|80630795|FG002|Overall Study|Lost to Follow-up|0|||
27669451|NCT01434680|80630796|FG003|Overall Study|Lost to Follow-up|0|||
27669452|NCT01434680|80630793|FG000|Overall Study|Protocol Violation|1|||
27669453|NCT01434680|80630794|FG001|Overall Study|Protocol Violation|1|||
27669454|NCT01434680|80630795|FG002|Overall Study|Protocol Violation|0|||
27784007|NCT02207413|81040572|FG000|Overall Study|Withdrawal by Subject|1|||
27669455|NCT01434680|80630796|FG003|Overall Study|Protocol Violation|0|||
27669456|NCT02561247|80630797|FG000|Overall Study|Protocol Violation|1|||
27669457|NCT02561247|80630797|FG000|Overall Study|Withdrawal by Subject|1|||
27669458|NCT02561247|80630797|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
27669459|NCT00511836|80630799|FG000|Double-blind Period|Lost to Follow-up|1|||
27669460|NCT00511836|80630800|FG001|Double-blind Period|Lost to Follow-up|0|||
27669461|NCT03119688|80630802|FG000|Overall Study|Adverse Event|4|||
27865765|NCT00996892|81342012|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
27669462|NCT01233999|80630807|FG000|Overall Study|Withdrawal by Subject|1|||
27669463|NCT01233999|80630807|FG000|Overall Study|Lost to Follow-up|1|||
27669464|NCT00719043|80630810|FG000|Overall Study|Adverse Event|5|||
27669465|NCT00719043|80630811|FG001|Overall Study|Adverse Event|1|||
27669466|NCT00719043|80630812|FG002|Overall Study|Adverse Event|2|||
27669467|NCT00719043|80630813|FG003|Overall Study|Adverse Event|2|||
27669468|NCT00719043|80630814|FG004|Overall Study|Adverse Event|1|||
27669469|NCT00719043|80630815|FG005|Overall Study|Adverse Event|4|||
27669470|NCT00719043|80630816|FG006|Overall Study|Adverse Event|4|||
27669471|NCT00719043|80630810|FG000|Overall Study|Lost to Follow-up|14|||
27669472|NCT00719043|80630811|FG001|Overall Study|Lost to Follow-up|10|||
27669473|NCT00719043|80630812|FG002|Overall Study|Lost to Follow-up|8|||
27669474|NCT00719043|80630813|FG003|Overall Study|Lost to Follow-up|9|||
27669475|NCT00719043|80630814|FG004|Overall Study|Lost to Follow-up|10|||
27669476|NCT00719043|80630815|FG005|Overall Study|Lost to Follow-up|9|||
27669477|NCT00719043|80630816|FG006|Overall Study|Lost to Follow-up|9|||
27669478|NCT00719043|80630810|FG000|Overall Study|Protocol Violation|0|||
27669479|NCT00719043|80630811|FG001|Overall Study|Protocol Violation|0|||
27669480|NCT00719043|80630812|FG002|Overall Study|Protocol Violation|0|||
27865766|NCT00996892|81342013|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
27669481|NCT00719043|80630813|FG003|Overall Study|Protocol Violation|0|||
27669482|NCT00719043|80630814|FG004|Overall Study|Protocol Violation|0|||
27669483|NCT00719043|80630815|FG005|Overall Study|Protocol Violation|1|||
27865767|NCT00996892|81342014|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
27865768|NCT00996892|81341995|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
27865769|NCT00996892|81341996|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
27865770|NCT00996892|81341997|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
27865771|NCT00996892|81341998|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
27865772|NCT00996892|81341999|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
27865773|NCT00996892|81342000|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
27865774|NCT00996892|81342001|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
27865775|NCT00996892|81342002|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
27865776|NCT00996892|81342003|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
27865777|NCT00996892|81342004|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
27865778|NCT00996892|81342005|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
27865779|NCT00996892|81342006|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
27865780|NCT00996892|81342007|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
27865781|NCT00996892|81342008|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
27865782|NCT00996892|81342009|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
27865783|NCT00996892|81342010|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
27865784|NCT00996892|81342011|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
27865785|NCT00996892|81342012|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
27865786|NCT00996892|81342013|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
27865787|NCT00996892|81342014|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
27865788|NCT00996892|81341995|FG000|Dose-Escalation Stage 1A|Death|0|||
27865789|NCT00996892|81341996|FG001|Dose-Escalation Stage 1A|Death|0|||
27865790|NCT00996892|81341997|FG002|Dose-Escalation Stage 1A|Death|0|||
27865791|NCT00996892|81341998|FG003|Dose-Escalation Stage 1A|Death|0|||
27865792|NCT00996892|81341999|FG004|Dose-Escalation Stage 1A|Death|0|||
27865793|NCT00996892|81342000|FG005|Dose-Escalation Stage 1A|Death|0|||
27865794|NCT00996892|81342001|FG006|Dose-Escalation Stage 1A|Death|0|||
27669484|NCT00719043|80630816|FG006|Overall Study|Protocol Violation|0|||
27865795|NCT00996892|81342002|FG007|Dose-Escalation Stage 1A|Death|0|||
27865796|NCT00996892|81342003|FG008|Dose-Escalation Stage 1A|Death|0|||
27865797|NCT00996892|81342004|FG009|Dose-Escalation Stage 1A|Death|2|||
27865798|NCT00996892|81342005|FG010|Dose-Escalation Stage 1A|Death|0|||
27865799|NCT00996892|81342006|FG011|Dose-Escalation Stage 1A|Death|1|||
27972782|NCT02370537|81730124|FG000|Part B|Withdrawal by Subject|0|||
27669485|NCT00719043|80630810|FG000|Overall Study|Other|1|||
27669486|NCT00719043|80630811|FG001|Overall Study|Other|0|||
27669487|NCT00719043|80630812|FG002|Overall Study|Other|1|||
27669488|NCT00719043|80630813|FG003|Overall Study|Other|2|||
27669489|NCT00719043|80630814|FG004|Overall Study|Other|0|||
27669490|NCT00719043|80630815|FG005|Overall Study|Other|2|||
27669491|NCT00719043|80630816|FG006|Overall Study|Other|1|||
27669492|NCT00719043|80630810|FG000|Overall Study|Withdrawal by Subject|12|||
27669493|NCT00719043|80630811|FG001|Overall Study|Withdrawal by Subject|14|||
27669494|NCT00719043|80630812|FG002|Overall Study|Withdrawal by Subject|9|||
27865800|NCT00996892|81342007|FG012|Dose-Escalation Stage 1A|Death|1|||
27865801|NCT00996892|81342008|FG013|Dose-Escalation Stage 1A|Death|0|||
27865802|NCT00996892|81342009|FG014|Dose-Escalation Stage 1A|Death|0|||
27865803|NCT00996892|81342010|FG015|Dose-Escalation Stage 1A|Death|0|||
27865804|NCT00996892|81342011|FG016|Dose-Escalation Stage 1A|Death|0|||
27865805|NCT00996892|81342012|FG017|Dose-Escalation Stage 1A|Death|0|||
27865806|NCT00996892|81342013|FG018|Dose-Escalation Stage 1A|Death|0|||
27865807|NCT00996892|81342014|FG019|Dose-Escalation Stage 1A|Death|0|||
27865808|NCT00996892|81341995|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
27669495|NCT00719043|80630813|FG003|Overall Study|Withdrawal by Subject|10|||
27669496|NCT00719043|80630814|FG004|Overall Study|Withdrawal by Subject|16|||
27669497|NCT00719043|80630815|FG005|Overall Study|Withdrawal by Subject|18|||
27669498|NCT00719043|80630816|FG006|Overall Study|Withdrawal by Subject|14|||
27669499|NCT03616964|80630818|FG000|Overall Study|Adverse Event|15|||
27669500|NCT03616964|80630819|FG001|Overall Study|Adverse Event|10|||
27669501|NCT03616964|80630820|FG002|Overall Study|Adverse Event|16|||
27669502|NCT03616964|80630818|FG000|Overall Study|Death|3|||
27669503|NCT03616964|80630819|FG001|Overall Study|Death|0|||
27669504|NCT03616964|80630820|FG002|Overall Study|Death|4|||
27669505|NCT03616964|80630818|FG000|Overall Study|Lack of Efficacy|4|||
27669506|NCT03616964|80630819|FG001|Overall Study|Lack of Efficacy|8|||
27669507|NCT03616964|80630820|FG002|Overall Study|Lack of Efficacy|8|||
27669508|NCT03616964|80630818|FG000|Overall Study|Lost to Follow-up|2|||
27669509|NCT03616964|80630819|FG001|Overall Study|Lost to Follow-up|1|||
27669510|NCT03616964|80630820|FG002|Overall Study|Lost to Follow-up|3|||
27669511|NCT03616964|80630818|FG000|Overall Study|Withdrawal by Subject|18|||
27669512|NCT03616964|80630819|FG001|Overall Study|Withdrawal by Subject|14|||
27669513|NCT03616964|80630820|FG002|Overall Study|Withdrawal by Subject|21|||
27669514|NCT03616964|80630818|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
27669515|NCT03616964|80630819|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
27669516|NCT03616964|80630820|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
27669517|NCT03616964|80630818|FG000|Overall Study|Sponsor's Decision|1|||
27669518|NCT03616964|80630819|FG001|Overall Study|Sponsor's Decision|0|||
27669519|NCT03616964|80630820|FG002|Overall Study|Sponsor's Decision|0|||
27669520|NCT03616964|80630818|FG000|Overall Study|Physician Decision|0|||
27669521|NCT03616964|80630819|FG001|Overall Study|Physician Decision|2|||
27669522|NCT03616964|80630820|FG002|Overall Study|Physician Decision|0|||
27669523|NCT03616964|80630818|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
27669524|NCT03616964|80630819|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
27669525|NCT03616964|80630820|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
27669526|NCT03616964|80630818|FG000|Overall Study|Protocol Violation|0|||
27669527|NCT03616964|80630819|FG001|Overall Study|Protocol Violation|1|||
27669528|NCT03616964|80630820|FG002|Overall Study|Protocol Violation|0|||
27669529|NCT03616964|80630818|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
27669530|NCT03616964|80630819|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
27669531|NCT03616964|80630820|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
27669532|NCT03616964|80630818|FG000|Overall Study|Randomized but Never Treated|1|||
27669533|NCT03616964|80630819|FG001|Overall Study|Randomized but Never Treated|1|||
27669534|NCT03616964|80630820|FG002|Overall Study|Randomized but Never Treated|1|||
27669535|NCT03414047|80630827|FG000|Overall Study|Adverse Event|0|||
27669536|NCT03414047|80630828|FG001|Overall Study|Adverse Event|0|||
27669537|NCT03414047|80630829|FG002|Overall Study|Adverse Event|1|||
27669538|NCT03414047|80630830|FG003|Overall Study|Adverse Event|1|||
27669539|NCT03414047|80630827|FG000|Overall Study|Physician Decision|1|||
27669540|NCT03414047|80630828|FG001|Overall Study|Physician Decision|0|||
27669541|NCT03414047|80630829|FG002|Overall Study|Physician Decision|0|||
27669542|NCT03414047|80630830|FG003|Overall Study|Physician Decision|1|||
27669543|NCT03414047|80630827|FG000|Overall Study|Withdrawal by Subject|1|||
27669544|NCT03414047|80630828|FG001|Overall Study|Withdrawal by Subject|0|||
27669545|NCT03414047|80630829|FG002|Overall Study|Withdrawal by Subject|2|||
27669546|NCT03414047|80630830|FG003|Overall Study|Withdrawal by Subject|0|||
27669547|NCT00477464|80630831|FG000|Overall Study|Lost to Follow-up|1|||
27669548|NCT00477464|80630831|FG000|Overall Study|Death|36|||
27865809|NCT00996892|81341996|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
27865810|NCT00996892|81341997|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
27865811|NCT00996892|81341998|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
27669549|NCT00477464|80630831|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
27669550|NCT04245345|80630832|FG000|Overall Study|Death|1|||
27669551|NCT04245345|80630832|FG000|Overall Study|Exited prior to implant|5|||
27669552|NCT04245345|80630832|FG000|Overall Study|Exited prior to 1-month|9|||
27669553|NCT04245345|80630832|FG000|Overall Study|Missed 1-month visit|3|||
27669554|NCT04245345|80630832|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
27669555|NCT04245345|80630832|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
27669556|NCT01407276|80630842|FG000|Overall Study|Withdrawal by Subject|0|||
27865812|NCT00996892|81341999|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
27669557|NCT01407276|80630843|FG001|Overall Study|Withdrawal by Subject|0|||
27669558|NCT01407276|80630844|FG002|Overall Study|Withdrawal by Subject|0|||
27669559|NCT01407276|80630845|FG003|Overall Study|Withdrawal by Subject|0|||
27669560|NCT01407276|80630846|FG004|Overall Study|Withdrawal by Subject|0|||
27669561|NCT01407276|80630847|FG005|Overall Study|Withdrawal by Subject|0|||
27669562|NCT01407276|80630848|FG006|Overall Study|Withdrawal by Subject|0|||
27669563|NCT01407276|80630849|FG007|Overall Study|Withdrawal by Subject|1|||
27669564|NCT00412880|80630851|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
27669565|NCT00412880|80630851|FG000|Overall Study|Consent withdrawn|1|||
27669566|NCT00412880|80630851|FG000|Overall Study|Adverse Event|1|||
27669567|NCT00412880|80630851|FG000|Overall Study|Progressive disease|20|||
27669568|NCT03277352|80630852|FG000|Overall Study|Study Terminated By Sponsor|2|||
27669569|NCT03277352|80630852|FG000|Overall Study|Withdrawal by Subject|4|||
27669570|NCT03277352|80630852|FG000|Overall Study|Death|4|||
27669571|NCT00684203|80630853|FG000|Overall Study|Adverse Event|6|||
27669572|NCT00684203|80630854|FG001|Overall Study|Adverse Event|4|||
27669573|NCT00684203|80630855|FG002|Overall Study|Adverse Event|8|||
27669574|NCT00684203|80630856|FG003|Overall Study|Adverse Event|0|||
27669575|NCT00684203|80630857|FG004|Overall Study|Adverse Event|0|||
27669576|NCT00684203|80630858|FG005|Overall Study|Adverse Event|0|||
27669577|NCT00684203|80630853|FG000|Overall Study|Protocol-defined clinical event|3|||
27669578|NCT00684203|80630854|FG001|Overall Study|Protocol-defined clinical event|1|||
27669579|NCT00684203|80630855|FG002|Overall Study|Protocol-defined clinical event|0|||
27669580|NCT00684203|80630856|FG003|Overall Study|Protocol-defined clinical event|0|||
27669581|NCT00684203|80630857|FG004|Overall Study|Protocol-defined clinical event|0|||
27669582|NCT00684203|80630858|FG005|Overall Study|Protocol-defined clinical event|0|||
27669583|NCT00684203|80630853|FG000|Overall Study|Withdrawal by Subject|0|||
27669584|NCT00684203|80630854|FG001|Overall Study|Withdrawal by Subject|2|||
27669585|NCT00684203|80630855|FG002|Overall Study|Withdrawal by Subject|1|||
27972783|NCT02370537|81730125|FG001|Part B|Withdrawal by Subject|1|||
27972784|NCT02370537|81730126|FG002|Part B|Withdrawal by Subject|0|||
27972785|NCT04096820|81730130|FG000|Overall Study|Did not return for intervention|2|||
27972786|NCT04096820|81730130|FG000|Overall Study|Death|1|||
27972787|NCT02596958|81730131|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
27972788|NCT02596958|81730131|FG000|Overall Study|Cancer Progression|441|||
27972789|NCT02596958|81730131|FG000|Overall Study|Death From Cancer|112|||
27972790|NCT02596958|81730131|FG000|Overall Study|Death From Other Cause|33|||
27972791|NCT02596958|81730131|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
27972792|NCT02596958|81730131|FG000|Overall Study|Administrative Reasons/Other|231|||
27972793|NCT02596958|81730131|FG000|Overall Study|Lost to Follow-up|33|||
27972794|NCT02596958|81730131|FG000|Overall Study|Missing|32|||
27972795|NCT02596958|81730131|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
27972796|NCT00322023|81730132|FG000|Overall Study|various|0|||
27972797|NCT00322023|81730133|FG001|Overall Study|various|2|||
27972798|NCT00322023|81730134|FG002|Overall Study|various|6|||
27972799|NCT00223808|81730135|FG000|Overall Study|<5 hrs therapy before discharge|3|||
27972800|NCT00223808|81730136|FG001|Overall Study|<5 hrs therapy before discharge|5|||
27972801|NCT00223808|81730137|FG002|Overall Study|<5 hrs therapy before discharge|5|||
27972802|NCT01271010|81730138|FG000|Overall Study|Reason not specified|11|||
27972803|NCT01271010|81730138|FG000|Overall Study|Start of new CLL therapy|1|||
27972804|NCT01271010|81730138|FG000|Overall Study|Protocol Violation|1|||
27972805|NCT01271010|81730138|FG000|Overall Study|Death|2|||
27972806|NCT01271010|81730138|FG000|Overall Study|Progression and relapse of disease|1|||
27972807|NCT01271010|81730138|FG000|Overall Study|Withdrawal by Subject|18|||
27972808|NCT01271010|81730138|FG000|Overall Study|Disease progression|27|||
27972809|NCT02752958|81730139|FG000|Overall Study|Adverse Event|3|||
27972810|NCT02752958|81730139|FG000|Overall Study|Lost to Follow-up|1|||
27972811|NCT02752958|81730139|FG000|Overall Study|Protocol Violation|1|||
27972812|NCT02752958|81730139|FG000|Overall Study|Withdrawal by Subject|2|||
27972813|NCT02752958|81730139|FG000|Overall Study|Other (Reason not specified)|2|||
27972814|NCT02685748|81730144|FG000|Overall Study|Withdrawal by Subject|3|||
27972815|NCT02685748|81730145|FG001|Overall Study|Withdrawal by Subject|2|||
27972816|NCT00470093|81730153|FG000|Overall Study|Adverse Event|2|||
27972817|NCT00489424|81730154|FG000|Overall Study|Adverse Event|3|||
27972818|NCT00489424|81730155|FG001|Overall Study|Adverse Event|3|||
27972819|NCT00489424|81730156|FG002|Overall Study|Adverse Event|4|||
27972820|NCT00489424|81730154|FG000|Overall Study|Lack of Efficacy|1|||
27972821|NCT00489424|81730155|FG001|Overall Study|Lack of Efficacy|0|||
27972822|NCT00489424|81730156|FG002|Overall Study|Lack of Efficacy|0|||
27972823|NCT00489424|81730154|FG000|Overall Study|Administrative problems|0|||
27669586|NCT00684203|80630856|FG003|Overall Study|Withdrawal by Subject|0|||
27669587|NCT00684203|80630857|FG004|Overall Study|Withdrawal by Subject|0|||
27669588|NCT00684203|80630858|FG005|Overall Study|Withdrawal by Subject|0|||
27669589|NCT00684203|80630853|FG000|Overall Study|Did not meet protocol eligibility|0|||
27669590|NCT00684203|80630854|FG001|Overall Study|Did not meet protocol eligibility|1|||
27669591|NCT00684203|80630855|FG002|Overall Study|Did not meet protocol eligibility|0|||
27972824|NCT00489424|81730155|FG001|Overall Study|Administrative problems|2|||
27972825|NCT00489424|81730156|FG002|Overall Study|Administrative problems|1|||
27972826|NCT01345591|81730157|FG000|Overall Study|Lost to Follow-up|1|||
27972827|NCT03334851|81730159|FG000|Overall Study|Other|0|||
27972828|NCT03334851|81730160|FG001|Overall Study|Other|0|||
27669592|NCT00684203|80630856|FG003|Overall Study|Did not meet protocol eligibility|0|||
27669593|NCT00684203|80630857|FG004|Overall Study|Did not meet protocol eligibility|0|||
27669594|NCT00684203|80630858|FG005|Overall Study|Did not meet protocol eligibility|0|||
27669595|NCT00469456|80630859|FG000|Overall Study|Adverse Event|4|||
27669596|NCT00469456|80630860|FG001|Overall Study|Adverse Event|3|||
27669597|NCT00469456|80630859|FG000|Overall Study|Protocol Violation|1|||
27669598|NCT00469456|80630860|FG001|Overall Study|Protocol Violation|0|||
27784008|NCT02207413|81040573|FG001|Overall Study|Withdrawal by Subject|0|||
27784009|NCT02207413|81040574|FG002|Overall Study|Withdrawal by Subject|0|||
27784010|NCT02207413|81040575|FG003|Overall Study|Withdrawal by Subject|0|||
27669599|NCT00469456|80630859|FG000|Overall Study|Withdrawal by Subject|4|||
27669600|NCT00469456|80630860|FG001|Overall Study|Withdrawal by Subject|1|||
27669601|NCT02344173|80630861|FG000|Procedure|Ablation Procedure Not Performed|7|||
27784011|NCT02207413|81040576|FG004|Overall Study|Withdrawal by Subject|3|||
27784012|NCT02207413|81040577|FG005|Overall Study|Withdrawal by Subject|7|||
27784013|NCT02207413|81040572|FG000|Overall Study|Lost to Follow-up|0|||
27784014|NCT02207413|81040573|FG001|Overall Study|Lost to Follow-up|0|||
27784015|NCT02207413|81040574|FG002|Overall Study|Lost to Follow-up|0|||
27784016|NCT02207413|81040575|FG003|Overall Study|Lost to Follow-up|1|||
27784017|NCT02207413|81040576|FG004|Overall Study|Lost to Follow-up|1|||
27784018|NCT02207413|81040577|FG005|Overall Study|Lost to Follow-up|5|||
27784019|NCT02207413|81040572|FG000|Overall Study|Adverse Event|0|||
27784020|NCT02207413|81040573|FG001|Overall Study|Adverse Event|0|||
27784021|NCT02207413|81040574|FG002|Overall Study|Adverse Event|0|||
27784022|NCT02207413|81040575|FG003|Overall Study|Adverse Event|0|||
27784023|NCT02207413|81040576|FG004|Overall Study|Adverse Event|2|||
27784024|NCT02207413|81040577|FG005|Overall Study|Adverse Event|1|||
27784025|NCT02207413|81040572|FG000|Overall Study|Migrated/moved from study area|0|||
27784026|NCT02207413|81040573|FG001|Overall Study|Migrated/moved from study area|0|||
27784027|NCT02207413|81040574|FG002|Overall Study|Migrated/moved from study area|0|||
27784028|NCT02207413|81040575|FG003|Overall Study|Migrated/moved from study area|0|||
27784029|NCT02207413|81040576|FG004|Overall Study|Migrated/moved from study area|1|||
27784030|NCT02207413|81040577|FG005|Overall Study|Migrated/moved from study area|0|||
27784031|NCT03188991|81040585|FG000|Overall Study|Withdrawal by Subject|0|||
27784032|NCT03188991|81040586|FG001|Overall Study|Withdrawal by Subject|0|||
27784033|NCT03188991|81040587|FG002|Overall Study|Withdrawal by Subject|0|||
27784034|NCT03188991|81040588|FG003|Overall Study|Withdrawal by Subject|1|||
27784035|NCT04354870|81040589|FG000|Overall Study|Lost to Follow-up|32|||
27784036|NCT04354870|81040590|FG001|Overall Study|Lost to Follow-up|12|||
27784037|NCT04354870|81040589|FG000|Overall Study|Withdrawal by Subject|10|||
27784038|NCT04354870|81040590|FG001|Overall Study|Withdrawal by Subject|16|||
27784039|NCT04354870|81040589|FG000|Overall Study|Did not complete all study visits|6|||
27784040|NCT04354870|81040590|FG001|Overall Study|Did not complete all study visits|5|||
27784041|NCT02624713|81040591|FG000|Overall Study|Lost to Follow-up|14|||
27784042|NCT02624713|81040592|FG001|Overall Study|Lost to Follow-up|0|||
27784043|NCT01207427|81040593|FG000|Double-blind Treatment Period|Adverse Event|0|||
27784044|NCT01207427|81040594|FG001|Double-blind Treatment Period|Adverse Event|1|||
27784045|NCT01207427|81040595|FG002|Double-blind Treatment Period|Adverse Event|0|||
27784046|NCT01207427|81040593|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27784047|NCT01207427|81040594|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27784048|NCT01207427|81040595|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27784049|NCT01207427|81040593|FG000|Double-blind Treatment Period|Protocol Violation|2|||
27784050|NCT01207427|81040594|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27784051|NCT01207427|81040595|FG002|Double-blind Treatment Period|Protocol Violation|1|||
27972829|NCT03334851|81730161|FG002|Overall Study|Other|0|||
27972830|NCT03334851|81730162|FG003|Overall Study|Other|0|||
27972831|NCT03334851|81730163|FG004|Overall Study|Other|0|||
27972832|NCT03334851|81730164|FG005|Overall Study|Other|0|||
27669602|NCT02344173|80630861|FG000|12-month Visit|Death|8|||
27784052|NCT01207427|81040593|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27784053|NCT01207427|81040594|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27784054|NCT01207427|81040595|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27784055|NCT02275052|81040596|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27972833|NCT03334851|81730165|FG006|Overall Study|Other|0|||
27784056|NCT02275052|81040597|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27784057|NCT02275052|81040598|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27784058|NCT02275052|81040599|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27784059|NCT02275052|81040596|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
27784060|NCT02275052|81040597|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
27784061|NCT02275052|81040598|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
27784062|NCT02275052|81040599|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
27784063|NCT02275052|81040596|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
27784064|NCT02275052|81040597|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
27784065|NCT02275052|81040598|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27784066|NCT02275052|81040599|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27784067|NCT02275052|81040596|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
27784068|NCT02275052|81040597|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
27784069|NCT02275052|81040598|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
27784070|NCT02275052|81040599|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
27784071|NCT02275052|81040596|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
27784072|NCT02275052|81040597|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
27784073|NCT02275052|81040598|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
27784074|NCT02275052|81040599|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
27784075|NCT02275052|81040596|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
27784076|NCT02275052|81040597|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
27784077|NCT02275052|81040598|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
27784078|NCT02275052|81040599|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
27784079|NCT02275052|81040596|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
27571664|NCT03616912|80278882|FG003|Overall Study|Death|0|||
27571665|NCT03616912|80278883|FG004|Overall Study|Death|0|||
27571666|NCT03616912|80278884|FG005|Overall Study|Death|0|||
27571667|NCT03616912|80278879|FG000|Overall Study|Lack of Efficacy|13|||
27784080|NCT02275052|81040597|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
27972834|NCT03334851|81730166|FG007|Overall Study|Other|1|||
27972835|NCT03334851|81730167|FG008|Overall Study|Other|0|||
27972836|NCT03334851|81730168|FG009|Overall Study|Other|0|||
27972837|NCT03334851|81730169|FG010|Overall Study|Other|0|||
27972838|NCT03334851|81730170|FG011|Overall Study|Other|0|||
27972839|NCT03334851|81730171|FG012|Overall Study|Other|0|||
27784081|NCT02275052|81040598|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
27784082|NCT02275052|81040599|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
27784083|NCT02275052|81040596|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27784084|NCT02275052|81040597|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27784085|NCT02275052|81040598|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
27784086|NCT02275052|81040599|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
27784087|NCT02275052|81040596|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27784088|NCT02275052|81040597|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27784089|NCT02275052|81040598|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27784090|NCT02275052|81040599|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
27784091|NCT02275052|81040596|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
27784092|NCT02275052|81040597|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
27784093|NCT02275052|81040598|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
27784094|NCT02275052|81040599|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
27784095|NCT02275052|81040596|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27784096|NCT02275052|81040597|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27833018|NCT02658487|81219436|FG000|Overall Study|Adverse Event|1|||
27833019|NCT02658487|81219436|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
27833020|NCT02658487|81219436|FG000|Overall Study|Refractory AML|1|||
27833021|NCT00848536|81219437|FG000|Overall Study|Adverse Event|2|||
27972840|NCT03334851|81730159|FG000|Overall Study|Adverse Event|0|||
27972841|NCT03334851|81730160|FG001|Overall Study|Adverse Event|0|||
27833022|NCT00848536|81219438|FG001|Overall Study|Adverse Event|2|||
27833023|NCT00848536|81219437|FG000|Overall Study|Withdrawal by Subject|0|||
27833024|NCT00848536|81219438|FG001|Overall Study|Withdrawal by Subject|1|||
27972842|NCT03334851|81730161|FG002|Overall Study|Adverse Event|0|||
27972843|NCT03334851|81730162|FG003|Overall Study|Adverse Event|0|||
27972844|NCT03334851|81730163|FG004|Overall Study|Adverse Event|0|||
27571668|NCT03616912|80278880|FG001|Overall Study|Lack of Efficacy|6|||
27833025|NCT00848536|81219437|FG000|Overall Study|Protocol Violation|0|||
27784097|NCT02275052|81040598|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27784098|NCT02275052|81040599|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
27784099|NCT01070381|81040600|FG000|Period 2, 1 Week of Wear|Handling|0|||
27784100|NCT01070381|81040601|FG001|Period 2, 1 Week of Wear|Handling|1|||
27784101|NCT01070381|81040600|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
27784102|NCT01070381|81040601|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
27784103|NCT00303602|81040608|FG000|Overall Study|Adverse Event|2|||
27784104|NCT00303602|81040609|FG001|Overall Study|Adverse Event|2|||
27784105|NCT00303602|81040608|FG000|Overall Study|Withdrawal by Subject|5|||
27784106|NCT00303602|81040609|FG001|Overall Study|Withdrawal by Subject|6|||
27784107|NCT00303602|81040608|FG000|Overall Study|Lost to Follow-up|5|||
27784108|NCT00303602|81040609|FG001|Overall Study|Lost to Follow-up|2|||
27784109|NCT00303602|81040608|FG000|Overall Study|Protocol entry criteria not met|2|||
27784110|NCT00303602|81040609|FG001|Overall Study|Protocol entry criteria not met|2|||
27784111|NCT00303602|81040608|FG000|Overall Study|Physician Decision|2|||
27784112|NCT00303602|81040609|FG001|Overall Study|Physician Decision|1|||
27784113|NCT00303602|81040608|FG000|Overall Study|Noncompliance|2|||
27784114|NCT00303602|81040609|FG001|Overall Study|Noncompliance|2|||
27784115|NCT00303602|81040608|FG000|Overall Study|Protocol Violation|1|||
27784116|NCT00303602|81040609|FG001|Overall Study|Protocol Violation|0|||
27784117|NCT05102734|81040610|FG000|Overall Study|Did not require vasopressors|1|||
27784118|NCT05102734|81040611|FG001|Overall Study|Did not require vasopressors|0|||
27784119|NCT05102734|81040610|FG000|Overall Study|Did not have functioning PA catheter|1|||
27784120|NCT05102734|81040611|FG001|Overall Study|Did not have functioning PA catheter|0|||
27784121|NCT05102734|81040610|FG000|Overall Study|Inadequate video quality|2|||
27784122|NCT05102734|81040611|FG001|Overall Study|Inadequate video quality|0|||
27784123|NCT00242658|81040612|FG000|Overall Study|Lost to Follow-up|22|||
27784124|NCT00242658|81040613|FG001|Overall Study|Lost to Follow-up|19|||
27784125|NCT00003389|81040624|FG000|Overall Study|Disease progression|6|||
27784126|NCT00003389|81040625|FG001|Overall Study|Disease progression|1|||
27784127|NCT00003389|81040624|FG000|Overall Study|Adverse Event|13|||
27784128|NCT00003389|81040625|FG001|Overall Study|Adverse Event|2|||
27784129|NCT00003389|81040624|FG000|Overall Study|Death|0|||
27784130|NCT00003389|81040625|FG001|Overall Study|Death|3|||
27784131|NCT00003389|81040624|FG000|Overall Study|Withdrawal by Subject|12|||
27784132|NCT00003389|81040625|FG001|Overall Study|Withdrawal by Subject|5|||
27784133|NCT00003389|81040624|FG000|Overall Study|Alternative therapy|2|||
27784134|NCT00003389|81040625|FG001|Overall Study|Alternative therapy|1|||
27784135|NCT00003389|81040624|FG000|Overall Study|Complicating disease|1|||
27784136|NCT00003389|81040625|FG001|Overall Study|Complicating disease|0|||
27784137|NCT00003389|81040624|FG000|Overall Study|Off-treatment reason missing|31|||
27784138|NCT00003389|81040625|FG001|Overall Study|Off-treatment reason missing|21|||
27784139|NCT00003389|81040624|FG000|Overall Study|Ineligible|33|||
27784140|NCT00003389|81040625|FG001|Overall Study|Ineligible|27|||
27784141|NCT00186121|81040626|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
27784142|NCT00186121|81040626|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
27784143|NCT00186121|81040626|FG000|Overall Study|Not eligible (no treatment)|1|||
27784144|NCT00724243|81040631|FG000|Overall Study|Lack of Efficacy|10|||
27784145|NCT00724243|81040631|FG000|Overall Study|Adverse Event|5|||
27784146|NCT03730987|81040635|FG000|Overall Study|Lost to Follow-up|2|||
27784147|NCT03730987|81040636|FG001|Overall Study|Lost to Follow-up|0|||
27784148|NCT03730987|81040637|FG002|Overall Study|Lost to Follow-up|2|||
27784149|NCT03730987|81040638|FG003|Overall Study|Lost to Follow-up|0|||
27784150|NCT01791543|81040639|FG000|Overall Study|Lost to Follow-up|1|||
27784151|NCT01791543|81040639|FG000|Overall Study|Adverse Event|1|||
27784152|NCT01345162|81040642|FG000|Overall Study|Protocol Violation|2|||
27784153|NCT01345162|81040643|FG001|Overall Study|Protocol Violation|4|||
27784154|NCT00635804|81040661|FG000|Overall Study|Adverse Event|0|||
27784155|NCT00635804|81040662|FG001|Overall Study|Adverse Event|0|||
27784156|NCT00635804|81040663|FG002|Overall Study|Adverse Event|0|||
27784157|NCT00635804|81040664|FG003|Overall Study|Adverse Event|0|||
27784158|NCT00635804|81040665|FG004|Overall Study|Adverse Event|0|||
27784159|NCT00635804|81040666|FG005|Overall Study|Adverse Event|1|||
27784160|NCT00635804|81040667|FG006|Overall Study|Adverse Event|0|||
27784161|NCT00635804|81040668|FG007|Overall Study|Adverse Event|0|||
27784162|NCT00635804|81040661|FG000|Overall Study|Withdrawal by Subject|1|||
27784163|NCT00635804|81040662|FG001|Overall Study|Withdrawal by Subject|0|||
27784164|NCT00635804|81040663|FG002|Overall Study|Withdrawal by Subject|0|||
27784165|NCT00635804|81040664|FG003|Overall Study|Withdrawal by Subject|0|||
27784166|NCT00635804|81040665|FG004|Overall Study|Withdrawal by Subject|0|||
27784167|NCT00635804|81040666|FG005|Overall Study|Withdrawal by Subject|0|||
27784168|NCT00635804|81040667|FG006|Overall Study|Withdrawal by Subject|0|||
27571669|NCT03616912|80278881|FG002|Overall Study|Lack of Efficacy|8|||
27784169|NCT00635804|81040668|FG007|Overall Study|Withdrawal by Subject|0|||
27784170|NCT02612129|81040670|FG000|Single Dose Treatment Period|Screening Failure|1|||
27784171|NCT02612129|81040671|FG001|Single Dose Treatment Period|Screening Failure|0|||
27784172|NCT02612129|81040672|FG002|Single Dose Treatment Period|Screening Failure|0|||
27865813|NCT00996892|81342000|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
27865814|NCT00996892|81342001|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
27865815|NCT00996892|81342002|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
27865816|NCT00996892|81342003|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
27865817|NCT00996892|81342004|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
27865818|NCT00996892|81342005|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
27865819|NCT00996892|81342006|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
27865820|NCT00996892|81342007|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
27865821|NCT00996892|81342008|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
27865822|NCT00996892|81342009|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
27865823|NCT00996892|81342010|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
27865824|NCT00996892|81342011|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
27865825|NCT00996892|81342012|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
27865826|NCT00996892|81342013|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
27865827|NCT00996892|81342014|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
27865828|NCT00996892|81341995|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865829|NCT00996892|81341996|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865830|NCT00996892|81341997|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865831|NCT00996892|81341998|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865832|NCT00996892|81341999|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865833|NCT00996892|81342000|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865834|NCT00996892|81342001|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865835|NCT00996892|81342002|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865836|NCT00996892|81342003|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865837|NCT00996892|81342004|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27865838|NCT00996892|81342005|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27865839|NCT00996892|81342006|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27865840|NCT00996892|81342007|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
27865841|NCT00996892|81342008|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865842|NCT00996892|81342009|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865843|NCT00996892|81342010|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865844|NCT00996892|81342011|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865845|NCT00996892|81342012|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865846|NCT00996892|81342013|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865847|NCT00996892|81342014|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
27865848|NCT00996892|81341995|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
27865849|NCT00996892|81341996|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
27865850|NCT00996892|81341997|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
27865851|NCT00996892|81341998|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
27865852|NCT00996892|81341999|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
27865853|NCT00996892|81342000|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
27865854|NCT00996892|81342001|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
27865855|NCT00996892|81342002|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
27865856|NCT00996892|81342003|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
27865857|NCT00996892|81342004|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
27865858|NCT00996892|81342005|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
27865859|NCT00996892|81342006|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
27865860|NCT00996892|81342007|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
27865861|NCT00996892|81342008|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
27865862|NCT00996892|81342009|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
27865863|NCT00996892|81342010|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
27865864|NCT00996892|81342011|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
27865865|NCT00996892|81342012|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
27865866|NCT00996892|81342013|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
27865867|NCT00996892|81342014|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
27865868|NCT00996892|81341995|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
27865869|NCT00996892|81341996|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
27865870|NCT00996892|81341997|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
27865871|NCT00996892|81341998|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
27865872|NCT00996892|81341999|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
27865873|NCT00996892|81342000|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
27865874|NCT00996892|81342001|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
27865875|NCT00996892|81342002|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
27784173|NCT02612129|81040670|FG000|Continuous Treatment Period|Early Escape|0|||
27865876|NCT00996892|81342003|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
27784174|NCT02612129|81040671|FG001|Continuous Treatment Period|Early Escape|2|||
27865877|NCT00996892|81342004|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
27865878|NCT00996892|81342005|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
27865879|NCT00996892|81342006|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
27865880|NCT00996892|81342007|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
27571670|NCT03616912|80278882|FG003|Overall Study|Lack of Efficacy|4|||
27571671|NCT03616912|80278883|FG004|Overall Study|Lack of Efficacy|5|||
27571672|NCT03616912|80278884|FG005|Overall Study|Lack of Efficacy|1|||
27571673|NCT03616912|80278879|FG000|Overall Study|Lost to Follow-up|1|||
27571674|NCT03616912|80278880|FG001|Overall Study|Lost to Follow-up|2|||
27571675|NCT03616912|80278881|FG002|Overall Study|Lost to Follow-up|3|||
27571676|NCT03616912|80278882|FG003|Overall Study|Lost to Follow-up|0|||
27571677|NCT03616912|80278883|FG004|Overall Study|Lost to Follow-up|0|||
27571678|NCT03616912|80278884|FG005|Overall Study|Lost to Follow-up|0|||
27571679|NCT03616912|80278879|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
27571680|NCT03616912|80278880|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
27571681|NCT03616912|80278881|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
27571682|NCT03616912|80278882|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
27571683|NCT03616912|80278883|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
27571684|NCT03616912|80278884|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
27571685|NCT03616912|80278879|FG000|Overall Study|Withdrawal by Subject|12|||
27571686|NCT03616912|80278880|FG001|Overall Study|Withdrawal by Subject|12|||
27784175|NCT02612129|81040672|FG002|Continuous Treatment Period|Early Escape|0|||
27784176|NCT02612129|81040670|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
27571687|NCT03616912|80278881|FG002|Overall Study|Withdrawal by Subject|15|||
27571688|NCT03616912|80278882|FG003|Overall Study|Withdrawal by Subject|2|||
27571689|NCT03616912|80278883|FG004|Overall Study|Withdrawal by Subject|0|||
27571690|NCT03616912|80278884|FG005|Overall Study|Withdrawal by Subject|2|||
27571691|NCT03616912|80278879|FG000|Overall Study|Study Terminated by Sponsor|0|||
27571692|NCT03616912|80278880|FG001|Overall Study|Study Terminated by Sponsor|0|||
27571693|NCT03616912|80278881|FG002|Overall Study|Study Terminated by Sponsor|0|||
27571694|NCT03616912|80278882|FG003|Overall Study|Study Terminated by Sponsor|10|||
27784177|NCT02612129|81040671|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
27784178|NCT02612129|81040672|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
27784179|NCT02612129|81040670|FG000|Continuous Treatment Period|Safety Reasons|0|||
27784180|NCT02612129|81040671|FG001|Continuous Treatment Period|Safety Reasons|3|||
27784181|NCT02612129|81040672|FG002|Continuous Treatment Period|Safety Reasons|0|||
27784182|NCT02612129|81040670|FG000|Continuous Treatment Period|Death|0|||
27784183|NCT02612129|81040671|FG001|Continuous Treatment Period|Death|1|||
27784184|NCT02612129|81040672|FG002|Continuous Treatment Period|Death|0|||
27571695|NCT03616912|80278883|FG004|Overall Study|Study Terminated by Sponsor|9|||
27571696|NCT03616912|80278884|FG005|Overall Study|Study Terminated by Sponsor|11|||
27669603|NCT02344173|80630861|FG000|12-month Visit|Withdrawal by Subject|30|||
27669604|NCT02344173|80630861|FG000|12-month Visit|Lost to Follow-up|58|||
27669605|NCT01667549|80630862|FG000|Overall Study|Withdrawal by Subject|3|||
27669606|NCT01667549|80630863|FG001|Overall Study|Withdrawal by Subject|5|||
27669607|NCT01667549|80630864|FG002|Overall Study|Withdrawal by Subject|7|||
27669608|NCT01667549|80630865|FG003|Overall Study|Withdrawal by Subject|6|||
27669609|NCT01667549|80630866|FG004|Overall Study|Withdrawal by Subject|1|||
27669610|NCT03016598|80630867|FG000|Overall Study|Lost to Follow-up|0|||
27669611|NCT03016598|80630868|FG001|Overall Study|Lost to Follow-up|2|||
27669612|NCT01777490|80630870|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
27669613|NCT01777490|80630871|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
27669614|NCT01777490|80630872|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
27669615|NCT01777490|80630873|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
27669616|NCT00174447|80630878|FG000|Overall Study|Adverse Event|19|||
27669617|NCT00174447|80630878|FG000|Overall Study|Withdrawal by Subject|15|||
27669618|NCT00174447|80630878|FG000|Overall Study|Protocol Violation|1|||
27669619|NCT00174447|80630878|FG000|Overall Study|Lack of Efficacy|1|||
27669620|NCT00174447|80630878|FG000|Overall Study|Administrative reason/Other|2|||
27669621|NCT00761956|80630879|FG000|Overall Study|Lost to Follow-up|6|||
27669622|NCT00761956|80630880|FG001|Overall Study|Lost to Follow-up|11|||
27669623|NCT00761956|80630879|FG000|Overall Study|Withdrawal by Subject|3|||
27669624|NCT00761956|80630880|FG001|Overall Study|Withdrawal by Subject|8|||
27669625|NCT00761956|80630879|FG000|Overall Study|Death|0|||
27669626|NCT00761956|80630880|FG001|Overall Study|Death|1|||
27669627|NCT00761956|80630879|FG000|Overall Study|Adverse Event|26|||
27784185|NCT02612129|81040670|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
27571697|NCT03616912|80278879|FG000|Overall Study|Protocol Deviation|1|||
27571698|NCT03616912|80278880|FG001|Overall Study|Protocol Deviation|1|||
27571699|NCT03616912|80278881|FG002|Overall Study|Protocol Deviation|0|||
27571700|NCT03616912|80278882|FG003|Overall Study|Protocol Deviation|0|||
27571701|NCT03616912|80278883|FG004|Overall Study|Protocol Deviation|0|||
27571702|NCT03616912|80278884|FG005|Overall Study|Protocol Deviation|0|||
27571703|NCT03616912|80278879|FG000|Overall Study|Pregnancy|1|||
27571704|NCT03616912|80278880|FG001|Overall Study|Pregnancy|0|||
27571705|NCT03616912|80278881|FG002|Overall Study|Pregnancy|4|||
27571706|NCT03616912|80278882|FG003|Overall Study|Pregnancy|0|||
27669628|NCT00761956|80630880|FG001|Overall Study|Adverse Event|34|||
27669629|NCT00740870|80630881|FG000|Overall Study|Not Catheterized|4|||
27669630|NCT00740870|80630881|FG000|Overall Study|Further testing contraindicated implant|17|||
27669631|NCT00344032|80630886|FG000|Overall Study|Adverse Event|0|||
27669632|NCT00344032|80630887|FG001|Overall Study|Adverse Event|1|||
27669633|NCT00344032|80630886|FG000|Overall Study|Withdrawal by Subject|6|||
27669634|NCT00344032|80630887|FG001|Overall Study|Withdrawal by Subject|2|||
27669635|NCT00344032|80630886|FG000|Overall Study|Lost to Follow-up|4|||
27669636|NCT00344032|80630887|FG001|Overall Study|Lost to Follow-up|6|||
27669637|NCT00344032|80630886|FG000|Overall Study|Physician Decision|4|||
27669638|NCT00344032|80630887|FG001|Overall Study|Physician Decision|1|||
27669639|NCT04698915|80630888|FG000|Overall Study|Adverse Event|2|||
27669640|NCT04698915|80630889|FG001|Overall Study|Adverse Event|0|||
27669641|NCT04698915|80630888|FG000|Overall Study|Death|23|||
27669642|NCT04698915|80630889|FG001|Overall Study|Death|20|||
27669643|NCT04698915|80630888|FG000|Overall Study|Physician Decision|1|||
27669644|NCT04698915|80630889|FG001|Overall Study|Physician Decision|1|||
27669645|NCT04698915|80630888|FG000|Overall Study|Lost to Follow-up|1|||
27669646|NCT04698915|80630889|FG001|Overall Study|Lost to Follow-up|0|||
27669647|NCT04698915|80630888|FG000|Overall Study|Study Terminated by Sponsor|55|||
27669648|NCT04698915|80630889|FG001|Overall Study|Study Terminated by Sponsor|60|||
27669649|NCT04698915|80630888|FG000|Overall Study|Withdrawal by Subject|2|||
27669650|NCT04698915|80630889|FG001|Overall Study|Withdrawal by Subject|3|||
27669651|NCT02019641|80630890|FG000|10-Week Follow up|Withdrawal by investigator|2|||
27669652|NCT02019641|80630891|FG001|10-Week Follow up|Withdrawal by investigator|0|||
27669653|NCT02019641|80630892|FG002|10-Week Follow up|Withdrawal by investigator|0|||
27669654|NCT02019641|80630890|FG000|10-Week Follow up|Withdrawal by Subject|1|||
27669655|NCT02019641|80630891|FG001|10-Week Follow up|Withdrawal by Subject|1|||
27669656|NCT02019641|80630892|FG002|10-Week Follow up|Withdrawal by Subject|0|||
27669657|NCT02019641|80630890|FG000|20-Week Follow up|Withdrawal by investigator|0|||
27669658|NCT02019641|80630891|FG001|20-Week Follow up|Withdrawal by investigator|0|||
27669659|NCT02019641|80630892|FG002|20-Week Follow up|Withdrawal by investigator|1|||
27669660|NCT01209598|80630894|FG000|Overall Study|Withdrawal by Subject|1|||
27669661|NCT01209598|80630895|FG001|Overall Study|Withdrawal by Subject|0|||
27669662|NCT01270828|80630898|FG000|Pregabalin CR SB|Reason Unspecified|0|||
27669663|NCT01270828|80630899|FG001|Pregabalin CR SB|Reason Unspecified|0|||
27669664|NCT01270828|80630900|FG002|Pregabalin CR SB|Reason Unspecified|8|||
27669665|NCT01270828|80630898|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
27669666|NCT01270828|80630899|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
27669667|NCT01270828|80630900|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
27669668|NCT01270828|80630898|FG000|Pregabalin CR SB|Related adverse event|0|||
27669669|NCT01270828|80630899|FG001|Pregabalin CR SB|Related adverse event|0|||
27669670|NCT01270828|80630900|FG002|Pregabalin CR SB|Related adverse event|46|||
27669671|NCT01270828|80630898|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
27669672|NCT01270828|80630899|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
27669673|NCT01270828|80630900|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
27669674|NCT01270828|80630898|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
27669675|NCT01270828|80630899|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
27669676|NCT01270828|80630900|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
27784186|NCT02612129|81040671|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
27784187|NCT02612129|81040672|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
27784188|NCT00948389|81040673|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
27784189|NCT00948389|81040674|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
27571707|NCT03616912|80278883|FG004|Overall Study|Pregnancy|0|||
27571708|NCT03616912|80278884|FG005|Overall Study|Pregnancy|0|||
27571709|NCT03616912|80278879|FG000|Overall Study|Protocol Violation|1|||
27571710|NCT03616912|80278880|FG001|Overall Study|Protocol Violation|0|||
27571711|NCT03616912|80278881|FG002|Overall Study|Protocol Violation|2|||
27571712|NCT03616912|80278882|FG003|Overall Study|Protocol Violation|0|||
27571713|NCT03616912|80278883|FG004|Overall Study|Protocol Violation|0|||
27571714|NCT03616912|80278884|FG005|Overall Study|Protocol Violation|0|||
27669677|NCT01270828|80630898|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
27571715|NCT03616912|80278879|FG000|Overall Study|Physician Decision|2|||
27669678|NCT01270828|80630899|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
27669679|NCT01270828|80630900|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
27669680|NCT01270828|80630898|FG000|Pregabalin CR SB|Unrelated AE|0|||
27669681|NCT01270828|80630899|FG001|Pregabalin CR SB|Unrelated AE|0|||
27669682|NCT01270828|80630900|FG002|Pregabalin CR SB|Unrelated AE|8|||
27669683|NCT01270828|80630898|FG000|Pregabalin CR SB|Protocol Violation|0|||
27571716|NCT03616912|80278880|FG001|Overall Study|Physician Decision|0|||
27571717|NCT03616912|80278881|FG002|Overall Study|Physician Decision|0|||
27669684|NCT01270828|80630899|FG001|Pregabalin CR SB|Protocol Violation|0|||
27669685|NCT01270828|80630900|FG002|Pregabalin CR SB|Protocol Violation|8|||
27669686|NCT01270828|80630898|FG000|Double Blind Phase|Death|0|||
27669687|NCT01270828|80630899|FG001|Double Blind Phase|Death|1|||
27669688|NCT01270828|80630900|FG002|Double Blind Phase|Death|0|||
27669689|NCT01270828|80630898|FG000|Double Blind Phase|Protocol Violation|0|||
27669690|NCT01270828|80630899|FG001|Double Blind Phase|Protocol Violation|1|||
27669691|NCT01270828|80630900|FG002|Double Blind Phase|Protocol Violation|0|||
27669692|NCT01270828|80630898|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
27669693|NCT01270828|80630899|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
27669694|NCT01270828|80630900|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
27669695|NCT01270828|80630898|FG000|Double Blind Phase|Reason Unspecified|7|||
27669696|NCT01270828|80630899|FG001|Double Blind Phase|Reason Unspecified|4|||
27669697|NCT01270828|80630900|FG002|Double Blind Phase|Reason Unspecified|0|||
27669698|NCT01270828|80630898|FG000|Double Blind Phase|Withdrawal by Subject|6|||
27669699|NCT01270828|80630899|FG001|Double Blind Phase|Withdrawal by Subject|15|||
27669700|NCT01270828|80630900|FG002|Double Blind Phase|Withdrawal by Subject|0|||
27669701|NCT01270828|80630898|FG000|Double Blind Phase|Lost to Follow-up|1|||
27669702|NCT01270828|80630899|FG001|Double Blind Phase|Lost to Follow-up|2|||
27669703|NCT01270828|80630900|FG002|Double Blind Phase|Lost to Follow-up|0|||
27669704|NCT01270828|80630898|FG000|Double Blind Phase|Lack of Efficacy|2|||
27669705|NCT01270828|80630899|FG001|Double Blind Phase|Lack of Efficacy|11|||
27669706|NCT01270828|80630900|FG002|Double Blind Phase|Lack of Efficacy|0|||
27669707|NCT01270828|80630898|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
27669708|NCT01270828|80630899|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
27669709|NCT01270828|80630900|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
27669710|NCT01270828|80630898|FG000|Double Blind Phase|Adverse event related to study drug|5|||
27669711|NCT01270828|80630899|FG001|Double Blind Phase|Adverse event related to study drug|7|||
27669712|NCT01270828|80630900|FG002|Double Blind Phase|Adverse event related to study drug|0|||
27669713|NCT00908349|80630901|FG000|Overall Study|Adverse Event|10|||
27669714|NCT00908349|80630901|FG000|Overall Study|Withdrawal by Subject|9|||
27669715|NCT00908349|80630901|FG000|Overall Study|Physician Decision|5|||
27669716|NCT00908349|80630901|FG000|Overall Study|Lost to Follow-up|5|||
27669717|NCT00908349|80630901|FG000|Overall Study|Various|6|||
27669718|NCT03297398|80630905|FG000|Overall Study|Sponsor's decision|6|||
27669719|NCT03297398|80630906|FG001|Overall Study|Sponsor's decision|9|||
27669720|NCT03297398|80630907|FG002|Overall Study|Sponsor's decision|7|||
27669721|NCT03297398|80630905|FG000|Overall Study|Adverse Event|1|||
27571718|NCT03616912|80278882|FG003|Overall Study|Physician Decision|0|||
27571719|NCT03616912|80278883|FG004|Overall Study|Physician Decision|1|||
27571720|NCT03616912|80278884|FG005|Overall Study|Physician Decision|0|||
27571721|NCT03616912|80278879|FG000|Overall Study|Randomized But Never Treated|0|||
27571722|NCT03616912|80278880|FG001|Overall Study|Randomized But Never Treated|2|||
27669722|NCT03297398|80630906|FG001|Overall Study|Adverse Event|4|||
27571723|NCT03616912|80278881|FG002|Overall Study|Randomized But Never Treated|0|||
27669723|NCT03297398|80630907|FG002|Overall Study|Adverse Event|4|||
27669724|NCT03297398|80630905|FG000|Overall Study|Withdrawal by Subject|1|||
27669725|NCT03297398|80630906|FG001|Overall Study|Withdrawal by Subject|2|||
27669726|NCT03297398|80630907|FG002|Overall Study|Withdrawal by Subject|2|||
27669727|NCT03297398|80630905|FG000|Overall Study|Protocol Violation|0|||
27669728|NCT03297398|80630906|FG001|Overall Study|Protocol Violation|2|||
27669729|NCT03297398|80630907|FG002|Overall Study|Protocol Violation|0|||
27669730|NCT03297398|80630905|FG000|Overall Study|Physician Decision|0|||
27669731|NCT03297398|80630906|FG001|Overall Study|Physician Decision|0|||
27669732|NCT03297398|80630907|FG002|Overall Study|Physician Decision|1|||
27669733|NCT03297398|80630905|FG000|Overall Study|Lost to Follow-up|0|||
27669734|NCT03297398|80630906|FG001|Overall Study|Lost to Follow-up|0|||
27669735|NCT03297398|80630907|FG002|Overall Study|Lost to Follow-up|1|||
27669736|NCT01243411|80630908|FG000|Overall Study|Withdrawal by Subject|18|||
27669737|NCT01243411|80630908|FG000|Overall Study|Lost to Follow-up|10|||
27669738|NCT01243411|80630908|FG000|Overall Study|Adverse Event|5|||
27669739|NCT01243411|80630908|FG000|Overall Study|Other|8|||
27669740|NCT01983462|80630909|FG000|Overall Study|Adverse Event|1|||
27669741|NCT01983462|80630910|FG001|Overall Study|Adverse Event|0|||
27669742|NCT01983462|80630911|FG002|Overall Study|Adverse Event|0|||
27571724|NCT03616912|80278882|FG003|Overall Study|Randomized But Never Treated|0|||
27571725|NCT03616912|80278883|FG004|Overall Study|Randomized But Never Treated|0|||
27571726|NCT03616912|80278884|FG005|Overall Study|Randomized But Never Treated|0|||
27571727|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
27571728|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
27571729|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
27571730|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
27571731|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
27669743|NCT03635086|80630912|FG000|Overall Study|Withdrawal of consent|0|||
27784190|NCT00948389|81040675|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
27972845|NCT03334851|81730164|FG005|Overall Study|Adverse Event|0|||
27669744|NCT03635086|80630913|FG001|Overall Study|Withdrawal of consent|0|||
27669745|NCT03635086|80630914|FG002|Overall Study|Withdrawal of consent|1|||
27784191|NCT00948389|81040676|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
27669746|NCT03635086|80630915|FG003|Overall Study|Withdrawal of consent|0|||
27669747|NCT03635086|80630916|FG004|Overall Study|Withdrawal of consent|0|||
27669748|NCT03635086|80630912|FG000|Overall Study|Adverse Event|0|||
27669749|NCT03635086|80630913|FG001|Overall Study|Adverse Event|1|||
27669750|NCT03635086|80630914|FG002|Overall Study|Adverse Event|0|||
27669751|NCT03635086|80630915|FG003|Overall Study|Adverse Event|0|||
27669752|NCT03635086|80630916|FG004|Overall Study|Adverse Event|0|||
27669753|NCT03635086|80630912|FG000|Overall Study|Lost to Follow-up|1|||
27669754|NCT03635086|80630913|FG001|Overall Study|Lost to Follow-up|0|||
27669755|NCT03635086|80630914|FG002|Overall Study|Lost to Follow-up|0|||
27669756|NCT03635086|80630915|FG003|Overall Study|Lost to Follow-up|0|||
27669757|NCT03635086|80630916|FG004|Overall Study|Lost to Follow-up|0|||
27669758|NCT02806505|80630917|FG000|Overall Study|Adverse event/intercurrent illness|1|||
27669759|NCT02806505|80630918|FG001|Overall Study|Adverse event/intercurrent illness|3|||
27669760|NCT02806505|80630917|FG000|Overall Study|Death|4|||
27669761|NCT02806505|80630918|FG001|Overall Study|Death|0|||
27669762|NCT02806505|80630917|FG000|Overall Study|Did not cooperate/refused treatment|3|||
27669763|NCT02806505|80630918|FG001|Overall Study|Did not cooperate/refused treatment|3|||
27669764|NCT02806505|80630917|FG000|Overall Study|Failure to return|0|||
27669765|NCT02806505|80630918|FG001|Overall Study|Failure to return|1|||
27669766|NCT02806505|80630917|FG000|Overall Study|Insufficient therapeutic response|2|||
27669767|NCT02806505|80630918|FG001|Overall Study|Insufficient therapeutic response|4|||
27669768|NCT02548078|80630920|FG000|Overall Study|Serious adverse event/Adverse event|1|||
27669769|NCT02548078|80630921|FG001|Overall Study|Serious adverse event/Adverse event|0|||
27669770|NCT02548078|80630920|FG000|Overall Study|Moved from study area|3|||
27669771|NCT02548078|80630921|FG001|Overall Study|Moved from study area|3|||
27669772|NCT02548078|80630920|FG000|Overall Study|Lost to Follow-up|1|||
27669773|NCT02548078|80630921|FG001|Overall Study|Lost to Follow-up|3|||
27669774|NCT02762903|80630922|FG000|Overall Study|Lost to Follow-up|0|||
27669775|NCT02762903|80630923|FG001|Overall Study|Lost to Follow-up|1|||
27669776|NCT03512197|80630924|FG000|Overall Study|Guardian decision|1|||
27669777|NCT03512197|80630925|FG001|Overall Study|Guardian decision|1|||
27669778|NCT03512197|80630924|FG000|Overall Study|Lack of Efficacy|19|||
27669779|NCT03512197|80630925|FG001|Overall Study|Lack of Efficacy|11|||
27669780|NCT03512197|80630924|FG000|Overall Study|New Therapy for Study Indication|16|||
27669781|NCT03512197|80630925|FG001|Overall Study|New Therapy for Study Indication|16|||
27669782|NCT03512197|80630924|FG000|Overall Study|Physician Decision|60|||
27669783|NCT03512197|80630925|FG001|Overall Study|Physician Decision|60|||
27669784|NCT03512197|80630924|FG000|Overall Study|Protocol Violation|0|||
27669785|NCT03512197|80630925|FG001|Overall Study|Protocol Violation|2|||
27669786|NCT03512197|80630924|FG000|Overall Study|Terminated by Sponsored|46|||
27669787|NCT03512197|80630925|FG001|Overall Study|Terminated by Sponsored|50|||
27669788|NCT03512197|80630924|FG000|Overall Study|Subject Decision|15|||
27669789|NCT03512197|80630925|FG001|Overall Study|Subject Decision|12|||
27669790|NCT03512197|80630924|FG000|Overall Study|Withdrawal of informed consent|20|||
27669791|NCT03512197|80630925|FG001|Overall Study|Withdrawal of informed consent|14|||
27669792|NCT03512197|80630924|FG000|Overall Study|Adverse Event|30|||
27669793|NCT03512197|80630925|FG001|Overall Study|Adverse Event|34|||
27669794|NCT03512197|80630924|FG000|Overall Study|Death|14|||
27669795|NCT03512197|80630925|FG001|Overall Study|Death|9|||
27669796|NCT03512197|80630924|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
27669797|NCT03512197|80630925|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
27669798|NCT03512197|80630924|FG000|Overall Study|Missing|3|||
27669799|NCT03512197|80630925|FG001|Overall Study|Missing|13|||
27669800|NCT01806389|80630933|FG000|Overall Study|Withdrawal by Subject|4|||
27669801|NCT01850823|80630936|FG000|Overall Study|Early Visit Window|0|||
27669802|NCT01850823|80630937|FG001|Overall Study|Early Visit Window|1|||
27669803|NCT01850823|80630938|FG002|Overall Study|Early Visit Window|4|||
27669804|NCT01850823|80630936|FG000|Overall Study|Enrolled in Error|0|||
27669805|NCT01850823|80630937|FG001|Overall Study|Enrolled in Error|1|||
27669806|NCT01850823|80630938|FG002|Overall Study|Enrolled in Error|2|||
27669807|NCT01850823|80630936|FG000|Overall Study|Lack of Efficacy|1|||
27571732|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
27571733|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
27669808|NCT01850823|80630937|FG001|Overall Study|Lack of Efficacy|0|||
27669809|NCT01850823|80630938|FG002|Overall Study|Lack of Efficacy|0|||
27669810|NCT01850823|80630936|FG000|Overall Study|Lost to Follow-up|0|||
27669811|NCT01850823|80630937|FG001|Overall Study|Lost to Follow-up|0|||
27784192|NCT00948389|81040677|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
27784193|NCT00948389|81040673|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
27669812|NCT01850823|80630938|FG002|Overall Study|Lost to Follow-up|1|||
27669813|NCT01850823|80630936|FG000|Overall Study|Restricted Medication|0|||
27669814|NCT01850823|80630937|FG001|Overall Study|Restricted Medication|0|||
27669815|NCT01850823|80630938|FG002|Overall Study|Restricted Medication|2|||
27669816|NCT01850823|80630936|FG000|Overall Study|Significant worstening of SAR|0|||
27669817|NCT01850823|80630937|FG001|Overall Study|Significant worstening of SAR|1|||
27669818|NCT01850823|80630938|FG002|Overall Study|Significant worstening of SAR|0|||
27669819|NCT01850823|80630936|FG000|Overall Study|Withdrawal by Subject|2|||
27571734|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
27571735|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
27571736|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
27571737|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
27571738|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
27669820|NCT01850823|80630937|FG001|Overall Study|Withdrawal by Subject|0|||
27669821|NCT01850823|80630938|FG002|Overall Study|Withdrawal by Subject|1|||
27669822|NCT02781311|80630939|FG000|Overall Study|Adverse Event|2|||
27669823|NCT02781311|80630940|FG001|Overall Study|Adverse Event|6|||
27669824|NCT02781311|80630941|FG002|Overall Study|Adverse Event|1|||
27669825|NCT02781311|80630939|FG000|Overall Study|Withdrawal of Consent|11|||
27669826|NCT02781311|80630940|FG001|Overall Study|Withdrawal of Consent|12|||
27669827|NCT02781311|80630941|FG002|Overall Study|Withdrawal of Consent|2|||
27669828|NCT02781311|80630939|FG000|Overall Study|Lost to Follow-up|11|||
27669829|NCT02781311|80630940|FG001|Overall Study|Lost to Follow-up|8|||
27669830|NCT02781311|80630941|FG002|Overall Study|Lost to Follow-up|1|||
27669831|NCT02781311|80630939|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27669832|NCT02781311|80630940|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27669833|NCT02781311|80630941|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27669834|NCT00988533|80630942|FG000|Overall Study|Lost to Follow-up|3|||
27669835|NCT00813098|80630943|FG000|Overall Study|Adverse Event|2|||
27571739|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
27571740|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
27571741|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
27571742|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
27571743|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
27571744|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
27669836|NCT00813098|80630944|FG001|Overall Study|Adverse Event|4|||
27669837|NCT00813098|80630945|FG002|Overall Study|Adverse Event|1|||
27972846|NCT03334851|81730165|FG006|Overall Study|Adverse Event|0|||
27972847|NCT03334851|81730166|FG007|Overall Study|Adverse Event|1|||
27972848|NCT03334851|81730167|FG008|Overall Study|Adverse Event|0|||
27972849|NCT03334851|81730168|FG009|Overall Study|Adverse Event|0|||
27972850|NCT03334851|81730169|FG010|Overall Study|Adverse Event|0|||
27972851|NCT03334851|81730170|FG011|Overall Study|Adverse Event|0|||
27669838|NCT00813098|80630943|FG000|Overall Study|Withdrawal by Subject|0|||
27669839|NCT00813098|80630944|FG001|Overall Study|Withdrawal by Subject|1|||
27669840|NCT00813098|80630945|FG002|Overall Study|Withdrawal by Subject|0|||
27972852|NCT03334851|81730171|FG012|Overall Study|Adverse Event|0|||
27972853|NCT03334851|81730159|FG000|Overall Study|Withdrawal by Subject|0|||
27972854|NCT03334851|81730160|FG001|Overall Study|Withdrawal by Subject|0|||
27669841|NCT00813098|80630943|FG000|Overall Study|Inability to complete study procedures|1|||
27669842|NCT00813098|80630944|FG001|Overall Study|Inability to complete study procedures|0|||
27669843|NCT00813098|80630945|FG002|Overall Study|Inability to complete study procedures|0|||
27669844|NCT00813098|80630943|FG000|Overall Study|Lost to Follow-up|0|||
27669845|NCT00813098|80630944|FG001|Overall Study|Lost to Follow-up|1|||
27669846|NCT00813098|80630945|FG002|Overall Study|Lost to Follow-up|0|||
27784194|NCT00948389|81040674|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
27784195|NCT00948389|81040675|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
27669847|NCT00813098|80630943|FG000|Overall Study|Protocol Violation|0|||
27571745|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
27571746|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
27669848|NCT00813098|80630944|FG001|Overall Study|Protocol Violation|0|||
27669849|NCT00813098|80630945|FG002|Overall Study|Protocol Violation|1|||
27669850|NCT00813098|80630943|FG000|Overall Study|Principal Investigator decision|0|||
27972855|NCT03334851|81730161|FG002|Overall Study|Withdrawal by Subject|0|||
27972856|NCT03334851|81730162|FG003|Overall Study|Withdrawal by Subject|0|||
27972857|NCT03334851|81730163|FG004|Overall Study|Withdrawal by Subject|0|||
27571747|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Other|3|||
27571748|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Other|0|||
27571749|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Other|2|||
27571750|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Other|2|||
27571751|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Other|7|||
27571752|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571753|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571754|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571755|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
27571756|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571757|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571758|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571759|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571760|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571761|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
27571762|NCT00213148|80278887|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
27571763|NCT00213148|80278888|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
27571764|NCT00213148|80278889|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
27571765|NCT00213148|80278890|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
27571766|NCT00213148|80278891|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
27571767|NCT00213148|80278887|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
27571768|NCT00213148|80278888|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
27571769|NCT00213148|80278889|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
27669851|NCT00813098|80630944|FG001|Overall Study|Principal Investigator decision|1|||
27669852|NCT00813098|80630945|FG002|Overall Study|Principal Investigator decision|0|||
27669853|NCT00813098|80630943|FG000|Overall Study|Withdrew Consent|0|||
27669854|NCT00813098|80630944|FG001|Overall Study|Withdrew Consent|1|||
27669855|NCT00813098|80630945|FG002|Overall Study|Withdrew Consent|0|||
27669856|NCT01375114|80630947|FG000|Overall Study|Lost to Follow-up|1|||
27669857|NCT01375114|80630948|FG001|Overall Study|Lost to Follow-up|0|||
27669858|NCT01375114|80630949|FG002|Overall Study|Lost to Follow-up|1|||
27669859|NCT01375114|80630947|FG000|Overall Study|Disease Progression|3|||
27669860|NCT01375114|80630948|FG001|Overall Study|Disease Progression|2|||
27669861|NCT01375114|80630949|FG002|Overall Study|Disease Progression|2|||
27669862|NCT01375114|80630947|FG000|Overall Study|Patient Changed Mind|0|||
27669863|NCT01375114|80630948|FG001|Overall Study|Patient Changed Mind|0|||
27669864|NCT01375114|80630949|FG002|Overall Study|Patient Changed Mind|2|||
27669865|NCT01375114|80630947|FG000|Overall Study|Pruritus|0|||
27669866|NCT01375114|80630948|FG001|Overall Study|Pruritus|0|||
27669867|NCT01375114|80630949|FG002|Overall Study|Pruritus|1|||
27669868|NCT01375114|80630947|FG000|Overall Study|Restlessness|0|||
27669869|NCT01375114|80630948|FG001|Overall Study|Restlessness|0|||
27669870|NCT01375114|80630949|FG002|Overall Study|Restlessness|1|||
27669871|NCT01375114|80630947|FG000|Overall Study|Diarrhea|0|||
27669872|NCT01375114|80630948|FG001|Overall Study|Diarrhea|0|||
27669873|NCT01375114|80630949|FG002|Overall Study|Diarrhea|1|||
27669874|NCT01375114|80630947|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
27669875|NCT01375114|80630948|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
27669876|NCT01375114|80630949|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
27669877|NCT01375114|80630947|FG000|Overall Study|Nausea|0|||
27669878|NCT01375114|80630948|FG001|Overall Study|Nausea|1|||
27669879|NCT01375114|80630949|FG002|Overall Study|Nausea|0|||
27669880|NCT01375114|80630947|FG000|Overall Study|Increased AST/ALT|0|||
27669881|NCT01375114|80630948|FG001|Overall Study|Increased AST/ALT|1|||
27669882|NCT01375114|80630949|FG002|Overall Study|Increased AST/ALT|0|||
27669883|NCT01375114|80630947|FG000|Overall Study|Vaginal Hemorrhage|0|||
27669884|NCT01375114|80630948|FG001|Overall Study|Vaginal Hemorrhage|1|||
27669885|NCT01375114|80630949|FG002|Overall Study|Vaginal Hemorrhage|0|||
27669886|NCT01375114|80630947|FG000|Overall Study|Family problem|0|||
27669887|NCT01375114|80630948|FG001|Overall Study|Family problem|1|||
27669888|NCT01375114|80630949|FG002|Overall Study|Family problem|0|||
27669889|NCT01375114|80630947|FG000|Overall Study|Protocol Violation|2|||
27669890|NCT01375114|80630948|FG001|Overall Study|Protocol Violation|0|||
27669891|NCT01375114|80630949|FG002|Overall Study|Protocol Violation|0|||
27571770|NCT00213148|80278890|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
27571771|NCT00213148|80278891|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
27571772|NCT00213148|80278887|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
27571773|NCT00213148|80278888|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
27571774|NCT00213148|80278889|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
27571775|NCT00213148|80278890|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
27571776|NCT00213148|80278891|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
27669892|NCT01834586|80630951|FG000|Overall Study|Adverse Event|1|||
27669893|NCT02760485|80630952|FG000|Phase 1|Death|3|||
27669894|NCT02760485|80630953|FG001|Phase 1|Death|6|||
27669895|NCT02760485|80630954|FG002|Phase 1|Death|0|||
27669896|NCT02760485|80630952|FG000|Phase 1|Withdrawal by Subject|2|||
27669897|NCT02760485|80630953|FG001|Phase 1|Withdrawal by Subject|0|||
27669898|NCT02760485|80630954|FG002|Phase 1|Withdrawal by Subject|0|||
27972858|NCT03334851|81730164|FG005|Overall Study|Withdrawal by Subject|0|||
27972859|NCT03334851|81730165|FG006|Overall Study|Withdrawal by Subject|0|||
27571777|NCT00213148|80278887|FG000|Cycle 2 (1 Month)|Other|2|||
27571778|NCT00213148|80278888|FG001|Cycle 2 (1 Month)|Other|1|||
27571779|NCT00213148|80278889|FG002|Cycle 2 (1 Month)|Other|2|||
27571780|NCT00213148|80278890|FG003|Cycle 2 (1 Month)|Other|8|||
27571781|NCT00213148|80278891|FG004|Cycle 2 (1 Month)|Other|7|||
27571782|NCT00213148|80278887|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571783|NCT00213148|80278888|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
27571784|NCT00213148|80278889|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571785|NCT00213148|80278890|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571786|NCT00213148|80278891|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
27571787|NCT00213148|80278887|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
27571788|NCT00213148|80278888|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571789|NCT00213148|80278889|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571790|NCT00213148|80278890|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571791|NCT00213148|80278891|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
27571792|NCT00213148|80278887|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
27571793|NCT00213148|80278888|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
27571794|NCT00213148|80278889|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
27571795|NCT00213148|80278890|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
27571796|NCT00213148|80278891|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
27571797|NCT00213148|80278887|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
27571798|NCT00213148|80278888|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
27571799|NCT00213148|80278889|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
27571800|NCT00213148|80278890|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
27571801|NCT00213148|80278891|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
27571802|NCT00213148|80278887|FG000|Cycle 3 (1 Month)|Other|0|||
27571803|NCT00213148|80278888|FG001|Cycle 3 (1 Month)|Other|0|||
27571804|NCT00213148|80278889|FG002|Cycle 3 (1 Month)|Other|1|||
27571805|NCT00213148|80278890|FG003|Cycle 3 (1 Month)|Other|1|||
27571806|NCT00213148|80278891|FG004|Cycle 3 (1 Month)|Other|0|||
27571807|NCT03325166|80278892|FG000|Overall Study|Adverse Event|1|||
27571808|NCT04187196|80278893|FG000|Overall Study|Screen Failure|2|||
27571809|NCT04187196|80278894|FG001|Overall Study|Screen Failure|0|||
27571810|NCT02643251|80278898|FG000|Overall Study|Adverse Event|3|||
27571811|NCT02643251|80278899|FG001|Overall Study|Adverse Event|1|||
27571812|NCT02643251|80278898|FG000|Overall Study|Withdrawal by Subject|2|||
27571813|NCT02643251|80278899|FG001|Overall Study|Withdrawal by Subject|0|||
27571814|NCT02643251|80278898|FG000|Overall Study|Lost to Follow-up|4|||
27571815|NCT02643251|80278899|FG001|Overall Study|Lost to Follow-up|1|||
27571816|NCT02643251|80278898|FG000|Overall Study|Protocol Violation|1|||
27571817|NCT02643251|80278899|FG001|Overall Study|Protocol Violation|0|||
27571818|NCT02643251|80278898|FG000|Overall Study|PI Decision to terminate patient|1|||
27571819|NCT02643251|80278899|FG001|Overall Study|PI Decision to terminate patient|0|||
27669899|NCT02760485|80630952|FG000|Phase 1|Progressive Disease|1|||
27972860|NCT03334851|81730166|FG007|Overall Study|Withdrawal by Subject|0|||
27972861|NCT03334851|81730167|FG008|Overall Study|Withdrawal by Subject|0|||
27972862|NCT03334851|81730168|FG009|Overall Study|Withdrawal by Subject|0|||
27972863|NCT03334851|81730169|FG010|Overall Study|Withdrawal by Subject|1|||
27972864|NCT03334851|81730170|FG011|Overall Study|Withdrawal by Subject|0|||
27972865|NCT03334851|81730171|FG012|Overall Study|Withdrawal by Subject|1|||
27972866|NCT03334851|81730159|FG000|Overall Study|Lost to Follow-up|0|||
27972867|NCT03334851|81730160|FG001|Overall Study|Lost to Follow-up|0|||
27972868|NCT03334851|81730161|FG002|Overall Study|Lost to Follow-up|0|||
27972869|NCT03334851|81730162|FG003|Overall Study|Lost to Follow-up|0|||
27972870|NCT03334851|81730163|FG004|Overall Study|Lost to Follow-up|0|||
27972871|NCT03334851|81730164|FG005|Overall Study|Lost to Follow-up|0|||
27972872|NCT03334851|81730165|FG006|Overall Study|Lost to Follow-up|0|||
27972873|NCT03334851|81730166|FG007|Overall Study|Lost to Follow-up|0|||
27972874|NCT03334851|81730167|FG008|Overall Study|Lost to Follow-up|0|||
27972875|NCT03334851|81730168|FG009|Overall Study|Lost to Follow-up|0|||
27972876|NCT03334851|81730169|FG010|Overall Study|Lost to Follow-up|2|||
27972877|NCT03334851|81730170|FG011|Overall Study|Lost to Follow-up|1|||
27571820|NCT01864291|80278903|FG000|Overall Study|need for revision surgery|2|||
27571821|NCT02849548|80278907|FG000|Overall Study|Lost to Follow-up|1|||
27571822|NCT02849548|80278908|FG001|Overall Study|Lost to Follow-up|2|||
27571823|NCT02849548|80278907|FG000|Overall Study|Protocol Violation|1|||
27571824|NCT02849548|80278908|FG001|Overall Study|Protocol Violation|0|||
27571825|NCT00838565|80278909|FG000|Overall Study|Withdrawal by Subject|0|||
27972878|NCT03334851|81730171|FG012|Overall Study|Lost to Follow-up|0|||
27972879|NCT00543803|81730172|FG000|Overall Study|Adverse Event|14|||
27972880|NCT00543803|81730172|FG000|Overall Study|Lack of Efficacy|22|||
27972881|NCT00543803|81730172|FG000|Overall Study|Lost to Follow-up|20|||
27972882|NCT00543803|81730172|FG000|Overall Study|Other|86|||
27972883|NCT01646645|81730173|FG000|Overall Study|No Treated|1|||
27972884|NCT01646645|81730173|FG000|Overall Study|Inevaluable Donor|29|||
27972885|NCT02867813|81730174|FG000|Overall Study|Withdrawal by Subject|57|||
27669900|NCT02760485|80630953|FG001|Phase 1|Progressive Disease|0|||
27669901|NCT02760485|80630954|FG002|Phase 1|Progressive Disease|0|||
27669902|NCT02760485|80630952|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
27669903|NCT02760485|80630953|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
27669904|NCT02760485|80630954|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
27669905|NCT02760485|80630952|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
27669906|NCT02760485|80630953|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
27669907|NCT02760485|80630954|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
27669908|NCT02760485|80630952|FG000|Phase 2|Death|0|||
27669909|NCT02760485|80630953|FG001|Phase 2|Death|0|||
27669910|NCT02760485|80630954|FG002|Phase 2|Death|12|||
27669911|NCT02760485|80630952|FG000|Phase 2|Withdrawal by Subject|0|||
27669912|NCT02760485|80630953|FG001|Phase 2|Withdrawal by Subject|0|||
27669913|NCT02760485|80630954|FG002|Phase 2|Withdrawal by Subject|3|||
27669914|NCT02760485|80630952|FG000|Phase 2|Progressive Disease|0|||
27669915|NCT02760485|80630953|FG001|Phase 2|Progressive Disease|0|||
27669916|NCT02760485|80630954|FG002|Phase 2|Progressive Disease|1|||
27669917|NCT02760485|80630952|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
27669918|NCT02760485|80630953|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
27669919|NCT02760485|80630954|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
27669920|NCT03774875|80630957|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
27669921|NCT03774875|80630958|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
27669922|NCT03774875|80630957|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
27669923|NCT03774875|80630958|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
27669924|NCT03774875|80630957|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
27669925|NCT03774875|80630958|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
27669926|NCT03774875|80630957|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
27669927|NCT03774875|80630958|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
27669928|NCT03774875|80630957|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
27669929|NCT03774875|80630958|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
27669930|NCT03774875|80630957|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
27669931|NCT03774875|80630958|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
27669932|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
27669933|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
27669934|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
27669935|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
27669936|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
27669937|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
27669938|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
27669939|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
27669940|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
27669941|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
27669942|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
27669943|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
27669944|NCT03774875|80630957|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
27669945|NCT03774875|80630958|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
27669946|NCT00030823|80630959|FG000|Overall Study|Withdrawal by Subject|1|||
27669947|NCT02725567|80630960|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
27669948|NCT02725567|80630961|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
27669949|NCT02725567|80630960|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
27669950|NCT02725567|80630961|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
27669951|NCT02725567|80630960|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
27669952|NCT02725567|80630961|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
27669953|NCT00623363|80630964|FG000|Overall Study|Adverse Event|2|||
27669954|NCT00623363|80630965|FG001|Overall Study|Adverse Event|2|||
27669955|NCT01057251|80630966|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
27669956|NCT01057251|80630967|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
27669957|NCT01057251|80630966|FG000|Overall Study|Adverse Event|4|||
27669958|NCT01057251|80630967|FG001|Overall Study|Adverse Event|2|||
27669959|NCT01057251|80630966|FG000|Overall Study|Lack of Efficacy|2|||
27669960|NCT01057251|80630967|FG001|Overall Study|Lack of Efficacy|11|||
27669961|NCT01057251|80630966|FG000|Overall Study|Protocol Violation|6|||
27669962|NCT01057251|80630967|FG001|Overall Study|Protocol Violation|2|||
27669963|NCT01057251|80630966|FG000|Overall Study|Withdrawal by Subject|4|||
27669964|NCT01057251|80630967|FG001|Overall Study|Withdrawal by Subject|5|||
27669965|NCT01057251|80630966|FG000|Overall Study|Lost to Follow-up|7|||
27669966|NCT01057251|80630967|FG001|Overall Study|Lost to Follow-up|6|||
27669967|NCT01057251|80630966|FG000|Overall Study|Other Reason|1|||
27669968|NCT01057251|80630967|FG001|Overall Study|Other Reason|1|||
27669969|NCT00778921|80630970|FG000|Overall Study|Adverse Event|9|||
27669970|NCT00778921|80630971|FG001|Overall Study|Adverse Event|10|||
27669971|NCT00778921|80630972|FG002|Overall Study|Adverse Event|14|||
27669972|NCT00778921|80630970|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
27669973|NCT00778921|80630971|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
27669974|NCT00778921|80630972|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
27669975|NCT00778921|80630970|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
27669976|NCT00778921|80630971|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27669977|NCT00778921|80630972|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
27669978|NCT00778921|80630970|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
27669979|NCT00778921|80630971|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
27669980|NCT00778921|80630972|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
27669981|NCT00778921|80630970|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
27669982|NCT00778921|80630971|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
27669983|NCT00778921|80630972|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
27669984|NCT00778921|80630970|FG000|Overall Study|Patient withdrew request|3|||
27669985|NCT00778921|80630971|FG001|Overall Study|Patient withdrew request|1|||
27669986|NCT00778921|80630972|FG002|Overall Study|Patient withdrew request|6|||
27669987|NCT00778921|80630970|FG000|Overall Study|Lost to Follow-up|0|||
27669988|NCT00778921|80630971|FG001|Overall Study|Lost to Follow-up|2|||
27669989|NCT00778921|80630972|FG002|Overall Study|Lost to Follow-up|1|||
27669990|NCT00778921|80630970|FG000|Overall Study|Administrative Problems|1|||
27669991|NCT00778921|80630971|FG001|Overall Study|Administrative Problems|2|||
27669992|NCT00778921|80630972|FG002|Overall Study|Administrative Problems|0|||
27669993|NCT00778921|80630970|FG000|Overall Study|Protocol Violation|3|||
27669994|NCT00778921|80630971|FG001|Overall Study|Protocol Violation|0|||
27669995|NCT00778921|80630972|FG002|Overall Study|Protocol Violation|2|||
27669996|NCT00778921|80630970|FG000|Overall Study|Not treated|0|||
27669997|NCT00778921|80630971|FG001|Overall Study|Not treated|2|||
27669998|NCT00778921|80630972|FG002|Overall Study|Not treated|2|||
27669999|NCT03174782|80630973|FG000|Overall Study|Protocol Violation|1|||
27670000|NCT03174782|80630974|FG001|Overall Study|Protocol Violation|0|||
27670001|NCT03174782|80630973|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
27670002|NCT03174782|80630974|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
27670003|NCT03000348|80630976|FG000|Overall Study|Adverse Event|1|||
27670004|NCT03000348|80630977|FG001|Overall Study|Adverse Event|1|||
27670005|NCT03000348|80630978|FG002|Overall Study|Adverse Event|1|||
27571826|NCT00838565|80278910|FG001|Overall Study|Withdrawal by Subject|0|||
27571827|NCT00838565|80278911|FG002|Overall Study|Withdrawal by Subject|1|||
27571828|NCT00838565|80278912|FG003|Overall Study|Withdrawal by Subject|0|||
27571829|NCT00838565|80278913|FG004|Overall Study|Withdrawal by Subject|0|||
27670006|NCT03000348|80630979|FG003|Overall Study|Adverse Event|1|||
27784196|NCT00948389|81040676|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
27784197|NCT00948389|81040677|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
27784198|NCT00948389|81040673|FG000|Overall Study|Both Progression and Toxicity|1|||
27784199|NCT00948389|81040674|FG001|Overall Study|Both Progression and Toxicity|0|||
27784200|NCT00948389|81040675|FG002|Overall Study|Both Progression and Toxicity|0|||
27784201|NCT00948389|81040676|FG003|Overall Study|Both Progression and Toxicity|0|||
27784202|NCT00948389|81040677|FG004|Overall Study|Both Progression and Toxicity|0|||
27784203|NCT02561572|81040678|FG000|Overall Study|Inadequate time before surgery|2|||
27784204|NCT02561572|81040679|FG001|Overall Study|Inadequate time before surgery|1|||
27784205|NCT02561572|81040678|FG000|Overall Study|Protocol Violation|0|||
27784206|NCT02561572|81040679|FG001|Overall Study|Protocol Violation|1|||
27784207|NCT02146274|81040687|FG000|Overall Study|Protocol Violation|73|||
27784208|NCT00701064|81040691|FG000|Overall Study|Protocol Violation|1|||
27784209|NCT00701064|81040692|FG001|Overall Study|Protocol Violation|1|||
27784210|NCT00701064|81040691|FG000|Overall Study|Withdrawal by Subject|1|||
27784211|NCT00701064|81040692|FG001|Overall Study|Withdrawal by Subject|1|||
27784212|NCT00701064|81040691|FG000|Overall Study|initiated other PTSD treatment|2|||
27784213|NCT00701064|81040692|FG001|Overall Study|initiated other PTSD treatment|2|||
27784214|NCT00983827|81040693|FG000|Overall Study|Withdrawal by Subject|1|||
27784215|NCT02062385|81040694|FG000|Overall Study|Adverse Event|19|||
27784216|NCT02062385|81040695|FG001|Overall Study|Adverse Event|13|||
27784217|NCT02062385|81040696|FG002|Overall Study|Adverse Event|1|||
27784218|NCT02062385|81040697|FG003|Overall Study|Adverse Event|0|||
27784219|NCT02062385|81040694|FG000|Overall Study|Protocol Violation|1|||
27670007|NCT03000348|80630980|FG004|Overall Study|Adverse Event|1|||
27670008|NCT03000348|80630981|FG005|Overall Study|Adverse Event|1|||
27670009|NCT03000348|80630976|FG000|Overall Study|Lost to Follow-up|0|||
27784220|NCT02062385|81040695|FG001|Overall Study|Protocol Violation|0|||
27784221|NCT02062385|81040696|FG002|Overall Study|Protocol Violation|0|||
27784222|NCT02062385|81040697|FG003|Overall Study|Protocol Violation|0|||
27784223|NCT02062385|81040694|FG000|Overall Study|Incomplete EPI by database lock|2|||
27784224|NCT02062385|81040695|FG001|Overall Study|Incomplete EPI by database lock|0|||
27784225|NCT02062385|81040696|FG002|Overall Study|Incomplete EPI by database lock|0|||
27571830|NCT00838565|80278914|FG005|Overall Study|Withdrawal by Subject|2|||
27571831|NCT00838565|80278909|FG000|Overall Study|Other|0|||
27571832|NCT00838565|80278910|FG001|Overall Study|Other|2|||
27571833|NCT00838565|80278911|FG002|Overall Study|Other|0|||
27571834|NCT00838565|80278912|FG003|Overall Study|Other|0|||
27571835|NCT00838565|80278913|FG004|Overall Study|Other|0|||
27571836|NCT00838565|80278914|FG005|Overall Study|Other|0|||
27571837|NCT00838565|80278909|FG000|Overall Study|Randomized but not Treated|0|||
27571838|NCT00838565|80278910|FG001|Overall Study|Randomized but not Treated|1|||
27571839|NCT00838565|80278911|FG002|Overall Study|Randomized but not Treated|0|||
27571840|NCT00838565|80278912|FG003|Overall Study|Randomized but not Treated|0|||
27571841|NCT00838565|80278913|FG004|Overall Study|Randomized but not Treated|0|||
27571842|NCT00838565|80278914|FG005|Overall Study|Randomized but not Treated|0|||
27571843|NCT01192152|80278915|FG000|Period 1|left prematurely (while on treatment B)|0|||
27571844|NCT01192152|80278916|FG001|Period 1|left prematurely (while on treatment B)|1|||
27571845|NCT01192152|80278915|FG000|Period 3|family emergency|1|||
27571846|NCT01192152|80278916|FG001|Period 3|family emergency|0|||
27571847|NCT00302003|80278917|FG000|Overall Study|Lack of Efficacy|62|||
27571848|NCT00302003|80278917|FG000|Overall Study|Lost to Follow-up|1|||
27571849|NCT00302003|80278917|FG000|Overall Study|Physician Decision|2|||
27571850|NCT00302003|80278917|FG000|Overall Study|Withdrawal by Subject|5|||
27571851|NCT00302003|80278917|FG000|Overall Study|Ineligible|9|||
27571852|NCT00302003|80278917|FG000|Overall Study|Protocol Violation|1|||
27571853|NCT01120210|80278918|FG000|MAIN INFUSION|Adverse Event|1|||
27571854|NCT01120210|80278919|FG001|MAIN INFUSION|Adverse Event|0|||
27571855|NCT01120210|80278918|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
27571856|NCT01120210|80278919|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
27571857|NCT04244786|80278920|FG000|Overall Study|Adverse Event|0|||
27571858|NCT04244786|80278921|FG001|Overall Study|Adverse Event|0|||
27784226|NCT02062385|81040697|FG003|Overall Study|Incomplete EPI by database lock|0|||
27784227|NCT02062385|81040694|FG000|Overall Study|Moved|10|||
27784228|NCT02062385|81040695|FG001|Overall Study|Moved|11|||
27784229|NCT02062385|81040696|FG002|Overall Study|Moved|1|||
27784230|NCT02062385|81040697|FG003|Overall Study|Moved|0|||
27784231|NCT02062385|81040694|FG000|Overall Study|Withdrawn by parent/guardian|46|||
27784232|NCT02062385|81040695|FG001|Overall Study|Withdrawn by parent/guardian|41|||
27784233|NCT02062385|81040696|FG002|Overall Study|Withdrawn by parent/guardian|9|||
27784234|NCT02062385|81040697|FG003|Overall Study|Withdrawn by parent/guardian|8|||
27784235|NCT02062385|81040694|FG000|Overall Study|Death|0|||
27784236|NCT02062385|81040695|FG001|Overall Study|Death|0|||
27784237|NCT02062385|81040696|FG002|Overall Study|Death|0|||
27784238|NCT02062385|81040697|FG003|Overall Study|Death|1|||
27784239|NCT02062385|81040694|FG000|Overall Study|Lost to Follow-up|0|||
27784240|NCT02062385|81040695|FG001|Overall Study|Lost to Follow-up|0|||
27784241|NCT02062385|81040696|FG002|Overall Study|Lost to Follow-up|1|||
27571859|NCT04244786|80278922|FG002|Overall Study|Adverse Event|2|||
27571860|NCT04244786|80278920|FG000|Overall Study|Withdrawal by Subject|0|||
27571861|NCT04244786|80278921|FG001|Overall Study|Withdrawal by Subject|0|||
27571862|NCT04244786|80278922|FG002|Overall Study|Withdrawal by Subject|5|||
27571863|NCT01239368|80278923|FG000|Overall Study|Principal investigator discretion|1|||
27571864|NCT01239368|80278924|FG001|Overall Study|Principal investigator discretion|0|||
27571865|NCT01239368|80278925|FG002|Overall Study|Principal investigator discretion|0|||
27571866|NCT01239368|80278926|FG003|Overall Study|Principal investigator discretion|0|||
27571867|NCT01239368|80278927|FG004|Overall Study|Principal investigator discretion|1|||
27571868|NCT01239368|80278928|FG005|Overall Study|Principal investigator discretion|2|||
27571869|NCT01239368|80278929|FG006|Overall Study|Principal investigator discretion|0|||
27784242|NCT02062385|81040697|FG003|Overall Study|Lost to Follow-up|0|||
27784243|NCT01757821|81040698|FG000|Overall Study|Adverse Event|1|||
27571870|NCT01239368|80278930|FG007|Overall Study|Principal investigator discretion|0|||
27571871|NCT01239368|80278931|FG008|Overall Study|Principal investigator discretion|0|||
27571872|NCT01239368|80278932|FG009|Overall Study|Principal investigator discretion|1|||
27784244|NCT01592773|81040699|FG000|Overall Study|Study Terminated by Sponsor|582|||
27784245|NCT01592773|81040699|FG000|Overall Study|Withdrawal by Subject|35|||
27571873|NCT01239368|80278923|FG000|Overall Study|Disease progression on study|1|||
27571874|NCT01239368|80278924|FG001|Overall Study|Disease progression on study|1|||
27571875|NCT01239368|80278925|FG002|Overall Study|Disease progression on study|1|||
27784246|NCT01592773|81040699|FG000|Overall Study|Lost to Follow-up|19|||
27784247|NCT01592773|81040699|FG000|Overall Study|Adverse Event|17|||
27571876|NCT01239368|80278926|FG003|Overall Study|Disease progression on study|1|||
27571877|NCT01239368|80278927|FG004|Overall Study|Disease progression on study|4|||
27571878|NCT01239368|80278928|FG005|Overall Study|Disease progression on study|2|||
27571879|NCT01239368|80278929|FG006|Overall Study|Disease progression on study|5|||
27571880|NCT01239368|80278930|FG007|Overall Study|Disease progression on study|0|||
27571881|NCT01239368|80278931|FG008|Overall Study|Disease progression on study|0|||
27571882|NCT01239368|80278932|FG009|Overall Study|Disease progression on study|2|||
27571883|NCT01239368|80278923|FG000|Overall Study|Refused further treatment|0|||
27571884|NCT01239368|80278924|FG001|Overall Study|Refused further treatment|0|||
27571885|NCT01239368|80278925|FG002|Overall Study|Refused further treatment|0|||
27571886|NCT01239368|80278926|FG003|Overall Study|Refused further treatment|0|||
27571887|NCT01239368|80278927|FG004|Overall Study|Refused further treatment|0|||
27571888|NCT01239368|80278928|FG005|Overall Study|Refused further treatment|0|||
27571889|NCT01239368|80278929|FG006|Overall Study|Refused further treatment|0|||
27571890|NCT01239368|80278930|FG007|Overall Study|Refused further treatment|0|||
27571891|NCT01239368|80278931|FG008|Overall Study|Refused further treatment|0|||
27571892|NCT01239368|80278932|FG009|Overall Study|Refused further treatment|1|||
27571893|NCT01239368|80278923|FG000|Overall Study|Death|0|||
27571894|NCT01239368|80278924|FG001|Overall Study|Death|0|||
27571895|NCT01239368|80278925|FG002|Overall Study|Death|0|||
27571896|NCT01239368|80278926|FG003|Overall Study|Death|0|||
27571897|NCT01239368|80278927|FG004|Overall Study|Death|0|||
27571898|NCT01239368|80278928|FG005|Overall Study|Death|0|||
27571899|NCT01239368|80278929|FG006|Overall Study|Death|1|||
27571900|NCT01239368|80278930|FG007|Overall Study|Death|0|||
27571901|NCT01239368|80278931|FG008|Overall Study|Death|0|||
27571902|NCT01239368|80278932|FG009|Overall Study|Death|0|||
27571903|NCT02553421|80278934|FG000|Overall Study|Lost to Follow-up|21|||
27571904|NCT02553421|80278935|FG001|Overall Study|Lost to Follow-up|1|||
27571905|NCT02553421|80278934|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
27571906|NCT02553421|80278935|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
27571907|NCT02553421|80278934|FG000|Overall Study|Improper Device Placement|3|||
27571908|NCT02553421|80278935|FG001|Overall Study|Improper Device Placement|0|||
27571909|NCT03277261|80278936|FG000|Overall Study|Adverse Event|17|||
27571910|NCT03277261|80278937|FG001|Overall Study|Adverse Event|1|||
27571911|NCT03277261|80278936|FG000|Overall Study|Participant Withdrawal of Consent|6|||
27571912|NCT03277261|80278937|FG001|Overall Study|Participant Withdrawal of Consent|15|||
27571913|NCT03277261|80278936|FG000|Overall Study|Investigator / Sponsor Decision|4|||
27571914|NCT03277261|80278937|FG001|Overall Study|Investigator / Sponsor Decision|2|||
27571915|NCT03277261|80278936|FG000|Overall Study|Pregnancy|2|||
27571916|NCT03277261|80278937|FG001|Overall Study|Pregnancy|0|||
27670010|NCT03000348|80630977|FG001|Overall Study|Lost to Follow-up|0|||
27784248|NCT01592773|81040699|FG000|Overall Study|Lack of Efficacy|9|||
27784249|NCT01592773|81040699|FG000|Overall Study|Protocol Violation|2|||
27784250|NCT01592773|81040699|FG000|Overall Study|Inclusion/exclusion not meet|1|||
27571917|NCT03277261|80278936|FG000|Overall Study|Lost to Follow-up|2|||
27670011|NCT03000348|80630978|FG002|Overall Study|Lost to Follow-up|1|||
27670012|NCT03000348|80630979|FG003|Overall Study|Lost to Follow-up|0|||
27670013|NCT03000348|80630980|FG004|Overall Study|Lost to Follow-up|0|||
27670014|NCT03000348|80630981|FG005|Overall Study|Lost to Follow-up|0|||
27670015|NCT03000348|80630976|FG000|Overall Study|Withdrawal by Subject|0|||
27670016|NCT03000348|80630977|FG001|Overall Study|Withdrawal by Subject|1|||
27670017|NCT03000348|80630978|FG002|Overall Study|Withdrawal by Subject|0|||
27670018|NCT03000348|80630979|FG003|Overall Study|Withdrawal by Subject|0|||
27670019|NCT03000348|80630980|FG004|Overall Study|Withdrawal by Subject|0|||
27670020|NCT03000348|80630981|FG005|Overall Study|Withdrawal by Subject|0|||
27670021|NCT03000348|80630976|FG000|Overall Study|Consent|0|||
27670022|NCT03000348|80630977|FG001|Overall Study|Consent|0|||
27670023|NCT03000348|80630978|FG002|Overall Study|Consent|0|||
27670024|NCT03000348|80630979|FG003|Overall Study|Consent|0|||
27670025|NCT03000348|80630980|FG004|Overall Study|Consent|1|||
27670026|NCT03000348|80630981|FG005|Overall Study|Consent|0|||
27670027|NCT03000348|80630976|FG000|Overall Study|Failure to expectorate sputum|1|||
27670028|NCT03000348|80630977|FG001|Overall Study|Failure to expectorate sputum|0|||
27670029|NCT03000348|80630978|FG002|Overall Study|Failure to expectorate sputum|1|||
27670030|NCT03000348|80630979|FG003|Overall Study|Failure to expectorate sputum|0|||
27670031|NCT03000348|80630980|FG004|Overall Study|Failure to expectorate sputum|1|||
27670032|NCT03000348|80630981|FG005|Overall Study|Failure to expectorate sputum|0|||
27784251|NCT01592773|81040699|FG000|Overall Study|Other Reason|1|||
27784252|NCT00364351|81040705|FG000|Overall Study|Adverse Event|90|||
27571918|NCT03277261|80278937|FG001|Overall Study|Lost to Follow-up|2|||
27571919|NCT03277261|80278936|FG000|Overall Study|Lack of Efficacy|2|||
27571920|NCT03277261|80278937|FG001|Overall Study|Lack of Efficacy|2|||
27571921|NCT03277261|80278936|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
27571922|NCT03277261|80278937|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
27571923|NCT00423891|80278940|FG000|Enrolled|Withdrawal by Subject|0|||
27670033|NCT03000348|80630976|FG000|Overall Study|No gram negative|1|||
27784253|NCT00364351|81040706|FG001|Overall Study|Adverse Event|44|||
27784254|NCT00364351|81040705|FG000|Overall Study|Condition under investigation worsened|469|||
27784255|NCT00364351|81040706|FG001|Overall Study|Condition under investigation worsened|497|||
27784256|NCT00364351|81040705|FG000|Overall Study|Prohibited concomitant medication|0|||
27784257|NCT00364351|81040706|FG001|Overall Study|Prohibited concomitant medication|2|||
27784258|NCT00364351|81040705|FG000|Overall Study|Lost to Follow-up|1|||
27571924|NCT00423891|80278941|FG001|Enrolled|Withdrawal by Subject|0|||
27571925|NCT00423891|80278942|FG002|Enrolled|Withdrawal by Subject|1|||
27571926|NCT00423891|80278940|FG000|Enrolled|Lost to Follow-up|0|||
27784259|NCT00364351|81040706|FG001|Overall Study|Lost to Follow-up|1|||
27784260|NCT00364351|81040705|FG000|Overall Study|Withdrawal by Subject|30|||
27784261|NCT00364351|81040706|FG001|Overall Study|Withdrawal by Subject|29|||
27784262|NCT00364351|81040705|FG000|Overall Study|Incorrect enrollment|1|||
27784263|NCT00364351|81040706|FG001|Overall Study|Incorrect enrollment|1|||
27784264|NCT00364351|81040705|FG000|Overall Study|Sponsor decision|1|||
27784265|NCT00364351|81040706|FG001|Overall Study|Sponsor decision|0|||
27784266|NCT00364351|81040705|FG000|Overall Study|Poor treatment compliance|0|||
27784267|NCT00364351|81040706|FG001|Overall Study|Poor treatment compliance|3|||
27784268|NCT00364351|81040705|FG000|Overall Study|Investigator error|0|||
27784269|NCT00364351|81040706|FG001|Overall Study|Investigator error|2|||
27784270|NCT00364351|81040705|FG000|Overall Study|Patient could not travel to site|0|||
27784271|NCT00364351|81040706|FG001|Overall Study|Patient could not travel to site|1|||
27784272|NCT00364351|81040705|FG000|Overall Study|Randomised treatment not started|0|||
27784273|NCT00364351|81040706|FG001|Overall Study|Randomised treatment not started|3|||
27784274|NCT02743494|81040707|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
27784275|NCT02743494|81040708|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
27784276|NCT02743494|81040707|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
27784277|NCT02743494|81040708|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
27784278|NCT02743494|81040707|FG000|Treatment Period|Completed treatment|229|||
27784279|NCT02743494|81040708|FG001|Treatment Period|Completed treatment|99|||
27784280|NCT02743494|81040707|FG000|Treatment Period|Disease recurrence|149|||
27571927|NCT00423891|80278941|FG001|Enrolled|Lost to Follow-up|0|||
27972886|NCT02867813|81730175|FG001|Overall Study|Withdrawal by Subject|56|||
27571928|NCT00423891|80278942|FG002|Enrolled|Lost to Follow-up|1|||
27571929|NCT00423891|80278940|FG000|Enrolled|No longer met criteria|11|||
27571930|NCT00423891|80278941|FG001|Enrolled|No longer met criteria|2|||
27571931|NCT00423891|80278942|FG002|Enrolled|No longer met criteria|1|||
27571932|NCT00423891|80278940|FG000|Treatment|Withdrawal by Subject|1|||
27571933|NCT00423891|80278941|FG001|Treatment|Withdrawal by Subject|0|||
27571934|NCT00423891|80278942|FG002|Treatment|Withdrawal by Subject|0|||
27571935|NCT00423891|80278940|FG000|Treatment|Lost to Follow-up|1|||
27571936|NCT00423891|80278941|FG001|Treatment|Lost to Follow-up|0|||
27571937|NCT00423891|80278942|FG002|Treatment|Lost to Follow-up|0|||
27571938|NCT00423891|80278940|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
27571939|NCT00423891|80278941|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
27571940|NCT00423891|80278942|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
27571941|NCT00423891|80278940|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
27784281|NCT02743494|81040708|FG001|Treatment Period|Disease recurrence|113|||
27972887|NCT02867813|81730174|FG000|Overall Study|Decision by Sponsor|7|||
27972888|NCT02867813|81730175|FG001|Overall Study|Decision by Sponsor|7|||
27972889|NCT02867813|81730174|FG000|Overall Study|Lost to Follow-up|91|||
27972890|NCT02867813|81730175|FG001|Overall Study|Lost to Follow-up|78|||
27972891|NCT02867813|81730174|FG000|Overall Study|Missing|2|||
27972892|NCT02867813|81730175|FG001|Overall Study|Missing|1|||
27972893|NCT02867813|81730174|FG000|Overall Study|Death|294|||
27972894|NCT02867813|81730175|FG001|Overall Study|Death|268|||
27972895|NCT02210221|81730176|FG000|Overall Study|Lack of Efficacy|7|||
27972896|NCT02210221|81730176|FG000|Overall Study|Withdrawal by Subject|43|||
27972897|NCT01145352|81730179|FG000|Overall Study|Found to have been registered twice|6|||
27972898|NCT01145352|81730179|FG000|Overall Study|Treated before marketing approval|4|||
27972899|NCT01145352|81730179|FG000|Overall Study|Syringe formulation was used|1|||
27972900|NCT03280303|81730182|FG000|Overall Study|Death|505|||
27784282|NCT02743494|81040707|FG000|Treatment Period|Study drug toxicity|57|||
27784283|NCT02743494|81040708|FG001|Treatment Period|Study drug toxicity|8|||
27571942|NCT00423891|80278941|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
27571943|NCT00423891|80278942|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
27571944|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
27670034|NCT03000348|80630977|FG001|Overall Study|No gram negative|2|||
27784284|NCT02743494|81040707|FG000|Treatment Period|Death|1|||
27784285|NCT02743494|81040708|FG001|Treatment Period|Death|0|||
27972901|NCT03280303|81730182|FG000|Overall Study|Study terminated by sponsor|383|||
27972902|NCT03280303|81730182|FG000|Overall Study|Other|148|||
27972903|NCT03280303|81730182|FG000|Overall Study|No longer willing to participate in study|101|||
27972904|NCT03280303|81730182|FG000|Overall Study|Lost to follow up|39|||
27972905|NCT03280303|81730182|FG000|Overall Study|Adverse Event|20|||
27972906|NCT02763254|81730183|FG000|Overall Study|Adverse Event|1|||
27571945|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
27571946|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
27571947|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
27571948|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
27571949|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
27571950|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
27571951|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
27571952|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
27571953|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
27571954|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
27571955|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
27571956|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
27571957|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
27571958|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
27571959|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
27865881|NCT00996892|81342008|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
27865882|NCT00996892|81342009|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
27865883|NCT00996892|81342010|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
27865884|NCT00996892|81342011|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
27865885|NCT00996892|81342012|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
27865886|NCT00996892|81342013|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
27865887|NCT00996892|81342014|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
27865888|NCT00996892|81341995|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
27865889|NCT00996892|81341996|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
27865890|NCT00996892|81341997|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
27865891|NCT00996892|81341998|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
27865892|NCT00996892|81341999|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
27865893|NCT00996892|81342000|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
27865894|NCT00996892|81342001|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
27865895|NCT00996892|81342002|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
27865896|NCT00996892|81342003|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
27865897|NCT00996892|81342004|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
27865898|NCT00996892|81342005|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
27865899|NCT00996892|81342006|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
27865900|NCT00996892|81342007|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
27571960|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
27571961|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
27571962|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
27571963|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
27571964|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
27571965|NCT00934544|80278944|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
27571966|NCT00934544|80278945|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
27571967|NCT00934544|80278946|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
27571968|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
27865901|NCT00996892|81342008|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
27865902|NCT00996892|81342009|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
27865903|NCT00996892|81342010|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
27865904|NCT00996892|81342011|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
27865905|NCT00996892|81342012|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
27865906|NCT00996892|81342013|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
27865907|NCT00996892|81342014|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
27865908|NCT00996892|81341995|FG000|Expansion Stage 2|Adverse Event|0|||
27865909|NCT00996892|81341996|FG001|Expansion Stage 2|Adverse Event|0|||
27571969|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
27571970|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
27571971|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
27571972|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
27571973|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
27571974|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
27571975|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
27571976|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
27571977|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
27670035|NCT03000348|80630978|FG002|Overall Study|No gram negative|1|||
27865910|NCT00996892|81341997|FG002|Expansion Stage 2|Adverse Event|0|||
27865911|NCT00996892|81341998|FG003|Expansion Stage 2|Adverse Event|0|||
27865912|NCT00996892|81341999|FG004|Expansion Stage 2|Adverse Event|0|||
27865913|NCT00996892|81342000|FG005|Expansion Stage 2|Adverse Event|0|||
27571978|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
27571979|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
27571980|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
27571981|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
27571982|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
27571983|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
27571984|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
27571985|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
27571986|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
27571987|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
27571988|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
27571989|NCT00934544|80278944|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
27571990|NCT00934544|80278945|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
27571991|NCT00934544|80278946|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
27571992|NCT01914666|80278947|FG000|Treatment Period|Lack of Efficacy|0|||
27571993|NCT01914666|80278948|FG001|Treatment Period|Lack of Efficacy|0|||
27571994|NCT01914666|80278949|FG002|Treatment Period|Lack of Efficacy|2|||
27571995|NCT01914666|80278947|FG000|Treatment Period|Adverse Event|10|||
27784286|NCT02743494|81040707|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
27784287|NCT02743494|81040708|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
27865914|NCT00996892|81342001|FG006|Expansion Stage 2|Adverse Event|0|||
27865915|NCT00996892|81342002|FG007|Expansion Stage 2|Adverse Event|0|||
27865916|NCT00996892|81342003|FG008|Expansion Stage 2|Adverse Event|0|||
27865917|NCT00996892|81342004|FG009|Expansion Stage 2|Adverse Event|0|||
27865918|NCT00996892|81342005|FG010|Expansion Stage 2|Adverse Event|0|||
27865919|NCT00996892|81342006|FG011|Expansion Stage 2|Adverse Event|0|||
27865920|NCT00996892|81342007|FG012|Expansion Stage 2|Adverse Event|0|||
27865921|NCT00996892|81342008|FG013|Expansion Stage 2|Adverse Event|0|||
27865922|NCT00996892|81342009|FG014|Expansion Stage 2|Adverse Event|0|||
27865923|NCT00996892|81342010|FG015|Expansion Stage 2|Adverse Event|0|||
27865924|NCT00996892|81342011|FG016|Expansion Stage 2|Adverse Event|0|||
27865925|NCT00996892|81342012|FG017|Expansion Stage 2|Adverse Event|0|||
27865926|NCT00996892|81342013|FG018|Expansion Stage 2|Adverse Event|3|||
27865927|NCT00996892|81342014|FG019|Expansion Stage 2|Adverse Event|0|||
27865928|NCT00996892|81341995|FG000|Expansion Stage 2|Death|0|||
27865929|NCT00996892|81341996|FG001|Expansion Stage 2|Death|0|||
27865930|NCT00996892|81341997|FG002|Expansion Stage 2|Death|0|||
27865931|NCT00996892|81341998|FG003|Expansion Stage 2|Death|0|||
27865932|NCT00996892|81341999|FG004|Expansion Stage 2|Death|0|||
27865933|NCT00996892|81342000|FG005|Expansion Stage 2|Death|0|||
27865934|NCT00996892|81342001|FG006|Expansion Stage 2|Death|0|||
27865935|NCT00996892|81342002|FG007|Expansion Stage 2|Death|0|||
27865936|NCT00996892|81342003|FG008|Expansion Stage 2|Death|0|||
27865937|NCT00996892|81342004|FG009|Expansion Stage 2|Death|0|||
27865938|NCT00996892|81342005|FG010|Expansion Stage 2|Death|0|||
27865939|NCT00996892|81342006|FG011|Expansion Stage 2|Death|0|||
27784288|NCT02743494|81040707|FG000|Treatment Period|Participant request to discontinue treatment|30|||
27784289|NCT02743494|81040708|FG001|Treatment Period|Participant request to discontinue treatment|5|||
27784290|NCT02743494|81040707|FG000|Treatment Period|Participant withdrew consent|12|||
27784291|NCT02743494|81040708|FG001|Treatment Period|Participant withdrew consent|4|||
27784292|NCT02743494|81040707|FG000|Treatment Period|Lost to Follow-up|0|||
27784293|NCT02743494|81040708|FG001|Treatment Period|Lost to Follow-up|1|||
27784294|NCT02743494|81040707|FG000|Treatment Period|Poor/Non-compliance|1|||
27784295|NCT02743494|81040708|FG001|Treatment Period|Poor/Non-compliance|0|||
27571996|NCT01914666|80278948|FG001|Treatment Period|Adverse Event|4|||
27571997|NCT01914666|80278949|FG002|Treatment Period|Adverse Event|2|||
27571998|NCT01914666|80278947|FG000|Treatment Period|Withdrawal by Subject|3|||
27784296|NCT02743494|81040707|FG000|Treatment Period|Other reasons|7|||
27784297|NCT02743494|81040708|FG001|Treatment Period|Other reasons|2|||
27784298|NCT02074059|81040709|FG000|Overall Study|Death|0|||
27865940|NCT00996892|81342007|FG012|Expansion Stage 2|Death|0|||
27865941|NCT00996892|81342008|FG013|Expansion Stage 2|Death|0|||
27865942|NCT00996892|81342009|FG014|Expansion Stage 2|Death|0|||
27865943|NCT00996892|81342010|FG015|Expansion Stage 2|Death|0|||
27865944|NCT00996892|81342011|FG016|Expansion Stage 2|Death|0|||
27865945|NCT00996892|81342012|FG017|Expansion Stage 2|Death|0|||
27865946|NCT00996892|81342013|FG018|Expansion Stage 2|Death|2|||
27865947|NCT00996892|81342014|FG019|Expansion Stage 2|Death|0|||
27784299|NCT02074059|81040710|FG001|Overall Study|Death|0|||
27784300|NCT02074059|81040711|FG002|Overall Study|Death|0|||
27865948|NCT00996892|81341995|FG000|Expansion Stage 2|Physician Decision|0|||
27865949|NCT00996892|81341996|FG001|Expansion Stage 2|Physician Decision|0|||
27865950|NCT00996892|81341997|FG002|Expansion Stage 2|Physician Decision|0|||
27865951|NCT00996892|81341998|FG003|Expansion Stage 2|Physician Decision|0|||
27865952|NCT00996892|81341999|FG004|Expansion Stage 2|Physician Decision|0|||
27865953|NCT00996892|81342000|FG005|Expansion Stage 2|Physician Decision|0|||
27571999|NCT01914666|80278948|FG001|Treatment Period|Withdrawal by Subject|2|||
27572000|NCT01914666|80278949|FG002|Treatment Period|Withdrawal by Subject|2|||
27572001|NCT01914666|80278947|FG000|Treatment Period|Physician Decision|0|||
27670036|NCT03000348|80630979|FG003|Overall Study|No gram negative|1|||
27670037|NCT03000348|80630980|FG004|Overall Study|No gram negative|1|||
27670038|NCT03000348|80630981|FG005|Overall Study|No gram negative|1|||
27670039|NCT03000348|80630976|FG000|Overall Study|Patient had no transport|0|||
27670040|NCT03000348|80630977|FG001|Overall Study|Patient had no transport|0|||
27670041|NCT03000348|80630978|FG002|Overall Study|Patient had no transport|0|||
27670042|NCT03000348|80630979|FG003|Overall Study|Patient had no transport|1|||
27670043|NCT03000348|80630980|FG004|Overall Study|Patient had no transport|0|||
27670044|NCT03000348|80630981|FG005|Overall Study|Patient had no transport|0|||
27670045|NCT03000348|80630976|FG000|Overall Study|Dosing|0|||
27670046|NCT03000348|80630977|FG001|Overall Study|Dosing|0|||
27670047|NCT03000348|80630978|FG002|Overall Study|Dosing|0|||
27670048|NCT03000348|80630979|FG003|Overall Study|Dosing|0|||
27670049|NCT03000348|80630980|FG004|Overall Study|Dosing|1|||
27670050|NCT03000348|80630981|FG005|Overall Study|Dosing|0|||
27670051|NCT00320398|80630984|FG000|Overall Study|Adverse Event|1|||
27670052|NCT00320398|80630985|FG001|Overall Study|Adverse Event|4|||
27670053|NCT00320398|80630984|FG000|Overall Study|Other|1|||
27670054|NCT00320398|80630985|FG001|Overall Study|Other|0|||
27670055|NCT04544865|80630986|FG000|Overall Study|Death|0|||
27670056|NCT04544865|80630987|FG001|Overall Study|Death|2|||
27670057|NCT04544865|80630986|FG000|Overall Study|Lost to Follow-up|11|||
27670058|NCT04544865|80630987|FG001|Overall Study|Lost to Follow-up|7|||
27670059|NCT04544865|80630986|FG000|Overall Study|Withdrawal by Subject|0|||
27670060|NCT04544865|80630987|FG001|Overall Study|Withdrawal by Subject|1|||
27670061|NCT04544865|80630986|FG000|Overall Study|Other|0|||
27670062|NCT04544865|80630987|FG001|Overall Study|Other|1|||
27670063|NCT01772823|80630988|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
27670064|NCT01772823|80630989|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
27670065|NCT01772823|80630988|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
27670066|NCT01772823|80630989|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
27670067|NCT01772823|80630988|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
27670068|NCT01772823|80630989|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
27670069|NCT01772823|80630988|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
27572002|NCT01914666|80278948|FG001|Treatment Period|Physician Decision|0|||
27572003|NCT01914666|80278949|FG002|Treatment Period|Physician Decision|2|||
27572004|NCT03851016|80278952|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27572005|NCT03851016|80278953|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
27572006|NCT00794196|80278954|FG000|Overall Study|Lost to Follow-up|5|||
27572007|NCT00794196|80278955|FG001|Overall Study|Lost to Follow-up|23|||
27572008|NCT00502697|80278956|FG000|Overall Study|Withdrawal by Subject|3|||
27572009|NCT00502697|80278957|FG001|Overall Study|Withdrawal by Subject|1|||
27572010|NCT00502697|80278956|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
27572011|NCT00502697|80278957|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
27572012|NCT00502697|80278956|FG000|Overall Study|found not to meet eligibility criteria|3|||
27572013|NCT00502697|80278957|FG001|Overall Study|found not to meet eligibility criteria|4|||
27572014|NCT00502697|80278956|FG000|Overall Study|did not meet assignment criteria|4|||
27572015|NCT00502697|80278957|FG001|Overall Study|did not meet assignment criteria|2|||
27572016|NCT01247090|80278960|FG000|Overall Study|Physician Decision|1|||
27572017|NCT01247090|80278961|FG001|Overall Study|Physician Decision|0|||
27670070|NCT01772823|80630989|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
27670071|NCT01772823|80630988|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
27572018|NCT01247090|80278962|FG002|Overall Study|Physician Decision|0|||
27572019|NCT01247090|80278960|FG000|Overall Study|Withdrawal by Subject|0|||
27972907|NCT05599451|81730184|FG000|Overall Study|Not randomized|11|||
27670072|NCT01772823|80630989|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
27972908|NCT05599451|81730185|FG001|Overall Study|Not randomized|0|||
27972909|NCT05599451|81730186|FG002|Overall Study|Not randomized|0|||
27972910|NCT05599451|81730187|FG003|Overall Study|Not randomized|0|||
27972911|NCT05599451|81730188|FG004|Overall Study|Not randomized|0|||
27972912|NCT05599451|81730184|FG000|Overall Study|Physician Decision|0|||
27972913|NCT05599451|81730185|FG001|Overall Study|Physician Decision|0|||
27972914|NCT05599451|81730186|FG002|Overall Study|Physician Decision|0|||
27972915|NCT05599451|81730187|FG003|Overall Study|Physician Decision|1|||
27972916|NCT05599451|81730188|FG004|Overall Study|Physician Decision|0|||
27972917|NCT01352741|81730189|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
27972918|NCT01352741|81730190|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
27972919|NCT01352741|81730189|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
27972920|NCT01352741|81730190|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
27972921|NCT01352741|81730189|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
27972922|NCT01352741|81730190|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
27972923|NCT01352741|81730189|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
27972924|NCT01352741|81730190|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
27972925|NCT01352741|81730189|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
27972926|NCT01352741|81730190|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
27972927|NCT01352741|81730189|FG000|Open-label Tapentadol Titration Period|Other|4|||
27972928|NCT01352741|81730190|FG001|Open-label Tapentadol Titration Period|Other|0|||
27972929|NCT01352741|81730189|FG000|Double-blind Comparative Period|Protocol Violation|2|||
27972930|NCT01352741|81730190|FG001|Double-blind Comparative Period|Protocol Violation|0|||
27972931|NCT01352741|81730189|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
27972932|NCT01352741|81730190|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
27972933|NCT01352741|81730189|FG000|Double-blind Comparative Period|Adverse Event|16|||
27972934|NCT01352741|81730190|FG001|Double-blind Comparative Period|Adverse Event|17|||
27972935|NCT01352741|81730189|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
27670073|NCT01772823|80630988|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
27670074|NCT01772823|80630989|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
27784301|NCT02074059|81040712|FG003|Overall Study|Death|0|||
27784302|NCT02074059|81040713|FG004|Overall Study|Death|1|||
27784303|NCT02074059|81040714|FG005|Overall Study|Death|1|||
27784304|NCT00386152|81040715|FG000|Overall Study|Adverse Event|6|||
27784305|NCT00386152|81040716|FG001|Overall Study|Adverse Event|5|||
27784306|NCT00386152|81040717|FG002|Overall Study|Adverse Event|4|||
27784307|NCT00386152|81040715|FG000|Overall Study|Chang from original chemo stratification|4|||
27784308|NCT00386152|81040716|FG001|Overall Study|Chang from original chemo stratification|5|||
27784309|NCT00386152|81040717|FG002|Overall Study|Chang from original chemo stratification|6|||
27784310|NCT00386152|81040715|FG000|Overall Study|Death|3|||
27784311|NCT00386152|81040716|FG001|Overall Study|Death|0|||
27784312|NCT00386152|81040717|FG002|Overall Study|Death|1|||
27784313|NCT00386152|81040715|FG000|Overall Study|Disease progression|7|||
27784314|NCT00386152|81040716|FG001|Overall Study|Disease progression|4|||
27784315|NCT00386152|81040717|FG002|Overall Study|Disease progression|5|||
27784316|NCT00386152|81040715|FG000|Overall Study|Physician Decision|13|||
27784317|NCT00386152|81040716|FG001|Overall Study|Physician Decision|10|||
27784318|NCT00386152|81040717|FG002|Overall Study|Physician Decision|4|||
27784319|NCT00386152|81040715|FG000|Overall Study|Lost to Follow-up|1|||
27865954|NCT00996892|81342001|FG006|Expansion Stage 2|Physician Decision|0|||
27784320|NCT00386152|81040716|FG001|Overall Study|Lost to Follow-up|0|||
27784321|NCT00386152|81040717|FG002|Overall Study|Lost to Follow-up|0|||
27784322|NCT00386152|81040715|FG000|Overall Study|Completed chemotherapy|4|||
27784323|NCT00386152|81040716|FG001|Overall Study|Completed chemotherapy|5|||
27784324|NCT00386152|81040717|FG002|Overall Study|Completed chemotherapy|1|||
27784325|NCT00386152|81040715|FG000|Overall Study|Protocol Violation|3|||
27784326|NCT00386152|81040716|FG001|Overall Study|Protocol Violation|5|||
27784327|NCT00386152|81040717|FG002|Overall Study|Protocol Violation|2|||
27784328|NCT00386152|81040715|FG000|Overall Study|Withdrawal by Subject|3|||
27784329|NCT00386152|81040716|FG001|Overall Study|Withdrawal by Subject|6|||
27784330|NCT00386152|81040717|FG002|Overall Study|Withdrawal by Subject|10|||
27784331|NCT03328325|81040718|FG000|Overall Study|Lost to Follow-up|4|||
27784332|NCT03328325|81040718|FG000|Overall Study|Physician Decision|1|||
27784333|NCT03328325|81040718|FG000|Overall Study|Withdrawal by Subject|3|||
27784334|NCT03328325|81040718|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
27784335|NCT02127970|81040722|FG000|Overall Study|Adverse Event|2|||
27784336|NCT02127970|81040723|FG001|Overall Study|Adverse Event|1|||
27784337|NCT02127970|81040722|FG000|Overall Study|Death|1|||
27784338|NCT02127970|81040723|FG001|Overall Study|Death|1|||
27784339|NCT02127970|81040722|FG000|Overall Study|Lost to Follow-up|14|||
27784340|NCT02127970|81040723|FG001|Overall Study|Lost to Follow-up|14|||
27784341|NCT02127970|81040722|FG000|Overall Study|Reason not Specified|4|||
27784342|NCT02127970|81040723|FG001|Overall Study|Reason not Specified|7|||
27784343|NCT02127970|81040722|FG000|Overall Study|Pregnancy|0|||
27784344|NCT02127970|81040723|FG001|Overall Study|Pregnancy|1|||
27784345|NCT02127970|81040722|FG000|Overall Study|Subject Withdrew Consent|5|||
27784346|NCT02127970|81040723|FG001|Overall Study|Subject Withdrew Consent|3|||
27784347|NCT00361504|81040724|FG000|Overall Study|Withdrawal by Subject|94|||
27784348|NCT00361504|81040725|FG001|Overall Study|Withdrawal by Subject|31|||
27784349|NCT00361504|81040724|FG000|Overall Study|Lost to Follow-up|40|||
27784350|NCT00361504|81040725|FG001|Overall Study|Lost to Follow-up|7|||
27784351|NCT00361504|81040724|FG000|Overall Study|Adverse Event|203|||
27784352|NCT00361504|81040725|FG001|Overall Study|Adverse Event|82|||
27784353|NCT00361504|81040724|FG000|Overall Study|Lack of Efficacy|72|||
27784354|NCT00361504|81040725|FG001|Overall Study|Lack of Efficacy|7|||
27972936|NCT01352741|81730190|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
27572020|NCT01247090|80278961|FG001|Overall Study|Withdrawal by Subject|1|||
27572021|NCT01247090|80278962|FG002|Overall Study|Withdrawal by Subject|0|||
27572022|NCT00989833|80278963|FG000|Overall Study|Lost to Follow-up|0|||
27572023|NCT00989833|80278964|FG001|Overall Study|Lost to Follow-up|1|||
27572024|NCT00989833|80278965|FG002|Overall Study|Lost to Follow-up|0|||
27572025|NCT00989833|80278963|FG000|Overall Study|Protocol Violation|1|||
27572026|NCT00989833|80278964|FG001|Overall Study|Protocol Violation|2|||
27572027|NCT00989833|80278965|FG002|Overall Study|Protocol Violation|1|||
27972937|NCT01352741|81730189|FG000|Double-blind Comparative Period|Death|0|||
27972938|NCT01352741|81730190|FG001|Double-blind Comparative Period|Death|1|||
27784355|NCT00361504|81040724|FG000|Overall Study|Resolution of Pain|2|||
27784356|NCT00361504|81040725|FG001|Overall Study|Resolution of Pain|0|||
27784357|NCT00361504|81040724|FG000|Overall Study|Study medication non compliant|42|||
27784358|NCT00361504|81040725|FG001|Overall Study|Study medication non compliant|15|||
27784359|NCT00361504|81040724|FG000|Overall Study|All other|28|||
27972939|NCT01352741|81730189|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
27972940|NCT01352741|81730190|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
27972941|NCT01352741|81730189|FG000|Double-blind Comparative Period|Other|1|||
27972942|NCT01352741|81730190|FG001|Double-blind Comparative Period|Other|2|||
27865955|NCT00996892|81342002|FG007|Expansion Stage 2|Physician Decision|0|||
27865956|NCT00996892|81342003|FG008|Expansion Stage 2|Physician Decision|0|||
27865957|NCT00996892|81342004|FG009|Expansion Stage 2|Physician Decision|0|||
27865958|NCT00996892|81342005|FG010|Expansion Stage 2|Physician Decision|0|||
27865959|NCT00996892|81342006|FG011|Expansion Stage 2|Physician Decision|0|||
27865960|NCT00996892|81342007|FG012|Expansion Stage 2|Physician Decision|0|||
27865961|NCT00996892|81342008|FG013|Expansion Stage 2|Physician Decision|0|||
27865962|NCT00996892|81342009|FG014|Expansion Stage 2|Physician Decision|0|||
27865963|NCT00996892|81342010|FG015|Expansion Stage 2|Physician Decision|0|||
27865964|NCT00996892|81342011|FG016|Expansion Stage 2|Physician Decision|0|||
27865965|NCT00996892|81342012|FG017|Expansion Stage 2|Physician Decision|0|||
27865966|NCT00996892|81342013|FG018|Expansion Stage 2|Physician Decision|1|||
27865967|NCT00996892|81342014|FG019|Expansion Stage 2|Physician Decision|0|||
27865968|NCT00996892|81341995|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
27865969|NCT00996892|81341996|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
27865970|NCT00996892|81341997|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
27865971|NCT00996892|81341998|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
27865972|NCT00996892|81341999|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
27572028|NCT00989833|80278963|FG000|Overall Study|Withdrawal by Subject|0|||
27572029|NCT00989833|80278964|FG001|Overall Study|Withdrawal by Subject|0|||
27972943|NCT01352741|81730189|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
27972944|NCT01352741|81730190|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
27972945|NCT01352741|81730189|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
27972946|NCT01352741|81730190|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
27972947|NCT01352741|81730189|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
27972948|NCT01352741|81730190|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
27972949|NCT01352741|81730189|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
27972950|NCT01352741|81730190|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
27972951|NCT03298984|81730191|FG000|Overall Study|Physician Decision|1|||
27972952|NCT03298984|81730192|FG001|Overall Study|Physician Decision|0|||
27865973|NCT00996892|81342000|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
27865974|NCT00996892|81342001|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
27572030|NCT00989833|80278965|FG002|Overall Study|Withdrawal by Subject|1|||
27572031|NCT00989833|80278963|FG000|Overall Study|Incorrectly randomized|1|||
27572032|NCT00989833|80278964|FG001|Overall Study|Incorrectly randomized|0|||
27572033|NCT00989833|80278965|FG002|Overall Study|Incorrectly randomized|0|||
27572034|NCT02052739|80278966|FG000|Overall Study|Withdrew due to Adverse Event|3|||
27572035|NCT02052739|80278967|FG001|Overall Study|Withdrew due to Adverse Event|0|||
27572036|NCT02052739|80278966|FG000|Overall Study|Participant Died|2|||
27572037|NCT02052739|80278967|FG001|Overall Study|Participant Died|1|||
27572038|NCT00836875|80278968|FG000|Overall Study|Death|3|||
27572039|NCT00836875|80278969|FG001|Overall Study|Death|2|||
27572040|NCT00836875|80278968|FG000|Overall Study|Withdrawal by Subject|0|||
27572041|NCT00836875|80278969|FG001|Overall Study|Withdrawal by Subject|1|||
27572042|NCT00670228|80278975|FG000|Overall Study|Adverse Event|1|||
27572043|NCT00670228|80278976|FG001|Overall Study|Adverse Event|0|||
27572044|NCT00670228|80278975|FG000|Overall Study|Death or MACE|0|||
27572045|NCT00670228|80278976|FG001|Overall Study|Death or MACE|1|||
27572046|NCT00670228|80278975|FG000|Overall Study|Not treated|2|||
27572047|NCT00670228|80278976|FG001|Overall Study|Not treated|2|||
27572048|NCT00670228|80278975|FG000|Overall Study|Not meeting the selection criteria|2|||
27572049|NCT00670228|80278976|FG001|Overall Study|Not meeting the selection criteria|0|||
27572050|NCT01533246|80278977|FG000|Overall Study|Adverse Event|1|||
27572051|NCT01533246|80278977|FG000|Overall Study|Withdrawal by Subject|1|||
27572052|NCT01786629|80278979|FG000|Overall Study|Lack of Efficacy|0|||
27572053|NCT01786629|80278980|FG001|Overall Study|Lack of Efficacy|4|||
27572054|NCT01786629|80278979|FG000|Overall Study|Adverse Event|0|||
27572055|NCT01786629|80278980|FG001|Overall Study|Adverse Event|1|||
27572056|NCT05074433|80278981|FG000|Overall Study|Adverse Event|0|||
27572057|NCT05074433|80278982|FG001|Overall Study|Adverse Event|2|||
27572058|NCT05074433|80278983|FG002|Overall Study|Adverse Event|0|||
27572059|NCT05074433|80278984|FG003|Overall Study|Adverse Event|1|||
27572060|NCT05074433|80278981|FG000|Overall Study|Sponsor Request|0|||
27572061|NCT05074433|80278982|FG001|Overall Study|Sponsor Request|1|||
27572062|NCT05074433|80278983|FG002|Overall Study|Sponsor Request|1|||
27572063|NCT05074433|80278984|FG003|Overall Study|Sponsor Request|0|||
27572064|NCT05074433|80278981|FG000|Overall Study|Death|1|||
27572065|NCT05074433|80278982|FG001|Overall Study|Death|0|||
27784360|NCT00361504|81040725|FG001|Overall Study|All other|3|||
27572066|NCT05074433|80278983|FG002|Overall Study|Death|0|||
27572067|NCT05074433|80278984|FG003|Overall Study|Death|0|||
27572068|NCT05074433|80278981|FG000|Overall Study|Lost to Follow-up|0|||
27572069|NCT05074433|80278982|FG001|Overall Study|Lost to Follow-up|0|||
27572070|NCT05074433|80278983|FG002|Overall Study|Lost to Follow-up|2|||
27572071|NCT05074433|80278984|FG003|Overall Study|Lost to Follow-up|0|||
27572072|NCT05074433|80278981|FG000|Overall Study|Subject Decision|8|||
27972953|NCT03298984|81730193|FG002|Overall Study|Physician Decision|0|||
27972954|NCT03298984|81730194|FG003|Overall Study|Physician Decision|6|||
27972955|NCT03298984|81730191|FG000|Overall Study|Lack of Efficacy|0|||
27972956|NCT03298984|81730192|FG001|Overall Study|Lack of Efficacy|1|||
27972957|NCT03298984|81730193|FG002|Overall Study|Lack of Efficacy|1|||
27972958|NCT03298984|81730194|FG003|Overall Study|Lack of Efficacy|4|||
27972959|NCT03298984|81730191|FG000|Overall Study|Relapsed disease (following remission)|0|||
27972960|NCT03298984|81730192|FG001|Overall Study|Relapsed disease (following remission)|0|||
27972961|NCT03298984|81730193|FG002|Overall Study|Relapsed disease (following remission)|1|||
27972962|NCT03298984|81730194|FG003|Overall Study|Relapsed disease (following remission)|1|||
27972963|NCT03298984|81730191|FG000|Overall Study|Adverse Event|0|||
27972964|NCT03298984|81730192|FG001|Overall Study|Adverse Event|0|||
27972965|NCT03298984|81730193|FG002|Overall Study|Adverse Event|0|||
27572073|NCT05074433|80278982|FG001|Overall Study|Subject Decision|6|||
27572074|NCT05074433|80278983|FG002|Overall Study|Subject Decision|4|||
27572075|NCT05074433|80278984|FG003|Overall Study|Subject Decision|5|||
27572076|NCT02342704|80278985|FG000|Overall Study|Physician Decision|0|||
27572077|NCT02342704|80278986|FG001|Overall Study|Physician Decision|3|||
27572078|NCT02342704|80278985|FG000|Overall Study|Sponsor Termination|49|||
27572079|NCT02342704|80278986|FG001|Overall Study|Sponsor Termination|43|||
27572080|NCT02342704|80278985|FG000|Overall Study|Other|0|||
27572081|NCT02342704|80278986|FG001|Overall Study|Other|1|||
27572082|NCT02342704|80278985|FG000|Overall Study|Withdrawal by Subject|1|||
27572083|NCT02342704|80278986|FG001|Overall Study|Withdrawal by Subject|0|||
27572084|NCT02342704|80278985|FG000|Overall Study|Lost to Follow-up|2|||
27572085|NCT02342704|80278986|FG001|Overall Study|Lost to Follow-up|1|||
27572086|NCT02342704|80278985|FG000|Overall Study|Adverse Event|1|||
27572087|NCT02342704|80278986|FG001|Overall Study|Adverse Event|3|||
27572088|NCT03591575|80278987|FG000|Overall Study|Adverse Event|2|||
27572089|NCT03591575|80278988|FG001|Overall Study|Adverse Event|0|||
27572090|NCT03591575|80278987|FG000|Overall Study|Withdrawal by Subject|4|||
27972966|NCT03298984|81730194|FG003|Overall Study|Adverse Event|1|||
27972967|NCT03298984|81730191|FG000|Overall Study|Death|0|||
27972968|NCT03298984|81730192|FG001|Overall Study|Death|0|||
27972969|NCT03298984|81730193|FG002|Overall Study|Death|0|||
27972970|NCT03298984|81730194|FG003|Overall Study|Death|2|||
27972971|NCT03298984|81730191|FG000|Overall Study|Insurance Company Decision|0|||
27972972|NCT03298984|81730192|FG001|Overall Study|Insurance Company Decision|0|||
27972973|NCT03298984|81730193|FG002|Overall Study|Insurance Company Decision|0|||
27972974|NCT03298984|81730194|FG003|Overall Study|Insurance Company Decision|1|||
27972975|NCT02780856|81730196|FG000|Overall Study|Lost to Follow-up|1|||
27972976|NCT00835640|81730198|FG000|Second Intervention|Protocol Violation|1|||
27972977|NCT00835640|81730199|FG001|Second Intervention|Protocol Violation|0|||
27972978|NCT05275010|81730207|FG000|Overall Study|Reason Not Specified|4|||
27972979|NCT05275010|81730208|FG001|Overall Study|Reason Not Specified|1|||
27972980|NCT05275010|81730207|FG000|Overall Study|Withdrawal by Subject|1|||
27972981|NCT05275010|81730208|FG001|Overall Study|Withdrawal by Subject|0|||
27972982|NCT05275010|81730207|FG000|Overall Study|Lost to Follow-up|0|||
27972983|NCT05275010|81730208|FG001|Overall Study|Lost to Follow-up|1|||
27972984|NCT03425006|81730209|FG000|Overall Study|Withdrawal by Subject|1|||
27972985|NCT03425006|81730209|FG000|Overall Study|Physician Decision|1|||
27972986|NCT03425006|81730209|FG000|Overall Study|Death|1|||
27972987|NCT02725593|81730212|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
27972988|NCT02725593|81730213|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
27972989|NCT02725593|81730212|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
27972990|NCT02725593|81730213|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
27572091|NCT03591575|80278988|FG001|Overall Study|Withdrawal by Subject|1|||
27572092|NCT01552772|80279000|FG000|Overall Study|Lost to Follow-up|2|||
27572093|NCT01552772|80279000|FG000|Overall Study|Adverse Event|1|||
27972991|NCT02725593|81730212|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
27972992|NCT02725593|81730213|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
27972993|NCT02725593|81730212|FG000|Long Term Extension|Withdrawal by Subject|1|||
27972994|NCT02725593|81730213|FG001|Long Term Extension|Withdrawal by Subject|3|||
27972995|NCT03640052|81730214|FG000|Overall Study|Lost to Follow-up|0|||
27972996|NCT03640052|81730215|FG001|Overall Study|Lost to Follow-up|1|||
27972997|NCT03640052|81730216|FG002|Overall Study|Lost to Follow-up|0|||
27572094|NCT01552772|80279000|FG000|Overall Study|Protocol Deviation|1|||
27572095|NCT02448875|80279001|FG000|Overall Study|Adverse Event|2|||
27572096|NCT02448875|80279002|FG001|Overall Study|Adverse Event|1|||
27572097|NCT02448875|80279003|FG002|Overall Study|Adverse Event|0|||
27784361|NCT04794491|81040726|FG000|Overall Study|Adverse Event|1|||
27972998|NCT03640052|81730217|FG003|Overall Study|Lost to Follow-up|0|||
27972999|NCT03640052|81730218|FG004|Overall Study|Lost to Follow-up|0|||
27973000|NCT01824823|81730219|FG000|Overall Study|Lack of Efficacy|1|||
27973001|NCT01824823|81730220|FG001|Overall Study|Lack of Efficacy|1|||
27572098|NCT02448875|80279001|FG000|Overall Study|Lost to Follow-up|1|||
27572099|NCT02448875|80279002|FG001|Overall Study|Lost to Follow-up|0|||
27572100|NCT02448875|80279003|FG002|Overall Study|Lost to Follow-up|0|||
27572101|NCT02448875|80279001|FG000|Overall Study|Investigator Decision|3|||
27572102|NCT02448875|80279002|FG001|Overall Study|Investigator Decision|0|||
27572103|NCT02448875|80279003|FG002|Overall Study|Investigator Decision|1|||
27572104|NCT02448875|80279001|FG000|Overall Study|Withdrawal by Subject|1|||
27572105|NCT02448875|80279002|FG001|Overall Study|Withdrawal by Subject|0|||
27572106|NCT02448875|80279003|FG002|Overall Study|Withdrawal by Subject|0|||
27572107|NCT01541930|80279006|FG000|Overall Study|Withdrawal by Subject|1|||
27572108|NCT02181556|80279007|FG000|Overall Study|Withdrawal by Subject|1|||
27572109|NCT01147653|80279008|FG000|Year 2|Withdrawal by Subject|2|||
27572110|NCT01147653|80279009|FG001|Year 2|Withdrawal by Subject|3|||
27572111|NCT01886833|80279010|FG000|Overall Study|IgA not available from both periods|204|||
27572112|NCT01158222|80279015|FG000|Overall Study|Not eligible for intermediate phase|17|||
27572113|NCT02256891|80279016|FG000|Overall Study|Death|0|||
27572114|NCT02256891|80279017|FG001|Overall Study|Death|2|||
27572115|NCT02256891|80279016|FG000|Overall Study|Lost to Follow-up|0|||
27572116|NCT02256891|80279017|FG001|Overall Study|Lost to Follow-up|3|||
27572117|NCT02256891|80279016|FG000|Overall Study|Physician Decision|7|||
27572118|NCT02256891|80279017|FG001|Overall Study|Physician Decision|3|||
27572119|NCT02256891|80279016|FG000|Overall Study|Screen Fail|5|||
27572120|NCT02256891|80279017|FG001|Overall Study|Screen Fail|4|||
27572121|NCT02256891|80279016|FG000|Overall Study|Equipment Malfunction|0|||
27572122|NCT02256891|80279017|FG001|Overall Study|Equipment Malfunction|1|||
27572123|NCT00997503|80279018|FG000|Overall Study|Death|53|||
27572124|NCT00997503|80279018|FG000|Overall Study|Withdrawal by Subject|76|||
27572125|NCT00997503|80279018|FG000|Overall Study|Lost to Follow-up|33|||
27572126|NCT00997503|80279018|FG000|Overall Study|Adverse Event|3|||
27572127|NCT00997503|80279018|FG000|Overall Study|Physician Decision|10|||
27572128|NCT00997503|80279018|FG000|Overall Study|Missed 12-month follow-up|85|||
27572129|NCT00997503|80279018|FG000|Overall Study|Other reason|13|||
27572130|NCT03299842|80279019|FG000|Overall Study|Caregiver withdrew consent|2|||
27572131|NCT03299842|80279019|FG000|Overall Study|Child would not keep the watch on|3|||
27572132|NCT03467425|80279024|FG000|Overall Study|Adverse Event|9|||
27572133|NCT03467425|80279025|FG001|Overall Study|Adverse Event|9|||
27572134|NCT03467425|80279024|FG000|Overall Study|Lack of Efficacy|3|||
27572135|NCT03467425|80279025|FG001|Overall Study|Lack of Efficacy|1|||
27572136|NCT03467425|80279024|FG000|Overall Study|Protocol Violation|0|||
27572137|NCT03467425|80279025|FG001|Overall Study|Protocol Violation|1|||
27572138|NCT03467425|80279024|FG000|Overall Study|Lost to Follow-up|18|||
27572139|NCT03467425|80279025|FG001|Overall Study|Lost to Follow-up|25|||
27572140|NCT03467425|80279024|FG000|Overall Study|Physician Decision|2|||
27572141|NCT03467425|80279025|FG001|Overall Study|Physician Decision|1|||
27572142|NCT03467425|80279024|FG000|Overall Study|Withdrawal by Subject|15|||
27572143|NCT03467425|80279025|FG001|Overall Study|Withdrawal by Subject|17|||
27572144|NCT01467076|80279028|FG000|Overall Study|Lost to Follow-up|1|||
27572145|NCT01467076|80279029|FG001|Overall Study|Lost to Follow-up|0|||
27572146|NCT01467076|80279030|FG002|Overall Study|Lost to Follow-up|0|||
27572147|NCT01849588|80279031|FG000|Overall Study|Lack of Efficacy|3|||
27572148|NCT02023151|80279034|FG000|Overall Study|Lost to Follow-up|4|||
27572149|NCT02418468|80279041|FG000|Overall Study|Adverse Event|1|||
27572150|NCT02418468|80279042|FG001|Overall Study|Adverse Event|0|||
27572151|NCT02418468|80279041|FG000|Overall Study|Withdrawal of informed consent|1|||
27572152|NCT02418468|80279042|FG001|Overall Study|Withdrawal of informed consent|1|||
27572153|NCT02410811|80279043|FG000|Overall Study|Withdrawal by Subject|0|||
27572154|NCT02410811|80279044|FG001|Overall Study|Withdrawal by Subject|0|||
27572155|NCT02410811|80279045|FG002|Overall Study|Withdrawal by Subject|1|||
27572156|NCT02410811|80279046|FG003|Overall Study|Withdrawal by Subject|0|||
27572157|NCT01337297|80279054|FG000|Overall Study|They entered to single anodal tDCS|4|||
27572158|NCT01337297|80279055|FG001|Overall Study|They entered to single anodal tDCS|3|||
27572159|NCT01337297|80279054|FG000|Overall Study|Lost to Follow-up|1|||
27572160|NCT01337297|80279055|FG001|Overall Study|Lost to Follow-up|3|||
27572161|NCT02075320|80279056|FG000|Overall Study|Withdrawal by Subject|2|||
27572162|NCT01971346|80279064|FG000|Overall Study|Protocol Violation|3|||
27572163|NCT01971346|80279064|FG000|Overall Study|Lost to Follow-up|2|||
27572164|NCT01971346|80279064|FG000|Overall Study|Withdrawal by Subject|2|||
27572165|NCT01971346|80279064|FG000|Overall Study|Physician Decision|1|||
27572166|NCT02603809|80279065|FG000|Overall Study|Withdrawal by Subject|4|||
27572167|NCT02603809|80279066|FG001|Overall Study|Withdrawal by Subject|1|||
27572168|NCT02603809|80279067|FG002|Overall Study|Withdrawal by Subject|2|||
27572169|NCT02603809|80279068|FG003|Overall Study|Withdrawal by Subject|3|||
27572170|NCT02603809|80279069|FG004|Overall Study|Withdrawal by Subject|3|||
27572171|NCT02603809|80279070|FG005|Overall Study|Withdrawal by Subject|4|||
27572172|NCT02603809|80279065|FG000|Overall Study|Lost to Follow-up|2|||
27572173|NCT02603809|80279066|FG001|Overall Study|Lost to Follow-up|3|||
27572174|NCT02603809|80279067|FG002|Overall Study|Lost to Follow-up|1|||
27572175|NCT02603809|80279068|FG003|Overall Study|Lost to Follow-up|4|||
27572176|NCT02603809|80279069|FG004|Overall Study|Lost to Follow-up|2|||
27572177|NCT02603809|80279070|FG005|Overall Study|Lost to Follow-up|2|||
27572178|NCT02603809|80279065|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
27572179|NCT02603809|80279066|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
27572180|NCT02603809|80279067|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
27572181|NCT02603809|80279068|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
27572182|NCT02603809|80279069|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
27572183|NCT02603809|80279070|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
27572184|NCT02603809|80279065|FG000|Overall Study|Physician Decision|0|||
27572185|NCT02603809|80279066|FG001|Overall Study|Physician Decision|0|||
27572186|NCT02603809|80279067|FG002|Overall Study|Physician Decision|0|||
27572187|NCT02603809|80279068|FG003|Overall Study|Physician Decision|1|||
27572188|NCT02603809|80279069|FG004|Overall Study|Physician Decision|2|||
27572189|NCT02603809|80279070|FG005|Overall Study|Physician Decision|1|||
27833026|NCT00848536|81219438|FG001|Overall Study|Protocol Violation|1|||
27572190|NCT02603809|80279065|FG000|Overall Study|Adverse Event|3|||
27572191|NCT02603809|80279066|FG001|Overall Study|Adverse Event|0|||
27572192|NCT02603809|80279067|FG002|Overall Study|Adverse Event|2|||
27572193|NCT02603809|80279068|FG003|Overall Study|Adverse Event|2|||
27572194|NCT02603809|80279069|FG004|Overall Study|Adverse Event|1|||
27572195|NCT02603809|80279070|FG005|Overall Study|Adverse Event|1|||
27572196|NCT02603809|80279065|FG000|Overall Study|Lack of Efficacy|0|||
27572197|NCT02603809|80279066|FG001|Overall Study|Lack of Efficacy|1|||
27572198|NCT02603809|80279067|FG002|Overall Study|Lack of Efficacy|0|||
27572199|NCT02603809|80279068|FG003|Overall Study|Lack of Efficacy|0|||
27572200|NCT02603809|80279069|FG004|Overall Study|Lack of Efficacy|0|||
27572201|NCT02603809|80279070|FG005|Overall Study|Lack of Efficacy|1|||
27572202|NCT01574352|80279071|FG000|Overall Study|Withdrawal by Subject|6|||
27572203|NCT01574352|80279072|FG001|Overall Study|Withdrawal by Subject|13|||
27572204|NCT01574352|80279071|FG000|Overall Study|Injury in non-camp related sport|1|||
27572205|NCT01574352|80279072|FG001|Overall Study|Injury in non-camp related sport|0|||
27572206|NCT04476030|80279075|FG000|Overall Study|Withdrawal by Subject|20|||
27572207|NCT04476030|80279076|FG001|Overall Study|Withdrawal by Subject|16|||
27572208|NCT04476030|80279075|FG000|Overall Study|Adverse Event|10|||
27572209|NCT04476030|80279076|FG001|Overall Study|Adverse Event|11|||
27572210|NCT04476030|80279075|FG000|Overall Study|Lost to Follow-up|7|||
27572211|NCT04476030|80279076|FG001|Overall Study|Lost to Follow-up|4|||
27572212|NCT04476030|80279075|FG000|Overall Study|Physician Decision|1|||
27572213|NCT04476030|80279076|FG001|Overall Study|Physician Decision|1|||
27572214|NCT04476030|80279075|FG000|Overall Study|Protocol Deviation|2|||
27572215|NCT04476030|80279076|FG001|Overall Study|Protocol Deviation|0|||
27572216|NCT04476030|80279075|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
27572217|NCT04476030|80279076|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
27572218|NCT04476030|80279075|FG000|Overall Study|Randomized but not Dosed|2|||
27572219|NCT04476030|80279076|FG001|Overall Study|Randomized but not Dosed|8|||
27572220|NCT01857063|80279077|FG000|Period 1 (7 Days)|Adverse Event|0|||
27572221|NCT01857063|80279078|FG001|Period 1 (7 Days)|Adverse Event|1|||
27572222|NCT01857063|80279077|FG000|Period 1 (7 Days)|Physician Decision|1|||
27572223|NCT01857063|80279078|FG001|Period 1 (7 Days)|Physician Decision|0|||
27572224|NCT01857063|80279077|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
27572225|NCT01857063|80279078|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
27572226|NCT01857063|80279077|FG000|Period 2 (7 Days)|Adverse Event|2|||
27572227|NCT01857063|80279078|FG001|Period 2 (7 Days)|Adverse Event|1|||
27572228|NCT01857063|80279077|FG000|Period 2 (7 Days)|Physician Decision|1|||
27572229|NCT01857063|80279078|FG001|Period 2 (7 Days)|Physician Decision|1|||
27784362|NCT04794491|81040726|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
27572230|NCT01857063|80279077|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
27572231|NCT01857063|80279078|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
27572232|NCT03450707|80279079|FG000|Overall Study|Outside enrollment window|4|||
27572233|NCT03450707|80279080|FG001|Overall Study|Outside enrollment window|1|||
27572234|NCT03450707|80279079|FG000|Overall Study|Death|1|||
27572235|NCT03450707|80279080|FG001|Overall Study|Death|0|||
27572236|NCT03450707|80279079|FG000|Overall Study|Indication for thiamine|1|||
27572237|NCT03450707|80279080|FG001|Overall Study|Indication for thiamine|1|||
27572238|NCT03450707|80279079|FG000|Overall Study|Evidence of traumatic brain injury|1|||
27572239|NCT03450707|80279080|FG001|Overall Study|Evidence of traumatic brain injury|0|||
27572240|NCT03450707|80279079|FG000|Overall Study|Following commands|0|||
27572241|NCT03450707|80279080|FG001|Overall Study|Following commands|3|||
27572242|NCT03450707|80279079|FG000|Overall Study|Lactate < 3.5|0|||
27572243|NCT03450707|80279080|FG001|Overall Study|Lactate < 3.5|2|||
27670075|NCT01772823|80630988|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
27670076|NCT01772823|80630989|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
27670077|NCT01772823|80630988|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
27670078|NCT01772823|80630989|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
27670079|NCT01772823|80630988|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
27670080|NCT01772823|80630989|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
27670081|NCT01772823|80630988|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
27670082|NCT01772823|80630989|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
27670083|NCT01772823|80630988|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
27670084|NCT01772823|80630989|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
27670085|NCT01772823|80630988|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
27670086|NCT01772823|80630989|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
27572244|NCT03450707|80279079|FG000|Overall Study|Rearrest with ECMO|0|||
27572245|NCT03450707|80279080|FG001|Overall Study|Rearrest with ECMO|1|||
27572246|NCT03450707|80279079|FG000|Overall Study|Indication for thiamine + head CT results|0|||
27572247|NCT03450707|80279080|FG001|Overall Study|Indication for thiamine + head CT results|1|||
27572248|NCT03450707|80279079|FG000|Overall Study|Family/patient goals of care|0|||
27572249|NCT03450707|80279080|FG001|Overall Study|Family/patient goals of care|1|||
27572250|NCT01465464|80279081|FG000|Overall Study|Adverse Event|96|||
27572251|NCT01465464|80279082|FG001|Overall Study|Adverse Event|49|||
27572252|NCT01465464|80279081|FG000|Overall Study|Lack of Efficacy|139|||
27572253|NCT01465464|80279082|FG001|Overall Study|Lack of Efficacy|190|||
27572254|NCT01465464|80279081|FG000|Overall Study|Physician Decision|13|||
27572255|NCT01465464|80279082|FG001|Overall Study|Physician Decision|5|||
27572256|NCT01465464|80279081|FG000|Overall Study|Protocol Violation|1|||
27572257|NCT01465464|80279082|FG001|Overall Study|Protocol Violation|1|||
27572258|NCT01465464|80279081|FG000|Overall Study|Withdrawal by Subject|46|||
27572259|NCT01465464|80279082|FG001|Overall Study|Withdrawal by Subject|30|||
27572260|NCT01465464|80279081|FG000|Overall Study|Other|9|||
27572261|NCT01465464|80279082|FG001|Overall Study|Other|3|||
27572262|NCT01465464|80279081|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
27572263|NCT01465464|80279082|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
27572264|NCT00376168|80279083|FG000|Overall Study|Adverse Event|1|||
27572265|NCT00376168|80279084|FG001|Overall Study|Adverse Event|1|||
27572266|NCT00376168|80279083|FG000|Overall Study|Pregnancy|1|||
27572267|NCT00376168|80279084|FG001|Overall Study|Pregnancy|0|||
27572268|NCT00218543|80279085|FG000|Overall Study|Lost to Follow-up|8|||
27572269|NCT00218543|80279085|FG000|Overall Study|relocated|1|||
27572270|NCT00218543|80279085|FG000|Overall Study|Withdrawal by Subject|1|||
27572271|NCT00218543|80279085|FG000|Overall Study|Physician Decision|3|||
27572272|NCT00218543|80279085|FG000|Overall Study|Adverse Event|2|||
27572273|NCT00358527|80279086|FG000|Overall Study|Adverse Event|4|||
27572274|NCT00358527|80279087|FG001|Overall Study|Adverse Event|0|||
27572275|NCT00358527|80279086|FG000|Overall Study|Withdrawal by Subject|1|||
27572276|NCT00358527|80279087|FG001|Overall Study|Withdrawal by Subject|1|||
27572277|NCT00358527|80279086|FG000|Overall Study|Non-compliance with protocol|6|||
27572278|NCT00358527|80279087|FG001|Overall Study|Non-compliance with protocol|1|||
27572279|NCT00358527|80279086|FG000|Overall Study|Administrative|2|||
27572280|NCT00358527|80279087|FG001|Overall Study|Administrative|1|||
27572281|NCT02375672|80279088|FG000|Overall Study|remain on follow up|20|||
27572282|NCT01639040|80279095|FG000|Overall Study|Adverse Event|1|||
27572283|NCT01639040|80279096|FG001|Overall Study|Adverse Event|0|||
27572284|NCT01859715|80279097|FG000|Overall Study|No 2nd VAS|16|||
27572285|NCT01859715|80279098|FG001|Overall Study|No 2nd VAS|8|||
27670087|NCT01772823|80630988|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
27670088|NCT01772823|80630989|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
27572286|NCT01859715|80279099|FG002|Overall Study|No 2nd VAS|23|||
27572287|NCT03878134|80279104|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
27572288|NCT01557400|80279106|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
27572289|NCT01557400|80279106|FG000|Overall Study|Adverse Event|3|||
27572290|NCT01557400|80279106|FG000|Overall Study|Lost to Follow-up|5|||
27572291|NCT01557400|80279106|FG000|Overall Study|Withdrawal by Subject|9|||
27572292|NCT03400033|80279109|FG000|Overall Study|Withdrawal by Subject|1|||
27572293|NCT03400033|80279110|FG001|Overall Study|Withdrawal by Subject|2|||
27572294|NCT00720941|80279118|FG000|Overall Study|Death|334|||
27572295|NCT00720941|80279119|FG001|Overall Study|Death|335|||
27572296|NCT00720941|80279118|FG000|Overall Study|Protocol Violation|0|||
27572297|NCT00720941|80279119|FG001|Overall Study|Protocol Violation|2|||
27572298|NCT00720941|80279118|FG000|Overall Study|Lost to Follow-up|17|||
27572299|NCT00720941|80279119|FG001|Overall Study|Lost to Follow-up|15|||
27572300|NCT00720941|80279118|FG000|Overall Study|Physician Decision|1|||
27572301|NCT00720941|80279119|FG001|Overall Study|Physician Decision|5|||
27572302|NCT00720941|80279118|FG000|Overall Study|Withdrawal by Subject|27|||
27572303|NCT00720941|80279119|FG001|Overall Study|Withdrawal by Subject|35|||
27572304|NCT00720941|80279118|FG000|Overall Study|Ongoing|34|||
27865975|NCT00996892|81342002|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
27865976|NCT00996892|81342003|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
27865977|NCT00996892|81342004|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
27865978|NCT00996892|81342005|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
27865979|NCT00996892|81342006|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
27865980|NCT00996892|81342007|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
27865981|NCT00996892|81342008|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
27865982|NCT00996892|81342009|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
27865983|NCT00996892|81342010|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
27865984|NCT00996892|81342011|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
27865985|NCT00996892|81342012|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
27865986|NCT00996892|81342013|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
27865987|NCT00996892|81342014|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
27865988|NCT00996892|81341995|FG000|Expansion Stage 2|Disease Progression|0|||
27865989|NCT00996892|81341996|FG001|Expansion Stage 2|Disease Progression|0|||
27865990|NCT00996892|81341997|FG002|Expansion Stage 2|Disease Progression|0|||
27865991|NCT00996892|81341998|FG003|Expansion Stage 2|Disease Progression|0|||
27865992|NCT00996892|81341999|FG004|Expansion Stage 2|Disease Progression|0|||
27865993|NCT00996892|81342000|FG005|Expansion Stage 2|Disease Progression|0|||
27865994|NCT00996892|81342001|FG006|Expansion Stage 2|Disease Progression|0|||
27865995|NCT00996892|81342002|FG007|Expansion Stage 2|Disease Progression|0|||
27865996|NCT00996892|81342003|FG008|Expansion Stage 2|Disease Progression|0|||
27865997|NCT00996892|81342004|FG009|Expansion Stage 2|Disease Progression|0|||
27865998|NCT00996892|81342005|FG010|Expansion Stage 2|Disease Progression|0|||
27865999|NCT00996892|81342006|FG011|Expansion Stage 2|Disease Progression|0|||
27866000|NCT00996892|81342007|FG012|Expansion Stage 2|Disease Progression|0|||
27866001|NCT00996892|81342008|FG013|Expansion Stage 2|Disease Progression|0|||
27866002|NCT00996892|81342009|FG014|Expansion Stage 2|Disease Progression|0|||
27866003|NCT00996892|81342010|FG015|Expansion Stage 2|Disease Progression|0|||
27866004|NCT00996892|81342011|FG016|Expansion Stage 2|Disease Progression|0|||
27866005|NCT00996892|81342012|FG017|Expansion Stage 2|Disease Progression|0|||
27866006|NCT00996892|81342013|FG018|Expansion Stage 2|Disease Progression|28|||
27973002|NCT01824823|81730219|FG000|Overall Study|Off-treatment reason not submitted|1|||
27973003|NCT01824823|81730220|FG001|Overall Study|Off-treatment reason not submitted|0|||
27973004|NCT00350870|81730221|FG000|Overall Study|Withdrawal by Subject|21|||
27572305|NCT00720941|80279119|FG001|Overall Study|Ongoing|23|||
27572306|NCT00779675|80279120|FG000|Treatment Period|Adverse Event|87|||
27572307|NCT00779675|80279120|FG000|Treatment Period|Treatment Failure|80|||
27572308|NCT00779675|80279120|FG000|Treatment Period|Transferred to Another Study|38|||
27572309|NCT00779675|80279120|FG000|Treatment Period|Lost to Follow-up|23|||
27572310|NCT00779675|80279120|FG000|Treatment Period|Withdrawal by Subject|46|||
27572311|NCT00779675|80279120|FG000|Treatment Period|Protocol Violation|54|||
27572312|NCT00779675|80279120|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
27572313|NCT00779675|80279120|FG000|Treatment Period|Administrative|3|||
27572314|NCT00779675|80279120|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
27572315|NCT00779675|80279120|FG000|Extended Treatment Period|Protocol Violation|13|||
27572316|NCT00779675|80279120|FG000|Extended Treatment Period|Adverse Event|6|||
27572317|NCT00779675|80279120|FG000|Extended Treatment Period|Treatment Failure|11|||
27572318|NCT00779675|80279120|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
27572319|NCT00779675|80279120|FG000|Extended Treatment Period|Lost to Follow-up|6|||
27572320|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
27572321|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
27572322|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
27572323|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
27572324|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
27572325|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
27572326|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
27572327|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
27572328|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
27866007|NCT00996892|81342014|FG019|Expansion Stage 2|Disease Progression|0|||
27572329|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
27572330|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
27572331|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
27572332|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
27670089|NCT01772823|80630988|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
27866008|NCT00996892|81341995|FG000|Expansion Stage 2A|Adverse Event|0|||
27572333|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
27866009|NCT00996892|81341996|FG001|Expansion Stage 2A|Adverse Event|0|||
27866010|NCT00996892|81341997|FG002|Expansion Stage 2A|Adverse Event|0|||
27866011|NCT00996892|81341998|FG003|Expansion Stage 2A|Adverse Event|0|||
27866012|NCT00996892|81341999|FG004|Expansion Stage 2A|Adverse Event|0|||
27866013|NCT00996892|81342000|FG005|Expansion Stage 2A|Adverse Event|0|||
27866014|NCT00996892|81342001|FG006|Expansion Stage 2A|Adverse Event|0|||
27866015|NCT00996892|81342002|FG007|Expansion Stage 2A|Adverse Event|0|||
27866016|NCT00996892|81342003|FG008|Expansion Stage 2A|Adverse Event|0|||
27866017|NCT00996892|81342004|FG009|Expansion Stage 2A|Adverse Event|0|||
27866018|NCT00996892|81342005|FG010|Expansion Stage 2A|Adverse Event|0|||
27572334|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
27572335|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Death|5|||
27572336|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Death|0|||
27572337|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Death|2|||
27572338|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Death|0|||
27572339|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Death|4|||
27572340|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
27572341|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
27572342|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
27572343|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
27866019|NCT00996892|81342006|FG011|Expansion Stage 2A|Adverse Event|0|||
27866020|NCT00996892|81342007|FG012|Expansion Stage 2A|Adverse Event|0|||
27866021|NCT00996892|81342008|FG013|Expansion Stage 2A|Adverse Event|0|||
27866022|NCT00996892|81342009|FG014|Expansion Stage 2A|Adverse Event|0|||
27866023|NCT00996892|81342010|FG015|Expansion Stage 2A|Adverse Event|0|||
27866024|NCT00996892|81342011|FG016|Expansion Stage 2A|Adverse Event|0|||
27866025|NCT00996892|81342012|FG017|Expansion Stage 2A|Adverse Event|0|||
27866026|NCT00996892|81342013|FG018|Expansion Stage 2A|Adverse Event|0|||
27866027|NCT00996892|81342014|FG019|Expansion Stage 2A|Adverse Event|8|||
27866028|NCT00996892|81341995|FG000|Expansion Stage 2A|Physician Decision|0|||
27866029|NCT00996892|81341996|FG001|Expansion Stage 2A|Physician Decision|0|||
27866030|NCT00996892|81341997|FG002|Expansion Stage 2A|Physician Decision|0|||
27866031|NCT00996892|81341998|FG003|Expansion Stage 2A|Physician Decision|0|||
27866032|NCT00996892|81341999|FG004|Expansion Stage 2A|Physician Decision|0|||
27866033|NCT00996892|81342000|FG005|Expansion Stage 2A|Physician Decision|0|||
27866034|NCT00996892|81342001|FG006|Expansion Stage 2A|Physician Decision|0|||
27866035|NCT00996892|81342002|FG007|Expansion Stage 2A|Physician Decision|0|||
27866036|NCT00996892|81342003|FG008|Expansion Stage 2A|Physician Decision|0|||
27866037|NCT00996892|81342004|FG009|Expansion Stage 2A|Physician Decision|0|||
27866038|NCT00996892|81342005|FG010|Expansion Stage 2A|Physician Decision|0|||
27866039|NCT00996892|81342006|FG011|Expansion Stage 2A|Physician Decision|0|||
27866040|NCT00996892|81342007|FG012|Expansion Stage 2A|Physician Decision|0|||
27866041|NCT00996892|81342008|FG013|Expansion Stage 2A|Physician Decision|0|||
27866042|NCT00996892|81342009|FG014|Expansion Stage 2A|Physician Decision|0|||
27866043|NCT00996892|81342010|FG015|Expansion Stage 2A|Physician Decision|0|||
27866044|NCT00996892|81342011|FG016|Expansion Stage 2A|Physician Decision|0|||
27866045|NCT00996892|81342012|FG017|Expansion Stage 2A|Physician Decision|0|||
27866046|NCT00996892|81342013|FG018|Expansion Stage 2A|Physician Decision|0|||
27866047|NCT00996892|81342014|FG019|Expansion Stage 2A|Physician Decision|2|||
27866048|NCT00996892|81341995|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
27866049|NCT00996892|81341996|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
27866050|NCT00996892|81341997|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
27866051|NCT00996892|81341998|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
27866052|NCT00996892|81341999|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
27866053|NCT00996892|81342000|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
27866054|NCT00996892|81342001|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
27866055|NCT00996892|81342002|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
27866056|NCT00996892|81342003|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
27866057|NCT00996892|81342004|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
27572344|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
27572345|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
27572346|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
27572347|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
27572348|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
27572349|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
27866058|NCT00996892|81342005|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
27866059|NCT00996892|81342006|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
27866060|NCT00996892|81342007|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
27866061|NCT00996892|81342008|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
27866062|NCT00996892|81342009|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
27866063|NCT00996892|81342010|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
27866064|NCT00996892|81342011|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
27866065|NCT00996892|81342012|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
27572350|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
27572351|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
27572352|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
27572353|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
27572354|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
27572355|NCT01604343|80279121|FG000|Prior to W52 Administration(Through W52)|Other|15|||
27572356|NCT01604343|80279122|FG001|Prior to W52 Administration(Through W52)|Other|0|||
27572357|NCT01604343|80279123|FG002|Prior to W52 Administration(Through W52)|Other|10|||
27572358|NCT01604343|80279124|FG003|Prior to W52 Administration(Through W52)|Other|0|||
27572359|NCT01604343|80279125|FG004|Prior to W52 Administration(Through W52)|Other|6|||
27572360|NCT01604343|80279121|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
27572361|NCT01604343|80279122|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
27572362|NCT01604343|80279123|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
27572363|NCT01604343|80279124|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
27572364|NCT01604343|80279125|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
27572365|NCT01604343|80279121|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
27572366|NCT01604343|80279122|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
27572367|NCT01604343|80279123|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
27572368|NCT01604343|80279124|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
27572369|NCT01604343|80279125|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
27572370|NCT01604343|80279121|FG000|Week 52 to Week 104|Adverse Event|0|||
27572371|NCT01604343|80279122|FG001|Week 52 to Week 104|Adverse Event|12|||
27572372|NCT01604343|80279123|FG002|Week 52 to Week 104|Adverse Event|26|||
27572373|NCT01604343|80279124|FG003|Week 52 to Week 104|Adverse Event|21|||
27572374|NCT01604343|80279125|FG004|Week 52 to Week 104|Adverse Event|27|||
27572375|NCT01604343|80279121|FG000|Week 52 to Week 104|Death|0|||
27572376|NCT01604343|80279122|FG001|Week 52 to Week 104|Death|4|||
27572377|NCT01604343|80279123|FG002|Week 52 to Week 104|Death|2|||
27572378|NCT01604343|80279124|FG003|Week 52 to Week 104|Death|5|||
27572379|NCT01604343|80279125|FG004|Week 52 to Week 104|Death|0|||
27572380|NCT01604343|80279121|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
27572381|NCT01604343|80279122|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
27572382|NCT01604343|80279123|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
27572383|NCT01604343|80279124|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
27572384|NCT01604343|80279125|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
27572385|NCT01604343|80279121|FG000|Week 52 to Week 104|Physician Decision|0|||
27572386|NCT01604343|80279122|FG001|Week 52 to Week 104|Physician Decision|1|||
27572387|NCT01604343|80279123|FG002|Week 52 to Week 104|Physician Decision|0|||
27572388|NCT01604343|80279124|FG003|Week 52 to Week 104|Physician Decision|0|||
27784363|NCT04794491|81040726|FG000|Overall Study|Noncompliance With Study Intervention|1|||
27784364|NCT04794491|81040726|FG000|Overall Study|Withdrawal by Subject|2|||
27784365|NCT00851721|81040731|FG000|Overall Study|planned surgery|1|||
27784366|NCT00851721|81040732|FG001|Overall Study|planned surgery|0|||
27784367|NCT00851721|81040731|FG000|Overall Study|Death|1|||
27784368|NCT00851721|81040732|FG001|Overall Study|Death|0|||
27784369|NCT00851721|81040731|FG000|Overall Study|Adverse Event|0|||
27784370|NCT00851721|81040732|FG001|Overall Study|Adverse Event|1|||
27572389|NCT01604343|80279125|FG004|Week 52 to Week 104|Physician Decision|2|||
27572390|NCT01604343|80279121|FG000|Week 52 to Week 104|Pregnancy|0|||
27572391|NCT01604343|80279122|FG001|Week 52 to Week 104|Pregnancy|0|||
27572392|NCT01604343|80279123|FG002|Week 52 to Week 104|Pregnancy|1|||
27572393|NCT01604343|80279124|FG003|Week 52 to Week 104|Pregnancy|2|||
27572394|NCT01604343|80279125|FG004|Week 52 to Week 104|Pregnancy|1|||
27572395|NCT01604343|80279121|FG000|Week 52 to Week 104|Other|0|||
27572396|NCT01604343|80279122|FG001|Week 52 to Week 104|Other|11|||
27572397|NCT01604343|80279123|FG002|Week 52 to Week 104|Other|11|||
27572398|NCT01604343|80279124|FG003|Week 52 to Week 104|Other|6|||
27572399|NCT01604343|80279125|FG004|Week 52 to Week 104|Other|3|||
27572400|NCT01604343|80279121|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
27572401|NCT01604343|80279122|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
27784371|NCT03763942|81040733|FG000|Overall Study|Lost to Follow-up|114|||
27572402|NCT01604343|80279123|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
27572403|NCT01604343|80279124|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
27572404|NCT01604343|80279125|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
27572405|NCT01604343|80279121|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
27572406|NCT01604343|80279122|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
27572407|NCT01604343|80279123|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
27572408|NCT01604343|80279124|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
27572409|NCT01604343|80279125|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
27572410|NCT01604343|80279121|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
27572411|NCT01604343|80279122|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
27572412|NCT01604343|80279123|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
27572413|NCT01604343|80279124|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
27572414|NCT01604343|80279125|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
27572415|NCT05091307|80279126|FG000|Overall Study|Death|0|||
27572416|NCT05091307|80279127|FG001|Overall Study|Death|0|||
27784372|NCT03763942|81040734|FG001|Overall Study|Lost to Follow-up|54|||
27784373|NCT03763942|81040733|FG000|Overall Study|Protocol Violation|1|||
27784374|NCT03763942|81040734|FG001|Overall Study|Protocol Violation|0|||
27784375|NCT03763942|81040733|FG000|Overall Study|Withdrawal by Subject|2|||
27784376|NCT03763942|81040734|FG001|Overall Study|Withdrawal by Subject|0|||
27784377|NCT03763942|81040733|FG000|Overall Study|Other|2|||
27784378|NCT03763942|81040734|FG001|Overall Study|Other|3|||
27784379|NCT00669240|81040735|FG000|Overall Study|Lack of Efficacy|33|||
27784380|NCT00669240|81040735|FG000|Overall Study|Withdrawal by Subject|42|||
27784381|NCT00669240|81040735|FG000|Overall Study|Lost to Follow-up|34|||
27784382|NCT00669240|81040735|FG000|Overall Study|Adverse Event|21|||
27784383|NCT00669240|81040735|FG000|Overall Study|Other|19|||
27784384|NCT00669240|81040735|FG000|Overall Study|Enrolled but not treated|15|||
27784385|NCT00669240|81040735|FG000|Overall Study|Enrolled but no dosing record|1|||
27784386|NCT00740116|81040736|FG000|Overall Study|Withdrawal by Subject|1|||
27784387|NCT00740116|81040737|FG001|Overall Study|Withdrawal by Subject|1|||
27784388|NCT00740116|81040736|FG000|Overall Study|Protocol Violation|1|||
27784389|NCT00740116|81040737|FG001|Overall Study|Protocol Violation|4|||
27784390|NCT02132312|81040738|FG000|Overall Study|Adverse Event|2|||
27784391|NCT02132312|81040739|FG001|Overall Study|Adverse Event|0|||
27784392|NCT02132312|81040738|FG000|Overall Study|Physician Decision|1|||
27784393|NCT02132312|81040739|FG001|Overall Study|Physician Decision|1|||
27784394|NCT02132312|81040738|FG000|Overall Study|Protocol Violation|0|||
27784395|NCT02132312|81040739|FG001|Overall Study|Protocol Violation|1|||
27784396|NCT02132312|81040738|FG000|Overall Study|Withdrawal by Subject|1|||
27784397|NCT02132312|81040739|FG001|Overall Study|Withdrawal by Subject|0|||
27784398|NCT02132312|81040738|FG000|Overall Study|Lost to Follow-up|2|||
27784399|NCT02132312|81040739|FG001|Overall Study|Lost to Follow-up|1|||
27784400|NCT00508001|81040740|FG000|Overall Study|Adverse Event|2|||
27784401|NCT00508001|81040741|FG001|Overall Study|Adverse Event|0|||
27784402|NCT00508001|81040742|FG002|Overall Study|Adverse Event|4|||
27784403|NCT00508001|81040740|FG000|Overall Study|condition under investigation worsened|13|||
27784404|NCT00508001|81040741|FG001|Overall Study|condition under investigation worsened|7|||
27784405|NCT00508001|81040742|FG002|Overall Study|condition under investigation worsened|1|||
27784406|NCT00508001|81040740|FG000|Overall Study|Death|0|||
27784407|NCT00508001|81040741|FG001|Overall Study|Death|1|||
27784408|NCT00508001|81040742|FG002|Overall Study|Death|1|||
27784409|NCT00508001|81040740|FG000|Overall Study|Withdrawal by Subject|4|||
27784410|NCT00508001|81040741|FG001|Overall Study|Withdrawal by Subject|4|||
27784411|NCT00508001|81040742|FG002|Overall Study|Withdrawal by Subject|1|||
27784412|NCT01397409|81040751|FG000|Stage 2|Adverse Event|0|||
27784413|NCT01397409|81040752|FG001|Stage 2|Adverse Event|0|||
27784414|NCT01397409|81040753|FG002|Stage 2|Adverse Event|0|||
27784415|NCT01397409|81040754|FG003|Stage 2|Adverse Event|0|||
27784416|NCT01397409|81040755|FG004|Stage 2|Adverse Event|6|||
27784417|NCT01397409|81040756|FG005|Stage 2|Adverse Event|3|||
27784418|NCT01397409|81040757|FG006|Stage 2|Adverse Event|0|||
27784419|NCT01397409|81040758|FG007|Stage 2|Adverse Event|0|||
27572417|NCT05091307|80279128|FG002|Overall Study|Death|1|||
27572418|NCT05091307|80279129|FG003|Overall Study|Death|0|||
27784420|NCT01397409|81040759|FG008|Stage 2|Adverse Event|0|||
27784421|NCT01397409|81040760|FG009|Stage 2|Adverse Event|0|||
27784422|NCT01397409|81040751|FG000|Stage 2|Personal Reasons|0|||
27784423|NCT01397409|81040752|FG001|Stage 2|Personal Reasons|0|||
27784424|NCT01397409|81040753|FG002|Stage 2|Personal Reasons|0|||
27784425|NCT01397409|81040754|FG003|Stage 2|Personal Reasons|0|||
27784426|NCT01397409|81040755|FG004|Stage 2|Personal Reasons|1|||
27784427|NCT01397409|81040756|FG005|Stage 2|Personal Reasons|0|||
27784428|NCT01397409|81040757|FG006|Stage 2|Personal Reasons|0|||
27784429|NCT01397409|81040758|FG007|Stage 2|Personal Reasons|0|||
27784430|NCT01397409|81040759|FG008|Stage 2|Personal Reasons|0|||
27784431|NCT01397409|81040760|FG009|Stage 2|Personal Reasons|0|||
27784432|NCT01397409|81040751|FG000|Stage 2|Other Miscellaneous Reasons|0|||
27784433|NCT01397409|81040752|FG001|Stage 2|Other Miscellaneous Reasons|0|||
27866066|NCT00996892|81342013|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
27866067|NCT00996892|81342014|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
27866068|NCT00996892|81341995|FG000|Expansion Stage 2A|Disease Progression|0|||
27866069|NCT00996892|81341996|FG001|Expansion Stage 2A|Disease Progression|0|||
27866070|NCT00996892|81341997|FG002|Expansion Stage 2A|Disease Progression|0|||
27866071|NCT00996892|81341998|FG003|Expansion Stage 2A|Disease Progression|0|||
27866072|NCT00996892|81341999|FG004|Expansion Stage 2A|Disease Progression|0|||
27866073|NCT00996892|81342000|FG005|Expansion Stage 2A|Disease Progression|0|||
27866074|NCT00996892|81342001|FG006|Expansion Stage 2A|Disease Progression|0|||
27866075|NCT00996892|81342002|FG007|Expansion Stage 2A|Disease Progression|0|||
27866076|NCT00996892|81342003|FG008|Expansion Stage 2A|Disease Progression|0|||
27866077|NCT00996892|81342004|FG009|Expansion Stage 2A|Disease Progression|0|||
27866078|NCT00996892|81342005|FG010|Expansion Stage 2A|Disease Progression|0|||
27866079|NCT00996892|81342006|FG011|Expansion Stage 2A|Disease Progression|0|||
27866080|NCT00996892|81342007|FG012|Expansion Stage 2A|Disease Progression|0|||
27866081|NCT00996892|81342008|FG013|Expansion Stage 2A|Disease Progression|0|||
27866082|NCT00996892|81342009|FG014|Expansion Stage 2A|Disease Progression|0|||
27866083|NCT00996892|81342010|FG015|Expansion Stage 2A|Disease Progression|0|||
27866084|NCT00996892|81342011|FG016|Expansion Stage 2A|Disease Progression|0|||
27866085|NCT00996892|81342012|FG017|Expansion Stage 2A|Disease Progression|0|||
27866086|NCT00996892|81342013|FG018|Expansion Stage 2A|Disease Progression|0|||
27784434|NCT01397409|81040753|FG002|Stage 2|Other Miscellaneous Reasons|0|||
27784435|NCT01397409|81040754|FG003|Stage 2|Other Miscellaneous Reasons|0|||
27784436|NCT01397409|81040755|FG004|Stage 2|Other Miscellaneous Reasons|1|||
27784437|NCT01397409|81040756|FG005|Stage 2|Other Miscellaneous Reasons|1|||
27784438|NCT01397409|81040757|FG006|Stage 2|Other Miscellaneous Reasons|0|||
27784439|NCT01397409|81040758|FG007|Stage 2|Other Miscellaneous Reasons|0|||
27784440|NCT01397409|81040759|FG008|Stage 2|Other Miscellaneous Reasons|0|||
27784441|NCT01397409|81040760|FG009|Stage 2|Other Miscellaneous Reasons|0|||
27784442|NCT01397409|81040751|FG000|Stage 3|Adverse Event|0|||
27784443|NCT01397409|81040752|FG001|Stage 3|Adverse Event|0|||
27784444|NCT01397409|81040753|FG002|Stage 3|Adverse Event|0|||
27784445|NCT01397409|81040754|FG003|Stage 3|Adverse Event|0|||
27784446|NCT01397409|81040755|FG004|Stage 3|Adverse Event|0|||
27784447|NCT01397409|81040756|FG005|Stage 3|Adverse Event|0|||
27784448|NCT01397409|81040757|FG006|Stage 3|Adverse Event|0|||
27866087|NCT00996892|81342014|FG019|Expansion Stage 2A|Disease Progression|31|||
27866088|NCT03548337|81342015|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
27866089|NCT03548337|81342016|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
27866090|NCT03548337|81342015|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
27866091|NCT03548337|81342016|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
27866092|NCT03548337|81342015|FG000|Infant Series|Lost to Follow-up|2|||
27866093|NCT03548337|81342016|FG001|Infant Series|Lost to Follow-up|1|||
27866094|NCT03548337|81342015|FG000|Infant Series|Adverse Event|0|||
27866095|NCT03548337|81342016|FG001|Infant Series|Adverse Event|2|||
27866096|NCT03548337|81342015|FG000|Infant Series|Randomized but Not Vaccinated|1|||
27866097|NCT03548337|81342016|FG001|Infant Series|Randomized but Not Vaccinated|0|||
27866098|NCT03548337|81342015|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
27866099|NCT03548337|81342016|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
27866100|NCT02439970|81342024|FG000|Overall Study|Study Terminated|2|||
27866101|NCT02439970|81342025|FG001|Overall Study|Study Terminated|3|||
27866102|NCT03510598|81342028|FG000|Overall Study|Withdrawal by Subject|1|||
27784449|NCT01397409|81040758|FG007|Stage 3|Adverse Event|1|||
27784450|NCT01397409|81040759|FG008|Stage 3|Adverse Event|0|||
27866103|NCT02729909|81342029|FG000|Overall Study|Lost to Follow-up|0|||
27866104|NCT02729909|81342030|FG001|Overall Study|Lost to Follow-up|1|||
27866105|NCT02729909|81342029|FG000|Overall Study|Lack of Efficacy|0|||
27866106|NCT02729909|81342030|FG001|Overall Study|Lack of Efficacy|2|||
27866107|NCT02729909|81342029|FG000|Overall Study|Significant Protocol Deviation|0|||
27866108|NCT02729909|81342030|FG001|Overall Study|Significant Protocol Deviation|2|||
27866109|NCT02729909|81342029|FG000|Overall Study|Voluntary Withdrawal|1|||
27866110|NCT02729909|81342030|FG001|Overall Study|Voluntary Withdrawal|0|||
27866111|NCT01473407|81342032|FG000|Overall Study|Physician Decision|1|||
27866112|NCT01473407|81342033|FG001|Overall Study|Physician Decision|4|||
27866113|NCT01473407|81342032|FG000|Overall Study|Lost to Follow-up|10|||
27866114|NCT01473407|81342033|FG001|Overall Study|Lost to Follow-up|4|||
27866115|NCT01473407|81342032|FG000|Overall Study|Adverse Event|8|||
27866116|NCT01473407|81342033|FG001|Overall Study|Adverse Event|8|||
27784451|NCT01397409|81040760|FG009|Stage 3|Adverse Event|0|||
27784452|NCT01397409|81040751|FG000|Stage 3|Other Miscellaneous Reasons|0|||
27784453|NCT01397409|81040752|FG001|Stage 3|Other Miscellaneous Reasons|0|||
27784454|NCT01397409|81040753|FG002|Stage 3|Other Miscellaneous Reasons|0|||
27784455|NCT01397409|81040754|FG003|Stage 3|Other Miscellaneous Reasons|0|||
27784456|NCT01397409|81040755|FG004|Stage 3|Other Miscellaneous Reasons|0|||
27784457|NCT01397409|81040756|FG005|Stage 3|Other Miscellaneous Reasons|0|||
27784458|NCT01397409|81040757|FG006|Stage 3|Other Miscellaneous Reasons|0|||
27784459|NCT01397409|81040758|FG007|Stage 3|Other Miscellaneous Reasons|1|||
27784460|NCT01397409|81040759|FG008|Stage 3|Other Miscellaneous Reasons|0|||
27784461|NCT01397409|81040760|FG009|Stage 3|Other Miscellaneous Reasons|0|||
27784462|NCT02055976|81040773|FG000|Overall Study|Other|0|||
27784463|NCT02055976|81040774|FG001|Overall Study|Other|0|||
27784464|NCT02055976|81040775|FG002|Overall Study|Other|1|||
27784465|NCT02055976|81040776|FG003|Overall Study|Other|0|||
27784466|NCT02055976|81040777|FG004|Overall Study|Other|0|||
27784467|NCT02055976|81040778|FG005|Overall Study|Other|0|||
27784468|NCT02055976|81040779|FG006|Overall Study|Other|0|||
27784469|NCT02055976|81040780|FG007|Overall Study|Other|0|||
27784470|NCT02055976|81040781|FG008|Overall Study|Other|0|||
27784471|NCT02055976|81040773|FG000|Overall Study|Adverse Event|0|||
27784472|NCT02055976|81040774|FG001|Overall Study|Adverse Event|0|||
27784473|NCT02055976|81040775|FG002|Overall Study|Adverse Event|0|||
27784474|NCT02055976|81040776|FG003|Overall Study|Adverse Event|0|||
27784475|NCT02055976|81040777|FG004|Overall Study|Adverse Event|0|||
27784476|NCT02055976|81040778|FG005|Overall Study|Adverse Event|1|||
27784477|NCT02055976|81040779|FG006|Overall Study|Adverse Event|1|||
27784478|NCT02055976|81040780|FG007|Overall Study|Adverse Event|0|||
27784479|NCT02055976|81040781|FG008|Overall Study|Adverse Event|0|||
27784480|NCT02055976|81040773|FG000|Overall Study|Does not meet entrance criteria|0|||
27784481|NCT02055976|81040774|FG001|Overall Study|Does not meet entrance criteria|0|||
27784482|NCT02055976|81040775|FG002|Overall Study|Does not meet entrance criteria|0|||
27784483|NCT02055976|81040776|FG003|Overall Study|Does not meet entrance criteria|0|||
27784484|NCT02055976|81040777|FG004|Overall Study|Does not meet entrance criteria|0|||
27784485|NCT02055976|81040778|FG005|Overall Study|Does not meet entrance criteria|0|||
27784486|NCT02055976|81040779|FG006|Overall Study|Does not meet entrance criteria|1|||
27784487|NCT02055976|81040780|FG007|Overall Study|Does not meet entrance criteria|0|||
27784488|NCT02055976|81040781|FG008|Overall Study|Does not meet entrance criteria|0|||
27784489|NCT02055976|81040773|FG000|Overall Study|Lost to Follow-up|0|||
27784490|NCT02055976|81040774|FG001|Overall Study|Lost to Follow-up|0|||
27784491|NCT02055976|81040775|FG002|Overall Study|Lost to Follow-up|0|||
27784492|NCT02055976|81040776|FG003|Overall Study|Lost to Follow-up|1|||
27784493|NCT02055976|81040777|FG004|Overall Study|Lost to Follow-up|0|||
27784494|NCT02055976|81040778|FG005|Overall Study|Lost to Follow-up|0|||
27784495|NCT02055976|81040779|FG006|Overall Study|Lost to Follow-up|0|||
27784496|NCT02055976|81040780|FG007|Overall Study|Lost to Follow-up|0|||
27784497|NCT02055976|81040781|FG008|Overall Study|Lost to Follow-up|0|||
27784498|NCT03145207|81040788|FG000|Overall Study|volunteer started taking allergy shots|1|||
27784499|NCT03145207|81040788|FG000|Overall Study|baseline blood pressure high|1|||
27784500|NCT02911285|81040789|FG000|Overall Study|Lost to Follow-up|8|||
27784501|NCT02911285|81040790|FG001|Overall Study|Lost to Follow-up|5|||
27784502|NCT02911285|81040789|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
27784503|NCT02911285|81040790|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
27866117|NCT01473407|81342032|FG000|Overall Study|Randomization Error|3|||
27784504|NCT01681004|81040795|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
27784505|NCT01681004|81040796|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
27784506|NCT01681004|81040795|FG000|Study Completion|Lost to Follow-up|8|||
27784507|NCT01681004|81040796|FG001|Study Completion|Lost to Follow-up|3|||
27784508|NCT01681004|81040795|FG000|Study Completion|Physician Decision|1|||
27784509|NCT01681004|81040796|FG001|Study Completion|Physician Decision|3|||
27784510|NCT01681004|81040795|FG000|Study Completion|Site Termination|2|||
27784511|NCT01681004|81040796|FG001|Study Completion|Site Termination|1|||
27784512|NCT01681004|81040795|FG000|Study Completion|Death|1|||
27784513|NCT01681004|81040796|FG001|Study Completion|Death|1|||
27784514|NCT00157157|81040803|FG000|Overall Study|Withdrawal by Subject|6|||
27784515|NCT00157157|81040803|FG000|Overall Study|Physician Decision|1|||
27866118|NCT01473407|81342033|FG001|Overall Study|Randomization Error|1|||
27866119|NCT01473407|81342032|FG000|Overall Study|Withdrawal by Subject|4|||
27784516|NCT00157157|81040803|FG000|Overall Study|Lost to Follow-up|1|||
27784517|NCT00157157|81040803|FG000|Overall Study|Enrolled in another study|1|||
27784518|NCT00157157|81040803|FG000|Overall Study|Met exclusion criteria|1|||
27784519|NCT00157157|81040803|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
27784520|NCT03650387|81040806|FG000|Overall Study|Withdrawal by Subject|13|||
27866120|NCT01473407|81342033|FG001|Overall Study|Withdrawal by Subject|7|||
27866121|NCT01473407|81342032|FG000|Overall Study|Kidney Transplant|7|||
27784521|NCT03650387|81040806|FG000|Overall Study|Lost to Follow-up|12|||
27784522|NCT03650387|81040806|FG000|Overall Study|Adverse Event (Not related)|1|||
27784523|NCT03650387|81040806|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
27784524|NCT00795717|81040811|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
27784525|NCT00795717|81040812|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
27572419|NCT05091307|80279126|FG000|Overall Study|Lost to Follow-up|33|||
27572420|NCT05091307|80279127|FG001|Overall Study|Lost to Follow-up|33|||
27572421|NCT05091307|80279128|FG002|Overall Study|Lost to Follow-up|2|||
27784526|NCT00795717|81040811|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
27784527|NCT00795717|81040812|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
27784528|NCT00795717|81040811|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
27784529|NCT00795717|81040812|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
27784530|NCT00795717|81040811|FG000|Phase II|too busy|0|||
27784531|NCT00795717|81040812|FG001|Phase II|too busy|1|||
27784532|NCT00265109|81040813|FG000|Overall Study|Withdrawal by Subject|5|||
27784533|NCT00265109|81040813|FG000|Overall Study|Adverse Event|1|||
27784534|NCT01654224|81040815|FG000|Overall Study|Lost to Follow-up|2|||
27784535|NCT01654224|81040816|FG001|Overall Study|Lost to Follow-up|2|||
27784536|NCT01654224|81040815|FG000|Overall Study|Did not receive allocation|1|||
27784537|NCT01654224|81040816|FG001|Overall Study|Did not receive allocation|8|||
27784538|NCT01654224|81040815|FG000|Overall Study|Insufficient blood sample|3|||
27784539|NCT01654224|81040816|FG001|Overall Study|Insufficient blood sample|2|||
27784540|NCT01298661|81040824|FG000|Overall Study|Withdrawal by Subject|2|||
27866122|NCT01473407|81342033|FG001|Overall Study|Kidney Transplant|6|||
27866123|NCT01473407|81342032|FG000|Overall Study|Vacation/Travel|1|||
27866124|NCT01473407|81342033|FG001|Overall Study|Vacation/Travel|1|||
27866125|NCT01473407|81342032|FG000|Overall Study|Elevated Hemoglobin|1|||
27866126|NCT01473407|81342033|FG001|Overall Study|Elevated Hemoglobin|0|||
27866127|NCT01473407|81342032|FG000|Overall Study|Patient Received Aranesp|1|||
27866128|NCT01473407|81342033|FG001|Overall Study|Patient Received Aranesp|0|||
27866129|NCT01473407|81342032|FG000|Overall Study|Patient Lost Green Card Status|1|||
27866130|NCT01473407|81342033|FG001|Overall Study|Patient Lost Green Card Status|0|||
27866131|NCT01473407|81342032|FG000|Overall Study|Temperature Excursion|2|||
27866132|NCT01473407|81342033|FG001|Overall Study|Temperature Excursion|3|||
27866133|NCT01473407|81342032|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
27866134|NCT01473407|81342033|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
27866135|NCT01473407|81342032|FG000|Overall Study|Sponsor's Decision|10|||
27866136|NCT01473407|81342033|FG001|Overall Study|Sponsor's Decision|10|||
27866137|NCT01473407|81342032|FG000|Overall Study|Site Closure|1|||
27866138|NCT01473407|81342033|FG001|Overall Study|Site Closure|0|||
27866139|NCT02871492|81342035|FG000|Overall Study|Lost to Follow-up|6|||
27866140|NCT02871492|81342036|FG001|Overall Study|Lost to Follow-up|3|||
27866141|NCT02871492|81342037|FG002|Overall Study|Lost to Follow-up|5|||
27866142|NCT02871492|81342035|FG000|Overall Study|Withdrawal by Subject|0|||
27866143|NCT02871492|81342036|FG001|Overall Study|Withdrawal by Subject|0|||
27866144|NCT02871492|81342037|FG002|Overall Study|Withdrawal by Subject|1|||
27866145|NCT01885195|81342042|FG000|Overall Study|Adverse Event|29|||
27866146|NCT01885195|81342042|FG000|Overall Study|Death|1|||
27866147|NCT01885195|81342042|FG000|Overall Study|Disease Progression|67|||
27866148|NCT01885195|81342042|FG000|Overall Study|Protocol Deviation|2|||
27866149|NCT01885195|81342042|FG000|Overall Study|Physician Decision|3|||
27866150|NCT01885195|81342042|FG000|Overall Study|Patient/guardian decision|8|||
27866151|NCT02682927|81342045|FG000|Overall Study|Adverse Event|0|||
27572422|NCT05091307|80279129|FG003|Overall Study|Lost to Follow-up|0|||
27572423|NCT05091307|80279126|FG000|Overall Study|Physician Decision|1|||
27572424|NCT05091307|80279127|FG001|Overall Study|Physician Decision|0|||
27572425|NCT05091307|80279128|FG002|Overall Study|Physician Decision|0|||
27784541|NCT01298661|81040825|FG001|Overall Study|Withdrawal by Subject|0|||
27866152|NCT02682927|81342046|FG001|Overall Study|Adverse Event|0|||
27866153|NCT02682927|81342047|FG002|Overall Study|Adverse Event|5|||
27866154|NCT02682927|81342048|FG003|Overall Study|Adverse Event|1|||
27784542|NCT01298661|81040826|FG002|Overall Study|Withdrawal by Subject|2|||
27784543|NCT00495794|81040827|FG000|Overall Study|Pharmacist did not activate patient|522|||
27784544|NCT00495794|81040828|FG001|Overall Study|Pharmacist did not activate patient|0|||
27784545|NCT04557189|81040835|FG000|Overall Study|Adverse Event|0|||
27784546|NCT04557189|81040836|FG001|Overall Study|Adverse Event|1|||
27784547|NCT04557189|81040835|FG000|Overall Study|Lost to Follow-up|1|||
27784548|NCT04557189|81040836|FG001|Overall Study|Lost to Follow-up|1|||
27784549|NCT04557189|81040835|FG000|Overall Study|Withdrawal by Subject|2|||
27784550|NCT04557189|81040836|FG001|Overall Study|Withdrawal by Subject|1|||
27784551|NCT04557189|81040835|FG000|Overall Study|Reason not Specified|3|||
27784552|NCT04557189|81040836|FG001|Overall Study|Reason not Specified|6|||
27866155|NCT02682927|81342049|FG004|Overall Study|Adverse Event|0|||
27866156|NCT02682927|81342050|FG005|Overall Study|Adverse Event|2|||
27866157|NCT02682927|81342045|FG000|Overall Study|Death|0|||
27866158|NCT02682927|81342046|FG001|Overall Study|Death|0|||
27866159|NCT02682927|81342047|FG002|Overall Study|Death|0|||
27866160|NCT02682927|81342048|FG003|Overall Study|Death|1|||
27572426|NCT05091307|80279129|FG003|Overall Study|Physician Decision|0|||
27866161|NCT02682927|81342049|FG004|Overall Study|Death|0|||
27572427|NCT05091307|80279126|FG000|Overall Study|Protocol Violation|1|||
27572428|NCT05091307|80279127|FG001|Overall Study|Protocol Violation|0|||
27572429|NCT05091307|80279128|FG002|Overall Study|Protocol Violation|0|||
27866162|NCT02682927|81342050|FG005|Overall Study|Death|0|||
27866163|NCT02682927|81342045|FG000|Overall Study|Lack of Efficacy|1|||
27866164|NCT02682927|81342046|FG001|Overall Study|Lack of Efficacy|0|||
27866165|NCT02682927|81342047|FG002|Overall Study|Lack of Efficacy|0|||
27784553|NCT03798366|81040837|FG000|Overall Study|Lost to Follow-up|0|||
27784554|NCT03798366|81040838|FG001|Overall Study|Lost to Follow-up|1|||
27784555|NCT00408408|81040839|FG000|Overall Study|No follow up data|2|||
27784556|NCT00408408|81040840|FG001|Overall Study|No follow up data|3|||
27784557|NCT00408408|81040841|FG002|Overall Study|No follow up data|0|||
27784558|NCT00408408|81040842|FG003|Overall Study|No follow up data|7|||
27784559|NCT00408408|81040843|FG004|Overall Study|No follow up data|5|||
27784560|NCT00408408|81040844|FG005|Overall Study|No follow up data|3|||
27784561|NCT00765726|81040845|FG000|Overall Study|Withdrawal by Subject|1|||
27784562|NCT00765726|81040845|FG000|Overall Study|Discontinuation of study by sponsor|8|||
27784563|NCT00877929|81040847|FG000|Overall Study|Adverse Event|11|||
27784564|NCT00877929|81040848|FG001|Overall Study|Adverse Event|20|||
27866166|NCT02682927|81342048|FG003|Overall Study|Lack of Efficacy|1|||
27866167|NCT02682927|81342049|FG004|Overall Study|Lack of Efficacy|0|||
27572430|NCT05091307|80279129|FG003|Overall Study|Protocol Violation|0|||
27572431|NCT05091307|80279126|FG000|Overall Study|Withdrawal by Subject|16|||
27572432|NCT05091307|80279127|FG001|Overall Study|Withdrawal by Subject|16|||
27572433|NCT05091307|80279128|FG002|Overall Study|Withdrawal by Subject|0|||
27572434|NCT05091307|80279129|FG003|Overall Study|Withdrawal by Subject|1|||
27572435|NCT05091307|80279126|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
27572436|NCT05091307|80279127|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
27572437|NCT05091307|80279128|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
27572438|NCT05091307|80279129|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
27572439|NCT05091307|80279126|FG000|Overall Study|Initiated Prohibited Medication|1|||
27572440|NCT05091307|80279127|FG001|Overall Study|Initiated Prohibited Medication|0|||
27784565|NCT00877929|81040847|FG000|Overall Study|Protocol Violation|3|||
27784566|NCT00877929|81040848|FG001|Overall Study|Protocol Violation|3|||
27784567|NCT00877929|81040847|FG000|Overall Study|Lost to Follow-up|0|||
27866168|NCT02682927|81342050|FG005|Overall Study|Lack of Efficacy|0|||
27866169|NCT02682927|81342045|FG000|Overall Study|Other|0|||
27572441|NCT05091307|80279128|FG002|Overall Study|Initiated Prohibited Medication|0|||
27866170|NCT02682927|81342046|FG001|Overall Study|Other|0|||
27572442|NCT05091307|80279129|FG003|Overall Study|Initiated Prohibited Medication|0|||
27572443|NCT05091307|80279126|FG000|Overall Study|Other|4|||
27572444|NCT05091307|80279127|FG001|Overall Study|Other|4|||
27572445|NCT05091307|80279128|FG002|Overall Study|Other|0|||
27572446|NCT05091307|80279129|FG003|Overall Study|Other|0|||
27572447|NCT05091307|80279126|FG000|Overall Study|Randomized but not vaccinated|0|||
27572448|NCT05091307|80279127|FG001|Overall Study|Randomized but not vaccinated|2|||
27973005|NCT00350870|81730222|FG001|Overall Study|Withdrawal by Subject|17|||
27973006|NCT00350870|81730223|FG002|Overall Study|Withdrawal by Subject|15|||
27973007|NCT00350870|81730224|FG003|Overall Study|Withdrawal by Subject|14|||
27973008|NCT00350870|81730221|FG000|Overall Study|Physician Decision|1|||
27973009|NCT00350870|81730222|FG001|Overall Study|Physician Decision|0|||
27973010|NCT00350870|81730223|FG002|Overall Study|Physician Decision|1|||
27973011|NCT00350870|81730224|FG003|Overall Study|Physician Decision|1|||
27572449|NCT05091307|80279128|FG002|Overall Study|Randomized but not vaccinated|0|||
27973012|NCT00541866|81730230|FG000|Overall Study|Adverse Event|3|||
27973013|NCT00541866|81730231|FG001|Overall Study|Adverse Event|0|||
27973014|NCT00541866|81730232|FG002|Overall Study|Adverse Event|0|||
27572450|NCT05091307|80279129|FG003|Overall Study|Randomized but not vaccinated|0|||
27572451|NCT02474199|80279130|FG000|Overall Study|Lost to Follow-up|1|||
27973015|NCT00541866|81730233|FG003|Overall Study|Adverse Event|0|||
27973016|NCT00541866|81730234|FG004|Overall Study|Adverse Event|0|||
27973017|NCT00541866|81730230|FG000|Overall Study|Death|1|||
27973018|NCT00541866|81730231|FG001|Overall Study|Death|0|||
27973019|NCT00541866|81730232|FG002|Overall Study|Death|0|||
27973020|NCT00541866|81730233|FG003|Overall Study|Death|0|||
27973021|NCT00541866|81730234|FG004|Overall Study|Death|0|||
27973022|NCT00541866|81730230|FG000|Overall Study|Lack of Efficacy|19|||
27973023|NCT00541866|81730231|FG001|Overall Study|Lack of Efficacy|15|||
27973024|NCT00541866|81730232|FG002|Overall Study|Lack of Efficacy|10|||
27973025|NCT00541866|81730233|FG003|Overall Study|Lack of Efficacy|12|||
27973026|NCT00541866|81730234|FG004|Overall Study|Lack of Efficacy|14|||
27973027|NCT00541866|81730230|FG000|Overall Study|Not Reported or Other|11|||
27973028|NCT00541866|81730231|FG001|Overall Study|Not Reported or Other|3|||
27973029|NCT00541866|81730232|FG002|Overall Study|Not Reported or Other|3|||
27973030|NCT00541866|81730233|FG003|Overall Study|Not Reported or Other|3|||
27973031|NCT00541866|81730234|FG004|Overall Study|Not Reported or Other|1|||
27572452|NCT02474199|80279131|FG001|Overall Study|Lost to Follow-up|0|||
27973032|NCT00541866|81730230|FG000|Overall Study|Physician Decision|0|||
27572453|NCT02474199|80279132|FG002|Overall Study|Lost to Follow-up|0|||
27572454|NCT02474199|80279133|FG003|Overall Study|Lost to Follow-up|0|||
27572455|NCT02474199|80279130|FG000|Overall Study|Withdrawal by Subject|1|||
27572456|NCT02474199|80279131|FG001|Overall Study|Withdrawal by Subject|2|||
27572457|NCT02474199|80279132|FG002|Overall Study|Withdrawal by Subject|0|||
27572458|NCT02474199|80279133|FG003|Overall Study|Withdrawal by Subject|1|||
27572459|NCT02474199|80279130|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
27670090|NCT01772823|80630989|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
27670091|NCT01772823|80630988|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
27670092|NCT01772823|80630989|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
27670093|NCT01772823|80630988|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
27670094|NCT01772823|80630989|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
27670095|NCT01169636|80630992|FG000|Overall Study|Adverse Event|0|||
27670096|NCT01169636|80630993|FG001|Overall Study|Adverse Event|0|||
27670097|NCT01169636|80630994|FG002|Overall Study|Adverse Event|1|||
27670098|NCT01169636|80630995|FG003|Overall Study|Adverse Event|1|||
27670099|NCT01169636|80630996|FG004|Overall Study|Adverse Event|0|||
27670100|NCT01169636|80630992|FG000|Overall Study|Screen failure|0|||
27670101|NCT01169636|80630993|FG001|Overall Study|Screen failure|0|||
27670102|NCT01169636|80630994|FG002|Overall Study|Screen failure|2|||
27973033|NCT00541866|81730231|FG001|Overall Study|Physician Decision|0|||
27973034|NCT00541866|81730232|FG002|Overall Study|Physician Decision|2|||
27973035|NCT00541866|81730233|FG003|Overall Study|Physician Decision|1|||
27973036|NCT00541866|81730234|FG004|Overall Study|Physician Decision|0|||
27973037|NCT04195438|81730235|FG000|Overall Study|Withdrawal by Subject|1|||
27973038|NCT01865812|81730236|FG000|Primary Treatment Phase|Adverse Event|2|||
27572460|NCT02474199|80279131|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
27670103|NCT01169636|80630995|FG003|Overall Study|Screen failure|0|||
27670104|NCT01169636|80630996|FG004|Overall Study|Screen failure|0|||
27670105|NCT01169636|80630992|FG000|Overall Study|Withdrawal by Subject|0|||
27670106|NCT01169636|80630993|FG001|Overall Study|Withdrawal by Subject|0|||
27670107|NCT01169636|80630994|FG002|Overall Study|Withdrawal by Subject|0|||
27670108|NCT01169636|80630995|FG003|Overall Study|Withdrawal by Subject|0|||
27670109|NCT01169636|80630996|FG004|Overall Study|Withdrawal by Subject|3|||
27670110|NCT01728623|80630997|FG000|Overall Study|Disease progression|26|||
27670111|NCT01728623|80630997|FG000|Overall Study|Adverse Event|1|||
27670112|NCT01728623|80630997|FG000|Overall Study|Withdrawal by Subject|1|||
27670113|NCT02658175|80630998|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
27670114|NCT02658175|80630999|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
27670115|NCT02658175|80631000|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
27572461|NCT02474199|80279132|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
27572462|NCT02474199|80279133|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
27572463|NCT02474199|80279130|FG000|Overall Study|Did not meet eligibility criteria|0|||
27572464|NCT02474199|80279131|FG001|Overall Study|Did not meet eligibility criteria|0|||
27670116|NCT02658175|80630998|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
27670117|NCT02658175|80630999|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
27670118|NCT02658175|80631000|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
27670119|NCT02658175|80630998|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
27670120|NCT02658175|80630999|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
27670121|NCT02658175|80631000|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
27670122|NCT02658175|80630998|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
27670123|NCT02658175|80630999|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
27670124|NCT02658175|80631000|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
27670125|NCT02658175|80630998|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
27670126|NCT02658175|80630999|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
27670127|NCT02658175|80631000|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
27670128|NCT02658175|80630998|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
27572465|NCT02474199|80279132|FG002|Overall Study|Did not meet eligibility criteria|2|||
27572466|NCT02474199|80279133|FG003|Overall Study|Did not meet eligibility criteria|2|||
27572467|NCT00684424|80279136|FG000|Overall Study|Adverse Event|1|||
27572468|NCT00684424|80279136|FG000|Overall Study|Lost to Follow-up|2|||
27572469|NCT00684424|80279136|FG000|Overall Study|Other|2|||
27572470|NCT01140477|80279137|FG000|Overall Study|Lost to Follow-up|4|||
27670129|NCT02658175|80630999|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
27670130|NCT02658175|80631000|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
27670131|NCT02658175|80630998|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
27866171|NCT02682927|81342047|FG002|Overall Study|Other|0|||
27973039|NCT01865812|81730237|FG001|Primary Treatment Phase|Adverse Event|0|||
27973040|NCT01865812|81730236|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
27572471|NCT01140477|80279138|FG001|Overall Study|Lost to Follow-up|0|||
27572472|NCT01140477|80279137|FG000|Overall Study|Withdrawal by Subject|1|||
27572473|NCT01140477|80279138|FG001|Overall Study|Withdrawal by Subject|4|||
27572474|NCT01140477|80279137|FG000|Overall Study|Surgical complication preventing implant|2|||
27572475|NCT01140477|80279138|FG001|Overall Study|Surgical complication preventing implant|0|||
27572476|NCT01140477|80279137|FG000|Overall Study|Death|1|||
27572477|NCT01140477|80279138|FG001|Overall Study|Death|1|||
27572478|NCT01140477|80279137|FG000|Overall Study|Subject explanted|0|||
27572479|NCT01140477|80279138|FG001|Overall Study|Subject explanted|1|||
27572480|NCT01433263|80279139|FG000|Overall Study|Adverse Event|3|||
27572481|NCT01433263|80279140|FG001|Overall Study|Adverse Event|1|||
27572482|NCT01433263|80279139|FG000|Overall Study|Death|5|||
27670132|NCT02658175|80630999|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
27670133|NCT02658175|80631000|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
27670134|NCT02658175|80630998|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
27670135|NCT02658175|80630999|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
27670136|NCT02658175|80631000|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
27670137|NCT02658175|80630998|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
27670138|NCT02658175|80630999|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
27670139|NCT02658175|80631000|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
27670140|NCT02658175|80630998|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
27670141|NCT02658175|80630999|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
27670142|NCT02658175|80631000|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
27670143|NCT01438840|80631001|FG000|Core Study|Adverse Event|0|||
27670144|NCT01438840|80631002|FG001|Core Study|Adverse Event|3|||
27670145|NCT01438840|80631003|FG002|Core Study|Adverse Event|0|||
27670146|NCT01438840|80631001|FG000|Core Study|Lack of Efficacy|15|||
27670147|NCT01438840|80631002|FG001|Core Study|Lack of Efficacy|7|||
27572483|NCT01433263|80279140|FG001|Overall Study|Death|3|||
27572484|NCT01433263|80279139|FG000|Overall Study|Lost to Follow-up|0|||
27572485|NCT01433263|80279140|FG001|Overall Study|Lost to Follow-up|1|||
27572486|NCT01433263|80279139|FG000|Overall Study|Protocol Deviation|1|||
27670148|NCT01438840|80631003|FG002|Core Study|Lack of Efficacy|0|||
27670149|NCT01438840|80631001|FG000|Core Study|Withdrawal of consent|1|||
27670150|NCT01438840|80631002|FG001|Core Study|Withdrawal of consent|0|||
27670151|NCT01438840|80631003|FG002|Core Study|Withdrawal of consent|0|||
27866172|NCT02682927|81342048|FG003|Overall Study|Other|2|||
27866173|NCT02682927|81342049|FG004|Overall Study|Other|0|||
27670152|NCT01438840|80631001|FG000|Extension Phase|Adverse Event|0|||
27670153|NCT01438840|80631002|FG001|Extension Phase|Adverse Event|0|||
27670154|NCT01438840|80631003|FG002|Extension Phase|Adverse Event|3|||
27670155|NCT01438840|80631001|FG000|Extension Phase|Lost to Follow-up|0|||
27670156|NCT01438840|80631002|FG001|Extension Phase|Lost to Follow-up|0|||
27670157|NCT01438840|80631003|FG002|Extension Phase|Lost to Follow-up|1|||
27670158|NCT01438840|80631001|FG000|Extension Phase|Withdrawal by Subject|0|||
27670159|NCT01438840|80631002|FG001|Extension Phase|Withdrawal by Subject|0|||
27670160|NCT01438840|80631003|FG002|Extension Phase|Withdrawal by Subject|3|||
27670161|NCT01438840|80631001|FG000|Extension Phase|Lack of Efficacy|0|||
27670162|NCT01438840|80631002|FG001|Extension Phase|Lack of Efficacy|0|||
27670163|NCT01438840|80631003|FG002|Extension Phase|Lack of Efficacy|2|||
27670164|NCT01438840|80631001|FG000|Extension Phase|Other|0|||
27670165|NCT01438840|80631002|FG001|Extension Phase|Other|0|||
27866174|NCT02682927|81342050|FG005|Overall Study|Other|0|||
27572487|NCT01433263|80279140|FG001|Overall Study|Protocol Deviation|0|||
27572488|NCT01433263|80279139|FG000|Overall Study|Withdrawal by Subject|10|||
27572489|NCT01433263|80279140|FG001|Overall Study|Withdrawal by Subject|7|||
27572490|NCT01723228|80279141|FG000|Overall Study|Adverse Event|2|||
27670166|NCT01438840|80631003|FG002|Extension Phase|Other|1|||
27784568|NCT00877929|81040848|FG001|Overall Study|Lost to Follow-up|1|||
27572491|NCT01723228|80279142|FG001|Overall Study|Adverse Event|6|||
27670167|NCT01263054|80631004|FG000|Overall Study|Death|1|||
27670168|NCT01263054|80631005|FG001|Overall Study|Death|0|||
27670169|NCT01263054|80631004|FG000|Overall Study|Lost to Follow-up|2|||
27670170|NCT01263054|80631005|FG001|Overall Study|Lost to Follow-up|2|||
27670171|NCT01263054|80631004|FG000|Overall Study|Withdrawal by Subject|1|||
27670172|NCT01263054|80631005|FG001|Overall Study|Withdrawal by Subject|3|||
27670173|NCT01263054|80631004|FG000|Overall Study|Qualification Violation|1|||
27670174|NCT01263054|80631005|FG001|Overall Study|Qualification Violation|0|||
27670175|NCT01263054|80631004|FG000|Overall Study|Other|0|||
27670176|NCT01263054|80631005|FG001|Overall Study|Other|1|||
27670177|NCT02575950|80631006|FG000|Overall Study|Withdrawal by Subject|0|||
27670178|NCT02575950|80631007|FG001|Overall Study|Withdrawal by Subject|0|||
27670179|NCT02575950|80631008|FG002|Overall Study|Withdrawal by Subject|0|||
27670180|NCT02575950|80631009|FG003|Overall Study|Withdrawal by Subject|2|||
27670181|NCT02575950|80631006|FG000|Overall Study|Lost to Follow-up|0|||
27670182|NCT02575950|80631007|FG001|Overall Study|Lost to Follow-up|1|||
27670183|NCT02575950|80631008|FG002|Overall Study|Lost to Follow-up|0|||
27670184|NCT02575950|80631009|FG003|Overall Study|Lost to Follow-up|3|||
27670185|NCT00464945|80631010|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
27670186|NCT00464945|80631011|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
27670187|NCT00464945|80631010|FG000|Infant Series|Protocol Violation|1|||
27670188|NCT00464945|80631011|FG001|Infant Series|Protocol Violation|0|||
27670189|NCT00464945|80631010|FG000|Infant Series|Lost to Follow-up|1|||
27670190|NCT00464945|80631011|FG001|Infant Series|Lost to Follow-up|0|||
27670191|NCT00464945|80631010|FG000|After Infant Series|Withdrawal by Subject|0|||
27670192|NCT00464945|80631011|FG001|After Infant Series|Withdrawal by Subject|2|||
27670193|NCT00464945|80631010|FG000|Toddler Dose|Lost to Follow-up|0|||
27670194|NCT00464945|80631011|FG001|Toddler Dose|Lost to Follow-up|1|||
27670195|NCT02447718|80631012|FG000|Overall Study|Lost to Follow-up|8|||
27670196|NCT02447718|80631013|FG001|Overall Study|Lost to Follow-up|0|||
27670197|NCT02447718|80631012|FG000|Overall Study|Withdrawal by Subject|3|||
27670198|NCT02447718|80631013|FG001|Overall Study|Withdrawal by Subject|0|||
27670199|NCT02447718|80631012|FG000|Overall Study|Screen Failure|1|||
27670200|NCT02447718|80631013|FG001|Overall Study|Screen Failure|0|||
27670201|NCT00508274|80631014|FG000|Overall Study|Adverse Event|5|||
27670202|NCT00508274|80631014|FG000|Overall Study|Death|7|||
27670203|NCT00508274|80631014|FG000|Overall Study|Disease progression|32|||
27670204|NCT00508274|80631014|FG000|Overall Study|Withdrawal by Subject|1|||
27670205|NCT00508274|80631014|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
27670206|NCT00508274|80631014|FG000|Overall Study|Missing|3|||
27670207|NCT04156399|80631015|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
27670208|NCT04156399|80631015|FG000|Overall Study|study suspension due to COVID pandemic|3|||
27670209|NCT00966979|80631022|FG000|Overall Study|Death|1|||
27670210|NCT00966979|80631022|FG000|Overall Study|Lost to Follow-up|6|||
27670211|NCT00966979|80631022|FG000|Overall Study|Withdrawal by Subject|14|||
27670212|NCT00966979|80631022|FG000|Overall Study|Adverse Event|5|||
27670213|NCT00966979|80631022|FG000|Overall Study|Sponsor terminated early|49|||
27670214|NCT00966979|80631022|FG000|Overall Study|Censored because surgery not done|2|||
27670215|NCT00966979|80631022|FG000|Overall Study|Censored because study device was not implanted|14|||
27670216|NCT00966979|80631022|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
27670217|NCT00952848|80631024|FG000|Overall Study|Withdrawal by Subject|4|||
27784569|NCT00877929|81040847|FG000|Overall Study|Withdrawal by Subject|4|||
27784570|NCT00877929|81040848|FG001|Overall Study|Withdrawal by Subject|4|||
27784571|NCT00877929|81040847|FG000|Overall Study|Lack of Efficacy|0|||
27784572|NCT00877929|81040848|FG001|Overall Study|Lack of Efficacy|1|||
27784573|NCT00877929|81040847|FG000|Overall Study|Other reason (not specified)|2|||
27866175|NCT02682927|81342045|FG000|Overall Study|Withdrawal by Subject|2|||
27670218|NCT03418493|80631027|FG000|Overall Study|Adverse Event|1|||
27670219|NCT03418493|80631028|FG001|Overall Study|Adverse Event|0|||
27670220|NCT03418493|80631029|FG002|Overall Study|Adverse Event|0|||
27670221|NCT03418493|80631030|FG003|Overall Study|Adverse Event|0|||
27670222|NCT03418493|80631031|FG004|Overall Study|Adverse Event|0|||
27670223|NCT03418493|80631032|FG005|Overall Study|Adverse Event|0|||
27670224|NCT03418493|80631033|FG006|Overall Study|Adverse Event|0|||
27670225|NCT03418493|80631034|FG007|Overall Study|Adverse Event|0|||
27670226|NCT03418493|80631035|FG008|Overall Study|Adverse Event|0|||
27670227|NCT03418493|80631036|FG009|Overall Study|Adverse Event|0|||
27784574|NCT00877929|81040848|FG001|Overall Study|Other reason (not specified)|6|||
27784575|NCT01482598|81040849|FG000|Overall Study|Death|7|||
27784576|NCT01482598|81040850|FG001|Overall Study|Death|10|||
27670228|NCT03418493|80631037|FG010|Overall Study|Adverse Event|0|||
27670229|NCT03418493|80631027|FG000|Overall Study|Protocol Violation|0|||
27670230|NCT03418493|80631028|FG001|Overall Study|Protocol Violation|0|||
27670231|NCT03418493|80631029|FG002|Overall Study|Protocol Violation|0|||
27670232|NCT03418493|80631030|FG003|Overall Study|Protocol Violation|0|||
27670233|NCT03418493|80631031|FG004|Overall Study|Protocol Violation|0|||
27670234|NCT03418493|80631032|FG005|Overall Study|Protocol Violation|0|||
27670235|NCT03418493|80631033|FG006|Overall Study|Protocol Violation|0|||
27670236|NCT03418493|80631034|FG007|Overall Study|Protocol Violation|0|||
27670237|NCT03418493|80631035|FG008|Overall Study|Protocol Violation|0|||
27670238|NCT03418493|80631036|FG009|Overall Study|Protocol Violation|1|||
27670239|NCT03418493|80631037|FG010|Overall Study|Protocol Violation|0|||
27670240|NCT01006616|80631043|FG000|Period 1 (6 Months)|Adverse Event|10|||
27670241|NCT01006616|80631044|FG001|Period 1 (6 Months)|Adverse Event|31|||
27670242|NCT01006616|80631045|FG002|Period 1 (6 Months)|Adverse Event|37|||
27670243|NCT01006616|80631046|FG003|Period 1 (6 Months)|Adverse Event|9|||
27670244|NCT01006616|80631043|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
27670245|NCT01006616|80631044|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
27670246|NCT01006616|80631045|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
27670247|NCT01006616|80631046|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
27670248|NCT01006616|80631043|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
27670249|NCT01006616|80631044|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
27670250|NCT01006616|80631045|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
27670251|NCT01006616|80631046|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
27670252|NCT01006616|80631043|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
27670253|NCT01006616|80631044|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
27670254|NCT01006616|80631045|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
27670255|NCT01006616|80631046|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
27670256|NCT01006616|80631043|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
27670257|NCT01006616|80631044|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
27670258|NCT01006616|80631045|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
27670259|NCT01006616|80631046|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
27670260|NCT01006616|80631043|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
27670261|NCT01006616|80631044|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
27670262|NCT01006616|80631045|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
27670263|NCT01006616|80631046|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
27670264|NCT01006616|80631043|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
27670265|NCT01006616|80631044|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
27670266|NCT01006616|80631045|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
27670267|NCT01006616|80631046|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
27670268|NCT01006616|80631043|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
27670269|NCT01006616|80631044|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
27670270|NCT01006616|80631045|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
27670271|NCT01006616|80631046|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
27670272|NCT01006616|80631043|FG000|Period 1 (6 Months)|Not Treated|0|||
27670273|NCT01006616|80631044|FG001|Period 1 (6 Months)|Not Treated|0|||
27670274|NCT01006616|80631045|FG002|Period 1 (6 Months)|Not Treated|1|||
27670275|NCT01006616|80631046|FG003|Period 1 (6 Months)|Not Treated|1|||
27670276|NCT01006616|80631043|FG000|Period 2 (18 Months)|Adverse Event|6|||
27670277|NCT01006616|80631044|FG001|Period 2 (18 Months)|Adverse Event|6|||
27670278|NCT01006616|80631045|FG002|Period 2 (18 Months)|Adverse Event|6|||
27670279|NCT01006616|80631046|FG003|Period 2 (18 Months)|Adverse Event|4|||
27670280|NCT01006616|80631043|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
27670281|NCT01006616|80631044|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
27670282|NCT01006616|80631045|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
27670283|NCT01006616|80631046|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
27670284|NCT01006616|80631043|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
27670285|NCT01006616|80631044|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
27670286|NCT01006616|80631045|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
27784577|NCT01482598|81040849|FG000|Overall Study|Physician Decision|0|||
27670287|NCT01006616|80631046|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
27670288|NCT01006616|80631043|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
27670289|NCT01006616|80631044|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
27670290|NCT01006616|80631045|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
27670291|NCT01006616|80631046|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
27670292|NCT01006616|80631043|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
27784578|NCT01482598|81040850|FG001|Overall Study|Physician Decision|3|||
27670293|NCT01006616|80631044|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
27670294|NCT01006616|80631045|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
27784579|NCT01482598|81040849|FG000|Overall Study|Withdrawal by Subject|4|||
27784580|NCT01482598|81040850|FG001|Overall Study|Withdrawal by Subject|5|||
27784581|NCT01482598|81040849|FG000|Overall Study|Lost to Follow-up|5|||
27784582|NCT01482598|81040850|FG001|Overall Study|Lost to Follow-up|4|||
27670295|NCT01006616|80631046|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
27784583|NCT02146352|81040851|FG000|Overall Study|Death|1|||
27572492|NCT01723228|80279141|FG000|Overall Study|Withdrawal by Subject|2|||
27572493|NCT01723228|80279142|FG001|Overall Study|Withdrawal by Subject|1|||
27572494|NCT01723228|80279141|FG000|Overall Study|Protocol Violation|0|||
27784584|NCT02146352|81040851|FG000|Overall Study|Patient entered hospice care|1|||
27784585|NCT02785588|81040855|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
27784586|NCT02785588|81040855|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
27784587|NCT02145429|81040856|FG000|Overall Study|Death|4|||
27784588|NCT02145429|81040857|FG001|Overall Study|Death|5|||
27784589|NCT02145429|81040856|FG000|Overall Study|Lost to Follow-up|4|||
27784590|NCT02145429|81040857|FG001|Overall Study|Lost to Follow-up|3|||
27784591|NCT02145429|81040856|FG000|Overall Study|Withdrawal by Subject|8|||
27784592|NCT02145429|81040857|FG001|Overall Study|Withdrawal by Subject|3|||
27866176|NCT02682927|81342046|FG001|Overall Study|Withdrawal by Subject|0|||
27866177|NCT02682927|81342047|FG002|Overall Study|Withdrawal by Subject|1|||
27866178|NCT02682927|81342048|FG003|Overall Study|Withdrawal by Subject|0|||
27866179|NCT02682927|81342049|FG004|Overall Study|Withdrawal by Subject|1|||
27866180|NCT02682927|81342050|FG005|Overall Study|Withdrawal by Subject|1|||
27670296|NCT01006616|80631043|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
27670297|NCT01006616|80631044|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
27670298|NCT01006616|80631045|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
27670299|NCT01006616|80631046|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
27670300|NCT01006616|80631043|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
27866181|NCT03278626|81342065|FG000|Overall Study|Death|2|||
27866182|NCT03278626|81342065|FG000|Overall Study|Toxicity|1|||
27866183|NCT03278626|81342065|FG000|Overall Study|Disease Progression|2|||
27866184|NCT01645787|81342069|FG000|Washout (2 Weeks)|Adverse Event|1|||
27866185|NCT01645787|81342070|FG001|Washout (2 Weeks)|Adverse Event|0|||
27866186|NCT03336528|81342074|FG000|Overall Study|Protocol Violation|1|||
27866187|NCT03336528|81342075|FG001|Overall Study|Protocol Violation|1|||
27866188|NCT03336528|81342074|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
27866189|NCT03336528|81342075|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
27866190|NCT03336528|81342074|FG000|Overall Study|Did not receive study medication|1|||
27866191|NCT03336528|81342075|FG001|Overall Study|Did not receive study medication|2|||
27866192|NCT05022212|81342086|FG000|Overall Study|Lost to Follow-up|0|||
27866193|NCT05022212|81342087|FG001|Overall Study|Lost to Follow-up|2|||
27866194|NCT01098487|81342088|FG000|Overall Study|Adverse Event|22|||
27866195|NCT01098487|81342088|FG000|Overall Study|Lack of Efficacy|11|||
27866196|NCT01098487|81342088|FG000|Overall Study|Withdrawal by Subject|7|||
27866197|NCT01098487|81342088|FG000|Overall Study|Lost to Follow-up|3|||
27866198|NCT01098487|81342088|FG000|Overall Study|Physician Decision|1|||
27866199|NCT00339144|81342089|FG000|Overall Study|Disease progression|5|||
27866200|NCT00339144|81342090|FG001|Overall Study|Disease progression|2|||
27866201|NCT00339144|81342091|FG002|Overall Study|Disease progression|2|||
27866202|NCT00339144|81342089|FG000|Overall Study|Study drug toxicity|3|||
27866203|NCT00339144|81342090|FG001|Overall Study|Study drug toxicity|1|||
27866204|NCT00339144|81342091|FG002|Overall Study|Study drug toxicity|1|||
27866205|NCT00339144|81342089|FG000|Overall Study|Participant's request to discontinuation|1|||
27866206|NCT00339144|81342090|FG001|Overall Study|Participant's request to discontinuation|0|||
27866207|NCT00339144|81342091|FG002|Overall Study|Participant's request to discontinuation|1|||
27866208|NCT02203331|81342092|FG000|Overall Study|Pregnancy|1|||
27866209|NCT02203331|81342093|FG001|Overall Study|Pregnancy|0|||
27866210|NCT02203331|81342094|FG002|Overall Study|Pregnancy|0|||
27866211|NCT02203331|81342095|FG003|Overall Study|Pregnancy|0|||
27670301|NCT01006616|80631044|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
27670302|NCT01006616|80631045|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
27670303|NCT01006616|80631046|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
27670304|NCT01006616|80631043|FG000|Period 2 (18 Months)|Study Terminated|63|||
27670305|NCT01006616|80631044|FG001|Period 2 (18 Months)|Study Terminated|46|||
27670306|NCT01006616|80631045|FG002|Period 2 (18 Months)|Study Terminated|44|||
27670307|NCT01006616|80631046|FG003|Period 2 (18 Months)|Study Terminated|70|||
27784593|NCT00489216|81040859|FG000|Overall Study|Adverse Event|1|||
27784594|NCT01453439|81040862|FG000|Treatment Phase|Withdrawal by Subject|13|||
27866212|NCT02203331|81342096|FG004|Overall Study|Pregnancy|2|||
27866213|NCT02203331|81342097|FG005|Overall Study|Pregnancy|0|||
27866214|NCT02203331|81342092|FG000|Overall Study|Withdrawal by Subject|1|||
27866215|NCT02203331|81342093|FG001|Overall Study|Withdrawal by Subject|0|||
27866216|NCT02203331|81342094|FG002|Overall Study|Withdrawal by Subject|1|||
27866217|NCT02203331|81342095|FG003|Overall Study|Withdrawal by Subject|0|||
27784595|NCT01453439|81040863|FG001|Treatment Phase|Withdrawal by Subject|10|||
27784596|NCT01453439|81040862|FG000|Treatment Phase|Suicidal Ideation|2|||
27784597|NCT01453439|81040863|FG001|Treatment Phase|Suicidal Ideation|0|||
27784598|NCT01453439|81040862|FG000|Treatment Phase|Need for higher level of care|1|||
27784599|NCT01453439|81040863|FG001|Treatment Phase|Need for higher level of care|1|||
27784600|NCT01453439|81040862|FG000|Treatment Phase|Therapist conflict of interest|1|||
27784601|NCT01453439|81040863|FG001|Treatment Phase|Therapist conflict of interest|0|||
27784602|NCT01453439|81040862|FG000|Follow-up|Withdrawal by Subject|0|||
27784603|NCT01453439|81040863|FG001|Follow-up|Withdrawal by Subject|1|||
27784604|NCT01453439|81040862|FG000|Follow-up|Lost to Follow-up|5|||
27784605|NCT01453439|81040863|FG001|Follow-up|Lost to Follow-up|10|||
27784606|NCT00211536|81040864|FG000|Overall Study|Withdrawal by Subject|2|||
27784607|NCT00211536|81040865|FG001|Overall Study|Withdrawal by Subject|2|||
27784608|NCT00211536|81040864|FG000|Overall Study|Physician Decision|0|||
27784609|NCT00211536|81040865|FG001|Overall Study|Physician Decision|5|||
27784610|NCT00211536|81040864|FG000|Overall Study|Adverse Event|2|||
27784611|NCT00211536|81040865|FG001|Overall Study|Adverse Event|0|||
27784612|NCT02545504|81040866|FG000|Overall Study|Death|174|||
27784613|NCT02545504|81040867|FG001|Overall Study|Death|168|||
27784614|NCT02545504|81040866|FG000|Overall Study|Unknown reason|30|||
27784615|NCT02545504|81040867|FG001|Overall Study|Unknown reason|32|||
27784616|NCT02545504|81040866|FG000|Overall Study|Withdrew consent|9|||
27784617|NCT02545504|81040867|FG001|Overall Study|Withdrew consent|11|||
27784618|NCT02545504|81040866|FG000|Overall Study|Investigator's discretion|3|||
27784619|NCT02545504|81040867|FG001|Overall Study|Investigator's discretion|1|||
27784620|NCT02545504|81040866|FG000|Overall Study|Lost to Follow-up|2|||
27784621|NCT02545504|81040867|FG001|Overall Study|Lost to Follow-up|2|||
27784622|NCT01004159|81040869|FG000|Overall Study|Adverse Event|2|||
27784623|NCT01004159|81040869|FG000|Overall Study|Disease Progression|18|||
27572495|NCT01723228|80279142|FG001|Overall Study|Protocol Violation|2|||
27572496|NCT01723228|80279141|FG000|Overall Study|Lost to Follow-up|2|||
27572497|NCT01723228|80279142|FG001|Overall Study|Lost to Follow-up|1|||
27572498|NCT01723228|80279141|FG000|Overall Study|Other|2|||
27572499|NCT01723228|80279142|FG001|Overall Study|Other|1|||
27784624|NCT02452034|81040870|FG000|Overall Study|Adverse Event|0|||
27784625|NCT02452034|81040871|FG001|Overall Study|Adverse Event|0|||
27784626|NCT02452034|81040872|FG002|Overall Study|Adverse Event|0|||
27784627|NCT02452034|81040873|FG003|Overall Study|Adverse Event|0|||
27784628|NCT02452034|81040874|FG004|Overall Study|Adverse Event|0|||
27784629|NCT02452034|81040875|FG005|Overall Study|Adverse Event|1|||
27784630|NCT02452034|81040870|FG000|Overall Study|Death|0|||
27784631|NCT02452034|81040871|FG001|Overall Study|Death|0|||
27784632|NCT02452034|81040872|FG002|Overall Study|Death|0|||
27784633|NCT02452034|81040873|FG003|Overall Study|Death|0|||
27784634|NCT02452034|81040874|FG004|Overall Study|Death|1|||
27784635|NCT02452034|81040875|FG005|Overall Study|Death|1|||
27784636|NCT02452034|81040870|FG000|Overall Study|Physician Decision|0|||
27784637|NCT02452034|81040871|FG001|Overall Study|Physician Decision|1|||
27572500|NCT01207778|80279145|FG000|Overall Study|Lost to Follow-up|0|||
27572501|NCT01207778|80279146|FG001|Overall Study|Lost to Follow-up|3|||
27784638|NCT02452034|81040872|FG002|Overall Study|Physician Decision|1|||
27784639|NCT02452034|81040873|FG003|Overall Study|Physician Decision|0|||
27784640|NCT02452034|81040874|FG004|Overall Study|Physician Decision|0|||
27784641|NCT02452034|81040875|FG005|Overall Study|Physician Decision|0|||
27784642|NCT02452034|81040870|FG000|Overall Study|Protocol Violation|0|||
27784643|NCT02452034|81040871|FG001|Overall Study|Protocol Violation|0|||
27784644|NCT02452034|81040872|FG002|Overall Study|Protocol Violation|0|||
27784645|NCT02452034|81040873|FG003|Overall Study|Protocol Violation|0|||
27866218|NCT02203331|81342096|FG004|Overall Study|Withdrawal by Subject|0|||
27866219|NCT02203331|81342097|FG005|Overall Study|Withdrawal by Subject|3|||
27866220|NCT02203331|81342092|FG000|Overall Study|Adverse Event|4|||
27866221|NCT02203331|81342093|FG001|Overall Study|Adverse Event|8|||
27784646|NCT02452034|81040874|FG004|Overall Study|Protocol Violation|0|||
27784647|NCT02452034|81040875|FG005|Overall Study|Protocol Violation|1|||
27784648|NCT02452034|81040870|FG000|Overall Study|Screen Failure|1|||
27866222|NCT02203331|81342094|FG002|Overall Study|Adverse Event|3|||
27784649|NCT02452034|81040871|FG001|Overall Study|Screen Failure|0|||
27784650|NCT02452034|81040872|FG002|Overall Study|Screen Failure|0|||
27784651|NCT02452034|81040873|FG003|Overall Study|Screen Failure|1|||
27784652|NCT02452034|81040874|FG004|Overall Study|Screen Failure|0|||
27784653|NCT02452034|81040875|FG005|Overall Study|Screen Failure|0|||
27572502|NCT01207778|80279147|FG002|Overall Study|Lost to Follow-up|3|||
27572503|NCT02547129|80282020|FG000|Overall Study|Difficulty with ongoing infection|1|||
27572504|NCT02547129|80282021|FG001|Overall Study|Difficulty with ongoing infection|0|||
27784654|NCT02452034|81040870|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
27784655|NCT02452034|81040871|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
27784656|NCT02452034|81040872|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
27784657|NCT02452034|81040873|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
27866223|NCT02203331|81342095|FG003|Overall Study|Adverse Event|4|||
27866224|NCT02203331|81342096|FG004|Overall Study|Adverse Event|3|||
27572505|NCT01256710|80282025|FG000|Overall Study|Death|449|||
27572506|NCT01256710|80282025|FG000|Overall Study|System Explant|67|||
27572507|NCT01256710|80282025|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
27572508|NCT01256710|80282025|FG000|Overall Study|Lost to Follow-up|67|||
27572509|NCT01256710|80282025|FG000|Overall Study|Withdrawal by Subject|29|||
27572510|NCT01256710|80282025|FG000|Overall Study|Physician Decision|9|||
27572511|NCT01256710|80282025|FG000|Overall Study|Subject Noncompliance|2|||
27572512|NCT01256710|80282025|FG000|Overall Study|Study Terminated by Sponsor|273|||
27572513|NCT01143090|80282028|FG000|Overall Study|Lack of Efficacy|2|||
27572514|NCT01143090|80282028|FG000|Overall Study|Adverse Event|17|||
27572515|NCT01143090|80282028|FG000|Overall Study|Lost to Follow-up|9|||
27784658|NCT02452034|81040874|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
27784659|NCT02452034|81040875|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
27784660|NCT00103207|81040877|FG000|Overall Study|Adverse Event|3|||
27784661|NCT00103207|81040877|FG000|Overall Study|Death|1|||
27973041|NCT01865812|81730237|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
27973042|NCT01865812|81730236|FG000|Long-term Safety Extension Phase|Pruritus|0|||
27973043|NCT01865812|81730237|FG001|Long-term Safety Extension Phase|Pruritus|3|||
27973044|NCT01865812|81730236|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
27973045|NCT01865812|81730237|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
27784662|NCT00103207|81040877|FG000|Overall Study|Withdrawal by Subject|2|||
27784663|NCT00103207|81040877|FG000|Overall Study|Other complicating disease|1|||
27784664|NCT00103207|81040877|FG000|Overall Study|Ineligible|4|||
27784665|NCT00103207|81040877|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
27784666|NCT00283062|81040880|FG000|Overall Study|Did not receive any study medication|5|||
27784667|NCT00283062|81040881|FG001|Overall Study|Did not receive any study medication|4|||
27784668|NCT00283062|81040882|FG002|Overall Study|Did not receive any study medication|36|||
27784669|NCT00283062|81040883|FG003|Overall Study|Did not receive any study medication|45|||
27784670|NCT00283062|81040880|FG000|Overall Study|Adverse Event|2|||
27784671|NCT00283062|81040881|FG001|Overall Study|Adverse Event|0|||
27784672|NCT00283062|81040882|FG002|Overall Study|Adverse Event|1|||
27784673|NCT00283062|81040883|FG003|Overall Study|Adverse Event|0|||
27784674|NCT00283062|81040880|FG000|Overall Study|Lost to Follow-up|1|||
27784675|NCT00283062|81040881|FG001|Overall Study|Lost to Follow-up|0|||
27784676|NCT00283062|81040882|FG002|Overall Study|Lost to Follow-up|1|||
27784677|NCT00283062|81040883|FG003|Overall Study|Lost to Follow-up|0|||
27784678|NCT00283062|81040880|FG000|Overall Study|Progressive disease|0|||
27784679|NCT00283062|81040881|FG001|Overall Study|Progressive disease|0|||
27784680|NCT00283062|81040882|FG002|Overall Study|Progressive disease|1|||
27784681|NCT00283062|81040883|FG003|Overall Study|Progressive disease|0|||
27784682|NCT00283062|81040880|FG000|Overall Study|Participant did not wish to continue|3|||
27784683|NCT00283062|81040881|FG001|Overall Study|Participant did not wish to continue|2|||
27784684|NCT00283062|81040882|FG002|Overall Study|Participant did not wish to continue|1|||
27784685|NCT00283062|81040883|FG003|Overall Study|Participant did not wish to continue|0|||
27784686|NCT00283062|81040880|FG000|Overall Study|Undefined|0|||
27784687|NCT00283062|81040881|FG001|Overall Study|Undefined|1|||
27784688|NCT00283062|81040882|FG002|Overall Study|Undefined|1|||
27784689|NCT00283062|81040883|FG003|Overall Study|Undefined|4|||
27784690|NCT00283062|81040880|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
27784691|NCT00283062|81040881|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
27784692|NCT00283062|81040882|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
27784693|NCT00283062|81040883|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
27866225|NCT02203331|81342097|FG005|Overall Study|Adverse Event|3|||
27973046|NCT01865812|81730236|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
27973047|NCT01865812|81730237|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
27973048|NCT04795167|81730241|FG000|Overall Study|Death|1|||
27973049|NCT04795167|81730242|FG001|Overall Study|Death|18|||
27973050|NCT04795167|81730243|FG002|Overall Study|Death|1|||
27973051|NCT04795167|81730241|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
27973052|NCT04795167|81730242|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
27973053|NCT04795167|81730243|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
27973054|NCT04239222|81730248|FG000|Baseline|Withdrawal by Subject|0|||
27973055|NCT04239222|81730249|FG001|Baseline|Withdrawal by Subject|0|||
27973056|NCT04239222|81730250|FG002|Baseline|Withdrawal by Subject|1|||
27973057|NCT04239222|81730251|FG003|Baseline|Withdrawal by Subject|1|||
27973058|NCT04239222|81730248|FG000|First Foot Assignment|Withdrawal by Subject|0|||
27973059|NCT04239222|81730249|FG001|First Foot Assignment|Withdrawal by Subject|0|||
27973060|NCT04239222|81730250|FG002|First Foot Assignment|Withdrawal by Subject|1|||
27973061|NCT04239222|81730251|FG003|First Foot Assignment|Withdrawal by Subject|0|||
27784694|NCT02408016|81040885|FG000|Overall Study|Death|6|||
27973062|NCT04239222|81730248|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
27973063|NCT04239222|81730249|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
27973064|NCT04239222|81730250|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
27973065|NCT04239222|81730251|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
27784695|NCT02408016|81040886|FG001|Overall Study|Death|1|||
27784696|NCT02408016|81040887|FG002|Overall Study|Death|0|||
27784697|NCT02408016|81040885|FG000|Overall Study|Physician Decision|0|||
27784698|NCT02408016|81040886|FG001|Overall Study|Physician Decision|2|||
27784699|NCT02408016|81040887|FG002|Overall Study|Physician Decision|0|||
27784700|NCT00808665|81040889|FG000|Overall Study|Withdrawal by Subject|1|||
27784701|NCT00808665|81040890|FG001|Overall Study|Withdrawal by Subject|0|||
27784702|NCT00808665|81040889|FG000|Overall Study|only required minimally invasive surgery|1|||
27784703|NCT00808665|81040890|FG001|Overall Study|only required minimally invasive surgery|0|||
27784704|NCT00808665|81040889|FG000|Overall Study|surgery cancelled|1|||
27572516|NCT01143090|80282028|FG000|Overall Study|Protocol Violation|2|||
27572517|NCT01143090|80282028|FG000|Overall Study|Withdrawal by Subject|18|||
27784705|NCT00808665|81040890|FG001|Overall Study|surgery cancelled|0|||
27784706|NCT00808665|81040889|FG000|Overall Study|required an additional procedure|0|||
27784707|NCT00808665|81040890|FG001|Overall Study|required an additional procedure|1|||
27784708|NCT00808665|81040889|FG000|Overall Study|Physician Decision|3|||
27784709|NCT00808665|81040890|FG001|Overall Study|Physician Decision|1|||
27784710|NCT00808665|81040889|FG000|Overall Study|Medication stopped by resident|0|||
27784711|NCT00808665|81040890|FG001|Overall Study|Medication stopped by resident|1|||
27784712|NCT00723489|81040893|FG000|Overall Study|Physician Decision|0|||
27784713|NCT00723489|81040894|FG001|Overall Study|Physician Decision|1|||
27784714|NCT00723489|81040895|FG002|Overall Study|Physician Decision|0|||
27784715|NCT00723489|81040896|FG003|Overall Study|Physician Decision|0|||
27784716|NCT00723489|81040893|FG000|Overall Study|Pregnancy|0|||
27572518|NCT01143090|80282028|FG000|Overall Study|Non-compliance with study drug|1|||
27572519|NCT01143090|80282028|FG000|Overall Study|Failure to meet eligibility criteria|1|||
27572520|NCT01143090|80282028|FG000|Overall Study|Administrative|1|||
27572521|NCT00437034|80282036|FG000|Overall Study|Adverse Event|1|||
27572522|NCT00437034|80282036|FG000|Overall Study|Disease progression during treatment|5|||
27572523|NCT02434770|80282037|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
27572524|NCT02434770|80282038|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
27572525|NCT02434770|80282039|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
27572526|NCT02434770|80282037|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
27572527|NCT02434770|80282038|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
27572528|NCT02434770|80282039|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
27572529|NCT02434770|80282037|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
27572530|NCT02434770|80282038|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
27572531|NCT02434770|80282039|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
27572532|NCT02434770|80282037|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
27572533|NCT02434770|80282038|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
27572534|NCT02434770|80282039|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
27572535|NCT02434770|80282037|FG000|Week 1 to Week 18|Death|1|||
27572536|NCT02434770|80282038|FG001|Week 1 to Week 18|Death|0|||
27572537|NCT02434770|80282039|FG002|Week 1 to Week 18|Death|0|||
27572538|NCT02434770|80282037|FG000|Week 18 to Week|Lost to Follow-up|2|||
27572539|NCT02434770|80282038|FG001|Week 18 to Week|Lost to Follow-up|2|||
27572540|NCT02434770|80282039|FG002|Week 18 to Week|Lost to Follow-up|1|||
27572541|NCT02434770|80282037|FG000|Week 18 to Week|Withdrawal by Subject|0|||
27572542|NCT02434770|80282038|FG001|Week 18 to Week|Withdrawal by Subject|0|||
27572543|NCT02434770|80282039|FG002|Week 18 to Week|Withdrawal by Subject|2|||
27572544|NCT02434770|80282037|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
27572545|NCT02434770|80282038|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
27572546|NCT02434770|80282039|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
27572547|NCT01454726|80282040|FG000|Overall Study|Withdrawal by Subject|0|||
27572548|NCT01454726|80282041|FG001|Overall Study|Withdrawal by Subject|1|||
27572549|NCT01069289|80282042|FG000|Overall Study|Withdrawal by Subject|15|||
27572550|NCT01069289|80282043|FG001|Overall Study|Withdrawal by Subject|26|||
27784717|NCT00723489|81040894|FG001|Overall Study|Pregnancy|0|||
27572551|NCT01069289|80282042|FG000|Overall Study|Adverse Event|21|||
27572552|NCT01069289|80282043|FG001|Overall Study|Adverse Event|28|||
27572553|NCT01069289|80282042|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27784718|NCT00723489|81040895|FG002|Overall Study|Pregnancy|0|||
27784719|NCT00723489|81040896|FG003|Overall Study|Pregnancy|1|||
27784720|NCT00723489|81040893|FG000|Overall Study|Withdrawal by Subject|0|||
27784721|NCT00723489|81040894|FG001|Overall Study|Withdrawal by Subject|0|||
27784722|NCT00723489|81040895|FG002|Overall Study|Withdrawal by Subject|0|||
27572554|NCT01069289|80282043|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27572555|NCT01069289|80282042|FG000|Overall Study|Severe non-compliance to protocol|3|||
27572556|NCT01069289|80282043|FG001|Overall Study|Severe non-compliance to protocol|2|||
27572557|NCT01069289|80282042|FG000|Overall Study|Due to deteriorating health condition|1|||
27572558|NCT01069289|80282043|FG001|Overall Study|Due to deteriorating health condition|0|||
27572559|NCT02940691|80282045|FG000|Overall Study|Lost to Follow-up|5|||
27572560|NCT02940691|80282045|FG000|Overall Study|Incarceration|1|||
27572561|NCT03027466|80282059|FG000|Overall Study|Opting out of the app|1869|||
27572562|NCT03027466|80282060|FG001|Overall Study|Opting out of the app|1819|||
27572563|NCT03027466|80282061|FG002|Overall Study|Opting out of the app|1743|||
27572564|NCT03027466|80282062|FG003|Overall Study|Opting out of the app|1821|||
27572565|NCT00749775|80282066|FG000|Overall Study|Protocol Violation|24|||
27572566|NCT00749775|80282066|FG000|Overall Study|Lost to Follow-up|36|||
27572567|NCT00749775|80282066|FG000|Overall Study|No visit after first day of treatment|44|||
27572568|NCT00749775|80282066|FG000|Overall Study|No drug administration|3|||
27572569|NCT00670800|80282068|FG000|Overall Study|2 controls were insulin resistant|0|||
27572570|NCT00670800|80282069|FG001|Overall Study|2 controls were insulin resistant|2|||
27572571|NCT00958776|80282074|FG000|Overall Study|Adverse Event|0|||
27572572|NCT00958776|80282075|FG001|Overall Study|Adverse Event|1|||
27572573|NCT00958776|80282074|FG000|Overall Study|Physician Decision|1|||
27572574|NCT00958776|80282075|FG001|Overall Study|Physician Decision|0|||
27572575|NCT00958776|80282074|FG000|Overall Study|Lost to Follow-up|2|||
27572576|NCT00958776|80282075|FG001|Overall Study|Lost to Follow-up|6|||
27572577|NCT00958776|80282074|FG000|Overall Study|Withdrawal by Subject|7|||
27572578|NCT00958776|80282075|FG001|Overall Study|Withdrawal by Subject|16|||
27572579|NCT00958776|80282074|FG000|Overall Study|Protocol Violation|1|||
27572580|NCT00958776|80282075|FG001|Overall Study|Protocol Violation|1|||
27784723|NCT00723489|81040896|FG003|Overall Study|Withdrawal by Subject|1|||
27784724|NCT00723489|81040893|FG000|Overall Study|Seropositive at baseline|1|||
27784725|NCT00723489|81040894|FG001|Overall Study|Seropositive at baseline|0|||
27784726|NCT00723489|81040895|FG002|Overall Study|Seropositive at baseline|0|||
27784727|NCT00723489|81040896|FG003|Overall Study|Seropositive at baseline|0|||
27784728|NCT00723489|81040893|FG000|Overall Study|Prohibited Medication|0|||
27784729|NCT00723489|81040894|FG001|Overall Study|Prohibited Medication|0|||
27784730|NCT00723489|81040895|FG002|Overall Study|Prohibited Medication|0|||
27784731|NCT00723489|81040896|FG003|Overall Study|Prohibited Medication|1|||
27784732|NCT00723489|81040893|FG000|Overall Study|Samples Collected Out of Window|0|||
27784733|NCT00723489|81040894|FG001|Overall Study|Samples Collected Out of Window|3|||
27784734|NCT00723489|81040895|FG002|Overall Study|Samples Collected Out of Window|0|||
27784735|NCT00723489|81040896|FG003|Overall Study|Samples Collected Out of Window|0|||
27784736|NCT01130831|81040901|FG000|Overall Study|Withdrawal by Subject|7|||
27784737|NCT01130831|81040901|FG000|Overall Study|Death|4|||
27784738|NCT01130831|81040901|FG000|Overall Study|Information was missing|3|||
27572581|NCT00958776|80282074|FG000|Overall Study|Death|2|||
27572582|NCT00958776|80282075|FG001|Overall Study|Death|1|||
27572583|NCT00958776|80282074|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
27572584|NCT00958776|80282075|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
27572585|NCT00958776|80282074|FG000|Overall Study|Missing|1|||
27572586|NCT00958776|80282075|FG001|Overall Study|Missing|1|||
27784739|NCT02576951|81040902|FG000|Overall Study|Lost to Follow-up|0|||
27784740|NCT02576951|81040903|FG001|Overall Study|Lost to Follow-up|0|||
27784741|NCT02576951|81040904|FG002|Overall Study|Lost to Follow-up|2|||
27784742|NCT02576951|81040905|FG003|Overall Study|Lost to Follow-up|2|||
27784743|NCT02576951|81040902|FG000|Overall Study|Withdrawal by Subject|1|||
27784744|NCT02576951|81040903|FG001|Overall Study|Withdrawal by Subject|0|||
27784745|NCT02576951|81040904|FG002|Overall Study|Withdrawal by Subject|0|||
27784746|NCT02576951|81040905|FG003|Overall Study|Withdrawal by Subject|2|||
27784747|NCT02576951|81040902|FG000|Overall Study|Protocol Violation|0|||
27784748|NCT02576951|81040903|FG001|Overall Study|Protocol Violation|0|||
27784749|NCT02576951|81040904|FG002|Overall Study|Protocol Violation|0|||
27784750|NCT02576951|81040905|FG003|Overall Study|Protocol Violation|1|||
27784751|NCT03525613|81040906|FG000|Overall Study|Adverse Event|11|||
27973066|NCT02099344|81730252|FG000|Overall Study|Physician Decision|1|||
27784752|NCT03525613|81040907|FG001|Overall Study|Adverse Event|8|||
27784753|NCT03525613|81040908|FG002|Overall Study|Adverse Event|3|||
27784754|NCT03525613|81040909|FG003|Overall Study|Adverse Event|3|||
27973067|NCT02099344|81730253|FG001|Overall Study|Physician Decision|0|||
27973068|NCT00772369|81730254|FG000|Overall Study|Did not return record release form|1|||
27572587|NCT00640510|80282076|FG000|Overall Study|Lack of Efficacy|0|||
27572588|NCT00640510|80282077|FG001|Overall Study|Lack of Efficacy|1|||
27572589|NCT00640510|80282076|FG000|Overall Study|Protocol Violation|1|||
27572590|NCT00640510|80282077|FG001|Overall Study|Protocol Violation|0|||
27784755|NCT03525613|81040906|FG000|Overall Study|Lost to Follow-up|4|||
27784756|NCT03525613|81040907|FG001|Overall Study|Lost to Follow-up|5|||
27784757|NCT03525613|81040908|FG002|Overall Study|Lost to Follow-up|3|||
27973069|NCT02182440|81732523|FG000|Overall Study|Adverse Event|0|||
27572591|NCT00640510|80282076|FG000|Overall Study|Physician Decision|0|||
27866226|NCT02203331|81342092|FG000|Overall Study|Other Reasons|1|||
27866227|NCT02203331|81342093|FG001|Overall Study|Other Reasons|2|||
27866228|NCT02203331|81342094|FG002|Overall Study|Other Reasons|0|||
27866229|NCT02203331|81342095|FG003|Overall Study|Other Reasons|2|||
27866230|NCT02203331|81342096|FG004|Overall Study|Other Reasons|0|||
27866231|NCT02203331|81342097|FG005|Overall Study|Other Reasons|0|||
27784758|NCT03525613|81040909|FG003|Overall Study|Lost to Follow-up|2|||
27784759|NCT03525613|81040906|FG000|Overall Study|Physician Decision|0|||
27784760|NCT03525613|81040907|FG001|Overall Study|Physician Decision|1|||
27784761|NCT03525613|81040908|FG002|Overall Study|Physician Decision|0|||
27572592|NCT00640510|80282077|FG001|Overall Study|Physician Decision|1|||
27572593|NCT02107703|80282081|FG000|Overall Study|Withdrawal by Subject|46|||
27572594|NCT02107703|80282082|FG001|Overall Study|Withdrawal by Subject|21|||
27572595|NCT02107703|80282081|FG000|Overall Study|Lost to Follow-up|20|||
27784762|NCT03525613|81040909|FG003|Overall Study|Physician Decision|1|||
27784763|NCT03525613|81040906|FG000|Overall Study|Consent Withdrawal|25|||
27784764|NCT03525613|81040907|FG001|Overall Study|Consent Withdrawal|16|||
27784765|NCT03525613|81040908|FG002|Overall Study|Consent Withdrawal|12|||
27784766|NCT03525613|81040909|FG003|Overall Study|Consent Withdrawal|9|||
27784767|NCT03525613|81040906|FG000|Overall Study|Death|20|||
27784768|NCT03525613|81040907|FG001|Overall Study|Death|9|||
27784769|NCT03525613|81040908|FG002|Overall Study|Death|7|||
27784770|NCT03525613|81040909|FG003|Overall Study|Death|1|||
27784771|NCT03525613|81040906|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
27784772|NCT03525613|81040907|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
27784773|NCT03525613|81040908|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
27784774|NCT03525613|81040909|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
27784775|NCT03655951|81040910|FG000|Overall Study|Lost to Follow-up|39|||
27784776|NCT03655951|81040911|FG001|Overall Study|Lost to Follow-up|20|||
27784777|NCT03655951|81040910|FG000|Overall Study|Withdrawal by Subject|0|||
27784778|NCT03655951|81040911|FG001|Overall Study|Withdrawal by Subject|1|||
27784779|NCT01638546|81040912|FG000|Overall Study|Adverse Event|1|||
27784780|NCT01638546|81040913|FG001|Overall Study|Adverse Event|3|||
27784781|NCT01383317|81043712|FG000|Overall Study|Lost to Follow-up|2|||
27784782|NCT01383317|81043713|FG001|Overall Study|Lost to Follow-up|1|||
27784783|NCT01383317|81043712|FG000|Overall Study|Death|1|||
27784784|NCT01383317|81043713|FG001|Overall Study|Death|0|||
27784785|NCT01383317|81043712|FG000|Overall Study|Adverse Event|0|||
27784786|NCT01383317|81043713|FG001|Overall Study|Adverse Event|1|||
27784787|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
27784788|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
27784789|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
27784790|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
27784791|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
27784792|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
27784793|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
27784794|NCT00950755|81043714|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
27784795|NCT00950755|81043714|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
27784796|NCT00950755|81043714|FG000|Long-Term Follow-Up|Death|8|||
27784797|NCT02442284|81043715|FG000|Overall Study|Adverse Event|1|||
27784798|NCT02442284|81043715|FG000|Overall Study|Withdrew Consent|2|||
27784799|NCT02442284|81043715|FG000|Overall Study|Lost to Follow-up|3|||
27784800|NCT02442284|81043715|FG000|Overall Study|Other|1|||
27784801|NCT01928758|81043716|FG000|Overall Study|Lost to Follow-up|14|||
27572596|NCT02107703|80282082|FG001|Overall Study|Lost to Follow-up|9|||
27572597|NCT02107703|80282081|FG000|Overall Study|On study treatment/follow up|48|||
27572598|NCT02107703|80282082|FG001|Overall Study|On study treatment/follow up|5|||
27572599|NCT02920983|80282083|FG000|Dispense 1|Unacceptable Lens Fit|0|||
27572600|NCT02920983|80282084|FG001|Dispense 1|Unacceptable Lens Fit|0|||
27572601|NCT02920983|80282085|FG002|Dispense 1|Unacceptable Lens Fit|0|||
27784802|NCT01928758|81043717|FG001|Overall Study|Lost to Follow-up|9|||
27784803|NCT01928758|81043716|FG000|Overall Study|Withdrawal by Subject|5|||
27784804|NCT01928758|81043717|FG001|Overall Study|Withdrawal by Subject|2|||
27784805|NCT01928758|81043716|FG000|Overall Study|Adverse Event|3|||
27784806|NCT01928758|81043717|FG001|Overall Study|Adverse Event|5|||
27784807|NCT01928758|81043716|FG000|Overall Study|Protocol Violation|3|||
27572602|NCT02920983|80282086|FG003|Dispense 1|Unacceptable Lens Fit|0|||
27572603|NCT02920983|80282087|FG004|Dispense 1|Unacceptable Lens Fit|1|||
27572604|NCT02920983|80282088|FG005|Dispense 1|Unacceptable Lens Fit|0|||
27572605|NCT02920983|80282083|FG000|Dispense 2|Unscceptable lens fit|1|||
27572606|NCT02920983|80282084|FG001|Dispense 2|Unscceptable lens fit|0|||
27866232|NCT02203331|81342092|FG000|Overall Study|Lack of Efficacy|0|||
27572607|NCT02920983|80282085|FG002|Dispense 2|Unscceptable lens fit|0|||
27572608|NCT02920983|80282086|FG003|Dispense 2|Unscceptable lens fit|0|||
27784808|NCT01928758|81043717|FG001|Overall Study|Protocol Violation|4|||
27866233|NCT02203331|81342093|FG001|Overall Study|Lack of Efficacy|2|||
27866234|NCT02203331|81342094|FG002|Overall Study|Lack of Efficacy|1|||
27866235|NCT02203331|81342095|FG003|Overall Study|Lack of Efficacy|0|||
27866236|NCT02203331|81342096|FG004|Overall Study|Lack of Efficacy|0|||
27866237|NCT02203331|81342097|FG005|Overall Study|Lack of Efficacy|1|||
27866238|NCT02203331|81342092|FG000|Overall Study|Protocol Violation|0|||
27866239|NCT02203331|81342093|FG001|Overall Study|Protocol Violation|2|||
27866240|NCT02203331|81342094|FG002|Overall Study|Protocol Violation|0|||
27866241|NCT02203331|81342095|FG003|Overall Study|Protocol Violation|1|||
27866242|NCT02203331|81342096|FG004|Overall Study|Protocol Violation|1|||
27866243|NCT02203331|81342097|FG005|Overall Study|Protocol Violation|0|||
27866244|NCT02203331|81342092|FG000|Overall Study|Lost to Follow-up|0|||
27866245|NCT02203331|81342093|FG001|Overall Study|Lost to Follow-up|0|||
27866246|NCT02203331|81342094|FG002|Overall Study|Lost to Follow-up|0|||
27866247|NCT02203331|81342095|FG003|Overall Study|Lost to Follow-up|0|||
27866248|NCT02203331|81342096|FG004|Overall Study|Lost to Follow-up|1|||
27866249|NCT02203331|81342097|FG005|Overall Study|Lost to Follow-up|0|||
27866250|NCT04868500|81342103|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
27866251|NCT04868500|81342104|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
27866252|NCT04868500|81342103|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
27866253|NCT04868500|81342104|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
27866254|NCT01653912|81342115|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27866255|NCT01653912|81342116|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
27866256|NCT01653912|81342117|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27572609|NCT02920983|80282087|FG004|Dispense 2|Unscceptable lens fit|1|||
27572610|NCT02920983|80282088|FG005|Dispense 2|Unscceptable lens fit|0|||
27572611|NCT02920983|80282083|FG000|Dispense 3|Unacceptable Lens Fit|1|||
27572612|NCT02920983|80282084|FG001|Dispense 3|Unacceptable Lens Fit|1|||
27572613|NCT02920983|80282085|FG002|Dispense 3|Unacceptable Lens Fit|0|||
27572614|NCT02920983|80282086|FG003|Dispense 3|Unacceptable Lens Fit|0|||
27866257|NCT01653912|81342118|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27866258|NCT01653912|81342119|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27866259|NCT01653912|81342120|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
27866260|NCT01653912|81342115|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27866261|NCT01653912|81342116|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27866262|NCT01653912|81342117|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
27866263|NCT01653912|81342118|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27866264|NCT01653912|81342119|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27866265|NCT01653912|81342120|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
27866266|NCT01653912|81342115|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27866267|NCT01653912|81342116|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27866268|NCT01653912|81342117|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27866269|NCT01653912|81342118|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
27866270|NCT01653912|81342119|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27866271|NCT01653912|81342120|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
27866272|NCT01653912|81342115|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866273|NCT01653912|81342116|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866274|NCT01653912|81342117|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866275|NCT01653912|81342118|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
27866276|NCT01653912|81342119|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866277|NCT01653912|81342120|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866278|NCT01653912|81342115|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27866279|NCT01653912|81342116|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27866280|NCT01653912|81342117|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27866281|NCT01653912|81342118|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27866282|NCT01653912|81342119|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
27866283|NCT01653912|81342120|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
27866284|NCT01653912|81342115|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27866285|NCT01653912|81342116|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27866286|NCT01653912|81342117|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27866287|NCT01653912|81342118|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27866288|NCT01653912|81342119|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
27866289|NCT01653912|81342120|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
27866290|NCT01653912|81342115|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27572615|NCT02920983|80282087|FG004|Dispense 3|Unacceptable Lens Fit|1|||
27572616|NCT02920983|80282088|FG005|Dispense 3|Unacceptable Lens Fit|0|||
27572617|NCT00145509|80282098|FG000|Overall Study|Adverse Event|10|||
27572618|NCT00145509|80282099|FG001|Overall Study|Adverse Event|3|||
27572619|NCT00145509|80282098|FG000|Overall Study|Lack of Efficacy|3|||
27572620|NCT00145509|80282099|FG001|Overall Study|Lack of Efficacy|1|||
27572621|NCT00145509|80282098|FG000|Overall Study|Lost to Follow-up|5|||
27670308|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
27670309|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
27670310|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
27670311|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
27670312|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
27670313|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
27670314|NCT03201900|80631047|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
27670315|NCT03201900|80631047|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
27866291|NCT01653912|81342116|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866292|NCT01653912|81342117|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866293|NCT01653912|81342118|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866294|NCT01653912|81342119|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
27866295|NCT01653912|81342120|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
27866296|NCT02794246|81342127|FG000|Overall Study|Withdrawal by Subject|2|||
27670316|NCT03201900|80631047|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
27670317|NCT03201900|80631047|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
27784809|NCT00736840|81043718|FG000|Overall Study|Lost to Follow-up|13|||
27784810|NCT00337935|81043719|FG000|Overall Study|Adverse Event|2|||
27670318|NCT03201900|80631047|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
27670319|NCT03201900|80631047|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
27670320|NCT03201900|80631047|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
27784811|NCT00337935|81043720|FG001|Overall Study|Adverse Event|5|||
27670321|NCT01099579|80631050|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
27670322|NCT01099579|80631051|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
27670323|NCT01099579|80631052|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
27670324|NCT01099579|80631050|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
27670325|NCT01099579|80631051|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
27784812|NCT00337935|81043719|FG000|Overall Study|Death|2|||
27784813|NCT00337935|81043720|FG001|Overall Study|Death|8|||
27784814|NCT00337935|81043719|FG000|Overall Study|Physician Decision|1|||
27784815|NCT00337935|81043720|FG001|Overall Study|Physician Decision|1|||
27784816|NCT00337935|81043719|FG000|Overall Study|Lost to Follow-up|0|||
27784817|NCT00337935|81043720|FG001|Overall Study|Lost to Follow-up|1|||
27784818|NCT00337935|81043719|FG000|Overall Study|Protocol Violation|4|||
27784819|NCT00337935|81043720|FG001|Overall Study|Protocol Violation|3|||
27784820|NCT00337935|81043719|FG000|Overall Study|Withdrawal by Subject|1|||
27784821|NCT00337935|81043720|FG001|Overall Study|Withdrawal by Subject|7|||
27784822|NCT00337935|81043719|FG000|Overall Study|Other|0|||
27784823|NCT00337935|81043720|FG001|Overall Study|Other|1|||
27784824|NCT00337935|81043719|FG000|Overall Study|Lack of Efficacy|0|||
27784825|NCT00337935|81043720|FG001|Overall Study|Lack of Efficacy|1|||
27866297|NCT02794246|81342127|FG000|Overall Study|Physician Decision|4|||
27973070|NCT02182440|81732524|FG001|Overall Study|Adverse Event|1|||
27973071|NCT02182440|81732525|FG002|Overall Study|Adverse Event|0|||
27973072|NCT02182440|81732526|FG003|Overall Study|Adverse Event|0|||
27973073|NCT02182440|81732523|FG000|Overall Study|Death|31|||
27973074|NCT02182440|81732524|FG001|Overall Study|Death|8|||
27973075|NCT02182440|81732525|FG002|Overall Study|Death|5|||
27973076|NCT02182440|81732526|FG003|Overall Study|Death|16|||
27572622|NCT00145509|80282099|FG001|Overall Study|Lost to Follow-up|9|||
27572623|NCT00145509|80282098|FG000|Overall Study|Withdrew Consent|2|||
27784826|NCT05604781|81043737|FG000|Overall Study|Lost to Follow-up|3|||
27784827|NCT05604781|81043737|FG000|Overall Study|Adverse Event|1|||
27973077|NCT02182440|81732523|FG000|Overall Study|Protocol Violation|0|||
27973078|NCT02182440|81732524|FG001|Overall Study|Protocol Violation|1|||
27670326|NCT01099579|80631052|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
27670327|NCT01099579|80631050|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
27670328|NCT01099579|80631051|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
27670329|NCT01099579|80631052|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
27670330|NCT01099579|80631050|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
27670331|NCT01099579|80631051|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
27670332|NCT01099579|80631052|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
27670333|NCT01099579|80631050|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
27670334|NCT01099579|80631051|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
27670335|NCT01099579|80631052|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
27670336|NCT01099579|80631050|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
27670337|NCT01099579|80631051|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
27670338|NCT01099579|80631052|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
27670339|NCT01099579|80631050|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
27670340|NCT01099579|80631051|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
27670341|NCT01099579|80631052|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
27670342|NCT01099579|80631050|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
27670343|NCT01099579|80631051|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
27670344|NCT01099579|80631052|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
27670345|NCT01099579|80631050|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
27670346|NCT01099579|80631051|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
27670347|NCT01099579|80631052|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
27670348|NCT01099579|80631050|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
27784828|NCT00608426|81043738|FG000|Overall Study|Death|32|||
27784829|NCT00608426|81043739|FG001|Overall Study|Death|36|||
27784830|NCT00608426|81043738|FG000|Overall Study|Lost to Follow-up|485|||
27784831|NCT00608426|81043739|FG001|Overall Study|Lost to Follow-up|521|||
27670349|NCT01099579|80631051|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
27670350|NCT01099579|80631052|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
27784832|NCT00608426|81043738|FG000|Overall Study|refused, health issues, wrong address|319|||
27784833|NCT00608426|81043739|FG001|Overall Study|refused, health issues, wrong address|348|||
27784834|NCT00166504|81043743|FG000|Overall Study|Adverse Event|3|||
27784835|NCT00166504|81043744|FG001|Overall Study|Adverse Event|3|||
27866298|NCT02309138|81342128|FG000|Overall Study|Withdrawal by Subject|44|||
27866299|NCT02309138|81342129|FG001|Overall Study|Withdrawal by Subject|15|||
27973079|NCT02182440|81732525|FG002|Overall Study|Protocol Violation|0|||
27973080|NCT02182440|81732526|FG003|Overall Study|Protocol Violation|0|||
27973081|NCT02182440|81732523|FG000|Overall Study|Physician Decision|1|||
27973082|NCT02182440|81732524|FG001|Overall Study|Physician Decision|0|||
27973083|NCT02182440|81732525|FG002|Overall Study|Physician Decision|0|||
27973084|NCT02182440|81732526|FG003|Overall Study|Physician Decision|0|||
27973085|NCT02182440|81732523|FG000|Overall Study|Withdrawal by Subject|1|||
27973086|NCT02182440|81732524|FG001|Overall Study|Withdrawal by Subject|1|||
27973087|NCT02182440|81732525|FG002|Overall Study|Withdrawal by Subject|3|||
27973088|NCT02182440|81732526|FG003|Overall Study|Withdrawal by Subject|4|||
27973089|NCT02182440|81732523|FG000|Overall Study|different, e.g adm other hospital|12|||
27973090|NCT02182440|81732524|FG001|Overall Study|different, e.g adm other hospital|3|||
27572624|NCT00145509|80282099|FG001|Overall Study|Withdrew Consent|7|||
27670351|NCT04354168|80631053|FG000|Overall Study|Lost to Follow-up|22|||
27784836|NCT00166504|81043743|FG000|Overall Study|Lost to Follow-up|1|||
27973091|NCT02182440|81732525|FG002|Overall Study|different, e.g adm other hospital|3|||
27973092|NCT02182440|81732526|FG003|Overall Study|different, e.g adm other hospital|10|||
27973093|NCT01921218|81732527|FG000|Overall Study|Death|2|||
27670352|NCT00394589|80631054|FG000|Overall Study|Adverse Event|2|||
27670353|NCT00394589|80631055|FG001|Overall Study|Adverse Event|1|||
27670354|NCT00394589|80631056|FG002|Overall Study|Adverse Event|2|||
27670355|NCT00394589|80631054|FG000|Overall Study|Lack of Efficacy|2|||
27670356|NCT00394589|80631055|FG001|Overall Study|Lack of Efficacy|2|||
27670357|NCT00394589|80631056|FG002|Overall Study|Lack of Efficacy|3|||
27670358|NCT00394589|80631054|FG000|Overall Study|Protocol Violation|4|||
27670359|NCT00394589|80631055|FG001|Overall Study|Protocol Violation|0|||
27670360|NCT00394589|80631056|FG002|Overall Study|Protocol Violation|2|||
27670361|NCT03448536|80631057|FG000|Overall Study|Protocol Violation|2|||
27670362|NCT03448536|80631058|FG001|Overall Study|Protocol Violation|0|||
27670363|NCT03448536|80631057|FG000|Overall Study|Pregnancy|1|||
27670364|NCT03448536|80631058|FG001|Overall Study|Pregnancy|0|||
27670365|NCT03448536|80631057|FG000|Overall Study|Withdrawal by Subject|1|||
27670366|NCT03448536|80631058|FG001|Overall Study|Withdrawal by Subject|2|||
27670367|NCT03448536|80631057|FG000|Overall Study|Lost to Follow-up|3|||
27670368|NCT03448536|80631058|FG001|Overall Study|Lost to Follow-up|2|||
27670369|NCT03448536|80631057|FG000|Overall Study|Inadequate pain reporter|1|||
27670370|NCT03448536|80631058|FG001|Overall Study|Inadequate pain reporter|0|||
27670371|NCT03448536|80631057|FG000|Overall Study|Other|3|||
27670372|NCT03448536|80631058|FG001|Overall Study|Other|0|||
27670373|NCT03448536|80631057|FG000|Overall Study|Physician Decision|1|||
27670374|NCT03448536|80631058|FG001|Overall Study|Physician Decision|0|||
27670375|NCT03783689|80634687|FG000|Overall Study|Adverse Event|2|||
27670376|NCT03783689|80634688|FG001|Overall Study|Adverse Event|0|||
27670377|NCT03783689|80634687|FG000|Overall Study|Lost to Follow-up|2|||
27670378|NCT03783689|80634688|FG001|Overall Study|Lost to Follow-up|1|||
27670379|NCT03783689|80634687|FG000|Overall Study|Physician Decision|2|||
27866300|NCT02309138|81342128|FG000|Overall Study|Protocol Violation|4|||
27866301|NCT02309138|81342129|FG001|Overall Study|Protocol Violation|2|||
27866302|NCT02309138|81342128|FG000|Overall Study|delivered before visit 2|0|||
27572625|NCT00145509|80282098|FG000|Overall Study|Reason not provided|2|||
27572626|NCT00145509|80282099|FG001|Overall Study|Reason not provided|1|||
27572627|NCT02042924|80282100|FG000|Overall Study|Early Death|1|||
27572628|NCT00004031|80282106|FG000|Overall Study|Adverse Event|5|||
27572629|NCT00004031|80282107|FG001|Overall Study|Adverse Event|0|||
27572630|NCT00004031|80282106|FG000|Overall Study|Refusal unrelated to adverse events|2|||
27572631|NCT00004031|80282107|FG001|Overall Study|Refusal unrelated to adverse events|11|||
27572632|NCT00004031|80282106|FG000|Overall Study|Progression/relapse|9|||
27572633|NCT00004031|80282107|FG001|Overall Study|Progression/relapse|4|||
27572634|NCT00004031|80282106|FG000|Overall Study|Death|3|||
27572635|NCT00004031|80282107|FG001|Overall Study|Death|1|||
27572636|NCT00004031|80282106|FG000|Overall Study|Other- not protocol specified|3|||
27866303|NCT02309138|81342129|FG001|Overall Study|delivered before visit 2|1|||
27866304|NCT03180645|81342130|FG000|Overall Study|Adverse Event|0|||
27572637|NCT00004031|80282107|FG001|Overall Study|Other- not protocol specified|3|||
27572638|NCT00004031|80282106|FG000|Overall Study|Reason under review|3|||
27572639|NCT00004031|80282107|FG001|Overall Study|Reason under review|2|||
27572640|NCT02806726|80282117|FG000|Overall Study|Lost to Follow-up|1|||
27572641|NCT00101101|80282118|FG000|Overall Study|never received vaccine|20|||
27572642|NCT02059148|80282121|FG000|Treatment 1|Protocol Violation|0|||
27572643|NCT02059148|80282122|FG001|Treatment 1|Protocol Violation|0|||
27572644|NCT02059148|80282123|FG002|Treatment 1|Protocol Violation|0|||
27572645|NCT02059148|80282124|FG003|Treatment 1|Protocol Violation|0|||
27572646|NCT02059148|80282125|FG004|Treatment 1|Protocol Violation|0|||
27572647|NCT02059148|80282126|FG005|Treatment 1|Protocol Violation|1|||
27572648|NCT00279708|80282127|FG000|Overall Study|Withdrawal by Subject|2|||
27572649|NCT00279708|80282128|FG001|Overall Study|Withdrawal by Subject|3|||
27572650|NCT00279708|80282127|FG000|Overall Study|Adverse Event|1|||
27572651|NCT00279708|80282128|FG001|Overall Study|Adverse Event|1|||
27572652|NCT01956110|80282129|FG000|Overall Study|Protocol Violation|25|||
27572653|NCT01956110|80282130|FG001|Overall Study|Protocol Violation|11|||
27572654|NCT01956110|80282129|FG000|Overall Study|Adverse Event|9|||
27572655|NCT01956110|80282130|FG001|Overall Study|Adverse Event|10|||
27572656|NCT01956110|80282129|FG000|Overall Study|Personal reasons|1|||
27572657|NCT01956110|80282130|FG001|Overall Study|Personal reasons|1|||
27670380|NCT03783689|80634688|FG001|Overall Study|Physician Decision|1|||
27670381|NCT03783689|80634687|FG000|Overall Study|Withdrawal by Subject|3|||
27670382|NCT03783689|80634688|FG001|Overall Study|Withdrawal by Subject|3|||
27670383|NCT01813305|80634689|FG000|Overall Study|Withdrawal by Subject|12|||
27670384|NCT01813305|80634690|FG001|Overall Study|Withdrawal by Subject|5|||
27866305|NCT03180645|81342131|FG001|Overall Study|Adverse Event|1|||
27572658|NCT00360334|80282131|FG000|Overall Study|Adverse Event|7|||
27572659|NCT00360334|80282132|FG001|Overall Study|Adverse Event|4|||
27572660|NCT00360334|80282131|FG000|Overall Study|Protocol Violation|1|||
27572661|NCT00360334|80282132|FG001|Overall Study|Protocol Violation|1|||
27670385|NCT01813305|80634689|FG000|Overall Study|Safety Concern|4|||
27670386|NCT01813305|80634690|FG001|Overall Study|Safety Concern|0|||
27670387|NCT01813305|80634689|FG000|Overall Study|Ulcer became worse|4|||
27670388|NCT01813305|80634690|FG001|Overall Study|Ulcer became worse|0|||
27670389|NCT01813305|80634689|FG000|Overall Study|Physician Decision|4|||
27670390|NCT01813305|80634690|FG001|Overall Study|Physician Decision|0|||
27670391|NCT01813305|80634689|FG000|Overall Study|Lost to Follow-up|3|||
27670392|NCT01813305|80634690|FG001|Overall Study|Lost to Follow-up|1|||
27670393|NCT01813305|80634689|FG000|Overall Study|Protocol Violation|1|||
27670394|NCT01813305|80634690|FG001|Overall Study|Protocol Violation|0|||
27670395|NCT01813305|80634689|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
27670396|NCT01813305|80634690|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
27670397|NCT00853372|80634691|FG000|Overall Study|Death|30|||
27670398|NCT00853372|80634692|FG001|Overall Study|Death|26|||
27572662|NCT00360334|80282131|FG000|Overall Study|Physician Decision|2|||
27572663|NCT00360334|80282132|FG001|Overall Study|Physician Decision|3|||
27572664|NCT00360334|80282131|FG000|Overall Study|Lack of Efficacy|0|||
27572665|NCT00360334|80282132|FG001|Overall Study|Lack of Efficacy|1|||
27670399|NCT00853372|80634691|FG000|Overall Study|Lost to Follow-up|1|||
27670400|NCT00853372|80634692|FG001|Overall Study|Lost to Follow-up|2|||
27670401|NCT00853372|80634691|FG000|Overall Study|Full Consent Withdrawn|1|||
27670402|NCT00853372|80634692|FG001|Overall Study|Full Consent Withdrawn|1|||
27670403|NCT01470599|80634697|FG000|Overall Study|Did not meet entrance criteria|1|||
27670404|NCT01470599|80634698|FG001|Overall Study|Did not meet entrance criteria|0|||
27572666|NCT00360334|80282131|FG000|Overall Study|Entry criterion not met|1|||
27572667|NCT00360334|80282132|FG001|Overall Study|Entry criterion not met|2|||
27572668|NCT00360334|80282131|FG000|Overall Study|Subject decision|8|||
27572669|NCT00360334|80282132|FG001|Overall Study|Subject decision|2|||
27572670|NCT01183975|80282133|FG000|Overall Study|Lost to Follow-up|73|||
27572671|NCT01434290|80282134|FG000|Overall Study|Protocol Violation|6|||
27572672|NCT01434290|80282135|FG001|Overall Study|Protocol Violation|3|||
27572673|NCT01434290|80282134|FG000|Overall Study|No protocol treatment|2|||
27572674|NCT01434290|80282135|FG001|Overall Study|No protocol treatment|4|||
27572675|NCT01988571|80282136|FG000|Overall Study|Death|3|||
27572676|NCT01988571|80282137|FG001|Overall Study|Death|1|||
27572677|NCT01988571|80282136|FG000|Overall Study|Physician Decision|2|||
27572678|NCT01988571|80282137|FG001|Overall Study|Physician Decision|1|||
27572679|NCT01988571|80282136|FG000|Overall Study|Lost to Follow-up|3|||
27572680|NCT01988571|80282137|FG001|Overall Study|Lost to Follow-up|0|||
27572681|NCT01988571|80282136|FG000|Overall Study|Withdrawal by Subject|31|||
27572682|NCT01988571|80282137|FG001|Overall Study|Withdrawal by Subject|33|||
27572683|NCT00006184|80282138|FG000|Overall Study|Death|1|||
27572684|NCT00006184|80282139|FG001|Overall Study|Death|0|||
27572685|NCT00931307|80282145|FG000|Overall Study|Lack of Efficacy|12|||
27572686|NCT00931307|80282145|FG000|Overall Study|Biomicroscopy|1|||
27572687|NCT00595582|80282146|FG000|Overall Study|Pilot study that PI terminated|2|||
27572688|NCT00595582|80282146|FG000|Overall Study|Lost to Follow-up|1|||
27572689|NCT00595582|80282146|FG000|Overall Study|Adverse Event|2|||
27572690|NCT00595582|80282146|FG000|Overall Study|Physician Decision|5|||
27572691|NCT02759120|80282148|FG000|Overall Study|Death|34|||
27572692|NCT02759120|80282149|FG001|Overall Study|Death|36|||
27572693|NCT02759120|80282148|FG000|Overall Study|Lost to Follow-up|4|||
27572694|NCT02759120|80282149|FG001|Overall Study|Lost to Follow-up|7|||
27572695|NCT02759120|80282148|FG000|Overall Study|Physician Decision|3|||
27572696|NCT02759120|80282149|FG001|Overall Study|Physician Decision|0|||
27572697|NCT02759120|80282148|FG000|Overall Study|Withdrawal by Subject|28|||
27572698|NCT02759120|80282149|FG001|Overall Study|Withdrawal by Subject|15|||
27572699|NCT02759120|80282148|FG000|Overall Study|Moved out of area|3|||
27572700|NCT02759120|80282149|FG001|Overall Study|Moved out of area|4|||
27572701|NCT02759120|80282148|FG000|Overall Study|Lung transplant|3|||
27572702|NCT02759120|80282149|FG001|Overall Study|Lung transplant|5|||
27572703|NCT02759120|80282148|FG000|Overall Study|Other reason not completed|10|||
27572704|NCT02759120|80282149|FG001|Overall Study|Other reason not completed|12|||
27572705|NCT01176292|80282150|FG000|Overall Study|Lost to Follow-up|2|||
27572706|NCT01176292|80282151|FG001|Overall Study|Lost to Follow-up|4|||
27572707|NCT01176292|80282150|FG000|Overall Study|Adverse Event|1|||
27572708|NCT01176292|80282151|FG001|Overall Study|Adverse Event|1|||
27572709|NCT01176292|80282150|FG000|Overall Study|Physician Decision|0|||
27670405|NCT01470599|80634697|FG000|Overall Study|Lost to Follow-up|2|||
27670406|NCT01470599|80634698|FG001|Overall Study|Lost to Follow-up|1|||
27670407|NCT01470599|80634697|FG000|Overall Study|Withdrawal by Subject|3|||
27670408|NCT01470599|80634698|FG001|Overall Study|Withdrawal by Subject|4|||
27572710|NCT01176292|80282151|FG001|Overall Study|Physician Decision|2|||
27572711|NCT01176292|80282150|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
27572712|NCT01176292|80282151|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
27572713|NCT01502644|80282152|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
27572714|NCT01502644|80282153|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
27572715|NCT01502644|80282154|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
27572716|NCT01502644|80282155|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
27572717|NCT01502644|80282152|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
27670409|NCT01470599|80634697|FG000|Overall Study|Other|1|||
27572718|NCT01502644|80282153|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
27572719|NCT01502644|80282154|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
27973094|NCT01921218|81732528|FG001|Overall Study|Death|1|||
27572720|NCT01502644|80282155|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
27572721|NCT01502644|80282152|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
27572722|NCT01502644|80282153|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
27572723|NCT01502644|80282154|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
27572724|NCT01502644|80282155|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
27572725|NCT01502644|80282152|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
27572726|NCT01502644|80282153|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
27572727|NCT01502644|80282154|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
27572728|NCT01502644|80282155|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
27572729|NCT01502644|80282152|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
27572730|NCT01502644|80282153|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
27572731|NCT01502644|80282154|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
27572732|NCT01502644|80282155|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
27572733|NCT00706966|80282156|FG000|Overall Study|Adverse Event|1|||
27572734|NCT00436748|80282158|FG000|Overall Study|Ineligibility Determined|1|||
27572735|NCT00436748|80282159|FG001|Overall Study|Ineligibility Determined|1|||
27572736|NCT00436748|80282158|FG000|Overall Study|Adverse Event|0|||
27572737|NCT00436748|80282159|FG001|Overall Study|Adverse Event|2|||
27572738|NCT00436748|80282158|FG000|Overall Study|Consent Withdrawn|1|||
27572739|NCT00436748|80282159|FG001|Overall Study|Consent Withdrawn|4|||
27670410|NCT01470599|80634698|FG001|Overall Study|Other|0|||
27973095|NCT01921218|81732527|FG000|Overall Study|Withdrawal by Subject|0|||
27973096|NCT01921218|81732528|FG001|Overall Study|Withdrawal by Subject|2|||
27973097|NCT01921218|81732527|FG000|Overall Study|Kidney transplant|1|||
27973098|NCT01921218|81732528|FG001|Overall Study|Kidney transplant|1|||
27973099|NCT03100539|81732529|FG000|Overall Study|Lost to Follow-up|60|||
27973100|NCT03100539|81732530|FG001|Overall Study|Lost to Follow-up|54|||
27973101|NCT03100539|81732531|FG002|Overall Study|Lost to Follow-up|17|||
27973102|NCT03100539|81732529|FG000|Overall Study|Uncollected|8|||
27973103|NCT03100539|81732530|FG001|Overall Study|Uncollected|8|||
27973104|NCT03100539|81732531|FG002|Overall Study|Uncollected|0|||
27973105|NCT03100539|81732529|FG000|Overall Study|Ally Health|0|||
27670411|NCT01470599|80634697|FG000|Overall Study|Protocol Violation|3|||
27670412|NCT01470599|80634698|FG001|Overall Study|Protocol Violation|1|||
27670413|NCT01470599|80634697|FG000|Overall Study|Adverse event related to study drug|2|||
27670414|NCT01470599|80634698|FG001|Overall Study|Adverse event related to study drug|5|||
27670415|NCT01470599|80634697|FG000|Overall Study|Insufficient clinical response|6|||
27670416|NCT01470599|80634698|FG001|Overall Study|Insufficient clinical response|27|||
27670417|NCT01470599|80634697|FG000|Overall Study|Adverse event not related to study drug|1|||
27670418|NCT01470599|80634698|FG001|Overall Study|Adverse event not related to study drug|5|||
27670419|NCT02994784|80634699|FG000|6 Months Follow-up|Lost to Follow-up|3|||
27670420|NCT04468230|80634700|FG000|Overall Study|Adverse Event|2|||
27670421|NCT04398368|80634701|FG000|Overall Study|Withdrawal by Subject|2|||
27670422|NCT00975676|80634702|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
27670423|NCT00975676|80634703|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
27670424|NCT00550446|80634704|FG000|Up To Week 12|Adverse Event|2|||
27670425|NCT00550446|80634705|FG001|Up To Week 12|Adverse Event|2|||
27670426|NCT00550446|80634706|FG002|Up To Week 12|Adverse Event|0|||
27670427|NCT00550446|80634707|FG003|Up To Week 12|Adverse Event|0|||
27670428|NCT00550446|80634708|FG004|Up To Week 12|Adverse Event|2|||
27670429|NCT00550446|80634709|FG005|Up To Week 12|Adverse Event|2|||
27670430|NCT00550446|80634710|FG006|Up To Week 12|Adverse Event|1|||
27670431|NCT00550446|80634711|FG007|Up To Week 12|Adverse Event|0|||
27670432|NCT00550446|80634712|FG008|Up To Week 12|Adverse Event|0|||
27670433|NCT00550446|80634713|FG009|Up To Week 12|Adverse Event|0|||
27670434|NCT00550446|80634714|FG010|Up To Week 12|Adverse Event|0|||
27670435|NCT00550446|80634704|FG000|Up To Week 12|Lack of Efficacy|3|||
27670436|NCT00550446|80634705|FG001|Up To Week 12|Lack of Efficacy|1|||
27670437|NCT00550446|80634706|FG002|Up To Week 12|Lack of Efficacy|0|||
27670438|NCT00550446|80634707|FG003|Up To Week 12|Lack of Efficacy|1|||
27670439|NCT00550446|80634708|FG004|Up To Week 12|Lack of Efficacy|0|||
27670440|NCT00550446|80634709|FG005|Up To Week 12|Lack of Efficacy|3|||
27670441|NCT00550446|80634710|FG006|Up To Week 12|Lack of Efficacy|3|||
27670442|NCT00550446|80634711|FG007|Up To Week 12|Lack of Efficacy|0|||
27670443|NCT00550446|80634712|FG008|Up To Week 12|Lack of Efficacy|0|||
27670444|NCT00550446|80634713|FG009|Up To Week 12|Lack of Efficacy|0|||
27670445|NCT00550446|80634714|FG010|Up To Week 12|Lack of Efficacy|0|||
27670446|NCT00550446|80634704|FG000|Up To Week 12|Lost to Follow-up|0|||
27670447|NCT00550446|80634705|FG001|Up To Week 12|Lost to Follow-up|1|||
27670448|NCT00550446|80634706|FG002|Up To Week 12|Lost to Follow-up|0|||
27670449|NCT00550446|80634707|FG003|Up To Week 12|Lost to Follow-up|0|||
27572740|NCT00436748|80282158|FG000|Overall Study|Administrative Decision|1|||
27572741|NCT00436748|80282159|FG001|Overall Study|Administrative Decision|0|||
27572742|NCT00436748|80282158|FG000|Overall Study|Lost to Follow-up|0|||
27572743|NCT00436748|80282159|FG001|Overall Study|Lost to Follow-up|1|||
27572744|NCT00436748|80282158|FG000|Overall Study|Protocol-specified Criteria|5|||
27572745|NCT00436748|80282159|FG001|Overall Study|Protocol-specified Criteria|4|||
27572746|NCT00436748|80282158|FG000|Overall Study|Other|3|||
27670450|NCT00550446|80634708|FG004|Up To Week 12|Lost to Follow-up|1|||
27670451|NCT00550446|80634709|FG005|Up To Week 12|Lost to Follow-up|1|||
27670452|NCT00550446|80634710|FG006|Up To Week 12|Lost to Follow-up|2|||
27670453|NCT00550446|80634711|FG007|Up To Week 12|Lost to Follow-up|0|||
27670454|NCT00550446|80634712|FG008|Up To Week 12|Lost to Follow-up|0|||
27670455|NCT00550446|80634713|FG009|Up To Week 12|Lost to Follow-up|0|||
27670456|NCT00550446|80634714|FG010|Up To Week 12|Lost to Follow-up|0|||
27670457|NCT00550446|80634704|FG000|Up To Week 12|Withdrawal by Subject|2|||
27670458|NCT00550446|80634705|FG001|Up To Week 12|Withdrawal by Subject|0|||
27670459|NCT00550446|80634706|FG002|Up To Week 12|Withdrawal by Subject|3|||
27670460|NCT00550446|80634707|FG003|Up To Week 12|Withdrawal by Subject|2|||
27670461|NCT00550446|80634708|FG004|Up To Week 12|Withdrawal by Subject|0|||
27572747|NCT00436748|80282159|FG001|Overall Study|Other|0|||
27670462|NCT00550446|80634709|FG005|Up To Week 12|Withdrawal by Subject|1|||
27670463|NCT00550446|80634710|FG006|Up To Week 12|Withdrawal by Subject|3|||
27670464|NCT00550446|80634711|FG007|Up To Week 12|Withdrawal by Subject|0|||
27670465|NCT00550446|80634712|FG008|Up To Week 12|Withdrawal by Subject|0|||
27670466|NCT00550446|80634713|FG009|Up To Week 12|Withdrawal by Subject|0|||
27670467|NCT00550446|80634714|FG010|Up To Week 12|Withdrawal by Subject|0|||
27670468|NCT00550446|80634704|FG000|Up To Week 12|Other|3|||
27670469|NCT00550446|80634705|FG001|Up To Week 12|Other|0|||
27670470|NCT00550446|80634706|FG002|Up To Week 12|Other|0|||
27670471|NCT00550446|80634707|FG003|Up To Week 12|Other|0|||
27670472|NCT00550446|80634708|FG004|Up To Week 12|Other|0|||
27670473|NCT00550446|80634709|FG005|Up To Week 12|Other|1|||
27572748|NCT01712984|80282162|FG000|Overall Study|Adverse Event|0|||
27670474|NCT00550446|80634710|FG006|Up To Week 12|Other|4|||
27670475|NCT00550446|80634711|FG007|Up To Week 12|Other|0|||
27670476|NCT00550446|80634712|FG008|Up To Week 12|Other|0|||
27670477|NCT00550446|80634713|FG009|Up To Week 12|Other|0|||
27572749|NCT01712984|80282163|FG001|Overall Study|Adverse Event|0|||
27572750|NCT01712984|80282164|FG002|Overall Study|Adverse Event|1|||
27572751|NCT01712984|80282162|FG000|Overall Study|Protocol Violation|2|||
27572752|NCT01712984|80282163|FG001|Overall Study|Protocol Violation|0|||
27572753|NCT01712984|80282164|FG002|Overall Study|Protocol Violation|1|||
27572754|NCT01712984|80282162|FG000|Overall Study|Lost to Follow-up|8|||
27572755|NCT01712984|80282163|FG001|Overall Study|Lost to Follow-up|10|||
27572756|NCT01712984|80282164|FG002|Overall Study|Lost to Follow-up|1|||
27973106|NCT03100539|81732530|FG001|Overall Study|Ally Health|0|||
27572757|NCT01712984|80282162|FG000|Overall Study|Withdrawal by Subject|6|||
27572758|NCT01712984|80282163|FG001|Overall Study|Withdrawal by Subject|6|||
27572759|NCT01712984|80282164|FG002|Overall Study|Withdrawal by Subject|7|||
27572760|NCT02777125|80282171|FG000|Overall Study|Consent form violation|14|||
27572761|NCT02777125|80282172|FG001|Overall Study|Consent form violation|12|||
27572762|NCT02777125|80282171|FG000|Overall Study|Assent form violation|21|||
27572763|NCT02777125|80282172|FG001|Overall Study|Assent form violation|23|||
27572764|NCT02777125|80282171|FG000|Overall Study|Protocol Violation|8|||
27572765|NCT02777125|80282172|FG001|Overall Study|Protocol Violation|12|||
27572766|NCT02852265|80282173|FG000|3-month Follow-up|Lost to Follow-up|1|||
27572767|NCT02852265|80282174|FG001|3-month Follow-up|Lost to Follow-up|1|||
27572768|NCT01565291|80282175|FG000|Overall Study|Withdrawal by Subject|1|||
27572769|NCT01565291|80282176|FG001|Overall Study|Withdrawal by Subject|0|||
27572770|NCT00326612|80282177|FG000|Overall Study|They did not have a seizure requiring tx|129|||
27572771|NCT00326612|80282178|FG001|Overall Study|They did not have a seizure requiring tx|137|||
27572772|NCT03742141|80282179|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
27572773|NCT02696096|80282186|FG000|Overall Study|ruled out at screening|1|||
27572774|NCT02696096|80282186|FG000|Overall Study|did not attend second fMRI|1|||
27572775|NCT01589822|80282191|FG000|Overall Study|Withdrawal by Subject|1|||
27572776|NCT01589822|80282192|FG001|Overall Study|Withdrawal by Subject|2|||
27572777|NCT01589822|80282193|FG002|Overall Study|Withdrawal by Subject|0|||
27572778|NCT01589822|80282191|FG000|Overall Study|Death|1|||
27572779|NCT01589822|80282192|FG001|Overall Study|Death|0|||
27572780|NCT01589822|80282193|FG002|Overall Study|Death|0|||
27572781|NCT01589822|80282191|FG000|Overall Study|Missed 90 day visit|2|||
27572782|NCT01589822|80282192|FG001|Overall Study|Missed 90 day visit|1|||
27572783|NCT01589822|80282193|FG002|Overall Study|Missed 90 day visit|1|||
27572784|NCT02884089|80282196|FG000|Period 1|Dosing error|2|||
27572785|NCT02884089|80282197|FG001|Period 1|Dosing error|2|||
27572786|NCT02884089|80282198|FG002|Period 1|Dosing error|0|||
27572787|NCT02884089|80282199|FG003|Period 1|Dosing error|0|||
27572788|NCT02884089|80282196|FG000|Washout Period 1|Lost to Follow-up|0|||
27572789|NCT02884089|80282197|FG001|Washout Period 1|Lost to Follow-up|1|||
27572790|NCT02884089|80282198|FG002|Washout Period 1|Lost to Follow-up|0|||
27572791|NCT02884089|80282199|FG003|Washout Period 1|Lost to Follow-up|1|||
27973107|NCT03100539|81732531|FG002|Overall Study|Ally Health|3|||
27572792|NCT02884089|80282196|FG000|Washout Period 1|Withdrawal by Subject|0|||
27572793|NCT02884089|80282197|FG001|Washout Period 1|Withdrawal by Subject|1|||
27572794|NCT02884089|80282198|FG002|Washout Period 1|Withdrawal by Subject|0|||
27670478|NCT00550446|80634714|FG010|Up To Week 12|Other|0|||
27670479|NCT00550446|80634704|FG000|Up To Week 12|Randomized not treated|0|||
27670480|NCT00550446|80634705|FG001|Up To Week 12|Randomized not treated|1|||
27670481|NCT00550446|80634706|FG002|Up To Week 12|Randomized not treated|1|||
27670482|NCT00550446|80634707|FG003|Up To Week 12|Randomized not treated|0|||
27670483|NCT00550446|80634708|FG004|Up To Week 12|Randomized not treated|0|||
27670484|NCT00550446|80634709|FG005|Up To Week 12|Randomized not treated|0|||
27670485|NCT00550446|80634710|FG006|Up To Week 12|Randomized not treated|0|||
27670486|NCT00550446|80634711|FG007|Up To Week 12|Randomized not treated|0|||
27670487|NCT00550446|80634712|FG008|Up To Week 12|Randomized not treated|0|||
27670488|NCT00550446|80634713|FG009|Up To Week 12|Randomized not treated|0|||
27670489|NCT00550446|80634714|FG010|Up To Week 12|Randomized not treated|0|||
27670490|NCT00550446|80634704|FG000|Post Week 12|Adverse Event|2|||
27670491|NCT00550446|80634705|FG001|Post Week 12|Adverse Event|1|||
27670492|NCT00550446|80634706|FG002|Post Week 12|Adverse Event|1|||
27670493|NCT00550446|80634707|FG003|Post Week 12|Adverse Event|1|||
27670494|NCT00550446|80634708|FG004|Post Week 12|Adverse Event|1|||
27973108|NCT03100539|81732529|FG000|Overall Study|Disinterest|0|||
27572795|NCT02884089|80282199|FG003|Washout Period 1|Withdrawal by Subject|0|||
27572796|NCT02884089|80282196|FG000|Period 2|Adverse Event|1|||
27572797|NCT02884089|80282197|FG001|Period 2|Adverse Event|0|||
27572798|NCT02884089|80282198|FG002|Period 2|Adverse Event|0|||
27572799|NCT02884089|80282199|FG003|Period 2|Adverse Event|0|||
27572800|NCT02884089|80282196|FG000|Period 3|Withdrawal by Subject|0|||
27572801|NCT02884089|80282197|FG001|Period 3|Withdrawal by Subject|0|||
27572802|NCT02884089|80282198|FG002|Period 3|Withdrawal by Subject|1|||
27572803|NCT02884089|80282199|FG003|Period 3|Withdrawal by Subject|0|||
27670495|NCT00550446|80634709|FG005|Post Week 12|Adverse Event|1|||
27670496|NCT00550446|80634710|FG006|Post Week 12|Adverse Event|0|||
27670497|NCT00550446|80634711|FG007|Post Week 12|Adverse Event|0|||
27973109|NCT03100539|81732530|FG001|Overall Study|Disinterest|0|||
27572804|NCT02884089|80282196|FG000|Washout Period 3|Withdrawal by Subject|0|||
27572805|NCT02884089|80282197|FG001|Washout Period 3|Withdrawal by Subject|0|||
27572806|NCT02884089|80282198|FG002|Washout Period 3|Withdrawal by Subject|1|||
27572807|NCT02884089|80282199|FG003|Washout Period 3|Withdrawal by Subject|0|||
27572808|NCT02884089|80282196|FG000|Washout Period 3|Lost to Follow-up|0|||
27572809|NCT02884089|80282197|FG001|Washout Period 3|Lost to Follow-up|0|||
27572810|NCT02884089|80282198|FG002|Washout Period 3|Lost to Follow-up|0|||
27572811|NCT02884089|80282199|FG003|Washout Period 3|Lost to Follow-up|1|||
27572812|NCT02884089|80282196|FG000|Period 4|Withdrawal by Subject|0|||
27572813|NCT02884089|80282197|FG001|Period 4|Withdrawal by Subject|1|||
27572814|NCT02884089|80282198|FG002|Period 4|Withdrawal by Subject|0|||
27572815|NCT02884089|80282199|FG003|Period 4|Withdrawal by Subject|0|||
27572816|NCT02884089|80282196|FG000|Period 4|Lost to Follow-up|1|||
27572817|NCT02884089|80282197|FG001|Period 4|Lost to Follow-up|0|||
27572818|NCT02884089|80282198|FG002|Period 4|Lost to Follow-up|0|||
27572819|NCT02884089|80282199|FG003|Period 4|Lost to Follow-up|0|||
27572820|NCT02884089|80282196|FG000|Follow-up Visit|Withdrawal by Subject|1|||
27572821|NCT02884089|80282197|FG001|Follow-up Visit|Withdrawal by Subject|0|||
27572822|NCT02884089|80282198|FG002|Follow-up Visit|Withdrawal by Subject|0|||
27572823|NCT02884089|80282199|FG003|Follow-up Visit|Withdrawal by Subject|1|||
27572824|NCT03191903|80282200|FG000|Overall Study|Withdrawal by Subject|6|||
27572825|NCT03191903|80282201|FG001|Overall Study|Withdrawal by Subject|5|||
27572826|NCT03191903|80282202|FG002|Overall Study|Withdrawal by Subject|4|||
27572827|NCT03191903|80282200|FG000|Overall Study|Adverse Event|1|||
27572828|NCT03191903|80282201|FG001|Overall Study|Adverse Event|0|||
27572829|NCT03191903|80282202|FG002|Overall Study|Adverse Event|0|||
27572830|NCT02388737|80282203|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
27572831|NCT02388737|80282204|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
27572832|NCT02388737|80282205|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
27866306|NCT03180645|81342132|FG002|Overall Study|Adverse Event|2|||
27572833|NCT02388737|80282203|FG000|Overall Study|Major Protocol Deviation|18|||
27572834|NCT02388737|80282204|FG001|Overall Study|Major Protocol Deviation|25|||
27572835|NCT02388737|80282205|FG002|Overall Study|Major Protocol Deviation|22|||
27572836|NCT02388737|80282203|FG000|Overall Study|Lost to Follow-up|5|||
27572837|NCT02388737|80282204|FG001|Overall Study|Lost to Follow-up|1|||
27572838|NCT02388737|80282205|FG002|Overall Study|Lost to Follow-up|4|||
27572839|NCT02388737|80282203|FG000|Overall Study|Voluntary Withdrawal|10|||
27866307|NCT01198132|81342136|FG000|Overall Study|Withdrawal by Subject|4|||
27866308|NCT01198132|81342137|FG001|Overall Study|Withdrawal by Subject|5|||
27866309|NCT01198132|81342136|FG000|Overall Study|Physician Decision|5|||
27866310|NCT01198132|81342137|FG001|Overall Study|Physician Decision|4|||
27866311|NCT01198132|81342136|FG000|Overall Study|Other Unspecified|3|||
27866312|NCT01198132|81342137|FG001|Overall Study|Other Unspecified|6|||
27866313|NCT01198132|81342136|FG000|Overall Study|Lack of Efficacy|2|||
27866314|NCT01198132|81342137|FG001|Overall Study|Lack of Efficacy|3|||
27866315|NCT01198132|81342136|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
27866316|NCT01198132|81342137|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
27866317|NCT01198132|81342136|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
27866318|NCT01198132|81342137|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
27866319|NCT01198132|81342136|FG000|Overall Study|Adverse Event|0|||
27866320|NCT01198132|81342137|FG001|Overall Study|Adverse Event|1|||
27866321|NCT01198132|81342136|FG000|Overall Study|Protocol Violation|1|||
27866322|NCT01198132|81342137|FG001|Overall Study|Protocol Violation|0|||
27866323|NCT03151304|81342143|FG000|Overall Study|Termination of study by Sponsor|23|||
27866324|NCT03151304|81342143|FG000|Overall Study|missing|3|||
27973110|NCT03100539|81732531|FG002|Overall Study|Disinterest|22|||
27572840|NCT02388737|80282204|FG001|Overall Study|Voluntary Withdrawal|18|||
27572841|NCT02388737|80282205|FG002|Overall Study|Voluntary Withdrawal|17|||
27572842|NCT02388737|80282203|FG000|Overall Study|Lack of Efficacy|3|||
27866325|NCT03151304|81342143|FG000|Overall Study|Withdrawal by Subject|8|||
27866326|NCT03151304|81342143|FG000|Overall Study|multiple reasons|30|||
27866327|NCT02123446|81346400|FG000|Washout Period (1 Day)|Physician Decision|1|||
27973111|NCT03100539|81732529|FG000|Overall Study|Veteran Health|0|||
27973112|NCT03100539|81732530|FG001|Overall Study|Veteran Health|0|||
27973113|NCT03100539|81732531|FG002|Overall Study|Veteran Health|8|||
27973114|NCT03100539|81732529|FG000|Overall Study|Moved|0|||
27973115|NCT03100539|81732530|FG001|Overall Study|Moved|0|||
27973116|NCT03100539|81732531|FG002|Overall Study|Moved|1|||
27973117|NCT03100539|81732529|FG000|Overall Study|Scheduling Conflicts|0|||
27973118|NCT03100539|81732530|FG001|Overall Study|Scheduling Conflicts|0|||
27973119|NCT03100539|81732531|FG002|Overall Study|Scheduling Conflicts|12|||
27973120|NCT00496483|81732533|FG000|Overall Study|Not dosed|9|||
27973121|NCT00496483|81732533|FG000|Overall Study|Adverse Event|2|||
27572843|NCT02388737|80282204|FG001|Overall Study|Lack of Efficacy|0|||
27572844|NCT02388737|80282205|FG002|Overall Study|Lack of Efficacy|3|||
27784837|NCT00166504|81043744|FG001|Overall Study|Lost to Follow-up|1|||
27784838|NCT00166504|81043743|FG000|Overall Study|Withdrawal by Subject|1|||
27784839|NCT00166504|81043744|FG001|Overall Study|Withdrawal by Subject|0|||
27784840|NCT01393444|81043745|FG000|Overall Study|Withdrawal by Subject|1|||
27784841|NCT01393444|81043745|FG000|Overall Study|Determined ineligible during screening.|2|||
27784842|NCT03418727|81043748|FG000|Overall Study|Adverse Event|1|||
27784843|NCT03418727|81043749|FG001|Overall Study|Adverse Event|2|||
27784844|NCT03418727|81043750|FG002|Overall Study|Adverse Event|0|||
27572845|NCT02388737|80282203|FG000|Overall Study|Reason Not Specified|5|||
27572846|NCT02388737|80282204|FG001|Overall Study|Reason Not Specified|5|||
27572847|NCT02388737|80282205|FG002|Overall Study|Reason Not Specified|4|||
27572848|NCT00192075|80282206|FG000|Overall Study|Disease Progression|23|||
27572849|NCT00192075|80282207|FG001|Overall Study|Disease Progression|6|||
27572850|NCT00192075|80282206|FG000|Overall Study|Adverse Event|1|||
27572851|NCT00192075|80282207|FG001|Overall Study|Adverse Event|3|||
27572852|NCT00192075|80282206|FG000|Overall Study|Death|0|||
27572853|NCT00192075|80282207|FG001|Overall Study|Death|1|||
27784845|NCT03418727|81043748|FG000|Overall Study|Withdrawal by Subject|0|||
27784846|NCT03418727|81043749|FG001|Overall Study|Withdrawal by Subject|0|||
27784847|NCT03418727|81043750|FG002|Overall Study|Withdrawal by Subject|2|||
27784848|NCT02534324|81043754|FG000|Overall Study|Protocol Violation|4|||
27784849|NCT02534324|81043755|FG001|Overall Study|Protocol Violation|1|||
27784850|NCT02534324|81043754|FG000|Overall Study|Lost to Follow-up|20|||
27784851|NCT02534324|81043755|FG001|Overall Study|Lost to Follow-up|7|||
27784852|NCT02534324|81043754|FG000|Overall Study|Adverse Event|1|||
27784853|NCT02534324|81043755|FG001|Overall Study|Adverse Event|0|||
27784854|NCT02418000|81043771|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
27784855|NCT02418000|81043772|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784856|NCT02418000|81043773|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784857|NCT02418000|81043774|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784858|NCT02418000|81043775|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784859|NCT02418000|81043771|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
27784860|NCT02418000|81043772|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27784861|NCT02418000|81043773|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27784862|NCT02418000|81043774|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27784863|NCT02418000|81043775|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
27784864|NCT02418000|81043771|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
27784865|NCT02418000|81043772|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27572854|NCT00192075|80282206|FG000|Overall Study|Lack of Efficacy|0|||
27572855|NCT00192075|80282207|FG001|Overall Study|Lack of Efficacy|0|||
27572856|NCT00192075|80282206|FG000|Overall Study|Physician Decision|3|||
27784866|NCT02418000|81043773|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27784867|NCT02418000|81043774|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27784868|NCT02418000|81043775|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
27784869|NCT02418000|81043771|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784870|NCT02418000|81043772|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
27833027|NCT00848536|81219437|FG000|Overall Study|Noncompliance|1|||
27833028|NCT00848536|81219438|FG001|Overall Study|Noncompliance|0|||
27572857|NCT00192075|80282207|FG001|Overall Study|Physician Decision|0|||
27572858|NCT00192075|80282206|FG000|Overall Study|Withdrawal by Subject|5|||
27572859|NCT00192075|80282207|FG001|Overall Study|Withdrawal by Subject|5|||
27572860|NCT00192075|80282206|FG000|Overall Study|Patient Non-Compliance|0|||
27572861|NCT00192075|80282207|FG001|Overall Study|Patient Non-Compliance|1|||
27670498|NCT00550446|80634712|FG008|Post Week 12|Adverse Event|0|||
27670499|NCT00550446|80634713|FG009|Post Week 12|Adverse Event|4|||
27670500|NCT00550446|80634714|FG010|Post Week 12|Adverse Event|0|||
27670501|NCT00550446|80634704|FG000|Post Week 12|Lack of Efficacy|0|||
27670502|NCT00550446|80634705|FG001|Post Week 12|Lack of Efficacy|0|||
27670503|NCT00550446|80634706|FG002|Post Week 12|Lack of Efficacy|1|||
27670504|NCT00550446|80634707|FG003|Post Week 12|Lack of Efficacy|0|||
27670505|NCT00550446|80634708|FG004|Post Week 12|Lack of Efficacy|0|||
27670506|NCT00550446|80634709|FG005|Post Week 12|Lack of Efficacy|0|||
27670507|NCT00550446|80634710|FG006|Post Week 12|Lack of Efficacy|0|||
27670508|NCT00550446|80634711|FG007|Post Week 12|Lack of Efficacy|1|||
27670509|NCT00550446|80634712|FG008|Post Week 12|Lack of Efficacy|1|||
27670510|NCT00550446|80634713|FG009|Post Week 12|Lack of Efficacy|2|||
27670511|NCT00550446|80634714|FG010|Post Week 12|Lack of Efficacy|1|||
27670512|NCT00550446|80634704|FG000|Post Week 12|Lost to Follow-up|0|||
27670513|NCT00550446|80634705|FG001|Post Week 12|Lost to Follow-up|0|||
27670514|NCT00550446|80634706|FG002|Post Week 12|Lost to Follow-up|1|||
27670515|NCT00550446|80634707|FG003|Post Week 12|Lost to Follow-up|1|||
27670516|NCT00550446|80634708|FG004|Post Week 12|Lost to Follow-up|0|||
27670517|NCT00550446|80634709|FG005|Post Week 12|Lost to Follow-up|0|||
27670518|NCT00550446|80634710|FG006|Post Week 12|Lost to Follow-up|1|||
27670519|NCT00550446|80634711|FG007|Post Week 12|Lost to Follow-up|0|||
27670520|NCT00550446|80634712|FG008|Post Week 12|Lost to Follow-up|0|||
27670521|NCT00550446|80634713|FG009|Post Week 12|Lost to Follow-up|0|||
27670522|NCT00550446|80634714|FG010|Post Week 12|Lost to Follow-up|0|||
27670523|NCT00550446|80634704|FG000|Post Week 12|Withdrawal by Subject|0|||
27670524|NCT00550446|80634705|FG001|Post Week 12|Withdrawal by Subject|0|||
27670525|NCT00550446|80634706|FG002|Post Week 12|Withdrawal by Subject|0|||
27670526|NCT00550446|80634707|FG003|Post Week 12|Withdrawal by Subject|0|||
27670527|NCT00550446|80634708|FG004|Post Week 12|Withdrawal by Subject|1|||
27670528|NCT00550446|80634709|FG005|Post Week 12|Withdrawal by Subject|0|||
27670529|NCT00550446|80634710|FG006|Post Week 12|Withdrawal by Subject|0|||
27670530|NCT00550446|80634711|FG007|Post Week 12|Withdrawal by Subject|0|||
27670531|NCT00550446|80634712|FG008|Post Week 12|Withdrawal by Subject|0|||
27670532|NCT00550446|80634713|FG009|Post Week 12|Withdrawal by Subject|0|||
27670533|NCT00550446|80634714|FG010|Post Week 12|Withdrawal by Subject|0|||
27670534|NCT00550446|80634704|FG000|Post Week 12|Other|1|||
27670535|NCT00550446|80634705|FG001|Post Week 12|Other|1|||
27670536|NCT00550446|80634706|FG002|Post Week 12|Other|0|||
27670537|NCT00550446|80634707|FG003|Post Week 12|Other|1|||
27670538|NCT00550446|80634708|FG004|Post Week 12|Other|0|||
27670539|NCT00550446|80634709|FG005|Post Week 12|Other|0|||
27670540|NCT00550446|80634710|FG006|Post Week 12|Other|1|||
27670541|NCT00550446|80634711|FG007|Post Week 12|Other|0|||
27670542|NCT00550446|80634712|FG008|Post Week 12|Other|1|||
27670543|NCT00550446|80634713|FG009|Post Week 12|Other|1|||
27670544|NCT00550446|80634714|FG010|Post Week 12|Other|0|||
27670545|NCT02716298|80634715|FG000|First Intervention (1 Month)|Lens discomfort|1|||
27670546|NCT02716298|80634716|FG001|First Intervention (1 Month)|Lens discomfort|1|||
27670547|NCT03634839|80634723|FG000|First Intervention (2 Hours)|Adverse Event|0|||
27670548|NCT03634839|80634724|FG001|First Intervention (2 Hours)|Adverse Event|2|||
27670549|NCT01266161|80634725|FG000|Overall Study|Ineligible|1|||
27670550|NCT01266161|80634726|FG001|Overall Study|Ineligible|0|||
27670551|NCT01266161|80634725|FG000|Overall Study|Lack of Efficacy|0|||
27670552|NCT01266161|80634726|FG001|Overall Study|Lack of Efficacy|1|||
27670553|NCT01266161|80634725|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
27670554|NCT01266161|80634726|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
27572862|NCT00192075|80282206|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
27572863|NCT00192075|80282207|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
27572864|NCT00192075|80282206|FG000|Overall Study|Other|5|||
27670555|NCT01845805|80634727|FG000|Overall Study|Withdrawal by Subject|1|||
27670556|NCT01845805|80634728|FG001|Overall Study|Withdrawal by Subject|2|||
27670557|NCT01845805|80634727|FG000|Overall Study|Disease Progression|13|||
27670558|NCT01845805|80634728|FG001|Overall Study|Disease Progression|14|||
27670559|NCT01845805|80634727|FG000|Overall Study|Drug-related Toxicity|4|||
27670560|NCT01845805|80634728|FG001|Overall Study|Drug-related Toxicity|0|||
27572865|NCT00192075|80282207|FG001|Overall Study|Other|2|||
27670561|NCT00381797|80634729|FG000|Overall Study|Withdrawal by Subject|1|||
27670562|NCT00381797|80634730|FG001|Overall Study|Withdrawal by Subject|1|||
27670563|NCT00381797|80634731|FG002|Overall Study|Withdrawal by Subject|0|||
27670564|NCT00381797|80634732|FG003|Overall Study|Withdrawal by Subject|0|||
27670565|NCT00381797|80634733|FG004|Overall Study|Withdrawal by Subject|2|||
27572866|NCT02624284|80282210|FG000|Overall Study|Withdrawal by Subject|3|||
27572867|NCT02624284|80282211|FG001|Overall Study|Withdrawal by Subject|6|||
27572868|NCT02624284|80282212|FG002|Overall Study|Withdrawal by Subject|3|||
27572869|NCT02624284|80282210|FG000|Overall Study|Protocol Violation|9|||
27572870|NCT02624284|80282211|FG001|Overall Study|Protocol Violation|10|||
27866328|NCT02123446|81346401|FG001|Washout Period (1 Day)|Physician Decision|0|||
27866329|NCT03464630|81346402|FG000|Overall Study|Lost to Follow-up|62|||
27866330|NCT03464630|81346403|FG001|Overall Study|Lost to Follow-up|52|||
27866331|NCT03464630|81346402|FG000|Overall Study|Withdrawal by Subject|16|||
27866332|NCT03464630|81346403|FG001|Overall Study|Withdrawal by Subject|10|||
27866333|NCT03464630|81346402|FG000|Overall Study|Passive Disengagement|8|||
27866334|NCT03464630|81346403|FG001|Overall Study|Passive Disengagement|4|||
27866335|NCT00380744|81346404|FG000|Overall Study|Death|0|||
27572871|NCT02624284|80282212|FG002|Overall Study|Protocol Violation|7|||
27572872|NCT02624284|80282210|FG000|Overall Study|Revealed exclusionary condition|2|||
27866336|NCT00380744|81346405|FG001|Overall Study|Death|0|||
27866337|NCT00380744|81346406|FG002|Overall Study|Death|0|||
27973122|NCT00496483|81732533|FG000|Overall Study|Lack of Efficacy|1|||
27973123|NCT01846663|81732534|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
27973124|NCT01846663|81732535|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
27973125|NCT01846663|81732534|FG000|Overall Study|Withdrawal by Subject|1|||
27973126|NCT01846663|81732535|FG001|Overall Study|Withdrawal by Subject|0|||
27973127|NCT01846663|81732534|FG000|Overall Study|Adverse Event|1|||
27973128|NCT01846663|81732535|FG001|Overall Study|Adverse Event|2|||
27973129|NCT01118520|81732536|FG000|Overall Study|AAA repair|9|||
27973130|NCT01118520|81732537|FG001|Overall Study|AAA repair|7|||
27973131|NCT01118520|81732538|FG002|Overall Study|AAA repair|9|||
27973132|NCT01118520|81732536|FG000|Overall Study|Adverse Event|3|||
27973133|NCT01118520|81732537|FG001|Overall Study|Adverse Event|3|||
27973134|NCT01118520|81732538|FG002|Overall Study|Adverse Event|3|||
27973135|NCT01118520|81732536|FG000|Overall Study|Withdrawal by Subject|8|||
27973136|NCT01118520|81732537|FG001|Overall Study|Withdrawal by Subject|13|||
27973137|NCT01118520|81732538|FG002|Overall Study|Withdrawal by Subject|8|||
27973138|NCT01804582|81732547|FG000|Overall Study|Lost to Follow-up|47|||
27973139|NCT01804582|81732548|FG001|Overall Study|Lost to Follow-up|56|||
27973140|NCT01804582|81732547|FG000|Overall Study|Physician Decision|2|||
27973141|NCT01804582|81732548|FG001|Overall Study|Physician Decision|0|||
27973142|NCT03831880|81732553|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
27973143|NCT03831880|81732554|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
27973144|NCT03831880|81732553|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
27973145|NCT03831880|81732554|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
27973146|NCT01159171|81732555|FG000|Overall Study|Adverse Event|11|||
27973147|NCT01159171|81732555|FG000|Overall Study|Progression of Disease|28|||
27973148|NCT01159171|81732555|FG000|Overall Study|Protocol Violation|1|||
27973149|NCT01159171|81732555|FG000|Overall Study|Need for Surgery|5|||
27973150|NCT01159171|81732555|FG000|Overall Study|Medical Decision|4|||
27973151|NCT01159171|81732555|FG000|Overall Study|Death|1|||
27973152|NCT01349322|81732559|FG000|Overall Study|Protocol Violation|45|||
27973153|NCT01349322|81732560|FG001|Overall Study|Protocol Violation|47|||
27973154|NCT03389555|81732561|FG000|Overall Study|Protocol Violation|1|||
27973155|NCT03389555|81732562|FG001|Overall Study|Protocol Violation|3|||
27973156|NCT03389555|81732561|FG000|Overall Study|Death|1|||
27973157|NCT03389555|81732562|FG001|Overall Study|Death|0|||
27973158|NCT00596154|81732563|FG000|Overall Study|Not Evaluable|2|||
27973159|NCT01177553|81732564|FG000|Overall Study|babies not yet 6 months of age|1|||
27973160|NCT01177553|81732565|FG001|Overall Study|babies not yet 6 months of age|0|||
27973161|NCT03816176|81732566|FG000|Overall Study|Miscellaneous|5|||
27973162|NCT03816176|81732566|FG000|Overall Study|Lack of Efficacy|4|||
27973163|NCT03816176|81732566|FG000|Overall Study|Adverse Event|3|||
27973164|NCT03727646|81732572|FG000|Overall Study|Adverse Event|1|||
27973165|NCT03727646|81732573|FG001|Overall Study|Adverse Event|0|||
27572873|NCT02624284|80282211|FG001|Overall Study|Revealed exclusionary condition|2|||
27670566|NCT00381797|80634729|FG000|Overall Study|Ineligible|0|||
27866338|NCT00380744|81346407|FG003|Overall Study|Death|0|||
27866339|NCT00380744|81346408|FG004|Overall Study|Death|0|||
27866340|NCT00380744|81346409|FG005|Overall Study|Death|0|||
27973166|NCT00129701|81732574|FG000|Overall Study|Withdrawal by Subject|33|||
27973167|NCT04417218|81732575|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
27973168|NCT04417218|81732576|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
27973169|NCT03895086|81732577|FG000|Overall Study|Early termination study|1|||
27973170|NCT03895086|81732578|FG001|Overall Study|Early termination study|0|||
27973171|NCT00608023|81732580|FG000|Overall Study|Withdrawal by Subject|8|||
27973172|NCT00608023|81732581|FG001|Overall Study|Withdrawal by Subject|10|||
27973173|NCT00608023|81732582|FG002|Overall Study|Withdrawal by Subject|7|||
27973174|NCT00608023|81732580|FG000|Overall Study|Adverse Event|1|||
27973175|NCT00608023|81732581|FG001|Overall Study|Adverse Event|4|||
27973176|NCT00608023|81732582|FG002|Overall Study|Adverse Event|5|||
27973177|NCT00608023|81732580|FG000|Overall Study|Lost to Follow-up|2|||
27973178|NCT00608023|81732581|FG001|Overall Study|Lost to Follow-up|2|||
27572874|NCT02624284|80282212|FG002|Overall Study|Revealed exclusionary condition|0|||
27572875|NCT02624284|80282210|FG000|Overall Study|Adverse Event|0|||
27784871|NCT02418000|81043773|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784872|NCT02418000|81043774|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784873|NCT02418000|81043775|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
27784874|NCT02418000|81043771|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27784875|NCT02418000|81043772|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
27784876|NCT02418000|81043773|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27784877|NCT02418000|81043774|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27784878|NCT02418000|81043775|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
27784879|NCT02418000|81043771|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784880|NCT02418000|81043772|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27866341|NCT00380744|81346410|FG006|Overall Study|Death|1|||
27866342|NCT00380744|81346404|FG000|Overall Study|Withdrawal by Subject|1|||
27866343|NCT00380744|81346405|FG001|Overall Study|Withdrawal by Subject|0|||
27866344|NCT00380744|81346406|FG002|Overall Study|Withdrawal by Subject|0|||
27866345|NCT00380744|81346407|FG003|Overall Study|Withdrawal by Subject|0|||
27866346|NCT00380744|81346408|FG004|Overall Study|Withdrawal by Subject|0|||
27866347|NCT00380744|81346409|FG005|Overall Study|Withdrawal by Subject|0|||
27866348|NCT00380744|81346410|FG006|Overall Study|Withdrawal by Subject|0|||
27866349|NCT00489255|81346418|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
27866350|NCT00489255|81346419|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
27866351|NCT00489255|81346418|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
27866352|NCT00489255|81346419|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
27866353|NCT00489255|81346418|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
27866354|NCT00489255|81346419|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
27866355|NCT00489255|81346418|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
27866356|NCT00489255|81346419|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
27866357|NCT00489255|81346418|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
27572876|NCT02624284|80282211|FG001|Overall Study|Adverse Event|0|||
27784881|NCT02418000|81043773|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
27784882|NCT02418000|81043774|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27866358|NCT00489255|81346419|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
27866359|NCT00489255|81346418|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
27973179|NCT00608023|81732582|FG002|Overall Study|Lost to Follow-up|1|||
27973180|NCT00608023|81732580|FG000|Overall Study|Protocol Violation|1|||
27973181|NCT00608023|81732581|FG001|Overall Study|Protocol Violation|3|||
27973182|NCT00608023|81732582|FG002|Overall Study|Protocol Violation|1|||
27973183|NCT00608023|81732580|FG000|Overall Study|Unknown reason|0|||
27973184|NCT00608023|81732581|FG001|Overall Study|Unknown reason|3|||
27973185|NCT00608023|81732582|FG002|Overall Study|Unknown reason|0|||
27973186|NCT02442310|81732583|FG000|Overall Study|Adverse Event|2|||
27973187|NCT02442310|81732583|FG000|Overall Study|Withdrawal by Subject|1|||
27973188|NCT04508751|81732588|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
27973189|NCT04508751|81732589|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
27973190|NCT04508751|81732590|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
27973191|NCT05593913|81732593|FG000|Overall Study|Insufficient image quality|39|||
27973192|NCT03894969|81732596|FG000|Overall Study|Adverse Event|0|||
27973193|NCT03894969|81732597|FG001|Overall Study|Adverse Event|2|||
27973194|NCT03894969|81732598|FG002|Overall Study|Adverse Event|0|||
27973195|NCT03894969|81732599|FG003|Overall Study|Adverse Event|1|||
27973196|NCT03894969|81732600|FG004|Overall Study|Adverse Event|2|||
27973197|NCT03894969|81732596|FG000|Overall Study|Lost to Follow-up|3|||
27973198|NCT03894969|81732597|FG001|Overall Study|Lost to Follow-up|1|||
27973199|NCT03894969|81732598|FG002|Overall Study|Lost to Follow-up|1|||
27973200|NCT03894969|81732599|FG003|Overall Study|Lost to Follow-up|0|||
27973201|NCT03894969|81732600|FG004|Overall Study|Lost to Follow-up|0|||
27973202|NCT03894969|81732596|FG000|Overall Study|Withdrawal by Subject|2|||
27973203|NCT03894969|81732597|FG001|Overall Study|Withdrawal by Subject|1|||
27973204|NCT03894969|81732598|FG002|Overall Study|Withdrawal by Subject|3|||
27973205|NCT03894969|81732599|FG003|Overall Study|Withdrawal by Subject|4|||
27973206|NCT03894969|81732600|FG004|Overall Study|Withdrawal by Subject|8|||
27973207|NCT03894969|81732596|FG000|Overall Study|Other|0|||
27973208|NCT03894969|81732597|FG001|Overall Study|Other|0|||
27973209|NCT03894969|81732598|FG002|Overall Study|Other|0|||
27973210|NCT03894969|81732599|FG003|Overall Study|Other|0|||
27973211|NCT03894969|81732600|FG004|Overall Study|Other|3|||
27973212|NCT03894969|81732596|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
27973213|NCT03894969|81732597|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
27973214|NCT03894969|81732598|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
27973215|NCT03894969|81732599|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
27973216|NCT03894969|81732600|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
27973217|NCT03894969|81732596|FG000|Overall Study|Solicited Adverse Event|0|||
27973218|NCT03894969|81732597|FG001|Overall Study|Solicited Adverse Event|1|||
27973219|NCT03894969|81732598|FG002|Overall Study|Solicited Adverse Event|0|||
27973220|NCT03894969|81732599|FG003|Overall Study|Solicited Adverse Event|0|||
27973221|NCT03894969|81732600|FG004|Overall Study|Solicited Adverse Event|0|||
27973222|NCT01080768|81732601|FG000|Overall Study|Protocol Deviation|2|||
27973223|NCT01080768|81732602|FG001|Overall Study|Protocol Deviation|1|||
27973224|NCT01774253|81732603|FG000|Overall Study|Lack of Efficacy|4|||
27973225|NCT01774253|81732603|FG000|Overall Study|Physician Decision|2|||
27973226|NCT01774253|81732603|FG000|Overall Study|Withdrawal by Subject|2|||
27973227|NCT01774253|81732603|FG000|Overall Study|Death|1|||
27973228|NCT02150057|81732604|FG000|Overall Study|Lost to Follow-up|6|||
27973229|NCT02150057|81732605|FG001|Overall Study|Lost to Follow-up|4|||
27973230|NCT01327053|81732606|FG000|Overall Study|Adverse Event|23|||
27973231|NCT01327053|81732607|FG001|Overall Study|Adverse Event|57|||
27973232|NCT01327053|81732606|FG000|Overall Study|Patient/guardian decision|11|||
27973233|NCT01327053|81732607|FG001|Overall Study|Patient/guardian decision|35|||
27973234|NCT01327053|81732606|FG000|Overall Study|Physician Decision|10|||
27973235|NCT01327053|81732607|FG001|Overall Study|Physician Decision|14|||
27973236|NCT01327053|81732606|FG000|Overall Study|Death|1|||
27973237|NCT01327053|81732607|FG001|Overall Study|Death|5|||
27973238|NCT01327053|81732606|FG000|Overall Study|Lost to Follow-up|2|||
27973239|NCT01327053|81732607|FG001|Overall Study|Lost to Follow-up|4|||
27973240|NCT01327053|81732606|FG000|Overall Study|Non-compliance with study treatment|0|||
27973241|NCT01327053|81732607|FG001|Overall Study|Non-compliance with study treatment|5|||
27866360|NCT00489255|81346419|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
27866361|NCT00489255|81346418|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
27973242|NCT01327053|81732606|FG000|Overall Study|Study terminated by Sponsor|1|||
27973243|NCT01327053|81732607|FG001|Overall Study|Study terminated by Sponsor|3|||
27973244|NCT01327053|81732606|FG000|Overall Study|Progressive disease|31|||
27973245|NCT01327053|81732607|FG001|Overall Study|Progressive disease|26|||
27973246|NCT01327053|81732606|FG000|Overall Study|Protocol Violation|0|||
27973247|NCT01327053|81732607|FG001|Overall Study|Protocol Violation|1|||
27973248|NCT01327053|81732606|FG000|Overall Study|Untreated|0|||
27973249|NCT01327053|81732607|FG001|Overall Study|Untreated|1|||
27973250|NCT04941807|81732608|FG000|Overall Study|Lost to Follow-up|1|||
27973251|NCT04941807|81732609|FG001|Overall Study|Lost to Follow-up|1|||
27973252|NCT00744978|81732610|FG000|Period 1|Lost to Follow-up|1|||
27973253|NCT00744978|81732611|FG001|Period 1|Lost to Follow-up|0|||
27973254|NCT00744978|81732610|FG000|Period 1|Withdrawal by Subject|0|||
27572877|NCT02624284|80282212|FG002|Overall Study|Adverse Event|1|||
27572878|NCT00834912|80282214|FG000|Treatment Period 1|Adverse Event|0|||
27973255|NCT00744978|81732611|FG001|Period 1|Withdrawal by Subject|2|||
27973256|NCT00744978|81732610|FG000|Period 1|Other|0|||
27973257|NCT00744978|81732611|FG001|Period 1|Other|2|||
27973258|NCT00744978|81732610|FG000|Period 1|Adverse Event|4|||
27973259|NCT00744978|81732611|FG001|Period 1|Adverse Event|0|||
27973260|NCT00744978|81732610|FG000|Period 1|Randomized but not Treated|1|||
27973261|NCT00744978|81732611|FG001|Period 1|Randomized but not Treated|1|||
27973262|NCT00744978|81732610|FG000|Period 2|Adverse Event|0|||
27973263|NCT00744978|81732611|FG001|Period 2|Adverse Event|1|||
27973264|NCT00006164|81732612|FG000|Overall Study|Withdrew or lost to follow-up|70|||
27973265|NCT00006164|81732613|FG001|Overall Study|Withdrew or lost to follow-up|81|||
27973266|NCT02981407|81732616|FG000|Overall Study|Withdrawal by Subject|2|||
27973267|NCT02981407|81732617|FG001|Overall Study|Withdrawal by Subject|0|||
27973268|NCT01238835|81732618|FG000|Overall Study|Death|124|||
27973269|NCT01238835|81732618|FG000|Overall Study|Withdrawal by Subject|9|||
27973270|NCT01238835|81732618|FG000|Overall Study|Lost to Follow-up|1|||
27973271|NCT01238835|81732618|FG000|Overall Study|Site early discontinuation|2|||
27973272|NCT00642174|81732620|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
27973273|NCT00642174|81732621|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
27973274|NCT03392883|81732622|FG000|Overall Study|Lost to Follow-up|122|||
27973275|NCT03392883|81732623|FG001|Overall Study|Lost to Follow-up|13|||
27973276|NCT03392883|81732624|FG002|Overall Study|Lost to Follow-up|9|||
27973277|NCT03392883|81732622|FG000|Overall Study|Death|4|||
27973278|NCT03392883|81732623|FG001|Overall Study|Death|0|||
27973279|NCT03392883|81732624|FG002|Overall Study|Death|0|||
27973280|NCT03392883|81732622|FG000|Overall Study|Lack of Efficacy|29|||
27973281|NCT03392883|81732623|FG001|Overall Study|Lack of Efficacy|0|||
27973282|NCT03392883|81732624|FG002|Overall Study|Lack of Efficacy|0|||
27973283|NCT03392883|81732622|FG000|Overall Study|Withdrawal by Subject|180|||
27973284|NCT03392883|81732623|FG001|Overall Study|Withdrawal by Subject|0|||
27973285|NCT03392883|81732624|FG002|Overall Study|Withdrawal by Subject|0|||
27973286|NCT03392883|81732622|FG000|Overall Study|Adverse Event|1|||
27973287|NCT03392883|81732623|FG001|Overall Study|Adverse Event|0|||
27973288|NCT03392883|81732624|FG002|Overall Study|Adverse Event|0|||
27973289|NCT03960580|81732625|FG000|Overall Study|Adverse Event|2|||
27973290|NCT03960580|81732626|FG001|Overall Study|Adverse Event|1|||
27973291|NCT03960580|81732627|FG002|Overall Study|Adverse Event|1|||
27973292|NCT03960580|81732625|FG000|Overall Study|Lost to Follow-up|1|||
27973293|NCT03960580|81732626|FG001|Overall Study|Lost to Follow-up|0|||
27973294|NCT03960580|81732627|FG002|Overall Study|Lost to Follow-up|0|||
27973295|NCT03960580|81732625|FG000|Overall Study|Lack of Efficacy|2|||
27973296|NCT03960580|81732626|FG001|Overall Study|Lack of Efficacy|1|||
27973297|NCT03960580|81732627|FG002|Overall Study|Lack of Efficacy|0|||
27973298|NCT03960580|81732625|FG000|Overall Study|Protocol Violation|0|||
27973299|NCT03960580|81732626|FG001|Overall Study|Protocol Violation|0|||
27973300|NCT03960580|81732627|FG002|Overall Study|Protocol Violation|1|||
27973301|NCT03960580|81732625|FG000|Overall Study|Withdrawal by Subject|1|||
27973302|NCT03960580|81732626|FG001|Overall Study|Withdrawal by Subject|1|||
27973303|NCT03960580|81732627|FG002|Overall Study|Withdrawal by Subject|1|||
27973304|NCT03960580|81732625|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
27973305|NCT03960580|81732626|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
27973306|NCT03960580|81732627|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
27973307|NCT03158012|81732631|FG000|Overall Study|Withdrawal by Subject|0|||
27973308|NCT03158012|81732632|FG001|Overall Study|Withdrawal by Subject|1|||
27973309|NCT01170065|81732644|FG000|Overall Study|Adverse Event|17|||
27973310|NCT01170065|81732645|FG001|Overall Study|Adverse Event|50|||
27973311|NCT01170065|81732646|FG002|Overall Study|Adverse Event|10|||
27973312|NCT01170065|81732644|FG000|Overall Study|Lost to Follow-up|1|||
27973313|NCT01170065|81732645|FG001|Overall Study|Lost to Follow-up|4|||
27973314|NCT01170065|81732646|FG002|Overall Study|Lost to Follow-up|1|||
27973315|NCT01170065|81732644|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
27670567|NCT00381797|80634730|FG001|Overall Study|Ineligible|0|||
27670568|NCT00381797|80634731|FG002|Overall Study|Ineligible|0|||
27670569|NCT00381797|80634732|FG003|Overall Study|Ineligible|1|||
27670570|NCT00381797|80634733|FG004|Overall Study|Ineligible|0|||
27670571|NCT04042077|80634734|FG000|Overall Study|Adverse Event|0|||
27670572|NCT04042077|80634735|FG001|Overall Study|Adverse Event|1|||
27670573|NCT04042077|80634734|FG000|Overall Study|Death|2|||
27670574|NCT04042077|80634735|FG001|Overall Study|Death|1|||
27670575|NCT04042077|80634734|FG000|Overall Study|Physician Decision|2|||
27670576|NCT04042077|80634735|FG001|Overall Study|Physician Decision|0|||
27670577|NCT04042077|80634734|FG000|Overall Study|Withdrawal by Subject|3|||
27670578|NCT04042077|80634735|FG001|Overall Study|Withdrawal by Subject|2|||
27670579|NCT04042077|80634734|FG000|Overall Study|Lack of Efficacy|0|||
27670580|NCT04042077|80634735|FG001|Overall Study|Lack of Efficacy|1|||
27670581|NCT00905034|80634737|FG000|Overall Study|Withdrawal by Subject|1|||
27670582|NCT04016272|80634738|FG000|Overall Study|Withdrawal by Subject|1|||
27670583|NCT04016272|80634739|FG001|Overall Study|Withdrawal by Subject|2|||
27973316|NCT01170065|81732645|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
27973317|NCT01170065|81732646|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
27973318|NCT01170065|81732644|FG000|Overall Study|Reason other than specified|3|||
27973319|NCT01170065|81732645|FG001|Overall Study|Reason other than specified|8|||
27670584|NCT00839332|80634740|FG000|Phase 1|Disease Progression|38|||
27670585|NCT00839332|80634741|FG001|Phase 1|Disease Progression|0|||
27670586|NCT00839332|80634742|FG002|Phase 1|Disease Progression|0|||
27670587|NCT00839332|80634740|FG000|Phase 1|Adverse Event|6|||
27670588|NCT00839332|80634741|FG001|Phase 1|Adverse Event|0|||
27670589|NCT00839332|80634742|FG002|Phase 1|Adverse Event|0|||
27670590|NCT00839332|80634740|FG000|Phase 1|Withdrawal by Subject|4|||
27670591|NCT00839332|80634741|FG001|Phase 1|Withdrawal by Subject|0|||
27670592|NCT00839332|80634742|FG002|Phase 1|Withdrawal by Subject|0|||
27670593|NCT00839332|80634740|FG000|Phase 1|Physician Decision|2|||
27670594|NCT00839332|80634741|FG001|Phase 1|Physician Decision|0|||
27670595|NCT00839332|80634742|FG002|Phase 1|Physician Decision|0|||
27670596|NCT00839332|80634740|FG000|Phase 2|Protocol Violation|0|||
27670597|NCT00839332|80634741|FG001|Phase 2|Protocol Violation|1|||
27670598|NCT00839332|80634742|FG002|Phase 2|Protocol Violation|0|||
27670599|NCT00839332|80634740|FG000|Phase 2|Disease Progression|0|||
27670600|NCT00839332|80634741|FG001|Phase 2|Disease Progression|46|||
27670601|NCT00839332|80634742|FG002|Phase 2|Disease Progression|21|||
27670602|NCT00839332|80634740|FG000|Phase 2|Adverse Event|0|||
27670603|NCT00839332|80634741|FG001|Phase 2|Adverse Event|8|||
27670604|NCT00839332|80634742|FG002|Phase 2|Adverse Event|6|||
27973320|NCT01170065|81732646|FG002|Overall Study|Reason other than specified|3|||
27670605|NCT00839332|80634740|FG000|Phase 2|Death|0|||
27670606|NCT00839332|80634741|FG001|Phase 2|Death|4|||
27670607|NCT00839332|80634742|FG002|Phase 2|Death|2|||
27670608|NCT00839332|80634740|FG000|Phase 2|Withdrawal by Subject|0|||
27670609|NCT00839332|80634741|FG001|Phase 2|Withdrawal by Subject|5|||
27670610|NCT00839332|80634742|FG002|Phase 2|Withdrawal by Subject|8|||
27670611|NCT00839332|80634740|FG000|Phase 2|Physician Decision|0|||
27670612|NCT00839332|80634741|FG001|Phase 2|Physician Decision|4|||
27670613|NCT00839332|80634742|FG002|Phase 2|Physician Decision|1|||
27670614|NCT00839332|80634740|FG000|Phase 2|Lost to Follow-up|0|||
27670615|NCT00839332|80634741|FG001|Phase 2|Lost to Follow-up|0|||
27670616|NCT00839332|80634742|FG002|Phase 2|Lost to Follow-up|1|||
27670617|NCT00573651|80634743|FG000|Overall Study|Lost to Follow-up|3|||
27670618|NCT00573651|80634743|FG000|Overall Study|Withdrawal by Subject|1|||
27670619|NCT01437423|80634744|FG000|Overall Study|Lost to Follow-up|12|||
27670620|NCT01437423|80634744|FG000|Overall Study|Off label usage|3|||
27670621|NCT00732992|80634745|FG000|Overall Study|Adverse Event|1|||
27670622|NCT00732992|80634746|FG001|Overall Study|Adverse Event|1|||
27670623|NCT00732992|80634745|FG000|Overall Study|Objective Progression or Relapse|3|||
27670624|NCT00732992|80634746|FG001|Overall Study|Objective Progression or Relapse|5|||
27670625|NCT00732992|80634745|FG000|Overall Study|Global Deterioration of Health Status|1|||
27670626|NCT00732992|80634746|FG001|Overall Study|Global Deterioration of Health Status|0|||
27670627|NCT00732992|80634745|FG000|Overall Study|Withdrawal by Subject|1|||
27670628|NCT00732992|80634746|FG001|Overall Study|Withdrawal by Subject|0|||
27670629|NCT01288209|80634747|FG000|Overall Study|Withdrawal by Subject|1|||
27973321|NCT01170065|81732644|FG000|Overall Study|Ongoing after planned observation time|5|||
27973322|NCT01170065|81732645|FG001|Overall Study|Ongoing after planned observation time|26|||
27670630|NCT01288209|80634748|FG001|Overall Study|Withdrawal by Subject|3|||
27670631|NCT01288209|80634747|FG000|Overall Study|Other|1|||
27670632|NCT01288209|80634748|FG001|Overall Study|Other|0|||
27670633|NCT03470545|80634754|FG000|Overall Study|Death|0|||
27670634|NCT03470545|80634755|FG001|Overall Study|Death|1|||
27670635|NCT03470545|80634754|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
27670636|NCT03470545|80634755|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
27670637|NCT03470545|80634754|FG000|Overall Study|Adverse Event|2|||
27670638|NCT03470545|80634755|FG001|Overall Study|Adverse Event|0|||
27670639|NCT03470545|80634754|FG000|Overall Study|Withdrawal by Subject|1|||
27670640|NCT03470545|80634755|FG001|Overall Study|Withdrawal by Subject|1|||
27670641|NCT03470545|80634754|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
27670642|NCT03470545|80634755|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
27670643|NCT03229486|80634757|FG000|Overall Study|Protocol Violation|0|||
27670644|NCT03229486|80634758|FG001|Overall Study|Protocol Violation|1|||
27670645|NCT00664105|80634759|FG000|Overall Study|Death|3|||
27670646|NCT00664105|80634759|FG000|Overall Study|Withdrawal by Subject|5|||
27670647|NCT00664105|80634759|FG000|Overall Study|Adverse Event|9|||
27670648|NCT00664105|80634759|FG000|Overall Study|Disease progression|7|||
27973323|NCT01170065|81732646|FG002|Overall Study|Ongoing after planned observation time|10|||
27973324|NCT00931723|81732650|FG000|Overall Study|Withdrawal by Subject|11|||
27973325|NCT00931723|81732651|FG001|Overall Study|Withdrawal by Subject|13|||
27973326|NCT00931723|81732650|FG000|Overall Study|Adverse Event|6|||
27973327|NCT00931723|81732651|FG001|Overall Study|Adverse Event|13|||
27973328|NCT00931723|81732650|FG000|Overall Study|Lithium found in blood|0|||
27973329|NCT00931723|81732651|FG001|Overall Study|Lithium found in blood|1|||
27973330|NCT00931723|81732650|FG000|Overall Study|Condition under investigation worsened|1|||
27670649|NCT00612352|80634760|FG000|Overall Study|Adverse Event|1|||
27670650|NCT00612352|80634761|FG001|Overall Study|Adverse Event|0|||
27670651|NCT00612352|80634760|FG000|Overall Study|Withdrawal by Subject|3|||
27670652|NCT00612352|80634761|FG001|Overall Study|Withdrawal by Subject|5|||
27670653|NCT00612352|80634760|FG000|Overall Study|moved out of state|1|||
27670654|NCT00612352|80634761|FG001|Overall Study|moved out of state|0|||
27670655|NCT00612352|80634760|FG000|Overall Study|didn't return calls/show up on test date|4|||
27670656|NCT00612352|80634761|FG001|Overall Study|didn't return calls/show up on test date|1|||
27670657|NCT01466790|80634762|FG000|Overall Study|Adverse Event|1|||
27670658|NCT01466790|80634763|FG001|Overall Study|Adverse Event|0|||
27670659|NCT01466790|80634764|FG002|Overall Study|Adverse Event|0|||
27670660|NCT01466790|80634765|FG003|Overall Study|Adverse Event|0|||
27670661|NCT01466790|80634766|FG004|Overall Study|Adverse Event|2|||
27670662|NCT01466790|80634767|FG005|Overall Study|Adverse Event|0|||
27670663|NCT01466790|80634768|FG006|Overall Study|Adverse Event|0|||
27670664|NCT01466790|80634769|FG007|Overall Study|Adverse Event|0|||
27670665|NCT01466790|80634762|FG000|Overall Study|Lost to Follow-up|2|||
27670666|NCT01466790|80634763|FG001|Overall Study|Lost to Follow-up|0|||
27670667|NCT01466790|80634764|FG002|Overall Study|Lost to Follow-up|0|||
27973331|NCT00931723|81732651|FG001|Overall Study|Condition under investigation worsened|2|||
27973332|NCT00931723|81732650|FG000|Overall Study|Lost to Follow-up|1|||
27973333|NCT00931723|81732651|FG001|Overall Study|Lost to Follow-up|2|||
27973334|NCT00931723|81732650|FG000|Overall Study|Study-specific discontinuation criteria|1|||
27973335|NCT00931723|81732651|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27973336|NCT00931723|81732650|FG000|Overall Study|Severe non-compliance to protocol|2|||
27973337|NCT00931723|81732651|FG001|Overall Study|Severe non-compliance to protocol|0|||
27973338|NCT00931723|81732650|FG000|Overall Study|Safety reasons|0|||
27973339|NCT00931723|81732651|FG001|Overall Study|Safety reasons|1|||
27973340|NCT00931723|81732650|FG000|Overall Study|Took prohibited concomitant medication|0|||
27973341|NCT00931723|81732651|FG001|Overall Study|Took prohibited concomitant medication|1|||
27973342|NCT00931723|81732650|FG000|Overall Study|Lack or insufficient theraputic response|2|||
27973343|NCT00931723|81732651|FG001|Overall Study|Lack or insufficient theraputic response|5|||
27973344|NCT00931723|81732650|FG000|Overall Study|Sponsor decision|1|||
27973345|NCT00931723|81732651|FG001|Overall Study|Sponsor decision|0|||
27973346|NCT00931723|81732650|FG000|Overall Study|Late hospital discharge|1|||
27973347|NCT00931723|81732651|FG001|Overall Study|Late hospital discharge|0|||
27973348|NCT00075946|81732652|FG000|Overall Study|Path ineligible: undetermined histology|0|||
27973349|NCT00075946|81732653|FG001|Overall Study|Path ineligible: undetermined histology|0|||
27973350|NCT00075946|81732654|FG002|Overall Study|Path ineligible: undetermined histology|0|||
27973351|NCT00075946|81732655|FG003|Overall Study|Path ineligible: undetermined histology|0|||
27973352|NCT00075946|81732656|FG004|Overall Study|Path ineligible: undetermined histology|6|||
27973353|NCT00075946|81732652|FG000|Overall Study|Did not achieve response after induction|0|||
27572879|NCT00834912|80282215|FG001|Treatment Period 1|Adverse Event|1|||
27670668|NCT01466790|80634765|FG003|Overall Study|Lost to Follow-up|0|||
27670669|NCT01466790|80634766|FG004|Overall Study|Lost to Follow-up|0|||
27670670|NCT01466790|80634767|FG005|Overall Study|Lost to Follow-up|0|||
27670671|NCT01466790|80634768|FG006|Overall Study|Lost to Follow-up|0|||
27670672|NCT01466790|80634769|FG007|Overall Study|Lost to Follow-up|0|||
27973354|NCT00075946|81732653|FG001|Overall Study|Did not achieve response after induction|0|||
27670673|NCT01466790|80634762|FG000|Overall Study|Withdrawal by Subject|1|||
27670674|NCT01466790|80634763|FG001|Overall Study|Withdrawal by Subject|1|||
27973355|NCT00075946|81732654|FG002|Overall Study|Did not achieve response after induction|0|||
27973356|NCT00075946|81732655|FG003|Overall Study|Did not achieve response after induction|0|||
27670675|NCT01466790|80634764|FG002|Overall Study|Withdrawal by Subject|0|||
27670676|NCT01466790|80634765|FG003|Overall Study|Withdrawal by Subject|0|||
27670677|NCT01466790|80634766|FG004|Overall Study|Withdrawal by Subject|1|||
27670678|NCT01466790|80634767|FG005|Overall Study|Withdrawal by Subject|0|||
27670679|NCT01466790|80634768|FG006|Overall Study|Withdrawal by Subject|1|||
27670680|NCT01466790|80634769|FG007|Overall Study|Withdrawal by Subject|1|||
27670681|NCT00559377|80634770|FG000|Overall Study|Withdrawal by Subject|9|||
27670682|NCT03602586|80634771|FG000|Overall Study|Withdrawal by Subject|3|||
27670683|NCT00912223|80634772|FG000|Overall Study|Withdrawal by Subject|1|||
27670684|NCT00912223|80634772|FG000|Overall Study|Not transplanted|1|||
27670685|NCT00912223|80634772|FG000|Overall Study|Transformed disease|1|||
27670686|NCT01151423|80634773|FG000|Overall Study|Study terminated by Sponsor|9|||
27670687|NCT01151423|80634774|FG001|Overall Study|Study terminated by Sponsor|10|||
27670688|NCT01151423|80634773|FG000|Overall Study|Protocol Violation|0|||
27670689|NCT01151423|80634774|FG001|Overall Study|Protocol Violation|1|||
27670690|NCT01151423|80634773|FG000|Overall Study|Physician Decision|1|||
27670691|NCT01151423|80634774|FG001|Overall Study|Physician Decision|1|||
27670692|NCT01151423|80634773|FG000|Overall Study|Pregnancy|0|||
27670693|NCT01151423|80634774|FG001|Overall Study|Pregnancy|1|||
27670694|NCT01151423|80634773|FG000|Overall Study|Death|0|||
27670695|NCT01151423|80634774|FG001|Overall Study|Death|1|||
27670696|NCT01151423|80634773|FG000|Overall Study|Adverse Event|3|||
27670697|NCT01151423|80634774|FG001|Overall Study|Adverse Event|0|||
27670698|NCT01151423|80634773|FG000|Overall Study|Withdrawal by Subject|1|||
27670699|NCT01151423|80634774|FG001|Overall Study|Withdrawal by Subject|3|||
27670700|NCT01151423|80634773|FG000|Overall Study|Lost to Follow-up|1|||
27670701|NCT01151423|80634774|FG001|Overall Study|Lost to Follow-up|0|||
27670702|NCT01151423|80634773|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
27670703|NCT01151423|80634774|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
27670704|NCT01151423|80634773|FG000|Overall Study|Participated in other clinical trial|1|||
27670705|NCT01151423|80634774|FG001|Overall Study|Participated in other clinical trial|0|||
27670706|NCT01628692|80634790|FG000|Overall Study|Lack of Efficacy|4|||
27670707|NCT01628692|80634791|FG001|Overall Study|Lack of Efficacy|4|||
27670708|NCT01628692|80634792|FG002|Overall Study|Lack of Efficacy|5|||
27670709|NCT01628692|80634793|FG003|Overall Study|Lack of Efficacy|1|||
27670710|NCT01628692|80634794|FG004|Overall Study|Lack of Efficacy|4|||
27670711|NCT01628692|80634795|FG005|Overall Study|Lack of Efficacy|7|||
27670712|NCT01628692|80634790|FG000|Overall Study|Adverse Event|2|||
27670713|NCT01628692|80634791|FG001|Overall Study|Adverse Event|0|||
27670714|NCT01628692|80634792|FG002|Overall Study|Adverse Event|2|||
27866362|NCT00489255|81346419|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
27866363|NCT00489255|81346418|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
27866364|NCT00489255|81346419|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
27866365|NCT00489255|81346418|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
27866366|NCT00489255|81346419|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
27866367|NCT00489255|81346418|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
27866368|NCT00489255|81346419|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
27866369|NCT02046603|81346420|FG000|Overall Study|Other|11|||
27866370|NCT02046603|81346421|FG001|Overall Study|Other|66|||
27866371|NCT02046603|81346420|FG000|Overall Study|Protocol Violation|0|||
27866372|NCT02046603|81346421|FG001|Overall Study|Protocol Violation|1|||
27866373|NCT02046603|81346420|FG000|Overall Study|Participant/legal guardian decision|1|||
27866374|NCT02046603|81346421|FG001|Overall Study|Participant/legal guardian decision|3|||
27866375|NCT02046603|81346420|FG000|Overall Study|Physician Decision|2|||
27866376|NCT02046603|81346421|FG001|Overall Study|Physician Decision|1|||
27866377|NCT02046603|81346420|FG000|Overall Study|Lost to Follow-up|1|||
27866378|NCT02046603|81346421|FG001|Overall Study|Lost to Follow-up|2|||
27866379|NCT02046603|81346420|FG000|Overall Study|Death|0|||
27866380|NCT02046603|81346421|FG001|Overall Study|Death|1|||
27866381|NCT02046603|81346420|FG000|Overall Study|Adverse Event|0|||
27866382|NCT02046603|81346421|FG001|Overall Study|Adverse Event|1|||
27866383|NCT00911300|81346422|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
27866384|NCT00911300|81346423|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
27866385|NCT00911300|81346422|FG000|Overall Study|Death|1|||
27670715|NCT01628692|80634793|FG003|Overall Study|Adverse Event|0|||
27670716|NCT01628692|80634794|FG004|Overall Study|Adverse Event|0|||
27670717|NCT01628692|80634795|FG005|Overall Study|Adverse Event|0|||
27866386|NCT00911300|81346423|FG001|Overall Study|Death|0|||
27866387|NCT00911300|81346422|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
27973357|NCT00075946|81732656|FG004|Overall Study|Did not achieve response after induction|182|||
27670718|NCT01628692|80634790|FG000|Overall Study|Withdrawal by Subject|0|||
27866388|NCT00911300|81346423|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
27866389|NCT00911300|81346422|FG000|Overall Study|Adverse Event|14|||
27866390|NCT00911300|81346423|FG001|Overall Study|Adverse Event|6|||
27866391|NCT00911300|81346422|FG000|Overall Study|Protocol Violation|3|||
27866392|NCT00911300|81346423|FG001|Overall Study|Protocol Violation|2|||
27866393|NCT00911300|81346422|FG000|Overall Study|Consent Withdrawn|4|||
27866394|NCT00911300|81346423|FG001|Overall Study|Consent Withdrawn|12|||
27866395|NCT00911300|81346422|FG000|Overall Study|Coronary Angiography Performed|1|||
27866396|NCT00911300|81346423|FG001|Overall Study|Coronary Angiography Performed|0|||
27866397|NCT00911300|81346422|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
27866398|NCT00911300|81346423|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
27866399|NCT00911300|81346422|FG000|Overall Study|Received Commercial Treatment|1|||
27866400|NCT00911300|81346423|FG001|Overall Study|Received Commercial Treatment|0|||
27866401|NCT00911300|81346422|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
27866402|NCT00911300|81346423|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
27866403|NCT00911300|81346422|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
27866404|NCT00911300|81346423|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
27866405|NCT00911300|81346422|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
27866406|NCT00911300|81346423|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
27866407|NCT00911300|81346422|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
27572880|NCT00834912|80282216|FG002|Treatment Period 1|Adverse Event|0|||
27572881|NCT00834912|80282217|FG003|Treatment Period 1|Adverse Event|1|||
27572882|NCT00834912|80282218|FG004|Treatment Period 1|Adverse Event|0|||
27572883|NCT00834912|80282219|FG005|Treatment Period 1|Adverse Event|0|||
27572884|NCT00834912|80282214|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27572885|NCT00834912|80282215|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27572886|NCT00834912|80282216|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27572887|NCT00834912|80282217|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27572888|NCT00834912|80282218|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27572889|NCT00834912|80282219|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27572890|NCT03571516|80282220|FG000|Overall Study|Severe diarrhea|1|||
27572891|NCT03571516|80282221|FG001|Overall Study|Severe diarrhea|0|||
27572892|NCT03571516|80282220|FG000|Overall Study|Withdrawal by Subject|0|||
27572893|NCT03571516|80282221|FG001|Overall Study|Withdrawal by Subject|1|||
27572894|NCT02554656|80282223|FG000|Overall Study|Protocol Violation|3|||
27572895|NCT01073865|80282224|FG000|Overall Study|Reasons other than below|19|||
27572896|NCT01073865|80282225|FG001|Overall Study|Reasons other than below|31|||
27572897|NCT01073865|80282224|FG000|Overall Study|Lost to Follow-up|1|||
27572898|NCT01073865|80282225|FG001|Overall Study|Lost to Follow-up|1|||
27572899|NCT01073865|80282224|FG000|Overall Study|Death|3|||
27866408|NCT00911300|81346423|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
27572900|NCT01073865|80282225|FG001|Overall Study|Death|2|||
27572901|NCT01073865|80282224|FG000|Overall Study|Withdrawal by Subject|5|||
27572902|NCT01073865|80282225|FG001|Overall Study|Withdrawal by Subject|5|||
27572903|NCT00782210|80282226|FG000|Overall Study|Adverse Event|21|||
27572904|NCT00782210|80282227|FG001|Overall Study|Adverse Event|17|||
27572905|NCT00782210|80282228|FG002|Overall Study|Adverse Event|16|||
27572906|NCT00782210|80282226|FG000|Overall Study|Lost to Follow-up|2|||
27572907|NCT00782210|80282227|FG001|Overall Study|Lost to Follow-up|1|||
27572908|NCT00782210|80282228|FG002|Overall Study|Lost to Follow-up|2|||
27572909|NCT00782210|80282226|FG000|Overall Study|Withdrawal by Subject|11|||
27572910|NCT00782210|80282227|FG001|Overall Study|Withdrawal by Subject|8|||
27572911|NCT00782210|80282228|FG002|Overall Study|Withdrawal by Subject|11|||
27572912|NCT00782210|80282226|FG000|Overall Study|Non compliance with protocol|0|||
27572913|NCT00782210|80282227|FG001|Overall Study|Non compliance with protocol|3|||
27572914|NCT00782210|80282228|FG002|Overall Study|Non compliance with protocol|2|||
27572915|NCT00782210|80282226|FG000|Overall Study|Lack of Efficacy|13|||
27572916|NCT00782210|80282227|FG001|Overall Study|Lack of Efficacy|4|||
27572917|NCT00782210|80282228|FG002|Overall Study|Lack of Efficacy|1|||
27866409|NCT00911300|81346422|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
27866410|NCT00911300|81346423|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
27866411|NCT00911300|81346422|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
27866412|NCT00911300|81346423|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
27866413|NCT00911300|81346422|FG000|Overall Study|International Normalized Ratio Too High|0|||
27866414|NCT00911300|81346423|FG001|Overall Study|International Normalized Ratio Too High|1|||
27866415|NCT00911300|81346422|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
27866416|NCT00911300|81346423|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
27866417|NCT00911300|81346422|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
27866418|NCT00911300|81346423|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
27866419|NCT00911300|81346422|FG000|Overall Study|Physician Decision|0|||
27866420|NCT00911300|81346423|FG001|Overall Study|Physician Decision|1|||
27866421|NCT00911300|81346422|FG000|Overall Study|Treatment Stopped by Mistake|0|||
27572918|NCT00782210|80282226|FG000|Overall Study|Other reason not described above|3|||
27572919|NCT00782210|80282227|FG001|Overall Study|Other reason not described above|2|||
27572920|NCT00782210|80282228|FG002|Overall Study|Other reason not described above|3|||
27572921|NCT00418691|80282231|FG000|Overall Study|Lost to Follow-up|1|||
27572922|NCT00418691|80282232|FG001|Overall Study|Lost to Follow-up|2|||
27572923|NCT00418691|80282233|FG002|Overall Study|Lost to Follow-up|3|||
27866422|NCT00911300|81346423|FG001|Overall Study|Treatment Stopped by Mistake|1|||
27866423|NCT00911300|81346422|FG000|Overall Study|Randomized; No Study Medication Received|0|||
27866424|NCT00911300|81346423|FG001|Overall Study|Randomized; No Study Medication Received|2|||
27866425|NCT01371539|81346426|FG000|Period One: One Week|Lost to Follow-up|0|||
27866426|NCT01371539|81346427|FG001|Period One: One Week|Lost to Follow-up|1|||
27866427|NCT01371539|81346426|FG000|Period Two: One Week|Lost to Follow-up|0|||
27866428|NCT01371539|81346427|FG001|Period Two: One Week|Lost to Follow-up|1|||
27784883|NCT02418000|81043775|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784884|NCT02418000|81043771|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784885|NCT02418000|81043772|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784886|NCT02418000|81043773|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784887|NCT02418000|81043774|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
27784888|NCT02418000|81043775|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784889|NCT02418000|81043771|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27784890|NCT02418000|81043772|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27784891|NCT02418000|81043773|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27866429|NCT01371539|81346426|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
27866430|NCT01371539|81346427|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
27866431|NCT01371539|81346426|FG000|Period Two: One Week|Time/job conflict|0|||
27866432|NCT01371539|81346427|FG001|Period Two: One Week|Time/job conflict|1|||
27866433|NCT00445146|81346428|FG000|Overall Study|Withdrew Consent|29|||
27866434|NCT00445146|81346428|FG000|Overall Study|Lack of Efficacy|28|||
27866435|NCT00445146|81346428|FG000|Overall Study|Investigator's Discretion|22|||
27866436|NCT00445146|81346428|FG000|Overall Study|Adverse Event|13|||
27866437|NCT00445146|81346428|FG000|Overall Study|Lost to Follow-up|13|||
27866438|NCT00445146|81346428|FG000|Overall Study|Death|9|||
27866439|NCT00445146|81346428|FG000|Overall Study|Protocol Violation|4|||
27866440|NCT00445146|81346428|FG000|Overall Study|Pregnancy|1|||
27866441|NCT01128543|81346429|FG000|Overall Study|Withdrawal by Subject|3|||
27866442|NCT01128543|81346429|FG000|Overall Study|Protocol Violation|1|||
27866443|NCT02842073|81346432|FG000|Overall Study|Withdrawal by Subject|1|||
27866444|NCT01632280|81346442|FG000|Overall Study|Withdrawal by Subject|1|||
27866445|NCT01632280|81346443|FG001|Overall Study|Withdrawal by Subject|0|||
27866446|NCT02620579|81346445|FG000|Overall Study|Physician Decision|0|||
27866447|NCT02620579|81346446|FG001|Overall Study|Physician Decision|0|||
27866448|NCT02620579|81346447|FG002|Overall Study|Physician Decision|0|||
27866449|NCT02620579|81346448|FG003|Overall Study|Physician Decision|1|||
27866450|NCT02620579|81346445|FG000|Overall Study|Withdrawal by Subject|0|||
27866451|NCT02620579|81346446|FG001|Overall Study|Withdrawal by Subject|1|||
27866452|NCT02620579|81346447|FG002|Overall Study|Withdrawal by Subject|1|||
27866453|NCT02620579|81346448|FG003|Overall Study|Withdrawal by Subject|0|||
27866454|NCT01756079|81346452|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
27866455|NCT01756079|81346452|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
27866456|NCT01756079|81346452|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
27866457|NCT01756079|81346452|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
27866458|NCT01756079|81346452|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
27572924|NCT00418691|80282231|FG000|Overall Study|Started new medication voiding entry|0|||
27572925|NCT00418691|80282232|FG001|Overall Study|Started new medication voiding entry|0|||
27572926|NCT00418691|80282233|FG002|Overall Study|Started new medication voiding entry|1|||
27572927|NCT00418691|80282231|FG000|Overall Study|Progressive Disease|1|||
27572928|NCT00418691|80282232|FG001|Overall Study|Progressive Disease|0|||
27572929|NCT00418691|80282233|FG002|Overall Study|Progressive Disease|1|||
27572930|NCT00298831|80282238|FG000|Overall Study|Adverse Event|1|||
27572931|NCT00298831|80282238|FG000|Overall Study|Lost to Follow-up|3|||
27572932|NCT00298831|80282238|FG000|Overall Study|Withdrawal by Subject|1|||
27572933|NCT00298831|80282238|FG000|Overall Study|Participants did not receive treatment|27|||
27572934|NCT01603875|80282240|FG000|Overall Study|Preexisting rabies antibody|3|||
27572935|NCT01603875|80282241|FG001|Overall Study|Preexisting rabies antibody|4|||
27572936|NCT01603875|80282242|FG002|Overall Study|Preexisting rabies antibody|3|||
27572937|NCT01603875|80282240|FG000|Overall Study|Lost to Follow-up|4|||
27572938|NCT01603875|80282241|FG001|Overall Study|Lost to Follow-up|3|||
27572939|NCT01603875|80282242|FG002|Overall Study|Lost to Follow-up|6|||
27572940|NCT01603875|80282240|FG000|Overall Study|Protocol Violation|0|||
27572941|NCT01603875|80282241|FG001|Overall Study|Protocol Violation|1|||
27572942|NCT01603875|80282242|FG002|Overall Study|Protocol Violation|0|||
27572943|NCT00499603|80282243|FG000|Overall Study|Adverse Event|0|||
27572944|NCT00499603|80282244|FG001|Overall Study|Adverse Event|1|||
27784892|NCT02418000|81043774|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
27572945|NCT00357370|80282245|FG000|Cohort 2|Lack of Efficacy|0|||
27866459|NCT01118975|81346453|FG000|Overall Study|Adverse Event|0|||
27866460|NCT01118975|81346454|FG001|Overall Study|Adverse Event|1|||
27866461|NCT02015065|81346457|FG000|Overall Study|Death on study|1|||
27866462|NCT02015065|81346458|FG001|Overall Study|Death on study|2|||
27784893|NCT02418000|81043775|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
27572946|NCT00357370|80282246|FG001|Cohort 2|Lack of Efficacy|2|||
27572947|NCT00357370|80282247|FG002|Cohort 2|Lack of Efficacy|1|||
27572948|NCT00357370|80282245|FG000|Cohort 2|Adverse Event|1|||
27572949|NCT00357370|80282246|FG001|Cohort 2|Adverse Event|1|||
27572950|NCT00357370|80282247|FG002|Cohort 2|Adverse Event|1|||
27572951|NCT00357370|80282245|FG000|Cohort 2|Lost to Follow-up|0|||
27572952|NCT00357370|80282246|FG001|Cohort 2|Lost to Follow-up|1|||
27572953|NCT00357370|80282247|FG002|Cohort 2|Lost to Follow-up|0|||
27572954|NCT00357370|80282245|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
27572955|NCT00357370|80282246|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
27572956|NCT00357370|80282247|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
27572957|NCT00357370|80282245|FG000|Cohort 2|Withdrawal by Subject|0|||
27572958|NCT00357370|80282246|FG001|Cohort 2|Withdrawal by Subject|2|||
27572959|NCT00357370|80282247|FG002|Cohort 2|Withdrawal by Subject|0|||
27572960|NCT00427635|80282252|FG000|Treatment Phase|Withdrawal by Subject|1|||
27572961|NCT00427635|80282253|FG001|Treatment Phase|Withdrawal by Subject|0|||
27572962|NCT00427635|80282252|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
27572963|NCT00427635|80282253|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
27572964|NCT01785602|80282254|FG000|Overall Study|Withdrawal by Subject|2|||
27572965|NCT01785602|80282255|FG001|Overall Study|Withdrawal by Subject|0|||
27572966|NCT01785602|80282254|FG000|Overall Study|Lost to Follow-up|1|||
27572967|NCT01785602|80282255|FG001|Overall Study|Lost to Follow-up|1|||
27572968|NCT01785602|80282254|FG000|Overall Study|Adverse Event|3|||
27572969|NCT01785602|80282255|FG001|Overall Study|Adverse Event|5|||
27572970|NCT01785602|80282254|FG000|Overall Study|Administrative problems|7|||
27572971|NCT01785602|80282255|FG001|Overall Study|Administrative problems|3|||
27572972|NCT02433834|80282257|FG000|Overall Study|Protocol-specified criteria|7|||
27572973|NCT02433834|80282257|FG000|Overall Study|Protocol Violation|3|||
27866463|NCT02015065|81346459|FG002|Overall Study|Death on study|1|||
27866464|NCT03567980|81346465|FG000|Overall Study|Adverse Event|1|||
27866465|NCT00450801|81346466|FG000|Overall Study|Death|1|||
27866466|NCT00852202|81346467|FG000|Overall Study|Adverse Event|2|||
27866467|NCT00852202|81346468|FG001|Overall Study|Adverse Event|3|||
27572974|NCT02433834|80282257|FG000|Overall Study|Lost to Follow-up|6|||
27572975|NCT02433834|80282257|FG000|Overall Study|Withdrawal by Subject|14|||
27572976|NCT02433834|80282257|FG000|Overall Study|Adverse Event|6|||
27572977|NCT02433834|80282257|FG000|Overall Study|Physician Decision|1|||
27572978|NCT02487394|80282258|FG000|Phase 1|Withdrawal by Subject|0|||
27572979|NCT02487394|80282259|FG001|Phase 1|Withdrawal by Subject|1|||
27572980|NCT01633944|80282260|FG000|Open-label Titration Phase|Adverse Event|109|||
27572981|NCT01633944|80282261|FG001|Open-label Titration Phase|Adverse Event|0|||
27572982|NCT01633944|80282262|FG002|Open-label Titration Phase|Adverse Event|0|||
27572983|NCT01633944|80282260|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
27866468|NCT00852202|81346469|FG002|Overall Study|Adverse Event|7|||
27866469|NCT00852202|81346467|FG000|Overall Study|Lack of Efficacy|4|||
27866470|NCT00852202|81346468|FG001|Overall Study|Lack of Efficacy|1|||
27866471|NCT00852202|81346469|FG002|Overall Study|Lack of Efficacy|2|||
27866472|NCT00852202|81346467|FG000|Overall Study|Protocol Violation|2|||
27866473|NCT00852202|81346468|FG001|Overall Study|Protocol Violation|2|||
27866474|NCT00852202|81346469|FG002|Overall Study|Protocol Violation|7|||
27866475|NCT00852202|81346467|FG000|Overall Study|Withdrawal by Subject|3|||
27866476|NCT00852202|81346468|FG001|Overall Study|Withdrawal by Subject|1|||
27866477|NCT00852202|81346469|FG002|Overall Study|Withdrawal by Subject|2|||
27866478|NCT00852202|81346467|FG000|Overall Study|Lost to Follow-up|5|||
27866479|NCT00852202|81346468|FG001|Overall Study|Lost to Follow-up|5|||
27866480|NCT00852202|81346469|FG002|Overall Study|Lost to Follow-up|6|||
27866481|NCT00852202|81346467|FG000|Overall Study|pregnancy,moving away and surgery|1|||
27866482|NCT00852202|81346468|FG001|Overall Study|pregnancy,moving away and surgery|0|||
27866483|NCT00852202|81346469|FG002|Overall Study|pregnancy,moving away and surgery|2|||
27866484|NCT01450683|81346472|FG000|Overall Study|Adverse Event|2|||
27866485|NCT03573830|81346473|FG000|Overall Study|Dropped without completing treatment|0|||
27572984|NCT01633944|80282261|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
27572985|NCT01633944|80282262|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
27572986|NCT01633944|80282260|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
27572987|NCT01633944|80282261|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
27572988|NCT01633944|80282262|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
27572989|NCT01633944|80282260|FG000|Open-label Titration Phase|Protocol Violation|24|||
27572990|NCT01633944|80282261|FG001|Open-label Titration Phase|Protocol Violation|0|||
27572991|NCT01633944|80282262|FG002|Open-label Titration Phase|Protocol Violation|0|||
27572992|NCT01633944|80282260|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
27572993|NCT01633944|80282261|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
27572994|NCT01633944|80282262|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
27572995|NCT01633944|80282260|FG000|Open-label Titration Phase|Other|68|||
27866486|NCT03573830|81346474|FG001|Overall Study|Dropped without completing treatment|7|||
27866487|NCT03573830|81346473|FG000|Overall Study|Lost to Follow-up|4|||
27866488|NCT03573830|81346474|FG001|Overall Study|Lost to Follow-up|0|||
27866489|NCT00625872|81346475|FG000|Overall Study|Withdrawal by Subject|1|||
27572996|NCT01633944|80282261|FG001|Open-label Titration Phase|Other|0|||
27572997|NCT01633944|80282262|FG002|Open-label Titration Phase|Other|0|||
27572998|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27572999|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Adverse Event|13|||
27573000|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Adverse Event|7|||
27573001|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
27573002|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
27573003|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
27573004|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27573005|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
27573006|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
27573007|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
27573008|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
27573009|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
27573010|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27573011|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
27573012|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
27573013|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
27573014|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
27573015|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
27573016|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
27573017|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
27573018|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
27573019|NCT01633944|80282260|FG000|Double-blind Treatment Phase|Other|0|||
27573020|NCT01633944|80282261|FG001|Double-blind Treatment Phase|Other|7|||
27573021|NCT01633944|80282262|FG002|Double-blind Treatment Phase|Other|0|||
27573022|NCT00749463|80282263|FG000|Overall Study|Adverse Event|0|||
27573023|NCT00749463|80282264|FG001|Overall Study|Adverse Event|4|||
27573024|NCT00749463|80282265|FG002|Overall Study|Adverse Event|1|||
27573025|NCT00749463|80282263|FG000|Overall Study|Withdrawal by Subject|1|||
27573026|NCT00749463|80282264|FG001|Overall Study|Withdrawal by Subject|0|||
27670719|NCT01628692|80634791|FG001|Overall Study|Withdrawal by Subject|1|||
27670720|NCT01628692|80634792|FG002|Overall Study|Withdrawal by Subject|1|||
27670721|NCT01628692|80634793|FG003|Overall Study|Withdrawal by Subject|0|||
27784894|NCT02418000|81043771|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784895|NCT02418000|81043772|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784896|NCT02418000|81043773|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27784897|NCT02418000|81043774|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
27973358|NCT00075946|81732652|FG000|Overall Study|Incorrectly randomized (no response)|5|||
27973359|NCT00075946|81732653|FG001|Overall Study|Incorrectly randomized (no response)|5|||
27784898|NCT02418000|81043775|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
27784899|NCT03417102|81043776|FG000|Overall Study|Adverse Event|0|||
27784900|NCT03417102|81043777|FG001|Overall Study|Adverse Event|1|||
27784901|NCT03417102|81043776|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
27784902|NCT03417102|81043777|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
27784903|NCT03417102|81043776|FG000|Overall Study|Other|0|||
27784904|NCT03417102|81043777|FG001|Overall Study|Other|1|||
27784905|NCT00247962|81043778|FG000|Overall Study|Adverse Event|15|||
27784906|NCT00247962|81043779|FG001|Overall Study|Adverse Event|12|||
27784907|NCT00247962|81043778|FG000|Overall Study|Lost to Follow-up|3|||
27784908|NCT00247962|81043779|FG001|Overall Study|Lost to Follow-up|1|||
27784909|NCT00247962|81043778|FG000|Overall Study|Physician Decision|0|||
27784910|NCT00247962|81043779|FG001|Overall Study|Physician Decision|1|||
27784911|NCT00247962|81043778|FG000|Overall Study|Protocol Violation|1|||
27784912|NCT00247962|81043779|FG001|Overall Study|Protocol Violation|1|||
27784913|NCT00247962|81043778|FG000|Overall Study|Withdrawal by Subject|3|||
27784914|NCT00247962|81043779|FG001|Overall Study|Withdrawal by Subject|2|||
27784915|NCT00247962|81043778|FG000|Overall Study|Lack of Efficacy|4|||
27784916|NCT00247962|81043779|FG001|Overall Study|Lack of Efficacy|2|||
27784917|NCT02759939|81043780|FG000|Overall Study|Missing data on first outcome assessed|11|||
27784918|NCT02759939|81043781|FG001|Overall Study|Missing data on first outcome assessed|2|||
27573027|NCT00749463|80282265|FG002|Overall Study|Withdrawal by Subject|0|||
27573028|NCT01720069|80282266|FG000|Overall Study|Could not use e-diary correctly|0|||
27573029|NCT01720069|80282267|FG001|Overall Study|Could not use e-diary correctly|1|||
27573030|NCT01720069|80282268|FG002|Overall Study|Could not use e-diary correctly|1|||
27573031|NCT01720069|80282266|FG000|Overall Study|Randomised without baseline values|0|||
27573032|NCT01720069|80282267|FG001|Overall Study|Randomised without baseline values|0|||
27573033|NCT01720069|80282268|FG002|Overall Study|Randomised without baseline values|1|||
27670722|NCT01628692|80634794|FG004|Overall Study|Withdrawal by Subject|0|||
27784919|NCT02759939|81043782|FG002|Overall Study|Missing data on first outcome assessed|5|||
27784920|NCT02759939|81043783|FG003|Overall Study|Missing data on first outcome assessed|2|||
27866490|NCT00625872|81346476|FG001|Overall Study|Withdrawal by Subject|0|||
27866491|NCT00625872|81346475|FG000|Overall Study|Does not meet inclusion criteria|1|||
27866492|NCT00625872|81346476|FG001|Overall Study|Does not meet inclusion criteria|0|||
27573034|NCT01720069|80282266|FG000|Overall Study|Adverse Event|0|||
27573035|NCT01720069|80282267|FG001|Overall Study|Adverse Event|0|||
27573036|NCT01720069|80282268|FG002|Overall Study|Adverse Event|1|||
27573037|NCT01720069|80282266|FG000|Overall Study|Lack of Efficacy|0|||
27573038|NCT01720069|80282267|FG001|Overall Study|Lack of Efficacy|4|||
27573039|NCT01720069|80282268|FG002|Overall Study|Lack of Efficacy|0|||
27573040|NCT01720069|80282266|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
27573041|NCT01720069|80282267|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
27573042|NCT01720069|80282268|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
27573043|NCT01720069|80282266|FG000|Overall Study|Withdrawal by Subject|0|||
27573044|NCT01720069|80282267|FG001|Overall Study|Withdrawal by Subject|2|||
27573045|NCT01720069|80282268|FG002|Overall Study|Withdrawal by Subject|1|||
27573046|NCT01720069|80282266|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
27573047|NCT01720069|80282267|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
27670723|NCT01628692|80634795|FG005|Overall Study|Withdrawal by Subject|0|||
27670724|NCT01628692|80634790|FG000|Overall Study|Death|0|||
27784921|NCT02759939|81043780|FG000|Overall Study|Ineligible for T2 and T3|310|||
27784922|NCT02759939|81043781|FG001|Overall Study|Ineligible for T2 and T3|179|||
27784923|NCT02759939|81043782|FG002|Overall Study|Ineligible for T2 and T3|366|||
27784924|NCT02759939|81043783|FG003|Overall Study|Ineligible for T2 and T3|391|||
27784925|NCT02759939|81043780|FG000|Overall Study|Lost to Follow-up|735|||
27784926|NCT02759939|81043781|FG001|Overall Study|Lost to Follow-up|791|||
27784927|NCT02759939|81043782|FG002|Overall Study|Lost to Follow-up|783|||
27784928|NCT02759939|81043783|FG003|Overall Study|Lost to Follow-up|650|||
27784929|NCT02477215|81043784|FG000|Dose Escalation Phase|Physician Decision|1|||
27784930|NCT02477215|81043785|FG001|Dose Escalation Phase|Physician Decision|2|||
27784931|NCT02477215|81043786|FG002|Dose Escalation Phase|Physician Decision|0|||
27784932|NCT02477215|81043784|FG000|Fixed Dose Phase|Physician Decision|0|||
27784933|NCT02477215|81043785|FG001|Fixed Dose Phase|Physician Decision|7|||
27784934|NCT02477215|81043786|FG002|Fixed Dose Phase|Physician Decision|0|||
27784935|NCT02711306|81043787|FG000|Overall Study|Withdrawal by Subject|2|||
27784936|NCT02711306|81043788|FG001|Overall Study|Withdrawal by Subject|2|||
27784937|NCT00689299|81043799|FG000|Overall Study|Adverse Event|2|||
27784938|NCT00689299|81043800|FG001|Overall Study|Adverse Event|1|||
27784939|NCT00689299|81043801|FG002|Overall Study|Adverse Event|1|||
27784940|NCT00689299|81043799|FG000|Overall Study|Lost to Follow-up|0|||
27784941|NCT00689299|81043800|FG001|Overall Study|Lost to Follow-up|1|||
27784942|NCT00689299|81043801|FG002|Overall Study|Lost to Follow-up|1|||
27784943|NCT00689299|81043799|FG000|Overall Study|Withdrawal by Subject|4|||
27784944|NCT00689299|81043800|FG001|Overall Study|Withdrawal by Subject|1|||
27784945|NCT00689299|81043801|FG002|Overall Study|Withdrawal by Subject|3|||
27784946|NCT00689299|81043799|FG000|Overall Study|Protocol Violation|1|||
27784947|NCT00689299|81043800|FG001|Overall Study|Protocol Violation|0|||
27784948|NCT00689299|81043801|FG002|Overall Study|Protocol Violation|0|||
27784949|NCT03039699|81043802|FG000|Overall Study|Incorrect inclusion|5|||
27784950|NCT03039699|81043803|FG001|Overall Study|Incorrect inclusion|4|||
27784951|NCT03039699|81043802|FG000|Overall Study|Lack of data to assess study endpoint|5|||
27784952|NCT03039699|81043803|FG001|Overall Study|Lack of data to assess study endpoint|3|||
27784953|NCT03039699|81043802|FG000|Overall Study|Bacterial infection|12|||
27784954|NCT03039699|81043803|FG001|Overall Study|Bacterial infection|28|||
27784955|NCT01684930|81043806|FG000|Overall Study|Withdrawal by Subject|3|||
27784956|NCT01684930|81043807|FG001|Overall Study|Withdrawal by Subject|1|||
27784957|NCT03480360|81043808|FG000|Overall Study|Death|2|||
27784958|NCT01883362|81043811|FG000|Treatment|Adverse Event|1|||
27784959|NCT01883362|81043812|FG001|Treatment|Adverse Event|8|||
27784960|NCT01883362|81043811|FG000|Treatment|Withdrawal by Subject|6|||
27784961|NCT01883362|81043812|FG001|Treatment|Withdrawal by Subject|2|||
27784962|NCT01883362|81043811|FG000|Treatment|Administrative problems|4|||
27784963|NCT01883362|81043812|FG001|Treatment|Administrative problems|1|||
27784964|NCT01883362|81043811|FG000|Treatment|Relapse|4|||
27784965|NCT01883362|81043812|FG001|Treatment|Relapse|2|||
27784966|NCT01883362|81043811|FG000|Treatment|Randomized, not treated|1|||
27784967|NCT01883362|81043812|FG001|Treatment|Randomized, not treated|1|||
27784968|NCT01883362|81043811|FG000|Post Treatment Follow-up|Protocol Violation|0|||
27784969|NCT01883362|81043812|FG001|Post Treatment Follow-up|Protocol Violation|1|||
27784970|NCT01883362|81043811|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
27784971|NCT01883362|81043812|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
27784972|NCT01883362|81043811|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
27784973|NCT01883362|81043812|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
27784974|NCT01883362|81043811|FG000|Post Treatment Follow-up|Administrative problems|2|||
27784975|NCT01883362|81043812|FG001|Post Treatment Follow-up|Administrative problems|0|||
27784976|NCT01883362|81043811|FG000|Post Treatment Follow-up|Death|8|||
27573048|NCT01720069|80282268|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
27866493|NCT00625872|81346475|FG000|Overall Study|Terminated by sponsor|2|||
27866494|NCT00625872|81346476|FG001|Overall Study|Terminated by sponsor|5|||
27866495|NCT00625872|81346475|FG000|Overall Study|Randomized but not treated|0|||
27866496|NCT00625872|81346476|FG001|Overall Study|Randomized but not treated|1|||
27866497|NCT01108718|81346481|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
27866498|NCT01108718|81346482|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
27866499|NCT00741338|81346483|FG000|Overall Study|Adverse Event|0|||
27866500|NCT00741338|81346484|FG001|Overall Study|Adverse Event|1|||
27866501|NCT00447876|81346489|FG000|Overall Study|Withdrawal by Subject|1|||
27866502|NCT00447876|81346490|FG001|Overall Study|Withdrawal by Subject|4|||
27866503|NCT00447876|81346489|FG000|Overall Study|Lost to Follow-up|1|||
27866504|NCT00447876|81346490|FG001|Overall Study|Lost to Follow-up|0|||
27866505|NCT00447876|81346489|FG000|Overall Study|Deterioration of symptomology|1|||
27866506|NCT00447876|81346490|FG001|Overall Study|Deterioration of symptomology|0|||
27866507|NCT00958893|81346492|FG000|Overall Study|Study prematurely terminated|4|||
27866508|NCT02862730|81346493|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
27866509|NCT02862730|81346494|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
27866510|NCT02862730|81346495|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
27866511|NCT02862730|81346496|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
27866512|NCT02862730|81346497|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
27866513|NCT02862730|81346498|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
27866514|NCT02862730|81346499|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
27866515|NCT02862730|81346493|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
27866516|NCT02862730|81346494|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
27866517|NCT02862730|81346495|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
27866518|NCT02862730|81346496|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
27866519|NCT02862730|81346497|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
27866520|NCT02862730|81346498|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
27866521|NCT02862730|81346499|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
27866522|NCT02862730|81346493|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
27866523|NCT02862730|81346494|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
27866524|NCT02862730|81346495|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
27866525|NCT02862730|81346496|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
27866526|NCT02862730|81346497|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
27866527|NCT02862730|81346498|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
27866528|NCT02862730|81346499|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
27866529|NCT02862730|81346493|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
27866530|NCT02862730|81346494|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
27866531|NCT02862730|81346495|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
27866532|NCT02862730|81346496|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
27866533|NCT02862730|81346497|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
27866534|NCT02862730|81346498|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
27866535|NCT02862730|81346499|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
27866536|NCT00403585|81346500|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
27866537|NCT00403585|81346500|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
27866538|NCT00403585|81346500|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
27573049|NCT01720069|80282266|FG000|Overall Study|Non-compliance on using e-diary|0|||
27573050|NCT01720069|80282267|FG001|Overall Study|Non-compliance on using e-diary|0|||
27573051|NCT01720069|80282268|FG002|Overall Study|Non-compliance on using e-diary|1|||
27573052|NCT01720069|80282266|FG000|Overall Study|Lost to Follow-up|0|||
27573053|NCT01720069|80282267|FG001|Overall Study|Lost to Follow-up|0|||
27573054|NCT01720069|80282268|FG002|Overall Study|Lost to Follow-up|1|||
27573055|NCT01632891|80282271|FG000|Overall Study|Lost to Follow-up|0|||
27573056|NCT01632891|80282272|FG001|Overall Study|Lost to Follow-up|1|||
27573057|NCT01632891|80282271|FG000|Overall Study|Withdrawal by Subject|1|||
27573058|NCT01632891|80282272|FG001|Overall Study|Withdrawal by Subject|0|||
27973360|NCT00075946|81732654|FG002|Overall Study|Incorrectly randomized (no response)|5|||
27973361|NCT00075946|81732655|FG003|Overall Study|Incorrectly randomized (no response)|1|||
27973362|NCT00075946|81732656|FG004|Overall Study|Incorrectly randomized (no response)|0|||
27573059|NCT03491150|80282273|FG000|Overall Study|Adverse Event|1|||
27573060|NCT03491150|80282274|FG001|Overall Study|Adverse Event|0|||
27866539|NCT02256436|81346501|FG000|Overall Study|Adverse Event|9|||
27866540|NCT02256436|81346502|FG001|Overall Study|Adverse Event|14|||
27866541|NCT02256436|81346501|FG000|Overall Study|Death|216|||
27866542|NCT02256436|81346502|FG001|Overall Study|Death|208|||
27866543|NCT02256436|81346501|FG000|Overall Study|Lost to Follow-up|1|||
27866544|NCT02256436|81346502|FG001|Overall Study|Lost to Follow-up|2|||
27866545|NCT02256436|81346501|FG000|Overall Study|Physician Decision|1|||
27670725|NCT01628692|80634791|FG001|Overall Study|Death|1|||
27573061|NCT03491150|80282273|FG000|Overall Study|Study Terminated by Sponsor|74|||
27573062|NCT03491150|80282274|FG001|Overall Study|Study Terminated by Sponsor|70|||
27784977|NCT01883362|81043812|FG001|Post Treatment Follow-up|Death|4|||
27784978|NCT01883362|81043811|FG000|Post Treatment Follow-up|Relapse|1|||
27784979|NCT01883362|81043812|FG001|Post Treatment Follow-up|Relapse|2|||
27784980|NCT02493712|81043815|FG000|Overall Study|Withdrawal by Subject|1|||
27784981|NCT02493712|81043816|FG001|Overall Study|Withdrawal by Subject|0|||
27784982|NCT02493712|81043817|FG002|Overall Study|Withdrawal by Subject|2|||
27784983|NCT02493712|81043815|FG000|Overall Study|Protocol Violation|0|||
27784984|NCT02493712|81043816|FG001|Overall Study|Protocol Violation|0|||
27784985|NCT02493712|81043817|FG002|Overall Study|Protocol Violation|1|||
27784986|NCT02493712|81043815|FG000|Overall Study|Lost to Follow-up|1|||
27784987|NCT02493712|81043816|FG001|Overall Study|Lost to Follow-up|0|||
27784988|NCT02493712|81043817|FG002|Overall Study|Lost to Follow-up|0|||
27784989|NCT02493712|81043815|FG000|Overall Study|Physician Decision|0|||
27784990|NCT02493712|81043816|FG001|Overall Study|Physician Decision|1|||
27784991|NCT02493712|81043817|FG002|Overall Study|Physician Decision|0|||
27784992|NCT02493712|81043815|FG000|Overall Study|Lack of Efficacy|0|||
27784993|NCT02493712|81043816|FG001|Overall Study|Lack of Efficacy|5|||
27784994|NCT02493712|81043817|FG002|Overall Study|Lack of Efficacy|3|||
27784995|NCT01066546|81043818|FG000|Overall Study|Study terminated by sponsor|5|||
27784996|NCT01474993|81043819|FG000|Overall Study|Lost to Follow-up|1|||
27784997|NCT01474993|81043820|FG001|Overall Study|Lost to Follow-up|2|||
27784998|NCT01474993|81043819|FG000|Overall Study|Adverse Event|0|||
27784999|NCT01474993|81043820|FG001|Overall Study|Adverse Event|1|||
27785000|NCT03982069|81043824|FG000|Overall Study|Lost to Follow-up|5|||
27785001|NCT03982069|81043825|FG001|Overall Study|Lost to Follow-up|5|||
27785002|NCT03982069|81043826|FG002|Overall Study|Lost to Follow-up|3|||
27785003|NCT03982069|81043827|FG003|Overall Study|Lost to Follow-up|5|||
27785004|NCT03982069|81043824|FG000|Overall Study|Physician Decision|0|||
27785005|NCT03982069|81043825|FG001|Overall Study|Physician Decision|1|||
27785006|NCT03982069|81043826|FG002|Overall Study|Physician Decision|0|||
27785007|NCT03982069|81043827|FG003|Overall Study|Physician Decision|0|||
27785008|NCT03982069|81043824|FG000|Overall Study|Withdrawal by Subject|2|||
27785009|NCT03982069|81043825|FG001|Overall Study|Withdrawal by Subject|1|||
27785010|NCT03982069|81043826|FG002|Overall Study|Withdrawal by Subject|5|||
27785011|NCT03982069|81043827|FG003|Overall Study|Withdrawal by Subject|2|||
27785012|NCT03982069|81043824|FG000|Overall Study|Specimen loss|3|||
27785013|NCT03982069|81043825|FG001|Overall Study|Specimen loss|3|||
27785014|NCT03982069|81043826|FG002|Overall Study|Specimen loss|1|||
27785015|NCT03982069|81043827|FG003|Overall Study|Specimen loss|1|||
27785016|NCT01078389|81043828|FG000|Overall Study|Adverse Event|10|||
27785017|NCT01078389|81043829|FG001|Overall Study|Adverse Event|6|||
27785018|NCT01078389|81043828|FG000|Overall Study|Major Protocol Deviation|2|||
27785019|NCT01078389|81043829|FG001|Overall Study|Major Protocol Deviation|0|||
27785020|NCT01078389|81043828|FG000|Overall Study|Lost to Follow-up|23|||
27785021|NCT01078389|81043829|FG001|Overall Study|Lost to Follow-up|23|||
27785022|NCT01078389|81043828|FG000|Overall Study|Voluntary Withdrawal|20|||
27785023|NCT01078389|81043829|FG001|Overall Study|Voluntary Withdrawal|36|||
27785024|NCT01078389|81043828|FG000|Overall Study|Other|9|||
27785025|NCT01078389|81043829|FG001|Overall Study|Other|2|||
27785026|NCT01475214|81043839|FG000|Overall Study|Lost to Follow-up|1|||
27785027|NCT01475214|81043840|FG001|Overall Study|Lost to Follow-up|0|||
27785028|NCT01475214|81043841|FG002|Overall Study|Lost to Follow-up|1|||
27573063|NCT03491150|80282273|FG000|Overall Study|Other|0|||
27785029|NCT01475214|81043839|FG000|Overall Study|Physician Decision|2|||
27785030|NCT01475214|81043840|FG001|Overall Study|Physician Decision|0|||
27785031|NCT01475214|81043841|FG002|Overall Study|Physician Decision|0|||
27785032|NCT01475214|81043839|FG000|Overall Study|Withdrawal by Subject|2|||
27785033|NCT01475214|81043840|FG001|Overall Study|Withdrawal by Subject|4|||
27785034|NCT01475214|81043841|FG002|Overall Study|Withdrawal by Subject|1|||
27785035|NCT00689611|81043842|FG000|Overall Study|Death|6|||
27785036|NCT00689611|81043843|FG001|Overall Study|Death|9|||
27785037|NCT00689611|81043842|FG000|Overall Study|Withdrawal by Subject|8|||
27573064|NCT03491150|80282274|FG001|Overall Study|Other|1|||
27785038|NCT00689611|81043843|FG001|Overall Study|Withdrawal by Subject|9|||
27785039|NCT00689611|81043842|FG000|Overall Study|Lost to Follow-up|27|||
27785040|NCT00689611|81043843|FG001|Overall Study|Lost to Follow-up|28|||
27785041|NCT01823991|81043847|FG000|Overall Study|Withdrawal by Subject|8|||
27785042|NCT01823991|81043848|FG001|Overall Study|Withdrawal by Subject|5|||
27785043|NCT03691831|81043849|FG000|Overall Study|Lost to Follow-up|16|||
27785044|NCT03691831|81043850|FG001|Overall Study|Lost to Follow-up|12|||
27785045|NCT03691831|81043849|FG000|Overall Study|Withdrawal by Subject|9|||
27785046|NCT03691831|81043850|FG001|Overall Study|Withdrawal by Subject|17|||
27785047|NCT03691831|81043849|FG000|Overall Study|Investigator Decision|2|||
27785048|NCT03691831|81043850|FG001|Overall Study|Investigator Decision|2|||
27785049|NCT00203294|81043855|FG000|Overall Study|Withdrawal by Subject|8|||
27785050|NCT00203294|81043856|FG001|Overall Study|Withdrawal by Subject|13|||
27785051|NCT02173158|81043861|FG000|Efficacy Phase|Adverse Event|1|||
27785052|NCT01616173|81043862|FG000|Overall Study|Lost to Follow-up|0|||
27785053|NCT01616173|81043863|FG001|Overall Study|Lost to Follow-up|2|||
27785054|NCT01616173|81043864|FG002|Overall Study|Lost to Follow-up|0|||
27785055|NCT01377194|81043865|FG000|Overall Study|Adverse Event|3|||
27785056|NCT01377194|81043866|FG001|Overall Study|Adverse Event|12|||
27785057|NCT01377194|81043867|FG002|Overall Study|Adverse Event|19|||
27785058|NCT01377194|81043865|FG000|Overall Study|Lack of Efficacy|3|||
27785059|NCT01377194|81043866|FG001|Overall Study|Lack of Efficacy|3|||
27785060|NCT01377194|81043867|FG002|Overall Study|Lack of Efficacy|3|||
27785061|NCT01377194|81043865|FG000|Overall Study|Protocol Violation|4|||
27785062|NCT01377194|81043866|FG001|Overall Study|Protocol Violation|10|||
27785063|NCT01377194|81043867|FG002|Overall Study|Protocol Violation|6|||
27785064|NCT01377194|81043865|FG000|Overall Study|Withdrawal by Subject|8|||
27785065|NCT01377194|81043866|FG001|Overall Study|Withdrawal by Subject|10|||
27785066|NCT01377194|81043867|FG002|Overall Study|Withdrawal by Subject|7|||
27785067|NCT01377194|81043865|FG000|Overall Study|Lost to Follow-up|14|||
27785068|NCT01377194|81043866|FG001|Overall Study|Lost to Follow-up|8|||
27785069|NCT01377194|81043867|FG002|Overall Study|Lost to Follow-up|11|||
27785070|NCT01569568|81043871|FG000|Overall Study|Physician Decision|0|||
27785071|NCT01569568|81043872|FG001|Overall Study|Physician Decision|2|||
27785072|NCT02079077|81043873|FG000|Overall Study|Lost to Follow-up|5|||
27785073|NCT02079077|81043874|FG001|Overall Study|Lost to Follow-up|7|||
27785074|NCT02079077|81043873|FG000|Overall Study|Became STIs Positive|1|||
27785075|NCT02079077|81043874|FG001|Overall Study|Became STIs Positive|2|||
27785076|NCT00565721|81043875|FG000|Overall Study|Screen Failure|2|||
27785077|NCT00565721|81043875|FG000|Overall Study|Lost to Follow-up|6|||
27785078|NCT00565721|81043875|FG000|Overall Study|Technical Problems|1|||
27785079|NCT00565721|81043875|FG000|Overall Study|Physician Decision|2|||
27785080|NCT00565721|81043875|FG000|Overall Study|Other reasons|6|||
27785081|NCT03219372|81043876|FG000|Overall Study|Withdrawal by Subject|1|||
27785082|NCT03219372|81043877|FG001|Overall Study|Withdrawal by Subject|0|||
27785083|NCT02383966|81043878|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
27785084|NCT02383966|81043879|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
27785085|NCT02383966|81043878|FG000|Overall Study|Randomized, but not treated|1|||
27785086|NCT02383966|81043879|FG001|Overall Study|Randomized, but not treated|3|||
27785087|NCT00174460|81043880|FG000|Overall Study|Withdrawal by Subject|0|||
27785088|NCT00174460|81043881|FG001|Overall Study|Withdrawal by Subject|1|||
27785089|NCT02370173|81043882|FG000|Overall Study|Protocol Violation|1|||
27785090|NCT02370173|81043883|FG001|Overall Study|Protocol Violation|1|||
27785091|NCT02370173|81043882|FG000|Overall Study|Withdrawal by Subject|2|||
27785092|NCT02370173|81043883|FG001|Overall Study|Withdrawal by Subject|2|||
27785093|NCT04225026|81043884|FG000|Overall Study|Withdrawal by Subject|4|||
27785094|NCT04225026|81043884|FG000|Overall Study|Adverse Event|1|||
27785095|NCT04225026|81043884|FG000|Overall Study|Other|1|||
27785096|NCT04225026|81043884|FG000|Overall Study|Death|11|||
27785097|NCT04225026|81043884|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
27785098|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Death|2|||
27785099|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Death|0|||
27785100|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Adverse Event|33|||
27785101|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Adverse Event|31|||
27785102|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
27785103|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
27785104|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
27785105|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
27785106|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
27785107|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
27785108|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Other|7|||
27785109|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Other|8|||
27785110|NCT00280059|81043885|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
27785111|NCT00280059|81043886|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
27785112|NCT01230827|81043887|FG000|Overall Study|Lost to Follow-up|0|||
27785113|NCT01230827|81043888|FG001|Overall Study|Lost to Follow-up|0|||
27785114|NCT01230827|81043889|FG002|Overall Study|Lost to Follow-up|1|||
27785115|NCT01230827|81043890|FG003|Overall Study|Lost to Follow-up|3|||
27785116|NCT01230827|81043887|FG000|Overall Study|Withdrawal by Subject|1|||
27785117|NCT01230827|81043888|FG001|Overall Study|Withdrawal by Subject|0|||
27785118|NCT01230827|81043889|FG002|Overall Study|Withdrawal by Subject|3|||
27785119|NCT01230827|81043890|FG003|Overall Study|Withdrawal by Subject|2|||
27785120|NCT01230827|81043887|FG000|Overall Study|Lack of Efficacy|14|||
27785121|NCT01230827|81043888|FG001|Overall Study|Lack of Efficacy|1|||
27785122|NCT01230827|81043889|FG002|Overall Study|Lack of Efficacy|2|||
27785123|NCT01230827|81043890|FG003|Overall Study|Lack of Efficacy|3|||
27785124|NCT01230827|81043887|FG000|Overall Study|Adverse Event|4|||
27785125|NCT01230827|81043888|FG001|Overall Study|Adverse Event|2|||
27785126|NCT01230827|81043889|FG002|Overall Study|Adverse Event|3|||
27785127|NCT01230827|81043890|FG003|Overall Study|Adverse Event|7|||
27785128|NCT01230827|81043887|FG000|Overall Study|Recovery|0|||
27785129|NCT01230827|81043888|FG001|Overall Study|Recovery|6|||
27785130|NCT01230827|81043889|FG002|Overall Study|Recovery|0|||
27785131|NCT01230827|81043890|FG003|Overall Study|Recovery|0|||
27785132|NCT01230827|81043887|FG000|Overall Study|Study terminated by Sponsor|0|||
27785133|NCT01230827|81043888|FG001|Overall Study|Study terminated by Sponsor|2|||
27785134|NCT01230827|81043889|FG002|Overall Study|Study terminated by Sponsor|56|||
27785135|NCT01230827|81043890|FG003|Overall Study|Study terminated by Sponsor|63|||
27785136|NCT03077646|81043891|FG000|Overall Study|Lost to Follow-up|29|||
27785137|NCT03077646|81043892|FG001|Overall Study|Lost to Follow-up|30|||
27785138|NCT03077646|81043893|FG002|Overall Study|Lost to Follow-up|31|||
27785139|NCT03769753|81043894|FG000|Overall Study|Not Treated|6|||
27785140|NCT03769753|81043894|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
27785141|NCT02898662|81043895|FG000|Overall Study|Adverse Event|1|||
27785142|NCT02898662|81043896|FG001|Overall Study|Adverse Event|0|||
27670726|NCT01628692|80634792|FG002|Overall Study|Death|0|||
27670727|NCT01628692|80634793|FG003|Overall Study|Death|0|||
27670728|NCT01628692|80634794|FG004|Overall Study|Death|0|||
27670729|NCT01628692|80634795|FG005|Overall Study|Death|0|||
27670730|NCT01628692|80634790|FG000|Overall Study|Poor compliance/noncompliance|1|||
27670731|NCT01628692|80634791|FG001|Overall Study|Poor compliance/noncompliance|0|||
27670732|NCT01628692|80634792|FG002|Overall Study|Poor compliance/noncompliance|0|||
27973363|NCT00075946|81732652|FG000|Overall Study|Adverse Event|2|||
27785143|NCT02898662|81043895|FG000|Overall Study|Loss of asthma control|23|||
27785144|NCT02898662|81043896|FG001|Overall Study|Loss of asthma control|24|||
27785145|NCT02898662|81043895|FG000|Overall Study|Withdrawal by Subject|4|||
27785146|NCT02898662|81043896|FG001|Overall Study|Withdrawal by Subject|1|||
27785147|NCT02898662|81043895|FG000|Overall Study|Technical issue|0|||
27785148|NCT02898662|81043896|FG001|Overall Study|Technical issue|1|||
27785149|NCT02898662|81043895|FG000|Overall Study|Randomized in error|0|||
27785150|NCT02898662|81043896|FG001|Overall Study|Randomized in error|1|||
27785151|NCT02898662|81043895|FG000|Overall Study|Subject decision|1|||
27785152|NCT02898662|81043896|FG001|Overall Study|Subject decision|0|||
27785153|NCT02898662|81043895|FG000|Overall Study|Other|0|||
27785154|NCT02898662|81043896|FG001|Overall Study|Other|1|||
27785155|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
27785156|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
27785157|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
27785158|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
27785159|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
27785160|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
27785161|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Death|1|||
27785162|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Death|1|||
27785163|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Death|1|||
27785164|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Death|0|||
27785165|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Death|0|||
27785166|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Death|0|||
27785167|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
27785168|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
27785169|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
27785170|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
27785171|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
27785172|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
27785173|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
27785174|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
27785175|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
27785176|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
27973364|NCT00075946|81732653|FG001|Overall Study|Adverse Event|10|||
27973365|NCT00075946|81732654|FG002|Overall Study|Adverse Event|0|||
27973366|NCT00075946|81732655|FG003|Overall Study|Adverse Event|2|||
27973367|NCT00075946|81732656|FG004|Overall Study|Adverse Event|0|||
27670733|NCT01628692|80634793|FG003|Overall Study|Poor compliance/noncompliance|0|||
27670734|NCT01628692|80634794|FG004|Overall Study|Poor compliance/noncompliance|0|||
27670735|NCT01628692|80634795|FG005|Overall Study|Poor compliance/noncompliance|0|||
27670736|NCT01628692|80634790|FG000|Overall Study|Administrative reason by sponsor|0|||
27670737|NCT01628692|80634791|FG001|Overall Study|Administrative reason by sponsor|0|||
27670738|NCT01628692|80634792|FG002|Overall Study|Administrative reason by sponsor|0|||
27670739|NCT01628692|80634793|FG003|Overall Study|Administrative reason by sponsor|0|||
27670740|NCT01628692|80634794|FG004|Overall Study|Administrative reason by sponsor|0|||
27670741|NCT01628692|80634795|FG005|Overall Study|Administrative reason by sponsor|1|||
27670742|NCT01628692|80634790|FG000|Overall Study|Completed 12 Week only|0|||
27670743|NCT01628692|80634791|FG001|Overall Study|Completed 12 Week only|0|||
27670744|NCT01628692|80634792|FG002|Overall Study|Completed 12 Week only|0|||
27785177|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
27785178|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
27973368|NCT00075946|81732652|FG000|Overall Study|Death|0|||
27973369|NCT00075946|81732653|FG001|Overall Study|Death|1|||
27973370|NCT00075946|81732654|FG002|Overall Study|Death|0|||
27973371|NCT00075946|81732655|FG003|Overall Study|Death|0|||
27973372|NCT00075946|81732656|FG004|Overall Study|Death|0|||
27670745|NCT01628692|80634793|FG003|Overall Study|Completed 12 Week only|0|||
27785179|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
27785180|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
27785181|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
27785182|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
27785183|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
27973373|NCT00075946|81732652|FG000|Overall Study|Withdrawal by Subject|23|||
27785184|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
27785185|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
27785186|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
27785187|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
27785188|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
27785189|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
27785190|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
27785191|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
27785192|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
27785193|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
27785194|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
27785195|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
27785196|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
27785197|NCT03370133|81043897|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
27785198|NCT03370133|81043898|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
27785199|NCT03370133|81043899|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
27785200|NCT03370133|81043900|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
27785201|NCT03370133|81043901|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
27785202|NCT03370133|81043902|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
27785203|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
27785204|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
27785205|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
27785206|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
27785207|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
27785208|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
27785209|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
27785210|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
27785211|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
27785212|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
27785213|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
27973374|NCT00075946|81732653|FG001|Overall Study|Withdrawal by Subject|58|||
27573065|NCT03491150|80282273|FG000|Overall Study|Withdrawal by Subject|1|||
27973375|NCT00075946|81732654|FG002|Overall Study|Withdrawal by Subject|4|||
27973376|NCT00075946|81732655|FG003|Overall Study|Withdrawal by Subject|9|||
27973377|NCT00075946|81732656|FG004|Overall Study|Withdrawal by Subject|0|||
27973378|NCT00075946|81732652|FG000|Overall Study|Alternative therapy|16|||
27973379|NCT00075946|81732653|FG001|Overall Study|Alternative therapy|2|||
27973380|NCT00075946|81732654|FG002|Overall Study|Alternative therapy|5|||
27973381|NCT00075946|81732655|FG003|Overall Study|Alternative therapy|0|||
27973382|NCT00075946|81732656|FG004|Overall Study|Alternative therapy|0|||
27973383|NCT00075946|81732652|FG000|Overall Study|Other complicating disease|7|||
27973384|NCT00075946|81732653|FG001|Overall Study|Other complicating disease|13|||
27973385|NCT00075946|81732654|FG002|Overall Study|Other complicating disease|1|||
27973386|NCT00075946|81732655|FG003|Overall Study|Other complicating disease|4|||
27973387|NCT00075946|81732656|FG004|Overall Study|Other complicating disease|0|||
27973388|NCT00075946|81732652|FG000|Overall Study|No response to retreatment|23|||
27573066|NCT03491150|80282274|FG001|Overall Study|Withdrawal by Subject|2|||
27573067|NCT02126969|80282281|FG000|Overall Study|Withdrawal by Subject|1|||
27573068|NCT02126969|80282282|FG001|Overall Study|Withdrawal by Subject|2|||
27573069|NCT01466270|80282287|FG000|Overall Study|Withdrawal by Subject|4|||
27573070|NCT01466270|80282288|FG001|Overall Study|Withdrawal by Subject|1|||
27573071|NCT01466270|80282287|FG000|Overall Study|Physician Decision|1|||
27573072|NCT01466270|80282288|FG001|Overall Study|Physician Decision|0|||
27573073|NCT01466270|80282287|FG000|Overall Study|Lost to Follow-up|1|||
27573074|NCT01466270|80282288|FG001|Overall Study|Lost to Follow-up|3|||
27573075|NCT01466270|80282287|FG000|Overall Study|Progression|1|||
27573076|NCT01466270|80282288|FG001|Overall Study|Progression|0|||
27573077|NCT01466270|80282287|FG000|Overall Study|Toxicity|4|||
27573078|NCT01466270|80282288|FG001|Overall Study|Toxicity|1|||
27573079|NCT01466270|80282287|FG000|Overall Study|Multiple|1|||
27573080|NCT01466270|80282288|FG001|Overall Study|Multiple|1|||
27573081|NCT03102918|80282290|FG000|Overall Study|Protocol Violation|1|||
27573082|NCT03102918|80282291|FG001|Overall Study|Protocol Violation|0|||
27785214|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
27785215|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
27973389|NCT00075946|81732653|FG001|Overall Study|No response to retreatment|0|||
27973390|NCT00075946|81732654|FG002|Overall Study|No response to retreatment|2|||
27573083|NCT00353366|80282296|FG000|Overall Study|Adverse Event|8|||
27573084|NCT00353366|80282296|FG000|Overall Study|Protocol Violation|12|||
27573085|NCT00353366|80282296|FG000|Overall Study|Withdrawal by Subject|12|||
27573086|NCT00353366|80282296|FG000|Overall Study|Lost to Follow-up|92|||
27573087|NCT00353366|80282296|FG000|Overall Study|Other|19|||
27973391|NCT00075946|81732655|FG003|Overall Study|No response to retreatment|0|||
27785216|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
27785217|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
27785218|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
27785219|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
27785220|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
27785221|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
27785222|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
27670746|NCT01628692|80634794|FG004|Overall Study|Completed 12 Week only|0|||
27670747|NCT01628692|80634795|FG005|Overall Study|Completed 12 Week only|1|||
27670756|NCT03128671|80634801|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
27670757|NCT03128671|80634802|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
27670758|NCT03128671|80634801|FG000|Allocation|Death|1|||
27670759|NCT03128671|80634802|FG001|Allocation|Death|0|||
27670760|NCT03128671|80634801|FG000|Allocation|Withdrawal by Subject|4|||
27785223|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
27785224|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
27785225|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
27785226|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
27785227|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
27785228|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
27785229|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
27785230|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
27785231|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
27785232|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
27785233|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
27973392|NCT00075946|81732656|FG004|Overall Study|No response to retreatment|0|||
27670761|NCT03128671|80634802|FG001|Allocation|Withdrawal by Subject|0|||
27670762|NCT03128671|80634801|FG000|Intervention|Withdrawal by Subject|11|||
27670763|NCT03128671|80634802|FG001|Intervention|Withdrawal by Subject|10|||
27670764|NCT03128671|80634801|FG000|Intervention|Palliative/hospice care initiated|9|||
27670765|NCT03128671|80634802|FG001|Intervention|Palliative/hospice care initiated|10|||
27670766|NCT03128671|80634801|FG000|Intervention|Death|13|||
27670767|NCT03128671|80634802|FG001|Intervention|Death|11|||
27670768|NCT03128671|80634801|FG000|Intervention|Interrupted by hurricane|1|||
27670769|NCT03128671|80634802|FG001|Intervention|Interrupted by hurricane|0|||
27670770|NCT03128671|80634801|FG000|Intervention|Physician Decision|2|||
27973393|NCT00075946|81732652|FG000|Overall Study|Time to progression less than 6 months|15|||
27973394|NCT00075946|81732653|FG001|Overall Study|Time to progression less than 6 months|30|||
27973395|NCT00075946|81732654|FG002|Overall Study|Time to progression less than 6 months|8|||
27973396|NCT00075946|81732655|FG003|Overall Study|Time to progression less than 6 months|3|||
27973397|NCT00075946|81732656|FG004|Overall Study|Time to progression less than 6 months|0|||
27973398|NCT00075946|81732652|FG000|Overall Study|Other|57|||
27670771|NCT03128671|80634802|FG001|Intervention|Physician Decision|3|||
27670772|NCT00368641|80634803|FG000|Overall Study|Adverse Event|2|||
27670773|NCT00368641|80634804|FG001|Overall Study|Adverse Event|1|||
27670774|NCT00368641|80634803|FG000|Overall Study|Death|1|||
27670775|NCT00368641|80634804|FG001|Overall Study|Death|0|||
27670776|NCT00368641|80634803|FG000|Overall Study|Withdrawal by Subject|1|||
27670777|NCT00368641|80634804|FG001|Overall Study|Withdrawal by Subject|0|||
27670778|NCT00368641|80634803|FG000|Overall Study|Sponsor decision to terminate study|2|||
27670779|NCT00368641|80634804|FG001|Overall Study|Sponsor decision to terminate study|5|||
27670780|NCT01547598|80634805|FG000|Overall Study|Withdrew consent|1|||
27670781|NCT01547598|80634806|FG001|Overall Study|Withdrew consent|1|||
27670782|NCT01547598|80634805|FG000|Overall Study|Lost to Follow-up|1|||
27670783|NCT01547598|80634806|FG001|Overall Study|Lost to Follow-up|1|||
27670784|NCT01547598|80634805|FG000|Overall Study|Adverse Event|1|||
27670785|NCT01547598|80634806|FG001|Overall Study|Adverse Event|1|||
27670786|NCT01547598|80634805|FG000|Overall Study|Protocol Violation|1|||
27670787|NCT01547598|80634806|FG001|Overall Study|Protocol Violation|1|||
27670788|NCT01547598|80634805|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27973399|NCT00075946|81732653|FG001|Overall Study|Other|32|||
27670789|NCT01547598|80634806|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27670790|NCT00810342|80634807|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
27670791|NCT00810342|80634808|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
27670792|NCT00810342|80634807|FG000|Month 1 Follow-up|Pregnancy|1|||
27670793|NCT00810342|80634808|FG001|Month 1 Follow-up|Pregnancy|0|||
27670794|NCT00810342|80634807|FG000|6-month Follow-up|Lost to Follow-up|18|||
27670795|NCT00810342|80634808|FG001|6-month Follow-up|Lost to Follow-up|6|||
27670796|NCT00810342|80634807|FG000|6-month Follow-up|Pregnancy|6|||
27670797|NCT00810342|80634808|FG001|6-month Follow-up|Pregnancy|2|||
27670798|NCT00810342|80634807|FG000|12-month Followup|Pregnancy|9|||
27670799|NCT00810342|80634808|FG001|12-month Followup|Pregnancy|10|||
27670800|NCT00810342|80634807|FG000|12-month Followup|Lost to Follow-up|3|||
27670801|NCT00810342|80634808|FG001|12-month Followup|Lost to Follow-up|1|||
27670802|NCT01190644|80634809|FG000|Overall Study|Death|2|||
27670803|NCT01190644|80634809|FG000|Overall Study|Disease progression|1|||
27670804|NCT03371823|80634811|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
27670805|NCT03371823|80634812|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
27670806|NCT00224029|80634817|FG000|Overall Study|Lost to Follow-up|1|||
27670807|NCT00224029|80634817|FG000|Overall Study|Withdrawal by Subject|4|||
27670808|NCT00224029|80634817|FG000|Overall Study|Other|1|||
27670809|NCT01930214|80634818|FG000|Overall Study|Death|4|||
27670810|NCT01930214|80634819|FG001|Overall Study|Death|4|||
27670811|NCT01930214|80634820|FG002|Overall Study|Death|11|||
27670812|NCT01930214|80634818|FG000|Overall Study|Lost to Follow-up|12|||
27670813|NCT01930214|80634819|FG001|Overall Study|Lost to Follow-up|13|||
27670814|NCT01930214|80634820|FG002|Overall Study|Lost to Follow-up|12|||
27670815|NCT01930214|80634818|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
27670816|NCT01930214|80634819|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
27670817|NCT01930214|80634820|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
27670818|NCT01930214|80634818|FG000|Overall Study|Physician Decision|2|||
27670819|NCT01930214|80634819|FG001|Overall Study|Physician Decision|0|||
27670820|NCT01930214|80634820|FG002|Overall Study|Physician Decision|0|||
27670821|NCT02872311|80634822|FG000|Overall Study|Death|2|||
27670822|NCT02872311|80634823|FG001|Overall Study|Death|0|||
27573088|NCT00025883|80282300|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
27670823|NCT02872311|80634824|FG002|Overall Study|Death|0|||
27670824|NCT02872311|80634825|FG003|Overall Study|Death|0|||
27670825|NCT02872311|80634826|FG004|Overall Study|Death|0|||
27573089|NCT00025883|80282300|FG000|Overall Study|no baseline data|1|||
27670826|NCT02872311|80634822|FG000|Overall Study|Lost to Follow-up|2|||
27670827|NCT02872311|80634823|FG001|Overall Study|Lost to Follow-up|0|||
27670828|NCT02872311|80634824|FG002|Overall Study|Lost to Follow-up|0|||
27670829|NCT02872311|80634825|FG003|Overall Study|Lost to Follow-up|0|||
27670830|NCT02872311|80634826|FG004|Overall Study|Lost to Follow-up|0|||
27670831|NCT02872311|80634822|FG000|Overall Study|Protocol Violation|0|||
27670832|NCT02872311|80634823|FG001|Overall Study|Protocol Violation|2|||
27670833|NCT02872311|80634824|FG002|Overall Study|Protocol Violation|1|||
27670834|NCT02872311|80634825|FG003|Overall Study|Protocol Violation|0|||
27670835|NCT02872311|80634826|FG004|Overall Study|Protocol Violation|0|||
27670836|NCT03596242|80634827|FG000|Overall Study|Lost to Follow-up|2|||
27670837|NCT03596242|80634828|FG001|Overall Study|Lost to Follow-up|2|||
27670838|NCT01214421|80634829|FG000|Overall Study|Lost to Follow-up|7|||
27670839|NCT01214421|80634830|FG001|Overall Study|Lost to Follow-up|3|||
27670840|NCT01214421|80634831|FG002|Overall Study|Lost to Follow-up|7|||
27670841|NCT01214421|80634832|FG003|Overall Study|Lost to Follow-up|3|||
27670842|NCT01214421|80634829|FG000|Overall Study|Adverse Event|16|||
27670843|NCT01214421|80634830|FG001|Overall Study|Adverse Event|35|||
27670844|NCT01214421|80634831|FG002|Overall Study|Adverse Event|14|||
27785234|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
27866546|NCT02256436|81346502|FG001|Overall Study|Physician Decision|0|||
27670845|NCT01214421|80634832|FG003|Overall Study|Adverse Event|3|||
27670846|NCT01214421|80634829|FG000|Overall Study|Sponsor Discontinued Site|1|||
27670847|NCT01214421|80634830|FG001|Overall Study|Sponsor Discontinued Site|2|||
27670848|NCT01214421|80634831|FG002|Overall Study|Sponsor Discontinued Site|0|||
27670849|NCT01214421|80634832|FG003|Overall Study|Sponsor Discontinued Site|0|||
27670850|NCT01214421|80634829|FG000|Overall Study|Withdrawal Criteria Met|3|||
27670851|NCT01214421|80634830|FG001|Overall Study|Withdrawal Criteria Met|0|||
27670852|NCT01214421|80634831|FG002|Overall Study|Withdrawal Criteria Met|2|||
27670853|NCT01214421|80634832|FG003|Overall Study|Withdrawal Criteria Met|1|||
27670854|NCT01214421|80634829|FG000|Overall Study|Physician Decision|2|||
27670855|NCT01214421|80634830|FG001|Overall Study|Physician Decision|0|||
27670856|NCT01214421|80634831|FG002|Overall Study|Physician Decision|4|||
27670857|NCT01214421|80634832|FG003|Overall Study|Physician Decision|0|||
27866547|NCT02256436|81346501|FG000|Overall Study|Protocol Violation|0|||
27670858|NCT01214421|80634829|FG000|Overall Study|Withdrawal by Subject|21|||
27670859|NCT01214421|80634830|FG001|Overall Study|Withdrawal by Subject|18|||
27670860|NCT01214421|80634831|FG002|Overall Study|Withdrawal by Subject|11|||
27670861|NCT01214421|80634832|FG003|Overall Study|Withdrawal by Subject|2|||
27670862|NCT00025506|80634834|FG000|Overall Study|Ineligible: clerical error|1|||
27670863|NCT00025506|80634834|FG000|Overall Study|Ineligible: wrong cell type|5|||
27670864|NCT00025506|80634834|FG000|Overall Study|Ineligible: inadequate pathology|2|||
27670865|NCT00025506|80634834|FG000|Overall Study|Never Treated|2|||
27670866|NCT02980523|80634844|FG000|Overall Study|Lost to Follow-up|1|||
27670867|NCT02980523|80634845|FG001|Overall Study|Lost to Follow-up|4|||
27670868|NCT02980523|80634846|FG002|Overall Study|Lost to Follow-up|1|||
27670869|NCT02980523|80634847|FG003|Overall Study|Lost to Follow-up|2|||
27670870|NCT02980523|80634848|FG004|Overall Study|Lost to Follow-up|1|||
27670871|NCT02980523|80634844|FG000|Overall Study|Excluded from analysis|1|||
27670872|NCT02980523|80634845|FG001|Overall Study|Excluded from analysis|3|||
27670873|NCT02980523|80634846|FG002|Overall Study|Excluded from analysis|1|||
27670874|NCT02980523|80634847|FG003|Overall Study|Excluded from analysis|1|||
27670875|NCT02980523|80634848|FG004|Overall Study|Excluded from analysis|1|||
27670876|NCT02980523|80634844|FG000|Overall Study|Lack of Efficacy|1|||
27670877|NCT02980523|80634845|FG001|Overall Study|Lack of Efficacy|4|||
27670878|NCT02980523|80634846|FG002|Overall Study|Lack of Efficacy|4|||
27670879|NCT02980523|80634847|FG003|Overall Study|Lack of Efficacy|5|||
27670880|NCT02980523|80634848|FG004|Overall Study|Lack of Efficacy|8|||
27670881|NCT02980523|80634844|FG000|Overall Study|Did not receive intervention|0|||
27670882|NCT02980523|80634845|FG001|Overall Study|Did not receive intervention|0|||
27670883|NCT02980523|80634846|FG002|Overall Study|Did not receive intervention|0|||
27670884|NCT02980523|80634847|FG003|Overall Study|Did not receive intervention|1|||
27670885|NCT02980523|80634848|FG004|Overall Study|Did not receive intervention|0|||
27670886|NCT00079339|80634849|FG000|Overall Study|Adverse Event|1|||
27670887|NCT00079339|80634850|FG001|Overall Study|Adverse Event|7|||
27670888|NCT00079339|80634851|FG002|Overall Study|Adverse Event|2|||
27670889|NCT00079339|80634849|FG000|Overall Study|Death|1|||
27670890|NCT00079339|80634850|FG001|Overall Study|Death|0|||
27670891|NCT00079339|80634851|FG002|Overall Study|Death|0|||
27670892|NCT00079339|80634849|FG000|Overall Study|Non-compliance|0|||
27670893|NCT00079339|80634850|FG001|Overall Study|Non-compliance|0|||
27670894|NCT00079339|80634851|FG002|Overall Study|Non-compliance|1|||
27670895|NCT00079339|80634849|FG000|Overall Study|Withdrawal by Subject|0|||
27670896|NCT00079339|80634850|FG001|Overall Study|Withdrawal by Subject|4|||
27670897|NCT00079339|80634851|FG002|Overall Study|Withdrawal by Subject|1|||
27670898|NCT00079339|80634849|FG000|Overall Study|Disease progression|3|||
27670899|NCT00079339|80634850|FG001|Overall Study|Disease progression|28|||
27670900|NCT00079339|80634851|FG002|Overall Study|Disease progression|2|||
27670901|NCT00872001|80634852|FG000|Overall Study|Adverse Event|34|||
27670902|NCT00872001|80634853|FG001|Overall Study|Adverse Event|23|||
27670903|NCT00872001|80634852|FG000|Overall Study|Protocol Defined Clinical Event|5|||
27670904|NCT00872001|80634853|FG001|Overall Study|Protocol Defined Clinical Event|7|||
27670905|NCT00872001|80634852|FG000|Overall Study|Lost to Follow-up|13|||
27670906|NCT00872001|80634853|FG001|Overall Study|Lost to Follow-up|12|||
27670907|NCT00872001|80634852|FG000|Overall Study|Withdrawal by Subject|18|||
27670908|NCT00872001|80634853|FG001|Overall Study|Withdrawal by Subject|30|||
27670909|NCT00872001|80634852|FG000|Overall Study|Protocol Violation|5|||
27670910|NCT00872001|80634853|FG001|Overall Study|Protocol Violation|8|||
27670911|NCT00872001|80634852|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
27670912|NCT00872001|80634853|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
27973400|NCT00075946|81732654|FG002|Overall Study|Other|3|||
27973401|NCT00075946|81732655|FG003|Overall Study|Other|11|||
27973402|NCT00075946|81732656|FG004|Overall Study|Other|0|||
27973403|NCT02649218|81732676|FG000|Overall Study|Adverse Event|8|||
27973404|NCT02649218|81732676|FG000|Overall Study|Lack of Efficacy|8|||
27973405|NCT02649218|81732676|FG000|Overall Study|Pregnancy|3|||
27973406|NCT02649218|81732676|FG000|Overall Study|Protocol Violation|3|||
27973407|NCT02649218|81732676|FG000|Overall Study|Physician Decision|1|||
27973408|NCT02649218|81732676|FG000|Overall Study|Withdrawal by Subject|2|||
27973409|NCT01453946|81732679|FG000|Overall Study|Did not receive drug for the taper phase|1|||
27973410|NCT01453946|81732679|FG000|Overall Study|Protocol Violation|2|||
27973411|NCT01453946|81732679|FG000|Overall Study|Lack of Efficacy|3|||
27973412|NCT01453946|81732679|FG000|Overall Study|Adverse Event|3|||
27973413|NCT02578680|81732685|FG000|Overall Study|Death|329|||
27670913|NCT00872001|80634852|FG000|Overall Study|Administrative|23|||
27670914|NCT00872001|80634853|FG001|Overall Study|Administrative|15|||
27670915|NCT00723125|80634854|FG000|Overall Study|Met Dx|1|||
27670916|NCT00723125|80634855|FG001|Overall Study|Met Dx|0|||
27670917|NCT00723125|80634854|FG000|Overall Study|Withdrawal by Subject|15|||
27670918|NCT00723125|80634855|FG001|Overall Study|Withdrawal by Subject|6|||
27670919|NCT00723125|80634854|FG000|Overall Study|Adverse Event|2|||
27973414|NCT02578680|81732686|FG001|Overall Study|Death|181|||
27670920|NCT00723125|80634855|FG001|Overall Study|Adverse Event|0|||
27670921|NCT01310699|80634856|FG000|Overall Study|Patients did not complete tandem.|4|||
27670922|NCT01310699|80634857|FG001|Overall Study|Patients did not complete tandem.|6|||
27866548|NCT02256436|81346502|FG001|Overall Study|Protocol Violation|1|||
27973415|NCT02578680|81732685|FG000|Overall Study|Lost to Follow-up|3|||
27973416|NCT02578680|81732686|FG001|Overall Study|Lost to Follow-up|1|||
27973417|NCT02578680|81732685|FG000|Overall Study|Physician Decision|0|||
27973418|NCT02578680|81732686|FG001|Overall Study|Physician Decision|1|||
27973419|NCT02578680|81732685|FG000|Overall Study|Protocol Violation|1|||
27973420|NCT02578680|81732686|FG001|Overall Study|Protocol Violation|1|||
27973421|NCT02578680|81732685|FG000|Overall Study|Sponsor Decision|64|||
27973422|NCT02578680|81732686|FG001|Overall Study|Sponsor Decision|13|||
27973423|NCT02578680|81732685|FG000|Overall Study|Withdrawal by Subject|13|||
27973424|NCT02578680|81732686|FG001|Overall Study|Withdrawal by Subject|9|||
27973425|NCT01819129|81732687|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
27973426|NCT01819129|81732688|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
27973427|NCT01819129|81732687|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
27973428|NCT01819129|81732688|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
27973429|NCT01819129|81732687|FG000|Overall Study|Other, Subject moved out of the country|0|||
27973430|NCT01819129|81732688|FG001|Overall Study|Other, Subject moved out of the country|1|||
27973431|NCT01819129|81732687|FG000|Overall Study|Withdrawal by Subject|15|||
27973432|NCT01819129|81732688|FG001|Overall Study|Withdrawal by Subject|15|||
27973433|NCT01819129|81732687|FG000|Overall Study|Lost to Follow-up|5|||
27973434|NCT01819129|81732688|FG001|Overall Study|Lost to Follow-up|2|||
27973435|NCT01819129|81732687|FG000|Overall Study|Lack of Efficacy|0|||
27973436|NCT01819129|81732688|FG001|Overall Study|Lack of Efficacy|1|||
27973437|NCT01819129|81732687|FG000|Overall Study|Adverse Event|1|||
27973438|NCT01819129|81732688|FG001|Overall Study|Adverse Event|4|||
27973439|NCT01819129|81732687|FG000|Overall Study|Death|1|||
27973440|NCT01819129|81732688|FG001|Overall Study|Death|1|||
27973441|NCT01819129|81732687|FG000|Overall Study|Withdrawal Criteria|20|||
27573090|NCT00025883|80282300|FG000|Overall Study|Death|1|||
27573091|NCT00025883|80282300|FG000|Overall Study|Adverse Event|1|||
27573092|NCT00025883|80282300|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
27573093|NCT02412631|80282303|FG000|Overall Study|Adverse Event|1|||
27573094|NCT02412631|80282304|FG001|Overall Study|Adverse Event|2|||
27670923|NCT01078922|80634860|FG000|Overall Study|Adverse Event|1|||
27670924|NCT01585298|80634873|FG000|Overall Study|Study completion was not documented.|1|||
27670925|NCT01585298|80634873|FG000|Overall Study|Protocol deviation|1|||
27670926|NCT01585298|80634873|FG000|Overall Study|Administrative problems|4|||
27670927|NCT01585298|80634873|FG000|Overall Study|Lost to Follow-up|2|||
27670928|NCT01585298|80634873|FG000|Overall Study|Withdrawal by Subject|4|||
27670929|NCT01585298|80634873|FG000|Overall Study|Abnormal test procedure results|1|||
27670930|NCT01585298|80634873|FG000|Overall Study|Adverse Event|24|||
27670931|NCT01772563|80634874|FG000|Cycle 1|Dose limiting toxicity|2|||
27670932|NCT01772563|80634874|FG000|Cycle 1|Progressive disease|2|||
27670933|NCT01772563|80634874|FG000|Cycle 2 and Beyond|Progressive disease|17|||
27785235|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
27785236|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
27785237|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
27785238|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
27785239|NCT03370133|81043897|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
27785240|NCT03370133|81043898|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
27785241|NCT03370133|81043899|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
27785242|NCT03370133|81043900|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
27785243|NCT03370133|81043901|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
27785244|NCT03370133|81043902|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
27785245|NCT03672006|81043904|FG000|Overall Study|exclusion criteria met|0|||
27785246|NCT03672006|81043905|FG001|Overall Study|exclusion criteria met|1|||
27785247|NCT04034225|81043906|FG000|Overall Study|Death|3|||
27785248|NCT04034225|81043906|FG000|Overall Study|Withdrawal by Subject|2|||
27785249|NCT04034225|81043906|FG000|Overall Study|Study termination by Sponsor|18|||
27785250|NCT04034225|81043906|FG000|Overall Study|Physician Decision|1|||
27785251|NCT04034225|81043906|FG000|Overall Study|Lack of Efficacy|1|||
27785252|NCT00490815|81043907|FG000|Overall Study|Adverse Event|2|||
27785253|NCT00490815|81043908|FG001|Overall Study|Adverse Event|3|||
27785254|NCT00490815|81043907|FG000|Overall Study|Withdrawal by Subject|4|||
27785255|NCT00490815|81043908|FG001|Overall Study|Withdrawal by Subject|0|||
27785256|NCT00490815|81043907|FG000|Overall Study|Lost to Follow-up|1|||
27785257|NCT00490815|81043908|FG001|Overall Study|Lost to Follow-up|3|||
27785258|NCT00490815|81043907|FG000|Overall Study|Death|1|||
27573095|NCT02412631|80282303|FG000|Overall Study|Lost to Follow-up|5|||
27670934|NCT01772563|80634874|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
27670935|NCT01772563|80634874|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
27785259|NCT00490815|81043908|FG001|Overall Study|Death|3|||
27785260|NCT01087944|81043909|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
27785261|NCT01087944|81043910|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
27785262|NCT01087944|81043909|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
27785263|NCT01087944|81043910|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
27973442|NCT01819129|81732688|FG001|Overall Study|Withdrawal Criteria|15|||
27973443|NCT01799239|81732691|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
27670936|NCT03713320|80634878|FG000|Randomized Period|Adverse Event|1|||
27785264|NCT00660829|81043921|FG000|Overall Study|Adverse Event|3|||
27785265|NCT00660829|81043922|FG001|Overall Study|Adverse Event|4|||
27785266|NCT00660829|81043921|FG000|Overall Study|Lack of Efficacy|2|||
27785267|NCT00660829|81043922|FG001|Overall Study|Lack of Efficacy|3|||
27785268|NCT00660829|81043921|FG000|Overall Study|Non-Compliance|0|||
27785269|NCT00660829|81043922|FG001|Overall Study|Non-Compliance|4|||
27785270|NCT00660829|81043921|FG000|Overall Study|Withdrawal by Subject|1|||
27785271|NCT00660829|81043922|FG001|Overall Study|Withdrawal by Subject|2|||
27785272|NCT00660829|81043921|FG000|Overall Study|Lost to Follow-up|3|||
27785273|NCT00660829|81043922|FG001|Overall Study|Lost to Follow-up|2|||
27785274|NCT00660829|81043921|FG000|Overall Study|Other|9|||
27785275|NCT00660829|81043922|FG001|Overall Study|Other|4|||
27785276|NCT04511533|81043925|FG000|Treatment|Other|2|||
27785277|NCT04511533|81043925|FG000|Treatment|Withdrawal by Subject|11|||
27785278|NCT04511533|81043925|FG000|Treatment|Death|5|||
27785279|NCT04511533|81043925|FG000|Treatment|Physician Decision|1|||
27785280|NCT04511533|81043925|FG000|Treatment|Progressive Disease|61|||
27785281|NCT04511533|81043925|FG000|Follow-Up|Other|7|||
27785282|NCT04511533|81043925|FG000|Follow-Up|Withdrawal by Subject|5|||
27785283|NCT04511533|81043925|FG000|Follow-Up|Lost to Follow-up|2|||
27785284|NCT04511533|81043925|FG000|Follow-Up|Death|4|||
27785285|NCT01012765|81043926|FG000|Treatment Period 1|Adverse Event|1|||
27785286|NCT01012765|81043927|FG001|Treatment Period 1|Adverse Event|0|||
27785287|NCT01012765|81043928|FG002|Treatment Period 1|Adverse Event|1|||
27785288|NCT01012765|81043929|FG003|Treatment Period 1|Adverse Event|0|||
27785289|NCT01012765|81043930|FG004|Treatment Period 1|Adverse Event|0|||
27785290|NCT01012765|81043931|FG005|Treatment Period 1|Adverse Event|0|||
27785291|NCT01012765|81043926|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27785292|NCT01012765|81043927|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27785293|NCT01012765|81043928|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27785294|NCT01012765|81043929|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27785295|NCT01012765|81043930|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27785296|NCT01012765|81043931|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27785297|NCT01012765|81043926|FG000|Treatment Period 1|Administrative problems|0|||
27785298|NCT01012765|81043927|FG001|Treatment Period 1|Administrative problems|0|||
27785299|NCT01012765|81043928|FG002|Treatment Period 1|Administrative problems|1|||
27785300|NCT01012765|81043929|FG003|Treatment Period 1|Administrative problems|1|||
27785301|NCT01012765|81043930|FG004|Treatment Period 1|Administrative problems|1|||
27785302|NCT01012765|81043931|FG005|Treatment Period 1|Administrative problems|0|||
27785303|NCT01012765|81043926|FG000|Treatment Period 1|Protocol Violation|0|||
27785304|NCT01012765|81043927|FG001|Treatment Period 1|Protocol Violation|0|||
27785305|NCT01012765|81043928|FG002|Treatment Period 1|Protocol Violation|0|||
27785306|NCT01012765|81043929|FG003|Treatment Period 1|Protocol Violation|2|||
27785307|NCT01012765|81043930|FG004|Treatment Period 1|Protocol Violation|1|||
27785308|NCT01012765|81043931|FG005|Treatment Period 1|Protocol Violation|0|||
27785309|NCT01012765|81043926|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27785310|NCT01012765|81043927|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27785311|NCT01012765|81043928|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27785312|NCT01012765|81043929|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27785313|NCT01012765|81043930|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
27785314|NCT01012765|81043931|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
27785315|NCT01012765|81043926|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27785316|NCT01012765|81043927|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27785317|NCT01012765|81043928|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27785318|NCT01012765|81043929|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27785319|NCT01012765|81043930|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27785320|NCT01012765|81043931|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27785321|NCT01012765|81043926|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
27785322|NCT01012765|81043927|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
27785323|NCT01012765|81043928|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
27785324|NCT01012765|81043929|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
27785325|NCT01012765|81043930|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
27785326|NCT01012765|81043931|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
27866549|NCT02256436|81346501|FG000|Overall Study|Withdrawal by Subject|26|||
27866550|NCT02256436|81346502|FG001|Overall Study|Withdrawal by Subject|10|||
27785327|NCT01012765|81043926|FG000|Treatment Period 2|Adverse Event|0|||
27785328|NCT01012765|81043927|FG001|Treatment Period 2|Adverse Event|1|||
27785329|NCT01012765|81043928|FG002|Treatment Period 2|Adverse Event|1|||
27785330|NCT01012765|81043929|FG003|Treatment Period 2|Adverse Event|0|||
27785331|NCT01012765|81043930|FG004|Treatment Period 2|Adverse Event|0|||
27785332|NCT01012765|81043931|FG005|Treatment Period 2|Adverse Event|0|||
27785333|NCT01012765|81043926|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27785334|NCT01012765|81043927|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
27785335|NCT01012765|81043928|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
27866551|NCT02256436|81346501|FG000|Overall Study|Transferred to Extension Study|11|||
27785336|NCT01012765|81043929|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27573096|NCT02412631|80282304|FG001|Overall Study|Lost to Follow-up|9|||
27573097|NCT02412631|80282303|FG000|Overall Study|Withdrawal by Subject|9|||
27573098|NCT02412631|80282304|FG001|Overall Study|Withdrawal by Subject|3|||
27573099|NCT02412631|80282303|FG000|Overall Study|Early stop by FDA|5|||
27573100|NCT02412631|80282304|FG001|Overall Study|Early stop by FDA|2|||
27573101|NCT02412631|80282303|FG000|Overall Study|Unspecified reason|6|||
27573102|NCT02412631|80282304|FG001|Overall Study|Unspecified reason|8|||
27573103|NCT02223767|80282305|FG000|Overall Study|Withdrawal by Subject|4|||
27573104|NCT02223767|80282306|FG001|Overall Study|Withdrawal by Subject|4|||
27573105|NCT00727714|80282307|FG000|Overall Study|Lost to Follow-up|2|||
27573106|NCT01020019|80282308|FG000|Overall Study|Lost to Follow-up|21|||
27573107|NCT01020019|80282309|FG001|Overall Study|Lost to Follow-up|18|||
27573108|NCT01020019|80282308|FG000|Overall Study|Adverse Event|1|||
27866552|NCT02256436|81346502|FG001|Overall Study|Transferred to Extension Study|23|||
27866553|NCT02256436|81346501|FG000|Overall Study|Did Not Continue on Extension Study|8|||
27866554|NCT02256436|81346502|FG001|Overall Study|Did Not Continue on Extension Study|12|||
27866555|NCT02088697|81346503|FG000|Period I|Physician Decision|1|||
27866556|NCT02088697|81346504|FG001|Period I|Physician Decision|4|||
27866557|NCT02088697|81346503|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
27866558|NCT02088697|81346504|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
27866559|NCT02108912|81346513|FG000|Overall Study|Lost to Follow-up|1|||
27866560|NCT02108912|81346514|FG001|Overall Study|Lost to Follow-up|1|||
27866561|NCT02108912|81346513|FG000|Overall Study|lack of transportation|1|||
27866562|NCT02108912|81346514|FG001|Overall Study|lack of transportation|0|||
27866563|NCT02108912|81346513|FG000|Overall Study|high blood pressure|1|||
27866564|NCT02108912|81346514|FG001|Overall Study|high blood pressure|0|||
27866565|NCT01682811|81346515|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27866566|NCT01682811|81346516|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27866567|NCT01682811|81346517|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27866568|NCT01682811|81346518|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27866569|NCT01682811|81346519|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
27866570|NCT01682811|81346520|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27866571|NCT01682811|81346521|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
27866572|NCT01682811|81346515|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
27866573|NCT01682811|81346516|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
27866574|NCT01682811|81346517|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
27866575|NCT01682811|81346518|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
27866576|NCT01682811|81346519|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
27866577|NCT01682811|81346520|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
27866578|NCT01682811|81346521|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
27866579|NCT01682811|81346515|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
27866580|NCT01682811|81346516|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
27866581|NCT01682811|81346517|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
27866582|NCT01682811|81346518|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
27866583|NCT01682811|81346519|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
27866584|NCT01682811|81346520|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
27866585|NCT01682811|81346521|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
27866586|NCT01682811|81346515|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
27866587|NCT01682811|81346516|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
27866588|NCT01682811|81346517|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
27866589|NCT01682811|81346518|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
27866590|NCT01682811|81346519|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
27866591|NCT01682811|81346520|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
27866592|NCT01682811|81346521|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
27866593|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
27866594|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
27973444|NCT01799239|81732692|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
27866595|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
27866596|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
27866597|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
27866598|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
27866599|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
27866600|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
27866601|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
27866602|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
27573109|NCT01020019|80282309|FG001|Overall Study|Adverse Event|5|||
27573110|NCT01020019|80282308|FG000|Overall Study|not interested in treatment|4|||
27573111|NCT01020019|80282309|FG001|Overall Study|not interested in treatment|4|||
27573112|NCT01020019|80282308|FG000|Overall Study|moving|0|||
27866603|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
27670937|NCT03713320|80634879|FG001|Randomized Period|Adverse Event|5|||
27670938|NCT03713320|80634880|FG002|Randomized Period|Adverse Event|0|||
27573113|NCT01020019|80282309|FG001|Overall Study|moving|2|||
27670939|NCT03713320|80634878|FG000|Randomized Period|Physician Decision|1|||
27866604|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
27866605|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
27866606|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
27866607|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
27866608|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
27866609|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
27866610|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
27866611|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
27866612|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
27866613|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
27866614|NCT04040192|81346522|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
27866615|NCT04040192|81346523|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
27573114|NCT01434823|80282310|FG000|Overall Study|Incomplete data in medical record|4|||
27573115|NCT01434823|80282311|FG001|Overall Study|Incomplete data in medical record|7|||
27573116|NCT00325234|80282312|FG000|Overall Study|Adverse Event|10|||
27573117|NCT00325234|80282313|FG001|Overall Study|Adverse Event|7|||
27573118|NCT00325234|80282312|FG000|Overall Study|Death due to Study Disease|1|||
27573119|NCT00325234|80282313|FG001|Overall Study|Death due to Study Disease|0|||
27573120|NCT00325234|80282312|FG000|Overall Study|Entry Criteria Not Met|1|||
27573121|NCT00325234|80282313|FG001|Overall Study|Entry Criteria Not Met|2|||
27573122|NCT00325234|80282312|FG000|Overall Study|Subject Decision|6|||
27573123|NCT00325234|80282313|FG001|Overall Study|Subject Decision|8|||
27573124|NCT00325234|80282312|FG000|Overall Study|Physician Decision|17|||
27573125|NCT00325234|80282313|FG001|Overall Study|Physician Decision|12|||
27573126|NCT00325234|80282312|FG000|Overall Study|Progressive Disease|34|||
27573127|NCT00325234|80282313|FG001|Overall Study|Progressive Disease|37|||
27573128|NCT01800903|80282314|FG000|Second Test Period|unable to catheterise|1|||
27573129|NCT01800903|80282315|FG001|Second Test Period|unable to catheterise|0|||
27573130|NCT01800903|80282316|FG002|Second Test Period|unable to catheterise|0|||
27573131|NCT01800903|80282317|FG003|Second Test Period|unable to catheterise|0|||
27573132|NCT01800903|80282318|FG004|Second Test Period|unable to catheterise|0|||
27573133|NCT01800903|80282319|FG005|Second Test Period|unable to catheterise|0|||
27573134|NCT01430585|80282325|FG000|Overall Study|Death|1|||
27573135|NCT01430585|80282325|FG000|Overall Study|Objective Progression or Relapse|3|||
27573136|NCT01430585|80282325|FG000|Overall Study|Study Terminated by Sponsor|3|||
27573137|NCT01430585|80282325|FG000|Overall Study|Other|7|||
27573138|NCT02586012|80282328|FG000|Overall Study|Withdrawal by Subject|1|||
27573139|NCT02586012|80282329|FG001|Overall Study|Withdrawal by Subject|1|||
27573140|NCT02586012|80282330|FG002|Overall Study|Withdrawal by Subject|0|||
27573141|NCT02586012|80282331|FG003|Overall Study|Withdrawal by Subject|1|||
27573142|NCT02586012|80282332|FG004|Overall Study|Withdrawal by Subject|0|||
27573143|NCT02586012|80282333|FG005|Overall Study|Withdrawal by Subject|2|||
27573144|NCT02586012|80282328|FG000|Overall Study|Protocol Violation|0|||
27573145|NCT02586012|80282329|FG001|Overall Study|Protocol Violation|0|||
27573146|NCT02586012|80282330|FG002|Overall Study|Protocol Violation|0|||
27573147|NCT02586012|80282331|FG003|Overall Study|Protocol Violation|0|||
27573148|NCT02586012|80282332|FG004|Overall Study|Protocol Violation|0|||
27573149|NCT02586012|80282333|FG005|Overall Study|Protocol Violation|1|||
27866616|NCT04040192|81346524|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
27573150|NCT02586012|80282328|FG000|Overall Study|study terminated|0|||
27573151|NCT02586012|80282329|FG001|Overall Study|study terminated|2|||
27670940|NCT03713320|80634879|FG001|Randomized Period|Physician Decision|1|||
27670941|NCT03713320|80634880|FG002|Randomized Period|Physician Decision|0|||
27573152|NCT02586012|80282330|FG002|Overall Study|study terminated|1|||
27573153|NCT02586012|80282331|FG003|Overall Study|study terminated|1|||
27573154|NCT02586012|80282332|FG004|Overall Study|study terminated|1|||
27573155|NCT02586012|80282333|FG005|Overall Study|study terminated|0|||
27573156|NCT01516879|80282334|FG000|Overall Study|Withdrawal by Subject|9|||
27573157|NCT01516879|80282335|FG001|Overall Study|Withdrawal by Subject|11|||
27573158|NCT01516879|80282334|FG000|Overall Study|Death|0|||
27573159|NCT01516879|80282335|FG001|Overall Study|Death|2|||
27573160|NCT01516879|80282334|FG000|Overall Study|Lost to Follow-up|2|||
27573161|NCT01516879|80282335|FG001|Overall Study|Lost to Follow-up|11|||
27573162|NCT01516879|80282334|FG000|Overall Study|Other|5|||
27670942|NCT03713320|80634878|FG000|Randomized Period|Withdrawal by Subject|4|||
27573163|NCT01516879|80282335|FG001|Overall Study|Other|10|||
27573164|NCT02388997|80282336|FG000|Overall Study|Adverse Event|1|||
27573165|NCT02388997|80282337|FG001|Overall Study|Adverse Event|2|||
27573166|NCT02388997|80282336|FG000|Overall Study|Withdrawal by Subject|2|||
27573167|NCT02388997|80282337|FG001|Overall Study|Withdrawal by Subject|1|||
27573168|NCT02388997|80282336|FG000|Overall Study|Lung function exclusion criteria|0|||
27573169|NCT02388997|80282337|FG001|Overall Study|Lung function exclusion criteria|2|||
27573170|NCT02388997|80282336|FG000|Overall Study|Tested positive for virus during run-in|0|||
27573171|NCT02388997|80282337|FG001|Overall Study|Tested positive for virus during run-in|1|||
27573172|NCT02673775|80282338|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
27573173|NCT02673775|80282339|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
27573174|NCT02673775|80282338|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
27573175|NCT02673775|80282339|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
27573176|NCT02673775|80282338|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
27573177|NCT02673775|80282339|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
27573178|NCT02673775|80282338|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
27573179|NCT02673775|80282339|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
27573180|NCT00578565|80285550|FG000|Overall Study|Adverse Event|3|||
27573181|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
27573182|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
27573183|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Graft loss|1|||
27573184|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Graft loss|2|||
27573185|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Death|5|||
27573186|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Death|3|||
27573187|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
27573188|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
27573189|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
27573190|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
27573191|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
27573192|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
27573193|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
27573194|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
27573195|NCT00378014|80285555|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
27573196|NCT00378014|80285556|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
27573197|NCT00378014|80285555|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
27573198|NCT00378014|80285556|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
27573199|NCT00378014|80285555|FG000|Extension (Month 12 to Month 59)|Death|1|||
27573200|NCT00378014|80285556|FG001|Extension (Month 12 to Month 59)|Death|2|||
27573201|NCT00378014|80285555|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
27573202|NCT00378014|80285556|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
27573203|NCT00378014|80285555|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
27573204|NCT00378014|80285556|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
27573205|NCT00378014|80285555|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
27573206|NCT00378014|80285556|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
27573207|NCT00378014|80285555|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
27573208|NCT00378014|80285556|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
27573209|NCT00111228|80285557|FG000|Overall Study|Withdrawal by Subject|5|||
27573210|NCT00111228|80285558|FG001|Overall Study|Withdrawal by Subject|1|||
27573211|NCT00111228|80285559|FG002|Overall Study|Withdrawal by Subject|0|||
27785337|NCT01012765|81043930|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27785338|NCT01012765|81043931|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
27785339|NCT00450814|81043934|FG000|Overall Study|Failed to complete the initial therapy|0|||
27785340|NCT00450814|81043935|FG001|Overall Study|Failed to complete the initial therapy|0|||
27785341|NCT00450814|81043936|FG002|Overall Study|Failed to complete the initial therapy|0|||
27785342|NCT00450814|81043937|FG003|Overall Study|Failed to complete the initial therapy|1|||
27785343|NCT00450814|81043938|FG004|Overall Study|Failed to complete the initial therapy|1|||
27785344|NCT00450814|81043939|FG005|Overall Study|Failed to complete the initial therapy|1|||
27785345|NCT00450814|81043940|FG006|Overall Study|Failed to complete the initial therapy|0|||
27785346|NCT00450814|81043941|FG007|Overall Study|Failed to complete the initial therapy|0|||
27866617|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
27973445|NCT01799239|81732691|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
27973446|NCT01799239|81732692|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
27573212|NCT02178475|80285560|FG000|Overall Study|Withdrawal by Subject|7|||
27573213|NCT02178475|80285560|FG000|Overall Study|Lost to Follow-up|10|||
27573214|NCT02178475|80285560|FG000|Overall Study|Death|13|||
27573215|NCT02178475|80285560|FG000|Overall Study|Protocol-specified Criteria|99|||
27573216|NCT01916304|80285565|FG000|Overall Study|Screening failure|17|||
27573217|NCT00355238|80285566|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27573218|NCT00355238|80285567|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27573219|NCT00355238|80285568|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27573220|NCT00355238|80285569|FG003|Overall Study|Adverse event unrelated to study drug|1|||
27573221|NCT00355238|80285566|FG000|Overall Study|Death|1|||
27573222|NCT00355238|80285567|FG001|Overall Study|Death|0|||
27573223|NCT00355238|80285568|FG002|Overall Study|Death|0|||
27573224|NCT00355238|80285569|FG003|Overall Study|Death|0|||
27573225|NCT00355238|80285566|FG000|Overall Study|Disease progression|37|||
27573226|NCT00355238|80285567|FG001|Overall Study|Disease progression|36|||
27573227|NCT00355238|80285568|FG002|Overall Study|Disease progression|16|||
27573228|NCT00355238|80285569|FG003|Overall Study|Disease progression|11|||
27973447|NCT01799239|81732691|FG000|Period 1 (7 Days)|Protocol Violation|0|||
27973448|NCT01799239|81732692|FG001|Period 1 (7 Days)|Protocol Violation|1|||
27973449|NCT01799239|81732691|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
27973450|NCT01799239|81732692|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
27973451|NCT01799239|81732691|FG000|Period 2 (7 Days)|Protocol Violation|1|||
27973452|NCT01799239|81732692|FG001|Period 2 (7 Days)|Protocol Violation|0|||
27785347|NCT00450814|81043942|FG008|Overall Study|Failed to complete the initial therapy|0|||
27785348|NCT00450814|81043943|FG009|Overall Study|Failed to complete the initial therapy|0|||
27973453|NCT01466660|81732696|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
27973454|NCT01466660|81732697|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
27973455|NCT01466660|81732696|FG000|Overall Study|Worsening of underlying cancer disease|5|||
27973456|NCT01466660|81732697|FG001|Overall Study|Worsening of underlying cancer disease|2|||
27973457|NCT01466660|81732696|FG000|Overall Study|Other adverse event|19|||
27973458|NCT01466660|81732697|FG001|Overall Study|Other adverse event|18|||
27973459|NCT01466660|81732696|FG000|Overall Study|Protocol Violation|2|||
27973460|NCT01466660|81732697|FG001|Overall Study|Protocol Violation|1|||
27973461|NCT01466660|81732696|FG000|Overall Study|Refused continuation of trial medication|4|||
27973462|NCT01466660|81732697|FG001|Overall Study|Refused continuation of trial medication|3|||
27973463|NCT01466660|81732696|FG000|Overall Study|Other reason not defined above|10|||
27973464|NCT01466660|81732697|FG001|Overall Study|Other reason not defined above|8|||
27973465|NCT02264665|81732698|FG000|Overall Study|Other|0|||
27973466|NCT02264665|81732699|FG001|Overall Study|Other|0|||
27973467|NCT02264665|81732700|FG002|Overall Study|Other|3|||
27973468|NCT02264665|81732701|FG003|Overall Study|Other|0|||
27973469|NCT02264665|81732702|FG004|Overall Study|Other|0|||
27973470|NCT02264665|81732703|FG005|Overall Study|Other|0|||
27973471|NCT02264665|81732704|FG006|Overall Study|Other|0|||
27973472|NCT02264665|81732698|FG000|Overall Study|Death|9|||
27973473|NCT02264665|81732699|FG001|Overall Study|Death|8|||
27973474|NCT02264665|81732700|FG002|Overall Study|Death|13|||
27973475|NCT02264665|81732701|FG003|Overall Study|Death|5|||
27973476|NCT02264665|81732702|FG004|Overall Study|Death|0|||
27973477|NCT02264665|81732703|FG005|Overall Study|Death|0|||
27973478|NCT02264665|81732704|FG006|Overall Study|Death|1|||
27973479|NCT02264665|81732698|FG000|Overall Study|Lost to Follow-up|1|||
27973480|NCT02264665|81732699|FG001|Overall Study|Lost to Follow-up|0|||
27973481|NCT02264665|81732700|FG002|Overall Study|Lost to Follow-up|2|||
27973482|NCT02264665|81732701|FG003|Overall Study|Lost to Follow-up|1|||
27973483|NCT02264665|81732702|FG004|Overall Study|Lost to Follow-up|0|||
27973484|NCT02264665|81732703|FG005|Overall Study|Lost to Follow-up|0|||
27973485|NCT02264665|81732704|FG006|Overall Study|Lost to Follow-up|0|||
27973486|NCT02264665|81732698|FG000|Overall Study|Participant decision|0|||
27973487|NCT02264665|81732699|FG001|Overall Study|Participant decision|0|||
27973488|NCT02264665|81732700|FG002|Overall Study|Participant decision|0|||
27973489|NCT02264665|81732701|FG003|Overall Study|Participant decision|1|||
27973490|NCT02264665|81732702|FG004|Overall Study|Participant decision|0|||
27973491|NCT02264665|81732703|FG005|Overall Study|Participant decision|0|||
27973492|NCT02264665|81732704|FG006|Overall Study|Participant decision|0|||
27973493|NCT02264665|81732698|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
27973494|NCT02264665|81732699|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
27973495|NCT02264665|81732700|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
27973496|NCT02264665|81732701|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
27973497|NCT02264665|81732702|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
27973498|NCT02264665|81732703|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
27973499|NCT02264665|81732704|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
27973500|NCT02264665|81732698|FG000|Overall Study|Data Missing|0|||
27973501|NCT02264665|81732699|FG001|Overall Study|Data Missing|0|||
27973502|NCT02264665|81732700|FG002|Overall Study|Data Missing|1|||
27973503|NCT02264665|81732701|FG003|Overall Study|Data Missing|0|||
27785349|NCT00450814|81043944|FG010|Overall Study|Failed to complete the initial therapy|0|||
27785350|NCT00450814|81043934|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
27973504|NCT02264665|81732702|FG004|Overall Study|Data Missing|0|||
27866618|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
27973505|NCT02264665|81732703|FG005|Overall Study|Data Missing|0|||
27973506|NCT02264665|81732704|FG006|Overall Study|Data Missing|0|||
27973507|NCT03224507|81732707|FG000|Overall Study|Death|3|||
27973508|NCT03224507|81732708|FG001|Overall Study|Death|0|||
27973509|NCT03224507|81732707|FG000|Overall Study|Lack of Efficacy|6|||
27973510|NCT03224507|81732708|FG001|Overall Study|Lack of Efficacy|0|||
27973511|NCT03224507|81732707|FG000|Overall Study|Withdrawal by Subject|6|||
27973512|NCT03224507|81732708|FG001|Overall Study|Withdrawal by Subject|0|||
27973513|NCT00521599|81732709|FG000|Overall Study|Adverse Event|5|||
27973514|NCT00521599|81732710|FG001|Overall Study|Adverse Event|7|||
27973515|NCT00521599|81732711|FG002|Overall Study|Adverse Event|6|||
27973516|NCT00521599|81732709|FG000|Overall Study|Treatment Failure|8|||
27973517|NCT00521599|81732710|FG001|Overall Study|Treatment Failure|9|||
27670943|NCT03713320|80634879|FG001|Randomized Period|Withdrawal by Subject|0|||
27670944|NCT03713320|80634880|FG002|Randomized Period|Withdrawal by Subject|0|||
27670945|NCT03713320|80634878|FG000|Randomized Period|Participant decision|3|||
27670946|NCT03713320|80634879|FG001|Randomized Period|Participant decision|1|||
27670947|NCT03713320|80634880|FG002|Randomized Period|Participant decision|0|||
27670948|NCT03713320|80634878|FG000|Randomized Period|Study terminated by sponsor|6|||
27670949|NCT03713320|80634879|FG001|Randomized Period|Study terminated by sponsor|3|||
27670950|NCT03713320|80634880|FG002|Randomized Period|Study terminated by sponsor|0|||
27670951|NCT03713320|80634878|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
27670952|NCT03713320|80634879|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
27670953|NCT03713320|80634880|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
27670954|NCT03713320|80634878|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
27785351|NCT00450814|81043935|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
27785352|NCT00450814|81043936|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
27785353|NCT00450814|81043937|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
27785354|NCT00450814|81043938|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
27785355|NCT00450814|81043939|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
27785356|NCT00450814|81043940|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
27785357|NCT00450814|81043941|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
27785358|NCT00450814|81043942|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
27785359|NCT00450814|81043943|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
27785360|NCT00450814|81043944|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
27973518|NCT00521599|81732711|FG002|Overall Study|Treatment Failure|22|||
27973519|NCT00521599|81732709|FG000|Overall Study|Lost to Follow-up|2|||
27973520|NCT00521599|81732710|FG001|Overall Study|Lost to Follow-up|1|||
27973521|NCT00521599|81732711|FG002|Overall Study|Lost to Follow-up|2|||
27973522|NCT00521599|81732709|FG000|Overall Study|Withdrawal by Subject|3|||
27670955|NCT03713320|80634879|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
27670956|NCT03713320|80634880|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
27973523|NCT00521599|81732710|FG001|Overall Study|Withdrawal by Subject|5|||
27973524|NCT00521599|81732711|FG002|Overall Study|Withdrawal by Subject|1|||
27973525|NCT00521599|81732709|FG000|Overall Study|Withdrawal by subject treatment related|3|||
27973526|NCT00521599|81732710|FG001|Overall Study|Withdrawal by subject treatment related|1|||
27973527|NCT00521599|81732711|FG002|Overall Study|Withdrawal by subject treatment related|2|||
27973528|NCT00521599|81732709|FG000|Overall Study|Protocol Violation|2|||
27973529|NCT00521599|81732710|FG001|Overall Study|Protocol Violation|4|||
27973530|NCT00521599|81732711|FG002|Overall Study|Protocol Violation|2|||
27973531|NCT00521599|81732709|FG000|Overall Study|Did not meet protocol eligibility|2|||
27973532|NCT00521599|81732710|FG001|Overall Study|Did not meet protocol eligibility|2|||
27973533|NCT00521599|81732711|FG002|Overall Study|Did not meet protocol eligibility|1|||
27973534|NCT04752566|81732718|FG000|Overall Study|Protocol Violation|0|||
27973535|NCT04752566|81732719|FG001|Overall Study|Protocol Violation|1|||
27973536|NCT04752566|81732718|FG000|Overall Study|Death|1|||
27973537|NCT04752566|81732719|FG001|Overall Study|Death|0|||
27973538|NCT04752566|81732718|FG000|Overall Study|Adverse Event|1|||
27973539|NCT04752566|81732719|FG001|Overall Study|Adverse Event|0|||
27973540|NCT04752566|81732718|FG000|Overall Study|Withdrawal by Subject|2|||
27973541|NCT04752566|81732719|FG001|Overall Study|Withdrawal by Subject|0|||
27973542|NCT04752566|81732718|FG000|Overall Study|Physician Decision|1|||
27670957|NCT02895360|80634883|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
27973543|NCT04752566|81732719|FG001|Overall Study|Physician Decision|1|||
27670958|NCT02895360|80634884|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27670959|NCT02895360|80634885|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27973544|NCT02186652|81732725|FG000|Overall Study|Lost to Follow-up|2|||
27973545|NCT02186652|81732726|FG001|Overall Study|Lost to Follow-up|0|||
27973546|NCT01945216|81732728|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
27973547|NCT01945216|81732728|FG000|Overall Study|Protocol Violation|42|||
27670960|NCT02895360|80634886|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27670961|NCT02895360|80634887|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27670962|NCT02895360|80634888|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
27670963|NCT02895360|80634883|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27670964|NCT02895360|80634884|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
27670965|NCT02895360|80634885|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27670966|NCT02895360|80634886|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27670967|NCT02895360|80634887|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27670968|NCT02895360|80634888|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
27670969|NCT02895360|80634883|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27670970|NCT02895360|80634884|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27670971|NCT02895360|80634885|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
27670972|NCT02895360|80634886|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27670973|NCT02895360|80634887|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27670974|NCT02895360|80634888|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
27670975|NCT02895360|80634883|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27670976|NCT02895360|80634884|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27670977|NCT02895360|80634885|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
27670978|NCT02895360|80634886|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27670979|NCT02895360|80634887|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27670980|NCT02895360|80634888|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
27670981|NCT02895360|80634883|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27670982|NCT02895360|80634884|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27670983|NCT02895360|80634885|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27785361|NCT01177943|81043946|FG000|First Intervention|Withdrawal by Subject|2|||
27670984|NCT02895360|80634886|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
27670985|NCT02895360|80634887|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27670986|NCT02895360|80634888|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
27670987|NCT02895360|80634883|FG000|Phase 2a|Adverse Event|0|||
27670988|NCT02895360|80634884|FG001|Phase 2a|Adverse Event|0|||
27670989|NCT02895360|80634885|FG002|Phase 2a|Adverse Event|0|||
27670990|NCT02895360|80634886|FG003|Phase 2a|Adverse Event|0|||
27670991|NCT02895360|80634887|FG004|Phase 2a|Adverse Event|0|||
27670992|NCT02895360|80634888|FG005|Phase 2a|Adverse Event|1|||
27670993|NCT02895360|80634883|FG000|Phase 2a|Progressive disease|0|||
27670994|NCT02895360|80634884|FG001|Phase 2a|Progressive disease|0|||
27670995|NCT02895360|80634885|FG002|Phase 2a|Progressive disease|0|||
27670996|NCT02895360|80634886|FG003|Phase 2a|Progressive disease|0|||
27670997|NCT02895360|80634887|FG004|Phase 2a|Progressive disease|11|||
27670998|NCT02895360|80634888|FG005|Phase 2a|Progressive disease|11|||
27670999|NCT00113269|80634889|FG000|Overall Study|Not transplanted, donor issues|4|||
27671000|NCT00113269|80634890|FG001|Overall Study|Not transplanted, donor issues|0|||
27671001|NCT00113269|80634891|FG002|Overall Study|Not transplanted, donor issues|2|||
27671002|NCT00113269|80634892|FG003|Overall Study|Not transplanted, donor issues|2|||
27671003|NCT00113269|80634889|FG000|Overall Study|Not transplanted, recipient issues|2|||
27671004|NCT00113269|80634890|FG001|Overall Study|Not transplanted, recipient issues|1|||
27671005|NCT00113269|80634891|FG002|Overall Study|Not transplanted, recipient issues|7|||
27671006|NCT00113269|80634892|FG003|Overall Study|Not transplanted, recipient issues|4|||
27671007|NCT00113269|80634889|FG000|Overall Study|Early graft loss, technical|0|||
27671008|NCT00113269|80634890|FG001|Overall Study|Early graft loss, technical|0|||
27671009|NCT00113269|80634891|FG002|Overall Study|Early graft loss, technical|2|||
27671010|NCT00113269|80634892|FG003|Overall Study|Early graft loss, technical|0|||
27671011|NCT00113269|80634889|FG000|Overall Study|Death in operating room|0|||
27671012|NCT00113269|80634890|FG001|Overall Study|Death in operating room|0|||
27671013|NCT00113269|80634891|FG002|Overall Study|Death in operating room|0|||
27671014|NCT00113269|80634892|FG003|Overall Study|Death in operating room|1|||
27671015|NCT00113269|80634889|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
27671016|NCT00113269|80634890|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
27671017|NCT00113269|80634891|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
27671018|NCT00113269|80634892|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
27671019|NCT00113269|80634889|FG000|Overall Study|Adverse Event|2|||
27671020|NCT00113269|80634890|FG001|Overall Study|Adverse Event|7|||
27671021|NCT00113269|80634891|FG002|Overall Study|Adverse Event|11|||
27671022|NCT00113269|80634892|FG003|Overall Study|Adverse Event|7|||
27671023|NCT00113269|80634889|FG000|Overall Study|Withdrawal by Subject|4|||
27671024|NCT00113269|80634890|FG001|Overall Study|Withdrawal by Subject|3|||
27671025|NCT00113269|80634891|FG002|Overall Study|Withdrawal by Subject|4|||
27671026|NCT00113269|80634892|FG003|Overall Study|Withdrawal by Subject|2|||
27671027|NCT00113269|80634889|FG000|Overall Study|Graft loss|6|||
27671028|NCT00113269|80634890|FG001|Overall Study|Graft loss|6|||
27671029|NCT00113269|80634891|FG002|Overall Study|Graft loss|4|||
27671030|NCT00113269|80634892|FG003|Overall Study|Graft loss|9|||
27671031|NCT00113269|80634889|FG000|Overall Study|Protocol Violation|1|||
27671032|NCT00113269|80634890|FG001|Overall Study|Protocol Violation|0|||
27973548|NCT01945216|81732728|FG000|Overall Study|CRF not assured by investigators|5|||
27671033|NCT00113269|80634891|FG002|Overall Study|Protocol Violation|4|||
27671034|NCT00113269|80634892|FG003|Overall Study|Protocol Violation|2|||
27671035|NCT00113269|80634889|FG000|Overall Study|Lost to Follow-up|2|||
27671036|NCT00113269|80634890|FG001|Overall Study|Lost to Follow-up|3|||
27671037|NCT00113269|80634891|FG002|Overall Study|Lost to Follow-up|6|||
27671038|NCT00113269|80634892|FG003|Overall Study|Lost to Follow-up|3|||
27671039|NCT00113269|80634889|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
27671040|NCT00113269|80634890|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
27671041|NCT00113269|80634891|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
27671042|NCT00113269|80634892|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
27671043|NCT00113269|80634889|FG000|Overall Study|Discontinued due to rejection|0|||
27671044|NCT00113269|80634890|FG001|Overall Study|Discontinued due to rejection|0|||
27671045|NCT00113269|80634891|FG002|Overall Study|Discontinued due to rejection|1|||
27671046|NCT00113269|80634892|FG003|Overall Study|Discontinued due to rejection|0|||
27671047|NCT00113269|80634889|FG000|Overall Study|Moved|0|||
27671048|NCT00113269|80634890|FG001|Overall Study|Moved|1|||
27671049|NCT00113269|80634891|FG002|Overall Study|Moved|0|||
27671050|NCT00113269|80634892|FG003|Overall Study|Moved|3|||
27671051|NCT00113269|80634889|FG000|Overall Study|Received pancreas transplant|0|||
27671052|NCT00113269|80634890|FG001|Overall Study|Received pancreas transplant|0|||
27671053|NCT00113269|80634891|FG002|Overall Study|Received pancreas transplant|0|||
27671054|NCT00113269|80634892|FG003|Overall Study|Received pancreas transplant|2|||
27671055|NCT00113269|80634889|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
27671056|NCT00113269|80634890|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
27671057|NCT00113269|80634891|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
27671058|NCT00113269|80634892|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
27671059|NCT00113269|80634889|FG000|Overall Study|Did not meet eligibility criteria|1|||
27671060|NCT00113269|80634890|FG001|Overall Study|Did not meet eligibility criteria|0|||
27671061|NCT00113269|80634891|FG002|Overall Study|Did not meet eligibility criteria|0|||
27671062|NCT00113269|80634892|FG003|Overall Study|Did not meet eligibility criteria|1|||
27671063|NCT00113269|80634889|FG000|Overall Study|Unable to return for follow up|2|||
27671064|NCT00113269|80634890|FG001|Overall Study|Unable to return for follow up|1|||
27671065|NCT00113269|80634891|FG002|Overall Study|Unable to return for follow up|0|||
27671066|NCT00113269|80634892|FG003|Overall Study|Unable to return for follow up|0|||
27671067|NCT00321685|80634893|FG000|Overall Study|Adverse Event|18|||
27671068|NCT00321685|80634893|FG000|Overall Study|Death|2|||
27671069|NCT00321685|80634893|FG000|Overall Study|Withdrawal by Subject|8|||
27671070|NCT00321685|80634893|FG000|Overall Study|Alternative therapy|1|||
27671071|NCT00321685|80634893|FG000|Overall Study|Complicating disese|1|||
27671072|NCT00321685|80634893|FG000|Overall Study|Other|5|||
27671073|NCT00321685|80634893|FG000|Overall Study|Not start protocol therapy|2|||
27671074|NCT00321685|80634893|FG000|Overall Study|Ineligible|2|||
27671075|NCT05382039|80634894|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
27671076|NCT05382039|80634895|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
27671077|NCT05382039|80634896|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
27671078|NCT05382039|80634894|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
27671079|NCT05382039|80634895|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
27671080|NCT05382039|80634896|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
27671081|NCT05382039|80634894|FG000|Overall Study|waiting for confirmation|0|||
27671082|NCT05382039|80634895|FG001|Overall Study|waiting for confirmation|0|||
27671083|NCT05382039|80634896|FG002|Overall Study|waiting for confirmation|1|||
27671084|NCT00085566|80634897|FG000|Overall Study|Adverse Event|0|||
27671085|NCT00085566|80634898|FG001|Overall Study|Adverse Event|0|||
27671086|NCT00085566|80634899|FG002|Overall Study|Adverse Event|10|||
27785362|NCT01177943|81043947|FG001|First Intervention|Withdrawal by Subject|0|||
27785363|NCT01219959|81043948|FG000|Overall Study|Adverse Event|6|||
27785364|NCT01219959|81043949|FG001|Overall Study|Adverse Event|14|||
27785365|NCT01219959|81043948|FG000|Overall Study|Physician Decision|0|||
27785366|NCT01219959|81043949|FG001|Overall Study|Physician Decision|4|||
27785367|NCT01219959|81043948|FG000|Overall Study|Withdrawal by Subject|0|||
27785368|NCT01219959|81043949|FG001|Overall Study|Withdrawal by Subject|2|||
27785369|NCT01219959|81043948|FG000|Overall Study|Renal Transplantation|0|||
27671087|NCT00085566|80634897|FG000|Overall Study|Patient Not treated|0|||
27671088|NCT00085566|80634898|FG001|Overall Study|Patient Not treated|0|||
27671089|NCT00085566|80634899|FG002|Overall Study|Patient Not treated|3|||
27671090|NCT00085566|80634897|FG000|Overall Study|Clinical progression|0|||
27671091|NCT00085566|80634898|FG001|Overall Study|Clinical progression|0|||
27671092|NCT00085566|80634899|FG002|Overall Study|Clinical progression|1|||
27671093|NCT01322009|80634901|FG000|Overall Study|Death|0|||
27785370|NCT01219959|81043949|FG001|Overall Study|Renal Transplantation|3|||
27785371|NCT01219959|81043948|FG000|Overall Study|Other|1|||
27785372|NCT01219959|81043949|FG001|Overall Study|Other|0|||
27785373|NCT03044730|81043950|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
27785374|NCT03044730|81043950|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
27785375|NCT03044730|81043950|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
27785376|NCT03044730|81043950|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
27785377|NCT03044730|81043950|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
27785378|NCT03044730|81043950|FG000|Cycles 4 and Beyond|Adverse Event|1|||
27785379|NCT03044730|81043950|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
27785380|NCT03044730|81043950|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
27785381|NCT03044730|81043950|FG000|On Follow-up for 2 Years|Death|17|||
27785382|NCT01233284|81043953|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
27785383|NCT01233284|81043954|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27785384|NCT01233284|81043955|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27785385|NCT01233284|81043956|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27785386|NCT01233284|81043957|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27785387|NCT01233284|81043953|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27785388|NCT01233284|81043954|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
27785389|NCT01233284|81043955|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27785390|NCT01233284|81043956|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27785391|NCT01233284|81043957|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27785392|NCT01233284|81043953|FG000|Period 1 (4 Weeks)|Other|0|||
27785393|NCT01233284|81043954|FG001|Period 1 (4 Weeks)|Other|0|||
27785394|NCT01233284|81043955|FG002|Period 1 (4 Weeks)|Other|1|||
27785395|NCT01233284|81043956|FG003|Period 1 (4 Weeks)|Other|0|||
27785396|NCT01233284|81043957|FG004|Period 1 (4 Weeks)|Other|0|||
27785397|NCT01233284|81043953|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27785398|NCT01233284|81043954|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27785399|NCT01233284|81043955|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
27785400|NCT01233284|81043956|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27785401|NCT01233284|81043957|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
27785402|NCT01233284|81043953|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27785403|NCT01233284|81043954|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27785404|NCT01233284|81043955|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
27785405|NCT01233284|81043956|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27785406|NCT01233284|81043957|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27573229|NCT00355238|80285566|FG000|Overall Study|Study drug toxicity|11|||
27785407|NCT01233284|81043953|FG000|Period 3 (4 Weeks)|Other|0|||
27785408|NCT01233284|81043954|FG001|Period 3 (4 Weeks)|Other|0|||
27785409|NCT01233284|81043955|FG002|Period 3 (4 Weeks)|Other|0|||
27785410|NCT01233284|81043956|FG003|Period 3 (4 Weeks)|Other|1|||
27785411|NCT01233284|81043957|FG004|Period 3 (4 Weeks)|Other|0|||
27573230|NCT00355238|80285567|FG001|Overall Study|Study drug toxicity|7|||
27573231|NCT00355238|80285568|FG002|Overall Study|Study drug toxicity|5|||
27866619|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
27866620|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
27866621|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
27573232|NCT00355238|80285569|FG003|Overall Study|Study drug toxicity|2|||
27573233|NCT00355238|80285566|FG000|Overall Study|Participant withdrew consent|3|||
27573234|NCT00355238|80285567|FG001|Overall Study|Participant withdrew consent|1|||
27573235|NCT00355238|80285568|FG002|Overall Study|Participant withdrew consent|0|||
27785412|NCT01233284|81043953|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
27785413|NCT01233284|81043954|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
27785414|NCT01233284|81043955|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
27866622|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
27866623|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
27866624|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
27866625|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
27866626|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
27866627|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
27866628|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
27866629|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27866630|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
27866631|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
27866632|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
27866633|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
27866634|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
27866635|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
27785415|NCT01233284|81043956|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
27785416|NCT01233284|81043957|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
27785417|NCT01233284|81043953|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27573236|NCT00355238|80285569|FG003|Overall Study|Participant withdrew consent|0|||
27573237|NCT00355238|80285566|FG000|Overall Study|Participant request to discontinue study treatment|1|||
27785418|NCT01233284|81043954|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27866636|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
27866637|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
27866638|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
27866639|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
27866640|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
27866641|NCT04040192|81346522|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
27866642|NCT04040192|81346523|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
27866643|NCT04040192|81346524|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
27866644|NCT04152863|81346527|FG000|Overall Study|Death|13|||
27866645|NCT04152863|81346528|FG001|Overall Study|Death|12|||
27866646|NCT04152863|81346529|FG002|Overall Study|Death|7|||
27973549|NCT02046226|81732729|FG000|Overall Study|Lost to Follow-up|7|||
27671094|NCT01322009|80634902|FG001|Overall Study|Death|1|||
27866647|NCT04152863|81346527|FG000|Overall Study|Physician Decision|1|||
27866648|NCT04152863|81346528|FG001|Overall Study|Physician Decision|1|||
27866649|NCT04152863|81346529|FG002|Overall Study|Physician Decision|1|||
27866650|NCT04152863|81346527|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
27866651|NCT04152863|81346528|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
27866652|NCT04152863|81346529|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
27866653|NCT04152863|81346527|FG000|Overall Study|Withdrawal by Subject|2|||
27866654|NCT04152863|81346528|FG001|Overall Study|Withdrawal by Subject|1|||
27866655|NCT04152863|81346529|FG002|Overall Study|Withdrawal by Subject|3|||
27866656|NCT01512160|81346530|FG000|Overall Study|Lost to Follow-up|1|||
27866657|NCT01512160|81346531|FG001|Overall Study|Lost to Follow-up|0|||
27866658|NCT01512160|81346532|FG002|Overall Study|Lost to Follow-up|0|||
27866659|NCT01512160|81346533|FG003|Overall Study|Lost to Follow-up|0|||
27866660|NCT01512160|81346530|FG000|Overall Study|Withdrawal by Subject|1|||
27866661|NCT01512160|81346531|FG001|Overall Study|Withdrawal by Subject|0|||
27866662|NCT01512160|81346532|FG002|Overall Study|Withdrawal by Subject|0|||
27866663|NCT01512160|81346533|FG003|Overall Study|Withdrawal by Subject|1|||
27866664|NCT01696279|81346534|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
27866665|NCT01696279|81346535|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
27866666|NCT01696279|81346536|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
27866667|NCT01696279|81346537|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
27866668|NCT01696279|81346534|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
27866669|NCT01696279|81346535|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
27866670|NCT01696279|81346536|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
27866671|NCT01696279|81346537|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
27866672|NCT01696279|81346534|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
27866673|NCT01696279|81346535|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
27866674|NCT01696279|81346536|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
27866675|NCT01696279|81346537|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
27866676|NCT01696279|81346534|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
27866677|NCT01696279|81346535|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
27866678|NCT01696279|81346536|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
27866679|NCT01696279|81346537|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
27866680|NCT01696279|81346534|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
27866681|NCT01696279|81346535|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
27866682|NCT01696279|81346536|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
27866683|NCT01696279|81346537|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
27671095|NCT01322009|80634901|FG000|Overall Study|Adverse Event|0|||
27671096|NCT01322009|80634902|FG001|Overall Study|Adverse Event|1|||
27671097|NCT01322009|80634901|FG000|Overall Study|ng tube discontinued|0|||
27671098|NCT01322009|80634902|FG001|Overall Study|ng tube discontinued|1|||
27671099|NCT00458393|80634903|FG000|Overall Study|Withdrawal by Subject|67|||
27671100|NCT00458393|80634904|FG001|Overall Study|Withdrawal by Subject|80|||
27671101|NCT00458393|80634903|FG000|Overall Study|Physician Decision|31|||
27671102|NCT00458393|80634904|FG001|Overall Study|Physician Decision|22|||
27671103|NCT00458393|80634903|FG000|Overall Study|Relocated|77|||
27671104|NCT00458393|80634904|FG001|Overall Study|Relocated|81|||
27671105|NCT00458393|80634903|FG000|Overall Study|Lost to Follow-up|115|||
27866684|NCT01696279|81346534|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
27866685|NCT01696279|81346535|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
27866686|NCT01696279|81346536|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
27866687|NCT01696279|81346537|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
27973550|NCT05807464|81732730|FG000|Overall Study|Adverse Event|1|||
27671106|NCT00458393|80634904|FG001|Overall Study|Lost to Follow-up|92|||
27866688|NCT01696279|81346534|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
27671107|NCT00458393|80634903|FG000|Overall Study|Sites marked other on the form.|19|||
27671108|NCT00458393|80634904|FG001|Overall Study|Sites marked other on the form.|20|||
27671109|NCT01740154|80634905|FG000|Overall Study|Adverse Event|1|||
27866689|NCT01696279|81346535|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
27866690|NCT01696279|81346536|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
27866691|NCT01696279|81346537|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
27866692|NCT01696279|81346534|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
27671110|NCT04952701|80634910|FG000|Control Lens|Physician Decision|4|||
27671111|NCT04952701|80634910|FG000|Test Lens|Physician Decision|1|||
27671112|NCT01844726|80634913|FG000|Overall Study|Withdrawal by Subject|0|||
27671113|NCT01844726|80634914|FG001|Overall Study|Withdrawal by Subject|1|||
27671114|NCT01844726|80634913|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
27671115|NCT01844726|80634914|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
27671116|NCT00307164|80634915|FG000|Overall Study|Death|1|||
27671117|NCT00307164|80634916|FG001|Overall Study|Death|0|||
27671118|NCT00307164|80634915|FG000|Overall Study|Severe debilitation, unable to continue|1|||
27671119|NCT00307164|80634916|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27671120|NCT00307164|80634915|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
27671121|NCT00307164|80634916|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
27671122|NCT00307164|80634915|FG000|Overall Study|Withdrawal by Subject|1|||
27671123|NCT00307164|80634916|FG001|Overall Study|Withdrawal by Subject|8|||
27671124|NCT00307164|80634915|FG000|Overall Study|Not compliant with requirements|4|||
27671125|NCT00307164|80634916|FG001|Overall Study|Not compliant with requirements|4|||
27785419|NCT01233284|81043955|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27785420|NCT01233284|81043956|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
27785421|NCT01233284|81043957|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
27785422|NCT00422942|81043958|FG000|Overall Study|Study terminated by Sponsor|3|||
27866693|NCT01696279|81346535|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
27866694|NCT01696279|81346536|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
27866695|NCT01696279|81346537|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
27866696|NCT01696279|81346534|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
27866697|NCT01696279|81346535|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
27866698|NCT01696279|81346536|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
27866699|NCT01696279|81346537|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
27866700|NCT01696279|81346534|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
27866701|NCT01696279|81346535|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
27866702|NCT01696279|81346536|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
27866703|NCT01696279|81346537|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
27866704|NCT01696279|81346534|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
27866705|NCT01696279|81346535|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
27866706|NCT01696279|81346536|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
27866707|NCT01696279|81346537|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
27866708|NCT00041132|81346538|FG000|Overall Study|Adverse Event|19|||
27866709|NCT00041132|81346538|FG000|Overall Study|Death|1|||
27866710|NCT00041132|81346538|FG000|Overall Study|Not Eligible|7|||
27866711|NCT00041132|81346538|FG000|Overall Study|Withdrawal by Subject|1|||
27866712|NCT00041132|81346538|FG000|Overall Study|Physician Decision|2|||
27866713|NCT03076775|81346543|FG000|Overall Study|Lost to Follow-up|1|||
27866714|NCT03076775|81346544|FG001|Overall Study|Lost to Follow-up|0|||
27866715|NCT04096040|81346545|FG000|Overall Study|Protocol Violation|12|||
27866716|NCT04096040|81346545|FG000|Overall Study|Non-compliant site|4|||
27785423|NCT01398176|81043960|FG000|Overall Study|Lost to Follow-up|1|||
27785424|NCT01398176|81043961|FG001|Overall Study|Lost to Follow-up|3|||
27785425|NCT01398176|81043960|FG000|Overall Study|Physician Decision|2|||
27785426|NCT01398176|81043961|FG001|Overall Study|Physician Decision|3|||
27785427|NCT03382639|81043964|FG000|Overall Study|Adverse Event|2|||
27785428|NCT03382639|81043965|FG001|Overall Study|Adverse Event|0|||
27785429|NCT03382639|81043966|FG002|Overall Study|Adverse Event|1|||
27785430|NCT03382639|81043967|FG003|Overall Study|Adverse Event|1|||
27785431|NCT03382639|81043964|FG000|Overall Study|Lost to Follow-up|1|||
27785432|NCT03382639|81043965|FG001|Overall Study|Lost to Follow-up|0|||
27785433|NCT03382639|81043966|FG002|Overall Study|Lost to Follow-up|0|||
27785434|NCT03382639|81043967|FG003|Overall Study|Lost to Follow-up|0|||
27785435|NCT03382639|81043964|FG000|Overall Study|Withdrawal by Subject|4|||
27785436|NCT03382639|81043965|FG001|Overall Study|Withdrawal by Subject|3|||
27785437|NCT03382639|81043966|FG002|Overall Study|Withdrawal by Subject|2|||
27973551|NCT00884039|81732731|FG000|Overall Study|Withdrawal by Subject|0|||
27973552|NCT00884039|81732732|FG001|Overall Study|Withdrawal by Subject|1|||
27671126|NCT00307164|80634915|FG000|Overall Study|Lost to Follow-up|6|||
27671127|NCT00307164|80634916|FG001|Overall Study|Lost to Follow-up|1|||
27671128|NCT01017263|80634918|FG000|Overall Study|not eligible|12|||
27785438|NCT03382639|81043967|FG003|Overall Study|Withdrawal by Subject|3|||
27785439|NCT03382639|81043964|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
27866717|NCT00324987|81346547|FG000|Overall Study|Adverse Event|2|||
27866718|NCT00324987|81346548|FG001|Overall Study|Adverse Event|1|||
27866719|NCT00324987|81346547|FG000|Overall Study|Withdrawal by Subject|1|||
27866720|NCT00324987|81346548|FG001|Overall Study|Withdrawal by Subject|1|||
27866721|NCT00324987|81346547|FG000|Overall Study|Progression|1|||
27866722|NCT00324987|81346548|FG001|Overall Study|Progression|1|||
27866723|NCT00324987|81346547|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
27866724|NCT00324987|81346548|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
27866725|NCT01420965|81346551|FG000|Overall Study|Withdrawal by Subject|1|||
27866726|NCT01420965|81346552|FG001|Overall Study|Withdrawal by Subject|0|||
27866727|NCT01420965|81346553|FG002|Overall Study|Withdrawal by Subject|0|||
27866728|NCT01420965|81346551|FG000|Overall Study|Adverse Event|0|||
27866729|NCT01420965|81346552|FG001|Overall Study|Adverse Event|1|||
27866730|NCT01420965|81346553|FG002|Overall Study|Adverse Event|0|||
27866731|NCT00683657|81346554|FG000|Overall Study|Adverse Event|0|||
27866732|NCT00683657|81346555|FG001|Overall Study|Adverse Event|1|||
27866733|NCT00683657|81346554|FG000|Overall Study|Subject Withdrew Consent|1|||
27866734|NCT00683657|81346555|FG001|Overall Study|Subject Withdrew Consent|0|||
27866735|NCT00402116|81346556|FG000|Overall Study|Jaw infection after surgery-other|1|||
27866736|NCT00402116|81346557|FG001|Overall Study|Jaw infection after surgery-other|0|||
27866737|NCT00402116|81346558|FG002|Overall Study|Jaw infection after surgery-other|0|||
27866738|NCT00402116|81346556|FG000|Overall Study|Withdrawal by Subject|1|||
27866739|NCT00402116|81346557|FG001|Overall Study|Withdrawal by Subject|0|||
27866740|NCT00402116|81346558|FG002|Overall Study|Withdrawal by Subject|5|||
27866741|NCT00402116|81346556|FG000|Overall Study|Treatment completed per protocol|1|||
27866742|NCT00402116|81346557|FG001|Overall Study|Treatment completed per protocol|1|||
27866743|NCT00402116|81346558|FG002|Overall Study|Treatment completed per protocol|2|||
27866744|NCT00402116|81346556|FG000|Overall Study|other complicating disease|0|||
27866745|NCT00402116|81346557|FG001|Overall Study|other complicating disease|0|||
27866746|NCT00402116|81346558|FG002|Overall Study|other complicating disease|2|||
27866747|NCT00402116|81346556|FG000|Overall Study|Disease Progression|0|||
27866748|NCT00402116|81346557|FG001|Overall Study|Disease Progression|4|||
27866749|NCT00402116|81346558|FG002|Overall Study|Disease Progression|38|||
27866750|NCT00402116|81346556|FG000|Overall Study|mistaken thrombocytopenia|0|||
27866751|NCT00402116|81346557|FG001|Overall Study|mistaken thrombocytopenia|0|||
27866752|NCT00402116|81346558|FG002|Overall Study|mistaken thrombocytopenia|1|||
27866753|NCT00402116|81346556|FG000|Overall Study|decline related hyponatremia/tumor|0|||
27866754|NCT00402116|81346557|FG001|Overall Study|decline related hyponatremia/tumor|0|||
27866755|NCT00402116|81346558|FG002|Overall Study|decline related hyponatremia/tumor|1|||
27866756|NCT00402116|81346556|FG000|Overall Study|Adverse Event|0|||
27866757|NCT00402116|81346557|FG001|Overall Study|Adverse Event|1|||
27866758|NCT00402116|81346558|FG002|Overall Study|Adverse Event|6|||
27866759|NCT00442962|81346568|FG000|Overall Study|Pregnancy|1|||
27866760|NCT00442962|81346568|FG000|Overall Study|Lost to Follow-up|7|||
27866761|NCT00805675|81346573|FG000|Overall Study|Adverse Event|0|||
27866762|NCT00805675|81346574|FG001|Overall Study|Adverse Event|0|||
27866763|NCT00805675|81346575|FG002|Overall Study|Adverse Event|1|||
27866764|NCT00477633|81346578|FG000|Overall Study|Did not receive treatment|23|||
27866765|NCT00477633|81346578|FG000|Overall Study|Adverse Event|143|||
27866766|NCT00477633|81346578|FG000|Overall Study|Pregnancy|23|||
27866767|NCT00477633|81346578|FG000|Overall Study|Lost to Follow-up|271|||
27866768|NCT00477633|81346578|FG000|Overall Study|Withdrawal by Subject|149|||
27866769|NCT00477633|81346578|FG000|Overall Study|Protocol Violation|25|||
27866770|NCT00477633|81346578|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
27866771|NCT02096744|81346579|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
27785440|NCT03382639|81043965|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
27785441|NCT03382639|81043966|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
27785442|NCT03382639|81043967|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
27785443|NCT03382639|81043964|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
27785444|NCT03382639|81043965|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
27785445|NCT03382639|81043966|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
27785446|NCT03382639|81043967|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
27785447|NCT03382639|81043964|FG000|Overall Study|Other|2|||
27785448|NCT03382639|81043965|FG001|Overall Study|Other|0|||
27785449|NCT03382639|81043966|FG002|Overall Study|Other|0|||
27785450|NCT03382639|81043967|FG003|Overall Study|Other|3|||
27785451|NCT04409262|81043968|FG000|Overall Study|Adverse Event|0|||
27785452|NCT04409262|81043969|FG001|Overall Study|Adverse Event|2|||
27785453|NCT04409262|81043968|FG000|Overall Study|Death|55|||
27785454|NCT04409262|81043969|FG001|Overall Study|Death|97|||
27785455|NCT04409262|81043968|FG000|Overall Study|Lost to Follow-up|12|||
27866772|NCT02096744|81346580|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
27866773|NCT02096744|81346579|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
27785456|NCT04409262|81043969|FG001|Overall Study|Lost to Follow-up|23|||
27866774|NCT02096744|81346580|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
27866775|NCT02096744|81346579|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
27785457|NCT04409262|81043968|FG000|Overall Study|Lack of Staff|0|||
27785458|NCT04409262|81043969|FG001|Overall Study|Lack of Staff|1|||
27866776|NCT02096744|81346580|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
27866777|NCT02792699|81346599|FG000|Overall Study|Adverse Event|1|||
27866778|NCT02792699|81346600|FG001|Overall Study|Adverse Event|2|||
27866779|NCT02792699|81346601|FG002|Overall Study|Adverse Event|4|||
27866780|NCT02792699|81346599|FG000|Overall Study|Withdrawal by Subject|4|||
27866781|NCT02792699|81346600|FG001|Overall Study|Withdrawal by Subject|4|||
27866782|NCT02792699|81346601|FG002|Overall Study|Withdrawal by Subject|3|||
27866783|NCT02792699|81346599|FG000|Overall Study|Lost to Follow-up|0|||
27866784|NCT02792699|81346600|FG001|Overall Study|Lost to Follow-up|1|||
27866785|NCT02792699|81346601|FG002|Overall Study|Lost to Follow-up|2|||
27866786|NCT02792699|81346599|FG000|Overall Study|Physician Decision|2|||
27866787|NCT02792699|81346600|FG001|Overall Study|Physician Decision|0|||
27866788|NCT02792699|81346601|FG002|Overall Study|Physician Decision|0|||
27866789|NCT02792699|81346599|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
27866790|NCT02792699|81346600|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
27866791|NCT02792699|81346601|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
27866792|NCT02792699|81346599|FG000|Overall Study|Other|1|||
27866793|NCT02792699|81346600|FG001|Overall Study|Other|0|||
27866794|NCT02792699|81346601|FG002|Overall Study|Other|0|||
27866795|NCT02460679|81346607|FG000|Overall Study|Investigator Decision|1|||
27866796|NCT02460679|81346607|FG000|Overall Study|Withdrawal by Subject|4|||
27866797|NCT00359801|81346608|FG000|Overall Study|Lost to Follow-up|72|||
27866798|NCT00359801|81346609|FG001|Overall Study|Lost to Follow-up|58|||
27866799|NCT00359801|81346608|FG000|Overall Study|Withdrawal by Subject|143|||
27866800|NCT00359801|81346609|FG001|Overall Study|Withdrawal by Subject|96|||
27866801|NCT00359801|81346608|FG000|Overall Study|Other|66|||
27866802|NCT00359801|81346609|FG001|Overall Study|Other|46|||
27973553|NCT00884039|81732731|FG000|Overall Study|Lack of Efficacy|2|||
27973554|NCT00884039|81732732|FG001|Overall Study|Lack of Efficacy|0|||
27973555|NCT01474772|81732734|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
27973556|NCT01474772|81732735|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
27973557|NCT01474772|81732734|FG000|Period 1|AE not Related to Study Drug|1|||
27973558|NCT01474772|81732735|FG001|Period 1|AE not Related to Study Drug|0|||
27973559|NCT01474772|81732734|FG000|Period 1|Withdrawal by Subject|3|||
27973560|NCT01474772|81732735|FG001|Period 1|Withdrawal by Subject|1|||
27973561|NCT01474772|81732734|FG000|Period 1|Lost to Follow-up|1|||
27973562|NCT01474772|81732735|FG001|Period 1|Lost to Follow-up|0|||
27973563|NCT01474772|81732734|FG000|Period 1|Reason not Specified|1|||
27785459|NCT04409262|81043968|FG000|Overall Study|Protocol Violation|3|||
27785460|NCT04409262|81043969|FG001|Overall Study|Protocol Violation|1|||
27785461|NCT04409262|81043968|FG000|Overall Study|Withdrawal by Subject|5|||
27785462|NCT04409262|81043969|FG001|Overall Study|Withdrawal by Subject|10|||
27785463|NCT01636076|81043970|FG000|Overall Study|Terminated by sponsor|1|||
27785464|NCT01636076|81043971|FG001|Overall Study|Terminated by sponsor|1|||
27785465|NCT01636076|81043970|FG000|Overall Study|Lack of Efficacy|0|||
27785466|NCT01636076|81043971|FG001|Overall Study|Lack of Efficacy|1|||
27785467|NCT01636076|81043970|FG000|Overall Study|Lost to Follow-up|1|||
27785468|NCT01636076|81043971|FG001|Overall Study|Lost to Follow-up|0|||
27785469|NCT01636076|81043970|FG000|Overall Study|Physician Decision|1|||
27785470|NCT01636076|81043971|FG001|Overall Study|Physician Decision|1|||
27785471|NCT01636076|81043970|FG000|Overall Study|Non-compliance with study treatment|1|||
27785472|NCT01636076|81043971|FG001|Overall Study|Non-compliance with study treatment|1|||
27785473|NCT01636076|81043970|FG000|Overall Study|Adverse Event|6|||
27785474|NCT01636076|81043971|FG001|Overall Study|Adverse Event|11|||
27785475|NCT01636076|81043970|FG000|Overall Study|Withdrawal by Subject|7|||
27785476|NCT01636076|81043971|FG001|Overall Study|Withdrawal by Subject|10|||
27785477|NCT02030067|81043975|FG000|Overall Study|Disease Progression|1|||
27785478|NCT02030067|81043976|FG001|Overall Study|Disease Progression|1|||
27785479|NCT02030067|81043977|FG002|Overall Study|Disease Progression|2|||
27785480|NCT02030067|81043978|FG003|Overall Study|Disease Progression|2|||
27866803|NCT00359801|81346608|FG000|Overall Study|Final Status Unknown: missing data|7|||
27866804|NCT00359801|81346609|FG001|Overall Study|Final Status Unknown: missing data|4|||
27866805|NCT00359801|81346608|FG000|Overall Study|Sponsor Decision|17|||
27866806|NCT00359801|81346609|FG001|Overall Study|Sponsor Decision|16|||
27866807|NCT00995774|81346612|FG000|Training Period 2|Withdrawal by Subject|2|||
27866808|NCT00995774|81346613|FG001|Training Period 2|Withdrawal by Subject|0|||
27866809|NCT00658879|81346614|FG000|Overall Study|Protocol Violation|1|||
27785481|NCT02030067|81043979|FG004|Overall Study|Disease Progression|3|||
27785482|NCT02030067|81043980|FG005|Overall Study|Disease Progression|2|||
27785483|NCT02030067|81043981|FG006|Overall Study|Disease Progression|3|||
27785484|NCT02030067|81043982|FG007|Overall Study|Disease Progression|3|||
27785485|NCT02030067|81043983|FG008|Overall Study|Disease Progression|4|||
27785486|NCT02030067|81043984|FG009|Overall Study|Disease Progression|3|||
27866810|NCT00998309|81346615|FG000|Overall Study|Protocol Violation|4|||
27973564|NCT01474772|81732735|FG001|Period 1|Reason not Specified|1|||
27973565|NCT01474772|81732734|FG000|Washout|AE not Related to Study Drug|2|||
27973566|NCT01474772|81732735|FG001|Washout|AE not Related to Study Drug|0|||
27973567|NCT01474772|81732734|FG000|Washout|Withdrawal by Subject|1|||
27973568|NCT01474772|81732735|FG001|Washout|Withdrawal by Subject|0|||
27973569|NCT01474772|81732734|FG000|Washout|Lost to Follow-up|0|||
27973570|NCT01474772|81732735|FG001|Washout|Lost to Follow-up|1|||
27973571|NCT01474772|81732734|FG000|Washout|Reason not Specified|0|||
27973572|NCT01474772|81732735|FG001|Washout|Reason not Specified|1|||
27973573|NCT01474772|81732734|FG000|Period 2|Death|0|||
27973574|NCT01474772|81732735|FG001|Period 2|Death|1|||
27973575|NCT01474772|81732734|FG000|Period 2|AE Related to Study Drug|0|||
27866811|NCT02552121|81346616|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
27866812|NCT02552121|81346617|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866813|NCT02552121|81346618|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866814|NCT02552121|81346619|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866815|NCT02552121|81346620|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866816|NCT02552121|81346621|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866817|NCT02552121|81346622|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866818|NCT02552121|81346623|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
27866819|NCT02552121|81346616|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
27866820|NCT02552121|81346617|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866821|NCT02552121|81346618|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866822|NCT02552121|81346619|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866823|NCT02552121|81346620|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866824|NCT02552121|81346621|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866825|NCT02552121|81346622|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866826|NCT02552121|81346623|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
27866827|NCT02552121|81346616|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27866828|NCT02552121|81346617|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
27866829|NCT02552121|81346618|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27866830|NCT02552121|81346619|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27866831|NCT02552121|81346620|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27866832|NCT02552121|81346621|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27785487|NCT02030067|81043985|FG010|Overall Study|Disease Progression|7|||
27785488|NCT02030067|81043986|FG011|Overall Study|Disease Progression|2|||
27785489|NCT02030067|81043987|FG012|Overall Study|Disease Progression|59|||
27785490|NCT02030067|81043975|FG000|Overall Study|Withdrawal by Subject|0|||
27785491|NCT02030067|81043976|FG001|Overall Study|Withdrawal by Subject|0|||
27785492|NCT02030067|81043977|FG002|Overall Study|Withdrawal by Subject|0|||
27785493|NCT02030067|81043978|FG003|Overall Study|Withdrawal by Subject|1|||
27785494|NCT02030067|81043979|FG004|Overall Study|Withdrawal by Subject|0|||
27785495|NCT02030067|81043980|FG005|Overall Study|Withdrawal by Subject|0|||
27785496|NCT02030067|81043981|FG006|Overall Study|Withdrawal by Subject|0|||
27785497|NCT02030067|81043982|FG007|Overall Study|Withdrawal by Subject|1|||
27785498|NCT02030067|81043983|FG008|Overall Study|Withdrawal by Subject|0|||
27785499|NCT02030067|81043984|FG009|Overall Study|Withdrawal by Subject|0|||
27785500|NCT02030067|81043985|FG010|Overall Study|Withdrawal by Subject|3|||
27785501|NCT02030067|81043986|FG011|Overall Study|Withdrawal by Subject|0|||
27785502|NCT02030067|81043987|FG012|Overall Study|Withdrawal by Subject|6|||
27785503|NCT02030067|81043975|FG000|Overall Study|Physician Decision|0|||
27785504|NCT02030067|81043976|FG001|Overall Study|Physician Decision|0|||
27866833|NCT02552121|81346622|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27785505|NCT02030067|81043977|FG002|Overall Study|Physician Decision|0|||
27866834|NCT02552121|81346623|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
27973576|NCT01474772|81732735|FG001|Period 2|AE Related to Study Drug|1|||
27866835|NCT02552121|81346616|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866836|NCT02552121|81346617|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
27866837|NCT02552121|81346618|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866838|NCT02552121|81346619|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866839|NCT02552121|81346620|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866840|NCT02552121|81346621|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866841|NCT02552121|81346622|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866842|NCT02552121|81346623|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
27866843|NCT02552121|81346616|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27866844|NCT02552121|81346617|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
27866845|NCT02552121|81346618|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27866846|NCT02552121|81346619|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27866847|NCT02552121|81346620|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27866848|NCT02552121|81346621|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27866849|NCT02552121|81346622|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27866850|NCT02552121|81346623|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
27785506|NCT02030067|81043978|FG003|Overall Study|Physician Decision|0|||
27785507|NCT02030067|81043979|FG004|Overall Study|Physician Decision|0|||
27785508|NCT02030067|81043980|FG005|Overall Study|Physician Decision|0|||
27785509|NCT02030067|81043981|FG006|Overall Study|Physician Decision|0|||
27785510|NCT02030067|81043982|FG007|Overall Study|Physician Decision|0|||
27785511|NCT02030067|81043983|FG008|Overall Study|Physician Decision|0|||
27785512|NCT02030067|81043984|FG009|Overall Study|Physician Decision|0|||
27785513|NCT02030067|81043985|FG010|Overall Study|Physician Decision|1|||
27785514|NCT02030067|81043986|FG011|Overall Study|Physician Decision|0|||
27785515|NCT02030067|81043987|FG012|Overall Study|Physician Decision|3|||
27785516|NCT02030067|81043975|FG000|Overall Study|other reasons|0|||
27785517|NCT02030067|81043976|FG001|Overall Study|other reasons|0|||
27785518|NCT02030067|81043977|FG002|Overall Study|other reasons|0|||
27785519|NCT02030067|81043978|FG003|Overall Study|other reasons|0|||
27785520|NCT02030067|81043979|FG004|Overall Study|other reasons|0|||
27785521|NCT02030067|81043980|FG005|Overall Study|other reasons|1|||
27785522|NCT02030067|81043981|FG006|Overall Study|other reasons|0|||
27785523|NCT02030067|81043982|FG007|Overall Study|other reasons|0|||
27785524|NCT02030067|81043983|FG008|Overall Study|other reasons|2|||
27785525|NCT02030067|81043984|FG009|Overall Study|other reasons|0|||
27785526|NCT02030067|81043985|FG010|Overall Study|other reasons|0|||
27785527|NCT02030067|81043986|FG011|Overall Study|other reasons|0|||
27785528|NCT02030067|81043987|FG012|Overall Study|other reasons|4|||
27785529|NCT02030067|81043975|FG000|Overall Study|Adverse Event|0|||
27785530|NCT02030067|81043976|FG001|Overall Study|Adverse Event|0|||
27785531|NCT02030067|81043977|FG002|Overall Study|Adverse Event|0|||
27785532|NCT02030067|81043978|FG003|Overall Study|Adverse Event|0|||
27785533|NCT02030067|81043979|FG004|Overall Study|Adverse Event|0|||
27785534|NCT02030067|81043980|FG005|Overall Study|Adverse Event|0|||
27785535|NCT02030067|81043981|FG006|Overall Study|Adverse Event|0|||
27785536|NCT02030067|81043982|FG007|Overall Study|Adverse Event|0|||
27785537|NCT02030067|81043983|FG008|Overall Study|Adverse Event|0|||
27785538|NCT02030067|81043984|FG009|Overall Study|Adverse Event|0|||
27785539|NCT02030067|81043985|FG010|Overall Study|Adverse Event|0|||
27785540|NCT02030067|81043986|FG011|Overall Study|Adverse Event|1|||
27785541|NCT02030067|81043987|FG012|Overall Study|Adverse Event|8|||
27785542|NCT01854918|81043989|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
27785543|NCT01854918|81043990|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
27785544|NCT01854918|81043989|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
27785545|NCT01854918|81043990|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
27785546|NCT01854918|81043989|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
27785547|NCT01854918|81043990|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
27785548|NCT01854918|81043989|FG000|SOC-controlled Period (Year 1)|Death|5|||
27785549|NCT01854918|81043990|FG001|SOC-controlled Period (Year 1)|Death|5|||
27785550|NCT01854918|81043989|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
27785551|NCT01854918|81043990|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
27866851|NCT02552121|81346616|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27866852|NCT02552121|81346617|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
27866853|NCT02552121|81346618|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27785552|NCT01854918|81043989|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
27785553|NCT01854918|81043990|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
27785554|NCT01854918|81043989|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
27785555|NCT01854918|81043990|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
27785556|NCT01854918|81043989|FG000|All-IP Period (Years 2 and 3)|Death|5|||
27785557|NCT01854918|81043990|FG001|All-IP Period (Years 2 and 3)|Death|16|||
27785558|NCT00302731|81043996|FG000|Overall Study|Lost to Follow-up|1|||
27785559|NCT00302731|81043997|FG001|Overall Study|Lost to Follow-up|2|||
27785560|NCT00302731|81043998|FG002|Overall Study|Lost to Follow-up|0|||
27866854|NCT02552121|81346619|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27866855|NCT02552121|81346620|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27866856|NCT02552121|81346621|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27866857|NCT02552121|81346622|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27866858|NCT02552121|81346623|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
27866859|NCT02552121|81346616|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
27866860|NCT02552121|81346617|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
27866861|NCT02552121|81346618|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
27866862|NCT02552121|81346619|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
27866863|NCT02552121|81346620|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
27866864|NCT02552121|81346621|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
27866865|NCT02552121|81346622|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
27866866|NCT02552121|81346623|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
27866867|NCT02552121|81346616|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
27866868|NCT02552121|81346617|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
27973577|NCT01474772|81732734|FG000|Period 2|AE not Related to Study Drug|4|||
27973578|NCT01474772|81732735|FG001|Period 2|AE not Related to Study Drug|1|||
27785561|NCT00302731|81043999|FG003|Overall Study|Lost to Follow-up|0|||
27785562|NCT00302731|81043996|FG000|Overall Study|Adverse Event|0|||
27785563|NCT00302731|81043997|FG001|Overall Study|Adverse Event|2|||
27785564|NCT00302731|81043998|FG002|Overall Study|Adverse Event|2|||
27785565|NCT00302731|81043999|FG003|Overall Study|Adverse Event|0|||
27785566|NCT00302731|81043996|FG000|Overall Study|Withdrawal by Subject|1|||
27785567|NCT00302731|81043997|FG001|Overall Study|Withdrawal by Subject|1|||
27785568|NCT00302731|81043998|FG002|Overall Study|Withdrawal by Subject|0|||
27785569|NCT00302731|81043999|FG003|Overall Study|Withdrawal by Subject|0|||
27785570|NCT00302731|81043996|FG000|Overall Study|Protocol Violation|1|||
27785571|NCT00302731|81043997|FG001|Overall Study|Protocol Violation|0|||
27785572|NCT00302731|81043998|FG002|Overall Study|Protocol Violation|0|||
27973579|NCT01474772|81732734|FG000|Period 2|Lack of Efficacy|1|||
27973580|NCT01474772|81732735|FG001|Period 2|Lack of Efficacy|0|||
27785573|NCT00302731|81043999|FG003|Overall Study|Protocol Violation|0|||
27785574|NCT00302731|81043996|FG000|Overall Study|cancer unrelated to study discovered|1|||
27785575|NCT00302731|81043997|FG001|Overall Study|cancer unrelated to study discovered|0|||
27785576|NCT00302731|81043998|FG002|Overall Study|cancer unrelated to study discovered|1|||
27785577|NCT00302731|81043999|FG003|Overall Study|cancer unrelated to study discovered|0|||
27785578|NCT02135848|81044000|FG000|Overall Study|Adverse Event|2|||
27785579|NCT02135848|81044001|FG001|Overall Study|Adverse Event|0|||
27785580|NCT02135848|81044000|FG000|Overall Study|Withdrawal by Subject|1|||
27785581|NCT02135848|81044001|FG001|Overall Study|Withdrawal by Subject|1|||
27785582|NCT02554721|81044005|FG000|Overall Study|Adverse Event|1|||
27785583|NCT02554721|81044006|FG001|Overall Study|Adverse Event|0|||
27785584|NCT02554721|81044007|FG002|Overall Study|Adverse Event|0|||
27785585|NCT02554721|81044008|FG003|Overall Study|Adverse Event|0|||
27785586|NCT02554721|81044009|FG004|Overall Study|Adverse Event|1|||
27785587|NCT02554721|81044005|FG000|Overall Study|Noncompliance|0|||
27785588|NCT02554721|81044006|FG001|Overall Study|Noncompliance|0|||
27785589|NCT02554721|81044007|FG002|Overall Study|Noncompliance|0|||
27866869|NCT02552121|81346618|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
27866870|NCT02552121|81346619|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
27973581|NCT01474772|81732734|FG000|Period 2|Withdrawal by Subject|3|||
27973582|NCT01474772|81732735|FG001|Period 2|Withdrawal by Subject|4|||
27973583|NCT01474772|81732734|FG000|Period 2|Lost to Follow-up|1|||
27973584|NCT01474772|81732735|FG001|Period 2|Lost to Follow-up|1|||
27973585|NCT01474772|81732734|FG000|Period 2|Reason not Specified|0|||
27785590|NCT02554721|81044008|FG003|Overall Study|Noncompliance|0|||
27785591|NCT02554721|81044009|FG004|Overall Study|Noncompliance|1|||
27785592|NCT00945945|81044010|FG000|Overall Study|Adverse Event|15|||
27785593|NCT00945945|81044011|FG001|Overall Study|Adverse Event|35|||
27785594|NCT00945945|81044010|FG000|Overall Study|Withdrawal by Subject|7|||
27785595|NCT00945945|81044011|FG001|Overall Study|Withdrawal by Subject|10|||
27866871|NCT02552121|81346620|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
27973586|NCT01474772|81732735|FG001|Period 2|Reason not Specified|2|||
27785596|NCT00945945|81044010|FG000|Overall Study|Lost to Follow-up|4|||
27785597|NCT00945945|81044011|FG001|Overall Study|Lost to Follow-up|5|||
27866872|NCT02552121|81346621|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
27866873|NCT02552121|81346622|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
27866874|NCT02552121|81346623|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
27866875|NCT02552121|81346616|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
27866876|NCT02552121|81346617|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
27866877|NCT02552121|81346618|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
27866878|NCT02552121|81346619|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
27866879|NCT02552121|81346620|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
27785598|NCT00945945|81044010|FG000|Overall Study|Lack of Efficacy|6|||
27785599|NCT00945945|81044011|FG001|Overall Study|Lack of Efficacy|2|||
27785600|NCT00945945|81044010|FG000|Overall Study|Protocol Violation|4|||
27785601|NCT00945945|81044011|FG001|Overall Study|Protocol Violation|2|||
27785602|NCT00945945|81044010|FG000|Overall Study|Entry Criteria Not Met|0|||
27785603|NCT00945945|81044011|FG001|Overall Study|Entry Criteria Not Met|1|||
27785604|NCT00768040|81044012|FG000|Overall Study|Adverse Event|3|||
27866880|NCT02552121|81346621|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
27866881|NCT02552121|81346622|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
27866882|NCT02552121|81346623|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
27866883|NCT02552121|81346616|FG000|Part 2: Cohort Expansion|Death|0|||
27866884|NCT02552121|81346617|FG001|Part 2: Cohort Expansion|Death|0|||
27866885|NCT02552121|81346618|FG002|Part 2: Cohort Expansion|Death|1|||
27866886|NCT02552121|81346619|FG003|Part 2: Cohort Expansion|Death|0|||
27866887|NCT02552121|81346620|FG004|Part 2: Cohort Expansion|Death|0|||
27866888|NCT02552121|81346621|FG005|Part 2: Cohort Expansion|Death|0|||
27866889|NCT02552121|81346622|FG006|Part 2: Cohort Expansion|Death|0|||
27866890|NCT02552121|81346623|FG007|Part 2: Cohort Expansion|Death|0|||
27866891|NCT01174043|81346624|FG000|Overall Study|Disease progression|5|||
27866892|NCT01174043|81346624|FG000|Overall Study|Adverse Event|3|||
27866893|NCT01174043|81346624|FG000|Overall Study|Death|1|||
27866894|NCT01174043|81346624|FG000|Overall Study|Withdrawal by Subject|2|||
27866895|NCT03449446|81346625|FG000|Overall Study|Randomized but Never Treated|0|||
27866896|NCT03449446|81346626|FG001|Overall Study|Randomized but Never Treated|0|||
27866897|NCT03449446|81346627|FG002|Overall Study|Randomized but Never Treated|1|||
27866898|NCT03449446|81346628|FG003|Overall Study|Randomized but Never Treated|1|||
27866899|NCT03449446|81346629|FG004|Overall Study|Randomized but Never Treated|1|||
27866900|NCT03449446|81346630|FG005|Overall Study|Randomized but Never Treated|0|||
27866901|NCT03449446|81346631|FG006|Overall Study|Randomized but Never Treated|0|||
27866902|NCT03449446|81346625|FG000|Overall Study|Unknown Reason|33|||
27866903|NCT03449446|81346626|FG001|Overall Study|Unknown Reason|1|||
27866904|NCT03449446|81346627|FG002|Overall Study|Unknown Reason|1|||
27866905|NCT03449446|81346628|FG003|Overall Study|Unknown Reason|1|||
27866906|NCT03449446|81346629|FG004|Overall Study|Unknown Reason|2|||
27866907|NCT03449446|81346630|FG005|Overall Study|Unknown Reason|2|||
27866908|NCT03449446|81346631|FG006|Overall Study|Unknown Reason|0|||
27866909|NCT03449446|81346625|FG000|Overall Study|Withdrew Consent|1|||
27866910|NCT03449446|81346626|FG001|Overall Study|Withdrew Consent|3|||
27866911|NCT03449446|81346627|FG002|Overall Study|Withdrew Consent|1|||
27866912|NCT03449446|81346628|FG003|Overall Study|Withdrew Consent|4|||
27866913|NCT03449446|81346629|FG004|Overall Study|Withdrew Consent|4|||
27866914|NCT03449446|81346630|FG005|Overall Study|Withdrew Consent|4|||
27866915|NCT03449446|81346631|FG006|Overall Study|Withdrew Consent|1|||
27866916|NCT03449446|81346625|FG000|Overall Study|Adverse Event|1|||
27866917|NCT03449446|81346626|FG001|Overall Study|Adverse Event|2|||
27866918|NCT03449446|81346627|FG002|Overall Study|Adverse Event|1|||
27866919|NCT03449446|81346628|FG003|Overall Study|Adverse Event|0|||
27866920|NCT03449446|81346629|FG004|Overall Study|Adverse Event|0|||
27866921|NCT03449446|81346630|FG005|Overall Study|Adverse Event|2|||
27866922|NCT03449446|81346631|FG006|Overall Study|Adverse Event|0|||
27866923|NCT03449446|81346625|FG000|Overall Study|Lost to Follow-up|0|||
27866924|NCT03449446|81346626|FG001|Overall Study|Lost to Follow-up|0|||
27866925|NCT03449446|81346627|FG002|Overall Study|Lost to Follow-up|2|||
27866926|NCT03449446|81346628|FG003|Overall Study|Lost to Follow-up|1|||
27866927|NCT03449446|81346629|FG004|Overall Study|Lost to Follow-up|3|||
27785605|NCT00768040|81044013|FG001|Overall Study|Adverse Event|2|||
27785606|NCT00768040|81044012|FG000|Overall Study|Abnormal laboratory value|1|||
27785607|NCT00768040|81044013|FG001|Overall Study|Abnormal laboratory value|1|||
27866928|NCT03449446|81346630|FG005|Overall Study|Lost to Follow-up|0|||
27866929|NCT03449446|81346631|FG006|Overall Study|Lost to Follow-up|0|||
27866930|NCT03449446|81346625|FG000|Overall Study|Investigator's Discretion|0|||
27866931|NCT03449446|81346626|FG001|Overall Study|Investigator's Discretion|1|||
27866932|NCT03449446|81346627|FG002|Overall Study|Investigator's Discretion|1|||
27866933|NCT03449446|81346628|FG003|Overall Study|Investigator's Discretion|2|||
27866934|NCT03449446|81346629|FG004|Overall Study|Investigator's Discretion|0|||
27866935|NCT03449446|81346630|FG005|Overall Study|Investigator's Discretion|0|||
27866936|NCT03449446|81346631|FG006|Overall Study|Investigator's Discretion|0|||
27866937|NCT03449446|81346625|FG000|Overall Study|Non Compliance with Study Drug|1|||
27866938|NCT03449446|81346626|FG001|Overall Study|Non Compliance with Study Drug|0|||
27866939|NCT03449446|81346627|FG002|Overall Study|Non Compliance with Study Drug|0|||
27866940|NCT03449446|81346628|FG003|Overall Study|Non Compliance with Study Drug|0|||
27866941|NCT03449446|81346629|FG004|Overall Study|Non Compliance with Study Drug|0|||
27866942|NCT03449446|81346630|FG005|Overall Study|Non Compliance with Study Drug|0|||
27866943|NCT03449446|81346631|FG006|Overall Study|Non Compliance with Study Drug|0|||
27866944|NCT03449446|81346625|FG000|Overall Study|Protocol Violation|0|||
27866945|NCT03449446|81346626|FG001|Overall Study|Protocol Violation|0|||
27866946|NCT03449446|81346627|FG002|Overall Study|Protocol Violation|0|||
27866947|NCT03449446|81346628|FG003|Overall Study|Protocol Violation|0|||
27866948|NCT03449446|81346629|FG004|Overall Study|Protocol Violation|1|||
27866949|NCT03449446|81346630|FG005|Overall Study|Protocol Violation|1|||
27866950|NCT03449446|81346631|FG006|Overall Study|Protocol Violation|0|||
27866951|NCT03449446|81346625|FG000|Overall Study|Death|0|||
27866952|NCT03449446|81346626|FG001|Overall Study|Death|0|||
27866953|NCT03449446|81346627|FG002|Overall Study|Death|0|||
27866954|NCT03449446|81346628|FG003|Overall Study|Death|0|||
27866955|NCT03449446|81346629|FG004|Overall Study|Death|1|||
27866956|NCT03449446|81346630|FG005|Overall Study|Death|0|||
27866957|NCT03449446|81346631|FG006|Overall Study|Death|0|||
27973587|NCT01474772|81732734|FG000|Follow-up|AE not Related to Study Drug|0|||
27973588|NCT01474772|81732735|FG001|Follow-up|AE not Related to Study Drug|1|||
27973589|NCT03754582|81732743|FG000|Treatment Phase|Adverse Event|0|||
27973590|NCT03754582|81732744|FG001|Treatment Phase|Adverse Event|1|||
27973591|NCT03754582|81732745|FG002|Treatment Phase|Adverse Event|0|||
27973592|NCT03754582|81732743|FG000|Follow-up Phase|Other|0|||
27973593|NCT03754582|81732744|FG001|Follow-up Phase|Other|0|||
27973594|NCT03754582|81732745|FG002|Follow-up Phase|Other|1|||
27973595|NCT00027378|81732747|FG000|Overall Study|Physician Decision|0|||
27973596|NCT00027378|81732748|FG001|Overall Study|Physician Decision|3|||
27973597|NCT01289353|81732749|FG000|Overall Study|Lost to Follow-up|2|||
27973598|NCT00758264|81732750|FG000|Active Phase|Withdrawal by Subject|0|||
27973599|NCT00758264|81732751|FG001|Active Phase|Withdrawal by Subject|0|||
27973600|NCT00758264|81732752|FG002|Active Phase|Withdrawal by Subject|1|||
27973601|NCT00758264|81732750|FG000|Active Phase|Lost to Follow-up|1|||
27973602|NCT00758264|81732751|FG001|Active Phase|Lost to Follow-up|0|||
27973603|NCT00758264|81732752|FG002|Active Phase|Lost to Follow-up|0|||
27973604|NCT00758264|81732750|FG000|Active Phase|Other|0|||
27973605|NCT00758264|81732751|FG001|Active Phase|Other|0|||
27973606|NCT00758264|81732752|FG002|Active Phase|Other|4|||
27973607|NCT01510145|81732753|FG000|Overall Study|Adverse Event|6|||
27973608|NCT01510145|81732753|FG000|Overall Study|Lost to Follow-up|5|||
27973609|NCT01510145|81732753|FG000|Overall Study|Withdrawal by Subject|6|||
27785608|NCT00553319|81044016|FG000|Overall Study|Lost to Follow-up|10|||
27785609|NCT00553319|81044017|FG001|Overall Study|Lost to Follow-up|9|||
27785610|NCT00553319|81044018|FG002|Overall Study|Lost to Follow-up|5|||
27785611|NCT00553319|81044016|FG000|Overall Study|wanted treatment elsewhere|2|||
27785612|NCT00553319|81044017|FG001|Overall Study|wanted treatment elsewhere|1|||
27785613|NCT00553319|81044018|FG002|Overall Study|wanted treatment elsewhere|1|||
27785614|NCT00553319|81044016|FG000|Overall Study|non-compliance|0|||
27973610|NCT01510145|81732753|FG000|Overall Study|Relative reported subject withdrew|1|||
27973611|NCT01328535|81732760|FG000|Overall Study|Ineligible|1|||
27973612|NCT04753658|81732761|FG000|Overall Study|Progressive disease|7|||
27671129|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
27671130|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
27671131|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
27671132|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
27671133|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
27671134|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
27671135|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
27671136|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
27671137|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
27671138|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
27671139|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
27973613|NCT04753658|81732761|FG000|Overall Study|Other|7|||
27973614|NCT04753658|81732761|FG000|Overall Study|Adverse Event|1|||
27973615|NCT02526524|81732764|FG000|Overall Study|Withdrawal by Subject|3|||
27973616|NCT02526524|81732765|FG001|Overall Study|Withdrawal by Subject|3|||
27973617|NCT02526524|81732766|FG002|Overall Study|Withdrawal by Subject|6|||
27973618|NCT02526524|81732767|FG003|Overall Study|Withdrawal by Subject|1|||
27671140|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
27785615|NCT00553319|81044017|FG001|Overall Study|non-compliance|0|||
27785616|NCT00553319|81044018|FG002|Overall Study|non-compliance|2|||
27866958|NCT03257865|81346636|FG000|Overall Study|Adverse Event|4|||
27866959|NCT03257865|81346637|FG001|Overall Study|Adverse Event|8|||
27866960|NCT03257865|81346636|FG000|Overall Study|Lack of Efficacy|1|||
27866961|NCT03257865|81346637|FG001|Overall Study|Lack of Efficacy|2|||
27866962|NCT03257865|81346636|FG000|Overall Study|Non-compliance with Study Drug|0|||
27671141|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
27671142|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
27671143|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
27671144|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
27671145|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
27671146|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
27671147|NCT03569475|80634919|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
27671148|NCT03569475|80634920|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
27671149|NCT03569475|80634921|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
27671150|NCT03569475|80634919|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
27671151|NCT03569475|80634920|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
27671152|NCT03569475|80634921|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
27671153|NCT03569475|80634919|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
27671154|NCT03569475|80634920|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
27671155|NCT03569475|80634921|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
27671156|NCT01242371|80634922|FG000|Overall Study|Withdrawal by Subject|2|||
27671157|NCT01242371|80634923|FG001|Overall Study|Withdrawal by Subject|2|||
27671158|NCT01242371|80634922|FG000|Overall Study|Protocol Violation|0|||
27671159|NCT01242371|80634923|FG001|Overall Study|Protocol Violation|3|||
27671160|NCT04009629|80634926|FG000|Overall Study|Withdrawal by Subject|2|||
27671161|NCT04009629|80634927|FG001|Overall Study|Withdrawal by Subject|0|||
27671162|NCT02599688|80634928|FG000|Overall Study|Lack of Efficacy|1|||
27671163|NCT02599688|80634928|FG000|Overall Study|Withdrawal by Subject|1|||
27671164|NCT02599688|80634928|FG000|Overall Study|Termination by Sponsor|2|||
27671165|NCT01236352|80634929|FG000|Overall Study|Death|0|||
27671166|NCT01236352|80634930|FG001|Overall Study|Death|0|||
27671167|NCT01236352|80634931|FG002|Overall Study|Death|0|||
27671168|NCT01236352|80634932|FG003|Overall Study|Death|0|||
27671169|NCT01236352|80634933|FG004|Overall Study|Death|0|||
27671170|NCT01236352|80634934|FG005|Overall Study|Death|0|||
27671171|NCT01236352|80634935|FG006|Overall Study|Death|0|||
27671172|NCT01236352|80634936|FG007|Overall Study|Death|1|||
27671173|NCT01236352|80634937|FG008|Overall Study|Death|0|||
27671174|NCT01236352|80634938|FG009|Overall Study|Death|0|||
27671175|NCT01236352|80634939|FG010|Overall Study|Death|0|||
27671176|NCT01236352|80634929|FG000|Overall Study|Withdrawal by Subject|0|||
27671177|NCT01236352|80634930|FG001|Overall Study|Withdrawal by Subject|0|||
27671178|NCT01236352|80634931|FG002|Overall Study|Withdrawal by Subject|0|||
27671179|NCT01236352|80634932|FG003|Overall Study|Withdrawal by Subject|0|||
27785617|NCT00553319|81044016|FG000|Overall Study|incarceration|1|||
27785618|NCT00553319|81044017|FG001|Overall Study|incarceration|0|||
27785619|NCT00553319|81044018|FG002|Overall Study|incarceration|0|||
27785620|NCT00553319|81044016|FG000|Overall Study|moved|1|||
27785621|NCT00553319|81044017|FG001|Overall Study|moved|0|||
27785622|NCT00553319|81044018|FG002|Overall Study|moved|1|||
27785623|NCT01874288|81044019|FG000|Overall Study|Withdrawal by Subject|1|||
27785624|NCT01874288|81044020|FG001|Overall Study|Withdrawal by Subject|0|||
27785625|NCT01874288|81044021|FG002|Overall Study|Withdrawal by Subject|2|||
27785626|NCT01874288|81044022|FG003|Overall Study|Withdrawal by Subject|1|||
27785627|NCT01874288|81044023|FG004|Overall Study|Withdrawal by Subject|1|||
27785628|NCT01874288|81044019|FG000|Overall Study|Physician Decision|0|||
27785629|NCT01874288|81044020|FG001|Overall Study|Physician Decision|0|||
27785630|NCT01874288|81044021|FG002|Overall Study|Physician Decision|0|||
27785631|NCT01874288|81044022|FG003|Overall Study|Physician Decision|1|||
27785632|NCT01874288|81044023|FG004|Overall Study|Physician Decision|0|||
27785633|NCT01874288|81044019|FG000|Overall Study|Progressive disease|2|||
27785634|NCT01874288|81044020|FG001|Overall Study|Progressive disease|0|||
27785635|NCT01874288|81044021|FG002|Overall Study|Progressive disease|3|||
27785636|NCT01874288|81044022|FG003|Overall Study|Progressive disease|5|||
27671180|NCT01236352|80634933|FG004|Overall Study|Withdrawal by Subject|0|||
27671181|NCT01236352|80634934|FG005|Overall Study|Withdrawal by Subject|0|||
27671182|NCT01236352|80634935|FG006|Overall Study|Withdrawal by Subject|0|||
27671183|NCT01236352|80634936|FG007|Overall Study|Withdrawal by Subject|0|||
27671184|NCT01236352|80634937|FG008|Overall Study|Withdrawal by Subject|0|||
27785637|NCT01874288|81044023|FG004|Overall Study|Progressive disease|1|||
27785638|NCT00401726|81044028|FG000|Overall Study|Adverse Event|34|||
27785639|NCT00401726|81044029|FG001|Overall Study|Adverse Event|45|||
27785640|NCT00401726|81044028|FG000|Overall Study|Death|0|||
27785641|NCT00401726|81044029|FG001|Overall Study|Death|3|||
27785642|NCT00401726|81044028|FG000|Overall Study|Sponsor Request|0|||
27671185|NCT01236352|80634938|FG009|Overall Study|Withdrawal by Subject|2|||
27671186|NCT01236352|80634939|FG010|Overall Study|Withdrawal by Subject|1|||
27671187|NCT01236352|80634929|FG000|Overall Study|Adverse Event|0|||
27785643|NCT00401726|81044029|FG001|Overall Study|Sponsor Request|1|||
27785644|NCT00401726|81044028|FG000|Overall Study|Physician Decision|3|||
27785645|NCT00401726|81044029|FG001|Overall Study|Physician Decision|6|||
27785646|NCT00401726|81044028|FG000|Overall Study|Lost to Follow-up|23|||
27785647|NCT00401726|81044029|FG001|Overall Study|Lost to Follow-up|20|||
27785648|NCT00401726|81044028|FG000|Overall Study|Protocol Violation|6|||
27785649|NCT00401726|81044029|FG001|Overall Study|Protocol Violation|3|||
27785650|NCT00401726|81044028|FG000|Overall Study|Withdrawal by Subject|18|||
27785651|NCT00401726|81044029|FG001|Overall Study|Withdrawal by Subject|24|||
27785652|NCT00401726|81044028|FG000|Overall Study|Lack of Efficacy|4|||
27785653|NCT00401726|81044029|FG001|Overall Study|Lack of Efficacy|6|||
27785654|NCT00401726|81044028|FG000|Overall Study|Protocol Deviation|9|||
27785655|NCT00401726|81044029|FG001|Overall Study|Protocol Deviation|4|||
27785656|NCT02972658|81047191|FG000|Overall Study|Adverse Event|0|||
27785657|NCT02972658|81047192|FG001|Overall Study|Adverse Event|3|||
27785658|NCT02972658|81047193|FG002|Overall Study|Adverse Event|0|||
27785659|NCT02972658|81047194|FG003|Overall Study|Adverse Event|2|||
27785660|NCT02972658|81047191|FG000|Overall Study|Other-determined by Investigator|1|||
27785661|NCT02972658|81047192|FG001|Overall Study|Other-determined by Investigator|1|||
27785662|NCT02972658|81047193|FG002|Overall Study|Other-determined by Investigator|0|||
27785663|NCT02972658|81047194|FG003|Overall Study|Other-determined by Investigator|0|||
27785664|NCT02972658|81047191|FG000|Overall Study|Death|0|||
27785665|NCT02972658|81047192|FG001|Overall Study|Death|0|||
27785666|NCT02972658|81047193|FG002|Overall Study|Death|0|||
27785667|NCT02972658|81047194|FG003|Overall Study|Death|1|||
27785668|NCT02972658|81047191|FG000|Overall Study|Lost to Follow-up|0|||
27785669|NCT02972658|81047192|FG001|Overall Study|Lost to Follow-up|1|||
27785670|NCT02972658|81047193|FG002|Overall Study|Lost to Follow-up|1|||
27973619|NCT02526524|81732768|FG004|Overall Study|Withdrawal by Subject|9|||
27973620|NCT02526524|81732769|FG005|Overall Study|Withdrawal by Subject|5|||
27973621|NCT02526524|81732764|FG000|Overall Study|Adverse Event|3|||
27973622|NCT02526524|81732765|FG001|Overall Study|Adverse Event|2|||
27973623|NCT02526524|81732766|FG002|Overall Study|Adverse Event|4|||
27973624|NCT02526524|81732767|FG003|Overall Study|Adverse Event|2|||
27973625|NCT02526524|81732768|FG004|Overall Study|Adverse Event|6|||
27973626|NCT02526524|81732769|FG005|Overall Study|Adverse Event|8|||
27973627|NCT02526524|81732764|FG000|Overall Study|Lost to Follow-up|2|||
27973628|NCT02526524|81732765|FG001|Overall Study|Lost to Follow-up|3|||
27973629|NCT02526524|81732766|FG002|Overall Study|Lost to Follow-up|8|||
27973630|NCT02526524|81732767|FG003|Overall Study|Lost to Follow-up|1|||
27973631|NCT02526524|81732768|FG004|Overall Study|Lost to Follow-up|2|||
27973632|NCT02526524|81732769|FG005|Overall Study|Lost to Follow-up|5|||
27973633|NCT02526524|81732764|FG000|Overall Study|Protocol Violation|3|||
27973634|NCT02526524|81732765|FG001|Overall Study|Protocol Violation|1|||
27973635|NCT02526524|81732766|FG002|Overall Study|Protocol Violation|5|||
27973636|NCT02526524|81732767|FG003|Overall Study|Protocol Violation|3|||
27785671|NCT02972658|81047194|FG003|Overall Study|Lost to Follow-up|2|||
27785672|NCT02972658|81047191|FG000|Overall Study|Progressive Disease|0|||
27785673|NCT02972658|81047192|FG001|Overall Study|Progressive Disease|1|||
27785674|NCT02972658|81047193|FG002|Overall Study|Progressive Disease|0|||
27785675|NCT02972658|81047194|FG003|Overall Study|Progressive Disease|1|||
27785676|NCT02972658|81047191|FG000|Overall Study|Withdrawal by Subject|4|||
27785677|NCT02972658|81047192|FG001|Overall Study|Withdrawal by Subject|4|||
27785678|NCT02972658|81047193|FG002|Overall Study|Withdrawal by Subject|1|||
27785679|NCT02972658|81047194|FG003|Overall Study|Withdrawal by Subject|6|||
27785680|NCT02972658|81047191|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
27785681|NCT02972658|81047192|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
27785682|NCT02972658|81047193|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
27785683|NCT02972658|81047194|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
27785684|NCT02972658|81047191|FG000|Overall Study|Sponsor Decision|70|||
27866963|NCT03257865|81346637|FG001|Overall Study|Non-compliance with Study Drug|2|||
27573238|NCT00355238|80285567|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27785685|NCT02972658|81047192|FG001|Overall Study|Sponsor Decision|127|||
27785686|NCT02972658|81047193|FG002|Overall Study|Sponsor Decision|72|||
27785687|NCT02972658|81047194|FG003|Overall Study|Sponsor Decision|119|||
27973637|NCT02526524|81732768|FG004|Overall Study|Protocol Violation|4|||
27785688|NCT02577107|81047197|FG000|Overall Study|Protocol deviation|0|||
27785689|NCT02577107|81047198|FG001|Overall Study|Protocol deviation|1|||
27785690|NCT00972309|81047199|FG000|Overall Study|Switched to alternative treatment|0|||
27785691|NCT00972309|81047200|FG001|Overall Study|Switched to alternative treatment|2|||
27785692|NCT00972309|81047199|FG000|Overall Study|Refused further treatment|0|||
27785693|NCT00972309|81047200|FG001|Overall Study|Refused further treatment|1|||
27785694|NCT00972309|81047199|FG000|Overall Study|Late determination of ineligibility|0|||
27866964|NCT03257865|81346636|FG000|Overall Study|Withdrawal by Subject|23|||
27973638|NCT02526524|81732769|FG005|Overall Study|Protocol Violation|3|||
27973639|NCT02526524|81732764|FG000|Overall Study|Loss of Glucose Control|0|||
27973640|NCT02526524|81732765|FG001|Overall Study|Loss of Glucose Control|0|||
27866965|NCT03257865|81346637|FG001|Overall Study|Withdrawal by Subject|17|||
27866966|NCT03257865|81346636|FG000|Overall Study|Physician Decision|3|||
27866967|NCT03257865|81346637|FG001|Overall Study|Physician Decision|1|||
27866968|NCT03257865|81346636|FG000|Overall Study|Other|0|||
27866969|NCT03257865|81346637|FG001|Overall Study|Other|1|||
27866970|NCT03257865|81346636|FG000|Overall Study|Lost to Follow-up|4|||
27866971|NCT03257865|81346637|FG001|Overall Study|Lost to Follow-up|4|||
27866972|NCT01098474|81346638|FG000|Active Phase|Other|0|||
27866973|NCT01098474|81346639|FG001|Active Phase|Other|0|||
27866974|NCT01098474|81346640|FG002|Active Phase|Other|3|||
27785695|NCT00972309|81047200|FG001|Overall Study|Late determination of ineligibility|1|||
27866975|NCT01098474|81346641|FG003|Active Phase|Other|0|||
27866976|NCT01098474|81346642|FG004|Active Phase|Other|0|||
27866977|NCT01098474|81346643|FG005|Active Phase|Other|0|||
27785696|NCT00972309|81047199|FG000|Overall Study|Second malignancy|1|||
27785697|NCT00972309|81047200|FG001|Overall Study|Second malignancy|1|||
27785698|NCT00972309|81047199|FG000|Overall Study|Visa issues|0|||
27785699|NCT00972309|81047200|FG001|Overall Study|Visa issues|1|||
27785700|NCT00972309|81047199|FG000|Overall Study|Secondary cancer (SCC)|0|||
27785701|NCT00972309|81047200|FG001|Overall Study|Secondary cancer (SCC)|1|||
27785702|NCT00972309|81047199|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
27785703|NCT00972309|81047200|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
27785704|NCT00972309|81047199|FG000|Overall Study|Lost to Follow-up|1|||
27785705|NCT00972309|81047200|FG001|Overall Study|Lost to Follow-up|1|||
27785706|NCT00972309|81047199|FG000|Overall Study|Disease progression on study|10|||
27785707|NCT00972309|81047200|FG001|Overall Study|Disease progression on study|4|||
27785708|NCT03795233|81047201|FG000|Overall Study|Withdrawal by Subject|2|||
27785709|NCT03795233|81047202|FG001|Overall Study|Withdrawal by Subject|1|||
27785710|NCT03795233|81047201|FG000|Overall Study|Lost to Follow-up|1|||
27785711|NCT03795233|81047202|FG001|Overall Study|Lost to Follow-up|0|||
27785712|NCT03795233|81047201|FG000|Overall Study|Death|1|||
27785713|NCT03795233|81047202|FG001|Overall Study|Death|0|||
27785714|NCT04212221|81047205|FG000|Overall Study|Remained on Treatment|0|||
27785715|NCT04212221|81047206|FG001|Overall Study|Remained on Treatment|0|||
27785716|NCT04212221|81047207|FG002|Overall Study|Remained on Treatment|0|||
27785717|NCT04212221|81047208|FG003|Overall Study|Remained on Treatment|1|||
27785718|NCT04212221|81047209|FG004|Overall Study|Remained on Treatment|0|||
27785719|NCT04212221|81047210|FG005|Overall Study|Remained on Treatment|0|||
27785720|NCT04212221|81047211|FG006|Overall Study|Remained on Treatment|3|||
27785721|NCT04212221|81047212|FG007|Overall Study|Remained on Treatment|9|||
27785722|NCT04212221|81047205|FG000|Overall Study|Adverse Event|0|||
27785723|NCT04212221|81047206|FG001|Overall Study|Adverse Event|0|||
27785724|NCT04212221|81047207|FG002|Overall Study|Adverse Event|0|||
27785725|NCT04212221|81047208|FG003|Overall Study|Adverse Event|0|||
27785726|NCT04212221|81047209|FG004|Overall Study|Adverse Event|0|||
27785727|NCT04212221|81047210|FG005|Overall Study|Adverse Event|0|||
27785728|NCT04212221|81047211|FG006|Overall Study|Adverse Event|2|||
27785729|NCT04212221|81047212|FG007|Overall Study|Adverse Event|3|||
27785730|NCT04212221|81047205|FG000|Overall Study|Death|0|||
27785731|NCT04212221|81047206|FG001|Overall Study|Death|0|||
27785732|NCT04212221|81047207|FG002|Overall Study|Death|0|||
27785733|NCT04212221|81047208|FG003|Overall Study|Death|0|||
27785734|NCT04212221|81047209|FG004|Overall Study|Death|0|||
27785735|NCT04212221|81047210|FG005|Overall Study|Death|0|||
27785736|NCT04212221|81047211|FG006|Overall Study|Death|0|||
27785737|NCT04212221|81047212|FG007|Overall Study|Death|2|||
27785738|NCT04212221|81047205|FG000|Overall Study|Disease progression according to irRECIST|1|||
27866978|NCT01098474|81346638|FG000|Active Phase|Withdrawal by Subject|1|||
27973641|NCT02526524|81732766|FG002|Overall Study|Loss of Glucose Control|3|||
27671188|NCT01236352|80634930|FG001|Overall Study|Adverse Event|0|||
27785739|NCT04212221|81047206|FG001|Overall Study|Disease progression according to irRECIST|2|||
27785740|NCT04212221|81047207|FG002|Overall Study|Disease progression according to irRECIST|3|||
27866979|NCT01098474|81346639|FG001|Active Phase|Withdrawal by Subject|1|||
27785741|NCT04212221|81047208|FG003|Overall Study|Disease progression according to irRECIST|3|||
27785742|NCT04212221|81047209|FG004|Overall Study|Disease progression according to irRECIST|2|||
27785743|NCT04212221|81047210|FG005|Overall Study|Disease progression according to irRECIST|2|||
27785744|NCT04212221|81047211|FG006|Overall Study|Disease progression according to irRECIST|21|||
27785745|NCT04212221|81047212|FG007|Overall Study|Disease progression according to irRECIST|17|||
27866980|NCT01098474|81346640|FG002|Active Phase|Withdrawal by Subject|2|||
27866981|NCT01098474|81346641|FG003|Active Phase|Withdrawal by Subject|0|||
27866982|NCT01098474|81346642|FG004|Active Phase|Withdrawal by Subject|0|||
27866983|NCT01098474|81346643|FG005|Active Phase|Withdrawal by Subject|0|||
27785746|NCT04212221|81047205|FG000|Overall Study|Global Deterioration of Health Status|0|||
27866984|NCT01098474|81346638|FG000|Active Phase|Lost to Follow-up|1|||
27785747|NCT04212221|81047206|FG001|Overall Study|Global Deterioration of Health Status|0|||
27785748|NCT04212221|81047207|FG002|Overall Study|Global Deterioration of Health Status|0|||
27785749|NCT04212221|81047208|FG003|Overall Study|Global Deterioration of Health Status|0|||
27785750|NCT04212221|81047209|FG004|Overall Study|Global Deterioration of Health Status|0|||
27785751|NCT04212221|81047210|FG005|Overall Study|Global Deterioration of Health Status|0|||
27785752|NCT04212221|81047211|FG006|Overall Study|Global Deterioration of Health Status|0|||
27785753|NCT04212221|81047212|FG007|Overall Study|Global Deterioration of Health Status|2|||
27785754|NCT04212221|81047205|FG000|Overall Study|Investigator's Decision|0|||
27785755|NCT04212221|81047206|FG001|Overall Study|Investigator's Decision|0|||
27785756|NCT04212221|81047207|FG002|Overall Study|Investigator's Decision|0|||
27785757|NCT04212221|81047208|FG003|Overall Study|Investigator's Decision|1|||
27785758|NCT04212221|81047209|FG004|Overall Study|Investigator's Decision|0|||
27785759|NCT04212221|81047210|FG005|Overall Study|Investigator's Decision|0|||
27785760|NCT04212221|81047211|FG006|Overall Study|Investigator's Decision|3|||
27785761|NCT04212221|81047212|FG007|Overall Study|Investigator's Decision|0|||
27785762|NCT04212221|81047205|FG000|Overall Study|Participant refused to continue treatment|0|||
27785763|NCT04212221|81047206|FG001|Overall Study|Participant refused to continue treatment|1|||
27785764|NCT04212221|81047207|FG002|Overall Study|Participant refused to continue treatment|0|||
27785765|NCT04212221|81047208|FG003|Overall Study|Participant refused to continue treatment|1|||
27785766|NCT04212221|81047209|FG004|Overall Study|Participant refused to continue treatment|1|||
27785767|NCT04212221|81047210|FG005|Overall Study|Participant refused to continue treatment|2|||
27785768|NCT04212221|81047211|FG006|Overall Study|Participant refused to continue treatment|4|||
27785769|NCT04212221|81047212|FG007|Overall Study|Participant refused to continue treatment|2|||
27785770|NCT04212221|81047205|FG000|Overall Study|Protocol Violation|0|||
27785771|NCT04212221|81047206|FG001|Overall Study|Protocol Violation|0|||
27785772|NCT04212221|81047207|FG002|Overall Study|Protocol Violation|0|||
27785773|NCT04212221|81047208|FG003|Overall Study|Protocol Violation|0|||
27785774|NCT04212221|81047209|FG004|Overall Study|Protocol Violation|0|||
27785775|NCT04212221|81047210|FG005|Overall Study|Protocol Violation|0|||
27785776|NCT04212221|81047211|FG006|Overall Study|Protocol Violation|0|||
27785777|NCT04212221|81047212|FG007|Overall Study|Protocol Violation|1|||
27785778|NCT02505945|81047217|FG000|Overall Study|Withdrawal by Subject|13|||
27785779|NCT02505945|81047218|FG001|Overall Study|Withdrawal by Subject|2|||
27785780|NCT02505945|81047217|FG000|Overall Study|Adverse Event|1|||
27785781|NCT02505945|81047218|FG001|Overall Study|Adverse Event|0|||
27785782|NCT02505945|81047217|FG000|Overall Study|Physician Decision|2|||
27785783|NCT02505945|81047218|FG001|Overall Study|Physician Decision|1|||
27785784|NCT02505945|81047217|FG000|Overall Study|Lost to Follow-up|6|||
27785785|NCT02505945|81047218|FG001|Overall Study|Lost to Follow-up|1|||
27785786|NCT01016912|81047222|FG000|End of Treatment Period|Lack of Efficacy|0|||
27785787|NCT01016912|81047223|FG001|End of Treatment Period|Lack of Efficacy|1|||
27785788|NCT01016912|81047224|FG002|End of Treatment Period|Lack of Efficacy|0|||
27785789|NCT01016912|81047225|FG003|End of Treatment Period|Lack of Efficacy|4|||
27785790|NCT01016912|81047226|FG004|End of Treatment Period|Lack of Efficacy|4|||
27785791|NCT01016912|81047222|FG000|End of Treatment Period|Adverse Event|0|||
27785792|NCT01016912|81047223|FG001|End of Treatment Period|Adverse Event|1|||
27785793|NCT01016912|81047224|FG002|End of Treatment Period|Adverse Event|1|||
27785794|NCT01016912|81047225|FG003|End of Treatment Period|Adverse Event|0|||
27785795|NCT01016912|81047226|FG004|End of Treatment Period|Adverse Event|0|||
27785796|NCT01016912|81047222|FG000|End of Treatment Period|Completed double-blind period only|0|||
27785797|NCT01016912|81047223|FG001|End of Treatment Period|Completed double-blind period only|1|||
27785798|NCT01016912|81047224|FG002|End of Treatment Period|Completed double-blind period only|0|||
27785799|NCT01016912|81047225|FG003|End of Treatment Period|Completed double-blind period only|0|||
27785800|NCT01016912|81047226|FG004|End of Treatment Period|Completed double-blind period only|0|||
27785801|NCT01016912|81047222|FG000|Follow-up Period|Other reason|0|||
27785802|NCT01016912|81047223|FG001|Follow-up Period|Other reason|0|||
27785803|NCT01016912|81047224|FG002|Follow-up Period|Other reason|1|||
27785804|NCT01016912|81047225|FG003|Follow-up Period|Other reason|1|||
27785805|NCT01016912|81047226|FG004|Follow-up Period|Other reason|0|||
27785806|NCT02708524|81047228|FG000|Overall Study|Adverse Event|0|||
27785807|NCT02708524|81047229|FG001|Overall Study|Adverse Event|1|||
27866985|NCT01098474|81346639|FG001|Active Phase|Lost to Follow-up|0|||
27866986|NCT01098474|81346640|FG002|Active Phase|Lost to Follow-up|0|||
27866987|NCT01098474|81346641|FG003|Active Phase|Lost to Follow-up|0|||
27785808|NCT02708524|81047230|FG002|Overall Study|Adverse Event|0|||
27785809|NCT02708524|81047231|FG003|Overall Study|Adverse Event|0|||
27785810|NCT02708524|81047228|FG000|Overall Study|Lens Discomfort|1|||
27785811|NCT02708524|81047229|FG001|Overall Study|Lens Discomfort|0|||
27785812|NCT02708524|81047230|FG002|Overall Study|Lens Discomfort|1|||
27785813|NCT02708524|81047231|FG003|Overall Study|Lens Discomfort|0|||
27785814|NCT02708524|81047228|FG000|Overall Study|Lost to Follow-up|1|||
27785815|NCT02708524|81047229|FG001|Overall Study|Lost to Follow-up|1|||
27785816|NCT02708524|81047230|FG002|Overall Study|Lost to Follow-up|1|||
27785817|NCT02708524|81047231|FG003|Overall Study|Lost to Follow-up|0|||
27785818|NCT02708524|81047228|FG000|Overall Study|Protocol Violation|0|||
27785819|NCT02708524|81047229|FG001|Overall Study|Protocol Violation|1|||
27785820|NCT02708524|81047230|FG002|Overall Study|Protocol Violation|0|||
27785821|NCT02708524|81047231|FG003|Overall Study|Protocol Violation|0|||
27785822|NCT02708524|81047228|FG000|Overall Study|Withdrawal by Subject|1|||
27785823|NCT02708524|81047229|FG001|Overall Study|Withdrawal by Subject|1|||
27785824|NCT02708524|81047230|FG002|Overall Study|Withdrawal by Subject|0|||
27785825|NCT02708524|81047231|FG003|Overall Study|Withdrawal by Subject|0|||
27785826|NCT02708524|81047228|FG000|Overall Study|Dispensed incorrect study lens|0|||
27785827|NCT02708524|81047229|FG001|Overall Study|Dispensed incorrect study lens|1|||
27785828|NCT02708524|81047230|FG002|Overall Study|Dispensed incorrect study lens|1|||
27785829|NCT02708524|81047231|FG003|Overall Study|Dispensed incorrect study lens|0|||
27785830|NCT02708524|81047228|FG000|Overall Study|Did not wear lens at final visit|0|||
27785831|NCT02708524|81047229|FG001|Overall Study|Did not wear lens at final visit|1|||
27785832|NCT02708524|81047230|FG002|Overall Study|Did not wear lens at final visit|0|||
27785833|NCT02708524|81047231|FG003|Overall Study|Did not wear lens at final visit|0|||
27785834|NCT02708524|81047228|FG000|Overall Study|Subject lost study lens|1|||
27785835|NCT02708524|81047229|FG001|Overall Study|Subject lost study lens|0|||
27785836|NCT02708524|81047230|FG002|Overall Study|Subject lost study lens|0|||
27785837|NCT02708524|81047231|FG003|Overall Study|Subject lost study lens|0|||
27785838|NCT00656136|81047235|FG000|Overall Study|Progressive disease|177|||
27785839|NCT00656136|81047236|FG001|Overall Study|Progressive disease|322|||
27785840|NCT00656136|81047235|FG000|Overall Study|Other Adverse Event|5|||
27785841|NCT00656136|81047236|FG001|Overall Study|Other Adverse Event|51|||
27785842|NCT00656136|81047235|FG000|Overall Study|Protocol Violation|2|||
27785843|NCT00656136|81047236|FG001|Overall Study|Protocol Violation|3|||
27785844|NCT00656136|81047235|FG000|Overall Study|Patient refused to take study medication|7|||
27785845|NCT00656136|81047236|FG001|Overall Study|Patient refused to take study medication|10|||
27785846|NCT00656136|81047235|FG000|Overall Study|Unknown and others|4|||
27785847|NCT00656136|81047236|FG001|Overall Study|Unknown and others|4|||
27785848|NCT00125138|81047237|FG000|Overall Study|Adverse Event|1|||
27785849|NCT00125138|81047238|FG001|Overall Study|Adverse Event|0|||
27785850|NCT00125138|81047239|FG002|Overall Study|Adverse Event|3|||
27785851|NCT00125138|81047240|FG003|Overall Study|Adverse Event|2|||
27785852|NCT00125138|81047237|FG000|Overall Study|Withdrawal by Subject|2|||
27785853|NCT00125138|81047238|FG001|Overall Study|Withdrawal by Subject|3|||
27785854|NCT00125138|81047239|FG002|Overall Study|Withdrawal by Subject|1|||
27785855|NCT00125138|81047240|FG003|Overall Study|Withdrawal by Subject|1|||
27785856|NCT00125138|81047237|FG000|Overall Study|Lack of Efficacy|0|||
27785857|NCT00125138|81047238|FG001|Overall Study|Lack of Efficacy|0|||
27785858|NCT00125138|81047239|FG002|Overall Study|Lack of Efficacy|0|||
27785859|NCT00125138|81047240|FG003|Overall Study|Lack of Efficacy|1|||
27785860|NCT00125138|81047237|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
27785861|NCT00125138|81047238|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
27785862|NCT00125138|81047239|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
27785863|NCT00125138|81047240|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
27785864|NCT03007472|81047241|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
27785865|NCT03007472|81047241|FG000|Overall Study|Death|2|||
27785866|NCT03007472|81047241|FG000|Overall Study|Loss to Follow Up|1|||
27785867|NCT00960323|81047242|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
27785868|NCT00787527|81047244|FG000|Overall Study|Toxicity|3|||
27785869|NCT03417999|81047245|FG000|Overall Study|Withdrawal by Subject|1|||
27785870|NCT03417999|81047246|FG001|Overall Study|Withdrawal by Subject|0|||
27785871|NCT03417999|81047247|FG002|Overall Study|Withdrawal by Subject|0|||
27785872|NCT03417999|81047245|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
27785873|NCT03417999|81047246|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
27785874|NCT03417999|81047247|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
27785875|NCT03417999|81047245|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
27785876|NCT03417999|81047246|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
27785877|NCT03417999|81047247|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
27785878|NCT03417999|81047245|FG000|Overall Study|Inadequate study staff available to process samples|0|||
27785879|NCT03417999|81047246|FG001|Overall Study|Inadequate study staff available to process samples|0|||
27785880|NCT03417999|81047247|FG002|Overall Study|Inadequate study staff available to process samples|1|||
27785881|NCT00087685|81047248|FG000|Overall Study|Adverse Event|5|||
27785882|NCT00087685|81047248|FG000|Overall Study|Non-Compliance|1|||
27785883|NCT00087685|81047248|FG000|Overall Study|Progressive Disease|5|||
27785884|NCT00087685|81047248|FG000|Overall Study|Withdrawal by Subject|3|||
27785885|NCT02906644|81047251|FG000|First 2 Weeks|Withdrawal by Subject|0|||
27785886|NCT02906644|81047252|FG001|First 2 Weeks|Withdrawal by Subject|2|||
27785887|NCT02906644|81047251|FG000|First 2 Weeks|Physician Decision|1|||
27785888|NCT02906644|81047252|FG001|First 2 Weeks|Physician Decision|1|||
27671189|NCT01236352|80634931|FG002|Overall Study|Adverse Event|0|||
27785889|NCT02906644|81047251|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
27866988|NCT01098474|81346642|FG004|Active Phase|Lost to Follow-up|0|||
27785890|NCT02906644|81047252|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
27785891|NCT02906644|81047251|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
27785892|NCT02906644|81047252|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
27785893|NCT00134563|81047253|FG000|Overall Study|Not treated due to protocol violation|0|||
27785894|NCT00134563|81047254|FG001|Overall Study|Not treated due to protocol violation|1|||
27785895|NCT00134563|81047255|FG002|Overall Study|Not treated due to protocol violation|1|||
27785896|NCT00134563|81047253|FG000|Overall Study|Adverse Event|29|||
27785897|NCT00134563|81047254|FG001|Overall Study|Adverse Event|37|||
27785898|NCT00134563|81047255|FG002|Overall Study|Adverse Event|38|||
27785899|NCT00134563|81047253|FG000|Overall Study|Lack of Efficacy|24|||
27785900|NCT00134563|81047254|FG001|Overall Study|Lack of Efficacy|14|||
27785901|NCT00134563|81047255|FG002|Overall Study|Lack of Efficacy|17|||
27785902|NCT00134563|81047253|FG000|Overall Study|Protocol Violation|3|||
27785903|NCT00134563|81047254|FG001|Overall Study|Protocol Violation|2|||
27785904|NCT00134563|81047255|FG002|Overall Study|Protocol Violation|5|||
27785905|NCT00134563|81047253|FG000|Overall Study|Lost to Follow-up|4|||
27785906|NCT00134563|81047254|FG001|Overall Study|Lost to Follow-up|0|||
27785907|NCT00134563|81047255|FG002|Overall Study|Lost to Follow-up|2|||
27785908|NCT00134563|81047253|FG000|Overall Study|progressive disease|11|||
27785909|NCT00134563|81047254|FG001|Overall Study|progressive disease|4|||
27785910|NCT00134563|81047255|FG002|Overall Study|progressive disease|2|||
27785911|NCT00134563|81047253|FG000|Overall Study|did not wish to continue|33|||
27785912|NCT00134563|81047254|FG001|Overall Study|did not wish to continue|32|||
27785913|NCT00134563|81047255|FG002|Overall Study|did not wish to continue|26|||
27785914|NCT00134563|81047253|FG000|Overall Study|Reason other than above|0|||
27785915|NCT00134563|81047254|FG001|Overall Study|Reason other than above|2|||
27785916|NCT00134563|81047255|FG002|Overall Study|Reason other than above|5|||
27785917|NCT02516605|81047257|FG000|Overall Study|Protocol Violation|0|||
27785918|NCT02516605|81047258|FG001|Overall Study|Protocol Violation|0|||
27785919|NCT02516605|81047259|FG002|Overall Study|Protocol Violation|0|||
27785920|NCT02516605|81047260|FG003|Overall Study|Protocol Violation|0|||
27785921|NCT02516605|81047261|FG004|Overall Study|Protocol Violation|1|||
27785922|NCT02516605|81047257|FG000|Overall Study|Withdrawal by Subject|0|||
27785923|NCT02516605|81047258|FG001|Overall Study|Withdrawal by Subject|0|||
27785924|NCT02516605|81047259|FG002|Overall Study|Withdrawal by Subject|0|||
27785925|NCT02516605|81047260|FG003|Overall Study|Withdrawal by Subject|1|||
27785926|NCT02516605|81047261|FG004|Overall Study|Withdrawal by Subject|0|||
27785927|NCT01038609|81047262|FG000|Overall Study|Adverse Event|0|||
27785928|NCT01038609|81047263|FG001|Overall Study|Adverse Event|0|||
27785929|NCT01038609|81047264|FG002|Overall Study|Adverse Event|1|||
27785930|NCT01038609|81047265|FG003|Overall Study|Adverse Event|0|||
27785931|NCT01038609|81047266|FG004|Overall Study|Adverse Event|0|||
27785932|NCT01038609|81047262|FG000|Overall Study|Dosing Error|0|||
27785933|NCT01038609|81047263|FG001|Overall Study|Dosing Error|0|||
27785934|NCT01038609|81047264|FG002|Overall Study|Dosing Error|0|||
27785935|NCT01038609|81047265|FG003|Overall Study|Dosing Error|1|||
27785936|NCT01038609|81047266|FG004|Overall Study|Dosing Error|1|||
27785937|NCT01038609|81047262|FG000|Overall Study|Death in the Family|1|||
27785938|NCT01038609|81047263|FG001|Overall Study|Death in the Family|0|||
27785939|NCT01038609|81047264|FG002|Overall Study|Death in the Family|0|||
27785940|NCT01038609|81047265|FG003|Overall Study|Death in the Family|0|||
27866989|NCT01098474|81346643|FG005|Active Phase|Lost to Follow-up|0|||
27785941|NCT01038609|81047266|FG004|Overall Study|Death in the Family|0|||
27785942|NCT01038609|81047262|FG000|Overall Study|Refusal of Blood Draws|0|||
27785943|NCT01038609|81047263|FG001|Overall Study|Refusal of Blood Draws|1|||
27785944|NCT01038609|81047264|FG002|Overall Study|Refusal of Blood Draws|0|||
27785945|NCT01038609|81047265|FG003|Overall Study|Refusal of Blood Draws|0|||
27785946|NCT01038609|81047266|FG004|Overall Study|Refusal of Blood Draws|0|||
27785947|NCT02312934|81047267|FG000|Overall Study|Lost to Follow-up|1|||
27785948|NCT02312934|81047268|FG001|Overall Study|Lost to Follow-up|0|||
27785949|NCT02312934|81047267|FG000|Overall Study|Physician Decision|1|||
27785950|NCT02312934|81047268|FG001|Overall Study|Physician Decision|0|||
27785951|NCT04335929|81047271|FG000|Overall Study|Lost to Follow-up|10|||
27785952|NCT04585789|81047272|FG000|Overall Study|Withdrawal by Subject|1|||
27785953|NCT04585789|81047273|FG001|Overall Study|Withdrawal by Subject|0|||
27785954|NCT04585789|81047272|FG000|Overall Study|Ongoing|9|||
27785955|NCT04585789|81047273|FG001|Overall Study|Ongoing|10|||
27785956|NCT01072175|81047284|FG000|Part A (Drug-Drug Interaction)|Death|1|||
27785957|NCT01072175|81047285|FG001|Part A (Drug-Drug Interaction)|Death|0|||
27785958|NCT01072175|81047286|FG002|Part A (Drug-Drug Interaction)|Death|0|||
27785959|NCT01072175|81047287|FG003|Part A (Drug-Drug Interaction)|Death|0|||
27866990|NCT01098474|81346638|FG000|Follow Up Phase|Travelled out of study area|0|||
27785960|NCT01072175|81047288|FG004|Part A (Drug-Drug Interaction)|Death|0|||
27785961|NCT01072175|81047289|FG005|Part A (Drug-Drug Interaction)|Death|0|||
27785962|NCT01072175|81047290|FG006|Part A (Drug-Drug Interaction)|Death|0|||
27973642|NCT02526524|81732767|FG003|Overall Study|Loss of Glucose Control|0|||
27973643|NCT02526524|81732768|FG004|Overall Study|Loss of Glucose Control|2|||
27973644|NCT02526524|81732769|FG005|Overall Study|Loss of Glucose Control|0|||
27671190|NCT01236352|80634932|FG003|Overall Study|Adverse Event|0|||
27671191|NCT01236352|80634933|FG004|Overall Study|Adverse Event|0|||
27973645|NCT02526524|81732764|FG000|Overall Study|Physician Decision|0|||
27973646|NCT02526524|81732765|FG001|Overall Study|Physician Decision|0|||
27973647|NCT02526524|81732766|FG002|Overall Study|Physician Decision|0|||
27973648|NCT02526524|81732767|FG003|Overall Study|Physician Decision|0|||
27973649|NCT02526524|81732768|FG004|Overall Study|Physician Decision|1|||
27973650|NCT02526524|81732769|FG005|Overall Study|Physician Decision|0|||
27973651|NCT02526524|81732764|FG000|Overall Study|Sponsor Decision|1|||
27973652|NCT02526524|81732765|FG001|Overall Study|Sponsor Decision|0|||
27973653|NCT02526524|81732766|FG002|Overall Study|Sponsor Decision|0|||
27973654|NCT02526524|81732767|FG003|Overall Study|Sponsor Decision|0|||
27973655|NCT02526524|81732768|FG004|Overall Study|Sponsor Decision|0|||
27973656|NCT02526524|81732769|FG005|Overall Study|Sponsor Decision|0|||
27973657|NCT01133405|81732770|FG000|Period 1|Withdrawal by Subject|0|||
27973658|NCT01133405|81732771|FG001|Period 1|Withdrawal by Subject|1|||
27973659|NCT01133405|81732772|FG002|Period 1|Withdrawal by Subject|0|||
27973660|NCT01133405|81732773|FG003|Period 1|Withdrawal by Subject|1|||
27973661|NCT01133405|81732774|FG004|Period 1|Withdrawal by Subject|0|||
27973662|NCT01133405|81732775|FG005|Period 1|Withdrawal by Subject|1|||
27973663|NCT01133405|81732776|FG006|Period 1|Withdrawal by Subject|0|||
27973664|NCT01133405|81732777|FG007|Period 1|Withdrawal by Subject|0|||
27671192|NCT01236352|80634934|FG005|Overall Study|Adverse Event|0|||
27671193|NCT01236352|80634935|FG006|Overall Study|Adverse Event|2|||
27671194|NCT01236352|80634936|FG007|Overall Study|Adverse Event|0|||
27671195|NCT01236352|80634937|FG008|Overall Study|Adverse Event|0|||
27671196|NCT01236352|80634938|FG009|Overall Study|Adverse Event|4|||
27785963|NCT01072175|81047291|FG007|Part A (Drug-Drug Interaction)|Death|0|||
27785964|NCT01072175|81047292|FG008|Part A (Drug-Drug Interaction)|Death|0|||
27785965|NCT01072175|81047293|FG009|Part A (Drug-Drug Interaction)|Death|0|||
27785966|NCT01072175|81047294|FG010|Part A (Drug-Drug Interaction)|Death|0|||
27785967|NCT01072175|81047295|FG011|Part A (Drug-Drug Interaction)|Death|0|||
27785968|NCT01072175|81047296|FG012|Part A (Drug-Drug Interaction)|Death|0|||
27785969|NCT01072175|81047284|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
27785970|NCT01072175|81047285|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785971|NCT01072175|81047286|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785972|NCT01072175|81047287|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785973|NCT01072175|81047288|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785974|NCT01072175|81047289|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785975|NCT01072175|81047290|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785976|NCT01072175|81047291|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785977|NCT01072175|81047292|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785978|NCT01072175|81047293|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785979|NCT01072175|81047294|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785980|NCT01072175|81047295|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785981|NCT01072175|81047296|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
27785982|NCT01072175|81047284|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
27785983|NCT01072175|81047285|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785984|NCT01072175|81047286|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785985|NCT01072175|81047287|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785986|NCT01072175|81047288|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785987|NCT01072175|81047289|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785988|NCT01072175|81047290|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785989|NCT01072175|81047291|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785990|NCT01072175|81047292|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785991|NCT01072175|81047293|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785992|NCT01072175|81047294|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785993|NCT01072175|81047295|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785994|NCT01072175|81047296|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
27785995|NCT01072175|81047284|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
27785996|NCT01072175|81047285|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
27785997|NCT01072175|81047286|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
27973665|NCT01133405|81732778|FG008|Period 1|Withdrawal by Subject|0|||
27973666|NCT01133405|81732779|FG009|Period 1|Withdrawal by Subject|0|||
27973667|NCT01133405|81732770|FG000|Period 1|Physician Decision|0|||
27973668|NCT01133405|81732771|FG001|Period 1|Physician Decision|0|||
27973669|NCT01133405|81732772|FG002|Period 1|Physician Decision|0|||
27973670|NCT01133405|81732773|FG003|Period 1|Physician Decision|1|||
27671197|NCT01236352|80634939|FG010|Overall Study|Adverse Event|1|||
27973671|NCT01133405|81732774|FG004|Period 1|Physician Decision|0|||
27973672|NCT01133405|81732775|FG005|Period 1|Physician Decision|0|||
27973673|NCT01133405|81732776|FG006|Period 1|Physician Decision|0|||
27973674|NCT01133405|81732777|FG007|Period 1|Physician Decision|0|||
27973675|NCT01133405|81732778|FG008|Period 1|Physician Decision|0|||
27973676|NCT01133405|81732779|FG009|Period 1|Physician Decision|0|||
27973677|NCT01133405|81732770|FG000|Period 1|Discontinued after randomization|1|||
27973678|NCT01133405|81732771|FG001|Period 1|Discontinued after randomization|0|||
27671198|NCT01236352|80634929|FG000|Overall Study|Study drug toxicity|0|||
27671199|NCT01236352|80634930|FG001|Overall Study|Study drug toxicity|0|||
27671200|NCT01236352|80634931|FG002|Overall Study|Study drug toxicity|0|||
27671201|NCT01236352|80634932|FG003|Overall Study|Study drug toxicity|0|||
27671202|NCT01236352|80634933|FG004|Overall Study|Study drug toxicity|0|||
27671203|NCT01236352|80634934|FG005|Overall Study|Study drug toxicity|1|||
27671204|NCT01236352|80634935|FG006|Overall Study|Study drug toxicity|1|||
27671205|NCT01236352|80634936|FG007|Overall Study|Study drug toxicity|0|||
27671206|NCT01236352|80634937|FG008|Overall Study|Study drug toxicity|0|||
27671207|NCT01236352|80634938|FG009|Overall Study|Study drug toxicity|2|||
27671208|NCT01236352|80634939|FG010|Overall Study|Study drug toxicity|2|||
27671209|NCT01236352|80634929|FG000|Overall Study|Disease progression|1|||
27671210|NCT01236352|80634930|FG001|Overall Study|Disease progression|2|||
27671211|NCT01236352|80634931|FG002|Overall Study|Disease progression|1|||
27671212|NCT01236352|80634932|FG003|Overall Study|Disease progression|2|||
27671213|NCT01236352|80634933|FG004|Overall Study|Disease progression|2|||
27671214|NCT01236352|80634934|FG005|Overall Study|Disease progression|2|||
27671215|NCT01236352|80634935|FG006|Overall Study|Disease progression|1|||
27671216|NCT01236352|80634936|FG007|Overall Study|Disease progression|3|||
27671217|NCT01236352|80634937|FG008|Overall Study|Disease progression|2|||
27671218|NCT01236352|80634938|FG009|Overall Study|Disease progression|2|||
27671219|NCT01236352|80634939|FG010|Overall Study|Disease progression|2|||
27671220|NCT01236352|80634929|FG000|Overall Study|Poor/Non-compliance|1|||
27671221|NCT01236352|80634930|FG001|Overall Study|Poor/Non-compliance|0|||
27671222|NCT01236352|80634931|FG002|Overall Study|Poor/Non-compliance|0|||
27671223|NCT01236352|80634932|FG003|Overall Study|Poor/Non-compliance|0|||
27671224|NCT01236352|80634933|FG004|Overall Study|Poor/Non-compliance|0|||
27671225|NCT01236352|80634934|FG005|Overall Study|Poor/Non-compliance|0|||
27671226|NCT01236352|80634935|FG006|Overall Study|Poor/Non-compliance|0|||
27671227|NCT01236352|80634936|FG007|Overall Study|Poor/Non-compliance|0|||
27671228|NCT01236352|80634937|FG008|Overall Study|Poor/Non-compliance|0|||
27671229|NCT01236352|80634938|FG009|Overall Study|Poor/Non-compliance|0|||
27671230|NCT01236352|80634939|FG010|Overall Study|Poor/Non-compliance|0|||
27671231|NCT01236352|80634929|FG000|Overall Study|Maximum clinical benefit|1|||
27671232|NCT01236352|80634930|FG001|Overall Study|Maximum clinical benefit|1|||
27671233|NCT01236352|80634931|FG002|Overall Study|Maximum clinical benefit|1|||
27671234|NCT01236352|80634932|FG003|Overall Study|Maximum clinical benefit|0|||
27671235|NCT01236352|80634933|FG004|Overall Study|Maximum clinical benefit|2|||
27671236|NCT01236352|80634934|FG005|Overall Study|Maximum clinical benefit|0|||
27671237|NCT01236352|80634935|FG006|Overall Study|Maximum clinical benefit|3|||
27671238|NCT01236352|80634936|FG007|Overall Study|Maximum clinical benefit|1|||
27671239|NCT01236352|80634937|FG008|Overall Study|Maximum clinical benefit|1|||
27671240|NCT01236352|80634938|FG009|Overall Study|Maximum clinical benefit|4|||
27671241|NCT01236352|80634939|FG010|Overall Study|Maximum clinical benefit|2|||
27671242|NCT01236352|80634929|FG000|Overall Study|Subject request to discontinue treatment|0|||
27671243|NCT01236352|80634930|FG001|Overall Study|Subject request to discontinue treatment|0|||
27671244|NCT01236352|80634931|FG002|Overall Study|Subject request to discontinue treatment|1|||
27785998|NCT01072175|81047287|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
27785999|NCT01072175|81047288|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
27786000|NCT01072175|81047289|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
27786001|NCT01072175|81047290|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
27786002|NCT01072175|81047291|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
27786003|NCT01072175|81047292|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
27786004|NCT01072175|81047293|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
27786005|NCT01072175|81047294|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
27786006|NCT01072175|81047295|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
27786007|NCT01072175|81047296|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
27973679|NCT01133405|81732772|FG002|Period 1|Discontinued after randomization|0|||
27671245|NCT01236352|80634932|FG003|Overall Study|Subject request to discontinue treatment|1|||
27973680|NCT01133405|81732773|FG003|Period 1|Discontinued after randomization|0|||
27671246|NCT01236352|80634933|FG004|Overall Study|Subject request to discontinue treatment|0|||
27671247|NCT01236352|80634934|FG005|Overall Study|Subject request to discontinue treatment|1|||
27671248|NCT01236352|80634935|FG006|Overall Study|Subject request to discontinue treatment|0|||
27671249|NCT01236352|80634936|FG007|Overall Study|Subject request to discontinue treatment|0|||
27671250|NCT01236352|80634937|FG008|Overall Study|Subject request to discontinue treatment|0|||
27671251|NCT01236352|80634938|FG009|Overall Study|Subject request to discontinue treatment|1|||
27786008|NCT01072175|81047284|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786009|NCT01072175|81047285|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786010|NCT01072175|81047286|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
27786011|NCT01072175|81047287|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786012|NCT01072175|81047288|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
27786013|NCT01072175|81047289|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27671252|NCT01236352|80634939|FG010|Overall Study|Subject request to discontinue treatment|4|||
27671253|NCT01236352|80634929|FG000|Overall Study|Subject to receive drug via EAP|1|||
27671254|NCT01236352|80634930|FG001|Overall Study|Subject to receive drug via EAP|1|||
27671255|NCT01236352|80634931|FG002|Overall Study|Subject to receive drug via EAP|1|||
27671256|NCT01236352|80634932|FG003|Overall Study|Subject to receive drug via EAP|0|||
27671257|NCT01236352|80634933|FG004|Overall Study|Subject to receive drug via EAP|0|||
27671258|NCT01236352|80634934|FG005|Overall Study|Subject to receive drug via EAP|0|||
27671259|NCT01236352|80634935|FG006|Overall Study|Subject to receive drug via EAP|0|||
27671260|NCT01236352|80634936|FG007|Overall Study|Subject to receive drug via EAP|2|||
27671261|NCT01236352|80634937|FG008|Overall Study|Subject to receive drug via EAP|0|||
27671262|NCT01236352|80634938|FG009|Overall Study|Subject to receive drug via EAP|4|||
27671263|NCT01236352|80634939|FG010|Overall Study|Subject to receive drug via EAP|0|||
27671264|NCT01236352|80634929|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
27671265|NCT01236352|80634930|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
27671266|NCT01236352|80634931|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
27671267|NCT01236352|80634932|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
27671268|NCT01236352|80634933|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
27671269|NCT01236352|80634934|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
27671270|NCT01236352|80634935|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
27671271|NCT01236352|80634936|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
27671272|NCT01236352|80634937|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
27786014|NCT01072175|81047290|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786015|NCT01072175|81047291|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786016|NCT01072175|81047292|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786017|NCT01072175|81047293|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786018|NCT01072175|81047294|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786019|NCT01072175|81047295|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786020|NCT01072175|81047296|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
27786021|NCT01072175|81047284|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786022|NCT01072175|81047285|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
27786023|NCT01072175|81047286|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786024|NCT01072175|81047287|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
27786025|NCT01072175|81047288|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
27786026|NCT01072175|81047289|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786027|NCT01072175|81047290|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786028|NCT01072175|81047291|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786029|NCT01072175|81047292|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786030|NCT01072175|81047293|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786031|NCT01072175|81047294|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786032|NCT01072175|81047295|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786033|NCT01072175|81047296|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
27786034|NCT01072175|81047284|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786035|NCT01072175|81047285|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786036|NCT01072175|81047286|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
27786037|NCT01072175|81047287|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
27786038|NCT01072175|81047288|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
27786039|NCT01072175|81047289|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786040|NCT01072175|81047290|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786041|NCT01072175|81047291|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786042|NCT01072175|81047292|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786043|NCT01072175|81047293|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786044|NCT01072175|81047294|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786045|NCT01072175|81047295|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786046|NCT01072175|81047296|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
27786047|NCT01072175|81047284|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786048|NCT01072175|81047285|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
27786049|NCT01072175|81047286|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27671273|NCT01236352|80634938|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
27786050|NCT01072175|81047287|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
27786051|NCT01072175|81047288|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
27786052|NCT01072175|81047289|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786053|NCT01072175|81047290|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786054|NCT01072175|81047291|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786055|NCT01072175|81047292|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786056|NCT01072175|81047293|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786057|NCT01072175|81047294|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786058|NCT01072175|81047295|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786059|NCT01072175|81047296|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
27786060|NCT01072175|81047284|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
27786061|NCT01072175|81047285|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
27786062|NCT01072175|81047286|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
27786063|NCT01072175|81047287|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
27786064|NCT01072175|81047288|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
27786065|NCT01072175|81047289|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
27786066|NCT01072175|81047290|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
27973681|NCT01133405|81732774|FG004|Period 1|Discontinued after randomization|0|||
27973682|NCT01133405|81732775|FG005|Period 1|Discontinued after randomization|0|||
27786067|NCT01072175|81047291|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
27786068|NCT01072175|81047292|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
27786069|NCT01072175|81047293|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
27786070|NCT01072175|81047294|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
27786071|NCT01072175|81047295|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
27786072|NCT01072175|81047296|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
27786073|NCT01072175|81047284|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786074|NCT01072175|81047285|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786075|NCT01072175|81047286|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786076|NCT01072175|81047287|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786077|NCT01072175|81047288|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786078|NCT01072175|81047289|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
27786079|NCT01072175|81047290|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
27786080|NCT01072175|81047291|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
27786081|NCT01072175|81047292|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786082|NCT01072175|81047293|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786083|NCT01072175|81047294|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786084|NCT01072175|81047295|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27786085|NCT01072175|81047296|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
27866991|NCT01098474|81346639|FG001|Follow Up Phase|Travelled out of study area|0|||
27866992|NCT01098474|81346640|FG002|Follow Up Phase|Travelled out of study area|0|||
27866993|NCT01098474|81346641|FG003|Follow Up Phase|Travelled out of study area|0|||
27866994|NCT01098474|81346642|FG004|Follow Up Phase|Travelled out of study area|1|||
27866995|NCT01098474|81346643|FG005|Follow Up Phase|Travelled out of study area|0|||
27866996|NCT01098474|81346638|FG000|Follow Up Phase|Other|0|||
27866997|NCT01098474|81346639|FG001|Follow Up Phase|Other|0|||
27866998|NCT01098474|81346640|FG002|Follow Up Phase|Other|0|||
27866999|NCT01098474|81346641|FG003|Follow Up Phase|Other|0|||
27867000|NCT01098474|81346642|FG004|Follow Up Phase|Other|0|||
27867001|NCT01098474|81346643|FG005|Follow Up Phase|Other|4|||
27867002|NCT01098474|81346638|FG000|Follow Up Phase|Withdrawal by Subject|0|||
27867003|NCT01098474|81346639|FG001|Follow Up Phase|Withdrawal by Subject|0|||
27867004|NCT01098474|81346640|FG002|Follow Up Phase|Withdrawal by Subject|0|||
27867005|NCT01098474|81346641|FG003|Follow Up Phase|Withdrawal by Subject|2|||
27867006|NCT01098474|81346642|FG004|Follow Up Phase|Withdrawal by Subject|0|||
27867007|NCT01098474|81346643|FG005|Follow Up Phase|Withdrawal by Subject|1|||
27973683|NCT01133405|81732776|FG006|Period 1|Discontinued after randomization|1|||
27973684|NCT01133405|81732777|FG007|Period 1|Discontinued after randomization|0|||
27973685|NCT01133405|81732778|FG008|Period 1|Discontinued after randomization|0|||
27973686|NCT01133405|81732779|FG009|Period 1|Discontinued after randomization|0|||
27973687|NCT01133405|81732770|FG000|Period 1|Received drug only in period 2|0|||
27973688|NCT01133405|81732771|FG001|Period 1|Received drug only in period 2|1|||
27973689|NCT01133405|81732772|FG002|Period 1|Received drug only in period 2|0|||
27973690|NCT01133405|81732773|FG003|Period 1|Received drug only in period 2|2|||
27973691|NCT01133405|81732774|FG004|Period 1|Received drug only in period 2|0|||
27973692|NCT01133405|81732775|FG005|Period 1|Received drug only in period 2|1|||
27973693|NCT01133405|81732776|FG006|Period 1|Received drug only in period 2|0|||
27973694|NCT01133405|81732777|FG007|Period 1|Received drug only in period 2|0|||
27973695|NCT01133405|81732778|FG008|Period 1|Received drug only in period 2|0|||
27973696|NCT01133405|81732779|FG009|Period 1|Received drug only in period 2|0|||
27973697|NCT01133405|81732770|FG000|Period 1|Received drug only in period 3|0|||
27973698|NCT01133405|81732771|FG001|Period 1|Received drug only in period 3|1|||
27973699|NCT01133405|81732772|FG002|Period 1|Received drug only in period 3|1|||
27973700|NCT01133405|81732773|FG003|Period 1|Received drug only in period 3|0|||
27973701|NCT01133405|81732774|FG004|Period 1|Received drug only in period 3|0|||
27786086|NCT01072175|81047284|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786087|NCT01072175|81047285|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786088|NCT01072175|81047286|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786089|NCT01072175|81047287|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786090|NCT01072175|81047288|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786091|NCT01072175|81047289|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786092|NCT01072175|81047290|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
27786093|NCT01072175|81047291|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
27786094|NCT01072175|81047292|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786095|NCT01072175|81047293|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786096|NCT01072175|81047294|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786097|NCT01072175|81047295|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786098|NCT01072175|81047296|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
27786099|NCT01072175|81047284|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786100|NCT01072175|81047285|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786101|NCT01072175|81047286|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786102|NCT01072175|81047287|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786103|NCT01072175|81047288|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786104|NCT01072175|81047289|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
27786105|NCT01072175|81047290|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
27786106|NCT01072175|81047291|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
27786107|NCT01072175|81047292|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786108|NCT01072175|81047293|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27973702|NCT01133405|81732775|FG005|Period 1|Received drug only in period 3|0|||
27973703|NCT01133405|81732776|FG006|Period 1|Received drug only in period 3|0|||
27973704|NCT01133405|81732777|FG007|Period 1|Received drug only in period 3|0|||
27973705|NCT01133405|81732778|FG008|Period 1|Received drug only in period 3|0|||
27973706|NCT01133405|81732779|FG009|Period 1|Received drug only in period 3|0|||
27973707|NCT01133405|81732770|FG000|Period 2|Adverse Event|0|||
27973708|NCT01133405|81732771|FG001|Period 2|Adverse Event|0|||
27973709|NCT01133405|81732772|FG002|Period 2|Adverse Event|1|||
27973710|NCT01133405|81732773|FG003|Period 2|Adverse Event|0|||
27973711|NCT01133405|81732774|FG004|Period 2|Adverse Event|0|||
27973712|NCT01133405|81732775|FG005|Period 2|Adverse Event|0|||
27973713|NCT01133405|81732776|FG006|Period 2|Adverse Event|0|||
27973714|NCT01133405|81732777|FG007|Period 2|Adverse Event|0|||
27973715|NCT01133405|81732778|FG008|Period 2|Adverse Event|0|||
27973716|NCT01133405|81732779|FG009|Period 2|Adverse Event|0|||
27973717|NCT01133405|81732770|FG000|Period 2|Withdrawal by Subject|0|||
27973718|NCT01133405|81732771|FG001|Period 2|Withdrawal by Subject|0|||
27973719|NCT01133405|81732772|FG002|Period 2|Withdrawal by Subject|0|||
27973720|NCT01133405|81732773|FG003|Period 2|Withdrawal by Subject|1|||
27973721|NCT01133405|81732774|FG004|Period 2|Withdrawal by Subject|0|||
27973722|NCT01133405|81732775|FG005|Period 2|Withdrawal by Subject|1|||
27973723|NCT01133405|81732776|FG006|Period 2|Withdrawal by Subject|0|||
27973724|NCT01133405|81732777|FG007|Period 2|Withdrawal by Subject|0|||
27973725|NCT01133405|81732778|FG008|Period 2|Withdrawal by Subject|0|||
27973726|NCT01133405|81732779|FG009|Period 2|Withdrawal by Subject|0|||
27973727|NCT01133405|81732770|FG000|Period 2|Entry Criteria Not Met|0|||
27973728|NCT01133405|81732771|FG001|Period 2|Entry Criteria Not Met|1|||
27973729|NCT01133405|81732772|FG002|Period 2|Entry Criteria Not Met|0|||
27973730|NCT01133405|81732773|FG003|Period 2|Entry Criteria Not Met|0|||
27973731|NCT01133405|81732774|FG004|Period 2|Entry Criteria Not Met|0|||
27973732|NCT01133405|81732775|FG005|Period 2|Entry Criteria Not Met|0|||
27973733|NCT01133405|81732776|FG006|Period 2|Entry Criteria Not Met|0|||
27973734|NCT01133405|81732777|FG007|Period 2|Entry Criteria Not Met|0|||
27973735|NCT01133405|81732778|FG008|Period 2|Entry Criteria Not Met|0|||
27867008|NCT01098474|81346638|FG000|Follow Up Phase|Lost to Follow-up|0|||
27973736|NCT01133405|81732779|FG009|Period 2|Entry Criteria Not Met|0|||
27973737|NCT01133405|81732770|FG000|Period 2|Physician Decision|0|||
27973738|NCT01133405|81732771|FG001|Period 2|Physician Decision|0|||
27973739|NCT01133405|81732772|FG002|Period 2|Physician Decision|0|||
27973740|NCT01133405|81732773|FG003|Period 2|Physician Decision|0|||
27973741|NCT01133405|81732774|FG004|Period 2|Physician Decision|0|||
27973742|NCT01133405|81732775|FG005|Period 2|Physician Decision|1|||
27973743|NCT01133405|81732776|FG006|Period 2|Physician Decision|0|||
27973744|NCT01133405|81732777|FG007|Period 2|Physician Decision|0|||
27973745|NCT01133405|81732778|FG008|Period 2|Physician Decision|0|||
27973746|NCT01133405|81732779|FG009|Period 2|Physician Decision|0|||
27973747|NCT02323204|81732780|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
27973748|NCT02323204|81732781|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
27786109|NCT01072175|81047294|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786110|NCT01072175|81047295|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786111|NCT01072175|81047296|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
27786112|NCT01072175|81047284|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786113|NCT01072175|81047285|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786114|NCT01072175|81047286|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786115|NCT01072175|81047287|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786116|NCT01072175|81047288|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786117|NCT01072175|81047289|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
27786118|NCT01072175|81047290|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
27786119|NCT01072175|81047291|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786120|NCT01072175|81047292|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786121|NCT01072175|81047293|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786122|NCT01072175|81047294|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786123|NCT01072175|81047295|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786124|NCT01072175|81047296|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
27786125|NCT01072175|81047284|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786126|NCT01072175|81047285|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786127|NCT01072175|81047286|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786128|NCT01072175|81047287|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786129|NCT01072175|81047288|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786130|NCT01072175|81047289|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786131|NCT01072175|81047290|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786132|NCT01072175|81047291|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786133|NCT01072175|81047292|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
27786134|NCT01072175|81047293|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786135|NCT01072175|81047294|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786136|NCT01072175|81047295|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786137|NCT01072175|81047296|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
27786138|NCT01072175|81047284|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786139|NCT01072175|81047285|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786140|NCT01072175|81047286|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786141|NCT01072175|81047287|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786142|NCT01072175|81047288|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786143|NCT01072175|81047289|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786144|NCT01072175|81047290|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786145|NCT01072175|81047291|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786146|NCT01072175|81047292|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
27786147|NCT01072175|81047293|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786148|NCT01072175|81047294|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786149|NCT01072175|81047295|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786150|NCT01072175|81047296|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
27786151|NCT01072175|81047284|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786152|NCT01072175|81047285|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786153|NCT01072175|81047286|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786154|NCT01072175|81047287|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786155|NCT01072175|81047288|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786156|NCT01072175|81047289|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786157|NCT01072175|81047290|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786158|NCT01072175|81047291|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786159|NCT01072175|81047292|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
27786160|NCT01072175|81047293|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786161|NCT01072175|81047294|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786162|NCT01072175|81047295|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786163|NCT01072175|81047296|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
27786164|NCT01072175|81047284|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786165|NCT01072175|81047285|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786166|NCT01072175|81047286|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786167|NCT01072175|81047287|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786168|NCT01072175|81047288|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786169|NCT01072175|81047289|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786170|NCT01072175|81047290|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786171|NCT01072175|81047291|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786172|NCT01072175|81047292|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
27786173|NCT01072175|81047293|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786174|NCT01072175|81047294|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786175|NCT01072175|81047295|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786176|NCT01072175|81047296|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
27786177|NCT01072175|81047284|FG000|Part D (HPMC Capsules)|Death|0|||
27786178|NCT01072175|81047285|FG001|Part D (HPMC Capsules)|Death|0|||
27786179|NCT01072175|81047286|FG002|Part D (HPMC Capsules)|Death|0|||
27786180|NCT01072175|81047287|FG003|Part D (HPMC Capsules)|Death|0|||
27786181|NCT01072175|81047288|FG004|Part D (HPMC Capsules)|Death|0|||
27786182|NCT01072175|81047289|FG005|Part D (HPMC Capsules)|Death|0|||
27786183|NCT01072175|81047290|FG006|Part D (HPMC Capsules)|Death|0|||
27786184|NCT01072175|81047291|FG007|Part D (HPMC Capsules)|Death|0|||
27786185|NCT01072175|81047292|FG008|Part D (HPMC Capsules)|Death|0|||
27786186|NCT01072175|81047293|FG009|Part D (HPMC Capsules)|Death|10|||
27786187|NCT01072175|81047294|FG010|Part D (HPMC Capsules)|Death|12|||
27786188|NCT01072175|81047295|FG011|Part D (HPMC Capsules)|Death|28|||
27786189|NCT01072175|81047296|FG012|Part D (HPMC Capsules)|Death|26|||
27786190|NCT01072175|81047284|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
27786191|NCT01072175|81047285|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
27786192|NCT01072175|81047286|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
27786193|NCT01072175|81047287|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
27786194|NCT01072175|81047288|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
27786195|NCT01072175|81047289|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
27786196|NCT01072175|81047290|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
27786197|NCT01072175|81047291|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
27786198|NCT01072175|81047292|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
27786199|NCT01072175|81047293|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
27786200|NCT01072175|81047294|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
27786201|NCT01072175|81047295|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
27786202|NCT01072175|81047296|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
27786203|NCT01072175|81047284|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786204|NCT01072175|81047285|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786205|NCT01072175|81047286|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786206|NCT01072175|81047287|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786207|NCT01072175|81047288|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786208|NCT01072175|81047289|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786209|NCT01072175|81047290|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786210|NCT01072175|81047291|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786211|NCT01072175|81047292|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786212|NCT01072175|81047293|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
27786213|NCT01072175|81047294|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
27786214|NCT01072175|81047295|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
27786215|NCT01072175|81047296|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
27786216|NCT01072175|81047284|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786217|NCT01072175|81047285|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786218|NCT01072175|81047286|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786219|NCT01072175|81047287|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786220|NCT01072175|81047288|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786221|NCT01072175|81047289|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786222|NCT01072175|81047290|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786223|NCT01072175|81047291|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786224|NCT01072175|81047292|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
27786225|NCT01072175|81047293|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
27786226|NCT01072175|81047294|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
27786227|NCT01072175|81047295|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
27786228|NCT01072175|81047296|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
27786229|NCT01072175|81047284|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786230|NCT01072175|81047285|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786231|NCT01072175|81047286|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786232|NCT01072175|81047287|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786233|NCT01072175|81047288|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786234|NCT01072175|81047289|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786235|NCT01072175|81047290|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786236|NCT01072175|81047291|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786237|NCT01072175|81047292|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786238|NCT01072175|81047293|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786239|NCT01072175|81047294|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
27786240|NCT01072175|81047295|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
27786241|NCT01072175|81047296|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
27786242|NCT02463097|81047297|FG000|Overall Study|Withdrawal by Subject|1|||
27786243|NCT00911508|81047298|FG000|Overall Study|Lost to Follow-up|27|||
27786244|NCT00911508|81047299|FG001|Overall Study|Lost to Follow-up|18|||
27786245|NCT00911508|81047298|FG000|Overall Study|Withdrawal by Subject|79|||
27867009|NCT01098474|81346639|FG001|Follow Up Phase|Lost to Follow-up|0|||
27786246|NCT00911508|81047299|FG001|Overall Study|Withdrawal by Subject|112|||
27786247|NCT03172026|81047300|FG000|Overall Study|Withdrawal by Subject|1|||
27786248|NCT03172026|81047301|FG001|Overall Study|Withdrawal by Subject|0|||
27786249|NCT03172026|81047300|FG000|Overall Study|COVID restrictions|1|||
27786250|NCT03172026|81047301|FG001|Overall Study|COVID restrictions|0|||
27786251|NCT03487549|81047302|FG000|Overall Study|Protocol Violation|0|||
27786252|NCT03487549|81047303|FG001|Overall Study|Protocol Violation|1|||
27786253|NCT03487549|81047302|FG000|Overall Study|Lost to Follow-up|2|||
27786254|NCT03487549|81047303|FG001|Overall Study|Lost to Follow-up|1|||
27786255|NCT03487549|81047302|FG000|Overall Study|Withdrawal by Subject|2|||
27786256|NCT03487549|81047303|FG001|Overall Study|Withdrawal by Subject|0|||
27786257|NCT01370499|81047304|FG000|Overall Study|Adverse Event|38|||
27786258|NCT01370499|81047305|FG001|Overall Study|Adverse Event|12|||
27786259|NCT01370499|81047304|FG000|Overall Study|Lack of Efficacy|4|||
27786260|NCT01370499|81047305|FG001|Overall Study|Lack of Efficacy|2|||
27786261|NCT01370499|81047304|FG000|Overall Study|Lost to Follow-up|2|||
27786262|NCT01370499|81047305|FG001|Overall Study|Lost to Follow-up|1|||
27786263|NCT01370499|81047304|FG000|Overall Study|Physician Decision|3|||
27786264|NCT01370499|81047305|FG001|Overall Study|Physician Decision|3|||
27786265|NCT01370499|81047304|FG000|Overall Study|Protocol Violation|5|||
27786266|NCT01370499|81047305|FG001|Overall Study|Protocol Violation|4|||
27786267|NCT01370499|81047304|FG000|Overall Study|Withdrawal by Subject|18|||
27786268|NCT01370499|81047305|FG001|Overall Study|Withdrawal by Subject|7|||
27786269|NCT01370499|81047304|FG000|Overall Study|Sponsor Decision|41|||
27786270|NCT01370499|81047305|FG001|Overall Study|Sponsor Decision|15|||
27786271|NCT02198040|81047308|FG000|Overall Study|Work reasons|0|||
27786272|NCT02198040|81047309|FG001|Overall Study|Work reasons|1|||
27786273|NCT02198040|81047310|FG002|Overall Study|Work reasons|0|||
27786274|NCT02198040|81047308|FG000|Overall Study|Withdrawal by Subject|0|||
27786275|NCT02198040|81047309|FG001|Overall Study|Withdrawal by Subject|0|||
27786276|NCT02198040|81047310|FG002|Overall Study|Withdrawal by Subject|1|||
27786277|NCT02930889|81047313|FG000|Overall Study|Lost to Follow-up|2|||
27786278|NCT02930889|81047313|FG000|Overall Study|Withdrawal by Subject|6|||
27786279|NCT02930889|81047313|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
27786280|NCT01365182|81047314|FG000|Overall Study|Withdrawal by Subject|10|||
27786281|NCT01365182|81047315|FG001|Overall Study|Withdrawal by Subject|13|||
27786282|NCT01365182|81047316|FG002|Overall Study|Withdrawal by Subject|12|||
27786283|NCT03287960|81047317|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
27786284|NCT03287960|81047317|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
27786285|NCT01005966|81047320|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27786286|NCT01005966|81047321|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786287|NCT01005966|81047322|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786288|NCT01005966|81047323|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786289|NCT01005966|81047324|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
27786290|NCT01005966|81047320|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27786291|NCT01005966|81047321|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
27786292|NCT01005966|81047322|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
27786293|NCT01005966|81047323|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
27786294|NCT01005966|81047324|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
27786295|NCT01005966|81047320|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27786296|NCT01005966|81047321|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27786297|NCT01005966|81047322|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27786298|NCT01005966|81047323|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
27786299|NCT01005966|81047324|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
27786300|NCT01005966|81047320|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786301|NCT01005966|81047321|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
27786302|NCT01005966|81047322|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
27786303|NCT01005966|81047323|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786304|NCT01005966|81047324|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
27786305|NCT01005966|81047320|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786306|NCT01005966|81047321|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786307|NCT01005966|81047322|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786308|NCT01005966|81047323|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27973749|NCT02323204|81732782|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
27973750|NCT02323204|81732783|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
27786309|NCT01005966|81047324|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27786310|NCT01005966|81047320|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27867010|NCT01098474|81346640|FG002|Follow Up Phase|Lost to Follow-up|0|||
27867011|NCT01098474|81346641|FG003|Follow Up Phase|Lost to Follow-up|0|||
27973751|NCT02323204|81732780|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
27786311|NCT01005966|81047321|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27786312|NCT01005966|81047322|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27786313|NCT01005966|81047323|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27867012|NCT01098474|81346642|FG004|Follow Up Phase|Lost to Follow-up|1|||
27786314|NCT01005966|81047324|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27786315|NCT01005966|81047320|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
27786316|NCT01005966|81047321|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
27786317|NCT01005966|81047322|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
27786318|NCT01005966|81047323|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
27786319|NCT01005966|81047324|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
27786320|NCT01005966|81047320|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27786321|NCT01005966|81047321|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
27786322|NCT01005966|81047322|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27786323|NCT01005966|81047323|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27786324|NCT01005966|81047324|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
27786325|NCT01005966|81047320|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
27786326|NCT01005966|81047321|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
27786327|NCT01005966|81047322|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
27786328|NCT01005966|81047323|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
27786329|NCT01005966|81047324|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
27786330|NCT00135694|81047325|FG000|Overall Study|Adverse Event|17|||
27786331|NCT00135694|81047326|FG001|Overall Study|Adverse Event|4|||
27786332|NCT00135694|81047327|FG002|Overall Study|Adverse Event|0|||
27786333|NCT00135694|81047325|FG000|Overall Study|Death|14|||
27786334|NCT00135694|81047326|FG001|Overall Study|Death|1|||
27786335|NCT00135694|81047327|FG002|Overall Study|Death|2|||
27786336|NCT00135694|81047325|FG000|Overall Study|Lost to Follow-up|8|||
27786337|NCT00135694|81047326|FG001|Overall Study|Lost to Follow-up|7|||
27786338|NCT00135694|81047327|FG002|Overall Study|Lost to Follow-up|1|||
27786339|NCT00135694|81047325|FG000|Overall Study|Withdrawal by Subject|41|||
27786340|NCT00135694|81047326|FG001|Overall Study|Withdrawal by Subject|7|||
27786341|NCT00135694|81047327|FG002|Overall Study|Withdrawal by Subject|4|||
27786342|NCT00135694|81047325|FG000|Overall Study|Protocol Violation|19|||
27786343|NCT00135694|81047326|FG001|Overall Study|Protocol Violation|1|||
27786344|NCT00135694|81047327|FG002|Overall Study|Protocol Violation|0|||
27786345|NCT00135694|81047325|FG000|Overall Study|Hepatitis C related reasons|39|||
27786346|NCT00135694|81047326|FG001|Overall Study|Hepatitis C related reasons|1|||
27786347|NCT00135694|81047327|FG002|Overall Study|Hepatitis C related reasons|0|||
27786348|NCT00135694|81047325|FG000|Overall Study|Ineligible for Random assignment|42|||
27786349|NCT00135694|81047326|FG001|Overall Study|Ineligible for Random assignment|0|||
27786350|NCT00135694|81047327|FG002|Overall Study|Ineligible for Random assignment|0|||
27786351|NCT02039687|81047329|FG000|Overall Study|Adverse Event|0|||
27786352|NCT02039687|81047330|FG001|Overall Study|Adverse Event|0|||
27786353|NCT02039687|81047331|FG002|Overall Study|Adverse Event|1|||
27786354|NCT02039687|81047332|FG003|Overall Study|Adverse Event|0|||
27786355|NCT02039687|81047329|FG000|Overall Study|Withdrawal by Subject|0|||
27786356|NCT02039687|81047330|FG001|Overall Study|Withdrawal by Subject|1|||
27786357|NCT02039687|81047331|FG002|Overall Study|Withdrawal by Subject|0|||
27786358|NCT02039687|81047332|FG003|Overall Study|Withdrawal by Subject|0|||
27786359|NCT02039687|81047329|FG000|Overall Study|treatment assignment could not be confir|0|||
27786360|NCT02039687|81047330|FG001|Overall Study|treatment assignment could not be confir|0|||
27786361|NCT02039687|81047331|FG002|Overall Study|treatment assignment could not be confir|2|||
27786362|NCT02039687|81047332|FG003|Overall Study|treatment assignment could not be confir|0|||
27786363|NCT04246996|81047333|FG000|Overall Study|Physician Decision|1|||
27786364|NCT04246996|81047334|FG001|Overall Study|Physician Decision|1|||
27786365|NCT04246996|81047333|FG000|Overall Study|Did not meet eligibility criteria|1|||
27786366|NCT04246996|81047334|FG001|Overall Study|Did not meet eligibility criteria|4|||
27786367|NCT01856920|81047335|FG000|Overall Study|Disease Progression On Study|3|||
27786368|NCT01856920|81047336|FG001|Overall Study|Disease Progression On Study|4|||
27786369|NCT01856920|81047335|FG000|Overall Study|Disease Progression before Treatment|1|||
27786370|NCT01856920|81047336|FG001|Overall Study|Disease Progression before Treatment|0|||
27786371|NCT01856920|81047335|FG000|Overall Study|Ineligible|0|||
27786372|NCT01856920|81047336|FG001|Overall Study|Ineligible|1|||
27786373|NCT01856920|81047335|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
27786374|NCT01856920|81047336|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
27786375|NCT01856920|81047335|FG000|Overall Study|Refused further Treatment|5|||
27786376|NCT01856920|81047336|FG001|Overall Study|Refused further Treatment|1|||
27786377|NCT01856920|81047335|FG000|Overall Study|Other Reasons|0|||
27786378|NCT01856920|81047336|FG001|Overall Study|Other Reasons|1|||
27786379|NCT01856920|81047335|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
27786380|NCT01856920|81047336|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
27786381|NCT01101321|81047337|FG000|Period 1|Withdrawal by Subject|1|||
27786382|NCT01101321|81047338|FG001|Period 1|Withdrawal by Subject|1|||
27786383|NCT01101321|81047337|FG000|Period 1|Adverse Event|3|||
27786384|NCT01101321|81047338|FG001|Period 1|Adverse Event|3|||
27786385|NCT01640353|81047339|FG000|Overall Study|Withdrew prior to treatment|10|||
27786386|NCT01640353|81047339|FG000|Overall Study|Withdrawn from analysis at term site|12|||
27786387|NCT01640353|81047339|FG000|Overall Study|Withdrawal by Subject|5|||
27786388|NCT01640353|81047339|FG000|Overall Study|Death|2|||
27786389|NCT01640353|81047339|FG000|Overall Study|Early site termination|3|||
27786390|NCT01640353|81047339|FG000|Overall Study|Lost to Follow-up|12|||
27786391|NCT01640353|81047339|FG000|Overall Study|Physician Decision|1|||
27786392|NCT00285857|81047341|FG000|Overall Study|Withdrawal by Subject|2|||
27786393|NCT00285857|81047341|FG000|Overall Study|Inadequate initial breast cytology|1|||
27786394|NCT00285857|81047341|FG000|Overall Study|Adverse Event|1|||
27786395|NCT02335411|81047342|FG000|Overall Study|Death|223|||
27786396|NCT02335411|81047343|FG001|Overall Study|Death|22|||
27786397|NCT02335411|81047344|FG002|Overall Study|Death|26|||
27786398|NCT02335411|81047342|FG000|Overall Study|Physician Decision|3|||
27786399|NCT02335411|81047343|FG001|Overall Study|Physician Decision|0|||
27786400|NCT02335411|81047344|FG002|Overall Study|Physician Decision|0|||
27786401|NCT02335411|81047342|FG000|Overall Study|Protocol Violation|1|||
27786402|NCT02335411|81047343|FG001|Overall Study|Protocol Violation|0|||
27786403|NCT02335411|81047344|FG002|Overall Study|Protocol Violation|0|||
27786404|NCT02335411|81047342|FG000|Overall Study|Withdrawal by Subject|11|||
27786405|NCT02335411|81047343|FG001|Overall Study|Withdrawal by Subject|0|||
27786406|NCT02335411|81047344|FG002|Overall Study|Withdrawal by Subject|3|||
27786407|NCT02335411|81047342|FG000|Overall Study|Sponsor Decision|12|||
27786408|NCT02335411|81047343|FG001|Overall Study|Sponsor Decision|3|||
27786409|NCT02335411|81047344|FG002|Overall Study|Sponsor Decision|2|||
27786410|NCT02335411|81047342|FG000|Overall Study|Adverse Event|9|||
27786411|NCT02335411|81047343|FG001|Overall Study|Adverse Event|0|||
27786412|NCT02335411|81047344|FG002|Overall Study|Adverse Event|0|||
27786413|NCT00121485|81047345|FG000|Overall Study|Not implanted|1|||
27786414|NCT00121485|81047346|FG001|Overall Study|Not implanted|5|||
27786415|NCT00121485|81047345|FG000|Overall Study|Crossover|0|||
27786416|NCT00121485|81047346|FG001|Overall Study|Crossover|2|||
27786417|NCT03380091|81047347|FG000|Overall Study|Withdrawal by Subject|2|||
27786418|NCT03380091|81047348|FG001|Overall Study|Withdrawal by Subject|1|||
27786419|NCT03759340|81047354|FG000|Overall Study|Adverse Event|2|||
27786420|NCT03759340|81047354|FG000|Overall Study|Lost to Follow-up|1|||
27786421|NCT03759340|81047354|FG000|Overall Study|Withdrawal by Subject|15|||
27786422|NCT03759340|81047354|FG000|Overall Study|Study Terminated by Sponsor|38|||
27786423|NCT00883896|81047355|FG000|Overall Study|Lost to Follow-up|0|||
27973752|NCT02323204|81732781|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
27973753|NCT02323204|81732782|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
27786424|NCT00883896|81047356|FG001|Overall Study|Lost to Follow-up|0|||
27786425|NCT00883896|81047357|FG002|Overall Study|Lost to Follow-up|0|||
27786426|NCT00883896|81047358|FG003|Overall Study|Lost to Follow-up|2|||
27786427|NCT00883896|81047355|FG000|Overall Study|Withdrawal by Subject|5|||
27786428|NCT00883896|81047356|FG001|Overall Study|Withdrawal by Subject|0|||
27786429|NCT00883896|81047357|FG002|Overall Study|Withdrawal by Subject|1|||
27786430|NCT00883896|81047358|FG003|Overall Study|Withdrawal by Subject|3|||
27786431|NCT00883896|81047355|FG000|Overall Study|Lack of Efficacy|0|||
27786432|NCT00883896|81047356|FG001|Overall Study|Lack of Efficacy|0|||
27786433|NCT00883896|81047357|FG002|Overall Study|Lack of Efficacy|0|||
27786434|NCT00883896|81047358|FG003|Overall Study|Lack of Efficacy|2|||
27786435|NCT00883896|81047355|FG000|Overall Study|Other|1|||
27786436|NCT00883896|81047356|FG001|Overall Study|Other|0|||
27786437|NCT00883896|81047357|FG002|Overall Study|Other|0|||
27786438|NCT00883896|81047358|FG003|Overall Study|Other|0|||
27786439|NCT01277757|81047359|FG000|Overall Study|Disease Progression|1|||
27786440|NCT01277757|81047359|FG000|Overall Study|Withdrawal by Subject|1|||
27786441|NCT02985541|81047360|FG000|Overall Study|Withdrawal by Subject|33|||
27786442|NCT02985541|81047360|FG000|Overall Study|Lost to Follow-up|26|||
27786443|NCT02985541|81047360|FG000|Overall Study|Adverse Event|27|||
27786444|NCT02985541|81047360|FG000|Overall Study|Physician Decision|2|||
27786445|NCT02985541|81047360|FG000|Overall Study|Pregnancy|2|||
27786446|NCT02985541|81047360|FG000|Overall Study|Wish for pregnancy|44|||
27973754|NCT02323204|81732783|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
27786447|NCT02985541|81047360|FG000|Overall Study|Other reason|5|||
27786448|NCT02985541|81047360|FG000|Overall Study|Not valid for analysis|2|||
27786449|NCT01955005|81047365|FG000|Overall Study|Withdrawal by Subject|3|||
27786450|NCT01955005|81047366|FG001|Overall Study|Withdrawal by Subject|5|||
27786451|NCT01710709|81047367|FG000|Overall Study|Lost to Follow-up|29|||
27786452|NCT01710709|81047367|FG000|Overall Study|Adverse Event|48|||
27786453|NCT01710709|81047367|FG000|Overall Study|Participant met withdrawal criteria|33|||
27786454|NCT01710709|81047367|FG000|Overall Study|Participant withdrawn by investigator|2|||
27786455|NCT01710709|81047367|FG000|Overall Study|Withdrawal by Subject|53|||
27786456|NCT01710709|81047367|FG000|Overall Study|Protocol Violation|5|||
27786457|NCT01710709|81047367|FG000|Overall Study|Lack of Efficacy|3|||
27786458|NCT03802331|81047368|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
27786459|NCT03802331|81047369|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
27786460|NCT00545584|81047370|FG000|Overall Study|Only one reason for discontinuation|62|||
27786461|NCT00545584|81047371|FG001|Overall Study|Only one reason for discontinuation|61|||
27786462|NCT00545584|81047372|FG002|Overall Study|Only one reason for discontinuation|48|||
27973755|NCT02323204|81732780|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
27973756|NCT02323204|81732781|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
27786463|NCT00545584|81047370|FG000|Overall Study|Two or more reasons for discontinuation|17|||
27786464|NCT00545584|81047371|FG001|Overall Study|Two or more reasons for discontinuation|19|||
27786465|NCT00545584|81047372|FG002|Overall Study|Two or more reasons for discontinuation|8|||
27786466|NCT02033369|81047373|FG000|Overall Study|Physician Decision|1|||
27786467|NCT02033369|81047374|FG001|Overall Study|Physician Decision|2|||
27786468|NCT02033369|81047373|FG000|Overall Study|Not a good demographic match|0|||
27786469|NCT02033369|81047374|FG001|Overall Study|Not a good demographic match|2|||
27786470|NCT02033369|81047373|FG000|Overall Study|Withdrawal by Subject|1|||
27786471|NCT02033369|81047374|FG001|Overall Study|Withdrawal by Subject|1|||
27786472|NCT02033369|81047373|FG000|Overall Study|Lost to Follow-up|1|||
27786473|NCT02033369|81047374|FG001|Overall Study|Lost to Follow-up|0|||
27786474|NCT02033369|81047373|FG000|Overall Study|Protocol Violation|2|||
27786475|NCT02033369|81047374|FG001|Overall Study|Protocol Violation|0|||
27786476|NCT01083121|81047375|FG000|Overall Study|Use of Humira outside the approved label|81|||
27786477|NCT00461552|81047378|FG000|Overall Study|Drug Dispensing error|0|||
27786478|NCT00461552|81047379|FG001|Overall Study|Drug Dispensing error|2|||
27786479|NCT01224171|81047380|FG000|Overall Study|Adverse Event|8|||
27786480|NCT01224171|81047381|FG001|Overall Study|Adverse Event|4|||
27786481|NCT01224171|81047380|FG000|Overall Study|Protocol Violation|0|||
27786482|NCT01224171|81047381|FG001|Overall Study|Protocol Violation|1|||
27786483|NCT01224171|81047380|FG000|Overall Study|Lack of Efficacy|5|||
27786484|NCT01224171|81047381|FG001|Overall Study|Lack of Efficacy|1|||
27786485|NCT01224171|81047380|FG000|Overall Study|Withdrawal of Consent|2|||
27786486|NCT01224171|81047381|FG001|Overall Study|Withdrawal of Consent|4|||
27786487|NCT01224171|81047380|FG000|Overall Study|Lost to Follow-up|0|||
27786488|NCT01224171|81047381|FG001|Overall Study|Lost to Follow-up|3|||
27786489|NCT02756182|81047384|FG000|Overall Study|StudyTechnical Difficulties|4|||
27786490|NCT02569996|81047389|FG000|Overall Study|Adverse Event|6|||
27786491|NCT02569996|81047389|FG000|Overall Study|Physician Decision|3|||
27786492|NCT02569996|81047389|FG000|Overall Study|Progression of the disease|18|||
27786493|NCT02569996|81047389|FG000|Overall Study|New anti-lymphoma treatment|1|||
27786494|NCT02569996|81047389|FG000|Overall Study|Non-compliance|9|||
27786495|NCT02569996|81047389|FG000|Overall Study|Withdrawal by Subject|5|||
27786496|NCT02569996|81047389|FG000|Overall Study|Lost to Follow-up|5|||
27786497|NCT02569996|81047389|FG000|Overall Study|Complete remission|7|||
27786498|NCT02569996|81047389|FG000|Overall Study|Unknown reason|1|||
27786499|NCT00374452|81047391|FG000|Overall Study|Left clinic before intervention started|4|||
27786500|NCT00374452|81047392|FG001|Overall Study|Left clinic before intervention started|1|||
27786501|NCT00374452|81047391|FG000|Overall Study|Change in job role before intervention|0|||
27786502|NCT00374452|81047392|FG001|Overall Study|Change in job role before intervention|1|||
27786503|NCT00374452|81047391|FG000|Overall Study|Left clinic after intervention started|1|||
27786504|NCT00374452|81047392|FG001|Overall Study|Left clinic after intervention started|1|||
27786505|NCT00374452|81047391|FG000|Overall Study|Withdrawal by Subject|0|||
27786506|NCT00374452|81047392|FG001|Overall Study|Withdrawal by Subject|2|||
27786507|NCT01287403|81047393|FG000|1st Intervention (1 Day)|Adverse Event|1|||
27867013|NCT01098474|81346643|FG005|Follow Up Phase|Lost to Follow-up|0|||
27867014|NCT02289456|81346650|FG000|Induction Period|Death|2|||
27867015|NCT02289456|81346650|FG000|Induction Period|Adverse Event|11|||
27867016|NCT02289456|81346650|FG000|Induction Period|Progressive Disease (PD)|4|||
27867017|NCT02289456|81346650|FG000|Induction Period|Symptomatic Deterioration|4|||
27867018|NCT02289456|81346650|FG000|Induction Period|Withdrawal by Subject|2|||
27867019|NCT02289456|81346650|FG000|Induction Period|Miscellaneous|1|||
27867020|NCT02289456|81346650|FG000|Monotherapy Period|Death|1|||
27867021|NCT02289456|81346650|FG000|Monotherapy Period|Adverse Event|1|||
27867022|NCT02289456|81346650|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
27867023|NCT02289456|81346650|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
27867024|NCT02289456|81346650|FG000|Monotherapy Period|Withdrawal by Subject|2|||
27867025|NCT02289456|81346650|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
27867026|NCT02289456|81346650|FG000|Monotherapy Period|Miscellaneous|1|||
27867027|NCT03629184|81346651|FG000|Overall Study|Withdrawal by Subject|2|||
27867028|NCT03629184|81346652|FG001|Overall Study|Withdrawal by Subject|1|||
27973757|NCT02323204|81732782|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
27786508|NCT02506101|81047394|FG000|Overall Study|Transportation issues|1|||
27786509|NCT02506101|81047395|FG001|Overall Study|Transportation issues|0|||
27786510|NCT02506101|81047394|FG000|Overall Study|No enrollment and staff unavailability|1|||
27786511|NCT02506101|81047395|FG001|Overall Study|No enrollment and staff unavailability|0|||
27786512|NCT02546193|81047396|FG000|Overall Study|Withdrawal by Subject|2|||
27786513|NCT02546193|81047397|FG001|Overall Study|Withdrawal by Subject|0|||
27867029|NCT03629184|81346651|FG000|Overall Study|Physician Decision|1|||
27786514|NCT02546193|81047398|FG002|Overall Study|Withdrawal by Subject|1|||
27786515|NCT02546193|81047399|FG003|Overall Study|Withdrawal by Subject|0|||
27867030|NCT03629184|81346652|FG001|Overall Study|Physician Decision|0|||
27867031|NCT00425373|81346653|FG000|Overall Study|Adverse Event|2|||
27867032|NCT00425373|81346654|FG001|Overall Study|Adverse Event|2|||
27867033|NCT00425373|81346655|FG002|Overall Study|Adverse Event|0|||
27867034|NCT00425373|81346656|FG003|Overall Study|Adverse Event|1|||
27867035|NCT00425373|81346657|FG004|Overall Study|Adverse Event|4|||
27867036|NCT00425373|81346658|FG005|Overall Study|Adverse Event|6|||
27867037|NCT00425373|81346659|FG006|Overall Study|Adverse Event|2|||
27867038|NCT00425373|81346660|FG007|Overall Study|Adverse Event|3|||
27867039|NCT00425373|81346661|FG008|Overall Study|Adverse Event|8|||
27867040|NCT00425373|81346653|FG000|Overall Study|Lost to Follow-up|0|||
27867041|NCT00425373|81346654|FG001|Overall Study|Lost to Follow-up|1|||
27867042|NCT00425373|81346655|FG002|Overall Study|Lost to Follow-up|0|||
27867043|NCT00425373|81346656|FG003|Overall Study|Lost to Follow-up|0|||
27867044|NCT00425373|81346657|FG004|Overall Study|Lost to Follow-up|1|||
27867045|NCT00425373|81346658|FG005|Overall Study|Lost to Follow-up|0|||
27867046|NCT00425373|81346659|FG006|Overall Study|Lost to Follow-up|0|||
27867047|NCT00425373|81346660|FG007|Overall Study|Lost to Follow-up|0|||
27867048|NCT00425373|81346661|FG008|Overall Study|Lost to Follow-up|0|||
27867049|NCT00425373|81346653|FG000|Overall Study|Protocol Violation|1|||
27867050|NCT00425373|81346654|FG001|Overall Study|Protocol Violation|0|||
27867051|NCT00425373|81346655|FG002|Overall Study|Protocol Violation|1|||
27867052|NCT00425373|81346656|FG003|Overall Study|Protocol Violation|0|||
27867053|NCT00425373|81346657|FG004|Overall Study|Protocol Violation|0|||
27867054|NCT00425373|81346658|FG005|Overall Study|Protocol Violation|0|||
27867055|NCT00425373|81346659|FG006|Overall Study|Protocol Violation|0|||
27867056|NCT00425373|81346660|FG007|Overall Study|Protocol Violation|5|||
27867057|NCT00425373|81346661|FG008|Overall Study|Protocol Violation|3|||
27867058|NCT00425373|81346653|FG000|Overall Study|Withdrawal by Subject|2|||
27867059|NCT00425373|81346654|FG001|Overall Study|Withdrawal by Subject|0|||
27867060|NCT00425373|81346655|FG002|Overall Study|Withdrawal by Subject|2|||
27867061|NCT00425373|81346656|FG003|Overall Study|Withdrawal by Subject|1|||
27867062|NCT00425373|81346657|FG004|Overall Study|Withdrawal by Subject|4|||
27867063|NCT00425373|81346658|FG005|Overall Study|Withdrawal by Subject|0|||
27867064|NCT00425373|81346659|FG006|Overall Study|Withdrawal by Subject|2|||
27867065|NCT00425373|81346660|FG007|Overall Study|Withdrawal by Subject|2|||
27867066|NCT00425373|81346661|FG008|Overall Study|Withdrawal by Subject|2|||
27867067|NCT00425373|81346653|FG000|Overall Study|Lack of Efficacy|0|||
27867068|NCT00425373|81346654|FG001|Overall Study|Lack of Efficacy|0|||
27867069|NCT00425373|81346655|FG002|Overall Study|Lack of Efficacy|0|||
27867070|NCT00425373|81346656|FG003|Overall Study|Lack of Efficacy|0|||
27867071|NCT00425373|81346657|FG004|Overall Study|Lack of Efficacy|1|||
27867072|NCT00425373|81346658|FG005|Overall Study|Lack of Efficacy|3|||
27867073|NCT00425373|81346659|FG006|Overall Study|Lack of Efficacy|3|||
27867074|NCT00425373|81346660|FG007|Overall Study|Lack of Efficacy|0|||
27867075|NCT00425373|81346661|FG008|Overall Study|Lack of Efficacy|5|||
27867076|NCT00461253|81346662|FG000|Overall Study|Death|985|||
27867077|NCT00461253|81346663|FG001|Overall Study|Death|0|||
27867078|NCT00461253|81346662|FG000|Overall Study|Protocol Violation|613|||
27867079|NCT00461253|81346663|FG001|Overall Study|Protocol Violation|236|||
27867080|NCT00461253|81346662|FG000|Overall Study|no response|2609|||
27867081|NCT00461253|81346663|FG001|Overall Study|no response|11789|||
27867082|NCT00461253|81346662|FG000|Overall Study|administrative|773|||
27867083|NCT00461253|81346663|FG001|Overall Study|administrative|7773|||
27867084|NCT01973595|81346664|FG000|Washout|Withdrawal by Subject|1|||
27867085|NCT01973595|81346665|FG001|Washout|Withdrawal by Subject|0|||
27867086|NCT01973595|81346666|FG002|Washout|Withdrawal by Subject|1|||
27867087|NCT01973595|81346667|FG003|Washout|Withdrawal by Subject|0|||
27867088|NCT02463357|81346668|FG000|Overall Study|Withdrawal by Subject|1|||
27867089|NCT02463357|81346669|FG001|Overall Study|Withdrawal by Subject|0|||
27867090|NCT02463357|81346670|FG002|Overall Study|Withdrawal by Subject|0|||
27867091|NCT02463357|81346671|FG003|Overall Study|Withdrawal by Subject|0|||
27867092|NCT02463357|81346672|FG004|Overall Study|Withdrawal by Subject|0|||
27573239|NCT00355238|80285568|FG002|Overall Study|Participant request to discontinue study treatment|1|||
27573240|NCT00355238|80285569|FG003|Overall Study|Participant request to discontinue study treatment|0|||
27573241|NCT02932891|80285570|FG000|Overall Study|Lost to Follow-up|2|||
27573242|NCT02932891|80285570|FG000|Overall Study|HPA Suppress|2|||
27573243|NCT04545515|80285571|FG000|Overall Study|Adverse Event|1|||
27573244|NCT04545515|80285571|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
27573245|NCT04545515|80285571|FG000|Overall Study|Commercial drug is available for participant|7|||
27573246|NCT04144166|80285573|FG000|Overall Study|Discharged before study start|1|||
27573247|NCT04144166|80285573|FG000|Overall Study|Pregnancy|1|||
27867093|NCT02463357|81346668|FG000|Overall Study|Withdrawal by Subject|0|||
27867094|NCT02463357|81346669|FG001|Overall Study|Withdrawal by Subject|0|||
27867095|NCT02463357|81346670|FG002|Overall Study|Withdrawal by Subject|0|||
27867096|NCT02463357|81346671|FG003|Overall Study|Withdrawal by Subject|0|||
27867097|NCT02463357|81346672|FG004|Overall Study|Withdrawal by Subject|1|||
27867098|NCT00761657|81346676|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
27573248|NCT04144166|80285573|FG000|Overall Study|Nail polish could not be removed from finger|1|||
27573249|NCT00261716|80285574|FG000|Overall Study|Withdrawal by Subject|6|||
27573250|NCT00261716|80285575|FG001|Overall Study|Withdrawal by Subject|8|||
27573251|NCT00261716|80285574|FG000|Overall Study|Lost to Follow-up|0|||
27573252|NCT00261716|80285575|FG001|Overall Study|Lost to Follow-up|2|||
27573253|NCT03228680|80285576|FG000|Overall Study|Adverse Event|13|||
27573254|NCT03228680|80285577|FG001|Overall Study|Adverse Event|18|||
27573255|NCT03228680|80285576|FG000|Overall Study|Randomization failure|0|||
27573256|NCT03228680|80285577|FG001|Overall Study|Randomization failure|1|||
27573257|NCT03228680|80285576|FG000|Overall Study|Withdrawal by Subject|1|||
27573258|NCT03228680|80285577|FG001|Overall Study|Withdrawal by Subject|0|||
27573259|NCT03228680|80285576|FG000|Overall Study|Other|9|||
27573260|NCT03228680|80285577|FG001|Overall Study|Other|16|||
27573261|NCT02203591|80285580|FG000|Overall Study|Did not meet treatment day baseline|147|||
27573262|NCT02203591|80285581|FG001|Overall Study|Did not meet treatment day baseline|141|||
27573263|NCT02203591|80285582|FG002|Overall Study|Did not meet treatment day baseline|150|||
27786516|NCT02546193|81047396|FG000|Overall Study|Not eligible at time of induction|4|||
27786517|NCT02546193|81047397|FG001|Overall Study|Not eligible at time of induction|6|||
27786518|NCT02546193|81047398|FG002|Overall Study|Not eligible at time of induction|1|||
27786519|NCT02546193|81047399|FG003|Overall Study|Not eligible at time of induction|0|||
27867099|NCT00761657|81346677|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
27867100|NCT00761657|81346678|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
27867101|NCT00761657|81346679|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
27867102|NCT00761657|81346680|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
27867103|NCT00761657|81346681|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
27867104|NCT00761657|81346682|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
27867105|NCT00761657|81346683|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
27786520|NCT01349816|81047405|FG000|Overall Study|Withdrawal by Subject|4|||
27786521|NCT01349816|81047405|FG000|Overall Study|Physician Decision|1|||
27786522|NCT01349816|81047405|FG000|Overall Study|Adverse Event|14|||
27786523|NCT01349816|81047405|FG000|Overall Study|Lost to Follow-up|2|||
27786524|NCT01349816|81047405|FG000|Overall Study|Protocol Violation|1|||
27786525|NCT01349816|81047405|FG000|Overall Study|Protocol-specified criteria|8|||
27786526|NCT02569398|81047406|FG000|Overall Study|Adverse Event|0|||
27786527|NCT02569398|81047407|FG001|Overall Study|Adverse Event|1|||
27786528|NCT02569398|81047408|FG002|Overall Study|Adverse Event|6|||
27786529|NCT02569398|81047406|FG000|Overall Study|Withdrawal by Subject|43|||
27786530|NCT02569398|81047407|FG001|Overall Study|Withdrawal by Subject|43|||
27786531|NCT02569398|81047408|FG002|Overall Study|Withdrawal by Subject|30|||
27786532|NCT02569398|81047406|FG000|Overall Study|Study terminated by sponsor|130|||
27786533|NCT02569398|81047407|FG001|Overall Study|Study terminated by sponsor|131|||
27786534|NCT02569398|81047408|FG002|Overall Study|Study terminated by sponsor|134|||
27786535|NCT02569398|81047406|FG000|Overall Study|Other|12|||
27786536|NCT02569398|81047407|FG001|Overall Study|Other|14|||
27786537|NCT02569398|81047408|FG002|Overall Study|Other|13|||
27786538|NCT02926833|81047409|FG000|Overall Study|Death|1|||
27786539|NCT02926833|81047410|FG001|Overall Study|Death|1|||
27786540|NCT02926833|81047411|FG002|Overall Study|Death|2|||
27786541|NCT02926833|81047412|FG003|Overall Study|Death|13|||
27786542|NCT02926833|81047409|FG000|Overall Study|Lost to Follow-up|1|||
27786543|NCT02926833|81047410|FG001|Overall Study|Lost to Follow-up|2|||
27786544|NCT02926833|81047411|FG002|Overall Study|Lost to Follow-up|0|||
27786545|NCT02926833|81047412|FG003|Overall Study|Lost to Follow-up|3|||
27786546|NCT02926833|81047409|FG000|Overall Study|Full Consent Withdrawal|0|||
27786547|NCT02926833|81047410|FG001|Overall Study|Full Consent Withdrawal|0|||
27786548|NCT02926833|81047411|FG002|Overall Study|Full Consent Withdrawal|0|||
27786549|NCT02926833|81047412|FG003|Overall Study|Full Consent Withdrawal|2|||
27786550|NCT02926833|81047409|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
27786551|NCT02926833|81047410|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
27786552|NCT02926833|81047411|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
27786553|NCT02926833|81047412|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
27786554|NCT02926833|81047409|FG000|Overall Study|Investigator Decision|0|||
27786555|NCT02926833|81047410|FG001|Overall Study|Investigator Decision|1|||
27786556|NCT02926833|81047411|FG002|Overall Study|Investigator Decision|0|||
27786557|NCT02926833|81047412|FG003|Overall Study|Investigator Decision|0|||
27786558|NCT02926833|81047409|FG000|Overall Study|Adverse Event|0|||
27786559|NCT02926833|81047410|FG001|Overall Study|Adverse Event|0|||
27786560|NCT02926833|81047411|FG002|Overall Study|Adverse Event|1|||
27867106|NCT00761657|81346684|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
27786561|NCT02926833|81047412|FG003|Overall Study|Adverse Event|0|||
27786562|NCT02926833|81047409|FG000|Overall Study|Partial Withdrawal of Consent|0|||
27786563|NCT02926833|81047410|FG001|Overall Study|Partial Withdrawal of Consent|0|||
27867107|NCT00761657|81346676|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27573264|NCT02203591|80285583|FG003|Overall Study|Did not meet treatment day baseline|45|||
27573265|NCT02203591|80285584|FG004|Overall Study|Did not meet treatment day baseline|33|||
27573266|NCT02203591|80285585|FG005|Overall Study|Did not meet treatment day baseline|35|||
27573267|NCT02203591|80285586|FG006|Overall Study|Did not meet treatment day baseline|29|||
27573268|NCT02203591|80285587|FG007|Overall Study|Did not meet treatment day baseline|12|||
27867108|NCT00761657|81346677|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27867109|NCT00761657|81346678|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
27867110|NCT00761657|81346679|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
27867111|NCT00761657|81346680|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27867112|NCT00761657|81346681|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27867113|NCT00761657|81346682|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27867114|NCT00761657|81346683|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27867115|NCT00761657|81346684|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
27867116|NCT00761657|81346676|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
27867117|NCT00761657|81346677|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
27867118|NCT00761657|81346678|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
27867119|NCT00761657|81346679|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
27867120|NCT00761657|81346680|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
27867121|NCT00761657|81346681|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
27867122|NCT00761657|81346682|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
27867123|NCT00761657|81346683|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
27867124|NCT00761657|81346684|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
27867125|NCT00761657|81346676|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
27867126|NCT00761657|81346677|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
27786564|NCT02926833|81047411|FG002|Overall Study|Partial Withdrawal of Consent|0|||
27786565|NCT02926833|81047412|FG003|Overall Study|Partial Withdrawal of Consent|1|||
27786566|NCT01430559|81047413|FG000|Overall Study|Adverse Event|7|||
27786567|NCT01430559|81047414|FG001|Overall Study|Adverse Event|3|||
27786568|NCT01430559|81047413|FG000|Overall Study|Entry criteria not met|1|||
27786569|NCT01430559|81047414|FG001|Overall Study|Entry criteria not met|1|||
27786570|NCT01430559|81047413|FG000|Overall Study|Lost to Follow-up|1|||
27786571|NCT01430559|81047414|FG001|Overall Study|Lost to Follow-up|0|||
27786572|NCT01430559|81047413|FG000|Overall Study|Medication error|1|||
27786573|NCT01430559|81047414|FG001|Overall Study|Medication error|0|||
27786574|NCT01430559|81047413|FG000|Overall Study|Withdrawal by Subject|3|||
27786575|NCT01430559|81047414|FG001|Overall Study|Withdrawal by Subject|2|||
27786576|NCT01430559|81047413|FG000|Overall Study|Protocol Violation|1|||
27786577|NCT01430559|81047414|FG001|Overall Study|Protocol Violation|0|||
27786578|NCT01430559|81047413|FG000|Overall Study|Other|3|||
27786579|NCT01430559|81047414|FG001|Overall Study|Other|3|||
27786580|NCT01430559|81047413|FG000|Overall Study|Randomized, Not Treated|3|||
27786581|NCT01430559|81047414|FG001|Overall Study|Randomized, Not Treated|3|||
27786582|NCT00779506|81047415|FG000|Overall Study|Screening Failed|2|||
27786583|NCT00779506|81047415|FG000|Overall Study|Adverse Event|4|||
27786584|NCT00779506|81047415|FG000|Overall Study|Lack of Efficacy|11|||
27786585|NCT00779506|81047415|FG000|Overall Study|Protocol Violation|5|||
27786586|NCT00779506|81047415|FG000|Overall Study|Withdrawal by Subject|6|||
27786587|NCT00779506|81047415|FG000|Overall Study|Lost to Follow-up|1|||
27786588|NCT03159455|81047416|FG000|Overall Study|Adverse Event|0|||
27786589|NCT03159455|81047417|FG001|Overall Study|Adverse Event|0|||
27786590|NCT03159455|81047418|FG002|Overall Study|Adverse Event|0|||
27786591|NCT03159455|81047419|FG003|Overall Study|Adverse Event|0|||
27867127|NCT00761657|81346678|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
27867128|NCT00761657|81346679|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
27867129|NCT00761657|81346680|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
27867130|NCT00761657|81346681|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
27867131|NCT00761657|81346682|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
27867132|NCT00761657|81346683|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
27867133|NCT00761657|81346684|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
27867134|NCT00474266|81346685|FG000|Overall Study|Withdrawal by Subject|7|||
27867135|NCT00474266|81346686|FG001|Overall Study|Withdrawal by Subject|20|||
27973758|NCT02323204|81732783|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
27973759|NCT02323204|81732780|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
27973760|NCT02323204|81732781|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
27973761|NCT02323204|81732782|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
27973762|NCT02323204|81732783|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
27973763|NCT02323204|81732780|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
27867136|NCT00474266|81346687|FG002|Overall Study|Withdrawal by Subject|4|||
27867137|NCT00474266|81346688|FG003|Overall Study|Withdrawal by Subject|7|||
27867138|NCT00141778|81346689|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
27973764|NCT02323204|81732781|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
27973765|NCT02323204|81732782|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
27786592|NCT03159455|81047420|FG004|Overall Study|Adverse Event|0|||
27786593|NCT03159455|81047421|FG005|Overall Study|Adverse Event|1|||
27786594|NCT01855919|81047424|FG000|Overall Study|Adverse Event|16|||
27786595|NCT01855919|81047425|FG001|Overall Study|Adverse Event|8|||
27786596|NCT01855919|81047424|FG000|Overall Study|Lack of Efficacy|1|||
27786597|NCT01855919|81047425|FG001|Overall Study|Lack of Efficacy|3|||
27786598|NCT01855919|81047424|FG000|Overall Study|Withdrawal by Subject|4|||
27786599|NCT01855919|81047425|FG001|Overall Study|Withdrawal by Subject|10|||
27973766|NCT02323204|81732783|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
27973767|NCT02323204|81732780|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
27973768|NCT02323204|81732781|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
27867139|NCT00141778|81346690|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
27786600|NCT01855919|81047424|FG000|Overall Study|Entry Criteria Not Met|1|||
27786601|NCT01855919|81047425|FG001|Overall Study|Entry Criteria Not Met|1|||
27786602|NCT01855919|81047424|FG000|Overall Study|Protocol Violation|1|||
27786603|NCT01855919|81047425|FG001|Overall Study|Protocol Violation|4|||
27786604|NCT04524663|81047426|FG000|Overall Study|Withdrawal by Subject|0|||
27786605|NCT04524663|81047427|FG001|Overall Study|Withdrawal by Subject|2|||
27786606|NCT03911401|81047428|FG000|Overall Study|Adverse Event|1|||
27786607|NCT03911401|81047429|FG001|Overall Study|Adverse Event|2|||
27786608|NCT03911401|81047430|FG002|Overall Study|Adverse Event|5|||
27786609|NCT03911401|81047428|FG000|Overall Study|Lack of Efficacy|1|||
27786610|NCT03911401|81047429|FG001|Overall Study|Lack of Efficacy|1|||
27786611|NCT03911401|81047430|FG002|Overall Study|Lack of Efficacy|8|||
27786612|NCT03911401|81047428|FG000|Overall Study|Physician Decision|0|||
27786613|NCT03911401|81047429|FG001|Overall Study|Physician Decision|0|||
27786614|NCT03911401|81047430|FG002|Overall Study|Physician Decision|1|||
27786615|NCT03911401|81047428|FG000|Overall Study|Withdrawal by Subject|1|||
27786616|NCT03911401|81047429|FG001|Overall Study|Withdrawal by Subject|2|||
27786617|NCT03911401|81047430|FG002|Overall Study|Withdrawal by Subject|0|||
27786618|NCT03911401|81047428|FG000|Overall Study|Withdrawal by parent/guardian|4|||
27786619|NCT03911401|81047429|FG001|Overall Study|Withdrawal by parent/guardian|4|||
27786620|NCT03911401|81047430|FG002|Overall Study|Withdrawal by parent/guardian|11|||
27786621|NCT03938857|81047431|FG000|Overall Study|Physician Decision|1|||
27786622|NCT03938857|81047432|FG001|Overall Study|Physician Decision|0|||
27786623|NCT03938857|81047433|FG002|Overall Study|Physician Decision|0|||
27786624|NCT03938857|81047434|FG003|Overall Study|Physician Decision|0|||
27786625|NCT02390167|81047435|FG000|Overall Study|Lost to Follow-up|1|||
27786626|NCT00033514|81047438|FG000|Overall Study|Lost to Follow-up|1|||
27786627|NCT00033514|81047439|FG001|Overall Study|Lost to Follow-up|1|||
27786628|NCT00033514|81047438|FG000|Overall Study|Withdrawal by Subject|0|||
27786629|NCT00033514|81047439|FG001|Overall Study|Withdrawal by Subject|3|||
27786630|NCT01270139|81047440|FG000|Overall Study|Adverse Event|8|||
27786631|NCT01270139|81047441|FG001|Overall Study|Adverse Event|17|||
27786632|NCT01270139|81047442|FG002|Overall Study|Adverse Event|18|||
27786633|NCT01270139|81047440|FG000|Overall Study|Lost to Follow-up|10|||
27786634|NCT01270139|81047441|FG001|Overall Study|Lost to Follow-up|9|||
27786635|NCT01270139|81047442|FG002|Overall Study|Lost to Follow-up|2|||
27786636|NCT03258710|81047443|FG000|Overall Study|Adverse Event|1|||
27786637|NCT03258710|81047443|FG000|Overall Study|Protocol-defined stopping criteria|1|||
27786638|NCT03258710|81047443|FG000|Overall Study|Physician Decision|1|||
27786639|NCT03737812|81047444|FG000|Overall Study|Withdrawal by Subject|1|||
27786640|NCT03737812|81047445|FG001|Overall Study|Withdrawal by Subject|2|||
27786641|NCT03737812|81047446|FG002|Overall Study|Withdrawal by Subject|1|||
27786642|NCT03737812|81047444|FG000|Overall Study|Sponsor Discontinued the Study|4|||
27786643|NCT03737812|81047445|FG001|Overall Study|Sponsor Discontinued the Study|3|||
27786644|NCT03737812|81047446|FG002|Overall Study|Sponsor Discontinued the Study|2|||
27786645|NCT03737812|81047444|FG000|Overall Study|Adverse Event|0|||
27786646|NCT03737812|81047445|FG001|Overall Study|Adverse Event|1|||
27786647|NCT03737812|81047446|FG002|Overall Study|Adverse Event|0|||
27786648|NCT03737812|81047444|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
27786649|NCT03737812|81047445|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
27786650|NCT03737812|81047446|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
27786651|NCT01220024|81047448|FG000|Overall Study|Lost to Follow-up|1|||
27786652|NCT01220024|81047449|FG001|Overall Study|Lost to Follow-up|1|||
27786653|NCT04391894|81047455|FG000|Overall Study|Adverse Event|1|||
27786654|NCT04391894|81047456|FG001|Overall Study|Adverse Event|1|||
27786655|NCT04391894|81047457|FG002|Overall Study|Adverse Event|1|||
27786656|NCT04391894|81047458|FG003|Overall Study|Adverse Event|1|||
27867140|NCT00141778|81346691|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
27867141|NCT00141778|81346689|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
27867142|NCT00141778|81346690|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
27973769|NCT02323204|81732782|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
27786657|NCT04391894|81047459|FG004|Overall Study|Adverse Event|1|||
27786658|NCT04391894|81047455|FG000|Overall Study|Lost to Follow-up|1|||
27786659|NCT04391894|81047456|FG001|Overall Study|Lost to Follow-up|0|||
27786660|NCT04391894|81047457|FG002|Overall Study|Lost to Follow-up|0|||
27786661|NCT04391894|81047458|FG003|Overall Study|Lost to Follow-up|0|||
27786662|NCT04391894|81047459|FG004|Overall Study|Lost to Follow-up|0|||
27786663|NCT04391894|81047455|FG000|Overall Study|Protocol Violation|0|||
27786664|NCT04391894|81047456|FG001|Overall Study|Protocol Violation|0|||
27786665|NCT04391894|81047457|FG002|Overall Study|Protocol Violation|0|||
27786666|NCT04391894|81047458|FG003|Overall Study|Protocol Violation|1|||
27786667|NCT04391894|81047459|FG004|Overall Study|Protocol Violation|0|||
27867143|NCT00141778|81346691|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
27867144|NCT00141778|81346689|FG000|Started Study Medication|Withdrawal by Subject|0|||
27867145|NCT00141778|81346690|FG001|Started Study Medication|Withdrawal by Subject|2|||
27867146|NCT00141778|81346691|FG002|Started Study Medication|Withdrawal by Subject|0|||
27867147|NCT00141778|81346689|FG000|Started Study Medication|Difficulty Swallowing|0|||
27867148|NCT00141778|81346690|FG001|Started Study Medication|Difficulty Swallowing|1|||
27867149|NCT00141778|81346691|FG002|Started Study Medication|Difficulty Swallowing|0|||
27867150|NCT00141778|81346689|FG000|Started Study Medication|Chest Discomfort|0|||
27867151|NCT00141778|81346690|FG001|Started Study Medication|Chest Discomfort|0|||
27867152|NCT00141778|81346691|FG002|Started Study Medication|Chest Discomfort|1|||
27867153|NCT00104572|81346692|FG000|Overall Study|Withdrawal by Subject|3|||
27867154|NCT00104572|81346693|FG001|Overall Study|Withdrawal by Subject|3|||
27867155|NCT00104572|81346694|FG002|Overall Study|Withdrawal by Subject|0|||
27867156|NCT02289729|81346695|FG000|Overall Study|Lack of Efficacy|3|||
27867157|NCT02289729|81346695|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
27973770|NCT02323204|81732783|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
27973771|NCT02323204|81732780|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27973772|NCT02323204|81732781|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
27973773|NCT02323204|81732782|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27973774|NCT02323204|81732783|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
27973775|NCT02323204|81732780|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
27973776|NCT02323204|81732781|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
27973777|NCT02323204|81732782|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
27973778|NCT02323204|81732783|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
27973779|NCT02323204|81732780|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27973780|NCT02323204|81732781|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
27973781|NCT02323204|81732782|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
27973782|NCT02323204|81732783|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
27973783|NCT03730961|81737652|FG000|Overall Study|Adverse Event|0|||
27973784|NCT03730961|81737653|FG001|Overall Study|Adverse Event|1|||
27973785|NCT01598753|81737655|FG000|Overall Study|Adverse Event|1|||
27973786|NCT01598753|81737656|FG001|Overall Study|Adverse Event|9|||
27973787|NCT01598753|81737657|FG002|Overall Study|Adverse Event|1|||
27973788|NCT01598753|81737658|FG003|Overall Study|Adverse Event|7|||
27973789|NCT01598753|81737655|FG000|Overall Study|Lost to Follow-up|4|||
27973790|NCT01598753|81737656|FG001|Overall Study|Lost to Follow-up|3|||
27973791|NCT01598753|81737657|FG002|Overall Study|Lost to Follow-up|7|||
27973792|NCT01598753|81737658|FG003|Overall Study|Lost to Follow-up|5|||
27973793|NCT01598753|81737655|FG000|Overall Study|Physician Decision|0|||
27973794|NCT01598753|81737656|FG001|Overall Study|Physician Decision|1|||
27973795|NCT01598753|81737657|FG002|Overall Study|Physician Decision|0|||
27973796|NCT01598753|81737658|FG003|Overall Study|Physician Decision|2|||
27973797|NCT01598753|81737655|FG000|Overall Study|Withdrawal by Subject|7|||
27973798|NCT01598753|81737656|FG001|Overall Study|Withdrawal by Subject|2|||
27973799|NCT01598753|81737657|FG002|Overall Study|Withdrawal by Subject|0|||
27973800|NCT01598753|81737658|FG003|Overall Study|Withdrawal by Subject|1|||
27973801|NCT03920293|81737659|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
27973802|NCT03920293|81737660|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
27973803|NCT03920293|81737659|FG000|Randomized-Controlled Period|Physician Decision|1|||
27973804|NCT03920293|81737660|FG001|Randomized-Controlled Period|Physician Decision|2|||
27973805|NCT03920293|81737659|FG000|Randomized-Controlled Period|Adverse Event|0|||
27973806|NCT03920293|81737660|FG001|Randomized-Controlled Period|Adverse Event|2|||
27973807|NCT03920293|81737659|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
27973808|NCT03920293|81737660|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
27973809|NCT03920293|81737659|FG000|Randomized-Controlled Period|Death|2|||
27973810|NCT03920293|81737660|FG001|Randomized-Controlled Period|Death|0|||
27973811|NCT03920293|81737659|FG000|Randomized-Controlled Period|Protocol Violation|1|||
27973812|NCT03920293|81737660|FG001|Randomized-Controlled Period|Protocol Violation|0|||
27973813|NCT03920293|81737659|FG000|Randomized-Controlled Period|Noncompliance|1|||
27973814|NCT03920293|81737660|FG001|Randomized-Controlled Period|Noncompliance|0|||
27973815|NCT03920293|81737659|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
27973816|NCT03920293|81737660|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
27973817|NCT03920293|81737659|FG000|Open- Label Extension Period|Death|3|||
27973818|NCT03920293|81737660|FG001|Open- Label Extension Period|Death|3|||
27973819|NCT03920293|81737659|FG000|Open- Label Extension Period|Physician Decision|5|||
27973820|NCT03920293|81737660|FG001|Open- Label Extension Period|Physician Decision|3|||
27973821|NCT03920293|81737659|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
27973822|NCT03920293|81737660|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
27867158|NCT02289729|81346695|FG000|Overall Study|Withdrawal by Subject|1|||
27867159|NCT02289729|81346695|FG000|Overall Study|Death|1|||
27973823|NCT04346108|81737661|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
27786668|NCT04391894|81047455|FG000|Overall Study|Withdrawal by Subject|2|||
27786669|NCT04391894|81047456|FG001|Overall Study|Withdrawal by Subject|0|||
27786670|NCT04391894|81047457|FG002|Overall Study|Withdrawal by Subject|3|||
27786671|NCT04391894|81047458|FG003|Overall Study|Withdrawal by Subject|0|||
27973824|NCT04346108|81737662|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
27973825|NCT04346108|81737663|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
27973826|NCT04346108|81737661|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
27973827|NCT04346108|81737662|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
27973828|NCT04346108|81737663|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
27973829|NCT03054350|81737664|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
27973830|NCT03054350|81737665|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
27973831|NCT03054350|81737666|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
27973832|NCT03054350|81737667|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
27973833|NCT03054350|81737668|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
27973834|NCT03054350|81737669|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
27973835|NCT03054350|81737664|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
27973836|NCT03054350|81737665|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
27973837|NCT03054350|81737666|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
27973838|NCT03054350|81737667|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
27973839|NCT03054350|81737668|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
27973840|NCT03054350|81737669|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
27973841|NCT03054350|81737664|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
27786672|NCT04391894|81047459|FG004|Overall Study|Withdrawal by Subject|1|||
27786673|NCT04391894|81047455|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
27786674|NCT04391894|81047456|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
27786675|NCT04391894|81047457|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
27786676|NCT04391894|81047458|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
27786677|NCT04391894|81047459|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
27786678|NCT01967134|81047460|FG000|Overall Study|Lost to Follow-up|0|||
27786679|NCT01967134|81047461|FG001|Overall Study|Lost to Follow-up|1|||
27786680|NCT01967134|81047462|FG002|Overall Study|Lost to Follow-up|0|||
27786681|NCT04382066|81047463|FG000|Overall Study|Adverse Event|1|||
27786682|NCT04382066|81047464|FG001|Overall Study|Adverse Event|0|||
27786683|NCT04382066|81047465|FG002|Overall Study|Adverse Event|0|||
27786684|NCT04382066|81047463|FG000|Overall Study|Death|1|||
27786685|NCT04382066|81047464|FG001|Overall Study|Death|0|||
27786686|NCT04382066|81047465|FG002|Overall Study|Death|1|||
27786687|NCT00310440|81047468|FG000|Overall Study|Lost to Follow-up|17|||
27786688|NCT00310440|81047469|FG001|Overall Study|Lost to Follow-up|8|||
27786689|NCT00310440|81047468|FG000|Overall Study|Withdrawal by Subject|2|||
27786690|NCT00310440|81047469|FG001|Overall Study|Withdrawal by Subject|1|||
27786691|NCT00310440|81047468|FG000|Overall Study|Missed 12 Month Visit|7|||
27786692|NCT00310440|81047469|FG001|Overall Study|Missed 12 Month Visit|4|||
27786693|NCT00598585|81047470|FG000|Overall Study|Lost to Follow-up|1|||
27786694|NCT00598585|81047471|FG001|Overall Study|Lost to Follow-up|0|||
27786695|NCT00660816|81047479|FG000|Overall Study|Adverse Event|1|||
27786696|NCT00660816|81047480|FG001|Overall Study|Adverse Event|2|||
27786697|NCT00660816|81047479|FG000|Overall Study|Withdrawal by Subject|1|||
27786698|NCT00660816|81047480|FG001|Overall Study|Withdrawal by Subject|0|||
27786699|NCT00660816|81047479|FG000|Overall Study|Death|0|||
27786700|NCT00660816|81047480|FG001|Overall Study|Death|2|||
27786701|NCT00660816|81047479|FG000|Overall Study|Lack of Efficacy|1|||
27786702|NCT00660816|81047480|FG001|Overall Study|Lack of Efficacy|0|||
27786703|NCT00660816|81047479|FG000|Overall Study|Physician Decision|0|||
27786704|NCT00660816|81047480|FG001|Overall Study|Physician Decision|2|||
27786705|NCT00660816|81047479|FG000|Overall Study|Protocol Violation|1|||
27786706|NCT00660816|81047480|FG001|Overall Study|Protocol Violation|0|||
27786707|NCT00660816|81047479|FG000|Overall Study|Disease Progression|16|||
27786708|NCT00660816|81047480|FG001|Overall Study|Disease Progression|12|||
27786709|NCT00660816|81047479|FG000|Overall Study|Complicating Disease|0|||
27786710|NCT00660816|81047480|FG001|Overall Study|Complicating Disease|1|||
27786711|NCT03726320|81047481|FG000|Overall Study|Lost to Follow-up|2|||
27786712|NCT03726320|81047482|FG001|Overall Study|Lost to Follow-up|4|||
27786713|NCT03726320|81047483|FG002|Overall Study|Lost to Follow-up|0|||
27786714|NCT03726320|81047481|FG000|Overall Study|Time Constraints|4|||
27786715|NCT03726320|81047482|FG001|Overall Study|Time Constraints|1|||
27786716|NCT03726320|81047483|FG002|Overall Study|Time Constraints|0|||
27786717|NCT03726320|81047481|FG000|Overall Study|Ineligible after enrollment|3|||
27786718|NCT03726320|81047482|FG001|Overall Study|Ineligible after enrollment|3|||
27786719|NCT03726320|81047483|FG002|Overall Study|Ineligible after enrollment|0|||
27786720|NCT03726320|81047481|FG000|Overall Study|Clinic / insurance issue|2|||
27973842|NCT03054350|81737665|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
27973843|NCT03054350|81737666|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
27973844|NCT03054350|81737667|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
27973845|NCT03054350|81737668|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
27973846|NCT03054350|81737669|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
27973847|NCT03054350|81737664|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
27973848|NCT03054350|81737665|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
27973849|NCT03054350|81737666|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
27973850|NCT03054350|81737667|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
27973851|NCT03054350|81737668|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
27973852|NCT03054350|81737669|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
27973853|NCT04606199|81737670|FG000|Overall Study|Withdrawal by Subject|2|||
27973854|NCT00435162|81737684|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
27973855|NCT00435162|81737685|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
27973856|NCT00435162|81737686|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
27973857|NCT00435162|81737687|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
27973858|NCT00435162|81737688|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
27973859|NCT00435162|81737689|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
27973860|NCT02826421|81737690|FG000|Overall Study|Adverse Event|1|||
27973861|NCT02826421|81737691|FG001|Overall Study|Adverse Event|0|||
27973862|NCT02826421|81737692|FG002|Overall Study|Adverse Event|0|||
27973863|NCT02826421|81737693|FG003|Overall Study|Adverse Event|1|||
27973864|NCT02826421|81737690|FG000|Overall Study|Withdrawal by Subject|1|||
27973865|NCT02826421|81737691|FG001|Overall Study|Withdrawal by Subject|3|||
27973866|NCT02826421|81737692|FG002|Overall Study|Withdrawal by Subject|1|||
27786721|NCT03726320|81047482|FG001|Overall Study|Clinic / insurance issue|0|||
27786722|NCT03726320|81047483|FG002|Overall Study|Clinic / insurance issue|0|||
27786723|NCT03726320|81047481|FG000|Overall Study|Language barrier|1|||
27786724|NCT03726320|81047482|FG001|Overall Study|Language barrier|0|||
27786725|NCT03726320|81047483|FG002|Overall Study|Language barrier|0|||
27786726|NCT03726320|81047481|FG000|Overall Study|Provider left the clinic|0|||
27786727|NCT03726320|81047482|FG001|Overall Study|Provider left the clinic|0|||
27786728|NCT03726320|81047483|FG002|Overall Study|Provider left the clinic|1|||
27786729|NCT01265719|81047485|FG000|Overall Study|Does not meet entrance criteria|0|||
27786730|NCT01265719|81047486|FG001|Overall Study|Does not meet entrance criteria|3|||
27786731|NCT01265719|81047485|FG000|Overall Study|Other reasons|2|||
27786732|NCT01265719|81047486|FG001|Overall Study|Other reasons|0|||
27786733|NCT01265719|81047485|FG000|Overall Study|Withdrawal by Subject|8|||
27786734|NCT01265719|81047486|FG001|Overall Study|Withdrawal by Subject|3|||
27786735|NCT01265719|81047485|FG000|Overall Study|Lost to Follow-up|2|||
27786736|NCT01265719|81047486|FG001|Overall Study|Lost to Follow-up|7|||
27786737|NCT01265719|81047485|FG000|Overall Study|Adverse Event|2|||
27786738|NCT01265719|81047486|FG001|Overall Study|Adverse Event|0|||
27786739|NCT02195531|81047487|FG000|Overall Study|Withdrawal by Subject|1|||
27786740|NCT02195531|81047488|FG001|Overall Study|Withdrawal by Subject|1|||
27786741|NCT02195531|81047489|FG002|Overall Study|Withdrawal by Subject|1|||
27786742|NCT01151085|81047497|FG000|Overall Study|Lost to Follow-up|31|||
27786743|NCT01151085|81047497|FG000|Overall Study|Protocol Violation|25|||
27786744|NCT00985114|81047498|FG000|Overall Study|Adverse Event|1|||
27786745|NCT00985114|81047499|FG001|Overall Study|Adverse Event|0|||
27786746|NCT00985114|81047498|FG000|Overall Study|Withdrawal by Subject|0|||
27786747|NCT00985114|81047499|FG001|Overall Study|Withdrawal by Subject|2|||
27786748|NCT04594213|81047500|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
27786749|NCT04594213|81047501|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
27786750|NCT04594213|81047502|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
27786751|NCT04594213|81047503|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
27786752|NCT04594213|81047504|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
27786753|NCT04594213|81047505|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
27786754|NCT04594213|81047500|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
27786755|NCT04594213|81047501|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
27786756|NCT04594213|81047502|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
27786757|NCT04594213|81047503|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
27786758|NCT04594213|81047504|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
27786759|NCT04594213|81047505|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
27786760|NCT04594213|81047500|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
27786761|NCT04594213|81047501|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27786762|NCT04594213|81047502|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
27786763|NCT04594213|81047503|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27786764|NCT04594213|81047504|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27786765|NCT04594213|81047505|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27786766|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27786767|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27786768|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27786769|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27786770|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
27786771|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27786772|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27786773|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27786774|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27786775|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
27786776|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
27786777|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
27786778|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27786779|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27786780|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27786781|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27786782|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27786783|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
27786784|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27786785|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27786786|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27786787|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
27786788|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27786789|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27786790|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
27786791|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
27786792|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
27786793|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
27786794|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
27786795|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
27786796|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
27786797|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
27786798|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
27786799|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
27786800|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
27786801|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
27786802|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
27786803|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
27786804|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
27786805|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
27786806|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
27786807|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
27786808|NCT04594213|81047500|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
27786809|NCT04594213|81047501|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
27786810|NCT04594213|81047502|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
27786811|NCT04594213|81047503|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
27786812|NCT04594213|81047504|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
27786813|NCT04594213|81047505|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
27786814|NCT00772031|81047506|FG000|Overall Study|Early termination of trial|12|||
27786815|NCT00772031|81047507|FG001|Overall Study|Early termination of trial|10|||
27786816|NCT00772031|81047506|FG000|Overall Study|Lost to Follow-up|20|||
27786817|NCT00772031|81047507|FG001|Overall Study|Lost to Follow-up|33|||
27786818|NCT01491802|81047508|FG000|Overall Study|Adverse Event|1|||
27786819|NCT01491802|81047509|FG001|Overall Study|Adverse Event|1|||
27786820|NCT01491802|81047508|FG000|Overall Study|Withdrawal by Subject|0|||
27786821|NCT01491802|81047509|FG001|Overall Study|Withdrawal by Subject|1|||
27786822|NCT00421928|81047510|FG000|Overall Study|Adverse Event|61|||
27786823|NCT00421928|81047511|FG001|Overall Study|Adverse Event|140|||
27786824|NCT00421928|81047512|FG002|Overall Study|Adverse Event|22|||
27786825|NCT00421928|81047510|FG000|Overall Study|Lost to Follow-up|5|||
27786826|NCT00421928|81047511|FG001|Overall Study|Lost to Follow-up|0|||
27786827|NCT00421928|81047512|FG002|Overall Study|Lost to Follow-up|3|||
27786828|NCT00421928|81047510|FG000|Overall Study|Withdrawal by Subject|50|||
27786829|NCT00421928|81047511|FG001|Overall Study|Withdrawal by Subject|48|||
27786830|NCT00421928|81047512|FG002|Overall Study|Withdrawal by Subject|43|||
27786831|NCT00421928|81047510|FG000|Overall Study|Lack of Efficacy|15|||
27786832|NCT00421928|81047511|FG001|Overall Study|Lack of Efficacy|7|||
27786833|NCT00421928|81047512|FG002|Overall Study|Lack of Efficacy|35|||
27786834|NCT00421928|81047510|FG000|Overall Study|Study drug non-compliant|6|||
27786835|NCT00421928|81047511|FG001|Overall Study|Study drug non-compliant|7|||
27786836|NCT00421928|81047512|FG002|Overall Study|Study drug non-compliant|4|||
27786837|NCT00421928|81047510|FG000|Overall Study|All other|26|||
27786838|NCT00421928|81047511|FG001|Overall Study|All other|21|||
27973867|NCT02826421|81737693|FG003|Overall Study|Withdrawal by Subject|1|||
27973868|NCT02826421|81737690|FG000|Overall Study|Reason not given|1|||
27973869|NCT02826421|81737691|FG001|Overall Study|Reason not given|0|||
27973870|NCT02826421|81737692|FG002|Overall Study|Reason not given|1|||
27973871|NCT02826421|81737693|FG003|Overall Study|Reason not given|0|||
27973872|NCT02974855|81737695|FG000|Overall Study|Adverse Event|0|||
27973873|NCT02974855|81737696|FG001|Overall Study|Adverse Event|1|||
27973874|NCT02974855|81737697|FG002|Overall Study|Adverse Event|0|||
27973875|NCT02974855|81737698|FG003|Overall Study|Adverse Event|1|||
27973876|NCT01360398|81737701|FG000|Overall Study|Withdrawal by Subject|14|||
27973877|NCT01360398|81737701|FG000|Overall Study|Other|7|||
27973878|NCT01360398|81737701|FG000|Overall Study|Migrated/moved from study area|1|||
27973879|NCT00937404|81737702|FG000|Overall Study|Protocol Violation|1|||
27973880|NCT00937404|81737702|FG000|Overall Study|Withdrawal by Subject|1|||
27973881|NCT01571284|81737703|FG000|Overall Study|Participant's decision|84|||
27973882|NCT01571284|81737703|FG000|Overall Study|Lost to Follow-up|3|||
27973883|NCT01571284|81737703|FG000|Overall Study|Enrolled but not treated|2|||
27973884|NCT01571284|81737703|FG000|Overall Study|Other than specified above|80|||
27973885|NCT02098369|81737704|FG000|Overall Study|Withdrawal by Subject|1|||
27973886|NCT02098369|81737705|FG001|Overall Study|Withdrawal by Subject|5|||
27973887|NCT02098369|81737706|FG002|Overall Study|Withdrawal by Subject|0|||
27973888|NCT02098369|81737704|FG000|Overall Study|Lost to Follow-up|5|||
27973889|NCT02098369|81737705|FG001|Overall Study|Lost to Follow-up|1|||
27973890|NCT02098369|81737706|FG002|Overall Study|Lost to Follow-up|3|||
27973891|NCT02098369|81737704|FG000|Overall Study|Death|1|||
27973892|NCT02098369|81737705|FG001|Overall Study|Death|1|||
27973893|NCT02098369|81737706|FG002|Overall Study|Death|1|||
27973894|NCT02098369|81737704|FG000|Overall Study|Other|0|||
27671274|NCT01236352|80634939|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
27671275|NCT01236352|80634929|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27786839|NCT00421928|81047512|FG002|Overall Study|All other|27|||
27786840|NCT00421928|81047510|FG000|Overall Study|Death|0|||
27786841|NCT00421928|81047511|FG001|Overall Study|Death|1|||
27786842|NCT00421928|81047512|FG002|Overall Study|Death|0|||
27786843|NCT02889861|81047515|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
27786844|NCT00699582|81047516|FG000|Overall Study|Adverse Event|4|||
27786845|NCT00699582|81047517|FG001|Overall Study|Adverse Event|11|||
27786846|NCT00699582|81047518|FG002|Overall Study|Adverse Event|23|||
27786847|NCT00699582|81047516|FG000|Overall Study|Withdrawal by Subject|6|||
27786848|NCT00699582|81047517|FG001|Overall Study|Withdrawal by Subject|7|||
27786849|NCT00699582|81047518|FG002|Overall Study|Withdrawal by Subject|4|||
27786850|NCT00699582|81047516|FG000|Overall Study|Lack of Efficacy|1|||
27786851|NCT00699582|81047517|FG001|Overall Study|Lack of Efficacy|0|||
27786852|NCT00699582|81047518|FG002|Overall Study|Lack of Efficacy|1|||
27786853|NCT00699582|81047516|FG000|Overall Study|Progressive Disease|1|||
27786854|NCT00699582|81047517|FG001|Overall Study|Progressive Disease|0|||
27786855|NCT00699582|81047518|FG002|Overall Study|Progressive Disease|0|||
27786856|NCT00699582|81047516|FG000|Overall Study|Administrative/Other|4|||
27786857|NCT00699582|81047517|FG001|Overall Study|Administrative/Other|3|||
27786858|NCT00699582|81047518|FG002|Overall Study|Administrative/Other|0|||
27786859|NCT00699582|81047516|FG000|Overall Study|Randomized, Not Treated|2|||
27786860|NCT00699582|81047517|FG001|Overall Study|Randomized, Not Treated|1|||
27786861|NCT00699582|81047518|FG002|Overall Study|Randomized, Not Treated|0|||
27786862|NCT01319422|81050973|FG000|Overall Study|Withdrawal by Subject|1|||
27786863|NCT01319422|81050974|FG001|Overall Study|Withdrawal by Subject|0|||
27786864|NCT00561912|81050979|FG000|Overall Study|ineligible|1|||
27786865|NCT00933543|81050980|FG000|Overall Study|Adverse Event|2|||
27786866|NCT00933543|81050981|FG001|Overall Study|Adverse Event|1|||
27786867|NCT00933543|81050980|FG000|Overall Study|Lost to Follow-up|0|||
27786868|NCT00933543|81050981|FG001|Overall Study|Lost to Follow-up|1|||
27786869|NCT00933543|81050980|FG000|Overall Study|Withdrawal by Subject|0|||
27786870|NCT00933543|81050981|FG001|Overall Study|Withdrawal by Subject|1|||
27786871|NCT00933543|81050980|FG000|Overall Study|Lack of Efficacy|0|||
27973895|NCT02098369|81737705|FG001|Overall Study|Other|2|||
27671276|NCT01236352|80634930|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27671277|NCT01236352|80634931|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27786872|NCT00933543|81050981|FG001|Overall Study|Lack of Efficacy|3|||
27786873|NCT00933543|81050980|FG000|Overall Study|Other|1|||
27786874|NCT00933543|81050981|FG001|Overall Study|Other|1|||
27973896|NCT02098369|81737706|FG002|Overall Study|Other|1|||
27973897|NCT00996281|81737707|FG000|Overall Study|Adverse Event|75|||
27973898|NCT00996281|81737708|FG001|Overall Study|Adverse Event|37|||
27973899|NCT00996281|81737707|FG000|Overall Study|Major Protocol Deviation|6|||
27973900|NCT00996281|81737708|FG001|Overall Study|Major Protocol Deviation|7|||
27973901|NCT00996281|81737707|FG000|Overall Study|Lost to Follow-up|14|||
27973902|NCT00996281|81737708|FG001|Overall Study|Lost to Follow-up|16|||
27671278|NCT01236352|80634932|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27786875|NCT01283282|81050982|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
27973903|NCT00996281|81737707|FG000|Overall Study|Withdrawal by Subject|31|||
27671279|NCT01236352|80634933|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27786876|NCT01283282|81050983|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
27786877|NCT01283282|81050982|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
27786878|NCT01283282|81050983|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
27786879|NCT01283282|81050982|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
27786880|NCT01283282|81050983|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
27786881|NCT01190839|81050985|FG000|Overall Study|Adverse Event|32|||
27786882|NCT01190839|81050986|FG001|Overall Study|Adverse Event|41|||
27786883|NCT01190839|81050985|FG000|Overall Study|Protocol Violation|2|||
27786884|NCT01190839|81050986|FG001|Overall Study|Protocol Violation|2|||
27786885|NCT01190839|81050985|FG000|Overall Study|Lost to Follow-up|7|||
27786886|NCT01190839|81050986|FG001|Overall Study|Lost to Follow-up|1|||
27786887|NCT01190839|81050985|FG000|Overall Study|Death|1|||
27786888|NCT01190839|81050986|FG001|Overall Study|Death|0|||
27786889|NCT01190839|81050985|FG000|Overall Study|Trial stopped by Sponsor|71|||
27786890|NCT01190839|81050986|FG001|Overall Study|Trial stopped by Sponsor|68|||
27786891|NCT01190839|81050985|FG000|Overall Study|Undefined|35|||
27786892|NCT01190839|81050986|FG001|Overall Study|Undefined|31|||
27786893|NCT01190839|81050985|FG000|Overall Study|Randomized but not treated|2|||
27786894|NCT01190839|81050986|FG001|Overall Study|Randomized but not treated|4|||
27786895|NCT00368069|81050987|FG000|Overall Study|Adverse Event|5|||
27786896|NCT00368069|81050988|FG001|Overall Study|Adverse Event|2|||
27786897|NCT00368069|81050987|FG000|Overall Study|Lack of Efficacy|0|||
27786898|NCT00368069|81050988|FG001|Overall Study|Lack of Efficacy|1|||
27786899|NCT00368069|81050987|FG000|Overall Study|Lost to Follow-up|1|||
27786900|NCT00368069|81050988|FG001|Overall Study|Lost to Follow-up|0|||
27786901|NCT00368069|81050987|FG000|Overall Study|Protocol Violation|0|||
27786902|NCT00368069|81050988|FG001|Overall Study|Protocol Violation|2|||
27786903|NCT00368069|81050987|FG000|Overall Study|Withdrawal of Consent|2|||
27786904|NCT00368069|81050988|FG001|Overall Study|Withdrawal of Consent|1|||
27786905|NCT00368069|81050987|FG000|Overall Study|no blood sampling possible|0|||
27786906|NCT00368069|81050988|FG001|Overall Study|no blood sampling possible|1|||
27786907|NCT04308668|81050989|FG000|Overall Study|Lost to Follow-up|32|||
27786908|NCT04308668|81050990|FG001|Overall Study|Lost to Follow-up|38|||
27786909|NCT04308668|81050989|FG000|Overall Study|Withdrawal by Subject|4|||
27786910|NCT04308668|81050990|FG001|Overall Study|Withdrawal by Subject|4|||
27786911|NCT01004861|81050991|FG000|Overall Study|Disease progression|3|||
27786912|NCT01004861|81050992|FG001|Overall Study|Disease progression|4|||
27786913|NCT01004861|81050993|FG002|Overall Study|Disease progression|5|||
27786914|NCT01004861|81050994|FG003|Overall Study|Disease progression|4|||
27786915|NCT01004861|81050995|FG004|Overall Study|Disease progression|4|||
27786916|NCT01004861|81050996|FG005|Overall Study|Disease progression|4|||
27973904|NCT00996281|81737708|FG001|Overall Study|Withdrawal by Subject|20|||
27671280|NCT01236352|80634934|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27786917|NCT01004861|81050997|FG006|Overall Study|Disease progression|5|||
27786918|NCT01004861|81050998|FG007|Overall Study|Disease progression|1|||
27786919|NCT01004861|81050999|FG008|Overall Study|Disease progression|4|||
27786920|NCT01004861|81051000|FG009|Overall Study|Disease progression|7|||
27786921|NCT01004861|81051001|FG010|Overall Study|Disease progression|6|||
27786922|NCT01004861|81051002|FG011|Overall Study|Disease progression|3|||
27786923|NCT01004861|81051003|FG012|Overall Study|Disease progression|8|||
27786924|NCT01004861|81050991|FG000|Overall Study|Physician Decision|0|||
27786925|NCT01004861|81050992|FG001|Overall Study|Physician Decision|2|||
27786926|NCT01004861|81050993|FG002|Overall Study|Physician Decision|1|||
27786927|NCT01004861|81050994|FG003|Overall Study|Physician Decision|1|||
27786928|NCT01004861|81050995|FG004|Overall Study|Physician Decision|1|||
27786929|NCT01004861|81050996|FG005|Overall Study|Physician Decision|0|||
27786930|NCT01004861|81050997|FG006|Overall Study|Physician Decision|0|||
27786931|NCT01004861|81050998|FG007|Overall Study|Physician Decision|1|||
27786932|NCT01004861|81050999|FG008|Overall Study|Physician Decision|0|||
27786933|NCT01004861|81051000|FG009|Overall Study|Physician Decision|0|||
27786934|NCT01004861|81051001|FG010|Overall Study|Physician Decision|0|||
27786935|NCT01004861|81051002|FG011|Overall Study|Physician Decision|0|||
27786936|NCT01004861|81051003|FG012|Overall Study|Physician Decision|3|||
27786937|NCT01004861|81050991|FG000|Overall Study|Adverse Event|0|||
27786938|NCT01004861|81050992|FG001|Overall Study|Adverse Event|0|||
27786939|NCT01004861|81050993|FG002|Overall Study|Adverse Event|0|||
27973905|NCT00996281|81737707|FG000|Overall Study|Lack of Efficacy|0|||
27973906|NCT00996281|81737708|FG001|Overall Study|Lack of Efficacy|2|||
27786940|NCT01004861|81050994|FG003|Overall Study|Adverse Event|1|||
27786941|NCT01004861|81050995|FG004|Overall Study|Adverse Event|0|||
27786942|NCT01004861|81050996|FG005|Overall Study|Adverse Event|2|||
27786943|NCT01004861|81050997|FG006|Overall Study|Adverse Event|1|||
27786944|NCT01004861|81050998|FG007|Overall Study|Adverse Event|1|||
27786945|NCT01004861|81050999|FG008|Overall Study|Adverse Event|13|||
27786946|NCT01004861|81051000|FG009|Overall Study|Adverse Event|1|||
27786947|NCT01004861|81051001|FG010|Overall Study|Adverse Event|1|||
27786948|NCT01004861|81051002|FG011|Overall Study|Adverse Event|0|||
27786949|NCT01004861|81051003|FG012|Overall Study|Adverse Event|2|||
27786950|NCT01004861|81050991|FG000|Overall Study|Protocol Violation|0|||
27671281|NCT01236352|80634935|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27671282|NCT01236352|80634936|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27786951|NCT01004861|81050992|FG001|Overall Study|Protocol Violation|0|||
27786952|NCT01004861|81050993|FG002|Overall Study|Protocol Violation|0|||
27786953|NCT01004861|81050994|FG003|Overall Study|Protocol Violation|0|||
27786954|NCT01004861|81050995|FG004|Overall Study|Protocol Violation|1|||
27786955|NCT01004861|81050996|FG005|Overall Study|Protocol Violation|0|||
27786956|NCT01004861|81050997|FG006|Overall Study|Protocol Violation|0|||
27786957|NCT01004861|81050998|FG007|Overall Study|Protocol Violation|0|||
27786958|NCT01004861|81050999|FG008|Overall Study|Protocol Violation|0|||
27786959|NCT01004861|81051000|FG009|Overall Study|Protocol Violation|0|||
27786960|NCT01004861|81051001|FG010|Overall Study|Protocol Violation|0|||
27786961|NCT01004861|81051002|FG011|Overall Study|Protocol Violation|0|||
27671283|NCT01236352|80634937|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27671284|NCT01236352|80634938|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
27671285|NCT01236352|80634939|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
27671286|NCT01236352|80634929|FG000|Overall Study|Lack of response to drug|0|||
27671287|NCT01236352|80634930|FG001|Overall Study|Lack of response to drug|0|||
27671288|NCT01236352|80634931|FG002|Overall Study|Lack of response to drug|0|||
27671289|NCT01236352|80634932|FG003|Overall Study|Lack of response to drug|0|||
27671290|NCT01236352|80634933|FG004|Overall Study|Lack of response to drug|0|||
27671291|NCT01236352|80634934|FG005|Overall Study|Lack of response to drug|0|||
27671292|NCT01236352|80634935|FG006|Overall Study|Lack of response to drug|0|||
27671293|NCT01236352|80634936|FG007|Overall Study|Lack of response to drug|0|||
27671294|NCT01236352|80634937|FG008|Overall Study|Lack of response to drug|0|||
27671295|NCT01236352|80634938|FG009|Overall Study|Lack of response to drug|1|||
27671296|NCT01236352|80634939|FG010|Overall Study|Lack of response to drug|1|||
27671297|NCT01236352|80634929|FG000|Overall Study|Patient transferred to IST|0|||
27671298|NCT01236352|80634930|FG001|Overall Study|Patient transferred to IST|0|||
27671299|NCT01236352|80634931|FG002|Overall Study|Patient transferred to IST|0|||
27671300|NCT01236352|80634932|FG003|Overall Study|Patient transferred to IST|0|||
27671301|NCT01236352|80634933|FG004|Overall Study|Patient transferred to IST|0|||
27671302|NCT01236352|80634934|FG005|Overall Study|Patient transferred to IST|0|||
27671303|NCT01236352|80634935|FG006|Overall Study|Patient transferred to IST|0|||
27671304|NCT01236352|80634936|FG007|Overall Study|Patient transferred to IST|0|||
27671305|NCT01236352|80634937|FG008|Overall Study|Patient transferred to IST|0|||
27671306|NCT01236352|80634938|FG009|Overall Study|Patient transferred to IST|2|||
27671307|NCT01236352|80634939|FG010|Overall Study|Patient transferred to IST|6|||
27671308|NCT01447576|80634940|FG000|Overall Study|Lost to Follow-up|52|||
27671309|NCT01447576|80634940|FG000|Overall Study|Adverse Event|127|||
27671310|NCT01447576|80634940|FG000|Overall Study|Participant met withdrawal criteria|40|||
27671311|NCT01447576|80634940|FG000|Overall Study|Withdrawal by Subject|100|||
27671312|NCT01447576|80634940|FG000|Overall Study|Protocol deviation|83|||
27671313|NCT01447576|80634940|FG000|Overall Study|Lack of Efficacy|68|||
27671314|NCT01447576|80634940|FG000|Overall Study|Physician Decision|6|||
27671315|NCT01375751|80634941|FG000|Overall Study|Other|0|||
27671316|NCT01375751|80634942|FG001|Overall Study|Other|1|||
27671317|NCT01375751|80634943|FG002|Overall Study|Other|0|||
27671318|NCT02209181|80634944|FG000|Overall Study|Adverse Event|1|||
27671319|NCT02209181|80634945|FG001|Overall Study|Adverse Event|0|||
27671320|NCT02209181|80634946|FG002|Overall Study|Adverse Event|1|||
27671321|NCT02209181|80634947|FG003|Overall Study|Adverse Event|0|||
27671322|NCT02209181|80634944|FG000|Overall Study|Withdrawal by Subject|0|||
27671323|NCT02209181|80634945|FG001|Overall Study|Withdrawal by Subject|1|||
27671324|NCT02209181|80634946|FG002|Overall Study|Withdrawal by Subject|0|||
27671325|NCT02209181|80634947|FG003|Overall Study|Withdrawal by Subject|0|||
27671326|NCT01547117|80634950|FG000|Overall Study|Physician Decision|0|||
27671327|NCT01547117|80634951|FG001|Overall Study|Physician Decision|1|||
27671328|NCT01547117|80634952|FG002|Overall Study|Physician Decision|1|||
27671329|NCT01547117|80634953|FG003|Overall Study|Physician Decision|3|||
27671330|NCT01547117|80634950|FG000|Overall Study|Withdrawal by Subject|1|||
27671331|NCT01547117|80634951|FG001|Overall Study|Withdrawal by Subject|2|||
27671332|NCT01547117|80634952|FG002|Overall Study|Withdrawal by Subject|1|||
27671333|NCT01547117|80634953|FG003|Overall Study|Withdrawal by Subject|2|||
27671334|NCT02650466|80634954|FG000|Overall Study|Physician Decision|1|||
27671335|NCT02650466|80634954|FG000|Overall Study|Withdrawal by Subject|5|||
27671336|NCT02650466|80634954|FG000|Overall Study|Lost to Follow-up|1|||
27671337|NCT00823836|80634955|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
27671338|NCT00823836|80634956|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
27671339|NCT00823836|80634955|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
27671340|NCT00823836|80634956|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
27671341|NCT00823836|80634955|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
27671342|NCT00823836|80634956|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
27786962|NCT01004861|81051003|FG012|Overall Study|Protocol Violation|0|||
27786963|NCT01004861|81050991|FG000|Overall Study|Lost to Follow-up|0|||
27786964|NCT01004861|81050992|FG001|Overall Study|Lost to Follow-up|0|||
27671343|NCT00823836|80634955|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
27671344|NCT00823836|80634956|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
27671345|NCT00823836|80634955|FG000|Long-term Phase|Adverse Event|3|||
27671346|NCT00823836|80634956|FG001|Long-term Phase|Adverse Event|2|||
27671347|NCT00823836|80634955|FG000|Long-term Phase|Physician Decision|1|||
27671348|NCT00823836|80634956|FG001|Long-term Phase|Physician Decision|2|||
27671349|NCT00823836|80634955|FG000|Long-term Phase|Withdrawal by Subject|1|||
27671350|NCT00823836|80634956|FG001|Long-term Phase|Withdrawal by Subject|1|||
27671351|NCT02165826|80634957|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
27671352|NCT02165826|80634958|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
27786965|NCT01004861|81050993|FG002|Overall Study|Lost to Follow-up|0|||
27671353|NCT02165826|80634959|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
27671354|NCT02165826|80634957|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
27671355|NCT02165826|80634958|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
27671356|NCT02165826|80634959|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
27671357|NCT02165826|80634957|FG000|Main Treatment Period|Lost to Follow-up|4|||
27671358|NCT02165826|80634958|FG001|Main Treatment Period|Lost to Follow-up|2|||
27671359|NCT02165826|80634959|FG002|Main Treatment Period|Lost to Follow-up|1|||
27671360|NCT02165826|80634957|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
27671361|NCT02165826|80634958|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
27671362|NCT02165826|80634959|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
27671363|NCT02165826|80634957|FG000|Main Treatment Period|Lack of Efficacy|2|||
27671364|NCT02165826|80634958|FG001|Main Treatment Period|Lack of Efficacy|0|||
27671365|NCT02165826|80634959|FG002|Main Treatment Period|Lack of Efficacy|0|||
27671366|NCT02165826|80634957|FG000|Main Treatment Period|Reason Not Specified|8|||
27671367|NCT02165826|80634958|FG001|Main Treatment Period|Reason Not Specified|5|||
27671368|NCT02165826|80634959|FG002|Main Treatment Period|Reason Not Specified|16|||
27671369|NCT02165826|80634957|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
27671370|NCT02165826|80634958|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
27671371|NCT02165826|80634959|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
27671372|NCT02165826|80634957|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
27671373|NCT02165826|80634958|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
27671374|NCT02165826|80634959|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
27671375|NCT02165826|80634957|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
27671376|NCT02165826|80634958|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
27671377|NCT02165826|80634959|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
27671378|NCT02165826|80634957|FG000|Down-Titration Period|Reason Not Specified|1|||
27671379|NCT02165826|80634958|FG001|Down-Titration Period|Reason Not Specified|0|||
27671380|NCT02165826|80634959|FG002|Down-Titration Period|Reason Not Specified|2|||
27786966|NCT01004861|81050994|FG003|Overall Study|Lost to Follow-up|0|||
27786967|NCT01004861|81050995|FG004|Overall Study|Lost to Follow-up|0|||
27786968|NCT01004861|81050996|FG005|Overall Study|Lost to Follow-up|0|||
27786969|NCT01004861|81050997|FG006|Overall Study|Lost to Follow-up|0|||
27786970|NCT01004861|81050998|FG007|Overall Study|Lost to Follow-up|1|||
27786971|NCT01004861|81050999|FG008|Overall Study|Lost to Follow-up|3|||
27786972|NCT01004861|81051000|FG009|Overall Study|Lost to Follow-up|0|||
27786973|NCT01004861|81051001|FG010|Overall Study|Lost to Follow-up|0|||
27786974|NCT01004861|81051002|FG011|Overall Study|Lost to Follow-up|1|||
27786975|NCT01004861|81051003|FG012|Overall Study|Lost to Follow-up|0|||
27786976|NCT01004861|81050991|FG000|Overall Study|Non-compliance|0|||
27786977|NCT01004861|81050992|FG001|Overall Study|Non-compliance|0|||
27786978|NCT01004861|81050993|FG002|Overall Study|Non-compliance|0|||
27786979|NCT01004861|81050994|FG003|Overall Study|Non-compliance|0|||
27786980|NCT01004861|81050995|FG004|Overall Study|Non-compliance|0|||
27786981|NCT01004861|81050996|FG005|Overall Study|Non-compliance|0|||
27786982|NCT01004861|81050997|FG006|Overall Study|Non-compliance|0|||
27786983|NCT01004861|81050998|FG007|Overall Study|Non-compliance|0|||
27786984|NCT01004861|81050999|FG008|Overall Study|Non-compliance|5|||
27786985|NCT01004861|81051000|FG009|Overall Study|Non-compliance|0|||
27786986|NCT01004861|81051001|FG010|Overall Study|Non-compliance|0|||
27786987|NCT01004861|81051002|FG011|Overall Study|Non-compliance|0|||
27786988|NCT01004861|81051003|FG012|Overall Study|Non-compliance|1|||
27786989|NCT01004861|81050991|FG000|Overall Study|Other|0|||
27786990|NCT01004861|81050992|FG001|Overall Study|Other|0|||
27786991|NCT01004861|81050993|FG002|Overall Study|Other|0|||
27786992|NCT01004861|81050994|FG003|Overall Study|Other|0|||
27786993|NCT01004861|81050995|FG004|Overall Study|Other|0|||
27671381|NCT01124097|80634961|FG000|Overall Study|Withdrawal by Subject|4|||
27671382|NCT01124097|80634962|FG001|Overall Study|Withdrawal by Subject|3|||
27786994|NCT01004861|81050996|FG005|Overall Study|Other|0|||
27786995|NCT01004861|81050997|FG006|Overall Study|Other|0|||
27786996|NCT01004861|81050998|FG007|Overall Study|Other|0|||
27786997|NCT01004861|81050999|FG008|Overall Study|Other|0|||
27786998|NCT01004861|81051000|FG009|Overall Study|Other|2|||
27973907|NCT00996281|81737707|FG000|Overall Study|Other|5|||
27786999|NCT01004861|81051001|FG010|Overall Study|Other|1|||
27787000|NCT01004861|81051002|FG011|Overall Study|Other|2|||
27787001|NCT01004861|81051003|FG012|Overall Study|Other|3|||
27787002|NCT01004861|81050991|FG000|Overall Study|Patient decision|0|||
27787003|NCT01004861|81050992|FG001|Overall Study|Patient decision|0|||
27787004|NCT01004861|81050993|FG002|Overall Study|Patient decision|0|||
27787005|NCT01004861|81050994|FG003|Overall Study|Patient decision|0|||
27787006|NCT01004861|81050995|FG004|Overall Study|Patient decision|1|||
27787007|NCT01004861|81050996|FG005|Overall Study|Patient decision|0|||
27787008|NCT01004861|81050997|FG006|Overall Study|Patient decision|1|||
27787009|NCT01004861|81050998|FG007|Overall Study|Patient decision|0|||
27787010|NCT01004861|81050999|FG008|Overall Study|Patient decision|7|||
27787011|NCT01004861|81051000|FG009|Overall Study|Patient decision|1|||
27787012|NCT01004861|81051001|FG010|Overall Study|Patient decision|1|||
27787013|NCT01004861|81051002|FG011|Overall Study|Patient decision|2|||
27787014|NCT01004861|81051003|FG012|Overall Study|Patient decision|3|||
27787015|NCT01004861|81050991|FG000|Overall Study|Transitioned to Phase 4 study|0|||
27787016|NCT01004861|81050992|FG001|Overall Study|Transitioned to Phase 4 study|0|||
27787017|NCT01004861|81050993|FG002|Overall Study|Transitioned to Phase 4 study|0|||
27787018|NCT01004861|81050994|FG003|Overall Study|Transitioned to Phase 4 study|0|||
27787019|NCT01004861|81050995|FG004|Overall Study|Transitioned to Phase 4 study|0|||
27787020|NCT01004861|81050996|FG005|Overall Study|Transitioned to Phase 4 study|0|||
27787021|NCT01004861|81050997|FG006|Overall Study|Transitioned to Phase 4 study|0|||
27787022|NCT01004861|81050998|FG007|Overall Study|Transitioned to Phase 4 study|0|||
27787023|NCT01004861|81050999|FG008|Overall Study|Transitioned to Phase 4 study|2|||
27787024|NCT01004861|81051000|FG009|Overall Study|Transitioned to Phase 4 study|0|||
27787025|NCT01004861|81051001|FG010|Overall Study|Transitioned to Phase 4 study|0|||
27787026|NCT01004861|81051002|FG011|Overall Study|Transitioned to Phase 4 study|0|||
27787027|NCT01004861|81051003|FG012|Overall Study|Transitioned to Phase 4 study|0|||
27787028|NCT01004861|81050991|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787029|NCT01004861|81050992|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787030|NCT01004861|81050993|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787031|NCT01004861|81050994|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787032|NCT01004861|81050995|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787033|NCT01004861|81050996|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787034|NCT01004861|81050997|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787035|NCT01004861|81050998|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787036|NCT01004861|81050999|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
27787037|NCT01004861|81051000|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787038|NCT01004861|81051001|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787039|NCT01004861|81051002|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787040|NCT01004861|81051003|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
27787041|NCT01004861|81050991|FG000|Overall Study|Patient withdrew|0|||
27787042|NCT01004861|81050992|FG001|Overall Study|Patient withdrew|0|||
27787043|NCT01004861|81050993|FG002|Overall Study|Patient withdrew|0|||
27787044|NCT01004861|81050994|FG003|Overall Study|Patient withdrew|0|||
27787045|NCT01004861|81050995|FG004|Overall Study|Patient withdrew|0|||
27787046|NCT01004861|81050996|FG005|Overall Study|Patient withdrew|0|||
27787047|NCT01004861|81050997|FG006|Overall Study|Patient withdrew|0|||
27787048|NCT01004861|81050998|FG007|Overall Study|Patient withdrew|0|||
27787049|NCT01004861|81050999|FG008|Overall Study|Patient withdrew|1|||
27787050|NCT01004861|81051000|FG009|Overall Study|Patient withdrew|0|||
27973908|NCT00996281|81737708|FG001|Overall Study|Other|7|||
27973909|NCT03245736|81737709|FG000|Overall Study|Adverse Event|1|||
27973910|NCT03245736|81737709|FG000|Overall Study|Progressive Disease|4|||
27973911|NCT02233738|81737713|FG000|Overall Study|Lost to Follow-up|5|||
27973912|NCT02233738|81737714|FG001|Overall Study|Lost to Follow-up|12|||
27973913|NCT02233738|81737713|FG000|Overall Study|Death|0|||
27973914|NCT02233738|81737714|FG001|Overall Study|Death|1|||
27973915|NCT02233738|81737713|FG000|Overall Study|Withdrawal by Subject|0|||
27973916|NCT02233738|81737714|FG001|Overall Study|Withdrawal by Subject|1|||
27973917|NCT02233738|81737713|FG000|Overall Study|Did not return after Baseline|3|||
27973918|NCT02233738|81737714|FG001|Overall Study|Did not return after Baseline|2|||
27973919|NCT01396265|81737715|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
27787051|NCT01004861|81051001|FG010|Overall Study|Patient withdrew|0|||
27787052|NCT01004861|81051002|FG011|Overall Study|Patient withdrew|0|||
27787053|NCT01004861|81051003|FG012|Overall Study|Patient withdrew|0|||
27787054|NCT01004861|81050991|FG000|Overall Study|Surgical resection|0|||
27787055|NCT01004861|81050992|FG001|Overall Study|Surgical resection|0|||
27787056|NCT01004861|81050993|FG002|Overall Study|Surgical resection|0|||
27787057|NCT01004861|81050994|FG003|Overall Study|Surgical resection|0|||
27973920|NCT01071200|81737720|FG000|Overall Study|Lack of ovarian response|1|||
27973921|NCT01071200|81737721|FG001|Overall Study|Lack of ovarian response|1|||
27973922|NCT01071200|81737720|FG000|Overall Study|No fertilization|4|||
27973923|NCT01071200|81737721|FG001|Overall Study|No fertilization|0|||
27973924|NCT01071200|81737720|FG000|Overall Study|No oocytes retrieved|1|||
27973925|NCT01071200|81737721|FG001|Overall Study|No oocytes retrieved|1|||
27973926|NCT01071200|81737720|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
27973927|NCT01071200|81737721|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
27973928|NCT01071200|81737720|FG000|Overall Study|No viable embryos|0|||
27973929|NCT01071200|81737721|FG001|Overall Study|No viable embryos|1|||
27973930|NCT02460783|81737722|FG000|Overall Study|Withdrawal by Subject|1|||
27973931|NCT02460783|81737723|FG001|Overall Study|Withdrawal by Subject|3|||
27973932|NCT02460783|81737722|FG000|Overall Study|Lost to Follow-up|1|||
27973933|NCT02460783|81737723|FG001|Overall Study|Lost to Follow-up|1|||
27973934|NCT01904149|81737724|FG000|Overall Study|Adverse Event|3|||
27973935|NCT01904149|81737725|FG001|Overall Study|Adverse Event|4|||
27973936|NCT01904149|81737726|FG002|Overall Study|Adverse Event|0|||
27973937|NCT01904149|81737727|FG003|Overall Study|Adverse Event|1|||
27973938|NCT01904149|81737728|FG004|Overall Study|Adverse Event|1|||
27973939|NCT01904149|81737729|FG005|Overall Study|Adverse Event|2|||
27973940|NCT01904149|81737724|FG000|Overall Study|Lack of Efficacy|0|||
27973941|NCT01904149|81737725|FG001|Overall Study|Lack of Efficacy|3|||
27973942|NCT01904149|81737726|FG002|Overall Study|Lack of Efficacy|1|||
27973943|NCT01904149|81737727|FG003|Overall Study|Lack of Efficacy|3|||
27973944|NCT01904149|81737728|FG004|Overall Study|Lack of Efficacy|3|||
27973945|NCT01904149|81737729|FG005|Overall Study|Lack of Efficacy|1|||
27973946|NCT01904149|81737724|FG000|Overall Study|Withdrawal by Subject|1|||
27973947|NCT01904149|81737725|FG001|Overall Study|Withdrawal by Subject|3|||
27973948|NCT01904149|81737726|FG002|Overall Study|Withdrawal by Subject|1|||
27973949|NCT01904149|81737727|FG003|Overall Study|Withdrawal by Subject|0|||
27973950|NCT01904149|81737728|FG004|Overall Study|Withdrawal by Subject|1|||
27973951|NCT01904149|81737729|FG005|Overall Study|Withdrawal by Subject|0|||
27973952|NCT01904149|81737724|FG000|Overall Study|Protocol Violation|0|||
27973953|NCT01904149|81737725|FG001|Overall Study|Protocol Violation|1|||
27973954|NCT01904149|81737726|FG002|Overall Study|Protocol Violation|0|||
27973955|NCT01904149|81737727|FG003|Overall Study|Protocol Violation|0|||
27973956|NCT01904149|81737728|FG004|Overall Study|Protocol Violation|0|||
27973957|NCT01904149|81737729|FG005|Overall Study|Protocol Violation|0|||
27973958|NCT01904149|81737724|FG000|Overall Study|non compliance with study drug|1|||
27973959|NCT01904149|81737725|FG001|Overall Study|non compliance with study drug|0|||
27973960|NCT01904149|81737726|FG002|Overall Study|non compliance with study drug|0|||
27973961|NCT01904149|81737727|FG003|Overall Study|non compliance with study drug|0|||
27973962|NCT01904149|81737728|FG004|Overall Study|non compliance with study drug|0|||
27787058|NCT01004861|81050995|FG004|Overall Study|Surgical resection|0|||
27787059|NCT01004861|81050996|FG005|Overall Study|Surgical resection|0|||
27787060|NCT01004861|81050997|FG006|Overall Study|Surgical resection|0|||
27787061|NCT01004861|81050998|FG007|Overall Study|Surgical resection|0|||
27787062|NCT01004861|81050999|FG008|Overall Study|Surgical resection|1|||
27787063|NCT01004861|81051000|FG009|Overall Study|Surgical resection|0|||
27787064|NCT01004861|81051001|FG010|Overall Study|Surgical resection|0|||
27787065|NCT01004861|81051002|FG011|Overall Study|Surgical resection|0|||
27973963|NCT01904149|81737729|FG005|Overall Study|non compliance with study drug|0|||
27973964|NCT00515294|81737730|FG000|Overall Study|Lost to Follow-up|3|||
27973965|NCT00515294|81737731|FG001|Overall Study|Lost to Follow-up|2|||
27787066|NCT01004861|81051003|FG012|Overall Study|Surgical resection|0|||
27787067|NCT01004861|81050991|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787068|NCT01004861|81050992|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27973966|NCT00515294|81737732|FG002|Overall Study|Lost to Follow-up|3|||
27973967|NCT00515294|81737733|FG003|Overall Study|Lost to Follow-up|1|||
27973968|NCT00515294|81737730|FG000|Overall Study|Driver simulator problems|1|||
27973969|NCT00515294|81737731|FG001|Overall Study|Driver simulator problems|1|||
27973970|NCT00515294|81737732|FG002|Overall Study|Driver simulator problems|1|||
27973971|NCT00515294|81737733|FG003|Overall Study|Driver simulator problems|3|||
27973972|NCT00515294|81737730|FG000|Overall Study|Caffeine amount inaccurate|5|||
27973973|NCT00515294|81737731|FG001|Overall Study|Caffeine amount inaccurate|0|||
27973974|NCT00515294|81737732|FG002|Overall Study|Caffeine amount inaccurate|7|||
27787069|NCT01004861|81050993|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787070|NCT01004861|81050994|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27973975|NCT00515294|81737733|FG003|Overall Study|Caffeine amount inaccurate|0|||
27973976|NCT03263923|81737734|FG000|Overall Study|Withdrawal by Subject|10|||
27973977|NCT03263923|81737735|FG001|Overall Study|Withdrawal by Subject|8|||
27973978|NCT03263923|81737734|FG000|Overall Study|Lost to Follow-up|15|||
27973979|NCT03263923|81737735|FG001|Overall Study|Lost to Follow-up|13|||
27973980|NCT02403635|81737736|FG000|Overall Study|Not eligible|9|||
27973981|NCT01498575|81737740|FG000|Overall Sample|Withdrawal by Subject|60|||
27973982|NCT01498575|81737741|FG001|Overall Sample|Withdrawal by Subject|14|||
27973983|NCT01498575|81737740|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
27787071|NCT01004861|81050995|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787072|NCT01004861|81050996|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787073|NCT01004861|81050997|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787074|NCT01004861|81050998|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787075|NCT01004861|81050999|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
27787076|NCT01004861|81051000|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787077|NCT01004861|81051001|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787078|NCT01004861|81051002|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787079|NCT01004861|81051003|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
27787080|NCT01004861|81050991|FG000|Overall Study|Study termination by Sponsor|0|||
27787081|NCT01004861|81050992|FG001|Overall Study|Study termination by Sponsor|0|||
27787082|NCT01004861|81050993|FG002|Overall Study|Study termination by Sponsor|0|||
27787083|NCT01004861|81050994|FG003|Overall Study|Study termination by Sponsor|0|||
27787084|NCT01004861|81050995|FG004|Overall Study|Study termination by Sponsor|0|||
27787085|NCT01004861|81050996|FG005|Overall Study|Study termination by Sponsor|0|||
27787086|NCT01004861|81050997|FG006|Overall Study|Study termination by Sponsor|0|||
27787087|NCT01004861|81050998|FG007|Overall Study|Study termination by Sponsor|0|||
27787088|NCT01004861|81050999|FG008|Overall Study|Study termination by Sponsor|1|||
27787089|NCT01004861|81051000|FG009|Overall Study|Study termination by Sponsor|0|||
27787090|NCT01004861|81051001|FG010|Overall Study|Study termination by Sponsor|0|||
27787091|NCT01004861|81051002|FG011|Overall Study|Study termination by Sponsor|0|||
27787092|NCT01004861|81051003|FG012|Overall Study|Study termination by Sponsor|0|||
27787093|NCT00594958|81051004|FG000|Overall Study|Withdrawal by Subject|1|||
27787094|NCT00594958|81051005|FG001|Overall Study|Withdrawal by Subject|0|||
27787095|NCT00594958|81051006|FG002|Overall Study|Withdrawal by Subject|1|||
27787096|NCT00594958|81051004|FG000|Overall Study|Adverse Event|4|||
27787097|NCT00594958|81051005|FG001|Overall Study|Adverse Event|1|||
27787098|NCT00594958|81051006|FG002|Overall Study|Adverse Event|2|||
27787099|NCT00594958|81051004|FG000|Overall Study|Pregnancy|0|||
27787100|NCT00594958|81051005|FG001|Overall Study|Pregnancy|2|||
27787101|NCT00594958|81051006|FG002|Overall Study|Pregnancy|0|||
27787102|NCT00594958|81051004|FG000|Overall Study|Protocol Violation|1|||
27787103|NCT00594958|81051005|FG001|Overall Study|Protocol Violation|0|||
27787104|NCT00594958|81051006|FG002|Overall Study|Protocol Violation|2|||
27787105|NCT00594958|81051004|FG000|Overall Study|Lost to Follow-up|5|||
27787106|NCT00594958|81051005|FG001|Overall Study|Lost to Follow-up|0|||
27787107|NCT00594958|81051006|FG002|Overall Study|Lost to Follow-up|3|||
27787108|NCT00594958|81051004|FG000|Overall Study|administrative|3|||
27787109|NCT00594958|81051005|FG001|Overall Study|administrative|0|||
27787110|NCT00594958|81051006|FG002|Overall Study|administrative|2|||
27787111|NCT04863898|81051007|FG000|Overall Study|Away from study clinic during intervention training period|2|||
27787112|NCT04863898|81051007|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
27787113|NCT04863898|81051007|FG000|Overall Study|Lost to Follow-up|3|||
27787114|NCT04863898|81051007|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
27787115|NCT04863898|81051007|FG000|Overall Study|No longer employed at clinic|3|||
27787116|NCT01161173|81051010|FG000|Overall Study|Protocol Violation|13|||
27787117|NCT01161173|81051010|FG000|Overall Study|Lost to Follow-up|7|||
27787118|NCT01161173|81051010|FG000|Overall Study|Progressive Disease|82|||
27787119|NCT01161173|81051010|FG000|Overall Study|Withdrawal of Consent|5|||
27787120|NCT01161173|81051010|FG000|Overall Study|Unacceptable Toxicity|21|||
27787121|NCT01161173|81051010|FG000|Overall Study|Death|194|||
27787122|NCT01161173|81051010|FG000|Overall Study|End of Study|2|||
27787123|NCT01161173|81051010|FG000|Overall Study|Reasons Not Specified|23|||
27787124|NCT00405756|81051011|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
27787125|NCT00405756|81051012|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
27787126|NCT00405756|81051013|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
27787127|NCT00405756|81051011|FG000|Double-blind Treatment|Adverse Event|31|||
27787128|NCT00405756|81051012|FG001|Double-blind Treatment|Adverse Event|27|||
27787129|NCT00405756|81051013|FG002|Double-blind Treatment|Adverse Event|12|||
27787130|NCT00405756|81051011|FG000|Double-blind Treatment|Disease Progression|47|||
27787131|NCT00405756|81051012|FG001|Double-blind Treatment|Disease Progression|81|||
27787132|NCT00405756|81051013|FG002|Double-blind Treatment|Disease Progression|102|||
27787133|NCT00405756|81051011|FG000|Double-blind Treatment|Lack of Efficacy|1|||
27787134|NCT00405756|81051012|FG001|Double-blind Treatment|Lack of Efficacy|4|||
27787135|NCT00405756|81051013|FG002|Double-blind Treatment|Lack of Efficacy|2|||
27787136|NCT00405756|81051011|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
27787137|NCT00405756|81051012|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
27787138|NCT00405756|81051013|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
27787139|NCT00405756|81051011|FG000|Double-blind Treatment|Lost to Follow-up|1|||
27787140|NCT00405756|81051012|FG001|Double-blind Treatment|Lost to Follow-up|0|||
27787141|NCT00405756|81051013|FG002|Double-blind Treatment|Lost to Follow-up|0|||
27787142|NCT00405756|81051011|FG000|Double-blind Treatment|Death|4|||
27787143|NCT00405756|81051012|FG001|Double-blind Treatment|Death|4|||
27787144|NCT00405756|81051013|FG002|Double-blind Treatment|Death|4|||
27787145|NCT00405756|81051011|FG000|Double-blind Treatment|Protocol Violation|1|||
27787146|NCT00405756|81051012|FG001|Double-blind Treatment|Protocol Violation|0|||
27787147|NCT00405756|81051013|FG002|Double-blind Treatment|Protocol Violation|2|||
27787148|NCT00405756|81051011|FG000|Double-blind Treatment|Other|7|||
27787149|NCT00405756|81051012|FG001|Double-blind Treatment|Other|4|||
27787150|NCT00405756|81051013|FG002|Double-blind Treatment|Other|4|||
27787151|NCT00405756|81051011|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
27787152|NCT00405756|81051012|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
27787153|NCT00405756|81051013|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
27787154|NCT00405756|81051011|FG000|Open-label Extension|Adverse Event|1|||
27787155|NCT00405756|81051012|FG001|Open-label Extension|Adverse Event|3|||
27787156|NCT00405756|81051013|FG002|Open-label Extension|Adverse Event|7|||
27787157|NCT00405756|81051011|FG000|Open-label Extension|Disease Progression|8|||
27787158|NCT00405756|81051012|FG001|Open-label Extension|Disease Progression|23|||
27787159|NCT00405756|81051013|FG002|Open-label Extension|Disease Progression|26|||
27787160|NCT00405756|81051011|FG000|Open-label Extension|Withdrawal by Subject|2|||
27787161|NCT00405756|81051012|FG001|Open-label Extension|Withdrawal by Subject|3|||
27787162|NCT00405756|81051013|FG002|Open-label Extension|Withdrawal by Subject|3|||
27973984|NCT01498575|81737741|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
27973985|NCT01498575|81737740|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
27973986|NCT01498575|81737741|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
27973987|NCT01574157|81737742|FG000|Overall Study|Withdrawal by Subject|4|||
27973988|NCT01574157|81737743|FG001|Overall Study|Withdrawal by Subject|5|||
27973989|NCT01574157|81737742|FG000|Overall Study|Lost to Follow-up|0|||
27973990|NCT01574157|81737743|FG001|Overall Study|Lost to Follow-up|3|||
27973991|NCT05438602|81737752|FG000|Treatment (15 Days)|Adverse Event|2|||
27973992|NCT05438602|81737753|FG001|Treatment (15 Days)|Adverse Event|1|||
27973993|NCT05438602|81737754|FG002|Treatment (15 Days)|Adverse Event|3|||
27973994|NCT05438602|81737752|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
27973995|NCT05438602|81737753|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
27787163|NCT00405756|81051011|FG000|Open-label Extension|Death|1|||
27787164|NCT00405756|81051012|FG001|Open-label Extension|Death|2|||
27787165|NCT00405756|81051013|FG002|Open-label Extension|Death|4|||
27973996|NCT05438602|81737754|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
27973997|NCT05438602|81737752|FG000|Treatment (15 Days)|Other|0|||
27973998|NCT05438602|81737753|FG001|Treatment (15 Days)|Other|0|||
27973999|NCT05438602|81737754|FG002|Treatment (15 Days)|Other|1|||
27974000|NCT05438602|81737752|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
27787166|NCT00405756|81051011|FG000|Open-label Extension|Other|0|||
27787167|NCT00405756|81051012|FG001|Open-label Extension|Other|1|||
27787168|NCT00405756|81051013|FG002|Open-label Extension|Other|7|||
27787169|NCT00405756|81051011|FG000|Follow-up|Ongoing in Follow-up Period|52|||
27787170|NCT00405756|81051012|FG001|Follow-up|Ongoing in Follow-up Period|51|||
27787171|NCT00405756|81051013|FG002|Follow-up|Ongoing in Follow-up Period|60|||
27787172|NCT00405756|81051011|FG000|Follow-up|Death|21|||
27974001|NCT05438602|81737753|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
27974002|NCT05438602|81737754|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
27974003|NCT05438602|81737752|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
27974004|NCT05438602|81737753|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
27974005|NCT05438602|81737754|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
27974006|NCT05438602|81737752|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
27974007|NCT05438602|81737753|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
27974008|NCT05438602|81737754|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
27974009|NCT05438602|81737752|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
27974010|NCT05438602|81737753|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
27974011|NCT05438602|81737754|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
27974012|NCT05438602|81737752|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
27974013|NCT05438602|81737753|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
27974014|NCT05438602|81737754|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
27974015|NCT05438602|81737752|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
27974016|NCT05438602|81737753|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
27974017|NCT05438602|81737754|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
27974018|NCT05438602|81737752|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
27974019|NCT05438602|81737753|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
27974020|NCT05438602|81737754|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
27974021|NCT00241631|81737755|FG000|Run in (2 Weeks)|Physician Decision|3|||
27974022|NCT00241631|81737756|FG001|Run in (2 Weeks)|Physician Decision|3|||
27974023|NCT00241631|81737755|FG000|Phase 1 (4 Weeks)|sore throat|1|||
27974024|NCT00241631|81737756|FG001|Phase 1 (4 Weeks)|sore throat|0|||
27974025|NCT00241631|81737755|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
27974026|NCT00241631|81737756|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
27974027|NCT00241631|81737755|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
27974028|NCT00241631|81737756|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
27974029|NCT00241631|81737755|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
27974030|NCT00241631|81737756|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
27974031|NCT00457821|81737757|FG000|Part 2|Withdrawal by Subject|0|||
27974032|NCT00457821|81737758|FG001|Part 2|Withdrawal by Subject|0|||
27974033|NCT00457821|81737759|FG002|Part 2|Withdrawal by Subject|0|||
27974034|NCT00457821|81737760|FG003|Part 2|Withdrawal by Subject|0|||
27974035|NCT00457821|81737761|FG004|Part 2|Withdrawal by Subject|0|||
27974036|NCT00457821|81737762|FG005|Part 2|Withdrawal by Subject|0|||
27974037|NCT00457821|81737763|FG006|Part 2|Withdrawal by Subject|0|||
27974038|NCT00457821|81737764|FG007|Part 2|Withdrawal by Subject|1|||
27974039|NCT03746600|81737765|FG000|Overall Study|Withdrawal by Subject|3|||
27974040|NCT03746600|81737766|FG001|Overall Study|Withdrawal by Subject|3|||
27974041|NCT03746600|81737765|FG000|Overall Study|dismissed from study|1|||
27974042|NCT03746600|81737766|FG001|Overall Study|dismissed from study|0|||
27974043|NCT03746600|81737765|FG000|Overall Study|Lost to Follow-up|1|||
27974044|NCT03746600|81737766|FG001|Overall Study|Lost to Follow-up|0|||
27787173|NCT00405756|81051012|FG001|Follow-up|Death|31|||
27974045|NCT02927925|81737767|FG000|Overall Study|Death|16|||
27787174|NCT00405756|81051013|FG002|Follow-up|Death|24|||
27787175|NCT00405756|81051011|FG000|Follow-up|Lost to Follow-up|2|||
27787176|NCT00405756|81051012|FG001|Follow-up|Lost to Follow-up|8|||
27787177|NCT00405756|81051013|FG002|Follow-up|Lost to Follow-up|4|||
27787178|NCT04115488|81051029|FG000|Overall Study|Adverse Event|8|||
27787179|NCT04115488|81051030|FG001|Overall Study|Adverse Event|4|||
27787180|NCT04115488|81051029|FG000|Overall Study|Withdrawal by Subject|3|||
27867160|NCT03447743|81346696|FG000|Overall Study|Withdrawal by Subject|2|||
27867161|NCT03447743|81346696|FG000|Overall Study|Lost to Follow-up|3|||
27867162|NCT03447743|81346696|FG000|Overall Study|Adverse Event|1|||
27867163|NCT03447743|81346696|FG000|Overall Study|Did not meet criteria to continue|1|||
27867164|NCT02565511|81346697|FG000|Overall Study|Study terminated by Sponsor|35|||
27867165|NCT02565511|81346698|FG001|Overall Study|Study terminated by Sponsor|22|||
27867166|NCT02565511|81346699|FG002|Overall Study|Study terminated by Sponsor|235|||
27867167|NCT02565511|81346700|FG003|Overall Study|Study terminated by Sponsor|156|||
27867168|NCT02565511|81346697|FG000|Overall Study|Withdrawal by Subject|3|||
27867169|NCT02565511|81346698|FG001|Overall Study|Withdrawal by Subject|0|||
27867170|NCT02565511|81346699|FG002|Overall Study|Withdrawal by Subject|12|||
27867171|NCT02565511|81346700|FG003|Overall Study|Withdrawal by Subject|5|||
27867172|NCT02565511|81346697|FG000|Overall Study|Adverse Event|0|||
27867173|NCT02565511|81346698|FG001|Overall Study|Adverse Event|0|||
27867174|NCT02565511|81346699|FG002|Overall Study|Adverse Event|1|||
27867175|NCT02565511|81346700|FG003|Overall Study|Adverse Event|1|||
27867176|NCT02565511|81346697|FG000|Overall Study|Lost to Follow-up|4|||
27867177|NCT02565511|81346698|FG001|Overall Study|Lost to Follow-up|1|||
27867178|NCT02565511|81346699|FG002|Overall Study|Lost to Follow-up|0|||
27867179|NCT02565511|81346700|FG003|Overall Study|Lost to Follow-up|1|||
27867180|NCT02565511|81346697|FG000|Overall Study|Physician Decision|0|||
27867181|NCT02565511|81346698|FG001|Overall Study|Physician Decision|0|||
27867182|NCT02565511|81346699|FG002|Overall Study|Physician Decision|0|||
27867183|NCT02565511|81346700|FG003|Overall Study|Physician Decision|1|||
27867184|NCT02565511|81346697|FG000|Overall Study|Protocol deviation|0|||
27867185|NCT02565511|81346698|FG001|Overall Study|Protocol deviation|0|||
27867186|NCT02565511|81346699|FG002|Overall Study|Protocol deviation|3|||
27867187|NCT02565511|81346700|FG003|Overall Study|Protocol deviation|0|||
27867188|NCT00822692|81346715|FG000|Overall Study|Lost to Follow-up|17|||
27867189|NCT00822692|81346716|FG001|Overall Study|Lost to Follow-up|25|||
27867190|NCT02215967|81346722|FG000|Overall Study|Patient became ineligible for treatment|0|||
27867191|NCT02215967|81346723|FG001|Overall Study|Patient became ineligible for treatment|0|||
27867192|NCT02215967|81346724|FG002|Overall Study|Patient became ineligible for treatment|0|||
27867193|NCT02215967|81346725|FG003|Overall Study|Patient became ineligible for treatment|3|||
27867194|NCT02215967|81346722|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
27867195|NCT02215967|81346723|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
27867196|NCT02215967|81346724|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
27867197|NCT02215967|81346725|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
27867198|NCT01260701|81346726|FG000|Overall Study|Adverse Event|9|||
27867199|NCT01260701|81346726|FG000|Overall Study|Withdrawal by Subject|2|||
27867200|NCT01260701|81346726|FG000|Overall Study|Progression|53|||
27867201|NCT01260701|81346726|FG000|Overall Study|Death|2|||
27867202|NCT01260701|81346726|FG000|Overall Study|Not protocol specified|3|||
27867203|NCT01260701|81346726|FG000|Overall Study|Under review|1|||
27867204|NCT01260701|81346726|FG000|Overall Study|Ineligible|4|||
27867205|NCT01260701|81346726|FG000|Overall Study|Did not begin protocol therapy|1|||
27867206|NCT03280381|81346727|FG000|Overall Study|Physician Decision|0|||
27867207|NCT03280381|81346728|FG001|Overall Study|Physician Decision|2|||
27867208|NCT01557517|81346730|FG000|Overall Study|Death|1|||
27867209|NCT01557517|81346731|FG001|Overall Study|Death|0|||
27867210|NCT01557517|81346730|FG000|Overall Study|Refused further treatment|0|||
27787181|NCT04115488|81051030|FG001|Overall Study|Withdrawal by Subject|6|||
27787182|NCT04115488|81051029|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
27787183|NCT04115488|81051030|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
27867211|NCT01557517|81346731|FG001|Overall Study|Refused further treatment|2|||
27867212|NCT01557517|81346730|FG000|Overall Study|Adverse Event|0|||
27787184|NCT04115488|81051029|FG000|Overall Study|Patient 's location change|1|||
27867213|NCT01557517|81346731|FG001|Overall Study|Adverse Event|2|||
27867214|NCT01557517|81346730|FG000|Overall Study|Pt declined before treatment started|1|||
27867215|NCT01557517|81346731|FG001|Overall Study|Pt declined before treatment started|0|||
27787185|NCT04115488|81051030|FG001|Overall Study|Patient 's location change|0|||
27787186|NCT04115488|81051029|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
27787187|NCT04115488|81051030|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
27787188|NCT00486720|81051035|FG000|Overall Study|Adverse Event|1|||
27787189|NCT00486720|81051036|FG001|Overall Study|Adverse Event|2|||
27787190|NCT00486720|81051035|FG000|Overall Study|Lack of Efficacy|4|||
27974046|NCT02927925|81737767|FG000|Overall Study|Physician Decision|1|||
27974047|NCT02927925|81737767|FG000|Overall Study|Withdrawal by Subject|11|||
27974048|NCT02927925|81737767|FG000|Overall Study|Other|3|||
27974049|NCT02927925|81737767|FG000|Overall Study|Disease progression at clinical cutoff|1|||
27974050|NCT04484649|81737768|FG000|Overall Study|Lost to Follow-up|2|||
27974051|NCT04484649|81737769|FG001|Overall Study|Lost to Follow-up|1|||
27974052|NCT04484649|81737768|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
27573269|NCT02203591|80285580|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
27787191|NCT00486720|81051036|FG001|Overall Study|Lack of Efficacy|6|||
27787192|NCT00486720|81051035|FG000|Overall Study|Physician Decision|1|||
27787193|NCT00486720|81051036|FG001|Overall Study|Physician Decision|2|||
27787194|NCT00486720|81051035|FG000|Overall Study|Protocol Violation|1|||
27787195|NCT00486720|81051036|FG001|Overall Study|Protocol Violation|0|||
27787196|NCT00486720|81051035|FG000|Overall Study|Withdrawal by Subject|3|||
27787197|NCT00486720|81051036|FG001|Overall Study|Withdrawal by Subject|1|||
27787198|NCT00486720|81051035|FG000|Overall Study|Progressive Disease|0|||
27787199|NCT00486720|81051036|FG001|Overall Study|Progressive Disease|1|||
27787200|NCT01756846|81051037|FG000|Overall Study|Lost to Follow-up|5|||
27787201|NCT01756846|81051038|FG001|Overall Study|Lost to Follow-up|10|||
27867216|NCT00616421|81346738|FG000|Overall Study|Withdrawal by Subject|9|||
27867217|NCT00616421|81346739|FG001|Overall Study|Withdrawal by Subject|11|||
27974053|NCT04484649|81737769|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
27974054|NCT02358031|81737770|FG000|Overall Study|Death|253|||
27974055|NCT02358031|81737771|FG001|Overall Study|Death|237|||
27974056|NCT02358031|81737772|FG002|Overall Study|Death|266|||
27974057|NCT02358031|81737770|FG000|Overall Study|Lost to Follow-up|1|||
27974058|NCT02358031|81737771|FG001|Overall Study|Lost to Follow-up|1|||
27974059|NCT02358031|81737772|FG002|Overall Study|Lost to Follow-up|0|||
27974060|NCT02358031|81737770|FG000|Overall Study|Withdrawal by Subject|19|||
27974061|NCT02358031|81737771|FG001|Overall Study|Withdrawal by Subject|14|||
27974062|NCT02358031|81737772|FG002|Overall Study|Withdrawal by Subject|18|||
27974063|NCT02358031|81737770|FG000|Overall Study|Sponsor Decision|26|||
27974064|NCT02358031|81737771|FG001|Overall Study|Sponsor Decision|28|||
27974065|NCT02358031|81737772|FG002|Overall Study|Sponsor Decision|16|||
27974066|NCT02701777|81737773|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
27974067|NCT02701777|81737774|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
27974068|NCT02701777|81737775|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
27974069|NCT02701777|81737776|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
27974070|NCT02701777|81737773|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
27974071|NCT02701777|81737774|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
27974072|NCT02701777|81737775|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
27974073|NCT02701777|81737776|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
27974074|NCT02136680|81737777|FG000|Overall Study|No Longer Interested|1|||
27974075|NCT02136680|81737778|FG001|Overall Study|No Longer Interested|1|||
27974076|NCT02136680|81737777|FG000|Overall Study|No longer receiving care at clinic|3|||
27974077|NCT02136680|81737778|FG001|Overall Study|No longer receiving care at clinic|5|||
27974078|NCT02136680|81737777|FG000|Overall Study|Moved away|5|||
27974079|NCT02136680|81737778|FG001|Overall Study|Moved away|4|||
27974080|NCT02136680|81737777|FG000|Overall Study|Unable to schedule|17|||
27974081|NCT02136680|81737778|FG001|Overall Study|Unable to schedule|16|||
27974082|NCT02136680|81737777|FG000|Overall Study|Study ended before interview due|6|||
27974083|NCT02136680|81737778|FG001|Overall Study|Study ended before interview due|3|||
27974084|NCT04677660|81737782|FG000|Overall Study|Lost to Follow-up|0|||
27974085|NCT04677660|81737783|FG001|Overall Study|Lost to Follow-up|2|||
27974086|NCT04677660|81737782|FG000|Overall Study|Withdrawal by Subject|0|||
27974087|NCT04677660|81737783|FG001|Overall Study|Withdrawal by Subject|1|||
27974088|NCT04677660|81737782|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
27974089|NCT04677660|81737783|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
27974090|NCT02509039|81737787|FG000|Overall Study|Adverse Event|0|||
27974091|NCT02509039|81737788|FG001|Overall Study|Adverse Event|1|||
27974092|NCT02509039|81737789|FG002|Overall Study|Adverse Event|1|||
27974093|NCT02509039|81737790|FG003|Overall Study|Adverse Event|1|||
27974094|NCT02509039|81737787|FG000|Overall Study|Withdrawal by Subject|0|||
27974095|NCT02509039|81737788|FG001|Overall Study|Withdrawal by Subject|0|||
27974096|NCT02509039|81737789|FG002|Overall Study|Withdrawal by Subject|1|||
27974097|NCT02509039|81737790|FG003|Overall Study|Withdrawal by Subject|0|||
27974098|NCT02509039|81737787|FG000|Overall Study|Progressive disease|2|||
27974099|NCT02509039|81737788|FG001|Overall Study|Progressive disease|2|||
27974100|NCT02509039|81737789|FG002|Overall Study|Progressive disease|1|||
27974101|NCT02509039|81737790|FG003|Overall Study|Progressive disease|5|||
27974102|NCT02509039|81737787|FG000|Overall Study|Study terminated by Sponsor|1|||
27974103|NCT02509039|81737788|FG001|Overall Study|Study terminated by Sponsor|0|||
27974104|NCT02509039|81737789|FG002|Overall Study|Study terminated by Sponsor|0|||
27974105|NCT02509039|81737790|FG003|Overall Study|Study terminated by Sponsor|0|||
27974106|NCT03593681|81737791|FG000|Overall Study|Inadequate sample collected|12|||
27974107|NCT03593681|81737791|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
27974108|NCT03593681|81737791|FG000|Overall Study|Protocol Violation|3|||
27974109|NCT03593681|81737791|FG000|Overall Study|Withdrawal by Subject|3|||
27787202|NCT01756846|81051037|FG000|Overall Study|Withdrawal by Subject|1|||
27974110|NCT03593681|81737791|FG000|Overall Study|Procedure not attempted|3|||
27974111|NCT03593681|81737791|FG000|Overall Study|Adverse Event|2|||
27974112|NCT03593681|81737791|FG000|Overall Study|Physician Decision|1|||
27974113|NCT05659719|81737793|FG000|Overall Study|At sponsor's request|0|||
27974114|NCT05659719|81737794|FG001|Overall Study|At sponsor's request|0|||
27974115|NCT05659719|81737795|FG002|Overall Study|At sponsor's request|0|||
27974116|NCT05659719|81737796|FG003|Overall Study|At sponsor's request|95|||
27974117|NCT05659719|81737793|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
27974118|NCT05659719|81737794|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
27974119|NCT05659719|81737795|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
27974120|NCT05659719|81737796|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
27974121|NCT05659719|81737793|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
27974122|NCT05659719|81737794|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
27974123|NCT05659719|81737795|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
27974124|NCT05659719|81737796|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
27974125|NCT05659719|81737793|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
27974126|NCT05659719|81737794|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
27974127|NCT05659719|81737795|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
27974128|NCT05659719|81737796|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
27974129|NCT05659719|81737793|FG000|Overall Study|Lost to Follow-up|0|||
27974130|NCT05659719|81737794|FG001|Overall Study|Lost to Follow-up|0|||
27974131|NCT05659719|81737795|FG002|Overall Study|Lost to Follow-up|0|||
27974132|NCT05659719|81737796|FG003|Overall Study|Lost to Follow-up|2|||
27974133|NCT05659719|81737793|FG000|Overall Study|Moved to another observational study|0|||
27974134|NCT05659719|81737794|FG001|Overall Study|Moved to another observational study|0|||
27974135|NCT05659719|81737795|FG002|Overall Study|Moved to another observational study|0|||
27974136|NCT05659719|81737796|FG003|Overall Study|Moved to another observational study|1|||
27974137|NCT05659719|81737793|FG000|Overall Study|The child was enrolled in an interventional study|0|||
27974138|NCT05659719|81737794|FG001|Overall Study|The child was enrolled in an interventional study|0|||
27974139|NCT05659719|81737795|FG002|Overall Study|The child was enrolled in an interventional study|0|||
27974140|NCT05659719|81737796|FG003|Overall Study|The child was enrolled in an interventional study|55|||
27974141|NCT05659719|81737793|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
27974142|NCT05659719|81737794|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
27974143|NCT05659719|81737795|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
27974144|NCT05659719|81737796|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
27974145|NCT05659719|81737793|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
27974146|NCT05659719|81737794|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
27974147|NCT05659719|81737795|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
27974148|NCT05659719|81737796|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
27974149|NCT02298179|81737799|FG000|Overall Study|Lost to Follow-up|0|||
27974150|NCT02298179|81737800|FG001|Overall Study|Lost to Follow-up|0|||
27974151|NCT02298179|81737801|FG002|Overall Study|Lost to Follow-up|1|||
27974152|NCT02298179|81737802|FG003|Overall Study|Lost to Follow-up|0|||
27974153|NCT02298179|81737803|FG004|Overall Study|Lost to Follow-up|0|||
27974154|NCT02298179|81737804|FG005|Overall Study|Lost to Follow-up|0|||
27974155|NCT02298179|81737805|FG006|Overall Study|Lost to Follow-up|0|||
27974156|NCT02298179|81737806|FG007|Overall Study|Lost to Follow-up|1|||
27974157|NCT02298179|81737807|FG008|Overall Study|Lost to Follow-up|0|||
27974158|NCT02298179|81737808|FG009|Overall Study|Lost to Follow-up|0|||
27974159|NCT02298179|81737809|FG010|Overall Study|Lost to Follow-up|0|||
27974160|NCT02298179|81737810|FG011|Overall Study|Lost to Follow-up|0|||
27974161|NCT00445848|81737813|FG000|Overall Study|Adverse Event|14|||
27974162|NCT00445848|81737813|FG000|Overall Study|Withdrawal by Subject|4|||
27974163|NCT00445848|81737813|FG000|Overall Study|Progression|62|||
27974164|NCT00445848|81737813|FG000|Overall Study|Other-Not protocol specified|5|||
27867218|NCT00616421|81346740|FG002|Overall Study|Withdrawal by Subject|8|||
27974165|NCT00683917|81737814|FG000|Overall Study|Study prematurely terminated|10|||
27974166|NCT02118766|81737815|FG000|Overall Study|Adverse Event|7|||
27974167|NCT02118766|81737816|FG001|Overall Study|Adverse Event|2|||
27974168|NCT02118766|81737815|FG000|Overall Study|Withdrawal by Subject|3|||
27671383|NCT01124097|80634963|FG002|Overall Study|Withdrawal by Subject|2|||
27671384|NCT01124097|80634964|FG003|Overall Study|Withdrawal by Subject|3|||
27671385|NCT01124097|80634961|FG000|Overall Study|Lack of Efficacy|2|||
27671386|NCT01124097|80634962|FG001|Overall Study|Lack of Efficacy|3|||
27671387|NCT01124097|80634963|FG002|Overall Study|Lack of Efficacy|1|||
27671388|NCT01124097|80634964|FG003|Overall Study|Lack of Efficacy|3|||
27974169|NCT02118766|81737816|FG001|Overall Study|Withdrawal by Subject|6|||
27974170|NCT02118766|81737815|FG000|Overall Study|Lost to Follow-up|5|||
27671389|NCT01124097|80634961|FG000|Overall Study|Adverse Event|24|||
27671390|NCT01124097|80634962|FG001|Overall Study|Adverse Event|15|||
27671391|NCT01124097|80634963|FG002|Overall Study|Adverse Event|15|||
27671392|NCT01124097|80634964|FG003|Overall Study|Adverse Event|7|||
27671393|NCT01124097|80634961|FG000|Overall Study|Protocol Violation|2|||
27974171|NCT02118766|81737816|FG001|Overall Study|Lost to Follow-up|4|||
27974172|NCT02118766|81737815|FG000|Overall Study|Withdrawal by parent/guardian|12|||
27974173|NCT02118766|81737816|FG001|Overall Study|Withdrawal by parent/guardian|18|||
27974174|NCT02118766|81737815|FG000|Overall Study|Other|3|||
27671394|NCT01124097|80634962|FG001|Overall Study|Protocol Violation|0|||
27671395|NCT01124097|80634963|FG002|Overall Study|Protocol Violation|2|||
27671396|NCT01124097|80634964|FG003|Overall Study|Protocol Violation|1|||
27671397|NCT01124097|80634961|FG000|Overall Study|Physician Decision|2|||
27671398|NCT01124097|80634962|FG001|Overall Study|Physician Decision|1|||
27671399|NCT01124097|80634963|FG002|Overall Study|Physician Decision|0|||
27671400|NCT01124097|80634964|FG003|Overall Study|Physician Decision|0|||
27671401|NCT02058836|80634965|FG000|Overall Study|Withdrawal by Subject|1|||
27671402|NCT02058836|80634966|FG001|Overall Study|Withdrawal by Subject|1|||
27671403|NCT04962698|80634971|FG000|Motor Imagery|Technical difficulty|1|||
27671404|NCT04962698|80634972|FG001|Motor Imagery|Technical difficulty|0|||
27671405|NCT04962698|80634971|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
27671406|NCT04962698|80634972|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
27671407|NCT04962698|80634971|FG000|Kinesthetic MI|Technical difficulty|1|||
27671408|NCT04962698|80634972|FG001|Kinesthetic MI|Technical difficulty|0|||
27671409|NCT04962698|80634971|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
27671410|NCT04962698|80634972|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
27671411|NCT04962698|80634971|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
27671412|NCT04962698|80634972|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
27671413|NCT04962698|80634971|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
27671414|NCT04962698|80634972|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
27671415|NCT04962698|80634971|FG000|Virtual-hand Interaction|Technical difficulty|1|||
27671416|NCT04962698|80634972|FG001|Virtual-hand Interaction|Technical difficulty|0|||
27671417|NCT04962698|80634971|FG000|Robotic Action Observation|Technical difficulty|1|||
27671418|NCT04962698|80634972|FG001|Robotic Action Observation|Technical difficulty|0|||
27671419|NCT04962698|80634971|FG000|Rest|Technical difficulty|1|||
27974175|NCT02118766|81737816|FG001|Overall Study|Other|1|||
27974176|NCT03028480|81737817|FG000|Overall Study|No revisit after the first prescription date|2|||
27974177|NCT03028480|81737817|FG000|Overall Study|Did not use the drug|1|||
27974178|NCT03028480|81737817|FG000|Overall Study|Violation of the enrollment deadline|10|||
27974179|NCT03028480|81737817|FG000|Overall Study|Case report forms were not collected|21|||
27974180|NCT00230282|81737819|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
27974181|NCT00230282|81737819|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
27671420|NCT04962698|80634972|FG001|Rest|Technical difficulty|0|||
27671421|NCT04962698|80634971|FG000|Rest|Exclusion criteria met after enrollment|0|||
27671422|NCT04962698|80634972|FG001|Rest|Exclusion criteria met after enrollment|2|||
27671423|NCT01318876|80634973|FG000|Day 8 Survey|email address invalid|96|||
27671424|NCT01318876|80634973|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
27671425|NCT01318876|80634973|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
27671426|NCT03443414|80634980|FG000|Overall Study|Adverse Event|6|||
27974182|NCT00230282|81737819|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
27974183|NCT00230282|81737819|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
27671427|NCT03443414|80634981|FG001|Overall Study|Adverse Event|0|||
27671428|NCT03443414|80634982|FG002|Overall Study|Adverse Event|4|||
27671429|NCT03443414|80634983|FG003|Overall Study|Adverse Event|2|||
27671430|NCT03443414|80634984|FG004|Overall Study|Adverse Event|3|||
27671431|NCT03443414|80634980|FG000|Overall Study|Withdrawal by Subject|3|||
27671432|NCT03443414|80634981|FG001|Overall Study|Withdrawal by Subject|2|||
27671433|NCT03443414|80634982|FG002|Overall Study|Withdrawal by Subject|2|||
27671434|NCT03443414|80634983|FG003|Overall Study|Withdrawal by Subject|2|||
27671435|NCT03443414|80634984|FG004|Overall Study|Withdrawal by Subject|1|||
27974184|NCT00246025|81737822|FG000|Overall Study|Adverse Event|7|||
27974185|NCT00246025|81737823|FG001|Overall Study|Adverse Event|9|||
27974186|NCT00246025|81737824|FG002|Overall Study|Adverse Event|9|||
27974187|NCT00246025|81737825|FG003|Overall Study|Adverse Event|10|||
27974188|NCT00246025|81737822|FG000|Overall Study|Withdrawal by Subject|3|||
27974189|NCT00246025|81737823|FG001|Overall Study|Withdrawal by Subject|0|||
27974190|NCT00246025|81737824|FG002|Overall Study|Withdrawal by Subject|1|||
27671436|NCT03443414|80634980|FG000|Overall Study|Death|0|||
27671437|NCT03443414|80634981|FG001|Overall Study|Death|1|||
27671438|NCT03443414|80634982|FG002|Overall Study|Death|0|||
27671439|NCT03443414|80634983|FG003|Overall Study|Death|1|||
27671440|NCT03443414|80634984|FG004|Overall Study|Death|0|||
27787203|NCT01756846|81051038|FG001|Overall Study|Withdrawal by Subject|2|||
27787204|NCT01200758|81051039|FG000|Stage I|Death|0|||
27671441|NCT03443414|80634980|FG000|Overall Study|Reason not specified|2|||
27671442|NCT03443414|80634981|FG001|Overall Study|Reason not specified|0|||
27671443|NCT03443414|80634982|FG002|Overall Study|Reason not specified|0|||
27671444|NCT03443414|80634983|FG003|Overall Study|Reason not specified|0|||
27671445|NCT03443414|80634984|FG004|Overall Study|Reason not specified|1|||
27671446|NCT00992992|80634987|FG000|Overall Study|Lost to Follow-up|3|||
27671447|NCT00992992|80634987|FG000|Overall Study|Death|16|||
27787205|NCT01200758|81051040|FG001|Stage I|Death|1|||
27787206|NCT01200758|81051041|FG002|Stage I|Death|0|||
27787207|NCT01200758|81051042|FG003|Stage I|Death|0|||
27787208|NCT01200758|81051039|FG000|Stage I|Physician Decision|1|||
27787209|NCT01200758|81051040|FG001|Stage I|Physician Decision|1|||
27671448|NCT00992992|80634987|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
27671449|NCT00992992|80634987|FG000|Overall Study|Sponsor Closed the Study|4|||
27671450|NCT01458522|80634990|FG000|Overall Study|Withdrawal by Subject|2|||
27671451|NCT01458522|80634991|FG001|Overall Study|Withdrawal by Subject|2|||
27671452|NCT01458522|80634990|FG000|Overall Study|Physician Decision|1|||
27671453|NCT01458522|80634991|FG001|Overall Study|Physician Decision|9|||
27671454|NCT02581059|80634992|FG000|Study Treatment|Disease Progression|1|||
27671455|NCT02581059|80634993|FG001|Study Treatment|Disease Progression|1|||
27787210|NCT01200758|81051041|FG002|Stage I|Physician Decision|0|||
27671456|NCT02581059|80634992|FG000|Study Treatment|Adverse Event|2|||
27671457|NCT02581059|80634993|FG001|Study Treatment|Adverse Event|1|||
27671458|NCT02581059|80634992|FG000|Study Treatment|Death|1|||
27671459|NCT02581059|80634993|FG001|Study Treatment|Death|1|||
27787211|NCT01200758|81051042|FG003|Stage I|Physician Decision|0|||
27974191|NCT00246025|81737825|FG003|Overall Study|Withdrawal by Subject|2|||
27787212|NCT01200758|81051039|FG000|Stage I|Lack of Efficacy|2|||
27787213|NCT01200758|81051040|FG001|Stage I|Lack of Efficacy|1|||
27787214|NCT01200758|81051041|FG002|Stage I|Lack of Efficacy|0|||
27787215|NCT01200758|81051042|FG003|Stage I|Lack of Efficacy|0|||
27787216|NCT01200758|81051039|FG000|Stage I|Adverse Event|5|||
27787217|NCT01200758|81051040|FG001|Stage I|Adverse Event|5|||
27671460|NCT02581059|80634992|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
27671461|NCT02581059|80634993|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
27671462|NCT02581059|80634992|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
27671463|NCT02581059|80634993|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
27671464|NCT02581059|80634992|FG000|Follow up|Death|1|||
27671465|NCT02581059|80634993|FG001|Follow up|Death|3|||
27671466|NCT02581059|80634992|FG000|Follow up|study terminated|1|||
27671467|NCT02581059|80634993|FG001|Follow up|study terminated|1|||
27671468|NCT02581059|80634992|FG000|Follow up|screen failure|0|||
27671469|NCT02581059|80634993|FG001|Follow up|screen failure|1|||
27671470|NCT02581059|80634992|FG000|Follow up|Patient started new clinical trial|1|||
27671471|NCT02581059|80634993|FG001|Follow up|Patient started new clinical trial|0|||
27671472|NCT03546816|80634994|FG000|Overall Study|Adverse Event|5|||
27671473|NCT03546816|80634995|FG001|Overall Study|Adverse Event|3|||
27671474|NCT03546816|80634994|FG000|Overall Study|Lack of Efficacy|2|||
27671475|NCT03546816|80634995|FG001|Overall Study|Lack of Efficacy|4|||
27671476|NCT03546816|80634994|FG000|Overall Study|Pregnancy|1|||
27573270|NCT02203591|80285581|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
27573271|NCT02203591|80285582|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
27671477|NCT03546816|80634995|FG001|Overall Study|Pregnancy|0|||
27671478|NCT03546816|80634994|FG000|Overall Study|Physician Decision|2|||
27671479|NCT03546816|80634995|FG001|Overall Study|Physician Decision|0|||
27671480|NCT03546816|80634994|FG000|Overall Study|Withdrawal by Subject|8|||
27671481|NCT03546816|80634995|FG001|Overall Study|Withdrawal by Subject|10|||
27671482|NCT03546816|80634994|FG000|Overall Study|Lost to Follow-up|3|||
27671483|NCT03546816|80634995|FG001|Overall Study|Lost to Follow-up|2|||
27671484|NCT00302159|80634996|FG000|Overall Study|pt declined before treatment started|1|||
27671485|NCT00302159|80634996|FG000|Overall Study|pt started Avastin|1|||
27671486|NCT01606319|80634997|FG000|Overall Study|Lost to Follow-up|17|||
27787218|NCT01200758|81051041|FG002|Stage I|Adverse Event|0|||
27787219|NCT01200758|81051042|FG003|Stage I|Adverse Event|0|||
27787220|NCT01200758|81051039|FG000|Stage I|Withdrawal by Subject|1|||
27787221|NCT01200758|81051040|FG001|Stage I|Withdrawal by Subject|2|||
27787222|NCT01200758|81051041|FG002|Stage I|Withdrawal by Subject|0|||
27787223|NCT01200758|81051042|FG003|Stage I|Withdrawal by Subject|0|||
27787224|NCT01200758|81051039|FG000|Stage I|Disease Progression|9|||
27787225|NCT01200758|81051040|FG001|Stage I|Disease Progression|7|||
27787226|NCT01200758|81051041|FG002|Stage I|Disease Progression|0|||
27787227|NCT01200758|81051042|FG003|Stage I|Disease Progression|0|||
27787228|NCT01200758|81051039|FG000|Stage 2|Disease Progression|0|||
27787229|NCT01200758|81051040|FG001|Stage 2|Disease Progression|0|||
27787230|NCT01200758|81051041|FG002|Stage 2|Disease Progression|16|||
27787231|NCT01200758|81051042|FG003|Stage 2|Disease Progression|21|||
27787232|NCT01200758|81051039|FG000|Stage 2|Lack of Efficacy|0|||
27787233|NCT01200758|81051040|FG001|Stage 2|Lack of Efficacy|0|||
27787234|NCT01200758|81051041|FG002|Stage 2|Lack of Efficacy|4|||
27787235|NCT01200758|81051042|FG003|Stage 2|Lack of Efficacy|2|||
27787236|NCT01200758|81051039|FG000|Stage 2|Physician Decision|0|||
27787237|NCT01200758|81051040|FG001|Stage 2|Physician Decision|0|||
27787238|NCT01200758|81051041|FG002|Stage 2|Physician Decision|5|||
27974192|NCT00246025|81737822|FG000|Overall Study|unsuitable medical history was found|0|||
27974193|NCT00246025|81737823|FG001|Overall Study|unsuitable medical history was found|0|||
27974194|NCT00246025|81737824|FG002|Overall Study|unsuitable medical history was found|0|||
27974195|NCT00246025|81737825|FG003|Overall Study|unsuitable medical history was found|1|||
27974196|NCT01338610|81737826|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
27974197|NCT01338610|81737827|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
27974198|NCT01338610|81737828|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
27974199|NCT01338610|81737826|FG000|Overall Study|Protocol Violation|1|||
27974200|NCT01338610|81737827|FG001|Overall Study|Protocol Violation|0|||
27974201|NCT01338610|81737828|FG002|Overall Study|Protocol Violation|1|||
27573272|NCT02203591|80285583|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
27787239|NCT01200758|81051042|FG003|Stage 2|Physician Decision|7|||
27787240|NCT01200758|81051039|FG000|Stage 2|Adverse Event|0|||
27787241|NCT01200758|81051040|FG001|Stage 2|Adverse Event|0|||
27573273|NCT02203591|80285584|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
27573274|NCT02203591|80285585|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
27573275|NCT02203591|80285586|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
27573276|NCT02203591|80285587|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
27573277|NCT01371656|80285588|FG000|Overall Study|Death|7|||
27573278|NCT01371656|80285589|FG001|Overall Study|Death|4|||
27573279|NCT01371656|80285588|FG000|Overall Study|Physician Decision|46|||
27787242|NCT01200758|81051041|FG002|Stage 2|Adverse Event|5|||
27787243|NCT01200758|81051042|FG003|Stage 2|Adverse Event|9|||
27787244|NCT01200758|81051039|FG000|Stage 2|Withdrawal by Subject|0|||
27787245|NCT01200758|81051040|FG001|Stage 2|Withdrawal by Subject|0|||
27787246|NCT01200758|81051041|FG002|Stage 2|Withdrawal by Subject|4|||
27787247|NCT01200758|81051042|FG003|Stage 2|Withdrawal by Subject|1|||
27787248|NCT01200758|81051039|FG000|Stage 2|Lost to Follow-up|0|||
27787249|NCT01200758|81051040|FG001|Stage 2|Lost to Follow-up|0|||
27787250|NCT01200758|81051041|FG002|Stage 2|Lost to Follow-up|3|||
27787251|NCT01200758|81051042|FG003|Stage 2|Lost to Follow-up|1|||
27787252|NCT01200758|81051039|FG000|Stage 2|Protocol Violation|0|||
27787253|NCT01200758|81051040|FG001|Stage 2|Protocol Violation|0|||
27787254|NCT01200758|81051041|FG002|Stage 2|Protocol Violation|1|||
27787255|NCT01200758|81051042|FG003|Stage 2|Protocol Violation|4|||
27787256|NCT01200758|81051039|FG000|Stage 2|Death|0|||
27787257|NCT01200758|81051040|FG001|Stage 2|Death|0|||
27787258|NCT01200758|81051041|FG002|Stage 2|Death|3|||
27787259|NCT01200758|81051042|FG003|Stage 2|Death|5|||
27787260|NCT03633461|81051043|FG000|Overall Study|Lost to Follow-up|0|||
27787261|NCT03633461|81051044|FG001|Overall Study|Lost to Follow-up|1|||
27787262|NCT04576702|81051047|FG000|Overall Study|Death|1|||
27787263|NCT04576702|81051048|FG001|Overall Study|Death|0|||
27787264|NCT04576702|81051049|FG002|Overall Study|Death|0|||
27787265|NCT04576702|81051050|FG003|Overall Study|Death|0|||
27787266|NCT04576702|81051047|FG000|Overall Study|Withdrawal by Subject|0|||
27787267|NCT04576702|81051048|FG001|Overall Study|Withdrawal by Subject|2|||
27787268|NCT04576702|81051049|FG002|Overall Study|Withdrawal by Subject|1|||
27787269|NCT04576702|81051050|FG003|Overall Study|Withdrawal by Subject|0|||
27787270|NCT04576702|81051047|FG000|Overall Study|Lost to Follow-up|3|||
27787271|NCT04576702|81051048|FG001|Overall Study|Lost to Follow-up|3|||
27787272|NCT04576702|81051049|FG002|Overall Study|Lost to Follow-up|3|||
27787273|NCT04576702|81051050|FG003|Overall Study|Lost to Follow-up|4|||
27787274|NCT00948896|81051051|FG000|Randomization to 24 Months of Age|Death|1|||
27787275|NCT00948896|81051052|FG001|Randomization to 24 Months of Age|Death|0|||
27787276|NCT00948896|81051053|FG002|Randomization to 24 Months of Age|Death|0|||
27787277|NCT00948896|81051054|FG003|Randomization to 24 Months of Age|Death|0|||
27787278|NCT00948896|81051055|FG004|Randomization to 24 Months of Age|Death|2|||
27787279|NCT00948896|81051056|FG005|Randomization to 24 Months of Age|Death|1|||
27787280|NCT00948896|81051057|FG006|Randomization to 24 Months of Age|Death|2|||
27787281|NCT00948896|81051058|FG007|Randomization to 24 Months of Age|Death|1|||
27787282|NCT00948896|81051051|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
27787283|NCT00948896|81051052|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
27787284|NCT00948896|81051053|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
27787285|NCT00948896|81051054|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
27787286|NCT00948896|81051055|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
27787287|NCT00948896|81051056|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
27787288|NCT00948896|81051057|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
27787289|NCT00948896|81051058|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
27787290|NCT00948896|81051051|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
27787291|NCT00948896|81051052|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
27787292|NCT00948896|81051053|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
27787293|NCT00948896|81051054|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
27787294|NCT00948896|81051055|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
27787295|NCT00948896|81051056|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
27787296|NCT00948896|81051057|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
27787297|NCT00948896|81051058|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
27787298|NCT00948896|81051051|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
27787299|NCT00948896|81051052|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
27787300|NCT00948896|81051053|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
27787301|NCT00948896|81051054|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
27787302|NCT00948896|81051055|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
27787303|NCT00948896|81051056|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
27787304|NCT00948896|81051057|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
27787305|NCT00948896|81051058|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
27787306|NCT00948896|81051051|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27787307|NCT00948896|81051052|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
27787308|NCT00948896|81051053|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
27787309|NCT00948896|81051054|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
27787310|NCT00948896|81051055|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27787311|NCT00948896|81051056|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
27787312|NCT00948896|81051057|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27787313|NCT00948896|81051058|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
27787314|NCT00948896|81051051|FG000|24 Months of Age to 36 Months of Age|Death|0|||
27787315|NCT00948896|81051052|FG001|24 Months of Age to 36 Months of Age|Death|2|||
27787316|NCT00948896|81051053|FG002|24 Months of Age to 36 Months of Age|Death|2|||
27787317|NCT00948896|81051054|FG003|24 Months of Age to 36 Months of Age|Death|0|||
27787318|NCT00948896|81051055|FG004|24 Months of Age to 36 Months of Age|Death|0|||
27787319|NCT00948896|81051056|FG005|24 Months of Age to 36 Months of Age|Death|1|||
27787320|NCT00948896|81051057|FG006|24 Months of Age to 36 Months of Age|Death|0|||
27787321|NCT00948896|81051058|FG007|24 Months of Age to 36 Months of Age|Death|0|||
27787322|NCT00948896|81051051|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
27787323|NCT00948896|81051052|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27787324|NCT00948896|81051053|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
27787325|NCT00948896|81051054|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
27787326|NCT00948896|81051055|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27787327|NCT00948896|81051056|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27787328|NCT00948896|81051057|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27787329|NCT00948896|81051058|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
27787330|NCT00948896|81051051|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
27787331|NCT00948896|81051052|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27787332|NCT00948896|81051053|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
27787333|NCT00948896|81051054|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27787334|NCT00948896|81051055|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
27787335|NCT00948896|81051056|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27787336|NCT00948896|81051057|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27787337|NCT00948896|81051058|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
27787338|NCT00948896|81051051|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27787339|NCT00948896|81051052|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27787340|NCT00948896|81051053|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
27787341|NCT00948896|81051054|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27787342|NCT00948896|81051055|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27787343|NCT00948896|81051056|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
27787344|NCT00948896|81051057|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27787345|NCT00948896|81051058|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
27787346|NCT00948896|81051051|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787347|NCT00948896|81051052|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787348|NCT00948896|81051053|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787349|NCT00948896|81051054|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
27787350|NCT00948896|81051055|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787351|NCT00948896|81051056|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787352|NCT00948896|81051057|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787353|NCT00948896|81051058|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
27787354|NCT01786707|81051059|FG000|Overall Study|Lost to Follow-up|1|||
27787355|NCT01786707|81051060|FG001|Overall Study|Lost to Follow-up|1|||
27787356|NCT03922945|81051061|FG000|Overall Study|Adverse Event|1|||
27787357|NCT03922945|81051062|FG001|Overall Study|Adverse Event|1|||
27787358|NCT03922945|81051063|FG002|Overall Study|Adverse Event|2|||
27787359|NCT03922945|81051061|FG000|Overall Study|Lost to Follow-up|13|||
27787360|NCT03922945|81051062|FG001|Overall Study|Lost to Follow-up|9|||
27787361|NCT03922945|81051063|FG002|Overall Study|Lost to Follow-up|20|||
27787362|NCT03922945|81051061|FG000|Overall Study|Lack of Efficacy|2|||
27787363|NCT03922945|81051062|FG001|Overall Study|Lack of Efficacy|0|||
27787364|NCT03922945|81051063|FG002|Overall Study|Lack of Efficacy|1|||
27787365|NCT03922945|81051061|FG000|Overall Study|Protocol Non-Compliance|0|||
27787366|NCT03922945|81051062|FG001|Overall Study|Protocol Non-Compliance|0|||
27787367|NCT03922945|81051063|FG002|Overall Study|Protocol Non-Compliance|1|||
27867219|NCT00616421|81346738|FG000|Overall Study|Lost to Follow-up|12|||
27974202|NCT01338610|81737826|FG000|Overall Study|Adverse Event|3|||
27974203|NCT01338610|81737827|FG001|Overall Study|Adverse Event|0|||
27974204|NCT01338610|81737828|FG002|Overall Study|Adverse Event|0|||
27974205|NCT01566695|81737829|FG000|Overall Study|Lack of Efficacy|18|||
27573280|NCT01371656|80285589|FG001|Overall Study|Physician Decision|7|||
27974206|NCT01566695|81737830|FG001|Overall Study|Lack of Efficacy|45|||
27787368|NCT03922945|81051061|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
27787369|NCT03922945|81051062|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
27787370|NCT03922945|81051063|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
27787371|NCT03922945|81051061|FG000|Overall Study|All Other Personal Reasons|1|||
27787372|NCT03922945|81051062|FG001|Overall Study|All Other Personal Reasons|1|||
27787373|NCT03922945|81051063|FG002|Overall Study|All Other Personal Reasons|2|||
27787374|NCT00672490|81051066|FG000|Overall Study|Withdrawal by Subject|8|||
27787375|NCT00672490|81051067|FG001|Overall Study|Withdrawal by Subject|8|||
27974207|NCT01566695|81737829|FG000|Overall Study|Adverse Event|28|||
27974208|NCT01566695|81737830|FG001|Overall Study|Adverse Event|27|||
27974209|NCT01566695|81737829|FG000|Overall Study|Death|20|||
27974210|NCT01566695|81737830|FG001|Overall Study|Death|8|||
27974211|NCT01566695|81737829|FG000|Overall Study|Withdrawal by Subject|14|||
27974212|NCT01566695|81737830|FG001|Overall Study|Withdrawal by Subject|7|||
27974213|NCT01566695|81737829|FG000|Overall Study|Progressive Disease|11|||
27974214|NCT01566695|81737830|FG001|Overall Study|Progressive Disease|6|||
27974215|NCT01566695|81737829|FG000|Overall Study|Miscellaneous|4|||
27974216|NCT01566695|81737830|FG001|Overall Study|Miscellaneous|6|||
27974217|NCT02785458|81737833|FG000|1 Month|Withdrawal by Subject|2|||
27974218|NCT02785458|81737834|FG001|1 Month|Withdrawal by Subject|1|||
27974219|NCT02785458|81737833|FG000|1 Month|Lost to Follow-up|38|||
27974220|NCT02785458|81737834|FG001|1 Month|Lost to Follow-up|31|||
27974221|NCT02785458|81737833|FG000|1 Month|Deemed Ineligible|1|||
27974222|NCT02785458|81737834|FG001|1 Month|Deemed Ineligible|0|||
27974223|NCT02785458|81737833|FG000|1 Month|Completed Evaluation by Baseline|42|||
27974224|NCT02785458|81737834|FG001|1 Month|Completed Evaluation by Baseline|39|||
27974225|NCT02785458|81737833|FG000|1 Month|Partial Interview|0|||
27974226|NCT02785458|81737834|FG001|1 Month|Partial Interview|4|||
27974227|NCT02785458|81737833|FG000|3 Months|Withdrawal by Subject|3|||
27974228|NCT02785458|81737834|FG001|3 Months|Withdrawal by Subject|1|||
27974229|NCT02785458|81737833|FG000|3 Months|Lost to Follow-up|25|||
27974230|NCT02785458|81737834|FG001|3 Months|Lost to Follow-up|21|||
27974231|NCT02785458|81737833|FG000|3 Months|Completed Evaluation at 1 Month|100|||
27974232|NCT02785458|81737834|FG001|3 Months|Completed Evaluation at 1 Month|89|||
27974233|NCT04422561|81737849|FG000|Overall Study|Lost to Follow-up|25|||
27974234|NCT04422561|81737850|FG001|Overall Study|Lost to Follow-up|11|||
27974235|NCT03352453|81737851|FG000|Overall Study|Miscellaneous Reasons|1|||
27974236|NCT03352453|81737852|FG001|Overall Study|Miscellaneous Reasons|2|||
27974237|NCT03352453|81737851|FG000|Overall Study|Lack of Efficacy|1|||
27974238|NCT03352453|81737852|FG001|Overall Study|Lack of Efficacy|0|||
27974239|NCT03352453|81737851|FG000|Overall Study|Withdrawal by Subject|8|||
27974240|NCT03352453|81737852|FG001|Overall Study|Withdrawal by Subject|14|||
27974241|NCT03352453|81737851|FG000|Overall Study|Study Terminated by Sponsor|2|||
27974242|NCT03352453|81737852|FG001|Overall Study|Study Terminated by Sponsor|1|||
27974243|NCT03352453|81737851|FG000|Overall Study|Protocol Deviation|1|||
27974244|NCT03352453|81737852|FG001|Overall Study|Protocol Deviation|0|||
27974245|NCT03352453|81737851|FG000|Overall Study|Lost to Follow-up|7|||
27974246|NCT03352453|81737852|FG001|Overall Study|Lost to Follow-up|6|||
27974247|NCT03352453|81737851|FG000|Overall Study|Adverse Event|2|||
27974248|NCT03352453|81737852|FG001|Overall Study|Adverse Event|9|||
27974249|NCT02791191|81737880|FG000|Overall Study|Adverse Event|2|||
27974250|NCT02791191|81737881|FG001|Overall Study|Adverse Event|4|||
27974251|NCT02791191|81737882|FG002|Overall Study|Adverse Event|5|||
27974252|NCT02791191|81737880|FG000|Overall Study|Lack of Efficacy|0|||
27974253|NCT02791191|81737881|FG001|Overall Study|Lack of Efficacy|1|||
27974254|NCT02791191|81737882|FG002|Overall Study|Lack of Efficacy|0|||
27974255|NCT02791191|81737880|FG000|Overall Study|Study Drug Non-Compliance|0|||
27974256|NCT02791191|81737881|FG001|Overall Study|Study Drug Non-Compliance|2|||
27974257|NCT02791191|81737882|FG002|Overall Study|Study Drug Non-Compliance|0|||
27974258|NCT02791191|81737880|FG000|Overall Study|Site Closed by Sponsor|1|||
27787376|NCT00672490|81051066|FG000|Overall Study|Lack of Compliance|2|||
27787377|NCT00672490|81051067|FG001|Overall Study|Lack of Compliance|7|||
27787378|NCT00672490|81051066|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
27867220|NCT00616421|81346739|FG001|Overall Study|Lost to Follow-up|26|||
27974259|NCT02791191|81737881|FG001|Overall Study|Site Closed by Sponsor|1|||
27974260|NCT02791191|81737882|FG002|Overall Study|Site Closed by Sponsor|3|||
27974261|NCT02791191|81737880|FG000|Overall Study|Progressive Disease|1|||
27974262|NCT02791191|81737881|FG001|Overall Study|Progressive Disease|0|||
27974263|NCT02791191|81737882|FG002|Overall Study|Progressive Disease|0|||
27974264|NCT02791191|81737880|FG000|Overall Study|Study Terminated by Sponsor|29|||
27974265|NCT02791191|81737881|FG001|Overall Study|Study Terminated by Sponsor|101|||
27974266|NCT02791191|81737882|FG002|Overall Study|Study Terminated by Sponsor|109|||
27974267|NCT02791191|81737880|FG000|Overall Study|Withdrawal by Subject|3|||
27974268|NCT02791191|81737881|FG001|Overall Study|Withdrawal by Subject|1|||
27974269|NCT02791191|81737882|FG002|Overall Study|Withdrawal by Subject|3|||
27974270|NCT02791191|81737880|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
27974271|NCT02791191|81737881|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
27974272|NCT02791191|81737882|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
27787379|NCT00672490|81051067|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
27787380|NCT00672490|81051066|FG000|Overall Study|Adverse Event|5|||
27787381|NCT00672490|81051067|FG001|Overall Study|Adverse Event|8|||
27787382|NCT00672490|81051066|FG000|Overall Study|Violation of Concomitant Medicine|1|||
27787383|NCT00672490|81051067|FG001|Overall Study|Violation of Concomitant Medicine|0|||
27787384|NCT00672490|81051066|FG000|Overall Study|Intolerance|0|||
27787385|NCT00672490|81051067|FG001|Overall Study|Intolerance|2|||
27867221|NCT00616421|81346740|FG002|Overall Study|Lost to Follow-up|30|||
27867222|NCT00616421|81346738|FG000|Overall Study|Inappropriate enrollment|3|||
27867223|NCT00616421|81346739|FG001|Overall Study|Inappropriate enrollment|0|||
27867224|NCT00616421|81346740|FG002|Overall Study|Inappropriate enrollment|1|||
27867225|NCT00616421|81346738|FG000|Overall Study|Administrative reason|1|||
27867226|NCT00616421|81346739|FG001|Overall Study|Administrative reason|0|||
27867227|NCT00616421|81346740|FG002|Overall Study|Administrative reason|0|||
27867228|NCT00616421|81346738|FG000|Overall Study|Protocol Violation|0|||
27867229|NCT00616421|81346739|FG001|Overall Study|Protocol Violation|1|||
27867230|NCT00616421|81346740|FG002|Overall Study|Protocol Violation|2|||
27867231|NCT00616421|81346738|FG000|Overall Study|Unable to classify|1|||
27867232|NCT00616421|81346739|FG001|Overall Study|Unable to classify|0|||
27867233|NCT00616421|81346740|FG002|Overall Study|Unable to classify|0|||
27867234|NCT05445492|81346741|FG000|Overall Study|Physician Decision|1|||
27867235|NCT02481869|81346744|FG000|Overall Study|Lost to Follow-up|3|||
27867236|NCT02481869|81346745|FG001|Overall Study|Lost to Follow-up|4|||
27867237|NCT02481869|81346744|FG000|Overall Study|Withdrawal by Subject|2|||
27867238|NCT02481869|81346745|FG001|Overall Study|Withdrawal by Subject|0|||
27867239|NCT03071276|81346747|FG000|Overall Study|Adverse Event|1|||
27867240|NCT03071276|81346747|FG000|Overall Study|Lack of Efficacy|14|||
27867241|NCT00307086|81346748|FG000|Overall Study|ineligible|5|||
27867242|NCT00314951|81346751|FG000|Treatment|Didn't meet criteria for mITT population|16|||
27867243|NCT00314951|81346752|FG001|Treatment|Didn't meet criteria for mITT population|11|||
27867244|NCT00314951|81346751|FG000|Follow-up|mITT failure|44|||
27867245|NCT00314951|81346752|FG001|Follow-up|mITT failure|34|||
27867246|NCT01964976|81346753|FG000|Overall Study|Protocol Violation|31|||
27867247|NCT00489827|81346754|FG000|Overall Study|Intraoperative exclusion criteria|1|||
27867248|NCT00489827|81346755|FG001|Overall Study|Intraoperative exclusion criteria|1|||
27867249|NCT00489827|81346754|FG000|Overall Study|Intraoperative exclusion criteria|1|||
27867250|NCT00489827|81346755|FG001|Overall Study|Intraoperative exclusion criteria|1|||
27867251|NCT00101283|81346759|FG000|Overall Study|Withdrawal by Subject|0|||
27867252|NCT00101283|81346760|FG001|Overall Study|Withdrawal by Subject|1|||
27867253|NCT00101283|81346759|FG000|Overall Study|Insurance Refusal|0|||
27867254|NCT00101283|81346760|FG001|Overall Study|Insurance Refusal|1|||
27867255|NCT00101283|81346759|FG000|Overall Study|Prostate Cancer Recurrence|0|||
27867256|NCT00101283|81346760|FG001|Overall Study|Prostate Cancer Recurrence|1|||
27867257|NCT01755091|81346772|FG000|Overall Study|Withdrawal by Subject|6|||
27867258|NCT01755091|81346773|FG001|Overall Study|Withdrawal by Subject|1|||
27867259|NCT01755091|81346774|FG002|Overall Study|Withdrawal by Subject|3|||
27867260|NCT01755091|81346772|FG000|Overall Study|Adverse Event|1|||
27867261|NCT01755091|81346773|FG001|Overall Study|Adverse Event|1|||
27867262|NCT01755091|81346774|FG002|Overall Study|Adverse Event|1|||
27867263|NCT01755091|81346772|FG000|Overall Study|Lost to Follow-up|1|||
27867264|NCT01755091|81346773|FG001|Overall Study|Lost to Follow-up|0|||
27867265|NCT01755091|81346774|FG002|Overall Study|Lost to Follow-up|1|||
27867266|NCT01755091|81346772|FG000|Overall Study|Physician Decision|1|||
27867267|NCT01755091|81346773|FG001|Overall Study|Physician Decision|1|||
27867268|NCT01755091|81346774|FG002|Overall Study|Physician Decision|2|||
27867269|NCT01256502|81346775|FG000|Overall Study|Had scaffold removed|4|||
27867270|NCT01256502|81346775|FG000|Overall Study|Personal reasons|5|||
27867271|NCT01256502|81346775|FG000|Overall Study|Protocol deviation|1|||
27867272|NCT02290405|81349539|FG000|Overall Study|Withdrawal by Subject|1|||
27867273|NCT02290405|81349540|FG001|Overall Study|Withdrawal by Subject|0|||
27867274|NCT00490841|81349541|FG000|Overall Study|Death|5|||
27867275|NCT00490841|81349541|FG000|Overall Study|Withdrawal by Subject|4|||
27867276|NCT00490841|81349541|FG000|Overall Study|Lost to Follow-up|1|||
27867277|NCT00490841|81349541|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
27787386|NCT00672490|81051066|FG000|Overall Study|Lost to Follow-up|1|||
27867278|NCT00129545|81349542|FG000|Overall Study|Death|5|||
27867279|NCT00129545|81349543|FG001|Overall Study|Death|60|||
27867280|NCT00129545|81349544|FG002|Overall Study|Death|44|||
27867281|NCT00129545|81349542|FG000|Overall Study|Withdrawal by Subject|3|||
27974273|NCT00006046|81737883|FG000|Overall Study|Adverse Event|3|||
27974274|NCT00006046|81737884|FG001|Overall Study|Adverse Event|0|||
27974275|NCT00006046|81737885|FG002|Overall Study|Adverse Event|0|||
27974276|NCT00006046|81737886|FG003|Overall Study|Adverse Event|0|||
27974277|NCT00006046|81737887|FG004|Overall Study|Adverse Event|0|||
27974278|NCT00006046|81737883|FG000|Overall Study|Disease Progression|2|||
27974279|NCT00006046|81737884|FG001|Overall Study|Disease Progression|0|||
27974280|NCT00006046|81737885|FG002|Overall Study|Disease Progression|0|||
27974281|NCT00006046|81737886|FG003|Overall Study|Disease Progression|0|||
27974282|NCT00006046|81737887|FG004|Overall Study|Disease Progression|0|||
27974283|NCT00613925|81737889|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
27974284|NCT00613925|81737890|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
27974285|NCT01713283|81737892|FG000|Overall Study|Lack of Efficacy|10|||
27974286|NCT01713283|81737893|FG001|Overall Study|Lack of Efficacy|2|||
27974287|NCT01713283|81737892|FG000|Overall Study|Lost to Follow-up|1|||
27974288|NCT01713283|81737893|FG001|Overall Study|Lost to Follow-up|1|||
27974289|NCT02214225|81737894|FG000|Overall Study|Lost to Follow-up|46|||
27974290|NCT02214225|81737895|FG001|Overall Study|Lost to Follow-up|18|||
27974291|NCT02214225|81737896|FG002|Overall Study|Lost to Follow-up|18|||
27974292|NCT02214225|81737894|FG000|Overall Study|Withdrawal by Subject|2|||
27974293|NCT02214225|81737895|FG001|Overall Study|Withdrawal by Subject|0|||
27974294|NCT02214225|81737896|FG002|Overall Study|Withdrawal by Subject|2|||
27974295|NCT02214225|81737894|FG000|Overall Study|Death|5|||
27974296|NCT02214225|81737895|FG001|Overall Study|Death|0|||
27974297|NCT02214225|81737896|FG002|Overall Study|Death|1|||
27974298|NCT02214225|81737894|FG000|Overall Study|randomized in error, not vaccinated|2|||
27974299|NCT02214225|81737895|FG001|Overall Study|randomized in error, not vaccinated|1|||
27974300|NCT02214225|81737896|FG002|Overall Study|randomized in error, not vaccinated|1|||
27974301|NCT03618628|81737897|FG000|Overall Study|Death|1|||
27974302|NCT03618628|81737897|FG000|Overall Study|Lost to Follow-up|1|||
27974303|NCT00394901|81737898|FG000|Baseline Phase|Protocol Violation|0|||
27974304|NCT00394901|81737899|FG001|Baseline Phase|Protocol Violation|0|||
27974305|NCT00394901|81737900|FG002|Baseline Phase|Protocol Violation|1|||
27974306|NCT00394901|81737901|FG003|Baseline Phase|Protocol Violation|0|||
27787387|NCT00672490|81051067|FG001|Overall Study|Lost to Follow-up|5|||
27787388|NCT00672490|81051066|FG000|Overall Study|No reason was provided|6|||
27787389|NCT00672490|81051067|FG001|Overall Study|No reason was provided|2|||
27787390|NCT00649220|81051068|FG000|Overall Study|Adverse Event|2|||
27787391|NCT00649220|81051068|FG000|Overall Study|Withdrawal by Subject|1|||
27787392|NCT00643006|81051070|FG000|Overall Study|Lost to Follow-up|5|||
27787393|NCT00643006|81051071|FG001|Overall Study|Lost to Follow-up|4|||
27787394|NCT00761891|81051072|FG000|Overall Study|Withdrawal by Subject|10|||
27787395|NCT01189201|81051073|FG000|Overall Study|Adverse Event|1|||
27974307|NCT00394901|81737898|FG000|Double-blind Phase|Adverse Event|5|||
27974308|NCT00394901|81737899|FG001|Double-blind Phase|Adverse Event|7|||
27974309|NCT00394901|81737900|FG002|Double-blind Phase|Adverse Event|16|||
27974310|NCT00394901|81737901|FG003|Double-blind Phase|Adverse Event|20|||
27974311|NCT00394901|81737898|FG000|Double-blind Phase|Lack of Efficacy|6|||
27974312|NCT00394901|81737899|FG001|Double-blind Phase|Lack of Efficacy|4|||
27974313|NCT00394901|81737900|FG002|Double-blind Phase|Lack of Efficacy|1|||
27787396|NCT00027027|81051074|FG000|Overall Study|Adverse Event|0|||
27787397|NCT00027027|81051075|FG001|Overall Study|Adverse Event|0|||
27787398|NCT00027027|81051076|FG002|Overall Study|Adverse Event|1|||
27787399|NCT00027027|81051077|FG003|Overall Study|Adverse Event|0|||
27787400|NCT00027027|81051078|FG004|Overall Study|Adverse Event|1|||
27787401|NCT00027027|81051074|FG000|Overall Study|Admitted for Signs of PD|0|||
27787402|NCT00027027|81051075|FG001|Overall Study|Admitted for Signs of PD|0|||
27787403|NCT00027027|81051076|FG002|Overall Study|Admitted for Signs of PD|0|||
27787404|NCT00027027|81051077|FG003|Overall Study|Admitted for Signs of PD|0|||
27787405|NCT00027027|81051078|FG004|Overall Study|Admitted for Signs of PD|1|||
27787406|NCT00027027|81051074|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
27787407|NCT00027027|81051075|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
27787408|NCT00027027|81051076|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
27787409|NCT00027027|81051077|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
27974314|NCT00394901|81737901|FG003|Double-blind Phase|Lack of Efficacy|3|||
27974315|NCT00394901|81737898|FG000|Double-blind Phase|Withdrawal by Subject|2|||
27974316|NCT00394901|81737899|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27974317|NCT00394901|81737900|FG002|Double-blind Phase|Withdrawal by Subject|0|||
27974318|NCT00394901|81737901|FG003|Double-blind Phase|Withdrawal by Subject|0|||
27974319|NCT00394901|81737898|FG000|Double-blind Phase|Lost to Follow-up|0|||
27974320|NCT00394901|81737899|FG001|Double-blind Phase|Lost to Follow-up|0|||
27974321|NCT00394901|81737900|FG002|Double-blind Phase|Lost to Follow-up|0|||
27974322|NCT00394901|81737901|FG003|Double-blind Phase|Lost to Follow-up|1|||
27974323|NCT00394901|81737898|FG000|Double-blind Phase|Protocol Violation|0|||
27974324|NCT00394901|81737899|FG001|Double-blind Phase|Protocol Violation|0|||
27787410|NCT00027027|81051078|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
27974325|NCT00394901|81737900|FG002|Double-blind Phase|Protocol Violation|0|||
27787411|NCT00027027|81051074|FG000|Overall Study|PD Requiring Surgery|0|||
27787412|NCT00027027|81051075|FG001|Overall Study|PD Requiring Surgery|0|||
27787413|NCT00027027|81051076|FG002|Overall Study|PD Requiring Surgery|1|||
27787414|NCT00027027|81051077|FG003|Overall Study|PD Requiring Surgery|0|||
27787415|NCT00027027|81051078|FG004|Overall Study|PD Requiring Surgery|0|||
27787416|NCT00027027|81051074|FG000|Overall Study|Physician Decision Due To PD|2|||
27787417|NCT00027027|81051075|FG001|Overall Study|Physician Decision Due To PD|3|||
27787418|NCT00027027|81051076|FG002|Overall Study|Physician Decision Due To PD|2|||
27787419|NCT00027027|81051077|FG003|Overall Study|Physician Decision Due To PD|3|||
27787420|NCT00027027|81051078|FG004|Overall Study|Physician Decision Due To PD|5|||
27787421|NCT00027027|81051074|FG000|Overall Study|Withdrawal by Subject|0|||
27787422|NCT00027027|81051075|FG001|Overall Study|Withdrawal by Subject|0|||
27787423|NCT00027027|81051076|FG002|Overall Study|Withdrawal by Subject|0|||
27787424|NCT00027027|81051077|FG003|Overall Study|Withdrawal by Subject|0|||
27787425|NCT00027027|81051078|FG004|Overall Study|Withdrawal by Subject|1|||
27787426|NCT01801475|81051084|FG000|Overall Study|Withdrawal by Subject|0|||
27787427|NCT01801475|81051085|FG001|Overall Study|Withdrawal by Subject|0|||
27787428|NCT01801475|81051086|FG002|Overall Study|Withdrawal by Subject|0|||
27787429|NCT01801475|81051087|FG003|Overall Study|Withdrawal by Subject|0|||
27787430|NCT01801475|81051088|FG004|Overall Study|Withdrawal by Subject|1|||
27787431|NCT04052425|81051089|FG000|24-Week Double-blind Period|Adverse Event|0|||
27787432|NCT04052425|81051090|FG001|24-Week Double-blind Period|Adverse Event|1|||
27787433|NCT04052425|81051091|FG002|24-Week Double-blind Period|Adverse Event|0|||
27787434|NCT04052425|81051092|FG003|24-Week Double-blind Period|Adverse Event|0|||
27787435|NCT04052425|81051089|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
27787436|NCT04052425|81051090|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
27787437|NCT04052425|81051091|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
27787438|NCT04052425|81051092|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
27787439|NCT04052425|81051089|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
27974326|NCT00394901|81737901|FG003|Double-blind Phase|Protocol Violation|1|||
27974327|NCT00394901|81737898|FG000|Double-blind Phase|Death|1|||
27974328|NCT00394901|81737899|FG001|Double-blind Phase|Death|0|||
27974329|NCT00394901|81737900|FG002|Double-blind Phase|Death|0|||
27974330|NCT00394901|81737901|FG003|Double-blind Phase|Death|0|||
27974331|NCT00394901|81737898|FG000|Double-blind Phase|Subject's Personal Reason|1|||
27974332|NCT00394901|81737899|FG001|Double-blind Phase|Subject's Personal Reason|0|||
27974333|NCT00394901|81737900|FG002|Double-blind Phase|Subject's Personal Reason|0|||
27974334|NCT00394901|81737901|FG003|Double-blind Phase|Subject's Personal Reason|1|||
27974335|NCT00394901|81737898|FG000|Double-blind Phase|Lack of Compliance|0|||
27974336|NCT00394901|81737899|FG001|Double-blind Phase|Lack of Compliance|3|||
27974337|NCT00394901|81737900|FG002|Double-blind Phase|Lack of Compliance|0|||
27974338|NCT00394901|81737901|FG003|Double-blind Phase|Lack of Compliance|0|||
27974339|NCT00394901|81737898|FG000|Double-blind Phase|Entry into another study was found|0|||
27974340|NCT00394901|81737899|FG001|Double-blind Phase|Entry into another study was found|0|||
27974341|NCT00394901|81737900|FG002|Double-blind Phase|Entry into another study was found|1|||
27974342|NCT00394901|81737901|FG003|Double-blind Phase|Entry into another study was found|0|||
27974343|NCT00394901|81737898|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
27974344|NCT00394901|81737899|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
27974345|NCT00394901|81737900|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
27974346|NCT00394901|81737901|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
27974347|NCT02229214|81737902|FG000|Overall Study|Adverse Event|2|||
27974348|NCT02229214|81737903|FG001|Overall Study|Adverse Event|0|||
27974349|NCT02229214|81737902|FG000|Overall Study|Withdrawal by Subject|4|||
27974350|NCT02229214|81737903|FG001|Overall Study|Withdrawal by Subject|0|||
27974351|NCT00645528|81737904|FG000|Overall Study|Did not show up for Visit 2|7|||
27974352|NCT01166958|81737905|FG000|Overall Study|Withdrawal by Subject|1|||
27974353|NCT01166958|81737906|FG001|Overall Study|Withdrawal by Subject|0|||
27974354|NCT03372460|81737907|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
27974355|NCT03372460|81737908|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
27974356|NCT03272828|81737914|FG000|Overall Study|Lost to Follow-up|7|||
27787440|NCT04052425|81051090|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
27787441|NCT04052425|81051091|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
27787442|NCT04052425|81051092|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
27671487|NCT01606319|80634998|FG001|Overall Study|Lost to Follow-up|14|||
27787443|NCT04052425|81051089|FG000|24-Week Double-blind Period|Physician Decision|1|||
27787444|NCT04052425|81051090|FG001|24-Week Double-blind Period|Physician Decision|0|||
27974357|NCT03272828|81737915|FG001|Overall Study|Lost to Follow-up|7|||
27974358|NCT03272828|81737914|FG000|Overall Study|Withdrawal by Subject|2|||
27974359|NCT03272828|81737915|FG001|Overall Study|Withdrawal by Subject|0|||
27974360|NCT03272828|81737914|FG000|Overall Study|Deceased|1|||
27974361|NCT03272828|81737915|FG001|Overall Study|Deceased|1|||
27974362|NCT03272828|81737914|FG000|Overall Study|Failed implant|1|||
27974363|NCT03272828|81737915|FG001|Overall Study|Failed implant|2|||
27974364|NCT02226562|81737921|FG000|Overall Study|Lost to Follow-up|0|||
27974365|NCT02226562|81737922|FG001|Overall Study|Lost to Follow-up|1|||
27974366|NCT02573246|81737929|FG000|Overall Study|Lost to Follow-up|2|||
27974367|NCT02573246|81737930|FG001|Overall Study|Lost to Follow-up|0|||
27974368|NCT02573246|81737931|FG002|Overall Study|Lost to Follow-up|0|||
27974369|NCT02573246|81737932|FG003|Overall Study|Lost to Follow-up|0|||
27974370|NCT02573246|81737933|FG004|Overall Study|Lost to Follow-up|1|||
27974371|NCT02573246|81737929|FG000|Overall Study|Withdrawal by Subject|0|||
27974372|NCT02573246|81737930|FG001|Overall Study|Withdrawal by Subject|0|||
27974373|NCT02573246|81737931|FG002|Overall Study|Withdrawal by Subject|0|||
27974374|NCT02573246|81737932|FG003|Overall Study|Withdrawal by Subject|0|||
27974375|NCT02573246|81737933|FG004|Overall Study|Withdrawal by Subject|1|||
27974376|NCT02573246|81737929|FG000|Overall Study|Physician Decision|1|||
27974377|NCT02573246|81737930|FG001|Overall Study|Physician Decision|1|||
27974378|NCT02573246|81737931|FG002|Overall Study|Physician Decision|3|||
27974379|NCT02573246|81737932|FG003|Overall Study|Physician Decision|2|||
27974380|NCT02573246|81737933|FG004|Overall Study|Physician Decision|2|||
27974381|NCT01779869|81737934|FG000|Overall Study|Physician Decision|2|||
27974382|NCT00983515|81737935|FG000|Ritonavir Alone|liver panel out of range|6|||
27974383|NCT00983515|81737935|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
27974384|NCT01952665|81737936|FG000|Overall Study|Physician Decision|3|||
27974385|NCT01952665|81737937|FG001|Overall Study|Physician Decision|2|||
27671488|NCT01606319|80634997|FG000|Overall Study|Withdrawal by Subject|9|||
27671489|NCT01606319|80634998|FG001|Overall Study|Withdrawal by Subject|12|||
27671490|NCT01606319|80634997|FG000|Overall Study|Physician Decision|1|||
27671491|NCT01606319|80634998|FG001|Overall Study|Physician Decision|2|||
27671492|NCT01606319|80634997|FG000|Overall Study|Lack of Efficacy|6|||
27671493|NCT01606319|80634998|FG001|Overall Study|Lack of Efficacy|8|||
27671494|NCT01606319|80634997|FG000|Overall Study|Adverse Event|1|||
27671495|NCT01606319|80634998|FG001|Overall Study|Adverse Event|4|||
27671496|NCT00003477|80635001|FG000|Overall Study|Not evalauable|4|||
27671497|NCT02881047|80635002|FG000|Overall Study|Adverse Event|1|||
27671498|NCT02881047|80635002|FG000|Overall Study|Withdrawal by Subject|1|||
27671499|NCT01755546|80635003|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
27671500|NCT01755546|80635003|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
27671501|NCT01755546|80635003|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
27671502|NCT01755546|80635003|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
27671503|NCT01755546|80635003|FG000|Titration Phase|Adverse Event|11|||
27671504|NCT01755546|80635003|FG000|Titration Phase|Lack of Efficacy|18|||
27671505|NCT01755546|80635003|FG000|Titration Phase|Protocol Violation|9|||
27671506|NCT01755546|80635003|FG000|Titration Phase|Lost to Follow-up|2|||
27671507|NCT01755546|80635003|FG000|Titration Phase|Other and Continuing|22|||
27671508|NCT01755546|80635003|FG000|Titration Phase|Withdrawal by Subject|8|||
27671509|NCT01755546|80635003|FG000|Long Term Treatment|Adverse Event|12|||
27787445|NCT04052425|81051091|FG002|24-Week Double-blind Period|Physician Decision|0|||
27787446|NCT04052425|81051092|FG003|24-Week Double-blind Period|Physician Decision|0|||
27671510|NCT01755546|80635003|FG000|Long Term Treatment|Lack of Efficacy|6|||
27671511|NCT01755546|80635003|FG000|Long Term Treatment|Protocol Violation|10|||
27671512|NCT01755546|80635003|FG000|Long Term Treatment|Withdrawal by Subject|35|||
27671513|NCT01755546|80635003|FG000|Long Term Treatment|Lost to Follow-up|17|||
27671514|NCT01755546|80635003|FG000|Long Term Treatment|other and ongoing|41|||
27671515|NCT02706951|80635004|FG000|Period 1|Adverse Event|1|||
27671516|NCT02706951|80635005|FG001|Period 1|Adverse Event|5|||
27671517|NCT02706951|80635006|FG002|Period 1|Adverse Event|3|||
27787447|NCT04052425|81051089|FG000|24-Week Double-blind Period|Protocol Violation|1|||
27787448|NCT04052425|81051090|FG001|24-Week Double-blind Period|Protocol Violation|0|||
27671518|NCT02706951|80635007|FG003|Period 1|Adverse Event|0|||
27671519|NCT02706951|80635008|FG004|Period 1|Adverse Event|0|||
27671520|NCT02706951|80635004|FG000|Period 1|Withdrawal by Subject|10|||
27671521|NCT02706951|80635005|FG001|Period 1|Withdrawal by Subject|6|||
27671522|NCT02706951|80635006|FG002|Period 1|Withdrawal by Subject|6|||
27671523|NCT02706951|80635007|FG003|Period 1|Withdrawal by Subject|0|||
27671524|NCT02706951|80635008|FG004|Period 1|Withdrawal by Subject|0|||
27671525|NCT02706951|80635004|FG000|Period 1|Lost to Follow-up|0|||
27787449|NCT04052425|81051091|FG002|24-Week Double-blind Period|Protocol Violation|0|||
27787450|NCT04052425|81051092|FG003|24-Week Double-blind Period|Protocol Violation|0|||
27671526|NCT02706951|80635005|FG001|Period 1|Lost to Follow-up|4|||
27787451|NCT04052425|81051089|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
27671527|NCT02706951|80635006|FG002|Period 1|Lost to Follow-up|1|||
27974386|NCT01952665|81737936|FG000|Overall Study|Lost to Follow-up|1|||
27974387|NCT01952665|81737937|FG001|Overall Study|Lost to Follow-up|2|||
27974388|NCT01952665|81737936|FG000|Overall Study|Adverse Event|2|||
27974389|NCT01952665|81737937|FG001|Overall Study|Adverse Event|1|||
27974390|NCT01952665|81737936|FG000|Overall Study|Protocol Violation|0|||
27974391|NCT01952665|81737937|FG001|Overall Study|Protocol Violation|1|||
27974392|NCT02435680|81737943|FG000|Overall Study|Physician Decision|3|||
27671528|NCT02706951|80635007|FG003|Period 1|Lost to Follow-up|0|||
27671529|NCT02706951|80635008|FG004|Period 1|Lost to Follow-up|0|||
27671530|NCT02706951|80635004|FG000|Period 1|Other|2|||
27671531|NCT02706951|80635005|FG001|Period 1|Other|1|||
27671532|NCT02706951|80635006|FG002|Period 1|Other|0|||
27671533|NCT02706951|80635007|FG003|Period 1|Other|0|||
27671534|NCT02706951|80635008|FG004|Period 1|Other|0|||
27671535|NCT02706951|80635004|FG000|Period 2|Adverse Event|0|||
27671536|NCT02706951|80635005|FG001|Period 2|Adverse Event|0|||
27671537|NCT02706951|80635006|FG002|Period 2|Adverse Event|0|||
27671538|NCT02706951|80635007|FG003|Period 2|Adverse Event|25|||
27671539|NCT02706951|80635008|FG004|Period 2|Adverse Event|34|||
27671540|NCT02706951|80635004|FG000|Period 2|Withdrawal by Subject|0|||
27671541|NCT02706951|80635005|FG001|Period 2|Withdrawal by Subject|0|||
27671542|NCT02706951|80635006|FG002|Period 2|Withdrawal by Subject|0|||
27671543|NCT02706951|80635007|FG003|Period 2|Withdrawal by Subject|38|||
27671544|NCT02706951|80635008|FG004|Period 2|Withdrawal by Subject|44|||
27671545|NCT02706951|80635004|FG000|Period 2|Lost to Follow-up|0|||
27671546|NCT02706951|80635005|FG001|Period 2|Lost to Follow-up|0|||
27671547|NCT02706951|80635006|FG002|Period 2|Lost to Follow-up|0|||
27671548|NCT02706951|80635007|FG003|Period 2|Lost to Follow-up|17|||
27671549|NCT02706951|80635008|FG004|Period 2|Lost to Follow-up|9|||
27671550|NCT02706951|80635004|FG000|Period 2|COVID-19 Related|0|||
27671551|NCT02706951|80635005|FG001|Period 2|COVID-19 Related|0|||
27671552|NCT02706951|80635006|FG002|Period 2|COVID-19 Related|0|||
27671553|NCT02706951|80635007|FG003|Period 2|COVID-19 Related|1|||
27671554|NCT02706951|80635008|FG004|Period 2|COVID-19 Related|2|||
27671555|NCT02706951|80635004|FG000|Period 2|Other|0|||
27671556|NCT02706951|80635005|FG001|Period 2|Other|0|||
27671557|NCT02706951|80635006|FG002|Period 2|Other|0|||
27671558|NCT02706951|80635007|FG003|Period 2|Other|37|||
27671559|NCT02706951|80635008|FG004|Period 2|Other|31|||
27671560|NCT03065933|80635010|FG000|Overall Study|study terminated|5|||
27671561|NCT00936598|80635015|FG000|Overall Study|Withdrawal by Subject|1|||
27671562|NCT00936598|80635016|FG001|Overall Study|Withdrawal by Subject|0|||
27671563|NCT00936598|80635015|FG000|Overall Study|Ineligible after consent|1|||
27671564|NCT00936598|80635016|FG001|Overall Study|Ineligible after consent|0|||
27671565|NCT02485899|80639062|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
27671566|NCT02485899|80639063|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27671567|NCT02485899|80639062|FG000|Overall Study|Withdrawal by Subject|1|||
27671568|NCT02485899|80639063|FG001|Overall Study|Withdrawal by Subject|0|||
27671569|NCT02485899|80639062|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
27671570|NCT02485899|80639063|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
27671571|NCT01333111|80639064|FG000|Overall Study|patient undergoing major surgery|0|||
27671572|NCT01333111|80639065|FG001|Overall Study|patient undergoing major surgery|2|||
27671573|NCT01333111|80639066|FG002|Overall Study|patient undergoing major surgery|0|||
27671574|NCT01333111|80639064|FG000|Overall Study|personal reasons|0|||
27671575|NCT01333111|80639065|FG001|Overall Study|personal reasons|0|||
27787452|NCT04052425|81051090|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
27787453|NCT04052425|81051091|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
27787454|NCT04052425|81051092|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
27787455|NCT04052425|81051089|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
27787456|NCT04052425|81051090|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
27787457|NCT04052425|81051091|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
27787458|NCT04052425|81051092|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
27787459|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
27787460|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
27787461|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
27787462|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
27787463|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
27787464|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
27787465|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
27787466|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
27787467|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
27671576|NCT01333111|80639066|FG002|Overall Study|personal reasons|1|||
27671577|NCT01333111|80639064|FG000|Overall Study|unclassified|1|||
27671578|NCT01333111|80639065|FG001|Overall Study|unclassified|0|||
27671579|NCT01333111|80639066|FG002|Overall Study|unclassified|0|||
27671580|NCT01333111|80639064|FG000|Overall Study|withdrawal criteria|0|||
27671581|NCT01333111|80639065|FG001|Overall Study|withdrawal criteria|1|||
27671582|NCT01333111|80639066|FG002|Overall Study|withdrawal criteria|0|||
27671583|NCT01333111|80639064|FG000|Overall Study|Non-compliance|1|||
27671584|NCT01333111|80639065|FG001|Overall Study|Non-compliance|0|||
27671585|NCT01333111|80639066|FG002|Overall Study|Non-compliance|0|||
27671586|NCT01333111|80639064|FG000|Overall Study|Ineffective therapy|0|||
27671587|NCT01333111|80639065|FG001|Overall Study|Ineffective therapy|0|||
27671588|NCT01333111|80639066|FG002|Overall Study|Ineffective therapy|1|||
27671589|NCT00490945|80639067|FG000|Overall Study|Adverse Event|0|||
27671590|NCT00490945|80639068|FG001|Overall Study|Adverse Event|1|||
27671591|NCT00490945|80639069|FG002|Overall Study|Adverse Event|0|||
27671592|NCT00490945|80639070|FG003|Overall Study|Adverse Event|0|||
27671593|NCT00490945|80639071|FG004|Overall Study|Adverse Event|0|||
27671594|NCT03126110|80639074|FG000|Phase 1|Death|2|||
27671595|NCT03126110|80639075|FG001|Phase 1|Death|2|||
27671596|NCT03126110|80639076|FG002|Phase 1|Death|4|||
27671597|NCT03126110|80639077|FG003|Phase 1|Death|3|||
27671598|NCT03126110|80639078|FG004|Phase 1|Death|4|||
27671599|NCT03126110|80639079|FG005|Phase 1|Death|4|||
27671600|NCT03126110|80639080|FG006|Phase 1|Death|3|||
27671601|NCT03126110|80639081|FG007|Phase 1|Death|4|||
27671602|NCT03126110|80639082|FG008|Phase 1|Death|5|||
27671603|NCT03126110|80639083|FG009|Phase 1|Death|2|||
27671604|NCT03126110|80639084|FG010|Phase 1|Death|6|||
27671605|NCT03126110|80639085|FG011|Phase 1|Death|0|||
27671606|NCT03126110|80639086|FG012|Phase 1|Death|0|||
27671607|NCT03126110|80639087|FG013|Phase 1|Death|0|||
27671608|NCT03126110|80639088|FG014|Phase 1|Death|0|||
27671609|NCT03126110|80639089|FG015|Phase 1|Death|0|||
27671610|NCT03126110|80639090|FG016|Phase 1|Death|0|||
27671611|NCT03126110|80639074|FG000|Phase 1|Lost to Follow-up|0|||
27671612|NCT03126110|80639075|FG001|Phase 1|Lost to Follow-up|1|||
27671613|NCT03126110|80639076|FG002|Phase 1|Lost to Follow-up|0|||
27671614|NCT03126110|80639077|FG003|Phase 1|Lost to Follow-up|0|||
27671615|NCT03126110|80639078|FG004|Phase 1|Lost to Follow-up|0|||
27671616|NCT03126110|80639079|FG005|Phase 1|Lost to Follow-up|0|||
27671617|NCT03126110|80639080|FG006|Phase 1|Lost to Follow-up|0|||
27671618|NCT03126110|80639081|FG007|Phase 1|Lost to Follow-up|0|||
27671619|NCT03126110|80639082|FG008|Phase 1|Lost to Follow-up|1|||
27671620|NCT03126110|80639083|FG009|Phase 1|Lost to Follow-up|0|||
27671621|NCT03126110|80639084|FG010|Phase 1|Lost to Follow-up|0|||
27671622|NCT03126110|80639085|FG011|Phase 1|Lost to Follow-up|0|||
27671623|NCT03126110|80639086|FG012|Phase 1|Lost to Follow-up|0|||
27671624|NCT03126110|80639087|FG013|Phase 1|Lost to Follow-up|0|||
27671625|NCT03126110|80639088|FG014|Phase 1|Lost to Follow-up|0|||
27671626|NCT03126110|80639089|FG015|Phase 1|Lost to Follow-up|0|||
27671627|NCT03126110|80639090|FG016|Phase 1|Lost to Follow-up|0|||
27671628|NCT03126110|80639074|FG000|Phase 1|Withdrawal by Subject|1|||
27671629|NCT03126110|80639075|FG001|Phase 1|Withdrawal by Subject|0|||
27671630|NCT03126110|80639076|FG002|Phase 1|Withdrawal by Subject|0|||
27671631|NCT03126110|80639077|FG003|Phase 1|Withdrawal by Subject|1|||
27671632|NCT03126110|80639078|FG004|Phase 1|Withdrawal by Subject|1|||
27671633|NCT03126110|80639079|FG005|Phase 1|Withdrawal by Subject|0|||
27671634|NCT03126110|80639080|FG006|Phase 1|Withdrawal by Subject|0|||
27671635|NCT03126110|80639081|FG007|Phase 1|Withdrawal by Subject|0|||
27671636|NCT03126110|80639082|FG008|Phase 1|Withdrawal by Subject|2|||
27671637|NCT03126110|80639083|FG009|Phase 1|Withdrawal by Subject|1|||
27671638|NCT03126110|80639084|FG010|Phase 1|Withdrawal by Subject|0|||
27671639|NCT03126110|80639085|FG011|Phase 1|Withdrawal by Subject|0|||
27671640|NCT03126110|80639086|FG012|Phase 1|Withdrawal by Subject|0|||
27671641|NCT03126110|80639087|FG013|Phase 1|Withdrawal by Subject|0|||
27671642|NCT03126110|80639088|FG014|Phase 1|Withdrawal by Subject|0|||
27671643|NCT03126110|80639089|FG015|Phase 1|Withdrawal by Subject|0|||
27671644|NCT03126110|80639090|FG016|Phase 1|Withdrawal by Subject|0|||
27671645|NCT03126110|80639074|FG000|Phase 1|Safety follow-up no longer necessary|1|||
27671646|NCT03126110|80639075|FG001|Phase 1|Safety follow-up no longer necessary|0|||
27671647|NCT03126110|80639076|FG002|Phase 1|Safety follow-up no longer necessary|0|||
27671648|NCT03126110|80639077|FG003|Phase 1|Safety follow-up no longer necessary|0|||
27671649|NCT03126110|80639078|FG004|Phase 1|Safety follow-up no longer necessary|0|||
27671650|NCT03126110|80639079|FG005|Phase 1|Safety follow-up no longer necessary|0|||
27671651|NCT03126110|80639080|FG006|Phase 1|Safety follow-up no longer necessary|0|||
27671652|NCT03126110|80639081|FG007|Phase 1|Safety follow-up no longer necessary|0|||
27671653|NCT03126110|80639082|FG008|Phase 1|Safety follow-up no longer necessary|0|||
27671654|NCT03126110|80639083|FG009|Phase 1|Safety follow-up no longer necessary|0|||
27671655|NCT03126110|80639084|FG010|Phase 1|Safety follow-up no longer necessary|0|||
27671656|NCT03126110|80639085|FG011|Phase 1|Safety follow-up no longer necessary|0|||
27671657|NCT03126110|80639086|FG012|Phase 1|Safety follow-up no longer necessary|0|||
27671658|NCT03126110|80639087|FG013|Phase 1|Safety follow-up no longer necessary|0|||
27671659|NCT03126110|80639088|FG014|Phase 1|Safety follow-up no longer necessary|0|||
27671660|NCT03126110|80639089|FG015|Phase 1|Safety follow-up no longer necessary|0|||
27671661|NCT03126110|80639090|FG016|Phase 1|Safety follow-up no longer necessary|0|||
27671662|NCT03126110|80639074|FG000|Phase 1|Survival follow-up no longer necessary|0|||
27671663|NCT03126110|80639075|FG001|Phase 1|Survival follow-up no longer necessary|0|||
27671664|NCT03126110|80639076|FG002|Phase 1|Survival follow-up no longer necessary|1|||
27671665|NCT03126110|80639077|FG003|Phase 1|Survival follow-up no longer necessary|0|||
27671666|NCT03126110|80639078|FG004|Phase 1|Survival follow-up no longer necessary|0|||
27671667|NCT03126110|80639079|FG005|Phase 1|Survival follow-up no longer necessary|0|||
27671668|NCT03126110|80639080|FG006|Phase 1|Survival follow-up no longer necessary|0|||
27671669|NCT03126110|80639081|FG007|Phase 1|Survival follow-up no longer necessary|0|||
27671670|NCT03126110|80639082|FG008|Phase 1|Survival follow-up no longer necessary|0|||
27671671|NCT03126110|80639083|FG009|Phase 1|Survival follow-up no longer necessary|0|||
27671672|NCT03126110|80639084|FG010|Phase 1|Survival follow-up no longer necessary|0|||
27671673|NCT03126110|80639085|FG011|Phase 1|Survival follow-up no longer necessary|0|||
27671674|NCT03126110|80639086|FG012|Phase 1|Survival follow-up no longer necessary|0|||
27671675|NCT03126110|80639087|FG013|Phase 1|Survival follow-up no longer necessary|0|||
27671676|NCT03126110|80639088|FG014|Phase 1|Survival follow-up no longer necessary|0|||
27671677|NCT03126110|80639089|FG015|Phase 1|Survival follow-up no longer necessary|0|||
27671678|NCT03126110|80639090|FG016|Phase 1|Survival follow-up no longer necessary|0|||
27671679|NCT03126110|80639074|FG000|Phase 2|Study terminated by the sponsor|0|||
27671680|NCT03126110|80639075|FG001|Phase 2|Study terminated by the sponsor|0|||
27671681|NCT03126110|80639076|FG002|Phase 2|Study terminated by the sponsor|0|||
27671682|NCT03126110|80639077|FG003|Phase 2|Study terminated by the sponsor|0|||
27671683|NCT03126110|80639078|FG004|Phase 2|Study terminated by the sponsor|0|||
27671684|NCT03126110|80639079|FG005|Phase 2|Study terminated by the sponsor|0|||
27671685|NCT03126110|80639080|FG006|Phase 2|Study terminated by the sponsor|0|||
27671686|NCT03126110|80639081|FG007|Phase 2|Study terminated by the sponsor|0|||
27671687|NCT03126110|80639082|FG008|Phase 2|Study terminated by the sponsor|0|||
27671688|NCT03126110|80639083|FG009|Phase 2|Study terminated by the sponsor|0|||
27671689|NCT03126110|80639084|FG010|Phase 2|Study terminated by the sponsor|0|||
27671690|NCT03126110|80639085|FG011|Phase 2|Study terminated by the sponsor|0|||
27671691|NCT03126110|80639086|FG012|Phase 2|Study terminated by the sponsor|0|||
27671692|NCT03126110|80639087|FG013|Phase 2|Study terminated by the sponsor|4|||
27671693|NCT03126110|80639088|FG014|Phase 2|Study terminated by the sponsor|0|||
27671694|NCT03126110|80639089|FG015|Phase 2|Study terminated by the sponsor|0|||
27671695|NCT03126110|80639090|FG016|Phase 2|Study terminated by the sponsor|0|||
27671696|NCT03126110|80639074|FG000|Phase 2|Withdrawal by Subject|0|||
27671697|NCT03126110|80639075|FG001|Phase 2|Withdrawal by Subject|0|||
27671698|NCT03126110|80639076|FG002|Phase 2|Withdrawal by Subject|0|||
27671699|NCT03126110|80639077|FG003|Phase 2|Withdrawal by Subject|0|||
27671700|NCT03126110|80639078|FG004|Phase 2|Withdrawal by Subject|0|||
27671701|NCT03126110|80639079|FG005|Phase 2|Withdrawal by Subject|0|||
27671702|NCT03126110|80639080|FG006|Phase 2|Withdrawal by Subject|0|||
27671703|NCT03126110|80639081|FG007|Phase 2|Withdrawal by Subject|0|||
27671704|NCT03126110|80639082|FG008|Phase 2|Withdrawal by Subject|0|||
27671705|NCT03126110|80639083|FG009|Phase 2|Withdrawal by Subject|0|||
27671706|NCT03126110|80639084|FG010|Phase 2|Withdrawal by Subject|0|||
27671707|NCT03126110|80639085|FG011|Phase 2|Withdrawal by Subject|1|||
27671708|NCT03126110|80639086|FG012|Phase 2|Withdrawal by Subject|3|||
27671709|NCT03126110|80639087|FG013|Phase 2|Withdrawal by Subject|3|||
27671710|NCT03126110|80639088|FG014|Phase 2|Withdrawal by Subject|2|||
27671711|NCT03126110|80639089|FG015|Phase 2|Withdrawal by Subject|1|||
27671712|NCT03126110|80639090|FG016|Phase 2|Withdrawal by Subject|0|||
27671713|NCT03126110|80639074|FG000|Phase 2|Lost to Follow-up|0|||
27671714|NCT03126110|80639075|FG001|Phase 2|Lost to Follow-up|0|||
27671715|NCT03126110|80639076|FG002|Phase 2|Lost to Follow-up|0|||
27671716|NCT03126110|80639077|FG003|Phase 2|Lost to Follow-up|0|||
27671717|NCT03126110|80639078|FG004|Phase 2|Lost to Follow-up|0|||
27671718|NCT03126110|80639079|FG005|Phase 2|Lost to Follow-up|0|||
27671719|NCT03126110|80639080|FG006|Phase 2|Lost to Follow-up|0|||
27671720|NCT03126110|80639081|FG007|Phase 2|Lost to Follow-up|0|||
27671721|NCT03126110|80639082|FG008|Phase 2|Lost to Follow-up|0|||
27671722|NCT03126110|80639083|FG009|Phase 2|Lost to Follow-up|0|||
27671723|NCT03126110|80639084|FG010|Phase 2|Lost to Follow-up|0|||
27671724|NCT03126110|80639085|FG011|Phase 2|Lost to Follow-up|1|||
27671725|NCT03126110|80639086|FG012|Phase 2|Lost to Follow-up|1|||
27671726|NCT03126110|80639087|FG013|Phase 2|Lost to Follow-up|1|||
27671727|NCT03126110|80639088|FG014|Phase 2|Lost to Follow-up|2|||
27671728|NCT03126110|80639089|FG015|Phase 2|Lost to Follow-up|0|||
27671729|NCT03126110|80639090|FG016|Phase 2|Lost to Follow-up|0|||
27671730|NCT03126110|80639074|FG000|Phase 2|Death|0|||
27671731|NCT03126110|80639075|FG001|Phase 2|Death|0|||
27671732|NCT03126110|80639076|FG002|Phase 2|Death|0|||
27671733|NCT03126110|80639077|FG003|Phase 2|Death|0|||
27671734|NCT03126110|80639078|FG004|Phase 2|Death|0|||
27974393|NCT02435680|81737944|FG001|Overall Study|Physician Decision|0|||
27671735|NCT03126110|80639079|FG005|Phase 2|Death|0|||
27671736|NCT03126110|80639080|FG006|Phase 2|Death|0|||
27671737|NCT03126110|80639081|FG007|Phase 2|Death|0|||
27671738|NCT03126110|80639082|FG008|Phase 2|Death|0|||
27671739|NCT03126110|80639083|FG009|Phase 2|Death|0|||
27671740|NCT03126110|80639084|FG010|Phase 2|Death|0|||
27671741|NCT03126110|80639085|FG011|Phase 2|Death|6|||
27671742|NCT03126110|80639086|FG012|Phase 2|Death|12|||
27671743|NCT03126110|80639087|FG013|Phase 2|Death|25|||
27671744|NCT03126110|80639088|FG014|Phase 2|Death|11|||
27671745|NCT03126110|80639089|FG015|Phase 2|Death|3|||
27671746|NCT03126110|80639090|FG016|Phase 2|Death|2|||
27671747|NCT03126110|80639074|FG000|Phase 2|Progressive Disease|0|||
27671748|NCT03126110|80639075|FG001|Phase 2|Progressive Disease|0|||
27671749|NCT03126110|80639076|FG002|Phase 2|Progressive Disease|0|||
27671750|NCT03126110|80639077|FG003|Phase 2|Progressive Disease|0|||
27787468|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
27787469|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
27787470|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
27787471|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
27787472|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
27787473|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
27787474|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
27787475|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
27974394|NCT02435680|81737945|FG002|Overall Study|Physician Decision|0|||
27974395|NCT02435680|81737943|FG000|Overall Study|subject / guardian decision|0|||
27974396|NCT02435680|81737944|FG001|Overall Study|subject / guardian decision|3|||
27974397|NCT02435680|81737945|FG002|Overall Study|subject / guardian decision|2|||
27974398|NCT02435680|81737943|FG000|Overall Study|Adverse Event|8|||
27974399|NCT02435680|81737944|FG001|Overall Study|Adverse Event|3|||
27974400|NCT02435680|81737945|FG002|Overall Study|Adverse Event|2|||
27974401|NCT02435680|81737943|FG000|Overall Study|progressive disease|10|||
27974402|NCT02435680|81737944|FG001|Overall Study|progressive disease|7|||
27974403|NCT02435680|81737945|FG002|Overall Study|progressive disease|11|||
27974404|NCT02435680|81737943|FG000|Overall Study|not treated|0|||
27974405|NCT02435680|81737944|FG001|Overall Study|not treated|0|||
27974406|NCT02435680|81737945|FG002|Overall Study|not treated|1|||
27974407|NCT01866423|81737946|FG000|Overall Study|Lack of Efficacy|3|||
27974408|NCT01866423|81737946|FG000|Overall Study|Sponsor Decision|1|||
27974409|NCT01874275|81737947|FG000|Overall Study|Lost to Follow-up|1|||
27974410|NCT01874275|81737948|FG001|Overall Study|Lost to Follow-up|0|||
27974411|NCT00223977|81737949|FG000|Overall Study|Adverse Event|7|||
27974412|NCT00223977|81737950|FG001|Overall Study|Adverse Event|10|||
27974413|NCT00223977|81737951|FG002|Overall Study|Adverse Event|0|||
27974414|NCT00223977|81737949|FG000|Overall Study|Protocol Violation|0|||
27974415|NCT00223977|81737950|FG001|Overall Study|Protocol Violation|0|||
27974416|NCT00223977|81737951|FG002|Overall Study|Protocol Violation|1|||
27974417|NCT00223977|81737949|FG000|Overall Study|Withdrawal by Subject|1|||
27974418|NCT00223977|81737950|FG001|Overall Study|Withdrawal by Subject|1|||
27974419|NCT00223977|81737951|FG002|Overall Study|Withdrawal by Subject|2|||
27974420|NCT00223977|81737949|FG000|Overall Study|Other|1|||
27974421|NCT00223977|81737950|FG001|Overall Study|Other|0|||
27974422|NCT00223977|81737951|FG002|Overall Study|Other|0|||
27974423|NCT03510468|81737952|FG000|Overall Study|Lost to Follow-up|1|||
27974424|NCT03510468|81737952|FG000|Overall Study|Adverse Event|5|||
27974425|NCT03510468|81737952|FG000|Overall Study|Physician Decision|1|||
27974426|NCT03510468|81737952|FG000|Overall Study|non-compliant with treatment|2|||
27974427|NCT03510468|81737952|FG000|Overall Study|Missed visit|1|||
27974428|NCT01605227|81737953|FG000|Overall Study|Did not receive study treatment|2|||
27974429|NCT01605227|81737954|FG001|Overall Study|Did not receive study treatment|3|||
27974430|NCT01605227|81737953|FG000|Overall Study|Adverse Event|228|||
27974431|NCT01605227|81737954|FG001|Overall Study|Adverse Event|42|||
27974432|NCT01605227|81737953|FG000|Overall Study|Progressive Disease|132|||
27974433|NCT01605227|81737954|FG001|Overall Study|Progressive Disease|128|||
27974434|NCT01605227|81737953|FG000|Overall Study|Clinical Deterioration|227|||
27974435|NCT01605227|81737954|FG001|Overall Study|Clinical Deterioration|133|||
27974436|NCT01605227|81737953|FG000|Overall Study|Lost to Follow-up|1|||
27974437|NCT01605227|81737954|FG001|Overall Study|Lost to Follow-up|0|||
27974438|NCT01605227|81737953|FG000|Overall Study|Protocol Violation|1|||
27974439|NCT01605227|81737954|FG001|Overall Study|Protocol Violation|0|||
27974440|NCT01605227|81737953|FG000|Overall Study|Physician Decision|9|||
27974441|NCT01605227|81737954|FG001|Overall Study|Physician Decision|7|||
27974442|NCT01605227|81737953|FG000|Overall Study|Withdrawal by Subject|18|||
27974443|NCT01605227|81737954|FG001|Overall Study|Withdrawal by Subject|14|||
27974444|NCT01605227|81737953|FG000|Overall Study|Sponsor Decision|2|||
27974445|NCT01605227|81737954|FG001|Overall Study|Sponsor Decision|0|||
27974446|NCT01605227|81737953|FG000|Overall Study|Started New Therapy|1|||
27974447|NCT01605227|81737954|FG001|Overall Study|Started New Therapy|0|||
27974448|NCT01605227|81737953|FG000|Overall Study|Subject Decision|0|||
27974449|NCT01605227|81737954|FG001|Overall Study|Subject Decision|1|||
27974450|NCT01605227|81737953|FG000|Overall Study|Dose Held >6 weeks|0|||
27974451|NCT01605227|81737954|FG001|Overall Study|Dose Held >6 weeks|1|||
27974452|NCT03549871|81737961|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
27974453|NCT03549871|81737962|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
27974454|NCT03549871|81737961|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
27787476|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
27787477|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
27974455|NCT03549871|81737962|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
27787478|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
27974456|NCT03549871|81737961|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
27974457|NCT03549871|81737962|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
27974458|NCT03549871|81737961|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
27671751|NCT03126110|80639078|FG004|Phase 2|Progressive Disease|0|||
27671752|NCT03126110|80639079|FG005|Phase 2|Progressive Disease|0|||
27671753|NCT03126110|80639080|FG006|Phase 2|Progressive Disease|0|||
27671754|NCT03126110|80639081|FG007|Phase 2|Progressive Disease|0|||
27671755|NCT03126110|80639082|FG008|Phase 2|Progressive Disease|0|||
27671756|NCT03126110|80639083|FG009|Phase 2|Progressive Disease|0|||
27671757|NCT03126110|80639084|FG010|Phase 2|Progressive Disease|0|||
27671758|NCT03126110|80639085|FG011|Phase 2|Progressive Disease|0|||
27787479|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
27671759|NCT03126110|80639086|FG012|Phase 2|Progressive Disease|0|||
27671760|NCT03126110|80639087|FG013|Phase 2|Progressive Disease|1|||
27671761|NCT03126110|80639088|FG014|Phase 2|Progressive Disease|0|||
27671762|NCT03126110|80639089|FG015|Phase 2|Progressive Disease|0|||
27671763|NCT03126110|80639090|FG016|Phase 2|Progressive Disease|0|||
27787480|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
27787481|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
27787482|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
27787483|NCT04052425|81051089|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
27787484|NCT04052425|81051090|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
27573281|NCT01371656|80285588|FG000|Overall Study|Withdrawal by Subject|7|||
27573282|NCT01371656|80285589|FG001|Overall Study|Withdrawal by Subject|0|||
27671764|NCT03126110|80639074|FG000|Phase 2|Started new treatment|0|||
27671765|NCT03126110|80639075|FG001|Phase 2|Started new treatment|0|||
27671766|NCT03126110|80639076|FG002|Phase 2|Started new treatment|0|||
27671767|NCT03126110|80639077|FG003|Phase 2|Started new treatment|0|||
27671768|NCT03126110|80639078|FG004|Phase 2|Started new treatment|0|||
27671769|NCT03126110|80639079|FG005|Phase 2|Started new treatment|0|||
27671770|NCT03126110|80639080|FG006|Phase 2|Started new treatment|0|||
27671771|NCT03126110|80639081|FG007|Phase 2|Started new treatment|0|||
27671772|NCT03126110|80639082|FG008|Phase 2|Started new treatment|0|||
27671773|NCT03126110|80639083|FG009|Phase 2|Started new treatment|0|||
27671774|NCT03126110|80639084|FG010|Phase 2|Started new treatment|0|||
27573283|NCT01371656|80285588|FG000|Overall Study|Ineligible|4|||
27573284|NCT01371656|80285589|FG001|Overall Study|Ineligible|3|||
27573285|NCT01856543|80285594|FG000|Overall Study|Treatment discontinued|6|||
27573286|NCT01856543|80285595|FG001|Overall Study|Treatment discontinued|3|||
27573287|NCT01856543|80285594|FG000|Overall Study|Withdrawn before start|7|||
27671775|NCT03126110|80639085|FG011|Phase 2|Started new treatment|0|||
27671776|NCT03126110|80639086|FG012|Phase 2|Started new treatment|0|||
27671777|NCT03126110|80639087|FG013|Phase 2|Started new treatment|0|||
27671778|NCT03126110|80639088|FG014|Phase 2|Started new treatment|1|||
27671779|NCT03126110|80639089|FG015|Phase 2|Started new treatment|0|||
27787485|NCT04052425|81051091|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
27787486|NCT04052425|81051092|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
27787487|NCT03868059|81051093|FG000|Overall Study|Adverse Event|3|||
27787488|NCT03868059|81051093|FG000|Overall Study|Lost to Follow-up|3|||
27787489|NCT03868059|81051093|FG000|Overall Study|Withdrawal by Subject|6|||
27787490|NCT00682539|81051096|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
27787491|NCT00682539|81051097|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
27787492|NCT00682539|81051098|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
27787493|NCT00682539|81051096|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
27787494|NCT00682539|81051097|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
27974459|NCT03549871|81737962|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
27974460|NCT03549871|81737961|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
27974461|NCT03549871|81737962|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
27974462|NCT03549871|81737961|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
27974463|NCT03549871|81737962|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
27974464|NCT03549871|81737961|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
27573288|NCT01856543|80285595|FG001|Overall Study|Withdrawn before start|3|||
27573289|NCT02953821|80285598|FG000|Overall Study|Adverse Event|0|||
27573290|NCT02953821|80285599|FG001|Overall Study|Adverse Event|4|||
27573291|NCT02953821|80285598|FG000|Overall Study|Death|1|||
27573292|NCT02953821|80285599|FG001|Overall Study|Death|0|||
27671780|NCT03126110|80639090|FG016|Phase 2|Started new treatment|0|||
27671781|NCT03409731|80639095|FG000|Overall Study|Withdrawal by Subject|17|||
27671782|NCT03409731|80639095|FG000|Overall Study|Death|4|||
27671783|NCT02684123|80639098|FG000|Phase 1|Lack of Efficacy|5|||
27671784|NCT02684123|80639099|FG001|Phase 1|Lack of Efficacy|0|||
27671785|NCT02684123|80639098|FG000|Phase 1|Adverse Event|3|||
27671786|NCT02684123|80639099|FG001|Phase 1|Adverse Event|0|||
27671787|NCT02684123|80639098|FG000|Phase 1|Lost to Follow-up|0|||
27671788|NCT02684123|80639099|FG001|Phase 1|Lost to Follow-up|1|||
27787495|NCT00682539|81051098|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
27787496|NCT02988115|81051099|FG000|Overall Study|Adverse Event|6|||
27787497|NCT02988115|81051100|FG001|Overall Study|Adverse Event|1|||
27787498|NCT02988115|81051099|FG000|Overall Study|Sponsor Decision|5|||
27787499|NCT02988115|81051100|FG001|Overall Study|Sponsor Decision|2|||
27787500|NCT02988115|81051099|FG000|Overall Study|Withdrawal by Subject|1|||
27787501|NCT02988115|81051100|FG001|Overall Study|Withdrawal by Subject|1|||
27787502|NCT02988115|81051099|FG000|Overall Study|Withdrawn by Mistake|1|||
27787503|NCT02988115|81051100|FG001|Overall Study|Withdrawn by Mistake|0|||
27787504|NCT02988115|81051099|FG000|Overall Study|Lost to Follow-up|1|||
27787505|NCT02988115|81051100|FG001|Overall Study|Lost to Follow-up|0|||
27787506|NCT00267202|81051106|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
27787507|NCT00267202|81051107|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27787508|NCT00267202|81051106|FG000|Overall Study|Withdrawal by Subject|12|||
27787509|NCT00267202|81051107|FG001|Overall Study|Withdrawal by Subject|15|||
27787510|NCT00267202|81051106|FG000|Overall Study|Adverse Event|13|||
27787511|NCT00267202|81051107|FG001|Overall Study|Adverse Event|7|||
27787512|NCT00267202|81051106|FG000|Overall Study|Protocol Violation|2|||
27787513|NCT00267202|81051107|FG001|Overall Study|Protocol Violation|3|||
27787514|NCT00267202|81051106|FG000|Overall Study|Administrative problems|2|||
27787515|NCT00267202|81051107|FG001|Overall Study|Administrative problems|1|||
27787516|NCT00267202|81051106|FG000|Overall Study|Lost to Follow-up|3|||
27787517|NCT00267202|81051107|FG001|Overall Study|Lost to Follow-up|0|||
27787518|NCT01020812|81051108|FG000|Overall Study|Physician Decision|1|||
27787519|NCT01020812|81051108|FG000|Overall Study|Withdrawal by Subject|1|||
27787520|NCT01020812|81051108|FG000|Overall Study|Protocol Violation|1|||
27787521|NCT01249404|81051109|FG000|Overall Study|Study treatment not received|0|||
27787522|NCT01249404|81051110|FG001|Overall Study|Study treatment not received|1|||
27787523|NCT01249404|81051111|FG002|Overall Study|Study treatment not received|2|||
27787524|NCT01249404|81051109|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
27787525|NCT01249404|81051110|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
27787526|NCT01249404|81051111|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
27787527|NCT01249404|81051109|FG000|Overall Study|Adverse Event|2|||
27787528|NCT01249404|81051110|FG001|Overall Study|Adverse Event|2|||
27787529|NCT01249404|81051111|FG002|Overall Study|Adverse Event|2|||
27787530|NCT01249404|81051109|FG000|Overall Study|Withdrawal by Subject|2|||
27787531|NCT01249404|81051110|FG001|Overall Study|Withdrawal by Subject|2|||
27787532|NCT01249404|81051111|FG002|Overall Study|Withdrawal by Subject|0|||
27787533|NCT01249404|81051109|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
27787534|NCT01249404|81051110|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
27787535|NCT01249404|81051111|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
27787536|NCT01249404|81051109|FG000|Overall Study|Non compliance to visit schedule|0|||
27787537|NCT01249404|81051110|FG001|Overall Study|Non compliance to visit schedule|1|||
27974465|NCT03549871|81737962|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
27974466|NCT03549871|81737961|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
27974467|NCT03549871|81737962|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
27974468|NCT03549871|81737961|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
27974469|NCT03549871|81737962|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
27974470|NCT03549871|81737961|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
27974471|NCT03549871|81737962|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
27974472|NCT03549871|81737961|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
27974473|NCT03549871|81737962|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
27974474|NCT02240368|81737963|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
27974475|NCT02240368|81737964|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
27974476|NCT02240368|81737965|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
27974477|NCT02240368|81737963|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
27974478|NCT02240368|81737964|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
27974479|NCT02240368|81737965|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
27974480|NCT03176472|81737967|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
27974481|NCT03176472|81737968|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
27974482|NCT03176472|81737967|FG000|Double Blind Treatment Period|Adverse Event|0|||
27974483|NCT03176472|81737968|FG001|Double Blind Treatment Period|Adverse Event|5|||
27787538|NCT01249404|81051111|FG002|Overall Study|Non compliance to visit schedule|0|||
27787539|NCT02213666|81051112|FG000|Overall Study|Withdrawal by Subject|1|||
27974484|NCT03176472|81737967|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
27787540|NCT00903357|81051115|FG000|First Intervention|Withdrawal by Subject|5|||
27787541|NCT00903357|81051116|FG001|First Intervention|Withdrawal by Subject|3|||
27787542|NCT00903357|81051115|FG000|First Intervention|Flu|0|||
27787543|NCT00903357|81051116|FG001|First Intervention|Flu|1|||
27671789|NCT02684123|80639098|FG000|Phase 2|Lack of Efficacy|1|||
27974485|NCT03176472|81737968|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27974486|NCT03176472|81737967|FG000|Double Blind Treatment Period|Physician Decision|0|||
27974487|NCT03176472|81737968|FG001|Double Blind Treatment Period|Physician Decision|1|||
27974488|NCT03176472|81737967|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27974489|NCT03176472|81737968|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27974490|NCT03176472|81737967|FG000|Double Blind Treatment Period|Not Provided|1|||
27974491|NCT03176472|81737968|FG001|Double Blind Treatment Period|Not Provided|0|||
27974492|NCT03176472|81737967|FG000|Open Label Extension|Withdrawal by Subject|3|||
27974493|NCT03176472|81737968|FG001|Open Label Extension|Withdrawal by Subject|4|||
27974494|NCT03176472|81737967|FG000|Open Label Extension|Adverse Event|2|||
27974495|NCT03176472|81737968|FG001|Open Label Extension|Adverse Event|4|||
27974496|NCT03176472|81737967|FG000|Open Label Extension|Lost to Follow-up|1|||
27974497|NCT03176472|81737968|FG001|Open Label Extension|Lost to Follow-up|2|||
27974498|NCT03176472|81737967|FG000|Open Label Extension|Protocol Violation|0|||
27974499|NCT03176472|81737968|FG001|Open Label Extension|Protocol Violation|1|||
27974500|NCT03176472|81737967|FG000|Open Label Extension|Not Provided|2|||
27787544|NCT00903357|81051115|FG000|Wash Out Period of 2 Weeks|Flu|0|||
27787545|NCT00903357|81051116|FG001|Wash Out Period of 2 Weeks|Flu|1|||
27787546|NCT00903357|81051115|FG000|Second Intervention|Lost to Follow-up|1|||
27787547|NCT00903357|81051116|FG001|Second Intervention|Lost to Follow-up|0|||
27787548|NCT03799198|81051117|FG000|Overall Study|Lost to Follow-up|4|||
27787549|NCT03799198|81051118|FG001|Overall Study|Lost to Follow-up|8|||
27787550|NCT03799198|81051117|FG000|Overall Study|Death|0|||
27787551|NCT03799198|81051118|FG001|Overall Study|Death|1|||
27787552|NCT05403502|81051119|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
27974501|NCT03176472|81737968|FG001|Open Label Extension|Not Provided|1|||
27974502|NCT03483038|81737969|FG000|Overall Study|Subjects still in follow-up|18|||
27974503|NCT01730339|81737970|FG000|Overall Study|Withdrawal by Subject|3|||
27974504|NCT01730339|81737971|FG001|Overall Study|Withdrawal by Subject|2|||
27974505|NCT01730339|81737970|FG000|Overall Study|Lost to Follow-up|1|||
27974506|NCT01730339|81737971|FG001|Overall Study|Lost to Follow-up|1|||
27974507|NCT01730339|81737970|FG000|Overall Study|Un-specified|1|||
27974508|NCT01730339|81737971|FG001|Overall Study|Un-specified|0|||
27974509|NCT00068250|81737972|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
27974510|NCT00068250|81737973|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
27974511|NCT00068250|81737974|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
27974512|NCT00068250|81737975|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
27974513|NCT00717522|81737982|FG000|Overall Study|Disease Progression|5|||
27974514|NCT00717522|81737982|FG000|Overall Study|Adverse Event|1|||
27974515|NCT00717522|81737982|FG000|Overall Study|Death|1|||
27974516|NCT03610581|81737983|FG000|Overall Study|Study terminated by sponsor|2|||
27974517|NCT03610581|81737984|FG001|Overall Study|Study terminated by sponsor|0|||
27974518|NCT03610581|81737983|FG000|Overall Study|Other|0|||
27974519|NCT03610581|81737984|FG001|Overall Study|Other|1|||
27974520|NCT03610581|81737983|FG000|Overall Study|Withdrawal by Subject|1|||
27974521|NCT03610581|81737984|FG001|Overall Study|Withdrawal by Subject|0|||
27974522|NCT01559259|81737989|FG000|Overall Study|Withdrawal by Subject|0|||
27974523|NCT01559259|81737990|FG001|Overall Study|Withdrawal by Subject|0|||
27974524|NCT01559259|81737991|FG002|Overall Study|Withdrawal by Subject|0|||
27974525|NCT01559259|81737992|FG003|Overall Study|Withdrawal by Subject|1|||
27974526|NCT01559259|81737993|FG004|Overall Study|Withdrawal by Subject|0|||
27974527|NCT01559259|81737989|FG000|Overall Study|Adverse Event|0|||
27974528|NCT01559259|81737990|FG001|Overall Study|Adverse Event|1|||
27974529|NCT01559259|81737991|FG002|Overall Study|Adverse Event|1|||
27974530|NCT01559259|81737992|FG003|Overall Study|Adverse Event|0|||
27974531|NCT01559259|81737993|FG004|Overall Study|Adverse Event|0|||
27974532|NCT00969761|81737994|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27974533|NCT00969761|81737995|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974534|NCT00969761|81737996|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974535|NCT00969761|81737997|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27787553|NCT05403502|81051119|FG000|Humalog Lead-In Period|Physician Decision|2|||
27787554|NCT05403502|81051119|FG000|Humalog Lead-In Period|Protocol Violation|1|||
27974536|NCT00969761|81737998|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974537|NCT00969761|81737999|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974538|NCT00969761|81738000|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974539|NCT00969761|81738001|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974540|NCT00969761|81738002|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27974541|NCT00969761|81738003|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
27974542|NCT00969761|81738004|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974543|NCT00969761|81738005|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
27974544|NCT00969761|81737994|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974545|NCT00969761|81737995|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974546|NCT00969761|81737996|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
27974547|NCT00969761|81737997|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974548|NCT00969761|81737998|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974549|NCT00969761|81737999|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974550|NCT00969761|81738000|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974551|NCT00969761|81738001|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974552|NCT00969761|81738002|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974553|NCT00969761|81738003|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974554|NCT00969761|81738004|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974555|NCT00969761|81738005|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
27974556|NCT00969761|81737994|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974557|NCT00969761|81737995|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974558|NCT00969761|81737996|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
27974559|NCT00969761|81737997|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974560|NCT00969761|81737998|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974561|NCT00969761|81737999|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974562|NCT00969761|81738000|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974563|NCT00969761|81738001|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974564|NCT00969761|81738002|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974565|NCT00969761|81738003|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974566|NCT00969761|81738004|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974567|NCT00969761|81738005|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
27974568|NCT00969761|81737994|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974569|NCT00969761|81737995|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974570|NCT00969761|81737996|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974571|NCT00969761|81737997|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974572|NCT00969761|81737998|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974573|NCT00969761|81737999|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974574|NCT00969761|81738000|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974575|NCT00969761|81738001|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974576|NCT00969761|81738002|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
27974577|NCT00969761|81738003|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974578|NCT00969761|81738004|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974579|NCT00969761|81738005|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
27974580|NCT00969761|81737994|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
27974581|NCT00969761|81737995|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27974582|NCT00969761|81737996|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
27974583|NCT00969761|81737997|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27974584|NCT00969761|81737998|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
27974585|NCT00969761|81737999|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27974586|NCT00969761|81738000|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27974587|NCT00969761|81738001|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
27974588|NCT00969761|81738002|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
27974589|NCT00969761|81738003|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
27974590|NCT00969761|81738004|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27974591|NCT00969761|81738005|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
27974592|NCT00969761|81737994|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974593|NCT00969761|81737995|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974594|NCT00969761|81737996|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974595|NCT00969761|81737997|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
27974596|NCT00969761|81737998|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
27974597|NCT00969761|81737999|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974598|NCT00969761|81738000|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974599|NCT00969761|81738001|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974600|NCT00969761|81738002|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
27974601|NCT00969761|81738003|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974602|NCT00969761|81738004|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974603|NCT00969761|81738005|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
27974604|NCT01089023|81742243|FG000|Overall Study|Lost to Follow-up|3|||
27974605|NCT01089023|81742243|FG000|Overall Study|Adverse Event|1|||
27974606|NCT01089023|81742243|FG000|Overall Study|Withdrawal by Subject|1|||
27974607|NCT01089023|81742243|FG000|Overall Study|Protocol Violation|1|||
27974608|NCT01089023|81742243|FG000|Overall Study|Lack of Efficacy|1|||
27671790|NCT02684123|80639099|FG001|Phase 2|Lack of Efficacy|8|||
27573293|NCT02953821|80285598|FG000|Overall Study|Progressive Disease|5|||
27974609|NCT02928029|81742244|FG000|Overall Study|Withdrawal by Subject|0|||
27974610|NCT02928029|81742245|FG001|Overall Study|Withdrawal by Subject|1|||
27974611|NCT02928029|81742244|FG000|Overall Study|Radiological progression|1|||
27974612|NCT02928029|81742245|FG001|Overall Study|Radiological progression|0|||
27974613|NCT02928029|81742244|FG000|Overall Study|Clinical progression|1|||
27974614|NCT02928029|81742245|FG001|Overall Study|Clinical progression|2|||
27974615|NCT02928029|81742244|FG000|Overall Study|AE not related to clinical progression|1|||
27974616|NCT02928029|81742245|FG001|Overall Study|AE not related to clinical progression|1|||
27787555|NCT05403502|81051119|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
27787556|NCT05403502|81051119|FG000|Lyumjev Treatment Period|Physician Decision|2|||
27787557|NCT00508872|81051125|FG000|Overall Study|Lost to Follow-up|1|||
27787558|NCT00508872|81051125|FG000|Overall Study|Physician Decision|1|||
27787559|NCT02260804|81051133|FG000|Induction Study Period|Protocol Violation|2|||
27787560|NCT02260804|81051134|FG001|Induction Study Period|Protocol Violation|0|||
27974617|NCT00916058|81742249|FG000|Phase 1|Screen Failure|0|||
27974618|NCT00916058|81742250|FG001|Phase 1|Screen Failure|0|||
27974619|NCT00916058|81742251|FG002|Phase 1|Screen Failure|0|||
27974620|NCT00916058|81742252|FG003|Phase 1|Screen Failure|0|||
27974621|NCT00916058|81742253|FG004|Phase 1|Screen Failure|0|||
27974622|NCT00916058|81742254|FG005|Phase 1|Screen Failure|1|||
27974623|NCT00916058|81742255|FG006|Phase 1|Screen Failure|0|||
27974624|NCT00916058|81742249|FG000|Phase 2|Screen Failure|0|||
27974625|NCT00916058|81742250|FG001|Phase 2|Screen Failure|0|||
27974626|NCT00916058|81742251|FG002|Phase 2|Screen Failure|0|||
27974627|NCT00916058|81742252|FG003|Phase 2|Screen Failure|0|||
27974628|NCT00916058|81742253|FG004|Phase 2|Screen Failure|0|||
27974629|NCT00916058|81742254|FG005|Phase 2|Screen Failure|0|||
27974630|NCT00916058|81742255|FG006|Phase 2|Screen Failure|3|||
27974631|NCT00934947|81742256|FG000|Overall Study|Adverse Event|0|||
27974632|NCT00934947|81742257|FG001|Overall Study|Adverse Event|2|||
27974633|NCT03784846|81742260|FG000|Pre-COVID Study|Lost to Follow-up|3|||
27974634|NCT03784846|81742261|FG001|Pre-COVID Study|Lost to Follow-up|3|||
27974635|NCT03784846|81742262|FG002|Pre-COVID Study|Lost to Follow-up|2|||
27974636|NCT03784846|81742260|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
27974637|NCT03784846|81742261|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
27974638|NCT03784846|81742262|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
27974639|NCT03784846|81742260|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
27974640|NCT03784846|81742261|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
27974641|NCT03784846|81742262|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
27974642|NCT03784846|81742260|FG000|Post-COVID Study|Lost to Follow-up|3|||
27974643|NCT03784846|81742261|FG001|Post-COVID Study|Lost to Follow-up|5|||
27974644|NCT03784846|81742262|FG002|Post-COVID Study|Lost to Follow-up|1|||
27974645|NCT03784846|81742260|FG000|Post-COVID Study|Withdrawal by Subject|1|||
27974646|NCT03784846|81742261|FG001|Post-COVID Study|Withdrawal by Subject|2|||
27974647|NCT03784846|81742262|FG002|Post-COVID Study|Withdrawal by Subject|0|||
27974648|NCT01728077|81742266|FG000|Overall Study|Lack of Efficacy|3|||
27974649|NCT01728077|81742267|FG001|Overall Study|Lack of Efficacy|1|||
27974650|NCT01728077|81742266|FG000|Overall Study|Lost to Follow-up|1|||
27974651|NCT01728077|81742267|FG001|Overall Study|Lost to Follow-up|0|||
27974652|NCT01728077|81742266|FG000|Overall Study|Subject choice|2|||
27974653|NCT01728077|81742267|FG001|Overall Study|Subject choice|3|||
27974654|NCT01728077|81742266|FG000|Overall Study|Death|0|||
27974655|NCT01728077|81742267|FG001|Overall Study|Death|1|||
27974656|NCT01728077|81742266|FG000|Overall Study|Patient moving|1|||
27974657|NCT01728077|81742267|FG001|Overall Study|Patient moving|0|||
27974658|NCT01728077|81742266|FG000|Overall Study|Non compliance|1|||
27974659|NCT01728077|81742267|FG001|Overall Study|Non compliance|0|||
27974660|NCT00896363|81742270|FG000|Overall Study|Adverse Event|3|||
27974661|NCT00896363|81742271|FG001|Overall Study|Adverse Event|4|||
27974662|NCT00896363|81742272|FG002|Overall Study|Adverse Event|2|||
27974663|NCT00896363|81742270|FG000|Overall Study|Lack of Efficacy|0|||
27974664|NCT00896363|81742271|FG001|Overall Study|Lack of Efficacy|2|||
27974665|NCT00896363|81742272|FG002|Overall Study|Lack of Efficacy|1|||
27974666|NCT00896363|81742270|FG000|Overall Study|Withdrawal by Subject|3|||
27974667|NCT00896363|81742271|FG001|Overall Study|Withdrawal by Subject|5|||
27974668|NCT00896363|81742272|FG002|Overall Study|Withdrawal by Subject|5|||
27974669|NCT02754141|81742274|FG000|Overall Study|Disease progression|11|||
27974670|NCT02754141|81742275|FG001|Overall Study|Disease progression|7|||
27974671|NCT02754141|81742276|FG002|Overall Study|Disease progression|8|||
27974672|NCT02754141|81742277|FG003|Overall Study|Disease progression|5|||
27974673|NCT02754141|81742278|FG004|Overall Study|Disease progression|7|||
27974674|NCT02754141|81742279|FG005|Overall Study|Disease progression|7|||
27974675|NCT02754141|81742280|FG006|Overall Study|Disease progression|7|||
27974676|NCT02754141|81742281|FG007|Overall Study|Disease progression|6|||
27974677|NCT02754141|81742282|FG008|Overall Study|Disease progression|11|||
27974678|NCT02754141|81742283|FG009|Overall Study|Disease progression|16|||
27974679|NCT02754141|81742284|FG010|Overall Study|Disease progression|18|||
27974680|NCT02754141|81742285|FG011|Overall Study|Disease progression|13|||
27787561|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
27974681|NCT02754141|81742286|FG012|Overall Study|Disease progression|10|||
27974682|NCT02754141|81742287|FG013|Overall Study|Disease progression|12|||
27974683|NCT02754141|81742288|FG014|Overall Study|Disease progression|12|||
27974684|NCT02754141|81742289|FG015|Overall Study|Disease progression|14|||
27974685|NCT02754141|81742290|FG016|Overall Study|Disease progression|0|||
27974686|NCT02754141|81742291|FG017|Overall Study|Disease progression|1|||
27974687|NCT02754141|81742274|FG000|Overall Study|Study drug toxicity|1|||
27974688|NCT02754141|81742275|FG001|Overall Study|Study drug toxicity|1|||
27974689|NCT02754141|81742276|FG002|Overall Study|Study drug toxicity|0|||
27974690|NCT02754141|81742277|FG003|Overall Study|Study drug toxicity|0|||
27974691|NCT02754141|81742278|FG004|Overall Study|Study drug toxicity|0|||
27974692|NCT02754141|81742279|FG005|Overall Study|Study drug toxicity|0|||
27974693|NCT02754141|81742280|FG006|Overall Study|Study drug toxicity|0|||
27974694|NCT02754141|81742281|FG007|Overall Study|Study drug toxicity|0|||
27974695|NCT02754141|81742282|FG008|Overall Study|Study drug toxicity|0|||
27974696|NCT02754141|81742283|FG009|Overall Study|Study drug toxicity|0|||
27974697|NCT02754141|81742284|FG010|Overall Study|Study drug toxicity|2|||
27974698|NCT02754141|81742285|FG011|Overall Study|Study drug toxicity|1|||
27974699|NCT02754141|81742286|FG012|Overall Study|Study drug toxicity|1|||
27974700|NCT02754141|81742287|FG013|Overall Study|Study drug toxicity|0|||
27974701|NCT02754141|81742288|FG014|Overall Study|Study drug toxicity|0|||
27974702|NCT02754141|81742289|FG015|Overall Study|Study drug toxicity|0|||
27974703|NCT02754141|81742290|FG016|Overall Study|Study drug toxicity|0|||
27974704|NCT02754141|81742291|FG017|Overall Study|Study drug toxicity|0|||
27974705|NCT02754141|81742274|FG000|Overall Study|AE unrelated to study drug|1|||
27974706|NCT02754141|81742275|FG001|Overall Study|AE unrelated to study drug|1|||
27974707|NCT02754141|81742276|FG002|Overall Study|AE unrelated to study drug|0|||
27974708|NCT02754141|81742277|FG003|Overall Study|AE unrelated to study drug|1|||
27974709|NCT02754141|81742278|FG004|Overall Study|AE unrelated to study drug|3|||
27974710|NCT02754141|81742279|FG005|Overall Study|AE unrelated to study drug|2|||
27974711|NCT02754141|81742280|FG006|Overall Study|AE unrelated to study drug|1|||
27974712|NCT02754141|81742281|FG007|Overall Study|AE unrelated to study drug|0|||
27974713|NCT02754141|81742282|FG008|Overall Study|AE unrelated to study drug|0|||
27974714|NCT02754141|81742283|FG009|Overall Study|AE unrelated to study drug|0|||
27974715|NCT02754141|81742284|FG010|Overall Study|AE unrelated to study drug|0|||
27974716|NCT02754141|81742285|FG011|Overall Study|AE unrelated to study drug|0|||
27974717|NCT02754141|81742286|FG012|Overall Study|AE unrelated to study drug|0|||
27974718|NCT02754141|81742287|FG013|Overall Study|AE unrelated to study drug|0|||
27974719|NCT02754141|81742288|FG014|Overall Study|AE unrelated to study drug|0|||
27974720|NCT02754141|81742289|FG015|Overall Study|AE unrelated to study drug|0|||
27974721|NCT02754141|81742290|FG016|Overall Study|AE unrelated to study drug|0|||
27974722|NCT02754141|81742291|FG017|Overall Study|AE unrelated to study drug|0|||
27974723|NCT02754141|81742274|FG000|Overall Study|Request to discontinue|0|||
27974724|NCT02754141|81742275|FG001|Overall Study|Request to discontinue|0|||
27974725|NCT02754141|81742276|FG002|Overall Study|Request to discontinue|0|||
27974726|NCT02754141|81742277|FG003|Overall Study|Request to discontinue|0|||
27974727|NCT02754141|81742278|FG004|Overall Study|Request to discontinue|0|||
27974728|NCT02754141|81742279|FG005|Overall Study|Request to discontinue|0|||
27974729|NCT02754141|81742280|FG006|Overall Study|Request to discontinue|0|||
27974730|NCT02754141|81742281|FG007|Overall Study|Request to discontinue|0|||
27974731|NCT02754141|81742282|FG008|Overall Study|Request to discontinue|1|||
27974732|NCT02754141|81742283|FG009|Overall Study|Request to discontinue|0|||
27974733|NCT02754141|81742284|FG010|Overall Study|Request to discontinue|0|||
27974734|NCT02754141|81742285|FG011|Overall Study|Request to discontinue|0|||
27974735|NCT02754141|81742286|FG012|Overall Study|Request to discontinue|0|||
27974736|NCT02754141|81742287|FG013|Overall Study|Request to discontinue|1|||
27974737|NCT02754141|81742288|FG014|Overall Study|Request to discontinue|1|||
27974738|NCT02754141|81742289|FG015|Overall Study|Request to discontinue|0|||
27974739|NCT02754141|81742290|FG016|Overall Study|Request to discontinue|0|||
27974740|NCT02754141|81742291|FG017|Overall Study|Request to discontinue|0|||
27974741|NCT02754141|81742274|FG000|Overall Study|Withdrew consent|0|||
27974742|NCT02754141|81742275|FG001|Overall Study|Withdrew consent|0|||
27974743|NCT02754141|81742276|FG002|Overall Study|Withdrew consent|0|||
27974744|NCT02754141|81742277|FG003|Overall Study|Withdrew consent|0|||
27974745|NCT02754141|81742278|FG004|Overall Study|Withdrew consent|0|||
27974746|NCT02754141|81742279|FG005|Overall Study|Withdrew consent|0|||
27974747|NCT02754141|81742280|FG006|Overall Study|Withdrew consent|0|||
27974748|NCT02754141|81742281|FG007|Overall Study|Withdrew consent|0|||
27974749|NCT02754141|81742282|FG008|Overall Study|Withdrew consent|0|||
27974750|NCT02754141|81742283|FG009|Overall Study|Withdrew consent|1|||
27974751|NCT02754141|81742284|FG010|Overall Study|Withdrew consent|0|||
27974752|NCT02754141|81742285|FG011|Overall Study|Withdrew consent|0|||
27974753|NCT02754141|81742286|FG012|Overall Study|Withdrew consent|0|||
27974754|NCT02754141|81742287|FG013|Overall Study|Withdrew consent|0|||
27974755|NCT02754141|81742288|FG014|Overall Study|Withdrew consent|0|||
27974756|NCT02754141|81742289|FG015|Overall Study|Withdrew consent|0|||
27974757|NCT02754141|81742290|FG016|Overall Study|Withdrew consent|0|||
27974758|NCT02754141|81742291|FG017|Overall Study|Withdrew consent|0|||
27974759|NCT02754141|81742274|FG000|Overall Study|Maximum clinical benefit|0|||
27974760|NCT02754141|81742275|FG001|Overall Study|Maximum clinical benefit|0|||
27974761|NCT02754141|81742276|FG002|Overall Study|Maximum clinical benefit|0|||
27974762|NCT02754141|81742277|FG003|Overall Study|Maximum clinical benefit|1|||
27974763|NCT02754141|81742278|FG004|Overall Study|Maximum clinical benefit|0|||
27974764|NCT02754141|81742279|FG005|Overall Study|Maximum clinical benefit|0|||
27974765|NCT02754141|81742280|FG006|Overall Study|Maximum clinical benefit|0|||
27974766|NCT02754141|81742281|FG007|Overall Study|Maximum clinical benefit|0|||
27974767|NCT02754141|81742282|FG008|Overall Study|Maximum clinical benefit|0|||
27974768|NCT02754141|81742283|FG009|Overall Study|Maximum clinical benefit|0|||
27974769|NCT02754141|81742284|FG010|Overall Study|Maximum clinical benefit|0|||
27974770|NCT02754141|81742285|FG011|Overall Study|Maximum clinical benefit|0|||
27974771|NCT02754141|81742286|FG012|Overall Study|Maximum clinical benefit|0|||
27974772|NCT02754141|81742287|FG013|Overall Study|Maximum clinical benefit|0|||
27974773|NCT02754141|81742288|FG014|Overall Study|Maximum clinical benefit|0|||
27974774|NCT02754141|81742289|FG015|Overall Study|Maximum clinical benefit|0|||
27974775|NCT02754141|81742290|FG016|Overall Study|Maximum clinical benefit|0|||
27974776|NCT02754141|81742291|FG017|Overall Study|Maximum clinical benefit|0|||
27974777|NCT02754141|81742274|FG000|Overall Study|No longer meets study criteria|0|||
27974778|NCT02754141|81742275|FG001|Overall Study|No longer meets study criteria|0|||
27974779|NCT02754141|81742276|FG002|Overall Study|No longer meets study criteria|0|||
27974780|NCT02754141|81742277|FG003|Overall Study|No longer meets study criteria|1|||
27974781|NCT02754141|81742278|FG004|Overall Study|No longer meets study criteria|0|||
27974782|NCT02754141|81742279|FG005|Overall Study|No longer meets study criteria|0|||
27974783|NCT02754141|81742280|FG006|Overall Study|No longer meets study criteria|0|||
27974784|NCT02754141|81742281|FG007|Overall Study|No longer meets study criteria|0|||
27974785|NCT02754141|81742282|FG008|Overall Study|No longer meets study criteria|0|||
27974786|NCT02754141|81742283|FG009|Overall Study|No longer meets study criteria|0|||
27974787|NCT02754141|81742284|FG010|Overall Study|No longer meets study criteria|0|||
27974788|NCT02754141|81742285|FG011|Overall Study|No longer meets study criteria|0|||
27974789|NCT02754141|81742286|FG012|Overall Study|No longer meets study criteria|0|||
27974790|NCT02754141|81742287|FG013|Overall Study|No longer meets study criteria|0|||
27974791|NCT02754141|81742288|FG014|Overall Study|No longer meets study criteria|0|||
27974792|NCT02754141|81742289|FG015|Overall Study|No longer meets study criteria|0|||
27974793|NCT02754141|81742290|FG016|Overall Study|No longer meets study criteria|0|||
27974794|NCT02754141|81742291|FG017|Overall Study|No longer meets study criteria|0|||
27974795|NCT02754141|81742274|FG000|Overall Study|Other reasons|0|||
27974796|NCT02754141|81742275|FG001|Overall Study|Other reasons|0|||
27974797|NCT02754141|81742276|FG002|Overall Study|Other reasons|0|||
27974798|NCT02754141|81742277|FG003|Overall Study|Other reasons|0|||
27974799|NCT02754141|81742278|FG004|Overall Study|Other reasons|0|||
27974800|NCT02754141|81742279|FG005|Overall Study|Other reasons|0|||
27974801|NCT02754141|81742280|FG006|Overall Study|Other reasons|0|||
27974802|NCT02754141|81742281|FG007|Overall Study|Other reasons|1|||
27974803|NCT02754141|81742282|FG008|Overall Study|Other reasons|0|||
27974804|NCT02754141|81742283|FG009|Overall Study|Other reasons|0|||
27974805|NCT02754141|81742284|FG010|Overall Study|Other reasons|0|||
27974806|NCT02754141|81742285|FG011|Overall Study|Other reasons|0|||
27974807|NCT02754141|81742286|FG012|Overall Study|Other reasons|2|||
27974808|NCT02754141|81742287|FG013|Overall Study|Other reasons|0|||
27974809|NCT02754141|81742288|FG014|Overall Study|Other reasons|0|||
27974810|NCT02754141|81742289|FG015|Overall Study|Other reasons|0|||
27974811|NCT02754141|81742290|FG016|Overall Study|Other reasons|0|||
27974812|NCT02754141|81742291|FG017|Overall Study|Other reasons|0|||
27974813|NCT02754141|81742274|FG000|Overall Study|Completed treatment as per protocol|0|||
27974814|NCT02754141|81742275|FG001|Overall Study|Completed treatment as per protocol|1|||
27974815|NCT02754141|81742276|FG002|Overall Study|Completed treatment as per protocol|0|||
27974816|NCT02754141|81742277|FG003|Overall Study|Completed treatment as per protocol|0|||
27974817|NCT02754141|81742278|FG004|Overall Study|Completed treatment as per protocol|0|||
27974818|NCT02754141|81742279|FG005|Overall Study|Completed treatment as per protocol|0|||
27974819|NCT02754141|81742280|FG006|Overall Study|Completed treatment as per protocol|0|||
27974820|NCT02754141|81742281|FG007|Overall Study|Completed treatment as per protocol|0|||
27974821|NCT02754141|81742282|FG008|Overall Study|Completed treatment as per protocol|0|||
27974822|NCT02754141|81742283|FG009|Overall Study|Completed treatment as per protocol|0|||
27974823|NCT02754141|81742284|FG010|Overall Study|Completed treatment as per protocol|0|||
27974824|NCT02754141|81742285|FG011|Overall Study|Completed treatment as per protocol|0|||
27974825|NCT02754141|81742286|FG012|Overall Study|Completed treatment as per protocol|1|||
27974826|NCT02754141|81742287|FG013|Overall Study|Completed treatment as per protocol|0|||
27974827|NCT02754141|81742288|FG014|Overall Study|Completed treatment as per protocol|0|||
27974828|NCT02754141|81742289|FG015|Overall Study|Completed treatment as per protocol|0|||
27974829|NCT02754141|81742290|FG016|Overall Study|Completed treatment as per protocol|0|||
27974830|NCT02754141|81742291|FG017|Overall Study|Completed treatment as per protocol|0|||
27974831|NCT02754141|81742274|FG000|Overall Study|Not completing monotherapy|0|||
27974832|NCT02754141|81742275|FG001|Overall Study|Not completing monotherapy|0|||
27974833|NCT02754141|81742276|FG002|Overall Study|Not completing monotherapy|0|||
27671791|NCT00617929|80639100|FG000|Overall Study|Physician Decision|1|||
27671792|NCT03482752|80639101|FG000|Overall Study|Withdrawal by Subject|2|||
27671793|NCT03482752|80639101|FG000|Overall Study|Lost to Follow-up|1|||
27671794|NCT03482752|80639101|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
27671795|NCT01150045|80639102|FG000|Overall Study|Protocol Violation|0|||
27974834|NCT02754141|81742277|FG003|Overall Study|Not completing monotherapy|0|||
27974835|NCT02754141|81742278|FG004|Overall Study|Not completing monotherapy|0|||
27974836|NCT02754141|81742279|FG005|Overall Study|Not completing monotherapy|0|||
27974837|NCT02754141|81742280|FG006|Overall Study|Not completing monotherapy|0|||
27974838|NCT02754141|81742281|FG007|Overall Study|Not completing monotherapy|0|||
27974839|NCT02754141|81742282|FG008|Overall Study|Not completing monotherapy|0|||
27974840|NCT02754141|81742283|FG009|Overall Study|Not completing monotherapy|0|||
27974841|NCT02754141|81742284|FG010|Overall Study|Not completing monotherapy|0|||
27974842|NCT02754141|81742285|FG011|Overall Study|Not completing monotherapy|0|||
27974843|NCT02754141|81742286|FG012|Overall Study|Not completing monotherapy|0|||
27787562|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
27787563|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
27867282|NCT00129545|81349543|FG001|Overall Study|Withdrawal by Subject|18|||
27867283|NCT00129545|81349544|FG002|Overall Study|Withdrawal by Subject|44|||
27974844|NCT02754141|81742287|FG013|Overall Study|Not completing monotherapy|1|||
27974845|NCT02754141|81742288|FG014|Overall Study|Not completing monotherapy|0|||
27974846|NCT02754141|81742289|FG015|Overall Study|Not completing monotherapy|0|||
27974847|NCT02754141|81742290|FG016|Overall Study|Not completing monotherapy|0|||
27974848|NCT02754141|81742291|FG017|Overall Study|Not completing monotherapy|0|||
27974849|NCT03060512|81742294|FG000|Overall Study|Adverse Event|4|||
27974850|NCT03060512|81742295|FG001|Overall Study|Adverse Event|6|||
27974851|NCT03060512|81742294|FG000|Overall Study|Lost to Follow-up|1|||
27867284|NCT00129545|81349542|FG000|Overall Study|Lost to Follow-up|2|||
27867285|NCT00129545|81349543|FG001|Overall Study|Lost to Follow-up|22|||
27867286|NCT00129545|81349544|FG002|Overall Study|Lost to Follow-up|13|||
27867287|NCT00129545|81349542|FG000|Overall Study|Physician Decision|0|||
27867288|NCT00129545|81349543|FG001|Overall Study|Physician Decision|3|||
27867289|NCT00129545|81349544|FG002|Overall Study|Physician Decision|10|||
27867290|NCT00129545|81349542|FG000|Overall Study|Device not implanted|16|||
27867291|NCT00129545|81349543|FG001|Overall Study|Device not implanted|61|||
27867292|NCT00129545|81349544|FG002|Overall Study|Device not implanted|0|||
27974852|NCT03060512|81742295|FG001|Overall Study|Lost to Follow-up|1|||
27573294|NCT02953821|80285599|FG001|Overall Study|Progressive Disease|1|||
27867293|NCT02652949|81349545|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
27974853|NCT03060512|81742294|FG000|Overall Study|Withdrawal by Subject|1|||
27671796|NCT01150045|80639103|FG001|Overall Study|Protocol Violation|1|||
27671797|NCT01150045|80639104|FG002|Overall Study|Protocol Violation|0|||
27867294|NCT02652949|81349545|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
27974854|NCT03060512|81742295|FG001|Overall Study|Withdrawal by Subject|0|||
27974855|NCT03060512|81742294|FG000|Overall Study|Non-compliance with study medication|1|||
27974856|NCT03060512|81742295|FG001|Overall Study|Non-compliance with study medication|2|||
27974857|NCT00350272|81742298|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
27974858|NCT00350272|81742299|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
27974859|NCT00350272|81742298|FG000|Blinded 12-Week Treatment|Death|1|||
27974860|NCT00350272|81742299|FG001|Blinded 12-Week Treatment|Death|0|||
27974861|NCT00350272|81742298|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
27974862|NCT00350272|81742299|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
27974863|NCT00350272|81742298|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
27974864|NCT00350272|81742299|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
27974865|NCT00350272|81742298|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
27974866|NCT00350272|81742299|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
27974867|NCT00350272|81742298|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
27974868|NCT00350272|81742299|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
27974869|NCT00350272|81742298|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
27974870|NCT00350272|81742299|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
27787564|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
27787565|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
27787566|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
27787567|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
27787568|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
27787569|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
27787570|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
27787571|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
27787572|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
27787573|NCT02260804|81051133|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
27787574|NCT02260804|81051134|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
27787575|NCT02260804|81051133|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
27787576|NCT02260804|81051134|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
27787577|NCT02260804|81051133|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
27787578|NCT02260804|81051134|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
27867295|NCT02652949|81349545|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
27974871|NCT00350272|81742298|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
27671798|NCT01150045|80639105|FG003|Overall Study|Protocol Violation|1|||
27671799|NCT01289210|80639106|FG000|Overall Study|Adverse Event|1|||
27671800|NCT03062449|80639107|FG000|Overall Study|Withdrawal by Subject|7|||
27671801|NCT03062449|80639108|FG001|Overall Study|Withdrawal by Subject|1|||
27671802|NCT04092452|80639114|FG000|Overall Study|Adverse Event|1|||
27671803|NCT04092452|80639115|FG001|Overall Study|Adverse Event|3|||
27671804|NCT04092452|80639116|FG002|Overall Study|Adverse Event|3|||
27671805|NCT04092452|80639117|FG003|Overall Study|Adverse Event|7|||
27671806|NCT04092452|80639114|FG000|Overall Study|Lack of Efficacy|1|||
27671807|NCT04092452|80639115|FG001|Overall Study|Lack of Efficacy|1|||
27671808|NCT04092452|80639116|FG002|Overall Study|Lack of Efficacy|1|||
27671809|NCT04092452|80639117|FG003|Overall Study|Lack of Efficacy|0|||
27671810|NCT04092452|80639114|FG000|Overall Study|Lost to Follow-up|4|||
27671811|NCT04092452|80639115|FG001|Overall Study|Lost to Follow-up|3|||
27671812|NCT04092452|80639116|FG002|Overall Study|Lost to Follow-up|5|||
27671813|NCT04092452|80639117|FG003|Overall Study|Lost to Follow-up|1|||
27671814|NCT04092452|80639114|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27671815|NCT04092452|80639115|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27671816|NCT04092452|80639116|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27671817|NCT04092452|80639117|FG003|Overall Study|Non-Compliance With Study Drug|1|||
27974872|NCT00350272|81742299|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
27974873|NCT00350272|81742298|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
27671818|NCT04092452|80639114|FG000|Overall Study|Physician Decision|1|||
27671819|NCT04092452|80639115|FG001|Overall Study|Physician Decision|0|||
27671820|NCT04092452|80639116|FG002|Overall Study|Physician Decision|1|||
27671821|NCT04092452|80639117|FG003|Overall Study|Physician Decision|0|||
27787579|NCT02260804|81051133|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
27974874|NCT00350272|81742299|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
27974875|NCT00350272|81742298|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
27974876|NCT00350272|81742299|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
27787580|NCT02260804|81051134|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
27787581|NCT04491591|81051136|FG000|Overall Study|Accidently randomized|3|||
27787582|NCT04491591|81051137|FG001|Overall Study|Accidently randomized|1|||
27787583|NCT04491591|81051138|FG002|Overall Study|Accidently randomized|0|||
27787584|NCT04491591|81051136|FG000|Overall Study|Did not complete survey|28|||
27787585|NCT04491591|81051137|FG001|Overall Study|Did not complete survey|20|||
27787586|NCT04491591|81051138|FG002|Overall Study|Did not complete survey|3|||
27787587|NCT03198559|81051151|FG000|Overall Study|Adverse Event|2|||
27787588|NCT02406586|81051153|FG000|Overall Study|Lost to Follow-up|0|||
27787589|NCT02406586|81051154|FG001|Overall Study|Lost to Follow-up|4|||
27787590|NCT02406586|81051155|FG002|Overall Study|Lost to Follow-up|2|||
27787591|NCT02406586|81051153|FG000|Overall Study|Withdrawal by Subject|1|||
27787592|NCT02406586|81051154|FG001|Overall Study|Withdrawal by Subject|0|||
27787593|NCT02406586|81051155|FG002|Overall Study|Withdrawal by Subject|0|||
27787594|NCT03287089|81051158|FG000|Overall Study|Lost to Follow-up|0|||
27787595|NCT03287089|81051159|FG001|Overall Study|Lost to Follow-up|2|||
27787596|NCT03287089|81051158|FG000|Overall Study|Physician Decision|0|||
27787597|NCT03287089|81051159|FG001|Overall Study|Physician Decision|2|||
27787598|NCT03287089|81051158|FG000|Overall Study|Withdrawal by Subject|0|||
27787599|NCT03287089|81051159|FG001|Overall Study|Withdrawal by Subject|2|||
27787600|NCT03205605|81051160|FG000|Overall Study|Withdrawal by Subject|1|||
27787601|NCT00848965|81051164|FG000|Overall Study|Adverse Event|1|||
27787602|NCT00848965|81051164|FG000|Overall Study|Withdrawal by Subject|1|||
27787603|NCT00422227|81051167|FG000|Overall Study|Adverse Event|3|||
27787604|NCT00422227|81051168|FG001|Overall Study|Adverse Event|8|||
27787605|NCT00422227|81051167|FG000|Overall Study|Lost to Follow-up|1|||
27787606|NCT00422227|81051168|FG001|Overall Study|Lost to Follow-up|3|||
27787607|NCT00422227|81051167|FG000|Overall Study|Withdrawal by Subject|0|||
27787608|NCT00422227|81051168|FG001|Overall Study|Withdrawal by Subject|4|||
27787609|NCT03359811|81051169|FG000|Overall Study|Protocol Violation|2|||
27787610|NCT03359811|81051170|FG001|Overall Study|Protocol Violation|0|||
27787611|NCT00438815|81051173|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
27787612|NCT00438815|81051173|FG000|Overall Study|3-month follow-up no longer required|12|||
27787613|NCT00438815|81051173|FG000|Overall Study|Noncompliance with protocol requirements|9|||
27787614|NCT00438815|81051173|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
27787615|NCT00438815|81051173|FG000|Overall Study|Lost to Follow-up|6|||
27787616|NCT00438815|81051173|FG000|Overall Study|Withdrawal by Subject|6|||
27787617|NCT00438815|81051173|FG000|Overall Study|Death|1|||
27787618|NCT02127931|81051174|FG000|Overall Study|Glitch in Game|1|||
27787619|NCT01858701|81051175|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
27787620|NCT01858701|81051176|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
27787621|NCT01858701|81051175|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
27787622|NCT01858701|81051176|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
27787623|NCT01858701|81051175|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
27867296|NCT02652949|81349545|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
27974877|NCT00350272|81742298|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
27974878|NCT00350272|81742299|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
27974879|NCT00856206|81742306|FG000|Overall Study|Protocol Violation|6|||
27974880|NCT00856206|81742307|FG001|Overall Study|Protocol Violation|18|||
27974881|NCT00856206|81742306|FG000|Overall Study|Adverse Event|10|||
27974882|NCT00856206|81742307|FG001|Overall Study|Adverse Event|46|||
27974883|NCT00856206|81742306|FG000|Overall Study|Lack of Efficacy|1|||
27974884|NCT00856206|81742307|FG001|Overall Study|Lack of Efficacy|2|||
27974885|NCT00856206|81742306|FG000|Overall Study|Withdrawal by Subject|15|||
27671822|NCT04092452|80639114|FG000|Overall Study|Pregnancy|2|||
27787624|NCT01858701|81051176|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
27787625|NCT01858701|81051175|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
27787626|NCT01858701|81051176|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
27787627|NCT02985996|81051177|FG000|Overall Study|Withdrawal by Subject|0|||
27787628|NCT02985996|81051178|FG001|Overall Study|Withdrawal by Subject|0|||
27974886|NCT00856206|81742307|FG001|Overall Study|Withdrawal by Subject|36|||
27787629|NCT02985996|81051179|FG002|Overall Study|Withdrawal by Subject|1|||
27974887|NCT00856206|81742306|FG000|Overall Study|Lost to Follow-up|13|||
27974888|NCT00856206|81742307|FG001|Overall Study|Lost to Follow-up|39|||
27974889|NCT00856206|81742306|FG000|Overall Study|Death|2|||
27974890|NCT00856206|81742307|FG001|Overall Study|Death|2|||
27787630|NCT02985996|81051180|FG003|Overall Study|Withdrawal by Subject|0|||
27787631|NCT02985996|81051181|FG004|Overall Study|Withdrawal by Subject|0|||
27787632|NCT02985996|81051177|FG000|Overall Study|Protocol Violation|0|||
27787633|NCT02985996|81051178|FG001|Overall Study|Protocol Violation|1|||
27787634|NCT02985996|81051179|FG002|Overall Study|Protocol Violation|0|||
27787635|NCT02985996|81051180|FG003|Overall Study|Protocol Violation|0|||
27787636|NCT02985996|81051181|FG004|Overall Study|Protocol Violation|0|||
27787637|NCT00496782|81051182|FG000|Overall Study|Protocol Violation|1|||
27787638|NCT00496782|81051183|FG001|Overall Study|Protocol Violation|2|||
27787639|NCT02528331|81051184|FG000|Overall Study|Withdrawal by Subject|2|||
27787640|NCT02061293|81051185|FG000|Overall Study|Elevated Blood Pressure|1|||
27787641|NCT02061293|81051186|FG001|Overall Study|Elevated Blood Pressure|1|||
27787642|NCT00334893|81051187|FG000|Overall Study|Not Treated|1|||
27787643|NCT00334893|81051188|FG001|Overall Study|Not Treated|0|||
27787644|NCT02743117|81051189|FG000|Overall Study|Lost to Follow-up|0|||
27787645|NCT02743117|81051190|FG001|Overall Study|Lost to Follow-up|1|||
27787646|NCT02743117|81051189|FG000|Overall Study|Other|1|||
27787647|NCT02743117|81051190|FG001|Overall Study|Other|0|||
27787648|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
27787649|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
27787650|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
27787651|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
27787652|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
27787653|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
27787654|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
27787655|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
27787656|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
27974891|NCT00856206|81742306|FG000|Overall Study|Decision by the Sponsor|4|||
27974892|NCT00856206|81742307|FG001|Overall Study|Decision by the Sponsor|8|||
27974893|NCT00856206|81742306|FG000|Overall Study|Other than specified above|3|||
27974894|NCT00856206|81742307|FG001|Overall Study|Other than specified above|10|||
27974895|NCT00610441|81742310|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
27974896|NCT00610441|81742311|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
27974897|NCT00610441|81742312|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
27974898|NCT00610441|81742313|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
27974899|NCT00610441|81742310|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
27974900|NCT00610441|81742311|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
27974901|NCT00610441|81742312|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
27974902|NCT00610441|81742313|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
27974903|NCT00610441|81742310|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
27974904|NCT00610441|81742311|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
27671823|NCT04092452|80639115|FG001|Overall Study|Pregnancy|0|||
27671824|NCT04092452|80639116|FG002|Overall Study|Pregnancy|0|||
27671825|NCT04092452|80639117|FG003|Overall Study|Pregnancy|0|||
27671826|NCT04092452|80639114|FG000|Overall Study|Protocol Deviation|1|||
27671827|NCT04092452|80639115|FG001|Overall Study|Protocol Deviation|0|||
27671828|NCT04092452|80639116|FG002|Overall Study|Protocol Deviation|0|||
27671829|NCT04092452|80639117|FG003|Overall Study|Protocol Deviation|0|||
27671830|NCT04092452|80639114|FG000|Overall Study|Withdrawal by Subject|3|||
27671831|NCT04092452|80639115|FG001|Overall Study|Withdrawal by Subject|10|||
27671832|NCT04092452|80639116|FG002|Overall Study|Withdrawal by Subject|3|||
27671833|NCT04092452|80639117|FG003|Overall Study|Withdrawal by Subject|5|||
27671834|NCT04092452|80639114|FG000|Overall Study|Other|0|||
27671835|NCT04092452|80639115|FG001|Overall Study|Other|0|||
27671836|NCT04092452|80639116|FG002|Overall Study|Other|1|||
27671837|NCT04092452|80639117|FG003|Overall Study|Other|2|||
27671838|NCT01296555|80639120|FG000|Overall Study|Adverse Event|0|||
27671839|NCT01296555|80639121|FG001|Overall Study|Adverse Event|0|||
27671840|NCT01296555|80639122|FG002|Overall Study|Adverse Event|1|||
27671841|NCT01296555|80639123|FG003|Overall Study|Adverse Event|1|||
27671842|NCT01296555|80639124|FG004|Overall Study|Adverse Event|2|||
27974905|NCT00610441|81742312|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
27974906|NCT00610441|81742313|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
27671843|NCT01296555|80639125|FG005|Overall Study|Adverse Event|4|||
27671844|NCT01296555|80639126|FG006|Overall Study|Adverse Event|1|||
27671845|NCT01296555|80639127|FG007|Overall Study|Adverse Event|4|||
27671846|NCT01296555|80639128|FG008|Overall Study|Adverse Event|3|||
27671847|NCT01296555|80639129|FG009|Overall Study|Adverse Event|1|||
27671848|NCT01296555|80639130|FG010|Overall Study|Adverse Event|0|||
27671849|NCT01296555|80639131|FG011|Overall Study|Adverse Event|4|||
27787657|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
27787658|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
27787659|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
27787660|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
27787661|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
27787662|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
27787663|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
27787664|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
27787665|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
27787666|NCT00570492|81051191|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
27787667|NCT00570492|81051192|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
27787668|NCT00570492|81051193|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
27787669|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27787670|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
27787671|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
27787672|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
27787673|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
27787674|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
27787675|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
27787676|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
27787677|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
27787678|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
27787679|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
27787680|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
27787681|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
27787682|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
27787683|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
27787684|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
27787685|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
27787686|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
27787687|NCT00570492|81051191|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
27974907|NCT00610441|81742310|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
27974908|NCT00610441|81742311|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
27974909|NCT00610441|81742312|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
27974910|NCT00610441|81742313|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
27787688|NCT00570492|81051192|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
27787689|NCT00570492|81051193|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
27787690|NCT02028182|81051194|FG000|Overall Study|Protocol Violation|2|||
27787691|NCT00451191|81051197|FG000|Overall Study|withdrawal or received alternate tx|15|||
27787692|NCT00451191|81051198|FG001|Overall Study|withdrawal or received alternate tx|11|||
27787693|NCT00223990|81051199|FG000|Overall Study|Moved from area|2|||
27787694|NCT00223990|81051200|FG001|Overall Study|Moved from area|1|||
27787695|NCT00223990|81051199|FG000|Overall Study|Withdrawal by Subject|4|||
27787696|NCT00223990|81051200|FG001|Overall Study|Withdrawal by Subject|8|||
27787697|NCT00223990|81051199|FG000|Overall Study|Lost to Follow-up|1|||
27787698|NCT00223990|81051200|FG001|Overall Study|Lost to Follow-up|0|||
27787699|NCT00383292|81051201|FG000|Overall Study|Adverse Event|4|||
27787700|NCT00383292|81051202|FG001|Overall Study|Adverse Event|1|||
27787701|NCT00383292|81051203|FG002|Overall Study|Adverse Event|2|||
27787702|NCT00383292|81051201|FG000|Overall Study|Death|3|||
27787703|NCT00383292|81051202|FG001|Overall Study|Death|3|||
27974911|NCT00610441|81742310|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
27974912|NCT00610441|81742311|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
27787704|NCT00383292|81051203|FG002|Overall Study|Death|3|||
27787705|NCT00383292|81051201|FG000|Overall Study|Physician Decision|4|||
27787706|NCT00383292|81051202|FG001|Overall Study|Physician Decision|0|||
27787707|NCT00383292|81051203|FG002|Overall Study|Physician Decision|1|||
27787708|NCT00383292|81051201|FG000|Overall Study|Withdrawal by Subject|3|||
27787709|NCT00383292|81051202|FG001|Overall Study|Withdrawal by Subject|2|||
27787710|NCT00383292|81051203|FG002|Overall Study|Withdrawal by Subject|2|||
27787711|NCT00383292|81051201|FG000|Overall Study|Other|1|||
27787712|NCT00383292|81051202|FG001|Overall Study|Other|0|||
27787713|NCT00383292|81051203|FG002|Overall Study|Other|0|||
27787714|NCT03457701|81051204|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
27787715|NCT03457701|81051205|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
27787716|NCT03457701|81051204|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
27787717|NCT03457701|81051205|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
27974913|NCT00610441|81742312|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
27787718|NCT00750061|81051210|FG000|Overall Study|Adverse Event|2|||
27787719|NCT00750061|81051211|FG001|Overall Study|Adverse Event|0|||
27787720|NCT00750061|81051210|FG000|Overall Study|Withdrawal by Subject|0|||
27787721|NCT00750061|81051211|FG001|Overall Study|Withdrawal by Subject|1|||
27787722|NCT00750061|81051210|FG000|Overall Study|Physician Decision|0|||
27787723|NCT00750061|81051211|FG001|Overall Study|Physician Decision|1|||
27787724|NCT01539512|81051212|FG000|Overall Study|Adverse Event|9|||
27787725|NCT01539512|81051213|FG001|Overall Study|Adverse Event|7|||
27787726|NCT01539512|81051212|FG000|Overall Study|Physician Decision|1|||
27787727|NCT01539512|81051213|FG001|Overall Study|Physician Decision|1|||
27787728|NCT01539512|81051212|FG000|Overall Study|Withdrawal by Subject|12|||
27787729|NCT01539512|81051213|FG001|Overall Study|Withdrawal by Subject|5|||
27787730|NCT01539512|81051212|FG000|Overall Study|Richter's Transformation|1|||
27787731|NCT01539512|81051213|FG001|Overall Study|Richter's Transformation|0|||
27787732|NCT00711009|81051214|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
27787733|NCT00711009|81051215|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
27787734|NCT00711009|81051214|FG000|Overall Study|Withdrawal by Subject|4|||
27787735|NCT00711009|81051215|FG001|Overall Study|Withdrawal by Subject|2|||
27787736|NCT00711009|81051214|FG000|Overall Study|Lost to Follow-up|3|||
27787737|NCT00711009|81051215|FG001|Overall Study|Lost to Follow-up|9|||
27787738|NCT00711009|81051214|FG000|Overall Study|Participant Noncompliant|0|||
27787739|NCT00711009|81051215|FG001|Overall Study|Participant Noncompliant|1|||
27787740|NCT00711009|81051214|FG000|Overall Study|Virologic Failure|2|||
27787741|NCT00711009|81051215|FG001|Overall Study|Virologic Failure|1|||
27787742|NCT00711009|81051214|FG000|Overall Study|Pregnancy|1|||
27787743|NCT00711009|81051215|FG001|Overall Study|Pregnancy|0|||
27787744|NCT00711009|81051214|FG000|Overall Study|Site closing|0|||
27787745|NCT00711009|81051215|FG001|Overall Study|Site closing|1|||
27787746|NCT00711009|81051214|FG000|Overall Study|Dose adjustment|1|||
27787747|NCT00711009|81051215|FG001|Overall Study|Dose adjustment|0|||
27787748|NCT01348828|81051222|FG000|Overall Study|Death|20|||
27787749|NCT01348828|81051222|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
27787750|NCT01348828|81051222|FG000|Overall Study|Conversion|2|||
27787751|NCT01348828|81051222|FG000|Overall Study|missed visit|1|||
27787752|NCT02438787|81051223|FG000|Overall Study|Adverse Event|1|||
27787753|NCT02438787|81051224|FG001|Overall Study|Adverse Event|0|||
27787754|NCT02438787|81051225|FG002|Overall Study|Adverse Event|2|||
27787755|NCT02438787|81051223|FG000|Overall Study|Lack of Efficacy|1|||
27787756|NCT02438787|81051224|FG001|Overall Study|Lack of Efficacy|2|||
27787757|NCT02438787|81051225|FG002|Overall Study|Lack of Efficacy|0|||
27787758|NCT02438787|81051223|FG000|Overall Study|Lost to Follow-up|0|||
27787759|NCT02438787|81051224|FG001|Overall Study|Lost to Follow-up|1|||
27787760|NCT02438787|81051225|FG002|Overall Study|Lost to Follow-up|0|||
27787761|NCT02438787|81051223|FG000|Overall Study|Protocol Violation|0|||
27787762|NCT02438787|81051224|FG001|Overall Study|Protocol Violation|0|||
27787763|NCT02438787|81051225|FG002|Overall Study|Protocol Violation|1|||
27974914|NCT00610441|81742313|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
27974915|NCT00610441|81742310|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27974916|NCT00610441|81742311|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
27974917|NCT00610441|81742312|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27974918|NCT00610441|81742313|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27974919|NCT00610441|81742310|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
27787764|NCT02438787|81051223|FG000|Overall Study|Withdrawal by Subject|15|||
27787765|NCT02438787|81051224|FG001|Overall Study|Withdrawal by Subject|7|||
27787766|NCT02438787|81051225|FG002|Overall Study|Withdrawal by Subject|10|||
27787767|NCT02438787|81051223|FG000|Overall Study|Study discontinued by sponsor|64|||
27787768|NCT02438787|81051224|FG001|Overall Study|Study discontinued by sponsor|72|||
27787769|NCT02438787|81051225|FG002|Overall Study|Study discontinued by sponsor|69|||
27787770|NCT02438787|81051223|FG000|Overall Study|Other|0|||
27787771|NCT02438787|81051224|FG001|Overall Study|Other|1|||
27787772|NCT02438787|81051225|FG002|Overall Study|Other|0|||
27974920|NCT00610441|81742311|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
27974921|NCT00610441|81742312|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
27787773|NCT02438787|81051223|FG000|Overall Study|Site terminated by sponsor|0|||
27787774|NCT02438787|81051224|FG001|Overall Study|Site terminated by sponsor|0|||
27787775|NCT02438787|81051225|FG002|Overall Study|Site terminated by sponsor|1|||
27787776|NCT00764465|81051226|FG000|Overall Study|Adverse Event|2|||
27787777|NCT00764465|81051227|FG001|Overall Study|Adverse Event|0|||
27787778|NCT00764465|81051228|FG002|Overall Study|Adverse Event|0|||
27787779|NCT00764465|81051229|FG003|Overall Study|Adverse Event|1|||
27787780|NCT00764465|81051230|FG004|Overall Study|Adverse Event|1|||
27787781|NCT00764465|81051231|FG005|Overall Study|Adverse Event|1|||
27974922|NCT00610441|81742313|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
27974923|NCT00610441|81742310|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
27787782|NCT00764465|81051226|FG000|Overall Study|Withdrawal by Subject|0|||
27787783|NCT00764465|81051227|FG001|Overall Study|Withdrawal by Subject|1|||
27787784|NCT00764465|81051228|FG002|Overall Study|Withdrawal by Subject|1|||
27787785|NCT00764465|81051229|FG003|Overall Study|Withdrawal by Subject|0|||
27787786|NCT00764465|81051230|FG004|Overall Study|Withdrawal by Subject|0|||
27787787|NCT00764465|81051231|FG005|Overall Study|Withdrawal by Subject|0|||
27787788|NCT01396434|81051232|FG000|Overall Study|Lost to Follow-up|1|||
27787789|NCT01396434|81051233|FG001|Overall Study|Lost to Follow-up|0|||
27787790|NCT01396434|81051234|FG002|Overall Study|Lost to Follow-up|0|||
27787791|NCT01396434|81051232|FG000|Overall Study|Other|10|||
27787792|NCT01396434|81051233|FG001|Overall Study|Other|0|||
27787793|NCT01396434|81051234|FG002|Overall Study|Other|0|||
27787794|NCT01233076|81051238|FG000|Period 2, One Week|Lost to Follow-up|1|||
27787795|NCT01233076|81051239|FG001|Period 2, One Week|Lost to Follow-up|0|||
27787796|NCT01054443|81051242|FG000|Overall Study|Withdrawal by Subject|0|||
27787797|NCT01054443|81051243|FG001|Overall Study|Withdrawal by Subject|0|||
27787798|NCT01054443|81051244|FG002|Overall Study|Withdrawal by Subject|0|||
27787799|NCT01054443|81051245|FG003|Overall Study|Withdrawal by Subject|1|||
27787800|NCT04298229|81051246|FG000|Overall Study|Physician Decision|1|||
27787801|NCT04298229|81051247|FG001|Overall Study|Physician Decision|1|||
27787802|NCT04298229|81051246|FG000|Overall Study|Withdrawal by Subject|1|||
27787803|NCT04298229|81051247|FG001|Overall Study|Withdrawal by Subject|1|||
27787804|NCT04298229|81051246|FG000|Overall Study|Did not receive IV loop diuretics|2|||
27787805|NCT04298229|81051247|FG001|Overall Study|Did not receive IV loop diuretics|0|||
27787806|NCT01610752|81051249|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
27787807|NCT01610752|81051250|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
27787808|NCT01610752|81051251|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
27787809|NCT01694849|81051256|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
27787810|NCT01694849|81051257|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
27787811|NCT01694849|81051258|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
27787812|NCT01694849|81051256|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
27787813|NCT01694849|81051257|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
27787814|NCT01694849|81051258|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
27787815|NCT01694849|81051256|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
27787816|NCT01694849|81051257|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
27787817|NCT01694849|81051258|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
27974924|NCT00610441|81742311|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
27974925|NCT00610441|81742312|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
27974926|NCT00610441|81742313|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
27974927|NCT00610441|81742310|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
27974928|NCT00610441|81742311|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
27974929|NCT00610441|81742312|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
27787818|NCT01694849|81051256|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
27787819|NCT01694849|81051257|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
27787820|NCT01694849|81051258|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
27787821|NCT01694849|81051256|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
27787822|NCT01694849|81051257|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
27787823|NCT01694849|81051258|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
27787824|NCT01694849|81051256|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
27787825|NCT01694849|81051257|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
27787826|NCT01694849|81051258|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
27787827|NCT01694849|81051256|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
27787828|NCT01694849|81051257|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
27787829|NCT01694849|81051258|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
27787830|NCT01694849|81051256|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
27787831|NCT01694849|81051257|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
27787832|NCT01694849|81051258|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
27787833|NCT00792467|81051261|FG000|Overall Study|progression of disease|17|||
27787834|NCT00792467|81051261|FG000|Overall Study|Adverse Event|1|||
27787835|NCT00792467|81051261|FG000|Overall Study|patient request|1|||
27787836|NCT00792467|81051261|FG000|Overall Study|Lost to Follow-up|1|||
27787837|NCT00792467|81051261|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
27787838|NCT00792467|81051261|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
27787839|NCT04235959|81051262|FG000|Overall Study|Protocol Violation|0|||
27787840|NCT04235959|81051263|FG001|Overall Study|Protocol Violation|1|||
27787841|NCT04235959|81051264|FG002|Overall Study|Protocol Violation|0|||
27787842|NCT04235959|81051262|FG000|Overall Study|Adverse Event|1|||
27787843|NCT04235959|81051263|FG001|Overall Study|Adverse Event|0|||
27787844|NCT04235959|81051264|FG002|Overall Study|Adverse Event|0|||
27787845|NCT01159665|81051266|FG000|Overall Study|Withdrawal by Subject|0|||
27787846|NCT01159665|81051267|FG001|Overall Study|Withdrawal by Subject|1|||
27787847|NCT01159665|81051268|FG002|Overall Study|Withdrawal by Subject|0|||
27787848|NCT01159665|81051269|FG003|Overall Study|Withdrawal by Subject|0|||
27974930|NCT00610441|81742313|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
27787849|NCT01159665|81051270|FG004|Overall Study|Withdrawal by Subject|0|||
27787850|NCT01159665|81051271|FG005|Overall Study|Withdrawal by Subject|0|||
27787851|NCT03288987|81051272|FG000|Overall Study|Protocol Violation|10|||
27787852|NCT03288987|81051273|FG001|Overall Study|Protocol Violation|4|||
27787853|NCT02451137|81051280|FG000|Overall Study|Randomized but not treated|19|||
27787854|NCT02451137|81051281|FG001|Overall Study|Randomized but not treated|27|||
27787855|NCT02451137|81051280|FG000|Overall Study|Adverse Event|43|||
27787856|NCT02451137|81051281|FG001|Overall Study|Adverse Event|42|||
27787857|NCT02451137|81051280|FG000|Overall Study|Lack of Efficacy|4|||
27787858|NCT02451137|81051281|FG001|Overall Study|Lack of Efficacy|9|||
27787859|NCT02451137|81051280|FG000|Overall Study|Participant decision:discontinue insulin|41|||
27787860|NCT02451137|81051281|FG001|Overall Study|Participant decision:discontinue insulin|43|||
27787861|NCT02451137|81051280|FG000|Overall Study|Hypoglycemia|2|||
27787862|NCT02451137|81051281|FG001|Overall Study|Hypoglycemia|1|||
27787863|NCT02451137|81051280|FG000|Overall Study|Investigator's decision|23|||
27787864|NCT02451137|81051281|FG001|Overall Study|Investigator's decision|19|||
27787865|NCT02451137|81051280|FG000|Overall Study|Lost to Follow-up|53|||
27787866|NCT02451137|81051281|FG001|Overall Study|Lost to Follow-up|61|||
27787867|NCT02451137|81051280|FG000|Overall Study|Physician Decision|6|||
27787868|NCT02451137|81051281|FG001|Overall Study|Physician Decision|5|||
27974931|NCT01665430|81742314|FG000|Overall Study|Adverse Event|1|||
27974932|NCT01665430|81742314|FG000|Overall Study|Withdrawal by Subject|6|||
27974933|NCT01665430|81742314|FG000|Overall Study|Other Unspecified|2|||
27974934|NCT03440918|81742315|FG000|Overall Study|Protocol Violation|0|||
27974935|NCT03440918|81742316|FG001|Overall Study|Protocol Violation|16|||
27974936|NCT01740089|81742321|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
27974937|NCT01740089|81742322|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
27974938|NCT01740089|81742323|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
27974939|NCT01740089|81742321|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
27974940|NCT01740089|81742322|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
27974941|NCT01740089|81742323|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
27974942|NCT01740089|81742321|FG000|After 12 Weeks|Lack of Efficacy|3|||
27974943|NCT01740089|81742322|FG001|After 12 Weeks|Lack of Efficacy|1|||
27974944|NCT01740089|81742323|FG002|After 12 Weeks|Lack of Efficacy|4|||
27974945|NCT01740089|81742321|FG000|After 12 Weeks|Adverse Event|2|||
27974946|NCT01740089|81742322|FG001|After 12 Weeks|Adverse Event|0|||
27974947|NCT01740089|81742323|FG002|After 12 Weeks|Adverse Event|5|||
27974948|NCT01740089|81742321|FG000|After 12 Weeks|Protocol Violation|1|||
27974949|NCT01740089|81742322|FG001|After 12 Weeks|Protocol Violation|1|||
27974950|NCT01740089|81742323|FG002|After 12 Weeks|Protocol Violation|1|||
27974951|NCT01740089|81742321|FG000|After 12 Weeks|Withdrawal by Subject|1|||
27974952|NCT01740089|81742322|FG001|After 12 Weeks|Withdrawal by Subject|1|||
27974953|NCT01740089|81742323|FG002|After 12 Weeks|Withdrawal by Subject|1|||
27974954|NCT04209114|81742324|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
27974955|NCT04209114|81742325|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
27974956|NCT04209114|81742326|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
27974957|NCT04209114|81742324|FG000|Pre-Treatment Phase|Other reasons|0|||
27974958|NCT04209114|81742325|FG001|Pre-Treatment Phase|Other reasons|0|||
27974959|NCT04209114|81742326|FG002|Pre-Treatment Phase|Other reasons|1|||
27974960|NCT04209114|81742324|FG000|Pre-Treatment Phase|Death|0|||
27974961|NCT04209114|81742325|FG001|Pre-Treatment Phase|Death|0|||
27974962|NCT04209114|81742326|FG002|Pre-Treatment Phase|Death|1|||
27974963|NCT04209114|81742324|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
27974964|NCT04209114|81742325|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
27974965|NCT04209114|81742326|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
27974966|NCT04209114|81742324|FG000|Treatment Phase|Other reasons|5|||
27974967|NCT04209114|81742325|FG001|Treatment Phase|Other reasons|3|||
27974968|NCT04209114|81742326|FG002|Treatment Phase|Other reasons|0|||
27974969|NCT04209114|81742324|FG000|Treatment Phase|Lost to Follow-up|1|||
27974970|NCT04209114|81742325|FG001|Treatment Phase|Lost to Follow-up|0|||
27974971|NCT04209114|81742326|FG002|Treatment Phase|Lost to Follow-up|0|||
27671850|NCT01296555|80639132|FG012|Overall Study|Adverse Event|1|||
27787869|NCT02451137|81051280|FG000|Overall Study|Sponsor decision|13|||
27787870|NCT02451137|81051281|FG001|Overall Study|Sponsor decision|25|||
27974972|NCT04209114|81742324|FG000|Treatment Phase|Participant withdrew consent|1|||
27974973|NCT04209114|81742325|FG001|Treatment Phase|Participant withdrew consent|0|||
27974974|NCT04209114|81742326|FG002|Treatment Phase|Participant withdrew consent|0|||
27974975|NCT04209114|81742324|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
27974976|NCT04209114|81742325|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
27974977|NCT04209114|81742326|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
27974978|NCT04209114|81742324|FG000|Treatment Phase|Death|4|||
27974979|NCT04209114|81742325|FG001|Treatment Phase|Death|1|||
27974980|NCT04209114|81742326|FG002|Treatment Phase|Death|0|||
27974981|NCT04209114|81742324|FG000|Treatment Phase|Study drug toxicity|4|||
27974982|NCT04209114|81742325|FG001|Treatment Phase|Study drug toxicity|6|||
27787871|NCT02451137|81051280|FG000|Overall Study|Withdrawal by Subject|40|||
27787872|NCT02451137|81051281|FG001|Overall Study|Withdrawal by Subject|63|||
27787873|NCT02451137|81051280|FG000|Overall Study|Other than specified above|2|||
27974983|NCT04209114|81742326|FG002|Treatment Phase|Study drug toxicity|0|||
27974984|NCT04209114|81742324|FG000|Treatment Phase|Disease progression|6|||
27974985|NCT04209114|81742325|FG001|Treatment Phase|Disease progression|9|||
27974986|NCT04209114|81742326|FG002|Treatment Phase|Disease progression|0|||
27974987|NCT03220581|81742333|FG000|Overall Study|Withdrawal by Subject|0|||
27974988|NCT03220581|81742334|FG001|Overall Study|Withdrawal by Subject|1|||
27974989|NCT03220581|81742333|FG000|Overall Study|Lost to Follow-up|3|||
27974990|NCT03220581|81742334|FG001|Overall Study|Lost to Follow-up|6|||
27974991|NCT02437305|81742337|FG000|Overall Study|Lost to Follow-up|18|||
27974992|NCT02437305|81742338|FG001|Overall Study|Lost to Follow-up|12|||
27974993|NCT00866047|81742339|FG000|Treatment Period|Progressive disease|13|||
27974994|NCT00866047|81742339|FG000|Treatment Period|Adverse Event|16|||
27974995|NCT00866047|81742339|FG000|Treatment Period|Physician Decision|14|||
27974996|NCT00866047|81742339|FG000|Treatment Period|Withdrawal by Subject|5|||
27974997|NCT00866047|81742339|FG000|Follow-up Period|Lost to Follow-up|5|||
27573295|NCT02953821|80285598|FG000|Overall Study|Lost to Follow-up|2|||
27974998|NCT02088073|81742345|FG000|Acute Phase|Withdrawal by Subject|5|||
27974999|NCT02088073|81742346|FG001|Acute Phase|Withdrawal by Subject|0|||
27975000|NCT02088073|81742347|FG002|Acute Phase|Withdrawal by Subject|0|||
27975001|NCT02088073|81742348|FG003|Acute Phase|Withdrawal by Subject|0|||
27975002|NCT02088073|81742349|FG004|Acute Phase|Withdrawal by Subject|0|||
27975003|NCT02088073|81742345|FG000|Acute Phase|Hyperkalemia|2|||
27975004|NCT02088073|81742346|FG001|Acute Phase|Hyperkalemia|0|||
27975005|NCT02088073|81742347|FG002|Acute Phase|Hyperkalemia|0|||
27975006|NCT02088073|81742348|FG003|Acute Phase|Hyperkalemia|0|||
27975007|NCT02088073|81742349|FG004|Acute Phase|Hyperkalemia|0|||
27975008|NCT02088073|81742345|FG000|Maintanance Phase|Withdrawal by Subject|0|||
27975009|NCT02088073|81742346|FG001|Maintanance Phase|Withdrawal by Subject|2|||
27975010|NCT02088073|81742347|FG002|Maintanance Phase|Withdrawal by Subject|0|||
27975011|NCT02088073|81742348|FG003|Maintanance Phase|Withdrawal by Subject|0|||
27975012|NCT02088073|81742349|FG004|Maintanance Phase|Withdrawal by Subject|0|||
27975013|NCT02088073|81742345|FG000|Maintanance Phase|Adverse Event|0|||
27975014|NCT02088073|81742346|FG001|Maintanance Phase|Adverse Event|0|||
27975015|NCT02088073|81742347|FG002|Maintanance Phase|Adverse Event|3|||
27975016|NCT02088073|81742348|FG003|Maintanance Phase|Adverse Event|0|||
27573296|NCT02953821|80285599|FG001|Overall Study|Lost to Follow-up|0|||
27573297|NCT02953821|80285598|FG000|Overall Study|Physician Decision|1|||
27573298|NCT02953821|80285599|FG001|Overall Study|Physician Decision|1|||
27573299|NCT02953821|80285598|FG000|Overall Study|Withdrawal by Subject|3|||
27573300|NCT02953821|80285599|FG001|Overall Study|Withdrawal by Subject|3|||
27573301|NCT02953821|80285598|FG000|Overall Study|Change of address|0|||
27573302|NCT02953821|80285599|FG001|Overall Study|Change of address|1|||
27573303|NCT02953821|80285598|FG000|Overall Study|Lack of Efficacy|1|||
27573304|NCT02953821|80285599|FG001|Overall Study|Lack of Efficacy|0|||
27573305|NCT02953821|80285598|FG000|Overall Study|Out of state for indeterminate time|0|||
27573306|NCT02953821|80285599|FG001|Overall Study|Out of state for indeterminate time|1|||
27573307|NCT02953821|80285598|FG000|Overall Study|No improvement|0|||
27573308|NCT02953821|80285599|FG001|Overall Study|No improvement|1|||
27573309|NCT02953821|80285598|FG000|Overall Study|Refused follow-up visit|2|||
27573310|NCT02953821|80285599|FG001|Overall Study|Refused follow-up visit|1|||
27867297|NCT02652949|81349545|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
27975017|NCT02088073|81742349|FG004|Maintanance Phase|Adverse Event|1|||
27975018|NCT02088073|81742345|FG000|Maintanance Phase|Physician Decision|0|||
27975019|NCT02088073|81742346|FG001|Maintanance Phase|Physician Decision|0|||
27975020|NCT02088073|81742347|FG002|Maintanance Phase|Physician Decision|0|||
27975021|NCT02088073|81742348|FG003|Maintanance Phase|Physician Decision|0|||
27975022|NCT02088073|81742349|FG004|Maintanance Phase|Physician Decision|1|||
27975023|NCT02088073|81742345|FG000|Maintanance Phase|Sponsor's decision|0|||
27573311|NCT01888497|80285606|FG000|Washout Period 1|Withdrawal by Subject|0|||
27573312|NCT01888497|80285607|FG001|Washout Period 1|Withdrawal by Subject|0|||
27573313|NCT01888497|80285608|FG002|Washout Period 1|Withdrawal by Subject|1|||
27573314|NCT01888497|80285609|FG003|Washout Period 1|Withdrawal by Subject|1|||
27671851|NCT01296555|80639133|FG013|Overall Study|Adverse Event|4|||
27671852|NCT01296555|80639134|FG014|Overall Study|Adverse Event|0|||
27671853|NCT01296555|80639135|FG015|Overall Study|Adverse Event|0|||
27671854|NCT01296555|80639136|FG016|Overall Study|Adverse Event|0|||
27671855|NCT01296555|80639137|FG017|Overall Study|Adverse Event|0|||
27671856|NCT01296555|80639138|FG018|Overall Study|Adverse Event|0|||
27671857|NCT01296555|80639139|FG019|Overall Study|Adverse Event|1|||
27671858|NCT01296555|80639140|FG020|Overall Study|Adverse Event|0|||
27671859|NCT01296555|80639141|FG021|Overall Study|Adverse Event|0|||
27671860|NCT01296555|80639142|FG022|Overall Study|Adverse Event|0|||
27671861|NCT01296555|80639143|FG023|Overall Study|Adverse Event|0|||
27671862|NCT01296555|80639144|FG024|Overall Study|Adverse Event|0|||
27671863|NCT01296555|80639145|FG025|Overall Study|Adverse Event|0|||
27671864|NCT01296555|80639146|FG026|Overall Study|Adverse Event|0|||
27671865|NCT01296555|80639147|FG027|Overall Study|Adverse Event|0|||
27671866|NCT01296555|80639148|FG028|Overall Study|Adverse Event|0|||
27671867|NCT01296555|80639120|FG000|Overall Study|Reason Not Specified|0|||
27671868|NCT01296555|80639121|FG001|Overall Study|Reason Not Specified|0|||
27671869|NCT01296555|80639122|FG002|Overall Study|Reason Not Specified|0|||
27671870|NCT01296555|80639123|FG003|Overall Study|Reason Not Specified|0|||
27671871|NCT01296555|80639124|FG004|Overall Study|Reason Not Specified|0|||
27671872|NCT01296555|80639125|FG005|Overall Study|Reason Not Specified|0|||
27671873|NCT01296555|80639126|FG006|Overall Study|Reason Not Specified|0|||
27671874|NCT01296555|80639127|FG007|Overall Study|Reason Not Specified|0|||
27671875|NCT01296555|80639128|FG008|Overall Study|Reason Not Specified|0|||
27787874|NCT02451137|81051281|FG001|Overall Study|Other than specified above|3|||
27787875|NCT03772574|81051282|FG000|Overall Study|Protocol Violation|2|||
27787876|NCT03772574|81051283|FG001|Overall Study|Protocol Violation|0|||
27787877|NCT03772574|81051284|FG002|Overall Study|Protocol Violation|0|||
27787878|NCT03772574|81051282|FG000|Overall Study|Discomfort|0|||
27787879|NCT03772574|81051283|FG001|Overall Study|Discomfort|5|||
27867298|NCT02652949|81349545|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
27867299|NCT02652949|81349545|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
27787880|NCT03772574|81051284|FG002|Overall Study|Discomfort|4|||
27867300|NCT02652949|81349545|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
27867301|NCT02652949|81349545|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
27867302|NCT02652949|81349545|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
27867303|NCT02652949|81349545|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
27867304|NCT02652949|81349545|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
27867305|NCT02652949|81349545|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
27867306|NCT02652949|81349545|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
27867307|NCT02652949|81349545|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
27867308|NCT02652949|81349545|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
27867309|NCT02652949|81349545|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
27671876|NCT01296555|80639129|FG009|Overall Study|Reason Not Specified|0|||
27671877|NCT01296555|80639130|FG010|Overall Study|Reason Not Specified|0|||
27787881|NCT00475657|81051285|FG000|Overall Study|Death|1|||
27787882|NCT00475657|81051285|FG000|Overall Study|Sponsor's Decision|3|||
27787883|NCT01503229|81055876|FG000|Overall Study|Withdrew consent|1|||
27787884|NCT04563845|81055877|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787885|NCT04563845|81055878|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787886|NCT04563845|81055879|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787887|NCT04563845|81055880|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787888|NCT04563845|81055881|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787889|NCT04563845|81055882|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787890|NCT04563845|81055883|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787891|NCT04563845|81055884|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
27787892|NCT04563845|81055885|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787893|NCT04563845|81055886|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787894|NCT04563845|81055887|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787895|NCT04563845|81055888|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787896|NCT04563845|81055889|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787897|NCT04563845|81055890|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
27787898|NCT04563845|81055877|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27867310|NCT02856802|81349547|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
27867311|NCT02856802|81349548|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
27671878|NCT01296555|80639131|FG011|Overall Study|Reason Not Specified|0|||
27671879|NCT01296555|80639132|FG012|Overall Study|Reason Not Specified|0|||
27671880|NCT01296555|80639133|FG013|Overall Study|Reason Not Specified|1|||
27671881|NCT01296555|80639134|FG014|Overall Study|Reason Not Specified|2|||
27671882|NCT01296555|80639135|FG015|Overall Study|Reason Not Specified|3|||
27671883|NCT01296555|80639136|FG016|Overall Study|Reason Not Specified|7|||
27787899|NCT04563845|81055878|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787900|NCT04563845|81055879|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787901|NCT04563845|81055880|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787902|NCT04563845|81055881|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
27787903|NCT04563845|81055882|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787904|NCT04563845|81055883|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787905|NCT04563845|81055884|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787906|NCT04563845|81055885|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787907|NCT04563845|81055886|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787908|NCT04563845|81055887|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787909|NCT04563845|81055888|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787910|NCT04563845|81055889|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787911|NCT04563845|81055890|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
27787912|NCT01474291|81055891|FG000|Overall Study|Not Evaluable for Efficacy|26|||
27787913|NCT01474291|81055891|FG000|Overall Study|Lack of Treatment Efficacy|88|||
27787914|NCT01474291|81055891|FG000|Overall Study|Adverse Event|53|||
27787915|NCT01474291|81055891|FG000|Overall Study|Lost to Follow-up|29|||
27787916|NCT01474291|81055891|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
27787917|NCT01474291|81055891|FG000|Overall Study|No Reason Reported|10|||
27787918|NCT01474291|81055891|FG000|Overall Study|Death|2|||
27787919|NCT01471197|81055892|FG000|Overall Study|Disease Progression|4|||
27787920|NCT01471197|81055893|FG001|Overall Study|Disease Progression|2|||
27787921|NCT01471197|81055892|FG000|Overall Study|Death|1|||
27787922|NCT01471197|81055893|FG001|Overall Study|Death|0|||
27787923|NCT01471197|81055892|FG000|Overall Study|Study Drug Toxicity|1|||
27787924|NCT01471197|81055893|FG001|Overall Study|Study Drug Toxicity|0|||
27787925|NCT01258738|81055894|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
27787926|NCT01258738|81055895|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
27787927|NCT01258738|81055894|FG000|Double-blind Period|Withdrawal by Subject|2|||
27787928|NCT01258738|81055895|FG001|Double-blind Period|Withdrawal by Subject|2|||
27787929|NCT01258738|81055894|FG000|Double-blind Period|Protocol Violation|1|||
27787930|NCT01258738|81055895|FG001|Double-blind Period|Protocol Violation|1|||
27787931|NCT01258738|81055894|FG000|Double-blind Period|Adverse Event|3|||
27787932|NCT01258738|81055895|FG001|Double-blind Period|Adverse Event|1|||
27787933|NCT01258738|81055894|FG000|Open-label Period|Did not meet inclusion criteria|0|||
27787934|NCT01258738|81055895|FG001|Open-label Period|Did not meet inclusion criteria|1|||
27787935|NCT01258738|81055894|FG000|Open-label Period|Insufficient clinical response|5|||
27787936|NCT01258738|81055895|FG001|Open-label Period|Insufficient clinical response|3|||
27787937|NCT01258738|81055894|FG000|Open-label Period|Lost to Follow-up|0|||
27787938|NCT01258738|81055895|FG001|Open-label Period|Lost to Follow-up|2|||
27787939|NCT01258738|81055894|FG000|Open-label Period|Withdrawal by Subject|5|||
27787940|NCT01258738|81055895|FG001|Open-label Period|Withdrawal by Subject|6|||
27787941|NCT01258738|81055894|FG000|Open-label Period|Protocol Violation|2|||
27787942|NCT01258738|81055895|FG001|Open-label Period|Protocol Violation|2|||
27787943|NCT01258738|81055894|FG000|Open-label Period|Adverse Event|4|||
27787944|NCT01258738|81055895|FG001|Open-label Period|Adverse Event|5|||
27787945|NCT01258738|81055894|FG000|Open-label Period|Other Reasons|0|||
27787946|NCT01258738|81055895|FG001|Open-label Period|Other Reasons|1|||
27787947|NCT01258738|81055894|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
27787948|NCT01258738|81055895|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
27787949|NCT04652245|81055899|FG000|Wash-Out Period|Adverse Event|0|||
27787950|NCT04652245|81055900|FG001|Wash-Out Period|Adverse Event|2|||
27787951|NCT04652245|81055899|FG000|Wash-Out Period|Withdrawal by Subject|0|||
27787952|NCT04652245|81055900|FG001|Wash-Out Period|Withdrawal by Subject|2|||
27787953|NCT04668066|81055901|FG000|Part 1: Treatment Phase|Adverse Event|0|||
27787954|NCT04668066|81055902|FG001|Part 1: Treatment Phase|Adverse Event|0|||
27787955|NCT04668066|81055903|FG002|Part 1: Treatment Phase|Adverse Event|0|||
27787956|NCT04668066|81055904|FG003|Part 1: Treatment Phase|Adverse Event|0|||
27787957|NCT04668066|81055905|FG004|Part 1: Treatment Phase|Adverse Event|0|||
27787958|NCT04668066|81055906|FG005|Part 1: Treatment Phase|Adverse Event|0|||
27787959|NCT04668066|81055907|FG006|Part 1: Treatment Phase|Adverse Event|0|||
27787960|NCT04668066|81055908|FG007|Part 1: Treatment Phase|Adverse Event|0|||
27787961|NCT04668066|81055909|FG008|Part 1: Treatment Phase|Adverse Event|0|||
27787962|NCT04668066|81055910|FG009|Part 1: Treatment Phase|Adverse Event|0|||
27787963|NCT04668066|81055911|FG010|Part 1: Treatment Phase|Adverse Event|0|||
27787964|NCT04668066|81055912|FG011|Part 1: Treatment Phase|Adverse Event|1|||
27787965|NCT04668066|81055913|FG012|Part 1: Treatment Phase|Adverse Event|1|||
27787966|NCT04668066|81055914|FG013|Part 1: Treatment Phase|Adverse Event|0|||
27787967|NCT04668066|81055915|FG014|Part 1: Treatment Phase|Adverse Event|0|||
27787968|NCT04668066|81055916|FG015|Part 1: Treatment Phase|Adverse Event|0|||
27787969|NCT04668066|81055917|FG016|Part 1: Treatment Phase|Adverse Event|0|||
27975024|NCT02088073|81742346|FG001|Maintanance Phase|Sponsor's decision|2|||
27787970|NCT04668066|81055918|FG017|Part 1: Treatment Phase|Adverse Event|0|||
27975025|NCT02088073|81742347|FG002|Maintanance Phase|Sponsor's decision|0|||
27787971|NCT04668066|81055919|FG018|Part 1: Treatment Phase|Adverse Event|0|||
27975026|NCT02088073|81742348|FG003|Maintanance Phase|Sponsor's decision|2|||
27975027|NCT02088073|81742349|FG004|Maintanance Phase|Sponsor's decision|1|||
27975028|NCT02088073|81742345|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
27975029|NCT02088073|81742346|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
27975030|NCT02088073|81742347|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
27975031|NCT02088073|81742348|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
27975032|NCT02088073|81742349|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
27975033|NCT02088073|81742345|FG000|Maintanance Phase|Miscellaneous|0|||
27975034|NCT02088073|81742346|FG001|Maintanance Phase|Miscellaneous|2|||
27975035|NCT02088073|81742347|FG002|Maintanance Phase|Miscellaneous|1|||
27975036|NCT02088073|81742348|FG003|Maintanance Phase|Miscellaneous|2|||
27975037|NCT02088073|81742349|FG004|Maintanance Phase|Miscellaneous|1|||
27975038|NCT02088073|81742345|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
27975039|NCT02088073|81742346|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
27975040|NCT02088073|81742347|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
27671884|NCT01296555|80639137|FG017|Overall Study|Reason Not Specified|4|||
27671885|NCT01296555|80639138|FG018|Overall Study|Reason Not Specified|3|||
27671886|NCT01296555|80639139|FG019|Overall Study|Reason Not Specified|7|||
27671887|NCT01296555|80639140|FG020|Overall Study|Reason Not Specified|11|||
27671888|NCT01296555|80639141|FG021|Overall Study|Reason Not Specified|5|||
27671889|NCT01296555|80639142|FG022|Overall Study|Reason Not Specified|5|||
27671890|NCT01296555|80639143|FG023|Overall Study|Reason Not Specified|7|||
27787972|NCT04668066|81055901|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
27867312|NCT02856802|81349547|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
27867313|NCT02856802|81349548|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
27867314|NCT02856802|81349547|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
27975041|NCT02088073|81742348|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
27671891|NCT01296555|80639144|FG024|Overall Study|Reason Not Specified|2|||
27671892|NCT01296555|80639145|FG025|Overall Study|Reason Not Specified|2|||
27671893|NCT01296555|80639146|FG026|Overall Study|Reason Not Specified|19|||
27671894|NCT01296555|80639147|FG027|Overall Study|Reason Not Specified|11|||
27671895|NCT01296555|80639148|FG028|Overall Study|Reason Not Specified|9|||
27671896|NCT01296555|80639120|FG000|Overall Study|Physician Decision|0|||
27671897|NCT01296555|80639121|FG001|Overall Study|Physician Decision|0|||
27787973|NCT04668066|81055902|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787974|NCT04668066|81055903|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
27787975|NCT04668066|81055904|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787976|NCT04668066|81055905|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787977|NCT04668066|81055906|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787978|NCT04668066|81055907|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787979|NCT04668066|81055908|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787980|NCT04668066|81055909|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787981|NCT04668066|81055910|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787982|NCT04668066|81055911|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787983|NCT04668066|81055912|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
27975042|NCT02088073|81742349|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
27975043|NCT02088073|81742345|FG000|Maintanance Phase|Subject compliance|0|||
27867315|NCT02856802|81349548|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
27975044|NCT02088073|81742346|FG001|Maintanance Phase|Subject compliance|1|||
27975045|NCT02088073|81742347|FG002|Maintanance Phase|Subject compliance|0|||
27787984|NCT04668066|81055913|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
27671898|NCT01296555|80639122|FG002|Overall Study|Physician Decision|0|||
27671899|NCT01296555|80639123|FG003|Overall Study|Physician Decision|0|||
27671900|NCT01296555|80639124|FG004|Overall Study|Physician Decision|1|||
27787985|NCT04668066|81055914|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
27671901|NCT01296555|80639125|FG005|Overall Study|Physician Decision|0|||
27671902|NCT01296555|80639126|FG006|Overall Study|Physician Decision|0|||
27671903|NCT01296555|80639127|FG007|Overall Study|Physician Decision|0|||
27671904|NCT01296555|80639128|FG008|Overall Study|Physician Decision|0|||
27787986|NCT04668066|81055915|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787987|NCT04668066|81055916|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787988|NCT04668066|81055917|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787989|NCT04668066|81055918|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
27787990|NCT04668066|81055919|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
27975046|NCT02088073|81742348|FG003|Maintanance Phase|Subject compliance|0|||
27975047|NCT02088073|81742349|FG004|Maintanance Phase|Subject compliance|0|||
27975048|NCT00624819|81742356|FG000|Follow-up Period: Year 4|Parents decision|0|||
27975049|NCT00624819|81742357|FG001|Follow-up Period: Year 4|Parents decision|0|||
27975050|NCT00624819|81742358|FG002|Follow-up Period: Year 4|Parents decision|1|||
27975051|NCT00624819|81742359|FG003|Follow-up Period: Year 4|Parents decision|0|||
27975052|NCT00624819|81742356|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
27975053|NCT00624819|81742357|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
27975054|NCT00624819|81742358|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
27975055|NCT00624819|81742359|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
27975056|NCT01133275|81742360|FG000|Overall Study|Withdrawal by Subject|1|||
27975057|NCT01133275|81742360|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
27975058|NCT00076336|81742361|FG000|Overall Study|Death|13|||
27975059|NCT00076336|81742362|FG001|Overall Study|Death|17|||
27975060|NCT00076336|81742361|FG000|Overall Study|Adverse Event|4|||
27975061|NCT00076336|81742362|FG001|Overall Study|Adverse Event|4|||
27975062|NCT00076336|81742361|FG000|Overall Study|Lost to Follow-up|4|||
27975063|NCT00076336|81742362|FG001|Overall Study|Lost to Follow-up|4|||
27975064|NCT00076336|81742361|FG000|Overall Study|Non-Compliance|2|||
27975065|NCT00076336|81742362|FG001|Overall Study|Non-Compliance|0|||
27975066|NCT00076336|81742361|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
27975067|NCT00076336|81742362|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
27975068|NCT00076336|81742361|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
27975069|NCT00076336|81742362|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
27975070|NCT00076336|81742361|FG000|Overall Study|Liver Transplantation|3|||
27975071|NCT00076336|81742362|FG001|Overall Study|Liver Transplantation|3|||
27975072|NCT00076336|81742361|FG000|Overall Study|Virologic Breakthrough|14|||
27975073|NCT00076336|81742362|FG001|Overall Study|Virologic Breakthrough|16|||
27975074|NCT00076336|81742361|FG000|Overall Study|Treatment failure|4|||
27975075|NCT00076336|81742362|FG001|Overall Study|Treatment failure|5|||
27975076|NCT03777917|81742363|FG000|Overall Study|Withdrawal by Subject|1|||
27975077|NCT03777917|81742364|FG001|Overall Study|Withdrawal by Subject|0|||
27975078|NCT03777917|81742363|FG000|Overall Study|Physician Decision|1|||
27975079|NCT03777917|81742364|FG001|Overall Study|Physician Decision|0|||
27975080|NCT03777917|81742363|FG000|Overall Study|Lost to Follow-up|6|||
27975081|NCT03777917|81742364|FG001|Overall Study|Lost to Follow-up|2|||
27975082|NCT03777917|81742363|FG000|Overall Study|Other|1|||
27975083|NCT03777917|81742364|FG001|Overall Study|Other|0|||
27975084|NCT03762616|81742365|FG000|Overall Study|Protocol Violation|2|||
27975085|NCT00355342|81742366|FG000|Overall Study|Adverse Event|13|||
27975086|NCT00355342|81742367|FG001|Overall Study|Adverse Event|15|||
27975087|NCT00355342|81742366|FG000|Overall Study|Lost to Follow-up|4|||
27975088|NCT00355342|81742367|FG001|Overall Study|Lost to Follow-up|2|||
27975089|NCT00355342|81742366|FG000|Overall Study|Withdrawal by Subject|14|||
27975090|NCT00355342|81742367|FG001|Overall Study|Withdrawal by Subject|11|||
27975091|NCT00355342|81742366|FG000|Overall Study|Sponsor terminated study|2|||
27975092|NCT00355342|81742367|FG001|Overall Study|Sponsor terminated study|2|||
27975093|NCT00355342|81742366|FG000|Overall Study|Overcompliant-PI discretion|1|||
27975094|NCT00355342|81742367|FG001|Overall Study|Overcompliant-PI discretion|0|||
27975095|NCT00355342|81742366|FG000|Overall Study|Use of prohibited medication|1|||
27975096|NCT00355342|81742367|FG001|Overall Study|Use of prohibited medication|0|||
27975097|NCT00355342|81742366|FG000|Overall Study|COPD exacerbation|1|||
27975098|NCT00355342|81742367|FG001|Overall Study|COPD exacerbation|1|||
27975099|NCT00355342|81742366|FG000|Overall Study|Dispensed wrong study drug kit|1|||
27975100|NCT00355342|81742367|FG001|Overall Study|Dispensed wrong study drug kit|0|||
27975101|NCT00355342|81742366|FG000|Overall Study|Non-compliance with Dexa scans|1|||
27975102|NCT00355342|81742367|FG001|Overall Study|Non-compliance with Dexa scans|0|||
27975103|NCT00355342|81742366|FG000|Overall Study|Withdrawal by participant and physician|1|||
27975104|NCT00355342|81742367|FG001|Overall Study|Withdrawal by participant and physician|0|||
27975105|NCT00355342|81742366|FG000|Overall Study|Participant relocated|0|||
27975106|NCT00355342|81742367|FG001|Overall Study|Participant relocated|1|||
27975107|NCT00355342|81742366|FG000|Overall Study|Participant discontinued study drug|0|||
27975108|NCT00355342|81742367|FG001|Overall Study|Participant discontinued study drug|1|||
27975109|NCT00355342|81742366|FG000|Overall Study|Study management|0|||
27671905|NCT01296555|80639129|FG009|Overall Study|Physician Decision|0|||
27671906|NCT01296555|80639130|FG010|Overall Study|Physician Decision|0|||
27787991|NCT04668066|81055901|FG000|Part 1: Treatment Phase|Other|0|||
27787992|NCT04668066|81055902|FG001|Part 1: Treatment Phase|Other|0|||
27787993|NCT04668066|81055903|FG002|Part 1: Treatment Phase|Other|0|||
27787994|NCT04668066|81055904|FG003|Part 1: Treatment Phase|Other|0|||
27787995|NCT04668066|81055905|FG004|Part 1: Treatment Phase|Other|0|||
27787996|NCT04668066|81055906|FG005|Part 1: Treatment Phase|Other|0|||
27787997|NCT04668066|81055907|FG006|Part 1: Treatment Phase|Other|0|||
27975110|NCT00355342|81742367|FG001|Overall Study|Study management|1|||
27975111|NCT00355342|81742366|FG000|Overall Study|Protocol Violation|0|||
27975112|NCT00355342|81742367|FG001|Overall Study|Protocol Violation|1|||
27975113|NCT00355342|81742366|FG000|Overall Study|Use of protocol excluded medication|0|||
27975114|NCT00355342|81742367|FG001|Overall Study|Use of protocol excluded medication|1|||
27975115|NCT02640625|81742370|FG000|Overall Study|Adverse Event|1|||
27975116|NCT00789581|81742371|FG000|AC Therapy|Adverse Event|2|||
27975117|NCT00789581|81742372|FG001|AC Therapy|Adverse Event|3|||
27975118|NCT00789581|81742371|FG000|AC Therapy|Withdrawal by Subject|4|||
27975119|NCT00789581|81742372|FG001|AC Therapy|Withdrawal by Subject|7|||
27975120|NCT00789581|81742371|FG000|AC Therapy|Disease recurrence|3|||
27975121|NCT00789581|81742372|FG001|AC Therapy|Disease recurrence|1|||
27975122|NCT00789581|81742371|FG000|AC Therapy|Intercurrent Illness|1|||
27975123|NCT00789581|81742372|FG001|AC Therapy|Intercurrent Illness|0|||
27975124|NCT00789581|81742371|FG000|AC Therapy|Never Treated|1|||
27975125|NCT00789581|81742372|FG001|AC Therapy|Never Treated|4|||
27975126|NCT00789581|81742371|FG000|AC Therapy|Other|0|||
27975127|NCT00789581|81742372|FG001|AC Therapy|Other|2|||
27975128|NCT00789581|81742371|FG000|Adjuvant Therapy|Never treated|2|||
27975129|NCT00789581|81742372|FG001|Adjuvant Therapy|Never treated|2|||
27975130|NCT00789581|81742371|FG000|Adjuvant Therapy|Adverse Event|20|||
27975131|NCT00789581|81742372|FG001|Adjuvant Therapy|Adverse Event|44|||
27787998|NCT04668066|81055908|FG007|Part 1: Treatment Phase|Other|0|||
27975132|NCT00789581|81742371|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
27975133|NCT00789581|81742372|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
27975134|NCT00789581|81742371|FG000|Adjuvant Therapy|Disease recurrence|2|||
27975135|NCT00789581|81742372|FG001|Adjuvant Therapy|Disease recurrence|1|||
27975136|NCT00789581|81742371|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
27975137|NCT00789581|81742372|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
27975138|NCT00789581|81742371|FG000|Adjuvant Therapy|Protocol Violation|1|||
27975139|NCT00789581|81742372|FG001|Adjuvant Therapy|Protocol Violation|1|||
27975140|NCT00789581|81742371|FG000|Adjuvant Therapy|Other|0|||
27975141|NCT00789581|81742372|FG001|Adjuvant Therapy|Other|1|||
27975142|NCT03500172|81742375|FG000|Period 1: Baseline Randomization|Death|0|||
27975143|NCT03500172|81742376|FG001|Period 1: Baseline Randomization|Death|0|||
27975144|NCT03500172|81742377|FG002|Period 1: Baseline Randomization|Death|0|||
27975145|NCT03500172|81742378|FG003|Period 1: Baseline Randomization|Death|0|||
27975146|NCT03500172|81742379|FG004|Period 1: Baseline Randomization|Death|0|||
27975147|NCT03500172|81742380|FG005|Period 1: Baseline Randomization|Death|0|||
27975148|NCT03500172|81742381|FG006|Period 1: Baseline Randomization|Death|0|||
27975149|NCT03500172|81742382|FG007|Period 1: Baseline Randomization|Death|0|||
27975150|NCT03500172|81742383|FG008|Period 1: Baseline Randomization|Death|0|||
27975151|NCT03500172|81742384|FG009|Period 1: Baseline Randomization|Death|2|||
27975152|NCT03500172|81742385|FG010|Period 1: Baseline Randomization|Death|0|||
27975153|NCT03500172|81742375|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
27975154|NCT03500172|81742376|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
27975155|NCT03500172|81742377|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
27975156|NCT03500172|81742378|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
27573315|NCT01888497|80285606|FG000|Washout Period 2|Adverse Event|0|||
27573316|NCT01888497|80285607|FG001|Washout Period 2|Adverse Event|0|||
27573317|NCT01888497|80285608|FG002|Washout Period 2|Adverse Event|0|||
27573318|NCT01888497|80285609|FG003|Washout Period 2|Adverse Event|1|||
27573319|NCT01888497|80285606|FG000|Washout Period 2|Withdrawal by Subject|0|||
27573320|NCT01888497|80285607|FG001|Washout Period 2|Withdrawal by Subject|0|||
27787999|NCT04668066|81055909|FG008|Part 1: Treatment Phase|Other|0|||
27788000|NCT04668066|81055910|FG009|Part 1: Treatment Phase|Other|0|||
27788001|NCT04668066|81055911|FG010|Part 1: Treatment Phase|Other|0|||
27573321|NCT01888497|80285608|FG002|Washout Period 2|Withdrawal by Subject|0|||
27788002|NCT04668066|81055912|FG011|Part 1: Treatment Phase|Other|1|||
27975157|NCT03500172|81742379|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
27975158|NCT03500172|81742380|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
27975159|NCT03500172|81742381|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
27975160|NCT03500172|81742382|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
27975161|NCT03500172|81742383|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
27975162|NCT03500172|81742384|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
27975163|NCT03500172|81742385|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
27788003|NCT04668066|81055913|FG012|Part 1: Treatment Phase|Other|0|||
27975164|NCT03500172|81742375|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
27788004|NCT04668066|81055914|FG013|Part 1: Treatment Phase|Other|0|||
27975165|NCT03500172|81742376|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
27975166|NCT03500172|81742377|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
27573322|NCT01888497|80285609|FG003|Washout Period 2|Withdrawal by Subject|1|||
27573323|NCT05091528|80285610|FG000|Overall Study|Study Termination by Sponsor|0|||
27975167|NCT03500172|81742378|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
27975168|NCT03500172|81742379|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
27975169|NCT03500172|81742380|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
27975170|NCT03500172|81742381|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
27975171|NCT03500172|81742382|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
27975172|NCT03500172|81742383|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
27975173|NCT03500172|81742384|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
27975174|NCT03500172|81742385|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
27975175|NCT03500172|81742375|FG000|Period 2: Re-Randomization|Death|0|||
27975176|NCT03500172|81742376|FG001|Period 2: Re-Randomization|Death|0|||
27975177|NCT03500172|81742377|FG002|Period 2: Re-Randomization|Death|0|||
27975178|NCT03500172|81742378|FG003|Period 2: Re-Randomization|Death|4|||
27975179|NCT03500172|81742379|FG004|Period 2: Re-Randomization|Death|2|||
27975180|NCT03500172|81742380|FG005|Period 2: Re-Randomization|Death|0|||
27975181|NCT03500172|81742381|FG006|Period 2: Re-Randomization|Death|5|||
27975182|NCT03500172|81742382|FG007|Period 2: Re-Randomization|Death|2|||
27975183|NCT03500172|81742383|FG008|Period 2: Re-Randomization|Death|0|||
27975184|NCT03500172|81742384|FG009|Period 2: Re-Randomization|Death|0|||
27975185|NCT03500172|81742385|FG010|Period 2: Re-Randomization|Death|0|||
27975186|NCT02210689|81742390|FG000|Overall Study|Withdrawal by Subject|7|||
27975187|NCT02210689|81742391|FG001|Overall Study|Withdrawal by Subject|4|||
27975188|NCT02210689|81742392|FG002|Overall Study|Withdrawal by Subject|2|||
27975189|NCT02210689|81742390|FG000|Overall Study|Adverse Event|0|||
27975190|NCT02210689|81742391|FG001|Overall Study|Adverse Event|1|||
27975191|NCT02210689|81742392|FG002|Overall Study|Adverse Event|0|||
27975192|NCT02210689|81742390|FG000|Overall Study|Protocol Violation|1|||
27975193|NCT02210689|81742391|FG001|Overall Study|Protocol Violation|0|||
27975194|NCT02210689|81742392|FG002|Overall Study|Protocol Violation|0|||
27975195|NCT02210689|81742390|FG000|Overall Study|Lost to Follow-up|11|||
27975196|NCT02210689|81742391|FG001|Overall Study|Lost to Follow-up|9|||
27975197|NCT02210689|81742392|FG002|Overall Study|Lost to Follow-up|5|||
27975198|NCT02210689|81742390|FG000|Overall Study|Pregnancy|0|||
27975199|NCT02210689|81742391|FG001|Overall Study|Pregnancy|1|||
27975200|NCT02210689|81742392|FG002|Overall Study|Pregnancy|0|||
27975201|NCT02210689|81742390|FG000|Overall Study|Lack of Efficacy|0|||
27975202|NCT02210689|81742391|FG001|Overall Study|Lack of Efficacy|1|||
27975203|NCT02210689|81742392|FG002|Overall Study|Lack of Efficacy|5|||
27975204|NCT02210689|81742390|FG000|Overall Study|Prohibited medication|2|||
27975205|NCT02210689|81742391|FG001|Overall Study|Prohibited medication|8|||
27975206|NCT02210689|81742392|FG002|Overall Study|Prohibited medication|1|||
27573324|NCT05091528|80285611|FG001|Overall Study|Study Termination by Sponsor|1|||
27573325|NCT05091528|80285612|FG002|Overall Study|Study Termination by Sponsor|0|||
27975207|NCT02210689|81742390|FG000|Overall Study|Negative Nugent score at baseline|6|||
27975208|NCT02210689|81742391|FG001|Overall Study|Negative Nugent score at baseline|2|||
27975209|NCT02210689|81742392|FG002|Overall Study|Negative Nugent score at baseline|2|||
27975210|NCT02210689|81742390|FG000|Overall Study|Other|25|||
27975211|NCT02210689|81742391|FG001|Overall Study|Other|21|||
27975212|NCT02210689|81742392|FG002|Overall Study|Other|8|||
27975213|NCT04979897|81742396|FG000|Overall Study|Death|1|||
27975214|NCT04979897|81742397|FG001|Overall Study|Death|8|||
27975215|NCT04979897|81742396|FG000|Overall Study|Lost to Follow-up|111|||
27975216|NCT04979897|81742397|FG001|Overall Study|Lost to Follow-up|56|||
27975217|NCT04979897|81742396|FG000|Overall Study|Withdrawal by Subject|7|||
27975218|NCT04979897|81742397|FG001|Overall Study|Withdrawal by Subject|2|||
27975219|NCT02256267|81742398|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
27975220|NCT02256267|81742398|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
27975221|NCT01967823|81742399|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
27975222|NCT03249935|81742400|FG000|Overall Study|Discharged from facility early|36|||
27975223|NCT03249935|81742400|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
27975224|NCT03249935|81742400|FG000|Overall Study|Protocol Violation|5|||
27975225|NCT02692040|81742403|FG000|Overall Study|Protocol Violation|0|||
27975226|NCT02692040|81742404|FG001|Overall Study|Protocol Violation|0|||
27573326|NCT05091528|80285613|FG003|Overall Study|Study Termination by Sponsor|1|||
27573327|NCT00057746|80285614|FG000|Overall Study|Withdrawal by Subject|0|||
27975227|NCT02692040|81742405|FG002|Overall Study|Protocol Violation|0|||
27975228|NCT02692040|81742406|FG003|Overall Study|Protocol Violation|0|||
27975229|NCT02692040|81742407|FG004|Overall Study|Protocol Violation|0|||
27975230|NCT02692040|81742408|FG005|Overall Study|Protocol Violation|0|||
27975231|NCT02692040|81742409|FG006|Overall Study|Protocol Violation|0|||
27975232|NCT02692040|81742410|FG007|Overall Study|Protocol Violation|0|||
27975233|NCT02692040|81742411|FG008|Overall Study|Protocol Violation|0|||
27975234|NCT02692040|81742412|FG009|Overall Study|Protocol Violation|0|||
27975235|NCT02692040|81742413|FG010|Overall Study|Protocol Violation|0|||
27975236|NCT02692040|81742414|FG011|Overall Study|Protocol Violation|0|||
27975237|NCT02692040|81742415|FG012|Overall Study|Protocol Violation|1|||
27573328|NCT00057746|80285615|FG001|Overall Study|Withdrawal by Subject|0|||
27975238|NCT02692040|81742416|FG013|Overall Study|Protocol Violation|0|||
27975239|NCT02692040|81742417|FG014|Overall Study|Protocol Violation|0|||
27975240|NCT02692040|81742418|FG015|Overall Study|Protocol Violation|0|||
27975241|NCT02692040|81742419|FG016|Overall Study|Protocol Violation|0|||
27975242|NCT02692040|81742403|FG000|Overall Study|Adverse Event|0|||
27975243|NCT02692040|81742404|FG001|Overall Study|Adverse Event|0|||
27975244|NCT02692040|81742405|FG002|Overall Study|Adverse Event|0|||
27975245|NCT02692040|81742406|FG003|Overall Study|Adverse Event|0|||
27975246|NCT02692040|81742407|FG004|Overall Study|Adverse Event|0|||
27975247|NCT02692040|81742408|FG005|Overall Study|Adverse Event|0|||
27975248|NCT02692040|81742409|FG006|Overall Study|Adverse Event|0|||
27975249|NCT02692040|81742410|FG007|Overall Study|Adverse Event|0|||
27975250|NCT02692040|81742411|FG008|Overall Study|Adverse Event|0|||
27975251|NCT02692040|81742412|FG009|Overall Study|Adverse Event|0|||
27975252|NCT02692040|81742413|FG010|Overall Study|Adverse Event|0|||
27975253|NCT02692040|81742414|FG011|Overall Study|Adverse Event|0|||
27975254|NCT02692040|81742415|FG012|Overall Study|Adverse Event|0|||
27975255|NCT02692040|81742416|FG013|Overall Study|Adverse Event|3|||
27975256|NCT02692040|81742417|FG014|Overall Study|Adverse Event|1|||
27975257|NCT02692040|81742418|FG015|Overall Study|Adverse Event|1|||
27975258|NCT02692040|81742419|FG016|Overall Study|Adverse Event|0|||
27975259|NCT01886690|81742420|FG000|Overall Study|Protocol Violation|0|||
27975260|NCT01886690|81742421|FG001|Overall Study|Protocol Violation|1|||
27975261|NCT01886690|81742420|FG000|Overall Study|Personal Reasons|0|||
27975262|NCT01886690|81742421|FG001|Overall Study|Personal Reasons|1|||
27975263|NCT01778049|81742422|FG000|Open Label Treatment Period|Adverse Event|5|||
27975264|NCT01778049|81742423|FG001|Open Label Treatment Period|Adverse Event|15|||
27975265|NCT01778049|81742424|FG002|Open Label Treatment Period|Adverse Event|0|||
27975266|NCT01778049|81742425|FG003|Open Label Treatment Period|Adverse Event|0|||
27975267|NCT01778049|81742426|FG004|Open Label Treatment Period|Adverse Event|0|||
27975268|NCT01778049|81742427|FG005|Open Label Treatment Period|Adverse Event|0|||
27975269|NCT01778049|81742422|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
27975270|NCT01778049|81742423|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
27975271|NCT01778049|81742424|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
27975272|NCT01778049|81742425|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
27975273|NCT01778049|81742426|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
27975274|NCT01778049|81742427|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
27975275|NCT01778049|81742422|FG000|Open Label Treatment Period|Protocol Violation|5|||
27975276|NCT01778049|81742423|FG001|Open Label Treatment Period|Protocol Violation|5|||
27975277|NCT01778049|81742424|FG002|Open Label Treatment Period|Protocol Violation|0|||
27975278|NCT01778049|81742425|FG003|Open Label Treatment Period|Protocol Violation|0|||
27975279|NCT01778049|81742426|FG004|Open Label Treatment Period|Protocol Violation|0|||
27975280|NCT01778049|81742427|FG005|Open Label Treatment Period|Protocol Violation|0|||
27975281|NCT01778049|81742422|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
27975282|NCT01778049|81742423|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
27975283|NCT01778049|81742424|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
27975284|NCT01778049|81742425|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
27975285|NCT01778049|81742426|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
27975286|NCT01778049|81742427|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
27975287|NCT01778049|81742422|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
27975288|NCT01778049|81742423|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
27975289|NCT01778049|81742424|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
27975290|NCT01778049|81742425|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
27975291|NCT01778049|81742426|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
27975292|NCT01778049|81742427|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
27975293|NCT01778049|81742422|FG000|Open Label Treatment Period|Not treated|2|||
27975294|NCT01778049|81742423|FG001|Open Label Treatment Period|Not treated|1|||
27975295|NCT01778049|81742424|FG002|Open Label Treatment Period|Not treated|0|||
27975296|NCT01778049|81742425|FG003|Open Label Treatment Period|Not treated|0|||
27975297|NCT01778049|81742426|FG004|Open Label Treatment Period|Not treated|0|||
27975298|NCT01778049|81742427|FG005|Open Label Treatment Period|Not treated|0|||
27975299|NCT01778049|81742422|FG000|Open Label Treatment Period|Other reason not defined above|77|||
27975300|NCT01778049|81742423|FG001|Open Label Treatment Period|Other reason not defined above|94|||
27975301|NCT01778049|81742424|FG002|Open Label Treatment Period|Other reason not defined above|0|||
27975302|NCT01778049|81742425|FG003|Open Label Treatment Period|Other reason not defined above|0|||
27975303|NCT01778049|81742426|FG004|Open Label Treatment Period|Other reason not defined above|0|||
27975304|NCT01778049|81742427|FG005|Open Label Treatment Period|Other reason not defined above|0|||
27975305|NCT01778049|81742422|FG000|Double Blind Treatment Period|Adverse Event|0|||
27975306|NCT01778049|81742423|FG001|Double Blind Treatment Period|Adverse Event|0|||
27975307|NCT01778049|81742424|FG002|Double Blind Treatment Period|Adverse Event|4|||
27975308|NCT01778049|81742425|FG003|Double Blind Treatment Period|Adverse Event|5|||
27975309|NCT01778049|81742426|FG004|Double Blind Treatment Period|Adverse Event|3|||
27975310|NCT01778049|81742427|FG005|Double Blind Treatment Period|Adverse Event|2|||
27975311|NCT01778049|81742422|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
27975312|NCT01778049|81742423|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27975313|NCT01778049|81742424|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27975314|NCT01778049|81742425|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
27975315|NCT01778049|81742426|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
27975316|NCT01778049|81742427|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
27975317|NCT01778049|81742422|FG000|Double Blind Treatment Period|Protocol Violation|0|||
27975318|NCT01778049|81742423|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27975319|NCT01778049|81742424|FG002|Double Blind Treatment Period|Protocol Violation|2|||
27975320|NCT01778049|81742425|FG003|Double Blind Treatment Period|Protocol Violation|0|||
27975321|NCT01778049|81742426|FG004|Double Blind Treatment Period|Protocol Violation|0|||
27975322|NCT01778049|81742427|FG005|Double Blind Treatment Period|Protocol Violation|0|||
27975323|NCT01778049|81742422|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
27975324|NCT01778049|81742423|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27975325|NCT01778049|81742424|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
27975326|NCT01778049|81742425|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
27975327|NCT01778049|81742426|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
27975328|NCT01778049|81742427|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
27975329|NCT01778049|81742422|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
27975330|NCT01778049|81742423|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
27975331|NCT01778049|81742424|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
27975332|NCT01778049|81742425|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
27975333|NCT01778049|81742426|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27975334|NCT01778049|81742427|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
27975335|NCT01778049|81742422|FG000|Double Blind Treatment Period|Not treated|0|||
27975336|NCT01778049|81742423|FG001|Double Blind Treatment Period|Not treated|0|||
27975337|NCT01778049|81742424|FG002|Double Blind Treatment Period|Not treated|0|||
27975338|NCT01778049|81742425|FG003|Double Blind Treatment Period|Not treated|2|||
27975339|NCT01778049|81742426|FG004|Double Blind Treatment Period|Not treated|2|||
27975340|NCT01778049|81742427|FG005|Double Blind Treatment Period|Not treated|0|||
27975341|NCT01778049|81742422|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
27975342|NCT01778049|81742423|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
27975343|NCT01778049|81742424|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
27975344|NCT01778049|81742425|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
27975345|NCT01778049|81742426|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
27975346|NCT01778049|81742427|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
27975347|NCT00405964|81742428|FG000|Overall Study|Treatment Failure|17|||
27975348|NCT00405964|81742429|FG001|Overall Study|Treatment Failure|45|||
27975349|NCT00405964|81742428|FG000|Overall Study|Adverse Event|7|||
27975350|NCT00405964|81742429|FG001|Overall Study|Adverse Event|16|||
27975351|NCT00405964|81742428|FG000|Overall Study|Lost to Follow-up|5|||
27975352|NCT00405964|81742429|FG001|Overall Study|Lost to Follow-up|5|||
27975353|NCT00405964|81742428|FG000|Overall Study|Withdrawal by Subject|19|||
27975354|NCT00405964|81742429|FG001|Overall Study|Withdrawal by Subject|23|||
27975355|NCT00405964|81742428|FG000|Overall Study|Protocol Violation|11|||
27975356|NCT00405964|81742429|FG001|Overall Study|Protocol Violation|6|||
27975357|NCT01514240|81742432|FG000|Overall Study|Adverse Event|4|||
27975358|NCT01514240|81742433|FG001|Overall Study|Adverse Event|4|||
27975359|NCT01514240|81742432|FG000|Overall Study|Subject Decision|2|||
27975360|NCT01514240|81742433|FG001|Overall Study|Subject Decision|7|||
27975361|NCT01813721|81742434|FG000|Overall Study|Ineligibility determined|63|||
27975362|NCT01813721|81742434|FG000|Overall Study|Withdrawal by Subject|1|||
27975363|NCT03362931|81742437|FG000|Overall Study|Adverse Event|1|||
27975364|NCT03362931|81742437|FG000|Overall Study|Death|2|||
27975365|NCT01174004|81742444|FG000|Overall Study|Adverse Event|2|||
27975366|NCT01174004|81742445|FG001|Overall Study|Adverse Event|10|||
27975367|NCT01174004|81742444|FG000|Overall Study|Withdrawal by Subject|2|||
27975368|NCT01174004|81742445|FG001|Overall Study|Withdrawal by Subject|3|||
27975369|NCT01174004|81742444|FG000|Overall Study|At Discretion of Sponsor|2|||
27671907|NCT01296555|80639131|FG011|Overall Study|Physician Decision|0|||
27671908|NCT01296555|80639132|FG012|Overall Study|Physician Decision|0|||
27975370|NCT01174004|81742445|FG001|Overall Study|At Discretion of Sponsor|2|||
27975371|NCT01174004|81742444|FG000|Overall Study|Protocol Violation|0|||
27975372|NCT01174004|81742445|FG001|Overall Study|Protocol Violation|1|||
27975373|NCT01174004|81742444|FG000|Overall Study|Physician Decision|1|||
27975374|NCT01174004|81742445|FG001|Overall Study|Physician Decision|0|||
27975375|NCT01140568|81742453|FG000|Overall Study|disease progression|31|||
27671909|NCT01296555|80639133|FG013|Overall Study|Physician Decision|1|||
27975376|NCT01140568|81742453|FG000|Overall Study|Withdrawal by Subject|1|||
27975377|NCT01140568|81742453|FG000|Overall Study|Screen Fail|4|||
27975378|NCT00159913|81742454|FG000|Overall Study|Adverse Event|1|||
27975379|NCT00159913|81742455|FG001|Overall Study|Adverse Event|0|||
27788005|NCT04668066|81055915|FG014|Part 1: Treatment Phase|Other|0|||
27788006|NCT04668066|81055916|FG015|Part 1: Treatment Phase|Other|0|||
27788007|NCT04668066|81055917|FG016|Part 1: Treatment Phase|Other|0|||
27788008|NCT04668066|81055918|FG017|Part 1: Treatment Phase|Other|0|||
27788009|NCT04668066|81055919|FG018|Part 1: Treatment Phase|Other|0|||
27788010|NCT04668066|81055901|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27975380|NCT00159913|81742456|FG002|Overall Study|Adverse Event|1|||
27975381|NCT00159913|81742457|FG003|Overall Study|Adverse Event|0|||
27975382|NCT00159913|81742454|FG000|Overall Study|Withdrawal by Subject|0|||
27975383|NCT00159913|81742455|FG001|Overall Study|Withdrawal by Subject|0|||
27975384|NCT00159913|81742456|FG002|Overall Study|Withdrawal by Subject|0|||
27975385|NCT00159913|81742457|FG003|Overall Study|Withdrawal by Subject|1|||
27788011|NCT04668066|81055902|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788012|NCT04668066|81055903|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788013|NCT04668066|81055904|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788014|NCT04668066|81055905|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27975386|NCT00159913|81742454|FG000|Overall Study|Lost to Follow-up|0|||
27975387|NCT00159913|81742455|FG001|Overall Study|Lost to Follow-up|0|||
27975388|NCT00159913|81742456|FG002|Overall Study|Lost to Follow-up|0|||
27975389|NCT00159913|81742457|FG003|Overall Study|Lost to Follow-up|1|||
27975390|NCT00159913|81742454|FG000|Overall Study|Protocol Violation|1|||
27975391|NCT00159913|81742455|FG001|Overall Study|Protocol Violation|0|||
27975392|NCT00159913|81742456|FG002|Overall Study|Protocol Violation|1|||
27975393|NCT00159913|81742457|FG003|Overall Study|Protocol Violation|0|||
27975394|NCT00765882|81742458|FG000|Overall Study|Adverse Event|10|||
27975395|NCT00765882|81742459|FG001|Overall Study|Adverse Event|21|||
27975396|NCT00765882|81742460|FG002|Overall Study|Adverse Event|20|||
27975397|NCT00765882|81742458|FG000|Overall Study|Lack of Efficacy|4|||
27975398|NCT00765882|81742459|FG001|Overall Study|Lack of Efficacy|0|||
27975399|NCT00765882|81742460|FG002|Overall Study|Lack of Efficacy|1|||
27975400|NCT00765882|81742458|FG000|Overall Study|Protocol Violation|4|||
27975401|NCT00765882|81742459|FG001|Overall Study|Protocol Violation|3|||
27975402|NCT00765882|81742460|FG002|Overall Study|Protocol Violation|1|||
27975403|NCT00765882|81742458|FG000|Overall Study|Withdrawal by Subject|2|||
27975404|NCT00765882|81742459|FG001|Overall Study|Withdrawal by Subject|6|||
27975405|NCT00765882|81742460|FG002|Overall Study|Withdrawal by Subject|6|||
27975406|NCT00765882|81742458|FG000|Overall Study|Lost to Follow-up|1|||
27975407|NCT00765882|81742459|FG001|Overall Study|Lost to Follow-up|9|||
27975408|NCT00765882|81742460|FG002|Overall Study|Lost to Follow-up|6|||
27975409|NCT00765882|81742458|FG000|Overall Study|Other Reason|3|||
27975410|NCT00765882|81742459|FG001|Overall Study|Other Reason|1|||
27975411|NCT00765882|81742460|FG002|Overall Study|Other Reason|2|||
27975412|NCT03351114|81742461|FG000|Overall Study|Withdrawal by Subject|1|||
27975413|NCT00888329|81742462|FG000|Overall Study|Physician Decision|6|||
27975414|NCT00888329|81742463|FG001|Overall Study|Physician Decision|9|||
27975415|NCT03664674|81742467|FG000|Overall Study|Adverse Event|1|||
27975416|NCT03664674|81742468|FG001|Overall Study|Adverse Event|1|||
27975417|NCT03664674|81742467|FG000|Overall Study|Physician Decision|0|||
27975418|NCT03664674|81742468|FG001|Overall Study|Physician Decision|1|||
27975419|NCT03664674|81742467|FG000|Overall Study|Withdrawal by Subject|2|||
27788015|NCT04668066|81055906|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27975420|NCT03664674|81742468|FG001|Overall Study|Withdrawal by Subject|0|||
27975421|NCT02498067|81742469|FG000|Overall Study|Lost to Follow-up|22|||
27975422|NCT02498067|81742469|FG000|Overall Study|Did not meet inclusion criteria|11|||
27975423|NCT00107315|81742470|FG000|Overall Study|Disease Progression|9|||
27975424|NCT00107315|81742470|FG000|Overall Study|Adverse Event|4|||
27975425|NCT00107315|81742470|FG000|Overall Study|Withdrawal by Subject|2|||
27975426|NCT00977938|81742471|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
27975427|NCT00977938|81742472|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
27975428|NCT00977938|81742473|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
27975429|NCT00977938|81742474|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
27975430|NCT00977938|81742471|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
27975431|NCT00977938|81742472|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
27975432|NCT00977938|81742473|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
27975433|NCT00977938|81742474|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
27975434|NCT00977938|81742471|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
27975435|NCT00977938|81742472|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
27975436|NCT00977938|81742473|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
27975437|NCT00977938|81742474|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
27975438|NCT00977938|81742471|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
27975439|NCT00977938|81742472|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
27975440|NCT00977938|81742473|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
27975441|NCT00977938|81742474|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
27573329|NCT00057746|80285616|FG002|Overall Study|Withdrawal by Subject|1|||
27573330|NCT04091646|80285617|FG000|Overall Study|Adverse Event|2|||
27573331|NCT04091646|80285618|FG001|Overall Study|Adverse Event|1|||
27573332|NCT04091646|80285617|FG000|Overall Study|Lost to Follow-up|6|||
27573333|NCT04091646|80285618|FG001|Overall Study|Lost to Follow-up|2|||
27573334|NCT04091646|80285617|FG000|Overall Study|Protocol Violation|0|||
27573335|NCT04091646|80285618|FG001|Overall Study|Protocol Violation|1|||
27573336|NCT04091646|80285617|FG000|Overall Study|Withdrawal by Subject|4|||
27573337|NCT04091646|80285618|FG001|Overall Study|Withdrawal by Subject|1|||
27573338|NCT04091646|80285617|FG000|Overall Study|Participant Incarcerated|1|||
27573339|NCT04091646|80285618|FG001|Overall Study|Participant Incarcerated|0|||
27573340|NCT03019627|80285619|FG000|Overall Study|Adverse Event|8|||
27573341|NCT03019627|80285620|FG001|Overall Study|Adverse Event|0|||
27573342|NCT03019627|80285619|FG000|Overall Study|Unrelated to adverse event|1|||
27573343|NCT03019627|80285620|FG001|Overall Study|Unrelated to adverse event|3|||
27573344|NCT03019627|80285619|FG000|Overall Study|Lost to Follow-up|2|||
27573345|NCT03019627|80285620|FG001|Overall Study|Lost to Follow-up|1|||
27573346|NCT03019627|80285619|FG000|Overall Study|not compliance|2|||
27573347|NCT03019627|80285620|FG001|Overall Study|not compliance|2|||
27573348|NCT03019627|80285619|FG000|Overall Study|Other|2|||
27573349|NCT03019627|80285620|FG001|Overall Study|Other|2|||
27573350|NCT01440946|80285624|FG000|Overall Study|Lost to Follow-up|1|||
27573351|NCT01440946|80285625|FG001|Overall Study|Lost to Follow-up|1|||
27573352|NCT01440946|80285624|FG000|Overall Study|Physician Decision|1|||
27573353|NCT01440946|80285625|FG001|Overall Study|Physician Decision|0|||
27573354|NCT00280566|80285630|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
27573355|NCT00280566|80285631|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
27573356|NCT00280566|80285632|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
27573357|NCT00280566|80285630|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
27573358|NCT00280566|80285631|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
27573359|NCT00280566|80285632|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
27573360|NCT00280566|80285630|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
27573361|NCT00280566|80285631|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
27573362|NCT00280566|80285632|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
27573363|NCT00280566|80285630|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
27573364|NCT00280566|80285631|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
27573365|NCT00280566|80285632|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
27573366|NCT00280566|80285630|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
27573367|NCT00280566|80285631|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
27573368|NCT00280566|80285632|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
27573369|NCT00280566|80285630|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
27573370|NCT00280566|80285631|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
27573371|NCT00280566|80285632|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
27573372|NCT00280566|80285630|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
27573373|NCT00280566|80285631|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
27573374|NCT00280566|80285632|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
27573375|NCT00280566|80285630|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
27573376|NCT00280566|80285631|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
27573377|NCT00280566|80285632|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
27573378|NCT00280566|80285630|FG000|Period 2 Double Blind|Adverse Event|0|||
27573379|NCT00280566|80285631|FG001|Period 2 Double Blind|Adverse Event|11|||
27671910|NCT01296555|80639134|FG014|Overall Study|Physician Decision|0|||
27671911|NCT01296555|80639135|FG015|Overall Study|Physician Decision|0|||
27573380|NCT00280566|80285632|FG002|Period 2 Double Blind|Adverse Event|15|||
27573381|NCT00280566|80285630|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
27975442|NCT00977938|81742471|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
27573382|NCT00280566|80285631|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
27573383|NCT00280566|80285632|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
27573384|NCT00280566|80285630|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
27573385|NCT00280566|80285631|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
27573386|NCT00280566|80285632|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
27573387|NCT00280566|80285630|FG000|Period 2 Double Blind|miscellaneous|0|||
27671912|NCT01296555|80639136|FG016|Overall Study|Physician Decision|0|||
27573388|NCT00280566|80285631|FG001|Period 2 Double Blind|miscellaneous|10|||
27573389|NCT00280566|80285632|FG002|Period 2 Double Blind|miscellaneous|5|||
27573390|NCT01257204|80285634|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27573391|NCT01257204|80285635|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
27573392|NCT01257204|80285636|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
27573393|NCT01257204|80285634|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
27671913|NCT01296555|80639137|FG017|Overall Study|Physician Decision|0|||
27671914|NCT01296555|80639138|FG018|Overall Study|Physician Decision|0|||
27671915|NCT01296555|80639139|FG019|Overall Study|Physician Decision|1|||
27788016|NCT04668066|81055907|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788017|NCT04668066|81055908|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788018|NCT04668066|81055909|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788019|NCT04668066|81055910|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788020|NCT04668066|81055911|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788021|NCT04668066|81055912|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788022|NCT04668066|81055913|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
27788023|NCT04668066|81055914|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788024|NCT04668066|81055915|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788025|NCT04668066|81055916|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
27788026|NCT04668066|81055917|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788027|NCT04668066|81055918|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788028|NCT04668066|81055919|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
27788029|NCT04668066|81055901|FG000|Part 1: Follow-Up|Adverse Event|0|||
27788030|NCT04668066|81055902|FG001|Part 1: Follow-Up|Adverse Event|0|||
27788031|NCT04668066|81055903|FG002|Part 1: Follow-Up|Adverse Event|0|||
27788032|NCT04668066|81055904|FG003|Part 1: Follow-Up|Adverse Event|0|||
27788033|NCT04668066|81055905|FG004|Part 1: Follow-Up|Adverse Event|0|||
27788034|NCT04668066|81055906|FG005|Part 1: Follow-Up|Adverse Event|0|||
27788035|NCT04668066|81055907|FG006|Part 1: Follow-Up|Adverse Event|0|||
27788036|NCT04668066|81055908|FG007|Part 1: Follow-Up|Adverse Event|0|||
27788037|NCT04668066|81055909|FG008|Part 1: Follow-Up|Adverse Event|0|||
27788038|NCT04668066|81055910|FG009|Part 1: Follow-Up|Adverse Event|0|||
27788039|NCT04668066|81055911|FG010|Part 1: Follow-Up|Adverse Event|0|||
27788040|NCT04668066|81055912|FG011|Part 1: Follow-Up|Adverse Event|1|||
27788041|NCT04668066|81055913|FG012|Part 1: Follow-Up|Adverse Event|0|||
27788042|NCT04668066|81055914|FG013|Part 1: Follow-Up|Adverse Event|0|||
27788043|NCT04668066|81055915|FG014|Part 1: Follow-Up|Adverse Event|0|||
27788044|NCT04668066|81055916|FG015|Part 1: Follow-Up|Adverse Event|0|||
27788045|NCT04668066|81055917|FG016|Part 1: Follow-Up|Adverse Event|0|||
27788046|NCT04668066|81055918|FG017|Part 1: Follow-Up|Adverse Event|0|||
27788047|NCT04668066|81055919|FG018|Part 1: Follow-Up|Adverse Event|0|||
27788048|NCT04668066|81055901|FG000|Part 1: Follow-Up|Other|0|||
27788049|NCT04668066|81055902|FG001|Part 1: Follow-Up|Other|0|||
27788050|NCT04668066|81055903|FG002|Part 1: Follow-Up|Other|0|||
27788051|NCT04668066|81055904|FG003|Part 1: Follow-Up|Other|0|||
27788052|NCT04668066|81055905|FG004|Part 1: Follow-Up|Other|0|||
27788053|NCT04668066|81055906|FG005|Part 1: Follow-Up|Other|0|||
27788054|NCT04668066|81055907|FG006|Part 1: Follow-Up|Other|0|||
27788055|NCT04668066|81055908|FG007|Part 1: Follow-Up|Other|0|||
27788056|NCT04668066|81055909|FG008|Part 1: Follow-Up|Other|0|||
27788057|NCT04668066|81055910|FG009|Part 1: Follow-Up|Other|0|||
27788058|NCT04668066|81055911|FG010|Part 1: Follow-Up|Other|0|||
27788059|NCT04668066|81055912|FG011|Part 1: Follow-Up|Other|1|||
27788060|NCT04668066|81055913|FG012|Part 1: Follow-Up|Other|1|||
27788061|NCT04668066|81055914|FG013|Part 1: Follow-Up|Other|0|||
27788062|NCT04668066|81055915|FG014|Part 1: Follow-Up|Other|0|||
27788063|NCT04668066|81055916|FG015|Part 1: Follow-Up|Other|0|||
27788064|NCT04668066|81055917|FG016|Part 1: Follow-Up|Other|0|||
27788065|NCT04668066|81055918|FG017|Part 1: Follow-Up|Other|0|||
27788066|NCT04668066|81055919|FG018|Part 1: Follow-Up|Other|0|||
27788067|NCT04668066|81055901|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788068|NCT04668066|81055902|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
27573394|NCT01257204|80285635|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
27788069|NCT04668066|81055903|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788070|NCT04668066|81055904|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788071|NCT04668066|81055905|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788072|NCT04668066|81055906|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788073|NCT04668066|81055907|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788074|NCT04668066|81055908|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788075|NCT04668066|81055909|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788076|NCT04668066|81055910|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788077|NCT04668066|81055911|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788078|NCT04668066|81055912|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788079|NCT04668066|81055913|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
27788080|NCT04668066|81055914|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
27573395|NCT01257204|80285636|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
27671916|NCT01296555|80639140|FG020|Overall Study|Physician Decision|0|||
27788081|NCT04668066|81055915|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788082|NCT04668066|81055916|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
27788083|NCT04668066|81055917|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788084|NCT04668066|81055918|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788085|NCT04668066|81055919|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
27788086|NCT04668066|81055901|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788087|NCT04668066|81055902|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788088|NCT04668066|81055903|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788089|NCT04668066|81055904|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788090|NCT04668066|81055905|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788091|NCT04668066|81055906|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788092|NCT04668066|81055907|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788093|NCT04668066|81055908|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788094|NCT04668066|81055909|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788095|NCT04668066|81055910|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788096|NCT04668066|81055911|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788097|NCT04668066|81055912|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788098|NCT04668066|81055913|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788099|NCT04668066|81055914|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788100|NCT04668066|81055915|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788101|NCT04668066|81055916|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788102|NCT04668066|81055917|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788103|NCT04668066|81055918|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
27788104|NCT04668066|81055919|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
27788105|NCT04668066|81055901|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788106|NCT04668066|81055902|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788107|NCT04668066|81055903|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788108|NCT04668066|81055904|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788109|NCT04668066|81055905|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788110|NCT04668066|81055906|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788111|NCT04668066|81055907|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788112|NCT04668066|81055908|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788113|NCT04668066|81055909|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788114|NCT04668066|81055910|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
27671917|NCT01296555|80639141|FG021|Overall Study|Physician Decision|0|||
27671918|NCT01296555|80639142|FG022|Overall Study|Physician Decision|0|||
27671919|NCT01296555|80639143|FG023|Overall Study|Physician Decision|0|||
27671920|NCT01296555|80639144|FG024|Overall Study|Physician Decision|0|||
27788115|NCT04668066|81055911|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788116|NCT04668066|81055912|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788117|NCT04668066|81055913|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788118|NCT04668066|81055914|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788119|NCT04668066|81055915|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788120|NCT04668066|81055916|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788121|NCT04668066|81055917|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
27788122|NCT04668066|81055918|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
27975443|NCT00977938|81742472|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
27975444|NCT00977938|81742473|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
27975445|NCT00977938|81742474|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
27975446|NCT00977938|81742471|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
27975447|NCT00977938|81742472|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
27975448|NCT00977938|81742473|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
27975449|NCT00977938|81742474|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
27975450|NCT04612842|81742475|FG000|Overall Study|Lost to Follow-up|20|||
27975451|NCT04612842|81742476|FG001|Overall Study|Lost to Follow-up|11|||
27975452|NCT04612842|81742475|FG000|Overall Study|Withdrawal by Subject|26|||
27975453|NCT04612842|81742476|FG001|Overall Study|Withdrawal by Subject|15|||
27788123|NCT04668066|81055919|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
27788124|NCT04668066|81055901|FG000|Part 2: Treatment Phase|Other|0|||
27788125|NCT04668066|81055902|FG001|Part 2: Treatment Phase|Other|0|||
27788126|NCT04668066|81055903|FG002|Part 2: Treatment Phase|Other|0|||
27788127|NCT04668066|81055904|FG003|Part 2: Treatment Phase|Other|0|||
27788128|NCT04668066|81055905|FG004|Part 2: Treatment Phase|Other|0|||
27788129|NCT04668066|81055906|FG005|Part 2: Treatment Phase|Other|0|||
27788130|NCT04668066|81055907|FG006|Part 2: Treatment Phase|Other|0|||
27788131|NCT04668066|81055908|FG007|Part 2: Treatment Phase|Other|0|||
27788132|NCT04668066|81055909|FG008|Part 2: Treatment Phase|Other|0|||
27788133|NCT04668066|81055910|FG009|Part 2: Treatment Phase|Other|0|||
27788134|NCT04668066|81055911|FG010|Part 2: Treatment Phase|Other|0|||
27975454|NCT04612842|81742475|FG000|Overall Study|Death|2|||
27788135|NCT04668066|81055912|FG011|Part 2: Treatment Phase|Other|0|||
27788136|NCT04668066|81055913|FG012|Part 2: Treatment Phase|Other|0|||
27788137|NCT04668066|81055914|FG013|Part 2: Treatment Phase|Other|0|||
27788138|NCT04668066|81055915|FG014|Part 2: Treatment Phase|Other|0|||
27975455|NCT04612842|81742476|FG001|Overall Study|Death|2|||
27671921|NCT01296555|80639145|FG025|Overall Study|Physician Decision|0|||
27975456|NCT00477269|81742482|FG000|Core Study|Adverse Event|6|||
27975457|NCT00477269|81742483|FG001|Core Study|Adverse Event|4|||
27975458|NCT00477269|81742484|FG002|Core Study|Adverse Event|0|||
27788139|NCT04668066|81055916|FG015|Part 2: Treatment Phase|Other|0|||
27788140|NCT04668066|81055917|FG016|Part 2: Treatment Phase|Other|0|||
27788141|NCT04668066|81055918|FG017|Part 2: Treatment Phase|Other|0|||
27788142|NCT04668066|81055919|FG018|Part 2: Treatment Phase|Other|1|||
27788143|NCT04668066|81055901|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788144|NCT04668066|81055902|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788145|NCT04668066|81055903|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788146|NCT04668066|81055904|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788147|NCT04668066|81055905|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788148|NCT04668066|81055906|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788149|NCT04668066|81055907|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788150|NCT04668066|81055908|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788151|NCT04668066|81055909|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788152|NCT04668066|81055910|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788153|NCT04668066|81055911|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788154|NCT04668066|81055912|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788155|NCT04668066|81055913|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788156|NCT04668066|81055914|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788157|NCT04668066|81055915|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788158|NCT04668066|81055916|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788159|NCT04668066|81055917|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788160|NCT04668066|81055918|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
27788161|NCT04668066|81055919|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
27788162|NCT00945815|81055920|FG000|Overall Study|Death|3|||
27788163|NCT00945815|81055920|FG000|Overall Study|Not protocol specified|1|||
27788164|NCT00945815|81055920|FG000|Overall Study|Ineligible|3|||
27788165|NCT00945815|81055920|FG000|Overall Study|Did not begin protocol therapy|1|||
27788166|NCT00077766|81055921|FG000|Overall Study|Adverse Event|1|||
27788167|NCT00077766|81055922|FG001|Overall Study|Adverse Event|1|||
27867316|NCT02856802|81349547|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
27975459|NCT00477269|81742482|FG000|Core Study|Death|3|||
27975460|NCT00477269|81742483|FG001|Core Study|Death|3|||
27975461|NCT00477269|81742484|FG002|Core Study|Death|0|||
27975462|NCT00477269|81742482|FG000|Core Study|Withdrawn Consent|0|||
27975463|NCT00477269|81742483|FG001|Core Study|Withdrawn Consent|1|||
27975464|NCT00477269|81742484|FG002|Core Study|Withdrawn Consent|0|||
27975465|NCT00477269|81742482|FG000|Open Label Extension|Adverse Event|0|||
27975466|NCT00477269|81742483|FG001|Open Label Extension|Adverse Event|0|||
27975467|NCT00477269|81742484|FG002|Open Label Extension|Adverse Event|4|||
27975468|NCT00477269|81742482|FG000|Open Label Extension|Abnormal laboratory values|0|||
27975469|NCT00477269|81742483|FG001|Open Label Extension|Abnormal laboratory values|0|||
27975470|NCT00477269|81742484|FG002|Open Label Extension|Abnormal laboratory values|1|||
27975471|NCT00477269|81742482|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
27975472|NCT00477269|81742483|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
27975473|NCT00477269|81742484|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
27975474|NCT00477269|81742482|FG000|Open Label Extension|Adminiatrative problems|0|||
27975475|NCT00477269|81742483|FG001|Open Label Extension|Adminiatrative problems|0|||
27975476|NCT00477269|81742484|FG002|Open Label Extension|Adminiatrative problems|2|||
27975477|NCT00477269|81742482|FG000|Open Label Extension|Death|0|||
27975478|NCT00477269|81742483|FG001|Open Label Extension|Death|0|||
27975479|NCT00477269|81742484|FG002|Open Label Extension|Death|4|||
27975480|NCT03158272|81742485|FG000|Overall Study|Disease progression|3|||
27975481|NCT03158272|81742486|FG001|Overall Study|Disease progression|3|||
27975482|NCT03158272|81742487|FG002|Overall Study|Disease progression|4|||
27975483|NCT03158272|81742488|FG003|Overall Study|Disease progression|6|||
27788168|NCT00077766|81055921|FG000|Overall Study|Withdrawal by Subject|4|||
27788169|NCT00077766|81055922|FG001|Overall Study|Withdrawal by Subject|3|||
27975484|NCT03158272|81742485|FG000|Overall Study|Death|0|||
27975485|NCT03158272|81742486|FG001|Overall Study|Death|0|||
27788170|NCT00077766|81055921|FG000|Overall Study|Death|12|||
27788171|NCT00077766|81055922|FG001|Overall Study|Death|10|||
27788172|NCT00077766|81055921|FG000|Overall Study|Lost to Follow-up|2|||
27788173|NCT00077766|81055922|FG001|Overall Study|Lost to Follow-up|0|||
27975486|NCT03158272|81742487|FG002|Overall Study|Death|1|||
27975487|NCT03158272|81742488|FG003|Overall Study|Death|0|||
27975488|NCT03158272|81742485|FG000|Overall Study|Other reasons|0|||
27975489|NCT03158272|81742486|FG001|Overall Study|Other reasons|0|||
27975490|NCT03158272|81742487|FG002|Overall Study|Other reasons|1|||
27975491|NCT03158272|81742488|FG003|Overall Study|Other reasons|0|||
27788174|NCT00077766|81055921|FG000|Overall Study|Protocol Violation|1|||
27788175|NCT00077766|81055922|FG001|Overall Study|Protocol Violation|0|||
27788176|NCT00077766|81055921|FG000|Overall Study|Kidney Transplantation|9|||
27788177|NCT00077766|81055922|FG001|Overall Study|Kidney Transplantation|5|||
27788178|NCT00077766|81055921|FG000|Overall Study|Transplantation|5|||
27788179|NCT00077766|81055922|FG001|Overall Study|Transplantation|1|||
27788180|NCT00077766|81055921|FG000|Overall Study|Investigators Discretion|1|||
27788181|NCT00077766|81055922|FG001|Overall Study|Investigators Discretion|0|||
27788182|NCT00077766|81055921|FG000|Overall Study|Participant's decision|1|||
27788183|NCT00077766|81055922|FG001|Overall Study|Participant's decision|0|||
27788184|NCT00077766|81055921|FG000|Overall Study|Dialysis Discontinued|1|||
27788185|NCT00077766|81055922|FG001|Overall Study|Dialysis Discontinued|0|||
27788186|NCT00077766|81055921|FG000|Overall Study|Dialysis|0|||
27788187|NCT00077766|81055922|FG001|Overall Study|Dialysis|1|||
27788188|NCT00077766|81055921|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
27788189|NCT00077766|81055922|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
27788190|NCT00077766|81055921|FG000|Overall Study|Started Nocturnal Dialysis|0|||
27788191|NCT00077766|81055922|FG001|Overall Study|Started Nocturnal Dialysis|1|||
27788192|NCT00077766|81055921|FG000|Overall Study|Stop Dialysis|0|||
27788193|NCT00077766|81055922|FG001|Overall Study|Stop Dialysis|1|||
27788194|NCT00077766|81055921|FG000|Overall Study|Participants Vacation|2|||
27788195|NCT00077766|81055922|FG001|Overall Study|Participants Vacation|1|||
27788196|NCT02643420|81055924|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
27975492|NCT03158272|81742485|FG000|Overall Study|Adverse event unrelated to the drug|0|||
27975493|NCT03158272|81742486|FG001|Overall Study|Adverse event unrelated to the drug|1|||
27975494|NCT03158272|81742487|FG002|Overall Study|Adverse event unrelated to the drug|0|||
27671922|NCT01296555|80639146|FG026|Overall Study|Physician Decision|0|||
27671923|NCT01296555|80639147|FG027|Overall Study|Physician Decision|0|||
27671924|NCT01296555|80639148|FG028|Overall Study|Physician Decision|0|||
27671925|NCT01296555|80639120|FG000|Overall Study|Progressive Disease|6|||
27671926|NCT01296555|80639121|FG001|Overall Study|Progressive Disease|3|||
27671927|NCT01296555|80639122|FG002|Overall Study|Progressive Disease|3|||
27671928|NCT01296555|80639123|FG003|Overall Study|Progressive Disease|7|||
27671929|NCT01296555|80639124|FG004|Overall Study|Progressive Disease|6|||
27671930|NCT01296555|80639125|FG005|Overall Study|Progressive Disease|16|||
27671931|NCT01296555|80639126|FG006|Overall Study|Progressive Disease|16|||
27671932|NCT01296555|80639127|FG007|Overall Study|Progressive Disease|8|||
27671933|NCT01296555|80639128|FG008|Overall Study|Progressive Disease|7|||
27671934|NCT01296555|80639129|FG009|Overall Study|Progressive Disease|18|||
27671935|NCT01296555|80639130|FG010|Overall Study|Progressive Disease|7|||
27671936|NCT01296555|80639131|FG011|Overall Study|Progressive Disease|14|||
27671937|NCT01296555|80639132|FG012|Overall Study|Progressive Disease|5|||
27671938|NCT01296555|80639133|FG013|Overall Study|Progressive Disease|12|||
27671939|NCT01296555|80639134|FG014|Overall Study|Progressive Disease|1|||
27671940|NCT01296555|80639135|FG015|Overall Study|Progressive Disease|1|||
27671941|NCT01296555|80639136|FG016|Overall Study|Progressive Disease|0|||
27671942|NCT01296555|80639137|FG017|Overall Study|Progressive Disease|0|||
27671943|NCT01296555|80639138|FG018|Overall Study|Progressive Disease|0|||
27671944|NCT01296555|80639139|FG019|Overall Study|Progressive Disease|1|||
27671945|NCT01296555|80639140|FG020|Overall Study|Progressive Disease|0|||
27671946|NCT01296555|80639141|FG021|Overall Study|Progressive Disease|0|||
27671947|NCT01296555|80639142|FG022|Overall Study|Progressive Disease|0|||
27671948|NCT01296555|80639143|FG023|Overall Study|Progressive Disease|0|||
27671949|NCT01296555|80639144|FG024|Overall Study|Progressive Disease|1|||
27671950|NCT01296555|80639145|FG025|Overall Study|Progressive Disease|0|||
27671951|NCT01296555|80639146|FG026|Overall Study|Progressive Disease|5|||
27671952|NCT01296555|80639147|FG027|Overall Study|Progressive Disease|1|||
27671953|NCT01296555|80639148|FG028|Overall Study|Progressive Disease|0|||
27671954|NCT01296555|80639120|FG000|Overall Study|Protocol Violation|0|||
27671955|NCT01296555|80639121|FG001|Overall Study|Protocol Violation|0|||
27671956|NCT01296555|80639122|FG002|Overall Study|Protocol Violation|0|||
27671957|NCT01296555|80639123|FG003|Overall Study|Protocol Violation|0|||
27788197|NCT02643420|81055925|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
27788198|NCT02643420|81055924|FG000|Overall Study|Withdrawal by Subject|25|||
27788199|NCT02643420|81055925|FG001|Overall Study|Withdrawal by Subject|19|||
27788200|NCT02643420|81055924|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
27788201|NCT02643420|81055925|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
27788202|NCT02643420|81055924|FG000|Overall Study|Lost to Follow-up|6|||
27788203|NCT02643420|81055925|FG001|Overall Study|Lost to Follow-up|10|||
27671958|NCT01296555|80639124|FG004|Overall Study|Protocol Violation|0|||
27975495|NCT03158272|81742488|FG003|Overall Study|Adverse event unrelated to the drug|0|||
27671959|NCT01296555|80639125|FG005|Overall Study|Protocol Violation|0|||
27671960|NCT01296555|80639126|FG006|Overall Study|Protocol Violation|0|||
27671961|NCT01296555|80639127|FG007|Overall Study|Protocol Violation|0|||
27671962|NCT01296555|80639128|FG008|Overall Study|Protocol Violation|0|||
27671963|NCT01296555|80639129|FG009|Overall Study|Protocol Violation|0|||
27671964|NCT01296555|80639130|FG010|Overall Study|Protocol Violation|0|||
27671965|NCT01296555|80639131|FG011|Overall Study|Protocol Violation|0|||
27671966|NCT01296555|80639132|FG012|Overall Study|Protocol Violation|0|||
27788204|NCT02643420|81055924|FG000|Overall Study|Investigator Decision|2|||
27788205|NCT02643420|81055925|FG001|Overall Study|Investigator Decision|4|||
27788206|NCT02643420|81055924|FG000|Overall Study|Sponsor decision|1|||
27788207|NCT02643420|81055925|FG001|Overall Study|Sponsor decision|1|||
27671967|NCT01296555|80639133|FG013|Overall Study|Protocol Violation|1|||
27671968|NCT01296555|80639134|FG014|Overall Study|Protocol Violation|0|||
27671969|NCT01296555|80639135|FG015|Overall Study|Protocol Violation|0|||
27788208|NCT02643420|81055924|FG000|Overall Study|Death|0|||
27788209|NCT02643420|81055925|FG001|Overall Study|Death|2|||
27788210|NCT02643420|81055924|FG000|Overall Study|Reason not Specified|8|||
27788211|NCT02643420|81055925|FG001|Overall Study|Reason not Specified|7|||
27788212|NCT02268214|81055926|FG000|Overall Study|Subject no longer meets study criteria|0|||
27788213|NCT02268214|81055927|FG001|Overall Study|Subject no longer meets study criteria|2|||
27788214|NCT02268214|81055928|FG002|Overall Study|Subject no longer meets study criteria|0|||
27788215|NCT02268214|81055926|FG000|Overall Study|Pregnancy|2|||
27788216|NCT02268214|81055927|FG001|Overall Study|Pregnancy|2|||
27788217|NCT02268214|81055928|FG002|Overall Study|Pregnancy|1|||
27788218|NCT02268214|81055926|FG000|Overall Study|Lost to Follow-up|3|||
27788219|NCT02268214|81055927|FG001|Overall Study|Lost to Follow-up|3|||
27788220|NCT02268214|81055928|FG002|Overall Study|Lost to Follow-up|4|||
27788221|NCT02268214|81055926|FG000|Overall Study|Lack of Efficacy|1|||
27788222|NCT02268214|81055927|FG001|Overall Study|Lack of Efficacy|0|||
27788223|NCT02268214|81055928|FG002|Overall Study|Lack of Efficacy|2|||
27788224|NCT02268214|81055926|FG000|Overall Study|Adverse Event|11|||
27788225|NCT02268214|81055927|FG001|Overall Study|Adverse Event|14|||
27788226|NCT02268214|81055928|FG002|Overall Study|Adverse Event|9|||
27788227|NCT02268214|81055926|FG000|Overall Study|Withdrawal by Subject|4|||
27788228|NCT02268214|81055927|FG001|Overall Study|Withdrawal by Subject|5|||
27788229|NCT02268214|81055928|FG002|Overall Study|Withdrawal by Subject|10|||
27788230|NCT02268214|81055926|FG000|Overall Study|Subject request to discontinue treatment|10|||
27788231|NCT02268214|81055927|FG001|Overall Study|Subject request to discontinue treatment|8|||
27788232|NCT02268214|81055928|FG002|Overall Study|Subject request to discontinue treatment|6|||
27788233|NCT02268214|81055926|FG000|Overall Study|Poor/non-compliance|2|||
27788234|NCT02268214|81055927|FG001|Overall Study|Poor/non-compliance|1|||
27788235|NCT02268214|81055928|FG002|Overall Study|Poor/non-compliance|2|||
27788236|NCT02268214|81055926|FG000|Overall Study|Other reasons|7|||
27788237|NCT02268214|81055927|FG001|Overall Study|Other reasons|3|||
27788238|NCT02268214|81055928|FG002|Overall Study|Other reasons|3|||
27788239|NCT02268214|81055926|FG000|Overall Study|Not entering long-term period|2|||
27788240|NCT02268214|81055927|FG001|Overall Study|Not entering long-term period|3|||
27788241|NCT02268214|81055928|FG002|Overall Study|Not entering long-term period|5|||
27788242|NCT01119118|81055933|FG000|Overall Study|Adverse Event|1|||
27788243|NCT02058940|81055934|FG000|Overall Study|Discharged from Critical Care Unit|1|||
27788244|NCT02221882|81055936|FG000|Overall Study|Withdrawal by Subject|0|||
27788245|NCT02221882|81055937|FG001|Overall Study|Withdrawal by Subject|0|||
27788246|NCT02221882|81055938|FG002|Overall Study|Withdrawal by Subject|4|||
27788247|NCT02221882|81055939|FG003|Overall Study|Withdrawal by Subject|2|||
27788248|NCT02221882|81055940|FG004|Overall Study|Withdrawal by Subject|2|||
27788249|NCT02221882|81055941|FG005|Overall Study|Withdrawal by Subject|2|||
27788250|NCT02221882|81055936|FG000|Overall Study|Death|0|||
27788251|NCT02221882|81055937|FG001|Overall Study|Death|1|||
27788252|NCT02221882|81055938|FG002|Overall Study|Death|0|||
27788253|NCT02221882|81055939|FG003|Overall Study|Death|0|||
27788254|NCT02221882|81055940|FG004|Overall Study|Death|0|||
27788255|NCT02221882|81055941|FG005|Overall Study|Death|0|||
27788256|NCT00039377|81055943|FG000|Initial Registration|Adverse Event|2|||
27788257|NCT00039377|81055944|FG001|Initial Registration|Adverse Event|0|||
27788258|NCT00039377|81055945|FG002|Initial Registration|Adverse Event|0|||
27788259|NCT00039377|81055946|FG003|Initial Registration|Adverse Event|0|||
27671970|NCT01296555|80639136|FG016|Overall Study|Protocol Violation|0|||
27788260|NCT00039377|81055943|FG000|Initial Registration|Relapsed|6|||
27788261|NCT00039377|81055944|FG001|Initial Registration|Relapsed|0|||
27788262|NCT00039377|81055945|FG002|Initial Registration|Relapsed|0|||
27788263|NCT00039377|81055946|FG003|Initial Registration|Relapsed|0|||
27788264|NCT00039377|81055943|FG000|Initial Registration|Received non-protocol therapy|11|||
27788265|NCT00039377|81055944|FG001|Initial Registration|Received non-protocol therapy|0|||
27788266|NCT00039377|81055945|FG002|Initial Registration|Received non-protocol therapy|0|||
27788267|NCT00039377|81055946|FG003|Initial Registration|Received non-protocol therapy|0|||
27788268|NCT00039377|81055943|FG000|Initial Registration|Withdrawal by Subject|3|||
27788269|NCT00039377|81055944|FG001|Initial Registration|Withdrawal by Subject|0|||
27788270|NCT00039377|81055945|FG002|Initial Registration|Withdrawal by Subject|0|||
27788271|NCT00039377|81055946|FG003|Initial Registration|Withdrawal by Subject|0|||
27788272|NCT00960869|81055947|FG000|Overall Study|Adverse Event|17|||
27671971|NCT01296555|80639137|FG017|Overall Study|Protocol Violation|0|||
27788273|NCT00960869|81055948|FG001|Overall Study|Adverse Event|26|||
27788274|NCT00960869|81055947|FG000|Overall Study|Withdrawal by Subject|16|||
27788275|NCT00960869|81055948|FG001|Overall Study|Withdrawal by Subject|14|||
27788276|NCT00960869|81055947|FG000|Overall Study|Lost to Follow-up|1|||
27788277|NCT00960869|81055948|FG001|Overall Study|Lost to Follow-up|4|||
27788278|NCT00960869|81055947|FG000|Overall Study|Misc|19|||
27788279|NCT00960869|81055948|FG001|Overall Study|Misc|18|||
27788280|NCT00663208|81055949|FG000|Treatment Period|Lost to Follow-up|0|||
27788281|NCT00663208|81055950|FG001|Treatment Period|Lost to Follow-up|1|||
27975496|NCT01287221|81742492|FG000|Overall Study|Lack of Perceived Benefit|1|||
27975497|NCT01287221|81742493|FG001|Overall Study|Lack of Perceived Benefit|1|||
27975498|NCT01287221|81742492|FG000|Overall Study|Adverse Event|3|||
27975499|NCT01287221|81742493|FG001|Overall Study|Adverse Event|3|||
27975500|NCT01287221|81742492|FG000|Overall Study|Withdrawal by Subject|0|||
27975501|NCT01287221|81742493|FG001|Overall Study|Withdrawal by Subject|1|||
27975502|NCT00160199|81742494|FG000|Overall Study|Adverse Event|5|||
27975503|NCT00160199|81742495|FG001|Overall Study|Adverse Event|14|||
27975504|NCT00160199|81742494|FG000|Overall Study|Lack of Efficacy|0|||
27975505|NCT00160199|81742495|FG001|Overall Study|Lack of Efficacy|1|||
27975506|NCT00160199|81742494|FG000|Overall Study|Lost to Follow-up|7|||
27975507|NCT00160199|81742495|FG001|Overall Study|Lost to Follow-up|7|||
27975508|NCT00160199|81742494|FG000|Overall Study|Withdrawal by Subject|4|||
27975509|NCT00160199|81742495|FG001|Overall Study|Withdrawal by Subject|6|||
27975510|NCT00160199|81742494|FG000|Overall Study|Administrative|0|||
27975511|NCT00160199|81742495|FG001|Overall Study|Administrative|1|||
27975512|NCT00160199|81742494|FG000|Overall Study|Protocol Violation|8|||
27975513|NCT00160199|81742495|FG001|Overall Study|Protocol Violation|8|||
27975514|NCT01457950|81742496|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
27975515|NCT01457950|81742497|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
27975516|NCT01457950|81742498|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
27975517|NCT01457950|81742499|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
27975518|NCT01457950|81742496|FG000|Double-Blind Phase|Protocol Violation|2|||
27975519|NCT01457950|81742497|FG001|Double-Blind Phase|Protocol Violation|1|||
27975520|NCT01457950|81742498|FG002|Double-Blind Phase|Protocol Violation|0|||
27975521|NCT01457950|81742499|FG003|Double-Blind Phase|Protocol Violation|0|||
27788282|NCT00663208|81055951|FG002|Treatment Period|Lost to Follow-up|0|||
27788283|NCT00663208|81055952|FG003|Treatment Period|Lost to Follow-up|0|||
27788284|NCT00663208|81055953|FG004|Treatment Period|Lost to Follow-up|0|||
27788285|NCT00663208|81055954|FG005|Treatment Period|Lost to Follow-up|0|||
27788286|NCT00663208|81055955|FG006|Treatment Period|Lost to Follow-up|0|||
27788287|NCT00663208|81055949|FG000|Follow-up Period|Lost to Follow-up|2|||
27788288|NCT00663208|81055950|FG001|Follow-up Period|Lost to Follow-up|0|||
27788289|NCT00663208|81055951|FG002|Follow-up Period|Lost to Follow-up|3|||
27788290|NCT00663208|81055952|FG003|Follow-up Period|Lost to Follow-up|2|||
27788291|NCT00663208|81055953|FG004|Follow-up Period|Lost to Follow-up|0|||
27788292|NCT00663208|81055954|FG005|Follow-up Period|Lost to Follow-up|0|||
27788293|NCT00663208|81055955|FG006|Follow-up Period|Lost to Follow-up|0|||
27788294|NCT00663208|81055949|FG000|Follow-up Period|Other reason|1|||
27788295|NCT00663208|81055950|FG001|Follow-up Period|Other reason|0|||
27788296|NCT00663208|81055951|FG002|Follow-up Period|Other reason|0|||
27788297|NCT00663208|81055952|FG003|Follow-up Period|Other reason|0|||
27788298|NCT00663208|81055953|FG004|Follow-up Period|Other reason|0|||
27788299|NCT00663208|81055954|FG005|Follow-up Period|Other reason|0|||
27975522|NCT01457950|81742496|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
27975523|NCT01457950|81742497|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
27975524|NCT01457950|81742498|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27975525|NCT01457950|81742499|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27975526|NCT01457950|81742496|FG000|Open-Label Phase|Adverse Event|0|||
27975527|NCT01457950|81742497|FG001|Open-Label Phase|Adverse Event|0|||
27788300|NCT00663208|81055955|FG006|Follow-up Period|Other reason|1|||
27975528|NCT01457950|81742498|FG002|Open-Label Phase|Adverse Event|0|||
27788301|NCT01215968|81055957|FG000|Overall Study|Adverse Event|0|||
27788302|NCT01215968|81055958|FG001|Overall Study|Adverse Event|2|||
27788303|NCT01215968|81055957|FG000|Overall Study|Protocol Violation|2|||
27788304|NCT01215968|81055958|FG001|Overall Study|Protocol Violation|4|||
27975529|NCT01457950|81742499|FG003|Open-Label Phase|Adverse Event|1|||
27975530|NCT01457950|81742496|FG000|Open-Label Phase|Protocol Violation|0|||
27975531|NCT01457950|81742497|FG001|Open-Label Phase|Protocol Violation|0|||
27975532|NCT01457950|81742498|FG002|Open-Label Phase|Protocol Violation|0|||
27975533|NCT01457950|81742499|FG003|Open-Label Phase|Protocol Violation|1|||
27975534|NCT01457950|81742496|FG000|Open-Label Phase|Withdrawal by Subject|0|||
27975535|NCT01457950|81742497|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27975536|NCT01457950|81742498|FG002|Open-Label Phase|Withdrawal by Subject|2|||
27975537|NCT01457950|81742499|FG003|Open-Label Phase|Withdrawal by Subject|0|||
27975538|NCT01710527|81742500|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
27975539|NCT01710527|81742501|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
27975540|NCT02813668|81742502|FG000|Overall Study|Death|4|||
27975541|NCT02813668|81742502|FG000|Overall Study|Lost to Follow-up|509|||
27975542|NCT02813668|81742502|FG000|Overall Study|Withdrawal by Subject|148|||
27975543|NCT02813668|81742502|FG000|Overall Study|No longer at worksite|85|||
27975544|NCT02813668|81742502|FG000|Overall Study|Medical reasons not related to the study|4|||
27975545|NCT02275117|81742503|FG000|Overall Study|Adverse Event|0|||
27975546|NCT02275117|81742504|FG001|Overall Study|Adverse Event|0|||
27975547|NCT02275117|81742505|FG002|Overall Study|Adverse Event|0|||
27975548|NCT02275117|81742506|FG003|Overall Study|Adverse Event|0|||
27975549|NCT02275117|81742507|FG004|Overall Study|Adverse Event|1|||
27975550|NCT02275117|81742503|FG000|Overall Study|Lack of Efficacy|6|||
27975551|NCT02275117|81742504|FG001|Overall Study|Lack of Efficacy|7|||
27975552|NCT02275117|81742505|FG002|Overall Study|Lack of Efficacy|5|||
27975553|NCT02275117|81742506|FG003|Overall Study|Lack of Efficacy|2|||
27975554|NCT02275117|81742507|FG004|Overall Study|Lack of Efficacy|10|||
27975555|NCT02275117|81742503|FG000|Overall Study|Lost to Follow-up|11|||
27975556|NCT02275117|81742504|FG001|Overall Study|Lost to Follow-up|16|||
27975557|NCT02275117|81742505|FG002|Overall Study|Lost to Follow-up|15|||
27975558|NCT02275117|81742506|FG003|Overall Study|Lost to Follow-up|16|||
27975559|NCT02275117|81742507|FG004|Overall Study|Lost to Follow-up|8|||
27975560|NCT02275117|81742503|FG000|Overall Study|Physician Decision|0|||
27975561|NCT02275117|81742504|FG001|Overall Study|Physician Decision|1|||
27975562|NCT02275117|81742505|FG002|Overall Study|Physician Decision|1|||
27975563|NCT02275117|81742506|FG003|Overall Study|Physician Decision|0|||
27975564|NCT02275117|81742507|FG004|Overall Study|Physician Decision|1|||
27975565|NCT02275117|81742503|FG000|Overall Study|Protocol Violation|1|||
27975566|NCT02275117|81742504|FG001|Overall Study|Protocol Violation|0|||
27975567|NCT02275117|81742505|FG002|Overall Study|Protocol Violation|1|||
27975568|NCT02275117|81742506|FG003|Overall Study|Protocol Violation|1|||
27975569|NCT02275117|81742507|FG004|Overall Study|Protocol Violation|0|||
27975570|NCT02275117|81742503|FG000|Overall Study|Withdrawal by Subject|6|||
27975571|NCT02275117|81742504|FG001|Overall Study|Withdrawal by Subject|4|||
27975572|NCT02275117|81742505|FG002|Overall Study|Withdrawal by Subject|7|||
27975573|NCT02275117|81742506|FG003|Overall Study|Withdrawal by Subject|3|||
27975574|NCT02275117|81742507|FG004|Overall Study|Withdrawal by Subject|3|||
27975575|NCT02275117|81742503|FG000|Overall Study|Terminated by Sponsor|4|||
27975576|NCT02275117|81742504|FG001|Overall Study|Terminated by Sponsor|4|||
27975577|NCT02275117|81742505|FG002|Overall Study|Terminated by Sponsor|4|||
27975578|NCT02275117|81742506|FG003|Overall Study|Terminated by Sponsor|6|||
27975579|NCT02275117|81742507|FG004|Overall Study|Terminated by Sponsor|4|||
27975580|NCT02275117|81742503|FG000|Overall Study|Worsening of Study Indication|0|||
27975581|NCT02275117|81742504|FG001|Overall Study|Worsening of Study Indication|1|||
27975582|NCT02275117|81742505|FG002|Overall Study|Worsening of Study Indication|2|||
27975583|NCT02275117|81742506|FG003|Overall Study|Worsening of Study Indication|0|||
27975584|NCT02275117|81742507|FG004|Overall Study|Worsening of Study Indication|0|||
27975585|NCT02275117|81742503|FG000|Overall Study|Study Burden|5|||
27975586|NCT02275117|81742504|FG001|Overall Study|Study Burden|4|||
27975587|NCT02275117|81742505|FG002|Overall Study|Study Burden|7|||
27975588|NCT02275117|81742506|FG003|Overall Study|Study Burden|5|||
27975589|NCT02275117|81742507|FG004|Overall Study|Study Burden|7|||
27975590|NCT02275117|81742503|FG000|Overall Study|Other|1|||
27975591|NCT02275117|81742504|FG001|Overall Study|Other|0|||
27975592|NCT02275117|81742505|FG002|Overall Study|Other|0|||
27975593|NCT02275117|81742506|FG003|Overall Study|Other|0|||
27975594|NCT02275117|81742507|FG004|Overall Study|Other|2|||
27975595|NCT00293709|81742508|FG000|Overall Study|Other|47|||
27975596|NCT02908685|81742511|FG000|Part 1 OLE|Withdrawal by Subject|0|||
27975597|NCT02908685|81742512|FG001|Part 1 OLE|Withdrawal by Subject|0|||
27975598|NCT02908685|81742513|FG002|Part 1 OLE|Withdrawal by Subject|0|||
27975599|NCT02908685|81742514|FG003|Part 1 OLE|Withdrawal by Subject|0|||
27975600|NCT02908685|81742515|FG004|Part 1 OLE|Withdrawal by Subject|0|||
27975601|NCT02908685|81742516|FG005|Part 1 OLE|Withdrawal by Subject|0|||
27975602|NCT02908685|81742517|FG006|Part 1 OLE|Withdrawal by Subject|0|||
27975603|NCT02908685|81742518|FG007|Part 1 OLE|Withdrawal by Subject|0|||
27975604|NCT02908685|81742519|FG008|Part 1 OLE|Withdrawal by Subject|0|||
27975605|NCT02908685|81742520|FG009|Part 1 OLE|Withdrawal by Subject|0|||
27975606|NCT02908685|81742521|FG010|Part 1 OLE|Withdrawal by Subject|2|||
27975607|NCT02908685|81742522|FG011|Part 1 OLE|Withdrawal by Subject|1|||
27975608|NCT02908685|81742523|FG012|Part 1 OLE|Withdrawal by Subject|0|||
27975609|NCT02908685|81742524|FG013|Part 1 OLE|Withdrawal by Subject|0|||
27975610|NCT02908685|81742511|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975611|NCT02908685|81742512|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975612|NCT02908685|81742513|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975613|NCT02908685|81742514|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975614|NCT02908685|81742515|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975615|NCT02908685|81742516|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975616|NCT02908685|81742517|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975617|NCT02908685|81742518|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975618|NCT02908685|81742519|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975619|NCT02908685|81742520|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975620|NCT02908685|81742521|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975621|NCT02908685|81742522|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
27975622|NCT02908685|81742523|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
27975623|NCT02908685|81742524|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
27975624|NCT02908685|81742511|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975625|NCT02908685|81742512|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975626|NCT02908685|81742513|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27788305|NCT01215968|81055957|FG000|Overall Study|Not received study drug|0|||
27788306|NCT01215968|81055958|FG001|Overall Study|Not received study drug|1|||
27788307|NCT00471237|81055959|FG000|Overall Study|Adverse Event|6|||
27788308|NCT00471237|81055960|FG001|Overall Study|Adverse Event|5|||
27788309|NCT00471237|81055961|FG002|Overall Study|Adverse Event|4|||
27788310|NCT00471237|81055962|FG003|Overall Study|Adverse Event|8|||
27788311|NCT00471237|81055963|FG004|Overall Study|Adverse Event|7|||
27788312|NCT00471237|81055964|FG005|Overall Study|Adverse Event|5|||
27788313|NCT00471237|81055965|FG006|Overall Study|Adverse Event|0|||
27788314|NCT00471237|81055959|FG000|Overall Study|Lost to Follow-up|1|||
27788315|NCT00471237|81055960|FG001|Overall Study|Lost to Follow-up|1|||
27788316|NCT00471237|81055961|FG002|Overall Study|Lost to Follow-up|0|||
27788317|NCT00471237|81055962|FG003|Overall Study|Lost to Follow-up|2|||
27788318|NCT00471237|81055963|FG004|Overall Study|Lost to Follow-up|3|||
27788319|NCT00471237|81055964|FG005|Overall Study|Lost to Follow-up|0|||
27788320|NCT00471237|81055965|FG006|Overall Study|Lost to Follow-up|0|||
27788321|NCT00471237|81055959|FG000|Overall Study|Protocol Violation|3|||
27788322|NCT00471237|81055960|FG001|Overall Study|Protocol Violation|6|||
27788323|NCT00471237|81055961|FG002|Overall Study|Protocol Violation|3|||
27788324|NCT00471237|81055962|FG003|Overall Study|Protocol Violation|2|||
27788325|NCT00471237|81055963|FG004|Overall Study|Protocol Violation|2|||
27788326|NCT00471237|81055964|FG005|Overall Study|Protocol Violation|4|||
27788327|NCT00471237|81055965|FG006|Overall Study|Protocol Violation|1|||
27788328|NCT00471237|81055959|FG000|Overall Study|Withdrawal by Subject|8|||
27788329|NCT00471237|81055960|FG001|Overall Study|Withdrawal by Subject|6|||
27788330|NCT00471237|81055961|FG002|Overall Study|Withdrawal by Subject|5|||
27867317|NCT02856802|81349548|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
27867318|NCT02856802|81349547|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
27867319|NCT02856802|81349548|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
27867320|NCT02856802|81349547|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
27867321|NCT02856802|81349548|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
27867322|NCT00261950|81349551|FG000|Overall Study|Lost to Follow-up|2|||
27867323|NCT00261950|81349551|FG000|Overall Study|Death|6|||
27867324|NCT00261950|81349551|FG000|Overall Study|Withdrawal by Subject|5|||
27867325|NCT00261950|81349551|FG000|Overall Study|Other|1|||
27867326|NCT00261950|81349551|FG000|Overall Study|Physician Decision|1|||
27867327|NCT00261950|81349551|FG000|Overall Study|Protocol specified Criteria|11|||
27867328|NCT01346293|81349554|FG000|Overall Study|Protocol Violation|30|||
27867329|NCT01346293|81349555|FG001|Overall Study|Protocol Violation|9|||
27867330|NCT01346293|81349554|FG000|Overall Study|Lost to Follow-up|21|||
27867331|NCT01346293|81349555|FG001|Overall Study|Lost to Follow-up|8|||
27867332|NCT01346293|81349554|FG000|Overall Study|Withdrawal by Subject|15|||
27867333|NCT01346293|81349555|FG001|Overall Study|Withdrawal by Subject|4|||
27867334|NCT01346293|81349554|FG000|Overall Study|Other|1|||
27867335|NCT01346293|81349555|FG001|Overall Study|Other|0|||
27867336|NCT00996489|81349556|FG000|Overall Study|Device failure|45|||
27867337|NCT00996489|81349556|FG000|Overall Study|Discontinued|116|||
27788331|NCT00471237|81055962|FG003|Overall Study|Withdrawal by Subject|8|||
27867338|NCT00739063|81349557|FG000|Overall Study|Screen failures|8|||
27867339|NCT02586155|81349558|FG000|Overall Study|Adverse Event|2|||
27788332|NCT00471237|81055963|FG004|Overall Study|Withdrawal by Subject|7|||
27788333|NCT00471237|81055964|FG005|Overall Study|Withdrawal by Subject|4|||
27788334|NCT00471237|81055965|FG006|Overall Study|Withdrawal by Subject|2|||
27788335|NCT00471237|81055959|FG000|Overall Study|Sponsor terminated study|20|||
27788336|NCT00471237|81055960|FG001|Overall Study|Sponsor terminated study|23|||
27788337|NCT00471237|81055961|FG002|Overall Study|Sponsor terminated study|19|||
27975627|NCT02908685|81742514|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975628|NCT02908685|81742515|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975629|NCT02908685|81742516|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27573396|NCT01257204|80285634|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
27573397|NCT01257204|80285635|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
27573398|NCT01257204|80285636|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
27975630|NCT02908685|81742517|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975631|NCT02908685|81742518|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27573399|NCT01257204|80285634|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27573400|NCT01257204|80285635|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
27573401|NCT01257204|80285636|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27573402|NCT01257204|80285634|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
27573403|NCT01257204|80285635|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
27573404|NCT01257204|80285636|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
27573405|NCT01257204|80285634|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
27573406|NCT01257204|80285635|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
27573407|NCT01257204|80285636|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
27573408|NCT01257204|80285634|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
27573409|NCT01257204|80285635|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
27573410|NCT01257204|80285636|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
27573411|NCT01257204|80285634|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
27573412|NCT01257204|80285635|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
27573413|NCT01257204|80285636|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
27573414|NCT01257204|80285634|FG000|Follow-up Period (up to Week 48)|Other|0|||
27573415|NCT01257204|80285635|FG001|Follow-up Period (up to Week 48)|Other|0|||
27573416|NCT01257204|80285636|FG002|Follow-up Period (up to Week 48)|Other|5|||
27573417|NCT00515827|80285642|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
27573418|NCT00515827|80285643|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
27573419|NCT00515827|80285642|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
27788338|NCT00471237|81055962|FG003|Overall Study|Sponsor terminated study|22|||
27788339|NCT00471237|81055963|FG004|Overall Study|Sponsor terminated study|18|||
27788340|NCT00471237|81055964|FG005|Overall Study|Sponsor terminated study|24|||
27788341|NCT00471237|81055965|FG006|Overall Study|Sponsor terminated study|0|||
27788342|NCT00471237|81055959|FG000|Overall Study|Non-compliance|0|||
27788343|NCT00471237|81055960|FG001|Overall Study|Non-compliance|1|||
27788344|NCT00471237|81055961|FG002|Overall Study|Non-compliance|0|||
27788345|NCT00471237|81055962|FG003|Overall Study|Non-compliance|1|||
27788346|NCT00471237|81055963|FG004|Overall Study|Non-compliance|0|||
27788347|NCT00471237|81055964|FG005|Overall Study|Non-compliance|0|||
27867340|NCT02586155|81349559|FG001|Overall Study|Adverse Event|3|||
27867341|NCT02586155|81349558|FG000|Overall Study|Withdrawal by Subject|31|||
27867342|NCT02586155|81349559|FG001|Overall Study|Withdrawal by Subject|24|||
27867343|NCT02586155|81349558|FG000|Overall Study|Lost to Follow-up|7|||
27867344|NCT02586155|81349559|FG001|Overall Study|Lost to Follow-up|13|||
27867345|NCT02586155|81349558|FG000|Overall Study|Death|61|||
27867346|NCT02586155|81349559|FG001|Overall Study|Death|72|||
27867347|NCT02586155|81349558|FG000|Overall Study|Other reasons|26|||
27975632|NCT02908685|81742519|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27788348|NCT00471237|81055965|FG006|Overall Study|Non-compliance|0|||
27788349|NCT00471237|81055959|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
27788350|NCT00471237|81055960|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
27867348|NCT02586155|81349559|FG001|Overall Study|Other reasons|15|||
27867349|NCT02452476|81349560|FG000|Overall Study|Death|4|||
27867350|NCT02452476|81349561|FG001|Overall Study|Death|7|||
27867351|NCT02452476|81349560|FG000|Overall Study|Lost to Follow-up|1|||
27867352|NCT02452476|81349561|FG001|Overall Study|Lost to Follow-up|1|||
27573420|NCT00515827|80285643|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
27573421|NCT00403273|80285647|FG000|Overall Study|Lost to Follow-up|3|||
27573422|NCT00403273|80285648|FG001|Overall Study|Lost to Follow-up|2|||
27573423|NCT00403273|80285647|FG000|Overall Study|Physician Decision|0|||
27573424|NCT00403273|80285648|FG001|Overall Study|Physician Decision|1|||
27573425|NCT00403273|80285647|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
27573426|NCT00403273|80285648|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
27867353|NCT02452476|81349560|FG000|Overall Study|Physician Decision|1|||
27573427|NCT01387607|80285649|FG000|Overall Study|Adverse Event|23|||
27573428|NCT01387607|80285650|FG001|Overall Study|Adverse Event|11|||
27573429|NCT01387607|80285649|FG000|Overall Study|Lack of Efficacy|8|||
27573430|NCT01387607|80285650|FG001|Overall Study|Lack of Efficacy|6|||
27573431|NCT01387607|80285649|FG000|Overall Study|Lost to Follow-up|2|||
27573432|NCT01387607|80285650|FG001|Overall Study|Lost to Follow-up|1|||
27573433|NCT01387607|80285649|FG000|Overall Study|No longer meets eligibility criteria|0|||
27573434|NCT01387607|80285650|FG001|Overall Study|No longer meets eligibility criteria|1|||
27573435|NCT01387607|80285649|FG000|Overall Study|Protocol Violation|1|||
27573436|NCT01387607|80285650|FG001|Overall Study|Protocol Violation|5|||
27573437|NCT01387607|80285649|FG000|Overall Study|Withdrawal by Subject|13|||
27573438|NCT01387607|80285650|FG001|Overall Study|Withdrawal by Subject|14|||
27573439|NCT01387607|80285649|FG000|Overall Study|Other|1|||
27573440|NCT01387607|80285650|FG001|Overall Study|Other|1|||
27573441|NCT01387607|80285649|FG000|Overall Study|Randomized, not treated|3|||
27573442|NCT01387607|80285650|FG001|Overall Study|Randomized, not treated|6|||
27573443|NCT00259857|80285668|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
27573444|NCT00259857|80285669|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
27573445|NCT00259857|80285668|FG000|24 Months Treatment|Lost to Follow-up|0|||
27573446|NCT00259857|80285669|FG001|24 Months Treatment|Lost to Follow-up|3|||
27573447|NCT02318693|80285670|FG000|Overall Study|Protocol Violation|0|||
27573448|NCT02318693|80285671|FG001|Overall Study|Protocol Violation|1|||
27573449|NCT02310672|80285672|FG000|Overall Study|Death|1|||
27573450|NCT02310672|80285672|FG000|Overall Study|Lost to Follow-up|1|||
27573451|NCT02310672|80285672|FG000|Overall Study|Withdrawal by Subject|1|||
27573452|NCT02310672|80285672|FG000|Overall Study|Sponsor's decision|12|||
27573453|NCT00577122|80285673|FG000|Overall Study|Adverse Event|0|||
27573454|NCT00577122|80285674|FG001|Overall Study|Adverse Event|2|||
27573455|NCT00577122|80285673|FG000|Overall Study|Progression, relapse during active trt|6|||
27573456|NCT00577122|80285674|FG001|Overall Study|Progression, relapse during active trt|8|||
27573457|NCT00577122|80285673|FG000|Overall Study|Prog, refract disease during active trt|8|||
27573458|NCT00577122|80285674|FG001|Overall Study|Prog, refract disease during active trt|5|||
27573459|NCT00577122|80285673|FG000|Overall Study|Alternative Therapy|0|||
27573460|NCT00577122|80285674|FG001|Overall Study|Alternative Therapy|1|||
27573461|NCT03256552|80285678|FG000|Overall Study|Protocol Violation|1|||
27573462|NCT03256552|80285678|FG000|Overall Study|Physician Decision|1|||
27573463|NCT03256552|80285678|FG000|Overall Study|Adverse Event|1|||
27573464|NCT03256552|80285678|FG000|Overall Study|Withdrawal by Subject|2|||
27573465|NCT00953329|80285679|FG000|Overall Study|Lack of Efficacy|1|||
27573466|NCT03852316|80285682|FG000|Overall Study|Protocol Violation|1|||
27573467|NCT03852316|80285682|FG000|Overall Study|Withdrawal by Subject|2|||
27573468|NCT03852316|80285682|FG000|Overall Study|Enrolled but Device not Utilized|1|||
27573469|NCT00004412|80285683|FG000|Randomized Period|Moved to Crossover Period|3|||
27573470|NCT00004412|80285684|FG001|Randomized Period|Moved to Crossover Period|0|||
27573471|NCT00004412|80285685|FG002|Randomized Period|Moved to Crossover Period|0|||
27573472|NCT03265119|80285686|FG000|Overall Study|Adverse Event|2|||
27573473|NCT03265119|80285687|FG001|Overall Study|Adverse Event|1|||
27573474|NCT03265119|80285686|FG000|Overall Study|Lack of Efficacy|3|||
27573475|NCT03265119|80285687|FG001|Overall Study|Lack of Efficacy|0|||
27573476|NCT03265119|80285686|FG000|Overall Study|Protocol Violation|1|||
27573477|NCT03265119|80285687|FG001|Overall Study|Protocol Violation|2|||
27573478|NCT03265119|80285686|FG000|Overall Study|Withdrawal by Subject|2|||
27573479|NCT03265119|80285687|FG001|Overall Study|Withdrawal by Subject|4|||
27671972|NCT01296555|80639138|FG018|Overall Study|Protocol Violation|0|||
27573480|NCT03265119|80285686|FG000|Overall Study|Lost to Follow-up|1|||
27573481|NCT03265119|80285687|FG001|Overall Study|Lost to Follow-up|0|||
27573482|NCT03265119|80285686|FG000|Overall Study|Lack of Compliance|1|||
27573483|NCT03265119|80285687|FG001|Overall Study|Lack of Compliance|0|||
27573484|NCT03144180|80285688|FG000|Overall Study|STAT Delivery|1|||
27573485|NCT03144180|80285689|FG001|Overall Study|STAT Delivery|1|||
27573486|NCT03144180|80285688|FG000|Overall Study|Provider forgot to fill out forms|1|||
27573487|NCT03144180|80285689|FG001|Overall Study|Provider forgot to fill out forms|3|||
27573488|NCT03144180|80285688|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
27573489|NCT03144180|80285689|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
27573490|NCT03144180|80285688|FG000|Overall Study|Scrub tech removed tube cap|0|||
27573491|NCT03144180|80285689|FG001|Overall Study|Scrub tech removed tube cap|1|||
27573492|NCT03277846|80285690|FG000|Overall Study|Inpatient stay too brief|12|||
27573493|NCT03277846|80285691|FG001|Overall Study|Inpatient stay too brief|11|||
27573494|NCT04380857|80285692|FG000|Overall Study|Lost to Follow-up|3|||
27573495|NCT04380857|80285693|FG001|Overall Study|Lost to Follow-up|3|||
27573496|NCT01485861|80285698|FG000|Phase Ib|Death|1|||
27573497|NCT01485861|80285699|FG001|Phase Ib|Death|0|||
27573498|NCT01485861|80285700|FG002|Phase Ib|Death|0|||
27573499|NCT01485861|80285701|FG003|Phase Ib|Death|0|||
27573500|NCT01485861|80285702|FG004|Phase Ib|Death|0|||
27573501|NCT01485861|80285703|FG005|Phase Ib|Death|0|||
27573502|NCT01485861|80285698|FG000|Phase Ib|Physician Decision|1|||
27573503|NCT01485861|80285699|FG001|Phase Ib|Physician Decision|1|||
27573504|NCT01485861|80285700|FG002|Phase Ib|Physician Decision|0|||
27573505|NCT01485861|80285701|FG003|Phase Ib|Physician Decision|0|||
27573506|NCT01485861|80285702|FG004|Phase Ib|Physician Decision|0|||
27573507|NCT01485861|80285703|FG005|Phase Ib|Physician Decision|0|||
27573508|NCT01485861|80285698|FG000|Phase Ib|Adverse Event|0|||
27573509|NCT01485861|80285699|FG001|Phase Ib|Adverse Event|4|||
27573510|NCT01485861|80285700|FG002|Phase Ib|Adverse Event|0|||
27573511|NCT01485861|80285701|FG003|Phase Ib|Adverse Event|0|||
27573512|NCT01485861|80285702|FG004|Phase Ib|Adverse Event|0|||
27573513|NCT01485861|80285703|FG005|Phase Ib|Adverse Event|0|||
27573514|NCT01485861|80285698|FG000|Phase Ib|Progression of disease|5|||
27573515|NCT01485861|80285699|FG001|Phase Ib|Progression of disease|0|||
27573516|NCT01485861|80285700|FG002|Phase Ib|Progression of disease|0|||
27573517|NCT01485861|80285701|FG003|Phase Ib|Progression of disease|0|||
27573518|NCT01485861|80285702|FG004|Phase Ib|Progression of disease|0|||
27573519|NCT01485861|80285703|FG005|Phase Ib|Progression of disease|0|||
27573520|NCT01485861|80285698|FG000|Phase Ib|Other|3|||
27573521|NCT01485861|80285699|FG001|Phase Ib|Other|0|||
27573522|NCT01485861|80285700|FG002|Phase Ib|Other|0|||
27573523|NCT01485861|80285701|FG003|Phase Ib|Other|0|||
27573524|NCT01485861|80285702|FG004|Phase Ib|Other|0|||
27573525|NCT01485861|80285703|FG005|Phase Ib|Other|0|||
27573526|NCT01485861|80285698|FG000|Phase Ib|Withdrawal by Subject|4|||
27573527|NCT01485861|80285699|FG001|Phase Ib|Withdrawal by Subject|1|||
27573528|NCT01485861|80285700|FG002|Phase Ib|Withdrawal by Subject|0|||
27573529|NCT01485861|80285701|FG003|Phase Ib|Withdrawal by Subject|0|||
27573530|NCT01485861|80285702|FG004|Phase Ib|Withdrawal by Subject|0|||
27573531|NCT01485861|80285703|FG005|Phase Ib|Withdrawal by Subject|0|||
27573532|NCT01485861|80285698|FG000|Phase II|Death|0|||
27573533|NCT01485861|80285699|FG001|Phase II|Death|0|||
27573534|NCT01485861|80285700|FG002|Phase II|Death|67|||
27573535|NCT01485861|80285701|FG003|Phase II|Death|71|||
27573536|NCT01485861|80285702|FG004|Phase II|Death|68|||
27573537|NCT01485861|80285703|FG005|Phase II|Death|0|||
27573538|NCT01485861|80285698|FG000|Phase II|Progression of Disease|0|||
27573539|NCT01485861|80285699|FG001|Phase II|Progression of Disease|0|||
27573540|NCT01485861|80285700|FG002|Phase II|Progression of Disease|1|||
27573541|NCT01485861|80285701|FG003|Phase II|Progression of Disease|0|||
27573542|NCT01485861|80285702|FG004|Phase II|Progression of Disease|0|||
27573543|NCT01485861|80285703|FG005|Phase II|Progression of Disease|0|||
27573544|NCT01485861|80285698|FG000|Phase II|Other|0|||
27573545|NCT01485861|80285699|FG001|Phase II|Other|0|||
27573546|NCT01485861|80285700|FG002|Phase II|Other|0|||
27573547|NCT01485861|80285701|FG003|Phase II|Other|1|||
27573548|NCT01485861|80285702|FG004|Phase II|Other|0|||
27573549|NCT01485861|80285703|FG005|Phase II|Other|0|||
27573550|NCT01485861|80285698|FG000|Phase II|Withdrawal by Subject|0|||
27573551|NCT01485861|80285699|FG001|Phase II|Withdrawal by Subject|0|||
27573552|NCT01485861|80285700|FG002|Phase II|Withdrawal by Subject|6|||
27573553|NCT01485861|80285701|FG003|Phase II|Withdrawal by Subject|3|||
27573554|NCT01485861|80285702|FG004|Phase II|Withdrawal by Subject|4|||
27573555|NCT01485861|80285703|FG005|Phase II|Withdrawal by Subject|0|||
27573556|NCT01485861|80285698|FG000|Phase II|Lost to Follow-up|0|||
27573557|NCT01485861|80285699|FG001|Phase II|Lost to Follow-up|0|||
27573558|NCT01485861|80285700|FG002|Phase II|Lost to Follow-up|2|||
27573559|NCT01485861|80285701|FG003|Phase II|Lost to Follow-up|3|||
27573560|NCT01485861|80285702|FG004|Phase II|Lost to Follow-up|5|||
27573561|NCT01485861|80285703|FG005|Phase II|Lost to Follow-up|0|||
27573562|NCT01485861|80285698|FG000|Phase II|Study Ended|0|||
27573563|NCT01485861|80285699|FG001|Phase II|Study Ended|0|||
27573564|NCT01485861|80285700|FG002|Phase II|Study Ended|7|||
27573565|NCT01485861|80285701|FG003|Phase II|Study Ended|8|||
27573566|NCT01485861|80285702|FG004|Phase II|Study Ended|6|||
27573567|NCT01485861|80285703|FG005|Phase II|Study Ended|0|||
27573568|NCT01485861|80285698|FG000|Safety Phase|Death|0|||
27573569|NCT01485861|80285699|FG001|Safety Phase|Death|0|||
27573570|NCT01485861|80285700|FG002|Safety Phase|Death|0|||
27573571|NCT01485861|80285701|FG003|Safety Phase|Death|0|||
27573572|NCT01485861|80285702|FG004|Safety Phase|Death|0|||
27573573|NCT01485861|80285703|FG005|Safety Phase|Death|2|||
27788351|NCT00471237|81055961|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
27867354|NCT02452476|81349561|FG001|Overall Study|Physician Decision|1|||
27573574|NCT01485861|80285698|FG000|Safety Phase|Adverse Event|0|||
27573575|NCT01485861|80285699|FG001|Safety Phase|Adverse Event|0|||
27573576|NCT01485861|80285700|FG002|Safety Phase|Adverse Event|0|||
27573577|NCT01485861|80285701|FG003|Safety Phase|Adverse Event|0|||
27573578|NCT01485861|80285702|FG004|Safety Phase|Adverse Event|0|||
27573579|NCT01485861|80285703|FG005|Safety Phase|Adverse Event|1|||
27573580|NCT01485861|80285698|FG000|Safety Phase|Other|0|||
27573581|NCT01485861|80285699|FG001|Safety Phase|Other|0|||
27573582|NCT01485861|80285700|FG002|Safety Phase|Other|0|||
27573583|NCT01485861|80285701|FG003|Safety Phase|Other|0|||
27573584|NCT01485861|80285702|FG004|Safety Phase|Other|0|||
27573585|NCT01485861|80285703|FG005|Safety Phase|Other|5|||
27573586|NCT01485861|80285698|FG000|Safety Phase|Progression of Disease|0|||
27573587|NCT01485861|80285699|FG001|Safety Phase|Progression of Disease|0|||
27573588|NCT01485861|80285700|FG002|Safety Phase|Progression of Disease|0|||
27573589|NCT01485861|80285701|FG003|Safety Phase|Progression of Disease|0|||
27573590|NCT01485861|80285702|FG004|Safety Phase|Progression of Disease|0|||
27573591|NCT01485861|80285703|FG005|Safety Phase|Progression of Disease|9|||
27788352|NCT00471237|81055962|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
27788353|NCT00471237|81055963|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
27788354|NCT00471237|81055964|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
27975633|NCT02908685|81742520|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975634|NCT02908685|81742521|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975635|NCT02908685|81742522|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975636|NCT02908685|81742523|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
27975637|NCT02908685|81742524|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
27975638|NCT02908685|81742511|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975639|NCT02908685|81742512|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27573592|NCT01485861|80285698|FG000|Safety Phase|Withdrawal by Subject|0|||
27573593|NCT01485861|80285699|FG001|Safety Phase|Withdrawal by Subject|0|||
27573594|NCT01485861|80285700|FG002|Safety Phase|Withdrawal by Subject|0|||
27573595|NCT01485861|80285701|FG003|Safety Phase|Withdrawal by Subject|0|||
27573596|NCT01485861|80285702|FG004|Safety Phase|Withdrawal by Subject|0|||
27573597|NCT01485861|80285703|FG005|Safety Phase|Withdrawal by Subject|6|||
27573598|NCT01485861|80285698|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
27573599|NCT01485861|80285699|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
27573600|NCT01485861|80285700|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
27573601|NCT01485861|80285701|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
27573602|NCT01485861|80285702|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
27573603|NCT01485861|80285703|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
27573604|NCT01852292|80285705|FG000|Overall Study|Untreated - did not receive study drug|3|||
27573605|NCT01852292|80285706|FG001|Overall Study|Untreated - did not receive study drug|1|||
27573606|NCT01852292|80285705|FG000|Overall Study|Death|9|||
27573607|NCT01852292|80285706|FG001|Overall Study|Death|8|||
27573608|NCT01852292|80285705|FG000|Overall Study|Patient/guardian decision|8|||
27573609|NCT01852292|80285706|FG001|Overall Study|Patient/guardian decision|4|||
27573610|NCT01852292|80285705|FG000|Overall Study|Adverse Event|8|||
27573611|NCT01852292|80285706|FG001|Overall Study|Adverse Event|11|||
27573612|NCT01852292|80285705|FG000|Overall Study|Physician Decision|6|||
27573613|NCT01852292|80285706|FG001|Overall Study|Physician Decision|2|||
27573614|NCT01852292|80285705|FG000|Overall Study|Protocol Violation|2|||
27573615|NCT01852292|80285706|FG001|Overall Study|Protocol Violation|0|||
27573616|NCT01852292|80285705|FG000|Overall Study|Non-compliance with study treatment|1|||
27573617|NCT01852292|80285706|FG001|Overall Study|Non-compliance with study treatment|0|||
27573618|NCT01852292|80285705|FG000|Overall Study|Study terminated by Sponsor|0|||
27573619|NCT01852292|80285706|FG001|Overall Study|Study terminated by Sponsor|1|||
27573620|NCT01852292|80285705|FG000|Overall Study|Progressive disease|42|||
27573621|NCT01852292|80285706|FG001|Overall Study|Progressive disease|52|||
27573622|NCT01454934|80285710|FG000|Overall Study|Clinical progression|28|||
27573623|NCT01454934|80285711|FG001|Overall Study|Clinical progression|25|||
27573624|NCT01454934|80285710|FG000|Overall Study|Other|6|||
27573625|NCT01454934|80285711|FG001|Overall Study|Other|17|||
27573626|NCT01454934|80285710|FG000|Overall Study|Adverse Event|28|||
27573627|NCT01454934|80285711|FG001|Overall Study|Adverse Event|24|||
27573628|NCT01454934|80285710|FG000|Overall Study|Withdrawn consent|2|||
27573629|NCT01454934|80285711|FG001|Overall Study|Withdrawn consent|5|||
27573630|NCT01454934|80285710|FG000|Overall Study|Withdrawal by Subject|11|||
27573631|NCT01454934|80285711|FG001|Overall Study|Withdrawal by Subject|15|||
27573632|NCT01454934|80285710|FG000|Overall Study|Disease progression|194|||
27573633|NCT01454934|80285711|FG001|Overall Study|Disease progression|181|||
27573634|NCT01454934|80285710|FG000|Overall Study|Lost to Follow-up|0|||
27573635|NCT01454934|80285711|FG001|Overall Study|Lost to Follow-up|1|||
27573636|NCT01454934|80285710|FG000|Overall Study|Not treated|1|||
27671973|NCT01296555|80639139|FG019|Overall Study|Protocol Violation|0|||
27671974|NCT01296555|80639140|FG020|Overall Study|Protocol Violation|0|||
27671975|NCT01296555|80639141|FG021|Overall Study|Protocol Violation|0|||
27671976|NCT01296555|80639142|FG022|Overall Study|Protocol Violation|0|||
27671977|NCT01296555|80639143|FG023|Overall Study|Protocol Violation|0|||
27671978|NCT01296555|80639144|FG024|Overall Study|Protocol Violation|0|||
27671979|NCT01296555|80639145|FG025|Overall Study|Protocol Violation|0|||
27671980|NCT01296555|80639146|FG026|Overall Study|Protocol Violation|0|||
27671981|NCT01296555|80639147|FG027|Overall Study|Protocol Violation|0|||
27671982|NCT01296555|80639148|FG028|Overall Study|Protocol Violation|0|||
27671983|NCT01296555|80639120|FG000|Overall Study|Study Terminated By Sponsor|0|||
27671984|NCT01296555|80639121|FG001|Overall Study|Study Terminated By Sponsor|0|||
27671985|NCT01296555|80639122|FG002|Overall Study|Study Terminated By Sponsor|0|||
27671986|NCT01296555|80639123|FG003|Overall Study|Study Terminated By Sponsor|0|||
27671987|NCT01296555|80639124|FG004|Overall Study|Study Terminated By Sponsor|0|||
27671988|NCT01296555|80639125|FG005|Overall Study|Study Terminated By Sponsor|0|||
27671989|NCT01296555|80639126|FG006|Overall Study|Study Terminated By Sponsor|0|||
27788355|NCT00471237|81055965|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
27788356|NCT00471237|81055959|FG000|Overall Study|Early stopping due to non-efficacy|1|||
27573637|NCT01454934|80285711|FG001|Overall Study|Not treated|2|||
27573638|NCT03192150|80285714|FG000|Overall Study|Adverse Event|14|||
27788357|NCT00471237|81055960|FG001|Overall Study|Early stopping due to non-efficacy|0|||
27867355|NCT02452476|81349560|FG000|Overall Study|Not treated|5|||
27573639|NCT03192150|80285715|FG001|Overall Study|Adverse Event|12|||
27573640|NCT03192150|80285714|FG000|Overall Study|Lack of Efficacy|23|||
27573641|NCT03192150|80285715|FG001|Overall Study|Lack of Efficacy|30|||
27573642|NCT03192150|80285714|FG000|Overall Study|Lost to Follow-up|1|||
27573643|NCT03192150|80285715|FG001|Overall Study|Lost to Follow-up|1|||
27671990|NCT01296555|80639127|FG007|Overall Study|Study Terminated By Sponsor|0|||
27671991|NCT01296555|80639128|FG008|Overall Study|Study Terminated By Sponsor|0|||
27671992|NCT01296555|80639129|FG009|Overall Study|Study Terminated By Sponsor|0|||
27867356|NCT02452476|81349561|FG001|Overall Study|Not treated|1|||
27671993|NCT01296555|80639130|FG010|Overall Study|Study Terminated By Sponsor|0|||
27671994|NCT01296555|80639131|FG011|Overall Study|Study Terminated By Sponsor|0|||
27671995|NCT01296555|80639132|FG012|Overall Study|Study Terminated By Sponsor|0|||
27671996|NCT01296555|80639133|FG013|Overall Study|Study Terminated By Sponsor|0|||
27671997|NCT01296555|80639134|FG014|Overall Study|Study Terminated By Sponsor|0|||
27671998|NCT01296555|80639135|FG015|Overall Study|Study Terminated By Sponsor|0|||
27671999|NCT01296555|80639136|FG016|Overall Study|Study Terminated By Sponsor|0|||
27672000|NCT01296555|80639137|FG017|Overall Study|Study Terminated By Sponsor|0|||
27672001|NCT01296555|80639138|FG018|Overall Study|Study Terminated By Sponsor|0|||
27672002|NCT01296555|80639139|FG019|Overall Study|Study Terminated By Sponsor|0|||
27672003|NCT01296555|80639140|FG020|Overall Study|Study Terminated By Sponsor|0|||
27672004|NCT01296555|80639141|FG021|Overall Study|Study Terminated By Sponsor|0|||
27672005|NCT01296555|80639142|FG022|Overall Study|Study Terminated By Sponsor|0|||
27672006|NCT01296555|80639143|FG023|Overall Study|Study Terminated By Sponsor|0|||
27672007|NCT01296555|80639144|FG024|Overall Study|Study Terminated By Sponsor|0|||
27672008|NCT01296555|80639145|FG025|Overall Study|Study Terminated By Sponsor|1|||
27672009|NCT01296555|80639146|FG026|Overall Study|Study Terminated By Sponsor|0|||
27672010|NCT01296555|80639147|FG027|Overall Study|Study Terminated By Sponsor|0|||
27672011|NCT01296555|80639148|FG028|Overall Study|Study Terminated By Sponsor|0|||
27672012|NCT01296555|80639120|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672013|NCT01296555|80639121|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672014|NCT01296555|80639122|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27788358|NCT00471237|81055961|FG002|Overall Study|Early stopping due to non-efficacy|0|||
27788359|NCT00471237|81055962|FG003|Overall Study|Early stopping due to non-efficacy|0|||
27672015|NCT01296555|80639123|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672016|NCT01296555|80639124|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672017|NCT01296555|80639125|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672018|NCT01296555|80639126|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672019|NCT01296555|80639127|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672020|NCT01296555|80639128|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672021|NCT01296555|80639129|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27788360|NCT00471237|81055963|FG004|Overall Study|Early stopping due to non-efficacy|1|||
27788361|NCT00471237|81055964|FG005|Overall Study|Early stopping due to non-efficacy|0|||
27788362|NCT00471237|81055965|FG006|Overall Study|Early stopping due to non-efficacy|0|||
27788363|NCT00471237|81055959|FG000|Overall Study|Participant planned to travel to abraod|1|||
27788364|NCT00471237|81055960|FG001|Overall Study|Participant planned to travel to abraod|0|||
27788365|NCT00471237|81055961|FG002|Overall Study|Participant planned to travel to abraod|0|||
27788366|NCT00471237|81055962|FG003|Overall Study|Participant planned to travel to abraod|0|||
27788367|NCT00471237|81055963|FG004|Overall Study|Participant planned to travel to abraod|0|||
27788368|NCT00471237|81055964|FG005|Overall Study|Participant planned to travel to abraod|1|||
27788369|NCT00471237|81055965|FG006|Overall Study|Participant planned to travel to abraod|0|||
27788370|NCT00471237|81055959|FG000|Overall Study|High parathyroid hormone|0|||
27975640|NCT02908685|81742513|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975641|NCT02908685|81742514|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975642|NCT02908685|81742515|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975643|NCT02908685|81742516|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975644|NCT02908685|81742517|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975645|NCT02908685|81742518|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975646|NCT02908685|81742519|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975647|NCT02908685|81742520|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975648|NCT02908685|81742521|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27788371|NCT00471237|81055960|FG001|Overall Study|High parathyroid hormone|0|||
27573644|NCT03192150|80285714|FG000|Overall Study|Withdrawal by Subject|4|||
27788372|NCT00471237|81055961|FG002|Overall Study|High parathyroid hormone|1|||
27788373|NCT00471237|81055962|FG003|Overall Study|High parathyroid hormone|0|||
27788374|NCT00471237|81055963|FG004|Overall Study|High parathyroid hormone|0|||
27788375|NCT00471237|81055964|FG005|Overall Study|High parathyroid hormone|0|||
27788376|NCT00471237|81055965|FG006|Overall Study|High parathyroid hormone|0|||
27788377|NCT00471237|81055959|FG000|Overall Study|Participant lost medication|0|||
27788378|NCT00471237|81055960|FG001|Overall Study|Participant lost medication|0|||
27975649|NCT02908685|81742522|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975650|NCT02908685|81742523|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
27975651|NCT02908685|81742524|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
27975652|NCT02908685|81742511|FG000|Part 2 OLE: > Month 24|Death|0|||
27975653|NCT02908685|81742512|FG001|Part 2 OLE: > Month 24|Death|0|||
27975654|NCT02908685|81742513|FG002|Part 2 OLE: > Month 24|Death|0|||
27573645|NCT03192150|80285715|FG001|Overall Study|Withdrawal by Subject|2|||
27672022|NCT01296555|80639130|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672023|NCT01296555|80639131|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672024|NCT01296555|80639132|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672025|NCT01296555|80639133|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672026|NCT01296555|80639134|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27788379|NCT00471237|81055961|FG002|Overall Study|Participant lost medication|0|||
27788380|NCT00471237|81055962|FG003|Overall Study|Participant lost medication|0|||
27788381|NCT00471237|81055963|FG004|Overall Study|Participant lost medication|1|||
27788382|NCT00471237|81055964|FG005|Overall Study|Participant lost medication|0|||
27788383|NCT00471237|81055965|FG006|Overall Study|Participant lost medication|0|||
27788384|NCT00471237|81055959|FG000|Overall Study|Administration of prohibited medicine|0|||
27788385|NCT00471237|81055960|FG001|Overall Study|Administration of prohibited medicine|0|||
27788386|NCT00471237|81055961|FG002|Overall Study|Administration of prohibited medicine|0|||
27788387|NCT00471237|81055962|FG003|Overall Study|Administration of prohibited medicine|0|||
27788388|NCT00471237|81055963|FG004|Overall Study|Administration of prohibited medicine|1|||
27788389|NCT00471237|81055964|FG005|Overall Study|Administration of prohibited medicine|0|||
27788390|NCT00471237|81055965|FG006|Overall Study|Administration of prohibited medicine|0|||
27788391|NCT00471237|81055959|FG000|Overall Study|Participant shifted residence|0|||
27788392|NCT00471237|81055960|FG001|Overall Study|Participant shifted residence|0|||
27788393|NCT00471237|81055961|FG002|Overall Study|Participant shifted residence|0|||
27788394|NCT00471237|81055962|FG003|Overall Study|Participant shifted residence|0|||
27788395|NCT00471237|81055963|FG004|Overall Study|Participant shifted residence|1|||
27788396|NCT00471237|81055964|FG005|Overall Study|Participant shifted residence|0|||
27788397|NCT00471237|81055965|FG006|Overall Study|Participant shifted residence|0|||
27788398|NCT00471237|81055959|FG000|Overall Study|Participant's decision|0|||
27788399|NCT00471237|81055960|FG001|Overall Study|Participant's decision|0|||
27788400|NCT00471237|81055961|FG002|Overall Study|Participant's decision|0|||
27788401|NCT00471237|81055962|FG003|Overall Study|Participant's decision|0|||
27788402|NCT00471237|81055963|FG004|Overall Study|Participant's decision|0|||
27788403|NCT00471237|81055964|FG005|Overall Study|Participant's decision|1|||
27788404|NCT00471237|81055965|FG006|Overall Study|Participant's decision|0|||
27788405|NCT01241591|81055966|FG000|Overall Study|Lack of Efficacy|5|||
27788406|NCT01241591|81055967|FG001|Overall Study|Lack of Efficacy|2|||
27788407|NCT01241591|81055968|FG002|Overall Study|Lack of Efficacy|2|||
27788408|NCT01241591|81055969|FG003|Overall Study|Lack of Efficacy|3|||
27788409|NCT01241591|81055966|FG000|Overall Study|Protocol Violation|5|||
27788410|NCT01241591|81055967|FG001|Overall Study|Protocol Violation|2|||
27975655|NCT02908685|81742514|FG003|Part 2 OLE: > Month 24|Death|0|||
27788411|NCT01241591|81055968|FG002|Overall Study|Protocol Violation|3|||
27788412|NCT01241591|81055969|FG003|Overall Study|Protocol Violation|0|||
27788413|NCT01241591|81055966|FG000|Overall Study|Lost to Follow-up|1|||
27788414|NCT01241591|81055967|FG001|Overall Study|Lost to Follow-up|2|||
27975656|NCT02908685|81742515|FG004|Part 2 OLE: > Month 24|Death|0|||
27975657|NCT02908685|81742516|FG005|Part 2 OLE: > Month 24|Death|0|||
27975658|NCT02908685|81742517|FG006|Part 2 OLE: > Month 24|Death|0|||
27975659|NCT02908685|81742518|FG007|Part 2 OLE: > Month 24|Death|0|||
27975660|NCT02908685|81742519|FG008|Part 2 OLE: > Month 24|Death|0|||
27975661|NCT02908685|81742520|FG009|Part 2 OLE: > Month 24|Death|0|||
27975662|NCT02908685|81742521|FG010|Part 2 OLE: > Month 24|Death|0|||
27975663|NCT02908685|81742522|FG011|Part 2 OLE: > Month 24|Death|0|||
27975664|NCT02908685|81742523|FG012|Part 2 OLE: > Month 24|Death|1|||
27975665|NCT02908685|81742524|FG013|Part 2 OLE: > Month 24|Death|0|||
27975666|NCT02908685|81742511|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
27788415|NCT01241591|81055968|FG002|Overall Study|Lost to Follow-up|2|||
27788416|NCT01241591|81055969|FG003|Overall Study|Lost to Follow-up|2|||
27788417|NCT01241591|81055966|FG000|Overall Study|Screen Failure|3|||
27788418|NCT01241591|81055967|FG001|Overall Study|Screen Failure|2|||
27788419|NCT01241591|81055968|FG002|Overall Study|Screen Failure|1|||
27788420|NCT01241591|81055969|FG003|Overall Study|Screen Failure|0|||
27975667|NCT02908685|81742512|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
27975668|NCT02908685|81742513|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
27975669|NCT02908685|81742514|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
27975670|NCT02908685|81742515|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
27975671|NCT02908685|81742516|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
27975672|NCT02908685|81742517|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
27975673|NCT02908685|81742518|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
27788421|NCT01241591|81055966|FG000|Overall Study|Withdrawal by Subject|6|||
27975674|NCT02908685|81742519|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
27788422|NCT01241591|81055967|FG001|Overall Study|Withdrawal by Subject|4|||
27975675|NCT02908685|81742520|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
27975676|NCT02908685|81742521|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
27975677|NCT02908685|81742522|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
27573646|NCT03192150|80285714|FG000|Overall Study|Protocol Violation|5|||
27788423|NCT01241591|81055968|FG002|Overall Study|Withdrawal by Subject|2|||
27788424|NCT01241591|81055969|FG003|Overall Study|Withdrawal by Subject|2|||
27788425|NCT01241591|81055966|FG000|Overall Study|Other|0|||
27788426|NCT01241591|81055967|FG001|Overall Study|Other|1|||
27788427|NCT01241591|81055968|FG002|Overall Study|Other|0|||
27788428|NCT01241591|81055969|FG003|Overall Study|Other|1|||
27788429|NCT01241591|81055966|FG000|Overall Study|Adverse Event|3|||
27788430|NCT01241591|81055967|FG001|Overall Study|Adverse Event|11|||
27788431|NCT01241591|81055968|FG002|Overall Study|Adverse Event|12|||
27788432|NCT01241591|81055969|FG003|Overall Study|Adverse Event|4|||
27788433|NCT00976989|81055970|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27788434|NCT00976989|81055971|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27788435|NCT00976989|81055972|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
27788436|NCT00976989|81055970|FG000|Overall Study|Death|5|||
27788437|NCT00976989|81055971|FG001|Overall Study|Death|7|||
27788438|NCT00976989|81055972|FG002|Overall Study|Death|10|||
27867357|NCT03624192|81349562|FG000|Overall Study|Lost to Follow-up|1|||
27867358|NCT03624192|81349563|FG001|Overall Study|Lost to Follow-up|1|||
27788439|NCT00976989|81055970|FG000|Overall Study|Refused Treatment|4|||
27788440|NCT00976989|81055971|FG001|Overall Study|Refused Treatment|3|||
27788441|NCT00976989|81055972|FG002|Overall Study|Refused Treatment|5|||
27788442|NCT00976989|81055970|FG000|Overall Study|Failure to Return|2|||
27788443|NCT00976989|81055971|FG001|Overall Study|Failure to Return|1|||
27788444|NCT00976989|81055972|FG002|Overall Study|Failure to Return|0|||
27788445|NCT00976989|81055970|FG000|Overall Study|Recurrence of Disease|0|||
27788446|NCT00976989|81055971|FG001|Overall Study|Recurrence of Disease|1|||
27788447|NCT00976989|81055972|FG002|Overall Study|Recurrence of Disease|0|||
27788448|NCT00976989|81055970|FG000|Overall Study|Other|1|||
27788449|NCT00976989|81055971|FG001|Overall Study|Other|0|||
27788450|NCT00976989|81055972|FG002|Overall Study|Other|1|||
27788451|NCT02600559|81055973|FG000|Overall Study|Withdrawal by Subject|3|||
27788452|NCT02600559|81055973|FG000|Overall Study|Lost to Follow-up|20|||
27788453|NCT02431559|81055980|FG000|Overall Study|Adverse Event|0|||
27788454|NCT02431559|81055981|FG001|Overall Study|Adverse Event|1|||
27788455|NCT02431559|81055982|FG002|Overall Study|Adverse Event|0|||
27788456|NCT02431559|81055983|FG003|Overall Study|Adverse Event|4|||
27788457|NCT02431559|81055980|FG000|Overall Study|Progressive disease|2|||
27788458|NCT02431559|81055981|FG001|Overall Study|Progressive disease|1|||
27867359|NCT01144715|81349564|FG000|Overall Study|Lost to Follow-up|2|||
27867360|NCT01144715|81349565|FG001|Overall Study|Lost to Follow-up|1|||
27867361|NCT01144715|81349564|FG000|Overall Study|Withdrawal by Subject|2|||
27867362|NCT01144715|81349565|FG001|Overall Study|Withdrawal by Subject|1|||
27867363|NCT01144715|81349564|FG000|Overall Study|Adverse Event|0|||
27867364|NCT01144715|81349565|FG001|Overall Study|Adverse Event|1|||
27867365|NCT00005957|81349566|FG000|Overall Study|No treated|3|||
27867366|NCT00005957|81349567|FG001|Overall Study|No treated|9|||
27867367|NCT00005957|81349566|FG000|Overall Study|Crossover to the other arm|5|||
27867368|NCT00005957|81349567|FG001|Overall Study|Crossover to the other arm|19|||
27867369|NCT02899195|81349568|FG000|Concurrent Durvalumab|Adverse Event|4|||
27867370|NCT02899195|81349568|FG000|Concurrent Durvalumab|Physician Decision|1|||
27867371|NCT02899195|81349568|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
27867372|NCT02899195|81349568|FG000|Concurrent Durvalumab|Progressive Disease|5|||
27867373|NCT02899195|81349568|FG000|Maintenance Durvalumab|Adverse Event|1|||
27788459|NCT02431559|81055982|FG002|Overall Study|Progressive disease|4|||
27788460|NCT02431559|81055983|FG003|Overall Study|Progressive disease|22|||
27788461|NCT02431559|81055980|FG000|Overall Study|Withdrawal by Subject|0|||
27788462|NCT02431559|81055981|FG001|Overall Study|Withdrawal by Subject|1|||
27788463|NCT02431559|81055982|FG002|Overall Study|Withdrawal by Subject|0|||
27867374|NCT02899195|81349568|FG000|Maintenance Durvalumab|Physician Decision|1|||
27867375|NCT02899195|81349568|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
27867376|NCT02899195|81349568|FG000|Maintenance Durvalumab|Progressive Disease|31|||
27867377|NCT00134901|81349569|FG000|Overall Study|Lost to Follow-up|5|||
27867378|NCT00134901|81349570|FG001|Overall Study|Lost to Follow-up|5|||
27867379|NCT00134901|81349569|FG000|Overall Study|discontinued intervention|12|||
27788464|NCT02431559|81055983|FG003|Overall Study|Withdrawal by Subject|4|||
27788465|NCT02431559|81055980|FG000|Overall Study|Physician Decision|0|||
27788466|NCT02431559|81055981|FG001|Overall Study|Physician Decision|0|||
27867380|NCT00134901|81349570|FG001|Overall Study|discontinued intervention|10|||
27867381|NCT04778904|81349572|FG000|Overall Study|Protocol Violation|1|||
27867382|NCT04778904|81349573|FG001|Overall Study|Protocol Violation|0|||
27788467|NCT02431559|81055982|FG002|Overall Study|Physician Decision|0|||
27788468|NCT02431559|81055983|FG003|Overall Study|Physician Decision|1|||
27788469|NCT00690573|81055988|FG000|Overall Study|Lack of Efficacy|8|||
27788470|NCT00690573|81055988|FG000|Overall Study|Withdrawal by Subject|1|||
27788471|NCT03710824|81055992|FG000|Overall Study|Withdrawal by Subject|1|||
27788472|NCT03710824|81055992|FG000|Overall Study|Lost to Follow-up|3|||
27788473|NCT03710824|81055992|FG000|Overall Study|Adverse Event|25|||
27788474|NCT03710824|81055992|FG000|Overall Study|Treatment discontinuation|2|||
27788475|NCT02539160|81055993|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
27788476|NCT02539160|81055994|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
27788477|NCT02539160|81055995|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
27788478|NCT02539160|81055996|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
27788479|NCT02539160|81055993|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
27788480|NCT02539160|81055994|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
27788481|NCT02539160|81055995|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
27788482|NCT02539160|81055996|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
27788483|NCT02539160|81055993|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
27788484|NCT02539160|81055994|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
27788485|NCT02539160|81055995|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
27788486|NCT02539160|81055996|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
27788487|NCT02441517|81055997|FG000|Overall Study|Lost to Follow-up|1|||
27788488|NCT02441517|81055997|FG000|Overall Study|Withdrawal by Subject|2|||
27788489|NCT02441517|81055997|FG000|Overall Study|Study Terminated by Sponsor|1|||
27788490|NCT02058849|81055998|FG000|Overall Study|Hospitalization|1|||
27788491|NCT02058849|81055999|FG001|Overall Study|Hospitalization|1|||
27788492|NCT02058849|81055998|FG000|Overall Study|Death|1|||
27788493|NCT02058849|81055999|FG001|Overall Study|Death|0|||
27788494|NCT02058849|81055998|FG000|Overall Study|Lost to Follow-up|1|||
27788495|NCT02058849|81055999|FG001|Overall Study|Lost to Follow-up|0|||
27788496|NCT02058849|81055998|FG000|Overall Study|Withdrawal by Subject|4|||
27788497|NCT02058849|81055999|FG001|Overall Study|Withdrawal by Subject|0|||
27788498|NCT03556202|81056000|FG000|Extension Treatment Period|Adverse Event|18|||
27788499|NCT03556202|81056001|FG001|Extension Treatment Period|Adverse Event|14|||
27788500|NCT03556202|81056002|FG002|Extension Treatment Period|Adverse Event|9|||
27788501|NCT03556202|81056000|FG000|Extension Treatment Period|Death|2|||
27788502|NCT03556202|81056001|FG001|Extension Treatment Period|Death|6|||
27788503|NCT03556202|81056002|FG002|Extension Treatment Period|Death|0|||
27788504|NCT03556202|81056000|FG000|Extension Treatment Period|Lack of Efficacy|5|||
27788505|NCT03556202|81056001|FG001|Extension Treatment Period|Lack of Efficacy|12|||
27788506|NCT03556202|81056002|FG002|Extension Treatment Period|Lack of Efficacy|18|||
27788507|NCT03556202|81056000|FG000|Extension Treatment Period|Lost to Follow-up|9|||
27788508|NCT03556202|81056001|FG001|Extension Treatment Period|Lost to Follow-up|20|||
27788509|NCT03556202|81056002|FG002|Extension Treatment Period|Lost to Follow-up|2|||
27788510|NCT03556202|81056000|FG000|Extension Treatment Period|Pregnancy|2|||
27788511|NCT03556202|81056001|FG001|Extension Treatment Period|Pregnancy|4|||
27788512|NCT03556202|81056002|FG002|Extension Treatment Period|Pregnancy|3|||
27788513|NCT03556202|81056000|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
27788514|NCT03556202|81056001|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
27788515|NCT03556202|81056002|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
27788516|NCT03556202|81056000|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
27788517|NCT03556202|81056001|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
27788518|NCT03556202|81056002|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
27788519|NCT03556202|81056000|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
27788520|NCT03556202|81056001|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
27788521|NCT03556202|81056002|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
27788522|NCT03556202|81056000|FG000|Extension Treatment Period|Physician Decision|0|||
27788523|NCT03556202|81056001|FG001|Extension Treatment Period|Physician Decision|8|||
27788524|NCT03556202|81056002|FG002|Extension Treatment Period|Physician Decision|2|||
27788525|NCT03556202|81056000|FG000|Extension Treatment Period|Protocol Violation|0|||
27788526|NCT03556202|81056001|FG001|Extension Treatment Period|Protocol Violation|1|||
27672027|NCT01296555|80639135|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672028|NCT01296555|80639136|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672029|NCT01296555|80639137|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27788527|NCT03556202|81056002|FG002|Extension Treatment Period|Protocol Violation|1|||
27788528|NCT03556202|81056000|FG000|Extension Treatment Period|Sponsor Decision|0|||
27788529|NCT03556202|81056001|FG001|Extension Treatment Period|Sponsor Decision|1|||
27788530|NCT03556202|81056002|FG002|Extension Treatment Period|Sponsor Decision|0|||
27788531|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
27867383|NCT04778904|81349574|FG002|Overall Study|Protocol Violation|0|||
27788532|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
27788533|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
27788534|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Death|1|||
27788535|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Death|0|||
27788536|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Death|0|||
27788537|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
27788538|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
27788539|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
27788540|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
27788541|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
27788542|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
27788543|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
27788544|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
27788545|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
27788546|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
27788547|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
27788548|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
27788549|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
27788550|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
27788551|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
27788552|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
27788553|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
27788554|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
27788555|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
27788556|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
27788557|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
27788558|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
27788559|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
27788560|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
27788561|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
27788562|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
27788563|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
27788564|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
27788565|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
27788566|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
27788567|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
27788568|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
27788569|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
27788570|NCT03556202|81056000|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
27788571|NCT03556202|81056001|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
27788572|NCT03556202|81056002|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
27788573|NCT00934661|81056003|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
27788574|NCT00934661|81056004|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
27788575|NCT01411917|81056005|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
27788576|NCT01411917|81056006|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
27788577|NCT00706901|81056014|FG000|Overall Study|Lost to Follow-up|2|||
27788578|NCT00706901|81056015|FG001|Overall Study|Lost to Follow-up|3|||
27788579|NCT00706901|81056016|FG002|Overall Study|Lost to Follow-up|2|||
27788580|NCT00706901|81056014|FG000|Overall Study|Withdrawal by Subject|4|||
27788581|NCT00706901|81056015|FG001|Overall Study|Withdrawal by Subject|2|||
27788582|NCT00706901|81056016|FG002|Overall Study|Withdrawal by Subject|5|||
27788583|NCT00706901|81056014|FG000|Overall Study|In Jail|1|||
27788584|NCT00706901|81056015|FG001|Overall Study|In Jail|0|||
27788585|NCT00706901|81056016|FG002|Overall Study|In Jail|1|||
27788586|NCT00706901|81056014|FG000|Overall Study|Death|1|||
27788587|NCT00706901|81056015|FG001|Overall Study|Death|0|||
27788588|NCT00706901|81056016|FG002|Overall Study|Death|0|||
27788589|NCT00887822|81056017|FG000|Overall Study|Insufficient therapeutic response|53|||
27788590|NCT00887822|81056018|FG001|Overall Study|Insufficient therapeutic response|55|||
27788591|NCT00887822|81056017|FG000|Overall Study|Adverse Event|14|||
27788592|NCT00887822|81056018|FG001|Overall Study|Adverse Event|17|||
27788593|NCT00887822|81056017|FG000|Overall Study|Failure to return|11|||
27788594|NCT00887822|81056018|FG001|Overall Study|Failure to return|11|||
27788595|NCT00887822|81056017|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
27788596|NCT00887822|81056018|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
27788597|NCT00887822|81056017|FG000|Overall Study|Administrative/Other than specified|5|||
27788598|NCT00887822|81056018|FG001|Overall Study|Administrative/Other than specified|4|||
27788599|NCT00887822|81056017|FG000|Overall Study|Death|2|||
27788600|NCT00887822|81056018|FG001|Overall Study|Death|3|||
27788601|NCT00887822|81056017|FG000|Overall Study|Protocol Violation|0|||
27788602|NCT00887822|81056018|FG001|Overall Study|Protocol Violation|1|||
27788603|NCT00887822|81056017|FG000|Overall Study|Randomized but not treated|0|||
27788604|NCT00887822|81056018|FG001|Overall Study|Randomized but not treated|1|||
27788605|NCT01884675|81056019|FG000|Overall Study|Study closed/terminated|3|||
27788606|NCT01884675|81056020|FG001|Overall Study|Study closed/terminated|2|||
27788607|NCT01021423|81056027|FG000|Overall Study|Study terminated|4|||
27788608|NCT01021423|81056028|FG001|Overall Study|Study terminated|5|||
27788609|NCT01425268|81056029|FG000|Overall Study|Withdrawal by Subject|2|||
27867384|NCT04778904|81349575|FG003|Overall Study|Protocol Violation|0|||
27867385|NCT04778904|81349572|FG000|Overall Study|Withdrawal by Subject|0|||
27867386|NCT04778904|81349573|FG001|Overall Study|Withdrawal by Subject|0|||
27975678|NCT02908685|81742523|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
27975679|NCT02908685|81742524|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
27975680|NCT02908685|81742511|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975681|NCT02908685|81742512|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975682|NCT02908685|81742513|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975683|NCT02908685|81742514|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975684|NCT02908685|81742515|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975685|NCT02908685|81742516|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975686|NCT02908685|81742517|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975687|NCT02908685|81742518|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975688|NCT02908685|81742519|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975689|NCT02908685|81742520|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975690|NCT02908685|81742521|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975691|NCT02908685|81742522|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
27975692|NCT02908685|81742523|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
27975693|NCT02908685|81742524|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
27975694|NCT00694096|81742537|FG000|Overall Study|Withdrawal by Subject|5|||
27975695|NCT05028517|81742538|FG000|Overall Study|Lost to Follow-up|13|||
27975696|NCT05028517|81742539|FG001|Overall Study|Lost to Follow-up|20|||
27975697|NCT05028517|81742540|FG002|Overall Study|Lost to Follow-up|12|||
27975698|NCT05028517|81742538|FG000|Overall Study|Withdrawal by Subject|0|||
27975699|NCT05028517|81742539|FG001|Overall Study|Withdrawal by Subject|0|||
27975700|NCT05028517|81742540|FG002|Overall Study|Withdrawal by Subject|1|||
27975701|NCT05427539|81742549|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
27975702|NCT05427539|81742550|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
27975703|NCT05427539|81742549|FG000|Period 1|Withdrawal by Subject|1|||
27975704|NCT05427539|81742550|FG001|Period 1|Withdrawal by Subject|0|||
27975705|NCT01135914|81742551|FG000|Overall Study|Withdrawal by Subject|1|||
27975706|NCT01135914|81742552|FG001|Overall Study|Withdrawal by Subject|3|||
27975707|NCT01135914|81742553|FG002|Overall Study|Withdrawal by Subject|6|||
27975708|NCT01135914|81742551|FG000|Overall Study|Lost to Follow-up|1|||
27975709|NCT01135914|81742552|FG001|Overall Study|Lost to Follow-up|0|||
27975710|NCT01135914|81742553|FG002|Overall Study|Lost to Follow-up|1|||
27975711|NCT01135914|81742551|FG000|Overall Study|Protocol Violation|0|||
27975712|NCT01135914|81742552|FG001|Overall Study|Protocol Violation|0|||
27975713|NCT01135914|81742553|FG002|Overall Study|Protocol Violation|3|||
27975714|NCT01135914|81742551|FG000|Overall Study|Lack of Efficacy|2|||
27975715|NCT01135914|81742552|FG001|Overall Study|Lack of Efficacy|1|||
27975716|NCT01135914|81742553|FG002|Overall Study|Lack of Efficacy|10|||
27975717|NCT01135914|81742551|FG000|Overall Study|Adverse Event|0|||
27975718|NCT01135914|81742552|FG001|Overall Study|Adverse Event|1|||
27573647|NCT03192150|80285715|FG001|Overall Study|Protocol Violation|2|||
27573648|NCT03192150|80285714|FG000|Overall Study|Surgery Canceled|6|||
27573649|NCT03192150|80285715|FG001|Overall Study|Surgery Canceled|2|||
27573650|NCT03192150|80285714|FG000|Overall Study|Other-Various Administrative Reasons|2|||
27672030|NCT01296555|80639138|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27975719|NCT01135914|81742553|FG002|Overall Study|Adverse Event|2|||
27975720|NCT00367744|81742554|FG000|Overall Study|Lost to Follow-up|4|||
27975721|NCT00367744|81742555|FG001|Overall Study|Lost to Follow-up|5|||
27788610|NCT01425268|81056030|FG001|Overall Study|Withdrawal by Subject|0|||
27788611|NCT01425268|81056029|FG000|Overall Study|Sponsor Decision|5|||
27788612|NCT01425268|81056030|FG001|Overall Study|Sponsor Decision|0|||
27788613|NCT01425268|81056029|FG000|Overall Study|Physician Decision|1|||
27867387|NCT04778904|81349574|FG002|Overall Study|Withdrawal by Subject|1|||
27975722|NCT03733028|81742556|FG000|Overall Study|Study was stopped by PI|1|||
27975723|NCT03733028|81742557|FG001|Overall Study|Study was stopped by PI|2|||
27975724|NCT02434354|81742558|FG000|Overall Study|screen fail|3|||
27975725|NCT04493684|81742559|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
27975726|NCT04493684|81742560|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975727|NCT04493684|81742561|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
27975728|NCT04493684|81742562|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975729|NCT04493684|81742563|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975730|NCT04493684|81742564|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
27975731|NCT04493684|81742565|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975732|NCT04493684|81742566|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975733|NCT04493684|81742567|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975734|NCT04493684|81742568|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975735|NCT04493684|81742569|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975736|NCT04493684|81742570|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975737|NCT04493684|81742571|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975738|NCT04493684|81742572|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975739|NCT04493684|81742573|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975740|NCT04493684|81742574|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975741|NCT04493684|81742575|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
27975742|NCT04493684|81742559|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
27975743|NCT04493684|81742560|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975744|NCT04493684|81742561|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975745|NCT04493684|81742562|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975746|NCT04493684|81742563|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975747|NCT04493684|81742564|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975748|NCT04493684|81742565|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975749|NCT04493684|81742566|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975750|NCT04493684|81742567|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975751|NCT04493684|81742568|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975752|NCT04493684|81742569|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975753|NCT04493684|81742570|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975754|NCT04493684|81742571|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975755|NCT04493684|81742572|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975756|NCT04493684|81742573|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975757|NCT04493684|81742574|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975758|NCT04493684|81742575|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
27975759|NCT04493684|81742559|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975760|NCT04493684|81742560|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975761|NCT04493684|81742561|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975762|NCT04493684|81742562|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975763|NCT04493684|81742563|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975764|NCT04493684|81742564|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975765|NCT04493684|81742565|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
27975766|NCT04493684|81742566|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975767|NCT04493684|81742567|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975768|NCT04493684|81742568|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975769|NCT04493684|81742569|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975770|NCT04493684|81742570|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975771|NCT04493684|81742571|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975772|NCT04493684|81742572|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975773|NCT04493684|81742573|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975774|NCT04493684|81742574|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975775|NCT04493684|81742575|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
27975776|NCT04493684|81742559|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
27975777|NCT04493684|81742560|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975778|NCT04493684|81742561|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975779|NCT04493684|81742562|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27788614|NCT01425268|81056030|FG001|Overall Study|Physician Decision|0|||
27975780|NCT04493684|81742563|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975781|NCT04493684|81742564|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975782|NCT04493684|81742565|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975783|NCT04493684|81742566|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975784|NCT04493684|81742567|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975785|NCT04493684|81742568|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975786|NCT04493684|81742569|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975787|NCT04493684|81742570|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975788|NCT04493684|81742571|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975789|NCT04493684|81742572|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975790|NCT04493684|81742573|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975791|NCT04493684|81742574|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975792|NCT04493684|81742575|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
27975793|NCT04493684|81742559|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975794|NCT04493684|81742560|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975795|NCT04493684|81742561|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975796|NCT04493684|81742562|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975797|NCT04493684|81742563|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975798|NCT04493684|81742564|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
27975799|NCT04493684|81742565|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975800|NCT04493684|81742566|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975801|NCT04493684|81742567|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975802|NCT04493684|81742568|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975803|NCT04493684|81742569|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975804|NCT04493684|81742570|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975805|NCT04493684|81742571|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975806|NCT04493684|81742572|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975807|NCT04493684|81742573|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975808|NCT04493684|81742574|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975809|NCT04493684|81742575|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
27975810|NCT04493684|81742559|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975811|NCT04493684|81742560|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975812|NCT04493684|81742561|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975813|NCT04493684|81742562|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975814|NCT04493684|81742563|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975815|NCT04493684|81742564|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975816|NCT04493684|81742565|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975817|NCT04493684|81742566|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975818|NCT04493684|81742567|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975819|NCT04493684|81742568|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975820|NCT04493684|81742569|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975821|NCT04493684|81742570|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
27975822|NCT04493684|81742571|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975823|NCT04493684|81742572|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975824|NCT04493684|81742573|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975825|NCT04493684|81742574|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27788615|NCT02713490|81056034|FG000|Overall Study|Withdrawal by Subject|2|||
27788616|NCT02713490|81056035|FG001|Overall Study|Withdrawal by Subject|1|||
27788617|NCT02713490|81056034|FG000|Overall Study|Did not receive study drug|1|||
27788618|NCT02713490|81056035|FG001|Overall Study|Did not receive study drug|0|||
27573651|NCT03192150|80285715|FG001|Overall Study|Other-Various Administrative Reasons|5|||
27573652|NCT00774995|80285716|FG000|Overall Study|Protocol Violation|0|||
27788619|NCT02713490|81056034|FG000|Overall Study|Met exclusion criteria|0|||
27573653|NCT00774995|80285717|FG001|Overall Study|Protocol Violation|0|||
27788620|NCT02713490|81056035|FG001|Overall Study|Met exclusion criteria|1|||
27975826|NCT04493684|81742575|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
27975827|NCT04493684|81742559|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975828|NCT04493684|81742560|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975829|NCT04493684|81742561|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975830|NCT04493684|81742562|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975831|NCT04493684|81742563|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975832|NCT04493684|81742564|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975833|NCT04493684|81742565|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975834|NCT04493684|81742566|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975835|NCT04493684|81742567|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975836|NCT04493684|81742568|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975837|NCT04493684|81742569|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975838|NCT04493684|81742570|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975839|NCT04493684|81742571|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975840|NCT04493684|81742572|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975841|NCT04493684|81742573|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27788621|NCT00752895|81056036|FG000|Overall Study|Withdrawal by Subject|8|||
27788622|NCT00752895|81056037|FG001|Overall Study|Withdrawal by Subject|3|||
27788623|NCT03781167|81056038|FG000|Overall Study|Adverse Event|23|||
27788624|NCT03781167|81056039|FG001|Overall Study|Adverse Event|25|||
27788625|NCT03781167|81056038|FG000|Overall Study|Withdrew consent|16|||
27788626|NCT03781167|81056039|FG001|Overall Study|Withdrew consent|12|||
27788627|NCT03781167|81056038|FG000|Overall Study|Lost to Follow-up|0|||
27867388|NCT04778904|81349575|FG003|Overall Study|Withdrawal by Subject|0|||
27867389|NCT01266031|81349578|FG000|Overall Study|Not treated|0|||
27573654|NCT00774995|80285718|FG002|Overall Study|Protocol Violation|1|||
27573655|NCT00774995|80285719|FG003|Overall Study|Protocol Violation|0|||
27573656|NCT02118428|80285720|FG000|Overall Study|Physician Decision|0|||
27573657|NCT02118428|80285721|FG001|Overall Study|Physician Decision|1|||
27573658|NCT02118428|80285722|FG002|Overall Study|Physician Decision|0|||
27573659|NCT02118428|80285720|FG000|Overall Study|Withdrawal by Subject|2|||
27573660|NCT02118428|80285721|FG001|Overall Study|Withdrawal by Subject|2|||
27573661|NCT02118428|80285722|FG002|Overall Study|Withdrawal by Subject|0|||
27573662|NCT02118428|80285720|FG000|Overall Study|Death|7|||
27573663|NCT02118428|80285721|FG001|Overall Study|Death|5|||
27573664|NCT02118428|80285722|FG002|Overall Study|Death|0|||
27573665|NCT02118428|80285720|FG000|Overall Study|Lost to Follow-up|3|||
27573666|NCT02118428|80285721|FG001|Overall Study|Lost to Follow-up|1|||
27573667|NCT02118428|80285722|FG002|Overall Study|Lost to Follow-up|0|||
27573668|NCT02118428|80285720|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
27573669|NCT02118428|80285721|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
27573670|NCT02118428|80285722|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
27573671|NCT00354172|80285723|FG000|Overall Study|Did not receive transplant|1|||
27573672|NCT02896400|80285724|FG000|1 Month Follow-up|Lost to Follow-up|7|||
27573673|NCT02896400|80285725|FG001|1 Month Follow-up|Lost to Follow-up|7|||
27573674|NCT02896400|80285726|FG002|1 Month Follow-up|Lost to Follow-up|5|||
27573675|NCT02896400|80285727|FG003|1 Month Follow-up|Lost to Follow-up|8|||
27573676|NCT02896400|80285728|FG004|1 Month Follow-up|Lost to Follow-up|9|||
27573677|NCT02896400|80285729|FG005|1 Month Follow-up|Lost to Follow-up|6|||
27573678|NCT02896400|80285730|FG006|1 Month Follow-up|Lost to Follow-up|5|||
27573679|NCT02896400|80285731|FG007|1 Month Follow-up|Lost to Follow-up|6|||
27573680|NCT02896400|80285732|FG008|1 Month Follow-up|Lost to Follow-up|4|||
27573681|NCT02896400|80285733|FG009|1 Month Follow-up|Lost to Follow-up|7|||
27573682|NCT02896400|80285734|FG010|1 Month Follow-up|Lost to Follow-up|5|||
27573683|NCT02896400|80285735|FG011|1 Month Follow-up|Lost to Follow-up|5|||
27573684|NCT02896400|80285736|FG012|1 Month Follow-up|Lost to Follow-up|3|||
27573685|NCT02896400|80285737|FG013|1 Month Follow-up|Lost to Follow-up|4|||
27573686|NCT02896400|80285738|FG014|1 Month Follow-up|Lost to Follow-up|1|||
27573687|NCT02896400|80285739|FG015|1 Month Follow-up|Lost to Follow-up|2|||
27573688|NCT02896400|80285724|FG000|1 Month Follow-up|Death|0|||
27573689|NCT02896400|80285725|FG001|1 Month Follow-up|Death|0|||
27573690|NCT02896400|80285726|FG002|1 Month Follow-up|Death|0|||
27573691|NCT02896400|80285727|FG003|1 Month Follow-up|Death|0|||
27573692|NCT02896400|80285728|FG004|1 Month Follow-up|Death|0|||
27573693|NCT02896400|80285729|FG005|1 Month Follow-up|Death|0|||
27573694|NCT02896400|80285730|FG006|1 Month Follow-up|Death|0|||
27573695|NCT02896400|80285731|FG007|1 Month Follow-up|Death|0|||
27573696|NCT02896400|80285732|FG008|1 Month Follow-up|Death|0|||
27573697|NCT02896400|80285733|FG009|1 Month Follow-up|Death|0|||
27573698|NCT02896400|80285734|FG010|1 Month Follow-up|Death|0|||
27573699|NCT02896400|80285735|FG011|1 Month Follow-up|Death|0|||
27573700|NCT02896400|80285736|FG012|1 Month Follow-up|Death|0|||
27573701|NCT02896400|80285737|FG013|1 Month Follow-up|Death|0|||
27788628|NCT03781167|81056039|FG001|Overall Study|Lost to Follow-up|1|||
27788629|NCT03781167|81056038|FG000|Overall Study|Lack of Efficacy|4|||
27975842|NCT04493684|81742574|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
27975843|NCT04493684|81742575|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
27975844|NCT04493684|81742559|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975845|NCT04493684|81742560|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975846|NCT04493684|81742561|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975847|NCT04493684|81742562|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975848|NCT04493684|81742563|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975849|NCT04493684|81742564|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975850|NCT04493684|81742565|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975851|NCT04493684|81742566|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975852|NCT04493684|81742567|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975853|NCT04493684|81742568|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27788630|NCT03781167|81056039|FG001|Overall Study|Lack of Efficacy|5|||
27788631|NCT03781167|81056038|FG000|Overall Study|Difficulty with drug delivery system|2|||
27788632|NCT03781167|81056039|FG001|Overall Study|Difficulty with drug delivery system|3|||
27788633|NCT03781167|81056038|FG000|Overall Study|Other, not specified|2|||
27975854|NCT04493684|81742569|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27573702|NCT02896400|80285738|FG014|1 Month Follow-up|Death|0|||
27975855|NCT04493684|81742570|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975856|NCT04493684|81742571|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975857|NCT04493684|81742572|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975858|NCT04493684|81742573|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975859|NCT04493684|81742574|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
27975860|NCT04493684|81742575|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
27975861|NCT03305419|81742576|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975862|NCT03305419|81742577|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
27975863|NCT03305419|81742578|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975864|NCT03305419|81742579|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975865|NCT03305419|81742580|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975866|NCT03305419|81742581|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975867|NCT03305419|81742582|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975868|NCT03305419|81742583|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
27975869|NCT03305419|81742576|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
27975870|NCT03305419|81742577|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975871|NCT03305419|81742578|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975872|NCT03305419|81742579|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975873|NCT03305419|81742580|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975874|NCT03305419|81742581|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975875|NCT03305419|81742582|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975876|NCT03305419|81742583|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
27975877|NCT03305419|81742576|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
27975878|NCT03305419|81742577|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975879|NCT03305419|81742578|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975880|NCT03305419|81742579|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975881|NCT03305419|81742580|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975882|NCT03305419|81742581|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975883|NCT03305419|81742582|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975884|NCT03305419|81742583|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
27975885|NCT03305419|81742576|FG000|Part B (14 Days)|Adverse Event|0|||
27573703|NCT02896400|80285739|FG015|1 Month Follow-up|Death|1|||
27573704|NCT02896400|80285724|FG000|3 Month Follow-up|Lost to Follow-up|6|||
27573705|NCT02896400|80285725|FG001|3 Month Follow-up|Lost to Follow-up|3|||
27573706|NCT02896400|80285726|FG002|3 Month Follow-up|Lost to Follow-up|6|||
27788634|NCT03781167|81056039|FG001|Overall Study|Other, not specified|2|||
27788635|NCT01013207|81056040|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
27788636|NCT02361307|81056049|FG000|Overall Study|Unstable medical condition.|0|||
27788637|NCT02361307|81056050|FG001|Overall Study|Unstable medical condition.|1|||
27788638|NCT00598442|81056051|FG000|Overall Study|Adverse Event|3|||
27788639|NCT00598442|81056052|FG001|Overall Study|Adverse Event|0|||
27975886|NCT03305419|81742577|FG001|Part B (14 Days)|Adverse Event|0|||
27788640|NCT00598442|81056053|FG002|Overall Study|Adverse Event|0|||
27788641|NCT00598442|81056051|FG000|Overall Study|Death|19|||
27788642|NCT00598442|81056052|FG001|Overall Study|Death|11|||
27573707|NCT02896400|80285727|FG003|3 Month Follow-up|Lost to Follow-up|11|||
27788643|NCT00598442|81056053|FG002|Overall Study|Death|11|||
27788644|NCT00598442|81056051|FG000|Overall Study|Lost to Follow-up|4|||
27788645|NCT00598442|81056052|FG001|Overall Study|Lost to Follow-up|3|||
27975887|NCT03305419|81742578|FG002|Part B (14 Days)|Adverse Event|0|||
27975888|NCT03305419|81742579|FG003|Part B (14 Days)|Adverse Event|0|||
27975889|NCT03305419|81742580|FG004|Part B (14 Days)|Adverse Event|1|||
27975890|NCT03305419|81742581|FG005|Part B (14 Days)|Adverse Event|2|||
27975891|NCT03305419|81742582|FG006|Part B (14 Days)|Adverse Event|4|||
27975892|NCT03305419|81742583|FG007|Part B (14 Days)|Adverse Event|0|||
27975893|NCT03305419|81742576|FG000|Part B (14 Days)|Physician Decision|0|||
27975894|NCT03305419|81742577|FG001|Part B (14 Days)|Physician Decision|0|||
27975895|NCT03305419|81742578|FG002|Part B (14 Days)|Physician Decision|0|||
27975896|NCT03305419|81742579|FG003|Part B (14 Days)|Physician Decision|0|||
27975897|NCT03305419|81742580|FG004|Part B (14 Days)|Physician Decision|2|||
27975898|NCT03305419|81742581|FG005|Part B (14 Days)|Physician Decision|8|||
27975899|NCT03305419|81742582|FG006|Part B (14 Days)|Physician Decision|1|||
27975900|NCT03305419|81742583|FG007|Part B (14 Days)|Physician Decision|0|||
27975901|NCT01994863|81742584|FG000|Period 1|Adverse Event|4|||
27975902|NCT01994863|81742585|FG001|Period 1|Adverse Event|0|||
27975903|NCT01994863|81742584|FG000|Period 1|Withdrawal by Subject|1|||
27975904|NCT01994863|81742585|FG001|Period 1|Withdrawal by Subject|0|||
27975905|NCT01994863|81742584|FG000|Period 1|Trial stopped by sponsor|1|||
27975906|NCT01994863|81742585|FG001|Period 1|Trial stopped by sponsor|3|||
27975907|NCT01994863|81742584|FG000|Period 1|Lack of Efficacy|1|||
27975908|NCT01994863|81742585|FG001|Period 1|Lack of Efficacy|0|||
27975909|NCT01994863|81742584|FG000|Period 2|Adverse Event|0|||
27975910|NCT01994863|81742585|FG001|Period 2|Adverse Event|1|||
27975911|NCT01994863|81742584|FG000|Period 2|Lack of Efficacy|0|||
27975912|NCT01994863|81742585|FG001|Period 2|Lack of Efficacy|2|||
27975913|NCT01994863|81742584|FG000|Period 2|Withdrawal by Subject|1|||
27975914|NCT01994863|81742585|FG001|Period 2|Withdrawal by Subject|1|||
27975915|NCT03773133|81742586|FG000|Overall Study|Screen Failure|8|||
27975916|NCT01146652|81742587|FG000|Overall Study|Adverse Event|506|||
27975917|NCT01146652|81742588|FG001|Overall Study|Adverse Event|15|||
27975918|NCT01146652|81742587|FG000|Overall Study|Lack of Efficacy|91|||
27975919|NCT01146652|81742588|FG001|Overall Study|Lack of Efficacy|7|||
27975920|NCT01146652|81742587|FG000|Overall Study|Poor compliance to protocol|38|||
27975921|NCT01146652|81742588|FG001|Overall Study|Poor compliance to protocol|1|||
27975922|NCT01146652|81742587|FG000|Overall Study|Other unspecified reasons|314|||
27975923|NCT01146652|81742588|FG001|Overall Study|Other unspecified reasons|22|||
27975924|NCT01146652|81742587|FG000|Overall Study|Enrolled but not treated|2|||
27975925|NCT01146652|81742588|FG001|Overall Study|Enrolled but not treated|0|||
27975926|NCT01456195|81742589|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27975927|NCT01456195|81742590|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
27975928|NCT01456195|81742591|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27975929|NCT01456195|81742589|FG000|Overall Study|Lost to Follow-up|3|||
27975930|NCT01456195|81742590|FG001|Overall Study|Lost to Follow-up|1|||
27975931|NCT01456195|81742591|FG002|Overall Study|Lost to Follow-up|3|||
27975932|NCT01456195|81742589|FG000|Overall Study|Voluntary Withdrawal|5|||
27975933|NCT01456195|81742590|FG001|Overall Study|Voluntary Withdrawal|3|||
27975934|NCT01456195|81742591|FG002|Overall Study|Voluntary Withdrawal|7|||
27975935|NCT01456195|81742589|FG000|Overall Study|Lack of Efficacy|0|||
27975936|NCT01456195|81742590|FG001|Overall Study|Lack of Efficacy|1|||
27975937|NCT01456195|81742591|FG002|Overall Study|Lack of Efficacy|0|||
27975938|NCT01456195|81742589|FG000|Overall Study|Other Reasons|2|||
27975939|NCT01456195|81742590|FG001|Overall Study|Other Reasons|1|||
27975940|NCT01456195|81742591|FG002|Overall Study|Other Reasons|3|||
27975941|NCT01185964|81742594|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
27975942|NCT01185964|81742595|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
27975943|NCT01185964|81742596|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
27975944|NCT01185964|81742597|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
27975945|NCT01185964|81742594|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
27975946|NCT01185964|81742595|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
27573708|NCT02896400|80285728|FG004|3 Month Follow-up|Lost to Follow-up|12|||
27573709|NCT02896400|80285729|FG005|3 Month Follow-up|Lost to Follow-up|6|||
27573710|NCT02896400|80285730|FG006|3 Month Follow-up|Lost to Follow-up|4|||
27975947|NCT01185964|81742596|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
27975948|NCT01185964|81742597|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
27975949|NCT01185964|81742594|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
27975950|NCT01185964|81742595|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
27975951|NCT01185964|81742596|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
27975952|NCT01185964|81742597|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
27975953|NCT01185964|81742594|FG000|Phase 1b and Phase 2|Adverse Event|1|||
27975954|NCT01185964|81742595|FG001|Phase 1b and Phase 2|Adverse Event|0|||
27975955|NCT01185964|81742596|FG002|Phase 1b and Phase 2|Adverse Event|2|||
27975956|NCT01185964|81742597|FG003|Phase 1b and Phase 2|Adverse Event|0|||
27975957|NCT01185964|81742594|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
27975958|NCT01185964|81742595|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
27573711|NCT02896400|80285731|FG007|3 Month Follow-up|Lost to Follow-up|3|||
27975959|NCT01185964|81742596|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
27975960|NCT01185964|81742597|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
27975961|NCT01185964|81742594|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
27975962|NCT01185964|81742595|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
27975963|NCT01185964|81742596|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
27975964|NCT01185964|81742597|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
27975965|NCT01185964|81742594|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
27975966|NCT01185964|81742595|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
27975967|NCT01185964|81742596|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
27975968|NCT01185964|81742597|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
27975969|NCT01185964|81742594|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
27975970|NCT01185964|81742595|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
27975971|NCT01185964|81742596|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
27975972|NCT01185964|81742597|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
27975973|NCT01323270|81742600|FG000|Overall Study|Withdrawal by Subject|19|||
27975974|NCT01323270|81742601|FG001|Overall Study|Withdrawal by Subject|10|||
27975975|NCT01323270|81742600|FG000|Overall Study|Protocol Violation|9|||
27975976|NCT01323270|81742601|FG001|Overall Study|Protocol Violation|7|||
27975977|NCT01323270|81742600|FG000|Overall Study|Lost to Follow-up|4|||
27975978|NCT01323270|81742601|FG001|Overall Study|Lost to Follow-up|6|||
27975979|NCT01323270|81742600|FG000|Overall Study|Adverse Event|8|||
27975980|NCT01323270|81742601|FG001|Overall Study|Adverse Event|0|||
27975981|NCT01323270|81742600|FG000|Overall Study|Other|0|||
27975982|NCT01323270|81742601|FG001|Overall Study|Other|3|||
27975983|NCT01323270|81742600|FG000|Overall Study|Physician Decision|0|||
27975984|NCT01323270|81742601|FG001|Overall Study|Physician Decision|2|||
27975985|NCT01323270|81742600|FG000|Overall Study|Not eligible|1|||
27975986|NCT01323270|81742601|FG001|Overall Study|Not eligible|1|||
27975987|NCT01323270|81742600|FG000|Overall Study|Death|1|||
27975988|NCT01323270|81742601|FG001|Overall Study|Death|0|||
27975989|NCT01323270|81742600|FG000|Overall Study|Randomized, but not vaccinated|1|||
27975990|NCT01323270|81742601|FG001|Overall Study|Randomized, but not vaccinated|0|||
27975991|NCT00693017|81742605|FG000|Overall Study|Sponsor Decision|2|||
27975992|NCT00693017|81742606|FG001|Overall Study|Sponsor Decision|1|||
27975993|NCT00693017|81742605|FG000|Overall Study|Death|0|||
27975994|NCT00693017|81742606|FG001|Overall Study|Death|1|||
27975995|NCT02334683|81742607|FG000|First 12 Week Period|Lost to Follow-up|1|||
27975996|NCT02334683|81742608|FG001|First 12 Week Period|Lost to Follow-up|0|||
27975997|NCT02334683|81742607|FG000|Second 12 Week Period|Adverse Event|0|||
27975998|NCT02334683|81742608|FG001|Second 12 Week Period|Adverse Event|1|||
27975999|NCT00867087|81742609|FG000|Overall Study|Other|1|||
27976000|NCT00867087|81742609|FG000|Overall Study|Withdrawal by Subject|4|||
27976001|NCT00867087|81742609|FG000|Overall Study|Death|37|||
27976002|NCT01069861|81742612|FG000|Overall Study|Death|1|||
27976003|NCT01069861|81742612|FG000|Overall Study|Adverse Event|1|||
27976004|NCT01069861|81742612|FG000|Overall Study|Did not meet entrance criteria|1|||
27976005|NCT00493636|81742613|FG000|Overall Study|Withdrawal by Subject|1|||
27976006|NCT00493636|81742614|FG001|Overall Study|Withdrawal by Subject|0|||
27976007|NCT00493636|81742613|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
27976008|NCT00493636|81742614|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
27976009|NCT00493636|81742613|FG000|Overall Study|Mis-randomization|1|||
27976010|NCT00493636|81742614|FG001|Overall Study|Mis-randomization|1|||
27976011|NCT00585546|81742616|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
27976012|NCT00585546|81742616|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
27976013|NCT01187446|81742619|FG000|Overall Study|Patient started non-protocol therapy|0|||
27976014|NCT01187446|81742620|FG001|Overall Study|Patient started non-protocol therapy|1|||
27976015|NCT00824005|81742621|FG000|Overall Study|Death|0|||
27976016|NCT00824005|81742622|FG001|Overall Study|Death|1|||
27976017|NCT00824005|81742621|FG000|Overall Study|Lost to Follow-up|0|||
27976018|NCT00824005|81742622|FG001|Overall Study|Lost to Follow-up|1|||
27976019|NCT02653495|81742623|FG000|Overall Study|Lost to Follow-up|2|||
27976020|NCT02653495|81742624|FG001|Overall Study|Lost to Follow-up|0|||
27976021|NCT02653495|81742623|FG000|Overall Study|Screening Failure|10|||
27976022|NCT02653495|81742624|FG001|Overall Study|Screening Failure|0|||
27976023|NCT01156389|81746101|FG000|Overall Study|Elevated liver enzymes|4|||
27976024|NCT01156389|81746102|FG001|Overall Study|Elevated liver enzymes|0|||
27976025|NCT01156389|81746101|FG000|Overall Study|Vomiting|0|||
27976026|NCT01156389|81746102|FG001|Overall Study|Vomiting|1|||
27976027|NCT04863248|81746103|FG000|Overall Study|Sponsor Terminated|4|||
27976028|NCT04863248|81746104|FG001|Overall Study|Sponsor Terminated|1|||
27976029|NCT04863248|81746103|FG000|Overall Study|Death|0|||
27976030|NCT04863248|81746104|FG001|Overall Study|Death|1|||
27976031|NCT04863248|81746103|FG000|Overall Study|Withdrawal by Subject|0|||
27976032|NCT04863248|81746104|FG001|Overall Study|Withdrawal by Subject|1|||
27976033|NCT03095027|81746106|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
27976034|NCT03095027|81746107|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
27573712|NCT02896400|80285732|FG008|3 Month Follow-up|Lost to Follow-up|6|||
27573713|NCT02896400|80285733|FG009|3 Month Follow-up|Lost to Follow-up|5|||
27573714|NCT02896400|80285734|FG010|3 Month Follow-up|Lost to Follow-up|6|||
27573715|NCT02896400|80285735|FG011|3 Month Follow-up|Lost to Follow-up|6|||
27573716|NCT02896400|80285736|FG012|3 Month Follow-up|Lost to Follow-up|3|||
27573717|NCT02896400|80285737|FG013|3 Month Follow-up|Lost to Follow-up|5|||
27573718|NCT02896400|80285738|FG014|3 Month Follow-up|Lost to Follow-up|3|||
27573719|NCT02896400|80285739|FG015|3 Month Follow-up|Lost to Follow-up|2|||
27976035|NCT00847665|81746108|FG000|Overall Study|Withdrawal by Subject|1|||
27976036|NCT00847665|81746109|FG001|Overall Study|Withdrawal by Subject|0|||
27976037|NCT00541099|81746110|FG000|Overall Study|Ineligible|3|||
27976038|NCT00354107|81746111|FG000|Overall Study|Adverse Event|2|||
27573720|NCT02896400|80285724|FG000|3 Month Follow-up|Death|0|||
27573721|NCT02896400|80285725|FG001|3 Month Follow-up|Death|0|||
27573722|NCT02896400|80285726|FG002|3 Month Follow-up|Death|0|||
27573723|NCT02896400|80285727|FG003|3 Month Follow-up|Death|0|||
27573724|NCT02896400|80285728|FG004|3 Month Follow-up|Death|0|||
27573725|NCT02896400|80285729|FG005|3 Month Follow-up|Death|0|||
27573726|NCT02896400|80285730|FG006|3 Month Follow-up|Death|0|||
27573727|NCT02896400|80285731|FG007|3 Month Follow-up|Death|0|||
27573728|NCT02896400|80285732|FG008|3 Month Follow-up|Death|0|||
27573729|NCT02896400|80285733|FG009|3 Month Follow-up|Death|0|||
27573730|NCT02896400|80285734|FG010|3 Month Follow-up|Death|0|||
27573731|NCT02896400|80285735|FG011|3 Month Follow-up|Death|0|||
27573732|NCT02896400|80285736|FG012|3 Month Follow-up|Death|0|||
27573733|NCT02896400|80285737|FG013|3 Month Follow-up|Death|1|||
27573734|NCT02896400|80285738|FG014|3 Month Follow-up|Death|1|||
27573735|NCT02896400|80285739|FG015|3 Month Follow-up|Death|0|||
27573736|NCT02896400|80285724|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573737|NCT02896400|80285725|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
27573738|NCT02896400|80285726|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573739|NCT02896400|80285727|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573740|NCT02896400|80285728|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
27573741|NCT02896400|80285729|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573742|NCT02896400|80285730|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
27573743|NCT02896400|80285731|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
27573744|NCT02896400|80285732|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573745|NCT02896400|80285733|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573746|NCT02896400|80285734|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
27573747|NCT02896400|80285735|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
27573748|NCT02896400|80285736|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573749|NCT02896400|80285737|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
27573750|NCT02896400|80285738|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
27573751|NCT02896400|80285739|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
27573752|NCT02896400|80285724|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
27573753|NCT02896400|80285725|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
27573754|NCT02896400|80285726|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
27573755|NCT02896400|80285727|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
27573756|NCT02896400|80285728|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
27573757|NCT02896400|80285729|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
27573758|NCT02896400|80285730|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
27573759|NCT02896400|80285731|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
27573760|NCT02896400|80285732|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
27573761|NCT02896400|80285733|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
27573762|NCT02896400|80285734|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
27573763|NCT02896400|80285735|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
27573764|NCT02896400|80285736|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
27573765|NCT02896400|80285737|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
27573766|NCT02896400|80285738|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
27573767|NCT02896400|80285739|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
27573768|NCT01848990|80285746|FG000|Overall Study|Adverse Event|6|||
27573769|NCT01848990|80285747|FG001|Overall Study|Adverse Event|2|||
27573770|NCT01848990|80285748|FG002|Overall Study|Adverse Event|0|||
27573771|NCT01848990|80285746|FG000|Overall Study|Lost to Follow-up|6|||
27573772|NCT01848990|80285747|FG001|Overall Study|Lost to Follow-up|2|||
27573773|NCT01848990|80285748|FG002|Overall Study|Lost to Follow-up|2|||
27573774|NCT01848990|80285746|FG000|Overall Study|Protocol Violation|1|||
27573775|NCT01848990|80285747|FG001|Overall Study|Protocol Violation|1|||
27573776|NCT01848990|80285748|FG002|Overall Study|Protocol Violation|0|||
27788646|NCT00598442|81056053|FG002|Overall Study|Lost to Follow-up|3|||
27672031|NCT01296555|80639139|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
27672032|NCT01296555|80639140|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27788647|NCT00598442|81056051|FG000|Overall Study|Physician Decision|2|||
27788648|NCT00598442|81056052|FG001|Overall Study|Physician Decision|1|||
27788649|NCT00598442|81056053|FG002|Overall Study|Physician Decision|1|||
27788650|NCT00598442|81056051|FG000|Overall Study|Withdrawal by Subject|8|||
27788651|NCT00598442|81056052|FG001|Overall Study|Withdrawal by Subject|16|||
27788652|NCT00598442|81056053|FG002|Overall Study|Withdrawal by Subject|6|||
27788653|NCT00598442|81056051|FG000|Overall Study|Noncompliance|0|||
27788654|NCT00598442|81056052|FG001|Overall Study|Noncompliance|2|||
27788655|NCT00598442|81056053|FG002|Overall Study|Noncompliance|1|||
27788656|NCT00598442|81056051|FG000|Overall Study|Relocation|1|||
27788657|NCT00598442|81056052|FG001|Overall Study|Relocation|4|||
27788658|NCT00598442|81056053|FG002|Overall Study|Relocation|0|||
27788659|NCT00598442|81056051|FG000|Overall Study|Renal transplant|0|||
27867390|NCT01266031|81349579|FG001|Overall Study|Not treated|3|||
27976039|NCT00354107|81746111|FG000|Overall Study|Physician Decision|2|||
27976040|NCT00354107|81746111|FG000|Overall Study|Withdrawal by Subject|1|||
27976041|NCT02387164|81746114|FG000|Overall Study|Lost to Follow-up|2|||
27976042|NCT02387164|81746115|FG001|Overall Study|Lost to Follow-up|0|||
27976043|NCT02387164|81746114|FG000|Overall Study|Diagnosed|1|||
27976044|NCT02387164|81746115|FG001|Overall Study|Diagnosed|2|||
27976045|NCT03622112|81746116|FG000|Overall Study|Withdrawal by Subject|6|||
27976046|NCT03622112|81746117|FG001|Overall Study|Withdrawal by Subject|2|||
27976047|NCT03622112|81746118|FG002|Overall Study|Withdrawal by Subject|4|||
27976048|NCT03622112|81746119|FG003|Overall Study|Withdrawal by Subject|2|||
27976049|NCT03622112|81746120|FG004|Overall Study|Withdrawal by Subject|1|||
27976050|NCT03622112|81746121|FG005|Overall Study|Withdrawal by Subject|2|||
27976051|NCT03622112|81746122|FG006|Overall Study|Withdrawal by Subject|2|||
27976052|NCT03622112|81746116|FG000|Overall Study|Death|0|||
27976053|NCT03622112|81746117|FG001|Overall Study|Death|0|||
27976054|NCT03622112|81746118|FG002|Overall Study|Death|0|||
27976055|NCT03622112|81746119|FG003|Overall Study|Death|1|||
27976056|NCT03622112|81746120|FG004|Overall Study|Death|0|||
27788660|NCT00598442|81056052|FG001|Overall Study|Renal transplant|0|||
27788661|NCT00598442|81056053|FG002|Overall Study|Renal transplant|1|||
27788662|NCT00598442|81056051|FG000|Overall Study|Site closed by sponsor|5|||
27788663|NCT00598442|81056052|FG001|Overall Study|Site closed by sponsor|2|||
27976057|NCT03622112|81746121|FG005|Overall Study|Death|0|||
27976058|NCT03622112|81746122|FG006|Overall Study|Death|0|||
27976059|NCT03622112|81746116|FG000|Overall Study|Lost to Follow-up|1|||
27976060|NCT03622112|81746117|FG001|Overall Study|Lost to Follow-up|1|||
27976061|NCT03622112|81746118|FG002|Overall Study|Lost to Follow-up|0|||
27788664|NCT00598442|81056053|FG002|Overall Study|Site closed by sponsor|1|||
27788665|NCT00598442|81056051|FG000|Overall Study|Started dialysis|1|||
27788666|NCT00598442|81056052|FG001|Overall Study|Started dialysis|0|||
27788667|NCT00598442|81056053|FG002|Overall Study|Started dialysis|0|||
27788668|NCT00727246|81056054|FG000|Overall Study|could not complete MRI|0|||
27788669|NCT00727246|81056055|FG001|Overall Study|could not complete MRI|1|||
27788670|NCT00727246|81056056|FG002|Overall Study|could not complete MRI|0|||
27788671|NCT00727246|81056057|FG003|Overall Study|could not complete MRI|1|||
27788672|NCT00727246|81056054|FG000|Overall Study|incidental finding|0|||
27788673|NCT00727246|81056055|FG001|Overall Study|incidental finding|0|||
27788674|NCT00727246|81056056|FG002|Overall Study|incidental finding|0|||
27788675|NCT00727246|81056057|FG003|Overall Study|incidental finding|1|||
27788676|NCT00727246|81056054|FG000|Overall Study|withdrawn|0|||
27788677|NCT00727246|81056055|FG001|Overall Study|withdrawn|0|||
27788678|NCT00727246|81056056|FG002|Overall Study|withdrawn|1|||
27788679|NCT00727246|81056057|FG003|Overall Study|withdrawn|0|||
27788680|NCT03841331|81056058|FG000|Overall Study|Withdrawal by Subject|4|||
27788681|NCT03841331|81056059|FG001|Overall Study|Withdrawal by Subject|9|||
27788682|NCT03841331|81056058|FG000|Overall Study|Lost to Follow-up|5|||
27788683|NCT03841331|81056059|FG001|Overall Study|Lost to Follow-up|1|||
27788684|NCT00542321|81056072|FG000|Overall Study|Death|0|||
27788685|NCT00542321|81056073|FG001|Overall Study|Death|1|||
27788686|NCT01302366|81056074|FG000|Overall Study|patient choice or noncompliance|5|||
27788687|NCT04196023|81056075|FG000|Overall Study|Withdrawal by Subject|0|||
27788688|NCT04196023|81056076|FG001|Overall Study|Withdrawal by Subject|1|||
27788689|NCT04196023|81056075|FG000|Overall Study|Adverse Event|3|||
27788690|NCT04196023|81056076|FG001|Overall Study|Adverse Event|1|||
27788691|NCT04196023|81056075|FG000|Overall Study|Lost to Follow-up|0|||
27788692|NCT04196023|81056076|FG001|Overall Study|Lost to Follow-up|1|||
27788693|NCT03053180|81056077|FG000|Overall Study|Failure to Return|1|||
27788694|NCT00505765|81056082|FG000|Overall Study|Withdrawal by Subject|1|||
27788695|NCT00505765|81056083|FG001|Overall Study|Withdrawal by Subject|0|||
27788696|NCT00505765|81056084|FG002|Overall Study|Withdrawal by Subject|0|||
27788697|NCT00505765|81056082|FG000|Overall Study|Adverse Event|1|||
27788698|NCT00505765|81056083|FG001|Overall Study|Adverse Event|2|||
27788699|NCT00505765|81056084|FG002|Overall Study|Adverse Event|0|||
27788700|NCT00505765|81056082|FG000|Overall Study|Noncompliance|0|||
27788701|NCT00505765|81056083|FG001|Overall Study|Noncompliance|1|||
27788702|NCT00505765|81056084|FG002|Overall Study|Noncompliance|3|||
27788703|NCT03319368|81056087|FG000|Overall Study|Discharge swabs not collected from resident|57|||
27788704|NCT03319368|81056088|FG001|Overall Study|Discharge swabs not collected from resident|46|||
27788705|NCT01605370|81056092|FG000|Overall Study|Adverse Event|1|||
27788706|NCT01605370|81056093|FG001|Overall Study|Adverse Event|0|||
27788707|NCT02613910|81056094|FG000|Overall Study|Termination of study|1|||
27788708|NCT04823494|81056095|FG000|Overall Study|Programming software malfunction.|1|||
27788709|NCT04823494|81056096|FG001|Overall Study|Programming software malfunction.|0|||
27867391|NCT01266031|81349580|FG002|Overall Study|Not treated|2|||
27976062|NCT03622112|81746119|FG003|Overall Study|Lost to Follow-up|0|||
27976063|NCT03622112|81746120|FG004|Overall Study|Lost to Follow-up|0|||
27788710|NCT04823494|81056095|FG000|Overall Study|Withdrawal by Subject|1|||
27788711|NCT04823494|81056096|FG001|Overall Study|Withdrawal by Subject|0|||
27867392|NCT02503787|81349581|FG000|Enrollment|Withdrawal by Subject|6|||
27867393|NCT02503787|81349581|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
27867394|NCT02503787|81349581|FG000|Enrollment|Physician Decision|2|||
27867395|NCT02503787|81349581|FG000|Enrollment|Insurance issue|2|||
27867396|NCT02503787|81349581|FG000|Enrollment|Lost to Follow-up|1|||
27867397|NCT02503787|81349581|FG000|Enrollment|Study closure|1|||
27867398|NCT02503787|81349581|FG000|Enrollment|Adverse Event|1|||
27867399|NCT02503787|81349581|FG000|Enrollment|Protocol Violation|1|||
27867400|NCT02503787|81349581|FG000|Enrollment|Inability to implant system|1|||
27867401|NCT02503787|81349581|FG000|Enrollment|Unable to be programmed|1|||
27867402|NCT02503787|81349581|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
27867403|NCT02503787|81349581|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
27867404|NCT02503787|81349581|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
27867405|NCT02503787|81349581|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
27867406|NCT02503787|81349581|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
27788712|NCT04823494|81056095|FG000|Overall Study|Devices lost|0|||
27788713|NCT04823494|81056096|FG001|Overall Study|Devices lost|1|||
27788714|NCT00561795|81056097|FG000|Overall Study|Adverse Event|3|||
27788715|NCT00561795|81056098|FG001|Overall Study|Adverse Event|3|||
27788716|NCT00561795|81056099|FG002|Overall Study|Adverse Event|0|||
27788717|NCT00561795|81056100|FG003|Overall Study|Adverse Event|0|||
27788718|NCT00561795|81056097|FG000|Overall Study|Study Closed/Terminated|0|||
27788719|NCT00561795|81056098|FG001|Overall Study|Study Closed/Terminated|3|||
27788720|NCT00561795|81056099|FG002|Overall Study|Study Closed/Terminated|0|||
27867407|NCT02503787|81349581|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
27867408|NCT00704132|81349582|FG000|Overall Study|Clinical Adverse Experience|1|||
27976064|NCT03622112|81746121|FG005|Overall Study|Lost to Follow-up|0|||
27788721|NCT00561795|81056100|FG003|Overall Study|Study Closed/Terminated|0|||
27788722|NCT00561795|81056097|FG000|Overall Study|Physician Decision|1|||
27788723|NCT00561795|81056098|FG001|Overall Study|Physician Decision|0|||
27788724|NCT00561795|81056099|FG002|Overall Study|Physician Decision|0|||
27788725|NCT00561795|81056100|FG003|Overall Study|Physician Decision|0|||
27788726|NCT01465958|81056101|FG000|Run-in Phase|Protocol Violation|1|||
27788727|NCT01465958|81056102|FG001|Run-in Phase|Protocol Violation|0|||
27788728|NCT01465958|81056101|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
27788729|NCT01465958|81056102|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
27788730|NCT02329834|81056103|FG000|Overall Study|Physician Decision|1|||
27788731|NCT02329834|81056104|FG001|Overall Study|Physician Decision|0|||
27788732|NCT01453296|81056105|FG000|Treatment Period 1|Adverse Event|0|||
27788733|NCT01453296|81056106|FG001|Treatment Period 1|Adverse Event|1|||
27788734|NCT01453296|81056105|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
27788735|NCT01453296|81056106|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
27788736|NCT01453296|81056105|FG000|Treatment Period 2|Adverse Event|1|||
27788737|NCT01453296|81056106|FG001|Treatment Period 2|Adverse Event|0|||
27788738|NCT01453296|81056105|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27788739|NCT01453296|81056106|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27788740|NCT02452892|81056111|FG000|Week 1 Initial Randommization|Adverse Event|1|||
27788741|NCT02452892|81056112|FG001|Week 1 Initial Randommization|Adverse Event|0|||
27788742|NCT02452892|81056113|FG002|Week 1 Initial Randommization|Adverse Event|0|||
27788743|NCT02452892|81056114|FG003|Week 1 Initial Randommization|Adverse Event|0|||
27788744|NCT02452892|81056111|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
27788745|NCT02452892|81056112|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
27788746|NCT02452892|81056113|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
27788747|NCT02452892|81056114|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
27788748|NCT02452892|81056111|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
27788749|NCT02452892|81056112|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
27788750|NCT02452892|81056113|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
27788751|NCT02452892|81056114|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
27788752|NCT02452892|81056111|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
27788753|NCT02452892|81056112|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
27788754|NCT02452892|81056113|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
27788755|NCT02452892|81056114|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
27788756|NCT02452892|81056111|FG000|Follow-up|Withdrawal by Subject|0|||
27788757|NCT02452892|81056112|FG001|Follow-up|Withdrawal by Subject|0|||
27788758|NCT02452892|81056113|FG002|Follow-up|Withdrawal by Subject|0|||
27788759|NCT02452892|81056114|FG003|Follow-up|Withdrawal by Subject|1|||
27788760|NCT02452892|81056111|FG000|Follow-up|Subject left town on Day 42|1|||
27788761|NCT02452892|81056112|FG001|Follow-up|Subject left town on Day 42|0|||
27788762|NCT02452892|81056113|FG002|Follow-up|Subject left town on Day 42|0|||
27788763|NCT02452892|81056114|FG003|Follow-up|Subject left town on Day 42|0|||
27788764|NCT02331680|81056115|FG000|Overall Study|Adverse Event|3|||
27788765|NCT02331680|81056116|FG001|Overall Study|Adverse Event|0|||
27788766|NCT02331680|81056117|FG002|Overall Study|Adverse Event|2|||
27788767|NCT02331680|81056115|FG000|Overall Study|Physician Decision|1|||
27788768|NCT02331680|81056116|FG001|Overall Study|Physician Decision|1|||
27788769|NCT02331680|81056117|FG002|Overall Study|Physician Decision|2|||
27788770|NCT02331680|81056115|FG000|Overall Study|Withdrawal by Subject|0|||
27573777|NCT01848990|80285746|FG000|Overall Study|Withdrawal by Subject|29|||
27573778|NCT01848990|80285747|FG001|Overall Study|Withdrawal by Subject|10|||
27788771|NCT02331680|81056116|FG001|Overall Study|Withdrawal by Subject|1|||
27788772|NCT02331680|81056117|FG002|Overall Study|Withdrawal by Subject|2|||
27788773|NCT02331680|81056115|FG000|Overall Study|Met withdrawal criteria|2|||
27788774|NCT02331680|81056116|FG001|Overall Study|Met withdrawal criteria|2|||
27573779|NCT01848990|80285748|FG002|Overall Study|Withdrawal by Subject|11|||
27573780|NCT01848990|80285746|FG000|Overall Study|Physician Decision|1|||
27788775|NCT02331680|81056117|FG002|Overall Study|Met withdrawal criteria|5|||
27788776|NCT02331680|81056115|FG000|Overall Study|Non-compliance with study drug|0|||
27788777|NCT02331680|81056116|FG001|Overall Study|Non-compliance with study drug|0|||
27788778|NCT02331680|81056117|FG002|Overall Study|Non-compliance with study drug|1|||
27788779|NCT02331680|81056115|FG000|Overall Study|Protocol Violation|0|||
27788780|NCT02331680|81056116|FG001|Overall Study|Protocol Violation|0|||
27788781|NCT02331680|81056117|FG002|Overall Study|Protocol Violation|3|||
27788782|NCT03831282|81056119|FG000|Overall Study|Could not place sensor|1|||
27788783|NCT00579059|81056120|FG000|Overall Study|Study Canceled at 1 Year|21|||
27788784|NCT00579059|81056121|FG001|Overall Study|Study Canceled at 1 Year|10|||
27788785|NCT01654666|81056122|FG000|Overall Study|Protocol Violation|7|||
27788786|NCT01654666|81056123|FG001|Overall Study|Protocol Violation|4|||
27788787|NCT01654666|81056124|FG002|Overall Study|Protocol Violation|8|||
27788788|NCT01654666|81056122|FG000|Overall Study|Lost to Follow-up|4|||
27788789|NCT01654666|81056123|FG001|Overall Study|Lost to Follow-up|5|||
27788790|NCT01654666|81056124|FG002|Overall Study|Lost to Follow-up|5|||
27788791|NCT01654666|81056122|FG000|Overall Study|Withdrawal by Subject|4|||
27788792|NCT01654666|81056123|FG001|Overall Study|Withdrawal by Subject|4|||
27788793|NCT01654666|81056124|FG002|Overall Study|Withdrawal by Subject|1|||
27788794|NCT01003691|81056125|FG000|Overall Study|Adverse Event|0|||
27788795|NCT01003691|81056126|FG001|Overall Study|Adverse Event|0|||
27788796|NCT01003691|81056127|FG002|Overall Study|Adverse Event|0|||
27788797|NCT01003691|81056128|FG003|Overall Study|Adverse Event|1|||
27788798|NCT04678557|81056129|FG000|Overall Study|Withdrawal by Subject|1|||
27788799|NCT04678557|81056130|FG001|Overall Study|Withdrawal by Subject|0|||
27788800|NCT04678557|81056129|FG000|Overall Study|Lack of Efficacy|0|||
27788801|NCT04678557|81056130|FG001|Overall Study|Lack of Efficacy|13|||
27788802|NCT04678557|81056129|FG000|Overall Study|Safety Evaluation|0|||
27976065|NCT03622112|81746122|FG006|Overall Study|Lost to Follow-up|0|||
27976066|NCT03622112|81746116|FG000|Overall Study|Study-specific withdrawal criteria|10|||
27976067|NCT03622112|81746117|FG001|Overall Study|Study-specific withdrawal criteria|8|||
27976068|NCT03622112|81746118|FG002|Overall Study|Study-specific withdrawal criteria|7|||
27788803|NCT04678557|81056130|FG001|Overall Study|Safety Evaluation|1|||
27976069|NCT03622112|81746119|FG003|Overall Study|Study-specific withdrawal criteria|6|||
27976070|NCT03622112|81746120|FG004|Overall Study|Study-specific withdrawal criteria|4|||
27976071|NCT03622112|81746121|FG005|Overall Study|Study-specific withdrawal criteria|18|||
27976072|NCT03622112|81746122|FG006|Overall Study|Study-specific withdrawal criteria|4|||
27976073|NCT03622112|81746116|FG000|Overall Study|Protocol Violation|2|||
27976074|NCT03622112|81746117|FG001|Overall Study|Protocol Violation|0|||
27976075|NCT03622112|81746118|FG002|Overall Study|Protocol Violation|1|||
27976076|NCT03622112|81746119|FG003|Overall Study|Protocol Violation|1|||
27976077|NCT03622112|81746120|FG004|Overall Study|Protocol Violation|0|||
27976078|NCT03622112|81746121|FG005|Overall Study|Protocol Violation|0|||
27976079|NCT03622112|81746122|FG006|Overall Study|Protocol Violation|0|||
27976080|NCT03622112|81746116|FG000|Overall Study|Adverse Event|6|||
27976081|NCT03622112|81746117|FG001|Overall Study|Adverse Event|8|||
27976082|NCT03622112|81746118|FG002|Overall Study|Adverse Event|4|||
27976083|NCT03622112|81746119|FG003|Overall Study|Adverse Event|11|||
27976084|NCT03622112|81746120|FG004|Overall Study|Adverse Event|4|||
27976085|NCT03622112|81746121|FG005|Overall Study|Adverse Event|20|||
27976086|NCT03622112|81746122|FG006|Overall Study|Adverse Event|2|||
27976087|NCT03622112|81746116|FG000|Overall Study|Reason not specified|0|||
27976088|NCT03622112|81746117|FG001|Overall Study|Reason not specified|1|||
27976089|NCT03622112|81746118|FG002|Overall Study|Reason not specified|0|||
27976090|NCT03622112|81746119|FG003|Overall Study|Reason not specified|1|||
27976091|NCT03622112|81746120|FG004|Overall Study|Reason not specified|1|||
27976092|NCT03622112|81746121|FG005|Overall Study|Reason not specified|2|||
27976093|NCT03622112|81746122|FG006|Overall Study|Reason not specified|1|||
27976094|NCT03141788|81746123|FG000|Overall Study|Lost to Follow-up|1|||
27976095|NCT03141788|81746123|FG000|Overall Study|Protocol Violation|3|||
27788804|NCT00689728|81056131|FG000|Double-Blind Treatment|Adverse Event|1|||
27788805|NCT00689728|81056132|FG001|Double-Blind Treatment|Adverse Event|0|||
27976096|NCT03141788|81746123|FG000|Overall Study|Withdrawal by Subject|4|||
27976097|NCT00853125|81746125|FG000|Overall Study|Study participant's donor was CMV +|1|||
27976098|NCT03215706|81746127|FG000|Randomization|Adverse Event unrelated to study drug|1|||
27976099|NCT03215706|81746128|FG001|Randomization|Adverse Event unrelated to study drug|0|||
27976100|NCT03215706|81746127|FG000|Randomization|participant withdrew consent|1|||
27573781|NCT01848990|80285747|FG001|Overall Study|Physician Decision|1|||
27788806|NCT00689728|81056133|FG002|Double-Blind Treatment|Adverse Event|0|||
27788807|NCT00689728|81056131|FG000|Double-Blind Treatment|Protocol Violation|0|||
27788808|NCT00689728|81056132|FG001|Double-Blind Treatment|Protocol Violation|0|||
27976101|NCT03215706|81746128|FG001|Randomization|participant withdrew consent|3|||
27976102|NCT03215706|81746127|FG000|Randomization|no longer meets study criteria|1|||
27976103|NCT03215706|81746128|FG001|Randomization|no longer meets study criteria|4|||
27976104|NCT03215706|81746127|FG000|Randomization|other reasons|0|||
27976105|NCT03215706|81746128|FG001|Randomization|other reasons|2|||
27976106|NCT03215706|81746127|FG000|Treatment Period|Disease Progression|150|||
27976107|NCT03215706|81746128|FG001|Treatment Period|Disease Progression|142|||
27976108|NCT03215706|81746127|FG000|Treatment Period|Study Drug Toxicity|53|||
27976109|NCT03215706|81746128|FG001|Treatment Period|Study Drug Toxicity|21|||
27976110|NCT03215706|81746127|FG000|Treatment Period|Death|2|||
27976111|NCT03215706|81746128|FG001|Treatment Period|Death|1|||
27976112|NCT03215706|81746127|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
27976113|NCT03215706|81746128|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
27976114|NCT03215706|81746127|FG000|Treatment Period|Request to D/C treatment|1|||
27976115|NCT03215706|81746128|FG001|Treatment Period|Request to D/C treatment|6|||
27976116|NCT03215706|81746127|FG000|Treatment Period|Participant withdrew consent|3|||
27976117|NCT03215706|81746128|FG001|Treatment Period|Participant withdrew consent|4|||
27976118|NCT03215706|81746127|FG000|Treatment Period|Lost to Follow-up|0|||
27976119|NCT03215706|81746128|FG001|Treatment Period|Lost to Follow-up|1|||
27976120|NCT03215706|81746127|FG000|Treatment Period|Other Reasons|4|||
27976121|NCT03215706|81746128|FG001|Treatment Period|Other Reasons|5|||
27976122|NCT03215706|81746127|FG000|Treatment Period|Ongoing in the treatment period|105|||
27976123|NCT03215706|81746128|FG001|Treatment Period|Ongoing in the treatment period|43|||
27976124|NCT03946124|81746129|FG000|Overall Study|Withdrawal by Subject|19|||
27976125|NCT02312219|81746130|FG000|Overall Study|Withdrawal by Subject|1|||
27976126|NCT02312219|81746131|FG001|Overall Study|Withdrawal by Subject|2|||
27976127|NCT02312219|81746130|FG000|Overall Study|could not schedule imaging in time|0|||
27976128|NCT02312219|81746131|FG001|Overall Study|could not schedule imaging in time|2|||
27976129|NCT02312219|81746130|FG000|Overall Study|Other|0|||
27976130|NCT02312219|81746131|FG001|Overall Study|Other|1|||
27976131|NCT02312219|81746130|FG000|Overall Study|Not randomized. Ineligible|0|||
27976132|NCT02312219|81746131|FG001|Overall Study|Not randomized. Ineligible|1|||
27976133|NCT00875056|81746132|FG000|Overall Study|Adverse Event|6|||
27976134|NCT00875056|81746133|FG001|Overall Study|Adverse Event|1|||
27976135|NCT00875056|81746134|FG002|Overall Study|Adverse Event|2|||
27976136|NCT00875056|81746132|FG000|Overall Study|Progressive Disease|14|||
27976137|NCT00875056|81746133|FG001|Overall Study|Progressive Disease|8|||
27976138|NCT00875056|81746134|FG002|Overall Study|Progressive Disease|3|||
27976139|NCT00875056|81746132|FG000|Overall Study|Withdrawal by Subject|3|||
27976140|NCT00875056|81746133|FG001|Overall Study|Withdrawal by Subject|0|||
27976141|NCT00875056|81746134|FG002|Overall Study|Withdrawal by Subject|1|||
27976142|NCT02142283|81746135|FG000|Overall Study|Death|20|||
27976143|NCT02142283|81746136|FG001|Overall Study|Death|18|||
27976144|NCT02142283|81746135|FG000|Overall Study|Withdrawal by Subject|1|||
27976145|NCT02142283|81746136|FG001|Overall Study|Withdrawal by Subject|3|||
27976146|NCT03349645|81746137|FG000|Overall Study|Sponsor Terminated Study|75|||
27976147|NCT03349645|81746137|FG000|Overall Study|Withdrawal by Subject|4|||
27976148|NCT03349645|81746137|FG000|Overall Study|Protocol Violation|1|||
27976149|NCT03349645|81746137|FG000|Overall Study|Other|2|||
27976150|NCT03455829|81746138|FG000|Overall Study|Death|2|||
27976151|NCT03455829|81746139|FG001|Overall Study|Death|3|||
27976152|NCT03455829|81746140|FG002|Overall Study|Death|2|||
27976153|NCT03455829|81746141|FG003|Overall Study|Death|4|||
27976154|NCT03455829|81746142|FG004|Overall Study|Death|2|||
27976155|NCT03455829|81746138|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
27976156|NCT03455829|81746139|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
27976157|NCT03455829|81746140|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
27976158|NCT03455829|81746141|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
27976159|NCT03455829|81746142|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
27976160|NCT03455829|81746138|FG000|Overall Study|Disease progression|0|||
27976161|NCT03455829|81746139|FG001|Overall Study|Disease progression|0|||
27976162|NCT03455829|81746140|FG002|Overall Study|Disease progression|0|||
27976163|NCT03455829|81746141|FG003|Overall Study|Disease progression|1|||
27976164|NCT03455829|81746142|FG004|Overall Study|Disease progression|1|||
27976165|NCT03553498|81746145|FG000|Overall Study|Missing primary outcome|1|||
27976166|NCT03553498|81746146|FG001|Overall Study|Missing primary outcome|2|||
27976167|NCT00933244|81746158|FG000|Overall Study|Withdrawal by Subject|5|||
27976168|NCT00933244|81746159|FG001|Overall Study|Withdrawal by Subject|1|||
27976169|NCT00933244|81746160|FG002|Overall Study|Withdrawal by Subject|3|||
27976170|NCT01669421|81746161|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
27976171|NCT01669421|81746161|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
27976172|NCT00171925|81746181|FG000|Overall Study|Adverse Event|10|||
27976173|NCT00171925|81746182|FG001|Overall Study|Adverse Event|6|||
27976174|NCT00171925|81746181|FG000|Overall Study|Protocol Violation|1|||
27573782|NCT01848990|80285748|FG002|Overall Study|Physician Decision|0|||
27573783|NCT01848990|80285746|FG000|Overall Study|Non Compliance|1|||
27788809|NCT00689728|81056133|FG002|Double-Blind Treatment|Protocol Violation|1|||
27788810|NCT00689728|81056131|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
27788811|NCT00689728|81056132|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
27788812|NCT00689728|81056133|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
27788813|NCT00689728|81056131|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
27788814|NCT00689728|81056132|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
27788815|NCT00689728|81056133|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
27788816|NCT00689728|81056131|FG000|Rescue|Adverse Event|0|||
27788817|NCT00689728|81056132|FG001|Rescue|Adverse Event|1|||
27788818|NCT00689728|81056133|FG002|Rescue|Adverse Event|0|||
27788819|NCT00689728|81056131|FG000|Rescue|Withdrawal by Subject|1|||
27788820|NCT00689728|81056132|FG001|Rescue|Withdrawal by Subject|1|||
27788821|NCT00689728|81056133|FG002|Rescue|Withdrawal by Subject|1|||
27788822|NCT00689728|81056131|FG000|Optional Follow-Up|Adverse Event|1|||
27788823|NCT00689728|81056132|FG001|Optional Follow-Up|Adverse Event|0|||
27788824|NCT00689728|81056133|FG002|Optional Follow-Up|Adverse Event|0|||
27788825|NCT00689728|81056131|FG000|Optional Follow-Up|Lack of Efficacy|0|||
27788826|NCT00689728|81056132|FG001|Optional Follow-Up|Lack of Efficacy|1|||
27788827|NCT00689728|81056133|FG002|Optional Follow-Up|Lack of Efficacy|1|||
27788828|NCT00689728|81056131|FG000|Optional Follow-Up|Lost to Follow-up|0|||
27788829|NCT00689728|81056132|FG001|Optional Follow-Up|Lost to Follow-up|1|||
27788830|NCT00689728|81056133|FG002|Optional Follow-Up|Lost to Follow-up|1|||
27788831|NCT00689728|81056131|FG000|Optional Follow-Up|Protocol Violation|0|||
27788832|NCT00689728|81056132|FG001|Optional Follow-Up|Protocol Violation|0|||
27788833|NCT00689728|81056133|FG002|Optional Follow-Up|Protocol Violation|1|||
27788834|NCT00689728|81056131|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
27788835|NCT00689728|81056132|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
27788836|NCT00689728|81056133|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
27788837|NCT03099096|81056134|FG000|Overall Study|Adverse Event|1|||
27788838|NCT03099096|81056134|FG000|Overall Study|Physician Decision|1|||
27788839|NCT02500732|81056135|FG000|Overall Study|Physician Decision|0|||
27788840|NCT02500732|81056136|FG001|Overall Study|Physician Decision|1|||
27788841|NCT00953576|81056137|FG000|Overall Study|Adverse Event|0|||
27788842|NCT00953576|81056138|FG001|Overall Study|Adverse Event|1|||
27788843|NCT00953576|81056137|FG000|Overall Study|Ineligible after Consent|2|||
27788844|NCT00953576|81056138|FG001|Overall Study|Ineligible after Consent|0|||
27788845|NCT00423137|81056141|FG000|Overall Study|Lost to Follow-up|0|||
27788846|NCT00423137|81056142|FG001|Overall Study|Lost to Follow-up|0|||
27788847|NCT00423137|81056143|FG002|Overall Study|Lost to Follow-up|1|||
27788848|NCT00423137|81056144|FG003|Overall Study|Lost to Follow-up|0|||
27788849|NCT00423137|81056141|FG000|Overall Study|Protocol Violation|0|||
27788850|NCT00423137|81056142|FG001|Overall Study|Protocol Violation|0|||
27788851|NCT00423137|81056143|FG002|Overall Study|Protocol Violation|0|||
27788852|NCT00423137|81056144|FG003|Overall Study|Protocol Violation|1|||
27788853|NCT00423137|81056141|FG000|Overall Study|Adverse Event Study disease worse|1|||
27788854|NCT00423137|81056142|FG001|Overall Study|Adverse Event Study disease worse|0|||
27788855|NCT00423137|81056143|FG002|Overall Study|Adverse Event Study disease worse|3|||
27788856|NCT00423137|81056144|FG003|Overall Study|Adverse Event Study disease worse|1|||
27788857|NCT00423137|81056141|FG000|Overall Study|Adverse Event Other|0|||
27788858|NCT00423137|81056142|FG001|Overall Study|Adverse Event Other|0|||
27788859|NCT00423137|81056143|FG002|Overall Study|Adverse Event Other|2|||
27788860|NCT00423137|81056144|FG003|Overall Study|Adverse Event Other|0|||
27788861|NCT04533204|81056145|FG000|Overall Study|Unable to understand training instructions|1|||
27788862|NCT04533204|81056146|FG001|Overall Study|Unable to understand training instructions|1|||
27788863|NCT01258803|81056149|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
27788864|NCT01258803|81056150|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
27788865|NCT01258803|81056151|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
27788866|NCT01258803|81056152|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
27788867|NCT01258803|81056153|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
27788868|NCT01258803|81056154|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
27788869|NCT01258803|81056149|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
27788870|NCT01258803|81056150|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
27788871|NCT01258803|81056151|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
27788872|NCT01258803|81056152|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
27788873|NCT01258803|81056153|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
27788874|NCT01258803|81056154|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
27788875|NCT01258803|81056149|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
27788876|NCT01258803|81056150|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
27788877|NCT01258803|81056151|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
27788878|NCT01258803|81056152|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
27788879|NCT01258803|81056153|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
27573784|NCT01848990|80285747|FG001|Overall Study|Non Compliance|0|||
27573785|NCT01848990|80285748|FG002|Overall Study|Non Compliance|0|||
27573786|NCT01848990|80285746|FG000|Overall Study|Death|1|||
27573787|NCT01848990|80285747|FG001|Overall Study|Death|0|||
27573788|NCT01848990|80285748|FG002|Overall Study|Death|1|||
27573789|NCT01848990|80285746|FG000|Overall Study|Other|1|||
27573790|NCT01848990|80285747|FG001|Overall Study|Other|4|||
27573791|NCT01848990|80285748|FG002|Overall Study|Other|2|||
27573792|NCT00281840|80285749|FG000|Overall Study|Adverse Event|12|||
27573793|NCT00281840|80285749|FG000|Overall Study|Physician Decision|6|||
27573794|NCT00281840|80285749|FG000|Overall Study|Withdrawal by Subject|3|||
27573795|NCT00281840|80285749|FG000|Overall Study|Disease Progression|2|||
27573796|NCT00281840|80285749|FG000|Overall Study|exceed maximum delay in treatment|1|||
27573797|NCT00281840|80285749|FG000|Overall Study|Complicating Disease|1|||
27573798|NCT04152447|80285750|FG000|Overall Study|Lost to Follow-up|1|||
27573799|NCT04152447|80285751|FG001|Overall Study|Lost to Follow-up|0|||
27573800|NCT04152447|80285750|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
27573801|NCT04152447|80285751|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
27573802|NCT04152447|80285750|FG000|Overall Study|Withdrawal by Subject|0|||
27573803|NCT04152447|80285751|FG001|Overall Study|Withdrawal by Subject|1|||
27573804|NCT04152447|80285750|FG000|Overall Study|Found ineligible after enrolling|1|||
27573805|NCT04152447|80285751|FG001|Overall Study|Found ineligible after enrolling|1|||
27573806|NCT04152447|80285750|FG000|Overall Study|Did not receive VR headset in time.|0|||
27573807|NCT04152447|80285751|FG001|Overall Study|Did not receive VR headset in time.|2|||
27573808|NCT00799617|80285752|FG000|Main Testosterone Trial|Randomized in error|1|||
27573809|NCT00799617|80285753|FG001|Main Testosterone Trial|Randomized in error|1|||
27573810|NCT00799617|80285752|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
27573811|NCT00799617|80285753|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
27573812|NCT00799617|80285752|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
27573813|NCT00799617|80285753|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
27573814|NCT00799617|80285752|FG000|Sexual Funtion Trial|No Baseline Data|4|||
27573815|NCT00799617|80285753|FG001|Sexual Funtion Trial|No Baseline Data|7|||
27976175|NCT00171925|81746182|FG001|Overall Study|Protocol Violation|1|||
27976176|NCT00171925|81746181|FG000|Overall Study|Withdrawal by Subject|6|||
27976177|NCT00171925|81746182|FG001|Overall Study|Withdrawal by Subject|9|||
27976178|NCT00171925|81746181|FG000|Overall Study|Lost to Follow-up|2|||
27976179|NCT00171925|81746182|FG001|Overall Study|Lost to Follow-up|2|||
27976180|NCT00171925|81746181|FG000|Overall Study|Administrative problems|10|||
27976181|NCT00171925|81746182|FG001|Overall Study|Administrative problems|11|||
27976182|NCT00171925|81746181|FG000|Overall Study|Death|1|||
27976183|NCT00171925|81746182|FG001|Overall Study|Death|2|||
27976184|NCT03834506|81746183|FG000|Overall Study|Death|336|||
27976185|NCT03834506|81746184|FG001|Overall Study|Death|326|||
27976186|NCT03834506|81746183|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27976187|NCT03834506|81746184|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27976188|NCT03834506|81746183|FG000|Overall Study|Withdrawal by Subject|10|||
27976189|NCT03834506|81746184|FG001|Overall Study|Withdrawal by Subject|8|||
27976190|NCT03834506|81746183|FG000|Overall Study|Sponsor decision|165|||
27976191|NCT03834506|81746184|FG001|Overall Study|Sponsor decision|178|||
27976192|NCT03834506|81746183|FG000|Overall Study|Physician Decision|3|||
27976193|NCT03834506|81746184|FG001|Overall Study|Physician Decision|1|||
27976194|NCT03834506|81746183|FG000|Overall Study|Lost to Follow-up|0|||
27976195|NCT03834506|81746184|FG001|Overall Study|Lost to Follow-up|1|||
27976196|NCT00413920|81746195|FG000|Overall Study|Adverse Event|9|||
27976197|NCT00413920|81746196|FG001|Overall Study|Adverse Event|11|||
27976198|NCT00413920|81746195|FG000|Overall Study|Lack of Efficacy|11|||
27976199|NCT00413920|81746196|FG001|Overall Study|Lack of Efficacy|9|||
27976200|NCT00413920|81746195|FG000|Overall Study|Death|3|||
27976201|NCT00413920|81746196|FG001|Overall Study|Death|5|||
27976202|NCT00413920|81746195|FG000|Overall Study|Graft Loss|5|||
27976203|NCT00413920|81746196|FG001|Overall Study|Graft Loss|3|||
27976204|NCT01367704|81746203|FG000|Overall Study|Lost to Follow-up|47|||
27976205|NCT01367704|81746204|FG001|Overall Study|Lost to Follow-up|161|||
27976206|NCT02370641|81746208|FG000|Overall Study|dropped study|4|||
27573816|NCT00799617|80285752|FG000|Physical Function Trial|Lost to Follow-up|6|||
27573817|NCT00799617|80285753|FG001|Physical Function Trial|Lost to Follow-up|11|||
27573818|NCT00799617|80285752|FG000|Vitality Trial|Lost to Follow-up|7|||
27573819|NCT00799617|80285753|FG001|Vitality Trial|Lost to Follow-up|22|||
27573820|NCT00799617|80285752|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
27573821|NCT00799617|80285753|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
27573822|NCT00799617|80285752|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
27976207|NCT02370641|81746209|FG001|Overall Study|dropped study|2|||
27976208|NCT01643850|81746210|FG000|Overall Study|Withdrawal by Subject|0|||
27976209|NCT01643850|81746211|FG001|Overall Study|Withdrawal by Subject|0|||
27976210|NCT01643850|81746212|FG002|Overall Study|Withdrawal by Subject|0|||
27976211|NCT01643850|81746213|FG003|Overall Study|Withdrawal by Subject|0|||
27976212|NCT01643850|81746214|FG004|Overall Study|Withdrawal by Subject|1|||
27976213|NCT01643850|81746215|FG005|Overall Study|Withdrawal by Subject|0|||
27976214|NCT01643850|81746216|FG006|Overall Study|Withdrawal by Subject|0|||
27976215|NCT01643850|81746217|FG007|Overall Study|Withdrawal by Subject|0|||
27976216|NCT01643850|81746218|FG008|Overall Study|Withdrawal by Subject|0|||
27976217|NCT01643850|81746210|FG000|Overall Study|Lost to Follow-up|0|||
27976218|NCT01643850|81746211|FG001|Overall Study|Lost to Follow-up|0|||
27976219|NCT01643850|81746212|FG002|Overall Study|Lost to Follow-up|0|||
27976220|NCT01643850|81746213|FG003|Overall Study|Lost to Follow-up|0|||
27976221|NCT01643850|81746214|FG004|Overall Study|Lost to Follow-up|0|||
27976222|NCT01643850|81746215|FG005|Overall Study|Lost to Follow-up|0|||
27976223|NCT01643850|81746216|FG006|Overall Study|Lost to Follow-up|1|||
27976224|NCT01643850|81746217|FG007|Overall Study|Lost to Follow-up|0|||
27976225|NCT01643850|81746218|FG008|Overall Study|Lost to Follow-up|1|||
27976226|NCT01643850|81746210|FG000|Overall Study|Adverse Event|0|||
27976227|NCT01643850|81746211|FG001|Overall Study|Adverse Event|0|||
27976228|NCT01643850|81746212|FG002|Overall Study|Adverse Event|0|||
27976229|NCT01643850|81746213|FG003|Overall Study|Adverse Event|0|||
27976230|NCT01643850|81746214|FG004|Overall Study|Adverse Event|1|||
27976231|NCT01643850|81746215|FG005|Overall Study|Adverse Event|0|||
27976232|NCT01643850|81746216|FG006|Overall Study|Adverse Event|0|||
27976233|NCT01643850|81746217|FG007|Overall Study|Adverse Event|0|||
27976234|NCT01643850|81746218|FG008|Overall Study|Adverse Event|0|||
27976235|NCT01643850|81746210|FG000|Overall Study|Administrative Problems|0|||
27976236|NCT01643850|81746211|FG001|Overall Study|Administrative Problems|0|||
27976237|NCT01643850|81746212|FG002|Overall Study|Administrative Problems|1|||
27976238|NCT01643850|81746213|FG003|Overall Study|Administrative Problems|0|||
27976239|NCT01643850|81746214|FG004|Overall Study|Administrative Problems|1|||
27976240|NCT01643850|81746215|FG005|Overall Study|Administrative Problems|0|||
27976241|NCT01643850|81746216|FG006|Overall Study|Administrative Problems|0|||
27976242|NCT01643850|81746217|FG007|Overall Study|Administrative Problems|0|||
27976243|NCT01643850|81746218|FG008|Overall Study|Administrative Problems|0|||
27976244|NCT02590562|81746219|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
27976245|NCT00536874|81746224|FG000|Overall Study|Adverse Event|1|||
27976246|NCT00536874|81746224|FG000|Overall Study|Death|2|||
27976247|NCT00536874|81746224|FG000|Overall Study|Withdrawal by Subject|1|||
27976248|NCT03089944|81746225|FG000|Overall Study|Lost to Follow-up|8|||
27788880|NCT01258803|81056154|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
27788881|NCT02210559|81056160|FG000|Overall Study|Progressive Disease|3|||
27976249|NCT03089944|81746225|FG000|Overall Study|Withdrew Consent|2|||
27976250|NCT03089944|81746225|FG000|Overall Study|Adverse Event|1|||
27976251|NCT03089944|81746225|FG000|Overall Study|Other|1|||
27976252|NCT04706273|81746229|FG000|Overall Study|Withdrawal by Subject|27|||
27976253|NCT04706273|81746229|FG000|Overall Study|Physician Decision|1|||
27976254|NCT04706273|81746229|FG000|Overall Study|Lost to Follow-up|42|||
27976255|NCT04706273|81746229|FG000|Overall Study|Death|85|||
27976256|NCT04706273|81746229|FG000|Overall Study|Amputation that removes study device|2|||
27976257|NCT04706273|81746229|FG000|Overall Study|Surgical bypass|3|||
27976258|NCT04706273|81746229|FG000|Overall Study|Changing hospital|23|||
27788882|NCT02210559|81056161|FG001|Overall Study|Progressive Disease|2|||
27788883|NCT02210559|81056160|FG000|Overall Study|Adverse Event|2|||
27788884|NCT02210559|81056161|FG001|Overall Study|Adverse Event|2|||
27788885|NCT02210559|81056160|FG000|Overall Study|Physician Decision|1|||
27788886|NCT02210559|81056161|FG001|Overall Study|Physician Decision|0|||
27573823|NCT00799617|80285753|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
27788887|NCT02210559|81056160|FG000|Overall Study|Withdrawal by Subject|0|||
27788888|NCT02210559|81056161|FG001|Overall Study|Withdrawal by Subject|1|||
27788889|NCT02210559|81056160|FG000|Overall Study|Other than specified|0|||
27788890|NCT02210559|81056161|FG001|Overall Study|Other than specified|1|||
27788891|NCT02304484|81056164|FG000|Overall Study|Death|9|||
27788892|NCT02304484|81056164|FG000|Overall Study|Withdrawal by Subject|14|||
27788893|NCT02304484|81056164|FG000|Overall Study|Lost to Follow-up|2|||
27788894|NCT03426995|81056165|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788895|NCT03426995|81056166|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788896|NCT03426995|81056167|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
27976259|NCT04706273|81746229|FG000|Overall Study|Unable to attend hospital|2|||
27976260|NCT01028716|81746230|FG000|Overall Study|Physician Decision|1|||
27976261|NCT00523705|81746241|FG000|Overall Study|No time for study.|0|||
27976262|NCT00523705|81746242|FG001|Overall Study|No time for study.|1|||
27976263|NCT02046174|81746245|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
27976264|NCT02046174|81746246|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
27976265|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
27976266|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
27867409|NCT00704132|81349583|FG001|Overall Study|Clinical Adverse Experience|0|||
27867410|NCT00704132|81349582|FG000|Overall Study|Lack of Efficacy|0|||
27867411|NCT00704132|81349583|FG001|Overall Study|Lack of Efficacy|1|||
27867412|NCT00704132|81349582|FG000|Overall Study|Withdrawal by Subject|0|||
27867413|NCT00704132|81349583|FG001|Overall Study|Withdrawal by Subject|1|||
27867414|NCT00492778|81349584|FG000|Overall Study|Ineligible by Pathology Review|8|||
27867415|NCT00492778|81349585|FG001|Overall Study|Ineligible by Pathology Review|1|||
27867416|NCT02276807|81349586|FG000|Overall Study|Withdrawal by Subject|8|||
27976267|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
27976268|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
27976269|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
27976270|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
27976271|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
27976272|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
27788897|NCT03426995|81056168|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27976273|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
27976274|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
27976275|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Other|1|||
27976276|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Other|1|||
27788898|NCT03426995|81056169|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788899|NCT03426995|81056170|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788900|NCT03426995|81056171|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788901|NCT03426995|81056172|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788902|NCT03426995|81056173|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788903|NCT03426995|81056174|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788904|NCT03426995|81056175|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788905|NCT03426995|81056176|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788906|NCT03426995|81056177|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788907|NCT03426995|81056178|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788908|NCT03426995|81056179|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788909|NCT03426995|81056180|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788910|NCT03426995|81056181|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788911|NCT03426995|81056182|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788912|NCT03426995|81056183|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
27788913|NCT03426995|81056165|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788914|NCT03426995|81056166|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788915|NCT03426995|81056167|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788916|NCT03426995|81056168|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788917|NCT03426995|81056169|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788918|NCT03426995|81056170|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
27788919|NCT03426995|81056171|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788920|NCT03426995|81056172|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788921|NCT03426995|81056173|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788922|NCT03426995|81056174|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788923|NCT03426995|81056175|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788924|NCT03426995|81056176|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788925|NCT03426995|81056177|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788926|NCT03426995|81056178|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788927|NCT03426995|81056179|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788928|NCT03426995|81056180|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788929|NCT03426995|81056181|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788930|NCT03426995|81056182|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788931|NCT03426995|81056183|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
27788932|NCT03426995|81056165|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788933|NCT03426995|81056166|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788934|NCT03426995|81056167|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788935|NCT03426995|81056168|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788936|NCT03426995|81056169|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
27788937|NCT03426995|81056170|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
27788938|NCT03426995|81056171|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788939|NCT03426995|81056172|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788940|NCT03426995|81056173|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27867417|NCT02276807|81349587|FG001|Overall Study|Withdrawal by Subject|7|||
27867418|NCT02276807|81349586|FG000|Overall Study|Lost to Follow-up|10|||
27867419|NCT02276807|81349587|FG001|Overall Study|Lost to Follow-up|10|||
27976277|NCT02075047|81746247|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
27788941|NCT03426995|81056174|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788942|NCT03426995|81056175|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788943|NCT03426995|81056176|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788944|NCT03426995|81056177|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788945|NCT03426995|81056178|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788946|NCT03426995|81056179|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788947|NCT03426995|81056180|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788948|NCT03426995|81056181|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788949|NCT03426995|81056182|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788950|NCT03426995|81056183|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
27788951|NCT03426995|81056165|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788952|NCT03426995|81056166|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788953|NCT03426995|81056167|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788954|NCT03426995|81056168|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788955|NCT03426995|81056169|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788956|NCT03426995|81056170|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788957|NCT03426995|81056171|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788958|NCT03426995|81056172|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788959|NCT03426995|81056173|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788960|NCT03426995|81056174|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788961|NCT03426995|81056175|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
27788962|NCT03426995|81056176|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788963|NCT03426995|81056177|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788964|NCT03426995|81056178|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788965|NCT03426995|81056179|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788966|NCT03426995|81056180|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788967|NCT03426995|81056181|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788968|NCT03426995|81056182|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788969|NCT03426995|81056183|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
27788970|NCT03426995|81056165|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788971|NCT03426995|81056166|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788972|NCT03426995|81056167|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788973|NCT03426995|81056168|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788974|NCT03426995|81056169|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788975|NCT03426995|81056170|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788976|NCT03426995|81056171|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788977|NCT03426995|81056172|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
27788978|NCT03426995|81056173|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788979|NCT03426995|81056174|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788980|NCT03426995|81056175|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788981|NCT03426995|81056176|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788982|NCT03426995|81056177|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788983|NCT03426995|81056178|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788984|NCT03426995|81056179|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788985|NCT03426995|81056180|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788986|NCT03426995|81056181|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788987|NCT03426995|81056182|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788988|NCT03426995|81056183|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
27788989|NCT03426995|81056165|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788990|NCT03426995|81056166|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788991|NCT03426995|81056167|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788992|NCT03426995|81056168|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788993|NCT03426995|81056169|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788994|NCT03426995|81056170|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788995|NCT03426995|81056171|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788996|NCT03426995|81056172|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788997|NCT03426995|81056173|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788998|NCT03426995|81056174|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27788999|NCT03426995|81056175|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27789000|NCT03426995|81056176|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27789001|NCT03426995|81056177|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27789002|NCT03426995|81056178|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27976278|NCT02075047|81746248|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
27976279|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
27976280|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
27789003|NCT03426995|81056179|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
27789004|NCT03426995|81056180|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
27789005|NCT03426995|81056181|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27789006|NCT03426995|81056182|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27789007|NCT03426995|81056183|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
27789008|NCT03426995|81056165|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789009|NCT03426995|81056166|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789010|NCT03426995|81056167|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789011|NCT03426995|81056168|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789012|NCT03426995|81056169|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789013|NCT03426995|81056170|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789014|NCT03426995|81056171|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789015|NCT03426995|81056172|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789016|NCT03426995|81056173|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789017|NCT03426995|81056174|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789018|NCT03426995|81056175|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789019|NCT03426995|81056176|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789020|NCT03426995|81056177|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27976281|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
27976282|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
27976283|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
27976284|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
27976285|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
27976286|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
27976287|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
27976288|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
27976289|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Other|1|||
27976290|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Other|2|||
27976291|NCT02075047|81746247|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
27976292|NCT02075047|81746248|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
27976293|NCT04569136|81746249|FG000|Overall Study|Lost to Follow-up|2|||
27976294|NCT04569136|81746250|FG001|Overall Study|Lost to Follow-up|0|||
27976295|NCT04569136|81746251|FG002|Overall Study|Lost to Follow-up|1|||
27976296|NCT01340937|81746252|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
27976297|NCT01340937|81746253|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
27976298|NCT01340937|81746254|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
27976299|NCT01340937|81746255|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
27976300|NCT01340937|81746252|FG000|Period 1: Infant Series|Adverse Event|0|||
27976301|NCT01340937|81746253|FG001|Period 1: Infant Series|Adverse Event|1|||
27976302|NCT01340937|81746254|FG002|Period 1: Infant Series|Adverse Event|4|||
27976303|NCT01340937|81746255|FG003|Period 1: Infant Series|Adverse Event|0|||
27976304|NCT01340937|81746252|FG000|Period 1: Infant Series|Death|2|||
27976305|NCT01340937|81746253|FG001|Period 1: Infant Series|Death|0|||
27976306|NCT01340937|81746254|FG002|Period 1: Infant Series|Death|2|||
27976307|NCT01340937|81746255|FG003|Period 1: Infant Series|Death|0|||
27976308|NCT01340937|81746252|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
27976309|NCT01340937|81746253|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
27976310|NCT01340937|81746254|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
27976311|NCT01340937|81746255|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
27976312|NCT01340937|81746252|FG000|Period 1: Infant Series|Physician Decision|2|||
27976313|NCT01340937|81746253|FG001|Period 1: Infant Series|Physician Decision|3|||
27976314|NCT01340937|81746254|FG002|Period 1: Infant Series|Physician Decision|1|||
27976315|NCT01340937|81746255|FG003|Period 1: Infant Series|Physician Decision|0|||
27976316|NCT01340937|81746252|FG000|Period 1: Infant Series|Protocol Violation|1|||
27976317|NCT01340937|81746253|FG001|Period 1: Infant Series|Protocol Violation|4|||
27789021|NCT03426995|81056178|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789022|NCT03426995|81056179|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
27789023|NCT03426995|81056180|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
27976318|NCT01340937|81746254|FG002|Period 1: Infant Series|Protocol Violation|4|||
27976319|NCT01340937|81746255|FG003|Period 1: Infant Series|Protocol Violation|3|||
27976320|NCT01340937|81746252|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
27976321|NCT01340937|81746253|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
27976322|NCT01340937|81746254|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
27976323|NCT01340937|81746255|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
27976324|NCT01340937|81746252|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
27976325|NCT01340937|81746253|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
27976326|NCT01340937|81746254|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
27976327|NCT01340937|81746255|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
27573824|NCT00799617|80285752|FG000|Bone Trial|Month 12 scan not available|6|||
27573825|NCT00799617|80285753|FG001|Bone Trial|Month 12 scan not available|16|||
27573826|NCT00799617|80285752|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
27573827|NCT00799617|80285753|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
27573828|NCT00799617|80285752|FG000|Anemia Trial|Withdrawal by Subject|3|||
27573829|NCT00799617|80285753|FG001|Anemia Trial|Withdrawal by Subject|3|||
27573830|NCT02708680|80285754|FG000|Overall Study|Withdrawal by Subject|4|||
27573831|NCT02708680|80285755|FG001|Overall Study|Withdrawal by Subject|12|||
27573832|NCT02708680|80285756|FG002|Overall Study|Withdrawal by Subject|12|||
27573833|NCT02708680|80285754|FG000|Overall Study|Death|4|||
27573834|NCT02708680|80285755|FG001|Overall Study|Death|19|||
27573835|NCT02708680|80285756|FG002|Overall Study|Death|21|||
27573836|NCT02708680|80285754|FG000|Overall Study|Lost to Follow-up|0|||
27573837|NCT02708680|80285755|FG001|Overall Study|Lost to Follow-up|3|||
27573838|NCT02708680|80285756|FG002|Overall Study|Lost to Follow-up|3|||
27573839|NCT02708680|80285754|FG000|Overall Study|Study Terminated By Sponsor|0|||
27573840|NCT02708680|80285755|FG001|Overall Study|Study Terminated By Sponsor|5|||
27573841|NCT02708680|80285756|FG002|Overall Study|Study Terminated By Sponsor|4|||
27573842|NCT02708680|80285754|FG000|Overall Study|Other than Specified|0|||
27573843|NCT02708680|80285755|FG001|Overall Study|Other than Specified|0|||
27573844|NCT02708680|80285756|FG002|Overall Study|Other than Specified|1|||
27573845|NCT02708680|80285754|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
27573846|NCT02708680|80285755|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
27573847|NCT02708680|80285756|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
27573848|NCT00480636|80285757|FG000|Overall Study|Death|12|||
27573849|NCT00480636|80285757|FG000|Overall Study|Lost to Follow-up|4|||
27573850|NCT00480636|80285757|FG000|Overall Study|Other|2|||
27573851|NCT00480636|80285757|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
27573852|NCT02316717|80285758|FG000|Overall Study|Adverse Event|2|||
27573853|NCT02316717|80285759|FG001|Overall Study|Adverse Event|2|||
27573854|NCT02316717|80285760|FG002|Overall Study|Adverse Event|0|||
27573855|NCT02316717|80285758|FG000|Overall Study|Lost to Follow-up|1|||
27573856|NCT02316717|80285759|FG001|Overall Study|Lost to Follow-up|2|||
27573857|NCT02316717|80285760|FG002|Overall Study|Lost to Follow-up|1|||
27573858|NCT02316717|80285758|FG000|Overall Study|Non compliance|3|||
27573859|NCT02316717|80285759|FG001|Overall Study|Non compliance|1|||
27573860|NCT02316717|80285760|FG002|Overall Study|Non compliance|0|||
27573861|NCT02316717|80285758|FG000|Overall Study|Protocol Violation|2|||
27573862|NCT02316717|80285759|FG001|Overall Study|Protocol Violation|0|||
27573863|NCT02316717|80285760|FG002|Overall Study|Protocol Violation|0|||
27573864|NCT02316717|80285758|FG000|Overall Study|Withdrawal by Subject|2|||
27573865|NCT02316717|80285759|FG001|Overall Study|Withdrawal by Subject|1|||
27573866|NCT02316717|80285760|FG002|Overall Study|Withdrawal by Subject|1|||
27573867|NCT02316717|80285758|FG000|Overall Study|Death|0|||
27573868|NCT02316717|80285759|FG001|Overall Study|Death|0|||
27573869|NCT02316717|80285760|FG002|Overall Study|Death|1|||
27573870|NCT02316717|80285758|FG000|Overall Study|Physician Decision|0|||
27573871|NCT02316717|80285759|FG001|Overall Study|Physician Decision|1|||
27573872|NCT02316717|80285760|FG002|Overall Study|Physician Decision|0|||
27573873|NCT02316717|80285758|FG000|Overall Study|TBC|1|||
27976328|NCT01340937|81746252|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
27976329|NCT01340937|81746253|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
27976330|NCT01340937|81746254|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
27573874|NCT02316717|80285759|FG001|Overall Study|TBC|0|||
27573875|NCT02316717|80285760|FG002|Overall Study|TBC|0|||
27573876|NCT00519649|80285761|FG000|Overall Study|Withdrawal by Subject|1|||
27573877|NCT00689481|80285763|FG000|Overall Study|Adverse Event|7|||
27573878|NCT00689481|80285764|FG001|Overall Study|Adverse Event|1|||
27573879|NCT00689481|80285763|FG000|Overall Study|Lost to Follow-up|4|||
27573880|NCT00689481|80285764|FG001|Overall Study|Lost to Follow-up|3|||
27573881|NCT00689481|80285763|FG000|Overall Study|Lack of Efficacy|4|||
27573882|NCT00689481|80285764|FG001|Overall Study|Lack of Efficacy|3|||
27573883|NCT00689481|80285763|FG000|Overall Study|Non-compliance with study treatment|1|||
27573884|NCT00689481|80285764|FG001|Overall Study|Non-compliance with study treatment|1|||
27573885|NCT00689481|80285763|FG000|Overall Study|Withdrawal by Subject|8|||
27573886|NCT00689481|80285764|FG001|Overall Study|Withdrawal by Subject|4|||
27976331|NCT01340937|81746255|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
27976332|NCT01340937|81746252|FG000|Period 2: Interim Period|Adverse Event|1|||
27976333|NCT01340937|81746253|FG001|Period 2: Interim Period|Adverse Event|0|||
27789024|NCT03426995|81056181|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27976334|NCT01340937|81746254|FG002|Period 2: Interim Period|Adverse Event|1|||
27976335|NCT01340937|81746255|FG003|Period 2: Interim Period|Adverse Event|0|||
27976336|NCT01340937|81746252|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
27976337|NCT01340937|81746253|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
27976338|NCT01340937|81746254|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
27976339|NCT01340937|81746255|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
27976340|NCT01340937|81746252|FG000|Period 2: Interim Period|Physician Decision|0|||
27976341|NCT01340937|81746253|FG001|Period 2: Interim Period|Physician Decision|1|||
27789025|NCT03426995|81056182|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789026|NCT03426995|81056183|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
27789027|NCT01590628|81056186|FG000|Overall Study|Death|2|||
27789028|NCT01590628|81056187|FG001|Overall Study|Death|0|||
27789029|NCT04145531|81056188|FG000|Part A|Adverse Event|2|||
27573887|NCT00689481|80285763|FG000|Overall Study|Excluded medication started during study|0|||
27789030|NCT04145531|81056189|FG001|Part A|Adverse Event|12|||
27789031|NCT04145531|81056190|FG002|Part A|Adverse Event|6|||
27789032|NCT04145531|81056191|FG003|Part A|Adverse Event|0|||
27789033|NCT04145531|81056188|FG000|Part A|Death|1|||
27789034|NCT04145531|81056189|FG001|Part A|Death|2|||
27789035|NCT04145531|81056190|FG002|Part A|Death|0|||
27789036|NCT04145531|81056191|FG003|Part A|Death|0|||
27789037|NCT04145531|81056188|FG000|Part A|Physician Decision|2|||
27789038|NCT04145531|81056189|FG001|Part A|Physician Decision|5|||
27789039|NCT04145531|81056190|FG002|Part A|Physician Decision|2|||
27789040|NCT04145531|81056191|FG003|Part A|Physician Decision|0|||
27789041|NCT04145531|81056188|FG000|Part A|Progressive disease|0|||
27789042|NCT04145531|81056189|FG001|Part A|Progressive disease|2|||
27789043|NCT04145531|81056190|FG002|Part A|Progressive disease|1|||
27789044|NCT04145531|81056191|FG003|Part A|Progressive disease|0|||
27867420|NCT03323398|81349588|FG000|Overall Study|Other than Specified|0|||
27976342|NCT01340937|81746254|FG002|Period 2: Interim Period|Physician Decision|1|||
27976343|NCT01340937|81746255|FG003|Period 2: Interim Period|Physician Decision|0|||
27976344|NCT01340937|81746252|FG000|Period 2: Interim Period|Protocol Violation|5|||
27976345|NCT01340937|81746253|FG001|Period 2: Interim Period|Protocol Violation|3|||
27976346|NCT01340937|81746254|FG002|Period 2: Interim Period|Protocol Violation|6|||
27976347|NCT01340937|81746255|FG003|Period 2: Interim Period|Protocol Violation|3|||
27976348|NCT01340937|81746252|FG000|Period 2: Interim Period|Technical problems|4|||
27573888|NCT00689481|80285764|FG001|Overall Study|Excluded medication started during study|1|||
27976349|NCT01340937|81746253|FG001|Period 2: Interim Period|Technical problems|4|||
27976350|NCT01340937|81746254|FG002|Period 2: Interim Period|Technical problems|6|||
27976351|NCT01340937|81746255|FG003|Period 2: Interim Period|Technical problems|3|||
27976352|NCT01340937|81746252|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
27976353|NCT01340937|81746253|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
27976354|NCT01340937|81746254|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
27976355|NCT01340937|81746255|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
27789045|NCT04145531|81056188|FG000|Part A|Protocol deviation|0|||
27976356|NCT01340937|81746252|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
27789046|NCT04145531|81056189|FG001|Part A|Protocol deviation|0|||
27789047|NCT04145531|81056190|FG002|Part A|Protocol deviation|1|||
27789048|NCT04145531|81056191|FG003|Part A|Protocol deviation|0|||
27789049|NCT04145531|81056188|FG000|Part A|Withdrawal by parent or guardian|1|||
27789050|NCT04145531|81056189|FG001|Part A|Withdrawal by parent or guardian|0|||
27789051|NCT04145531|81056190|FG002|Part A|Withdrawal by parent or guardian|0|||
27789052|NCT04145531|81056191|FG003|Part A|Withdrawal by parent or guardian|0|||
27789053|NCT04145531|81056188|FG000|Part A|Withdrawal by participant|0|||
27789054|NCT04145531|81056189|FG001|Part A|Withdrawal by participant|0|||
27976357|NCT01340937|81746253|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
27789055|NCT04145531|81056190|FG002|Part A|Withdrawal by participant|1|||
27789056|NCT04145531|81056191|FG003|Part A|Withdrawal by participant|0|||
27789057|NCT04145531|81056188|FG000|Part A|Other|0|||
27789058|NCT04145531|81056189|FG001|Part A|Other|0|||
27789059|NCT04145531|81056190|FG002|Part A|Other|1|||
27789060|NCT04145531|81056191|FG003|Part A|Other|0|||
27789061|NCT04145531|81056188|FG000|Part B|Adverse Event|0|||
27789062|NCT04145531|81056189|FG001|Part B|Adverse Event|0|||
27789063|NCT04145531|81056190|FG002|Part B|Adverse Event|0|||
27789064|NCT04145531|81056191|FG003|Part B|Adverse Event|21|||
27789065|NCT04145531|81056188|FG000|Part B|Physician Decision|0|||
27789066|NCT04145531|81056189|FG001|Part B|Physician Decision|0|||
27789067|NCT04145531|81056190|FG002|Part B|Physician Decision|0|||
27976358|NCT01340937|81746254|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
27976359|NCT01340937|81746255|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
27789068|NCT04145531|81056191|FG003|Part B|Physician Decision|7|||
27976360|NCT01340937|81746252|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
27976361|NCT01340937|81746253|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
27789069|NCT04145531|81056188|FG000|Part B|Progressive disease|0|||
27789070|NCT04145531|81056189|FG001|Part B|Progressive disease|0|||
27789071|NCT04145531|81056190|FG002|Part B|Progressive disease|0|||
27789072|NCT04145531|81056191|FG003|Part B|Progressive disease|1|||
27789073|NCT04145531|81056188|FG000|Part B|Recurrent disease|0|||
27789074|NCT04145531|81056189|FG001|Part B|Recurrent disease|0|||
27789075|NCT04145531|81056190|FG002|Part B|Recurrent disease|0|||
27789076|NCT04145531|81056191|FG003|Part B|Recurrent disease|1|||
27789077|NCT04145531|81056188|FG000|Part B|Withdrawal by parent or guardian|0|||
27789078|NCT04145531|81056189|FG001|Part B|Withdrawal by parent or guardian|0|||
27789079|NCT04145531|81056190|FG002|Part B|Withdrawal by parent or guardian|0|||
27789080|NCT04145531|81056191|FG003|Part B|Withdrawal by parent or guardian|3|||
27976362|NCT01340937|81746254|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
27976363|NCT01340937|81746255|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
27976364|NCT01340937|81746252|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
27976365|NCT01340937|81746253|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
27976366|NCT01340937|81746254|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
27976367|NCT01340937|81746255|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
27976368|NCT01149486|81746257|FG000|First Intervention|Adverse Event|0|||
27976369|NCT01149486|81746258|FG001|First Intervention|Adverse Event|1|||
27976370|NCT00098722|81746263|FG000|Double Blind Phase|Adverse Event|7|||
27976371|NCT00098722|81746264|FG001|Double Blind Phase|Adverse Event|7|||
27976372|NCT00098722|81746265|FG002|Double Blind Phase|Adverse Event|3|||
27976373|NCT00098722|81746266|FG003|Double Blind Phase|Adverse Event|0|||
27789081|NCT04145531|81056188|FG000|Part B|Withdrawal by participant|0|||
27789082|NCT04145531|81056189|FG001|Part B|Withdrawal by participant|0|||
27789083|NCT04145531|81056190|FG002|Part B|Withdrawal by participant|0|||
27789084|NCT04145531|81056191|FG003|Part B|Withdrawal by participant|1|||
27789085|NCT04145531|81056188|FG000|Part B|Other|0|||
27976374|NCT00098722|81746267|FG004|Double Blind Phase|Adverse Event|0|||
27976375|NCT00098722|81746268|FG005|Double Blind Phase|Adverse Event|0|||
27976376|NCT00098722|81746269|FG006|Double Blind Phase|Adverse Event|0|||
27789086|NCT04145531|81056189|FG001|Part B|Other|0|||
27789087|NCT04145531|81056190|FG002|Part B|Other|0|||
27789088|NCT04145531|81056191|FG003|Part B|Other|1|||
27789089|NCT01050998|81056192|FG000|Overall Study|Adverse Event|1|||
27789090|NCT01050998|81056193|FG001|Overall Study|Adverse Event|0|||
27789091|NCT01050998|81056194|FG002|Overall Study|Adverse Event|1|||
27789092|NCT01050998|81056195|FG003|Overall Study|Adverse Event|0|||
27789093|NCT01050998|81056196|FG004|Overall Study|Adverse Event|2|||
27789094|NCT01050998|81056192|FG000|Overall Study|Withdrawal by Subject|0|||
27789095|NCT01050998|81056193|FG001|Overall Study|Withdrawal by Subject|0|||
27789096|NCT01050998|81056194|FG002|Overall Study|Withdrawal by Subject|0|||
27789097|NCT01050998|81056195|FG003|Overall Study|Withdrawal by Subject|1|||
27976377|NCT00098722|81746263|FG000|Double Blind Phase|Death|2|||
27789098|NCT01050998|81056196|FG004|Overall Study|Withdrawal by Subject|3|||
27789099|NCT01050998|81056192|FG000|Overall Study|Other|3|||
27789100|NCT01050998|81056193|FG001|Overall Study|Other|2|||
27789101|NCT01050998|81056194|FG002|Overall Study|Other|1|||
27789102|NCT01050998|81056195|FG003|Overall Study|Other|1|||
27789103|NCT01050998|81056196|FG004|Overall Study|Other|5|||
27789104|NCT01050998|81056192|FG000|Overall Study|Data integrity issues|0|||
27789105|NCT01050998|81056193|FG001|Overall Study|Data integrity issues|0|||
27789106|NCT01050998|81056194|FG002|Overall Study|Data integrity issues|1|||
27789107|NCT01050998|81056195|FG003|Overall Study|Data integrity issues|1|||
27789108|NCT01050998|81056196|FG004|Overall Study|Data integrity issues|4|||
27976378|NCT00098722|81746264|FG001|Double Blind Phase|Death|5|||
27976379|NCT00098722|81746265|FG002|Double Blind Phase|Death|0|||
27976380|NCT00098722|81746266|FG003|Double Blind Phase|Death|0|||
27976381|NCT00098722|81746267|FG004|Double Blind Phase|Death|0|||
27976382|NCT00098722|81746268|FG005|Double Blind Phase|Death|0|||
27976383|NCT00098722|81746269|FG006|Double Blind Phase|Death|0|||
27976384|NCT00098722|81746263|FG000|Double Blind Phase|Lack of Efficacy|21|||
27976385|NCT00098722|81746264|FG001|Double Blind Phase|Lack of Efficacy|23|||
27976386|NCT00098722|81746265|FG002|Double Blind Phase|Lack of Efficacy|15|||
27976387|NCT00098722|81746266|FG003|Double Blind Phase|Lack of Efficacy|0|||
27976388|NCT00098722|81746267|FG004|Double Blind Phase|Lack of Efficacy|0|||
27976389|NCT00098722|81746268|FG005|Double Blind Phase|Lack of Efficacy|0|||
27976390|NCT00098722|81746269|FG006|Double Blind Phase|Lack of Efficacy|0|||
27976391|NCT00098722|81746263|FG000|Double Blind Phase|Participant defaulted|16|||
27976392|NCT00098722|81746264|FG001|Double Blind Phase|Participant defaulted|11|||
27976393|NCT00098722|81746265|FG002|Double Blind Phase|Participant defaulted|9|||
27976394|NCT00098722|81746266|FG003|Double Blind Phase|Participant defaulted|0|||
27976395|NCT00098722|81746267|FG004|Double Blind Phase|Participant defaulted|0|||
27976396|NCT00098722|81746268|FG005|Double Blind Phase|Participant defaulted|0|||
27976397|NCT00098722|81746269|FG006|Double Blind Phase|Participant defaulted|0|||
27976398|NCT00098722|81746263|FG000|Double Blind Phase|Pregnancy|1|||
27976399|NCT00098722|81746264|FG001|Double Blind Phase|Pregnancy|0|||
27976400|NCT00098722|81746265|FG002|Double Blind Phase|Pregnancy|0|||
27976401|NCT00098722|81746266|FG003|Double Blind Phase|Pregnancy|0|||
27976402|NCT00098722|81746267|FG004|Double Blind Phase|Pregnancy|0|||
27976403|NCT00098722|81746268|FG005|Double Blind Phase|Pregnancy|0|||
27976404|NCT00098722|81746269|FG006|Double Blind Phase|Pregnancy|0|||
27976405|NCT00098722|81746263|FG000|Double Blind Phase|Randomized, not treated|4|||
27976406|NCT00098722|81746264|FG001|Double Blind Phase|Randomized, not treated|3|||
27976407|NCT00098722|81746265|FG002|Double Blind Phase|Randomized, not treated|3|||
27976408|NCT00098722|81746266|FG003|Double Blind Phase|Randomized, not treated|0|||
27976409|NCT00098722|81746267|FG004|Double Blind Phase|Randomized, not treated|0|||
27976410|NCT00098722|81746268|FG005|Double Blind Phase|Randomized, not treated|0|||
27976411|NCT00098722|81746269|FG006|Double Blind Phase|Randomized, not treated|0|||
27976412|NCT00098722|81746263|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
27976413|NCT00098722|81746264|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
27976414|NCT00098722|81746265|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
27976415|NCT00098722|81746266|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
27976416|NCT00098722|81746267|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
27976417|NCT00098722|81746268|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
27976418|NCT00098722|81746269|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
27976419|NCT00098722|81746263|FG000|Double Blind Phase|Other|7|||
27976420|NCT00098722|81746264|FG001|Double Blind Phase|Other|8|||
27976421|NCT00098722|81746265|FG002|Double Blind Phase|Other|7|||
27976422|NCT00098722|81746266|FG003|Double Blind Phase|Other|0|||
27976423|NCT00098722|81746267|FG004|Double Blind Phase|Other|0|||
27976424|NCT00098722|81746268|FG005|Double Blind Phase|Other|0|||
27976425|NCT00098722|81746269|FG006|Double Blind Phase|Other|0|||
27976426|NCT00098722|81746263|FG000|Open Label Phase|Adverse Event|0|||
27976427|NCT00098722|81746264|FG001|Open Label Phase|Adverse Event|0|||
27976428|NCT00098722|81746265|FG002|Open Label Phase|Adverse Event|0|||
27976429|NCT00098722|81746266|FG003|Open Label Phase|Adverse Event|5|||
27976430|NCT00098722|81746267|FG004|Open Label Phase|Adverse Event|0|||
27976431|NCT00098722|81746268|FG005|Open Label Phase|Adverse Event|0|||
27976432|NCT00098722|81746269|FG006|Open Label Phase|Adverse Event|0|||
27976433|NCT00098722|81746263|FG000|Open Label Phase|Death|0|||
27789109|NCT02992743|81056198|FG000|Overall Study|Withdrawal by Subject|1|||
27789110|NCT02992743|81056199|FG001|Overall Study|Withdrawal by Subject|1|||
27789111|NCT02992743|81056198|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
27789112|NCT02992743|81056199|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
27976434|NCT00098722|81746264|FG001|Open Label Phase|Death|0|||
27976435|NCT00098722|81746265|FG002|Open Label Phase|Death|0|||
27976436|NCT00098722|81746266|FG003|Open Label Phase|Death|2|||
27976437|NCT00098722|81746267|FG004|Open Label Phase|Death|0|||
27976438|NCT00098722|81746268|FG005|Open Label Phase|Death|0|||
27976439|NCT00098722|81746269|FG006|Open Label Phase|Death|0|||
27976440|NCT00098722|81746263|FG000|Open Label Phase|Lack of Efficacy|0|||
27976441|NCT00098722|81746264|FG001|Open Label Phase|Lack of Efficacy|0|||
27976442|NCT00098722|81746265|FG002|Open Label Phase|Lack of Efficacy|0|||
27976443|NCT00098722|81746266|FG003|Open Label Phase|Lack of Efficacy|8|||
27976444|NCT00098722|81746267|FG004|Open Label Phase|Lack of Efficacy|0|||
27976445|NCT00098722|81746268|FG005|Open Label Phase|Lack of Efficacy|0|||
27976446|NCT00098722|81746269|FG006|Open Label Phase|Lack of Efficacy|0|||
27976447|NCT00098722|81746263|FG000|Open Label Phase|Pregnancy|0|||
27976448|NCT00098722|81746264|FG001|Open Label Phase|Pregnancy|0|||
27976449|NCT00098722|81746265|FG002|Open Label Phase|Pregnancy|0|||
27976450|NCT00098722|81746266|FG003|Open Label Phase|Pregnancy|1|||
27976451|NCT00098722|81746267|FG004|Open Label Phase|Pregnancy|0|||
27976452|NCT00098722|81746268|FG005|Open Label Phase|Pregnancy|0|||
27976453|NCT00098722|81746269|FG006|Open Label Phase|Pregnancy|0|||
27976454|NCT00098722|81746263|FG000|Open Label Phase|Participant defaulted|0|||
27976455|NCT00098722|81746264|FG001|Open Label Phase|Participant defaulted|0|||
27976456|NCT00098722|81746265|FG002|Open Label Phase|Participant defaulted|0|||
27976457|NCT00098722|81746266|FG003|Open Label Phase|Participant defaulted|18|||
27976458|NCT00098722|81746267|FG004|Open Label Phase|Participant defaulted|0|||
27573889|NCT00689481|80285763|FG000|Overall Study|Subject early term, left on vacation|0|||
27573890|NCT00689481|80285764|FG001|Overall Study|Subject early term, left on vacation|1|||
27976459|NCT00098722|81746268|FG005|Open Label Phase|Participant defaulted|0|||
27976460|NCT00098722|81746269|FG006|Open Label Phase|Participant defaulted|0|||
27976461|NCT00098722|81746263|FG000|Open Label Phase|Ongoing at cut-off date|0|||
27976462|NCT00098722|81746264|FG001|Open Label Phase|Ongoing at cut-off date|0|||
27976463|NCT00098722|81746265|FG002|Open Label Phase|Ongoing at cut-off date|0|||
27573891|NCT01631474|80285765|FG000|Overall Study|Lost to Follow-up|8|||
27976464|NCT00098722|81746266|FG003|Open Label Phase|Ongoing at cut-off date|220|||
27976465|NCT00098722|81746267|FG004|Open Label Phase|Ongoing at cut-off date|50|||
27976466|NCT00098722|81746268|FG005|Open Label Phase|Ongoing at cut-off date|0|||
27976467|NCT00098722|81746269|FG006|Open Label Phase|Ongoing at cut-off date|0|||
27976468|NCT00098722|81746263|FG000|Open Label Phase|Other|0|||
27976469|NCT00098722|81746264|FG001|Open Label Phase|Other|0|||
27976470|NCT00098722|81746265|FG002|Open Label Phase|Other|0|||
27976471|NCT00098722|81746266|FG003|Open Label Phase|Other|18|||
27976472|NCT00098722|81746267|FG004|Open Label Phase|Other|0|||
27976473|NCT00098722|81746268|FG005|Open Label Phase|Other|0|||
27976474|NCT00098722|81746269|FG006|Open Label Phase|Other|0|||
27976475|NCT00098722|81746263|FG000|Observation Phase|Death|0|||
27976476|NCT00098722|81746264|FG001|Observation Phase|Death|0|||
27976477|NCT00098722|81746265|FG002|Observation Phase|Death|0|||
27976478|NCT00098722|81746266|FG003|Observation Phase|Death|0|||
27976479|NCT00098722|81746267|FG004|Observation Phase|Death|0|||
27976480|NCT00098722|81746268|FG005|Observation Phase|Death|5|||
27976481|NCT00098722|81746269|FG006|Observation Phase|Death|3|||
27976482|NCT00098722|81746263|FG000|Observation Phase|Lack of Efficacy|0|||
27976483|NCT00098722|81746264|FG001|Observation Phase|Lack of Efficacy|0|||
27976484|NCT00098722|81746265|FG002|Observation Phase|Lack of Efficacy|0|||
27976485|NCT00098722|81746266|FG003|Observation Phase|Lack of Efficacy|0|||
27976486|NCT00098722|81746267|FG004|Observation Phase|Lack of Efficacy|0|||
27976487|NCT00098722|81746268|FG005|Observation Phase|Lack of Efficacy|2|||
27976488|NCT00098722|81746269|FG006|Observation Phase|Lack of Efficacy|0|||
27976489|NCT00098722|81746263|FG000|Observation Phase|Participant defaulted|0|||
27976490|NCT00098722|81746264|FG001|Observation Phase|Participant defaulted|0|||
27976491|NCT00098722|81746265|FG002|Observation Phase|Participant defaulted|0|||
27976492|NCT00098722|81746266|FG003|Observation Phase|Participant defaulted|0|||
27976493|NCT00098722|81746267|FG004|Observation Phase|Participant defaulted|0|||
27976494|NCT00098722|81746268|FG005|Observation Phase|Participant defaulted|17|||
27976495|NCT00098722|81746269|FG006|Observation Phase|Participant defaulted|4|||
27789113|NCT02992743|81056198|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
27789114|NCT02992743|81056199|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
27789115|NCT02992743|81056198|FG000|Overall Study|No measurable disease|1|||
27573892|NCT01631474|80285766|FG001|Overall Study|Lost to Follow-up|5|||
27789116|NCT02992743|81056199|FG001|Overall Study|No measurable disease|0|||
27789117|NCT02992743|81056198|FG000|Overall Study|Lost to Follow-up|0|||
27789118|NCT02992743|81056199|FG001|Overall Study|Lost to Follow-up|1|||
27789119|NCT04988035|81056200|FG000|Overall Study|Death|19|||
27789120|NCT04988035|81056201|FG001|Overall Study|Death|13|||
27976496|NCT00098722|81746263|FG000|Observation Phase|Other|0|||
27976497|NCT00098722|81746264|FG001|Observation Phase|Other|0|||
27976498|NCT00098722|81746265|FG002|Observation Phase|Other|0|||
27976499|NCT00098722|81746266|FG003|Observation Phase|Other|0|||
27976500|NCT00098722|81746267|FG004|Observation Phase|Other|0|||
27976501|NCT00098722|81746268|FG005|Observation Phase|Other|21|||
27976502|NCT00098722|81746269|FG006|Observation Phase|Other|10|||
27976503|NCT01688921|81746272|FG000|Overall Study|Lost to Follow-up|7|||
27976504|NCT01688921|81746273|FG001|Overall Study|Lost to Follow-up|13|||
27976505|NCT01688921|81746272|FG000|Overall Study|Physician Decision|6|||
27976506|NCT01688921|81746273|FG001|Overall Study|Physician Decision|1|||
27976507|NCT01688921|81746272|FG000|Overall Study|Protocol Violation|0|||
27789121|NCT04988035|81056200|FG000|Overall Study|Lost to Follow-up|12|||
27789122|NCT04988035|81056201|FG001|Overall Study|Lost to Follow-up|6|||
27789123|NCT04988035|81056200|FG000|Overall Study|Protocol Violation|0|||
27789124|NCT04988035|81056201|FG001|Overall Study|Protocol Violation|1|||
27867421|NCT03323398|81349589|FG001|Overall Study|Other than Specified|1|||
27867422|NCT03323398|81349590|FG002|Overall Study|Other than Specified|2|||
27976508|NCT01688921|81746273|FG001|Overall Study|Protocol Violation|1|||
27789125|NCT04988035|81056200|FG000|Overall Study|Withdrawal by Subject|2|||
27867423|NCT03323398|81349591|FG003|Overall Study|Other than Specified|0|||
27976509|NCT01688921|81746272|FG000|Overall Study|informed consent|3|||
27976510|NCT01688921|81746273|FG001|Overall Study|informed consent|0|||
27976511|NCT01328041|81746274|FG000|Overall Study|Adverse Event|7|||
27976512|NCT01328041|81746274|FG000|Overall Study|Lack of Efficacy|27|||
27976513|NCT01328041|81746274|FG000|Overall Study|Protocol Violation|7|||
27976514|NCT01328041|81746274|FG000|Overall Study|Lost to Follow-up|7|||
27976515|NCT01328041|81746274|FG000|Overall Study|Physician Decision|2|||
27976516|NCT01328041|81746274|FG000|Overall Study|Withdrawal by Subject|7|||
27976517|NCT04126564|81746275|FG000|Overall Study|Withdrawal by Subject|0|||
27976518|NCT04126564|81746276|FG001|Overall Study|Withdrawal by Subject|2|||
27976519|NCT04126564|81746275|FG000|Overall Study|Lost to Follow-up|0|||
27672033|NCT01296555|80639141|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672034|NCT01296555|80639142|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27976520|NCT04126564|81746276|FG001|Overall Study|Lost to Follow-up|1|||
27672035|NCT01296555|80639143|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27789126|NCT04988035|81056201|FG001|Overall Study|Withdrawal by Subject|4|||
27789127|NCT04988035|81056200|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
27789128|NCT04988035|81056201|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
27789129|NCT00489411|81056202|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
27789130|NCT00489411|81056203|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
27789131|NCT00489411|81056202|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
27789132|NCT00489411|81056203|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
27789133|NCT00489411|81056202|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
27789134|NCT00489411|81056203|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
27789135|NCT00489411|81056202|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
27789136|NCT00489411|81056203|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
27789137|NCT00489411|81056202|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
27789138|NCT00489411|81056203|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
27789139|NCT04837807|81056206|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
27789140|NCT04837807|81056207|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
27789141|NCT00429026|81056208|FG000|Overall Study|Inevaluable for response.|40|||
27789142|NCT02341482|81056212|FG000|Overall Study|Adverse Event|1|||
27789143|NCT01871870|81056214|FG000|Overall Study|Hardware issues|7|||
27789144|NCT01871870|81056214|FG000|Overall Study|hyperglycemia|2|||
27789145|NCT01308476|81056215|FG000|Overall Study|Lost to Follow-up|2|||
27976521|NCT03353922|81746277|FG000|Overall Study|Withdrawal by Subject|1|||
27976522|NCT03353922|81746278|FG001|Overall Study|Withdrawal by Subject|0|||
27976523|NCT03353922|81746279|FG002|Overall Study|Withdrawal by Subject|1|||
27976524|NCT03353922|81746280|FG003|Overall Study|Withdrawal by Subject|1|||
27867424|NCT03323398|81349592|FG004|Overall Study|Other than Specified|0|||
27976525|NCT03353922|81746281|FG004|Overall Study|Withdrawal by Subject|0|||
27976526|NCT03353922|81746282|FG005|Overall Study|Withdrawal by Subject|0|||
27976527|NCT03353922|81746277|FG000|Overall Study|Adverse Event|0|||
27976528|NCT03353922|81746278|FG001|Overall Study|Adverse Event|1|||
27976529|NCT03353922|81746279|FG002|Overall Study|Adverse Event|0|||
27976530|NCT03353922|81746280|FG003|Overall Study|Adverse Event|0|||
27976531|NCT03353922|81746281|FG004|Overall Study|Adverse Event|0|||
27976532|NCT03353922|81746282|FG005|Overall Study|Adverse Event|0|||
27976533|NCT00900146|81746283|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
27976534|NCT00900146|81746284|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
27976535|NCT00900146|81746285|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
27976536|NCT00900146|81746286|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
27976537|NCT00900146|81746287|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
27976538|NCT00900146|81746283|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
27976539|NCT00900146|81746284|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
27976540|NCT00900146|81746285|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
27976541|NCT00900146|81746286|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
27976542|NCT00900146|81746287|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
27976543|NCT00900146|81746283|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
27976544|NCT00900146|81746284|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27976545|NCT00900146|81746285|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27976546|NCT00900146|81746286|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27976547|NCT00900146|81746287|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
27976548|NCT00900146|81746283|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
27976549|NCT00900146|81746284|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
27976550|NCT00900146|81746285|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
27976551|NCT00900146|81746286|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
27976552|NCT00900146|81746287|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
27976553|NCT00900146|81746283|FG000|Intermediate: Period III|Lost to Follow-up|2|||
27976554|NCT00900146|81746284|FG001|Intermediate: Period III|Lost to Follow-up|0|||
27976555|NCT00900146|81746285|FG002|Intermediate: Period III|Lost to Follow-up|0|||
27976556|NCT00900146|81746286|FG003|Intermediate: Period III|Lost to Follow-up|0|||
27789146|NCT01308476|81056216|FG001|Overall Study|Lost to Follow-up|2|||
27789147|NCT01308476|81056215|FG000|Overall Study|Other|1|||
27789148|NCT01308476|81056216|FG001|Overall Study|Other|0|||
27789149|NCT04398030|81056220|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
27789150|NCT04398030|81056221|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
27789151|NCT04398030|81056220|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
27789152|NCT04398030|81056221|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
27789153|NCT01911546|81056222|FG000|Overall Study|Lost to Follow-up|1|||
27789154|NCT01911546|81056222|FG000|Overall Study|Everolimus was discontinued|5|||
27976557|NCT00900146|81746287|FG004|Intermediate: Period III|Lost to Follow-up|1|||
27976558|NCT00900146|81746283|FG000|Intermediate: Period III|Administrative problems|85|||
27789155|NCT00532441|81056223|FG000|Overall Study|Death|1|||
27976559|NCT00900146|81746284|FG001|Intermediate: Period III|Administrative problems|92|||
27976560|NCT00900146|81746285|FG002|Intermediate: Period III|Administrative problems|84|||
27976561|NCT00900146|81746286|FG003|Intermediate: Period III|Administrative problems|90|||
27976562|NCT00900146|81746287|FG004|Intermediate: Period III|Administrative problems|163|||
27976563|NCT01286987|81746291|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
27976564|NCT01286987|81746292|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
27976565|NCT01286987|81746293|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
27976566|NCT01286987|81746294|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
27976567|NCT01286987|81746295|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
27976568|NCT01286987|81746296|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
27976569|NCT01286987|81746297|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
27976570|NCT01286987|81746298|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
27976571|NCT01286987|81746299|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
27976572|NCT01286987|81746300|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
27976573|NCT01286987|81746301|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
27976574|NCT01286987|81746302|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
27976575|NCT01286987|81746303|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
27976576|NCT01286987|81746304|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
27976577|NCT01286987|81746305|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
27976578|NCT01286987|81746291|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
27976579|NCT01286987|81746292|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
27976580|NCT01286987|81746293|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
27976581|NCT01286987|81746294|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
27976582|NCT01286987|81746295|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
27573893|NCT01631474|80285767|FG002|Overall Study|Lost to Follow-up|7|||
27573894|NCT01631474|80285768|FG003|Overall Study|Lost to Follow-up|5|||
27573895|NCT01631474|80285769|FG004|Overall Study|Lost to Follow-up|5|||
27573896|NCT01631474|80285765|FG000|Overall Study|Withdrawal by Subject|4|||
27573897|NCT01631474|80285766|FG001|Overall Study|Withdrawal by Subject|4|||
27573898|NCT01631474|80285767|FG002|Overall Study|Withdrawal by Subject|2|||
27573899|NCT01631474|80285768|FG003|Overall Study|Withdrawal by Subject|6|||
27573900|NCT01631474|80285769|FG004|Overall Study|Withdrawal by Subject|5|||
27573901|NCT01631474|80285765|FG000|Overall Study|Lack of Efficacy|2|||
27573902|NCT01631474|80285766|FG001|Overall Study|Lack of Efficacy|2|||
27573903|NCT01631474|80285767|FG002|Overall Study|Lack of Efficacy|0|||
27573904|NCT01631474|80285768|FG003|Overall Study|Lack of Efficacy|0|||
27573905|NCT01631474|80285769|FG004|Overall Study|Lack of Efficacy|2|||
27573906|NCT01631474|80285765|FG000|Overall Study|Noncompliance with Study Drug|0|||
27573907|NCT01631474|80285766|FG001|Overall Study|Noncompliance with Study Drug|0|||
27976583|NCT01286987|81746296|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
27976584|NCT01286987|81746297|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
27976585|NCT01286987|81746298|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
27976586|NCT01286987|81746299|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
27976587|NCT01286987|81746300|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
27976588|NCT01286987|81746301|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
27976589|NCT01286987|81746302|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
27976590|NCT01286987|81746303|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
27976591|NCT01286987|81746304|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
27976592|NCT01286987|81746305|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
27976593|NCT01286987|81746291|FG000|Part 1: Dose Escalation|Physician Decision|0|||
27976594|NCT01286987|81746292|FG001|Part 1: Dose Escalation|Physician Decision|0|||
27976595|NCT01286987|81746293|FG002|Part 1: Dose Escalation|Physician Decision|0|||
27976596|NCT01286987|81746294|FG003|Part 1: Dose Escalation|Physician Decision|0|||
27976597|NCT01286987|81746295|FG004|Part 1: Dose Escalation|Physician Decision|1|||
27976598|NCT01286987|81746296|FG005|Part 1: Dose Escalation|Physician Decision|0|||
27976599|NCT01286987|81746297|FG006|Part 1: Dose Escalation|Physician Decision|0|||
27976600|NCT01286987|81746298|FG007|Part 1: Dose Escalation|Physician Decision|0|||
27976601|NCT01286987|81746299|FG008|Part 1: Dose Escalation|Physician Decision|0|||
27976602|NCT01286987|81746300|FG009|Part 1: Dose Escalation|Physician Decision|0|||
27976603|NCT01286987|81746301|FG010|Part 1: Dose Escalation|Physician Decision|0|||
27976604|NCT01286987|81746302|FG011|Part 1: Dose Escalation|Physician Decision|0|||
27976605|NCT01286987|81746303|FG012|Part 1: Dose Escalation|Physician Decision|0|||
27976606|NCT01286987|81746304|FG013|Part 1: Dose Escalation|Physician Decision|0|||
27976607|NCT01286987|81746305|FG014|Part 1: Dose Escalation|Physician Decision|0|||
27573908|NCT01631474|80285767|FG002|Overall Study|Noncompliance with Study Drug|0|||
27573909|NCT01631474|80285768|FG003|Overall Study|Noncompliance with Study Drug|0|||
27573910|NCT01631474|80285769|FG004|Overall Study|Noncompliance with Study Drug|1|||
27976608|NCT01286987|81746291|FG000|Part 2: Dose Expansion|Death|0|||
27976609|NCT01286987|81746292|FG001|Part 2: Dose Expansion|Death|0|||
27976610|NCT01286987|81746293|FG002|Part 2: Dose Expansion|Death|0|||
27976611|NCT01286987|81746294|FG003|Part 2: Dose Expansion|Death|0|||
27573911|NCT01631474|80285765|FG000|Overall Study|Adverse Event|0|||
27573912|NCT01631474|80285766|FG001|Overall Study|Adverse Event|1|||
27573913|NCT01631474|80285767|FG002|Overall Study|Adverse Event|0|||
27789156|NCT00532441|81056224|FG001|Overall Study|Death|0|||
27789157|NCT02815670|81056229|FG000|Overall Study|Prematurely discontinued of the trial|1|||
27976612|NCT01286987|81746295|FG004|Part 2: Dose Expansion|Death|0|||
27976613|NCT01286987|81746296|FG005|Part 2: Dose Expansion|Death|0|||
27976614|NCT01286987|81746297|FG006|Part 2: Dose Expansion|Death|0|||
27976615|NCT01286987|81746298|FG007|Part 2: Dose Expansion|Death|0|||
27976616|NCT01286987|81746299|FG008|Part 2: Dose Expansion|Death|0|||
27976617|NCT01286987|81746300|FG009|Part 2: Dose Expansion|Death|0|||
27789158|NCT00965458|81056238|FG000|Overall Study|Adverse Event|1|||
27789159|NCT00965458|81056239|FG001|Overall Study|Adverse Event|0|||
27789160|NCT00965458|81056238|FG000|Overall Study|Lost to Follow-up|1|||
27789161|NCT00965458|81056239|FG001|Overall Study|Lost to Follow-up|3|||
27789162|NCT00965458|81056238|FG000|Overall Study|Withdrawal by Subject|0|||
27789163|NCT00965458|81056239|FG001|Overall Study|Withdrawal by Subject|1|||
27789164|NCT01682876|81058889|FG000|Overall Study|Administrative reason|4|||
27789165|NCT01682876|81058890|FG001|Overall Study|Administrative reason|4|||
27789166|NCT01682876|81058891|FG002|Overall Study|Administrative reason|0|||
27789167|NCT01682876|81058892|FG003|Overall Study|Administrative reason|3|||
27789168|NCT01682876|81058889|FG000|Overall Study|Adverse Event|0|||
27789169|NCT01682876|81058890|FG001|Overall Study|Adverse Event|0|||
27789170|NCT01682876|81058891|FG002|Overall Study|Adverse Event|0|||
27789171|NCT01682876|81058892|FG003|Overall Study|Adverse Event|1|||
27789172|NCT01682876|81058889|FG000|Overall Study|Lost to Follow-up|11|||
27789173|NCT01682876|81058890|FG001|Overall Study|Lost to Follow-up|15|||
27789174|NCT01682876|81058891|FG002|Overall Study|Lost to Follow-up|9|||
27789175|NCT01682876|81058892|FG003|Overall Study|Lost to Follow-up|11|||
27789176|NCT01682876|81058889|FG000|Overall Study|Protocol Violation|1|||
27789177|NCT01682876|81058890|FG001|Overall Study|Protocol Violation|1|||
27789178|NCT01682876|81058891|FG002|Overall Study|Protocol Violation|1|||
27789179|NCT01682876|81058892|FG003|Overall Study|Protocol Violation|1|||
27789180|NCT01682876|81058889|FG000|Overall Study|Withdrawal by Subject|4|||
27789181|NCT01682876|81058890|FG001|Overall Study|Withdrawal by Subject|0|||
27789182|NCT01682876|81058891|FG002|Overall Study|Withdrawal by Subject|0|||
27789183|NCT01682876|81058892|FG003|Overall Study|Withdrawal by Subject|2|||
27789184|NCT01682876|81058889|FG000|Overall Study|Other|1|||
27789185|NCT01682876|81058890|FG001|Overall Study|Other|0|||
27789186|NCT01682876|81058891|FG002|Overall Study|Other|1|||
27789187|NCT01682876|81058892|FG003|Overall Study|Other|1|||
27789188|NCT01000311|81058894|FG000|Overall Study|Adverse Event|2|||
27789189|NCT01000311|81058895|FG001|Overall Study|Adverse Event|5|||
27789190|NCT01000311|81058894|FG000|Overall Study|Withdrawal by Subject|16|||
27789191|NCT01000311|81058895|FG001|Overall Study|Withdrawal by Subject|24|||
27789192|NCT01000311|81058894|FG000|Overall Study|Lost to Follow-up|15|||
27789193|NCT01000311|81058895|FG001|Overall Study|Lost to Follow-up|24|||
27976618|NCT01286987|81746301|FG010|Part 2: Dose Expansion|Death|0|||
27976619|NCT01286987|81746302|FG011|Part 2: Dose Expansion|Death|0|||
27976620|NCT01286987|81746303|FG012|Part 2: Dose Expansion|Death|1|||
27976621|NCT01286987|81746304|FG013|Part 2: Dose Expansion|Death|1|||
27789194|NCT01000311|81058894|FG000|Overall Study|Protocol Violation|1|||
27789195|NCT01000311|81058895|FG001|Overall Study|Protocol Violation|2|||
27789196|NCT01000311|81058894|FG000|Overall Study|Inappropriate enrollment|2|||
27789197|NCT01000311|81058895|FG001|Overall Study|Inappropriate enrollment|0|||
27789198|NCT01000311|81058894|FG000|Overall Study|Administrative reason|9|||
27789199|NCT01000311|81058895|FG001|Overall Study|Administrative reason|15|||
27789200|NCT01002573|81058896|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
27789201|NCT01002573|81058897|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
27789202|NCT02706327|81058900|FG000|Overall Study|Lost to Follow-up|1|||
27789203|NCT02706327|81058901|FG001|Overall Study|Lost to Follow-up|1|||
27789204|NCT02706327|81058902|FG002|Overall Study|Lost to Follow-up|2|||
27789205|NCT00348348|81058905|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
27789206|NCT00348348|81058906|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
27789207|NCT00348348|81058905|FG000|Overall Study|Lack of Efficacy|1|||
27789208|NCT00348348|81058906|FG001|Overall Study|Lack of Efficacy|1|||
27789209|NCT00348348|81058905|FG000|Overall Study|Lost to Follow-up|8|||
27789210|NCT00348348|81058906|FG001|Overall Study|Lost to Follow-up|10|||
27789211|NCT00348348|81058905|FG000|Overall Study|Withdrawal by Subject|4|||
27789212|NCT00348348|81058906|FG001|Overall Study|Withdrawal by Subject|1|||
27976622|NCT01286987|81746305|FG014|Part 2: Dose Expansion|Death|0|||
27976623|NCT01286987|81746291|FG000|Part 2: Dose Expansion|Physician Decision|0|||
27789213|NCT00348348|81058905|FG000|Overall Study|Other|7|||
27789214|NCT00348348|81058906|FG001|Overall Study|Other|4|||
27789215|NCT00348348|81058905|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
27789216|NCT00348348|81058906|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
27789217|NCT00348348|81058905|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
27789218|NCT00348348|81058906|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
27789219|NCT00348348|81058905|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
27789220|NCT00348348|81058906|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
27789221|NCT00348348|81058905|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
27789222|NCT00348348|81058906|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
27789223|NCT00348348|81058905|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
27789224|NCT00348348|81058906|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
27789225|NCT00348348|81058905|FG000|Overall Study|Adverse event probably related to study|1|||
27789226|NCT00348348|81058906|FG001|Overall Study|Adverse event probably related to study|0|||
27789227|NCT00346775|81058909|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
27789228|NCT00346775|81058910|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
27789229|NCT00346775|81058909|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
27789230|NCT00346775|81058910|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
27789231|NCT00346775|81058909|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
27789232|NCT00346775|81058910|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
27789233|NCT02491463|81058913|FG000|Overall Study|Withdrawal by Subject|1|||
27789234|NCT02491463|81058914|FG001|Overall Study|Withdrawal by Subject|2|||
27789235|NCT02491463|81058915|FG002|Overall Study|Withdrawal by Subject|0|||
27789236|NCT02491463|81058916|FG003|Overall Study|Withdrawal by Subject|0|||
27789237|NCT02491463|81058913|FG000|Overall Study|Migrated/moved from study area|1|||
27789238|NCT02491463|81058914|FG001|Overall Study|Migrated/moved from study area|5|||
27789239|NCT02491463|81058915|FG002|Overall Study|Migrated/moved from study area|1|||
27789240|NCT02491463|81058916|FG003|Overall Study|Migrated/moved from study area|1|||
27789241|NCT02491463|81058913|FG000|Overall Study|Lost to Follow-up|0|||
27789242|NCT02491463|81058914|FG001|Overall Study|Lost to Follow-up|3|||
27789243|NCT02491463|81058915|FG002|Overall Study|Lost to Follow-up|3|||
27789244|NCT02491463|81058916|FG003|Overall Study|Lost to Follow-up|0|||
27789245|NCT02059265|81058917|FG000|Overall Study|Ineligible|4|||
27789246|NCT01945034|81058926|FG000|Overall Study|Medication Error|0|||
27789247|NCT01945034|81058927|FG001|Overall Study|Medication Error|1|||
27789248|NCT01945034|81058928|FG002|Overall Study|Medication Error|0|||
27789249|NCT01945034|81058926|FG000|Overall Study|Withdrawal by Subject|0|||
27789250|NCT01945034|81058927|FG001|Overall Study|Withdrawal by Subject|3|||
27789251|NCT01945034|81058928|FG002|Overall Study|Withdrawal by Subject|1|||
27789252|NCT01945034|81058926|FG000|Overall Study|Other|0|||
27789253|NCT01945034|81058927|FG001|Overall Study|Other|1|||
27789254|NCT01945034|81058928|FG002|Overall Study|Other|3|||
27789255|NCT01945034|81058926|FG000|Overall Study|Lost to Follow-up|0|||
27789256|NCT01945034|81058927|FG001|Overall Study|Lost to Follow-up|0|||
27789257|NCT01945034|81058928|FG002|Overall Study|Lost to Follow-up|2|||
27789258|NCT01945034|81058926|FG000|Overall Study|Protocol Violation|1|||
27789259|NCT01945034|81058927|FG001|Overall Study|Protocol Violation|0|||
27789260|NCT01945034|81058928|FG002|Overall Study|Protocol Violation|1|||
27789261|NCT02120456|81058929|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789262|NCT02120456|81058930|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789263|NCT02120456|81058931|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789264|NCT02120456|81058932|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789265|NCT02120456|81058933|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789266|NCT02120456|81058934|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789267|NCT02120456|81058935|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
27789268|NCT02120456|81058936|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789269|NCT02120456|81058937|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
27789270|NCT02120456|81058929|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789271|NCT02120456|81058930|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789272|NCT02120456|81058931|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789273|NCT02120456|81058932|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789274|NCT02120456|81058933|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789275|NCT02120456|81058934|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789276|NCT02120456|81058935|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
27789277|NCT02120456|81058936|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789278|NCT02120456|81058937|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
27789279|NCT02120456|81058929|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789280|NCT02120456|81058930|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789281|NCT02120456|81058931|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789282|NCT02120456|81058932|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789283|NCT02120456|81058933|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789284|NCT02120456|81058934|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789285|NCT02120456|81058935|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789286|NCT02120456|81058936|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
27789287|NCT02120456|81058937|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
27789288|NCT01641952|81058938|FG000|Overall Study|Lost to Follow-up|28|||
27789289|NCT01641952|81058938|FG000|Overall Study|Adverse Event|6|||
27789290|NCT03246152|81058942|FG000|Overall Study|Lost to Follow-up|2|||
27789291|NCT03246152|81058942|FG000|Overall Study|Protocol Violation|1|||
27789292|NCT03557775|81058943|FG000|Overall Study|Withdrawal by Subject|1|||
27789293|NCT03557775|81058944|FG001|Overall Study|Withdrawal by Subject|2|||
27789294|NCT03557775|81058945|FG002|Overall Study|Withdrawal by Subject|4|||
27789295|NCT03557775|81058943|FG000|Overall Study|Physician Decision|0|||
27789296|NCT03557775|81058944|FG001|Overall Study|Physician Decision|1|||
27789297|NCT03557775|81058945|FG002|Overall Study|Physician Decision|0|||
27789298|NCT02503215|81058950|FG000|Overall Study|Unable to wear compression stockings|1|||
27789299|NCT02503215|81058950|FG000|Overall Study|Unable to use positive airway pressure|2|||
27789300|NCT03000075|81058951|FG000|Part A|Adverse Event|4|||
27789301|NCT03000075|81058952|FG001|Part A|Adverse Event|0|||
27789302|NCT03000075|81058953|FG002|Part A|Adverse Event|0|||
27789303|NCT03000075|81058954|FG003|Part A|Adverse Event|0|||
27789304|NCT03000075|81058955|FG004|Part A|Adverse Event|0|||
27789305|NCT03000075|81058956|FG005|Part A|Adverse Event|0|||
27789306|NCT03000075|81058957|FG006|Part A|Adverse Event|0|||
27789307|NCT03000075|81058951|FG000|Part B|Not dosed due to AE|0|||
27789308|NCT03000075|81058952|FG001|Part B|Not dosed due to AE|0|||
27789309|NCT03000075|81058953|FG002|Part B|Not dosed due to AE|0|||
27789310|NCT03000075|81058954|FG003|Part B|Not dosed due to AE|0|||
27789311|NCT03000075|81058955|FG004|Part B|Not dosed due to AE|0|||
27789312|NCT03000075|81058956|FG005|Part B|Not dosed due to AE|2|||
27789313|NCT03000075|81058957|FG006|Part B|Not dosed due to AE|1|||
27789314|NCT03000075|81058951|FG000|Part B|Adverse Event|0|||
27789315|NCT03000075|81058952|FG001|Part B|Adverse Event|0|||
27789316|NCT03000075|81058953|FG002|Part B|Adverse Event|0|||
27789317|NCT03000075|81058954|FG003|Part B|Adverse Event|0|||
27789318|NCT03000075|81058955|FG004|Part B|Adverse Event|1|||
27789319|NCT03000075|81058956|FG005|Part B|Adverse Event|0|||
27789320|NCT03000075|81058957|FG006|Part B|Adverse Event|0|||
27789321|NCT00920582|81058958|FG000|Overall Study|Lost to Follow-up|5|||
27789322|NCT00920582|81058959|FG001|Overall Study|Lost to Follow-up|1|||
27789323|NCT00920582|81058960|FG002|Overall Study|Lost to Follow-up|2|||
27789324|NCT00920582|81058961|FG003|Overall Study|Lost to Follow-up|0|||
27789325|NCT00920582|81058958|FG000|Overall Study|Withdrawal by Subject|5|||
27789326|NCT00920582|81058959|FG001|Overall Study|Withdrawal by Subject|4|||
27789327|NCT00920582|81058960|FG002|Overall Study|Withdrawal by Subject|6|||
27789328|NCT00920582|81058961|FG003|Overall Study|Withdrawal by Subject|3|||
27789329|NCT00920582|81058958|FG000|Overall Study|Protocol Violation|1|||
27789330|NCT00920582|81058959|FG001|Overall Study|Protocol Violation|0|||
27789331|NCT00920582|81058960|FG002|Overall Study|Protocol Violation|0|||
27789332|NCT00920582|81058961|FG003|Overall Study|Protocol Violation|0|||
27789333|NCT00920582|81058958|FG000|Overall Study|Other|2|||
27789334|NCT00920582|81058959|FG001|Overall Study|Other|1|||
27789335|NCT00920582|81058960|FG002|Overall Study|Other|3|||
27789336|NCT00920582|81058961|FG003|Overall Study|Other|2|||
27789337|NCT02044094|81058965|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
27789338|NCT02044094|81058965|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
27789339|NCT02044094|81058965|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
27789340|NCT02044094|81058965|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
27789341|NCT02044094|81058965|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
27976624|NCT01286987|81746292|FG001|Part 2: Dose Expansion|Physician Decision|0|||
27976625|NCT01286987|81746293|FG002|Part 2: Dose Expansion|Physician Decision|0|||
27976626|NCT01286987|81746294|FG003|Part 2: Dose Expansion|Physician Decision|0|||
27976627|NCT01286987|81746295|FG004|Part 2: Dose Expansion|Physician Decision|0|||
27976628|NCT01286987|81746296|FG005|Part 2: Dose Expansion|Physician Decision|0|||
27976629|NCT01286987|81746297|FG006|Part 2: Dose Expansion|Physician Decision|0|||
27573914|NCT01631474|80285768|FG003|Overall Study|Adverse Event|0|||
27789342|NCT02044094|81058965|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
27789343|NCT02044094|81058965|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
27789344|NCT02044094|81058965|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
27789345|NCT00914940|81058974|FG000|D0 to D100 Post-transplant|Death|2|||
27867425|NCT03323398|81349593|FG005|Overall Study|Other than Specified|0|||
27789346|NCT00914940|81058974|FG000|D101 to 2 Years Post-transplant|Death|8|||
27789347|NCT00914940|81058974|FG000|2 Years to 5 Years Post-transplant|Death|3|||
27789348|NCT02950831|81058975|FG000|Overall Study|Lost to Follow-up|1|||
27789349|NCT02950831|81058975|FG000|Overall Study|Withdrawal by Subject|3|||
27789350|NCT02950831|81058975|FG000|Overall Study|stimulation trail failure|5|||
27789351|NCT01479777|81058976|FG000|Overall Study|Physician Decision|2|||
27867426|NCT03323398|81349594|FG006|Overall Study|Other than Specified|1|||
27789352|NCT02283411|81058980|FG000|Overall Study|Withdrawal by Subject|3|||
27789353|NCT02283411|81058980|FG000|Overall Study|Screen Failed|28|||
27789354|NCT01707667|81058981|FG000|Period 1|expulsion of colonic sensor catheter|1|||
27976630|NCT01286987|81746298|FG007|Part 2: Dose Expansion|Physician Decision|0|||
27976631|NCT01286987|81746299|FG008|Part 2: Dose Expansion|Physician Decision|0|||
27789355|NCT01707667|81058982|FG001|Period 1|expulsion of colonic sensor catheter|0|||
27789356|NCT01608321|81058983|FG000|Overall Study|Withdrawal by Subject|1|||
27789357|NCT01608321|81058984|FG001|Overall Study|Withdrawal by Subject|0|||
27789358|NCT01733758|81058987|FG000|Overall Study|Adverse Event|5|||
27789359|NCT01733758|81058988|FG001|Overall Study|Adverse Event|7|||
27789360|NCT01733758|81058989|FG002|Overall Study|Adverse Event|8|||
27789361|NCT01733758|81058990|FG003|Overall Study|Adverse Event|1|||
27789362|NCT01733758|81058987|FG000|Overall Study|Withdrawal by Subject|1|||
27789363|NCT01733758|81058988|FG001|Overall Study|Withdrawal by Subject|1|||
27789364|NCT01733758|81058989|FG002|Overall Study|Withdrawal by Subject|5|||
27789365|NCT01733758|81058990|FG003|Overall Study|Withdrawal by Subject|3|||
27789366|NCT01733758|81058987|FG000|Overall Study|Persistent Hyperglycemia|3|||
27789367|NCT01733758|81058988|FG001|Overall Study|Persistent Hyperglycemia|2|||
27789368|NCT01733758|81058989|FG002|Overall Study|Persistent Hyperglycemia|0|||
27789369|NCT01733758|81058990|FG003|Overall Study|Persistent Hyperglycemia|0|||
27789370|NCT01733758|81058987|FG000|Overall Study|Protocol Violation|0|||
27789371|NCT01733758|81058988|FG001|Overall Study|Protocol Violation|1|||
27789372|NCT01733758|81058989|FG002|Overall Study|Protocol Violation|2|||
27789373|NCT01733758|81058990|FG003|Overall Study|Protocol Violation|2|||
27789374|NCT01733758|81058987|FG000|Overall Study|Non-compliance|1|||
27976632|NCT01286987|81746300|FG009|Part 2: Dose Expansion|Physician Decision|0|||
27976633|NCT01286987|81746301|FG010|Part 2: Dose Expansion|Physician Decision|1|||
27976634|NCT01286987|81746302|FG011|Part 2: Dose Expansion|Physician Decision|1|||
27976635|NCT01286987|81746303|FG012|Part 2: Dose Expansion|Physician Decision|0|||
27976636|NCT01286987|81746304|FG013|Part 2: Dose Expansion|Physician Decision|1|||
27976637|NCT01286987|81746305|FG014|Part 2: Dose Expansion|Physician Decision|0|||
27976638|NCT01286987|81746291|FG000|Part 2: Dose Expansion|Other|0|||
27976639|NCT01286987|81746292|FG001|Part 2: Dose Expansion|Other|0|||
27976640|NCT01286987|81746293|FG002|Part 2: Dose Expansion|Other|0|||
27976641|NCT01286987|81746294|FG003|Part 2: Dose Expansion|Other|0|||
27976642|NCT01286987|81746295|FG004|Part 2: Dose Expansion|Other|0|||
27976643|NCT01286987|81746296|FG005|Part 2: Dose Expansion|Other|0|||
27976644|NCT01286987|81746297|FG006|Part 2: Dose Expansion|Other|0|||
27976645|NCT01286987|81746298|FG007|Part 2: Dose Expansion|Other|0|||
27976646|NCT01286987|81746299|FG008|Part 2: Dose Expansion|Other|0|||
27976647|NCT01286987|81746300|FG009|Part 2: Dose Expansion|Other|0|||
27976648|NCT01286987|81746301|FG010|Part 2: Dose Expansion|Other|0|||
27976649|NCT01286987|81746302|FG011|Part 2: Dose Expansion|Other|0|||
27976650|NCT01286987|81746303|FG012|Part 2: Dose Expansion|Other|0|||
27976651|NCT01286987|81746304|FG013|Part 2: Dose Expansion|Other|1|||
27976652|NCT01286987|81746305|FG014|Part 2: Dose Expansion|Other|0|||
27976653|NCT01286987|81746291|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
27976654|NCT01286987|81746292|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
27976655|NCT01286987|81746293|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
27976656|NCT01286987|81746294|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
27976657|NCT01286987|81746295|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
27976658|NCT01286987|81746296|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
27976659|NCT01286987|81746297|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
27976660|NCT01286987|81746298|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
27976661|NCT01286987|81746299|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
27976662|NCT01286987|81746300|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
27976663|NCT01286987|81746301|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
27976664|NCT01286987|81746302|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
27976665|NCT01286987|81746303|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
27976666|NCT01286987|81746304|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
27976667|NCT01286987|81746305|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
27976668|NCT01286987|81746291|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
27976669|NCT01286987|81746292|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
27976670|NCT01286987|81746293|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
27976671|NCT01286987|81746294|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
27976672|NCT01286987|81746295|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
27976673|NCT01286987|81746296|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
27976674|NCT01286987|81746297|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
27976675|NCT01286987|81746298|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
27976676|NCT01286987|81746299|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
27976677|NCT01286987|81746300|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
27976678|NCT01286987|81746301|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
27976679|NCT01286987|81746302|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
27976680|NCT01286987|81746303|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
27976681|NCT01286987|81746304|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
27976682|NCT01286987|81746305|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
27976683|NCT01286987|81746291|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976684|NCT01286987|81746292|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27789375|NCT01733758|81058988|FG001|Overall Study|Non-compliance|0|||
27789376|NCT01733758|81058989|FG002|Overall Study|Non-compliance|0|||
27789377|NCT01733758|81058990|FG003|Overall Study|Non-compliance|0|||
27976685|NCT01286987|81746293|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976686|NCT01286987|81746294|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27867427|NCT03323398|81349595|FG007|Overall Study|Other than Specified|0|||
27867428|NCT03323398|81349596|FG008|Overall Study|Other than Specified|2|||
27867429|NCT03323398|81349588|FG000|Overall Study|Lost to Follow-up|1|||
27867430|NCT03323398|81349589|FG001|Overall Study|Lost to Follow-up|2|||
27867431|NCT03323398|81349590|FG002|Overall Study|Lost to Follow-up|1|||
27867432|NCT03323398|81349591|FG003|Overall Study|Lost to Follow-up|0|||
27867433|NCT03323398|81349592|FG004|Overall Study|Lost to Follow-up|0|||
27867434|NCT03323398|81349593|FG005|Overall Study|Lost to Follow-up|0|||
27867435|NCT03323398|81349594|FG006|Overall Study|Lost to Follow-up|0|||
27867436|NCT03323398|81349595|FG007|Overall Study|Lost to Follow-up|0|||
27867437|NCT03323398|81349596|FG008|Overall Study|Lost to Follow-up|0|||
27867438|NCT03323398|81349588|FG000|Overall Study|Death|4|||
27867439|NCT03323398|81349589|FG001|Overall Study|Death|6|||
27867440|NCT03323398|81349590|FG002|Overall Study|Death|2|||
27867441|NCT03323398|81349591|FG003|Overall Study|Death|2|||
27867442|NCT03323398|81349592|FG004|Overall Study|Death|1|||
27867443|NCT03323398|81349593|FG005|Overall Study|Death|2|||
27867444|NCT03323398|81349594|FG006|Overall Study|Death|0|||
27867445|NCT03323398|81349595|FG007|Overall Study|Death|0|||
27867446|NCT03323398|81349596|FG008|Overall Study|Death|6|||
27867447|NCT03323398|81349588|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
27867448|NCT03323398|81349589|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
27867449|NCT03323398|81349590|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
27867450|NCT03323398|81349591|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
27867451|NCT03323398|81349592|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
27867452|NCT03323398|81349593|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
27867453|NCT03323398|81349594|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
27867454|NCT03323398|81349595|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
27867455|NCT03323398|81349596|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
27867456|NCT03323398|81349588|FG000|Overall Study|Withdrawal by Subject|2|||
27867457|NCT03323398|81349589|FG001|Overall Study|Withdrawal by Subject|1|||
27867458|NCT03323398|81349590|FG002|Overall Study|Withdrawal by Subject|3|||
27867459|NCT03323398|81349591|FG003|Overall Study|Withdrawal by Subject|0|||
27867460|NCT03323398|81349592|FG004|Overall Study|Withdrawal by Subject|0|||
27867461|NCT03323398|81349593|FG005|Overall Study|Withdrawal by Subject|1|||
27867462|NCT03323398|81349594|FG006|Overall Study|Withdrawal by Subject|0|||
27867463|NCT03323398|81349595|FG007|Overall Study|Withdrawal by Subject|0|||
27867464|NCT03323398|81349596|FG008|Overall Study|Withdrawal by Subject|0|||
27867465|NCT03323398|81349588|FG000|Overall Study|Participant was Put on Hospice|0|||
27867466|NCT03323398|81349589|FG001|Overall Study|Participant was Put on Hospice|0|||
27867467|NCT03323398|81349590|FG002|Overall Study|Participant was Put on Hospice|0|||
27867468|NCT03323398|81349591|FG003|Overall Study|Participant was Put on Hospice|0|||
27867469|NCT03323398|81349592|FG004|Overall Study|Participant was Put on Hospice|0|||
27867470|NCT03323398|81349593|FG005|Overall Study|Participant was Put on Hospice|0|||
27867471|NCT03323398|81349594|FG006|Overall Study|Participant was Put on Hospice|1|||
27867472|NCT03323398|81349595|FG007|Overall Study|Participant was Put on Hospice|0|||
27867473|NCT03323398|81349596|FG008|Overall Study|Participant was Put on Hospice|0|||
27867474|NCT03323398|81349588|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
27867475|NCT03323398|81349589|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
27867476|NCT03323398|81349590|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
27867477|NCT03323398|81349591|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
27867478|NCT03323398|81349592|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
27976687|NCT01286987|81746295|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976688|NCT01286987|81746296|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976689|NCT01286987|81746297|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976690|NCT01286987|81746298|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27867479|NCT03323398|81349593|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
27867480|NCT03323398|81349594|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
27867481|NCT03323398|81349595|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
27867482|NCT03323398|81349596|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
27867483|NCT04411914|81349597|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
27867484|NCT04411914|81349598|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
27867485|NCT01333397|81349600|FG000|Overall Study|Lost to Follow-up|1|||
27867486|NCT01333397|81349601|FG001|Overall Study|Lost to Follow-up|0|||
27867487|NCT01333397|81349602|FG002|Overall Study|Lost to Follow-up|0|||
27867488|NCT01333397|81349603|FG003|Overall Study|Lost to Follow-up|1|||
27867489|NCT01333397|81349604|FG004|Overall Study|Lost to Follow-up|0|||
27867490|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
27976691|NCT01286987|81746299|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976692|NCT01286987|81746300|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27867491|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
27867492|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
27867493|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
27867494|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
27867495|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
27867496|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
27867497|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
27867498|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
27867499|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
27976693|NCT01286987|81746301|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
27789378|NCT01733758|81058987|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
27789379|NCT01733758|81058988|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
27789380|NCT01733758|81058989|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
27789381|NCT01733758|81058990|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
27976694|NCT01286987|81746302|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976695|NCT01286987|81746303|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27789382|NCT01733758|81058987|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
27789383|NCT01733758|81058988|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
27976696|NCT01286987|81746304|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976697|NCT01286987|81746305|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
27976698|NCT00554619|81746306|FG000|Overall Study|Adverse Event|1|||
27976699|NCT00554619|81746306|FG000|Overall Study|Physician Decision|1|||
27976700|NCT00554619|81746306|FG000|Overall Study|Liver Function Test Abnormality|1|||
27976701|NCT01691014|81746307|FG000|Overall Study|Premature Termination|1|||
27976702|NCT01691014|81746308|FG001|Overall Study|Premature Termination|6|||
27976703|NCT01691014|81746309|FG002|Overall Study|Premature Termination|0|||
27976704|NCT01691014|81746310|FG003|Overall Study|Premature Termination|3|||
27976705|NCT01691014|81746307|FG000|Overall Study|Other|0|||
27976706|NCT01691014|81746308|FG001|Overall Study|Other|0|||
27976707|NCT01691014|81746309|FG002|Overall Study|Other|2|||
27867500|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
27867501|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
27867502|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
27867503|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
27789384|NCT01733758|81058989|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
27867504|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
27976708|NCT01691014|81746310|FG003|Overall Study|Other|0|||
27976709|NCT01691014|81746307|FG000|Overall Study|Withdrawal by Subject|0|||
27789385|NCT01733758|81058990|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
27789386|NCT04366258|81058993|FG000|Baseline Assessments|Screen Failure|21|||
27976710|NCT01691014|81746308|FG001|Overall Study|Withdrawal by Subject|1|||
27789387|NCT04366258|81058993|FG000|Baseline Assessments|Early Termination|3|||
27789388|NCT00399542|81058994|FG000|Overall Study|Adverse Event|18|||
27789389|NCT00399542|81058995|FG001|Overall Study|Adverse Event|15|||
27789390|NCT00399542|81058994|FG000|Overall Study|Protocol Violation|13|||
27789391|NCT00399542|81058995|FG001|Overall Study|Protocol Violation|3|||
27789392|NCT00399542|81058994|FG000|Overall Study|Withdrawal by Subject|28|||
27789393|NCT00399542|81058995|FG001|Overall Study|Withdrawal by Subject|10|||
27789394|NCT00399542|81058994|FG000|Overall Study|Lack of Efficacy|18|||
27789395|NCT00399542|81058995|FG001|Overall Study|Lack of Efficacy|8|||
27789396|NCT00399542|81058994|FG000|Overall Study|Lost to Follow-up|6|||
27789397|NCT00399542|81058995|FG001|Overall Study|Lost to Follow-up|6|||
27789398|NCT00399542|81058994|FG000|Overall Study|Other|1|||
27789399|NCT00399542|81058995|FG001|Overall Study|Other|0|||
27789400|NCT00399542|81058994|FG000|Overall Study|Physician Decision|0|||
27789401|NCT00399542|81058995|FG001|Overall Study|Physician Decision|1|||
27789402|NCT02190604|81059003|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789403|NCT02190604|81059004|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789404|NCT02190604|81059005|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789405|NCT02190604|81059006|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789406|NCT02190604|81059007|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789407|NCT02190604|81059008|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789408|NCT02190604|81059009|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789409|NCT02190604|81059010|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789410|NCT02190604|81059011|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789411|NCT02190604|81059012|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789412|NCT02190604|81059013|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789413|NCT02190604|81059014|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789414|NCT02190604|81059015|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789415|NCT02190604|81059016|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789416|NCT02190604|81059017|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
27789417|NCT02190604|81059018|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789418|NCT02190604|81059019|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789419|NCT02190604|81059020|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789420|NCT02190604|81059021|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
27789421|NCT02190604|81059003|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789422|NCT02190604|81059004|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789423|NCT02190604|81059005|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789424|NCT02190604|81059006|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789425|NCT02190604|81059007|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789426|NCT02190604|81059008|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27867505|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
27867506|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
27867507|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
27789427|NCT02190604|81059009|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789428|NCT02190604|81059010|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789429|NCT02190604|81059011|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789430|NCT02190604|81059012|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789431|NCT02190604|81059013|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789432|NCT02190604|81059014|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27976711|NCT01691014|81746309|FG002|Overall Study|Withdrawal by Subject|1|||
27976712|NCT01691014|81746310|FG003|Overall Study|Withdrawal by Subject|1|||
27976713|NCT01691014|81746307|FG000|Overall Study|Adverse Event|0|||
27976714|NCT01691014|81746308|FG001|Overall Study|Adverse Event|5|||
27976715|NCT01691014|81746309|FG002|Overall Study|Adverse Event|1|||
27976716|NCT01691014|81746310|FG003|Overall Study|Adverse Event|1|||
27976717|NCT01691014|81746307|FG000|Overall Study|Lack of Efficacy|2|||
27976718|NCT01691014|81746308|FG001|Overall Study|Lack of Efficacy|3|||
27976719|NCT01691014|81746309|FG002|Overall Study|Lack of Efficacy|7|||
27976720|NCT01691014|81746310|FG003|Overall Study|Lack of Efficacy|0|||
27789433|NCT02190604|81059015|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789434|NCT02190604|81059016|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
27789435|NCT02190604|81059017|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27672036|NCT01296555|80639144|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672037|NCT01296555|80639145|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672038|NCT01296555|80639146|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672039|NCT01296555|80639147|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672040|NCT01296555|80639148|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
27672041|NCT01296555|80639120|FG000|Overall Study|Death|0|||
27672042|NCT01296555|80639121|FG001|Overall Study|Death|0|||
27672043|NCT01296555|80639122|FG002|Overall Study|Death|0|||
27672044|NCT01296555|80639123|FG003|Overall Study|Death|2|||
27672045|NCT01296555|80639124|FG004|Overall Study|Death|1|||
27672046|NCT01296555|80639125|FG005|Overall Study|Death|0|||
27672047|NCT01296555|80639126|FG006|Overall Study|Death|2|||
27672048|NCT01296555|80639127|FG007|Overall Study|Death|0|||
27672049|NCT01296555|80639128|FG008|Overall Study|Death|0|||
27672050|NCT01296555|80639129|FG009|Overall Study|Death|1|||
27672051|NCT01296555|80639130|FG010|Overall Study|Death|0|||
27672052|NCT01296555|80639131|FG011|Overall Study|Death|1|||
27672053|NCT01296555|80639132|FG012|Overall Study|Death|0|||
27672054|NCT01296555|80639133|FG013|Overall Study|Death|2|||
27672055|NCT01296555|80639134|FG014|Overall Study|Death|27|||
27672056|NCT01296555|80639135|FG015|Overall Study|Death|15|||
27672057|NCT01296555|80639136|FG016|Overall Study|Death|11|||
27672058|NCT01296555|80639137|FG017|Overall Study|Death|11|||
27672059|NCT01296555|80639138|FG018|Overall Study|Death|17|||
27789436|NCT02190604|81059018|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789437|NCT02190604|81059019|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27976721|NCT02279719|81746311|FG000|Overall Study|Patients randomized but never treated|0|||
27976722|NCT02279719|81746312|FG001|Overall Study|Patients randomized but never treated|0|||
27672060|NCT01296555|80639139|FG019|Overall Study|Death|12|||
27672061|NCT01296555|80639140|FG020|Overall Study|Death|13|||
27672062|NCT01296555|80639141|FG021|Overall Study|Death|12|||
27672063|NCT01296555|80639142|FG022|Overall Study|Death|12|||
27672064|NCT01296555|80639143|FG023|Overall Study|Death|13|||
27672065|NCT01296555|80639144|FG024|Overall Study|Death|7|||
27672066|NCT01296555|80639145|FG025|Overall Study|Death|7|||
27672067|NCT01296555|80639146|FG026|Overall Study|Death|35|||
27672068|NCT01296555|80639147|FG027|Overall Study|Death|92|||
27789438|NCT02190604|81059020|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789439|NCT02190604|81059021|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
27789440|NCT00003526|81059022|FG000|Overall Study|Not evaluable|6|||
27789441|NCT00483119|81059025|FG000|Overall Study|Adverse Event|0|||
27789442|NCT00483119|81059026|FG001|Overall Study|Adverse Event|1|||
27789443|NCT00483119|81059025|FG000|Overall Study|Physician Decision|1|||
27789444|NCT00483119|81059026|FG001|Overall Study|Physician Decision|0|||
27789445|NCT03339999|81059027|FG000|Overall Study|Adverse Event|1|||
27789446|NCT03339999|81059028|FG001|Overall Study|Adverse Event|2|||
27789447|NCT03339999|81059029|FG002|Overall Study|Adverse Event|2|||
27789448|NCT03339999|81059030|FG003|Overall Study|Adverse Event|1|||
27789449|NCT03339999|81059027|FG000|Overall Study|Lack of Efficacy|0|||
27789450|NCT03339999|81059028|FG001|Overall Study|Lack of Efficacy|1|||
27789451|NCT03339999|81059029|FG002|Overall Study|Lack of Efficacy|0|||
27789452|NCT03339999|81059030|FG003|Overall Study|Lack of Efficacy|0|||
27789453|NCT03339999|81059027|FG000|Overall Study|Lost to Follow-up|0|||
27789454|NCT03339999|81059028|FG001|Overall Study|Lost to Follow-up|0|||
27789455|NCT03339999|81059029|FG002|Overall Study|Lost to Follow-up|0|||
27789456|NCT03339999|81059030|FG003|Overall Study|Lost to Follow-up|1|||
27789457|NCT03339999|81059027|FG000|Overall Study|Study Terminated by Sponsor|6|||
27789458|NCT03339999|81059028|FG001|Overall Study|Study Terminated by Sponsor|3|||
27789459|NCT03339999|81059029|FG002|Overall Study|Study Terminated by Sponsor|4|||
27789460|NCT03339999|81059030|FG003|Overall Study|Study Terminated by Sponsor|3|||
27976723|NCT02279719|81746313|FG002|Overall Study|Patients randomized but never treated|0|||
27976724|NCT02279719|81746314|FG003|Overall Study|Patients randomized but never treated|0|||
27976725|NCT02279719|81746315|FG004|Overall Study|Patients randomized but never treated|3|||
27976726|NCT02279719|81746316|FG005|Overall Study|Patients randomized but never treated|0|||
27976727|NCT02279719|81746317|FG006|Overall Study|Patients randomized but never treated|3|||
27976728|NCT02351349|81746319|FG000|Overall Study|Withdrawal by Subject|2|||
27976729|NCT02351349|81746320|FG001|Overall Study|Withdrawal by Subject|3|||
27976730|NCT00868530|81746321|FG000|Overall Study|Adverse Event|3|||
27976731|NCT00868530|81746321|FG000|Overall Study|Lost to Follow-up|1|||
27976732|NCT02594098|81746322|FG000|Overall Study|Lack of Efficacy|17|||
27976733|NCT02594098|81746323|FG001|Overall Study|Lack of Efficacy|6|||
27976734|NCT02594098|81746322|FG000|Overall Study|Withdrawal by Subject|1|||
27976735|NCT02594098|81746323|FG001|Overall Study|Withdrawal by Subject|3|||
27976736|NCT02594098|81746322|FG000|Overall Study|Terminated participation|6|||
27976737|NCT02594098|81746323|FG001|Overall Study|Terminated participation|2|||
27976738|NCT02594098|81746322|FG000|Overall Study|Seek alternative treatment|2|||
27976739|NCT02594098|81746323|FG001|Overall Study|Seek alternative treatment|1|||
27976740|NCT02594098|81746322|FG000|Overall Study|Other|0|||
27976741|NCT02594098|81746323|FG001|Overall Study|Other|1|||
27976742|NCT00496197|81746326|FG000|Overall Study|Discontinued study due to death|43|||
27976743|NCT00496197|81746326|FG000|Overall Study|Adverse Event|13|||
27976744|NCT00496197|81746326|FG000|Overall Study|Does not meet entrance criteria|5|||
27976745|NCT00496197|81746326|FG000|Overall Study|Insufficient clinical response|3|||
27976746|NCT00496197|81746326|FG000|Overall Study|Insufficient bacteriological response|10|||
27976747|NCT00496197|81746326|FG000|Overall Study|Lost to Follow-up|11|||
27976748|NCT00496197|81746326|FG000|Overall Study|Withdrawal by Subject|11|||
27976749|NCT00496197|81746326|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
27976750|NCT00496197|81746326|FG000|Overall Study|Other|14|||
27976751|NCT00496197|81746326|FG000|Overall Study|Protocol Violation|8|||
27976752|NCT03242772|81746327|FG000|Overall Study|Lost to Follow-up|2|||
27976753|NCT03242772|81746328|FG001|Overall Study|Lost to Follow-up|0|||
27976754|NCT03242772|81746327|FG000|Overall Study|Physician Decision|0|||
27976755|NCT03242772|81746328|FG001|Overall Study|Physician Decision|1|||
27976756|NCT03242772|81746327|FG000|Overall Study|Withdrawal by Subject|1|||
27976757|NCT03242772|81746328|FG001|Overall Study|Withdrawal by Subject|0|||
27976758|NCT00846040|81746329|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
27976759|NCT00846040|81746330|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
27976760|NCT00846040|81746331|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
27976761|NCT00846040|81746329|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
27976762|NCT00846040|81746330|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
27976763|NCT00846040|81746331|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
27976764|NCT01318070|81746332|FG000|Overall Study|Adverse Event|1|||
27789461|NCT02452320|81059032|FG000|Overall Study|Adverse Event|0|||
27789462|NCT02452320|81059033|FG001|Overall Study|Adverse Event|1|||
27789463|NCT02687815|81059038|FG000|Overall Study|Lost to Follow-up|2|||
27789464|NCT02687815|81059039|FG001|Overall Study|Lost to Follow-up|4|||
27789465|NCT02687815|81059038|FG000|Overall Study|Withdrawal by Subject|2|||
27976765|NCT01318070|81746333|FG001|Overall Study|Adverse Event|1|||
27976766|NCT01318070|81746334|FG002|Overall Study|Adverse Event|5|||
27976767|NCT01318070|81746332|FG000|Overall Study|Withdrawal by Subject|0|||
27976768|NCT01318070|81746333|FG001|Overall Study|Withdrawal by Subject|1|||
27976769|NCT01318070|81746334|FG002|Overall Study|Withdrawal by Subject|1|||
27976770|NCT01318070|81746332|FG000|Overall Study|Lack of Efficacy|0|||
27867508|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
27867509|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
27976771|NCT01318070|81746333|FG001|Overall Study|Lack of Efficacy|0|||
27976772|NCT01318070|81746334|FG002|Overall Study|Lack of Efficacy|1|||
27976773|NCT01318070|81746332|FG000|Overall Study|Principal Investigator Discretion|1|||
27976774|NCT01318070|81746333|FG001|Overall Study|Principal Investigator Discretion|0|||
27976775|NCT01318070|81746334|FG002|Overall Study|Principal Investigator Discretion|0|||
27976776|NCT00590824|81746335|FG000|Overall Study|Disease could not be resected|0|||
27976777|NCT00590824|81746336|FG001|Overall Study|Disease could not be resected|2|||
27976778|NCT00590824|81746337|FG002|Overall Study|Disease could not be resected|1|||
27976779|NCT00590824|81746338|FG003|Overall Study|Disease could not be resected|0|||
27976780|NCT00590824|81746335|FG000|Overall Study|Adverse Event|0|||
27976781|NCT00590824|81746336|FG001|Overall Study|Adverse Event|0|||
27976782|NCT00590824|81746337|FG002|Overall Study|Adverse Event|0|||
27976783|NCT00590824|81746338|FG003|Overall Study|Adverse Event|1|||
27976784|NCT00525824|81746340|FG000|Overall Study|Adverse Event|7|||
27976785|NCT00525824|81746341|FG001|Overall Study|Adverse Event|11|||
27976786|NCT00525824|81746342|FG002|Overall Study|Adverse Event|6|||
27976787|NCT00525824|81746343|FG003|Overall Study|Adverse Event|7|||
27976788|NCT00525824|81746340|FG000|Overall Study|Withdrawal by Subject|5|||
27976789|NCT00525824|81746341|FG001|Overall Study|Withdrawal by Subject|9|||
27976790|NCT00525824|81746342|FG002|Overall Study|Withdrawal by Subject|3|||
27976791|NCT00525824|81746343|FG003|Overall Study|Withdrawal by Subject|4|||
27976792|NCT00525824|81746340|FG000|Overall Study|Lost to Follow-up|4|||
27976793|NCT00525824|81746341|FG001|Overall Study|Lost to Follow-up|2|||
27976794|NCT00525824|81746342|FG002|Overall Study|Lost to Follow-up|4|||
27976795|NCT00525824|81746343|FG003|Overall Study|Lost to Follow-up|0|||
27976796|NCT00525824|81746340|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
27976797|NCT00525824|81746341|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
27867510|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
27867511|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
27976798|NCT00525824|81746342|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
27976799|NCT00525824|81746343|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
27976800|NCT00525824|81746340|FG000|Overall Study|Severe non-compliance|0|||
27976801|NCT00525824|81746341|FG001|Overall Study|Severe non-compliance|1|||
27976802|NCT00525824|81746342|FG002|Overall Study|Severe non-compliance|1|||
27976803|NCT00525824|81746343|FG003|Overall Study|Severe non-compliance|1|||
27976804|NCT00525824|81746340|FG000|Overall Study|Safety reasons|1|||
27976805|NCT00525824|81746341|FG001|Overall Study|Safety reasons|0|||
27976806|NCT00525824|81746342|FG002|Overall Study|Safety reasons|1|||
27976807|NCT00525824|81746343|FG003|Overall Study|Safety reasons|0|||
27976808|NCT00525824|81746340|FG000|Overall Study|Other|1|||
27976809|NCT00525824|81746341|FG001|Overall Study|Other|3|||
27976810|NCT00525824|81746342|FG002|Overall Study|Other|3|||
27976811|NCT00525824|81746343|FG003|Overall Study|Other|1|||
27976812|NCT02635347|81746344|FG000|Overall Study|Failed screening|20|||
27976813|NCT02635347|81746345|FG001|Overall Study|Failed screening|7|||
27976814|NCT02456636|81746346|FG000|Overall Study|Death|0|||
27976815|NCT02456636|81746347|FG001|Overall Study|Death|3|||
27976816|NCT02456636|81746348|FG002|Overall Study|Death|0|||
27976817|NCT02456636|81746346|FG000|Overall Study|Pregnancy|1|||
27976818|NCT02456636|81746347|FG001|Overall Study|Pregnancy|3|||
27976819|NCT02456636|81746348|FG002|Overall Study|Pregnancy|5|||
27976820|NCT02456636|81746346|FG000|Overall Study|Physician Decision|4|||
27976821|NCT02456636|81746347|FG001|Overall Study|Physician Decision|5|||
27976822|NCT02456636|81746348|FG002|Overall Study|Physician Decision|4|||
27976823|NCT02456636|81746346|FG000|Overall Study|Withdrawal by Subject|13|||
27976824|NCT02456636|81746347|FG001|Overall Study|Withdrawal by Subject|14|||
27976825|NCT02456636|81746348|FG002|Overall Study|Withdrawal by Subject|16|||
27976826|NCT02456636|81746346|FG000|Overall Study|Lost to Follow-up|50|||
27976827|NCT02456636|81746347|FG001|Overall Study|Lost to Follow-up|44|||
27976828|NCT02456636|81746348|FG002|Overall Study|Lost to Follow-up|50|||
27976829|NCT02838901|81746351|FG000|Overall Study|Withdrawal by Subject|1|||
27976830|NCT02838901|81746352|FG001|Overall Study|Withdrawal by Subject|1|||
27976831|NCT02838901|81746351|FG000|Overall Study|Lost to Follow-up|1|||
27976832|NCT02838901|81746352|FG001|Overall Study|Lost to Follow-up|1|||
27976833|NCT00664560|81746353|FG000|Overall Study|Adverse Event|19|||
27976834|NCT00664560|81746354|FG001|Overall Study|Adverse Event|16|||
27976835|NCT00664560|81746355|FG002|Overall Study|Adverse Event|7|||
27976836|NCT00664560|81746353|FG000|Overall Study|Withdrawal by Subject|9|||
27976837|NCT00664560|81746354|FG001|Overall Study|Withdrawal by Subject|13|||
27976838|NCT00664560|81746355|FG002|Overall Study|Withdrawal by Subject|7|||
27976839|NCT00664560|81746353|FG000|Overall Study|Lost to Follow-up|0|||
27976840|NCT00664560|81746354|FG001|Overall Study|Lost to Follow-up|2|||
27976841|NCT00664560|81746355|FG002|Overall Study|Lost to Follow-up|0|||
27573915|NCT01631474|80285769|FG004|Overall Study|Adverse Event|0|||
27573916|NCT02287896|80285770|FG000|Second Injection Visit|Withdrawal by Subject|0|||
27573917|NCT02287896|80285771|FG001|Second Injection Visit|Withdrawal by Subject|1|||
27573918|NCT02143843|80285772|FG000|Overall Study|Adverse Event|8|||
27573919|NCT02143843|80285772|FG000|Overall Study|Lack of Efficacy|2|||
27573920|NCT02143843|80285772|FG000|Overall Study|Withdrawal by Subject|2|||
27573921|NCT00528528|80285775|FG000|Overall Study|Lost to Follow-up|0|||
27573922|NCT00528528|80285776|FG001|Overall Study|Lost to Follow-up|0|||
27573923|NCT00528528|80285777|FG002|Overall Study|Lost to Follow-up|1|||
27573924|NCT00528528|80285778|FG003|Overall Study|Lost to Follow-up|1|||
27573925|NCT00528528|80285775|FG000|Overall Study|Ineligible to continue the trial|0|||
27573926|NCT00528528|80285776|FG001|Overall Study|Ineligible to continue the trial|0|||
27573927|NCT00528528|80285777|FG002|Overall Study|Ineligible to continue the trial|0|||
27976842|NCT00664560|81746353|FG000|Overall Study|Other|11|||
27976843|NCT00664560|81746354|FG001|Overall Study|Other|4|||
27976844|NCT00664560|81746355|FG002|Overall Study|Other|5|||
27976845|NCT00042432|81746357|FG000|Overall Study|Adverse Event|4|||
27976846|NCT00042432|81746358|FG001|Overall Study|Adverse Event|1|||
27976847|NCT00042432|81746357|FG000|Overall Study|Withdrawal by Subject|1|||
27976848|NCT00042432|81746358|FG001|Overall Study|Withdrawal by Subject|3|||
27976849|NCT00042432|81746357|FG000|Overall Study|Death|0|||
27976850|NCT00042432|81746358|FG001|Overall Study|Death|2|||
27976851|NCT00042432|81746357|FG000|Overall Study|Ineligibility determined|1|||
27976852|NCT00042432|81746358|FG001|Overall Study|Ineligibility determined|0|||
27976853|NCT00042432|81746357|FG000|Overall Study|Initiation of maintenance dialysis|1|||
27976854|NCT00042432|81746358|FG001|Overall Study|Initiation of maintenance dialysis|1|||
27976855|NCT00042432|81746357|FG000|Overall Study|Other|2|||
27976856|NCT00042432|81746358|FG001|Overall Study|Other|0|||
27976857|NCT02153346|81746361|FG000|Overall Study|Lost to Follow-up|11|||
27976858|NCT02956850|81746367|FG000|Overall Study|Withdrawal by Subject|0|||
27976859|NCT02956850|81746368|FG001|Overall Study|Withdrawal by Subject|0|||
27976860|NCT02956850|81746369|FG002|Overall Study|Withdrawal by Subject|0|||
27976861|NCT02956850|81746370|FG003|Overall Study|Withdrawal by Subject|0|||
27976862|NCT02956850|81746371|FG004|Overall Study|Withdrawal by Subject|0|||
27573928|NCT00528528|80285778|FG003|Overall Study|Ineligible to continue the trial|1|||
27573929|NCT00528528|80285775|FG000|Overall Study|Other|0|||
27976863|NCT02956850|81746372|FG005|Overall Study|Withdrawal by Subject|0|||
27976864|NCT02956850|81746373|FG006|Overall Study|Withdrawal by Subject|0|||
27976865|NCT02956850|81746374|FG007|Overall Study|Withdrawal by Subject|0|||
27976866|NCT02956850|81746375|FG008|Overall Study|Withdrawal by Subject|0|||
27976867|NCT02956850|81746376|FG009|Overall Study|Withdrawal by Subject|0|||
27573930|NCT00528528|80285776|FG001|Overall Study|Other|1|||
27573931|NCT00528528|80285777|FG002|Overall Study|Other|0|||
27573932|NCT00528528|80285778|FG003|Overall Study|Other|0|||
27573933|NCT00528528|80285775|FG000|Overall Study|Withdrawal by Subject|3|||
27573934|NCT00528528|80285776|FG001|Overall Study|Withdrawal by Subject|2|||
27573935|NCT00528528|80285777|FG002|Overall Study|Withdrawal by Subject|1|||
27573936|NCT00528528|80285778|FG003|Overall Study|Withdrawal by Subject|1|||
27573937|NCT00528528|80285775|FG000|Overall Study|Ongoing participant|0|||
27573938|NCT00528528|80285776|FG001|Overall Study|Ongoing participant|0|||
27573939|NCT00528528|80285777|FG002|Overall Study|Ongoing participant|1|||
27573940|NCT00528528|80285778|FG003|Overall Study|Ongoing participant|0|||
27573941|NCT00179647|80285787|FG000|Overall Study|Adverse Event|294|||
27573942|NCT00179647|80285787|FG000|Overall Study|Lack of Efficacy|478|||
27573943|NCT00179647|80285787|FG000|Overall Study|Withdrawal by Subject|83|||
27573944|NCT00179647|80285787|FG000|Overall Study|Lost to Follow-up|4|||
27573945|NCT00179647|80285787|FG000|Overall Study|Death|94|||
27573946|NCT00179647|80285787|FG000|Overall Study|Other|960|||
27573947|NCT03364049|80285788|FG000|Overall Study|Death|6|||
27573948|NCT03364049|80285789|FG001|Overall Study|Death|4|||
27573949|NCT03364049|80285790|FG002|Overall Study|Death|5|||
27573950|NCT03364049|80285791|FG003|Overall Study|Death|14|||
27573951|NCT03364049|80285788|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
27573952|NCT03364049|80285789|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
27573953|NCT03364049|80285790|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
27573954|NCT03364049|80285791|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
27573955|NCT03364049|80285788|FG000|Overall Study|Withdrawal by Subject|0|||
27573956|NCT03364049|80285789|FG001|Overall Study|Withdrawal by Subject|1|||
27573957|NCT03364049|80285790|FG002|Overall Study|Withdrawal by Subject|1|||
27573958|NCT03364049|80285791|FG003|Overall Study|Withdrawal by Subject|1|||
27573959|NCT01451424|80285792|FG000|Overall Study|Withdrawal by Subject|1|||
27573960|NCT01451424|80285793|FG001|Overall Study|Withdrawal by Subject|1|||
27573961|NCT01451424|80285794|FG002|Overall Study|Withdrawal by Subject|0|||
27573962|NCT01451424|80285795|FG003|Overall Study|Withdrawal by Subject|2|||
27573963|NCT01451424|80285792|FG000|Overall Study|Lost to Follow-up|0|||
27573964|NCT01451424|80285793|FG001|Overall Study|Lost to Follow-up|1|||
27573965|NCT01451424|80285794|FG002|Overall Study|Lost to Follow-up|0|||
27573966|NCT01451424|80285795|FG003|Overall Study|Lost to Follow-up|1|||
27573967|NCT01451424|80285792|FG000|Overall Study|Physician Decision|0|||
27573968|NCT01451424|80285793|FG001|Overall Study|Physician Decision|0|||
27573969|NCT01451424|80285794|FG002|Overall Study|Physician Decision|1|||
27573970|NCT01451424|80285795|FG003|Overall Study|Physician Decision|1|||
27573971|NCT01451424|80285792|FG000|Overall Study|Adverse Event|0|||
27573972|NCT01451424|80285793|FG001|Overall Study|Adverse Event|0|||
27573973|NCT01451424|80285794|FG002|Overall Study|Adverse Event|0|||
27789466|NCT02687815|81059039|FG001|Overall Study|Withdrawal by Subject|4|||
27789467|NCT01729559|81059042|FG000|Overall Study|Protocol Violation|31|||
27789468|NCT01729559|81059043|FG001|Overall Study|Protocol Violation|28|||
27573974|NCT01451424|80285795|FG003|Overall Study|Adverse Event|1|||
27573975|NCT01096784|80285797|FG000|Overall Study|Withdrawal by Subject|2|||
27573976|NCT01096784|80285798|FG001|Overall Study|Withdrawal by Subject|1|||
27573977|NCT01096784|80285797|FG000|Overall Study|Adverse Event|11|||
27573978|NCT01096784|80285798|FG001|Overall Study|Adverse Event|9|||
27573979|NCT01096784|80285797|FG000|Overall Study|Protocol Deviation|2|||
27573980|NCT01096784|80285798|FG001|Overall Study|Protocol Deviation|2|||
27573981|NCT01096784|80285797|FG000|Overall Study|Administrative Decision|0|||
27573982|NCT01096784|80285798|FG001|Overall Study|Administrative Decision|1|||
27573983|NCT01096784|80285797|FG000|Overall Study|Other Unspecified|0|||
27573984|NCT01096784|80285798|FG001|Overall Study|Other Unspecified|1|||
27573985|NCT02399085|80285799|FG000|Overall Study|Adverse Event|16|||
27573986|NCT02399085|80285799|FG000|Overall Study|Death|2|||
27573987|NCT02399085|80285799|FG000|Overall Study|Withdrawal by Subject|8|||
27573988|NCT02399085|80285799|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
27573989|NCT02399085|80285799|FG000|Overall Study|Physician Decision|5|||
27573990|NCT04399161|80285800|FG000|Overall Study|Withdrawal by Subject|1|||
27573991|NCT04399161|80285801|FG001|Overall Study|Withdrawal by Subject|0|||
27789469|NCT00596466|81059048|FG000|Overall Study|Lack of Efficacy|5|||
27789470|NCT00596466|81059048|FG000|Overall Study|Adverse Event|4|||
27789471|NCT00596466|81059048|FG000|Overall Study|Withdrawal by Subject|2|||
27789472|NCT00596466|81059048|FG000|Overall Study|Protocol Violation|2|||
27573992|NCT04399161|80285802|FG002|Overall Study|Withdrawal by Subject|2|||
27573993|NCT04399161|80285800|FG000|Overall Study|Protocol Violation|1|||
27573994|NCT04399161|80285801|FG001|Overall Study|Protocol Violation|2|||
27573995|NCT04399161|80285802|FG002|Overall Study|Protocol Violation|0|||
27573996|NCT04013191|80285803|FG000|Overall Study|Adverse Event|1|||
27789473|NCT00596466|81059048|FG000|Overall Study|Unpecified|2|||
27573997|NCT04013191|80285804|FG001|Overall Study|Adverse Event|0|||
27789474|NCT00596466|81059048|FG000|Overall Study|Enrolled, not treated|2|||
27573998|NCT02047110|80285805|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
27573999|NCT02047110|80285806|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
27574000|NCT02047110|80285807|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
27574001|NCT02047110|80285808|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
27574002|NCT02047110|80285805|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
27574003|NCT02047110|80285806|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
27574004|NCT02047110|80285807|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
27574005|NCT02047110|80285808|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
27574006|NCT02047110|80285805|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
27574007|NCT02047110|80285806|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
27574008|NCT02047110|80285807|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
27574009|NCT02047110|80285808|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
27574010|NCT02047110|80285805|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
27574011|NCT02047110|80285806|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
27574012|NCT02047110|80285807|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
27574013|NCT02047110|80285808|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
27574014|NCT02047110|80285805|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
27574015|NCT02047110|80285806|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
27574016|NCT02047110|80285807|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
27574017|NCT02047110|80285808|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
27574018|NCT02047110|80285805|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
27574019|NCT02047110|80285806|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
27574020|NCT02047110|80285807|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
27574021|NCT02047110|80285808|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
27574022|NCT02047110|80285805|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
27574023|NCT02047110|80285806|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
27574024|NCT02047110|80285807|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
27574025|NCT02047110|80285808|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
27574026|NCT02047110|80285805|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
27574027|NCT02047110|80285806|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
27574028|NCT02047110|80285807|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
27574029|NCT02047110|80285808|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
27574030|NCT02047110|80285805|FG000|Escape Treatment Period|Adverse Event|1|||
27574031|NCT02047110|80285806|FG001|Escape Treatment Period|Adverse Event|2|||
27574032|NCT02047110|80285807|FG002|Escape Treatment Period|Adverse Event|2|||
27574033|NCT02047110|80285808|FG003|Escape Treatment Period|Adverse Event|0|||
27574034|NCT02047110|80285805|FG000|Escape Treatment Period|Other than specified|1|||
27574035|NCT02047110|80285806|FG001|Escape Treatment Period|Other than specified|2|||
27574036|NCT02047110|80285807|FG002|Escape Treatment Period|Other than specified|0|||
27574037|NCT02047110|80285808|FG003|Escape Treatment Period|Other than specified|1|||
27574038|NCT02047110|80285805|FG000|OLE Treatment Period|Other than specified|0|||
27574039|NCT02047110|80285806|FG001|OLE Treatment Period|Other than specified|0|||
27574040|NCT02047110|80285807|FG002|OLE Treatment Period|Other than specified|1|||
27574041|NCT02047110|80285808|FG003|OLE Treatment Period|Other than specified|0|||
27574042|NCT00654381|80285809|FG000|1st Stage|Adverse Event|3|||
27574043|NCT00654381|80285810|FG001|1st Stage|Adverse Event|3|||
27574044|NCT00654381|80285811|FG002|1st Stage|Adverse Event|3|||
27789475|NCT00499694|81059049|FG000|Overall Study|Patient never received treatment.|1|||
27789476|NCT05056311|81059050|FG000|Overall Study|Lost to Follow-up|14|||
27574045|NCT00654381|80285812|FG003|1st Stage|Adverse Event|3|||
27574046|NCT00654381|80285813|FG004|1st Stage|Adverse Event|2|||
27574047|NCT00654381|80285814|FG005|1st Stage|Adverse Event|1|||
27574048|NCT00654381|80285809|FG000|1st Stage|Withdrawal by Subject|0|||
27574049|NCT00654381|80285810|FG001|1st Stage|Withdrawal by Subject|0|||
27574050|NCT00654381|80285811|FG002|1st Stage|Withdrawal by Subject|0|||
27574051|NCT00654381|80285812|FG003|1st Stage|Withdrawal by Subject|1|||
27574052|NCT00654381|80285813|FG004|1st Stage|Withdrawal by Subject|0|||
27574053|NCT00654381|80285814|FG005|1st Stage|Withdrawal by Subject|1|||
27574054|NCT00654381|80285809|FG000|1st Stage|Investigator's decision|0|||
27574055|NCT00654381|80285810|FG001|1st Stage|Investigator's decision|0|||
27574056|NCT00654381|80285811|FG002|1st Stage|Investigator's decision|0|||
27574057|NCT00654381|80285812|FG003|1st Stage|Investigator's decision|1|||
27574058|NCT00654381|80285813|FG004|1st Stage|Investigator's decision|0|||
27574059|NCT00654381|80285814|FG005|1st Stage|Investigator's decision|0|||
27574060|NCT00654381|80285809|FG000|2nd Stage|Adverse Event|2|||
27574061|NCT00654381|80285810|FG001|2nd Stage|Adverse Event|0|||
27574062|NCT00654381|80285811|FG002|2nd Stage|Adverse Event|2|||
27574063|NCT00654381|80285812|FG003|2nd Stage|Adverse Event|3|||
27574064|NCT00654381|80285813|FG004|2nd Stage|Adverse Event|7|||
27574065|NCT00654381|80285814|FG005|2nd Stage|Adverse Event|2|||
27574066|NCT00654381|80285809|FG000|2nd Stage|Withdrawal by Subject|0|||
27574067|NCT00654381|80285810|FG001|2nd Stage|Withdrawal by Subject|0|||
27574068|NCT00654381|80285811|FG002|2nd Stage|Withdrawal by Subject|0|||
27574069|NCT00654381|80285812|FG003|2nd Stage|Withdrawal by Subject|0|||
27574070|NCT00654381|80285813|FG004|2nd Stage|Withdrawal by Subject|1|||
27574071|NCT00654381|80285814|FG005|2nd Stage|Withdrawal by Subject|1|||
27574072|NCT00654381|80285809|FG000|2nd Stage|Investigator's decision|0|||
27574073|NCT00654381|80285810|FG001|2nd Stage|Investigator's decision|0|||
27574074|NCT00654381|80285811|FG002|2nd Stage|Investigator's decision|1|||
27574075|NCT00654381|80285812|FG003|2nd Stage|Investigator's decision|1|||
27574076|NCT00654381|80285813|FG004|2nd Stage|Investigator's decision|0|||
27574077|NCT00654381|80285814|FG005|2nd Stage|Investigator's decision|0|||
27574078|NCT00654381|80285809|FG000|Extension Stage|Adverse Event|1|||
27574079|NCT00654381|80285810|FG001|Extension Stage|Adverse Event|2|||
27574080|NCT00654381|80285811|FG002|Extension Stage|Adverse Event|9|||
27574081|NCT00654381|80285812|FG003|Extension Stage|Adverse Event|7|||
27574082|NCT00654381|80285813|FG004|Extension Stage|Adverse Event|1|||
27574083|NCT00654381|80285814|FG005|Extension Stage|Adverse Event|1|||
27574084|NCT00654381|80285809|FG000|Extension Stage|Protocol Violation|0|||
27574085|NCT00654381|80285810|FG001|Extension Stage|Protocol Violation|0|||
27574086|NCT00654381|80285811|FG002|Extension Stage|Protocol Violation|0|||
27574087|NCT00654381|80285812|FG003|Extension Stage|Protocol Violation|1|||
27574088|NCT00654381|80285813|FG004|Extension Stage|Protocol Violation|0|||
27574089|NCT00654381|80285814|FG005|Extension Stage|Protocol Violation|0|||
27574090|NCT00654381|80285809|FG000|Extension Stage|Lack of Efficacy|0|||
27574091|NCT00654381|80285810|FG001|Extension Stage|Lack of Efficacy|0|||
27574092|NCT00654381|80285811|FG002|Extension Stage|Lack of Efficacy|1|||
27574093|NCT00654381|80285812|FG003|Extension Stage|Lack of Efficacy|0|||
27574094|NCT00654381|80285813|FG004|Extension Stage|Lack of Efficacy|0|||
27574095|NCT00654381|80285814|FG005|Extension Stage|Lack of Efficacy|0|||
27574096|NCT00654381|80285809|FG000|Extension Stage|Withdrawal by Subject|0|||
27574097|NCT00654381|80285810|FG001|Extension Stage|Withdrawal by Subject|0|||
27672069|NCT01296555|80639148|FG028|Overall Study|Death|44|||
27672070|NCT01296555|80639120|FG000|Overall Study|Lost to Follow-up|0|||
27789477|NCT05056311|81059050|FG000|Overall Study|Withdrawal by Subject|1|||
27789478|NCT05056311|81059050|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
27789479|NCT03193996|81059051|FG000|Overall Study|Withdrawal by Subject|4|||
27789480|NCT03193996|81059051|FG000|Overall Study|Lost to Follow-up|4|||
27789481|NCT03193996|81059051|FG000|Overall Study|Physician Decision|2|||
27789482|NCT03193996|81059051|FG000|Overall Study|Pregnancy|1|||
27789483|NCT03193996|81059051|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
27789484|NCT03193996|81059051|FG000|Overall Study|Complicating disease|1|||
27789485|NCT00096031|81059052|FG000|Overall Study|Adverse Event|3|||
27867512|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
27867513|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
27867514|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
27789486|NCT00096031|81059052|FG000|Overall Study|Lack of Efficacy|42|||
27789487|NCT00096031|81059052|FG000|Overall Study|Death|4|||
27789488|NCT00096031|81059052|FG000|Overall Study|Withdrawal by Subject|1|||
27789489|NCT00096031|81059052|FG000|Overall Study|Ineligible|8|||
27789490|NCT00096031|81059052|FG000|Overall Study|Not protocol specified|5|||
27789491|NCT02147132|81059053|FG000|Overall Study|Lost to Follow-up|1|||
27867515|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
27867516|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
27867517|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
27574098|NCT00654381|80285811|FG002|Extension Stage|Withdrawal by Subject|1|||
27574099|NCT00654381|80285812|FG003|Extension Stage|Withdrawal by Subject|1|||
27574100|NCT00654381|80285813|FG004|Extension Stage|Withdrawal by Subject|1|||
27574101|NCT00654381|80285814|FG005|Extension Stage|Withdrawal by Subject|1|||
27574102|NCT00654381|80285809|FG000|Extension Stage|Closure of the trial site|0|||
27574103|NCT00654381|80285810|FG001|Extension Stage|Closure of the trial site|0|||
27574104|NCT00654381|80285811|FG002|Extension Stage|Closure of the trial site|0|||
27574105|NCT00654381|80285812|FG003|Extension Stage|Closure of the trial site|0|||
27574106|NCT00654381|80285813|FG004|Extension Stage|Closure of the trial site|1|||
27574107|NCT00654381|80285814|FG005|Extension Stage|Closure of the trial site|1|||
27789492|NCT02147132|81059054|FG001|Overall Study|Lost to Follow-up|0|||
27789493|NCT02147132|81059055|FG002|Overall Study|Lost to Follow-up|0|||
27789494|NCT02147132|81059056|FG003|Overall Study|Lost to Follow-up|0|||
27672071|NCT01296555|80639121|FG001|Overall Study|Lost to Follow-up|0|||
27976868|NCT02956850|81746377|FG010|Overall Study|Withdrawal by Subject|0|||
27976869|NCT02956850|81746378|FG011|Overall Study|Withdrawal by Subject|0|||
27976870|NCT02956850|81746379|FG012|Overall Study|Withdrawal by Subject|0|||
27976871|NCT02956850|81746380|FG013|Overall Study|Withdrawal by Subject|0|||
27976872|NCT02956850|81746381|FG014|Overall Study|Withdrawal by Subject|0|||
27672072|NCT01296555|80639122|FG002|Overall Study|Lost to Follow-up|0|||
27672073|NCT01296555|80639123|FG003|Overall Study|Lost to Follow-up|0|||
27672074|NCT01296555|80639124|FG004|Overall Study|Lost to Follow-up|0|||
27672075|NCT01296555|80639125|FG005|Overall Study|Lost to Follow-up|0|||
27672076|NCT01296555|80639126|FG006|Overall Study|Lost to Follow-up|0|||
27672077|NCT01296555|80639127|FG007|Overall Study|Lost to Follow-up|0|||
27672078|NCT01296555|80639128|FG008|Overall Study|Lost to Follow-up|0|||
27672079|NCT01296555|80639129|FG009|Overall Study|Lost to Follow-up|0|||
27976873|NCT02956850|81746382|FG015|Overall Study|Withdrawal by Subject|0|||
27976874|NCT02956850|81746383|FG016|Overall Study|Withdrawal by Subject|0|||
27976875|NCT02956850|81746384|FG017|Overall Study|Withdrawal by Subject|1|||
27976876|NCT00468676|81746385|FG000|Overall Study|Lost to Follow-up|14|||
27976877|NCT00468676|81746386|FG001|Overall Study|Lost to Follow-up|11|||
27976878|NCT00468676|81746385|FG000|Overall Study|Death|2|||
27976879|NCT00468676|81746386|FG001|Overall Study|Death|1|||
27976880|NCT01371643|81746387|FG000|Overall Study|Withdrawal by Subject|3|||
27976881|NCT01371643|81746388|FG001|Overall Study|Withdrawal by Subject|0|||
27976882|NCT02969590|81746391|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
27672080|NCT01296555|80639130|FG010|Overall Study|Lost to Follow-up|0|||
27574108|NCT02404311|80285815|FG000|Part A: Month 0-18|Death|2|||
27672081|NCT01296555|80639131|FG011|Overall Study|Lost to Follow-up|0|||
27672082|NCT01296555|80639132|FG012|Overall Study|Lost to Follow-up|0|||
27672083|NCT01296555|80639133|FG013|Overall Study|Lost to Follow-up|0|||
27672084|NCT01296555|80639134|FG014|Overall Study|Lost to Follow-up|2|||
27672085|NCT01296555|80639135|FG015|Overall Study|Lost to Follow-up|1|||
27672086|NCT01296555|80639136|FG016|Overall Study|Lost to Follow-up|0|||
27672087|NCT01296555|80639137|FG017|Overall Study|Lost to Follow-up|2|||
27789495|NCT00265382|81059065|FG000|Overall Study|Adverse Event|21|||
27789496|NCT00265382|81059065|FG000|Overall Study|Laboratory Abnormality|1|||
27789497|NCT00265382|81059065|FG000|Overall Study|Lost to Follow-up|3|||
27789498|NCT00265382|81059065|FG000|Overall Study|Lack of Efficacy|6|||
27789499|NCT00265382|81059065|FG000|Overall Study|Miscellaneous|6|||
27789500|NCT00265382|81059065|FG000|Overall Study|Withdrawal by Subject|13|||
27789501|NCT00265382|81059065|FG000|Overall Study|Study terminated by sponsor|94|||
27789502|NCT00265382|81059065|FG000|Overall Study|Death|1|||
27574109|NCT02404311|80285816|FG001|Part A: Month 0-18|Death|0|||
27574110|NCT02404311|80285817|FG002|Part A: Month 0-18|Death|0|||
27574111|NCT02404311|80285818|FG003|Part A: Month 0-18|Death|0|||
27672088|NCT01296555|80639138|FG018|Overall Study|Lost to Follow-up|0|||
27672089|NCT01296555|80639139|FG019|Overall Study|Lost to Follow-up|2|||
27672090|NCT01296555|80639140|FG020|Overall Study|Lost to Follow-up|3|||
27672091|NCT01296555|80639141|FG021|Overall Study|Lost to Follow-up|2|||
27672092|NCT01296555|80639142|FG022|Overall Study|Lost to Follow-up|0|||
27789503|NCT02163759|81059066|FG000|Overall Study|Withdrawal by Subject|1|||
27976883|NCT02969590|81746392|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
27976884|NCT02969590|81746393|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
27976885|NCT00953680|81746394|FG000|Period 1|Withdrawal by Subject|0|||
27976886|NCT00953680|81746395|FG001|Period 1|Withdrawal by Subject|1|||
27867518|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
27867519|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
27867520|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
27867521|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
27867522|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
27867523|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
27867524|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
27867525|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
27867526|NCT04043455|81349605|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
27867527|NCT04043455|81349606|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
27867528|NCT04043455|81349607|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
27867529|NCT04043455|81349608|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
27867530|NCT04043455|81349609|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
27867531|NCT04043455|81349610|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
27867532|NCT04043455|81349605|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
27867533|NCT04043455|81349606|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
27867534|NCT04043455|81349607|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
27867535|NCT04043455|81349608|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
27867536|NCT04043455|81349609|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
27867537|NCT04043455|81349610|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
27867538|NCT04043455|81349605|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
27867539|NCT04043455|81349606|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
27867540|NCT04043455|81349607|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
27867541|NCT04043455|81349608|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
27867542|NCT04043455|81349609|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
27672093|NCT01296555|80639143|FG023|Overall Study|Lost to Follow-up|0|||
27672094|NCT01296555|80639144|FG024|Overall Study|Lost to Follow-up|0|||
27789504|NCT02163759|81059067|FG001|Overall Study|Withdrawal by Subject|5|||
27789505|NCT02163759|81059068|FG002|Overall Study|Withdrawal by Subject|1|||
27789506|NCT02163759|81059066|FG000|Overall Study|Adverse Event|0|||
27789507|NCT02163759|81059067|FG001|Overall Study|Adverse Event|0|||
27789508|NCT02163759|81059068|FG002|Overall Study|Adverse Event|1|||
27789509|NCT02163759|81059066|FG000|Overall Study|Death|0|||
27789510|NCT02163759|81059067|FG001|Overall Study|Death|0|||
27789511|NCT02163759|81059068|FG002|Overall Study|Death|1|||
27672095|NCT01296555|80639145|FG025|Overall Study|Lost to Follow-up|0|||
27672096|NCT01296555|80639146|FG026|Overall Study|Lost to Follow-up|3|||
27672097|NCT01296555|80639147|FG027|Overall Study|Lost to Follow-up|13|||
27672098|NCT01296555|80639148|FG028|Overall Study|Lost to Follow-up|5|||
27672099|NCT01296555|80639120|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27672100|NCT01296555|80639121|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27672101|NCT01296555|80639122|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27672102|NCT01296555|80639123|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27672103|NCT01296555|80639124|FG004|Overall Study|Non-Compliance With Study Drug|0|||
27672104|NCT01296555|80639125|FG005|Overall Study|Non-Compliance With Study Drug|0|||
27789512|NCT02369874|81059069|FG000|Overall Study|Lost to Follow-up|2|||
27789513|NCT02369874|81059070|FG001|Overall Study|Lost to Follow-up|2|||
27789514|NCT02369874|81059071|FG002|Overall Study|Lost to Follow-up|2|||
27789515|NCT02369874|81059069|FG000|Overall Study|Withdrawal by Subject|7|||
27789516|NCT02369874|81059070|FG001|Overall Study|Withdrawal by Subject|9|||
27789517|NCT02369874|81059071|FG002|Overall Study|Withdrawal by Subject|27|||
27789518|NCT02369874|81059069|FG000|Overall Study|Miscellaneous|1|||
27789519|NCT02369874|81059070|FG001|Overall Study|Miscellaneous|1|||
27789520|NCT02369874|81059071|FG002|Overall Study|Miscellaneous|0|||
27789521|NCT02369874|81059069|FG000|Overall Study|On Treatment/Off Study|34|||
27789522|NCT02369874|81059070|FG001|Overall Study|On Treatment/Off Study|45|||
27672105|NCT01296555|80639126|FG006|Overall Study|Non-Compliance With Study Drug|0|||
27789523|NCT02369874|81059071|FG002|Overall Study|On Treatment/Off Study|32|||
27789524|NCT00834366|81059072|FG000|Treatment Period 1|Adverse Event|1|||
27789525|NCT00834366|81059073|FG001|Treatment Period 1|Adverse Event|1|||
27789526|NCT01589185|81059074|FG000|Overall Study|Death|1|||
27789527|NCT01589185|81059075|FG001|Overall Study|Death|2|||
27672106|NCT01296555|80639127|FG007|Overall Study|Non-Compliance With Study Drug|1|||
27672107|NCT01296555|80639128|FG008|Overall Study|Non-Compliance With Study Drug|0|||
27672108|NCT01296555|80639129|FG009|Overall Study|Non-Compliance With Study Drug|0|||
27672109|NCT01296555|80639130|FG010|Overall Study|Non-Compliance With Study Drug|0|||
27672110|NCT01296555|80639131|FG011|Overall Study|Non-Compliance With Study Drug|0|||
27789528|NCT01589185|81059076|FG002|Overall Study|Death|2|||
27789529|NCT01589185|81059077|FG003|Overall Study|Death|0|||
27789530|NCT01589185|81059078|FG004|Overall Study|Death|1|||
27789531|NCT01589185|81059074|FG000|Overall Study|Lost to Follow-up|1|||
27789532|NCT01589185|81059075|FG001|Overall Study|Lost to Follow-up|0|||
27789533|NCT01589185|81059076|FG002|Overall Study|Lost to Follow-up|2|||
27789534|NCT01589185|81059077|FG003|Overall Study|Lost to Follow-up|3|||
27789535|NCT01589185|81059078|FG004|Overall Study|Lost to Follow-up|0|||
27789536|NCT03237325|81059080|FG000|Overall Study|Lost to Follow-up|3|||
27789537|NCT03237325|81059081|FG001|Overall Study|Lost to Follow-up|5|||
27789538|NCT03237325|81059080|FG000|Overall Study|Physician Decision|2|||
27789539|NCT03237325|81059081|FG001|Overall Study|Physician Decision|4|||
27789540|NCT03237325|81059080|FG000|Overall Study|Withdrawal by Subject|9|||
27789541|NCT03237325|81059081|FG001|Overall Study|Withdrawal by Subject|12|||
27789542|NCT03237325|81059080|FG000|Overall Study|Noncompliance with Study Procedures|1|||
27789543|NCT03237325|81059081|FG001|Overall Study|Noncompliance with Study Procedures|1|||
27789544|NCT03237325|81059080|FG000|Overall Study|Termination by Sponsor|0|||
27789545|NCT03237325|81059081|FG001|Overall Study|Termination by Sponsor|1|||
27789546|NCT03237325|81059080|FG000|Overall Study|Reason other than described|0|||
27789547|NCT03237325|81059081|FG001|Overall Study|Reason other than described|2|||
27789548|NCT02146365|81059083|FG000|Overall Study|Lost to Follow-up|2|||
27789549|NCT02146365|81059084|FG001|Overall Study|Lost to Follow-up|1|||
27789550|NCT02146365|81059085|FG002|Overall Study|Lost to Follow-up|3|||
27789551|NCT02146365|81059086|FG003|Overall Study|Lost to Follow-up|3|||
27789552|NCT02146365|81059087|FG004|Overall Study|Lost to Follow-up|1|||
27789553|NCT02146365|81059088|FG005|Overall Study|Lost to Follow-up|1|||
27789554|NCT02146365|81059089|FG006|Overall Study|Lost to Follow-up|0|||
27789555|NCT02146365|81059090|FG007|Overall Study|Lost to Follow-up|1|||
27789556|NCT02146365|81059083|FG000|Overall Study|Withdrawal by Subject|1|||
27789557|NCT02146365|81059084|FG001|Overall Study|Withdrawal by Subject|2|||
27789558|NCT02146365|81059085|FG002|Overall Study|Withdrawal by Subject|1|||
27789559|NCT02146365|81059086|FG003|Overall Study|Withdrawal by Subject|5|||
27789560|NCT02146365|81059087|FG004|Overall Study|Withdrawal by Subject|1|||
27789561|NCT02146365|81059088|FG005|Overall Study|Withdrawal by Subject|0|||
27789562|NCT02146365|81059089|FG006|Overall Study|Withdrawal by Subject|0|||
27789563|NCT02146365|81059090|FG007|Overall Study|Withdrawal by Subject|0|||
27789564|NCT02146365|81059083|FG000|Overall Study|Unable to Comply with Protocol|0|||
27789565|NCT02146365|81059084|FG001|Overall Study|Unable to Comply with Protocol|1|||
27789566|NCT02146365|81059085|FG002|Overall Study|Unable to Comply with Protocol|1|||
27789567|NCT02146365|81059086|FG003|Overall Study|Unable to Comply with Protocol|0|||
27789568|NCT02146365|81059087|FG004|Overall Study|Unable to Comply with Protocol|0|||
27789569|NCT02146365|81059088|FG005|Overall Study|Unable to Comply with Protocol|0|||
27789570|NCT02146365|81059089|FG006|Overall Study|Unable to Comply with Protocol|0|||
27789571|NCT02146365|81059090|FG007|Overall Study|Unable to Comply with Protocol|0|||
27789572|NCT02146365|81059083|FG000|Overall Study|Other|1|||
27789573|NCT02146365|81059084|FG001|Overall Study|Other|0|||
27789574|NCT02146365|81059085|FG002|Overall Study|Other|2|||
27789575|NCT02146365|81059086|FG003|Overall Study|Other|1|||
27789576|NCT02146365|81059087|FG004|Overall Study|Other|0|||
27789577|NCT02146365|81059088|FG005|Overall Study|Other|0|||
27789578|NCT02146365|81059089|FG006|Overall Study|Other|0|||
27789579|NCT02146365|81059090|FG007|Overall Study|Other|0|||
27789580|NCT01041027|81059091|FG000|Overall Study|Withdrawal by Subject|2|||
27789581|NCT01041027|81059091|FG000|Overall Study|Protocol Violation|1|||
27789582|NCT01041027|81059091|FG000|Overall Study|Delayed Radiation Therapy|1|||
27789583|NCT01041027|81059091|FG000|Overall Study|Adverse Event|4|||
27789584|NCT01098266|81059097|FG000|Overall Study|Physician Decision|1|||
27789585|NCT01098266|81059098|FG001|Overall Study|Physician Decision|0|||
27789586|NCT01098266|81059097|FG000|Overall Study|Death|3|||
27789587|NCT01098266|81059098|FG001|Overall Study|Death|2|||
27789588|NCT01098266|81059097|FG000|Overall Study|Withdrawal by Subject|3|||
27672111|NCT01296555|80639132|FG012|Overall Study|Non-Compliance With Study Drug|0|||
27789589|NCT01098266|81059098|FG001|Overall Study|Withdrawal by Subject|5|||
27789590|NCT00777920|81059099|FG000|Overall Study|Adverse Event|39|||
27789591|NCT00777920|81059099|FG000|Overall Study|Withdrawal of Consent|4|||
27789592|NCT00777920|81059099|FG000|Overall Study|Lost to Follow-up|1|||
27789593|NCT00777920|81059099|FG000|Overall Study|Investigator's discretion|1|||
27789594|NCT00777920|81059099|FG000|Overall Study|Clinical status did not improve|1|||
27789595|NCT00777920|81059099|FG000|Overall Study|Other, not specified|4|||
27789596|NCT01266967|81059102|FG000|Overall Study|Death|69|||
27789597|NCT01266967|81059103|FG001|Overall Study|Death|61|||
27789598|NCT01266967|81059102|FG000|Overall Study|Study Closed/Terminated|15|||
27789599|NCT01266967|81059103|FG001|Overall Study|Study Closed/Terminated|17|||
27789600|NCT01266967|81059102|FG000|Overall Study|Lost to Follow-up|2|||
27789601|NCT01266967|81059103|FG001|Overall Study|Lost to Follow-up|1|||
27789602|NCT01266967|81059102|FG000|Overall Study|Physician Decision|0|||
27789603|NCT01266967|81059103|FG001|Overall Study|Physician Decision|1|||
27789604|NCT01266967|81059102|FG000|Overall Study|Withdrawal by Subject|3|||
27789605|NCT01266967|81059103|FG001|Overall Study|Withdrawal by Subject|3|||
27789606|NCT00965562|81059104|FG000|Overall Study|Lost to Follow-up|1|||
27789607|NCT00965562|81059105|FG001|Overall Study|Lost to Follow-up|2|||
27976887|NCT03770728|81746396|FG000|Overall Study|Adverse Event|1|||
27976888|NCT03770728|81746397|FG001|Overall Study|Adverse Event|0|||
27976889|NCT03770728|81746398|FG002|Overall Study|Adverse Event|1|||
27976890|NCT03770728|81746399|FG003|Overall Study|Adverse Event|0|||
27976891|NCT03770728|81746396|FG000|Overall Study|Poor compliance to protocol|0|||
27976892|NCT03770728|81746397|FG001|Overall Study|Poor compliance to protocol|0|||
27976893|NCT03770728|81746398|FG002|Overall Study|Poor compliance to protocol|1|||
27976894|NCT03770728|81746399|FG003|Overall Study|Poor compliance to protocol|0|||
27976895|NCT03770728|81746396|FG000|Overall Study|Withdrawal by Subject|13|||
27976896|NCT03770728|81746397|FG001|Overall Study|Withdrawal by Subject|8|||
27976897|NCT03770728|81746398|FG002|Overall Study|Withdrawal by Subject|9|||
27976898|NCT03770728|81746399|FG003|Overall Study|Withdrawal by Subject|13|||
27976899|NCT03770728|81746396|FG000|Overall Study|Other than specified|24|||
27976900|NCT03770728|81746397|FG001|Overall Study|Other than specified|23|||
27976901|NCT03770728|81746398|FG002|Overall Study|Other than specified|21|||
27976902|NCT03770728|81746399|FG003|Overall Study|Other than specified|22|||
27976903|NCT02743780|81746400|FG000|Part 3 (7 Days)|Adverse Event|0|||
27789608|NCT00965562|81059106|FG002|Overall Study|Lost to Follow-up|3|||
27789609|NCT00965562|81059104|FG000|Overall Study|Withdrawal by Subject|2|||
27789610|NCT00965562|81059105|FG001|Overall Study|Withdrawal by Subject|2|||
27789611|NCT00965562|81059106|FG002|Overall Study|Withdrawal by Subject|0|||
27789612|NCT01319994|81059121|FG000|Overall Study|Protocol Violation|7|||
27789613|NCT01319994|81059122|FG001|Overall Study|Protocol Violation|6|||
27789614|NCT00719706|81059129|FG000|Overall Study|Adverse Event|5|||
27789615|NCT00719706|81059130|FG001|Overall Study|Adverse Event|4|||
27789616|NCT00719706|81059129|FG000|Overall Study|Withdrawal by Subject|1|||
27789617|NCT00719706|81059130|FG001|Overall Study|Withdrawal by Subject|2|||
27789618|NCT00719706|81059129|FG000|Overall Study|Protocol Violation|3|||
27789619|NCT00719706|81059130|FG001|Overall Study|Protocol Violation|0|||
27789620|NCT00148109|81059131|FG000|Overall Study|Lack of Efficacy|10|||
27789621|NCT00148109|81059132|FG001|Overall Study|Lack of Efficacy|18|||
27789622|NCT00148109|81059131|FG000|Overall Study|Adverse Event|0|||
27789623|NCT00148109|81059132|FG001|Overall Study|Adverse Event|2|||
27789624|NCT00148109|81059131|FG000|Overall Study|Withdrawal by Subject|2|||
27789625|NCT00148109|81059132|FG001|Overall Study|Withdrawal by Subject|0|||
27789626|NCT01303159|81059135|FG000|Overall Study|Death|16|||
27789627|NCT01303159|81059135|FG000|Overall Study|Study Termination|7|||
27789628|NCT00313716|81059136|FG000|Overall Study|Death|3|||
27789629|NCT00313716|81059137|FG001|Overall Study|Death|2|||
27789630|NCT00313716|81059138|FG002|Overall Study|Death|9|||
27789631|NCT00313716|81059139|FG003|Overall Study|Death|3|||
27789632|NCT00313716|81059140|FG004|Overall Study|Death|5|||
27789633|NCT00313716|81059141|FG005|Overall Study|Death|9|||
27789634|NCT00313716|81059136|FG000|Overall Study|Lost to Follow-up|2|||
27789635|NCT00313716|81059137|FG001|Overall Study|Lost to Follow-up|5|||
27789636|NCT00313716|81059138|FG002|Overall Study|Lost to Follow-up|2|||
27789637|NCT00313716|81059139|FG003|Overall Study|Lost to Follow-up|1|||
27789638|NCT00313716|81059140|FG004|Overall Study|Lost to Follow-up|0|||
27789639|NCT00313716|81059141|FG005|Overall Study|Lost to Follow-up|4|||
27789640|NCT00313716|81059136|FG000|Overall Study|Withdrawal by Subject|0|||
27789641|NCT00313716|81059137|FG001|Overall Study|Withdrawal by Subject|1|||
27789642|NCT00313716|81059138|FG002|Overall Study|Withdrawal by Subject|1|||
27789643|NCT00313716|81059139|FG003|Overall Study|Withdrawal by Subject|0|||
27789644|NCT00313716|81059140|FG004|Overall Study|Withdrawal by Subject|1|||
27789645|NCT00313716|81059141|FG005|Overall Study|Withdrawal by Subject|0|||
27789646|NCT00253747|81059142|FG000|Overall Study|Lost to Follow-up|13|||
27789647|NCT00253747|81059143|FG001|Overall Study|Lost to Follow-up|14|||
27789648|NCT00253747|81059142|FG000|Overall Study|Withdrawal by Subject|10|||
27976904|NCT02743780|81746401|FG001|Part 3 (7 Days)|Adverse Event|0|||
27789649|NCT00253747|81059143|FG001|Overall Study|Withdrawal by Subject|11|||
27789650|NCT00253747|81059142|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
27789651|NCT00253747|81059143|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
27789652|NCT00066573|81059144|FG000|Overall Study|Did not received protocol treatment|28|||
27789653|NCT00066573|81059145|FG001|Overall Study|Did not received protocol treatment|28|||
27789654|NCT04822701|81059146|FG000|Overall Study|Not treated|2|||
27789655|NCT04822701|81059147|FG001|Overall Study|Not treated|0|||
27789656|NCT04822701|81059146|FG000|Overall Study|Lost to Follow-up|1|||
27789657|NCT04822701|81059147|FG001|Overall Study|Lost to Follow-up|0|||
27789658|NCT04822701|81059146|FG000|Overall Study|Withdrawal by Subject|1|||
27789659|NCT04822701|81059147|FG001|Overall Study|Withdrawal by Subject|0|||
27789660|NCT02501642|81062155|FG000|Overall Study|Lost to Follow-up|7|||
27789661|NCT02501642|81062156|FG001|Overall Study|Lost to Follow-up|11|||
27976905|NCT02743780|81746402|FG002|Part 3 (7 Days)|Adverse Event|1|||
27976906|NCT02743780|81746403|FG003|Part 3 (7 Days)|Adverse Event|0|||
27789662|NCT01333501|81062158|FG000|Overall Study|Adverse Event|3|||
27789663|NCT01333501|81062159|FG001|Overall Study|Adverse Event|1|||
27789664|NCT01333501|81062158|FG000|Overall Study|Abnormal laboratory value|2|||
27789665|NCT01333501|81062159|FG001|Overall Study|Abnormal laboratory value|1|||
27789666|NCT01333501|81062158|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27789667|NCT01333501|81062159|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
27789668|NCT01333501|81062158|FG000|Overall Study|Withdrawn consent|3|||
27789669|NCT01333501|81062159|FG001|Overall Study|Withdrawn consent|12|||
27789670|NCT00227591|81062162|FG000|Overall Study|Withdrawal by Subject|1|||
27789671|NCT01326312|81062163|FG000|Overall Study|Adverse Event|11|||
27789672|NCT01326312|81062164|FG001|Overall Study|Adverse Event|11|||
27789673|NCT01326312|81062165|FG002|Overall Study|Adverse Event|1|||
27789674|NCT01326312|81062163|FG000|Overall Study|Withdrawal by Subject|1|||
27789675|NCT01326312|81062164|FG001|Overall Study|Withdrawal by Subject|2|||
27789676|NCT01326312|81062165|FG002|Overall Study|Withdrawal by Subject|1|||
27789677|NCT01326312|81062163|FG000|Overall Study|Protocol Violation|0|||
27789678|NCT01326312|81062164|FG001|Overall Study|Protocol Violation|1|||
27789679|NCT01326312|81062165|FG002|Overall Study|Protocol Violation|0|||
27789680|NCT01326312|81062163|FG000|Overall Study|Lack of Efficacy|13|||
27789681|NCT01326312|81062164|FG001|Overall Study|Lack of Efficacy|7|||
27789682|NCT01326312|81062165|FG002|Overall Study|Lack of Efficacy|1|||
27789683|NCT01326312|81062163|FG000|Overall Study|Death|1|||
27789684|NCT01326312|81062164|FG001|Overall Study|Death|0|||
27789685|NCT01326312|81062165|FG002|Overall Study|Death|1|||
27789686|NCT01326312|81062163|FG000|Overall Study|progressive disease|0|||
27789687|NCT01326312|81062164|FG001|Overall Study|progressive disease|1|||
27789688|NCT01326312|81062165|FG002|Overall Study|progressive disease|1|||
27789689|NCT01326312|81062163|FG000|Overall Study|Study terminated by Sponsor|8|||
27789690|NCT01326312|81062164|FG001|Overall Study|Study terminated by Sponsor|32|||
27789691|NCT01326312|81062165|FG002|Overall Study|Study terminated by Sponsor|46|||
27789692|NCT01326312|81062163|FG000|Overall Study|Treatment arm terminated|19|||
27789693|NCT01326312|81062164|FG001|Overall Study|Treatment arm terminated|0|||
27789694|NCT01326312|81062165|FG002|Overall Study|Treatment arm terminated|0|||
27789695|NCT01326312|81062163|FG000|Overall Study|QTc > 500|0|||
27789696|NCT01326312|81062164|FG001|Overall Study|QTc > 500|1|||
27789697|NCT01326312|81062165|FG002|Overall Study|QTc > 500|0|||
27789698|NCT03764813|81062168|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
27789699|NCT03764813|81062169|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
27789700|NCT03764813|81062170|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
27789701|NCT03764813|81062171|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
27789702|NCT01243762|81062173|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27789703|NCT01243762|81062174|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
27789704|NCT01243762|81062175|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27789705|NCT01243762|81062176|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27789706|NCT01243762|81062177|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
27789707|NCT01243762|81062178|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
27789708|NCT01243762|81062179|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
27789709|NCT01243762|81062173|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27789710|NCT01243762|81062174|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
27789711|NCT01243762|81062175|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27789712|NCT01243762|81062176|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
27789713|NCT01243762|81062177|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27789714|NCT01243762|81062178|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27789715|NCT01243762|81062179|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
27789716|NCT01243762|81062173|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
27789717|NCT01243762|81062174|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
27789718|NCT01243762|81062175|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
27789719|NCT01243762|81062176|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
27789720|NCT01243762|81062177|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
27789721|NCT01243762|81062178|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
27867543|NCT04043455|81349610|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
27867544|NCT04043455|81349605|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
27867545|NCT04043455|81349606|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
27867546|NCT04043455|81349607|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
27867547|NCT04043455|81349608|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
27867548|NCT04043455|81349609|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
27789722|NCT01243762|81062179|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
27789723|NCT01243762|81062173|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27867549|NCT04043455|81349610|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
27789724|NCT01243762|81062174|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
27789725|NCT01243762|81062175|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27789726|NCT01243762|81062176|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27789727|NCT01243762|81062177|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27789728|NCT01243762|81062178|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27789729|NCT01243762|81062179|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
27789730|NCT01243762|81062173|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27789731|NCT01243762|81062174|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
27789732|NCT01243762|81062175|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27789733|NCT01243762|81062176|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27789734|NCT01243762|81062177|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27789735|NCT01243762|81062178|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
27789736|NCT01243762|81062179|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
27789737|NCT01243762|81062173|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
27789738|NCT01243762|81062174|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
27789739|NCT01243762|81062175|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
27789740|NCT01243762|81062176|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
27789741|NCT01243762|81062177|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
27789742|NCT01243762|81062178|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
27789743|NCT01243762|81062179|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
27789744|NCT01243762|81062173|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27789745|NCT01243762|81062174|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
27789746|NCT01243762|81062175|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27789747|NCT01243762|81062176|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27789748|NCT01243762|81062177|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
27789749|NCT01243762|81062178|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27789750|NCT01243762|81062179|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
27789751|NCT01243762|81062173|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27789752|NCT01243762|81062174|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27789753|NCT01243762|81062175|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27789754|NCT01243762|81062176|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
27789755|NCT01243762|81062177|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
27789756|NCT01243762|81062178|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27789757|NCT01243762|81062179|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
27789758|NCT03075826|81062180|FG000|Overall Study|Withdrawal by Subject|1|||
27789759|NCT03075826|81062180|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
27789760|NCT00690612|81062183|FG000|Overall Study|Adverse Event|1|||
27789761|NCT00690612|81062183|FG000|Overall Study|Withdrawal by Subject|2|||
27789762|NCT02180659|81062188|FG000|Overall Study|Adverse Event|1|||
27789763|NCT02180659|81062189|FG001|Overall Study|Adverse Event|0|||
27789764|NCT02180659|81062188|FG000|Overall Study|Lost to Follow-up|4|||
27789765|NCT02180659|81062189|FG001|Overall Study|Lost to Follow-up|2|||
27789766|NCT02180659|81062188|FG000|Overall Study|Subject incarcerated during conduct|1|||
27789767|NCT02180659|81062189|FG001|Overall Study|Subject incarcerated during conduct|0|||
27789768|NCT02180659|81062188|FG000|Overall Study|Withdrawal by Subject|0|||
27789769|NCT02180659|81062189|FG001|Overall Study|Withdrawal by Subject|2|||
27789770|NCT02180659|81062188|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
27789771|NCT02180659|81062189|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
27789772|NCT00525499|81062190|FG000|Overall Study|Lost to Follow-up|2|||
27789773|NCT00525499|81062191|FG001|Overall Study|Lost to Follow-up|4|||
27789774|NCT00525499|81062192|FG002|Overall Study|Lost to Follow-up|1|||
27789775|NCT00525499|81062193|FG003|Overall Study|Lost to Follow-up|4|||
27789776|NCT00525499|81062190|FG000|Overall Study|Adverse Event|0|||
27789777|NCT00525499|81062191|FG001|Overall Study|Adverse Event|1|||
27789778|NCT00525499|81062192|FG002|Overall Study|Adverse Event|0|||
27789779|NCT00525499|81062193|FG003|Overall Study|Adverse Event|1|||
27789780|NCT00525499|81062190|FG000|Overall Study|Withdrawal by Subject|5|||
27789781|NCT00525499|81062191|FG001|Overall Study|Withdrawal by Subject|1|||
27789782|NCT00525499|81062192|FG002|Overall Study|Withdrawal by Subject|5|||
27789783|NCT00525499|81062193|FG003|Overall Study|Withdrawal by Subject|2|||
27789784|NCT00525499|81062190|FG000|Overall Study|Protocol Violation|0|||
27789785|NCT00525499|81062191|FG001|Overall Study|Protocol Violation|1|||
27789786|NCT00525499|81062192|FG002|Overall Study|Protocol Violation|1|||
27789787|NCT00525499|81062193|FG003|Overall Study|Protocol Violation|0|||
27789788|NCT01347931|81062195|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
27789789|NCT03532048|81062196|FG000|Overall Study|Lost to Follow-up|12|||
27789790|NCT03532048|81062197|FG001|Overall Study|Lost to Follow-up|17|||
27789791|NCT03532048|81062196|FG000|Overall Study|Withdrawal by Subject|7|||
27789792|NCT03532048|81062197|FG001|Overall Study|Withdrawal by Subject|0|||
27789793|NCT01846039|81062198|FG000|Overall Study|Protocol Violation|1|||
27789794|NCT01846039|81062198|FG000|Overall Study|Subject Withdrew Consent|1|||
27789795|NCT01361308|81062199|FG000|Overall Study|Withdrawal by Subject|9|||
27789796|NCT01361308|81062200|FG001|Overall Study|Withdrawal by Subject|13|||
27789797|NCT01361308|81062199|FG000|Overall Study|Physician Decision|3|||
27789798|NCT01361308|81062200|FG001|Overall Study|Physician Decision|3|||
27789799|NCT01361308|81062199|FG000|Overall Study|Lack of Efficacy|2|||
27789800|NCT01361308|81062200|FG001|Overall Study|Lack of Efficacy|0|||
27789801|NCT01361308|81062199|FG000|Overall Study|Protocol Violation|1|||
27789802|NCT01361308|81062200|FG001|Overall Study|Protocol Violation|0|||
27789803|NCT01361308|81062199|FG000|Overall Study|Lost to Follow-up|5|||
27789804|NCT01361308|81062200|FG001|Overall Study|Lost to Follow-up|4|||
27789805|NCT01361308|81062199|FG000|Overall Study|Adverse Event|8|||
27789806|NCT01361308|81062200|FG001|Overall Study|Adverse Event|4|||
27789807|NCT01361308|81062199|FG000|Overall Study|Eligibility Criteria Not Met|2|||
27789808|NCT01361308|81062200|FG001|Overall Study|Eligibility Criteria Not Met|3|||
27789809|NCT01361308|81062199|FG000|Overall Study|Failed C-SSRS|5|||
27789810|NCT01361308|81062200|FG001|Overall Study|Failed C-SSRS|2|||
27789811|NCT01361308|81062199|FG000|Overall Study|Other|0|||
27789812|NCT01361308|81062200|FG001|Overall Study|Other|1|||
27789813|NCT02734290|81062203|FG000|Overall Study|Adverse Event|1|||
27789814|NCT02734290|81062204|FG001|Overall Study|Adverse Event|0|||
27789815|NCT02734290|81062203|FG000|Overall Study|Death|1|||
27789816|NCT02734290|81062204|FG001|Overall Study|Death|0|||
27789817|NCT03358407|81062205|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789818|NCT03358407|81062206|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789819|NCT03358407|81062207|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
27789820|NCT03358407|81062208|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789821|NCT03358407|81062209|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789822|NCT03358407|81062210|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789823|NCT03358407|81062211|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789824|NCT03358407|81062212|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789825|NCT03358407|81062213|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789826|NCT03358407|81062214|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
27789827|NCT03358407|81062205|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789828|NCT03358407|81062206|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789829|NCT03358407|81062207|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789830|NCT03358407|81062208|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789831|NCT03358407|81062209|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
27789832|NCT03358407|81062210|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789833|NCT03358407|81062211|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789834|NCT03358407|81062212|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789835|NCT03358407|81062213|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27867550|NCT04043455|81349605|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
27672112|NCT01296555|80639133|FG013|Overall Study|Non-Compliance With Study Drug|0|||
27672113|NCT01296555|80639134|FG014|Overall Study|Non-Compliance With Study Drug|0|||
27672114|NCT01296555|80639135|FG015|Overall Study|Non-Compliance With Study Drug|0|||
27672115|NCT01296555|80639136|FG016|Overall Study|Non-Compliance With Study Drug|0|||
27672116|NCT01296555|80639137|FG017|Overall Study|Non-Compliance With Study Drug|0|||
27672117|NCT01296555|80639138|FG018|Overall Study|Non-Compliance With Study Drug|0|||
27672118|NCT01296555|80639139|FG019|Overall Study|Non-Compliance With Study Drug|0|||
27672119|NCT01296555|80639140|FG020|Overall Study|Non-Compliance With Study Drug|0|||
27672120|NCT01296555|80639141|FG021|Overall Study|Non-Compliance With Study Drug|0|||
27672121|NCT01296555|80639142|FG022|Overall Study|Non-Compliance With Study Drug|0|||
27672122|NCT01296555|80639143|FG023|Overall Study|Non-Compliance With Study Drug|0|||
27672123|NCT01296555|80639144|FG024|Overall Study|Non-Compliance With Study Drug|0|||
27789836|NCT03358407|81062214|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789837|NCT03358407|81062205|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789838|NCT03358407|81062206|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789839|NCT03358407|81062207|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789840|NCT03358407|81062208|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789841|NCT03358407|81062209|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789842|NCT03358407|81062210|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
27789843|NCT03358407|81062211|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789844|NCT03358407|81062212|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
27789845|NCT03358407|81062213|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27867551|NCT04043455|81349606|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
27867552|NCT04043455|81349607|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
27789846|NCT03358407|81062214|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
27789847|NCT03358407|81062205|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789848|NCT03358407|81062206|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27672124|NCT01296555|80639145|FG025|Overall Study|Non-Compliance With Study Drug|0|||
27672125|NCT01296555|80639146|FG026|Overall Study|Non-Compliance With Study Drug|0|||
27672126|NCT01296555|80639147|FG027|Overall Study|Non-Compliance With Study Drug|0|||
27672127|NCT01296555|80639148|FG028|Overall Study|Non-Compliance With Study Drug|0|||
27672128|NCT01296555|80639120|FG000|Overall Study|Withdrawal by Subject|0|||
27672129|NCT01296555|80639121|FG001|Overall Study|Withdrawal by Subject|0|||
27672130|NCT01296555|80639122|FG002|Overall Study|Withdrawal by Subject|0|||
27789849|NCT03358407|81062207|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789850|NCT03358407|81062208|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789851|NCT03358407|81062209|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789852|NCT03358407|81062210|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
27789853|NCT03358407|81062211|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789854|NCT03358407|81062212|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
27789855|NCT03358407|81062213|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789856|NCT03358407|81062214|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
27789857|NCT03358407|81062205|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789858|NCT03358407|81062206|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789859|NCT03358407|81062207|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789860|NCT03358407|81062208|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789861|NCT03358407|81062209|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789862|NCT03358407|81062210|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
27789863|NCT03358407|81062211|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
27789864|NCT03358407|81062212|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789865|NCT03358407|81062213|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789866|NCT03358407|81062214|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
27789867|NCT03358407|81062205|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789868|NCT03358407|81062206|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789869|NCT03358407|81062207|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789870|NCT03358407|81062208|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789871|NCT03358407|81062209|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789872|NCT03358407|81062210|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
27789873|NCT03358407|81062211|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
27789874|NCT03358407|81062212|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
27789875|NCT03358407|81062213|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789876|NCT03358407|81062214|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
27789877|NCT00594568|81062215|FG000|Initial Treatment|Adverse Event|51|||
27789878|NCT00594568|81062216|FG001|Initial Treatment|Adverse Event|121|||
27789879|NCT00594568|81062217|FG002|Initial Treatment|Adverse Event|144|||
27789880|NCT00594568|81062215|FG000|Initial Treatment|Death|6|||
27789881|NCT00594568|81062216|FG001|Initial Treatment|Death|11|||
27789882|NCT00594568|81062217|FG002|Initial Treatment|Death|15|||
27789883|NCT00594568|81062215|FG000|Initial Treatment|Lost to Follow-up|4|||
27789884|NCT00594568|81062216|FG001|Initial Treatment|Lost to Follow-up|1|||
27789885|NCT00594568|81062217|FG002|Initial Treatment|Lost to Follow-up|4|||
27789886|NCT00594568|81062215|FG000|Initial Treatment|Physician Decision|3|||
27789887|NCT00594568|81062216|FG001|Initial Treatment|Physician Decision|2|||
27789888|NCT00594568|81062217|FG002|Initial Treatment|Physician Decision|4|||
27789889|NCT00594568|81062215|FG000|Initial Treatment|Protocol Violation|2|||
27789890|NCT00594568|81062216|FG001|Initial Treatment|Protocol Violation|2|||
27789891|NCT00594568|81062217|FG002|Initial Treatment|Protocol Violation|5|||
27789892|NCT00594568|81062215|FG000|Initial Treatment|Withdrawal by Subject|25|||
27789893|NCT00594568|81062216|FG001|Initial Treatment|Withdrawal by Subject|31|||
27789894|NCT00594568|81062217|FG002|Initial Treatment|Withdrawal by Subject|46|||
27789895|NCT00594568|81062215|FG000|Initial Treatment|Sponsor decision|193|||
27789896|NCT00594568|81062216|FG001|Initial Treatment|Sponsor decision|142|||
27867553|NCT04043455|81349608|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
27867554|NCT04043455|81349609|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
27789897|NCT00594568|81062217|FG002|Initial Treatment|Sponsor decision|147|||
27789898|NCT00594568|81062215|FG000|Initial Treatment|Caregiver decision|21|||
27789899|NCT00594568|81062216|FG001|Initial Treatment|Caregiver decision|36|||
27789900|NCT00594568|81062217|FG002|Initial Treatment|Caregiver decision|36|||
27789901|NCT00594568|81062215|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
27789902|NCT00594568|81062216|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
27789903|NCT00594568|81062217|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
27789904|NCT00594568|81062215|FG000|Initial Treatment|Entry criteria exclusion|0|||
27789905|NCT00594568|81062216|FG001|Initial Treatment|Entry criteria exclusion|1|||
27789906|NCT00594568|81062217|FG002|Initial Treatment|Entry criteria exclusion|1|||
27789907|NCT00594568|81062215|FG000|Delayed Start|Death|0|||
27789908|NCT00594568|81062216|FG001|Delayed Start|Death|0|||
27789909|NCT00594568|81062217|FG002|Delayed Start|Death|1|||
27672131|NCT01296555|80639123|FG003|Overall Study|Withdrawal by Subject|0|||
27789910|NCT00594568|81062215|FG000|Delayed Start|Adverse Event|12|||
27789911|NCT00594568|81062216|FG001|Delayed Start|Adverse Event|2|||
27789912|NCT00594568|81062217|FG002|Delayed Start|Adverse Event|2|||
27789913|NCT00594568|81062215|FG000|Delayed Start|Withdrawal by Subject|4|||
27789914|NCT00594568|81062216|FG001|Delayed Start|Withdrawal by Subject|3|||
27789915|NCT00594568|81062217|FG002|Delayed Start|Withdrawal by Subject|0|||
27789916|NCT00594568|81062215|FG000|Delayed Start|Physician Decision|0|||
27789917|NCT00594568|81062216|FG001|Delayed Start|Physician Decision|0|||
27789918|NCT00594568|81062217|FG002|Delayed Start|Physician Decision|1|||
27789919|NCT00594568|81062215|FG000|Delayed Start|Lost to Follow-up|0|||
27789920|NCT00594568|81062216|FG001|Delayed Start|Lost to Follow-up|0|||
27789921|NCT00594568|81062217|FG002|Delayed Start|Lost to Follow-up|1|||
27789922|NCT00594568|81062215|FG000|Delayed Start|Caregiver Decision|5|||
27789923|NCT00594568|81062216|FG001|Delayed Start|Caregiver Decision|6|||
27789924|NCT00594568|81062217|FG002|Delayed Start|Caregiver Decision|2|||
27789925|NCT00594568|81062215|FG000|Delayed Start|Sponsor Decision|77|||
27789926|NCT00594568|81062216|FG001|Delayed Start|Sponsor Decision|66|||
27789927|NCT00594568|81062217|FG002|Delayed Start|Sponsor Decision|59|||
27789928|NCT00594568|81062215|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
27789929|NCT00594568|81062216|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
27789930|NCT00594568|81062217|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
27789931|NCT00594568|81062215|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
27789932|NCT00594568|81062216|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
27789933|NCT00594568|81062217|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
27789934|NCT00594568|81062215|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
27789935|NCT00594568|81062216|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
27789936|NCT00594568|81062217|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
27789937|NCT00594568|81062215|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
27789938|NCT00594568|81062216|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
27789939|NCT00594568|81062217|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
27789940|NCT00594568|81062215|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
27789941|NCT00594568|81062216|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
27789942|NCT00594568|81062217|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
27789943|NCT00594568|81062215|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
27789944|NCT00594568|81062216|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
27789945|NCT00594568|81062217|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
27789946|NCT00869362|81062218|FG000|Overall Study|Death|0|||
27789947|NCT00869362|81062219|FG001|Overall Study|Death|2|||
27789948|NCT00869362|81062218|FG000|Overall Study|Lost to Follow-up|1|||
27789949|NCT00869362|81062219|FG001|Overall Study|Lost to Follow-up|3|||
27789950|NCT02967055|81062220|FG000|Overall Study|Excluded|40|||
27789951|NCT02967055|81062220|FG000|Overall Study|Screen fail|3|||
27789952|NCT02967055|81062220|FG000|Overall Study|Lost to Follow-up|2|||
27789953|NCT02967055|81062220|FG000|Overall Study|Stopped due to side effects|3|||
27789954|NCT02967055|81062220|FG000|Overall Study|Stopped due to drug cost|1|||
27789955|NCT00796367|81062225|FG000|Overall Study|Adverse Event|6|||
27789956|NCT00796367|81062226|FG001|Overall Study|Adverse Event|4|||
27789957|NCT00796367|81062227|FG002|Overall Study|Adverse Event|7|||
27789958|NCT00796367|81062225|FG000|Overall Study|Lost to Follow-up|5|||
27789959|NCT00796367|81062226|FG001|Overall Study|Lost to Follow-up|4|||
27789960|NCT00796367|81062227|FG002|Overall Study|Lost to Follow-up|21|||
27789961|NCT00796367|81062225|FG000|Overall Study|Withdrawal by Subject|9|||
27789962|NCT00796367|81062226|FG001|Overall Study|Withdrawal by Subject|11|||
27789963|NCT00796367|81062227|FG002|Overall Study|Withdrawal by Subject|12|||
27789964|NCT00796367|81062225|FG000|Overall Study|Lack of Efficacy|2|||
27789965|NCT00796367|81062226|FG001|Overall Study|Lack of Efficacy|1|||
27789966|NCT00796367|81062227|FG002|Overall Study|Lack of Efficacy|0|||
27789967|NCT00796367|81062225|FG000|Overall Study|non compliance|3|||
27789968|NCT00796367|81062226|FG001|Overall Study|non compliance|1|||
27789969|NCT00796367|81062227|FG002|Overall Study|non compliance|1|||
27789970|NCT00796367|81062225|FG000|Overall Study|Pregnancy|1|||
27789971|NCT00796367|81062226|FG001|Overall Study|Pregnancy|0|||
27789972|NCT00796367|81062227|FG002|Overall Study|Pregnancy|1|||
27789973|NCT00796367|81062225|FG000|Overall Study|Requirement for restricted medication|2|||
27789974|NCT00796367|81062226|FG001|Overall Study|Requirement for restricted medication|0|||
27789975|NCT00796367|81062227|FG002|Overall Study|Requirement for restricted medication|2|||
27789976|NCT00796367|81062225|FG000|Overall Study|other|2|||
27672132|NCT01296555|80639124|FG004|Overall Study|Withdrawal by Subject|1|||
27672133|NCT01296555|80639125|FG005|Overall Study|Withdrawal by Subject|0|||
27789977|NCT00796367|81062226|FG001|Overall Study|other|4|||
27976907|NCT02743780|81746404|FG004|Part 3 (7 Days)|Adverse Event|0|||
27574112|NCT02404311|80285819|FG004|Part A: Month 0-18|Death|0|||
27789978|NCT00796367|81062227|FG002|Overall Study|other|3|||
27789979|NCT04983589|81062228|FG000|Overall Study|Withdrawal by Subject|0|||
27976908|NCT02650128|81746405|FG000|Overall Study|Death|2|||
27574113|NCT02404311|80285815|FG000|Part A: Month 0-18|Physician Decision|1|||
27672134|NCT01296555|80639126|FG006|Overall Study|Withdrawal by Subject|1|||
27789980|NCT04983589|81062229|FG001|Overall Study|Withdrawal by Subject|3|||
27789981|NCT04983589|81062228|FG000|Overall Study|COVID-19 Infection|1|||
27789982|NCT04983589|81062229|FG001|Overall Study|COVID-19 Infection|0|||
27789983|NCT04983589|81062228|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
27789984|NCT04983589|81062229|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
27789985|NCT02983305|81062231|FG000|Overall Study|incomplete data|2|||
27789986|NCT02983305|81062232|FG001|Overall Study|incomplete data|0|||
27789987|NCT04621227|81062233|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
27789988|NCT04621227|81062233|FG000|Period 3 (29 Days)|Adverse Event|1|||
27789989|NCT04621227|81062233|FG000|Period 8 (2 Days)|Adverse Event|1|||
27789990|NCT00812968|81062236|FG000|Overall Study|Relapse after erythroid response|6|||
27789991|NCT00812968|81062236|FG000|Overall Study|Disease progression|1|||
27789992|NCT00812968|81062236|FG000|Overall Study|No further treatment required|1|||
27789993|NCT00812968|81062236|FG000|Overall Study|Study closed due to marketing approval|3|||
27789994|NCT04409509|81062240|FG000|Overall Study|Failure to meet randomization requirement|1|||
27789995|NCT04409509|81062241|FG001|Overall Study|Failure to meet randomization requirement|0|||
27789996|NCT04409509|81062240|FG000|Overall Study|Adverse Event|0|||
27789997|NCT04409509|81062241|FG001|Overall Study|Adverse Event|1|||
27789998|NCT04409509|81062240|FG000|Overall Study|Death|11|||
27789999|NCT04409509|81062241|FG001|Overall Study|Death|10|||
27790000|NCT04409509|81062240|FG000|Overall Study|Non-compliance with study drug|0|||
27790001|NCT04409509|81062241|FG001|Overall Study|Non-compliance with study drug|1|||
27790002|NCT04409509|81062240|FG000|Overall Study|Lost to Follow-up|0|||
27790003|NCT04409509|81062241|FG001|Overall Study|Lost to Follow-up|3|||
27790004|NCT04409509|81062240|FG000|Overall Study|Withdrawal by Subject|0|||
27790005|NCT04409509|81062241|FG001|Overall Study|Withdrawal by Subject|3|||
27790006|NCT04409509|81062240|FG000|Overall Study|Randomized by mistake|0|||
27790007|NCT04409509|81062241|FG001|Overall Study|Randomized by mistake|1|||
27790008|NCT04409509|81062240|FG000|Overall Study|Other|1|||
27790009|NCT04409509|81062241|FG001|Overall Study|Other|1|||
27790010|NCT03410693|81062244|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
27790011|NCT03410693|81062245|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
27790012|NCT03410693|81062244|FG000|Overall Study|Disc trt: Lost to follow up|0|||
27790013|NCT03410693|81062245|FG001|Overall Study|Disc trt: Lost to follow up|1|||
27790014|NCT03410693|81062244|FG000|Overall Study|Disc trt: radiological progression|58|||
27790015|NCT03410693|81062245|FG001|Overall Study|Disc trt: radiological progression|50|||
27790016|NCT03410693|81062244|FG000|Overall Study|Disc trt: Other|1|||
27790017|NCT03410693|81062245|FG001|Overall Study|Disc trt: Other|0|||
27790018|NCT03410693|81062244|FG000|Overall Study|Study drug never administered|1|||
27790019|NCT03410693|81062245|FG001|Overall Study|Study drug never administered|6|||
27790020|NCT03410693|81062244|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
27790021|NCT03410693|81062245|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
27790022|NCT03410693|81062244|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
27574114|NCT02404311|80285816|FG001|Part A: Month 0-18|Physician Decision|0|||
27790023|NCT03410693|81062245|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
27790024|NCT03410693|81062244|FG000|Overall Study|Disc trt: Physician decision|0|||
27790025|NCT03410693|81062245|FG001|Overall Study|Disc trt: Physician decision|5|||
27790026|NCT03410693|81062244|FG000|Overall Study|Disc trt: clinical progression|1|||
27790027|NCT03410693|81062245|FG001|Overall Study|Disc trt: clinical progression|5|||
27790028|NCT03410693|81062244|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
27790029|NCT03410693|81062245|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
27790030|NCT00779857|81062246|FG000|Overall Study|Death|1|||
27790031|NCT00779857|81062246|FG000|Overall Study|Withdrawal by Subject|3|||
27790032|NCT00779857|81062246|FG000|Overall Study|Missed Visit|2|||
27790033|NCT01409382|81062247|FG000|Overall Study|Lost to Follow-up|1|||
27790034|NCT01409382|81062248|FG001|Overall Study|Lost to Follow-up|1|||
27976909|NCT00787930|81746406|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
27790035|NCT01409382|81062247|FG000|Overall Study|Protocol Violation|0|||
27790036|NCT01409382|81062248|FG001|Overall Study|Protocol Violation|3|||
27790037|NCT01409382|81062247|FG000|Overall Study|Multiple pregnancy|2|||
27790038|NCT01409382|81062248|FG001|Overall Study|Multiple pregnancy|4|||
27790039|NCT01409382|81062247|FG000|Overall Study|Still pregnant when study ended|13|||
27790040|NCT01409382|81062248|FG001|Overall Study|Still pregnant when study ended|2|||
27790041|NCT01409382|81062247|FG000|Overall Study|Did not manage to get pregnant|64|||
27790042|NCT01409382|81062248|FG001|Overall Study|Did not manage to get pregnant|70|||
27790043|NCT01409382|81062247|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
27976910|NCT02891681|81746407|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
27790044|NCT01409382|81062248|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
27790045|NCT01958619|81062249|FG000|Overall Study|Protocol Violation|2|||
27790046|NCT01958619|81062250|FG001|Overall Study|Protocol Violation|0|||
27790047|NCT01958619|81062251|FG002|Overall Study|Protocol Violation|1|||
27790048|NCT01958619|81062252|FG003|Overall Study|Protocol Violation|0|||
27790049|NCT01004822|81062256|FG000|Overall Study|Objective progression or relapse|3|||
27790050|NCT01004822|81062257|FG001|Overall Study|Objective progression or relapse|3|||
27790051|NCT01004822|81062258|FG002|Overall Study|Objective progression or relapse|0|||
27790052|NCT01004822|81062259|FG003|Overall Study|Objective progression or relapse|1|||
27790053|NCT01004822|81062260|FG004|Overall Study|Objective progression or relapse|2|||
27790054|NCT01004822|81062261|FG005|Overall Study|Objective progression or relapse|2|||
27790055|NCT01004822|81062262|FG006|Overall Study|Objective progression or relapse|1|||
27790056|NCT01004822|81062263|FG007|Overall Study|Objective progression or relapse|4|||
27790057|NCT01004822|81062256|FG000|Overall Study|Global deterioration of health status|0|||
27790058|NCT01004822|81062257|FG001|Overall Study|Global deterioration of health status|0|||
27790059|NCT01004822|81062258|FG002|Overall Study|Global deterioration of health status|0|||
27790060|NCT01004822|81062259|FG003|Overall Study|Global deterioration of health status|1|||
27790061|NCT01004822|81062260|FG004|Overall Study|Global deterioration of health status|0|||
27790062|NCT01004822|81062261|FG005|Overall Study|Global deterioration of health status|0|||
27790063|NCT01004822|81062262|FG006|Overall Study|Global deterioration of health status|1|||
27790064|NCT01004822|81062263|FG007|Overall Study|Global deterioration of health status|0|||
27790065|NCT01004822|81062256|FG000|Overall Study|No longer willing to continue|0|||
27790066|NCT01004822|81062257|FG001|Overall Study|No longer willing to continue|0|||
27790067|NCT01004822|81062258|FG002|Overall Study|No longer willing to continue|0|||
27790068|NCT01004822|81062259|FG003|Overall Study|No longer willing to continue|1|||
27790069|NCT01004822|81062260|FG004|Overall Study|No longer willing to continue|2|||
27790070|NCT01004822|81062261|FG005|Overall Study|No longer willing to continue|1|||
27790071|NCT01004822|81062262|FG006|Overall Study|No longer willing to continue|1|||
27790072|NCT01004822|81062263|FG007|Overall Study|No longer willing to continue|0|||
27790073|NCT01004822|81062256|FG000|Overall Study|Adverse Event|0|||
27790074|NCT01004822|81062257|FG001|Overall Study|Adverse Event|0|||
27790075|NCT01004822|81062258|FG002|Overall Study|Adverse Event|0|||
27790076|NCT01004822|81062259|FG003|Overall Study|Adverse Event|0|||
27790077|NCT01004822|81062260|FG004|Overall Study|Adverse Event|0|||
27790078|NCT01004822|81062261|FG005|Overall Study|Adverse Event|0|||
27790079|NCT01004822|81062262|FG006|Overall Study|Adverse Event|1|||
27790080|NCT01004822|81062263|FG007|Overall Study|Adverse Event|1|||
27790081|NCT01004822|81062256|FG000|Overall Study|Other|0|||
27790082|NCT01004822|81062257|FG001|Overall Study|Other|0|||
27790083|NCT01004822|81062258|FG002|Overall Study|Other|4|||
27790084|NCT01004822|81062259|FG003|Overall Study|Other|1|||
27790085|NCT01004822|81062260|FG004|Overall Study|Other|0|||
27790086|NCT01004822|81062261|FG005|Overall Study|Other|1|||
27790087|NCT01004822|81062262|FG006|Overall Study|Other|0|||
27790088|NCT01004822|81062263|FG007|Overall Study|Other|0|||
27790089|NCT02696382|81062268|FG000|Overall Study|Death|7|||
27790090|NCT02696382|81062269|FG001|Overall Study|Death|2|||
27790091|NCT02696382|81062268|FG000|Overall Study|Withdrawal by Subject|5|||
27790092|NCT02696382|81062269|FG001|Overall Study|Withdrawal by Subject|12|||
27790093|NCT02696382|81062268|FG000|Overall Study|Lost to Follow-up|4|||
27790094|NCT02696382|81062269|FG001|Overall Study|Lost to Follow-up|7|||
27790095|NCT01473602|81062270|FG000|Overall Study|Adverse Event|1|||
27790096|NCT01473602|81062271|FG001|Overall Study|Adverse Event|2|||
27790097|NCT01473602|81062270|FG000|Overall Study|Death|0|||
27672135|NCT01296555|80639127|FG007|Overall Study|Withdrawal by Subject|0|||
27672136|NCT01296555|80639128|FG008|Overall Study|Withdrawal by Subject|0|||
27672137|NCT01296555|80639129|FG009|Overall Study|Withdrawal by Subject|0|||
27672138|NCT01296555|80639130|FG010|Overall Study|Withdrawal by Subject|1|||
27672139|NCT01296555|80639131|FG011|Overall Study|Withdrawal by Subject|1|||
27672140|NCT01296555|80639132|FG012|Overall Study|Withdrawal by Subject|0|||
27672141|NCT01296555|80639133|FG013|Overall Study|Withdrawal by Subject|0|||
27672142|NCT01296555|80639134|FG014|Overall Study|Withdrawal by Subject|3|||
27790098|NCT01473602|81062271|FG001|Overall Study|Death|1|||
27790099|NCT01473602|81062270|FG000|Overall Study|Lost to Follow-up|1|||
27790100|NCT01473602|81062271|FG001|Overall Study|Lost to Follow-up|1|||
27790101|NCT01473602|81062270|FG000|Overall Study|Withdrawal by Subject|5|||
27790102|NCT01473602|81062271|FG001|Overall Study|Withdrawal by Subject|4|||
27790103|NCT01473602|81062270|FG000|Overall Study|Physician Decision|1|||
27790104|NCT01473602|81062271|FG001|Overall Study|Physician Decision|0|||
27790105|NCT00234533|81062272|FG000|Overall Study|Withdrawal by Subject|6|||
27790106|NCT00234533|81062272|FG000|Overall Study|Adverse Event|2|||
27672143|NCT01296555|80639135|FG015|Overall Study|Withdrawal by Subject|0|||
27672144|NCT01296555|80639136|FG016|Overall Study|Withdrawal by Subject|2|||
27672145|NCT01296555|80639137|FG017|Overall Study|Withdrawal by Subject|1|||
27790107|NCT00234533|81062272|FG000|Overall Study|Enrolled but not treated|3|||
27790108|NCT00229931|81062273|FG000|Overall Study|Death|1|||
27790109|NCT00229931|81062274|FG001|Overall Study|Death|0|||
27790110|NCT00229931|81062273|FG000|Overall Study|Lost to Follow-up|3|||
27790111|NCT00229931|81062274|FG001|Overall Study|Lost to Follow-up|2|||
27790112|NCT00501969|81062276|FG000|Overall Study|Major Protocol Violation|4|||
27790113|NCT00501969|81062276|FG000|Overall Study|Lack of Efficacy|29|||
27790114|NCT00501969|81062276|FG000|Overall Study|Adverse Event|76|||
27790115|NCT00501969|81062276|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
27790116|NCT00501969|81062276|FG000|Overall Study|Subject withdrew consent|51|||
27790117|NCT00501969|81062276|FG000|Overall Study|Lost to Follow-up|4|||
27790118|NCT00501969|81062276|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
27790119|NCT00501969|81062276|FG000|Overall Study|Other: Sponsors Request|10|||
27790120|NCT00501969|81062276|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
27790121|NCT00501969|81062276|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
27790122|NCT00501969|81062276|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
27790123|NCT00501969|81062276|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
27790124|NCT00501969|81062276|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
27790125|NCT00501969|81062276|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
27790126|NCT00501969|81062276|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
27790127|NCT00501969|81062276|FG000|Overall Study|Other: As Required by Local EC|2|||
27790128|NCT00501969|81062276|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
27790129|NCT00501969|81062276|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
27790130|NCT00379639|81062277|FG000|Overall Study|Disease Progression|3|||
27790131|NCT00379639|81062278|FG001|Overall Study|Disease Progression|3|||
27790132|NCT00379639|81062279|FG002|Overall Study|Disease Progression|3|||
27790133|NCT00379639|81062280|FG003|Overall Study|Disease Progression|4|||
27790134|NCT00379639|81062281|FG004|Overall Study|Disease Progression|4|||
27790135|NCT00379639|81062277|FG000|Overall Study|Physician Decision|0|||
27790136|NCT00379639|81062278|FG001|Overall Study|Physician Decision|2|||
27790137|NCT00379639|81062279|FG002|Overall Study|Physician Decision|1|||
27790138|NCT00379639|81062280|FG003|Overall Study|Physician Decision|1|||
27790139|NCT00379639|81062281|FG004|Overall Study|Physician Decision|0|||
27790140|NCT00379639|81062277|FG000|Overall Study|Symptomatic Deterioration|0|||
27790141|NCT00379639|81062278|FG001|Overall Study|Symptomatic Deterioration|0|||
27790142|NCT00379639|81062279|FG002|Overall Study|Symptomatic Deterioration|1|||
27790143|NCT00379639|81062280|FG003|Overall Study|Symptomatic Deterioration|0|||
27790144|NCT00379639|81062281|FG004|Overall Study|Symptomatic Deterioration|1|||
27790145|NCT00379639|81062277|FG000|Overall Study|Adverse Event|0|||
27790146|NCT00379639|81062278|FG001|Overall Study|Adverse Event|0|||
27790147|NCT00379639|81062279|FG002|Overall Study|Adverse Event|1|||
27790148|NCT00379639|81062280|FG003|Overall Study|Adverse Event|0|||
27790149|NCT00379639|81062281|FG004|Overall Study|Adverse Event|1|||
27790150|NCT00379639|81062277|FG000|Overall Study|Lost to Follow-up|0|||
27790151|NCT00379639|81062278|FG001|Overall Study|Lost to Follow-up|0|||
27790152|NCT00379639|81062279|FG002|Overall Study|Lost to Follow-up|0|||
27790153|NCT00379639|81062280|FG003|Overall Study|Lost to Follow-up|1|||
27790154|NCT00379639|81062281|FG004|Overall Study|Lost to Follow-up|0|||
27790155|NCT00379639|81062277|FG000|Overall Study|Other|0|||
27790156|NCT00379639|81062278|FG001|Overall Study|Other|0|||
27790157|NCT00379639|81062279|FG002|Overall Study|Other|3|||
27790158|NCT00379639|81062280|FG003|Overall Study|Other|0|||
27790159|NCT00379639|81062281|FG004|Overall Study|Other|0|||
27790160|NCT03732534|81062282|FG000|Overall Study|Study terminated by Sponsor|6|||
27790161|NCT00381680|81062283|FG000|Overall Study|Adverse Event|9|||
27790162|NCT00381680|81062284|FG001|Overall Study|Adverse Event|3|||
27790163|NCT00381680|81062283|FG000|Overall Study|Death|10|||
27790164|NCT00381680|81062284|FG001|Overall Study|Death|7|||
27790165|NCT00381680|81062283|FG000|Overall Study|Lost to Follow-up|3|||
27790166|NCT00381680|81062284|FG001|Overall Study|Lost to Follow-up|2|||
27790167|NCT00381680|81062283|FG000|Overall Study|Physician Decision|25|||
27790168|NCT00381680|81062284|FG001|Overall Study|Physician Decision|6|||
27790169|NCT00381680|81062283|FG000|Overall Study|Withdrawal by Subject|3|||
27790170|NCT00381680|81062284|FG001|Overall Study|Withdrawal by Subject|1|||
27790171|NCT00381680|81062283|FG000|Overall Study|Entry onto another COG Trial|1|||
27790172|NCT00381680|81062284|FG001|Overall Study|Entry onto another COG Trial|2|||
27790173|NCT00381680|81062283|FG000|Overall Study|Alternative Therapy|11|||
27790174|NCT00381680|81062284|FG001|Overall Study|Alternative Therapy|5|||
27790175|NCT00381680|81062283|FG000|Overall Study|Secondary Malignancy|3|||
27790176|NCT00381680|81062284|FG001|Overall Study|Secondary Malignancy|0|||
27790177|NCT00381680|81062283|FG000|Overall Study|Delay initiation|1|||
27790178|NCT00381680|81062284|FG001|Overall Study|Delay initiation|0|||
27790179|NCT00381680|81062283|FG000|Overall Study|Stem Cell Transplant|26|||
27790180|NCT00381680|81062284|FG001|Overall Study|Stem Cell Transplant|10|||
27790181|NCT00381680|81062283|FG000|Overall Study|Relapse|18|||
27790182|NCT00381680|81062284|FG001|Overall Study|Relapse|9|||
27790183|NCT00381680|81062283|FG000|Overall Study|Induction Failure|4|||
27790184|NCT00381680|81062284|FG001|Overall Study|Induction Failure|1|||
27790185|NCT00381680|81062283|FG000|Overall Study|Progression|1|||
27790186|NCT00381680|81062284|FG001|Overall Study|Progression|1|||
27790187|NCT00381680|81062283|FG000|Overall Study|Other not otherwise specified|7|||
27790188|NCT00381680|81062284|FG001|Overall Study|Other not otherwise specified|2|||
27790189|NCT00381680|81062283|FG000|Overall Study|Ineligible|3|||
27790190|NCT00381680|81062284|FG001|Overall Study|Ineligible|1|||
27790191|NCT03446157|81062285|FG000|Overall Study|Death|11|||
27790192|NCT03446157|81062286|FG001|Overall Study|Death|9|||
27790193|NCT03446157|81062285|FG000|Overall Study|Lost to Follow-up|0|||
27790194|NCT03446157|81062286|FG001|Overall Study|Lost to Follow-up|1|||
27790195|NCT03446157|81062285|FG000|Overall Study|Withdrawal by Subject|2|||
27790196|NCT03446157|81062286|FG001|Overall Study|Withdrawal by Subject|1|||
27976911|NCT02891681|81746408|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
27976912|NCT02891681|81746409|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
27976913|NCT02891681|81746407|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
27976914|NCT02891681|81746408|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
27976915|NCT02891681|81746409|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
27976916|NCT02891681|81746407|FG000|Overall Study|Taken off study after first imaging appointment|1|||
27976917|NCT02891681|81746408|FG001|Overall Study|Taken off study after first imaging appointment|0|||
27976918|NCT02891681|81746409|FG002|Overall Study|Taken off study after first imaging appointment|0|||
27976919|NCT01218100|81746410|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
27976920|NCT01218100|81746411|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
27976921|NCT01218100|81746412|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
27976922|NCT01218100|81746413|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
27976923|NCT01218100|81746410|FG000|Overall Study|Adverse Event|4|||
27672146|NCT01296555|80639138|FG018|Overall Study|Withdrawal by Subject|0|||
27672147|NCT01296555|80639139|FG019|Overall Study|Withdrawal by Subject|1|||
27672148|NCT01296555|80639140|FG020|Overall Study|Withdrawal by Subject|1|||
27672149|NCT01296555|80639141|FG021|Overall Study|Withdrawal by Subject|1|||
27672150|NCT01296555|80639142|FG022|Overall Study|Withdrawal by Subject|3|||
27672151|NCT01296555|80639143|FG023|Overall Study|Withdrawal by Subject|0|||
27672152|NCT01296555|80639144|FG024|Overall Study|Withdrawal by Subject|0|||
27672153|NCT01296555|80639145|FG025|Overall Study|Withdrawal by Subject|0|||
27672154|NCT01296555|80639146|FG026|Overall Study|Withdrawal by Subject|8|||
27672155|NCT01296555|80639147|FG027|Overall Study|Withdrawal by Subject|4|||
27672156|NCT01296555|80639148|FG028|Overall Study|Withdrawal by Subject|2|||
27672157|NCT00943722|80639149|FG000|Base Study|Adverse Event|0|||
27672158|NCT00943722|80639150|FG001|Base Study|Adverse Event|0|||
27672159|NCT00943722|80639151|FG002|Base Study|Adverse Event|0|||
27672160|NCT00943722|80639152|FG003|Base Study|Adverse Event|1|||
27672161|NCT00943722|80639153|FG004|Base Study|Adverse Event|0|||
27672162|NCT00943722|80639154|FG005|Base Study|Adverse Event|0|||
27672163|NCT00943722|80639155|FG006|Base Study|Adverse Event|0|||
27790197|NCT01519700|81062287|FG000|Overall Study|Death|1|||
27790198|NCT01519700|81062288|FG001|Overall Study|Death|0|||
27790199|NCT01519700|81062289|FG002|Overall Study|Death|0|||
27790200|NCT01519700|81062290|FG003|Overall Study|Death|0|||
27790201|NCT01519700|81062287|FG000|Overall Study|Lost to Follow-up|0|||
27790202|NCT01519700|81062288|FG001|Overall Study|Lost to Follow-up|0|||
27790203|NCT01519700|81062289|FG002|Overall Study|Lost to Follow-up|1|||
27790204|NCT01519700|81062290|FG003|Overall Study|Lost to Follow-up|1|||
27790205|NCT01519700|81062287|FG000|Overall Study|Physician Decision|1|||
27790206|NCT01519700|81062288|FG001|Overall Study|Physician Decision|1|||
27790207|NCT01519700|81062289|FG002|Overall Study|Physician Decision|3|||
27790208|NCT01519700|81062290|FG003|Overall Study|Physician Decision|0|||
27790209|NCT01519700|81062287|FG000|Overall Study|Withdrawal by Subject|5|||
27790210|NCT01519700|81062288|FG001|Overall Study|Withdrawal by Subject|3|||
27790211|NCT01519700|81062289|FG002|Overall Study|Withdrawal by Subject|3|||
27790212|NCT01519700|81062290|FG003|Overall Study|Withdrawal by Subject|2|||
27790213|NCT01519700|81062287|FG000|Overall Study|Other Reason|2|||
27790214|NCT01519700|81062288|FG001|Overall Study|Other Reason|2|||
27790215|NCT01519700|81062289|FG002|Overall Study|Other Reason|0|||
27790216|NCT01519700|81062290|FG003|Overall Study|Other Reason|4|||
27867555|NCT04043455|81349610|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
27867556|NCT00613171|81349618|FG000|Overall Study|Adverse Event|7|||
27976924|NCT01218100|81746411|FG001|Overall Study|Adverse Event|6|||
27976925|NCT01218100|81746412|FG002|Overall Study|Adverse Event|6|||
27574115|NCT02404311|80285817|FG002|Part A: Month 0-18|Physician Decision|0|||
27672164|NCT00943722|80639149|FG000|Base Study|Lost to Follow-up|12|||
27790217|NCT01014442|81062291|FG000|Overall Study|Adverse Event|0|||
27790218|NCT01014442|81062292|FG001|Overall Study|Adverse Event|8|||
27672165|NCT00943722|80639150|FG001|Base Study|Lost to Follow-up|8|||
27672166|NCT00943722|80639151|FG002|Base Study|Lost to Follow-up|10|||
27672167|NCT00943722|80639152|FG003|Base Study|Lost to Follow-up|8|||
27672168|NCT00943722|80639153|FG004|Base Study|Lost to Follow-up|11|||
27672169|NCT00943722|80639154|FG005|Base Study|Lost to Follow-up|0|||
27672170|NCT00943722|80639155|FG006|Base Study|Lost to Follow-up|0|||
27790219|NCT01014442|81062291|FG000|Overall Study|Withdrawal by Subject|4|||
27790220|NCT01014442|81062292|FG001|Overall Study|Withdrawal by Subject|4|||
27790221|NCT01014442|81062291|FG000|Overall Study|Protocol Violation|2|||
27790222|NCT01014442|81062292|FG001|Overall Study|Protocol Violation|5|||
27790223|NCT01014442|81062291|FG000|Overall Study|Lack of Compliance|0|||
27790224|NCT01014442|81062292|FG001|Overall Study|Lack of Compliance|1|||
27790225|NCT01014442|81062291|FG000|Overall Study|Unspecified Reason|1|||
27790226|NCT01014442|81062292|FG001|Overall Study|Unspecified Reason|1|||
27790227|NCT00625846|81062301|FG000|Overall Study|Withdrawal by Subject|2|||
27790228|NCT00625846|81062302|FG001|Overall Study|Withdrawal by Subject|0|||
27790229|NCT00625846|81062303|FG002|Overall Study|Withdrawal by Subject|1|||
27790230|NCT00625846|81062304|FG003|Overall Study|Withdrawal by Subject|2|||
27790231|NCT02764229|81062310|FG000|Overall Study|Withdrawal by Subject|15|||
27790232|NCT02764229|81062310|FG000|Overall Study|Adverse Event|9|||
27790233|NCT02764229|81062310|FG000|Overall Study|Physician Decision|5|||
27790234|NCT02764229|81062310|FG000|Overall Study|Lost to Follow-up|3|||
27790235|NCT02764229|81062310|FG000|Overall Study|Lack of Efficacy|1|||
27790236|NCT02764229|81062310|FG000|Overall Study|Study Stopped by Sponsor|69|||
27790237|NCT00465101|81062311|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
27790238|NCT00465101|81062311|FG000|Overall Study|Change in health precluded follow up|4|||
27790239|NCT00465101|81062311|FG000|Overall Study|Did not meet study criteria|4|||
27790240|NCT00465101|81062311|FG000|Overall Study|Lost to Follow-up|5|||
27790241|NCT00465101|81062311|FG000|Overall Study|Other|6|||
27790242|NCT00465101|81062311|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
27790243|NCT00465101|81062311|FG000|Overall Study|Patient postponed procedure|1|||
27790244|NCT00465101|81062311|FG000|Overall Study|Site closed due to IRB expiration|1|||
27790245|NCT00465101|81062311|FG000|Overall Study|Unable to obtain IRB approval|1|||
27790246|NCT00465101|81062311|FG000|Overall Study|Death|3|||
27790247|NCT00465101|81062311|FG000|Overall Study|Withdrawal by Subject|25|||
27790248|NCT00465101|81062311|FG000|Overall Study|Physician Decision|1|||
27790249|NCT00465101|81062311|FG000|Overall Study|Withdrew consent prior to procedure|3|||
27790250|NCT05022121|81062312|FG000|Overall Study|Lack of Efficacy|1|||
27790251|NCT05022121|81062313|FG001|Overall Study|Lack of Efficacy|0|||
27790252|NCT05022121|81062312|FG000|Overall Study|Lost to Follow-up|0|||
27790253|NCT05022121|81062313|FG001|Overall Study|Lost to Follow-up|2|||
27790254|NCT01428882|81062316|FG000|Overall Study|Lack of Efficacy|2|||
27790255|NCT01428882|81062317|FG001|Overall Study|Lack of Efficacy|7|||
27790256|NCT01428882|81062316|FG000|Overall Study|Protocol Violation|4|||
27790257|NCT01428882|81062317|FG001|Overall Study|Protocol Violation|3|||
27790258|NCT02046993|81062318|FG000|Overall Study|Withdrawal by Subject|2|||
27790259|NCT02046993|81062319|FG001|Overall Study|Withdrawal by Subject|10|||
27790260|NCT02046993|81062318|FG000|Overall Study|Lost to Follow-up|1|||
27790261|NCT02046993|81062319|FG001|Overall Study|Lost to Follow-up|1|||
27790262|NCT04516291|81062320|FG000|Treatment Period (24 Weeks)|Other|1|||
27790263|NCT04516291|81062321|FG001|Treatment Period (24 Weeks)|Other|0|||
27790264|NCT04516291|81062322|FG002|Treatment Period (24 Weeks)|Other|0|||
27790265|NCT04516291|81062323|FG003|Treatment Period (24 Weeks)|Other|2|||
27790266|NCT04516291|81062324|FG004|Treatment Period (24 Weeks)|Other|2|||
27790267|NCT04516291|81062325|FG005|Treatment Period (24 Weeks)|Other|4|||
27790268|NCT04516291|81062326|FG006|Treatment Period (24 Weeks)|Other|2|||
27976926|NCT01218100|81746413|FG003|Overall Study|Adverse Event|7|||
27976927|NCT01218100|81746410|FG000|Overall Study|Lack of Efficacy|9|||
27976928|NCT01218100|81746411|FG001|Overall Study|Lack of Efficacy|6|||
27976929|NCT01218100|81746412|FG002|Overall Study|Lack of Efficacy|5|||
27976930|NCT01218100|81746413|FG003|Overall Study|Lack of Efficacy|12|||
27976931|NCT01218100|81746410|FG000|Overall Study|Protocol Violation|0|||
27790269|NCT04516291|81062327|FG007|Treatment Period (24 Weeks)|Other|0|||
27790270|NCT04516291|81062320|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27790271|NCT04516291|81062321|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
27790272|NCT04516291|81062322|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
27790273|NCT04516291|81062323|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27790274|NCT04516291|81062324|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
27790275|NCT04516291|81062325|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27790276|NCT04516291|81062326|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27790277|NCT04516291|81062327|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27672171|NCT00943722|80639149|FG000|Base Study|Physician Decision|1|||
27672172|NCT00943722|80639150|FG001|Base Study|Physician Decision|0|||
27790278|NCT04516291|81062320|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
27790279|NCT04516291|81062321|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
27790280|NCT04516291|81062322|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
27790281|NCT04516291|81062323|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
27790282|NCT04516291|81062324|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
27790283|NCT04516291|81062325|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
27790284|NCT04516291|81062326|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
27867557|NCT00613171|81349618|FG000|Overall Study|Withdrawal by Subject|3|||
27976932|NCT01218100|81746411|FG001|Overall Study|Protocol Violation|0|||
27976933|NCT01218100|81746412|FG002|Overall Study|Protocol Violation|1|||
27976934|NCT01218100|81746413|FG003|Overall Study|Protocol Violation|1|||
27976935|NCT01218100|81746410|FG000|Overall Study|Withdrawal by Subject|5|||
27790285|NCT04516291|81062327|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
27790286|NCT04516291|81062320|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27976936|NCT01218100|81746411|FG001|Overall Study|Withdrawal by Subject|2|||
27976937|NCT01218100|81746412|FG002|Overall Study|Withdrawal by Subject|6|||
27976938|NCT01218100|81746413|FG003|Overall Study|Withdrawal by Subject|7|||
27976939|NCT01218100|81746410|FG000|Overall Study|Lost to Follow-up|3|||
27976940|NCT01218100|81746411|FG001|Overall Study|Lost to Follow-up|8|||
27976941|NCT01218100|81746412|FG002|Overall Study|Lost to Follow-up|2|||
27976942|NCT01218100|81746413|FG003|Overall Study|Lost to Follow-up|1|||
27976943|NCT01218100|81746410|FG000|Overall Study|Other Reason|2|||
27976944|NCT01218100|81746411|FG001|Overall Study|Other Reason|2|||
27976945|NCT01218100|81746412|FG002|Overall Study|Other Reason|6|||
27976946|NCT01218100|81746413|FG003|Overall Study|Other Reason|4|||
27976947|NCT02141490|81746414|FG000|Overall Study|Screening failures|4|||
27976948|NCT02141490|81746415|FG001|Overall Study|Screening failures|0|||
27976949|NCT02141490|81746416|FG002|Overall Study|Screening failures|0|||
27976950|NCT04070326|81746423|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
27976951|NCT04070326|81746424|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
27976952|NCT01777542|81746425|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
27976953|NCT01777542|81746426|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
27976954|NCT03831945|81746427|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
27976955|NCT03831945|81746428|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
27976956|NCT03831945|81746427|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
27976957|NCT03831945|81746428|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
27976958|NCT03831945|81746427|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
27976959|NCT03831945|81746428|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
27976960|NCT02723006|81746429|FG000|Overall Study|Withdrawal by Subject|0|||
27976961|NCT02723006|81746430|FG001|Overall Study|Withdrawal by Subject|1|||
27976962|NCT02723006|81746431|FG002|Overall Study|Withdrawal by Subject|1|||
27976963|NCT02723006|81746429|FG000|Overall Study|Study Terminated by Sponsor|1|||
27976964|NCT02723006|81746430|FG001|Overall Study|Study Terminated by Sponsor|6|||
27976965|NCT02723006|81746431|FG002|Overall Study|Study Terminated by Sponsor|6|||
27976966|NCT02818036|81746432|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
27976967|NCT02818036|81746433|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
27976968|NCT02818036|81746432|FG000|Overall Study|Withdrawal by Subject|1|||
27976969|NCT02818036|81746433|FG001|Overall Study|Withdrawal by Subject|0|||
27976970|NCT01133626|81746445|FG000|Overall Study|Adverse Event|0|||
27976971|NCT01133626|81746446|FG001|Overall Study|Adverse Event|1|||
27976972|NCT01133626|81746447|FG002|Overall Study|Adverse Event|0|||
27976973|NCT01133626|81746445|FG000|Overall Study|Withdrawal by Subject|1|||
27976974|NCT01133626|81746446|FG001|Overall Study|Withdrawal by Subject|2|||
27976975|NCT01133626|81746447|FG002|Overall Study|Withdrawal by Subject|2|||
27976976|NCT01133626|81746445|FG000|Overall Study|Other|0|||
27976977|NCT01133626|81746446|FG001|Overall Study|Other|2|||
27976978|NCT01133626|81746447|FG002|Overall Study|Other|0|||
27976979|NCT03002623|81749770|FG000|Overall Study|Lost to Follow-up|1|||
27976980|NCT03002623|81749771|FG001|Overall Study|Lost to Follow-up|0|||
27976981|NCT03002623|81749770|FG000|Overall Study|Physician Decision|1|||
27976982|NCT03002623|81749771|FG001|Overall Study|Physician Decision|1|||
27976983|NCT00357656|81749777|FG000|Overall Study|Other, No surgery performed|0|||
27976984|NCT00357656|81749778|FG001|Overall Study|Other, No surgery performed|3|||
27976985|NCT00546260|81749779|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
27976986|NCT00546260|81749780|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
27976987|NCT01596335|81749781|FG000|Overall Study|exacerbation of primary disease|5|||
27976988|NCT01596335|81749782|FG001|Overall Study|exacerbation of primary disease|9|||
27790287|NCT04516291|81062321|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27790288|NCT04516291|81062322|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27790289|NCT04516291|81062323|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27790290|NCT04516291|81062324|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27790291|NCT04516291|81062325|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27790292|NCT04516291|81062326|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27790293|NCT04516291|81062327|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27976989|NCT01739933|81749783|FG000|Overall Study|Death|89|||
27976990|NCT01739933|81749784|FG001|Overall Study|Death|86|||
27976991|NCT01739933|81749783|FG000|Overall Study|Withdrawal by Subject|10|||
27976992|NCT01739933|81749784|FG001|Overall Study|Withdrawal by Subject|8|||
27976993|NCT01739933|81749783|FG000|Overall Study|Lost to Follow-up|3|||
27976994|NCT01739933|81749784|FG001|Overall Study|Lost to Follow-up|10|||
27976995|NCT01739933|81749783|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
27976996|NCT01739933|81749784|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
27976997|NCT00794365|81749785|FG000|Overall Study|Lost to Follow-up|38|||
27976998|NCT00794365|81749785|FG000|Overall Study|Other|17|||
27976999|NCT00794365|81749785|FG000|Overall Study|Poor Compliance|11|||
27977000|NCT00794365|81749785|FG000|Overall Study|Adverse Event|10|||
27977001|NCT00794365|81749785|FG000|Overall Study|Lack of Efficacy|3|||
27977002|NCT01974752|81749790|FG000|Overall Study|Death|33|||
27977003|NCT01974752|81749791|FG001|Overall Study|Death|11|||
27977004|NCT01974752|81749790|FG000|Overall Study|Lost to Follow-up|2|||
27977005|NCT01974752|81749791|FG001|Overall Study|Lost to Follow-up|0|||
27977006|NCT01974752|81749790|FG000|Overall Study|Withdrawal by Subject|2|||
27977007|NCT01974752|81749791|FG001|Overall Study|Withdrawal by Subject|3|||
27977008|NCT01974752|81749790|FG000|Overall Study|Other Eligibility Criteria|0|||
27977009|NCT01974752|81749791|FG001|Overall Study|Other Eligibility Criteria|1|||
27977010|NCT01969500|81749798|FG000|Overall Study|Death|0|||
27977011|NCT01969500|81749799|FG001|Overall Study|Death|1|||
27977012|NCT01969500|81749798|FG000|Overall Study|extended hospitalization|1|||
27977013|NCT01969500|81749799|FG001|Overall Study|extended hospitalization|1|||
27977014|NCT01390779|81749802|FG000|Overall Study|Physician Decision|1|||
27977015|NCT00495521|81749805|FG000|Overall Study|Physician Decision|0|||
27977016|NCT00495521|81749806|FG001|Overall Study|Physician Decision|1|||
27977017|NCT03515551|81749808|FG000|Overall Study|Death|4|||
27977018|NCT03515551|81749809|FG001|Overall Study|Death|1|||
27977019|NCT03515551|81749810|FG002|Overall Study|Death|2|||
27977020|NCT03515551|81749811|FG003|Overall Study|Death|2|||
27977021|NCT03515551|81749812|FG004|Overall Study|Death|2|||
27977022|NCT03515551|81749813|FG005|Overall Study|Death|4|||
27977023|NCT03515551|81749814|FG006|Overall Study|Death|1|||
27977024|NCT03515551|81749808|FG000|Overall Study|Lost to Follow-up|0|||
27977025|NCT03515551|81749809|FG001|Overall Study|Lost to Follow-up|0|||
27977026|NCT03515551|81749810|FG002|Overall Study|Lost to Follow-up|1|||
27977027|NCT03515551|81749811|FG003|Overall Study|Lost to Follow-up|0|||
27977028|NCT03515551|81749812|FG004|Overall Study|Lost to Follow-up|0|||
27977029|NCT03515551|81749813|FG005|Overall Study|Lost to Follow-up|0|||
27977030|NCT03515551|81749814|FG006|Overall Study|Lost to Follow-up|0|||
27977031|NCT03515551|81749808|FG000|Overall Study|Withdrawal by Subject|0|||
27977032|NCT03515551|81749809|FG001|Overall Study|Withdrawal by Subject|1|||
27977033|NCT03515551|81749810|FG002|Overall Study|Withdrawal by Subject|0|||
27977034|NCT03515551|81749811|FG003|Overall Study|Withdrawal by Subject|0|||
27977035|NCT03515551|81749812|FG004|Overall Study|Withdrawal by Subject|0|||
27977036|NCT03515551|81749813|FG005|Overall Study|Withdrawal by Subject|0|||
27977037|NCT03515551|81749814|FG006|Overall Study|Withdrawal by Subject|1|||
27977038|NCT03515551|81749808|FG000|Overall Study|Study ended by sponsor|0|||
27977039|NCT03515551|81749809|FG001|Overall Study|Study ended by sponsor|0|||
27977040|NCT03515551|81749810|FG002|Overall Study|Study ended by sponsor|2|||
27977041|NCT03515551|81749811|FG003|Overall Study|Study ended by sponsor|1|||
27977042|NCT03515551|81749812|FG004|Overall Study|Study ended by sponsor|3|||
27977043|NCT03515551|81749813|FG005|Overall Study|Study ended by sponsor|0|||
27977044|NCT03515551|81749814|FG006|Overall Study|Study ended by sponsor|3|||
27977045|NCT03515551|81749808|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27977046|NCT03515551|81749809|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
27977047|NCT03515551|81749810|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27977048|NCT03515551|81749811|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27977049|NCT03515551|81749812|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27977050|NCT03515551|81749813|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27977051|NCT03515551|81749814|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
27977052|NCT03538444|81749815|FG000|Overall Study|opioid withdrawal|1|||
27977053|NCT03538444|81749816|FG001|Overall Study|opioid withdrawal|0|||
27977054|NCT02078102|81749817|FG000|Overall Study|Adverse Event|1|||
27977055|NCT02078102|81749818|FG001|Overall Study|Adverse Event|0|||
27977056|NCT02078102|81749817|FG000|Overall Study|Withdrawal by Subject|1|||
27977057|NCT02078102|81749818|FG001|Overall Study|Withdrawal by Subject|0|||
27977058|NCT02078102|81749817|FG000|Overall Study|Physician Decision|0|||
27977059|NCT02078102|81749818|FG001|Overall Study|Physician Decision|1|||
27977060|NCT00168103|81749819|FG000|Overall Study|Withdrawal by Subject|1|||
27977061|NCT00168103|81749820|FG001|Overall Study|Withdrawal by Subject|2|||
27977062|NCT00168103|81749821|FG002|Overall Study|Withdrawal by Subject|1|||
27977063|NCT00168103|81749822|FG003|Overall Study|Withdrawal by Subject|0|||
27977064|NCT00168103|81749819|FG000|Overall Study|Lost to Follow-up|1|||
27977065|NCT00168103|81749820|FG001|Overall Study|Lost to Follow-up|3|||
27977066|NCT00168103|81749821|FG002|Overall Study|Lost to Follow-up|0|||
27977067|NCT00168103|81749822|FG003|Overall Study|Lost to Follow-up|0|||
27977068|NCT01143051|81749823|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
27672173|NCT00943722|80639151|FG002|Base Study|Physician Decision|0|||
27977069|NCT01143051|81749824|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
27977070|NCT01143051|81749825|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
27977071|NCT01143051|81749826|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
27977072|NCT01143051|81749827|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
27574116|NCT02404311|80285818|FG003|Part A: Month 0-18|Physician Decision|0|||
27574117|NCT02404311|80285819|FG004|Part A: Month 0-18|Physician Decision|0|||
27574118|NCT02404311|80285815|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
27574119|NCT02404311|80285816|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
27574120|NCT02404311|80285817|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
27574121|NCT02404311|80285818|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
27574122|NCT02404311|80285819|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
27574123|NCT02404311|80285815|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
27574124|NCT02404311|80285816|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
27790294|NCT04516291|81062320|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
27790295|NCT04516291|81062321|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
27790296|NCT04516291|81062322|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
27790297|NCT04516291|81062323|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
27790298|NCT04516291|81062324|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
27790299|NCT04516291|81062325|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
27790300|NCT04516291|81062326|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
27790301|NCT04516291|81062327|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
27790302|NCT04516291|81062320|FG000|Follow-up Period (12 Weeks)|Other|0|||
27790303|NCT04516291|81062321|FG001|Follow-up Period (12 Weeks)|Other|1|||
27790304|NCT04516291|81062322|FG002|Follow-up Period (12 Weeks)|Other|0|||
27790305|NCT04516291|81062323|FG003|Follow-up Period (12 Weeks)|Other|2|||
27790306|NCT04516291|81062324|FG004|Follow-up Period (12 Weeks)|Other|0|||
27790307|NCT04516291|81062325|FG005|Follow-up Period (12 Weeks)|Other|0|||
27790308|NCT04516291|81062326|FG006|Follow-up Period (12 Weeks)|Other|0|||
27790309|NCT04516291|81062327|FG007|Follow-up Period (12 Weeks)|Other|0|||
27790310|NCT04516291|81062320|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790311|NCT04516291|81062321|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790312|NCT04516291|81062322|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790313|NCT04516291|81062323|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790314|NCT04516291|81062324|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
27790315|NCT04516291|81062325|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790316|NCT04516291|81062326|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790317|NCT04516291|81062327|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27790318|NCT04516291|81062320|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
27790319|NCT04516291|81062321|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
27790320|NCT04516291|81062322|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
27790321|NCT04516291|81062323|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
27790322|NCT04516291|81062324|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
27790323|NCT04516291|81062325|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
27790324|NCT04516291|81062326|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
27790325|NCT04516291|81062327|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
27790326|NCT00761462|81062328|FG000|Treatment|Subjects never received study medication|23|||
27790327|NCT00761462|81062329|FG001|Treatment|Subjects never received study medication|12|||
27790328|NCT00761462|81062328|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
27790329|NCT00761462|81062329|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
27790330|NCT00761462|81062328|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
27790331|NCT00761462|81062329|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
27790332|NCT00761462|81062328|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
27790333|NCT00761462|81062329|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
27790334|NCT02545270|81062333|FG000|Overall Study|technical difficulties|0|||
27790335|NCT02545270|81062334|FG001|Overall Study|technical difficulties|1|||
27790336|NCT02545270|81062335|FG002|Overall Study|technical difficulties|0|||
27790337|NCT02545270|81062333|FG000|Overall Study|Videos being too similar to other|0|||
27790338|NCT02545270|81062334|FG001|Overall Study|Videos being too similar to other|0|||
27790339|NCT02545270|81062335|FG002|Overall Study|Videos being too similar to other|2|||
27790340|NCT00483574|81062336|FG000|Overall Study|Adverse Event|6|||
27790341|NCT00483574|81062337|FG001|Overall Study|Adverse Event|0|||
27790342|NCT00483574|81062336|FG000|Overall Study|Protocol Violation|28|||
27790343|NCT00483574|81062337|FG001|Overall Study|Protocol Violation|9|||
27790344|NCT00483574|81062336|FG000|Overall Study|Lost to Follow-up|16|||
27790345|NCT00483574|81062337|FG001|Overall Study|Lost to Follow-up|4|||
27790346|NCT00483574|81062336|FG000|Overall Study|Withdrawal by Subject|52|||
27790347|NCT00483574|81062337|FG001|Overall Study|Withdrawal by Subject|0|||
27790348|NCT01160770|81062339|FG000|Overall Study|Adverse Event|10|||
27790349|NCT01160770|81062339|FG000|Overall Study|Protocol Violation|2|||
27977073|NCT01143051|81749828|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
27574125|NCT02404311|80285817|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
27790350|NCT01160770|81062339|FG000|Overall Study|Subject/parent/caregiver request|33|||
27790351|NCT01160770|81062339|FG000|Overall Study|Physician Decision|1|||
27790352|NCT01160770|81062339|FG000|Overall Study|Lost to Follow-up|7|||
27790353|NCT01160770|81062339|FG000|Overall Study|Study termination or sponsor request|1|||
27977074|NCT01143051|81749823|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
27574126|NCT02404311|80285818|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
27574127|NCT02404311|80285819|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
27977075|NCT01143051|81749824|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
27977076|NCT01143051|81749825|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
27977077|NCT01143051|81749826|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
27977078|NCT01143051|81749827|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
27977079|NCT01143051|81749828|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
27977080|NCT00869050|81749831|FG000|Overall Study|Screen Failure|3|||
27977081|NCT02699450|81749832|FG000|Overall Study|Death|2|||
27977082|NCT02699450|81749833|FG001|Overall Study|Death|1|||
27977083|NCT02699450|81749834|FG002|Overall Study|Death|2|||
27977084|NCT02699450|81749832|FG000|Overall Study|Met Criteria for Study Exit|0|||
27977085|NCT02699450|81749833|FG001|Overall Study|Met Criteria for Study Exit|0|||
27977086|NCT02699450|81749834|FG002|Overall Study|Met Criteria for Study Exit|1|||
27977087|NCT02699450|81749832|FG000|Overall Study|Protocol Violation|4|||
27977088|NCT02699450|81749833|FG001|Overall Study|Protocol Violation|3|||
27977089|NCT02699450|81749834|FG002|Overall Study|Protocol Violation|5|||
27977090|NCT02699450|81749832|FG000|Overall Study|Lost to Follow-up|3|||
27977091|NCT02699450|81749833|FG001|Overall Study|Lost to Follow-up|0|||
27977092|NCT02699450|81749834|FG002|Overall Study|Lost to Follow-up|5|||
27977093|NCT02699450|81749832|FG000|Overall Study|Physician Decision|2|||
27977094|NCT02699450|81749833|FG001|Overall Study|Physician Decision|0|||
27977095|NCT02699450|81749834|FG002|Overall Study|Physician Decision|0|||
27977096|NCT02699450|81749832|FG000|Overall Study|Withdrawal by Subject|3|||
27790354|NCT01160770|81062339|FG000|Overall Study|Death|9|||
27790355|NCT01160770|81062339|FG000|Overall Study|Lack of Efficacy|15|||
27790356|NCT01160770|81062339|FG000|Overall Study|Other Reasons|1|||
27790357|NCT02543918|81062340|FG000|Overall Study|Never treated|0|||
27790358|NCT02543918|81062341|FG001|Overall Study|Never treated|1|||
27790359|NCT02543918|81062340|FG000|Overall Study|Lost to Follow-up|1|||
27790360|NCT02543918|81062341|FG001|Overall Study|Lost to Follow-up|1|||
27790361|NCT02543918|81062340|FG000|Overall Study|Withdrawal by Subject|1|||
27790362|NCT02543918|81062341|FG001|Overall Study|Withdrawal by Subject|1|||
27790363|NCT02543918|81062340|FG000|Overall Study|Adverse Event|1|||
27790364|NCT02543918|81062341|FG001|Overall Study|Adverse Event|1|||
27790365|NCT01495793|81062342|FG000|Overall Study|Lost to Follow-up|1|||
27790366|NCT01495793|81062342|FG000|Overall Study|Violation of inclusion criteria|1|||
27790367|NCT01096017|81062343|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
27790368|NCT01096017|81062344|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
27790369|NCT01846442|81062345|FG000|Overall Study|Adverse Event|2|||
27790370|NCT01846442|81062346|FG001|Overall Study|Adverse Event|4|||
27790371|NCT01846442|81062347|FG002|Overall Study|Adverse Event|2|||
27790372|NCT01846442|81062348|FG003|Overall Study|Adverse Event|1|||
27977097|NCT02699450|81749833|FG001|Overall Study|Withdrawal by Subject|1|||
27977098|NCT02699450|81749834|FG002|Overall Study|Withdrawal by Subject|2|||
27977099|NCT02699450|81749832|FG000|Overall Study|Adverse Event|1|||
27977100|NCT02699450|81749833|FG001|Overall Study|Adverse Event|0|||
27977101|NCT02699450|81749834|FG002|Overall Study|Adverse Event|0|||
27977102|NCT04316741|81749835|FG000|Baseline Enrollment|Lost to Follow-up|1|||
27977103|NCT04316741|81749836|FG001|Baseline Enrollment|Lost to Follow-up|1|||
27977104|NCT04316741|81749835|FG000|Immediate Post-Test|Lost to Follow-up|5|||
27977105|NCT04316741|81749836|FG001|Immediate Post-Test|Lost to Follow-up|1|||
27977106|NCT04316741|81749835|FG000|1-month Post-test|Lost to Follow-up|7|||
27977107|NCT04316741|81749836|FG001|1-month Post-test|Lost to Follow-up|2|||
27977108|NCT04316741|81749835|FG000|3-month Follow-up|Lost to Follow-up|10|||
27977109|NCT04316741|81749836|FG001|3-month Follow-up|Lost to Follow-up|2|||
27977110|NCT01873729|81749837|FG000|Overall Study|Withdrawal by Subject|1|||
27977111|NCT02851407|81749840|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27977112|NCT02851407|81749841|FG001|Overall Study|Withdrawal by parent/guardian|7|||
27977113|NCT02851407|81749840|FG000|Overall Study|Protocol deviation|0|||
27977114|NCT02851407|81749841|FG001|Overall Study|Protocol deviation|1|||
27977115|NCT02851407|81749840|FG000|Overall Study|Transferred to another hospital to continue|1|||
27977116|NCT02851407|81749841|FG001|Overall Study|Transferred to another hospital to continue|0|||
27574128|NCT02404311|80285815|FG000|Part A: Month 0-18|HIV Infection|6|||
27790373|NCT01846442|81062345|FG000|Overall Study|Lost to Follow-up|0|||
27790374|NCT01846442|81062346|FG001|Overall Study|Lost to Follow-up|0|||
27977117|NCT02851407|81749840|FG000|Overall Study|Other Death|30|||
27977118|NCT02851407|81749841|FG001|Overall Study|Other Death|20|||
27977119|NCT02851407|81749840|FG000|Overall Study|Adverse event, serious fatal|6|||
27672174|NCT00943722|80639152|FG003|Base Study|Physician Decision|0|||
27672175|NCT00943722|80639153|FG004|Base Study|Physician Decision|1|||
27790375|NCT01846442|81062347|FG002|Overall Study|Lost to Follow-up|1|||
27790376|NCT01846442|81062348|FG003|Overall Study|Lost to Follow-up|0|||
27977120|NCT02851407|81749841|FG001|Overall Study|Adverse event, serious fatal|8|||
27977121|NCT02851407|81749840|FG000|Overall Study|Consent withdrawn by participant|5|||
27977122|NCT02851407|81749841|FG001|Overall Study|Consent withdrawn by participant|3|||
27977123|NCT02851407|81749840|FG000|Overall Study|Screen failure|2|||
27977124|NCT02851407|81749841|FG001|Overall Study|Screen failure|1|||
27977125|NCT02851407|81749840|FG000|Overall Study|Disease relapse|9|||
27977126|NCT02851407|81749841|FG001|Overall Study|Disease relapse|6|||
27977127|NCT02851407|81749840|FG000|Overall Study|Physician Decision|7|||
27977128|NCT02851407|81749841|FG001|Overall Study|Physician Decision|6|||
27977129|NCT02851407|81749840|FG000|Overall Study|Transferred to hospital closer to home|0|||
27977130|NCT02851407|81749841|FG001|Overall Study|Transferred to hospital closer to home|1|||
27977131|NCT02851407|81749840|FG000|Overall Study|Enrolled in an investigational study|0|||
27977132|NCT02851407|81749841|FG001|Overall Study|Enrolled in an investigational study|1|||
27977133|NCT02851407|81749840|FG000|Overall Study|Early recovery|1|||
27977134|NCT02851407|81749841|FG001|Overall Study|Early recovery|0|||
27977135|NCT02851407|81749840|FG000|Overall Study|Adverse event, non-fatal|7|||
27977136|NCT02851407|81749841|FG001|Overall Study|Adverse event, non-fatal|5|||
27977137|NCT02851407|81749840|FG000|Overall Study|Lost to Follow-up|0|||
27977138|NCT02851407|81749841|FG001|Overall Study|Lost to Follow-up|2|||
27977139|NCT01294462|81749842|FG000|Overall Study|Lost to Follow-up|1|||
27977140|NCT01294462|81749843|FG001|Overall Study|Lost to Follow-up|0|||
27977141|NCT01294462|81749842|FG000|Overall Study|Withdrawal by Subject|65|||
27977142|NCT01294462|81749843|FG001|Overall Study|Withdrawal by Subject|63|||
27977143|NCT00681564|81749848|FG000|Overall Study|Lost to Follow-up|6|||
27977144|NCT00681564|81749849|FG001|Overall Study|Lost to Follow-up|6|||
27977145|NCT00681564|81749848|FG000|Overall Study|Withdrawal by Subject|0|||
27977146|NCT00681564|81749849|FG001|Overall Study|Withdrawal by Subject|1|||
27977147|NCT00681564|81749848|FG000|Overall Study|Death|0|||
27977148|NCT00681564|81749849|FG001|Overall Study|Death|1|||
27977149|NCT02825420|81749854|FG000|Overall Study|Death|30|||
27977150|NCT02825420|81749855|FG001|Overall Study|Death|12|||
27977151|NCT02825420|81749854|FG000|Overall Study|Progressive disease|6|||
27977152|NCT02825420|81749855|FG001|Overall Study|Progressive disease|1|||
27977153|NCT02825420|81749854|FG000|Overall Study|Lost to Follow-up|2|||
27977154|NCT02825420|81749855|FG001|Overall Study|Lost to Follow-up|2|||
27977155|NCT02825420|81749854|FG000|Overall Study|Withdrawal by Subject|1|||
27977156|NCT02825420|81749855|FG001|Overall Study|Withdrawal by Subject|1|||
27977157|NCT02825420|81749854|FG000|Overall Study|Protocol amendment not signed|1|||
27977158|NCT02825420|81749855|FG001|Overall Study|Protocol amendment not signed|1|||
27977159|NCT02825420|81749854|FG000|Overall Study|Physician Decision|1|||
27977160|NCT02825420|81749855|FG001|Overall Study|Physician Decision|0|||
27977161|NCT02825420|81749854|FG000|Overall Study|Did not receive PLD|2|||
27977162|NCT02825420|81749855|FG001|Overall Study|Did not receive PLD|0|||
27977163|NCT00539513|81749856|FG000|Overall Study|Withdrawal by Subject|2|||
27977164|NCT00539513|81749857|FG001|Overall Study|Withdrawal by Subject|1|||
27977165|NCT00539513|81749856|FG000|Overall Study|Lost to Follow-up|0|||
27977166|NCT00539513|81749857|FG001|Overall Study|Lost to Follow-up|1|||
27977167|NCT01442064|81749859|FG000|Overall Study|Adverse Event|2|||
27977168|NCT01442064|81749860|FG001|Overall Study|Adverse Event|2|||
27977169|NCT01442064|81749861|FG002|Overall Study|Adverse Event|2|||
27977170|NCT01442064|81749862|FG003|Overall Study|Adverse Event|1|||
27977171|NCT01442064|81749863|FG004|Overall Study|Adverse Event|2|||
27977172|NCT01442064|81749864|FG005|Overall Study|Adverse Event|0|||
27977173|NCT01442064|81749859|FG000|Overall Study|Death|0|||
27977174|NCT01442064|81749860|FG001|Overall Study|Death|1|||
27977175|NCT01442064|81749861|FG002|Overall Study|Death|3|||
27977176|NCT01442064|81749862|FG003|Overall Study|Death|3|||
27977177|NCT01442064|81749863|FG004|Overall Study|Death|1|||
27977178|NCT01442064|81749864|FG005|Overall Study|Death|3|||
27977179|NCT01442064|81749859|FG000|Overall Study|Lost to Follow-up|5|||
27977180|NCT01442064|81749860|FG001|Overall Study|Lost to Follow-up|5|||
27977181|NCT01442064|81749861|FG002|Overall Study|Lost to Follow-up|1|||
27977182|NCT01442064|81749862|FG003|Overall Study|Lost to Follow-up|1|||
27977183|NCT01442064|81749863|FG004|Overall Study|Lost to Follow-up|3|||
27977184|NCT01442064|81749864|FG005|Overall Study|Lost to Follow-up|3|||
27977185|NCT01442064|81749859|FG000|Overall Study|Physician Decision|1|||
27977186|NCT01442064|81749860|FG001|Overall Study|Physician Decision|1|||
27977187|NCT01442064|81749861|FG002|Overall Study|Physician Decision|2|||
27977188|NCT01442064|81749862|FG003|Overall Study|Physician Decision|3|||
27977189|NCT01442064|81749863|FG004|Overall Study|Physician Decision|3|||
27574129|NCT02404311|80285816|FG001|Part A: Month 0-18|HIV Infection|2|||
27574130|NCT02404311|80285817|FG002|Part A: Month 0-18|HIV Infection|0|||
27977190|NCT01442064|81749864|FG005|Overall Study|Physician Decision|1|||
27977191|NCT01442064|81749859|FG000|Overall Study|Withdrawal by Subject|6|||
27574131|NCT02404311|80285818|FG003|Part A: Month 0-18|HIV Infection|0|||
27790377|NCT01846442|81062345|FG000|Overall Study|Withdrawal by Subject|3|||
27977192|NCT01442064|81749860|FG001|Overall Study|Withdrawal by Subject|3|||
27977193|NCT01442064|81749861|FG002|Overall Study|Withdrawal by Subject|2|||
27977194|NCT01442064|81749862|FG003|Overall Study|Withdrawal by Subject|2|||
27977195|NCT01442064|81749863|FG004|Overall Study|Withdrawal by Subject|2|||
27977196|NCT01442064|81749864|FG005|Overall Study|Withdrawal by Subject|1|||
27977197|NCT01442064|81749859|FG000|Overall Study|Sponsor decision|82|||
27977198|NCT01442064|81749860|FG001|Overall Study|Sponsor decision|88|||
27977199|NCT01442064|81749861|FG002|Overall Study|Sponsor decision|92|||
27977200|NCT01442064|81749862|FG003|Overall Study|Sponsor decision|88|||
27977201|NCT01442064|81749863|FG004|Overall Study|Sponsor decision|95|||
27977202|NCT01442064|81749864|FG005|Overall Study|Sponsor decision|87|||
27977203|NCT01442064|81749859|FG000|Overall Study|Subject non-compliance|0|||
27977204|NCT01442064|81749860|FG001|Overall Study|Subject non-compliance|0|||
27977205|NCT01442064|81749861|FG002|Overall Study|Subject non-compliance|0|||
27977206|NCT01442064|81749862|FG003|Overall Study|Subject non-compliance|0|||
27977207|NCT01442064|81749863|FG004|Overall Study|Subject non-compliance|0|||
27977208|NCT01442064|81749864|FG005|Overall Study|Subject non-compliance|2|||
27977209|NCT01442064|81749859|FG000|Overall Study|Condition mandated other intervention|1|||
27977210|NCT01442064|81749860|FG001|Overall Study|Condition mandated other intervention|1|||
27977211|NCT01442064|81749861|FG002|Overall Study|Condition mandated other intervention|2|||
27977212|NCT01442064|81749862|FG003|Overall Study|Condition mandated other intervention|0|||
27977213|NCT01442064|81749863|FG004|Overall Study|Condition mandated other intervention|0|||
27977214|NCT01442064|81749864|FG005|Overall Study|Condition mandated other intervention|2|||
27977215|NCT01165320|81749866|FG000|Overall Study|Clinical adverse experience|2|||
27977216|NCT01165320|81749867|FG001|Overall Study|Clinical adverse experience|1|||
27977217|NCT01165320|81749868|FG002|Overall Study|Clinical adverse experience|0|||
27977218|NCT01165320|81749866|FG000|Overall Study|Laboratory adverse experience|1|||
27977219|NCT01165320|81749867|FG001|Overall Study|Laboratory adverse experience|0|||
27977220|NCT01165320|81749868|FG002|Overall Study|Laboratory adverse experience|0|||
27977221|NCT01165320|81749866|FG000|Overall Study|Lack of Efficacy|0|||
27977222|NCT01165320|81749867|FG001|Overall Study|Lack of Efficacy|2|||
27977223|NCT01165320|81749868|FG002|Overall Study|Lack of Efficacy|0|||
27977224|NCT01165320|81749866|FG000|Overall Study|Reason unknown|0|||
27977225|NCT01165320|81749867|FG001|Overall Study|Reason unknown|1|||
27977226|NCT01165320|81749868|FG002|Overall Study|Reason unknown|0|||
27977227|NCT03532932|81749871|FG000|Overall Study|Protocol Deviation|33|||
27977228|NCT03532932|81749872|FG001|Overall Study|Protocol Deviation|31|||
27977229|NCT03532932|81749871|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
27977230|NCT03532932|81749872|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
27977231|NCT03532932|81749871|FG000|Overall Study|Withdrawal by Subject|2|||
27977232|NCT03532932|81749872|FG001|Overall Study|Withdrawal by Subject|0|||
27977233|NCT03532932|81749871|FG000|Overall Study|Lost to Follow-up|15|||
27977234|NCT03532932|81749872|FG001|Overall Study|Lost to Follow-up|9|||
27977235|NCT03532932|81749871|FG000|Overall Study|Adverse Event|4|||
27977236|NCT03532932|81749872|FG001|Overall Study|Adverse Event|3|||
27977237|NCT03532932|81749871|FG000|Overall Study|Death|0|||
27977238|NCT03532932|81749872|FG001|Overall Study|Death|2|||
27977239|NCT03532932|81749871|FG000|Overall Study|Other|11|||
27977240|NCT03532932|81749872|FG001|Overall Study|Other|16|||
27977241|NCT03372551|81749877|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
27977242|NCT03372551|81749878|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
27977243|NCT02744612|81749879|FG000|Overall Study|Withdrawal by Subject|0|||
27977244|NCT02744612|81749880|FG001|Overall Study|Withdrawal by Subject|2|||
27977245|NCT01666119|81749885|FG000|Overall Study|Adverse Event|6|||
27977246|NCT01666119|81749885|FG000|Overall Study|Withdrawal by Subject|16|||
27977247|NCT01666119|81749885|FG000|Overall Study|Lost to Follow-up|7|||
27977248|NCT01666119|81749885|FG000|Overall Study|non compliance with study medication, pa|18|||
27977249|NCT01666119|81749885|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
27977250|NCT00303446|81749886|FG000|Overall Study|Withdrawal by Subject|2|||
27977251|NCT00303446|81749887|FG001|Overall Study|Withdrawal by Subject|2|||
27977252|NCT00303446|81749886|FG000|Overall Study|Death|0|||
27977253|NCT00303446|81749887|FG001|Overall Study|Death|1|||
27977254|NCT00303446|81749886|FG000|Overall Study|Physician Decision|0|||
27977255|NCT00303446|81749887|FG001|Overall Study|Physician Decision|1|||
27977256|NCT01007123|81749888|FG000|Overall Study|Adverse Event|3|||
27977257|NCT01007123|81749889|FG001|Overall Study|Adverse Event|4|||
27977258|NCT01007123|81749890|FG002|Overall Study|Adverse Event|7|||
27977259|NCT01007123|81749891|FG003|Overall Study|Adverse Event|1|||
27977260|NCT01007123|81749888|FG000|Overall Study|Lack of Efficacy|1|||
27977261|NCT01007123|81749889|FG001|Overall Study|Lack of Efficacy|0|||
27977262|NCT01007123|81749890|FG002|Overall Study|Lack of Efficacy|1|||
27977263|NCT01007123|81749891|FG003|Overall Study|Lack of Efficacy|4|||
27977264|NCT01007123|81749888|FG000|Overall Study|Protocol Violation|1|||
27977265|NCT01007123|81749889|FG001|Overall Study|Protocol Violation|1|||
27977266|NCT01007123|81749890|FG002|Overall Study|Protocol Violation|2|||
27977267|NCT01007123|81749891|FG003|Overall Study|Protocol Violation|1|||
27977268|NCT01007123|81749888|FG000|Overall Study|Withdrawal by Subject|1|||
27977269|NCT01007123|81749889|FG001|Overall Study|Withdrawal by Subject|0|||
27977270|NCT01007123|81749890|FG002|Overall Study|Withdrawal by Subject|1|||
27977271|NCT01007123|81749891|FG003|Overall Study|Withdrawal by Subject|0|||
27977272|NCT01007123|81749888|FG000|Overall Study|Lost to Follow-up|0|||
27977273|NCT01007123|81749889|FG001|Overall Study|Lost to Follow-up|1|||
27977274|NCT01007123|81749890|FG002|Overall Study|Lost to Follow-up|0|||
27977275|NCT01007123|81749891|FG003|Overall Study|Lost to Follow-up|0|||
27977276|NCT01816906|81749892|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
27977277|NCT01816906|81749893|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
27977278|NCT01816906|81749892|FG000|Six Months|Lost to Follow-up|14|||
27977279|NCT01816906|81749893|FG001|Six Months|Lost to Follow-up|16|||
27977280|NCT01816906|81749892|FG000|12 Months|Adverse Event|2|||
27977281|NCT01816906|81749893|FG001|12 Months|Adverse Event|2|||
27977282|NCT01816906|81749892|FG000|12 Months|Death|0|||
27977283|NCT01816906|81749893|FG001|12 Months|Death|2|||
27977284|NCT01816906|81749892|FG000|12 Months|Lost to Follow-up|2|||
27977285|NCT01816906|81749893|FG001|12 Months|Lost to Follow-up|1|||
27977286|NCT03383783|81749894|FG000|Overall Study|Withdrawal by Subject|2|||
27977287|NCT01703117|81749895|FG000|Overall Study|Adverse Event|4|||
27977288|NCT01703117|81749896|FG001|Overall Study|Adverse Event|3|||
27977289|NCT01703117|81749895|FG000|Overall Study|Withdrawal by Subject|0|||
27977290|NCT01703117|81749896|FG001|Overall Study|Withdrawal by Subject|1|||
27977291|NCT04224272|81749897|FG000|Part 1 - Dose Finding|Death|4|||
27977292|NCT04224272|81749897|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
27977293|NCT04224272|81749897|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
27977294|NCT04224272|81749897|FG000|Part 2 - Dose Expansion|Death|10|||
27977295|NCT04224272|81749897|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
27977296|NCT02014480|81749898|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27977297|NCT02014480|81749899|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27977298|NCT02014480|81749900|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
27977299|NCT02014480|81749901|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27977300|NCT02014480|81749902|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27977301|NCT02014480|81749903|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27977302|NCT02014480|81749898|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27977303|NCT02014480|81749899|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27977304|NCT02014480|81749900|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27977305|NCT02014480|81749901|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
27977306|NCT02014480|81749902|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27977307|NCT02014480|81749903|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27977308|NCT02014480|81749898|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27977309|NCT02014480|81749899|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27977310|NCT02014480|81749900|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
27977311|NCT02014480|81749901|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27977312|NCT02014480|81749902|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27977313|NCT02014480|81749903|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27977314|NCT02014480|81749898|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27977315|NCT02014480|81749899|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27977316|NCT02014480|81749900|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
27977317|NCT02014480|81749901|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27977318|NCT02014480|81749902|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27977319|NCT02014480|81749903|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27977320|NCT02014480|81749898|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27977321|NCT02014480|81749899|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
27977322|NCT02014480|81749900|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27977323|NCT02014480|81749901|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27977324|NCT02014480|81749902|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27977325|NCT02014480|81749903|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27977326|NCT02014480|81749898|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
27977327|NCT02014480|81749899|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
27977328|NCT02014480|81749900|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
27977329|NCT02014480|81749901|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
27977330|NCT02014480|81749902|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
27977331|NCT02014480|81749903|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
27977332|NCT02014480|81749898|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27977333|NCT02014480|81749899|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27977334|NCT02014480|81749900|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27977335|NCT02014480|81749901|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27977336|NCT02014480|81749902|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27977337|NCT02014480|81749903|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
27790378|NCT01846442|81062346|FG001|Overall Study|Withdrawal by Subject|2|||
27790379|NCT01846442|81062347|FG002|Overall Study|Withdrawal by Subject|0|||
27790380|NCT01846442|81062348|FG003|Overall Study|Withdrawal by Subject|1|||
27790381|NCT01846442|81062345|FG000|Overall Study|Left the city/Lost medication|1|||
27790382|NCT01846442|81062346|FG001|Overall Study|Left the city/Lost medication|0|||
27790383|NCT01846442|81062347|FG002|Overall Study|Left the city/Lost medication|1|||
27867558|NCT00613171|81349618|FG000|Overall Study|Reason not Specified|4|||
27977338|NCT00919867|81749904|FG000|First Intervention|Withdrawal by Subject|0|||
27977339|NCT00919867|81749905|FG001|First Intervention|Withdrawal by Subject|0|||
27977340|NCT00919867|81749906|FG002|First Intervention|Withdrawal by Subject|1|||
27977341|NCT00919867|81749907|FG003|First Intervention|Withdrawal by Subject|0|||
27977342|NCT00919867|81749908|FG004|First Intervention|Withdrawal by Subject|0|||
27977343|NCT00919867|81749909|FG005|First Intervention|Withdrawal by Subject|0|||
27977344|NCT00919867|81749904|FG000|First Intervention|Physician Decision|0|||
27977345|NCT00919867|81749905|FG001|First Intervention|Physician Decision|0|||
27977346|NCT00919867|81749906|FG002|First Intervention|Physician Decision|0|||
27977347|NCT00919867|81749907|FG003|First Intervention|Physician Decision|0|||
27977348|NCT00919867|81749908|FG004|First Intervention|Physician Decision|0|||
27977349|NCT00919867|81749909|FG005|First Intervention|Physician Decision|1|||
27977350|NCT00591149|81749915|FG000|Overall Study|Adverse Event|4|||
27977351|NCT00591149|81749915|FG000|Overall Study|Withdrawal by Subject|1|||
27977352|NCT01510184|81749916|FG000|Overall Study|Sponsor discretion|28|||
27977353|NCT01510184|81749917|FG001|Overall Study|Sponsor discretion|28|||
27977354|NCT01510184|81749916|FG000|Overall Study|Death|1|||
27977355|NCT01510184|81749917|FG001|Overall Study|Death|2|||
27977356|NCT01510184|81749916|FG000|Overall Study|Withdrawal by Subject|1|||
27977357|NCT01510184|81749917|FG001|Overall Study|Withdrawal by Subject|4|||
27977358|NCT01510184|81749916|FG000|Overall Study|Other|0|||
27977359|NCT01510184|81749917|FG001|Overall Study|Other|1|||
27977360|NCT01342965|81749919|FG000|Overall Study|Death|58|||
27977361|NCT01342965|81749920|FG001|Overall Study|Death|57|||
27977362|NCT01342965|81749919|FG000|Overall Study|Lost to Follow-up|5|||
27977363|NCT01342965|81749920|FG001|Overall Study|Lost to Follow-up|3|||
27977364|NCT01342965|81749919|FG000|Overall Study|Other Reasons- Unspecified|44|||
27977365|NCT01342965|81749920|FG001|Overall Study|Other Reasons- Unspecified|38|||
27977366|NCT01342965|81749919|FG000|Overall Study|Withdrawal by Subject|2|||
27977367|NCT01342965|81749920|FG001|Overall Study|Withdrawal by Subject|9|||
27977368|NCT00197145|81749921|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
27977369|NCT00197145|81749922|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
27977370|NCT00197145|81749921|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
27977371|NCT00197145|81749922|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
27977372|NCT00197145|81749921|FG000|Period 1: Randomized Treatment Phase|Other|2|||
27977373|NCT00197145|81749922|FG001|Period 1: Randomized Treatment Phase|Other|2|||
27977374|NCT00197145|81749921|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
27977375|NCT00197145|81749922|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
27977376|NCT00197145|81749921|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
27977377|NCT00197145|81749922|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
27977378|NCT00197145|81749921|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
27977379|NCT00197145|81749922|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
27977380|NCT00197145|81749921|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
27977381|NCT00197145|81749922|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
27977382|NCT00197145|81749921|FG000|Period 2 : Open Label Phase|Other|1|||
27977383|NCT00197145|81749922|FG001|Period 2 : Open Label Phase|Other|0|||
27977384|NCT00871117|81749924|FG000|Overall Study|Lost to Follow-up|5|||
27977385|NCT00871117|81749925|FG001|Overall Study|Lost to Follow-up|6|||
27977386|NCT00871117|81749924|FG000|Overall Study|Other|0|||
27977387|NCT00871117|81749925|FG001|Overall Study|Other|4|||
27977388|NCT04465877|81749926|FG000|Overall Study|Noncompliant with study requirements|0|||
27977389|NCT04465877|81749927|FG001|Overall Study|Noncompliant with study requirements|0|||
27977390|NCT04465877|81749928|FG002|Overall Study|Noncompliant with study requirements|1|||
27977391|NCT04465877|81749929|FG003|Overall Study|Noncompliant with study requirements|0|||
27977392|NCT01996592|81749934|FG000|Overall Study|no response to text/no diary entry|32|||
27977393|NCT01996592|81749934|FG000|Overall Study|change in surgical date|4|||
27977394|NCT01996592|81749934|FG000|Overall Study|Withdrawal by Subject|5|||
27977395|NCT01996592|81749934|FG000|Overall Study|change in mode of delivery|4|||
27977396|NCT01081301|81749935|FG000|Overall Study|Bereaved|3|||
27977397|NCT01081301|81749935|FG000|Overall Study|Too busy|5|||
27977398|NCT01081301|81749935|FG000|Overall Study|Patient too ill|2|||
27977399|NCT01081301|81749935|FG000|Overall Study|Lost to Follow-up|4|||
27977400|NCT00787137|81749936|FG000|Overall Study|Study Termination|0|||
27977401|NCT00787137|81749937|FG001|Overall Study|Study Termination|0|||
27977402|NCT00787137|81749938|FG002|Overall Study|Study Termination|1|||
27977403|NCT02133664|81749939|FG000|Overall Study|Lost to Follow-up|2|||
27790384|NCT01846442|81062348|FG003|Overall Study|Left the city/Lost medication|1|||
27977404|NCT02133664|81749940|FG001|Overall Study|Lost to Follow-up|1|||
27977405|NCT02133664|81749939|FG000|Overall Study|Adverse Event|3|||
27977406|NCT02133664|81749940|FG001|Overall Study|Adverse Event|6|||
27574132|NCT02404311|80285819|FG004|Part A: Month 0-18|HIV Infection|0|||
27977407|NCT01344538|81749941|FG000|Overall Study|Adverse Event|1|||
27574133|NCT02404311|80285815|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
27574134|NCT02404311|80285816|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
27977408|NCT01344538|81749942|FG001|Overall Study|Adverse Event|1|||
27977409|NCT01344538|81749941|FG000|Overall Study|Lost to Follow-up|1|||
27977410|NCT01344538|81749942|FG001|Overall Study|Lost to Follow-up|0|||
27977411|NCT02118597|81749948|FG000|Overall Study|Sponsor terminated the study|14|||
27977412|NCT02118597|81749948|FG000|Overall Study|Serious Adverse Event|1|||
27977413|NCT02118597|81749948|FG000|Overall Study|Investigator's decision|1|||
27574135|NCT02404311|80285817|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
27574136|NCT02404311|80285818|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
27574137|NCT02404311|80285819|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
27574138|NCT01448850|80285822|FG000|Overall Study|Death|3|||
27574139|NCT01448850|80285823|FG001|Overall Study|Death|6|||
27574140|NCT01448850|80285822|FG000|Overall Study|Withdrawal by Subject|13|||
27574141|NCT01448850|80285823|FG001|Overall Study|Withdrawal by Subject|21|||
27574142|NCT01448850|80285822|FG000|Overall Study|Lost to Follow-up|3|||
27574143|NCT01448850|80285823|FG001|Overall Study|Lost to Follow-up|1|||
27574144|NCT01448850|80285822|FG000|Overall Study|Other|15|||
27574145|NCT01448850|80285823|FG001|Overall Study|Other|12|||
27574146|NCT00240071|80285824|FG000|Overall Study|Withdrawal by Subject|3|||
27574147|NCT02376166|80285826|FG000|Overall Study|Adverse Event|1|||
27574148|NCT02376166|80285826|FG000|Overall Study|Discontinued metformin early|2|||
27574149|NCT03795922|80285829|FG000|Overall Study|Adverse Event|2|||
27574150|NCT03795922|80285830|FG001|Overall Study|Adverse Event|1|||
27574151|NCT03795922|80285829|FG000|Overall Study|Withdrawal by Subject|5|||
27574152|NCT03795922|80285830|FG001|Overall Study|Withdrawal by Subject|13|||
27574153|NCT03795922|80285829|FG000|Overall Study|Lost to Follow-up|2|||
27574154|NCT03795922|80285830|FG001|Overall Study|Lost to Follow-up|3|||
27790385|NCT03186794|81062349|FG000|Overall Study|Physician Decision|2|||
27790386|NCT03186794|81062349|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
27790387|NCT00604175|81062350|FG000|Entry Through Week 28|Death|2|||
27790388|NCT00604175|81062351|FG001|Entry Through Week 28|Death|0|||
27790389|NCT00604175|81062352|FG002|Entry Through Week 28|Death|0|||
27790390|NCT00604175|81062350|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
27790391|NCT00604175|81062351|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
27790392|NCT00604175|81062352|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
27790393|NCT00604175|81062350|FG000|Entry Through Week 28|Lost to Follow-up|4|||
27790394|NCT00604175|81062351|FG001|Entry Through Week 28|Lost to Follow-up|3|||
27790395|NCT00604175|81062352|FG002|Entry Through Week 28|Lost to Follow-up|0|||
27790396|NCT00604175|81062350|FG000|Entry Through Week 28|Ineligible|1|||
27790397|NCT00604175|81062351|FG001|Entry Through Week 28|Ineligible|0|||
27790398|NCT00604175|81062352|FG002|Entry Through Week 28|Ineligible|0|||
27867559|NCT02181790|81349622|FG000|Overall Study|study terminated|2|||
27867560|NCT02181790|81349623|FG001|Overall Study|study terminated|0|||
27867561|NCT02856555|81349624|FG000|Overall Study|Adverse Event|1|||
27867562|NCT02856555|81349625|FG001|Overall Study|Adverse Event|0|||
27867563|NCT02856555|81349626|FG002|Overall Study|Adverse Event|0|||
27867564|NCT02856555|81349624|FG000|Overall Study|Lost to Follow-up|1|||
27867565|NCT02856555|81349625|FG001|Overall Study|Lost to Follow-up|3|||
27867566|NCT02856555|81349626|FG002|Overall Study|Lost to Follow-up|0|||
27867567|NCT02856555|81349624|FG000|Overall Study|Withdrawal by Subject|3|||
27867568|NCT02856555|81349625|FG001|Overall Study|Withdrawal by Subject|0|||
27867569|NCT02856555|81349626|FG002|Overall Study|Withdrawal by Subject|0|||
27867570|NCT02856555|81349624|FG000|Overall Study|Randomized but Never Treated|0|||
27867571|NCT02856555|81349625|FG001|Overall Study|Randomized but Never Treated|1|||
27867572|NCT02856555|81349626|FG002|Overall Study|Randomized but Never Treated|0|||
27867573|NCT00887289|81349631|FG000|Overall Study|Lack of Efficacy|14|||
27867574|NCT00887289|81349631|FG000|Overall Study|Adverse Event|27|||
27867575|NCT00887289|81349631|FG000|Overall Study|Withdrawal by Subject|26|||
27867576|NCT00887289|81349631|FG000|Overall Study|Lost to Follow-up|8|||
27867577|NCT00887289|81349631|FG000|Overall Study|Other|20|||
27867578|NCT02633787|81349632|FG000|Overall Study|Withdrawal by Subject|1|||
27867579|NCT00345631|81349641|FG000|Overall Study|Withdrawal by Subject|1|||
27867580|NCT00345631|81349642|FG001|Overall Study|Withdrawal by Subject|0|||
27867581|NCT00345631|81349643|FG002|Overall Study|Withdrawal by Subject|1|||
27574155|NCT03795922|80285829|FG000|Overall Study|Pregnancy|0|||
27790399|NCT00604175|81062350|FG000|Entry Through Week 28|Did not start intervention|2|||
27790400|NCT00604175|81062351|FG001|Entry Through Week 28|Did not start intervention|0|||
27790401|NCT00604175|81062352|FG002|Entry Through Week 28|Did not start intervention|1|||
27867582|NCT00345631|81349641|FG000|Overall Study|Adverse Event|0|||
27867583|NCT00345631|81349642|FG001|Overall Study|Adverse Event|1|||
27867584|NCT00345631|81349643|FG002|Overall Study|Adverse Event|0|||
27867585|NCT00345631|81349641|FG000|Overall Study|Lost to Follow-up|3|||
27867586|NCT00345631|81349642|FG001|Overall Study|Lost to Follow-up|7|||
27867587|NCT00345631|81349643|FG002|Overall Study|Lost to Follow-up|4|||
27867588|NCT00345631|81349641|FG000|Overall Study|Other reasons|0|||
27867589|NCT00345631|81349642|FG001|Overall Study|Other reasons|0|||
27867590|NCT00345631|81349643|FG002|Overall Study|Other reasons|1|||
27867591|NCT00535405|81349644|FG000|Overall Study|Adverse Event|6|||
27867592|NCT00535405|81349645|FG001|Overall Study|Adverse Event|8|||
27867593|NCT00535405|81349646|FG002|Overall Study|Adverse Event|3|||
27574156|NCT03795922|80285830|FG001|Overall Study|Pregnancy|1|||
27574157|NCT03795922|80285829|FG000|Overall Study|Physician Decision|1|||
27574158|NCT03795922|80285830|FG001|Overall Study|Physician Decision|2|||
27790402|NCT00604175|81062350|FG000|Week 29 Through Week 72|Death|0|||
27790403|NCT00604175|81062351|FG001|Week 29 Through Week 72|Death|0|||
27574159|NCT03795922|80285829|FG000|Overall Study|Protocol Violation|0|||
27574160|NCT03795922|80285830|FG001|Overall Study|Protocol Violation|1|||
27574161|NCT03795922|80285829|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
27574162|NCT03795922|80285830|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
27574163|NCT02517905|80285831|FG000|Overall Study|Lost to Follow-up|4|||
27574164|NCT02517905|80285832|FG001|Overall Study|Lost to Follow-up|0|||
27574165|NCT02517905|80285831|FG000|Overall Study|Withdrawal by Subject|4|||
27574166|NCT02517905|80285832|FG001|Overall Study|Withdrawal by Subject|0|||
27574167|NCT02517905|80285831|FG000|Overall Study|Screen failure|2|||
27574168|NCT02517905|80285832|FG001|Overall Study|Screen failure|2|||
27574169|NCT03945981|80285841|FG000|Overall Study|Lost to Follow-up|12|||
27574170|NCT03945981|80285841|FG000|Overall Study|Physician Decision|4|||
27574171|NCT03945981|80285841|FG000|Overall Study|Withdrawal by Subject|6|||
27574172|NCT03945981|80285841|FG000|Overall Study|Protocol Violation|1|||
27574173|NCT01797536|80285842|FG000|Overall Study|Adverse Event|0|||
27574174|NCT01797536|80285843|FG001|Overall Study|Adverse Event|1|||
27574175|NCT01797536|80285844|FG002|Overall Study|Adverse Event|0|||
27574176|NCT01797536|80285845|FG003|Overall Study|Adverse Event|0|||
27574177|NCT03568942|80285846|FG000|Overall Study|Family emergency|1|||
27574178|NCT03568942|80285846|FG000|Overall Study|Lost to Follow-up|1|||
27574179|NCT01539226|80285847|FG000|Overall Study|Withdrawal by Subject|24|||
27574180|NCT01539226|80285848|FG001|Overall Study|Withdrawal by Subject|54|||
27574181|NCT01539226|80285847|FG000|Overall Study|Lost to Follow-up|20|||
27574182|NCT01539226|80285848|FG001|Overall Study|Lost to Follow-up|54|||
27574183|NCT01539226|80285847|FG000|Overall Study|Death|1|||
27574184|NCT01539226|80285848|FG001|Overall Study|Death|2|||
27574185|NCT01539226|80285847|FG000|Overall Study|Adverse Event|2|||
27574186|NCT01539226|80285848|FG001|Overall Study|Adverse Event|0|||
27574187|NCT01539226|80285847|FG000|Overall Study|Pregnancy|13|||
27574188|NCT01539226|80285848|FG001|Overall Study|Pregnancy|29|||
27574189|NCT01539226|80285847|FG000|Overall Study|inappropriate enrollment|0|||
27574190|NCT01539226|80285848|FG001|Overall Study|inappropriate enrollment|1|||
27574191|NCT01539226|80285847|FG000|Overall Study|Multiple Reasons|3|||
27574192|NCT01539226|80285848|FG001|Overall Study|Multiple Reasons|1|||
27574193|NCT01539226|80285847|FG000|Overall Study|not HIV seroconversion-related|93|||
27574194|NCT01539226|80285848|FG001|Overall Study|not HIV seroconversion-related|176|||
27574195|NCT01539226|80285847|FG000|Overall Study|HIV seroconversion-related|55|||
27574196|NCT01539226|80285848|FG001|Overall Study|HIV seroconversion-related|80|||
27574197|NCT01539226|80285847|FG000|Overall Study|Non-compliance|6|||
27574198|NCT01539226|80285848|FG001|Overall Study|Non-compliance|8|||
27574199|NCT00586469|80285849|FG000|Overall Study|Adverse Event|0|||
27574200|NCT00586469|80285850|FG001|Overall Study|Adverse Event|1|||
27574201|NCT00463060|80285851|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
27574202|NCT00463060|80285851|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
27574203|NCT01109316|80285852|FG000|Study Period 1|Adverse Event|0|||
27574204|NCT01109316|80285853|FG001|Study Period 1|Adverse Event|0|||
27574205|NCT01109316|80285854|FG002|Study Period 1|Adverse Event|1|||
27574206|NCT01109316|80285855|FG003|Study Period 1|Adverse Event|0|||
27574207|NCT01109316|80285856|FG004|Study Period 1|Adverse Event|0|||
27574208|NCT01109316|80285857|FG005|Study Period 1|Adverse Event|0|||
27672176|NCT00943722|80639154|FG005|Base Study|Physician Decision|0|||
27672177|NCT00943722|80639155|FG006|Base Study|Physician Decision|0|||
27977414|NCT01767493|81749949|FG000|Overall Study|screen failures|3|||
27977415|NCT02761694|81749950|FG000|Overall Study|Lack of Efficacy|0|||
27977416|NCT02761694|81749951|FG001|Overall Study|Lack of Efficacy|0|||
27977417|NCT02761694|81749952|FG002|Overall Study|Lack of Efficacy|0|||
27672178|NCT00943722|80639149|FG000|Base Study|Pregnancy|0|||
27672179|NCT00943722|80639150|FG001|Base Study|Pregnancy|0|||
27672180|NCT00943722|80639151|FG002|Base Study|Pregnancy|1|||
27672181|NCT00943722|80639152|FG003|Base Study|Pregnancy|0|||
27672182|NCT00943722|80639153|FG004|Base Study|Pregnancy|2|||
27672183|NCT00943722|80639154|FG005|Base Study|Pregnancy|0|||
27672184|NCT00943722|80639155|FG006|Base Study|Pregnancy|0|||
27672185|NCT00943722|80639149|FG000|Base Study|Protocol Violation|0|||
27672186|NCT00943722|80639150|FG001|Base Study|Protocol Violation|1|||
27672187|NCT00943722|80639151|FG002|Base Study|Protocol Violation|0|||
27672188|NCT00943722|80639152|FG003|Base Study|Protocol Violation|0|||
27672189|NCT00943722|80639153|FG004|Base Study|Protocol Violation|2|||
27672190|NCT00943722|80639154|FG005|Base Study|Protocol Violation|0|||
27672191|NCT00943722|80639155|FG006|Base Study|Protocol Violation|0|||
27672192|NCT00943722|80639149|FG000|Base Study|Withdrawal by Subject|12|||
27672193|NCT00943722|80639150|FG001|Base Study|Withdrawal by Subject|13|||
27672194|NCT00943722|80639151|FG002|Base Study|Withdrawal by Subject|2|||
27672195|NCT00943722|80639152|FG003|Base Study|Withdrawal by Subject|13|||
27672196|NCT00943722|80639153|FG004|Base Study|Withdrawal by Subject|8|||
27672197|NCT00943722|80639154|FG005|Base Study|Withdrawal by Subject|0|||
27672198|NCT00943722|80639155|FG006|Base Study|Withdrawal by Subject|0|||
27672199|NCT00943722|80639149|FG000|Base Study|Month 12 visit not completed|0|||
27672200|NCT00943722|80639150|FG001|Base Study|Month 12 visit not completed|0|||
27672201|NCT00943722|80639151|FG002|Base Study|Month 12 visit not completed|0|||
27672202|NCT00943722|80639152|FG003|Base Study|Month 12 visit not completed|0|||
27672203|NCT00943722|80639153|FG004|Base Study|Month 12 visit not completed|2|||
27672204|NCT00943722|80639154|FG005|Base Study|Month 12 visit not completed|0|||
27672205|NCT00943722|80639155|FG006|Base Study|Month 12 visit not completed|0|||
27672206|NCT00943722|80639149|FG000|First Extension Study: EXT 1|Adverse Event|0|||
27790404|NCT00604175|81062352|FG002|Week 29 Through Week 72|Death|1|||
27790405|NCT00604175|81062350|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
27790406|NCT00604175|81062351|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
27790407|NCT00604175|81062352|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
27790408|NCT00604175|81062350|FG000|Week 29 Through Week 72|Site closure|0|||
27790409|NCT00604175|81062351|FG001|Week 29 Through Week 72|Site closure|1|||
27790410|NCT00604175|81062352|FG002|Week 29 Through Week 72|Site closure|0|||
27790411|NCT00604175|81062350|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
27790412|NCT00604175|81062351|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
27790413|NCT00604175|81062352|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
27790414|NCT01593761|81062355|FG000|Overall Study|Lost to Follow-up|1|||
27790415|NCT01593761|81062355|FG000|Overall Study|culture negative for MRSA at baseline|5|||
27790416|NCT01593761|81062355|FG000|Overall Study|positive for hepatitis C virus|1|||
27790417|NCT01593761|81062355|FG000|Overall Study|secondary cellulitis|1|||
27867594|NCT00535405|81349647|FG003|Overall Study|Adverse Event|8|||
27867595|NCT00535405|81349648|FG004|Overall Study|Adverse Event|6|||
27867596|NCT00535405|81349644|FG000|Overall Study|Lost to Follow-up|1|||
27867597|NCT00535405|81349645|FG001|Overall Study|Lost to Follow-up|3|||
27977418|NCT02761694|81749953|FG003|Overall Study|Lack of Efficacy|0|||
27977419|NCT02761694|81749954|FG004|Overall Study|Lack of Efficacy|0|||
27977420|NCT02761694|81749955|FG005|Overall Study|Lack of Efficacy|0|||
27574209|NCT01109316|80285852|FG000|Study Period 1|Lost to Follow-up|0|||
27574210|NCT01109316|80285853|FG001|Study Period 1|Lost to Follow-up|0|||
27574211|NCT01109316|80285854|FG002|Study Period 1|Lost to Follow-up|1|||
27977421|NCT02761694|81749956|FG006|Overall Study|Lack of Efficacy|6|||
27574212|NCT01109316|80285855|FG003|Study Period 1|Lost to Follow-up|1|||
27574213|NCT01109316|80285856|FG004|Study Period 1|Lost to Follow-up|0|||
27574214|NCT01109316|80285857|FG005|Study Period 1|Lost to Follow-up|0|||
27672207|NCT00943722|80639150|FG001|First Extension Study: EXT 1|Adverse Event|0|||
27672208|NCT00943722|80639151|FG002|First Extension Study: EXT 1|Adverse Event|0|||
27672209|NCT00943722|80639152|FG003|First Extension Study: EXT 1|Adverse Event|0|||
27672210|NCT00943722|80639153|FG004|First Extension Study: EXT 1|Adverse Event|0|||
27672211|NCT00943722|80639154|FG005|First Extension Study: EXT 1|Adverse Event|1|||
27672212|NCT00943722|80639155|FG006|First Extension Study: EXT 1|Adverse Event|0|||
27672213|NCT00943722|80639149|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
27672214|NCT00943722|80639150|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
27672215|NCT00943722|80639151|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
27672216|NCT00943722|80639152|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
27672217|NCT00943722|80639153|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
27790418|NCT00090259|81062356|FG000|Overall Study|Lost to Follow-up|30|||
27867598|NCT00535405|81349646|FG002|Overall Study|Lost to Follow-up|3|||
27867599|NCT00535405|81349647|FG003|Overall Study|Lost to Follow-up|2|||
27867600|NCT00535405|81349648|FG004|Overall Study|Lost to Follow-up|1|||
27574215|NCT01109316|80285852|FG000|Study Period 1|Withdrawal by Subject|0|||
27574216|NCT01109316|80285853|FG001|Study Period 1|Withdrawal by Subject|0|||
27574217|NCT01109316|80285854|FG002|Study Period 1|Withdrawal by Subject|1|||
27574218|NCT01109316|80285855|FG003|Study Period 1|Withdrawal by Subject|0|||
27574219|NCT01109316|80285856|FG004|Study Period 1|Withdrawal by Subject|2|||
27574220|NCT01109316|80285857|FG005|Study Period 1|Withdrawal by Subject|0|||
27574221|NCT01109316|80285852|FG000|Study Period 1|Sponsor Decision|0|||
27574222|NCT01109316|80285853|FG001|Study Period 1|Sponsor Decision|0|||
27574223|NCT01109316|80285854|FG002|Study Period 1|Sponsor Decision|0|||
27574224|NCT01109316|80285855|FG003|Study Period 1|Sponsor Decision|0|||
27867601|NCT00535405|81349644|FG000|Overall Study|Physician Decision|3|||
27867602|NCT00535405|81349645|FG001|Overall Study|Physician Decision|2|||
27867603|NCT00535405|81349646|FG002|Overall Study|Physician Decision|0|||
27867604|NCT00535405|81349647|FG003|Overall Study|Physician Decision|1|||
27867605|NCT00535405|81349648|FG004|Overall Study|Physician Decision|1|||
27867606|NCT00535405|81349644|FG000|Overall Study|Protocol Violation|2|||
27867607|NCT00535405|81349645|FG001|Overall Study|Protocol Violation|2|||
27867608|NCT00535405|81349646|FG002|Overall Study|Protocol Violation|2|||
27867609|NCT00535405|81349647|FG003|Overall Study|Protocol Violation|1|||
27867610|NCT00535405|81349648|FG004|Overall Study|Protocol Violation|0|||
27867611|NCT00535405|81349644|FG000|Overall Study|Withdrawal by Subject|5|||
27867612|NCT00535405|81349645|FG001|Overall Study|Withdrawal by Subject|11|||
27867613|NCT00535405|81349646|FG002|Overall Study|Withdrawal by Subject|10|||
27867614|NCT00535405|81349647|FG003|Overall Study|Withdrawal by Subject|10|||
27867615|NCT00535405|81349648|FG004|Overall Study|Withdrawal by Subject|8|||
27867616|NCT02368314|81349655|FG000|Overall Study|Withdrawal by Subject|2|||
27867617|NCT02368314|81349656|FG001|Overall Study|Withdrawal by Subject|1|||
27867618|NCT02368314|81349655|FG000|Overall Study|Adverse Event|1|||
27867619|NCT02368314|81349656|FG001|Overall Study|Adverse Event|2|||
27867620|NCT01433055|81349659|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
27867621|NCT01433055|81349660|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
27867622|NCT01433055|81349659|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
27867623|NCT01433055|81349660|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
27574225|NCT01109316|80285856|FG004|Study Period 1|Sponsor Decision|0|||
27574226|NCT01109316|80285857|FG005|Study Period 1|Sponsor Decision|2|||
27574227|NCT01109316|80285852|FG000|Study Period 2|Entry Criteria Not Met|0|||
27574228|NCT01109316|80285853|FG001|Study Period 2|Entry Criteria Not Met|1|||
27574229|NCT01109316|80285854|FG002|Study Period 2|Entry Criteria Not Met|0|||
27867624|NCT02929056|81349661|FG000|Overall Study|Lost to Follow-up|0|||
27867625|NCT02929056|81349662|FG001|Overall Study|Lost to Follow-up|1|||
27867626|NCT00270855|81349663|FG000|Overall Study|Withdrawal by Subject|8|||
27867627|NCT00270855|81349664|FG001|Overall Study|Withdrawal by Subject|8|||
27867628|NCT04138043|81349665|FG000|Overall Study|Withdrawal by Subject|0|||
27867629|NCT04138043|81349666|FG001|Overall Study|Withdrawal by Subject|1|||
27867630|NCT01911273|81349667|FG000|Overall Study|Progression of Disease|1|||
27867631|NCT01911273|81349668|FG001|Overall Study|Progression of Disease|0|||
27867632|NCT01911273|81349667|FG000|Overall Study|Withdrawal by Subject|0|||
27867633|NCT01911273|81349668|FG001|Overall Study|Withdrawal by Subject|2|||
27574230|NCT01109316|80285855|FG003|Study Period 2|Entry Criteria Not Met|0|||
27574231|NCT01109316|80285856|FG004|Study Period 2|Entry Criteria Not Met|0|||
27574232|NCT01109316|80285857|FG005|Study Period 2|Entry Criteria Not Met|0|||
27574233|NCT01109316|80285852|FG000|Study Period 2|Physician Decision|0|||
27672218|NCT00943722|80639154|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
27672219|NCT00943722|80639155|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
27672220|NCT00943722|80639149|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27672221|NCT00943722|80639150|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27672222|NCT00943722|80639151|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27672223|NCT00943722|80639152|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27672224|NCT00943722|80639153|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
27672225|NCT00943722|80639154|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
27672226|NCT00943722|80639155|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
27672227|NCT00943722|80639149|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
27790419|NCT00090259|81062357|FG001|Overall Study|Lost to Follow-up|26|||
27790420|NCT00090259|81062356|FG000|Overall Study|Withdrawal by Subject|21|||
27790421|NCT00090259|81062357|FG001|Overall Study|Withdrawal by Subject|15|||
27790422|NCT00090259|81062356|FG000|Overall Study|Investigator site closed|11|||
27672228|NCT00943722|80639150|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
27672229|NCT00943722|80639151|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
27672230|NCT00943722|80639152|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
27672231|NCT00943722|80639153|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
27672232|NCT00943722|80639154|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
27672233|NCT00943722|80639155|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
27672234|NCT00943722|80639149|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
27672235|NCT00943722|80639150|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
27672236|NCT00943722|80639151|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
27672237|NCT00943722|80639152|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
27672238|NCT00943722|80639153|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
27672239|NCT00943722|80639154|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
27672240|NCT00943722|80639155|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
27672241|NCT00943722|80639149|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27672242|NCT00943722|80639150|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27790423|NCT00090259|81062357|FG001|Overall Study|Investigator site closed|7|||
27790424|NCT00726882|81062359|FG000|Overall Study|Withdrawal by Subject|5|||
27790425|NCT00726882|81062359|FG000|Overall Study|Lost to Follow-up|7|||
27790426|NCT00726882|81062359|FG000|Overall Study|Other|10|||
27790427|NCT00938366|81062360|FG000|Overall Study|Withdrawal by Subject|1|||
27790428|NCT00938366|81062361|FG001|Overall Study|Withdrawal by Subject|0|||
27790429|NCT02219477|81062369|FG000|Overall Study|Adverse Event|0|||
27790430|NCT02219477|81062370|FG001|Overall Study|Adverse Event|1|||
27790431|NCT02219477|81062371|FG002|Overall Study|Adverse Event|1|||
27790432|NCT02219477|81062369|FG000|Overall Study|Withdrawal by Subject|0|||
27790433|NCT02219477|81062370|FG001|Overall Study|Withdrawal by Subject|1|||
27672243|NCT00943722|80639151|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27672244|NCT00943722|80639152|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27672245|NCT00943722|80639153|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
27672246|NCT00943722|80639154|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
27672247|NCT00943722|80639155|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
27790434|NCT02219477|81062371|FG002|Overall Study|Withdrawal by Subject|0|||
27790435|NCT01545375|81062372|FG000|Overall Study|Adverse Event|2|||
27790436|NCT01545375|81062373|FG001|Overall Study|Adverse Event|1|||
27790437|NCT01545375|81062372|FG000|Overall Study|Lost to Follow-up|34|||
27790438|NCT01545375|81062373|FG001|Overall Study|Lost to Follow-up|31|||
27790439|NCT01545375|81062372|FG000|Overall Study|Protocol Violation|3|||
27790440|NCT01545375|81062373|FG001|Overall Study|Protocol Violation|3|||
27790441|NCT01545375|81062372|FG000|Overall Study|Withdrawal by Subject|58|||
27790442|NCT01545375|81062373|FG001|Overall Study|Withdrawal by Subject|55|||
27790443|NCT00314262|81062374|FG000|Overall Study|Adverse Event|2|||
27790444|NCT00314262|81062374|FG000|Overall Study|Withdrawal by Subject|2|||
27790445|NCT00314262|81062374|FG000|Overall Study|Physician Decision|1|||
27790446|NCT01374516|81062375|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
27790447|NCT01374516|81062376|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
27790448|NCT01374516|81062375|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
27790449|NCT01374516|81062376|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
27790450|NCT01374516|81062375|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
27790451|NCT01374516|81062376|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
27790452|NCT01374516|81062375|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
27790453|NCT01374516|81062376|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
27977422|NCT02761694|81749957|FG007|Overall Study|Lack of Efficacy|0|||
27977423|NCT02761694|81749958|FG008|Overall Study|Lack of Efficacy|0|||
27672248|NCT00943722|80639149|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
27977424|NCT02761694|81749959|FG009|Overall Study|Lack of Efficacy|1|||
27672249|NCT00943722|80639150|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
27672250|NCT00943722|80639151|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
27672251|NCT00943722|80639152|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
27672252|NCT00943722|80639153|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
27977425|NCT02761694|81749960|FG010|Overall Study|Lack of Efficacy|1|||
27977426|NCT02761694|81749961|FG011|Overall Study|Lack of Efficacy|4|||
27977427|NCT02761694|81749950|FG000|Overall Study|Death|0|||
27977428|NCT02761694|81749951|FG001|Overall Study|Death|0|||
27977429|NCT02761694|81749952|FG002|Overall Study|Death|0|||
27977430|NCT02761694|81749953|FG003|Overall Study|Death|0|||
27977431|NCT02761694|81749954|FG004|Overall Study|Death|0|||
27977432|NCT02761694|81749955|FG005|Overall Study|Death|0|||
27977433|NCT02761694|81749956|FG006|Overall Study|Death|2|||
27977434|NCT02761694|81749957|FG007|Overall Study|Death|0|||
27977435|NCT02761694|81749958|FG008|Overall Study|Death|2|||
27977436|NCT02761694|81749959|FG009|Overall Study|Death|2|||
27977437|NCT02761694|81749960|FG010|Overall Study|Death|1|||
27977438|NCT02761694|81749961|FG011|Overall Study|Death|0|||
27977439|NCT02761694|81749950|FG000|Overall Study|Physician Decision|0|||
27977440|NCT02761694|81749951|FG001|Overall Study|Physician Decision|0|||
27977441|NCT02761694|81749952|FG002|Overall Study|Physician Decision|0|||
27977442|NCT02761694|81749953|FG003|Overall Study|Physician Decision|0|||
27977443|NCT02761694|81749954|FG004|Overall Study|Physician Decision|0|||
27977444|NCT02761694|81749955|FG005|Overall Study|Physician Decision|0|||
27977445|NCT02761694|81749956|FG006|Overall Study|Physician Decision|1|||
27977446|NCT02761694|81749957|FG007|Overall Study|Physician Decision|0|||
27977447|NCT02761694|81749958|FG008|Overall Study|Physician Decision|0|||
27977448|NCT02761694|81749959|FG009|Overall Study|Physician Decision|0|||
27977449|NCT02761694|81749960|FG010|Overall Study|Physician Decision|0|||
27977450|NCT02761694|81749961|FG011|Overall Study|Physician Decision|0|||
27977451|NCT02761694|81749950|FG000|Overall Study|Withdrawal by Subject|0|||
27977452|NCT02761694|81749951|FG001|Overall Study|Withdrawal by Subject|0|||
27977453|NCT02761694|81749952|FG002|Overall Study|Withdrawal by Subject|0|||
27977454|NCT02761694|81749953|FG003|Overall Study|Withdrawal by Subject|1|||
27977455|NCT02761694|81749954|FG004|Overall Study|Withdrawal by Subject|0|||
27977456|NCT02761694|81749955|FG005|Overall Study|Withdrawal by Subject|0|||
27977457|NCT02761694|81749956|FG006|Overall Study|Withdrawal by Subject|4|||
27977458|NCT02761694|81749957|FG007|Overall Study|Withdrawal by Subject|0|||
27977459|NCT02761694|81749958|FG008|Overall Study|Withdrawal by Subject|2|||
27977460|NCT02761694|81749959|FG009|Overall Study|Withdrawal by Subject|1|||
27977461|NCT02761694|81749960|FG010|Overall Study|Withdrawal by Subject|0|||
27790454|NCT01374516|81062375|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
27790455|NCT01374516|81062376|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
27867634|NCT00587860|81349675|FG000|Overall Study|Lost to Follow-up|2|||
27977462|NCT02761694|81749961|FG011|Overall Study|Withdrawal by Subject|0|||
27977463|NCT02761694|81749950|FG000|Overall Study|Lost to Follow-up|0|||
27977464|NCT02761694|81749951|FG001|Overall Study|Lost to Follow-up|0|||
27672253|NCT00943722|80639154|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
27790456|NCT01374516|81062375|FG000|Surveillance Expansion Period|Protocol Violation|386|||
27977465|NCT02761694|81749952|FG002|Overall Study|Lost to Follow-up|0|||
27977466|NCT02761694|81749953|FG003|Overall Study|Lost to Follow-up|0|||
27977467|NCT02761694|81749954|FG004|Overall Study|Lost to Follow-up|0|||
27977468|NCT02761694|81749955|FG005|Overall Study|Lost to Follow-up|0|||
27977469|NCT02761694|81749956|FG006|Overall Study|Lost to Follow-up|1|||
27977470|NCT02761694|81749957|FG007|Overall Study|Lost to Follow-up|0|||
27977471|NCT02761694|81749958|FG008|Overall Study|Lost to Follow-up|0|||
27977472|NCT02761694|81749959|FG009|Overall Study|Lost to Follow-up|0|||
27977473|NCT02761694|81749960|FG010|Overall Study|Lost to Follow-up|0|||
27977474|NCT02761694|81749961|FG011|Overall Study|Lost to Follow-up|1|||
27977475|NCT02761694|81749950|FG000|Overall Study|Adverse Event|0|||
27977476|NCT02761694|81749951|FG001|Overall Study|Adverse Event|0|||
27977477|NCT02761694|81749952|FG002|Overall Study|Adverse Event|0|||
27977478|NCT02761694|81749953|FG003|Overall Study|Adverse Event|0|||
27977479|NCT02761694|81749954|FG004|Overall Study|Adverse Event|0|||
27977480|NCT02761694|81749955|FG005|Overall Study|Adverse Event|0|||
27977481|NCT02761694|81749956|FG006|Overall Study|Adverse Event|1|||
27977482|NCT02761694|81749957|FG007|Overall Study|Adverse Event|0|||
27977483|NCT02761694|81749958|FG008|Overall Study|Adverse Event|1|||
27977484|NCT02761694|81749959|FG009|Overall Study|Adverse Event|0|||
27977485|NCT02761694|81749960|FG010|Overall Study|Adverse Event|0|||
27977486|NCT02761694|81749961|FG011|Overall Study|Adverse Event|1|||
27977487|NCT02761694|81749950|FG000|Overall Study|Other|4|||
27977488|NCT02761694|81749951|FG001|Overall Study|Other|4|||
27977489|NCT02761694|81749952|FG002|Overall Study|Other|1|||
27977490|NCT02761694|81749953|FG003|Overall Study|Other|2|||
27977491|NCT02761694|81749954|FG004|Overall Study|Other|3|||
27977492|NCT02761694|81749955|FG005|Overall Study|Other|3|||
27977493|NCT02761694|81749956|FG006|Overall Study|Other|18|||
27977494|NCT02761694|81749957|FG007|Overall Study|Other|8|||
27977495|NCT02761694|81749958|FG008|Overall Study|Other|0|||
27977496|NCT02761694|81749959|FG009|Overall Study|Other|1|||
27977497|NCT02761694|81749960|FG010|Overall Study|Other|1|||
27977498|NCT02761694|81749961|FG011|Overall Study|Other|0|||
27977499|NCT03554772|81749966|FG000|Overall Study|Lost to Follow-up|0|||
27977500|NCT03554772|81749967|FG001|Overall Study|Lost to Follow-up|0|||
27977501|NCT03554772|81749968|FG002|Overall Study|Lost to Follow-up|0|||
27977502|NCT03554772|81749969|FG003|Overall Study|Lost to Follow-up|2|||
27977503|NCT03366103|81749971|FG000|Overall Study|Disease Progression|3|||
27977504|NCT03366103|81749972|FG001|Overall Study|Disease Progression|1|||
27977505|NCT03366103|81749973|FG002|Overall Study|Disease Progression|0|||
27977506|NCT03366103|81749971|FG000|Overall Study|Adverse Event|0|||
27977507|NCT03366103|81749972|FG001|Overall Study|Adverse Event|1|||
27977508|NCT03366103|81749973|FG002|Overall Study|Adverse Event|0|||
27977509|NCT00149994|81749974|FG000|Overall Study|Administrative problems:|1|||
27977510|NCT00149994|81749975|FG001|Overall Study|Administrative problems:|0|||
27977511|NCT00149994|81749974|FG000|Overall Study|Protocol Violation|0|||
27977512|NCT00149994|81749975|FG001|Overall Study|Protocol Violation|1|||
27977513|NCT00511433|81749976|FG000|Overall Study|Adverse Event|5|||
27977514|NCT00511433|81749977|FG001|Overall Study|Adverse Event|0|||
27977515|NCT00511433|81749976|FG000|Overall Study|Other Reason|1|||
27977516|NCT00511433|81749977|FG001|Overall Study|Other Reason|1|||
27977517|NCT04143217|81749978|FG000|Overall Study|Withdrawal by Subject|42|||
27977518|NCT04143217|81749978|FG000|Overall Study|Adverse Event|29|||
27977519|NCT04143217|81749978|FG000|Overall Study|Lost to Follow-up|29|||
27977520|NCT04143217|81749978|FG000|Overall Study|Lack of Efficacy|15|||
27977521|NCT04143217|81749978|FG000|Overall Study|Physician Decision|1|||
27977522|NCT04143217|81749978|FG000|Overall Study|Non-Compliance With Study Drug|6|||
27977523|NCT04143217|81749978|FG000|Overall Study|Other, Multiple Categories|11|||
27977524|NCT03002818|81749979|FG000|Overall Study|Decision of the investigator|1|||
27977525|NCT01170598|81749982|FG000|Overall Study|Withdrawal by Subject|1|||
27977526|NCT01170598|81749982|FG000|Overall Study|Death|3|||
27977527|NCT01170598|81749982|FG000|Overall Study|Lost to Follow-up|1|||
27977528|NCT01170598|81749982|FG000|Overall Study|Refused|1|||
27977529|NCT01765426|81749983|FG000|Overall Study|Lost to Follow-up|0|||
27977530|NCT01765426|81749984|FG001|Overall Study|Lost to Follow-up|1|||
27977531|NCT01765426|81749985|FG002|Overall Study|Lost to Follow-up|0|||
27790457|NCT01374516|81062376|FG001|Surveillance Expansion Period|Protocol Violation|217|||
27977532|NCT01765426|81749986|FG003|Overall Study|Lost to Follow-up|0|||
27977533|NCT01129882|81749987|FG000|Overall Study|Adverse Event|39|||
27574234|NCT01109316|80285853|FG001|Study Period 2|Physician Decision|0|||
27790458|NCT01374516|81062375|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
27977534|NCT01129882|81749987|FG000|Overall Study|Death|6|||
27977535|NCT01129882|81749987|FG000|Overall Study|Lack of Efficacy|5|||
27977536|NCT01129882|81749987|FG000|Overall Study|Lost to Follow-up|13|||
27977537|NCT01129882|81749987|FG000|Overall Study|Physician Decision|27|||
27977538|NCT01129882|81749987|FG000|Overall Study|Protocol Deviation|3|||
27977539|NCT01129882|81749987|FG000|Overall Study|Withdrawal Criteria Met|19|||
27977540|NCT01129882|81749987|FG000|Overall Study|Trial Termination by Sponsor|6|||
27977541|NCT01129882|81749987|FG000|Overall Study|Withdrawal by Subject|160|||
27977542|NCT01011933|81749988|FG000|Overall Study|Wrong cell type|1|||
27977543|NCT01011933|81749988|FG000|Overall Study|Improper pre-protocol Rx|1|||
27977544|NCT01011933|81749988|FG000|Overall Study|Inadequate pathology|1|||
27977545|NCT01011933|81749988|FG000|Overall Study|Never treated|1|||
27977546|NCT02549352|81749991|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
27977547|NCT02549352|81749992|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
27977548|NCT02549352|81749991|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
27977549|NCT02549352|81749992|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
27977550|NCT02549352|81749991|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
27977551|NCT02549352|81749992|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
27977552|NCT02549352|81749991|FG000|12-month Follow-up|Withdrawal by Subject|4|||
27977553|NCT02549352|81749992|FG001|12-month Follow-up|Withdrawal by Subject|5|||
27977554|NCT02549352|81749991|FG000|12-month Follow-up|Lost to Follow-up|3|||
27977555|NCT02549352|81749992|FG001|12-month Follow-up|Lost to Follow-up|2|||
27977556|NCT02549352|81749991|FG000|12-month Follow-up|Death|0|||
27977557|NCT02549352|81749992|FG001|12-month Follow-up|Death|1|||
27977558|NCT02549352|81749991|FG000|12-month Follow-up|Protocol Violation|0|||
27977559|NCT02549352|81749992|FG001|12-month Follow-up|Protocol Violation|1|||
27977560|NCT02549352|81749991|FG000|12-month Follow-up|Other|1|||
27977561|NCT02549352|81749992|FG001|12-month Follow-up|Other|3|||
27977562|NCT02836873|81749993|FG000|Overall Study|Protocol Violation|0|||
27977563|NCT02836873|81749994|FG001|Overall Study|Protocol Violation|1|||
27977564|NCT02836873|81749993|FG000|Overall Study|Adverse Event|1|||
27977565|NCT02836873|81749994|FG001|Overall Study|Adverse Event|4|||
27977566|NCT02836873|81749993|FG000|Overall Study|Withdrawal by Subject|2|||
27977567|NCT02836873|81749994|FG001|Overall Study|Withdrawal by Subject|2|||
27977568|NCT02836873|81749993|FG000|Overall Study|Lost to Follow-up|1|||
27977569|NCT02836873|81749994|FG001|Overall Study|Lost to Follow-up|3|||
27977570|NCT02836873|81749993|FG000|Overall Study|Physician Decision|0|||
27977571|NCT02836873|81749994|FG001|Overall Study|Physician Decision|1|||
27977572|NCT02836873|81749993|FG000|Overall Study|Other|1|||
27977573|NCT02836873|81749994|FG001|Overall Study|Other|0|||
27977574|NCT03283098|81749997|FG000|Overall Study|Withdrawal by Subject|0|||
27977575|NCT03283098|81749998|FG001|Overall Study|Withdrawal by Subject|1|||
27977576|NCT01697462|81749999|FG000|Overall Study|Disease Progression|1|||
27977577|NCT01697462|81749999|FG000|Overall Study|Adverse Event|6|||
27977578|NCT01697462|81749999|FG000|Overall Study|Lost to Follow-up|21|||
27977579|NCT01697462|81749999|FG000|Overall Study|Withdrawal by Subject|12|||
27977580|NCT01697462|81749999|FG000|Overall Study|Investigator Decision|21|||
27977581|NCT01697462|81749999|FG000|Overall Study|Death|1|||
27977582|NCT01697462|81749999|FG000|Overall Study|Other|10|||
27977583|NCT01697462|81749999|FG000|Overall Study|Missing|5|||
27977584|NCT01515475|81750000|FG000|Overall Study|Lost to Follow-up|20|||
27977585|NCT01515475|81750001|FG001|Overall Study|Lost to Follow-up|15|||
27977586|NCT01515475|81750002|FG002|Overall Study|Lost to Follow-up|12|||
27977587|NCT01515475|81750003|FG003|Overall Study|Lost to Follow-up|12|||
27977588|NCT00791557|81750005|FG000|Overall Study|Adverse Event|1|||
27977589|NCT03780959|81750006|FG000|Part 1|Adverse Event|1|||
27977590|NCT03780959|81750007|FG001|Part 1|Adverse Event|0|||
27977591|NCT03780959|81750008|FG002|Part 1|Adverse Event|0|||
27977592|NCT03780959|81750006|FG000|Part 1|Withdrawal by Subject|1|||
27977593|NCT03780959|81750007|FG001|Part 1|Withdrawal by Subject|0|||
27977594|NCT03780959|81750008|FG002|Part 1|Withdrawal by Subject|0|||
27977595|NCT03780959|81750006|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
27977596|NCT03780959|81750007|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
27977597|NCT03780959|81750008|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
27977598|NCT03780959|81750006|FG000|Part 1|Response Status|2|||
27977599|NCT03780959|81750007|FG001|Part 1|Response Status|0|||
27977600|NCT03780959|81750008|FG002|Part 1|Response Status|0|||
27977601|NCT03780959|81750006|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
27977602|NCT03780959|81750007|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
27977603|NCT03780959|81750008|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
27977604|NCT03780959|81750006|FG000|Part 2|Response Status|0|||
27977605|NCT03780959|81750007|FG001|Part 2|Response Status|18|||
27977606|NCT03780959|81750008|FG002|Part 2|Response Status|6|||
27977607|NCT02966795|81750010|FG000|Overall Study|Patient Left the Country|0|||
27977608|NCT02966795|81750011|FG001|Overall Study|Patient Left the Country|1|||
27977609|NCT00434759|81750012|FG000|Overall Study|Lack of Efficacy|5|||
27867635|NCT00587860|81349676|FG001|Overall Study|Lost to Follow-up|2|||
27977610|NCT00434759|81750013|FG001|Overall Study|Lack of Efficacy|4|||
27977611|NCT00434759|81750012|FG000|Overall Study|Withdrawal by Subject|17|||
27977612|NCT00434759|81750013|FG001|Overall Study|Withdrawal by Subject|1|||
27977613|NCT00434759|81750012|FG000|Overall Study|family affairs|2|||
27977614|NCT00434759|81750013|FG001|Overall Study|family affairs|0|||
27977615|NCT02255565|81750014|FG000|Overall Study|Withdrawal by Subject|0|||
27977616|NCT02255565|81750015|FG001|Overall Study|Withdrawal by Subject|1|||
27977617|NCT02255565|81750016|FG002|Overall Study|Withdrawal by Subject|0|||
27977618|NCT02513823|81750019|FG000|Overall Study|Lost to Follow-up|4|||
27977619|NCT02513823|81750019|FG000|Overall Study|Physician Decision|1|||
27977620|NCT01667562|81750020|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
27977621|NCT01667562|81750021|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
27977622|NCT01667562|81750020|FG000|Erlotinib Phase|Lost to Follow-up|0|||
27977623|NCT01667562|81750021|FG001|Erlotinib Phase|Lost to Follow-up|1|||
27977624|NCT01667562|81750020|FG000|Erlotinib Phase|Adverse Event|0|||
27977625|NCT01667562|81750021|FG001|Erlotinib Phase|Adverse Event|1|||
27977626|NCT01667562|81750020|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
27977627|NCT01667562|81750021|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
27977628|NCT02174523|81750022|FG000|Overall Study|Withdrawal by Subject|1|||
27977629|NCT02174523|81750023|FG001|Overall Study|Withdrawal by Subject|0|||
27977630|NCT04962230|81750024|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
27977631|NCT04962230|81750024|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
27977632|NCT00490139|81750025|FG000|Overall Study|Death|106|||
27977633|NCT00490139|81750026|FG001|Overall Study|Death|119|||
27977634|NCT00490139|81750027|FG002|Overall Study|Death|168|||
27977635|NCT00490139|81750028|FG003|Overall Study|Death|135|||
27977636|NCT00490139|81750025|FG000|Overall Study|Lost to Follow-up|56|||
27977637|NCT00490139|81750026|FG001|Overall Study|Lost to Follow-up|46|||
27977638|NCT00490139|81750027|FG002|Overall Study|Lost to Follow-up|58|||
27977639|NCT00490139|81750028|FG003|Overall Study|Lost to Follow-up|56|||
27977640|NCT00490139|81750025|FG000|Overall Study|Participant Withdrew Consent|146|||
27977641|NCT00490139|81750026|FG001|Overall Study|Participant Withdrew Consent|110|||
27977642|NCT00490139|81750027|FG002|Overall Study|Participant Withdrew Consent|208|||
27977643|NCT00490139|81750028|FG003|Overall Study|Participant Withdrew Consent|116|||
27977644|NCT02370095|81750029|FG000|Overall Study|Withdrawal by Subject|0|||
27977645|NCT02370095|81750030|FG001|Overall Study|Withdrawal by Subject|1|||
27977646|NCT03344640|81750032|FG000|Overall Study|Adverse Event|1|||
27977647|NCT03344640|81750033|FG001|Overall Study|Adverse Event|0|||
27977648|NCT03344640|81750032|FG000|Overall Study|Physician Decision|1|||
27977649|NCT03344640|81750033|FG001|Overall Study|Physician Decision|1|||
27977650|NCT03344640|81750032|FG000|Overall Study|Withdrawal by Subject|1|||
27977651|NCT03344640|81750033|FG001|Overall Study|Withdrawal by Subject|2|||
27977652|NCT03344640|81750032|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
27977653|NCT03344640|81750033|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
27977654|NCT01962987|81750035|FG000|Overall Study|Adverse Event|4|||
27977655|NCT01962987|81750036|FG001|Overall Study|Adverse Event|4|||
27977656|NCT01962987|81750037|FG002|Overall Study|Adverse Event|0|||
27977657|NCT01962987|81750035|FG000|Overall Study|Lost to Follow-up|0|||
27977658|NCT01962987|81750036|FG001|Overall Study|Lost to Follow-up|0|||
27977659|NCT01962987|81750037|FG002|Overall Study|Lost to Follow-up|1|||
27977660|NCT01962987|81750035|FG000|Overall Study|Non compliance with dosing requirements|4|||
27977661|NCT01962987|81750036|FG001|Overall Study|Non compliance with dosing requirements|2|||
27977662|NCT01962987|81750037|FG002|Overall Study|Non compliance with dosing requirements|0|||
27977663|NCT01962987|81750035|FG000|Overall Study|Miscellaneous|1|||
27977664|NCT01962987|81750036|FG001|Overall Study|Miscellaneous|9|||
27977665|NCT01962987|81750037|FG002|Overall Study|Miscellaneous|2|||
27977666|NCT01962987|81750035|FG000|Overall Study|Restricted medication|5|||
27977667|NCT01962987|81750036|FG001|Overall Study|Restricted medication|1|||
27977668|NCT01962987|81750037|FG002|Overall Study|Restricted medication|1|||
27977669|NCT01962987|81750035|FG000|Overall Study|Serious Adverse Event|1|||
27977670|NCT01962987|81750036|FG001|Overall Study|Serious Adverse Event|0|||
27977671|NCT01962987|81750037|FG002|Overall Study|Serious Adverse Event|0|||
27977672|NCT01962987|81750035|FG000|Overall Study|Withdrawal by Subject|11|||
27977673|NCT01962987|81750036|FG001|Overall Study|Withdrawal by Subject|10|||
27977674|NCT01962987|81750037|FG002|Overall Study|Withdrawal by Subject|6|||
27977675|NCT01962987|81750035|FG000|Overall Study|Randomized in Error|4|||
27977676|NCT01962987|81750036|FG001|Overall Study|Randomized in Error|2|||
27977677|NCT01962987|81750037|FG002|Overall Study|Randomized in Error|2|||
27574235|NCT01109316|80285854|FG002|Study Period 2|Physician Decision|0|||
27574236|NCT01109316|80285855|FG003|Study Period 2|Physician Decision|1|||
27574237|NCT01109316|80285856|FG004|Study Period 2|Physician Decision|0|||
27574238|NCT01109316|80285857|FG005|Study Period 2|Physician Decision|0|||
27574239|NCT01109316|80285852|FG000|Study Period 2|Protocol Violation|1|||
27574240|NCT01109316|80285853|FG001|Study Period 2|Protocol Violation|0|||
27574241|NCT01109316|80285854|FG002|Study Period 2|Protocol Violation|0|||
27672254|NCT00943722|80639155|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
27977678|NCT01920893|81750040|FG000|Overall Study|Adverse Event|5|||
27977679|NCT01920893|81750041|FG001|Overall Study|Adverse Event|2|||
27672255|NCT00943722|80639149|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
27977680|NCT01920893|81750040|FG000|Overall Study|Lack of Efficacy|2|||
27977681|NCT01920893|81750041|FG001|Overall Study|Lack of Efficacy|0|||
27977682|NCT01448824|81750042|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27977683|NCT01448824|81750043|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27977684|NCT01448824|81750044|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27977685|NCT01448824|81750045|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27977686|NCT01448824|81750046|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27574242|NCT01109316|80285855|FG003|Study Period 2|Protocol Violation|0|||
27574243|NCT01109316|80285856|FG004|Study Period 2|Protocol Violation|0|||
27672256|NCT00943722|80639150|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
27574244|NCT01109316|80285857|FG005|Study Period 2|Protocol Violation|0|||
27574245|NCT01109316|80285852|FG000|Study Period 2|Withdrawal by Subject|0|||
27574246|NCT01109316|80285853|FG001|Study Period 2|Withdrawal by Subject|0|||
27574247|NCT01109316|80285854|FG002|Study Period 2|Withdrawal by Subject|1|||
27574248|NCT01109316|80285855|FG003|Study Period 2|Withdrawal by Subject|0|||
27574249|NCT01109316|80285856|FG004|Study Period 2|Withdrawal by Subject|0|||
27574250|NCT01109316|80285857|FG005|Study Period 2|Withdrawal by Subject|1|||
27574251|NCT01109316|80285852|FG000|Study Period 3|Lost to Follow-up|0|||
27574252|NCT01109316|80285853|FG001|Study Period 3|Lost to Follow-up|0|||
27574253|NCT01109316|80285854|FG002|Study Period 3|Lost to Follow-up|0|||
27574254|NCT01109316|80285855|FG003|Study Period 3|Lost to Follow-up|0|||
27574255|NCT01109316|80285856|FG004|Study Period 3|Lost to Follow-up|1|||
27574256|NCT01109316|80285857|FG005|Study Period 3|Lost to Follow-up|0|||
27574257|NCT01109316|80285852|FG000|Study Period 3|Withdrawal by Subject|1|||
27574258|NCT01109316|80285853|FG001|Study Period 3|Withdrawal by Subject|0|||
27574259|NCT01109316|80285854|FG002|Study Period 3|Withdrawal by Subject|0|||
27977687|NCT01448824|81750047|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27977688|NCT01448824|81750048|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
27977689|NCT01448824|81750049|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
27977690|NCT01448824|81750042|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27977691|NCT01448824|81750043|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27977692|NCT01448824|81750044|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27977693|NCT01448824|81750045|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
27977694|NCT01448824|81750046|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
27977695|NCT01448824|81750047|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
27977696|NCT01448824|81750048|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27977697|NCT01448824|81750049|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
27977698|NCT01448824|81750042|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977699|NCT01448824|81750043|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977700|NCT01448824|81750044|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977701|NCT01448824|81750045|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977702|NCT01448824|81750046|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977703|NCT01448824|81750047|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
27977704|NCT01448824|81750048|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977705|NCT01448824|81750049|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
27977706|NCT01448824|81750042|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
27977707|NCT01448824|81750043|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
27977708|NCT01448824|81750044|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
27977709|NCT01448824|81750045|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
27977710|NCT01448824|81750046|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
27977711|NCT01448824|81750047|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
27977712|NCT01448824|81750048|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
27977713|NCT01448824|81750049|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
27574260|NCT01109316|80285855|FG003|Study Period 3|Withdrawal by Subject|0|||
27574261|NCT01109316|80285856|FG004|Study Period 3|Withdrawal by Subject|1|||
27574262|NCT01109316|80285857|FG005|Study Period 3|Withdrawal by Subject|0|||
27574263|NCT04709575|80285859|FG000|Overall Study|Withdrawal by Subject|6|||
27574264|NCT04709575|80285860|FG001|Overall Study|Withdrawal by Subject|2|||
27790459|NCT01374516|81062376|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
27790460|NCT01374516|81062375|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
27977714|NCT01448824|81750042|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977715|NCT01448824|81750043|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977716|NCT01448824|81750044|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977717|NCT01448824|81750045|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977718|NCT01448824|81750046|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977719|NCT01448824|81750047|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977720|NCT01448824|81750048|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
27977721|NCT01448824|81750049|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
27977722|NCT01448824|81750042|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977723|NCT01448824|81750043|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977724|NCT01448824|81750044|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977725|NCT01448824|81750045|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977726|NCT01448824|81750046|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977727|NCT01448824|81750047|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977728|NCT01448824|81750048|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
27977729|NCT01448824|81750049|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
27977730|NCT01448824|81750042|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977731|NCT01448824|81750043|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977732|NCT01448824|81750044|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977733|NCT01448824|81750045|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977734|NCT01448824|81750046|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977735|NCT01448824|81750047|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977736|NCT01448824|81750048|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
27977737|NCT01448824|81750049|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
27977738|NCT01448824|81750042|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27977739|NCT01448824|81750043|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27977740|NCT01448824|81750044|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27977741|NCT01448824|81750045|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27977742|NCT01448824|81750046|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27977743|NCT01448824|81750047|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27790461|NCT01374516|81062376|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
27790462|NCT01374516|81062375|FG000|Surveillance Expansion Period|Serious adverse event|20|||
27790463|NCT01374516|81062376|FG001|Surveillance Expansion Period|Serious adverse event|5|||
27790464|NCT04120116|81062379|FG000|Overall Study|Lost to Follow-up|0|||
27790465|NCT04120116|81062380|FG001|Overall Study|Lost to Follow-up|1|||
27790466|NCT04120116|81062381|FG002|Overall Study|Lost to Follow-up|0|||
27790467|NCT04120116|81062382|FG003|Overall Study|Lost to Follow-up|2|||
27790468|NCT04120116|81062379|FG000|Overall Study|Withdrawal by Subject|1|||
27977744|NCT01448824|81750048|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
27977745|NCT01448824|81750049|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
27977746|NCT00089986|81750050|FG000|Overall Study|Adverse Event|6|||
27977747|NCT00089986|81750051|FG001|Overall Study|Adverse Event|9|||
27977748|NCT00089986|81750052|FG002|Overall Study|Adverse Event|6|||
27977749|NCT00089986|81750050|FG000|Overall Study|Lost to Follow-up|3|||
27790469|NCT04120116|81062380|FG001|Overall Study|Withdrawal by Subject|0|||
27977750|NCT00089986|81750051|FG001|Overall Study|Lost to Follow-up|1|||
27977751|NCT00089986|81750052|FG002|Overall Study|Lost to Follow-up|1|||
27977752|NCT00089986|81750050|FG000|Overall Study|Protocol Violation|0|||
27977753|NCT00089986|81750051|FG001|Overall Study|Protocol Violation|1|||
27977754|NCT00089986|81750052|FG002|Overall Study|Protocol Violation|0|||
27977755|NCT00089986|81750050|FG000|Overall Study|Patient transferred to another hospital|2|||
27977756|NCT00089986|81750051|FG001|Overall Study|Patient transferred to another hospital|1|||
27977757|NCT00089986|81750052|FG002|Overall Study|Patient transferred to another hospital|0|||
27977758|NCT00089986|81750050|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
27574265|NCT04709575|80285859|FG000|Overall Study|Lost to Follow-up|2|||
27574266|NCT04709575|80285860|FG001|Overall Study|Lost to Follow-up|2|||
27574267|NCT04709575|80285859|FG000|Overall Study|Adverse Event|1|||
27977759|NCT00089986|81750051|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
27977760|NCT00089986|81750052|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
27977761|NCT00089986|81750050|FG000|Overall Study|Hemohlobin stopping rule|0|||
27574268|NCT04709575|80285860|FG001|Overall Study|Adverse Event|0|||
27574269|NCT04709575|80285859|FG000|Overall Study|Protocol Violation|1|||
27790470|NCT04120116|81062381|FG002|Overall Study|Withdrawal by Subject|1|||
27977762|NCT00089986|81750051|FG001|Overall Study|Hemohlobin stopping rule|1|||
27977763|NCT00089986|81750052|FG002|Overall Study|Hemohlobin stopping rule|0|||
27977764|NCT00089986|81750050|FG000|Overall Study|Investigator decision to withdrew|0|||
27977765|NCT00089986|81750051|FG001|Overall Study|Investigator decision to withdrew|1|||
27977766|NCT00089986|81750052|FG002|Overall Study|Investigator decision to withdrew|0|||
27977767|NCT00089986|81750050|FG000|Overall Study|Enrollment in another study|0|||
27977768|NCT00089986|81750051|FG001|Overall Study|Enrollment in another study|1|||
27977769|NCT00089986|81750052|FG002|Overall Study|Enrollment in another study|0|||
27977770|NCT00089986|81750050|FG000|Overall Study|Family decision|0|||
27977771|NCT00089986|81750051|FG001|Overall Study|Family decision|1|||
27977772|NCT00089986|81750052|FG002|Overall Study|Family decision|0|||
27977773|NCT00089986|81750050|FG000|Overall Study|Do not resuscitate (DNR)|0|||
27977774|NCT00089986|81750051|FG001|Overall Study|Do not resuscitate (DNR)|0|||
27977775|NCT00089986|81750052|FG002|Overall Study|Do not resuscitate (DNR)|1|||
27977776|NCT00089986|81750050|FG000|Overall Study|Withdrawal by Subject|3|||
27977777|NCT00089986|81750051|FG001|Overall Study|Withdrawal by Subject|6|||
27977778|NCT00089986|81750052|FG002|Overall Study|Withdrawal by Subject|2|||
27977779|NCT01902888|81750053|FG000|Overall Study|Study Terminated|3|||
27977780|NCT00526110|81750057|FG000|Overall Study|Adverse Event|2|||
27977781|NCT00526110|81750058|FG001|Overall Study|Adverse Event|9|||
27977782|NCT00526110|81750057|FG000|Overall Study|Disease Progression|0|||
27977783|NCT00526110|81750058|FG001|Overall Study|Disease Progression|19|||
27977784|NCT00526110|81750057|FG000|Overall Study|Maximal Response|0|||
27977785|NCT00526110|81750058|FG001|Overall Study|Maximal Response|6|||
27977786|NCT00526110|81750057|FG000|Overall Study|Withdrawal by Subject|0|||
27574270|NCT04709575|80285860|FG001|Overall Study|Protocol Violation|1|||
27672257|NCT00943722|80639151|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
27672258|NCT00943722|80639152|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
27977787|NCT00526110|81750058|FG001|Overall Study|Withdrawal by Subject|2|||
27977788|NCT00526110|81750057|FG000|Overall Study|Poor Tolerance|0|||
27977789|NCT00526110|81750058|FG001|Overall Study|Poor Tolerance|5|||
27977790|NCT03385265|81750065|FG000|Overall Study|Withdrawal by Subject|5|||
27977791|NCT03385265|81750066|FG001|Overall Study|Withdrawal by Subject|2|||
27977792|NCT03385265|81750067|FG002|Overall Study|Withdrawal by Subject|5|||
27977793|NCT03385265|81750068|FG003|Overall Study|Withdrawal by Subject|2|||
27977794|NCT03627065|81750069|FG000|Overall Study|Study Terminated by sponsor|1|||
27977795|NCT03627065|81750069|FG000|Overall Study|Withdrawal by Subject|2|||
27977796|NCT01269385|81750070|FG000|Overall Study|Adverse Event|1|||
27672259|NCT00943722|80639153|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
27672260|NCT00943722|80639154|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
27672261|NCT00943722|80639155|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
27672262|NCT00943722|80639149|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27672263|NCT00943722|80639150|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27672264|NCT00943722|80639151|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27672265|NCT00943722|80639152|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27672266|NCT00943722|80639153|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
27672267|NCT00943722|80639154|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
27672268|NCT00943722|80639155|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
27672269|NCT01336205|80639159|FG000|Overall Study|Other|22|||
27790471|NCT04120116|81062382|FG003|Overall Study|Withdrawal by Subject|1|||
27790472|NCT04120116|81062379|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
27790473|NCT04120116|81062380|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
27833029|NCT00848536|81219437|FG000|Overall Study|Inadequate Control of IOP|1|||
27977797|NCT01269385|81750071|FG001|Overall Study|Adverse Event|1|||
27977798|NCT01269385|81750072|FG002|Overall Study|Adverse Event|0|||
27574271|NCT04171414|80285861|FG000|Overall Study|Death|1|||
27977799|NCT01269385|81750073|FG003|Overall Study|Adverse Event|0|||
27977800|NCT00953524|81750074|FG000|Overall Study|Adverse Event|2|||
27672270|NCT01336205|80639160|FG001|Overall Study|Other|9|||
27672271|NCT01336205|80639159|FG000|Overall Study|Lost to Follow-up|40|||
27672272|NCT01336205|80639160|FG001|Overall Study|Lost to Follow-up|20|||
27672273|NCT01336205|80639159|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
27833030|NCT00848536|81219438|FG001|Overall Study|Inadequate Control of IOP|1|||
27977801|NCT00953524|81750075|FG001|Overall Study|Adverse Event|0|||
27977802|NCT00953524|81750076|FG002|Overall Study|Adverse Event|1|||
27977803|NCT00953524|81750077|FG003|Overall Study|Adverse Event|2|||
27977804|NCT00953524|81750074|FG000|Overall Study|Protocol Violation|18|||
27977805|NCT00953524|81750075|FG001|Overall Study|Protocol Violation|10|||
27977806|NCT00953524|81750076|FG002|Overall Study|Protocol Violation|11|||
27977807|NCT00953524|81750077|FG003|Overall Study|Protocol Violation|6|||
27977808|NCT00953524|81750074|FG000|Overall Study|Lost to Follow-up|0|||
27977809|NCT00953524|81750075|FG001|Overall Study|Lost to Follow-up|1|||
27977810|NCT00953524|81750076|FG002|Overall Study|Lost to Follow-up|1|||
27977811|NCT00953524|81750077|FG003|Overall Study|Lost to Follow-up|0|||
27977812|NCT00953524|81750074|FG000|Overall Study|Withdrawal by Subject|2|||
27977813|NCT00953524|81750075|FG001|Overall Study|Withdrawal by Subject|4|||
27977814|NCT00953524|81750076|FG002|Overall Study|Withdrawal by Subject|1|||
27977815|NCT00953524|81750077|FG003|Overall Study|Withdrawal by Subject|0|||
27977816|NCT00106691|81750080|FG000|Overall Study|Adverse Event|60|||
27977817|NCT00106691|81750081|FG001|Overall Study|Adverse Event|64|||
27977818|NCT00106691|81750080|FG000|Overall Study|Lost to Follow-up|23|||
27977819|NCT00106691|81750081|FG001|Overall Study|Lost to Follow-up|18|||
27977820|NCT00106691|81750080|FG000|Overall Study|Physician Decision|18|||
27977821|NCT00106691|81750081|FG001|Overall Study|Physician Decision|21|||
27977822|NCT00106691|81750080|FG000|Overall Study|Protocol Violation|13|||
27977823|NCT00106691|81750081|FG001|Overall Study|Protocol Violation|18|||
27977824|NCT00106691|81750080|FG000|Overall Study|Withdrawal by Subject|75|||
27977825|NCT00106691|81750081|FG001|Overall Study|Withdrawal by Subject|70|||
27977826|NCT00106691|81750080|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
27977827|NCT00106691|81750081|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
27977828|NCT00106691|81750080|FG000|Overall Study|QTc>480|3|||
27977829|NCT00106691|81750081|FG001|Overall Study|QTc>480|1|||
27977830|NCT00106691|81750080|FG000|Overall Study|mililtary deployment|2|||
27977831|NCT00106691|81750081|FG001|Overall Study|mililtary deployment|0|||
27977832|NCT00106691|81750080|FG000|Overall Study|Study Site Closing/PI Moved|1|||
27977833|NCT00106691|81750081|FG001|Overall Study|Study Site Closing/PI Moved|2|||
27790474|NCT04120116|81062381|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
27977834|NCT00106691|81750080|FG000|Overall Study|Cardiologist recommendation|1|||
27977835|NCT00106691|81750081|FG001|Overall Study|Cardiologist recommendation|0|||
27977836|NCT00106691|81750080|FG000|Overall Study|Pt. moved to another state|1|||
27977837|NCT00106691|81750081|FG001|Overall Study|Pt. moved to another state|0|||
27790475|NCT04120116|81062382|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
27790476|NCT01855607|81062383|FG000|Overall Study|Withdrawal by Subject|1|||
27790477|NCT01855607|81062383|FG000|Overall Study|Study was terminated|11|||
27790478|NCT05147311|81062388|FG000|Overall Study|Did not complete survey|2|||
27790479|NCT05147311|81062389|FG001|Overall Study|Did not complete survey|1|||
27790480|NCT05147311|81062388|FG000|Overall Study|Patient too sick|1|||
27790481|NCT05147311|81062389|FG001|Overall Study|Patient too sick|2|||
27790482|NCT05147311|81062388|FG000|Overall Study|Death|0|||
27790483|NCT05147311|81062389|FG001|Overall Study|Death|1|||
27790484|NCT05147311|81062388|FG000|Overall Study|Declined survey|1|||
27790485|NCT05147311|81062389|FG001|Overall Study|Declined survey|0|||
27790486|NCT01459016|81062390|FG000|Overall Study|Withdrawal by Subject|11|||
27790487|NCT01459016|81062390|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
27790488|NCT00083226|81062393|FG000|Overall Study|Lack of Efficacy|19|||
27790489|NCT00083226|81062393|FG000|Overall Study|Adverse Event|9|||
27790490|NCT00083226|81062393|FG000|Overall Study|Death|4|||
27790491|NCT00083226|81062393|FG000|Overall Study|Withdrawal by Subject|4|||
27574272|NCT04171414|80285861|FG000|Overall Study|Withdrawal by Subject|1|||
27790492|NCT00083226|81062393|FG000|Overall Study|Other|2|||
27790493|NCT00083226|81062393|FG000|Overall Study|ineligible or not receiving treatment|4|||
27833031|NCT00848536|81219437|FG000|Overall Study|Patient Moved|0|||
27833032|NCT00848536|81219438|FG001|Overall Study|Patient Moved|2|||
27833033|NCT02294981|81219440|FG000|Overall Study|Lost to Follow-up|1|||
27833034|NCT03131895|81219441|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
27833035|NCT03131895|81219442|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
27833036|NCT03131895|81219443|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
27833037|NCT03131895|81219444|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
27833038|NCT03131895|81219441|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
27833039|NCT03131895|81219442|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
27833040|NCT03131895|81219443|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
27833041|NCT03131895|81219444|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
27977838|NCT00106691|81750080|FG000|Overall Study|Taking exclusionary avodart|1|||
27977839|NCT00106691|81750081|FG001|Overall Study|Taking exclusionary avodart|0|||
27977840|NCT00106691|81750080|FG000|Overall Study|Not able to discontinue plavix|0|||
27977841|NCT00106691|81750081|FG001|Overall Study|Not able to discontinue plavix|1|||
27977842|NCT03093974|81750082|FG000|Overall Study|Withdrawal by Subject|32|||
27977843|NCT03093974|81750083|FG001|Overall Study|Withdrawal by Subject|27|||
27977844|NCT03093974|81750082|FG000|Overall Study|Adverse Event|17|||
27977845|NCT03093974|81750083|FG001|Overall Study|Adverse Event|24|||
27977846|NCT03093974|81750082|FG000|Overall Study|Death|0|||
27977847|NCT03093974|81750083|FG001|Overall Study|Death|1|||
27977848|NCT03093974|81750082|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27977849|NCT03093974|81750083|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27977850|NCT03093974|81750082|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
27977851|NCT03093974|81750083|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
27977852|NCT03093974|81750082|FG000|Overall Study|Lost to Follow-up|0|||
27977853|NCT03093974|81750083|FG001|Overall Study|Lost to Follow-up|1|||
27977854|NCT03093974|81750082|FG000|Overall Study|Other|1|||
27977855|NCT03093974|81750083|FG001|Overall Study|Other|2|||
27977856|NCT01822535|81750084|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
27977857|NCT01822535|81750085|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
27977858|NCT01822535|81750084|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
27977859|NCT01822535|81750085|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
27977860|NCT01822535|81750084|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
27977861|NCT01822535|81750085|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
27977862|NCT05239221|81750086|FG000|Overall Study|Adverse Event|0|||
27574273|NCT01585766|80285862|FG000|Overall Study|Withdrawal by Subject|0|||
27574274|NCT01585766|80285863|FG001|Overall Study|Withdrawal by Subject|1|||
27574275|NCT01585766|80285864|FG002|Overall Study|Withdrawal by Subject|1|||
27574276|NCT01585766|80285865|FG003|Overall Study|Withdrawal by Subject|0|||
27574277|NCT01585766|80285866|FG004|Overall Study|Withdrawal by Subject|0|||
27574278|NCT01585766|80285867|FG005|Overall Study|Withdrawal by Subject|0|||
27574279|NCT01585766|80285862|FG000|Overall Study|Death|0|||
27574280|NCT01585766|80285863|FG001|Overall Study|Death|1|||
27574281|NCT01585766|80285864|FG002|Overall Study|Death|0|||
27574282|NCT01585766|80285865|FG003|Overall Study|Death|0|||
27574283|NCT01585766|80285866|FG004|Overall Study|Death|0|||
27574284|NCT01585766|80285867|FG005|Overall Study|Death|0|||
27574285|NCT01585766|80285862|FG000|Overall Study|Physician Decision|0|||
27574286|NCT01585766|80285863|FG001|Overall Study|Physician Decision|0|||
27574287|NCT01585766|80285864|FG002|Overall Study|Physician Decision|1|||
27672274|NCT01336205|80639160|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
27672275|NCT01336205|80639159|FG000|Overall Study|Lack of Efficacy|4|||
27672276|NCT01336205|80639160|FG001|Overall Study|Lack of Efficacy|0|||
27672277|NCT01336205|80639159|FG000|Overall Study|Severe noncompliance with protocol|9|||
27672278|NCT01336205|80639160|FG001|Overall Study|Severe noncompliance with protocol|2|||
27672279|NCT01336205|80639159|FG000|Overall Study|Adverse Event|56|||
27672280|NCT01336205|80639160|FG001|Overall Study|Adverse Event|6|||
27672281|NCT01336205|80639159|FG000|Overall Study|Death|1|||
27672282|NCT01336205|80639160|FG001|Overall Study|Death|1|||
27672283|NCT01336205|80639159|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
27672284|NCT01336205|80639160|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
27672285|NCT01336205|80639159|FG000|Overall Study|Withdrawal by Subject|72|||
27672286|NCT01336205|80639160|FG001|Overall Study|Withdrawal by Subject|38|||
27672287|NCT01336205|80639159|FG000|Overall Study|Did not receive treatment|4|||
27672288|NCT01336205|80639160|FG001|Overall Study|Did not receive treatment|0|||
27672289|NCT04732871|80639165|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
27672290|NCT04732871|80639166|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
27790494|NCT03326323|81062394|FG000|Overall Study|Unable to receive ANH protocol|3|||
27977863|NCT05239221|81750087|FG001|Overall Study|Adverse Event|0|||
27977864|NCT05239221|81750088|FG002|Overall Study|Adverse Event|0|||
27977865|NCT05239221|81750089|FG003|Overall Study|Adverse Event|0|||
27977866|NCT05239221|81750090|FG004|Overall Study|Adverse Event|0|||
27977867|NCT05239221|81750091|FG005|Overall Study|Adverse Event|0|||
27977868|NCT05239221|81750092|FG006|Overall Study|Adverse Event|1|||
27977869|NCT05239221|81750093|FG007|Overall Study|Adverse Event|0|||
27977870|NCT05239221|81750094|FG008|Overall Study|Adverse Event|0|||
27977871|NCT05239221|81750095|FG009|Overall Study|Adverse Event|0|||
27977872|NCT05239221|81750096|FG010|Overall Study|Adverse Event|1|||
27574288|NCT01585766|80285865|FG003|Overall Study|Physician Decision|0|||
27790495|NCT00761969|81062395|FG000|Overall Study|Death|112|||
27574289|NCT01585766|80285866|FG004|Overall Study|Physician Decision|0|||
27574290|NCT01585766|80285867|FG005|Overall Study|Physician Decision|0|||
27574291|NCT00952341|80285868|FG000|Cycle 1|Adverse Event|4|||
27672291|NCT04732871|80639167|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
27672292|NCT04732871|80639165|FG000|Overall Study|Lost to Follow-up|7|||
27672293|NCT04732871|80639166|FG001|Overall Study|Lost to Follow-up|4|||
27672294|NCT04732871|80639167|FG002|Overall Study|Lost to Follow-up|3|||
27790496|NCT00761969|81062396|FG001|Overall Study|Death|47|||
27790497|NCT00761969|81062395|FG000|Overall Study|Lost to Follow-up|88|||
27790498|NCT00761969|81062396|FG001|Overall Study|Lost to Follow-up|93|||
27790499|NCT00462501|81062397|FG000|Overall Study|Not treated|3|||
27790500|NCT00462501|81062397|FG000|Overall Study|Adverse Event|2|||
27790501|NCT01945866|81062398|FG000|Overall Study|Eyes did not complete or were dropped|2|||
27790502|NCT01945866|81062399|FG001|Overall Study|Eyes did not complete or were dropped|0|||
27790503|NCT00494234|81062400|FG000|Overall Study|Withdrawal by Subject|1|||
27790504|NCT00494234|81062401|FG001|Overall Study|Withdrawal by Subject|0|||
27790505|NCT00494234|81062400|FG000|Overall Study|Disease progression|11|||
27790506|NCT00494234|81062401|FG001|Overall Study|Disease progression|8|||
27790507|NCT00494234|81062400|FG000|Overall Study|Death|2|||
27790508|NCT00494234|81062401|FG001|Overall Study|Death|1|||
27790509|NCT00167414|81062402|FG000|Overall Study|Death|10|||
27790510|NCT02646566|81062409|FG000|Overall Study|Lost to Follow-up|5|||
27790511|NCT02646566|81062410|FG001|Overall Study|Lost to Follow-up|4|||
27790512|NCT02646566|81062411|FG002|Overall Study|Lost to Follow-up|5|||
27790513|NCT02646566|81062409|FG000|Overall Study|Treatment failure|1|||
27790514|NCT02646566|81062410|FG001|Overall Study|Treatment failure|0|||
27790515|NCT02646566|81062411|FG002|Overall Study|Treatment failure|0|||
27790516|NCT00908375|81062412|FG000|Overall Study|Withdrawal by Subject|2|||
27790517|NCT00908375|81062413|FG001|Overall Study|Withdrawal by Subject|4|||
27790518|NCT00908375|81062412|FG000|Overall Study|Lost to Follow-up|8|||
27790519|NCT00908375|81062413|FG001|Overall Study|Lost to Follow-up|6|||
27790520|NCT01876901|81062415|FG000|Overall Study|Protocol Violation|10|||
27790521|NCT01876901|81062416|FG001|Overall Study|Protocol Violation|2|||
27790522|NCT01876901|81062415|FG000|Overall Study|No or other surgical intervention|7|||
27790523|NCT01876901|81062416|FG001|Overall Study|No or other surgical intervention|5|||
27790524|NCT03778021|81062417|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
27790525|NCT03778021|81062418|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
27790526|NCT05111548|81062419|FG000|Overall Study|Withdrawal by Subject|2|||
27790527|NCT05111548|81062420|FG001|Overall Study|Withdrawal by Subject|1|||
27790528|NCT05111548|81062419|FG000|Overall Study|Adverse Event|1|||
27790529|NCT05111548|81062420|FG001|Overall Study|Adverse Event|0|||
27790530|NCT03890731|81062421|FG000|Overall Study|Progressive disease|1|||
27790531|NCT03890731|81062421|FG000|Overall Study|Patient's decision|1|||
27790532|NCT03890731|81062421|FG000|Overall Study|Adverse Event|4|||
27790533|NCT01821391|81062427|FG000|Overall Study|Adverse Event|1|||
27790534|NCT01821391|81062428|FG001|Overall Study|Adverse Event|0|||
27790535|NCT04221373|81062429|FG000|Overall Study|Physician Decision|4|||
27790536|NCT04221373|81062430|FG001|Overall Study|Physician Decision|0|||
27790537|NCT03783026|81062435|FG000|Treatment Phase|Adverse Event|15|||
27790538|NCT03783026|81062435|FG000|Treatment Phase|Lack of Efficacy|11|||
27790539|NCT03783026|81062435|FG000|Treatment Phase|Withdrawal by Subject|6|||
27790540|NCT03783026|81062435|FG000|Treatment Phase|Lost to Follow-up|2|||
27790541|NCT03783026|81062435|FG000|Treatment Phase|Protocol Deviation|8|||
27790542|NCT03783026|81062435|FG000|Treatment Phase|Did Not Receive Treatment|1|||
27790543|NCT03783026|81062435|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
27790544|NCT00752206|81062436|FG000|Overall Study|Disease progression|8|||
27790545|NCT00752206|81062437|FG001|Overall Study|Disease progression|11|||
27790546|NCT00752206|81062436|FG000|Overall Study|Pregnancy|1|||
27790547|NCT00752206|81062437|FG001|Overall Study|Pregnancy|0|||
27867636|NCT00587860|81349675|FG000|Overall Study|Withdrawal by Subject|3|||
27867637|NCT00587860|81349676|FG001|Overall Study|Withdrawal by Subject|3|||
27790548|NCT01646268|81062440|FG000|Overall Study|Adverse Event|6|||
27790549|NCT01646268|81062441|FG001|Overall Study|Adverse Event|7|||
27790550|NCT01646268|81062440|FG000|Overall Study|Lack of Efficacy|1|||
27790551|NCT01646268|81062441|FG001|Overall Study|Lack of Efficacy|3|||
27790552|NCT01646268|81062440|FG000|Overall Study|Protocol Violation|0|||
27790553|NCT01646268|81062441|FG001|Overall Study|Protocol Violation|1|||
27790554|NCT01646268|81062440|FG000|Overall Study|Withdrawal by Subject|2|||
27790555|NCT01646268|81062441|FG001|Overall Study|Withdrawal by Subject|5|||
27790556|NCT01646268|81062440|FG000|Overall Study|Other|2|||
27574292|NCT00952341|80285869|FG001|Cycle 1|Adverse Event|1|||
27574293|NCT00952341|80285868|FG000|Cycle 1|Withdrawal by Subject|3|||
27574294|NCT00952341|80285869|FG001|Cycle 1|Withdrawal by Subject|8|||
27574295|NCT00952341|80285868|FG000|Cycle 1|Protocol Violation|2|||
27574296|NCT00952341|80285869|FG001|Cycle 1|Protocol Violation|1|||
27977873|NCT05239221|81750097|FG011|Overall Study|Adverse Event|1|||
27977874|NCT05239221|81750098|FG012|Overall Study|Adverse Event|0|||
27977875|NCT05239221|81750099|FG013|Overall Study|Adverse Event|0|||
27977876|NCT05239221|81750100|FG014|Overall Study|Adverse Event|0|||
27977877|NCT05239221|81750101|FG015|Overall Study|Adverse Event|0|||
27977878|NCT05239221|81750086|FG000|Overall Study|Withdrawal by Subject|0|||
27977879|NCT05239221|81750087|FG001|Overall Study|Withdrawal by Subject|0|||
27977880|NCT05239221|81750088|FG002|Overall Study|Withdrawal by Subject|0|||
27977881|NCT05239221|81750089|FG003|Overall Study|Withdrawal by Subject|0|||
27977882|NCT05239221|81750090|FG004|Overall Study|Withdrawal by Subject|0|||
27977883|NCT05239221|81750091|FG005|Overall Study|Withdrawal by Subject|0|||
27977884|NCT05239221|81750092|FG006|Overall Study|Withdrawal by Subject|0|||
27977885|NCT05239221|81750093|FG007|Overall Study|Withdrawal by Subject|0|||
27977886|NCT05239221|81750094|FG008|Overall Study|Withdrawal by Subject|0|||
27977887|NCT05239221|81750095|FG009|Overall Study|Withdrawal by Subject|0|||
27977888|NCT05239221|81750096|FG010|Overall Study|Withdrawal by Subject|1|||
27977889|NCT05239221|81750097|FG011|Overall Study|Withdrawal by Subject|0|||
27977890|NCT05239221|81750098|FG012|Overall Study|Withdrawal by Subject|0|||
27977891|NCT05239221|81750099|FG013|Overall Study|Withdrawal by Subject|0|||
27977892|NCT05239221|81750100|FG014|Overall Study|Withdrawal by Subject|0|||
27977893|NCT05239221|81750101|FG015|Overall Study|Withdrawal by Subject|1|||
27977894|NCT01852825|81750104|FG000|Overall Study|Withdrawal by Subject|2|||
27977895|NCT01852825|81750105|FG001|Overall Study|Withdrawal by Subject|0|||
27977896|NCT01852825|81750106|FG002|Overall Study|Withdrawal by Subject|0|||
27977897|NCT00445939|81750107|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
27977898|NCT00445939|81750108|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
27977899|NCT00445939|81750109|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
27977900|NCT00445939|81750110|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
27977901|NCT00445939|81750107|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
27977902|NCT00445939|81750108|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
27977903|NCT00445939|81750109|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
27977904|NCT00445939|81750110|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
27977905|NCT00657371|81750116|FG000|Overall Study|Poor bowel preparation|15|||
27977906|NCT00657371|81750116|FG000|Overall Study|Unable to intubate the cecum|5|||
27977907|NCT00657371|81750116|FG000|Overall Study|Protocol Violation|2|||
27977908|NCT00657371|81750116|FG000|Overall Study|Device- related reasons|13|||
27977909|NCT00657371|81750116|FG000|Overall Study|Pre-existing medical condition|4|||
27977910|NCT03630302|81750118|FG000|Surgery|hardware issue prevented LFP recordings|1|||
27977911|NCT03630302|81750118|FG000|3 Month Visit|Adverse Event|2|||
27977912|NCT03630302|81750118|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
27977913|NCT04662073|81750120|FG000|Overall Study|Withdrawal by Subject|1|||
27977914|NCT04662073|81750121|FG001|Overall Study|Withdrawal by Subject|0|||
27977915|NCT03724981|81750123|FG000|First Device|Protocol Violation|1|||
27977916|NCT03724981|81750124|FG001|First Device|Protocol Violation|1|||
27977917|NCT02961790|81750125|FG000|Overall Study|Canceled|4|||
27977918|NCT02961790|81750126|FG001|Overall Study|Canceled|5|||
27977919|NCT02961790|81750127|FG002|Overall Study|Canceled|1|||
27977920|NCT02961790|81750128|FG003|Overall Study|Canceled|4|||
27977921|NCT02961790|81750125|FG000|Overall Study|without baseline data|4|||
27977922|NCT02961790|81750126|FG001|Overall Study|without baseline data|0|||
27977923|NCT02961790|81750127|FG002|Overall Study|without baseline data|1|||
27977924|NCT02961790|81750128|FG003|Overall Study|without baseline data|0|||
27977925|NCT02961790|81750125|FG000|Overall Study|without post baseline data|7|||
27977926|NCT02961790|81750126|FG001|Overall Study|without post baseline data|6|||
27977927|NCT02961790|81750127|FG002|Overall Study|without post baseline data|4|||
27977928|NCT02961790|81750128|FG003|Overall Study|without post baseline data|1|||
27977929|NCT01561755|81750129|FG000|Overall Study|Lost to Follow-up|0|||
27977930|NCT01561755|81750130|FG001|Overall Study|Lost to Follow-up|1|||
27977931|NCT02446418|81750132|FG000|Overall Study|Adverse Event|4|||
27977932|NCT02446418|81750133|FG001|Overall Study|Adverse Event|8|||
27977933|NCT02446418|81750132|FG000|Overall Study|Physician Decision|5|||
27977934|NCT02446418|81750133|FG001|Overall Study|Physician Decision|1|||
27977935|NCT02446418|81750132|FG000|Overall Study|Withdrawal by Subject|3|||
27977936|NCT02446418|81750133|FG001|Overall Study|Withdrawal by Subject|3|||
27977937|NCT02446418|81750132|FG000|Overall Study|Lost to Follow-up|2|||
27867638|NCT03142191|81349677|FG000|Placebo Controlled Period|Death|0|||
27574297|NCT00952341|80285868|FG000|Cycle 1|Lost to Follow-up|11|||
27574298|NCT00952341|80285869|FG001|Cycle 1|Lost to Follow-up|2|||
27977938|NCT02446418|81750133|FG001|Overall Study|Lost to Follow-up|2|||
27977939|NCT02446418|81750132|FG000|Overall Study|Protocol Violation|1|||
27977940|NCT02446418|81750133|FG001|Overall Study|Protocol Violation|2|||
27977941|NCT02446418|81750132|FG000|Overall Study|Lack of Efficacy|2|||
27977942|NCT02446418|81750133|FG001|Overall Study|Lack of Efficacy|0|||
27977943|NCT02446418|81750132|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
27977944|NCT02446418|81750133|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
27977945|NCT01628367|81750138|FG000|Overall Study|Adverse Event|1|||
27977946|NCT01628367|81750139|FG001|Overall Study|Adverse Event|0|||
27977947|NCT04912895|81753142|FG000|Overall Study|Unable to provide specimen|2|||
27977948|NCT04912895|81753143|FG001|Overall Study|Unable to provide specimen|0|||
27977949|NCT04912895|81753144|FG002|Overall Study|Unable to provide specimen|0|||
27977950|NCT02680574|81753146|FG000|Overall Study|Death|137|||
27977951|NCT02680574|81753147|FG001|Overall Study|Death|137|||
27977952|NCT02680574|81753146|FG000|Overall Study|Withdrawal by Subject|17|||
27977953|NCT02680574|81753147|FG001|Overall Study|Withdrawal by Subject|9|||
27977954|NCT02680574|81753146|FG000|Overall Study|Lost to Follow-up|4|||
27977955|NCT02680574|81753147|FG001|Overall Study|Lost to Follow-up|6|||
27977956|NCT00428220|81753148|FG000|Overall Study|Participant died|8|||
27977957|NCT00428220|81753148|FG000|Overall Study|Global deterioration of health status|7|||
27977958|NCT00428220|81753148|FG000|Overall Study|Lost to Follow-up|4|||
27977959|NCT00428220|81753148|FG000|Overall Study|Objective progression or relapse|123|||
27977960|NCT00428220|81753148|FG000|Overall Study|Participant refused continued treatment|7|||
27977961|NCT00428220|81753148|FG000|Overall Study|Adverse Event|51|||
27977962|NCT00428220|81753148|FG000|Overall Study|Other|23|||
27977963|NCT00364533|81753149|FG000|Overall Study|Adverse Event|8|||
27977964|NCT00364533|81753150|FG001|Overall Study|Adverse Event|7|||
27977965|NCT00364533|81753151|FG002|Overall Study|Adverse Event|15|||
27977966|NCT00364533|81753152|FG003|Overall Study|Adverse Event|5|||
27977967|NCT00364533|81753153|FG004|Overall Study|Adverse Event|2|||
27977968|NCT00364533|81753149|FG000|Overall Study|Withdrawal by Subject|4|||
27977969|NCT00364533|81753150|FG001|Overall Study|Withdrawal by Subject|8|||
27977970|NCT00364533|81753151|FG002|Overall Study|Withdrawal by Subject|6|||
27977971|NCT00364533|81753152|FG003|Overall Study|Withdrawal by Subject|6|||
27977972|NCT00364533|81753153|FG004|Overall Study|Withdrawal by Subject|6|||
27977973|NCT00364533|81753149|FG000|Overall Study|Lack of Efficacy|22|||
27977974|NCT00364533|81753150|FG001|Overall Study|Lack of Efficacy|22|||
27977975|NCT00364533|81753151|FG002|Overall Study|Lack of Efficacy|21|||
27977976|NCT00364533|81753152|FG003|Overall Study|Lack of Efficacy|17|||
27977977|NCT00364533|81753153|FG004|Overall Study|Lack of Efficacy|42|||
27977978|NCT00364533|81753149|FG000|Overall Study|Subject discharged from hospital|4|||
27977979|NCT00364533|81753150|FG001|Overall Study|Subject discharged from hospital|1|||
27977980|NCT00364533|81753151|FG002|Overall Study|Subject discharged from hospital|2|||
27977981|NCT00364533|81753152|FG003|Overall Study|Subject discharged from hospital|3|||
27977982|NCT00364533|81753153|FG004|Overall Study|Subject discharged from hospital|1|||
27977983|NCT00364533|81753149|FG000|Overall Study|Variations in drug compliance|2|||
27977984|NCT00364533|81753150|FG001|Overall Study|Variations in drug compliance|1|||
27977985|NCT00364533|81753151|FG002|Overall Study|Variations in drug compliance|1|||
27977986|NCT00364533|81753152|FG003|Overall Study|Variations in drug compliance|0|||
27977987|NCT00364533|81753153|FG004|Overall Study|Variations in drug compliance|0|||
27977988|NCT00364533|81753149|FG000|Overall Study|Non-compliance|1|||
27977989|NCT00364533|81753150|FG001|Overall Study|Non-compliance|0|||
27977990|NCT00364533|81753151|FG002|Overall Study|Non-compliance|0|||
27977991|NCT00364533|81753152|FG003|Overall Study|Non-compliance|0|||
27977992|NCT00364533|81753153|FG004|Overall Study|Non-compliance|0|||
27977993|NCT00364533|81753149|FG000|Overall Study|Protocol Violation|1|||
27977994|NCT00364533|81753150|FG001|Overall Study|Protocol Violation|1|||
27977995|NCT00364533|81753151|FG002|Overall Study|Protocol Violation|0|||
27977996|NCT00364533|81753152|FG003|Overall Study|Protocol Violation|0|||
27977997|NCT00364533|81753153|FG004|Overall Study|Protocol Violation|0|||
27977998|NCT04342689|81753154|FG000|Overall Study|Withdrawal by Subject|32|||
27977999|NCT04342689|81753155|FG001|Overall Study|Withdrawal by Subject|33|||
27978000|NCT04342689|81753154|FG000|Overall Study|Lost to Follow-up|10|||
27978001|NCT04342689|81753155|FG001|Overall Study|Lost to Follow-up|12|||
27978002|NCT01420627|81753162|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
27978003|NCT02410824|81753163|FG000|First Intervention (One Week)|Headache|0|||
27978004|NCT02410824|81753164|FG001|First Intervention (One Week)|Headache|1|||
27978005|NCT00353873|81753165|FG000|Overall Study|Protocol Violation|1|||
27978006|NCT00353873|81753166|FG001|Overall Study|Protocol Violation|2|||
27978007|NCT00353873|81753165|FG000|Overall Study|Exacerbation|1|||
27978008|NCT00353873|81753166|FG001|Overall Study|Exacerbation|0|||
27978009|NCT00353873|81753165|FG000|Overall Study|Adverse Event|1|||
27978010|NCT00353873|81753166|FG001|Overall Study|Adverse Event|0|||
27978011|NCT00353873|81753165|FG000|Overall Study|Physician Decision|2|||
27978012|NCT00353873|81753166|FG001|Overall Study|Physician Decision|0|||
27978013|NCT00353873|81753165|FG000|Overall Study|Withdrawal by Subject|1|||
27978014|NCT00353873|81753166|FG001|Overall Study|Withdrawal by Subject|1|||
27978015|NCT01958021|81753167|FG000|Overall Study|Progressive disease|87|||
27978016|NCT01958021|81753168|FG001|Overall Study|Progressive disease|146|||
27978017|NCT01958021|81753167|FG000|Overall Study|Adverse Event|25|||
27978018|NCT01958021|81753168|FG001|Overall Study|Adverse Event|7|||
27978019|NCT01958021|81753167|FG000|Overall Study|Subject/guardian decision|12|||
27978020|NCT01958021|81753168|FG001|Overall Study|Subject/guardian decision|13|||
27978021|NCT01958021|81753167|FG000|Overall Study|Physician Decision|10|||
27978022|NCT01958021|81753168|FG001|Overall Study|Physician Decision|13|||
27978023|NCT01958021|81753167|FG000|Overall Study|Protocol Violation|3|||
27978024|NCT01958021|81753168|FG001|Overall Study|Protocol Violation|1|||
27978025|NCT01958021|81753167|FG000|Overall Study|Death|2|||
27978026|NCT01958021|81753168|FG001|Overall Study|Death|0|||
27978027|NCT02075632|81753169|FG000|Overall Study|Adverse Event|1|||
27978028|NCT02075632|81753170|FG001|Overall Study|Adverse Event|1|||
27978029|NCT02075632|81753169|FG000|Overall Study|Lost to Follow-up|0|||
27978030|NCT02075632|81753170|FG001|Overall Study|Lost to Follow-up|3|||
27978031|NCT02075632|81753169|FG000|Overall Study|Withdrawal by Subject|0|||
27978032|NCT02075632|81753170|FG001|Overall Study|Withdrawal by Subject|1|||
27978033|NCT02251717|81753171|FG000|Overall Study|Adverse Event|0|||
27978034|NCT02251717|81753172|FG001|Overall Study|Adverse Event|1|||
27978035|NCT02251717|81753171|FG000|Overall Study|Withdrew Consent|1|||
27978036|NCT02251717|81753172|FG001|Overall Study|Withdrew Consent|0|||
27978037|NCT02753127|81753181|FG000|Overall Study|Lost to Follow-up|13|||
27978038|NCT02753127|81753182|FG001|Overall Study|Lost to Follow-up|11|||
27978039|NCT02753127|81753181|FG000|Overall Study|Withdrawal by Subject|37|||
27978040|NCT02753127|81753182|FG001|Overall Study|Withdrawal by Subject|47|||
27978041|NCT02753127|81753181|FG000|Overall Study|Other|3|||
27978042|NCT02753127|81753182|FG001|Overall Study|Other|8|||
27978043|NCT02753127|81753181|FG000|Overall Study|Hospice|0|||
27978044|NCT02753127|81753182|FG001|Overall Study|Hospice|2|||
27978045|NCT00623545|81753183|FG000|Overall Study|Adverse Event|6|||
27978046|NCT00623545|81753183|FG000|Overall Study|Withdrawal by Subject|4|||
27978047|NCT01154283|81753184|FG000|0-6 Weeks|Withdrawal by Subject|7|||
27978048|NCT01154283|81753185|FG001|0-6 Weeks|Withdrawal by Subject|2|||
27978049|NCT01154283|81753184|FG000|0-6 Weeks|Death|0|||
27978050|NCT01154283|81753185|FG001|0-6 Weeks|Death|1|||
27978051|NCT01154283|81753184|FG000|7-12 Weeks|Death|1|||
27978052|NCT01154283|81753185|FG001|7-12 Weeks|Death|0|||
27978053|NCT01154283|81753184|FG000|7-12 Weeks|Withdrawal by Subject|0|||
27978054|NCT01154283|81753185|FG001|7-12 Weeks|Withdrawal by Subject|1|||
27978055|NCT04676867|81753186|FG000|Overall Study|Screen failure|0|||
27978056|NCT04676867|81753187|FG001|Overall Study|Screen failure|0|||
27978057|NCT04676867|81753188|FG002|Overall Study|Screen failure|6|||
27978058|NCT04676867|81753189|FG003|Overall Study|Screen failure|2|||
27978059|NCT04676867|81753186|FG000|Overall Study|Death|0|||
27978060|NCT04676867|81753187|FG001|Overall Study|Death|0|||
27978061|NCT04676867|81753188|FG002|Overall Study|Death|1|||
27978062|NCT04676867|81753189|FG003|Overall Study|Death|0|||
27978063|NCT04676867|81753186|FG000|Overall Study|Withdrawal by Subject|2|||
27978064|NCT04676867|81753187|FG001|Overall Study|Withdrawal by Subject|2|||
27978065|NCT04676867|81753188|FG002|Overall Study|Withdrawal by Subject|4|||
27978066|NCT04676867|81753189|FG003|Overall Study|Withdrawal by Subject|4|||
27978067|NCT04676867|81753186|FG000|Overall Study|Lost to Follow-up|1|||
27978068|NCT04676867|81753187|FG001|Overall Study|Lost to Follow-up|0|||
27978069|NCT04676867|81753188|FG002|Overall Study|Lost to Follow-up|0|||
27978070|NCT04676867|81753189|FG003|Overall Study|Lost to Follow-up|0|||
27978071|NCT01224821|81753192|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
27978072|NCT01224821|81753192|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
27978073|NCT01224821|81753192|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
27978074|NCT01224821|81753192|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
27978075|NCT01224821|81753192|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
27978076|NCT01224821|81753192|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
27978077|NCT01224821|81753192|FG000|Long-Term Follow-Up|Death|2|||
27978078|NCT01224821|81753192|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
27978079|NCT03943550|81753193|FG000|Overall Study|Adverse Event|0|||
27978080|NCT03943550|81753194|FG001|Overall Study|Adverse Event|0|||
27978081|NCT03943550|81753195|FG002|Overall Study|Adverse Event|1|||
27978082|NCT03943550|81753193|FG000|Overall Study|Lost to Follow-up|0|||
27978083|NCT03943550|81753194|FG001|Overall Study|Lost to Follow-up|0|||
27978084|NCT03943550|81753195|FG002|Overall Study|Lost to Follow-up|1|||
27978085|NCT03943550|81753193|FG000|Overall Study|Progressive Disease|0|||
27978086|NCT03943550|81753194|FG001|Overall Study|Progressive Disease|0|||
27978087|NCT03943550|81753195|FG002|Overall Study|Progressive Disease|2|||
27978088|NCT03943550|81753193|FG000|Overall Study|Participant Moved Out of the Country|0|||
27574299|NCT00952341|80285868|FG000|Cycle 1|Physician Decision|0|||
27978089|NCT03943550|81753194|FG001|Overall Study|Participant Moved Out of the Country|1|||
27978090|NCT03943550|81753195|FG002|Overall Study|Participant Moved Out of the Country|0|||
27978091|NCT00066469|81753200|FG000|Overall Study|Death|3|||
27978092|NCT00066469|81753200|FG000|Overall Study|Lack of Efficacy|9|||
27978093|NCT00066469|81753200|FG000|Overall Study|Lost to Follow-up|1|||
27978094|NCT00066469|81753200|FG000|Overall Study|Physician Decision|1|||
27978095|NCT00066469|81753200|FG000|Overall Study|Withdrawal by Subject|1|||
27978096|NCT00066469|81753200|FG000|Overall Study|ineligible|1|||
27978097|NCT00642369|81753209|FG000|Overall Study|Adverse Event|2|||
27978098|NCT00642369|81753210|FG001|Overall Study|Adverse Event|3|||
27978099|NCT00642369|81753209|FG000|Overall Study|Withdrawal by Subject|1|||
27978100|NCT00642369|81753210|FG001|Overall Study|Withdrawal by Subject|0|||
27978101|NCT00642369|81753209|FG000|Overall Study|misdiagnosis|0|||
27978102|NCT00642369|81753210|FG001|Overall Study|misdiagnosis|1|||
27978103|NCT00642369|81753209|FG000|Overall Study|Lack of Efficacy|2|||
27978104|NCT00642369|81753210|FG001|Overall Study|Lack of Efficacy|2|||
27978105|NCT02649855|81753217|FG000|Overall Study|Refused further treatment|2|||
27978106|NCT02649855|81753218|FG001|Overall Study|Refused further treatment|1|||
27978107|NCT02649855|81753219|FG002|Overall Study|Refused further treatment|1|||
27978108|NCT02649855|81753217|FG000|Overall Study|Withdrew consent|0|||
27978109|NCT02649855|81753218|FG001|Overall Study|Withdrew consent|1|||
27978110|NCT02649855|81753219|FG002|Overall Study|Withdrew consent|0|||
27978111|NCT02649855|81753217|FG000|Overall Study|Switched to alternative treatment|0|||
27978112|NCT02649855|81753218|FG001|Overall Study|Switched to alternative treatment|1|||
27978113|NCT02649855|81753219|FG002|Overall Study|Switched to alternative treatment|1|||
27790557|NCT01646268|81062441|FG001|Overall Study|Other|0|||
27790558|NCT00198107|81065386|FG000|Double-Blind Period|Adverse Event|1|||
27790559|NCT00198107|81065387|FG001|Double-Blind Period|Adverse Event|1|||
27790560|NCT00198107|81065388|FG002|Double-Blind Period|Adverse Event|0|||
27790561|NCT00198107|81065386|FG000|Double-Blind Period|Lack of Efficacy|2|||
27790562|NCT00198107|81065387|FG001|Double-Blind Period|Lack of Efficacy|0|||
27790563|NCT00198107|81065388|FG002|Double-Blind Period|Lack of Efficacy|0|||
27790564|NCT00198107|81065386|FG000|Double-Blind Period|Lost to Follow-up|2|||
27790565|NCT00198107|81065387|FG001|Double-Blind Period|Lost to Follow-up|1|||
27790566|NCT00198107|81065388|FG002|Double-Blind Period|Lost to Follow-up|0|||
27790567|NCT00198107|81065386|FG000|Double-Blind Period|Physician Decision|1|||
27790568|NCT00198107|81065387|FG001|Double-Blind Period|Physician Decision|0|||
27790569|NCT00198107|81065388|FG002|Double-Blind Period|Physician Decision|0|||
27790570|NCT00198107|81065386|FG000|Double-Blind Period|Withdrawal by Subject|0|||
27790571|NCT00198107|81065387|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27790572|NCT00198107|81065388|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27790573|NCT00198107|81065386|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
27790574|NCT00198107|81065387|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
27790575|NCT00198107|81065388|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
27790576|NCT00664066|81065389|FG000|Overall Study|Study terminated|3|||
27790577|NCT01336647|81065390|FG000|Overall Study|Lost to Follow-up|4|||
27790578|NCT01336647|81065391|FG001|Overall Study|Lost to Follow-up|1|||
27790579|NCT01336647|81065392|FG002|Overall Study|Lost to Follow-up|3|||
27790580|NCT02389621|81065398|FG000|Treatment Period|Withdrawal by Subject|1|||
27790581|NCT02389621|81065399|FG001|Treatment Period|Withdrawal by Subject|1|||
27790582|NCT02389621|81065398|FG000|Posttreatment Period|Adverse Event|3|||
27790583|NCT02389621|81065399|FG001|Posttreatment Period|Adverse Event|1|||
27790584|NCT02389621|81065398|FG000|Posttreatment Period|Withdrawal by Subject|3|||
27790585|NCT02389621|81065399|FG001|Posttreatment Period|Withdrawal by Subject|2|||
27790586|NCT02389621|81065398|FG000|Posttreatment Period|Lost to Follow-up|1|||
27790587|NCT02389621|81065399|FG001|Posttreatment Period|Lost to Follow-up|1|||
27790588|NCT02389621|81065398|FG000|Posttreatment Period|Other - Miscellaneous|2|||
27790589|NCT02389621|81065399|FG001|Posttreatment Period|Other - Miscellaneous|0|||
27790590|NCT01886105|81065400|FG000|Overall Study|Lack of Efficacy|3|||
27978114|NCT02649855|81753217|FG000|Overall Study|Principal investigator discretion|0|||
27790591|NCT04066894|81065401|FG000|Overall Study|Lack of Efficacy|1|||
27978115|NCT02649855|81753218|FG001|Overall Study|Principal investigator discretion|1|||
27978116|NCT02649855|81753219|FG002|Overall Study|Principal investigator discretion|1|||
27790592|NCT04066894|81065401|FG000|Overall Study|Screen Failure|1|||
27790593|NCT00656669|81065410|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
27790594|NCT00656669|81065410|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
27790595|NCT00656669|81065410|FG000|AC (Cycles 6-9)|Adverse Event|1|||
27790596|NCT00656669|81065410|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
27790597|NCT00535262|81065411|FG000|Overall Study|No funding|3|||
27790598|NCT01519635|81065414|FG000|Overall Study|Withdrawal by Subject|0|||
27790599|NCT01519635|81065415|FG001|Overall Study|Withdrawal by Subject|1|||
27790600|NCT01519635|81065414|FG000|Overall Study|No possibility to put a catheter|1|||
27790601|NCT01519635|81065415|FG001|Overall Study|No possibility to put a catheter|2|||
27790602|NCT00061568|81065416|FG000|Overall Study|Lost to Follow-up|12|||
27790603|NCT00061568|81065417|FG001|Overall Study|Lost to Follow-up|0|||
27790604|NCT00061568|81065416|FG000|Overall Study|Death|6|||
27790605|NCT00061568|81065417|FG001|Overall Study|Death|0|||
27790606|NCT00061568|81065416|FG000|Overall Study|Withdrawal by Subject|1|||
27790607|NCT00061568|81065417|FG001|Overall Study|Withdrawal by Subject|0|||
27790608|NCT02422186|81065418|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
27790609|NCT02422186|81065419|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
27790610|NCT02422186|81065418|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
27790611|NCT02422186|81065419|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
27790612|NCT02422186|81065418|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
27790613|NCT02422186|81065419|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
27790614|NCT02422186|81065418|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
27790615|NCT02422186|81065419|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
27790616|NCT02422186|81065418|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
27790617|NCT02422186|81065419|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
27790618|NCT02422186|81065418|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
27790619|NCT02422186|81065419|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
27790620|NCT02422186|81065418|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
27790621|NCT02422186|81065419|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
27790622|NCT02422186|81065418|FG000|Follow-up Phase (2 Weeks)|Other|3|||
27790623|NCT02422186|81065419|FG001|Follow-up Phase (2 Weeks)|Other|0|||
27790624|NCT02087865|81065421|FG000|Overall Study|Withdrawal by Subject|6|||
27790625|NCT02087865|81065422|FG001|Overall Study|Withdrawal by Subject|0|||
27790626|NCT02087865|81065423|FG002|Overall Study|Withdrawal by Subject|1|||
27790627|NCT02087865|81065421|FG000|Overall Study|Lost to Follow-up|0|||
27790628|NCT02087865|81065422|FG001|Overall Study|Lost to Follow-up|0|||
27790629|NCT02087865|81065423|FG002|Overall Study|Lost to Follow-up|1|||
27790630|NCT02087865|81065421|FG000|Overall Study|Drug Non-compliance|0|||
27790631|NCT02087865|81065422|FG001|Overall Study|Drug Non-compliance|2|||
27790632|NCT02087865|81065423|FG002|Overall Study|Drug Non-compliance|0|||
27790633|NCT02087865|81065421|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
27790634|NCT02087865|81065422|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
27790635|NCT02087865|81065423|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
27790636|NCT01250418|81065424|FG000|Overall Study|monitor data failure|1|||
27790637|NCT01250418|81065425|FG001|Overall Study|monitor data failure|1|||
27790638|NCT01422876|81065426|FG000|Week 24|Lost to Follow-up|1|||
27790639|NCT01422876|81065427|FG001|Week 24|Lost to Follow-up|1|||
27790640|NCT01422876|81065428|FG002|Week 24|Lost to Follow-up|2|||
27790641|NCT01422876|81065429|FG003|Week 24|Lost to Follow-up|4|||
27790642|NCT01422876|81065430|FG004|Week 24|Lost to Follow-up|2|||
27790643|NCT01422876|81065431|FG005|Week 24|Lost to Follow-up|0|||
27790644|NCT01422876|81065432|FG006|Week 24|Lost to Follow-up|1|||
27790645|NCT01422876|81065433|FG007|Week 24|Lost to Follow-up|3|||
27790646|NCT01422876|81065434|FG008|Week 24|Lost to Follow-up|3|||
27790647|NCT01422876|81065435|FG009|Week 24|Lost to Follow-up|4|||
27790648|NCT01422876|81065426|FG000|Week 24|Consent withdrawn|5|||
27790649|NCT01422876|81065427|FG001|Week 24|Consent withdrawn|1|||
27790650|NCT01422876|81065428|FG002|Week 24|Consent withdrawn|3|||
27790651|NCT01422876|81065429|FG003|Week 24|Consent withdrawn|4|||
27790652|NCT01422876|81065430|FG004|Week 24|Consent withdrawn|5|||
27790653|NCT01422876|81065431|FG005|Week 24|Consent withdrawn|6|||
27790654|NCT01422876|81065432|FG006|Week 24|Consent withdrawn|5|||
27790655|NCT01422876|81065433|FG007|Week 24|Consent withdrawn|4|||
27790656|NCT01422876|81065434|FG008|Week 24|Consent withdrawn|3|||
27790657|NCT01422876|81065435|FG009|Week 24|Consent withdrawn|6|||
27790658|NCT01422876|81065426|FG000|Week 24|Death|0|||
27790659|NCT01422876|81065427|FG001|Week 24|Death|1|||
27790660|NCT01422876|81065428|FG002|Week 24|Death|0|||
27790661|NCT01422876|81065429|FG003|Week 24|Death|0|||
27790662|NCT01422876|81065430|FG004|Week 24|Death|0|||
27790663|NCT01422876|81065431|FG005|Week 24|Death|0|||
27790664|NCT01422876|81065432|FG006|Week 24|Death|0|||
27790665|NCT01422876|81065433|FG007|Week 24|Death|0|||
27790666|NCT01422876|81065434|FG008|Week 24|Death|0|||
27790667|NCT01422876|81065435|FG009|Week 24|Death|0|||
27867639|NCT03142191|81349678|FG001|Placebo Controlled Period|Death|1|||
27867640|NCT03142191|81349679|FG002|Placebo Controlled Period|Death|1|||
27867641|NCT03142191|81349680|FG003|Placebo Controlled Period|Death|0|||
27867642|NCT03142191|81349681|FG004|Placebo Controlled Period|Death|0|||
27978117|NCT02649855|81753217|FG000|Overall Study|No treatment, per protocol|1|||
27978118|NCT02649855|81753218|FG001|Overall Study|No treatment, per protocol|0|||
27978119|NCT02649855|81753219|FG002|Overall Study|No treatment, per protocol|0|||
27978120|NCT02649855|81753217|FG000|Overall Study|Initiate new treatment|1|||
27978121|NCT02649855|81753218|FG001|Overall Study|Initiate new treatment|0|||
27978122|NCT02649855|81753219|FG002|Overall Study|Initiate new treatment|0|||
27978123|NCT00431951|81753220|FG000|Overall Study|Inability to follow study procedures|1|||
27978124|NCT00431951|81753221|FG001|Overall Study|Inability to follow study procedures|0|||
27978125|NCT00431951|81753222|FG002|Overall Study|Inability to follow study procedures|1|||
27978126|NCT00431951|81753223|FG003|Overall Study|Inability to follow study procedures|2|||
27978127|NCT00431951|81753220|FG000|Overall Study|Lost to Follow-up|0|||
27978128|NCT00431951|81753221|FG001|Overall Study|Lost to Follow-up|1|||
27867643|NCT03142191|81349677|FG000|Placebo Controlled Period|Adverse Event|4|||
27867644|NCT03142191|81349678|FG001|Placebo Controlled Period|Adverse Event|5|||
27867645|NCT03142191|81349679|FG002|Placebo Controlled Period|Adverse Event|1|||
27867646|NCT03142191|81349680|FG003|Placebo Controlled Period|Adverse Event|0|||
27867647|NCT03142191|81349681|FG004|Placebo Controlled Period|Adverse Event|0|||
27978129|NCT00431951|81753222|FG002|Overall Study|Lost to Follow-up|0|||
27978130|NCT00431951|81753223|FG003|Overall Study|Lost to Follow-up|0|||
27978131|NCT00431951|81753220|FG000|Overall Study|Withdrawal by Subject|0|||
27978132|NCT00431951|81753221|FG001|Overall Study|Withdrawal by Subject|1|||
27790668|NCT01422876|81065426|FG000|Week 52|Lost to Follow-up|3|||
27790669|NCT01422876|81065427|FG001|Week 52|Lost to Follow-up|5|||
27790670|NCT01422876|81065428|FG002|Week 52|Lost to Follow-up|7|||
27790671|NCT01422876|81065429|FG003|Week 52|Lost to Follow-up|5|||
27790672|NCT01422876|81065430|FG004|Week 52|Lost to Follow-up|8|||
27790673|NCT01422876|81065431|FG005|Week 52|Lost to Follow-up|5|||
27790674|NCT01422876|81065432|FG006|Week 52|Lost to Follow-up|5|||
27790675|NCT01422876|81065433|FG007|Week 52|Lost to Follow-up|8|||
27790676|NCT01422876|81065434|FG008|Week 52|Lost to Follow-up|7|||
27790677|NCT01422876|81065435|FG009|Week 52|Lost to Follow-up|8|||
27790678|NCT01422876|81065426|FG000|Week 52|Consent withdrawn|9|||
27790679|NCT01422876|81065427|FG001|Week 52|Consent withdrawn|4|||
27790680|NCT01422876|81065428|FG002|Week 52|Consent withdrawn|6|||
27790681|NCT01422876|81065429|FG003|Week 52|Consent withdrawn|12|||
27790682|NCT01422876|81065430|FG004|Week 52|Consent withdrawn|7|||
27790683|NCT01422876|81065431|FG005|Week 52|Consent withdrawn|12|||
27790684|NCT01422876|81065432|FG006|Week 52|Consent withdrawn|10|||
27790685|NCT01422876|81065433|FG007|Week 52|Consent withdrawn|12|||
27790686|NCT01422876|81065434|FG008|Week 52|Consent withdrawn|13|||
27790687|NCT01422876|81065435|FG009|Week 52|Consent withdrawn|9|||
27790688|NCT01422876|81065426|FG000|Week 52|Death|0|||
27790689|NCT01422876|81065427|FG001|Week 52|Death|1|||
27790690|NCT01422876|81065428|FG002|Week 52|Death|0|||
27790691|NCT01422876|81065429|FG003|Week 52|Death|1|||
27790692|NCT01422876|81065430|FG004|Week 52|Death|0|||
27790693|NCT01422876|81065431|FG005|Week 52|Death|0|||
27790694|NCT01422876|81065432|FG006|Week 52|Death|1|||
27790695|NCT01422876|81065433|FG007|Week 52|Death|3|||
27790696|NCT01422876|81065434|FG008|Week 52|Death|1|||
27790697|NCT01422876|81065435|FG009|Week 52|Death|0|||
27790698|NCT01980056|81065436|FG000|Overall Study|Death|1|||
27790699|NCT01980056|81065437|FG001|Overall Study|Death|1|||
27790700|NCT01980056|81065438|FG002|Overall Study|Death|0|||
27790701|NCT03329404|81065442|FG000|Overall Study|The study was suspended.|1|||
27790702|NCT03329404|81065443|FG001|Overall Study|The study was suspended.|4|||
27790703|NCT05102162|81065445|FG000|Overall Study|Withdrawal by Subject|3|||
27790704|NCT05102162|81065446|FG001|Overall Study|Withdrawal by Subject|0|||
27790705|NCT05102162|81065445|FG000|Overall Study|Baseline cultures negative|4|||
27790706|NCT05102162|81065446|FG001|Overall Study|Baseline cultures negative|2|||
27790707|NCT05102162|81065445|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
27790708|NCT05102162|81065446|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
27790709|NCT05102162|81065445|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
27790710|NCT05102162|81065446|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
27790711|NCT01976104|81065447|FG000|Overall Study|Adverse Event|0|||
27790712|NCT01976104|81065448|FG001|Overall Study|Adverse Event|0|||
27790713|NCT01976104|81065449|FG002|Overall Study|Adverse Event|1|||
27790714|NCT01976104|81065450|FG003|Overall Study|Adverse Event|0|||
27790715|NCT01976104|81065447|FG000|Overall Study|Lost to Follow-up|3|||
27790716|NCT01976104|81065448|FG001|Overall Study|Lost to Follow-up|0|||
27790717|NCT01976104|81065449|FG002|Overall Study|Lost to Follow-up|1|||
27790718|NCT01976104|81065450|FG003|Overall Study|Lost to Follow-up|1|||
27790719|NCT01976104|81065447|FG000|Overall Study|Subject Choice|0|||
27790720|NCT01976104|81065448|FG001|Overall Study|Subject Choice|1|||
27790721|NCT01976104|81065449|FG002|Overall Study|Subject Choice|0|||
27790722|NCT01976104|81065450|FG003|Overall Study|Subject Choice|1|||
27790723|NCT01976104|81065447|FG000|Overall Study|Withdrawal by Subject|3|||
27790724|NCT01976104|81065448|FG001|Overall Study|Withdrawal by Subject|0|||
27790725|NCT01976104|81065449|FG002|Overall Study|Withdrawal by Subject|0|||
27790726|NCT01976104|81065450|FG003|Overall Study|Withdrawal by Subject|1|||
27790727|NCT01976104|81065447|FG000|Overall Study|Other|0|||
27790728|NCT01976104|81065448|FG001|Overall Study|Other|1|||
27790729|NCT01976104|81065449|FG002|Overall Study|Other|0|||
27790730|NCT01976104|81065450|FG003|Overall Study|Other|0|||
27790731|NCT02842736|81065452|FG000|Overall Study|Lost to Follow-up|13|||
27867648|NCT03142191|81349677|FG000|Placebo Controlled Period|Progressive Disease|1|||
27867649|NCT03142191|81349678|FG001|Placebo Controlled Period|Progressive Disease|0|||
27867650|NCT03142191|81349679|FG002|Placebo Controlled Period|Progressive Disease|1|||
27790732|NCT02842736|81065452|FG000|Overall Study|Intervention for menstrual bleeding|17|||
27790733|NCT02842736|81065452|FG000|Overall Study|Withdrawal by Subject|4|||
27790734|NCT02842736|81065452|FG000|Overall Study|Pregnancy|3|||
27790735|NCT02842736|81065452|FG000|Overall Study|Hysterectomy for fibroids|2|||
27790736|NCT02842736|81065452|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
27790737|NCT02842736|81065452|FG000|Overall Study|IUD: Mirena|1|||
27790738|NCT01748162|81065453|FG000|Overall Study|no additional croup episodes to evaluate|2|||
27790739|NCT01748162|81065454|FG001|Overall Study|no additional croup episodes to evaluate|2|||
27790740|NCT01748162|81065453|FG000|Overall Study|participant consented but did not begin|0|||
27790741|NCT01748162|81065454|FG001|Overall Study|participant consented but did not begin|1|||
27790742|NCT01748162|81065453|FG000|Overall Study|reasons not available|3|||
27790743|NCT01748162|81065454|FG001|Overall Study|reasons not available|2|||
27790744|NCT03522506|81065456|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27790745|NCT03522506|81065457|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27790746|NCT03522506|81065458|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27790747|NCT03522506|81065459|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27790748|NCT03522506|81065456|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27790749|NCT03522506|81065457|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27790750|NCT03522506|81065458|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27790751|NCT03522506|81065459|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
27790752|NCT00909857|81065462|FG000|Overall Study|Withdrawal by Subject|6|||
27790753|NCT00909857|81065463|FG001|Overall Study|Withdrawal by Subject|10|||
27790754|NCT00909857|81065462|FG000|Overall Study|Adverse Event|5|||
27790755|NCT00909857|81065463|FG001|Overall Study|Adverse Event|5|||
27790756|NCT00909857|81065462|FG000|Overall Study|Lost to Follow-up|2|||
27790757|NCT00909857|81065463|FG001|Overall Study|Lost to Follow-up|5|||
27790758|NCT00909857|81065462|FG000|Overall Study|Protocol Violation|2|||
27790759|NCT00909857|81065463|FG001|Overall Study|Protocol Violation|1|||
27790760|NCT00909857|81065462|FG000|Overall Study|Pregnancy|1|||
27790761|NCT00909857|81065463|FG001|Overall Study|Pregnancy|0|||
27790762|NCT00909857|81065462|FG000|Overall Study|Other|1|||
27790763|NCT00909857|81065463|FG001|Overall Study|Other|0|||
27790764|NCT00909857|81065462|FG000|Overall Study|Did not receive study medication|19|||
27790765|NCT00909857|81065463|FG001|Overall Study|Did not receive study medication|24|||
27790766|NCT01864746|81065465|FG000|Overall Study|Disease recurrence|25|||
27790767|NCT01864746|81065466|FG001|Overall Study|Disease recurrence|40|||
27790768|NCT01864746|81065465|FG000|Overall Study|Second primary invasive nonbreast|2|||
27790769|NCT01864746|81065466|FG001|Overall Study|Second primary invasive nonbreast|3|||
27790770|NCT01864746|81065465|FG000|Overall Study|Death|2|||
27790771|NCT01864746|81065466|FG001|Overall Study|Death|1|||
27790772|NCT01864746|81065465|FG000|Overall Study|Adverse Event|33|||
27790773|NCT01864746|81065466|FG001|Overall Study|Adverse Event|5|||
27790774|NCT01864746|81065465|FG000|Overall Study|Withdrawal by Subject|56|||
27790775|NCT01864746|81065466|FG001|Overall Study|Withdrawal by Subject|41|||
27790776|NCT01864746|81065465|FG000|Overall Study|Physician Decision|5|||
27790777|NCT01864746|81065466|FG001|Overall Study|Physician Decision|6|||
27790778|NCT03471507|81065475|FG000|Overall Study|Lost to Follow-up|1|||
27790779|NCT03471507|81065476|FG001|Overall Study|Lost to Follow-up|3|||
27790780|NCT03471507|81065475|FG000|Overall Study|Physician Decision|0|||
27790781|NCT03471507|81065476|FG001|Overall Study|Physician Decision|1|||
27790782|NCT03471507|81065475|FG000|Overall Study|Withdrawal by Subject|2|||
27790783|NCT03471507|81065476|FG001|Overall Study|Withdrawal by Subject|1|||
27790784|NCT00509223|81065477|FG000|Overall Study|Lost to Follow-up|1|||
27790785|NCT00509223|81065478|FG001|Overall Study|Lost to Follow-up|1|||
27790786|NCT00509223|81065477|FG000|Overall Study|Adverse Event|1|||
27790787|NCT00509223|81065478|FG001|Overall Study|Adverse Event|1|||
27790788|NCT00509223|81065477|FG000|Overall Study|Withdrawal by Subject|25|||
27790789|NCT00509223|81065478|FG001|Overall Study|Withdrawal by Subject|6|||
27790790|NCT00509223|81065477|FG000|Overall Study|Including: subject change of address|5|||
27790791|NCT00509223|81065478|FG001|Overall Study|Including: subject change of address|2|||
27790792|NCT00509223|81065477|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
27790793|NCT00509223|81065478|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
27790794|NCT03919669|81065479|FG000|Overall Study|Withdrawal by Subject|1|||
27790795|NCT03919669|81065480|FG001|Overall Study|Withdrawal by Subject|0|||
27790796|NCT03919669|81065481|FG002|Overall Study|Withdrawal by Subject|0|||
27978133|NCT00431951|81753222|FG002|Overall Study|Withdrawal by Subject|0|||
27978134|NCT00431951|81753223|FG003|Overall Study|Withdrawal by Subject|0|||
27978135|NCT00431951|81753220|FG000|Overall Study|Adverse Event|0|||
27790797|NCT00718809|81065484|FG000|Overall Study|Disease progression|9|||
27790798|NCT00718809|81065485|FG001|Overall Study|Disease progression|7|||
27790799|NCT00718809|81065484|FG000|Overall Study|Adverse Event|1|||
27790800|NCT00718809|81065485|FG001|Overall Study|Adverse Event|1|||
27790801|NCT00718809|81065484|FG000|Overall Study|Withdrawal by Subject|0|||
27790802|NCT00718809|81065485|FG001|Overall Study|Withdrawal by Subject|1|||
27790803|NCT00718809|81065484|FG000|Overall Study|Lost to Follow-up|1|||
27978136|NCT00431951|81753221|FG001|Overall Study|Adverse Event|0|||
27790804|NCT00718809|81065485|FG001|Overall Study|Lost to Follow-up|0|||
27790805|NCT00718809|81065484|FG000|Overall Study|Noncompliance|1|||
27790806|NCT00718809|81065485|FG001|Overall Study|Noncompliance|0|||
27790807|NCT04768881|81065486|FG000|Overall Study|Completed Study Follow-up|0|||
27790808|NCT04768881|81065487|FG001|Overall Study|Completed Study Follow-up|2|||
27790809|NCT04768881|81065486|FG000|Overall Study|Death|3|||
27790810|NCT04768881|81065487|FG001|Overall Study|Death|2|||
27790811|NCT04768881|81065486|FG000|Overall Study|Study Terminated by Sponsor|2|||
27790812|NCT04768881|81065487|FG001|Overall Study|Study Terminated by Sponsor|2|||
27790813|NCT04768881|81065486|FG000|Overall Study|Withdrawal by Subject|2|||
27790814|NCT04768881|81065487|FG001|Overall Study|Withdrawal by Subject|0|||
27790815|NCT04768881|81065486|FG000|Overall Study|Other|2|||
27790816|NCT04768881|81065487|FG001|Overall Study|Other|0|||
27574300|NCT00952341|80285869|FG001|Cycle 1|Physician Decision|1|||
27790817|NCT01761565|81065488|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
27867651|NCT03142191|81349680|FG003|Placebo Controlled Period|Progressive Disease|0|||
27978137|NCT00431951|81753222|FG002|Overall Study|Adverse Event|1|||
27574301|NCT00952341|80285868|FG000|Cycle 2|Withdrawal by Subject|1|||
27574302|NCT00952341|80285869|FG001|Cycle 2|Withdrawal by Subject|1|||
27574303|NCT00952341|80285868|FG000|Cycle 2|Protocol Violation|1|||
27790818|NCT00814502|81065489|FG000|Overall Study|Adverse Event|1|||
27790819|NCT00814502|81065490|FG001|Overall Study|Adverse Event|0|||
27790820|NCT00814502|81065489|FG000|Overall Study|Withdrawal by Subject|0|||
27790821|NCT00814502|81065490|FG001|Overall Study|Withdrawal by Subject|2|||
27790822|NCT01195662|81065494|FG000|Double Blind Treatment Period|Adverse Event|4|||
27790823|NCT01195662|81065495|FG001|Double Blind Treatment Period|Adverse Event|1|||
27790824|NCT01195662|81065496|FG002|Double Blind Treatment Period|Adverse Event|2|||
27790825|NCT01195662|81065494|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
27790826|NCT01195662|81065495|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
27790827|NCT01195662|81065496|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
27790828|NCT01195662|81065494|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
27790829|NCT01195662|81065495|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
27790830|NCT01195662|81065496|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
27790831|NCT01195662|81065494|FG000|Double Blind Treatment Period|Administrative reason|2|||
27790832|NCT01195662|81065495|FG001|Double Blind Treatment Period|Administrative reason|1|||
27790833|NCT01195662|81065496|FG002|Double Blind Treatment Period|Administrative reason|1|||
27790834|NCT01195662|81065494|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
27790835|NCT01195662|81065495|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
27790836|NCT01195662|81065496|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
27790837|NCT01195662|81065494|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
27790838|NCT01195662|81065495|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
27978138|NCT00431951|81753223|FG003|Overall Study|Adverse Event|0|||
27978139|NCT00996801|81753224|FG000|Overall Study|Adverse Event|6|||
27978140|NCT00996801|81753225|FG001|Overall Study|Adverse Event|4|||
27978141|NCT00996801|81753226|FG002|Overall Study|Adverse Event|12|||
27790839|NCT01195662|81065496|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
27790840|NCT01195662|81065494|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
27790841|NCT01195662|81065495|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27790842|NCT01195662|81065496|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27790843|NCT01195662|81065494|FG000|Double Blind Treatment Period|Non-specified|3|||
27790844|NCT01195662|81065495|FG001|Double Blind Treatment Period|Non-specified|0|||
27790845|NCT01195662|81065496|FG002|Double Blind Treatment Period|Non-specified|0|||
27790846|NCT01195662|81065494|FG000|Double Blind Treatment Period|Missing disposition information|0|||
27790847|NCT01195662|81065495|FG001|Double Blind Treatment Period|Missing disposition information|1|||
27790848|NCT01195662|81065496|FG002|Double Blind Treatment Period|Missing disposition information|1|||
27790849|NCT01195662|81065494|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
27867652|NCT03142191|81349681|FG004|Placebo Controlled Period|Progressive Disease|0|||
27978142|NCT00996801|81753227|FG003|Overall Study|Adverse Event|17|||
27978143|NCT00996801|81753228|FG004|Overall Study|Adverse Event|31|||
27978144|NCT00996801|81753229|FG005|Overall Study|Adverse Event|3|||
27978145|NCT00996801|81753224|FG000|Overall Study|Lack of Efficacy|3|||
27978146|NCT00996801|81753225|FG001|Overall Study|Lack of Efficacy|0|||
27978147|NCT00996801|81753226|FG002|Overall Study|Lack of Efficacy|1|||
27978148|NCT00996801|81753227|FG003|Overall Study|Lack of Efficacy|3|||
27978149|NCT00996801|81753228|FG004|Overall Study|Lack of Efficacy|0|||
27978150|NCT00996801|81753229|FG005|Overall Study|Lack of Efficacy|1|||
27978151|NCT00996801|81753224|FG000|Overall Study|Lost to Follow-up|0|||
27978152|NCT00996801|81753225|FG001|Overall Study|Lost to Follow-up|0|||
27978153|NCT00996801|81753226|FG002|Overall Study|Lost to Follow-up|0|||
27978154|NCT00996801|81753227|FG003|Overall Study|Lost to Follow-up|3|||
27978155|NCT00996801|81753228|FG004|Overall Study|Lost to Follow-up|3|||
27790850|NCT01195662|81065495|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
27867653|NCT03142191|81349677|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
27978156|NCT00996801|81753229|FG005|Overall Study|Lost to Follow-up|2|||
27790851|NCT01195662|81065496|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
27978157|NCT00996801|81753224|FG000|Overall Study|Physician Decision|0|||
27978158|NCT00996801|81753225|FG001|Overall Study|Physician Decision|0|||
27978159|NCT00996801|81753226|FG002|Overall Study|Physician Decision|0|||
27978160|NCT00996801|81753227|FG003|Overall Study|Physician Decision|1|||
27978161|NCT00996801|81753228|FG004|Overall Study|Physician Decision|0|||
27978162|NCT00996801|81753229|FG005|Overall Study|Physician Decision|0|||
27978163|NCT00996801|81753224|FG000|Overall Study|Progressive Disease|0|||
27978164|NCT00996801|81753225|FG001|Overall Study|Progressive Disease|1|||
27978165|NCT00996801|81753226|FG002|Overall Study|Progressive Disease|0|||
27978166|NCT00996801|81753227|FG003|Overall Study|Progressive Disease|0|||
27978167|NCT00996801|81753228|FG004|Overall Study|Progressive Disease|0|||
27978168|NCT00996801|81753229|FG005|Overall Study|Progressive Disease|0|||
27978169|NCT00996801|81753224|FG000|Overall Study|Protocol Violation|3|||
27978170|NCT00996801|81753225|FG001|Overall Study|Protocol Violation|4|||
27978171|NCT00996801|81753226|FG002|Overall Study|Protocol Violation|1|||
27978172|NCT00996801|81753227|FG003|Overall Study|Protocol Violation|2|||
27978173|NCT00996801|81753228|FG004|Overall Study|Protocol Violation|3|||
27978174|NCT00996801|81753229|FG005|Overall Study|Protocol Violation|4|||
27978175|NCT00996801|81753224|FG000|Overall Study|Study Terminated by Sponsor|0|||
27978176|NCT00996801|81753225|FG001|Overall Study|Study Terminated by Sponsor|1|||
27978177|NCT00996801|81753226|FG002|Overall Study|Study Terminated by Sponsor|0|||
27978178|NCT00996801|81753227|FG003|Overall Study|Study Terminated by Sponsor|0|||
27978179|NCT00996801|81753228|FG004|Overall Study|Study Terminated by Sponsor|46|||
27978180|NCT00996801|81753229|FG005|Overall Study|Study Terminated by Sponsor|0|||
27978181|NCT00996801|81753224|FG000|Overall Study|Withdrawal by Subject|8|||
27978182|NCT00996801|81753225|FG001|Overall Study|Withdrawal by Subject|6|||
27978183|NCT00996801|81753226|FG002|Overall Study|Withdrawal by Subject|9|||
27978184|NCT00996801|81753227|FG003|Overall Study|Withdrawal by Subject|5|||
27978185|NCT00996801|81753228|FG004|Overall Study|Withdrawal by Subject|5|||
27978186|NCT00996801|81753229|FG005|Overall Study|Withdrawal by Subject|9|||
27978187|NCT03812185|81753230|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
27978188|NCT02419131|81753231|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
27978189|NCT02419131|81753232|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
27978190|NCT02419131|81753233|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
27978191|NCT02419131|81753231|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
27978192|NCT02419131|81753232|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
27978193|NCT02419131|81753233|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
27978194|NCT01414205|81753234|FG000|Overall Study|Death|5|||
27978195|NCT01414205|81753235|FG001|Overall Study|Death|1|||
27978196|NCT01414205|81753234|FG000|Overall Study|Lost to Follow-up|1|||
27978197|NCT01414205|81753235|FG001|Overall Study|Lost to Follow-up|4|||
27574304|NCT00952341|80285869|FG001|Cycle 2|Protocol Violation|0|||
27574305|NCT00952341|80285868|FG000|Cycle 2|Lost to Follow-up|6|||
27574306|NCT00952341|80285869|FG001|Cycle 2|Lost to Follow-up|9|||
27574307|NCT00952341|80285868|FG000|Cycle 2|Physician Decision|1|||
27574308|NCT00952341|80285869|FG001|Cycle 2|Physician Decision|1|||
27574309|NCT00952341|80285868|FG000|Cycle 2|Progressive Disease|0|||
27574310|NCT00952341|80285869|FG001|Cycle 2|Progressive Disease|1|||
27574311|NCT00326911|80285870|FG000|Overall Study|Hospitalization prior to treatment|0|||
27574312|NCT00326911|80285871|FG001|Overall Study|Hospitalization prior to treatment|1|||
27574313|NCT00326911|80285870|FG000|Overall Study|Physician decision prior to treatment|1|||
27574314|NCT00326911|80285871|FG001|Overall Study|Physician decision prior to treatment|0|||
27574315|NCT00326911|80285870|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
27574316|NCT00326911|80285871|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
27574317|NCT00700011|80285872|FG000|Overall Study|Death|0|||
27574318|NCT00700011|80285873|FG001|Overall Study|Death|1|||
27574319|NCT01067352|80285880|FG000|Overall Study|Withdrawal by Subject|1|||
27574320|NCT01067352|80285881|FG001|Overall Study|Withdrawal by Subject|2|||
27574321|NCT01067352|80285882|FG002|Overall Study|Withdrawal by Subject|1|||
27574322|NCT01067352|80285880|FG000|Overall Study|Physician Decision|0|||
27574323|NCT01067352|80285881|FG001|Overall Study|Physician Decision|1|||
27574324|NCT01067352|80285882|FG002|Overall Study|Physician Decision|0|||
27574325|NCT01800916|80285884|FG000|Test Period 1 (1 Week)|Convex product user|0|||
27574326|NCT01800916|80285885|FG001|Test Period 1 (1 Week)|Convex product user|0|||
27574327|NCT01800916|80285886|FG002|Test Period 1 (1 Week)|Convex product user|0|||
27574328|NCT01800916|80285887|FG003|Test Period 1 (1 Week)|Convex product user|1|||
27574329|NCT01800916|80285888|FG004|Test Period 1 (1 Week)|Convex product user|0|||
27978198|NCT01414205|81753234|FG000|Overall Study|Physician Decision|0|||
27574330|NCT01800916|80285889|FG005|Test Period 1 (1 Week)|Convex product user|0|||
27574331|NCT01800916|80285890|FG006|Test Period 1 (1 Week)|Convex product user|0|||
27574332|NCT01800916|80285891|FG007|Test Period 1 (1 Week)|Convex product user|0|||
27574333|NCT01800916|80285892|FG008|Test Period 1 (1 Week)|Convex product user|0|||
27574334|NCT01800916|80285884|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
27574335|NCT01800916|80285885|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
27978199|NCT01414205|81753235|FG001|Overall Study|Physician Decision|1|||
27978200|NCT01414205|81753234|FG000|Overall Study|Randomized but not Treated|1|||
27978201|NCT01414205|81753235|FG001|Overall Study|Randomized but not Treated|1|||
27978202|NCT03276052|81753236|FG000|Overall Study|Withdrawal by Subject|5|||
27978203|NCT03276052|81753236|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
27978204|NCT00235391|81753237|FG000|Overall Study|Adverse Event|4|||
27574336|NCT01800916|80285886|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
27574337|NCT01800916|80285887|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
27574338|NCT01800916|80285888|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
27574339|NCT01800916|80285889|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
27574340|NCT01800916|80285890|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
27574341|NCT01800916|80285891|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
27574342|NCT01800916|80285892|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
27574343|NCT01700179|80285893|FG000|Overall Study|Physician Decision|2|||
27574344|NCT00714259|80285896|FG000|Overall Study|Death|2|||
27574345|NCT00826267|80285897|FG000|Overall Study|Other Adverse Event|1|||
27574346|NCT00826267|80285898|FG001|Overall Study|Other Adverse Event|0|||
27574347|NCT00826267|80285899|FG002|Overall Study|Other Adverse Event|0|||
27574348|NCT00699972|80285900|FG000|Overall Study|Adverse Event|7|||
27574349|NCT00699972|80285901|FG001|Overall Study|Adverse Event|9|||
27574350|NCT00699972|80285902|FG002|Overall Study|Adverse Event|24|||
27574351|NCT00699972|80285900|FG000|Overall Study|Lost to Follow-up|0|||
27574352|NCT00699972|80285901|FG001|Overall Study|Lost to Follow-up|2|||
27574353|NCT00699972|80285902|FG002|Overall Study|Lost to Follow-up|0|||
27574354|NCT00699972|80285900|FG000|Overall Study|Withdrawal by Subject|3|||
27574355|NCT00699972|80285901|FG001|Overall Study|Withdrawal by Subject|7|||
27574356|NCT00699972|80285902|FG002|Overall Study|Withdrawal by Subject|4|||
27574357|NCT00699972|80285900|FG000|Overall Study|Lack of Efficacy|2|||
27574358|NCT00699972|80285901|FG001|Overall Study|Lack of Efficacy|0|||
27574359|NCT00699972|80285902|FG002|Overall Study|Lack of Efficacy|2|||
27574360|NCT00699972|80285900|FG000|Overall Study|Administrative/Other|3|||
27574361|NCT00699972|80285901|FG001|Overall Study|Administrative/Other|1|||
27574362|NCT00699972|80285902|FG002|Overall Study|Administrative/Other|4|||
27574363|NCT00699972|80285900|FG000|Overall Study|Randomized, Not Treated|1|||
27574364|NCT00699972|80285901|FG001|Overall Study|Randomized, Not Treated|0|||
27574365|NCT00699972|80285902|FG002|Overall Study|Randomized, Not Treated|1|||
27574366|NCT01234467|80285903|FG000|Overall Study|Adverse Event|3|||
27574367|NCT01234467|80285903|FG000|Overall Study|Death|2|||
27574368|NCT01234467|80285903|FG000|Overall Study|Withdrawal by Subject|2|||
27574369|NCT01234467|80285903|FG000|Overall Study|Disease Progression|2|||
27574370|NCT01234467|80285903|FG000|Overall Study|Clinical deterioration|1|||
27574371|NCT01234467|80285903|FG000|Overall Study|Physician Decision|1|||
27574372|NCT01234467|80285903|FG000|Overall Study|Other complicating disease (stroke)|1|||
27574373|NCT01440322|80289012|FG000|Overall Study|Discomfort|2|||
27574374|NCT01440322|80289013|FG001|Overall Study|Discomfort|0|||
27574375|NCT01440322|80289012|FG000|Overall Study|Biomicroscopy|1|||
27574376|NCT01440322|80289013|FG001|Overall Study|Biomicroscopy|0|||
27574377|NCT01440322|80289012|FG000|Overall Study|Symptoms and Problems|1|||
27574378|NCT01440322|80289013|FG001|Overall Study|Symptoms and Problems|0|||
27574379|NCT01440322|80289012|FG000|Overall Study|Unacceptable Subjective Vision|1|||
27574380|NCT01440322|80289013|FG001|Overall Study|Unacceptable Subjective Vision|0|||
27574381|NCT01440322|80289012|FG000|Overall Study|Other Product Related|1|||
27574382|NCT01440322|80289013|FG001|Overall Study|Other Product Related|0|||
27574383|NCT01440322|80289012|FG000|Overall Study|Unrelated Medical Problem|0|||
27574384|NCT01440322|80289013|FG001|Overall Study|Unrelated Medical Problem|1|||
27574385|NCT01440322|80289012|FG000|Overall Study|Other Non-Product Related|1|||
27574386|NCT01440322|80289013|FG001|Overall Study|Other Non-Product Related|0|||
27574387|NCT00724451|80289014|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
27574388|NCT00724451|80289014|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
27574389|NCT00724451|80289014|FG000|Overall Study|Not Eligible for Treatment|431|||
27574390|NCT00724451|80289014|FG000|Overall Study|Participant Refused Treatment|89|||
27574391|NCT00724451|80289014|FG000|Overall Study|Never Started Treatment|89|||
27574392|NCT00724451|80289014|FG000|Overall Study|Unknown; No Data Sources Available|9|||
27574393|NCT00724451|80289014|FG000|Overall Study|Physician Decision|116|||
27574394|NCT00724451|80289014|FG000|Overall Study|Withdrawal by Subject|45|||
27574395|NCT00724451|80289014|FG000|Overall Study|Investigator + Participant Decision|13|||
27574396|NCT00785486|80289016|FG000|Midazolam Alone|Withdrawal by Subject|1|||
27574397|NCT01976845|80289020|FG000|Overall Study|Physician Decision|8|||
27574398|NCT01976845|80289021|FG001|Overall Study|Physician Decision|8|||
27790852|NCT01195662|81065494|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
27790853|NCT01195662|81065495|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
27790854|NCT01195662|81065496|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
27574399|NCT01976845|80289022|FG002|Overall Study|Physician Decision|3|||
27574400|NCT01782313|80289023|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
27574401|NCT01782313|80289023|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
27574402|NCT01782313|80289023|FG000|Treated Cycle 3|Progressive Disease|21|||
27574403|NCT01782313|80289023|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
27574404|NCT01782313|80289023|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
27574405|NCT01782313|80289023|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
27574406|NCT01782313|80289023|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
27574407|NCT01782313|80289023|FG000|Survival Follow up|Lost to Follow-up|1|||
27574408|NCT01706250|80289024|FG000|Overall Study|Lost to Follow-up|2|||
27574409|NCT00529386|80289025|FG000|Overall Study|Lost to Follow-up|1|||
27574410|NCT00705575|80289027|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27790855|NCT01339273|81065497|FG000|Overall Study|Lost to Follow-up|8|||
27978205|NCT00235391|81753238|FG001|Overall Study|Adverse Event|5|||
27978206|NCT00235391|81753239|FG002|Overall Study|Adverse Event|10|||
27978207|NCT00235391|81753240|FG003|Overall Study|Adverse Event|72|||
27978208|NCT00235391|81753241|FG004|Overall Study|Adverse Event|5|||
27978209|NCT00235391|81753242|FG005|Overall Study|Adverse Event|2|||
27978210|NCT00235391|81753237|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27978211|NCT00235391|81753238|FG001|Overall Study|Abnormal laboratory value(s)|5|||
27978212|NCT00235391|81753239|FG002|Overall Study|Abnormal laboratory value(s)|4|||
27790856|NCT01339273|81065498|FG001|Overall Study|Lost to Follow-up|8|||
27790857|NCT02777554|81065499|FG000|Overall Study|Adverse Event|4|||
27790858|NCT02777554|81065500|FG001|Overall Study|Adverse Event|4|||
27790859|NCT02777554|81065501|FG002|Overall Study|Adverse Event|0|||
27790860|NCT02777554|81065502|FG003|Overall Study|Adverse Event|1|||
27790861|NCT02777554|81065503|FG004|Overall Study|Adverse Event|0|||
27790862|NCT02777554|81065504|FG005|Overall Study|Adverse Event|0|||
27790863|NCT02777554|81065499|FG000|Overall Study|Withdrawal by Subject|3|||
27790864|NCT02777554|81065500|FG001|Overall Study|Withdrawal by Subject|1|||
27790865|NCT02777554|81065501|FG002|Overall Study|Withdrawal by Subject|1|||
27790866|NCT02777554|81065502|FG003|Overall Study|Withdrawal by Subject|0|||
27978213|NCT00235391|81753240|FG003|Overall Study|Abnormal laboratory value(s)|27|||
27978214|NCT00235391|81753241|FG004|Overall Study|Abnormal laboratory value(s)|1|||
27978215|NCT00235391|81753242|FG005|Overall Study|Abnormal laboratory value(s)|2|||
27978216|NCT00235391|81753237|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27978217|NCT00235391|81753238|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27978218|NCT00235391|81753239|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27978219|NCT00235391|81753240|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
27574411|NCT00705575|80289028|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27574412|NCT00705575|80289027|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27574413|NCT00705575|80289028|FG001|Overall Study|Abnormal test procedure result(s)|12|||
27574414|NCT00705575|80289027|FG000|Overall Study|Adverse Event|11|||
27574415|NCT00705575|80289028|FG001|Overall Study|Adverse Event|15|||
27574416|NCT00705575|80289027|FG000|Overall Study|Lost to Follow-up|3|||
27574417|NCT00705575|80289028|FG001|Overall Study|Lost to Follow-up|4|||
27574418|NCT00705575|80289027|FG000|Overall Study|Protocol Violation|2|||
27574419|NCT00705575|80289028|FG001|Overall Study|Protocol Violation|2|||
27574420|NCT00705575|80289027|FG000|Overall Study|Withdrawal by Subject|5|||
27574421|NCT00705575|80289028|FG001|Overall Study|Withdrawal by Subject|10|||
27574422|NCT03240575|80289029|FG000|Overall Study|Adverse Event|0|||
27574423|NCT03240575|80289030|FG001|Overall Study|Adverse Event|2|||
27574424|NCT03240575|80289031|FG002|Overall Study|Adverse Event|0|||
27574425|NCT03240575|80289032|FG003|Overall Study|Adverse Event|1|||
27574426|NCT03240575|80289029|FG000|Overall Study|Withdrawal by Subject|2|||
27574427|NCT03240575|80289030|FG001|Overall Study|Withdrawal by Subject|11|||
27574428|NCT03240575|80289031|FG002|Overall Study|Withdrawal by Subject|0|||
27574429|NCT03240575|80289032|FG003|Overall Study|Withdrawal by Subject|1|||
27574430|NCT03240575|80289029|FG000|Overall Study|Other|0|||
27574431|NCT03240575|80289030|FG001|Overall Study|Other|1|||
27574432|NCT03240575|80289031|FG002|Overall Study|Other|0|||
27574433|NCT03240575|80289032|FG003|Overall Study|Other|0|||
27574434|NCT00548808|80289038|FG000|Overall Study|Lost to Follow-up|9|||
27790867|NCT02777554|81065503|FG004|Overall Study|Withdrawal by Subject|0|||
27790868|NCT02777554|81065504|FG005|Overall Study|Withdrawal by Subject|0|||
27790869|NCT02777554|81065499|FG000|Overall Study|Discharged early due to hurricane|22|||
27790870|NCT02777554|81065500|FG001|Overall Study|Discharged early due to hurricane|20|||
27790871|NCT02777554|81065501|FG002|Overall Study|Discharged early due to hurricane|0|||
27790872|NCT02777554|81065502|FG003|Overall Study|Discharged early due to hurricane|0|||
27790873|NCT02777554|81065503|FG004|Overall Study|Discharged early due to hurricane|0|||
27790874|NCT02777554|81065504|FG005|Overall Study|Discharged early due to hurricane|0|||
27790875|NCT02777554|81065499|FG000|Overall Study|Other - Miscellaneous|1|||
27790876|NCT02777554|81065500|FG001|Overall Study|Other - Miscellaneous|0|||
27790877|NCT02777554|81065501|FG002|Overall Study|Other - Miscellaneous|0|||
27790878|NCT02777554|81065502|FG003|Overall Study|Other - Miscellaneous|0|||
27790879|NCT02777554|81065503|FG004|Overall Study|Other - Miscellaneous|0|||
27790880|NCT02777554|81065504|FG005|Overall Study|Other - Miscellaneous|0|||
27790881|NCT03808298|81065505|FG000|Overall Study|Adverse Event|3|||
27790882|NCT03808298|81065505|FG000|Overall Study|Physician Decision|1|||
27790883|NCT03808298|81065505|FG000|Overall Study|Withdrawal by Subject|1|||
27790884|NCT03808298|81065505|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
27790885|NCT01714726|81065506|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
27790886|NCT01714726|81065507|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
27790887|NCT01714726|81065508|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
27574435|NCT00548808|80289039|FG001|Overall Study|Lost to Follow-up|3|||
27574436|NCT00548808|80289038|FG000|Overall Study|Protocol Violation|8|||
27574437|NCT00548808|80289039|FG001|Overall Study|Protocol Violation|8|||
27574438|NCT00548808|80289038|FG000|Overall Study|Withdrawal by Subject|8|||
27574439|NCT00548808|80289039|FG001|Overall Study|Withdrawal by Subject|4|||
27574440|NCT00548808|80289038|FG000|Overall Study|Physician Decision|6|||
27574441|NCT00548808|80289039|FG001|Overall Study|Physician Decision|3|||
27574442|NCT00548808|80289038|FG000|Overall Study|Adverse Event|4|||
27574443|NCT00548808|80289039|FG001|Overall Study|Adverse Event|5|||
27574444|NCT00548808|80289038|FG000|Overall Study|Death|2|||
27574445|NCT00548808|80289039|FG001|Overall Study|Death|0|||
27574446|NCT00548808|80289038|FG000|Overall Study|Entry Criteria Not Met|2|||
27574447|NCT00548808|80289039|FG001|Overall Study|Entry Criteria Not Met|2|||
27574448|NCT00548808|80289038|FG000|Overall Study|Lack of Efficacy|2|||
27574449|NCT00548808|80289039|FG001|Overall Study|Lack of Efficacy|0|||
27867654|NCT03142191|81349678|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
27867655|NCT03142191|81349679|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
27574450|NCT00548808|80289038|FG000|Overall Study|Sponsor Decision|1|||
27574451|NCT00548808|80289039|FG001|Overall Study|Sponsor Decision|1|||
27574452|NCT04115358|80289040|FG000|Overall Study|exfoliation|0|||
27574453|NCT04115358|80289041|FG001|Overall Study|exfoliation|0|||
27790888|NCT01714726|81065509|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
27790889|NCT01714726|81065506|FG000|Double-Blinded Induction Period|Adverse Event|0|||
27790890|NCT01714726|81065507|FG001|Double-Blinded Induction Period|Adverse Event|1|||
27790891|NCT01714726|81065508|FG002|Double-Blinded Induction Period|Adverse Event|0|||
27790892|NCT01714726|81065509|FG003|Double-Blinded Induction Period|Adverse Event|0|||
27574454|NCT04115358|80289042|FG002|Overall Study|exfoliation|1|||
27574455|NCT04122443|80289043|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
27574456|NCT04122443|80289044|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
27574457|NCT04122443|80289045|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
27790893|NCT01714726|81065506|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
27790894|NCT01714726|81065507|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
27790895|NCT01714726|81065508|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
27790896|NCT01714726|81065509|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
27790897|NCT01714726|81065506|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
27790898|NCT01714726|81065507|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
27790899|NCT01714726|81065508|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
27790900|NCT01714726|81065509|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
27790901|NCT01714726|81065506|FG000|Open-Label Period|Other|0|||
27790902|NCT01714726|81065507|FG001|Open-Label Period|Other|0|||
27790903|NCT01714726|81065508|FG002|Open-Label Period|Other|1|||
27790904|NCT01714726|81065509|FG003|Open-Label Period|Other|3|||
27790905|NCT01714726|81065506|FG000|Open-Label Period|Adverse Event|0|||
27790906|NCT01714726|81065507|FG001|Open-Label Period|Adverse Event|0|||
27790907|NCT01714726|81065508|FG002|Open-Label Period|Adverse Event|1|||
27790908|NCT01714726|81065509|FG003|Open-Label Period|Adverse Event|0|||
27790909|NCT01714726|81065506|FG000|Open-Label Period|Withdrawal by Subject|0|||
27790910|NCT01714726|81065507|FG001|Open-Label Period|Withdrawal by Subject|0|||
27790911|NCT01714726|81065508|FG002|Open-Label Period|Withdrawal by Subject|9|||
27790912|NCT01714726|81065509|FG003|Open-Label Period|Withdrawal by Subject|19|||
27790913|NCT01714726|81065506|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
27790914|NCT01714726|81065507|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
27790915|NCT01714726|81065508|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
27790916|NCT01714726|81065509|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
27790917|NCT01714726|81065506|FG000|Open-Label Period|Lost to Follow-up|0|||
27790918|NCT01714726|81065507|FG001|Open-Label Period|Lost to Follow-up|0|||
27574458|NCT04122443|80289043|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
27574459|NCT04122443|80289044|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
27574460|NCT04122443|80289045|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
27574461|NCT00179413|80289046|FG000|Overall Study|Adverse Event|38|||
27574462|NCT00179413|80289047|FG001|Overall Study|Adverse Event|20|||
27574463|NCT00179413|80289046|FG000|Overall Study|Withdrawal by Subject|87|||
27574464|NCT00179413|80289047|FG001|Overall Study|Withdrawal by Subject|95|||
27574465|NCT00098839|80289048|FG000|Overall Study|Adverse Event|5|||
27574466|NCT00098839|80289049|FG001|Overall Study|Adverse Event|2|||
27574467|NCT00098839|80289048|FG000|Overall Study|Death|1|||
27574468|NCT00098839|80289049|FG001|Overall Study|Death|2|||
27574469|NCT00098839|80289048|FG000|Overall Study|Physician Decision|4|||
27790919|NCT01714726|81065508|FG002|Open-Label Period|Lost to Follow-up|3|||
27790920|NCT01714726|81065509|FG003|Open-Label Period|Lost to Follow-up|4|||
27790921|NCT00219349|81065511|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
27790922|NCT00219349|81065511|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
27790923|NCT00219349|81065511|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
27790924|NCT00219349|81065511|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
27790925|NCT04177862|81065512|FG000|Overall Study|Protocol Violation|2|||
27790926|NCT04177862|81065513|FG001|Overall Study|Protocol Violation|7|||
27790927|NCT01317199|81065514|FG000|Dose-escalation Phase 1|Physician Decision|5|||
27790928|NCT01317199|81065515|FG001|Dose-escalation Phase 1|Physician Decision|0|||
27790929|NCT01317199|81065516|FG002|Dose-escalation Phase 1|Physician Decision|0|||
27790930|NCT01317199|81065517|FG003|Dose-escalation Phase 1|Physician Decision|0|||
27790931|NCT01317199|81065514|FG000|Dose-escalation Phase 1|Disease progression|1|||
27790932|NCT01317199|81065515|FG001|Dose-escalation Phase 1|Disease progression|0|||
27790933|NCT01317199|81065516|FG002|Dose-escalation Phase 1|Disease progression|0|||
27790934|NCT01317199|81065517|FG003|Dose-escalation Phase 1|Disease progression|0|||
27790935|NCT01317199|81065514|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
27790936|NCT01317199|81065515|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
27790937|NCT01317199|81065516|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
27790938|NCT01317199|81065517|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
27574470|NCT00098839|80289049|FG001|Overall Study|Physician Decision|14|||
27790939|NCT01317199|81065514|FG000|Randomized Phase 2|Disease progression|0|||
27790940|NCT01317199|81065515|FG001|Randomized Phase 2|Disease progression|3|||
27790941|NCT01317199|81065516|FG002|Randomized Phase 2|Disease progression|7|||
27790942|NCT01317199|81065517|FG003|Randomized Phase 2|Disease progression|5|||
27790943|NCT01317199|81065514|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
27790944|NCT01317199|81065515|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
27790945|NCT01317199|81065516|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
27790946|NCT01317199|81065517|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
27790947|NCT01317199|81065514|FG000|Randomized Phase 2|Adverse Event|0|||
27672295|NCT04732871|80639165|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
27672296|NCT04732871|80639166|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
27672297|NCT04732871|80639167|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
27672298|NCT04732871|80639165|FG000|Overall Study|Migrated / moved from the study area|5|||
27672299|NCT04732871|80639166|FG001|Overall Study|Migrated / moved from the study area|0|||
27672300|NCT04732871|80639167|FG002|Overall Study|Migrated / moved from the study area|0|||
27672301|NCT04732871|80639165|FG000|Overall Study|Other|1|||
27672302|NCT04732871|80639166|FG001|Overall Study|Other|0|||
27672303|NCT04732871|80639167|FG002|Overall Study|Other|1|||
27672304|NCT04732871|80639165|FG000|Overall Study|Ongoing|6|||
27672305|NCT04732871|80639166|FG001|Overall Study|Ongoing|0|||
27672306|NCT04732871|80639167|FG002|Overall Study|Ongoing|1|||
27672307|NCT04732871|80639165|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
27672308|NCT04732871|80639166|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
27672309|NCT04732871|80639167|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
27672310|NCT02132117|80639168|FG000|Overall Study|Adverse Event|6|||
27672311|NCT02132117|80639169|FG001|Overall Study|Adverse Event|1|||
27672312|NCT02132117|80639168|FG000|Overall Study|Lost to Follow-up|2|||
27672313|NCT02132117|80639169|FG001|Overall Study|Lost to Follow-up|2|||
27672314|NCT02132117|80639168|FG000|Overall Study|Personal Reasons|1|||
27672315|NCT02132117|80639169|FG001|Overall Study|Personal Reasons|2|||
27672316|NCT02132117|80639168|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27672317|NCT02132117|80639169|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27672318|NCT00590564|80639170|FG000|Overall Study|Withdrawal by Subject|4|||
27672319|NCT00590564|80639170|FG000|Overall Study|Lost to Follow-up|6|||
27672320|NCT00590564|80639170|FG000|Overall Study|Protocol Violation|1|||
27672321|NCT00590564|80639170|FG000|Overall Study|Patient Found to be Ineligible|1|||
27672322|NCT00590564|80639170|FG000|Overall Study|Patient Non-compliance|6|||
27672323|NCT00891046|80639171|FG000|Overall Study|Protocol Violation|1|||
27672324|NCT00891046|80639172|FG001|Overall Study|Protocol Violation|1|||
27672325|NCT00891046|80639173|FG002|Overall Study|Protocol Violation|0|||
27672326|NCT00891046|80639174|FG003|Overall Study|Protocol Violation|0|||
27672327|NCT00891046|80639175|FG004|Overall Study|Protocol Violation|1|||
27672328|NCT00891046|80639171|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27672329|NCT00891046|80639172|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27672330|NCT00891046|80639173|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
27672331|NCT00891046|80639174|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27672332|NCT00891046|80639175|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
27672333|NCT00891046|80639171|FG000|Overall Study|Administrative problems|0|||
27672334|NCT00891046|80639172|FG001|Overall Study|Administrative problems|0|||
27672335|NCT00891046|80639173|FG002|Overall Study|Administrative problems|0|||
27672336|NCT00891046|80639174|FG003|Overall Study|Administrative problems|0|||
27672337|NCT00891046|80639175|FG004|Overall Study|Administrative problems|1|||
27672338|NCT00891046|80639171|FG000|Overall Study|Participant no longer required drug|0|||
27672339|NCT00891046|80639172|FG001|Overall Study|Participant no longer required drug|2|||
27672340|NCT00891046|80639173|FG002|Overall Study|Participant no longer required drug|0|||
27672341|NCT00891046|80639174|FG003|Overall Study|Participant no longer required drug|0|||
27672342|NCT00891046|80639175|FG004|Overall Study|Participant no longer required drug|1|||
27672343|NCT00891046|80639171|FG000|Overall Study|Adverse Event|4|||
27672344|NCT00891046|80639172|FG001|Overall Study|Adverse Event|3|||
27672345|NCT00891046|80639173|FG002|Overall Study|Adverse Event|2|||
27672346|NCT00891046|80639174|FG003|Overall Study|Adverse Event|0|||
27672347|NCT00891046|80639175|FG004|Overall Study|Adverse Event|14|||
27672348|NCT00891046|80639171|FG000|Overall Study|Withdrawal by Subject|2|||
27672349|NCT00891046|80639172|FG001|Overall Study|Withdrawal by Subject|1|||
27672350|NCT00891046|80639173|FG002|Overall Study|Withdrawal by Subject|2|||
27672351|NCT00891046|80639174|FG003|Overall Study|Withdrawal by Subject|1|||
27672352|NCT00891046|80639175|FG004|Overall Study|Withdrawal by Subject|1|||
27672353|NCT00891046|80639171|FG000|Overall Study|Lost to Follow-up|0|||
27672354|NCT00891046|80639172|FG001|Overall Study|Lost to Follow-up|0|||
27672355|NCT00891046|80639173|FG002|Overall Study|Lost to Follow-up|0|||
27672356|NCT00891046|80639174|FG003|Overall Study|Lost to Follow-up|0|||
27672357|NCT00891046|80639175|FG004|Overall Study|Lost to Follow-up|1|||
27672358|NCT03004404|80639176|FG000|Period 2|Adverse Event|0|||
27672359|NCT03004404|80639177|FG001|Period 2|Adverse Event|0|||
27672360|NCT03004404|80639178|FG002|Period 2|Adverse Event|0|||
27672361|NCT03004404|80639179|FG003|Period 2|Adverse Event|0|||
27672362|NCT03004404|80639180|FG004|Period 2|Adverse Event|0|||
27672363|NCT03004404|80639181|FG005|Period 2|Adverse Event|0|||
27672364|NCT03004404|80639182|FG006|Period 2|Adverse Event|0|||
27672365|NCT03004404|80639183|FG007|Period 2|Adverse Event|0|||
27672366|NCT03004404|80639184|FG008|Period 2|Adverse Event|1|||
27672367|NCT03004404|80639185|FG009|Period 2|Adverse Event|0|||
27672368|NCT03004404|80639186|FG010|Period 2|Adverse Event|0|||
27672369|NCT03004404|80639187|FG011|Period 2|Adverse Event|0|||
27672370|NCT03004404|80639188|FG012|Period 2|Adverse Event|0|||
27672371|NCT03004404|80639189|FG013|Period 2|Adverse Event|0|||
27790948|NCT01317199|81065515|FG001|Randomized Phase 2|Adverse Event|0|||
27790949|NCT01317199|81065516|FG002|Randomized Phase 2|Adverse Event|0|||
27790950|NCT01317199|81065517|FG003|Randomized Phase 2|Adverse Event|1|||
27790951|NCT01317199|81065514|FG000|Randomized Phase 2|Comorbidities|0|||
27790952|NCT01317199|81065515|FG001|Randomized Phase 2|Comorbidities|2|||
27790953|NCT01317199|81065516|FG002|Randomized Phase 2|Comorbidities|2|||
27790954|NCT01317199|81065517|FG003|Randomized Phase 2|Comorbidities|2|||
27790955|NCT01317199|81065514|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
27790956|NCT01317199|81065515|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
27790957|NCT01317199|81065516|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
27790958|NCT01317199|81065517|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
27790959|NCT01317199|81065514|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
27790960|NCT01317199|81065515|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
27790961|NCT01317199|81065516|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
27790962|NCT01317199|81065517|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
27790963|NCT01317199|81065514|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
27790964|NCT01317199|81065515|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
27790965|NCT01317199|81065516|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
27790966|NCT01317199|81065517|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
27790967|NCT01317199|81065514|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
27574471|NCT00098839|80289048|FG000|Overall Study|Withdrawal by Subject|1|||
27790968|NCT01317199|81065515|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
27790969|NCT01317199|81065516|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
27790970|NCT01317199|81065517|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
27790971|NCT02067728|81065518|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
27790972|NCT02067728|81065519|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
27790973|NCT02067728|81065518|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
27790974|NCT02067728|81065519|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
27790975|NCT02067728|81065518|FG000|6 Month Measurements|Unable to attend|114|||
27790976|NCT02067728|81065519|FG001|6 Month Measurements|Unable to attend|97|||
27790977|NCT01381068|81065522|FG000|Overall Study|Death|1|||
27790978|NCT01381068|81065523|FG001|Overall Study|Death|0|||
27790979|NCT00483717|81065532|FG000|Overall Study|Protocol Violation|5|||
27790980|NCT00483717|81065533|FG001|Overall Study|Protocol Violation|7|||
27790981|NCT00483717|81065532|FG000|Overall Study|Time of dosing missing|1|||
27790982|NCT00483717|81065533|FG001|Overall Study|Time of dosing missing|1|||
27790983|NCT00483717|81065532|FG000|Overall Study|No treatment for migraine|16|||
27790984|NCT00483717|81065533|FG001|Overall Study|No treatment for migraine|13|||
27790985|NCT00483717|81065532|FG000|Overall Study|Lost to Follow-up|1|||
27790986|NCT00483717|81065533|FG001|Overall Study|Lost to Follow-up|0|||
27790987|NCT00483717|81065532|FG000|Overall Study|Withdrawal by Subject|1|||
27790988|NCT00483717|81065533|FG001|Overall Study|Withdrawal by Subject|0|||
27790989|NCT02392377|81065537|FG000|Overall Study|Withdrawal by Subject|0|||
27790990|NCT02392377|81065538|FG001|Overall Study|Withdrawal by Subject|1|||
27790991|NCT02158949|81065540|FG000|Overall Study|Withdrawal by Subject|1|||
27790992|NCT02158949|81065541|FG001|Overall Study|Withdrawal by Subject|0|||
27790993|NCT02158949|81065540|FG000|Overall Study|Lost to Follow-up|5|||
27790994|NCT02158949|81065541|FG001|Overall Study|Lost to Follow-up|11|||
27790995|NCT03433482|81065543|FG000|Overall Study|Lost to Follow-up|1|||
27790996|NCT03433482|81065544|FG001|Overall Study|Lost to Follow-up|0|||
27790997|NCT03433482|81065545|FG002|Overall Study|Lost to Follow-up|1|||
27790998|NCT03433482|81065546|FG003|Overall Study|Lost to Follow-up|1|||
27790999|NCT03433482|81065543|FG000|Overall Study|Withdrawal by Subject|0|||
27791000|NCT03433482|81065544|FG001|Overall Study|Withdrawal by Subject|0|||
27791001|NCT03433482|81065545|FG002|Overall Study|Withdrawal by Subject|1|||
27791002|NCT03433482|81065546|FG003|Overall Study|Withdrawal by Subject|0|||
27791003|NCT03433482|81065543|FG000|Overall Study|Unknown reason|0|||
27791004|NCT03433482|81065544|FG001|Overall Study|Unknown reason|0|||
27791005|NCT03433482|81065545|FG002|Overall Study|Unknown reason|2|||
27791006|NCT03433482|81065546|FG003|Overall Study|Unknown reason|0|||
27791007|NCT01484691|81065547|FG000|Overall Study|Withdrawal by Subject|1|||
27791008|NCT01484691|81065548|FG001|Overall Study|Withdrawal by Subject|1|||
27791009|NCT01484691|81065549|FG002|Overall Study|Withdrawal by Subject|1|||
27791010|NCT01484691|81065547|FG000|Overall Study|Physician Decision|0|||
27791011|NCT01484691|81065548|FG001|Overall Study|Physician Decision|2|||
27867656|NCT03142191|81349680|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
27867657|NCT03142191|81349681|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
27791012|NCT01484691|81065549|FG002|Overall Study|Physician Decision|1|||
27791013|NCT01353209|81065556|FG000|Overall Study|Adverse Event|1|||
27791014|NCT01353209|81065557|FG001|Overall Study|Adverse Event|1|||
27791015|NCT00422058|81065560|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
27791016|NCT00422058|81065561|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
27791017|NCT00422058|81065562|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
27791018|NCT00422058|81065563|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
27791019|NCT00422058|81065564|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
27791020|NCT00422058|81065565|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
27791021|NCT00422058|81065560|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
27791022|NCT00422058|81065561|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
27791023|NCT00422058|81065562|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
27791024|NCT00422058|81065563|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
27791025|NCT00422058|81065564|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
27791026|NCT00422058|81065565|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
27791027|NCT00422058|81065560|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
27791028|NCT00422058|81065561|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
27791029|NCT00422058|81065562|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
27791030|NCT00422058|81065563|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
27791031|NCT00422058|81065564|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
27791032|NCT00422058|81065565|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
27791033|NCT00422058|81065560|FG000|Double-Blind, Week 0-20|Other|11|||
27791034|NCT00422058|81065561|FG001|Double-Blind, Week 0-20|Other|3|||
27791035|NCT00422058|81065562|FG002|Double-Blind, Week 0-20|Other|8|||
27791036|NCT00422058|81065563|FG003|Double-Blind, Week 0-20|Other|8|||
27791037|NCT00422058|81065564|FG004|Double-Blind, Week 0-20|Other|4|||
27791038|NCT00422058|81065565|FG005|Double-Blind, Week 0-20|Other|10|||
27791039|NCT00422058|81065560|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
27791040|NCT00422058|81065561|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
27791041|NCT00422058|81065562|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
27791042|NCT00422058|81065563|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
27791043|NCT00422058|81065564|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
27791044|NCT00422058|81065565|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
27791045|NCT00422058|81065560|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
27791046|NCT00422058|81065561|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
27791047|NCT00422058|81065562|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
27791048|NCT00422058|81065563|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
27791049|NCT00422058|81065564|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
27791050|NCT00422058|81065565|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
27791051|NCT00422058|81065560|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
27791052|NCT00422058|81065561|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
27791053|NCT00422058|81065562|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
27791054|NCT00422058|81065563|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
27791055|NCT00422058|81065564|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
27791056|NCT00422058|81065565|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
27791057|NCT00422058|81065560|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
27791058|NCT00422058|81065561|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
27791059|NCT00422058|81065562|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
27791060|NCT00422058|81065563|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
27791061|NCT00422058|81065564|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
27791062|NCT00422058|81065565|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
27791063|NCT00422058|81065560|FG000|Open-Label Extension, Week 20-104|Other|13|||
27791064|NCT00422058|81065561|FG001|Open-Label Extension, Week 20-104|Other|14|||
27791065|NCT00422058|81065562|FG002|Open-Label Extension, Week 20-104|Other|6|||
27791066|NCT00422058|81065563|FG003|Open-Label Extension, Week 20-104|Other|13|||
27791067|NCT00422058|81065564|FG004|Open-Label Extension, Week 20-104|Other|16|||
27791068|NCT00422058|81065565|FG005|Open-Label Extension, Week 20-104|Other|18|||
27791069|NCT03233009|81065566|FG000|Overall Study|Lost to Follow-up|1|||
27791070|NCT00577382|81065577|FG000|Overall Study|Adverse Event|0|||
27791071|NCT00577382|81065578|FG001|Overall Study|Adverse Event|6|||
27791072|NCT00577382|81065577|FG000|Overall Study|Withdrawal by Subject|0|||
27791073|NCT00577382|81065578|FG001|Overall Study|Withdrawal by Subject|1|||
27791074|NCT00577382|81065577|FG000|Overall Study|Progressive Disease|17|||
27791075|NCT00577382|81065578|FG001|Overall Study|Progressive Disease|19|||
27791076|NCT00577382|81065577|FG000|Overall Study|Intercurrent Illness|1|||
27791077|NCT00577382|81065578|FG001|Overall Study|Intercurrent Illness|2|||
27791078|NCT00577382|81065577|FG000|Overall Study|Death|1|||
27791079|NCT00577382|81065578|FG001|Overall Study|Death|1|||
27791080|NCT00577382|81065577|FG000|Overall Study|Lost to Follow-up|2|||
27791081|NCT00577382|81065578|FG001|Overall Study|Lost to Follow-up|2|||
27791082|NCT01798056|81065579|FG000|Overall Study|Serious Adverse Event|13|||
27791083|NCT01798056|81065580|FG001|Overall Study|Serious Adverse Event|12|||
27791084|NCT01798056|81065579|FG000|Overall Study|Withdrawal by Subject|12|||
27791085|NCT01798056|81065580|FG001|Overall Study|Withdrawal by Subject|9|||
27791086|NCT01798056|81065579|FG000|Overall Study|Migrated/moved from study area|1|||
27791087|NCT01798056|81065580|FG001|Overall Study|Migrated/moved from study area|1|||
27791088|NCT01798056|81065579|FG000|Overall Study|Lost to Follow-up|1|||
27791089|NCT01798056|81065580|FG001|Overall Study|Lost to Follow-up|1|||
27791090|NCT01798056|81065579|FG000|Overall Study|Other|0|||
27791091|NCT01798056|81065580|FG001|Overall Study|Other|2|||
27791092|NCT01541644|81065581|FG000|Overall Study|Withdrawal by Subject|3|||
27791093|NCT00536991|81065584|FG000|Overall Study|Withdrawal by Subject|10|||
27791094|NCT00536991|81065584|FG000|Overall Study|Physician Decision|1|||
27791095|NCT00536991|81065584|FG000|Overall Study|patient ineligible|2|||
27791096|NCT00859313|81065588|FG000|Overall Study|Lack of Efficacy|2|||
27791097|NCT00859313|81065588|FG000|Overall Study|Adverse Event|1|||
27791098|NCT00859313|81065588|FG000|Overall Study|staff error|1|||
27791099|NCT04640168|81065589|FG000|Overall Study|Withdrawal by Subject|8|||
27791100|NCT04640168|81065590|FG001|Overall Study|Withdrawal by Subject|7|||
27791101|NCT04640168|81065589|FG000|Overall Study|Lost to Follow-up|1|||
27791102|NCT04640168|81065590|FG001|Overall Study|Lost to Follow-up|0|||
27791103|NCT04640168|81065589|FG000|Overall Study|Enrolled but not treated|12|||
27791104|NCT04640168|81065590|FG001|Overall Study|Enrolled but not treated|12|||
27791105|NCT02325739|81065591|FG000|Phase I Part|Adverse Event|1|||
27791106|NCT02325739|81065592|FG001|Phase I Part|Adverse Event|0|||
27791107|NCT02325739|81065593|FG002|Phase I Part|Adverse Event|1|||
27791108|NCT02325739|81065594|FG003|Phase I Part|Adverse Event|2|||
27791109|NCT02325739|81065595|FG004|Phase I Part|Adverse Event|3|||
27791110|NCT02325739|81065596|FG005|Phase I Part|Adverse Event|1|||
27791111|NCT02325739|81065597|FG006|Phase I Part|Adverse Event|0|||
27791112|NCT02325739|81065598|FG007|Phase I Part|Adverse Event|2|||
27791113|NCT02325739|81065599|FG008|Phase I Part|Adverse Event|0|||
27791114|NCT02325739|81065600|FG009|Phase I Part|Adverse Event|0|||
27791115|NCT02325739|81065601|FG010|Phase I Part|Adverse Event|0|||
27791116|NCT02325739|81065591|FG000|Phase I Part|Progressive disease|9|||
27791117|NCT02325739|81065592|FG001|Phase I Part|Progressive disease|6|||
27791118|NCT02325739|81065593|FG002|Phase I Part|Progressive disease|3|||
27791119|NCT02325739|81065594|FG003|Phase I Part|Progressive disease|23|||
27791120|NCT02325739|81065595|FG004|Phase I Part|Progressive disease|14|||
27791121|NCT02325739|81065596|FG005|Phase I Part|Progressive disease|6|||
27791122|NCT02325739|81065597|FG006|Phase I Part|Progressive disease|6|||
27791123|NCT02325739|81065598|FG007|Phase I Part|Progressive disease|3|||
27791124|NCT02325739|81065599|FG008|Phase I Part|Progressive disease|0|||
27791125|NCT02325739|81065600|FG009|Phase I Part|Progressive disease|0|||
27791126|NCT02325739|81065601|FG010|Phase I Part|Progressive disease|0|||
27791127|NCT02325739|81065591|FG000|Phase I Part|Subject/guardian decision|1|||
27791128|NCT02325739|81065592|FG001|Phase I Part|Subject/guardian decision|0|||
27791129|NCT02325739|81065593|FG002|Phase I Part|Subject/guardian decision|1|||
27791130|NCT02325739|81065594|FG003|Phase I Part|Subject/guardian decision|1|||
27791131|NCT02325739|81065595|FG004|Phase I Part|Subject/guardian decision|0|||
27791132|NCT02325739|81065596|FG005|Phase I Part|Subject/guardian decision|0|||
27791133|NCT02325739|81065597|FG006|Phase I Part|Subject/guardian decision|0|||
27791134|NCT02325739|81065598|FG007|Phase I Part|Subject/guardian decision|1|||
27791135|NCT02325739|81065599|FG008|Phase I Part|Subject/guardian decision|0|||
27791136|NCT02325739|81065600|FG009|Phase I Part|Subject/guardian decision|0|||
27791137|NCT02325739|81065601|FG010|Phase I Part|Subject/guardian decision|0|||
27791138|NCT02325739|81065591|FG000|Phase I Part|Death|0|||
27791139|NCT02325739|81065592|FG001|Phase I Part|Death|0|||
27791140|NCT02325739|81065593|FG002|Phase I Part|Death|0|||
27791141|NCT02325739|81065594|FG003|Phase I Part|Death|0|||
27791142|NCT02325739|81065595|FG004|Phase I Part|Death|2|||
27791143|NCT02325739|81065596|FG005|Phase I Part|Death|0|||
27791144|NCT02325739|81065597|FG006|Phase I Part|Death|0|||
27791145|NCT02325739|81065598|FG007|Phase I Part|Death|0|||
27791146|NCT02325739|81065599|FG008|Phase I Part|Death|0|||
27791147|NCT02325739|81065600|FG009|Phase I Part|Death|0|||
27791148|NCT02325739|81065601|FG010|Phase I Part|Death|0|||
27791149|NCT02325739|81065591|FG000|Phase II Part|Adverse Event|0|||
27791150|NCT02325739|81065592|FG001|Phase II Part|Adverse Event|0|||
27791151|NCT02325739|81065593|FG002|Phase II Part|Adverse Event|0|||
27791152|NCT02325739|81065594|FG003|Phase II Part|Adverse Event|0|||
27791153|NCT02325739|81065595|FG004|Phase II Part|Adverse Event|0|||
27791154|NCT02325739|81065596|FG005|Phase II Part|Adverse Event|0|||
27791155|NCT02325739|81065597|FG006|Phase II Part|Adverse Event|0|||
27791156|NCT02325739|81065598|FG007|Phase II Part|Adverse Event|0|||
27791157|NCT02325739|81065599|FG008|Phase II Part|Adverse Event|4|||
27791158|NCT02325739|81065600|FG009|Phase II Part|Adverse Event|5|||
27791159|NCT02325739|81065601|FG010|Phase II Part|Adverse Event|1|||
27791160|NCT02325739|81065591|FG000|Phase II Part|Physician Decision|0|||
27791161|NCT02325739|81065592|FG001|Phase II Part|Physician Decision|0|||
27791162|NCT02325739|81065593|FG002|Phase II Part|Physician Decision|0|||
27791163|NCT02325739|81065594|FG003|Phase II Part|Physician Decision|0|||
27867658|NCT03142191|81349677|FG000|Placebo Controlled Period|Other Reasons|1|||
27791164|NCT02325739|81065595|FG004|Phase II Part|Physician Decision|0|||
27791165|NCT02325739|81065596|FG005|Phase II Part|Physician Decision|0|||
27791166|NCT02325739|81065597|FG006|Phase II Part|Physician Decision|0|||
27791167|NCT02325739|81065598|FG007|Phase II Part|Physician Decision|0|||
27791168|NCT02325739|81065599|FG008|Phase II Part|Physician Decision|0|||
27791169|NCT02325739|81065600|FG009|Phase II Part|Physician Decision|1|||
27791170|NCT02325739|81065601|FG010|Phase II Part|Physician Decision|0|||
27791171|NCT02325739|81065591|FG000|Phase II Part|Progressive disease|0|||
27791172|NCT02325739|81065592|FG001|Phase II Part|Progressive disease|0|||
27791173|NCT02325739|81065593|FG002|Phase II Part|Progressive disease|0|||
27791174|NCT02325739|81065594|FG003|Phase II Part|Progressive disease|0|||
27791175|NCT02325739|81065595|FG004|Phase II Part|Progressive disease|0|||
27791176|NCT02325739|81065596|FG005|Phase II Part|Progressive disease|0|||
27791177|NCT02325739|81065597|FG006|Phase II Part|Progressive disease|0|||
27791178|NCT02325739|81065598|FG007|Phase II Part|Progressive disease|0|||
27791179|NCT02325739|81065599|FG008|Phase II Part|Progressive disease|22|||
27791180|NCT02325739|81065600|FG009|Phase II Part|Progressive disease|29|||
27791181|NCT02325739|81065601|FG010|Phase II Part|Progressive disease|18|||
27791182|NCT02325739|81065591|FG000|Phase II Part|Subject/guardian decision|0|||
27791183|NCT02325739|81065592|FG001|Phase II Part|Subject/guardian decision|0|||
27791184|NCT02325739|81065593|FG002|Phase II Part|Subject/guardian decision|0|||
27791185|NCT02325739|81065594|FG003|Phase II Part|Subject/guardian decision|0|||
27791186|NCT02325739|81065595|FG004|Phase II Part|Subject/guardian decision|0|||
27791187|NCT02325739|81065596|FG005|Phase II Part|Subject/guardian decision|0|||
27791188|NCT02325739|81065597|FG006|Phase II Part|Subject/guardian decision|0|||
27791189|NCT02325739|81065598|FG007|Phase II Part|Subject/guardian decision|0|||
27791190|NCT02325739|81065599|FG008|Phase II Part|Subject/guardian decision|4|||
27791191|NCT02325739|81065600|FG009|Phase II Part|Subject/guardian decision|1|||
27791192|NCT02325739|81065601|FG010|Phase II Part|Subject/guardian decision|1|||
27791193|NCT02064231|81065602|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
27791194|NCT02064231|81065603|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
27791195|NCT02064231|81065604|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
27791196|NCT02064231|81065605|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
27791197|NCT02064231|81065602|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
27791198|NCT02064231|81065603|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
27791199|NCT02064231|81065604|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
27791200|NCT02064231|81065605|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
27791201|NCT02064231|81065602|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
27791202|NCT02064231|81065603|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
27791203|NCT02064231|81065604|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
27791204|NCT02064231|81065605|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
27791205|NCT02064231|81065602|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
27791206|NCT02064231|81065603|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
27791207|NCT02064231|81065604|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
27791208|NCT02064231|81065605|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
27791209|NCT02319642|81065607|FG000|Overall Study|Adverse Event|2|||
27791210|NCT02319642|81065608|FG001|Overall Study|Adverse Event|4|||
27791211|NCT02319642|81065607|FG000|Overall Study|Lack of Efficacy|1|||
27791212|NCT02319642|81065608|FG001|Overall Study|Lack of Efficacy|1|||
27791213|NCT02319642|81065607|FG000|Overall Study|Withdrawal by Subject|1|||
27791214|NCT02319642|81065608|FG001|Overall Study|Withdrawal by Subject|1|||
27791215|NCT00627094|81065609|FG000|Overall Study|Adverse Event|8|||
27791216|NCT00627094|81065610|FG001|Overall Study|Adverse Event|7|||
27791217|NCT00627094|81065609|FG000|Overall Study|Lost to Follow-up|1|||
27791218|NCT00627094|81065610|FG001|Overall Study|Lost to Follow-up|0|||
27791219|NCT00627094|81065609|FG000|Overall Study|Withdrawal by Subject|1|||
27791220|NCT00627094|81065610|FG001|Overall Study|Withdrawal by Subject|1|||
27791221|NCT00627094|81065609|FG000|Overall Study|ulcer healed|1|||
27791222|NCT00627094|81065610|FG001|Overall Study|ulcer healed|7|||
27791223|NCT00627094|81065609|FG000|Overall Study|Other reason|1|||
27791224|NCT00627094|81065610|FG001|Overall Study|Other reason|0|||
27791225|NCT02184988|81065611|FG000|Overall Study|Pregnancy|2|||
27791226|NCT02184988|81065611|FG000|Overall Study|Adverse Event|2|||
27791227|NCT02184988|81065611|FG000|Overall Study|moving away/travelling/unable to complet|6|||
27791228|NCT02184988|81065611|FG000|Overall Study|work scheduling issues|4|||
27791229|NCT02184988|81065611|FG000|Overall Study|various other reasons|9|||
27791230|NCT02184988|81065611|FG000|Overall Study|Lost to Follow-up|32|||
27791231|NCT01207219|81065621|FG000|Overall Study|changed diagnosis during study period|5|||
27791232|NCT01207219|81065622|FG001|Overall Study|changed diagnosis during study period|3|||
27791233|NCT01207219|81065623|FG002|Overall Study|changed diagnosis during study period|1|||
27791234|NCT01207219|81065621|FG000|Overall Study|Lost to Follow-up|6|||
27791235|NCT01207219|81065622|FG001|Overall Study|Lost to Follow-up|8|||
27791236|NCT01207219|81065623|FG002|Overall Study|Lost to Follow-up|6|||
27791237|NCT02116309|81065624|FG000|Overall Study|Lost to Follow-up|0|||
27791238|NCT02116309|81065625|FG001|Overall Study|Lost to Follow-up|1|||
27791239|NCT00700115|81065628|FG000|Overall Study|Withdrawal by Subject|1|||
27791240|NCT00700115|81065629|FG001|Overall Study|Withdrawal by Subject|0|||
27791241|NCT00700115|81065628|FG000|Overall Study|Lost to Follow-up|0|||
27791242|NCT00700115|81065629|FG001|Overall Study|Lost to Follow-up|1|||
27791243|NCT01711736|81065630|FG000|Overall Study|Lost to Follow-up|4|||
27791244|NCT01711736|81065631|FG001|Overall Study|Lost to Follow-up|1|||
27791245|NCT01711736|81065630|FG000|Overall Study|Withdrawal by Subject|6|||
27791246|NCT01711736|81065631|FG001|Overall Study|Withdrawal by Subject|6|||
27791247|NCT01711736|81065630|FG000|Overall Study|Migrated/moved from study area|2|||
27791248|NCT01711736|81065631|FG001|Overall Study|Migrated/moved from study area|1|||
27791249|NCT00905437|81065632|FG000|Overall Study|Adverse Event|3|||
27791250|NCT00905437|81065633|FG001|Overall Study|Adverse Event|2|||
27791251|NCT00905437|81065632|FG000|Overall Study|Lost to Follow-up|0|||
27791252|NCT00905437|81065633|FG001|Overall Study|Lost to Follow-up|1|||
27791253|NCT00905437|81065632|FG000|Overall Study|Withdrawal by Subject|0|||
27791254|NCT00905437|81065633|FG001|Overall Study|Withdrawal by Subject|1|||
27791255|NCT00905437|81065632|FG000|Overall Study|Other|5|||
27791256|NCT00905437|81065633|FG001|Overall Study|Other|6|||
27791257|NCT01674010|81065634|FG000|Open Treatment Phase 1|Adverse Event|10|||
27791258|NCT01674010|81065635|FG001|Open Treatment Phase 1|Adverse Event|0|||
27791259|NCT01674010|81065636|FG002|Open Treatment Phase 1|Adverse Event|0|||
27791260|NCT01674010|81065634|FG000|Open Treatment Phase 1|Death|1|||
27791261|NCT01674010|81065635|FG001|Open Treatment Phase 1|Death|0|||
27791262|NCT01674010|81065636|FG002|Open Treatment Phase 1|Death|0|||
27791263|NCT01674010|81065634|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
27791264|NCT01674010|81065635|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
27791265|NCT01674010|81065636|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
27791266|NCT01674010|81065634|FG000|Open Treatment Phase 1|Physician Decision|9|||
27791267|NCT01674010|81065635|FG001|Open Treatment Phase 1|Physician Decision|0|||
27791268|NCT01674010|81065636|FG002|Open Treatment Phase 1|Physician Decision|0|||
27791269|NCT01674010|81065634|FG000|Open Treatment Phase 1|Protocol Violation|7|||
27791270|NCT01674010|81065635|FG001|Open Treatment Phase 1|Protocol Violation|0|||
27791271|NCT01674010|81065636|FG002|Open Treatment Phase 1|Protocol Violation|0|||
27791272|NCT01674010|81065634|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
27791273|NCT01674010|81065635|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
27791274|NCT01674010|81065636|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
27791275|NCT01674010|81065634|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
27791276|NCT01674010|81065635|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
27791277|NCT01674010|81065636|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
27791278|NCT01674010|81065634|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
27791279|NCT01674010|81065635|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
27791280|NCT01674010|81065636|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
27791281|NCT01674010|81065634|FG000|Randomization Phase 2|Adverse Event|0|||
27791282|NCT01674010|81065635|FG001|Randomization Phase 2|Adverse Event|1|||
27791283|NCT01674010|81065636|FG002|Randomization Phase 2|Adverse Event|1|||
27791284|NCT01674010|81065634|FG000|Randomization Phase 2|Lost to Follow-up|0|||
27791285|NCT01674010|81065635|FG001|Randomization Phase 2|Lost to Follow-up|1|||
27791286|NCT01674010|81065636|FG002|Randomization Phase 2|Lost to Follow-up|2|||
27791287|NCT01674010|81065634|FG000|Randomization Phase 2|Mood episode recurrence|0|||
27791288|NCT01674010|81065635|FG001|Randomization Phase 2|Mood episode recurrence|8|||
27791289|NCT01674010|81065636|FG002|Randomization Phase 2|Mood episode recurrence|2|||
27791290|NCT01674010|81065634|FG000|Randomization Phase 2|Physician Decision|0|||
27791291|NCT01674010|81065635|FG001|Randomization Phase 2|Physician Decision|0|||
27791292|NCT01674010|81065636|FG002|Randomization Phase 2|Physician Decision|2|||
27791293|NCT01674010|81065634|FG000|Randomization Phase 2|Pregnancy|0|||
27791294|NCT01674010|81065635|FG001|Randomization Phase 2|Pregnancy|1|||
27791295|NCT01674010|81065636|FG002|Randomization Phase 2|Pregnancy|1|||
27791296|NCT01674010|81065634|FG000|Randomization Phase 2|Protocol Violation|0|||
27791297|NCT01674010|81065635|FG001|Randomization Phase 2|Protocol Violation|1|||
27791298|NCT01674010|81065636|FG002|Randomization Phase 2|Protocol Violation|1|||
27791299|NCT01674010|81065634|FG000|Randomization Phase 2|Sponsor Decision|0|||
27791300|NCT01674010|81065635|FG001|Randomization Phase 2|Sponsor Decision|42|||
27791301|NCT01674010|81065636|FG002|Randomization Phase 2|Sponsor Decision|45|||
27791302|NCT01674010|81065634|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
27791303|NCT01674010|81065635|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
27791304|NCT01674010|81065636|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
27791305|NCT01340794|81065637|FG000|Overall Study|Withdrawal by Subject|0|||
27791306|NCT01340794|81065638|FG001|Overall Study|Withdrawal by Subject|1|||
27791307|NCT05993299|81068967|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
27791308|NCT05993299|81068967|FG000|Overall Study|Ongoing|4|||
27791309|NCT01118949|81068970|FG000|Overall Study|Adverse Event|5|||
27791310|NCT01118949|81068970|FG000|Overall Study|Withdrawal by Subject|4|||
27791311|NCT02946515|81068978|FG000|Overall Study|Lost to Follow-up|2|||
27791312|NCT02946515|81068979|FG001|Overall Study|Lost to Follow-up|1|||
27791313|NCT05182840|81068984|FG000|Run-in Period|Not treated|0|||
27791314|NCT05182840|81068985|FG001|Run-in Period|Not treated|1|||
27791315|NCT05182840|81068986|FG002|Run-in Period|Not treated|0|||
27791316|NCT05182840|81068987|FG003|Run-in Period|Not treated|0|||
27791317|NCT05182840|81068988|FG004|Run-in Period|Not treated|0|||
27791318|NCT05182840|81068989|FG005|Run-in Period|Not treated|0|||
27791319|NCT05182840|81068990|FG006|Run-in Period|Not treated|0|||
27791320|NCT05182840|81068991|FG007|Run-in Period|Not treated|0|||
27791321|NCT05182840|81068992|FG008|Run-in Period|Not treated|0|||
27791322|NCT05182840|81068993|FG009|Run-in Period|Not treated|0|||
27791323|NCT05182840|81068984|FG000|Run-in Period|Other reason but not sponsor termination|14|||
27791324|NCT05182840|81068985|FG001|Run-in Period|Other reason but not sponsor termination|18|||
27791325|NCT05182840|81068986|FG002|Run-in Period|Other reason but not sponsor termination|0|||
27791326|NCT05182840|81068987|FG003|Run-in Period|Other reason but not sponsor termination|0|||
27791327|NCT05182840|81068988|FG004|Run-in Period|Other reason but not sponsor termination|0|||
27791328|NCT05182840|81068989|FG005|Run-in Period|Other reason but not sponsor termination|0|||
27791329|NCT05182840|81068990|FG006|Run-in Period|Other reason but not sponsor termination|0|||
27791330|NCT05182840|81068991|FG007|Run-in Period|Other reason but not sponsor termination|0|||
27791331|NCT05182840|81068992|FG008|Run-in Period|Other reason but not sponsor termination|0|||
27791332|NCT05182840|81068993|FG009|Run-in Period|Other reason but not sponsor termination|0|||
27791333|NCT05182840|81068984|FG000|Run-in Period|No reason available|2|||
27791334|NCT05182840|81068985|FG001|Run-in Period|No reason available|2|||
27791335|NCT05182840|81068986|FG002|Run-in Period|No reason available|0|||
27791336|NCT05182840|81068987|FG003|Run-in Period|No reason available|0|||
27791337|NCT05182840|81068988|FG004|Run-in Period|No reason available|0|||
27791338|NCT05182840|81068989|FG005|Run-in Period|No reason available|0|||
27791339|NCT05182840|81068990|FG006|Run-in Period|No reason available|0|||
27791340|NCT05182840|81068991|FG007|Run-in Period|No reason available|0|||
27791341|NCT05182840|81068992|FG008|Run-in Period|No reason available|0|||
27791342|NCT05182840|81068993|FG009|Run-in Period|No reason available|0|||
27791343|NCT05182840|81068984|FG000|Run-in Period|Burden of study procedures|2|||
27791344|NCT05182840|81068985|FG001|Run-in Period|Burden of study procedures|2|||
27791345|NCT05182840|81068986|FG002|Run-in Period|Burden of study procedures|0|||
27791346|NCT05182840|81068987|FG003|Run-in Period|Burden of study procedures|0|||
27791347|NCT05182840|81068988|FG004|Run-in Period|Burden of study procedures|0|||
27791348|NCT05182840|81068989|FG005|Run-in Period|Burden of study procedures|0|||
27791349|NCT05182840|81068990|FG006|Run-in Period|Burden of study procedures|0|||
27791350|NCT05182840|81068991|FG007|Run-in Period|Burden of study procedures|0|||
27791351|NCT05182840|81068992|FG008|Run-in Period|Burden of study procedures|0|||
27791352|NCT05182840|81068993|FG009|Run-in Period|Burden of study procedures|0|||
27791353|NCT05182840|81068984|FG000|Run-in Period|Change of residence|1|||
27791354|NCT05182840|81068985|FG001|Run-in Period|Change of residence|0|||
27791355|NCT05182840|81068986|FG002|Run-in Period|Change of residence|0|||
27791356|NCT05182840|81068987|FG003|Run-in Period|Change of residence|0|||
27791357|NCT05182840|81068988|FG004|Run-in Period|Change of residence|0|||
27791358|NCT05182840|81068989|FG005|Run-in Period|Change of residence|0|||
27791359|NCT05182840|81068990|FG006|Run-in Period|Change of residence|0|||
27791360|NCT05182840|81068991|FG007|Run-in Period|Change of residence|0|||
27791361|NCT05182840|81068992|FG008|Run-in Period|Change of residence|0|||
27791362|NCT05182840|81068993|FG009|Run-in Period|Change of residence|0|||
27791363|NCT05182840|81068984|FG000|Run-in Period|Adverse Event|5|||
27791364|NCT05182840|81068985|FG001|Run-in Period|Adverse Event|5|||
27791365|NCT05182840|81068986|FG002|Run-in Period|Adverse Event|0|||
27791366|NCT05182840|81068987|FG003|Run-in Period|Adverse Event|0|||
27791367|NCT05182840|81068988|FG004|Run-in Period|Adverse Event|0|||
27791368|NCT05182840|81068989|FG005|Run-in Period|Adverse Event|0|||
27791369|NCT05182840|81068990|FG006|Run-in Period|Adverse Event|0|||
27791370|NCT05182840|81068991|FG007|Run-in Period|Adverse Event|0|||
27791371|NCT05182840|81068992|FG008|Run-in Period|Adverse Event|0|||
27791372|NCT05182840|81068993|FG009|Run-in Period|Adverse Event|0|||
27791373|NCT05182840|81068984|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
27791374|NCT05182840|81068985|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
27791375|NCT05182840|81068986|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791376|NCT05182840|81068987|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791377|NCT05182840|81068988|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791378|NCT05182840|81068989|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791379|NCT05182840|81068990|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791380|NCT05182840|81068991|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791381|NCT05182840|81068992|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791382|NCT05182840|81068993|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
27791383|NCT05182840|81068984|FG000|Treatment Period|Reason missing|0|||
27791384|NCT05182840|81068985|FG001|Treatment Period|Reason missing|0|||
27791385|NCT05182840|81068986|FG002|Treatment Period|Reason missing|1|||
27791386|NCT05182840|81068987|FG003|Treatment Period|Reason missing|0|||
27791387|NCT05182840|81068988|FG004|Treatment Period|Reason missing|0|||
27791388|NCT05182840|81068989|FG005|Treatment Period|Reason missing|0|||
27791389|NCT05182840|81068990|FG006|Treatment Period|Reason missing|0|||
27791390|NCT05182840|81068991|FG007|Treatment Period|Reason missing|0|||
27791391|NCT05182840|81068992|FG008|Treatment Period|Reason missing|0|||
27791392|NCT05182840|81068993|FG009|Treatment Period|Reason missing|0|||
27791393|NCT05182840|81068984|FG000|Treatment Period|Other but not sponsor termination|0|||
27791394|NCT05182840|81068985|FG001|Treatment Period|Other but not sponsor termination|0|||
27791395|NCT05182840|81068986|FG002|Treatment Period|Other but not sponsor termination|8|||
27791396|NCT05182840|81068987|FG003|Treatment Period|Other but not sponsor termination|6|||
27791397|NCT05182840|81068988|FG004|Treatment Period|Other but not sponsor termination|6|||
27791398|NCT05182840|81068989|FG005|Treatment Period|Other but not sponsor termination|7|||
27791399|NCT05182840|81068990|FG006|Treatment Period|Other but not sponsor termination|5|||
27791400|NCT05182840|81068991|FG007|Treatment Period|Other but not sponsor termination|8|||
27791401|NCT05182840|81068992|FG008|Treatment Period|Other but not sponsor termination|7|||
27791402|NCT05182840|81068993|FG009|Treatment Period|Other but not sponsor termination|2|||
27791403|NCT05182840|81068984|FG000|Treatment Period|Protocol deviation|0|||
27791404|NCT05182840|81068985|FG001|Treatment Period|Protocol deviation|0|||
27791405|NCT05182840|81068986|FG002|Treatment Period|Protocol deviation|0|||
27791406|NCT05182840|81068987|FG003|Treatment Period|Protocol deviation|0|||
27791407|NCT05182840|81068988|FG004|Treatment Period|Protocol deviation|0|||
27791408|NCT05182840|81068989|FG005|Treatment Period|Protocol deviation|0|||
27791409|NCT05182840|81068990|FG006|Treatment Period|Protocol deviation|0|||
27791410|NCT05182840|81068991|FG007|Treatment Period|Protocol deviation|0|||
27791411|NCT05182840|81068992|FG008|Treatment Period|Protocol deviation|1|||
27791412|NCT05182840|81068993|FG009|Treatment Period|Protocol deviation|0|||
27791413|NCT05182840|81068984|FG000|Treatment Period|No reason available|0|||
27791414|NCT05182840|81068985|FG001|Treatment Period|No reason available|0|||
27791415|NCT05182840|81068986|FG002|Treatment Period|No reason available|0|||
27791416|NCT05182840|81068987|FG003|Treatment Period|No reason available|1|||
27791417|NCT05182840|81068988|FG004|Treatment Period|No reason available|0|||
27791418|NCT05182840|81068989|FG005|Treatment Period|No reason available|2|||
27791419|NCT05182840|81068990|FG006|Treatment Period|No reason available|0|||
27791420|NCT05182840|81068991|FG007|Treatment Period|No reason available|1|||
27791421|NCT05182840|81068992|FG008|Treatment Period|No reason available|0|||
27791422|NCT05182840|81068993|FG009|Treatment Period|No reason available|0|||
27791423|NCT05182840|81068984|FG000|Treatment Period|Burden of study procedures|0|||
27791424|NCT05182840|81068985|FG001|Treatment Period|Burden of study procedures|0|||
27791425|NCT05182840|81068986|FG002|Treatment Period|Burden of study procedures|0|||
27791426|NCT05182840|81068987|FG003|Treatment Period|Burden of study procedures|0|||
27791427|NCT05182840|81068988|FG004|Treatment Period|Burden of study procedures|1|||
27791428|NCT05182840|81068989|FG005|Treatment Period|Burden of study procedures|0|||
27791429|NCT05182840|81068990|FG006|Treatment Period|Burden of study procedures|0|||
27791430|NCT05182840|81068991|FG007|Treatment Period|Burden of study procedures|0|||
27791431|NCT05182840|81068992|FG008|Treatment Period|Burden of study procedures|0|||
27791432|NCT05182840|81068993|FG009|Treatment Period|Burden of study procedures|0|||
27791433|NCT05182840|81068984|FG000|Treatment Period|Change of residence|0|||
27791434|NCT05182840|81068985|FG001|Treatment Period|Change of residence|0|||
27791435|NCT05182840|81068986|FG002|Treatment Period|Change of residence|0|||
27791436|NCT05182840|81068987|FG003|Treatment Period|Change of residence|0|||
27791437|NCT05182840|81068988|FG004|Treatment Period|Change of residence|0|||
27791438|NCT05182840|81068989|FG005|Treatment Period|Change of residence|1|||
27791439|NCT05182840|81068990|FG006|Treatment Period|Change of residence|0|||
27791440|NCT05182840|81068991|FG007|Treatment Period|Change of residence|0|||
27791441|NCT05182840|81068992|FG008|Treatment Period|Change of residence|0|||
27791442|NCT05182840|81068993|FG009|Treatment Period|Change of residence|0|||
27791443|NCT05182840|81068984|FG000|Treatment Period|Adverse Event|0|||
27791444|NCT05182840|81068985|FG001|Treatment Period|Adverse Event|0|||
27791445|NCT05182840|81068986|FG002|Treatment Period|Adverse Event|4|||
27791446|NCT05182840|81068987|FG003|Treatment Period|Adverse Event|16|||
27791447|NCT05182840|81068988|FG004|Treatment Period|Adverse Event|12|||
27791448|NCT05182840|81068989|FG005|Treatment Period|Adverse Event|6|||
27791449|NCT05182840|81068990|FG006|Treatment Period|Adverse Event|4|||
27791450|NCT05182840|81068991|FG007|Treatment Period|Adverse Event|8|||
27791451|NCT05182840|81068992|FG008|Treatment Period|Adverse Event|16|||
27791452|NCT05182840|81068993|FG009|Treatment Period|Adverse Event|5|||
27791453|NCT05182840|81068984|FG000|Treatment Period|Not treated with study drug|0|||
27791454|NCT05182840|81068985|FG001|Treatment Period|Not treated with study drug|0|||
27791455|NCT05182840|81068986|FG002|Treatment Period|Not treated with study drug|0|||
27791456|NCT05182840|81068987|FG003|Treatment Period|Not treated with study drug|1|||
27791457|NCT05182840|81068988|FG004|Treatment Period|Not treated with study drug|0|||
27791458|NCT05182840|81068989|FG005|Treatment Period|Not treated with study drug|0|||
27791459|NCT05182840|81068990|FG006|Treatment Period|Not treated with study drug|1|||
27791460|NCT05182840|81068991|FG007|Treatment Period|Not treated with study drug|1|||
27791461|NCT05182840|81068992|FG008|Treatment Period|Not treated with study drug|0|||
27791462|NCT05182840|81068993|FG009|Treatment Period|Not treated with study drug|0|||
27791463|NCT00650806|81068995|FG000|Overall Study|Adverse Event|0|||
27791464|NCT00650806|81068996|FG001|Overall Study|Adverse Event|5|||
27791465|NCT00650806|81068997|FG002|Overall Study|Adverse Event|3|||
27791466|NCT00650806|81068998|FG003|Overall Study|Adverse Event|4|||
27791467|NCT00650806|81068995|FG000|Overall Study|Lost to Follow-up|7|||
27791468|NCT00650806|81068996|FG001|Overall Study|Lost to Follow-up|6|||
27791469|NCT00650806|81068997|FG002|Overall Study|Lost to Follow-up|11|||
27791470|NCT00650806|81068998|FG003|Overall Study|Lost to Follow-up|10|||
27791471|NCT00650806|81068995|FG000|Overall Study|Protocol Violation|0|||
27791472|NCT00650806|81068996|FG001|Overall Study|Protocol Violation|0|||
27791473|NCT00650806|81068997|FG002|Overall Study|Protocol Violation|0|||
27791474|NCT00650806|81068998|FG003|Overall Study|Protocol Violation|1|||
27791475|NCT00650806|81068995|FG000|Overall Study|Pregnancy|0|||
27978220|NCT00235391|81753241|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
27978221|NCT00235391|81753242|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
27574472|NCT00098839|80289049|FG001|Overall Study|Withdrawal by Subject|0|||
27574473|NCT00098839|80289048|FG000|Overall Study|Refusal of further protocol therapy|3|||
27574474|NCT00098839|80289049|FG001|Overall Study|Refusal of further protocol therapy|1|||
27574475|NCT00098839|80289048|FG000|Overall Study|Relapse|6|||
27574476|NCT00098839|80289049|FG001|Overall Study|Relapse|3|||
27978222|NCT00235391|81753237|FG000|Overall Study|Condition no longer requires treatment|3|||
27978223|NCT00235391|81753238|FG001|Overall Study|Condition no longer requires treatment|0|||
27978224|NCT00235391|81753239|FG002|Overall Study|Condition no longer requires treatment|0|||
27978225|NCT00235391|81753240|FG003|Overall Study|Condition no longer requires treatment|11|||
27574477|NCT00098839|80289048|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
27574478|NCT00098839|80289049|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
27574479|NCT00098839|80289048|FG000|Overall Study|Ineligible|2|||
27574480|NCT00098839|80289049|FG001|Overall Study|Ineligible|0|||
27574481|NCT04300296|80289052|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
27574482|NCT04300296|80289053|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
27574483|NCT04300296|80289054|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
27574484|NCT04300296|80289055|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
27574485|NCT04300296|80289056|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
27574486|NCT04300296|80289057|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
27574487|NCT04300296|80289052|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
27574488|NCT04300296|80289053|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
27574489|NCT04300296|80289054|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
27574490|NCT04300296|80289055|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
27574491|NCT04300296|80289056|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
27574492|NCT04300296|80289057|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
27574493|NCT04300296|80289052|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
27574494|NCT04300296|80289053|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
27574495|NCT04300296|80289054|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
27574496|NCT04300296|80289055|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
27574497|NCT04300296|80289056|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
27574498|NCT04300296|80289057|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
27574499|NCT04300296|80289052|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
27574500|NCT04300296|80289053|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
27791476|NCT00650806|81068996|FG001|Overall Study|Pregnancy|0|||
27791477|NCT00650806|81068997|FG002|Overall Study|Pregnancy|0|||
27791478|NCT00650806|81068998|FG003|Overall Study|Pregnancy|1|||
27791479|NCT00650806|81068995|FG000|Overall Study|Withdrawal by Subject|7|||
27978226|NCT00235391|81753241|FG004|Overall Study|Condition no longer requires treatment|1|||
27978227|NCT00235391|81753242|FG005|Overall Study|Condition no longer requires treatment|0|||
27574501|NCT04300296|80289054|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
27574502|NCT04300296|80289055|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
27574503|NCT04300296|80289056|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
27791480|NCT00650806|81068996|FG001|Overall Study|Withdrawal by Subject|5|||
27791481|NCT00650806|81068997|FG002|Overall Study|Withdrawal by Subject|8|||
27791482|NCT00650806|81068998|FG003|Overall Study|Withdrawal by Subject|6|||
27791483|NCT00650806|81068995|FG000|Overall Study|Noncompliance with study drug regimen|1|||
27978228|NCT00235391|81753237|FG000|Overall Study|Protocol deviation|0|||
27978229|NCT00235391|81753238|FG001|Overall Study|Protocol deviation|0|||
27672372|NCT03004404|80639190|FG014|Period 2|Adverse Event|0|||
27672373|NCT03004404|80639191|FG015|Period 2|Adverse Event|1|||
27672374|NCT02706847|80639192|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
27672375|NCT02706847|80639193|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
27672376|NCT02706847|80639194|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
27672377|NCT02706847|80639195|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
27672378|NCT02706847|80639192|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
27672379|NCT02706847|80639193|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
27672380|NCT02706847|80639194|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
27672381|NCT02706847|80639195|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
27672382|NCT02706847|80639192|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
27672383|NCT02706847|80639193|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
27672384|NCT02706847|80639194|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
27672385|NCT02706847|80639195|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
27672386|NCT02706847|80639192|FG000|Period 1: Day 1 to Week 12|Other|4|||
27672387|NCT02706847|80639193|FG001|Period 1: Day 1 to Week 12|Other|4|||
27672388|NCT02706847|80639194|FG002|Period 1: Day 1 to Week 12|Other|2|||
27672389|NCT02706847|80639195|FG003|Period 1: Day 1 to Week 12|Other|2|||
27672390|NCT02706847|80639192|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
27672391|NCT02706847|80639193|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
27672392|NCT02706847|80639194|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
27672393|NCT02706847|80639195|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
27672394|NCT02706847|80639192|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
27672395|NCT02706847|80639193|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
27978230|NCT00235391|81753239|FG002|Overall Study|Protocol deviation|1|||
27978231|NCT00235391|81753240|FG003|Overall Study|Protocol deviation|11|||
27978232|NCT00235391|81753241|FG004|Overall Study|Protocol deviation|0|||
27672396|NCT02706847|80639194|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
27672397|NCT02706847|80639195|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
27978233|NCT00235391|81753242|FG005|Overall Study|Protocol deviation|0|||
27978234|NCT00235391|81753237|FG000|Overall Study|Withdrawal by Subject|2|||
27978235|NCT00235391|81753238|FG001|Overall Study|Withdrawal by Subject|3|||
27978236|NCT00235391|81753239|FG002|Overall Study|Withdrawal by Subject|3|||
27978237|NCT00235391|81753240|FG003|Overall Study|Withdrawal by Subject|61|||
27978238|NCT00235391|81753241|FG004|Overall Study|Withdrawal by Subject|5|||
27978239|NCT00235391|81753242|FG005|Overall Study|Withdrawal by Subject|0|||
27672398|NCT02706847|80639192|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
27672399|NCT02706847|80639193|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
27672400|NCT02706847|80639194|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
27672401|NCT02706847|80639195|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
27672402|NCT02706847|80639192|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
27672403|NCT02706847|80639193|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
27672404|NCT02706847|80639194|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
27672405|NCT02706847|80639195|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
27672406|NCT02706847|80639192|FG000|Period 1: Week 12 to Week 24|Other|1|||
27672407|NCT02706847|80639193|FG001|Period 1: Week 12 to Week 24|Other|0|||
27672408|NCT02706847|80639194|FG002|Period 1: Week 12 to Week 24|Other|1|||
27672409|NCT02706847|80639195|FG003|Period 1: Week 12 to Week 24|Other|4|||
27672410|NCT02706847|80639192|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
27672411|NCT02706847|80639193|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
27672412|NCT02706847|80639194|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
27672413|NCT02706847|80639195|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
27672414|NCT02706847|80639192|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
27672415|NCT02706847|80639193|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
27672416|NCT02706847|80639194|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
27672417|NCT02706847|80639195|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
27672418|NCT02706847|80639192|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
27672419|NCT02706847|80639193|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
27672420|NCT02706847|80639194|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
27672421|NCT02706847|80639195|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
27791484|NCT00650806|81068996|FG001|Overall Study|Noncompliance with study drug regimen|1|||
27791485|NCT00650806|81068997|FG002|Overall Study|Noncompliance with study drug regimen|0|||
27978240|NCT00235391|81753237|FG000|Overall Study|Lost to Follow-up|0|||
27978241|NCT00235391|81753238|FG001|Overall Study|Lost to Follow-up|3|||
27978242|NCT00235391|81753239|FG002|Overall Study|Lost to Follow-up|3|||
27672422|NCT02706847|80639192|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
27672423|NCT02706847|80639193|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
27672424|NCT02706847|80639194|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
27672425|NCT02706847|80639195|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
27672426|NCT02706847|80639192|FG000|Period 2: Week 24 to Week 260|Other|8|||
27672427|NCT02706847|80639193|FG001|Period 2: Week 24 to Week 260|Other|5|||
27978243|NCT00235391|81753240|FG003|Overall Study|Lost to Follow-up|16|||
27574504|NCT04300296|80289057|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
27574505|NCT04300296|80289052|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
27574506|NCT04300296|80289053|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
27574507|NCT04300296|80289054|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
27574508|NCT04300296|80289055|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
27574509|NCT04300296|80289056|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
27574510|NCT04300296|80289057|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
27574511|NCT04300296|80289052|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
27978244|NCT00235391|81753241|FG004|Overall Study|Lost to Follow-up|0|||
27574512|NCT04300296|80289053|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
27574513|NCT04300296|80289054|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
27672428|NCT02706847|80639194|FG002|Period 2: Week 24 to Week 260|Other|15|||
27791486|NCT00650806|81068998|FG003|Overall Study|Noncompliance with study drug regimen|0|||
27791487|NCT00650806|81068995|FG000|Overall Study|Study terminated by sponsor|2|||
27791488|NCT00650806|81068996|FG001|Overall Study|Study terminated by sponsor|3|||
27791489|NCT00650806|81068997|FG002|Overall Study|Study terminated by sponsor|5|||
27791490|NCT00650806|81068998|FG003|Overall Study|Study terminated by sponsor|4|||
27791491|NCT00650806|81068995|FG000|Overall Study|Other|1|||
27791492|NCT00650806|81068996|FG001|Overall Study|Other|1|||
27791493|NCT00650806|81068997|FG002|Overall Study|Other|2|||
27791494|NCT00650806|81068998|FG003|Overall Study|Other|0|||
27791495|NCT01458535|81068999|FG000|Overall Study|Other|0|||
27791496|NCT01458535|81069000|FG001|Overall Study|Other|0|||
27791497|NCT01458535|81069001|FG002|Overall Study|Other|0|||
27791498|NCT01458535|81069002|FG003|Overall Study|Other|0|||
27791499|NCT01458535|81069003|FG004|Overall Study|Other|1|||
27791500|NCT01458535|81069004|FG005|Overall Study|Other|1|||
27791501|NCT01458535|81068999|FG000|Overall Study|Withdrawal by Subject|0|||
27791502|NCT01458535|81069000|FG001|Overall Study|Withdrawal by Subject|0|||
27791503|NCT01458535|81069001|FG002|Overall Study|Withdrawal by Subject|2|||
27791504|NCT01458535|81069002|FG003|Overall Study|Withdrawal by Subject|0|||
27791505|NCT01458535|81069003|FG004|Overall Study|Withdrawal by Subject|1|||
27791506|NCT01458535|81069004|FG005|Overall Study|Withdrawal by Subject|1|||
27791507|NCT01458535|81068999|FG000|Overall Study|Lost to Follow-up|0|||
27791508|NCT01458535|81069000|FG001|Overall Study|Lost to Follow-up|2|||
27791509|NCT01458535|81069001|FG002|Overall Study|Lost to Follow-up|0|||
27791510|NCT01458535|81069002|FG003|Overall Study|Lost to Follow-up|3|||
27791511|NCT01458535|81069003|FG004|Overall Study|Lost to Follow-up|2|||
27791512|NCT01458535|81069004|FG005|Overall Study|Lost to Follow-up|2|||
27791513|NCT01458535|81068999|FG000|Overall Study|Adverse Event|0|||
27791514|NCT01458535|81069000|FG001|Overall Study|Adverse Event|0|||
27791515|NCT01458535|81069001|FG002|Overall Study|Adverse Event|0|||
27791516|NCT01458535|81069002|FG003|Overall Study|Adverse Event|1|||
27978245|NCT00235391|81753242|FG005|Overall Study|Lost to Follow-up|0|||
27978246|NCT00235391|81753237|FG000|Overall Study|Administrative problems|0|||
27978247|NCT00235391|81753238|FG001|Overall Study|Administrative problems|0|||
27978248|NCT00235391|81753239|FG002|Overall Study|Administrative problems|0|||
27672429|NCT02706847|80639195|FG003|Period 2: Week 24 to Week 260|Other|15|||
27672430|NCT01210651|80639196|FG000|Overall Study|Lost to Follow-up|1|||
27672431|NCT01210651|80639197|FG001|Overall Study|Lost to Follow-up|1|||
27672432|NCT01210651|80639196|FG000|Overall Study|schedule conflicts|1|||
27672433|NCT01210651|80639197|FG001|Overall Study|schedule conflicts|5|||
27672434|NCT01210651|80639196|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
27672435|NCT01210651|80639197|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
27672436|NCT01210651|80639196|FG000|Overall Study|Withdrawal by Subject|1|||
27672437|NCT01210651|80639197|FG001|Overall Study|Withdrawal by Subject|1|||
27672438|NCT01210651|80639196|FG000|Overall Study|Injury outside study|2|||
27672439|NCT01210651|80639197|FG001|Overall Study|Injury outside study|0|||
27672440|NCT02296892|80639199|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
27672441|NCT02296892|80639200|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
27672442|NCT02296892|80639201|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
27791517|NCT01458535|81069003|FG004|Overall Study|Adverse Event|0|||
27791518|NCT01458535|81069004|FG005|Overall Study|Adverse Event|0|||
27791519|NCT01301625|81069005|FG000|Overall Study|Death|5|||
27791520|NCT01301625|81069005|FG000|Overall Study|Not Due|21|||
27791521|NCT01301625|81069005|FG000|Overall Study|Expected|8|||
27978249|NCT00235391|81753240|FG003|Overall Study|Administrative problems|1|||
27978250|NCT00235391|81753241|FG004|Overall Study|Administrative problems|0|||
27672443|NCT02296892|80639199|FG000|Overall Study|Lost to Follow-up|5|||
27791522|NCT01301625|81069005|FG000|Overall Study|Lost to Follow-up|1|||
27791523|NCT03602976|81069006|FG000|Overall Study|Withdrawal by Subject|1|||
27791524|NCT02222246|81069009|FG000|Overall Study|No Emergency Department Visits|27|||
27791525|NCT02222246|81069010|FG001|Overall Study|No Emergency Department Visits|26|||
27791526|NCT02222246|81069009|FG000|Overall Study|Physician Decision|0|||
27791527|NCT02222246|81069010|FG001|Overall Study|Physician Decision|1|||
27791528|NCT00674440|81069012|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
27672444|NCT02296892|80639200|FG001|Overall Study|Lost to Follow-up|0|||
27672445|NCT02296892|80639201|FG002|Overall Study|Lost to Follow-up|1|||
27672446|NCT02287233|80639204|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
27672447|NCT02287233|80639205|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
27672448|NCT02287233|80639206|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
27672449|NCT02287233|80639204|FG000|Overall Study|Adverse Event Related to Progression|0|||
27672450|NCT02287233|80639205|FG001|Overall Study|Adverse Event Related to Progression|2|||
27672451|NCT02287233|80639206|FG002|Overall Study|Adverse Event Related to Progression|8|||
27672452|NCT02287233|80639204|FG000|Overall Study|Physician Decision|1|||
27672453|NCT02287233|80639205|FG001|Overall Study|Physician Decision|2|||
27672454|NCT02287233|80639206|FG002|Overall Study|Physician Decision|4|||
27672455|NCT02287233|80639204|FG000|Overall Study|Progressive Disease with Death|0|||
27672456|NCT02287233|80639205|FG001|Overall Study|Progressive Disease with Death|0|||
27672457|NCT02287233|80639206|FG002|Overall Study|Progressive Disease with Death|10|||
27672458|NCT02287233|80639204|FG000|Overall Study|Progressive Disease Without Death|2|||
27672459|NCT02287233|80639205|FG001|Overall Study|Progressive Disease Without Death|3|||
27672460|NCT02287233|80639206|FG002|Overall Study|Progressive Disease Without Death|20|||
27672461|NCT02287233|80639204|FG000|Overall Study|Withdrawal by Subject|1|||
27672462|NCT02287233|80639205|FG001|Overall Study|Withdrawal by Subject|1|||
27672463|NCT02287233|80639206|FG002|Overall Study|Withdrawal by Subject|7|||
27672464|NCT02287233|80639204|FG000|Overall Study|Other|3|||
27672465|NCT02287233|80639205|FG001|Overall Study|Other|0|||
27672466|NCT02287233|80639206|FG002|Overall Study|Other|15|||
27672467|NCT02287233|80639204|FG000|Overall Study|Did Not Receive Treatment|0|||
27672468|NCT02287233|80639205|FG001|Overall Study|Did Not Receive Treatment|0|||
27672469|NCT02287233|80639206|FG002|Overall Study|Did Not Receive Treatment|2|||
27672470|NCT01426347|80639207|FG000|Overall Study|Lost to Follow-up|0|||
27672471|NCT01426347|80639208|FG001|Overall Study|Lost to Follow-up|3|||
27672472|NCT01426347|80639207|FG000|Overall Study|Protocol Violation|2|||
27672473|NCT01426347|80639208|FG001|Overall Study|Protocol Violation|0|||
27672474|NCT01426347|80639207|FG000|Overall Study|Withdrawal by Subject|5|||
27672475|NCT01426347|80639208|FG001|Overall Study|Withdrawal by Subject|0|||
27672476|NCT01677299|80639209|FG000|Overall Study|Adverse Event|0|||
27672477|NCT01677299|80639210|FG001|Overall Study|Adverse Event|2|||
27672478|NCT01677299|80639211|FG002|Overall Study|Adverse Event|1|||
27672479|NCT01677299|80639212|FG003|Overall Study|Adverse Event|0|||
27672480|NCT01677299|80639209|FG000|Overall Study|Withdrawal by Subject|0|||
27672481|NCT01677299|80639210|FG001|Overall Study|Withdrawal by Subject|1|||
27672482|NCT01677299|80639211|FG002|Overall Study|Withdrawal by Subject|0|||
27672483|NCT01677299|80639212|FG003|Overall Study|Withdrawal by Subject|1|||
27672484|NCT02402322|80639213|FG000|Pretreatment|Withdrawal by Subject|3|||
27672485|NCT02402322|80639214|FG001|Pretreatment|Withdrawal by Subject|1|||
27672486|NCT02402322|80639215|FG002|Pretreatment|Withdrawal by Subject|1|||
27672487|NCT02402322|80639213|FG000|Follow-up|Withdrawal by Subject|6|||
27672488|NCT02402322|80639214|FG001|Follow-up|Withdrawal by Subject|3|||
27672489|NCT02402322|80639215|FG002|Follow-up|Withdrawal by Subject|24|||
27672490|NCT02466243|80639216|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
27672491|NCT02466243|80639217|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
27672492|NCT02466243|80639216|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
27672493|NCT02466243|80639217|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
27672494|NCT02466243|80639216|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
27672495|NCT02466243|80639217|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
27672496|NCT02466243|80639216|FG000|Part B Open-label Treatment Period|Missing|2|||
27672497|NCT02466243|80639217|FG001|Part B Open-label Treatment Period|Missing|2|||
27672498|NCT01436305|80639219|FG000|Overall Study|Death|1|||
27672499|NCT01436305|80639220|FG001|Overall Study|Death|0|||
27672500|NCT01436305|80639221|FG002|Overall Study|Death|0|||
27672501|NCT01436305|80639219|FG000|Overall Study|Lost to Follow-up|0|||
27672502|NCT01436305|80639220|FG001|Overall Study|Lost to Follow-up|1|||
27672503|NCT01436305|80639221|FG002|Overall Study|Lost to Follow-up|0|||
27672504|NCT01436305|80639219|FG000|Overall Study|Withdrawal by Subject|1|||
27672505|NCT01436305|80639220|FG001|Overall Study|Withdrawal by Subject|3|||
27672506|NCT01436305|80639221|FG002|Overall Study|Withdrawal by Subject|0|||
27672507|NCT02719743|80639222|FG000|Overall Study|Consent withdrawal|0|||
27672508|NCT02719743|80639223|FG001|Overall Study|Consent withdrawal|2|||
27672509|NCT02719743|80639224|FG002|Overall Study|Consent withdrawal|0|||
27672510|NCT02719743|80639225|FG003|Overall Study|Consent withdrawal|1|||
27672511|NCT02719743|80639226|FG004|Overall Study|Consent withdrawal|0|||
27672512|NCT02719743|80639222|FG000|Overall Study|Migrated/moved from study area|0|||
27672513|NCT02719743|80639223|FG001|Overall Study|Migrated/moved from study area|0|||
27672514|NCT02719743|80639224|FG002|Overall Study|Migrated/moved from study area|0|||
27672515|NCT02719743|80639225|FG003|Overall Study|Migrated/moved from study area|0|||
27672516|NCT02719743|80639226|FG004|Overall Study|Migrated/moved from study area|2|||
27672517|NCT02719743|80639222|FG000|Overall Study|Lost to Follow-up|1|||
27672518|NCT02719743|80639223|FG001|Overall Study|Lost to Follow-up|1|||
27791529|NCT00674440|81069012|FG000|Overall Study|did not have surgery, so unevaluable|7|||
27791530|NCT00674440|81069012|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
27791531|NCT00145795|81069013|FG000|Overall Study|Adverse Event|1|||
27791532|NCT00145795|81069014|FG001|Overall Study|Adverse Event|0|||
27791533|NCT03735680|81069015|FG000|Overall Study|Withdrawal by Subject|0|||
27791534|NCT03735680|81069016|FG001|Overall Study|Withdrawal by Subject|1|||
27791535|NCT03735680|81069017|FG002|Overall Study|Withdrawal by Subject|0|||
27791536|NCT03735680|81069018|FG003|Overall Study|Withdrawal by Subject|0|||
27791537|NCT03735680|81069019|FG004|Overall Study|Withdrawal by Subject|0|||
27791538|NCT03735680|81069020|FG005|Overall Study|Withdrawal by Subject|1|||
27791539|NCT03735680|81069015|FG000|Overall Study|Patient unable or unwilling to continue|0|||
27791540|NCT03735680|81069016|FG001|Overall Study|Patient unable or unwilling to continue|0|||
27791541|NCT03735680|81069017|FG002|Overall Study|Patient unable or unwilling to continue|1|||
27791542|NCT03735680|81069018|FG003|Overall Study|Patient unable or unwilling to continue|0|||
27791543|NCT03735680|81069019|FG004|Overall Study|Patient unable or unwilling to continue|0|||
27791544|NCT03735680|81069020|FG005|Overall Study|Patient unable or unwilling to continue|0|||
27791545|NCT03878108|81069021|FG000|Overall Study|Adverse Event|1|||
27791546|NCT03878108|81069022|FG001|Overall Study|Adverse Event|0|||
27791547|NCT00124709|81069023|FG000|Overall Study|Randomized but did not take medication|3|||
27791548|NCT00124709|81069024|FG001|Overall Study|Randomized but did not take medication|1|||
27791549|NCT00124709|81069023|FG000|Overall Study|Adverse Event|3|||
27791550|NCT00124709|81069024|FG001|Overall Study|Adverse Event|0|||
27791551|NCT00124709|81069023|FG000|Overall Study|Lack of Efficacy|5|||
27791552|NCT00124709|81069024|FG001|Overall Study|Lack of Efficacy|10|||
27791553|NCT00124709|81069023|FG000|Overall Study|Protocol Violation|3|||
27791554|NCT00124709|81069024|FG001|Overall Study|Protocol Violation|5|||
27791555|NCT00124709|81069023|FG000|Overall Study|Withdrawal by Subject|127|||
27791556|NCT00124709|81069024|FG001|Overall Study|Withdrawal by Subject|136|||
27791557|NCT00124709|81069023|FG000|Overall Study|Lost to Follow-up|114|||
27791558|NCT00124709|81069024|FG001|Overall Study|Lost to Follow-up|120|||
27791559|NCT00593385|81069025|FG000|Overall Study|Death|14|||
27791560|NCT00593385|81069025|FG000|Overall Study|Lost to Follow-up|17|||
27791561|NCT00593385|81069025|FG000|Overall Study|Withdrawal by Subject|9|||
27791562|NCT02684370|81069026|FG000|Part A|Adverse Event|2|||
27791563|NCT02684370|81069027|FG001|Part A|Adverse Event|0|||
27791564|NCT02684370|81069028|FG002|Part A|Adverse Event|1|||
27791565|NCT02684370|81069029|FG003|Part A|Adverse Event|0|||
27791566|NCT02684370|81069030|FG004|Part A|Adverse Event|0|||
27791567|NCT02684370|81069031|FG005|Part A|Adverse Event|0|||
27791568|NCT02684370|81069026|FG000|Part A|Lost to Follow-up|1|||
27791569|NCT02684370|81069027|FG001|Part A|Lost to Follow-up|1|||
27791570|NCT02684370|81069028|FG002|Part A|Lost to Follow-up|0|||
27791571|NCT02684370|81069029|FG003|Part A|Lost to Follow-up|0|||
27791572|NCT02684370|81069030|FG004|Part A|Lost to Follow-up|0|||
27791573|NCT02684370|81069031|FG005|Part A|Lost to Follow-up|0|||
27791574|NCT02684370|81069026|FG000|Part A|Subject Withdrawal|1|||
27791575|NCT02684370|81069027|FG001|Part A|Subject Withdrawal|0|||
27791576|NCT02684370|81069028|FG002|Part A|Subject Withdrawal|3|||
27791577|NCT02684370|81069029|FG003|Part A|Subject Withdrawal|0|||
27791578|NCT02684370|81069030|FG004|Part A|Subject Withdrawal|0|||
27791579|NCT02684370|81069031|FG005|Part A|Subject Withdrawal|0|||
27791580|NCT02684370|81069026|FG000|Part A|Other|0|||
27791581|NCT02684370|81069027|FG001|Part A|Other|0|||
27978251|NCT00235391|81753242|FG005|Overall Study|Administrative problems|0|||
27978252|NCT00235391|81753237|FG000|Overall Study|Death|0|||
27978253|NCT00235391|81753238|FG001|Overall Study|Death|0|||
27978254|NCT00235391|81753239|FG002|Overall Study|Death|1|||
27791582|NCT02684370|81069028|FG002|Part A|Other|1|||
27791583|NCT02684370|81069029|FG003|Part A|Other|0|||
27791584|NCT02684370|81069030|FG004|Part A|Other|0|||
27791585|NCT02684370|81069031|FG005|Part A|Other|0|||
27791586|NCT02684370|81069026|FG000|Part B|Adverse Event|0|||
27791587|NCT02684370|81069027|FG001|Part B|Adverse Event|0|||
27791588|NCT02684370|81069028|FG002|Part B|Adverse Event|0|||
27791589|NCT02684370|81069029|FG003|Part B|Adverse Event|0|||
27791590|NCT02684370|81069030|FG004|Part B|Adverse Event|2|||
27791591|NCT02684370|81069031|FG005|Part B|Adverse Event|1|||
27978255|NCT00235391|81753240|FG003|Overall Study|Death|4|||
27978256|NCT00235391|81753241|FG004|Overall Study|Death|0|||
27672519|NCT02719743|80639224|FG002|Overall Study|Lost to Follow-up|0|||
27791592|NCT02684370|81069026|FG000|Part B|Lost to Follow-up|0|||
27791593|NCT02684370|81069027|FG001|Part B|Lost to Follow-up|0|||
27791594|NCT02684370|81069028|FG002|Part B|Lost to Follow-up|0|||
27978257|NCT00235391|81753242|FG005|Overall Study|Death|0|||
27978258|NCT03023826|81753243|FG000|Period 1|Withdrawal by Subject|0|||
27791595|NCT02684370|81069029|FG003|Part B|Lost to Follow-up|1|||
27791596|NCT02684370|81069030|FG004|Part B|Lost to Follow-up|2|||
27791597|NCT02684370|81069031|FG005|Part B|Lost to Follow-up|5|||
27791598|NCT02684370|81069026|FG000|Part B|Subject Withdrawal|0|||
27791599|NCT02684370|81069027|FG001|Part B|Subject Withdrawal|0|||
27791600|NCT02684370|81069028|FG002|Part B|Subject Withdrawal|0|||
27791601|NCT02684370|81069029|FG003|Part B|Subject Withdrawal|1|||
27791602|NCT02684370|81069030|FG004|Part B|Subject Withdrawal|1|||
27791603|NCT02684370|81069031|FG005|Part B|Subject Withdrawal|2|||
27791604|NCT00824993|81069035|FG000|Overall Study|Withdrawal by Subject|1|||
27791605|NCT00824993|81069036|FG001|Overall Study|Withdrawal by Subject|1|||
27791606|NCT00824993|81069035|FG000|Overall Study|Malignancy Relapse|9|||
27791607|NCT00824993|81069036|FG001|Overall Study|Malignancy Relapse|10|||
27791608|NCT00824993|81069035|FG000|Overall Study|Rapid Bone Loss|0|||
27791609|NCT00824993|81069036|FG001|Overall Study|Rapid Bone Loss|1|||
27791610|NCT00824993|81069035|FG000|Overall Study|Non-Compliant|2|||
27791611|NCT00824993|81069036|FG001|Overall Study|Non-Compliant|1|||
27791612|NCT00824993|81069035|FG000|Overall Study|Insurance Issue|2|||
27791613|NCT00824993|81069036|FG001|Overall Study|Insurance Issue|1|||
27791614|NCT00824993|81069035|FG000|Overall Study|Death|0|||
27791615|NCT00824993|81069036|FG001|Overall Study|Death|3|||
27791616|NCT01869959|81069039|FG000|Randomization Period|Physician Decision|0|||
27791617|NCT01869959|81069040|FG001|Randomization Period|Physician Decision|0|||
27791618|NCT01869959|81069041|FG002|Randomization Period|Physician Decision|0|||
27791619|NCT01869959|81069042|FG003|Randomization Period|Physician Decision|0|||
27791620|NCT01869959|81069043|FG004|Randomization Period|Physician Decision|1|||
27791621|NCT01869959|81069039|FG000|Treatment Period|Adverse Event|1|||
27791622|NCT01869959|81069040|FG001|Treatment Period|Adverse Event|0|||
27791623|NCT01869959|81069041|FG002|Treatment Period|Adverse Event|3|||
27791624|NCT01869959|81069042|FG003|Treatment Period|Adverse Event|1|||
27791625|NCT01869959|81069043|FG004|Treatment Period|Adverse Event|0|||
27791626|NCT01869959|81069039|FG000|Treatment Period|Sponsor decision|0|||
27791627|NCT01869959|81069040|FG001|Treatment Period|Sponsor decision|1|||
27791628|NCT01869959|81069041|FG002|Treatment Period|Sponsor decision|0|||
27791629|NCT01869959|81069042|FG003|Treatment Period|Sponsor decision|1|||
27791630|NCT01869959|81069043|FG004|Treatment Period|Sponsor decision|0|||
27791631|NCT01869959|81069039|FG000|Treatment Period|Withdrawal by Subject|0|||
27791632|NCT01869959|81069040|FG001|Treatment Period|Withdrawal by Subject|1|||
27791633|NCT01869959|81069041|FG002|Treatment Period|Withdrawal by Subject|0|||
27791634|NCT01869959|81069042|FG003|Treatment Period|Withdrawal by Subject|0|||
27791635|NCT01869959|81069043|FG004|Treatment Period|Withdrawal by Subject|0|||
27791636|NCT00795886|81069045|FG000|Overall Study|Death|10|||
27791637|NCT01399619|81069047|FG000|Overall Study|Adverse Event|10|||
27791638|NCT01399619|81069048|FG001|Overall Study|Adverse Event|0|||
27791639|NCT01399619|81069049|FG002|Overall Study|Adverse Event|4|||
27791640|NCT01399619|81069050|FG003|Overall Study|Adverse Event|10|||
27791641|NCT01399619|81069047|FG000|Overall Study|Lack of Efficacy|9|||
27791642|NCT01399619|81069048|FG001|Overall Study|Lack of Efficacy|0|||
27791643|NCT01399619|81069049|FG002|Overall Study|Lack of Efficacy|5|||
27791644|NCT01399619|81069050|FG003|Overall Study|Lack of Efficacy|0|||
27791645|NCT01399619|81069047|FG000|Overall Study|Withdrawal by Subject|6|||
27791646|NCT01399619|81069048|FG001|Overall Study|Withdrawal by Subject|0|||
27791647|NCT01399619|81069049|FG002|Overall Study|Withdrawal by Subject|3|||
27791648|NCT01399619|81069050|FG003|Overall Study|Withdrawal by Subject|4|||
27791649|NCT01399619|81069047|FG000|Overall Study|Protocol Violation|0|||
27791650|NCT01399619|81069048|FG001|Overall Study|Protocol Violation|0|||
27791651|NCT01399619|81069049|FG002|Overall Study|Protocol Violation|0|||
27791652|NCT01399619|81069050|FG003|Overall Study|Protocol Violation|1|||
27791653|NCT01399619|81069047|FG000|Overall Study|Not treated|0|||
27791654|NCT01399619|81069048|FG001|Overall Study|Not treated|0|||
27791655|NCT01399619|81069049|FG002|Overall Study|Not treated|0|||
27791656|NCT01399619|81069050|FG003|Overall Study|Not treated|2|||
27791657|NCT04150107|81069051|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
27791658|NCT04150107|81069052|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
27791659|NCT04150107|81069051|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
27791660|NCT04150107|81069052|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
27791661|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
27791662|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
27791663|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791664|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791665|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791666|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791667|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791668|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791669|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791670|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791671|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791672|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
27791673|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
27791674|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791675|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791676|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791677|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791678|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791679|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
27791680|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791681|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791682|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791683|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
27791684|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
27791685|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791686|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
27672520|NCT02719743|80639225|FG003|Overall Study|Lost to Follow-up|0|||
27672521|NCT02719743|80639226|FG004|Overall Study|Lost to Follow-up|0|||
27672522|NCT03636373|80639234|FG000|Overall Study|Study closure due to Covid-19|1|||
27672523|NCT03636373|80639235|FG001|Overall Study|Study closure due to Covid-19|0|||
27672524|NCT01441583|80639236|FG000|Overall Study|Withdrawal by Subject|1|||
27672525|NCT01441583|80639237|FG001|Overall Study|Withdrawal by Subject|1|||
27672526|NCT01441583|80639238|FG002|Overall Study|Withdrawal by Subject|1|||
27672527|NCT01441583|80639236|FG000|Overall Study|Death|1|||
27672528|NCT01441583|80639237|FG001|Overall Study|Death|0|||
27672529|NCT01441583|80639238|FG002|Overall Study|Death|4|||
27672530|NCT01441583|80639236|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
27672531|NCT01441583|80639237|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
27672532|NCT01441583|80639238|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
27672533|NCT02547441|80639241|FG000|Double-Blind Study Period|Adverse Event|4|||
27672534|NCT02547441|80639242|FG001|Double-Blind Study Period|Adverse Event|9|||
27672535|NCT02547441|80639241|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
27672536|NCT02547441|80639242|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
27672537|NCT02547441|80639241|FG000|Double-Blind Study Period|Physician Decision|1|||
27672538|NCT02547441|80639242|FG001|Double-Blind Study Period|Physician Decision|0|||
27672539|NCT02547441|80639241|FG000|Double-Blind Study Period|Protocol Violation|1|||
27672540|NCT02547441|80639242|FG001|Double-Blind Study Period|Protocol Violation|2|||
27672541|NCT02547441|80639241|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
27672542|NCT02547441|80639242|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
27672543|NCT02547441|80639241|FG000|Double-Blind Study Period|Sponsor Decision|1|||
27672544|NCT02547441|80639242|FG001|Double-Blind Study Period|Sponsor Decision|0|||
27672545|NCT02547441|80639241|FG000|Open-Label Study Period|Adverse Event|10|||
27672546|NCT02547441|80639242|FG001|Open-Label Study Period|Adverse Event|11|||
27672547|NCT02547441|80639241|FG000|Open-Label Study Period|Lack of Efficacy|3|||
27672548|NCT02547441|80639242|FG001|Open-Label Study Period|Lack of Efficacy|2|||
27672549|NCT02547441|80639241|FG000|Open-Label Study Period|Lost to Follow-up|7|||
27672550|NCT02547441|80639242|FG001|Open-Label Study Period|Lost to Follow-up|8|||
27672551|NCT02547441|80639241|FG000|Open-Label Study Period|Physician Decision|1|||
27672552|NCT02547441|80639242|FG001|Open-Label Study Period|Physician Decision|0|||
27672553|NCT02547441|80639241|FG000|Open-Label Study Period|Protocol Violation|2|||
27672554|NCT02547441|80639242|FG001|Open-Label Study Period|Protocol Violation|0|||
27672555|NCT02547441|80639241|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
27672556|NCT02547441|80639242|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
27672557|NCT02547441|80639241|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
27672558|NCT02547441|80639242|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
27672559|NCT04650698|80639243|FG000|Overall Study|Protocol Violation|2|||
27672560|NCT04650698|80639244|FG001|Overall Study|Protocol Violation|1|||
27672561|NCT04650698|80639243|FG000|Overall Study|Withdrawal by Subject|0|||
27672562|NCT04650698|80639244|FG001|Overall Study|Withdrawal by Subject|1|||
27672563|NCT00516139|80639245|FG000|Overall Study|Adverse Event|27|||
27672564|NCT00516139|80639245|FG000|Overall Study|Lost to Follow-up|1|||
27672565|NCT00516139|80639245|FG000|Overall Study|Protocol Violation|1|||
27672566|NCT00516139|80639245|FG000|Overall Study|Withdrawal by Subject|8|||
27672567|NCT00516139|80639245|FG000|Overall Study|Lack of Efficacy|1|||
27672568|NCT00583947|80639246|FG000|Cross-over Period|Adverse Event|2|||
27672569|NCT00583947|80639247|FG001|Cross-over Period|Adverse Event|0|||
27791687|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791688|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791689|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27867659|NCT03142191|81349678|FG001|Placebo Controlled Period|Other Reasons|0|||
27978259|NCT03023826|81753244|FG001|Period 1|Withdrawal by Subject|0|||
27672570|NCT00583947|80639246|FG000|Cross-over Period|Withdrawal by Subject|2|||
27672571|NCT00583947|80639247|FG001|Cross-over Period|Withdrawal by Subject|0|||
27672572|NCT00583947|80639246|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
27672573|NCT00583947|80639247|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
27672574|NCT00583947|80639246|FG000|Cross-over Period|Other|1|||
27672575|NCT00583947|80639247|FG001|Cross-over Period|Other|1|||
27672576|NCT01790295|80639252|FG000|Overall Study|Adverse Event|1|||
27791690|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791691|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791692|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791693|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791694|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791695|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791696|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
27791697|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
27574514|NCT04300296|80289055|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
27791698|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
27791699|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
27791700|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
27791701|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
27791702|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
27791703|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
27791704|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
27791705|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
27791706|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
27791707|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
27978260|NCT03023826|81753245|FG002|Period 1|Withdrawal by Subject|0|||
27978261|NCT03023826|81753246|FG003|Period 1|Withdrawal by Subject|0|||
27978262|NCT03023826|81753247|FG004|Period 1|Withdrawal by Subject|1|||
27978263|NCT03023826|81753248|FG005|Period 1|Withdrawal by Subject|0|||
27978264|NCT00966719|81753258|FG000|Overall Study|Lost to Follow-up|6|||
27978265|NCT00966719|81753259|FG001|Overall Study|Lost to Follow-up|11|||
27978266|NCT01537081|81753260|FG000|Overall Study|Adverse Event|5|||
27978267|NCT01537081|81753261|FG001|Overall Study|Adverse Event|2|||
27978268|NCT01537081|81753262|FG002|Overall Study|Adverse Event|2|||
27978269|NCT01537081|81753260|FG000|Overall Study|Lack of Efficacy|2|||
27978270|NCT01537081|81753261|FG001|Overall Study|Lack of Efficacy|1|||
27978271|NCT01537081|81753262|FG002|Overall Study|Lack of Efficacy|0|||
27978272|NCT01537081|81753260|FG000|Overall Study|Lost to Follow-up|17|||
27978273|NCT01537081|81753261|FG001|Overall Study|Lost to Follow-up|15|||
27978274|NCT01537081|81753262|FG002|Overall Study|Lost to Follow-up|9|||
27978275|NCT01537081|81753260|FG000|Overall Study|Protocol Violation|3|||
27978276|NCT01537081|81753261|FG001|Overall Study|Protocol Violation|2|||
27978277|NCT01537081|81753262|FG002|Overall Study|Protocol Violation|2|||
27978278|NCT01537081|81753260|FG000|Overall Study|Withdrawal by Subject|6|||
27978279|NCT01537081|81753261|FG001|Overall Study|Withdrawal by Subject|11|||
27978280|NCT01537081|81753262|FG002|Overall Study|Withdrawal by Subject|3|||
27978281|NCT01537081|81753260|FG000|Overall Study|Physician Decision|5|||
27978282|NCT01537081|81753261|FG001|Overall Study|Physician Decision|6|||
27978283|NCT01537081|81753262|FG002|Overall Study|Physician Decision|0|||
27978284|NCT01537081|81753260|FG000|Overall Study|Sponsor decision|0|||
27791708|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
27791709|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791710|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791711|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791712|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791713|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27978285|NCT01537081|81753261|FG001|Overall Study|Sponsor decision|1|||
27978286|NCT01537081|81753262|FG002|Overall Study|Sponsor decision|0|||
27978287|NCT01537081|81753260|FG000|Overall Study|Assigned but never dosed|1|||
27978288|NCT01537081|81753261|FG001|Overall Study|Assigned but never dosed|0|||
27978289|NCT01537081|81753262|FG002|Overall Study|Assigned but never dosed|0|||
27978290|NCT00837876|81753263|FG000|Overall Study|Death|2|||
27978291|NCT00837876|81753263|FG000|Overall Study|Adverse Event|7|||
27978292|NCT00837876|81753263|FG000|Overall Study|Physician Decision|1|||
27978293|NCT00837876|81753263|FG000|Overall Study|Withdrawal by Subject|3|||
27791714|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
27791715|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791716|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791717|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791718|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791719|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791720|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
27791721|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791722|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791723|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791724|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791725|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791726|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
27791727|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791728|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791729|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791730|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791731|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791732|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
27791733|NCT00151775|81069056|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791734|NCT00151775|81069057|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791735|NCT00151775|81069058|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791736|NCT00151775|81069059|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791737|NCT00151775|81069060|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791738|NCT00151775|81069061|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791739|NCT00151775|81069062|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
27791740|NCT00151775|81069063|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791741|NCT00151775|81069064|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791742|NCT00151775|81069065|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791743|NCT00151775|81069066|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791744|NCT00151775|81069067|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
27791745|NCT00151775|81069056|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791746|NCT00151775|81069057|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791747|NCT00151775|81069058|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791748|NCT00151775|81069059|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791749|NCT00151775|81069060|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791750|NCT00151775|81069061|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
27791751|NCT00151775|81069062|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791752|NCT00151775|81069063|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791753|NCT00151775|81069064|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791754|NCT00151775|81069065|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791755|NCT00151775|81069066|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791756|NCT00151775|81069067|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
27791757|NCT00151775|81069056|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
27791758|NCT00151775|81069057|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
27791759|NCT00151775|81069058|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
27791760|NCT00151775|81069059|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
27791761|NCT00151775|81069060|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
27791762|NCT00151775|81069061|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
27791763|NCT00151775|81069062|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
27791764|NCT00151775|81069063|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
27791765|NCT00151775|81069064|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
27791766|NCT00151775|81069065|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
27791767|NCT00151775|81069066|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
27791768|NCT00151775|81069067|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
27791769|NCT00151775|81069056|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791770|NCT00151775|81069057|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791771|NCT00151775|81069058|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791772|NCT00151775|81069059|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791773|NCT00151775|81069060|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27978294|NCT00837876|81753263|FG000|Overall Study|disease progression|24|||
27978295|NCT00520013|81753264|FG000|Overall Study|Withdrawal by Subject|0|||
27791774|NCT00151775|81069061|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27978296|NCT00520013|81753265|FG001|Overall Study|Withdrawal by Subject|0|||
27978297|NCT00520013|81753266|FG002|Overall Study|Withdrawal by Subject|1|||
27978298|NCT00520013|81753264|FG000|Overall Study|Adverse Event|2|||
27791775|NCT00151775|81069062|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
27791776|NCT00151775|81069063|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791777|NCT00151775|81069064|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791778|NCT00151775|81069065|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27574515|NCT04300296|80289056|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
27574516|NCT04300296|80289057|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
27574517|NCT04300296|80289052|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
27574518|NCT04300296|80289053|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
27574519|NCT04300296|80289054|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
27574520|NCT04300296|80289055|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
27574521|NCT04300296|80289056|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
27574522|NCT04300296|80289057|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
27574523|NCT02127307|80289059|FG000|Overall Study|Protocol Violation|36|||
27574524|NCT02127307|80289059|FG000|Overall Study|Lost to Follow-up|2|||
27574525|NCT02127307|80289059|FG000|Overall Study|Death|101|||
27574526|NCT02127307|80289059|FG000|Overall Study|Other than specified above|169|||
27574527|NCT00424372|80289064|FG000|Overall Study|Death|1|||
27574528|NCT00424372|80289064|FG000|Overall Study|Adverse Event|18|||
27574529|NCT00424372|80289064|FG000|Overall Study|Lack of Efficacy|6|||
27574530|NCT00424372|80289064|FG000|Overall Study|Withdrawal by Subject|4|||
27574531|NCT00424372|80289064|FG000|Overall Study|Protocol Violation|1|||
27574532|NCT00424372|80289064|FG000|Overall Study|Health deterioration|1|||
27574533|NCT02579616|80289067|FG000|Overall Study|Participants did not receive treatment|3|||
27574534|NCT00779766|80289068|FG000|Month 24|Serious Adverse Event|2|||
27574535|NCT00779766|80289069|FG001|Month 24|Serious Adverse Event|3|||
27574536|NCT00779766|80289068|FG000|Month 24|Adverse Event|3|||
27574537|NCT00779766|80289069|FG001|Month 24|Adverse Event|3|||
27574538|NCT00779766|80289068|FG000|Month 24|Protocol Violation|3|||
27574539|NCT00779766|80289069|FG001|Month 24|Protocol Violation|1|||
27574540|NCT00779766|80289068|FG000|Month 24|Withdrawal by Subject|159|||
27574541|NCT00779766|80289069|FG001|Month 24|Withdrawal by Subject|127|||
27574542|NCT00779766|80289068|FG000|Month 24|Migrated/moved from study area|138|||
27574543|NCT00779766|80289069|FG001|Month 24|Migrated/moved from study area|162|||
27574544|NCT00779766|80289068|FG000|Month 24|Lost to Follow-up|9|||
27574545|NCT00779766|80289069|FG001|Month 24|Lost to Follow-up|9|||
27574546|NCT00779766|80289068|FG000|Month 24|Other|18|||
27574547|NCT00779766|80289069|FG001|Month 24|Other|27|||
27574548|NCT00779766|80289068|FG000|Month 48|Withdrawal by Subject|68|||
27574549|NCT00779766|80289069|FG001|Month 48|Withdrawal by Subject|63|||
27574550|NCT00779766|80289068|FG000|Month 48|Migrated/moved from study area|76|||
27574551|NCT00779766|80289069|FG001|Month 48|Migrated/moved from study area|75|||
27574552|NCT00779766|80289068|FG000|Month 48|Lost to Follow-up|29|||
27574553|NCT00779766|80289069|FG001|Month 48|Lost to Follow-up|30|||
27574554|NCT00779766|80289068|FG000|Month 48|Other|1|||
27672577|NCT01790295|80639252|FG000|Overall Study|Death|4|||
27672578|NCT01790295|80639252|FG000|Overall Study|Lack of Efficacy|2|||
27978299|NCT00520013|81753265|FG001|Overall Study|Adverse Event|10|||
27978300|NCT00520013|81753266|FG002|Overall Study|Adverse Event|7|||
27978301|NCT00520013|81753264|FG000|Overall Study|Progressive Disease|7|||
27978302|NCT00520013|81753265|FG001|Overall Study|Progressive Disease|3|||
27978303|NCT00520013|81753266|FG002|Overall Study|Progressive Disease|0|||
27978304|NCT00520013|81753264|FG000|Overall Study|Clinical Progression|3|||
27978305|NCT00520013|81753265|FG001|Overall Study|Clinical Progression|1|||
27978306|NCT00520013|81753266|FG002|Overall Study|Clinical Progression|0|||
27978307|NCT00520013|81753264|FG000|Overall Study|Death|0|||
27978308|NCT00520013|81753265|FG001|Overall Study|Death|1|||
27978309|NCT00520013|81753266|FG002|Overall Study|Death|0|||
27978310|NCT00520013|81753264|FG000|Overall Study|Physician Decision|0|||
27978311|NCT00520013|81753265|FG001|Overall Study|Physician Decision|0|||
27978312|NCT00520013|81753266|FG002|Overall Study|Physician Decision|3|||
27978313|NCT03294135|81753274|FG000|Overall Study|Serious Adverse Event|1|||
27978314|NCT03294135|81753275|FG001|Overall Study|Serious Adverse Event|0|||
27574555|NCT00779766|80289069|FG001|Month 48|Other|0|||
27574556|NCT00779766|80289068|FG000|Month 72|Withdrawal by Subject|55|||
27672579|NCT01790295|80639252|FG000|Overall Study|Study closure|4|||
27672580|NCT04594733|80639253|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27574557|NCT00779766|80289069|FG001|Month 72|Withdrawal by Subject|71|||
27574558|NCT00779766|80289068|FG000|Month 72|Migrated/moved from study area|124|||
27791779|NCT00151775|81069066|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27978315|NCT03294135|81753276|FG002|Overall Study|Serious Adverse Event|0|||
27978316|NCT03294135|81753274|FG000|Overall Study|Lost to Follow-up|1|||
27978317|NCT03294135|81753275|FG001|Overall Study|Lost to Follow-up|0|||
27978318|NCT03294135|81753276|FG002|Overall Study|Lost to Follow-up|1|||
27978319|NCT03294135|81753274|FG000|Overall Study|Withdrawal by Subject|0|||
27574559|NCT00779766|80289069|FG001|Month 72|Migrated/moved from study area|109|||
27978320|NCT03294135|81753275|FG001|Overall Study|Withdrawal by Subject|0|||
27978321|NCT03294135|81753276|FG002|Overall Study|Withdrawal by Subject|1|||
27791780|NCT00151775|81069067|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
27791781|NCT00151775|81069056|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791782|NCT00151775|81069057|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791783|NCT00151775|81069058|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
27791784|NCT00151775|81069059|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791785|NCT00151775|81069060|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791786|NCT00151775|81069061|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791787|NCT00151775|81069062|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791788|NCT00151775|81069063|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791789|NCT00151775|81069064|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791790|NCT00151775|81069065|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791791|NCT00151775|81069066|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791792|NCT00151775|81069067|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
27791793|NCT00151775|81069056|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791794|NCT00151775|81069057|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27672581|NCT04594733|80639254|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
27672582|NCT04594733|80639253|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
27791795|NCT00151775|81069058|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
27791796|NCT00151775|81069059|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791797|NCT00151775|81069060|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791798|NCT00151775|81069061|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791799|NCT00151775|81069062|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791800|NCT00151775|81069063|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791801|NCT00151775|81069064|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791802|NCT00151775|81069065|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791803|NCT00151775|81069066|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791804|NCT00151775|81069067|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
27791805|NCT00151775|81069056|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791806|NCT00151775|81069057|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791807|NCT00151775|81069058|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791808|NCT00151775|81069059|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791809|NCT00151775|81069060|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791810|NCT00151775|81069061|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791811|NCT00151775|81069062|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791812|NCT00151775|81069063|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791813|NCT00151775|81069064|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791814|NCT00151775|81069065|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791815|NCT00151775|81069066|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
27791816|NCT00151775|81069067|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
27791817|NCT00151775|81069056|FG000|Period 4: Open Label|Increased blood pressure|0|||
27791818|NCT00151775|81069057|FG001|Period 4: Open Label|Increased blood pressure|0|||
27791819|NCT00151775|81069058|FG002|Period 4: Open Label|Increased blood pressure|0|||
27791820|NCT00151775|81069059|FG003|Period 4: Open Label|Increased blood pressure|0|||
27791821|NCT00151775|81069060|FG004|Period 4: Open Label|Increased blood pressure|1|||
27791822|NCT00151775|81069061|FG005|Period 4: Open Label|Increased blood pressure|0|||
27791823|NCT00151775|81069062|FG006|Period 4: Open Label|Increased blood pressure|0|||
27791824|NCT00151775|81069063|FG007|Period 4: Open Label|Increased blood pressure|0|||
27978322|NCT03294135|81753274|FG000|Overall Study|Other|2|||
27978323|NCT03294135|81753275|FG001|Overall Study|Other|0|||
27978324|NCT03294135|81753276|FG002|Overall Study|Other|0|||
27978325|NCT03958656|81753278|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
27978326|NCT03958656|81753279|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
27978327|NCT03958656|81753280|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
27978328|NCT03958656|81753281|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
27978329|NCT03958656|81753278|FG000|Overall Study|No longer meets eligibility criteria|0|||
27978330|NCT03958656|81753279|FG001|Overall Study|No longer meets eligibility criteria|0|||
27978331|NCT03958656|81753280|FG002|Overall Study|No longer meets eligibility criteria|1|||
27978332|NCT03958656|81753281|FG003|Overall Study|No longer meets eligibility criteria|0|||
27978333|NCT03958656|81753278|FG000|Overall Study|Started anti-cancer treatment|0|||
27978334|NCT03958656|81753279|FG001|Overall Study|Started anti-cancer treatment|0|||
27672583|NCT04594733|80639254|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
27672584|NCT04594733|80639253|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
27791825|NCT00151775|81069064|FG008|Period 4: Open Label|Increased blood pressure|0|||
27791826|NCT00151775|81069065|FG009|Period 4: Open Label|Increased blood pressure|1|||
27978335|NCT03958656|81753280|FG002|Overall Study|Started anti-cancer treatment|1|||
27978336|NCT03958656|81753281|FG003|Overall Study|Started anti-cancer treatment|0|||
27978337|NCT01444027|81753282|FG000|Overall Study|Withdrawal by Subject|4|||
27978338|NCT01444027|81753283|FG001|Overall Study|Withdrawal by Subject|10|||
27791827|NCT00151775|81069066|FG010|Period 4: Open Label|Increased blood pressure|0|||
27791828|NCT00151775|81069067|FG011|Period 4: Open Label|Increased blood pressure|0|||
27791829|NCT00151775|81069056|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
27791830|NCT00151775|81069057|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
27791831|NCT00151775|81069058|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
27791832|NCT00151775|81069059|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
27791833|NCT00151775|81069060|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
27791834|NCT00151775|81069061|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
27791835|NCT00151775|81069062|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
27791836|NCT00151775|81069063|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
27791837|NCT00151775|81069064|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
27791838|NCT00151775|81069065|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
27791839|NCT00151775|81069066|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
27791840|NCT00151775|81069067|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
27791841|NCT00151775|81069056|FG000|Period 4: Open Label|Adverse Event|0|||
27791842|NCT00151775|81069057|FG001|Period 4: Open Label|Adverse Event|0|||
27791843|NCT00151775|81069058|FG002|Period 4: Open Label|Adverse Event|0|||
27791844|NCT00151775|81069059|FG003|Period 4: Open Label|Adverse Event|0|||
27791845|NCT00151775|81069060|FG004|Period 4: Open Label|Adverse Event|1|||
27791846|NCT00151775|81069061|FG005|Period 4: Open Label|Adverse Event|0|||
27791847|NCT00151775|81069062|FG006|Period 4: Open Label|Adverse Event|0|||
27791848|NCT00151775|81069063|FG007|Period 4: Open Label|Adverse Event|0|||
27791849|NCT00151775|81069064|FG008|Period 4: Open Label|Adverse Event|0|||
27791850|NCT00151775|81069065|FG009|Period 4: Open Label|Adverse Event|2|||
27791851|NCT00151775|81069066|FG010|Period 4: Open Label|Adverse Event|0|||
27791852|NCT00151775|81069067|FG011|Period 4: Open Label|Adverse Event|0|||
27791853|NCT00151775|81069056|FG000|Period 4: Open Label|Lost to Follow-up|0|||
27791854|NCT00151775|81069057|FG001|Period 4: Open Label|Lost to Follow-up|0|||
27791855|NCT00151775|81069058|FG002|Period 4: Open Label|Lost to Follow-up|0|||
27791856|NCT00151775|81069059|FG003|Period 4: Open Label|Lost to Follow-up|0|||
27791857|NCT00151775|81069060|FG004|Period 4: Open Label|Lost to Follow-up|17|||
27791858|NCT00151775|81069061|FG005|Period 4: Open Label|Lost to Follow-up|0|||
27791859|NCT00151775|81069062|FG006|Period 4: Open Label|Lost to Follow-up|0|||
27791860|NCT00151775|81069063|FG007|Period 4: Open Label|Lost to Follow-up|0|||
27791861|NCT00151775|81069064|FG008|Period 4: Open Label|Lost to Follow-up|0|||
27791862|NCT00151775|81069065|FG009|Period 4: Open Label|Lost to Follow-up|7|||
27791863|NCT00151775|81069066|FG010|Period 4: Open Label|Lost to Follow-up|0|||
27791864|NCT00151775|81069067|FG011|Period 4: Open Label|Lost to Follow-up|0|||
27791865|NCT00151775|81069056|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
27791866|NCT00151775|81069057|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
27791867|NCT00151775|81069058|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
27791868|NCT00151775|81069059|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
27791869|NCT00151775|81069060|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
27672585|NCT04594733|80639254|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
27672586|NCT04411186|80639255|FG000|Overall Study|Withdrawn due to protocol violation|0|||
27672587|NCT04411186|80639256|FG001|Overall Study|Withdrawn due to protocol violation|1|||
27672588|NCT03432390|80639257|FG000|Apnea Period|Protocol Violation|2|||
27672589|NCT03432390|80639258|FG001|Apnea Period|Protocol Violation|2|||
27672590|NCT02643628|80639262|FG000|Overall Study|Lost to Follow-up|1|||
27672591|NCT02643628|80639263|FG001|Overall Study|Lost to Follow-up|4|||
27791870|NCT00151775|81069061|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
27791871|NCT00151775|81069062|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
27791872|NCT00151775|81069063|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
27791873|NCT00151775|81069064|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
27791874|NCT00151775|81069065|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
27867660|NCT03142191|81349679|FG002|Placebo Controlled Period|Other Reasons|0|||
27867661|NCT03142191|81349680|FG003|Placebo Controlled Period|Other Reasons|0|||
27867662|NCT03142191|81349681|FG004|Placebo Controlled Period|Other Reasons|0|||
27978339|NCT01444027|81753284|FG002|Overall Study|Withdrawal by Subject|24|||
27574560|NCT00779766|80289068|FG000|Month 72|Lost to Follow-up|6|||
27574561|NCT00779766|80289069|FG001|Month 72|Lost to Follow-up|8|||
27574562|NCT00779766|80289068|FG000|Month 72|Other|0|||
27574563|NCT00779766|80289069|FG001|Month 72|Other|1|||
27574564|NCT00183872|80289070|FG000|Overall Study|Death|3|||
27791875|NCT00151775|81069066|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
27791876|NCT00151775|81069067|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
27791877|NCT00151775|81069056|FG000|Period 4: Open Label|Other|0|||
27867663|NCT03142191|81349677|FG000|Active Treatment Extension Period|Death|2|||
27574565|NCT00183872|80289070|FG000|Overall Study|Adverse Event|9|||
27574566|NCT00183872|80289070|FG000|Overall Study|Withdrawal by Subject|2|||
27672592|NCT02643628|80639262|FG000|Overall Study|Withdrawal by Subject|0|||
27791878|NCT00151775|81069057|FG001|Period 4: Open Label|Other|0|||
27791879|NCT00151775|81069058|FG002|Period 4: Open Label|Other|0|||
27791880|NCT00151775|81069059|FG003|Period 4: Open Label|Other|0|||
27791881|NCT00151775|81069060|FG004|Period 4: Open Label|Other|1|||
27791882|NCT00151775|81069061|FG005|Period 4: Open Label|Other|0|||
27791883|NCT00151775|81069062|FG006|Period 4: Open Label|Other|0|||
27791884|NCT00151775|81069063|FG007|Period 4: Open Label|Other|0|||
27791885|NCT00151775|81069064|FG008|Period 4: Open Label|Other|0|||
27791886|NCT00151775|81069065|FG009|Period 4: Open Label|Other|3|||
27791887|NCT00151775|81069066|FG010|Period 4: Open Label|Other|0|||
27791888|NCT00151775|81069067|FG011|Period 4: Open Label|Other|0|||
27791889|NCT00151775|81069056|FG000|Period 4: Open Label|Physician Decision|0|||
27791890|NCT00151775|81069057|FG001|Period 4: Open Label|Physician Decision|0|||
27791891|NCT00151775|81069058|FG002|Period 4: Open Label|Physician Decision|0|||
27791892|NCT00151775|81069059|FG003|Period 4: Open Label|Physician Decision|0|||
27791893|NCT00151775|81069060|FG004|Period 4: Open Label|Physician Decision|0|||
27791894|NCT00151775|81069061|FG005|Period 4: Open Label|Physician Decision|0|||
27791895|NCT00151775|81069062|FG006|Period 4: Open Label|Physician Decision|0|||
27791896|NCT00151775|81069063|FG007|Period 4: Open Label|Physician Decision|0|||
27791897|NCT00151775|81069064|FG008|Period 4: Open Label|Physician Decision|0|||
27791898|NCT00151775|81069065|FG009|Period 4: Open Label|Physician Decision|2|||
27791899|NCT00151775|81069066|FG010|Period 4: Open Label|Physician Decision|0|||
27791900|NCT00151775|81069067|FG011|Period 4: Open Label|Physician Decision|0|||
27672593|NCT02643628|80639263|FG001|Overall Study|Withdrawal by Subject|1|||
27672594|NCT02643628|80639262|FG000|Overall Study|Relocated out of state|0|||
27791901|NCT00151775|81069056|FG000|Period 4: Open Label|Protocol Violation|0|||
27791902|NCT00151775|81069057|FG001|Period 4: Open Label|Protocol Violation|0|||
27791903|NCT00151775|81069058|FG002|Period 4: Open Label|Protocol Violation|0|||
27791904|NCT00151775|81069059|FG003|Period 4: Open Label|Protocol Violation|0|||
27672595|NCT02643628|80639263|FG001|Overall Study|Relocated out of state|1|||
27672596|NCT00585078|80639274|FG000|Overall Study|Withdrawal by Subject|4|||
27672597|NCT00585078|80639274|FG000|Overall Study|Poor performance status|1|||
27672598|NCT00585078|80639274|FG000|Overall Study|Disease Progression|24|||
27672599|NCT00585078|80639274|FG000|Overall Study|Adverse Event|10|||
27672600|NCT00585078|80639274|FG000|Overall Study|Death|1|||
27672601|NCT02284009|80639275|FG000|Overall Study|Adverse Event|3|||
27672602|NCT02284009|80639276|FG001|Overall Study|Adverse Event|0|||
27672603|NCT02284009|80639275|FG000|Overall Study|Lost to Follow-up|1|||
27672604|NCT02284009|80639276|FG001|Overall Study|Lost to Follow-up|3|||
27791905|NCT00151775|81069060|FG004|Period 4: Open Label|Protocol Violation|1|||
27791906|NCT00151775|81069061|FG005|Period 4: Open Label|Protocol Violation|0|||
27791907|NCT00151775|81069062|FG006|Period 4: Open Label|Protocol Violation|0|||
27791908|NCT00151775|81069063|FG007|Period 4: Open Label|Protocol Violation|0|||
27791909|NCT00151775|81069064|FG008|Period 4: Open Label|Protocol Violation|0|||
27791910|NCT00151775|81069065|FG009|Period 4: Open Label|Protocol Violation|0|||
27791911|NCT00151775|81069066|FG010|Period 4: Open Label|Protocol Violation|0|||
27791912|NCT00151775|81069067|FG011|Period 4: Open Label|Protocol Violation|0|||
27791913|NCT00978120|81069068|FG000|Overall Study|Death|0|||
27791914|NCT00978120|81069069|FG001|Overall Study|Death|0|||
27791915|NCT00978120|81069070|FG002|Overall Study|Death|0|||
27672605|NCT02284009|80639275|FG000|Overall Study|Physician Decision|0|||
27672606|NCT02284009|80639276|FG001|Overall Study|Physician Decision|2|||
27672607|NCT02284009|80639275|FG000|Overall Study|Withdrawal by Subject|2|||
27672608|NCT02284009|80639276|FG001|Overall Study|Withdrawal by Subject|5|||
27672609|NCT00926575|80639277|FG000|Overall Study|Adverse Event|1|||
27672610|NCT00926575|80639278|FG001|Overall Study|Adverse Event|1|||
27672611|NCT00926575|80639277|FG000|Overall Study|Death|4|||
27672612|NCT00926575|80639278|FG001|Overall Study|Death|4|||
27672613|NCT00926575|80639277|FG000|Overall Study|Lost to Follow-up|1|||
27672614|NCT00926575|80639278|FG001|Overall Study|Lost to Follow-up|1|||
27672615|NCT00926575|80639277|FG000|Overall Study|Physician Decision|1|||
27672616|NCT00926575|80639278|FG001|Overall Study|Physician Decision|2|||
27672617|NCT00926575|80639277|FG000|Overall Study|Protocol Violation|1|||
27672618|NCT00926575|80639278|FG001|Overall Study|Protocol Violation|0|||
27672619|NCT00926575|80639277|FG000|Overall Study|Withdrawal by Subject|8|||
27672620|NCT00926575|80639278|FG001|Overall Study|Withdrawal by Subject|9|||
27791916|NCT00978120|81069071|FG003|Overall Study|Death|1|||
27791917|NCT00978120|81069068|FG000|Overall Study|Lost to Follow-up|0|||
27867664|NCT03142191|81349678|FG001|Active Treatment Extension Period|Death|1|||
27672621|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
27672622|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
27791918|NCT00978120|81069069|FG001|Overall Study|Lost to Follow-up|0|||
27791919|NCT00978120|81069070|FG002|Overall Study|Lost to Follow-up|3|||
27791920|NCT00978120|81069071|FG003|Overall Study|Lost to Follow-up|0|||
27791921|NCT00978120|81069068|FG000|Overall Study|Withdrawal by Subject|2|||
27791922|NCT00978120|81069069|FG001|Overall Study|Withdrawal by Subject|0|||
27672623|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
27672624|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
27672625|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
27978340|NCT01444027|81753282|FG000|Overall Study|Lost to Follow-up|26|||
27978341|NCT01444027|81753283|FG001|Overall Study|Lost to Follow-up|20|||
27791923|NCT00978120|81069070|FG002|Overall Study|Withdrawal by Subject|0|||
27791924|NCT00978120|81069071|FG003|Overall Study|Withdrawal by Subject|0|||
27791925|NCT00978120|81069068|FG000|Overall Study|Moved out of state|0|||
27791926|NCT00978120|81069069|FG001|Overall Study|Moved out of state|0|||
27791927|NCT00978120|81069070|FG002|Overall Study|Moved out of state|0|||
27791928|NCT00978120|81069071|FG003|Overall Study|Moved out of state|1|||
27791929|NCT01683565|81069072|FG000|Overall Study|Lost to Follow-up|2|||
27791930|NCT01683565|81069073|FG001|Overall Study|Lost to Follow-up|0|||
27791931|NCT01683565|81069072|FG000|Overall Study|Discontinued Intervention|1|||
27791932|NCT01683565|81069073|FG001|Overall Study|Discontinued Intervention|1|||
27791933|NCT01725217|81069077|FG000|Overall Study|Withdrawal by Subject|1|||
27791934|NCT01725217|81069078|FG001|Overall Study|Withdrawal by Subject|0|||
27791935|NCT01725217|81069079|FG002|Overall Study|Withdrawal by Subject|0|||
27791936|NCT03480243|81069080|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
27791937|NCT03480243|81069080|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
27791938|NCT00762073|81069081|FG000|Overall Study|Lack of Efficacy|1|||
27791939|NCT00762073|81069082|FG001|Overall Study|Lack of Efficacy|1|||
27791940|NCT00762073|81069083|FG002|Overall Study|Lack of Efficacy|0|||
27791941|NCT00762073|81069084|FG003|Overall Study|Lack of Efficacy|0|||
27791942|NCT00762073|81069081|FG000|Overall Study|Adverse Event|1|||
27791943|NCT00762073|81069082|FG001|Overall Study|Adverse Event|0|||
27791944|NCT00762073|81069083|FG002|Overall Study|Adverse Event|1|||
27791945|NCT00762073|81069084|FG003|Overall Study|Adverse Event|1|||
27791946|NCT00762073|81069081|FG000|Overall Study|Significant Subject Noncompliance|0|||
27791947|NCT00762073|81069082|FG001|Overall Study|Significant Subject Noncompliance|1|||
27791948|NCT00762073|81069083|FG002|Overall Study|Significant Subject Noncompliance|0|||
27791949|NCT00762073|81069084|FG003|Overall Study|Significant Subject Noncompliance|1|||
27978342|NCT01444027|81753284|FG002|Overall Study|Lost to Follow-up|14|||
27978343|NCT01300819|81753285|FG000|Overall Study|Adverse Event|9|||
27791950|NCT00762073|81069081|FG000|Overall Study|Withdrawal by Subject|1|||
27791951|NCT00762073|81069082|FG001|Overall Study|Withdrawal by Subject|2|||
27791952|NCT00762073|81069083|FG002|Overall Study|Withdrawal by Subject|1|||
27791953|NCT00762073|81069084|FG003|Overall Study|Withdrawal by Subject|1|||
27791954|NCT00762073|81069081|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
27791955|NCT00762073|81069082|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
27791956|NCT00762073|81069083|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
27791957|NCT00762073|81069084|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
27791958|NCT00122954|81069085|FG000|Overall Study|Withdrawal by Subject|2|||
27978344|NCT01300819|81753286|FG001|Overall Study|Adverse Event|27|||
27978345|NCT01300819|81753285|FG000|Overall Study|Lack of Efficacy|2|||
27978346|NCT01300819|81753286|FG001|Overall Study|Lack of Efficacy|1|||
27978347|NCT01300819|81753285|FG000|Overall Study|Withdrawal by Subject|10|||
27978348|NCT01300819|81753286|FG001|Overall Study|Withdrawal by Subject|12|||
27978349|NCT01300819|81753285|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
27978350|NCT01300819|81753286|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
27978351|NCT01300819|81753285|FG000|Overall Study|Refusal to down titrate study drug|0|||
27978352|NCT01300819|81753286|FG001|Overall Study|Refusal to down titrate study drug|1|||
27978353|NCT01300819|81753285|FG000|Overall Study|Administrative reason|0|||
27978354|NCT01300819|81753286|FG001|Overall Study|Administrative reason|1|||
27978355|NCT01300819|81753285|FG000|Overall Study|Safety follow up not done by mistake|0|||
27978356|NCT01300819|81753286|FG001|Overall Study|Safety follow up not done by mistake|1|||
27978357|NCT01300819|81753285|FG000|Overall Study|Follow up call was not done|1|||
27791959|NCT00122954|81069086|FG001|Overall Study|Withdrawal by Subject|2|||
27791960|NCT00122954|81069085|FG000|Overall Study|Protocol Violation|0|||
27791961|NCT00122954|81069086|FG001|Overall Study|Protocol Violation|1|||
27791962|NCT00621309|81069089|FG000|Overall Study|Withdrawal by Subject|2|||
27791963|NCT00621309|81069090|FG001|Overall Study|Withdrawal by Subject|0|||
27791964|NCT00621309|81069091|FG002|Overall Study|Withdrawal by Subject|1|||
27791965|NCT00621309|81069092|FG003|Overall Study|Withdrawal by Subject|1|||
27791966|NCT00621309|81069093|FG004|Overall Study|Withdrawal by Subject|1|||
27791967|NCT00621309|81069094|FG005|Overall Study|Withdrawal by Subject|1|||
27791968|NCT02596009|81069097|FG000|Overall Study|Administrative problems|0|||
27791969|NCT02596009|81069098|FG001|Overall Study|Administrative problems|1|||
27791970|NCT02596009|81069099|FG002|Overall Study|Administrative problems|0|||
27791971|NCT02596009|81069100|FG003|Overall Study|Administrative problems|0|||
27791972|NCT02596009|81069101|FG004|Overall Study|Administrative problems|0|||
27791973|NCT02596009|81069102|FG005|Overall Study|Administrative problems|0|||
27978358|NCT01300819|81753286|FG001|Overall Study|Follow up call was not done|0|||
27978359|NCT03461406|81753287|FG000|Overall Study|Death|1|||
27978360|NCT03461406|81753288|FG001|Overall Study|Death|2|||
27978361|NCT03461406|81753287|FG000|Overall Study|Consent Withdrawn by Participant|0|||
27978362|NCT03461406|81753288|FG001|Overall Study|Consent Withdrawn by Participant|1|||
27978363|NCT03461406|81753287|FG000|Overall Study|Screen Failure|3|||
27791974|NCT00131937|81069103|FG000|Overall Study|Adverse Event|3|||
27791975|NCT00131937|81069103|FG000|Overall Study|Withdrawal by Subject|2|||
27791976|NCT00131937|81069103|FG000|Overall Study|Physician Decision|1|||
27791977|NCT00131937|81069103|FG000|Overall Study|Disease Progression|7|||
27791978|NCT00131937|81069103|FG000|Overall Study|Alternative therapy|1|||
27791979|NCT00071006|81069104|FG000|Overall Study|Lack of Efficacy|7|||
27791980|NCT00071006|81069104|FG000|Overall Study|Adverse Event|1|||
27791981|NCT00071006|81069104|FG000|Overall Study|Withdrawal by Subject|1|||
27978364|NCT03461406|81753288|FG001|Overall Study|Screen Failure|1|||
27978365|NCT03461406|81753287|FG000|Overall Study|Reason not Specified|1|||
27978366|NCT03461406|81753288|FG001|Overall Study|Reason not Specified|3|||
27978367|NCT03461406|81753287|FG000|Overall Study|Lost to Follow-up|3|||
27978368|NCT03461406|81753288|FG001|Overall Study|Lost to Follow-up|0|||
27978369|NCT02436408|81753289|FG000|Overall Study|Death|1|||
27978370|NCT00583791|81753290|FG000|Overall Study|Other|67|||
27978371|NCT00583791|81753290|FG000|Overall Study|Death|6|||
27978372|NCT02688088|81753291|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
27978373|NCT02688088|81753292|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
27978374|NCT02688088|81753293|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
27978375|NCT02688088|81753294|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
27978376|NCT02688088|81753295|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
27978377|NCT02688088|81753291|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
27978378|NCT02688088|81753292|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
27978379|NCT02688088|81753293|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
27978380|NCT02688088|81753294|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
27978381|NCT02688088|81753295|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
27978382|NCT02688088|81753291|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
27978383|NCT02688088|81753292|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
27978384|NCT02688088|81753293|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
27978385|NCT02688088|81753294|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
27978386|NCT02688088|81753295|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
27978387|NCT02688088|81753291|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
27978388|NCT02688088|81753292|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
27978389|NCT02688088|81753293|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
27978390|NCT02688088|81753294|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
27978391|NCT02688088|81753295|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
27791982|NCT00071006|81069104|FG000|Overall Study|Other|3|||
27791983|NCT04113746|81069105|FG000|Overall Study|Lost to Follow-up|4|||
27791984|NCT04113746|81069106|FG001|Overall Study|Lost to Follow-up|4|||
27791985|NCT03417245|81069109|FG000|Overall Study|Adverse Event|1|||
27791986|NCT03417245|81069110|FG001|Overall Study|Adverse Event|0|||
27978392|NCT02688088|81753291|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
27978393|NCT02688088|81753292|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
27978394|NCT02688088|81753293|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
27978395|NCT02688088|81753294|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
27978396|NCT02688088|81753295|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
27978397|NCT02688088|81753291|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
27978398|NCT02688088|81753292|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
27978399|NCT02688088|81753293|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
27791987|NCT03417245|81069109|FG000|Overall Study|Protocol Violation|1|||
27791988|NCT03417245|81069110|FG001|Overall Study|Protocol Violation|0|||
27791989|NCT03417245|81069109|FG000|Overall Study|Withdrawal by Subject|1|||
27978400|NCT02688088|81753294|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
27978401|NCT02688088|81753295|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
27978402|NCT02688088|81753291|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
27978403|NCT02688088|81753292|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
27791990|NCT03417245|81069110|FG001|Overall Study|Withdrawal by Subject|1|||
27791991|NCT02396849|81069113|FG000|Overall Study|Lost to Follow-up|1|||
27791992|NCT02396849|81069114|FG001|Overall Study|Lost to Follow-up|1|||
27978404|NCT02688088|81753293|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
27978405|NCT02688088|81753294|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
27978406|NCT02688088|81753295|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
27978407|NCT02688088|81753291|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
27978408|NCT02688088|81753292|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
27791993|NCT02396849|81069113|FG000|Overall Study|Did not tolerate intervention|1|||
27978409|NCT02688088|81753293|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
27978410|NCT02688088|81753294|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
27791994|NCT02396849|81069114|FG001|Overall Study|Did not tolerate intervention|1|||
27791995|NCT00344968|81069115|FG000|Overall Study|Adverse Event|5|||
27978411|NCT02688088|81753295|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
27978412|NCT02688088|81753291|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
27978413|NCT02688088|81753292|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
27978414|NCT02688088|81753293|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
27978415|NCT02688088|81753294|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
27978416|NCT02688088|81753295|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
27978417|NCT01479595|81753296|FG000|Overall Study|Protocol deviation|0|||
27978418|NCT01479595|81753297|FG001|Overall Study|Protocol deviation|1|||
27574567|NCT00183872|80289070|FG000|Overall Study|Drug delayed more than 28 days|2|||
27574568|NCT01866709|80289073|FG000|Overall Study|Adverse Event|1|||
27574569|NCT01866709|80289074|FG001|Overall Study|Adverse Event|0|||
27574570|NCT02141516|80289075|FG000|Overall Study|Adverse Event|0|||
27574571|NCT02141516|80289076|FG001|Overall Study|Adverse Event|1|||
27574572|NCT02141516|80289077|FG002|Overall Study|Adverse Event|0|||
27574573|NCT02141516|80289075|FG000|Overall Study|Lost to Follow-up|0|||
27574574|NCT02141516|80289076|FG001|Overall Study|Lost to Follow-up|1|||
27574575|NCT02141516|80289077|FG002|Overall Study|Lost to Follow-up|0|||
27574576|NCT02141516|80289075|FG000|Overall Study|Other|0|||
27672626|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
27791996|NCT00344968|81069116|FG001|Overall Study|Adverse Event|4|||
27791997|NCT00344968|81069117|FG002|Overall Study|Adverse Event|15|||
27791998|NCT00344968|81069115|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27791999|NCT00344968|81069116|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27792000|NCT00344968|81069117|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
27792001|NCT00344968|81069115|FG000|Overall Study|Protocol Violation|2|||
27792002|NCT00344968|81069116|FG001|Overall Study|Protocol Violation|2|||
27792003|NCT00344968|81069117|FG002|Overall Study|Protocol Violation|5|||
27792004|NCT00344968|81069115|FG000|Overall Study|Withdrawal by Subject|14|||
27792005|NCT00344968|81069116|FG001|Overall Study|Withdrawal by Subject|31|||
27792006|NCT00344968|81069117|FG002|Overall Study|Withdrawal by Subject|27|||
27792007|NCT00344968|81069115|FG000|Overall Study|Lost to Follow-up|24|||
27792008|NCT00344968|81069116|FG001|Overall Study|Lost to Follow-up|37|||
27792009|NCT00344968|81069117|FG002|Overall Study|Lost to Follow-up|37|||
27792010|NCT00344968|81069115|FG000|Overall Study|Death|11|||
27792011|NCT00344968|81069116|FG001|Overall Study|Death|27|||
27792012|NCT00344968|81069117|FG002|Overall Study|Death|31|||
27792013|NCT00344968|81069115|FG000|Overall Study|Other|0|||
27792014|NCT00344968|81069116|FG001|Overall Study|Other|1|||
27792015|NCT00344968|81069117|FG002|Overall Study|Other|0|||
27792016|NCT00240331|81069118|FG000|Overall Study|Withdrawal by Subject|125|||
27792017|NCT00240331|81069119|FG001|Overall Study|Withdrawal by Subject|132|||
27792018|NCT00240331|81069118|FG000|Overall Study|Option selected by investigator|1|||
27792019|NCT00240331|81069119|FG001|Overall Study|Option selected by investigator|2|||
27792020|NCT00054639|81069124|FG000|Overall Study|Lack of Efficacy|1|||
27792021|NCT00054639|81069124|FG000|Overall Study|Physician Decision|1|||
27792022|NCT00308555|81069125|FG000|Overall Study|Withdrawal by Subject|1|||
27792023|NCT00308555|81069126|FG001|Overall Study|Withdrawal by Subject|0|||
27792024|NCT00308555|81069125|FG000|Overall Study|Physician Decision|2|||
27792025|NCT00308555|81069126|FG001|Overall Study|Physician Decision|0|||
27792026|NCT00924820|81069136|FG000|Overall Study|Death|2|||
27792027|NCT00924820|81069136|FG000|Overall Study|Ineligible, Screen Failure|5|||
27792028|NCT02551874|81069142|FG000|Overall Study|Lost to Follow-up|0|||
27792029|NCT02551874|81069143|FG001|Overall Study|Lost to Follow-up|2|||
27792030|NCT02551874|81069142|FG000|Overall Study|Pregnancy|0|||
27792031|NCT02551874|81069143|FG001|Overall Study|Pregnancy|1|||
27792032|NCT02551874|81069142|FG000|Overall Study|Reason not reported|10|||
27792033|NCT02551874|81069143|FG001|Overall Study|Reason not reported|4|||
27792034|NCT02551874|81069142|FG000|Overall Study|Did not receive randomized treatment|0|||
27792035|NCT02551874|81069143|FG001|Overall Study|Did not receive randomized treatment|7|||
27792036|NCT02551874|81069142|FG000|Overall Study|Did not enter long-term study|18|||
27792037|NCT02551874|81069143|FG001|Overall Study|Did not enter long-term study|25|||
27792038|NCT00998166|81069144|FG000|Overall Study|Early Study Termination|8|||
27792039|NCT00548340|81069147|FG000|Overall Study|Protocol Violation|2|||
27792040|NCT00548340|81069148|FG001|Overall Study|Protocol Violation|3|||
27792041|NCT00548340|81069149|FG002|Overall Study|Protocol Violation|3|||
27792042|NCT00548340|81069147|FG000|Overall Study|Adverse Event|2|||
27978419|NCT01479595|81753296|FG000|Overall Study|Adverse Event|2|||
27978420|NCT01479595|81753297|FG001|Overall Study|Adverse Event|1|||
27574577|NCT02141516|80289076|FG001|Overall Study|Other|3|||
27574578|NCT02141516|80289077|FG002|Overall Study|Other|0|||
27574579|NCT01400841|80289078|FG000|Initial Study Phase (6 Months)|Death|1|||
27574580|NCT01400841|80289078|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
27792043|NCT00548340|81069148|FG001|Overall Study|Adverse Event|2|||
27792044|NCT00548340|81069149|FG002|Overall Study|Adverse Event|2|||
27792045|NCT00548340|81069147|FG000|Overall Study|Lost to Follow-up|1|||
27574581|NCT04879745|80289081|FG000|Overall Study|Lost to Follow-up|4|||
27574582|NCT04879745|80289082|FG001|Overall Study|Lost to Follow-up|1|||
27574583|NCT00436280|80289083|FG000|Period 1: Induction|Adverse Event|8|||
27574584|NCT00436280|80289083|FG000|Period 1: Induction|Progressive Disease|12|||
27574585|NCT00436280|80289083|FG000|Period 1: Induction|Stable Disease|6|||
27574586|NCT00436280|80289083|FG000|Period 1: Induction|Withdrawal by Subject|1|||
27574587|NCT00436280|80289083|FG000|Period 1: Induction|Death|1|||
27792046|NCT00548340|81069148|FG001|Overall Study|Lost to Follow-up|1|||
27792047|NCT00548340|81069149|FG002|Overall Study|Lost to Follow-up|0|||
27792048|NCT00548340|81069147|FG000|Overall Study|Withdrawal by Subject|2|||
27792049|NCT00548340|81069148|FG001|Overall Study|Withdrawal by Subject|4|||
27792050|NCT00548340|81069149|FG002|Overall Study|Withdrawal by Subject|3|||
27792051|NCT00548340|81069147|FG000|Overall Study|Other|1|||
27792052|NCT00548340|81069148|FG001|Overall Study|Other|1|||
27792053|NCT00548340|81069149|FG002|Overall Study|Other|1|||
27792054|NCT01826201|81069150|FG000|Overall Study|Non compliance with protocol|4|||
27792055|NCT03917654|81069153|FG000|Year 1|Withdrawal by Subject|1|||
27792056|NCT03917654|81069154|FG001|Year 1|Withdrawal by Subject|0|||
27792057|NCT03917654|81069155|FG002|Year 1|Withdrawal by Subject|0|||
27792058|NCT03917654|81069156|FG003|Year 1|Withdrawal by Subject|0|||
27792059|NCT03917654|81069157|FG004|Year 1|Withdrawal by Subject|0|||
27792060|NCT03917654|81069158|FG005|Year 1|Withdrawal by Subject|1|||
27792061|NCT03917654|81069159|FG006|Year 1|Withdrawal by Subject|6|||
27792062|NCT03917654|81069160|FG007|Year 1|Withdrawal by Subject|2|||
27792063|NCT03917654|81069161|FG008|Year 1|Withdrawal by Subject|5|||
27792064|NCT03917654|81069162|FG009|Year 1|Withdrawal by Subject|3|||
27792065|NCT03917654|81069163|FG010|Year 1|Withdrawal by Subject|1|||
27792066|NCT03917654|81069164|FG011|Year 1|Withdrawal by Subject|0|||
27792067|NCT03917654|81069153|FG000|Year 1|Travel|0|||
27792068|NCT03917654|81069154|FG001|Year 1|Travel|1|||
27792069|NCT03917654|81069155|FG002|Year 1|Travel|1|||
27792070|NCT03917654|81069156|FG003|Year 1|Travel|0|||
27792071|NCT03917654|81069157|FG004|Year 1|Travel|4|||
27792072|NCT03917654|81069158|FG005|Year 1|Travel|4|||
27792073|NCT03917654|81069159|FG006|Year 1|Travel|10|||
27792074|NCT03917654|81069160|FG007|Year 1|Travel|8|||
27792075|NCT03917654|81069161|FG008|Year 1|Travel|2|||
27792076|NCT03917654|81069162|FG009|Year 1|Travel|5|||
27792077|NCT03917654|81069163|FG010|Year 1|Travel|3|||
27792078|NCT03917654|81069164|FG011|Year 1|Travel|3|||
27792079|NCT03917654|81069153|FG000|Year 1|Subject moved away from site|0|||
27792080|NCT03917654|81069154|FG001|Year 1|Subject moved away from site|1|||
27792081|NCT03917654|81069155|FG002|Year 1|Subject moved away from site|0|||
27792082|NCT03917654|81069156|FG003|Year 1|Subject moved away from site|0|||
27792083|NCT03917654|81069157|FG004|Year 1|Subject moved away from site|0|||
27792084|NCT03917654|81069158|FG005|Year 1|Subject moved away from site|0|||
27792085|NCT03917654|81069159|FG006|Year 1|Subject moved away from site|1|||
27792086|NCT03917654|81069160|FG007|Year 1|Subject moved away from site|2|||
27792087|NCT03917654|81069161|FG008|Year 1|Subject moved away from site|1|||
27792088|NCT03917654|81069162|FG009|Year 1|Subject moved away from site|0|||
27792089|NCT03917654|81069163|FG010|Year 1|Subject moved away from site|0|||
27792090|NCT03917654|81069164|FG011|Year 1|Subject moved away from site|3|||
27792091|NCT03917654|81069153|FG000|Year 1|Spouse/Family member request|0|||
27792092|NCT03917654|81069154|FG001|Year 1|Spouse/Family member request|0|||
27792093|NCT03917654|81069155|FG002|Year 1|Spouse/Family member request|1|||
27792094|NCT03917654|81069156|FG003|Year 1|Spouse/Family member request|0|||
27792095|NCT03917654|81069157|FG004|Year 1|Spouse/Family member request|1|||
27792096|NCT03917654|81069158|FG005|Year 1|Spouse/Family member request|0|||
27792097|NCT03917654|81069159|FG006|Year 1|Spouse/Family member request|0|||
27792098|NCT03917654|81069160|FG007|Year 1|Spouse/Family member request|2|||
27792099|NCT03917654|81069161|FG008|Year 1|Spouse/Family member request|0|||
27792100|NCT03917654|81069162|FG009|Year 1|Spouse/Family member request|0|||
27792101|NCT03917654|81069163|FG010|Year 1|Spouse/Family member request|0|||
27574588|NCT00436280|80289083|FG000|Period 2: Consolidation|Adverse Event|1|||
27792102|NCT03917654|81069164|FG011|Year 1|Spouse/Family member request|1|||
27792103|NCT03917654|81069153|FG000|Year 1|Death|0|||
27792104|NCT03917654|81069154|FG001|Year 1|Death|0|||
27792105|NCT03917654|81069155|FG002|Year 1|Death|0|||
27792106|NCT03917654|81069156|FG003|Year 1|Death|0|||
27792107|NCT03917654|81069157|FG004|Year 1|Death|0|||
27792108|NCT03917654|81069158|FG005|Year 1|Death|0|||
27792109|NCT03917654|81069159|FG006|Year 1|Death|0|||
27574589|NCT00436280|80289083|FG000|Period 2: Consolidation|Progressive Disease|10|||
27792110|NCT03917654|81069160|FG007|Year 1|Death|0|||
27792111|NCT03917654|81069161|FG008|Year 1|Death|1|||
27792112|NCT03917654|81069162|FG009|Year 1|Death|1|||
27792113|NCT03917654|81069163|FG010|Year 1|Death|0|||
27792114|NCT03917654|81069164|FG011|Year 1|Death|0|||
27792115|NCT03917654|81069153|FG000|Year 1|Lost to Follow-up|0|||
27792116|NCT03917654|81069154|FG001|Year 1|Lost to Follow-up|0|||
27792117|NCT03917654|81069155|FG002|Year 1|Lost to Follow-up|0|||
27978421|NCT01945775|81753298|FG000|Overall Study|Death|214|||
27978422|NCT01945775|81753299|FG001|Overall Study|Death|98|||
27978423|NCT01945775|81753298|FG000|Overall Study|Lost to Follow-up|12|||
27978424|NCT01945775|81753299|FG001|Overall Study|Lost to Follow-up|7|||
27978425|NCT01945775|81753298|FG000|Overall Study|Withdrawal by Subject|11|||
27978426|NCT01945775|81753299|FG001|Overall Study|Withdrawal by Subject|21|||
27978427|NCT01945775|81753298|FG000|Overall Study|Other|50|||
27978428|NCT01945775|81753299|FG001|Overall Study|Other|18|||
27978429|NCT00806442|81753305|FG000|Overall Study|Lost to Follow-up|3|||
27978430|NCT00806442|81753306|FG001|Overall Study|Lost to Follow-up|2|||
27978431|NCT00806442|81753305|FG000|Overall Study|Withdrawal by Subject|1|||
27978432|NCT00806442|81753306|FG001|Overall Study|Withdrawal by Subject|5|||
27978433|NCT01344629|81753307|FG000|Crossover Period 2|Withdrawal by Subject|0|||
27978434|NCT01344629|81753308|FG001|Crossover Period 2|Withdrawal by Subject|1|||
27978435|NCT00240110|81753313|FG000|Overall Study|Lost to Follow-up|6|||
27978436|NCT00240110|81753314|FG001|Overall Study|Lost to Follow-up|7|||
27978437|NCT00320255|81753315|FG000|Overall Study|Lack of Efficacy|1|||
27978438|NCT00320255|81753316|FG001|Overall Study|Lack of Efficacy|0|||
27978439|NCT00320255|81753317|FG002|Overall Study|Lack of Efficacy|0|||
27978440|NCT00320255|81753318|FG003|Overall Study|Lack of Efficacy|0|||
27978441|NCT00320255|81753319|FG004|Overall Study|Lack of Efficacy|0|||
27978442|NCT00320255|81753320|FG005|Overall Study|Lack of Efficacy|0|||
27978443|NCT00320255|81753315|FG000|Overall Study|Adverse Event|5|||
27978444|NCT00320255|81753316|FG001|Overall Study|Adverse Event|2|||
27978445|NCT00320255|81753317|FG002|Overall Study|Adverse Event|3|||
27978446|NCT00320255|81753318|FG003|Overall Study|Adverse Event|2|||
27978447|NCT00320255|81753319|FG004|Overall Study|Adverse Event|0|||
27978448|NCT00320255|81753320|FG005|Overall Study|Adverse Event|0|||
27978449|NCT00320255|81753315|FG000|Overall Study|Withdrawal by Subject|1|||
27978450|NCT00320255|81753316|FG001|Overall Study|Withdrawal by Subject|2|||
27978451|NCT00320255|81753317|FG002|Overall Study|Withdrawal by Subject|2|||
27978452|NCT00320255|81753318|FG003|Overall Study|Withdrawal by Subject|4|||
27978453|NCT00320255|81753319|FG004|Overall Study|Withdrawal by Subject|0|||
27978454|NCT00320255|81753320|FG005|Overall Study|Withdrawal by Subject|0|||
27978455|NCT00320255|81753315|FG000|Overall Study|Poor compliance/noncompliance|1|||
27978456|NCT00320255|81753316|FG001|Overall Study|Poor compliance/noncompliance|1|||
27978457|NCT00320255|81753317|FG002|Overall Study|Poor compliance/noncompliance|0|||
27978458|NCT00320255|81753318|FG003|Overall Study|Poor compliance/noncompliance|1|||
27978459|NCT00320255|81753319|FG004|Overall Study|Poor compliance/noncompliance|0|||
27978460|NCT00320255|81753320|FG005|Overall Study|Poor compliance/noncompliance|0|||
27978461|NCT00320255|81753315|FG000|Overall Study|No longer meets study criteria|0|||
27978462|NCT00320255|81753316|FG001|Overall Study|No longer meets study criteria|0|||
27978463|NCT00320255|81753317|FG002|Overall Study|No longer meets study criteria|0|||
27978464|NCT00320255|81753318|FG003|Overall Study|No longer meets study criteria|1|||
27978465|NCT00320255|81753319|FG004|Overall Study|No longer meets study criteria|0|||
27978466|NCT00320255|81753320|FG005|Overall Study|No longer meets study criteria|0|||
27978467|NCT00320255|81753315|FG000|Overall Study|Other|3|||
27978468|NCT00320255|81753316|FG001|Overall Study|Other|2|||
27978469|NCT00320255|81753317|FG002|Overall Study|Other|1|||
27978470|NCT00320255|81753318|FG003|Overall Study|Other|0|||
27978471|NCT00320255|81753319|FG004|Overall Study|Other|0|||
27978472|NCT00320255|81753320|FG005|Overall Study|Other|0|||
27978473|NCT02193087|81753323|FG000|Overall Study|Adverse Event|2|||
27978474|NCT02193087|81753324|FG001|Overall Study|Adverse Event|0|||
27978475|NCT02193087|81753325|FG002|Overall Study|Adverse Event|0|||
27978476|NCT02193087|81753326|FG003|Overall Study|Adverse Event|11|||
27978477|NCT02193087|81753323|FG000|Overall Study|Lost to Follow-up|14|||
27978478|NCT02193087|81753324|FG001|Overall Study|Lost to Follow-up|6|||
27978479|NCT02193087|81753325|FG002|Overall Study|Lost to Follow-up|4|||
27978480|NCT02193087|81753326|FG003|Overall Study|Lost to Follow-up|37|||
27978481|NCT02193087|81753323|FG000|Overall Study|Protocol Violation|2|||
27978482|NCT02193087|81753324|FG001|Overall Study|Protocol Violation|0|||
27978483|NCT02193087|81753325|FG002|Overall Study|Protocol Violation|1|||
27978484|NCT02193087|81753326|FG003|Overall Study|Protocol Violation|2|||
27978485|NCT02193087|81753323|FG000|Overall Study|Withdrawal by Subject|10|||
27978486|NCT02193087|81753324|FG001|Overall Study|Withdrawal by Subject|3|||
27978487|NCT02193087|81753325|FG002|Overall Study|Withdrawal by Subject|1|||
27978488|NCT02193087|81753326|FG003|Overall Study|Withdrawal by Subject|19|||
27978489|NCT02193087|81753323|FG000|Overall Study|Other Reason Not Specified|7|||
27978490|NCT02193087|81753324|FG001|Overall Study|Other Reason Not Specified|2|||
27978491|NCT02193087|81753325|FG002|Overall Study|Other Reason Not Specified|1|||
27978492|NCT02193087|81753326|FG003|Overall Study|Other Reason Not Specified|9|||
27978493|NCT02193087|81753323|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
27978494|NCT02193087|81753324|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
27978495|NCT02193087|81753325|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
27978496|NCT02193087|81753326|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
27978497|NCT02358044|81753327|FG000|Overall Study|Adverse Event|0|||
27978498|NCT02358044|81753328|FG001|Overall Study|Adverse Event|1|||
27792118|NCT03917654|81069156|FG003|Year 1|Lost to Follow-up|0|||
27792119|NCT03917654|81069157|FG004|Year 1|Lost to Follow-up|0|||
27792120|NCT03917654|81069158|FG005|Year 1|Lost to Follow-up|0|||
27792121|NCT03917654|81069159|FG006|Year 1|Lost to Follow-up|2|||
27792122|NCT03917654|81069160|FG007|Year 1|Lost to Follow-up|0|||
27574590|NCT00436280|80289083|FG000|Period 2: Consolidation|Stable Disease|1|||
27574591|NCT00436280|80289083|FG000|Period 2: Consolidation|Physician Decision|2|||
27574592|NCT00436280|80289083|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
27574593|NCT00436280|80289083|FG000|Period 2: Consolidation|Death|1|||
27574594|NCT00436280|80289083|FG000|Period 3: Maintenance|Adverse Event|6|||
27574595|NCT00436280|80289083|FG000|Period 3: Maintenance|Progressive Disease|12|||
27574596|NCT01687166|80289086|FG000|Overall Study|Attempt subject|2|||
27574597|NCT01687166|80289087|FG001|Overall Study|Attempt subject|3|||
27574598|NCT01687166|80289088|FG002|Overall Study|Attempt subject|2|||
27574599|NCT01687166|80289089|FG003|Overall Study|Attempt subject|0|||
27574600|NCT01687166|80289086|FG000|Overall Study|Did not meet eligibility criteria|4|||
27574601|NCT01687166|80289087|FG001|Overall Study|Did not meet eligibility criteria|6|||
27574602|NCT01687166|80289088|FG002|Overall Study|Did not meet eligibility criteria|1|||
27574603|NCT01687166|80289089|FG003|Overall Study|Did not meet eligibility criteria|1|||
27574604|NCT01687166|80289086|FG000|Overall Study|Adverse Event|2|||
27574605|NCT01687166|80289087|FG001|Overall Study|Adverse Event|1|||
27574606|NCT01687166|80289088|FG002|Overall Study|Adverse Event|0|||
27574607|NCT01687166|80289089|FG003|Overall Study|Adverse Event|0|||
27574608|NCT01687166|80289086|FG000|Overall Study|Physician Decision|3|||
27574609|NCT01687166|80289087|FG001|Overall Study|Physician Decision|2|||
27672627|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
27672628|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
27672629|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
27672630|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
27672631|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
27672632|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
27672633|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
27672634|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
27672635|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
27672636|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
27672637|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
27672638|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
27672639|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Missing|2|||
27672640|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Missing|1|||
27672641|NCT00443209|80639282|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
27672642|NCT00443209|80639283|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
27672643|NCT00443209|80639282|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
27672644|NCT00443209|80639283|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
27672645|NCT00443209|80639282|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
27672646|NCT00443209|80639283|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
27672647|NCT00443209|80639282|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
27672648|NCT00443209|80639283|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
27792123|NCT03917654|81069161|FG008|Year 1|Lost to Follow-up|0|||
27792124|NCT03917654|81069162|FG009|Year 1|Lost to Follow-up|0|||
27792125|NCT03917654|81069163|FG010|Year 1|Lost to Follow-up|0|||
27792126|NCT03917654|81069164|FG011|Year 1|Lost to Follow-up|0|||
27792127|NCT03917654|81069153|FG000|Year 1|Missed visits|0|||
27792128|NCT03917654|81069154|FG001|Year 1|Missed visits|0|||
27978499|NCT02358044|81753327|FG000|Overall Study|Lost to Follow-up|2|||
27792129|NCT03917654|81069155|FG002|Year 1|Missed visits|0|||
27792130|NCT03917654|81069156|FG003|Year 1|Missed visits|0|||
27792131|NCT03917654|81069157|FG004|Year 1|Missed visits|0|||
27792132|NCT03917654|81069158|FG005|Year 1|Missed visits|0|||
27792133|NCT03917654|81069159|FG006|Year 1|Missed visits|0|||
27978500|NCT02358044|81753328|FG001|Overall Study|Lost to Follow-up|1|||
27978501|NCT02358044|81753327|FG000|Overall Study|Physician Decision|0|||
27978502|NCT02358044|81753328|FG001|Overall Study|Physician Decision|1|||
27672649|NCT00443209|80639282|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
27792134|NCT03917654|81069160|FG007|Year 1|Missed visits|0|||
27792135|NCT03917654|81069161|FG008|Year 1|Missed visits|0|||
27792136|NCT03917654|81069162|FG009|Year 1|Missed visits|0|||
27792137|NCT03917654|81069163|FG010|Year 1|Missed visits|1|||
27792138|NCT03917654|81069164|FG011|Year 1|Missed visits|1|||
27792139|NCT03917654|81069153|FG000|Year 1|Pregnancy|0|||
27792140|NCT03917654|81069154|FG001|Year 1|Pregnancy|0|||
27978503|NCT02358044|81753327|FG000|Overall Study|Withdrawal by Subject|0|||
27574610|NCT01687166|80289088|FG002|Overall Study|Physician Decision|1|||
27574611|NCT01687166|80289089|FG003|Overall Study|Physician Decision|0|||
27574612|NCT01687166|80289086|FG000|Overall Study|Withdrawal by Subject|11|||
27574613|NCT01687166|80289087|FG001|Overall Study|Withdrawal by Subject|4|||
27574614|NCT01687166|80289088|FG002|Overall Study|Withdrawal by Subject|3|||
27792141|NCT03917654|81069155|FG002|Year 1|Pregnancy|0|||
27792142|NCT03917654|81069156|FG003|Year 1|Pregnancy|0|||
27792143|NCT03917654|81069157|FG004|Year 1|Pregnancy|0|||
27792144|NCT03917654|81069158|FG005|Year 1|Pregnancy|0|||
27792145|NCT03917654|81069159|FG006|Year 1|Pregnancy|0|||
27792146|NCT03917654|81069160|FG007|Year 1|Pregnancy|1|||
27792147|NCT03917654|81069161|FG008|Year 1|Pregnancy|0|||
27792148|NCT03917654|81069162|FG009|Year 1|Pregnancy|1|||
27672650|NCT00443209|80639283|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
27672651|NCT00443209|80639282|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
27672652|NCT00443209|80639283|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
27672653|NCT00443209|80639282|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
27672654|NCT00443209|80639283|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
27672655|NCT02460562|80639287|FG000|Overall Study|Lost to Follow-up|15|||
27672656|NCT02460562|80639288|FG001|Overall Study|Lost to Follow-up|16|||
27672657|NCT01929876|80639290|FG000|Period 2|Non-Compliance|1|||
27672658|NCT01111240|80639291|FG000|Overall Study|Adverse Event|190|||
27672659|NCT01111240|80639291|FG000|Overall Study|Lack of Efficacy|545|||
27672660|NCT01111240|80639291|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
27672661|NCT01111240|80639291|FG000|Overall Study|Other|312|||
27672662|NCT00784147|80639292|FG000|Overall Study|Lost to Follow-up|2|||
27672663|NCT00784147|80639293|FG001|Overall Study|Lost to Follow-up|4|||
27672664|NCT00784147|80639292|FG000|Overall Study|Withdrawal by Subject|1|||
27672665|NCT00784147|80639293|FG001|Overall Study|Withdrawal by Subject|3|||
27792149|NCT03917654|81069163|FG010|Year 1|Pregnancy|0|||
27792150|NCT03917654|81069164|FG011|Year 1|Pregnancy|0|||
27672666|NCT00784147|80639292|FG000|Overall Study|Physician Decision|2|||
27672667|NCT00784147|80639293|FG001|Overall Study|Physician Decision|1|||
27672668|NCT00784147|80639292|FG000|Overall Study|Protocol Violation|1|||
27672669|NCT00784147|80639293|FG001|Overall Study|Protocol Violation|1|||
27672670|NCT00784147|80639292|FG000|Overall Study|Death|2|||
27672671|NCT00784147|80639293|FG001|Overall Study|Death|0|||
27672672|NCT01266018|80639294|FG000|Overall Study|Physician Decision|1|||
27672673|NCT01266018|80639295|FG001|Overall Study|Physician Decision|0|||
27792151|NCT03917654|81069153|FG000|Year 2|Travel|1|||
27792152|NCT03917654|81069154|FG001|Year 2|Travel|0|||
27792153|NCT03917654|81069155|FG002|Year 2|Travel|0|||
27792154|NCT03917654|81069156|FG003|Year 2|Travel|0|||
27792155|NCT03917654|81069157|FG004|Year 2|Travel|1|||
27978504|NCT02358044|81753328|FG001|Overall Study|Withdrawal by Subject|4|||
27978505|NCT02608450|81753331|FG000|Overall Study|Lost to Follow-up|39|||
27792156|NCT03917654|81069158|FG005|Year 2|Travel|1|||
27792157|NCT03917654|81069159|FG006|Year 2|Travel|2|||
27792158|NCT03917654|81069160|FG007|Year 2|Travel|1|||
27792159|NCT03917654|81069161|FG008|Year 2|Travel|0|||
27792160|NCT03917654|81069162|FG009|Year 2|Travel|1|||
27792161|NCT03917654|81069163|FG010|Year 2|Travel|0|||
27792162|NCT03917654|81069164|FG011|Year 2|Travel|1|||
27792163|NCT03917654|81069153|FG000|Year 2|Married|1|||
27792164|NCT03917654|81069154|FG001|Year 2|Married|0|||
27792165|NCT03917654|81069155|FG002|Year 2|Married|0|||
27792166|NCT03917654|81069156|FG003|Year 2|Married|0|||
27792167|NCT03917654|81069157|FG004|Year 2|Married|0|||
27792168|NCT03917654|81069158|FG005|Year 2|Married|0|||
27978506|NCT02608450|81753332|FG001|Overall Study|Lost to Follow-up|32|||
27978507|NCT02608450|81753331|FG000|Overall Study|Withdrawal by Subject|21|||
27978508|NCT02608450|81753332|FG001|Overall Study|Withdrawal by Subject|15|||
27978509|NCT02608450|81753331|FG000|Overall Study|Adverse Event|3|||
27672674|NCT01266018|80639294|FG000|Overall Study|Progressive disease|0|||
27672675|NCT01266018|80639295|FG001|Overall Study|Progressive disease|1|||
27792169|NCT03917654|81069159|FG006|Year 2|Married|1|||
27792170|NCT03917654|81069160|FG007|Year 2|Married|1|||
27978510|NCT02608450|81753332|FG001|Overall Study|Adverse Event|6|||
27978511|NCT02608450|81753331|FG000|Overall Study|Withdrawal by parent|2|||
27978512|NCT02608450|81753332|FG001|Overall Study|Withdrawal by parent|3|||
27978513|NCT02608450|81753331|FG000|Overall Study|Lack of Efficacy|0|||
27978514|NCT02608450|81753332|FG001|Overall Study|Lack of Efficacy|3|||
27792171|NCT03917654|81069161|FG008|Year 2|Married|0|||
27792172|NCT03917654|81069162|FG009|Year 2|Married|0|||
27978515|NCT02608450|81753331|FG000|Overall Study|Noncompliance with study drug|0|||
27672676|NCT02825251|80639296|FG000|Overall Study|Adverse Event|0|||
27672677|NCT02825251|80639297|FG001|Overall Study|Adverse Event|1|||
27672678|NCT02825251|80639296|FG000|Overall Study|Lost to Follow-up|0|||
27672679|NCT02825251|80639297|FG001|Overall Study|Lost to Follow-up|1|||
27792173|NCT03917654|81069163|FG010|Year 2|Married|0|||
27792174|NCT03917654|81069164|FG011|Year 2|Married|0|||
27792175|NCT03917654|81069153|FG000|Year 2|Subject moved away from site|1|||
27792176|NCT03917654|81069154|FG001|Year 2|Subject moved away from site|0|||
27792177|NCT03917654|81069155|FG002|Year 2|Subject moved away from site|0|||
27792178|NCT03917654|81069156|FG003|Year 2|Subject moved away from site|0|||
27792179|NCT03917654|81069157|FG004|Year 2|Subject moved away from site|1|||
27792180|NCT03917654|81069158|FG005|Year 2|Subject moved away from site|0|||
27792181|NCT03917654|81069159|FG006|Year 2|Subject moved away from site|2|||
27792182|NCT03917654|81069160|FG007|Year 2|Subject moved away from site|3|||
27978516|NCT02608450|81753332|FG001|Overall Study|Noncompliance with study drug|2|||
27978517|NCT02608450|81753331|FG000|Overall Study|Physician Decision|0|||
27792183|NCT03917654|81069161|FG008|Year 2|Subject moved away from site|0|||
27792184|NCT03917654|81069162|FG009|Year 2|Subject moved away from site|2|||
27792185|NCT03917654|81069163|FG010|Year 2|Subject moved away from site|0|||
27792186|NCT03917654|81069164|FG011|Year 2|Subject moved away from site|1|||
27792187|NCT03917654|81069153|FG000|Year 2|Year 2 Screening failure|0|||
27792188|NCT03917654|81069154|FG001|Year 2|Year 2 Screening failure|1|||
27792189|NCT03917654|81069155|FG002|Year 2|Year 2 Screening failure|0|||
27792190|NCT03917654|81069156|FG003|Year 2|Year 2 Screening failure|0|||
27792191|NCT03917654|81069157|FG004|Year 2|Year 2 Screening failure|2|||
27792192|NCT03917654|81069158|FG005|Year 2|Year 2 Screening failure|0|||
27792193|NCT03917654|81069159|FG006|Year 2|Year 2 Screening failure|4|||
27672680|NCT02825251|80639296|FG000|Overall Study|Withdrawal by Subject|1|||
27672681|NCT02825251|80639297|FG001|Overall Study|Withdrawal by Subject|4|||
27672682|NCT02825251|80639296|FG000|Overall Study|Unclassified|2|||
27672683|NCT02825251|80639297|FG001|Overall Study|Unclassified|0|||
27672684|NCT01090011|80639298|FG000|Overall Study|Progressive disease|128|||
27672685|NCT01090011|80639298|FG000|Overall Study|Adverse Event|32|||
27792194|NCT03917654|81069160|FG007|Year 2|Year 2 Screening failure|3|||
27792195|NCT03917654|81069161|FG008|Year 2|Year 2 Screening failure|10|||
27792196|NCT03917654|81069162|FG009|Year 2|Year 2 Screening failure|2|||
27792197|NCT03917654|81069163|FG010|Year 2|Year 2 Screening failure|1|||
27792198|NCT03917654|81069164|FG011|Year 2|Year 2 Screening failure|1|||
27792199|NCT03917654|81069153|FG000|Year 2|Death|0|||
27792200|NCT03917654|81069154|FG001|Year 2|Death|0|||
27792201|NCT03917654|81069155|FG002|Year 2|Death|0|||
27792202|NCT03917654|81069156|FG003|Year 2|Death|0|||
27792203|NCT03917654|81069157|FG004|Year 2|Death|0|||
27792204|NCT03917654|81069158|FG005|Year 2|Death|1|||
27792205|NCT03917654|81069159|FG006|Year 2|Death|0|||
27792206|NCT03917654|81069160|FG007|Year 2|Death|0|||
27792207|NCT03917654|81069161|FG008|Year 2|Death|1|||
27792208|NCT03917654|81069162|FG009|Year 2|Death|1|||
27792209|NCT03917654|81069163|FG010|Year 2|Death|0|||
27792210|NCT03917654|81069164|FG011|Year 2|Death|0|||
27792211|NCT03917654|81069153|FG000|Year 2|Withdrawal by Subject|0|||
27792212|NCT03917654|81069154|FG001|Year 2|Withdrawal by Subject|0|||
27792213|NCT03917654|81069155|FG002|Year 2|Withdrawal by Subject|0|||
27792214|NCT03917654|81069156|FG003|Year 2|Withdrawal by Subject|0|||
27792215|NCT03917654|81069157|FG004|Year 2|Withdrawal by Subject|0|||
27792216|NCT03917654|81069158|FG005|Year 2|Withdrawal by Subject|0|||
27792217|NCT03917654|81069159|FG006|Year 2|Withdrawal by Subject|3|||
27792218|NCT03917654|81069160|FG007|Year 2|Withdrawal by Subject|0|||
27792219|NCT03917654|81069161|FG008|Year 2|Withdrawal by Subject|2|||
27792220|NCT03917654|81069162|FG009|Year 2|Withdrawal by Subject|5|||
27672686|NCT01090011|80639298|FG000|Overall Study|Protocol Violation|1|||
27792221|NCT03917654|81069163|FG010|Year 2|Withdrawal by Subject|0|||
27792222|NCT03917654|81069164|FG011|Year 2|Withdrawal by Subject|0|||
27792223|NCT03917654|81069153|FG000|Year 2|Spouse/family member request|0|||
27792224|NCT03917654|81069154|FG001|Year 2|Spouse/family member request|0|||
27792225|NCT03917654|81069155|FG002|Year 2|Spouse/family member request|0|||
27792226|NCT03917654|81069156|FG003|Year 2|Spouse/family member request|0|||
27792227|NCT03917654|81069157|FG004|Year 2|Spouse/family member request|0|||
27792228|NCT03917654|81069158|FG005|Year 2|Spouse/family member request|0|||
27792229|NCT03917654|81069159|FG006|Year 2|Spouse/family member request|1|||
27792230|NCT03917654|81069160|FG007|Year 2|Spouse/family member request|0|||
27792231|NCT03917654|81069161|FG008|Year 2|Spouse/family member request|0|||
27792232|NCT03917654|81069162|FG009|Year 2|Spouse/family member request|0|||
27792233|NCT03917654|81069163|FG010|Year 2|Spouse/family member request|0|||
27792234|NCT03917654|81069164|FG011|Year 2|Spouse/family member request|0|||
27792235|NCT03917654|81069153|FG000|Year 2|Lost to Follow-up|0|||
27792236|NCT03917654|81069154|FG001|Year 2|Lost to Follow-up|0|||
27792237|NCT03917654|81069155|FG002|Year 2|Lost to Follow-up|0|||
27672687|NCT01090011|80639298|FG000|Overall Study|Refusal to start/continue medication|5|||
27792238|NCT03917654|81069156|FG003|Year 2|Lost to Follow-up|0|||
27792239|NCT03917654|81069157|FG004|Year 2|Lost to Follow-up|0|||
27672688|NCT01090011|80639298|FG000|Overall Study|Other reason not defined above|5|||
27672689|NCT00760747|80639303|FG000|Study Period II|Adverse Event|3|||
27792240|NCT03917654|81069158|FG005|Year 2|Lost to Follow-up|0|||
27792241|NCT03917654|81069159|FG006|Year 2|Lost to Follow-up|1|||
27672690|NCT00760747|80639304|FG001|Study Period II|Adverse Event|4|||
27672691|NCT00760747|80639303|FG000|Study Period II|Lack of Efficacy|0|||
27672692|NCT00760747|80639304|FG001|Study Period II|Lack of Efficacy|6|||
27792242|NCT03917654|81069160|FG007|Year 2|Lost to Follow-up|0|||
27792243|NCT03917654|81069161|FG008|Year 2|Lost to Follow-up|1|||
27792244|NCT03917654|81069162|FG009|Year 2|Lost to Follow-up|0|||
27792245|NCT03917654|81069163|FG010|Year 2|Lost to Follow-up|0|||
27792246|NCT03917654|81069164|FG011|Year 2|Lost to Follow-up|1|||
27792247|NCT03917654|81069153|FG000|Year 2|Adverse Event|0|||
27792248|NCT03917654|81069154|FG001|Year 2|Adverse Event|0|||
27792249|NCT03917654|81069155|FG002|Year 2|Adverse Event|0|||
27792250|NCT03917654|81069156|FG003|Year 2|Adverse Event|0|||
27792251|NCT03917654|81069157|FG004|Year 2|Adverse Event|0|||
27792252|NCT03917654|81069158|FG005|Year 2|Adverse Event|0|||
27792253|NCT03917654|81069159|FG006|Year 2|Adverse Event|0|||
27792254|NCT03917654|81069160|FG007|Year 2|Adverse Event|0|||
27792255|NCT03917654|81069161|FG008|Year 2|Adverse Event|0|||
27574615|NCT01687166|80289089|FG003|Overall Study|Withdrawal by Subject|0|||
27574616|NCT01687166|80289086|FG000|Overall Study|Lost to Follow-up|2|||
27792256|NCT03917654|81069162|FG009|Year 2|Adverse Event|1|||
27792257|NCT03917654|81069163|FG010|Year 2|Adverse Event|0|||
27792258|NCT03917654|81069164|FG011|Year 2|Adverse Event|0|||
27574617|NCT01687166|80289087|FG001|Overall Study|Lost to Follow-up|5|||
27574618|NCT01687166|80289088|FG002|Overall Study|Lost to Follow-up|1|||
27574619|NCT01687166|80289089|FG003|Overall Study|Lost to Follow-up|0|||
27574620|NCT01687166|80289086|FG000|Overall Study|Equipment/Device Availability|0|||
27574621|NCT01687166|80289087|FG001|Overall Study|Equipment/Device Availability|1|||
27792259|NCT04144140|81069165|FG000|Overall Study|Other|0|||
27792260|NCT04144140|81069166|FG001|Overall Study|Other|0|||
27792261|NCT04144140|81069167|FG002|Overall Study|Other|0|||
27792262|NCT04144140|81069168|FG003|Overall Study|Other|0|||
27792263|NCT04144140|81069169|FG004|Overall Study|Other|0|||
27792264|NCT04144140|81069170|FG005|Overall Study|Other|1|||
27792265|NCT04144140|81069171|FG006|Overall Study|Other|0|||
27792266|NCT01275170|81069172|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
27792267|NCT01275170|81069173|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792268|NCT01275170|81069174|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792269|NCT01275170|81069175|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792270|NCT01275170|81069176|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792271|NCT01275170|81069177|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792272|NCT01275170|81069178|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792273|NCT01275170|81069179|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
27792274|NCT01298362|81069182|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
27792275|NCT01298362|81069183|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
27792276|NCT00347776|81069184|FG000|1.5 Month Follow-up|Death|2|||
27792277|NCT00347776|81069185|FG001|1.5 Month Follow-up|Death|0|||
27792278|NCT00347776|81069186|FG002|1.5 Month Follow-up|Death|0|||
27792279|NCT00347776|81069184|FG000|1.5 Month Follow-up|reached the endpoint|12|||
27792280|NCT00347776|81069185|FG001|1.5 Month Follow-up|reached the endpoint|8|||
27792281|NCT00347776|81069186|FG002|1.5 Month Follow-up|reached the endpoint|12|||
27792282|NCT00347776|81069184|FG000|6 Month Follow-up|Death|2|||
27792283|NCT00347776|81069185|FG001|6 Month Follow-up|Death|1|||
27792284|NCT00347776|81069186|FG002|6 Month Follow-up|Death|3|||
27792285|NCT00347776|81069184|FG000|6 Month Follow-up|reached endpont|20|||
27792286|NCT00347776|81069185|FG001|6 Month Follow-up|reached endpont|12|||
27792287|NCT00347776|81069186|FG002|6 Month Follow-up|reached endpont|15|||
27792288|NCT00347776|81069184|FG000|12 Month Follow-up|Lost to Follow-up|7|||
27792289|NCT00347776|81069185|FG001|12 Month Follow-up|Lost to Follow-up|6|||
27792290|NCT00347776|81069186|FG002|12 Month Follow-up|Lost to Follow-up|6|||
27792291|NCT00347776|81069184|FG000|12 Month Follow-up|Death|3|||
27792292|NCT00347776|81069185|FG001|12 Month Follow-up|Death|4|||
27792293|NCT00347776|81069186|FG002|12 Month Follow-up|Death|4|||
27978518|NCT02608450|81753332|FG001|Overall Study|Physician Decision|1|||
27574622|NCT01687166|80289088|FG002|Overall Study|Equipment/Device Availability|0|||
27574623|NCT01687166|80289089|FG003|Overall Study|Equipment/Device Availability|0|||
27574624|NCT01687166|80289086|FG000|Overall Study|Death|1|||
27574625|NCT01687166|80289087|FG001|Overall Study|Death|1|||
27574626|NCT01687166|80289088|FG002|Overall Study|Death|0|||
27574627|NCT01687166|80289089|FG003|Overall Study|Death|0|||
27574628|NCT01687166|80289086|FG000|Overall Study|Protocol Violation|1|||
27574629|NCT01687166|80289087|FG001|Overall Study|Protocol Violation|1|||
27574630|NCT01687166|80289088|FG002|Overall Study|Protocol Violation|1|||
27574631|NCT01687166|80289089|FG003|Overall Study|Protocol Violation|0|||
27574632|NCT01687166|80289086|FG000|Overall Study|Subject moved out of state|0|||
27574633|NCT01687166|80289087|FG001|Overall Study|Subject moved out of state|1|||
27574634|NCT01687166|80289088|FG002|Overall Study|Subject moved out of state|0|||
27672693|NCT00760747|80639303|FG000|Study Period II|Parent/Caregiver Decision|3|||
27672694|NCT00760747|80639304|FG001|Study Period II|Parent/Caregiver Decision|0|||
27792294|NCT00347776|81069184|FG000|12 Month Follow-up|Reached endpoint|13|||
27792295|NCT00347776|81069185|FG001|12 Month Follow-up|Reached endpoint|6|||
27792296|NCT00347776|81069186|FG002|12 Month Follow-up|Reached endpoint|9|||
27792297|NCT02797951|81069193|FG000|Overall Study|Adverse Event|4|||
27792298|NCT02797951|81069193|FG000|Overall Study|Death|1|||
27792299|NCT02797951|81069193|FG000|Overall Study|Lack of Efficacy|19|||
27792300|NCT02797951|81069193|FG000|Overall Study|Lost to Follow-up|4|||
27792301|NCT02797951|81069193|FG000|Overall Study|Physician Decision|6|||
27978519|NCT02608450|81753331|FG000|Overall Study|Pregnancy|0|||
27574635|NCT01687166|80289089|FG003|Overall Study|Subject moved out of state|0|||
27574636|NCT01687166|80289086|FG000|Overall Study|Patient unable to be compliant|1|||
27574637|NCT01687166|80289087|FG001|Overall Study|Patient unable to be compliant|0|||
27792302|NCT02797951|81069193|FG000|Overall Study|Withdrawal by Subject|15|||
27792303|NCT00975000|81069196|FG000|Overall Study|Other|1|||
27792304|NCT00975000|81069197|FG001|Overall Study|Other|0|||
27574638|NCT01687166|80289088|FG002|Overall Study|Patient unable to be compliant|0|||
27574639|NCT01687166|80289089|FG003|Overall Study|Patient unable to be compliant|0|||
27574640|NCT01687166|80289086|FG000|Overall Study|Physician choice to use different device|1|||
27574641|NCT01687166|80289087|FG001|Overall Study|Physician choice to use different device|2|||
27574642|NCT01687166|80289088|FG002|Overall Study|Physician choice to use different device|4|||
27574643|NCT01687166|80289089|FG003|Overall Study|Physician choice to use different device|0|||
27792305|NCT00975000|81069196|FG000|Overall Study|Adverse Event|1|||
27792306|NCT00975000|81069197|FG001|Overall Study|Adverse Event|1|||
27792307|NCT00975000|81069196|FG000|Overall Study|Withdrawal by Subject|2|||
27978520|NCT02608450|81753332|FG001|Overall Study|Pregnancy|1|||
27978521|NCT02608450|81753331|FG000|Overall Study|Progressive disease|1|||
27978522|NCT02608450|81753332|FG001|Overall Study|Progressive disease|0|||
27978523|NCT02608450|81753331|FG000|Overall Study|Multiple reasons|0|||
27978524|NCT02608450|81753332|FG001|Overall Study|Multiple reasons|2|||
27978525|NCT00989235|81753334|FG000|Overall Study|Death|0|||
27978526|NCT00989235|81753335|FG001|Overall Study|Death|1|||
27978527|NCT00989235|81753334|FG000|Overall Study|Adverse Event|0|||
27978528|NCT00989235|81753335|FG001|Overall Study|Adverse Event|1|||
27978529|NCT00989235|81753334|FG000|Overall Study|Lack of Efficacy|1|||
27978530|NCT00989235|81753335|FG001|Overall Study|Lack of Efficacy|0|||
27978531|NCT00989235|81753334|FG000|Overall Study|Withdrawal of Consent|1|||
27978532|NCT00989235|81753335|FG001|Overall Study|Withdrawal of Consent|1|||
27978533|NCT00989235|81753334|FG000|Overall Study|Desire to Become Pregnant|1|||
27978534|NCT00989235|81753335|FG001|Overall Study|Desire to Become Pregnant|0|||
27978535|NCT00989235|81753334|FG000|Overall Study|Randomized by Mistake|0|||
27978536|NCT00989235|81753335|FG001|Overall Study|Randomized by Mistake|2|||
27792308|NCT00975000|81069197|FG001|Overall Study|Withdrawal by Subject|2|||
27792309|NCT00975000|81069196|FG000|Overall Study|Lost to Follow-up|0|||
27792310|NCT00975000|81069197|FG001|Overall Study|Lost to Follow-up|1|||
27792311|NCT00975000|81069196|FG000|Overall Study|Protocol-specified Criteria|1|||
27792312|NCT00975000|81069197|FG001|Overall Study|Protocol-specified Criteria|0|||
27792313|NCT00975000|81069196|FG000|Overall Study|Non-compliance|0|||
27792314|NCT00975000|81069197|FG001|Overall Study|Non-compliance|1|||
27792315|NCT00943826|81069198|FG000|Concurrent Phase|Adverse Event|50|||
27792316|NCT00943826|81069199|FG001|Concurrent Phase|Adverse Event|27|||
27792317|NCT00943826|81069198|FG000|Concurrent Phase|Withdrew consent|3|||
27792318|NCT00943826|81069199|FG001|Concurrent Phase|Withdrew consent|7|||
27792319|NCT00943826|81069198|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
27792320|NCT00943826|81069199|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
27792321|NCT00943826|81069198|FG000|Concurrent Phase|Administrative reasons|2|||
27792322|NCT00943826|81069199|FG001|Concurrent Phase|Administrative reasons|1|||
27792323|NCT00943826|81069198|FG000|Concurrent Phase|Protocol Violation|1|||
27792324|NCT00943826|81069199|FG001|Concurrent Phase|Protocol Violation|0|||
27792325|NCT00943826|81069198|FG000|Maintenance Phase|Adverse Event|31|||
27792326|NCT00943826|81069199|FG001|Maintenance Phase|Adverse Event|30|||
27792327|NCT00943826|81069198|FG000|Maintenance Phase|Withdrew consent|2|||
27792328|NCT00943826|81069199|FG001|Maintenance Phase|Withdrew consent|4|||
27792329|NCT00943826|81069198|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
27792330|NCT00943826|81069199|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
27792331|NCT00943826|81069198|FG000|Maintenance Phase|Administrative reasons|4|||
27792332|NCT00943826|81069199|FG001|Maintenance Phase|Administrative reasons|1|||
27792333|NCT00943826|81069198|FG000|Maintenance Phase|Failure to return|0|||
27792334|NCT00943826|81069199|FG001|Maintenance Phase|Failure to return|1|||
27792335|NCT00943826|81069198|FG000|Monotherapy Phase|Adverse Event|42|||
27792336|NCT00943826|81069199|FG001|Monotherapy Phase|Adverse Event|5|||
27792337|NCT00943826|81069198|FG000|Monotherapy Phase|Administrative reasons|11|||
27792338|NCT00943826|81069199|FG001|Monotherapy Phase|Administrative reasons|5|||
27792339|NCT00943826|81069198|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
27978537|NCT00989235|81753334|FG000|Overall Study|Lost to Follow-up|0|||
27978538|NCT00989235|81753335|FG001|Overall Study|Lost to Follow-up|1|||
27978539|NCT03080883|81753336|FG000|Overall Study|Withdrawal by Subject|11|||
27978540|NCT03080883|81753337|FG001|Overall Study|Withdrawal by Subject|15|||
27978541|NCT03080883|81753336|FG000|Overall Study|Adverse Event|22|||
27792340|NCT00943826|81069199|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
27792341|NCT00943826|81069198|FG000|Monotherapy Phase|Withdrew Consent|2|||
27792342|NCT00943826|81069199|FG001|Monotherapy Phase|Withdrew Consent|3|||
27978542|NCT03080883|81753337|FG001|Overall Study|Adverse Event|22|||
27978543|NCT03080883|81753336|FG000|Overall Study|Alternative Therapy|0|||
27978544|NCT03080883|81753337|FG001|Overall Study|Alternative Therapy|3|||
27978545|NCT03080883|81753336|FG000|Overall Study|Other Complicating Disease|9|||
27978546|NCT03080883|81753337|FG001|Overall Study|Other Complicating Disease|5|||
27792343|NCT00943826|81069198|FG000|Monotherapy Phase|Failure to return|2|||
27792344|NCT00943826|81069199|FG001|Monotherapy Phase|Failure to return|1|||
27792345|NCT00943826|81069198|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
27792346|NCT00943826|81069199|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
27978547|NCT03080883|81753336|FG000|Overall Study|Death|21|||
27792347|NCT00943826|81069198|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
27792348|NCT00943826|81069199|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
27792349|NCT00943826|81069198|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
27792350|NCT00943826|81069199|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
27792351|NCT00943826|81069198|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
27792352|NCT00943826|81069199|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
27792353|NCT00779142|81069200|FG000|Overall Study|Screen Failures|3|||
27792354|NCT00883129|81069201|FG000|Overall Study|Adverse Event|7|||
27792355|NCT00883129|81069202|FG001|Overall Study|Adverse Event|15|||
27792356|NCT00883129|81069201|FG000|Overall Study|Withdrawal by Subject|8|||
27792357|NCT00883129|81069202|FG001|Overall Study|Withdrawal by Subject|9|||
27792358|NCT00883129|81069201|FG000|Overall Study|Non-compliance|3|||
27792359|NCT00883129|81069202|FG001|Overall Study|Non-compliance|6|||
27792360|NCT00883129|81069201|FG000|Overall Study|Lost to Follow-up|1|||
27792361|NCT00883129|81069202|FG001|Overall Study|Lost to Follow-up|2|||
27978548|NCT03080883|81753337|FG001|Overall Study|Death|16|||
27978549|NCT03080883|81753336|FG000|Overall Study|Physician Decision|2|||
27978550|NCT03080883|81753337|FG001|Overall Study|Physician Decision|2|||
27978551|NCT03080883|81753336|FG000|Overall Study|Disease Progression|2|||
27978552|NCT03080883|81753337|FG001|Overall Study|Disease Progression|8|||
27978553|NCT03080883|81753336|FG000|Overall Study|Lost to Follow-up|1|||
27978554|NCT03080883|81753337|FG001|Overall Study|Lost to Follow-up|1|||
27978555|NCT00276094|81753344|FG000|Overall Study|Adverse Event|15|||
27978556|NCT00276094|81753345|FG001|Overall Study|Adverse Event|13|||
27978557|NCT00276094|81753346|FG002|Overall Study|Adverse Event|11|||
27978558|NCT00276094|81753344|FG000|Overall Study|Withdrawal by Subject|14|||
27978559|NCT00276094|81753345|FG001|Overall Study|Withdrawal by Subject|14|||
27978560|NCT00276094|81753346|FG002|Overall Study|Withdrawal by Subject|12|||
27978561|NCT00276094|81753344|FG000|Overall Study|Protocol Violation|16|||
27978562|NCT00276094|81753345|FG001|Overall Study|Protocol Violation|7|||
27978563|NCT00276094|81753346|FG002|Overall Study|Protocol Violation|10|||
27978564|NCT00276094|81753344|FG000|Overall Study|Lost to Follow-up|8|||
27978565|NCT00276094|81753345|FG001|Overall Study|Lost to Follow-up|6|||
27978566|NCT00276094|81753346|FG002|Overall Study|Lost to Follow-up|4|||
27978567|NCT00276094|81753344|FG000|Overall Study|Other-Subject moved out of country|1|||
27978568|NCT00276094|81753345|FG001|Overall Study|Other-Subject moved out of country|0|||
27574644|NCT01687166|80289086|FG000|Overall Study|Insurance|0|||
27792362|NCT00883129|81069201|FG000|Overall Study|Death|1|||
27792363|NCT00883129|81069202|FG001|Overall Study|Death|2|||
27792364|NCT00883129|81069201|FG000|Overall Study|Defined Treatment Failure|0|||
27792365|NCT00883129|81069202|FG001|Overall Study|Defined Treatment Failure|2|||
27978569|NCT00276094|81753346|FG002|Overall Study|Other-Subject moved out of country|0|||
27978570|NCT00276094|81753344|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
27792366|NCT03704194|81069205|FG000|Overall Study|Withdrawal by Subject|0|||
27792367|NCT03704194|81069206|FG001|Overall Study|Withdrawal by Subject|1|||
27792368|NCT02074982|81069208|FG000|Overall Study|Adverse Event|15|||
27792369|NCT02074982|81069209|FG001|Overall Study|Adverse Event|7|||
27792370|NCT02074982|81069208|FG000|Overall Study|Lack of Efficacy|6|||
27792371|NCT02074982|81069209|FG001|Overall Study|Lack of Efficacy|1|||
27792372|NCT02074982|81069208|FG000|Overall Study|Lost to Follow-up|9|||
27792373|NCT02074982|81069209|FG001|Overall Study|Lost to Follow-up|10|||
27792374|NCT02074982|81069208|FG000|Overall Study|Non-compliance with study treatment|0|||
27792375|NCT02074982|81069209|FG001|Overall Study|Non-compliance with study treatment|2|||
27792376|NCT02074982|81069208|FG000|Overall Study|Physician Decision|1|||
27792377|NCT02074982|81069209|FG001|Overall Study|Physician Decision|1|||
27792378|NCT02074982|81069208|FG000|Overall Study|Pregnancy|1|||
27792379|NCT02074982|81069209|FG001|Overall Study|Pregnancy|2|||
27978571|NCT00276094|81753345|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
27792380|NCT02074982|81069208|FG000|Overall Study|Protocol deviation|4|||
27792381|NCT02074982|81069209|FG001|Overall Study|Protocol deviation|3|||
27978572|NCT00276094|81753346|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
27978573|NCT00276094|81753344|FG000|Overall Study|Other-Lack of efficacy|1|||
27792382|NCT02074982|81069208|FG000|Overall Study|Technical problems|0|||
27792383|NCT02074982|81069209|FG001|Overall Study|Technical problems|2|||
27792384|NCT02074982|81069208|FG000|Overall Study|Subject/guardian decision|15|||
27978574|NCT00276094|81753345|FG001|Overall Study|Other-Lack of efficacy|0|||
27978575|NCT00276094|81753346|FG002|Overall Study|Other-Lack of efficacy|0|||
27792385|NCT02074982|81069209|FG001|Overall Study|Subject/guardian decision|24|||
27792386|NCT02074982|81069208|FG000|Overall Study|Death|0|||
27792387|NCT02074982|81069209|FG001|Overall Study|Death|2|||
27792388|NCT03985293|81069210|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
27792389|NCT03985293|81069211|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
27792390|NCT03985293|81069212|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
27792391|NCT03985293|81069213|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
27792392|NCT03985293|81069214|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
27792393|NCT03985293|81069215|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
27792394|NCT03985293|81069210|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
27792395|NCT03985293|81069211|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
27792396|NCT03985293|81069212|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
27792397|NCT03985293|81069213|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
27792398|NCT03985293|81069214|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
27978576|NCT00276094|81753344|FG000|Overall Study|Other-Refused follow-up visit|1|||
27978577|NCT00276094|81753345|FG001|Overall Study|Other-Refused follow-up visit|0|||
27978578|NCT00276094|81753346|FG002|Overall Study|Other-Refused follow-up visit|0|||
27978579|NCT00276094|81753344|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
27978580|NCT00276094|81753345|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
27978581|NCT00276094|81753346|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
27978582|NCT00276094|81753344|FG000|Overall Study|Other-Relocation|0|||
27978583|NCT00276094|81753345|FG001|Overall Study|Other-Relocation|1|||
27978584|NCT00276094|81753346|FG002|Overall Study|Other-Relocation|0|||
27978585|NCT00276094|81753344|FG000|Overall Study|Other-Study medication lost|0|||
27978586|NCT00276094|81753345|FG001|Overall Study|Other-Study medication lost|0|||
27978587|NCT00276094|81753346|FG002|Overall Study|Other-Study medication lost|1|||
27978588|NCT01416441|81753350|FG000|Overall Study|Lost to Follow-up|5|||
27978589|NCT01416441|81753350|FG000|Overall Study|Adverse Event|6|||
27978590|NCT01416441|81753350|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
27978591|NCT01416441|81753350|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
27978592|NCT01416441|81753350|FG000|Overall Study|Investigator Withdrew Subject|2|||
27978593|NCT01416441|81753350|FG000|Overall Study|Subject Withdrew Consent|12|||
27978594|NCT01416441|81753350|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
27978595|NCT01036529|81753351|FG000|Overall Study|Adverse Event|0|||
27978596|NCT01036529|81753352|FG001|Overall Study|Adverse Event|1|||
27978597|NCT01036529|81753351|FG000|Overall Study|Lost to Follow-up|0|||
27978598|NCT01036529|81753352|FG001|Overall Study|Lost to Follow-up|1|||
27978599|NCT01036529|81753351|FG000|Overall Study|Physician Decision|1|||
27978600|NCT01036529|81753352|FG001|Overall Study|Physician Decision|0|||
27978601|NCT01036529|81753351|FG000|Overall Study|Withdrawal by Subject|1|||
27978602|NCT01036529|81753352|FG001|Overall Study|Withdrawal by Subject|1|||
27978603|NCT01036529|81753351|FG000|Overall Study|Sponsor study termination|11|||
27978604|NCT01036529|81753352|FG001|Overall Study|Sponsor study termination|12|||
27978605|NCT00815191|81753354|FG000|Overall Study|Protocol Violation|1|||
27978606|NCT00815191|81753355|FG001|Overall Study|Protocol Violation|1|||
27978607|NCT03697993|81753356|FG000|Overall Study|Became Ineligible after Enrollment|1|||
27978608|NCT03697993|81753357|FG001|Overall Study|Became Ineligible after Enrollment|3|||
27978609|NCT03697993|81753356|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
27978610|NCT03697993|81753357|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
27978611|NCT03697993|81753356|FG000|Overall Study|Lost to Follow-up|3|||
27978612|NCT03697993|81753357|FG001|Overall Study|Lost to Follow-up|0|||
27978613|NCT03697993|81753356|FG000|Overall Study|Physician Decision|4|||
27978614|NCT03697993|81753357|FG001|Overall Study|Physician Decision|0|||
27792399|NCT03985293|81069215|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
27792400|NCT03985293|81069210|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
27792401|NCT03985293|81069211|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
27792402|NCT03985293|81069212|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
27792403|NCT03985293|81069213|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
27792404|NCT03985293|81069214|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
27978615|NCT03697993|81753356|FG000|Overall Study|Initial Urine Culture Negative|0|||
27978616|NCT03697993|81753357|FG001|Overall Study|Initial Urine Culture Negative|1|||
27978617|NCT01155466|81753360|FG000|Overall Study|Adverse Event|13|||
27978618|NCT01155466|81753361|FG001|Overall Study|Adverse Event|15|||
27978619|NCT01155466|81753362|FG002|Overall Study|Adverse Event|6|||
27978620|NCT01155466|81753363|FG003|Overall Study|Adverse Event|17|||
27978621|NCT01155466|81753364|FG004|Overall Study|Adverse Event|18|||
27792405|NCT03985293|81069215|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
27792406|NCT03985293|81069210|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
27792407|NCT03985293|81069211|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
27792408|NCT03985293|81069212|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
27792409|NCT03985293|81069213|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
27792410|NCT03985293|81069214|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
27792411|NCT03985293|81069215|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
27792412|NCT03985293|81069210|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
27792413|NCT03985293|81069211|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
27792414|NCT03985293|81069212|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
27792415|NCT03985293|81069213|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
27792416|NCT03985293|81069214|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
27792417|NCT03985293|81069215|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
27792418|NCT03985293|81069210|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
27792419|NCT03985293|81069211|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
27792420|NCT03985293|81069212|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
27792421|NCT03985293|81069213|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
27792422|NCT03985293|81069214|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
27978622|NCT01155466|81753360|FG000|Overall Study|Lost to Follow-up|0|||
27978623|NCT01155466|81753361|FG001|Overall Study|Lost to Follow-up|0|||
27792423|NCT03985293|81069215|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
27792424|NCT03985293|81069210|FG000|FOLLOW-UP|Lost to Follow-up|0|||
27792425|NCT03985293|81069211|FG001|FOLLOW-UP|Lost to Follow-up|0|||
27792426|NCT03985293|81069212|FG002|FOLLOW-UP|Lost to Follow-up|1|||
27792427|NCT03985293|81069213|FG003|FOLLOW-UP|Lost to Follow-up|0|||
27792428|NCT03985293|81069214|FG004|FOLLOW-UP|Lost to Follow-up|0|||
27792429|NCT03985293|81069215|FG005|FOLLOW-UP|Lost to Follow-up|0|||
27792430|NCT02851069|81069216|FG000|Overall Study|Failure to Return|3|||
27792431|NCT02851069|81069216|FG000|Overall Study|Other|3|||
27792432|NCT04887922|81069219|FG000|1st Randomization|Decided not to have surgery|0|||
27792433|NCT04887922|81069220|FG001|1st Randomization|Decided not to have surgery|1|||
27792434|NCT04887922|81069221|FG002|1st Randomization|Decided not to have surgery|0|||
27792435|NCT04887922|81069222|FG003|1st Randomization|Decided not to have surgery|0|||
27792436|NCT04887922|81069223|FG004|1st Randomization|Decided not to have surgery|0|||
27792437|NCT01808508|81069224|FG000|Overall Study|Lost to Follow-up|1|||
27792438|NCT01808508|81069225|FG001|Overall Study|Lost to Follow-up|0|||
27792439|NCT01808508|81069226|FG002|Overall Study|Lost to Follow-up|0|||
27792440|NCT02230332|81069227|FG000|Overall Study|Adverse Event|2|||
27792441|NCT02230332|81069228|FG001|Overall Study|Adverse Event|1|||
27792442|NCT02230332|81069227|FG000|Overall Study|Lost to Follow-up|1|||
27792443|NCT02230332|81069228|FG001|Overall Study|Lost to Follow-up|0|||
27792444|NCT02230332|81069227|FG000|Overall Study|Protocol Violation|1|||
27978624|NCT01155466|81753362|FG002|Overall Study|Lost to Follow-up|0|||
27978625|NCT01155466|81753363|FG003|Overall Study|Lost to Follow-up|0|||
27978626|NCT01155466|81753364|FG004|Overall Study|Lost to Follow-up|2|||
27978627|NCT01155466|81753360|FG000|Overall Study|Withdrawal by Subject|7|||
27978628|NCT01155466|81753361|FG001|Overall Study|Withdrawal by Subject|5|||
27792445|NCT02230332|81069228|FG001|Overall Study|Protocol Violation|0|||
27978629|NCT01155466|81753362|FG002|Overall Study|Withdrawal by Subject|9|||
27792446|NCT00209560|81069229|FG000|Overall Study|Lack of Efficacy|1|||
27792447|NCT00209560|81069230|FG001|Overall Study|Lack of Efficacy|0|||
27792448|NCT00910000|81069231|FG000|Overall Study|Adverse Event|0|||
27792449|NCT00910000|81069232|FG001|Overall Study|Adverse Event|3|||
27792450|NCT00910000|81069233|FG002|Overall Study|Adverse Event|2|||
27792451|NCT00910000|81069234|FG003|Overall Study|Adverse Event|2|||
27792452|NCT00910000|81069235|FG004|Overall Study|Adverse Event|0|||
27792453|NCT00910000|81069236|FG005|Overall Study|Adverse Event|1|||
27792454|NCT00910000|81069231|FG000|Overall Study|Withdrawal by Subject|0|||
27792455|NCT00910000|81069232|FG001|Overall Study|Withdrawal by Subject|0|||
27792456|NCT00910000|81069233|FG002|Overall Study|Withdrawal by Subject|1|||
27978630|NCT01155466|81753363|FG003|Overall Study|Withdrawal by Subject|4|||
27792457|NCT00910000|81069234|FG003|Overall Study|Withdrawal by Subject|0|||
27792458|NCT00910000|81069235|FG004|Overall Study|Withdrawal by Subject|1|||
27792459|NCT00910000|81069236|FG005|Overall Study|Withdrawal by Subject|0|||
27792460|NCT01366846|81069239|FG000|Overall Study|Withdrawal by Subject|2|||
27792461|NCT01366846|81069240|FG001|Overall Study|Withdrawal by Subject|0|||
27792462|NCT01366846|81069241|FG002|Overall Study|Withdrawal by Subject|0|||
27792463|NCT01366846|81069242|FG003|Overall Study|Withdrawal by Subject|0|||
27792464|NCT01366846|81069239|FG000|Overall Study|Communication Difficulties|1|||
27792465|NCT01366846|81069240|FG001|Overall Study|Communication Difficulties|4|||
27792466|NCT01366846|81069241|FG002|Overall Study|Communication Difficulties|0|||
27792467|NCT01366846|81069242|FG003|Overall Study|Communication Difficulties|1|||
27792468|NCT01366846|81069239|FG000|Overall Study|Scheduling Conflicts|0|||
27792469|NCT01366846|81069240|FG001|Overall Study|Scheduling Conflicts|0|||
27792470|NCT01366846|81069241|FG002|Overall Study|Scheduling Conflicts|1|||
27792471|NCT01366846|81069242|FG003|Overall Study|Scheduling Conflicts|0|||
27792472|NCT04189224|81069243|FG000|Period 2|Adverse Event|0|||
27978631|NCT01155466|81753364|FG004|Overall Study|Withdrawal by Subject|4|||
27978632|NCT01155466|81753360|FG000|Overall Study|Protocol Violation|0|||
27978633|NCT01155466|81753361|FG001|Overall Study|Protocol Violation|0|||
27978634|NCT01155466|81753362|FG002|Overall Study|Protocol Violation|2|||
27978635|NCT01155466|81753363|FG003|Overall Study|Protocol Violation|0|||
27978636|NCT01155466|81753364|FG004|Overall Study|Protocol Violation|1|||
27978637|NCT01155466|81753360|FG000|Overall Study|Administrative|0|||
27978638|NCT01155466|81753361|FG001|Overall Study|Administrative|3|||
27978639|NCT01155466|81753362|FG002|Overall Study|Administrative|0|||
27978640|NCT01155466|81753363|FG003|Overall Study|Administrative|0|||
27978641|NCT01155466|81753364|FG004|Overall Study|Administrative|0|||
27978642|NCT01155466|81753360|FG000|Overall Study|Randomized not treated|2|||
27978643|NCT01155466|81753361|FG001|Overall Study|Randomized not treated|2|||
27978644|NCT01155466|81753362|FG002|Overall Study|Randomized not treated|3|||
27978645|NCT01155466|81753363|FG003|Overall Study|Randomized not treated|0|||
27978646|NCT01155466|81753364|FG004|Overall Study|Randomized not treated|2|||
27978647|NCT02242981|81753365|FG000|Overall Study|Withdrawal by Subject|1|||
27978648|NCT03444766|81753373|FG000|Overall Study|Other Reasons|2|||
27978649|NCT03444766|81753373|FG000|Overall Study|Participant Withdrew Consent|5|||
27978650|NCT03444766|81753373|FG000|Overall Study|Lost to Follow-up|2|||
27978651|NCT03444766|81753373|FG000|Overall Study|Death|2|||
27978652|NCT03444766|81753373|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
27978653|NCT03444766|81753373|FG000|Overall Study|Disease Progression|49|||
27978654|NCT02914548|81753376|FG000|Overall Study|Adverse Event|15|||
27978655|NCT02914548|81753377|FG001|Overall Study|Adverse Event|7|||
27978656|NCT02914548|81753378|FG002|Overall Study|Adverse Event|15|||
27978657|NCT02914548|81753376|FG000|Overall Study|Physician Decision|2|||
27978658|NCT02914548|81753377|FG001|Overall Study|Physician Decision|2|||
27978659|NCT02914548|81753378|FG002|Overall Study|Physician Decision|0|||
27978660|NCT02914548|81753376|FG000|Overall Study|Protocol Violation|1|||
27978661|NCT02914548|81753377|FG001|Overall Study|Protocol Violation|0|||
27978662|NCT02914548|81753378|FG002|Overall Study|Protocol Violation|0|||
27978663|NCT02914548|81753376|FG000|Overall Study|Withdrawal by Subject|3|||
27978664|NCT02914548|81753377|FG001|Overall Study|Withdrawal by Subject|4|||
27978665|NCT02914548|81753378|FG002|Overall Study|Withdrawal by Subject|4|||
27978666|NCT02914548|81753376|FG000|Overall Study|>40% of body surface area|0|||
27978667|NCT02914548|81753377|FG001|Overall Study|>40% of body surface area|1|||
27978668|NCT02914548|81753378|FG002|Overall Study|>40% of body surface area|1|||
27978669|NCT01066780|81753379|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
27978670|NCT01066780|81753380|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
27978671|NCT02847858|81753383|FG000|Overall Study|Lost to Follow-up|401|||
27978672|NCT02847858|81753384|FG001|Overall Study|Lost to Follow-up|269|||
27978673|NCT01100567|81753385|FG000|Overall Study|Withdrawal by Subject|5|||
27978674|NCT01100567|81753386|FG001|Overall Study|Withdrawal by Subject|8|||
27978675|NCT01100567|81753385|FG000|Overall Study|Early Hospital Discharge|6|||
27978676|NCT01100567|81753386|FG001|Overall Study|Early Hospital Discharge|4|||
27792473|NCT04189224|81069244|FG001|Period 2|Adverse Event|1|||
27792474|NCT01556490|81069245|FG000|Randomized Patients Summary|Protocol Violation|22|||
27792475|NCT01556490|81069246|FG001|Randomized Patients Summary|Protocol Violation|23|||
27792476|NCT01556490|81069245|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
27978677|NCT01100567|81753385|FG000|Overall Study|Lost to Follow-up|1|||
27978678|NCT01100567|81753386|FG001|Overall Study|Lost to Follow-up|2|||
27978679|NCT01100567|81753385|FG000|Overall Study|Physician Decision|0|||
27978680|NCT01100567|81753386|FG001|Overall Study|Physician Decision|1|||
27978681|NCT01100567|81753385|FG000|Overall Study|Deemed ineligible after consent|0|||
27978682|NCT01100567|81753386|FG001|Overall Study|Deemed ineligible after consent|1|||
27978683|NCT01688739|81753387|FG000|Overall Study|Administrative Decision|1|||
27978684|NCT01688739|81753388|FG001|Overall Study|Administrative Decision|0|||
27978685|NCT01688739|81753389|FG002|Overall Study|Administrative Decision|0|||
27978686|NCT01688739|81753390|FG003|Overall Study|Administrative Decision|0|||
27792477|NCT01556490|81069246|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
27792478|NCT01891669|81069247|FG000|Overall Study|Death|0|||
27792479|NCT01891669|81069248|FG001|Overall Study|Death|0|||
27792480|NCT01891669|81069249|FG002|Overall Study|Death|0|||
27792481|NCT01891669|81069250|FG003|Overall Study|Death|0|||
27792482|NCT01891669|81069251|FG004|Overall Study|Death|0|||
27792483|NCT01891669|81069252|FG005|Overall Study|Death|0|||
27792484|NCT01891669|81069253|FG006|Overall Study|Death|0|||
27978687|NCT01688739|81753391|FG004|Overall Study|Administrative Decision|0|||
27978688|NCT01688739|81753392|FG005|Overall Study|Administrative Decision|0|||
27978689|NCT01688739|81753393|FG006|Overall Study|Administrative Decision|0|||
27978690|NCT01688739|81753394|FG007|Overall Study|Administrative Decision|0|||
27978691|NCT01688739|81753395|FG008|Overall Study|Administrative Decision|0|||
27978692|NCT01688739|81753396|FG009|Overall Study|Administrative Decision|0|||
27978693|NCT02982018|81753397|FG000|Overall Study|Incorrect Lens Dispensed|1|||
27978694|NCT02982018|81753398|FG001|Overall Study|Incorrect Lens Dispensed|0|||
27978695|NCT02982018|81753397|FG000|Overall Study|Protocol Violation|1|||
27978696|NCT02982018|81753398|FG001|Overall Study|Protocol Violation|1|||
27978697|NCT02982018|81753397|FG000|Overall Study|Adverse Event|1|||
27978698|NCT02982018|81753398|FG001|Overall Study|Adverse Event|1|||
27978699|NCT02982018|81753397|FG000|Overall Study|Lens Discomfort|2|||
27978700|NCT02982018|81753398|FG001|Overall Study|Lens Discomfort|0|||
27978701|NCT02982018|81753397|FG000|Overall Study|Withdrawal by Subject|0|||
27978702|NCT02982018|81753398|FG001|Overall Study|Withdrawal by Subject|1|||
27978703|NCT01219933|81753399|FG000|Overall Study|Adverse Event|8|||
27978704|NCT01219933|81753399|FG000|Overall Study|No LDA reached|5|||
27978705|NCT01219933|81753399|FG000|Overall Study|No LDA maintained|7|||
27792485|NCT01891669|81069254|FG007|Overall Study|Death|1|||
27792486|NCT01891669|81069255|FG008|Overall Study|Death|0|||
27792487|NCT01891669|81069256|FG009|Overall Study|Death|1|||
27792488|NCT01891669|81069247|FG000|Overall Study|Withdrawal by Subject|1|||
27792489|NCT01891669|81069248|FG001|Overall Study|Withdrawal by Subject|1|||
27792490|NCT01891669|81069249|FG002|Overall Study|Withdrawal by Subject|0|||
27792491|NCT01891669|81069250|FG003|Overall Study|Withdrawal by Subject|0|||
27792492|NCT01891669|81069251|FG004|Overall Study|Withdrawal by Subject|0|||
27792493|NCT01891669|81069252|FG005|Overall Study|Withdrawal by Subject|0|||
27792494|NCT01891669|81069253|FG006|Overall Study|Withdrawal by Subject|1|||
27792495|NCT01891669|81069254|FG007|Overall Study|Withdrawal by Subject|2|||
27792496|NCT01891669|81069255|FG008|Overall Study|Withdrawal by Subject|1|||
27792497|NCT01891669|81069256|FG009|Overall Study|Withdrawal by Subject|1|||
27792498|NCT01891669|81069247|FG000|Overall Study|Other|1|||
27792499|NCT01891669|81069248|FG001|Overall Study|Other|0|||
27792500|NCT01891669|81069249|FG002|Overall Study|Other|0|||
27792501|NCT01891669|81069250|FG003|Overall Study|Other|0|||
27792502|NCT01891669|81069251|FG004|Overall Study|Other|0|||
27792503|NCT01891669|81069252|FG005|Overall Study|Other|0|||
27792504|NCT01891669|81069253|FG006|Overall Study|Other|0|||
27792505|NCT01891669|81069254|FG007|Overall Study|Other|1|||
27792506|NCT01891669|81069255|FG008|Overall Study|Other|0|||
27792507|NCT01891669|81069256|FG009|Overall Study|Other|0|||
27792508|NCT01012609|81069258|FG000|Overall Study|Withdrawal by Subject|1|||
27792509|NCT01012609|81069259|FG001|Overall Study|Withdrawal by Subject|1|||
27792510|NCT03575806|81069260|FG000|Overall Study|Withdrawal by Subject|0|||
27792511|NCT03575806|81069261|FG001|Overall Study|Withdrawal by Subject|2|||
27792512|NCT03575806|81069260|FG000|Overall Study|Protocol Violation|0|||
27792513|NCT03575806|81069261|FG001|Overall Study|Protocol Violation|2|||
27792514|NCT00877799|81069265|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
27978706|NCT01219933|81753399|FG000|Overall Study|Lost to Follow-up|3|||
27978707|NCT01219933|81753399|FG000|Overall Study|GC free|1|||
27978708|NCT01219933|81753399|FG000|Overall Study|Withdrawal by Subject|5|||
27978709|NCT01219933|81753399|FG000|Overall Study|Protocol Violation|8|||
27978710|NCT01219933|81753399|FG000|Overall Study|Lack of Efficacy|1|||
27978711|NCT00747344|81753400|FG000|Controlled Period|Adverse Event|3|||
27978712|NCT00747344|81753401|FG001|Controlled Period|Adverse Event|0|||
27978713|NCT00747344|81753402|FG002|Controlled Period|Adverse Event|0|||
27978714|NCT00747344|81753403|FG003|Controlled Period|Adverse Event|0|||
27978715|NCT00747344|81753400|FG000|Controlled Period|Lack of Efficacy|2|||
27978716|NCT00747344|81753401|FG001|Controlled Period|Lack of Efficacy|1|||
27792515|NCT00877799|81069266|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
27792516|NCT00877799|81069267|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
27792517|NCT00877799|81069268|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
27792518|NCT00877799|81069269|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
27792519|NCT00877799|81069265|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
27792520|NCT00877799|81069266|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
27792521|NCT00877799|81069267|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
27792522|NCT00877799|81069268|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
27792523|NCT00877799|81069269|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
27792524|NCT00877799|81069265|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27792525|NCT00877799|81069266|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
27792526|NCT00877799|81069267|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27792527|NCT00877799|81069268|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27792528|NCT00877799|81069269|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
27792529|NCT00877799|81069265|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27792530|NCT00877799|81069266|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27792531|NCT00877799|81069267|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27792532|NCT00877799|81069268|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
27792533|NCT00877799|81069269|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
27792534|NCT00877799|81069265|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
27792535|NCT00877799|81069266|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
27792536|NCT00877799|81069267|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
27792537|NCT00877799|81069268|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
27792538|NCT00877799|81069269|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
27792539|NCT01740297|81069270|FG000|Overall Study|Withdrawal by Subject|4|||
27792540|NCT01740297|81069271|FG001|Overall Study|Withdrawal by Subject|16|||
27792541|NCT01740297|81069272|FG002|Overall Study|Withdrawal by Subject|17|||
27792542|NCT01740297|81069270|FG000|Overall Study|Death|8|||
27978717|NCT00747344|81753402|FG002|Controlled Period|Lack of Efficacy|0|||
27978718|NCT00747344|81753403|FG003|Controlled Period|Lack of Efficacy|0|||
27978719|NCT00747344|81753400|FG000|Controlled Period|Other|0|||
27978720|NCT00747344|81753401|FG001|Controlled Period|Other|3|||
27978721|NCT00747344|81753402|FG002|Controlled Period|Other|0|||
27978722|NCT00747344|81753403|FG003|Controlled Period|Other|0|||
27978723|NCT00747344|81753400|FG000|After Controlled Period|Adverse Event|0|||
27978724|NCT00747344|81753401|FG001|After Controlled Period|Adverse Event|0|||
27978725|NCT00747344|81753402|FG002|After Controlled Period|Adverse Event|0|||
27978726|NCT00747344|81753403|FG003|After Controlled Period|Adverse Event|1|||
27978727|NCT00711113|81753404|FG000|Overall Study|Lost to Follow-up|9|||
27978728|NCT00711113|81753404|FG000|Overall Study|Implant lost|2|||
27978729|NCT00554099|81753407|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
27978730|NCT00554099|81753408|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
27978731|NCT00554099|81753409|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
27978732|NCT00554099|81753407|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
27978733|NCT00554099|81753408|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
27978734|NCT00554099|81753409|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
27978735|NCT00554099|81753407|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27978736|NCT00554099|81753408|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
27978737|NCT00554099|81753409|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
27978738|NCT00554099|81753407|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
27978739|NCT00554099|81753408|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
27978740|NCT00554099|81753409|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
27792543|NCT01740297|81069271|FG001|Overall Study|Death|46|||
27792544|NCT01740297|81069272|FG002|Overall Study|Death|40|||
27792545|NCT01740297|81069270|FG000|Overall Study|Lost to Follow-up|1|||
27792546|NCT01740297|81069271|FG001|Overall Study|Lost to Follow-up|2|||
27792547|NCT01740297|81069272|FG002|Overall Study|Lost to Follow-up|4|||
27978741|NCT00554099|81753407|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
27978742|NCT00554099|81753408|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
27978743|NCT00554099|81753409|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
27978744|NCT00554099|81753407|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
27978745|NCT00554099|81753408|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
27978746|NCT00554099|81753409|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
27978747|NCT00554099|81753407|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
27978748|NCT00554099|81753408|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
27978749|NCT00554099|81753409|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
27978750|NCT00554099|81753407|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
27978751|NCT00554099|81753408|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
27978752|NCT00554099|81753409|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
27978753|NCT00554099|81753407|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
27978754|NCT00554099|81753408|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
27792548|NCT03209973|81069273|FG000|Overall Study|Withdrawal by Subject|7|||
27792549|NCT03209973|81069273|FG000|Overall Study|Lost to Follow-up|2|||
27792550|NCT03209973|81069273|FG000|Overall Study|Death|8|||
27792551|NCT03209973|81069273|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
27792552|NCT03209973|81069273|FG000|Overall Study|Sponsor Decision|18|||
27792553|NCT03209973|81069273|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
27792554|NCT03209973|81069273|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
27792555|NCT00563706|81069278|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
27792556|NCT00563706|81069279|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
27792557|NCT00563706|81069280|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
27792558|NCT00563706|81069281|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
27792559|NCT00563706|81069282|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
27792560|NCT00563706|81069283|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
27792561|NCT00563706|81069284|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
27792562|NCT00563706|81069285|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
27792563|NCT00563706|81069286|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
27792564|NCT00563706|81069278|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
27792565|NCT00563706|81069279|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
27792566|NCT00563706|81069280|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
27792567|NCT00563706|81069281|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
27792568|NCT00563706|81069282|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
27792569|NCT00563706|81069283|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
27792570|NCT00563706|81069284|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
27792571|NCT00563706|81069285|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
27792572|NCT00563706|81069286|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
27792573|NCT00563706|81069278|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
27792574|NCT00563706|81069279|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
27792575|NCT00563706|81069280|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
27792576|NCT00563706|81069281|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
27792577|NCT00563706|81069282|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
27792578|NCT00563706|81069283|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
27792579|NCT00563706|81069284|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
27792580|NCT00563706|81069285|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
27792581|NCT00563706|81069286|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
27792582|NCT00563706|81069278|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
27792583|NCT00563706|81069279|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27792584|NCT00563706|81069280|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27792585|NCT00563706|81069281|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27978755|NCT00554099|81753409|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
27574645|NCT01687166|80289087|FG001|Overall Study|Insurance|0|||
27574646|NCT01687166|80289088|FG002|Overall Study|Insurance|1|||
27574647|NCT01687166|80289089|FG003|Overall Study|Insurance|1|||
27574648|NCT02177266|80289092|FG000|Overall Study|Adverse Event|0|||
27574649|NCT02177266|80289093|FG001|Overall Study|Adverse Event|1|||
27574650|NCT02177266|80289092|FG000|Overall Study|Withdrawal by Subject|1|||
27574651|NCT02177266|80289093|FG001|Overall Study|Withdrawal by Subject|0|||
27574652|NCT00574405|80289094|FG000|Overall Study|Withdrawal by Subject|3|||
27574653|NCT00574405|80289095|FG001|Overall Study|Withdrawal by Subject|2|||
27574654|NCT05009251|80289096|FG000|Overall Study|Protocol Violation|100|||
27574655|NCT05009251|80289097|FG001|Overall Study|Protocol Violation|105|||
27978756|NCT02639338|81753410|FG000|Overall Study|Lost to Follow-up|2|||
27574656|NCT05009251|80289098|FG002|Overall Study|Protocol Violation|119|||
27574657|NCT05009251|80289099|FG003|Overall Study|Protocol Violation|120|||
27574658|NCT05009251|80289100|FG004|Overall Study|Protocol Violation|119|||
27574659|NCT05009251|80289096|FG000|Overall Study|Death|25|||
27574660|NCT05009251|80289097|FG001|Overall Study|Death|22|||
27574661|NCT05009251|80289098|FG002|Overall Study|Death|24|||
27574662|NCT05009251|80289099|FG003|Overall Study|Death|19|||
27574663|NCT05009251|80289100|FG004|Overall Study|Death|15|||
27574664|NCT03252522|80289101|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
27574665|NCT03252522|80289102|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
27574666|NCT03252522|80289103|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
27574667|NCT03252522|80289101|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
27574668|NCT03252522|80289102|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
27574669|NCT03252522|80289103|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
27574670|NCT03252522|80289101|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
27574671|NCT03252522|80289102|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
27574672|NCT03252522|80289103|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
27574673|NCT03252522|80289101|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
27574674|NCT03252522|80289102|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
27574675|NCT03252522|80289103|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
27574676|NCT03252522|80289101|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
27574677|NCT03252522|80289102|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
27574678|NCT03252522|80289103|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
27574679|NCT03252522|80289101|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
27574680|NCT03252522|80289102|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
27574681|NCT03252522|80289103|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
27574682|NCT03252522|80289101|FG000|Phase 2: Open Label|Adverse Event|0|||
27574683|NCT03252522|80289102|FG001|Phase 2: Open Label|Adverse Event|0|||
27574684|NCT03252522|80289103|FG002|Phase 2: Open Label|Adverse Event|2|||
27574685|NCT03252522|80289101|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
27574686|NCT03252522|80289102|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
27574687|NCT03252522|80289103|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
27574688|NCT00773097|80289106|FG000|Overall Study|Withdrawal by Subject|1|||
27574689|NCT00773097|80289106|FG000|Overall Study|Physician Decision|6|||
27574690|NCT02797262|80289107|FG000|Overall Study|Withdrawal by Subject|5|||
27574691|NCT02797262|80289108|FG001|Overall Study|Withdrawal by Subject|1|||
27574692|NCT02797262|80289107|FG000|Overall Study|Lost to Follow-up|10|||
27574693|NCT02797262|80289108|FG001|Overall Study|Lost to Follow-up|7|||
27574694|NCT02797262|80289107|FG000|Overall Study|Death|1|||
27574695|NCT02797262|80289108|FG001|Overall Study|Death|2|||
27574696|NCT02797262|80289107|FG000|Overall Study|Adverse Event|1|||
27574697|NCT02797262|80289108|FG001|Overall Study|Adverse Event|0|||
27574698|NCT02797262|80289107|FG000|Overall Study|COVID-19|2|||
27574699|NCT02797262|80289108|FG001|Overall Study|COVID-19|1|||
27574700|NCT02797262|80289107|FG000|Overall Study|Out-of-country|1|||
27574701|NCT02797262|80289108|FG001|Overall Study|Out-of-country|0|||
27574702|NCT00678691|80289109|FG000|Overall Study|Adverse Event|6|||
27574703|NCT00678691|80289110|FG001|Overall Study|Adverse Event|4|||
27574704|NCT01158924|80289111|FG000|Overall Study|Withdrawal by Subject|1|||
27574705|NCT01158924|80289112|FG001|Overall Study|Withdrawal by Subject|2|||
27574706|NCT01158924|80289111|FG000|Overall Study|Lost to Follow-up|0|||
27574707|NCT01158924|80289112|FG001|Overall Study|Lost to Follow-up|1|||
27574708|NCT05044234|80289115|FG000|Overall Study|Lost to Follow-up|2|||
27574709|NCT05044234|80289116|FG001|Overall Study|Lost to Follow-up|1|||
27574710|NCT05044234|80289117|FG002|Overall Study|Lost to Follow-up|1|||
27574711|NCT05044234|80289118|FG003|Overall Study|Lost to Follow-up|2|||
27574712|NCT05044234|80289115|FG000|Overall Study|Withdrawal by Subject|6|||
27574713|NCT05044234|80289116|FG001|Overall Study|Withdrawal by Subject|4|||
27574714|NCT05044234|80289117|FG002|Overall Study|Withdrawal by Subject|5|||
27574715|NCT05044234|80289118|FG003|Overall Study|Withdrawal by Subject|8|||
27574716|NCT05044234|80289115|FG000|Overall Study|Study terminated by Sponsor|21|||
27672695|NCT00760747|80639303|FG000|Study Period II|Protocol Violation|6|||
27792586|NCT00563706|81069282|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27792587|NCT00563706|81069283|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27574717|NCT05044234|80289116|FG001|Overall Study|Study terminated by Sponsor|21|||
27574718|NCT05044234|80289117|FG002|Overall Study|Study terminated by Sponsor|20|||
27574719|NCT05044234|80289118|FG003|Overall Study|Study terminated by Sponsor|14|||
27574720|NCT05044234|80289115|FG000|Overall Study|Other, not specified|0|||
27574721|NCT05044234|80289116|FG001|Overall Study|Other, not specified|0|||
27574722|NCT05044234|80289117|FG002|Overall Study|Other, not specified|1|||
27574723|NCT05044234|80289118|FG003|Overall Study|Other, not specified|2|||
27574724|NCT05044234|80289115|FG000|Overall Study|Delayed data entry|0|||
27574725|NCT05044234|80289116|FG001|Overall Study|Delayed data entry|0|||
27574726|NCT05044234|80289117|FG002|Overall Study|Delayed data entry|0|||
27574727|NCT05044234|80289118|FG003|Overall Study|Delayed data entry|1|||
27574728|NCT03921411|80289119|FG000|Overall Study|Withdrawal by Subject|1|||
27574729|NCT03921411|80289119|FG000|Overall Study|Protocol Deviation|2|||
27574730|NCT03921411|80289119|FG000|Overall Study|Enrolled, but never treated|2|||
27574731|NCT00978731|80289120|FG000|Overall Study|Death|4|||
27574732|NCT00978731|80289121|FG001|Overall Study|Death|1|||
27574733|NCT00978731|80289122|FG002|Overall Study|Death|1|||
27574734|NCT00978731|80289123|FG003|Overall Study|Death|0|||
27574735|NCT00978731|80289120|FG000|Overall Study|Lost to Follow-up|0|||
27574736|NCT00978731|80289121|FG001|Overall Study|Lost to Follow-up|0|||
27574737|NCT00978731|80289122|FG002|Overall Study|Lost to Follow-up|0|||
27574738|NCT00978731|80289123|FG003|Overall Study|Lost to Follow-up|1|||
27574739|NCT00978731|80289120|FG000|Overall Study|Adverse Event|5|||
27574740|NCT00978731|80289121|FG001|Overall Study|Adverse Event|2|||
27574741|NCT00978731|80289122|FG002|Overall Study|Adverse Event|0|||
27574742|NCT00978731|80289123|FG003|Overall Study|Adverse Event|0|||
27574743|NCT00978731|80289120|FG000|Overall Study|Participant's request|1|||
27574744|NCT00978731|80289121|FG001|Overall Study|Participant's request|0|||
27574745|NCT00978731|80289122|FG002|Overall Study|Participant's request|0|||
27574746|NCT00978731|80289123|FG003|Overall Study|Participant's request|0|||
27574747|NCT00978731|80289120|FG000|Overall Study|Administrative reason|3|||
27574748|NCT00978731|80289121|FG001|Overall Study|Administrative reason|3|||
27574749|NCT00978731|80289122|FG002|Overall Study|Administrative reason|1|||
27574750|NCT00978731|80289123|FG003|Overall Study|Administrative reason|0|||
27574751|NCT00978731|80289120|FG000|Overall Study|Deterioration without progression|0|||
27574752|NCT00978731|80289121|FG001|Overall Study|Deterioration without progression|1|||
27574753|NCT00978731|80289122|FG002|Overall Study|Deterioration without progression|0|||
27574754|NCT00978731|80289123|FG003|Overall Study|Deterioration without progression|0|||
27574755|NCT00978731|80289120|FG000|Overall Study|Disease progression/relapse|5|||
27574756|NCT00978731|80289121|FG001|Overall Study|Disease progression/relapse|4|||
27574757|NCT00978731|80289122|FG002|Overall Study|Disease progression/relapse|2|||
27574758|NCT00978731|80289123|FG003|Overall Study|Disease progression/relapse|2|||
27574759|NCT00978731|80289120|FG000|Overall Study|Study closure|3|||
27574760|NCT00978731|80289121|FG001|Overall Study|Study closure|4|||
27574761|NCT00978731|80289122|FG002|Overall Study|Study closure|1|||
27574762|NCT00978731|80289123|FG003|Overall Study|Study closure|1|||
27574763|NCT00978731|80289120|FG000|Overall Study|No response|1|||
27574764|NCT00978731|80289121|FG001|Overall Study|No response|0|||
27574765|NCT00978731|80289122|FG002|Overall Study|No response|0|||
27574766|NCT00978731|80289123|FG003|Overall Study|No response|0|||
27574767|NCT02684006|80289124|FG000|Overall Study|Ongoing|31|||
27574768|NCT02684006|80289125|FG001|Overall Study|Ongoing|10|||
27574769|NCT02684006|80289124|FG000|Overall Study|Other|7|||
27574770|NCT02684006|80289125|FG001|Overall Study|Other|6|||
27574771|NCT02684006|80289124|FG000|Overall Study|Protocol Violation|2|||
27574772|NCT02684006|80289125|FG001|Overall Study|Protocol Violation|1|||
27574773|NCT02684006|80289124|FG000|Overall Study|Non-compliance with study drug|1|||
27574774|NCT02684006|80289125|FG001|Overall Study|Non-compliance with study drug|1|||
27792588|NCT00563706|81069284|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27792589|NCT00563706|81069285|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
27792590|NCT00563706|81069286|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
27792591|NCT00563706|81069278|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27792592|NCT00563706|81069279|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27792593|NCT00563706|81069280|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27574775|NCT02684006|80289124|FG000|Overall Study|No longer meets eligibility criteria|6|||
27574776|NCT02684006|80289125|FG001|Overall Study|No longer meets eligibility criteria|2|||
27574777|NCT02684006|80289124|FG000|Overall Study|Lost to Follow-up|0|||
27574778|NCT02684006|80289125|FG001|Overall Study|Lost to Follow-up|1|||
27574779|NCT02684006|80289124|FG000|Overall Study|Death|24|||
27574780|NCT02684006|80289125|FG001|Overall Study|Death|22|||
27574781|NCT02684006|80289124|FG000|Overall Study|Global deterioration of health status|18|||
27574782|NCT02684006|80289125|FG001|Overall Study|Global deterioration of health status|20|||
27574783|NCT02684006|80289124|FG000|Overall Study|Physician Decision|14|||
27574784|NCT02684006|80289125|FG001|Overall Study|Physician Decision|9|||
27574785|NCT02684006|80289124|FG000|Overall Study|Adverse Event|74|||
27574786|NCT02684006|80289125|FG001|Overall Study|Adverse Event|65|||
27574787|NCT02684006|80289124|FG000|Overall Study|Withdrawal by Subject|29|||
27574788|NCT02684006|80289125|FG001|Overall Study|Withdrawal by Subject|41|||
27574789|NCT02684006|80289124|FG000|Overall Study|Progressive disease|236|||
27574790|NCT02684006|80289125|FG001|Overall Study|Progressive disease|266|||
27574791|NCT01306617|80289126|FG000|Overall Study|Adverse Event|1|||
27574792|NCT01306617|80289127|FG001|Overall Study|Adverse Event|0|||
27574793|NCT01306617|80289128|FG002|Overall Study|Adverse Event|0|||
27574794|NCT01306617|80289126|FG000|Overall Study|Virologic Failure|0|||
27574795|NCT01306617|80289127|FG001|Overall Study|Virologic Failure|0|||
27574796|NCT01306617|80289128|FG002|Overall Study|Virologic Failure|5|||
27574797|NCT01306617|80289126|FG000|Overall Study|Non-compliance|0|||
27574798|NCT01306617|80289127|FG001|Overall Study|Non-compliance|1|||
27792594|NCT00563706|81069281|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27792595|NCT00563706|81069282|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27792596|NCT00563706|81069283|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27792597|NCT00563706|81069284|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
27792598|NCT00563706|81069285|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
27792599|NCT00563706|81069286|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
27792600|NCT03839693|81069287|FG000|Overall Study|Lost to Follow-up|0|||
27792601|NCT03839693|81069288|FG001|Overall Study|Lost to Follow-up|2|||
27978757|NCT02639338|81753411|FG001|Overall Study|Lost to Follow-up|2|||
27978758|NCT02639338|81753410|FG000|Overall Study|Withdrew Consent|1|||
27978759|NCT02639338|81753411|FG001|Overall Study|Withdrew Consent|2|||
27978760|NCT02639338|81753410|FG000|Overall Study|Death|1|||
27978761|NCT02639338|81753411|FG001|Overall Study|Death|0|||
27978762|NCT02639338|81753410|FG000|Overall Study|Randomized but Not Treated|0|||
27978763|NCT02639338|81753411|FG001|Overall Study|Randomized but Not Treated|1|||
27978764|NCT00609791|81753412|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
27978765|NCT00289198|81753413|FG000|Overall Study|Adverse Event|0|||
27978766|NCT00289198|81753414|FG001|Overall Study|Adverse Event|2|||
27978767|NCT00289198|81753413|FG000|Overall Study|Protocol Violation|2|||
27978768|NCT00289198|81753414|FG001|Overall Study|Protocol Violation|1|||
27978769|NCT00289198|81753413|FG000|Overall Study|Withdrawal by Subject|4|||
27978770|NCT00289198|81753414|FG001|Overall Study|Withdrawal by Subject|1|||
27978771|NCT00289198|81753413|FG000|Overall Study|Lack of Efficacy|2|||
27978772|NCT00289198|81753414|FG001|Overall Study|Lack of Efficacy|0|||
27978773|NCT00289198|81753413|FG000|Overall Study|Other: Low compliance|0|||
27978774|NCT00289198|81753414|FG001|Overall Study|Other: Low compliance|1|||
27978775|NCT00289198|81753413|FG000|Overall Study|Other: Physician's decision|0|||
27978776|NCT00289198|81753414|FG001|Overall Study|Other: Physician's decision|1|||
27978777|NCT00289198|81753413|FG000|Overall Study|Other: Unable to attend on schedule|2|||
27978778|NCT00289198|81753414|FG001|Overall Study|Other: Unable to attend on schedule|1|||
27978779|NCT00289198|81753413|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
27978780|NCT00289198|81753414|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
27574799|NCT01306617|80289128|FG002|Overall Study|Non-compliance|0|||
27574800|NCT01610791|80289129|FG000|Overall Study|Lost to Follow-up|7|||
27574801|NCT01610791|80289129|FG000|Overall Study|Adverse Event|6|||
27574802|NCT01610791|80289129|FG000|Overall Study|Physician Decision|1|||
27574803|NCT01610791|80289129|FG000|Overall Study|Adverse event and Investigator decision|1|||
27574804|NCT01610791|80289129|FG000|Overall Study|Death|1|||
27978781|NCT00289198|81753413|FG000|Overall Study|Other: Impossible to come on visit|0|||
27978782|NCT00289198|81753414|FG001|Overall Study|Other: Impossible to come on visit|1|||
27978783|NCT00700102|81753415|FG000|Overall Study|Died|394|||
27978784|NCT00700102|81753416|FG001|Overall Study|Died|385|||
27978785|NCT00700102|81753415|FG000|Overall Study|Lost to Follow-up|8|||
27978786|NCT00700102|81753416|FG001|Overall Study|Lost to Follow-up|10|||
27978787|NCT00413374|81753431|FG000|Overall Study|Ineligible due to screening criteria.|3|||
27978788|NCT00413374|81753432|FG001|Overall Study|Ineligible due to screening criteria.|0|||
27978789|NCT00413374|81753431|FG000|Overall Study|Adverse Event|1|||
27978790|NCT00413374|81753432|FG001|Overall Study|Adverse Event|0|||
27978791|NCT00413374|81753431|FG000|Overall Study|Lost to Follow-up|1|||
27978792|NCT00413374|81753432|FG001|Overall Study|Lost to Follow-up|0|||
27978793|NCT00413374|81753431|FG000|Overall Study|Surgery|1|||
27978794|NCT00413374|81753432|FG001|Overall Study|Surgery|0|||
27978795|NCT01891344|81753436|FG000|Overall Study|Ongoing|6|||
27978796|NCT01891344|81753437|FG001|Overall Study|Ongoing|2|||
27978797|NCT01891344|81753438|FG002|Overall Study|Ongoing|0|||
27978798|NCT01891344|81753439|FG003|Overall Study|Ongoing|1|||
27978799|NCT01891344|81753440|FG004|Overall Study|Ongoing|4|||
27978800|NCT01891344|81753441|FG005|Overall Study|Ongoing|1|||
27978801|NCT01891344|81753442|FG006|Overall Study|Ongoing|0|||
27978802|NCT01891344|81753443|FG007|Overall Study|Ongoing|0|||
27978803|NCT00598078|81753444|FG000|Period 2 (Day 2)|Adverse Event|1|||
27574805|NCT01610791|80289129|FG000|Overall Study|Not determined|5|||
27574806|NCT02148003|80289130|FG000|Overall Study|Failed inclusion criteria|1|||
27574807|NCT02148003|80289131|FG001|Overall Study|Failed inclusion criteria|0|||
27574808|NCT02148003|80289130|FG000|Overall Study|Met exclusion criteria|0|||
27792602|NCT03839693|81069289|FG002|Overall Study|Lost to Follow-up|2|||
27792603|NCT03839693|81069287|FG000|Overall Study|Withdrawal by Subject|1|||
27792604|NCT03839693|81069288|FG001|Overall Study|Withdrawal by Subject|0|||
27978804|NCT00598078|81753445|FG001|Period 2 (Day 2)|Adverse Event|0|||
27978805|NCT03730012|81753450|FG000|Overall Study|Adverse Event|0|||
27978806|NCT03730012|81753451|FG001|Overall Study|Adverse Event|1|||
27978807|NCT03730012|81753450|FG000|Overall Study|Lack of Efficacy|1|||
27978808|NCT03730012|81753451|FG001|Overall Study|Lack of Efficacy|5|||
27978809|NCT03730012|81753450|FG000|Overall Study|Withdrawal by Subject|0|||
27574809|NCT02148003|80289131|FG001|Overall Study|Met exclusion criteria|1|||
27978810|NCT03730012|81753451|FG001|Overall Study|Withdrawal by Subject|1|||
27978811|NCT03730012|81753450|FG000|Overall Study|Miscellaneous|2|||
27978812|NCT03730012|81753451|FG001|Overall Study|Miscellaneous|1|||
27672696|NCT00760747|80639304|FG001|Study Period II|Protocol Violation|3|||
27574810|NCT02148003|80289130|FG000|Overall Study|Withdrawal by Subject|0|||
27574811|NCT02148003|80289131|FG001|Overall Study|Withdrawal by Subject|1|||
27574812|NCT01641367|80289133|FG000|Cohorts|Death|18|||
27672697|NCT00760747|80639303|FG000|Study Period II|Withdrawal by Subject|1|||
27978813|NCT01460407|81753452|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
27978814|NCT01460407|81753453|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
27792605|NCT03839693|81069289|FG002|Overall Study|Withdrawal by Subject|2|||
27792606|NCT03839693|81069287|FG000|Overall Study|subject moved out of the area|1|||
27792607|NCT03839693|81069288|FG001|Overall Study|subject moved out of the area|0|||
27792608|NCT03839693|81069289|FG002|Overall Study|subject moved out of the area|0|||
27792609|NCT01329562|81069298|FG000|Overall Study|Protocol Violation|5|||
27792610|NCT01329562|81069299|FG001|Overall Study|Protocol Violation|3|||
27792611|NCT01329562|81069298|FG000|Overall Study|Lost to Follow-up|1|||
27792612|NCT01329562|81069299|FG001|Overall Study|Lost to Follow-up|1|||
27792613|NCT01329562|81069298|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
27792614|NCT01329562|81069299|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
27792615|NCT01329562|81069298|FG000|Overall Study|Physician Decision|0|||
27792616|NCT01329562|81069299|FG001|Overall Study|Physician Decision|1|||
27792617|NCT03563716|81072266|FG000|Overall Study|Death|20|||
27792618|NCT03563716|81072267|FG001|Overall Study|Death|14|||
27792619|NCT03563716|81072266|FG000|Overall Study|Withdrawal by Subject|3|||
27792620|NCT03563716|81072267|FG001|Overall Study|Withdrawal by Subject|3|||
27792621|NCT03563716|81072266|FG000|Overall Study|Still on Study|45|||
27792622|NCT03563716|81072267|FG001|Overall Study|Still on Study|50|||
27792623|NCT03605758|81072270|FG000|Overall Study|Lost to Follow-up|2|||
27792624|NCT03605758|81072271|FG001|Overall Study|Lost to Follow-up|1|||
27792625|NCT03605758|81072270|FG000|Overall Study|Illness|0|||
27792626|NCT03605758|81072271|FG001|Overall Study|Illness|1|||
27792627|NCT03605758|81072270|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
27792628|NCT03605758|81072271|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
27792629|NCT03292731|81072272|FG000|Overall Study|Protocol Violation|4|||
27792630|NCT03292731|81072273|FG001|Overall Study|Protocol Violation|11|||
27792631|NCT03292731|81072274|FG002|Overall Study|Protocol Violation|1|||
27792632|NCT04281030|81072279|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
27792633|NCT04281030|81072280|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
27792634|NCT04281030|81072279|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
27792635|NCT04281030|81072280|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
27792636|NCT03586427|81072283|FG000|Overall Study|Lost to Follow-up|0|||
27792637|NCT03586427|81072284|FG001|Overall Study|Lost to Follow-up|3|||
27792638|NCT03586427|81072285|FG002|Overall Study|Lost to Follow-up|1|||
27792639|NCT03586427|81072286|FG003|Overall Study|Lost to Follow-up|3|||
27792640|NCT03586427|81072287|FG004|Overall Study|Lost to Follow-up|3|||
27792641|NCT03586427|81072283|FG000|Overall Study|Withdrawal by Subject|0|||
27792642|NCT03586427|81072284|FG001|Overall Study|Withdrawal by Subject|1|||
27792643|NCT03586427|81072285|FG002|Overall Study|Withdrawal by Subject|2|||
27792644|NCT03586427|81072286|FG003|Overall Study|Withdrawal by Subject|1|||
27792645|NCT03586427|81072287|FG004|Overall Study|Withdrawal by Subject|1|||
27792646|NCT03586427|81072283|FG000|Overall Study|Adverse Event|0|||
27792647|NCT03586427|81072284|FG001|Overall Study|Adverse Event|0|||
27792648|NCT03586427|81072285|FG002|Overall Study|Adverse Event|1|||
27792649|NCT03586427|81072286|FG003|Overall Study|Adverse Event|0|||
27792650|NCT03586427|81072287|FG004|Overall Study|Adverse Event|0|||
27792651|NCT03586427|81072283|FG000|Overall Study|Protocol Violation|0|||
27792652|NCT03586427|81072284|FG001|Overall Study|Protocol Violation|0|||
27792653|NCT03586427|81072285|FG002|Overall Study|Protocol Violation|1|||
27792654|NCT03586427|81072286|FG003|Overall Study|Protocol Violation|0|||
27792655|NCT03586427|81072287|FG004|Overall Study|Protocol Violation|1|||
27792656|NCT03586427|81072283|FG000|Overall Study|Noncompliance with study drug|0|||
27978815|NCT00385723|81753454|FG000|Overall Study|Lost to Follow-up|1|||
27978816|NCT00385723|81753455|FG001|Overall Study|Lost to Follow-up|1|||
27978817|NCT00385723|81753456|FG002|Overall Study|Lost to Follow-up|0|||
27978818|NCT00385723|81753454|FG000|Overall Study|Withdrawal by Subject|1|||
27978819|NCT00385723|81753455|FG001|Overall Study|Withdrawal by Subject|0|||
27978820|NCT00385723|81753456|FG002|Overall Study|Withdrawal by Subject|2|||
27978821|NCT03968159|81753462|FG000|Overall Study|Adverse Event|4|||
27978822|NCT03968159|81753463|FG001|Overall Study|Adverse Event|4|||
27978823|NCT03968159|81753462|FG000|Overall Study|Lost to Follow-up|1|||
27978824|NCT03968159|81753463|FG001|Overall Study|Lost to Follow-up|1|||
27978825|NCT03968159|81753462|FG000|Overall Study|Use of prohibited medication|0|||
27792657|NCT03586427|81072284|FG001|Overall Study|Noncompliance with study drug|0|||
27792658|NCT03586427|81072285|FG002|Overall Study|Noncompliance with study drug|1|||
27792659|NCT03586427|81072286|FG003|Overall Study|Noncompliance with study drug|0|||
27792660|NCT03586427|81072287|FG004|Overall Study|Noncompliance with study drug|0|||
27792661|NCT00698009|81072304|FG000|Overall Study|Withdrawal by Subject|1|||
27792662|NCT03526549|81072305|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
27792663|NCT03526549|81072306|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
27792664|NCT03526549|81072305|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
27978826|NCT03968159|81753463|FG001|Overall Study|Use of prohibited medication|1|||
27672698|NCT00760747|80639304|FG001|Study Period II|Withdrawal by Subject|0|||
27792665|NCT03526549|81072306|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
27792666|NCT03526549|81072305|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
27792667|NCT03526549|81072306|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
27792668|NCT03526549|81072305|FG000|Open-label Phase|Adverse Event|4|||
27792669|NCT03526549|81072306|FG001|Open-label Phase|Adverse Event|0|||
27792670|NCT03526549|81072305|FG000|Open-label Phase|Withdrawal by Subject|54|||
27792671|NCT03526549|81072306|FG001|Open-label Phase|Withdrawal by Subject|0|||
27792672|NCT03526549|81072305|FG000|Open-label Phase|Lost to Follow-up|35|||
27792673|NCT03526549|81072306|FG001|Open-label Phase|Lost to Follow-up|0|||
27792674|NCT03526549|81072305|FG000|Open-label Phase|Other than Specified|5|||
27792675|NCT03526549|81072306|FG001|Open-label Phase|Other than Specified|0|||
27792676|NCT01269346|81072318|FG000|Treatment Phase|Disease progression|3|||
27792677|NCT01269346|81072318|FG000|Treatment Phase|Adverse Event|3|||
27792678|NCT01269346|81072318|FG000|Treatment Phase|Withdrawal by Subject|1|||
27792679|NCT01269346|81072318|FG000|Treatment Phase|Other|2|||
27792680|NCT01269346|81072318|FG000|Extension Phase|Adverse Event|6|||
27792681|NCT01269346|81072318|FG000|Extension Phase|Withdrawal by Subject|4|||
27792682|NCT01269346|81072318|FG000|Extension Phase|Disease progression|22|||
27792683|NCT01269346|81072318|FG000|Extension Phase|Physician decision or participant choice|9|||
27792684|NCT01269346|81072318|FG000|Extension Phase|Clinical progression|1|||
27792685|NCT01269346|81072318|FG000|Extension Phase|Started a prohibited con med|1|||
27792686|NCT01569074|81072319|FG000|Overall Study|Study stopped|6|||
27792687|NCT01569074|81072320|FG001|Overall Study|Study stopped|6|||
27792688|NCT01569074|81072321|FG002|Overall Study|Study stopped|8|||
27792689|NCT01569074|81072322|FG003|Overall Study|Study stopped|7|||
27792690|NCT01569074|81072323|FG004|Overall Study|Study stopped|7|||
27792691|NCT01569074|81072319|FG000|Overall Study|Study-specific discontinuation criteria|0|||
27792692|NCT01569074|81072320|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27792693|NCT01569074|81072321|FG002|Overall Study|Study-specific discontinuation criteria|0|||
27792694|NCT01569074|81072322|FG003|Overall Study|Study-specific discontinuation criteria|0|||
27792695|NCT01569074|81072323|FG004|Overall Study|Study-specific discontinuation criteria|0|||
27792696|NCT01569074|81072319|FG000|Overall Study|Severe non-compliance to protocol|0|||
27792697|NCT01569074|81072320|FG001|Overall Study|Severe non-compliance to protocol|0|||
27792698|NCT01569074|81072321|FG002|Overall Study|Severe non-compliance to protocol|1|||
27792699|NCT01569074|81072322|FG003|Overall Study|Severe non-compliance to protocol|0|||
27792700|NCT01569074|81072323|FG004|Overall Study|Severe non-compliance to protocol|0|||
27792701|NCT01569074|81072319|FG000|Overall Study|eg change in circumstances|0|||
27574813|NCT01641367|80289134|FG001|Cohorts|Death|1|||
27574814|NCT01641367|80289135|FG002|Cohorts|Death|2|||
27574815|NCT01641367|80289136|FG003|Cohorts|Death|0|||
27574816|NCT01641367|80289137|FG004|Cohorts|Death|1|||
27792702|NCT01569074|81072320|FG001|Overall Study|eg change in circumstances|2|||
27792703|NCT01569074|81072321|FG002|Overall Study|eg change in circumstances|0|||
27792704|NCT01569074|81072322|FG003|Overall Study|eg change in circumstances|1|||
27574817|NCT01641367|80289138|FG005|Cohorts|Death|1|||
27574818|NCT01641367|80289139|FG006|Cohorts|Death|0|||
27792705|NCT01569074|81072323|FG004|Overall Study|eg change in circumstances|1|||
27574819|NCT01641367|80289140|FG007|Cohorts|Death|0|||
27574820|NCT01641367|80289133|FG000|Cohorts|Lost to Follow-up|16|||
27792706|NCT01569074|81072319|FG000|Overall Study|Adverse Event|1|||
27792707|NCT01569074|81072320|FG001|Overall Study|Adverse Event|0|||
27574821|NCT01641367|80289134|FG001|Cohorts|Lost to Follow-up|0|||
27574822|NCT01641367|80289135|FG002|Cohorts|Lost to Follow-up|2|||
27574823|NCT01641367|80289136|FG003|Cohorts|Lost to Follow-up|0|||
27574824|NCT01641367|80289137|FG004|Cohorts|Lost to Follow-up|2|||
27574825|NCT01641367|80289138|FG005|Cohorts|Lost to Follow-up|0|||
27574826|NCT01641367|80289139|FG006|Cohorts|Lost to Follow-up|0|||
27978827|NCT03968159|81753462|FG000|Overall Study|Protocol Violation|2|||
27978828|NCT03968159|81753463|FG001|Overall Study|Protocol Violation|2|||
27978829|NCT03968159|81753462|FG000|Overall Study|Withdrawal by Subject|4|||
27978830|NCT03968159|81753463|FG001|Overall Study|Withdrawal by Subject|6|||
27978831|NCT03968159|81753462|FG000|Overall Study|Lack of Efficacy|0|||
27978832|NCT03968159|81753463|FG001|Overall Study|Lack of Efficacy|1|||
27978833|NCT03968159|81753462|FG000|Overall Study|Not further specified|2|||
27978834|NCT03968159|81753463|FG001|Overall Study|Not further specified|0|||
27574827|NCT01641367|80289140|FG007|Cohorts|Lost to Follow-up|0|||
27574828|NCT01641367|80289133|FG000|Randomized Adherence Intervention|Death|0|||
27574829|NCT01641367|80289134|FG001|Randomized Adherence Intervention|Death|0|||
27574830|NCT01641367|80289135|FG002|Randomized Adherence Intervention|Death|0|||
27574831|NCT01641367|80289136|FG003|Randomized Adherence Intervention|Death|0|||
27574832|NCT01641367|80289137|FG004|Randomized Adherence Intervention|Death|0|||
27574833|NCT01641367|80289138|FG005|Randomized Adherence Intervention|Death|0|||
27574834|NCT01641367|80289139|FG006|Randomized Adherence Intervention|Death|11|||
27574835|NCT01641367|80289140|FG007|Randomized Adherence Intervention|Death|12|||
27574836|NCT01641367|80289133|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
27574837|NCT01641367|80289134|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
27574838|NCT01641367|80289135|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
27574839|NCT01641367|80289136|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
27574840|NCT01641367|80289137|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
27574841|NCT01641367|80289138|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
27574842|NCT01641367|80289139|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
27574843|NCT01641367|80289140|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
27574844|NCT02488629|80289141|FG000|Overall Study|Lack of Efficacy|3|||
27574845|NCT02488629|80289142|FG001|Overall Study|Lack of Efficacy|1|||
27574846|NCT02488629|80289143|FG002|Overall Study|Lack of Efficacy|0|||
27574847|NCT02488629|80289144|FG003|Overall Study|Lack of Efficacy|0|||
27574848|NCT02488629|80289141|FG000|Overall Study|Withdrawal by Subject|0|||
27574849|NCT02488629|80289142|FG001|Overall Study|Withdrawal by Subject|1|||
27574850|NCT02488629|80289143|FG002|Overall Study|Withdrawal by Subject|0|||
27574851|NCT02488629|80289144|FG003|Overall Study|Withdrawal by Subject|0|||
27574852|NCT02043015|80289147|FG000|Overall Study|Lost to Follow-up|4|||
27574853|NCT02043015|80289147|FG000|Overall Study|Withdrawal by Subject|4|||
27574854|NCT02043015|80289147|FG000|Overall Study|Removed once target enrollment reached|15|||
27672699|NCT00760747|80639303|FG000|Study Period II|No drug administered|0|||
27672700|NCT00760747|80639304|FG001|Study Period II|No drug administered|1|||
27792708|NCT01569074|81072321|FG002|Overall Study|Adverse Event|3|||
27792709|NCT01569074|81072322|FG003|Overall Study|Adverse Event|0|||
27792710|NCT01569074|81072323|FG004|Overall Study|Adverse Event|0|||
27792711|NCT03323034|81072336|FG000|Overall Study|Lack of Efficacy|5|||
27792712|NCT03323034|81072337|FG001|Overall Study|Lack of Efficacy|5|||
27792713|NCT03323034|81072338|FG002|Overall Study|Lack of Efficacy|6|||
27792714|NCT03323034|81072339|FG003|Overall Study|Lack of Efficacy|5|||
27978835|NCT00740714|81753464|FG000|Overall Study|Withdrawal by Subject|17|||
27978836|NCT00740714|81753465|FG001|Overall Study|Withdrawal by Subject|19|||
27978837|NCT00740714|81753466|FG002|Overall Study|Withdrawal by Subject|29|||
27574855|NCT02043015|80289147|FG000|Overall Study|Participant moved away from study city|4|||
27574856|NCT02043015|80289147|FG000|Overall Study|Incarceration|1|||
27792715|NCT03323034|81072340|FG004|Overall Study|Lack of Efficacy|5|||
27792716|NCT03323034|81072336|FG000|Overall Study|Physician Decision|0|||
27792717|NCT03323034|81072337|FG001|Overall Study|Physician Decision|0|||
27792718|NCT03323034|81072338|FG002|Overall Study|Physician Decision|0|||
27792719|NCT03323034|81072339|FG003|Overall Study|Physician Decision|0|||
27792720|NCT03323034|81072340|FG004|Overall Study|Physician Decision|1|||
27792721|NCT03323034|81072336|FG000|Overall Study|Withdrawal by Subject|1|||
27792722|NCT03323034|81072337|FG001|Overall Study|Withdrawal by Subject|1|||
27792723|NCT03323034|81072338|FG002|Overall Study|Withdrawal by Subject|0|||
27792724|NCT03323034|81072339|FG003|Overall Study|Withdrawal by Subject|1|||
27792725|NCT03323034|81072340|FG004|Overall Study|Withdrawal by Subject|0|||
27792726|NCT04139642|81072341|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
27574857|NCT01282424|80289148|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
27792727|NCT04139642|81072342|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
27978838|NCT02741570|81753467|FG000|Pre-Treatment Period|Other reasons|0|||
27574858|NCT01282424|80289148|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
27574859|NCT01282424|80289148|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
27574860|NCT01282424|80289148|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
27574861|NCT01282424|80289148|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
27672701|NCT00760747|80639303|FG000|Study Period III|Adverse Event|1|||
27978839|NCT02741570|81753468|FG001|Pre-Treatment Period|Other reasons|3|||
27978840|NCT02741570|81753467|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
27978841|NCT02741570|81753468|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
27978842|NCT02741570|81753467|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
27574862|NCT01282424|80289148|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
27672702|NCT00760747|80639304|FG001|Study Period III|Adverse Event|0|||
27672703|NCT00760747|80639303|FG000|Study Period III|Lack of Efficacy|1|||
27792728|NCT01640964|81072346|FG000|Overall Study|Lost to Follow-up|0|||
27792729|NCT01640964|81072347|FG001|Overall Study|Lost to Follow-up|0|||
27792730|NCT01640964|81072348|FG002|Overall Study|Lost to Follow-up|1|||
27792731|NCT01640964|81072346|FG000|Overall Study|Protocol Deviation|1|||
27792732|NCT01640964|81072347|FG001|Overall Study|Protocol Deviation|1|||
27792733|NCT01640964|81072348|FG002|Overall Study|Protocol Deviation|2|||
27792734|NCT02057549|81072349|FG000|Overall Study|Lost to Follow-up|1|||
27792735|NCT02057549|81072350|FG001|Overall Study|Lost to Follow-up|0|||
27792736|NCT02057549|81072349|FG000|Overall Study|Physician Decision|1|||
27792737|NCT02057549|81072350|FG001|Overall Study|Physician Decision|0|||
27792738|NCT02057549|81072349|FG000|Overall Study|Withdrawal by Subject|1|||
27792739|NCT02057549|81072350|FG001|Overall Study|Withdrawal by Subject|0|||
27792740|NCT03743571|81072351|FG000|Overall Study|Withdrawal by Subject|1|||
27792741|NCT03743571|81072352|FG001|Overall Study|Withdrawal by Subject|1|||
27792742|NCT03743571|81072351|FG000|Overall Study|Lost to Follow-up|1|||
27792743|NCT03743571|81072352|FG001|Overall Study|Lost to Follow-up|2|||
27792744|NCT00938015|81072355|FG000|Overall Study|Death|2|||
27792745|NCT00938015|81072355|FG000|Overall Study|Lost to Follow-up|32|||
27792746|NCT00938015|81072355|FG000|Overall Study|Adverse Event|32|||
27792747|NCT00938015|81072355|FG000|Overall Study|Non-responder|52|||
27792748|NCT00938015|81072355|FG000|Overall Study|Reason not related to Etanercept|29|||
27792749|NCT04478994|81072362|FG000|Overall Study|Withdrawal by Subject|1|||
27792750|NCT04478994|81072363|FG001|Overall Study|Withdrawal by Subject|1|||
27792751|NCT01060007|81072364|FG000|Overall Study|Withdrawal by Subject|1|||
27792752|NCT01060007|81072364|FG000|Overall Study|Inevaluable for response at surgery|3|||
27792753|NCT00290511|81072365|FG000|Overall Study|Adverse Event|1|||
27792754|NCT00290511|81072365|FG000|Overall Study|Death|1|||
27792755|NCT00290511|81072365|FG000|Overall Study|Physician Decision|1|||
27792756|NCT00290511|81072365|FG000|Overall Study|Withdrawal by Subject|1|||
27792757|NCT04753606|81072367|FG000|Overall Study|Adverse Event|1|||
27792758|NCT04753606|81072368|FG001|Overall Study|Adverse Event|0|||
27792759|NCT04753606|81072369|FG002|Overall Study|Adverse Event|0|||
27792760|NCT00807040|81072370|FG000|Overall Study|Death|24|||
27792761|NCT00807040|81072371|FG001|Overall Study|Death|29|||
27792762|NCT00807040|81072370|FG000|Overall Study|Withdrawal by Subject|8|||
27792763|NCT00807040|81072371|FG001|Overall Study|Withdrawal by Subject|6|||
27792764|NCT00807040|81072370|FG000|Overall Study|Lost to Follow-up|4|||
27792765|NCT00807040|81072371|FG001|Overall Study|Lost to Follow-up|6|||
27792766|NCT00648739|81072372|FG000|Overall Study|Adverse Event|1|||
27792767|NCT00648739|81072373|FG001|Overall Study|Adverse Event|0|||
27792768|NCT00648739|81072374|FG002|Overall Study|Adverse Event|1|||
27792769|NCT00648739|81072375|FG003|Overall Study|Adverse Event|2|||
27792770|NCT00648739|81072376|FG004|Overall Study|Adverse Event|1|||
27792771|NCT00648739|81072377|FG005|Overall Study|Adverse Event|0|||
27792772|NCT00648739|81072378|FG006|Overall Study|Adverse Event|0|||
27792773|NCT00648739|81072372|FG000|Overall Study|Withdrawal by Subject|1|||
27792774|NCT00648739|81072373|FG001|Overall Study|Withdrawal by Subject|0|||
27792775|NCT00648739|81072374|FG002|Overall Study|Withdrawal by Subject|1|||
27792776|NCT00648739|81072375|FG003|Overall Study|Withdrawal by Subject|0|||
27792777|NCT00648739|81072376|FG004|Overall Study|Withdrawal by Subject|0|||
27792778|NCT00648739|81072377|FG005|Overall Study|Withdrawal by Subject|2|||
27792779|NCT00648739|81072378|FG006|Overall Study|Withdrawal by Subject|0|||
27792780|NCT00648739|81072372|FG000|Overall Study|Lack of Efficacy|0|||
27792781|NCT00648739|81072373|FG001|Overall Study|Lack of Efficacy|0|||
27792782|NCT00648739|81072374|FG002|Overall Study|Lack of Efficacy|0|||
27792783|NCT00648739|81072375|FG003|Overall Study|Lack of Efficacy|0|||
27792784|NCT00648739|81072376|FG004|Overall Study|Lack of Efficacy|1|||
27792785|NCT00648739|81072377|FG005|Overall Study|Lack of Efficacy|2|||
27792786|NCT00648739|81072378|FG006|Overall Study|Lack of Efficacy|0|||
27792787|NCT00648739|81072372|FG000|Overall Study|Investigator Considered it Advisable|0|||
27792788|NCT00648739|81072373|FG001|Overall Study|Investigator Considered it Advisable|0|||
27792789|NCT00648739|81072374|FG002|Overall Study|Investigator Considered it Advisable|0|||
27792790|NCT00648739|81072375|FG003|Overall Study|Investigator Considered it Advisable|0|||
27792791|NCT00648739|81072376|FG004|Overall Study|Investigator Considered it Advisable|0|||
27792792|NCT00648739|81072377|FG005|Overall Study|Investigator Considered it Advisable|1|||
27792793|NCT00648739|81072378|FG006|Overall Study|Investigator Considered it Advisable|1|||
27792794|NCT00648739|81072372|FG000|Overall Study|Death|0|||
27792795|NCT00648739|81072373|FG001|Overall Study|Death|1|||
27574863|NCT01282424|80289148|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
27574864|NCT01282424|80289148|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
27574865|NCT00071812|80289153|FG000|24-Week Double-Blind Period|Adverse Event|2|||
27574866|NCT00071812|80289154|FG001|24-Week Double-Blind Period|Adverse Event|3|||
27978843|NCT02741570|81753468|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
27978844|NCT02741570|81753467|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
27978845|NCT02741570|81753468|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
27978846|NCT02741570|81753467|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
27978847|NCT02741570|81753468|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
27978848|NCT02741570|81753467|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
27978849|NCT02741570|81753468|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
27978850|NCT02741570|81753467|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
27978851|NCT02741570|81753468|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27978852|NCT02741570|81753467|FG000|Pre-Treatment Period|Death|0|||
27978853|NCT02741570|81753468|FG001|Pre-Treatment Period|Death|1|||
27978854|NCT02741570|81753467|FG000|Pre-Treatment Period|Disease progression|0|||
27978855|NCT02741570|81753468|FG001|Pre-Treatment Period|Disease progression|1|||
27978856|NCT02741570|81753467|FG000|Treatment Period|Other reasons|47|||
27978857|NCT02741570|81753468|FG001|Treatment Period|Other reasons|12|||
27978858|NCT02741570|81753467|FG000|Treatment Period|Poor/non-compliance|0|||
27978859|NCT02741570|81753468|FG001|Treatment Period|Poor/non-compliance|2|||
27978860|NCT02741570|81753467|FG000|Treatment Period|Maximum clinical benefit|4|||
27978861|NCT02741570|81753468|FG001|Treatment Period|Maximum clinical benefit|6|||
27978862|NCT02741570|81753467|FG000|Treatment Period|Lost to Follow-up|1|||
27978863|NCT02741570|81753468|FG001|Treatment Period|Lost to Follow-up|3|||
27978864|NCT02741570|81753467|FG000|Treatment Period|Participant withdrew consent|9|||
27978865|NCT02741570|81753468|FG001|Treatment Period|Participant withdrew consent|13|||
27978866|NCT02741570|81753467|FG000|Treatment Period|Participant request to discontinue treatment|8|||
27978867|NCT02741570|81753468|FG001|Treatment Period|Participant request to discontinue treatment|23|||
27978868|NCT02741570|81753467|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
27978869|NCT02741570|81753468|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
27978870|NCT02741570|81753467|FG000|Treatment Period|Death|9|||
27978871|NCT02741570|81753468|FG001|Treatment Period|Death|7|||
27978872|NCT02741570|81753467|FG000|Treatment Period|Study drug toxicity|55|||
27978873|NCT02741570|81753468|FG001|Treatment Period|Study drug toxicity|47|||
27978874|NCT02741570|81753467|FG000|Treatment Period|Disease progression|294|||
27978875|NCT02741570|81753468|FG001|Treatment Period|Disease progression|301|||
27978876|NCT02741570|81753467|FG000|Treatment Period|Administrative reason by sponsor|0|||
27978877|NCT02741570|81753468|FG001|Treatment Period|Administrative reason by sponsor|1|||
27978878|NCT01741532|81753469|FG000|Overall Study|Adverse Event|4|||
27978879|NCT01741532|81753470|FG001|Overall Study|Adverse Event|0|||
27978880|NCT01741532|81753469|FG000|Overall Study|Withdrawal by Subject|1|||
27978881|NCT01741532|81753470|FG001|Overall Study|Withdrawal by Subject|1|||
27978882|NCT01741532|81753469|FG000|Overall Study|Protocol Violation|0|||
27978883|NCT01741532|81753470|FG001|Overall Study|Protocol Violation|1|||
27978884|NCT01741532|81753469|FG000|Overall Study|Worsening of the disease|3|||
27978885|NCT01741532|81753470|FG001|Overall Study|Worsening of the disease|1|||
27978886|NCT01741532|81753469|FG000|Overall Study|Sponsor decision|1|||
27978887|NCT01741532|81753470|FG001|Overall Study|Sponsor decision|0|||
27978888|NCT01741532|81753469|FG000|Overall Study|Medical event|1|||
27574867|NCT00071812|80289155|FG002|24-Week Double-Blind Period|Adverse Event|4|||
27574868|NCT00071812|80289156|FG003|24-Week Double-Blind Period|Adverse Event|4|||
27574869|NCT00071812|80289153|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
27574870|NCT00071812|80289154|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
27574871|NCT00071812|80289155|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
27574872|NCT00071812|80289156|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
27574873|NCT00071812|80289153|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
27574874|NCT00071812|80289154|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
27574875|NCT00071812|80289155|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
27574876|NCT00071812|80289156|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
27574877|NCT00071812|80289153|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
27574878|NCT00071812|80289154|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
27574879|NCT00071812|80289155|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
27574880|NCT00071812|80289156|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
27574881|NCT00071812|80289153|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
27574882|NCT00071812|80289154|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
27574883|NCT00071812|80289155|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
27574884|NCT00071812|80289156|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
27672704|NCT00760747|80639304|FG001|Study Period III|Lack of Efficacy|0|||
27978889|NCT01741532|81753470|FG001|Overall Study|Medical event|0|||
27978890|NCT01095653|81753471|FG000|Overall Study|Lack of Efficacy|3|||
27978891|NCT01095653|81753472|FG001|Overall Study|Lack of Efficacy|0|||
27978892|NCT01095653|81753473|FG002|Overall Study|Lack of Efficacy|0|||
27978893|NCT01095653|81753471|FG000|Overall Study|Adverse Event|1|||
27978894|NCT01095653|81753472|FG001|Overall Study|Adverse Event|4|||
27978895|NCT01095653|81753473|FG002|Overall Study|Adverse Event|4|||
27978896|NCT01095653|81753471|FG000|Overall Study|Lost to Follow-up|1|||
27978897|NCT01095653|81753472|FG001|Overall Study|Lost to Follow-up|0|||
27978898|NCT01095653|81753473|FG002|Overall Study|Lost to Follow-up|4|||
27978899|NCT01095653|81753471|FG000|Overall Study|Withdrawal by Subject|4|||
27978900|NCT01095653|81753472|FG001|Overall Study|Withdrawal by Subject|5|||
27978901|NCT01095653|81753473|FG002|Overall Study|Withdrawal by Subject|3|||
27978902|NCT01095653|81753471|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
27978903|NCT01095653|81753472|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
27978904|NCT01095653|81753473|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
27978905|NCT02827500|81753474|FG000|Overall Study|Death|7|||
27978906|NCT02827500|81753475|FG001|Overall Study|Death|3|||
27978907|NCT02827500|81753474|FG000|Overall Study|Lost to Follow-up|1|||
27978908|NCT02827500|81753475|FG001|Overall Study|Lost to Follow-up|1|||
27978909|NCT02827500|81753474|FG000|Overall Study|Withdrawal by Subject|3|||
27978910|NCT02827500|81753475|FG001|Overall Study|Withdrawal by Subject|1|||
27978911|NCT02827500|81753474|FG000|Overall Study|Missing primary endpoint data|3|||
27978912|NCT02827500|81753475|FG001|Overall Study|Missing primary endpoint data|1|||
27978913|NCT02827500|81753474|FG000|Overall Study|Other|5|||
27978914|NCT02827500|81753475|FG001|Overall Study|Other|1|||
27978915|NCT00545532|81753481|FG000|Overall Study|Withdrawal by Subject|1|||
27978916|NCT00545532|81753482|FG001|Overall Study|Withdrawal by Subject|3|||
27978917|NCT00545532|81753481|FG000|Overall Study|Lost to Follow-up|5|||
27978918|NCT00545532|81753482|FG001|Overall Study|Lost to Follow-up|6|||
27978919|NCT00545532|81753481|FG000|Overall Study|Death|0|||
27978920|NCT00545532|81753482|FG001|Overall Study|Death|1|||
27978921|NCT00378599|81753483|FG000|Overall Study|Adverse Event|38|||
27978922|NCT00378599|81753483|FG000|Overall Study|Protocol Violation|2|||
27978923|NCT00378599|81753483|FG000|Overall Study|Treatment failure|7|||
27978924|NCT00378599|81753483|FG000|Overall Study|Withdrawal by Subject|5|||
27978925|NCT00886119|81753484|FG000|Period 1|Did not meet inclusion criteria|1|||
27978926|NCT00886119|81753485|FG001|Period 1|Did not meet inclusion criteria|0|||
27978927|NCT01655381|81755826|FG000|Overall Study|Investigator Decision|1|||
27978928|NCT01655381|81755826|FG000|Overall Study|Moved to Another City|1|||
27978929|NCT01655381|81755826|FG000|Overall Study|Insufficient Treatment Response|1|||
27978930|NCT03405935|81755829|FG000|Overall Study|Adverse Event|3|||
27978931|NCT03405935|81755829|FG000|Overall Study|Death|2|||
27978932|NCT03405935|81755829|FG000|Overall Study|Withdrawal by Subject|1|||
27978933|NCT03405935|81755829|FG000|Overall Study|Lost to Follow-up|2|||
27978934|NCT05590000|81755831|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
27978935|NCT03283150|81755832|FG000|Overall Study|Withdrawal by Subject|6|||
27978936|NCT03283150|81755833|FG001|Overall Study|Withdrawal by Subject|0|||
27978937|NCT03283150|81755834|FG002|Overall Study|Withdrawal by Subject|0|||
27978938|NCT00810901|81755837|FG000|Overall Study|Lost to Follow-up|88|||
27574885|NCT00071812|80289153|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
27574886|NCT00071812|80289154|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
27574887|NCT00071812|80289155|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
27792796|NCT00648739|81072374|FG002|Overall Study|Death|0|||
27792797|NCT00648739|81072375|FG003|Overall Study|Death|0|||
27792798|NCT00648739|81072376|FG004|Overall Study|Death|0|||
27792799|NCT00648739|81072377|FG005|Overall Study|Death|0|||
27792800|NCT00648739|81072378|FG006|Overall Study|Death|0|||
27792801|NCT00648739|81072372|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
27792802|NCT00648739|81072373|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
27792803|NCT00648739|81072374|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
27792804|NCT00648739|81072375|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
27792805|NCT00648739|81072376|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
27792806|NCT00648739|81072377|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
27867665|NCT03142191|81349679|FG002|Active Treatment Extension Period|Death|1|||
27867666|NCT03142191|81349680|FG003|Active Treatment Extension Period|Death|1|||
27867667|NCT03142191|81349681|FG004|Active Treatment Extension Period|Death|0|||
27867668|NCT03142191|81349677|FG000|Active Treatment Extension Period|Adverse Event|6|||
27867669|NCT03142191|81349678|FG001|Active Treatment Extension Period|Adverse Event|5|||
27574888|NCT00071812|80289156|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
27978939|NCT00810901|81755838|FG001|Overall Study|Lost to Follow-up|58|||
27978940|NCT01591863|81755840|FG000|Overall Study|Adverse Event|3|||
27978941|NCT01591863|81755840|FG000|Overall Study|Withdrawal by Subject|1|||
27978942|NCT01591863|81755840|FG000|Overall Study|recurrence|9|||
27978943|NCT01591863|81755840|FG000|Overall Study|Lack of Efficacy|1|||
27792807|NCT00648739|81072378|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
27978944|NCT00973102|81755841|FG000|Overall Study|Protocol Violation|1|||
27978945|NCT00973102|81755842|FG001|Overall Study|Protocol Violation|0|||
27978946|NCT00973102|81755841|FG000|Overall Study|Prisoner|0|||
27792808|NCT00648739|81072372|FG000|Overall Study|Follow-up Visits Not Completed|0|||
27792809|NCT00648739|81072373|FG001|Overall Study|Follow-up Visits Not Completed|1|||
27792810|NCT00648739|81072374|FG002|Overall Study|Follow-up Visits Not Completed|0|||
27792811|NCT00648739|81072375|FG003|Overall Study|Follow-up Visits Not Completed|0|||
27792812|NCT00648739|81072376|FG004|Overall Study|Follow-up Visits Not Completed|0|||
27792813|NCT00648739|81072377|FG005|Overall Study|Follow-up Visits Not Completed|0|||
27792814|NCT00648739|81072378|FG006|Overall Study|Follow-up Visits Not Completed|0|||
27792815|NCT01058707|81072379|FG000|Overall Study|Disease Progression|15|||
27792816|NCT01058707|81072380|FG001|Overall Study|Disease Progression|20|||
27792817|NCT01058707|81072381|FG002|Overall Study|Disease Progression|20|||
27792818|NCT01058707|81072382|FG003|Overall Study|Disease Progression|15|||
27792819|NCT01058707|81072383|FG004|Overall Study|Disease Progression|23|||
27792820|NCT01058707|81072384|FG005|Overall Study|Disease Progression|10|||
27792821|NCT01058707|81072385|FG006|Overall Study|Disease Progression|12|||
27792822|NCT01058707|81072379|FG000|Overall Study|Adverse Event|11|||
27672705|NCT00760747|80639303|FG000|Study Period III|Parent/Caregiver Decision|0|||
27672706|NCT00760747|80639304|FG001|Study Period III|Parent/Caregiver Decision|1|||
27672707|NCT00760747|80639303|FG000|Study Period III|Protocol Violation|1|||
27672708|NCT00760747|80639304|FG001|Study Period III|Protocol Violation|1|||
27672709|NCT00760747|80639303|FG000|Study Period III|Physician Decision|0|||
27792823|NCT01058707|81072380|FG001|Overall Study|Adverse Event|4|||
27792824|NCT01058707|81072381|FG002|Overall Study|Adverse Event|7|||
27792825|NCT01058707|81072382|FG003|Overall Study|Adverse Event|6|||
27792826|NCT01058707|81072383|FG004|Overall Study|Adverse Event|7|||
27792827|NCT01058707|81072384|FG005|Overall Study|Adverse Event|3|||
27792828|NCT01058707|81072385|FG006|Overall Study|Adverse Event|1|||
27792829|NCT01058707|81072379|FG000|Overall Study|Subject Decision|5|||
27792830|NCT01058707|81072380|FG001|Overall Study|Subject Decision|3|||
27792831|NCT01058707|81072381|FG002|Overall Study|Subject Decision|3|||
27792832|NCT01058707|81072382|FG003|Overall Study|Subject Decision|1|||
27792833|NCT01058707|81072383|FG004|Overall Study|Subject Decision|2|||
27792834|NCT01058707|81072384|FG005|Overall Study|Subject Decision|3|||
27792835|NCT01058707|81072385|FG006|Overall Study|Subject Decision|6|||
27792836|NCT01058707|81072379|FG000|Overall Study|Lost to Follow-up|0|||
27792837|NCT01058707|81072380|FG001|Overall Study|Lost to Follow-up|0|||
27792838|NCT01058707|81072381|FG002|Overall Study|Lost to Follow-up|1|||
27574889|NCT00071812|80289153|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27574890|NCT00071812|80289154|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27574891|NCT00071812|80289155|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27574892|NCT00071812|80289156|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
27574893|NCT00071812|80289153|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
27574894|NCT00071812|80289154|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
27574895|NCT00071812|80289155|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
27574896|NCT00071812|80289156|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
27574897|NCT00071812|80289153|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27574898|NCT00071812|80289154|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27574899|NCT00071812|80289155|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27574900|NCT00071812|80289156|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
27672710|NCT00760747|80639304|FG001|Study Period III|Physician Decision|1|||
27792839|NCT01058707|81072382|FG003|Overall Study|Lost to Follow-up|0|||
27792840|NCT01058707|81072383|FG004|Overall Study|Lost to Follow-up|0|||
27792841|NCT01058707|81072384|FG005|Overall Study|Lost to Follow-up|0|||
27792842|NCT01058707|81072385|FG006|Overall Study|Lost to Follow-up|0|||
27792843|NCT01058707|81072379|FG000|Overall Study|Reason Not Specified|0|||
27792844|NCT01058707|81072380|FG001|Overall Study|Reason Not Specified|3|||
27792845|NCT01058707|81072381|FG002|Overall Study|Reason Not Specified|2|||
27978947|NCT00973102|81755842|FG001|Overall Study|Prisoner|1|||
27978948|NCT01463111|81755848|FG000|Overall Study|Withdrawal by Subject|2|||
27978949|NCT01463111|81755848|FG000|Overall Study|Lost to Follow-up|5|||
27978950|NCT01463111|81755848|FG000|Overall Study|Physician Decision|2|||
27978951|NCT02485925|81755849|FG000|Overall Study|Withdrawal by Subject|3|||
27978952|NCT02485925|81755849|FG000|Overall Study|Death|1|||
27978953|NCT02485925|81755849|FG000|Overall Study|Lost to Follow-up|11|||
27978954|NCT01460719|81755853|FG000|Overall Study|Adverse Event|1|||
27978955|NCT01460719|81755853|FG000|Overall Study|Withdrawal by Subject|1|||
27978956|NCT01484834|81755855|FG000|Overall Study|Lost to Follow-up|5|||
27978957|NCT01484834|81755856|FG001|Overall Study|Lost to Follow-up|8|||
27978958|NCT01484834|81755857|FG002|Overall Study|Lost to Follow-up|1|||
27978959|NCT01484834|81755858|FG003|Overall Study|Lost to Follow-up|4|||
27978960|NCT01998893|81755866|FG000|Overall Study|Adverse Event|2|||
27978961|NCT01998893|81755866|FG000|Overall Study|Death|1|||
27978962|NCT01998893|81755866|FG000|Overall Study|Lost to Follow-up|8|||
27978963|NCT01998893|81755866|FG000|Overall Study|Physician Decision|2|||
27978964|NCT01998893|81755866|FG000|Overall Study|Protocol Violation|2|||
27978965|NCT01998893|81755866|FG000|Overall Study|Withdrawal by Subject|1|||
27978966|NCT01998893|81755866|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
27978967|NCT01920152|81755867|FG000|Overall Study|Withdrawal by Subject|1|||
27978968|NCT01920152|81755868|FG001|Overall Study|Withdrawal by Subject|2|||
27978969|NCT01842581|81755869|FG000|Overall Study|Adverse Event|6|||
27978970|NCT01842581|81755870|FG001|Overall Study|Adverse Event|4|||
27978971|NCT01842581|81755869|FG000|Overall Study|HE breakthrough|26|||
27978972|NCT01842581|81755870|FG001|Overall Study|HE breakthrough|13|||
27978973|NCT01842581|81755869|FG000|Overall Study|Liver transplant|2|||
27978974|NCT01842581|81755870|FG001|Overall Study|Liver transplant|0|||
27978975|NCT01842581|81755869|FG000|Overall Study|Lost to Follow-up|2|||
27978976|NCT01842581|81755870|FG001|Overall Study|Lost to Follow-up|5|||
27978977|NCT01842581|81755869|FG000|Overall Study|Withdrawal by Subject|5|||
27978978|NCT01842581|81755870|FG001|Overall Study|Withdrawal by Subject|7|||
27978979|NCT01842581|81755869|FG000|Overall Study|Other than specified|3|||
27978980|NCT01842581|81755870|FG001|Overall Study|Other than specified|1|||
27978981|NCT00711802|81755871|FG000|Overall Study|Not treated (no further detail)|2|||
27978982|NCT00711802|81755872|FG001|Overall Study|Not treated (no further detail)|1|||
27978983|NCT00711802|81755873|FG002|Overall Study|Not treated (no further detail)|2|||
27978984|NCT00711802|81755874|FG003|Overall Study|Not treated (no further detail)|0|||
27978985|NCT00711802|81755875|FG004|Overall Study|Not treated (no further detail)|2|||
27978986|NCT00711802|81755876|FG005|Overall Study|Not treated (no further detail)|0|||
27792846|NCT01058707|81072382|FG003|Overall Study|Reason Not Specified|0|||
27978987|NCT00711802|81755877|FG006|Overall Study|Not treated (no further detail)|0|||
27978988|NCT00711802|81755878|FG007|Overall Study|Not treated (no further detail)|0|||
27792847|NCT01058707|81072383|FG004|Overall Study|Reason Not Specified|7|||
27792848|NCT01058707|81072384|FG005|Overall Study|Reason Not Specified|1|||
27792849|NCT01058707|81072385|FG006|Overall Study|Reason Not Specified|7|||
27792850|NCT00285012|81072386|FG000|Assigned to Study Treatment (Tx)|Other|2|||
27792851|NCT00285012|81072387|FG001|Assigned to Study Treatment (Tx)|Other|3|||
27792852|NCT00285012|81072386|FG000|Received Study Tx|Death|2|||
27978989|NCT00711802|81755871|FG000|Overall Study|Adverse Event|0|||
27574901|NCT00071812|80289153|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
27574902|NCT00071812|80289154|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
27792853|NCT00285012|81072387|FG001|Received Study Tx|Death|1|||
27792854|NCT00285012|81072386|FG000|Received Study Tx|Adverse Event|5|||
27978990|NCT00711802|81755872|FG001|Overall Study|Adverse Event|0|||
27978991|NCT00711802|81755873|FG002|Overall Study|Adverse Event|0|||
27978992|NCT00711802|81755874|FG003|Overall Study|Adverse Event|0|||
27792855|NCT00285012|81072387|FG001|Received Study Tx|Adverse Event|11|||
27792856|NCT00285012|81072386|FG000|Received Study Tx|Lack of Efficacy|0|||
27978993|NCT00711802|81755875|FG004|Overall Study|Adverse Event|1|||
27978994|NCT00711802|81755876|FG005|Overall Study|Adverse Event|1|||
27978995|NCT00711802|81755877|FG006|Overall Study|Adverse Event|0|||
27978996|NCT00711802|81755878|FG007|Overall Study|Adverse Event|0|||
27574903|NCT00071812|80289155|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
27574904|NCT00071812|80289156|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
27574905|NCT03354429|80289168|FG000|Overall Study|Withdrawal by Subject|8|||
27574906|NCT03354429|80289169|FG001|Overall Study|Withdrawal by Subject|7|||
27574907|NCT03354429|80289168|FG000|Overall Study|Lost to Follow-up|1|||
27574908|NCT03354429|80289169|FG001|Overall Study|Lost to Follow-up|0|||
27574909|NCT01410110|80289170|FG000|Overall Study|Withdrawal by Subject|4|||
27574910|NCT01410110|80289171|FG001|Overall Study|Withdrawal by Subject|2|||
27792857|NCT00285012|81072387|FG001|Received Study Tx|Lack of Efficacy|3|||
27792858|NCT00285012|81072386|FG000|Received Study Tx|Lost to Follow-up|29|||
27792859|NCT00285012|81072387|FG001|Received Study Tx|Lost to Follow-up|31|||
27792860|NCT00285012|81072386|FG000|Received Study Tx|Withdrawal by Subject|31|||
27792861|NCT00285012|81072387|FG001|Received Study Tx|Withdrawal by Subject|43|||
27792862|NCT00285012|81072386|FG000|Received Study Tx|Other|5|||
27792863|NCT00285012|81072387|FG001|Received Study Tx|Other|5|||
27792864|NCT00278473|81072398|FG000|Overall Study|drop out|4|||
27792865|NCT00278473|81072399|FG001|Overall Study|drop out|3|||
27574911|NCT00293384|80289172|FG000|Overall Study|Non-compliance|2|||
27574912|NCT00293384|80289172|FG000|Overall Study|Missed dosage/study drug|1|||
27574913|NCT00293384|80289172|FG000|Overall Study|Ineligible|2|||
27574914|NCT02472756|80289175|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
27574915|NCT02472756|80289175|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
27574916|NCT02472756|80289175|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
27574917|NCT02472756|80289175|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
27574918|NCT02472756|80289175|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
27574919|NCT00546715|80289176|FG000|Overall Study|Withdrawal by Subject|0|||
27574920|NCT00546715|80289177|FG001|Overall Study|Withdrawal by Subject|1|||
27574921|NCT00546715|80289178|FG002|Overall Study|Withdrawal by Subject|0|||
27574922|NCT00546715|80289179|FG003|Overall Study|Withdrawal by Subject|0|||
27574923|NCT00646204|80289180|FG000|Overall Study|Adverse Event|3|||
27574924|NCT00646204|80289181|FG001|Overall Study|Adverse Event|0|||
27574925|NCT00646204|80289180|FG000|Overall Study|Withdrawal by Subject|1|||
27574926|NCT00646204|80289181|FG001|Overall Study|Withdrawal by Subject|0|||
27574927|NCT00596011|80289182|FG000|Overall Study|Withdrawal by Subject|2|||
27574928|NCT00596011|80289183|FG001|Overall Study|Withdrawal by Subject|3|||
27574929|NCT00596011|80289182|FG000|Overall Study|Adverse Event|11|||
27574930|NCT00596011|80289183|FG001|Overall Study|Adverse Event|7|||
27574931|NCT04537806|80289186|FG000|Overall Study|Randomized but not treated|1|||
27574932|NCT04537806|80289187|FG001|Overall Study|Randomized but not treated|0|||
27574933|NCT04537806|80289186|FG000|Overall Study|Adverse Event|1|||
27574934|NCT04537806|80289187|FG001|Overall Study|Adverse Event|1|||
27792866|NCT00633217|81072400|FG000|Overall Study|Adverse Event|5|||
27792867|NCT00633217|81072401|FG001|Overall Study|Adverse Event|9|||
27792868|NCT00633217|81072400|FG000|Overall Study|Lack of Efficacy|0|||
27792869|NCT00633217|81072401|FG001|Overall Study|Lack of Efficacy|2|||
27978997|NCT00711802|81755871|FG000|Overall Study|Microbiological failure|0|||
27978998|NCT00711802|81755872|FG001|Overall Study|Microbiological failure|1|||
27978999|NCT00711802|81755873|FG002|Overall Study|Microbiological failure|0|||
27979000|NCT00711802|81755874|FG003|Overall Study|Microbiological failure|0|||
27979001|NCT00711802|81755875|FG004|Overall Study|Microbiological failure|0|||
27979002|NCT00711802|81755876|FG005|Overall Study|Microbiological failure|1|||
27979003|NCT00711802|81755877|FG006|Overall Study|Microbiological failure|0|||
27979004|NCT00711802|81755878|FG007|Overall Study|Microbiological failure|0|||
27574935|NCT01957475|80289188|FG000|Test Period 1|Withdrawal by Subject|1|||
27574936|NCT01957475|80289189|FG001|Test Period 1|Withdrawal by Subject|0|||
27574937|NCT01957475|80289188|FG000|Test Period 1|Other|1|||
27979005|NCT00711802|81755871|FG000|Overall Study|Protocol Violation|0|||
27979006|NCT00711802|81755872|FG001|Overall Study|Protocol Violation|0|||
27979007|NCT00711802|81755873|FG002|Overall Study|Protocol Violation|0|||
27979008|NCT00711802|81755874|FG003|Overall Study|Protocol Violation|1|||
27979009|NCT00711802|81755875|FG004|Overall Study|Protocol Violation|0|||
27979010|NCT00711802|81755876|FG005|Overall Study|Protocol Violation|0|||
27979011|NCT00711802|81755877|FG006|Overall Study|Protocol Violation|0|||
27979012|NCT00711802|81755878|FG007|Overall Study|Protocol Violation|0|||
27979013|NCT00711802|81755871|FG000|Overall Study|Physician Decision|0|||
27979014|NCT00711802|81755872|FG001|Overall Study|Physician Decision|2|||
27979015|NCT00711802|81755873|FG002|Overall Study|Physician Decision|0|||
27979016|NCT00711802|81755874|FG003|Overall Study|Physician Decision|0|||
27979017|NCT00711802|81755875|FG004|Overall Study|Physician Decision|0|||
27979018|NCT00711802|81755876|FG005|Overall Study|Physician Decision|0|||
27979019|NCT00711802|81755877|FG006|Overall Study|Physician Decision|0|||
27979020|NCT00711802|81755878|FG007|Overall Study|Physician Decision|0|||
27979021|NCT00711802|81755871|FG000|Overall Study|Withdrawal by Subject|0|||
27979022|NCT00711802|81755872|FG001|Overall Study|Withdrawal by Subject|1|||
27979023|NCT00711802|81755873|FG002|Overall Study|Withdrawal by Subject|0|||
27979024|NCT00711802|81755874|FG003|Overall Study|Withdrawal by Subject|1|||
27979025|NCT00711802|81755875|FG004|Overall Study|Withdrawal by Subject|0|||
27979026|NCT00711802|81755876|FG005|Overall Study|Withdrawal by Subject|0|||
27979027|NCT00711802|81755877|FG006|Overall Study|Withdrawal by Subject|0|||
27979028|NCT00711802|81755878|FG007|Overall Study|Withdrawal by Subject|0|||
27979029|NCT00711802|81755871|FG000|Overall Study|Lost to Follow-up|0|||
27867670|NCT03142191|81349679|FG002|Active Treatment Extension Period|Adverse Event|4|||
27979030|NCT00711802|81755872|FG001|Overall Study|Lost to Follow-up|0|||
27979031|NCT00711802|81755873|FG002|Overall Study|Lost to Follow-up|3|||
27979032|NCT00711802|81755874|FG003|Overall Study|Lost to Follow-up|1|||
27979033|NCT00711802|81755875|FG004|Overall Study|Lost to Follow-up|10|||
27979034|NCT00711802|81755876|FG005|Overall Study|Lost to Follow-up|6|||
27979035|NCT00711802|81755877|FG006|Overall Study|Lost to Follow-up|4|||
27979036|NCT00711802|81755878|FG007|Overall Study|Lost to Follow-up|2|||
27979037|NCT00711802|81755871|FG000|Overall Study|Reason not reported|0|||
27979038|NCT00711802|81755872|FG001|Overall Study|Reason not reported|1|||
27979039|NCT00711802|81755873|FG002|Overall Study|Reason not reported|1|||
27979040|NCT00711802|81755874|FG003|Overall Study|Reason not reported|0|||
27979041|NCT00711802|81755875|FG004|Overall Study|Reason not reported|1|||
27979042|NCT00711802|81755876|FG005|Overall Study|Reason not reported|0|||
27979043|NCT00711802|81755877|FG006|Overall Study|Reason not reported|1|||
27979044|NCT00711802|81755878|FG007|Overall Study|Reason not reported|0|||
27979045|NCT00652899|81755879|FG000|Overall Study|Death|1|||
27979046|NCT00652899|81755879|FG000|Overall Study|Treating physician decision|1|||
27979047|NCT00086502|81755880|FG000|Overall Study|Adverse Event|11|||
27979048|NCT00086502|81755881|FG001|Overall Study|Adverse Event|2|||
27979049|NCT00086502|81755880|FG000|Overall Study|Lack of Efficacy|0|||
27979050|NCT00086502|81755881|FG001|Overall Study|Lack of Efficacy|2|||
27979051|NCT00086502|81755880|FG000|Overall Study|Lost to Follow-up|3|||
27979052|NCT00086502|81755881|FG001|Overall Study|Lost to Follow-up|1|||
27979053|NCT00086502|81755880|FG000|Overall Study|Physician Decision|1|||
27979054|NCT00086502|81755881|FG001|Overall Study|Physician Decision|1|||
27979055|NCT00086502|81755880|FG000|Overall Study|Pregnancy|0|||
27979056|NCT00086502|81755881|FG001|Overall Study|Pregnancy|1|||
27979057|NCT00086502|81755880|FG000|Overall Study|Protocol Violation|3|||
27979058|NCT00086502|81755881|FG001|Overall Study|Protocol Violation|3|||
27979059|NCT00086502|81755880|FG000|Overall Study|Withdrawal by Subject|5|||
27979060|NCT00086502|81755881|FG001|Overall Study|Withdrawal by Subject|6|||
27979061|NCT00086502|81755880|FG000|Overall Study|Patient Moved|1|||
27979062|NCT00086502|81755881|FG001|Overall Study|Patient Moved|1|||
27979063|NCT00086502|81755880|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
27979064|NCT00086502|81755881|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
27979065|NCT00086502|81755880|FG000|Overall Study|Patient Accidentally Unblinded|1|||
27979066|NCT00086502|81755881|FG001|Overall Study|Patient Accidentally Unblinded|0|||
27979067|NCT01231321|81755882|FG000|Overall Study|Adverse Event|3|||
27979068|NCT01231321|81755882|FG000|Overall Study|Lack of Efficacy|2|||
27979069|NCT04584346|81755883|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
27979070|NCT04584346|81755884|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
27979071|NCT00260065|81755885|FG000|Overall Study|Progressive Disease|22|||
27979072|NCT00260065|81755885|FG000|Overall Study|Adverse Event|17|||
27979073|NCT00260065|81755885|FG000|Overall Study|Death|13|||
27979074|NCT00260065|81755885|FG000|Overall Study|Withdrawal by Subject|13|||
27979075|NCT00260065|81755885|FG000|Overall Study|Physician Decision|19|||
27979076|NCT00260065|81755885|FG000|Overall Study|Not otherwise specified|8|||
27979077|NCT00260065|81755885|FG000|Overall Study|Medication Noncompliance|1|||
27979078|NCT03322423|81755886|FG000|Period 1|Subject no longer eligible|0|||
27979079|NCT03322423|81755887|FG001|Period 1|Subject no longer eligible|1|||
27979080|NCT03322423|81755886|FG000|Period 1|Withdrawal by Subject|0|||
27979081|NCT03322423|81755887|FG001|Period 1|Withdrawal by Subject|1|||
27979082|NCT03322423|81755886|FG000|Period 1|Incorrect Lens Dispensed|1|||
27979083|NCT03322423|81755887|FG001|Period 1|Incorrect Lens Dispensed|0|||
27979084|NCT03322423|81755886|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
27979085|NCT03322423|81755887|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
27979086|NCT03322423|81755886|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
27979087|NCT03322423|81755887|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
27979088|NCT03322423|81755886|FG000|Period 2|Protocol Violation|1|||
27979089|NCT03322423|81755887|FG001|Period 2|Protocol Violation|0|||
27979090|NCT03322423|81755886|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
27979091|NCT03322423|81755887|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
27979092|NCT04035564|81755897|FG000|Overall Study|Protocol Violation|1|||
27979093|NCT04035564|81755898|FG001|Overall Study|Protocol Violation|2|||
27574938|NCT01957475|80289189|FG001|Test Period 1|Other|0|||
27574939|NCT01957475|80289188|FG000|Test Period 1|Lack of Efficacy|0|||
27574940|NCT01957475|80289189|FG001|Test Period 1|Lack of Efficacy|1|||
27792870|NCT00633217|81072400|FG000|Overall Study|Protocol Violation|3|||
27792871|NCT00633217|81072401|FG001|Overall Study|Protocol Violation|7|||
27979094|NCT04035564|81755897|FG000|Overall Study|No laboratory available|2|||
27979095|NCT04035564|81755898|FG001|Overall Study|No laboratory available|2|||
27979096|NCT04035564|81755897|FG000|Overall Study|Guardian declined consent|1|||
27979097|NCT04035564|81755898|FG001|Overall Study|Guardian declined consent|2|||
27979098|NCT01610596|81755899|FG000|Overall Study|Lost to Follow-up|0|||
27979099|NCT01610596|81755900|FG001|Overall Study|Lost to Follow-up|1|||
27979100|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
27979101|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
27979102|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
27979103|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
27979104|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
27979105|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
27979106|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
27574941|NCT01957475|80289188|FG000|Test Period 2|Adverse Event|1|||
27574942|NCT01957475|80289189|FG001|Test Period 2|Adverse Event|0|||
27574943|NCT01438541|80289194|FG000|Overall Study|Physician Decision|1|||
27574944|NCT01438541|80289194|FG000|Overall Study|Withdrawal by Subject|1|||
27574945|NCT01438541|80289194|FG000|Overall Study|discharge from the hospital|5|||
27574946|NCT02871375|80289196|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
27574947|NCT02871375|80289197|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
27574948|NCT04251533|80289198|FG000|Overall Study|Progressive disease|33|||
27574949|NCT04251533|80289199|FG001|Overall Study|Progressive disease|29|||
27574950|NCT04251533|80289200|FG002|Overall Study|Progressive disease|22|||
27574951|NCT04251533|80289198|FG000|Overall Study|Death|5|||
27574952|NCT04251533|80289199|FG001|Overall Study|Death|1|||
27574953|NCT04251533|80289200|FG002|Overall Study|Death|3|||
27574954|NCT04251533|80289198|FG000|Overall Study|Physician Decision|3|||
27574955|NCT04251533|80289199|FG001|Overall Study|Physician Decision|2|||
27574956|NCT04251533|80289200|FG002|Overall Study|Physician Decision|4|||
27574957|NCT04251533|80289198|FG000|Overall Study|Participant decision|1|||
27574958|NCT04251533|80289199|FG001|Overall Study|Participant decision|3|||
27574959|NCT04251533|80289200|FG002|Overall Study|Participant decision|1|||
27574960|NCT04251533|80289198|FG000|Overall Study|Adverse Event|2|||
27574961|NCT04251533|80289199|FG001|Overall Study|Adverse Event|1|||
27574962|NCT04251533|80289200|FG002|Overall Study|Adverse Event|1|||
27574963|NCT02711800|80289203|FG000|Overall Study|Lost to Follow-up|1|||
27574964|NCT02711800|80289203|FG000|Overall Study|Withdrawal by Subject|1|||
27574965|NCT01898793|80289206|FG000|Overall Study|Death|2|||
27574966|NCT01898793|80289207|FG001|Overall Study|Death|1|||
27979107|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
27979108|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
27979109|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
27574967|NCT01898793|80289208|FG002|Overall Study|Death|4|||
27574968|NCT01898793|80289209|FG003|Overall Study|Death|0|||
27574969|NCT01898793|80289210|FG004|Overall Study|Death|0|||
27574970|NCT01898793|80289211|FG005|Overall Study|Death|0|||
27574971|NCT01898793|80289212|FG006|Overall Study|Death|0|||
27574972|NCT03075644|80289214|FG000|Overall Study|Withdrawal by Subject|1|||
27574973|NCT03075644|80289215|FG001|Overall Study|Withdrawal by Subject|1|||
27574974|NCT01420081|80289216|FG000|Overall Study|Death|1|||
27574975|NCT01420081|80289217|FG001|Overall Study|Death|0|||
27574976|NCT01420081|80289218|FG002|Overall Study|Death|8|||
27574977|NCT01420081|80289219|FG003|Overall Study|Death|0|||
27574978|NCT01420081|80289220|FG004|Overall Study|Death|7|||
27574979|NCT01420081|80289221|FG005|Overall Study|Death|12|||
27574980|NCT01420081|80289222|FG006|Overall Study|Death|0|||
27574981|NCT01420081|80289223|FG007|Overall Study|Death|1|||
27574982|NCT01420081|80289224|FG008|Overall Study|Death|1|||
27574983|NCT01420081|80289216|FG000|Overall Study|Lost to Follow-up|0|||
27574984|NCT01420081|80289217|FG001|Overall Study|Lost to Follow-up|0|||
27574985|NCT01420081|80289218|FG002|Overall Study|Lost to Follow-up|0|||
27574986|NCT01420081|80289219|FG003|Overall Study|Lost to Follow-up|0|||
27574987|NCT01420081|80289220|FG004|Overall Study|Lost to Follow-up|1|||
27574988|NCT01420081|80289221|FG005|Overall Study|Lost to Follow-up|1|||
27574989|NCT01420081|80289222|FG006|Overall Study|Lost to Follow-up|0|||
27574990|NCT01420081|80289223|FG007|Overall Study|Lost to Follow-up|0|||
27574991|NCT01420081|80289224|FG008|Overall Study|Lost to Follow-up|0|||
27979110|NCT03906656|81755901|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
27979111|NCT03906656|81755902|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
27979112|NCT03906656|81755901|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
27979113|NCT03906656|81755902|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
27979114|NCT03906656|81755901|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
27979115|NCT03906656|81755902|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
27979116|NCT03906656|81755901|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
27979117|NCT03906656|81755902|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
27979118|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
27979119|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
27574992|NCT01420081|80289216|FG000|Overall Study|Study Terminated by Sponsor|2|||
27574993|NCT01420081|80289217|FG001|Overall Study|Study Terminated by Sponsor|1|||
27574994|NCT01420081|80289218|FG002|Overall Study|Study Terminated by Sponsor|1|||
27574995|NCT01420081|80289219|FG003|Overall Study|Study Terminated by Sponsor|3|||
27574996|NCT01420081|80289220|FG004|Overall Study|Study Terminated by Sponsor|11|||
27574997|NCT01420081|80289221|FG005|Overall Study|Study Terminated by Sponsor|7|||
27574998|NCT01420081|80289222|FG006|Overall Study|Study Terminated by Sponsor|3|||
27574999|NCT01420081|80289223|FG007|Overall Study|Study Terminated by Sponsor|2|||
27575000|NCT01420081|80289224|FG008|Overall Study|Study Terminated by Sponsor|2|||
27575001|NCT01420081|80289216|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
27575002|NCT01420081|80289217|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
27867671|NCT03142191|81349680|FG003|Active Treatment Extension Period|Adverse Event|1|||
27575003|NCT01420081|80289218|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
27575004|NCT01420081|80289219|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
27575005|NCT01420081|80289220|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
27575006|NCT01420081|80289221|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
27575007|NCT01420081|80289222|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
27575008|NCT01420081|80289223|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
27575009|NCT01420081|80289224|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
27575010|NCT01420081|80289216|FG000|Overall Study|Other Reasons|0|||
27575011|NCT01420081|80289217|FG001|Overall Study|Other Reasons|0|||
27575012|NCT01420081|80289218|FG002|Overall Study|Other Reasons|1|||
27575013|NCT01420081|80289219|FG003|Overall Study|Other Reasons|0|||
27575014|NCT01420081|80289220|FG004|Overall Study|Other Reasons|0|||
27575015|NCT01420081|80289221|FG005|Overall Study|Other Reasons|0|||
27575016|NCT01420081|80289222|FG006|Overall Study|Other Reasons|0|||
27575017|NCT01420081|80289223|FG007|Overall Study|Other Reasons|0|||
27575018|NCT01420081|80289224|FG008|Overall Study|Other Reasons|0|||
27575019|NCT02908529|80289225|FG000|Overall Study|Lost to Follow-up|0|||
27575020|NCT02908529|80289226|FG001|Overall Study|Lost to Follow-up|2|||
27575021|NCT00414661|80289227|FG000|Overall Study|Death|2|||
27575022|NCT00414661|80289228|FG001|Overall Study|Death|5|||
27575023|NCT00414661|80289229|FG002|Overall Study|Death|0|||
27575024|NCT00414661|80289230|FG003|Overall Study|Death|0|||
27575025|NCT00414661|80289227|FG000|Overall Study|Lost to Follow-up|1|||
27575026|NCT00414661|80289228|FG001|Overall Study|Lost to Follow-up|4|||
27575027|NCT00414661|80289229|FG002|Overall Study|Lost to Follow-up|0|||
27575028|NCT00414661|80289230|FG003|Overall Study|Lost to Follow-up|1|||
27575029|NCT00414661|80289227|FG000|Overall Study|Withdrawal by Subject|5|||
27575030|NCT00414661|80289228|FG001|Overall Study|Withdrawal by Subject|2|||
27575031|NCT00414661|80289229|FG002|Overall Study|Withdrawal by Subject|2|||
27575032|NCT00414661|80289230|FG003|Overall Study|Withdrawal by Subject|2|||
27575033|NCT00414661|80289227|FG000|Overall Study|Other|6|||
27979120|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
27979121|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
27979122|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
27575034|NCT00414661|80289228|FG001|Overall Study|Other|3|||
27575035|NCT00414661|80289229|FG002|Overall Study|Other|0|||
27575036|NCT00414661|80289230|FG003|Overall Study|Other|0|||
27575037|NCT04055116|80289240|FG000|First Intervention|Physician Decision|2|||
27979123|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
27979124|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
27979125|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
27575038|NCT04055116|80289241|FG001|First Intervention|Physician Decision|7|||
27575039|NCT02751983|80289242|FG000|Treatment|Stopped ACT, but Remained in study|2|||
27575040|NCT02751983|80289243|FG001|Treatment|Stopped ACT, but Remained in study|0|||
27575041|NCT02751983|80289242|FG000|Treatment|Discharged prior to beginning ACT|2|||
27575042|NCT02751983|80289243|FG001|Treatment|Discharged prior to beginning ACT|0|||
27575043|NCT02751983|80289242|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
27575044|NCT02751983|80289243|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
27575045|NCT02751983|80289242|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
27575046|NCT02751983|80289243|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
27575047|NCT02751983|80289242|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
27575048|NCT02751983|80289243|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
27575049|NCT02357576|80289244|FG000|Treatment Period|Withdrawal by Subject|0|||
27575050|NCT02357576|80289245|FG001|Treatment Period|Withdrawal by Subject|1|||
27979126|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
27979127|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
27575051|NCT02357576|80289244|FG000|Treatment Period|Physician Decision|0|||
27575052|NCT02357576|80289245|FG001|Treatment Period|Physician Decision|1|||
27575053|NCT02357576|80289244|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
27575054|NCT02357576|80289245|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
27575055|NCT02357576|80289244|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
27575056|NCT02357576|80289245|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
27575057|NCT02357576|80289244|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
27575058|NCT02357576|80289245|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
27575059|NCT02357576|80289244|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
27979128|NCT03906656|81755901|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
27575060|NCT02357576|80289245|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
27575061|NCT02907359|80289246|FG000|Overall Study|Death|234|||
27575062|NCT02907359|80289247|FG001|Overall Study|Death|117|||
27575063|NCT02907359|80289246|FG000|Overall Study|Withdrawal by Subject|6|||
27575064|NCT02907359|80289247|FG001|Overall Study|Withdrawal by Subject|11|||
27575065|NCT02907359|80289246|FG000|Overall Study|Lost to Follow-up|1|||
27575066|NCT02907359|80289247|FG001|Overall Study|Lost to Follow-up|0|||
27575067|NCT00110812|80289248|FG000|Main Study|Death|0|||
27575068|NCT00110812|80289249|FG001|Main Study|Death|0|||
27575069|NCT00110812|80289250|FG002|Main Study|Death|2|||
27575070|NCT00110812|80289248|FG000|Main Study|Withdrawal by Subject|0|||
27575071|NCT00110812|80289249|FG001|Main Study|Withdrawal by Subject|0|||
27575072|NCT00110812|80289250|FG002|Main Study|Withdrawal by Subject|1|||
27575073|NCT00110812|80289248|FG000|Main Study|Lost to Follow-up|8|||
27575074|NCT00110812|80289249|FG001|Main Study|Lost to Follow-up|11|||
27575075|NCT00110812|80289250|FG002|Main Study|Lost to Follow-up|10|||
27575076|NCT00110812|80289248|FG000|Extended Follow-up|Death|1|||
27575077|NCT00110812|80289249|FG001|Extended Follow-up|Death|0|||
27575078|NCT00110812|80289250|FG002|Extended Follow-up|Death|3|||
27575079|NCT00110812|80289248|FG000|Extended Follow-up|Withdrawal by Subject|0|||
27575080|NCT00110812|80289249|FG001|Extended Follow-up|Withdrawal by Subject|1|||
27575081|NCT00110812|80289250|FG002|Extended Follow-up|Withdrawal by Subject|0|||
27575082|NCT00110812|80289248|FG000|Extended Follow-up|Lost to Follow-up|1|||
27575083|NCT00110812|80289249|FG001|Extended Follow-up|Lost to Follow-up|3|||
27575084|NCT00110812|80289250|FG002|Extended Follow-up|Lost to Follow-up|1|||
27575085|NCT04497987|80289252|FG000|Overall Study|Adverse Event|1|||
27575086|NCT04497987|80289253|FG001|Overall Study|Adverse Event|0|||
27575087|NCT04497987|80289252|FG000|Overall Study|Death|21|||
27575088|NCT04497987|80289253|FG001|Overall Study|Death|13|||
27575089|NCT04497987|80289252|FG000|Overall Study|Lost to Follow-up|19|||
27575090|NCT04497987|80289253|FG001|Overall Study|Lost to Follow-up|17|||
27575091|NCT04497987|80289252|FG000|Overall Study|Other - as reported by the investigator|22|||
27575092|NCT04497987|80289253|FG001|Overall Study|Other - as reported by the investigator|16|||
27575093|NCT04497987|80289252|FG000|Overall Study|Physician Decision|1|||
27575094|NCT04497987|80289253|FG001|Overall Study|Physician Decision|0|||
27575095|NCT04497987|80289252|FG000|Overall Study|Withdrawal by Subject|35|||
27575096|NCT04497987|80289253|FG001|Overall Study|Withdrawal by Subject|21|||
27575097|NCT03120013|80289254|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27575098|NCT03120013|80289255|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27575099|NCT01660711|80289257|FG000|Overall Study|Adverse Event|7|||
27575100|NCT01660711|80289257|FG000|Overall Study|Withdrawal by Subject|1|||
27575101|NCT02840877|80289258|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
27575102|NCT02840877|80289258|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
27575103|NCT02840877|80289258|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
27575104|NCT02840877|80289258|FG000|Baseline to 12 Weeks|Death|1|||
27575105|NCT02840877|80289258|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
27575106|NCT02840877|80289258|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
27575107|NCT02840877|80289258|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
27575108|NCT02840877|80289258|FG000|12 Weeks to 6 Months|Treatment failure|1|||
27575109|NCT02840877|80289258|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
27575110|NCT02840877|80289258|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
27575111|NCT02840877|80289258|FG000|12 Weeks to 6 Months|Death|1|||
27575112|NCT02840877|80289258|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
27575113|NCT02840877|80289258|FG000|6 Months to 18 Months|Treatment failure|7|||
27575114|NCT02840877|80289258|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
27575115|NCT02840877|80289258|FG000|6 Months to 18 Months|Moved/transferred out|6|||
27575116|NCT02840877|80289258|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
27575117|NCT02840877|80289258|FG000|6 Months to 18 Months|Death|4|||
27575118|NCT02840877|80289258|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
27575119|NCT02840877|80289258|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
27575120|NCT02840877|80289258|FG000|6 Months to 18 Months|Still in study.|14|||
27575121|NCT01205165|80289259|FG000|Overall Study|Lost to Follow-up|2|||
27575122|NCT01987427|80289260|FG000|Overall Study|Adverse Event|4|||
27575123|NCT01987427|80289261|FG001|Overall Study|Adverse Event|2|||
27575124|NCT01987427|80289262|FG002|Overall Study|Adverse Event|8|||
27575125|NCT01987427|80289260|FG000|Overall Study|Lost to Follow-up|6|||
27792872|NCT00633217|81072400|FG000|Overall Study|Lost to Follow-up|2|||
27792873|NCT00633217|81072401|FG001|Overall Study|Lost to Follow-up|2|||
27575126|NCT01987427|80289261|FG001|Overall Study|Lost to Follow-up|6|||
27575127|NCT01987427|80289262|FG002|Overall Study|Lost to Follow-up|9|||
27575128|NCT01987427|80289260|FG000|Overall Study|Withdrawal by Subject|2|||
27575129|NCT01987427|80289261|FG001|Overall Study|Withdrawal by Subject|1|||
27575130|NCT01987427|80289262|FG002|Overall Study|Withdrawal by Subject|3|||
27575131|NCT01987427|80289260|FG000|Overall Study|Lack of Efficacy|1|||
27575132|NCT01987427|80289261|FG001|Overall Study|Lack of Efficacy|0|||
27575133|NCT01987427|80289262|FG002|Overall Study|Lack of Efficacy|0|||
27575134|NCT01987427|80289260|FG000|Overall Study|Other|1|||
27575135|NCT01987427|80289261|FG001|Overall Study|Other|1|||
27575136|NCT01987427|80289262|FG002|Overall Study|Other|0|||
27575137|NCT00767676|80289272|FG000|Overall Study|Investigator error|54|||
27575138|NCT00723606|80289273|FG000|Overall Study|Adverse Event|2|||
27575139|NCT00723606|80289274|FG001|Overall Study|Adverse Event|5|||
27575140|NCT00723606|80289273|FG000|Overall Study|Other|2|||
27575141|NCT00723606|80289274|FG001|Overall Study|Other|0|||
27575142|NCT00723606|80289273|FG000|Overall Study|Withdrawal by Subject|0|||
27575143|NCT00723606|80289274|FG001|Overall Study|Withdrawal by Subject|2|||
27575144|NCT00482391|80289280|FG000|Overall Study|Withdrawal by Subject|1|||
27575145|NCT00482391|80289280|FG000|Overall Study|Adverse Event|1|||
27575146|NCT00482391|80289280|FG000|Overall Study|Death|1|||
27575147|NCT00622635|80289283|FG000|Treatment Period 1|Adverse Event|0|||
27575148|NCT00622635|80289284|FG001|Treatment Period 1|Adverse Event|0|||
27575149|NCT00622635|80289285|FG002|Treatment Period 1|Adverse Event|1|||
27575150|NCT00622635|80289286|FG003|Treatment Period 1|Adverse Event|0|||
27575151|NCT00622635|80289287|FG004|Treatment Period 1|Adverse Event|0|||
27575152|NCT00622635|80289288|FG005|Treatment Period 1|Adverse Event|0|||
27575153|NCT00622635|80289283|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27575154|NCT00622635|80289284|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27575155|NCT00622635|80289285|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27575156|NCT00622635|80289286|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27575157|NCT00622635|80289287|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27575158|NCT00622635|80289288|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27867672|NCT03142191|81349681|FG004|Active Treatment Extension Period|Adverse Event|0|||
27575159|NCT00622635|80289283|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
27575160|NCT00622635|80289284|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
27575161|NCT00622635|80289285|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
27575162|NCT00622635|80289286|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
27575163|NCT00622635|80289287|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
27575164|NCT00622635|80289288|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
27979129|NCT03906656|81755902|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
27979130|NCT03906656|81755901|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
27979131|NCT03906656|81755902|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
27979132|NCT03906656|81755901|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
27979133|NCT03906656|81755902|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
27979134|NCT03906656|81755901|FG000|Home Use 2 (3 Months)|Death|2|||
27979135|NCT03906656|81755902|FG001|Home Use 2 (3 Months)|Death|0|||
27979136|NCT03906656|81755901|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
27979137|NCT03906656|81755902|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
27575165|NCT00622635|80289283|FG000|Treatment Period 2|Adverse Event|1|||
27575166|NCT00622635|80289284|FG001|Treatment Period 2|Adverse Event|0|||
27792874|NCT00633217|81072400|FG000|Overall Study|Investigator Discretion|2|||
27792875|NCT00633217|81072401|FG001|Overall Study|Investigator Discretion|0|||
27979138|NCT03906656|81755901|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
27575167|NCT00622635|80289285|FG002|Treatment Period 2|Adverse Event|0|||
27979139|NCT03906656|81755902|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
27575168|NCT00622635|80289286|FG003|Treatment Period 2|Adverse Event|0|||
27575169|NCT00622635|80289287|FG004|Treatment Period 2|Adverse Event|0|||
27575170|NCT00622635|80289288|FG005|Treatment Period 2|Adverse Event|0|||
27792876|NCT00633217|81072400|FG000|Overall Study|Withdrew Consent|3|||
27792877|NCT00633217|81072401|FG001|Overall Study|Withdrew Consent|3|||
27792878|NCT00578448|81072402|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
27979140|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
27979141|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
27979142|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
27979143|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
27979144|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
27979145|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
27979146|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
27979147|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
27979148|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
27979149|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
27979150|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
27575171|NCT00622635|80289283|FG000|Treatment Period 3|Adverse Event|0|||
27979151|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
27792879|NCT00578448|81072402|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
27792880|NCT00578448|81072402|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
27792881|NCT00578448|81072402|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
27979152|NCT01632241|81755913|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
27575172|NCT00622635|80289284|FG001|Treatment Period 3|Adverse Event|0|||
27575173|NCT00622635|80289285|FG002|Treatment Period 3|Adverse Event|0|||
27575174|NCT00622635|80289286|FG003|Treatment Period 3|Adverse Event|2|||
27575175|NCT00622635|80289287|FG004|Treatment Period 3|Adverse Event|0|||
27575176|NCT00622635|80289288|FG005|Treatment Period 3|Adverse Event|0|||
27575177|NCT00622635|80289283|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27575178|NCT00622635|80289284|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27575179|NCT00622635|80289285|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27575180|NCT00622635|80289286|FG003|Treatment Period 3|Withdrawal by Subject|1|||
27575181|NCT00622635|80289287|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27575182|NCT00622635|80289288|FG005|Treatment Period 3|Withdrawal by Subject|0|||
27575183|NCT01632800|80289289|FG000|Overall Study|Subject did not fit in apparatus|1|||
27575184|NCT03746522|80289290|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
27575185|NCT03746522|80289291|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
27575186|NCT03746522|80289292|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
27575187|NCT03746522|80289290|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
27575188|NCT03746522|80289291|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
27575189|NCT03746522|80289292|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
27575190|NCT03746522|80289290|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
27575191|NCT03746522|80289291|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
27575192|NCT03746522|80289292|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
27575193|NCT03746522|80289290|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
27575194|NCT03746522|80289291|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
27575195|NCT03746522|80289292|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
27575196|NCT03746522|80289290|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
27979153|NCT01632241|81755914|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
27979154|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
27979155|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
27979156|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
27979157|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
27979158|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
27979159|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
27979160|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
27979161|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
27979162|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
27979163|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
27979164|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
27979165|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
27979166|NCT01632241|81755913|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
27979167|NCT01632241|81755914|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
27979168|NCT02241187|81755915|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
27979169|NCT03356977|81755916|FG000|Overall Study|Lost to Follow-up|3|||
27979170|NCT03356977|81755916|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27979171|NCT05291936|81755919|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
27979172|NCT05291936|81755920|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
27979173|NCT05291936|81755919|FG000|Period 1|Withdrew Consent during study|1|||
27979174|NCT05291936|81755920|FG001|Period 1|Withdrew Consent during study|0|||
27979175|NCT05291936|81755919|FG000|Period 2|Adverse Event|0|||
27979176|NCT05291936|81755920|FG001|Period 2|Adverse Event|1|||
27979177|NCT05291936|81755919|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
27979178|NCT05291936|81755920|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
27979179|NCT02226198|81755921|FG000|Lead-in Phase|Protocol Violation|1|||
27979180|NCT02226198|81755922|FG001|Lead-in Phase|Protocol Violation|0|||
27979181|NCT02226198|81755923|FG002|Lead-in Phase|Protocol Violation|0|||
27979182|NCT02226198|81755921|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
27979183|NCT02226198|81755922|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
27672711|NCT01390441|80639305|FG000|Treatment Period|Protocol Violation|0|||
27672712|NCT01390441|80639306|FG001|Treatment Period|Protocol Violation|1|||
27792882|NCT01353586|81072406|FG000|Overall Study|Procedure terminated prior to ablation|3|||
27792883|NCT01353586|81072407|FG001|Overall Study|Procedure terminated prior to ablation|0|||
27792884|NCT01353586|81072406|FG000|Overall Study|Never had insertion of study catheter|4|||
27792885|NCT01353586|81072407|FG001|Overall Study|Never had insertion of study catheter|1|||
27792886|NCT01353586|81072406|FG000|Overall Study|Neurological exam not done|0|||
27792887|NCT01353586|81072407|FG001|Overall Study|Neurological exam not done|1|||
27792888|NCT03075215|81072427|FG000|12-Month Primary Endpoint|Death|152|||
27792889|NCT03075215|81072427|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
27792890|NCT03075215|81072427|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
27792891|NCT03075215|81072427|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
27792892|NCT00798161|81072428|FG000|Overall Study|Adverse Event|3|||
27792893|NCT00798161|81072429|FG001|Overall Study|Adverse Event|4|||
27792894|NCT00798161|81072430|FG002|Overall Study|Adverse Event|6|||
27792895|NCT00798161|81072431|FG003|Overall Study|Adverse Event|6|||
27792896|NCT00798161|81072432|FG004|Overall Study|Adverse Event|5|||
27792897|NCT00798161|81072433|FG005|Overall Study|Adverse Event|2|||
27792898|NCT00798161|81072434|FG006|Overall Study|Adverse Event|4|||
27792899|NCT00798161|81072428|FG000|Overall Study|Protocol Violation|2|||
27792900|NCT00798161|81072429|FG001|Overall Study|Protocol Violation|1|||
27792901|NCT00798161|81072430|FG002|Overall Study|Protocol Violation|3|||
27792902|NCT00798161|81072431|FG003|Overall Study|Protocol Violation|3|||
27792903|NCT00798161|81072432|FG004|Overall Study|Protocol Violation|3|||
27792904|NCT00798161|81072433|FG005|Overall Study|Protocol Violation|2|||
27792905|NCT00798161|81072434|FG006|Overall Study|Protocol Violation|0|||
27792906|NCT00798161|81072428|FG000|Overall Study|Lost to Follow-up|1|||
27672713|NCT01390441|80639307|FG002|Treatment Period|Protocol Violation|0|||
27672714|NCT01390441|80639308|FG003|Treatment Period|Protocol Violation|0|||
27672715|NCT01390441|80639309|FG004|Treatment Period|Protocol Violation|0|||
27672716|NCT01390441|80639305|FG000|Treatment Period|Physician Decision|0|||
27672717|NCT01390441|80639306|FG001|Treatment Period|Physician Decision|0|||
27672718|NCT01390441|80639307|FG002|Treatment Period|Physician Decision|0|||
27672719|NCT01390441|80639308|FG003|Treatment Period|Physician Decision|1|||
27672720|NCT01390441|80639309|FG004|Treatment Period|Physician Decision|0|||
27672721|NCT01390441|80639305|FG000|Treatment Period|Lack of Efficacy|0|||
27672722|NCT01390441|80639306|FG001|Treatment Period|Lack of Efficacy|0|||
27672723|NCT01390441|80639307|FG002|Treatment Period|Lack of Efficacy|0|||
27672724|NCT01390441|80639308|FG003|Treatment Period|Lack of Efficacy|0|||
27672725|NCT01390441|80639309|FG004|Treatment Period|Lack of Efficacy|1|||
27672726|NCT01390441|80639305|FG000|Treatment Period|Unknown due to early stopping of study|0|||
27672727|NCT01390441|80639306|FG001|Treatment Period|Unknown due to early stopping of study|0|||
27672728|NCT01390441|80639307|FG002|Treatment Period|Unknown due to early stopping of study|8|||
27672729|NCT01390441|80639308|FG003|Treatment Period|Unknown due to early stopping of study|11|||
27672730|NCT01390441|80639309|FG004|Treatment Period|Unknown due to early stopping of study|7|||
27672731|NCT01390441|80639305|FG000|Treatment Period|Adverse Event|0|||
27672732|NCT01390441|80639306|FG001|Treatment Period|Adverse Event|0|||
27672733|NCT01390441|80639307|FG002|Treatment Period|Adverse Event|1|||
27672734|NCT01390441|80639308|FG003|Treatment Period|Adverse Event|1|||
27672735|NCT01390441|80639309|FG004|Treatment Period|Adverse Event|2|||
27672736|NCT01390441|80639305|FG000|Treatment Period|Withdrawal by Subject|0|||
27672737|NCT01390441|80639306|FG001|Treatment Period|Withdrawal by Subject|0|||
27672738|NCT01390441|80639307|FG002|Treatment Period|Withdrawal by Subject|1|||
27672739|NCT01390441|80639308|FG003|Treatment Period|Withdrawal by Subject|0|||
27672740|NCT01390441|80639309|FG004|Treatment Period|Withdrawal by Subject|1|||
27792907|NCT00798161|81072429|FG001|Overall Study|Lost to Follow-up|3|||
27792908|NCT00798161|81072430|FG002|Overall Study|Lost to Follow-up|4|||
27792909|NCT00798161|81072431|FG003|Overall Study|Lost to Follow-up|3|||
27672741|NCT01390441|80639305|FG000|Treatment Period|Lost to Follow-up|1|||
27672742|NCT01390441|80639306|FG001|Treatment Period|Lost to Follow-up|0|||
27672743|NCT01390441|80639307|FG002|Treatment Period|Lost to Follow-up|0|||
27672744|NCT01390441|80639308|FG003|Treatment Period|Lost to Follow-up|0|||
27792910|NCT00798161|81072432|FG004|Overall Study|Lost to Follow-up|4|||
27792911|NCT00798161|81072433|FG005|Overall Study|Lost to Follow-up|0|||
27792912|NCT00798161|81072434|FG006|Overall Study|Lost to Follow-up|0|||
27672745|NCT01390441|80639309|FG004|Treatment Period|Lost to Follow-up|0|||
27792913|NCT00798161|81072428|FG000|Overall Study|Withdrawal by Subject|5|||
27792914|NCT00798161|81072429|FG001|Overall Study|Withdrawal by Subject|4|||
27792915|NCT00798161|81072430|FG002|Overall Study|Withdrawal by Subject|5|||
27792916|NCT00798161|81072431|FG003|Overall Study|Withdrawal by Subject|4|||
27792917|NCT00798161|81072432|FG004|Overall Study|Withdrawal by Subject|2|||
27792918|NCT00798161|81072433|FG005|Overall Study|Withdrawal by Subject|3|||
27792919|NCT00798161|81072434|FG006|Overall Study|Withdrawal by Subject|1|||
27792920|NCT00798161|81072428|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
27792921|NCT00798161|81072429|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
27792922|NCT00798161|81072430|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
27792923|NCT00798161|81072431|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
27792924|NCT00798161|81072432|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
27792925|NCT00798161|81072433|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
27792926|NCT00798161|81072434|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
27792927|NCT02769832|81072435|FG000|Overall Study|Death|30|||
27792928|NCT00956813|81072436|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
27792929|NCT00956813|81072437|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
27792930|NCT00956813|81072436|FG000|Flaxseed and Placebo|Ineligible|3|||
27792931|NCT00956813|81072437|FG001|Flaxseed and Placebo|Ineligible|1|||
27792932|NCT03958045|81072438|FG000|Overall Study|Withdrawal by Subject|1|||
27792933|NCT00968539|81072439|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
27792934|NCT00968539|81072440|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27792935|NCT03466060|81072443|FG000|Period 1|Test Lens Damage|0|||
27792936|NCT03466060|81072444|FG001|Period 1|Test Lens Damage|2|||
27792937|NCT03466060|81072445|FG002|Period 1|Test Lens Damage|0|||
27792938|NCT03466060|81072446|FG003|Period 1|Test Lens Damage|0|||
27792939|NCT03466060|81072447|FG004|Period 1|Test Lens Damage|0|||
27792940|NCT03466060|81072448|FG005|Period 1|Test Lens Damage|0|||
27792941|NCT03466060|81072443|FG000|Period 1|Withdrawal by Subject|0|||
27792942|NCT03466060|81072444|FG001|Period 1|Withdrawal by Subject|0|||
27792943|NCT03466060|81072445|FG002|Period 1|Withdrawal by Subject|2|||
27792944|NCT03466060|81072446|FG003|Period 1|Withdrawal by Subject|0|||
27792945|NCT03466060|81072447|FG004|Period 1|Withdrawal by Subject|0|||
27792946|NCT03466060|81072448|FG005|Period 1|Withdrawal by Subject|0|||
27792947|NCT03466060|81072443|FG000|Period 1|Lost to Follow-up|0|||
27792948|NCT03466060|81072444|FG001|Period 1|Lost to Follow-up|0|||
27792949|NCT03466060|81072445|FG002|Period 1|Lost to Follow-up|0|||
27792950|NCT03466060|81072446|FG003|Period 1|Lost to Follow-up|1|||
27792951|NCT03466060|81072447|FG004|Period 1|Lost to Follow-up|0|||
27792952|NCT03466060|81072448|FG005|Period 1|Lost to Follow-up|0|||
27792953|NCT03466060|81072443|FG000|Period 1|Grade 2 Conjunctivitis|0|||
27792954|NCT03466060|81072444|FG001|Period 1|Grade 2 Conjunctivitis|0|||
27792955|NCT03466060|81072445|FG002|Period 1|Grade 2 Conjunctivitis|1|||
27792956|NCT03466060|81072446|FG003|Period 1|Grade 2 Conjunctivitis|0|||
27792957|NCT03466060|81072447|FG004|Period 1|Grade 2 Conjunctivitis|0|||
27979184|NCT02226198|81755923|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
27979185|NCT00524589|81755924|FG000|Overall Study|Withdrawal by Subject|2|||
27979186|NCT00524589|81755924|FG000|Overall Study|Disease Progression|16|||
27979187|NCT00857948|81755937|FG000|Overall Study|Withdrawal by Subject|2|||
27979188|NCT00857948|81755938|FG001|Overall Study|Withdrawal by Subject|0|||
27979189|NCT00857948|81755939|FG002|Overall Study|Withdrawal by Subject|0|||
27979190|NCT00857948|81755940|FG003|Overall Study|Withdrawal by Subject|0|||
27979191|NCT00857948|81755937|FG000|Overall Study|Protocol Violation|1|||
27979192|NCT00857948|81755938|FG001|Overall Study|Protocol Violation|0|||
27979193|NCT00857948|81755939|FG002|Overall Study|Protocol Violation|1|||
27979194|NCT00857948|81755940|FG003|Overall Study|Protocol Violation|0|||
27979195|NCT02739321|81755946|FG000|Overall Study|Lack of Efficacy|1|||
27979196|NCT02739321|81755947|FG001|Overall Study|Lack of Efficacy|1|||
27979197|NCT02739321|81755946|FG000|Overall Study|Lost to Follow-up|1|||
27979198|NCT02739321|81755947|FG001|Overall Study|Lost to Follow-up|1|||
27979199|NCT02739321|81755946|FG000|Overall Study|Withdrawal by Subject|1|||
27979200|NCT02739321|81755947|FG001|Overall Study|Withdrawal by Subject|2|||
27979201|NCT02576860|81755948|FG000|Overall Study|Adverse Event|6|||
27979202|NCT02576860|81755949|FG001|Overall Study|Adverse Event|6|||
27979203|NCT02576860|81755948|FG000|Overall Study|Lost to Follow-up|5|||
27979204|NCT02576860|81755949|FG001|Overall Study|Lost to Follow-up|7|||
27979205|NCT02576860|81755948|FG000|Overall Study|Physician Decision|0|||
27979206|NCT02576860|81755949|FG001|Overall Study|Physician Decision|1|||
27979207|NCT02576860|81755948|FG000|Overall Study|Protocol Violation|0|||
27979208|NCT02576860|81755949|FG001|Overall Study|Protocol Violation|2|||
27979209|NCT02576860|81755948|FG000|Overall Study|Withdrawal by Subject|13|||
27979210|NCT02576860|81755949|FG001|Overall Study|Withdrawal by Subject|8|||
27979211|NCT02576860|81755948|FG000|Overall Study|Disallowed medication|1|||
27979212|NCT02576860|81755949|FG001|Overall Study|Disallowed medication|0|||
27575197|NCT03746522|80289291|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
27792958|NCT03466060|81072448|FG005|Period 1|Grade 2 Conjunctivitis|0|||
27792959|NCT03466060|81072443|FG000|Period 2|Lens Handling Difficulties|0|||
27792960|NCT03466060|81072444|FG001|Period 2|Lens Handling Difficulties|0|||
27792961|NCT03466060|81072445|FG002|Period 2|Lens Handling Difficulties|1|||
27792962|NCT03466060|81072446|FG003|Period 2|Lens Handling Difficulties|0|||
27792963|NCT03466060|81072447|FG004|Period 2|Lens Handling Difficulties|0|||
27792964|NCT03466060|81072448|FG005|Period 2|Lens Handling Difficulties|0|||
27792965|NCT02152631|81072450|FG000|Overall Study|Adverse Event|32|||
27792966|NCT02152631|81072451|FG001|Overall Study|Adverse Event|4|||
27979213|NCT01300351|81755952|FG000|Overall Study|Did not receive treatment|2|||
27979214|NCT01300351|81755953|FG001|Overall Study|Did not receive treatment|0|||
27792967|NCT02152631|81072450|FG000|Overall Study|Withdrawal by Subject|13|||
27792968|NCT02152631|81072451|FG001|Overall Study|Withdrawal by Subject|16|||
27792969|NCT02152631|81072450|FG000|Overall Study|Noncompliance with study drug|1|||
27792970|NCT02152631|81072451|FG001|Overall Study|Noncompliance with study drug|0|||
27792971|NCT02152631|81072450|FG000|Overall Study|Physician Decision|1|||
27792972|NCT02152631|81072451|FG001|Overall Study|Physician Decision|2|||
27979215|NCT01300351|81755952|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
27792973|NCT02152631|81072450|FG000|Overall Study|Lost to Follow-up|0|||
27792974|NCT02152631|81072451|FG001|Overall Study|Lost to Follow-up|1|||
27672746|NCT01390441|80639305|FG000|Extension Period|Protocol Violation|3|||
27672747|NCT01390441|80639306|FG001|Extension Period|Protocol Violation|1|||
27672748|NCT01390441|80639307|FG002|Extension Period|Protocol Violation|0|||
27672749|NCT01390441|80639308|FG003|Extension Period|Protocol Violation|1|||
27672750|NCT01390441|80639309|FG004|Extension Period|Protocol Violation|0|||
27672751|NCT01107899|80639311|FG000|Overall Study|Physician Decision|5|||
27672752|NCT01107899|80639312|FG001|Overall Study|Physician Decision|0|||
27672753|NCT01107899|80639313|FG002|Overall Study|Physician Decision|3|||
27672754|NCT01107899|80639311|FG000|Overall Study|Withdrawal by Subject|0|||
27672755|NCT01107899|80639312|FG001|Overall Study|Withdrawal by Subject|0|||
27979216|NCT01300351|81755953|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
27979217|NCT01300351|81755952|FG000|Overall Study|Lost to Follow-up|0|||
27979218|NCT01300351|81755953|FG001|Overall Study|Lost to Follow-up|1|||
27672756|NCT01107899|80639313|FG002|Overall Study|Withdrawal by Subject|1|||
27672757|NCT04160988|80639314|FG000|Overall Study|poor image quality|28|||
27672758|NCT02906020|80639315|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
27792975|NCT02152631|81072450|FG000|Overall Study|On Treatment|19|||
27792976|NCT02152631|81072451|FG001|Overall Study|On Treatment|3|||
27792977|NCT01018680|81072454|FG000|Overall Study|Adverse Event|23|||
27792978|NCT01018680|81072455|FG001|Overall Study|Adverse Event|40|||
27792979|NCT01018680|81072454|FG000|Overall Study|Withdrawal by Subject|10|||
27792980|NCT01018680|81072455|FG001|Overall Study|Withdrawal by Subject|10|||
27792981|NCT01018680|81072454|FG000|Overall Study|Protocol Violation|5|||
27792982|NCT01018680|81072455|FG001|Overall Study|Protocol Violation|8|||
27672759|NCT02906020|80639316|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
27672760|NCT02906020|80639317|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
27672761|NCT02906020|80639318|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
27672762|NCT02906020|80639319|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
27672763|NCT02906020|80639320|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
27672764|NCT02906020|80639321|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
27672765|NCT02906020|80639322|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
27672766|NCT02906020|80639323|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
27672767|NCT02906020|80639324|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
27672768|NCT02906020|80639325|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
27672769|NCT02906020|80639326|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
27672770|NCT02906020|80639327|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
27672771|NCT02906020|80639328|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
27672772|NCT02906020|80639329|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
27672773|NCT02906020|80639330|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
27672774|NCT02906020|80639315|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672775|NCT02906020|80639316|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672776|NCT02906020|80639317|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672777|NCT02906020|80639318|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672778|NCT02906020|80639319|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672779|NCT02906020|80639320|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672780|NCT02906020|80639321|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672781|NCT02906020|80639322|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672782|NCT02906020|80639323|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
27672783|NCT02906020|80639324|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
27672784|NCT02906020|80639325|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672785|NCT02906020|80639326|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672786|NCT02906020|80639327|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672787|NCT02906020|80639328|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672788|NCT02906020|80639329|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672789|NCT02906020|80639330|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
27672790|NCT02906020|80639315|FG000|Part 2: Double-blind Treatment Period|Other|0|||
27672791|NCT02906020|80639316|FG001|Part 2: Double-blind Treatment Period|Other|0|||
27672792|NCT02906020|80639317|FG002|Part 2: Double-blind Treatment Period|Other|0|||
27672793|NCT02906020|80639318|FG003|Part 2: Double-blind Treatment Period|Other|0|||
27672794|NCT02906020|80639319|FG004|Part 2: Double-blind Treatment Period|Other|0|||
27672795|NCT02906020|80639320|FG005|Part 2: Double-blind Treatment Period|Other|0|||
27792983|NCT01018680|81072454|FG000|Overall Study|Sponsor Decision|6|||
27792984|NCT01018680|81072455|FG001|Overall Study|Sponsor Decision|7|||
27792985|NCT01018680|81072454|FG000|Overall Study|Lack of Efficacy|8|||
27792986|NCT01018680|81072455|FG001|Overall Study|Lack of Efficacy|2|||
27792987|NCT01018680|81072454|FG000|Overall Study|Lost to Follow-up|5|||
27792988|NCT01018680|81072455|FG001|Overall Study|Lost to Follow-up|3|||
27792989|NCT01018680|81072454|FG000|Overall Study|Entry Criteria Not Met|1|||
27792990|NCT01018680|81072455|FG001|Overall Study|Entry Criteria Not Met|4|||
27979219|NCT01300351|81755952|FG000|Overall Study|Adverse Event|0|||
27979220|NCT01300351|81755953|FG001|Overall Study|Adverse Event|4|||
27672796|NCT02906020|80639321|FG006|Part 2: Double-blind Treatment Period|Other|0|||
27672797|NCT02906020|80639322|FG007|Part 2: Double-blind Treatment Period|Other|0|||
27672798|NCT02906020|80639323|FG008|Part 2: Double-blind Treatment Period|Other|6|||
27672799|NCT02906020|80639324|FG009|Part 2: Double-blind Treatment Period|Other|10|||
27672800|NCT02906020|80639325|FG010|Part 2: Double-blind Treatment Period|Other|0|||
27672801|NCT02906020|80639326|FG011|Part 2: Double-blind Treatment Period|Other|0|||
27672802|NCT02906020|80639327|FG012|Part 2: Double-blind Treatment Period|Other|0|||
27672803|NCT02906020|80639328|FG013|Part 2: Double-blind Treatment Period|Other|0|||
27672804|NCT02906020|80639329|FG014|Part 2: Double-blind Treatment Period|Other|0|||
27672805|NCT02906020|80639330|FG015|Part 2: Double-blind Treatment Period|Other|0|||
27672806|NCT02906020|80639315|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672807|NCT02906020|80639316|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672808|NCT02906020|80639317|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672809|NCT02906020|80639318|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672810|NCT02906020|80639319|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672811|NCT02906020|80639320|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672812|NCT02906020|80639321|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672813|NCT02906020|80639322|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672814|NCT02906020|80639323|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672815|NCT02906020|80639324|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672816|NCT02906020|80639325|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672817|NCT02906020|80639326|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672818|NCT02906020|80639327|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
27672819|NCT02906020|80639328|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
27672820|NCT02906020|80639329|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672821|NCT02906020|80639330|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
27672822|NCT02906020|80639315|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672823|NCT02906020|80639316|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672824|NCT02906020|80639317|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672825|NCT02906020|80639318|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672826|NCT02906020|80639319|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672827|NCT02906020|80639320|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672828|NCT02906020|80639321|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672829|NCT02906020|80639322|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672830|NCT02906020|80639323|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672831|NCT02906020|80639324|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672832|NCT02906020|80639325|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672833|NCT02906020|80639326|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672834|NCT02906020|80639327|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
27672835|NCT02906020|80639328|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
27672836|NCT02906020|80639329|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
27672837|NCT02906020|80639330|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
27672838|NCT02906020|80639315|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672839|NCT02906020|80639316|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672840|NCT02906020|80639317|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672841|NCT02906020|80639318|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672842|NCT02906020|80639319|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672843|NCT02906020|80639320|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672844|NCT02906020|80639321|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672845|NCT02906020|80639322|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672846|NCT02906020|80639323|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672847|NCT02906020|80639324|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672848|NCT02906020|80639325|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672849|NCT02906020|80639326|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672850|NCT02906020|80639327|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
27672851|NCT02906020|80639328|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
27672852|NCT02906020|80639329|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672853|NCT02906020|80639330|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
27672854|NCT02906020|80639315|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672855|NCT02906020|80639316|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672856|NCT02906020|80639317|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672857|NCT02906020|80639318|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672858|NCT02906020|80639319|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672859|NCT02906020|80639320|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672860|NCT02906020|80639321|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672861|NCT02906020|80639322|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27792991|NCT01018680|81072454|FG000|Overall Study|Physician Decision|3|||
27792992|NCT01018680|81072455|FG001|Overall Study|Physician Decision|1|||
27792993|NCT03930615|81072459|FG000|Overall Study|Death|9|||
27792994|NCT03930615|81072460|FG001|Overall Study|Death|3|||
27792995|NCT03930615|81072459|FG000|Overall Study|Lost to Follow-up|1|||
27792996|NCT03930615|81072460|FG001|Overall Study|Lost to Follow-up|2|||
27792997|NCT03930615|81072459|FG000|Overall Study|Physician Decision|3|||
27792998|NCT03930615|81072460|FG001|Overall Study|Physician Decision|4|||
27792999|NCT03930615|81072459|FG000|Overall Study|Withdrawal by Subject|13|||
27793000|NCT03930615|81072460|FG001|Overall Study|Withdrawal by Subject|2|||
27793001|NCT03930615|81072459|FG000|Overall Study|Not treated|1|||
27793002|NCT03930615|81072460|FG001|Overall Study|Not treated|1|||
27793003|NCT00326118|81072461|FG000|Active Phase|Withdrawal by Subject|4|||
27793004|NCT00326118|81072462|FG001|Active Phase|Withdrawal by Subject|1|||
27793005|NCT00902265|81072466|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
27979221|NCT01300351|81755952|FG000|Overall Study|Withdrawal by Subject|7|||
27979222|NCT01300351|81755953|FG001|Overall Study|Withdrawal by Subject|10|||
27979223|NCT03421743|81755956|FG000|Overall Study|Lack of Efficacy|1|||
27979224|NCT03421743|81755957|FG001|Overall Study|Lack of Efficacy|0|||
27793006|NCT00902265|81072466|FG000|Overall Study|Adverse Event|2|||
27793007|NCT00902265|81072466|FG000|Overall Study|Lack of Efficacy|2|||
27979225|NCT03421743|81755956|FG000|Overall Study|Adverse Event|2|||
27979226|NCT03421743|81755957|FG001|Overall Study|Adverse Event|1|||
27979227|NCT03421743|81755956|FG000|Overall Study|Withdrawal by Subject|0|||
27979228|NCT03421743|81755957|FG001|Overall Study|Withdrawal by Subject|1|||
27979229|NCT02788201|81755958|FG000|Overall Study|Death|1|||
27979230|NCT02788201|81755959|FG001|Overall Study|Death|1|||
27979231|NCT02788201|81755960|FG002|Overall Study|Death|1|||
27672862|NCT02906020|80639323|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672863|NCT02906020|80639324|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672864|NCT02906020|80639325|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672865|NCT02906020|80639326|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672866|NCT02906020|80639327|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
27672867|NCT02906020|80639328|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
27672868|NCT02906020|80639329|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672869|NCT02906020|80639330|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
27672870|NCT02906020|80639315|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672871|NCT02906020|80639316|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672872|NCT02906020|80639317|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672873|NCT02906020|80639318|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672874|NCT02906020|80639319|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672875|NCT02906020|80639320|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672876|NCT02906020|80639321|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672877|NCT02906020|80639322|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672878|NCT02906020|80639323|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672879|NCT02906020|80639324|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672880|NCT02906020|80639325|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672881|NCT02906020|80639326|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
27672882|NCT02906020|80639327|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
27672883|NCT02906020|80639328|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
27672884|NCT02906020|80639329|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
27672885|NCT02906020|80639330|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
27672886|NCT02906020|80639315|FG000|Part 2: Long-term Follow-up Period|Other|0|||
27672887|NCT02906020|80639316|FG001|Part 2: Long-term Follow-up Period|Other|0|||
27672888|NCT02906020|80639317|FG002|Part 2: Long-term Follow-up Period|Other|0|||
27672889|NCT02906020|80639318|FG003|Part 2: Long-term Follow-up Period|Other|0|||
27672890|NCT02906020|80639319|FG004|Part 2: Long-term Follow-up Period|Other|0|||
27979232|NCT02788201|81755961|FG003|Overall Study|Death|1|||
27979233|NCT02788201|81755962|FG004|Overall Study|Death|0|||
27979234|NCT02788201|81755963|FG005|Overall Study|Death|1|||
27979235|NCT02788201|81755958|FG000|Overall Study|Ineligible|0|||
27979236|NCT02788201|81755959|FG001|Overall Study|Ineligible|0|||
27979237|NCT02788201|81755960|FG002|Overall Study|Ineligible|0|||
27979238|NCT02788201|81755961|FG003|Overall Study|Ineligible|0|||
27979239|NCT02788201|81755962|FG004|Overall Study|Ineligible|0|||
27793008|NCT00902265|81072466|FG000|Overall Study|Protocol Violation|1|||
27793009|NCT03253809|81072467|FG000|Overall Study|Unable to obtain study related data|14|||
27979240|NCT02788201|81755963|FG005|Overall Study|Ineligible|1|||
27979241|NCT02788201|81755958|FG000|Overall Study|Withdrawal by Subject|0|||
27793010|NCT04629534|81072471|FG000|Overall Study|Physician Decision|1|||
27793011|NCT04629534|81072472|FG001|Overall Study|Physician Decision|0|||
27793012|NCT04629534|81072471|FG000|Overall Study|Protocol Violation|0|||
27793013|NCT04629534|81072472|FG001|Overall Study|Protocol Violation|2|||
27979242|NCT02788201|81755959|FG001|Overall Study|Withdrawal by Subject|0|||
27979243|NCT02788201|81755960|FG002|Overall Study|Withdrawal by Subject|0|||
27979244|NCT02788201|81755961|FG003|Overall Study|Withdrawal by Subject|0|||
27979245|NCT02788201|81755962|FG004|Overall Study|Withdrawal by Subject|0|||
27979246|NCT02788201|81755963|FG005|Overall Study|Withdrawal by Subject|1|||
27979247|NCT00283868|81755964|FG000|Overall Study|Lost to Follow-up|7|||
27979248|NCT00283868|81755965|FG001|Overall Study|Lost to Follow-up|8|||
27979249|NCT03582813|81755971|FG000|Overall Study|Lost to Follow-up|18|||
27979250|NCT03582813|81755972|FG001|Overall Study|Lost to Follow-up|21|||
27979251|NCT03582813|81755971|FG000|Overall Study|Withdrawal by Subject|1|||
27979252|NCT03582813|81755972|FG001|Overall Study|Withdrawal by Subject|0|||
27979253|NCT01145053|81755973|FG000|Overall Study|Adverse Event|22|||
27979254|NCT01145053|81755973|FG000|Overall Study|Lost to Follow-up|28|||
27979255|NCT01145053|81755973|FG000|Overall Study|Withdrawal by Subject|25|||
27979256|NCT01145053|81755973|FG000|Overall Study|Other|18|||
27979257|NCT02317809|81755977|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
27979258|NCT02317809|81755978|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
27979259|NCT02317809|81755977|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
27979260|NCT02317809|81755978|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
27979261|NCT02395055|81755979|FG000|Overall Study|Withdrawal by Subject|7|||
27979262|NCT02395055|81755980|FG001|Overall Study|Withdrawal by Subject|3|||
27979263|NCT03515941|81755984|FG000|Overall Study|Adverse Event|1|||
27979264|NCT03515941|81755985|FG001|Overall Study|Adverse Event|0|||
27979265|NCT01241760|81755988|FG000|Overall Study|Adverse Event|1|||
27979266|NCT01241760|81755989|FG001|Overall Study|Adverse Event|0|||
27979267|NCT01241760|81755988|FG000|Overall Study|Lost to Follow-up|18|||
27867673|NCT03142191|81349677|FG000|Active Treatment Extension Period|Progressive Disease|10|||
27672891|NCT02906020|80639320|FG005|Part 2: Long-term Follow-up Period|Other|0|||
27979268|NCT01241760|81755989|FG001|Overall Study|Lost to Follow-up|22|||
27672892|NCT02906020|80639321|FG006|Part 2: Long-term Follow-up Period|Other|0|||
27979269|NCT01241760|81755988|FG000|Overall Study|Withdrawal by Subject|13|||
27979270|NCT01241760|81755989|FG001|Overall Study|Withdrawal by Subject|13|||
27979271|NCT01241760|81755988|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
27979272|NCT01241760|81755989|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
27979273|NCT01241760|81755988|FG000|Overall Study|Other|1|||
27979274|NCT01241760|81755989|FG001|Overall Study|Other|1|||
27979275|NCT00687609|81755990|FG000|Overall Study|Physician Decision|1|||
27979276|NCT00687609|81755990|FG000|Overall Study|Withdrawal by Subject|2|||
27979277|NCT00581828|81755991|FG000|Overall Study|Protocol Violation|1|||
27979278|NCT04135859|81755995|FG000|Overall Study|Withdrawal by Subject|1|||
27979279|NCT04135859|81755996|FG001|Overall Study|Withdrawal by Subject|0|||
27575198|NCT03746522|80289292|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
27575199|NCT01340976|80289293|FG000|Overall Study|Physician Decision|2|||
27575200|NCT01340976|80289294|FG001|Overall Study|Physician Decision|0|||
27575201|NCT01340976|80289295|FG002|Overall Study|Physician Decision|1|||
27575202|NCT01340976|80289296|FG003|Overall Study|Physician Decision|1|||
27575203|NCT01340976|80289297|FG004|Overall Study|Physician Decision|1|||
27575204|NCT01340976|80289298|FG005|Overall Study|Physician Decision|0|||
27575205|NCT01340976|80289293|FG000|Overall Study|Death|0|||
27575206|NCT01340976|80289294|FG001|Overall Study|Death|1|||
27575207|NCT01340976|80289295|FG002|Overall Study|Death|0|||
27575208|NCT01340976|80289296|FG003|Overall Study|Death|0|||
27575209|NCT01340976|80289297|FG004|Overall Study|Death|0|||
27575210|NCT01340976|80289298|FG005|Overall Study|Death|0|||
27575211|NCT01340976|80289293|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
27575212|NCT01340976|80289294|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
27575213|NCT01340976|80289295|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
27575214|NCT01340976|80289296|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
27575215|NCT01340976|80289297|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
27575216|NCT01340976|80289298|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
27575217|NCT01340976|80289293|FG000|Overall Study|Withdrawal by Subject|0|||
27575218|NCT01340976|80289294|FG001|Overall Study|Withdrawal by Subject|0|||
27575219|NCT01340976|80289295|FG002|Overall Study|Withdrawal by Subject|0|||
27575220|NCT01340976|80289296|FG003|Overall Study|Withdrawal by Subject|1|||
27575221|NCT01340976|80289297|FG004|Overall Study|Withdrawal by Subject|1|||
27793014|NCT00585468|81072473|FG000|First Intervention|Withdrawal by Subject|1|||
27979280|NCT04135859|81755995|FG000|Overall Study|Withdrawal due to screening failure|1|||
27979281|NCT04135859|81755996|FG001|Overall Study|Withdrawal due to screening failure|2|||
27979282|NCT04135859|81755995|FG000|Overall Study|Did not complete stress test|3|||
27979283|NCT04135859|81755996|FG001|Overall Study|Did not complete stress test|3|||
27979284|NCT04135859|81755995|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
27979285|NCT04135859|81755996|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
27979286|NCT00908115|81756002|FG000|Overall Study|Other|14|||
27979287|NCT02463032|81756007|FG000|Overall Study|Lack of Efficacy|61|||
27979288|NCT02463032|81756008|FG001|Overall Study|Lack of Efficacy|50|||
27979289|NCT02463032|81756007|FG000|Overall Study|Death|8|||
27979290|NCT02463032|81756008|FG001|Overall Study|Death|8|||
27979291|NCT02463032|81756007|FG000|Overall Study|Adverse Event|2|||
27979292|NCT02463032|81756008|FG001|Overall Study|Adverse Event|6|||
27979293|NCT01565941|81756009|FG000|Overall Study|Withdrawn by parent/guardian|3|||
27979294|NCT01565941|81756010|FG001|Overall Study|Withdrawn by parent/guardian|2|||
27979295|NCT01565941|81756009|FG000|Overall Study|Randomized; did not receive intevention|8|||
27979296|NCT01565941|81756010|FG001|Overall Study|Randomized; did not receive intevention|2|||
27979297|NCT00707746|81756011|FG000|Treatment Period|Adverse Event|2|||
27979298|NCT00707746|81756012|FG001|Treatment Period|Adverse Event|4|||
27979299|NCT00707746|81756011|FG000|Treatment Period|Ineligibility|0|||
27575222|NCT01340976|80289298|FG005|Overall Study|Withdrawal by Subject|0|||
27575223|NCT01340976|80289293|FG000|Overall Study|Other anemia treatment|1|||
27979300|NCT00707746|81756012|FG001|Treatment Period|Ineligibility|1|||
27979301|NCT03149003|81756013|FG000|Overall Study|Randomized but not treated|0|||
27979302|NCT03149003|81756014|FG001|Overall Study|Randomized but not treated|1|||
27979303|NCT03149003|81756015|FG002|Overall Study|Randomized but not treated|18|||
27979304|NCT01527383|81756016|FG000|Overall Study|Adverse Event|5|||
27979305|NCT01527383|81756017|FG001|Overall Study|Adverse Event|0|||
27979306|NCT01527383|81756016|FG000|Overall Study|Lost to Follow-up|3|||
27979307|NCT01527383|81756017|FG001|Overall Study|Lost to Follow-up|0|||
27979308|NCT01527383|81756016|FG000|Overall Study|Physician Decision|2|||
27979309|NCT01527383|81756017|FG001|Overall Study|Physician Decision|0|||
27979310|NCT01527383|81756016|FG000|Overall Study|Pregnancy|1|||
27979311|NCT01527383|81756017|FG001|Overall Study|Pregnancy|0|||
27979312|NCT01527383|81756016|FG000|Overall Study|Protocol Violation|1|||
27979313|NCT01527383|81756017|FG001|Overall Study|Protocol Violation|0|||
27979314|NCT01527383|81756016|FG000|Overall Study|Screen failure|1|||
27979315|NCT01527383|81756017|FG001|Overall Study|Screen failure|0|||
27979316|NCT01527383|81756016|FG000|Overall Study|Participant moved|0|||
27979317|NCT01527383|81756017|FG001|Overall Study|Participant moved|1|||
27979318|NCT01527383|81756016|FG000|Overall Study|Withdrawal by Subject|2|||
27979319|NCT01527383|81756017|FG001|Overall Study|Withdrawal by Subject|3|||
27979320|NCT03759041|81756018|FG000|Overall Study|Withdrawal by Subject|4|||
27979321|NCT03759041|81756019|FG001|Overall Study|Withdrawal by Subject|10|||
27979322|NCT03759041|81756020|FG002|Overall Study|Withdrawal by Subject|10|||
27979323|NCT03759041|81756018|FG000|Overall Study|Adverse Event|1|||
27979324|NCT03759041|81756019|FG001|Overall Study|Adverse Event|3|||
27979325|NCT03759041|81756020|FG002|Overall Study|Adverse Event|4|||
27979326|NCT03759041|81756018|FG000|Overall Study|Lack of Efficacy|0|||
27979327|NCT03759041|81756019|FG001|Overall Study|Lack of Efficacy|0|||
27979328|NCT03759041|81756020|FG002|Overall Study|Lack of Efficacy|1|||
27979329|NCT03759041|81756018|FG000|Overall Study|Study Terminated by Sponsor|15|||
27979330|NCT03759041|81756019|FG001|Overall Study|Study Terminated by Sponsor|16|||
27979331|NCT03759041|81756020|FG002|Overall Study|Study Terminated by Sponsor|10|||
27979332|NCT03759041|81756018|FG000|Overall Study|Other reason for discontinuation|0|||
27979333|NCT03759041|81756019|FG001|Overall Study|Other reason for discontinuation|2|||
27979334|NCT03759041|81756020|FG002|Overall Study|Other reason for discontinuation|1|||
27979335|NCT03759041|81756018|FG000|Overall Study|Lost to Follow-up|7|||
27979336|NCT03759041|81756019|FG001|Overall Study|Lost to Follow-up|2|||
27979337|NCT03759041|81756020|FG002|Overall Study|Lost to Follow-up|2|||
27979338|NCT03759041|81756018|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
27979339|NCT03759041|81756019|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
27979340|NCT03759041|81756020|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
27979341|NCT03285958|81756023|FG000|Overall Study|Lost to Follow-up|1|||
27979342|NCT03285958|81756024|FG001|Overall Study|Lost to Follow-up|1|||
27979343|NCT03285958|81756023|FG000|Overall Study|Withdrawal by Subject|1|||
27979344|NCT03285958|81756024|FG001|Overall Study|Withdrawal by Subject|0|||
27979345|NCT03285958|81756023|FG000|Overall Study|Not able to attend required orientation|3|||
27979346|NCT03285958|81756024|FG001|Overall Study|Not able to attend required orientation|0|||
27979347|NCT03757130|81756025|FG000|Overall Study|Lost to Follow-up|0|||
27979348|NCT03757130|81756026|FG001|Overall Study|Lost to Follow-up|0|||
27979349|NCT03757130|81756027|FG002|Overall Study|Lost to Follow-up|0|||
27979350|NCT03757130|81756028|FG003|Overall Study|Lost to Follow-up|1|||
27979351|NCT03757130|81756029|FG004|Overall Study|Lost to Follow-up|0|||
27979352|NCT03757130|81756030|FG005|Overall Study|Lost to Follow-up|0|||
27979353|NCT03757130|81756031|FG006|Overall Study|Lost to Follow-up|0|||
27979354|NCT03757130|81756032|FG007|Overall Study|Lost to Follow-up|1|||
27979355|NCT03757130|81756025|FG000|Overall Study|Withdrawal by Subject|0|||
27979356|NCT03757130|81756026|FG001|Overall Study|Withdrawal by Subject|0|||
27979357|NCT03757130|81756027|FG002|Overall Study|Withdrawal by Subject|0|||
27979358|NCT03757130|81756028|FG003|Overall Study|Withdrawal by Subject|0|||
27979359|NCT03757130|81756029|FG004|Overall Study|Withdrawal by Subject|0|||
27979360|NCT03757130|81756030|FG005|Overall Study|Withdrawal by Subject|0|||
27979361|NCT03757130|81756031|FG006|Overall Study|Withdrawal by Subject|1|||
27979362|NCT03757130|81756032|FG007|Overall Study|Withdrawal by Subject|0|||
27979363|NCT00787202|81756037|FG000|Overall Study|Adverse Event|3|||
27979364|NCT00787202|81756038|FG001|Overall Study|Adverse Event|2|||
27979365|NCT00787202|81756039|FG002|Overall Study|Adverse Event|0|||
27979366|NCT00787202|81756040|FG003|Overall Study|Adverse Event|0|||
27979367|NCT00787202|81756041|FG004|Overall Study|Adverse Event|2|||
27979368|NCT00787202|81756037|FG000|Overall Study|Lack of Efficacy|5|||
27867674|NCT03142191|81349678|FG001|Active Treatment Extension Period|Progressive Disease|5|||
27867675|NCT03142191|81349679|FG002|Active Treatment Extension Period|Progressive Disease|4|||
27979369|NCT00787202|81756038|FG001|Overall Study|Lack of Efficacy|6|||
27979370|NCT00787202|81756039|FG002|Overall Study|Lack of Efficacy|5|||
27979371|NCT00787202|81756040|FG003|Overall Study|Lack of Efficacy|2|||
27979372|NCT00787202|81756041|FG004|Overall Study|Lack of Efficacy|1|||
27979373|NCT00787202|81756037|FG000|Overall Study|Lost to Follow-up|1|||
27979374|NCT00787202|81756038|FG001|Overall Study|Lost to Follow-up|0|||
27979375|NCT00787202|81756039|FG002|Overall Study|Lost to Follow-up|0|||
27979376|NCT00787202|81756040|FG003|Overall Study|Lost to Follow-up|0|||
27867676|NCT03142191|81349680|FG003|Active Treatment Extension Period|Progressive Disease|1|||
27867677|NCT03142191|81349681|FG004|Active Treatment Extension Period|Progressive Disease|2|||
27867678|NCT03142191|81349677|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
27867679|NCT03142191|81349678|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
27867680|NCT03142191|81349679|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
27979377|NCT00787202|81756041|FG004|Overall Study|Lost to Follow-up|0|||
27979378|NCT00787202|81756037|FG000|Overall Study|Withdrawal by Subject|2|||
27979379|NCT00787202|81756038|FG001|Overall Study|Withdrawal by Subject|2|||
27979380|NCT00787202|81756039|FG002|Overall Study|Withdrawal by Subject|2|||
27979381|NCT00787202|81756040|FG003|Overall Study|Withdrawal by Subject|0|||
27979382|NCT00787202|81756041|FG004|Overall Study|Withdrawal by Subject|0|||
27979383|NCT00787202|81756037|FG000|Overall Study|Protocol Violation|2|||
27979384|NCT00787202|81756038|FG001|Overall Study|Protocol Violation|1|||
27979385|NCT00787202|81756039|FG002|Overall Study|Protocol Violation|0|||
27979386|NCT00787202|81756040|FG003|Overall Study|Protocol Violation|0|||
27979387|NCT00787202|81756041|FG004|Overall Study|Protocol Violation|1|||
27979388|NCT00787202|81756037|FG000|Overall Study|Randomized, not treated|1|||
27979389|NCT00787202|81756038|FG001|Overall Study|Randomized, not treated|0|||
27979390|NCT00787202|81756039|FG002|Overall Study|Randomized, not treated|0|||
27672893|NCT02906020|80639322|FG007|Part 2: Long-term Follow-up Period|Other|0|||
27672894|NCT02906020|80639323|FG008|Part 2: Long-term Follow-up Period|Other|0|||
27672895|NCT02906020|80639324|FG009|Part 2: Long-term Follow-up Period|Other|0|||
27672896|NCT02906020|80639325|FG010|Part 2: Long-term Follow-up Period|Other|0|||
27672897|NCT02906020|80639326|FG011|Part 2: Long-term Follow-up Period|Other|0|||
27672898|NCT02906020|80639327|FG012|Part 2: Long-term Follow-up Period|Other|13|||
27672899|NCT02906020|80639328|FG013|Part 2: Long-term Follow-up Period|Other|8|||
27672900|NCT02906020|80639329|FG014|Part 2: Long-term Follow-up Period|Other|3|||
27672901|NCT02906020|80639330|FG015|Part 2: Long-term Follow-up Period|Other|2|||
27672902|NCT03865953|80639336|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
27672903|NCT03865953|80639337|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
27672904|NCT03865953|80639336|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
27672905|NCT03865953|80639337|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
27672906|NCT03865953|80639336|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
27672907|NCT03865953|80639337|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
27672908|NCT00755417|80639338|FG000|Overall Study|Adverse Event|28|||
27672909|NCT00755417|80639339|FG001|Overall Study|Adverse Event|20|||
27672910|NCT00755417|80639340|FG002|Overall Study|Adverse Event|7|||
27672911|NCT00755417|80639338|FG000|Overall Study|Lack of Efficacy|8|||
27672912|NCT00755417|80639339|FG001|Overall Study|Lack of Efficacy|4|||
27672913|NCT00755417|80639340|FG002|Overall Study|Lack of Efficacy|9|||
27672914|NCT00755417|80639338|FG000|Overall Study|Protocol Violation|2|||
27672915|NCT00755417|80639339|FG001|Overall Study|Protocol Violation|1|||
27672916|NCT00755417|80639340|FG002|Overall Study|Protocol Violation|1|||
27672917|NCT00755417|80639338|FG000|Overall Study|Lost to Follow-up|3|||
27979391|NCT00787202|81756040|FG003|Overall Study|Randomized, not treated|0|||
27979392|NCT00787202|81756041|FG004|Overall Study|Randomized, not treated|0|||
27979393|NCT00259298|81756043|FG000|Overall Study|Withdrawal by Subject|1|||
27672918|NCT00755417|80639339|FG001|Overall Study|Lost to Follow-up|0|||
27672919|NCT00755417|80639340|FG002|Overall Study|Lost to Follow-up|1|||
27672920|NCT00755417|80639338|FG000|Overall Study|Withdrawal by Subject|12|||
27672921|NCT00755417|80639339|FG001|Overall Study|Withdrawal by Subject|12|||
27672922|NCT00755417|80639340|FG002|Overall Study|Withdrawal by Subject|12|||
27672923|NCT00755417|80639338|FG000|Overall Study|Not specified or missing data|9|||
27672924|NCT00755417|80639339|FG001|Overall Study|Not specified or missing data|18|||
27672925|NCT00755417|80639340|FG002|Overall Study|Not specified or missing data|12|||
27793015|NCT00585468|81072474|FG001|First Intervention|Withdrawal by Subject|1|||
27793016|NCT00467051|81072475|FG000|Overall Study|Adverse Event|2|||
27793017|NCT03733301|81072482|FG000|Overall Study|Screen Fail|1|||
27793018|NCT03733301|81072483|FG001|Overall Study|Screen Fail|0|||
27793019|NCT03733301|81072484|FG002|Overall Study|Screen Fail|0|||
27793020|NCT03733301|81072482|FG000|Overall Study|Non-compliance|1|||
27867681|NCT03142191|81349680|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
27867682|NCT03142191|81349681|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
27867683|NCT03142191|81349677|FG000|Active Treatment Extension Period|Physician Decision|2|||
27979394|NCT00259298|81756043|FG000|Overall Study|Physician Decision|2|||
27979395|NCT02634606|81756044|FG000|Overall Study|unable to obtain the drug at start|13|||
27979396|NCT02278614|81756046|FG000|Overall Study|Withdrawal by Subject|3|||
27979397|NCT02278614|81756047|FG001|Overall Study|Withdrawal by Subject|5|||
27979398|NCT02278614|81756046|FG000|Overall Study|Adverse Event|1|||
27979399|NCT02278614|81756047|FG001|Overall Study|Adverse Event|0|||
27793021|NCT03733301|81072483|FG001|Overall Study|Non-compliance|0|||
27793022|NCT03733301|81072484|FG002|Overall Study|Non-compliance|0|||
27793023|NCT03733301|81072482|FG000|Overall Study|Lack of Efficacy|2|||
27979400|NCT02278614|81756046|FG000|Overall Study|left eye was not eligible|1|||
27979401|NCT02278614|81756047|FG001|Overall Study|left eye was not eligible|0|||
27979402|NCT02726880|81756048|FG000|Overall Study|Withdrawal by Subject|2|||
27979403|NCT02726880|81756049|FG001|Overall Study|Withdrawal by Subject|0|||
27979404|NCT02726880|81756048|FG000|Overall Study|Lost to Follow-up|1|||
27979405|NCT02726880|81756049|FG001|Overall Study|Lost to Follow-up|3|||
27979406|NCT01440517|81756050|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
27979407|NCT02525939|81759848|FG000|Overall Study|Lost to Follow-up|27|||
27979408|NCT02525939|81759849|FG001|Overall Study|Lost to Follow-up|24|||
27979409|NCT02525939|81759848|FG000|Overall Study|Physician Decision|0|||
27979410|NCT02525939|81759849|FG001|Overall Study|Physician Decision|1|||
27979411|NCT02525939|81759848|FG000|Overall Study|Withdrawal by Subject|24|||
27979412|NCT02525939|81759849|FG001|Overall Study|Withdrawal by Subject|39|||
27979413|NCT02525939|81759848|FG000|Overall Study|Death|180|||
27979414|NCT02525939|81759849|FG001|Overall Study|Death|179|||
27979415|NCT02536300|81759851|FG000|Overall Study|Investigator's Discretion|17|||
27979416|NCT02536300|81759852|FG001|Overall Study|Investigator's Discretion|11|||
27979417|NCT02536300|81759853|FG002|Overall Study|Investigator's Discretion|2|||
27979418|NCT02536300|81759851|FG000|Overall Study|Progressive Disease|11|||
27979419|NCT02536300|81759852|FG001|Overall Study|Progressive Disease|7|||
27979420|NCT02536300|81759853|FG002|Overall Study|Progressive Disease|6|||
27979421|NCT02536300|81759851|FG000|Overall Study|Study Terminated by Sponsor|6|||
27979422|NCT02536300|81759852|FG001|Overall Study|Study Terminated by Sponsor|4|||
27979423|NCT02536300|81759853|FG002|Overall Study|Study Terminated by Sponsor|7|||
27979424|NCT02536300|81759851|FG000|Overall Study|Death|7|||
27979425|NCT02536300|81759852|FG001|Overall Study|Death|0|||
27979426|NCT02536300|81759853|FG002|Overall Study|Death|5|||
27979427|NCT02536300|81759851|FG000|Overall Study|Withdrew Consent|4|||
27979428|NCT02536300|81759852|FG001|Overall Study|Withdrew Consent|2|||
27979429|NCT02536300|81759853|FG002|Overall Study|Withdrew Consent|0|||
27979430|NCT02536300|81759851|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
27979431|NCT02536300|81759852|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
27979432|NCT02536300|81759853|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
27979433|NCT02536300|81759851|FG000|Overall Study|Enrolled but Never Treated|0|||
27979434|NCT02536300|81759852|FG001|Overall Study|Enrolled but Never Treated|0|||
27979435|NCT02536300|81759853|FG002|Overall Study|Enrolled but Never Treated|1|||
27979436|NCT02536300|81759851|FG000|Overall Study|Non-compliance With Study Drug|1|||
27979437|NCT02536300|81759852|FG001|Overall Study|Non-compliance With Study Drug|0|||
27979438|NCT02536300|81759853|FG002|Overall Study|Non-compliance With Study Drug|0|||
27979439|NCT02536300|81759851|FG000|Overall Study|Protocol Violation|0|||
27979440|NCT02536300|81759852|FG001|Overall Study|Protocol Violation|1|||
27979441|NCT02536300|81759853|FG002|Overall Study|Protocol Violation|0|||
27979442|NCT00424190|81759854|FG000|Overall Study|Withdrew consent|3|||
27979443|NCT00424190|81759855|FG001|Overall Study|Withdrew consent|4|||
27979444|NCT00424190|81759854|FG000|Overall Study|Death|3|||
27979445|NCT00424190|81759855|FG001|Overall Study|Death|0|||
27979446|NCT00424190|81759854|FG000|Overall Study|Noncompliance|1|||
27979447|NCT00424190|81759855|FG001|Overall Study|Noncompliance|2|||
27979448|NCT00424190|81759854|FG000|Overall Study|Request of sponsor or investigator|0|||
27979449|NCT00424190|81759855|FG001|Overall Study|Request of sponsor or investigator|2|||
27979450|NCT00424190|81759854|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
27979451|NCT00424190|81759855|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
27979452|NCT00424190|81759854|FG000|Overall Study|Other|15|||
27979453|NCT00424190|81759855|FG001|Overall Study|Other|21|||
27979454|NCT01253265|81759856|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
27979455|NCT01253265|81759857|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
27979456|NCT01253265|81759858|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
27979457|NCT01253265|81759859|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
27979458|NCT01253265|81759860|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
27979459|NCT01253265|81759856|FG000|Overall Study|Withdrawal by Subject|0|||
27979460|NCT01253265|81759857|FG001|Overall Study|Withdrawal by Subject|0|||
27979461|NCT01253265|81759858|FG002|Overall Study|Withdrawal by Subject|0|||
27979462|NCT01253265|81759859|FG003|Overall Study|Withdrawal by Subject|0|||
27575224|NCT01340976|80289294|FG001|Overall Study|Other anemia treatment|0|||
27575225|NCT01340976|80289295|FG002|Overall Study|Other anemia treatment|2|||
27575226|NCT01340976|80289296|FG003|Overall Study|Other anemia treatment|1|||
27575227|NCT01340976|80289297|FG004|Overall Study|Other anemia treatment|0|||
27575228|NCT01340976|80289298|FG005|Overall Study|Other anemia treatment|1|||
27575229|NCT01340976|80289293|FG000|Overall Study|Adverse Event|0|||
27575230|NCT01340976|80289294|FG001|Overall Study|Adverse Event|1|||
27575231|NCT01340976|80289295|FG002|Overall Study|Adverse Event|0|||
27575232|NCT01340976|80289296|FG003|Overall Study|Adverse Event|0|||
27575233|NCT01340976|80289297|FG004|Overall Study|Adverse Event|0|||
27575234|NCT01340976|80289298|FG005|Overall Study|Adverse Event|0|||
27575235|NCT03304379|80289299|FG000|Overall Study|Protocol Violation|8|||
27575236|NCT03304379|80289300|FG001|Overall Study|Protocol Violation|10|||
27575237|NCT03304379|80289301|FG002|Overall Study|Protocol Violation|5|||
27575238|NCT03304379|80289302|FG003|Overall Study|Protocol Violation|0|||
27575239|NCT03304379|80289303|FG004|Overall Study|Protocol Violation|2|||
27575240|NCT03304379|80289299|FG000|Overall Study|Adverse Event|4|||
27575241|NCT03304379|80289300|FG001|Overall Study|Adverse Event|20|||
27575242|NCT03304379|80289301|FG002|Overall Study|Adverse Event|17|||
27575243|NCT03304379|80289302|FG003|Overall Study|Adverse Event|1|||
27575244|NCT03304379|80289303|FG004|Overall Study|Adverse Event|0|||
27575245|NCT03304379|80289299|FG000|Overall Study|Lack of Efficacy|17|||
27575246|NCT03304379|80289300|FG001|Overall Study|Lack of Efficacy|16|||
27575247|NCT03304379|80289301|FG002|Overall Study|Lack of Efficacy|20|||
27575248|NCT03304379|80289302|FG003|Overall Study|Lack of Efficacy|0|||
27575249|NCT03304379|80289303|FG004|Overall Study|Lack of Efficacy|0|||
27575250|NCT03304379|80289299|FG000|Overall Study|Physician Decision|6|||
27575251|NCT03304379|80289300|FG001|Overall Study|Physician Decision|10|||
27575252|NCT03304379|80289301|FG002|Overall Study|Physician Decision|6|||
27575253|NCT03304379|80289302|FG003|Overall Study|Physician Decision|9|||
27575254|NCT03304379|80289303|FG004|Overall Study|Physician Decision|10|||
27575255|NCT03304379|80289299|FG000|Overall Study|Withdrawal by Subject|26|||
27575256|NCT03304379|80289300|FG001|Overall Study|Withdrawal by Subject|58|||
27575257|NCT03304379|80289301|FG002|Overall Study|Withdrawal by Subject|66|||
27575258|NCT03304379|80289302|FG003|Overall Study|Withdrawal by Subject|3|||
27575259|NCT03304379|80289303|FG004|Overall Study|Withdrawal by Subject|5|||
27575260|NCT03304379|80289299|FG000|Overall Study|Lost to Follow-up|8|||
27575261|NCT03304379|80289300|FG001|Overall Study|Lost to Follow-up|24|||
27575262|NCT03304379|80289301|FG002|Overall Study|Lost to Follow-up|35|||
27575263|NCT03304379|80289302|FG003|Overall Study|Lost to Follow-up|4|||
27575264|NCT03304379|80289303|FG004|Overall Study|Lost to Follow-up|0|||
27575265|NCT03304379|80289299|FG000|Overall Study|Death|1|||
27575266|NCT03304379|80289300|FG001|Overall Study|Death|2|||
27575267|NCT03304379|80289301|FG002|Overall Study|Death|0|||
27575268|NCT03304379|80289302|FG003|Overall Study|Death|0|||
27575269|NCT03304379|80289303|FG004|Overall Study|Death|0|||
27575270|NCT03304379|80289299|FG000|Overall Study|Other|0|||
27575271|NCT03304379|80289300|FG001|Overall Study|Other|1|||
27575272|NCT03304379|80289301|FG002|Overall Study|Other|0|||
27575273|NCT03304379|80289302|FG003|Overall Study|Other|0|||
27575274|NCT03304379|80289303|FG004|Overall Study|Other|0|||
27575275|NCT02247349|80292822|FG000|Overall Study|Disease Progression|7|||
27575276|NCT02247349|80292823|FG001|Overall Study|Disease Progression|4|||
27575277|NCT02247349|80292824|FG002|Overall Study|Disease Progression|26|||
27575278|NCT02247349|80292825|FG003|Overall Study|Disease Progression|31|||
27575279|NCT02247349|80292826|FG004|Overall Study|Disease Progression|16|||
27575280|NCT02247349|80292827|FG005|Overall Study|Disease Progression|6|||
27575281|NCT02247349|80292822|FG000|Overall Study|Study drug toxicity|0|||
27575282|NCT02247349|80292823|FG001|Overall Study|Study drug toxicity|1|||
27575283|NCT02247349|80292824|FG002|Overall Study|Study drug toxicity|1|||
27575284|NCT02247349|80292825|FG003|Overall Study|Study drug toxicity|1|||
27575285|NCT02247349|80292826|FG004|Overall Study|Study drug toxicity|2|||
27575286|NCT02247349|80292827|FG005|Overall Study|Study drug toxicity|2|||
27575287|NCT02247349|80292822|FG000|Overall Study|Death|0|||
27575288|NCT02247349|80292823|FG001|Overall Study|Death|0|||
27575289|NCT02247349|80292824|FG002|Overall Study|Death|0|||
27575290|NCT02247349|80292825|FG003|Overall Study|Death|1|||
27575291|NCT02247349|80292826|FG004|Overall Study|Death|0|||
27575292|NCT02247349|80292827|FG005|Overall Study|Death|0|||
27575293|NCT02247349|80292822|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
27575294|NCT02247349|80292823|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
27575295|NCT02247349|80292824|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
27575296|NCT02247349|80292825|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
27575297|NCT02247349|80292826|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
27575298|NCT02247349|80292827|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
27575299|NCT02247349|80292822|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27575300|NCT02247349|80292823|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27575301|NCT02247349|80292824|FG002|Overall Study|Participant request to discontinue study treatment|1|||
27575302|NCT02247349|80292825|FG003|Overall Study|Participant request to discontinue study treatment|2|||
27979463|NCT01253265|81759860|FG004|Overall Study|Withdrawal by Subject|1|||
27979464|NCT00613080|81759866|FG000|Overall Study|Ineligible / no protocol treatment|11|||
27979465|NCT00343915|81759870|FG000|Primary Study|Withdrawal by Subject|1|||
27979466|NCT00343915|81759871|FG001|Primary Study|Withdrawal by Subject|0|||
27979467|NCT00343915|81759870|FG000|Primary Study|Lost to Follow-up|2|||
27979468|NCT00343915|81759871|FG001|Primary Study|Lost to Follow-up|3|||
27979469|NCT00343915|81759870|FG000|Primary Study|Other|1|||
27979470|NCT00343915|81759871|FG001|Primary Study|Other|0|||
27979471|NCT01565564|81759872|FG000|Overall Study|Lost to Follow-up|5|||
27979472|NCT01565564|81759873|FG001|Overall Study|Lost to Follow-up|1|||
27979473|NCT02084238|81759874|FG000|Overall Study|Lost to Follow-up|2|||
27979474|NCT03899064|81759875|FG000|Overall Study|Lost to Follow-up|1|||
27979475|NCT03899064|81759875|FG000|Overall Study|Protocol Violation|2|||
27575303|NCT02247349|80292826|FG004|Overall Study|Participant request to discontinue study treatment|1|||
27575304|NCT02247349|80292827|FG005|Overall Study|Participant request to discontinue study treatment|0|||
27575305|NCT02247349|80292822|FG000|Overall Study|Withdrawal by Subject|0|||
27575306|NCT02247349|80292823|FG001|Overall Study|Withdrawal by Subject|1|||
27575307|NCT02247349|80292824|FG002|Overall Study|Withdrawal by Subject|0|||
27575308|NCT02247349|80292825|FG003|Overall Study|Withdrawal by Subject|0|||
27575309|NCT02247349|80292826|FG004|Overall Study|Withdrawal by Subject|0|||
27575310|NCT02247349|80292827|FG005|Overall Study|Withdrawal by Subject|0|||
27575311|NCT02247349|80292822|FG000|Overall Study|Administrative reason by sponsor|0|||
27575312|NCT02247349|80292823|FG001|Overall Study|Administrative reason by sponsor|0|||
27793024|NCT03733301|81072483|FG001|Overall Study|Lack of Efficacy|3|||
27793025|NCT03733301|81072484|FG002|Overall Study|Lack of Efficacy|0|||
27793026|NCT03733301|81072482|FG000|Overall Study|Adverse Event|0|||
27793027|NCT03733301|81072483|FG001|Overall Study|Adverse Event|1|||
27793028|NCT03733301|81072484|FG002|Overall Study|Adverse Event|3|||
27793029|NCT03733301|81072482|FG000|Overall Study|Withdrawal by Subject|3|||
27793030|NCT03733301|81072483|FG001|Overall Study|Withdrawal by Subject|5|||
27793031|NCT03733301|81072484|FG002|Overall Study|Withdrawal by Subject|1|||
27793032|NCT01300741|81072498|FG000|Overall Study|Lens deposits|1|||
27793033|NCT01300741|81072498|FG000|Overall Study|Lost to Follow-up|1|||
27793034|NCT01300741|81072498|FG000|Overall Study|Discomfort|1|||
27793035|NCT03155269|81072499|FG000|Overall Study|Withdrawal by Subject|4|||
27793036|NCT03155269|81072500|FG001|Overall Study|Withdrawal by Subject|5|||
27793037|NCT03155269|81072499|FG000|Overall Study|Lost to Follow-up|1|||
27793038|NCT03155269|81072500|FG001|Overall Study|Lost to Follow-up|2|||
27793039|NCT00026312|81072503|FG000|Overall Study|Adverse Event|0|||
27793040|NCT00026312|81072504|FG001|Overall Study|Adverse Event|32|||
27793041|NCT00026312|81072503|FG000|Overall Study|Death|1|||
27793042|NCT00026312|81072504|FG001|Overall Study|Death|7|||
27793043|NCT00026312|81072503|FG000|Overall Study|Lack of Efficacy|19|||
27793044|NCT00026312|81072504|FG001|Overall Study|Lack of Efficacy|114|||
27793045|NCT00026312|81072503|FG000|Overall Study|Lost to Follow-up|0|||
27793046|NCT00026312|81072504|FG001|Overall Study|Lost to Follow-up|5|||
27793047|NCT00026312|81072503|FG000|Overall Study|Physician Decision|1|||
27793048|NCT00026312|81072504|FG001|Overall Study|Physician Decision|37|||
27793049|NCT00026312|81072503|FG000|Overall Study|Protocol Violation|0|||
27793050|NCT00026312|81072504|FG001|Overall Study|Protocol Violation|3|||
27793051|NCT00026312|81072503|FG000|Overall Study|Withdrawal by Subject|1|||
27979476|NCT03899064|81759875|FG000|Overall Study|Withdrawal by Subject|2|||
27793052|NCT00026312|81072504|FG001|Overall Study|Withdrawal by Subject|6|||
27793053|NCT00026312|81072503|FG000|Overall Study|Ineligible|4|||
27793054|NCT00026312|81072504|FG001|Overall Study|Ineligible|5|||
27793055|NCT00026312|81072503|FG000|Overall Study|Entry onto another COG study|0|||
27793056|NCT00026312|81072504|FG001|Overall Study|Entry onto another COG study|1|||
27793057|NCT00026312|81072503|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
27793058|NCT00026312|81072504|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
27979477|NCT03899064|81759875|FG000|Overall Study|Other|2|||
27979478|NCT01009346|81759876|FG000|Overall Study|Adverse Event|4|||
27672926|NCT01015677|80639343|FG000|Overall Study|Adverse Event|0|||
27672927|NCT01015677|80639344|FG001|Overall Study|Adverse Event|1|||
27672928|NCT01015677|80639345|FG002|Overall Study|Adverse Event|0|||
27793059|NCT01965600|81072508|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
27793060|NCT01965600|81072509|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
27793061|NCT01965600|81072510|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
27575313|NCT02247349|80292824|FG002|Overall Study|Administrative reason by sponsor|0|||
27575314|NCT02247349|80292825|FG003|Overall Study|Administrative reason by sponsor|0|||
27575315|NCT02247349|80292826|FG004|Overall Study|Administrative reason by sponsor|1|||
27575316|NCT02247349|80292827|FG005|Overall Study|Administrative reason by sponsor|0|||
27575317|NCT02247349|80292822|FG000|Overall Study|Other reasons|0|||
27575318|NCT02247349|80292823|FG001|Overall Study|Other reasons|0|||
27575319|NCT02247349|80292824|FG002|Overall Study|Other reasons|1|||
27575320|NCT02247349|80292825|FG003|Overall Study|Other reasons|0|||
27575321|NCT02247349|80292826|FG004|Overall Study|Other reasons|0|||
27575322|NCT02247349|80292827|FG005|Overall Study|Other reasons|0|||
27575323|NCT00833924|80292828|FG000|Overall Study|Death|21|||
27575324|NCT00833924|80292828|FG000|Overall Study|Conversion|2|||
27793062|NCT01965600|81072511|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
27793063|NCT01965600|81072508|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
27793064|NCT01965600|81072509|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
27793065|NCT01965600|81072510|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
27793066|NCT01965600|81072511|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
27793067|NCT01965600|81072508|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
27793068|NCT01965600|81072509|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
27867684|NCT03142191|81349678|FG001|Active Treatment Extension Period|Physician Decision|0|||
27867685|NCT03142191|81349679|FG002|Active Treatment Extension Period|Physician Decision|0|||
27867686|NCT03142191|81349680|FG003|Active Treatment Extension Period|Physician Decision|0|||
27867687|NCT03142191|81349681|FG004|Active Treatment Extension Period|Physician Decision|0|||
27867688|NCT03142191|81349677|FG000|Active Treatment Extension Period|Other Reasons|3|||
27867689|NCT03142191|81349678|FG001|Active Treatment Extension Period|Other Reasons|3|||
27793069|NCT01965600|81072510|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
27793070|NCT01965600|81072511|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
27793071|NCT01965600|81072508|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
27867690|NCT03142191|81349679|FG002|Active Treatment Extension Period|Other Reasons|3|||
27867691|NCT03142191|81349680|FG003|Active Treatment Extension Period|Other Reasons|8|||
27575325|NCT00833924|80292828|FG000|Overall Study|Lost to Follow-up|2|||
27575326|NCT00833924|80292828|FG000|Overall Study|Withdrawal by Subject|13|||
27575327|NCT00833924|80292828|FG000|Overall Study|In study follow-up|71|||
27575328|NCT03586999|80292832|FG000|Overall Study|Lack of Efficacy|2|||
27575329|NCT01978184|80292843|FG000|Overall Study|Progressive disease|5|||
27575330|NCT01978184|80292844|FG001|Overall Study|Progressive disease|5|||
27575331|NCT01978184|80292843|FG000|Overall Study|Other than PDA|2|||
27575332|NCT01978184|80292844|FG001|Overall Study|Other than PDA|2|||
27672929|NCT01015677|80639343|FG000|Overall Study|Lack of Efficacy|0|||
27575333|NCT01978184|80292843|FG000|Overall Study|Physician Decision|0|||
27575334|NCT01978184|80292844|FG001|Overall Study|Physician Decision|3|||
27575335|NCT01978184|80292843|FG000|Overall Study|Noncompliance|1|||
27575336|NCT01978184|80292844|FG001|Overall Study|Noncompliance|2|||
27575337|NCT01978184|80292843|FG000|Overall Study|Death|1|||
27575338|NCT01978184|80292844|FG001|Overall Study|Death|0|||
27575339|NCT01978184|80292843|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
27575340|NCT01978184|80292844|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
27575341|NCT01850004|80292845|FG000|Overall Study|Poor/Non-compliance|1|||
27575342|NCT01850004|80292845|FG000|Overall Study|Participant Withdrew Consent|9|||
27575343|NCT01850004|80292845|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
27575344|NCT01850004|80292845|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
27575345|NCT01850004|80292845|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
27575346|NCT01850004|80292845|FG000|Overall Study|Other Reasons|2|||
27575347|NCT01850004|80292845|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
27867692|NCT03142191|81349681|FG004|Active Treatment Extension Period|Other Reasons|3|||
27979479|NCT00930969|81759877|FG000|Overall Study|Death|5|||
27575348|NCT01850004|80292845|FG000|Overall Study|Maximum Clinical Benefit|4|||
27979480|NCT00930969|81759877|FG000|Overall Study|Lost to Follow-up|1|||
27979481|NCT00930969|81759877|FG000|Overall Study|Physician Decision|13|||
27979482|NCT00930969|81759877|FG000|Overall Study|Withdrawal by Subject|19|||
27979483|NCT02080260|81759878|FG000|Overall Study|Death|18|||
27979484|NCT02080260|81759878|FG000|Overall Study|Withdrawal by Subject|1|||
27979485|NCT01048866|81759879|FG000|Overall Study|Adverse Event|1|||
27979486|NCT01048866|81759880|FG001|Overall Study|Adverse Event|0|||
27979487|NCT01048866|81759879|FG000|Overall Study|Protocol Violation|1|||
27575349|NCT01209624|80292847|FG000|Overall Study|Death|2|||
27979488|NCT01048866|81759880|FG001|Overall Study|Protocol Violation|0|||
27979489|NCT01048866|81759879|FG000|Overall Study|Physician Decision|1|||
27979490|NCT01048866|81759880|FG001|Overall Study|Physician Decision|0|||
27979491|NCT01048866|81759879|FG000|Overall Study|Withdrawal by Subject|0|||
27979492|NCT01048866|81759880|FG001|Overall Study|Withdrawal by Subject|2|||
27979493|NCT01048866|81759879|FG000|Overall Study|Lost to Follow-up|0|||
27979494|NCT01048866|81759880|FG001|Overall Study|Lost to Follow-up|2|||
27979495|NCT01048866|81759879|FG000|Overall Study|Other|1|||
27979496|NCT01048866|81759880|FG001|Overall Study|Other|1|||
27979497|NCT00993499|81759885|FG000|Run-in Period (8 Days)|Adverse Event|0|||
27979498|NCT00993499|81759886|FG001|Run-in Period (8 Days)|Adverse Event|1|||
27979499|NCT00993499|81759887|FG002|Run-in Period (8 Days)|Adverse Event|0|||
27979500|NCT00993499|81759888|FG003|Run-in Period (8 Days)|Adverse Event|0|||
27979501|NCT00993499|81759889|FG004|Run-in Period (8 Days)|Adverse Event|0|||
27979502|NCT00993499|81759890|FG005|Run-in Period (8 Days)|Adverse Event|0|||
27979503|NCT00993499|81759885|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
27979504|NCT00993499|81759886|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27979505|NCT00993499|81759887|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27979506|NCT00993499|81759888|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27979507|NCT00993499|81759889|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27979508|NCT00993499|81759890|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
27979509|NCT00993499|81759885|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
27979510|NCT00993499|81759886|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
27979511|NCT00993499|81759887|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
27979512|NCT00993499|81759888|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
27979513|NCT00993499|81759889|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
27979514|NCT00993499|81759890|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
27979515|NCT00993499|81759885|FG000|Run-in Period (8 Days)|Progressive disease|0|||
27979516|NCT00993499|81759886|FG001|Run-in Period (8 Days)|Progressive disease|1|||
27979517|NCT00993499|81759887|FG002|Run-in Period (8 Days)|Progressive disease|1|||
27979518|NCT00993499|81759888|FG003|Run-in Period (8 Days)|Progressive disease|0|||
27979519|NCT00993499|81759889|FG004|Run-in Period (8 Days)|Progressive disease|0|||
27979520|NCT00993499|81759890|FG005|Run-in Period (8 Days)|Progressive disease|0|||
27979521|NCT00993499|81759885|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
27979522|NCT00993499|81759886|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
27979523|NCT00993499|81759887|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
27979524|NCT00993499|81759888|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
27575350|NCT01209624|80292847|FG000|Overall Study|Adverse Event|13|||
27979525|NCT00993499|81759889|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
27979526|NCT00993499|81759890|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
27979527|NCT00993499|81759885|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
27979528|NCT00993499|81759886|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
27575351|NCT01209624|80292847|FG000|Overall Study|Lack of Efficacy|17|||
27575352|NCT01209624|80292847|FG000|Overall Study|Lost to Follow-up|290|||
27575353|NCT01209624|80292847|FG000|Overall Study|Other|4|||
27575354|NCT01114516|80292848|FG000|Overall Study|Lost to Follow-up|2|||
27575355|NCT01114516|80292849|FG001|Overall Study|Lost to Follow-up|1|||
27575356|NCT03592641|80292850|FG000|Overall Study|Withdrawal by Subject|1|||
27575357|NCT02649972|80292851|FG000|Overall Study|Not treated|1|||
27575358|NCT02520531|80292852|FG000|Overall Study|Revision of study device components|2|||
27575359|NCT02520531|80292853|FG001|Overall Study|Revision of study device components|2|||
27575360|NCT02520531|80292852|FG000|Overall Study|Death|1|||
27575361|NCT02520531|80292853|FG001|Overall Study|Death|2|||
27575362|NCT02520531|80292852|FG000|Overall Study|Lost to Follow-up|1|||
27867693|NCT03142191|81349677|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
27979529|NCT00993499|81759887|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27979530|NCT00993499|81759888|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27575363|NCT02520531|80292853|FG001|Overall Study|Lost to Follow-up|1|||
27575364|NCT02520531|80292852|FG000|Overall Study|Meet exclusion criterion|0|||
27575365|NCT02520531|80292853|FG001|Overall Study|Meet exclusion criterion|1|||
27575366|NCT02520531|80292852|FG000|Overall Study|Withdrawal by Subject|1|||
27575367|NCT02520531|80292853|FG001|Overall Study|Withdrawal by Subject|0|||
27575368|NCT02520531|80292852|FG000|Overall Study|Not study device|1|||
27575369|NCT02520531|80292853|FG001|Overall Study|Not study device|0|||
27575370|NCT04085523|80292857|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
27575371|NCT04085523|80292858|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
27575372|NCT04085523|80292859|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
27575373|NCT04085523|80292860|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
27575374|NCT04085523|80292861|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
27575375|NCT04085523|80292862|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
27575376|NCT03194646|80292863|FG000|Overall Study|Adverse Event|24|||
27575377|NCT03194646|80292864|FG001|Overall Study|Adverse Event|25|||
27575378|NCT03194646|80292865|FG002|Overall Study|Adverse Event|14|||
27575379|NCT03194646|80292866|FG003|Overall Study|Adverse Event|17|||
27575380|NCT03194646|80292863|FG000|Overall Study|Lack of Efficacy|4|||
27575381|NCT03194646|80292864|FG001|Overall Study|Lack of Efficacy|2|||
27575382|NCT03194646|80292865|FG002|Overall Study|Lack of Efficacy|2|||
27575383|NCT03194646|80292866|FG003|Overall Study|Lack of Efficacy|12|||
27575384|NCT03194646|80292863|FG000|Overall Study|Lost to Follow-up|30|||
27575385|NCT03194646|80292864|FG001|Overall Study|Lost to Follow-up|22|||
27575386|NCT03194646|80292865|FG002|Overall Study|Lost to Follow-up|12|||
27575387|NCT03194646|80292866|FG003|Overall Study|Lost to Follow-up|35|||
27575388|NCT03194646|80292863|FG000|Overall Study|Non-compliance with study drug|4|||
27575389|NCT03194646|80292864|FG001|Overall Study|Non-compliance with study drug|0|||
27575390|NCT03194646|80292865|FG002|Overall Study|Non-compliance with study drug|1|||
27575391|NCT03194646|80292866|FG003|Overall Study|Non-compliance with study drug|1|||
27575392|NCT03194646|80292863|FG000|Overall Study|Other|89|||
27575393|NCT03194646|80292864|FG001|Overall Study|Other|68|||
27575394|NCT03194646|80292865|FG002|Overall Study|Other|34|||
27575395|NCT03194646|80292866|FG003|Overall Study|Other|31|||
27575396|NCT03194646|80292863|FG000|Overall Study|Physician Decision|7|||
27575397|NCT03194646|80292864|FG001|Overall Study|Physician Decision|9|||
27575398|NCT03194646|80292865|FG002|Overall Study|Physician Decision|5|||
27575399|NCT03194646|80292866|FG003|Overall Study|Physician Decision|4|||
27575400|NCT03194646|80292863|FG000|Overall Study|Pregnancy|4|||
27575401|NCT03194646|80292864|FG001|Overall Study|Pregnancy|5|||
27575402|NCT03194646|80292865|FG002|Overall Study|Pregnancy|1|||
27575403|NCT03194646|80292866|FG003|Overall Study|Pregnancy|2|||
27575404|NCT03194646|80292863|FG000|Overall Study|Protocol Violation|4|||
27575405|NCT03194646|80292864|FG001|Overall Study|Protocol Violation|2|||
27575406|NCT03194646|80292865|FG002|Overall Study|Protocol Violation|1|||
27575407|NCT03194646|80292866|FG003|Overall Study|Protocol Violation|1|||
27575408|NCT03194646|80292863|FG000|Overall Study|Site terminated by sponsor|0|||
27575409|NCT03194646|80292864|FG001|Overall Study|Site terminated by sponsor|0|||
27575410|NCT03194646|80292865|FG002|Overall Study|Site terminated by sponsor|2|||
27575411|NCT03194646|80292866|FG003|Overall Study|Site terminated by sponsor|0|||
27979531|NCT00993499|81759889|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27575412|NCT03194646|80292863|FG000|Overall Study|Study terminated by sponsor|62|||
27575413|NCT03194646|80292864|FG001|Overall Study|Study terminated by sponsor|61|||
27575414|NCT03194646|80292865|FG002|Overall Study|Study terminated by sponsor|30|||
27575415|NCT03194646|80292866|FG003|Overall Study|Study terminated by sponsor|34|||
27575416|NCT03194646|80292863|FG000|Overall Study|Withdrawal by Subject|75|||
27575417|NCT03194646|80292864|FG001|Overall Study|Withdrawal by Subject|74|||
27575418|NCT03194646|80292865|FG002|Overall Study|Withdrawal by Subject|36|||
27575419|NCT03194646|80292866|FG003|Overall Study|Withdrawal by Subject|131|||
27575420|NCT03194646|80292863|FG000|Overall Study|Missing|1|||
27575421|NCT03194646|80292864|FG001|Overall Study|Missing|0|||
27575422|NCT03194646|80292865|FG002|Overall Study|Missing|1|||
27575423|NCT03194646|80292866|FG003|Overall Study|Missing|12|||
27575424|NCT03459196|80292867|FG000|Overall Study|Subject didn't receive study catheter|2|||
27575425|NCT02644967|80292868|FG000|Overall Study|Death|26|||
27575426|NCT02644967|80292868|FG000|Overall Study|Physician Decision|1|||
27575427|NCT02644967|80292868|FG000|Overall Study|Withdrawal by Subject|2|||
27979532|NCT00993499|81759890|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
27979533|NCT00993499|81759885|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27979534|NCT00993499|81759886|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27979535|NCT00993499|81759887|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
27979536|NCT00993499|81759888|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
27979537|NCT00993499|81759889|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27575428|NCT02644967|80292868|FG000|Overall Study|Protocol Violation|1|||
27575429|NCT02644967|80292868|FG000|Overall Study|Progressive Disease|1|||
27672930|NCT01015677|80639344|FG001|Overall Study|Lack of Efficacy|1|||
27979538|NCT00993499|81759890|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
27979539|NCT00993499|81759885|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27979540|NCT00993499|81759886|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27979541|NCT00993499|81759887|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
27979542|NCT00993499|81759888|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27979543|NCT00993499|81759889|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27979544|NCT00993499|81759890|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
27979545|NCT00993499|81759885|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27979546|NCT00993499|81759886|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
27979547|NCT00993499|81759887|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27979548|NCT00993499|81759888|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27979549|NCT00993499|81759889|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27979550|NCT00993499|81759890|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
27979551|NCT00993499|81759885|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
27979552|NCT00993499|81759886|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
27979553|NCT00993499|81759887|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
27979554|NCT00993499|81759888|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
27979555|NCT00993499|81759889|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
27979556|NCT00993499|81759890|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
27979557|NCT00993499|81759885|FG000|Discontinued After Starting Course 3|DLT|1|||
27979558|NCT00993499|81759886|FG001|Discontinued After Starting Course 3|DLT|0|||
27979559|NCT00993499|81759887|FG002|Discontinued After Starting Course 3|DLT|2|||
27979560|NCT00993499|81759888|FG003|Discontinued After Starting Course 3|DLT|1|||
27979561|NCT00993499|81759889|FG004|Discontinued After Starting Course 3|DLT|0|||
27979562|NCT00993499|81759890|FG005|Discontinued After Starting Course 3|DLT|0|||
27979563|NCT00993499|81759885|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
27979564|NCT00993499|81759886|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
27979565|NCT00993499|81759887|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
27979566|NCT00993499|81759888|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
27979567|NCT00993499|81759889|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
27979568|NCT00993499|81759890|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
27979569|NCT00849875|81759891|FG000|Overall Study|Death|28|||
27979570|NCT00849875|81759891|FG000|Overall Study|Ongoing (unknown completion status)|11|||
27979571|NCT00849875|81759891|FG000|Overall Study|Others|6|||
27979572|NCT00849875|81759891|FG000|Overall Study|Lost to Follow-up|2|||
27979573|NCT02558400|81759894|FG000|Overall Study|Adverse Event|47|||
27979574|NCT02558400|81759895|FG001|Overall Study|Adverse Event|53|||
27979575|NCT02558400|81759896|FG002|Overall Study|Adverse Event|4|||
27979576|NCT02558400|81759894|FG000|Overall Study|Withdrawal by Subject|13|||
27979577|NCT02558400|81759895|FG001|Overall Study|Withdrawal by Subject|9|||
27979578|NCT02558400|81759896|FG002|Overall Study|Withdrawal by Subject|8|||
27979579|NCT02558400|81759894|FG000|Overall Study|Non-Compliant|0|||
27979580|NCT02558400|81759895|FG001|Overall Study|Non-Compliant|1|||
27979581|NCT02558400|81759896|FG002|Overall Study|Non-Compliant|3|||
27979582|NCT02558400|81759894|FG000|Overall Study|Lost to Follow-up|5|||
27979583|NCT02558400|81759895|FG001|Overall Study|Lost to Follow-up|5|||
27979584|NCT02558400|81759896|FG002|Overall Study|Lost to Follow-up|4|||
27979585|NCT02558400|81759894|FG000|Overall Study|Lack of Efficacy|0|||
27979586|NCT02558400|81759895|FG001|Overall Study|Lack of Efficacy|13|||
27979587|NCT02558400|81759896|FG002|Overall Study|Lack of Efficacy|1|||
27979588|NCT02558400|81759894|FG000|Overall Study|Disallowed Concurrent Medication|6|||
27979589|NCT02558400|81759895|FG001|Overall Study|Disallowed Concurrent Medication|7|||
27979590|NCT02558400|81759896|FG002|Overall Study|Disallowed Concurrent Medication|5|||
27672931|NCT01015677|80639345|FG002|Overall Study|Lack of Efficacy|0|||
27672932|NCT01015677|80639343|FG000|Overall Study|Protocol Violation|0|||
27672933|NCT01015677|80639344|FG001|Overall Study|Protocol Violation|1|||
27672934|NCT01015677|80639345|FG002|Overall Study|Protocol Violation|0|||
27979591|NCT02558400|81759894|FG000|Overall Study|Physician Decision|2|||
27979592|NCT02558400|81759895|FG001|Overall Study|Physician Decision|2|||
27979593|NCT02558400|81759896|FG002|Overall Study|Physician Decision|0|||
27979594|NCT02558400|81759894|FG000|Overall Study|Protocol Violation|6|||
27979595|NCT02558400|81759895|FG001|Overall Study|Protocol Violation|3|||
27979596|NCT02558400|81759896|FG002|Overall Study|Protocol Violation|8|||
27979597|NCT02558400|81759894|FG000|Overall Study|Death|0|||
27979598|NCT02558400|81759895|FG001|Overall Study|Death|1|||
27979599|NCT02558400|81759896|FG002|Overall Study|Death|0|||
27979600|NCT02558400|81759894|FG000|Overall Study|Ineligible for the study|0|||
27979601|NCT02558400|81759895|FG001|Overall Study|Ineligible for the study|2|||
27979602|NCT02558400|81759896|FG002|Overall Study|Ineligible for the study|0|||
27979603|NCT02528357|81759901|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979604|NCT02528357|81759902|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
27979605|NCT02528357|81759903|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979606|NCT02528357|81759904|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979607|NCT02528357|81759905|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979608|NCT02528357|81759906|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979609|NCT02528357|81759907|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979610|NCT02528357|81759908|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979611|NCT02528357|81759909|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979612|NCT02528357|81759910|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979613|NCT02528357|81759911|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979614|NCT02528357|81759912|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979615|NCT02528357|81759913|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979616|NCT02528357|81759914|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979617|NCT02528357|81759915|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979618|NCT02528357|81759916|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979619|NCT02528357|81759917|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979620|NCT02528357|81759918|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979621|NCT02528357|81759919|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
27979622|NCT02528357|81759901|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979623|NCT02528357|81759902|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979624|NCT02528357|81759903|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979625|NCT02528357|81759904|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
27979626|NCT02528357|81759905|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979627|NCT02528357|81759906|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
27979628|NCT02528357|81759907|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979629|NCT02528357|81759908|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
27575430|NCT02644967|80292868|FG000|Overall Study|Study Terminated by Sponsor|4|||
27575431|NCT04111497|80292869|FG000|Overall Study|relapse of primary disease|1|||
27575432|NCT04111497|80292869|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
27575433|NCT02880371|80292876|FG000|Phase 1b|Lost to Follow-up|1|||
27575434|NCT02880371|80292877|FG001|Phase 1b|Lost to Follow-up|0|||
27575435|NCT02880371|80292878|FG002|Phase 1b|Lost to Follow-up|0|||
27979630|NCT02528357|81759909|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979631|NCT02528357|81759910|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979632|NCT02528357|81759911|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979633|NCT02528357|81759912|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979634|NCT02528357|81759913|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979635|NCT02528357|81759914|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979636|NCT02528357|81759915|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979637|NCT02528357|81759916|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979638|NCT02528357|81759917|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979639|NCT02528357|81759918|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27979640|NCT02528357|81759919|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
27575436|NCT02880371|80292879|FG003|Phase 1b|Lost to Follow-up|0|||
27575437|NCT02880371|80292880|FG004|Phase 1b|Lost to Follow-up|0|||
27575438|NCT02880371|80292881|FG005|Phase 1b|Lost to Follow-up|0|||
27979641|NCT02528357|81759901|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979642|NCT02528357|81759902|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979643|NCT02528357|81759903|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
27979644|NCT02528357|81759904|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979645|NCT02528357|81759905|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
27979646|NCT02528357|81759906|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27575439|NCT02880371|80292882|FG006|Phase 1b|Lost to Follow-up|0|||
27575440|NCT02880371|80292883|FG007|Phase 1b|Lost to Follow-up|0|||
27575441|NCT02880371|80292876|FG000|Phase 1b|Participants terminated by Sponsor|1|||
27979647|NCT02528357|81759907|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
27979648|NCT02528357|81759908|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
27575442|NCT02880371|80292877|FG001|Phase 1b|Participants terminated by Sponsor|0|||
27575443|NCT02880371|80292878|FG002|Phase 1b|Participants terminated by Sponsor|0|||
27979649|NCT02528357|81759909|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979650|NCT02528357|81759910|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979651|NCT02528357|81759911|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979652|NCT02528357|81759912|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979653|NCT02528357|81759913|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979654|NCT02528357|81759914|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979655|NCT02528357|81759915|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979656|NCT02528357|81759916|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979657|NCT02528357|81759917|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979658|NCT02528357|81759918|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979659|NCT02528357|81759919|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
27979660|NCT02528357|81759901|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979661|NCT02528357|81759902|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979662|NCT02528357|81759903|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979663|NCT02528357|81759904|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979664|NCT02528357|81759905|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27979665|NCT02528357|81759906|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979666|NCT02528357|81759907|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979667|NCT02528357|81759908|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979668|NCT02528357|81759909|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979669|NCT02528357|81759910|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979670|NCT02528357|81759911|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979671|NCT02528357|81759912|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979672|NCT02528357|81759913|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979673|NCT02528357|81759914|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979674|NCT02528357|81759915|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27575444|NCT02880371|80292879|FG003|Phase 1b|Participants terminated by Sponsor|0|||
27575445|NCT02880371|80292880|FG004|Phase 1b|Participants terminated by Sponsor|0|||
27575446|NCT02880371|80292881|FG005|Phase 1b|Participants terminated by Sponsor|0|||
27575447|NCT02880371|80292882|FG006|Phase 1b|Participants terminated by Sponsor|0|||
27575448|NCT02880371|80292883|FG007|Phase 1b|Participants terminated by Sponsor|0|||
27575449|NCT02880371|80292876|FG000|Phase 1b|Withdrawal by Subject|0|||
27575450|NCT02880371|80292877|FG001|Phase 1b|Withdrawal by Subject|0|||
27575451|NCT02880371|80292878|FG002|Phase 1b|Withdrawal by Subject|1|||
27575452|NCT02880371|80292879|FG003|Phase 1b|Withdrawal by Subject|0|||
27575453|NCT02880371|80292880|FG004|Phase 1b|Withdrawal by Subject|0|||
27575454|NCT02880371|80292881|FG005|Phase 1b|Withdrawal by Subject|0|||
27672935|NCT01015677|80639343|FG000|Overall Study|Withdrawal by Subject|1|||
27672936|NCT01015677|80639344|FG001|Overall Study|Withdrawal by Subject|1|||
27979675|NCT02528357|81759916|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979676|NCT02528357|81759917|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979677|NCT02528357|81759918|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979678|NCT02528357|81759919|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979679|NCT02528357|81759901|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979680|NCT02528357|81759902|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979681|NCT02528357|81759903|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27672937|NCT01015677|80639345|FG002|Overall Study|Withdrawal by Subject|0|||
27672938|NCT01774305|80639350|FG000|Overall Study|Physician Decision|1|||
27672939|NCT01774305|80639351|FG001|Overall Study|Physician Decision|0|||
27672940|NCT02394665|80639352|FG000|Overall Study|Physician Decision|1|||
27672941|NCT02394665|80639353|FG001|Overall Study|Physician Decision|0|||
27672942|NCT02394665|80639354|FG002|Overall Study|Physician Decision|0|||
27672943|NCT03021551|80639355|FG000|Overall Study|Equipment Issues|2|||
27672944|NCT03021551|80639355|FG000|Overall Study|Protocol Violation|1|||
27672945|NCT00825305|80639356|FG000|Overall Study|Adverse Event|1|||
27672946|NCT00825305|80639357|FG001|Overall Study|Adverse Event|1|||
27672947|NCT00825305|80639356|FG000|Overall Study|Withdrawal by Subject|6|||
27672948|NCT00825305|80639357|FG001|Overall Study|Withdrawal by Subject|12|||
27672949|NCT00825305|80639356|FG000|Overall Study|Inappropriate inclusion|1|||
27672950|NCT00825305|80639357|FG001|Overall Study|Inappropriate inclusion|0|||
27672951|NCT00825305|80639356|FG000|Overall Study|Protocol Violation|9|||
27672952|NCT00825305|80639357|FG001|Overall Study|Protocol Violation|9|||
27672953|NCT00825305|80639356|FG000|Overall Study|Can not be classified|0|||
27672954|NCT00825305|80639357|FG001|Overall Study|Can not be classified|1|||
27672955|NCT01130168|80639364|FG000|Period 1|Withdrawal by Subject|0|||
27672956|NCT01130168|80639365|FG001|Period 1|Withdrawal by Subject|1|||
27672957|NCT01130168|80639366|FG002|Period 1|Withdrawal by Subject|0|||
27672958|NCT01130168|80639367|FG003|Period 1|Withdrawal by Subject|1|||
27672959|NCT01130168|80639368|FG004|Period 1|Withdrawal by Subject|0|||
27672960|NCT01130168|80639369|FG005|Period 1|Withdrawal by Subject|0|||
27672961|NCT01130168|80639364|FG000|Period 1|Discontinued For Other Reason|0|||
27672962|NCT01130168|80639365|FG001|Period 1|Discontinued For Other Reason|0|||
27672963|NCT01130168|80639366|FG002|Period 1|Discontinued For Other Reason|1|||
27672964|NCT01130168|80639367|FG003|Period 1|Discontinued For Other Reason|1|||
27672965|NCT01130168|80639368|FG004|Period 1|Discontinued For Other Reason|0|||
27672966|NCT01130168|80639369|FG005|Period 1|Discontinued For Other Reason|0|||
27672967|NCT01130168|80639364|FG000|Period 1|Adverse Event|0|||
27672968|NCT01130168|80639365|FG001|Period 1|Adverse Event|0|||
27672969|NCT01130168|80639366|FG002|Period 1|Adverse Event|0|||
27672970|NCT01130168|80639367|FG003|Period 1|Adverse Event|1|||
27672971|NCT01130168|80639368|FG004|Period 1|Adverse Event|0|||
27672972|NCT01130168|80639369|FG005|Period 1|Adverse Event|0|||
27672973|NCT03672175|80639370|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
27672974|NCT03672175|80639371|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
27672975|NCT03672175|80639372|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
27672976|NCT03672175|80639370|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
27672977|NCT03672175|80639371|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
27672978|NCT03672175|80639372|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
27672979|NCT03672175|80639370|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
27575455|NCT02880371|80292882|FG006|Phase 1b|Withdrawal by Subject|0|||
27575456|NCT02880371|80292883|FG007|Phase 1b|Withdrawal by Subject|0|||
27575457|NCT02880371|80292876|FG000|Phase 1b|Death|4|||
27672980|NCT03672175|80639371|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
27672981|NCT03672175|80639372|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
27672982|NCT03672175|80639370|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
27672983|NCT03672175|80639371|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
27672984|NCT03672175|80639372|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
27672985|NCT03672175|80639370|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
27672986|NCT03672175|80639371|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
27672987|NCT03672175|80639372|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
27672988|NCT03672175|80639370|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
27672989|NCT03672175|80639371|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
27672990|NCT03672175|80639372|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
27672991|NCT03672175|80639370|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
27672992|NCT03672175|80639371|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
27672993|NCT03672175|80639372|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
27672994|NCT03672175|80639370|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
27672995|NCT03672175|80639371|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
27672996|NCT03672175|80639372|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
27672997|NCT03672175|80639370|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
27672998|NCT03672175|80639371|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
27672999|NCT03672175|80639372|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
27673000|NCT03672175|80639370|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
27673001|NCT03672175|80639371|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
27673002|NCT03672175|80639372|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
27673003|NCT03672175|80639370|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
27673004|NCT03672175|80639371|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
27673005|NCT03672175|80639372|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
27673006|NCT03672175|80639370|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
27673007|NCT03672175|80639371|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
27673008|NCT03672175|80639372|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
27673009|NCT02106195|80639373|FG000|Overall Study|Adverse Event|2|||
27673010|NCT02106195|80639373|FG000|Overall Study|Protocol Violation|1|||
27673011|NCT02484547|80639374|FG000|Placebo-Controlled Period|Adverse Event|10|||
27793072|NCT01965600|81072509|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
27793073|NCT01965600|81072510|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
27673012|NCT02484547|80639375|FG001|Placebo-Controlled Period|Adverse Event|13|||
27673013|NCT02484547|80639376|FG002|Placebo-Controlled Period|Adverse Event|20|||
27673014|NCT02484547|80639377|FG003|Placebo-Controlled Period|Adverse Event|0|||
27673015|NCT02484547|80639378|FG004|Placebo-Controlled Period|Adverse Event|0|||
27673016|NCT02484547|80639379|FG005|Placebo-Controlled Period|Adverse Event|0|||
27673017|NCT02484547|80639380|FG006|Placebo-Controlled Period|Adverse Event|0|||
27673018|NCT02484547|80639374|FG000|Placebo-Controlled Period|Change of Treatment|0|||
27673019|NCT02484547|80639375|FG001|Placebo-Controlled Period|Change of Treatment|0|||
27673020|NCT02484547|80639376|FG002|Placebo-Controlled Period|Change of Treatment|1|||
27673021|NCT02484547|80639377|FG003|Placebo-Controlled Period|Change of Treatment|0|||
27673022|NCT02484547|80639378|FG004|Placebo-Controlled Period|Change of Treatment|0|||
27673023|NCT02484547|80639379|FG005|Placebo-Controlled Period|Change of Treatment|0|||
27673024|NCT02484547|80639380|FG006|Placebo-Controlled Period|Change of Treatment|0|||
27673025|NCT02484547|80639374|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
27673026|NCT02484547|80639375|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
27673027|NCT02484547|80639376|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
27673028|NCT02484547|80639377|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
27673029|NCT02484547|80639378|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
27673030|NCT02484547|80639379|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
27673031|NCT02484547|80639380|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
27673032|NCT02484547|80639374|FG000|Placebo-Controlled Period|Death|5|||
27673033|NCT02484547|80639375|FG001|Placebo-Controlled Period|Death|0|||
27673034|NCT02484547|80639376|FG002|Placebo-Controlled Period|Death|6|||
27673035|NCT02484547|80639377|FG003|Placebo-Controlled Period|Death|0|||
27673036|NCT02484547|80639378|FG004|Placebo-Controlled Period|Death|0|||
27673037|NCT02484547|80639379|FG005|Placebo-Controlled Period|Death|0|||
27673038|NCT02484547|80639380|FG006|Placebo-Controlled Period|Death|0|||
27793074|NCT01965600|81072511|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
27979682|NCT02528357|81759904|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979683|NCT02528357|81759905|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979684|NCT02528357|81759906|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979685|NCT02528357|81759907|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979686|NCT02528357|81759908|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27673039|NCT02484547|80639374|FG000|Placebo-Controlled Period|Disease Progression|2|||
27673040|NCT02484547|80639375|FG001|Placebo-Controlled Period|Disease Progression|0|||
27793075|NCT01965600|81072508|FG000|Second Intervention|Study terminated by Sponsor|0|||
27793076|NCT01965600|81072509|FG001|Second Intervention|Study terminated by Sponsor|0|||
27673041|NCT02484547|80639376|FG002|Placebo-Controlled Period|Disease Progression|1|||
27673042|NCT02484547|80639377|FG003|Placebo-Controlled Period|Disease Progression|0|||
27673043|NCT02484547|80639378|FG004|Placebo-Controlled Period|Disease Progression|0|||
27673044|NCT02484547|80639379|FG005|Placebo-Controlled Period|Disease Progression|0|||
27673045|NCT02484547|80639380|FG006|Placebo-Controlled Period|Disease Progression|0|||
27673046|NCT02484547|80639374|FG000|Placebo-Controlled Period|Investigator Decision|2|||
27979687|NCT02528357|81759909|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979688|NCT02528357|81759910|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979689|NCT02528357|81759911|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979690|NCT02528357|81759912|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979691|NCT02528357|81759913|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979692|NCT02528357|81759914|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
27979693|NCT02528357|81759915|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
27979694|NCT02528357|81759916|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979695|NCT02528357|81759917|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979696|NCT02528357|81759918|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979697|NCT02528357|81759919|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
27979698|NCT02528357|81759901|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979699|NCT02528357|81759902|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979700|NCT02528357|81759903|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979701|NCT02528357|81759904|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979702|NCT02528357|81759905|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979703|NCT02528357|81759906|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979704|NCT02528357|81759907|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979705|NCT02528357|81759908|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979706|NCT02528357|81759909|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979707|NCT02528357|81759910|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979708|NCT02528357|81759911|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979709|NCT02528357|81759912|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979710|NCT02528357|81759913|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979711|NCT02528357|81759914|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
27979712|NCT02528357|81759915|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979713|NCT02528357|81759916|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979714|NCT02528357|81759917|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979715|NCT02528357|81759918|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979716|NCT02528357|81759919|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
27979717|NCT02528357|81759901|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979718|NCT02528357|81759902|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979719|NCT02528357|81759903|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979720|NCT02528357|81759904|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979721|NCT02528357|81759905|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979722|NCT02528357|81759906|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979723|NCT02528357|81759907|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979724|NCT02528357|81759908|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979725|NCT02528357|81759909|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979726|NCT02528357|81759910|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979727|NCT02528357|81759911|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
27979728|NCT02528357|81759912|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979729|NCT02528357|81759913|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
27979730|NCT02528357|81759914|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
27979731|NCT02528357|81759915|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
27979732|NCT02528357|81759916|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979733|NCT02528357|81759917|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979734|NCT02528357|81759918|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979735|NCT02528357|81759919|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
27979736|NCT02528357|81759901|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979737|NCT02528357|81759902|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979738|NCT02528357|81759903|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979739|NCT02528357|81759904|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979740|NCT02528357|81759905|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979741|NCT02528357|81759906|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979742|NCT02528357|81759907|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27793077|NCT01965600|81072510|FG002|Second Intervention|Study terminated by Sponsor|2|||
27793078|NCT01965600|81072511|FG003|Second Intervention|Study terminated by Sponsor|2|||
27673047|NCT02484547|80639375|FG001|Placebo-Controlled Period|Investigator Decision|2|||
27979743|NCT02528357|81759908|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979744|NCT02528357|81759909|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27979745|NCT02528357|81759910|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27979746|NCT02528357|81759911|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979747|NCT02528357|81759912|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
27979748|NCT02528357|81759913|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
27979749|NCT02528357|81759914|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27979750|NCT02528357|81759915|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27979751|NCT02528357|81759916|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979752|NCT02528357|81759917|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27867694|NCT03142191|81349678|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
27867695|NCT03142191|81349679|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
27979753|NCT02528357|81759918|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979754|NCT02528357|81759919|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27673048|NCT02484547|80639376|FG002|Placebo-Controlled Period|Investigator Decision|5|||
27673049|NCT02484547|80639377|FG003|Placebo-Controlled Period|Investigator Decision|0|||
27673050|NCT02484547|80639378|FG004|Placebo-Controlled Period|Investigator Decision|0|||
27673051|NCT02484547|80639379|FG005|Placebo-Controlled Period|Investigator Decision|0|||
27673052|NCT02484547|80639380|FG006|Placebo-Controlled Period|Investigator Decision|0|||
27673053|NCT02484547|80639374|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
27673054|NCT02484547|80639375|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
27673055|NCT02484547|80639376|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
27673056|NCT02484547|80639377|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
27673057|NCT02484547|80639378|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
27673058|NCT02484547|80639379|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
27673059|NCT02484547|80639380|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
27673060|NCT02484547|80639374|FG000|Placebo-Controlled Period|Relocation|1|||
27673061|NCT02484547|80639375|FG001|Placebo-Controlled Period|Relocation|1|||
27673062|NCT02484547|80639376|FG002|Placebo-Controlled Period|Relocation|1|||
27673063|NCT02484547|80639377|FG003|Placebo-Controlled Period|Relocation|0|||
27673064|NCT02484547|80639378|FG004|Placebo-Controlled Period|Relocation|0|||
27793079|NCT04637815|81072512|FG000|Overall Study|Death|1|||
27793080|NCT04637815|81072513|FG001|Overall Study|Death|0|||
27793081|NCT04637815|81072512|FG000|Overall Study|Lost to Follow-up|5|||
27793082|NCT04637815|81072513|FG001|Overall Study|Lost to Follow-up|2|||
27793083|NCT03185949|81072514|FG000|ITT Analysis|Withdrawal by Subject|4|||
27793084|NCT03185949|81072515|FG001|ITT Analysis|Withdrawal by Subject|3|||
27793085|NCT03185949|81072514|FG000|PP Analysis|Protocol Violation|2|||
27793086|NCT03185949|81072515|FG001|PP Analysis|Protocol Violation|2|||
27793087|NCT03185949|81072514|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
27793088|NCT03185949|81072515|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
27793089|NCT00326625|81072519|FG000|Overall Study|Adverse Event|20|||
27793090|NCT00326625|81072520|FG001|Overall Study|Adverse Event|9|||
27673065|NCT02484547|80639379|FG005|Placebo-Controlled Period|Relocation|0|||
27673066|NCT02484547|80639380|FG006|Placebo-Controlled Period|Relocation|0|||
27673067|NCT02484547|80639374|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
27793091|NCT00326625|81072519|FG000|Overall Study|Withdrawal by Subject|15|||
27793092|NCT00326625|81072520|FG001|Overall Study|Withdrawal by Subject|12|||
27793093|NCT00326625|81072519|FG000|Overall Study|Death|18|||
27575458|NCT02880371|80292877|FG001|Phase 1b|Death|6|||
27575459|NCT02880371|80292878|FG002|Phase 1b|Death|5|||
27575460|NCT02880371|80292879|FG003|Phase 1b|Death|1|||
27575461|NCT02880371|80292880|FG004|Phase 1b|Death|0|||
27575462|NCT02880371|80292881|FG005|Phase 1b|Death|0|||
27575463|NCT02880371|80292882|FG006|Phase 1b|Death|0|||
27575464|NCT02880371|80292883|FG007|Phase 1b|Death|0|||
27575465|NCT02880371|80292876|FG000|Phase 1b|Enrolled but not Treated|0|||
27575466|NCT02880371|80292877|FG001|Phase 1b|Enrolled but not Treated|1|||
27575467|NCT02880371|80292878|FG002|Phase 1b|Enrolled but not Treated|0|||
27575468|NCT02880371|80292879|FG003|Phase 1b|Enrolled but not Treated|0|||
27575469|NCT02880371|80292880|FG004|Phase 1b|Enrolled but not Treated|0|||
27575470|NCT02880371|80292881|FG005|Phase 1b|Enrolled but not Treated|0|||
27575471|NCT02880371|80292882|FG006|Phase 1b|Enrolled but not Treated|0|||
27575472|NCT02880371|80292883|FG007|Phase 1b|Enrolled but not Treated|0|||
27575473|NCT02880371|80292876|FG000|Phase 2|Enrolled but not Treated|0|||
27575474|NCT02880371|80292877|FG001|Phase 2|Enrolled but not Treated|0|||
27575475|NCT02880371|80292878|FG002|Phase 2|Enrolled but not Treated|0|||
27575476|NCT02880371|80292879|FG003|Phase 2|Enrolled but not Treated|0|||
27575477|NCT02880371|80292880|FG004|Phase 2|Enrolled but not Treated|0|||
27575478|NCT02880371|80292881|FG005|Phase 2|Enrolled but not Treated|1|||
27575479|NCT02880371|80292882|FG006|Phase 2|Enrolled but not Treated|1|||
27575480|NCT02880371|80292883|FG007|Phase 2|Enrolled but not Treated|0|||
27575481|NCT02880371|80292876|FG000|Phase 2|Other|0|||
27575482|NCT02880371|80292877|FG001|Phase 2|Other|0|||
27575483|NCT02880371|80292878|FG002|Phase 2|Other|0|||
27575484|NCT02880371|80292879|FG003|Phase 2|Other|0|||
27575485|NCT02880371|80292880|FG004|Phase 2|Other|0|||
27575486|NCT02880371|80292881|FG005|Phase 2|Other|1|||
27575487|NCT02880371|80292882|FG006|Phase 2|Other|2|||
27575488|NCT02880371|80292883|FG007|Phase 2|Other|1|||
27575489|NCT02880371|80292876|FG000|Phase 2|Participants terminated by Sponsor|0|||
27575490|NCT02880371|80292877|FG001|Phase 2|Participants terminated by Sponsor|0|||
27575491|NCT02880371|80292878|FG002|Phase 2|Participants terminated by Sponsor|0|||
27575492|NCT02880371|80292879|FG003|Phase 2|Participants terminated by Sponsor|0|||
27575493|NCT02880371|80292880|FG004|Phase 2|Participants terminated by Sponsor|1|||
27575494|NCT02880371|80292881|FG005|Phase 2|Participants terminated by Sponsor|6|||
27575495|NCT02880371|80292882|FG006|Phase 2|Participants terminated by Sponsor|1|||
27575496|NCT02880371|80292883|FG007|Phase 2|Participants terminated by Sponsor|5|||
27575497|NCT02880371|80292876|FG000|Phase 2|Death|0|||
27575498|NCT02880371|80292877|FG001|Phase 2|Death|0|||
27575499|NCT02880371|80292878|FG002|Phase 2|Death|0|||
27575500|NCT02880371|80292879|FG003|Phase 2|Death|0|||
27575501|NCT02880371|80292880|FG004|Phase 2|Death|1|||
27575502|NCT02880371|80292881|FG005|Phase 2|Death|10|||
27575503|NCT02880371|80292882|FG006|Phase 2|Death|20|||
27575504|NCT02880371|80292883|FG007|Phase 2|Death|5|||
27575505|NCT02880371|80292876|FG000|Phase 2|Lost to Follow-up|0|||
27575506|NCT02880371|80292877|FG001|Phase 2|Lost to Follow-up|0|||
27575507|NCT02880371|80292878|FG002|Phase 2|Lost to Follow-up|0|||
27575508|NCT02880371|80292879|FG003|Phase 2|Lost to Follow-up|0|||
27793094|NCT00326625|81072520|FG001|Overall Study|Death|16|||
27575509|NCT02880371|80292880|FG004|Phase 2|Lost to Follow-up|0|||
27575510|NCT02880371|80292881|FG005|Phase 2|Lost to Follow-up|0|||
27575511|NCT02880371|80292882|FG006|Phase 2|Lost to Follow-up|3|||
27575512|NCT02880371|80292883|FG007|Phase 2|Lost to Follow-up|0|||
27575513|NCT02880371|80292876|FG000|Phase 2|Withdrawal by Subject|0|||
27575514|NCT02880371|80292877|FG001|Phase 2|Withdrawal by Subject|0|||
27575515|NCT02880371|80292878|FG002|Phase 2|Withdrawal by Subject|0|||
27575516|NCT02880371|80292879|FG003|Phase 2|Withdrawal by Subject|0|||
27575517|NCT02880371|80292880|FG004|Phase 2|Withdrawal by Subject|0|||
27575518|NCT02880371|80292881|FG005|Phase 2|Withdrawal by Subject|1|||
27575519|NCT02880371|80292882|FG006|Phase 2|Withdrawal by Subject|1|||
27575520|NCT02880371|80292883|FG007|Phase 2|Withdrawal by Subject|0|||
27575521|NCT02880371|80292876|FG000|Phase 2|End of Study page not completed by error|0|||
27575522|NCT02880371|80292877|FG001|Phase 2|End of Study page not completed by error|0|||
27575523|NCT02880371|80292878|FG002|Phase 2|End of Study page not completed by error|0|||
27575524|NCT02880371|80292879|FG003|Phase 2|End of Study page not completed by error|0|||
27575525|NCT02880371|80292880|FG004|Phase 2|End of Study page not completed by error|0|||
27575526|NCT02880371|80292881|FG005|Phase 2|End of Study page not completed by error|1|||
27867696|NCT03142191|81349680|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
27867697|NCT03142191|81349681|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
27867698|NCT01107197|81349684|FG000|Overall Study|Death|12|||
27867699|NCT01107197|81349685|FG001|Overall Study|Death|10|||
27867700|NCT01107197|81349684|FG000|Overall Study|Lost to Follow-up|5|||
27867701|NCT01107197|81349685|FG001|Overall Study|Lost to Follow-up|8|||
27867702|NCT01107197|81349684|FG000|Overall Study|Withdrawal by Subject|3|||
27867703|NCT01107197|81349685|FG001|Overall Study|Withdrawal by Subject|5|||
27867704|NCT02211417|81349690|FG000|Overall Study|Withdrawal by Subject|11|||
27867705|NCT02211417|81349691|FG001|Overall Study|Withdrawal by Subject|8|||
27575527|NCT02880371|80292882|FG006|Phase 2|End of Study page not completed by error|0|||
27575528|NCT02880371|80292883|FG007|Phase 2|End of Study page not completed by error|0|||
27575529|NCT03417141|80292886|FG000|Overall Study|Withdrawal by Subject|1|||
27575530|NCT03417141|80292886|FG000|Overall Study|Protocol Violation|3|||
27575531|NCT04258839|80292893|FG000|Overall Study|Adverse Event|2|||
27575532|NCT04258839|80292894|FG001|Overall Study|Adverse Event|4|||
27575533|NCT04258839|80292893|FG000|Overall Study|Lack of Efficacy|0|||
27575534|NCT04258839|80292894|FG001|Overall Study|Lack of Efficacy|2|||
27575535|NCT04258839|80292893|FG000|Overall Study|Lost to Follow-up|2|||
27575536|NCT04258839|80292894|FG001|Overall Study|Lost to Follow-up|0|||
27575537|NCT04258839|80292893|FG000|Overall Study|Withdrawal by Subject|1|||
27575538|NCT04258839|80292894|FG001|Overall Study|Withdrawal by Subject|2|||
27575539|NCT04258839|80292893|FG000|Overall Study|Withdrawal by Caregiver|5|||
27575540|NCT04258839|80292894|FG001|Overall Study|Withdrawal by Caregiver|6|||
27575541|NCT04258839|80292893|FG000|Overall Study|Reason not Specified|0|||
27575542|NCT04258839|80292894|FG001|Overall Study|Reason not Specified|1|||
27575543|NCT01632579|80292895|FG000|Washout Period|Adverse Event|1|||
27575544|NCT01632579|80292896|FG001|Washout Period|Adverse Event|0|||
27575545|NCT01632579|80292897|FG002|Washout Period|Adverse Event|0|||
27979755|NCT02528357|81759901|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979756|NCT02528357|81759902|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979757|NCT02528357|81759903|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979758|NCT02528357|81759904|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979759|NCT02528357|81759905|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979760|NCT02528357|81759906|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979761|NCT02528357|81759907|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979762|NCT02528357|81759908|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979763|NCT02528357|81759909|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979764|NCT02528357|81759910|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979765|NCT02528357|81759911|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979766|NCT02528357|81759912|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979767|NCT02528357|81759913|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979768|NCT02528357|81759914|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979769|NCT02528357|81759915|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979770|NCT02528357|81759916|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979771|NCT02528357|81759917|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
27979772|NCT02528357|81759918|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979773|NCT02528357|81759919|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
27979774|NCT02528357|81759901|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979775|NCT02528357|81759902|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979776|NCT02528357|81759903|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979777|NCT02528357|81759904|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979778|NCT02528357|81759905|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979779|NCT02528357|81759906|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27867706|NCT02211417|81349690|FG000|Overall Study|Protocol Violation|1|||
27867707|NCT02211417|81349691|FG001|Overall Study|Protocol Violation|0|||
27575546|NCT01632579|80292898|FG003|Washout Period|Adverse Event|0|||
27575547|NCT01632579|80292899|FG004|Washout Period|Adverse Event|0|||
27575548|NCT01632579|80292900|FG005|Washout Period|Adverse Event|0|||
27575549|NCT01632579|80292901|FG006|Washout Period|Adverse Event|0|||
27575550|NCT01632579|80292902|FG007|Washout Period|Adverse Event|0|||
27575551|NCT01632579|80292903|FG008|Washout Period|Adverse Event|0|||
27575552|NCT01632579|80292895|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
27575553|NCT01632579|80292896|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
27575554|NCT01632579|80292897|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
27575555|NCT01632579|80292898|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
27575556|NCT01632579|80292899|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
27979780|NCT02528357|81759907|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979781|NCT02528357|81759908|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979782|NCT02528357|81759909|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979783|NCT02528357|81759910|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979784|NCT02528357|81759911|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979785|NCT02528357|81759912|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979786|NCT02528357|81759913|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979787|NCT02528357|81759914|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979788|NCT02528357|81759915|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979789|NCT02528357|81759916|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
27979790|NCT02528357|81759917|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
27979791|NCT02528357|81759918|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
27979792|NCT02528357|81759919|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
27979793|NCT00343382|81759921|FG000|Overall Study|Adverse Event|2|||
27979794|NCT00343382|81759922|FG001|Overall Study|Adverse Event|10|||
27979795|NCT00343382|81759923|FG002|Overall Study|Adverse Event|7|||
27979796|NCT00343382|81759921|FG000|Overall Study|Withdrawal by Subject|1|||
27979797|NCT00343382|81759922|FG001|Overall Study|Withdrawal by Subject|2|||
27979798|NCT00343382|81759923|FG002|Overall Study|Withdrawal by Subject|6|||
27979799|NCT00343382|81759921|FG000|Overall Study|Other Reason Not Specified|1|||
27979800|NCT00343382|81759922|FG001|Overall Study|Other Reason Not Specified|2|||
27979801|NCT00343382|81759923|FG002|Overall Study|Other Reason Not Specified|4|||
27979802|NCT04032080|81759924|FG000|Overall Study|Death|6|||
27979803|NCT00276614|81759926|FG000|Overall Study|Progression of disease under study|3|||
27979804|NCT00350623|81759928|FG000|Overall Study|Lost to Follow-up|8|||
27979805|NCT00350623|81759929|FG001|Overall Study|Lost to Follow-up|3|||
27979806|NCT00350623|81759930|FG002|Overall Study|Lost to Follow-up|4|||
27979807|NCT00350623|81759928|FG000|Overall Study|Withdrawal by Subject|0|||
27979808|NCT00350623|81759929|FG001|Overall Study|Withdrawal by Subject|1|||
27979809|NCT00350623|81759930|FG002|Overall Study|Withdrawal by Subject|1|||
27979810|NCT00350623|81759928|FG000|Overall Study|patient traveling outside the country|0|||
27979811|NCT00350623|81759929|FG001|Overall Study|patient traveling outside the country|0|||
27979812|NCT00350623|81759930|FG002|Overall Study|patient traveling outside the country|1|||
27979813|NCT03691779|81759931|FG000|Part B (24 Weeks)|Adverse Event|0|||
27979814|NCT03691779|81759932|FG001|Part B (24 Weeks)|Adverse Event|1|||
27979815|NCT03691779|81759931|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
27979816|NCT03691779|81759932|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
27979817|NCT01064687|81759933|FG000|Overall Study|Adverse Event|9|||
27979818|NCT01064687|81759934|FG001|Overall Study|Adverse Event|4|||
27979819|NCT01064687|81759935|FG002|Overall Study|Adverse Event|10|||
27979820|NCT01064687|81759936|FG003|Overall Study|Adverse Event|3|||
27979821|NCT01064687|81759933|FG000|Overall Study|Death|1|||
27979822|NCT01064687|81759934|FG001|Overall Study|Death|1|||
27979823|NCT01064687|81759935|FG002|Overall Study|Death|0|||
27979824|NCT01064687|81759936|FG003|Overall Study|Death|0|||
27979825|NCT01064687|81759933|FG000|Overall Study|Entry Criteria Not Met|3|||
27979826|NCT01064687|81759934|FG001|Overall Study|Entry Criteria Not Met|0|||
27979827|NCT01064687|81759935|FG002|Overall Study|Entry Criteria Not Met|0|||
27979828|NCT01064687|81759936|FG003|Overall Study|Entry Criteria Not Met|0|||
27979829|NCT01064687|81759933|FG000|Overall Study|Lack of Efficacy|1|||
27979830|NCT01064687|81759934|FG001|Overall Study|Lack of Efficacy|0|||
27575557|NCT01632579|80292900|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
27575558|NCT01632579|80292901|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
27673068|NCT02484547|80639375|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
27793095|NCT00326625|81072519|FG000|Overall Study|Lost to Follow-up|1|||
27979831|NCT01064687|81759935|FG002|Overall Study|Lack of Efficacy|2|||
27979832|NCT01064687|81759936|FG003|Overall Study|Lack of Efficacy|3|||
27979833|NCT01064687|81759933|FG000|Overall Study|Lost to Follow-up|7|||
27979834|NCT01064687|81759934|FG001|Overall Study|Lost to Follow-up|10|||
27979835|NCT01064687|81759935|FG002|Overall Study|Lost to Follow-up|13|||
27979836|NCT01064687|81759936|FG003|Overall Study|Lost to Follow-up|5|||
27979837|NCT01064687|81759933|FG000|Overall Study|Physician Decision|2|||
27979838|NCT01064687|81759934|FG001|Overall Study|Physician Decision|2|||
27979839|NCT01064687|81759935|FG002|Overall Study|Physician Decision|0|||
27979840|NCT01064687|81759936|FG003|Overall Study|Physician Decision|0|||
27979841|NCT01064687|81759933|FG000|Overall Study|Protocol Violation|1|||
27979842|NCT01064687|81759934|FG001|Overall Study|Protocol Violation|1|||
27979843|NCT01064687|81759935|FG002|Overall Study|Protocol Violation|0|||
27979844|NCT01064687|81759936|FG003|Overall Study|Protocol Violation|1|||
27979845|NCT01064687|81759933|FG000|Overall Study|Sponsor Decision|0|||
27979846|NCT01064687|81759934|FG001|Overall Study|Sponsor Decision|0|||
27979847|NCT01064687|81759935|FG002|Overall Study|Sponsor Decision|3|||
27979848|NCT01064687|81759936|FG003|Overall Study|Sponsor Decision|0|||
27979849|NCT01064687|81759933|FG000|Overall Study|Withdrawal by Subject|9|||
27979850|NCT01064687|81759934|FG001|Overall Study|Withdrawal by Subject|7|||
27979851|NCT01064687|81759935|FG002|Overall Study|Withdrawal by Subject|12|||
27979852|NCT01064687|81759936|FG003|Overall Study|Withdrawal by Subject|5|||
27979853|NCT01064687|81759933|FG000|Overall Study|Treatment Noncompliance|1|||
27979854|NCT01064687|81759934|FG001|Overall Study|Treatment Noncompliance|1|||
27979855|NCT01064687|81759935|FG002|Overall Study|Treatment Noncompliance|1|||
27979856|NCT01064687|81759936|FG003|Overall Study|Treatment Noncompliance|0|||
27979857|NCT03541187|81759937|FG000|Overall Study|Lost to Follow-up|2|||
27979858|NCT03541187|81759938|FG001|Overall Study|Lost to Follow-up|6|||
27979859|NCT03541187|81759937|FG000|Overall Study|Pregnancy|0|||
27575559|NCT01632579|80292902|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
27575560|NCT01632579|80292903|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
27575561|NCT01479621|80292904|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
27575562|NCT01479621|80292905|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27575563|NCT01479621|80292906|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27575564|NCT01479621|80292907|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27575565|NCT01479621|80292908|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27575566|NCT01479621|80292909|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27575567|NCT01479621|80292910|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27575568|NCT01479621|80292904|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
27575569|NCT01479621|80292905|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27575570|NCT01479621|80292906|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27575571|NCT01479621|80292907|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27575572|NCT01479621|80292908|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27575573|NCT01479621|80292909|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27575574|NCT01479621|80292910|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27575575|NCT01479621|80292904|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
27793096|NCT00326625|81072520|FG001|Overall Study|Lost to Follow-up|0|||
27793097|NCT00326625|81072519|FG000|Overall Study|prescheduled medical intervention|0|||
27793098|NCT00326625|81072520|FG001|Overall Study|prescheduled medical intervention|1|||
27793099|NCT00442572|81072521|FG000|Overall Study|Relapse|8|||
27793100|NCT00442572|81072522|FG001|Overall Study|Relapse|1|||
27793101|NCT00442572|81072521|FG000|Overall Study|Lost to Follow-up|0|||
27793102|NCT00442572|81072522|FG001|Overall Study|Lost to Follow-up|1|||
27793103|NCT00442572|81072521|FG000|Overall Study|Withdrawal by Subject|0|||
27793104|NCT00442572|81072522|FG001|Overall Study|Withdrawal by Subject|1|||
27979860|NCT03541187|81759938|FG001|Overall Study|Pregnancy|1|||
27979861|NCT03541187|81759937|FG000|Overall Study|Withdrawal by Subject|6|||
27979862|NCT03541187|81759938|FG001|Overall Study|Withdrawal by Subject|2|||
27979863|NCT03541187|81759937|FG000|Overall Study|Moved out of town|1|||
27979864|NCT03541187|81759938|FG001|Overall Study|Moved out of town|0|||
27979865|NCT03541187|81759937|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
27979866|NCT03541187|81759938|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
27979867|NCT03541187|81759937|FG000|Overall Study|Did not meet randomization criteria|1|||
27979868|NCT03541187|81759938|FG001|Overall Study|Did not meet randomization criteria|1|||
27979869|NCT03541187|81759937|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
27979870|NCT03541187|81759938|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
27979871|NCT03541187|81759937|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
27867708|NCT02211417|81349690|FG000|Overall Study|Pregnancy|0|||
27867709|NCT02211417|81349691|FG001|Overall Study|Pregnancy|1|||
27979872|NCT03541187|81759938|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
27979873|NCT02782325|81759939|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
27979874|NCT02782325|81759940|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
27979875|NCT02782325|81759941|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
27979876|NCT02782325|81759939|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
27979877|NCT02782325|81759940|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
27979878|NCT02782325|81759941|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
27979879|NCT03271047|81759942|FG000|Phase 1b: Dose Finding Period|Death|8|||
27979880|NCT03271047|81759943|FG001|Phase 1b: Dose Finding Period|Death|8|||
27979881|NCT03271047|81759944|FG002|Phase 1b: Dose Finding Period|Death|0|||
27979882|NCT03271047|81759945|FG003|Phase 1b: Dose Finding Period|Death|0|||
27979883|NCT03271047|81759942|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
27979884|NCT03271047|81759943|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
27979885|NCT03271047|81759944|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
27979886|NCT03271047|81759945|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
27979887|NCT03271047|81759942|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
27979888|NCT03271047|81759943|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
27979889|NCT03271047|81759944|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
27979890|NCT03271047|81759945|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
27979891|NCT03271047|81759942|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
27979892|NCT03271047|81759943|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
27979893|NCT03271047|81759944|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
27979894|NCT03271047|81759945|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
27979895|NCT03271047|81759942|FG000|Randomized Phase 2 Period|Other|0|||
27979896|NCT03271047|81759943|FG001|Randomized Phase 2 Period|Other|0|||
27979897|NCT03271047|81759944|FG002|Randomized Phase 2 Period|Other|0|||
27979898|NCT03271047|81759945|FG003|Randomized Phase 2 Period|Other|1|||
27979899|NCT03271047|81759942|FG000|Randomized Phase 2 Period|Death|0|||
27979900|NCT03271047|81759943|FG001|Randomized Phase 2 Period|Death|0|||
27979901|NCT03271047|81759944|FG002|Randomized Phase 2 Period|Death|20|||
27979902|NCT03271047|81759945|FG003|Randomized Phase 2 Period|Death|21|||
27979903|NCT03271047|81759942|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
27979904|NCT03271047|81759943|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
27979905|NCT03271047|81759944|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
27979906|NCT03271047|81759945|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
27979907|NCT03271047|81759942|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
27979908|NCT03271047|81759943|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
27979909|NCT03271047|81759944|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
27979910|NCT03271047|81759945|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
27979911|NCT03271047|81759942|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
27979912|NCT03271047|81759943|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
27979913|NCT03271047|81759944|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
27979914|NCT03271047|81759945|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
27979915|NCT04438499|81759946|FG000|Overall Study|Lack of Efficacy|2|||
27979916|NCT03157583|81759948|FG000|Overall Study|Other (did not meet study criteria)|1|||
27575576|NCT01479621|80292905|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27575577|NCT01479621|80292906|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27575578|NCT01479621|80292907|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27793105|NCT01789476|81072525|FG000|Overall Study|Lack of Efficacy|6|||
27793106|NCT01789476|81072526|FG001|Overall Study|Lack of Efficacy|2|||
27793107|NCT01789476|81072525|FG000|Overall Study|Adverse Event|1|||
27979917|NCT02642965|81759949|FG000|Overall Study|Lack of Efficacy|4|||
27793108|NCT01789476|81072526|FG001|Overall Study|Adverse Event|0|||
27793109|NCT01789476|81072525|FG000|Overall Study|Unable to get IV access|1|||
27979918|NCT02642965|81759949|FG000|Overall Study|Physician Decision|9|||
27979919|NCT01806064|81759950|FG000|Overall Study|Randomized Not Enrolled|0|||
27793110|NCT01789476|81072526|FG001|Overall Study|Unable to get IV access|0|||
27793111|NCT02322866|81072527|FG000|Overall Study|Adverse Event|6|||
27793112|NCT02322866|81072528|FG001|Overall Study|Adverse Event|11|||
27793113|NCT02322866|81072527|FG000|Overall Study|Withdrawal of Consent|16|||
27793114|NCT02322866|81072528|FG001|Overall Study|Withdrawal of Consent|25|||
27867710|NCT02211417|81349690|FG000|Overall Study|Lost to Follow-up|2|||
27673069|NCT02484547|80639376|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
27673070|NCT02484547|80639377|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
27673071|NCT02484547|80639378|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
27673072|NCT02484547|80639379|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
27673073|NCT02484547|80639380|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
27673074|NCT02484547|80639374|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
27673075|NCT02484547|80639375|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
27673076|NCT02484547|80639376|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
27673077|NCT02484547|80639377|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27673078|NCT02484547|80639378|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27673079|NCT02484547|80639379|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27673080|NCT02484547|80639380|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27673081|NCT02484547|80639374|FG000|Placebo-Controlled Period|Reason not Specified|216|||
27673082|NCT02484547|80639375|FG001|Placebo-Controlled Period|Reason not Specified|194|||
27673083|NCT02484547|80639376|FG002|Placebo-Controlled Period|Reason not Specified|183|||
27673084|NCT02484547|80639377|FG003|Placebo-Controlled Period|Reason not Specified|0|||
27673085|NCT02484547|80639378|FG004|Placebo-Controlled Period|Reason not Specified|0|||
27673086|NCT02484547|80639379|FG005|Placebo-Controlled Period|Reason not Specified|0|||
27673087|NCT02484547|80639380|FG006|Placebo-Controlled Period|Reason not Specified|0|||
27673088|NCT02484547|80639374|FG000|Long-Term Extension Period|Adverse Event|0|||
27673089|NCT02484547|80639375|FG001|Long-Term Extension Period|Adverse Event|0|||
27673090|NCT02484547|80639376|FG002|Long-Term Extension Period|Adverse Event|0|||
27673091|NCT02484547|80639377|FG003|Long-Term Extension Period|Adverse Event|0|||
27673092|NCT02484547|80639378|FG004|Long-Term Extension Period|Adverse Event|1|||
27673093|NCT02484547|80639379|FG005|Long-Term Extension Period|Adverse Event|3|||
27673094|NCT02484547|80639380|FG006|Long-Term Extension Period|Adverse Event|2|||
27673095|NCT02484547|80639374|FG000|Long-Term Extension Period|Death|0|||
27673096|NCT02484547|80639375|FG001|Long-Term Extension Period|Death|0|||
27673097|NCT02484547|80639376|FG002|Long-Term Extension Period|Death|0|||
27673098|NCT02484547|80639377|FG003|Long-Term Extension Period|Death|0|||
27673099|NCT02484547|80639378|FG004|Long-Term Extension Period|Death|0|||
27673100|NCT02484547|80639379|FG005|Long-Term Extension Period|Death|3|||
27673101|NCT02484547|80639380|FG006|Long-Term Extension Period|Death|0|||
27673102|NCT02484547|80639374|FG000|Long-Term Extension Period|Disease Progression|0|||
27673103|NCT02484547|80639375|FG001|Long-Term Extension Period|Disease Progression|0|||
27673104|NCT02484547|80639376|FG002|Long-Term Extension Period|Disease Progression|0|||
27673105|NCT02484547|80639377|FG003|Long-Term Extension Period|Disease Progression|0|||
27673106|NCT02484547|80639378|FG004|Long-Term Extension Period|Disease Progression|2|||
27673107|NCT02484547|80639379|FG005|Long-Term Extension Period|Disease Progression|4|||
27673108|NCT02484547|80639380|FG006|Long-Term Extension Period|Disease Progression|0|||
27673109|NCT02484547|80639374|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
27673110|NCT02484547|80639375|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
27673111|NCT02484547|80639376|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
27673112|NCT02484547|80639377|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
27673113|NCT02484547|80639378|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
27673114|NCT02484547|80639379|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
27673115|NCT02484547|80639380|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
27673116|NCT02484547|80639374|FG000|Long-Term Extension Period|Loss of Capacity|0|||
27673117|NCT02484547|80639375|FG001|Long-Term Extension Period|Loss of Capacity|0|||
27673118|NCT02484547|80639376|FG002|Long-Term Extension Period|Loss of Capacity|0|||
27673119|NCT02484547|80639377|FG003|Long-Term Extension Period|Loss of Capacity|0|||
27673120|NCT02484547|80639378|FG004|Long-Term Extension Period|Loss of Capacity|1|||
27673121|NCT02484547|80639379|FG005|Long-Term Extension Period|Loss of Capacity|0|||
27673122|NCT02484547|80639380|FG006|Long-Term Extension Period|Loss of Capacity|0|||
27673123|NCT02484547|80639374|FG000|Long-Term Extension Period|Change of Treatment|0|||
27673124|NCT02484547|80639375|FG001|Long-Term Extension Period|Change of Treatment|0|||
27673125|NCT02484547|80639376|FG002|Long-Term Extension Period|Change of Treatment|0|||
27673126|NCT02484547|80639377|FG003|Long-Term Extension Period|Change of Treatment|0|||
27673127|NCT02484547|80639378|FG004|Long-Term Extension Period|Change of Treatment|0|||
27673128|NCT02484547|80639379|FG005|Long-Term Extension Period|Change of Treatment|0|||
27673129|NCT02484547|80639380|FG006|Long-Term Extension Period|Change of Treatment|1|||
27673130|NCT02484547|80639374|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
27673131|NCT02484547|80639375|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
27673132|NCT02484547|80639376|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
27673133|NCT02484547|80639377|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
27673134|NCT02484547|80639378|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
27673135|NCT02484547|80639379|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
27673136|NCT02484547|80639380|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
27673137|NCT02484547|80639374|FG000|Long-Term Extension Period|Investigator Decision|0|||
27793115|NCT02322866|81072527|FG000|Overall Study|Lost to Follow-up|36|||
27793116|NCT02322866|81072528|FG001|Overall Study|Lost to Follow-up|39|||
27673138|NCT02484547|80639375|FG001|Long-Term Extension Period|Investigator Decision|0|||
27673139|NCT02484547|80639376|FG002|Long-Term Extension Period|Investigator Decision|0|||
27673140|NCT02484547|80639377|FG003|Long-Term Extension Period|Investigator Decision|2|||
27673141|NCT02484547|80639378|FG004|Long-Term Extension Period|Investigator Decision|1|||
27673142|NCT02484547|80639379|FG005|Long-Term Extension Period|Investigator Decision|0|||
27673143|NCT02484547|80639380|FG006|Long-Term Extension Period|Investigator Decision|1|||
27673144|NCT02484547|80639374|FG000|Long-Term Extension Period|Relocation|0|||
27673145|NCT02484547|80639375|FG001|Long-Term Extension Period|Relocation|0|||
27793117|NCT02322866|81072527|FG000|Overall Study|Protocol Violation|1|||
27793118|NCT02322866|81072528|FG001|Overall Study|Protocol Violation|0|||
27979920|NCT01806064|81759951|FG001|Overall Study|Randomized Not Enrolled|0|||
27979921|NCT01806064|81759952|FG002|Overall Study|Randomized Not Enrolled|0|||
27979922|NCT01806064|81759953|FG003|Overall Study|Randomized Not Enrolled|1|||
27979923|NCT01806064|81759954|FG004|Overall Study|Randomized Not Enrolled|2|||
27979924|NCT00746733|81759955|FG000|Second Intervention|Adverse Event|1|||
27979925|NCT00746733|81759956|FG001|Second Intervention|Adverse Event|0|||
27979926|NCT00746733|81759955|FG000|Third Intervention|Withdrawal by Subject|1|||
27979927|NCT00746733|81759956|FG001|Third Intervention|Withdrawal by Subject|1|||
27979928|NCT02231762|81759957|FG000|Combination Phase|Adverse Event|10|||
27979929|NCT02231762|81759958|FG001|Combination Phase|Adverse Event|0|||
27979930|NCT02231762|81759959|FG002|Combination Phase|Adverse Event|0|||
27979931|NCT02231762|81759960|FG003|Combination Phase|Adverse Event|0|||
27979932|NCT02231762|81759957|FG000|Combination Phase|Withdrawal by Subject|2|||
27575579|NCT01479621|80292908|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27575580|NCT01479621|80292909|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27575581|NCT01479621|80292910|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27575582|NCT01479621|80292904|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
27575583|NCT01479621|80292905|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27575584|NCT01479621|80292906|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27575585|NCT01479621|80292907|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27575586|NCT01479621|80292908|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27673146|NCT02484547|80639376|FG002|Long-Term Extension Period|Relocation|0|||
27673147|NCT02484547|80639377|FG003|Long-Term Extension Period|Relocation|1|||
27793119|NCT02322866|81072527|FG000|Overall Study|Noncompliance with Treatment|3|||
27793120|NCT02322866|81072528|FG001|Overall Study|Noncompliance with Treatment|4|||
27793121|NCT02322866|81072527|FG000|Overall Study|Lack of Efficacy|3|||
27793122|NCT02322866|81072528|FG001|Overall Study|Lack of Efficacy|1|||
27793123|NCT02322866|81072527|FG000|Overall Study|Other Miscellaneous Reasons|6|||
27793124|NCT02322866|81072528|FG001|Overall Study|Other Miscellaneous Reasons|6|||
27793125|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
27793126|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
27793127|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
27793128|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
27793129|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
27793130|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
27793131|NCT00828009|81072531|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
27793132|NCT00828009|81072531|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
27793133|NCT00828009|81072531|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
27793134|NCT00828009|81072531|FG000|Step 2 - Maintenance Therapy|Death|1|||
27793135|NCT00828009|81072531|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
27793136|NCT00828009|81072531|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
27979933|NCT02231762|81759958|FG001|Combination Phase|Withdrawal by Subject|0|||
27979934|NCT02231762|81759959|FG002|Combination Phase|Withdrawal by Subject|0|||
27979935|NCT02231762|81759960|FG003|Combination Phase|Withdrawal by Subject|0|||
27979936|NCT02231762|81759957|FG000|Combination Phase|Disease Progression|6|||
27979937|NCT02231762|81759958|FG001|Combination Phase|Disease Progression|0|||
27979938|NCT02231762|81759959|FG002|Combination Phase|Disease Progression|0|||
27979939|NCT02231762|81759960|FG003|Combination Phase|Disease Progression|0|||
27979940|NCT02231762|81759957|FG000|Combination Phase|Did not meet inclusion criteria|1|||
27979941|NCT02231762|81759958|FG001|Combination Phase|Did not meet inclusion criteria|0|||
27979942|NCT02231762|81759959|FG002|Combination Phase|Did not meet inclusion criteria|0|||
27979943|NCT02231762|81759960|FG003|Combination Phase|Did not meet inclusion criteria|0|||
27673148|NCT02484547|80639378|FG004|Long-Term Extension Period|Relocation|1|||
27673149|NCT02484547|80639379|FG005|Long-Term Extension Period|Relocation|0|||
27673150|NCT02484547|80639380|FG006|Long-Term Extension Period|Relocation|0|||
27673151|NCT02484547|80639374|FG000|Long-Term Extension Period|Study Visit Burden|0|||
27673152|NCT02484547|80639375|FG001|Long-Term Extension Period|Study Visit Burden|0|||
27673153|NCT02484547|80639376|FG002|Long-Term Extension Period|Study Visit Burden|0|||
27673154|NCT02484547|80639377|FG003|Long-Term Extension Period|Study Visit Burden|2|||
27979944|NCT02231762|81759957|FG000|Combination Phase|Protocol Violation|1|||
27979945|NCT02231762|81759958|FG001|Combination Phase|Protocol Violation|0|||
27575587|NCT01479621|80292909|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27575588|NCT01479621|80292910|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27575589|NCT01479621|80292904|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
27575590|NCT01479621|80292905|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27575591|NCT01479621|80292906|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27673155|NCT02484547|80639378|FG004|Long-Term Extension Period|Study Visit Burden|0|||
27673156|NCT02484547|80639379|FG005|Long-Term Extension Period|Study Visit Burden|0|||
27867711|NCT02211417|81349691|FG001|Overall Study|Lost to Follow-up|3|||
27867712|NCT02211417|81349690|FG000|Overall Study|Adverse Event|1|||
27867713|NCT02211417|81349691|FG001|Overall Study|Adverse Event|4|||
27867714|NCT03845296|81349693|FG000|Overall Study|On Treatment|2|||
27867715|NCT03845296|81349694|FG001|Overall Study|On Treatment|1|||
27867716|NCT03845296|81349693|FG000|Overall Study|Adverse Event|4|||
27867717|NCT03845296|81349694|FG001|Overall Study|Adverse Event|11|||
27867718|NCT03845296|81349693|FG000|Overall Study|Refusal unrelated to adverse event|0|||
27867719|NCT03845296|81349694|FG001|Overall Study|Refusal unrelated to adverse event|1|||
27867720|NCT03845296|81349693|FG000|Overall Study|Progression/relapse|14|||
27867721|NCT03845296|81349694|FG001|Overall Study|Progression/relapse|18|||
27867722|NCT03845296|81349693|FG000|Overall Study|Death|4|||
27867723|NCT03845296|81349694|FG001|Overall Study|Death|0|||
27867724|NCT03845296|81349693|FG000|Overall Study|Other - not protocol specified|1|||
27867725|NCT03845296|81349694|FG001|Overall Study|Other - not protocol specified|3|||
27867726|NCT03281876|81349697|FG000|Overall Study|Adverse Event|4|||
27867727|NCT03281876|81349698|FG001|Overall Study|Adverse Event|15|||
27867728|NCT03281876|81349697|FG000|Overall Study|Lost to Follow-up|1|||
27867729|NCT03281876|81349698|FG001|Overall Study|Lost to Follow-up|4|||
27867730|NCT03281876|81349697|FG000|Overall Study|Withdrawal by Subject|11|||
27867731|NCT03281876|81349698|FG001|Overall Study|Withdrawal by Subject|15|||
27867732|NCT03281876|81349697|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
27867733|NCT03281876|81349698|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27867734|NCT03281876|81349697|FG000|Overall Study|OTHER|5|||
27867735|NCT03281876|81349698|FG001|Overall Study|OTHER|5|||
27867736|NCT01427608|81349706|FG000|Overall Study|Death|1|||
27867737|NCT01427608|81349707|FG001|Overall Study|Death|0|||
27867738|NCT01427608|81349706|FG000|Overall Study|Withdrawal by Subject|7|||
27867739|NCT01427608|81349707|FG001|Overall Study|Withdrawal by Subject|3|||
27867740|NCT01427608|81349706|FG000|Overall Study|Relapsed-all cause|13|||
27867741|NCT01427608|81349707|FG001|Overall Study|Relapsed-all cause|34|||
27867742|NCT01427608|81349706|FG000|Overall Study|Events not attributed to study meds|0|||
27867743|NCT01427608|81349707|FG001|Overall Study|Events not attributed to study meds|1|||
27867744|NCT00626561|81349708|FG000|Overall Study|Withdrawal by Subject|2|||
27867745|NCT00626561|81349708|FG000|Overall Study|Disease Progression|2|||
27867746|NCT02892149|81349709|FG000|Overall Study|Death|262|||
27867747|NCT02892149|81349710|FG001|Overall Study|Death|278|||
27867748|NCT02892149|81349709|FG000|Overall Study|Withdrawal by Subject|53|||
27867749|NCT02892149|81349710|FG001|Overall Study|Withdrawal by Subject|47|||
27867750|NCT02892149|81349709|FG000|Overall Study|Lost to Follow-up|37|||
27867751|NCT02892149|81349710|FG001|Overall Study|Lost to Follow-up|31|||
27867752|NCT04238650|81349714|FG000|Overall Study|Withdrawal by Subject|0|||
27867753|NCT04238650|81349715|FG001|Overall Study|Withdrawal by Subject|1|||
27867754|NCT01106014|81349723|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
27867755|NCT01106014|81349724|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
27867756|NCT01106014|81349723|FG000|Overall Study|Adverse Event|78|||
27867757|NCT01106014|81349724|FG001|Overall Study|Adverse Event|42|||
27867758|NCT01106014|81349723|FG000|Overall Study|Withdrawal by Subject|43|||
27867759|NCT01106014|81349724|FG001|Overall Study|Withdrawal by Subject|37|||
27867760|NCT01106014|81349723|FG000|Overall Study|Administrative reason|7|||
27867761|NCT01106014|81349724|FG001|Overall Study|Administrative reason|6|||
27867762|NCT01106014|81349723|FG000|Overall Study|Lost to Follow-up|2|||
27867763|NCT01106014|81349724|FG001|Overall Study|Lost to Follow-up|3|||
27867764|NCT01478373|81349725|FG000|Treatment Phase|Protocol Violation|1|||
27867765|NCT01478373|81349725|FG000|Survival Phase|Adverse Event|8|||
27867766|NCT01478373|81349725|FG000|Survival Phase|Protocol Violation|1|||
27867767|NCT01478373|81349725|FG000|Survival Phase|crossover to another study|2|||
27867768|NCT01478373|81349725|FG000|Survival Phase|Progressive Disease|27|||
27867769|NCT03519087|81349726|FG000|Clinic Evaluation|Physician Decision|15|||
27867770|NCT03519087|81349727|FG001|Clinic Evaluation|Physician Decision|18|||
27867771|NCT03519087|81349728|FG002|Clinic Evaluation|Physician Decision|0|||
27867772|NCT03519087|81349729|FG003|Clinic Evaluation|Physician Decision|0|||
27867773|NCT03519087|81349730|FG004|Clinic Evaluation|Physician Decision|0|||
27867774|NCT03519087|81349726|FG000|Clinic Evaluation|Protocol Violation|1|||
27867775|NCT03519087|81349727|FG001|Clinic Evaluation|Protocol Violation|0|||
27867776|NCT03519087|81349728|FG002|Clinic Evaluation|Protocol Violation|0|||
27867777|NCT03519087|81349729|FG003|Clinic Evaluation|Protocol Violation|0|||
27867778|NCT03519087|81349730|FG004|Clinic Evaluation|Protocol Violation|0|||
27867779|NCT03519087|81349726|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
27867780|NCT03519087|81349727|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
27867781|NCT03519087|81349728|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
27867782|NCT03519087|81349729|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
27867783|NCT03519087|81349730|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
27867784|NCT03519087|81349726|FG000|Re-randomization for Treatment|Not appropriate|2|||
27867785|NCT03519087|81349727|FG001|Re-randomization for Treatment|Not appropriate|3|||
27867786|NCT03519087|81349728|FG002|Re-randomization for Treatment|Not appropriate|0|||
27867787|NCT03519087|81349729|FG003|Re-randomization for Treatment|Not appropriate|0|||
27867788|NCT03519087|81349730|FG004|Re-randomization for Treatment|Not appropriate|0|||
27867789|NCT03519087|81349726|FG000|Laboratory Testing|Lost to Follow-up|0|||
27867790|NCT03519087|81349727|FG001|Laboratory Testing|Lost to Follow-up|0|||
27867791|NCT03519087|81349728|FG002|Laboratory Testing|Lost to Follow-up|2|||
27867792|NCT03519087|81349729|FG003|Laboratory Testing|Lost to Follow-up|3|||
27867793|NCT03519087|81349730|FG004|Laboratory Testing|Lost to Follow-up|6|||
27867794|NCT03519087|81349726|FG000|Laboratory Testing|Protocol Violation|0|||
27867795|NCT03519087|81349727|FG001|Laboratory Testing|Protocol Violation|0|||
27867796|NCT03519087|81349728|FG002|Laboratory Testing|Protocol Violation|0|||
27867797|NCT03519087|81349729|FG003|Laboratory Testing|Protocol Violation|1|||
27867798|NCT03519087|81349730|FG004|Laboratory Testing|Protocol Violation|0|||
27867799|NCT00633243|81349732|FG000|Overall Study|Withdrawal by Subject|0|||
27867800|NCT00633243|81349733|FG001|Overall Study|Withdrawal by Subject|1|||
27867801|NCT00633243|81349732|FG000|Overall Study|incarceration|0|||
27867802|NCT00633243|81349733|FG001|Overall Study|incarceration|2|||
27867803|NCT00633243|81349732|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
27867804|NCT00633243|81349733|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
27867805|NCT00633243|81349732|FG000|Overall Study|Not comfortable with self-injecting|0|||
27867806|NCT00633243|81349733|FG001|Overall Study|Not comfortable with self-injecting|1|||
27867807|NCT00633243|81349732|FG000|Overall Study|Mental Health--Depression|0|||
27867808|NCT00633243|81349733|FG001|Overall Study|Mental Health--Depression|1|||
27867809|NCT00633243|81349732|FG000|Overall Study|Couldn't tolerate side-effects|1|||
27867810|NCT00633243|81349733|FG001|Overall Study|Couldn't tolerate side-effects|1|||
27867811|NCT01821807|81349734|FG000|Overall Study|Lost to Follow-up|3|||
27867812|NCT01821807|81349735|FG001|Overall Study|Lost to Follow-up|1|||
27867813|NCT04315506|81349738|FG000|Overall Study|Lost to Follow-up|74|||
27867814|NCT04315506|81349739|FG001|Overall Study|Lost to Follow-up|82|||
27867815|NCT04315506|81349738|FG000|Overall Study|Withdrawal by Subject|8|||
27867816|NCT04315506|81349739|FG001|Overall Study|Withdrawal by Subject|8|||
27867817|NCT04315506|81349738|FG000|Overall Study|Physician Decision|0|||
27867818|NCT04315506|81349739|FG001|Overall Study|Physician Decision|1|||
27867819|NCT02861014|81349740|FG000|Primary Analysis|Adverse Event|7|||
27867820|NCT02861014|81349740|FG000|Primary Analysis|Death|1|||
27867821|NCT02861014|81349740|FG000|Primary Analysis|Lack of Efficacy|3|||
27867822|NCT02861014|81349740|FG000|Primary Analysis|Physician Decision|2|||
27867823|NCT02861014|81349740|FG000|Primary Analysis|Pregnancy|4|||
27867824|NCT02861014|81349740|FG000|Primary Analysis|Protocol Violation|2|||
27867825|NCT02861014|81349740|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
27867826|NCT02861014|81349740|FG000|Primary Analysis|Withdrawal by Subject|14|||
27867827|NCT02861014|81349740|FG000|Primary Analysis|Commercial ocrelizumab|3|||
27867828|NCT02861014|81349740|FG000|Safety Follow-up|Adverse Event|1|||
27867829|NCT02861014|81349740|FG000|Safety Follow-up|Pregnancy|1|||
27867830|NCT02861014|81349740|FG000|Safety Follow-up|Withdrawal by Subject|9|||
27867831|NCT02861014|81349740|FG000|Safety Follow-up|Study terminated by sponsor|1|||
27867832|NCT02861014|81349740|FG000|Safety Follow-up|Physician Decision|1|||
27867833|NCT02861014|81349740|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
27867834|NCT02861014|81349740|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
27867835|NCT01924754|81349741|FG000|Overall Study|Lost to Follow-up|1|||
27867836|NCT01924754|81349742|FG001|Overall Study|Lost to Follow-up|2|||
27867837|NCT01924754|81349743|FG002|Overall Study|Lost to Follow-up|1|||
27867838|NCT01924754|81349741|FG000|Overall Study|Pregnancy|0|||
27867839|NCT01924754|81349742|FG001|Overall Study|Pregnancy|1|||
27867840|NCT01924754|81349743|FG002|Overall Study|Pregnancy|2|||
27979946|NCT02231762|81759959|FG002|Combination Phase|Protocol Violation|0|||
27867841|NCT04779879|81349745|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
27867842|NCT04779879|81349746|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
27867843|NCT04779879|81349747|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
27867844|NCT04779879|81349748|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
27867845|NCT04779879|81349749|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
27867846|NCT04779879|81349750|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
27867847|NCT04779879|81349745|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
27867848|NCT04779879|81349746|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
27867849|NCT04779879|81349747|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
27867850|NCT04779879|81349748|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
27867851|NCT04779879|81349749|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
27867852|NCT04779879|81349750|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
27867853|NCT04779879|81349745|FG000|Part C: Up to Week 36|Death|0|||
27867854|NCT04779879|81349746|FG001|Part C: Up to Week 36|Death|0|||
27867855|NCT04779879|81349747|FG002|Part C: Up to Week 36|Death|0|||
27867856|NCT04779879|81349748|FG003|Part C: Up to Week 36|Death|0|||
27867857|NCT04779879|81349749|FG004|Part C: Up to Week 36|Death|0|||
27867858|NCT04779879|81349750|FG005|Part C: Up to Week 36|Death|1|||
27867859|NCT04779879|81349745|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
27867860|NCT04779879|81349746|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
27867861|NCT04779879|81349747|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
27867862|NCT04779879|81349748|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
27867863|NCT04779879|81349749|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
27867864|NCT04779879|81349750|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
27867865|NCT04439201|81349751|FG000|Overall Study|Ineligible|2|||
27867866|NCT04439201|81349751|FG000|Overall Study|Never start protocol therapy|1|||
27979947|NCT02231762|81759960|FG003|Combination Phase|Protocol Violation|0|||
27979948|NCT02231762|81759957|FG000|Maintenance Phase|Disease progression|0|||
27979949|NCT02231762|81759958|FG001|Maintenance Phase|Disease progression|3|||
27979950|NCT02231762|81759959|FG002|Maintenance Phase|Disease progression|4|||
27673157|NCT02484547|80639380|FG006|Long-Term Extension Period|Study Visit Burden|3|||
27673158|NCT02484547|80639374|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27673159|NCT02484547|80639375|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27793137|NCT00828009|81072531|FG000|Step 2 - Maintenance Therapy|Other|1|||
27793138|NCT01432600|81072540|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
27793139|NCT01432600|81072541|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
27793140|NCT01432600|81072542|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
27793141|NCT03053102|81072543|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
27793142|NCT03053102|81072543|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
27793143|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
27979951|NCT02231762|81759960|FG003|Maintenance Phase|Disease progression|3|||
27979952|NCT02231762|81759957|FG000|Maintenance Phase|Adverse Event|0|||
27979953|NCT02231762|81759958|FG001|Maintenance Phase|Adverse Event|0|||
27979954|NCT02231762|81759959|FG002|Maintenance Phase|Adverse Event|1|||
27979955|NCT02231762|81759960|FG003|Maintenance Phase|Adverse Event|2|||
27673160|NCT02484547|80639376|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27673161|NCT02484547|80639377|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
27673162|NCT02484547|80639378|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
27793144|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
27793145|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Death|5|||
27793146|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Death|2|||
27793147|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
27673163|NCT02484547|80639379|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
27793148|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
27793149|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
27793150|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
27793151|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
27793152|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
27867867|NCT04439201|81349751|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
27979956|NCT02046070|81759961|FG000|Overall Study|Progressive Disease|18|||
27979957|NCT02046070|81759962|FG001|Overall Study|Progressive Disease|11|||
27979958|NCT02046070|81759963|FG002|Overall Study|Progressive Disease|40|||
27867868|NCT04439201|81349751|FG000|Overall Study|Mutation status not confirmed|4|||
27867869|NCT04439201|81349751|FG000|Overall Study|Adverse Event|1|||
27979959|NCT02046070|81759961|FG000|Overall Study|Adverse Event|8|||
27979960|NCT02046070|81759962|FG001|Overall Study|Adverse Event|10|||
27979961|NCT02046070|81759963|FG002|Overall Study|Adverse Event|17|||
27979962|NCT02046070|81759961|FG000|Overall Study|Withdrawal by Subject|1|||
27979963|NCT02046070|81759962|FG001|Overall Study|Withdrawal by Subject|2|||
27979964|NCT02046070|81759963|FG002|Overall Study|Withdrawal by Subject|6|||
27979965|NCT02046070|81759961|FG000|Overall Study|Study Terminated by Sponsor|1|||
27979966|NCT02046070|81759962|FG001|Overall Study|Study Terminated by Sponsor|1|||
27979967|NCT02046070|81759963|FG002|Overall Study|Study Terminated by Sponsor|1|||
27979968|NCT02046070|81759961|FG000|Overall Study|Reason not Specified|4|||
27979969|NCT02046070|81759962|FG001|Overall Study|Reason not Specified|4|||
27979970|NCT02046070|81759963|FG002|Overall Study|Reason not Specified|6|||
27979971|NCT02360293|81759964|FG000|Overall Study|Lost to Follow-up|73|||
27979972|NCT02360293|81759965|FG001|Overall Study|Lost to Follow-up|95|||
27979973|NCT02360293|81759964|FG000|Overall Study|Withdrawal by Subject|2|||
27979974|NCT02360293|81759965|FG001|Overall Study|Withdrawal by Subject|1|||
27979975|NCT02360293|81759964|FG000|Overall Study|Excluded|1|||
27979976|NCT02360293|81759965|FG001|Overall Study|Excluded|0|||
27979977|NCT00330928|81759966|FG000|Overall Study|Lost to Follow-up|6|||
27979978|NCT00330928|81759966|FG000|Overall Study|Physician Decision|9|||
27979979|NCT00330928|81759966|FG000|Overall Study|Death|1|||
27979980|NCT00330928|81759966|FG000|Overall Study|IVUS could not be performed.|1|||
27979981|NCT02855944|81759967|FG000|Period 1: Treatment|Ongoing|14|||
27979982|NCT02855944|81759968|FG001|Period 1: Treatment|Ongoing|0|||
27979983|NCT02855944|81759967|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
27979984|NCT02855944|81759968|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
27575592|NCT01479621|80292907|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27575593|NCT01479621|80292908|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27575594|NCT01479621|80292909|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27575595|NCT01479621|80292910|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27575596|NCT01479621|80292904|FG000|Treatment Period|Adverse Event|0|||
27575597|NCT01479621|80292905|FG001|Treatment Period|Adverse Event|0|||
27979985|NCT02855944|81759967|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
27979986|NCT02855944|81759968|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
27979987|NCT03662659|81759969|FG000|Pre-treatment|Participant no longer met study criteria|1|||
27979988|NCT03662659|81759970|FG001|Pre-treatment|Participant no longer met study criteria|1|||
27575598|NCT01479621|80292906|FG002|Treatment Period|Adverse Event|0|||
27575599|NCT01479621|80292907|FG003|Treatment Period|Adverse Event|0|||
27979989|NCT03662659|81759969|FG000|Pre-treatment|Other reasons|1|||
27979990|NCT03662659|81759970|FG001|Pre-treatment|Other reasons|0|||
27979991|NCT03662659|81759969|FG000|Treatment|Completed Treatment|0|||
27979992|NCT03662659|81759970|FG001|Treatment|Completed Treatment|3|||
27979993|NCT03662659|81759969|FG000|Treatment|Disease Progression|69|||
27979994|NCT03662659|81759970|FG001|Treatment|Disease Progression|78|||
27979995|NCT03662659|81759969|FG000|Treatment|Study Drug Toxicity|18|||
27979996|NCT03662659|81759970|FG001|Treatment|Study Drug Toxicity|8|||
27979997|NCT03662659|81759969|FG000|Treatment|Death|12|||
27979998|NCT03662659|81759970|FG001|Treatment|Death|7|||
27979999|NCT03662659|81759969|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
27980000|NCT03662659|81759970|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
27980001|NCT03662659|81759969|FG000|Treatment|Withdrawal by Subject|1|||
27980002|NCT03662659|81759970|FG001|Treatment|Withdrawal by Subject|1|||
27575600|NCT01479621|80292908|FG004|Treatment Period|Adverse Event|1|||
27575601|NCT01479621|80292909|FG005|Treatment Period|Adverse Event|2|||
27980003|NCT03662659|81759969|FG000|Treatment|Poor/Non-compliance|1|||
27980004|NCT03662659|81759970|FG001|Treatment|Poor/Non-compliance|0|||
27980005|NCT03662659|81759969|FG000|Treatment|Participant no longer meets study criteria|1|||
27980006|NCT03662659|81759970|FG001|Treatment|Participant no longer meets study criteria|0|||
27980007|NCT03662659|81759969|FG000|Treatment|Other reasons|6|||
27575602|NCT01479621|80292910|FG006|Treatment Period|Adverse Event|2|||
27980008|NCT03662659|81759970|FG001|Treatment|Other reasons|5|||
27980009|NCT00882908|81759973|FG000|Overall Study|Adverse Event|0|||
27980010|NCT00882908|81759974|FG001|Overall Study|Adverse Event|0|||
27980011|NCT00882908|81759975|FG002|Overall Study|Adverse Event|1|||
27980012|NCT00882908|81759976|FG003|Overall Study|Adverse Event|0|||
27980013|NCT00882908|81759977|FG004|Overall Study|Adverse Event|1|||
27980014|NCT00882908|81759973|FG000|Overall Study|Lost to Follow-up|3|||
27575603|NCT01479621|80292904|FG000|Treatment Period|Withdrawal by Subject|0|||
27575604|NCT01479621|80292905|FG001|Treatment Period|Withdrawal by Subject|4|||
27575605|NCT01479621|80292906|FG002|Treatment Period|Withdrawal by Subject|2|||
27575606|NCT01479621|80292907|FG003|Treatment Period|Withdrawal by Subject|2|||
27575607|NCT01479621|80292908|FG004|Treatment Period|Withdrawal by Subject|5|||
27575608|NCT01479621|80292909|FG005|Treatment Period|Withdrawal by Subject|5|||
27575609|NCT01479621|80292910|FG006|Treatment Period|Withdrawal by Subject|1|||
27575610|NCT01479621|80292904|FG000|Treatment Period|Physician Decision|0|||
27575611|NCT01479621|80292905|FG001|Treatment Period|Physician Decision|0|||
27575612|NCT01479621|80292906|FG002|Treatment Period|Physician Decision|0|||
27575613|NCT01479621|80292907|FG003|Treatment Period|Physician Decision|0|||
27575614|NCT01479621|80292908|FG004|Treatment Period|Physician Decision|1|||
27575615|NCT01479621|80292909|FG005|Treatment Period|Physician Decision|1|||
27575616|NCT01479621|80292910|FG006|Treatment Period|Physician Decision|0|||
27575617|NCT01479621|80292904|FG000|Treatment Period|Non-compliance to study drug|0|||
27575618|NCT01479621|80292905|FG001|Treatment Period|Non-compliance to study drug|1|||
27575619|NCT01479621|80292906|FG002|Treatment Period|Non-compliance to study drug|0|||
27575620|NCT01479621|80292907|FG003|Treatment Period|Non-compliance to study drug|0|||
27575621|NCT01479621|80292908|FG004|Treatment Period|Non-compliance to study drug|0|||
27575622|NCT01479621|80292909|FG005|Treatment Period|Non-compliance to study drug|0|||
27575623|NCT01479621|80292910|FG006|Treatment Period|Non-compliance to study drug|1|||
27575624|NCT01479621|80292904|FG000|Treatment Period|Protocol Violation|0|||
27575625|NCT01479621|80292905|FG001|Treatment Period|Protocol Violation|9|||
27793153|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Relapse|1|||
27793154|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Relapse|0|||
27793155|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
27575626|NCT01479621|80292906|FG002|Treatment Period|Protocol Violation|6|||
27575627|NCT01479621|80292907|FG003|Treatment Period|Protocol Violation|5|||
27575628|NCT01479621|80292908|FG004|Treatment Period|Protocol Violation|2|||
27575629|NCT01479621|80292909|FG005|Treatment Period|Protocol Violation|10|||
27575630|NCT01479621|80292910|FG006|Treatment Period|Protocol Violation|6|||
27575631|NCT01479621|80292904|FG000|Treatment Period|Pregnancy|0|||
27575632|NCT01479621|80292905|FG001|Treatment Period|Pregnancy|0|||
27575633|NCT01479621|80292906|FG002|Treatment Period|Pregnancy|2|||
27575634|NCT01479621|80292907|FG003|Treatment Period|Pregnancy|0|||
27575635|NCT01479621|80292908|FG004|Treatment Period|Pregnancy|0|||
27575636|NCT01479621|80292909|FG005|Treatment Period|Pregnancy|0|||
27575637|NCT01479621|80292910|FG006|Treatment Period|Pregnancy|0|||
27575638|NCT01479621|80292904|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
27575639|NCT01479621|80292905|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
27575640|NCT01479621|80292906|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
27575641|NCT01479621|80292907|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
27575642|NCT01479621|80292908|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
27575643|NCT01479621|80292909|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
27575644|NCT01479621|80292910|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
27575645|NCT01479621|80292904|FG000|Treatment Period|Lost to Follow-up|0|||
27575646|NCT01479621|80292905|FG001|Treatment Period|Lost to Follow-up|0|||
27575647|NCT01479621|80292906|FG002|Treatment Period|Lost to Follow-up|1|||
27575648|NCT01479621|80292907|FG003|Treatment Period|Lost to Follow-up|0|||
27575649|NCT01479621|80292908|FG004|Treatment Period|Lost to Follow-up|2|||
27575650|NCT01479621|80292909|FG005|Treatment Period|Lost to Follow-up|2|||
27575651|NCT01479621|80292910|FG006|Treatment Period|Lost to Follow-up|1|||
27575652|NCT01479621|80292904|FG000|Treatment Period|Met stopping criteria|0|||
27575653|NCT01479621|80292905|FG001|Treatment Period|Met stopping criteria|8|||
27575654|NCT01479621|80292906|FG002|Treatment Period|Met stopping criteria|7|||
27575655|NCT01479621|80292907|FG003|Treatment Period|Met stopping criteria|4|||
27575656|NCT01479621|80292908|FG004|Treatment Period|Met stopping criteria|9|||
27575657|NCT01479621|80292909|FG005|Treatment Period|Met stopping criteria|20|||
27575658|NCT01479621|80292910|FG006|Treatment Period|Met stopping criteria|6|||
27575659|NCT00910715|80292911|FG000|Overall Study|Lost to Follow-up|22|||
27575660|NCT00910715|80292912|FG001|Overall Study|Lost to Follow-up|26|||
27575661|NCT00910715|80292913|FG002|Overall Study|Lost to Follow-up|0|||
27575662|NCT03912233|80292914|FG000|Overall Study|Adverse Event|1|||
27575663|NCT03912233|80292915|FG001|Overall Study|Adverse Event|0|||
27575664|NCT03912233|80292916|FG002|Overall Study|Adverse Event|0|||
27575665|NCT03912233|80292917|FG003|Overall Study|Adverse Event|0|||
27575666|NCT03912233|80292918|FG004|Overall Study|Adverse Event|0|||
27673164|NCT02484547|80639380|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
27673165|NCT02484547|80639374|FG000|Long-Term Extension Period|Reason not Specified|0|||
27793156|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
27793157|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
27793158|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
27867870|NCT04439201|81349751|FG000|Overall Study|Death|7|||
27867871|NCT04439201|81349751|FG000|Overall Study|Withdrawal by Subject|2|||
27575667|NCT03912233|80292919|FG005|Overall Study|Adverse Event|0|||
27575668|NCT03912233|80292914|FG000|Overall Study|Physician Decision|1|||
27575669|NCT03912233|80292915|FG001|Overall Study|Physician Decision|0|||
27575670|NCT03912233|80292916|FG002|Overall Study|Physician Decision|0|||
27575671|NCT03912233|80292917|FG003|Overall Study|Physician Decision|0|||
27575672|NCT03912233|80292918|FG004|Overall Study|Physician Decision|0|||
27575673|NCT03912233|80292919|FG005|Overall Study|Physician Decision|0|||
27575674|NCT03912233|80292914|FG000|Overall Study|Other|0|||
27575675|NCT03912233|80292915|FG001|Overall Study|Other|0|||
27575676|NCT03912233|80292916|FG002|Overall Study|Other|0|||
27575677|NCT03912233|80292917|FG003|Overall Study|Other|0|||
27793159|NCT00111007|81072544|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
27793160|NCT00111007|81072545|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
27793161|NCT00111007|81072544|FG000|Active Follow-up|Adverse Event|1|||
27793162|NCT00111007|81072545|FG001|Active Follow-up|Adverse Event|0|||
27575678|NCT03912233|80292918|FG004|Overall Study|Other|7|||
27575679|NCT03912233|80292919|FG005|Overall Study|Other|12|||
27575680|NCT00589108|80292927|FG000|Overall Study|Lost to Follow-up|1|||
27575681|NCT00589108|80292928|FG001|Overall Study|Lost to Follow-up|1|||
27575682|NCT00589108|80292929|FG002|Overall Study|Lost to Follow-up|1|||
27575683|NCT00589108|80292927|FG000|Overall Study|Death|3|||
27575684|NCT00589108|80292928|FG001|Overall Study|Death|3|||
27575685|NCT00589108|80292929|FG002|Overall Study|Death|4|||
27575686|NCT01714310|80292930|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
27575687|NCT01714310|80292931|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
27575688|NCT01714310|80292932|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
27575689|NCT01714310|80292930|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
27575690|NCT01714310|80292931|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
27575691|NCT01714310|80292932|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
27575692|NCT01714310|80292930|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
27575693|NCT01714310|80292931|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
27575694|NCT01714310|80292932|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
27575695|NCT01714310|80292930|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
27575696|NCT01714310|80292931|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
27575697|NCT01714310|80292932|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
27575698|NCT01000051|80292942|FG000|Overall Study|Withdrawal by Subject|1|||
27575699|NCT01000051|80292943|FG001|Overall Study|Withdrawal by Subject|1|||
27575700|NCT01000051|80292942|FG000|Overall Study|Disease Progression|1|||
27575701|NCT01000051|80292943|FG001|Overall Study|Disease Progression|0|||
27575702|NCT01000051|80292942|FG000|Overall Study|Serious noncompliance|1|||
27575703|NCT01000051|80292943|FG001|Overall Study|Serious noncompliance|0|||
27575704|NCT03246958|80292947|FG000|Overall Study|Withdrawal by Subject|0|||
27575705|NCT03246958|80292948|FG001|Overall Study|Withdrawal by Subject|1|||
27575706|NCT03246958|80292949|FG002|Overall Study|Withdrawal by Subject|0|||
27575707|NCT03246958|80292950|FG003|Overall Study|Withdrawal by Subject|0|||
27575708|NCT03246958|80292951|FG004|Overall Study|Withdrawal by Subject|0|||
27575709|NCT03246958|80292952|FG005|Overall Study|Withdrawal by Subject|1|||
27575710|NCT03246958|80292953|FG006|Overall Study|Withdrawal by Subject|0|||
27575711|NCT03246958|80292947|FG000|Overall Study|Progression|13|||
27575712|NCT03246958|80292948|FG001|Overall Study|Progression|9|||
27575713|NCT03246958|80292949|FG002|Overall Study|Progression|3|||
27575714|NCT03246958|80292950|FG003|Overall Study|Progression|2|||
27575715|NCT03246958|80292951|FG004|Overall Study|Progression|1|||
27575716|NCT03246958|80292952|FG005|Overall Study|Progression|2|||
27575717|NCT03246958|80292953|FG006|Overall Study|Progression|1|||
27575718|NCT03246958|80292947|FG000|Overall Study|Adverse Event|2|||
27575719|NCT03246958|80292948|FG001|Overall Study|Adverse Event|2|||
27575720|NCT03246958|80292949|FG002|Overall Study|Adverse Event|0|||
27575721|NCT03246958|80292950|FG003|Overall Study|Adverse Event|1|||
27575722|NCT03246958|80292951|FG004|Overall Study|Adverse Event|1|||
27575723|NCT03246958|80292952|FG005|Overall Study|Adverse Event|0|||
27575724|NCT03246958|80292953|FG006|Overall Study|Adverse Event|2|||
27575725|NCT03246958|80292947|FG000|Overall Study|Death|0|||
27575726|NCT03246958|80292948|FG001|Overall Study|Death|1|||
27793163|NCT00111007|81072544|FG000|Active Follow-up|Death|2|||
27793164|NCT00111007|81072545|FG001|Active Follow-up|Death|0|||
27793165|NCT00111007|81072544|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
27793166|NCT00111007|81072545|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
27793167|NCT00111007|81072544|FG000|Long Term Follow-up|Death|34|||
27793168|NCT00111007|81072545|FG001|Long Term Follow-up|Death|39|||
27867872|NCT04439201|81349751|FG000|Overall Study|Disease progression|20|||
27575727|NCT03246958|80292949|FG002|Overall Study|Death|0|||
27575728|NCT03246958|80292950|FG003|Overall Study|Death|0|||
27575729|NCT03246958|80292951|FG004|Overall Study|Death|0|||
27575730|NCT03246958|80292952|FG005|Overall Study|Death|0|||
27575731|NCT03246958|80292953|FG006|Overall Study|Death|0|||
27575732|NCT03246958|80292947|FG000|Overall Study|Physician Decision|0|||
27575733|NCT03246958|80292948|FG001|Overall Study|Physician Decision|0|||
27793169|NCT00111007|81072544|FG000|Long Term Follow-up|Lost to Follow-up|1|||
27793170|NCT00111007|81072545|FG001|Long Term Follow-up|Lost to Follow-up|1|||
27793171|NCT00111007|81072544|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
27793172|NCT00111007|81072545|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
27793173|NCT00111007|81072544|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
27793174|NCT00111007|81072545|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
27793175|NCT00111007|81072544|FG000|Long Term Follow-up|Missing|10|||
27793176|NCT00111007|81072545|FG001|Long Term Follow-up|Missing|3|||
27793177|NCT04882085|81072546|FG000|Overall Study|Death|6|||
27793178|NCT04882085|81072547|FG001|Overall Study|Death|9|||
27793179|NCT04882085|81072546|FG000|Overall Study|Withdrawal by Subject|0|||
27793180|NCT04882085|81072547|FG001|Overall Study|Withdrawal by Subject|3|||
27793181|NCT04882085|81072546|FG000|Overall Study|Randomized not treated|1|||
27793182|NCT04882085|81072547|FG001|Overall Study|Randomized not treated|0|||
27793183|NCT03014570|81072548|FG000|Overall Study|COVID-19 Restrictions|38|||
27793184|NCT03014570|81072549|FG001|Overall Study|COVID-19 Restrictions|24|||
27793185|NCT03014570|81072548|FG000|Overall Study|Death|70|||
27793186|NCT03014570|81072549|FG001|Overall Study|Death|79|||
27793187|NCT03014570|81072548|FG000|Overall Study|Transfer from facility|11|||
27575734|NCT03246958|80292949|FG002|Overall Study|Physician Decision|0|||
27575735|NCT03246958|80292950|FG003|Overall Study|Physician Decision|1|||
27575736|NCT03246958|80292951|FG004|Overall Study|Physician Decision|0|||
27575737|NCT03246958|80292952|FG005|Overall Study|Physician Decision|0|||
27575738|NCT03246958|80292953|FG006|Overall Study|Physician Decision|0|||
27575739|NCT03246958|80292947|FG000|Overall Study|Never start treatment|1|||
27575740|NCT03246958|80292948|FG001|Overall Study|Never start treatment|0|||
27575741|NCT03246958|80292949|FG002|Overall Study|Never start treatment|0|||
27575742|NCT03246958|80292950|FG003|Overall Study|Never start treatment|0|||
27575743|NCT03246958|80292951|FG004|Overall Study|Never start treatment|0|||
27575744|NCT03246958|80292952|FG005|Overall Study|Never start treatment|0|||
27575745|NCT03246958|80292953|FG006|Overall Study|Never start treatment|0|||
27575746|NCT03246958|80292947|FG000|Overall Study|Over enrollment|0|||
27575747|NCT03246958|80292948|FG001|Overall Study|Over enrollment|2|||
27575748|NCT03246958|80292949|FG002|Overall Study|Over enrollment|0|||
27575749|NCT03246958|80292950|FG003|Overall Study|Over enrollment|0|||
27575750|NCT03246958|80292951|FG004|Overall Study|Over enrollment|0|||
27575751|NCT03246958|80292952|FG005|Overall Study|Over enrollment|0|||
27575752|NCT03246958|80292953|FG006|Overall Study|Over enrollment|0|||
27575753|NCT00451282|80292954|FG000|Overall Study|Lost to Follow-up|6|||
27575754|NCT00451282|80292955|FG001|Overall Study|Lost to Follow-up|5|||
27575755|NCT03235024|80292956|FG000|Overall Study|Adverse Event|2|||
27575756|NCT03235024|80292957|FG001|Overall Study|Adverse Event|2|||
27575757|NCT03235024|80292956|FG000|Overall Study|Death|1|||
27575758|NCT03235024|80292957|FG001|Overall Study|Death|0|||
27575759|NCT03235024|80292956|FG000|Overall Study|Lost to Follow-up|2|||
27575760|NCT03235024|80292957|FG001|Overall Study|Lost to Follow-up|5|||
27575761|NCT03235024|80292956|FG000|Overall Study|Protocol Violation|1|||
27575762|NCT03235024|80292957|FG001|Overall Study|Protocol Violation|0|||
27575763|NCT03235024|80292956|FG000|Overall Study|Withdrawal by Subject|0|||
27575764|NCT03235024|80292957|FG001|Overall Study|Withdrawal by Subject|3|||
27575765|NCT01777997|80292958|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
27575766|NCT01777997|80292958|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
27575767|NCT01777997|80292958|FG000|Weeks 48 to 72/96 on ART|Death|1|||
27575768|NCT01777997|80292958|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
27575769|NCT01470469|80292964|FG000|Overall Study|Withdrawal by Subject|4|||
27575770|NCT01470469|80292965|FG001|Overall Study|Withdrawal by Subject|6|||
27575771|NCT01470469|80292964|FG000|Overall Study|Lack of Efficacy|1|||
27575772|NCT01470469|80292965|FG001|Overall Study|Lack of Efficacy|7|||
27575773|NCT01470469|80292964|FG000|Overall Study|Adverse Event|0|||
27575774|NCT01470469|80292965|FG001|Overall Study|Adverse Event|7|||
27575775|NCT01470469|80292964|FG000|Overall Study|Lost to Follow-up|2|||
27793188|NCT03014570|81072549|FG001|Overall Study|Transfer from facility|14|||
27793189|NCT03014570|81072548|FG000|Overall Study|Hospitalized|5|||
27793190|NCT03014570|81072549|FG001|Overall Study|Hospitalized|3|||
27793191|NCT03014570|81072548|FG000|Overall Study|Transfer within facility|1|||
27980015|NCT00882908|81759974|FG001|Overall Study|Lost to Follow-up|5|||
27575776|NCT01470469|80292965|FG001|Overall Study|Lost to Follow-up|2|||
27575777|NCT01470469|80292964|FG000|Overall Study|Protocol Violation|1|||
27575778|NCT01470469|80292965|FG001|Overall Study|Protocol Violation|1|||
27575779|NCT01470469|80292964|FG000|Overall Study|Other|2|||
27575780|NCT01470469|80292965|FG001|Overall Study|Other|1|||
27793192|NCT03014570|81072549|FG001|Overall Study|Transfer within facility|0|||
27793193|NCT03014570|81072548|FG000|Overall Study|Site refusal|0|||
27793194|NCT03014570|81072549|FG001|Overall Study|Site refusal|11|||
27575781|NCT01986829|80292966|FG000|Overall Study|Death|1|||
27575782|NCT00080223|80292967|FG000|Overall Study|Adverse Event|23|||
27575783|NCT00080223|80292967|FG000|Overall Study|Death|21|||
27575784|NCT00080223|80292967|FG000|Overall Study|Withdrawal by Subject|13|||
27575785|NCT00080223|80292967|FG000|Overall Study|Lung Transplantation|9|||
27575786|NCT00080223|80292967|FG000|Overall Study|Non-compliance With Study Treatment|7|||
27575787|NCT00080223|80292967|FG000|Overall Study|Participant unwilling to continue|2|||
27575788|NCT00080223|80292967|FG000|Overall Study|Physician Decision|1|||
27575789|NCT00393939|80292968|FG000|Overall Study|Protocol Violation|1|||
27575790|NCT00393939|80292969|FG001|Overall Study|Protocol Violation|1|||
27575791|NCT00393939|80292968|FG000|Overall Study|Lost to Follow-up|2|||
27575792|NCT00393939|80292969|FG001|Overall Study|Lost to Follow-up|4|||
27575793|NCT00393939|80292968|FG000|Overall Study|Death|10|||
27575794|NCT00393939|80292969|FG001|Overall Study|Death|4|||
27575795|NCT00393939|80292968|FG000|Overall Study|Sponsor|5|||
27575796|NCT00393939|80292969|FG001|Overall Study|Sponsor|13|||
27575797|NCT00393939|80292968|FG000|Overall Study|Objective progression or relapse|239|||
27575798|NCT00393939|80292969|FG001|Overall Study|Objective progression or relapse|223|||
27575799|NCT00393939|80292968|FG000|Overall Study|Withdrawal by Subject|2|||
27575800|NCT00393939|80292969|FG001|Overall Study|Withdrawal by Subject|7|||
27575801|NCT00393939|80292968|FG000|Overall Study|Other|37|||
27575802|NCT00393939|80292969|FG001|Overall Study|Other|45|||
27575803|NCT04208412|80292974|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
27575804|NCT04208412|80292975|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
27575805|NCT04208412|80292974|FG000|Overall Study|Withdrawal by Subject|1|||
27575806|NCT04208412|80292975|FG001|Overall Study|Withdrawal by Subject|0|||
27575807|NCT04208412|80292974|FG000|Overall Study|Lost to Follow-up|0|||
27575808|NCT04208412|80292975|FG001|Overall Study|Lost to Follow-up|1|||
27575809|NCT02469610|80292976|FG000|Overall Study|Death|1|||
27575810|NCT02469610|80292977|FG001|Overall Study|Death|0|||
27575811|NCT02469610|80292976|FG000|Overall Study|Lost to Follow-up|1|||
27575812|NCT02469610|80292977|FG001|Overall Study|Lost to Follow-up|0|||
27575813|NCT02469610|80292976|FG000|Overall Study|exclusion criteria|2|||
27575814|NCT02469610|80292977|FG001|Overall Study|exclusion criteria|1|||
27575815|NCT00813124|80292980|FG000|Overall Study|Death|2|||
27575816|NCT00813124|80292980|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
27575817|NCT00813124|80292980|FG000|Overall Study|Withdrawal by Subject|1|||
27575818|NCT01701258|80292990|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
27575819|NCT01701258|80292991|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
27575820|NCT01701258|80292992|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
27575821|NCT01701258|80292993|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
27575822|NCT01701258|80292994|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
27575823|NCT01701258|80292995|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
27575824|NCT01701258|80292996|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
27575825|NCT01701258|80292997|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
27575826|NCT01701258|80292998|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
27575827|NCT01701258|80292999|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
27575828|NCT01701258|80293000|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
27575829|NCT01701258|80293001|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
27575830|NCT01701258|80293002|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
27575831|NCT01701258|80292990|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
27575832|NCT01701258|80292991|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
27575833|NCT01701258|80292992|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
27575834|NCT01701258|80292993|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
27575835|NCT01701258|80292994|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
27575836|NCT01701258|80292995|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
27575837|NCT01701258|80292996|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
27575838|NCT01701258|80292997|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
27575839|NCT01701258|80292998|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
27575840|NCT01701258|80292999|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
27575841|NCT01701258|80293000|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
27575842|NCT01701258|80293001|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
27575843|NCT01701258|80293002|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
27575844|NCT01701258|80292990|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
27575845|NCT01701258|80292991|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
27575846|NCT01701258|80292992|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
27575847|NCT01701258|80292993|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
27575848|NCT01701258|80292994|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
27575849|NCT01701258|80292995|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
27575850|NCT01701258|80292996|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
27575851|NCT01701258|80292997|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
27575852|NCT01701258|80292998|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
27575853|NCT01701258|80292999|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
27575854|NCT01701258|80293000|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
27980016|NCT00882908|81759975|FG002|Overall Study|Lost to Follow-up|3|||
27575855|NCT01701258|80293001|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
27575856|NCT01701258|80293002|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
27575857|NCT01701258|80292990|FG000|Assessment and Scheduling|Investigator Terminated|2|||
27575858|NCT01701258|80292991|FG001|Assessment and Scheduling|Investigator Terminated|0|||
27575859|NCT01701258|80292992|FG002|Assessment and Scheduling|Investigator Terminated|0|||
27575860|NCT01701258|80292993|FG003|Assessment and Scheduling|Investigator Terminated|0|||
27575861|NCT01701258|80292994|FG004|Assessment and Scheduling|Investigator Terminated|0|||
27575862|NCT01701258|80292995|FG005|Assessment and Scheduling|Investigator Terminated|0|||
27575863|NCT01701258|80292996|FG006|Assessment and Scheduling|Investigator Terminated|0|||
27575864|NCT01701258|80292997|FG007|Assessment and Scheduling|Investigator Terminated|0|||
27575865|NCT01701258|80292998|FG008|Assessment and Scheduling|Investigator Terminated|0|||
27575866|NCT01701258|80292999|FG009|Assessment and Scheduling|Investigator Terminated|0|||
27575867|NCT01701258|80293000|FG010|Assessment and Scheduling|Investigator Terminated|0|||
27575868|NCT01701258|80293001|FG011|Assessment and Scheduling|Investigator Terminated|0|||
27575869|NCT01701258|80293002|FG012|Assessment and Scheduling|Investigator Terminated|0|||
27575870|NCT03773757|80293003|FG000|Overall Study|Withdrawal by Subject|2|||
27575871|NCT03773757|80293004|FG001|Overall Study|Withdrawal by Subject|4|||
27575872|NCT00678561|80293007|FG000|Overall Study|Adverse Event|0|||
27575873|NCT00678561|80293008|FG001|Overall Study|Adverse Event|1|||
27575874|NCT00678561|80293009|FG002|Overall Study|Adverse Event|1|||
27575875|NCT00678561|80293010|FG003|Overall Study|Adverse Event|0|||
27575876|NCT00678561|80293011|FG004|Overall Study|Adverse Event|1|||
27575877|NCT00678561|80293012|FG005|Overall Study|Adverse Event|0|||
27575878|NCT00678561|80293013|FG006|Overall Study|Adverse Event|0|||
27575879|NCT00678561|80293014|FG007|Overall Study|Adverse Event|0|||
27575880|NCT00678561|80293007|FG000|Overall Study|Protocol Violation|0|||
27575881|NCT00678561|80293008|FG001|Overall Study|Protocol Violation|0|||
27575882|NCT00678561|80293009|FG002|Overall Study|Protocol Violation|0|||
27575883|NCT00678561|80293010|FG003|Overall Study|Protocol Violation|0|||
27575884|NCT00678561|80293011|FG004|Overall Study|Protocol Violation|1|||
27575885|NCT00678561|80293012|FG005|Overall Study|Protocol Violation|1|||
27575886|NCT00678561|80293013|FG006|Overall Study|Protocol Violation|0|||
27575887|NCT00678561|80293014|FG007|Overall Study|Protocol Violation|0|||
27575888|NCT00678561|80293007|FG000|Overall Study|Withdrawal by Subject|0|||
27575889|NCT00678561|80293008|FG001|Overall Study|Withdrawal by Subject|0|||
27575890|NCT00678561|80293009|FG002|Overall Study|Withdrawal by Subject|0|||
27575891|NCT00678561|80293010|FG003|Overall Study|Withdrawal by Subject|0|||
27575892|NCT00678561|80293011|FG004|Overall Study|Withdrawal by Subject|0|||
27575893|NCT00678561|80293012|FG005|Overall Study|Withdrawal by Subject|0|||
27575894|NCT00678561|80293013|FG006|Overall Study|Withdrawal by Subject|0|||
27575895|NCT00678561|80293014|FG007|Overall Study|Withdrawal by Subject|1|||
27575896|NCT00770120|80293015|FG000|Overall Study|Progression|31|||
27575897|NCT00770120|80293015|FG000|Overall Study|Adverse Event|11|||
27575898|NCT00770120|80293015|FG000|Overall Study|Not Protocol Specified|11|||
27575899|NCT00770120|80293015|FG000|Overall Study|Death|3|||
27575900|NCT00770120|80293015|FG000|Overall Study|Withdrawal by Subject|2|||
27575901|NCT00770120|80293015|FG000|Overall Study|Ineligible|1|||
27575902|NCT00770120|80293015|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
27575903|NCT00770120|80293015|FG000|Overall Study|Reason under Review|1|||
27575904|NCT01282216|80293016|FG000|Overall Study|Graft failure|0|||
27575905|NCT01282216|80293017|FG001|Overall Study|Graft failure|0|||
27575906|NCT01282216|80293018|FG002|Overall Study|Graft failure|3|||
27575907|NCT01282216|80293019|FG003|Overall Study|Graft failure|2|||
27575908|NCT01282216|80293016|FG000|Overall Study|Physician Decision|0|||
27575909|NCT01282216|80293017|FG001|Overall Study|Physician Decision|0|||
27575910|NCT01282216|80293018|FG002|Overall Study|Physician Decision|11|||
27575911|NCT01282216|80293019|FG003|Overall Study|Physician Decision|0|||
27575912|NCT01282216|80293016|FG000|Overall Study|Relapse|0|||
27575913|NCT01282216|80293017|FG001|Overall Study|Relapse|0|||
27575914|NCT01282216|80293018|FG002|Overall Study|Relapse|17|||
27575915|NCT01282216|80293019|FG003|Overall Study|Relapse|6|||
27575916|NCT01282216|80293016|FG000|Overall Study|Death|0|||
27575917|NCT01282216|80293017|FG001|Overall Study|Death|0|||
27575918|NCT01282216|80293018|FG002|Overall Study|Death|2|||
27793195|NCT01283009|81072550|FG000|Overall Study|Death|83|||
27575919|NCT01282216|80293019|FG003|Overall Study|Death|0|||
27575920|NCT02948842|80293020|FG000|Overall Study|Withdrawal by Subject|4|||
27575921|NCT02755831|80293021|FG000|Overall Study|Lost to Follow-up|3|||
27575922|NCT02755831|80293022|FG001|Overall Study|Lost to Follow-up|3|||
27575923|NCT03049813|80293024|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
27575924|NCT03049813|80293025|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
27793196|NCT01283009|81072551|FG001|Overall Study|Death|78|||
27575925|NCT03049813|80293026|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
27575926|NCT03049813|80293027|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
27575927|NCT03049813|80293024|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
27575928|NCT03049813|80293025|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
27575929|NCT03049813|80293026|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
27575930|NCT03049813|80293027|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
27575931|NCT03049813|80293024|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
27793197|NCT01283009|81072550|FG000|Overall Study|Study ended early|23|||
27575932|NCT03049813|80293025|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
27575933|NCT03049813|80293026|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
27575934|NCT03049813|80293027|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
27575935|NCT03049813|80293024|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
27575936|NCT03049813|80293025|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
27575937|NCT03049813|80293026|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
27575938|NCT03049813|80293027|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
27575939|NCT02460224|80293030|FG000|Overall Study|Adverse Event|0|||
27575940|NCT02460224|80293031|FG001|Overall Study|Adverse Event|0|||
27575941|NCT02460224|80293032|FG002|Overall Study|Adverse Event|0|||
27575942|NCT02460224|80293033|FG003|Overall Study|Adverse Event|0|||
27575943|NCT02460224|80293034|FG004|Overall Study|Adverse Event|0|||
27575944|NCT02460224|80293035|FG005|Overall Study|Adverse Event|0|||
27575945|NCT02460224|80293036|FG006|Overall Study|Adverse Event|1|||
27575946|NCT02460224|80293037|FG007|Overall Study|Adverse Event|0|||
27575947|NCT02460224|80293038|FG008|Overall Study|Adverse Event|0|||
27575948|NCT02460224|80293039|FG009|Overall Study|Adverse Event|0|||
27575949|NCT02460224|80293040|FG010|Overall Study|Adverse Event|0|||
27575950|NCT02460224|80293041|FG011|Overall Study|Adverse Event|0|||
27575951|NCT02460224|80293042|FG012|Overall Study|Adverse Event|1|||
27575952|NCT02460224|80293043|FG013|Overall Study|Adverse Event|0|||
27575953|NCT02460224|80293044|FG014|Overall Study|Adverse Event|0|||
27575954|NCT02460224|80293045|FG015|Overall Study|Adverse Event|0|||
27575955|NCT02460224|80293046|FG016|Overall Study|Adverse Event|1|||
27575956|NCT02460224|80293047|FG017|Overall Study|Adverse Event|0|||
27575957|NCT02460224|80293048|FG018|Overall Study|Adverse Event|1|||
27575958|NCT02460224|80293049|FG019|Overall Study|Adverse Event|0|||
27575959|NCT02460224|80293050|FG020|Overall Study|Adverse Event|1|||
27575960|NCT02460224|80293051|FG021|Overall Study|Adverse Event|1|||
27575961|NCT02460224|80293052|FG022|Overall Study|Adverse Event|1|||
27575962|NCT02460224|80293053|FG023|Overall Study|Adverse Event|0|||
27575963|NCT02460224|80293054|FG024|Overall Study|Adverse Event|0|||
27575964|NCT02460224|80293055|FG025|Overall Study|Adverse Event|0|||
27575965|NCT02460224|80293056|FG026|Overall Study|Adverse Event|11|||
27575966|NCT02460224|80293057|FG027|Overall Study|Adverse Event|1|||
27575967|NCT02460224|80293058|FG028|Overall Study|Adverse Event|6|||
27575968|NCT02460224|80293030|FG000|Overall Study|Death|0|||
27575969|NCT02460224|80293031|FG001|Overall Study|Death|0|||
27575970|NCT02460224|80293032|FG002|Overall Study|Death|0|||
27575971|NCT02460224|80293033|FG003|Overall Study|Death|0|||
27575972|NCT02460224|80293034|FG004|Overall Study|Death|0|||
27575973|NCT02460224|80293035|FG005|Overall Study|Death|2|||
27575974|NCT02460224|80293036|FG006|Overall Study|Death|1|||
27575975|NCT02460224|80293037|FG007|Overall Study|Death|0|||
27575976|NCT02460224|80293038|FG008|Overall Study|Death|0|||
27575977|NCT02460224|80293039|FG009|Overall Study|Death|1|||
27575978|NCT02460224|80293040|FG010|Overall Study|Death|0|||
27575979|NCT02460224|80293041|FG011|Overall Study|Death|0|||
27575980|NCT02460224|80293042|FG012|Overall Study|Death|0|||
27575981|NCT02460224|80293043|FG013|Overall Study|Death|1|||
27575982|NCT02460224|80293044|FG014|Overall Study|Death|0|||
27575983|NCT02460224|80293045|FG015|Overall Study|Death|0|||
27575984|NCT02460224|80293046|FG016|Overall Study|Death|2|||
27575985|NCT02460224|80293047|FG017|Overall Study|Death|1|||
27575986|NCT02460224|80293048|FG018|Overall Study|Death|0|||
27575987|NCT02460224|80293049|FG019|Overall Study|Death|2|||
27575988|NCT02460224|80293050|FG020|Overall Study|Death|0|||
27575989|NCT02460224|80293051|FG021|Overall Study|Death|0|||
27575990|NCT02460224|80293052|FG022|Overall Study|Death|0|||
27575991|NCT02460224|80293053|FG023|Overall Study|Death|0|||
27575992|NCT02460224|80293054|FG024|Overall Study|Death|1|||
27575993|NCT02460224|80293055|FG025|Overall Study|Death|1|||
27575994|NCT02460224|80293056|FG026|Overall Study|Death|5|||
27575995|NCT02460224|80293057|FG027|Overall Study|Death|0|||
27575996|NCT02460224|80293058|FG028|Overall Study|Death|1|||
27575997|NCT02460224|80293030|FG000|Overall Study|Lost to Follow-up|0|||
27575998|NCT02460224|80293031|FG001|Overall Study|Lost to Follow-up|0|||
27575999|NCT02460224|80293032|FG002|Overall Study|Lost to Follow-up|0|||
27673166|NCT02484547|80639375|FG001|Long-Term Extension Period|Reason not Specified|0|||
27673167|NCT02484547|80639376|FG002|Long-Term Extension Period|Reason not Specified|0|||
27980017|NCT00882908|81759976|FG003|Overall Study|Lost to Follow-up|1|||
27576000|NCT02460224|80293033|FG003|Overall Study|Lost to Follow-up|0|||
27576001|NCT02460224|80293034|FG004|Overall Study|Lost to Follow-up|0|||
27576002|NCT02460224|80293035|FG005|Overall Study|Lost to Follow-up|0|||
27576003|NCT02460224|80293036|FG006|Overall Study|Lost to Follow-up|0|||
27576004|NCT02460224|80293037|FG007|Overall Study|Lost to Follow-up|0|||
27576005|NCT02460224|80293038|FG008|Overall Study|Lost to Follow-up|0|||
27576006|NCT02460224|80293039|FG009|Overall Study|Lost to Follow-up|0|||
27576007|NCT02460224|80293040|FG010|Overall Study|Lost to Follow-up|0|||
27576008|NCT02460224|80293041|FG011|Overall Study|Lost to Follow-up|0|||
27576009|NCT02460224|80293042|FG012|Overall Study|Lost to Follow-up|0|||
27673168|NCT02484547|80639377|FG003|Long-Term Extension Period|Reason not Specified|119|||
27673169|NCT02484547|80639378|FG004|Long-Term Extension Period|Reason not Specified|117|||
27673170|NCT02484547|80639379|FG005|Long-Term Extension Period|Reason not Specified|223|||
27673171|NCT02484547|80639380|FG006|Long-Term Extension Period|Reason not Specified|231|||
27673172|NCT01657799|80639381|FG000|Overall Study|Adverse Event Related to progression|6|||
27673173|NCT01657799|80639382|FG001|Overall Study|Adverse Event Related to progression|8|||
27673174|NCT01657799|80639383|FG002|Overall Study|Adverse Event Related to progression|12|||
27673175|NCT01657799|80639381|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
27673176|NCT01657799|80639382|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
27673177|NCT01657799|80639383|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
27673178|NCT01657799|80639381|FG000|Overall Study|Withdrawal by Subject|13|||
27673179|NCT01657799|80639382|FG001|Overall Study|Withdrawal by Subject|10|||
27673180|NCT01657799|80639383|FG002|Overall Study|Withdrawal by Subject|10|||
27673181|NCT01657799|80639381|FG000|Overall Study|Lost to Follow-up|1|||
27673182|NCT01657799|80639382|FG001|Overall Study|Lost to Follow-up|0|||
27673183|NCT01657799|80639383|FG002|Overall Study|Lost to Follow-up|1|||
27673184|NCT01657799|80639381|FG000|Overall Study|Disease Progression|2|||
27673185|NCT01657799|80639382|FG001|Overall Study|Disease Progression|4|||
27673186|NCT01657799|80639383|FG002|Overall Study|Disease Progression|4|||
27673187|NCT01657799|80639381|FG000|Overall Study|Progressive Disease Clinical|7|||
27673188|NCT01657799|80639382|FG001|Overall Study|Progressive Disease Clinical|4|||
27673189|NCT01657799|80639383|FG002|Overall Study|Progressive Disease Clinical|7|||
27673190|NCT01657799|80639381|FG000|Overall Study|Radiographic & Clinical Progression|16|||
27673191|NCT01657799|80639382|FG001|Overall Study|Radiographic & Clinical Progression|11|||
27673192|NCT01657799|80639383|FG002|Overall Study|Radiographic & Clinical Progression|15|||
27673193|NCT01657799|80639381|FG000|Overall Study|Other|52|||
27673194|NCT01657799|80639382|FG001|Overall Study|Other|62|||
27673195|NCT01657799|80639383|FG002|Overall Study|Other|49|||
27673196|NCT02161406|80639387|FG000|Overall Study|Death|2|||
27673197|NCT02161406|80639388|FG001|Overall Study|Death|1|||
27673198|NCT02161406|80639387|FG000|Overall Study|Lost to Follow-up|2|||
27673199|NCT02161406|80639388|FG001|Overall Study|Lost to Follow-up|1|||
27673200|NCT02161406|80639387|FG000|Overall Study|Withdrawal by Subject|2|||
27673201|NCT02161406|80639388|FG001|Overall Study|Withdrawal by Subject|4|||
27673202|NCT02161406|80639387|FG000|Overall Study|investigator withdrew subject|3|||
27673203|NCT02161406|80639388|FG001|Overall Study|investigator withdrew subject|1|||
27673204|NCT02161406|80639387|FG000|Overall Study|Lack of Efficacy|1|||
27673205|NCT02161406|80639388|FG001|Overall Study|Lack of Efficacy|1|||
27673206|NCT02161406|80639387|FG000|Overall Study|relocation|0|||
27673207|NCT02161406|80639388|FG001|Overall Study|relocation|1|||
27673208|NCT02031536|80639389|FG000|Overall Study|ineligible|1|||
27673209|NCT02031536|80639390|FG001|Overall Study|ineligible|0|||
27673210|NCT00420784|80639391|FG000|Overall Study|Adverse Event|11|||
27673211|NCT00420784|80639392|FG001|Overall Study|Adverse Event|29|||
27673212|NCT00420784|80639393|FG002|Overall Study|Adverse Event|10|||
27673213|NCT00420784|80639394|FG003|Overall Study|Adverse Event|5|||
27673214|NCT00420784|80639391|FG000|Overall Study|Withdrawal by Subject|0|||
27673215|NCT00420784|80639392|FG001|Overall Study|Withdrawal by Subject|1|||
27980018|NCT00882908|81759977|FG004|Overall Study|Lost to Follow-up|2|||
27980019|NCT00882908|81759973|FG000|Overall Study|Protocol Violation|0|||
27980020|NCT00882908|81759974|FG001|Overall Study|Protocol Violation|1|||
27673216|NCT00420784|80639393|FG002|Overall Study|Withdrawal by Subject|0|||
27673217|NCT00420784|80639394|FG003|Overall Study|Withdrawal by Subject|0|||
27673218|NCT00420784|80639391|FG000|Overall Study|Lost to Follow-up|0|||
27673219|NCT00420784|80639392|FG001|Overall Study|Lost to Follow-up|0|||
27673220|NCT00420784|80639393|FG002|Overall Study|Lost to Follow-up|2|||
27673221|NCT00420784|80639394|FG003|Overall Study|Lost to Follow-up|1|||
27673222|NCT00420784|80639391|FG000|Overall Study|Virologic Stopping Rule|17|||
27673223|NCT00420784|80639392|FG001|Overall Study|Virologic Stopping Rule|26|||
27673224|NCT00420784|80639393|FG002|Overall Study|Virologic Stopping Rule|41|||
27673225|NCT00420784|80639394|FG003|Overall Study|Virologic Stopping Rule|67|||
27980021|NCT00882908|81759975|FG002|Overall Study|Protocol Violation|0|||
27980022|NCT00882908|81759976|FG003|Overall Study|Protocol Violation|0|||
27980023|NCT00882908|81759977|FG004|Overall Study|Protocol Violation|0|||
27673226|NCT00420784|80639391|FG000|Overall Study|Other|1|||
27673227|NCT00420784|80639392|FG001|Overall Study|Other|2|||
27673228|NCT00420784|80639393|FG002|Overall Study|Other|0|||
27673229|NCT00420784|80639394|FG003|Overall Study|Other|5|||
27673230|NCT02630706|80639397|FG000|Overall Study|Adverse Event|2|||
27673231|NCT02630706|80639398|FG001|Overall Study|Adverse Event|1|||
27673232|NCT02630706|80639399|FG002|Overall Study|Adverse Event|1|||
27673233|NCT02630706|80639397|FG000|Overall Study|Lost to Follow-up|0|||
27673234|NCT02630706|80639398|FG001|Overall Study|Lost to Follow-up|1|||
27673235|NCT02630706|80639399|FG002|Overall Study|Lost to Follow-up|2|||
27576010|NCT02460224|80293043|FG013|Overall Study|Lost to Follow-up|0|||
27673236|NCT02630706|80639397|FG000|Overall Study|Physician Decision|1|||
27980024|NCT00882908|81759973|FG000|Overall Study|Withdrawal by Subject|0|||
27980025|NCT00882908|81759974|FG001|Overall Study|Withdrawal by Subject|0|||
27673237|NCT02630706|80639398|FG001|Overall Study|Physician Decision|1|||
27673238|NCT02630706|80639399|FG002|Overall Study|Physician Decision|0|||
27980026|NCT00882908|81759975|FG002|Overall Study|Withdrawal by Subject|3|||
27980027|NCT00882908|81759976|FG003|Overall Study|Withdrawal by Subject|5|||
27980028|NCT00882908|81759977|FG004|Overall Study|Withdrawal by Subject|2|||
27980029|NCT00882908|81759973|FG000|Overall Study|Subject reached a virologic endpoint|0|||
27980030|NCT00882908|81759974|FG001|Overall Study|Subject reached a virologic endpoint|0|||
27980031|NCT00882908|81759975|FG002|Overall Study|Subject reached a virologic endpoint|0|||
27980032|NCT00882908|81759976|FG003|Overall Study|Subject reached a virologic endpoint|0|||
27980033|NCT00882908|81759977|FG004|Overall Study|Subject reached a virologic endpoint|1|||
27980034|NCT00882908|81759973|FG000|Overall Study|Study terminated in error|0|||
27980035|NCT00882908|81759974|FG001|Overall Study|Study terminated in error|0|||
27980036|NCT00882908|81759975|FG002|Overall Study|Study terminated in error|0|||
27980037|NCT00882908|81759976|FG003|Overall Study|Study terminated in error|1|||
27980038|NCT00882908|81759977|FG004|Overall Study|Study terminated in error|0|||
27980039|NCT02449018|81759978|FG000|Overall Study|Abnormal laboratory value|0|||
27980040|NCT02449018|81759979|FG001|Overall Study|Abnormal laboratory value|1|||
27980041|NCT02449018|81759978|FG000|Overall Study|Administrative problems|1|||
27980042|NCT02449018|81759979|FG001|Overall Study|Administrative problems|0|||
27980043|NCT02449018|81759978|FG000|Overall Study|Adverse Event|5|||
27980044|NCT02449018|81759979|FG001|Overall Study|Adverse Event|1|||
27980045|NCT02449018|81759978|FG000|Overall Study|Protocol deviation|4|||
27980046|NCT02449018|81759979|FG001|Overall Study|Protocol deviation|0|||
27980047|NCT02449018|81759978|FG000|Overall Study|Patient decision|2|||
27980048|NCT02449018|81759979|FG001|Overall Study|Patient decision|0|||
27980049|NCT01304329|81759981|FG000|Third Intervention (3 Days)|Adverse Event|0|||
27980050|NCT01304329|81759982|FG001|Third Intervention (3 Days)|Adverse Event|1|||
27980051|NCT01304329|81759983|FG002|Third Intervention (3 Days)|Adverse Event|0|||
27980052|NCT01304329|81759984|FG003|Third Intervention (3 Days)|Adverse Event|0|||
27980053|NCT01304329|81759985|FG004|Third Intervention (3 Days)|Adverse Event|0|||
27980054|NCT01304329|81759986|FG005|Third Intervention (3 Days)|Adverse Event|0|||
27980055|NCT03426631|81759987|FG000|Overall Study|Lost to Follow-up|0|||
27980056|NCT03426631|81759988|FG001|Overall Study|Lost to Follow-up|1|||
27980057|NCT00456599|81759991|FG000|Overall Study|Non-compliance|1|||
27980058|NCT00456599|81759991|FG000|Overall Study|Withdrawal by Subject|2|||
27980059|NCT00823212|81760001|FG000|Overall Study|Death|8|||
27980060|NCT00823212|81760002|FG001|Overall Study|Death|10|||
27980061|NCT00823212|81760001|FG000|Overall Study|Withdrawal by Subject|6|||
27980062|NCT00823212|81760002|FG001|Overall Study|Withdrawal by Subject|1|||
27980063|NCT00823212|81760001|FG000|Overall Study|Incarcerated|0|||
27980064|NCT00823212|81760002|FG001|Overall Study|Incarcerated|1|||
27980065|NCT00823212|81760001|FG000|Overall Study|Missed 12-month visit|21|||
27980066|NCT00823212|81760002|FG001|Overall Study|Missed 12-month visit|21|||
27980067|NCT03464422|81760003|FG000|Overall Study|Lost to Follow-up|2|||
27980068|NCT03464422|81760003|FG000|Overall Study|Withdrawal by Subject|2|||
27980069|NCT02654236|81760004|FG000|Overall Study|Withdrawal by Subject|0|||
27980070|NCT02654236|81760005|FG001|Overall Study|Withdrawal by Subject|0|||
27980071|NCT02654236|81760006|FG002|Overall Study|Withdrawal by Subject|2|||
27980072|NCT02421601|81760007|FG000|Overall Study|Adverse Event|4|||
27980073|NCT02421601|81760007|FG000|Overall Study|Lack of Efficacy|5|||
27980074|NCT02421601|81760007|FG000|Overall Study|Physician Decision|1|||
27980075|NCT02421601|81760007|FG000|Overall Study|Withdrawal by Subject|31|||
27980076|NCT02421601|81760007|FG000|Overall Study|Others|41|||
27980077|NCT04047420|81760009|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
27980078|NCT04047420|81760009|FG000|Washout Period|Refused Participation|2|||
27673239|NCT02630706|80639397|FG000|Overall Study|Pregnancy|0|||
27673240|NCT02630706|80639398|FG001|Overall Study|Pregnancy|1|||
27673241|NCT02630706|80639399|FG002|Overall Study|Pregnancy|0|||
27673242|NCT02630706|80639397|FG000|Overall Study|Withdrawal by Subject|4|||
27980079|NCT02012686|81760010|FG000|Overall Study|muscle contraction|0|||
27980080|NCT02012686|81760011|FG001|Overall Study|muscle contraction|1|||
27980081|NCT02012686|81760010|FG000|Overall Study|electrocardiography monitoring noise|0|||
27980082|NCT02012686|81760011|FG001|Overall Study|electrocardiography monitoring noise|1|||
27980083|NCT00432744|81760017|FG000|Months 0-6|Withdrawal by Subject|4|||
27980084|NCT00432744|81760018|FG001|Months 0-6|Withdrawal by Subject|4|||
27980085|NCT00432744|81760017|FG000|Months 0-6|Too disabled to score|1|||
27980086|NCT00432744|81760018|FG001|Months 0-6|Too disabled to score|0|||
27980087|NCT00432744|81760017|FG000|Months 7 - 12|Withdrawal by Subject|1|||
27980088|NCT00432744|81760018|FG001|Months 7 - 12|Withdrawal by Subject|0|||
27980089|NCT00432744|81760017|FG000|Months 7 - 12|Too disabled to score|0|||
27980090|NCT00432744|81760018|FG001|Months 7 - 12|Too disabled to score|1|||
27980091|NCT03099148|81760019|FG000|Wash-out|scheduling conflict|0|||
27980092|NCT03099148|81760020|FG001|Wash-out|scheduling conflict|1|||
27980093|NCT03099148|81760021|FG002|Wash-out|scheduling conflict|0|||
27980094|NCT03099148|81760022|FG003|Wash-out|scheduling conflict|0|||
27980095|NCT03099148|81760019|FG000|Wash-out|Adverse Event|0|||
27980096|NCT03099148|81760020|FG001|Wash-out|Adverse Event|1|||
27673243|NCT02630706|80639398|FG001|Overall Study|Withdrawal by Subject|5|||
27673244|NCT02630706|80639399|FG002|Overall Study|Withdrawal by Subject|7|||
27673245|NCT02166476|80639400|FG000|Overall Study|Withdrawal by Subject|5|||
27673246|NCT02166476|80639401|FG001|Overall Study|Withdrawal by Subject|7|||
27673247|NCT02166476|80639400|FG000|Overall Study|Adverse Event|3|||
27673248|NCT02166476|80639401|FG001|Overall Study|Adverse Event|3|||
27673249|NCT02166476|80639400|FG000|Overall Study|Lost to Follow-up|5|||
27980097|NCT03099148|81760021|FG002|Wash-out|Adverse Event|0|||
27980098|NCT03099148|81760022|FG003|Wash-out|Adverse Event|0|||
27980099|NCT01754194|81760023|FG000|Overall Study|Lost to Follow-up|39|||
27980100|NCT01754194|81760024|FG001|Overall Study|Lost to Follow-up|14|||
27980101|NCT01754194|81760023|FG000|Overall Study|Withdrawal by Subject|4|||
27980102|NCT01754194|81760024|FG001|Overall Study|Withdrawal by Subject|5|||
27980103|NCT01754194|81760023|FG000|Overall Study|Other|9|||
27980104|NCT01754194|81760024|FG001|Overall Study|Other|8|||
27980105|NCT00654004|81760027|FG000|Overall Study|Lost to Follow-up|1|||
27980106|NCT00654004|81760028|FG001|Overall Study|Lost to Follow-up|0|||
27673250|NCT02166476|80639401|FG001|Overall Study|Lost to Follow-up|10|||
27673251|NCT02166476|80639400|FG000|Overall Study|Physician Decision|1|||
27673252|NCT02166476|80639401|FG001|Overall Study|Physician Decision|0|||
27673253|NCT02166476|80639400|FG000|Overall Study|Unable to Come for Visit|0|||
27673254|NCT02166476|80639401|FG001|Overall Study|Unable to Come for Visit|3|||
27673255|NCT03024996|80639402|FG000|Overall Study|Death|57|||
27673256|NCT03024996|80639403|FG001|Overall Study|Death|55|||
27673257|NCT03024996|80639402|FG000|Overall Study|Disease relapse|1|||
27673258|NCT03024996|80639403|FG001|Overall Study|Disease relapse|0|||
27673259|NCT03024996|80639402|FG000|Overall Study|Lost to Follow-up|5|||
27673260|NCT03024996|80639403|FG001|Overall Study|Lost to Follow-up|10|||
27673261|NCT03024996|80639402|FG000|Overall Study|Other|3|||
27673262|NCT03024996|80639403|FG001|Overall Study|Other|3|||
27673263|NCT03024996|80639402|FG000|Overall Study|Physician Decision|0|||
27673264|NCT03024996|80639403|FG001|Overall Study|Physician Decision|1|||
27673265|NCT03024996|80639402|FG000|Overall Study|Study terminated by sponsor|303|||
27673266|NCT03024996|80639403|FG001|Overall Study|Study terminated by sponsor|283|||
27673267|NCT03024996|80639402|FG000|Overall Study|Withdrawal by Subject|21|||
27673268|NCT03024996|80639403|FG001|Overall Study|Withdrawal by Subject|36|||
27673269|NCT00856245|80639404|FG000|Overall Study|Was not transplanted|5|||
27673270|NCT00356759|80639405|FG000|Overall Study|Death|5|||
27673271|NCT00356759|80639406|FG001|Overall Study|Death|2|||
27673272|NCT00356759|80639405|FG000|Overall Study|Withdrawal by Subject|2|||
27673273|NCT00356759|80639406|FG001|Overall Study|Withdrawal by Subject|2|||
27673274|NCT00356759|80639405|FG000|Overall Study|Adverse Event|1|||
27673275|NCT00356759|80639406|FG001|Overall Study|Adverse Event|3|||
27673276|NCT00356759|80639405|FG000|Overall Study|Lost to Follow-up|1|||
27673277|NCT00356759|80639406|FG001|Overall Study|Lost to Follow-up|1|||
27673278|NCT00356759|80639405|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
27673279|NCT00356759|80639406|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
27673280|NCT01536171|80639407|FG000|Overall Study|Withdrawal by Subject|1|||
27673281|NCT02312206|80639408|FG000|Overall Study|Adverse Event|3|||
27673282|NCT02312206|80639409|FG001|Overall Study|Adverse Event|6|||
27673283|NCT02312206|80639408|FG000|Overall Study|Withdrawal by Subject|6|||
27673284|NCT02312206|80639409|FG001|Overall Study|Withdrawal by Subject|6|||
27867873|NCT04439201|81349751|FG000|Overall Study|Alternative therapy|1|||
27867874|NCT04439201|81349751|FG000|Overall Study|Physician Decision|1|||
27867875|NCT01320293|81349752|FG000|Overall Study|Lack of Efficacy|1|||
27673285|NCT02312206|80639408|FG000|Overall Study|Physician Decision|7|||
27673286|NCT02312206|80639409|FG001|Overall Study|Physician Decision|6|||
27673287|NCT02312206|80639408|FG000|Overall Study|Death|31|||
27673288|NCT02312206|80639409|FG001|Overall Study|Death|36|||
27673289|NCT02312206|80639408|FG000|Overall Study|Study Terminated by Sponsor|81|||
27673290|NCT02312206|80639409|FG001|Overall Study|Study Terminated by Sponsor|74|||
27673291|NCT02312206|80639408|FG000|Overall Study|Patient transferred to hospice|0|||
27673292|NCT02312206|80639409|FG001|Overall Study|Patient transferred to hospice|1|||
27673293|NCT02312206|80639408|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
27673294|NCT02312206|80639409|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
27673295|NCT02312206|80639408|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
27673296|NCT02312206|80639409|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
27673297|NCT02312206|80639408|FG000|Overall Study|Disease Progression|1|||
27980107|NCT00033540|81760029|FG000|Overall Study|Adverse Event|14|||
27673298|NCT02312206|80639409|FG001|Overall Study|Disease Progression|0|||
27673299|NCT04927364|80639411|FG000|Overall Study|Withdrawal by Subject|3|||
27793198|NCT01283009|81072551|FG001|Overall Study|Study ended early|26|||
27980108|NCT00033540|81760029|FG000|Overall Study|Death|1|||
27980109|NCT00033540|81760029|FG000|Overall Study|Progression|26|||
27980110|NCT00033540|81760029|FG000|Overall Study|Withdrawal by Subject|6|||
27867876|NCT01320293|81349752|FG000|Overall Study|Adverse Event|1|||
27980111|NCT00033540|81760029|FG000|Overall Study|Other|5|||
27980112|NCT00033540|81760029|FG000|Overall Study|Ineligible|3|||
27793199|NCT01283009|81072550|FG000|Overall Study|Withdrawal by Subject|10|||
27793200|NCT01283009|81072551|FG001|Overall Study|Withdrawal by Subject|8|||
27793201|NCT01283009|81072550|FG000|Overall Study|Physician Decision|1|||
27793202|NCT01283009|81072551|FG001|Overall Study|Physician Decision|1|||
27793203|NCT01283009|81072550|FG000|Overall Study|Lost to Follow-up|1|||
27793204|NCT01283009|81072551|FG001|Overall Study|Lost to Follow-up|0|||
27793205|NCT01283009|81072550|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
27793206|NCT01283009|81072551|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
27793207|NCT03901339|81072561|FG000|Overall Study|Death|220|||
27793208|NCT03901339|81072562|FG001|Overall Study|Death|192|||
27793209|NCT03901339|81072561|FG000|Overall Study|Informed consent withdrawn|13|||
27793210|NCT03901339|81072562|FG001|Overall Study|Informed consent withdrawn|40|||
27793211|NCT03901339|81072561|FG000|Overall Study|Sponsor request|30|||
27793212|NCT03901339|81072562|FG001|Overall Study|Sponsor request|23|||
27793213|NCT03901339|81072561|FG000|Overall Study|Reason not specified|5|||
27793214|NCT03901339|81072562|FG001|Overall Study|Reason not specified|7|||
27793215|NCT03901339|81072561|FG000|Overall Study|Lost to Follow-up|4|||
27793216|NCT03901339|81072562|FG001|Overall Study|Lost to Follow-up|7|||
27793217|NCT03901339|81072561|FG000|Overall Study|Covid19|0|||
27793218|NCT03901339|81072562|FG001|Overall Study|Covid19|2|||
27793219|NCT04003103|81072564|FG000|Overall Study|Death|1|||
27793220|NCT04003103|81072565|FG001|Overall Study|Death|0|||
27793221|NCT04003103|81072566|FG002|Overall Study|Death|0|||
27793222|NCT04003103|81072564|FG000|Overall Study|Lost to Follow-up|4|||
27793223|NCT04003103|81072565|FG001|Overall Study|Lost to Follow-up|3|||
27793224|NCT04003103|81072566|FG002|Overall Study|Lost to Follow-up|2|||
27793225|NCT04003103|81072564|FG000|Overall Study|Withdrawal by Subject|10|||
27793226|NCT04003103|81072565|FG001|Overall Study|Withdrawal by Subject|1|||
27793227|NCT04003103|81072566|FG002|Overall Study|Withdrawal by Subject|1|||
27793228|NCT04003103|81072564|FG000|Overall Study|Status not recorded|0|||
27793229|NCT04003103|81072565|FG001|Overall Study|Status not recorded|2|||
27793230|NCT04003103|81072566|FG002|Overall Study|Status not recorded|0|||
27793231|NCT02297438|81072567|FG000|Overall Study|Death|79|||
27793232|NCT02297438|81072568|FG001|Overall Study|Death|86|||
27793233|NCT02297438|81072567|FG000|Overall Study|Lost to Follow-up|9|||
27793234|NCT02297438|81072568|FG001|Overall Study|Lost to Follow-up|7|||
27793235|NCT02297438|81072567|FG000|Overall Study|Withdrawal by Subject|7|||
27867877|NCT02430480|81349753|FG000|Overall Study|Death|1|||
27867878|NCT02430480|81349753|FG000|Overall Study|Anesthesia concerns|1|||
27867879|NCT02430480|81349753|FG000|Overall Study|Progressed on treatment|1|||
27793236|NCT02297438|81072568|FG001|Overall Study|Withdrawal by Subject|0|||
27793237|NCT02297438|81072567|FG000|Overall Study|Other|9|||
27793238|NCT02297438|81072568|FG001|Overall Study|Other|5|||
27793239|NCT02297438|81072567|FG000|Overall Study|Ongoing|65|||
27793240|NCT02297438|81072568|FG001|Overall Study|Ongoing|73|||
27793241|NCT04888377|81072569|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
27793242|NCT04888377|81072570|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
27793243|NCT04888377|81072569|FG000|Overall Study|Physician Decision|6|||
27867880|NCT01597973|81349760|FG000|Overall Study|Found ineligible before study medication started|4|||
27867881|NCT01597973|81349761|FG001|Overall Study|Found ineligible before study medication started|2|||
27867882|NCT01597973|81349760|FG000|Overall Study|Eligible pathogen not confirmed|14|||
27867883|NCT01597973|81349761|FG001|Overall Study|Eligible pathogen not confirmed|15|||
27867884|NCT01597973|81349760|FG000|Overall Study|LAR not authorized to consent|0|||
27867885|NCT01597973|81349761|FG001|Overall Study|LAR not authorized to consent|1|||
27867886|NCT01597973|81349760|FG000|Overall Study|Ineligible due to early seizures|1|||
27980113|NCT00033540|81760029|FG000|Overall Study|Never received treatment|2|||
27980114|NCT00661388|81760030|FG000|Overall Study|Adverse Event|14|||
27980115|NCT00661388|81760030|FG000|Overall Study|Protocol Violation|7|||
27576011|NCT02460224|80293044|FG014|Overall Study|Lost to Follow-up|0|||
27576012|NCT02460224|80293045|FG015|Overall Study|Lost to Follow-up|0|||
27793244|NCT04888377|81072570|FG001|Overall Study|Physician Decision|6|||
27980116|NCT00661388|81760030|FG000|Overall Study|Renal transplantation|1|||
27980117|NCT00661388|81760030|FG000|Overall Study|Dialysis initiation|1|||
27980118|NCT00661388|81760030|FG000|Overall Study|Administrative reasons|1|||
27980119|NCT02535416|81760031|FG000|Overall Study|Family bereavement overseas|1|||
27867887|NCT01597973|81349761|FG001|Overall Study|Ineligible due to early seizures|0|||
27867888|NCT01597973|81349760|FG000|Overall Study|Ineligible due to non-target infection|1|||
27980120|NCT02535416|81760032|FG001|Overall Study|Family bereavement overseas|0|||
27576013|NCT02460224|80293046|FG016|Overall Study|Lost to Follow-up|0|||
27793245|NCT04888377|81072569|FG000|Overall Study|Withdrawal by Subject|7|||
27793246|NCT04888377|81072570|FG001|Overall Study|Withdrawal by Subject|3|||
27793247|NCT00944125|81072577|FG000|3 to 6 Months|Withdrawal by Subject|0|||
27793248|NCT00944125|81072578|FG001|3 to 6 Months|Withdrawal by Subject|2|||
27793249|NCT00944125|81072577|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
27793250|NCT00944125|81072578|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
27793251|NCT00924313|81075285|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
27793252|NCT01360021|81075286|FG000|Overall Study|Eligibility criteria + other|2|||
27673300|NCT04927364|80639411|FG000|Overall Study|Unable to complete preassessment MRI|1|||
27673301|NCT00832000|80639413|FG000|Overall Study|Adverse Event|2|||
27673302|NCT00832000|80639414|FG001|Overall Study|Adverse Event|0|||
27673303|NCT00832000|80639413|FG000|Overall Study|Withdrawal by Subject|1|||
27673304|NCT00832000|80639414|FG001|Overall Study|Withdrawal by Subject|0|||
27673305|NCT00832000|80639413|FG000|Overall Study|No calls to IVR in either period|1|||
27793253|NCT01360021|81075287|FG001|Overall Study|Eligibility criteria + other|1|||
27793254|NCT01360021|81075288|FG002|Overall Study|Eligibility criteria + other|1|||
27793255|NCT01360021|81075286|FG000|Overall Study|Protocol Violation|0|||
27793256|NCT01360021|81075287|FG001|Overall Study|Protocol Violation|0|||
27980121|NCT02535416|81760033|FG002|Overall Study|Family bereavement overseas|0|||
27980122|NCT02535416|81760034|FG003|Overall Study|Family bereavement overseas|0|||
27980123|NCT02535416|81760035|FG004|Overall Study|Family bereavement overseas|0|||
27980124|NCT02535416|81760036|FG005|Overall Study|Family bereavement overseas|0|||
27980125|NCT02535416|81760037|FG006|Overall Study|Family bereavement overseas|0|||
27980126|NCT02535416|81760038|FG007|Overall Study|Family bereavement overseas|0|||
27980127|NCT02535416|81760039|FG008|Overall Study|Family bereavement overseas|0|||
27980128|NCT01116427|81760042|FG000|Core Phase|Adverse Event|0|||
27980129|NCT01116427|81760043|FG001|Core Phase|Adverse Event|1|||
27980130|NCT01116427|81760042|FG000|Core Phase|Lost to Follow-up|1|||
27980131|NCT01116427|81760043|FG001|Core Phase|Lost to Follow-up|0|||
27980132|NCT01116427|81760042|FG000|Core Phase|Withdrawal by Subject|3|||
27980133|NCT01116427|81760043|FG001|Core Phase|Withdrawal by Subject|0|||
27980134|NCT01116427|81760042|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
27980135|NCT01116427|81760043|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
27980136|NCT01116427|81760042|FG000|Extension Phase|Adverse Event|1|||
27980137|NCT01116427|81760043|FG001|Extension Phase|Adverse Event|1|||
27980138|NCT01116427|81760042|FG000|Extension Phase|Lost to Follow-up|2|||
27980139|NCT01116427|81760043|FG001|Extension Phase|Lost to Follow-up|0|||
27980140|NCT01116427|81760042|FG000|Extension Phase|Withdrawal by Subject|5|||
27980141|NCT01116427|81760043|FG001|Extension Phase|Withdrawal by Subject|1|||
27980142|NCT01116427|81760042|FG000|Extension Phase|Not using appropriate birth control|1|||
27980143|NCT01116427|81760043|FG001|Extension Phase|Not using appropriate birth control|0|||
27980144|NCT02366767|81760046|FG000|Overall Study|left for home after 1 day at camp|1|||
27673306|NCT00832000|80639414|FG001|Overall Study|No calls to IVR in either period|1|||
27793257|NCT01360021|81075288|FG002|Overall Study|Protocol Violation|1|||
27793258|NCT01360021|81075286|FG000|Overall Study|Withdrawal by Subject|4|||
27793259|NCT01360021|81075287|FG001|Overall Study|Withdrawal by Subject|0|||
27793260|NCT01360021|81075288|FG002|Overall Study|Withdrawal by Subject|2|||
27793261|NCT01360021|81075286|FG000|Overall Study|Adverse Event|2|||
27793262|NCT01360021|81075287|FG001|Overall Study|Adverse Event|3|||
27793263|NCT01360021|81075288|FG002|Overall Study|Adverse Event|3|||
27793264|NCT03707145|81075290|FG000|Overall Study|Lost to Follow-up|0|||
27793265|NCT03707145|81075291|FG001|Overall Study|Lost to Follow-up|1|||
27793266|NCT03707145|81075292|FG002|Overall Study|Lost to Follow-up|1|||
27793267|NCT03707145|81075293|FG003|Overall Study|Lost to Follow-up|0|||
27793268|NCT02513732|81075301|FG000|Overall Study|Lost to Follow-up|11|||
27793269|NCT02513732|81075301|FG000|Overall Study|Death|9|||
27793270|NCT02513732|81075301|FG000|Overall Study|Changing hospital|2|||
27793271|NCT01036594|81075302|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
27793272|NCT01036594|81075303|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
27793273|NCT01036594|81075302|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
27793274|NCT01036594|81075303|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
27793275|NCT01036594|81075302|FG000|Week 12 Evaluation|Adverse Event|5|||
27793276|NCT01036594|81075303|FG001|Week 12 Evaluation|Adverse Event|0|||
27793277|NCT01036594|81075302|FG000|Week 12 Evaluation|Physician Decision|1|||
27793278|NCT01036594|81075303|FG001|Week 12 Evaluation|Physician Decision|0|||
27793279|NCT01036594|81075302|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
27793280|NCT01036594|81075303|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
27793281|NCT01036594|81075302|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
27793282|NCT01036594|81075303|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
27673307|NCT00832000|80639413|FG000|Overall Study|No calls to IVR in period 2|2|||
27867889|NCT01597973|81349761|FG001|Overall Study|Ineligible due to non-target infection|1|||
27980145|NCT02366767|81760047|FG001|Overall Study|left for home after 1 day at camp|0|||
27980146|NCT00693472|81760050|FG000|Part 1|Adverse Event|1|||
27980147|NCT00693472|81760051|FG001|Part 1|Adverse Event|1|||
27980148|NCT00693472|81760052|FG002|Part 1|Adverse Event|0|||
27673308|NCT00832000|80639414|FG001|Overall Study|No calls to IVR in period 2|0|||
27793283|NCT01036594|81075302|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
27793284|NCT01036594|81075303|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
27793285|NCT01036594|81075302|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
27793286|NCT01036594|81075303|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
27793287|NCT01036594|81075302|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
27793288|NCT01036594|81075303|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
27793289|NCT03668613|81075304|FG000|Overall Study|Adverse Event|1|||
27793290|NCT03668613|81075305|FG001|Overall Study|Adverse Event|2|||
27793291|NCT03668613|81075304|FG000|Overall Study|Lack of Efficacy|5|||
27793292|NCT03668613|81075305|FG001|Overall Study|Lack of Efficacy|1|||
27867890|NCT02165735|81349762|FG000|Overall Study|Lost to Follow-up|12|||
27867891|NCT02165735|81349763|FG001|Overall Study|Lost to Follow-up|10|||
27867892|NCT02165735|81349762|FG000|Overall Study|Withdrawal by Subject|3|||
27867893|NCT02165735|81349763|FG001|Overall Study|Withdrawal by Subject|0|||
27867894|NCT02165735|81349762|FG000|Overall Study|Participant indicated lack of time|1|||
27867895|NCT02165735|81349763|FG001|Overall Study|Participant indicated lack of time|3|||
27867896|NCT02165735|81349762|FG000|Overall Study|Protocol Violation|0|||
27867897|NCT02165735|81349763|FG001|Overall Study|Protocol Violation|1|||
27867898|NCT01461538|81349770|FG000|Overall Study|Death|15|||
27867899|NCT01461538|81349771|FG001|Overall Study|Death|6|||
27867900|NCT01461538|81349772|FG002|Overall Study|Death|2|||
27867901|NCT01461538|81349770|FG000|Overall Study|Study Stopped by Sponsor|2|||
27867902|NCT01461538|81349771|FG001|Overall Study|Study Stopped by Sponsor|1|||
27867903|NCT01461538|81349772|FG002|Overall Study|Study Stopped by Sponsor|0|||
27867904|NCT01461538|81349770|FG000|Overall Study|Withdrawal by Subject|1|||
27867905|NCT01461538|81349771|FG001|Overall Study|Withdrawal by Subject|1|||
27980149|NCT00693472|81760053|FG003|Part 1|Adverse Event|0|||
27980150|NCT00693472|81760050|FG000|Part 1|Lost to Follow-up|0|||
27980151|NCT00693472|81760051|FG001|Part 1|Lost to Follow-up|1|||
27793293|NCT03668613|81075304|FG000|Overall Study|Pregnancy|0|||
27793294|NCT03668613|81075305|FG001|Overall Study|Pregnancy|2|||
27793295|NCT03668613|81075304|FG000|Overall Study|Protocol Violation|1|||
27793296|NCT03668613|81075305|FG001|Overall Study|Protocol Violation|0|||
27793297|NCT03668613|81075304|FG000|Overall Study|Physician Decision|1|||
27793298|NCT03668613|81075305|FG001|Overall Study|Physician Decision|0|||
27793299|NCT03668613|81075304|FG000|Overall Study|Withdrawal by Subject|2|||
27793300|NCT03668613|81075305|FG001|Overall Study|Withdrawal by Subject|1|||
27793301|NCT03668613|81075304|FG000|Overall Study|Guardian decision|1|||
27980152|NCT00693472|81760052|FG002|Part 1|Lost to Follow-up|0|||
27980153|NCT00693472|81760053|FG003|Part 1|Lost to Follow-up|0|||
27980154|NCT00693472|81760050|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
27980155|NCT00693472|81760051|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
27980156|NCT00693472|81760052|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
27980157|NCT00693472|81760053|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
27980158|NCT00693472|81760050|FG000|Part 2|Adverse Event|0|||
27980159|NCT00693472|81760051|FG001|Part 2|Adverse Event|0|||
27980160|NCT00693472|81760052|FG002|Part 2|Adverse Event|1|||
27980161|NCT00693472|81760053|FG003|Part 2|Adverse Event|0|||
27980162|NCT00693472|81760050|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
27980163|NCT00693472|81760051|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
27980164|NCT00693472|81760052|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
27980165|NCT00693472|81760053|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
27980166|NCT00831701|81760054|FG000|Overall Study|Withdrawal by Subject|2|||
27980167|NCT00831701|81760055|FG001|Overall Study|Withdrawal by Subject|0|||
27980168|NCT00831701|81760054|FG000|Overall Study|Stone expulsion before first medication|2|||
27793302|NCT03668613|81075305|FG001|Overall Study|Guardian decision|0|||
27980169|NCT00831701|81760055|FG001|Overall Study|Stone expulsion before first medication|2|||
27980170|NCT00831701|81760054|FG000|Overall Study|Lost to Follow-up|1|||
27980171|NCT00831701|81760055|FG001|Overall Study|Lost to Follow-up|3|||
27980172|NCT01100528|81760056|FG000|Overall Study|Death|1|||
27867906|NCT01461538|81349772|FG002|Overall Study|Withdrawal by Subject|0|||
27867907|NCT05013008|81349773|FG000|Overall Study|Exclusion from mBFAS|5|||
27980173|NCT01100528|81760056|FG000|Overall Study|Withdrawal by Subject|2|||
27980174|NCT02266875|81760057|FG000|Overall Study|Withdrawal by Subject|9|||
27980175|NCT02266875|81760058|FG001|Overall Study|Withdrawal by Subject|0|||
27793303|NCT04505592|81075310|FG000|Overall Study|Death|2|||
27980176|NCT02266875|81760057|FG000|Overall Study|Lost to Follow-up|2|||
27980177|NCT02266875|81760058|FG001|Overall Study|Lost to Follow-up|0|||
27980178|NCT03242252|81760059|FG000|Overall Study|At the Participant's own Request|18|||
27980179|NCT03242252|81760060|FG001|Overall Study|At the Participant's own Request|10|||
27980180|NCT03242252|81760061|FG002|Overall Study|At the Participant's own Request|15|||
27980181|NCT03242252|81760059|FG000|Overall Study|Adverse Event|8|||
27980182|NCT03242252|81760060|FG001|Overall Study|Adverse Event|6|||
27980183|NCT03242252|81760061|FG002|Overall Study|Adverse Event|9|||
27980184|NCT03242252|81760059|FG000|Overall Study|Poor Compliance to Protocol|0|||
27980185|NCT03242252|81760060|FG001|Overall Study|Poor Compliance to Protocol|2|||
27980186|NCT03242252|81760061|FG002|Overall Study|Poor Compliance to Protocol|3|||
27980187|NCT03242252|81760059|FG000|Overall Study|Study Terminated by Sponsor|1|||
27980188|NCT03242252|81760060|FG001|Overall Study|Study Terminated by Sponsor|0|||
27980189|NCT03242252|81760061|FG002|Overall Study|Study Terminated by Sponsor|0|||
27980190|NCT03242252|81760059|FG000|Overall Study|Reason not Specified|4|||
27980191|NCT03242252|81760060|FG001|Overall Study|Reason not Specified|4|||
27980192|NCT03242252|81760061|FG002|Overall Study|Reason not Specified|1|||
27980193|NCT03242252|81760059|FG000|Overall Study|Lost to Follow-up|5|||
27980194|NCT03242252|81760060|FG001|Overall Study|Lost to Follow-up|1|||
27980195|NCT03242252|81760061|FG002|Overall Study|Lost to Follow-up|4|||
27980196|NCT02989805|81760062|FG000|Overall Study|invalid consent|6|||
27980197|NCT02989805|81760063|FG001|Overall Study|invalid consent|4|||
27980198|NCT00509093|81760066|FG000|Overall Study|Adverse Event|10|||
27980199|NCT00509093|81760066|FG000|Overall Study|Disease Progression|9|||
27793304|NCT04505592|81075311|FG001|Overall Study|Death|1|||
27793305|NCT00620776|81075312|FG000|Overall Study|Did not receive treatment|3|||
27793306|NCT00620776|81075313|FG001|Overall Study|Did not receive treatment|5|||
27793307|NCT00620776|81075312|FG000|Overall Study|Adverse Event|2|||
27793308|NCT00620776|81075313|FG001|Overall Study|Adverse Event|3|||
27793309|NCT00620776|81075312|FG000|Overall Study|Lack of Efficacy|2|||
27980200|NCT00509093|81760066|FG000|Overall Study|Transformed into MDS|1|||
27980201|NCT00509093|81760066|FG000|Overall Study|Withdrawal by Subject|3|||
27980202|NCT00509093|81760066|FG000|Overall Study|Physician Decision|1|||
27980203|NCT02776033|81760067|FG000|Overall Study|Withdrawal by Subject|0|||
27980204|NCT02776033|81760068|FG001|Overall Study|Withdrawal by Subject|0|||
27980205|NCT02776033|81760069|FG002|Overall Study|Withdrawal by Subject|2|||
27980206|NCT02776033|81760067|FG000|Overall Study|Physician Decision|2|||
27980207|NCT02776033|81760068|FG001|Overall Study|Physician Decision|0|||
27980208|NCT02776033|81760069|FG002|Overall Study|Physician Decision|0|||
27980209|NCT02776033|81760067|FG000|Overall Study|Lost to Follow-up|1|||
27980210|NCT02776033|81760068|FG001|Overall Study|Lost to Follow-up|0|||
27980211|NCT02776033|81760069|FG002|Overall Study|Lost to Follow-up|0|||
27980212|NCT02776033|81760067|FG000|Overall Study|Adverse Event|1|||
27980213|NCT02776033|81760068|FG001|Overall Study|Adverse Event|2|||
27980214|NCT02776033|81760069|FG002|Overall Study|Adverse Event|0|||
27980215|NCT01146288|81760070|FG000|First Intervention(1 Day)|Adverse Event|0|||
27980216|NCT01146288|81760071|FG001|First Intervention(1 Day)|Adverse Event|1|||
27980217|NCT02226549|81760074|FG000|Overall Study|Randomized but Never Treated|1|||
27980218|NCT02226549|81760075|FG001|Overall Study|Randomized but Never Treated|0|||
27980219|NCT02226549|81760074|FG000|Overall Study|Lost to Follow-up|0|||
27980220|NCT02226549|81760075|FG001|Overall Study|Lost to Follow-up|1|||
27980221|NCT01646203|81760076|FG000|Overall Study|Adverse Event|2|||
27980222|NCT01646203|81760077|FG001|Overall Study|Adverse Event|0|||
27980223|NCT01646203|81760078|FG002|Overall Study|Adverse Event|1|||
27980224|NCT01646203|81760076|FG000|Overall Study|Withdrawal by Subject|0|||
27980225|NCT01646203|81760077|FG001|Overall Study|Withdrawal by Subject|1|||
27980226|NCT01646203|81760078|FG002|Overall Study|Withdrawal by Subject|0|||
27980227|NCT01646203|81760076|FG000|Overall Study|Physician's Decision|0|||
27980228|NCT01646203|81760077|FG001|Overall Study|Physician's Decision|1|||
27980229|NCT01646203|81760078|FG002|Overall Study|Physician's Decision|0|||
27980230|NCT02120365|81760079|FG000|Overall Study|Withdrawal by Subject|0|||
27980231|NCT02120365|81760080|FG001|Overall Study|Withdrawal by Subject|0|||
27980232|NCT02120365|81760081|FG002|Overall Study|Withdrawal by Subject|2|||
27980233|NCT02120365|81760082|FG003|Overall Study|Withdrawal by Subject|4|||
27980234|NCT02120365|81760083|FG004|Overall Study|Withdrawal by Subject|0|||
27980235|NCT02120365|81760084|FG005|Overall Study|Withdrawal by Subject|2|||
27980236|NCT00186537|81760087|FG000|Overall Study|Withdrawal by Subject|4|||
27793310|NCT00620776|81075313|FG001|Overall Study|Lack of Efficacy|1|||
27980237|NCT00186537|81760088|FG001|Overall Study|Withdrawal by Subject|0|||
27980238|NCT00186537|81760089|FG002|Overall Study|Withdrawal by Subject|3|||
27980239|NCT00186537|81760087|FG000|Overall Study|ALT > 1.5 x ULN|3|||
27980240|NCT00186537|81760088|FG001|Overall Study|ALT > 1.5 x ULN|0|||
27980241|NCT00186537|81760089|FG002|Overall Study|ALT > 1.5 x ULN|0|||
27980242|NCT03550404|81760090|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
27980243|NCT03550404|81760091|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
27793311|NCT00620776|81075312|FG000|Overall Study|Lost to Follow-up|2|||
27793312|NCT00620776|81075313|FG001|Overall Study|Lost to Follow-up|5|||
27793313|NCT00620776|81075312|FG000|Overall Study|Withdrawal by Subject|3|||
27793314|NCT00620776|81075313|FG001|Overall Study|Withdrawal by Subject|2|||
27793315|NCT00437294|81075316|FG000|Overall Study|Adverse Event|5|||
27793316|NCT00437294|81075317|FG001|Overall Study|Adverse Event|4|||
27793317|NCT00437294|81075316|FG000|Overall Study|Death|5|||
27793318|NCT00437294|81075317|FG001|Overall Study|Death|2|||
27793319|NCT00437294|81075316|FG000|Overall Study|Physician Decision|0|||
27793320|NCT00437294|81075317|FG001|Overall Study|Physician Decision|3|||
27793321|NCT00437294|81075316|FG000|Overall Study|Withdrawal by Subject|5|||
27793322|NCT00437294|81075317|FG001|Overall Study|Withdrawal by Subject|0|||
27793323|NCT00437294|81075316|FG000|Overall Study|Progressive Disease|19|||
27793324|NCT00437294|81075317|FG001|Overall Study|Progressive Disease|23|||
27793325|NCT00437294|81075316|FG000|Overall Study|Sponsor Decision|8|||
27793326|NCT00437294|81075317|FG001|Overall Study|Sponsor Decision|9|||
27793327|NCT00437294|81075316|FG000|Overall Study|Protocol Violation|0|||
27793328|NCT00437294|81075317|FG001|Overall Study|Protocol Violation|1|||
27793329|NCT00437294|81075316|FG000|Overall Study|Entry criteria not met|1|||
27793330|NCT00437294|81075317|FG001|Overall Study|Entry criteria not met|1|||
27793331|NCT00352664|81075320|FG000|Overall Study|Withdrawal by Subject|7|||
27793332|NCT00352664|81075321|FG001|Overall Study|Withdrawal by Subject|0|||
27793333|NCT00556166|81075322|FG000|Overall Study|Withdrawal by Subject|1|||
27793334|NCT00539006|81075325|FG000|Pre-treatment|Other|0|||
27793335|NCT00539006|81075326|FG001|Pre-treatment|Other|1|||
27980244|NCT03550404|81760092|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
27980245|NCT03550404|81760090|FG000|Phase 2|Vacated position|1|||
27980246|NCT03550404|81760091|FG001|Phase 2|Vacated position|0|||
27980247|NCT03550404|81760092|FG002|Phase 2|Vacated position|0|||
27980248|NCT01439074|81760093|FG000|Overall Study|Lost to Follow-up|3|||
27980249|NCT01439074|81760094|FG001|Overall Study|Lost to Follow-up|4|||
27980250|NCT01439074|81760093|FG000|Overall Study|Subject shedding|1|||
27980251|NCT01439074|81760094|FG001|Overall Study|Subject shedding|0|||
27980252|NCT01439074|81760093|FG000|Overall Study|Withdrawal by Subject|1|||
27980253|NCT01439074|81760094|FG001|Overall Study|Withdrawal by Subject|5|||
27980254|NCT01439074|81760093|FG000|Overall Study|Other|4|||
27980255|NCT01439074|81760094|FG001|Overall Study|Other|4|||
27980256|NCT00844805|81760095|FG000|Treatment Phase|Adverse Event|5|||
27980257|NCT00844805|81760096|FG001|Treatment Phase|Adverse Event|1|||
27980258|NCT00844805|81760097|FG002|Treatment Phase|Adverse Event|0|||
27980259|NCT00844805|81760098|FG003|Treatment Phase|Adverse Event|0|||
27980260|NCT00844805|81760095|FG000|Treatment Phase|Withdrawal by Subject|3|||
27980261|NCT00844805|81760096|FG001|Treatment Phase|Withdrawal by Subject|4|||
27980262|NCT00844805|81760097|FG002|Treatment Phase|Withdrawal by Subject|0|||
27980263|NCT00844805|81760098|FG003|Treatment Phase|Withdrawal by Subject|0|||
27980264|NCT00844805|81760095|FG000|Treatment Phase|Noncompliance With Protocol|1|||
27980265|NCT00844805|81760096|FG001|Treatment Phase|Noncompliance With Protocol|0|||
27980266|NCT00844805|81760097|FG002|Treatment Phase|Noncompliance With Protocol|0|||
27980267|NCT00844805|81760098|FG003|Treatment Phase|Noncompliance With Protocol|0|||
27980268|NCT00844805|81760095|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
27980269|NCT00844805|81760096|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
27980270|NCT00844805|81760097|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
27980271|NCT00844805|81760098|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
27980272|NCT00844805|81760095|FG000|Follow-Up Phase|Adverse Event|0|||
27980273|NCT00844805|81760096|FG001|Follow-Up Phase|Adverse Event|0|||
27980274|NCT00844805|81760097|FG002|Follow-Up Phase|Adverse Event|1|||
27980275|NCT00844805|81760098|FG003|Follow-Up Phase|Adverse Event|0|||
27980276|NCT00844805|81760095|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
27980277|NCT00844805|81760096|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
27980278|NCT00844805|81760097|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
27980279|NCT00844805|81760098|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
27980280|NCT00844805|81760095|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
27980281|NCT00844805|81760096|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
27980282|NCT00844805|81760097|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
27576014|NCT02460224|80293047|FG017|Overall Study|Lost to Follow-up|0|||
27576015|NCT02460224|80293048|FG018|Overall Study|Lost to Follow-up|0|||
27673309|NCT01519778|80639415|FG000|Overall Study|Withdrawal by Subject|3|||
27793336|NCT00539006|81075327|FG002|Pre-treatment|Other|0|||
27793337|NCT00539006|81075328|FG003|Pre-treatment|Other|0|||
27980283|NCT00844805|81760098|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
27980284|NCT00844805|81760095|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
27980285|NCT00844805|81760096|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
27980286|NCT00844805|81760097|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
27793338|NCT00539006|81075325|FG000|Treatment Period 1|Lost to Follow-up|0|||
27793339|NCT00539006|81075326|FG001|Treatment Period 1|Lost to Follow-up|0|||
27793340|NCT00539006|81075327|FG002|Treatment Period 1|Lost to Follow-up|1|||
27793341|NCT00539006|81075328|FG003|Treatment Period 1|Lost to Follow-up|0|||
27793342|NCT00539006|81075325|FG000|Treatment Period 1|Protocol Violation|0|||
27576016|NCT02460224|80293049|FG019|Overall Study|Lost to Follow-up|0|||
27576017|NCT02460224|80293050|FG020|Overall Study|Lost to Follow-up|0|||
27576018|NCT02460224|80293051|FG021|Overall Study|Lost to Follow-up|0|||
27576019|NCT02460224|80293052|FG022|Overall Study|Lost to Follow-up|1|||
27576020|NCT02460224|80293053|FG023|Overall Study|Lost to Follow-up|0|||
27576021|NCT02460224|80293054|FG024|Overall Study|Lost to Follow-up|0|||
27576022|NCT02460224|80293055|FG025|Overall Study|Lost to Follow-up|0|||
27867908|NCT05013008|81349774|FG001|Overall Study|Exclusion from mBFAS|25|||
27867909|NCT04289363|81349775|FG000|Overall Study|Lost to Follow-up|14|||
27867910|NCT04289363|81349776|FG001|Overall Study|Lost to Follow-up|0|||
27867911|NCT01699815|81349777|FG000|Overall Study|Protocol Violation|4|||
27867912|NCT01699815|81349778|FG001|Overall Study|Protocol Violation|7|||
27867913|NCT01699815|81349777|FG000|Overall Study|record could not be located|1|||
27867914|NCT01699815|81349778|FG001|Overall Study|record could not be located|0|||
27867915|NCT01699815|81349777|FG000|Overall Study|Adverse Event|0|||
27867916|NCT01699815|81349778|FG001|Overall Study|Adverse Event|1|||
27867917|NCT02533180|81349779|FG000|Overall Study|Death|0|||
27867918|NCT02533180|81349780|FG001|Overall Study|Death|2|||
27867919|NCT02533180|81349779|FG000|Overall Study|Lost to Follow-up|0|||
27867920|NCT02533180|81349780|FG001|Overall Study|Lost to Follow-up|1|||
27867921|NCT02533180|81349779|FG000|Overall Study|Physician Decision|0|||
27867922|NCT02533180|81349780|FG001|Overall Study|Physician Decision|1|||
27867923|NCT02533180|81349779|FG000|Overall Study|Withdrawal by Subject|2|||
27867924|NCT02533180|81349780|FG001|Overall Study|Withdrawal by Subject|5|||
27867925|NCT02533180|81349779|FG000|Overall Study|Screen Failure|37|||
27867926|NCT02533180|81349780|FG001|Overall Study|Screen Failure|0|||
27867927|NCT02533180|81349779|FG000|Overall Study|Protocol Deviation|0|||
27867928|NCT02533180|81349780|FG001|Overall Study|Protocol Deviation|1|||
27867929|NCT02533180|81349779|FG000|Overall Study|Non-compliance|0|||
27867930|NCT02533180|81349780|FG001|Overall Study|Non-compliance|1|||
27867931|NCT00853099|81349781|FG000|Double-blind Period|Adverse Event|7|||
27867932|NCT00853099|81349782|FG001|Double-blind Period|Adverse Event|9|||
27867933|NCT00853099|81349783|FG002|Double-blind Period|Adverse Event|13|||
27867934|NCT00853099|81349784|FG003|Double-blind Period|Adverse Event|0|||
27867935|NCT00853099|81349781|FG000|Double-blind Period|Withdrawal by Subject|2|||
27867936|NCT00853099|81349782|FG001|Double-blind Period|Withdrawal by Subject|3|||
27867937|NCT00853099|81349783|FG002|Double-blind Period|Withdrawal by Subject|0|||
27867938|NCT00853099|81349784|FG003|Double-blind Period|Withdrawal by Subject|0|||
27867939|NCT00853099|81349781|FG000|Double-blind Period|Lack of Efficacy|14|||
27867940|NCT00853099|81349782|FG001|Double-blind Period|Lack of Efficacy|17|||
27867941|NCT00853099|81349783|FG002|Double-blind Period|Lack of Efficacy|16|||
27867942|NCT00853099|81349784|FG003|Double-blind Period|Lack of Efficacy|0|||
27867943|NCT00853099|81349781|FG000|Double-blind Period|Other|0|||
27867944|NCT00853099|81349782|FG001|Double-blind Period|Other|0|||
27867945|NCT00853099|81349783|FG002|Double-blind Period|Other|1|||
27867946|NCT00853099|81349784|FG003|Double-blind Period|Other|0|||
27867947|NCT00853099|81349781|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
27867948|NCT00853099|81349782|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
27867949|NCT00853099|81349783|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
27867950|NCT00853099|81349784|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
27867951|NCT00853099|81349781|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
27867952|NCT00853099|81349782|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
27867953|NCT00853099|81349783|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
27867954|NCT00853099|81349784|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
27867955|NCT00853099|81349781|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
27867956|NCT00853099|81349782|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
27867957|NCT00853099|81349783|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
27867958|NCT00853099|81349784|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
27867959|NCT00853099|81349781|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
27867960|NCT00853099|81349782|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
27867961|NCT00853099|81349783|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
27867962|NCT00853099|81349784|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
27867963|NCT00853099|81349781|FG000|Double-blind + Open-label Periods|Other|0|||
27867964|NCT00853099|81349782|FG001|Double-blind + Open-label Periods|Other|0|||
27867965|NCT00853099|81349783|FG002|Double-blind + Open-label Periods|Other|0|||
27867966|NCT00853099|81349784|FG003|Double-blind + Open-label Periods|Other|6|||
27867967|NCT01406574|81349792|FG000|Overall Study|Adverse Event|0|||
27867968|NCT01406574|81349793|FG001|Overall Study|Adverse Event|0|||
27867969|NCT01406574|81349794|FG002|Overall Study|Adverse Event|1|||
27867970|NCT01406574|81349795|FG003|Overall Study|Adverse Event|3|||
27867971|NCT01406574|81349792|FG000|Overall Study|Physician Decision|0|||
27576023|NCT02460224|80293056|FG026|Overall Study|Lost to Follow-up|0|||
27867972|NCT01406574|81349793|FG001|Overall Study|Physician Decision|0|||
27867973|NCT01406574|81349794|FG002|Overall Study|Physician Decision|0|||
27867974|NCT01406574|81349795|FG003|Overall Study|Physician Decision|1|||
27576024|NCT02460224|80293057|FG027|Overall Study|Lost to Follow-up|0|||
27867975|NCT01406574|81349792|FG000|Overall Study|Withdrawal by Subject|0|||
27576025|NCT02460224|80293058|FG028|Overall Study|Lost to Follow-up|0|||
27576026|NCT02460224|80293030|FG000|Overall Study|Physician Decision|0|||
27576027|NCT02460224|80293031|FG001|Overall Study|Physician Decision|1|||
27576028|NCT02460224|80293032|FG002|Overall Study|Physician Decision|0|||
27576029|NCT02460224|80293033|FG003|Overall Study|Physician Decision|0|||
27576030|NCT02460224|80293034|FG004|Overall Study|Physician Decision|1|||
27576031|NCT02460224|80293035|FG005|Overall Study|Physician Decision|0|||
27793343|NCT00539006|81075326|FG001|Treatment Period 1|Protocol Violation|0|||
27793344|NCT00539006|81075327|FG002|Treatment Period 1|Protocol Violation|1|||
27793345|NCT00539006|81075328|FG003|Treatment Period 1|Protocol Violation|0|||
27793346|NCT00539006|81075325|FG000|Treatment Period 1|Lack of Efficacy|0|||
27793347|NCT00539006|81075326|FG001|Treatment Period 1|Lack of Efficacy|0|||
27793348|NCT00539006|81075327|FG002|Treatment Period 1|Lack of Efficacy|0|||
27793349|NCT00539006|81075328|FG003|Treatment Period 1|Lack of Efficacy|1|||
27793350|NCT00539006|81075325|FG000|Washout|Adverse Event|2|||
27867976|NCT01406574|81349793|FG001|Overall Study|Withdrawal by Subject|1|||
27867977|NCT01406574|81349794|FG002|Overall Study|Withdrawal by Subject|0|||
27867978|NCT01406574|81349795|FG003|Overall Study|Withdrawal by Subject|0|||
27867979|NCT01406574|81349792|FG000|Overall Study|Definite progression of primary disease|1|||
27867980|NCT01406574|81349793|FG001|Overall Study|Definite progression of primary disease|0|||
27867981|NCT01406574|81349794|FG002|Overall Study|Definite progression of primary disease|0|||
27867982|NCT01406574|81349795|FG003|Overall Study|Definite progression of primary disease|0|||
27867983|NCT00193050|81353710|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
27867984|NCT00193050|81353710|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
27793351|NCT00539006|81075326|FG001|Washout|Adverse Event|1|||
27793352|NCT00539006|81075327|FG002|Washout|Adverse Event|0|||
27793353|NCT00539006|81075328|FG003|Washout|Adverse Event|0|||
27867985|NCT00193050|81353710|FG000|Neoadjuvant Treatment|Physician Decision|2|||
27576032|NCT02460224|80293036|FG006|Overall Study|Physician Decision|0|||
27576033|NCT02460224|80293037|FG007|Overall Study|Physician Decision|1|||
27793354|NCT00539006|81075325|FG000|Washout|Protocol Violation|1|||
27576034|NCT02460224|80293038|FG008|Overall Study|Physician Decision|0|||
27793355|NCT00539006|81075326|FG001|Washout|Protocol Violation|1|||
27867986|NCT00193050|81353710|FG000|Neoadjuvant Treatment|Adverse Event|2|||
27867987|NCT00193050|81353710|FG000|Adjuvant|Physician Decision|5|||
27793356|NCT00539006|81075327|FG002|Washout|Protocol Violation|0|||
27793357|NCT00539006|81075328|FG003|Washout|Protocol Violation|0|||
27793358|NCT00539006|81075325|FG000|Washout|Withdrawal by Subject|0|||
27793359|NCT00539006|81075326|FG001|Washout|Withdrawal by Subject|2|||
27793360|NCT00539006|81075327|FG002|Washout|Withdrawal by Subject|0|||
27793361|NCT00539006|81075328|FG003|Washout|Withdrawal by Subject|0|||
27793362|NCT00539006|81075325|FG000|Washout|Failed to meet continuation criteria|16|||
27793363|NCT00539006|81075326|FG001|Washout|Failed to meet continuation criteria|5|||
27793364|NCT00539006|81075327|FG002|Washout|Failed to meet continuation criteria|14|||
27793365|NCT00539006|81075328|FG003|Washout|Failed to meet continuation criteria|6|||
27793366|NCT00539006|81075325|FG000|Washout|Other|1|||
27793367|NCT00539006|81075326|FG001|Washout|Other|1|||
27793368|NCT00539006|81075327|FG002|Washout|Other|2|||
27793369|NCT00539006|81075328|FG003|Washout|Other|3|||
27793370|NCT00539006|81075325|FG000|Treatment Period 2|Protocol Violation|1|||
27793371|NCT00539006|81075326|FG001|Treatment Period 2|Protocol Violation|0|||
27793372|NCT00539006|81075327|FG002|Treatment Period 2|Protocol Violation|0|||
27793373|NCT00539006|81075328|FG003|Treatment Period 2|Protocol Violation|0|||
27793374|NCT00539006|81075325|FG000|Treatment Period 2|Other|0|||
27793375|NCT00539006|81075326|FG001|Treatment Period 2|Other|1|||
27793376|NCT00539006|81075327|FG002|Treatment Period 2|Other|0|||
27793377|NCT00539006|81075328|FG003|Treatment Period 2|Other|0|||
27793378|NCT01238861|81075331|FG000|Overall Study|Lost to Follow-up|4|||
27793379|NCT01238861|81075332|FG001|Overall Study|Lost to Follow-up|2|||
27793380|NCT01238861|81075333|FG002|Overall Study|Lost to Follow-up|3|||
27793381|NCT01238861|81075334|FG003|Overall Study|Lost to Follow-up|1|||
27793382|NCT01238861|81075335|FG004|Overall Study|Lost to Follow-up|1|||
27793383|NCT01238861|81075336|FG005|Overall Study|Lost to Follow-up|2|||
27793384|NCT01238861|81075331|FG000|Overall Study|Unplanned surgery|1|||
27793385|NCT01238861|81075332|FG001|Overall Study|Unplanned surgery|0|||
27793386|NCT01238861|81075333|FG002|Overall Study|Unplanned surgery|0|||
27793387|NCT01238861|81075334|FG003|Overall Study|Unplanned surgery|0|||
27793388|NCT01238861|81075335|FG004|Overall Study|Unplanned surgery|0|||
27793389|NCT01238861|81075336|FG005|Overall Study|Unplanned surgery|0|||
27793390|NCT01238861|81075331|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
27793391|NCT01238861|81075332|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
27793392|NCT01238861|81075333|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
27793393|NCT01238861|81075334|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
27793394|NCT01238861|81075335|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
27793395|NCT01238861|81075336|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
27793396|NCT01238861|81075331|FG000|Overall Study|Incorrect enrollment/randomization|0|||
27793397|NCT01238861|81075332|FG001|Overall Study|Incorrect enrollment/randomization|0|||
27793398|NCT01238861|81075333|FG002|Overall Study|Incorrect enrollment/randomization|1|||
27793399|NCT01238861|81075334|FG003|Overall Study|Incorrect enrollment/randomization|0|||
27793400|NCT01238861|81075335|FG004|Overall Study|Incorrect enrollment/randomization|1|||
27793401|NCT01238861|81075336|FG005|Overall Study|Incorrect enrollment/randomization|0|||
27793402|NCT01238861|81075331|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
27793403|NCT01238861|81075332|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
27793404|NCT01238861|81075333|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
27793405|NCT01238861|81075334|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
27793406|NCT01238861|81075335|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
27793407|NCT01238861|81075336|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
27793408|NCT01238861|81075331|FG000|Overall Study|Subject moved out of state/area|0|||
27793409|NCT01238861|81075332|FG001|Overall Study|Subject moved out of state/area|0|||
27793410|NCT01238861|81075333|FG002|Overall Study|Subject moved out of state/area|1|||
27793411|NCT01238861|81075334|FG003|Overall Study|Subject moved out of state/area|1|||
27793412|NCT01238861|81075335|FG004|Overall Study|Subject moved out of state/area|0|||
27793413|NCT01238861|81075336|FG005|Overall Study|Subject moved out of state/area|0|||
27793414|NCT01238861|81075331|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
27793415|NCT01238861|81075332|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
27793416|NCT01238861|81075333|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
27793417|NCT01238861|81075334|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
27793418|NCT01238861|81075335|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
27867988|NCT00193050|81353710|FG000|Adjuvant|Intercurrent Hospitalization|3|||
27980287|NCT00844805|81760098|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
27980288|NCT00844805|81760095|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
27793419|NCT01238861|81075336|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
27793420|NCT01238861|81075331|FG000|Overall Study|Personal problems|0|||
27793421|NCT01238861|81075332|FG001|Overall Study|Personal problems|0|||
27793422|NCT01238861|81075333|FG002|Overall Study|Personal problems|0|||
27793423|NCT01238861|81075334|FG003|Overall Study|Personal problems|1|||
27793424|NCT01238861|81075335|FG004|Overall Study|Personal problems|0|||
27793425|NCT01238861|81075336|FG005|Overall Study|Personal problems|0|||
27793426|NCT01238861|81075331|FG000|Overall Study|Unable to continue visits|0|||
27793427|NCT01238861|81075332|FG001|Overall Study|Unable to continue visits|0|||
27673310|NCT01519778|80639415|FG000|Overall Study|Lost to Follow-up|10|||
27793428|NCT01238861|81075333|FG002|Overall Study|Unable to continue visits|0|||
27793429|NCT01238861|81075334|FG003|Overall Study|Unable to continue visits|1|||
27793430|NCT01238861|81075335|FG004|Overall Study|Unable to continue visits|0|||
27793431|NCT01238861|81075336|FG005|Overall Study|Unable to continue visits|1|||
27793432|NCT01238861|81075331|FG000|Overall Study|Serious adverse event|0|||
27793433|NCT01238861|81075332|FG001|Overall Study|Serious adverse event|0|||
27793434|NCT01238861|81075333|FG002|Overall Study|Serious adverse event|0|||
27793435|NCT01238861|81075334|FG003|Overall Study|Serious adverse event|0|||
27793436|NCT01238861|81075335|FG004|Overall Study|Serious adverse event|0|||
27793437|NCT01238861|81075336|FG005|Overall Study|Serious adverse event|1|||
27793438|NCT01238861|81075331|FG000|Overall Study|Lack of compliance|0|||
27793439|NCT01238861|81075332|FG001|Overall Study|Lack of compliance|0|||
27793440|NCT01238861|81075333|FG002|Overall Study|Lack of compliance|0|||
27793441|NCT01238861|81075334|FG003|Overall Study|Lack of compliance|0|||
27793442|NCT01238861|81075335|FG004|Overall Study|Lack of compliance|0|||
27793443|NCT01238861|81075336|FG005|Overall Study|Lack of compliance|1|||
27793444|NCT01238861|81075331|FG000|Overall Study|Adverse Event|0|||
27793445|NCT01238861|81075332|FG001|Overall Study|Adverse Event|1|||
27793446|NCT01238861|81075333|FG002|Overall Study|Adverse Event|0|||
27793447|NCT01238861|81075334|FG003|Overall Study|Adverse Event|0|||
27793448|NCT01238861|81075335|FG004|Overall Study|Adverse Event|0|||
27793449|NCT01238861|81075336|FG005|Overall Study|Adverse Event|0|||
27793450|NCT01238861|81075331|FG000|Overall Study|Withdrawal by Subject|6|||
27793451|NCT01238861|81075332|FG001|Overall Study|Withdrawal by Subject|5|||
27793452|NCT01238861|81075333|FG002|Overall Study|Withdrawal by Subject|4|||
27793453|NCT01238861|81075334|FG003|Overall Study|Withdrawal by Subject|8|||
27793454|NCT01238861|81075335|FG004|Overall Study|Withdrawal by Subject|10|||
27793455|NCT01238861|81075336|FG005|Overall Study|Withdrawal by Subject|9|||
27793456|NCT04165824|81075337|FG000|Overall Study|Adverse Event|23|||
27793457|NCT04165824|81075337|FG000|Overall Study|Physician Decision|1|||
27793458|NCT04165824|81075337|FG000|Overall Study|Withdrawal by Subject|17|||
27793459|NCT04165824|81075337|FG000|Overall Study|Other|5|||
27793460|NCT00270205|81075338|FG000|Overall Study|Lost to Follow-up|1|||
27793461|NCT00270205|81075339|FG001|Overall Study|Lost to Follow-up|0|||
27793462|NCT00270205|81075340|FG002|Overall Study|Lost to Follow-up|0|||
27793463|NCT00270205|81075341|FG003|Overall Study|Lost to Follow-up|1|||
27793464|NCT01682681|81075342|FG000|Overall Study|Lack of Efficacy|62|||
27793465|NCT01682681|81075342|FG000|Overall Study|Withdrawal by Subject|1|||
27793466|NCT01682681|81075342|FG000|Overall Study|Moved to other hospital|10|||
27793467|NCT01682681|81075342|FG000|Overall Study|Lost to Follow-up|174|||
27793468|NCT01682681|81075342|FG000|Overall Study|Adverse Event|46|||
27793469|NCT01682681|81075342|FG000|Overall Study|tapering of topiramate|5|||
27793470|NCT01682681|81075342|FG000|Overall Study|Other|21|||
27793471|NCT01682681|81075342|FG000|Overall Study|Low compliance|13|||
27793472|NCT01153971|81075343|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
27793473|NCT01153971|81075343|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
27793474|NCT01153971|81075343|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
27793475|NCT01153971|81075343|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
27793476|NCT01153971|81075343|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
27793477|NCT01153971|81075343|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
27793478|NCT01153971|81075343|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
27980289|NCT00844805|81760096|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
27980290|NCT00844805|81760097|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
27980291|NCT00844805|81760098|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
27980292|NCT00461305|81760109|FG000|Treatment|Adverse Event|26|||
27980293|NCT00461305|81760110|FG001|Treatment|Adverse Event|3|||
27980294|NCT00461305|81760109|FG000|Treatment|Lost to Follow-up|4|||
27980295|NCT00461305|81760110|FG001|Treatment|Lost to Follow-up|2|||
27980296|NCT00461305|81760109|FG000|Treatment|Protocol Violation|13|||
27980297|NCT00461305|81760110|FG001|Treatment|Protocol Violation|2|||
27980298|NCT00461305|81760109|FG000|Treatment|Withdrawal by Subject|48|||
27673311|NCT01519778|80639415|FG000|Overall Study|Physician Decision|1|||
27980299|NCT00461305|81760110|FG001|Treatment|Withdrawal by Subject|2|||
27673312|NCT01536587|80639416|FG000|Overall Study|Adverse Event|2|||
27793479|NCT00474994|81075344|FG000|Overall Study|Patient Not treated|1|||
27793480|NCT00474994|81075344|FG000|Overall Study|Patient evaluable for toxicity only|3|||
27793481|NCT00474994|81075344|FG000|Overall Study|Patient found to be ineligible|1|||
27793482|NCT04341727|81075345|FG000|Overall Study|Withdrawal by Subject|0|||
27793483|NCT04341727|81075346|FG001|Overall Study|Withdrawal by Subject|0|||
27793484|NCT04341727|81075347|FG002|Overall Study|Withdrawal by Subject|1|||
27793485|NCT04341727|81075348|FG003|Overall Study|Withdrawal by Subject|0|||
27793486|NCT04341727|81075345|FG000|Overall Study|Lost to Follow-up|0|||
27793487|NCT04341727|81075346|FG001|Overall Study|Lost to Follow-up|0|||
27793488|NCT04341727|81075347|FG002|Overall Study|Lost to Follow-up|0|||
27793489|NCT04341727|81075348|FG003|Overall Study|Lost to Follow-up|1|||
27793490|NCT02674568|81075349|FG000|Overall Study|Withdrawal by Subject|5|||
27793491|NCT02674568|81075349|FG000|Overall Study|Death|303|||
27793492|NCT02674568|81075349|FG000|Overall Study|Physician Decision|2|||
27793493|NCT02674568|81075349|FG000|Overall Study|Lost to Follow-up|9|||
27793494|NCT02674568|81075349|FG000|Overall Study|Other, Not Specified|20|||
27793495|NCT04355767|81075350|FG000|Overall Study|Withdrawal by Subject|2|||
27980300|NCT00461305|81760109|FG000|Treatment|Never dispensed|5|||
27980301|NCT00461305|81760110|FG001|Treatment|Never dispensed|0|||
27980302|NCT00461305|81760109|FG000|Treatment|Study drug not taken|1|||
27980303|NCT00461305|81760110|FG001|Treatment|Study drug not taken|0|||
27980304|NCT00461305|81760109|FG000|Treatment|Partially missing diary|2|||
27980305|NCT00461305|81760110|FG001|Treatment|Partially missing diary|0|||
27980306|NCT00461305|81760109|FG000|Treatment|Other (missing drug etc)|2|||
27980307|NCT00461305|81760110|FG001|Treatment|Other (missing drug etc)|0|||
27980308|NCT00461305|81760109|FG000|Continued Treatment|Adverse Event|26|||
27980309|NCT00461305|81760110|FG001|Continued Treatment|Adverse Event|0|||
27980310|NCT00461305|81760109|FG000|Continued Treatment|Lost to Follow-up|4|||
27980311|NCT00461305|81760110|FG001|Continued Treatment|Lost to Follow-up|0|||
27980312|NCT00461305|81760109|FG000|Continued Treatment|Protocol Violation|13|||
27980313|NCT00461305|81760110|FG001|Continued Treatment|Protocol Violation|0|||
27980314|NCT00461305|81760109|FG000|Continued Treatment|Withdrawal by Subject|48|||
27980315|NCT00461305|81760110|FG001|Continued Treatment|Withdrawal by Subject|0|||
27980316|NCT00461305|81760109|FG000|Continued Treatment|Partially missing diary|2|||
27980317|NCT00461305|81760110|FG001|Continued Treatment|Partially missing diary|0|||
27980318|NCT00461305|81760109|FG000|Continued Treatment|Other (missing drug etc)|2|||
27980319|NCT00461305|81760110|FG001|Continued Treatment|Other (missing drug etc)|0|||
27980320|NCT01459913|81760112|FG000|Overall Study|Adverse Event|0|||
27980321|NCT01459913|81760113|FG001|Overall Study|Adverse Event|0|||
27980322|NCT01459913|81760114|FG002|Overall Study|Adverse Event|0|||
27980323|NCT01459913|81760115|FG003|Overall Study|Adverse Event|3|||
27980324|NCT01459913|81760112|FG000|Overall Study|Withdrawal by Subject|4|||
27980325|NCT01459913|81760113|FG001|Overall Study|Withdrawal by Subject|0|||
27980326|NCT01459913|81760114|FG002|Overall Study|Withdrawal by Subject|0|||
27980327|NCT01459913|81760115|FG003|Overall Study|Withdrawal by Subject|5|||
27980328|NCT01459913|81760112|FG000|Overall Study|Lost to Follow-up|7|||
27980329|NCT01459913|81760113|FG001|Overall Study|Lost to Follow-up|4|||
27980330|NCT01459913|81760114|FG002|Overall Study|Lost to Follow-up|1|||
27980331|NCT01459913|81760115|FG003|Overall Study|Lost to Follow-up|8|||
27980332|NCT01459913|81760112|FG000|Overall Study|Death|0|||
27980333|NCT01459913|81760113|FG001|Overall Study|Death|0|||
27980334|NCT01459913|81760114|FG002|Overall Study|Death|0|||
27980335|NCT01459913|81760115|FG003|Overall Study|Death|1|||
27980336|NCT01459913|81760112|FG000|Overall Study|Non- Compliance|0|||
27980337|NCT01459913|81760113|FG001|Overall Study|Non- Compliance|0|||
27980338|NCT01459913|81760114|FG002|Overall Study|Non- Compliance|0|||
27980339|NCT01459913|81760115|FG003|Overall Study|Non- Compliance|3|||
27980340|NCT01459913|81760112|FG000|Overall Study|Physician Decision|0|||
27980341|NCT01459913|81760113|FG001|Overall Study|Physician Decision|1|||
27980342|NCT01459913|81760114|FG002|Overall Study|Physician Decision|0|||
27980343|NCT01459913|81760115|FG003|Overall Study|Physician Decision|0|||
27793496|NCT04355767|81075351|FG001|Overall Study|Withdrawal by Subject|2|||
27793497|NCT04355767|81075350|FG000|Overall Study|Death|5|||
27867989|NCT00193050|81353710|FG000|Adjuvant|Lack of Efficacy|2|||
27980344|NCT01459913|81760112|FG000|Overall Study|Study Terminated by Sponsor|30|||
27980345|NCT01459913|81760113|FG001|Overall Study|Study Terminated by Sponsor|15|||
27980346|NCT01459913|81760114|FG002|Overall Study|Study Terminated by Sponsor|9|||
27980347|NCT01459913|81760115|FG003|Overall Study|Study Terminated by Sponsor|11|||
27980348|NCT01459913|81760112|FG000|Overall Study|Other|0|||
27980349|NCT01459913|81760113|FG001|Overall Study|Other|0|||
27980350|NCT01459913|81760114|FG002|Overall Study|Other|3|||
27980351|NCT01459913|81760115|FG003|Overall Study|Other|1|||
27980352|NCT01459913|81760112|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
27980353|NCT01459913|81760113|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
27980354|NCT01459913|81760114|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
27673313|NCT02201901|80639417|FG000|Overall Study|Randomized but never treated|0|||
27673314|NCT02201901|80639418|FG001|Overall Study|Randomized but never treated|1|||
27980355|NCT01459913|81760115|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
27980356|NCT02068118|81760117|FG000|18-month Comparative Study Period|Death|90|||
27980357|NCT02068118|81760118|FG001|18-month Comparative Study Period|Death|97|||
27980358|NCT02068118|81760117|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
27980359|NCT02068118|81760118|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
27980360|NCT02068118|81760117|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
27793498|NCT04355767|81075351|FG001|Overall Study|Death|1|||
27980361|NCT02068118|81760118|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
27980362|NCT02068118|81760117|FG000|18-month Comparative Study Period|Heart transplant|9|||
27980363|NCT02068118|81760118|FG001|18-month Comparative Study Period|Heart transplant|15|||
27980364|NCT02068118|81760117|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
27793499|NCT04054011|81075352|FG000|Overall Study|COVID|3|||
27576035|NCT02460224|80293039|FG009|Overall Study|Physician Decision|0|||
27576036|NCT02460224|80293040|FG010|Overall Study|Physician Decision|0|||
27576037|NCT02460224|80293041|FG011|Overall Study|Physician Decision|1|||
27576038|NCT02460224|80293042|FG012|Overall Study|Physician Decision|0|||
27576039|NCT02460224|80293043|FG013|Overall Study|Physician Decision|1|||
27673315|NCT02201901|80639419|FG002|Overall Study|Randomized but never treated|0|||
27793500|NCT04158739|81075353|FG000|Overall Study|Adverse Event|1|||
27793501|NCT04158739|81075354|FG001|Overall Study|Adverse Event|0|||
27793502|NCT04158739|81075353|FG000|Overall Study|Death|0|||
27793503|NCT04158739|81075354|FG001|Overall Study|Death|1|||
27793504|NCT04158739|81075353|FG000|Overall Study|Lack of Efficacy|3|||
27793505|NCT04158739|81075354|FG001|Overall Study|Lack of Efficacy|7|||
27793506|NCT04158739|81075353|FG000|Overall Study|Physician Decision|0|||
27793507|NCT04158739|81075354|FG001|Overall Study|Physician Decision|1|||
27793508|NCT04158739|81075353|FG000|Overall Study|Withdrawal by Subject|3|||
27793509|NCT04158739|81075354|FG001|Overall Study|Withdrawal by Subject|0|||
27793510|NCT03628781|81075355|FG000|Overall Study|Lost to Follow-up|16|||
27793511|NCT03628781|81075356|FG001|Overall Study|Lost to Follow-up|8|||
27793512|NCT03628781|81075355|FG000|Overall Study|Withdrawal by Subject|16|||
27980365|NCT02068118|81760118|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
27980366|NCT02068118|81760117|FG000|18-month Comparative Study Period|Hemiplegia|0|||
27980367|NCT02068118|81760118|FG001|18-month Comparative Study Period|Hemiplegia|1|||
27980368|NCT02068118|81760117|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
27980369|NCT02068118|81760118|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
27980370|NCT02068118|81760117|FG000|18-month Comparative Study Period|Move|0|||
27980371|NCT02068118|81760118|FG001|18-month Comparative Study Period|Move|1|||
27980372|NCT02068118|81760117|FG000|18-month Comparative Study Period|Hearing loss|0|||
27980373|NCT02068118|81760118|FG001|18-month Comparative Study Period|Hearing loss|1|||
27980374|NCT02068118|81760117|FG000|Extension Period|Death|0|||
27980375|NCT02068118|81760118|FG001|Extension Period|Death|2|||
27980376|NCT02068118|81760117|FG000|Extension Period|Withdrawal by Subject|1|||
27980377|NCT02068118|81760118|FG001|Extension Period|Withdrawal by Subject|0|||
27980378|NCT02068118|81760117|FG000|Extension Period|Heart transplant|1|||
27980379|NCT02068118|81760118|FG001|Extension Period|Heart transplant|0|||
27980380|NCT02068118|81760117|FG000|Extension Period|Wrong device use|0|||
27980381|NCT02068118|81760118|FG001|Extension Period|Wrong device use|1|||
27980382|NCT04021524|81760125|FG000|Overall Study|Change in surgical intervention|0|||
27980383|NCT04021524|81760126|FG001|Overall Study|Change in surgical intervention|1|||
27980384|NCT03077698|81760127|FG000|Progestin Monotherapy|Stable Disease|8|||
27793513|NCT03628781|81075356|FG001|Overall Study|Withdrawal by Subject|1|||
27793514|NCT00457249|81075357|FG000|Overall Study|Lost to Follow-up|3|||
27980385|NCT03077698|81760128|FG001|Progestin Monotherapy|Stable Disease|0|||
27576040|NCT02460224|80293044|FG014|Overall Study|Physician Decision|0|||
27576041|NCT02460224|80293045|FG015|Overall Study|Physician Decision|0|||
27793515|NCT00457249|81075358|FG001|Overall Study|Lost to Follow-up|0|||
27576042|NCT02460224|80293046|FG016|Overall Study|Physician Decision|2|||
27576043|NCT02460224|80293047|FG017|Overall Study|Physician Decision|1|||
27576044|NCT02460224|80293048|FG018|Overall Study|Physician Decision|1|||
27576045|NCT02460224|80293049|FG019|Overall Study|Physician Decision|2|||
27576046|NCT02460224|80293050|FG020|Overall Study|Physician Decision|1|||
27576047|NCT02460224|80293051|FG021|Overall Study|Physician Decision|1|||
27576048|NCT02460224|80293052|FG022|Overall Study|Physician Decision|0|||
27576049|NCT02460224|80293053|FG023|Overall Study|Physician Decision|0|||
27576050|NCT02460224|80293054|FG024|Overall Study|Physician Decision|1|||
27576051|NCT02460224|80293055|FG025|Overall Study|Physician Decision|0|||
27576052|NCT02460224|80293056|FG026|Overall Study|Physician Decision|14|||
27576053|NCT02460224|80293057|FG027|Overall Study|Physician Decision|1|||
27576054|NCT02460224|80293058|FG028|Overall Study|Physician Decision|6|||
27576055|NCT02460224|80293030|FG000|Overall Study|Progressive disease|15|||
27576056|NCT02460224|80293031|FG001|Overall Study|Progressive disease|11|||
27576057|NCT02460224|80293032|FG002|Overall Study|Progressive disease|5|||
27576058|NCT02460224|80293033|FG003|Overall Study|Progressive disease|6|||
27576059|NCT02460224|80293034|FG004|Overall Study|Progressive disease|3|||
27576060|NCT02460224|80293035|FG005|Overall Study|Progressive disease|26|||
27576061|NCT02460224|80293036|FG006|Overall Study|Progressive disease|28|||
27576062|NCT02460224|80293037|FG007|Overall Study|Progressive disease|4|||
27576063|NCT02460224|80293038|FG008|Overall Study|Progressive disease|5|||
27576064|NCT02460224|80293039|FG009|Overall Study|Progressive disease|9|||
27576065|NCT02460224|80293040|FG010|Overall Study|Progressive disease|5|||
27576066|NCT02460224|80293041|FG011|Overall Study|Progressive disease|4|||
27576067|NCT02460224|80293042|FG012|Overall Study|Progressive disease|5|||
27576068|NCT02460224|80293043|FG013|Overall Study|Progressive disease|4|||
27576069|NCT02460224|80293044|FG014|Overall Study|Progressive disease|5|||
27576070|NCT02460224|80293045|FG015|Overall Study|Progressive disease|5|||
27576071|NCT02460224|80293046|FG016|Overall Study|Progressive disease|15|||
27576072|NCT02460224|80293047|FG017|Overall Study|Progressive disease|3|||
27576073|NCT02460224|80293048|FG018|Overall Study|Progressive disease|8|||
27576074|NCT02460224|80293049|FG019|Overall Study|Progressive disease|3|||
27576075|NCT02460224|80293050|FG020|Overall Study|Progressive disease|4|||
27576076|NCT02460224|80293051|FG021|Overall Study|Progressive disease|9|||
27576077|NCT02460224|80293052|FG022|Overall Study|Progressive disease|4|||
27576078|NCT02460224|80293053|FG023|Overall Study|Progressive disease|11|||
27576079|NCT02460224|80293054|FG024|Overall Study|Progressive disease|4|||
27576080|NCT02460224|80293055|FG025|Overall Study|Progressive disease|5|||
27576081|NCT02460224|80293056|FG026|Overall Study|Progressive disease|85|||
27576082|NCT02460224|80293057|FG027|Overall Study|Progressive disease|17|||
27576083|NCT02460224|80293058|FG028|Overall Study|Progressive disease|77|||
27576084|NCT02460224|80293030|FG000|Overall Study|Subject/guardian decision|2|||
27576085|NCT02460224|80293031|FG001|Overall Study|Subject/guardian decision|0|||
27576086|NCT02460224|80293032|FG002|Overall Study|Subject/guardian decision|1|||
27576087|NCT02460224|80293033|FG003|Overall Study|Subject/guardian decision|0|||
27576088|NCT02460224|80293034|FG004|Overall Study|Subject/guardian decision|2|||
27576089|NCT02460224|80293035|FG005|Overall Study|Subject/guardian decision|2|||
27576090|NCT02460224|80293036|FG006|Overall Study|Subject/guardian decision|0|||
27576091|NCT02460224|80293037|FG007|Overall Study|Subject/guardian decision|0|||
27576092|NCT02460224|80293038|FG008|Overall Study|Subject/guardian decision|1|||
27576093|NCT02460224|80293039|FG009|Overall Study|Subject/guardian decision|1|||
27576094|NCT02460224|80293040|FG010|Overall Study|Subject/guardian decision|0|||
27576095|NCT02460224|80293041|FG011|Overall Study|Subject/guardian decision|1|||
27576096|NCT02460224|80293042|FG012|Overall Study|Subject/guardian decision|0|||
27673316|NCT02201901|80639417|FG000|Overall Study|Lack of Efficacy|7|||
27793516|NCT00457249|81075357|FG000|Overall Study|Protocol Violation|4|||
27867990|NCT01130493|81353716|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
27980386|NCT03077698|81760127|FG000|Progestin Monotherapy|Adverse Event|1|||
27980387|NCT03077698|81760128|FG001|Progestin Monotherapy|Adverse Event|0|||
27980388|NCT03077698|81760127|FG000|Progestin Monotherapy|Death|1|||
27576097|NCT02460224|80293043|FG013|Overall Study|Subject/guardian decision|0|||
27576098|NCT02460224|80293044|FG014|Overall Study|Subject/guardian decision|0|||
27576099|NCT02460224|80293045|FG015|Overall Study|Subject/guardian decision|1|||
27576100|NCT02460224|80293046|FG016|Overall Study|Subject/guardian decision|0|||
27576101|NCT02460224|80293047|FG017|Overall Study|Subject/guardian decision|1|||
27576102|NCT02460224|80293048|FG018|Overall Study|Subject/guardian decision|2|||
27576103|NCT02460224|80293049|FG019|Overall Study|Subject/guardian decision|0|||
27980389|NCT03077698|81760128|FG001|Progestin Monotherapy|Death|0|||
27980390|NCT03077698|81760127|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
27576104|NCT02460224|80293050|FG020|Overall Study|Subject/guardian decision|0|||
27576105|NCT02460224|80293051|FG021|Overall Study|Subject/guardian decision|1|||
27576106|NCT02460224|80293052|FG022|Overall Study|Subject/guardian decision|0|||
27980391|NCT03077698|81760128|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
27980392|NCT03077698|81760127|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
27576107|NCT02460224|80293053|FG023|Overall Study|Subject/guardian decision|0|||
27576108|NCT02460224|80293054|FG024|Overall Study|Subject/guardian decision|0|||
27576109|NCT02460224|80293055|FG025|Overall Study|Subject/guardian decision|0|||
27673317|NCT02201901|80639418|FG001|Overall Study|Lack of Efficacy|1|||
27673318|NCT02201901|80639419|FG002|Overall Study|Lack of Efficacy|6|||
27673319|NCT02201901|80639417|FG000|Overall Study|Death|3|||
27673320|NCT02201901|80639418|FG001|Overall Study|Death|3|||
27673321|NCT02201901|80639419|FG002|Overall Study|Death|3|||
27673322|NCT02201901|80639417|FG000|Overall Study|Lost to Follow-up|2|||
27673323|NCT02201901|80639418|FG001|Overall Study|Lost to Follow-up|3|||
27673324|NCT02201901|80639419|FG002|Overall Study|Lost to Follow-up|2|||
27673325|NCT02201901|80639417|FG000|Overall Study|Withdrew Consent|2|||
27673326|NCT02201901|80639418|FG001|Overall Study|Withdrew Consent|0|||
27673327|NCT02201901|80639419|FG002|Overall Study|Withdrew Consent|2|||
27673328|NCT02201901|80639417|FG000|Overall Study|Adverse Event|1|||
27673329|NCT02201901|80639418|FG001|Overall Study|Adverse Event|1|||
27673330|NCT02201901|80639419|FG002|Overall Study|Adverse Event|0|||
27673331|NCT02080403|80639420|FG000|Overall Study|Adverse Event|5|||
27673332|NCT02080403|80639421|FG001|Overall Study|Adverse Event|1|||
27673333|NCT02080403|80639420|FG000|Overall Study|Death|0|||
27673334|NCT02080403|80639421|FG001|Overall Study|Death|2|||
27673335|NCT02080403|80639420|FG000|Overall Study|Lost to Follow-up|2|||
27673336|NCT02080403|80639421|FG001|Overall Study|Lost to Follow-up|0|||
27673337|NCT02080403|80639420|FG000|Overall Study|Pregnancy|0|||
27673338|NCT02080403|80639421|FG001|Overall Study|Pregnancy|1|||
27673339|NCT02080403|80639420|FG000|Overall Study|Protocol Violation|3|||
27980393|NCT03077698|81760128|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
27980394|NCT03077698|81760127|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
27673340|NCT02080403|80639421|FG001|Overall Study|Protocol Violation|7|||
27673341|NCT02080403|80639420|FG000|Overall Study|Withdrawal by Subject|5|||
27673342|NCT02080403|80639421|FG001|Overall Study|Withdrawal by Subject|1|||
27673343|NCT03712449|80639422|FG000|Overall Study|Withdraw Consent|0|||
27673344|NCT03712449|80639423|FG001|Overall Study|Withdraw Consent|1|||
27673345|NCT01952847|80639426|FG000|Overall Study|Ineligible|1|||
27980395|NCT03077698|81760128|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
27980396|NCT03077698|81760127|FG000|Safety Follow Up|Withdrawal by Subject|2|||
27980397|NCT03077698|81760128|FG001|Safety Follow Up|Withdrawal by Subject|1|||
27980398|NCT03077698|81760127|FG000|Safety Follow Up|Transfer of care to hospice|1|||
27793517|NCT00457249|81075358|FG001|Overall Study|Protocol Violation|1|||
27793518|NCT00457249|81075357|FG000|Overall Study|Withdrawal by Subject|3|||
27793519|NCT00457249|81075358|FG001|Overall Study|Withdrawal by Subject|1|||
27793520|NCT00457249|81075357|FG000|Overall Study|Serious Adverse Events|2|||
27793521|NCT00457249|81075358|FG001|Overall Study|Serious Adverse Events|0|||
27793522|NCT03971422|81075359|FG000|Overall Study|Lost to Follow-up|0|||
27793523|NCT03971422|81075360|FG001|Overall Study|Lost to Follow-up|1|||
27793524|NCT03971422|81075361|FG002|Overall Study|Lost to Follow-up|0|||
27980399|NCT03077698|81760128|FG001|Safety Follow Up|Transfer of care to hospice|0|||
27980400|NCT00316888|81760129|FG000|Overall Study|Adverse Event|4|||
27673346|NCT01952847|80639427|FG001|Overall Study|Ineligible|0|||
27793525|NCT03971422|81075359|FG000|Overall Study|Lack of Efficacy|5|||
27980401|NCT00316888|81760130|FG001|Overall Study|Adverse Event|5|||
27980402|NCT00316888|81760129|FG000|Overall Study|Withdrawal by Subject|2|||
27980403|NCT00316888|81760130|FG001|Overall Study|Withdrawal by Subject|2|||
27673347|NCT01952847|80639428|FG002|Overall Study|Ineligible|0|||
27673348|NCT01952847|80639429|FG003|Overall Study|Ineligible|0|||
27673349|NCT01952847|80639426|FG000|Overall Study|Lack of Insurance Coverage|0|||
27673350|NCT01952847|80639427|FG001|Overall Study|Lack of Insurance Coverage|1|||
27980404|NCT00316888|81760129|FG000|Overall Study|Not start protocol therapy|0|||
27980405|NCT00316888|81760130|FG001|Overall Study|Not start protocol therapy|1|||
27673351|NCT01952847|80639428|FG002|Overall Study|Lack of Insurance Coverage|0|||
27673352|NCT01952847|80639429|FG003|Overall Study|Lack of Insurance Coverage|0|||
27673353|NCT01952847|80639426|FG000|Overall Study|Withdrawal by Subject|1|||
27673354|NCT01952847|80639427|FG001|Overall Study|Withdrawal by Subject|1|||
27673355|NCT01952847|80639428|FG002|Overall Study|Withdrawal by Subject|0|||
27793526|NCT03971422|81075360|FG001|Overall Study|Lack of Efficacy|1|||
27793527|NCT03971422|81075361|FG002|Overall Study|Lack of Efficacy|1|||
27673356|NCT01952847|80639429|FG003|Overall Study|Withdrawal by Subject|1|||
27673357|NCT00543062|80639430|FG000|Overall Study|Withdrawal by Subject|1|||
27673358|NCT00543062|80639431|FG001|Overall Study|Withdrawal by Subject|0|||
27673359|NCT00543062|80639432|FG002|Overall Study|Withdrawal by Subject|2|||
27673360|NCT00543062|80639433|FG003|Overall Study|Withdrawal by Subject|0|||
27673361|NCT00543062|80639430|FG000|Overall Study|Adverse Event|0|||
27673362|NCT00543062|80639431|FG001|Overall Study|Adverse Event|1|||
27673363|NCT00543062|80639432|FG002|Overall Study|Adverse Event|1|||
27673364|NCT00543062|80639433|FG003|Overall Study|Adverse Event|1|||
27673365|NCT00543062|80639430|FG000|Overall Study|Protocol Violation|1|||
27673366|NCT00543062|80639431|FG001|Overall Study|Protocol Violation|0|||
27673367|NCT00543062|80639432|FG002|Overall Study|Protocol Violation|0|||
27673368|NCT00543062|80639433|FG003|Overall Study|Protocol Violation|0|||
27673369|NCT03113383|80639434|FG000|Overall Study|Death|4|||
27673370|NCT03113383|80639435|FG001|Overall Study|Death|0|||
27673371|NCT00013611|80639440|FG000|Overall Study|Lost to Follow-up|91|||
27673372|NCT00013611|80639441|FG001|Overall Study|Lost to Follow-up|100|||
27673373|NCT00781937|80643187|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
27673374|NCT00781937|80643188|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
27673375|NCT00781937|80643187|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
27673376|NCT00781937|80643188|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
27673377|NCT00781937|80643187|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
27673378|NCT00781937|80643188|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
27673379|NCT00781937|80643187|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
27673380|NCT00781937|80643188|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
27673381|NCT00781937|80643187|FG000|Main Trial Period Through Week 56|Unclassified|10|||
27673382|NCT00781937|80643188|FG001|Main Trial Period Through Week 56|Unclassified|15|||
27673383|NCT00781937|80643187|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
27673384|NCT00781937|80643188|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
27673385|NCT00781937|80643187|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
27673386|NCT00781937|80643188|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
27673387|NCT02153905|80643191|FG000|Overall Study|Death|1|||
27673388|NCT02153905|80643192|FG001|Overall Study|Death|0|||
27980406|NCT02683668|81760131|FG000|Period 2|Withdrawal by Subject|0|||
27980407|NCT02683668|81760132|FG001|Period 2|Withdrawal by Subject|1|||
27980408|NCT02683668|81760133|FG002|Period 2|Withdrawal by Subject|0|||
27980409|NCT01638559|81760134|FG000|Overall Study|Lost to Follow-up|1|||
27980410|NCT01638559|81760134|FG000|Overall Study|Withdrawal by Subject|1|||
27980411|NCT01638559|81760134|FG000|Overall Study|Subject declined to travel for biopsy|1|||
27980412|NCT00475865|81760135|FG000|Overall Study|Adverse Event|0|||
27980413|NCT00475865|81760136|FG001|Overall Study|Adverse Event|3|||
27980414|NCT00475865|81760137|FG002|Overall Study|Adverse Event|4|||
27980415|NCT00475865|81760135|FG000|Overall Study|Lack of Efficacy|1|||
27980416|NCT00475865|81760136|FG001|Overall Study|Lack of Efficacy|0|||
27980417|NCT00475865|81760137|FG002|Overall Study|Lack of Efficacy|0|||
27980418|NCT00475865|81760135|FG000|Overall Study|Progressive disease|0|||
27980419|NCT00475865|81760136|FG001|Overall Study|Progressive disease|1|||
27980420|NCT00475865|81760137|FG002|Overall Study|Progressive disease|2|||
27980421|NCT00475865|81760135|FG000|Overall Study|Participant did not wish to continue|1|||
27980422|NCT00475865|81760136|FG001|Overall Study|Participant did not wish to continue|0|||
27980423|NCT00475865|81760137|FG002|Overall Study|Participant did not wish to continue|0|||
27576110|NCT02460224|80293056|FG026|Overall Study|Subject/guardian decision|6|||
27576111|NCT02460224|80293057|FG027|Overall Study|Subject/guardian decision|2|||
27673389|NCT01174264|80643193|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
27673390|NCT01174264|80643194|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
27673391|NCT01174264|80643195|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
27673392|NCT01174264|80643193|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
27673393|NCT01174264|80643194|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
27673394|NCT01174264|80643195|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
27980424|NCT00475865|81760135|FG000|Overall Study|Other than above|0|||
27980425|NCT00475865|81760136|FG001|Overall Study|Other than above|1|||
27673395|NCT01174264|80643193|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
27673396|NCT01174264|80643194|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
27673397|NCT01174264|80643195|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
27673398|NCT00916305|80643196|FG000|Overall Study|Lost to Follow-up|21|||
27980426|NCT00475865|81760137|FG002|Overall Study|Other than above|0|||
27980427|NCT00680368|81760138|FG000|Overall Study|not supervised, not eligible|15|||
27980428|NCT02689076|81760144|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
27980429|NCT02689076|81760145|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
27980430|NCT02689076|81760146|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
27980431|NCT02689076|81760144|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
27980432|NCT02689076|81760145|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
27980433|NCT02689076|81760146|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
27980434|NCT02689076|81760144|FG000|Overall Study|Did not have an HIE match|2|||
27980435|NCT02689076|81760145|FG001|Overall Study|Did not have an HIE match|0|||
27980436|NCT02689076|81760146|FG002|Overall Study|Did not have an HIE match|0|||
27980437|NCT02689076|81760144|FG000|Overall Study|Death during non-VA encounter|2|||
27980438|NCT02689076|81760145|FG001|Overall Study|Death during non-VA encounter|5|||
27980439|NCT02689076|81760146|FG002|Overall Study|Death during non-VA encounter|0|||
27980440|NCT02689076|81760144|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
27980441|NCT02689076|81760145|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
27980442|NCT02689076|81760146|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
27980443|NCT02689076|81760144|FG000|Overall Study|Participant no longer active in VA system|1|||
27980444|NCT02689076|81760145|FG001|Overall Study|Participant no longer active in VA system|0|||
27980445|NCT02689076|81760146|FG002|Overall Study|Participant no longer active in VA system|0|||
27980446|NCT02689076|81760144|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
27980447|NCT02689076|81760145|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
27980448|NCT02689076|81760146|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
27673399|NCT00916305|80643197|FG001|Overall Study|Lost to Follow-up|27|||
27673400|NCT00916305|80643196|FG000|Overall Study|Withdrawal by Subject|0|||
27673401|NCT00916305|80643197|FG001|Overall Study|Withdrawal by Subject|1|||
27673402|NCT04211389|80643198|FG000|Overall Study|Adverse Event|1|||
27673403|NCT04211389|80643199|FG001|Overall Study|Adverse Event|2|||
27793528|NCT03971422|81075359|FG000|Overall Study|Adverse event, not fatal|2|||
27793529|NCT03971422|81075360|FG001|Overall Study|Adverse event, not fatal|2|||
27793530|NCT03971422|81075361|FG002|Overall Study|Adverse event, not fatal|5|||
27793531|NCT03971422|81075359|FG000|Overall Study|Worsening of MG Symptoms|1|||
27793532|NCT03971422|81075360|FG001|Overall Study|Worsening of MG Symptoms|4|||
27793533|NCT03971422|81075361|FG002|Overall Study|Worsening of MG Symptoms|2|||
27793534|NCT03971422|81075359|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
27793535|NCT03971422|81075360|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
27793536|NCT03971422|81075361|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
27793537|NCT03971422|81075359|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
27793538|NCT03971422|81075360|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
27793539|NCT03971422|81075361|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
27793540|NCT03971422|81075359|FG000|Overall Study|Due to COVID-19 pandemic|0|||
27793541|NCT03971422|81075360|FG001|Overall Study|Due to COVID-19 pandemic|1|||
27793542|NCT03971422|81075361|FG002|Overall Study|Due to COVID-19 pandemic|1|||
27793555|NCT02918318|81075364|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
27793556|NCT02918318|81075365|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
27793557|NCT02918318|81075366|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
27793558|NCT02918318|81075367|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
27793559|NCT02918318|81075368|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
27793560|NCT02918318|81075364|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
27673404|NCT04211389|80643198|FG000|Overall Study|Lost to Follow-up|15|||
27673405|NCT04211389|80643199|FG001|Overall Study|Lost to Follow-up|7|||
27673406|NCT04211389|80643198|FG000|Overall Study|Protocol Violation|0|||
27793561|NCT02918318|81075365|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
27793562|NCT02918318|81075366|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
27793563|NCT02918318|81075367|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
27793564|NCT02918318|81075368|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
27793565|NCT02918318|81075364|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
27793566|NCT02918318|81075365|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
27793567|NCT02918318|81075366|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
27793568|NCT02918318|81075367|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
27793569|NCT02918318|81075368|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
27793570|NCT02918318|81075364|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
27793571|NCT02918318|81075365|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
27867991|NCT01130493|81353717|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
27867992|NCT01130493|81353718|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
27867993|NCT01130493|81353716|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
27867994|NCT01130493|81353717|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
27867995|NCT01130493|81353718|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
27867996|NCT01130493|81353716|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
27867997|NCT01130493|81353717|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
27867998|NCT01130493|81353718|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
27867999|NCT01130493|81353716|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
27868000|NCT01130493|81353717|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
27868001|NCT01130493|81353718|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
27868002|NCT01130493|81353716|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
27868003|NCT01130493|81353717|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
27868004|NCT01130493|81353718|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
27868005|NCT01130493|81353716|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
27868006|NCT01130493|81353717|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
27868007|NCT01130493|81353718|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
27868008|NCT01130493|81353716|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
27868009|NCT01130493|81353717|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
27868010|NCT01130493|81353718|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
27793572|NCT02918318|81075366|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
27793573|NCT02918318|81075367|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
27868011|NCT01130493|81353716|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
27868012|NCT01130493|81353717|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
27868013|NCT01130493|81353718|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
27868014|NCT01130493|81353716|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
27868015|NCT01130493|81353717|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
27868016|NCT01130493|81353718|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
27868017|NCT01130493|81353716|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
27868018|NCT01130493|81353717|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
27868019|NCT01130493|81353718|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
27868020|NCT01130493|81353716|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
27868021|NCT01130493|81353717|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
27868022|NCT01130493|81353718|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
27868023|NCT01130493|81353716|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
27868024|NCT01130493|81353717|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
27868025|NCT01130493|81353718|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
27868026|NCT01130493|81353716|FG000|Part 2: OLE|Adverse Event|0|||
27868027|NCT01130493|81353717|FG001|Part 2: OLE|Adverse Event|2|||
27868028|NCT01130493|81353718|FG002|Part 2: OLE|Adverse Event|1|||
27980449|NCT00459537|81760147|FG000|Overall Study|Adverse Event|1|||
27980450|NCT00459537|81760148|FG001|Overall Study|Adverse Event|6|||
27980451|NCT00459537|81760147|FG000|Overall Study|Lack of Efficacy|10|||
27980452|NCT00459537|81760148|FG001|Overall Study|Lack of Efficacy|11|||
27793574|NCT02918318|81075368|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
27793575|NCT02918318|81075364|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
27980453|NCT00459537|81760147|FG000|Overall Study|Withdrawal by Subject|20|||
27980454|NCT00459537|81760148|FG001|Overall Study|Withdrawal by Subject|26|||
27980455|NCT00459537|81760147|FG000|Overall Study|Lost to Follow-up|27|||
27980456|NCT00459537|81760148|FG001|Overall Study|Lost to Follow-up|30|||
27980457|NCT00459537|81760147|FG000|Overall Study|Administrative problems|3|||
27980458|NCT00459537|81760148|FG001|Overall Study|Administrative problems|0|||
27980459|NCT00459537|81760147|FG000|Overall Study|Protocol Violation|4|||
27980460|NCT00459537|81760148|FG001|Overall Study|Protocol Violation|3|||
27980461|NCT00459537|81760147|FG000|Overall Study|Missing|1|||
27980462|NCT00459537|81760148|FG001|Overall Study|Missing|0|||
27980463|NCT02636946|81760153|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
27980464|NCT02636946|81760154|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
27793576|NCT02918318|81075365|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
27793577|NCT02918318|81075366|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
27980465|NCT02636946|81760153|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
27793578|NCT02918318|81075367|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
27868029|NCT01130493|81353716|FG000|Part 2: OLE|Withdrawal by Subject|0|||
27868030|NCT01130493|81353717|FG001|Part 2: OLE|Withdrawal by Subject|1|||
27868031|NCT01130493|81353718|FG002|Part 2: OLE|Withdrawal by Subject|4|||
27793579|NCT02918318|81075368|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
27793580|NCT02918318|81075364|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
27793581|NCT02918318|81075365|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
27793582|NCT02918318|81075366|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
27980466|NCT02636946|81760154|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
27980467|NCT02636946|81760153|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
27980468|NCT02636946|81760154|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
27980469|NCT02636946|81760153|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
27980470|NCT02636946|81760154|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
27980471|NCT02636946|81760153|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
27980472|NCT02636946|81760154|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
27980473|NCT02636946|81760153|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
27980474|NCT02636946|81760154|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
27980475|NCT01143896|81760155|FG000|Overall Study|Did not complete Baseline Interview|5|||
27980476|NCT01143896|81760156|FG001|Overall Study|Did not complete Baseline Interview|4|||
27980477|NCT01143896|81760155|FG000|Overall Study|Lost to Follow-up|18|||
27980478|NCT01143896|81760156|FG001|Overall Study|Lost to Follow-up|13|||
27793583|NCT02918318|81075367|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
27793584|NCT02918318|81075368|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
27793585|NCT02918318|81075364|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
27793586|NCT02918318|81075365|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
27793587|NCT02918318|81075366|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
27793588|NCT02918318|81075367|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
27793589|NCT02918318|81075368|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
27793590|NCT02918318|81075364|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
27793591|NCT02918318|81075365|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
27793592|NCT02918318|81075366|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
27793593|NCT02918318|81075367|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
27793594|NCT02918318|81075368|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
27793595|NCT02918318|81075364|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
27793596|NCT02918318|81075365|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
27793597|NCT02918318|81075366|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
27793598|NCT02918318|81075367|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
27793599|NCT02918318|81075368|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
27793600|NCT02918318|81075364|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
27793601|NCT02918318|81075365|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
27793602|NCT02918318|81075366|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
27793603|NCT02918318|81075367|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
27793604|NCT02918318|81075368|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
27793605|NCT02918318|81075364|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
27793606|NCT02918318|81075365|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
27793607|NCT02918318|81075366|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
27793608|NCT02918318|81075367|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
27793609|NCT02918318|81075368|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
27793610|NCT02918318|81075364|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
27868032|NCT04564092|81353719|FG000|Overall Study|Withdrawal by Subject|1|||
27868033|NCT01399658|81353720|FG000|Overall Study|Ineligible|1|||
27576112|NCT02460224|80293058|FG028|Overall Study|Subject/guardian decision|3|||
27576113|NCT04068181|80293060|FG000|Overall Study|Withdrawal by Subject|2|||
27868034|NCT01399658|81353720|FG000|Overall Study|Machine Technical Issue|3|||
27980479|NCT01143896|81760155|FG000|Overall Study|Withdrawal by Subject|13|||
27793611|NCT02918318|81075365|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
27793612|NCT02918318|81075366|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
27793613|NCT02918318|81075367|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
27793614|NCT02918318|81075368|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
27793615|NCT03239340|81075369|FG000|Overall Study|Other|26|||
27793616|NCT03239340|81075369|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
27793617|NCT03239340|81075369|FG000|Overall Study|Death|40|||
27793618|NCT03239340|81075369|FG000|Overall Study|Lost to Follow-up|2|||
27793619|NCT03239340|81075369|FG000|Overall Study|Physician Decision|16|||
27868035|NCT01399658|81353720|FG000|Overall Study|Alternative therapy|1|||
27868036|NCT01399658|81353720|FG000|Overall Study|No reason given|1|||
27868037|NCT00191191|81353721|FG000|Overall Study|Entry Criteria Exclusion|2|||
27793620|NCT03239340|81075369|FG000|Overall Study|Withdrawal by Subject|27|||
27793621|NCT03290131|81075376|FG000|Overall Study|Adverse Event|22|||
27793622|NCT03290131|81075377|FG001|Overall Study|Adverse Event|57|||
27793623|NCT03290131|81075378|FG002|Overall Study|Adverse Event|11|||
27793624|NCT03290131|81075376|FG000|Overall Study|Withdrawal by Subject|18|||
27793625|NCT03290131|81075377|FG001|Overall Study|Withdrawal by Subject|13|||
27793626|NCT03290131|81075378|FG002|Overall Study|Withdrawal by Subject|8|||
27793627|NCT03290131|81075376|FG000|Overall Study|MS Relapse|2|||
27793628|NCT03290131|81075377|FG001|Overall Study|MS Relapse|1|||
27793629|NCT03290131|81075378|FG002|Overall Study|MS Relapse|0|||
27793630|NCT03290131|81075376|FG000|Overall Study|Unknown reason|0|||
27793631|NCT03290131|81075377|FG001|Overall Study|Unknown reason|1|||
27793632|NCT03290131|81075378|FG002|Overall Study|Unknown reason|0|||
27793633|NCT00684645|81075381|FG000|Overall Study|Death|2|||
27793634|NCT00684645|81075381|FG000|Overall Study|Progressive disease|67|||
27793635|NCT00684645|81075381|FG000|Overall Study|Adverse Event|27|||
27793636|NCT00684645|81075381|FG000|Overall Study|Lost to Follow-up|3|||
27793637|NCT00684645|81075381|FG000|Overall Study|Other|15|||
27793638|NCT00351611|81075386|FG000|Overall Study|Adverse Event|11|||
27793639|NCT00351611|81075387|FG001|Overall Study|Adverse Event|3|||
27793640|NCT00351611|81075386|FG000|Overall Study|Death|1|||
27793641|NCT00351611|81075387|FG001|Overall Study|Death|0|||
27793642|NCT00351611|81075386|FG000|Overall Study|Lost to Follow-up|1|||
27793643|NCT00351611|81075387|FG001|Overall Study|Lost to Follow-up|0|||
27793644|NCT00351611|81075386|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
27793645|NCT00351611|81075387|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
27793646|NCT00351611|81075386|FG000|Overall Study|Other|1|||
27793647|NCT00351611|81075387|FG001|Overall Study|Other|0|||
27793648|NCT00351611|81075386|FG000|Overall Study|Protocol Violation|0|||
27793649|NCT00351611|81075387|FG001|Overall Study|Protocol Violation|2|||
27793650|NCT02916056|81075391|FG000|Overall Study|Adverse Event|6|||
27793651|NCT02916056|81075391|FG000|Overall Study|Lost to Follow-up|1|||
27793652|NCT02916056|81075391|FG000|Overall Study|Other|12|||
27793653|NCT02916056|81075391|FG000|Overall Study|Protocol Violation|1|||
27793654|NCT02916056|81075391|FG000|Overall Study|Withdrawal by Subject|8|||
27793655|NCT02916056|81075391|FG000|Overall Study|Study Terminated by Sponsor|269|||
27793656|NCT04513665|81075392|FG000|Overall Study|Adverse Event|2|||
27793657|NCT04513665|81075393|FG001|Overall Study|Adverse Event|0|||
27793658|NCT04513665|81075392|FG000|Overall Study|Lack of Efficacy|14|||
27793659|NCT04513665|81075393|FG001|Overall Study|Lack of Efficacy|0|||
27793660|NCT01418365|81075394|FG000|First Intervention|Withdrawal by Subject|0|||
27793661|NCT01418365|81075395|FG001|First Intervention|Withdrawal by Subject|1|||
27868038|NCT00191191|81353722|FG001|Overall Study|Entry Criteria Exclusion|0|||
27868039|NCT00191191|81353721|FG000|Overall Study|Treated with Another Systemic Agent|1|||
27868040|NCT00191191|81353722|FG001|Overall Study|Treated with Another Systemic Agent|1|||
27868041|NCT00191191|81353721|FG000|Overall Study|Adverse Event|11|||
27868042|NCT00191191|81353722|FG001|Overall Study|Adverse Event|21|||
27868043|NCT00191191|81353721|FG000|Overall Study|Progressive Disease|84|||
27868044|NCT00191191|81353722|FG001|Overall Study|Progressive Disease|72|||
27868045|NCT00191191|81353721|FG000|Overall Study|Toxicity After Dose Reduction|7|||
27868046|NCT00191191|81353722|FG001|Overall Study|Toxicity After Dose Reduction|8|||
27868047|NCT00191191|81353721|FG000|Overall Study|Family/Caregiver Decision|5|||
27793662|NCT01418365|81075394|FG000|First Intervention|Non-compliance|1|||
27793663|NCT01418365|81075395|FG001|First Intervention|Non-compliance|0|||
27793664|NCT01418365|81075394|FG000|Second Intervention|Withdrawal by Subject|0|||
27793665|NCT01418365|81075395|FG001|Second Intervention|Withdrawal by Subject|1|||
27868048|NCT00191191|81353722|FG001|Overall Study|Family/Caregiver Decision|7|||
27793666|NCT00464308|81075396|FG000|Overall Study|Adverse Event|22|||
27868049|NCT00191191|81353721|FG000|Overall Study|Lost to Follow-up|1|||
27793667|NCT00464308|81075397|FG001|Overall Study|Adverse Event|27|||
27793668|NCT00464308|81075398|FG002|Overall Study|Adverse Event|16|||
27793669|NCT00464308|81075396|FG000|Overall Study|Lost to Follow-up|29|||
27793670|NCT00464308|81075397|FG001|Overall Study|Lost to Follow-up|19|||
27793671|NCT00464308|81075398|FG002|Overall Study|Lost to Follow-up|20|||
27793672|NCT00464308|81075396|FG000|Overall Study|Patient discontinued and other reasons|17|||
27868050|NCT00191191|81353722|FG001|Overall Study|Lost to Follow-up|0|||
27868051|NCT00191191|81353721|FG000|Overall Study|Physician Decision|3|||
27980480|NCT01143896|81760156|FG001|Overall Study|Withdrawal by Subject|5|||
27980481|NCT01143896|81760155|FG000|Overall Study|Death|6|||
27980482|NCT01143896|81760156|FG001|Overall Study|Death|3|||
27980483|NCT03374202|81760164|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
27980484|NCT03374202|81760165|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
27980485|NCT03374202|81760166|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
27980486|NCT03374202|81760164|FG000|Five Year Long Term Follow Up|Death|0|||
27980487|NCT03374202|81760165|FG001|Five Year Long Term Follow Up|Death|1|||
27980488|NCT03374202|81760166|FG002|Five Year Long Term Follow Up|Death|0|||
27980489|NCT03761394|81760169|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
27980490|NCT03761394|81760170|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
27980491|NCT03761394|81760171|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
27980492|NCT03761394|81760172|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
27980493|NCT03761394|81760169|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
27980494|NCT03761394|81760170|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
27980495|NCT03761394|81760171|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
27980496|NCT03761394|81760172|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
27980497|NCT03761394|81760169|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
27980498|NCT03761394|81760170|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
27980499|NCT03761394|81760171|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
27980500|NCT03761394|81760172|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
27980501|NCT03761394|81760169|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
27980502|NCT03761394|81760170|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
27980503|NCT03761394|81760171|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
27980504|NCT03761394|81760172|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
27980505|NCT03474081|81760173|FG000|Overall Study|Adverse Event|6|||
27980506|NCT03474081|81760174|FG001|Overall Study|Adverse Event|3|||
27980507|NCT03474081|81760173|FG000|Overall Study|Lost to Follow-up|2|||
27980508|NCT03474081|81760174|FG001|Overall Study|Lost to Follow-up|1|||
27980509|NCT03474081|81760173|FG000|Overall Study|Physician Decision|3|||
27980510|NCT03474081|81760174|FG001|Overall Study|Physician Decision|2|||
27980511|NCT03474081|81760173|FG000|Overall Study|Withdrawal by Subject|5|||
27980512|NCT03474081|81760174|FG001|Overall Study|Withdrawal by Subject|7|||
27980513|NCT03474081|81760173|FG000|Overall Study|Investigator site closed|1|||
27980514|NCT03474081|81760174|FG001|Overall Study|Investigator site closed|0|||
27980515|NCT03559699|81760175|FG000|Overall Study|Withdrawal by Subject|6|||
27980516|NCT03559699|81760175|FG000|Overall Study|Lost to Follow-up|1|||
27980517|NCT01350115|81760176|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
27980518|NCT01350115|81760177|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
27980519|NCT01350115|81760176|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
27980520|NCT01350115|81760177|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
27980521|NCT01350115|81760176|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
27980522|NCT01350115|81760177|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
27980523|NCT04384107|81760178|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
27980524|NCT04384107|81760179|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
27980525|NCT04384107|81760178|FG000|Overall Study|Lost to Follow-up|1|||
27980526|NCT04384107|81760179|FG001|Overall Study|Lost to Follow-up|0|||
27980527|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
27980528|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
27980529|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
27980530|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
27980531|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
27980532|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
27980533|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
27980534|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
27980535|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
27980536|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
27980537|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
27868052|NCT00191191|81353722|FG001|Overall Study|Physician Decision|2|||
27980538|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
27980539|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
27980540|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
27980541|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
27980542|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
27980543|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
27980544|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
27980545|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
27980546|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
27980547|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
27980548|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
27980549|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
27980550|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
27980551|NCT01672866|81760181|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
27980552|NCT01672866|81760182|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
27980553|NCT01672866|81760183|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
27980554|NCT01672866|81760181|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
27980555|NCT01672866|81760182|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
27793673|NCT00464308|81075397|FG001|Overall Study|Patient discontinued and other reasons|17|||
27980556|NCT01672866|81760183|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
27980557|NCT01672866|81760181|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
27980558|NCT01672866|81760182|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
27980559|NCT01672866|81760183|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
27980560|NCT01672866|81760181|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
27980561|NCT01672866|81760182|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
27980562|NCT01672866|81760183|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
27980563|NCT01672866|81760181|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
27980564|NCT01672866|81760182|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
27980565|NCT01672866|81760183|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
27980566|NCT00543296|81760184|FG000|Overall Study|Physician Decision|7|||
27980567|NCT02981524|81760185|FG000|Overall Study|Progressive Disease|14|||
27980568|NCT02981524|81760185|FG000|Overall Study|Death (unrelated)|1|||
27980569|NCT02981524|81760185|FG000|Overall Study|Treatment Related Toxicity|1|||
27980570|NCT02981524|81760185|FG000|Overall Study|Withdrawal by Subject|1|||
27793674|NCT00464308|81075398|FG002|Overall Study|Patient discontinued and other reasons|23|||
27793675|NCT00464308|81075396|FG000|Overall Study|Physician Decision|1|||
27793676|NCT00464308|81075397|FG001|Overall Study|Physician Decision|0|||
27793677|NCT00464308|81075398|FG002|Overall Study|Physician Decision|0|||
27793678|NCT00247416|81075400|FG000|Overall Study|3 patients were found to be ineligible|1|||
27793679|NCT00247416|81075401|FG001|Overall Study|3 patients were found to be ineligible|2|||
27793680|NCT02660489|81075402|FG000|Overall Study|Lost to Follow-up|1|||
27793681|NCT02660489|81075403|FG001|Overall Study|Lost to Follow-up|1|||
27868053|NCT00191191|81353721|FG000|Overall Study|Good Clinical Practice Violation|0|||
27868054|NCT00191191|81353722|FG001|Overall Study|Good Clinical Practice Violation|1|||
27868055|NCT01597778|81353725|FG000|Overall Study|Death|7|||
27868056|NCT01597778|81353726|FG001|Overall Study|Death|10|||
27868057|NCT01597778|81353725|FG000|Overall Study|Withdrawal by Subject|3|||
27868058|NCT01597778|81353726|FG001|Overall Study|Withdrawal by Subject|4|||
27868059|NCT01597778|81353725|FG000|Overall Study|Adverse Event|1|||
27868060|NCT01597778|81353726|FG001|Overall Study|Adverse Event|1|||
27793682|NCT02660489|81075402|FG000|Overall Study|Adverse Event|1|||
27793683|NCT02660489|81075403|FG001|Overall Study|Adverse Event|3|||
27793684|NCT02660489|81075402|FG000|Overall Study|no rhinovirus infection|4|||
27793685|NCT02660489|81075403|FG001|Overall Study|no rhinovirus infection|4|||
27793686|NCT04359758|81075404|FG000|Overall Study|Protocol Violation|3|||
27793687|NCT04359758|81075405|FG001|Overall Study|Protocol Violation|2|||
27793688|NCT05146999|81075407|FG000|Overall Study|Withdrew consent|6|||
27793689|NCT05146999|81075408|FG001|Overall Study|Withdrew consent|1|||
27793690|NCT05146999|81075407|FG000|Overall Study|Lost to Follow-up|3|||
27793691|NCT05146999|81075408|FG001|Overall Study|Lost to Follow-up|2|||
27793692|NCT05146999|81075407|FG000|Overall Study|Other|1|||
27793693|NCT05146999|81075408|FG001|Overall Study|Other|3|||
27793694|NCT02243709|81075409|FG000|Phase 1|Lost to Follow-up|0|||
27793695|NCT02243709|81075410|FG001|Phase 1|Lost to Follow-up|1|||
27793696|NCT02243709|81075409|FG000|Phase 1|Withdrawal by Subject|1|||
27868061|NCT01597778|81353725|FG000|Overall Study|Protocol Violation|1|||
27868062|NCT01597778|81353726|FG001|Overall Study|Protocol Violation|11|||
27868063|NCT01597778|81353725|FG000|Overall Study|Transplanted off protocol|2|||
27980571|NCT00392808|81760186|FG000|Overall Study|Lost to Follow-up|3|||
27793697|NCT02243709|81075410|FG001|Phase 1|Withdrawal by Subject|0|||
27793698|NCT02243709|81075409|FG000|Phase 1|Protocol Violation|0|||
27793699|NCT02243709|81075410|FG001|Phase 1|Protocol Violation|1|||
27793700|NCT02243709|81075409|FG000|Phase 1|Adverse Event|0|||
27868064|NCT01597778|81353726|FG001|Overall Study|Transplanted off protocol|3|||
27980572|NCT00392808|81760187|FG001|Overall Study|Lost to Follow-up|2|||
27980573|NCT00392808|81760188|FG002|Overall Study|Lost to Follow-up|1|||
27980574|NCT00392808|81760189|FG003|Overall Study|Lost to Follow-up|2|||
27793701|NCT02243709|81075410|FG001|Phase 1|Adverse Event|1|||
27793702|NCT05299359|81075412|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
27980575|NCT00392808|81760186|FG000|Overall Study|Unable to withdraw blood|3|||
27980576|NCT00392808|81760187|FG001|Overall Study|Unable to withdraw blood|1|||
27980577|NCT00392808|81760188|FG002|Overall Study|Unable to withdraw blood|1|||
27980578|NCT00392808|81760189|FG003|Overall Study|Unable to withdraw blood|2|||
27980579|NCT02066415|81760190|FG000|Overall Study|Decision by Sponsor|5|||
27980580|NCT02066415|81760191|FG001|Overall Study|Decision by Sponsor|4|||
27980581|NCT02066415|81760192|FG002|Overall Study|Decision by Sponsor|2|||
27980582|NCT02066415|81760190|FG000|Overall Study|Withdrawal by Subject|9|||
27980583|NCT02066415|81760191|FG001|Overall Study|Withdrawal by Subject|1|||
27980584|NCT02066415|81760192|FG002|Overall Study|Withdrawal by Subject|4|||
27980585|NCT02066415|81760190|FG000|Overall Study|Lost to Follow-up|7|||
27980586|NCT02066415|81760191|FG001|Overall Study|Lost to Follow-up|2|||
27980587|NCT02066415|81760192|FG002|Overall Study|Lost to Follow-up|2|||
27980588|NCT01595581|81760195|FG000|Overall Study|Withdrawal by Subject|1|||
27980589|NCT01595581|81760196|FG001|Overall Study|Withdrawal by Subject|0|||
27576114|NCT04068181|80293061|FG001|Overall Study|Withdrawal by Subject|0|||
27576115|NCT04068181|80293062|FG002|Overall Study|Withdrawal by Subject|0|||
27868065|NCT03682107|81353727|FG000|Overall Study|Withdrawal by Subject|0|||
27868066|NCT03682107|81353728|FG001|Overall Study|Withdrawal by Subject|1|||
27868067|NCT03682107|81353729|FG002|Overall Study|Withdrawal by Subject|0|||
27868068|NCT03682107|81353730|FG003|Overall Study|Withdrawal by Subject|0|||
27868069|NCT03682107|81353731|FG004|Overall Study|Withdrawal by Subject|0|||
27868070|NCT02717455|81353732|FG000|Overall Study|Adverse Event|1|||
27868071|NCT02717455|81353733|FG001|Overall Study|Adverse Event|0|||
27868072|NCT02717455|81353734|FG002|Overall Study|Adverse Event|0|||
27868073|NCT02717455|81353735|FG003|Overall Study|Adverse Event|2|||
27868074|NCT02717455|81353736|FG004|Overall Study|Adverse Event|2|||
27868075|NCT02717455|81353737|FG005|Overall Study|Adverse Event|2|||
27868076|NCT02717455|81353732|FG000|Overall Study|Withdrawal by Subject|1|||
27868077|NCT02717455|81353733|FG001|Overall Study|Withdrawal by Subject|1|||
27868078|NCT02717455|81353734|FG002|Overall Study|Withdrawal by Subject|0|||
27868079|NCT02717455|81353735|FG003|Overall Study|Withdrawal by Subject|2|||
27868080|NCT02717455|81353736|FG004|Overall Study|Withdrawal by Subject|2|||
27868081|NCT02717455|81353737|FG005|Overall Study|Withdrawal by Subject|1|||
27868082|NCT02717455|81353732|FG000|Overall Study|Death|1|||
27868083|NCT02717455|81353733|FG001|Overall Study|Death|0|||
27868084|NCT02717455|81353734|FG002|Overall Study|Death|0|||
27868085|NCT02717455|81353735|FG003|Overall Study|Death|0|||
27868086|NCT02717455|81353736|FG004|Overall Study|Death|1|||
27868087|NCT02717455|81353737|FG005|Overall Study|Death|0|||
27868088|NCT02717455|81353732|FG000|Overall Study|Did not receive study drug|0|||
27868089|NCT02717455|81353733|FG001|Overall Study|Did not receive study drug|0|||
27868090|NCT02717455|81353734|FG002|Overall Study|Did not receive study drug|0|||
27868091|NCT02717455|81353735|FG003|Overall Study|Did not receive study drug|1|||
27868092|NCT02717455|81353736|FG004|Overall Study|Did not receive study drug|0|||
27868093|NCT02717455|81353737|FG005|Overall Study|Did not receive study drug|1|||
27868094|NCT02717455|81353732|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
27868095|NCT02717455|81353733|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
27868096|NCT02717455|81353734|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
27868097|NCT02717455|81353735|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
27868098|NCT02717455|81353736|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
27868099|NCT02717455|81353737|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
27868100|NCT02717455|81353732|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
27868101|NCT02717455|81353733|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
27868102|NCT02717455|81353734|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
27868103|NCT02717455|81353735|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
27868104|NCT02717455|81353736|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
27868105|NCT02717455|81353737|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
27868106|NCT03717012|81353738|FG000|Overall Study|Due to trial termination|1|||
27868107|NCT03717012|81353739|FG001|Overall Study|Due to trial termination|2|||
27868108|NCT03717012|81353738|FG000|Overall Study|Protocol Violation|0|||
27868109|NCT03717012|81353739|FG001|Overall Study|Protocol Violation|2|||
27868110|NCT03717012|81353738|FG000|Overall Study|Adverse Event|0|||
27868111|NCT03717012|81353739|FG001|Overall Study|Adverse Event|1|||
27868112|NCT03717012|81353738|FG000|Overall Study|Lung transplant|0|||
27868113|NCT03717012|81353739|FG001|Overall Study|Lung transplant|1|||
27868114|NCT01232452|81353740|FG000|Overall Study|Adverse Event|17|||
27868115|NCT01232452|81353741|FG001|Overall Study|Adverse Event|15|||
27980590|NCT00334282|81760199|FG000|Overall Study|Lost to Follow-up|11|||
27980591|NCT00334282|81760200|FG001|Overall Study|Lost to Follow-up|5|||
27980592|NCT00334282|81760199|FG000|Overall Study|Withdrawal by Subject|17|||
27673407|NCT04211389|80643199|FG001|Overall Study|Protocol Violation|1|||
27980593|NCT00334282|81760200|FG001|Overall Study|Withdrawal by Subject|3|||
27793703|NCT05299359|81075413|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
27793704|NCT05299359|81075412|FG000|Main Part: Day 1 up to Day 366|Other|2|||
27793705|NCT05299359|81075413|FG001|Main Part: Day 1 up to Day 366|Other|0|||
27793706|NCT05299359|81075412|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
27793707|NCT05299359|81075413|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
27793708|NCT05299359|81075412|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
27793709|NCT05299359|81075413|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
27793710|NCT05299359|81075412|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
27793711|NCT05299359|81075413|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
27793712|NCT05299359|81075412|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
27793713|NCT05299359|81075413|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
27793714|NCT05299359|81075412|FG000|Extension Part: Day 1 to Day 366|Other|0|||
27793715|NCT05299359|81075413|FG001|Extension Part: Day 1 to Day 366|Other|1|||
27793716|NCT04780776|81075414|FG000|Titration Week 1-5|Lost to Follow-up|2|||
27793717|NCT04780776|81075415|FG001|Titration Week 1-5|Lost to Follow-up|8|||
27793718|NCT04780776|81075414|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
27793719|NCT04780776|81075415|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
27793720|NCT04780776|81075414|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
27793721|NCT04780776|81075415|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
27793722|NCT02325414|81075417|FG000|Overall Study|Withdrawal by Subject|3|||
27793723|NCT02325414|81075418|FG001|Overall Study|Withdrawal by Subject|1|||
27793724|NCT02325414|81075417|FG000|Overall Study|Lost to Follow-up|5|||
27793725|NCT02325414|81075418|FG001|Overall Study|Lost to Follow-up|5|||
27793726|NCT03843775|81075419|FG000|Overall Study|Adverse Event|1|||
27793727|NCT03843775|81075420|FG001|Overall Study|Adverse Event|1|||
27793728|NCT03843775|81075419|FG000|Overall Study|Lack of Efficacy|2|||
27793729|NCT03843775|81075420|FG001|Overall Study|Lack of Efficacy|6|||
27793730|NCT03843775|81075419|FG000|Overall Study|Withdrawal by Subject|0|||
27793731|NCT03843775|81075420|FG001|Overall Study|Withdrawal by Subject|1|||
27793732|NCT04812548|81075421|FG000|Overall Study|Adverse Event|2|||
27793733|NCT04812548|81075422|FG001|Overall Study|Adverse Event|7|||
27793734|NCT04812548|81075421|FG000|Overall Study|HSCT Planned|2|||
27793735|NCT04812548|81075422|FG001|Overall Study|HSCT Planned|3|||
27793736|NCT04812548|81075421|FG000|Overall Study|Progressive Disease|0|||
27793737|NCT04812548|81075422|FG001|Overall Study|Progressive Disease|2|||
27793738|NCT04812548|81075421|FG000|Overall Study|Death|0|||
27793739|NCT04812548|81075422|FG001|Overall Study|Death|1|||
27793740|NCT04812548|81075421|FG000|Overall Study|Post Study Access to Treatment|0|||
27793741|NCT04812548|81075422|FG001|Overall Study|Post Study Access to Treatment|1|||
27793742|NCT04812548|81075421|FG000|Overall Study|Withdrawal by Subject|0|||
27793743|NCT04812548|81075422|FG001|Overall Study|Withdrawal by Subject|1|||
27793744|NCT04812548|81075421|FG000|Overall Study|Physician Decision|1|||
27793745|NCT04812548|81075422|FG001|Overall Study|Physician Decision|0|||
27793746|NCT03179462|81075423|FG000|Overall Study|screening failure|1|||
27793747|NCT03179462|81075424|FG001|Overall Study|screening failure|2|||
27793748|NCT03179462|81075425|FG002|Overall Study|screening failure|0|||
27793749|NCT03273257|81075426|FG000|Overall Study|Death|0|||
27793750|NCT03273257|81075427|FG001|Overall Study|Death|1|||
27673408|NCT04211389|80643198|FG000|Overall Study|Withdrawal by Subject|10|||
27673409|NCT04211389|80643199|FG001|Overall Study|Withdrawal by Subject|11|||
27673410|NCT01660256|80643200|FG000|Overall Study|Adverse Event|4|||
27673411|NCT01660256|80643201|FG001|Overall Study|Adverse Event|0|||
27673412|NCT01660256|80643202|FG002|Overall Study|Adverse Event|2|||
27673413|NCT01660256|80643200|FG000|Overall Study|Withdrawal by Subject|1|||
27673414|NCT01660256|80643201|FG001|Overall Study|Withdrawal by Subject|0|||
27673415|NCT01660256|80643202|FG002|Overall Study|Withdrawal by Subject|2|||
27673416|NCT00447590|80643207|FG000|Overall Study|Withdrawal by Subject|26|||
27673417|NCT00447590|80643207|FG000|Overall Study|Lost to Follow-up|24|||
27673418|NCT00447590|80643207|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
27673419|NCT00383123|80643214|FG000|Overall Study|Adverse Event|1|||
27673420|NCT00383123|80643215|FG001|Overall Study|Adverse Event|0|||
27673421|NCT00383123|80643214|FG000|Overall Study|Lost to Follow-up|68|||
27673422|NCT00383123|80643215|FG001|Overall Study|Lost to Follow-up|61|||
27673423|NCT00383123|80643214|FG000|Overall Study|Protocol Violation|5|||
27673424|NCT00383123|80643215|FG001|Overall Study|Protocol Violation|1|||
27673425|NCT00383123|80643214|FG000|Overall Study|Withdrawal by Subject|27|||
27673426|NCT00383123|80643215|FG001|Overall Study|Withdrawal by Subject|18|||
27793751|NCT03273257|81075426|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
27793752|NCT03273257|81075427|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
27793753|NCT03273257|81075426|FG000|Overall Study|Study terminated|3|||
27673427|NCT00383123|80643214|FG000|Overall Study|Other reason|10|||
27793754|NCT03273257|81075427|FG001|Overall Study|Study terminated|2|||
27793755|NCT03205046|81075435|FG000|Overall Study|Death|10|||
27673428|NCT00383123|80643215|FG001|Overall Study|Other reason|6|||
27980594|NCT00334282|81760199|FG000|Overall Study|Death|194|||
27980595|NCT00334282|81760200|FG001|Overall Study|Death|100|||
27980596|NCT02437409|81760201|FG000|Overall Study|Withdrawal by Subject|3|||
27980597|NCT02437409|81760201|FG000|Overall Study|Screening failure|12|||
27980598|NCT01636713|81760202|FG000|Overall Study|Adverse Event|16|||
27980599|NCT01636713|81760203|FG001|Overall Study|Adverse Event|16|||
27980600|NCT01636713|81760204|FG002|Overall Study|Adverse Event|7|||
27980601|NCT01636713|81760202|FG000|Overall Study|Lack of Efficacy|6|||
27980602|NCT01636713|81760203|FG001|Overall Study|Lack of Efficacy|6|||
27980603|NCT01636713|81760204|FG002|Overall Study|Lack of Efficacy|2|||
27980604|NCT01636713|81760202|FG000|Overall Study|Protocol Violation|3|||
27980605|NCT01636713|81760203|FG001|Overall Study|Protocol Violation|0|||
27980606|NCT01636713|81760204|FG002|Overall Study|Protocol Violation|1|||
27980607|NCT01636713|81760202|FG000|Overall Study|Lost to Follow-up|0|||
27980608|NCT01636713|81760203|FG001|Overall Study|Lost to Follow-up|0|||
27980609|NCT01636713|81760204|FG002|Overall Study|Lost to Follow-up|1|||
27980610|NCT01636713|81760202|FG000|Overall Study|Withdrawal by Subject|5|||
27980611|NCT01636713|81760203|FG001|Overall Study|Withdrawal by Subject|4|||
27980612|NCT01636713|81760204|FG002|Overall Study|Withdrawal by Subject|8|||
27980613|NCT01636713|81760202|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27980614|NCT01636713|81760203|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27980615|NCT01636713|81760204|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
27980616|NCT02365285|81760205|FG000|Overall Study|Physician Decision|0|||
27980617|NCT02365285|81760206|FG001|Overall Study|Physician Decision|1|||
27980618|NCT02365285|81760207|FG002|Overall Study|Physician Decision|1|||
27980619|NCT02365285|81760208|FG003|Overall Study|Physician Decision|0|||
27980620|NCT02365285|81760205|FG000|Overall Study|Adverse Event|0|||
27980621|NCT02365285|81760206|FG001|Overall Study|Adverse Event|0|||
27980622|NCT02365285|81760207|FG002|Overall Study|Adverse Event|0|||
27980623|NCT02365285|81760208|FG003|Overall Study|Adverse Event|2|||
27980624|NCT03602885|81760226|FG000|Overall Study|Lost to Follow-up|3|||
27980625|NCT03602885|81760227|FG001|Overall Study|Lost to Follow-up|0|||
27980626|NCT02809053|81760228|FG000|Overall Study|Death|0|||
27980627|NCT02809053|81760229|FG001|Overall Study|Death|1|||
27980628|NCT02809053|81760228|FG000|Overall Study|Lost to Follow-up|3|||
27980629|NCT02809053|81760229|FG001|Overall Study|Lost to Follow-up|1|||
27980630|NCT02809053|81760228|FG000|Overall Study|Withdrawal by Subject|2|||
27980631|NCT02809053|81760229|FG001|Overall Study|Withdrawal by Subject|3|||
27980632|NCT02809053|81760228|FG000|Overall Study|Disease Progression|2|||
27980633|NCT02809053|81760229|FG001|Overall Study|Disease Progression|1|||
27980634|NCT03242018|81763666|FG000|Overall Study|Adverse Event|7|||
27980635|NCT03242018|81763667|FG001|Overall Study|Adverse Event|7|||
27980636|NCT03242018|81763668|FG002|Overall Study|Adverse Event|6|||
27980637|NCT03242018|81763666|FG000|Overall Study|Lost to Follow-up|2|||
27980638|NCT03242018|81763667|FG001|Overall Study|Lost to Follow-up|2|||
27980639|NCT03242018|81763668|FG002|Overall Study|Lost to Follow-up|2|||
27980640|NCT03242018|81763666|FG000|Overall Study|At the Participant's Own Request|5|||
27980641|NCT03242018|81763667|FG001|Overall Study|At the Participant's Own Request|1|||
27980642|NCT03242018|81763668|FG002|Overall Study|At the Participant's Own Request|4|||
27980643|NCT03242018|81763666|FG000|Overall Study|Reason Not Specified|3|||
27980644|NCT03242018|81763667|FG001|Overall Study|Reason Not Specified|4|||
27980645|NCT03242018|81763668|FG002|Overall Study|Reason Not Specified|1|||
27980646|NCT03242018|81763666|FG000|Overall Study|Study Terminated by Sponsor|1|||
27980647|NCT03242018|81763667|FG001|Overall Study|Study Terminated by Sponsor|0|||
27673429|NCT00281320|80643216|FG000|Overall Study|Adverse Event|12|||
27793756|NCT03205046|81075436|FG001|Overall Study|Death|6|||
27793757|NCT03205046|81075435|FG000|Overall Study|Withdrawal by Subject|1|||
27793758|NCT03205046|81075436|FG001|Overall Study|Withdrawal by Subject|2|||
27793759|NCT03205046|81075435|FG000|Overall Study|Lost to Follow-up|0|||
27793760|NCT03205046|81075436|FG001|Overall Study|Lost to Follow-up|1|||
27793761|NCT03205046|81075435|FG000|Overall Study|Study terminated by sponsor|2|||
27793762|NCT03205046|81075436|FG001|Overall Study|Study terminated by sponsor|1|||
27980648|NCT03242018|81763668|FG002|Overall Study|Study Terminated by Sponsor|1|||
27980649|NCT00096018|81763669|FG000|Overall Study|Became Ineligible (not treated)|0|||
27980650|NCT00096018|81763670|FG001|Overall Study|Became Ineligible (not treated)|3|||
27980651|NCT00096018|81763669|FG000|Overall Study|Miscellaneous (not treated)|0|||
27673430|NCT00281320|80643217|FG001|Overall Study|Adverse Event|9|||
27673431|NCT00281320|80643216|FG000|Overall Study|Lack of Efficacy|4|||
27673432|NCT00281320|80643217|FG001|Overall Study|Lack of Efficacy|3|||
27673433|NCT00281320|80643216|FG000|Overall Study|Withdrawal by Subject|5|||
27673434|NCT00281320|80643217|FG001|Overall Study|Withdrawal by Subject|6|||
27673435|NCT00281320|80643216|FG000|Overall Study|Lost to Follow-up|1|||
27673436|NCT00281320|80643217|FG001|Overall Study|Lost to Follow-up|2|||
27980652|NCT00096018|81763670|FG001|Overall Study|Miscellaneous (not treated)|2|||
27980653|NCT00096018|81763669|FG000|Overall Study|Adverse Event|0|||
27980654|NCT00096018|81763670|FG001|Overall Study|Adverse Event|5|||
27980655|NCT00096018|81763669|FG000|Overall Study|Death|0|||
27980656|NCT00096018|81763670|FG001|Overall Study|Death|1|||
27980657|NCT00096018|81763669|FG000|Overall Study|Withdrawal by Subject|0|||
27980658|NCT00096018|81763670|FG001|Overall Study|Withdrawal by Subject|2|||
27980659|NCT00096018|81763669|FG000|Overall Study|Miscellaneous|2|||
27980660|NCT00096018|81763670|FG001|Overall Study|Miscellaneous|1|||
27980661|NCT01685983|81763671|FG000|Overall Study|Adverse Event|7|||
27980662|NCT01685983|81763671|FG000|Overall Study|Death|1|||
27980663|NCT01685983|81763671|FG000|Overall Study|Withdrawal by Subject|19|||
27980664|NCT01685983|81763671|FG000|Overall Study|Protocol Violation|2|||
27980665|NCT01685983|81763671|FG000|Overall Study|Physician Decision|13|||
27980666|NCT01685983|81763671|FG000|Overall Study|Other|7|||
27980667|NCT01685983|81763671|FG000|Overall Study|Progressive Disease|32|||
27980668|NCT01685983|81763671|FG000|Overall Study|Noncompliance with Study Drug|1|||
27980669|NCT02308488|81763672|FG000|Overall Study|Withdrawal by Subject|2|||
27980670|NCT02876328|81763673|FG000|Overall Study|Death|2|||
27980671|NCT02876328|81763674|FG001|Overall Study|Death|1|||
27980672|NCT02876328|81763675|FG002|Overall Study|Death|3|||
27980673|NCT02876328|81763676|FG003|Overall Study|Death|0|||
27980674|NCT02876328|81763677|FG004|Overall Study|Death|0|||
27980675|NCT02876328|81763678|FG005|Overall Study|Death|0|||
27980676|NCT02876328|81763679|FG006|Overall Study|Death|1|||
27980677|NCT02876328|81763680|FG007|Overall Study|Death|3|||
27980678|NCT02876328|81763681|FG008|Overall Study|Death|0|||
27980679|NCT02876328|81763682|FG009|Overall Study|Death|1|||
27980680|NCT02876328|81763683|FG010|Overall Study|Death|1|||
27980681|NCT02876328|81763684|FG011|Overall Study|Death|0|||
27980682|NCT02876328|81763685|FG012|Overall Study|Death|0|||
27980683|NCT02876328|81763686|FG013|Overall Study|Death|0|||
27980684|NCT02876328|81763687|FG014|Overall Study|Death|0|||
27980685|NCT02876328|81763688|FG015|Overall Study|Death|0|||
27980686|NCT02876328|81763689|FG016|Overall Study|Death|1|||
27868116|NCT01232452|81353740|FG000|Overall Study|Withdrawal by Subject|11|||
27868117|NCT01232452|81353741|FG001|Overall Study|Withdrawal by Subject|8|||
27868118|NCT01232452|81353740|FG000|Overall Study|Physician Decision|8|||
27868119|NCT01232452|81353741|FG001|Overall Study|Physician Decision|12|||
27868120|NCT01232452|81353740|FG000|Overall Study|Protocol entry criterion not met|0|||
27868121|NCT01232452|81353741|FG001|Overall Study|Protocol entry criterion not met|2|||
27868122|NCT01232452|81353740|FG000|Overall Study|Sponsor Decision|3|||
27793763|NCT00572910|81075437|FG000|Overall Study|Adverse Event|1|||
27793764|NCT00572910|81075438|FG001|Overall Study|Adverse Event|2|||
27793765|NCT00572910|81075439|FG002|Overall Study|Adverse Event|0|||
27793766|NCT00572910|81075440|FG003|Overall Study|Adverse Event|2|||
27793767|NCT00572910|81075441|FG004|Overall Study|Adverse Event|0|||
27793768|NCT00572910|81075442|FG005|Overall Study|Adverse Event|0|||
27793769|NCT00572910|81075443|FG006|Overall Study|Adverse Event|4|||
27793770|NCT00572910|81075444|FG007|Overall Study|Adverse Event|2|||
27793771|NCT00572910|81075445|FG008|Overall Study|Adverse Event|1|||
27980687|NCT02876328|81763690|FG017|Overall Study|Death|1|||
27980688|NCT02876328|81763691|FG018|Overall Study|Death|0|||
27980689|NCT02876328|81763692|FG019|Overall Study|Death|0|||
27673437|NCT00281320|80643216|FG000|Overall Study|Other|3|||
27673438|NCT00281320|80643217|FG001|Overall Study|Other|1|||
27980690|NCT02876328|81763693|FG020|Overall Study|Death|0|||
27980691|NCT02876328|81763694|FG021|Overall Study|Death|1|||
27980692|NCT02876328|81763695|FG022|Overall Study|Death|0|||
27980693|NCT02876328|81763696|FG023|Overall Study|Death|0|||
27980694|NCT02876328|81763673|FG000|Overall Study|Withdrawal by Subject|0|||
27980695|NCT02876328|81763674|FG001|Overall Study|Withdrawal by Subject|2|||
27980696|NCT02876328|81763675|FG002|Overall Study|Withdrawal by Subject|3|||
27980697|NCT02876328|81763676|FG003|Overall Study|Withdrawal by Subject|3|||
27980698|NCT02876328|81763677|FG004|Overall Study|Withdrawal by Subject|0|||
27980699|NCT02876328|81763678|FG005|Overall Study|Withdrawal by Subject|1|||
27980700|NCT02876328|81763679|FG006|Overall Study|Withdrawal by Subject|0|||
27980701|NCT02876328|81763680|FG007|Overall Study|Withdrawal by Subject|1|||
27980702|NCT02876328|81763681|FG008|Overall Study|Withdrawal by Subject|1|||
27673439|NCT00475644|80643218|FG000|Overall Study|Protocol Violation|13|||
27673440|NCT02552147|80643219|FG000|First Intervention (7 Days)|Protocol Violation|1|||
27673441|NCT02552147|80643220|FG001|First Intervention (7 Days)|Protocol Violation|0|||
27793772|NCT00572910|81075446|FG009|Overall Study|Adverse Event|3|||
27868123|NCT01232452|81353741|FG001|Overall Study|Sponsor Decision|1|||
27980703|NCT02876328|81763682|FG009|Overall Study|Withdrawal by Subject|2|||
27793773|NCT00572910|81075447|FG010|Overall Study|Adverse Event|2|||
27793774|NCT00572910|81075437|FG000|Overall Study|Lost to Follow-up|0|||
27868124|NCT01232452|81353740|FG000|Overall Study|Protocol Violation|0|||
27980704|NCT02876328|81763683|FG010|Overall Study|Withdrawal by Subject|0|||
27980705|NCT02876328|81763684|FG011|Overall Study|Withdrawal by Subject|0|||
27980706|NCT02876328|81763685|FG012|Overall Study|Withdrawal by Subject|0|||
27980707|NCT02876328|81763686|FG013|Overall Study|Withdrawal by Subject|0|||
27980708|NCT02876328|81763687|FG014|Overall Study|Withdrawal by Subject|0|||
27980709|NCT02876328|81763688|FG015|Overall Study|Withdrawal by Subject|0|||
27980710|NCT02876328|81763689|FG016|Overall Study|Withdrawal by Subject|1|||
27980711|NCT02876328|81763690|FG017|Overall Study|Withdrawal by Subject|3|||
27980712|NCT02876328|81763691|FG018|Overall Study|Withdrawal by Subject|0|||
27868125|NCT01232452|81353741|FG001|Overall Study|Protocol Violation|1|||
27868126|NCT00451178|81353742|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
27868127|NCT00451178|81353743|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
27868128|NCT00451178|81353742|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
27868129|NCT00451178|81353743|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
27868130|NCT00451178|81353742|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
27868131|NCT00451178|81353743|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
27868132|NCT00451178|81353742|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
27793775|NCT00572910|81075438|FG001|Overall Study|Lost to Follow-up|1|||
27793776|NCT00572910|81075439|FG002|Overall Study|Lost to Follow-up|1|||
27793777|NCT00572910|81075440|FG003|Overall Study|Lost to Follow-up|2|||
27793778|NCT00572910|81075441|FG004|Overall Study|Lost to Follow-up|1|||
27868133|NCT00451178|81353743|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
27868134|NCT00451178|81353742|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
27868135|NCT00451178|81353743|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
27980713|NCT02876328|81763692|FG019|Overall Study|Withdrawal by Subject|0|||
27793779|NCT00572910|81075442|FG005|Overall Study|Lost to Follow-up|0|||
27793780|NCT00572910|81075443|FG006|Overall Study|Lost to Follow-up|0|||
27793781|NCT00572910|81075444|FG007|Overall Study|Lost to Follow-up|0|||
27793782|NCT00572910|81075445|FG008|Overall Study|Lost to Follow-up|0|||
27576116|NCT04068181|80293063|FG003|Overall Study|Withdrawal by Subject|0|||
27980714|NCT02876328|81763693|FG020|Overall Study|Withdrawal by Subject|1|||
27980715|NCT02876328|81763694|FG021|Overall Study|Withdrawal by Subject|0|||
27576117|NCT04068181|80293060|FG000|Overall Study|Lost to Follow-up|1|||
27576118|NCT04068181|80293061|FG001|Overall Study|Lost to Follow-up|0|||
27576119|NCT04068181|80293062|FG002|Overall Study|Lost to Follow-up|0|||
27576120|NCT04068181|80293063|FG003|Overall Study|Lost to Follow-up|0|||
27576121|NCT04068181|80293060|FG000|Overall Study|Death|8|||
27576122|NCT04068181|80293061|FG001|Overall Study|Death|8|||
27576123|NCT04068181|80293062|FG002|Overall Study|Death|4|||
27576124|NCT04068181|80293063|FG003|Overall Study|Death|2|||
27576125|NCT04068181|80293060|FG000|Overall Study|Continuing Study|16|||
27576126|NCT04068181|80293061|FG001|Overall Study|Continuing Study|7|||
27576127|NCT04068181|80293062|FG002|Overall Study|Continuing Study|11|||
27576128|NCT04068181|80293063|FG003|Overall Study|Continuing Study|13|||
27576129|NCT00458484|80293064|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
27576130|NCT00458484|80293065|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
27576131|NCT00458484|80293066|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
27576132|NCT00458484|80293067|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
27576133|NCT00458484|80293068|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
27576134|NCT00458484|80293069|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
27576135|NCT00458484|80293070|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
27576136|NCT02262728|80293071|FG000|Follow-up Phase (3 Years)|Death|0|||
27576137|NCT02262728|80293072|FG001|Follow-up Phase (3 Years)|Death|1|||
27576138|NCT02262728|80293071|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
27576139|NCT02262728|80293072|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
27793783|NCT00572910|81075446|FG009|Overall Study|Lost to Follow-up|1|||
27793784|NCT00572910|81075447|FG010|Overall Study|Lost to Follow-up|0|||
27576140|NCT02262728|80293071|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
27576141|NCT02262728|80293072|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
27576142|NCT03614793|80293082|FG000|Overall Study|Lost to Follow-up|1|||
27576143|NCT03614793|80293083|FG001|Overall Study|Lost to Follow-up|2|||
27576144|NCT03614793|80293082|FG000|Overall Study|Lack of Efficacy|0|||
27576145|NCT03614793|80293083|FG001|Overall Study|Lack of Efficacy|5|||
27576146|NCT03614793|80293082|FG000|Overall Study|Withdrawal by Subject|0|||
27673442|NCT02552147|80643219|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
27673443|NCT02552147|80643220|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
27793785|NCT00572910|81075437|FG000|Overall Study|Withdrawal by Subject|3|||
27793786|NCT00572910|81075438|FG001|Overall Study|Withdrawal by Subject|0|||
27793787|NCT00572910|81075439|FG002|Overall Study|Withdrawal by Subject|1|||
27793788|NCT00572910|81075440|FG003|Overall Study|Withdrawal by Subject|0|||
27793789|NCT00572910|81075441|FG004|Overall Study|Withdrawal by Subject|1|||
27576147|NCT03614793|80293083|FG001|Overall Study|Withdrawal by Subject|1|||
27793790|NCT00572910|81075442|FG005|Overall Study|Withdrawal by Subject|3|||
27793791|NCT00572910|81075443|FG006|Overall Study|Withdrawal by Subject|0|||
27793792|NCT00572910|81075444|FG007|Overall Study|Withdrawal by Subject|2|||
27868136|NCT00451178|81353742|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
27868137|NCT00451178|81353743|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
27576148|NCT03614793|80293082|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
27576149|NCT03614793|80293083|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
27576150|NCT01469065|80293084|FG000|Overall Study|Lack of Efficacy|0|||
27576151|NCT01469065|80293085|FG001|Overall Study|Lack of Efficacy|0|||
27576152|NCT01469065|80293086|FG002|Overall Study|Lack of Efficacy|0|||
27793793|NCT00572910|81075445|FG008|Overall Study|Withdrawal by Subject|2|||
27980716|NCT02876328|81763695|FG022|Overall Study|Withdrawal by Subject|0|||
27980717|NCT02876328|81763696|FG023|Overall Study|Withdrawal by Subject|0|||
27980718|NCT02876328|81763673|FG000|Overall Study|Missed 12 Month Visit|15|||
27868138|NCT00451178|81353742|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
27868139|NCT00451178|81353743|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
27868140|NCT00451178|81353742|FG000|Prior to Maintenance Therapy|PD|2|||
27868141|NCT00451178|81353743|FG001|Prior to Maintenance Therapy|PD|0|||
27868142|NCT00451178|81353742|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
27868143|NCT00451178|81353743|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
27868144|NCT00451178|81353742|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
27868145|NCT00451178|81353743|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
27980719|NCT02876328|81763674|FG001|Overall Study|Missed 12 Month Visit|10|||
27980720|NCT02876328|81763675|FG002|Overall Study|Missed 12 Month Visit|11|||
27980721|NCT02876328|81763676|FG003|Overall Study|Missed 12 Month Visit|6|||
27980722|NCT02876328|81763677|FG004|Overall Study|Missed 12 Month Visit|10|||
27980723|NCT02876328|81763678|FG005|Overall Study|Missed 12 Month Visit|14|||
27980724|NCT02876328|81763679|FG006|Overall Study|Missed 12 Month Visit|3|||
27980725|NCT02876328|81763680|FG007|Overall Study|Missed 12 Month Visit|8|||
27980726|NCT02876328|81763681|FG008|Overall Study|Missed 12 Month Visit|9|||
27980727|NCT02876328|81763682|FG009|Overall Study|Missed 12 Month Visit|5|||
27980728|NCT02876328|81763683|FG010|Overall Study|Missed 12 Month Visit|4|||
27980729|NCT02876328|81763684|FG011|Overall Study|Missed 12 Month Visit|1|||
27980730|NCT02876328|81763685|FG012|Overall Study|Missed 12 Month Visit|5|||
27980731|NCT02876328|81763686|FG013|Overall Study|Missed 12 Month Visit|4|||
27576153|NCT01469065|80293087|FG003|Overall Study|Lack of Efficacy|0|||
27576154|NCT01469065|80293088|FG004|Overall Study|Lack of Efficacy|1|||
27576155|NCT01469065|80293084|FG000|Overall Study|Other|0|||
27576156|NCT01469065|80293085|FG001|Overall Study|Other|1|||
27576157|NCT01469065|80293086|FG002|Overall Study|Other|0|||
27576158|NCT01469065|80293087|FG003|Overall Study|Other|0|||
27576159|NCT01469065|80293088|FG004|Overall Study|Other|0|||
27576160|NCT00501540|80293091|FG000|Overall Study|Death|5|||
27980732|NCT02876328|81763687|FG014|Overall Study|Missed 12 Month Visit|4|||
27980733|NCT02876328|81763688|FG015|Overall Study|Missed 12 Month Visit|4|||
27980734|NCT02876328|81763689|FG016|Overall Study|Missed 12 Month Visit|3|||
27980735|NCT02876328|81763690|FG017|Overall Study|Missed 12 Month Visit|6|||
27980736|NCT02876328|81763691|FG018|Overall Study|Missed 12 Month Visit|2|||
27980737|NCT02876328|81763692|FG019|Overall Study|Missed 12 Month Visit|2|||
27980738|NCT02876328|81763693|FG020|Overall Study|Missed 12 Month Visit|11|||
27980739|NCT02876328|81763694|FG021|Overall Study|Missed 12 Month Visit|7|||
27980740|NCT02876328|81763695|FG022|Overall Study|Missed 12 Month Visit|1|||
27980741|NCT02876328|81763696|FG023|Overall Study|Missed 12 Month Visit|0|||
27980742|NCT00762996|81763697|FG000|Period One|Protocol Violation|0|||
27980743|NCT00762996|81763698|FG001|Period One|Protocol Violation|0|||
27980744|NCT00762996|81763699|FG002|Period One|Protocol Violation|1|||
27980745|NCT00762996|81763700|FG003|Period One|Protocol Violation|0|||
27980746|NCT00762996|81763697|FG000|Period One|ineligible|0|||
27980747|NCT00762996|81763698|FG001|Period One|ineligible|0|||
27980748|NCT00762996|81763699|FG002|Period One|ineligible|1|||
27980749|NCT00762996|81763700|FG003|Period One|ineligible|1|||
27980750|NCT00762996|81763697|FG000|Period One|Adverse Event|0|||
27980751|NCT00762996|81763698|FG001|Period One|Adverse Event|0|||
27980752|NCT00762996|81763699|FG002|Period One|Adverse Event|1|||
27980753|NCT00762996|81763700|FG003|Period One|Adverse Event|0|||
27980754|NCT00762996|81763697|FG000|Period One|Withdrawal by Subject|0|||
27980755|NCT00762996|81763698|FG001|Period One|Withdrawal by Subject|0|||
27980756|NCT00762996|81763699|FG002|Period One|Withdrawal by Subject|1|||
27980757|NCT00762996|81763700|FG003|Period One|Withdrawal by Subject|0|||
27576161|NCT00850200|80293092|FG000|Overall Study|Physician Decision|2|||
27673444|NCT00730015|80643223|FG000|Overall Study|Adverse Event|11|||
27673445|NCT00730015|80643224|FG001|Overall Study|Adverse Event|10|||
27868146|NCT00451178|81353742|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
27868147|NCT00451178|81353743|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
27868148|NCT00451178|81353742|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
27980758|NCT00199888|81763704|FG000|Overall Study|Lost to Follow-up|1|||
27980759|NCT02804750|81763705|FG000|Period 1|Adverse Event|0|||
27980760|NCT02804750|81763706|FG001|Period 1|Adverse Event|2|||
27980761|NCT02804750|81763705|FG000|Period 1|Withdrawal by Subject|0|||
27980762|NCT02804750|81763706|FG001|Period 1|Withdrawal by Subject|1|||
27980763|NCT02804750|81763705|FG000|Period 2|Adverse Event|1|||
27980764|NCT02804750|81763706|FG001|Period 2|Adverse Event|0|||
27980765|NCT02804750|81763705|FG000|Period 3|Adverse Event|0|||
27980766|NCT02804750|81763706|FG001|Period 3|Adverse Event|2|||
27980767|NCT02804750|81763705|FG000|Period 4|Adverse Event|0|||
27980768|NCT02804750|81763706|FG001|Period 4|Adverse Event|5|||
27980769|NCT03779503|81763707|FG000|First Intervention|Adverse Event|0|||
27576162|NCT00850200|80293092|FG000|Overall Study|Did not recieve treatment|2|||
27576163|NCT00850200|80293092|FG000|Overall Study|Withdrawal by Subject|1|||
27673446|NCT00730015|80643225|FG002|Overall Study|Adverse Event|8|||
27980770|NCT03779503|81763708|FG001|First Intervention|Adverse Event|1|||
27980771|NCT03779503|81763707|FG000|First Intervention|Withdrawal by Subject|1|||
27980772|NCT03779503|81763708|FG001|First Intervention|Withdrawal by Subject|0|||
27980773|NCT03529110|81763709|FG000|Overall Study|Progressive Disease|66|||
27980774|NCT03529110|81763710|FG001|Overall Study|Progressive Disease|158|||
27980775|NCT03529110|81763709|FG000|Overall Study|Clinical Progression|4|||
27980776|NCT03529110|81763710|FG001|Overall Study|Clinical Progression|12|||
27980777|NCT03529110|81763709|FG000|Overall Study|Adverse Event|35|||
27980778|NCT03529110|81763710|FG001|Overall Study|Adverse Event|17|||
27980779|NCT03529110|81763709|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
27980780|NCT03529110|81763710|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
27980781|NCT03529110|81763709|FG000|Overall Study|Lack of Efficacy|3|||
27980782|NCT03529110|81763710|FG001|Overall Study|Lack of Efficacy|3|||
27980783|NCT03529110|81763709|FG000|Overall Study|Physician Decision|2|||
27980784|NCT03529110|81763710|FG001|Overall Study|Physician Decision|8|||
27980785|NCT03529110|81763709|FG000|Overall Study|Miscellaneous|2|||
27980786|NCT03529110|81763710|FG001|Overall Study|Miscellaneous|5|||
27980787|NCT03734029|81763711|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
27980788|NCT03734029|81763712|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
27980789|NCT03734029|81763711|FG000|Overall Study|Adverse Event|60|||
27980790|NCT03734029|81763712|FG001|Overall Study|Adverse Event|14|||
27980791|NCT03734029|81763711|FG000|Overall Study|Withdrawal by Subject|12|||
27980792|NCT03734029|81763712|FG001|Overall Study|Withdrawal by Subject|11|||
27980793|NCT03734029|81763711|FG000|Overall Study|Clinical progression by investigator|10|||
27980794|NCT03734029|81763712|FG001|Overall Study|Clinical progression by investigator|8|||
27980795|NCT03734029|81763711|FG000|Overall Study|Death|5|||
27980796|NCT03734029|81763712|FG001|Overall Study|Death|2|||
27980797|NCT03734029|81763711|FG000|Overall Study|Physician Decision|4|||
27980798|NCT03734029|81763712|FG001|Overall Study|Physician Decision|3|||
27980799|NCT03734029|81763711|FG000|Overall Study|Other|2|||
27980800|NCT03734029|81763712|FG001|Overall Study|Other|0|||
27980801|NCT03734029|81763711|FG000|Overall Study|Lost to Follow-up|0|||
27980802|NCT03734029|81763712|FG001|Overall Study|Lost to Follow-up|1|||
27980803|NCT03734029|81763711|FG000|Overall Study|Randomized, but not treated|2|||
27980804|NCT03734029|81763712|FG001|Overall Study|Randomized, but not treated|12|||
27980805|NCT01635764|81763716|FG000|Overall Study|Adverse Event|46|||
27980806|NCT01635764|81763716|FG000|Overall Study|Lack of Efficacy|76|||
27980807|NCT01635764|81763716|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
27980808|NCT01635764|81763716|FG000|Overall Study|Protocol Deviation|1|||
27980809|NCT01635764|81763716|FG000|Overall Study|Withdrew Consent|67|||
27980810|NCT01635764|81763716|FG000|Overall Study|Lost to Follow-up|53|||
27980811|NCT01635764|81763716|FG000|Overall Study|Other|28|||
27980812|NCT04258995|81763717|FG000|Overall Study|Lost to Follow-up|1|||
27980813|NCT04258995|81763718|FG001|Overall Study|Lost to Follow-up|1|||
27980814|NCT02525094|81763721|FG000|Overall Study|Lost to Follow-up|2|||
27980815|NCT02525094|81763722|FG001|Overall Study|Lost to Follow-up|1|||
27980816|NCT02525094|81763721|FG000|Overall Study|Withdrawal by Subject|5|||
27868149|NCT00451178|81353743|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
27868150|NCT00451178|81353742|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
27868151|NCT00451178|81353743|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
27980817|NCT02525094|81763722|FG001|Overall Study|Withdrawal by Subject|6|||
27980818|NCT02525094|81763721|FG000|Overall Study|Not Treated|1|||
27980819|NCT02525094|81763722|FG001|Overall Study|Not Treated|1|||
27980820|NCT02119156|81763723|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
27980821|NCT02119156|81763724|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
27980822|NCT02119156|81763725|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
27980823|NCT02119156|81763723|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
27980824|NCT02119156|81763724|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
27980825|NCT02119156|81763725|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
27980826|NCT02119156|81763723|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
27980827|NCT02119156|81763724|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
27980828|NCT02119156|81763725|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
27980829|NCT02119156|81763723|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
27980830|NCT02119156|81763724|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
27980831|NCT02119156|81763725|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
27980832|NCT02119156|81763723|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
27980833|NCT02119156|81763724|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
27980834|NCT02119156|81763725|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
27980835|NCT01288612|81763726|FG000|Overall Study|Unable to contact|11|||
27980836|NCT01288612|81763727|FG001|Overall Study|Unable to contact|16|||
27980837|NCT01288612|81763728|FG002|Overall Study|Unable to contact|20|||
27980838|NCT01288612|81763726|FG000|Overall Study|Declined|78|||
27980839|NCT01288612|81763727|FG001|Overall Study|Declined|63|||
27980840|NCT01288612|81763728|FG002|Overall Study|Declined|62|||
27980841|NCT01288612|81763726|FG000|Overall Study|Unable to intubate|0|||
27980842|NCT01288612|81763727|FG001|Overall Study|Unable to intubate|3|||
27980843|NCT01288612|81763728|FG002|Overall Study|Unable to intubate|0|||
27980844|NCT00657150|81763729|FG000|Overall Study|Adverse Event|19|||
27793794|NCT00572910|81075446|FG009|Overall Study|Withdrawal by Subject|2|||
27793795|NCT00572910|81075447|FG010|Overall Study|Withdrawal by Subject|1|||
27793796|NCT02871921|81075448|FG000|Overall Study|Withdrawal by Subject|34|||
27980845|NCT00657150|81763730|FG001|Overall Study|Adverse Event|10|||
27980846|NCT00657150|81763729|FG000|Overall Study|Non-compliant with protocol|5|||
27980847|NCT00657150|81763730|FG001|Overall Study|Non-compliant with protocol|9|||
27980848|NCT00657150|81763729|FG000|Overall Study|Lost to Follow-up|2|||
27980849|NCT00657150|81763730|FG001|Overall Study|Lost to Follow-up|0|||
27673447|NCT00730015|80643223|FG000|Overall Study|Protocol Violation|2|||
27793797|NCT02871921|81075449|FG001|Overall Study|Withdrawal by Subject|27|||
27793798|NCT02871921|81075450|FG002|Overall Study|Withdrawal by Subject|27|||
27793799|NCT02871921|81075451|FG003|Overall Study|Withdrawal by Subject|30|||
27793800|NCT01463631|81075452|FG000|Overall Study|Withdrawal by Subject|0|||
27793801|NCT01463631|81075453|FG001|Overall Study|Withdrawal by Subject|0|||
27793802|NCT01463631|81075454|FG002|Overall Study|Withdrawal by Subject|0|||
27793803|NCT01463631|81075455|FG003|Overall Study|Withdrawal by Subject|1|||
27793804|NCT01463631|81075452|FG000|Overall Study|Death|0|||
27793805|NCT01463631|81075453|FG001|Overall Study|Death|0|||
27793806|NCT01463631|81075454|FG002|Overall Study|Death|1|||
27793807|NCT01463631|81075455|FG003|Overall Study|Death|0|||
27793808|NCT01463631|81075452|FG000|Overall Study|Progressive Disease|0|||
27793809|NCT01463631|81075453|FG001|Overall Study|Progressive Disease|0|||
27793810|NCT01463631|81075454|FG002|Overall Study|Progressive Disease|0|||
27793811|NCT01463631|81075455|FG003|Overall Study|Progressive Disease|5|||
27793812|NCT01569594|81075456|FG000|Overall Study|Physician Decision|4|||
27793813|NCT01569594|81075456|FG000|Overall Study|Death|13|||
27793814|NCT01569594|81075456|FG000|Overall Study|Lost to Follow-up|22|||
27793815|NCT01569594|81075456|FG000|Overall Study|Adverse Event|2|||
27868152|NCT00451178|81353742|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
27868153|NCT00451178|81353743|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
27868154|NCT00451178|81353742|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
27868155|NCT00451178|81353743|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
27868156|NCT00378573|81353744|FG000|Treatment Period|Adverse Event|9|||
27868157|NCT00378573|81353744|FG000|Treatment Period|Physician Decision|1|||
27868158|NCT00378573|81353744|FG000|Treatment Period|Withdrawal by Subject|2|||
27868159|NCT00378573|81353744|FG000|Treatment Period|Disease Progression|4|||
27868160|NCT00378573|81353744|FG000|Treatment Period|Sponsor decision to close study|1|||
27868161|NCT00378573|81353744|FG000|Follow-up|Death|12|||
27868162|NCT00378573|81353744|FG000|Follow-up|Lost to Follow-up|1|||
27868163|NCT00378573|81353744|FG000|Follow-up|Withdrawal by Subject|1|||
27868164|NCT01277211|81353745|FG000|Overall Study|Adverse Event|60|||
27868165|NCT01277211|81353746|FG001|Overall Study|Adverse Event|22|||
27868166|NCT01277211|81353745|FG000|Overall Study|Pregnancy|9|||
27868167|NCT01277211|81353746|FG001|Overall Study|Pregnancy|4|||
27868168|NCT01277211|81353745|FG000|Overall Study|Lost to Follow-up|14|||
27868169|NCT01277211|81353746|FG001|Overall Study|Lost to Follow-up|9|||
27868170|NCT01277211|81353745|FG000|Overall Study|Did not wish to continue|17|||
27868171|NCT01277211|81353746|FG001|Overall Study|Did not wish to continue|0|||
27868172|NCT01277211|81353745|FG000|Overall Study|Withdrew Consent|9|||
27868173|NCT01277211|81353746|FG001|Overall Study|Withdrew Consent|9|||
27868174|NCT01277211|81353745|FG000|Overall Study|Non-compliance with protocol|13|||
27868175|NCT01277211|81353746|FG001|Overall Study|Non-compliance with protocol|4|||
27868176|NCT01277211|81353745|FG000|Overall Study|Did not meet protocol eligibility|1|||
27868177|NCT01277211|81353746|FG001|Overall Study|Did not meet protocol eligibility|0|||
27868178|NCT01277211|81353745|FG000|Overall Study|Administrative|3|||
27980850|NCT00657150|81763729|FG000|Overall Study|Withdrawal by Subject|51|||
27673448|NCT00730015|80643224|FG001|Overall Study|Protocol Violation|6|||
27673449|NCT00730015|80643225|FG002|Overall Study|Protocol Violation|4|||
27793816|NCT01569594|81075456|FG000|Overall Study|Withdrawal by Subject|13|||
27793817|NCT01569594|81075456|FG000|Overall Study|Other|4|||
27868179|NCT01277211|81353746|FG001|Overall Study|Administrative|0|||
27980851|NCT00657150|81763730|FG001|Overall Study|Withdrawal by Subject|36|||
27793818|NCT01569594|81075456|FG000|Overall Study|No ECM used|9|||
27793819|NCT02575807|81075457|FG000|Overall Study|Death|8|||
27980852|NCT00657150|81763729|FG000|Overall Study|Other|38|||
27980853|NCT00657150|81763730|FG001|Overall Study|Other|38|||
27980854|NCT00657150|81763729|FG000|Treatment|Adverse Event|60|||
27980855|NCT00657150|81763730|FG001|Treatment|Adverse Event|53|||
27980856|NCT00657150|81763729|FG000|Treatment|Non-compliant with protocol|10|||
27980857|NCT00657150|81763730|FG001|Treatment|Non-compliant with protocol|9|||
27980858|NCT00657150|81763729|FG000|Treatment|Lost to Follow-up|1|||
27980859|NCT00657150|81763730|FG001|Treatment|Lost to Follow-up|0|||
27980860|NCT00657150|81763729|FG000|Treatment|Withdrawal by Subject|23|||
27980861|NCT00657150|81763730|FG001|Treatment|Withdrawal by Subject|20|||
27980862|NCT00657150|81763729|FG000|Treatment|Other|13|||
27980863|NCT00657150|81763730|FG001|Treatment|Other|15|||
27980864|NCT00624780|81763733|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
27980865|NCT00624780|81763734|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
27980866|NCT00624780|81763735|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
27980867|NCT00624780|81763736|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
27980868|NCT00624780|81763737|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
27980869|NCT00624780|81763738|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
27980870|NCT00624780|81763733|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
27980871|NCT00624780|81763734|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
27980872|NCT00624780|81763735|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
27980873|NCT00624780|81763736|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
27980874|NCT00624780|81763737|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
27673450|NCT00730015|80643223|FG000|Overall Study|Withdrawal by Subject|12|||
27673451|NCT00730015|80643224|FG001|Overall Study|Withdrawal by Subject|12|||
27673452|NCT00730015|80643225|FG002|Overall Study|Withdrawal by Subject|8|||
27673453|NCT00730015|80643223|FG000|Overall Study|Lost to Follow-up|4|||
27673454|NCT00730015|80643224|FG001|Overall Study|Lost to Follow-up|10|||
27673455|NCT00730015|80643225|FG002|Overall Study|Lost to Follow-up|3|||
27673456|NCT00730015|80643223|FG000|Overall Study|Lack of Efficacy|1|||
27673457|NCT00730015|80643224|FG001|Overall Study|Lack of Efficacy|2|||
27673458|NCT00730015|80643225|FG002|Overall Study|Lack of Efficacy|8|||
27673459|NCT00730015|80643223|FG000|Overall Study|Other Reason|1|||
27673460|NCT00730015|80643224|FG001|Overall Study|Other Reason|0|||
27673461|NCT00730015|80643225|FG002|Overall Study|Other Reason|1|||
27673462|NCT01821937|80643227|FG000|Overall Study|Adverse Event|0|||
27673463|NCT01821937|80643228|FG001|Overall Study|Adverse Event|3|||
27673464|NCT00490698|80643230|FG000|Overall Study|Withdrawal by Subject|1|||
27673465|NCT00490698|80643230|FG000|Overall Study|Disease Progression|7|||
27673466|NCT00490698|80643230|FG000|Overall Study|Physician Decision|2|||
27673467|NCT04292470|80643233|FG000|Overall Study|Withdrawal by Subject|0|||
27673468|NCT04292470|80643234|FG001|Overall Study|Withdrawal by Subject|1|||
27673469|NCT03178045|80643235|FG000|Overall Study|Withdrawal by Subject|5|||
27673470|NCT03178045|80643236|FG001|Overall Study|Withdrawal by Subject|7|||
27673471|NCT03178045|80643235|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
27673472|NCT03178045|80643236|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
27673473|NCT03178045|80643235|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
27673474|NCT03178045|80643236|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
27673475|NCT02593123|80643237|FG000|Overall Study|Physician Decision|2|||
27673476|NCT02593123|80643238|FG001|Overall Study|Physician Decision|1|||
27980875|NCT00624780|81763738|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
27980876|NCT00624780|81763733|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
27980877|NCT00624780|81763734|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
27980878|NCT00624780|81763735|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
27980879|NCT00624780|81763736|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
27980880|NCT00624780|81763737|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
27980881|NCT00624780|81763738|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
27980882|NCT00624780|81763733|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
27673477|NCT02593123|80643237|FG000|Overall Study|Relapse|1|||
27673478|NCT02593123|80643238|FG001|Overall Study|Relapse|1|||
27673479|NCT01010204|80643239|FG000|Overall Study|Lost to Follow-up|2|||
27673480|NCT01010204|80643240|FG001|Overall Study|Lost to Follow-up|2|||
27793820|NCT02575807|81075458|FG001|Overall Study|Death|3|||
27868180|NCT01277211|81353745|FG000|Overall Study|Pregnancy wish|0|||
27980883|NCT00624780|81763734|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
27980884|NCT00624780|81763735|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
27980885|NCT00624780|81763736|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
27980886|NCT00624780|81763737|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
27980887|NCT00624780|81763738|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
27980888|NCT00624780|81763733|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
27980889|NCT00624780|81763734|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
27980890|NCT00624780|81763735|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
27673481|NCT01010204|80643239|FG000|Overall Study|Adverse Event|1|||
27673482|NCT01010204|80643240|FG001|Overall Study|Adverse Event|3|||
27980891|NCT00624780|81763736|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
27980892|NCT00624780|81763737|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
27980893|NCT00624780|81763738|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
27980894|NCT00624780|81763733|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
27980895|NCT00624780|81763734|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
27980896|NCT00624780|81763735|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
27980897|NCT00624780|81763736|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
27980898|NCT00624780|81763737|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
27980899|NCT00624780|81763738|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
27980900|NCT00624780|81763733|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
27980901|NCT00624780|81763734|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
27980902|NCT00624780|81763735|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
27980903|NCT00624780|81763736|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
27980904|NCT00624780|81763737|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
27980905|NCT00624780|81763738|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
27980906|NCT00624780|81763733|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
27980907|NCT00624780|81763734|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
27980908|NCT00624780|81763735|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
27980909|NCT00624780|81763736|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
27980910|NCT00624780|81763737|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
27980911|NCT00624780|81763738|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
27980912|NCT00624780|81763733|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
27980913|NCT00624780|81763734|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
27980914|NCT00624780|81763735|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
27868181|NCT01277211|81353746|FG001|Overall Study|Pregnancy wish|2|||
27868182|NCT01277211|81353745|FG000|Overall Study|Discontinued prior to treatment|24|||
27868183|NCT01277211|81353746|FG001|Overall Study|Discontinued prior to treatment|13|||
27868184|NCT02443740|81353747|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868185|NCT02443740|81353748|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868186|NCT02443740|81353749|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868187|NCT02443740|81353750|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868188|NCT02443740|81353751|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868189|NCT02443740|81353752|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
27868190|NCT02443740|81353753|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868191|NCT02443740|81353754|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868192|NCT02443740|81353755|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868193|NCT02443740|81353756|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868194|NCT02443740|81353757|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
27868195|NCT02443740|81353747|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
27868196|NCT02443740|81353748|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868197|NCT02443740|81353749|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868198|NCT02443740|81353750|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868199|NCT02443740|81353751|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868200|NCT02443740|81353752|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868201|NCT02443740|81353753|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
27576170|NCT02919670|80293099|FG000|Overall Study|Only 17 participants met compliance|43|||
27576171|NCT02919670|80293100|FG001|Overall Study|Only 17 participants met compliance|39|||
27576172|NCT00679341|80293104|FG000|Overall Study|Disease progression|42|||
27576173|NCT00679341|80293105|FG001|Overall Study|Disease progression|36|||
27576174|NCT00679341|80293104|FG000|Overall Study|Adverse Event|5|||
27576175|NCT00679341|80293105|FG001|Overall Study|Adverse Event|6|||
27673483|NCT01010204|80643239|FG000|Overall Study|Withdrawal by Subject|2|||
27673484|NCT01010204|80643240|FG001|Overall Study|Withdrawal by Subject|3|||
27673485|NCT01010204|80643239|FG000|Overall Study|psychiatric hospitalization|2|||
27673486|NCT01010204|80643240|FG001|Overall Study|psychiatric hospitalization|1|||
27673487|NCT01468077|80643244|FG000|Overall Study|Adverse Event|2|||
27673488|NCT01468077|80643245|FG001|Overall Study|Adverse Event|2|||
27673489|NCT01468077|80643244|FG000|Overall Study|Lack of Efficacy|1|||
27673490|NCT01468077|80643245|FG001|Overall Study|Lack of Efficacy|1|||
27980915|NCT00624780|81763736|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
27576176|NCT00679341|80293104|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
27673491|NCT01468077|80643244|FG000|Overall Study|Physician Decision|1|||
27980916|NCT00624780|81763737|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
27980917|NCT00624780|81763738|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
27576177|NCT00679341|80293105|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
27868202|NCT02443740|81353754|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868203|NCT02443740|81353755|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27673492|NCT01468077|80643245|FG001|Overall Study|Physician Decision|0|||
27673493|NCT00455741|80643248|FG000|Overall Study|Physician Decision|0|||
27673494|NCT00455741|80643249|FG001|Overall Study|Physician Decision|1|||
27673495|NCT00798304|80643253|FG000|Overall Study|Adverse Event|0|||
27673496|NCT00798304|80643254|FG001|Overall Study|Adverse Event|1|||
27673497|NCT00798304|80643255|FG002|Overall Study|Adverse Event|1|||
27673498|NCT00798304|80643253|FG000|Overall Study|Discontinuation by Sponsor|14|||
27673499|NCT00798304|80643254|FG001|Overall Study|Discontinuation by Sponsor|21|||
27673500|NCT00798304|80643255|FG002|Overall Study|Discontinuation by Sponsor|9|||
27673501|NCT02559310|80643256|FG000|Overall Study|Death|4|||
27673502|NCT02559310|80643257|FG001|Overall Study|Death|3|||
27980918|NCT00624780|81763733|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
27980919|NCT00624780|81763734|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
27980920|NCT00624780|81763735|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
27980921|NCT00624780|81763736|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
27980922|NCT00624780|81763737|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
27980923|NCT00624780|81763738|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
27980924|NCT00624780|81763733|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
27980925|NCT00624780|81763734|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
27980926|NCT00624780|81763735|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
27980927|NCT00624780|81763736|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
27980928|NCT00624780|81763737|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
27673503|NCT02559310|80643256|FG000|Overall Study|Lost to Follow-up|5|||
27673504|NCT02559310|80643257|FG001|Overall Study|Lost to Follow-up|3|||
27673505|NCT02559310|80643256|FG000|Overall Study|Physician Decision|2|||
27673506|NCT02559310|80643257|FG001|Overall Study|Physician Decision|1|||
27673507|NCT02559310|80643256|FG000|Overall Study|Withdrawal by Subject|13|||
27673508|NCT02559310|80643257|FG001|Overall Study|Withdrawal by Subject|9|||
27673509|NCT02559310|80643256|FG000|Overall Study|Sponsor Decision|0|||
27673510|NCT02559310|80643257|FG001|Overall Study|Sponsor Decision|1|||
27673511|NCT02559310|80643256|FG000|Overall Study|Randomized but not treated|3|||
27673512|NCT02559310|80643257|FG001|Overall Study|Randomized but not treated|2|||
27673513|NCT02419417|80643261|FG000|Overall Study|Disease progression|5|||
27673514|NCT02419417|80643262|FG001|Overall Study|Disease progression|4|||
27673515|NCT02419417|80643263|FG002|Overall Study|Disease progression|13|||
27673516|NCT02419417|80643264|FG003|Overall Study|Disease progression|10|||
27673517|NCT02419417|80643265|FG004|Overall Study|Disease progression|10|||
27673518|NCT02419417|80643266|FG005|Overall Study|Disease progression|3|||
27673519|NCT02419417|80643267|FG006|Overall Study|Disease progression|4|||
27673520|NCT02419417|80643268|FG007|Overall Study|Disease progression|5|||
27673521|NCT02419417|80643269|FG008|Overall Study|Disease progression|13|||
27673522|NCT02419417|80643270|FG009|Overall Study|Disease progression|9|||
27673523|NCT02419417|80643271|FG010|Overall Study|Disease progression|0|||
27673524|NCT02419417|80643261|FG000|Overall Study|Study drug toxicity|0|||
27673525|NCT02419417|80643262|FG001|Overall Study|Study drug toxicity|0|||
27673526|NCT02419417|80643263|FG002|Overall Study|Study drug toxicity|0|||
27673527|NCT02419417|80643264|FG003|Overall Study|Study drug toxicity|0|||
27673528|NCT02419417|80643265|FG004|Overall Study|Study drug toxicity|1|||
27673529|NCT02419417|80643266|FG005|Overall Study|Study drug toxicity|0|||
27980929|NCT00624780|81763738|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
27980930|NCT00624780|81763733|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
27673530|NCT02419417|80643267|FG006|Overall Study|Study drug toxicity|0|||
27673531|NCT02419417|80643268|FG007|Overall Study|Study drug toxicity|0|||
27673532|NCT02419417|80643269|FG008|Overall Study|Study drug toxicity|0|||
27673533|NCT02419417|80643270|FG009|Overall Study|Study drug toxicity|0|||
27673534|NCT02419417|80643271|FG010|Overall Study|Study drug toxicity|0|||
27673535|NCT02419417|80643261|FG000|Overall Study|Adverse event unrelated to study drug|0|||
27673536|NCT02419417|80643262|FG001|Overall Study|Adverse event unrelated to study drug|0|||
27673537|NCT02419417|80643263|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27673538|NCT02419417|80643264|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27673539|NCT02419417|80643265|FG004|Overall Study|Adverse event unrelated to study drug|2|||
27673540|NCT02419417|80643266|FG005|Overall Study|Adverse event unrelated to study drug|1|||
27673541|NCT02419417|80643267|FG006|Overall Study|Adverse event unrelated to study drug|0|||
27980931|NCT00624780|81763734|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
27980932|NCT00624780|81763735|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
27980933|NCT00624780|81763736|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
27980934|NCT00624780|81763737|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
27673542|NCT02419417|80643268|FG007|Overall Study|Adverse event unrelated to study drug|1|||
27673543|NCT02419417|80643269|FG008|Overall Study|Adverse event unrelated to study drug|0|||
27673544|NCT02419417|80643270|FG009|Overall Study|Adverse event unrelated to study drug|0|||
27673545|NCT02419417|80643271|FG010|Overall Study|Adverse event unrelated to study drug|0|||
27673546|NCT02419417|80643261|FG000|Overall Study|Participant request to discontinue|0|||
27673547|NCT02419417|80643262|FG001|Overall Study|Participant request to discontinue|0|||
27980935|NCT00624780|81763738|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
27980936|NCT00624780|81763733|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
27980937|NCT00624780|81763734|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
27980938|NCT00624780|81763735|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
27980939|NCT00624780|81763736|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
27980940|NCT00624780|81763737|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
27980941|NCT00624780|81763738|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
27673548|NCT02419417|80643263|FG002|Overall Study|Participant request to discontinue|0|||
27673549|NCT02419417|80643264|FG003|Overall Study|Participant request to discontinue|0|||
27673550|NCT02419417|80643265|FG004|Overall Study|Participant request to discontinue|0|||
27673551|NCT02419417|80643266|FG005|Overall Study|Participant request to discontinue|0|||
27673552|NCT02419417|80643267|FG006|Overall Study|Participant request to discontinue|0|||
27673553|NCT02419417|80643268|FG007|Overall Study|Participant request to discontinue|0|||
27673554|NCT02419417|80643269|FG008|Overall Study|Participant request to discontinue|0|||
27673555|NCT02419417|80643270|FG009|Overall Study|Participant request to discontinue|1|||
27673556|NCT02419417|80643271|FG010|Overall Study|Participant request to discontinue|0|||
27673557|NCT02419417|80643261|FG000|Overall Study|Withdrawal by Subject|0|||
27673558|NCT02419417|80643262|FG001|Overall Study|Withdrawal by Subject|0|||
27673559|NCT02419417|80643263|FG002|Overall Study|Withdrawal by Subject|0|||
27673560|NCT02419417|80643264|FG003|Overall Study|Withdrawal by Subject|0|||
27673561|NCT02419417|80643265|FG004|Overall Study|Withdrawal by Subject|0|||
27673562|NCT02419417|80643266|FG005|Overall Study|Withdrawal by Subject|0|||
27673563|NCT02419417|80643267|FG006|Overall Study|Withdrawal by Subject|0|||
27673564|NCT02419417|80643268|FG007|Overall Study|Withdrawal by Subject|0|||
27673565|NCT02419417|80643269|FG008|Overall Study|Withdrawal by Subject|0|||
27673566|NCT02419417|80643270|FG009|Overall Study|Withdrawal by Subject|0|||
27673567|NCT02419417|80643271|FG010|Overall Study|Withdrawal by Subject|1|||
27673568|NCT01261247|80643272|FG000|Overall Study|Ineligible|2|||
27673569|NCT02270671|80643273|FG000|Overall Study|Withdrawal by Subject|1|||
27673570|NCT02270671|80643274|FG001|Overall Study|Withdrawal by Subject|1|||
27673571|NCT02270671|80643273|FG000|Overall Study|Protocol Violation|0|||
27673572|NCT02270671|80643274|FG001|Overall Study|Protocol Violation|1|||
27673573|NCT02270671|80643273|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
27673574|NCT02270671|80643274|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
27673575|NCT02270671|80643273|FG000|Overall Study|Lost to Follow-up|2|||
27673576|NCT02270671|80643274|FG001|Overall Study|Lost to Follow-up|1|||
27673577|NCT01948076|80643276|FG000|Overall Study|Withdrawal by Subject|0|||
27673578|NCT01948076|80643277|FG001|Overall Study|Withdrawal by Subject|1|||
27673579|NCT03513068|80643278|FG000|Overall Study|Death|1|||
27673580|NCT03513068|80643279|FG001|Overall Study|Death|0|||
27673581|NCT03513068|80643278|FG000|Overall Study|Withdrawal by Subject|4|||
27673582|NCT03513068|80643279|FG001|Overall Study|Withdrawal by Subject|6|||
27673583|NCT02872012|80643286|FG000|Overall Study|Withdrawal by Subject|1|||
27673584|NCT02872012|80643287|FG001|Overall Study|Withdrawal by Subject|0|||
27673585|NCT02872012|80643288|FG002|Overall Study|Withdrawal by Subject|0|||
27673586|NCT02872012|80643289|FG003|Overall Study|Withdrawal by Subject|0|||
27673587|NCT02872012|80643290|FG004|Overall Study|Withdrawal by Subject|0|||
27673588|NCT02386839|80643293|FG000|Overall Study|Death|1|||
27673589|NCT02386839|80643294|FG001|Overall Study|Death|0|||
27673590|NCT02386839|80643293|FG000|Overall Study|Withdrawal by Subject|9|||
27673591|NCT02386839|80643294|FG001|Overall Study|Withdrawal by Subject|10|||
27673592|NCT02386839|80643293|FG000|Overall Study|Lost to Follow-up|4|||
27673593|NCT02386839|80643294|FG001|Overall Study|Lost to Follow-up|4|||
27673594|NCT02386839|80643293|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
27673595|NCT02386839|80643294|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
27673596|NCT02386839|80643293|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
27673597|NCT02386839|80643294|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
27673598|NCT02386839|80643293|FG000|Overall Study|Other (unspecified)|1|||
27673599|NCT02386839|80643294|FG001|Overall Study|Other (unspecified)|0|||
27673600|NCT00760513|80643295|FG000|Overall Study|Withdrawal by Subject|5|||
27980942|NCT00624780|81763733|FG000|Follow-up (Week 26)|Death|0|||
27980943|NCT00624780|81763734|FG001|Follow-up (Week 26)|Death|0|||
27673601|NCT00760513|80643296|FG001|Overall Study|Withdrawal by Subject|7|||
27673602|NCT01639742|80643299|FG000|Overall Study|Study Ongoing|17|||
27673603|NCT01639742|80643299|FG000|Overall Study|Lost to Follow-up|1|||
27673604|NCT01689363|80643304|FG000|Overall Study|Protocol Violation|0|||
27673605|NCT01689363|80643305|FG001|Overall Study|Protocol Violation|1|||
27673606|NCT01689363|80643306|FG002|Overall Study|Protocol Violation|0|||
27673607|NCT01689363|80643307|FG003|Overall Study|Protocol Violation|0|||
27673608|NCT01689363|80643308|FG004|Overall Study|Protocol Violation|0|||
27980944|NCT00624780|81763735|FG002|Follow-up (Week 26)|Death|1|||
27980945|NCT00624780|81763736|FG003|Follow-up (Week 26)|Death|0|||
27980946|NCT00624780|81763737|FG004|Follow-up (Week 26)|Death|0|||
27980947|NCT00624780|81763738|FG005|Follow-up (Week 26)|Death|0|||
27980948|NCT00624780|81763733|FG000|Follow-up (Week 26)|Adverse Event|0|||
27576178|NCT00679341|80293104|FG000|Overall Study|Death|1|||
27576179|NCT00679341|80293105|FG001|Overall Study|Death|1|||
27576180|NCT00679341|80293104|FG000|Overall Study|Other|1|||
27576181|NCT00679341|80293105|FG001|Overall Study|Other|0|||
27576182|NCT00679341|80293104|FG000|Overall Study|Physician Decision|1|||
27576183|NCT00679341|80293105|FG001|Overall Study|Physician Decision|0|||
27576184|NCT00679341|80293104|FG000|Overall Study|Not treated|0|||
27576185|NCT00679341|80293105|FG001|Overall Study|Not treated|2|||
27576186|NCT00679341|80293104|FG000|Overall Study|Physician/patient decision to withdraw|0|||
27576187|NCT00679341|80293105|FG001|Overall Study|Physician/patient decision to withdraw|6|||
27576188|NCT03337724|80293106|FG000|Overall Study|Reason not Specified|12|||
27576189|NCT03337724|80293107|FG001|Overall Study|Reason not Specified|21|||
27576190|NCT03337724|80293108|FG002|Overall Study|Reason not Specified|9|||
27576191|NCT03337724|80293109|FG003|Overall Study|Reason not Specified|9|||
27576192|NCT03337724|80293110|FG004|Overall Study|Reason not Specified|29|||
27576193|NCT03337724|80293106|FG000|Overall Study|Withdrawal by Subject|13|||
27576194|NCT03337724|80293107|FG001|Overall Study|Withdrawal by Subject|15|||
27576195|NCT03337724|80293108|FG002|Overall Study|Withdrawal by Subject|4|||
27576196|NCT03337724|80293109|FG003|Overall Study|Withdrawal by Subject|15|||
27576197|NCT03337724|80293110|FG004|Overall Study|Withdrawal by Subject|6|||
27576198|NCT03337724|80293106|FG000|Overall Study|Protocol Deviation|0|||
27576199|NCT03337724|80293107|FG001|Overall Study|Protocol Deviation|1|||
27576200|NCT03337724|80293108|FG002|Overall Study|Protocol Deviation|1|||
27576201|NCT03337724|80293109|FG003|Overall Study|Protocol Deviation|1|||
27576202|NCT03337724|80293110|FG004|Overall Study|Protocol Deviation|0|||
27576203|NCT03337724|80293106|FG000|Overall Study|Adverse Event|1|||
27576204|NCT03337724|80293107|FG001|Overall Study|Adverse Event|1|||
27576205|NCT03337724|80293108|FG002|Overall Study|Adverse Event|0|||
27576206|NCT03337724|80293109|FG003|Overall Study|Adverse Event|1|||
27576207|NCT03337724|80293110|FG004|Overall Study|Adverse Event|0|||
27576208|NCT03337724|80293106|FG000|Overall Study|Death|40|||
27576209|NCT03337724|80293107|FG001|Overall Study|Death|89|||
27576210|NCT03337724|80293108|FG002|Overall Study|Death|43|||
27576211|NCT03337724|80293109|FG003|Overall Study|Death|76|||
27576212|NCT03337724|80293110|FG004|Overall Study|Death|50|||
27576213|NCT03337724|80293106|FG000|Overall Study|Lost to Follow-up|5|||
27576214|NCT03337724|80293107|FG001|Overall Study|Lost to Follow-up|5|||
27576215|NCT03337724|80293108|FG002|Overall Study|Lost to Follow-up|4|||
27576216|NCT03337724|80293109|FG003|Overall Study|Lost to Follow-up|7|||
27576217|NCT03337724|80293110|FG004|Overall Study|Lost to Follow-up|4|||
27576218|NCT03337724|80293106|FG000|Overall Study|Physician Decision|16|||
27576219|NCT03337724|80293107|FG001|Overall Study|Physician Decision|34|||
27576220|NCT03337724|80293108|FG002|Overall Study|Physician Decision|14|||
27576221|NCT03337724|80293109|FG003|Overall Study|Physician Decision|34|||
27576222|NCT03337724|80293110|FG004|Overall Study|Physician Decision|13|||
27576223|NCT03337724|80293106|FG000|Overall Study|Progressive Disease|0|||
27576224|NCT03337724|80293107|FG001|Overall Study|Progressive Disease|2|||
27576225|NCT03337724|80293108|FG002|Overall Study|Progressive Disease|1|||
27576226|NCT03337724|80293109|FG003|Overall Study|Progressive Disease|2|||
27576227|NCT03337724|80293110|FG004|Overall Study|Progressive Disease|0|||
27576228|NCT03337724|80293106|FG000|Overall Study|Symptomatic Deterioration|0|||
27576229|NCT03337724|80293107|FG001|Overall Study|Symptomatic Deterioration|0|||
27576230|NCT03337724|80293108|FG002|Overall Study|Symptomatic Deterioration|0|||
27576231|NCT03337724|80293109|FG003|Overall Study|Symptomatic Deterioration|1|||
27576232|NCT03337724|80293110|FG004|Overall Study|Symptomatic Deterioration|0|||
27576233|NCT00691210|80293111|FG000|Overall Study|Progression of Disease|0|||
27673609|NCT01689363|80643309|FG005|Overall Study|Protocol Violation|0|||
27673610|NCT01689363|80643310|FG006|Overall Study|Protocol Violation|0|||
27673611|NCT01689363|80643311|FG007|Overall Study|Protocol Violation|0|||
27673612|NCT01807182|80643312|FG000|Overall Study|Death|1|||
27576234|NCT00691210|80293112|FG001|Overall Study|Progression of Disease|0|||
27576235|NCT00691210|80293113|FG002|Overall Study|Progression of Disease|0|||
27576236|NCT00691210|80293114|FG003|Overall Study|Progression of Disease|2|||
27576237|NCT00691210|80293115|FG004|Overall Study|Progression of Disease|0|||
27980949|NCT00624780|81763734|FG001|Follow-up (Week 26)|Adverse Event|0|||
27576238|NCT00691210|80293116|FG005|Overall Study|Progression of Disease|0|||
27576239|NCT00691210|80293117|FG006|Overall Study|Progression of Disease|0|||
27673613|NCT01807182|80643312|FG000|Overall Study|New therapy|1|||
27576240|NCT00691210|80293118|FG007|Overall Study|Progression of Disease|0|||
27576241|NCT00691210|80293111|FG000|Overall Study|Lack of Efficacy|0|||
27576242|NCT00691210|80293112|FG001|Overall Study|Lack of Efficacy|0|||
27576243|NCT00691210|80293113|FG002|Overall Study|Lack of Efficacy|0|||
27576244|NCT00691210|80293114|FG003|Overall Study|Lack of Efficacy|1|||
27576245|NCT00691210|80293115|FG004|Overall Study|Lack of Efficacy|0|||
27980950|NCT00624780|81763735|FG002|Follow-up (Week 26)|Adverse Event|0|||
27673614|NCT01807182|80643312|FG000|Overall Study|Moved to hospice care|1|||
27673615|NCT00416598|80643315|FG000|Induction & Intensification|Adverse Event|38|||
27673616|NCT00416598|80643315|FG000|Induction & Intensification|Death|32|||
27673617|NCT00416598|80643315|FG000|Induction & Intensification|Withdrawal by Subject|46|||
27673618|NCT00416598|80643315|FG000|Induction & Intensification|Alternative Treatment|135|||
27673619|NCT00416598|80643315|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
27673620|NCT00416598|80643315|FG000|Induction & Intensification|Relapse/progression|29|||
27673621|NCT00416598|80643315|FG000|Induction & Intensification|Failed induction|87|||
27673622|NCT00416598|80643315|FG000|Decitabine Maintenance|Adverse Event|5|||
27673623|NCT00416598|80643315|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
27673624|NCT00416598|80643315|FG000|Decitabine Maintenance|Progression/relapse|38|||
27673625|NCT00416598|80643315|FG000|Decitabine Maintenance|Alternative treatment|2|||
27673626|NCT00416598|80643315|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
27673627|NCT02563548|80643316|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
27673628|NCT02563548|80643317|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27673629|NCT02563548|80643318|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27673630|NCT02563548|80643319|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
27673631|NCT02563548|80643320|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27673632|NCT02563548|80643321|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
27673633|NCT02563548|80643316|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
27673634|NCT02563548|80643317|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
27673635|NCT02563548|80643318|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
27673636|NCT02563548|80643319|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
27673637|NCT02563548|80643320|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
27673638|NCT02563548|80643321|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
27673639|NCT02563548|80643316|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27673640|NCT02563548|80643317|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27673641|NCT02563548|80643318|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
27673642|NCT02563548|80643319|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27673643|NCT02563548|80643320|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27673644|NCT02563548|80643321|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
27673645|NCT02563548|80643316|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27673646|NCT02563548|80643317|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27673647|NCT02563548|80643318|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
27673648|NCT02563548|80643319|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
27673649|NCT02563548|80643320|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27673650|NCT02563548|80643321|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
27673651|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27673652|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27673653|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27673654|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
27673655|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
27673656|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
27673657|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27673658|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27673659|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27673660|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
27673661|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
27673662|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
27673663|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27673664|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27673665|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27673666|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27673667|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
27673668|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
27673669|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27980951|NCT00624780|81763736|FG003|Follow-up (Week 26)|Adverse Event|0|||
27980952|NCT00624780|81763737|FG004|Follow-up (Week 26)|Adverse Event|1|||
27980953|NCT00624780|81763738|FG005|Follow-up (Week 26)|Adverse Event|0|||
27980954|NCT00624780|81763733|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
27980955|NCT00624780|81763734|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
27673670|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27673671|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27673672|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
27980956|NCT00624780|81763735|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
27980957|NCT00624780|81763736|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
27980958|NCT00624780|81763737|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
27576246|NCT00691210|80293116|FG005|Overall Study|Lack of Efficacy|1|||
27673673|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
27673674|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
27673675|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27673676|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27673677|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27673678|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27673679|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
27673680|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
27673681|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27673682|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27673683|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27673684|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27673685|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
27673686|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
27673687|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27673688|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27673689|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27673690|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27673691|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
27673692|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
27673693|NCT02563548|80643316|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27673694|NCT02563548|80643317|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27673695|NCT02563548|80643318|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27673696|NCT02563548|80643319|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27673697|NCT02563548|80643320|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
27673698|NCT02563548|80643321|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
27673699|NCT01889069|80643322|FG000|Overall Study|Death|18|||
27673700|NCT01889069|80643322|FG000|Overall Study|Progression of Disease|14|||
27673701|NCT01889069|80643322|FG000|Overall Study|Lost to Follow-up|6|||
27673702|NCT01889069|80643322|FG000|Overall Study|Other|4|||
27673703|NCT01889069|80643322|FG000|Overall Study|Consent Withdrawal|3|||
27673704|NCT04140266|80643334|FG000|Overall Study|Physician Decision|2|||
27673705|NCT04140266|80643335|FG001|Overall Study|Physician Decision|0|||
27673706|NCT04140266|80643334|FG000|Overall Study|Withdrawal by Subject|4|||
27673707|NCT04140266|80643335|FG001|Overall Study|Withdrawal by Subject|2|||
27673708|NCT02367352|80643336|FG000|Overall Study|Progressive disease|7|||
27673709|NCT02367352|80643337|FG001|Overall Study|Progressive disease|0|||
27673710|NCT02367352|80643338|FG002|Overall Study|Progressive disease|0|||
27673711|NCT02367352|80643336|FG000|Overall Study|Participant Received Alternative Therapy|1|||
27673712|NCT02367352|80643337|FG001|Overall Study|Participant Received Alternative Therapy|0|||
27673713|NCT02367352|80643338|FG002|Overall Study|Participant Received Alternative Therapy|0|||
27673714|NCT02367352|80643336|FG000|Overall Study|Adverse Event|1|||
27673715|NCT02367352|80643337|FG001|Overall Study|Adverse Event|0|||
27673716|NCT02367352|80643338|FG002|Overall Study|Adverse Event|0|||
27673717|NCT03334253|80643339|FG000|Overall Study|Withdrawal by Subject|1|||
27673718|NCT03334253|80643340|FG001|Overall Study|Withdrawal by Subject|0|||
27673719|NCT03334253|80643339|FG000|Overall Study|Lost to Follow-up|4|||
27673720|NCT03334253|80643340|FG001|Overall Study|Lost to Follow-up|3|||
27673721|NCT03334253|80643339|FG000|Overall Study|Moved residence|2|||
27673722|NCT03334253|80643340|FG001|Overall Study|Moved residence|2|||
27673723|NCT02659098|80643341|FG000|Overall Study|Withdrawal by Subject|7|||
27673724|NCT00497874|80643344|FG000|Overall Study|Withdrawal by Subject|48|||
27673725|NCT00497874|80643345|FG001|Overall Study|Withdrawal by Subject|17|||
27673726|NCT00497874|80643344|FG000|Overall Study|Illness|8|||
27673727|NCT00497874|80643345|FG001|Overall Study|Illness|4|||
27673728|NCT00497874|80643344|FG000|Overall Study|Death|2|||
27673729|NCT00497874|80643345|FG001|Overall Study|Death|4|||
27793821|NCT02575807|81075459|FG002|Overall Study|Death|7|||
27793822|NCT02575807|81075460|FG003|Overall Study|Death|0|||
27673730|NCT00497874|80643344|FG000|Overall Study|Unable to contact|52|||
27673731|NCT00497874|80643345|FG001|Overall Study|Unable to contact|67|||
27673732|NCT00497874|80643344|FG000|Overall Study|Unable to schedule|37|||
27673733|NCT00497874|80643345|FG001|Overall Study|Unable to schedule|24|||
27673734|NCT01791413|80643346|FG000|Overall Study|Lost to Follow-up|5|||
27793823|NCT02575807|81075461|FG004|Overall Study|Death|1|||
27673735|NCT01791413|80643347|FG001|Overall Study|Lost to Follow-up|1|||
27673736|NCT00770588|80643348|FG000|Overall Study|Adverse Event|9|||
27673737|NCT00770588|80643349|FG001|Overall Study|Adverse Event|2|||
27673738|NCT00770588|80643348|FG000|Overall Study|Death caused by progression of disease|70|||
27673739|NCT00770588|80643349|FG001|Overall Study|Death caused by progression of disease|91|||
27673740|NCT00770588|80643348|FG000|Overall Study|Lost to Follow-up|1|||
27673741|NCT00770588|80643349|FG001|Overall Study|Lost to Follow-up|1|||
27673742|NCT00770588|80643348|FG000|Overall Study|Withdrawal by Subject|1|||
27673743|NCT00770588|80643349|FG001|Overall Study|Withdrawal by Subject|1|||
27673744|NCT04978090|80643350|FG000|Overall Study|unable to adequately fit device|2|||
27673745|NCT02990468|80643351|FG000|Phase 2: MTD|Change in treatment|0|||
27673746|NCT02990468|80643352|FG001|Phase 2: MTD|Change in treatment|0|||
27673747|NCT02990468|80643353|FG002|Phase 2: MTD|Change in treatment|1|||
27673748|NCT01262092|80643354|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
27673749|NCT01262092|80643355|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
27673750|NCT01262092|80643354|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
27673751|NCT01262092|80643355|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
27673752|NCT01262092|80643354|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
27673753|NCT01262092|80643355|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
27673754|NCT01262092|80643354|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
27673755|NCT01262092|80643355|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
27673756|NCT02689453|80643361|FG000|Overall Study|Progressive disease|0|||
27673757|NCT02689453|80643362|FG001|Overall Study|Progressive disease|1|||
27673758|NCT02689453|80643363|FG002|Overall Study|Progressive disease|1|||
27673759|NCT01453023|80643364|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
27673760|NCT01453023|80643365|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
27673761|NCT01453023|80643364|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
27673762|NCT01453023|80643365|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
27673763|NCT01453023|80643364|FG000|Treatment Period 2|Protocol Violation|0|||
27673764|NCT01453023|80643365|FG001|Treatment Period 2|Protocol Violation|1|||
27673765|NCT00575042|80643366|FG000|Overall Study|Adverse Event|2|||
27673766|NCT00575042|80643366|FG000|Overall Study|Lost to Follow-up|1|||
27673767|NCT01594827|80643367|FG000|Overall Study|Adverse Event|1|||
27673768|NCT01594827|80643368|FG001|Overall Study|Adverse Event|0|||
27673769|NCT01594827|80643367|FG000|Overall Study|Physician Decision|3|||
27673770|NCT01594827|80643368|FG001|Overall Study|Physician Decision|0|||
27673771|NCT02498236|80643378|FG000|Overall Study|Did not show for testing|1|||
27673772|NCT02498236|80643379|FG001|Overall Study|Did not show for testing|0|||
27673773|NCT02498236|80643380|FG002|Overall Study|Did not show for testing|0|||
27673774|NCT02498236|80643381|FG003|Overall Study|Did not show for testing|0|||
27673775|NCT02498236|80643382|FG004|Overall Study|Did not show for testing|0|||
27673776|NCT02498236|80643383|FG005|Overall Study|Did not show for testing|0|||
27673777|NCT02498236|80643384|FG006|Overall Study|Did not show for testing|0|||
27673778|NCT02498236|80643385|FG007|Overall Study|Did not show for testing|1|||
27673779|NCT02498236|80643378|FG000|Overall Study|Equipment failure|0|||
27673780|NCT02498236|80643379|FG001|Overall Study|Equipment failure|0|||
27673781|NCT02498236|80643380|FG002|Overall Study|Equipment failure|0|||
27673782|NCT02498236|80643381|FG003|Overall Study|Equipment failure|0|||
27673783|NCT02498236|80643382|FG004|Overall Study|Equipment failure|0|||
27673784|NCT02498236|80643383|FG005|Overall Study|Equipment failure|0|||
27673785|NCT02498236|80643384|FG006|Overall Study|Equipment failure|1|||
27673786|NCT02498236|80643385|FG007|Overall Study|Equipment failure|0|||
27673787|NCT02498236|80643378|FG000|Overall Study|Withdrawal by Subject|0|||
27673788|NCT02498236|80643379|FG001|Overall Study|Withdrawal by Subject|0|||
27673789|NCT02498236|80643380|FG002|Overall Study|Withdrawal by Subject|0|||
27673790|NCT02498236|80643381|FG003|Overall Study|Withdrawal by Subject|0|||
27673791|NCT02498236|80643382|FG004|Overall Study|Withdrawal by Subject|1|||
27673792|NCT02498236|80643383|FG005|Overall Study|Withdrawal by Subject|0|||
27673793|NCT02498236|80643384|FG006|Overall Study|Withdrawal by Subject|0|||
27673794|NCT02498236|80643385|FG007|Overall Study|Withdrawal by Subject|0|||
27673795|NCT04147195|80643389|FG000|Overall Study|Adverse Event|0|||
27673796|NCT04147195|80643390|FG001|Overall Study|Adverse Event|3|||
27793824|NCT02575807|81075457|FG000|Overall Study|Study terminated by Sponsor|0|||
27793825|NCT02575807|81075458|FG001|Overall Study|Study terminated by Sponsor|1|||
27793826|NCT02575807|81075459|FG002|Overall Study|Study terminated by Sponsor|7|||
27793827|NCT02575807|81075460|FG003|Overall Study|Study terminated by Sponsor|0|||
27673797|NCT04147195|80643389|FG000|Overall Study|Study Terminated by Sponsor|4|||
27673798|NCT04147195|80643390|FG001|Overall Study|Study Terminated by Sponsor|2|||
27673799|NCT04147195|80643389|FG000|Overall Study|Withdrawal by Subject|0|||
27673800|NCT04147195|80643390|FG001|Overall Study|Withdrawal by Subject|1|||
27673801|NCT00478205|80643392|FG000|Overall Study|Adverse Event|182|||
27673802|NCT00478205|80643393|FG001|Overall Study|Adverse Event|39|||
27673803|NCT00478205|80643392|FG000|Overall Study|Medication Non-compliance|9|||
27673804|NCT00478205|80643393|FG001|Overall Study|Medication Non-compliance|4|||
27673805|NCT00478205|80643392|FG000|Overall Study|Protocol Violation|15|||
27673806|NCT00478205|80643393|FG001|Overall Study|Protocol Violation|5|||
27673807|NCT00478205|80643392|FG000|Overall Study|Request of Investigator or Sponsor|4|||
27673808|NCT00478205|80643393|FG001|Overall Study|Request of Investigator or Sponsor|5|||
27868204|NCT02443740|81353756|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868205|NCT02443740|81353757|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
27868206|NCT02443740|81353747|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868207|NCT02443740|81353748|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868208|NCT02443740|81353749|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27980959|NCT00624780|81763738|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
27980960|NCT00624780|81763733|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
27980961|NCT00624780|81763734|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
27980962|NCT00624780|81763735|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
27980963|NCT00624780|81763736|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
27980964|NCT00624780|81763737|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
27980965|NCT00624780|81763738|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
27980966|NCT00624780|81763733|FG000|Follow-up (Week 26)|Other|1|||
27980967|NCT00624780|81763734|FG001|Follow-up (Week 26)|Other|1|||
27980968|NCT00624780|81763735|FG002|Follow-up (Week 26)|Other|0|||
27980969|NCT00624780|81763736|FG003|Follow-up (Week 26)|Other|0|||
27980970|NCT00624780|81763737|FG004|Follow-up (Week 26)|Other|0|||
27980971|NCT00624780|81763738|FG005|Follow-up (Week 26)|Other|0|||
27980972|NCT03323736|81763739|FG000|Overall Study|Screen Failure|14|||
27980973|NCT03323736|81763740|FG001|Overall Study|Screen Failure|9|||
27980974|NCT03323736|81763741|FG002|Overall Study|Screen Failure|1|||
27980975|NCT03323736|81763739|FG000|Overall Study|Withdrawal Before Treatment|3|||
27980976|NCT03323736|81763740|FG001|Overall Study|Withdrawal Before Treatment|1|||
27980977|NCT03323736|81763741|FG002|Overall Study|Withdrawal Before Treatment|1|||
27980978|NCT03323736|81763739|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
27980979|NCT03323736|81763740|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
27980980|NCT03323736|81763741|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
27980981|NCT02677844|81763742|FG000|Period 3|Withdrawal by Subject|0|||
27980982|NCT02677844|81763743|FG001|Period 3|Withdrawal by Subject|0|||
27980983|NCT02677844|81763744|FG002|Period 3|Withdrawal by Subject|0|||
27980984|NCT02677844|81763745|FG003|Period 3|Withdrawal by Subject|1|||
27980985|NCT02677844|81763746|FG004|Period 3|Withdrawal by Subject|0|||
27980986|NCT02677844|81763747|FG005|Period 3|Withdrawal by Subject|0|||
27980987|NCT02677844|81763748|FG006|Period 3|Withdrawal by Subject|0|||
27980988|NCT03458702|81763751|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
27980989|NCT03458702|81763752|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
27980990|NCT03458702|81763751|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
27980991|NCT03458702|81763752|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
27576247|NCT00691210|80293117|FG006|Overall Study|Lack of Efficacy|0|||
27576248|NCT00691210|80293118|FG007|Overall Study|Lack of Efficacy|0|||
27980992|NCT02250664|81763753|FG000|Overall Study|Lost to Follow-up|18|||
27980993|NCT02250664|81763754|FG001|Overall Study|Lost to Follow-up|28|||
27980994|NCT02250664|81763755|FG002|Overall Study|Lost to Follow-up|33|||
27980995|NCT02250664|81763753|FG000|Overall Study|Personal Reasons|7|||
27576249|NCT00797667|80293124|FG000|Overall Study|Lack of Efficacy|0|||
27576250|NCT00797667|80293125|FG001|Overall Study|Lack of Efficacy|1|||
27576251|NCT00797667|80293126|FG002|Overall Study|Lack of Efficacy|0|||
27576252|NCT00797667|80293124|FG000|Overall Study|Lost to Follow-up|8|||
27576253|NCT00797667|80293125|FG001|Overall Study|Lost to Follow-up|12|||
27576254|NCT00797667|80293126|FG002|Overall Study|Lost to Follow-up|2|||
27576255|NCT00797667|80293124|FG000|Overall Study|Physician Decision|3|||
27576256|NCT00797667|80293125|FG001|Overall Study|Physician Decision|1|||
27576257|NCT00797667|80293126|FG002|Overall Study|Physician Decision|0|||
27576258|NCT00797667|80293124|FG000|Overall Study|Pregnancy|2|||
27576259|NCT00797667|80293125|FG001|Overall Study|Pregnancy|0|||
27576260|NCT00797667|80293126|FG002|Overall Study|Pregnancy|0|||
27576261|NCT00797667|80293124|FG000|Overall Study|Protocol Violation|2|||
27576262|NCT00797667|80293125|FG001|Overall Study|Protocol Violation|7|||
27576263|NCT00797667|80293126|FG002|Overall Study|Protocol Violation|0|||
27576264|NCT00797667|80293124|FG000|Overall Study|Study Terminated by Sponsor|217|||
27576265|NCT00797667|80293125|FG001|Overall Study|Study Terminated by Sponsor|216|||
27576266|NCT00797667|80293126|FG002|Overall Study|Study Terminated by Sponsor|115|||
27576267|NCT00797667|80293124|FG000|Overall Study|Withdrawal by Subject|9|||
27576268|NCT00797667|80293125|FG001|Overall Study|Withdrawal by Subject|14|||
27576269|NCT00797667|80293126|FG002|Overall Study|Withdrawal by Subject|2|||
27576270|NCT00797667|80293124|FG000|Overall Study|Adverse Event|19|||
27576271|NCT00797667|80293125|FG001|Overall Study|Adverse Event|8|||
27576272|NCT00797667|80293126|FG002|Overall Study|Adverse Event|8|||
27576273|NCT02130765|80293131|FG000|Overall Study|Did not receive treatment|4|||
27576274|NCT02130765|80293132|FG001|Overall Study|Did not receive treatment|0|||
27576275|NCT02130765|80293133|FG002|Overall Study|Did not receive treatment|0|||
27980996|NCT02250664|81763754|FG001|Overall Study|Personal Reasons|8|||
27980997|NCT02250664|81763755|FG002|Overall Study|Personal Reasons|14|||
27980998|NCT02250664|81763753|FG000|Overall Study|Adverse Event|6|||
27980999|NCT02250664|81763754|FG001|Overall Study|Adverse Event|3|||
27981000|NCT02250664|81763755|FG002|Overall Study|Adverse Event|8|||
27981001|NCT02250664|81763753|FG000|Overall Study|Incarcerated|2|||
27981002|NCT02250664|81763754|FG001|Overall Study|Incarcerated|1|||
27981003|NCT02250664|81763755|FG002|Overall Study|Incarcerated|2|||
27981004|NCT02250664|81763753|FG000|Overall Study|Withdrawal by Subject|0|||
27981005|NCT02250664|81763754|FG001|Overall Study|Withdrawal by Subject|1|||
27981006|NCT02250664|81763755|FG002|Overall Study|Withdrawal by Subject|2|||
27981007|NCT02250664|81763753|FG000|Overall Study|Death|0|||
27981008|NCT02250664|81763754|FG001|Overall Study|Death|1|||
27981009|NCT02250664|81763755|FG002|Overall Study|Death|1|||
27981010|NCT02250664|81763753|FG000|Overall Study|Physician Decision|1|||
27981011|NCT02250664|81763754|FG001|Overall Study|Physician Decision|3|||
27981012|NCT02250664|81763755|FG002|Overall Study|Physician Decision|1|||
27981013|NCT02250664|81763753|FG000|Overall Study|Protocol Violation|1|||
27981014|NCT02250664|81763754|FG001|Overall Study|Protocol Violation|0|||
27981015|NCT02250664|81763755|FG002|Overall Study|Protocol Violation|1|||
27981016|NCT02250664|81763753|FG000|Overall Study|Reason unknown|1|||
27981017|NCT02250664|81763754|FG001|Overall Study|Reason unknown|0|||
27981018|NCT02250664|81763755|FG002|Overall Study|Reason unknown|0|||
27981019|NCT03869333|81763757|FG000|Overall Study|Lost to Follow-up|1|||
27981020|NCT03869333|81763758|FG001|Overall Study|Lost to Follow-up|0|||
27981021|NCT03869333|81763759|FG002|Overall Study|Lost to Follow-up|0|||
27981022|NCT03869333|81763760|FG003|Overall Study|Lost to Follow-up|0|||
27981023|NCT03869333|81763757|FG000|Overall Study|Pregnancy|1|||
27981024|NCT03869333|81763758|FG001|Overall Study|Pregnancy|0|||
27981025|NCT03869333|81763759|FG002|Overall Study|Pregnancy|0|||
27981026|NCT03869333|81763760|FG003|Overall Study|Pregnancy|0|||
27981027|NCT03869333|81763757|FG000|Overall Study|Physician Decision|0|||
27981028|NCT03869333|81763758|FG001|Overall Study|Physician Decision|1|||
27981029|NCT03869333|81763759|FG002|Overall Study|Physician Decision|0|||
27981030|NCT03869333|81763760|FG003|Overall Study|Physician Decision|0|||
27981031|NCT01751776|81763762|FG000|Overall Study|Adverse Event|0|||
27981032|NCT01751776|81763763|FG001|Overall Study|Adverse Event|0|||
27981033|NCT01751776|81763764|FG002|Overall Study|Adverse Event|0|||
27981034|NCT01751776|81763765|FG003|Overall Study|Adverse Event|0|||
27981035|NCT01751776|81763766|FG004|Overall Study|Adverse Event|0|||
27981036|NCT01751776|81763767|FG005|Overall Study|Adverse Event|0|||
27981037|NCT01751776|81763768|FG006|Overall Study|Adverse Event|4|||
27981038|NCT01751776|81763769|FG007|Overall Study|Adverse Event|2|||
27981039|NCT01751776|81763762|FG000|Overall Study|Consent withdrawn|0|||
27981040|NCT01751776|81763763|FG001|Overall Study|Consent withdrawn|0|||
27981041|NCT01751776|81763764|FG002|Overall Study|Consent withdrawn|0|||
27981042|NCT01751776|81763765|FG003|Overall Study|Consent withdrawn|0|||
27981043|NCT01751776|81763766|FG004|Overall Study|Consent withdrawn|0|||
27576276|NCT02130765|80293134|FG003|Overall Study|Did not receive treatment|0|||
27576277|NCT02082522|80293143|FG000|Overall Study|Sponsor termination|5|||
27576278|NCT02082522|80293144|FG001|Overall Study|Sponsor termination|3|||
27576279|NCT02082522|80293143|FG000|Overall Study|Withdrawal by Subject|2|||
27576280|NCT02082522|80293144|FG001|Overall Study|Withdrawal by Subject|4|||
27576281|NCT02082522|80293143|FG000|Overall Study|Death|1|||
27576282|NCT02082522|80293144|FG001|Overall Study|Death|0|||
27576283|NCT02082522|80293143|FG000|Overall Study|Lost to Follow-up|1|||
27576284|NCT02082522|80293144|FG001|Overall Study|Lost to Follow-up|0|||
27576285|NCT02082522|80293143|FG000|Overall Study|Physician Decision|3|||
27576286|NCT02082522|80293144|FG001|Overall Study|Physician Decision|1|||
27576287|NCT02082522|80293143|FG000|Overall Study|Disease progression|2|||
27576288|NCT02082522|80293144|FG001|Overall Study|Disease progression|2|||
27673809|NCT00478205|80643392|FG000|Overall Study|Withdrawal by Subject|61|||
27673810|NCT00478205|80643393|FG001|Overall Study|Withdrawal by Subject|22|||
27673811|NCT00478205|80643392|FG000|Overall Study|Lack of Efficacy|1|||
27981044|NCT01751776|81763767|FG005|Overall Study|Consent withdrawn|0|||
27673812|NCT00478205|80643393|FG001|Overall Study|Lack of Efficacy|0|||
27673813|NCT00478205|80643392|FG000|Overall Study|Other|24|||
27981045|NCT01751776|81763768|FG006|Overall Study|Consent withdrawn|0|||
27981046|NCT01751776|81763769|FG007|Overall Study|Consent withdrawn|1|||
27981047|NCT01751776|81763762|FG000|Overall Study|Other reason not specified above|0|||
27981048|NCT01751776|81763763|FG001|Overall Study|Other reason not specified above|0|||
27981049|NCT01751776|81763764|FG002|Overall Study|Other reason not specified above|0|||
27981050|NCT01751776|81763765|FG003|Overall Study|Other reason not specified above|0|||
27981051|NCT01751776|81763766|FG004|Overall Study|Other reason not specified above|0|||
27981052|NCT01751776|81763767|FG005|Overall Study|Other reason not specified above|0|||
27576289|NCT02082522|80293143|FG000|Overall Study|Chemotherapy change|1|||
27576290|NCT02082522|80293144|FG001|Overall Study|Chemotherapy change|3|||
27576291|NCT04524403|80293145|FG000|Overall Study|Withdrawal by Subject|10|||
27673814|NCT00478205|80643393|FG001|Overall Study|Other|12|||
27673815|NCT00943787|80643394|FG000|Overall Study|Physician Decision|4|||
27981053|NCT01751776|81763768|FG006|Overall Study|Other reason not specified above|0|||
27981054|NCT01751776|81763769|FG007|Overall Study|Other reason not specified above|1|||
27981055|NCT01282294|81763771|FG000|Overall Study|Lost to Follow-up|14|||
27981056|NCT01282294|81763771|FG000|Overall Study|Screening failure|1|||
27981057|NCT01282294|81763771|FG000|Overall Study|Adverse Event|1|||
27981058|NCT01282294|81763771|FG000|Overall Study|Patient non-compliance|2|||
27981059|NCT01282294|81763771|FG000|Overall Study|Physician Decision|1|||
27981060|NCT02130986|81763774|FG000|Overall Study|Withdrawal by Subject|4|||
27981061|NCT02130986|81763775|FG001|Overall Study|Withdrawal by Subject|4|||
27981062|NCT02130986|81763774|FG000|Overall Study|Lost to Follow-up|151|||
27981063|NCT02130986|81763775|FG001|Overall Study|Lost to Follow-up|160|||
27981064|NCT03187834|81763776|FG000|Overall Study|Lost to Follow-up|0|||
27981065|NCT03187834|81763777|FG001|Overall Study|Lost to Follow-up|1|||
27981066|NCT03187834|81763778|FG002|Overall Study|Lost to Follow-up|2|||
27981067|NCT03187834|81763779|FG003|Overall Study|Lost to Follow-up|2|||
27981068|NCT03187834|81763776|FG000|Overall Study|Had invalid anthropometric measurements|5|||
27981069|NCT03187834|81763777|FG001|Overall Study|Had invalid anthropometric measurements|3|||
27981070|NCT03187834|81763778|FG002|Overall Study|Had invalid anthropometric measurements|4|||
27981071|NCT03187834|81763779|FG003|Overall Study|Had invalid anthropometric measurements|2|||
27981072|NCT04340193|81763782|FG000|Overall Study|Other reason|0|||
27981073|NCT04340193|81763783|FG001|Overall Study|Other reason|0|||
27981074|NCT04340193|81763784|FG002|Overall Study|Other reason|1|||
27981075|NCT04340193|81763782|FG000|Overall Study|Disease recurrence|0|||
27981076|NCT04340193|81763783|FG001|Overall Study|Disease recurrence|1|||
27981077|NCT04340193|81763784|FG002|Overall Study|Disease recurrence|0|||
27981078|NCT04340193|81763782|FG000|Overall Study|Study drug toxicity|1|||
27981079|NCT04340193|81763783|FG001|Overall Study|Study drug toxicity|0|||
27981080|NCT04340193|81763784|FG002|Overall Study|Study drug toxicity|0|||
27981081|NCT04340193|81763782|FG000|Overall Study|Disease progression|1|||
27981082|NCT04340193|81763783|FG001|Overall Study|Disease progression|2|||
27981083|NCT04340193|81763784|FG002|Overall Study|Disease progression|3|||
27981084|NCT04340193|81763782|FG000|Overall Study|Administrative reasons by sponsor|0|||
27981085|NCT04340193|81763783|FG001|Overall Study|Administrative reasons by sponsor|1|||
27981086|NCT04340193|81763784|FG002|Overall Study|Administrative reasons by sponsor|0|||
27981087|NCT04340193|81763782|FG000|Overall Study|Adverse Event|1|||
27981088|NCT04340193|81763783|FG001|Overall Study|Adverse Event|1|||
27981089|NCT04340193|81763784|FG002|Overall Study|Adverse Event|0|||
27981090|NCT04284813|81763785|FG000|Overall Study|Withdrawal by Subject|1|||
27981091|NCT01545050|81763791|FG000|Overall Study|Lack of Efficacy|0|||
27981092|NCT01545050|81763792|FG001|Overall Study|Lack of Efficacy|0|||
27981093|NCT01545050|81763793|FG002|Overall Study|Lack of Efficacy|0|||
27981094|NCT01545050|81763794|FG003|Overall Study|Lack of Efficacy|3|||
27981095|NCT01545050|81763795|FG004|Overall Study|Lack of Efficacy|2|||
27981096|NCT01545050|81763791|FG000|Overall Study|Adverse Event|1|||
27981097|NCT01545050|81763792|FG001|Overall Study|Adverse Event|1|||
27981098|NCT01545050|81763793|FG002|Overall Study|Adverse Event|2|||
27981099|NCT01545050|81763794|FG003|Overall Study|Adverse Event|2|||
27981100|NCT01545050|81763795|FG004|Overall Study|Adverse Event|0|||
27981101|NCT01545050|81763791|FG000|Overall Study|Discontinued study treatment|1|||
27981102|NCT01545050|81763792|FG001|Overall Study|Discontinued study treatment|0|||
27981103|NCT01545050|81763793|FG002|Overall Study|Discontinued study treatment|0|||
27981104|NCT01545050|81763794|FG003|Overall Study|Discontinued study treatment|0|||
27981105|NCT01545050|81763795|FG004|Overall Study|Discontinued study treatment|0|||
27981106|NCT01545050|81763791|FG000|Overall Study|Withdrawal by Subject|1|||
27981107|NCT01545050|81763792|FG001|Overall Study|Withdrawal by Subject|0|||
27981108|NCT01545050|81763793|FG002|Overall Study|Withdrawal by Subject|0|||
27981109|NCT01545050|81763794|FG003|Overall Study|Withdrawal by Subject|2|||
27981110|NCT01545050|81763795|FG004|Overall Study|Withdrawal by Subject|1|||
27981111|NCT01545050|81763791|FG000|Overall Study|Participant no longer meets study criteria|0|||
27981112|NCT01545050|81763792|FG001|Overall Study|Participant no longer meets study criteria|2|||
27981113|NCT01545050|81763793|FG002|Overall Study|Participant no longer meets study criteria|0|||
27981114|NCT01545050|81763794|FG003|Overall Study|Participant no longer meets study criteria|0|||
27981115|NCT01545050|81763795|FG004|Overall Study|Participant no longer meets study criteria|1|||
27981116|NCT01545050|81763791|FG000|Overall Study|Administrative reason by sponsor|4|||
27981117|NCT01545050|81763792|FG001|Overall Study|Administrative reason by sponsor|2|||
27793828|NCT02575807|81075461|FG004|Overall Study|Study terminated by Sponsor|1|||
27981118|NCT01545050|81763793|FG002|Overall Study|Administrative reason by sponsor|3|||
27981119|NCT01545050|81763794|FG003|Overall Study|Administrative reason by sponsor|5|||
27981120|NCT01545050|81763795|FG004|Overall Study|Administrative reason by sponsor|5|||
27981121|NCT01400243|81763796|FG000|Overall Study|Protocol Violation|8|||
27793829|NCT02575807|81075457|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
27981122|NCT01400243|81763797|FG001|Overall Study|Protocol Violation|11|||
27981123|NCT03684304|81763798|FG000|Overall Study|Lost to Follow-up|19|||
27981124|NCT03684304|81763799|FG001|Overall Study|Lost to Follow-up|17|||
27981125|NCT03987932|81763804|FG000|Overall Study|Lost to Follow-up|2|||
27981126|NCT03987932|81763805|FG001|Overall Study|Lost to Follow-up|1|||
27981127|NCT03987932|81763806|FG002|Overall Study|Lost to Follow-up|1|||
27981128|NCT03987932|81763804|FG000|Overall Study|Non-study related elective surgery|0|||
27981129|NCT03987932|81763805|FG001|Overall Study|Non-study related elective surgery|0|||
27981130|NCT03987932|81763806|FG002|Overall Study|Non-study related elective surgery|1|||
27981131|NCT02616393|81763807|FG000|Overall Study|Death|5|||
27981132|NCT02616393|81763808|FG001|Overall Study|Death|12|||
27981133|NCT02616393|81763809|FG002|Overall Study|Death|1|||
27981134|NCT02616393|81763807|FG000|Overall Study|Termination by Sponsor|4|||
27981135|NCT02616393|81763808|FG001|Overall Study|Termination by Sponsor|5|||
27981136|NCT02616393|81763809|FG002|Overall Study|Termination by Sponsor|2|||
27981137|NCT02616393|81763807|FG000|Overall Study|Other|3|||
27981138|NCT02616393|81763808|FG001|Overall Study|Other|0|||
27981139|NCT02616393|81763809|FG002|Overall Study|Other|0|||
27981140|NCT02616393|81763807|FG000|Overall Study|Withdrawal by Subject|1|||
27981141|NCT02616393|81763808|FG001|Overall Study|Withdrawal by Subject|1|||
27981142|NCT02616393|81763809|FG002|Overall Study|Withdrawal by Subject|0|||
27981143|NCT02616393|81763807|FG000|Overall Study|Lost to Follow-up|0|||
27981144|NCT02616393|81763808|FG001|Overall Study|Lost to Follow-up|2|||
27981145|NCT02616393|81763809|FG002|Overall Study|Lost to Follow-up|0|||
27981146|NCT00907296|81763810|FG000|Overall Study|Ineligibility Determined|1|||
27981147|NCT00907296|81763811|FG001|Overall Study|Ineligibility Determined|0|||
27981148|NCT00907296|81763812|FG002|Overall Study|Ineligibility Determined|0|||
27673816|NCT00943787|80643394|FG000|Overall Study|Withdrawal by Subject|3|||
27673817|NCT01165177|80643395|FG000|Overall Study|Serious Adverse Event|227|||
27868209|NCT02443740|81353750|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868210|NCT02443740|81353751|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868211|NCT02443740|81353752|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
27868212|NCT02443740|81353753|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868213|NCT02443740|81353754|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868214|NCT02443740|81353755|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868215|NCT02443740|81353756|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868216|NCT02443740|81353757|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
27868217|NCT00396812|81353758|FG000|Overall Study|Physician Decision|1|||
27868218|NCT02348112|81353761|FG000|Overall Study|Withdrawal by Subject|32|||
27868219|NCT02348112|81353762|FG001|Overall Study|Withdrawal by Subject|29|||
27868220|NCT02348112|81353761|FG000|Overall Study|Lost to Follow-up|24|||
27868221|NCT02348112|81353762|FG001|Overall Study|Lost to Follow-up|20|||
27868222|NCT02348112|81353761|FG000|Overall Study|Physician Decision|17|||
27868223|NCT02348112|81353762|FG001|Overall Study|Physician Decision|15|||
27868224|NCT02348112|81353761|FG000|Overall Study|Site closed due to PI leaving|0|||
27868225|NCT02348112|81353762|FG001|Overall Study|Site closed due to PI leaving|30|||
27868226|NCT02348112|81353761|FG000|Overall Study|Sponsor withdrawal|0|||
27868227|NCT02348112|81353762|FG001|Overall Study|Sponsor withdrawal|7|||
27868228|NCT02348112|81353761|FG000|Overall Study|Death|0|||
27868229|NCT02348112|81353762|FG001|Overall Study|Death|1|||
27868230|NCT02308124|81353764|FG000|Overall Study|Lost to Follow-up|6|||
27868231|NCT02308124|81353765|FG001|Overall Study|Lost to Follow-up|6|||
27868232|NCT02308124|81353766|FG002|Overall Study|Lost to Follow-up|6|||
27868233|NCT02308124|81353764|FG000|Overall Study|Adverse Event|0|||
27868234|NCT02308124|81353765|FG001|Overall Study|Adverse Event|2|||
27868235|NCT02308124|81353766|FG002|Overall Study|Adverse Event|2|||
27868236|NCT02723344|81353767|FG000|Overall Study|Lost to Follow-up|0|||
27868237|NCT02723344|81353768|FG001|Overall Study|Lost to Follow-up|4|||
27868238|NCT01262872|81353769|FG000|Step 2|Death|0|||
27868239|NCT01262872|81353770|FG001|Step 2|Death|0|||
27868240|NCT01262872|81353771|FG002|Step 2|Death|0|||
27868241|NCT01262872|81353772|FG003|Step 2|Death|1|||
27868242|NCT01262872|81353773|FG004|Step 2|Death|0|||
27868243|NCT01262872|81353774|FG005|Step 2|Death|2|||
27868244|NCT01262872|81353775|FG006|Step 2|Death|2|||
27868245|NCT01262872|81353776|FG007|Step 2|Death|1|||
27868246|NCT01262872|81353769|FG000|Step 2|Protocol Violation|0|||
27868247|NCT01262872|81353770|FG001|Step 2|Protocol Violation|0|||
27868248|NCT01262872|81353771|FG002|Step 2|Protocol Violation|1|||
27868249|NCT01262872|81353772|FG003|Step 2|Protocol Violation|0|||
27868250|NCT01262872|81353773|FG004|Step 2|Protocol Violation|0|||
27981149|NCT00907296|81763813|FG003|Overall Study|Ineligibility Determined|1|||
27981150|NCT00907296|81763814|FG004|Overall Study|Ineligibility Determined|0|||
27981151|NCT00907296|81763815|FG005|Overall Study|Ineligibility Determined|0|||
27981152|NCT00907296|81763816|FG006|Overall Study|Ineligibility Determined|0|||
27981153|NCT00907296|81763817|FG007|Overall Study|Ineligibility Determined|1|||
27981154|NCT00907296|81763818|FG008|Overall Study|Ineligibility Determined|0|||
27673818|NCT01165177|80643396|FG001|Overall Study|Serious Adverse Event|235|||
27868251|NCT01262872|81353774|FG005|Step 2|Protocol Violation|0|||
27868252|NCT01262872|81353775|FG006|Step 2|Protocol Violation|3|||
27868253|NCT01262872|81353776|FG007|Step 2|Protocol Violation|1|||
27868254|NCT01262872|81353769|FG000|Step 2|Withdrawal by Subject|0|||
27868255|NCT01262872|81353770|FG001|Step 2|Withdrawal by Subject|0|||
27673819|NCT01165177|80643395|FG000|Overall Study|Withdrawal by Subject|368|||
27673820|NCT01165177|80643396|FG001|Overall Study|Withdrawal by Subject|354|||
27673821|NCT01165177|80643395|FG000|Overall Study|Protocol Violation|19|||
27673822|NCT01165177|80643396|FG001|Overall Study|Protocol Violation|21|||
27673823|NCT01165177|80643395|FG000|Overall Study|Non-serious adverse event|30|||
27673824|NCT01165177|80643396|FG001|Overall Study|Non-serious adverse event|18|||
27673825|NCT01165177|80643395|FG000|Overall Study|Other unspecified reasons|47|||
27673826|NCT01165177|80643396|FG001|Overall Study|Other unspecified reasons|35|||
27673827|NCT01165177|80643395|FG000|Overall Study|Suspected HZ episode|0|||
27673828|NCT01165177|80643396|FG001|Overall Study|Suspected HZ episode|2|||
27673829|NCT01165177|80643395|FG000|Overall Study|Lost to Follow-up|183|||
27673830|NCT01165177|80643396|FG001|Overall Study|Lost to Follow-up|194|||
27673831|NCT01165177|80643395|FG000|Overall Study|Migrated/ moved from study area|48|||
27673832|NCT01165177|80643396|FG001|Overall Study|Migrated/ moved from study area|43|||
27673833|NCT01304498|80643397|FG000|Overall Study|Adverse Event|1|||
27673834|NCT01304498|80643398|FG001|Overall Study|Adverse Event|1|||
27673835|NCT01304498|80643397|FG000|Overall Study|Withdrawal by Subject|2|||
27673836|NCT01304498|80643398|FG001|Overall Study|Withdrawal by Subject|3|||
27673837|NCT01304498|80643397|FG000|Overall Study|Protocol Violation|1|||
27673838|NCT01304498|80643398|FG001|Overall Study|Protocol Violation|0|||
27673839|NCT01304498|80643397|FG000|Overall Study|Lost to Follow-up|2|||
27673840|NCT01304498|80643398|FG001|Overall Study|Lost to Follow-up|1|||
27673841|NCT00307047|80643399|FG000|Overall Study|Lost to Follow-up|35|||
27673842|NCT00307047|80643400|FG001|Overall Study|Lost to Follow-up|24|||
27673843|NCT00307047|80643399|FG000|Overall Study|Withdrawal by Subject|6|||
27673844|NCT00307047|80643400|FG001|Overall Study|Withdrawal by Subject|6|||
27673845|NCT00307047|80643399|FG000|Overall Study|Physician Decision|1|||
27673846|NCT00307047|80643400|FG001|Overall Study|Physician Decision|2|||
27673847|NCT00307047|80643399|FG000|Overall Study|Lost to follow-up for other reasons|0|||
27673848|NCT00307047|80643400|FG001|Overall Study|Lost to follow-up for other reasons|1|||
27673849|NCT00307047|80643399|FG000|Overall Study|All death, all MI, all Revascularization|27|||
27673850|NCT00307047|80643400|FG001|Overall Study|All death, all MI, all Revascularization|16|||
27673851|NCT04936685|80643403|FG000|Overall Study|Protocol Violation|1|||
27673852|NCT04936685|80643404|FG001|Overall Study|Protocol Violation|0|||
27673853|NCT02641587|80643405|FG000|Confinement Period|Adverse Event|1|||
27673854|NCT02641587|80643406|FG001|Confinement Period|Adverse Event|0|||
27673855|NCT02641587|80643405|FG000|Confinement Period|Withdrawal by Subject|2|||
27673856|NCT02641587|80643406|FG001|Confinement Period|Withdrawal by Subject|1|||
27673857|NCT02641587|80643405|FG000|Ambulatory Period|Withdrawal by Subject|1|||
27673858|NCT02641587|80643406|FG001|Ambulatory Period|Withdrawal by Subject|0|||
27673859|NCT01649557|80643409|FG000|Overall Study|Lost to Follow-up|5|||
27673860|NCT01649557|80643410|FG001|Overall Study|Lost to Follow-up|0|||
27673861|NCT01649557|80643411|FG002|Overall Study|Lost to Follow-up|3|||
27673862|NCT01649557|80643409|FG000|Overall Study|Adverse Event|7|||
27673863|NCT01649557|80643410|FG001|Overall Study|Adverse Event|5|||
27673864|NCT01649557|80643411|FG002|Overall Study|Adverse Event|1|||
27673865|NCT01649557|80643409|FG000|Overall Study|Met withdrawal criteria|4|||
27673866|NCT01649557|80643410|FG001|Overall Study|Met withdrawal criteria|0|||
27673867|NCT01649557|80643411|FG002|Overall Study|Met withdrawal criteria|0|||
27868256|NCT01262872|81353771|FG002|Step 2|Withdrawal by Subject|4|||
27868257|NCT01262872|81353772|FG003|Step 2|Withdrawal by Subject|6|||
27868258|NCT01262872|81353773|FG004|Step 2|Withdrawal by Subject|3|||
27868259|NCT01262872|81353774|FG005|Step 2|Withdrawal by Subject|1|||
27868260|NCT01262872|81353775|FG006|Step 2|Withdrawal by Subject|2|||
27868261|NCT01262872|81353776|FG007|Step 2|Withdrawal by Subject|1|||
27673868|NCT01649557|80643409|FG000|Overall Study|Physician Decision|8|||
27673869|NCT01649557|80643410|FG001|Overall Study|Physician Decision|2|||
27673870|NCT01649557|80643411|FG002|Overall Study|Physician Decision|1|||
27868262|NCT01262872|81353769|FG000|Step 2|Migrated/moved from study area|0|||
27868263|NCT01262872|81353770|FG001|Step 2|Migrated/moved from study area|0|||
27673871|NCT01649557|80643409|FG000|Overall Study|Withdrawal by Subject|15|||
27673872|NCT01649557|80643410|FG001|Overall Study|Withdrawal by Subject|5|||
27673873|NCT01649557|80643411|FG002|Overall Study|Withdrawal by Subject|4|||
27868264|NCT01262872|81353771|FG002|Step 2|Migrated/moved from study area|4|||
27868265|NCT01262872|81353772|FG003|Step 2|Migrated/moved from study area|3|||
27673874|NCT01649557|80643409|FG000|Overall Study|Protocol deviation|0|||
27673875|NCT01649557|80643410|FG001|Overall Study|Protocol deviation|2|||
27673876|NCT01649557|80643411|FG002|Overall Study|Protocol deviation|0|||
27673877|NCT01649557|80643409|FG000|Overall Study|Lack of Efficacy|5|||
27673878|NCT01649557|80643410|FG001|Overall Study|Lack of Efficacy|0|||
27868266|NCT01262872|81353773|FG004|Step 2|Migrated/moved from study area|2|||
27868267|NCT01262872|81353774|FG005|Step 2|Migrated/moved from study area|6|||
27673879|NCT01649557|80643411|FG002|Overall Study|Lack of Efficacy|0|||
27673880|NCT01012947|80643412|FG000|Overall Study|Lost to Follow-up|131|||
27981155|NCT00907296|81763819|FG009|Overall Study|Ineligibility Determined|0|||
27981156|NCT00907296|81763810|FG000|Overall Study|Protocol Deviation|0|||
27981157|NCT00907296|81763811|FG001|Overall Study|Protocol Deviation|1|||
27981158|NCT00907296|81763812|FG002|Overall Study|Protocol Deviation|0|||
27981159|NCT00907296|81763813|FG003|Overall Study|Protocol Deviation|0|||
27981160|NCT00907296|81763814|FG004|Overall Study|Protocol Deviation|0|||
27981161|NCT00907296|81763815|FG005|Overall Study|Protocol Deviation|0|||
27981162|NCT00907296|81763816|FG006|Overall Study|Protocol Deviation|0|||
27673881|NCT01012947|80643413|FG001|Overall Study|Lost to Follow-up|135|||
27673882|NCT01012947|80643414|FG002|Overall Study|Lost to Follow-up|130|||
27673883|NCT01012947|80643415|FG003|Overall Study|Lost to Follow-up|118|||
27673884|NCT01012947|80643416|FG004|Overall Study|Lost to Follow-up|142|||
27673885|NCT00127842|80643419|FG000|Overall Study|Adverse Event|15|||
27673886|NCT00127842|80643419|FG000|Overall Study|Withdrawal by Subject|3|||
27673887|NCT00127842|80643419|FG000|Overall Study|Lost to Follow-up|1|||
27673888|NCT00127842|80643419|FG000|Overall Study|Lack of Efficacy|12|||
27673889|NCT00127842|80643419|FG000|Overall Study|Noncompliance|2|||
27673890|NCT00127842|80643419|FG000|Overall Study|Protocol Violation|1|||
27981163|NCT00907296|81763817|FG007|Overall Study|Protocol Deviation|0|||
27981164|NCT00907296|81763818|FG008|Overall Study|Protocol Deviation|0|||
27981165|NCT00907296|81763819|FG009|Overall Study|Protocol Deviation|0|||
27981166|NCT00907296|81763810|FG000|Overall Study|Noncompliance|1|||
27981167|NCT00907296|81763811|FG001|Overall Study|Noncompliance|1|||
27981168|NCT00907296|81763812|FG002|Overall Study|Noncompliance|1|||
27981169|NCT00907296|81763813|FG003|Overall Study|Noncompliance|0|||
27981170|NCT00907296|81763814|FG004|Overall Study|Noncompliance|0|||
27981171|NCT00907296|81763815|FG005|Overall Study|Noncompliance|1|||
27981172|NCT00907296|81763816|FG006|Overall Study|Noncompliance|0|||
27981173|NCT00907296|81763817|FG007|Overall Study|Noncompliance|2|||
27981174|NCT00907296|81763818|FG008|Overall Study|Noncompliance|0|||
27981175|NCT00907296|81763819|FG009|Overall Study|Noncompliance|0|||
27981176|NCT00907296|81763810|FG000|Overall Study|Adverse Event|2|||
27981177|NCT00907296|81763811|FG001|Overall Study|Adverse Event|0|||
27981178|NCT00907296|81763812|FG002|Overall Study|Adverse Event|0|||
27981179|NCT00907296|81763813|FG003|Overall Study|Adverse Event|0|||
27981180|NCT00907296|81763814|FG004|Overall Study|Adverse Event|0|||
27981181|NCT00907296|81763815|FG005|Overall Study|Adverse Event|0|||
27981182|NCT00907296|81763816|FG006|Overall Study|Adverse Event|1|||
27981183|NCT00907296|81763817|FG007|Overall Study|Adverse Event|0|||
27981184|NCT00907296|81763818|FG008|Overall Study|Adverse Event|0|||
27981185|NCT00907296|81763819|FG009|Overall Study|Adverse Event|1|||
27981186|NCT00907296|81763810|FG000|Overall Study|Withdrawal by Subject|7|||
27981187|NCT00907296|81763811|FG001|Overall Study|Withdrawal by Subject|2|||
27981188|NCT00907296|81763812|FG002|Overall Study|Withdrawal by Subject|1|||
27981189|NCT00907296|81763813|FG003|Overall Study|Withdrawal by Subject|1|||
27981190|NCT00907296|81763814|FG004|Overall Study|Withdrawal by Subject|1|||
27981191|NCT00907296|81763815|FG005|Overall Study|Withdrawal by Subject|5|||
27981192|NCT00907296|81763816|FG006|Overall Study|Withdrawal by Subject|3|||
27981193|NCT00907296|81763817|FG007|Overall Study|Withdrawal by Subject|2|||
27981194|NCT00907296|81763818|FG008|Overall Study|Withdrawal by Subject|4|||
27981195|NCT00907296|81763819|FG009|Overall Study|Withdrawal by Subject|2|||
27981196|NCT00907296|81763810|FG000|Overall Study|Lost to Follow-up|9|||
27981197|NCT00907296|81763811|FG001|Overall Study|Lost to Follow-up|1|||
27981198|NCT00907296|81763812|FG002|Overall Study|Lost to Follow-up|0|||
27981199|NCT00907296|81763813|FG003|Overall Study|Lost to Follow-up|2|||
27981200|NCT00907296|81763814|FG004|Overall Study|Lost to Follow-up|0|||
27981201|NCT00907296|81763815|FG005|Overall Study|Lost to Follow-up|3|||
27981202|NCT00907296|81763816|FG006|Overall Study|Lost to Follow-up|2|||
27673891|NCT00127842|80643419|FG000|Overall Study|Other|5|||
27981203|NCT00907296|81763817|FG007|Overall Study|Lost to Follow-up|2|||
27981204|NCT00907296|81763818|FG008|Overall Study|Lost to Follow-up|0|||
27981205|NCT00907296|81763819|FG009|Overall Study|Lost to Follow-up|4|||
27981206|NCT01299571|81763820|FG000|Overall Study|Protocol Violation|107|||
27673892|NCT02818998|80643422|FG000|Overall Study|Adverse Event|3|||
27981207|NCT01853072|81763822|FG000|Overall Study|Adverse event prior to treatment|0|||
27673893|NCT02818998|80643423|FG001|Overall Study|Adverse Event|2|||
27673894|NCT02818998|80643424|FG002|Overall Study|Adverse Event|1|||
27981208|NCT01853072|81763823|FG001|Overall Study|Adverse event prior to treatment|1|||
27981209|NCT01853072|81763822|FG000|Overall Study|Adverse Event|0|||
27981210|NCT01853072|81763823|FG001|Overall Study|Adverse Event|3|||
27981211|NCT01853072|81763822|FG000|Overall Study|Death|1|||
27981212|NCT01853072|81763823|FG001|Overall Study|Death|4|||
27981213|NCT01853072|81763822|FG000|Overall Study|Lost to Follow-up|0|||
27673895|NCT02818998|80643422|FG000|Overall Study|Lost to Follow-up|4|||
27673896|NCT02818998|80643423|FG001|Overall Study|Lost to Follow-up|1|||
27981214|NCT01853072|81763823|FG001|Overall Study|Lost to Follow-up|3|||
27981215|NCT01853072|81763822|FG000|Overall Study|Non-compliance with study drug|0|||
27981216|NCT01853072|81763823|FG001|Overall Study|Non-compliance with study drug|1|||
27981217|NCT01853072|81763822|FG000|Overall Study|Physician Decision|1|||
27673897|NCT02818998|80643424|FG002|Overall Study|Lost to Follow-up|2|||
27981218|NCT01853072|81763823|FG001|Overall Study|Physician Decision|1|||
27868268|NCT01262872|81353775|FG006|Step 2|Migrated/moved from study area|2|||
27868269|NCT01262872|81353776|FG007|Step 2|Migrated/moved from study area|3|||
27868270|NCT01570686|81353777|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27981219|NCT01853072|81763822|FG000|Overall Study|Withdrawal by Subject|1|||
27868271|NCT01570686|81353778|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27868272|NCT01570686|81353777|FG000|Overall Study|Administrative problems|0|||
27981220|NCT01853072|81763823|FG001|Overall Study|Withdrawal by Subject|2|||
27981221|NCT01853072|81763822|FG000|Overall Study|Reason not specified|9|||
27981222|NCT01853072|81763823|FG001|Overall Study|Reason not specified|6|||
27981223|NCT00320372|81763824|FG000|Overall Study|Physician Decision|4|||
27793830|NCT02575807|81075458|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
27793831|NCT02575807|81075459|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
27793832|NCT02575807|81075460|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
27793833|NCT02575807|81075461|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
27793834|NCT02575807|81075457|FG000|Overall Study|Terminated due to physician decision|0|||
27793835|NCT02575807|81075458|FG001|Overall Study|Terminated due to physician decision|0|||
27793836|NCT02575807|81075459|FG002|Overall Study|Terminated due to physician decision|1|||
27793837|NCT02575807|81075460|FG003|Overall Study|Terminated due to physician decision|0|||
27793838|NCT02575807|81075461|FG004|Overall Study|Terminated due to physician decision|0|||
27868273|NCT01570686|81353778|FG001|Overall Study|Administrative problems|1|||
27868274|NCT01570686|81353777|FG000|Overall Study|Adverse Event|8|||
27981224|NCT00320372|81763825|FG001|Overall Study|Physician Decision|7|||
27981225|NCT00320372|81763824|FG000|Overall Study|Death|7|||
27981226|NCT00320372|81763825|FG001|Overall Study|Death|8|||
27981227|NCT00320372|81763824|FG000|Overall Study|Withdrawal by Subject|55|||
27981228|NCT00320372|81763825|FG001|Overall Study|Withdrawal by Subject|37|||
27981229|NCT00320372|81763824|FG000|Overall Study|Non-Compliance|40|||
27981230|NCT00320372|81763825|FG001|Overall Study|Non-Compliance|39|||
27981231|NCT00320372|81763824|FG000|Overall Study|Did not Meet (I/E)|3|||
27981232|NCT00320372|81763825|FG001|Overall Study|Did not Meet (I/E)|1|||
27981233|NCT00320372|81763824|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
27981234|NCT00320372|81763825|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
27981235|NCT02383433|81763831|FG000|Overall Study|Disease progression|2|||
27981236|NCT00871923|81763832|FG000|Overall Study|Death|1|||
27981237|NCT00871923|81763832|FG000|Overall Study|Withdrawal by Subject|1|||
27981238|NCT00454649|81763833|FG000|Overall Study|Lack of Efficacy|2|||
27981239|NCT00454649|81763834|FG001|Overall Study|Lack of Efficacy|2|||
27981240|NCT00454649|81763835|FG002|Overall Study|Lack of Efficacy|10|||
27981241|NCT00454649|81763836|FG003|Overall Study|Lack of Efficacy|3|||
27981242|NCT00454649|81763837|FG004|Overall Study|Lack of Efficacy|0|||
27868275|NCT01570686|81353778|FG001|Overall Study|Adverse Event|6|||
27981243|NCT00454649|81763838|FG005|Overall Study|Lack of Efficacy|4|||
27981244|NCT00454649|81763839|FG006|Overall Study|Lack of Efficacy|5|||
27981245|NCT00454649|81763840|FG007|Overall Study|Lack of Efficacy|13|||
27981246|NCT00454649|81763841|FG008|Overall Study|Lack of Efficacy|10|||
27673898|NCT02818998|80643422|FG000|Overall Study|Withdrawal by sponsor|0|||
27673899|NCT02818998|80643423|FG001|Overall Study|Withdrawal by sponsor|1|||
27673900|NCT02818998|80643424|FG002|Overall Study|Withdrawal by sponsor|1|||
27673901|NCT02818998|80643422|FG000|Overall Study|Death|3|||
27673902|NCT02818998|80643423|FG001|Overall Study|Death|6|||
27673903|NCT02818998|80643424|FG002|Overall Study|Death|8|||
27673904|NCT02818998|80643422|FG000|Overall Study|Withdrawal by Subject|7|||
27673905|NCT02818998|80643423|FG001|Overall Study|Withdrawal by Subject|6|||
27981247|NCT00454649|81763842|FG009|Overall Study|Lack of Efficacy|2|||
27981248|NCT00454649|81763833|FG000|Overall Study|Adverse Event|0|||
27981249|NCT00454649|81763834|FG001|Overall Study|Adverse Event|1|||
27981250|NCT00454649|81763835|FG002|Overall Study|Adverse Event|3|||
27673906|NCT02818998|80643424|FG002|Overall Study|Withdrawal by Subject|6|||
27673907|NCT02818998|80643422|FG000|Overall Study|Physician Decision|1|||
27673908|NCT02818998|80643423|FG001|Overall Study|Physician Decision|0|||
27868276|NCT01570686|81353777|FG000|Overall Study|Lost to Follow-up|4|||
27868277|NCT01570686|81353778|FG001|Overall Study|Lost to Follow-up|3|||
27981251|NCT00454649|81763836|FG003|Overall Study|Adverse Event|0|||
27981252|NCT00454649|81763837|FG004|Overall Study|Adverse Event|1|||
27981253|NCT00454649|81763838|FG005|Overall Study|Adverse Event|2|||
27981254|NCT00454649|81763839|FG006|Overall Study|Adverse Event|3|||
27981255|NCT00454649|81763840|FG007|Overall Study|Adverse Event|4|||
27981256|NCT00454649|81763841|FG008|Overall Study|Adverse Event|6|||
27981257|NCT00454649|81763842|FG009|Overall Study|Adverse Event|2|||
27981258|NCT00454649|81763833|FG000|Overall Study|Lost to Follow-up|0|||
27981259|NCT00454649|81763834|FG001|Overall Study|Lost to Follow-up|0|||
27981260|NCT00454649|81763835|FG002|Overall Study|Lost to Follow-up|1|||
27981261|NCT00454649|81763836|FG003|Overall Study|Lost to Follow-up|0|||
27981262|NCT00454649|81763837|FG004|Overall Study|Lost to Follow-up|0|||
27981263|NCT00454649|81763838|FG005|Overall Study|Lost to Follow-up|0|||
27981264|NCT00454649|81763839|FG006|Overall Study|Lost to Follow-up|1|||
27981265|NCT00454649|81763840|FG007|Overall Study|Lost to Follow-up|0|||
27981266|NCT00454649|81763841|FG008|Overall Study|Lost to Follow-up|0|||
27981267|NCT00454649|81763842|FG009|Overall Study|Lost to Follow-up|0|||
27981268|NCT00454649|81763833|FG000|Overall Study|Other|1|||
27981269|NCT00454649|81763834|FG001|Overall Study|Other|1|||
27981270|NCT00454649|81763835|FG002|Overall Study|Other|5|||
27981271|NCT00454649|81763836|FG003|Overall Study|Other|3|||
27981272|NCT00454649|81763837|FG004|Overall Study|Other|0|||
27981273|NCT00454649|81763838|FG005|Overall Study|Other|0|||
27981274|NCT00454649|81763839|FG006|Overall Study|Other|0|||
27981275|NCT00454649|81763840|FG007|Overall Study|Other|0|||
27981276|NCT00454649|81763841|FG008|Overall Study|Other|3|||
27981277|NCT00454649|81763842|FG009|Overall Study|Other|1|||
27981278|NCT00454649|81763833|FG000|Overall Study|Withdrawal by Subject|0|||
27981279|NCT00454649|81763834|FG001|Overall Study|Withdrawal by Subject|0|||
27981280|NCT00454649|81763835|FG002|Overall Study|Withdrawal by Subject|0|||
27981281|NCT00454649|81763836|FG003|Overall Study|Withdrawal by Subject|0|||
27981282|NCT00454649|81763837|FG004|Overall Study|Withdrawal by Subject|0|||
27981283|NCT00454649|81763838|FG005|Overall Study|Withdrawal by Subject|1|||
27981284|NCT00454649|81763839|FG006|Overall Study|Withdrawal by Subject|0|||
27981285|NCT00454649|81763840|FG007|Overall Study|Withdrawal by Subject|2|||
27981286|NCT00454649|81763841|FG008|Overall Study|Withdrawal by Subject|1|||
27981287|NCT00454649|81763842|FG009|Overall Study|Withdrawal by Subject|0|||
27981288|NCT04208087|81763843|FG000|Overall Study|Adverse Event|1|||
27981289|NCT04208087|81763844|FG001|Overall Study|Adverse Event|0|||
27981290|NCT04208087|81763845|FG002|Overall Study|Adverse Event|0|||
27981291|NCT04208087|81763846|FG003|Overall Study|Adverse Event|0|||
27981292|NCT04208087|81763847|FG004|Overall Study|Adverse Event|0|||
27981293|NCT04208087|81763843|FG000|Overall Study|Withdrawal by Subject|0|||
27981294|NCT04208087|81763844|FG001|Overall Study|Withdrawal by Subject|0|||
27981295|NCT04208087|81763845|FG002|Overall Study|Withdrawal by Subject|1|||
27981296|NCT04208087|81763846|FG003|Overall Study|Withdrawal by Subject|0|||
27981297|NCT04208087|81763847|FG004|Overall Study|Withdrawal by Subject|0|||
27981298|NCT04208087|81763843|FG000|Overall Study|Other|0|||
27981299|NCT04208087|81763844|FG001|Overall Study|Other|0|||
27981300|NCT04208087|81763845|FG002|Overall Study|Other|0|||
27981301|NCT04208087|81763846|FG003|Overall Study|Other|0|||
27981302|NCT04208087|81763847|FG004|Overall Study|Other|1|||
27981303|NCT01439126|81763848|FG000|Overall Study|Adverse Event|2|||
27981304|NCT01439126|81763849|FG001|Overall Study|Adverse Event|0|||
27981305|NCT01439126|81763848|FG000|Overall Study|Withdrawal by Subject|5|||
27981306|NCT01439126|81763849|FG001|Overall Study|Withdrawal by Subject|21|||
27981307|NCT01439126|81763848|FG000|Overall Study|Protocol Violation|6|||
27981308|NCT01439126|81763849|FG001|Overall Study|Protocol Violation|4|||
27981309|NCT01439126|81763848|FG000|Overall Study|Lost to Follow-up|6|||
27981310|NCT01439126|81763849|FG001|Overall Study|Lost to Follow-up|3|||
27981311|NCT01439126|81763848|FG000|Overall Study|Other-Use of prohibited treatment|0|||
27981312|NCT01439126|81763849|FG001|Overall Study|Other-Use of prohibited treatment|2|||
27981313|NCT01439126|81763848|FG000|Overall Study|Other-Miscellaneous|12|||
27981314|NCT01439126|81763849|FG001|Overall Study|Other-Miscellaneous|12|||
27981315|NCT02713529|81763850|FG000|Overall Study|Withdrawal by Subject|3|||
27981316|NCT02713529|81763851|FG001|Overall Study|Withdrawal by Subject|1|||
27981317|NCT02713529|81763852|FG002|Overall Study|Withdrawal by Subject|4|||
27981318|NCT02713529|81763853|FG003|Overall Study|Withdrawal by Subject|2|||
27981319|NCT02713529|81763854|FG004|Overall Study|Withdrawal by Subject|0|||
27673909|NCT02818998|80643424|FG002|Overall Study|Physician Decision|0|||
27673910|NCT01443923|80643425|FG000|Overall Study|Adverse Event|1|||
27673911|NCT01443923|80643426|FG001|Overall Study|Adverse Event|0|||
27981320|NCT02713529|81763855|FG005|Overall Study|Withdrawal by Subject|1|||
27981321|NCT02713529|81763856|FG006|Overall Study|Withdrawal by Subject|1|||
27981322|NCT02713529|81763850|FG000|Overall Study|Lost to Follow-up|1|||
27673912|NCT00909532|80643431|FG000|Overall Study|Adverse Event|4|||
27981323|NCT02713529|81763851|FG001|Overall Study|Lost to Follow-up|0|||
27981324|NCT02713529|81763852|FG002|Overall Study|Lost to Follow-up|1|||
27673913|NCT00909532|80643432|FG001|Overall Study|Adverse Event|1|||
27673914|NCT00909532|80643431|FG000|Overall Study|Pregnancy|0|||
27981325|NCT02713529|81763853|FG003|Overall Study|Lost to Follow-up|0|||
27981326|NCT02713529|81763854|FG004|Overall Study|Lost to Follow-up|0|||
27981327|NCT02713529|81763855|FG005|Overall Study|Lost to Follow-up|0|||
27981328|NCT02713529|81763856|FG006|Overall Study|Lost to Follow-up|0|||
27981329|NCT02713529|81763850|FG000|Overall Study|Death|3|||
27673915|NCT00909532|80643432|FG001|Overall Study|Pregnancy|1|||
27981330|NCT02713529|81763851|FG001|Overall Study|Death|3|||
27981331|NCT02713529|81763852|FG002|Overall Study|Death|26|||
27981332|NCT02713529|81763853|FG003|Overall Study|Death|27|||
27981333|NCT02713529|81763854|FG004|Overall Study|Death|3|||
27981334|NCT02713529|81763855|FG005|Overall Study|Death|13|||
27981335|NCT02713529|81763856|FG006|Overall Study|Death|3|||
27981336|NCT03361189|81763861|FG000|Overall Study|Received heart transplant|1|||
27981337|NCT03361189|81763862|FG001|Overall Study|Received heart transplant|0|||
27981338|NCT03361189|81763861|FG000|Overall Study|Pacemake replacement|0|||
27981339|NCT03361189|81763862|FG001|Overall Study|Pacemake replacement|1|||
27981340|NCT03135210|81763863|FG000|Overall Study|Death|0|||
27981341|NCT03135210|81763864|FG001|Overall Study|Death|1|||
27981342|NCT01541917|81763865|FG000|Overall Study|Lost to Follow-up|2|||
27981343|NCT01541917|81763866|FG001|Overall Study|Lost to Follow-up|2|||
27981344|NCT01541917|81763865|FG000|Overall Study|Withdrawal by Subject|13|||
27981345|NCT01541917|81763866|FG001|Overall Study|Withdrawal by Subject|7|||
27981346|NCT02772978|81763875|FG000|Overall Study|Withdrawal by Subject|1|||
27981347|NCT02772978|81763876|FG001|Overall Study|Withdrawal by Subject|1|||
27981348|NCT00969436|81763878|FG000|Overall Study|Protocol Violation|1|||
27981349|NCT00969436|81763879|FG001|Overall Study|Protocol Violation|3|||
27981350|NCT00969436|81763880|FG002|Overall Study|Protocol Violation|0|||
27981351|NCT00969436|81763878|FG000|Overall Study|Migrated/moved from study area|12|||
27981352|NCT00969436|81763879|FG001|Overall Study|Migrated/moved from study area|10|||
27981353|NCT00969436|81763880|FG002|Overall Study|Migrated/moved from study area|2|||
27981354|NCT00969436|81763878|FG000|Overall Study|Father - serious health problem|0|||
27981355|NCT00969436|81763879|FG001|Overall Study|Father - serious health problem|0|||
27981356|NCT00969436|81763880|FG002|Overall Study|Father - serious health problem|1|||
27981357|NCT00969436|81763878|FG000|Overall Study|Parents personal problem|0|||
27981358|NCT00969436|81763879|FG001|Overall Study|Parents personal problem|0|||
27981359|NCT00969436|81763880|FG002|Overall Study|Parents personal problem|1|||
27981360|NCT00969436|81763878|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
27981361|NCT00969436|81763879|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
27981362|NCT00969436|81763880|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
27981363|NCT00969436|81763878|FG000|Overall Study|Withdrawal by Subject|3|||
27981364|NCT00969436|81763879|FG001|Overall Study|Withdrawal by Subject|0|||
27981365|NCT00969436|81763880|FG002|Overall Study|Withdrawal by Subject|2|||
27981366|NCT00969436|81763878|FG000|Overall Study|Lost to Follow-up|8|||
27981367|NCT00969436|81763879|FG001|Overall Study|Lost to Follow-up|8|||
27981368|NCT00969436|81763880|FG002|Overall Study|Lost to Follow-up|5|||
27981369|NCT01617447|81763881|FG000|Overall Study|Adverse Event|0|||
27981370|NCT01617447|81763882|FG001|Overall Study|Adverse Event|1|||
27981371|NCT01617447|81763881|FG000|Overall Study|Physician Decision|0|||
27981372|NCT01617447|81763882|FG001|Overall Study|Physician Decision|2|||
27981373|NCT03369431|81763888|FG000|Overall Study|Lost to Follow-up|1|||
27981374|NCT03369431|81763889|FG001|Overall Study|Lost to Follow-up|3|||
27981375|NCT03369431|81763888|FG000|Overall Study|Withdrawal by Subject|2|||
27981376|NCT03369431|81763889|FG001|Overall Study|Withdrawal by Subject|3|||
27981377|NCT03369431|81763888|FG000|Overall Study|Protocol Violation|1|||
27981378|NCT03369431|81763889|FG001|Overall Study|Protocol Violation|1|||
27981379|NCT00924404|81763890|FG000|Overall Study|Lost to Follow-up|6|||
27981380|NCT00924404|81763891|FG001|Overall Study|Lost to Follow-up|4|||
27981381|NCT00468845|81763894|FG000|Overall Study|Adverse Event|9|||
27981382|NCT00468845|81763895|FG001|Overall Study|Adverse Event|14|||
27981383|NCT00468845|81763896|FG002|Overall Study|Adverse Event|11|||
27981384|NCT00468845|81763894|FG000|Overall Study|Lost to Follow-up|2|||
27981385|NCT00468845|81763895|FG001|Overall Study|Lost to Follow-up|1|||
27981386|NCT00468845|81763896|FG002|Overall Study|Lost to Follow-up|2|||
27981387|NCT00468845|81763894|FG000|Overall Study|Other|4|||
27981388|NCT00468845|81763895|FG001|Overall Study|Other|9|||
27981389|NCT00468845|81763896|FG002|Overall Study|Other|5|||
27981390|NCT00468845|81763894|FG000|Overall Study|No longer willing to participate|5|||
27981391|NCT00468845|81763895|FG001|Overall Study|No longer willing to participate|6|||
27981392|NCT00468845|81763896|FG002|Overall Study|No longer willing to participate|10|||
27793839|NCT02575807|81075457|FG000|Overall Study|Subject ineligible - medical implant|0|||
27981393|NCT00468845|81763894|FG000|Overall Study|Randomized, not treated|1|||
27981394|NCT00468845|81763895|FG001|Overall Study|Randomized, not treated|4|||
27981395|NCT00468845|81763896|FG002|Overall Study|Randomized, not treated|2|||
27981396|NCT04376827|81763897|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
27981397|NCT04376827|81763898|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
27981398|NCT04376827|81763897|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
27981399|NCT04376827|81763898|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
27793840|NCT02575807|81075458|FG001|Overall Study|Subject ineligible - medical implant|0|||
27793841|NCT02575807|81075459|FG002|Overall Study|Subject ineligible - medical implant|0|||
27868278|NCT01570686|81353777|FG000|Overall Study|Protocol Deviation|3|||
27981400|NCT04376827|81763897|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
27981401|NCT04376827|81763898|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
27793842|NCT02575807|81075460|FG003|Overall Study|Subject ineligible - medical implant|1|||
27793843|NCT02575807|81075461|FG004|Overall Study|Subject ineligible - medical implant|0|||
27793844|NCT02575807|81075457|FG000|Overall Study|Withdrawal by Subject|0|||
27793845|NCT02575807|81075458|FG001|Overall Study|Withdrawal by Subject|0|||
27981402|NCT04376827|81763897|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
27981403|NCT04376827|81763898|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
27981404|NCT04376827|81763897|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
27981405|NCT04376827|81763898|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
27981406|NCT02712424|81763901|FG000|Overall Study|Lost to Follow-up|34|||
27981407|NCT02712424|81763902|FG001|Overall Study|Lost to Follow-up|32|||
27981408|NCT02117349|81763903|FG000|Overall Study|Withdrawal by Subject|1|||
27981409|NCT02117349|81763904|FG001|Overall Study|Withdrawal by Subject|0|||
27981410|NCT02117349|81763903|FG000|Overall Study|Lost to Follow-up|1|||
27981411|NCT02117349|81763904|FG001|Overall Study|Lost to Follow-up|1|||
27981412|NCT02117349|81763903|FG000|Overall Study|Death|1|||
27981413|NCT02117349|81763904|FG001|Overall Study|Death|0|||
27981414|NCT00780273|81763905|FG000|Overall Study|Death|1|||
27981415|NCT00780273|81763905|FG000|Overall Study|Lost to Follow-up|1|||
27981416|NCT00635089|81763908|FG000|Overall Study|Adverse Event|7|||
27981417|NCT00635089|81763908|FG000|Overall Study|Lack of Efficacy|28|||
27981418|NCT00635089|81763908|FG000|Overall Study|Protocol Deviation|4|||
27981419|NCT00635089|81763908|FG000|Overall Study|Lost to Follow-up|8|||
27981420|NCT00635089|81763908|FG000|Overall Study|Other|31|||
27981421|NCT03230292|81763910|FG000|Overall Study|Adverse Event|1|||
27981422|NCT03230292|81763910|FG000|Overall Study|Protocol Violation|1|||
27793846|NCT02575807|81075459|FG002|Overall Study|Withdrawal by Subject|1|||
27793847|NCT02575807|81075460|FG003|Overall Study|Withdrawal by Subject|1|||
27793848|NCT02575807|81075461|FG004|Overall Study|Withdrawal by Subject|2|||
27793849|NCT01015118|81075462|FG000|Overall Study|Protocol Violation|5|||
27793850|NCT01015118|81075463|FG001|Overall Study|Protocol Violation|6|||
27793851|NCT01015118|81075462|FG000|Overall Study|Withdrawal by Subject|103|||
27793852|NCT01015118|81075463|FG001|Overall Study|Withdrawal by Subject|27|||
27793853|NCT01015118|81075462|FG000|Overall Study|Other Adverse Event (AE)|141|||
27981423|NCT03230292|81763910|FG000|Overall Study|Lost to Follow-up|1|||
27981424|NCT03230292|81763910|FG000|Overall Study|Withdrawal by Subject|3|||
27981425|NCT01995552|81763919|FG000|Overall Study|Protocol Violation|1|||
27981426|NCT01995552|81763919|FG000|Overall Study|Lack of Efficacy|15|||
27981427|NCT01995552|81763919|FG000|Overall Study|Death|1|||
27981428|NCT02279498|81763920|FG000|Overall Study|Adverse Event|3|||
27981429|NCT02279498|81763921|FG001|Overall Study|Adverse Event|0|||
27981430|NCT02279498|81763920|FG000|Overall Study|Lack of Efficacy|4|||
27981431|NCT02279498|81763921|FG001|Overall Study|Lack of Efficacy|0|||
27981432|NCT02279498|81763920|FG000|Overall Study|Lost to Follow-up|0|||
27981433|NCT02279498|81763921|FG001|Overall Study|Lost to Follow-up|1|||
27981434|NCT02279498|81763920|FG000|Overall Study|Withdrawal by Subject|9|||
27981435|NCT02279498|81763921|FG001|Overall Study|Withdrawal by Subject|2|||
27981436|NCT02279498|81763920|FG000|Overall Study|Undefined|2|||
27981437|NCT02279498|81763921|FG001|Overall Study|Undefined|1|||
27981438|NCT01711866|81763922|FG000|Overall Study|Noncompliant|3|||
27981439|NCT01711866|81763922|FG000|Overall Study|Withdrawal by Subject|3|||
27981440|NCT01711866|81763922|FG000|Overall Study|Adverse Event|2|||
27981441|NCT02644356|81763924|FG000|Overall Study|Withdrawal by Subject|2|||
27981442|NCT01519674|81763927|FG000|Overall Study|Adverse Event|3|||
27981443|NCT01519674|81763928|FG001|Overall Study|Adverse Event|3|||
27981444|NCT01519674|81763929|FG002|Overall Study|Adverse Event|0|||
27981445|NCT01519674|81763927|FG000|Overall Study|Lack of Efficacy|1|||
27981446|NCT01519674|81763928|FG001|Overall Study|Lack of Efficacy|1|||
27981447|NCT01519674|81763929|FG002|Overall Study|Lack of Efficacy|1|||
27981448|NCT01519674|81763927|FG000|Overall Study|Protocol Violation|0|||
27981449|NCT01519674|81763928|FG001|Overall Study|Protocol Violation|3|||
27981450|NCT01519674|81763929|FG002|Overall Study|Protocol Violation|1|||
27981451|NCT01519674|81763927|FG000|Overall Study|Withdrawal Criteria|7|||
27981452|NCT01519674|81763928|FG001|Overall Study|Withdrawal Criteria|2|||
27868279|NCT01570686|81353778|FG001|Overall Study|Protocol Deviation|0|||
27868280|NCT01570686|81353777|FG000|Overall Study|Withdrawal by Subject|4|||
27981453|NCT01519674|81763929|FG002|Overall Study|Withdrawal Criteria|7|||
27981454|NCT01519674|81763927|FG000|Overall Study|Unsclassified|10|||
27981455|NCT01519674|81763928|FG001|Overall Study|Unsclassified|4|||
27793854|NCT01015118|81075463|FG001|Overall Study|Other Adverse Event (AE)|33|||
27793855|NCT01015118|81075462|FG000|Overall Study|Worsening or AE of underlying disease|5|||
27981456|NCT01519674|81763929|FG002|Overall Study|Unsclassified|3|||
27981457|NCT01827332|81763930|FG000|Overall Study|Lost to Follow-up|2|||
27981458|NCT01827332|81763931|FG001|Overall Study|Lost to Follow-up|1|||
27981459|NCT00316693|81763935|FG000|Overall Study|Adverse Event|6|||
27981460|NCT00316693|81763936|FG001|Overall Study|Adverse Event|1|||
27981461|NCT00316693|81763935|FG000|Overall Study|Protocol Violation|1|||
27981462|NCT00316693|81763936|FG001|Overall Study|Protocol Violation|0|||
27981463|NCT00316693|81763935|FG000|Overall Study|Withdrawal by Subject|6|||
27981464|NCT00316693|81763936|FG001|Overall Study|Withdrawal by Subject|6|||
27981465|NCT00316693|81763935|FG000|Overall Study|Lost to Follow-up|26|||
27981466|NCT00316693|81763936|FG001|Overall Study|Lost to Follow-up|34|||
27981467|NCT00316693|81763935|FG000|Overall Study|Other|38|||
27981468|NCT00316693|81763936|FG001|Overall Study|Other|44|||
27981469|NCT01561963|81763937|FG000|Overall Study|Adverse Event|1|||
27981470|NCT05136898|81763938|FG000|Overall Study|Adverse Event|2|||
27981471|NCT01522404|81763943|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
27981472|NCT01522404|81763944|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
27981473|NCT01522404|81763943|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
27981474|NCT01522404|81763944|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
27981475|NCT01522404|81763943|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
27981476|NCT01522404|81763944|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
27981477|NCT00489736|81763947|FG000|Overall Study|Lack of Efficacy|53|||
27981478|NCT00489736|81763948|FG001|Overall Study|Lack of Efficacy|14|||
27673916|NCT00909532|80643431|FG000|Overall Study|Prohibited Medication|2|||
27673917|NCT00909532|80643432|FG001|Overall Study|Prohibited Medication|1|||
27673918|NCT00909532|80643431|FG000|Overall Study|Withdrawal of Consent|1|||
27793856|NCT01015118|81075463|FG001|Overall Study|Worsening or AE of underlying disease|4|||
27793857|NCT01015118|81075462|FG000|Overall Study|Progressive disease|364|||
27793858|NCT01015118|81075463|FG001|Overall Study|Progressive disease|229|||
27793859|NCT01015118|81075462|FG000|Overall Study|Not treated|9|||
27793860|NCT01015118|81075463|FG001|Overall Study|Not treated|5|||
27793861|NCT01015118|81075462|FG000|Overall Study|Other than stated above|42|||
27793862|NCT01015118|81075463|FG001|Overall Study|Other than stated above|23|||
27793863|NCT00678652|81075464|FG000|Overall Study|Protocol Violation|2|||
27793864|NCT00678652|81075465|FG001|Overall Study|Protocol Violation|0|||
27793865|NCT00678652|81075466|FG002|Overall Study|Protocol Violation|0|||
27868281|NCT01570686|81353778|FG001|Overall Study|Withdrawal by Subject|4|||
27793866|NCT00678652|81075467|FG003|Overall Study|Protocol Violation|0|||
27793867|NCT00678652|81075464|FG000|Overall Study|Pregnancy|0|||
27793868|NCT00678652|81075465|FG001|Overall Study|Pregnancy|0|||
27793869|NCT00678652|81075466|FG002|Overall Study|Pregnancy|1|||
27793870|NCT00678652|81075467|FG003|Overall Study|Pregnancy|0|||
27793871|NCT00678652|81075464|FG000|Overall Study|Relocation|1|||
27793872|NCT00678652|81075465|FG001|Overall Study|Relocation|0|||
27793873|NCT00678652|81075466|FG002|Overall Study|Relocation|0|||
27793874|NCT00678652|81075467|FG003|Overall Study|Relocation|0|||
27793875|NCT01165424|81075472|FG000|Overall Study|Clinical adverse experiences|1|||
27793876|NCT01165424|81075472|FG000|Overall Study|Laboratory adverse experiences|1|||
27793877|NCT01165424|81075472|FG000|Overall Study|Did not meet entry criteria|1|||
27793878|NCT01165424|81075472|FG000|Overall Study|Participant moved (relocated)|1|||
27793879|NCT01071278|81075473|FG000|Overall Study|Premature Discontinuation|254|||
27793880|NCT01071278|81075473|FG000|Overall Study|Completion Status Unknown|459|||
27793881|NCT03644927|81075474|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
27793882|NCT03644927|81075475|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
27793883|NCT00183170|81075477|FG000|First Intervention|Did not complete study|1|||
27793884|NCT00183170|81075478|FG001|First Intervention|Did not complete study|0|||
27793885|NCT00183170|81075477|FG000|First Intervention|Did not meet targeted BrAC|1|||
27793886|NCT00183170|81075478|FG001|First Intervention|Did not meet targeted BrAC|0|||
27793887|NCT00183170|81075477|FG000|Washout 1 Week|Did not complete study|6|||
27793888|NCT00183170|81075478|FG001|Washout 1 Week|Did not complete study|8|||
27793889|NCT00183170|81075477|FG000|Second Intervention|Did not complete study|1|||
27793890|NCT00183170|81075478|FG001|Second Intervention|Did not complete study|0|||
27793891|NCT00183170|81075477|FG000|Second Intervention|Did not meet targeted BrAC|0|||
27793892|NCT00183170|81075478|FG001|Second Intervention|Did not meet targeted BrAC|2|||
27793893|NCT00953017|81075479|FG000|Overall Study|DId not show up for colonoscopy|4|||
27793894|NCT00953017|81075480|FG001|Overall Study|DId not show up for colonoscopy|4|||
27793895|NCT00953017|81075481|FG002|Overall Study|DId not show up for colonoscopy|5|||
27793896|NCT00953017|81075482|FG003|Overall Study|DId not show up for colonoscopy|4|||
27793897|NCT00953017|81075479|FG000|Overall Study|Incomplete data|1|||
27793898|NCT00953017|81075480|FG001|Overall Study|Incomplete data|1|||
27793899|NCT00953017|81075481|FG002|Overall Study|Incomplete data|0|||
27793900|NCT00953017|81075482|FG003|Overall Study|Incomplete data|0|||
27793901|NCT00953017|81075479|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
27793902|NCT00953017|81075480|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
27868282|NCT01570686|81353777|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27981479|NCT00489736|81763947|FG000|Overall Study|Adverse Event|32|||
27981480|NCT00489736|81763948|FG001|Overall Study|Adverse Event|45|||
27981481|NCT00489736|81763947|FG000|Overall Study|Poor compliance|6|||
27981482|NCT00489736|81763948|FG001|Overall Study|Poor compliance|2|||
27981483|NCT00489736|81763947|FG000|Overall Study|Not coded/ Not pre-specified|5|||
27793903|NCT00953017|81075481|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
27793904|NCT00953017|81075482|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
27981484|NCT00489736|81763948|FG001|Overall Study|Not coded/ Not pre-specified|8|||
27981485|NCT02456857|81763949|FG000|Overall Study|Disease Progression|4|||
27981486|NCT01703065|81763950|FG000|Overall Study|Lack of Efficacy|1|||
27673919|NCT00909532|80643432|FG001|Overall Study|Withdrawal of Consent|1|||
27673920|NCT00909532|80643431|FG000|Overall Study|Noncompliance with Study Requirements|0|||
27868283|NCT01570686|81353778|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27868284|NCT03971474|81353779|FG000|Overall Study|Adverse Event|11|||
27981487|NCT01703065|81763951|FG001|Overall Study|Lack of Efficacy|0|||
27981488|NCT03204890|81763952|FG000|Overall Study|Withdrawal by Subject|1|||
27981489|NCT00685373|81763953|FG000|Overall Study|Adverse Event|3|||
27981490|NCT00685373|81763953|FG000|Overall Study|Withdrawal by Subject|5|||
27981491|NCT00685373|81763953|FG000|Overall Study|Lack of Efficacy|3|||
27981492|NCT00685373|81763953|FG000|Overall Study|Condition no longer requires study drug|1|||
27981493|NCT00685373|81763953|FG000|Overall Study|Lost to Follow-up|2|||
27981494|NCT00685373|81763953|FG000|Overall Study|Protocol Violation|1|||
27981495|NCT00203021|81763954|FG000|Overall Study|Death|4|||
27981496|NCT00203021|81763955|FG001|Overall Study|Death|1|||
27981497|NCT00203021|81763954|FG000|Overall Study|Adverse Event|10|||
27981498|NCT00203021|81763955|FG001|Overall Study|Adverse Event|5|||
27981499|NCT00203021|81763954|FG000|Overall Study|Withdrawal by Subject|45|||
27981500|NCT00203021|81763955|FG001|Overall Study|Withdrawal by Subject|48|||
27981501|NCT00203021|81763954|FG000|Overall Study|Lost to Follow-up|9|||
27981502|NCT00203021|81763955|FG001|Overall Study|Lost to Follow-up|7|||
27981503|NCT00203021|81763954|FG000|Overall Study|Other than specified|11|||
27981504|NCT00203021|81763955|FG001|Overall Study|Other than specified|16|||
27981505|NCT00391391|81763956|FG000|Overall Study|Adverse Event|0|||
27981506|NCT00391391|81763957|FG001|Overall Study|Adverse Event|0|||
27981507|NCT00391391|81763958|FG002|Overall Study|Adverse Event|0|||
27981508|NCT00391391|81763959|FG003|Overall Study|Adverse Event|1|||
27981509|NCT00391391|81763956|FG000|Overall Study|Lost to Follow-up|1|||
27981510|NCT00391391|81763957|FG001|Overall Study|Lost to Follow-up|3|||
27981511|NCT00391391|81763958|FG002|Overall Study|Lost to Follow-up|7|||
27981512|NCT00391391|81763959|FG003|Overall Study|Lost to Follow-up|4|||
27981513|NCT00391391|81763956|FG000|Overall Study|Protocol Violation|2|||
27981514|NCT00391391|81763957|FG001|Overall Study|Protocol Violation|3|||
27981515|NCT00391391|81763958|FG002|Overall Study|Protocol Violation|6|||
27981516|NCT00391391|81763959|FG003|Overall Study|Protocol Violation|7|||
27981517|NCT00391391|81763956|FG000|Overall Study|Withdrawal by Subject|6|||
27981518|NCT00391391|81763957|FG001|Overall Study|Withdrawal by Subject|4|||
27981519|NCT00391391|81763958|FG002|Overall Study|Withdrawal by Subject|10|||
27981520|NCT00391391|81763959|FG003|Overall Study|Withdrawal by Subject|7|||
27981521|NCT02920957|81763962|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
27981522|NCT02920957|81763963|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
27981523|NCT02920957|81763962|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
27981524|NCT02920957|81763963|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
27981525|NCT02920957|81763962|FG000|First Intervention : 1 Month|Adverse Event|1|||
27981526|NCT02920957|81763963|FG001|First Intervention : 1 Month|Adverse Event|0|||
27981527|NCT02920957|81763962|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
27981528|NCT02920957|81763963|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
27981529|NCT02191605|81763964|FG000|Overall Study|Lost to Follow-up|9|||
27981530|NCT02191605|81763965|FG001|Overall Study|Lost to Follow-up|4|||
27981531|NCT02191605|81763966|FG002|Overall Study|Lost to Follow-up|7|||
27981532|NCT02191605|81763967|FG003|Overall Study|Lost to Follow-up|3|||
27981533|NCT02191605|81763968|FG004|Overall Study|Lost to Follow-up|4|||
27981534|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
27981535|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
27981536|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Death|1|||
27981537|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Death|0|||
27981538|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
27981539|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
27981540|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
27981541|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
27981542|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
27981543|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
27981544|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
27981545|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
27981546|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
27981547|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
27981548|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
27981549|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
27981550|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
27981551|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
27981552|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
27981553|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
27981554|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
27981555|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
27981556|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
27981557|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
27981558|NCT02927262|81763973|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
27981559|NCT02927262|81763974|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
27981560|NCT02927262|81763973|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
27981561|NCT02927262|81763974|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
27981562|NCT02927262|81763973|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
27981563|NCT02927262|81763974|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
27981564|NCT02927262|81763973|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
27981565|NCT02927262|81763974|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
27981566|NCT00054691|81763978|FG000|Overall Study|Unmeasurable Disease|2|||
27981567|NCT00054691|81763978|FG000|Overall Study|Noncompliant|1|||
27981568|NCT01839656|81763982|FG000|Overall Study|Withdrawal by Subject|1|||
27981569|NCT01839656|81763983|FG001|Overall Study|Withdrawal by Subject|1|||
27981570|NCT01839656|81763982|FG000|Overall Study|Adverse event, serious fatal|1|||
27981571|NCT01839656|81763983|FG001|Overall Study|Adverse event, serious fatal|4|||
27981572|NCT01839656|81763982|FG000|Overall Study|Early study closure|0|||
27981573|NCT01839656|81763983|FG001|Overall Study|Early study closure|11|||
27981574|NCT01839656|81763982|FG000|Overall Study|Adverse Event|1|||
27576292|NCT04524403|80293146|FG001|Overall Study|Withdrawal by Subject|3|||
27576293|NCT04524403|80293147|FG002|Overall Study|Withdrawal by Subject|8|||
27576294|NCT04524403|80293145|FG000|Overall Study|Lost to Follow-up|3|||
27981575|NCT01839656|81763983|FG001|Overall Study|Adverse Event|0|||
27981576|NCT00748709|81763984|FG000|Overall Study|Progressive disease|15|||
27981577|NCT00748709|81763984|FG000|Overall Study|Drug reducing Toxity|2|||
27981578|NCT00748709|81763984|FG000|Overall Study|Other Adverse Event|1|||
27981579|NCT00748709|81763984|FG000|Overall Study|Withdrawal by Subject|1|||
27981580|NCT00748709|81763984|FG000|Overall Study|Other Reasons|1|||
27981581|NCT02771626|81763985|FG000|Overall Study|Adverse Event|1|||
27981582|NCT02771626|81763986|FG001|Overall Study|Adverse Event|5|||
27981583|NCT02771626|81763987|FG002|Overall Study|Adverse Event|3|||
27981584|NCT02771626|81763988|FG003|Overall Study|Adverse Event|0|||
27981585|NCT02771626|81763989|FG004|Overall Study|Adverse Event|1|||
27981586|NCT02771626|81763990|FG005|Overall Study|Adverse Event|1|||
27981587|NCT02771626|81763985|FG000|Overall Study|Radiologic Disease Progression|6|||
27981588|NCT02771626|81763986|FG001|Overall Study|Radiologic Disease Progression|13|||
27981589|NCT02771626|81763987|FG002|Overall Study|Radiologic Disease Progression|10|||
27981590|NCT02771626|81763988|FG003|Overall Study|Radiologic Disease Progression|7|||
27981591|NCT02771626|81763989|FG004|Overall Study|Radiologic Disease Progression|28|||
27576295|NCT04524403|80293146|FG001|Overall Study|Lost to Follow-up|4|||
27576296|NCT04524403|80293147|FG002|Overall Study|Lost to Follow-up|3|||
27576297|NCT04524403|80293145|FG000|Overall Study|Adverse Event|3|||
27793905|NCT00953017|81075479|FG000|Overall Study|Brown stool prior to procedure|0|||
27793906|NCT00953017|81075480|FG001|Overall Study|Brown stool prior to procedure|0|||
27793907|NCT00953017|81075481|FG002|Overall Study|Brown stool prior to procedure|1|||
27793908|NCT00953017|81075482|FG003|Overall Study|Brown stool prior to procedure|0|||
27793909|NCT04456998|81075483|FG000|Overall Study|Adverse Event|0|||
27793910|NCT04456998|81075484|FG001|Overall Study|Adverse Event|4|||
27793911|NCT04456998|81075483|FG000|Overall Study|Protocol Deviation|0|||
27793912|NCT04456998|81075484|FG001|Overall Study|Protocol Deviation|1|||
27793913|NCT04456998|81075483|FG000|Overall Study|Withdrawal by Subject|0|||
27793914|NCT04456998|81075484|FG001|Overall Study|Withdrawal by Subject|1|||
27793915|NCT00669110|81075487|FG000|Overall Study|Adverse Event|4|||
27793916|NCT00669110|81075488|FG001|Overall Study|Adverse Event|3|||
27793917|NCT00669110|81075487|FG000|Overall Study|Caregiver request|3|||
27793918|NCT00669110|81075488|FG001|Overall Study|Caregiver request|2|||
27793919|NCT00669110|81075487|FG000|Overall Study|Physician Decision|0|||
27793920|NCT00669110|81075488|FG001|Overall Study|Physician Decision|1|||
27793921|NCT00669110|81075487|FG000|Overall Study|Lost to Follow-up|1|||
27793922|NCT00669110|81075488|FG001|Overall Study|Lost to Follow-up|0|||
27793923|NCT00669110|81075487|FG000|Overall Study|Protocol Violation|0|||
27793924|NCT00669110|81075488|FG001|Overall Study|Protocol Violation|5|||
27981592|NCT02771626|81763990|FG005|Overall Study|Radiologic Disease Progression|15|||
27576298|NCT04524403|80293146|FG001|Overall Study|Adverse Event|1|||
27793925|NCT00669110|81075487|FG000|Overall Study|Withdrawal by Subject|0|||
27793926|NCT00669110|81075488|FG001|Overall Study|Withdrawal by Subject|2|||
27793927|NCT05637515|81075489|FG000|Overall Study|Withdrawal by Subject|17|||
27576299|NCT04524403|80293147|FG002|Overall Study|Adverse Event|4|||
27793928|NCT05637515|81075490|FG001|Overall Study|Withdrawal by Subject|17|||
27576300|NCT04524403|80293145|FG000|Overall Study|Non-compliant with study drug|1|||
27576301|NCT04524403|80293146|FG001|Overall Study|Non-compliant with study drug|2|||
27576302|NCT04524403|80293147|FG002|Overall Study|Non-compliant with study drug|3|||
27576303|NCT04524403|80293145|FG000|Overall Study|Moved|0|||
27576304|NCT04524403|80293146|FG001|Overall Study|Moved|1|||
27673921|NCT00909532|80643432|FG001|Overall Study|Noncompliance with Study Requirements|2|||
27673922|NCT00909532|80643431|FG000|Overall Study|Physician Decision|1|||
27793929|NCT00679042|81075493|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
27793930|NCT00679042|81075493|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
27793931|NCT00679042|81075493|FG000|5-Year Follow Up|Death|1|||
27793932|NCT00679042|81075493|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
27793933|NCT00679042|81075493|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
27793934|NCT01068418|81075494|FG000|Overall Study|Physician Decision|12|||
27981593|NCT02771626|81763985|FG000|Overall Study|Symptomatic Deterioration|0|||
27981594|NCT02771626|81763986|FG001|Overall Study|Symptomatic Deterioration|4|||
27981595|NCT02771626|81763987|FG002|Overall Study|Symptomatic Deterioration|2|||
27981596|NCT02771626|81763988|FG003|Overall Study|Symptomatic Deterioration|0|||
27981597|NCT02771626|81763989|FG004|Overall Study|Symptomatic Deterioration|5|||
27981598|NCT02771626|81763990|FG005|Overall Study|Symptomatic Deterioration|2|||
27981599|NCT02771626|81763985|FG000|Overall Study|Participant Request|0|||
27981600|NCT02771626|81763986|FG001|Overall Study|Participant Request|1|||
27981601|NCT02771626|81763987|FG002|Overall Study|Participant Request|0|||
27981602|NCT02771626|81763988|FG003|Overall Study|Participant Request|2|||
27981603|NCT02771626|81763989|FG004|Overall Study|Participant Request|0|||
27981604|NCT02771626|81763990|FG005|Overall Study|Participant Request|1|||
27981605|NCT02771626|81763985|FG000|Overall Study|Investigator Decision|0|||
27981606|NCT02771626|81763986|FG001|Overall Study|Investigator Decision|1|||
27981607|NCT02771626|81763987|FG002|Overall Study|Investigator Decision|0|||
27981608|NCT02771626|81763988|FG003|Overall Study|Investigator Decision|0|||
27981609|NCT02771626|81763989|FG004|Overall Study|Investigator Decision|1|||
27981610|NCT02771626|81763990|FG005|Overall Study|Investigator Decision|0|||
27981611|NCT02771626|81763985|FG000|Overall Study|Study Termination by Sponsor|0|||
27981612|NCT02771626|81763986|FG001|Overall Study|Study Termination by Sponsor|2|||
27981613|NCT02771626|81763987|FG002|Overall Study|Study Termination by Sponsor|1|||
27981614|NCT02771626|81763988|FG003|Overall Study|Study Termination by Sponsor|0|||
27981615|NCT02771626|81763989|FG004|Overall Study|Study Termination by Sponsor|1|||
27981616|NCT02771626|81763990|FG005|Overall Study|Study Termination by Sponsor|0|||
27981617|NCT02771626|81763985|FG000|Overall Study|Informed Consent Withdrawn|0|||
27673923|NCT00909532|80643432|FG001|Overall Study|Physician Decision|0|||
27673924|NCT00909532|80643431|FG000|Overall Study|Wrong Genotype|1|||
27673925|NCT00909532|80643432|FG001|Overall Study|Wrong Genotype|0|||
27673926|NCT00909532|80643431|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
27673927|NCT00909532|80643432|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
27673928|NCT01814072|80643434|FG000|Overall Study|Lost to Follow-up|2|||
27673929|NCT01814072|80643435|FG001|Overall Study|Lost to Follow-up|2|||
27673930|NCT01814072|80643436|FG002|Overall Study|Lost to Follow-up|2|||
27673931|NCT01814072|80643437|FG003|Overall Study|Lost to Follow-up|0|||
27673932|NCT01814072|80643438|FG004|Overall Study|Lost to Follow-up|2|||
27673933|NCT01814072|80643439|FG005|Overall Study|Lost to Follow-up|3|||
27673934|NCT01814072|80643440|FG006|Overall Study|Lost to Follow-up|3|||
27673935|NCT01814072|80643441|FG007|Overall Study|Lost to Follow-up|1|||
27673936|NCT01814072|80643442|FG008|Overall Study|Lost to Follow-up|2|||
27673937|NCT01814072|80643443|FG009|Overall Study|Lost to Follow-up|3|||
27673938|NCT01814072|80643444|FG010|Overall Study|Lost to Follow-up|1|||
27673939|NCT01814072|80643445|FG011|Overall Study|Lost to Follow-up|2|||
27673940|NCT01814072|80643446|FG012|Overall Study|Lost to Follow-up|2|||
27673941|NCT01814072|80643447|FG013|Overall Study|Lost to Follow-up|1|||
27673942|NCT01814072|80643448|FG014|Overall Study|Lost to Follow-up|2|||
27673943|NCT01814072|80643449|FG015|Overall Study|Lost to Follow-up|1|||
27673944|NCT01814072|80643450|FG016|Overall Study|Lost to Follow-up|3|||
27673945|NCT01814072|80643451|FG017|Overall Study|Lost to Follow-up|1|||
27673946|NCT01814072|80643452|FG018|Overall Study|Lost to Follow-up|3|||
27673947|NCT01814072|80643453|FG019|Overall Study|Lost to Follow-up|3|||
27673948|NCT01814072|80643454|FG020|Overall Study|Lost to Follow-up|2|||
27673949|NCT01814072|80643455|FG021|Overall Study|Lost to Follow-up|1|||
27673950|NCT01814072|80643456|FG022|Overall Study|Lost to Follow-up|3|||
27673951|NCT01814072|80643457|FG023|Overall Study|Lost to Follow-up|1|||
27793935|NCT03690206|81075495|FG000|Overall Study|Withdrawal by Subject|2|||
27793936|NCT03690206|81075496|FG001|Overall Study|Withdrawal by Subject|0|||
27981618|NCT02771626|81763986|FG001|Overall Study|Informed Consent Withdrawn|0|||
27981619|NCT02771626|81763987|FG002|Overall Study|Informed Consent Withdrawn|1|||
27981620|NCT02771626|81763988|FG003|Overall Study|Informed Consent Withdrawn|0|||
27576305|NCT04524403|80293147|FG002|Overall Study|Moved|0|||
27673952|NCT01814072|80643458|FG024|Overall Study|Lost to Follow-up|4|||
27673953|NCT01814072|80643459|FG025|Overall Study|Lost to Follow-up|1|||
27673954|NCT01814072|80643460|FG026|Overall Study|Lost to Follow-up|1|||
27673955|NCT01814072|80643461|FG027|Overall Study|Lost to Follow-up|2|||
27576306|NCT00727194|80293150|FG000|Screening Period|Low QMG scores|0|||
27576307|NCT00727194|80293151|FG001|Screening Period|Low QMG scores|0|||
27576308|NCT00727194|80293152|FG002|Screening Period|Low QMG scores|6|||
27576309|NCT00727194|80293150|FG000|Screening Period|Lacked AChR antibodies|0|||
27576310|NCT00727194|80293151|FG001|Screening Period|Lacked AChR antibodies|0|||
27576311|NCT00727194|80293152|FG002|Screening Period|Lacked AChR antibodies|5|||
27576312|NCT00727194|80293150|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
27576313|NCT00727194|80293151|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
27576314|NCT00727194|80293152|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
27576315|NCT00727194|80293150|FG000|Screening Period|Severe infections|0|||
27576316|NCT00727194|80293151|FG001|Screening Period|Severe infections|0|||
27576317|NCT00727194|80293152|FG002|Screening Period|Severe infections|2|||
27576318|NCT00727194|80293150|FG000|Screening Period|History of thymoma|0|||
27576319|NCT00727194|80293151|FG001|Screening Period|History of thymoma|0|||
27576320|NCT00727194|80293152|FG002|Screening Period|History of thymoma|1|||
27576321|NCT00727194|80293150|FG000|Treatment Period 2|Lack of Efficacy|0|||
27576322|NCT00727194|80293151|FG001|Treatment Period 2|Lack of Efficacy|1|||
27576323|NCT00727194|80293152|FG002|Treatment Period 2|Lack of Efficacy|0|||
27576324|NCT00441337|80293155|FG000|Overall Study|Disease Progression|6|||
27576325|NCT00441337|80293156|FG001|Overall Study|Disease Progression|6|||
27576326|NCT00441337|80293157|FG002|Overall Study|Disease Progression|4|||
27576327|NCT00441337|80293158|FG003|Overall Study|Disease Progression|18|||
27576328|NCT00441337|80293155|FG000|Overall Study|Lost to Follow-up|0|||
27576329|NCT00441337|80293156|FG001|Overall Study|Lost to Follow-up|0|||
27576330|NCT00441337|80293157|FG002|Overall Study|Lost to Follow-up|0|||
27576331|NCT00441337|80293158|FG003|Overall Study|Lost to Follow-up|1|||
27576332|NCT00441337|80293155|FG000|Overall Study|Sponsor Decision|0|||
27576333|NCT00441337|80293156|FG001|Overall Study|Sponsor Decision|0|||
27576334|NCT00441337|80293157|FG002|Overall Study|Sponsor Decision|1|||
27576335|NCT00441337|80293158|FG003|Overall Study|Sponsor Decision|2|||
27576336|NCT00441337|80293155|FG000|Overall Study|Did not meet inclusion criteria|0|||
27576337|NCT00441337|80293156|FG001|Overall Study|Did not meet inclusion criteria|0|||
27576338|NCT00441337|80293157|FG002|Overall Study|Did not meet inclusion criteria|1|||
27576339|NCT00441337|80293158|FG003|Overall Study|Did not meet inclusion criteria|0|||
27576340|NCT00428610|80293166|FG000|Overall Study|Death Due to Adverse Event|3|||
27576341|NCT00428610|80293167|FG001|Overall Study|Death Due to Adverse Event|0|||
27576342|NCT00428610|80293168|FG002|Overall Study|Death Due to Adverse Event|5|||
27576343|NCT00428610|80293166|FG000|Overall Study|Death Due to Progressive Disease|0|||
27576344|NCT00428610|80293167|FG001|Overall Study|Death Due to Progressive Disease|0|||
27576345|NCT00428610|80293168|FG002|Overall Study|Death Due to Progressive Disease|2|||
27981621|NCT02771626|81763989|FG004|Overall Study|Informed Consent Withdrawn|1|||
27981622|NCT02771626|81763990|FG005|Overall Study|Informed Consent Withdrawn|1|||
27981623|NCT02771626|81763985|FG000|Overall Study|Other, Not Specified|1|||
27576346|NCT00428610|80293166|FG000|Overall Study|Adverse Event|2|||
27576347|NCT00428610|80293167|FG001|Overall Study|Adverse Event|3|||
27576348|NCT00428610|80293168|FG002|Overall Study|Adverse Event|2|||
27576349|NCT00428610|80293166|FG000|Overall Study|Investigator Decision|2|||
27576350|NCT00428610|80293167|FG001|Overall Study|Investigator Decision|1|||
27576351|NCT00428610|80293168|FG002|Overall Study|Investigator Decision|1|||
27868285|NCT03971474|81353780|FG001|Overall Study|Adverse Event|7|||
27868286|NCT03971474|81353779|FG000|Overall Study|Refusal unrelated to adverse event|5|||
27868287|NCT03971474|81353780|FG001|Overall Study|Refusal unrelated to adverse event|1|||
27868288|NCT03971474|81353779|FG000|Overall Study|Progression/relapse|40|||
27868289|NCT03971474|81353780|FG001|Overall Study|Progression/relapse|47|||
27868290|NCT03971474|81353779|FG000|Overall Study|Death|6|||
27868291|NCT03971474|81353780|FG001|Overall Study|Death|3|||
27868292|NCT03971474|81353779|FG000|Overall Study|Other - not protocol specified|5|||
27981624|NCT02771626|81763986|FG001|Overall Study|Other, Not Specified|0|||
27981625|NCT02771626|81763987|FG002|Overall Study|Other, Not Specified|0|||
27576352|NCT00428610|80293166|FG000|Overall Study|Progressive Disease|42|||
27576353|NCT00428610|80293167|FG001|Overall Study|Progressive Disease|14|||
27576354|NCT00428610|80293168|FG002|Overall Study|Progressive Disease|22|||
27576355|NCT00428610|80293166|FG000|Overall Study|Withdrawal by Subject|4|||
27576356|NCT00428610|80293167|FG001|Overall Study|Withdrawal by Subject|0|||
27576357|NCT00428610|80293168|FG002|Overall Study|Withdrawal by Subject|0|||
27576358|NCT00079274|80293169|FG000|Overall Study|Withdrawal by Subject|111|||
27981626|NCT02771626|81763988|FG003|Overall Study|Other, Not Specified|0|||
27576359|NCT00079274|80293170|FG001|Overall Study|Withdrawal by Subject|10|||
27576360|NCT00079274|80293171|FG002|Overall Study|Withdrawal by Subject|12|||
27576361|NCT00079274|80293172|FG003|Overall Study|Withdrawal by Subject|163|||
27576362|NCT00079274|80293173|FG004|Overall Study|Withdrawal by Subject|7|||
27576363|NCT00079274|80293174|FG005|Overall Study|Withdrawal by Subject|8|||
27576364|NCT00079274|80293175|FG006|Overall Study|Withdrawal by Subject|0|||
27981627|NCT02771626|81763989|FG004|Overall Study|Other, Not Specified|0|||
27576365|NCT00079274|80293169|FG000|Overall Study|Adverse Event|130|||
27576366|NCT00079274|80293170|FG001|Overall Study|Adverse Event|8|||
27576367|NCT00079274|80293171|FG002|Overall Study|Adverse Event|8|||
27576368|NCT00079274|80293172|FG003|Overall Study|Adverse Event|184|||
27576369|NCT00079274|80293173|FG004|Overall Study|Adverse Event|7|||
27793937|NCT03690206|81075497|FG002|Overall Study|Withdrawal by Subject|0|||
27793938|NCT03690206|81075495|FG000|Overall Study|ICF withdrawal|2|||
27793939|NCT03690206|81075496|FG001|Overall Study|ICF withdrawal|0|||
27793940|NCT03690206|81075497|FG002|Overall Study|ICF withdrawal|0|||
27793941|NCT01607398|81075498|FG000|Overall Study|Adverse Event|0|||
27576370|NCT00079274|80293174|FG005|Overall Study|Adverse Event|8|||
27576371|NCT00079274|80293175|FG006|Overall Study|Adverse Event|0|||
27576372|NCT00079274|80293169|FG000|Overall Study|Recurrence|21|||
27576373|NCT00079274|80293170|FG001|Overall Study|Recurrence|0|||
27576374|NCT00079274|80293171|FG002|Overall Study|Recurrence|1|||
27576375|NCT00079274|80293172|FG003|Overall Study|Recurrence|15|||
27576376|NCT00079274|80293173|FG004|Overall Study|Recurrence|0|||
27576377|NCT00079274|80293174|FG005|Overall Study|Recurrence|2|||
27576378|NCT00079274|80293175|FG006|Overall Study|Recurrence|0|||
27576379|NCT00079274|80293169|FG000|Overall Study|Alternate Treatment|6|||
27576380|NCT00079274|80293170|FG001|Overall Study|Alternate Treatment|1|||
27576381|NCT00079274|80293171|FG002|Overall Study|Alternate Treatment|0|||
27576382|NCT00079274|80293172|FG003|Overall Study|Alternate Treatment|3|||
27576383|NCT00079274|80293173|FG004|Overall Study|Alternate Treatment|0|||
27793942|NCT01607398|81075499|FG001|Overall Study|Adverse Event|2|||
27576384|NCT00079274|80293174|FG005|Overall Study|Alternate Treatment|0|||
27576385|NCT00079274|80293175|FG006|Overall Study|Alternate Treatment|0|||
27576386|NCT00079274|80293169|FG000|Overall Study|Other Medical Problems|6|||
27576387|NCT00079274|80293170|FG001|Overall Study|Other Medical Problems|1|||
27576388|NCT00079274|80293171|FG002|Overall Study|Other Medical Problems|0|||
27576389|NCT00079274|80293172|FG003|Overall Study|Other Medical Problems|7|||
27576390|NCT00079274|80293173|FG004|Overall Study|Other Medical Problems|0|||
27576391|NCT00079274|80293174|FG005|Overall Study|Other Medical Problems|0|||
27576392|NCT00079274|80293175|FG006|Overall Study|Other Medical Problems|0|||
27576393|NCT00079274|80293169|FG000|Overall Study|Death|4|||
27576394|NCT00079274|80293170|FG001|Overall Study|Death|0|||
27576395|NCT00079274|80293171|FG002|Overall Study|Death|1|||
27576396|NCT00079274|80293172|FG003|Overall Study|Death|15|||
27576397|NCT00079274|80293173|FG004|Overall Study|Death|0|||
27576398|NCT00079274|80293174|FG005|Overall Study|Death|0|||
27576399|NCT00079274|80293175|FG006|Overall Study|Death|0|||
27576400|NCT00079274|80293169|FG000|Overall Study|Cytogenetic resistance|0|||
27576401|NCT00079274|80293170|FG001|Overall Study|Cytogenetic resistance|0|||
27576402|NCT00079274|80293171|FG002|Overall Study|Cytogenetic resistance|0|||
27576403|NCT00079274|80293172|FG003|Overall Study|Cytogenetic resistance|2|||
27576404|NCT00079274|80293173|FG004|Overall Study|Cytogenetic resistance|0|||
27576405|NCT00079274|80293174|FG005|Overall Study|Cytogenetic resistance|0|||
27576406|NCT00079274|80293175|FG006|Overall Study|Cytogenetic resistance|0|||
27576407|NCT00079274|80293169|FG000|Overall Study|Other|43|||
27576408|NCT00079274|80293170|FG001|Overall Study|Other|7|||
27576409|NCT00079274|80293171|FG002|Overall Study|Other|5|||
27576410|NCT00079274|80293172|FG003|Overall Study|Other|55|||
27576411|NCT00079274|80293173|FG004|Overall Study|Other|1|||
27576412|NCT00079274|80293174|FG005|Overall Study|Other|2|||
27576413|NCT00079274|80293175|FG006|Overall Study|Other|0|||
27673956|NCT01814072|80643462|FG028|Overall Study|Lost to Follow-up|3|||
27793943|NCT01607398|81075498|FG000|Overall Study|Severe COPD|2|||
27793944|NCT01607398|81075499|FG001|Overall Study|Severe COPD|0|||
27793945|NCT03170271|81075500|FG000|Overall Study|Adverse Event|7|||
27793946|NCT03170271|81075501|FG001|Overall Study|Adverse Event|2|||
27793947|NCT03170271|81075500|FG000|Overall Study|Lost to Follow-up|0|||
27793948|NCT03170271|81075501|FG001|Overall Study|Lost to Follow-up|1|||
27793949|NCT03170271|81075500|FG000|Overall Study|Physician Decision|1|||
27793950|NCT03170271|81075501|FG001|Overall Study|Physician Decision|0|||
27793951|NCT03170271|81075500|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
27793952|NCT03170271|81075501|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
27793953|NCT03170271|81075500|FG000|Overall Study|Withdrawal by Subject|17|||
27793954|NCT03170271|81075501|FG001|Overall Study|Withdrawal by Subject|5|||
27793955|NCT03170271|81075500|FG000|Overall Study|Other|2|||
27576414|NCT02331446|80296133|FG000|Overall Study|Lost to Follow-up|2|||
27576415|NCT02331446|80296134|FG001|Overall Study|Lost to Follow-up|1|||
27576416|NCT02331446|80296135|FG002|Overall Study|Lost to Follow-up|0|||
27576417|NCT02331446|80296136|FG003|Overall Study|Lost to Follow-up|1|||
27576418|NCT02331446|80296133|FG000|Overall Study|Personal Problem|2|||
27576419|NCT02331446|80296134|FG001|Overall Study|Personal Problem|0|||
27576420|NCT02331446|80296135|FG002|Overall Study|Personal Problem|0|||
27576421|NCT02331446|80296136|FG003|Overall Study|Personal Problem|0|||
27576422|NCT02331446|80296133|FG000|Overall Study|Disease|0|||
27576423|NCT02331446|80296134|FG001|Overall Study|Disease|2|||
27576424|NCT02331446|80296135|FG002|Overall Study|Disease|2|||
27576425|NCT02331446|80296136|FG003|Overall Study|Disease|1|||
27793956|NCT03170271|81075501|FG001|Overall Study|Other|2|||
27793957|NCT03170271|81075500|FG000|Overall Study|Randomized in error|4|||
27793958|NCT03170271|81075501|FG001|Overall Study|Randomized in error|0|||
27576426|NCT02331446|80296133|FG000|Overall Study|Physician Decision|0|||
27576427|NCT02331446|80296134|FG001|Overall Study|Physician Decision|1|||
27576428|NCT02331446|80296135|FG002|Overall Study|Physician Decision|0|||
27576429|NCT02331446|80296136|FG003|Overall Study|Physician Decision|1|||
27576430|NCT02331446|80296133|FG000|Overall Study|Lost before baseline analysis|0|||
27576431|NCT02331446|80296134|FG001|Overall Study|Lost before baseline analysis|1|||
27576432|NCT02331446|80296135|FG002|Overall Study|Lost before baseline analysis|1|||
27576433|NCT02331446|80296136|FG003|Overall Study|Lost before baseline analysis|0|||
27576434|NCT00796861|80296137|FG000|Overall Study|Withdrawal by Subject|2|||
27576435|NCT00796861|80296137|FG000|Overall Study|Death|2|||
27576436|NCT03351049|80296138|FG000|Overall Study|Withdrawal|26|||
27576437|NCT03351049|80296139|FG001|Overall Study|Withdrawal|22|||
27576438|NCT04086472|80296142|FG000|Overall Study|Lost to Follow-up|1|||
27576439|NCT04086472|80296143|FG001|Overall Study|Lost to Follow-up|0|||
27576440|NCT04086472|80296144|FG002|Overall Study|Lost to Follow-up|0|||
27576441|NCT04086472|80296145|FG003|Overall Study|Lost to Follow-up|0|||
27576442|NCT04086472|80296146|FG004|Overall Study|Lost to Follow-up|1|||
27576443|NCT04086472|80296142|FG000|Overall Study|Physician Decision|0|||
27576444|NCT04086472|80296143|FG001|Overall Study|Physician Decision|1|||
27576445|NCT04086472|80296144|FG002|Overall Study|Physician Decision|1|||
27576446|NCT04086472|80296145|FG003|Overall Study|Physician Decision|0|||
27576447|NCT04086472|80296146|FG004|Overall Study|Physician Decision|0|||
27576448|NCT04086472|80296142|FG000|Overall Study|Withdrawal by Subject|1|||
27673957|NCT01814072|80643463|FG029|Overall Study|Lost to Follow-up|3|||
27673958|NCT01814072|80643464|FG030|Overall Study|Lost to Follow-up|2|||
27673959|NCT01814072|80643465|FG031|Overall Study|Lost to Follow-up|0|||
27673960|NCT01814072|80643434|FG000|Overall Study|Withdrawal by Subject|2|||
27673961|NCT01814072|80643435|FG001|Overall Study|Withdrawal by Subject|0|||
27981628|NCT02771626|81763990|FG005|Overall Study|Other, Not Specified|1|||
27981629|NCT02124772|81763992|FG000|Overall Study|Lack of Efficacy|2|||
27981630|NCT02124772|81763993|FG001|Overall Study|Lack of Efficacy|0|||
27981631|NCT02124772|81763994|FG002|Overall Study|Lack of Efficacy|0|||
27981632|NCT02124772|81763995|FG003|Overall Study|Lack of Efficacy|1|||
27981633|NCT02124772|81763996|FG004|Overall Study|Lack of Efficacy|2|||
27981634|NCT02124772|81763997|FG005|Overall Study|Lack of Efficacy|3|||
27673962|NCT01814072|80643436|FG002|Overall Study|Withdrawal by Subject|1|||
27576449|NCT04086472|80296143|FG001|Overall Study|Withdrawal by Subject|1|||
27576450|NCT04086472|80296144|FG002|Overall Study|Withdrawal by Subject|1|||
27576451|NCT04086472|80296145|FG003|Overall Study|Withdrawal by Subject|0|||
27673963|NCT01814072|80643437|FG003|Overall Study|Withdrawal by Subject|0|||
27793959|NCT00446134|81075502|FG000|Overall Study|Adverse Event|7|||
27981635|NCT02124772|81763998|FG006|Overall Study|Lack of Efficacy|0|||
27981636|NCT02124772|81763999|FG007|Overall Study|Lack of Efficacy|2|||
27576452|NCT04086472|80296146|FG004|Overall Study|Withdrawal by Subject|0|||
27576453|NCT04086472|80296142|FG000|Overall Study|Various reasons|2|||
27576454|NCT04086472|80296143|FG001|Overall Study|Various reasons|0|||
27981637|NCT02124772|81764000|FG008|Overall Study|Lack of Efficacy|0|||
27981638|NCT02124772|81764001|FG009|Overall Study|Lack of Efficacy|1|||
27981639|NCT02124772|81764002|FG010|Overall Study|Lack of Efficacy|0|||
27981640|NCT02124772|81764003|FG011|Overall Study|Lack of Efficacy|0|||
27981641|NCT02124772|81764004|FG012|Overall Study|Lack of Efficacy|1|||
27673964|NCT01814072|80643438|FG004|Overall Study|Withdrawal by Subject|2|||
27673965|NCT01814072|80643439|FG005|Overall Study|Withdrawal by Subject|3|||
27981642|NCT02124772|81763992|FG000|Overall Study|Adverse Event|1|||
27981643|NCT02124772|81763993|FG001|Overall Study|Adverse Event|4|||
27981644|NCT02124772|81763994|FG002|Overall Study|Adverse Event|1|||
27981645|NCT02124772|81763995|FG003|Overall Study|Adverse Event|5|||
27981646|NCT02124772|81763996|FG004|Overall Study|Adverse Event|2|||
27981647|NCT02124772|81763997|FG005|Overall Study|Adverse Event|1|||
27981648|NCT02124772|81763998|FG006|Overall Study|Adverse Event|1|||
27981649|NCT02124772|81763999|FG007|Overall Study|Adverse Event|5|||
27981650|NCT02124772|81764000|FG008|Overall Study|Adverse Event|0|||
27981651|NCT02124772|81764001|FG009|Overall Study|Adverse Event|3|||
27981652|NCT02124772|81764002|FG010|Overall Study|Adverse Event|1|||
27981653|NCT02124772|81764003|FG011|Overall Study|Adverse Event|3|||
27981654|NCT02124772|81764004|FG012|Overall Study|Adverse Event|1|||
27981655|NCT02124772|81763992|FG000|Overall Study|Withdrawal consent|0|||
27793960|NCT00446134|81075503|FG001|Overall Study|Adverse Event|17|||
27793961|NCT00446134|81075504|FG002|Overall Study|Adverse Event|13|||
27793962|NCT00446134|81075505|FG003|Overall Study|Adverse Event|18|||
27793963|NCT00446134|81075502|FG000|Overall Study|Lack of Efficacy|19|||
27793964|NCT00446134|81075503|FG001|Overall Study|Lack of Efficacy|19|||
27793965|NCT00446134|81075504|FG002|Overall Study|Lack of Efficacy|24|||
27793966|NCT00446134|81075505|FG003|Overall Study|Lack of Efficacy|19|||
27793967|NCT00446134|81075502|FG000|Overall Study|Protocol Violation|0|||
27793968|NCT00446134|81075503|FG001|Overall Study|Protocol Violation|2|||
27793969|NCT00446134|81075504|FG002|Overall Study|Protocol Violation|1|||
27793970|NCT00446134|81075505|FG003|Overall Study|Protocol Violation|0|||
27981656|NCT02124772|81763993|FG001|Overall Study|Withdrawal consent|1|||
27981657|NCT02124772|81763994|FG002|Overall Study|Withdrawal consent|1|||
27981658|NCT02124772|81763995|FG003|Overall Study|Withdrawal consent|1|||
27981659|NCT02124772|81763996|FG004|Overall Study|Withdrawal consent|0|||
27981660|NCT02124772|81763997|FG005|Overall Study|Withdrawal consent|1|||
27981661|NCT02124772|81763998|FG006|Overall Study|Withdrawal consent|1|||
27981662|NCT02124772|81763999|FG007|Overall Study|Withdrawal consent|0|||
27981663|NCT02124772|81764000|FG008|Overall Study|Withdrawal consent|0|||
27981664|NCT02124772|81764001|FG009|Overall Study|Withdrawal consent|1|||
27981665|NCT02124772|81764002|FG010|Overall Study|Withdrawal consent|0|||
27673966|NCT01814072|80643440|FG006|Overall Study|Withdrawal by Subject|1|||
27673967|NCT01814072|80643441|FG007|Overall Study|Withdrawal by Subject|0|||
27793971|NCT00446134|81075502|FG000|Overall Study|Lost to Follow-up|1|||
27793972|NCT00446134|81075503|FG001|Overall Study|Lost to Follow-up|3|||
27793973|NCT00446134|81075504|FG002|Overall Study|Lost to Follow-up|1|||
27793974|NCT00446134|81075505|FG003|Overall Study|Lost to Follow-up|1|||
27793975|NCT00446134|81075502|FG000|Overall Study|Withdrawal by Subject|3|||
27793976|NCT00446134|81075503|FG001|Overall Study|Withdrawal by Subject|3|||
27793977|NCT00446134|81075504|FG002|Overall Study|Withdrawal by Subject|1|||
27793978|NCT00446134|81075505|FG003|Overall Study|Withdrawal by Subject|3|||
27793979|NCT00446134|81075502|FG000|Overall Study|Physician Decision|0|||
27793980|NCT00446134|81075503|FG001|Overall Study|Physician Decision|0|||
27793981|NCT00446134|81075504|FG002|Overall Study|Physician Decision|0|||
27793982|NCT00446134|81075505|FG003|Overall Study|Physician Decision|2|||
27793983|NCT00446134|81075502|FG000|Overall Study|Adverse Event-Diarrhea|1|||
27793984|NCT00446134|81075503|FG001|Overall Study|Adverse Event-Diarrhea|1|||
27793985|NCT00446134|81075504|FG002|Overall Study|Adverse Event-Diarrhea|2|||
27793986|NCT00446134|81075505|FG003|Overall Study|Adverse Event-Diarrhea|0|||
27793987|NCT00446134|81075502|FG000|Overall Study|Reason Not Completed|3|||
27793988|NCT00446134|81075503|FG001|Overall Study|Reason Not Completed|0|||
27793989|NCT00446134|81075504|FG002|Overall Study|Reason Not Completed|1|||
27793990|NCT00446134|81075505|FG003|Overall Study|Reason Not Completed|2|||
27981666|NCT02124772|81764003|FG011|Overall Study|Withdrawal consent|1|||
27673968|NCT01814072|80643442|FG008|Overall Study|Withdrawal by Subject|1|||
27673969|NCT01814072|80643443|FG009|Overall Study|Withdrawal by Subject|2|||
27793991|NCT00359073|81075506|FG000|Overall Study|Withdrawal by Subject|1|||
27793992|NCT00359073|81075507|FG001|Overall Study|Withdrawal by Subject|1|||
27793993|NCT00359073|81075506|FG000|Overall Study|Eligibility criteria no longer met|3|||
27793994|NCT00359073|81075507|FG001|Overall Study|Eligibility criteria no longer met|0|||
27981667|NCT02124772|81764004|FG012|Overall Study|Withdrawal consent|0|||
27981668|NCT02124772|81763992|FG000|Overall Study|Investigator discretion|0|||
27673970|NCT01814072|80643444|FG010|Overall Study|Withdrawal by Subject|0|||
27981669|NCT02124772|81763993|FG001|Overall Study|Investigator discretion|2|||
27793995|NCT00359073|81075506|FG000|Overall Study|developed RV16 antibody|0|||
27793996|NCT00359073|81075507|FG001|Overall Study|developed RV16 antibody|1|||
27793997|NCT01600755|81075511|FG000|Overall Study|Withdrawal by Subject|6|||
27981670|NCT02124772|81763994|FG002|Overall Study|Investigator discretion|2|||
27981671|NCT02124772|81763995|FG003|Overall Study|Investigator discretion|1|||
27793998|NCT03505606|81075514|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
27793999|NCT03505606|81075515|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
27794000|NCT03505606|81075516|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
27794001|NCT03505606|81075514|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
27794002|NCT03505606|81075515|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
27794003|NCT03505606|81075516|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
27794004|NCT03505606|81075514|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
27794005|NCT03505606|81075515|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
27794006|NCT03505606|81075516|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
27794007|NCT03505606|81075514|FG000|Overall Study|Poor compliance with refractive correction|0|||
27794008|NCT03505606|81075515|FG001|Overall Study|Poor compliance with refractive correction|0|||
27794009|NCT03505606|81075516|FG002|Overall Study|Poor compliance with refractive correction|1|||
27794010|NCT03505606|81075514|FG000|Overall Study|Insufficient anisometropia|0|||
27794011|NCT03505606|81075515|FG001|Overall Study|Insufficient anisometropia|0|||
27794012|NCT03505606|81075516|FG002|Overall Study|Insufficient anisometropia|2|||
27794013|NCT03505606|81075514|FG000|Overall Study|Ectopia Lentis|0|||
27794014|NCT03505606|81075515|FG001|Overall Study|Ectopia Lentis|0|||
27794015|NCT03505606|81075516|FG002|Overall Study|Ectopia Lentis|1|||
27794016|NCT03505606|81075514|FG000|Overall Study|alternation of amblyopic eye|0|||
27794017|NCT03505606|81075515|FG001|Overall Study|alternation of amblyopic eye|1|||
27794018|NCT03505606|81075516|FG002|Overall Study|alternation of amblyopic eye|0|||
27794019|NCT05279807|81075517|FG000|Overall Study|Withdrawal by Subject|1|||
27794020|NCT05279807|81075518|FG001|Overall Study|Withdrawal by Subject|0|||
27981672|NCT02124772|81763996|FG004|Overall Study|Investigator discretion|1|||
27981673|NCT02124772|81763997|FG005|Overall Study|Investigator discretion|0|||
27981674|NCT02124772|81763998|FG006|Overall Study|Investigator discretion|1|||
27981675|NCT02124772|81763999|FG007|Overall Study|Investigator discretion|0|||
27981676|NCT02124772|81764000|FG008|Overall Study|Investigator discretion|0|||
27981677|NCT02124772|81764001|FG009|Overall Study|Investigator discretion|1|||
27981678|NCT02124772|81764002|FG010|Overall Study|Investigator discretion|0|||
27981679|NCT02124772|81764003|FG011|Overall Study|Investigator discretion|1|||
27981680|NCT02124772|81764004|FG012|Overall Study|Investigator discretion|0|||
27981681|NCT02124772|81763992|FG000|Overall Study|Progressive disease|0|||
27981682|NCT02124772|81763993|FG001|Overall Study|Progressive disease|0|||
27981683|NCT02124772|81763994|FG002|Overall Study|Progressive disease|0|||
27981684|NCT02124772|81763995|FG003|Overall Study|Progressive disease|0|||
27981685|NCT02124772|81763996|FG004|Overall Study|Progressive disease|0|||
27981686|NCT02124772|81763997|FG005|Overall Study|Progressive disease|0|||
27981687|NCT02124772|81763998|FG006|Overall Study|Progressive disease|1|||
27981688|NCT02124772|81763999|FG007|Overall Study|Progressive disease|1|||
27981689|NCT02124772|81764000|FG008|Overall Study|Progressive disease|0|||
27981690|NCT02124772|81764001|FG009|Overall Study|Progressive disease|0|||
27981691|NCT02124772|81764002|FG010|Overall Study|Progressive disease|0|||
27981692|NCT02124772|81764003|FG011|Overall Study|Progressive disease|0|||
27794021|NCT05279807|81075517|FG000|Overall Study|Adverse Event|0|||
27794022|NCT05279807|81075518|FG001|Overall Study|Adverse Event|1|||
27794023|NCT05279807|81075517|FG000|Overall Study|Laboratory Abnormal Results|1|||
27794024|NCT05279807|81075518|FG001|Overall Study|Laboratory Abnormal Results|0|||
27868293|NCT03971474|81353780|FG001|Overall Study|Other - not protocol specified|4|||
27868294|NCT03971474|81353779|FG000|Overall Study|On treatment|0|||
27868295|NCT03971474|81353780|FG001|Overall Study|On treatment|7|||
27868296|NCT00111241|81353781|FG000|Overall Study|Lost to Follow-up|1|||
27868297|NCT00111241|81353782|FG001|Overall Study|Lost to Follow-up|0|||
27868298|NCT00111241|81353781|FG000|Overall Study|Withdrawal by Subject|4|||
27868299|NCT00111241|81353782|FG001|Overall Study|Withdrawal by Subject|0|||
27868300|NCT00111241|81353781|FG000|Overall Study|Protocol Violation|9|||
27868301|NCT00111241|81353782|FG001|Overall Study|Protocol Violation|8|||
27576455|NCT04086472|80296144|FG002|Overall Study|Various reasons|0|||
27576456|NCT04086472|80296145|FG003|Overall Study|Various reasons|3|||
27576457|NCT04086472|80296146|FG004|Overall Study|Various reasons|1|||
27576458|NCT02103478|80296151|FG000|Overall Study|Adverse Event|0|||
27868302|NCT00111241|81353781|FG000|Overall Study|Adverse Event|1|||
27981693|NCT02124772|81764004|FG012|Overall Study|Progressive disease|0|||
27981694|NCT02124772|81763992|FG000|Overall Study|Other|0|||
27981695|NCT02124772|81763993|FG001|Overall Study|Other|7|||
27576459|NCT02103478|80296152|FG001|Overall Study|Adverse Event|0|||
27576460|NCT02103478|80296153|FG002|Overall Study|Adverse Event|1|||
27576461|NCT02103478|80296154|FG003|Overall Study|Adverse Event|1|||
27981696|NCT02124772|81763994|FG002|Overall Study|Other|2|||
27981697|NCT02124772|81763995|FG003|Overall Study|Other|5|||
27981698|NCT02124772|81763996|FG004|Overall Study|Other|4|||
27794025|NCT03409328|81075519|FG000|Overall Study|Lost to Follow-up|6|||
27794026|NCT03409328|81075520|FG001|Overall Study|Lost to Follow-up|3|||
27576462|NCT02103478|80296155|FG004|Overall Study|Adverse Event|2|||
27576463|NCT02103478|80296156|FG005|Overall Study|Adverse Event|1|||
27576464|NCT02103478|80296157|FG006|Overall Study|Adverse Event|0|||
27576465|NCT02103478|80296158|FG007|Overall Study|Adverse Event|0|||
27576466|NCT02103478|80296159|FG008|Overall Study|Adverse Event|0|||
27576467|NCT02103478|80296151|FG000|Overall Study|Death|2|||
27576468|NCT02103478|80296152|FG001|Overall Study|Death|2|||
27576469|NCT02103478|80296153|FG002|Overall Study|Death|1|||
27576470|NCT02103478|80296154|FG003|Overall Study|Death|1|||
27576471|NCT02103478|80296155|FG004|Overall Study|Death|5|||
27576472|NCT02103478|80296156|FG005|Overall Study|Death|15|||
27576473|NCT02103478|80296157|FG006|Overall Study|Death|14|||
27981699|NCT02124772|81763997|FG005|Overall Study|Other|3|||
27981700|NCT02124772|81763998|FG006|Overall Study|Other|4|||
27981701|NCT02124772|81763999|FG007|Overall Study|Other|1|||
27981702|NCT02124772|81764000|FG008|Overall Study|Other|1|||
27981703|NCT02124772|81764001|FG009|Overall Study|Other|1|||
27981704|NCT02124772|81764002|FG010|Overall Study|Other|1|||
27981705|NCT02124772|81764003|FG011|Overall Study|Other|1|||
27981706|NCT02124772|81764004|FG012|Overall Study|Other|0|||
27981707|NCT03689244|81764007|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
27981708|NCT03689244|81764008|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
27981709|NCT03689244|81764009|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
27981710|NCT03689244|81764010|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
27981711|NCT03689244|81764007|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
27981712|NCT03689244|81764008|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
27981713|NCT03689244|81764009|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
27981714|NCT03689244|81764010|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
27981715|NCT03689244|81764007|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
27981716|NCT03689244|81764008|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
27981717|NCT03689244|81764009|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
27981718|NCT03689244|81764010|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
27981719|NCT03689244|81764007|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
27981720|NCT03689244|81764008|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
27981721|NCT03689244|81764009|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
27981722|NCT03689244|81764010|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
27981723|NCT03689244|81764007|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
27981724|NCT03689244|81764008|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
27981725|NCT03689244|81764009|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
27981726|NCT03689244|81764010|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
27981727|NCT03689244|81764007|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
27981728|NCT03689244|81764008|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
27981729|NCT03689244|81764009|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
27981730|NCT03689244|81764010|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
27981731|NCT03689244|81764007|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
27981732|NCT03689244|81764008|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
27981733|NCT03689244|81764009|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
27981734|NCT03689244|81764010|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
27981735|NCT03689244|81764007|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
27981736|NCT03689244|81764008|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
27576474|NCT02103478|80296158|FG007|Overall Study|Death|10|||
27576475|NCT02103478|80296159|FG008|Overall Study|Death|11|||
27576476|NCT02103478|80296151|FG000|Overall Study|Progressive Disease|2|||
27576477|NCT02103478|80296152|FG001|Overall Study|Progressive Disease|1|||
27576478|NCT02103478|80296153|FG002|Overall Study|Progressive Disease|2|||
27576479|NCT02103478|80296154|FG003|Overall Study|Progressive Disease|0|||
27794027|NCT05257109|81075523|FG000|Overall Study|Withdrawal by Subject|1|||
27794028|NCT05257109|81075524|FG001|Overall Study|Withdrawal by Subject|0|||
27794029|NCT05257109|81075525|FG002|Overall Study|Withdrawal by Subject|0|||
27794030|NCT05257109|81075526|FG003|Overall Study|Withdrawal by Subject|0|||
27794031|NCT04964960|81075527|FG000|Overall Study|Withdrawal by Subject|1|||
27794032|NCT00822237|81075528|FG000|Dose 1 Vaccination|Not vaccinated|3|||
27794033|NCT00822237|81075529|FG001|Dose 1 Vaccination|Not vaccinated|0|||
27794034|NCT00822237|81075528|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
27794035|NCT00822237|81075529|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
27794036|NCT00822237|81075528|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
27794037|NCT00822237|81075529|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
27794038|NCT00822237|81075528|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
27794039|NCT00822237|81075529|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
27794040|NCT00822237|81075528|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
27794041|NCT00822237|81075529|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
27794042|NCT04633434|81075530|FG000|Overall Study|Lost to Follow-up|32|||
27794043|NCT04633434|81075531|FG001|Overall Study|Lost to Follow-up|32|||
27794044|NCT02252172|81075532|FG000|Overall Study|Lost to Follow-up|3|||
27794045|NCT02252172|81075533|FG001|Overall Study|Lost to Follow-up|1|||
27794046|NCT02252172|81075532|FG000|Overall Study|Ongoing|276|||
27794047|NCT02252172|81075533|FG001|Overall Study|Ongoing|298|||
27794048|NCT04881448|81075534|FG000|Overall Study|Study cancelled by sponsor|220|||
27794049|NCT04881448|81075534|FG000|Overall Study|Withdrawal by Subject|2|||
27794050|NCT04881448|81075534|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
27794051|NCT02985515|81075535|FG000|Olfaction Testing|Lost to Follow-up|0|||
27794052|NCT02985515|81075536|FG001|Olfaction Testing|Lost to Follow-up|5|||
27794053|NCT02985515|81075535|FG000|Olfaction Testing|Protocol Violation|0|||
27794054|NCT02985515|81075536|FG001|Olfaction Testing|Protocol Violation|3|||
27794055|NCT02526017|81075539|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794056|NCT02526017|81075540|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794057|NCT02526017|81075541|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27576480|NCT02103478|80296155|FG004|Overall Study|Progressive Disease|9|||
27576481|NCT02103478|80296156|FG005|Overall Study|Progressive Disease|1|||
27576482|NCT02103478|80296157|FG006|Overall Study|Progressive Disease|2|||
27576483|NCT02103478|80296158|FG007|Overall Study|Progressive Disease|0|||
27576484|NCT02103478|80296159|FG008|Overall Study|Progressive Disease|1|||
27576485|NCT02103478|80296151|FG000|Overall Study|Withdrawal by Subject|2|||
27576486|NCT02103478|80296152|FG001|Overall Study|Withdrawal by Subject|0|||
27576487|NCT02103478|80296153|FG002|Overall Study|Withdrawal by Subject|0|||
27576488|NCT02103478|80296154|FG003|Overall Study|Withdrawal by Subject|4|||
27576489|NCT02103478|80296155|FG004|Overall Study|Withdrawal by Subject|0|||
27576490|NCT02103478|80296156|FG005|Overall Study|Withdrawal by Subject|0|||
27576491|NCT02103478|80296157|FG006|Overall Study|Withdrawal by Subject|1|||
27576492|NCT02103478|80296158|FG007|Overall Study|Withdrawal by Subject|1|||
27576493|NCT02103478|80296159|FG008|Overall Study|Withdrawal by Subject|0|||
27981737|NCT03689244|81764009|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
27981738|NCT03689244|81764010|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
27981739|NCT03159104|81764011|FG000|Overall Study|Violation of inclusion criteria|1|||
27981740|NCT03159104|81764012|FG001|Overall Study|Violation of inclusion criteria|2|||
27981741|NCT00582738|81764013|FG000|Overall Study|Administrative Problems|7|||
27981742|NCT00582738|81764014|FG001|Overall Study|Administrative Problems|8|||
27981743|NCT00582738|81764013|FG000|Overall Study|Adverse Event|0|||
27981744|NCT00582738|81764014|FG001|Overall Study|Adverse Event|5|||
27981745|NCT00582738|81764013|FG000|Overall Study|Graft Lost|0|||
27981746|NCT00582738|81764014|FG001|Overall Study|Graft Lost|1|||
27981747|NCT00582738|81764013|FG000|Overall Study|Other|1|||
27981748|NCT00582738|81764014|FG001|Overall Study|Other|0|||
27981749|NCT00582738|81764013|FG000|Overall Study|Protocol Violation|1|||
27981750|NCT00582738|81764014|FG001|Overall Study|Protocol Violation|1|||
27981751|NCT00582738|81764013|FG000|Overall Study|Withdrawal by Subject|0|||
27981752|NCT00582738|81764014|FG001|Overall Study|Withdrawal by Subject|3|||
27981753|NCT02091284|81764015|FG000|Overall Study|Withdrawal by Subject|2|||
27981754|NCT02091284|81764016|FG001|Overall Study|Withdrawal by Subject|1|||
27981755|NCT02091284|81764015|FG000|Overall Study|unreliable data|1|||
27981756|NCT02091284|81764016|FG001|Overall Study|unreliable data|0|||
27981757|NCT03689712|81767157|FG000|Overall Study|Adverse Event|1|||
27981758|NCT03689712|81767158|FG001|Overall Study|Adverse Event|0|||
27981759|NCT03689712|81767157|FG000|Overall Study|Death|20|||
27981760|NCT03689712|81767158|FG001|Overall Study|Death|10|||
27981761|NCT03689712|81767157|FG000|Overall Study|Lost to Follow-up|6|||
27981762|NCT03689712|81767158|FG001|Overall Study|Lost to Follow-up|6|||
27981763|NCT03689712|81767157|FG000|Overall Study|Other|1|||
27981764|NCT03689712|81767158|FG001|Overall Study|Other|0|||
27981765|NCT03689712|81767157|FG000|Overall Study|Patient Non-Compliance|0|||
27981766|NCT03689712|81767158|FG001|Overall Study|Patient Non-Compliance|1|||
27981767|NCT03689712|81767157|FG000|Overall Study|Withdrawal by Subject|20|||
27981768|NCT03689712|81767158|FG001|Overall Study|Withdrawal by Subject|4|||
27981769|NCT03689712|81767157|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
27981770|NCT03689712|81767158|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
27981771|NCT03689712|81767157|FG000|Overall Study|Randomized but not Treated|13|||
27981772|NCT03689712|81767158|FG001|Overall Study|Randomized but not Treated|7|||
27981773|NCT03689712|81767157|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
27981774|NCT03689712|81767158|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
27576494|NCT02103478|80296151|FG000|Overall Study|Lost to Follow-up|0|||
27576495|NCT02103478|80296152|FG001|Overall Study|Lost to Follow-up|0|||
27981775|NCT02428413|81767162|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
27576496|NCT02103478|80296153|FG002|Overall Study|Lost to Follow-up|0|||
27576497|NCT02103478|80296154|FG003|Overall Study|Lost to Follow-up|0|||
27981776|NCT02428413|81767163|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
27981777|NCT02428413|81767162|FG000|Overall Study|Protocol Violation|1|||
27981778|NCT02428413|81767163|FG001|Overall Study|Protocol Violation|2|||
27981779|NCT02428413|81767162|FG000|Overall Study|Case Cancelled|2|||
27981780|NCT02428413|81767163|FG001|Overall Study|Case Cancelled|0|||
27981781|NCT02428413|81767162|FG000|Overall Study|Missed Cases|1|||
27981782|NCT02428413|81767163|FG001|Overall Study|Missed Cases|2|||
27981783|NCT02428413|81767162|FG000|Overall Study|Nurse Refusal|1|||
27981784|NCT02428413|81767163|FG001|Overall Study|Nurse Refusal|0|||
27794058|NCT02526017|81075542|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794059|NCT02526017|81075543|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
27794060|NCT02526017|81075544|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794061|NCT02526017|81075545|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794062|NCT02526017|81075546|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794063|NCT02526017|81075547|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
27794064|NCT02181673|81075550|FG000|Up to Week 24|Adverse Event|2|||
27794065|NCT02181673|81075551|FG001|Up to Week 24|Adverse Event|0|||
27794066|NCT02181673|81075552|FG002|Up to Week 24|Adverse Event|3|||
27794067|NCT02181673|81075550|FG000|Up to Week 24|Death|1|||
27794068|NCT02181673|81075551|FG001|Up to Week 24|Death|0|||
27576498|NCT02103478|80296155|FG004|Overall Study|Lost to Follow-up|0|||
27576499|NCT02103478|80296156|FG005|Overall Study|Lost to Follow-up|0|||
27576500|NCT02103478|80296157|FG006|Overall Study|Lost to Follow-up|0|||
27576501|NCT02103478|80296158|FG007|Overall Study|Lost to Follow-up|1|||
27576502|NCT02103478|80296159|FG008|Overall Study|Lost to Follow-up|0|||
27981785|NCT02017522|81767164|FG000|Overall Study|Withdrawal by Subject|1|||
27981786|NCT02096263|81767165|FG000|Overall Study|Adverse Event|1|||
27981787|NCT02096263|81767166|FG001|Overall Study|Adverse Event|0|||
27576503|NCT02103478|80296151|FG000|Overall Study|Other|1|||
27576504|NCT02103478|80296152|FG001|Overall Study|Other|3|||
27576505|NCT02103478|80296153|FG002|Overall Study|Other|2|||
27576506|NCT02103478|80296154|FG003|Overall Study|Other|0|||
27576507|NCT02103478|80296155|FG004|Overall Study|Other|3|||
27576508|NCT02103478|80296156|FG005|Overall Study|Other|8|||
27576509|NCT02103478|80296157|FG006|Overall Study|Other|8|||
27576510|NCT02103478|80296158|FG007|Overall Study|Other|4|||
27576511|NCT02103478|80296159|FG008|Overall Study|Other|2|||
27576512|NCT03085927|80296160|FG000|Overall Study|Withdrawal by Subject|1|||
27576513|NCT03085927|80296161|FG001|Overall Study|Withdrawal by Subject|4|||
27576514|NCT03085927|80296160|FG000|Overall Study|Lost to Follow-up|3|||
27576515|NCT03085927|80296161|FG001|Overall Study|Lost to Follow-up|1|||
27576516|NCT03085927|80296160|FG000|Overall Study|Death|1|||
27576517|NCT03085927|80296161|FG001|Overall Study|Death|0|||
27576518|NCT03085927|80296160|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
27576519|NCT03085927|80296161|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
27576520|NCT03085927|80296160|FG000|Overall Study|Dyad Became Ineligible|0|||
27576521|NCT03085927|80296161|FG001|Overall Study|Dyad Became Ineligible|1|||
27576522|NCT04776148|80296171|FG000|Overall Study|Death|172|||
27576523|NCT04776148|80296172|FG001|Overall Study|Death|188|||
27576524|NCT04776148|80296171|FG000|Overall Study|Lost to Follow-up|0|||
27576525|NCT04776148|80296172|FG001|Overall Study|Lost to Follow-up|1|||
27576526|NCT04776148|80296171|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27576527|NCT04776148|80296172|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27981788|NCT02096263|81767167|FG002|Overall Study|Adverse Event|1|||
27576528|NCT04776148|80296171|FG000|Overall Study|Withdrawal by Subject|2|||
27981789|NCT02096263|81767165|FG000|Overall Study|Lost to Follow-up|14|||
27576529|NCT04776148|80296172|FG001|Overall Study|Withdrawal by Subject|4|||
27981790|NCT02096263|81767166|FG001|Overall Study|Lost to Follow-up|18|||
27981791|NCT02096263|81767167|FG002|Overall Study|Lost to Follow-up|15|||
27576530|NCT04776148|80296171|FG000|Overall Study|Ongoing in Study|67|||
27576531|NCT04776148|80296172|FG001|Overall Study|Ongoing in Study|45|||
27576532|NCT02707640|80296173|FG000|Overall Study|Adverse Event|4|||
27576533|NCT02707640|80296174|FG001|Overall Study|Adverse Event|2|||
27794069|NCT02181673|81075552|FG002|Up to Week 24|Death|0|||
27981792|NCT02096263|81767165|FG000|Overall Study|Other|7|||
27576534|NCT02707640|80296173|FG000|Overall Study|Death|1|||
27576535|NCT02707640|80296174|FG001|Overall Study|Death|2|||
27576536|NCT02707640|80296173|FG000|Overall Study|Physician Decision|2|||
27576537|NCT02707640|80296174|FG001|Overall Study|Physician Decision|0|||
27576538|NCT02707640|80296173|FG000|Overall Study|Withdrawal by Subject|0|||
27576539|NCT02707640|80296174|FG001|Overall Study|Withdrawal by Subject|1|||
27576540|NCT02707640|80296173|FG000|Overall Study|Participant's Personal Decision|1|||
27576541|NCT02707640|80296174|FG001|Overall Study|Participant's Personal Decision|2|||
27576542|NCT02707640|80296173|FG000|Overall Study|Sponsor Discretion|1|||
27981793|NCT02096263|81767166|FG001|Overall Study|Other|9|||
27981794|NCT02096263|81767167|FG002|Overall Study|Other|6|||
27981795|NCT02096263|81767165|FG000|Overall Study|Sponsor study termination|0|||
27981796|NCT02096263|81767166|FG001|Overall Study|Sponsor study termination|0|||
27981797|NCT02096263|81767167|FG002|Overall Study|Sponsor study termination|1|||
27981798|NCT02096263|81767165|FG000|Overall Study|Protocol Violation|7|||
27981799|NCT02096263|81767166|FG001|Overall Study|Protocol Violation|2|||
27981800|NCT02096263|81767167|FG002|Overall Study|Protocol Violation|8|||
27981801|NCT02096263|81767165|FG000|Overall Study|Withdrawal by Subject|5|||
27981802|NCT02096263|81767166|FG001|Overall Study|Withdrawal by Subject|7|||
27981803|NCT02096263|81767167|FG002|Overall Study|Withdrawal by Subject|8|||
27981804|NCT02049138|81767168|FG000|Overall Study|Adverse Event|46|||
27981805|NCT02049138|81767169|FG001|Overall Study|Adverse Event|25|||
27981806|NCT02049138|81767170|FG002|Overall Study|Adverse Event|1|||
27794070|NCT02181673|81075550|FG000|Up to Week 24|Lack of Efficacy|1|||
27794071|NCT02181673|81075551|FG001|Up to Week 24|Lack of Efficacy|0|||
27794072|NCT02181673|81075552|FG002|Up to Week 24|Lack of Efficacy|0|||
27794073|NCT02181673|81075550|FG000|Up to Week 24|Lost to Follow-up|1|||
27794074|NCT02181673|81075551|FG001|Up to Week 24|Lost to Follow-up|0|||
27794075|NCT02181673|81075552|FG002|Up to Week 24|Lost to Follow-up|0|||
27794076|NCT02181673|81075550|FG000|Up to Week 24|Physician Decision|0|||
27576543|NCT02707640|80296174|FG001|Overall Study|Sponsor Discretion|0|||
27576544|NCT02265705|80296175|FG000|Treatment Period Week 0-24|Adverse Event|3|||
27576545|NCT02265705|80296176|FG001|Treatment Period Week 0-24|Adverse Event|2|||
27576546|NCT02265705|80296177|FG002|Treatment Period Week 0-24|Adverse Event|0|||
27576547|NCT02265705|80296178|FG003|Treatment Period Week 0-24|Adverse Event|0|||
27576548|NCT02265705|80296179|FG004|Treatment Period Week 0-24|Adverse Event|0|||
27576549|NCT02265705|80296180|FG005|Treatment Period Week 0-24|Adverse Event|0|||
27576550|NCT02265705|80296181|FG006|Treatment Period Week 0-24|Adverse Event|0|||
27576551|NCT02265705|80296175|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
27576552|NCT02265705|80296176|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
27576553|NCT02265705|80296177|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27576554|NCT02265705|80296178|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27576555|NCT02265705|80296179|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27576556|NCT02265705|80296180|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27576557|NCT02265705|80296181|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
27576558|NCT02265705|80296175|FG000|Treatment Period Week 0-24|Physician Decision|1|||
27576559|NCT02265705|80296176|FG001|Treatment Period Week 0-24|Physician Decision|0|||
27576560|NCT02265705|80296177|FG002|Treatment Period Week 0-24|Physician Decision|0|||
27576561|NCT02265705|80296178|FG003|Treatment Period Week 0-24|Physician Decision|0|||
27576562|NCT02265705|80296179|FG004|Treatment Period Week 0-24|Physician Decision|0|||
27576563|NCT02265705|80296180|FG005|Treatment Period Week 0-24|Physician Decision|0|||
27576564|NCT02265705|80296181|FG006|Treatment Period Week 0-24|Physician Decision|0|||
27576565|NCT02265705|80296175|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
27576566|NCT02265705|80296176|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
27576567|NCT02265705|80296177|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27576568|NCT02265705|80296178|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27576569|NCT02265705|80296179|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27576570|NCT02265705|80296180|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27576571|NCT02265705|80296181|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
27576572|NCT02265705|80296175|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
27576573|NCT02265705|80296176|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
27576574|NCT02265705|80296177|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
27576575|NCT02265705|80296178|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
27576576|NCT02265705|80296179|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
27576577|NCT02265705|80296180|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
27576578|NCT02265705|80296181|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
27576579|NCT02265705|80296175|FG000|Rescue Period|Withdrawal by Subject|0|||
27576580|NCT02265705|80296176|FG001|Rescue Period|Withdrawal by Subject|0|||
27576581|NCT02265705|80296177|FG002|Rescue Period|Withdrawal by Subject|1|||
27576582|NCT02265705|80296178|FG003|Rescue Period|Withdrawal by Subject|0|||
27576583|NCT02265705|80296179|FG004|Rescue Period|Withdrawal by Subject|0|||
27981807|NCT02049138|81767168|FG000|Overall Study|Withdrawal by Subject|57|||
27981808|NCT02049138|81767169|FG001|Overall Study|Withdrawal by Subject|21|||
27981809|NCT02049138|81767170|FG002|Overall Study|Withdrawal by Subject|5|||
27576584|NCT02265705|80296180|FG005|Rescue Period|Withdrawal by Subject|0|||
27794077|NCT02181673|81075551|FG001|Up to Week 24|Physician Decision|0|||
27981810|NCT02049138|81767168|FG000|Overall Study|Lost to Follow-up|18|||
27794078|NCT02181673|81075552|FG002|Up to Week 24|Physician Decision|3|||
27794079|NCT02181673|81075550|FG000|Up to Week 24|Withdrawal by Subject|10|||
27981811|NCT02049138|81767169|FG001|Overall Study|Lost to Follow-up|5|||
27794080|NCT02181673|81075551|FG001|Up to Week 24|Withdrawal by Subject|0|||
27794081|NCT02181673|81075552|FG002|Up to Week 24|Withdrawal by Subject|1|||
27576585|NCT02265705|80296181|FG006|Rescue Period|Withdrawal by Subject|0|||
27576586|NCT02265705|80296175|FG000|Rescue Period|Death|0|||
27576587|NCT02265705|80296176|FG001|Rescue Period|Death|0|||
27576588|NCT02265705|80296177|FG002|Rescue Period|Death|1|||
27576589|NCT02265705|80296178|FG003|Rescue Period|Death|0|||
27576590|NCT02265705|80296179|FG004|Rescue Period|Death|0|||
27576591|NCT02265705|80296180|FG005|Rescue Period|Death|0|||
27576592|NCT02265705|80296181|FG006|Rescue Period|Death|0|||
27576593|NCT02265705|80296175|FG000|Rescue Period|Lack of Efficacy|0|||
27576594|NCT02265705|80296176|FG001|Rescue Period|Lack of Efficacy|0|||
27576595|NCT02265705|80296177|FG002|Rescue Period|Lack of Efficacy|1|||
27576596|NCT02265705|80296178|FG003|Rescue Period|Lack of Efficacy|0|||
27576597|NCT02265705|80296179|FG004|Rescue Period|Lack of Efficacy|0|||
27576598|NCT02265705|80296180|FG005|Rescue Period|Lack of Efficacy|0|||
27576599|NCT02265705|80296181|FG006|Rescue Period|Lack of Efficacy|0|||
27576600|NCT02265705|80296175|FG000|Open Label Period|Adverse Event|0|||
27576601|NCT02265705|80296176|FG001|Open Label Period|Adverse Event|0|||
27576602|NCT02265705|80296177|FG002|Open Label Period|Adverse Event|0|||
27576603|NCT02265705|80296178|FG003|Open Label Period|Adverse Event|2|||
27576604|NCT02265705|80296179|FG004|Open Label Period|Adverse Event|2|||
27576605|NCT02265705|80296180|FG005|Open Label Period|Adverse Event|0|||
27576606|NCT02265705|80296181|FG006|Open Label Period|Adverse Event|0|||
27576607|NCT02265705|80296175|FG000|Open Label Period|Physician Decision|0|||
27794082|NCT02181673|81075550|FG000|Up to Week 24|Other|2|||
27794083|NCT02181673|81075551|FG001|Up to Week 24|Other|0|||
27794084|NCT02181673|81075552|FG002|Up to Week 24|Other|3|||
27794085|NCT02181673|81075550|FG000|Up to Week 24|Randomized not Treated|0|||
27794086|NCT02181673|81075551|FG001|Up to Week 24|Randomized not Treated|0|||
27794087|NCT02181673|81075552|FG002|Up to Week 24|Randomized not Treated|1|||
27794088|NCT02181673|81075550|FG000|Week 24-Week 60|Adverse Event|0|||
27981812|NCT02049138|81767170|FG002|Overall Study|Lost to Follow-up|1|||
27981813|NCT02049138|81767168|FG000|Overall Study|Lack of Efficacy|10|||
27981814|NCT02049138|81767169|FG001|Overall Study|Lack of Efficacy|26|||
27981815|NCT02049138|81767170|FG002|Overall Study|Lack of Efficacy|1|||
27981816|NCT02049138|81767168|FG000|Overall Study|Non-Compliance|15|||
27981817|NCT02049138|81767169|FG001|Overall Study|Non-Compliance|6|||
27981818|NCT02049138|81767170|FG002|Overall Study|Non-Compliance|0|||
27981819|NCT02049138|81767168|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
27981820|NCT02049138|81767169|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
27981821|NCT02049138|81767170|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
27576608|NCT02265705|80296176|FG001|Open Label Period|Physician Decision|0|||
27576609|NCT02265705|80296177|FG002|Open Label Period|Physician Decision|0|||
27576610|NCT02265705|80296178|FG003|Open Label Period|Physician Decision|0|||
27576611|NCT02265705|80296179|FG004|Open Label Period|Physician Decision|1|||
27576612|NCT02265705|80296180|FG005|Open Label Period|Physician Decision|0|||
27576613|NCT02265705|80296181|FG006|Open Label Period|Physician Decision|0|||
27576614|NCT02265705|80296175|FG000|Open Label Period|Withdrawal by Subject|0|||
27794089|NCT02181673|81075551|FG001|Week 24-Week 60|Adverse Event|4|||
27794090|NCT02181673|81075552|FG002|Week 24-Week 60|Adverse Event|10|||
27576615|NCT02265705|80296176|FG001|Open Label Period|Withdrawal by Subject|0|||
27576616|NCT02265705|80296177|FG002|Open Label Period|Withdrawal by Subject|0|||
27576617|NCT02265705|80296178|FG003|Open Label Period|Withdrawal by Subject|0|||
27576618|NCT02265705|80296179|FG004|Open Label Period|Withdrawal by Subject|2|||
27576619|NCT02265705|80296180|FG005|Open Label Period|Withdrawal by Subject|0|||
27576620|NCT02265705|80296181|FG006|Open Label Period|Withdrawal by Subject|0|||
27576621|NCT02265705|80296175|FG000|Follow-up Period|Sponsor Decision|0|||
27576622|NCT02265705|80296176|FG001|Follow-up Period|Sponsor Decision|0|||
27673971|NCT01814072|80643445|FG011|Overall Study|Withdrawal by Subject|0|||
27673972|NCT01814072|80643446|FG012|Overall Study|Withdrawal by Subject|1|||
27673973|NCT01814072|80643447|FG013|Overall Study|Withdrawal by Subject|1|||
27673974|NCT01814072|80643448|FG014|Overall Study|Withdrawal by Subject|1|||
27981822|NCT02049138|81767168|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
27981823|NCT02049138|81767169|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27981824|NCT02049138|81767170|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
27981825|NCT02049138|81767168|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
27981826|NCT02049138|81767169|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
27981827|NCT02049138|81767170|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
27981828|NCT02049138|81767168|FG000|Overall Study|Other|15|||
27981829|NCT02049138|81767169|FG001|Overall Study|Other|13|||
27981830|NCT02049138|81767170|FG002|Overall Study|Other|0|||
27673975|NCT01814072|80643449|FG015|Overall Study|Withdrawal by Subject|1|||
27673976|NCT01814072|80643450|FG016|Overall Study|Withdrawal by Subject|0|||
27673977|NCT01814072|80643451|FG017|Overall Study|Withdrawal by Subject|0|||
27981831|NCT02049138|81767168|FG000|Overall Study|Missing|0|||
27981832|NCT02049138|81767169|FG001|Overall Study|Missing|1|||
27981833|NCT02049138|81767170|FG002|Overall Study|Missing|0|||
27981834|NCT01167907|81767171|FG000|Overall Study|Protocol Violation|1|||
27981835|NCT01167907|81767172|FG001|Overall Study|Protocol Violation|0|||
27981836|NCT01167907|81767171|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
27981837|NCT01167907|81767172|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
27981838|NCT02230683|81767178|FG000|Overall Study|Adverse Event|1|||
27981839|NCT00758589|81767179|FG000|Overall Study|Adverse Event|3|||
27981840|NCT00758589|81767180|FG001|Overall Study|Adverse Event|2|||
27981841|NCT00758589|81767181|FG002|Overall Study|Adverse Event|5|||
27981842|NCT00758589|81767182|FG003|Overall Study|Adverse Event|4|||
27981843|NCT00758589|81767179|FG000|Overall Study|Withdrawal by Subject|0|||
27981844|NCT00758589|81767180|FG001|Overall Study|Withdrawal by Subject|1|||
27981845|NCT00758589|81767181|FG002|Overall Study|Withdrawal by Subject|1|||
27981846|NCT00758589|81767182|FG003|Overall Study|Withdrawal by Subject|1|||
27981847|NCT00758589|81767179|FG000|Overall Study|Palm stopped to work|0|||
27981848|NCT00758589|81767180|FG001|Overall Study|Palm stopped to work|0|||
27981849|NCT00758589|81767181|FG002|Overall Study|Palm stopped to work|0|||
27673978|NCT01814072|80643452|FG018|Overall Study|Withdrawal by Subject|0|||
27673979|NCT01814072|80643453|FG019|Overall Study|Withdrawal by Subject|2|||
27673980|NCT01814072|80643454|FG020|Overall Study|Withdrawal by Subject|0|||
27673981|NCT01814072|80643455|FG021|Overall Study|Withdrawal by Subject|0|||
27673982|NCT01814072|80643456|FG022|Overall Study|Withdrawal by Subject|1|||
27673983|NCT01814072|80643457|FG023|Overall Study|Withdrawal by Subject|0|||
27673984|NCT01814072|80643458|FG024|Overall Study|Withdrawal by Subject|2|||
27673985|NCT01814072|80643459|FG025|Overall Study|Withdrawal by Subject|1|||
27673986|NCT01814072|80643460|FG026|Overall Study|Withdrawal by Subject|1|||
27673987|NCT01814072|80643461|FG027|Overall Study|Withdrawal by Subject|2|||
27673988|NCT01814072|80643462|FG028|Overall Study|Withdrawal by Subject|1|||
27673989|NCT01814072|80643463|FG029|Overall Study|Withdrawal by Subject|0|||
27673990|NCT01814072|80643464|FG030|Overall Study|Withdrawal by Subject|0|||
27673991|NCT01814072|80643465|FG031|Overall Study|Withdrawal by Subject|0|||
27673992|NCT00475228|80643466|FG000|Overall Study|Lost to Follow-up|17|||
27673993|NCT00475228|80643467|FG001|Overall Study|Lost to Follow-up|17|||
27673994|NCT01013961|80643468|FG000|Overall Study|Adverse Event|2|||
27673995|NCT01013961|80643469|FG001|Overall Study|Adverse Event|2|||
27794091|NCT02181673|81075550|FG000|Week 24-Week 60|Other|0|||
27794092|NCT02181673|81075551|FG001|Week 24-Week 60|Other|2|||
27794093|NCT02181673|81075552|FG002|Week 24-Week 60|Other|1|||
27981850|NCT00758589|81767182|FG003|Overall Study|Palm stopped to work|1|||
27794094|NCT02181673|81075550|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
27981851|NCT01369680|81767185|FG000|Overall Study|Lost to Follow-up|0|||
27981852|NCT01369680|81767186|FG001|Overall Study|Lost to Follow-up|0|||
27576623|NCT02265705|80296177|FG002|Follow-up Period|Sponsor Decision|0|||
27576624|NCT02265705|80296178|FG003|Follow-up Period|Sponsor Decision|0|||
27576625|NCT02265705|80296179|FG004|Follow-up Period|Sponsor Decision|0|||
27576626|NCT02265705|80296180|FG005|Follow-up Period|Sponsor Decision|1|||
27673996|NCT01013961|80643468|FG000|Overall Study|Withdrawal by Subject|1|||
27981853|NCT01369680|81767187|FG002|Overall Study|Lost to Follow-up|1|||
27981854|NCT01369680|81767188|FG003|Overall Study|Lost to Follow-up|2|||
27794095|NCT02181673|81075551|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
27794096|NCT02181673|81075552|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
27981855|NCT02704689|81767189|FG000|Overall Study|Physician Decision|1|||
27981856|NCT02704689|81767189|FG000|Overall Study|Study device not implanted|2|||
27981857|NCT00885482|81767190|FG000|Overall Study|Pregnancy|1|||
27981858|NCT00885482|81767190|FG000|Overall Study|Lack of Efficacy|1|||
27981859|NCT00885482|81767190|FG000|Overall Study|Death|1|||
27981860|NCT00885482|81767190|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
27981861|NCT02581930|81767193|FG000|Overall Study|Withdrawal by Subject|1|||
27981862|NCT02581930|81767193|FG000|Overall Study|patient declined further treatment|1|||
27981863|NCT00897390|81767196|FG000|Overall Study|Adverse Event|2|||
27981864|NCT00897390|81767196|FG000|Overall Study|No Longer Met Study Criteria|1|||
27981865|NCT00897390|81767196|FG000|Overall Study|Personal Reasons|1|||
27981866|NCT00897390|81767196|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
27981867|NCT00117793|81767197|FG000|Overall Study|Withdrawal by Subject|12|||
27981868|NCT04109976|81767206|FG000|Overall Study|Withdrawal by Subject|1|||
27981869|NCT04109976|81767207|FG001|Overall Study|Withdrawal by Subject|0|||
27981870|NCT02391961|81767210|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
27981871|NCT02391961|81767211|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
27981872|NCT02391961|81767210|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
27981873|NCT02391961|81767211|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
27981874|NCT02391961|81767210|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27981875|NCT02391961|81767211|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27981876|NCT00673881|81767212|FG000|Overall Study|Withdrawal by Subject|1|||
27981877|NCT00286221|81767213|FG000|Overall Study|Protocol Violation|2|||
27981878|NCT00286221|81767214|FG001|Overall Study|Protocol Violation|1|||
27981879|NCT00286221|81767215|FG002|Overall Study|Protocol Violation|6|||
27981880|NCT00286221|81767216|FG003|Overall Study|Protocol Violation|4|||
27981881|NCT00286221|81767213|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
27981882|NCT00286221|81767214|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
27981883|NCT00286221|81767215|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
27981884|NCT00286221|81767216|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
27981885|NCT00286221|81767213|FG000|Overall Study|Inability to trigger PCA|2|||
27981886|NCT00286221|81767214|FG001|Overall Study|Inability to trigger PCA|0|||
27981887|NCT00286221|81767215|FG002|Overall Study|Inability to trigger PCA|0|||
27981888|NCT00286221|81767216|FG003|Overall Study|Inability to trigger PCA|0|||
27981889|NCT00286221|81767213|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
27981890|NCT00286221|81767214|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
27981891|NCT00286221|81767215|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
27981892|NCT00286221|81767216|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
27981893|NCT02434328|81767217|FG000|Overall Study|Adverse Event|9|||
27981894|NCT02434328|81767218|FG001|Overall Study|Adverse Event|4|||
27981895|NCT02434328|81767217|FG000|Overall Study|Lack of Efficacy|0|||
27981896|NCT02434328|81767218|FG001|Overall Study|Lack of Efficacy|2|||
27981897|NCT02434328|81767217|FG000|Overall Study|Physician Decision|0|||
27981898|NCT02434328|81767218|FG001|Overall Study|Physician Decision|1|||
27981899|NCT02434328|81767217|FG000|Overall Study|Withdrawal by Subject|12|||
27981900|NCT02434328|81767218|FG001|Overall Study|Withdrawal by Subject|21|||
27981901|NCT02434328|81767217|FG000|Overall Study|Death|4|||
27981902|NCT02434328|81767218|FG001|Overall Study|Death|7|||
27981903|NCT02434328|81767217|FG000|Overall Study|Lost to Follow-up|1|||
27981904|NCT02434328|81767218|FG001|Overall Study|Lost to Follow-up|6|||
27981905|NCT02434328|81767217|FG000|Overall Study|Other|4|||
27981906|NCT02434328|81767218|FG001|Overall Study|Other|1|||
27794097|NCT02181673|81075550|FG000|Week 24-Week 60|Pregnancy|0|||
27794098|NCT02181673|81075551|FG001|Week 24-Week 60|Pregnancy|0|||
27794099|NCT02181673|81075552|FG002|Week 24-Week 60|Pregnancy|1|||
27794100|NCT02181673|81075550|FG000|Week 24-Week 60|Lack of Efficacy|0|||
27794101|NCT02181673|81075551|FG001|Week 24-Week 60|Lack of Efficacy|0|||
27794102|NCT02181673|81075552|FG002|Week 24-Week 60|Lack of Efficacy|1|||
27794103|NCT02181673|81075550|FG000|Week 24-Week 60|Lost to Follow-up|0|||
27794104|NCT02181673|81075551|FG001|Week 24-Week 60|Lost to Follow-up|0|||
27794105|NCT02181673|81075552|FG002|Week 24-Week 60|Lost to Follow-up|1|||
27794106|NCT02181673|81075550|FG000|Week 24-Week 60|Physician Decision|0|||
27794107|NCT02181673|81075551|FG001|Week 24-Week 60|Physician Decision|0|||
27794108|NCT02181673|81075552|FG002|Week 24-Week 60|Physician Decision|1|||
27794109|NCT00554788|81075553|FG000|Overall Study|Adverse Event|0|||
27794110|NCT00554788|81075554|FG001|Overall Study|Adverse Event|1|||
27794111|NCT00554788|81075555|FG002|Overall Study|Adverse Event|2|||
27794112|NCT00554788|81075553|FG000|Overall Study|Lost to Follow-up|4|||
27981907|NCT00637572|81767221|FG000|Overall Study|Adverse Event|1|||
27981908|NCT00637572|81767222|FG001|Overall Study|Adverse Event|2|||
27576627|NCT02265705|80296181|FG006|Follow-up Period|Sponsor Decision|6|||
27576628|NCT02265705|80296175|FG000|Follow-up Period|Adverse Event|0|||
27794113|NCT00554788|81075554|FG001|Overall Study|Lost to Follow-up|3|||
27794114|NCT00554788|81075555|FG002|Overall Study|Lost to Follow-up|3|||
27794115|NCT00554788|81075553|FG000|Overall Study|Physician Decision|1|||
27794116|NCT00554788|81075554|FG001|Overall Study|Physician Decision|1|||
27794117|NCT00554788|81075555|FG002|Overall Study|Physician Decision|3|||
27981909|NCT00637572|81767221|FG000|Overall Study|Death|0|||
27981910|NCT00637572|81767222|FG001|Overall Study|Death|1|||
27981911|NCT00637572|81767221|FG000|Overall Study|Lost to Follow-up|0|||
27981912|NCT00637572|81767222|FG001|Overall Study|Lost to Follow-up|1|||
27673997|NCT01013961|80643469|FG001|Overall Study|Withdrawal by Subject|0|||
27673998|NCT01013961|80643468|FG000|Overall Study|Physician Decision|0|||
27673999|NCT01013961|80643469|FG001|Overall Study|Physician Decision|1|||
27674000|NCT04120376|80643471|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
27674001|NCT04120376|80643472|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
27674002|NCT03327831|80643475|FG000|Overall Study|Lost to Follow-up|2|||
27674003|NCT01896726|80643476|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
27674004|NCT01896726|80643476|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
27674005|NCT02595372|80643477|FG000|Overall Study|Adverse Event|6|||
27674006|NCT02595372|80643477|FG000|Overall Study|Physician Decision|2|||
27674007|NCT02595372|80643477|FG000|Overall Study|Disease Progression|1|||
27674008|NCT00884650|80643484|FG000|Overall Study|Did not return complete pain diaries|7|||
27674009|NCT00884650|80643485|FG001|Overall Study|Did not return complete pain diaries|7|||
27674010|NCT00884650|80643484|FG000|Overall Study|Admitted Post-Op|1|||
27674011|NCT00884650|80643485|FG001|Overall Study|Admitted Post-Op|0|||
27674012|NCT00884650|80643484|FG000|Overall Study|Femoral Stress Fracture|1|||
27674013|NCT00884650|80643485|FG001|Overall Study|Femoral Stress Fracture|0|||
27674014|NCT00884650|80643484|FG000|Overall Study|Pain Pump Complication|0|||
27674015|NCT00884650|80643485|FG001|Overall Study|Pain Pump Complication|1|||
27981913|NCT00637572|81767221|FG000|Overall Study|Physician Decision|1|||
27981914|NCT00637572|81767222|FG001|Overall Study|Physician Decision|1|||
27981915|NCT00637572|81767221|FG000|Overall Study|Withdrawal by Subject|0|||
27981916|NCT00637572|81767222|FG001|Overall Study|Withdrawal by Subject|2|||
27674016|NCT02636608|80643486|FG000|Overall Study|Failure to Return|4|||
27981917|NCT00637572|81767221|FG000|Overall Study|Illicit Drug Use|1|||
27981918|NCT00637572|81767222|FG001|Overall Study|Illicit Drug Use|0|||
27981919|NCT00581360|81767226|FG000|Overall Study|Withdrawal by Subject|1|||
27981920|NCT01930890|81767227|FG000|Overall Study|Study Termination|14|||
27981921|NCT01930890|81767228|FG001|Overall Study|Study Termination|28|||
27981922|NCT01930890|81767229|FG002|Overall Study|Study Termination|13|||
27981923|NCT01930890|81767230|FG003|Overall Study|Study Termination|25|||
27981924|NCT01930890|81767227|FG000|Overall Study|Death|0|||
27981925|NCT01930890|81767228|FG001|Overall Study|Death|0|||
27981926|NCT01930890|81767229|FG002|Overall Study|Death|0|||
27981927|NCT01930890|81767230|FG003|Overall Study|Death|1|||
27981928|NCT01930890|81767227|FG000|Overall Study|Investigator Decision|0|||
27981929|NCT01930890|81767228|FG001|Overall Study|Investigator Decision|1|||
27981930|NCT01930890|81767229|FG002|Overall Study|Investigator Decision|0|||
27981931|NCT01930890|81767230|FG003|Overall Study|Investigator Decision|0|||
27981932|NCT01930890|81767227|FG000|Overall Study|Consent Withdrawn|0|||
27981933|NCT01930890|81767228|FG001|Overall Study|Consent Withdrawn|3|||
27981934|NCT01930890|81767229|FG002|Overall Study|Consent Withdrawn|0|||
27981935|NCT01930890|81767230|FG003|Overall Study|Consent Withdrawn|1|||
27981936|NCT01930890|81767227|FG000|Overall Study|Adverse Event|0|||
27981937|NCT01930890|81767228|FG001|Overall Study|Adverse Event|1|||
27981938|NCT01930890|81767229|FG002|Overall Study|Adverse Event|0|||
27981939|NCT01930890|81767230|FG003|Overall Study|Adverse Event|0|||
27981940|NCT00530920|81767231|FG000|Overall Study|Randomized but not treated|0|||
27981941|NCT00530920|81767232|FG001|Overall Study|Randomized but not treated|2|||
27981942|NCT00530920|81767233|FG002|Overall Study|Randomized but not treated|0|||
27981943|NCT00530920|81767231|FG000|Overall Study|Adverse Event|0|||
27674017|NCT02636608|80643486|FG000|Overall Study|Insufficient Virological Response|1|||
27674018|NCT02636608|80643486|FG000|Overall Study|Death|3|||
27794118|NCT00554788|81075553|FG000|Overall Study|Withdrawal by Subject|0|||
27794119|NCT00554788|81075554|FG001|Overall Study|Withdrawal by Subject|0|||
27794120|NCT00554788|81075555|FG002|Overall Study|Withdrawal by Subject|1|||
27981944|NCT00530920|81767232|FG001|Overall Study|Adverse Event|0|||
27981945|NCT00530920|81767233|FG002|Overall Study|Adverse Event|3|||
27981946|NCT00530920|81767231|FG000|Overall Study|Withdrawal by Subject|0|||
27981947|NCT00530920|81767232|FG001|Overall Study|Withdrawal by Subject|0|||
27981948|NCT00530920|81767233|FG002|Overall Study|Withdrawal by Subject|1|||
27981949|NCT00499746|81767234|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
27981950|NCT00499746|81767234|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
27981951|NCT00499746|81767234|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
27981952|NCT00499746|81767234|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
27981953|NCT00864851|81767239|FG000|Overall Study|Withdrawal by Subject|0|||
27576629|NCT02265705|80296176|FG001|Follow-up Period|Adverse Event|0|||
27674019|NCT02636608|80643486|FG000|Overall Study|Other|2|||
27576630|NCT02265705|80296177|FG002|Follow-up Period|Adverse Event|0|||
27576631|NCT02265705|80296178|FG003|Follow-up Period|Adverse Event|0|||
27576632|NCT02265705|80296179|FG004|Follow-up Period|Adverse Event|0|||
27576633|NCT02265705|80296180|FG005|Follow-up Period|Adverse Event|0|||
27576634|NCT02265705|80296181|FG006|Follow-up Period|Adverse Event|3|||
27576635|NCT02265705|80296175|FG000|Follow-up Period|Physician Decision|0|||
27576636|NCT02265705|80296176|FG001|Follow-up Period|Physician Decision|0|||
27674020|NCT02636608|80643486|FG000|Overall Study|Did Not Receive Treatment|1|||
27794121|NCT00554788|81075553|FG000|Overall Study|Refusal of further protocol therapy|0|||
27794122|NCT00554788|81075554|FG001|Overall Study|Refusal of further protocol therapy|1|||
27794123|NCT00554788|81075555|FG002|Overall Study|Refusal of further protocol therapy|1|||
27794124|NCT00554788|81075553|FG000|Overall Study|Progressive disease|0|||
27794125|NCT00554788|81075554|FG001|Overall Study|Progressive disease|0|||
27794126|NCT00554788|81075555|FG002|Overall Study|Progressive disease|3|||
27794127|NCT00554788|81075553|FG000|Overall Study|Ineligible|2|||
27794128|NCT00554788|81075554|FG001|Overall Study|Ineligible|0|||
27794129|NCT00554788|81075555|FG002|Overall Study|Ineligible|1|||
27794130|NCT06067191|81075556|FG000|Overall Study|Withdrawal by Subject|0|||
27794131|NCT06067191|81075557|FG001|Overall Study|Withdrawal by Subject|1|||
27794132|NCT02975882|81075560|FG000|Overall Study|Adverse Event|1|||
27794133|NCT02975882|81075561|FG001|Overall Study|Adverse Event|2|||
27674021|NCT00250432|80643487|FG000|Overall Study|Adverse Event|25|||
27794134|NCT02975882|81075562|FG002|Overall Study|Adverse Event|1|||
27576637|NCT02265705|80296177|FG002|Follow-up Period|Physician Decision|0|||
27576638|NCT02265705|80296178|FG003|Follow-up Period|Physician Decision|0|||
27576639|NCT02265705|80296179|FG004|Follow-up Period|Physician Decision|0|||
27576640|NCT02265705|80296180|FG005|Follow-up Period|Physician Decision|0|||
27674022|NCT00250432|80643488|FG001|Overall Study|Adverse Event|29|||
27794135|NCT02975882|81075563|FG003|Overall Study|Adverse Event|1|||
27794136|NCT02975882|81075560|FG000|Overall Study|Death|0|||
27794137|NCT02975882|81075561|FG001|Overall Study|Death|1|||
27794138|NCT02975882|81075562|FG002|Overall Study|Death|0|||
27794139|NCT02975882|81075563|FG003|Overall Study|Death|0|||
27794140|NCT02975882|81075560|FG000|Overall Study|Lack of Efficacy|3|||
27794141|NCT02975882|81075561|FG001|Overall Study|Lack of Efficacy|7|||
27794142|NCT02975882|81075562|FG002|Overall Study|Lack of Efficacy|4|||
27794143|NCT02975882|81075563|FG003|Overall Study|Lack of Efficacy|3|||
27794144|NCT02975882|81075560|FG000|Overall Study|Physician Decision|0|||
27794145|NCT02975882|81075561|FG001|Overall Study|Physician Decision|2|||
27794146|NCT02975882|81075562|FG002|Overall Study|Physician Decision|4|||
27794147|NCT02975882|81075563|FG003|Overall Study|Physician Decision|2|||
27794148|NCT02975882|81075560|FG000|Overall Study|Ineligible|0|||
27794149|NCT02975882|81075561|FG001|Overall Study|Ineligible|1|||
27794150|NCT02975882|81075562|FG002|Overall Study|Ineligible|0|||
27794151|NCT02975882|81075563|FG003|Overall Study|Ineligible|0|||
27794152|NCT03128931|81078993|FG000|Overall Study|Physician Decision|1|||
27576641|NCT02265705|80296181|FG006|Follow-up Period|Physician Decision|1|||
27576642|NCT02265705|80296175|FG000|Follow-up Period|Withdrawal by Subject|0|||
27576643|NCT02265705|80296176|FG001|Follow-up Period|Withdrawal by Subject|0|||
27576644|NCT02265705|80296177|FG002|Follow-up Period|Withdrawal by Subject|0|||
27576645|NCT02265705|80296178|FG003|Follow-up Period|Withdrawal by Subject|0|||
27576646|NCT02265705|80296179|FG004|Follow-up Period|Withdrawal by Subject|0|||
27576647|NCT02265705|80296180|FG005|Follow-up Period|Withdrawal by Subject|0|||
27576648|NCT02265705|80296181|FG006|Follow-up Period|Withdrawal by Subject|1|||
27576649|NCT02556710|80296182|FG000|Overall Study|Surgical treatment|3|||
27576650|NCT02556710|80296183|FG001|Overall Study|Surgical treatment|0|||
27576651|NCT02556710|80296182|FG000|Overall Study|Required proscribed pain medication|2|||
27576652|NCT02556710|80296183|FG001|Overall Study|Required proscribed pain medication|1|||
27576653|NCT02556710|80296182|FG000|Overall Study|Lack of Efficacy|1|||
27576654|NCT02556710|80296183|FG001|Overall Study|Lack of Efficacy|0|||
27576655|NCT02556710|80296182|FG000|Overall Study|Worsening osteoarthritis|1|||
27576656|NCT02556710|80296183|FG001|Overall Study|Worsening osteoarthritis|0|||
27576657|NCT02556710|80296182|FG000|Overall Study|Moved out of state|1|||
27576658|NCT02556710|80296183|FG001|Overall Study|Moved out of state|0|||
27576659|NCT02556710|80296182|FG000|Overall Study|Missing reason|3|||
27576660|NCT02556710|80296183|FG001|Overall Study|Missing reason|1|||
27576661|NCT02556710|80296182|FG000|Overall Study|Pain as lack of efficacy|0|||
27576662|NCT02556710|80296183|FG001|Overall Study|Pain as lack of efficacy|4|||
27576663|NCT03056690|80296186|FG000|Overall Study|Adverse Event|3|||
27981954|NCT00864851|81767240|FG001|Overall Study|Withdrawal by Subject|1|||
27981955|NCT00864851|81767241|FG002|Overall Study|Withdrawal by Subject|0|||
27981956|NCT00864851|81767239|FG000|Overall Study|Physician Decision|1|||
27981957|NCT00864851|81767240|FG001|Overall Study|Physician Decision|0|||
27981958|NCT00864851|81767241|FG002|Overall Study|Physician Decision|0|||
27981959|NCT00864851|81767239|FG000|Overall Study|Death|1|||
27981960|NCT00864851|81767240|FG001|Overall Study|Death|0|||
27981961|NCT00864851|81767241|FG002|Overall Study|Death|0|||
27981962|NCT00864851|81767239|FG000|Overall Study|Patient uncooperative|1|||
27981963|NCT00864851|81767240|FG001|Overall Study|Patient uncooperative|0|||
27981964|NCT00864851|81767241|FG002|Overall Study|Patient uncooperative|0|||
27576664|NCT03056690|80296187|FG001|Overall Study|Adverse Event|2|||
27576665|NCT03056690|80296186|FG000|Overall Study|Lack of Efficacy|1|||
27576666|NCT03056690|80296187|FG001|Overall Study|Lack of Efficacy|2|||
27674023|NCT00250432|80643487|FG000|Overall Study|Lack of Efficacy|2|||
27674024|NCT00250432|80643488|FG001|Overall Study|Lack of Efficacy|1|||
27674025|NCT00250432|80643487|FG000|Overall Study|Lost to Follow-up|6|||
27674026|NCT00250432|80643488|FG001|Overall Study|Lost to Follow-up|5|||
27674027|NCT00250432|80643487|FG000|Overall Study|Patient Moved|0|||
27794153|NCT03128931|81078993|FG000|Overall Study|Equipment Issues|3|||
27576667|NCT03056690|80296186|FG000|Overall Study|Lost to Follow-up|3|||
27576668|NCT03056690|80296187|FG001|Overall Study|Lost to Follow-up|2|||
27674028|NCT00250432|80643488|FG001|Overall Study|Patient Moved|1|||
27794154|NCT03107715|81078994|FG000|Overall Study|did not deliver at the home hospital|4|||
27794155|NCT03107715|81078995|FG001|Overall Study|did not deliver at the home hospital|6|||
27794156|NCT03107715|81078994|FG000|Overall Study|infant stillborn|0|||
27794157|NCT03107715|81078995|FG001|Overall Study|infant stillborn|1|||
27981965|NCT00416715|81767242|FG000|Overall Study|Not evaluable for joint aches|7|||
27981966|NCT00416715|81767242|FG000|Overall Study|Vitamin D levels not evaluable|8|||
27794158|NCT04798027|81078997|FG000|Overall Study|Protocol Violation|0|||
27794159|NCT04798027|81078998|FG001|Overall Study|Protocol Violation|0|||
27794160|NCT04798027|81078999|FG002|Overall Study|Protocol Violation|0|||
27794161|NCT04798027|81079000|FG003|Overall Study|Protocol Violation|0|||
27794162|NCT04798027|81079001|FG004|Overall Study|Protocol Violation|1|||
27794163|NCT04798027|81079002|FG005|Overall Study|Protocol Violation|0|||
27794164|NCT04798027|81079003|FG006|Overall Study|Protocol Violation|0|||
27794165|NCT04798027|81079004|FG007|Overall Study|Protocol Violation|1|||
27794166|NCT04798027|81079005|FG008|Overall Study|Protocol Violation|0|||
27794167|NCT04798027|81078997|FG000|Overall Study|Withdrawal by Subject|1|||
27794168|NCT04798027|81078998|FG001|Overall Study|Withdrawal by Subject|0|||
27794169|NCT04798027|81078999|FG002|Overall Study|Withdrawal by Subject|1|||
27794170|NCT04798027|81079000|FG003|Overall Study|Withdrawal by Subject|1|||
27794171|NCT04798027|81079001|FG004|Overall Study|Withdrawal by Subject|1|||
27794172|NCT04798027|81079002|FG005|Overall Study|Withdrawal by Subject|1|||
27794173|NCT04798027|81079003|FG006|Overall Study|Withdrawal by Subject|3|||
27794174|NCT04798027|81079004|FG007|Overall Study|Withdrawal by Subject|2|||
27794175|NCT04798027|81079005|FG008|Overall Study|Withdrawal by Subject|2|||
27794176|NCT04798027|81078997|FG000|Overall Study|Lost to Follow-up|1|||
27794177|NCT04798027|81078998|FG001|Overall Study|Lost to Follow-up|3|||
27794178|NCT04798027|81078999|FG002|Overall Study|Lost to Follow-up|0|||
27794179|NCT04798027|81079000|FG003|Overall Study|Lost to Follow-up|0|||
27794180|NCT04798027|81079001|FG004|Overall Study|Lost to Follow-up|0|||
27794181|NCT04798027|81079002|FG005|Overall Study|Lost to Follow-up|1|||
27794182|NCT04798027|81079003|FG006|Overall Study|Lost to Follow-up|0|||
27794183|NCT04798027|81079004|FG007|Overall Study|Lost to Follow-up|0|||
27794184|NCT04798027|81079005|FG008|Overall Study|Lost to Follow-up|1|||
27576669|NCT03056690|80296186|FG000|Overall Study|Protocol Violation|2|||
27576670|NCT03056690|80296187|FG001|Overall Study|Protocol Violation|2|||
27576671|NCT03056690|80296186|FG000|Overall Study|Withdrawal by Subject|3|||
27576672|NCT03056690|80296187|FG001|Overall Study|Withdrawal by Subject|6|||
27576673|NCT03056690|80296186|FG000|Overall Study|Non-compliance with Study Drug|1|||
27576674|NCT03056690|80296187|FG001|Overall Study|Non-compliance with Study Drug|0|||
27576675|NCT03056690|80296186|FG000|Overall Study|Miscellaneous|1|||
27576676|NCT03056690|80296187|FG001|Overall Study|Miscellaneous|2|||
27576677|NCT02442830|80296189|FG000|Overall Study|Technical Failure|0|||
27576678|NCT02442830|80296190|FG001|Overall Study|Technical Failure|1|||
27576679|NCT05204134|80296191|FG000|Overall Study|Withdrawal by Subject|3|||
27794185|NCT04798027|81078997|FG000|Overall Study|Withdrawal by Sponsor|8|||
27794186|NCT04798027|81078998|FG001|Overall Study|Withdrawal by Sponsor|22|||
27794187|NCT04798027|81078999|FG002|Overall Study|Withdrawal by Sponsor|9|||
27576680|NCT05204134|80296191|FG000|Overall Study|Physician Decision|1|||
27576681|NCT03096782|80296194|FG000|Overall Study|Death|1|||
27794188|NCT04798027|81079000|FG003|Overall Study|Withdrawal by Sponsor|26|||
27794189|NCT04798027|81079001|FG004|Overall Study|Withdrawal by Sponsor|24|||
27794190|NCT04798027|81079002|FG005|Overall Study|Withdrawal by Sponsor|11|||
27794191|NCT04798027|81079003|FG006|Overall Study|Withdrawal by Sponsor|25|||
27868303|NCT00111241|81353782|FG001|Overall Study|Adverse Event|0|||
27868304|NCT04578535|81353787|FG000|Overall Study|Lost to Follow-up|1|||
27868305|NCT04578535|81353788|FG001|Overall Study|Lost to Follow-up|0|||
27868306|NCT04578535|81353789|FG002|Overall Study|Lost to Follow-up|0|||
27868307|NCT04578535|81353790|FG003|Overall Study|Lost to Follow-up|1|||
27868308|NCT04578535|81353791|FG004|Overall Study|Lost to Follow-up|0|||
27868309|NCT04578535|81353792|FG005|Overall Study|Lost to Follow-up|2|||
27868310|NCT04578535|81353787|FG000|Overall Study|Pregnancy|1|||
27868311|NCT04578535|81353788|FG001|Overall Study|Pregnancy|0|||
27868312|NCT04578535|81353789|FG002|Overall Study|Pregnancy|0|||
27868313|NCT04578535|81353790|FG003|Overall Study|Pregnancy|0|||
27868314|NCT04578535|81353791|FG004|Overall Study|Pregnancy|0|||
27868315|NCT04578535|81353792|FG005|Overall Study|Pregnancy|0|||
27868316|NCT04578535|81353787|FG000|Overall Study|Withdrawal by Subject|0|||
27868317|NCT04578535|81353788|FG001|Overall Study|Withdrawal by Subject|0|||
27868318|NCT04578535|81353789|FG002|Overall Study|Withdrawal by Subject|0|||
27868319|NCT04578535|81353790|FG003|Overall Study|Withdrawal by Subject|1|||
27868320|NCT04578535|81353791|FG004|Overall Study|Withdrawal by Subject|1|||
27868321|NCT04578535|81353792|FG005|Overall Study|Withdrawal by Subject|5|||
27868322|NCT04578535|81353787|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
27868323|NCT04578535|81353788|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
27868324|NCT04578535|81353789|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
27868325|NCT04578535|81353790|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
27868326|NCT04578535|81353791|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
27868327|NCT04578535|81353792|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
27868328|NCT00524420|81353798|FG000|Overall Study|Lack of Efficacy|1|||
27868329|NCT00524420|81353799|FG001|Overall Study|Lack of Efficacy|0|||
27868330|NCT02508935|81353800|FG000|Overall Study|Withdrawal by Subject|1|||
27868331|NCT02508935|81353800|FG000|Overall Study|Withdrawal by Caregiver|8|||
27868332|NCT02508935|81353800|FG000|Overall Study|Pain Score <4|1|||
27868333|NCT02508935|81353800|FG000|Overall Study|Emesis|3|||
27868334|NCT02508935|81353800|FG000|Overall Study|Adverse Event|3|||
27868335|NCT02508935|81353800|FG000|Overall Study|Protocol Violation|1|||
27868336|NCT02508935|81353800|FG000|Overall Study|Physician Decision|1|||
27868337|NCT02508935|81353800|FG000|Overall Study|Trial terminated by sponsor|5|||
27868338|NCT02676765|81353801|FG000|Overall Study|Lost to Follow-up|0|||
27868339|NCT02676765|81353802|FG001|Overall Study|Lost to Follow-up|1|||
27868340|NCT02756611|81353808|FG000|Overall Study|Death|70|||
27868341|NCT02756611|81353808|FG000|Overall Study|Withdrawal by Subject|2|||
27868342|NCT02756611|81353808|FG000|Overall Study|Lost to Follow-up|3|||
27868343|NCT02756611|81353808|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
27868344|NCT02756611|81353808|FG000|Overall Study|Other|10|||
27868345|NCT01514461|81353813|FG000|Overall Study|Adverse Event|2|||
27868346|NCT01514461|81353814|FG001|Overall Study|Adverse Event|1|||
27868347|NCT01514461|81353815|FG002|Overall Study|Adverse Event|3|||
27868348|NCT01514461|81353813|FG000|Overall Study|Physician Decision|1|||
27868349|NCT01514461|81353814|FG001|Overall Study|Physician Decision|1|||
27868350|NCT01514461|81353815|FG002|Overall Study|Physician Decision|0|||
27868351|NCT01514461|81353813|FG000|Overall Study|Patient/guardian decision|1|||
27868352|NCT01514461|81353814|FG001|Overall Study|Patient/guardian decision|1|||
27868353|NCT01514461|81353815|FG002|Overall Study|Patient/guardian decision|1|||
27868354|NCT01514461|81353813|FG000|Overall Study|Death|1|||
27868355|NCT01514461|81353814|FG001|Overall Study|Death|0|||
27868356|NCT01514461|81353815|FG002|Overall Study|Death|0|||
27868357|NCT03685344|81353816|FG000|Overall Study|Withdrawal by Subject|1|||
27868358|NCT03685344|81353817|FG001|Overall Study|Withdrawal by Subject|1|||
27868359|NCT03685344|81353818|FG002|Overall Study|Withdrawal by Subject|2|||
27981967|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
27981968|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
27981969|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
27981970|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
27981971|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
27981972|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
27981973|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
27981974|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
27981975|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
27981976|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
27981977|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
27868360|NCT03685344|81353819|FG003|Overall Study|Withdrawal by Subject|0|||
27868361|NCT03685344|81353816|FG000|Overall Study|Physician Decision|1|||
27868362|NCT03685344|81353817|FG001|Overall Study|Physician Decision|1|||
27868363|NCT03685344|81353818|FG002|Overall Study|Physician Decision|5|||
27868364|NCT03685344|81353819|FG003|Overall Study|Physician Decision|0|||
27868365|NCT03685344|81353816|FG000|Overall Study|Death|1|||
27868366|NCT03685344|81353817|FG001|Overall Study|Death|1|||
27981978|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
27981979|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
27981980|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
27981981|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
27981982|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
27981983|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
27981984|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
27981985|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
27981986|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
27981987|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
27981988|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
27981989|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
27981990|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
27981991|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
27981992|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
27981993|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
27981994|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
27981995|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
27981996|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
27981997|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
27981998|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
27981999|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
27868367|NCT03685344|81353818|FG002|Overall Study|Death|0|||
27868368|NCT03685344|81353819|FG003|Overall Study|Death|0|||
27982000|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
27794192|NCT04798027|81079004|FG007|Overall Study|Withdrawal by Sponsor|26|||
27794193|NCT04798027|81079005|FG008|Overall Study|Withdrawal by Sponsor|11|||
27794194|NCT01656850|81079013|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
27794195|NCT01656850|81079014|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
27794196|NCT00538473|81079017|FG000|Overall Study|Adverse Event|1|||
27982001|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
27982002|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
27982003|NCT02198794|81767243|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
27982004|NCT02198794|81767244|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
27794197|NCT00538473|81079018|FG001|Overall Study|Adverse Event|0|||
27794198|NCT00646282|81079019|FG000|Overall Study|Protocol terminated|4|||
27794199|NCT00646282|81079020|FG001|Overall Study|Protocol terminated|4|||
27794200|NCT05168657|81079021|FG000|Overall Study|Adverse Event|0|||
27794201|NCT05168657|81079022|FG001|Overall Study|Adverse Event|0|||
27794202|NCT05168657|81079023|FG002|Overall Study|Adverse Event|1|||
27794203|NCT05168657|81079024|FG003|Overall Study|Adverse Event|0|||
27794204|NCT05168657|81079025|FG004|Overall Study|Adverse Event|0|||
27794205|NCT05168657|81079026|FG005|Overall Study|Adverse Event|0|||
27794206|NCT05168657|81079027|FG006|Overall Study|Adverse Event|0|||
27794207|NCT05168657|81079028|FG007|Overall Study|Adverse Event|0|||
27794208|NCT00592007|81079029|FG000|Overall Study|Withdrawal by Subject|1|||
27794209|NCT00592007|81079029|FG000|Overall Study|patient ineligible (out of lab range)|1|||
27794210|NCT00054275|81079030|FG000|Overall Study|Withdrawal by Subject|4|||
27794211|NCT00054275|81079030|FG000|Overall Study|Adverse Event|5|||
27794212|NCT00054275|81079030|FG000|Overall Study|Progressive disease in cycle 1|1|||
27794213|NCT00054275|81079030|FG000|Overall Study|Physician Decision|1|||
27794214|NCT03387423|81079031|FG000|Overall Study|Lost to Follow-up|16|||
27794215|NCT03387423|81079032|FG001|Overall Study|Lost to Follow-up|12|||
27794216|NCT03387423|81079033|FG002|Overall Study|Lost to Follow-up|1|||
27794217|NCT03387423|81079034|FG003|Overall Study|Lost to Follow-up|0|||
27794218|NCT03387423|81079031|FG000|Overall Study|Other|0|||
27868369|NCT00770328|81353820|FG000|Overall Study|Adverse Event|11|||
27868370|NCT00770328|81353821|FG001|Overall Study|Adverse Event|2|||
27794219|NCT03387423|81079032|FG001|Overall Study|Other|3|||
27794220|NCT03387423|81079033|FG002|Overall Study|Other|0|||
27794221|NCT03387423|81079034|FG003|Overall Study|Other|0|||
27794222|NCT03387423|81079031|FG000|Overall Study|Administrative Reason|166|||
27794223|NCT03387423|81079032|FG001|Overall Study|Administrative Reason|89|||
27794224|NCT03387423|81079033|FG002|Overall Study|Administrative Reason|17|||
27794225|NCT03387423|81079034|FG003|Overall Study|Administrative Reason|19|||
27794226|NCT03387423|81079031|FG000|Overall Study|Revocation Consent|76|||
27794227|NCT03387423|81079032|FG001|Overall Study|Revocation Consent|32|||
27794228|NCT03387423|81079033|FG002|Overall Study|Revocation Consent|3|||
27794229|NCT03387423|81079034|FG003|Overall Study|Revocation Consent|5|||
27794230|NCT00564486|81079035|FG000|Overall Study|Adverse Event|0|||
27794231|NCT00564486|81079036|FG001|Overall Study|Adverse Event|1|||
27794232|NCT00564486|81079037|FG002|Overall Study|Adverse Event|0|||
27868371|NCT00770328|81353820|FG000|Overall Study|Lost to Follow-up|2|||
27868372|NCT00770328|81353821|FG001|Overall Study|Lost to Follow-up|2|||
27868373|NCT04841577|81353823|FG000|Overall Study|Adverse Event|5|||
27868374|NCT04841577|81353824|FG001|Overall Study|Adverse Event|10|||
27868375|NCT04841577|81353823|FG000|Overall Study|Lost to Follow-up|8|||
27868376|NCT04841577|81353824|FG001|Overall Study|Lost to Follow-up|7|||
27868377|NCT04841577|81353823|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
27868378|NCT04841577|81353824|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
27868379|NCT04841577|81353823|FG000|Overall Study|Other|0|||
27868380|NCT04841577|81353824|FG001|Overall Study|Other|1|||
27868381|NCT00098774|81353825|FG000|Overall Study|Adverse Event|2|||
27868382|NCT00098774|81353825|FG000|Overall Study|Disease Progression|9|||
27868383|NCT00098774|81353825|FG000|Overall Study|Withdrawal by Subject|1|||
27868384|NCT00098774|81353825|FG000|Overall Study|Failed (to respond) during induction|4|||
27868385|NCT00098774|81353825|FG000|Overall Study|Physician Decision|2|||
27868386|NCT01625988|81353826|FG000|Overall Study|Lost to Follow-up|5|||
27868387|NCT01625988|81353827|FG001|Overall Study|Lost to Follow-up|6|||
27794233|NCT00564486|81079038|FG003|Overall Study|Adverse Event|0|||
27868388|NCT01625988|81353826|FG000|Overall Study|Withdrawal by Subject|8|||
27868389|NCT01625988|81353827|FG001|Overall Study|Withdrawal by Subject|3|||
27868390|NCT01625988|81353826|FG000|Overall Study|Adverse Event|0|||
27868391|NCT01625988|81353827|FG001|Overall Study|Adverse Event|1|||
27868392|NCT01625988|81353826|FG000|Overall Study|Lack of Efficacy|0|||
27868393|NCT01625988|81353827|FG001|Overall Study|Lack of Efficacy|1|||
27868394|NCT01625988|81353826|FG000|Overall Study|Randomized Inappropriately|1|||
27868395|NCT01625988|81353827|FG001|Overall Study|Randomized Inappropriately|0|||
27868396|NCT01625988|81353826|FG000|Overall Study|Protocol Violation|0|||
27868397|NCT01625988|81353827|FG001|Overall Study|Protocol Violation|2|||
27868398|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
27868399|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
27868400|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
27868401|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
27868402|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
27868403|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
27868404|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
27868405|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
27868406|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
27794234|NCT00564486|81079035|FG000|Overall Study|Withdrawal by Subject|4|||
27794235|NCT00564486|81079036|FG001|Overall Study|Withdrawal by Subject|0|||
27794236|NCT00564486|81079037|FG002|Overall Study|Withdrawal by Subject|0|||
27868407|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
27794237|NCT00564486|81079038|FG003|Overall Study|Withdrawal by Subject|5|||
27794238|NCT00564486|81079035|FG000|Overall Study|Subject refused to have blood drawn|0|||
27794239|NCT00564486|81079036|FG001|Overall Study|Subject refused to have blood drawn|0|||
27794240|NCT00564486|81079037|FG002|Overall Study|Subject refused to have blood drawn|1|||
27868408|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
27868409|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
27794241|NCT00564486|81079038|FG003|Overall Study|Subject refused to have blood drawn|0|||
27868410|NCT02422797|81353830|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
27868411|NCT02422797|81353831|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
27868412|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
27868413|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
27868414|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
27868415|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
27868416|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
27868417|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
27868418|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
27868419|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
27868420|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
27868421|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
27868422|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
27868423|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
27868424|NCT02422797|81353830|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
27868425|NCT02422797|81353831|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
27868426|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
27868427|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
27868428|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
27868429|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
27868430|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
27868431|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
27868432|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
27868433|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
27868434|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
27868435|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
27868436|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
27868437|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
27868438|NCT02422797|81353830|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
27868439|NCT02422797|81353831|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
27868440|NCT03200717|81353832|FG000|Overall Study|Progressive disease|24|||
27868441|NCT03200717|81353833|FG001|Overall Study|Progressive disease|5|||
27868442|NCT03200717|81353832|FG000|Overall Study|Adverse Event|11|||
27868443|NCT03200717|81353833|FG001|Overall Study|Adverse Event|8|||
27868444|NCT03200717|81353832|FG000|Overall Study|Physician Decision|3|||
27868445|NCT03200717|81353833|FG001|Overall Study|Physician Decision|2|||
27868446|NCT03200717|81353832|FG000|Overall Study|Death|2|||
27868447|NCT03200717|81353833|FG001|Overall Study|Death|0|||
27868448|NCT03200717|81353832|FG000|Overall Study|Subject/Guardian Decision|1|||
27868449|NCT03200717|81353833|FG001|Overall Study|Subject/Guardian Decision|0|||
27982005|NCT02198794|81767245|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
27982006|NCT02198794|81767246|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
27982007|NCT02198794|81767243|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
27982008|NCT02198794|81767244|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
27982009|NCT02198794|81767245|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
27982010|NCT02198794|81767246|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
27982011|NCT02198794|81767243|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
27982012|NCT02198794|81767244|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
27982013|NCT02198794|81767245|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
27982014|NCT02198794|81767246|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
27982015|NCT02198794|81767243|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
27982016|NCT02198794|81767244|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
27982017|NCT02198794|81767245|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
27982018|NCT02198794|81767246|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
27982019|NCT02198794|81767243|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
27982020|NCT02198794|81767244|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
27982021|NCT02198794|81767245|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
27982022|NCT02198794|81767246|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
27982023|NCT02198794|81767243|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
27982024|NCT02198794|81767244|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
27868450|NCT03910673|81353834|FG000|Overall Study|Adverse Event|0|||
27868451|NCT03910673|81353835|FG001|Overall Study|Adverse Event|0|||
27868452|NCT03910673|81353836|FG002|Overall Study|Adverse Event|0|||
27868453|NCT03910673|81353837|FG003|Overall Study|Adverse Event|2|||
27868454|NCT03910673|81353838|FG004|Overall Study|Adverse Event|0|||
27868455|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
27868456|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
27868457|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
27868458|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Death|1|||
27868459|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Death|3|||
27868460|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Death|1|||
27868461|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
27868462|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
27868463|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
27868464|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
27868465|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
27868466|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
27868467|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
27868468|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
27868469|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
27868470|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
27868471|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
27868472|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
27868473|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
27868474|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
27868475|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
27868476|NCT00299130|81353840|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
27868477|NCT00299130|81353841|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
27868478|NCT00299130|81353842|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
27868479|NCT00299130|81353840|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
27982025|NCT02198794|81767245|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
27982026|NCT02198794|81767246|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
27982027|NCT01443130|81767247|FG000|Overall Study|Lost to Follow-up|44|||
27982028|NCT01443130|81767248|FG001|Overall Study|Lost to Follow-up|42|||
27982029|NCT01443130|81767249|FG002|Overall Study|Lost to Follow-up|50|||
27982030|NCT01443130|81767250|FG003|Overall Study|Lost to Follow-up|23|||
27982031|NCT01443130|81767251|FG004|Overall Study|Lost to Follow-up|25|||
27982032|NCT01443130|81767252|FG005|Overall Study|Lost to Follow-up|21|||
27982033|NCT01443130|81767247|FG000|Overall Study|Death|0|||
27982034|NCT01443130|81767248|FG001|Overall Study|Death|1|||
27982035|NCT01443130|81767249|FG002|Overall Study|Death|0|||
27982036|NCT01443130|81767250|FG003|Overall Study|Death|7|||
27982037|NCT01443130|81767251|FG004|Overall Study|Death|10|||
27982038|NCT01443130|81767252|FG005|Overall Study|Death|8|||
27982039|NCT01443130|81767247|FG000|Overall Study|Adverse Event|2|||
27982040|NCT01443130|81767248|FG001|Overall Study|Adverse Event|1|||
27982041|NCT01443130|81767249|FG002|Overall Study|Adverse Event|1|||
27982042|NCT01443130|81767250|FG003|Overall Study|Adverse Event|0|||
27982043|NCT01443130|81767251|FG004|Overall Study|Adverse Event|0|||
27982044|NCT01443130|81767252|FG005|Overall Study|Adverse Event|0|||
27982045|NCT01443130|81767247|FG000|Overall Study|Protocol Violation|2|||
27982046|NCT01443130|81767248|FG001|Overall Study|Protocol Violation|1|||
27982047|NCT01443130|81767249|FG002|Overall Study|Protocol Violation|3|||
27982048|NCT01443130|81767250|FG003|Overall Study|Protocol Violation|2|||
27982049|NCT01443130|81767251|FG004|Overall Study|Protocol Violation|2|||
27982050|NCT01443130|81767252|FG005|Overall Study|Protocol Violation|3|||
27982051|NCT01443130|81767247|FG000|Overall Study|Withdrawal by Subject|15|||
27982052|NCT01443130|81767248|FG001|Overall Study|Withdrawal by Subject|14|||
27982053|NCT01443130|81767249|FG002|Overall Study|Withdrawal by Subject|12|||
27982054|NCT01443130|81767250|FG003|Overall Study|Withdrawal by Subject|7|||
27982055|NCT01443130|81767251|FG004|Overall Study|Withdrawal by Subject|7|||
27982056|NCT01443130|81767252|FG005|Overall Study|Withdrawal by Subject|2|||
27982057|NCT01443130|81767247|FG000|Overall Study|Death of Subject's Infant|5|||
27982058|NCT01443130|81767248|FG001|Overall Study|Death of Subject's Infant|10|||
27982059|NCT01443130|81767249|FG002|Overall Study|Death of Subject's Infant|11|||
27982060|NCT01443130|81767250|FG003|Overall Study|Death of Subject's Infant|0|||
27982061|NCT01443130|81767251|FG004|Overall Study|Death of Subject's Infant|0|||
27982062|NCT01443130|81767252|FG005|Overall Study|Death of Subject's Infant|0|||
27982063|NCT02976103|81767253|FG000|Overall Study|Withdrawal by Subject|1|||
27868480|NCT00299130|81353841|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
27868481|NCT00299130|81353842|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
27868482|NCT00299130|81353840|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
27868483|NCT00299130|81353841|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
27868484|NCT00299130|81353842|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
27868485|NCT00299130|81353840|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
27868486|NCT00299130|81353841|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
27868487|NCT00299130|81353842|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
27868488|NCT00299130|81353840|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
27868489|NCT00299130|81353841|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
27868490|NCT00299130|81353842|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
27868491|NCT00299130|81353840|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
27982064|NCT02976103|81767254|FG001|Overall Study|Withdrawal by Subject|0|||
27982065|NCT02976103|81767253|FG000|Overall Study|Lost to Follow-up|12|||
27982066|NCT02976103|81767254|FG001|Overall Study|Lost to Follow-up|8|||
27982067|NCT02356887|81767261|FG000|Overall Study|poor compliance|2|||
27982068|NCT03002311|81767262|FG000|Overall Study|Lost to Follow-up|13|||
27982069|NCT03002311|81767263|FG001|Overall Study|Lost to Follow-up|26|||
27982070|NCT03002311|81767262|FG000|Overall Study|Referral provider called to schedule app|3|||
27982071|NCT03002311|81767263|FG001|Overall Study|Referral provider called to schedule app|3|||
27982072|NCT03002311|81767262|FG000|Overall Study|Physician Decision|3|||
27982073|NCT03002311|81767263|FG001|Overall Study|Physician Decision|1|||
27982074|NCT00308074|81767264|FG000|Overall Study|Withdrawal by Subject|1|||
27982075|NCT00798317|81767265|FG000|Overall Study|Physician Decision|0|||
27982076|NCT00798317|81767266|FG001|Overall Study|Physician Decision|1|||
27982077|NCT00798317|81767265|FG000|Overall Study|Withdrawal by Subject|5|||
27982078|NCT00798317|81767266|FG001|Overall Study|Withdrawal by Subject|4|||
27982079|NCT00798317|81767265|FG000|Overall Study|Lost to Follow-up|2|||
27982080|NCT00798317|81767266|FG001|Overall Study|Lost to Follow-up|2|||
27982081|NCT00798317|81767265|FG000|Overall Study|Adverse Event|2|||
27982082|NCT00798317|81767266|FG001|Overall Study|Adverse Event|0|||
27982083|NCT00798317|81767265|FG000|Overall Study|Death|1|||
27982084|NCT00798317|81767266|FG001|Overall Study|Death|0|||
27982085|NCT01114360|81767267|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
27982086|NCT01114360|81767268|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
27982087|NCT03883113|81767269|FG000|Overall Study|Physician Decision|4|||
27982088|NCT03883113|81767270|FG001|Overall Study|Physician Decision|2|||
27982089|NCT03883113|81767269|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
27982090|NCT03883113|81767270|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
27982091|NCT03883113|81767269|FG000|Overall Study|Pregnancy|1|||
27982092|NCT03883113|81767270|FG001|Overall Study|Pregnancy|0|||
27982093|NCT03883113|81767269|FG000|Overall Study|Adverse Event|0|||
27982094|NCT03883113|81767270|FG001|Overall Study|Adverse Event|1|||
27982095|NCT03883113|81767269|FG000|Overall Study|Withdrawal by Subject|1|||
27982096|NCT03883113|81767270|FG001|Overall Study|Withdrawal by Subject|2|||
27982097|NCT03883113|81767269|FG000|Overall Study|Lost to Follow-up|1|||
27982098|NCT03883113|81767270|FG001|Overall Study|Lost to Follow-up|0|||
27982099|NCT03263780|81767275|FG000|Overall Study|Withdrawal by Subject|3|||
27982100|NCT03263780|81767275|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
27982101|NCT03131596|81767278|FG000|Overall Study|Protocol Violation|3|||
27982102|NCT03131596|81767279|FG001|Overall Study|Protocol Violation|3|||
27982103|NCT03131596|81767278|FG000|Overall Study|Lost to Follow-up|3|||
27982104|NCT03131596|81767279|FG001|Overall Study|Lost to Follow-up|0|||
27982105|NCT02759315|81767280|FG000|Overall Study|Adverse Event|0|||
27982106|NCT02759315|81767281|FG001|Overall Study|Adverse Event|0|||
27982107|NCT02759315|81767282|FG002|Overall Study|Adverse Event|0|||
27982108|NCT02759315|81767283|FG003|Overall Study|Adverse Event|1|||
27982109|NCT02759315|81767284|FG004|Overall Study|Adverse Event|0|||
27868492|NCT00299130|81353841|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
27982110|NCT02759315|81767280|FG000|Overall Study|Death|0|||
27982111|NCT02759315|81767281|FG001|Overall Study|Death|0|||
27982112|NCT02759315|81767282|FG002|Overall Study|Death|1|||
27982113|NCT02759315|81767283|FG003|Overall Study|Death|0|||
27982114|NCT02759315|81767284|FG004|Overall Study|Death|0|||
27982115|NCT02759315|81767280|FG000|Overall Study|Lost to Follow-up|2|||
27982116|NCT02759315|81767281|FG001|Overall Study|Lost to Follow-up|0|||
27982117|NCT02759315|81767282|FG002|Overall Study|Lost to Follow-up|4|||
27982118|NCT02759315|81767283|FG003|Overall Study|Lost to Follow-up|0|||
27982119|NCT02759315|81767284|FG004|Overall Study|Lost to Follow-up|0|||
27982120|NCT02759315|81767280|FG000|Overall Study|Protocol Violation|0|||
27982121|NCT02759315|81767281|FG001|Overall Study|Protocol Violation|1|||
27794242|NCT00564486|81079035|FG000|Overall Study|Lost to Follow-up|3|||
27982122|NCT02759315|81767282|FG002|Overall Study|Protocol Violation|0|||
27982123|NCT02759315|81767283|FG003|Overall Study|Protocol Violation|0|||
27982124|NCT02759315|81767284|FG004|Overall Study|Protocol Violation|0|||
27982125|NCT02759315|81767280|FG000|Overall Study|Study terminated prior to completion|2|||
27982126|NCT02759315|81767281|FG001|Overall Study|Study terminated prior to completion|0|||
27982127|NCT02759315|81767282|FG002|Overall Study|Study terminated prior to completion|5|||
27982128|NCT02759315|81767283|FG003|Overall Study|Study terminated prior to completion|0|||
27982129|NCT02759315|81767284|FG004|Overall Study|Study terminated prior to completion|1|||
27982130|NCT04957758|81767285|FG000|Overall Study|Adverse Event|1|||
27982131|NCT04957758|81767286|FG001|Overall Study|Adverse Event|0|||
27982132|NCT04957758|81767285|FG000|Overall Study|Lost to Follow-up|0|||
27982133|NCT04957758|81767286|FG001|Overall Study|Lost to Follow-up|2|||
27982134|NCT04957758|81767285|FG000|Overall Study|Withdrawal by Subject|4|||
27982135|NCT04957758|81767286|FG001|Overall Study|Withdrawal by Subject|2|||
27982136|NCT04957758|81767285|FG000|Overall Study|Protocol Violation|0|||
27982137|NCT04957758|81767286|FG001|Overall Study|Protocol Violation|1|||
27982138|NCT02966015|81767287|FG000|Inclusion Visit|did not answer questionnaire|8|||
27982139|NCT02966015|81767288|FG001|Inclusion Visit|did not answer questionnaire|3|||
27982140|NCT01739803|81767289|FG000|Overall Study|Lost to Follow-up|9|||
27982141|NCT01739803|81767290|FG001|Overall Study|Lost to Follow-up|6|||
27982142|NCT00548717|81767291|FG000|Overall Study|Death|5|||
27982143|NCT00548717|81767292|FG001|Overall Study|Death|2|||
27982144|NCT00548717|81767291|FG000|Overall Study|Relapse|3|||
27982145|NCT00548717|81767292|FG001|Overall Study|Relapse|0|||
27982146|NCT00548717|81767291|FG000|Overall Study|Alternative treatment for GVHD|1|||
27982147|NCT00548717|81767292|FG001|Overall Study|Alternative treatment for GVHD|0|||
27982148|NCT05545644|81767298|FG000|Overall Study|Lost to Follow-up|4|||
27982149|NCT05545644|81767299|FG001|Overall Study|Lost to Follow-up|3|||
27982150|NCT01498185|81767301|FG000|Overall Study|Adverse Event|0|||
27982151|NCT01498185|81767302|FG001|Overall Study|Adverse Event|0|||
27982152|NCT01498185|81767303|FG002|Overall Study|Adverse Event|0|||
27982153|NCT01498185|81767304|FG003|Overall Study|Adverse Event|1|||
27982154|NCT01498185|81767305|FG004|Overall Study|Adverse Event|0|||
27982155|NCT01498185|81767301|FG000|Overall Study|Withdrawal by Subject|1|||
27982156|NCT01498185|81767302|FG001|Overall Study|Withdrawal by Subject|1|||
27982157|NCT01498185|81767303|FG002|Overall Study|Withdrawal by Subject|0|||
27982158|NCT01498185|81767304|FG003|Overall Study|Withdrawal by Subject|2|||
27982159|NCT01498185|81767305|FG004|Overall Study|Withdrawal by Subject|1|||
27982160|NCT01498185|81767301|FG000|Overall Study|No longer met criteria, etc|0|||
27982161|NCT01498185|81767302|FG001|Overall Study|No longer met criteria, etc|0|||
27982162|NCT01498185|81767303|FG002|Overall Study|No longer met criteria, etc|0|||
27982163|NCT01498185|81767304|FG003|Overall Study|No longer met criteria, etc|0|||
27982164|NCT01498185|81767305|FG004|Overall Study|No longer met criteria, etc|2|||
27982165|NCT03134183|81767306|FG000|Overall Study|Withdrawal by Subject|1|||
27982166|NCT03134183|81767307|FG001|Overall Study|Withdrawal by Subject|1|||
27982167|NCT03266172|81767308|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
27982168|NCT03266172|81767309|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
27982169|NCT03266172|81767310|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
27982170|NCT03266172|81767308|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
27982171|NCT03266172|81767309|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
27982172|NCT03266172|81767310|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
27982173|NCT03266172|81767308|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
27982174|NCT03266172|81767309|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
27674029|NCT00250432|80643487|FG000|Overall Study|Protocol Violation|0|||
27674030|NCT00250432|80643488|FG001|Overall Study|Protocol Violation|3|||
27674031|NCT00250432|80643487|FG000|Overall Study|Withdrawal by Subject|6|||
27982175|NCT03266172|81767310|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
27982176|NCT03266172|81767308|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
27982177|NCT03266172|81767309|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
27982178|NCT03266172|81767310|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
27982179|NCT03266172|81767308|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
27982180|NCT03266172|81767309|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
27982181|NCT03266172|81767310|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
27982182|NCT03266172|81767308|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
27982183|NCT03266172|81767309|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
27982184|NCT03266172|81767310|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
27982185|NCT05219669|81767314|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
27982186|NCT05219669|81767315|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
27982187|NCT05219669|81767316|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
27982188|NCT05219669|81767317|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
27982189|NCT05219669|81767318|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
27982190|NCT05219669|81767319|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
27982191|NCT00514020|81767320|FG000|Overall Study|Adverse Event|6|||
27982192|NCT00514020|81767320|FG000|Overall Study|Withdrawal by Subject|3|||
27982193|NCT00514020|81767320|FG000|Overall Study|Physician Decision|1|||
27982194|NCT00514020|81767320|FG000|Overall Study|disease progression|9|||
27868493|NCT00299130|81353842|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
27868494|NCT00299130|81353840|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
27868495|NCT00299130|81353841|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
27868496|NCT00299130|81353842|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
27868497|NCT00299130|81353840|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
27868498|NCT00299130|81353841|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
27868499|NCT00299130|81353842|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
27868500|NCT00299130|81353840|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
27868501|NCT00299130|81353841|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
27868502|NCT00299130|81353842|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
27868503|NCT00299130|81353840|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
27868504|NCT00299130|81353841|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
27868505|NCT00299130|81353842|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
27982195|NCT00514020|81767320|FG000|Overall Study|other complicating disease|2|||
27982196|NCT00514020|81767320|FG000|Overall Study|patient went to radiation treatment|1|||
27982197|NCT00514020|81767320|FG000|Overall Study|"patients moved to the no tx group"|6|||
27982198|NCT01969721|81767321|FG000|Overall Study|Adverse Event|3|||
27982199|NCT01969721|81767322|FG001|Overall Study|Adverse Event|8|||
27982200|NCT01969721|81767323|FG002|Overall Study|Adverse Event|3|||
27982201|NCT01969721|81767324|FG003|Overall Study|Adverse Event|2|||
27982202|NCT01969721|81767321|FG000|Overall Study|Lack of Efficacy|0|||
27868506|NCT01957397|81353846|FG000|Test Period 1|sudden leakage/small bag|1|||
27868507|NCT01957397|81353847|FG001|Test Period 1|sudden leakage/small bag|1|||
27868508|NCT01957397|81353846|FG000|Test Period 1|Withdrawal by Subject|1|||
27868509|NCT01957397|81353847|FG001|Test Period 1|Withdrawal by Subject|0|||
27868510|NCT01957397|81353846|FG000|Test Period 2|Adverse Event|0|||
27868511|NCT01957397|81353847|FG001|Test Period 2|Adverse Event|1|||
27868512|NCT01957397|81353846|FG000|Test Period 3|Adverse Event|1|||
27868513|NCT01957397|81353847|FG001|Test Period 3|Adverse Event|2|||
27868514|NCT01957397|81353846|FG000|Test Period 3|the adhesive did not work|1|||
27868515|NCT01957397|81353847|FG001|Test Period 3|the adhesive did not work|0|||
27868516|NCT01625091|81353848|FG000|Intervention|Death|1|||
27868517|NCT01625091|81353849|FG001|Intervention|Death|1|||
27868518|NCT01625091|81353848|FG000|Intervention|Withdrawal by Subject|4|||
27868519|NCT01625091|81353849|FG001|Intervention|Withdrawal by Subject|1|||
27868520|NCT01625091|81353848|FG000|Intervention|Adverse Event|0|||
27868521|NCT01625091|81353849|FG001|Intervention|Adverse Event|2|||
27868522|NCT01625091|81353848|FG000|Intervention|Lost to Follow-up|4|||
27868523|NCT01625091|81353849|FG001|Intervention|Lost to Follow-up|4|||
27868524|NCT01625091|81353848|FG000|Intervention|Study termination|2|||
27794243|NCT00564486|81079036|FG001|Overall Study|Lost to Follow-up|0|||
27794244|NCT00564486|81079037|FG002|Overall Study|Lost to Follow-up|2|||
27794245|NCT00564486|81079038|FG003|Overall Study|Lost to Follow-up|2|||
27794246|NCT01901393|81079041|FG000|Overall Study|Adverse Event|1|||
27794247|NCT01901393|81079042|FG001|Overall Study|Adverse Event|0|||
27794248|NCT04469465|81079050|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
27794249|NCT04469465|81079051|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
27794250|NCT04469465|81079050|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
27794251|NCT04469465|81079051|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
27794252|NCT04469465|81079050|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
27794253|NCT04469465|81079051|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
27794254|NCT04469465|81079050|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
27794255|NCT04469465|81079051|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
27794256|NCT04469465|81079050|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
27794257|NCT04469465|81079051|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
27794258|NCT04469465|81079050|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
27794259|NCT04469465|81079051|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
27794260|NCT04469465|81079050|FG000|Long-Term Extension (LTE)|Death|0|||
27794261|NCT04469465|81079051|FG001|Long-Term Extension (LTE)|Death|1|||
27794262|NCT04469465|81079050|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
27982203|NCT01969721|81767322|FG001|Overall Study|Lack of Efficacy|0|||
27982204|NCT01969721|81767323|FG002|Overall Study|Lack of Efficacy|1|||
27982205|NCT01969721|81767324|FG003|Overall Study|Lack of Efficacy|0|||
27794263|NCT04469465|81079051|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
27794264|NCT01803464|81079052|FG000|Overall Study|Incomplete data|0|||
27794265|NCT01803464|81079053|FG001|Overall Study|Incomplete data|0|||
27982206|NCT01969721|81767321|FG000|Overall Study|Non compliant with protocol|1|||
27982207|NCT01969721|81767322|FG001|Overall Study|Non compliant with protocol|1|||
27982208|NCT01969721|81767323|FG002|Overall Study|Non compliant with protocol|0|||
27982209|NCT01969721|81767324|FG003|Overall Study|Non compliant with protocol|2|||
27982210|NCT01969721|81767321|FG000|Overall Study|Other not defined above|0|||
27982211|NCT01969721|81767322|FG001|Overall Study|Other not defined above|2|||
27982212|NCT01969721|81767323|FG002|Overall Study|Other not defined above|0|||
27982213|NCT01969721|81767324|FG003|Overall Study|Other not defined above|0|||
27982214|NCT01969721|81767321|FG000|Overall Study|Discontinued during washout periods.|0|||
27982215|NCT01969721|81767322|FG001|Overall Study|Discontinued during washout periods.|1|||
27982216|NCT01969721|81767323|FG002|Overall Study|Discontinued during washout periods.|1|||
27982217|NCT01969721|81767324|FG003|Overall Study|Discontinued during washout periods.|2|||
27982218|NCT03836677|81767325|FG000|Period 1|Adverse Event|0|||
27982219|NCT03836677|81767326|FG001|Period 1|Adverse Event|1|||
27982220|NCT03836677|81767325|FG000|Period 2|Severe non-compliance to protocol|1|||
27982221|NCT03836677|81767326|FG001|Period 2|Severe non-compliance to protocol|0|||
27982222|NCT00454584|81767331|FG000|Controlled Period|Adverse Event|5|||
27982223|NCT00454584|81767332|FG001|Controlled Period|Adverse Event|2|||
27982224|NCT00454584|81767333|FG002|Controlled Period|Adverse Event|1|||
27982225|NCT00454584|81767334|FG003|Controlled Period|Adverse Event|0|||
27982226|NCT00454584|81767335|FG004|Controlled Period|Adverse Event|0|||
27982227|NCT00454584|81767336|FG005|Controlled Period|Adverse Event|0|||
27982228|NCT00454584|81767331|FG000|Controlled Period|Lost to Follow-up|1|||
27982229|NCT00454584|81767332|FG001|Controlled Period|Lost to Follow-up|2|||
27982230|NCT00454584|81767333|FG002|Controlled Period|Lost to Follow-up|2|||
27982231|NCT00454584|81767334|FG003|Controlled Period|Lost to Follow-up|0|||
27982232|NCT00454584|81767335|FG004|Controlled Period|Lost to Follow-up|0|||
27982233|NCT00454584|81767336|FG005|Controlled Period|Lost to Follow-up|0|||
27982234|NCT00454584|81767331|FG000|Controlled Period|Other|5|||
27982235|NCT00454584|81767332|FG001|Controlled Period|Other|4|||
27982236|NCT00454584|81767333|FG002|Controlled Period|Other|2|||
27982237|NCT00454584|81767334|FG003|Controlled Period|Other|0|||
27982238|NCT00454584|81767335|FG004|Controlled Period|Other|0|||
27982239|NCT00454584|81767336|FG005|Controlled Period|Other|0|||
27982240|NCT00454584|81767331|FG000|After Controlled Period|Adverse Event|0|||
27982241|NCT00454584|81767332|FG001|After Controlled Period|Adverse Event|0|||
27982242|NCT00454584|81767333|FG002|After Controlled Period|Adverse Event|0|||
27982243|NCT00454584|81767334|FG003|After Controlled Period|Adverse Event|9|||
27982244|NCT00454584|81767335|FG004|After Controlled Period|Adverse Event|3|||
27982245|NCT00454584|81767336|FG005|After Controlled Period|Adverse Event|9|||
27982246|NCT00454584|81767331|FG000|After Controlled Period|Lack of Efficacy|0|||
27982247|NCT00454584|81767332|FG001|After Controlled Period|Lack of Efficacy|0|||
27982248|NCT00454584|81767333|FG002|After Controlled Period|Lack of Efficacy|0|||
27982249|NCT00454584|81767334|FG003|After Controlled Period|Lack of Efficacy|1|||
27982250|NCT00454584|81767335|FG004|After Controlled Period|Lack of Efficacy|0|||
27982251|NCT00454584|81767336|FG005|After Controlled Period|Lack of Efficacy|0|||
27982252|NCT00454584|81767331|FG000|After Controlled Period|Lost to Follow-up|0|||
27982253|NCT00454584|81767332|FG001|After Controlled Period|Lost to Follow-up|0|||
27982254|NCT00454584|81767333|FG002|After Controlled Period|Lost to Follow-up|0|||
27982255|NCT00454584|81767334|FG003|After Controlled Period|Lost to Follow-up|2|||
27982256|NCT00454584|81767335|FG004|After Controlled Period|Lost to Follow-up|4|||
27982257|NCT00454584|81767336|FG005|After Controlled Period|Lost to Follow-up|6|||
27982258|NCT00454584|81767331|FG000|After Controlled Period|Other|0|||
27982259|NCT00454584|81767332|FG001|After Controlled Period|Other|0|||
27982260|NCT00454584|81767333|FG002|After Controlled Period|Other|0|||
27982261|NCT00454584|81767334|FG003|After Controlled Period|Other|1|||
27982262|NCT00454584|81767335|FG004|After Controlled Period|Other|0|||
27982263|NCT00454584|81767336|FG005|After Controlled Period|Other|0|||
27982264|NCT00454584|81767331|FG000|After Controlled Period|Other|0|||
27982265|NCT00454584|81767332|FG001|After Controlled Period|Other|0|||
27982266|NCT00454584|81767333|FG002|After Controlled Period|Other|0|||
27982267|NCT00454584|81767334|FG003|After Controlled Period|Other|13|||
27982268|NCT00454584|81767335|FG004|After Controlled Period|Other|5|||
27982269|NCT00454584|81767336|FG005|After Controlled Period|Other|17|||
27982270|NCT01999218|81767337|FG000|Overall Study|Hyperglycemia|18|||
27982271|NCT01999218|81767338|FG001|Overall Study|Hyperglycemia|17|||
27982272|NCT01999218|81767339|FG002|Overall Study|Hyperglycemia|17|||
27982273|NCT01999218|81767337|FG000|Overall Study|Lack of Efficacy|1|||
27982274|NCT01999218|81767338|FG001|Overall Study|Lack of Efficacy|0|||
27982275|NCT01999218|81767339|FG002|Overall Study|Lack of Efficacy|1|||
27794266|NCT01803464|81079054|FG002|Overall Study|Incomplete data|4|||
27982276|NCT01999218|81767337|FG000|Overall Study|Lost to Follow-up|22|||
27982277|NCT01999218|81767338|FG001|Overall Study|Lost to Follow-up|17|||
27982278|NCT01999218|81767339|FG002|Overall Study|Lost to Follow-up|18|||
27982279|NCT01999218|81767337|FG000|Overall Study|Non-Compliance With Study Drug|6|||
27868525|NCT01625091|81353849|FG001|Intervention|Study termination|3|||
27868526|NCT01625091|81353848|FG000|Post-intervention|Death|0|||
27868527|NCT01625091|81353849|FG001|Post-intervention|Death|1|||
27868528|NCT01625091|81353848|FG000|Post-intervention|Lost to Follow-up|2|||
27868529|NCT01625091|81353849|FG001|Post-intervention|Lost to Follow-up|0|||
27868530|NCT01625091|81353848|FG000|Post-intervention|Study termination|2|||
27868531|NCT01625091|81353849|FG001|Post-intervention|Study termination|1|||
27868532|NCT01228019|81353850|FG000|Overall Study|Dose Violation|70|||
27868533|NCT01228019|81353850|FG000|Overall Study|Duplicate enrollment|1|||
27868534|NCT01228019|81353850|FG000|Overall Study|Missing pre-treatment data|72|||
27868535|NCT01228019|81353850|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
27868536|NCT01228019|81353850|FG000|Overall Study|Violation of Entry Criterion|9|||
27868537|NCT02756208|81353851|FG000|Overall Study|Withdrawal by Subject|1|||
27868538|NCT02756208|81353852|FG001|Overall Study|Withdrawal by Subject|0|||
27868539|NCT02756208|81353853|FG002|Overall Study|Withdrawal by Subject|1|||
27868540|NCT02756208|81353854|FG003|Overall Study|Withdrawal by Subject|3|||
27868541|NCT02756208|81353851|FG000|Overall Study|Lost to Follow-up|3|||
27868542|NCT02756208|81353852|FG001|Overall Study|Lost to Follow-up|1|||
27868543|NCT02756208|81353853|FG002|Overall Study|Lost to Follow-up|1|||
27868544|NCT02756208|81353854|FG003|Overall Study|Lost to Follow-up|1|||
27868545|NCT02756208|81353851|FG000|Overall Study|Physician Decision|1|||
27868546|NCT02756208|81353852|FG001|Overall Study|Physician Decision|0|||
27868547|NCT02756208|81353853|FG002|Overall Study|Physician Decision|0|||
27868548|NCT02756208|81353854|FG003|Overall Study|Physician Decision|0|||
27868549|NCT02756208|81353851|FG000|Overall Study|Protocol Violation|0|||
27868550|NCT02756208|81353852|FG001|Overall Study|Protocol Violation|1|||
27868551|NCT02756208|81353853|FG002|Overall Study|Protocol Violation|0|||
27868552|NCT02756208|81353854|FG003|Overall Study|Protocol Violation|0|||
27868553|NCT00369486|81353857|FG000|4-Week Visit|Missed visit|2|||
27868554|NCT00369486|81353858|FG001|4-Week Visit|Missed visit|2|||
27868555|NCT00369486|81353859|FG002|4-Week Visit|Missed visit|0|||
27868556|NCT00369486|81353860|FG003|4-Week Visit|Missed visit|2|||
27868557|NCT00369486|81353861|FG004|4-Week Visit|Missed visit|1|||
27868558|NCT00369486|81353857|FG000|4-Week Visit|Dropped|0|||
27868559|NCT00369486|81353858|FG001|4-Week Visit|Dropped|0|||
27868560|NCT00369486|81353859|FG002|4-Week Visit|Dropped|1|||
27868561|NCT00369486|81353860|FG003|4-Week Visit|Dropped|0|||
27868562|NCT00369486|81353861|FG004|4-Week Visit|Dropped|0|||
27868563|NCT00369486|81353857|FG000|8-Week Visit|Missed visit|0|||
27868564|NCT00369486|81353858|FG001|8-Week Visit|Missed visit|1|||
27868565|NCT00369486|81353859|FG002|8-Week Visit|Missed visit|0|||
27868566|NCT00369486|81353860|FG003|8-Week Visit|Missed visit|0|||
27868567|NCT00369486|81353861|FG004|8-Week Visit|Missed visit|1|||
27868568|NCT00369486|81353857|FG000|8-Week Visit|Dropped|0|||
27868569|NCT00369486|81353858|FG001|8-Week Visit|Dropped|0|||
27868570|NCT00369486|81353859|FG002|8-Week Visit|Dropped|0|||
27868571|NCT00369486|81353860|FG003|8-Week Visit|Dropped|1|||
27868572|NCT00369486|81353861|FG004|8-Week Visit|Dropped|0|||
27868573|NCT00369486|81353857|FG000|17-Week Visit|Missed visit|0|||
27868574|NCT00369486|81353858|FG001|17-Week Visit|Missed visit|0|||
27868575|NCT00369486|81353859|FG002|17-Week Visit|Missed visit|1|||
27868576|NCT00369486|81353860|FG003|17-Week Visit|Missed visit|1|||
27868577|NCT00369486|81353861|FG004|17-Week Visit|Missed visit|1|||
27868578|NCT00369486|81353857|FG000|34-Week Visit|Dropped|0|||
27868579|NCT00369486|81353858|FG001|34-Week Visit|Dropped|1|||
27868580|NCT00369486|81353859|FG002|34-Week Visit|Dropped|1|||
27868581|NCT00369486|81353860|FG003|34-Week Visit|Dropped|3|||
27868582|NCT00369486|81353861|FG004|34-Week Visit|Dropped|3|||
27868583|NCT02536846|81353862|FG000|Overall Study|Withdrawal by Subject|1|||
27868584|NCT00715624|81353863|FG000|Overall Study|Adverse Event|12|||
27868585|NCT00715624|81353864|FG001|Overall Study|Adverse Event|37|||
27868586|NCT00715624|81353863|FG000|Overall Study|Lack of Efficacy|11|||
27868587|NCT00715624|81353864|FG001|Overall Study|Lack of Efficacy|11|||
27868588|NCT00715624|81353863|FG000|Overall Study|Lost to Follow-up|1|||
27868589|NCT00715624|81353864|FG001|Overall Study|Lost to Follow-up|2|||
27982280|NCT01999218|81767338|FG001|Overall Study|Non-Compliance With Study Drug|4|||
27982281|NCT01999218|81767339|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27982282|NCT01999218|81767337|FG000|Overall Study|Physician Decision|1|||
27868590|NCT00715624|81353863|FG000|Overall Study|Protocol Violation|1|||
27868591|NCT00715624|81353864|FG001|Overall Study|Protocol Violation|0|||
27868592|NCT00715624|81353863|FG000|Overall Study|Withdrawal by Subject|11|||
27868593|NCT00715624|81353864|FG001|Overall Study|Withdrawal by Subject|25|||
27868594|NCT00715624|81353863|FG000|Overall Study|Familial and personal reasons|10|||
27868595|NCT00715624|81353864|FG001|Overall Study|Familial and personal reasons|22|||
27868596|NCT00715624|81353863|FG000|Overall Study|Poor compliance|6|||
27868597|NCT00715624|81353864|FG001|Overall Study|Poor compliance|13|||
27868598|NCT00715624|81353863|FG000|Overall Study|Sponsor decision|0|||
27868599|NCT00715624|81353864|FG001|Overall Study|Sponsor decision|4|||
27868600|NCT00715624|81353863|FG000|Overall Study|Incorrect randomization (not treated)|0|||
27982283|NCT01999218|81767338|FG001|Overall Study|Physician Decision|4|||
27982284|NCT01999218|81767339|FG002|Overall Study|Physician Decision|6|||
27576682|NCT03096782|80296194|FG000|Overall Study|Participant Relapsed|1|||
27576683|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Adverse Event|9|||
27576684|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Adverse Event|2|||
27576685|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
27576686|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
27576687|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
27576688|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
27576689|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Physician Decision|1|||
27576690|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Physician Decision|1|||
27576691|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Pregnancy|2|||
27576692|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Pregnancy|0|||
27576693|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
27576694|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
27576695|NCT02896127|80296195|FG000|COMPLETED WEEK 52|Technical problems|1|||
27576696|NCT02896127|80296196|FG001|COMPLETED WEEK 52|Technical problems|0|||
27576697|NCT02896127|80296195|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
27576698|NCT02896127|80296196|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
27576699|NCT02896127|80296195|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
27576700|NCT02896127|80296196|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
27576701|NCT02896127|80296195|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
27576702|NCT02896127|80296196|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
27576703|NCT02896127|80296195|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
27576704|NCT02896127|80296196|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
27576705|NCT02896127|80296195|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
27576706|NCT02896127|80296196|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
27576707|NCT00413413|80296203|FG000|Single-Blind|Adverse Event|0|||
27576708|NCT00413413|80296204|FG001|Single-Blind|Adverse Event|9|||
27576709|NCT00413413|80296205|FG002|Single-Blind|Adverse Event|0|||
27576710|NCT00413413|80296203|FG000|Single-Blind|Lack of Efficacy|0|||
27576711|NCT00413413|80296204|FG001|Single-Blind|Lack of Efficacy|5|||
27576712|NCT00413413|80296205|FG002|Single-Blind|Lack of Efficacy|0|||
27576713|NCT00413413|80296203|FG000|Single-Blind|Subject no longer requires study drug|0|||
27576714|NCT00413413|80296204|FG001|Single-Blind|Subject no longer requires study drug|151|||
27576715|NCT00413413|80296205|FG002|Single-Blind|Subject no longer requires study drug|0|||
27576716|NCT00413413|80296203|FG000|Single-Blind|Protocol Violation|0|||
27576717|NCT00413413|80296204|FG001|Single-Blind|Protocol Violation|16|||
27576718|NCT00413413|80296205|FG002|Single-Blind|Protocol Violation|0|||
27576719|NCT00413413|80296203|FG000|Single-Blind|Withdrawal by Subject|0|||
27576720|NCT00413413|80296204|FG001|Single-Blind|Withdrawal by Subject|27|||
27576721|NCT00413413|80296205|FG002|Single-Blind|Withdrawal by Subject|0|||
27576722|NCT00413413|80296203|FG000|Single-Blind|Lost to Follow-up|0|||
27576723|NCT00413413|80296204|FG001|Single-Blind|Lost to Follow-up|8|||
27576724|NCT00413413|80296205|FG002|Single-Blind|Lost to Follow-up|0|||
27576725|NCT00413413|80296203|FG000|Double-Blind|Adverse Event|6|||
27576726|NCT00413413|80296204|FG001|Double-Blind|Adverse Event|0|||
27576727|NCT00413413|80296205|FG002|Double-Blind|Adverse Event|5|||
27576728|NCT00413413|80296203|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
27576729|NCT00413413|80296204|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
27576730|NCT00413413|80296205|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
27576731|NCT00413413|80296203|FG000|Double-Blind|Protocol deviation|1|||
27576732|NCT00413413|80296204|FG001|Double-Blind|Protocol deviation|2|||
27576733|NCT00413413|80296205|FG002|Double-Blind|Protocol deviation|1|||
27576734|NCT00413413|80296203|FG000|Double-Blind|Subject withdrew consent|4|||
27576735|NCT00413413|80296204|FG001|Double-Blind|Subject withdrew consent|6|||
27576736|NCT00413413|80296205|FG002|Double-Blind|Subject withdrew consent|9|||
27576737|NCT00413413|80296203|FG000|Double-Blind|Lost to Follow-up|3|||
27576738|NCT00413413|80296204|FG001|Double-Blind|Lost to Follow-up|4|||
27576739|NCT00413413|80296205|FG002|Double-Blind|Lost to Follow-up|2|||
27576740|NCT00382733|80296210|FG000|Overall Study|Withdrawal by Subject|0|||
27576741|NCT00382733|80296211|FG001|Overall Study|Withdrawal by Subject|1|||
27576742|NCT00382733|80296212|FG002|Overall Study|Withdrawal by Subject|0|||
27576743|NCT00382733|80296213|FG003|Overall Study|Withdrawal by Subject|0|||
27576744|NCT00382733|80296214|FG004|Overall Study|Withdrawal by Subject|0|||
27576745|NCT00440271|80296215|FG000|Overall Study|Protocol Violation|1|||
27576746|NCT00440271|80296216|FG001|Overall Study|Protocol Violation|1|||
27576747|NCT00440271|80296215|FG000|Overall Study|Adverse Event|0|||
27576748|NCT00440271|80296216|FG001|Overall Study|Adverse Event|1|||
27576749|NCT00440271|80296215|FG000|Overall Study|Lost to Follow-up|1|||
27576750|NCT00440271|80296216|FG001|Overall Study|Lost to Follow-up|0|||
27576751|NCT00440271|80296215|FG000|Overall Study|Withdrawal by Subject|0|||
27576752|NCT00440271|80296216|FG001|Overall Study|Withdrawal by Subject|2|||
27576753|NCT00440271|80296215|FG000|Overall Study|Lack of Efficacy|0|||
27576754|NCT00440271|80296216|FG001|Overall Study|Lack of Efficacy|1|||
27576755|NCT00440271|80296215|FG000|Overall Study|Due to closure of trial|8|||
27576756|NCT00440271|80296216|FG001|Overall Study|Due to closure of trial|10|||
27576757|NCT00440271|80296215|FG000|Overall Study|Other|2|||
27982285|NCT01999218|81767337|FG000|Overall Study|Protocol Violation|4|||
27982286|NCT01999218|81767338|FG001|Overall Study|Protocol Violation|5|||
27982287|NCT01999218|81767339|FG002|Overall Study|Protocol Violation|4|||
27982288|NCT01999218|81767337|FG000|Overall Study|Screen failure|0|||
27982289|NCT01999218|81767338|FG001|Overall Study|Screen failure|1|||
27982290|NCT01999218|81767339|FG002|Overall Study|Screen failure|0|||
27982291|NCT01999218|81767337|FG000|Overall Study|Study Terminated By Sponsor|7|||
27982292|NCT01999218|81767338|FG001|Overall Study|Study Terminated By Sponsor|5|||
27982293|NCT01999218|81767339|FG002|Overall Study|Study Terminated By Sponsor|12|||
27982294|NCT01999218|81767337|FG000|Overall Study|Participant moves|2|||
27982295|NCT01999218|81767338|FG001|Overall Study|Participant moves|5|||
27982296|NCT01999218|81767339|FG002|Overall Study|Participant moves|3|||
27982297|NCT01999218|81767337|FG000|Overall Study|Withdrawal by Subject|28|||
27982298|NCT01999218|81767338|FG001|Overall Study|Withdrawal by Subject|29|||
27982299|NCT01999218|81767339|FG002|Overall Study|Withdrawal by Subject|34|||
27982300|NCT01999218|81767337|FG000|Overall Study|Creatinine/eGFR|0|||
27982301|NCT01999218|81767338|FG001|Overall Study|Creatinine/eGFR|0|||
27982302|NCT01999218|81767339|FG002|Overall Study|Creatinine/eGFR|1|||
27982303|NCT01999218|81767337|FG000|Overall Study|Death|7|||
27982304|NCT01999218|81767338|FG001|Overall Study|Death|1|||
27982305|NCT01999218|81767339|FG002|Overall Study|Death|2|||
27982306|NCT01999218|81767337|FG000|Overall Study|Excluded Medication|1|||
27982307|NCT01999218|81767338|FG001|Overall Study|Excluded Medication|1|||
27982308|NCT01999218|81767339|FG002|Overall Study|Excluded Medication|2|||
27982309|NCT01999218|81767337|FG000|Overall Study|Adverse Event|9|||
27982310|NCT01999218|81767338|FG001|Overall Study|Adverse Event|7|||
27982311|NCT01999218|81767339|FG002|Overall Study|Adverse Event|7|||
27982312|NCT01999218|81767337|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
27982313|NCT01999218|81767338|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
27982314|NCT01999218|81767339|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
27982315|NCT02565810|81767340|FG000|Overall Study|Withdrawal by Subject|1|||
27982316|NCT01319721|81767341|FG000|Overall Study|Lost to Follow-up|1|||
27982317|NCT01319721|81767342|FG001|Overall Study|Lost to Follow-up|6|||
27982318|NCT02210091|81767345|FG000|Overall Study|Physician Decision|0|||
27982319|NCT02210091|81767346|FG001|Overall Study|Physician Decision|1|||
27982320|NCT02210091|81767345|FG000|Overall Study|Withdrawal by Sponsor|0|||
27982321|NCT02210091|81767346|FG001|Overall Study|Withdrawal by Sponsor|1|||
27982322|NCT00409344|81767349|FG000|Overall Study|no enrollment|0|||
27982323|NCT00409344|81767350|FG001|Overall Study|no enrollment|0|||
27982324|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
27982325|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
27982326|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
27982327|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
27982328|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
27982329|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
27982330|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
27982331|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
27982332|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
27982333|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
27982334|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
27982335|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
27982336|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
27982337|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
27982338|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
27982339|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
27982340|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
27982341|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
27982342|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
27982343|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
27982344|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
27982345|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
27982346|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
27982347|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
27868601|NCT00715624|81353864|FG001|Overall Study|Incorrect randomization (not treated)|1|||
27982348|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
27982349|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
27982350|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
27982351|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
27982352|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
27982353|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
27982354|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
27982355|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
27982356|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
27794267|NCT01803464|81079055|FG003|Overall Study|Incomplete data|0|||
27794268|NCT01803464|81079052|FG000|Overall Study|Withdrawal by Subject|1|||
27794269|NCT01803464|81079053|FG001|Overall Study|Withdrawal by Subject|0|||
27982357|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
27982358|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
27982359|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
27982360|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
27982361|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
27982362|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
27982363|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
27576758|NCT00440271|80296216|FG001|Overall Study|Other|0|||
27576759|NCT02465528|80296219|FG000|Overall Study|Progressive disease|0|||
27576760|NCT02465528|80296220|FG001|Overall Study|Progressive disease|2|||
27576761|NCT02465528|80296221|FG002|Overall Study|Progressive disease|9|||
27576762|NCT02465528|80296222|FG003|Overall Study|Progressive disease|4|||
27576763|NCT02465528|80296219|FG000|Overall Study|Study terminated by sponsor|1|||
27576764|NCT02465528|80296220|FG001|Overall Study|Study terminated by sponsor|2|||
27576765|NCT02465528|80296221|FG002|Overall Study|Study terminated by sponsor|0|||
27982364|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
27982365|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
27576766|NCT02465528|80296222|FG003|Overall Study|Study terminated by sponsor|0|||
27576767|NCT02465528|80296219|FG000|Overall Study|Withdrawal by Subject|0|||
27576768|NCT02465528|80296220|FG001|Overall Study|Withdrawal by Subject|0|||
27576769|NCT02465528|80296221|FG002|Overall Study|Withdrawal by Subject|2|||
27576770|NCT02465528|80296222|FG003|Overall Study|Withdrawal by Subject|0|||
27576771|NCT02465528|80296219|FG000|Overall Study|Adverse Event|0|||
27576772|NCT02465528|80296220|FG001|Overall Study|Adverse Event|0|||
27576773|NCT02465528|80296221|FG002|Overall Study|Adverse Event|0|||
27982366|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
27576774|NCT02465528|80296222|FG003|Overall Study|Adverse Event|1|||
27576775|NCT02465528|80296219|FG000|Overall Study|Physician Decision|0|||
27576776|NCT02465528|80296220|FG001|Overall Study|Physician Decision|0|||
27576777|NCT02465528|80296221|FG002|Overall Study|Physician Decision|1|||
27794270|NCT01803464|81079054|FG002|Overall Study|Withdrawal by Subject|0|||
27794271|NCT01803464|81079055|FG003|Overall Study|Withdrawal by Subject|0|||
27794272|NCT03683719|81079056|FG000|Overall Study|Lack of Efficacy|1|||
27794273|NCT03683719|81079057|FG001|Overall Study|Lack of Efficacy|3|||
27982367|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
27576778|NCT02465528|80296222|FG003|Overall Study|Physician Decision|0|||
27576779|NCT04304001|80296227|FG000|Overall Study|Lost to Follow-up|13|||
27576780|NCT04304001|80296228|FG001|Overall Study|Lost to Follow-up|9|||
27576781|NCT01649856|80296229|FG000|Overall Study|Withdrawal by Subject|14|||
27576782|NCT01649856|80296230|FG001|Overall Study|Withdrawal by Subject|14|||
27576783|NCT01649856|80296229|FG000|Overall Study|Protocol Violation|4|||
27576784|NCT01649856|80296230|FG001|Overall Study|Protocol Violation|4|||
27576785|NCT01649856|80296229|FG000|Overall Study|Treatment Failure|1|||
27576786|NCT01649856|80296230|FG001|Overall Study|Treatment Failure|1|||
27576787|NCT01649856|80296229|FG000|Overall Study|Death|69|||
27576788|NCT01649856|80296230|FG001|Overall Study|Death|34|||
27576789|NCT01649856|80296229|FG000|Overall Study|Stable or Progressed Disease|5|||
27576790|NCT01649856|80296230|FG001|Overall Study|Stable or Progressed Disease|3|||
27576791|NCT01649856|80296229|FG000|Overall Study|Lost to Follow-up|20|||
27576792|NCT01649856|80296230|FG001|Overall Study|Lost to Follow-up|16|||
27576793|NCT01649856|80296229|FG000|Overall Study|Lack of Compliance|6|||
27576794|NCT01649856|80296230|FG001|Overall Study|Lack of Compliance|1|||
27576795|NCT01649856|80296229|FG000|Overall Study|Other|20|||
27576796|NCT01649856|80296230|FG001|Overall Study|Other|5|||
27982368|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27576797|NCT03100825|80296232|FG000|Overall Study|Participant/Guardian Decision|7|||
27576798|NCT03100825|80296232|FG000|Overall Study|Physician Decision|1|||
27576799|NCT01707004|80296233|FG000|Overall Study|Physician Decision|3|||
27576800|NCT01824303|80296234|FG000|Randomized Study|Withdrawal by Subject|1|||
27576801|NCT01824303|80296235|FG001|Randomized Study|Withdrawal by Subject|1|||
27576802|NCT01824303|80296234|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
27794274|NCT03683719|81079058|FG002|Overall Study|Lack of Efficacy|4|||
27794275|NCT03683719|81079059|FG003|Overall Study|Lack of Efficacy|0|||
27576803|NCT01824303|80296235|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
27576804|NCT02489981|80296236|FG000|Overall Study|Adverse Event|21|||
27576805|NCT02489981|80296236|FG000|Overall Study|Insufficient effectiveness|16|||
27576806|NCT02489981|80296236|FG000|Overall Study|Improved|31|||
27576807|NCT02489981|80296236|FG000|Overall Study|Lost to Follow-up|31|||
27576808|NCT02489981|80296236|FG000|Overall Study|Other than listed|28|||
27576809|NCT00333229|80296237|FG000|Overall Study|Lack of Efficacy|0|||
27576810|NCT00333229|80296238|FG001|Overall Study|Lack of Efficacy|1|||
27794276|NCT03683719|81079060|FG004|Overall Study|Lack of Efficacy|4|||
27794277|NCT03683719|81079056|FG000|Overall Study|Adverse Event|6|||
27576811|NCT01034397|80296241|FG000|Overall Study|Lack of compliance|0|||
27576812|NCT01034397|80296242|FG001|Overall Study|Lack of compliance|1|||
27576813|NCT01034397|80296241|FG000|Overall Study|Lack of Efficacy|3|||
27576814|NCT01034397|80296242|FG001|Overall Study|Lack of Efficacy|0|||
27576815|NCT01034397|80296241|FG000|Overall Study|Adverse Event|4|||
27576816|NCT01034397|80296242|FG001|Overall Study|Adverse Event|0|||
27576817|NCT01034397|80296241|FG000|Overall Study|Other|0|||
27576818|NCT01034397|80296242|FG001|Overall Study|Other|1|||
27576819|NCT03149328|80296243|FG000|Overall Study|Withdrawal by Subject|30|||
27576820|NCT03149328|80296244|FG001|Overall Study|Withdrawal by Subject|26|||
27576821|NCT03149328|80296243|FG000|Overall Study|Changed Dialysis Modality|18|||
27576822|NCT03149328|80296244|FG001|Overall Study|Changed Dialysis Modality|1|||
27576823|NCT03149328|80296243|FG000|Overall Study|Transplant|9|||
27576824|NCT03149328|80296244|FG001|Overall Study|Transplant|1|||
27576825|NCT03149328|80296243|FG000|Overall Study|Lost to Follow-up|25|||
27576826|NCT03149328|80296244|FG001|Overall Study|Lost to Follow-up|16|||
27576827|NCT03149328|80296243|FG000|Overall Study|Left Study Site|1|||
27576828|NCT03149328|80296244|FG001|Overall Study|Left Study Site|2|||
27576829|NCT03149328|80296243|FG000|Overall Study|Language Barrier|1|||
27576830|NCT03149328|80296244|FG001|Overall Study|Language Barrier|0|||
27576831|NCT01110915|80296245|FG000|Overall Study|Death|2|||
27576832|NCT01110915|80296246|FG001|Overall Study|Death|1|||
27576833|NCT01110915|80296245|FG000|Overall Study|Lost to Follow-up|1|||
27576834|NCT01110915|80296246|FG001|Overall Study|Lost to Follow-up|0|||
27576835|NCT01110915|80296245|FG000|Overall Study|Withdrawal by Subject|7|||
27576836|NCT01110915|80296246|FG001|Overall Study|Withdrawal by Subject|1|||
27576837|NCT00773175|80296247|FG000|Overall Study|Adverse Event|2|||
27576838|NCT00773175|80296248|FG001|Overall Study|Adverse Event|0|||
27576839|NCT00773175|80296247|FG000|Overall Study|Consent Withdrawn|0|||
27576840|NCT00773175|80296248|FG001|Overall Study|Consent Withdrawn|2|||
27576841|NCT04439240|80296251|FG000|Overall Study|Ineligible|2|||
27576842|NCT04439240|80296251|FG000|Overall Study|Never started treatment|2|||
27576843|NCT04439240|80296251|FG000|Overall Study|Adverse Event|12|||
27576844|NCT04439240|80296251|FG000|Overall Study|Death|2|||
27576845|NCT04439240|80296251|FG000|Overall Study|Disease progression|25|||
27576846|NCT04439240|80296251|FG000|Overall Study|Other diseases|2|||
27576847|NCT04439240|80296251|FG000|Overall Study|Withdrawal by Subject|3|||
27576848|NCT04439240|80296251|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
27576849|NCT04439240|80296251|FG000|Overall Study|Symptomatic decline|1|||
27576850|NCT04439240|80296251|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
27576851|NCT04439240|80296251|FG000|Overall Study|Clinical progression|1|||
27576852|NCT02460198|80296255|FG000|Overall Study|Adverse Event|1|||
27576853|NCT02460198|80296256|FG001|Overall Study|Adverse Event|3|||
27576854|NCT02460198|80296255|FG000|Overall Study|Death|36|||
27576855|NCT02460198|80296256|FG001|Overall Study|Death|28|||
27576856|NCT02460198|80296255|FG000|Overall Study|Lost to Follow-up|1|||
27576857|NCT02460198|80296256|FG001|Overall Study|Lost to Follow-up|1|||
27576858|NCT02460198|80296255|FG000|Overall Study|Transferred to Extension Study|15|||
27576859|NCT02460198|80296256|FG001|Overall Study|Transferred to Extension Study|15|||
27576860|NCT02460198|80296255|FG000|Overall Study|Withdrawal by Subject|2|||
27576861|NCT02460198|80296256|FG001|Overall Study|Withdrawal by Subject|4|||
27576862|NCT02460198|80296255|FG000|Overall Study|Site Terminated By Sponsor|0|||
27576863|NCT02460198|80296256|FG001|Overall Study|Site Terminated By Sponsor|1|||
27576864|NCT02460198|80296255|FG000|Overall Study|Did Not Continue on Extension Study|6|||
27576865|NCT02460198|80296256|FG001|Overall Study|Did Not Continue on Extension Study|11|||
27576866|NCT00720876|80296258|FG000|Overall Study|found to be ineligible after starting tx|2|||
27576867|NCT01101841|80296259|FG000|Overall Study|Adverse Event|15|||
27576868|NCT01101841|80296260|FG001|Overall Study|Adverse Event|15|||
27576869|NCT01101841|80296259|FG000|Overall Study|Lost to Follow-up|9|||
27576870|NCT01101841|80296260|FG001|Overall Study|Lost to Follow-up|3|||
27576871|NCT01101841|80296259|FG000|Overall Study|Withdrawal by Subject|21|||
27576872|NCT01101841|80296260|FG001|Overall Study|Withdrawal by Subject|40|||
27576873|NCT01101841|80296259|FG000|Overall Study|Protocol Violation|1|||
27576874|NCT01101841|80296260|FG001|Overall Study|Protocol Violation|1|||
27576875|NCT01101841|80296259|FG000|Overall Study|Physician Decision|0|||
27576876|NCT01101841|80296260|FG001|Overall Study|Physician Decision|2|||
27576877|NCT01101841|80296259|FG000|Overall Study|Lack of Efficacy|0|||
27576878|NCT01101841|80296260|FG001|Overall Study|Lack of Efficacy|2|||
27576879|NCT01101841|80296259|FG000|Overall Study|Other|0|||
27576880|NCT01101841|80296260|FG001|Overall Study|Other|1|||
27576881|NCT01101841|80296259|FG000|Overall Study|Suicidality Tracking Scale|3|||
27576882|NCT01101841|80296260|FG001|Overall Study|Suicidality Tracking Scale|1|||
27576883|NCT01101841|80296259|FG000|Overall Study|Eligibility Criteria|1|||
27576884|NCT01101841|80296260|FG001|Overall Study|Eligibility Criteria|2|||
27576885|NCT03135522|80296261|FG000|Overall Study|Adverse Event|1|||
27576886|NCT03135522|80296262|FG001|Overall Study|Adverse Event|0|||
27576887|NCT02212730|80296278|FG000|Overall Study|Tumor not of the required cell histology|1|||
27576888|NCT02212730|80296279|FG001|Overall Study|Tumor not of the required cell histology|0|||
27576889|NCT02212730|80296278|FG000|Overall Study|Withdrawal by Subject|1|||
27576890|NCT02212730|80296279|FG001|Overall Study|Withdrawal by Subject|0|||
27576891|NCT02212730|80296278|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
27576892|NCT02212730|80296279|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
27576893|NCT00559962|80296283|FG000|Overall Study|Adverse Event|1|||
27576894|NCT00559962|80296284|FG001|Overall Study|Adverse Event|7|||
27576895|NCT00559962|80296285|FG002|Overall Study|Adverse Event|8|||
27576896|NCT00559962|80296286|FG003|Overall Study|Adverse Event|5|||
27576897|NCT00559962|80296287|FG004|Overall Study|Adverse Event|11|||
27576898|NCT00559962|80296288|FG005|Overall Study|Adverse Event|4|||
27576899|NCT00559962|80296289|FG006|Overall Study|Adverse Event|4|||
27576900|NCT00559962|80296290|FG007|Overall Study|Adverse Event|2|||
27576901|NCT00559962|80296283|FG000|Overall Study|Lost to Follow-up|0|||
27576902|NCT00559962|80296284|FG001|Overall Study|Lost to Follow-up|1|||
27576903|NCT00559962|80296285|FG002|Overall Study|Lost to Follow-up|0|||
27576904|NCT00559962|80296286|FG003|Overall Study|Lost to Follow-up|0|||
27576905|NCT00559962|80296287|FG004|Overall Study|Lost to Follow-up|0|||
27576906|NCT00559962|80296288|FG005|Overall Study|Lost to Follow-up|0|||
27576907|NCT00559962|80296289|FG006|Overall Study|Lost to Follow-up|0|||
27576908|NCT00559962|80296290|FG007|Overall Study|Lost to Follow-up|0|||
27576909|NCT00559962|80296283|FG000|Overall Study|Withdrawal by Subject|1|||
27576910|NCT00559962|80296284|FG001|Overall Study|Withdrawal by Subject|1|||
27576911|NCT00559962|80296285|FG002|Overall Study|Withdrawal by Subject|2|||
27576912|NCT00559962|80296286|FG003|Overall Study|Withdrawal by Subject|0|||
27576913|NCT00559962|80296287|FG004|Overall Study|Withdrawal by Subject|3|||
27576914|NCT00559962|80296288|FG005|Overall Study|Withdrawal by Subject|1|||
27576915|NCT00559962|80296289|FG006|Overall Study|Withdrawal by Subject|0|||
27576916|NCT00559962|80296290|FG007|Overall Study|Withdrawal by Subject|2|||
27576917|NCT00559962|80296283|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
27576918|NCT00559962|80296284|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
27576919|NCT00559962|80296285|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
27576920|NCT00559962|80296286|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
27576921|NCT00559962|80296287|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
27576922|NCT00559962|80296288|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
27576923|NCT00559962|80296289|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
27576924|NCT00559962|80296290|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
27576925|NCT00941733|80296291|FG000|Overall Study|Death|24|||
27576926|NCT00941733|80296292|FG001|Overall Study|Death|10|||
27576927|NCT00941733|80296291|FG000|Overall Study|Withdrawal by Subject|14|||
27576928|NCT00941733|80296292|FG001|Overall Study|Withdrawal by Subject|6|||
27576929|NCT00941733|80296291|FG000|Overall Study|Adverse Event|20|||
27576930|NCT00941733|80296292|FG001|Overall Study|Adverse Event|4|||
27576931|NCT00941733|80296291|FG000|Overall Study|Lost to Follow-up|1|||
27576932|NCT00941733|80296292|FG001|Overall Study|Lost to Follow-up|2|||
27576933|NCT00941733|80296291|FG000|Overall Study|Protocol Violation|15|||
27576934|NCT00941733|80296292|FG001|Overall Study|Protocol Violation|6|||
27576935|NCT03146650|80296299|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
27576936|NCT03146650|80296299|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
27576937|NCT03146650|80296299|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
27576938|NCT03146650|80296299|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
27576939|NCT03146650|80296299|FG000|2 Year Follow-up|Death|11|||
27576940|NCT03146650|80296299|FG000|2 Year Follow-up|Still in follow-up|7|||
27576941|NCT03146650|80296299|FG000|2 Year Follow-up|Lost to Follow-up|1|||
27576942|NCT00718042|80296300|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27576943|NCT00718042|80296301|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27576944|NCT00718042|80296302|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27576945|NCT00718042|80296303|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27868602|NCT00715624|81353863|FG000|Overall Study|Other|0|||
27576946|NCT00718042|80296304|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
27576947|NCT00718042|80296305|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
27576948|NCT00718042|80296300|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
27576949|NCT00718042|80296301|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27576950|NCT00718042|80296302|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27576951|NCT00718042|80296303|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27868603|NCT00715624|81353864|FG001|Overall Study|Other|1|||
27868604|NCT01023035|81353865|FG000|Treatment Period|Adverse Event|27|||
27868605|NCT01023035|81353866|FG001|Treatment Period|Adverse Event|32|||
27576952|NCT00718042|80296304|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
27576953|NCT00718042|80296305|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
27576954|NCT00718042|80296300|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27576955|NCT00718042|80296301|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
27576956|NCT00718042|80296302|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
27576957|NCT00718042|80296303|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27576958|NCT00718042|80296304|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27576959|NCT00718042|80296305|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
27576960|NCT00718042|80296300|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27576961|NCT00718042|80296301|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
27576962|NCT00718042|80296302|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27576963|NCT00718042|80296303|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27576964|NCT00718042|80296304|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27576965|NCT00718042|80296305|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
27576966|NCT00718042|80296300|FG000|Donor Follow-up|Lost to Follow-up|13|||
27576967|NCT00718042|80296301|FG001|Donor Follow-up|Lost to Follow-up|0|||
27576968|NCT00718042|80296302|FG002|Donor Follow-up|Lost to Follow-up|0|||
27576969|NCT00718042|80296303|FG003|Donor Follow-up|Lost to Follow-up|0|||
27576970|NCT00718042|80296304|FG004|Donor Follow-up|Lost to Follow-up|19|||
27576971|NCT00718042|80296305|FG005|Donor Follow-up|Lost to Follow-up|0|||
27576972|NCT02778204|80296306|FG000|Overall Study|Adverse Event|1|||
27576973|NCT02778204|80296307|FG001|Overall Study|Adverse Event|0|||
27576974|NCT02778204|80296308|FG002|Overall Study|Adverse Event|0|||
27576975|NCT02778204|80296309|FG003|Overall Study|Adverse Event|0|||
27576976|NCT02778204|80296306|FG000|Overall Study|Withdrawal by Subject|0|||
27576977|NCT02778204|80296307|FG001|Overall Study|Withdrawal by Subject|0|||
27576978|NCT02778204|80296308|FG002|Overall Study|Withdrawal by Subject|1|||
27576979|NCT02778204|80296309|FG003|Overall Study|Withdrawal by Subject|2|||
27576980|NCT02778204|80296306|FG000|Overall Study|Lost to Follow-up|1|||
27576981|NCT02778204|80296307|FG001|Overall Study|Lost to Follow-up|0|||
27576982|NCT02778204|80296308|FG002|Overall Study|Lost to Follow-up|2|||
27576983|NCT02778204|80296309|FG003|Overall Study|Lost to Follow-up|1|||
27576984|NCT02778204|80296306|FG000|Overall Study|Protocol Violation|0|||
27576985|NCT02778204|80296307|FG001|Overall Study|Protocol Violation|0|||
27576986|NCT02778204|80296308|FG002|Overall Study|Protocol Violation|1|||
27576987|NCT02778204|80296309|FG003|Overall Study|Protocol Violation|0|||
27576988|NCT02778204|80296306|FG000|Overall Study|Eligibility Violation|0|||
27576989|NCT02778204|80296307|FG001|Overall Study|Eligibility Violation|0|||
27576990|NCT02778204|80296308|FG002|Overall Study|Eligibility Violation|0|||
27576991|NCT02778204|80296309|FG003|Overall Study|Eligibility Violation|1|||
27576992|NCT03837899|80296312|FG000|Overall Study|Death|6|||
27576993|NCT03837899|80296313|FG001|Overall Study|Death|8|||
27576994|NCT03837899|80296314|FG002|Overall Study|Death|3|||
27576995|NCT03837899|80296315|FG003|Overall Study|Death|7|||
27576996|NCT03837899|80296316|FG004|Overall Study|Death|8|||
27576997|NCT03837899|80296317|FG005|Overall Study|Death|7|||
27576998|NCT03837899|80296312|FG000|Overall Study|Moved to post-trial access program|0|||
27576999|NCT03837899|80296313|FG001|Overall Study|Moved to post-trial access program|1|||
27577000|NCT03837899|80296314|FG002|Overall Study|Moved to post-trial access program|0|||
27577001|NCT03837899|80296315|FG003|Overall Study|Moved to post-trial access program|0|||
27577002|NCT03837899|80296316|FG004|Overall Study|Moved to post-trial access program|0|||
27577003|NCT03837899|80296317|FG005|Overall Study|Moved to post-trial access program|0|||
27577004|NCT03837899|80296312|FG000|Overall Study|Other|0|||
27577005|NCT03837899|80296313|FG001|Overall Study|Other|0|||
27577006|NCT03837899|80296314|FG002|Overall Study|Other|0|||
27577007|NCT03837899|80296315|FG003|Overall Study|Other|0|||
27577008|NCT03837899|80296316|FG004|Overall Study|Other|0|||
27577009|NCT03837899|80296317|FG005|Overall Study|Other|2|||
27577010|NCT03837899|80296312|FG000|Overall Study|Lost to Follow-up|0|||
27577011|NCT03837899|80296313|FG001|Overall Study|Lost to Follow-up|1|||
27577012|NCT03837899|80296314|FG002|Overall Study|Lost to Follow-up|0|||
27577013|NCT03837899|80296315|FG003|Overall Study|Lost to Follow-up|0|||
27577014|NCT03837899|80296316|FG004|Overall Study|Lost to Follow-up|0|||
27577015|NCT03837899|80296317|FG005|Overall Study|Lost to Follow-up|0|||
27794278|NCT03683719|81079057|FG001|Overall Study|Adverse Event|6|||
27794279|NCT03683719|81079058|FG002|Overall Study|Adverse Event|0|||
27794280|NCT03683719|81079059|FG003|Overall Study|Adverse Event|1|||
27577016|NCT03837899|80296312|FG000|Overall Study|Withdrawal by Subject|0|||
27577017|NCT03837899|80296313|FG001|Overall Study|Withdrawal by Subject|0|||
27577018|NCT03837899|80296314|FG002|Overall Study|Withdrawal by Subject|0|||
27577019|NCT03837899|80296315|FG003|Overall Study|Withdrawal by Subject|1|||
27577020|NCT03837899|80296316|FG004|Overall Study|Withdrawal by Subject|0|||
27577021|NCT03837899|80296317|FG005|Overall Study|Withdrawal by Subject|0|||
27577022|NCT03837899|80296312|FG000|Overall Study|Study specific discontinuation criteria|0|||
27577023|NCT03837899|80296313|FG001|Overall Study|Study specific discontinuation criteria|1|||
27577024|NCT03837899|80296314|FG002|Overall Study|Study specific discontinuation criteria|0|||
27794281|NCT03683719|81079060|FG004|Overall Study|Adverse Event|3|||
27577025|NCT03837899|80296315|FG003|Overall Study|Study specific discontinuation criteria|0|||
27577026|NCT03837899|80296316|FG004|Overall Study|Study specific discontinuation criteria|3|||
27577027|NCT03837899|80296317|FG005|Overall Study|Study specific discontinuation criteria|1|||
27577028|NCT00853658|80296318|FG000|Overall Study|Death|713|||
27577029|NCT00853658|80296319|FG001|Overall Study|Death|768|||
27577030|NCT00853658|80296320|FG002|Overall Study|Death|753|||
27577031|NCT00853658|80296318|FG000|Overall Study|Lost to Follow-up|11|||
27577032|NCT00853658|80296319|FG001|Overall Study|Lost to Follow-up|6|||
27577033|NCT00853658|80296320|FG002|Overall Study|Lost to Follow-up|11|||
27577034|NCT00853658|80296318|FG000|Overall Study|H.A. Request|26|||
27577035|NCT00853658|80296319|FG001|Overall Study|H.A. Request|23|||
27577036|NCT00853658|80296320|FG002|Overall Study|H.A. Request|19|||
27577037|NCT00853658|80296318|FG000|Overall Study|IRB request|0|||
27577038|NCT00853658|80296319|FG001|Overall Study|IRB request|0|||
27577039|NCT00853658|80296320|FG002|Overall Study|IRB request|2|||
27577040|NCT00853658|80296318|FG000|Overall Study|Vital Status known (alive) at study end|2|||
27577041|NCT00853658|80296319|FG001|Overall Study|Vital Status known (alive) at study end|3|||
27577042|NCT00853658|80296320|FG002|Overall Study|Vital Status known (alive) at study end|3|||
27577043|NCT00853658|80296318|FG000|Overall Study|Vital Status unknown at study end|1|||
27577044|NCT00853658|80296319|FG001|Overall Study|Vital Status unknown at study end|1|||
27577045|NCT00853658|80296320|FG002|Overall Study|Vital Status unknown at study end|0|||
27577046|NCT00853658|80296318|FG000|Overall Study|Vital Status at study end N/A|8|||
27577047|NCT00853658|80296319|FG001|Overall Study|Vital Status at study end N/A|10|||
27577048|NCT00853658|80296320|FG002|Overall Study|Vital Status at study end N/A|10|||
27577049|NCT00853658|80296318|FG000|Overall Study|Patient's request|21|||
27577050|NCT00853658|80296319|FG001|Overall Study|Patient's request|17|||
27577051|NCT00853658|80296320|FG002|Overall Study|Patient's request|11|||
27577052|NCT00853658|80296318|FG000|Overall Study|Missing study completion information|5|||
27577053|NCT00853658|80296319|FG001|Overall Study|Missing study completion information|4|||
27577054|NCT00853658|80296320|FG002|Overall Study|Missing study completion information|6|||
27577055|NCT01276327|80296325|FG000|Overall Study|Adverse Event|1|||
27577056|NCT01276327|80296326|FG001|Overall Study|Adverse Event|3|||
27577057|NCT01276327|80296325|FG000|Overall Study|Withdrawal by Subject|1|||
27577058|NCT01276327|80296326|FG001|Overall Study|Withdrawal by Subject|0|||
27577059|NCT01545817|80296327|FG000|Pazopanib|Disease progression|51|||
27577060|NCT01545817|80296328|FG001|Pazopanib|Disease progression|0|||
27577061|NCT01545817|80296327|FG000|Pazopanib|Adverse Event|19|||
27577062|NCT01545817|80296328|FG001|Pazopanib|Adverse Event|0|||
27577063|NCT01545817|80296327|FG000|Pazopanib|Other reason|4|||
27577064|NCT01545817|80296328|FG001|Pazopanib|Other reason|0|||
27577065|NCT01545817|80296327|FG000|Everolimus|Other reason|0|||
27577066|NCT01545817|80296328|FG001|Everolimus|Other reason|7|||
27577067|NCT01545817|80296327|FG000|Everolimus|Disease progression|0|||
27577068|NCT01545817|80296328|FG001|Everolimus|Disease progression|25|||
27577069|NCT01545817|80296327|FG000|Everolimus|Adverse Event|0|||
27577070|NCT01545817|80296328|FG001|Everolimus|Adverse Event|6|||
27982369|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982370|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
27982371|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982372|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982373|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
27982374|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982375|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982376|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982377|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982378|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
27982379|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
27982380|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982381|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982382|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982383|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982384|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982385|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27577071|NCT03306264|80296329|FG000|Overall Study|Death|33|||
27577072|NCT03306264|80296330|FG001|Overall Study|Death|25|||
27577073|NCT03306264|80296331|FG002|Overall Study|Death|34|||
27577074|NCT03306264|80296332|FG003|Overall Study|Death|34|||
27577075|NCT03306264|80296329|FG000|Overall Study|Complete Consent Withdrawal|4|||
27577076|NCT03306264|80296330|FG001|Overall Study|Complete Consent Withdrawal|4|||
27577077|NCT03306264|80296331|FG002|Overall Study|Complete Consent Withdrawal|1|||
27577078|NCT03306264|80296332|FG003|Overall Study|Complete Consent Withdrawal|8|||
27577079|NCT03306264|80296329|FG000|Overall Study|Lost to Follow-up|1|||
27577080|NCT03306264|80296330|FG001|Overall Study|Lost to Follow-up|0|||
27577081|NCT03306264|80296331|FG002|Overall Study|Lost to Follow-up|1|||
27577082|NCT03306264|80296332|FG003|Overall Study|Lost to Follow-up|0|||
27577083|NCT03306264|80296329|FG000|Overall Study|Rollover to ASTX727-06|10|||
27577084|NCT03306264|80296330|FG001|Overall Study|Rollover to ASTX727-06|18|||
27577085|NCT03306264|80296331|FG002|Overall Study|Rollover to ASTX727-06|4|||
27577086|NCT03306264|80296332|FG003|Overall Study|Rollover to ASTX727-06|2|||
27577087|NCT03306264|80296329|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
27794282|NCT03683719|81079056|FG000|Overall Study|Withdrawal by Subject|4|||
27982386|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982387|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982388|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982389|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
27982390|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982391|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982392|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
27982393|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982394|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982395|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982396|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982397|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982398|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982399|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982400|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
27982401|NCT02914561|81767359|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
27982402|NCT02914561|81767360|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
27982403|NCT02914561|81767361|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
27982404|NCT02914561|81767362|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
27982405|NCT02914561|81767363|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
27982406|NCT02914561|81767364|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
27982407|NCT02914561|81767365|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
27982408|NCT02914561|81767366|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
27982409|NCT02914561|81767367|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
27982410|NCT02914561|81767368|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
27982411|NCT02914561|81767369|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
27982412|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
27982413|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
27982414|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
27982415|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
27982416|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
27982417|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
27982418|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
27982419|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
27982420|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
27982421|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
27982422|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
27982423|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
27982424|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
27982425|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
27982426|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
27982427|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
27982428|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
27982429|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
27982430|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
27982431|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
27982432|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
27982433|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
27982434|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
27982435|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
27982436|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
27982437|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
27982438|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
27982439|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
27982440|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
27982441|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
27794283|NCT03683719|81079057|FG001|Overall Study|Withdrawal by Subject|4|||
27577088|NCT03306264|80296330|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
27577089|NCT03306264|80296331|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
27577090|NCT03306264|80296332|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
27982442|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
27982443|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
27982444|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
27982445|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982446|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982447|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982448|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982449|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982450|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982451|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
27982452|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982453|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
27982454|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
27982455|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
27982456|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27577091|NCT03484819|80296333|FG000|Overall Study|Death|2|||
27577092|NCT03484819|80296333|FG000|Overall Study|Adverse Event|2|||
27577093|NCT03484819|80296333|FG000|Overall Study|Physician Decision|1|||
27577094|NCT03484819|80296333|FG000|Overall Study|Withdrawal by Subject|2|||
27577095|NCT03484819|80296333|FG000|Overall Study|Disease Progression|4|||
27577096|NCT03484819|80296333|FG000|Overall Study|Complicating Condition|1|||
27577097|NCT03511560|80296336|FG000|Overall Study|Death|0|||
27577098|NCT03511560|80296337|FG001|Overall Study|Death|1|||
27868606|NCT01023035|81353867|FG002|Treatment Period|Adverse Event|50|||
27982457|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27577099|NCT03511560|80296336|FG000|Overall Study|Adverse Event|0|||
27577100|NCT03511560|80296337|FG001|Overall Study|Adverse Event|2|||
27577101|NCT03511560|80296336|FG000|Overall Study|Transplant cancelled|0|||
27577102|NCT03511560|80296337|FG001|Overall Study|Transplant cancelled|1|||
27794284|NCT03683719|81079058|FG002|Overall Study|Withdrawal by Subject|3|||
27794285|NCT03683719|81079059|FG003|Overall Study|Withdrawal by Subject|5|||
27794286|NCT03683719|81079060|FG004|Overall Study|Withdrawal by Subject|5|||
27794287|NCT03683719|81079056|FG000|Overall Study|Lost to Follow-up|1|||
27794288|NCT03683719|81079057|FG001|Overall Study|Lost to Follow-up|0|||
27794289|NCT03683719|81079058|FG002|Overall Study|Lost to Follow-up|0|||
27674032|NCT00250432|80643488|FG001|Overall Study|Withdrawal by Subject|2|||
27794290|NCT03683719|81079059|FG003|Overall Study|Lost to Follow-up|1|||
27577103|NCT03511560|80296336|FG000|Overall Study|Patient switched to another drug|1|||
27794291|NCT03683719|81079060|FG004|Overall Study|Lost to Follow-up|1|||
27794292|NCT03683719|81079056|FG000|Overall Study|Other personal reasons|0|||
27674033|NCT00250432|80643487|FG000|Overall Study|Pt died out of posttherapy report period|6|||
27794293|NCT03683719|81079057|FG001|Overall Study|Other personal reasons|0|||
27794294|NCT03683719|81079058|FG002|Overall Study|Other personal reasons|1|||
27794295|NCT03683719|81079059|FG003|Overall Study|Other personal reasons|0|||
27794296|NCT03683719|81079060|FG004|Overall Study|Other personal reasons|1|||
27794297|NCT03151707|81079061|FG000|Overall Study|Lost to Follow-up|6|||
27794298|NCT03728257|81079062|FG000|Overall Study|Death|3|||
27794299|NCT03728257|81079063|FG001|Overall Study|Death|0|||
27794300|NCT04969263|81079064|FG000|Overall Study|Death|1|||
27794301|NCT04969263|81079064|FG000|Overall Study|Lost to Follow-up|2|||
27794302|NCT04969263|81079064|FG000|Overall Study|Withdrawal by Subject|5|||
27794303|NCT04969263|81079064|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
27868607|NCT01023035|81353865|FG000|Treatment Period|Non-Medical Reasons|19|||
27868608|NCT01023035|81353866|FG001|Treatment Period|Non-Medical Reasons|22|||
27868609|NCT01023035|81353867|FG002|Treatment Period|Non-Medical Reasons|44|||
27982458|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27982459|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27794304|NCT01728376|81079067|FG000|Overall Study|Adverse Event|1|||
27794305|NCT01728376|81079068|FG001|Overall Study|Adverse Event|1|||
27794306|NCT01728376|81079069|FG002|Overall Study|Adverse Event|1|||
27794307|NCT01728376|81079070|FG003|Overall Study|Adverse Event|1|||
27794308|NCT01728376|81079071|FG004|Overall Study|Adverse Event|1|||
27794309|NCT01728376|81079072|FG005|Overall Study|Adverse Event|0|||
27794310|NCT01728376|81079067|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
27794311|NCT01728376|81079068|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
27868610|NCT01023035|81353865|FG000|Treatment Period|Treatment Failure|26|||
27868611|NCT01023035|81353866|FG001|Treatment Period|Treatment Failure|31|||
27794312|NCT01728376|81079069|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
27868612|NCT01023035|81353867|FG002|Treatment Period|Treatment Failure|24|||
27982460|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27982461|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27982462|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
27982463|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
27982464|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
27982465|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
27674034|NCT00250432|80643488|FG001|Overall Study|Pt died out of posttherapy report period|5|||
27674035|NCT00250432|80643487|FG000|Overall Study|Pt was considered untreatable|0|||
27674036|NCT00250432|80643488|FG001|Overall Study|Pt was considered untreatable|1|||
27674037|NCT01496365|80643489|FG000|Overall Study|Adverse Event|2|||
27674038|NCT01496365|80643490|FG001|Overall Study|Adverse Event|3|||
27674039|NCT01496365|80643491|FG002|Overall Study|Adverse Event|3|||
27868613|NCT01023035|81353865|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
27868614|NCT01023035|81353866|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
27868615|NCT01023035|81353867|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
27982466|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
27982467|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982468|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982469|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982470|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982471|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982472|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27674040|NCT01496365|80643492|FG003|Overall Study|Adverse Event|2|||
27674041|NCT01496365|80643493|FG004|Overall Study|Adverse Event|5|||
27868616|NCT01023035|81353865|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
27868617|NCT01023035|81353866|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
27868618|NCT01023035|81353867|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
27868619|NCT03066258|81353868|FG000|Overall Study|Death|1|||
27868620|NCT03066258|81353869|FG001|Overall Study|Death|0|||
27868621|NCT03066258|81353870|FG002|Overall Study|Death|0|||
27674042|NCT01496365|80643494|FG005|Overall Study|Adverse Event|6|||
27794313|NCT01728376|81079070|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
27794314|NCT01728376|81079071|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
27794315|NCT01728376|81079072|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
27794316|NCT01728376|81079067|FG000|Overall Study|No relevant bacteria|2|||
27794317|NCT01728376|81079068|FG001|Overall Study|No relevant bacteria|0|||
27868622|NCT03066258|81353871|FG003|Overall Study|Death|0|||
27868623|NCT03066258|81353872|FG004|Overall Study|Death|1|||
27868624|NCT01301729|81353873|FG000|Overall Study|Withdrawal by Subject|2|||
27674043|NCT01496365|80643495|FG006|Overall Study|Adverse Event|4|||
27794318|NCT01728376|81079069|FG002|Overall Study|No relevant bacteria|0|||
27794319|NCT01728376|81079070|FG003|Overall Study|No relevant bacteria|0|||
27794320|NCT01728376|81079071|FG004|Overall Study|No relevant bacteria|1|||
27868625|NCT01301729|81353873|FG000|Overall Study|Participant did not Return for Treatment|1|||
27868626|NCT01301729|81353873|FG000|Overall Study|Violated Selection Criteria|1|||
27868627|NCT00595309|81353874|FG000|Overall Study|Lost to Follow-up|1|||
27868628|NCT00595309|81353874|FG000|Overall Study|planned vaccination against yellow fever|1|||
27868629|NCT00595309|81353874|FG000|Overall Study|acute infection after V0|1|||
27868630|NCT00595309|81353874|FG000|Overall Study|personal reason|1|||
27868631|NCT00699998|81353881|FG000|Overall Study|Withdrawal by Subject|194|||
27868632|NCT00699998|81353882|FG001|Overall Study|Withdrawal by Subject|83|||
27868633|NCT00699998|81353883|FG002|Overall Study|Withdrawal by Subject|202|||
27868634|NCT00699998|81353884|FG003|Overall Study|Withdrawal by Subject|80|||
27868635|NCT00699998|81353881|FG000|Overall Study|Physician Decision|3|||
27868636|NCT00699998|81353882|FG001|Overall Study|Physician Decision|2|||
27868637|NCT00699998|81353883|FG002|Overall Study|Physician Decision|1|||
27868638|NCT00699998|81353884|FG003|Overall Study|Physician Decision|1|||
27674044|NCT01496365|80643489|FG000|Overall Study|Withdrawal by Subject|6|||
27674045|NCT01496365|80643490|FG001|Overall Study|Withdrawal by Subject|6|||
27674046|NCT01496365|80643491|FG002|Overall Study|Withdrawal by Subject|0|||
27674047|NCT01496365|80643492|FG003|Overall Study|Withdrawal by Subject|1|||
27674048|NCT01496365|80643493|FG004|Overall Study|Withdrawal by Subject|3|||
27674049|NCT01496365|80643494|FG005|Overall Study|Withdrawal by Subject|2|||
27674050|NCT01496365|80643495|FG006|Overall Study|Withdrawal by Subject|1|||
27674051|NCT01496365|80643489|FG000|Overall Study|Protocol Violation|2|||
27674052|NCT01496365|80643490|FG001|Overall Study|Protocol Violation|1|||
27982473|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
27982474|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982475|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
27982476|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982477|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
27982478|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982479|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982480|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982481|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982482|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982483|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982484|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27674053|NCT01496365|80643491|FG002|Overall Study|Protocol Violation|1|||
27674054|NCT01496365|80643492|FG003|Overall Study|Protocol Violation|0|||
27674055|NCT01496365|80643493|FG004|Overall Study|Protocol Violation|0|||
27674056|NCT01496365|80643494|FG005|Overall Study|Protocol Violation|1|||
27674057|NCT01496365|80643495|FG006|Overall Study|Protocol Violation|0|||
27674058|NCT01496365|80643489|FG000|Overall Study|Lack of Efficacy|1|||
27674059|NCT01496365|80643490|FG001|Overall Study|Lack of Efficacy|0|||
27794321|NCT01728376|81079072|FG005|Overall Study|No relevant bacteria|1|||
27794322|NCT01728376|81079067|FG000|Overall Study|Did not receive treatment|0|||
27794323|NCT01728376|81079068|FG001|Overall Study|Did not receive treatment|1|||
27794324|NCT01728376|81079069|FG002|Overall Study|Did not receive treatment|0|||
27794325|NCT01728376|81079070|FG003|Overall Study|Did not receive treatment|0|||
27794326|NCT01728376|81079071|FG004|Overall Study|Did not receive treatment|0|||
27794327|NCT01728376|81079072|FG005|Overall Study|Did not receive treatment|0|||
27794328|NCT01728376|81079067|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27794329|NCT01728376|81079068|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27794330|NCT01728376|81079069|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27794331|NCT01728376|81079070|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
27794332|NCT01728376|81079071|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
27794333|NCT01728376|81079072|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
27794334|NCT01907516|81079076|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
27794335|NCT01907516|81079077|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
27794336|NCT01907516|81079076|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
27794337|NCT01907516|81079077|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
27794338|NCT01907516|81079076|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
27794339|NCT01907516|81079077|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
27868639|NCT00699998|81353881|FG000|Overall Study|Lost to Follow-up|2|||
27674060|NCT01496365|80643491|FG002|Overall Study|Lack of Efficacy|0|||
27674061|NCT01496365|80643492|FG003|Overall Study|Lack of Efficacy|0|||
27794340|NCT01907516|81079076|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
27794341|NCT01907516|81079077|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
27868640|NCT00699998|81353882|FG001|Overall Study|Lost to Follow-up|1|||
27868641|NCT00699998|81353883|FG002|Overall Study|Lost to Follow-up|3|||
27868642|NCT00699998|81353884|FG003|Overall Study|Lost to Follow-up|1|||
27868643|NCT02766335|81353885|FG000|Initial Registration|Adverse Event|6|||
27674062|NCT01496365|80643493|FG004|Overall Study|Lack of Efficacy|0|||
27794342|NCT01819467|81079079|FG000|Overall Study|Physician Decision|20|||
27794343|NCT01819467|81079080|FG001|Overall Study|Physician Decision|9|||
27794344|NCT00761735|81079081|FG000|Overall Study|Lost to Follow-up|6|||
27794345|NCT00761735|81079081|FG000|Overall Study|Withdrawal by Subject|6|||
27794346|NCT00761735|81079081|FG000|Overall Study|Non-compliance with protocol|1|||
27794347|NCT00761735|81079081|FG000|Overall Study|Administrative|1|||
27794348|NCT04775953|81079085|FG000|Overall Study|Lost to Follow-up|6|||
27794349|NCT04775953|81079086|FG001|Overall Study|Lost to Follow-up|11|||
27794350|NCT04775953|81079085|FG000|Overall Study|Death|5|||
27794351|NCT04775953|81079086|FG001|Overall Study|Death|4|||
27794352|NCT04775953|81079085|FG000|Overall Study|Withdrawal by Subject|3|||
27794353|NCT04775953|81079086|FG001|Overall Study|Withdrawal by Subject|3|||
27794354|NCT04775953|81079085|FG000|Overall Study|Protocol Violation|2|||
27794355|NCT04775953|81079086|FG001|Overall Study|Protocol Violation|0|||
27794356|NCT04775953|81079085|FG000|Overall Study|Participant non-compliance|0|||
27794357|NCT04775953|81079086|FG001|Overall Study|Participant non-compliance|1|||
27794358|NCT02007512|81079087|FG000|Double Blind Treatment Period|Adverse Event|4|||
27794359|NCT02007512|81079088|FG001|Double Blind Treatment Period|Adverse Event|2|||
27794360|NCT02007512|81079089|FG002|Double Blind Treatment Period|Adverse Event|6|||
27794361|NCT02007512|81079090|FG003|Double Blind Treatment Period|Adverse Event|2|||
27794362|NCT02007512|81079087|FG000|Double Blind Treatment Period|Death|1|||
27794363|NCT02007512|81079088|FG001|Double Blind Treatment Period|Death|0|||
27794364|NCT02007512|81079089|FG002|Double Blind Treatment Period|Death|0|||
27794365|NCT02007512|81079090|FG003|Double Blind Treatment Period|Death|0|||
27794366|NCT02007512|81079087|FG000|Double Blind Treatment Period|Disease progression|44|||
27794367|NCT02007512|81079088|FG001|Double Blind Treatment Period|Disease progression|49|||
27794368|NCT02007512|81079089|FG002|Double Blind Treatment Period|Disease progression|45|||
27794369|NCT02007512|81079090|FG003|Double Blind Treatment Period|Disease progression|51|||
27794370|NCT02007512|81079087|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
27794371|NCT02007512|81079088|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
27794372|NCT02007512|81079089|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
27794373|NCT02007512|81079090|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
27794374|NCT02007512|81079087|FG000|Double Blind Treatment Period|Protocol Violation|0|||
27794375|NCT02007512|81079088|FG001|Double Blind Treatment Period|Protocol Violation|0|||
27794376|NCT02007512|81079089|FG002|Double Blind Treatment Period|Protocol Violation|0|||
27794377|NCT02007512|81079090|FG003|Double Blind Treatment Period|Protocol Violation|1|||
27794378|NCT02007512|81079087|FG000|Double Blind Treatment Period|Other|0|||
27794379|NCT02007512|81079088|FG001|Double Blind Treatment Period|Other|0|||
27794380|NCT02007512|81079089|FG002|Double Blind Treatment Period|Other|1|||
27794381|NCT02007512|81079090|FG003|Double Blind Treatment Period|Other|2|||
27794382|NCT02007512|81079087|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
27794383|NCT02007512|81079088|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
27794384|NCT02007512|81079089|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
27794385|NCT02007512|81079090|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
27794386|NCT02007512|81079087|FG000|Open Label Treatment Period|Adverse Event|0|||
27794387|NCT02007512|81079088|FG001|Open Label Treatment Period|Adverse Event|1|||
27794388|NCT02007512|81079089|FG002|Open Label Treatment Period|Adverse Event|0|||
27794389|NCT02007512|81079090|FG003|Open Label Treatment Period|Adverse Event|0|||
27794390|NCT02007512|81079087|FG000|Open Label Treatment Period|Other|0|||
27794391|NCT02007512|81079088|FG001|Open Label Treatment Period|Other|0|||
27868644|NCT02766335|81353886|FG001|Initial Registration|Adverse Event|3|||
27868645|NCT02766335|81353887|FG002|Initial Registration|Adverse Event|0|||
27868646|NCT02766335|81353885|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
27868647|NCT02766335|81353886|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
27868648|NCT02766335|81353887|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
27868649|NCT02766335|81353885|FG000|Initial Registration|Progression/relapse|49|||
27868650|NCT02766335|81353886|FG001|Initial Registration|Progression/relapse|15|||
27982485|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982486|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
27982487|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27982488|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
27674063|NCT01496365|80643494|FG005|Overall Study|Lack of Efficacy|1|||
27674064|NCT01496365|80643495|FG006|Overall Study|Lack of Efficacy|0|||
27674065|NCT01496365|80643489|FG000|Overall Study|Lost to Follow-up|0|||
27794392|NCT02007512|81079089|FG002|Open Label Treatment Period|Other|0|||
27794393|NCT02007512|81079090|FG003|Open Label Treatment Period|Other|1|||
27794394|NCT02007512|81079087|FG000|Open Label Treatment Period|Disease progression|0|||
27794395|NCT02007512|81079088|FG001|Open Label Treatment Period|Disease progression|17|||
27794396|NCT02007512|81079089|FG002|Open Label Treatment Period|Disease progression|0|||
27794397|NCT02007512|81079090|FG003|Open Label Treatment Period|Disease progression|11|||
27794398|NCT02007512|81079087|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
27794399|NCT02007512|81079088|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
27794400|NCT02007512|81079089|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
27794401|NCT02007512|81079090|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
27794402|NCT02353572|81079091|FG000|Overall Study|Withdrawal by Subject|1|||
27794403|NCT02353572|81079091|FG000|Overall Study|Study terminated|2|||
27794404|NCT02508649|81079092|FG000|Overall Study|Withdrawal by Subject|4|||
27794405|NCT02508649|81079093|FG001|Overall Study|Withdrawal by Subject|6|||
27794406|NCT02508649|81079094|FG002|Overall Study|Withdrawal by Subject|5|||
27794407|NCT02508649|81079095|FG003|Overall Study|Withdrawal by Subject|6|||
27794408|NCT02508649|81079092|FG000|Overall Study|Investigator withdrew the subject|1|||
27794409|NCT02508649|81079093|FG001|Overall Study|Investigator withdrew the subject|2|||
27794410|NCT02508649|81079094|FG002|Overall Study|Investigator withdrew the subject|1|||
27794411|NCT02508649|81079095|FG003|Overall Study|Investigator withdrew the subject|0|||
27794412|NCT02508649|81079092|FG000|Overall Study|Post randomization screening failure|12|||
27794413|NCT02508649|81079093|FG001|Overall Study|Post randomization screening failure|4|||
27794414|NCT02508649|81079094|FG002|Overall Study|Post randomization screening failure|9|||
27794415|NCT02508649|81079095|FG003|Overall Study|Post randomization screening failure|3|||
27794416|NCT02508649|81079092|FG000|Overall Study|Lost to Follow-up|1|||
27794417|NCT02508649|81079093|FG001|Overall Study|Lost to Follow-up|1|||
27794418|NCT02508649|81079094|FG002|Overall Study|Lost to Follow-up|0|||
27794419|NCT02508649|81079095|FG003|Overall Study|Lost to Follow-up|1|||
27794420|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794421|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794422|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794423|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
27794424|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
27794425|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794426|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794427|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794428|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794429|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
27794430|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794431|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27794432|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
27794433|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
27794434|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
27794435|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
27794436|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
27982489|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982490|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982491|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982492|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982493|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982494|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982495|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
27982496|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982497|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982498|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982499|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
27982500|NCT02914561|81767359|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982501|NCT02914561|81767360|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982502|NCT02914561|81767361|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982503|NCT02914561|81767362|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982504|NCT02914561|81767363|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27577104|NCT03511560|80296337|FG001|Overall Study|Patient switched to another drug|0|||
27577105|NCT00958880|80296338|FG000|Overall Study|Lost to Follow-up|2|||
27577106|NCT00958880|80296339|FG001|Overall Study|Lost to Follow-up|2|||
27577107|NCT00512096|80296340|FG000|Overall Study|Adverse Event|2|||
27577108|NCT00512096|80296340|FG000|Overall Study|Withdrawal by Subject|2|||
27577109|NCT00512096|80296340|FG000|Overall Study|Lack of Efficacy|3|||
27577110|NCT04960228|80296341|FG000|Overall Study|Withdrawal by Subject|216|||
27577111|NCT04960228|80296342|FG001|Overall Study|Withdrawal by Subject|35|||
27577112|NCT04960228|80296341|FG000|Overall Study|Failed attention check|69|||
27794437|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
27794438|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
27577113|NCT04960228|80296342|FG001|Overall Study|Failed attention check|148|||
27577114|NCT04960228|80296341|FG000|Overall Study|Flagged for response quality by Dynata|3|||
27577115|NCT04960228|80296342|FG001|Overall Study|Flagged for response quality by Dynata|3|||
27577116|NCT00550836|80296343|FG000|Overall Study|Withdrawal by Subject|3|||
27794439|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794440|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794441|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794442|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794443|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794444|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
27982505|NCT02914561|81767364|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982506|NCT02914561|81767365|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982507|NCT02914561|81767366|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
27982508|NCT02914561|81767367|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
27982509|NCT02914561|81767368|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
27982510|NCT02914561|81767369|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
27982511|NCT00896649|81767372|FG000|Overall Study|Physician Decision|1|||
27982512|NCT00896649|81767372|FG000|Overall Study|Pregnancy|1|||
27982513|NCT00896649|81767372|FG000|Overall Study|missing documentation|1|||
27982514|NCT00896649|81767372|FG000|Overall Study|technical difficulties|2|||
27982515|NCT02290938|81767373|FG000|Overall Study|Lost to Follow-up|14|||
27982516|NCT02290938|81767374|FG001|Overall Study|Lost to Follow-up|43|||
27577117|NCT00550836|80296344|FG001|Overall Study|Withdrawal by Subject|9|||
27577118|NCT00937547|80296345|FG000|Overall Study|misdiagnosis|1|||
27577119|NCT00937547|80296346|FG001|Overall Study|misdiagnosis|6|||
27577120|NCT00937547|80296347|FG002|Overall Study|misdiagnosis|7|||
27577121|NCT00775437|80296348|FG000|Overall Study|Loss of efficacy|2|||
27577122|NCT00775437|80296348|FG000|Overall Study|Withdrawal by Subject|3|||
27577123|NCT00775437|80296348|FG000|Overall Study|Lost to Follow-up|1|||
27577124|NCT01565993|80296349|FG000|Overall Study|Physician Decision|0|||
27577125|NCT01565993|80296350|FG001|Overall Study|Physician Decision|3|||
27577126|NCT03394391|80296351|FG000|Overall Study|Lost to Follow-up|1|||
27577127|NCT03394391|80296352|FG001|Overall Study|Lost to Follow-up|2|||
27577128|NCT01175382|80296354|FG000|Overall Study|Lost to Follow-up|4|||
27577129|NCT01175382|80296355|FG001|Overall Study|Lost to Follow-up|3|||
27577130|NCT01175382|80296356|FG002|Overall Study|Lost to Follow-up|1|||
27577131|NCT01175382|80296354|FG000|Overall Study|Physician Decision|0|||
27577132|NCT01175382|80296355|FG001|Overall Study|Physician Decision|1|||
27577133|NCT01175382|80296356|FG002|Overall Study|Physician Decision|0|||
27577134|NCT01175382|80296354|FG000|Overall Study|Withdrawal by Subject|0|||
27577135|NCT01175382|80296355|FG001|Overall Study|Withdrawal by Subject|0|||
27577136|NCT01175382|80296356|FG002|Overall Study|Withdrawal by Subject|1|||
27577137|NCT01175382|80296354|FG000|Overall Study|No longer having problem|1|||
27577138|NCT01175382|80296355|FG001|Overall Study|No longer having problem|0|||
27577139|NCT01175382|80296356|FG002|Overall Study|No longer having problem|1|||
27577140|NCT01175382|80296354|FG000|Overall Study|Unable/unwilling to attend visits|3|||
27577141|NCT01175382|80296355|FG001|Overall Study|Unable/unwilling to attend visits|1|||
27577142|NCT01175382|80296356|FG002|Overall Study|Unable/unwilling to attend visits|2|||
27577143|NCT01175382|80296354|FG000|Overall Study|Unwilling to follow protocol|0|||
27577144|NCT01175382|80296355|FG001|Overall Study|Unwilling to follow protocol|1|||
27577145|NCT01175382|80296356|FG002|Overall Study|Unwilling to follow protocol|0|||
27577146|NCT01175382|80296354|FG000|Overall Study|Unable to tolerate study meds|0|||
27577147|NCT01175382|80296355|FG001|Overall Study|Unable to tolerate study meds|1|||
27577148|NCT01175382|80296356|FG002|Overall Study|Unable to tolerate study meds|1|||
27577149|NCT02566759|80296358|FG000|All Parts|Withdrawal by Subject|0|||
27577150|NCT02566759|80296359|FG001|All Parts|Withdrawal by Subject|1|||
27577151|NCT02566759|80296360|FG002|All Parts|Withdrawal by Subject|0|||
27577152|NCT02566759|80296361|FG003|All Parts|Withdrawal by Subject|0|||
27577153|NCT02566759|80296362|FG004|All Parts|Withdrawal by Subject|0|||
27577154|NCT02566759|80296363|FG005|All Parts|Withdrawal by Subject|0|||
27577155|NCT02566759|80296364|FG006|All Parts|Withdrawal by Subject|0|||
27577156|NCT02566759|80296365|FG007|All Parts|Withdrawal by Subject|0|||
27577157|NCT02566759|80296366|FG008|All Parts|Withdrawal by Subject|0|||
27577158|NCT02566759|80296367|FG009|All Parts|Withdrawal by Subject|0|||
27577159|NCT02566759|80296368|FG010|All Parts|Withdrawal by Subject|0|||
27794445|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27577160|NCT02566759|80296369|FG011|All Parts|Withdrawal by Subject|0|||
27577161|NCT02566759|80296370|FG012|All Parts|Withdrawal by Subject|0|||
27577162|NCT02566759|80296371|FG013|All Parts|Withdrawal by Subject|0|||
27577163|NCT02566759|80296372|FG014|All Parts|Withdrawal by Subject|0|||
27577164|NCT02566759|80296373|FG015|All Parts|Withdrawal by Subject|0|||
27577165|NCT02566759|80296374|FG016|All Parts|Withdrawal by Subject|0|||
27577166|NCT02566759|80296358|FG000|All Parts|Adverse Event|0|||
27577167|NCT02566759|80296359|FG001|All Parts|Adverse Event|0|||
27577168|NCT02566759|80296360|FG002|All Parts|Adverse Event|0|||
27982517|NCT00430937|81767378|FG000|Overall Study|Adverse Event|3|||
27982518|NCT00430937|81767379|FG001|Overall Study|Adverse Event|8|||
27982519|NCT00430937|81767378|FG000|Overall Study|Death|0|||
27577169|NCT02566759|80296361|FG003|All Parts|Adverse Event|0|||
27577170|NCT02566759|80296362|FG004|All Parts|Adverse Event|0|||
27577171|NCT02566759|80296363|FG005|All Parts|Adverse Event|0|||
27577172|NCT02566759|80296364|FG006|All Parts|Adverse Event|0|||
27577173|NCT02566759|80296365|FG007|All Parts|Adverse Event|0|||
27674066|NCT01496365|80643490|FG001|Overall Study|Lost to Follow-up|1|||
27674067|NCT01496365|80643491|FG002|Overall Study|Lost to Follow-up|0|||
27674068|NCT01496365|80643492|FG003|Overall Study|Lost to Follow-up|0|||
27674069|NCT01496365|80643493|FG004|Overall Study|Lost to Follow-up|2|||
27674070|NCT01496365|80643494|FG005|Overall Study|Lost to Follow-up|0|||
27674071|NCT01496365|80643495|FG006|Overall Study|Lost to Follow-up|0|||
27674072|NCT01496365|80643489|FG000|Overall Study|Other|4|||
27674073|NCT01496365|80643490|FG001|Overall Study|Other|4|||
27674074|NCT01496365|80643491|FG002|Overall Study|Other|2|||
27674075|NCT01496365|80643492|FG003|Overall Study|Other|1|||
27674076|NCT01496365|80643493|FG004|Overall Study|Other|3|||
27674077|NCT01496365|80643494|FG005|Overall Study|Other|0|||
27674078|NCT01496365|80643495|FG006|Overall Study|Other|1|||
27674079|NCT00798434|80643496|FG000|Double-Blind|Adverse Event|22|||
27674080|NCT00798434|80643497|FG001|Double-Blind|Adverse Event|46|||
27674081|NCT00798434|80643496|FG000|Double-Blind|Death|0|||
27674082|NCT00798434|80643497|FG001|Double-Blind|Death|1|||
27674083|NCT00798434|80643496|FG000|Double-Blind|Lost to Follow-up|1|||
27674084|NCT00798434|80643497|FG001|Double-Blind|Lost to Follow-up|0|||
27674085|NCT00798434|80643496|FG000|Double-Blind|Lack of Efficacy|8|||
27674086|NCT00798434|80643497|FG001|Double-Blind|Lack of Efficacy|12|||
27674087|NCT00798434|80643496|FG000|Double-Blind|Withdrawal by Subject|17|||
27674088|NCT00798434|80643497|FG001|Double-Blind|Withdrawal by Subject|14|||
27674089|NCT00798434|80643496|FG000|Double-Blind|Protocol Violation|1|||
27674090|NCT00798434|80643497|FG001|Double-Blind|Protocol Violation|4|||
27674091|NCT00798434|80643496|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
27674092|NCT00798434|80643497|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
27674093|NCT00798434|80643496|FG000|Double-Blind|Other|1|||
27674094|NCT00798434|80643497|FG001|Double-Blind|Other|0|||
27674095|NCT00798434|80643496|FG000|Double-Blind|Not Treated|3|||
27674096|NCT00798434|80643497|FG001|Double-Blind|Not Treated|6|||
27674097|NCT00798434|80643496|FG000|Open-Label|Adverse Event|33|||
27674098|NCT00798434|80643497|FG001|Open-Label|Adverse Event|11|||
27674099|NCT00798434|80643496|FG000|Open-Label|Lack of Efficacy|5|||
27674100|NCT00798434|80643497|FG001|Open-Label|Lack of Efficacy|11|||
27674101|NCT00798434|80643496|FG000|Open-Label|Withdrawal by Subject|2|||
27674102|NCT00798434|80643497|FG001|Open-Label|Withdrawal by Subject|7|||
27674103|NCT00798434|80643496|FG000|Open-Label|Protocol Violation|1|||
27674104|NCT00798434|80643497|FG001|Open-Label|Protocol Violation|0|||
27674105|NCT00798434|80643496|FG000|Open-Label|Other|1|||
27674106|NCT00798434|80643497|FG001|Open-Label|Other|2|||
27674107|NCT00798434|80643496|FG000|Open-Label|Not Treated|0|||
27674108|NCT00798434|80643497|FG001|Open-Label|Not Treated|1|||
27674109|NCT02229227|80643498|FG000|Overall Study|Adverse Event|14|||
27674110|NCT02229227|80643499|FG001|Overall Study|Adverse Event|9|||
27674111|NCT02229227|80643498|FG000|Overall Study|Lack of Efficacy|3|||
27674112|NCT02229227|80643499|FG001|Overall Study|Lack of Efficacy|3|||
27674113|NCT02229227|80643498|FG000|Overall Study|Protocol Violation|6|||
27674114|NCT02229227|80643499|FG001|Overall Study|Protocol Violation|8|||
27674115|NCT02229227|80643498|FG000|Overall Study|Protocol defined stopping criteria|1|||
27674116|NCT02229227|80643499|FG001|Overall Study|Protocol defined stopping criteria|3|||
27674117|NCT02229227|80643498|FG000|Overall Study|Lost to Follow-up|3|||
27674118|NCT02229227|80643499|FG001|Overall Study|Lost to Follow-up|3|||
27674119|NCT02229227|80643498|FG000|Overall Study|Study terminated by sponsor|11|||
27674120|NCT02229227|80643499|FG001|Overall Study|Study terminated by sponsor|11|||
27674121|NCT02229227|80643498|FG000|Overall Study|Withdrawal by Subject|8|||
27674122|NCT02229227|80643499|FG001|Overall Study|Withdrawal by Subject|12|||
27674123|NCT02229227|80643498|FG000|Overall Study|Other|0|||
27674124|NCT02229227|80643499|FG001|Overall Study|Other|1|||
27674125|NCT02229227|80643498|FG000|Overall Study|Physician Decision|5|||
27674126|NCT02229227|80643499|FG001|Overall Study|Physician Decision|12|||
27674127|NCT00150618|80643500|FG000|Overall Study|Adverse Event|2|||
27674128|NCT00150618|80643501|FG001|Overall Study|Adverse Event|2|||
27674129|NCT00150618|80643502|FG002|Overall Study|Adverse Event|6|||
27674130|NCT00150618|80643503|FG003|Overall Study|Adverse Event|9|||
27674131|NCT00150618|80643504|FG004|Overall Study|Adverse Event|5|||
27674132|NCT00150618|80643500|FG000|Overall Study|Withdrawal by Subject|6|||
27674133|NCT00150618|80643501|FG001|Overall Study|Withdrawal by Subject|8|||
27674134|NCT00150618|80643502|FG002|Overall Study|Withdrawal by Subject|8|||
27674135|NCT00150618|80643503|FG003|Overall Study|Withdrawal by Subject|4|||
27577174|NCT02566759|80296366|FG008|All Parts|Adverse Event|0|||
27577175|NCT02566759|80296367|FG009|All Parts|Adverse Event|0|||
27577176|NCT02566759|80296368|FG010|All Parts|Adverse Event|0|||
27577177|NCT02566759|80296369|FG011|All Parts|Adverse Event|0|||
27577178|NCT02566759|80296370|FG012|All Parts|Adverse Event|1|||
27577179|NCT02566759|80296371|FG013|All Parts|Adverse Event|3|||
27577180|NCT02566759|80296372|FG014|All Parts|Adverse Event|0|||
27577181|NCT02566759|80296373|FG015|All Parts|Adverse Event|0|||
27577182|NCT02566759|80296374|FG016|All Parts|Adverse Event|0|||
27577183|NCT02566759|80296358|FG000|All Parts|Other|0|||
27577184|NCT02566759|80296359|FG001|All Parts|Other|0|||
27577185|NCT02566759|80296360|FG002|All Parts|Other|0|||
27577186|NCT02566759|80296361|FG003|All Parts|Other|0|||
27577187|NCT02566759|80296362|FG004|All Parts|Other|0|||
27577188|NCT02566759|80296363|FG005|All Parts|Other|0|||
27577189|NCT02566759|80296364|FG006|All Parts|Other|0|||
27577190|NCT02566759|80296365|FG007|All Parts|Other|0|||
27577191|NCT02566759|80296366|FG008|All Parts|Other|0|||
27577192|NCT02566759|80296367|FG009|All Parts|Other|0|||
27577193|NCT02566759|80296368|FG010|All Parts|Other|0|||
27577194|NCT02566759|80296369|FG011|All Parts|Other|0|||
27577195|NCT02566759|80296370|FG012|All Parts|Other|0|||
27577196|NCT02566759|80296371|FG013|All Parts|Other|2|||
27577197|NCT02566759|80296372|FG014|All Parts|Other|0|||
27577198|NCT02566759|80296373|FG015|All Parts|Other|0|||
27577199|NCT02566759|80296374|FG016|All Parts|Other|0|||
27577200|NCT02566759|80296358|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577201|NCT02566759|80296359|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577202|NCT02566759|80296360|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577203|NCT02566759|80296361|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577204|NCT02566759|80296362|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577205|NCT02566759|80296363|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27794446|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794447|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794448|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
27794449|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794450|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27982520|NCT00430937|81767379|FG001|Overall Study|Death|1|||
27982521|NCT00430937|81767378|FG000|Overall Study|Lost to Follow-up|6|||
27982522|NCT00430937|81767379|FG001|Overall Study|Lost to Follow-up|6|||
27982523|NCT00430937|81767378|FG000|Overall Study|Withdrawal by Subject|5|||
27982524|NCT00430937|81767379|FG001|Overall Study|Withdrawal by Subject|2|||
27982525|NCT00430937|81767378|FG000|Overall Study|Protocol Violation|3|||
27982526|NCT00430937|81767379|FG001|Overall Study|Protocol Violation|2|||
27982527|NCT00430937|81767378|FG000|Overall Study|Lack of Efficacy|6|||
27982528|NCT00430937|81767379|FG001|Overall Study|Lack of Efficacy|5|||
27982529|NCT00430937|81767378|FG000|Overall Study|Inappropriate enrollment|2|||
27982530|NCT00430937|81767379|FG001|Overall Study|Inappropriate enrollment|1|||
27982531|NCT00430937|81767378|FG000|Overall Study|Administrative reasons|1|||
27982532|NCT00430937|81767379|FG001|Overall Study|Administrative reasons|0|||
27982533|NCT00430937|81767378|FG000|Overall Study|Protocol discontinuation criteria met|1|||
27982534|NCT00430937|81767379|FG001|Overall Study|Protocol discontinuation criteria met|2|||
27982535|NCT00430937|81767378|FG000|Overall Study|Unable to classify|0|||
27982536|NCT00430937|81767379|FG001|Overall Study|Unable to classify|1|||
27982537|NCT00619489|81767385|FG000|Overall Study|Adverse Event|0|||
27982538|NCT00619489|81767386|FG001|Overall Study|Adverse Event|7|||
27982539|NCT00619489|81767385|FG000|Overall Study|Withdrawal by Subject|1|||
27982540|NCT00619489|81767386|FG001|Overall Study|Withdrawal by Subject|1|||
27982541|NCT00619489|81767385|FG000|Overall Study|Lack of Efficacy|0|||
27794451|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27982542|NCT00619489|81767386|FG001|Overall Study|Lack of Efficacy|11|||
27982543|NCT00619489|81767385|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
27982544|NCT00619489|81767386|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
27982545|NCT00576576|81767387|FG000|Overall Study|Lost to Follow-up|6|||
27982546|NCT00576576|81767387|FG000|Overall Study|Protocol Violation|1|||
27982547|NCT02469415|81767388|FG000|Overall Study|Withdrawal by Subject|1|||
27982548|NCT02469415|81767388|FG000|Overall Study|Investigational agent placed on hold|2|||
27982549|NCT01719003|81767392|FG000|Overall Study|Non compliant with protocol|1|||
27577206|NCT02566759|80296364|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577207|NCT02566759|80296365|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577208|NCT02566759|80296366|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577209|NCT02566759|80296367|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577210|NCT02566759|80296368|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577211|NCT02566759|80296369|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27674136|NCT00150618|80643504|FG004|Overall Study|Withdrawal by Subject|5|||
27982550|NCT01719003|81767393|FG001|Overall Study|Non compliant with protocol|1|||
27982551|NCT01719003|81767394|FG002|Overall Study|Non compliant with protocol|0|||
27982552|NCT01719003|81767395|FG003|Overall Study|Non compliant with protocol|1|||
27982553|NCT01719003|81767396|FG004|Overall Study|Non compliant with protocol|2|||
27982554|NCT01719003|81767397|FG005|Overall Study|Non compliant with protocol|1|||
27982555|NCT01719003|81767398|FG006|Overall Study|Non compliant with protocol|2|||
27982556|NCT01719003|81767399|FG007|Overall Study|Non compliant with protocol|3|||
27982557|NCT01719003|81767400|FG008|Overall Study|Non compliant with protocol|0|||
27982558|NCT01719003|81767392|FG000|Overall Study|Adverse Event|6|||
27982559|NCT01719003|81767393|FG001|Overall Study|Adverse Event|5|||
27982560|NCT01719003|81767394|FG002|Overall Study|Adverse Event|4|||
27982561|NCT01719003|81767395|FG003|Overall Study|Adverse Event|3|||
27982562|NCT01719003|81767396|FG004|Overall Study|Adverse Event|4|||
27982563|NCT01719003|81767397|FG005|Overall Study|Adverse Event|3|||
27982564|NCT01719003|81767398|FG006|Overall Study|Adverse Event|6|||
27982565|NCT01719003|81767399|FG007|Overall Study|Adverse Event|5|||
27982566|NCT01719003|81767400|FG008|Overall Study|Adverse Event|0|||
27982567|NCT01719003|81767392|FG000|Overall Study|Lost to Follow-up|0|||
27982568|NCT01719003|81767393|FG001|Overall Study|Lost to Follow-up|6|||
27982569|NCT01719003|81767394|FG002|Overall Study|Lost to Follow-up|7|||
27982570|NCT01719003|81767395|FG003|Overall Study|Lost to Follow-up|2|||
27982571|NCT01719003|81767396|FG004|Overall Study|Lost to Follow-up|3|||
27982572|NCT01719003|81767397|FG005|Overall Study|Lost to Follow-up|4|||
27982573|NCT01719003|81767398|FG006|Overall Study|Lost to Follow-up|3|||
27982574|NCT01719003|81767399|FG007|Overall Study|Lost to Follow-up|2|||
27982575|NCT01719003|81767400|FG008|Overall Study|Lost to Follow-up|2|||
27982576|NCT01719003|81767392|FG000|Overall Study|Refusal to continue, not due to AE|2|||
27982577|NCT01719003|81767393|FG001|Overall Study|Refusal to continue, not due to AE|5|||
27982578|NCT01719003|81767394|FG002|Overall Study|Refusal to continue, not due to AE|4|||
27982579|NCT01719003|81767395|FG003|Overall Study|Refusal to continue, not due to AE|4|||
27982580|NCT01719003|81767396|FG004|Overall Study|Refusal to continue, not due to AE|4|||
27982581|NCT01719003|81767397|FG005|Overall Study|Refusal to continue, not due to AE|3|||
27982582|NCT01719003|81767398|FG006|Overall Study|Refusal to continue, not due to AE|8|||
27982583|NCT01719003|81767399|FG007|Overall Study|Refusal to continue, not due to AE|7|||
27982584|NCT01719003|81767400|FG008|Overall Study|Refusal to continue, not due to AE|1|||
27982585|NCT01719003|81767392|FG000|Overall Study|Reason other than those specified|0|||
27982586|NCT01719003|81767393|FG001|Overall Study|Reason other than those specified|0|||
27982587|NCT01719003|81767394|FG002|Overall Study|Reason other than those specified|2|||
27982588|NCT01719003|81767395|FG003|Overall Study|Reason other than those specified|3|||
27982589|NCT01719003|81767396|FG004|Overall Study|Reason other than those specified|4|||
27982590|NCT01719003|81767397|FG005|Overall Study|Reason other than those specified|1|||
27982591|NCT01719003|81767398|FG006|Overall Study|Reason other than those specified|0|||
27982592|NCT01719003|81767399|FG007|Overall Study|Reason other than those specified|3|||
27982593|NCT01719003|81767400|FG008|Overall Study|Reason other than those specified|1|||
27982594|NCT01719003|81767392|FG000|Overall Study|Lack of Efficacy|0|||
27982595|NCT01719003|81767393|FG001|Overall Study|Lack of Efficacy|0|||
27982596|NCT01719003|81767394|FG002|Overall Study|Lack of Efficacy|0|||
27982597|NCT01719003|81767395|FG003|Overall Study|Lack of Efficacy|0|||
27982598|NCT01719003|81767396|FG004|Overall Study|Lack of Efficacy|0|||
27982599|NCT01719003|81767397|FG005|Overall Study|Lack of Efficacy|0|||
27982600|NCT01719003|81767398|FG006|Overall Study|Lack of Efficacy|1|||
27982601|NCT01719003|81767399|FG007|Overall Study|Lack of Efficacy|0|||
27982602|NCT01719003|81767400|FG008|Overall Study|Lack of Efficacy|0|||
27982603|NCT02715726|81767401|FG000|Overall Study|Adverse Event|2|||
27982604|NCT02715726|81767402|FG001|Overall Study|Adverse Event|6|||
27982605|NCT02715726|81767401|FG000|Overall Study|Protocol Violation|1|||
27982606|NCT02715726|81767402|FG001|Overall Study|Protocol Violation|0|||
27982607|NCT02715726|81767401|FG000|Overall Study|Death|2|||
27982608|NCT02715726|81767402|FG001|Overall Study|Death|1|||
27982609|NCT02715726|81767401|FG000|Overall Study|Participant moved|1|||
27982610|NCT02715726|81767402|FG001|Overall Study|Participant moved|3|||
27982611|NCT02715726|81767401|FG000|Overall Study|Other than specified above|11|||
27982612|NCT02715726|81767402|FG001|Overall Study|Other than specified above|15|||
27577212|NCT02566759|80296370|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27674137|NCT00150618|80643500|FG000|Overall Study|Lost to Follow-up|4|||
27868651|NCT02766335|81353887|FG002|Initial Registration|Progression/relapse|0|||
27982613|NCT02715726|81767401|FG000|Overall Study|Randomized but not treated|1|||
27982614|NCT02715726|81767402|FG001|Overall Study|Randomized but not treated|2|||
27982615|NCT05059977|81767403|FG000|Overall Study|Withdrawal by Subject|0|||
27982616|NCT05059977|81767404|FG001|Overall Study|Withdrawal by Subject|0|||
27982617|NCT05059977|81767405|FG002|Overall Study|Withdrawal by Subject|1|||
27982618|NCT00007020|81767406|FG000|Overall Study|Death|16|||
27982619|NCT00007020|81767406|FG000|Overall Study|Lost to Follow-up|13|||
27868652|NCT02766335|81353885|FG000|Initial Registration|Death|1|||
27982620|NCT00007020|81767406|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
27674138|NCT00150618|80643501|FG001|Overall Study|Lost to Follow-up|1|||
27674139|NCT00150618|80643502|FG002|Overall Study|Lost to Follow-up|5|||
27674140|NCT00150618|80643503|FG003|Overall Study|Lost to Follow-up|8|||
27674141|NCT00150618|80643504|FG004|Overall Study|Lost to Follow-up|4|||
27674142|NCT00150618|80643500|FG000|Overall Study|Protocol Violation|1|||
27674143|NCT00150618|80643501|FG001|Overall Study|Protocol Violation|0|||
27674144|NCT00150618|80643502|FG002|Overall Study|Protocol Violation|0|||
27674145|NCT00150618|80643503|FG003|Overall Study|Protocol Violation|0|||
27674146|NCT00150618|80643504|FG004|Overall Study|Protocol Violation|1|||
27674147|NCT00150618|80643500|FG000|Overall Study|Lack of Efficacy|1|||
27674148|NCT00150618|80643501|FG001|Overall Study|Lack of Efficacy|4|||
27674149|NCT00150618|80643502|FG002|Overall Study|Lack of Efficacy|7|||
27674150|NCT00150618|80643503|FG003|Overall Study|Lack of Efficacy|4|||
27674151|NCT00150618|80643504|FG004|Overall Study|Lack of Efficacy|6|||
27674152|NCT00150618|80643500|FG000|Overall Study|No study meds|0|||
27674153|NCT00150618|80643501|FG001|Overall Study|No study meds|0|||
27674154|NCT00150618|80643502|FG002|Overall Study|No study meds|0|||
27674155|NCT00150618|80643503|FG003|Overall Study|No study meds|0|||
27674156|NCT00150618|80643504|FG004|Overall Study|No study meds|2|||
27674157|NCT00150618|80643500|FG000|Overall Study|Physician Decision|0|||
27674158|NCT00150618|80643501|FG001|Overall Study|Physician Decision|2|||
27674159|NCT00150618|80643502|FG002|Overall Study|Physician Decision|0|||
27674160|NCT00150618|80643503|FG003|Overall Study|Physician Decision|0|||
27674161|NCT00150618|80643504|FG004|Overall Study|Physician Decision|1|||
27674162|NCT00150618|80643500|FG000|Overall Study|Lack of compliance|2|||
27674163|NCT00150618|80643501|FG001|Overall Study|Lack of compliance|1|||
27674164|NCT00150618|80643502|FG002|Overall Study|Lack of compliance|1|||
27794452|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
27982621|NCT00007020|81767406|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
27982622|NCT00007020|81767406|FG000|Overall Study|Pt cared for by outside physician|4|||
27982623|NCT00007020|81767406|FG000|Overall Study|No evidence of treatment|6|||
27982624|NCT00946322|81767408|FG000|Pre-treatment|participant failure to follow up|1|||
27982625|NCT00946322|81767408|FG000|Post-treatment|participant failure to follow up|2|||
27982626|NCT00046930|81767414|FG000|Overall Study|Ineligible|12|||
27982627|NCT00046930|81767415|FG001|Overall Study|Ineligible|4|||
27982628|NCT02455076|81767416|FG000|Inpatient|Withdrawal by Subject|1|||
27982629|NCT02455076|81767417|FG001|Inpatient|Withdrawal by Subject|0|||
27982630|NCT02455076|81767418|FG002|Inpatient|Withdrawal by Subject|0|||
27982631|NCT02455076|81767419|FG003|Inpatient|Withdrawal by Subject|0|||
27982632|NCT02455076|81767420|FG004|Inpatient|Withdrawal by Subject|0|||
27982633|NCT02455076|81767416|FG000|Inpatient|Discharged <24 h after admission|0|||
27982634|NCT02455076|81767417|FG001|Inpatient|Discharged <24 h after admission|1|||
27982635|NCT02455076|81767418|FG002|Inpatient|Discharged <24 h after admission|0|||
27982636|NCT02455076|81767419|FG003|Inpatient|Discharged <24 h after admission|0|||
27982637|NCT02455076|81767420|FG004|Inpatient|Discharged <24 h after admission|0|||
27982638|NCT02455076|81767416|FG000|Inpatient|Adverse Event|3|||
27982639|NCT02455076|81767417|FG001|Inpatient|Adverse Event|0|||
27982640|NCT02455076|81767418|FG002|Inpatient|Adverse Event|0|||
27982641|NCT02455076|81767419|FG003|Inpatient|Adverse Event|0|||
27982642|NCT02455076|81767420|FG004|Inpatient|Adverse Event|0|||
27982643|NCT02455076|81767416|FG000|Outpatient|Adverse Event|0|||
27982644|NCT02455076|81767417|FG001|Outpatient|Adverse Event|0|||
27982645|NCT02455076|81767418|FG002|Outpatient|Adverse Event|0|||
27982646|NCT02455076|81767419|FG003|Outpatient|Adverse Event|5|||
27982647|NCT02455076|81767420|FG004|Outpatient|Adverse Event|0|||
27982648|NCT02455076|81767416|FG000|Outpatient|Lost to Follow-up|0|||
27982649|NCT02455076|81767417|FG001|Outpatient|Lost to Follow-up|0|||
27982650|NCT02455076|81767418|FG002|Outpatient|Lost to Follow-up|0|||
27982651|NCT02455076|81767419|FG003|Outpatient|Lost to Follow-up|1|||
27982652|NCT02455076|81767420|FG004|Outpatient|Lost to Follow-up|12|||
27982653|NCT04375397|81767423|FG000|Overall Study|Death|1|||
27982654|NCT04375397|81767424|FG001|Overall Study|Death|1|||
27982655|NCT04375397|81767423|FG000|Overall Study|Withdrew consent|2|||
27794453|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
27794454|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
27674165|NCT00150618|80643503|FG003|Overall Study|Lack of compliance|0|||
27794455|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
27674166|NCT00150618|80643504|FG004|Overall Study|Lack of compliance|1|||
27674167|NCT00150618|80643500|FG000|Overall Study|Abnormal ECG|1|||
27982656|NCT04375397|81767424|FG001|Overall Study|Withdrew consent|0|||
27982657|NCT04375397|81767423|FG000|Overall Study|Lost to Follow-up|6|||
27982658|NCT04375397|81767424|FG001|Overall Study|Lost to Follow-up|4|||
27982659|NCT04375397|81767423|FG000|Overall Study|Other, not specified|0|||
27982660|NCT04375397|81767424|FG001|Overall Study|Other, not specified|1|||
27982661|NCT00587847|81767425|FG000|Overall Study|Lack of Efficacy|5|||
27674168|NCT00150618|80643501|FG001|Overall Study|Abnormal ECG|0|||
27674169|NCT00150618|80643502|FG002|Overall Study|Abnormal ECG|0|||
27794456|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
27982662|NCT00587847|81767425|FG000|Overall Study|Adverse Event|2|||
27982663|NCT00160654|81767426|FG000|Overall Study|Adverse Event|14|||
27982664|NCT00160654|81767426|FG000|Overall Study|Lack of Efficacy|4|||
27982665|NCT00160654|81767426|FG000|Overall Study|Lost to Follow-up|2|||
27982666|NCT00160654|81767426|FG000|Overall Study|Intake of expired drug|7|||
27982667|NCT00160654|81767426|FG000|Overall Study|Psychological trauma|1|||
27982668|NCT00160654|81767426|FG000|Overall Study|Sponsor decision|1|||
27982669|NCT00160654|81767426|FG000|Overall Study|Patient met exclusion criteria|1|||
27982670|NCT00160654|81767426|FG000|Overall Study|Patient decision|1|||
27982671|NCT00160654|81767426|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
27794457|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
27794458|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
27982672|NCT00160654|81767426|FG000|Overall Study|Met exclusion criteria|1|||
27982673|NCT02559414|81767430|FG000|Overall Study|Lost to Follow-up|0|||
27982674|NCT02559414|81767431|FG001|Overall Study|Lost to Follow-up|1|||
27982675|NCT02559414|81767432|FG002|Overall Study|Lost to Follow-up|0|||
27982676|NCT02559414|81767430|FG000|Overall Study|Withdrawal by Subject|1|||
27982677|NCT02559414|81767431|FG001|Overall Study|Withdrawal by Subject|0|||
27982678|NCT02559414|81767432|FG002|Overall Study|Withdrawal by Subject|1|||
27982679|NCT02559414|81767430|FG000|Overall Study|Other|0|||
27982680|NCT02559414|81767431|FG001|Overall Study|Other|1|||
27982681|NCT02559414|81767432|FG002|Overall Study|Other|1|||
27982682|NCT00490022|81767436|FG000|Overall Study|Adverse Event|0|||
27794459|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794460|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794461|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794462|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794463|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
27794464|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794465|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794466|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794467|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794468|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794469|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794470|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794471|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794472|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
27794473|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794474|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794475|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
27794476|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
27794477|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794478|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794479|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794480|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794481|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794482|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794483|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794484|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794485|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794486|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794487|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
27794488|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794489|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794490|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
27868653|NCT02766335|81353886|FG001|Initial Registration|Death|3|||
27868654|NCT02766335|81353887|FG002|Initial Registration|Death|0|||
27868655|NCT02766335|81353885|FG000|Initial Registration|not protocol specified|1|||
27982683|NCT00490022|81767437|FG001|Overall Study|Adverse Event|2|||
27982684|NCT00490022|81767436|FG000|Overall Study|Withdrawal by Subject|1|||
27982685|NCT00490022|81767437|FG001|Overall Study|Withdrawal by Subject|0|||
27982686|NCT00490022|81767436|FG000|Overall Study|Subject failed to disclose concommitant|0|||
27982687|NCT00490022|81767437|FG001|Overall Study|Subject failed to disclose concommitant|1|||
27982688|NCT02613169|81767442|FG000|Overall Study|Withdrawal by Subject|4|||
27982689|NCT02613169|81767443|FG001|Overall Study|Withdrawal by Subject|1|||
27794491|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794492|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794493|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
27794494|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
27794495|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
27794496|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
27794497|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
27794498|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794499|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
27794500|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794501|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794502|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
27794503|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794504|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794505|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27982690|NCT02613169|81767442|FG000|Overall Study|Lost to Follow-up|0|||
27982691|NCT02613169|81767443|FG001|Overall Study|Lost to Follow-up|5|||
27982692|NCT02613169|81767442|FG000|Overall Study|HIV|0|||
27982693|NCT02613169|81767443|FG001|Overall Study|HIV|2|||
27982694|NCT02613169|81767442|FG000|Overall Study|No TB infection endpoint|14|||
27982695|NCT02613169|81767443|FG001|Overall Study|No TB infection endpoint|9|||
27982696|NCT00664326|81770243|FG000|Overall Study|Adverse Event|14|||
27982697|NCT00664326|81770243|FG000|Overall Study|Noncompliance with study medication|3|||
27982698|NCT00664326|81770243|FG000|Overall Study|Withdrawal by Subject|1|||
27982699|NCT00664326|81770243|FG000|Overall Study|Physician Decision|1|||
27982700|NCT00664326|81770243|FG000|Overall Study|Other Reasons|3|||
27982701|NCT00664326|81770243|FG000|Overall Study|Death|2|||
27982702|NCT00664326|81770243|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
27982703|NCT02963701|81770244|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
27982704|NCT02963701|81770245|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
27982705|NCT02299076|81770248|FG000|Overall Study|Fraudulent Entries|20|||
27982706|NCT02299076|81770249|FG001|Overall Study|Fraudulent Entries|14|||
27982707|NCT00903331|81770252|FG000|Overall Study|Death|4|||
27982708|NCT00903331|81770253|FG001|Overall Study|Death|8|||
27982709|NCT00903331|81770252|FG000|Overall Study|Withdrawal of consent|1|||
27982710|NCT00903331|81770253|FG001|Overall Study|Withdrawal of consent|8|||
27982711|NCT00903331|81770252|FG000|Overall Study|Lung transplant|0|||
27982712|NCT00903331|81770253|FG001|Overall Study|Lung transplant|2|||
27982713|NCT01818492|81770254|FG000|Overall Study|Adverse Event|2|||
27982714|NCT01818492|81770254|FG000|Overall Study|Death|3|||
27982715|NCT01818492|81770254|FG000|Overall Study|Withdrawal by Subject|1|||
27982716|NCT01818492|81770254|FG000|Overall Study|Additional therapy when not allowed PP|4|||
27982717|NCT00262847|81770258|FG000|Overall Study|Disease Progression|309|||
27982718|NCT00262847|81770259|FG001|Overall Study|Disease Progression|274|||
27794506|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
27982719|NCT00262847|81770260|FG002|Overall Study|Disease Progression|195|||
27794507|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794508|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
27794509|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
27794510|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
27794511|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
27794512|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
27794513|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
27794514|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
27794515|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794516|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27982720|NCT00262847|81770258|FG000|Overall Study|Patient Refusal|41|||
27982721|NCT00262847|81770259|FG001|Overall Study|Patient Refusal|52|||
27982722|NCT00262847|81770260|FG002|Overall Study|Patient Refusal|47|||
27982723|NCT00262847|81770258|FG000|Overall Study|Adverse Event|74|||
27982724|NCT00262847|81770259|FG001|Overall Study|Adverse Event|88|||
27982725|NCT00262847|81770260|FG002|Overall Study|Adverse Event|108|||
27982726|NCT00262847|81770258|FG000|Overall Study|Death|8|||
27982727|NCT00262847|81770259|FG001|Overall Study|Death|8|||
27982728|NCT00262847|81770260|FG002|Overall Study|Death|11|||
27982729|NCT00262847|81770258|FG000|Overall Study|Concomitant disease|3|||
27982730|NCT00262847|81770259|FG001|Overall Study|Concomitant disease|2|||
27982731|NCT00262847|81770260|FG002|Overall Study|Concomitant disease|4|||
27982732|NCT00262847|81770258|FG000|Overall Study|Other Reasons|79|||
27982733|NCT00262847|81770259|FG001|Overall Study|Other Reasons|88|||
27794517|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
27794518|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794519|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794520|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794521|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794522|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27794523|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27794524|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27794525|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794526|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27794527|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794528|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27794529|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794530|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
27794531|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
27794532|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
27794533|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
27794534|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794535|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794536|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794537|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794538|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
27794539|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794540|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794541|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27982734|NCT00262847|81770260|FG002|Overall Study|Other Reasons|27|||
27982735|NCT00262847|81770258|FG000|Overall Study|Did not receive study treatment|4|||
27794542|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794543|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
27794544|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794545|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27982736|NCT00262847|81770259|FG001|Overall Study|Did not receive study treatment|1|||
27794546|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794547|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794548|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794549|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794550|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794551|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794552|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
27794553|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
27794554|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
27794555|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
27794556|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
27794557|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
27794558|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
27794559|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
27794560|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
27868656|NCT02766335|81353886|FG001|Initial Registration|not protocol specified|9|||
27982737|NCT00262847|81770260|FG002|Overall Study|Did not receive study treatment|4|||
27982738|NCT01198509|81770262|FG000|Overall Study|Withdrawal by Subject|1|||
27982739|NCT01198509|81770263|FG001|Overall Study|Withdrawal by Subject|0|||
27982740|NCT01198509|81770264|FG002|Overall Study|Withdrawal by Subject|0|||
27982741|NCT01198509|81770265|FG003|Overall Study|Withdrawal by Subject|0|||
27982742|NCT01198509|81770266|FG004|Overall Study|Withdrawal by Subject|0|||
27982743|NCT01198509|81770267|FG005|Overall Study|Withdrawal by Subject|0|||
27982744|NCT02544373|81770278|FG000|Overall Study|Lost to Follow-up|5|||
27982745|NCT02544373|81770279|FG001|Overall Study|Lost to Follow-up|3|||
27982746|NCT02544373|81770278|FG000|Overall Study|Withdrawal by Subject|8|||
27982747|NCT02544373|81770279|FG001|Overall Study|Withdrawal by Subject|2|||
27982748|NCT00549770|81770280|FG000|Overall Study|Protocol deviation|1|||
27982749|NCT00549770|81770281|FG001|Overall Study|Protocol deviation|1|||
27982750|NCT00549770|81770282|FG002|Overall Study|Protocol deviation|1|||
27982751|NCT00549770|81770283|FG003|Overall Study|Protocol deviation|2|||
27982752|NCT00549770|81770284|FG004|Overall Study|Protocol deviation|2|||
27982753|NCT00549770|81770285|FG005|Overall Study|Protocol deviation|2|||
27982754|NCT00549770|81770286|FG006|Overall Study|Protocol deviation|1|||
27794561|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
27577213|NCT02566759|80296371|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577214|NCT02566759|80296372|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27577215|NCT02566759|80296373|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
27794562|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
27577216|NCT02566759|80296374|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
27577217|NCT00061048|80296375|FG000|Overall Study|Adverse Event|2|||
27577218|NCT00061048|80296375|FG000|Overall Study|disease progression|20|||
27577219|NCT04177108|80296376|FG000|Overall Study|Withdrawal by Subject|4|||
27577220|NCT04177108|80296377|FG001|Overall Study|Withdrawal by Subject|8|||
27577221|NCT04177108|80296378|FG002|Overall Study|Withdrawal by Subject|9|||
27577222|NCT04177108|80296379|FG003|Overall Study|Withdrawal by Subject|11|||
27577223|NCT04177108|80296380|FG004|Overall Study|Withdrawal by Subject|13|||
27577224|NCT04177108|80296376|FG000|Overall Study|Physician Decision|23|||
27577225|NCT04177108|80296377|FG001|Overall Study|Physician Decision|15|||
27577226|NCT04177108|80296378|FG002|Overall Study|Physician Decision|18|||
27577227|NCT04177108|80296379|FG003|Overall Study|Physician Decision|29|||
27577228|NCT04177108|80296380|FG004|Overall Study|Physician Decision|23|||
27577229|NCT04177108|80296376|FG000|Overall Study|Reason Not Specified|0|||
27794563|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
27794564|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
27794565|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
27794566|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
27794567|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
27794568|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
27794569|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
27794570|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
27794571|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
27794572|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794573|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27577230|NCT04177108|80296377|FG001|Overall Study|Reason Not Specified|1|||
27577231|NCT04177108|80296378|FG002|Overall Study|Reason Not Specified|0|||
27577232|NCT04177108|80296379|FG003|Overall Study|Reason Not Specified|0|||
27577233|NCT04177108|80296380|FG004|Overall Study|Reason Not Specified|2|||
27577234|NCT04177108|80296376|FG000|Overall Study|Lost to Follow-up|0|||
27577235|NCT04177108|80296377|FG001|Overall Study|Lost to Follow-up|0|||
27577236|NCT04177108|80296378|FG002|Overall Study|Lost to Follow-up|1|||
27577237|NCT04177108|80296379|FG003|Overall Study|Lost to Follow-up|1|||
27577238|NCT04177108|80296380|FG004|Overall Study|Lost to Follow-up|1|||
27577239|NCT04177108|80296376|FG000|Overall Study|Death|16|||
27577240|NCT04177108|80296377|FG001|Overall Study|Death|19|||
27577241|NCT04177108|80296378|FG002|Overall Study|Death|13|||
27577242|NCT04177108|80296379|FG003|Overall Study|Death|17|||
27577243|NCT04177108|80296380|FG004|Overall Study|Death|18|||
27577244|NCT01023659|80296381|FG000|Overall Study|Lost to Follow-up|73|||
27577245|NCT01023659|80296382|FG001|Overall Study|Lost to Follow-up|228|||
27577246|NCT01023659|80296383|FG002|Overall Study|Lost to Follow-up|99|||
27577247|NCT03946670|80296385|FG000|Overall Study|Progressive Disease|26|||
27577248|NCT03946670|80296386|FG001|Overall Study|Progressive Disease|23|||
27577249|NCT03946670|80296385|FG000|Overall Study|Adverse Event|7|||
27577250|NCT03946670|80296386|FG001|Overall Study|Adverse Event|9|||
27577251|NCT03946670|80296385|FG000|Overall Study|Death|5|||
27577252|NCT03946670|80296386|FG001|Overall Study|Death|6|||
27577253|NCT03946670|80296385|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
27577254|NCT03946670|80296386|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
27982755|NCT00549770|81770287|FG007|Overall Study|Protocol deviation|2|||
27577255|NCT03946670|80296385|FG000|Overall Study|Subject Decision|4|||
27577256|NCT03946670|80296386|FG001|Overall Study|Subject Decision|4|||
27577257|NCT03946670|80296385|FG000|Overall Study|Physician Decision|3|||
27577258|NCT03946670|80296386|FG001|Overall Study|Physician Decision|3|||
27577259|NCT03946670|80296385|FG000|Overall Study|New Therapy for Study Indication|1|||
27577260|NCT03946670|80296386|FG001|Overall Study|New Therapy for Study Indication|0|||
27577261|NCT03946670|80296385|FG000|Overall Study|Not treated|1|||
27577262|NCT03946670|80296386|FG001|Overall Study|Not treated|1|||
27577263|NCT03698773|80296387|FG000|Overall Study|Lost to Follow-up|2|||
27982756|NCT00549770|81770280|FG000|Overall Study|Administrative problems|0|||
27982757|NCT00549770|81770281|FG001|Overall Study|Administrative problems|1|||
27982758|NCT00549770|81770282|FG002|Overall Study|Administrative problems|0|||
27794574|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794575|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794576|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27982759|NCT00549770|81770283|FG003|Overall Study|Administrative problems|0|||
27982760|NCT00549770|81770284|FG004|Overall Study|Administrative problems|0|||
27982761|NCT00549770|81770285|FG005|Overall Study|Administrative problems|0|||
27982762|NCT00549770|81770286|FG006|Overall Study|Administrative problems|0|||
27982763|NCT00549770|81770287|FG007|Overall Study|Administrative problems|1|||
27982764|NCT00549770|81770280|FG000|Overall Study|Lost to Follow-up|0|||
27982765|NCT00549770|81770281|FG001|Overall Study|Lost to Follow-up|0|||
27982766|NCT00549770|81770282|FG002|Overall Study|Lost to Follow-up|2|||
27982767|NCT00549770|81770283|FG003|Overall Study|Lost to Follow-up|2|||
27982768|NCT00549770|81770284|FG004|Overall Study|Lost to Follow-up|3|||
27982769|NCT00549770|81770285|FG005|Overall Study|Lost to Follow-up|2|||
27982770|NCT00549770|81770286|FG006|Overall Study|Lost to Follow-up|0|||
27982771|NCT00549770|81770287|FG007|Overall Study|Lost to Follow-up|0|||
27982772|NCT00549770|81770280|FG000|Overall Study|Withdrawal by Subject|4|||
27982773|NCT00549770|81770281|FG001|Overall Study|Withdrawal by Subject|6|||
27982774|NCT00549770|81770282|FG002|Overall Study|Withdrawal by Subject|4|||
27982775|NCT00549770|81770283|FG003|Overall Study|Withdrawal by Subject|5|||
27982776|NCT00549770|81770284|FG004|Overall Study|Withdrawal by Subject|6|||
27982777|NCT00549770|81770285|FG005|Overall Study|Withdrawal by Subject|6|||
27982778|NCT00549770|81770286|FG006|Overall Study|Withdrawal by Subject|4|||
27982779|NCT00549770|81770287|FG007|Overall Study|Withdrawal by Subject|9|||
27982780|NCT00549770|81770280|FG000|Overall Study|Lack of Efficacy|1|||
27794577|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794578|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794579|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794580|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27982781|NCT00549770|81770281|FG001|Overall Study|Lack of Efficacy|0|||
27794581|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794582|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
27794583|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794584|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794585|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794586|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794587|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27577264|NCT03698773|80296388|FG001|Overall Study|Lost to Follow-up|1|||
27577265|NCT04346615|80296392|FG000|Overall Study|Lost to Follow-up|0|||
27982782|NCT00549770|81770282|FG002|Overall Study|Lack of Efficacy|2|||
27577266|NCT04346615|80296393|FG001|Overall Study|Lost to Follow-up|2|||
27982783|NCT00549770|81770283|FG003|Overall Study|Lack of Efficacy|3|||
27982784|NCT00549770|81770284|FG004|Overall Study|Lack of Efficacy|5|||
27982785|NCT00549770|81770285|FG005|Overall Study|Lack of Efficacy|1|||
27982786|NCT00549770|81770286|FG006|Overall Study|Lack of Efficacy|3|||
27982787|NCT00549770|81770287|FG007|Overall Study|Lack of Efficacy|8|||
27982788|NCT00549770|81770280|FG000|Overall Study|Abnormal test procedure results|0|||
27982789|NCT00549770|81770281|FG001|Overall Study|Abnormal test procedure results|0|||
27982790|NCT00549770|81770282|FG002|Overall Study|Abnormal test procedure results|0|||
27982791|NCT00549770|81770283|FG003|Overall Study|Abnormal test procedure results|2|||
27982792|NCT00549770|81770284|FG004|Overall Study|Abnormal test procedure results|0|||
27982793|NCT00549770|81770285|FG005|Overall Study|Abnormal test procedure results|1|||
27982794|NCT00549770|81770286|FG006|Overall Study|Abnormal test procedure results|1|||
27577267|NCT04346615|80296392|FG000|Overall Study|Withdrawal by Subject|1|||
27577268|NCT04346615|80296393|FG001|Overall Study|Withdrawal by Subject|0|||
27577269|NCT04346615|80296392|FG000|Overall Study|Death|5|||
27577270|NCT04346615|80296393|FG001|Overall Study|Death|1|||
27577271|NCT04346615|80296392|FG000|Overall Study|Other|0|||
27577272|NCT04346615|80296393|FG001|Overall Study|Other|2|||
27794588|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27982795|NCT00549770|81770287|FG007|Overall Study|Abnormal test procedure results|1|||
27982796|NCT00549770|81770280|FG000|Overall Study|Abnormal laboratory values|0|||
27982797|NCT00549770|81770281|FG001|Overall Study|Abnormal laboratory values|0|||
27982798|NCT00549770|81770282|FG002|Overall Study|Abnormal laboratory values|0|||
27982799|NCT00549770|81770283|FG003|Overall Study|Abnormal laboratory values|0|||
27982800|NCT00549770|81770284|FG004|Overall Study|Abnormal laboratory values|0|||
27982801|NCT00549770|81770285|FG005|Overall Study|Abnormal laboratory values|1|||
27982802|NCT00549770|81770286|FG006|Overall Study|Abnormal laboratory values|0|||
27982803|NCT00549770|81770287|FG007|Overall Study|Abnormal laboratory values|0|||
27982804|NCT00549770|81770280|FG000|Overall Study|Adverse Event|1|||
27982805|NCT00549770|81770281|FG001|Overall Study|Adverse Event|3|||
27982806|NCT00549770|81770282|FG002|Overall Study|Adverse Event|1|||
27982807|NCT00549770|81770283|FG003|Overall Study|Adverse Event|2|||
27982808|NCT00549770|81770284|FG004|Overall Study|Adverse Event|1|||
27982809|NCT00549770|81770285|FG005|Overall Study|Adverse Event|0|||
27982810|NCT00549770|81770286|FG006|Overall Study|Adverse Event|5|||
27982811|NCT00549770|81770287|FG007|Overall Study|Adverse Event|4|||
27982812|NCT00300365|81770288|FG000|Overall Study|Lost to Follow-up|1|||
27982813|NCT00300365|81770289|FG001|Overall Study|Lost to Follow-up|0|||
27794589|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794590|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
27794591|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
27794592|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
27794593|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27794594|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27982814|NCT00300365|81770288|FG000|Overall Study|Physician Decision|2|||
27982815|NCT00300365|81770289|FG001|Overall Study|Physician Decision|0|||
27982816|NCT00300365|81770288|FG000|Overall Study|Withdrawal by Subject|1|||
27982817|NCT00300365|81770289|FG001|Overall Study|Withdrawal by Subject|0|||
27982818|NCT00300365|81770288|FG000|Overall Study|Adverse Event|0|||
27982819|NCT00300365|81770289|FG001|Overall Study|Adverse Event|2|||
27982820|NCT00870194|81770290|FG000|Overall Study|Adverse Event|10|||
27982821|NCT00870194|81770291|FG001|Overall Study|Adverse Event|5|||
27982822|NCT00870194|81770290|FG000|Overall Study|Lack of Efficacy|0|||
27982823|NCT00870194|81770291|FG001|Overall Study|Lack of Efficacy|1|||
27982824|NCT00870194|81770290|FG000|Overall Study|Lost to Follow-up|2|||
27982825|NCT00870194|81770291|FG001|Overall Study|Lost to Follow-up|0|||
27982826|NCT00870194|81770290|FG000|Overall Study|Physician Decision|3|||
27982827|NCT00870194|81770291|FG001|Overall Study|Physician Decision|1|||
27982828|NCT00870194|81770290|FG000|Overall Study|Protocol Violation|3|||
27982829|NCT00870194|81770291|FG001|Overall Study|Protocol Violation|3|||
27982830|NCT00870194|81770290|FG000|Overall Study|Entry Criteria Not Met|1|||
27982831|NCT00870194|81770291|FG001|Overall Study|Entry Criteria Not Met|2|||
27982832|NCT00870194|81770290|FG000|Overall Study|Subject Decision|7|||
27982833|NCT00870194|81770291|FG001|Overall Study|Subject Decision|2|||
27794595|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
27794596|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
27794597|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27794598|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
27794599|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27794600|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
27794601|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27794602|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27794603|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
27794604|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
27982834|NCT04033068|81770292|FG000|Overall Study|Withdrawal by Subject|0|||
27982835|NCT04033068|81770293|FG001|Overall Study|Withdrawal by Subject|0|||
27982836|NCT04033068|81770294|FG002|Overall Study|Withdrawal by Subject|1|||
27982837|NCT04033068|81770295|FG003|Overall Study|Withdrawal by Subject|0|||
27982838|NCT04033068|81770292|FG000|Overall Study|Lost to Follow-up|0|||
27982839|NCT04033068|81770293|FG001|Overall Study|Lost to Follow-up|1|||
27982840|NCT04033068|81770294|FG002|Overall Study|Lost to Follow-up|0|||
27982841|NCT04033068|81770295|FG003|Overall Study|Lost to Follow-up|0|||
27982842|NCT04033068|81770292|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
27982843|NCT04033068|81770293|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
27982844|NCT04033068|81770294|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
27982845|NCT04033068|81770295|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
27982846|NCT01606787|81770299|FG000|Overall Study|Withdrawal by Subject|4|||
27982847|NCT01606787|81770300|FG001|Overall Study|Withdrawal by Subject|5|||
27982848|NCT01606787|81770299|FG000|Overall Study|Surgery canceled|0|||
27982849|NCT01606787|81770300|FG001|Overall Study|Surgery canceled|2|||
27982850|NCT01378429|81770301|FG000|Overall Study|Noncompliance with study drug|1|||
27982851|NCT01378429|81770302|FG001|Overall Study|Noncompliance with study drug|0|||
27982852|NCT02758301|81770307|FG000|Overall Study|Death|12|||
27982853|NCT02758301|81770308|FG001|Overall Study|Death|0|||
27982854|NCT02758301|81770307|FG000|Overall Study|Physician Decision|10|||
27982855|NCT02758301|81770308|FG001|Overall Study|Physician Decision|1|||
27982856|NCT02758301|81770307|FG000|Overall Study|Withdrawal by Subject|5|||
27982857|NCT02758301|81770308|FG001|Overall Study|Withdrawal by Subject|6|||
27982858|NCT02758301|81770307|FG000|Overall Study|Lost to Follow-up|7|||
27982859|NCT02758301|81770308|FG001|Overall Study|Lost to Follow-up|0|||
27982860|NCT02758301|81770307|FG000|Overall Study|Protocol Violation|0|||
27982861|NCT02758301|81770308|FG001|Overall Study|Protocol Violation|1|||
27982862|NCT03022981|81770309|FG000|Overall Study|Adverse Event|0|||
27982863|NCT03022981|81770310|FG001|Overall Study|Adverse Event|1|||
27982864|NCT03022981|81770311|FG002|Overall Study|Adverse Event|0|||
27982865|NCT03022981|81770309|FG000|Overall Study|Investigator's Discretion|0|||
27794605|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
27794606|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
27982866|NCT03022981|81770310|FG001|Overall Study|Investigator's Discretion|1|||
27982867|NCT03022981|81770311|FG002|Overall Study|Investigator's Discretion|2|||
27982868|NCT03022981|81770309|FG000|Overall Study|Lost to Follow-up|6|||
27982869|NCT03022981|81770310|FG001|Overall Study|Lost to Follow-up|2|||
27982870|NCT03022981|81770311|FG002|Overall Study|Lost to Follow-up|1|||
27982871|NCT03022981|81770309|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27982872|NCT03022981|81770310|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27982873|NCT03022981|81770311|FG002|Overall Study|Non-Compliance With Study Drug|2|||
27982874|NCT03022981|81770309|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
27982875|NCT03022981|81770310|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
27982876|NCT03022981|81770311|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
27982877|NCT02598128|81770314|FG000|Period A: Days -7 to -1|Adverse Event|1|||
27982878|NCT02598128|81770315|FG001|Period A: Days -7 to -1|Adverse Event|0|||
27982879|NCT02598128|81770316|FG002|Period A: Days -7 to -1|Adverse Event|0|||
27982880|NCT02598128|81770317|FG003|Period A: Days -7 to -1|Adverse Event|0|||
27982881|NCT01475162|81770318|FG000|Overall Study|Physician Decision|1|||
27982882|NCT01475162|81770318|FG000|Overall Study|Death|10|||
27982883|NCT01475162|81770318|FG000|Overall Study|Study closed for safety|3|||
27982884|NCT00295932|81770322|FG000|Overall Study|Not Treated|0|||
27982885|NCT00295932|81770323|FG001|Overall Study|Not Treated|0|||
27982886|NCT00295932|81770324|FG002|Overall Study|Not Treated|0|||
27982887|NCT00295932|81770325|FG003|Overall Study|Not Treated|0|||
27982888|NCT00295932|81770326|FG004|Overall Study|Not Treated|0|||
27982889|NCT00295932|81770327|FG005|Overall Study|Not Treated|0|||
27982890|NCT00295932|81770328|FG006|Overall Study|Not Treated|0|||
27982891|NCT00295932|81770329|FG007|Overall Study|Not Treated|0|||
27982892|NCT00295932|81770330|FG008|Overall Study|Not Treated|0|||
27982893|NCT00295932|81770331|FG009|Overall Study|Not Treated|0|||
27982894|NCT00295932|81770332|FG010|Overall Study|Not Treated|1|||
27982895|NCT02177838|81770335|FG000|Overall Study|Withdrawal by Subject|1|||
27982896|NCT02177838|81770335|FG000|Overall Study|Physician Decision|1|||
27982897|NCT02177838|81770335|FG000|Overall Study|Death|1|||
27982898|NCT03773107|81770336|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
27982899|NCT03773107|81770337|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
27982900|NCT03773107|81770338|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
27982901|NCT03773107|81770339|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
27982902|NCT00129467|81770341|FG000|Received Intervention|Death|1|||
27982903|NCT00129467|81770342|FG001|Received Intervention|Death|1|||
27982904|NCT00129467|81770341|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
27982905|NCT00129467|81770342|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
27982906|NCT00129467|81770341|FG000|Received Intervention|Delirium|2|||
27982907|NCT00129467|81770342|FG001|Received Intervention|Delirium|0|||
27577273|NCT04346615|80296392|FG000|Overall Study|Randomized not treated|1|||
27577274|NCT04346615|80296393|FG001|Overall Study|Randomized not treated|0|||
27577275|NCT02337829|80296396|FG000|Overall Study|Death|0|||
27577276|NCT02337829|80296397|FG001|Overall Study|Death|1|||
27577277|NCT02337829|80296398|FG002|Overall Study|Death|0|||
27577278|NCT02337829|80296399|FG003|Overall Study|Death|0|||
27577279|NCT02337829|80296396|FG000|Overall Study|Study terminated by sponsor|12|||
27674170|NCT00150618|80643503|FG003|Overall Study|Abnormal ECG|0|||
27674171|NCT00150618|80643504|FG004|Overall Study|Abnormal ECG|0|||
27674172|NCT00150618|80643500|FG000|Overall Study|Sponsor's decision|0|||
27982908|NCT00129467|81770341|FG000|Received Intervention|Withdrawal by Subject|1|||
27982909|NCT00129467|81770342|FG001|Received Intervention|Withdrawal by Subject|0|||
27982910|NCT00129467|81770341|FG000|Received Intervention|Nausea|1|||
27982911|NCT00129467|81770342|FG001|Received Intervention|Nausea|0|||
27982912|NCT00129467|81770341|FG000|Received Intervention|Intolerance to citalopram|0|||
27982913|NCT00129467|81770342|FG001|Received Intervention|Intolerance to citalopram|1|||
27982914|NCT00129467|81770341|FG000|Received Intervention|Dizzyness, fatigue|0|||
27982915|NCT00129467|81770342|FG001|Received Intervention|Dizzyness, fatigue|1|||
27674173|NCT00150618|80643501|FG001|Overall Study|Sponsor's decision|0|||
27982916|NCT00129467|81770341|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
27982917|NCT00129467|81770342|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
27982918|NCT00129467|81770341|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
27868657|NCT02766335|81353887|FG002|Initial Registration|not protocol specified|0|||
27982919|NCT00129467|81770342|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
27982920|NCT01266317|81770343|FG000|Overall Study|Withdrawal by Subject|2|||
27982921|NCT00267150|81770344|FG000|Overall Study|Adverse Event|1|||
27982922|NCT00884832|81770347|FG000|Overall Study|Withdrawal by Subject|0|||
27577280|NCT02337829|80296397|FG001|Overall Study|Study terminated by sponsor|10|||
27577281|NCT02337829|80296398|FG002|Overall Study|Study terminated by sponsor|5|||
27674174|NCT00150618|80643502|FG002|Overall Study|Sponsor's decision|0|||
27982923|NCT00884832|81770348|FG001|Overall Study|Withdrawal by Subject|1|||
27982924|NCT02210832|81770349|FG000|Overall Study|Pregnancy termination .|3|||
27982925|NCT02210832|81770350|FG001|Overall Study|Pregnancy termination .|4|||
27982926|NCT02210832|81770351|FG002|Overall Study|Pregnancy termination .|1|||
27982927|NCT02210832|81770349|FG000|Overall Study|Lost to Follow-up|26|||
27982928|NCT02210832|81770350|FG001|Overall Study|Lost to Follow-up|32|||
27982929|NCT02210832|81770351|FG002|Overall Study|Lost to Follow-up|17|||
27982930|NCT00541346|81770359|FG000|Follow-up|Adverse Event|1|||
27982931|NCT01287195|81770360|FG000|Overall Study|Withdrawal by Subject|2|||
27577282|NCT02337829|80296399|FG003|Overall Study|Study terminated by sponsor|6|||
27577283|NCT02337829|80296396|FG000|Overall Study|discontinued for other reasons|6|||
27577284|NCT02337829|80296397|FG001|Overall Study|discontinued for other reasons|3|||
27577285|NCT02337829|80296398|FG002|Overall Study|discontinued for other reasons|1|||
27577286|NCT02337829|80296399|FG003|Overall Study|discontinued for other reasons|4|||
27577287|NCT02652624|80296410|FG000|Randomized Phase|Pregnancy|3|||
27577288|NCT02652624|80296411|FG001|Randomized Phase|Pregnancy|1|||
27577289|NCT02652624|80296410|FG000|Randomized Phase|Investigator's Discretion|0|||
27577290|NCT02652624|80296411|FG001|Randomized Phase|Investigator's Discretion|2|||
27577291|NCT02652624|80296410|FG000|Randomized Phase|Death|0|||
27577292|NCT02652624|80296411|FG001|Randomized Phase|Death|1|||
27577293|NCT02652624|80296410|FG000|Randomized Phase|Lost to Follow-up|0|||
27577294|NCT02652624|80296411|FG001|Randomized Phase|Lost to Follow-up|1|||
27577295|NCT02652624|80296410|FG000|Extension Phase|Lost to Follow-up|3|||
27577296|NCT02652624|80296411|FG001|Extension Phase|Lost to Follow-up|1|||
27577297|NCT02652624|80296410|FG000|Extension Phase|Pregnancy|1|||
27577298|NCT02652624|80296411|FG001|Extension Phase|Pregnancy|1|||
27577299|NCT02652624|80296410|FG000|Extension Phase|Adverse Event|0|||
27577300|NCT02652624|80296411|FG001|Extension Phase|Adverse Event|1|||
27577301|NCT02652624|80296410|FG000|Extension Phase|Withdrew Consent|0|||
27577302|NCT02652624|80296411|FG001|Extension Phase|Withdrew Consent|1|||
27577303|NCT04327934|80296413|FG000|Overall Study|Did not qualify|7|||
27577304|NCT04327934|80296414|FG001|Overall Study|Did not qualify|4|||
27577305|NCT04327934|80296413|FG000|Overall Study|Physician Decision|0|||
27577306|NCT04327934|80296414|FG001|Overall Study|Physician Decision|1|||
27577307|NCT00456092|80296417|FG000|Extension Phase|Grade 2 or Greater AE|2|||
27577308|NCT00456092|80296418|FG001|Extension Phase|Grade 2 or Greater AE|2|||
27577309|NCT00456092|80296419|FG002|Extension Phase|Grade 2 or Greater AE|0|||
27577310|NCT00456092|80296420|FG003|Extension Phase|Grade 2 or Greater AE|0|||
27577311|NCT00456092|80296421|FG004|Extension Phase|Grade 2 or Greater AE|2|||
27577312|NCT00456092|80296417|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
27577313|NCT00456092|80296418|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
27577314|NCT00456092|80296419|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
27577315|NCT00456092|80296420|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
27577316|NCT00456092|80296421|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
27577317|NCT00456092|80296417|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
27577318|NCT00456092|80296418|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
27577319|NCT00456092|80296419|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
27577320|NCT00456092|80296420|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
27577321|NCT00456092|80296421|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
27794607|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
27794608|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
27794609|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
27982932|NCT00491608|81770363|FG000|Overall Study|Death|2|||
27982933|NCT00491608|81770363|FG000|Overall Study|Withdrawal by Subject|1|||
27982934|NCT02621073|81770364|FG000|Overall Study|Lost to Follow-up|0|||
27982935|NCT02621073|81770365|FG001|Overall Study|Lost to Follow-up|1|||
27982936|NCT02621073|81770364|FG000|Overall Study|Physician Decision|3|||
27982937|NCT02621073|81770365|FG001|Overall Study|Physician Decision|2|||
27982938|NCT04232215|81770366|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
27982939|NCT04232215|81770367|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27982940|NCT03262116|81770368|FG000|Overall Study|Physician Decision|0|||
27982941|NCT03262116|81770369|FG001|Overall Study|Physician Decision|2|||
27982942|NCT03262116|81770370|FG002|Overall Study|Physician Decision|1|||
27982943|NCT03262116|81770371|FG003|Overall Study|Physician Decision|1|||
27982944|NCT03262116|81770372|FG004|Overall Study|Physician Decision|1|||
27982945|NCT03262116|81770373|FG005|Overall Study|Physician Decision|2|||
27982946|NCT04524455|81770379|FG000|Overall Study|Death|3|||
27982947|NCT04524455|81770380|FG001|Overall Study|Death|3|||
27982948|NCT04524455|81770379|FG000|Overall Study|Decision by Sponsor|0|||
27577322|NCT00456092|80296417|FG000|Extension Phase|Withdrew Consent|2|||
27577323|NCT00456092|80296418|FG001|Extension Phase|Withdrew Consent|0|||
27577324|NCT00456092|80296419|FG002|Extension Phase|Withdrew Consent|0|||
27577325|NCT00456092|80296420|FG003|Extension Phase|Withdrew Consent|0|||
27577326|NCT00456092|80296421|FG004|Extension Phase|Withdrew Consent|0|||
27577327|NCT00456092|80296417|FG000|Extension Phase|Lost to Follow-up|1|||
27577328|NCT00456092|80296418|FG001|Extension Phase|Lost to Follow-up|1|||
27577329|NCT00456092|80296419|FG002|Extension Phase|Lost to Follow-up|0|||
27577330|NCT00456092|80296420|FG003|Extension Phase|Lost to Follow-up|0|||
27577331|NCT00456092|80296421|FG004|Extension Phase|Lost to Follow-up|1|||
27982949|NCT04524455|81770380|FG001|Overall Study|Decision by Sponsor|2|||
27982950|NCT04524455|81770379|FG000|Overall Study|Withdrawal of Consent From Study|1|||
27982951|NCT04524455|81770380|FG001|Overall Study|Withdrawal of Consent From Study|0|||
27577332|NCT00456092|80296417|FG000|Extension Phase|Other|2|||
27577333|NCT00456092|80296418|FG001|Extension Phase|Other|0|||
27577334|NCT00456092|80296419|FG002|Extension Phase|Other|0|||
27577335|NCT00456092|80296420|FG003|Extension Phase|Other|1|||
27577336|NCT00456092|80296421|FG004|Extension Phase|Other|1|||
27577337|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
27577338|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
27577339|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
27577340|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
27577341|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
27577342|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
27577343|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
27577344|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
27577345|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
27577346|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
27577347|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
27577348|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
27577349|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
27577350|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
27577351|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
27577352|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
27577353|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
27577354|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
27577355|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
27577356|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
27577357|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
27577358|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
27577359|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
27577360|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
27577361|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
27577362|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
27577363|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
27577364|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
27577365|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
27577366|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
27577367|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
27577368|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
27577369|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
27577370|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
27577371|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
27577372|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
27982952|NCT04524455|81770379|FG000|Overall Study|Lost to Follow-up|0|||
27982953|NCT04524455|81770380|FG001|Overall Study|Lost to Follow-up|1|||
27982954|NCT00443781|81770381|FG000|Overall Study|Lost to Follow-up|10|||
27982955|NCT00443781|81770381|FG000|Overall Study|Physician Decision|2|||
27982956|NCT00443781|81770381|FG000|Overall Study|Protocol Violation|1|||
27982957|NCT00443781|81770381|FG000|Overall Study|Withdrawal by Subject|6|||
27982958|NCT00443781|81770381|FG000|Overall Study|Unable to comply with study follow up|2|||
27982959|NCT00443781|81770381|FG000|Overall Study|Investigator terminated participation|1|||
27982960|NCT00443781|81770381|FG000|Overall Study|Insurance not covered|2|||
27982961|NCT00443781|81770381|FG000|Overall Study|PD/FAD not done|1|||
27982962|NCT00612508|81770382|FG000|Overall Study|Withdrawal by Subject|3|||
27982963|NCT00612508|81770383|FG001|Overall Study|Withdrawal by Subject|4|||
27982964|NCT03233438|81770384|FG000|Overall Study|Lost to Follow-up|4|||
27982965|NCT03233438|81770385|FG001|Overall Study|Lost to Follow-up|9|||
27982966|NCT03233438|81770384|FG000|Overall Study|Withdrawal by Subject|2|||
27577373|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
27577374|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
27577375|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
27577376|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
27577377|NCT00456092|80296417|FG000|Treatment Phase (12 Weeks)|Other|1|||
27982967|NCT03233438|81770385|FG001|Overall Study|Withdrawal by Subject|1|||
27982968|NCT03233438|81770384|FG000|Overall Study|No recording of dalbavancin|0|||
27982969|NCT03233438|81770385|FG001|Overall Study|No recording of dalbavancin|1|||
27982970|NCT02723175|81770386|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
27982971|NCT02723175|81770387|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
27982972|NCT02723175|81770386|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
27577378|NCT00456092|80296418|FG001|Treatment Phase (12 Weeks)|Other|0|||
27577379|NCT00456092|80296419|FG002|Treatment Phase (12 Weeks)|Other|1|||
27982973|NCT02723175|81770387|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
27982974|NCT01751139|81770388|FG000|Overall Study|Other|135|||
27982975|NCT01751139|81770388|FG000|Overall Study|Sponsor study termination|1609|||
27982976|NCT01751139|81770388|FG000|Overall Study|Lost to Follow-up|240|||
27982977|NCT01751139|81770388|FG000|Overall Study|Withdrawal by Subject|251|||
27982978|NCT01751139|81770388|FG000|Overall Study|Adverse Event|1|||
27982979|NCT01751139|81770388|FG000|Overall Study|Death|31|||
27982980|NCT03412604|81770398|FG000|Overall Study|Withdrawal by Subject|1|||
27982981|NCT00413010|81770399|FG000|Overall Study|Adverse Event|8|||
27982982|NCT00413010|81770400|FG001|Overall Study|Adverse Event|4|||
27982983|NCT00413010|81770399|FG000|Overall Study|Laboratory abnormality|0|||
27982984|NCT00413010|81770400|FG001|Overall Study|Laboratory abnormality|2|||
27982985|NCT00413010|81770399|FG000|Overall Study|Lack of Efficacy|0|||
27982986|NCT00413010|81770400|FG001|Overall Study|Lack of Efficacy|3|||
27982987|NCT00413010|81770399|FG000|Overall Study|Lost to Follow-up|3|||
27982988|NCT00413010|81770400|FG001|Overall Study|Lost to Follow-up|0|||
27982989|NCT00413010|81770399|FG000|Overall Study|Withdrawal by Subject|7|||
27982990|NCT00413010|81770400|FG001|Overall Study|Withdrawal by Subject|2|||
27982991|NCT00413010|81770399|FG000|Overall Study|Due to termination of the study|54|||
27982992|NCT00413010|81770400|FG001|Overall Study|Due to termination of the study|52|||
27982993|NCT00527332|81770407|FG000|Overall Study|Protocol Violation|4|||
27577380|NCT00456092|80296420|FG003|Treatment Phase (12 Weeks)|Other|0|||
27577381|NCT00456092|80296421|FG004|Treatment Phase (12 Weeks)|Other|0|||
27577382|NCT00211081|80296424|FG000|Overall Study|Withdrawal by Subject|2|||
27577383|NCT04456699|80299238|FG000|Overall Study|Death|48|||
27982994|NCT00527332|81770408|FG001|Overall Study|Protocol Violation|8|||
27982995|NCT00527332|81770407|FG000|Overall Study|Withdrew consent|5|||
27982996|NCT00527332|81770408|FG001|Overall Study|Withdrew consent|1|||
27982997|NCT00330668|81770413|FG000|BID Dosing Period|Adverse Event|1|||
27982998|NCT00330668|81770413|FG000|BID Dosing Period|Lost to Follow-up|7|||
27982999|NCT00330668|81770413|FG000|BID Dosing Period|Non-Compliance|5|||
27983000|NCT00330668|81770413|FG000|BID Dosing Period|Withdrawal by Subject|19|||
27983001|NCT00330668|81770413|FG000|BID Dosing Period|Sponsor's decision|1|||
27983002|NCT00330668|81770413|FG000|BID Dosing Period|Other|3|||
27983003|NCT00330668|81770413|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
27983004|NCT00330668|81770413|FG000|QD Dosing Period|Other|1|||
27983005|NCT00330668|81770413|FG000|QD Dosing Period|Withdrawal by Subject|1|||
27983006|NCT00330668|81770413|FG000|QD Dosing Period|Lost to Follow-up|2|||
27983007|NCT00840060|81770417|FG000|Overall Study|Withdrawal by Subject|1|||
27983008|NCT00840060|81770418|FG001|Overall Study|Withdrawal by Subject|0|||
27983009|NCT00840060|81770417|FG000|Overall Study|Change in emotional/behavioral status|0|||
27577384|NCT04456699|80299239|FG001|Overall Study|Death|50|||
27577385|NCT04456699|80299240|FG002|Overall Study|Death|52|||
27577386|NCT04456699|80299238|FG000|Overall Study|Physician Decision|0|||
27577387|NCT04456699|80299239|FG001|Overall Study|Physician Decision|0|||
27577388|NCT04456699|80299240|FG002|Overall Study|Physician Decision|2|||
27577389|NCT04456699|80299238|FG000|Overall Study|Sponsor Decision|55|||
27577390|NCT04456699|80299239|FG001|Overall Study|Sponsor Decision|61|||
27577391|NCT04456699|80299240|FG002|Overall Study|Sponsor Decision|50|||
27577392|NCT04456699|80299238|FG000|Overall Study|Withdrawal by Subject|8|||
27577393|NCT04456699|80299239|FG001|Overall Study|Withdrawal by Subject|4|||
27577394|NCT04456699|80299240|FG002|Overall Study|Withdrawal by Subject|5|||
27577395|NCT00306592|80299241|FG000|Overall Study|Adverse Event|8|||
27577396|NCT00306592|80299242|FG001|Overall Study|Adverse Event|15|||
27577397|NCT00306592|80299241|FG000|Overall Study|Lost to Follow-up|1|||
27577398|NCT00306592|80299242|FG001|Overall Study|Lost to Follow-up|0|||
27577399|NCT00306592|80299241|FG000|Overall Study|Noncompliance|0|||
27983010|NCT00840060|81770418|FG001|Overall Study|Change in emotional/behavioral status|1|||
27577400|NCT00306592|80299242|FG001|Overall Study|Noncompliance|2|||
27983011|NCT00895661|81770420|FG000|Overall Study|Death|1|||
27983012|NCT00895661|81770420|FG000|Overall Study|reason unknown|2|||
27983013|NCT00869401|81770423|FG000|Overall Study|Withdrawal by Subject|0|||
27983014|NCT00869401|81770424|FG001|Overall Study|Withdrawal by Subject|0|||
27983015|NCT00869401|81770425|FG002|Overall Study|Withdrawal by Subject|0|||
27983016|NCT00869401|81770426|FG003|Overall Study|Withdrawal by Subject|5|||
27577401|NCT00306592|80299241|FG000|Overall Study|Persistent Antibodies|6|||
27983017|NCT00869401|81770427|FG004|Overall Study|Withdrawal by Subject|3|||
27983018|NCT00495755|81770431|FG000|Overall Study|Adverse Event|3|||
27983019|NCT02925741|81770436|FG000|Overall Study|Withdrawal by Subject|11|||
27577402|NCT00306592|80299242|FG001|Overall Study|Persistent Antibodies|3|||
27868658|NCT02766335|81353885|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
27983020|NCT02925741|81770437|FG001|Overall Study|Withdrawal by Subject|0|||
27983021|NCT01977690|81770438|FG000|Overall Study|Withdrawal by Subject|0|||
27577403|NCT00306592|80299241|FG000|Overall Study|Voluntary|10|||
27983022|NCT01977690|81770439|FG001|Overall Study|Withdrawal by Subject|4|||
27983023|NCT00558272|81770440|FG000|Overall Study|Adverse Event|10|||
27674175|NCT00150618|80643503|FG003|Overall Study|Sponsor's decision|1|||
27577404|NCT00306592|80299242|FG001|Overall Study|Voluntary|6|||
27577405|NCT00306592|80299241|FG000|Overall Study|Other|5|||
27983024|NCT00558272|81770441|FG001|Overall Study|Adverse Event|0|||
27983025|NCT00558272|81770440|FG000|Overall Study|Death|1|||
27983026|NCT00558272|81770441|FG001|Overall Study|Death|0|||
27983027|NCT00558272|81770440|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
27983028|NCT00558272|81770441|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
27983029|NCT00558272|81770440|FG000|Overall Study|AZ study team decision|0|||
27983030|NCT00558272|81770441|FG001|Overall Study|AZ study team decision|1|||
27983031|NCT00558272|81770440|FG000|Overall Study|Incorrectly enrolled|1|||
27983032|NCT00558272|81770441|FG001|Overall Study|Incorrectly enrolled|0|||
27983033|NCT00558272|81770440|FG000|Overall Study|Withdrawal by Subject|0|||
27983034|NCT00558272|81770441|FG001|Overall Study|Withdrawal by Subject|1|||
27983035|NCT00576472|81770442|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983036|NCT00576472|81770443|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983037|NCT00576472|81770444|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983038|NCT00576472|81770445|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
27983039|NCT00576472|81770446|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983040|NCT00576472|81770447|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983041|NCT00576472|81770448|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983042|NCT00576472|81770449|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983043|NCT00576472|81770450|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983044|NCT00576472|81770451|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983045|NCT00576472|81770452|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983046|NCT00576472|81770453|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983047|NCT00576472|81770454|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983048|NCT00576472|81770455|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983049|NCT00576472|81770456|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
27983050|NCT00576472|81770442|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
27983051|NCT00576472|81770443|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
27983052|NCT00576472|81770444|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
27983053|NCT00576472|81770445|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
27577406|NCT00306592|80299242|FG001|Overall Study|Other|10|||
27577407|NCT00306592|80299241|FG000|Overall Study|Other|1|||
27577408|NCT00306592|80299242|FG001|Overall Study|Other|2|||
27577409|NCT00306592|80299241|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
27577410|NCT00306592|80299242|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
27577411|NCT03296696|80299243|FG000|Overall Study|Started Other Antitumor Therapy|1|||
27577412|NCT03296696|80299244|FG001|Overall Study|Started Other Antitumor Therapy|2|||
27577413|NCT03296696|80299245|FG002|Overall Study|Started Other Antitumor Therapy|1|||
27577414|NCT03296696|80299246|FG003|Overall Study|Started Other Antitumor Therapy|2|||
27577415|NCT03296696|80299247|FG004|Overall Study|Started Other Antitumor Therapy|1|||
27577416|NCT03296696|80299248|FG005|Overall Study|Started Other Antitumor Therapy|1|||
27577417|NCT03296696|80299249|FG006|Overall Study|Started Other Antitumor Therapy|2|||
27577418|NCT03296696|80299250|FG007|Overall Study|Started Other Antitumor Therapy|3|||
27577419|NCT03296696|80299251|FG008|Overall Study|Started Other Antitumor Therapy|1|||
27577420|NCT03296696|80299252|FG009|Overall Study|Started Other Antitumor Therapy|0|||
27577421|NCT03296696|80299243|FG000|Overall Study|Death|0|||
27577422|NCT03296696|80299244|FG001|Overall Study|Death|1|||
27577423|NCT03296696|80299245|FG002|Overall Study|Death|1|||
27577424|NCT03296696|80299246|FG003|Overall Study|Death|2|||
27577425|NCT03296696|80299247|FG004|Overall Study|Death|2|||
27577426|NCT03296696|80299248|FG005|Overall Study|Death|3|||
27577427|NCT03296696|80299249|FG006|Overall Study|Death|1|||
27577428|NCT03296696|80299250|FG007|Overall Study|Death|2|||
27983054|NCT00576472|81770446|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
27983055|NCT00576472|81770447|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
27983056|NCT00576472|81770448|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
27577429|NCT03296696|80299251|FG008|Overall Study|Death|0|||
27577430|NCT03296696|80299252|FG009|Overall Study|Death|0|||
27577431|NCT03296696|80299243|FG000|Overall Study|Withdrawal by Subject|0|||
27577432|NCT03296696|80299244|FG001|Overall Study|Withdrawal by Subject|0|||
27577433|NCT03296696|80299245|FG002|Overall Study|Withdrawal by Subject|1|||
27577434|NCT03296696|80299246|FG003|Overall Study|Withdrawal by Subject|0|||
27794610|NCT01915498|81079096|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
27794611|NCT01915498|81079097|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
27577435|NCT03296696|80299247|FG004|Overall Study|Withdrawal by Subject|1|||
27577436|NCT03296696|80299248|FG005|Overall Study|Withdrawal by Subject|0|||
27983057|NCT00576472|81770449|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
27983058|NCT00576472|81770450|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
27577437|NCT03296696|80299249|FG006|Overall Study|Withdrawal by Subject|0|||
27577438|NCT03296696|80299250|FG007|Overall Study|Withdrawal by Subject|0|||
27577439|NCT03296696|80299251|FG008|Overall Study|Withdrawal by Subject|0|||
27577440|NCT03296696|80299252|FG009|Overall Study|Withdrawal by Subject|1|||
27577441|NCT04101526|80299257|FG000|Overall Study|Did not complete all sleep diary entries|0|||
27577442|NCT04101526|80299258|FG001|Overall Study|Did not complete all sleep diary entries|1|||
27577443|NCT00414050|80299259|FG000|Overall Study|Adverse Event|1|||
27577444|NCT00414050|80299260|FG001|Overall Study|Adverse Event|1|||
27577445|NCT00414050|80299261|FG002|Overall Study|Adverse Event|1|||
27577446|NCT00414050|80299262|FG003|Overall Study|Adverse Event|1|||
27577447|NCT00414050|80299259|FG000|Overall Study|Lost to Follow-up|2|||
27577448|NCT00414050|80299260|FG001|Overall Study|Lost to Follow-up|2|||
27577449|NCT00414050|80299261|FG002|Overall Study|Lost to Follow-up|1|||
27577450|NCT00414050|80299262|FG003|Overall Study|Lost to Follow-up|1|||
27577451|NCT00414050|80299259|FG000|Overall Study|Withdrawal by Subject|5|||
27577452|NCT00414050|80299260|FG001|Overall Study|Withdrawal by Subject|3|||
27577453|NCT00414050|80299261|FG002|Overall Study|Withdrawal by Subject|2|||
27577454|NCT00414050|80299262|FG003|Overall Study|Withdrawal by Subject|4|||
27577455|NCT00414050|80299259|FG000|Overall Study|Subject discontinued for other reason|1|||
27577456|NCT00414050|80299260|FG001|Overall Study|Subject discontinued for other reason|2|||
27577457|NCT00414050|80299261|FG002|Overall Study|Subject discontinued for other reason|2|||
27577458|NCT00414050|80299262|FG003|Overall Study|Subject discontinued for other reason|1|||
27577459|NCT00414050|80299259|FG000|Overall Study|Subject Moved|0|||
27577460|NCT00414050|80299260|FG001|Overall Study|Subject Moved|0|||
27983059|NCT00576472|81770451|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
27983060|NCT00576472|81770452|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
27577461|NCT00414050|80299261|FG002|Overall Study|Subject Moved|0|||
27577462|NCT00414050|80299262|FG003|Overall Study|Subject Moved|1|||
27577463|NCT00654628|80299269|FG000|6-week Active Treatment Period|Adverse Event|9|||
27577464|NCT00654628|80299269|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
27577465|NCT00654628|80299269|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
27577466|NCT00654628|80299269|FG000|6-week Active Treatment Period|Out of window period|1|||
27577467|NCT00654628|80299269|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
27577468|NCT00654628|80299269|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
27577469|NCT02962895|80299272|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
27577470|NCT02962895|80299273|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
27577471|NCT02962895|80299274|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
27577472|NCT02962895|80299275|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
27577473|NCT02962895|80299276|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
27577474|NCT02962895|80299277|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
27577475|NCT02962895|80299278|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
27577476|NCT02962895|80299272|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
27577477|NCT02962895|80299273|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
27577478|NCT02962895|80299274|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
27577479|NCT02962895|80299275|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
27577480|NCT02962895|80299276|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
27577481|NCT02962895|80299277|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
27577482|NCT02962895|80299278|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
27577483|NCT02962895|80299272|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
27577484|NCT02962895|80299273|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
27577485|NCT02962895|80299274|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
27577486|NCT02962895|80299275|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
27577487|NCT02962895|80299276|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
27577488|NCT02962895|80299277|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
27577489|NCT02962895|80299278|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
27577490|NCT02962895|80299272|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
27577491|NCT02962895|80299273|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
27577492|NCT02962895|80299274|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
27577493|NCT02962895|80299275|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
27577494|NCT02962895|80299276|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
27577495|NCT02962895|80299277|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
27577496|NCT02962895|80299278|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
27983061|NCT00576472|81770453|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
27983062|NCT00576472|81770454|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
27983063|NCT00576472|81770455|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
27983064|NCT00576472|81770456|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
27983065|NCT00576472|81770442|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983066|NCT00576472|81770443|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983067|NCT00576472|81770444|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983068|NCT00576472|81770445|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
27674176|NCT00150618|80643504|FG004|Overall Study|Sponsor's decision|0|||
27983069|NCT00576472|81770446|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27577497|NCT02962895|80299272|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
27577498|NCT02962895|80299273|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
27577499|NCT02962895|80299274|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
27577500|NCT02962895|80299275|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
27577501|NCT02962895|80299276|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
27577502|NCT02962895|80299277|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
27577503|NCT02962895|80299278|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
27577504|NCT02962895|80299272|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
27577505|NCT02962895|80299273|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
27577506|NCT02962895|80299274|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
27577507|NCT02962895|80299275|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
27577508|NCT02962895|80299276|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
27577509|NCT02962895|80299277|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
27577510|NCT02962895|80299278|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
27577511|NCT02962895|80299272|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
27577512|NCT02962895|80299273|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
27577513|NCT02962895|80299274|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
27577514|NCT02962895|80299275|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
27577515|NCT02962895|80299276|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
27577516|NCT02962895|80299277|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
27577517|NCT02962895|80299278|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
27577518|NCT02962895|80299272|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
27577519|NCT02962895|80299273|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
27577520|NCT02962895|80299274|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
27577521|NCT02962895|80299275|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
27577522|NCT02962895|80299276|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
27577523|NCT02962895|80299277|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
27577524|NCT02962895|80299278|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
27577525|NCT02962895|80299272|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
27577526|NCT02962895|80299273|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
27577527|NCT02962895|80299274|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
27577528|NCT02962895|80299275|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
27577529|NCT02962895|80299276|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
27577530|NCT02962895|80299277|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
27577531|NCT02962895|80299278|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
27577532|NCT02962895|80299272|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
27577533|NCT02962895|80299273|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
27577534|NCT02962895|80299274|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
27577535|NCT02962895|80299275|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
27577536|NCT02962895|80299276|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
27577537|NCT02962895|80299277|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
27577538|NCT02962895|80299278|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
27577539|NCT02962895|80299272|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
27577540|NCT02962895|80299273|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
27577541|NCT02962895|80299274|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
27577542|NCT02962895|80299275|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
27577543|NCT02962895|80299276|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
27577544|NCT02962895|80299277|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
27577545|NCT02962895|80299278|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
27577546|NCT02962895|80299272|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
27577547|NCT02962895|80299273|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
27577548|NCT02962895|80299274|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
27577549|NCT02962895|80299275|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
27577550|NCT02962895|80299276|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
27577551|NCT02962895|80299277|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
27577552|NCT02962895|80299278|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
27577553|NCT02962895|80299272|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
27577554|NCT02962895|80299273|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
27794612|NCT01915498|81079098|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
27794613|NCT01915498|81079099|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
27794614|NCT01915498|81079100|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
27577555|NCT02962895|80299274|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
27577556|NCT02962895|80299275|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
27674177|NCT00358644|80643507|FG000|Overall Study|Progressive Disease|21|||
27577557|NCT02962895|80299276|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
27577558|NCT02962895|80299277|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
27577559|NCT02962895|80299278|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
27577560|NCT02962895|80299272|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
27577561|NCT02962895|80299273|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
27577562|NCT02962895|80299274|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
27577563|NCT02962895|80299275|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
27577564|NCT02962895|80299276|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
27577565|NCT02962895|80299277|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
27577566|NCT02962895|80299278|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
27577567|NCT01461096|80299283|FG000|Overall Study|Death|3|||
27577568|NCT01461096|80299284|FG001|Overall Study|Death|6|||
27577569|NCT01461096|80299283|FG000|Overall Study|Severe debilitation, unable to continue|1|||
27577570|NCT01461096|80299284|FG001|Overall Study|Severe debilitation, unable to continue|1|||
27577571|NCT01461096|80299283|FG000|Overall Study|Subj not able to get to clinic|15|||
27577572|NCT01461096|80299284|FG001|Overall Study|Subj not able to get to clinic|13|||
27577573|NCT01461096|80299283|FG000|Overall Study|Site is closing|27|||
27577574|NCT01461096|80299284|FG001|Overall Study|Site is closing|30|||
27577575|NCT01461096|80299283|FG000|Overall Study|Withdrawal by Subject|5|||
27577576|NCT01461096|80299284|FG001|Overall Study|Withdrawal by Subject|3|||
27577577|NCT01461096|80299283|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
27577578|NCT01461096|80299284|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
27577579|NCT01461096|80299283|FG000|Overall Study|Lost to Follow-up|8|||
27577580|NCT01461096|80299284|FG001|Overall Study|Lost to Follow-up|4|||
27577581|NCT00612313|80299289|FG000|Overall Study|Withdrawal by Subject|6|||
27577582|NCT00612313|80299290|FG001|Overall Study|Withdrawal by Subject|9|||
27577583|NCT00612313|80299289|FG000|Overall Study|Lost to Follow-up|11|||
27577584|NCT00612313|80299290|FG001|Overall Study|Lost to Follow-up|4|||
27983070|NCT00576472|81770447|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983071|NCT00576472|81770448|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983072|NCT00576472|81770449|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983073|NCT00576472|81770450|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983074|NCT00576472|81770451|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983075|NCT00576472|81770452|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983076|NCT00576472|81770453|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983077|NCT00576472|81770454|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983078|NCT00576472|81770455|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983079|NCT00576472|81770456|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
27983080|NCT00576472|81770442|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
27983081|NCT00576472|81770443|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
27983082|NCT00576472|81770444|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
27983083|NCT00576472|81770445|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
27983084|NCT00576472|81770446|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
27983085|NCT00576472|81770447|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
27577585|NCT00807092|80299291|FG000|Overall Study|Adverse Event|0|||
27577586|NCT00807092|80299292|FG001|Overall Study|Adverse Event|1|||
27577587|NCT00807092|80299291|FG000|Overall Study|Protocol Violation|0|||
27577588|NCT00807092|80299292|FG001|Overall Study|Protocol Violation|2|||
27577589|NCT00807092|80299291|FG000|Overall Study|Withdrawal by Subject|1|||
27577590|NCT00807092|80299292|FG001|Overall Study|Withdrawal by Subject|0|||
27577591|NCT00807092|80299291|FG000|Overall Study|CGMS data collection failed|0|||
27577592|NCT00807092|80299292|FG001|Overall Study|CGMS data collection failed|1|||
27577593|NCT04709237|80299295|FG000|Overall Study|Lost to Follow-up|1|||
27577594|NCT04709237|80299296|FG001|Overall Study|Lost to Follow-up|0|||
27577595|NCT04709237|80299297|FG002|Overall Study|Lost to Follow-up|0|||
27577596|NCT03199469|80299298|FG000|Overall Study|Randomized, not treated|0|||
27577597|NCT03199469|80299299|FG001|Overall Study|Randomized, not treated|3|||
27577598|NCT03199469|80299298|FG000|Overall Study|Withdrawal by Subject|1|||
27577599|NCT03199469|80299299|FG001|Overall Study|Withdrawal by Subject|0|||
27577600|NCT03199469|80299298|FG000|Overall Study|Death|1|||
27577601|NCT03199469|80299299|FG001|Overall Study|Death|3|||
27577602|NCT03199469|80299298|FG000|Overall Study|Ongoing|5|||
27577603|NCT03199469|80299299|FG001|Overall Study|Ongoing|14|||
27577604|NCT04452344|80299300|FG000|Overall Study|Withdrawal by Subject|3|||
27577605|NCT04452344|80299301|FG001|Overall Study|Withdrawal by Subject|6|||
27577606|NCT04452344|80299300|FG000|Overall Study|Adverse Event|1|||
27577607|NCT04452344|80299301|FG001|Overall Study|Adverse Event|2|||
27577608|NCT04452344|80299300|FG000|Overall Study|Lost to Follow-up|2|||
27577609|NCT04452344|80299301|FG001|Overall Study|Lost to Follow-up|2|||
27577610|NCT04452344|80299300|FG000|Overall Study|No Post-Op Visit|6|||
27577611|NCT04452344|80299301|FG001|Overall Study|No Post-Op Visit|7|||
27577612|NCT04640311|80299302|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
27577613|NCT04640311|80299303|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577614|NCT04640311|80299304|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577615|NCT04640311|80299305|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577616|NCT04640311|80299306|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577617|NCT04640311|80299307|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577618|NCT04640311|80299308|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577619|NCT04640311|80299309|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577620|NCT04640311|80299310|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577621|NCT04640311|80299311|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577622|NCT04640311|80299312|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577623|NCT04640311|80299313|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577624|NCT04640311|80299314|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577625|NCT04640311|80299302|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577626|NCT04640311|80299303|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
27577627|NCT04640311|80299304|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577628|NCT04640311|80299305|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577629|NCT04640311|80299306|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577630|NCT04640311|80299307|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577631|NCT04640311|80299308|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577632|NCT04640311|80299309|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577633|NCT04640311|80299310|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577634|NCT04640311|80299311|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577635|NCT04640311|80299312|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577636|NCT04640311|80299313|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577637|NCT04640311|80299314|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
27577638|NCT04640311|80299302|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577639|NCT04640311|80299303|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
27577640|NCT04640311|80299304|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577641|NCT04640311|80299305|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577642|NCT04640311|80299306|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577643|NCT04640311|80299307|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577644|NCT04640311|80299308|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577645|NCT04640311|80299309|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577646|NCT04640311|80299310|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577647|NCT04640311|80299311|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577648|NCT04640311|80299312|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577649|NCT04640311|80299313|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577650|NCT04640311|80299314|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577651|NCT04640311|80299302|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
27577652|NCT04640311|80299303|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
27577653|NCT04640311|80299304|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
27577654|NCT04640311|80299305|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577655|NCT04640311|80299306|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577656|NCT04640311|80299307|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27674178|NCT00358644|80643507|FG000|Overall Study|Adverse Event|7|||
27794615|NCT01915498|81079101|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
27794616|NCT01915498|81079102|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
27794617|NCT01915498|81079103|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
27794618|NCT01915498|81079104|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
27794619|NCT01915498|81079105|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
27794620|NCT01915498|81079106|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
27794621|NCT01915498|81079107|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
27794622|NCT01915498|81079108|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
27794623|NCT01915498|81079109|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
27868659|NCT02766335|81353886|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
27868660|NCT02766335|81353887|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
27868661|NCT02766335|81353885|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
27868662|NCT02766335|81353886|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
27577657|NCT04640311|80299308|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577658|NCT04640311|80299309|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577659|NCT04640311|80299310|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577660|NCT04640311|80299311|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577661|NCT04640311|80299312|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577662|NCT04640311|80299313|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577663|NCT04640311|80299314|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
27577664|NCT04640311|80299302|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27577665|NCT04640311|80299303|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27674179|NCT00358644|80643507|FG000|Overall Study|Death|11|||
27674180|NCT00358644|80643507|FG000|Overall Study|Withdrawal by Subject|4|||
27674181|NCT00358644|80643507|FG000|Overall Study|Physician Decision|6|||
27794624|NCT01915498|81079110|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
27794625|NCT01915498|81079111|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
27794626|NCT01915498|81079112|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
27794627|NCT01915498|81079113|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
27794628|NCT01915498|81079114|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
27794629|NCT01915498|81079096|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794630|NCT01915498|81079097|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27983086|NCT00576472|81770448|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
27983087|NCT00576472|81770449|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
27983088|NCT00576472|81770450|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
27983089|NCT00576472|81770451|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
27983090|NCT00576472|81770452|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
27983091|NCT00576472|81770453|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
27983092|NCT00576472|81770454|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
27983093|NCT00576472|81770455|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
27983094|NCT00576472|81770456|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
27983095|NCT00576472|81770442|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983096|NCT00576472|81770443|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983097|NCT00576472|81770444|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983098|NCT00576472|81770445|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
27983099|NCT00576472|81770446|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983100|NCT00576472|81770447|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983101|NCT00576472|81770448|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
27674182|NCT00358644|80643507|FG000|Overall Study|Patient not eligible for study|1|||
27674183|NCT02392104|80643508|FG000|Overall Study|discontinuation of warfarin|3|||
27674184|NCT02392104|80643508|FG000|Overall Study|bleeding event|1|||
27674185|NCT02392104|80643508|FG000|Overall Study|transferred care to another doctor|2|||
27674186|NCT02392104|80643508|FG000|Overall Study|INR goal range changed|1|||
27674187|NCT02392104|80643508|FG000|Overall Study|admitted to skilled nursing facility|3|||
27674188|NCT02392104|80643508|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
27674189|NCT01602510|80643515|FG000|Open Label Phase|Adverse Event|46|||
27674190|NCT01602510|80643516|FG001|Open Label Phase|Adverse Event|0|||
27674191|NCT01602510|80643517|FG002|Open Label Phase|Adverse Event|0|||
27674192|NCT01602510|80643515|FG000|Open Label Phase|Lack of Efficacy|22|||
27674193|NCT01602510|80643516|FG001|Open Label Phase|Lack of Efficacy|0|||
27674194|NCT01602510|80643517|FG002|Open Label Phase|Lack of Efficacy|0|||
27674195|NCT01602510|80643515|FG000|Open Label Phase|Protocol Violation|15|||
27674196|NCT01602510|80643516|FG001|Open Label Phase|Protocol Violation|0|||
27674197|NCT01602510|80643517|FG002|Open Label Phase|Protocol Violation|0|||
27674198|NCT01602510|80643515|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
27674199|NCT01602510|80643516|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
27674200|NCT01602510|80643517|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
27674201|NCT01602510|80643515|FG000|Open Label Phase|Lost to Follow-up|22|||
27674202|NCT01602510|80643516|FG001|Open Label Phase|Lost to Follow-up|0|||
27674203|NCT01602510|80643517|FG002|Open Label Phase|Lost to Follow-up|0|||
27983102|NCT00576472|81770449|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983103|NCT00576472|81770450|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983104|NCT00576472|81770451|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983105|NCT00576472|81770452|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983106|NCT00576472|81770453|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983107|NCT00576472|81770454|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983108|NCT00576472|81770455|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983109|NCT00576472|81770456|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
27983110|NCT00576472|81770442|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983111|NCT00576472|81770443|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983112|NCT00576472|81770444|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983113|NCT00576472|81770445|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
27577666|NCT04640311|80299304|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
27674204|NCT01602510|80643515|FG000|Open Label Phase|Physician Decision|19|||
27794631|NCT01915498|81079098|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794632|NCT01915498|81079099|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794633|NCT01915498|81079100|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27868663|NCT02766335|81353887|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
27868664|NCT02755649|81353888|FG000|Overall Study|Transitioned into OLE study|99|||
27868665|NCT02755649|81353889|FG001|Overall Study|Transitioned into OLE study|98|||
27868666|NCT02755649|81353890|FG002|Overall Study|Transitioned into OLE study|100|||
27868667|NCT02755649|81353888|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
27868668|NCT02755649|81353889|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
27868669|NCT02755649|81353890|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
27868670|NCT02755649|81353888|FG000|Overall Study|Physician Decision|0|||
27868671|NCT02755649|81353889|FG001|Overall Study|Physician Decision|0|||
27868672|NCT02755649|81353890|FG002|Overall Study|Physician Decision|2|||
27868673|NCT02755649|81353888|FG000|Overall Study|Withdrawal by Subject|0|||
27983114|NCT00576472|81770446|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
27794634|NCT01915498|81079101|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794635|NCT01915498|81079102|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794636|NCT01915498|81079103|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794637|NCT01915498|81079104|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794638|NCT01915498|81079105|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794639|NCT01915498|81079106|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794640|NCT01915498|81079107|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794641|NCT01915498|81079108|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794642|NCT01915498|81079109|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794643|NCT01915498|81079110|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794644|NCT01915498|81079111|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794645|NCT01915498|81079112|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794646|NCT01915498|81079113|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
27794647|NCT01915498|81079114|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
27794648|NCT01915498|81079096|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794649|NCT01915498|81079097|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794650|NCT01915498|81079098|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794651|NCT01915498|81079099|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794652|NCT01915498|81079100|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794653|NCT01915498|81079101|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794654|NCT01915498|81079102|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794655|NCT01915498|81079103|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794656|NCT01915498|81079104|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794657|NCT01915498|81079105|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794658|NCT01915498|81079106|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794659|NCT01915498|81079107|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27868674|NCT02755649|81353889|FG001|Overall Study|Withdrawal by Subject|1|||
27868675|NCT02755649|81353890|FG002|Overall Study|Withdrawal by Subject|0|||
27868676|NCT02755649|81353888|FG000|Overall Study|Undecided|1|||
27983115|NCT00576472|81770447|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983116|NCT00576472|81770448|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
27983117|NCT00576472|81770449|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983118|NCT00576472|81770450|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983119|NCT00576472|81770451|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983120|NCT00576472|81770452|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983121|NCT00576472|81770453|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983122|NCT00576472|81770454|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983123|NCT00576472|81770455|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983124|NCT00576472|81770456|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
27983125|NCT00576472|81770442|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
27983126|NCT00576472|81770443|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
27983127|NCT00576472|81770444|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
27983128|NCT00576472|81770445|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
27794660|NCT01915498|81079108|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794661|NCT01915498|81079109|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794662|NCT01915498|81079110|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794663|NCT01915498|81079111|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794664|NCT01915498|81079112|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794665|NCT01915498|81079113|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
27794666|NCT01915498|81079114|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
27794667|NCT01915498|81079096|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794668|NCT01915498|81079097|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794669|NCT01915498|81079098|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794670|NCT01915498|81079099|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794671|NCT01915498|81079100|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794672|NCT01915498|81079101|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794673|NCT01915498|81079102|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794674|NCT01915498|81079103|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794675|NCT01915498|81079104|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27983129|NCT00576472|81770446|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
27983130|NCT00576472|81770447|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
27983131|NCT00576472|81770448|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
27983132|NCT00576472|81770449|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
27983133|NCT00576472|81770450|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
27983134|NCT00576472|81770451|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
27983135|NCT00576472|81770452|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
27983136|NCT00576472|81770453|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
27983137|NCT00576472|81770454|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
27794676|NCT01915498|81079105|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794677|NCT01915498|81079106|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794678|NCT01915498|81079107|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794679|NCT01915498|81079108|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794680|NCT01915498|81079109|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794681|NCT01915498|81079110|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794682|NCT01915498|81079111|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794683|NCT01915498|81079112|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794684|NCT01915498|81079113|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
27794685|NCT01915498|81079114|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
27794686|NCT03345485|81079115|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
27794687|NCT03345485|81079116|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
27794688|NCT03345485|81079117|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
27794689|NCT03345485|81079118|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
27794690|NCT03345485|81079119|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
27794691|NCT03345485|81079120|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
27794692|NCT03345485|81079121|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
27794693|NCT03345485|81079122|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
27794694|NCT03345485|81079123|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
27794695|NCT03345485|81079124|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
27794696|NCT03345485|81079125|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
27794697|NCT03345485|81079126|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
27794698|NCT03345485|81079127|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
27794699|NCT00665366|81079129|FG000|Overall Study|Lack of Efficacy|11|||
27794700|NCT00665366|81079130|FG001|Overall Study|Lack of Efficacy|10|||
27868677|NCT02755649|81353889|FG001|Overall Study|Undecided|0|||
27983138|NCT00576472|81770455|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
27868678|NCT02755649|81353890|FG002|Overall Study|Undecided|0|||
27868679|NCT03775486|81353891|FG000|Initial Therapy Phase|Other reason provided|0|||
27868680|NCT03775486|81353892|FG001|Initial Therapy Phase|Other reason provided|15|||
27868681|NCT03775486|81353891|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
27868682|NCT03775486|81353892|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
27868683|NCT03775486|81353891|FG000|Initial Therapy Phase|Protocol Violation|0|||
27983139|NCT00576472|81770456|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
27983140|NCT00576472|81770442|FG000|MPH Cross Over Phase|Physician Decision|0|||
27983141|NCT00576472|81770443|FG001|MPH Cross Over Phase|Physician Decision|0|||
27983142|NCT00576472|81770444|FG002|MPH Cross Over Phase|Physician Decision|0|||
27983143|NCT00576472|81770445|FG003|MPH Cross Over Phase|Physician Decision|0|||
27983144|NCT00576472|81770446|FG004|MPH Cross Over Phase|Physician Decision|0|||
27983145|NCT00576472|81770447|FG005|MPH Cross Over Phase|Physician Decision|0|||
27983146|NCT00576472|81770448|FG006|MPH Cross Over Phase|Physician Decision|4|||
27983147|NCT00576472|81770449|FG007|MPH Cross Over Phase|Physician Decision|0|||
27983148|NCT00576472|81770450|FG008|MPH Cross Over Phase|Physician Decision|0|||
27983149|NCT00576472|81770451|FG009|MPH Cross Over Phase|Physician Decision|0|||
27983150|NCT00576472|81770452|FG010|MPH Cross Over Phase|Physician Decision|0|||
27983151|NCT00576472|81770453|FG011|MPH Cross Over Phase|Physician Decision|0|||
27983152|NCT00576472|81770454|FG012|MPH Cross Over Phase|Physician Decision|0|||
27983153|NCT00576472|81770455|FG013|MPH Cross Over Phase|Physician Decision|0|||
27983154|NCT00576472|81770456|FG014|MPH Cross Over Phase|Physician Decision|0|||
27983155|NCT00576472|81770442|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983156|NCT00576472|81770443|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983157|NCT00576472|81770444|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983158|NCT00576472|81770445|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983159|NCT00576472|81770446|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983160|NCT00576472|81770447|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983161|NCT00576472|81770448|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983162|NCT00576472|81770449|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983163|NCT00576472|81770450|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
27983164|NCT00576472|81770451|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983165|NCT00576472|81770452|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
27983166|NCT00576472|81770453|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
27983167|NCT00576472|81770454|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983168|NCT00576472|81770455|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983169|NCT00576472|81770456|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
27983170|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983171|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983172|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983173|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983174|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983175|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983176|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983177|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983178|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983179|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983180|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983181|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983182|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983183|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
27983184|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
27983185|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
27983186|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
27983187|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
27983188|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
27983189|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
27983190|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
27983191|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
27983192|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
27983193|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
27983194|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
27983195|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
27983196|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
27983197|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
27983198|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
27983199|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
27983200|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
27868684|NCT03775486|81353892|FG001|Initial Therapy Phase|Protocol Violation|2|||
27868685|NCT03775486|81353891|FG000|Initial Therapy Phase|Adverse Event|0|||
27868686|NCT03775486|81353892|FG001|Initial Therapy Phase|Adverse Event|34|||
27983201|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
27983202|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
27577667|NCT04640311|80299305|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27794701|NCT00665366|81079129|FG000|Overall Study|Adverse Event|25|||
27794702|NCT00665366|81079130|FG001|Overall Study|Adverse Event|23|||
27794703|NCT00665366|81079129|FG000|Overall Study|Withdrawal by Subject|11|||
27794704|NCT00665366|81079130|FG001|Overall Study|Withdrawal by Subject|14|||
27794705|NCT00665366|81079129|FG000|Overall Study|Lost to Follow-up|3|||
27794706|NCT00665366|81079130|FG001|Overall Study|Lost to Follow-up|5|||
27794707|NCT00665366|81079129|FG000|Overall Study|Poor compliance/noncompliance|3|||
27794708|NCT00665366|81079130|FG001|Overall Study|Poor compliance/noncompliance|5|||
27794709|NCT00665366|81079129|FG000|Overall Study|Pregnancy|1|||
27794710|NCT00665366|81079130|FG001|Overall Study|Pregnancy|0|||
27794711|NCT00665366|81079129|FG000|Overall Study|No longer meets study criteria|0|||
27794712|NCT00665366|81079130|FG001|Overall Study|No longer meets study criteria|1|||
27794713|NCT00665366|81079129|FG000|Overall Study|Other reasons|4|||
27794714|NCT00665366|81079130|FG001|Overall Study|Other reasons|1|||
27794715|NCT01513759|81079131|FG000|Overall Study|Protocol Violation|4|||
27794716|NCT01513759|81079131|FG000|Overall Study|Death during catheter placement|1|||
27794717|NCT00602927|81079132|FG000|Period 1: 13 Days|Protocol Violation|2|||
27794718|NCT00602927|81079133|FG001|Period 1: 13 Days|Protocol Violation|4|||
27794719|NCT00602927|81079132|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
27794720|NCT00602927|81079133|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
27794721|NCT00602927|81079132|FG000|Period 1: 13 Days|Time|1|||
27794722|NCT00602927|81079133|FG001|Period 1: 13 Days|Time|0|||
27794723|NCT00602927|81079132|FG000|Period 1: 13 Days|Claustrophobia|0|||
27794724|NCT00602927|81079133|FG001|Period 1: 13 Days|Claustrophobia|1|||
27794725|NCT00602927|81079132|FG000|Period 2: 14 Days|Protocol Violation|0|||
27794726|NCT00602927|81079133|FG001|Period 2: 14 Days|Protocol Violation|2|||
27794727|NCT00602927|81079132|FG000|Period 3: 13 Days|Protocol Violation|0|||
27794728|NCT00602927|81079133|FG001|Period 3: 13 Days|Protocol Violation|1|||
27794729|NCT00602927|81079132|FG000|Period 3: 13 Days|MRI data quality|2|||
27794730|NCT00602927|81079133|FG001|Period 3: 13 Days|MRI data quality|2|||
27794731|NCT00938392|81079134|FG000|Overall Study|Adverse Event|0|||
27794732|NCT00938392|81079135|FG001|Overall Study|Adverse Event|1|||
27794733|NCT00938392|81079134|FG000|Overall Study|Withdrawal by Subject|0|||
27794734|NCT00938392|81079135|FG001|Overall Study|Withdrawal by Subject|1|||
27794735|NCT00938392|81079134|FG000|Overall Study|Lost to Follow-up|2|||
27794736|NCT00938392|81079135|FG001|Overall Study|Lost to Follow-up|2|||
27794737|NCT00110084|81079136|FG000|Overall Study|Adverse Event|9|||
27794738|NCT00110084|81079136|FG000|Overall Study|Death|1|||
27794739|NCT00110084|81079136|FG000|Overall Study|Patient Refusal|10|||
27794740|NCT00110084|81079136|FG000|Overall Study|Alternate Therapy|5|||
27794741|NCT00110084|81079136|FG000|Overall Study|Intercurrent Illness|1|||
27794742|NCT00110084|81079136|FG000|Overall Study|Other|2|||
27983203|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
27983204|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
27983205|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
27983206|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
27983207|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
27983208|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
27983209|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
27983210|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
27983211|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
27983212|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
27983213|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
27983214|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
27983215|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Side effects|0|||
27983216|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Side effects|0|||
27577668|NCT04640311|80299306|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27794743|NCT01157065|81079139|FG000|Overall Study|Death|0|||
27794744|NCT01157065|81079140|FG001|Overall Study|Death|1|||
27868687|NCT03775486|81353891|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
27868688|NCT03775486|81353892|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
27794745|NCT00816166|81079141|FG000|Overall Study|Lost to Follow-up|6|||
27794746|NCT00816166|81079142|FG001|Overall Study|Lost to Follow-up|10|||
27794747|NCT00816166|81079141|FG000|Overall Study|Death|4|||
27868689|NCT03775486|81353891|FG000|Maintenance Phase|Withdrawal by Subject|13|||
27868690|NCT03775486|81353892|FG001|Maintenance Phase|Withdrawal by Subject|12|||
27983217|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Side effects|0|||
27983218|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Side effects|0|||
27983219|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Side effects|0|||
27983220|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Side effects|0|||
27794748|NCT00816166|81079142|FG001|Overall Study|Death|2|||
27794749|NCT00980460|81079147|FG000|Overall Study|Death|0|||
27794750|NCT00980460|81079148|FG001|Overall Study|Death|0|||
27794751|NCT00980460|81079149|FG002|Overall Study|Death|1|||
27983221|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Side effects|0|||
27983222|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Side effects|0|||
27983223|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Side effects|0|||
27983224|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Side effects|0|||
27794752|NCT00980460|81079150|FG003|Overall Study|Death|2|||
27794753|NCT00980460|81079151|FG004|Overall Study|Death|1|||
27794754|NCT00980460|81079147|FG000|Overall Study|Lack of Efficacy|0|||
27794755|NCT00980460|81079148|FG001|Overall Study|Lack of Efficacy|0|||
27983225|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Side effects|0|||
27983226|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Side effects|0|||
27983227|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Side effects|0|||
27983228|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Side effects|0|||
27983229|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Side effects|8|||
27983230|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27794756|NCT00980460|81079149|FG002|Overall Study|Lack of Efficacy|10|||
27794757|NCT00980460|81079150|FG003|Overall Study|Lack of Efficacy|6|||
27794758|NCT00980460|81079151|FG004|Overall Study|Lack of Efficacy|8|||
27794759|NCT00980460|81079147|FG000|Overall Study|Lost to Follow-up|0|||
27794760|NCT00980460|81079148|FG001|Overall Study|Lost to Follow-up|0|||
27794761|NCT00980460|81079149|FG002|Overall Study|Lost to Follow-up|0|||
27794762|NCT00980460|81079150|FG003|Overall Study|Lost to Follow-up|1|||
27794763|NCT00980460|81079151|FG004|Overall Study|Lost to Follow-up|0|||
27794764|NCT00980460|81079147|FG000|Overall Study|Physician Decision|0|||
27868691|NCT03775486|81353891|FG000|Maintenance Phase|Death|44|||
27868692|NCT03775486|81353892|FG001|Maintenance Phase|Death|45|||
27868693|NCT00711880|81353893|FG000|Overall Study|Adverse Event|11|||
27983231|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983232|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983233|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983234|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983235|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983236|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983237|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983238|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983239|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983240|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983241|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983242|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983243|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
27983244|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
27983245|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
27983246|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
27983247|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
27983248|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
27983249|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
27983250|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
27983251|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
27983252|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
27983253|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
27983254|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
27983255|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
27983256|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
27983257|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
27983258|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
27983259|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
27983260|NCT00576472|81770442|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27577669|NCT04640311|80299307|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27983261|NCT00576472|81770443|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983262|NCT00576472|81770444|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983263|NCT00576472|81770445|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27577670|NCT04640311|80299308|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27794765|NCT00980460|81079148|FG001|Overall Study|Physician Decision|0|||
27794766|NCT00980460|81079149|FG002|Overall Study|Physician Decision|11|||
27868694|NCT00711880|81353894|FG001|Overall Study|Adverse Event|2|||
27983264|NCT00576472|81770446|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983265|NCT00576472|81770447|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983266|NCT00576472|81770448|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983267|NCT00576472|81770449|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983268|NCT00576472|81770450|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27794767|NCT00980460|81079150|FG003|Overall Study|Physician Decision|5|||
27794768|NCT00980460|81079151|FG004|Overall Study|Physician Decision|3|||
27794769|NCT00980460|81079147|FG000|Overall Study|Withdrawal by Subject|0|||
27794770|NCT00980460|81079148|FG001|Overall Study|Withdrawal by Subject|0|||
27794771|NCT00980460|81079149|FG002|Overall Study|Withdrawal by Subject|1|||
27794772|NCT00980460|81079150|FG003|Overall Study|Withdrawal by Subject|0|||
27794773|NCT00980460|81079151|FG004|Overall Study|Withdrawal by Subject|0|||
27983269|NCT00576472|81770451|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983270|NCT00576472|81770452|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983271|NCT00576472|81770453|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983272|NCT00576472|81770454|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983273|NCT00576472|81770455|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
27983274|NCT00576472|81770456|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
27983275|NCT03629912|81770466|FG000|Overall Study|Lost to Follow-up|19|||
27983276|NCT03629912|81770467|FG001|Overall Study|Lost to Follow-up|7|||
27983277|NCT03629912|81770468|FG002|Overall Study|Lost to Follow-up|5|||
27983278|NCT03629912|81770469|FG003|Overall Study|Lost to Follow-up|1|||
27983279|NCT03629912|81770466|FG000|Overall Study|Withdrawal by Subject|6|||
27983280|NCT03629912|81770467|FG001|Overall Study|Withdrawal by Subject|0|||
27983281|NCT03629912|81770468|FG002|Overall Study|Withdrawal by Subject|1|||
27983282|NCT03629912|81770469|FG003|Overall Study|Withdrawal by Subject|2|||
27983283|NCT03629912|81770466|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
27983284|NCT03629912|81770467|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
27983285|NCT03629912|81770468|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
27983286|NCT03629912|81770469|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
27983287|NCT03629912|81770466|FG000|Overall Study|Death|1|||
27983288|NCT03629912|81770467|FG001|Overall Study|Death|0|||
27983289|NCT03629912|81770468|FG002|Overall Study|Death|0|||
27983290|NCT03629912|81770469|FG003|Overall Study|Death|0|||
27983291|NCT00552760|81770470|FG000|Overall Study|Adverse Event|3|||
27983292|NCT00552760|81770471|FG001|Overall Study|Adverse Event|5|||
27983293|NCT00552760|81770470|FG000|Overall Study|Relapsed- Depressed Event|10|||
27983294|NCT00552760|81770471|FG001|Overall Study|Relapsed- Depressed Event|16|||
27983295|NCT00552760|81770470|FG000|Overall Study|Relapse- Manic Event|3|||
27983296|NCT00552760|81770471|FG001|Overall Study|Relapse- Manic Event|3|||
27983297|NCT00552760|81770470|FG000|Overall Study|Relapsed- Mixed Event|3|||
27983298|NCT00552760|81770471|FG001|Overall Study|Relapsed- Mixed Event|5|||
27983299|NCT00552760|81770470|FG000|Overall Study|Protocol Violation|0|||
27983300|NCT00552760|81770471|FG001|Overall Study|Protocol Violation|1|||
27983301|NCT00552760|81770470|FG000|Overall Study|Lost to Follow-up|1|||
27983302|NCT00552760|81770471|FG001|Overall Study|Lost to Follow-up|1|||
27983303|NCT00552760|81770470|FG000|Overall Study|Non-compliance|1|||
27983304|NCT00552760|81770471|FG001|Overall Study|Non-compliance|1|||
27983305|NCT00552760|81770470|FG000|Overall Study|Medical Condition|1|||
27983306|NCT00552760|81770471|FG001|Overall Study|Medical Condition|1|||
27983307|NCT00552760|81770470|FG000|Overall Study|Withdrawal by Subject|3|||
27794774|NCT00980460|81079147|FG000|Overall Study|Ineligible|0|||
27794775|NCT00980460|81079148|FG001|Overall Study|Ineligible|2|||
27794776|NCT00980460|81079149|FG002|Overall Study|Ineligible|3|||
27794777|NCT00980460|81079150|FG003|Overall Study|Ineligible|1|||
27794778|NCT00980460|81079151|FG004|Overall Study|Ineligible|4|||
27794779|NCT00980460|81079147|FG000|Overall Study|Refusal of further therapy|0|||
27794780|NCT00980460|81079148|FG001|Overall Study|Refusal of further therapy|2|||
27577671|NCT04640311|80299309|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27577672|NCT04640311|80299310|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27794781|NCT00980460|81079149|FG002|Overall Study|Refusal of further therapy|3|||
27983308|NCT00552760|81770471|FG001|Overall Study|Withdrawal by Subject|0|||
27983309|NCT00552760|81770470|FG000|Overall Study|Medication Change|1|||
27983310|NCT00552760|81770471|FG001|Overall Study|Medication Change|0|||
27983311|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
27983312|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
27983313|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
27983314|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
27983315|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
27674205|NCT01602510|80643516|FG001|Open Label Phase|Physician Decision|0|||
27794782|NCT00980460|81079150|FG003|Overall Study|Refusal of further therapy|2|||
27794783|NCT00980460|81079151|FG004|Overall Study|Refusal of further therapy|0|||
27794784|NCT00980460|81079147|FG000|Overall Study|No therapy within 42 days of resection|0|||
27983316|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
27983317|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
27983318|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
27983319|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
27983320|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
27983321|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
27794785|NCT00980460|81079148|FG001|Overall Study|No therapy within 42 days of resection|0|||
27983322|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
27983323|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
27983324|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
27983325|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
27983326|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
27983327|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
27983328|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
27983329|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
27983330|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
27983331|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
27983332|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
27983333|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
27983334|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
27983335|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
27983336|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
27983337|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
27983338|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
27983339|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
27983340|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
27983341|NCT00121641|81770475|FG000|24-week Short-term Treatment Period|Other Reason|1|||
27983342|NCT00121641|81770476|FG001|24-week Short-term Treatment Period|Other Reason|0|||
27983343|NCT00121641|81770477|FG002|24-week Short-term Treatment Period|Other Reason|0|||
27983344|NCT00121641|81770478|FG003|24-week Short-term Treatment Period|Other Reason|0|||
27674206|NCT01602510|80643517|FG002|Open Label Phase|Physician Decision|0|||
27674207|NCT01602510|80643515|FG000|Open Label Phase|Withdrawal by Subject|57|||
27674208|NCT01602510|80643516|FG001|Open Label Phase|Withdrawal by Subject|0|||
27674209|NCT01602510|80643517|FG002|Open Label Phase|Withdrawal by Subject|0|||
27674210|NCT01602510|80643515|FG000|Randomized Phase|Adverse Event|0|||
27674211|NCT01602510|80643516|FG001|Randomized Phase|Adverse Event|2|||
27674212|NCT01602510|80643517|FG002|Randomized Phase|Adverse Event|6|||
27674213|NCT01602510|80643515|FG000|Randomized Phase|Lack of Efficacy|0|||
27674214|NCT01602510|80643516|FG001|Randomized Phase|Lack of Efficacy|4|||
27674215|NCT01602510|80643517|FG002|Randomized Phase|Lack of Efficacy|4|||
27674216|NCT01602510|80643515|FG000|Randomized Phase|Protocol Violation|0|||
27674217|NCT01602510|80643516|FG001|Randomized Phase|Protocol Violation|3|||
27674218|NCT01602510|80643517|FG002|Randomized Phase|Protocol Violation|3|||
27674219|NCT01602510|80643515|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
27674220|NCT01602510|80643516|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
27674221|NCT01602510|80643517|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
27674222|NCT01602510|80643515|FG000|Randomized Phase|Lost to Follow-up|0|||
27674223|NCT01602510|80643516|FG001|Randomized Phase|Lost to Follow-up|1|||
27674224|NCT01602510|80643517|FG002|Randomized Phase|Lost to Follow-up|3|||
27674225|NCT01602510|80643515|FG000|Randomized Phase|Physician Decision|0|||
27674226|NCT01602510|80643516|FG001|Randomized Phase|Physician Decision|0|||
27674227|NCT01602510|80643517|FG002|Randomized Phase|Physician Decision|2|||
27674228|NCT01602510|80643515|FG000|Randomized Phase|Withdrawal by Subject|0|||
27674229|NCT01602510|80643516|FG001|Randomized Phase|Withdrawal by Subject|6|||
27674230|NCT01602510|80643517|FG002|Randomized Phase|Withdrawal by Subject|7|||
27674231|NCT00379769|80647093|FG000|Main Study|Death|57|||
27674232|NCT00379769|80647094|FG001|Main Study|Death|67|||
27674233|NCT00379769|80647095|FG002|Main Study|Death|54|||
27674234|NCT00379769|80647096|FG003|Main Study|Death|72|||
27674235|NCT00379769|80647097|FG004|Main Study|Death|0|||
27674236|NCT00379769|80647098|FG005|Main Study|Death|0|||
27674237|NCT00379769|80647093|FG000|Main Study|Adverse Event|5|||
27674238|NCT00379769|80647094|FG001|Main Study|Adverse Event|8|||
27674239|NCT00379769|80647095|FG002|Main Study|Adverse Event|10|||
27983345|NCT00121641|81770479|FG004|24-week Short-term Treatment Period|Other Reason|0|||
27674240|NCT00379769|80647096|FG003|Main Study|Adverse Event|11|||
27674241|NCT00379769|80647097|FG004|Main Study|Adverse Event|0|||
27674242|NCT00379769|80647098|FG005|Main Study|Adverse Event|0|||
27674243|NCT00379769|80647093|FG000|Main Study|Lost to Follow-up|29|||
27674244|NCT00379769|80647094|FG001|Main Study|Lost to Follow-up|29|||
27983346|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
27983347|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
27983348|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
27983349|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
27983350|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
27674245|NCT00379769|80647095|FG002|Main Study|Lost to Follow-up|25|||
27674246|NCT00379769|80647096|FG003|Main Study|Lost to Follow-up|26|||
27674247|NCT00379769|80647097|FG004|Main Study|Lost to Follow-up|0|||
27674248|NCT00379769|80647098|FG005|Main Study|Lost to Follow-up|0|||
27674249|NCT00379769|80647093|FG000|Main Study|Withdrawal by Subject|46|||
27674250|NCT00379769|80647094|FG001|Main Study|Withdrawal by Subject|56|||
27674251|NCT00379769|80647095|FG002|Main Study|Withdrawal by Subject|72|||
27674252|NCT00379769|80647096|FG003|Main Study|Withdrawal by Subject|70|||
27674253|NCT00379769|80647097|FG004|Main Study|Withdrawal by Subject|0|||
27674254|NCT00379769|80647098|FG005|Main Study|Withdrawal by Subject|0|||
27674255|NCT00379769|80647093|FG000|Main Study|Moved to survival status follow-up only|27|||
27794786|NCT00980460|81079149|FG002|Overall Study|No therapy within 42 days of resection|3|||
27794787|NCT00980460|81079150|FG003|Overall Study|No therapy within 42 days of resection|1|||
27794788|NCT00980460|81079151|FG004|Overall Study|No therapy within 42 days of resection|0|||
27794789|NCT00980460|81079147|FG000|Overall Study|No transplant by protocol timepoints|0|||
27983351|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
27983352|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
27983353|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
27868695|NCT00711880|81353893|FG000|Overall Study|Patient non-compliance|1|||
27868696|NCT00711880|81353894|FG001|Overall Study|Patient non-compliance|0|||
27868697|NCT00711880|81353893|FG000|Overall Study|Lack of Efficacy|1|||
27868698|NCT00711880|81353894|FG001|Overall Study|Lack of Efficacy|5|||
27868699|NCT01284361|81353905|FG000|Overall Study|Withdrawal by Subject|1|||
27868700|NCT01284361|81353905|FG000|Overall Study|Protocol Violation|5|||
27868701|NCT01284361|81353905|FG000|Overall Study|Adverse Event|1|||
27868702|NCT01284361|81353905|FG000|Overall Study|Lost to Follow-up|2|||
27868703|NCT02905032|81353906|FG000|Overall Study|Withdrawal by Subject|2|||
27868704|NCT02905032|81353907|FG001|Overall Study|Withdrawal by Subject|0|||
27868705|NCT02905032|81353908|FG002|Overall Study|Withdrawal by Subject|0|||
27794790|NCT00980460|81079148|FG001|Overall Study|No transplant by protocol timepoints|0|||
27794791|NCT00980460|81079149|FG002|Overall Study|No transplant by protocol timepoints|3|||
27794792|NCT00980460|81079150|FG003|Overall Study|No transplant by protocol timepoints|0|||
27868706|NCT02905032|81353906|FG000|Overall Study|Protocol Violation|6|||
27983354|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
27983355|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
27868707|NCT02905032|81353907|FG001|Overall Study|Protocol Violation|12|||
27868708|NCT02905032|81353908|FG002|Overall Study|Protocol Violation|0|||
27868709|NCT02910011|81353909|FG000|Overall Study|Physician Decision|2|||
27868710|NCT00799058|81353914|FG000|Overall Study|Withdrawal by Subject|2|||
27983356|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
27983357|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
27983358|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
27983359|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
27983360|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
27983361|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
27868711|NCT00799058|81353915|FG001|Overall Study|Withdrawal by Subject|2|||
27868712|NCT00799058|81353916|FG002|Overall Study|Withdrawal by Subject|2|||
27868713|NCT00799058|81353914|FG000|Overall Study|Lost to Follow-up|1|||
27868714|NCT00799058|81353915|FG001|Overall Study|Lost to Follow-up|2|||
27868715|NCT00799058|81353916|FG002|Overall Study|Lost to Follow-up|1|||
27868716|NCT00799058|81353914|FG000|Overall Study|Adverse Event|0|||
27868717|NCT00799058|81353915|FG001|Overall Study|Adverse Event|2|||
27868718|NCT00799058|81353916|FG002|Overall Study|Adverse Event|0|||
27868719|NCT00799058|81353914|FG000|Overall Study|Pregnancy|1|||
27868720|NCT00799058|81353915|FG001|Overall Study|Pregnancy|0|||
27868721|NCT00799058|81353916|FG002|Overall Study|Pregnancy|0|||
27868722|NCT00799058|81353914|FG000|Overall Study|Not adherent|3|||
27868723|NCT00799058|81353915|FG001|Overall Study|Not adherent|2|||
27983362|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
27868724|NCT00799058|81353916|FG002|Overall Study|Not adherent|1|||
27868725|NCT00799058|81353914|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
27983363|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
27983364|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
27983365|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
27983366|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
27983367|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
27983368|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
27983369|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
27983370|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
27983371|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
27983372|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
27983373|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
27983374|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
27983375|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
27983376|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
27983377|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
27983378|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
27983379|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
27983380|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
27983381|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
27983382|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
27983383|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
27983384|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
27983385|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
27983386|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Death|0|||
27983387|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Death|0|||
27983388|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Death|0|||
27794793|NCT00980460|81079151|FG004|Overall Study|No transplant by protocol timepoints|0|||
27577673|NCT04640311|80299311|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27577674|NCT04640311|80299312|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27983389|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Death|1|||
27983390|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Death|0|||
27983391|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Missing|0|||
27983392|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Missing|0|||
27983393|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Missing|1|||
27983394|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Missing|0|||
27983395|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Missing|0|||
27983396|NCT00121641|81770475|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
27983397|NCT00121641|81770476|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
27983398|NCT00121641|81770477|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
27983399|NCT00121641|81770478|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
27983400|NCT00121641|81770479|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
27983401|NCT00760838|81770480|FG000|Overall Study|Adverse Event|1|||
27983402|NCT00760838|81770481|FG001|Overall Study|Adverse Event|1|||
27983403|NCT00760838|81770480|FG000|Overall Study|Lack of Efficacy|1|||
27983404|NCT00760838|81770481|FG001|Overall Study|Lack of Efficacy|0|||
27983405|NCT00760838|81770480|FG000|Overall Study|Lost to Follow-up|2|||
27983406|NCT00760838|81770481|FG001|Overall Study|Lost to Follow-up|0|||
27983407|NCT00760838|81770480|FG000|Overall Study|Withdrawal by Subject|1|||
27983408|NCT00760838|81770481|FG001|Overall Study|Withdrawal by Subject|1|||
27983409|NCT01831817|81770482|FG000|Overall Study|Lost to Follow-up|1|||
27983410|NCT01831817|81770483|FG001|Overall Study|Lost to Follow-up|0|||
27983411|NCT01831817|81770484|FG002|Overall Study|Lost to Follow-up|0|||
27983412|NCT01831817|81770485|FG003|Overall Study|Lost to Follow-up|0|||
27983413|NCT01831817|81770482|FG000|Overall Study|Withdrawl of Consent|3|||
27983414|NCT01831817|81770483|FG001|Overall Study|Withdrawl of Consent|0|||
27983415|NCT01831817|81770484|FG002|Overall Study|Withdrawl of Consent|0|||
27983416|NCT01831817|81770485|FG003|Overall Study|Withdrawl of Consent|0|||
27983417|NCT01896271|81770494|FG000|Overall Study|Physician Decision|10|||
27983418|NCT02404649|81770499|FG000|Overall Study|Adverse Event|1|||
27983419|NCT02404649|81770500|FG001|Overall Study|Adverse Event|2|||
27983420|NCT02337725|81770501|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
27983421|NCT02337725|81770502|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
27577675|NCT04640311|80299313|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27577676|NCT04640311|80299314|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
27577677|NCT04640311|80299302|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27983422|NCT02337725|81770501|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
27983423|NCT02337725|81770502|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
27983424|NCT02337725|81770501|FG000|Overall Study|Major Protocol Deviation|0|||
27983425|NCT02337725|81770502|FG001|Overall Study|Major Protocol Deviation|1|||
27983426|NCT02337725|81770501|FG000|Overall Study|Voluntary Withdrawal|14|||
27983427|NCT02337725|81770502|FG001|Overall Study|Voluntary Withdrawal|3|||
27983428|NCT02337725|81770501|FG000|Overall Study|Lack of Efficacy|4|||
27983429|NCT02337725|81770502|FG001|Overall Study|Lack of Efficacy|0|||
27983430|NCT02345330|81770507|FG000|Overall Study|Death|1|||
27983431|NCT02345330|81770507|FG000|Overall Study|Progressive Disease|2|||
27983432|NCT01291277|81770508|FG000|Overall Study|Death|2|||
27983433|NCT01291277|81770509|FG001|Overall Study|Death|2|||
27983434|NCT01291277|81770508|FG000|Overall Study|Lost to Follow-up|3|||
27983435|NCT01291277|81770509|FG001|Overall Study|Lost to Follow-up|1|||
27983436|NCT03626545|81770510|FG000|Overall Study|Progressive disease|3|||
27983437|NCT03626545|81770511|FG001|Overall Study|Progressive disease|82|||
27983438|NCT03626545|81770512|FG002|Overall Study|Progressive disease|85|||
27983439|NCT03626545|81770510|FG000|Overall Study|Adverse Event|3|||
27983440|NCT03626545|81770511|FG001|Overall Study|Adverse Event|13|||
27983441|NCT03626545|81770512|FG002|Overall Study|Adverse Event|10|||
27983442|NCT03626545|81770510|FG000|Overall Study|Physician Decision|1|||
27983443|NCT03626545|81770511|FG001|Overall Study|Physician Decision|18|||
27983444|NCT03626545|81770512|FG002|Overall Study|Physician Decision|14|||
27983445|NCT03626545|81770510|FG000|Overall Study|Subject Decision|0|||
27983446|NCT03626545|81770511|FG001|Overall Study|Subject Decision|5|||
27983447|NCT03626545|81770512|FG002|Overall Study|Subject Decision|5|||
27983448|NCT03626545|81770510|FG000|Overall Study|Death|1|||
27983449|NCT03626545|81770511|FG001|Overall Study|Death|1|||
27983450|NCT03626545|81770512|FG002|Overall Study|Death|1|||
27577678|NCT04640311|80299303|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577679|NCT04640311|80299304|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577680|NCT04640311|80299305|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
27577681|NCT04640311|80299306|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577682|NCT04640311|80299307|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577683|NCT04640311|80299308|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
27577684|NCT04640311|80299309|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577685|NCT04640311|80299310|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577686|NCT04640311|80299311|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577687|NCT04640311|80299312|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577688|NCT04640311|80299313|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577689|NCT04640311|80299314|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
27577690|NCT04640311|80299302|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577691|NCT04640311|80299303|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27674256|NCT00379769|80647094|FG001|Main Study|Moved to survival status follow-up only|25|||
27794794|NCT00276458|81079152|FG000|Overall Study|Adverse Event|0|||
27983451|NCT03626545|81770510|FG000|Overall Study|Protocol Deviation|0|||
27983452|NCT03626545|81770511|FG001|Overall Study|Protocol Deviation|1|||
27983453|NCT03626545|81770512|FG002|Overall Study|Protocol Deviation|1|||
27983454|NCT03626545|81770510|FG000|Overall Study|Guardian Decision|0|||
27983455|NCT03626545|81770511|FG001|Overall Study|Guardian Decision|0|||
27983456|NCT03626545|81770512|FG002|Overall Study|Guardian Decision|1|||
27674257|NCT00379769|80647095|FG002|Main Study|Moved to survival status follow-up only|32|||
27674258|NCT00379769|80647096|FG003|Main Study|Moved to survival status follow-up only|36|||
27674259|NCT00379769|80647097|FG004|Main Study|Moved to survival status follow-up only|0|||
27674260|NCT00379769|80647098|FG005|Main Study|Moved to survival status follow-up only|0|||
27674261|NCT00379769|80647093|FG000|Main Study|Participant moved|3|||
27674262|NCT00379769|80647094|FG001|Main Study|Participant moved|2|||
27674263|NCT00379769|80647095|FG002|Main Study|Participant moved|3|||
27674264|NCT00379769|80647096|FG003|Main Study|Participant moved|3|||
27674265|NCT00379769|80647097|FG004|Main Study|Participant moved|0|||
27674266|NCT00379769|80647098|FG005|Main Study|Participant moved|0|||
27674267|NCT00379769|80647093|FG000|Main Study|Poor compliance|3|||
27674268|NCT00379769|80647094|FG001|Main Study|Poor compliance|2|||
27674269|NCT00379769|80647095|FG002|Main Study|Poor compliance|2|||
27674270|NCT00379769|80647096|FG003|Main Study|Poor compliance|1|||
27674271|NCT00379769|80647097|FG004|Main Study|Poor compliance|0|||
27983457|NCT02440789|81770513|FG000|Overall Study|Withdrawal by Subject|3|||
27983458|NCT02440789|81770513|FG000|Overall Study|Not willing to adhere to reqs|1|||
27983459|NCT04063787|81770514|FG000|Overall Study|Inadequate Doppler data|4|||
27983460|NCT04063787|81770514|FG000|Overall Study|Lost to Follow-up|2|||
27674272|NCT00379769|80647098|FG005|Main Study|Poor compliance|0|||
27674273|NCT00379769|80647093|FG000|Main Study|Prohibited glucose lowering medication|0|||
27674274|NCT00379769|80647094|FG001|Main Study|Prohibited glucose lowering medication|3|||
27674275|NCT00379769|80647095|FG002|Main Study|Prohibited glucose lowering medication|0|||
27674276|NCT00379769|80647096|FG003|Main Study|Prohibited glucose lowering medication|1|||
27674277|NCT00379769|80647097|FG004|Main Study|Prohibited glucose lowering medication|0|||
27674278|NCT00379769|80647098|FG005|Main Study|Prohibited glucose lowering medication|0|||
27674279|NCT00379769|80647093|FG000|Main Study|Site closed|4|||
27674280|NCT00379769|80647094|FG001|Main Study|Site closed|4|||
27674281|NCT00379769|80647095|FG002|Main Study|Site closed|4|||
27674282|NCT00379769|80647096|FG003|Main Study|Site closed|8|||
27674283|NCT00379769|80647097|FG004|Main Study|Site closed|0|||
27674284|NCT00379769|80647098|FG005|Main Study|Site closed|0|||
27674285|NCT00379769|80647093|FG000|Main Study|Entry criteria violation|0|||
27674286|NCT00379769|80647094|FG001|Main Study|Entry criteria violation|0|||
27674287|NCT00379769|80647095|FG002|Main Study|Entry criteria violation|1|||
27674288|NCT00379769|80647096|FG003|Main Study|Entry criteria violation|1|||
27674289|NCT00379769|80647097|FG004|Main Study|Entry criteria violation|0|||
27674290|NCT00379769|80647098|FG005|Main Study|Entry criteria violation|0|||
27674291|NCT00379769|80647093|FG000|Main Study|Participant did not take study drug|0|||
27674292|NCT00379769|80647094|FG001|Main Study|Participant did not take study drug|0|||
27983461|NCT04063787|81770514|FG000|Overall Study|Death|3|||
27983462|NCT00940485|81770515|FG000|Overall Study|HBeAb positive at Baseline|3|||
27674293|NCT00379769|80647095|FG002|Main Study|Participant did not take study drug|1|||
27674294|NCT00379769|80647096|FG003|Main Study|Participant did not take study drug|0|||
27674295|NCT00379769|80647097|FG004|Main Study|Participant did not take study drug|0|||
27674296|NCT00379769|80647098|FG005|Main Study|Participant did not take study drug|0|||
27674297|NCT00379769|80647093|FG000|Main Study|Physician Decision|2|||
27674298|NCT00379769|80647094|FG001|Main Study|Physician Decision|2|||
27674299|NCT00379769|80647095|FG002|Main Study|Physician Decision|1|||
27674300|NCT00379769|80647096|FG003|Main Study|Physician Decision|1|||
27674301|NCT00379769|80647097|FG004|Main Study|Physician Decision|0|||
27674302|NCT00379769|80647098|FG005|Main Study|Physician Decision|0|||
27674303|NCT00379769|80647093|FG000|Main Study|Participant completed study at visit 27|1|||
27674304|NCT00379769|80647094|FG001|Main Study|Participant completed study at visit 27|0|||
27674305|NCT00379769|80647095|FG002|Main Study|Participant completed study at visit 27|0|||
27674306|NCT00379769|80647096|FG003|Main Study|Participant completed study at visit 27|0|||
27674307|NCT00379769|80647097|FG004|Main Study|Participant completed study at visit 27|0|||
27674308|NCT00379769|80647098|FG005|Main Study|Participant completed study at visit 27|0|||
27674309|NCT00379769|80647093|FG000|Main Study|Personal reasons|1|||
27674310|NCT00379769|80647094|FG001|Main Study|Personal reasons|0|||
27674311|NCT00379769|80647095|FG002|Main Study|Personal reasons|0|||
27674312|NCT00379769|80647096|FG003|Main Study|Personal reasons|0|||
27674313|NCT00379769|80647097|FG004|Main Study|Personal reasons|0|||
27674314|NCT00379769|80647098|FG005|Main Study|Personal reasons|0|||
27674315|NCT00379769|80647093|FG000|Main Study|Risk of heart failure|0|||
27674316|NCT00379769|80647094|FG001|Main Study|Risk of heart failure|1|||
27674317|NCT00379769|80647095|FG002|Main Study|Risk of heart failure|0|||
27674318|NCT00379769|80647096|FG003|Main Study|Risk of heart failure|0|||
27674319|NCT00379769|80647097|FG004|Main Study|Risk of heart failure|0|||
27674320|NCT00379769|80647098|FG005|Main Study|Risk of heart failure|0|||
27674321|NCT00379769|80647093|FG000|Main Study|Investigator refused to log temperature|0|||
27674322|NCT00379769|80647094|FG001|Main Study|Investigator refused to log temperature|0|||
27674323|NCT00379769|80647095|FG002|Main Study|Investigator refused to log temperature|1|||
27983463|NCT00940485|81770516|FG001|Overall Study|HBeAb positive at Baseline|2|||
27983464|NCT00940485|81770515|FG000|Overall Study|Lost to Follow-up|2|||
27983465|NCT00940485|81770516|FG001|Overall Study|Lost to Follow-up|3|||
27674324|NCT00379769|80647096|FG003|Main Study|Investigator refused to log temperature|0|||
27674325|NCT00379769|80647097|FG004|Main Study|Investigator refused to log temperature|0|||
27674326|NCT00379769|80647098|FG005|Main Study|Investigator refused to log temperature|0|||
27674327|NCT00379769|80647093|FG000|Main Study|Reason unspecified|0|||
27674328|NCT00379769|80647094|FG001|Main Study|Reason unspecified|0|||
27983466|NCT00940485|81770515|FG000|Overall Study|Adverse Event|8|||
27577692|NCT04640311|80299304|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27674329|NCT00379769|80647095|FG002|Main Study|Reason unspecified|1|||
27983467|NCT00940485|81770516|FG001|Overall Study|Adverse Event|0|||
27983468|NCT00940485|81770515|FG000|Overall Study|Withdrawal by Subject|1|||
27983469|NCT00940485|81770516|FG001|Overall Study|Withdrawal by Subject|1|||
27983470|NCT00940485|81770515|FG000|Overall Study|Others|1|||
27983471|NCT00940485|81770516|FG001|Overall Study|Others|1|||
27983472|NCT01490294|81770519|FG000|Overall Study|Prematurely discontinuation|4|||
27983473|NCT01490294|81770520|FG001|Overall Study|Prematurely discontinuation|0|||
27983474|NCT01490294|81770521|FG002|Overall Study|Prematurely discontinuation|1|||
27983475|NCT01490294|81770522|FG003|Overall Study|Prematurely discontinuation|1|||
27983476|NCT01490294|81770519|FG000|Overall Study|Adverse Event|1|||
27983477|NCT01490294|81770520|FG001|Overall Study|Adverse Event|0|||
27983478|NCT01490294|81770521|FG002|Overall Study|Adverse Event|0|||
27983479|NCT01490294|81770522|FG003|Overall Study|Adverse Event|0|||
27983480|NCT00031460|81770525|FG000|Overall Study|Lost to Follow-up|0|||
27983481|NCT00031460|81770526|FG001|Overall Study|Lost to Follow-up|1|||
27983482|NCT00031460|81770525|FG000|Overall Study|Withdrawal by Subject|1|||
27983483|NCT00031460|81770526|FG001|Overall Study|Withdrawal by Subject|1|||
27983484|NCT00031460|81770525|FG000|Overall Study|Non-Compliant|1|||
27983485|NCT00031460|81770526|FG001|Overall Study|Non-Compliant|1|||
27983486|NCT00031460|81770525|FG000|Overall Study|Death|0|||
27983487|NCT00031460|81770526|FG001|Overall Study|Death|1|||
27983488|NCT00031460|81770525|FG000|Overall Study|Reactivation of Disease|5|||
27983489|NCT00031460|81770526|FG001|Overall Study|Reactivation of Disease|9|||
27983490|NCT00031460|81770525|FG000|Overall Study|Disruption of blinded drug supply|2|||
27983491|NCT00031460|81770526|FG001|Overall Study|Disruption of blinded drug supply|0|||
27983492|NCT00031460|81770525|FG000|Overall Study|Confirmed unevaluable|0|||
27983493|NCT00031460|81770526|FG001|Overall Study|Confirmed unevaluable|1|||
27983494|NCT01300455|81770527|FG000|Washout|Withdrawal by Subject|1|||
27983495|NCT01300455|81770528|FG001|Washout|Withdrawal by Subject|0|||
27983496|NCT05086510|81770529|FG000|Overall Study|Lost to Follow-up|0|||
27983497|NCT05086510|81770530|FG001|Overall Study|Lost to Follow-up|2|||
27983498|NCT05086510|81770529|FG000|Overall Study|Death|0|||
27983499|NCT05086510|81770530|FG001|Overall Study|Death|2|||
27983500|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
27983501|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
27983502|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
27983503|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
27674330|NCT00379769|80647096|FG003|Main Study|Reason unspecified|0|||
27983504|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
27983505|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
27983506|NCT01389323|81770532|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
27983507|NCT01389323|81770532|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
27983508|NCT01389323|81770532|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
27983509|NCT01389323|81770532|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
27577693|NCT04640311|80299305|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577694|NCT04640311|80299306|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27674331|NCT00379769|80647097|FG004|Main Study|Reason unspecified|0|||
27674332|NCT00379769|80647098|FG005|Main Study|Reason unspecified|0|||
27674333|NCT00379769|80647093|FG000|Observational Follow-up|Death|0|||
27983510|NCT01389323|81770532|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
27983511|NCT00324233|81773877|FG000|First Period|unable to insert catheter|1|||
27983512|NCT00324233|81773878|FG001|First Period|unable to insert catheter|0|||
27983513|NCT00324233|81773877|FG000|Second Period|unable to insert catheter|1|||
27983514|NCT00324233|81773878|FG001|Second Period|unable to insert catheter|1|||
27983515|NCT00324233|81773877|FG000|Second Period|Protocol Violation|4|||
27983516|NCT00324233|81773878|FG001|Second Period|Protocol Violation|6|||
27983517|NCT04881747|81773880|FG000|Period 2 Washout|Adverse Event|1|||
27674334|NCT00379769|80647094|FG001|Observational Follow-up|Death|0|||
27674335|NCT00379769|80647095|FG002|Observational Follow-up|Death|0|||
27674336|NCT00379769|80647096|FG003|Observational Follow-up|Death|0|||
27674337|NCT00379769|80647097|FG004|Observational Follow-up|Death|78|||
27674338|NCT00379769|80647098|FG005|Observational Follow-up|Death|70|||
27674339|NCT00379769|80647093|FG000|Observational Follow-up|Adverse Event|0|||
27674340|NCT00379769|80647094|FG001|Observational Follow-up|Adverse Event|0|||
27674341|NCT00379769|80647095|FG002|Observational Follow-up|Adverse Event|0|||
27674342|NCT00379769|80647096|FG003|Observational Follow-up|Adverse Event|0|||
27674343|NCT00379769|80647097|FG004|Observational Follow-up|Adverse Event|1|||
27674344|NCT00379769|80647098|FG005|Observational Follow-up|Adverse Event|0|||
27674345|NCT00379769|80647093|FG000|Observational Follow-up|Lost to Follow-up|0|||
27674346|NCT00379769|80647094|FG001|Observational Follow-up|Lost to Follow-up|0|||
27674347|NCT00379769|80647095|FG002|Observational Follow-up|Lost to Follow-up|0|||
27674348|NCT00379769|80647096|FG003|Observational Follow-up|Lost to Follow-up|0|||
27674349|NCT00379769|80647097|FG004|Observational Follow-up|Lost to Follow-up|25|||
27674350|NCT00379769|80647098|FG005|Observational Follow-up|Lost to Follow-up|27|||
27674351|NCT00379769|80647093|FG000|Observational Follow-up|Withdrawal by Subject|0|||
27674352|NCT00379769|80647094|FG001|Observational Follow-up|Withdrawal by Subject|0|||
27674353|NCT00379769|80647095|FG002|Observational Follow-up|Withdrawal by Subject|0|||
27674354|NCT00379769|80647096|FG003|Observational Follow-up|Withdrawal by Subject|0|||
27674355|NCT00379769|80647097|FG004|Observational Follow-up|Withdrawal by Subject|12|||
27577695|NCT04640311|80299307|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
27983518|NCT04881747|81773881|FG001|Period 2 Washout|Adverse Event|0|||
27577696|NCT04640311|80299308|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577697|NCT04640311|80299309|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27674356|NCT00379769|80647098|FG005|Observational Follow-up|Withdrawal by Subject|12|||
27674357|NCT00379769|80647093|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
27674358|NCT00379769|80647094|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
27674359|NCT00379769|80647095|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
27674360|NCT00379769|80647096|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
27983519|NCT04881747|81773882|FG002|Period 2 Washout|Adverse Event|0|||
27983520|NCT04881747|81773883|FG003|Period 2 Washout|Adverse Event|0|||
27674361|NCT00379769|80647097|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
27674362|NCT00379769|80647098|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
27674363|NCT00379769|80647093|FG000|Observational Follow-up|Physician Decision|0|||
27674364|NCT00379769|80647094|FG001|Observational Follow-up|Physician Decision|0|||
27674365|NCT00379769|80647095|FG002|Observational Follow-up|Physician Decision|0|||
27674366|NCT00379769|80647096|FG003|Observational Follow-up|Physician Decision|0|||
27674367|NCT00379769|80647097|FG004|Observational Follow-up|Physician Decision|8|||
27674368|NCT00379769|80647098|FG005|Observational Follow-up|Physician Decision|8|||
27674369|NCT00379769|80647093|FG000|Observational Follow-up|Site Closed Early|0|||
27674370|NCT00379769|80647094|FG001|Observational Follow-up|Site Closed Early|0|||
27674371|NCT00379769|80647095|FG002|Observational Follow-up|Site Closed Early|0|||
27674372|NCT00379769|80647096|FG003|Observational Follow-up|Site Closed Early|0|||
27674373|NCT00379769|80647097|FG004|Observational Follow-up|Site Closed Early|6|||
27674374|NCT00379769|80647098|FG005|Observational Follow-up|Site Closed Early|7|||
27674375|NCT00379769|80647093|FG000|Observational Follow-up|Participant Moved|0|||
27674376|NCT00379769|80647094|FG001|Observational Follow-up|Participant Moved|0|||
27674377|NCT00379769|80647095|FG002|Observational Follow-up|Participant Moved|0|||
27674378|NCT00379769|80647096|FG003|Observational Follow-up|Participant Moved|0|||
27674379|NCT00379769|80647097|FG004|Observational Follow-up|Participant Moved|0|||
27674380|NCT00379769|80647098|FG005|Observational Follow-up|Participant Moved|1|||
27674381|NCT00379769|80647093|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
27674382|NCT00379769|80647094|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
27674383|NCT00379769|80647095|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
27674384|NCT00379769|80647096|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
27674385|NCT00379769|80647097|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
27794795|NCT00276458|81079153|FG001|Overall Study|Adverse Event|2|||
27794796|NCT00276458|81079152|FG000|Overall Study|Lost to Follow-up|2|||
27794797|NCT00276458|81079153|FG001|Overall Study|Lost to Follow-up|2|||
27983521|NCT04881747|81773884|FG004|Period 2 Washout|Adverse Event|1|||
27983522|NCT04881747|81773885|FG005|Period 2 Washout|Adverse Event|0|||
27794798|NCT00276458|81079152|FG000|Overall Study|Protocol Violation|4|||
27794799|NCT00276458|81079153|FG001|Overall Study|Protocol Violation|3|||
27794800|NCT01308762|81079154|FG000|Overall Study|Protocol Violation|0|||
27983523|NCT04881747|81773880|FG000|Period 2 Washout|Withdrawal by Subject|1|||
27983524|NCT04881747|81773881|FG001|Period 2 Washout|Withdrawal by Subject|0|||
27983525|NCT04881747|81773882|FG002|Period 2 Washout|Withdrawal by Subject|0|||
27983526|NCT04881747|81773883|FG003|Period 2 Washout|Withdrawal by Subject|1|||
27983527|NCT04881747|81773884|FG004|Period 2 Washout|Withdrawal by Subject|0|||
27983528|NCT04881747|81773885|FG005|Period 2 Washout|Withdrawal by Subject|0|||
27983529|NCT00249613|81773888|FG000|12 Month Follow-up|Death|1|||
27983530|NCT00249613|81773889|FG001|12 Month Follow-up|Death|1|||
27983531|NCT00249613|81773888|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
27983532|NCT00249613|81773889|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
27983533|NCT00249613|81773888|FG000|12 Month Follow-up|Lost to Follow-up|10|||
27983534|NCT00249613|81773889|FG001|12 Month Follow-up|Lost to Follow-up|8|||
27983535|NCT00129961|81773890|FG000|Overall Study|Adverse Event|1|||
27577698|NCT04640311|80299310|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
27577699|NCT04640311|80299311|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27794801|NCT01308762|81079155|FG001|Overall Study|Protocol Violation|1|||
27794802|NCT01308762|81079156|FG002|Overall Study|Protocol Violation|0|||
27794803|NCT04619004|81079157|FG000|Overall Study|Death|114|||
27794804|NCT04619004|81079158|FG001|Overall Study|Death|28|||
27794805|NCT04619004|81079157|FG000|Overall Study|Lost to Follow-up|1|||
27794806|NCT04619004|81079158|FG001|Overall Study|Lost to Follow-up|1|||
27794807|NCT04619004|81079157|FG000|Overall Study|Withdrawal by Subject|24|||
27794808|NCT04619004|81079158|FG001|Overall Study|Withdrawal by Subject|7|||
27794809|NCT04619004|81079157|FG000|Overall Study|Other - Not specified|0|||
27794810|NCT04619004|81079158|FG001|Overall Study|Other - Not specified|1|||
27794811|NCT01392469|81079159|FG000|Overall Study|Adverse Event|2|||
27794812|NCT01392469|81079159|FG000|Overall Study|Withdrawal by Subject|1|||
27794813|NCT01392469|81079159|FG000|Overall Study|Protocol Violation|1|||
27794814|NCT02861534|81079164|FG000|Overall Study|Death|541|||
27794815|NCT02861534|81079165|FG001|Overall Study|Death|552|||
27794816|NCT02861534|81079164|FG000|Overall Study|Lost to Follow-up|14|||
27794817|NCT02861534|81079165|FG001|Overall Study|Lost to Follow-up|14|||
27794818|NCT02861534|81079164|FG000|Overall Study|Site Terminated by Sponsor|4|||
27794819|NCT02861534|81079165|FG001|Overall Study|Site Terminated by Sponsor|3|||
27794820|NCT02861534|81079164|FG000|Overall Study|Withdrawal by Subject|15|||
27794821|NCT02861534|81079165|FG001|Overall Study|Withdrawal by Subject|18|||
27794822|NCT01946204|81079166|FG000|Overall Study|Death|38|||
27577700|NCT04640311|80299312|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27983536|NCT00129961|81773891|FG001|Overall Study|Adverse Event|0|||
27983537|NCT00129961|81773890|FG000|Overall Study|Death|1|||
27983538|NCT00129961|81773891|FG001|Overall Study|Death|1|||
27983539|NCT00129961|81773890|FG000|Overall Study|Withdrawal by Sponsor|14|||
27983540|NCT00129961|81773891|FG001|Overall Study|Withdrawal by Sponsor|20|||
27983541|NCT00129961|81773890|FG000|Overall Study|Physician Decision|1|||
27983542|NCT00129961|81773891|FG001|Overall Study|Physician Decision|0|||
27983543|NCT00129961|81773890|FG000|Overall Study|Withdrawal by Subject|2|||
27983544|NCT00129961|81773891|FG001|Overall Study|Withdrawal by Subject|1|||
27983545|NCT00129961|81773890|FG000|Overall Study|Missing Record|0|||
27983546|NCT00129961|81773891|FG001|Overall Study|Missing Record|1|||
27983547|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
27983548|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
27983549|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
27983550|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
27983551|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
27983552|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
27983553|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
27983554|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
27983555|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Death|0|||
27983556|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Death|1|||
27983557|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
27983558|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
27983559|NCT03281304|81773892|FG000|Treatment Phase (up to 42 Months)|Other|0|||
27983560|NCT03281304|81773893|FG001|Treatment Phase (up to 42 Months)|Other|2|||
27983561|NCT03281304|81773892|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
27983562|NCT03281304|81773893|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
27983563|NCT01283542|81773894|FG000|Main Phase|Acute or progressive vision loss|1|||
27983564|NCT01283542|81773894|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
27983565|NCT01283542|81773894|FG000|Main Phase|abnormal laboratory values|5|||
27983566|NCT01283542|81773894|FG000|Extension Phase|Physician Decision|1|||
27983567|NCT01283542|81773894|FG000|Extension Phase|Adverse Event|1|||
27983568|NCT01283542|81773894|FG000|Extension Phase|Administrative problems|1|||
27983569|NCT03743064|81773895|FG000|Overall Study|Adverse Event|7|||
27983570|NCT03743064|81773896|FG001|Overall Study|Adverse Event|9|||
27983571|NCT03743064|81773895|FG000|Overall Study|Death|25|||
27983572|NCT03743064|81773896|FG001|Overall Study|Death|28|||
27983573|NCT03743064|81773895|FG000|Overall Study|Lost to Follow-up|3|||
27983574|NCT03743064|81773896|FG001|Overall Study|Lost to Follow-up|6|||
27983575|NCT03743064|81773895|FG000|Overall Study|Withdrawal by Subject|28|||
27983576|NCT03743064|81773896|FG001|Overall Study|Withdrawal by Subject|25|||
27983577|NCT03743064|81773895|FG000|Overall Study|Physician Decision|2|||
27983578|NCT03743064|81773896|FG001|Overall Study|Physician Decision|4|||
27983579|NCT03743064|81773895|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
27983580|NCT03743064|81773896|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
27983581|NCT02698371|81773898|FG000|All Participants Flow|Lost to Follow-up|3|||
27983582|NCT02698371|81773898|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
27983583|NCT02698371|81773898|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
27983584|NCT02698371|81773898|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
27983585|NCT02698371|81773898|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
27983586|NCT02698371|81773898|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
27983587|NCT02698371|81773898|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
27983588|NCT01457846|81773899|FG000|Overall Study|Death before treatment|1|||
27983589|NCT01457846|81773900|FG001|Overall Study|Death before treatment|2|||
27983590|NCT01457846|81773899|FG000|Overall Study|Did not receive treatment|0|||
27983591|NCT01457846|81773900|FG001|Overall Study|Did not receive treatment|1|||
27983592|NCT01457846|81773899|FG000|Overall Study|Death|27|||
27983593|NCT01457846|81773900|FG001|Overall Study|Death|16|||
27983594|NCT01457846|81773899|FG000|Overall Study|Unclassified reason for not completed|11|||
27983595|NCT01457846|81773900|FG001|Overall Study|Unclassified reason for not completed|10|||
27983596|NCT01457846|81773899|FG000|Overall Study|Withdrawal by Subject|1|||
27983597|NCT01457846|81773900|FG001|Overall Study|Withdrawal by Subject|1|||
27983598|NCT01457846|81773899|FG000|Overall Study|Lost to Follow-up|1|||
27983599|NCT01457846|81773900|FG001|Overall Study|Lost to Follow-up|0|||
27983600|NCT00708734|81773901|FG000|Overall Study|scheduling conflict|2|||
27983601|NCT00708734|81773901|FG000|Overall Study|moved|1|||
27983602|NCT00708734|81773901|FG000|Overall Study|leg injury|1|||
27983603|NCT00708734|81773901|FG000|Overall Study|knee replacement|1|||
27983604|NCT00708734|81773901|FG000|Overall Study|vertigo|1|||
27674386|NCT00379769|80647098|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
27674387|NCT01712061|80647100|FG000|Overall Study|Adverse Event|4|||
27983605|NCT00708734|81773901|FG000|Overall Study|leg fracture|1|||
27983606|NCT01110382|81773903|FG000|Overall Study|Withdrawal by Subject|0|||
27983607|NCT01110382|81773904|FG001|Overall Study|Withdrawal by Subject|1|||
27983608|NCT01110382|81773903|FG000|Overall Study|Protocol Violation|0|||
27983609|NCT01110382|81773904|FG001|Overall Study|Protocol Violation|1|||
27983610|NCT01659255|81773905|FG000|Overall Study|Adverse Event|0|||
27983611|NCT01659255|81773906|FG001|Overall Study|Adverse Event|0|||
27983612|NCT01659255|81773907|FG002|Overall Study|Adverse Event|0|||
27983613|NCT01659255|81773908|FG003|Overall Study|Adverse Event|0|||
27868726|NCT00799058|81353915|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
27868727|NCT00799058|81353916|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
27868728|NCT00799058|81353914|FG000|Overall Study|IP dispensing error|1|||
27868729|NCT00799058|81353915|FG001|Overall Study|IP dispensing error|0|||
27868730|NCT00799058|81353916|FG002|Overall Study|IP dispensing error|0|||
27868731|NCT00799058|81353914|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
27868732|NCT00799058|81353915|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
27868733|NCT00799058|81353916|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
27868734|NCT00799058|81353914|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
27868735|NCT00799058|81353915|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
27868736|NCT00799058|81353916|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
27868737|NCT00799058|81353914|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
27794823|NCT01946204|81079167|FG001|Overall Study|Death|59|||
27794824|NCT01946204|81079166|FG000|Overall Study|Withdrawal by Subject|37|||
27794825|NCT01946204|81079167|FG001|Overall Study|Withdrawal by Subject|50|||
27794826|NCT01946204|81079166|FG000|Overall Study|Lost to Follow-up|3|||
27794827|NCT01946204|81079167|FG001|Overall Study|Lost to Follow-up|7|||
27794828|NCT01946204|81079166|FG000|Overall Study|Ongoing|316|||
27794829|NCT01946204|81079167|FG001|Overall Study|Ongoing|687|||
27794830|NCT01946204|81079166|FG000|Overall Study|Other|7|||
27794831|NCT01946204|81079167|FG001|Overall Study|Other|3|||
27794832|NCT00337727|81079171|FG000|Overall Study|Adverse Event|5|||
27794833|NCT00337727|81079172|FG001|Overall Study|Adverse Event|3|||
27794834|NCT00337727|81079171|FG000|Overall Study|Lost to Follow-up|5|||
27794835|NCT00337727|81079172|FG001|Overall Study|Lost to Follow-up|4|||
27794836|NCT00337727|81079171|FG000|Overall Study|Physician Decision|1|||
27794837|NCT00337727|81079172|FG001|Overall Study|Physician Decision|0|||
27794838|NCT00337727|81079171|FG000|Overall Study|Protocol Violation|4|||
27794839|NCT00337727|81079172|FG001|Overall Study|Protocol Violation|0|||
27794840|NCT00337727|81079171|FG000|Overall Study|Withdrawal by Subject|3|||
27794841|NCT00337727|81079172|FG001|Overall Study|Withdrawal by Subject|5|||
27868738|NCT00799058|81353915|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
27868739|NCT00799058|81353916|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
27868740|NCT00799058|81353914|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
27868741|NCT00799058|81353915|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
27868742|NCT00799058|81353916|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
27868743|NCT02681510|81353928|FG000|Overall Study|Withdrawal by Subject|1|||
27868744|NCT02681510|81353928|FG000|Overall Study|Lost to Follow-up|9|||
27868745|NCT02301390|81353934|FG000|Overall Study|Withdrawal by Subject|3|||
27674388|NCT01712061|80647101|FG001|Overall Study|Adverse Event|9|||
27794842|NCT01371981|81079175|FG000|Overall Study|Adverse Event|12|||
27794843|NCT01371981|81079176|FG001|Overall Study|Adverse Event|17|||
27794844|NCT01371981|81079177|FG002|Overall Study|Adverse Event|0|||
27794845|NCT01371981|81079178|FG003|Overall Study|Adverse Event|4|||
27577701|NCT04640311|80299313|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27577702|NCT04640311|80299314|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
27868746|NCT02301390|81353935|FG001|Overall Study|Withdrawal by Subject|5|||
27868747|NCT02301390|81353934|FG000|Overall Study|Protocol Violation|1|||
27868748|NCT02301390|81353935|FG001|Overall Study|Protocol Violation|0|||
27868749|NCT02301390|81353934|FG000|Overall Study|Physician Decision|1|||
27868750|NCT02301390|81353935|FG001|Overall Study|Physician Decision|0|||
27868751|NCT02301390|81353934|FG000|Overall Study|Lost to Follow-up|0|||
27868752|NCT02301390|81353935|FG001|Overall Study|Lost to Follow-up|1|||
27868753|NCT02301390|81353934|FG000|Overall Study|Death|2|||
27868754|NCT02301390|81353935|FG001|Overall Study|Death|2|||
27868755|NCT02301390|81353934|FG000|Overall Study|Procedure not completed|0|||
27868756|NCT02301390|81353935|FG001|Overall Study|Procedure not completed|4|||
27868757|NCT02301390|81353934|FG000|Overall Study|Missed multiple visits|1|||
27868758|NCT02301390|81353935|FG001|Overall Study|Missed multiple visits|1|||
27868759|NCT02301390|81353934|FG000|Overall Study|study terminated|2|||
27868760|NCT02301390|81353935|FG001|Overall Study|study terminated|0|||
27868761|NCT01526057|81353937|FG000|Overall Study|Withdrawal by Subject|3|||
27868762|NCT01526057|81353938|FG001|Overall Study|Withdrawal by Subject|2|||
27868763|NCT01526057|81353939|FG002|Overall Study|Withdrawal by Subject|2|||
27868764|NCT01526057|81353937|FG000|Overall Study|Adverse Event|3|||
27868765|NCT01526057|81353938|FG001|Overall Study|Adverse Event|1|||
27868766|NCT01526057|81353939|FG002|Overall Study|Adverse Event|1|||
27983614|NCT01659255|81773909|FG004|Overall Study|Adverse Event|0|||
27983615|NCT01659255|81773910|FG005|Overall Study|Adverse Event|1|||
27983616|NCT01659255|81773911|FG006|Overall Study|Adverse Event|1|||
27983617|NCT01659255|81773912|FG007|Overall Study|Adverse Event|0|||
27983618|NCT01659255|81773913|FG008|Overall Study|Adverse Event|0|||
27983619|NCT01659255|81773914|FG009|Overall Study|Adverse Event|1|||
27983620|NCT01659255|81773915|FG010|Overall Study|Adverse Event|0|||
27983621|NCT01659255|81773916|FG011|Overall Study|Adverse Event|1|||
27983622|NCT01659255|81773917|FG012|Overall Study|Adverse Event|0|||
27983623|NCT01659255|81773918|FG013|Overall Study|Adverse Event|2|||
27983624|NCT01659255|81773919|FG014|Overall Study|Adverse Event|0|||
27983625|NCT01659255|81773920|FG015|Overall Study|Adverse Event|1|||
27983626|NCT01659255|81773921|FG016|Overall Study|Adverse Event|0|||
27983627|NCT01659255|81773905|FG000|Overall Study|Death|0|||
27983628|NCT01659255|81773906|FG001|Overall Study|Death|1|||
27983629|NCT01659255|81773907|FG002|Overall Study|Death|0|||
27983630|NCT01659255|81773908|FG003|Overall Study|Death|0|||
27983631|NCT01659255|81773909|FG004|Overall Study|Death|0|||
27983632|NCT01659255|81773910|FG005|Overall Study|Death|0|||
27983633|NCT01659255|81773911|FG006|Overall Study|Death|0|||
27983634|NCT01659255|81773912|FG007|Overall Study|Death|1|||
27983635|NCT01659255|81773913|FG008|Overall Study|Death|1|||
27983636|NCT01659255|81773914|FG009|Overall Study|Death|0|||
27983637|NCT01659255|81773915|FG010|Overall Study|Death|0|||
27983638|NCT01659255|81773916|FG011|Overall Study|Death|0|||
27983639|NCT01659255|81773917|FG012|Overall Study|Death|1|||
27983640|NCT01659255|81773918|FG013|Overall Study|Death|1|||
27983641|NCT01659255|81773919|FG014|Overall Study|Death|2|||
27983642|NCT01659255|81773920|FG015|Overall Study|Death|1|||
27983643|NCT01659255|81773921|FG016|Overall Study|Death|0|||
27983644|NCT01659255|81773905|FG000|Overall Study|Progressive Disease|2|||
27983645|NCT01659255|81773906|FG001|Overall Study|Progressive Disease|0|||
27983646|NCT01659255|81773907|FG002|Overall Study|Progressive Disease|0|||
27983647|NCT01659255|81773908|FG003|Overall Study|Progressive Disease|0|||
27983648|NCT01659255|81773909|FG004|Overall Study|Progressive Disease|0|||
27983649|NCT01659255|81773910|FG005|Overall Study|Progressive Disease|0|||
27983650|NCT01659255|81773911|FG006|Overall Study|Progressive Disease|0|||
27983651|NCT01659255|81773912|FG007|Overall Study|Progressive Disease|1|||
27983652|NCT01659255|81773913|FG008|Overall Study|Progressive Disease|0|||
27983653|NCT01659255|81773914|FG009|Overall Study|Progressive Disease|2|||
27577703|NCT04640311|80299302|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577704|NCT04640311|80299303|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27674389|NCT01712061|80647102|FG002|Overall Study|Adverse Event|5|||
27868767|NCT01526057|81353937|FG000|Overall Study|Death|1|||
27868768|NCT01526057|81353938|FG001|Overall Study|Death|0|||
27983654|NCT01659255|81773915|FG010|Overall Study|Progressive Disease|2|||
27983655|NCT01659255|81773916|FG011|Overall Study|Progressive Disease|3|||
27868769|NCT01526057|81353939|FG002|Overall Study|Death|0|||
27868770|NCT01526057|81353937|FG000|Overall Study|Lost to Follow-up|1|||
27868771|NCT01526057|81353938|FG001|Overall Study|Lost to Follow-up|0|||
27868772|NCT01526057|81353939|FG002|Overall Study|Lost to Follow-up|1|||
27868773|NCT01526057|81353937|FG000|Overall Study|Other|1|||
27983656|NCT01659255|81773917|FG012|Overall Study|Progressive Disease|5|||
27868774|NCT01526057|81353938|FG001|Overall Study|Other|0|||
27983657|NCT01659255|81773918|FG013|Overall Study|Progressive Disease|13|||
27983658|NCT01659255|81773919|FG014|Overall Study|Progressive Disease|6|||
27983659|NCT01659255|81773920|FG015|Overall Study|Progressive Disease|2|||
27983660|NCT01659255|81773921|FG016|Overall Study|Progressive Disease|3|||
27868775|NCT01526057|81353939|FG002|Overall Study|Other|1|||
27868776|NCT01526057|81353937|FG000|Overall Study|Protocol Violation|0|||
27868777|NCT01526057|81353938|FG001|Overall Study|Protocol Violation|0|||
27868778|NCT01526057|81353939|FG002|Overall Study|Protocol Violation|1|||
27868779|NCT01173120|81353940|FG000|Overall Study|Lack of Efficacy|2|||
27868780|NCT01173120|81353940|FG000|Overall Study|Lost to Follow-up|1|||
27868781|NCT01173120|81353940|FG000|Overall Study|Participant Decision|2|||
27868782|NCT01173120|81353940|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
27868783|NCT01173120|81353940|FG000|Overall Study|Switch-Participant Decision|12|||
27868784|NCT01173120|81353940|FG000|Overall Study|Switch-Difficulty With Device|12|||
27868785|NCT01994850|81353948|FG000|Overall Study|Physician Decision|1|||
27868786|NCT01994850|81353948|FG000|Overall Study|Withdrawal by Subject|1|||
27868787|NCT01286753|81353949|FG000|Overall Study|Adverse Event|7|||
27868788|NCT01286753|81353950|FG001|Overall Study|Adverse Event|6|||
27868789|NCT01286753|81353949|FG000|Overall Study|Progression|11|||
27868790|NCT01286753|81353950|FG001|Overall Study|Progression|13|||
27868791|NCT01286753|81353949|FG000|Overall Study|Refused Treatment|1|||
27868792|NCT01286753|81353950|FG001|Overall Study|Refused Treatment|0|||
27868793|NCT01286753|81353949|FG000|Overall Study|Withdrawal of Consent|0|||
27868794|NCT01286753|81353950|FG001|Overall Study|Withdrawal of Consent|2|||
27868795|NCT01286753|81353949|FG000|Overall Study|Discontinued to Join Extension Study|6|||
27868796|NCT01286753|81353950|FG001|Overall Study|Discontinued to Join Extension Study|4|||
27868797|NCT01286753|81353949|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
27868798|NCT01286753|81353950|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
27868799|NCT02498392|81353951|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
27868800|NCT02498392|81353952|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
27868801|NCT02498392|81353951|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
27868802|NCT02498392|81353952|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
27868803|NCT02498392|81353951|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
27868804|NCT02498392|81353952|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
27868805|NCT02498392|81353951|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
27868806|NCT02498392|81353952|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
27868807|NCT02498392|81353951|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
27868808|NCT02498392|81353952|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
27868809|NCT02498392|81353951|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
27868810|NCT02498392|81353952|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
27868811|NCT02439216|81353954|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
27868812|NCT02439216|81353955|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868813|NCT02439216|81353956|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868814|NCT02439216|81353957|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868815|NCT02439216|81353958|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868816|NCT02439216|81353959|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868817|NCT02439216|81353960|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868818|NCT02439216|81353961|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868819|NCT02439216|81353962|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
27868820|NCT02439216|81353954|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868821|NCT02439216|81353955|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868822|NCT02439216|81353956|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868823|NCT02439216|81353957|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868824|NCT02439216|81353958|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868825|NCT02439216|81353959|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868826|NCT02439216|81353960|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868827|NCT02439216|81353961|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
27868828|NCT02439216|81353962|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
27868829|NCT02439216|81353954|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868830|NCT02439216|81353955|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868831|NCT02439216|81353956|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868832|NCT02439216|81353957|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868833|NCT02439216|81353958|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868834|NCT02439216|81353959|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868835|NCT02439216|81353960|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
27868836|NCT02439216|81353961|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
27868837|NCT02439216|81353962|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
27868838|NCT02439216|81353954|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868839|NCT02439216|81353955|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868840|NCT02439216|81353956|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868841|NCT02439216|81353957|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868842|NCT02439216|81353958|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868843|NCT02439216|81353959|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868844|NCT02439216|81353960|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27868845|NCT02439216|81353961|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
27983661|NCT01659255|81773905|FG000|Overall Study|Withdrew Consent|0|||
27983662|NCT01659255|81773906|FG001|Overall Study|Withdrew Consent|0|||
27983663|NCT01659255|81773907|FG002|Overall Study|Withdrew Consent|0|||
27983664|NCT01659255|81773908|FG003|Overall Study|Withdrew Consent|0|||
27983665|NCT01659255|81773909|FG004|Overall Study|Withdrew Consent|0|||
27983666|NCT01659255|81773910|FG005|Overall Study|Withdrew Consent|0|||
27983667|NCT01659255|81773911|FG006|Overall Study|Withdrew Consent|0|||
27983668|NCT01659255|81773912|FG007|Overall Study|Withdrew Consent|0|||
27983669|NCT01659255|81773913|FG008|Overall Study|Withdrew Consent|0|||
27868846|NCT02439216|81353962|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
27868847|NCT02439216|81353954|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868848|NCT02439216|81353955|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868849|NCT02439216|81353956|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868850|NCT02439216|81353957|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868851|NCT02439216|81353958|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868852|NCT02439216|81353959|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868853|NCT02439216|81353960|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
27868854|NCT02439216|81353961|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
27868855|NCT02439216|81353962|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
27868856|NCT04542057|81353963|FG000|Overall Study|Death|3|||
27868857|NCT04542057|81353964|FG001|Overall Study|Death|1|||
27868858|NCT04542057|81353963|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
27868859|NCT04542057|81353964|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
27868860|NCT04542057|81353963|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
27868861|NCT04542057|81353964|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
27868862|NCT04542057|81353963|FG000|Overall Study|Adverse Event|15|||
27868863|NCT04542057|81353964|FG001|Overall Study|Adverse Event|6|||
27868864|NCT04542057|81353963|FG000|Overall Study|COVID-19 adverse event|6|||
27868865|NCT04542057|81353964|FG001|Overall Study|COVID-19 adverse event|4|||
27868866|NCT04542057|81353963|FG000|Overall Study|Lack of Efficacy|2|||
27868867|NCT04542057|81353964|FG001|Overall Study|Lack of Efficacy|5|||
27868868|NCT04542057|81353963|FG000|Overall Study|Study terminated by sponsor|1|||
27868869|NCT04542057|81353964|FG001|Overall Study|Study terminated by sponsor|0|||
27868870|NCT04542057|81353963|FG000|Overall Study|Investigator discretion|2|||
27868871|NCT04542057|81353964|FG001|Overall Study|Investigator discretion|1|||
27868872|NCT04542057|81353963|FG000|Overall Study|Withdrawal by Subject|52|||
27868873|NCT04542057|81353964|FG001|Overall Study|Withdrawal by Subject|30|||
27868874|NCT04542057|81353963|FG000|Overall Study|Lost to Follow-up|8|||
27868875|NCT04542057|81353964|FG001|Overall Study|Lost to Follow-up|11|||
27868876|NCT04542057|81353963|FG000|Overall Study|Other|2|||
27868877|NCT04542057|81353964|FG001|Overall Study|Other|2|||
27868878|NCT01133067|81353965|FG000|Overall Study|Death|136|||
27868879|NCT01133067|81353965|FG000|Overall Study|Lost to Follow-up|3|||
27868880|NCT04782076|81353972|FG000|Overall Study|Family Emergency|1|||
27868881|NCT03052751|81353973|FG000|Dosing Period 1|Adverse Event|0|||
27868882|NCT03052751|81353974|FG001|Dosing Period 1|Adverse Event|1|||
27868883|NCT03052751|81353975|FG002|Dosing Period 1|Adverse Event|0|||
27868884|NCT03052751|81353976|FG003|Dosing Period 1|Adverse Event|0|||
27868885|NCT03052751|81353977|FG004|Dosing Period 1|Adverse Event|0|||
27868886|NCT03052751|81353978|FG005|Dosing Period 1|Adverse Event|0|||
27868887|NCT03052751|81353973|FG000|Dosing Period 2|Adverse Event|0|||
27868888|NCT03052751|81353974|FG001|Dosing Period 2|Adverse Event|0|||
27868889|NCT03052751|81353975|FG002|Dosing Period 2|Adverse Event|3|||
27868890|NCT03052751|81353976|FG003|Dosing Period 2|Adverse Event|0|||
27868891|NCT03052751|81353977|FG004|Dosing Period 2|Adverse Event|0|||
27868892|NCT03052751|81353978|FG005|Dosing Period 2|Adverse Event|0|||
27868893|NCT03052751|81353973|FG000|Observation Period|Adverse Event|0|||
27868894|NCT03052751|81353974|FG001|Observation Period|Adverse Event|0|||
27868895|NCT03052751|81353975|FG002|Observation Period|Adverse Event|0|||
27868896|NCT03052751|81353976|FG003|Observation Period|Adverse Event|0|||
27868897|NCT03052751|81353977|FG004|Observation Period|Adverse Event|1|||
27868898|NCT03052751|81353978|FG005|Observation Period|Adverse Event|0|||
27868899|NCT00946920|81353982|FG000|Overall Study|Withdrawal by Subject|28|||
27983670|NCT01659255|81773914|FG009|Overall Study|Withdrew Consent|0|||
27983671|NCT01659255|81773915|FG010|Overall Study|Withdrew Consent|1|||
27983672|NCT01659255|81773916|FG011|Overall Study|Withdrew Consent|0|||
27983673|NCT01659255|81773917|FG012|Overall Study|Withdrew Consent|0|||
27868900|NCT00946920|81353983|FG001|Overall Study|Withdrawal by Subject|15|||
27868901|NCT00946920|81353982|FG000|Overall Study|Lost to Follow-up|2|||
27868902|NCT00946920|81353983|FG001|Overall Study|Lost to Follow-up|2|||
27868903|NCT00946920|81353982|FG000|Overall Study|Physician Decision|5|||
27868904|NCT00946920|81353983|FG001|Overall Study|Physician Decision|2|||
27868905|NCT00946920|81353982|FG000|Overall Study|Adverse Event|41|||
27868906|NCT00946920|81353983|FG001|Overall Study|Adverse Event|14|||
27868907|NCT00946920|81353982|FG000|Overall Study|Protocol Violation|16|||
27868908|NCT00946920|81353983|FG001|Overall Study|Protocol Violation|8|||
27868909|NCT00946920|81353982|FG000|Overall Study|Miscellaneous reasons|18|||
27868910|NCT00946920|81353983|FG001|Overall Study|Miscellaneous reasons|3|||
27868911|NCT01750190|81353984|FG000|Overall Study|Adverse Event|47|||
27868912|NCT01750190|81353985|FG001|Overall Study|Adverse Event|19|||
27868913|NCT01750190|81353984|FG000|Overall Study|Death|38|||
27868914|NCT01750190|81353985|FG001|Overall Study|Death|11|||
27868915|NCT01750190|81353984|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
27983674|NCT01659255|81773918|FG013|Overall Study|Withdrew Consent|1|||
27983675|NCT01659255|81773919|FG014|Overall Study|Withdrew Consent|0|||
27983676|NCT01659255|81773920|FG015|Overall Study|Withdrew Consent|0|||
27983677|NCT01659255|81773921|FG016|Overall Study|Withdrew Consent|0|||
27983678|NCT01659255|81773905|FG000|Overall Study|Investigator Decision|0|||
27794846|NCT01371981|81079179|FG004|Overall Study|Adverse Event|1|||
27794847|NCT01371981|81079180|FG005|Overall Study|Adverse Event|0|||
27983679|NCT01659255|81773906|FG001|Overall Study|Investigator Decision|0|||
27983680|NCT01659255|81773907|FG002|Overall Study|Investigator Decision|0|||
27983681|NCT01659255|81773908|FG003|Overall Study|Investigator Decision|0|||
27983682|NCT01659255|81773909|FG004|Overall Study|Investigator Decision|0|||
27983683|NCT01659255|81773910|FG005|Overall Study|Investigator Decision|0|||
27983684|NCT01659255|81773911|FG006|Overall Study|Investigator Decision|0|||
27983685|NCT01659255|81773912|FG007|Overall Study|Investigator Decision|0|||
27983686|NCT01659255|81773913|FG008|Overall Study|Investigator Decision|0|||
27983687|NCT01659255|81773914|FG009|Overall Study|Investigator Decision|0|||
27983688|NCT01659255|81773915|FG010|Overall Study|Investigator Decision|0|||
27983689|NCT01659255|81773916|FG011|Overall Study|Investigator Decision|0|||
27983690|NCT01659255|81773917|FG012|Overall Study|Investigator Decision|1|||
27983691|NCT01659255|81773918|FG013|Overall Study|Investigator Decision|1|||
27983692|NCT01659255|81773919|FG014|Overall Study|Investigator Decision|0|||
27983693|NCT01659255|81773920|FG015|Overall Study|Investigator Decision|0|||
27983694|NCT01659255|81773921|FG016|Overall Study|Investigator Decision|0|||
27983695|NCT01659255|81773905|FG000|Overall Study|Sponsor's Decision|0|||
27794848|NCT01371981|81079175|FG000|Overall Study|Death|22|||
27794849|NCT01371981|81079176|FG001|Overall Study|Death|16|||
27794850|NCT01371981|81079177|FG002|Overall Study|Death|0|||
27794851|NCT01371981|81079178|FG003|Overall Study|Death|0|||
27794852|NCT01371981|81079179|FG004|Overall Study|Death|2|||
27794853|NCT01371981|81079180|FG005|Overall Study|Death|2|||
27794854|NCT01371981|81079175|FG000|Overall Study|Lack of Efficacy|69|||
27794855|NCT01371981|81079176|FG001|Overall Study|Lack of Efficacy|61|||
27794856|NCT01371981|81079177|FG002|Overall Study|Lack of Efficacy|4|||
27794857|NCT01371981|81079178|FG003|Overall Study|Lack of Efficacy|8|||
27794858|NCT01371981|81079179|FG004|Overall Study|Lack of Efficacy|5|||
27794859|NCT01371981|81079180|FG005|Overall Study|Lack of Efficacy|0|||
27794860|NCT01371981|81079175|FG000|Overall Study|Physician Decision|48|||
27794861|NCT01371981|81079176|FG001|Overall Study|Physician Decision|63|||
27794862|NCT01371981|81079177|FG002|Overall Study|Physician Decision|1|||
27794863|NCT01371981|81079178|FG003|Overall Study|Physician Decision|7|||
27794864|NCT01371981|81079179|FG004|Overall Study|Physician Decision|14|||
27794865|NCT01371981|81079180|FG005|Overall Study|Physician Decision|3|||
27794866|NCT01371981|81079175|FG000|Overall Study|Withdrawal by Subject|12|||
27794867|NCT01371981|81079176|FG001|Overall Study|Withdrawal by Subject|19|||
27794868|NCT01371981|81079177|FG002|Overall Study|Withdrawal by Subject|1|||
27794869|NCT01371981|81079178|FG003|Overall Study|Withdrawal by Subject|2|||
27794870|NCT01371981|81079179|FG004|Overall Study|Withdrawal by Subject|10|||
27794871|NCT01371981|81079180|FG005|Overall Study|Withdrawal by Subject|3|||
27794872|NCT01371981|81079175|FG000|Overall Study|Ineligible|19|||
27983696|NCT01659255|81773906|FG001|Overall Study|Sponsor's Decision|0|||
27983697|NCT01659255|81773907|FG002|Overall Study|Sponsor's Decision|0|||
27983698|NCT01659255|81773908|FG003|Overall Study|Sponsor's Decision|0|||
27794873|NCT01371981|81079176|FG001|Overall Study|Ineligible|13|||
27794874|NCT01371981|81079177|FG002|Overall Study|Ineligible|0|||
27794875|NCT01371981|81079178|FG003|Overall Study|Ineligible|0|||
27794876|NCT01371981|81079179|FG004|Overall Study|Ineligible|0|||
27794877|NCT01371981|81079180|FG005|Overall Study|Ineligible|4|||
27794878|NCT01371981|81079175|FG000|Overall Study|Did not start treatment|2|||
27794879|NCT01371981|81079176|FG001|Overall Study|Did not start treatment|3|||
27794880|NCT01371981|81079177|FG002|Overall Study|Did not start treatment|0|||
27868916|NCT01750190|81353985|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
27868917|NCT01750190|81353984|FG000|Overall Study|Lost to Follow-up|28|||
27794881|NCT01371981|81079178|FG003|Overall Study|Did not start treatment|0|||
27868918|NCT01750190|81353985|FG001|Overall Study|Lost to Follow-up|7|||
27868919|NCT01750190|81353984|FG000|Overall Study|Physician Decision|16|||
27868920|NCT01750190|81353985|FG001|Overall Study|Physician Decision|17|||
27868921|NCT01750190|81353984|FG000|Overall Study|Protocol Violation|6|||
27868922|NCT01750190|81353985|FG001|Overall Study|Protocol Violation|5|||
27868923|NCT01750190|81353984|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
27868924|NCT01750190|81353985|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
27868925|NCT01750190|81353984|FG000|Overall Study|Withdrawal by Subject|83|||
27868926|NCT01750190|81353985|FG001|Overall Study|Withdrawal by Subject|89|||
27868927|NCT01750190|81353984|FG000|Overall Study|Kidney Transplant|8|||
27868928|NCT01750190|81353985|FG001|Overall Study|Kidney Transplant|4|||
27868929|NCT01750190|81353984|FG000|Overall Study|Dialysis|22|||
27868930|NCT01750190|81353985|FG001|Overall Study|Dialysis|8|||
27868931|NCT01750190|81353984|FG000|Overall Study|Other than Specified|13|||
27868932|NCT01750190|81353985|FG001|Overall Study|Other than Specified|4|||
27868933|NCT03817190|81353986|FG000|Overall Study|Early Termination|13|||
27868934|NCT03817190|81353987|FG001|Overall Study|Early Termination|20|||
27868935|NCT03817190|81353986|FG000|Overall Study|Adverse Event|10|||
27868936|NCT03817190|81353987|FG001|Overall Study|Adverse Event|17|||
27868937|NCT03817190|81353986|FG000|Overall Study|Withdrawal by Subject|12|||
27868938|NCT03817190|81353987|FG001|Overall Study|Withdrawal by Subject|8|||
27868939|NCT03817190|81353986|FG000|Overall Study|Lost to Follow-up|11|||
27868940|NCT03817190|81353987|FG001|Overall Study|Lost to Follow-up|7|||
27868941|NCT03817190|81353986|FG000|Overall Study|Lack of Efficacy|7|||
27868942|NCT03817190|81353987|FG001|Overall Study|Lack of Efficacy|5|||
27868943|NCT03817190|81353986|FG000|Overall Study|Investigator Decision|5|||
27868944|NCT03817190|81353987|FG001|Overall Study|Investigator Decision|1|||
27868945|NCT03817190|81353986|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
27868946|NCT03817190|81353987|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
27868947|NCT03817190|81353986|FG000|Overall Study|Lack of Contact|1|||
27868948|NCT03817190|81353987|FG001|Overall Study|Lack of Contact|0|||
27868949|NCT03817190|81353986|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
27868950|NCT03817190|81353987|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
27868951|NCT04146012|81353988|FG000|Overall Study|Study Terminated|30|||
27868952|NCT04146012|81353989|FG001|Overall Study|Study Terminated|15|||
27868953|NCT00584454|81353990|FG000|Overall Study|Adverse Event|1|||
27868954|NCT00584454|81353990|FG000|Overall Study|Relocation|1|||
27868955|NCT00584454|81353990|FG000|Overall Study|Clinical Hold|2|||
27868956|NCT03908437|81353991|FG000|Overall Study|Death|0|||
27868957|NCT03908437|81353992|FG001|Overall Study|Death|1|||
27868958|NCT03908437|81353991|FG000|Overall Study|Lost to Follow-up|31|||
27868959|NCT03908437|81353992|FG001|Overall Study|Lost to Follow-up|24|||
27868960|NCT02006732|81353993|FG000|Overall Study|Adverse Event|10|||
27868961|NCT02006732|81353994|FG001|Overall Study|Adverse Event|7|||
27868962|NCT02006732|81353995|FG002|Overall Study|Adverse Event|4|||
27868963|NCT02006732|81353996|FG003|Overall Study|Adverse Event|2|||
27868964|NCT02006732|81353993|FG000|Overall Study|Lack of Efficacy|6|||
27868965|NCT02006732|81353994|FG001|Overall Study|Lack of Efficacy|3|||
27868966|NCT02006732|81353995|FG002|Overall Study|Lack of Efficacy|1|||
27868967|NCT02006732|81353996|FG003|Overall Study|Lack of Efficacy|1|||
27868968|NCT02006732|81353993|FG000|Overall Study|Protocol Violation|1|||
27868969|NCT02006732|81353994|FG001|Overall Study|Protocol Violation|1|||
27868970|NCT02006732|81353995|FG002|Overall Study|Protocol Violation|0|||
27868971|NCT02006732|81353996|FG003|Overall Study|Protocol Violation|0|||
27868972|NCT02006732|81353993|FG000|Overall Study|Lost to Follow-up|0|||
27868973|NCT02006732|81353994|FG001|Overall Study|Lost to Follow-up|1|||
27868974|NCT02006732|81353995|FG002|Overall Study|Lost to Follow-up|0|||
27868975|NCT02006732|81353996|FG003|Overall Study|Lost to Follow-up|0|||
27868976|NCT02006732|81353993|FG000|Overall Study|Withdrawal by Subject|3|||
27868977|NCT02006732|81353994|FG001|Overall Study|Withdrawal by Subject|0|||
27868978|NCT02006732|81353995|FG002|Overall Study|Withdrawal by Subject|4|||
27868979|NCT02006732|81353996|FG003|Overall Study|Withdrawal by Subject|1|||
27868980|NCT00550459|81353997|FG000|Overall Study|Adverse Event|0|||
27868981|NCT00550459|81353998|FG001|Overall Study|Adverse Event|2|||
27868982|NCT00550459|81353997|FG000|Overall Study|Withdrawal by Subject|1|||
27868983|NCT00550459|81353998|FG001|Overall Study|Withdrawal by Subject|1|||
27868984|NCT02952586|81353999|FG000|Lead-In Phase (7 Days)|Death|0|||
27868985|NCT02952586|81354000|FG001|Lead-In Phase (7 Days)|Death|1|||
27983699|NCT01659255|81773909|FG004|Overall Study|Sponsor's Decision|0|||
27983700|NCT01659255|81773910|FG005|Overall Study|Sponsor's Decision|0|||
27983701|NCT01659255|81773911|FG006|Overall Study|Sponsor's Decision|1|||
27983702|NCT01659255|81773912|FG007|Overall Study|Sponsor's Decision|0|||
27983703|NCT01659255|81773913|FG008|Overall Study|Sponsor's Decision|0|||
27983704|NCT01659255|81773914|FG009|Overall Study|Sponsor's Decision|0|||
27983705|NCT01659255|81773915|FG010|Overall Study|Sponsor's Decision|0|||
27983706|NCT01659255|81773916|FG011|Overall Study|Sponsor's Decision|0|||
27983707|NCT01659255|81773917|FG012|Overall Study|Sponsor's Decision|0|||
27983708|NCT01659255|81773918|FG013|Overall Study|Sponsor's Decision|0|||
27983709|NCT01659255|81773919|FG014|Overall Study|Sponsor's Decision|0|||
27983710|NCT01659255|81773920|FG015|Overall Study|Sponsor's Decision|0|||
27983711|NCT01659255|81773921|FG016|Overall Study|Sponsor's Decision|0|||
27983712|NCT01659255|81773905|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983713|NCT01659255|81773906|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983714|NCT01659255|81773907|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983715|NCT01659255|81773908|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983716|NCT01659255|81773909|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983717|NCT01659255|81773910|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983718|NCT01659255|81773911|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983719|NCT01659255|81773912|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983720|NCT01659255|81773913|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983721|NCT01659255|81773914|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983722|NCT01659255|81773915|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983723|NCT01659255|81773916|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983724|NCT01659255|81773917|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983725|NCT01659255|81773918|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983726|NCT01659255|81773919|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983727|NCT01659255|81773920|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
27983728|NCT01659255|81773921|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
27983729|NCT01659255|81773905|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
27983730|NCT01659255|81773906|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
27983731|NCT01659255|81773907|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
27983732|NCT01659255|81773908|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
27983733|NCT01659255|81773909|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
27983734|NCT01659255|81773910|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
27983735|NCT01659255|81773911|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
27983736|NCT01659255|81773912|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
27983737|NCT01659255|81773913|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
27983738|NCT01659255|81773914|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
27983739|NCT01659255|81773915|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
27983740|NCT01659255|81773916|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
27983741|NCT01659255|81773917|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
27983742|NCT01659255|81773918|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
27983743|NCT01659255|81773919|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
27983744|NCT01659255|81773920|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
27983745|NCT01659255|81773921|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
27983746|NCT00881504|81773922|FG000|Overall Study|Withdrawal by Subject|1|||
27983747|NCT01177969|81773923|FG000|Overall Study|Protocol Violation|2|||
27983748|NCT01177969|81773924|FG001|Overall Study|Protocol Violation|1|||
27983749|NCT01177969|81773923|FG000|Overall Study|Withdrawal by Subject|1|||
27983750|NCT01177969|81773924|FG001|Overall Study|Withdrawal by Subject|2|||
27983751|NCT01038713|81773925|FG000|Overall Study|Patient to hospice|1|||
27983752|NCT01038713|81773926|FG001|Overall Study|Patient to hospice|1|||
27983753|NCT01038713|81773927|FG002|Overall Study|Patient to hospice|1|||
27983754|NCT01038713|81773925|FG000|Overall Study|Lost to Follow-up|3|||
27983755|NCT01038713|81773926|FG001|Overall Study|Lost to Follow-up|0|||
27983756|NCT01038713|81773927|FG002|Overall Study|Lost to Follow-up|0|||
27983757|NCT01038713|81773925|FG000|Overall Study|Neuroendocrine Tumor|0|||
27983758|NCT01038713|81773926|FG001|Overall Study|Neuroendocrine Tumor|1|||
27983759|NCT01038713|81773927|FG002|Overall Study|Neuroendocrine Tumor|0|||
27577705|NCT04640311|80299304|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27983760|NCT01038713|81773925|FG000|Overall Study|died from PEP|0|||
27577706|NCT04640311|80299305|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27983761|NCT01038713|81773926|FG001|Overall Study|died from PEP|1|||
27983762|NCT01038713|81773927|FG002|Overall Study|died from PEP|0|||
27983763|NCT01038713|81773925|FG000|Overall Study|Autoimmune Pancreatitis|1|||
27983764|NCT01038713|81773926|FG001|Overall Study|Autoimmune Pancreatitis|0|||
27983765|NCT01038713|81773927|FG002|Overall Study|Autoimmune Pancreatitis|0|||
27983766|NCT01716104|81773931|FG000|Overall Study|Do not meet inclusion criteria|6|||
27983767|NCT01716104|81773932|FG001|Overall Study|Do not meet inclusion criteria|7|||
27983768|NCT02900170|81773933|FG000|Overall Study|Lost to Follow-up|8|||
27983769|NCT03769311|81773934|FG000|Overall Study|Withdrawal by Subject|1|||
27983770|NCT00975143|81773935|FG000|Overall Study|Adverse Event|19|||
27983771|NCT00975143|81773936|FG001|Overall Study|Adverse Event|15|||
27983772|NCT00975143|81773935|FG000|Overall Study|Withdrawal by Subject|15|||
27983773|NCT00975143|81773936|FG001|Overall Study|Withdrawal by Subject|15|||
27983774|NCT00975143|81773935|FG000|Overall Study|Lost to Follow-up|20|||
27983775|NCT00975143|81773936|FG001|Overall Study|Lost to Follow-up|16|||
27983776|NCT00975143|81773935|FG000|Overall Study|Non-compliance|5|||
27983777|NCT00975143|81773936|FG001|Overall Study|Non-compliance|8|||
27983778|NCT00975143|81773935|FG000|Overall Study|Physician Decision|1|||
27983779|NCT00975143|81773936|FG001|Overall Study|Physician Decision|2|||
27983780|NCT00975143|81773935|FG000|Overall Study|Details not available|10|||
27983781|NCT00975143|81773936|FG001|Overall Study|Details not available|4|||
27983782|NCT01657760|81773939|FG000|Overall Study|Withdrawal by Subject|0|||
27983783|NCT01657760|81773940|FG001|Overall Study|Withdrawal by Subject|0|||
27983784|NCT01657760|81773941|FG002|Overall Study|Withdrawal by Subject|0|||
27983785|NCT01657760|81773942|FG003|Overall Study|Withdrawal by Subject|1|||
27983786|NCT01657760|81773939|FG000|Overall Study|Physician Decision|1|||
27983787|NCT01657760|81773940|FG001|Overall Study|Physician Decision|1|||
27983788|NCT01657760|81773941|FG002|Overall Study|Physician Decision|1|||
27983789|NCT01657760|81773942|FG003|Overall Study|Physician Decision|2|||
27983790|NCT02258529|81773945|FG000|Overall Study|Study Terminated by Sponsor|9|||
27983791|NCT02258529|81773945|FG000|Overall Study|Adverse Event|1|||
27983792|NCT00689793|81773946|FG000|Overall Study|Lost to Follow-up|4|||
27983793|NCT00689793|81773947|FG001|Overall Study|Lost to Follow-up|5|||
27983794|NCT00845065|81773948|FG000|Overall Study|Adverse Event|3|||
27983795|NCT00845065|81773949|FG001|Overall Study|Adverse Event|23|||
27983796|NCT00845065|81773948|FG000|Overall Study|Lack of Efficacy|43|||
27983797|NCT00845065|81773949|FG001|Overall Study|Lack of Efficacy|21|||
27983798|NCT00845065|81773948|FG000|Overall Study|Non-Medical Reasons|1|||
27983799|NCT00845065|81773949|FG001|Overall Study|Non-Medical Reasons|11|||
27983800|NCT00084656|81773950|FG000|Overall Study|Other reasons|0|||
27983801|NCT00084656|81773951|FG001|Overall Study|Other reasons|12|||
27983802|NCT00084656|81773952|FG002|Overall Study|Other reasons|11|||
27983803|NCT00084656|81773950|FG000|Overall Study|Withdrawal by Subject|15|||
27983804|NCT00084656|81773951|FG001|Overall Study|Withdrawal by Subject|4|||
27983805|NCT00084656|81773952|FG002|Overall Study|Withdrawal by Subject|4|||
27983806|NCT00084656|81773950|FG000|Overall Study|Disease relapse|0|||
27983807|NCT00084656|81773951|FG001|Overall Study|Disease relapse|9|||
27983808|NCT00084656|81773952|FG002|Overall Study|Disease relapse|10|||
27983809|NCT00084656|81773950|FG000|Overall Study|Disease progression|9|||
27983810|NCT00084656|81773951|FG001|Overall Study|Disease progression|0|||
27983811|NCT00084656|81773952|FG002|Overall Study|Disease progression|0|||
27983812|NCT00084656|81773950|FG000|Overall Study|Lost to Follow-up|1|||
27983813|NCT00084656|81773951|FG001|Overall Study|Lost to Follow-up|0|||
27983814|NCT00084656|81773952|FG002|Overall Study|Lost to Follow-up|1|||
27983815|NCT01533922|81773955|FG000|Overall Study|Adverse Event|5|||
27983816|NCT01533922|81773956|FG001|Overall Study|Adverse Event|8|||
27983817|NCT01533922|81773957|FG002|Overall Study|Adverse Event|6|||
27983818|NCT01533922|81773958|FG003|Overall Study|Adverse Event|3|||
27983819|NCT01533922|81773959|FG004|Overall Study|Adverse Event|4|||
27983820|NCT01533922|81773955|FG000|Overall Study|Lack of Efficacy|0|||
27983821|NCT01533922|81773956|FG001|Overall Study|Lack of Efficacy|0|||
27983822|NCT01533922|81773957|FG002|Overall Study|Lack of Efficacy|1|||
27674390|NCT01712061|80647100|FG000|Overall Study|Death|0|||
27983823|NCT01533922|81773958|FG003|Overall Study|Lack of Efficacy|0|||
27983824|NCT01533922|81773959|FG004|Overall Study|Lack of Efficacy|0|||
27983825|NCT01533922|81773955|FG000|Overall Study|Protocol Violation|0|||
27983826|NCT01533922|81773956|FG001|Overall Study|Protocol Violation|3|||
27983827|NCT01533922|81773957|FG002|Overall Study|Protocol Violation|0|||
27983828|NCT01533922|81773958|FG003|Overall Study|Protocol Violation|0|||
27983829|NCT01533922|81773959|FG004|Overall Study|Protocol Violation|1|||
27983830|NCT01533922|81773955|FG000|Overall Study|Withdrawal by Subject|3|||
27983831|NCT01533922|81773956|FG001|Overall Study|Withdrawal by Subject|1|||
27983832|NCT01533922|81773957|FG002|Overall Study|Withdrawal by Subject|2|||
27983833|NCT01533922|81773958|FG003|Overall Study|Withdrawal by Subject|2|||
27983834|NCT01533922|81773959|FG004|Overall Study|Withdrawal by Subject|1|||
27983835|NCT01533922|81773955|FG000|Overall Study|Other reason not defined above|2|||
27983836|NCT01533922|81773956|FG001|Overall Study|Other reason not defined above|0|||
27983837|NCT01533922|81773957|FG002|Overall Study|Other reason not defined above|1|||
27983838|NCT01533922|81773958|FG003|Overall Study|Other reason not defined above|0|||
27983839|NCT01533922|81773959|FG004|Overall Study|Other reason not defined above|0|||
27983840|NCT05026853|81773960|FG000|Overall Study|Cancelled appointment|1|||
27983841|NCT05026853|81773961|FG001|Overall Study|Cancelled appointment|0|||
27983842|NCT05026853|81773960|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
27983843|NCT05026853|81773961|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
27983844|NCT05026853|81773960|FG000|Overall Study|Did not complete 12-week survey|16|||
27983845|NCT05026853|81773961|FG001|Overall Study|Did not complete 12-week survey|16|||
27983846|NCT04094584|81773963|FG000|Overall Study|No interest in study|88|||
27983847|NCT04094584|81773963|FG000|Overall Study|Unwilling to undergo screening tests|36|||
27983848|NCT04094584|81773963|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
27983849|NCT04094584|81773963|FG000|Overall Study|Opioid use|7|||
27983850|NCT04094584|81773963|FG000|Overall Study|Need for major surgery in study period|4|||
27983851|NCT04094584|81773963|FG000|Overall Study|eligible but declined enrollment|4|||
27983852|NCT04094584|81773963|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
27983853|NCT04094584|81773963|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
27983854|NCT04094584|81773963|FG000|Overall Study|Lost to Follow-up|3|||
27983855|NCT04094584|81773963|FG000|Overall Study|Withdrawal by Subject|2|||
27983856|NCT04566692|81773964|FG000|Overall Study|Adverse Event|2|||
27577707|NCT04640311|80299306|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577708|NCT04640311|80299307|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577709|NCT04640311|80299308|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
27577710|NCT04640311|80299309|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577711|NCT04640311|80299310|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577712|NCT04640311|80299311|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577713|NCT04640311|80299312|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
27577714|NCT04640311|80299313|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577715|NCT04640311|80299314|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
27577716|NCT04640311|80299302|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577717|NCT04640311|80299303|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577718|NCT04640311|80299304|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577719|NCT04640311|80299305|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577720|NCT04640311|80299306|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577721|NCT04640311|80299307|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577722|NCT04640311|80299308|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577723|NCT04640311|80299309|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27674391|NCT01712061|80647101|FG001|Overall Study|Death|0|||
27674392|NCT01712061|80647102|FG002|Overall Study|Death|1|||
27674393|NCT01712061|80647100|FG000|Overall Study|Lost to Follow-up|1|||
27794882|NCT01371981|81079179|FG004|Overall Study|Did not start treatment|0|||
27794883|NCT01371981|81079180|FG005|Overall Study|Did not start treatment|2|||
27794884|NCT00449761|81079181|FG000|Overall Study|Disease progression|12|||
27794885|NCT00449761|81079181|FG000|Overall Study|Death|5|||
27983857|NCT04566692|81773965|FG001|Overall Study|Adverse Event|0|||
27983858|NCT04566692|81773964|FG000|Overall Study|Withdrawal by Subject|1|||
27983859|NCT04566692|81773965|FG001|Overall Study|Withdrawal by Subject|1|||
27983860|NCT00521222|81773966|FG000|Overall Study|Lost to Follow-up|0|||
27983861|NCT00521222|81773967|FG001|Overall Study|Lost to Follow-up|0|||
27983862|NCT00521222|81773968|FG002|Overall Study|Lost to Follow-up|1|||
27983863|NCT00521222|81773969|FG003|Overall Study|Lost to Follow-up|1|||
27983864|NCT00521222|81773966|FG000|Overall Study|Withdrawal by Subject|0|||
27983865|NCT00521222|81773967|FG001|Overall Study|Withdrawal by Subject|0|||
27983866|NCT00521222|81773968|FG002|Overall Study|Withdrawal by Subject|2|||
27983867|NCT00521222|81773969|FG003|Overall Study|Withdrawal by Subject|0|||
27983868|NCT00521222|81773966|FG000|Overall Study|Physician Decision|0|||
27983869|NCT00521222|81773967|FG001|Overall Study|Physician Decision|1|||
27983870|NCT00521222|81773968|FG002|Overall Study|Physician Decision|0|||
27983871|NCT00521222|81773969|FG003|Overall Study|Physician Decision|1|||
27983872|NCT01274429|81773970|FG000|Overall Study|Study closed do to lack of funding|5|||
27983873|NCT02760810|81773974|FG000|Overall Study|Protocol Violation|1|||
27983874|NCT00671437|81773975|FG000|Overall Study|Progressive disease before C1 week 8|8|||
27983875|NCT00671437|81773975|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
27983876|NCT00671437|81773975|FG000|Overall Study|Adverse Event|3|||
27983877|NCT00671437|81773975|FG000|Overall Study|Ineligible post-hoc|1|||
27983878|NCT00162266|81773977|FG000|Double-Blind Period|Adverse Event|5|||
27983879|NCT00162266|81773978|FG001|Double-Blind Period|Adverse Event|9|||
27674394|NCT01712061|80647101|FG001|Overall Study|Lost to Follow-up|0|||
27794886|NCT00449761|81079181|FG000|Overall Study|New cancer therapy|1|||
27794887|NCT00769132|81079188|FG000|Period 1|Adverse Event|1|||
27983880|NCT00162266|81773979|FG002|Double-Blind Period|Adverse Event|11|||
27983881|NCT00162266|81773980|FG003|Double-Blind Period|Adverse Event|0|||
27983882|NCT00162266|81773977|FG000|Double-Blind Period|Death|0|||
27983883|NCT00162266|81773978|FG001|Double-Blind Period|Death|1|||
27577724|NCT04640311|80299310|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577725|NCT04640311|80299311|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577726|NCT04640311|80299312|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27577727|NCT04640311|80299313|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
27577728|NCT04640311|80299314|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
27674395|NCT01712061|80647102|FG002|Overall Study|Lost to Follow-up|1|||
27674396|NCT01712061|80647100|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
27674397|NCT01712061|80647101|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
27674398|NCT01712061|80647102|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
27983884|NCT00162266|81773979|FG002|Double-Blind Period|Death|0|||
27983885|NCT00162266|81773980|FG003|Double-Blind Period|Death|0|||
27983886|NCT00162266|81773977|FG000|Double-Blind Period|Lost to Follow-up|1|||
27674399|NCT01712061|80647100|FG000|Overall Study|Medication Error Without Associated AE|0|||
27674400|NCT01712061|80647101|FG001|Overall Study|Medication Error Without Associated AE|1|||
27674401|NCT01712061|80647102|FG002|Overall Study|Medication Error Without Associated AE|0|||
27674402|NCT01712061|80647100|FG000|Overall Study|Withdrawal by Subject|1|||
27674403|NCT01712061|80647101|FG001|Overall Study|Withdrawal by Subject|7|||
27674404|NCT01712061|80647102|FG002|Overall Study|Withdrawal by Subject|1|||
27674405|NCT01712061|80647100|FG000|Overall Study|Other|0|||
27674406|NCT01712061|80647101|FG001|Overall Study|Other|3|||
27674407|NCT01712061|80647102|FG002|Overall Study|Other|0|||
27674408|NCT02577003|80647103|FG000|Overall Study|Adverse Event|2|||
27674409|NCT02577003|80647104|FG001|Overall Study|Adverse Event|4|||
27674410|NCT02577003|80647103|FG000|Overall Study|Withdrawal by Subject|0|||
27674411|NCT02577003|80647104|FG001|Overall Study|Withdrawal by Subject|1|||
27674412|NCT01077128|80647107|FG000|Overall Study|Adverse Event|8|||
27674413|NCT01077128|80647107|FG000|Overall Study|Lack of Efficacy|1|||
27674414|NCT01077128|80647107|FG000|Overall Study|Disease exacerbation|1|||
27983887|NCT00162266|81773978|FG001|Double-Blind Period|Lost to Follow-up|2|||
27983888|NCT00162266|81773979|FG002|Double-Blind Period|Lost to Follow-up|0|||
27983889|NCT00162266|81773980|FG003|Double-Blind Period|Lost to Follow-up|0|||
27983890|NCT00162266|81773977|FG000|Double-Blind Period|Other Reason|1|||
27983891|NCT00162266|81773978|FG001|Double-Blind Period|Other Reason|0|||
27983892|NCT00162266|81773979|FG002|Double-Blind Period|Other Reason|1|||
27983893|NCT00162266|81773980|FG003|Double-Blind Period|Other Reason|0|||
27983894|NCT00162266|81773977|FG000|Double-Blind Period|Lack of Efficacy|13|||
27983895|NCT00162266|81773978|FG001|Double-Blind Period|Lack of Efficacy|17|||
27983896|NCT00162266|81773979|FG002|Double-Blind Period|Lack of Efficacy|30|||
27983897|NCT00162266|81773980|FG003|Double-Blind Period|Lack of Efficacy|0|||
27983898|NCT00162266|81773977|FG000|Double-Blind Period|Withdrawal by Subject|5|||
27983899|NCT00162266|81773978|FG001|Double-Blind Period|Withdrawal by Subject|2|||
27983900|NCT00162266|81773979|FG002|Double-Blind Period|Withdrawal by Subject|6|||
27674415|NCT01077128|80647107|FG000|Overall Study|Adverse event and consent withdrawal|1|||
27674416|NCT01077128|80647107|FG000|Overall Study|Adverse event and disease exacerbation|1|||
27674417|NCT01077128|80647107|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
27674418|NCT01077128|80647107|FG000|Overall Study|Other|54|||
27674419|NCT01781832|80647111|FG000|Overall Study|Withdrawal by Subject|1|||
27674420|NCT00504075|80647112|FG000|Overall Study|Adverse Event|1|||
27794888|NCT00769132|81079189|FG001|Period 1|Adverse Event|0|||
27794889|NCT00769132|81079190|FG002|Period 1|Adverse Event|0|||
27983901|NCT00162266|81773980|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27983902|NCT00162266|81773977|FG000|Open-Label Period|Death|0|||
27983903|NCT00162266|81773978|FG001|Open-Label Period|Death|0|||
27983904|NCT00162266|81773979|FG002|Open-Label Period|Death|0|||
27983905|NCT00162266|81773980|FG003|Open-Label Period|Death|7|||
27983906|NCT00162266|81773977|FG000|Open-Label Period|Adverse Event|0|||
27983907|NCT00162266|81773978|FG001|Open-Label Period|Adverse Event|0|||
27983908|NCT00162266|81773979|FG002|Open-Label Period|Adverse Event|0|||
27983909|NCT00162266|81773980|FG003|Open-Label Period|Adverse Event|46|||
27983910|NCT00162266|81773977|FG000|Open-Label Period|Lack of Efficacy|0|||
27983911|NCT00162266|81773978|FG001|Open-Label Period|Lack of Efficacy|0|||
27674421|NCT00504075|80647112|FG000|Overall Study|Lost to Follow-up|5|||
27674422|NCT00504075|80647112|FG000|Overall Study|Withdrawal by Subject|1|||
27674423|NCT00504075|80647112|FG000|Overall Study|Required other therapeutic intervention|1|||
27674424|NCT00847626|80647113|FG000|Overall Study|Adverse Event|10|||
27674425|NCT00847626|80647114|FG001|Overall Study|Adverse Event|10|||
27794890|NCT00769132|81079191|FG003|Period 1|Adverse Event|1|||
27794891|NCT00769132|81079188|FG000|Period 2|Withdrawal by Subject|0|||
27794892|NCT00769132|81079189|FG001|Period 2|Withdrawal by Subject|0|||
27794893|NCT00769132|81079190|FG002|Period 2|Withdrawal by Subject|0|||
27983912|NCT00162266|81773979|FG002|Open-Label Period|Lack of Efficacy|0|||
27983913|NCT00162266|81773980|FG003|Open-Label Period|Lack of Efficacy|26|||
27983914|NCT00162266|81773977|FG000|Open-Label Period|Lost to Follow-up|0|||
27983915|NCT00162266|81773978|FG001|Open-Label Period|Lost to Follow-up|0|||
27983916|NCT00162266|81773979|FG002|Open-Label Period|Lost to Follow-up|0|||
27983917|NCT00162266|81773980|FG003|Open-Label Period|Lost to Follow-up|3|||
27983918|NCT00162266|81773977|FG000|Open-Label Period|Withdrawal by Subject|0|||
27983919|NCT00162266|81773978|FG001|Open-Label Period|Withdrawal by Subject|0|||
27983920|NCT00162266|81773979|FG002|Open-Label Period|Withdrawal by Subject|0|||
27983921|NCT00162266|81773980|FG003|Open-Label Period|Withdrawal by Subject|31|||
27983922|NCT00162266|81773977|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
27983923|NCT00162266|81773978|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
27983924|NCT00162266|81773979|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
27983925|NCT00162266|81773980|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
27983926|NCT00162266|81773977|FG000|Open-Label Period|Other Reasons|0|||
27868986|NCT02952586|81353999|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
27868987|NCT02952586|81354000|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
27868988|NCT02952586|81353999|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
27868989|NCT02952586|81354000|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
27868990|NCT02952586|81353999|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
27868991|NCT02952586|81354000|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
27868992|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
27868993|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
27868994|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
27868995|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
27868996|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
27868997|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
27868998|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
27868999|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
27869000|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
27869001|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
27869002|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
27869003|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
27869004|NCT02952586|81353999|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
27869005|NCT02952586|81354000|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
27869006|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Death|3|||
27869007|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Death|8|||
27869008|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
27869009|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
27869010|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
27869011|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
27869012|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
27869013|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
27869014|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
27869015|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
27869016|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
27869017|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
27869018|NCT02952586|81353999|FG000|CRT for Cisplatin (63 Days)|Other|1|||
27869019|NCT02952586|81354000|FG001|CRT for Cisplatin (63 Days)|Other|1|||
27869020|NCT02952586|81353999|FG000|CRT for IMRT (63 Days)|Death|5|||
27869021|NCT02952586|81354000|FG001|CRT for IMRT (63 Days)|Death|8|||
27869022|NCT02952586|81353999|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
27869023|NCT02952586|81354000|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
27983927|NCT00162266|81773978|FG001|Open-Label Period|Other Reasons|0|||
27983928|NCT00162266|81773979|FG002|Open-Label Period|Other Reasons|0|||
27983929|NCT00162266|81773980|FG003|Open-Label Period|Other Reasons|15|||
27983930|NCT01062061|81773981|FG000|Overall Study|Enrolled more than once|2|||
27983931|NCT01062061|81773981|FG000|Overall Study|Investigated before study start|13|||
27983932|NCT01062061|81773981|FG000|Overall Study|Outside chief indications|10|||
27983933|NCT01062061|81773981|FG000|Overall Study|Failed to meet inclusion criteria|2|||
27983934|NCT04030247|81773982|FG000|Overall Study|Withdrawal by Subject|4|||
27983935|NCT04030247|81773982|FG000|Overall Study|Lost to Follow-up|13|||
27983936|NCT00771615|81773984|FG000|Overall Study|Withdrawal by Subject|0|||
27983937|NCT00771615|81773985|FG001|Overall Study|Withdrawal by Subject|1|||
27983938|NCT00771615|81773986|FG002|Overall Study|Withdrawal by Subject|0|||
27983939|NCT00771615|81773987|FG003|Overall Study|Withdrawal by Subject|0|||
27983940|NCT00771615|81773988|FG004|Overall Study|Withdrawal by Subject|0|||
27983941|NCT00771615|81773989|FG005|Overall Study|Withdrawal by Subject|0|||
27983942|NCT00771615|81773990|FG006|Overall Study|Withdrawal by Subject|0|||
27983943|NCT00771615|81773991|FG007|Overall Study|Withdrawal by Subject|1|||
27983944|NCT00771615|81773992|FG008|Overall Study|Withdrawal by Subject|0|||
27983945|NCT00771615|81773984|FG000|Overall Study|Lost to Follow-up|1|||
27983946|NCT00771615|81773985|FG001|Overall Study|Lost to Follow-up|1|||
27983947|NCT00771615|81773986|FG002|Overall Study|Lost to Follow-up|1|||
27983948|NCT00771615|81773987|FG003|Overall Study|Lost to Follow-up|1|||
27983949|NCT00771615|81773988|FG004|Overall Study|Lost to Follow-up|0|||
27983950|NCT00771615|81773989|FG005|Overall Study|Lost to Follow-up|1|||
27983951|NCT00771615|81773990|FG006|Overall Study|Lost to Follow-up|1|||
27983952|NCT00771615|81773991|FG007|Overall Study|Lost to Follow-up|0|||
27577729|NCT02097134|80299315|FG000|Overall Study|Physician Decision|4|||
27869024|NCT02952586|81353999|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
27869025|NCT02952586|81354000|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
27869026|NCT02952586|81353999|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
27869027|NCT02952586|81354000|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
27869028|NCT02952586|81353999|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
27869029|NCT02952586|81354000|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
27869030|NCT02952586|81353999|FG000|CRT for IMRT (63 Days)|Other|1|||
27869031|NCT02952586|81354000|FG001|CRT for IMRT (63 Days)|Other|0|||
27869032|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Death|17|||
27869033|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Death|11|||
27869034|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
27869035|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
27869036|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
27869037|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
27869038|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
27869039|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
27869040|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
27869041|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
27869042|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
27869043|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
27869044|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
27869045|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
27869046|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
27869047|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
27869048|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Other|2|||
27869049|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Other|1|||
27869050|NCT02952586|81353999|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
27869051|NCT02952586|81354000|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
27869052|NCT02952586|81353999|FG000|Follow-Up Phase (90 Days)|Death|12|||
27869053|NCT02952586|81354000|FG001|Follow-Up Phase (90 Days)|Death|10|||
27869054|NCT02952586|81353999|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
27869055|NCT02952586|81354000|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
27869056|NCT02952586|81353999|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
27869057|NCT02952586|81354000|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
27869058|NCT02952586|81353999|FG000|Follow-Up Phase (90 Days)|Other|7|||
27869059|NCT02952586|81354000|FG001|Follow-Up Phase (90 Days)|Other|5|||
27869060|NCT02952586|81353999|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
27869061|NCT02952586|81354000|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
27869062|NCT02952586|81353999|FG000|LT Follow-up (up to 45 Months)|Death|51|||
27869063|NCT02952586|81354000|FG001|LT Follow-up (up to 45 Months)|Death|31|||
27869064|NCT02952586|81353999|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
27869065|NCT02952586|81354000|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
27869066|NCT02952586|81353999|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
27983953|NCT00771615|81773992|FG008|Overall Study|Lost to Follow-up|0|||
27983954|NCT03959982|81773995|FG000|Overall Study|Withdrawal by Subject|1|||
27983955|NCT03959982|81773996|FG001|Overall Study|Withdrawal by Subject|0|||
27983956|NCT03959982|81773995|FG000|Overall Study|Physician Decision|2|||
27983957|NCT03959982|81773996|FG001|Overall Study|Physician Decision|0|||
27983958|NCT03959982|81773995|FG000|Overall Study|Lost to Follow-up|1|||
27983959|NCT03959982|81773996|FG001|Overall Study|Lost to Follow-up|0|||
27983960|NCT03199391|81773997|FG000|Overall Study|Death|1|||
27983961|NCT03199391|81773997|FG000|Overall Study|Lost to Follow-up|3|||
27983962|NCT03199391|81773997|FG000|Overall Study|Adverse Event|2|||
27983963|NCT03199391|81773997|FG000|Overall Study|Withdrawal by Subject|10|||
27983964|NCT00086411|81773998|FG000|Overall Study|Lost to Follow-up|11|||
27983965|NCT00086411|81773999|FG001|Overall Study|Lost to Follow-up|11|||
27983966|NCT00086411|81774000|FG002|Overall Study|Lost to Follow-up|13|||
27983967|NCT00086411|81774001|FG003|Overall Study|Lost to Follow-up|12|||
27983968|NCT00042666|81774006|FG000|Overall Study|Adverse Event|2|||
27983969|NCT00042666|81774006|FG000|Overall Study|Death|4|||
27983970|NCT00042666|81774006|FG000|Overall Study|Protocol Violation|1|||
27983971|NCT00042666|81774006|FG000|Overall Study|Participant/Physician Perception|1|||
27983972|NCT00042666|81774006|FG000|Overall Study|Progressive Disease|41|||
27983973|NCT00042666|81774006|FG000|Overall Study|Other|1|||
27983974|NCT00042666|81774006|FG000|Overall Study|Other|4|||
27983975|NCT00387647|81774007|FG000|Overall Study|Death|18|||
27983976|NCT01746173|81774009|FG000|Overall Study|Disease Progression|2|||
27983977|NCT02726945|81774010|FG000|Overall Study|Withdrawal by Subject|0|||
27983978|NCT02726945|81774011|FG001|Overall Study|Withdrawal by Subject|0|||
27983979|NCT02726945|81774012|FG002|Overall Study|Withdrawal by Subject|1|||
27983980|NCT02726945|81774010|FG000|Overall Study|Elected to have total knee replacement|0|||
27983981|NCT02726945|81774011|FG001|Overall Study|Elected to have total knee replacement|1|||
27983982|NCT02726945|81774012|FG002|Overall Study|Elected to have total knee replacement|0|||
27983983|NCT01424228|81774019|FG000|Overall Study|Withdrawal by Subject|27|||
27983984|NCT01424228|81774020|FG001|Overall Study|Withdrawal by Subject|11|||
27983985|NCT01424228|81774019|FG000|Overall Study|Adverse Event|10|||
27983986|NCT01424228|81774020|FG001|Overall Study|Adverse Event|14|||
27983987|NCT01424228|81774019|FG000|Overall Study|Sponsor's decision|9|||
27983988|NCT01424228|81774020|FG001|Overall Study|Sponsor's decision|12|||
27983989|NCT01424228|81774019|FG000|Overall Study|Lack of Efficacy|5|||
27983990|NCT01424228|81774020|FG001|Overall Study|Lack of Efficacy|7|||
27983991|NCT01424228|81774019|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
27983992|NCT01424228|81774020|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
27983993|NCT01424228|81774019|FG000|Overall Study|Non-compliance|2|||
27983994|NCT01424228|81774020|FG001|Overall Study|Non-compliance|0|||
27983995|NCT01424228|81774019|FG000|Overall Study|Worsening of symptoms|1|||
27983996|NCT01424228|81774020|FG001|Overall Study|Worsening of symptoms|0|||
27983997|NCT01424228|81774019|FG000|Overall Study|Unplanned journey|0|||
27983998|NCT01424228|81774020|FG001|Overall Study|Unplanned journey|1|||
27983999|NCT01985360|81774023|FG000|Overall Study|Withdrawal by Subject|4|||
27577730|NCT02097134|80299315|FG000|Overall Study|Non-Protocol Therapy|1|||
27577731|NCT02097134|80299315|FG000|Overall Study|Progressive Disease|3|||
27577732|NCT02097134|80299315|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
27984000|NCT01985360|81774024|FG001|Overall Study|Withdrawal by Subject|0|||
27984001|NCT01985360|81774023|FG000|Overall Study|Lost to Follow-up|5|||
27984002|NCT01985360|81774024|FG001|Overall Study|Lost to Follow-up|3|||
27984003|NCT02392403|81774025|FG000|Overall Study|Adverse Event|1|||
27984004|NCT02392403|81774025|FG000|Overall Study|Death|1|||
27984005|NCT02392403|81774025|FG000|Overall Study|Withdrawal by Subject|1|||
27984006|NCT01147900|81774026|FG000|At Year 10|Lost to Follow-up|0|||
27984007|NCT01147900|81774027|FG001|At Year 10|Lost to Follow-up|1|||
27984008|NCT01147900|81774028|FG002|At Year 10|Lost to Follow-up|0|||
27674426|NCT00847626|80647115|FG002|Overall Study|Adverse Event|6|||
27674427|NCT00847626|80647116|FG003|Overall Study|Adverse Event|19|||
27674428|NCT00847626|80647117|FG004|Overall Study|Adverse Event|11|||
27984009|NCT03480009|81774030|FG000|Overall Study|Lost to Follow-up|4|||
27984010|NCT03480009|81774031|FG001|Overall Study|Lost to Follow-up|5|||
27984011|NCT03480009|81774032|FG002|Overall Study|Lost to Follow-up|4|||
27984012|NCT03480009|81774033|FG003|Overall Study|Lost to Follow-up|0|||
27984013|NCT02648217|81774034|FG000|Overall Study|Adverse Event|0|||
27984014|NCT02648217|81774035|FG001|Overall Study|Adverse Event|1|||
27984015|NCT02648217|81774034|FG000|Overall Study|Lost to Follow-up|1|||
27984016|NCT02648217|81774035|FG001|Overall Study|Lost to Follow-up|1|||
27984017|NCT02648217|81774034|FG000|Overall Study|Withdrawal by Subject|4|||
27984018|NCT02648217|81774035|FG001|Overall Study|Withdrawal by Subject|3|||
27984019|NCT02648217|81774034|FG000|Overall Study|Unclassified|5|||
27984020|NCT02648217|81774035|FG001|Overall Study|Unclassified|0|||
27984021|NCT00734071|81774036|FG000|Overall Study|Adverse Event|4|||
27984022|NCT00734071|81774037|FG001|Overall Study|Adverse Event|3|||
27984023|NCT00734071|81774036|FG000|Overall Study|Lack of Efficacy|3|||
27984024|NCT00734071|81774037|FG001|Overall Study|Lack of Efficacy|1|||
27984025|NCT00734071|81774036|FG000|Overall Study|Noncompliance|2|||
27984026|NCT00734071|81774037|FG001|Overall Study|Noncompliance|2|||
27984027|NCT00734071|81774036|FG000|Overall Study|Protocol Deviations|3|||
27984028|NCT00734071|81774037|FG001|Overall Study|Protocol Deviations|4|||
27984029|NCT00734071|81774036|FG000|Overall Study|Voluntary Withdrawal|9|||
27984030|NCT00734071|81774037|FG001|Overall Study|Voluntary Withdrawal|7|||
27984031|NCT00734071|81774036|FG000|Overall Study|Lost to Follow-up|16|||
27984032|NCT00734071|81774037|FG001|Overall Study|Lost to Follow-up|8|||
27984033|NCT00734071|81774036|FG000|Overall Study|Other|1|||
27674429|NCT00847626|80647118|FG005|Overall Study|Adverse Event|22|||
27674430|NCT00847626|80647119|FG006|Overall Study|Adverse Event|4|||
27674431|NCT00847626|80647120|FG007|Overall Study|Adverse Event|6|||
27674432|NCT00847626|80647121|FG008|Overall Study|Adverse Event|3|||
27984034|NCT00734071|81774037|FG001|Overall Study|Other|2|||
27984035|NCT00290498|81774038|FG000|Overall Study|Death|2|||
27674433|NCT00847626|80647122|FG009|Overall Study|Adverse Event|6|||
27674434|NCT00847626|80647123|FG010|Overall Study|Adverse Event|6|||
27674435|NCT00847626|80647113|FG000|Overall Study|Protocol Violation|2|||
27674436|NCT00847626|80647114|FG001|Overall Study|Protocol Violation|1|||
27674437|NCT00847626|80647115|FG002|Overall Study|Protocol Violation|2|||
27674438|NCT00847626|80647116|FG003|Overall Study|Protocol Violation|1|||
27674439|NCT00847626|80647117|FG004|Overall Study|Protocol Violation|1|||
27674440|NCT00847626|80647118|FG005|Overall Study|Protocol Violation|1|||
27674441|NCT00847626|80647119|FG006|Overall Study|Protocol Violation|1|||
27674442|NCT00847626|80647120|FG007|Overall Study|Protocol Violation|1|||
27674443|NCT00847626|80647121|FG008|Overall Study|Protocol Violation|0|||
27674444|NCT00847626|80647122|FG009|Overall Study|Protocol Violation|1|||
27674445|NCT00847626|80647123|FG010|Overall Study|Protocol Violation|1|||
27674446|NCT00847626|80647113|FG000|Overall Study|Lost to Follow-up|0|||
27794894|NCT00769132|81079191|FG003|Period 2|Withdrawal by Subject|1|||
27794895|NCT00769132|81079188|FG000|Period 3|Withdrawal by Subject|1|||
27984036|NCT00290498|81774039|FG001|Overall Study|Death|0|||
27984037|NCT00290498|81774038|FG000|Overall Study|Physician Decision|1|||
27984038|NCT00290498|81774039|FG001|Overall Study|Physician Decision|0|||
27984039|NCT00290498|81774038|FG000|Overall Study|Withdrawal by Subject|1|||
27984040|NCT00290498|81774039|FG001|Overall Study|Withdrawal by Subject|0|||
27984041|NCT00290498|81774038|FG000|Overall Study|Ineligible|3|||
27984042|NCT00290498|81774039|FG001|Overall Study|Ineligible|0|||
27984043|NCT00290498|81774038|FG000|Overall Study|Non-Compliance|1|||
27674447|NCT00847626|80647114|FG001|Overall Study|Lost to Follow-up|1|||
27674448|NCT00847626|80647115|FG002|Overall Study|Lost to Follow-up|1|||
27674449|NCT00847626|80647116|FG003|Overall Study|Lost to Follow-up|1|||
27674450|NCT00847626|80647117|FG004|Overall Study|Lost to Follow-up|0|||
27674451|NCT00847626|80647118|FG005|Overall Study|Lost to Follow-up|3|||
27674452|NCT00847626|80647119|FG006|Overall Study|Lost to Follow-up|1|||
27794896|NCT00769132|81079189|FG001|Period 3|Withdrawal by Subject|0|||
27984044|NCT00290498|81774039|FG001|Overall Study|Non-Compliance|0|||
27674453|NCT00847626|80647120|FG007|Overall Study|Lost to Follow-up|3|||
27674454|NCT00847626|80647121|FG008|Overall Study|Lost to Follow-up|1|||
27984045|NCT04349033|81774040|FG000|Overall Study|Lost to Follow-up|3|||
27674455|NCT00847626|80647122|FG009|Overall Study|Lost to Follow-up|0|||
27794897|NCT00769132|81079190|FG002|Period 3|Withdrawal by Subject|0|||
27984046|NCT04349033|81774041|FG001|Overall Study|Lost to Follow-up|1|||
27984047|NCT04349033|81774042|FG002|Overall Study|Lost to Follow-up|1|||
27984048|NCT02102399|81774043|FG000|Overall Study|Withdrawal by Subject|6|||
27984049|NCT02102399|81774044|FG001|Overall Study|Withdrawal by Subject|4|||
27984050|NCT01176565|81774045|FG000|Overall Study|Lost to Follow-up|12|||
27984051|NCT01176565|81774046|FG001|Overall Study|Lost to Follow-up|16|||
27984052|NCT01176565|81774045|FG000|Overall Study|Withdrawal by Subject|7|||
27674456|NCT00847626|80647123|FG010|Overall Study|Lost to Follow-up|1|||
27674457|NCT00847626|80647113|FG000|Overall Study|Withdrawal by Subject|5|||
27674458|NCT00847626|80647114|FG001|Overall Study|Withdrawal by Subject|5|||
27984053|NCT01176565|81774046|FG001|Overall Study|Withdrawal by Subject|1|||
27984054|NCT01176565|81774045|FG000|Overall Study|Not Analyzed (any other reason)|1|||
27984055|NCT01176565|81774046|FG001|Overall Study|Not Analyzed (any other reason)|2|||
27984056|NCT02014584|81774047|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27984057|NCT02014584|81774048|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
27984058|NCT02014584|81774049|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27984059|NCT02014584|81774050|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27984060|NCT02014584|81774051|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27984061|NCT02014584|81774052|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
27984062|NCT02014584|81774047|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
27984063|NCT02014584|81774048|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
27984064|NCT02014584|81774049|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27984065|NCT02014584|81774050|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27984066|NCT02014584|81774051|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27984067|NCT02014584|81774052|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
27984068|NCT02014584|81774047|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27984069|NCT02014584|81774048|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27984070|NCT02014584|81774049|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
27794898|NCT00769132|81079191|FG003|Period 3|Withdrawal by Subject|0|||
27794899|NCT00769132|81079188|FG000|Period 4|Withdrawal by Subject|0|||
27794900|NCT00769132|81079189|FG001|Period 4|Withdrawal by Subject|1|||
27794901|NCT00769132|81079190|FG002|Period 4|Withdrawal by Subject|0|||
27984071|NCT02014584|81774050|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27984072|NCT02014584|81774051|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27984073|NCT02014584|81774052|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
27984074|NCT02014584|81774047|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27984075|NCT02014584|81774048|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27869067|NCT02952586|81354000|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
27869068|NCT02952586|81353999|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
27869069|NCT02952586|81354000|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
27869070|NCT01757275|81354001|FG000|Overall Study|Lost to Follow-up|1|||
27869071|NCT01757275|81354002|FG001|Overall Study|Lost to Follow-up|2|||
27869072|NCT01757275|81354001|FG000|Overall Study|Adverse Event|3|||
27984076|NCT02014584|81774049|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
27794902|NCT00769132|81079191|FG003|Period 4|Withdrawal by Subject|0|||
27794903|NCT03353415|81079194|FG000|Masked CGM Wear|Lost to Follow-up|2|||
27794904|NCT03353415|81079194|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
27794905|NCT02723786|81079195|FG000|Overall Study|Lost to Follow-up|1|||
27794906|NCT05153629|81079196|FG000|Overall Study|Withdrawal by Subject|0|||
27794907|NCT05153629|81079197|FG001|Overall Study|Withdrawal by Subject|2|||
27794908|NCT03083639|81079198|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
27794909|NCT03083639|81079199|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
27794910|NCT03083639|81079198|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
27794911|NCT03083639|81079199|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
27869073|NCT01757275|81354002|FG001|Overall Study|Adverse Event|3|||
27984077|NCT02014584|81774050|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
27984078|NCT02014584|81774051|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27984079|NCT02014584|81774052|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
27984080|NCT02014584|81774047|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27794912|NCT03359473|81079201|FG000|Overall Study|Adverse Event|0|||
27794913|NCT03359473|81079202|FG001|Overall Study|Adverse Event|2|||
27794914|NCT03359473|81079203|FG002|Overall Study|Adverse Event|5|||
27794915|NCT03359473|81079204|FG003|Overall Study|Adverse Event|3|||
27794916|NCT03359473|81079201|FG000|Overall Study|Lost to Follow-up|0|||
27794917|NCT03359473|81079202|FG001|Overall Study|Lost to Follow-up|1|||
27794918|NCT03359473|81079203|FG002|Overall Study|Lost to Follow-up|0|||
27794919|NCT03359473|81079204|FG003|Overall Study|Lost to Follow-up|0|||
27794920|NCT03359473|81079201|FG000|Overall Study|Physician Decision|0|||
27794921|NCT03359473|81079202|FG001|Overall Study|Physician Decision|1|||
27794922|NCT03359473|81079203|FG002|Overall Study|Physician Decision|0|||
27794923|NCT03359473|81079204|FG003|Overall Study|Physician Decision|1|||
27794924|NCT03359473|81079201|FG000|Overall Study|Withdrawal by Subject|1|||
27794925|NCT03359473|81079202|FG001|Overall Study|Withdrawal by Subject|2|||
27794926|NCT03359473|81079203|FG002|Overall Study|Withdrawal by Subject|1|||
27794927|NCT03359473|81079204|FG003|Overall Study|Withdrawal by Subject|0|||
27794928|NCT03359473|81079201|FG000|Overall Study|Protocol-defined stopping criteria|1|||
27794929|NCT03359473|81079202|FG001|Overall Study|Protocol-defined stopping criteria|0|||
27794930|NCT03359473|81079203|FG002|Overall Study|Protocol-defined stopping criteria|0|||
27794931|NCT03359473|81079204|FG003|Overall Study|Protocol-defined stopping criteria|1|||
27794932|NCT01265875|81079205|FG000|Overall Study|Uncooperative/unreliable|1|||
27984081|NCT02014584|81774048|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27984082|NCT02014584|81774049|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27984083|NCT02014584|81774050|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27984084|NCT02014584|81774051|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
27984085|NCT02014584|81774052|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
27984086|NCT03684694|81774053|FG000|Phase 1|Withdrawal by Subject|1|||
27984087|NCT03684694|81774054|FG001|Phase 1|Withdrawal by Subject|0|||
27984088|NCT03684694|81774055|FG002|Phase 1|Withdrawal by Subject|0|||
27984089|NCT03684694|81774056|FG003|Phase 1|Withdrawal by Subject|0|||
27984090|NCT03684694|81774057|FG004|Phase 1|Withdrawal by Subject|0|||
27984091|NCT03684694|81774058|FG005|Phase 1|Withdrawal by Subject|0|||
27984092|NCT03684694|81774053|FG000|Phase 1|Investigator/Sponsor Decision|12|||
27984093|NCT03684694|81774054|FG001|Phase 1|Investigator/Sponsor Decision|2|||
27984094|NCT03684694|81774055|FG002|Phase 1|Investigator/Sponsor Decision|1|||
27984095|NCT03684694|81774056|FG003|Phase 1|Investigator/Sponsor Decision|0|||
27984096|NCT03684694|81774057|FG004|Phase 1|Investigator/Sponsor Decision|0|||
27984097|NCT03684694|81774058|FG005|Phase 1|Investigator/Sponsor Decision|0|||
27984098|NCT03684694|81774053|FG000|Phase 1|Death|24|||
27984099|NCT03684694|81774054|FG001|Phase 1|Death|0|||
27984100|NCT03684694|81774055|FG002|Phase 1|Death|3|||
27984101|NCT03684694|81774056|FG003|Phase 1|Death|0|||
27984102|NCT03684694|81774057|FG004|Phase 1|Death|0|||
27984103|NCT03684694|81774058|FG005|Phase 1|Death|0|||
27984104|NCT03684694|81774053|FG000|Phase 1|Lost to Follow-up|0|||
27984105|NCT03684694|81774054|FG001|Phase 1|Lost to Follow-up|0|||
27577733|NCT04382612|80299317|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
27984106|NCT03684694|81774055|FG002|Phase 1|Lost to Follow-up|1|||
27984107|NCT03684694|81774056|FG003|Phase 1|Lost to Follow-up|0|||
27984108|NCT03684694|81774057|FG004|Phase 1|Lost to Follow-up|0|||
27984109|NCT03684694|81774058|FG005|Phase 1|Lost to Follow-up|0|||
27984110|NCT03684694|81774053|FG000|Phase 1|Miscellaneous|0|||
27984111|NCT03684694|81774054|FG001|Phase 1|Miscellaneous|1|||
27984112|NCT03684694|81774055|FG002|Phase 1|Miscellaneous|0|||
27984113|NCT03684694|81774056|FG003|Phase 1|Miscellaneous|0|||
27984114|NCT03684694|81774057|FG004|Phase 1|Miscellaneous|0|||
27984115|NCT03684694|81774058|FG005|Phase 1|Miscellaneous|0|||
27984116|NCT03684694|81774053|FG000|Phase 2|Withdrawal by Subject|0|||
27984117|NCT03684694|81774054|FG001|Phase 2|Withdrawal by Subject|0|||
27984118|NCT03684694|81774055|FG002|Phase 2|Withdrawal by Subject|0|||
27984119|NCT03684694|81774056|FG003|Phase 2|Withdrawal by Subject|0|||
27984120|NCT03684694|81774057|FG004|Phase 2|Withdrawal by Subject|0|||
27984121|NCT03684694|81774058|FG005|Phase 2|Withdrawal by Subject|1|||
27984122|NCT03684694|81774053|FG000|Phase 2|Investigator/Sponsor Decision|0|||
27984123|NCT03684694|81774054|FG001|Phase 2|Investigator/Sponsor Decision|0|||
27984124|NCT03684694|81774055|FG002|Phase 2|Investigator/Sponsor Decision|0|||
27984125|NCT03684694|81774056|FG003|Phase 2|Investigator/Sponsor Decision|17|||
27984126|NCT03684694|81774057|FG004|Phase 2|Investigator/Sponsor Decision|16|||
27984127|NCT03684694|81774058|FG005|Phase 2|Investigator/Sponsor Decision|6|||
27984128|NCT03684694|81774053|FG000|Phase 2|Death|0|||
27984129|NCT03684694|81774054|FG001|Phase 2|Death|0|||
27674459|NCT00847626|80647115|FG002|Overall Study|Withdrawal by Subject|3|||
27674460|NCT00847626|80647116|FG003|Overall Study|Withdrawal by Subject|8|||
27674461|NCT00847626|80647117|FG004|Overall Study|Withdrawal by Subject|12|||
27674462|NCT00847626|80647118|FG005|Overall Study|Withdrawal by Subject|9|||
27674463|NCT00847626|80647119|FG006|Overall Study|Withdrawal by Subject|8|||
27674464|NCT00847626|80647120|FG007|Overall Study|Withdrawal by Subject|4|||
27674465|NCT00847626|80647121|FG008|Overall Study|Withdrawal by Subject|4|||
27674466|NCT00847626|80647122|FG009|Overall Study|Withdrawal by Subject|5|||
27674467|NCT00847626|80647123|FG010|Overall Study|Withdrawal by Subject|2|||
27674468|NCT00847626|80647113|FG000|Overall Study|Lack of Efficacy|3|||
27674469|NCT00847626|80647114|FG001|Overall Study|Lack of Efficacy|1|||
27794933|NCT02873195|81079208|FG000|Overall Study|Ineligible|5|||
27794934|NCT02873195|81079209|FG001|Overall Study|Ineligible|0|||
27794935|NCT02875340|81079210|FG000|Overall Study|Death|2|||
27674470|NCT00847626|80647115|FG002|Overall Study|Lack of Efficacy|0|||
27794936|NCT02875340|81079210|FG000|Overall Study|Withdrawal by Subject|2|||
27794937|NCT02875340|81079210|FG000|Overall Study|Physician Decision|3|||
27794938|NCT02875340|81079210|FG000|Overall Study|Adverse Event|1|||
27794939|NCT02860039|81079211|FG000|Overall Study|Death|4|||
27794940|NCT02860039|81079212|FG001|Overall Study|Death|0|||
27794941|NCT02860039|81079211|FG000|Overall Study|Lost to Follow-up|2|||
27794942|NCT02860039|81079212|FG001|Overall Study|Lost to Follow-up|2|||
27869074|NCT01757275|81354001|FG000|Overall Study|Withdrawal by Subject|2|||
27869075|NCT01757275|81354002|FG001|Overall Study|Withdrawal by Subject|4|||
27869076|NCT01757275|81354001|FG000|Overall Study|Not treated|3|||
27869077|NCT01757275|81354002|FG001|Overall Study|Not treated|4|||
27869078|NCT02797171|81354003|FG000|Overall Study|Lost to Follow-up|2|||
27869079|NCT02797171|81354004|FG001|Overall Study|Lost to Follow-up|0|||
27869080|NCT02797171|81354005|FG002|Overall Study|Lost to Follow-up|2|||
27869081|NCT02797171|81354006|FG003|Overall Study|Lost to Follow-up|1|||
27869082|NCT02797171|81354007|FG004|Overall Study|Lost to Follow-up|2|||
27869083|NCT02797171|81354008|FG005|Overall Study|Lost to Follow-up|0|||
27869084|NCT02797171|81354003|FG000|Overall Study|Withdrawal by Subject|1|||
27984130|NCT03684694|81774055|FG002|Phase 2|Death|0|||
27984131|NCT03684694|81774056|FG003|Phase 2|Death|28|||
27674471|NCT00847626|80647116|FG003|Overall Study|Lack of Efficacy|1|||
27794943|NCT02860039|81079211|FG000|Overall Study|Protocol Violation|3|||
27794944|NCT02860039|81079212|FG001|Overall Study|Protocol Violation|1|||
27794945|NCT02860039|81079211|FG000|Overall Study|Withdrawal by Subject|1|||
27794946|NCT02860039|81079212|FG001|Overall Study|Withdrawal by Subject|0|||
27869085|NCT02797171|81354004|FG001|Overall Study|Withdrawal by Subject|1|||
27794947|NCT02860039|81079211|FG000|Overall Study|Not otherwise eligible|1|||
27984132|NCT03684694|81774057|FG004|Phase 2|Death|14|||
27674472|NCT00847626|80647117|FG004|Overall Study|Lack of Efficacy|2|||
27674473|NCT00847626|80647118|FG005|Overall Study|Lack of Efficacy|0|||
27674474|NCT00847626|80647119|FG006|Overall Study|Lack of Efficacy|6|||
27869086|NCT02797171|81354005|FG002|Overall Study|Withdrawal by Subject|0|||
27984133|NCT03684694|81774058|FG005|Phase 2|Death|3|||
27984134|NCT03684694|81774053|FG000|Phase 2|Lost to Follow-up|0|||
27984135|NCT03684694|81774054|FG001|Phase 2|Lost to Follow-up|0|||
27794948|NCT02860039|81079212|FG001|Overall Study|Not otherwise eligible|1|||
27794949|NCT04285983|81079217|FG000|Overall Study|Protocol Violation|6|||
27794950|NCT02279888|81079218|FG000|Overall Study|Death|326|||
27794951|NCT02279888|81079218|FG000|Overall Study|Withdrawal by Subject|38|||
27794952|NCT02279888|81079218|FG000|Overall Study|Lost to Follow-up|21|||
27794953|NCT02279888|81079218|FG000|Overall Study|Physician Decision|62|||
27794954|NCT02279888|81079218|FG000|Overall Study|Subject Non-compliance|43|||
27794955|NCT02279888|81079218|FG000|Overall Study|Not implanted|14|||
27794956|NCT02279888|81079218|FG000|Overall Study|Visit not performed|26|||
27794957|NCT01843660|81079219|FG000|Overall Study|Other|30|||
27794958|NCT02666768|81079226|FG000|Overall Study|Withdrawal by Subject|4|||
27794959|NCT02787746|81079229|FG000|Overall Study|Adverse Event|42|||
27794960|NCT02787746|81079229|FG000|Overall Study|Withdrawal by Subject|65|||
27794961|NCT02787746|81079229|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
27794962|NCT01898884|81079230|FG000|Multiple Dose Period|Adverse Event|0|||
27794963|NCT01898884|81079231|FG001|Multiple Dose Period|Adverse Event|0|||
27794964|NCT01898884|81079232|FG002|Multiple Dose Period|Adverse Event|0|||
27794965|NCT01898884|81079233|FG003|Multiple Dose Period|Adverse Event|0|||
27794966|NCT01898884|81079234|FG004|Multiple Dose Period|Adverse Event|0|||
27794967|NCT01898884|81079235|FG005|Multiple Dose Period|Adverse Event|0|||
27794968|NCT01898884|81079236|FG006|Multiple Dose Period|Adverse Event|1|||
27794969|NCT01898884|81079237|FG007|Multiple Dose Period|Adverse Event|0|||
27794970|NCT01898884|81079238|FG008|Multiple Dose Period|Adverse Event|0|||
27794971|NCT01898884|81079230|FG000|Multiple Dose Period|Randomized Not Treated|0|||
27794972|NCT01898884|81079231|FG001|Multiple Dose Period|Randomized Not Treated|0|||
27794973|NCT01898884|81079232|FG002|Multiple Dose Period|Randomized Not Treated|0|||
27794974|NCT01898884|81079233|FG003|Multiple Dose Period|Randomized Not Treated|0|||
27794975|NCT01898884|81079234|FG004|Multiple Dose Period|Randomized Not Treated|0|||
27794976|NCT01898884|81079235|FG005|Multiple Dose Period|Randomized Not Treated|0|||
27794977|NCT01898884|81079236|FG006|Multiple Dose Period|Randomized Not Treated|0|||
27794978|NCT01898884|81079237|FG007|Multiple Dose Period|Randomized Not Treated|0|||
27794979|NCT01898884|81079238|FG008|Multiple Dose Period|Randomized Not Treated|1|||
27794980|NCT01371006|81081987|FG000|Overall Study|Adverse Event|1|||
27794981|NCT01371006|81081988|FG001|Overall Study|Adverse Event|0|||
27794982|NCT00491322|81081989|FG000|Overall Study|Protocol Violation|1|||
27794983|NCT00491322|81081990|FG001|Overall Study|Protocol Violation|0|||
27794984|NCT00491322|81081989|FG000|Overall Study|Pregnancy|0|||
27794985|NCT00491322|81081990|FG001|Overall Study|Pregnancy|1|||
27794986|NCT01615822|81081991|FG000|Period 1|Withdrawal by Subject|0|||
27794987|NCT01615822|81081992|FG001|Period 1|Withdrawal by Subject|1|||
27794988|NCT01615822|81081993|FG002|Period 1|Withdrawal by Subject|0|||
27794989|NCT01615822|81081991|FG000|Period 1|Adverse Event|1|||
27794990|NCT01615822|81081992|FG001|Period 1|Adverse Event|1|||
27794991|NCT01615822|81081993|FG002|Period 1|Adverse Event|0|||
27794992|NCT01615822|81081991|FG000|Period 2|Lost to Follow-up|0|||
27794993|NCT01615822|81081992|FG001|Period 2|Lost to Follow-up|1|||
27794994|NCT01615822|81081993|FG002|Period 2|Lost to Follow-up|2|||
27794995|NCT03996694|81081997|FG000|First Washout (7 Days)|positive urine drug screen|0|||
27794996|NCT03996694|81081998|FG001|First Washout (7 Days)|positive urine drug screen|0|||
27794997|NCT03996694|81081999|FG002|First Washout (7 Days)|positive urine drug screen|1|||
27794998|NCT03996694|81082000|FG003|First Washout (7 Days)|positive urine drug screen|0|||
27794999|NCT03996694|81082001|FG004|First Washout (7 Days)|positive urine drug screen|0|||
27795000|NCT03996694|81082002|FG005|First Washout (7 Days)|positive urine drug screen|0|||
27795001|NCT03996694|81081997|FG000|First Washout (7 Days)|Adverse Event|0|||
27795002|NCT03996694|81081998|FG001|First Washout (7 Days)|Adverse Event|1|||
27795003|NCT03996694|81081999|FG002|First Washout (7 Days)|Adverse Event|0|||
27795004|NCT03996694|81082000|FG003|First Washout (7 Days)|Adverse Event|0|||
27795005|NCT03996694|81082001|FG004|First Washout (7 Days)|Adverse Event|0|||
27795006|NCT03996694|81082002|FG005|First Washout (7 Days)|Adverse Event|0|||
27795007|NCT03996694|81081997|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
27795008|NCT03996694|81081998|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
27795009|NCT03996694|81081999|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
27795010|NCT03996694|81082000|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
27869087|NCT02797171|81354006|FG003|Overall Study|Withdrawal by Subject|0|||
27795011|NCT03996694|81082001|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
27795012|NCT03996694|81082002|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
27795013|NCT03996694|81081997|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
27795014|NCT03996694|81081998|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
27795015|NCT03996694|81081999|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
27795016|NCT03996694|81082000|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
27795017|NCT03996694|81082001|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
27795018|NCT03996694|81082002|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
27795019|NCT02325401|81082003|FG000|Overall Study|Withdrawal by Subject|0|||
27795020|NCT02325401|81082004|FG001|Overall Study|Withdrawal by Subject|1|||
27795021|NCT02325401|81082005|FG002|Overall Study|Withdrawal by Subject|1|||
27869088|NCT02797171|81354007|FG004|Overall Study|Withdrawal by Subject|0|||
27984136|NCT03684694|81774055|FG002|Phase 2|Lost to Follow-up|0|||
27984137|NCT03684694|81774056|FG003|Phase 2|Lost to Follow-up|1|||
27984138|NCT03684694|81774057|FG004|Phase 2|Lost to Follow-up|0|||
27984139|NCT03684694|81774058|FG005|Phase 2|Lost to Follow-up|0|||
27984140|NCT03684694|81774053|FG000|Phase 2|Miscellaneous|0|||
27984141|NCT03684694|81774054|FG001|Phase 2|Miscellaneous|0|||
27984142|NCT03684694|81774055|FG002|Phase 2|Miscellaneous|0|||
27984143|NCT03684694|81774056|FG003|Phase 2|Miscellaneous|3|||
27984144|NCT03684694|81774057|FG004|Phase 2|Miscellaneous|0|||
27984145|NCT03684694|81774058|FG005|Phase 2|Miscellaneous|0|||
27984146|NCT01264419|81774059|FG000|Overall Study|Lost to Follow-up|3|||
27984147|NCT02006069|81774060|FG000|Overall Study|MPP other programming|239|||
27984148|NCT02006069|81774061|FG001|Overall Study|MPP other programming|0|||
27984149|NCT02006069|81774060|FG000|Overall Study|RV only pacing|0|||
27984150|NCT02006069|81774061|FG001|Overall Study|RV only pacing|3|||
27984151|NCT01075984|81774062|FG000|Treatment Phase|Adverse Event|0|||
27984152|NCT01075984|81774063|FG001|Treatment Phase|Adverse Event|1|||
27984153|NCT01075984|81774064|FG002|Treatment Phase|Adverse Event|3|||
27984154|NCT01075984|81774065|FG003|Treatment Phase|Adverse Event|7|||
27984155|NCT01075984|81774066|FG004|Treatment Phase|Adverse Event|35|||
27984156|NCT01075984|81774062|FG000|Treatment Phase|Protocol Violation|0|||
27984157|NCT01075984|81774063|FG001|Treatment Phase|Protocol Violation|0|||
27984158|NCT01075984|81774064|FG002|Treatment Phase|Protocol Violation|1|||
27984159|NCT01075984|81774065|FG003|Treatment Phase|Protocol Violation|0|||
27984160|NCT01075984|81774066|FG004|Treatment Phase|Protocol Violation|3|||
27984161|NCT01075984|81774062|FG000|Treatment Phase|Withdrawal by Subject|0|||
27984162|NCT01075984|81774063|FG001|Treatment Phase|Withdrawal by Subject|0|||
27984163|NCT01075984|81774064|FG002|Treatment Phase|Withdrawal by Subject|2|||
27984164|NCT01075984|81774065|FG003|Treatment Phase|Withdrawal by Subject|0|||
27984165|NCT01075984|81774066|FG004|Treatment Phase|Withdrawal by Subject|15|||
27984166|NCT01075984|81774062|FG000|Treatment Phase|Treatment Failure|0|||
27984167|NCT01075984|81774063|FG001|Treatment Phase|Treatment Failure|0|||
27984168|NCT01075984|81774064|FG002|Treatment Phase|Treatment Failure|1|||
27984169|NCT01075984|81774065|FG003|Treatment Phase|Treatment Failure|0|||
27984170|NCT01075984|81774066|FG004|Treatment Phase|Treatment Failure|5|||
27984171|NCT01075984|81774062|FG000|Treatment Phase|Progression of disease|0|||
27984172|NCT01075984|81774063|FG001|Treatment Phase|Progression of disease|0|||
27984173|NCT01075984|81774064|FG002|Treatment Phase|Progression of disease|0|||
27984174|NCT01075984|81774065|FG003|Treatment Phase|Progression of disease|0|||
27984175|NCT01075984|81774066|FG004|Treatment Phase|Progression of disease|2|||
27984176|NCT01075984|81774062|FG000|Follow-up Phase|Protocol Violation|0|||
27984177|NCT01075984|81774063|FG001|Follow-up Phase|Protocol Violation|0|||
27984178|NCT01075984|81774064|FG002|Follow-up Phase|Protocol Violation|1|||
27984179|NCT01075984|81774065|FG003|Follow-up Phase|Protocol Violation|0|||
27984180|NCT01075984|81774066|FG004|Follow-up Phase|Protocol Violation|3|||
27674475|NCT00847626|80647120|FG007|Overall Study|Lack of Efficacy|2|||
27795022|NCT04512976|81082006|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
27984181|NCT01075984|81774062|FG000|Follow-up Phase|Adverse Event|0|||
27984182|NCT01075984|81774063|FG001|Follow-up Phase|Adverse Event|0|||
27984183|NCT01075984|81774064|FG002|Follow-up Phase|Adverse Event|0|||
27984184|NCT01075984|81774065|FG003|Follow-up Phase|Adverse Event|2|||
27984185|NCT01075984|81774066|FG004|Follow-up Phase|Adverse Event|27|||
27984186|NCT01075984|81774062|FG000|Follow-up Phase|Administrative|0|||
27984187|NCT01075984|81774063|FG001|Follow-up Phase|Administrative|0|||
27984188|NCT01075984|81774064|FG002|Follow-up Phase|Administrative|0|||
27984189|NCT01075984|81774065|FG003|Follow-up Phase|Administrative|0|||
27984190|NCT01075984|81774066|FG004|Follow-up Phase|Administrative|1|||
27984191|NCT01075984|81774062|FG000|Follow-up Phase|Withdrawal by Subject|0|||
27984192|NCT01075984|81774063|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27674476|NCT00847626|80647121|FG008|Overall Study|Lack of Efficacy|5|||
27674477|NCT00847626|80647122|FG009|Overall Study|Lack of Efficacy|1|||
27674478|NCT00847626|80647123|FG010|Overall Study|Lack of Efficacy|7|||
27674479|NCT00847626|80647113|FG000|Overall Study|Other|1|||
27674480|NCT00847626|80647114|FG001|Overall Study|Other|5|||
27674481|NCT00847626|80647115|FG002|Overall Study|Other|4|||
27795023|NCT04512976|81082007|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
27795024|NCT04512976|81082008|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
27795025|NCT04512976|81082009|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
27795026|NCT04512976|81082010|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
27795027|NCT04512976|81082011|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
27795028|NCT00391118|81082012|FG000|Overall Study|Adverse Event|3|||
27795029|NCT00391118|81082013|FG001|Overall Study|Adverse Event|10|||
27795030|NCT00391118|81082014|FG002|Overall Study|Adverse Event|7|||
27795031|NCT00391118|81082012|FG000|Overall Study|Lost to Follow-up|0|||
27795032|NCT00391118|81082013|FG001|Overall Study|Lost to Follow-up|2|||
27795033|NCT00391118|81082014|FG002|Overall Study|Lost to Follow-up|3|||
27795034|NCT00391118|81082012|FG000|Overall Study|Withdrawal by Subject|0|||
27795035|NCT00391118|81082013|FG001|Overall Study|Withdrawal by Subject|9|||
27795036|NCT00391118|81082014|FG002|Overall Study|Withdrawal by Subject|1|||
27795037|NCT00391118|81082012|FG000|Overall Study|Death|0|||
27795038|NCT00391118|81082013|FG001|Overall Study|Death|1|||
27795039|NCT00391118|81082014|FG002|Overall Study|Death|0|||
27795040|NCT00391118|81082012|FG000|Overall Study|Physician Decision|0|||
27795041|NCT00391118|81082013|FG001|Overall Study|Physician Decision|3|||
27795042|NCT00391118|81082014|FG002|Overall Study|Physician Decision|0|||
27795043|NCT00391118|81082012|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
27795044|NCT00391118|81082013|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
27795045|NCT00391118|81082014|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
27795046|NCT00391118|81082012|FG000|Overall Study|Progressive Disease|7|||
27795047|NCT00391118|81082013|FG001|Overall Study|Progressive Disease|26|||
27795048|NCT00391118|81082014|FG002|Overall Study|Progressive Disease|43|||
27795049|NCT00391118|81082012|FG000|Overall Study|Sponsor Decision|0|||
27795050|NCT00391118|81082013|FG001|Overall Study|Sponsor Decision|1|||
27795051|NCT00391118|81082014|FG002|Overall Study|Sponsor Decision|3|||
27795052|NCT00391118|81082012|FG000|Overall Study|Protocol Violation|1|||
27795053|NCT00391118|81082013|FG001|Overall Study|Protocol Violation|0|||
27795054|NCT00391118|81082014|FG002|Overall Study|Protocol Violation|0|||
27795055|NCT03519386|81082015|FG000|Overall Study|Withdrawal by Subject|4|||
27795056|NCT03519386|81082016|FG001|Overall Study|Withdrawal by Subject|1|||
27795057|NCT03519386|81082017|FG002|Overall Study|Withdrawal by Subject|2|||
27795058|NCT03519386|81082015|FG000|Overall Study|Physician Decision|1|||
27795059|NCT03519386|81082016|FG001|Overall Study|Physician Decision|1|||
27795060|NCT03519386|81082017|FG002|Overall Study|Physician Decision|1|||
27795061|NCT03519386|81082015|FG000|Overall Study|Lost to Follow-up|0|||
27795062|NCT03519386|81082016|FG001|Overall Study|Lost to Follow-up|1|||
27795063|NCT03519386|81082017|FG002|Overall Study|Lost to Follow-up|1|||
27795064|NCT03519386|81082015|FG000|Overall Study|Death|1|||
27795065|NCT03519386|81082016|FG001|Overall Study|Death|0|||
27795066|NCT03519386|81082017|FG002|Overall Study|Death|4|||
27795067|NCT03519386|81082015|FG000|Overall Study|Adverse Event|2|||
27795068|NCT03519386|81082016|FG001|Overall Study|Adverse Event|1|||
27795069|NCT03519386|81082017|FG002|Overall Study|Adverse Event|2|||
27795070|NCT03519386|81082015|FG000|Overall Study|Explanted|2|||
27795071|NCT03519386|81082016|FG001|Overall Study|Explanted|1|||
27795072|NCT03519386|81082017|FG002|Overall Study|Explanted|0|||
27795073|NCT03519386|81082015|FG000|Overall Study|Ongoing in study|190|||
27795074|NCT03519386|81082016|FG001|Overall Study|Ongoing in study|192|||
27869089|NCT02797171|81354008|FG005|Overall Study|Withdrawal by Subject|0|||
27984193|NCT01075984|81774064|FG002|Follow-up Phase|Withdrawal by Subject|0|||
27984194|NCT01075984|81774065|FG003|Follow-up Phase|Withdrawal by Subject|0|||
27674482|NCT00847626|80647116|FG003|Overall Study|Other|1|||
27674483|NCT00847626|80647117|FG004|Overall Study|Other|2|||
27795075|NCT03519386|81082017|FG002|Overall Study|Ongoing in study|183|||
27795076|NCT00902486|81082018|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
27795077|NCT00902486|81082019|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
27795078|NCT00902486|81082020|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
27795079|NCT00902486|81082021|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
27795080|NCT00902486|81082022|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
27795081|NCT00902486|81082023|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
27795082|NCT00902486|81082018|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
27795083|NCT00902486|81082019|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27795084|NCT00902486|81082020|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27795085|NCT00902486|81082021|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27795086|NCT00902486|81082022|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
27795087|NCT00902486|81082023|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
27795088|NCT00902486|81082018|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27795089|NCT00902486|81082019|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27795090|NCT00902486|81082020|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27795091|NCT00902486|81082021|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
27795092|NCT00902486|81082022|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
27795093|NCT00902486|81082023|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
27795094|NCT00902486|81082018|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27795095|NCT00902486|81082019|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27795096|NCT00902486|81082020|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27795097|NCT00902486|81082021|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
27795098|NCT00902486|81082022|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27795099|NCT00902486|81082023|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
27795100|NCT00902486|81082018|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27795101|NCT00902486|81082019|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27869090|NCT02797171|81354003|FG000|Overall Study|Protocol Violation|1|||
27984195|NCT01075984|81774066|FG004|Follow-up Phase|Withdrawal by Subject|10|||
27984196|NCT01075984|81774062|FG000|Follow-up Phase|Progression of disease|0|||
27984197|NCT01075984|81774063|FG001|Follow-up Phase|Progression of disease|0|||
27984198|NCT01075984|81774064|FG002|Follow-up Phase|Progression of disease|0|||
27984199|NCT01075984|81774065|FG003|Follow-up Phase|Progression of disease|0|||
27984200|NCT01075984|81774066|FG004|Follow-up Phase|Progression of disease|2|||
27984201|NCT01075984|81774062|FG000|Follow-up Phase|Treatment failure|0|||
27984202|NCT01075984|81774063|FG001|Follow-up Phase|Treatment failure|0|||
27984203|NCT01075984|81774064|FG002|Follow-up Phase|Treatment failure|0|||
27984204|NCT01075984|81774065|FG003|Follow-up Phase|Treatment failure|0|||
27984205|NCT01075984|81774066|FG004|Follow-up Phase|Treatment failure|4|||
27984206|NCT01732913|81774067|FG000|Overall Study|Study Terminated by Sponsor|105|||
27984207|NCT01732913|81774068|FG001|Overall Study|Study Terminated by Sponsor|55|||
27984208|NCT01732913|81774067|FG000|Overall Study|Withdrawal by Subject|27|||
27795102|NCT00902486|81082020|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27795103|NCT00902486|81082021|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
27795104|NCT00902486|81082022|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27833042|NCT03131895|81219441|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27833043|NCT03131895|81219442|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
27833044|NCT03131895|81219443|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27984209|NCT01732913|81774068|FG001|Overall Study|Withdrawal by Subject|4|||
27984210|NCT01732913|81774067|FG000|Overall Study|Physician Decision|14|||
27984211|NCT01732913|81774068|FG001|Overall Study|Physician Decision|7|||
27984212|NCT01732913|81774067|FG000|Overall Study|Other|7|||
27984213|NCT01732913|81774068|FG001|Overall Study|Other|1|||
27984214|NCT01732913|81774067|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
27984215|NCT01732913|81774068|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
27984216|NCT01624090|81774071|FG000|Overall Study|DLT, taken off therapy|0|||
27984217|NCT01624090|81774072|FG001|Overall Study|DLT, taken off therapy|1|||
27984218|NCT01624090|81774073|FG002|Overall Study|DLT, taken off therapy|0|||
27984219|NCT01624090|81774074|FG003|Overall Study|DLT, taken off therapy|0|||
27833045|NCT03131895|81219444|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
27833046|NCT03131895|81219441|FG000|Washout Period (at Least 5 Days)|Other|0|||
27833047|NCT03131895|81219442|FG001|Washout Period (at Least 5 Days)|Other|0|||
27833048|NCT03131895|81219443|FG002|Washout Period (at Least 5 Days)|Other|2|||
27833049|NCT03131895|81219444|FG003|Washout Period (at Least 5 Days)|Other|0|||
27833050|NCT03131895|81219441|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
27833051|NCT03131895|81219442|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
27833052|NCT03131895|81219443|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
27833053|NCT03131895|81219444|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
27833054|NCT03131895|81219441|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
27984220|NCT01624090|81774071|FG000|Overall Study|Withdrew prior to treatment|0|||
27984221|NCT01624090|81774072|FG001|Overall Study|Withdrew prior to treatment|1|||
27984222|NCT01624090|81774073|FG002|Overall Study|Withdrew prior to treatment|0|||
27984223|NCT01624090|81774074|FG003|Overall Study|Withdrew prior to treatment|0|||
27984224|NCT01624090|81774071|FG000|Overall Study|Died on study|0|||
27984225|NCT01624090|81774072|FG001|Overall Study|Died on study|0|||
27984226|NCT01624090|81774073|FG002|Overall Study|Died on study|2|||
27984227|NCT01624090|81774074|FG003|Overall Study|Died on study|0|||
27984228|NCT01624090|81774071|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
27984229|NCT01624090|81774072|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
27984230|NCT01624090|81774073|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
27795105|NCT00902486|81082023|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
27984231|NCT01624090|81774074|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
27984232|NCT01624090|81774071|FG000|Overall Study|Dose escalated|0|||
27984233|NCT01624090|81774072|FG001|Overall Study|Dose escalated|0|||
27984234|NCT01624090|81774073|FG002|Overall Study|Dose escalated|3|||
27984235|NCT01624090|81774074|FG003|Overall Study|Dose escalated|0|||
27984236|NCT00710385|81774075|FG000|Overall Study|Did not qualify|1|||
27984237|NCT00710385|81774075|FG000|Overall Study|Withdrawal by Subject|1|||
27984238|NCT00710385|81774075|FG000|Overall Study|Undisclosed back pain|1|||
27984239|NCT00710385|81774075|FG000|Overall Study|Physician Decision|1|||
27984240|NCT00710385|81774075|FG000|Overall Study|Undisclosed excessive methadone use|1|||
27984241|NCT02228096|81774079|FG000|Overall Study|Study terminated by Sponsor|24|||
27984242|NCT02228096|81774079|FG000|Overall Study|Lack of Efficacy|18|||
27674484|NCT00847626|80647118|FG005|Overall Study|Other|2|||
27674485|NCT00847626|80647119|FG006|Overall Study|Other|2|||
27674486|NCT00847626|80647120|FG007|Overall Study|Other|3|||
27674487|NCT00847626|80647121|FG008|Overall Study|Other|1|||
27674488|NCT00847626|80647122|FG009|Overall Study|Other|1|||
27674489|NCT00847626|80647123|FG010|Overall Study|Other|3|||
27674490|NCT01371708|80647124|FG000|Overall Study|Insufficient clinical response|3|||
27674491|NCT01371708|80647125|FG001|Overall Study|Insufficient clinical response|2|||
27674492|NCT01371708|80647126|FG002|Overall Study|Insufficient clinical response|0|||
27674493|NCT01371708|80647124|FG000|Overall Study|Lost to Follow-up|5|||
27674494|NCT01371708|80647125|FG001|Overall Study|Lost to Follow-up|9|||
27674495|NCT01371708|80647126|FG002|Overall Study|Lost to Follow-up|7|||
27674496|NCT01371708|80647124|FG000|Overall Study|Protocol Violation|2|||
27674497|NCT01371708|80647125|FG001|Overall Study|Protocol Violation|1|||
27674498|NCT01371708|80647126|FG002|Overall Study|Protocol Violation|2|||
27674499|NCT01371708|80647124|FG000|Overall Study|No longer willing to participate|7|||
27674500|NCT01371708|80647125|FG001|Overall Study|No longer willing to participate|7|||
27674501|NCT01371708|80647126|FG002|Overall Study|No longer willing to participate|13|||
27795106|NCT00902486|81082018|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27795107|NCT00902486|81082019|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27795108|NCT00902486|81082020|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27795109|NCT00902486|81082021|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
27795110|NCT00902486|81082022|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
27795111|NCT00902486|81082023|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
27795112|NCT00902486|81082018|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27674502|NCT01371708|80647124|FG000|Overall Study|Medication error/not related to AE|0|||
27984243|NCT02228096|81774079|FG000|Overall Study|Death|12|||
27984244|NCT02228096|81774079|FG000|Overall Study|Physician Decision|3|||
27984245|NCT02228096|81774079|FG000|Overall Study|Subject/guardian decision|2|||
27984246|NCT02228096|81774079|FG000|Overall Study|New therapy for study indication|1|||
27984247|NCT02228096|81774079|FG000|Overall Study|Enrolled, not infused|11|||
27795113|NCT00902486|81082019|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27795114|NCT00902486|81082020|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
27795115|NCT00902486|81082021|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
27795116|NCT00902486|81082022|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27795117|NCT00902486|81082023|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
27795118|NCT00902486|81082018|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27795119|NCT00902486|81082019|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27795120|NCT00902486|81082020|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27795121|NCT00902486|81082021|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27795122|NCT00902486|81082022|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
27795123|NCT00902486|81082023|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
27795124|NCT00902486|81082018|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27795125|NCT00902486|81082019|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27795126|NCT00902486|81082020|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27795127|NCT00902486|81082021|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
27795128|NCT00902486|81082022|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27795129|NCT00902486|81082023|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
27795130|NCT00902486|81082018|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27577734|NCT01430130|80299318|FG000|Overall Study|Lost to Follow-up|1|||
27577735|NCT01430130|80299318|FG000|Overall Study|Infection on Control Side of Incision|1|||
27577736|NCT00827372|80299319|FG000|Overall Study|Adverse Event|5|||
27577737|NCT00827372|80299319|FG000|Overall Study|Lack of Efficacy|3|||
27577738|NCT02477020|80299320|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
27577739|NCT02477020|80299321|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
27795131|NCT00902486|81082019|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27795132|NCT00902486|81082020|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
27795133|NCT00902486|81082021|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27795134|NCT00902486|81082022|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27795135|NCT00902486|81082023|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
27795136|NCT00902486|81082018|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
27795137|NCT00902486|81082019|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
27795138|NCT00902486|81082020|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
27795139|NCT00902486|81082021|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
27795140|NCT00902486|81082022|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
27795141|NCT00902486|81082023|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
27795142|NCT03940742|81082024|FG000|Overall Study|Lost to Follow-up|0|||
27795143|NCT03940742|81082025|FG001|Overall Study|Lost to Follow-up|0|||
27795144|NCT03940742|81082026|FG002|Overall Study|Lost to Follow-up|0|||
27795145|NCT03940742|81082027|FG003|Overall Study|Lost to Follow-up|1|||
27795146|NCT00320801|81082028|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
27795147|NCT00320801|81082029|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
27795148|NCT00320801|81082030|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
27795149|NCT00320801|81082031|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
27795150|NCT00320801|81082028|FG000|Open-label Run-in Period|Adverse Event|33|||
27795151|NCT00320801|81082029|FG001|Open-label Run-in Period|Adverse Event|0|||
27795152|NCT00320801|81082030|FG002|Open-label Run-in Period|Adverse Event|0|||
27795153|NCT00320801|81082031|FG003|Open-label Run-in Period|Adverse Event|0|||
27795154|NCT00320801|81082028|FG000|Open-label Run-in Period|Administrative|10|||
27795155|NCT00320801|81082029|FG001|Open-label Run-in Period|Administrative|0|||
27795156|NCT00320801|81082030|FG002|Open-label Run-in Period|Administrative|0|||
27577740|NCT02477020|80299320|FG000|Overall Study|Voluntary Withdrawal|7|||
27674503|NCT01371708|80647125|FG001|Overall Study|Medication error/not related to AE|1|||
27674504|NCT01371708|80647126|FG002|Overall Study|Medication error/not related to AE|0|||
27674505|NCT01371708|80647124|FG000|Overall Study|Other|3|||
27795157|NCT00320801|81082031|FG003|Open-label Run-in Period|Administrative|0|||
27795158|NCT00320801|81082028|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
27795159|NCT00320801|81082029|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
27795160|NCT00320801|81082030|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
27795161|NCT00320801|81082031|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
27795162|NCT00320801|81082028|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
27795163|NCT00320801|81082029|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
27795164|NCT00320801|81082030|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
27795165|NCT00320801|81082031|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
27795166|NCT00320801|81082028|FG000|Open-label Run-in Period|Did not qualify|1|||
27795167|NCT00320801|81082029|FG001|Open-label Run-in Period|Did not qualify|0|||
27795168|NCT00320801|81082030|FG002|Open-label Run-in Period|Did not qualify|0|||
27795169|NCT00320801|81082031|FG003|Open-label Run-in Period|Did not qualify|0|||
27795170|NCT00320801|81082028|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27795171|NCT00320801|81082029|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27795172|NCT00320801|81082030|FG002|Double-blind Phase|Withdrawal by Subject|1|||
27869091|NCT02797171|81354004|FG001|Overall Study|Protocol Violation|0|||
27984248|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
27984249|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
27984250|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
27984251|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
27984252|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
27984253|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
27984254|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
27984255|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
27674506|NCT01371708|80647125|FG001|Overall Study|Other|2|||
27674507|NCT01371708|80647126|FG002|Overall Study|Other|4|||
27674508|NCT01371708|80647124|FG000|Overall Study|Adverse Event|5|||
27674509|NCT01371708|80647125|FG001|Overall Study|Adverse Event|8|||
27674510|NCT01371708|80647126|FG002|Overall Study|Adverse Event|12|||
27674511|NCT01371708|80647124|FG000|Overall Study|Started but did not receive treatment|1|||
27984256|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
27984257|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
27984258|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
27984259|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
27984260|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
27984261|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
27984262|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
27984263|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
27984264|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
27984265|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
27984266|NCT01302054|81774080|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
27984267|NCT01302054|81774081|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
27984268|NCT01302054|81774082|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
27984269|NCT01302054|81774080|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
27984270|NCT01302054|81774081|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
27984271|NCT01302054|81774082|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
27984272|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27984273|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
27984274|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
27984275|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27984276|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
27984277|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27984278|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27984279|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
27984280|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
27984281|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
27984282|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
27984283|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
27984284|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27984285|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
27984286|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
27984287|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
27984288|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
27674512|NCT01371708|80647125|FG001|Overall Study|Started but did not receive treatment|0|||
27674513|NCT01371708|80647126|FG002|Overall Study|Started but did not receive treatment|1|||
27674514|NCT05262751|80647127|FG000|Washout Period 2|Adverse Event|1|||
27674515|NCT05262751|80647128|FG001|Washout Period 2|Adverse Event|0|||
27674516|NCT05262751|80647129|FG002|Washout Period 2|Adverse Event|0|||
27674517|NCT05262751|80647130|FG003|Washout Period 2|Adverse Event|0|||
27674518|NCT05262751|80647131|FG004|Washout Period 2|Adverse Event|0|||
27674519|NCT05262751|80647132|FG005|Washout Period 2|Adverse Event|0|||
27674520|NCT05262751|80647127|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
27795173|NCT00320801|81082031|FG003|Double-blind Phase|Withdrawal by Subject|0|||
27674521|NCT05262751|80647128|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
27674522|NCT05262751|80647129|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
27577741|NCT02477020|80299321|FG001|Overall Study|Voluntary Withdrawal|16|||
27795174|NCT00320801|81082028|FG000|Double-blind Phase|Adverse Event|0|||
27984289|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
27984290|NCT01302054|81774080|FG000|Double-Blind Treatment Phase|Other|0|||
27984291|NCT01302054|81774081|FG001|Double-Blind Treatment Phase|Other|4|||
27984292|NCT01302054|81774082|FG002|Double-Blind Treatment Phase|Other|9|||
27984293|NCT01554514|81774083|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
27984294|NCT01554514|81774083|FG000|Overall Study|Physician Decision|1|||
27984295|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
27984296|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
27984297|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
27984298|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
27984299|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
27984300|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
27984301|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
27984302|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
27984303|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
27984304|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
27984305|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
27984306|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
27984307|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
27984308|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
27984309|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
27984310|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
27984311|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
27984312|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
27984313|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
27984314|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
27984315|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
27984316|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
27984317|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
27984318|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
27984319|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
27984320|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
27984321|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
27984322|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
27984323|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
27984324|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
27984325|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
27984326|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
27984327|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
27984328|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
27984329|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
27984330|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
27984331|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
27984332|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
27984333|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
27984334|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
27984335|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
27984336|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
27984337|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
27984338|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
27984339|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
27984340|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
27984341|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
27577742|NCT02477020|80299320|FG000|Overall Study|Reason not Specified|3|||
27577743|NCT02477020|80299321|FG001|Overall Study|Reason not Specified|1|||
27577744|NCT02477020|80299320|FG000|Overall Study|Lack of Efficacy|14|||
27577745|NCT02477020|80299321|FG001|Overall Study|Lack of Efficacy|5|||
27577746|NCT01863446|80299322|FG000|Overall Study|Withdrawal by Subject|1|||
27577747|NCT01863446|80299323|FG001|Overall Study|Withdrawal by Subject|0|||
27577748|NCT01863446|80299324|FG002|Overall Study|Withdrawal by Subject|1|||
27577749|NCT01863446|80299325|FG003|Overall Study|Withdrawal by Subject|2|||
27577750|NCT01863446|80299322|FG000|Overall Study|Physician Decision|0|||
27577751|NCT01863446|80299323|FG001|Overall Study|Physician Decision|0|||
27577752|NCT01863446|80299324|FG002|Overall Study|Physician Decision|1|||
27577753|NCT01863446|80299325|FG003|Overall Study|Physician Decision|0|||
27577754|NCT01302964|80299326|FG000|Overall Study|Adverse Event|1|||
27577755|NCT01302964|80299327|FG001|Overall Study|Adverse Event|0|||
27577756|NCT04622254|80299328|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
27577757|NCT04622254|80299329|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
27577758|NCT04622254|80299330|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
27577759|NCT04622254|80299331|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
27577760|NCT04622254|80299332|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
27577761|NCT04622254|80299333|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
27577762|NCT04622254|80299328|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
27577763|NCT04622254|80299329|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
27577764|NCT04622254|80299330|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
27577765|NCT04622254|80299331|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
27577766|NCT04622254|80299332|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
27577767|NCT04622254|80299333|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
27577768|NCT04622254|80299328|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
27577769|NCT04622254|80299329|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
27577770|NCT04622254|80299330|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
27577771|NCT04622254|80299331|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
27577772|NCT04622254|80299332|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
27577773|NCT04622254|80299333|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
27577774|NCT04622254|80299328|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27577775|NCT04622254|80299329|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
27577776|NCT04622254|80299330|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
27577777|NCT04622254|80299331|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27577778|NCT04622254|80299332|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27795175|NCT00320801|81082029|FG001|Double-blind Phase|Adverse Event|2|||
27984342|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
27984343|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
27984344|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
27984345|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
27984346|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
27984347|NCT02008357|81774084|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
27984348|NCT02008357|81774085|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
27984349|NCT02008357|81774084|FG000|Open-label Extension Period|Adverse Event|8|||
27984350|NCT02008357|81774085|FG001|Open-label Extension Period|Adverse Event|7|||
27984351|NCT02008357|81774084|FG000|Open-label Extension Period|Death|7|||
27984352|NCT02008357|81774085|FG001|Open-label Extension Period|Death|4|||
27984353|NCT02008357|81774084|FG000|Open-label Extension Period|Lack of Efficacy|9|||
27984354|NCT02008357|81774085|FG001|Open-label Extension Period|Lack of Efficacy|5|||
27984355|NCT02008357|81774084|FG000|Open-label Extension Period|Lost to Follow-up|2|||
27984356|NCT02008357|81774085|FG001|Open-label Extension Period|Lost to Follow-up|2|||
27984357|NCT02008357|81774084|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
27984358|NCT02008357|81774085|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
27984359|NCT02008357|81774084|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
27984360|NCT02008357|81774085|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
27984361|NCT02008357|81774084|FG000|Open-label Extension Period|Safety Risk|2|||
27984362|NCT02008357|81774085|FG001|Open-label Extension Period|Safety Risk|1|||
27984363|NCT02008357|81774084|FG000|Open-label Extension Period|Non-Compliance|0|||
27984364|NCT02008357|81774085|FG001|Open-label Extension Period|Non-Compliance|1|||
27984365|NCT02008357|81774084|FG000|Open-label Extension Period|Investigator Recommendation|0|||
27984366|NCT02008357|81774085|FG001|Open-label Extension Period|Investigator Recommendation|1|||
27984367|NCT02008357|81774084|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
27984368|NCT02008357|81774085|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
27984369|NCT02008357|81774084|FG000|Open-label Extension Period|Coordinating Center Request|2|||
27984370|NCT02008357|81774085|FG001|Open-label Extension Period|Coordinating Center Request|4|||
27984371|NCT02008357|81774084|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
27984372|NCT02008357|81774085|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
27984373|NCT02008357|81774084|FG000|Open-label Extension Period|Study Ended|20|||
27984374|NCT02008357|81774085|FG001|Open-label Extension Period|Study Ended|25|||
27984375|NCT02008357|81774084|FG000|Open-label Extension Period|Personal Reasons|0|||
27984376|NCT02008357|81774085|FG001|Open-label Extension Period|Personal Reasons|1|||
27984377|NCT02008357|81774084|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
27984378|NCT02008357|81774085|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
27984379|NCT02008357|81774084|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
27984380|NCT02008357|81774085|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
27984381|NCT02008357|81774084|FG000|Open-label Extension Period|Other|2|||
27984382|NCT02008357|81774085|FG001|Open-label Extension Period|Other|0|||
27984383|NCT01263015|81774086|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
27984384|NCT01263015|81774087|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
27984385|NCT01263015|81774086|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
27984386|NCT01263015|81774087|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
27984387|NCT01263015|81774086|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
27984388|NCT01263015|81774087|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
27984389|NCT01263015|81774086|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
27984390|NCT01263015|81774087|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
27984391|NCT01263015|81774086|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
27984392|NCT01263015|81774087|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
27984393|NCT01263015|81774086|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
27984394|NCT01263015|81774087|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
27984395|NCT01263015|81774086|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
27984396|NCT01263015|81774087|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
27984397|NCT01263015|81774086|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
27984398|NCT01263015|81774087|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
27577779|NCT04622254|80299333|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
27577780|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27577781|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27577782|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27577783|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
27577784|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27984399|NCT01263015|81774086|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
27795176|NCT00320801|81082030|FG002|Double-blind Phase|Adverse Event|8|||
27984400|NCT01263015|81774087|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
27577785|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
27577786|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27577787|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27577788|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27577789|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
27577790|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
27577791|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
27577792|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27577793|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27577794|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27577795|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
27577796|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27577797|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
27577798|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27577799|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27577800|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27577801|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
27577802|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27577803|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
27577804|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
27577805|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
27577806|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
27577807|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
27577808|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
27577809|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
27577810|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
27577811|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
27577812|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
27577813|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
27577814|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
27577815|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
27577816|NCT04622254|80299328|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
27577817|NCT04622254|80299329|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
27577818|NCT04622254|80299330|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
27577819|NCT04622254|80299331|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
27577820|NCT04622254|80299332|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
27577821|NCT04622254|80299333|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
27577822|NCT01573624|80299342|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27577823|NCT01573624|80299343|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27577824|NCT01573624|80299344|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
27577825|NCT01573624|80299345|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27577826|NCT01573624|80299346|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27577827|NCT01573624|80299347|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
27577828|NCT01573624|80299348|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
27577829|NCT01573624|80299342|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
27577830|NCT01573624|80299343|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
27577831|NCT01573624|80299344|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
27577832|NCT01573624|80299345|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
27577833|NCT01573624|80299346|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
27577834|NCT01573624|80299347|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
27577835|NCT01573624|80299348|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
27577836|NCT01573624|80299342|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
27577837|NCT01573624|80299343|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27577838|NCT01573624|80299344|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27577839|NCT01573624|80299345|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27577840|NCT01573624|80299346|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27795177|NCT00320801|81082031|FG003|Double-blind Phase|Adverse Event|0|||
27795178|NCT00320801|81082028|FG000|Double-blind Phase|Administrative|0|||
27795179|NCT00320801|81082029|FG001|Double-blind Phase|Administrative|0|||
27984401|NCT01263015|81774086|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
27984402|NCT01263015|81774087|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
27984403|NCT01263015|81774086|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
27984404|NCT01263015|81774087|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
27984405|NCT01263015|81774086|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
27984406|NCT01263015|81774087|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
27984407|NCT01009086|81774088|FG000|Overall Study|Lack of Efficacy|16|||
27984408|NCT01009086|81774089|FG001|Overall Study|Lack of Efficacy|15|||
27984409|NCT01009086|81774090|FG002|Overall Study|Lack of Efficacy|9|||
27984410|NCT01009086|81774088|FG000|Overall Study|Lost to Follow-up|4|||
27984411|NCT01009086|81774089|FG001|Overall Study|Lost to Follow-up|5|||
27984412|NCT01009086|81774090|FG002|Overall Study|Lost to Follow-up|3|||
27984413|NCT01009086|81774088|FG000|Overall Study|Adverse Event|12|||
27984414|NCT01009086|81774089|FG001|Overall Study|Adverse Event|11|||
27984415|NCT01009086|81774090|FG002|Overall Study|Adverse Event|8|||
27984416|NCT01009086|81774088|FG000|Overall Study|Withdrawal by Subject|9|||
27984417|NCT01009086|81774089|FG001|Overall Study|Withdrawal by Subject|11|||
27984418|NCT01009086|81774090|FG002|Overall Study|Withdrawal by Subject|13|||
27984419|NCT01009086|81774088|FG000|Overall Study|Other|3|||
27984420|NCT01009086|81774089|FG001|Overall Study|Other|5|||
27984421|NCT01009086|81774090|FG002|Overall Study|Other|1|||
27984422|NCT03847909|81774091|FG000|Overall Study|Withdrawal by Subject|1|||
27984423|NCT03847909|81774092|FG001|Overall Study|Withdrawal by Subject|1|||
27984424|NCT00279812|81774093|FG000|Overall Study|Protocol Violation|1|||
27984425|NCT00279812|81774094|FG001|Overall Study|Protocol Violation|1|||
27795180|NCT00320801|81082030|FG002|Double-blind Phase|Administrative|4|||
27795181|NCT00320801|81082031|FG003|Double-blind Phase|Administrative|0|||
27795182|NCT00320801|81082028|FG000|Double-blind Phase|Lack of Efficacy|0|||
27795183|NCT00320801|81082029|FG001|Double-blind Phase|Lack of Efficacy|9|||
27795184|NCT00320801|81082030|FG002|Double-blind Phase|Lack of Efficacy|1|||
27795185|NCT00320801|81082031|FG003|Double-blind Phase|Lack of Efficacy|0|||
27795186|NCT00320801|81082028|FG000|Extension Phase|Withdrawal by Subject|0|||
27795187|NCT00320801|81082029|FG001|Extension Phase|Withdrawal by Subject|0|||
27795188|NCT00320801|81082030|FG002|Extension Phase|Withdrawal by Subject|0|||
27795189|NCT00320801|81082031|FG003|Extension Phase|Withdrawal by Subject|6|||
27795190|NCT00320801|81082028|FG000|Extension Phase|Adverse Event|0|||
27795191|NCT00320801|81082029|FG001|Extension Phase|Adverse Event|0|||
27795192|NCT00320801|81082030|FG002|Extension Phase|Adverse Event|0|||
27795193|NCT00320801|81082031|FG003|Extension Phase|Adverse Event|8|||
27795194|NCT00320801|81082028|FG000|Extension Phase|Administrative|0|||
27795195|NCT00320801|81082029|FG001|Extension Phase|Administrative|0|||
27795196|NCT00320801|81082030|FG002|Extension Phase|Administrative|0|||
27795197|NCT00320801|81082031|FG003|Extension Phase|Administrative|29|||
27795198|NCT00320801|81082028|FG000|Extension Phase|Lack of Efficacy|0|||
27795199|NCT00320801|81082029|FG001|Extension Phase|Lack of Efficacy|0|||
27795200|NCT00320801|81082030|FG002|Extension Phase|Lack of Efficacy|0|||
27795201|NCT00320801|81082031|FG003|Extension Phase|Lack of Efficacy|2|||
27795202|NCT00320801|81082028|FG000|Extension Phase|Lost to Follow-up|0|||
27795203|NCT00320801|81082029|FG001|Extension Phase|Lost to Follow-up|0|||
27795204|NCT00320801|81082030|FG002|Extension Phase|Lost to Follow-up|0|||
27795205|NCT00320801|81082031|FG003|Extension Phase|Lost to Follow-up|3|||
27795206|NCT00916617|81082032|FG000|Overall Study|Adverse Event|3|||
27795207|NCT00916617|81082033|FG001|Overall Study|Adverse Event|2|||
27795208|NCT00916617|81082034|FG002|Overall Study|Adverse Event|6|||
27795209|NCT00916617|81082035|FG003|Overall Study|Adverse Event|3|||
27795210|NCT00916617|81082032|FG000|Overall Study|Withdrawal by Subject|3|||
27795211|NCT00916617|81082033|FG001|Overall Study|Withdrawal by Subject|2|||
27795212|NCT00916617|81082034|FG002|Overall Study|Withdrawal by Subject|0|||
27795213|NCT00916617|81082035|FG003|Overall Study|Withdrawal by Subject|1|||
27795214|NCT00916617|81082032|FG000|Overall Study|Caregiver Request|3|||
27795215|NCT00916617|81082033|FG001|Overall Study|Caregiver Request|2|||
27795216|NCT00916617|81082034|FG002|Overall Study|Caregiver Request|1|||
27984426|NCT00279812|81774095|FG002|Overall Study|Protocol Violation|0|||
27984427|NCT00279812|81774096|FG003|Overall Study|Protocol Violation|0|||
27984428|NCT00279812|81774097|FG004|Overall Study|Protocol Violation|1|||
27984429|NCT00279812|81774098|FG005|Overall Study|Protocol Violation|0|||
27984430|NCT00279812|81774093|FG000|Overall Study|Withdrawal by Subject|0|||
27795217|NCT00916617|81082035|FG003|Overall Study|Caregiver Request|0|||
27795218|NCT00916617|81082032|FG000|Overall Study|Physician Decision|1|||
27577841|NCT01573624|80299347|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27795219|NCT00916617|81082033|FG001|Overall Study|Physician Decision|1|||
27577842|NCT01573624|80299348|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
27577843|NCT01573624|80299342|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27577844|NCT01573624|80299343|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27577845|NCT01573624|80299344|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27577846|NCT01573624|80299345|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27577847|NCT01573624|80299346|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27577848|NCT01573624|80299347|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
27577849|NCT01573624|80299348|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27577850|NCT01573624|80299342|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
27577851|NCT01573624|80299343|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
27869092|NCT02797171|81354005|FG002|Overall Study|Protocol Violation|0|||
27869093|NCT02797171|81354006|FG003|Overall Study|Protocol Violation|0|||
27869094|NCT02797171|81354007|FG004|Overall Study|Protocol Violation|0|||
27869095|NCT02797171|81354008|FG005|Overall Study|Protocol Violation|0|||
27869096|NCT02797171|81354003|FG000|Overall Study|Participant unable to adhere|0|||
27869097|NCT02797171|81354004|FG001|Overall Study|Participant unable to adhere|1|||
27984431|NCT00279812|81774094|FG001|Overall Study|Withdrawal by Subject|4|||
27577852|NCT01573624|80299344|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27577853|NCT01573624|80299345|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27577854|NCT01573624|80299346|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
27577855|NCT01573624|80299347|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27577856|NCT01573624|80299348|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
27577857|NCT01573624|80299342|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27577858|NCT01573624|80299343|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27577859|NCT01573624|80299344|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27577860|NCT01573624|80299345|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27577861|NCT01573624|80299346|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27577862|NCT01573624|80299347|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
27577863|NCT01573624|80299348|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
27577864|NCT01573624|80299342|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27577865|NCT01573624|80299343|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
27577866|NCT01573624|80299344|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27577867|NCT01573624|80299345|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
27577868|NCT01573624|80299346|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27577869|NCT01573624|80299347|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
27577870|NCT01573624|80299348|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
27577871|NCT01573624|80299342|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
27577872|NCT01573624|80299343|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27577873|NCT01573624|80299344|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
27577874|NCT01573624|80299345|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
27577875|NCT01573624|80299346|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27577876|NCT01573624|80299347|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27577877|NCT01573624|80299348|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27869098|NCT02797171|81354005|FG002|Overall Study|Participant unable to adhere|0|||
27869099|NCT02797171|81354006|FG003|Overall Study|Participant unable to adhere|0|||
27984432|NCT00279812|81774095|FG002|Overall Study|Withdrawal by Subject|2|||
27984433|NCT00279812|81774096|FG003|Overall Study|Withdrawal by Subject|0|||
27984434|NCT00279812|81774097|FG004|Overall Study|Withdrawal by Subject|0|||
27984435|NCT00279812|81774098|FG005|Overall Study|Withdrawal by Subject|0|||
27984436|NCT00279812|81774093|FG000|Overall Study|Adverse Event|0|||
27984437|NCT00279812|81774094|FG001|Overall Study|Adverse Event|1|||
27984438|NCT00279812|81774095|FG002|Overall Study|Adverse Event|1|||
27984439|NCT00279812|81774096|FG003|Overall Study|Adverse Event|0|||
27984440|NCT00279812|81774097|FG004|Overall Study|Adverse Event|2|||
27984441|NCT00279812|81774098|FG005|Overall Study|Adverse Event|1|||
27984442|NCT03442296|81774099|FG000|3 Month Follow-up|Death|3|||
27984443|NCT03442296|81774100|FG001|3 Month Follow-up|Death|1|||
27984444|NCT03442296|81774099|FG000|3 Month Follow-up|Lost to Follow-up|1|||
27984445|NCT03442296|81774100|FG001|3 Month Follow-up|Lost to Follow-up|1|||
27984446|NCT03442296|81774099|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
27984447|NCT03442296|81774100|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
27984448|NCT03442296|81774099|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
27984449|NCT03442296|81774100|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
27984450|NCT03442296|81774099|FG000|12 Month Follow-up|Incomplete measurement|1|||
27984451|NCT03442296|81774100|FG001|12 Month Follow-up|Incomplete measurement|1|||
27984452|NCT02717130|81774101|FG000|Overall Study|Withdrawal by Subject|1|||
27984453|NCT02717130|81774101|FG000|Overall Study|Adverse Event|1|||
27984454|NCT02717130|81774101|FG000|Overall Study|Physician Decision|1|||
27577878|NCT01573624|80299342|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27577879|NCT01573624|80299343|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27577880|NCT01573624|80299344|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27577881|NCT01573624|80299345|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27577882|NCT01573624|80299346|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27577883|NCT01573624|80299347|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
27577884|NCT01573624|80299348|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
27577885|NCT01573624|80299342|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27577886|NCT01573624|80299343|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27577887|NCT01573624|80299344|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27577888|NCT01573624|80299345|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
27577889|NCT01573624|80299346|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27577890|NCT01573624|80299347|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27577891|NCT01573624|80299348|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27577892|NCT01573624|80299342|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27577893|NCT01573624|80299343|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27577894|NCT01573624|80299344|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577895|NCT01573624|80299345|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577896|NCT01573624|80299346|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27577897|NCT01573624|80299347|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577898|NCT01573624|80299348|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
27577899|NCT01573624|80299342|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
27577900|NCT01573624|80299343|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
27577901|NCT01573624|80299344|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
27577902|NCT01573624|80299345|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
27577903|NCT01573624|80299346|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
27577904|NCT01573624|80299347|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
27577905|NCT01573624|80299348|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
27577906|NCT01573624|80299342|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27577907|NCT01573624|80299343|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
27577908|NCT01573624|80299344|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27577909|NCT01573624|80299345|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27577910|NCT01573624|80299346|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27577911|NCT01573624|80299347|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
27577912|NCT01573624|80299348|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
27577913|NCT01573624|80299342|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
27577914|NCT01573624|80299343|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27577915|NCT01573624|80299344|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27577916|NCT01573624|80299345|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27577917|NCT01573624|80299346|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27577918|NCT01573624|80299347|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27577919|NCT01573624|80299348|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
27577920|NCT01573624|80299342|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27577921|NCT01573624|80299343|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27577922|NCT01573624|80299344|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27577923|NCT01573624|80299345|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27577924|NCT01573624|80299346|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27577925|NCT01573624|80299347|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
27577926|NCT01573624|80299348|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
27577927|NCT01573624|80299342|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
27674523|NCT05262751|80647130|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
27577928|NCT01573624|80299343|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27577929|NCT01573624|80299344|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27577930|NCT01573624|80299345|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27577931|NCT01573624|80299346|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27577932|NCT01573624|80299347|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27577933|NCT01573624|80299348|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
27577934|NCT01573624|80299342|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
27577935|NCT01573624|80299343|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27674524|NCT05262751|80647131|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
27577936|NCT01573624|80299344|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27577937|NCT01573624|80299345|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27577938|NCT01573624|80299346|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27577939|NCT01573624|80299347|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
27577940|NCT01573624|80299348|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
27577941|NCT01573624|80299342|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
27577942|NCT01573624|80299343|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27577943|NCT01573624|80299344|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27577944|NCT01573624|80299345|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27577945|NCT01573624|80299346|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27577946|NCT01573624|80299347|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
27577947|NCT01573624|80299348|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
27577948|NCT01573624|80299342|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27577949|NCT01573624|80299343|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
27577950|NCT01573624|80299344|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27577951|NCT01573624|80299345|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27577952|NCT01573624|80299346|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27577953|NCT01573624|80299347|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27577954|NCT01573624|80299348|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
27577955|NCT01573624|80299342|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27577956|NCT01573624|80299343|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
27577957|NCT01573624|80299344|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27577958|NCT01573624|80299345|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27577959|NCT01573624|80299346|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27577960|NCT01573624|80299347|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27577961|NCT01573624|80299348|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
27577962|NCT01573624|80299342|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27577963|NCT01573624|80299343|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27577964|NCT01573624|80299344|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27577965|NCT01573624|80299345|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27577966|NCT01573624|80299346|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27577967|NCT01573624|80299347|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27577968|NCT01573624|80299348|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27577969|NCT01573624|80299342|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
27984455|NCT02717130|81774101|FG000|Overall Study|Study Closure|4|||
27984456|NCT01600092|81774104|FG000|Overall Study|Adverse Event|2|||
27577970|NCT01573624|80299343|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577971|NCT01573624|80299344|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577972|NCT01573624|80299345|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577973|NCT01573624|80299346|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
27577974|NCT01573624|80299347|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
27577975|NCT01573624|80299348|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
27577976|NCT01573624|80299342|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
27577977|NCT01573624|80299343|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27577978|NCT01573624|80299344|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27577979|NCT01573624|80299345|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27577980|NCT01573624|80299346|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
27577981|NCT01573624|80299347|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
27577982|NCT01573624|80299348|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
27577983|NCT01573624|80299342|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27577984|NCT01573624|80299343|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
27577985|NCT01573624|80299344|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27577986|NCT01573624|80299345|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27577987|NCT01573624|80299346|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27984457|NCT01600092|81774105|FG001|Overall Study|Adverse Event|0|||
27984458|NCT01600092|81774104|FG000|Overall Study|Lost to Follow-up|4|||
27577988|NCT01573624|80299347|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
27577989|NCT01573624|80299348|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
27577990|NCT01573624|80299342|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
27577991|NCT01573624|80299343|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27577992|NCT01573624|80299344|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27577993|NCT01573624|80299345|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27984459|NCT01600092|81774105|FG001|Overall Study|Lost to Follow-up|6|||
27577994|NCT01573624|80299346|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27577995|NCT01573624|80299347|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27577996|NCT01573624|80299348|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
27577997|NCT01573624|80299342|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27577998|NCT01573624|80299343|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27577999|NCT01573624|80299344|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27578000|NCT01573624|80299345|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27578001|NCT01573624|80299346|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
27578002|NCT01573624|80299347|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
27578003|NCT01573624|80299348|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
27578004|NCT01573624|80299342|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
27578005|NCT01573624|80299343|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27578006|NCT01573624|80299344|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27578007|NCT01573624|80299345|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27578008|NCT01573624|80299346|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27578009|NCT01573624|80299347|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27578010|NCT01573624|80299348|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
27578011|NCT00813761|80299349|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
27578012|NCT00813761|80299350|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
27578013|NCT00813761|80299351|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
27578014|NCT00813761|80299352|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
27674525|NCT05262751|80647132|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
27674526|NCT01327846|80647136|FG000|Core Phase|Subject decision (vital status: missing)|1|||
27674527|NCT01327846|80647137|FG001|Core Phase|Subject decision (vital status: missing)|2|||
27674528|NCT01327846|80647138|FG002|Core Phase|Subject decision (vital status: missing)|2|||
27674529|NCT01327846|80647139|FG003|Core Phase|Subject decision (vital status: missing)|1|||
27674530|NCT01327846|80647136|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
27674531|NCT01327846|80647137|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
27674532|NCT01327846|80647138|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
27674533|NCT01327846|80647139|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
27674534|NCT01327846|80647136|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
27674535|NCT01327846|80647137|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
27674536|NCT01327846|80647138|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
27674537|NCT01327846|80647139|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
27674538|NCT01327846|80647136|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
27674539|NCT01327846|80647137|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
27674540|NCT01327846|80647138|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
27674541|NCT01327846|80647139|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
27674542|NCT01327846|80647136|FG000|Core Phase|Lost to Follow-up|3|||
27674543|NCT01327846|80647137|FG001|Core Phase|Lost to Follow-up|3|||
27674544|NCT01327846|80647138|FG002|Core Phase|Lost to Follow-up|4|||
27674545|NCT01327846|80647139|FG003|Core Phase|Lost to Follow-up|5|||
27674546|NCT01327846|80647136|FG000|Extension Phase|Study terminated by sponsor|1073|||
27674547|NCT01327846|80647137|FG001|Extension Phase|Study terminated by sponsor|1124|||
27674548|NCT01327846|80647138|FG002|Extension Phase|Study terminated by sponsor|1067|||
27674549|NCT01327846|80647139|FG003|Extension Phase|Study terminated by sponsor|1660|||
27674550|NCT01327846|80647136|FG000|Extension Phase|Withdrawal by Subject|20|||
27674551|NCT01327846|80647137|FG001|Extension Phase|Withdrawal by Subject|13|||
27674552|NCT01327846|80647138|FG002|Extension Phase|Withdrawal by Subject|19|||
27674553|NCT01327846|80647139|FG003|Extension Phase|Withdrawal by Subject|37|||
27674554|NCT01327846|80647136|FG000|Extension Phase|Lost to Follow-up|4|||
27674555|NCT01327846|80647137|FG001|Extension Phase|Lost to Follow-up|3|||
27674556|NCT01327846|80647138|FG002|Extension Phase|Lost to Follow-up|4|||
27674557|NCT01327846|80647139|FG003|Extension Phase|Lost to Follow-up|7|||
27674558|NCT01327846|80647136|FG000|Extension Phase|Technical Problems|2|||
27674559|NCT01327846|80647137|FG001|Extension Phase|Technical Problems|4|||
27674560|NCT01327846|80647138|FG002|Extension Phase|Technical Problems|2|||
27674561|NCT01327846|80647139|FG003|Extension Phase|Technical Problems|2|||
27674562|NCT01001390|80647140|FG000|Overall Study|Failure to wear AFO device|2|||
27674563|NCT01001390|80647141|FG001|Overall Study|Failure to wear AFO device|0|||
27674564|NCT00913523|80647145|FG000|Overall Study|Withdrawal by Subject|3|||
27674565|NCT00913523|80647146|FG001|Overall Study|Withdrawal by Subject|2|||
27674566|NCT00913523|80647147|FG002|Overall Study|Withdrawal by Subject|2|||
27674567|NCT00913523|80647145|FG000|Overall Study|Lost to Follow-up|1|||
27674568|NCT00913523|80647146|FG001|Overall Study|Lost to Follow-up|1|||
27578015|NCT00813761|80299349|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
27578016|NCT00813761|80299350|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
27578017|NCT00813761|80299351|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
27674569|NCT00913523|80647147|FG002|Overall Study|Lost to Follow-up|1|||
27674570|NCT00913523|80647145|FG000|Overall Study|Adverse Event|1|||
27674571|NCT00913523|80647146|FG001|Overall Study|Adverse Event|0|||
27578018|NCT00813761|80299352|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
27578019|NCT00813761|80299349|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
27578020|NCT00813761|80299350|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
27578021|NCT00813761|80299351|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
27578022|NCT00813761|80299352|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
27578023|NCT00813761|80299349|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
27578024|NCT00813761|80299350|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
27578025|NCT00813761|80299351|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
27578026|NCT00813761|80299352|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
27578027|NCT00813761|80299349|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
27578028|NCT00813761|80299350|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
27869100|NCT02797171|81354007|FG004|Overall Study|Participant unable to adhere|0|||
27869101|NCT02797171|81354008|FG005|Overall Study|Participant unable to adhere|0|||
27869102|NCT02797171|81354003|FG000|Overall Study|Not Randomized|0|||
27869103|NCT02797171|81354004|FG001|Overall Study|Not Randomized|0|||
27869104|NCT02797171|81354005|FG002|Overall Study|Not Randomized|0|||
27869105|NCT02797171|81354006|FG003|Overall Study|Not Randomized|0|||
27869106|NCT02797171|81354007|FG004|Overall Study|Not Randomized|0|||
27869107|NCT02797171|81354008|FG005|Overall Study|Not Randomized|1|||
27869108|NCT03156504|81354012|FG000|Overall Study|Withdrawal by Subject|1|||
27869109|NCT03280264|81354018|FG000|Overall Study|Adverse Event|1|||
27869110|NCT03280264|81354018|FG000|Overall Study|Physician Decision|1|||
27869111|NCT03280264|81354018|FG000|Overall Study|Withdrawal by Subject|1|||
27869112|NCT02201784|81354021|FG000|Overall Study|Failure to achieve adequate block|2|||
27869113|NCT02201784|81354022|FG001|Overall Study|Failure to achieve adequate block|0|||
27869114|NCT01372748|81354025|FG000|Overall Study|Lost to Follow-up|16|||
27869115|NCT01372748|81354026|FG001|Overall Study|Lost to Follow-up|34|||
27869116|NCT01372748|81354025|FG000|Overall Study|Withdrawal by Subject|7|||
27869117|NCT01372748|81354026|FG001|Overall Study|Withdrawal by Subject|5|||
27869118|NCT01495702|81354031|FG000|Randomized Phase|Randomized But Not Treated|1|||
27869119|NCT01495702|81354032|FG001|Randomized Phase|Randomized But Not Treated|4|||
27869120|NCT01495702|81354031|FG000|Randomized Phase|Adverse Event|2|||
27869121|NCT01495702|81354032|FG001|Randomized Phase|Adverse Event|2|||
27869122|NCT01495702|81354031|FG000|Randomized Phase|Death|1|||
27869123|NCT01495702|81354032|FG001|Randomized Phase|Death|0|||
27869124|NCT01495702|81354031|FG000|Randomized Phase|Lack of Efficacy|2|||
27869125|NCT01495702|81354032|FG001|Randomized Phase|Lack of Efficacy|0|||
27869126|NCT01495702|81354031|FG000|Randomized Phase|Investigators Discretion|2|||
27869127|NCT01495702|81354032|FG001|Randomized Phase|Investigators Discretion|0|||
27869128|NCT01495702|81354031|FG000|Randomized Phase|Withdrew Consent|10|||
27869129|NCT01495702|81354032|FG001|Randomized Phase|Withdrew Consent|18|||
27869130|NCT01495702|81354031|FG000|Randomized Phase|Lost to Follow-up|4|||
27869131|NCT01495702|81354032|FG001|Randomized Phase|Lost to Follow-up|3|||
27869132|NCT01495702|81354031|FG000|Randomized Phase|Participant Noncompliance|1|||
27869133|NCT01495702|81354032|FG001|Randomized Phase|Participant Noncompliance|0|||
27869134|NCT01495702|81354031|FG000|Randomized Phase|Protocol Violation|3|||
27869135|NCT01495702|81354032|FG001|Randomized Phase|Protocol Violation|1|||
27869136|NCT04324021|81354035|FG000|Overall Study|Adverse Event|1|||
27869137|NCT04324021|81354036|FG001|Overall Study|Adverse Event|0|||
27869138|NCT04324021|81354037|FG002|Overall Study|Adverse Event|0|||
27869139|NCT04324021|81354035|FG000|Overall Study|Lack of Efficacy|0|||
27869140|NCT04324021|81354036|FG001|Overall Study|Lack of Efficacy|0|||
27869141|NCT04324021|81354037|FG002|Overall Study|Lack of Efficacy|1|||
27869142|NCT04324021|81354035|FG000|Overall Study|Death|1|||
27869143|NCT04324021|81354036|FG001|Overall Study|Death|1|||
27869144|NCT04324021|81354037|FG002|Overall Study|Death|0|||
27869145|NCT01060072|81354038|FG000|Overall Study|Adverse Event|1|||
27869146|NCT01060072|81354039|FG001|Overall Study|Adverse Event|1|||
27869147|NCT01060072|81354038|FG000|Overall Study|Physician Decision|0|||
27869148|NCT01060072|81354039|FG001|Overall Study|Physician Decision|2|||
27869149|NCT01060072|81354038|FG000|Overall Study|Protocol Violation|0|||
27869150|NCT01060072|81354039|FG001|Overall Study|Protocol Violation|1|||
27869151|NCT01060072|81354038|FG000|Overall Study|Acute cholecystitis|1|||
27869152|NCT01060072|81354039|FG001|Overall Study|Acute cholecystitis|0|||
27869153|NCT01060072|81354038|FG000|Overall Study|Excluded Medications|0|||
27869154|NCT01060072|81354039|FG001|Overall Study|Excluded Medications|1|||
27869155|NCT00417170|81354040|FG000|Overall Study|Adverse Event|1|||
27869156|NCT00417170|81354041|FG001|Overall Study|Adverse Event|1|||
27869157|NCT00417170|81354040|FG000|Overall Study|Withdrawal by Subject|1|||
27869158|NCT00417170|81354041|FG001|Overall Study|Withdrawal by Subject|1|||
27869159|NCT00417170|81354040|FG000|Overall Study|Lost to Follow-up|0|||
27869160|NCT00417170|81354041|FG001|Overall Study|Lost to Follow-up|1|||
27869161|NCT00171951|81354042|FG000|Overall Study|Adverse Event|1|||
27869162|NCT00171951|81354042|FG000|Overall Study|Abnormal Laboratory Values|2|||
27869163|NCT00171951|81354042|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27869164|NCT00171951|81354042|FG000|Overall Study|Participants Withdrew Consent|3|||
27869165|NCT00171951|81354042|FG000|Overall Study|New Cancer Therapy|5|||
27674572|NCT00913523|80647147|FG002|Overall Study|Adverse Event|0|||
27674573|NCT00913523|80647145|FG000|Overall Study|Protocol Violation|5|||
27984460|NCT01600092|81774104|FG000|Overall Study|Withdrawal by parent/guardian|8|||
27984461|NCT01600092|81774105|FG001|Overall Study|Withdrawal by parent/guardian|6|||
27984462|NCT01600092|81774104|FG000|Overall Study|Physician Decision|1|||
27674574|NCT00913523|80647146|FG001|Overall Study|Protocol Violation|8|||
27674575|NCT00913523|80647147|FG002|Overall Study|Protocol Violation|8|||
27984463|NCT01600092|81774105|FG001|Overall Study|Physician Decision|1|||
27984464|NCT01600092|81774104|FG000|Overall Study|Randomized but not vaccinated|3|||
27984465|NCT01600092|81774105|FG001|Overall Study|Randomized but not vaccinated|3|||
27984466|NCT00847015|81774112|FG000|Overall Study|Withdrawal by Subject|1|||
27984467|NCT00847015|81774112|FG000|Overall Study|declined any surgery|1|||
27674576|NCT00913523|80647145|FG000|Overall Study|Pregnancy|1|||
27674577|NCT00913523|80647146|FG001|Overall Study|Pregnancy|3|||
27984468|NCT00847015|81774112|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
27984469|NCT00025155|81774116|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
27984470|NCT00025155|81774116|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
27984471|NCT02198235|81774117|FG000|Overall Study|Lost to Follow-up|3|||
27984472|NCT02198235|81774118|FG001|Overall Study|Lost to Follow-up|2|||
27984473|NCT02198235|81774119|FG002|Overall Study|Lost to Follow-up|2|||
27984474|NCT03908476|81774120|FG000|Overall Study|Death|3|||
27984475|NCT03908476|81774121|FG001|Overall Study|Death|0|||
27984476|NCT03908476|81774120|FG000|Overall Study|Lost to Follow-up|3|||
27984477|NCT03908476|81774121|FG001|Overall Study|Lost to Follow-up|1|||
27984478|NCT03908476|81774120|FG000|Overall Study|Withdrawal by Subject|7|||
27984479|NCT03908476|81774121|FG001|Overall Study|Withdrawal by Subject|1|||
27984480|NCT03908476|81774120|FG000|Overall Study|Physician Decision|2|||
27984481|NCT03908476|81774121|FG001|Overall Study|Physician Decision|0|||
27984482|NCT03908476|81774120|FG000|Overall Study|System Explanted and not Replaced|4|||
27984483|NCT03908476|81774121|FG001|Overall Study|System Explanted and not Replaced|0|||
27984484|NCT03908476|81774120|FG000|Overall Study|Intrathecal Pump|1|||
27984485|NCT03908476|81774121|FG001|Overall Study|Intrathecal Pump|0|||
27984486|NCT03908476|81774120|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
27984487|NCT03908476|81774121|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
27984488|NCT01270256|81774123|FG000|Overall Study|Withdrawal by Subject|1|||
27984489|NCT01270256|81774124|FG001|Overall Study|Withdrawal by Subject|0|||
27984490|NCT01600053|81774125|FG000|Overall Study|Adverse Event|2|||
27984491|NCT01600053|81774125|FG000|Overall Study|trial will not meet the interim endpoint|9|||
27984492|NCT03848949|81774126|FG000|Overall Study|Lost to Follow-up|5|||
27984493|NCT03848949|81774127|FG001|Overall Study|Lost to Follow-up|7|||
27984494|NCT00895453|81774129|FG000|Overall Study|Lost to Follow-up|25|||
27984495|NCT00895453|81774130|FG001|Overall Study|Lost to Follow-up|25|||
27984496|NCT00895453|81774131|FG002|Overall Study|Lost to Follow-up|23|||
27984497|NCT01927055|81774134|FG000|Open-label|Adverse Event|6|||
27984498|NCT01927055|81774135|FG001|Open-label|Adverse Event|0|||
27984499|NCT01927055|81774136|FG002|Open-label|Adverse Event|0|||
27984500|NCT01927055|81774134|FG000|Open-label|Withdrawal by Subject|1|||
27984501|NCT01927055|81774135|FG001|Open-label|Withdrawal by Subject|0|||
27984502|NCT01927055|81774136|FG002|Open-label|Withdrawal by Subject|0|||
27984503|NCT01927055|81774134|FG000|Open-label|Study Stopped|4|||
27984504|NCT01927055|81774135|FG001|Open-label|Study Stopped|0|||
27984505|NCT01927055|81774136|FG002|Open-label|Study Stopped|0|||
27984506|NCT01927055|81774134|FG000|Open-label|Supine Hypertension|4|||
27984507|NCT01927055|81774135|FG001|Open-label|Supine Hypertension|0|||
27984508|NCT01927055|81774136|FG002|Open-label|Supine Hypertension|0|||
27984509|NCT01927055|81774134|FG000|Open-label|Difficulty attending study visits|1|||
27984510|NCT01927055|81774135|FG001|Open-label|Difficulty attending study visits|0|||
27984511|NCT01927055|81774136|FG002|Open-label|Difficulty attending study visits|0|||
27984512|NCT01927055|81774134|FG000|Double-Blind|Adverse Event|0|||
27984513|NCT01927055|81774135|FG001|Double-Blind|Adverse Event|1|||
27674578|NCT00913523|80647147|FG002|Overall Study|Pregnancy|0|||
27674579|NCT00913523|80647145|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
27984514|NCT01927055|81774136|FG002|Double-Blind|Adverse Event|1|||
27984515|NCT01927055|81774134|FG000|Double-Blind|Protocol Violation|0|||
27984516|NCT01927055|81774135|FG001|Double-Blind|Protocol Violation|0|||
27984517|NCT01927055|81774136|FG002|Double-Blind|Protocol Violation|1|||
27984518|NCT01927055|81774134|FG000|Double-Blind|Withdrawal by Subject|0|||
27984519|NCT01927055|81774135|FG001|Double-Blind|Withdrawal by Subject|2|||
27984520|NCT01927055|81774136|FG002|Double-Blind|Withdrawal by Subject|3|||
27984521|NCT01927055|81774134|FG000|Double-Blind|Study Stopped|0|||
27984522|NCT01927055|81774135|FG001|Double-Blind|Study Stopped|7|||
27984523|NCT01927055|81774136|FG002|Double-Blind|Study Stopped|7|||
27984524|NCT01927055|81774134|FG000|Double-Blind|Supine Hypertension|0|||
27984525|NCT01927055|81774135|FG001|Double-Blind|Supine Hypertension|0|||
27984526|NCT01927055|81774136|FG002|Double-Blind|Supine Hypertension|1|||
27984527|NCT01927055|81774134|FG000|Double-Blind|Extended Vacation|0|||
27984528|NCT01927055|81774135|FG001|Double-Blind|Extended Vacation|1|||
27984529|NCT01927055|81774136|FG002|Double-Blind|Extended Vacation|0|||
27984530|NCT03664765|81774141|FG000|Overall Study|Withdrawal by Subject|4|||
27984531|NCT03664765|81774142|FG001|Overall Study|Withdrawal by Subject|1|||
27984532|NCT03664765|81774141|FG000|Overall Study|Lost to Follow-up|0|||
27984533|NCT03664765|81774142|FG001|Overall Study|Lost to Follow-up|1|||
27984534|NCT01943552|81774143|FG000|Overall Study|Adverse Event|3|||
27984535|NCT01943552|81774144|FG001|Overall Study|Adverse Event|2|||
27984536|NCT01943552|81774143|FG000|Overall Study|Withdrawal by Subject|6|||
27984537|NCT01943552|81774144|FG001|Overall Study|Withdrawal by Subject|6|||
27984538|NCT01943552|81774143|FG000|Overall Study|Other Reasons|16|||
27984539|NCT01943552|81774144|FG001|Overall Study|Other Reasons|17|||
27674580|NCT00913523|80647146|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
27869166|NCT00171951|81354042|FG000|Overall Study|Reason not Specified|2|||
27869167|NCT03284723|81354044|FG000|Overall Study|Death|0|||
27869168|NCT03284723|81354045|FG001|Overall Study|Death|0|||
27984540|NCT01375608|81774145|FG000|Overall Study|Withdrawal by Subject|2|||
27984541|NCT04891107|81774146|FG000|Overall Study|Physician Decision|1|||
27984542|NCT04891107|81774146|FG000|Overall Study|Withdrawal by Subject|1|||
27984543|NCT04891107|81774146|FG000|Overall Study|Screen failure after consent|1|||
27984544|NCT00989781|81774147|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
27984545|NCT00989781|81774148|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
27984546|NCT00958217|81774149|FG000|Overall Study|Death|2|||
27984547|NCT00958217|81774150|FG001|Overall Study|Death|1|||
27984548|NCT00958217|81774149|FG000|Overall Study|Withdrawal by Subject|4|||
27984549|NCT00958217|81774150|FG001|Overall Study|Withdrawal by Subject|3|||
27984550|NCT00958217|81774149|FG000|Overall Study|Lost to Follow-up|17|||
27984551|NCT00958217|81774150|FG001|Overall Study|Lost to Follow-up|19|||
27674581|NCT00913523|80647147|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
27674582|NCT01240915|80647151|FG000|Overall Study|Adverse Event|0|||
27984552|NCT00958217|81774149|FG000|Overall Study|Moved out of area|1|||
27984553|NCT00958217|81774150|FG001|Overall Study|Moved out of area|1|||
27984554|NCT00958217|81774149|FG000|Overall Study|Inpatient hospitalization|0|||
27984555|NCT00958217|81774150|FG001|Overall Study|Inpatient hospitalization|1|||
27984556|NCT01272869|81774154|FG000|Period 2 (14 Days)|Adverse Event|1|||
27984557|NCT01272869|81774155|FG001|Period 2 (14 Days)|Adverse Event|0|||
27984558|NCT01455220|81774159|FG000|Overall Study|screen fail|30|||
27984559|NCT01581619|81774160|FG000|Overall Study|Withdrawal by Subject|1|||
27984560|NCT01581619|81774160|FG000|Overall Study|Lost to Follow-up|1|||
27984561|NCT02262754|81774161|FG000|Overall Study|Adverse Event|3|||
27984562|NCT02262754|81774162|FG001|Overall Study|Adverse Event|4|||
27984563|NCT02262754|81774163|FG002|Overall Study|Adverse Event|0|||
27984564|NCT02262754|81774161|FG000|Overall Study|Lack of Efficacy|2|||
27984565|NCT02262754|81774162|FG001|Overall Study|Lack of Efficacy|0|||
27984566|NCT02262754|81774163|FG002|Overall Study|Lack of Efficacy|1|||
27984567|NCT02262754|81774161|FG000|Overall Study|Lost to Follow-up|0|||
27984568|NCT02262754|81774162|FG001|Overall Study|Lost to Follow-up|0|||
27984569|NCT02262754|81774163|FG002|Overall Study|Lost to Follow-up|1|||
27984570|NCT02262754|81774161|FG000|Overall Study|No longer meets eligibility criteria|0|||
27869169|NCT03284723|81354046|FG002|Overall Study|Death|0|||
27869170|NCT03284723|81354047|FG003|Overall Study|Death|1|||
27869171|NCT03284723|81354048|FG004|Overall Study|Death|0|||
27869172|NCT03284723|81354049|FG005|Overall Study|Death|0|||
27869173|NCT03284723|81354050|FG006|Overall Study|Death|1|||
27869174|NCT03284723|81354051|FG007|Overall Study|Death|0|||
27869175|NCT03284723|81354052|FG008|Overall Study|Death|0|||
27869176|NCT03284723|81354053|FG009|Overall Study|Death|2|||
27869177|NCT03284723|81354054|FG010|Overall Study|Death|1|||
27984571|NCT02262754|81774162|FG001|Overall Study|No longer meets eligibility criteria|1|||
27984572|NCT02262754|81774163|FG002|Overall Study|No longer meets eligibility criteria|0|||
27984573|NCT02262754|81774161|FG000|Overall Study|Study terminated by sponsor|5|||
27869178|NCT03284723|81354055|FG011|Overall Study|Death|0|||
27869179|NCT03284723|81354044|FG000|Overall Study|Lost to Follow-up|0|||
27869180|NCT03284723|81354045|FG001|Overall Study|Lost to Follow-up|0|||
27984574|NCT02262754|81774162|FG001|Overall Study|Study terminated by sponsor|4|||
27984575|NCT02262754|81774163|FG002|Overall Study|Study terminated by sponsor|4|||
27984576|NCT02262754|81774161|FG000|Overall Study|Protocol Violation|1|||
27984577|NCT02262754|81774162|FG001|Overall Study|Protocol Violation|0|||
27984578|NCT02262754|81774163|FG002|Overall Study|Protocol Violation|0|||
27984579|NCT02262754|81774161|FG000|Overall Study|Withdrawal by Subject|1|||
27984580|NCT02262754|81774162|FG001|Overall Study|Withdrawal by Subject|0|||
27984581|NCT02262754|81774163|FG002|Overall Study|Withdrawal by Subject|1|||
27984582|NCT02262754|81774161|FG000|Overall Study|Other|4|||
27984583|NCT02262754|81774162|FG001|Overall Study|Other|0|||
27984584|NCT02262754|81774163|FG002|Overall Study|Other|2|||
27869181|NCT03284723|81354046|FG002|Overall Study|Lost to Follow-up|0|||
27869182|NCT03284723|81354047|FG003|Overall Study|Lost to Follow-up|0|||
27869183|NCT03284723|81354048|FG004|Overall Study|Lost to Follow-up|0|||
27869184|NCT03284723|81354049|FG005|Overall Study|Lost to Follow-up|2|||
27869185|NCT03284723|81354050|FG006|Overall Study|Lost to Follow-up|1|||
27869186|NCT03284723|81354051|FG007|Overall Study|Lost to Follow-up|0|||
27869187|NCT03284723|81354052|FG008|Overall Study|Lost to Follow-up|0|||
27869188|NCT03284723|81354053|FG009|Overall Study|Lost to Follow-up|2|||
27869189|NCT03284723|81354054|FG010|Overall Study|Lost to Follow-up|0|||
27869190|NCT03284723|81354055|FG011|Overall Study|Lost to Follow-up|0|||
27869191|NCT03284723|81354044|FG000|Overall Study|Study Terminated By Sponsor|0|||
27869192|NCT03284723|81354045|FG001|Overall Study|Study Terminated By Sponsor|0|||
27869193|NCT03284723|81354046|FG002|Overall Study|Study Terminated By Sponsor|0|||
27869194|NCT03284723|81354047|FG003|Overall Study|Study Terminated By Sponsor|0|||
27869195|NCT03284723|81354048|FG004|Overall Study|Study Terminated By Sponsor|1|||
27869196|NCT03284723|81354049|FG005|Overall Study|Study Terminated By Sponsor|0|||
27869197|NCT03284723|81354050|FG006|Overall Study|Study Terminated By Sponsor|0|||
27869198|NCT03284723|81354051|FG007|Overall Study|Study Terminated By Sponsor|0|||
27869199|NCT03284723|81354052|FG008|Overall Study|Study Terminated By Sponsor|1|||
27869200|NCT03284723|81354053|FG009|Overall Study|Study Terminated By Sponsor|1|||
27869201|NCT03284723|81354054|FG010|Overall Study|Study Terminated By Sponsor|1|||
27869202|NCT03284723|81354055|FG011|Overall Study|Study Terminated By Sponsor|1|||
27869203|NCT03284723|81354044|FG000|Overall Study|Withdrawal by Subject|0|||
27869204|NCT03284723|81354045|FG001|Overall Study|Withdrawal by Subject|0|||
27869205|NCT03284723|81354046|FG002|Overall Study|Withdrawal by Subject|0|||
27984585|NCT00566254|81774164|FG000|Overall Study|Adverse Event|3|||
27984586|NCT00566254|81774165|FG001|Overall Study|Adverse Event|1|||
27984587|NCT00566254|81774164|FG000|Overall Study|Protocol Violation|1|||
27984588|NCT00566254|81774165|FG001|Overall Study|Protocol Violation|3|||
27984589|NCT00566254|81774164|FG000|Overall Study|Withdrawal by Subject|1|||
27984590|NCT00566254|81774165|FG001|Overall Study|Withdrawal by Subject|2|||
27984591|NCT00566254|81774164|FG000|Overall Study|Lack of Efficacy|5|||
27984592|NCT00566254|81774165|FG001|Overall Study|Lack of Efficacy|6|||
27984593|NCT00566254|81774164|FG000|Overall Study|Other|0|||
27984594|NCT00566254|81774165|FG001|Overall Study|Other|2|||
27984595|NCT02271945|81774166|FG000|Overall Study|Death|3|||
27984596|NCT02271945|81774167|FG001|Overall Study|Death|3|||
27984597|NCT02271945|81774166|FG000|Overall Study|Withdrawal by Subject|1|||
27984598|NCT02271945|81774167|FG001|Overall Study|Withdrawal by Subject|1|||
27869206|NCT03284723|81354047|FG003|Overall Study|Withdrawal by Subject|0|||
27984599|NCT02271945|81774166|FG000|Overall Study|Other|1|||
27674583|NCT01240915|80647152|FG001|Overall Study|Adverse Event|0|||
27674584|NCT01240915|80647153|FG002|Overall Study|Adverse Event|0|||
27674585|NCT01240915|80647154|FG003|Overall Study|Adverse Event|1|||
27674586|NCT01240915|80647155|FG004|Overall Study|Adverse Event|0|||
27674587|NCT01240915|80647156|FG005|Overall Study|Adverse Event|2|||
27674588|NCT01240915|80647157|FG006|Overall Study|Adverse Event|0|||
27674589|NCT01240915|80647158|FG007|Overall Study|Adverse Event|0|||
27674590|NCT01240915|80647159|FG008|Overall Study|Adverse Event|1|||
27674591|NCT01240915|80647151|FG000|Overall Study|Lost to Follow-up|0|||
27674592|NCT01240915|80647152|FG001|Overall Study|Lost to Follow-up|0|||
27674593|NCT01240915|80647153|FG002|Overall Study|Lost to Follow-up|0|||
27674594|NCT01240915|80647154|FG003|Overall Study|Lost to Follow-up|0|||
27674595|NCT01240915|80647155|FG004|Overall Study|Lost to Follow-up|1|||
27674596|NCT01240915|80647156|FG005|Overall Study|Lost to Follow-up|1|||
27674597|NCT01240915|80647157|FG006|Overall Study|Lost to Follow-up|0|||
27674598|NCT01240915|80647158|FG007|Overall Study|Lost to Follow-up|1|||
27674599|NCT01240915|80647159|FG008|Overall Study|Lost to Follow-up|1|||
27674600|NCT01240915|80647151|FG000|Overall Study|Withdrawal by Subject|2|||
27674601|NCT01240915|80647152|FG001|Overall Study|Withdrawal by Subject|1|||
27674602|NCT01240915|80647153|FG002|Overall Study|Withdrawal by Subject|0|||
27674603|NCT01240915|80647154|FG003|Overall Study|Withdrawal by Subject|2|||
27674604|NCT01240915|80647155|FG004|Overall Study|Withdrawal by Subject|0|||
27984600|NCT02271945|81774167|FG001|Overall Study|Other|1|||
27984601|NCT00778895|81774171|FG000|Active Phase|Adverse Event|3|||
27984602|NCT00778895|81774172|FG001|Active Phase|Adverse Event|1|||
27674605|NCT01240915|80647156|FG005|Overall Study|Withdrawal by Subject|4|||
27984603|NCT00778895|81774173|FG002|Active Phase|Adverse Event|0|||
27674606|NCT01240915|80647157|FG006|Overall Study|Withdrawal by Subject|2|||
27674607|NCT01240915|80647158|FG007|Overall Study|Withdrawal by Subject|3|||
27674608|NCT01240915|80647159|FG008|Overall Study|Withdrawal by Subject|3|||
27674609|NCT01240915|80647151|FG000|Overall Study|Other|0|||
27795220|NCT00916617|81082034|FG002|Overall Study|Physician Decision|0|||
27795221|NCT00916617|81082035|FG003|Overall Study|Physician Decision|0|||
27795222|NCT00916617|81082032|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
27795223|NCT00916617|81082033|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
27795224|NCT00916617|81082034|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
27795225|NCT00916617|81082035|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
27795226|NCT00916617|81082032|FG000|Overall Study|Lost to Follow-up|2|||
27795227|NCT00916617|81082033|FG001|Overall Study|Lost to Follow-up|1|||
27984604|NCT00778895|81774171|FG000|Active Phase|Withdrawal by Subject|1|||
27984605|NCT00778895|81774172|FG001|Active Phase|Withdrawal by Subject|4|||
27984606|NCT00778895|81774173|FG002|Active Phase|Withdrawal by Subject|0|||
27984607|NCT00778895|81774171|FG000|Active Phase|Lost to Follow-up|1|||
27984608|NCT00778895|81774172|FG001|Active Phase|Lost to Follow-up|1|||
27984609|NCT00778895|81774173|FG002|Active Phase|Lost to Follow-up|0|||
27984610|NCT00778895|81774171|FG000|Active Phase|Other|2|||
27984611|NCT00778895|81774172|FG001|Active Phase|Other|0|||
27984612|NCT00778895|81774173|FG002|Active Phase|Other|0|||
27984613|NCT00778895|81774171|FG000|ESFU Phase|Adverse Event|2|||
27984614|NCT00778895|81774172|FG001|ESFU Phase|Adverse Event|1|||
27984615|NCT00778895|81774173|FG002|ESFU Phase|Adverse Event|0|||
27984616|NCT00778895|81774171|FG000|ESFU Phase|Withdrawal by Subject|1|||
27984617|NCT00778895|81774172|FG001|ESFU Phase|Withdrawal by Subject|4|||
27984618|NCT00778895|81774173|FG002|ESFU Phase|Withdrawal by Subject|0|||
27984619|NCT00778895|81774171|FG000|ESFU Phase|Lost to Follow-up|6|||
27984620|NCT00778895|81774172|FG001|ESFU Phase|Lost to Follow-up|7|||
27984621|NCT00778895|81774173|FG002|ESFU Phase|Lost to Follow-up|2|||
27984622|NCT00778895|81774171|FG000|ESFU Phase|Other|2|||
27984623|NCT00778895|81774172|FG001|ESFU Phase|Other|0|||
27984624|NCT00778895|81774173|FG002|ESFU Phase|Other|0|||
27984625|NCT02265796|81774174|FG000|Overall Study|Death|1|||
27984626|NCT02265796|81774175|FG001|Overall Study|Death|0|||
27984627|NCT02265796|81774174|FG000|Overall Study|started on excluded medication|1|||
27984628|NCT02265796|81774175|FG001|Overall Study|started on excluded medication|0|||
27984629|NCT02265796|81774174|FG000|Overall Study|Withdrawal by Subject|1|||
27984630|NCT02265796|81774175|FG001|Overall Study|Withdrawal by Subject|1|||
27984631|NCT00462748|81774178|FG000|Overall Study|Adverse Event|7|||
27984632|NCT00462748|81774179|FG001|Overall Study|Adverse Event|5|||
27984633|NCT00462748|81774180|FG002|Overall Study|Adverse Event|9|||
27984634|NCT00462748|81774178|FG000|Overall Study|Protocol Violation|0|||
27984635|NCT00462748|81774179|FG001|Overall Study|Protocol Violation|2|||
27984636|NCT00462748|81774180|FG002|Overall Study|Protocol Violation|1|||
27984637|NCT00462748|81774178|FG000|Overall Study|Withdrew consent|3|||
27984638|NCT00462748|81774179|FG001|Overall Study|Withdrew consent|3|||
27984639|NCT00462748|81774180|FG002|Overall Study|Withdrew consent|0|||
27984640|NCT00462748|81774178|FG000|Overall Study|Lost to Follow-up|1|||
27984641|NCT00462748|81774179|FG001|Overall Study|Lost to Follow-up|1|||
27984642|NCT00462748|81774180|FG002|Overall Study|Lost to Follow-up|1|||
27984643|NCT00462748|81774178|FG000|Overall Study|Discontinued after 41 days Rx|1|||
27984644|NCT00462748|81774179|FG001|Overall Study|Discontinued after 41 days Rx|0|||
27984645|NCT00462748|81774180|FG002|Overall Study|Discontinued after 41 days Rx|0|||
27984646|NCT01030874|81774185|FG000|Overall Study|Withdrawal by Subject|1|||
27984647|NCT01030874|81774186|FG001|Overall Study|Withdrawal by Subject|0|||
27984648|NCT01030874|81774185|FG000|Overall Study|Discharged in first 2 weeks|17|||
27984649|NCT01030874|81774186|FG001|Overall Study|Discharged in first 2 weeks|16|||
27984650|NCT00952614|81777048|FG000|Overall Study|Death|3|||
27984651|NCT00952614|81777048|FG000|Overall Study|Lost to Follow-up|3|||
27984652|NCT00952614|81777048|FG000|Overall Study|other reason|1|||
27984653|NCT02477553|81777049|FG000|Overall Study|Screening up-to-date|12|||
27984654|NCT02477553|81777050|FG001|Overall Study|Screening up-to-date|13|||
27984655|NCT02477553|81777049|FG000|Overall Study|No MD visit|1|||
27984656|NCT02477553|81777050|FG001|Overall Study|No MD visit|1|||
27984657|NCT02477553|81777049|FG000|Overall Study|Workup consistent w/CRC|1|||
27984658|NCT02477553|81777050|FG001|Overall Study|Workup consistent w/CRC|1|||
27984659|NCT02477553|81777049|FG000|Overall Study|Technical issues with intervention|2|||
27984660|NCT02477553|81777050|FG001|Overall Study|Technical issues with intervention|0|||
27984661|NCT02477553|81777049|FG000|Overall Study|Elevated risk for CRC|2|||
27984662|NCT02477553|81777050|FG001|Overall Study|Elevated risk for CRC|2|||
27984663|NCT02477553|81777049|FG000|Overall Study|MD advised against screening|1|||
27984664|NCT02477553|81777050|FG001|Overall Study|MD advised against screening|3|||
27984665|NCT02477553|81777049|FG000|Overall Study|patient deceased|1|||
27984666|NCT02477553|81777050|FG001|Overall Study|patient deceased|0|||
27984667|NCT00483041|81777051|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
27984668|NCT00483041|81777052|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
27984669|NCT01455194|81777059|FG000|Overall Study|Screen Failure|20|||
27984670|NCT01455194|81777060|FG001|Overall Study|Screen Failure|0|||
27869207|NCT03284723|81354048|FG004|Overall Study|Withdrawal by Subject|5|||
27869208|NCT03284723|81354049|FG005|Overall Study|Withdrawal by Subject|3|||
27869209|NCT03284723|81354050|FG006|Overall Study|Withdrawal by Subject|1|||
27869210|NCT03284723|81354051|FG007|Overall Study|Withdrawal by Subject|0|||
27869211|NCT03284723|81354052|FG008|Overall Study|Withdrawal by Subject|6|||
27869212|NCT03284723|81354053|FG009|Overall Study|Withdrawal by Subject|0|||
27869213|NCT03284723|81354054|FG010|Overall Study|Withdrawal by Subject|3|||
27869214|NCT03284723|81354055|FG011|Overall Study|Withdrawal by Subject|1|||
27869215|NCT03284723|81354044|FG000|Overall Study|Other|1|||
27869216|NCT03284723|81354045|FG001|Overall Study|Other|0|||
27869217|NCT03284723|81354046|FG002|Overall Study|Other|1|||
27869218|NCT03284723|81354047|FG003|Overall Study|Other|0|||
27869219|NCT03284723|81354048|FG004|Overall Study|Other|1|||
27869220|NCT03284723|81354049|FG005|Overall Study|Other|0|||
27869221|NCT03284723|81354050|FG006|Overall Study|Other|0|||
27869222|NCT03284723|81354051|FG007|Overall Study|Other|0|||
27869223|NCT03284723|81354052|FG008|Overall Study|Other|0|||
27869224|NCT03284723|81354053|FG009|Overall Study|Other|0|||
27869225|NCT03284723|81354054|FG010|Overall Study|Other|1|||
27869226|NCT03284723|81354055|FG011|Overall Study|Other|0|||
27869227|NCT03284723|81354044|FG000|Overall Study|Adverse Event|0|||
27869228|NCT03284723|81354045|FG001|Overall Study|Adverse Event|0|||
27984671|NCT01455194|81777061|FG002|Overall Study|Screen Failure|0|||
27984672|NCT01455194|81777062|FG003|Overall Study|Screen Failure|0|||
27984673|NCT01455194|81777059|FG000|Overall Study|Randomisation Failure|90|||
27984674|NCT01455194|81777060|FG001|Overall Study|Randomisation Failure|0|||
27984675|NCT01455194|81777061|FG002|Overall Study|Randomisation Failure|0|||
27984676|NCT01455194|81777062|FG003|Overall Study|Randomisation Failure|0|||
27984677|NCT01455194|81777059|FG000|Overall Study|Deterioration in asthma|12|||
27984678|NCT01455194|81777060|FG001|Overall Study|Deterioration in asthma|6|||
27984679|NCT01455194|81777061|FG002|Overall Study|Deterioration in asthma|14|||
27869229|NCT03284723|81354046|FG002|Overall Study|Adverse Event|0|||
27869230|NCT03284723|81354047|FG003|Overall Study|Adverse Event|0|||
27869231|NCT03284723|81354048|FG004|Overall Study|Adverse Event|0|||
27869232|NCT03284723|81354049|FG005|Overall Study|Adverse Event|0|||
27869233|NCT03284723|81354050|FG006|Overall Study|Adverse Event|0|||
27984680|NCT01455194|81777062|FG003|Overall Study|Deterioration in asthma|9|||
27984681|NCT01455194|81777059|FG000|Overall Study|Adverse Event|1|||
27984682|NCT01455194|81777060|FG001|Overall Study|Adverse Event|1|||
27984683|NCT01455194|81777061|FG002|Overall Study|Adverse Event|1|||
27984684|NCT01455194|81777062|FG003|Overall Study|Adverse Event|3|||
27869234|NCT03284723|81354051|FG007|Overall Study|Adverse Event|0|||
27869235|NCT03284723|81354052|FG008|Overall Study|Adverse Event|1|||
27984685|NCT01455194|81777059|FG000|Overall Study|Withdrawal by Subject|21|||
27984686|NCT01455194|81777060|FG001|Overall Study|Withdrawal by Subject|16|||
27984687|NCT01455194|81777061|FG002|Overall Study|Withdrawal by Subject|12|||
27984688|NCT01455194|81777062|FG003|Overall Study|Withdrawal by Subject|9|||
27984689|NCT01455194|81777059|FG000|Overall Study|Lost to Follow-up|2|||
27984690|NCT01455194|81777060|FG001|Overall Study|Lost to Follow-up|0|||
27984691|NCT01455194|81777061|FG002|Overall Study|Lost to Follow-up|1|||
27984692|NCT01455194|81777062|FG003|Overall Study|Lost to Follow-up|1|||
27984693|NCT01455194|81777059|FG000|Overall Study|Pregnancy|0|||
27984694|NCT01455194|81777060|FG001|Overall Study|Pregnancy|1|||
27984695|NCT01455194|81777061|FG002|Overall Study|Pregnancy|1|||
27984696|NCT01455194|81777062|FG003|Overall Study|Pregnancy|0|||
27869236|NCT03284723|81354053|FG009|Overall Study|Adverse Event|0|||
27869237|NCT03284723|81354054|FG010|Overall Study|Adverse Event|0|||
27984697|NCT01455194|81777059|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
27984698|NCT01455194|81777060|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
27984699|NCT01455194|81777061|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
27984700|NCT01455194|81777062|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
27984701|NCT01455194|81777059|FG000|Overall Study|Miscellaneous|4|||
27984702|NCT01455194|81777060|FG001|Overall Study|Miscellaneous|5|||
27984703|NCT01455194|81777061|FG002|Overall Study|Miscellaneous|1|||
27984704|NCT01455194|81777062|FG003|Overall Study|Miscellaneous|4|||
27984705|NCT01814670|81777065|FG000|Overall Study|Protocol Violation|12|||
27984706|NCT02211313|81777070|FG000|Overall Study|Treatment Failure|5|||
27984707|NCT02211313|81777071|FG001|Overall Study|Treatment Failure|2|||
27984708|NCT02211313|81777070|FG000|Overall Study|No Follow up Questionnaires|1|||
27984709|NCT02211313|81777071|FG001|Overall Study|No Follow up Questionnaires|1|||
27869238|NCT03284723|81354055|FG011|Overall Study|Adverse Event|0|||
27869239|NCT01659125|81357635|FG000|Overall Study|Withdrawal by Subject|2|||
27869240|NCT01659125|81357635|FG000|Overall Study|Lost to Follow-up|7|||
27869241|NCT01659125|81357635|FG000|Overall Study|Technical Problem|1|||
27869242|NCT01659125|81357635|FG000|Overall Study|Time Constraints|2|||
27869243|NCT01659125|81357635|FG000|Overall Study|Failed to Start Treatment|2|||
27869244|NCT00356525|81357641|FG000|Overall Study|Progressive Disease|8|||
27869245|NCT00356525|81357642|FG001|Overall Study|Progressive Disease|5|||
27869246|NCT00356525|81357643|FG002|Overall Study|Progressive Disease|4|||
27869247|NCT00356525|81357644|FG003|Overall Study|Progressive Disease|2|||
27869248|NCT00356525|81357641|FG000|Overall Study|Adverse Event|1|||
27869249|NCT00356525|81357642|FG001|Overall Study|Adverse Event|3|||
27869250|NCT00356525|81357643|FG002|Overall Study|Adverse Event|1|||
27869251|NCT00356525|81357644|FG003|Overall Study|Adverse Event|1|||
27869252|NCT00356525|81357641|FG000|Overall Study|Lost to Follow-up|1|||
27869253|NCT00356525|81357642|FG001|Overall Study|Lost to Follow-up|0|||
27869254|NCT00356525|81357643|FG002|Overall Study|Lost to Follow-up|0|||
27869255|NCT00356525|81357644|FG003|Overall Study|Lost to Follow-up|0|||
27869256|NCT00356525|81357641|FG000|Overall Study|Physician Decision|2|||
27869257|NCT00356525|81357642|FG001|Overall Study|Physician Decision|2|||
27869258|NCT00356525|81357643|FG002|Overall Study|Physician Decision|2|||
27869259|NCT00356525|81357644|FG003|Overall Study|Physician Decision|1|||
27869260|NCT00356525|81357641|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
27869261|NCT00356525|81357642|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
27869262|NCT00356525|81357643|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
27869263|NCT00356525|81357644|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
27869264|NCT00356525|81357641|FG000|Overall Study|Withdrawal by Subject|1|||
27984710|NCT02951429|81777073|FG000|Overall Study|Adverse Event|3|||
27984711|NCT02951429|81777074|FG001|Overall Study|Adverse Event|7|||
27984712|NCT02951429|81777073|FG000|Overall Study|Death|28|||
27984713|NCT02951429|81777074|FG001|Overall Study|Death|36|||
27869265|NCT00356525|81357642|FG001|Overall Study|Withdrawal by Subject|1|||
27984714|NCT02951429|81777073|FG000|Overall Study|Lack of Efficacy|0|||
27984715|NCT02951429|81777074|FG001|Overall Study|Lack of Efficacy|1|||
27984716|NCT02951429|81777073|FG000|Overall Study|Lost to Follow-up|0|||
27984717|NCT02951429|81777074|FG001|Overall Study|Lost to Follow-up|1|||
27984718|NCT02951429|81777073|FG000|Overall Study|Lung Transplantation|9|||
27984719|NCT02951429|81777074|FG001|Overall Study|Lung Transplantation|6|||
27869266|NCT00356525|81357643|FG002|Overall Study|Withdrawal by Subject|0|||
27869267|NCT00356525|81357644|FG003|Overall Study|Withdrawal by Subject|3|||
27869268|NCT00356525|81357641|FG000|Overall Study|Death|0|||
27869269|NCT00356525|81357642|FG001|Overall Study|Death|0|||
27869270|NCT00356525|81357643|FG002|Overall Study|Death|0|||
27869271|NCT00356525|81357644|FG003|Overall Study|Death|1|||
27869272|NCT00356525|81357641|FG000|Overall Study|Sponsor Decision|0|||
27984720|NCT02951429|81777073|FG000|Overall Study|Other|1|||
27984721|NCT02951429|81777074|FG001|Overall Study|Other|3|||
27984722|NCT02951429|81777073|FG000|Overall Study|Progressive Disease|1|||
27984723|NCT02951429|81777074|FG001|Overall Study|Progressive Disease|1|||
27984724|NCT02951429|81777073|FG000|Overall Study|Withdrawal by Subject|7|||
27984725|NCT02951429|81777074|FG001|Overall Study|Withdrawal by Subject|11|||
27984726|NCT02951429|81777073|FG000|Overall Study|Participant ongoing in the study|23|||
27984727|NCT02951429|81777074|FG001|Overall Study|Participant ongoing in the study|17|||
27984728|NCT01704456|81777075|FG000|Overall Study|Lost to Follow-up|8|||
27984729|NCT01704456|81777076|FG001|Overall Study|Lost to Follow-up|14|||
27984730|NCT01753401|81777077|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
27984731|NCT01753401|81777078|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
27984732|NCT01753401|81777079|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
27984733|NCT01753401|81777080|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
27984734|NCT01753401|81777077|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
27984735|NCT01753401|81777078|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
27984736|NCT01753401|81777079|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
27674610|NCT01240915|80647152|FG001|Overall Study|Other|0|||
27674611|NCT01240915|80647153|FG002|Overall Study|Other|0|||
27674612|NCT01240915|80647154|FG003|Overall Study|Other|0|||
27674613|NCT01240915|80647155|FG004|Overall Study|Other|2|||
27674614|NCT01240915|80647156|FG005|Overall Study|Other|0|||
27674615|NCT01240915|80647157|FG006|Overall Study|Other|0|||
27674616|NCT01240915|80647158|FG007|Overall Study|Other|0|||
27674617|NCT01240915|80647159|FG008|Overall Study|Other|0|||
27674618|NCT01240915|80647151|FG000|Overall Study|Insufficient Clinical Response|0|||
27674619|NCT01240915|80647152|FG001|Overall Study|Insufficient Clinical Response|0|||
27674620|NCT01240915|80647153|FG002|Overall Study|Insufficient Clinical Response|0|||
27674621|NCT01240915|80647154|FG003|Overall Study|Insufficient Clinical Response|0|||
27674622|NCT01240915|80647155|FG004|Overall Study|Insufficient Clinical Response|1|||
27674623|NCT01240915|80647156|FG005|Overall Study|Insufficient Clinical Response|3|||
27674624|NCT01240915|80647157|FG006|Overall Study|Insufficient Clinical Response|6|||
27984737|NCT01753401|81777080|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
27984738|NCT01753401|81777077|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
27984739|NCT01753401|81777078|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
27984740|NCT01753401|81777079|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
27984741|NCT01753401|81777080|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
27984742|NCT01753401|81777077|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
27984743|NCT01753401|81777078|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
27984744|NCT01753401|81777079|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
27984745|NCT01753401|81777080|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
27984746|NCT01753401|81777077|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
27984747|NCT01753401|81777078|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
27984748|NCT01753401|81777079|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
27984749|NCT01753401|81777080|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
27674625|NCT01240915|80647158|FG007|Overall Study|Insufficient Clinical Response|0|||
27795228|NCT00916617|81082034|FG002|Overall Study|Lost to Follow-up|0|||
27795229|NCT00916617|81082035|FG003|Overall Study|Lost to Follow-up|0|||
27795230|NCT00916617|81082032|FG000|Overall Study|Lack of Efficacy|1|||
27795231|NCT00916617|81082033|FG001|Overall Study|Lack of Efficacy|0|||
27795232|NCT00916617|81082034|FG002|Overall Study|Lack of Efficacy|0|||
27795233|NCT00916617|81082035|FG003|Overall Study|Lack of Efficacy|0|||
27795234|NCT00916617|81082032|FG000|Overall Study|Other|2|||
27795235|NCT00916617|81082033|FG001|Overall Study|Other|0|||
27795236|NCT00916617|81082034|FG002|Overall Study|Other|0|||
27795237|NCT00916617|81082035|FG003|Overall Study|Other|2|||
27795238|NCT04936334|81082036|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
27795239|NCT00890409|81082037|FG000|Overall Study|Lost to Follow-up|20|||
27795240|NCT00890409|81082038|FG001|Overall Study|Lost to Follow-up|21|||
27795241|NCT02867592|81082039|FG000|Overall Study|Adverse Event|3|||
27795242|NCT02867592|81082040|FG001|Overall Study|Adverse Event|0|||
27795243|NCT02867592|81082041|FG002|Overall Study|Adverse Event|2|||
27795244|NCT02867592|81082042|FG003|Overall Study|Adverse Event|1|||
27795245|NCT02867592|81082043|FG004|Overall Study|Adverse Event|1|||
27795246|NCT02867592|81082044|FG005|Overall Study|Adverse Event|5|||
27795247|NCT02867592|81082039|FG000|Overall Study|Death|0|||
27795248|NCT02867592|81082040|FG001|Overall Study|Death|0|||
27795249|NCT02867592|81082041|FG002|Overall Study|Death|0|||
27674626|NCT01240915|80647159|FG008|Overall Study|Insufficient Clinical Response|3|||
27795250|NCT02867592|81082042|FG003|Overall Study|Death|1|||
27795251|NCT02867592|81082043|FG004|Overall Study|Death|0|||
27795252|NCT02867592|81082044|FG005|Overall Study|Death|1|||
27984750|NCT01753401|81777077|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
27674627|NCT01256671|80647160|FG000|Overall Study|Adverse Event|29|||
27984751|NCT01753401|81777078|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
27984752|NCT01753401|81777079|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
27984753|NCT01753401|81777080|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
27984754|NCT01753401|81777077|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
27984755|NCT01753401|81777078|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
27984756|NCT01753401|81777079|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
27984757|NCT01753401|81777080|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
27984758|NCT00752726|81777081|FG000|Overall Study|Lost to Follow-up|2|||
27869273|NCT00356525|81357642|FG001|Overall Study|Sponsor Decision|0|||
27869274|NCT00356525|81357643|FG002|Overall Study|Sponsor Decision|0|||
27674628|NCT01256671|80647160|FG000|Overall Study|Lost to Follow-up|16|||
27674629|NCT01256671|80647160|FG000|Overall Study|Withdrawal by Subject|31|||
27674630|NCT01256671|80647160|FG000|Overall Study|Physician Decision|3|||
27674631|NCT01256671|80647160|FG000|Overall Study|Lack of Efficacy|4|||
27674632|NCT01256671|80647160|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
27674633|NCT01163474|80647161|FG000|Overall Study|Withdrawal by Subject|1|||
27674634|NCT01163474|80647161|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
27674635|NCT01163474|80647161|FG000|Overall Study|Lost to Follow-up|3|||
27674636|NCT00263211|80647162|FG000|Overall Study|Death|1|||
27674637|NCT00263211|80647163|FG001|Overall Study|Death|0|||
27795253|NCT02867592|81082039|FG000|Overall Study|Lack of Efficacy|8|||
27795254|NCT02867592|81082040|FG001|Overall Study|Lack of Efficacy|10|||
27674638|NCT00263211|80647162|FG000|Overall Study|Withdrawal by Subject|3|||
27869275|NCT00356525|81357644|FG003|Overall Study|Sponsor Decision|1|||
27795255|NCT02867592|81082041|FG002|Overall Study|Lack of Efficacy|8|||
27795256|NCT02867592|81082042|FG003|Overall Study|Lack of Efficacy|8|||
27795257|NCT02867592|81082043|FG004|Overall Study|Lack of Efficacy|12|||
27869276|NCT01056289|81357647|FG000|Open-label Phase|Adverse Event|29|||
27869277|NCT01056289|81357648|FG001|Open-label Phase|Adverse Event|0|||
27869278|NCT01056289|81357649|FG002|Open-label Phase|Adverse Event|0|||
27869279|NCT01056289|81357650|FG003|Open-label Phase|Adverse Event|0|||
27869280|NCT01056289|81357647|FG000|Open-label Phase|Lost to Follow-up|30|||
27869281|NCT01056289|81357648|FG001|Open-label Phase|Lost to Follow-up|0|||
27869282|NCT01056289|81357649|FG002|Open-label Phase|Lost to Follow-up|0|||
27869283|NCT01056289|81357650|FG003|Open-label Phase|Lost to Follow-up|0|||
27869284|NCT01056289|81357647|FG000|Open-label Phase|Other|9|||
27869285|NCT01056289|81357648|FG001|Open-label Phase|Other|0|||
27869286|NCT01056289|81357649|FG002|Open-label Phase|Other|0|||
27869287|NCT01056289|81357650|FG003|Open-label Phase|Other|0|||
27869288|NCT01056289|81357647|FG000|Open-label Phase|Protocol Violation|6|||
27869289|NCT01056289|81357648|FG001|Open-label Phase|Protocol Violation|0|||
27869290|NCT01056289|81357649|FG002|Open-label Phase|Protocol Violation|0|||
27869291|NCT01056289|81357650|FG003|Open-label Phase|Protocol Violation|0|||
27869292|NCT01056289|81357647|FG000|Open-label Phase|Withdrawal by Subject|26|||
27869293|NCT01056289|81357648|FG001|Open-label Phase|Withdrawal by Subject|0|||
27869294|NCT01056289|81357649|FG002|Open-label Phase|Withdrawal by Subject|0|||
27984759|NCT00752726|81777082|FG001|Overall Study|Lost to Follow-up|1|||
27795258|NCT02867592|81082044|FG005|Overall Study|Lack of Efficacy|17|||
27795259|NCT02867592|81082039|FG000|Overall Study|Physician Decision|1|||
27795260|NCT02867592|81082040|FG001|Overall Study|Physician Decision|2|||
27795261|NCT02867592|81082041|FG002|Overall Study|Physician Decision|2|||
27795262|NCT02867592|81082042|FG003|Overall Study|Physician Decision|0|||
27795263|NCT02867592|81082043|FG004|Overall Study|Physician Decision|5|||
27795264|NCT02867592|81082044|FG005|Overall Study|Physician Decision|1|||
27795265|NCT02867592|81082039|FG000|Overall Study|Protocol Violation|0|||
27795266|NCT02867592|81082040|FG001|Overall Study|Protocol Violation|0|||
27795267|NCT02867592|81082041|FG002|Overall Study|Protocol Violation|0|||
27795268|NCT02867592|81082042|FG003|Overall Study|Protocol Violation|0|||
27795269|NCT02867592|81082043|FG004|Overall Study|Protocol Violation|1|||
27795270|NCT02867592|81082044|FG005|Overall Study|Protocol Violation|1|||
27795271|NCT02867592|81082039|FG000|Overall Study|Withdrawal by Subject|0|||
27795272|NCT02867592|81082040|FG001|Overall Study|Withdrawal by Subject|1|||
27795273|NCT02867592|81082041|FG002|Overall Study|Withdrawal by Subject|0|||
27795274|NCT02867592|81082042|FG003|Overall Study|Withdrawal by Subject|1|||
27795275|NCT02867592|81082043|FG004|Overall Study|Withdrawal by Subject|3|||
27795276|NCT02867592|81082044|FG005|Overall Study|Withdrawal by Subject|3|||
27795277|NCT02867592|81082039|FG000|Overall Study|Ineligible|1|||
27795278|NCT02867592|81082040|FG001|Overall Study|Ineligible|1|||
27795279|NCT02867592|81082041|FG002|Overall Study|Ineligible|0|||
27674639|NCT00263211|80647163|FG001|Overall Study|Withdrawal by Subject|0|||
27795280|NCT02867592|81082042|FG003|Overall Study|Ineligible|0|||
27795281|NCT02867592|81082043|FG004|Overall Study|Ineligible|2|||
27795282|NCT02867592|81082044|FG005|Overall Study|Ineligible|0|||
27984760|NCT00752726|81777081|FG000|Overall Study|Adverse Event|3|||
27869295|NCT01056289|81357650|FG003|Open-label Phase|Withdrawal by Subject|0|||
27869296|NCT01056289|81357647|FG000|Open-label Phase|Lack of Efficacy|18|||
27869297|NCT01056289|81357648|FG001|Open-label Phase|Lack of Efficacy|0|||
27869298|NCT01056289|81357649|FG002|Open-label Phase|Lack of Efficacy|0|||
27869299|NCT01056289|81357650|FG003|Open-label Phase|Lack of Efficacy|0|||
27674640|NCT00263211|80647162|FG000|Overall Study|Protocol Violation|1|||
27674641|NCT00263211|80647163|FG001|Overall Study|Protocol Violation|0|||
27674642|NCT00263211|80647162|FG000|Overall Study|Disease Progression|0|||
27674643|NCT00263211|80647163|FG001|Overall Study|Disease Progression|1|||
27674644|NCT00362375|80647174|FG000|Overall Study|Lost to Follow-up|40|||
27674645|NCT00362375|80647175|FG001|Overall Study|Lost to Follow-up|35|||
27674646|NCT02397447|80647176|FG000|Overall Study|Lost to Follow-up|2|||
27674647|NCT02397447|80647177|FG001|Overall Study|Lost to Follow-up|2|||
27674648|NCT02536742|80647179|FG000|Overall Study|Did not start protocol therapy|1|||
27674649|NCT02536742|80647179|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
27674650|NCT01663506|80647180|FG000|Overall Study|Lack of Efficacy|3|||
27674651|NCT01663506|80647180|FG000|Overall Study|Consent Withdrawal by Subject|1|||
27674652|NCT01663506|80647180|FG000|Overall Study|Lost to Follow-up|1|||
27674653|NCT01663506|80647180|FG000|Overall Study|Adverse Event|1|||
27869300|NCT01056289|81357647|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
27869301|NCT01056289|81357648|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
27795283|NCT02867592|81082039|FG000|Overall Study|No Treatment|1|||
27795284|NCT02867592|81082040|FG001|Overall Study|No Treatment|0|||
27795285|NCT02867592|81082041|FG002|Overall Study|No Treatment|0|||
27795286|NCT02867592|81082042|FG003|Overall Study|No Treatment|0|||
27795287|NCT02867592|81082043|FG004|Overall Study|No Treatment|0|||
27795288|NCT02867592|81082044|FG005|Overall Study|No Treatment|0|||
27795289|NCT02867592|81082039|FG000|Overall Study|Still on Therapy|0|||
27795290|NCT02867592|81082040|FG001|Overall Study|Still on Therapy|0|||
27795291|NCT02867592|81082041|FG002|Overall Study|Still on Therapy|0|||
27795292|NCT02867592|81082042|FG003|Overall Study|Still on Therapy|0|||
27984761|NCT00752726|81777082|FG001|Overall Study|Adverse Event|0|||
27984762|NCT00752726|81777081|FG000|Overall Study|Withdrawal by Subject|5|||
27984763|NCT00752726|81777082|FG001|Overall Study|Withdrawal by Subject|10|||
27984764|NCT00752726|81777081|FG000|Overall Study|Other Reason|1|||
27795293|NCT02867592|81082043|FG004|Overall Study|Still on Therapy|1|||
27795294|NCT02867592|81082044|FG005|Overall Study|Still on Therapy|0|||
27795295|NCT02867592|81082039|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
27795296|NCT02867592|81082040|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
27795297|NCT02867592|81082041|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
27795298|NCT02867592|81082042|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
27795299|NCT02867592|81082043|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
27795300|NCT02867592|81082044|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
27795301|NCT02867592|81082039|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
27869302|NCT01056289|81357649|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
27869303|NCT01056289|81357650|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
27869304|NCT01056289|81357647|FG000|Double-blind Phase|Adverse Event|0|||
27869305|NCT01056289|81357648|FG001|Double-blind Phase|Adverse Event|1|||
27869306|NCT01056289|81357649|FG002|Double-blind Phase|Adverse Event|2|||
27869307|NCT01056289|81357650|FG003|Double-blind Phase|Adverse Event|1|||
27869308|NCT01056289|81357647|FG000|Double-blind Phase|Lost to Follow-up|0|||
27869309|NCT01056289|81357648|FG001|Double-blind Phase|Lost to Follow-up|2|||
27984765|NCT00752726|81777082|FG001|Overall Study|Other Reason|2|||
27984766|NCT02066129|81777083|FG000|Overall Study|Lost to Follow-up|13|||
27984767|NCT02066129|81777084|FG001|Overall Study|Lost to Follow-up|12|||
27984768|NCT02066129|81777083|FG000|Overall Study|Withdrawal by Subject|7|||
27984769|NCT02066129|81777084|FG001|Overall Study|Withdrawal by Subject|10|||
27984770|NCT02066129|81777083|FG000|Overall Study|Lack of Efficacy|8|||
27984771|NCT02066129|81777084|FG001|Overall Study|Lack of Efficacy|10|||
27984772|NCT02066129|81777083|FG000|Overall Study|Physician Decision|1|||
27984773|NCT02066129|81777084|FG001|Overall Study|Physician Decision|1|||
27984774|NCT04496453|81777085|FG000|Overall Study|Lost to Follow-up|6|||
27984775|NCT01067469|81777086|FG000|Overall Study|Withdrawal by Subject|0|||
27984776|NCT01067469|81777087|FG001|Overall Study|Withdrawal by Subject|1|||
27984777|NCT01067469|81777086|FG000|Overall Study|Disease Progression|0|||
27984778|NCT01067469|81777087|FG001|Overall Study|Disease Progression|1|||
27984779|NCT04598269|81777088|FG000|Overall Study|Adverse Event|0|||
27674654|NCT01663506|80647180|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
27674655|NCT02522728|80647181|FG000|Overall Study|Withdrawal by Subject|6|||
27674656|NCT02522728|80647182|FG001|Overall Study|Withdrawal by Subject|6|||
27795302|NCT02867592|81082040|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
27869310|NCT01056289|81357649|FG002|Double-blind Phase|Lost to Follow-up|2|||
27869311|NCT01056289|81357650|FG003|Double-blind Phase|Lost to Follow-up|2|||
27984780|NCT04598269|81777089|FG001|Overall Study|Adverse Event|3|||
27984781|NCT04598269|81777088|FG000|Overall Study|Withdrawal by Subject|1|||
27674657|NCT02522728|80647181|FG000|Overall Study|Death|4|||
27674658|NCT02522728|80647182|FG001|Overall Study|Death|3|||
27674659|NCT02522728|80647181|FG000|Overall Study|Adverse Event|2|||
27674660|NCT02522728|80647182|FG001|Overall Study|Adverse Event|1|||
27674661|NCT02522728|80647181|FG000|Overall Study|Did not receive randomized study device|0|||
27674662|NCT02522728|80647182|FG001|Overall Study|Did not receive randomized study device|1|||
27674663|NCT00844597|80647188|FG000|Overall Study|Adverse Event|0|||
27674664|NCT00844597|80647189|FG001|Overall Study|Adverse Event|0|||
27674665|NCT00844597|80647190|FG002|Overall Study|Adverse Event|0|||
27674666|NCT00844597|80647191|FG003|Overall Study|Adverse Event|1|||
27674667|NCT00844597|80647192|FG004|Overall Study|Adverse Event|0|||
27674668|NCT00844597|80647193|FG005|Overall Study|Adverse Event|0|||
27674669|NCT04593823|80647194|FG000|Overall Study|Withdrawal by Subject|1|||
27674670|NCT04593823|80647195|FG001|Overall Study|Withdrawal by Subject|1|||
27674671|NCT04593823|80647194|FG000|Overall Study|Lost to Follow-up|0|||
27674672|NCT04593823|80647195|FG001|Overall Study|Lost to Follow-up|1|||
27674673|NCT00725543|80647196|FG000|Overall Study|Adverse Event|10|||
27674674|NCT00725543|80647196|FG000|Overall Study|Lack of Efficacy|3|||
27674675|NCT00725543|80647196|FG000|Overall Study|Withdrawal by Subject|10|||
27674676|NCT00725543|80647196|FG000|Overall Study|Physician Decision|5|||
27674677|NCT00725543|80647196|FG000|Overall Study|Lost to Follow-up|4|||
27674678|NCT00725543|80647196|FG000|Overall Study|Non-compliance|2|||
27674679|NCT00725543|80647196|FG000|Overall Study|Other|119|||
27674680|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
27674681|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
27674682|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
27674683|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
27674684|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
27674685|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
27674686|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
27984782|NCT04598269|81777089|FG001|Overall Study|Withdrawal by Subject|4|||
27674687|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
27674688|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
27674689|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
27674690|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
27674691|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
27674692|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
27674693|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
27674694|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
27674695|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
27674696|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
27674697|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
27674698|NCT00132678|80647197|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
27674699|NCT00132678|80647198|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
27674700|NCT00132678|80647199|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
27795303|NCT02867592|81082041|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
27795304|NCT02867592|81082042|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
27795305|NCT02867592|81082043|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
27795306|NCT02867592|81082044|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
27795307|NCT03252756|81082048|FG000|Overall Study|Protocol Violation|2|||
27795308|NCT03252756|81082049|FG001|Overall Study|Protocol Violation|4|||
27795309|NCT03252756|81082048|FG000|Overall Study|COVID-19 Pandemic|1|||
27795310|NCT03252756|81082049|FG001|Overall Study|COVID-19 Pandemic|1|||
27795311|NCT03252756|81082048|FG000|Overall Study|Study Drug Expiration|0|||
27795312|NCT03252756|81082049|FG001|Overall Study|Study Drug Expiration|1|||
27795313|NCT03972709|81082051|FG000|Overall Study|Withdrawal by Subject|18|||
27795314|NCT03972709|81082052|FG001|Overall Study|Withdrawal by Subject|7|||
27795315|NCT03972709|81082053|FG002|Overall Study|Withdrawal by Subject|14|||
27795316|NCT03972709|81082051|FG000|Overall Study|Study Terminated by Sponsor|48|||
27984783|NCT04598269|81777088|FG000|Overall Study|Lost to Follow-up|1|||
27984784|NCT04598269|81777089|FG001|Overall Study|Lost to Follow-up|0|||
27984785|NCT04598269|81777088|FG000|Overall Study|Not Treated|2|||
27984786|NCT04598269|81777089|FG001|Overall Study|Not Treated|0|||
27984787|NCT01267175|81777090|FG000|Overall Study|Withdrawal by Subject|1|||
27984788|NCT01267175|81777090|FG000|Overall Study|Lost to Follow-up|1|||
27984789|NCT02408523|81777096|FG000|Overall Study|Adverse Event|4|||
27984790|NCT02408523|81777097|FG001|Overall Study|Adverse Event|10|||
27984791|NCT02408523|81777096|FG000|Overall Study|Lack of Efficacy|0|||
27984792|NCT02408523|81777097|FG001|Overall Study|Lack of Efficacy|1|||
27674701|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Death|2|||
27674702|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Death|0|||
27674703|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Death|0|||
27674704|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
27869312|NCT01056289|81357647|FG000|Double-blind Phase|Other|0|||
27869313|NCT01056289|81357648|FG001|Double-blind Phase|Other|0|||
27869314|NCT01056289|81357649|FG002|Double-blind Phase|Other|1|||
27984793|NCT02408523|81777096|FG000|Overall Study|Protocol Violation|1|||
27984794|NCT02408523|81777097|FG001|Overall Study|Protocol Violation|2|||
27984795|NCT02408523|81777096|FG000|Overall Study|Lost to Follow-up|2|||
27984796|NCT02408523|81777097|FG001|Overall Study|Lost to Follow-up|3|||
27984797|NCT02408523|81777096|FG000|Overall Study|Withdrawal by Subject|3|||
27984798|NCT02408523|81777097|FG001|Overall Study|Withdrawal by Subject|1|||
27984799|NCT02408523|81777096|FG000|Overall Study|Sponsor request|1|||
27984800|NCT02408523|81777097|FG001|Overall Study|Sponsor request|0|||
27578029|NCT00813761|80299351|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
27578030|NCT00813761|80299352|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
27578031|NCT00813761|80299349|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
27869315|NCT01056289|81357650|FG003|Double-blind Phase|Other|2|||
27984801|NCT02408523|81777096|FG000|Overall Study|Did not satisfy extension conditions|0|||
27984802|NCT02408523|81777097|FG001|Overall Study|Did not satisfy extension conditions|1|||
27984803|NCT00588094|81777098|FG000|Overall Study|Adverse Event|3|||
27984804|NCT00588094|81777098|FG000|Overall Study|Progression of Disease|2|||
27984805|NCT01571232|81777100|FG000|Overall Study|Lost to Follow-up|0|||
27984806|NCT01571232|81777101|FG001|Overall Study|Lost to Follow-up|1|||
27984807|NCT01571232|81777100|FG000|Overall Study|Withdrawal by Subject|1|||
27984808|NCT01571232|81777101|FG001|Overall Study|Withdrawal by Subject|0|||
27984809|NCT03966885|81777102|FG000|Overall Study|Death|1|||
27984810|NCT03966885|81777103|FG001|Overall Study|Death|0|||
27984811|NCT03966885|81777102|FG000|Overall Study|Lost to Follow-up|1|||
27984812|NCT03966885|81777103|FG001|Overall Study|Lost to Follow-up|2|||
27984813|NCT03966885|81777102|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
27984814|NCT03966885|81777103|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
27984815|NCT03966885|81777102|FG000|Overall Study|Moved from study area.|0|||
27984816|NCT03966885|81777103|FG001|Overall Study|Moved from study area.|2|||
27869316|NCT01056289|81357647|FG000|Double-blind Phase|Protocol Violation|0|||
27869317|NCT01056289|81357648|FG001|Double-blind Phase|Protocol Violation|0|||
27869318|NCT01056289|81357649|FG002|Double-blind Phase|Protocol Violation|1|||
27869319|NCT01056289|81357650|FG003|Double-blind Phase|Protocol Violation|1|||
27869320|NCT01056289|81357647|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27869321|NCT01056289|81357648|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27869322|NCT01056289|81357649|FG002|Double-blind Phase|Withdrawal by Subject|4|||
27869323|NCT01056289|81357650|FG003|Double-blind Phase|Withdrawal by Subject|2|||
27869324|NCT01056289|81357647|FG000|Double-blind Phase|Discontinuation symptom|0|||
27869325|NCT01056289|81357648|FG001|Double-blind Phase|Discontinuation symptom|1|||
27869326|NCT01056289|81357649|FG002|Double-blind Phase|Discontinuation symptom|2|||
27869327|NCT01056289|81357650|FG003|Double-blind Phase|Discontinuation symptom|2|||
27869328|NCT01056289|81357647|FG000|Double-blind Phase|Physician Decision|0|||
27869329|NCT01056289|81357648|FG001|Double-blind Phase|Physician Decision|0|||
27869330|NCT01056289|81357649|FG002|Double-blind Phase|Physician Decision|1|||
27869331|NCT01056289|81357650|FG003|Double-blind Phase|Physician Decision|0|||
27869332|NCT04825912|81357651|FG000|Overall Study|Death|3|||
27869333|NCT04825912|81357651|FG000|Overall Study|Withdrawal by Subject|1|||
27869334|NCT00789035|81357652|FG000|Overall Study|Adverse Event|0|||
27869335|NCT00789035|81357653|FG001|Overall Study|Adverse Event|2|||
27869336|NCT00789035|81357654|FG002|Overall Study|Adverse Event|0|||
27869337|NCT00789035|81357655|FG003|Overall Study|Adverse Event|1|||
27869338|NCT00789035|81357656|FG004|Overall Study|Adverse Event|3|||
27869339|NCT00789035|81357652|FG000|Overall Study|Lack of Efficacy|3|||
27869340|NCT00789035|81357653|FG001|Overall Study|Lack of Efficacy|0|||
27869341|NCT00789035|81357654|FG002|Overall Study|Lack of Efficacy|0|||
27869342|NCT00789035|81357655|FG003|Overall Study|Lack of Efficacy|0|||
27869343|NCT00789035|81357656|FG004|Overall Study|Lack of Efficacy|2|||
27869344|NCT00789035|81357652|FG000|Overall Study|Protocol Violation|1|||
27984817|NCT01641822|81777106|FG000|Run-in Phase|Noncompliance with study drug|1|||
27984818|NCT01641822|81777107|FG001|Run-in Phase|Noncompliance with study drug|0|||
27984819|NCT01641822|81777108|FG002|Run-in Phase|Noncompliance with study drug|0|||
27984820|NCT01641822|81777106|FG000|Run-in Phase|Adverse Event|3|||
27984821|NCT01641822|81777107|FG001|Run-in Phase|Adverse Event|0|||
27984822|NCT01641822|81777108|FG002|Run-in Phase|Adverse Event|0|||
27984823|NCT01641822|81777106|FG000|Run-in Phase|Withdrew consent|1|||
27984824|NCT01641822|81777107|FG001|Run-in Phase|Withdrew consent|0|||
27869345|NCT00789035|81357653|FG001|Overall Study|Protocol Violation|0|||
27869346|NCT00789035|81357654|FG002|Overall Study|Protocol Violation|0|||
27869347|NCT00789035|81357655|FG003|Overall Study|Protocol Violation|0|||
27869348|NCT00789035|81357656|FG004|Overall Study|Protocol Violation|0|||
27869349|NCT00789035|81357652|FG000|Overall Study|Withdrawal by Subject|0|||
27869350|NCT00789035|81357653|FG001|Overall Study|Withdrawal by Subject|2|||
27869351|NCT00789035|81357654|FG002|Overall Study|Withdrawal by Subject|0|||
27869352|NCT00789035|81357655|FG003|Overall Study|Withdrawal by Subject|0|||
27984825|NCT01641822|81777108|FG002|Run-in Phase|Withdrew consent|0|||
27869353|NCT00789035|81357656|FG004|Overall Study|Withdrawal by Subject|0|||
27869354|NCT00789035|81357652|FG000|Overall Study|Other reason not defined above|2|||
27869355|NCT00789035|81357653|FG001|Overall Study|Other reason not defined above|3|||
27869356|NCT00789035|81357654|FG002|Overall Study|Other reason not defined above|1|||
27869357|NCT00789035|81357655|FG003|Overall Study|Other reason not defined above|0|||
27984826|NCT01641822|81777106|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
27984827|NCT01641822|81777107|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
27984828|NCT01641822|81777108|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
27984829|NCT01641822|81777106|FG000|Comparative Phase|Noncompliance with study drug|0|||
27984830|NCT01641822|81777107|FG001|Comparative Phase|Noncompliance with study drug|1|||
27984831|NCT01641822|81777108|FG002|Comparative Phase|Noncompliance with study drug|0|||
27984832|NCT01641822|81777106|FG000|Comparative Phase|Investigator's discretion|0|||
27984833|NCT01641822|81777107|FG001|Comparative Phase|Investigator's discretion|0|||
27984834|NCT01641822|81777108|FG002|Comparative Phase|Investigator's discretion|1|||
27984835|NCT01641822|81777106|FG000|Comparative Phase|Pregnancy|0|||
27984836|NCT01641822|81777107|FG001|Comparative Phase|Pregnancy|0|||
27984837|NCT01641822|81777108|FG002|Comparative Phase|Pregnancy|1|||
27984838|NCT01641822|81777106|FG000|Comparative Phase|Adverse event, serious fatal|0|||
27984839|NCT01641822|81777107|FG001|Comparative Phase|Adverse event, serious fatal|1|||
27984840|NCT01641822|81777108|FG002|Comparative Phase|Adverse event, serious fatal|0|||
27984841|NCT01641822|81777106|FG000|Comparative Phase|Withdrew consent|0|||
27984842|NCT01641822|81777107|FG001|Comparative Phase|Withdrew consent|3|||
27984843|NCT01641822|81777108|FG002|Comparative Phase|Withdrew consent|7|||
27984844|NCT01641822|81777106|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
27984845|NCT01641822|81777107|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
27984846|NCT01641822|81777108|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
27984847|NCT04583956|81777109|FG000|Overall Study|Death|9|||
27984848|NCT04583956|81777110|FG001|Overall Study|Death|11|||
27984849|NCT04583956|81777109|FG000|Overall Study|Lost to Follow-up|7|||
27984850|NCT04583956|81777110|FG001|Overall Study|Lost to Follow-up|9|||
27984851|NCT04583956|81777109|FG000|Overall Study|Protocol Violation|2|||
27984852|NCT04583956|81777110|FG001|Overall Study|Protocol Violation|0|||
27984853|NCT04583956|81777109|FG000|Overall Study|Withdrawal by Subject|0|||
27984854|NCT04583956|81777110|FG001|Overall Study|Withdrawal by Subject|2|||
27984855|NCT04583956|81777109|FG000|Overall Study|Randomized but not dosed|2|||
27984856|NCT04583956|81777110|FG001|Overall Study|Randomized but not dosed|3|||
27984857|NCT04583956|81777109|FG000|Overall Study|Withdrawal of consent before product administration|1|||
27984858|NCT04583956|81777110|FG001|Overall Study|Withdrawal of consent before product administration|0|||
27984859|NCT01792518|81777111|FG000|Overall Study|Adverse Event|3|||
27984860|NCT01792518|81777112|FG001|Overall Study|Adverse Event|4|||
27795317|NCT03972709|81082052|FG001|Overall Study|Study Terminated by Sponsor|25|||
27795318|NCT03972709|81082053|FG002|Overall Study|Study Terminated by Sponsor|50|||
27795319|NCT03972709|81082051|FG000|Overall Study|Physician Decision|1|||
27795320|NCT03972709|81082052|FG001|Overall Study|Physician Decision|0|||
27795321|NCT03972709|81082053|FG002|Overall Study|Physician Decision|0|||
27795322|NCT03972709|81082051|FG000|Overall Study|COVID-19|0|||
27795323|NCT03972709|81082052|FG001|Overall Study|COVID-19|1|||
27795324|NCT03972709|81082053|FG002|Overall Study|COVID-19|1|||
27795325|NCT03972709|81082051|FG000|Overall Study|Lost to Follow-up|6|||
27795326|NCT03972709|81082052|FG001|Overall Study|Lost to Follow-up|1|||
27795327|NCT03972709|81082053|FG002|Overall Study|Lost to Follow-up|2|||
27795328|NCT03972709|81082051|FG000|Overall Study|Death|5|||
27795329|NCT03972709|81082052|FG001|Overall Study|Death|1|||
27795330|NCT03972709|81082053|FG002|Overall Study|Death|4|||
27795331|NCT03972709|81082051|FG000|Overall Study|Adverse Event|3|||
27795332|NCT03972709|81082052|FG001|Overall Study|Adverse Event|1|||
27795333|NCT03972709|81082053|FG002|Overall Study|Adverse Event|4|||
27795334|NCT03972709|81082051|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
27795335|NCT03972709|81082052|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
27795336|NCT03972709|81082053|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
27795337|NCT03972709|81082051|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
27795338|NCT03972709|81082052|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
27795339|NCT03972709|81082053|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
27795340|NCT03972709|81082051|FG000|Overall Study|Subject Unable to be Contacted|0|||
27795341|NCT03972709|81082052|FG001|Overall Study|Subject Unable to be Contacted|1|||
27795342|NCT03972709|81082053|FG002|Overall Study|Subject Unable to be Contacted|0|||
27795343|NCT03972709|81082051|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
27869358|NCT00789035|81357656|FG004|Overall Study|Other reason not defined above|1|||
27869359|NCT03404674|81357657|FG000|Overall Study|Inability to Attend Future Visits|0|||
27869360|NCT03404674|81357658|FG001|Overall Study|Inability to Attend Future Visits|1|||
27984861|NCT01792518|81777111|FG000|Overall Study|Protocol Violation|0|||
27869361|NCT03404674|81357659|FG002|Overall Study|Inability to Attend Future Visits|1|||
27578032|NCT00813761|80299350|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
27578033|NCT00813761|80299351|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
27578034|NCT00813761|80299352|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
27578035|NCT00813761|80299349|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
27578036|NCT00813761|80299350|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
27578037|NCT00813761|80299351|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
27578038|NCT00813761|80299352|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
27578039|NCT00813761|80299349|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
27578040|NCT00813761|80299350|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
27578041|NCT00813761|80299351|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
27578042|NCT00813761|80299352|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
27578043|NCT00813761|80299349|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
27578044|NCT00813761|80299350|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
27578045|NCT00813761|80299351|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
27578046|NCT00813761|80299352|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
27578047|NCT00813761|80299349|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
27578048|NCT00813761|80299350|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
27578049|NCT00813761|80299351|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
27578050|NCT00813761|80299352|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
27578051|NCT00813761|80299349|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
27578052|NCT00813761|80299350|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
27578053|NCT00813761|80299351|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
27578054|NCT00813761|80299352|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
27795344|NCT03972709|81082052|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
27795345|NCT03972709|81082053|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
27795346|NCT03972709|81082051|FG000|Overall Study|Subject Moved|0|||
27795347|NCT03972709|81082052|FG001|Overall Study|Subject Moved|1|||
27795348|NCT03972709|81082053|FG002|Overall Study|Subject Moved|0|||
27795349|NCT03972709|81082051|FG000|Overall Study|Missed Study Visits|1|||
27795350|NCT03972709|81082052|FG001|Overall Study|Missed Study Visits|0|||
27795351|NCT03972709|81082053|FG002|Overall Study|Missed Study Visits|0|||
27795352|NCT03231709|81082056|FG000|Treatment Period 1|Reason not Specified|0|||
27795353|NCT03231709|81082057|FG001|Treatment Period 1|Reason not Specified|1|||
27795354|NCT03231709|81082056|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
27795355|NCT03231709|81082057|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
27795356|NCT02780115|81082061|FG000|Overall Study|Withdrawal by Subject|0|||
27795357|NCT02780115|81082062|FG001|Overall Study|Withdrawal by Subject|1|||
27795358|NCT02780115|81082063|FG002|Overall Study|Withdrawal by Subject|1|||
27795359|NCT02780115|81082064|FG003|Overall Study|Withdrawal by Subject|0|||
27795360|NCT02780115|81082065|FG004|Overall Study|Withdrawal by Subject|0|||
27795361|NCT02780115|81082061|FG000|Overall Study|Adverse Event|0|||
27795362|NCT02780115|81082062|FG001|Overall Study|Adverse Event|0|||
27795363|NCT02780115|81082063|FG002|Overall Study|Adverse Event|0|||
27795364|NCT02780115|81082064|FG003|Overall Study|Adverse Event|1|||
27795365|NCT02780115|81082065|FG004|Overall Study|Adverse Event|1|||
27795366|NCT05378269|81082068|FG000|Overall Study|Protocol Violation|1|||
27795367|NCT05378269|81082069|FG001|Overall Study|Protocol Violation|0|||
27795368|NCT05378269|81082070|FG002|Overall Study|Protocol Violation|2|||
27795369|NCT05378269|81082071|FG003|Overall Study|Protocol Violation|0|||
27795370|NCT05378269|81082072|FG004|Overall Study|Protocol Violation|0|||
27795371|NCT00057330|81082077|FG000|Overall Study|Adverse Event|9|||
27795372|NCT00057330|81082078|FG001|Overall Study|Adverse Event|12|||
27795373|NCT00057330|81082077|FG000|Overall Study|Death|1|||
27795374|NCT00057330|81082078|FG001|Overall Study|Death|0|||
27795375|NCT00057330|81082077|FG000|Overall Study|Protocol Violation|1|||
27795376|NCT00057330|81082078|FG001|Overall Study|Protocol Violation|1|||
27795377|NCT00057330|81082077|FG000|Overall Study|Withdrawal by Subject|115|||
27795378|NCT00057330|81082078|FG001|Overall Study|Withdrawal by Subject|84|||
27795379|NCT00057330|81082077|FG000|Overall Study|Lost to Follow-up|745|||
27795380|NCT00057330|81082078|FG001|Overall Study|Lost to Follow-up|617|||
27795381|NCT00057330|81082077|FG000|Overall Study|Physician Decision|1|||
27795382|NCT00057330|81082078|FG001|Overall Study|Physician Decision|0|||
27795383|NCT00057330|81082077|FG000|Overall Study|Other|260|||
27795384|NCT00057330|81082078|FG001|Overall Study|Other|206|||
27795385|NCT03280628|81082082|FG000|Overall Study|Lost to Follow-up|8|||
27795386|NCT03280628|81082083|FG001|Overall Study|Lost to Follow-up|6|||
27795387|NCT03280628|81082084|FG002|Overall Study|Lost to Follow-up|11|||
27795388|NCT03039686|81082088|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
27578055|NCT00813761|80299349|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
27795389|NCT03039686|81082089|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
27795390|NCT03039686|81082090|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
27795391|NCT03039686|81082088|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
27795392|NCT03039686|81082089|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
27578056|NCT00813761|80299350|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
27578057|NCT00813761|80299351|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
27578058|NCT00813761|80299352|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
27578059|NCT03986944|80299353|FG000|Overall Study|Adverse Event|1|||
27578060|NCT03986944|80299354|FG001|Overall Study|Adverse Event|2|||
27578061|NCT03986944|80299355|FG002|Overall Study|Adverse Event|3|||
27578062|NCT03986944|80299353|FG000|Overall Study|Protocol Violation|0|||
27578063|NCT03986944|80299354|FG001|Overall Study|Protocol Violation|1|||
27578064|NCT03986944|80299355|FG002|Overall Study|Protocol Violation|1|||
27578065|NCT03986944|80299353|FG000|Overall Study|Withdrawal by Subject|3|||
27578066|NCT03986944|80299354|FG001|Overall Study|Withdrawal by Subject|5|||
27578067|NCT03986944|80299355|FG002|Overall Study|Withdrawal by Subject|5|||
27578068|NCT03986944|80299353|FG000|Overall Study|Study termination|10|||
27578069|NCT03986944|80299354|FG001|Overall Study|Study termination|10|||
27984862|NCT01792518|81777112|FG001|Overall Study|Protocol Violation|1|||
27578070|NCT03986944|80299355|FG002|Overall Study|Study termination|10|||
27578071|NCT03986944|80299353|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
27578072|NCT03986944|80299354|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
27578073|NCT03986944|80299355|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
27578074|NCT03986944|80299353|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
27578075|NCT03986944|80299354|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
27578076|NCT03986944|80299355|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
27578077|NCT02565381|80299356|FG000|Overall Study|Lost to Follow-up|1|||
27578078|NCT02565381|80299357|FG001|Overall Study|Lost to Follow-up|0|||
27578079|NCT02565381|80299358|FG002|Overall Study|Lost to Follow-up|1|||
27578080|NCT02985736|80299360|FG000|Overall Study|Lost to Follow-up|3|||
27578081|NCT02039427|80299361|FG000|Overall Study|Duration of surgery > 3h|1|||
27578082|NCT02039427|80299362|FG001|Overall Study|Duration of surgery > 3h|1|||
27578083|NCT02039427|80299363|FG002|Overall Study|Duration of surgery > 3h|0|||
27578084|NCT02039427|80299364|FG003|Overall Study|Duration of surgery > 3h|0|||
27578085|NCT02039427|80299361|FG000|Overall Study|Withdrawal on concent|0|||
27578086|NCT02039427|80299362|FG001|Overall Study|Withdrawal on concent|0|||
27578087|NCT02039427|80299363|FG002|Overall Study|Withdrawal on concent|0|||
27578088|NCT02039427|80299364|FG003|Overall Study|Withdrawal on concent|1|||
27578089|NCT02039427|80299361|FG000|Overall Study|Cancellation of surgery|0|||
27578090|NCT02039427|80299362|FG001|Overall Study|Cancellation of surgery|0|||
27578091|NCT02039427|80299363|FG002|Overall Study|Cancellation of surgery|1|||
27578092|NCT02039427|80299364|FG003|Overall Study|Cancellation of surgery|0|||
27578093|NCT02039427|80299361|FG000|Overall Study|Loss of follow - up|1|||
27578094|NCT02039427|80299362|FG001|Overall Study|Loss of follow - up|0|||
27578095|NCT02039427|80299363|FG002|Overall Study|Loss of follow - up|2|||
27578096|NCT02039427|80299364|FG003|Overall Study|Loss of follow - up|4|||
27578097|NCT02039427|80299361|FG000|Overall Study|Steroid Use|1|||
27578098|NCT02039427|80299362|FG001|Overall Study|Steroid Use|0|||
27578099|NCT02039427|80299363|FG002|Overall Study|Steroid Use|0|||
27578100|NCT02039427|80299364|FG003|Overall Study|Steroid Use|0|||
27578101|NCT00965848|80299368|FG000|Overall Study|Protocol Violation|3|||
27578102|NCT00965848|80299369|FG001|Overall Study|Protocol Violation|0|||
27578103|NCT00965848|80299370|FG002|Overall Study|Protocol Violation|1|||
27578104|NCT00965848|80299368|FG000|Overall Study|Death|11|||
27578105|NCT00965848|80299369|FG001|Overall Study|Death|1|||
27578106|NCT00965848|80299370|FG002|Overall Study|Death|5|||
27578107|NCT00965848|80299368|FG000|Overall Study|Lost to Follow-up|0|||
27578108|NCT00965848|80299369|FG001|Overall Study|Lost to Follow-up|0|||
27674705|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
27578109|NCT00965848|80299370|FG002|Overall Study|Lost to Follow-up|1|||
27578110|NCT00965848|80299368|FG000|Overall Study|Withdrawal by Subject|1|||
27578111|NCT00965848|80299369|FG001|Overall Study|Withdrawal by Subject|0|||
27578112|NCT00965848|80299370|FG002|Overall Study|Withdrawal by Subject|0|||
27578113|NCT00965848|80299368|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
27578114|NCT00965848|80299369|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
27578115|NCT00965848|80299370|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
27578116|NCT00965848|80299368|FG000|Overall Study|Not Clinically Evaluable|7|||
27578117|NCT00965848|80299369|FG001|Overall Study|Not Clinically Evaluable|1|||
27578118|NCT00965848|80299370|FG002|Overall Study|Not Clinically Evaluable|1|||
27578119|NCT00965848|80299368|FG000|Overall Study|Other|5|||
27578120|NCT00965848|80299369|FG001|Overall Study|Other|0|||
27578121|NCT00965848|80299370|FG002|Overall Study|Other|1|||
27984863|NCT01792518|81777111|FG000|Overall Study|Lost to Follow-up|3|||
27578122|NCT02370888|80299371|FG000|Overall Study|disease progression|2|||
27578123|NCT02370888|80299371|FG000|Overall Study|did not meet chimerism criteria|6|||
27578124|NCT01599650|80299372|FG000|Overall Study|Administrative issue|1|||
27578125|NCT01599650|80299373|FG001|Overall Study|Administrative issue|0|||
27578126|NCT01599650|80299374|FG002|Overall Study|Administrative issue|1|||
27984864|NCT01792518|81777112|FG001|Overall Study|Lost to Follow-up|1|||
27578127|NCT01599650|80299372|FG000|Overall Study|Physician Decision|2|||
27578128|NCT01599650|80299373|FG001|Overall Study|Physician Decision|0|||
27578129|NCT01599650|80299374|FG002|Overall Study|Physician Decision|7|||
27578130|NCT01599650|80299372|FG000|Overall Study|Protocol Violation|0|||
27578131|NCT01599650|80299373|FG001|Overall Study|Protocol Violation|3|||
27578132|NCT01599650|80299374|FG002|Overall Study|Protocol Violation|0|||
27578133|NCT01599650|80299372|FG000|Overall Study|Death|2|||
27578134|NCT01599650|80299373|FG001|Overall Study|Death|1|||
27578135|NCT01599650|80299374|FG002|Overall Study|Death|2|||
27578136|NCT01599650|80299372|FG000|Overall Study|Lost to Follow-up|3|||
27578137|NCT01599650|80299373|FG001|Overall Study|Lost to Follow-up|3|||
27578138|NCT01599650|80299374|FG002|Overall Study|Lost to Follow-up|3|||
27578139|NCT01599650|80299372|FG000|Overall Study|Withdrawal by Subject|11|||
27578140|NCT01599650|80299373|FG001|Overall Study|Withdrawal by Subject|11|||
27578141|NCT01599650|80299374|FG002|Overall Study|Withdrawal by Subject|10|||
27578142|NCT01599650|80299372|FG000|Overall Study|Adverse Event|3|||
27578143|NCT01599650|80299373|FG001|Overall Study|Adverse Event|8|||
27578144|NCT01599650|80299374|FG002|Overall Study|Adverse Event|4|||
27578145|NCT00912405|80299375|FG000|Overall Study|Lost to Follow-up|5|||
27578146|NCT02944578|80299376|FG000|Overall Study|Physician Decision|1|||
27578147|NCT02944578|80299377|FG001|Overall Study|Physician Decision|0|||
27578148|NCT01600040|80299380|FG000|Overall Study|Withdrawal by Subject|1|||
27578149|NCT02453594|80299381|FG000|Overall Study|Protocol Violation|0|||
27578150|NCT02453594|80299382|FG001|Overall Study|Protocol Violation|0|||
27578151|NCT02453594|80299383|FG002|Overall Study|Protocol Violation|1|||
27578152|NCT02453594|80299381|FG000|Overall Study|Cohort Was Closed|17|||
27578153|NCT02453594|80299382|FG001|Overall Study|Cohort Was Closed|21|||
27578154|NCT02453594|80299383|FG002|Overall Study|Cohort Was Closed|14|||
27578155|NCT02453594|80299381|FG000|Overall Study|Death|20|||
27578156|NCT02453594|80299382|FG001|Overall Study|Death|24|||
27578157|NCT02453594|80299383|FG002|Overall Study|Death|16|||
27578158|NCT02453594|80299381|FG000|Overall Study|Lost to Follow-up|6|||
27578159|NCT02453594|80299382|FG001|Overall Study|Lost to Follow-up|14|||
27578160|NCT02453594|80299383|FG002|Overall Study|Lost to Follow-up|2|||
27578161|NCT02453594|80299381|FG000|Overall Study|Physician Decision|2|||
27578162|NCT02453594|80299382|FG001|Overall Study|Physician Decision|4|||
27578163|NCT02453594|80299383|FG002|Overall Study|Physician Decision|0|||
27578164|NCT02453594|80299381|FG000|Overall Study|Site Terminated by Sponsor|1|||
27578165|NCT02453594|80299382|FG001|Overall Study|Site Terminated by Sponsor|0|||
27578166|NCT02453594|80299383|FG002|Overall Study|Site Terminated by Sponsor|1|||
27578167|NCT02453594|80299381|FG000|Overall Study|Transitioned to Extension Study|16|||
27578168|NCT02453594|80299382|FG001|Overall Study|Transitioned to Extension Study|9|||
27578169|NCT02453594|80299383|FG002|Overall Study|Transitioned to Extension Study|16|||
27578170|NCT02453594|80299381|FG000|Overall Study|Withdrawal by Subject|7|||
27578171|NCT02453594|80299382|FG001|Overall Study|Withdrawal by Subject|9|||
27578172|NCT02453594|80299383|FG002|Overall Study|Withdrawal by Subject|11|||
27578173|NCT02504866|80299387|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
27578174|NCT02504866|80299388|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
27578175|NCT02504866|80299389|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
27578176|NCT02564471|80299397|FG000|Overall Study|Adverse Event|1|||
27578177|NCT02564471|80299398|FG001|Overall Study|Adverse Event|0|||
27578178|NCT02564471|80299399|FG002|Overall Study|Adverse Event|0|||
27578179|NCT02564471|80299400|FG003|Overall Study|Adverse Event|0|||
27578180|NCT02564471|80299397|FG000|Overall Study|Withdrawal by Subject|2|||
27578181|NCT02564471|80299398|FG001|Overall Study|Withdrawal by Subject|1|||
27578182|NCT02564471|80299399|FG002|Overall Study|Withdrawal by Subject|3|||
27578183|NCT02564471|80299400|FG003|Overall Study|Withdrawal by Subject|0|||
27578184|NCT02564471|80299397|FG000|Overall Study|Lost to Follow-up|0|||
27578185|NCT02564471|80299398|FG001|Overall Study|Lost to Follow-up|2|||
27578186|NCT02564471|80299399|FG002|Overall Study|Lost to Follow-up|0|||
27578187|NCT02564471|80299400|FG003|Overall Study|Lost to Follow-up|0|||
27578188|NCT00983814|80299414|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
27578189|NCT00983814|80299415|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
27578190|NCT00983814|80299416|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
27578191|NCT00983814|80299414|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
27578192|NCT00983814|80299415|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
27578193|NCT00983814|80299416|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
27578194|NCT00983814|80299414|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
27578195|NCT00983814|80299415|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
27578196|NCT00983814|80299416|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
27578197|NCT00983814|80299414|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
27578198|NCT00983814|80299415|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
27578199|NCT00983814|80299416|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
27578200|NCT00983814|80299414|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
27578201|NCT00983814|80299415|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
27578202|NCT00983814|80299416|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
27578203|NCT02550652|80299417|FG000|Overall Study|Death|1|||
27578204|NCT02550652|80299418|FG001|Overall Study|Death|4|||
27578205|NCT02550652|80299417|FG000|Overall Study|Lack of Efficacy|1|||
27578206|NCT02550652|80299418|FG001|Overall Study|Lack of Efficacy|0|||
27578207|NCT02550652|80299417|FG000|Overall Study|Withdrawal by Subject|4|||
27578208|NCT02550652|80299418|FG001|Overall Study|Withdrawal by Subject|7|||
27578209|NCT02550652|80299417|FG000|Overall Study|Post Trial Access|1|||
27578210|NCT02550652|80299418|FG001|Overall Study|Post Trial Access|0|||
27578211|NCT02550652|80299417|FG000|Overall Study|Lost to Follow-up|1|||
27578212|NCT02550652|80299418|FG001|Overall Study|Lost to Follow-up|3|||
27578213|NCT02550652|80299417|FG000|Overall Study|Physician Decision|0|||
27578214|NCT02550652|80299418|FG001|Overall Study|Physician Decision|2|||
27578215|NCT02550652|80299417|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
27578216|NCT02550652|80299418|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
27578217|NCT03246529|80299423|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
27578218|NCT03246529|80299424|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
27578219|NCT03246529|80299425|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
27578220|NCT03246529|80299423|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
27578221|NCT03246529|80299424|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
27578222|NCT03246529|80299425|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
27578223|NCT03246529|80299423|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
27578224|NCT03246529|80299424|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
27578225|NCT03246529|80299425|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
27578226|NCT03246529|80299423|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
27578227|NCT03246529|80299424|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
27578228|NCT03246529|80299425|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
27578229|NCT03246529|80299423|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
27578230|NCT03246529|80299424|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
27578231|NCT03246529|80299425|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
27578232|NCT03246529|80299423|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
27578233|NCT03246529|80299424|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
27578234|NCT03246529|80299425|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
27578235|NCT03246529|80299423|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
27578236|NCT03246529|80299424|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
27578237|NCT03246529|80299425|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
27578238|NCT03246529|80299423|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
27578239|NCT03246529|80299424|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
27578240|NCT03246529|80299425|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
27578241|NCT03246529|80299423|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
27578242|NCT03246529|80299424|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
27578243|NCT03246529|80299425|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
27578244|NCT03003676|80299426|FG000|Overall Study|Lack of Efficacy|5|||
27578245|NCT03003676|80299427|FG001|Overall Study|Lack of Efficacy|7|||
27578246|NCT03003676|80299426|FG000|Overall Study|Withdrawal by Subject|0|||
27578247|NCT03003676|80299427|FG001|Overall Study|Withdrawal by Subject|1|||
27578248|NCT03003676|80299426|FG000|Overall Study|Hepatitis B infection|1|||
27578249|NCT03003676|80299427|FG001|Overall Study|Hepatitis B infection|0|||
27578250|NCT05070897|80299431|FG000|Overall Study|Protocol Violation|123|||
27578251|NCT05070897|80299432|FG001|Overall Study|Protocol Violation|68|||
27578252|NCT00667342|80299444|FG000|Overall Study|Protocol Violation|1|||
27578253|NCT00667342|80299445|FG001|Overall Study|Protocol Violation|0|||
27578254|NCT00667342|80299446|FG002|Overall Study|Protocol Violation|0|||
27578255|NCT00667342|80299444|FG000|Overall Study|Withdrawal by Subject|1|||
27578256|NCT00667342|80299445|FG001|Overall Study|Withdrawal by Subject|0|||
27578257|NCT00667342|80299446|FG002|Overall Study|Withdrawal by Subject|0|||
27578258|NCT00667342|80299444|FG000|Overall Study|Physician Decision|3|||
27578259|NCT00667342|80299445|FG001|Overall Study|Physician Decision|0|||
27578260|NCT00667342|80299446|FG002|Overall Study|Physician Decision|0|||
27578261|NCT00667342|80299444|FG000|Overall Study|Relapse or tumor progression|9|||
27578262|NCT00667342|80299445|FG001|Overall Study|Relapse or tumor progression|0|||
27578263|NCT00667342|80299446|FG002|Overall Study|Relapse or tumor progression|7|||
27578264|NCT00667342|80299444|FG000|Overall Study|Adverse Event|0|||
27578265|NCT00667342|80299445|FG001|Overall Study|Adverse Event|0|||
27578266|NCT00667342|80299446|FG002|Overall Study|Adverse Event|1|||
27578267|NCT00667342|80299444|FG000|Overall Study|Ineligible|0|||
27578268|NCT00667342|80299445|FG001|Overall Study|Ineligible|0|||
27578269|NCT00667342|80299446|FG002|Overall Study|Ineligible|1|||
27578270|NCT01375049|80299447|FG000|Overall Study|Adverse Event|2|||
27578271|NCT01375049|80299447|FG000|Overall Study|Lost to Follow-up|1|||
27578272|NCT01375049|80299447|FG000|Overall Study|Withdrawal by Subject|2|||
27984865|NCT01792518|81777111|FG000|Overall Study|Withdrawal by Subject|2|||
27578273|NCT01375049|80299447|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
27578274|NCT00633984|80299458|FG000|Overall Study|Lost to Follow-up|0|||
27578275|NCT00633984|80299459|FG001|Overall Study|Lost to Follow-up|6|||
27578276|NCT00633984|80299458|FG000|Overall Study|Withdrawal by Subject|8|||
27578277|NCT00633984|80299459|FG001|Overall Study|Withdrawal by Subject|7|||
27578278|NCT00633984|80299458|FG000|Overall Study|Hospitalized|1|||
27578279|NCT00633984|80299459|FG001|Overall Study|Hospitalized|0|||
27578280|NCT04532112|80299460|FG000|Overall Study|Adverse Event|3|||
27578281|NCT04532112|80299461|FG001|Overall Study|Adverse Event|0|||
27578282|NCT01332149|80299464|FG000|Overall Study|Adverse Event|11|||
27578283|NCT01332149|80299465|FG001|Overall Study|Adverse Event|9|||
27578284|NCT01332149|80299464|FG000|Overall Study|Other unspecified|5|||
27578285|NCT01332149|80299465|FG001|Overall Study|Other unspecified|7|||
27578286|NCT01332149|80299464|FG000|Overall Study|Protocol Violation|1|||
27578287|NCT01332149|80299465|FG001|Overall Study|Protocol Violation|3|||
27578288|NCT01332149|80299464|FG000|Overall Study|Withdrawal by Subject|4|||
27578289|NCT01332149|80299465|FG001|Overall Study|Withdrawal by Subject|5|||
27578290|NCT01332149|80299464|FG000|Overall Study|Lost to Follow-up|1|||
27578291|NCT01332149|80299465|FG001|Overall Study|Lost to Follow-up|1|||
27578292|NCT01332149|80299464|FG000|Overall Study|Insufficient clinical response|4|||
27578293|NCT01332149|80299465|FG001|Overall Study|Insufficient clinical response|7|||
27578294|NCT01332149|80299464|FG000|Overall Study|Did not meet entrance criteria|3|||
27578295|NCT01332149|80299465|FG001|Overall Study|Did not meet entrance criteria|4|||
27578296|NCT01332149|80299464|FG000|Overall Study|Randomized but not treated|1|||
27578297|NCT01332149|80299465|FG001|Overall Study|Randomized but not treated|2|||
27578298|NCT04661033|80299466|FG000|Overall Study|Adverse Event|0|||
27578299|NCT04661033|80299467|FG001|Overall Study|Adverse Event|0|||
27578300|NCT04661033|80299468|FG002|Overall Study|Adverse Event|1|||
27578301|NCT04661033|80299469|FG003|Overall Study|Adverse Event|0|||
27578302|NCT04661033|80299466|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
27578303|NCT04661033|80299467|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
27578304|NCT04661033|80299468|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
27578305|NCT04661033|80299469|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
27578306|NCT04661033|80299466|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
27578307|NCT04661033|80299467|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
27578308|NCT04661033|80299468|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
27578309|NCT04661033|80299469|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
27578310|NCT04661033|80299466|FG000|Overall Study|Early discontinuation as per PI|1|||
27578311|NCT04661033|80299467|FG001|Overall Study|Early discontinuation as per PI|0|||
27578312|NCT04661033|80299468|FG002|Overall Study|Early discontinuation as per PI|0|||
27578313|NCT04661033|80299469|FG003|Overall Study|Early discontinuation as per PI|0|||
27578314|NCT01465802|80299470|FG000|Overall Study|Study terminated by sponsor|1|||
27578315|NCT01465802|80299471|FG001|Overall Study|Study terminated by sponsor|0|||
27578316|NCT01465802|80299472|FG002|Overall Study|Study terminated by sponsor|0|||
27578317|NCT01465802|80299473|FG003|Overall Study|Study terminated by sponsor|1|||
27578318|NCT01465802|80299474|FG004|Overall Study|Study terminated by sponsor|7|||
27578319|NCT01465802|80299470|FG000|Overall Study|Withdrawal by Subject|7|||
27578320|NCT01465802|80299471|FG001|Overall Study|Withdrawal by Subject|7|||
27578321|NCT01465802|80299472|FG002|Overall Study|Withdrawal by Subject|0|||
27578322|NCT01465802|80299473|FG003|Overall Study|Withdrawal by Subject|8|||
27578323|NCT01465802|80299474|FG004|Overall Study|Withdrawal by Subject|1|||
27674706|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
27984866|NCT01792518|81777112|FG001|Overall Study|Withdrawal by Subject|0|||
27578324|NCT01465802|80299470|FG000|Overall Study|Lost to Follow-up|1|||
27578325|NCT01465802|80299471|FG001|Overall Study|Lost to Follow-up|1|||
27578326|NCT01465802|80299472|FG002|Overall Study|Lost to Follow-up|0|||
27578327|NCT01465802|80299473|FG003|Overall Study|Lost to Follow-up|0|||
27578328|NCT01465802|80299474|FG004|Overall Study|Lost to Follow-up|0|||
27578329|NCT01465802|80299470|FG000|Overall Study|Reason not specified|9|||
27578330|NCT01465802|80299471|FG001|Overall Study|Reason not specified|4|||
27578331|NCT01465802|80299472|FG002|Overall Study|Reason not specified|0|||
27578332|NCT01465802|80299473|FG003|Overall Study|Reason not specified|10|||
27578333|NCT01465802|80299474|FG004|Overall Study|Reason not specified|2|||
27578334|NCT01465802|80299470|FG000|Overall Study|Death|15|||
27578335|NCT01465802|80299471|FG001|Overall Study|Death|12|||
27578336|NCT01465802|80299472|FG002|Overall Study|Death|0|||
27578337|NCT01465802|80299473|FG003|Overall Study|Death|10|||
27578338|NCT01465802|80299474|FG004|Overall Study|Death|2|||
27578339|NCT04496258|80299475|FG000|Overall Study|Withdrawal by Subject|2|||
27578340|NCT04496258|80299476|FG001|Overall Study|Withdrawal by Subject|1|||
27578341|NCT01752933|80299477|FG000|Treatment|Disease Progression|3|||
27578342|NCT01752933|80299478|FG001|Treatment|Disease Progression|29|||
27578343|NCT01752933|80299477|FG000|Treatment|Withdrawal by Subject|0|||
27578344|NCT01752933|80299478|FG001|Treatment|Withdrawal by Subject|5|||
27578345|NCT01752933|80299477|FG000|Treatment|Adverse Event|1|||
27578346|NCT01752933|80299478|FG001|Treatment|Adverse Event|4|||
27578347|NCT01752933|80299477|FG000|Treatment|Physician Decision|0|||
27578348|NCT01752933|80299478|FG001|Treatment|Physician Decision|3|||
27674707|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
27674708|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
27984867|NCT01792518|81777111|FG000|Overall Study|Other Reason|0|||
27984868|NCT01792518|81777112|FG001|Overall Study|Other Reason|1|||
27795393|NCT03039686|81082090|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
27795394|NCT03039686|81082088|FG000|Double-blind Period|Withdrawal by Subject|2|||
27795395|NCT03039686|81082089|FG001|Double-blind Period|Withdrawal by Subject|2|||
27795396|NCT03039686|81082090|FG002|Double-blind Period|Withdrawal by Subject|1|||
27795397|NCT03039686|81082088|FG000|Double-blind Period|Death|0|||
27795398|NCT03039686|81082089|FG001|Double-blind Period|Death|0|||
27795399|NCT03039686|81082090|FG002|Double-blind Period|Death|1|||
27795400|NCT03039686|81082088|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
27795401|NCT03039686|81082089|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
27795402|NCT03039686|81082090|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
27869362|NCT03404674|81357660|FG003|Overall Study|Inability to Attend Future Visits|0|||
27869363|NCT03404674|81357661|FG004|Overall Study|Inability to Attend Future Visits|0|||
27869364|NCT03404674|81357662|FG005|Overall Study|Inability to Attend Future Visits|0|||
27869365|NCT03404674|81357657|FG000|Overall Study|Behavioral Problems|0|||
27869366|NCT03404674|81357658|FG001|Overall Study|Behavioral Problems|0|||
27869367|NCT03404674|81357659|FG002|Overall Study|Behavioral Problems|1|||
27869368|NCT03404674|81357660|FG003|Overall Study|Behavioral Problems|0|||
27869369|NCT03404674|81357661|FG004|Overall Study|Behavioral Problems|0|||
27869370|NCT03404674|81357662|FG005|Overall Study|Behavioral Problems|0|||
27869371|NCT03404674|81357657|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
27869372|NCT03404674|81357658|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
27795403|NCT03039686|81082088|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
27795404|NCT03039686|81082089|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
27795405|NCT03039686|81082090|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
27869373|NCT03404674|81357659|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
27869374|NCT03404674|81357660|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
27869375|NCT03404674|81357661|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
27869376|NCT03404674|81357662|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
27869377|NCT03267212|81357664|FG000|First Intervention|Lost to Follow-up|0|||
27869378|NCT03267212|81357665|FG001|First Intervention|Lost to Follow-up|2|||
27869379|NCT03267212|81357664|FG000|First Intervention|Withdrawal by Subject|1|||
27869380|NCT03267212|81357665|FG001|First Intervention|Withdrawal by Subject|1|||
27869381|NCT03267212|81357664|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
27869382|NCT03267212|81357665|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
27869383|NCT02964312|81357669|FG000|Overall Study|Lost to Follow-up|28|||
27869384|NCT02964312|81357669|FG000|Overall Study|Withdrawal by Subject|11|||
27869385|NCT02964312|81357669|FG000|Overall Study|Lack of Efficacy|10|||
27869386|NCT02964312|81357669|FG000|Overall Study|Did not consent to long-term FU|14|||
27869387|NCT02964312|81357669|FG000|Overall Study|Death|1|||
27869388|NCT03772717|81357670|FG000|Overall Study|Withdrawal by Subject|2|||
27869389|NCT03092219|81357675|FG000|Overall Study|Protocol Violation|7|||
27869390|NCT03092219|81357676|FG001|Overall Study|Protocol Violation|4|||
27869391|NCT03736031|81357677|FG000|Overall Study|Death|2|||
27869392|NCT03736031|81357678|FG001|Overall Study|Death|4|||
27869393|NCT03736031|81357677|FG000|Overall Study|Lost to Follow-up|21|||
27869394|NCT03736031|81357678|FG001|Overall Study|Lost to Follow-up|2|||
27869395|NCT03736031|81357677|FG000|Overall Study|Withdrawal by Subject|9|||
27869396|NCT03736031|81357678|FG001|Overall Study|Withdrawal by Subject|0|||
27869397|NCT01275729|81357679|FG000|Overall Study|Death|3|||
27869398|NCT01275729|81357679|FG000|Overall Study|Withdrawal by Subject|1|||
27869399|NCT02431364|81357683|FG000|Overall Study|Adverse Event|0|||
27869400|NCT02431364|81357684|FG001|Overall Study|Adverse Event|1|||
27869401|NCT02431364|81357685|FG002|Overall Study|Adverse Event|0|||
27869402|NCT02431364|81357686|FG003|Overall Study|Adverse Event|0|||
27869403|NCT02431364|81357687|FG004|Overall Study|Adverse Event|0|||
27869404|NCT02431364|81357683|FG000|Overall Study|Randomized but never treated|0|||
27869405|NCT02431364|81357684|FG001|Overall Study|Randomized but never treated|0|||
27869406|NCT02431364|81357685|FG002|Overall Study|Randomized but never treated|0|||
27869407|NCT02431364|81357686|FG003|Overall Study|Randomized but never treated|1|||
27869408|NCT02431364|81357687|FG004|Overall Study|Randomized but never treated|0|||
27869409|NCT00972595|81357688|FG000|Period 1|Adverse Event|1|||
27869410|NCT00972595|81357689|FG001|Period 1|Adverse Event|0|||
27869411|NCT01443728|81357690|FG000|Overall Study|Lost to Follow-up|2|||
27869412|NCT01443728|81357691|FG001|Overall Study|Lost to Follow-up|0|||
27869413|NCT01443728|81357690|FG000|Overall Study|Withdrawal by Subject|1|||
27869414|NCT01443728|81357691|FG001|Overall Study|Withdrawal by Subject|1|||
27984869|NCT03729245|81777113|FG000|Overall Study|Lost to Follow-up|5|||
27869415|NCT01443728|81357690|FG000|Overall Study|Adverse Event|0|||
27869416|NCT01443728|81357691|FG001|Overall Study|Adverse Event|2|||
27869417|NCT02566889|81357692|FG000|Overall Study|Withdrawal by Subject|3|||
27795406|NCT03039686|81082088|FG000|Open Label Period|Withdrawal by Subject|0|||
27795407|NCT03039686|81082089|FG001|Open Label Period|Withdrawal by Subject|3|||
27795408|NCT03039686|81082090|FG002|Open Label Period|Withdrawal by Subject|1|||
27795409|NCT05037409|81082091|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
27795410|NCT05037409|81082092|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
27795411|NCT05037409|81082093|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
27795412|NCT04059484|81082094|FG000|Overall Study|Adverse Event|2|||
27795413|NCT04059484|81082095|FG001|Overall Study|Adverse Event|5|||
27795414|NCT04059484|81082094|FG000|Overall Study|Withdrawal by Subject|5|||
27795415|NCT04059484|81082095|FG001|Overall Study|Withdrawal by Subject|3|||
27869418|NCT02566889|81357693|FG001|Overall Study|Withdrawal by Subject|1|||
27869419|NCT02566889|81357692|FG000|Overall Study|Adverse Event|4|||
27869420|NCT02566889|81357693|FG001|Overall Study|Adverse Event|2|||
27869421|NCT02566889|81357692|FG000|Overall Study|Other|6|||
27869422|NCT02566889|81357693|FG001|Overall Study|Other|2|||
27984870|NCT03729245|81777114|FG001|Overall Study|Lost to Follow-up|6|||
27984871|NCT03729245|81777113|FG000|Overall Study|Withdrawal by Subject|16|||
27795416|NCT04059484|81082094|FG000|Overall Study|Progressive disease|112|||
27795417|NCT04059484|81082095|FG001|Overall Study|Progressive disease|112|||
27795418|NCT04059484|81082094|FG000|Overall Study|Other|8|||
27795419|NCT04059484|81082095|FG001|Overall Study|Other|3|||
27795420|NCT04059484|81082094|FG000|Overall Study|Ongoing|20|||
27795421|NCT04059484|81082095|FG001|Overall Study|Ongoing|20|||
27795422|NCT01067339|81082096|FG000|Overall Study|Withdrawal by Subject|6|||
27795423|NCT01067339|81082097|FG001|Overall Study|Withdrawal by Subject|5|||
27795424|NCT00713830|81082098|FG000|Overall Study|Adverse Event|23|||
27795425|NCT00713830|81082099|FG001|Overall Study|Adverse Event|71|||
27795426|NCT00713830|81082098|FG000|Overall Study|Lack of Efficacy|24|||
27795427|NCT00713830|81082099|FG001|Overall Study|Lack of Efficacy|16|||
27795428|NCT00713830|81082098|FG000|Overall Study|Lost to Follow-up|2|||
27795429|NCT00713830|81082099|FG001|Overall Study|Lost to Follow-up|9|||
27795430|NCT00713830|81082098|FG000|Overall Study|Withdrawal by Subject|13|||
27795431|NCT00713830|81082099|FG001|Overall Study|Withdrawal by Subject|23|||
27984872|NCT03729245|81777114|FG001|Overall Study|Withdrawal by Subject|19|||
27984873|NCT03729245|81777113|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
27984874|NCT03729245|81777114|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
27984875|NCT03332160|81777115|FG000|Overall Study|Withdrawal by Subject|1|||
27984876|NCT03332160|81777116|FG001|Overall Study|Withdrawal by Subject|1|||
27984877|NCT03332160|81777115|FG000|Overall Study|Adverse Event|0|||
27984878|NCT03332160|81777116|FG001|Overall Study|Adverse Event|1|||
27984879|NCT03332160|81777115|FG000|Overall Study|Developed Exclusion Criteria|0|||
27984880|NCT03332160|81777116|FG001|Overall Study|Developed Exclusion Criteria|1|||
27984881|NCT03332160|81777115|FG000|Overall Study|Non-adherence to treatment|0|||
27984882|NCT03332160|81777116|FG001|Overall Study|Non-adherence to treatment|2|||
27984883|NCT00351273|81777117|FG000|Overall Study|Lost to Follow-up|1|||
27984884|NCT00351273|81777118|FG001|Overall Study|Lost to Follow-up|2|||
27984885|NCT00351273|81777119|FG002|Overall Study|Lost to Follow-up|5|||
27984886|NCT03149029|81777122|FG000|Overall Study|Adverse Event|2|||
27984887|NCT03149029|81777123|FG001|Overall Study|Adverse Event|0|||
27984888|NCT00471887|81777124|FG000|Overall Study|Adverse Event|9|||
27984889|NCT00257660|81777125|FG000|Overall Study|Lack of Efficacy|5|||
27984890|NCT00257660|81777126|FG001|Overall Study|Lack of Efficacy|23|||
27984891|NCT00257660|81777125|FG000|Overall Study|Withdrawal by Subject|2|||
27984892|NCT00257660|81777126|FG001|Overall Study|Withdrawal by Subject|0|||
27984893|NCT00257660|81777125|FG000|Overall Study|Lost to Follow-up|1|||
27984894|NCT00257660|81777126|FG001|Overall Study|Lost to Follow-up|0|||
27984895|NCT00257660|81777125|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
27984896|NCT00257660|81777126|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
27984897|NCT00257660|81777125|FG000|Overall Study|No longer wanted to do blood draws|1|||
27984898|NCT00257660|81777126|FG001|Overall Study|No longer wanted to do blood draws|0|||
27984899|NCT03927404|81777127|FG000|Overall Study|Withdrawal by Subject|1|||
27984900|NCT03597061|81777128|FG000|Overall Study|Lost to Follow-up|1|||
27984901|NCT03597061|81777129|FG001|Overall Study|Lost to Follow-up|0|||
27984902|NCT03597061|81777128|FG000|Overall Study|Protocol Violation|0|||
27984903|NCT03597061|81777129|FG001|Overall Study|Protocol Violation|1|||
27984904|NCT03688555|81777130|FG000|Treatment Period|Adverse Event|0|||
27984905|NCT03688555|81777131|FG001|Treatment Period|Adverse Event|0|||
27984906|NCT03688555|81777132|FG002|Treatment Period|Adverse Event|1|||
27984907|NCT00619099|81777133|FG000|Overall Study|Progressive Disease|7|||
27795432|NCT00713830|81082098|FG000|Overall Study|Poor Compliance to Protocol|7|||
27869423|NCT02661217|81357700|FG000|Overall Study|Physician Decision|12|||
27795433|NCT00713830|81082099|FG001|Overall Study|Poor Compliance to Protocol|14|||
27795434|NCT00713830|81082098|FG000|Overall Study|Familial and Personal Reasons|9|||
27795435|NCT00713830|81082099|FG001|Overall Study|Familial and Personal Reasons|34|||
27984908|NCT00619099|81777134|FG001|Overall Study|Progressive Disease|5|||
27984909|NCT00619099|81777133|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
27795436|NCT00713830|81082098|FG000|Overall Study|Sponsor Decision|4|||
27795437|NCT00713830|81082099|FG001|Overall Study|Sponsor Decision|10|||
27795438|NCT00819091|81082100|FG000|Overall Study|Adverse Event|3|||
27795439|NCT00819091|81082101|FG001|Overall Study|Adverse Event|5|||
27795440|NCT00819091|81082100|FG000|Overall Study|Protocol Violation|0|||
27795441|NCT00819091|81082101|FG001|Overall Study|Protocol Violation|1|||
27795442|NCT00819091|81082100|FG000|Overall Study|Lost to Follow-up|2|||
27795443|NCT00819091|81082101|FG001|Overall Study|Lost to Follow-up|0|||
27795444|NCT00819091|81082100|FG000|Overall Study|Withdrawal by Subject|1|||
27795445|NCT00819091|81082101|FG001|Overall Study|Withdrawal by Subject|2|||
27795446|NCT00819091|81082100|FG000|Overall Study|Other|1|||
27795447|NCT00819091|81082101|FG001|Overall Study|Other|2|||
27795448|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
27795449|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
27795450|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
27795451|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
27795452|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
27795453|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
27795454|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
27795455|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
27795456|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
27795457|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
27795458|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
27795459|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
27795460|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
27795461|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
27795462|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
27795463|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
27795464|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
27795465|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
27795466|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
27795467|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
27795468|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
27795469|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
27795470|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
27795471|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
27795472|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
27795473|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
27795474|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
27795475|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
27795476|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
27795477|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
27795478|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
27795479|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
27795480|NCT03747939|81082102|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
27795481|NCT03747939|81082103|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
27795482|NCT03747939|81082104|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
27795483|NCT03747939|81082105|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
27795484|NCT03747939|81082102|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
27795485|NCT03747939|81082103|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
27795486|NCT03747939|81082104|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
27795487|NCT03747939|81082105|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
27795488|NCT03747939|81082102|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
27795489|NCT03747939|81082103|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
27795490|NCT03747939|81082104|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
27795491|NCT03747939|81082105|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
27795492|NCT03747939|81082102|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
27795493|NCT03747939|81082103|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
27795494|NCT03747939|81082104|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
27795495|NCT03747939|81082105|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
27795496|NCT03747939|81082102|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
27795497|NCT03747939|81082103|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
27795498|NCT03747939|81082104|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
27795499|NCT03747939|81082105|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
27795500|NCT03747939|81082102|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
27795501|NCT03747939|81082103|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
27795502|NCT03747939|81082104|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
27795503|NCT03747939|81082105|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
27795504|NCT01035229|81082113|FG000|Overall Study|Adverse Event|61|||
27795505|NCT01035229|81082114|FG001|Overall Study|Adverse Event|14|||
27795506|NCT01035229|81082113|FG000|Overall Study|Withdrawal by Subject|20|||
27795507|NCT01035229|81082114|FG001|Overall Study|Withdrawal by Subject|7|||
27795508|NCT01035229|81082113|FG000|Overall Study|Lost to Follow-up|1|||
27795509|NCT01035229|81082114|FG001|Overall Study|Lost to Follow-up|0|||
27795510|NCT01035229|81082113|FG000|Overall Study|Administrative problems|1|||
27795511|NCT01035229|81082114|FG001|Overall Study|Administrative problems|1|||
27795512|NCT01035229|81082113|FG000|Overall Study|Death|13|||
27795513|NCT01035229|81082114|FG001|Overall Study|Death|5|||
27795514|NCT01035229|81082113|FG000|Overall Study|New cancer therapy|2|||
27795515|NCT01035229|81082114|FG001|Overall Study|New cancer therapy|0|||
27795516|NCT01035229|81082113|FG000|Overall Study|Protocol Violation|0|||
27795517|NCT01035229|81082114|FG001|Overall Study|Protocol Violation|2|||
27795518|NCT01035229|81082113|FG000|Overall Study|Sponsor's decision to end study|3|||
27795519|NCT01035229|81082114|FG001|Overall Study|Sponsor's decision to end study|3|||
27795520|NCT01035229|81082113|FG000|Overall Study|Disease Progression|261|||
27795521|NCT01035229|81082114|FG001|Overall Study|Disease Progression|152|||
27795522|NCT00530621|81082115|FG000|Overall Study|Adverse Event|11|||
27795523|NCT00530621|81082116|FG001|Overall Study|Adverse Event|8|||
27795524|NCT00530621|81082115|FG000|Overall Study|Physician Decision|2|||
27795525|NCT00530621|81082116|FG001|Overall Study|Physician Decision|4|||
27795526|NCT00530621|81082115|FG000|Overall Study|Progressive Disease (PD)|47|||
27984910|NCT00619099|81777134|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
27984911|NCT00619099|81777133|FG000|Overall Study|Adverse Event|4|||
27984912|NCT00619099|81777134|FG001|Overall Study|Adverse Event|3|||
27984913|NCT00619099|81777133|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
27984914|NCT00619099|81777134|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
27984915|NCT00619099|81777133|FG000|Overall Study|Withdrawal by Subject|10|||
27984916|NCT00619099|81777134|FG001|Overall Study|Withdrawal by Subject|2|||
27984917|NCT00619099|81777133|FG000|Overall Study|Physician Decision|9|||
27984918|NCT00619099|81777134|FG001|Overall Study|Physician Decision|6|||
27984919|NCT04969198|81777135|FG000|Overall Study|Withdrawal by Subject|20|||
27984920|NCT04969198|81777135|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
27984921|NCT04969198|81777135|FG000|Overall Study|Lost to Follow-up|20|||
27984922|NCT03596450|81777141|FG000|Overall Study|Death|9|||
27984923|NCT03596450|81777142|FG001|Overall Study|Death|9|||
27984924|NCT03596450|81777141|FG000|Overall Study|Protocol Violation|18|||
27984925|NCT03596450|81777142|FG001|Overall Study|Protocol Violation|26|||
27984926|NCT03596450|81777141|FG000|Overall Study|Lost to Follow-up|50|||
27984927|NCT03596450|81777142|FG001|Overall Study|Lost to Follow-up|56|||
27984928|NCT03596450|81777141|FG000|Overall Study|Adverse Event|14|||
27984929|NCT03596450|81777142|FG001|Overall Study|Adverse Event|7|||
27984930|NCT03596450|81777141|FG000|Overall Study|Withdrawal by Subject|38|||
27984931|NCT03596450|81777142|FG001|Overall Study|Withdrawal by Subject|36|||
27984932|NCT03596450|81777141|FG000|Overall Study|Accidentally Randomized|2|||
27984933|NCT03596450|81777142|FG001|Overall Study|Accidentally Randomized|0|||
27984934|NCT03596450|81777141|FG000|Overall Study|Other reasons|48|||
27984935|NCT03596450|81777142|FG001|Overall Study|Other reasons|53|||
27984936|NCT03596450|81777141|FG000|Overall Study|Pregnancy|2|||
27984937|NCT03596450|81777142|FG001|Overall Study|Pregnancy|0|||
27984938|NCT02273960|81777148|FG000|Short Term Period|Lost to Follow-up|1|||
27795527|NCT00530621|81082116|FG001|Overall Study|Progressive Disease (PD)|40|||
27795528|NCT00530621|81082115|FG000|Overall Study|Sponsor Decision|12|||
27984939|NCT02273960|81777149|FG001|Short Term Period|Lost to Follow-up|0|||
27795529|NCT00530621|81082116|FG001|Overall Study|Sponsor Decision|15|||
27795530|NCT00530621|81082115|FG000|Overall Study|Subject Decision|4|||
27795531|NCT00530621|81082116|FG001|Overall Study|Subject Decision|7|||
27795532|NCT00530621|81082115|FG000|Overall Study|Death|3|||
27795533|NCT00530621|81082116|FG001|Overall Study|Death|6|||
27984940|NCT02273960|81777150|FG002|Short Term Period|Lost to Follow-up|0|||
27984941|NCT02273960|81777151|FG003|Short Term Period|Lost to Follow-up|0|||
27984942|NCT02273960|81777148|FG000|Short Term Period|Lack of Efficacy|0|||
27984943|NCT02273960|81777149|FG001|Short Term Period|Lack of Efficacy|0|||
27984944|NCT02273960|81777150|FG002|Short Term Period|Lack of Efficacy|0|||
27984945|NCT02273960|81777151|FG003|Short Term Period|Lack of Efficacy|1|||
27984946|NCT02273960|81777148|FG000|Short Term Period|ST complete, not entering LTE|4|||
27795534|NCT00530621|81082115|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
27795535|NCT00530621|81082116|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
27795536|NCT05000931|81082117|FG000|Overall Study|Lost to Follow-up|1|||
27795537|NCT04993339|81082124|FG000|Overall Study|Lost to Follow-up|0|||
27795538|NCT04993339|81082125|FG001|Overall Study|Lost to Follow-up|1|||
27795539|NCT04993339|81082124|FG000|Overall Study|no MRI scan|3|||
27795540|NCT04993339|81082125|FG001|Overall Study|no MRI scan|1|||
27984947|NCT02273960|81777149|FG001|Short Term Period|ST complete, not entering LTE|6|||
27984948|NCT02273960|81777150|FG002|Short Term Period|ST complete, not entering LTE|4|||
27984949|NCT02273960|81777151|FG003|Short Term Period|ST complete, not entering LTE|5|||
27984950|NCT02273960|81777148|FG000|Long Term Extension|Death|0|||
27984951|NCT02273960|81777149|FG001|Long Term Extension|Death|0|||
27984952|NCT02273960|81777150|FG002|Long Term Extension|Death|0|||
27984953|NCT02273960|81777151|FG003|Long Term Extension|Death|1|||
27984954|NCT03429543|81777155|FG000|Overall Study|Adverse Event|1|||
27984955|NCT03429543|81777156|FG001|Overall Study|Adverse Event|1|||
27984956|NCT03429543|81777157|FG002|Overall Study|Adverse Event|0|||
27795541|NCT01523301|81082126|FG000|Overall Study|Adverse Event|25|||
27984957|NCT03429543|81777158|FG003|Overall Study|Adverse Event|0|||
27984958|NCT03429543|81777159|FG004|Overall Study|Adverse Event|0|||
27795542|NCT01523301|81082127|FG001|Overall Study|Adverse Event|16|||
27984959|NCT03429543|81777160|FG005|Overall Study|Adverse Event|2|||
27984960|NCT03429543|81777161|FG006|Overall Study|Adverse Event|0|||
27984961|NCT03429543|81777155|FG000|Overall Study|Lost to Follow-up|1|||
27984962|NCT03429543|81777156|FG001|Overall Study|Lost to Follow-up|0|||
27984963|NCT03429543|81777157|FG002|Overall Study|Lost to Follow-up|0|||
27984964|NCT03429543|81777158|FG003|Overall Study|Lost to Follow-up|0|||
27984965|NCT03429543|81777159|FG004|Overall Study|Lost to Follow-up|1|||
27984966|NCT03429543|81777160|FG005|Overall Study|Lost to Follow-up|0|||
27984967|NCT03429543|81777161|FG006|Overall Study|Lost to Follow-up|0|||
27984968|NCT03429543|81777155|FG000|Overall Study|Withdrawal by Subject|5|||
27984969|NCT03429543|81777156|FG001|Overall Study|Withdrawal by Subject|0|||
27984970|NCT03429543|81777157|FG002|Overall Study|Withdrawal by Subject|1|||
27984971|NCT03429543|81777158|FG003|Overall Study|Withdrawal by Subject|2|||
27984972|NCT03429543|81777159|FG004|Overall Study|Withdrawal by Subject|6|||
27984973|NCT03429543|81777160|FG005|Overall Study|Withdrawal by Subject|3|||
27984974|NCT03429543|81777161|FG006|Overall Study|Withdrawal by Subject|1|||
27984975|NCT03429543|81777155|FG000|Overall Study|Other reason than listed|0|||
27984976|NCT03429543|81777156|FG001|Overall Study|Other reason than listed|1|||
27984977|NCT03429543|81777157|FG002|Overall Study|Other reason than listed|0|||
27984978|NCT03429543|81777158|FG003|Overall Study|Other reason than listed|0|||
27984979|NCT03429543|81777159|FG004|Overall Study|Other reason than listed|4|||
27869424|NCT02661217|81357701|FG001|Overall Study|Physician Decision|15|||
27869425|NCT02661217|81357700|FG000|Overall Study|Lost to Follow-up|1|||
27869426|NCT02661217|81357701|FG001|Overall Study|Lost to Follow-up|4|||
27869427|NCT02661217|81357700|FG000|Overall Study|Protocol Deviation|0|||
27869428|NCT02661217|81357701|FG001|Overall Study|Protocol Deviation|4|||
27869429|NCT02661217|81357700|FG000|Overall Study|Non-compliance with study treatment|5|||
27869430|NCT02661217|81357701|FG001|Overall Study|Non-compliance with study treatment|5|||
27869431|NCT02661217|81357700|FG000|Overall Study|Death|21|||
27869432|NCT02661217|81357701|FG001|Overall Study|Death|15|||
27869433|NCT02661217|81357700|FG000|Overall Study|Adverse Event|10|||
27869434|NCT02661217|81357701|FG001|Overall Study|Adverse Event|8|||
27869435|NCT02661217|81357700|FG000|Overall Study|Withdrawal by Subject|15|||
27869436|NCT02661217|81357701|FG001|Overall Study|Withdrawal by Subject|19|||
27869437|NCT02661217|81357700|FG000|Overall Study|Did not enter follow-up epoch|7|||
27869438|NCT02661217|81357701|FG001|Overall Study|Did not enter follow-up epoch|10|||
27869439|NCT02661217|81357700|FG000|Overall Study|Death - no study drug received|1|||
27869440|NCT02661217|81357701|FG001|Overall Study|Death - no study drug received|2|||
27869441|NCT02661217|81357700|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
27869442|NCT02661217|81357701|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
27869443|NCT02925403|81357705|FG000|Overall Study|Lost to Follow-up|0|||
27869444|NCT02925403|81357706|FG001|Overall Study|Lost to Follow-up|1|||
27869445|NCT03348163|81357709|FG000|Overall Study|Withdrawal by Subject|2|||
27984980|NCT03429543|81777160|FG005|Overall Study|Other reason than listed|4|||
27984981|NCT03429543|81777161|FG006|Overall Study|Other reason than listed|0|||
27984982|NCT03429543|81777155|FG000|Overall Study|Not treated|0|||
27984983|NCT03429543|81777156|FG001|Overall Study|Not treated|0|||
27984984|NCT03429543|81777157|FG002|Overall Study|Not treated|0|||
27984985|NCT03429543|81777158|FG003|Overall Study|Not treated|0|||
27984986|NCT03429543|81777159|FG004|Overall Study|Not treated|1|||
27984987|NCT03429543|81777160|FG005|Overall Study|Not treated|0|||
27984988|NCT03429543|81777161|FG006|Overall Study|Not treated|0|||
27984989|NCT00483002|81777164|FG000|Overall Study|Adverse Event|68|||
27984990|NCT00483002|81777164|FG000|Overall Study|Lack of Efficacy|555|||
27984991|NCT00483002|81777164|FG000|Overall Study|Lost to Follow-up|962|||
27984992|NCT00483002|81777164|FG000|Overall Study|Other|2|||
27984993|NCT00483002|81777164|FG000|Overall Study|Other|967|||
27984994|NCT02943915|81777165|FG000|Overall Study|Withdrawal by Subject|2|||
27984995|NCT02943915|81777166|FG001|Overall Study|Withdrawal by Subject|1|||
27869446|NCT03348163|81357710|FG001|Overall Study|Withdrawal by Subject|0|||
27984996|NCT02943915|81777167|FG002|Overall Study|Withdrawal by Subject|0|||
27869447|NCT02964247|81357711|FG000|Overall Study|Lost to Follow-up|2|||
27984997|NCT02943915|81777168|FG003|Overall Study|Withdrawal by Subject|0|||
27984998|NCT02943915|81777165|FG000|Overall Study|Lost to Follow-up|3|||
27984999|NCT02943915|81777166|FG001|Overall Study|Lost to Follow-up|1|||
27985000|NCT02943915|81777167|FG002|Overall Study|Lost to Follow-up|0|||
27985001|NCT02943915|81777168|FG003|Overall Study|Lost to Follow-up|0|||
27985002|NCT02943915|81777165|FG000|Overall Study|excluded|0|||
27985003|NCT02943915|81777166|FG001|Overall Study|excluded|1|||
27985004|NCT02943915|81777167|FG002|Overall Study|excluded|0|||
27869448|NCT02964247|81357712|FG001|Overall Study|Lost to Follow-up|0|||
27869449|NCT02964247|81357711|FG000|Overall Study|Withdrawal by Subject|1|||
27869450|NCT02964247|81357712|FG001|Overall Study|Withdrawal by Subject|2|||
27869451|NCT03905694|81357720|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
27869452|NCT02413229|81357721|FG000|Overall Study|Adverse Event|0|||
27869453|NCT02413229|81357722|FG001|Overall Study|Adverse Event|0|||
27869454|NCT02413229|81357723|FG002|Overall Study|Adverse Event|0|||
27869455|NCT02413229|81357724|FG003|Overall Study|Adverse Event|1|||
27869456|NCT02413229|81357725|FG004|Overall Study|Adverse Event|0|||
27869457|NCT02413229|81357726|FG005|Overall Study|Adverse Event|0|||
27869458|NCT02413229|81357727|FG006|Overall Study|Adverse Event|0|||
27869459|NCT02413229|81357728|FG007|Overall Study|Adverse Event|1|||
27869460|NCT02413229|81357721|FG000|Overall Study|Lost to Follow-up|0|||
27869461|NCT02413229|81357722|FG001|Overall Study|Lost to Follow-up|0|||
27869462|NCT02413229|81357723|FG002|Overall Study|Lost to Follow-up|1|||
27869463|NCT02413229|81357724|FG003|Overall Study|Lost to Follow-up|0|||
27869464|NCT02413229|81357725|FG004|Overall Study|Lost to Follow-up|2|||
27869465|NCT02413229|81357726|FG005|Overall Study|Lost to Follow-up|0|||
27869466|NCT02413229|81357727|FG006|Overall Study|Lost to Follow-up|0|||
27869467|NCT02413229|81357728|FG007|Overall Study|Lost to Follow-up|0|||
27869468|NCT02413229|81357721|FG000|Overall Study|Withdrawal by Subject|1|||
27985005|NCT02943915|81777168|FG003|Overall Study|excluded|0|||
27985006|NCT02553538|81777172|FG000|Overall Study|Could Not Reach by Telephone|133|||
27985007|NCT02553538|81777173|FG001|Overall Study|Could Not Reach by Telephone|0|||
27985008|NCT02553538|81777172|FG000|Overall Study|Died or Left Network|54|||
27795543|NCT01523301|81082126|FG000|Overall Study|Lack of Efficacy|0|||
27795544|NCT01523301|81082127|FG001|Overall Study|Lack of Efficacy|2|||
27795545|NCT01523301|81082126|FG000|Overall Study|Protocol Violation|3|||
27795546|NCT01523301|81082127|FG001|Overall Study|Protocol Violation|4|||
27795547|NCT01523301|81082126|FG000|Overall Study|Lost to Follow-up|1|||
27985009|NCT02553538|81777173|FG001|Overall Study|Died or Left Network|56|||
27795548|NCT01523301|81082127|FG001|Overall Study|Lost to Follow-up|0|||
27795549|NCT01523301|81082126|FG000|Overall Study|Withdrawal by Subject|6|||
27795550|NCT01523301|81082127|FG001|Overall Study|Withdrawal by Subject|8|||
27795551|NCT01523301|81082126|FG000|Overall Study|Other Reason|0|||
27795552|NCT01523301|81082127|FG001|Overall Study|Other Reason|2|||
27985010|NCT04268745|81777178|FG000|Overall Study|Lost to Follow-up|2|||
27985011|NCT04268745|81777179|FG001|Overall Study|Lost to Follow-up|3|||
27795553|NCT00761761|81082131|FG000|Overall Study|Lost to Follow-up|3|||
27795554|NCT00761761|81082132|FG001|Overall Study|Lost to Follow-up|1|||
27795555|NCT00761761|81082131|FG000|Overall Study|Withdrawal by Subject|3|||
27795556|NCT00761761|81082132|FG001|Overall Study|Withdrawal by Subject|0|||
27795557|NCT02257736|81082133|FG000|Overall Study|Progressive disease|365|||
27795558|NCT02257736|81082134|FG001|Overall Study|Progressive disease|327|||
27795559|NCT02257736|81082133|FG000|Overall Study|Adverse Event|45|||
27795560|NCT02257736|81082134|FG001|Overall Study|Adverse Event|56|||
27869469|NCT02413229|81357722|FG001|Overall Study|Withdrawal by Subject|1|||
27985012|NCT04268745|81777178|FG000|Overall Study|Withdrawal by Subject|4|||
27985013|NCT04268745|81777179|FG001|Overall Study|Withdrawal by Subject|2|||
27985014|NCT04268745|81777178|FG000|Overall Study|Death in the family|1|||
27985015|NCT04268745|81777179|FG001|Overall Study|Death in the family|0|||
27985016|NCT01639755|81777180|FG000|Overall Study|Study Ongoing|15|||
27985017|NCT01639755|81777180|FG000|Overall Study|Patient had device explantation|4|||
27985018|NCT00718770|81777181|FG000|Overall Study|Adverse Event|1|||
27985019|NCT00718770|81777181|FG000|Overall Study|Lack of Efficacy|1|||
27985020|NCT00718770|81777181|FG000|Overall Study|Lack of Efficacy|1|||
27985021|NCT00718770|81777181|FG000|Overall Study|Adverse Event|1|||
27985022|NCT00718770|81777181|FG000|Overall Study|Lack of Efficacy|1|||
27985023|NCT00718770|81777181|FG000|Overall Study|Adverse Event|1|||
27985024|NCT00718770|81777181|FG000|Overall Study|Lack of Efficacy|1|||
27578349|NCT01752933|80299477|FG000|Treatment|Death|0|||
27795561|NCT02257736|81082133|FG000|Overall Study|Withdrawal by Subject|21|||
27795562|NCT02257736|81082134|FG001|Overall Study|Withdrawal by Subject|38|||
27869470|NCT02413229|81357723|FG002|Overall Study|Withdrawal by Subject|0|||
27869471|NCT02413229|81357724|FG003|Overall Study|Withdrawal by Subject|0|||
27985025|NCT00718770|81777181|FG000|Overall Study|Adverse Event|1|||
27985026|NCT00444067|81777182|FG000|Overall Study|Lost to Follow-up|0|||
27795563|NCT02257736|81082133|FG000|Overall Study|Death|11|||
27795564|NCT02257736|81082134|FG001|Overall Study|Death|6|||
27795565|NCT02257736|81082133|FG000|Overall Study|Physician Decision|5|||
27795566|NCT02257736|81082134|FG001|Overall Study|Physician Decision|9|||
27795567|NCT02257736|81082133|FG000|Overall Study|Non-Compliance with study drug|1|||
27869472|NCT02413229|81357725|FG004|Overall Study|Withdrawal by Subject|1|||
27869473|NCT02413229|81357726|FG005|Overall Study|Withdrawal by Subject|0|||
27869474|NCT02413229|81357727|FG006|Overall Study|Withdrawal by Subject|0|||
27985027|NCT00444067|81777183|FG001|Overall Study|Lost to Follow-up|1|||
27985028|NCT00820222|81777184|FG000|Overall Study|Lost to Follow-up|10|||
27985029|NCT00820222|81777185|FG001|Overall Study|Lost to Follow-up|9|||
27869475|NCT02413229|81357728|FG007|Overall Study|Withdrawal by Subject|2|||
27869476|NCT02413229|81357721|FG000|Overall Study|Progressive Disease|0|||
27869477|NCT02413229|81357722|FG001|Overall Study|Progressive Disease|0|||
27869478|NCT02413229|81357723|FG002|Overall Study|Progressive Disease|0|||
27869479|NCT02413229|81357724|FG003|Overall Study|Progressive Disease|0|||
27869480|NCT02413229|81357725|FG004|Overall Study|Progressive Disease|0|||
27869481|NCT02413229|81357726|FG005|Overall Study|Progressive Disease|0|||
27869482|NCT02413229|81357727|FG006|Overall Study|Progressive Disease|0|||
27869483|NCT02413229|81357728|FG007|Overall Study|Progressive Disease|1|||
27869484|NCT00805467|81357729|FG000|Overall Study|Lack of Efficacy|0|||
27869485|NCT00805467|81357730|FG001|Overall Study|Lack of Efficacy|8|||
27869486|NCT00805467|81357731|FG002|Overall Study|Lack of Efficacy|13|||
27869487|NCT00805467|81357732|FG003|Overall Study|Lack of Efficacy|86|||
27869488|NCT00805467|81357729|FG000|Overall Study|Lost to Follow-up|0|||
27869489|NCT00805467|81357730|FG001|Overall Study|Lost to Follow-up|1|||
27869490|NCT00805467|81357731|FG002|Overall Study|Lost to Follow-up|7|||
27578350|NCT01752933|80299478|FG001|Treatment|Death|2|||
27578351|NCT01752933|80299477|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
27578352|NCT01752933|80299478|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
27578353|NCT01752933|80299477|FG000|Treatment|Patient noncompliant|0|||
27795568|NCT02257736|81082134|FG001|Overall Study|Non-Compliance with study drug|2|||
27795569|NCT02257736|81082133|FG000|Overall Study|Protocol Violation|1|||
27795570|NCT02257736|81082134|FG001|Overall Study|Protocol Violation|0|||
27795571|NCT02257736|81082133|FG000|Overall Study|Other|1|||
27795572|NCT02257736|81082134|FG001|Overall Study|Other|7|||
27795573|NCT02257736|81082133|FG000|Overall Study|Randomized, not treated|1|||
27795574|NCT02257736|81082134|FG001|Overall Study|Randomized, not treated|2|||
27795575|NCT02940392|81082137|FG000|Overall Study|Lost to Follow-up|3|||
27795576|NCT02940392|81082137|FG000|Overall Study|Retreatment|3|||
27795577|NCT02940392|81082137|FG000|Overall Study|Death|2|||
27795578|NCT04854421|81082140|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
27795579|NCT04854421|81082141|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
27795580|NCT03099161|81082142|FG000|Overall Study|Adverse Event|0|||
27795581|NCT03099161|81082143|FG001|Overall Study|Adverse Event|0|||
27795582|NCT03099161|81082144|FG002|Overall Study|Adverse Event|2|||
27795583|NCT03099161|81082142|FG000|Overall Study|Physician Decision|2|||
27795584|NCT03099161|81082143|FG001|Overall Study|Physician Decision|0|||
27795585|NCT03099161|81082144|FG002|Overall Study|Physician Decision|0|||
27795586|NCT03099161|81082142|FG000|Overall Study|Progressive Disease|1|||
27795587|NCT03099161|81082143|FG001|Overall Study|Progressive Disease|4|||
27795588|NCT03099161|81082144|FG002|Overall Study|Progressive Disease|1|||
27795589|NCT02304302|81082148|FG000|Overall Study|Adverse Event|2|||
27795590|NCT02304302|81082149|FG001|Overall Study|Adverse Event|3|||
27795591|NCT02304302|81082148|FG000|Overall Study|Lost to Follow-up|1|||
27795592|NCT02304302|81082149|FG001|Overall Study|Lost to Follow-up|4|||
27795593|NCT02304302|81082148|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
27795594|NCT02304302|81082149|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
27795595|NCT00408005|81082155|FG000|Induction|Adverse Event|19|||
27795596|NCT00408005|81082156|FG001|Induction|Adverse Event|3|||
27795597|NCT00408005|81082157|FG002|Induction|Adverse Event|0|||
27795598|NCT00408005|81082158|FG003|Induction|Adverse Event|0|||
27795599|NCT00408005|81082159|FG004|Induction|Adverse Event|0|||
27795600|NCT00408005|81082160|FG005|Induction|Adverse Event|0|||
27795601|NCT00408005|81082161|FG006|Induction|Adverse Event|0|||
27795602|NCT00408005|81082162|FG007|Induction|Adverse Event|0|||
27795603|NCT00408005|81082155|FG000|Induction|Death|6|||
27795604|NCT00408005|81082156|FG001|Induction|Death|0|||
27795605|NCT00408005|81082157|FG002|Induction|Death|0|||
27795606|NCT00408005|81082158|FG003|Induction|Death|0|||
27795607|NCT00408005|81082159|FG004|Induction|Death|0|||
27795608|NCT00408005|81082160|FG005|Induction|Death|0|||
27795609|NCT00408005|81082161|FG006|Induction|Death|0|||
27795610|NCT00408005|81082162|FG007|Induction|Death|0|||
27795611|NCT00408005|81082155|FG000|Induction|Physician Decision|83|||
27795612|NCT00408005|81082156|FG001|Induction|Physician Decision|9|||
27795613|NCT00408005|81082157|FG002|Induction|Physician Decision|0|||
27795614|NCT00408005|81082158|FG003|Induction|Physician Decision|0|||
27795615|NCT00408005|81082159|FG004|Induction|Physician Decision|0|||
27795616|NCT00408005|81082160|FG005|Induction|Physician Decision|0|||
27869491|NCT00805467|81357732|FG003|Overall Study|Lost to Follow-up|21|||
27578354|NCT01752933|80299478|FG001|Treatment|Patient noncompliant|1|||
27795617|NCT00408005|81082161|FG006|Induction|Physician Decision|0|||
27795618|NCT00408005|81082162|FG007|Induction|Physician Decision|0|||
27869492|NCT00805467|81357729|FG000|Overall Study|Withdrawal by Subject|0|||
27869493|NCT00805467|81357730|FG001|Overall Study|Withdrawal by Subject|6|||
27869494|NCT00805467|81357731|FG002|Overall Study|Withdrawal by Subject|45|||
27578355|NCT01752933|80299477|FG000|Treatment|Patient unable to travel to appointments|0|||
27795619|NCT00408005|81082155|FG000|Induction|Withdrawal by Subject|2|||
27795620|NCT00408005|81082156|FG001|Induction|Withdrawal by Subject|4|||
27795621|NCT00408005|81082157|FG002|Induction|Withdrawal by Subject|0|||
27869495|NCT00805467|81357732|FG003|Overall Study|Withdrawal by Subject|50|||
27578356|NCT01752933|80299478|FG001|Treatment|Patient unable to travel to appointments|1|||
27578357|NCT01752933|80299477|FG000|Overall Study and Follow-up|Death|4|||
27578358|NCT01752933|80299478|FG001|Overall Study and Follow-up|Death|34|||
27578359|NCT01752933|80299477|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
27578360|NCT01752933|80299478|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
27578361|NCT01752933|80299477|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
27578362|NCT01752933|80299478|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
27578363|NCT01752933|80299477|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
27578364|NCT01752933|80299478|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
27578365|NCT04096560|80299479|FG000|Overall Study|Reason not Specified|1|||
27578366|NCT04096560|80299480|FG001|Overall Study|Reason not Specified|0|||
27578367|NCT04096560|80299481|FG002|Overall Study|Reason not Specified|0|||
27985030|NCT00820222|81777184|FG000|Overall Study|Withdrawal by Subject|19|||
27985031|NCT00820222|81777185|FG001|Overall Study|Withdrawal by Subject|21|||
27985032|NCT00820222|81777184|FG000|Overall Study|Physician Decision|93|||
27985033|NCT00820222|81777185|FG001|Overall Study|Physician Decision|88|||
27578368|NCT04096560|80299482|FG003|Overall Study|Reason not Specified|0|||
27578369|NCT04096560|80299483|FG004|Overall Study|Reason not Specified|1|||
27985034|NCT00820222|81777184|FG000|Overall Study|Sponsor Terminated Study|43|||
27985035|NCT00820222|81777185|FG001|Overall Study|Sponsor Terminated Study|65|||
27985036|NCT00820222|81777184|FG000|Overall Study|Unkown|11|||
27985037|NCT00820222|81777185|FG001|Overall Study|Unkown|7|||
27985038|NCT01079936|81777186|FG000|Phase I: MTD|First Remission Status|2|||
27985039|NCT01079936|81777187|FG001|Phase I: MTD|First Remission Status|0|||
27985040|NCT01079936|81777188|FG002|Phase I: MTD|First Remission Status|0|||
27985041|NCT01079936|81777189|FG003|Phase I: MTD|First Remission Status|0|||
27985042|NCT01079936|81777190|FG004|Phase I: MTD|First Remission Status|0|||
27985043|NCT01079936|81777186|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
27985044|NCT01079936|81777187|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
27985045|NCT01079936|81777188|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
27985046|NCT01079936|81777189|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
27985047|NCT01079936|81777190|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
27985048|NCT01079936|81777186|FG000|Phase II|Adverse Event|0|||
27985049|NCT01079936|81777187|FG001|Phase II|Adverse Event|0|||
27985050|NCT01079936|81777188|FG002|Phase II|Adverse Event|1|||
27985051|NCT01079936|81777189|FG003|Phase II|Adverse Event|0|||
27985052|NCT01079936|81777190|FG004|Phase II|Adverse Event|0|||
27985053|NCT01079936|81777186|FG000|Phase II|Insurance Issue|0|||
27985054|NCT01079936|81777187|FG001|Phase II|Insurance Issue|0|||
27985055|NCT01079936|81777188|FG002|Phase II|Insurance Issue|0|||
27985056|NCT01079936|81777189|FG003|Phase II|Insurance Issue|0|||
27985057|NCT01079936|81777190|FG004|Phase II|Insurance Issue|1|||
27985058|NCT02437084|81777191|FG000|Overall Study|Withdrawal by Subject|2|||
27985059|NCT02437084|81777191|FG000|Overall Study|Physician Decision|1|||
27985060|NCT00915551|81777192|FG000|Overall Study|Withdrawal by Subject|0|||
27985061|NCT00915551|81777193|FG001|Overall Study|Withdrawal by Subject|1|||
27985062|NCT00504894|81777195|FG000|Overall Study|fMRI technical problems|1|||
27985063|NCT00504894|81777196|FG001|Overall Study|fMRI technical problems|1|||
27985064|NCT00504894|81777197|FG002|Overall Study|fMRI technical problems|0|||
27985065|NCT00504894|81777195|FG000|Overall Study|Withdrawal by Subject|0|||
27985066|NCT00504894|81777196|FG001|Overall Study|Withdrawal by Subject|1|||
27985067|NCT00504894|81777197|FG002|Overall Study|Withdrawal by Subject|0|||
27985068|NCT00504894|81777195|FG000|Overall Study|Infusion technical problems|0|||
27985069|NCT00504894|81777196|FG001|Overall Study|Infusion technical problems|1|||
27985070|NCT00504894|81777197|FG002|Overall Study|Infusion technical problems|0|||
27578370|NCT04096560|80299484|FG005|Overall Study|Reason not Specified|1|||
27578371|NCT04096560|80299485|FG006|Overall Study|Reason not Specified|1|||
27578372|NCT04096560|80299486|FG007|Overall Study|Reason not Specified|0|||
27795622|NCT00408005|81082158|FG003|Induction|Withdrawal by Subject|0|||
27795623|NCT00408005|81082159|FG004|Induction|Withdrawal by Subject|0|||
27795624|NCT00408005|81082160|FG005|Induction|Withdrawal by Subject|0|||
27795625|NCT00408005|81082161|FG006|Induction|Withdrawal by Subject|0|||
27985071|NCT00504894|81777195|FG000|Overall Study|poor subject data|2|||
27985072|NCT00504894|81777196|FG001|Overall Study|poor subject data|0|||
27985073|NCT00504894|81777197|FG002|Overall Study|poor subject data|0|||
27985074|NCT01939366|81777201|FG000|Overall Study|Adverse Event|8|||
27985075|NCT01939366|81777202|FG001|Overall Study|Adverse Event|17|||
27985076|NCT01939366|81777203|FG002|Overall Study|Adverse Event|30|||
27985077|NCT01939366|81777204|FG003|Overall Study|Adverse Event|8|||
27985078|NCT01939366|81777205|FG004|Overall Study|Adverse Event|5|||
27985079|NCT01939366|81777201|FG000|Overall Study|Lack of Efficacy|2|||
27985080|NCT01939366|81777202|FG001|Overall Study|Lack of Efficacy|1|||
27985081|NCT01939366|81777203|FG002|Overall Study|Lack of Efficacy|1|||
27578373|NCT04096560|80299479|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
27985082|NCT01939366|81777204|FG003|Overall Study|Lack of Efficacy|1|||
27985083|NCT01939366|81777205|FG004|Overall Study|Lack of Efficacy|3|||
27985084|NCT01939366|81777201|FG000|Overall Study|Lost to Follow-up|1|||
27985085|NCT01939366|81777202|FG001|Overall Study|Lost to Follow-up|1|||
27985086|NCT01939366|81777203|FG002|Overall Study|Lost to Follow-up|0|||
27985087|NCT01939366|81777204|FG003|Overall Study|Lost to Follow-up|0|||
27985088|NCT01939366|81777205|FG004|Overall Study|Lost to Follow-up|0|||
27985089|NCT01939366|81777201|FG000|Overall Study|Withdrawal by Subject|1|||
27985090|NCT01939366|81777202|FG001|Overall Study|Withdrawal by Subject|0|||
27985091|NCT01939366|81777203|FG002|Overall Study|Withdrawal by Subject|2|||
27985092|NCT01939366|81777204|FG003|Overall Study|Withdrawal by Subject|2|||
27985093|NCT01939366|81777205|FG004|Overall Study|Withdrawal by Subject|3|||
27985094|NCT01939366|81777201|FG000|Overall Study|Inclusion criteria not met|0|||
27985095|NCT01939366|81777202|FG001|Overall Study|Inclusion criteria not met|1|||
27985096|NCT01939366|81777203|FG002|Overall Study|Inclusion criteria not met|1|||
27985097|NCT01939366|81777204|FG003|Overall Study|Inclusion criteria not met|0|||
27985098|NCT01939366|81777205|FG004|Overall Study|Inclusion criteria not met|1|||
27985099|NCT01939366|81777201|FG000|Overall Study|Other|0|||
27985100|NCT01939366|81777202|FG001|Overall Study|Other|0|||
27985101|NCT01939366|81777203|FG002|Overall Study|Other|2|||
27985102|NCT01939366|81777204|FG003|Overall Study|Other|2|||
27985103|NCT01939366|81777205|FG004|Overall Study|Other|1|||
27985104|NCT01939366|81777201|FG000|Overall Study|Protocol Violation|0|||
27985105|NCT01939366|81777202|FG001|Overall Study|Protocol Violation|0|||
27985106|NCT01939366|81777203|FG002|Overall Study|Protocol Violation|0|||
27985107|NCT01939366|81777204|FG003|Overall Study|Protocol Violation|1|||
27985108|NCT01939366|81777205|FG004|Overall Study|Protocol Violation|0|||
27985109|NCT01939366|81777201|FG000|Overall Study|Sponsor decision|0|||
27985110|NCT01939366|81777202|FG001|Overall Study|Sponsor decision|0|||
27985111|NCT01939366|81777203|FG002|Overall Study|Sponsor decision|0|||
27985112|NCT01939366|81777204|FG003|Overall Study|Sponsor decision|0|||
27985113|NCT01939366|81777205|FG004|Overall Study|Sponsor decision|2|||
27985114|NCT01939366|81777201|FG000|Overall Study|GCP non-compliance at site|2|||
27985115|NCT01939366|81777202|FG001|Overall Study|GCP non-compliance at site|3|||
27985116|NCT01939366|81777203|FG002|Overall Study|GCP non-compliance at site|2|||
27985117|NCT01939366|81777204|FG003|Overall Study|GCP non-compliance at site|3|||
27985118|NCT01939366|81777205|FG004|Overall Study|GCP non-compliance at site|3|||
27985119|NCT01895309|81777206|FG000|Overall Study|Adverse Event|13|||
27985120|NCT01895309|81777207|FG001|Overall Study|Adverse Event|17|||
27985121|NCT01895309|81777206|FG000|Overall Study|Protocol Violation|1|||
27985122|NCT01895309|81777207|FG001|Overall Study|Protocol Violation|0|||
27985123|NCT01895309|81777206|FG000|Overall Study|Lack of Efficacy|1|||
27985124|NCT01895309|81777207|FG001|Overall Study|Lack of Efficacy|3|||
27985125|NCT01895309|81777206|FG000|Overall Study|Lost to Follow-up|1|||
27985126|NCT01895309|81777207|FG001|Overall Study|Lost to Follow-up|3|||
27985127|NCT01895309|81777206|FG000|Overall Study|Physician Decision|15|||
27985128|NCT01895309|81777207|FG001|Overall Study|Physician Decision|10|||
27985129|NCT01895309|81777206|FG000|Overall Study|Withdrawal by Subject|9|||
27985130|NCT01895309|81777207|FG001|Overall Study|Withdrawal by Subject|18|||
27985131|NCT02540291|81777208|FG000|Overall Study|Death|7|||
27985132|NCT02540291|81777209|FG001|Overall Study|Death|7|||
27985133|NCT02540291|81777210|FG002|Overall Study|Death|5|||
27985134|NCT02540291|81777211|FG003|Overall Study|Death|7|||
27985135|NCT02540291|81777208|FG000|Overall Study|Lost to Follow-up|0|||
27985136|NCT02540291|81777209|FG001|Overall Study|Lost to Follow-up|0|||
27985137|NCT02540291|81777210|FG002|Overall Study|Lost to Follow-up|1|||
27985138|NCT02540291|81777211|FG003|Overall Study|Lost to Follow-up|0|||
27985139|NCT02540291|81777208|FG000|Overall Study|Withdrawal Of Consent|0|||
27985140|NCT02540291|81777209|FG001|Overall Study|Withdrawal Of Consent|1|||
27985141|NCT02540291|81777210|FG002|Overall Study|Withdrawal Of Consent|0|||
27985142|NCT02540291|81777211|FG003|Overall Study|Withdrawal Of Consent|0|||
27985143|NCT02540291|81777208|FG000|Overall Study|Study Terminated By Sponsor|1|||
27985144|NCT02540291|81777209|FG001|Overall Study|Study Terminated By Sponsor|0|||
27985145|NCT02540291|81777210|FG002|Overall Study|Study Terminated By Sponsor|0|||
27985146|NCT02540291|81777211|FG003|Overall Study|Study Terminated By Sponsor|0|||
27985147|NCT02540291|81777208|FG000|Overall Study|Other|0|||
27985148|NCT02540291|81777209|FG001|Overall Study|Other|0|||
27985149|NCT02540291|81777210|FG002|Overall Study|Other|1|||
27985150|NCT02540291|81777211|FG003|Overall Study|Other|0|||
27985151|NCT04699461|81777212|FG000|Overall Study|Withdrawal by Subject|1|||
27985152|NCT04699461|81777213|FG001|Overall Study|Withdrawal by Subject|0|||
27985153|NCT04699461|81777212|FG000|Overall Study|Study termination by sponsor|2|||
27985154|NCT04699461|81777213|FG001|Overall Study|Study termination by sponsor|1|||
27985155|NCT04699461|81777212|FG000|Overall Study|Death|1|||
27985156|NCT04699461|81777213|FG001|Overall Study|Death|0|||
27985157|NCT04699461|81777212|FG000|Overall Study|Radiographic progression|0|||
27985158|NCT04699461|81777213|FG001|Overall Study|Radiographic progression|1|||
27985159|NCT00727558|81777215|FG000|Overall Study|Lens issue|0|||
27985160|NCT00727558|81777216|FG001|Overall Study|Lens issue|1|||
27985161|NCT00727558|81777215|FG000|Overall Study|Adverse Event|0|||
27985162|NCT00727558|81777216|FG001|Overall Study|Adverse Event|1|||
27985163|NCT00727558|81777215|FG000|Overall Study|Subject unable to return for follow-up|1|||
27985164|NCT00727558|81777216|FG001|Overall Study|Subject unable to return for follow-up|1|||
27985165|NCT00727558|81777215|FG000|Overall Study|Lost to Follow-up|1|||
27985166|NCT00727558|81777216|FG001|Overall Study|Lost to Follow-up|0|||
27985167|NCT00094107|81777217|FG000|Overall Study|Lack of Efficacy|23|||
27985168|NCT00094107|81777217|FG000|Overall Study|Death|5|||
27985169|NCT00094107|81777217|FG000|Overall Study|Adverse Event|3|||
27985170|NCT00094107|81777217|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
27985171|NCT00551291|81777219|FG000|Overall Study|Physician Decision|1|||
27985172|NCT03101085|81777220|FG000|Overall Study|Lost to Follow-up|0|||
27985173|NCT03101085|81777221|FG001|Overall Study|Lost to Follow-up|1|||
27985174|NCT01141478|81777222|FG000|Overall Study|Withdrawal by Subject|1|||
27985175|NCT01141478|81777223|FG001|Overall Study|Withdrawal by Subject|1|||
27985176|NCT02708355|81777224|FG000|Overall Study|Adverse Event|1|||
27985177|NCT02708355|81777225|FG001|Overall Study|Adverse Event|0|||
27985178|NCT02708355|81777226|FG002|Overall Study|Adverse Event|0|||
27985179|NCT01972789|81777227|FG000|Overall Study|Adverse Event|11|||
27985180|NCT01972789|81777228|FG001|Overall Study|Adverse Event|4|||
27985181|NCT01972789|81777227|FG000|Overall Study|Subject withdrew consent|14|||
27985182|NCT01972789|81777228|FG001|Overall Study|Subject withdrew consent|12|||
27985183|NCT01972789|81777227|FG000|Overall Study|Lost to Follow-up|4|||
27985184|NCT01972789|81777228|FG001|Overall Study|Lost to Follow-up|7|||
27985185|NCT01972789|81777227|FG000|Overall Study|Death|7|||
27985186|NCT01972789|81777228|FG001|Overall Study|Death|5|||
27985187|NCT01972789|81777227|FG000|Overall Study|Protocol deviation|1|||
27985188|NCT01972789|81777228|FG001|Overall Study|Protocol deviation|0|||
27985189|NCT01972789|81777227|FG000|Overall Study|Physician Decision|3|||
27985190|NCT01972789|81777228|FG001|Overall Study|Physician Decision|2|||
27985191|NCT01966445|81777230|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27985192|NCT01966445|81777231|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27985193|NCT01966445|81777232|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27985194|NCT01966445|81777233|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
27985195|NCT01966445|81777234|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27985196|NCT01966445|81777235|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
27985197|NCT01966445|81777236|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
27578374|NCT04096560|80299480|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
27578375|NCT04096560|80299481|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
27578376|NCT04096560|80299482|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
27578377|NCT04096560|80299483|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
27578378|NCT04096560|80299484|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
27578379|NCT04096560|80299485|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
27578380|NCT04096560|80299486|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
27578381|NCT04096560|80299479|FG000|Overall Study|Study Terminated by Sponsor|0|||
27578382|NCT04096560|80299480|FG001|Overall Study|Study Terminated by Sponsor|0|||
27578383|NCT04096560|80299481|FG002|Overall Study|Study Terminated by Sponsor|0|||
27578384|NCT04096560|80299482|FG003|Overall Study|Study Terminated by Sponsor|5|||
27578385|NCT04096560|80299483|FG004|Overall Study|Study Terminated by Sponsor|6|||
27795626|NCT00408005|81082162|FG007|Induction|Withdrawal by Subject|0|||
27869496|NCT00805467|81357729|FG000|Overall Study|Protocol Violation|0|||
27869497|NCT00805467|81357730|FG001|Overall Study|Protocol Violation|3|||
27869498|NCT00805467|81357731|FG002|Overall Study|Protocol Violation|0|||
27869499|NCT00805467|81357732|FG003|Overall Study|Protocol Violation|5|||
27869500|NCT00805467|81357729|FG000|Overall Study|Adverse Event|0|||
27869501|NCT00805467|81357730|FG001|Overall Study|Adverse Event|13|||
27869502|NCT00805467|81357731|FG002|Overall Study|Adverse Event|26|||
27869503|NCT00805467|81357732|FG003|Overall Study|Adverse Event|57|||
27869504|NCT00805467|81357729|FG000|Overall Study|Death|0|||
27869505|NCT00805467|81357730|FG001|Overall Study|Death|2|||
27869506|NCT00805467|81357731|FG002|Overall Study|Death|7|||
27795627|NCT00408005|81082155|FG000|Induction|Ineligible|33|||
27869507|NCT00805467|81357732|FG003|Overall Study|Death|5|||
27869508|NCT00805467|81357729|FG000|Overall Study|Physician Decision|0|||
27869509|NCT00805467|81357730|FG001|Overall Study|Physician Decision|1|||
27869510|NCT00805467|81357731|FG002|Overall Study|Physician Decision|2|||
27985198|NCT01966445|81777230|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27985199|NCT01966445|81777231|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
27985200|NCT01966445|81777232|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27985201|NCT01966445|81777233|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
27985202|NCT01966445|81777234|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
27985203|NCT01966445|81777235|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27985204|NCT01966445|81777236|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
27985205|NCT01966445|81777230|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27985206|NCT01966445|81777231|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
27985207|NCT01966445|81777232|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
27985208|NCT01966445|81777233|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27985209|NCT01966445|81777234|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
27985210|NCT01966445|81777235|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27985211|NCT01966445|81777236|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
27985212|NCT01966445|81777230|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27985213|NCT01966445|81777231|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27985214|NCT01966445|81777232|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27985215|NCT01966445|81777233|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27985216|NCT01966445|81777234|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27985217|NCT01966445|81777235|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
27985218|NCT01966445|81777236|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
27985219|NCT01966445|81777230|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27985220|NCT01966445|81777231|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27985221|NCT01966445|81777232|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27985222|NCT01966445|81777233|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27985223|NCT01966445|81777234|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27985224|NCT01966445|81777235|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
27985225|NCT01966445|81777236|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
27985226|NCT04732949|81777237|FG000|Overall Study|Withdrawal by Subject|23|||
27985227|NCT04732949|81777238|FG001|Overall Study|Withdrawal by Subject|27|||
27985228|NCT04732949|81777237|FG000|Overall Study|Protocol Violation|0|||
27985229|NCT04732949|81777238|FG001|Overall Study|Protocol Violation|1|||
27985230|NCT04732949|81777237|FG000|Overall Study|Non-compliance|0|||
27985231|NCT04732949|81777238|FG001|Overall Study|Non-compliance|2|||
27985232|NCT04732949|81777237|FG000|Overall Study|Physician Decision|2|||
27985233|NCT04732949|81777238|FG001|Overall Study|Physician Decision|1|||
27985234|NCT04732949|81777237|FG000|Overall Study|Serious adverse event (Fatal)|16|||
27985235|NCT04732949|81777238|FG001|Overall Study|Serious adverse event (Fatal)|18|||
27985236|NCT04732949|81777237|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
27985237|NCT04732949|81777238|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
27985238|NCT04732949|81777237|FG000|Overall Study|Non-serious adverse event|1|||
27985239|NCT04732949|81777238|FG001|Overall Study|Non-serious adverse event|3|||
27985240|NCT04732949|81777237|FG000|Overall Study|Lost to Follow-up|26|||
27985241|NCT04732949|81777238|FG001|Overall Study|Lost to Follow-up|27|||
27985242|NCT04732949|81777237|FG000|Overall Study|Other|6|||
27985243|NCT04732949|81777238|FG001|Overall Study|Other|3|||
27985244|NCT01620528|81777241|FG000|Treatment Period|Did Not Receive Study Drug|0|||
27985245|NCT01620528|81777242|FG001|Treatment Period|Did Not Receive Study Drug|0|||
27985246|NCT01620528|81777243|FG002|Treatment Period|Did Not Receive Study Drug|1|||
27985247|NCT01620528|81777241|FG000|Treatment Period|Withdrawal by Subject|35|||
27985248|NCT01620528|81777242|FG001|Treatment Period|Withdrawal by Subject|21|||
27985249|NCT01620528|81777243|FG002|Treatment Period|Withdrawal by Subject|16|||
27985250|NCT01620528|81777241|FG000|Treatment Period|Adverse Event|17|||
27985251|NCT01620528|81777242|FG001|Treatment Period|Adverse Event|13|||
27985252|NCT01620528|81777243|FG002|Treatment Period|Adverse Event|21|||
27985253|NCT01620528|81777241|FG000|Treatment Period|Lost to Follow-up|16|||
27985254|NCT01620528|81777242|FG001|Treatment Period|Lost to Follow-up|8|||
27985255|NCT01620528|81777243|FG002|Treatment Period|Lost to Follow-up|14|||
27985256|NCT01620528|81777241|FG000|Treatment Period|Other|9|||
27985257|NCT01620528|81777242|FG001|Treatment Period|Other|5|||
27985258|NCT01620528|81777243|FG002|Treatment Period|Other|7|||
27985259|NCT01620528|81777241|FG000|Treatment Period|Subject Noncompliant|11|||
27985260|NCT01620528|81777242|FG001|Treatment Period|Subject Noncompliant|2|||
27985261|NCT01620528|81777243|FG002|Treatment Period|Subject Noncompliant|2|||
27985262|NCT01620528|81777241|FG000|Treatment Period|Pregnancy|7|||
27985263|NCT01620528|81777242|FG001|Treatment Period|Pregnancy|2|||
27985264|NCT01620528|81777243|FG002|Treatment Period|Pregnancy|2|||
27985265|NCT01620528|81777241|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
27985266|NCT01620528|81777242|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
27985267|NCT01620528|81777243|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
27674709|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
27985268|NCT01620528|81777241|FG000|Treatment Period|Exclusionary Medication Received|0|||
27985269|NCT01620528|81777242|FG001|Treatment Period|Exclusionary Medication Received|1|||
27985270|NCT01620528|81777243|FG002|Treatment Period|Exclusionary Medication Received|0|||
27674710|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
27985271|NCT01620528|81777241|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
27578386|NCT04096560|80299484|FG005|Overall Study|Study Terminated by Sponsor|4|||
27578387|NCT04096560|80299485|FG006|Overall Study|Study Terminated by Sponsor|6|||
27578388|NCT04096560|80299486|FG007|Overall Study|Study Terminated by Sponsor|1|||
27578389|NCT04096560|80299479|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578390|NCT04096560|80299480|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578391|NCT04096560|80299481|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578392|NCT04096560|80299482|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578393|NCT04096560|80299483|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578394|NCT04096560|80299484|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578395|NCT04096560|80299485|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
27578396|NCT04096560|80299486|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
27578397|NCT00927927|80299487|FG000|Overall Study|Withdrawal by Subject|0|||
27578398|NCT00927927|80299488|FG001|Overall Study|Withdrawal by Subject|0|||
27578399|NCT00927927|80299489|FG002|Overall Study|Withdrawal by Subject|0|||
27578400|NCT00927927|80299490|FG003|Overall Study|Withdrawal by Subject|0|||
27578401|NCT00927927|80299491|FG004|Overall Study|Withdrawal by Subject|0|||
27578402|NCT00927927|80299492|FG005|Overall Study|Withdrawal by Subject|0|||
27578403|NCT00927927|80299493|FG006|Overall Study|Withdrawal by Subject|0|||
27795628|NCT00408005|81082156|FG001|Induction|Ineligible|14|||
27985272|NCT01620528|81777242|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
27985273|NCT01620528|81777243|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
27985274|NCT01620528|81777241|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
27985275|NCT01620528|81777242|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
27985276|NCT01620528|81777243|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
27985277|NCT01620528|81777241|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
27985278|NCT01620528|81777242|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
27985279|NCT01620528|81777243|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
27985280|NCT01620528|81777241|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
27795629|NCT00408005|81082157|FG002|Induction|Ineligible|0|||
27578404|NCT00927927|80299494|FG007|Overall Study|Withdrawal by Subject|2|||
27795630|NCT00408005|81082158|FG003|Induction|Ineligible|0|||
27578405|NCT00927927|80299495|FG008|Overall Study|Withdrawal by Subject|0|||
27869511|NCT00805467|81357732|FG003|Overall Study|Physician Decision|6|||
27869512|NCT00805467|81357729|FG000|Overall Study|Not reported|0|||
27869513|NCT00805467|81357730|FG001|Overall Study|Not reported|0|||
27869514|NCT00805467|81357731|FG002|Overall Study|Not reported|3|||
27869515|NCT00805467|81357732|FG003|Overall Study|Not reported|7|||
27869516|NCT01401452|81357733|FG000|Overall Study|Adverse reaction|9|||
27869517|NCT01401452|81357733|FG000|Overall Study|Lost to Follow-up|12|||
27985281|NCT01620528|81777242|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
27985282|NCT01620528|81777243|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
27985283|NCT01620528|81777241|FG000|Post-Treatment Follow-Up Period|Other|6|||
27578406|NCT00927927|80299496|FG009|Overall Study|Withdrawal by Subject|0|||
27578407|NCT00927927|80299497|FG010|Overall Study|Withdrawal by Subject|0|||
27578408|NCT00927927|80299498|FG011|Overall Study|Withdrawal by Subject|2|||
27578409|NCT00927927|80299499|FG012|Overall Study|Withdrawal by Subject|0|||
27578410|NCT00927927|80299500|FG013|Overall Study|Withdrawal by Subject|0|||
27578411|NCT00927927|80299501|FG014|Overall Study|Withdrawal by Subject|0|||
27578412|NCT00587587|80299502|FG000|Overall Study|Lost to Follow-up|6|||
27578413|NCT00587587|80299503|FG001|Overall Study|Lost to Follow-up|1|||
27578414|NCT02970968|80299512|FG000|Overall Study|Withdrawal by Subject|3|||
27578415|NCT02970968|80299513|FG001|Overall Study|Withdrawal by Subject|3|||
27578416|NCT02970968|80299512|FG000|Overall Study|Adverse Event|1|||
27578417|NCT02970968|80299513|FG001|Overall Study|Adverse Event|2|||
27578418|NCT02970968|80299512|FG000|Overall Study|Lost to Follow-up|1|||
27578419|NCT02970968|80299513|FG001|Overall Study|Lost to Follow-up|1|||
27578420|NCT02970968|80299512|FG000|Overall Study|Non-Compliance|0|||
27578421|NCT02970968|80299513|FG001|Overall Study|Non-Compliance|1|||
27578422|NCT04360824|80299515|FG000|Overall Study|Withdrawal by Subject|2|||
27578423|NCT04360824|80299516|FG001|Overall Study|Withdrawal by Subject|1|||
27578424|NCT04360824|80299515|FG000|Overall Study|Did not receive assigned treatment|1|||
27578425|NCT04360824|80299516|FG001|Overall Study|Did not receive assigned treatment|3|||
27578426|NCT01743092|80299517|FG000|Overall Study|Lost to Follow-up|14|||
27578427|NCT01743092|80299518|FG001|Overall Study|Lost to Follow-up|15|||
27578428|NCT03064126|80299520|FG000|Overall Study|Death|40|||
27578429|NCT03064126|80299521|FG001|Overall Study|Death|16|||
27578430|NCT03064126|80299522|FG002|Overall Study|Death|4|||
27578431|NCT03064126|80299523|FG003|Overall Study|Death|2|||
27578432|NCT03064126|80299520|FG000|Overall Study|Withdrawal by Subject|17|||
27578433|NCT03064126|80299521|FG001|Overall Study|Withdrawal by Subject|9|||
27578434|NCT03064126|80299522|FG002|Overall Study|Withdrawal by Subject|0|||
27578435|NCT03064126|80299523|FG003|Overall Study|Withdrawal by Subject|2|||
27578436|NCT03064126|80299520|FG000|Overall Study|Lost to Follow-up|7|||
27578437|NCT03064126|80299521|FG001|Overall Study|Lost to Follow-up|3|||
27578438|NCT03064126|80299522|FG002|Overall Study|Lost to Follow-up|0|||
27578439|NCT03064126|80299523|FG003|Overall Study|Lost to Follow-up|0|||
27578440|NCT03064126|80299520|FG000|Overall Study|Adverse Event|2|||
27578441|NCT03064126|80299521|FG001|Overall Study|Adverse Event|0|||
27674711|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
27674712|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
27674713|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
27674714|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
27795631|NCT00408005|81082159|FG004|Induction|Ineligible|0|||
27985284|NCT01620528|81777242|FG001|Post-Treatment Follow-Up Period|Other|4|||
27985285|NCT01620528|81777243|FG002|Post-Treatment Follow-Up Period|Other|2|||
27985286|NCT02713867|81777244|FG000|Randomization|Other Reason|2|||
27985287|NCT02713867|81777245|FG001|Randomization|Other Reason|1|||
27985288|NCT02713867|81777244|FG000|Randomization|Participant Withdrew consent|0|||
27985289|NCT02713867|81777245|FG001|Randomization|Participant Withdrew consent|2|||
27985290|NCT02713867|81777244|FG000|Treatment Period|Other Reasons|22|||
27985291|NCT02713867|81777245|FG001|Treatment Period|Other Reasons|28|||
27985292|NCT02713867|81777244|FG000|Treatment Period|Administrative reason by sponsor|21|||
27985293|NCT02713867|81777245|FG001|Treatment Period|Administrative reason by sponsor|16|||
27578442|NCT03064126|80299522|FG002|Overall Study|Adverse Event|0|||
27795632|NCT00408005|81082160|FG005|Induction|Ineligible|0|||
27795633|NCT00408005|81082161|FG006|Induction|Ineligible|0|||
27578443|NCT03064126|80299523|FG003|Overall Study|Adverse Event|0|||
27578444|NCT03064126|80299520|FG000|Overall Study|Physician Decision|3|||
27578445|NCT03064126|80299521|FG001|Overall Study|Physician Decision|0|||
27578446|NCT03064126|80299522|FG002|Overall Study|Physician Decision|0|||
27795634|NCT00408005|81082162|FG007|Induction|Ineligible|0|||
27578447|NCT03064126|80299523|FG003|Overall Study|Physician Decision|0|||
27795635|NCT00408005|81082155|FG000|Induction|Refusal of Further Protocol Therapy|225|||
27795636|NCT00408005|81082156|FG001|Induction|Refusal of Further Protocol Therapy|44|||
27795637|NCT00408005|81082157|FG002|Induction|Refusal of Further Protocol Therapy|0|||
27795638|NCT00408005|81082158|FG003|Induction|Refusal of Further Protocol Therapy|0|||
27985294|NCT02713867|81777244|FG000|Treatment Period|No longer meets study criteria|2|||
27985295|NCT02713867|81777245|FG001|Treatment Period|No longer meets study criteria|1|||
27985296|NCT02713867|81777244|FG000|Treatment Period|Poor/Non Compliance|1|||
27674715|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
27674716|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
27674717|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
27674718|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
27674719|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
27674720|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
27674721|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
27674722|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
27674723|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
27985297|NCT02713867|81777245|FG001|Treatment Period|Poor/Non Compliance|0|||
27985298|NCT02713867|81777244|FG000|Treatment Period|Maximum Clinical Benefit|5|||
27985299|NCT02713867|81777245|FG001|Treatment Period|Maximum Clinical Benefit|6|||
27985300|NCT02713867|81777244|FG000|Treatment Period|Withdrew consent|3|||
27985301|NCT02713867|81777245|FG001|Treatment Period|Withdrew consent|6|||
27985302|NCT02713867|81777244|FG000|Treatment Period|Requested to Discontinue|8|||
27985303|NCT02713867|81777245|FG001|Treatment Period|Requested to Discontinue|8|||
27985304|NCT02713867|81777244|FG000|Treatment Period|AE unrelated to Study Drug|11|||
27985305|NCT02713867|81777245|FG001|Treatment Period|AE unrelated to Study Drug|10|||
27985306|NCT02713867|81777244|FG000|Treatment Period|Death|7|||
27985307|NCT02713867|81777245|FG001|Treatment Period|Death|3|||
27674724|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
27985308|NCT02713867|81777244|FG000|Treatment Period|Study Drug Toxicity|16|||
27985309|NCT02713867|81777245|FG001|Treatment Period|Study Drug Toxicity|19|||
27985310|NCT02713867|81777244|FG000|Treatment Period|Disease Progression|82|||
27985311|NCT02713867|81777245|FG001|Treatment Period|Disease Progression|83|||
27985312|NCT00849108|81777247|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
27985313|NCT00849108|81777248|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
27985314|NCT00849108|81777247|FG000|Cohort 2 Efficacy|Adverse Event|0|||
27985315|NCT00849108|81777248|FG001|Cohort 2 Efficacy|Adverse Event|1|||
27985316|NCT00849108|81777247|FG000|Cohort 2 Efficacy|Other|0|||
27674725|NCT00132678|80647197|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
27674726|NCT00132678|80647198|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
27674727|NCT00132678|80647199|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
27674728|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
27674729|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
27674730|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
27795639|NCT00408005|81082159|FG004|Induction|Refusal of Further Protocol Therapy|0|||
27795640|NCT00408005|81082160|FG005|Induction|Refusal of Further Protocol Therapy|0|||
27985317|NCT00849108|81777248|FG001|Cohort 2 Efficacy|Other|9|||
27985318|NCT00626405|81777249|FG000|Overall Study|Deemed Ineligible|1|||
27985319|NCT00626405|81777250|FG001|Overall Study|Deemed Ineligible|0|||
27985320|NCT00626405|81777249|FG000|Overall Study|Withdrawal by Subject|0|||
27985321|NCT00626405|81777250|FG001|Overall Study|Withdrawal by Subject|1|||
27985322|NCT00500760|81777251|FG000|Overall Study|Death|32|||
27985323|NCT00500760|81777252|FG001|Overall Study|Death|15|||
27985324|NCT00500760|81777251|FG000|Overall Study|Withdrawal by Subject|5|||
27985325|NCT00500760|81777252|FG001|Overall Study|Withdrawal by Subject|7|||
27985326|NCT00500760|81777251|FG000|Overall Study|Administrative decision|2|||
27985327|NCT00500760|81777252|FG001|Overall Study|Administrative decision|0|||
27985328|NCT00500760|81777251|FG000|Overall Study|Lost to Follow-up|3|||
27985329|NCT00500760|81777252|FG001|Overall Study|Lost to Follow-up|0|||
27985330|NCT00500760|81777251|FG000|Overall Study|Other|1|||
27985331|NCT00500760|81777252|FG001|Overall Study|Other|2|||
27985332|NCT04356040|81777253|FG000|Overall Study|Death|2|||
27985333|NCT04356040|81777254|FG001|Overall Study|Death|0|||
27985334|NCT04356040|81777253|FG000|Overall Study|Lost to Follow-up|1|||
27985335|NCT04356040|81777254|FG001|Overall Study|Lost to Follow-up|0|||
27985336|NCT04356040|81777253|FG000|Overall Study|Physician Decision|0|||
27985337|NCT04356040|81777254|FG001|Overall Study|Physician Decision|1|||
27795641|NCT00408005|81082161|FG006|Induction|Refusal of Further Protocol Therapy|0|||
27795642|NCT00408005|81082162|FG007|Induction|Refusal of Further Protocol Therapy|0|||
27985338|NCT04356040|81777253|FG000|Overall Study|Withdrawal by Subject|13|||
27985339|NCT04356040|81777254|FG001|Overall Study|Withdrawal by Subject|1|||
27985340|NCT04356040|81777253|FG000|Overall Study|Enrollment Pause|10|||
27985341|NCT04356040|81777254|FG001|Overall Study|Enrollment Pause|0|||
27985342|NCT04356040|81777253|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
27985343|NCT04356040|81777254|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
27985344|NCT04356040|81777253|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
27985345|NCT04356040|81777254|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
27985346|NCT04356040|81777253|FG000|Overall Study|PI left institution|3|||
27985347|NCT04356040|81777254|FG001|Overall Study|PI left institution|0|||
27869518|NCT01401452|81357733|FG000|Overall Study|Lack of Efficacy|30|||
27869519|NCT01401452|81357733|FG000|Overall Study|Participant developed breast cancer|1|||
27869520|NCT01401452|81357733|FG000|Overall Study|Tx stopped due to financial reasons|1|||
27869521|NCT01401452|81357733|FG000|Overall Study|Tx stopped by psychiatrist|1|||
27869522|NCT01401452|81357733|FG000|Overall Study|No more visits within the 36 wk followup|4|||
27869523|NCT01401452|81357733|FG000|Overall Study|Subject did not come to follow up visits|2|||
27985348|NCT01220180|81777257|FG000|Overall Study|Lost to Follow-up|76|||
27985349|NCT01220180|81777257|FG000|Overall Study|Other|72|||
27985350|NCT01220180|81777257|FG000|Overall Study|Adverse Event|35|||
27985351|NCT01220180|81777257|FG000|Overall Study|Lack of Efficacy|22|||
27985352|NCT01220180|81777257|FG000|Overall Study|Death|1|||
27985353|NCT01220180|81777257|FG000|Overall Study|Randomized but not treated|1|||
27985354|NCT03443427|81777262|FG000|Overall Study|Adverse Event|2|||
27985355|NCT03443427|81777263|FG001|Overall Study|Adverse Event|3|||
27985356|NCT03443427|81777262|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
27985357|NCT03443427|81777263|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
27985358|NCT03443427|81777262|FG000|Overall Study|Other|4|||
27985359|NCT03443427|81777263|FG001|Overall Study|Other|6|||
27985360|NCT00440310|81777264|FG000|Overall Study|Lost to Follow-up|4|||
27985361|NCT00440310|81777265|FG001|Overall Study|Lost to Follow-up|5|||
27795643|NCT00408005|81082155|FG000|Induction|Entered another COG therapeutic protocol|4|||
27795644|NCT00408005|81082156|FG001|Induction|Entered another COG therapeutic protocol|0|||
27795645|NCT00408005|81082157|FG002|Induction|Entered another COG therapeutic protocol|0|||
27795646|NCT00408005|81082158|FG003|Induction|Entered another COG therapeutic protocol|0|||
27795647|NCT00408005|81082159|FG004|Induction|Entered another COG therapeutic protocol|0|||
27795648|NCT00408005|81082160|FG005|Induction|Entered another COG therapeutic protocol|0|||
27795649|NCT00408005|81082161|FG006|Induction|Entered another COG therapeutic protocol|0|||
27795650|NCT00408005|81082162|FG007|Induction|Entered another COG therapeutic protocol|0|||
27795651|NCT00408005|81082155|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
27795652|NCT00408005|81082156|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
27869524|NCT01401452|81357733|FG000|Overall Study|Subject didn't return for routine visits|1|||
27869525|NCT01401452|81357733|FG000|Overall Study|Subject moved to another city|1|||
27869526|NCT01401452|81357733|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
27985362|NCT00440310|81777264|FG000|Overall Study|Protocol Violation|0|||
27985363|NCT00440310|81777265|FG001|Overall Study|Protocol Violation|1|||
27985364|NCT00440310|81777264|FG000|Overall Study|Withdrawal by Subject|15|||
27985365|NCT00440310|81777265|FG001|Overall Study|Withdrawal by Subject|14|||
27985366|NCT00440310|81777264|FG000|Overall Study|No Reply at EOS|7|||
27985367|NCT00440310|81777265|FG001|Overall Study|No Reply at EOS|7|||
27985368|NCT00440310|81777264|FG000|Overall Study|Other|1|||
27985369|NCT00440310|81777265|FG001|Overall Study|Other|0|||
27985370|NCT00440310|81777264|FG000|Overall Study|Status Unknown|1|||
27985371|NCT00440310|81777265|FG001|Overall Study|Status Unknown|3|||
27985372|NCT03908970|81777266|FG000|Overall Study|Adverse Event|7|||
27985373|NCT03908970|81777267|FG001|Overall Study|Adverse Event|21|||
27985374|NCT03908970|81777266|FG000|Overall Study|Physician Decision|1|||
27985375|NCT03908970|81777267|FG001|Overall Study|Physician Decision|4|||
27985376|NCT03908970|81777266|FG000|Overall Study|Withdrawal by Subject|9|||
27985377|NCT03908970|81777267|FG001|Overall Study|Withdrawal by Subject|22|||
27985378|NCT02925728|81777268|FG000|Overall Study|Death|3|||
27985379|NCT02925728|81777269|FG001|Overall Study|Death|5|||
27985380|NCT02925728|81777268|FG000|Overall Study|Physician Decision|1|||
27985381|NCT02925728|81777269|FG001|Overall Study|Physician Decision|0|||
27985382|NCT02925728|81777268|FG000|Overall Study|Withdrawal by Subject|1|||
27985383|NCT02925728|81777269|FG001|Overall Study|Withdrawal by Subject|0|||
27985384|NCT00453973|81777270|FG000|Overall Study|Adverse Event|4|||
27985385|NCT00453973|81777271|FG001|Overall Study|Adverse Event|9|||
27985386|NCT00453973|81777270|FG000|Overall Study|Withdrawal by Subject|7|||
27985387|NCT00453973|81777271|FG001|Overall Study|Withdrawal by Subject|6|||
27985388|NCT00453973|81777270|FG000|Overall Study|PI Decision|0|||
27985389|NCT00453973|81777271|FG001|Overall Study|PI Decision|2|||
27985390|NCT00453973|81777270|FG000|Overall Study|Relocation|1|||
27985391|NCT00453973|81777271|FG001|Overall Study|Relocation|0|||
27985392|NCT00453973|81777270|FG000|Overall Study|Renal transplant|1|||
27985393|NCT00453973|81777271|FG001|Overall Study|Renal transplant|1|||
27985394|NCT00453973|81777270|FG000|Overall Study|Site closed by sponsor|3|||
27985395|NCT00453973|81777271|FG001|Overall Study|Site closed by sponsor|0|||
27985396|NCT00453973|81777270|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
27985397|NCT00453973|81777271|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
27869527|NCT01401452|81357733|FG000|Overall Study|Psoriatic arthritis|1|||
27869528|NCT01401452|81357733|FG000|Overall Study|Participant stopped Tx|2|||
27869529|NCT01401452|81357733|FG000|Overall Study|Discontinuation for personal reasons|1|||
27869530|NCT01401452|81357733|FG000|Overall Study|Treatment failure|1|||
27869531|NCT01401452|81357733|FG000|Overall Study|Unsatisfactory output|1|||
27985398|NCT03688100|81777272|FG000|Overall Study|Lost to Follow-up|21|||
27985399|NCT03688100|81777273|FG001|Overall Study|Lost to Follow-up|15|||
27985400|NCT03688100|81777274|FG002|Overall Study|Lost to Follow-up|15|||
27985401|NCT03688100|81777275|FG003|Overall Study|Lost to Follow-up|18|||
27985402|NCT03688100|81777272|FG000|Overall Study|Withdrawal by Subject|19|||
27985403|NCT03688100|81777273|FG001|Overall Study|Withdrawal by Subject|16|||
27985404|NCT03688100|81777274|FG002|Overall Study|Withdrawal by Subject|0|||
27985405|NCT03688100|81777275|FG003|Overall Study|Withdrawal by Subject|0|||
27985406|NCT03688100|81777272|FG000|Overall Study|Death|36|||
27985407|NCT03688100|81777273|FG001|Overall Study|Death|27|||
27985408|NCT03688100|81777274|FG002|Overall Study|Death|0|||
27985409|NCT03688100|81777275|FG003|Overall Study|Death|0|||
27869532|NCT01401452|81357733|FG000|Overall Study|Subject withdrew because of Tx success|1|||
27869533|NCT01401452|81357733|FG000|Overall Study|Subject chose to discontinue treatment|1|||
27869534|NCT01401452|81357733|FG000|Overall Study|Participant withdrew consent|1|||
27869535|NCT02575833|81357734|FG000|Overall Study|Withdrawal by Subject|0|||
27869536|NCT02575833|81357735|FG001|Overall Study|Withdrawal by Subject|1|||
27869537|NCT02575833|81357734|FG000|Overall Study|Lost to Follow-up|1|||
27869538|NCT02575833|81357735|FG001|Overall Study|Lost to Follow-up|0|||
27869539|NCT03126435|81357736|FG000|Overall Study|Death|90|||
27869540|NCT03126435|81357737|FG001|Overall Study|Death|84|||
27869541|NCT03126435|81357736|FG000|Overall Study|Lost to Follow-up|4|||
27985410|NCT01423916|81777279|FG000|Overall Study|Adverse Event|5|||
27985411|NCT01423916|81777280|FG001|Overall Study|Adverse Event|9|||
27985412|NCT01423916|81777281|FG002|Overall Study|Adverse Event|2|||
27985413|NCT01423916|81777279|FG000|Overall Study|Met Withdrawal Criteria|1|||
27985414|NCT01423916|81777280|FG001|Overall Study|Met Withdrawal Criteria|1|||
27985415|NCT01423916|81777281|FG002|Overall Study|Met Withdrawal Criteria|1|||
27869542|NCT03126435|81357737|FG001|Overall Study|Lost to Follow-up|3|||
27869543|NCT03126435|81357736|FG000|Overall Study|Physician Decision|0|||
27869544|NCT03126435|81357737|FG001|Overall Study|Physician Decision|1|||
27869545|NCT03126435|81357736|FG000|Overall Study|Withdrawal by Subject|6|||
27869546|NCT03126435|81357737|FG001|Overall Study|Withdrawal by Subject|12|||
27869547|NCT03126435|81357736|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
27869548|NCT03126435|81357737|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
27869549|NCT03953612|81357740|FG000|Overall Study|Randomized but did not start|1|||
27869550|NCT03953612|81357741|FG001|Overall Study|Randomized but did not start|1|||
27869551|NCT03953612|81357742|FG002|Overall Study|Randomized but did not start|1|||
27869552|NCT03953612|81357740|FG000|Overall Study|Withdrawal by Subject|2|||
27869553|NCT03953612|81357741|FG001|Overall Study|Withdrawal by Subject|1|||
27869554|NCT03953612|81357742|FG002|Overall Study|Withdrawal by Subject|0|||
27869555|NCT00709995|81357743|FG000|Overall Study|Adverse Event|4|||
27869556|NCT00709995|81357744|FG001|Overall Study|Adverse Event|2|||
27869557|NCT00709995|81357743|FG000|Overall Study|Withdrawal by Subject|1|||
27869558|NCT00709995|81357744|FG001|Overall Study|Withdrawal by Subject|3|||
27869559|NCT04071405|81357745|FG000|Overall Study|Protocol Violation|3|||
27869560|NCT00398866|81357746|FG000|Overall Study|Adverse Event|1|||
27869561|NCT00398866|81357747|FG001|Overall Study|Adverse Event|0|||
27869562|NCT00398866|81357748|FG002|Overall Study|Adverse Event|0|||
27869563|NCT00398866|81357746|FG000|Overall Study|Lack of Efficacy|0|||
27869564|NCT00398866|81357747|FG001|Overall Study|Lack of Efficacy|0|||
27869565|NCT00398866|81357748|FG002|Overall Study|Lack of Efficacy|1|||
27869566|NCT00398866|81357746|FG000|Overall Study|Lost to Follow-up|7|||
27869567|NCT00398866|81357747|FG001|Overall Study|Lost to Follow-up|6|||
27985416|NCT01423916|81777279|FG000|Overall Study|Physician Decision|1|||
27985417|NCT01423916|81777280|FG001|Overall Study|Physician Decision|0|||
27985418|NCT01423916|81777281|FG002|Overall Study|Physician Decision|1|||
27578448|NCT03064126|80299520|FG000|Overall Study|Other reason for early termination|3|||
27578449|NCT03064126|80299521|FG001|Overall Study|Other reason for early termination|2|||
27869568|NCT00398866|81357748|FG002|Overall Study|Lost to Follow-up|4|||
27869569|NCT00398866|81357746|FG000|Overall Study|Withdrawal by Subject|5|||
27869570|NCT00398866|81357747|FG001|Overall Study|Withdrawal by Subject|1|||
27869571|NCT00398866|81357748|FG002|Overall Study|Withdrawal by Subject|2|||
27869572|NCT00398866|81357746|FG000|Overall Study|Unable to complete requirements of study|1|||
27869573|NCT00398866|81357747|FG001|Overall Study|Unable to complete requirements of study|1|||
27869574|NCT00398866|81357748|FG002|Overall Study|Unable to complete requirements of study|1|||
27869575|NCT03296527|81357753|FG000|Overall Study|Adverse Event|15|||
27869576|NCT03296527|81357754|FG001|Overall Study|Adverse Event|33|||
27985419|NCT01423916|81777279|FG000|Overall Study|Withdrawal by Subject|3|||
27985420|NCT01423916|81777280|FG001|Overall Study|Withdrawal by Subject|10|||
27985421|NCT01423916|81777281|FG002|Overall Study|Withdrawal by Subject|3|||
27985422|NCT01423916|81777279|FG000|Overall Study|Protocol Deviation|1|||
27869577|NCT03296527|81357753|FG000|Overall Study|Protocol Deviation|4|||
27869578|NCT03296527|81357754|FG001|Overall Study|Protocol Deviation|0|||
27869579|NCT03296527|81357753|FG000|Overall Study|Participant withdrew consent|3|||
27869580|NCT03296527|81357754|FG001|Overall Study|Participant withdrew consent|1|||
27869581|NCT03296527|81357753|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
27869582|NCT03296527|81357754|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
27869583|NCT03296527|81357753|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
27869584|NCT03296527|81357754|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
27869585|NCT03296527|81357753|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
27869586|NCT03296527|81357754|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
27985423|NCT01423916|81777280|FG001|Overall Study|Protocol Deviation|0|||
27985424|NCT01423916|81777281|FG002|Overall Study|Protocol Deviation|0|||
27985425|NCT02212678|81777283|FG000|Overall Study|Adverse Event|1|||
27985426|NCT00629798|81777284|FG000|Overall Study|Not Treated|4|||
27985427|NCT01331291|81777288|FG000|Overall Study|Lack of Efficacy|2|||
27985428|NCT01331291|81777289|FG001|Overall Study|Lack of Efficacy|8|||
27985429|NCT01331291|81777288|FG000|Overall Study|Death|0|||
27985430|NCT01331291|81777289|FG001|Overall Study|Death|1|||
27985431|NCT01422824|81777297|FG000|Overall Study|Case record form not evaluated|1|||
27985432|NCT01422824|81777297|FG000|Overall Study|Lost to Follow-up|37|||
27985433|NCT02445573|81777298|FG000|Overall Study|Withdrawal by Subject|1|||
27985434|NCT02445573|81777299|FG001|Overall Study|Withdrawal by Subject|1|||
27985435|NCT02445573|81777298|FG000|Overall Study|Lost to Follow-up|0|||
27985436|NCT02445573|81777299|FG001|Overall Study|Lost to Follow-up|1|||
27985437|NCT00098306|81777300|FG000|Double Blind|Randomized, not treated|9|||
27985438|NCT00098306|81777301|FG001|Double Blind|Randomized, not treated|5|||
27985439|NCT00098306|81777302|FG002|Double Blind|Randomized, not treated|2|||
27985440|NCT00098306|81777303|FG003|Double Blind|Randomized, not treated|0|||
27985441|NCT00098306|81777304|FG004|Double Blind|Randomized, not treated|0|||
27985442|NCT00098306|81777305|FG005|Double Blind|Randomized, not treated|0|||
27985443|NCT00098306|81777306|FG006|Double Blind|Randomized, not treated|0|||
27985444|NCT00098306|81777300|FG000|Double Blind|Ongoing at cut-off date|151|||
27985445|NCT00098306|81777301|FG001|Double Blind|Ongoing at cut-off date|166|||
27985446|NCT00098306|81777302|FG002|Double Blind|Ongoing at cut-off date|72|||
27985447|NCT00098306|81777303|FG003|Double Blind|Ongoing at cut-off date|0|||
27985448|NCT00098306|81777304|FG004|Double Blind|Ongoing at cut-off date|0|||
27985449|NCT00098306|81777305|FG005|Double Blind|Ongoing at cut-off date|0|||
27985450|NCT00098306|81777306|FG006|Double Blind|Ongoing at cut-off date|0|||
27985451|NCT00098306|81777300|FG000|Double Blind|Adverse Event|11|||
27985452|NCT00098306|81777301|FG001|Double Blind|Adverse Event|10|||
27985453|NCT00098306|81777302|FG002|Double Blind|Adverse Event|6|||
27985454|NCT00098306|81777303|FG003|Double Blind|Adverse Event|0|||
27985455|NCT00098306|81777304|FG004|Double Blind|Adverse Event|0|||
27985456|NCT00098306|81777305|FG005|Double Blind|Adverse Event|0|||
27985457|NCT00098306|81777306|FG006|Double Blind|Adverse Event|0|||
27985458|NCT00098306|81777300|FG000|Double Blind|Lack of Efficacy|43|||
27985459|NCT00098306|81777301|FG001|Double Blind|Lack of Efficacy|34|||
27985460|NCT00098306|81777302|FG002|Double Blind|Lack of Efficacy|17|||
27985461|NCT00098306|81777303|FG003|Double Blind|Lack of Efficacy|0|||
27985462|NCT00098306|81777304|FG004|Double Blind|Lack of Efficacy|0|||
27985463|NCT00098306|81777305|FG005|Double Blind|Lack of Efficacy|0|||
27985464|NCT00098306|81777306|FG006|Double Blind|Lack of Efficacy|0|||
27985465|NCT00098306|81777300|FG000|Double Blind|Death|1|||
27985466|NCT00098306|81777301|FG001|Double Blind|Death|4|||
27985467|NCT00098306|81777302|FG002|Double Blind|Death|1|||
27985468|NCT00098306|81777303|FG003|Double Blind|Death|0|||
27985469|NCT00098306|81777304|FG004|Double Blind|Death|0|||
27985470|NCT00098306|81777305|FG005|Double Blind|Death|0|||
27985471|NCT00098306|81777306|FG006|Double Blind|Death|0|||
27985472|NCT00098306|81777300|FG000|Double Blind|Participant defaulted|19|||
27985473|NCT00098306|81777301|FG001|Double Blind|Participant defaulted|18|||
27985474|NCT00098306|81777302|FG002|Double Blind|Participant defaulted|11|||
27985475|NCT00098306|81777303|FG003|Double Blind|Participant defaulted|0|||
27985476|NCT00098306|81777304|FG004|Double Blind|Participant defaulted|0|||
27985477|NCT00098306|81777305|FG005|Double Blind|Participant defaulted|0|||
27985478|NCT00098306|81777306|FG006|Double Blind|Participant defaulted|0|||
27985479|NCT00098306|81777300|FG000|Double Blind|Un-specified|7|||
27985480|NCT00098306|81777301|FG001|Double Blind|Un-specified|3|||
27674731|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
27674732|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
27985481|NCT00098306|81777302|FG002|Double Blind|Un-specified|11|||
27985482|NCT00098306|81777303|FG003|Double Blind|Un-specified|0|||
27985483|NCT00098306|81777304|FG004|Double Blind|Un-specified|0|||
27985484|NCT00098306|81777305|FG005|Double Blind|Un-specified|0|||
27985485|NCT00098306|81777306|FG006|Double Blind|Un-specified|0|||
27985486|NCT00098306|81777300|FG000|Open Label|Lack of Efficacy|0|||
27985487|NCT00098306|81777301|FG001|Open Label|Lack of Efficacy|0|||
27578450|NCT03064126|80299522|FG002|Overall Study|Other reason for early termination|0|||
27578451|NCT03064126|80299523|FG003|Overall Study|Other reason for early termination|0|||
27578452|NCT03064126|80299520|FG000|Overall Study|Missed Visit|3|||
27985488|NCT00098306|81777302|FG002|Open Label|Lack of Efficacy|0|||
27985489|NCT00098306|81777303|FG003|Open Label|Lack of Efficacy|13|||
27985490|NCT00098306|81777304|FG004|Open Label|Lack of Efficacy|0|||
27985491|NCT00098306|81777305|FG005|Open Label|Lack of Efficacy|0|||
27985492|NCT00098306|81777306|FG006|Open Label|Lack of Efficacy|0|||
27985493|NCT00098306|81777300|FG000|Open Label|Adverse Event|0|||
27985494|NCT00098306|81777301|FG001|Open Label|Adverse Event|0|||
27985495|NCT00098306|81777302|FG002|Open Label|Adverse Event|0|||
27985496|NCT00098306|81777303|FG003|Open Label|Adverse Event|2|||
27985497|NCT00098306|81777304|FG004|Open Label|Adverse Event|0|||
27985498|NCT00098306|81777305|FG005|Open Label|Adverse Event|0|||
27985499|NCT00098306|81777306|FG006|Open Label|Adverse Event|0|||
27985500|NCT00098306|81777300|FG000|Open Label|Death|0|||
27985501|NCT00098306|81777301|FG001|Open Label|Death|0|||
27985502|NCT00098306|81777302|FG002|Open Label|Death|0|||
27985503|NCT00098306|81777303|FG003|Open Label|Death|4|||
27985504|NCT00098306|81777304|FG004|Open Label|Death|0|||
27985505|NCT00098306|81777305|FG005|Open Label|Death|0|||
27985506|NCT00098306|81777306|FG006|Open Label|Death|0|||
27985507|NCT00098306|81777300|FG000|Open Label|Participant defaulted|0|||
27985508|NCT00098306|81777301|FG001|Open Label|Participant defaulted|0|||
27985509|NCT00098306|81777302|FG002|Open Label|Participant defaulted|0|||
27985510|NCT00098306|81777303|FG003|Open Label|Participant defaulted|24|||
27985511|NCT00098306|81777304|FG004|Open Label|Participant defaulted|0|||
27985512|NCT00098306|81777305|FG005|Open Label|Participant defaulted|0|||
27985513|NCT00098306|81777306|FG006|Open Label|Participant defaulted|0|||
27985514|NCT00098306|81777300|FG000|Open Label|Un-specified|0|||
27985515|NCT00098306|81777301|FG001|Open Label|Un-specified|0|||
27985516|NCT00098306|81777302|FG002|Open Label|Un-specified|0|||
27985517|NCT00098306|81777303|FG003|Open Label|Un-specified|15|||
27985518|NCT00098306|81777304|FG004|Open Label|Un-specified|0|||
27985519|NCT00098306|81777305|FG005|Open Label|Un-specified|0|||
27985520|NCT00098306|81777306|FG006|Open Label|Un-specified|0|||
27985521|NCT00098306|81777300|FG000|Open Label|Ongoing at cut-off date|0|||
27985522|NCT00098306|81777301|FG001|Open Label|Ongoing at cut-off date|0|||
27985523|NCT00098306|81777302|FG002|Open Label|Ongoing at cut-off date|0|||
27578453|NCT03064126|80299521|FG001|Overall Study|Missed Visit|1|||
27985524|NCT00098306|81777303|FG003|Open Label|Ongoing at cut-off date|269|||
27985525|NCT00098306|81777304|FG004|Open Label|Ongoing at cut-off date|62|||
27985526|NCT00098306|81777305|FG005|Open Label|Ongoing at cut-off date|0|||
27985527|NCT00098306|81777306|FG006|Open Label|Ongoing at cut-off date|0|||
27985528|NCT00098306|81777300|FG000|Observational Phase|Death|0|||
27985529|NCT00098306|81777301|FG001|Observational Phase|Death|0|||
27985530|NCT00098306|81777302|FG002|Observational Phase|Death|0|||
27985531|NCT00098306|81777303|FG003|Observational Phase|Death|0|||
27985532|NCT00098306|81777304|FG004|Observational Phase|Death|0|||
27985533|NCT00098306|81777305|FG005|Observational Phase|Death|5|||
27985534|NCT00098306|81777306|FG006|Observational Phase|Death|4|||
27985535|NCT00098306|81777300|FG000|Observational Phase|Participant defaulted|0|||
27985536|NCT00098306|81777301|FG001|Observational Phase|Participant defaulted|0|||
27985537|NCT00098306|81777302|FG002|Observational Phase|Participant defaulted|0|||
27985538|NCT00098306|81777303|FG003|Observational Phase|Participant defaulted|0|||
27985539|NCT00098306|81777304|FG004|Observational Phase|Participant defaulted|0|||
27985540|NCT00098306|81777305|FG005|Observational Phase|Participant defaulted|34|||
27985541|NCT00098306|81777306|FG006|Observational Phase|Participant defaulted|18|||
27985542|NCT00098306|81777300|FG000|Observational Phase|Un-specified|0|||
27985543|NCT00098306|81777301|FG001|Observational Phase|Un-specified|0|||
27985544|NCT00098306|81777302|FG002|Observational Phase|Un-specified|0|||
27985545|NCT00098306|81777303|FG003|Observational Phase|Un-specified|0|||
27985546|NCT00098306|81777304|FG004|Observational Phase|Un-specified|0|||
27985547|NCT00098306|81777305|FG005|Observational Phase|Un-specified|7|||
27985548|NCT00098306|81777306|FG006|Observational Phase|Un-specified|4|||
27985549|NCT00701805|81777309|FG000|Overall Study|Withdrawal by Subject|3|||
27985550|NCT00701805|81777310|FG001|Overall Study|Withdrawal by Subject|1|||
27985551|NCT00701805|81777311|FG002|Overall Study|Withdrawal by Subject|4|||
27985552|NCT00701805|81777312|FG003|Overall Study|Withdrawal by Subject|3|||
27985553|NCT00701805|81777309|FG000|Overall Study|Adverse Event|0|||
27985554|NCT00701805|81777310|FG001|Overall Study|Adverse Event|1|||
27985555|NCT00701805|81777311|FG002|Overall Study|Adverse Event|1|||
27985556|NCT00701805|81777312|FG003|Overall Study|Adverse Event|0|||
27985557|NCT00701805|81777309|FG000|Overall Study|Missed 7 consecutive doses|0|||
27985558|NCT00701805|81777310|FG001|Overall Study|Missed 7 consecutive doses|1|||
27985559|NCT00701805|81777311|FG002|Overall Study|Missed 7 consecutive doses|0|||
27985560|NCT00701805|81777312|FG003|Overall Study|Missed 7 consecutive doses|0|||
27985561|NCT00701805|81777309|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
27985562|NCT00701805|81777310|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
27985563|NCT00701805|81777311|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
27985564|NCT00701805|81777312|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
27985565|NCT00701805|81777309|FG000|Overall Study|Physician decision, change of therapy|0|||
27985566|NCT00701805|81777310|FG001|Overall Study|Physician decision, change of therapy|0|||
27985567|NCT00701805|81777311|FG002|Overall Study|Physician decision, change of therapy|0|||
27985568|NCT00701805|81777312|FG003|Overall Study|Physician decision, change of therapy|1|||
27985569|NCT00701805|81777309|FG000|Overall Study|Difficult to travel to dialysis site|0|||
27985570|NCT00701805|81777310|FG001|Overall Study|Difficult to travel to dialysis site|0|||
27985571|NCT00701805|81777311|FG002|Overall Study|Difficult to travel to dialysis site|1|||
27795653|NCT00408005|81082157|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
27985572|NCT00701805|81777312|FG003|Overall Study|Difficult to travel to dialysis site|0|||
27985573|NCT00701805|81777309|FG000|Overall Study|Resumption criteria were not met|0|||
27985574|NCT00701805|81777310|FG001|Overall Study|Resumption criteria were not met|1|||
27985575|NCT00701805|81777311|FG002|Overall Study|Resumption criteria were not met|0|||
27985576|NCT00701805|81777312|FG003|Overall Study|Resumption criteria were not met|0|||
27985577|NCT03755661|81777314|FG000|Overall Study|Lost to Follow-up|1|||
27985578|NCT03755661|81777315|FG001|Overall Study|Lost to Follow-up|0|||
27985579|NCT01948063|81779685|FG000|Overall Study|Boston MCI halted research protocol|0|||
27985580|NCT01948063|81779686|FG001|Overall Study|Boston MCI halted research protocol|1|||
27985581|NCT01948063|81779685|FG000|Overall Study|Discovered an enrollment in other study|0|||
27985582|NCT01948063|81779686|FG001|Overall Study|Discovered an enrollment in other study|1|||
27985583|NCT01948063|81779685|FG000|Overall Study|Blood samples were accidentally thawed|1|||
27985584|NCT01948063|81779686|FG001|Overall Study|Blood samples were accidentally thawed|0|||
27985585|NCT02745535|81779687|FG000|Overall Study|Death|1|||
27985586|NCT02745535|81779687|FG000|Overall Study|Adverse Event|3|||
27985587|NCT02745535|81779687|FG000|Overall Study|Lost to Follow-up|2|||
27985588|NCT05098509|81779688|FG000|Overall Study|Withdrawal by Subject|0|||
27985589|NCT05098509|81779689|FG001|Overall Study|Withdrawal by Subject|0|||
27985590|NCT05098509|81779690|FG002|Overall Study|Withdrawal by Subject|1|||
27985591|NCT05098509|81779691|FG003|Overall Study|Withdrawal by Subject|0|||
27985592|NCT05098509|81779688|FG000|Overall Study|Early study termination|1|||
27985593|NCT05098509|81779689|FG001|Overall Study|Early study termination|1|||
27985594|NCT05098509|81779690|FG002|Overall Study|Early study termination|1|||
27985595|NCT05098509|81779691|FG003|Overall Study|Early study termination|0|||
27985596|NCT04023682|81779698|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
27985597|NCT03517566|81779699|FG000|Overall Study|Adverse Event|5|||
27985598|NCT03517566|81779700|FG001|Overall Study|Adverse Event|2|||
27985599|NCT03517566|81779701|FG002|Overall Study|Adverse Event|2|||
27985600|NCT03517566|81779702|FG003|Overall Study|Adverse Event|8|||
27985601|NCT03517566|81779703|FG004|Overall Study|Adverse Event|7|||
27985602|NCT03517566|81779699|FG000|Overall Study|Lack of Efficacy|3|||
27985603|NCT03517566|81779700|FG001|Overall Study|Lack of Efficacy|2|||
27985604|NCT03517566|81779701|FG002|Overall Study|Lack of Efficacy|1|||
27985605|NCT03517566|81779702|FG003|Overall Study|Lack of Efficacy|1|||
27985606|NCT03517566|81779703|FG004|Overall Study|Lack of Efficacy|4|||
27985607|NCT03517566|81779699|FG000|Overall Study|Lost to Follow-up|3|||
27985608|NCT03517566|81779700|FG001|Overall Study|Lost to Follow-up|1|||
27985609|NCT03517566|81779701|FG002|Overall Study|Lost to Follow-up|1|||
27985610|NCT03517566|81779702|FG003|Overall Study|Lost to Follow-up|1|||
27985611|NCT03517566|81779703|FG004|Overall Study|Lost to Follow-up|0|||
27985612|NCT03517566|81779699|FG000|Overall Study|Physician Decision|1|||
27985613|NCT03517566|81779700|FG001|Overall Study|Physician Decision|1|||
27985614|NCT03517566|81779701|FG002|Overall Study|Physician Decision|0|||
27985615|NCT03517566|81779702|FG003|Overall Study|Physician Decision|1|||
27985616|NCT03517566|81779703|FG004|Overall Study|Physician Decision|0|||
27985617|NCT03517566|81779699|FG000|Overall Study|Pregnancy|0|||
27985618|NCT03517566|81779700|FG001|Overall Study|Pregnancy|1|||
27985619|NCT03517566|81779701|FG002|Overall Study|Pregnancy|0|||
27985620|NCT03517566|81779702|FG003|Overall Study|Pregnancy|0|||
27985621|NCT03517566|81779703|FG004|Overall Study|Pregnancy|0|||
27985622|NCT03517566|81779699|FG000|Overall Study|Protocol Deviation|0|||
27985623|NCT03517566|81779700|FG001|Overall Study|Protocol Deviation|1|||
27985624|NCT03517566|81779701|FG002|Overall Study|Protocol Deviation|0|||
27985625|NCT03517566|81779702|FG003|Overall Study|Protocol Deviation|1|||
27985626|NCT03517566|81779703|FG004|Overall Study|Protocol Deviation|1|||
27985627|NCT03517566|81779699|FG000|Overall Study|Study terminated by Sponsor|11|||
27985628|NCT03517566|81779700|FG001|Overall Study|Study terminated by Sponsor|5|||
27985629|NCT03517566|81779701|FG002|Overall Study|Study terminated by Sponsor|6|||
27985630|NCT03517566|81779702|FG003|Overall Study|Study terminated by Sponsor|14|||
27985631|NCT03517566|81779703|FG004|Overall Study|Study terminated by Sponsor|12|||
27985632|NCT03517566|81779699|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
27985633|NCT03517566|81779700|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
27985634|NCT03517566|81779701|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
27985635|NCT03517566|81779702|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
27985636|NCT03517566|81779703|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
27985637|NCT04896593|81779706|FG000|Overall Study|Withdrawal by Subject|2|||
27985638|NCT04896593|81779706|FG000|Overall Study|Lost to Follow-up|1|||
27985639|NCT04896593|81779706|FG000|Overall Study|Did not complete onboarding|2|||
27985640|NCT02690714|81779709|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
27985641|NCT02690714|81779709|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
27985642|NCT00454181|81779711|FG000|Overall Study|Adverse Event|1|||
27985643|NCT00454181|81779712|FG001|Overall Study|Adverse Event|1|||
27985644|NCT00454181|81779711|FG000|Overall Study|Lost to Follow-up|11|||
27985645|NCT00454181|81779712|FG001|Overall Study|Lost to Follow-up|1|||
27985646|NCT00454181|81779711|FG000|Overall Study|Protocol Violation|1|||
27985647|NCT00454181|81779712|FG001|Overall Study|Protocol Violation|1|||
27985648|NCT00454181|81779711|FG000|Overall Study|Withdrawal by Subject|2|||
27985649|NCT00454181|81779712|FG001|Overall Study|Withdrawal by Subject|0|||
27985650|NCT00950742|81779713|FG000|Overall Study|Other Adverse Event|1|||
27985651|NCT00950742|81779714|FG001|Overall Study|Other Adverse Event|0|||
27985652|NCT00950742|81779713|FG000|Overall Study|Withdrawal by Subject|3|||
27985653|NCT00950742|81779714|FG001|Overall Study|Withdrawal by Subject|0|||
27985654|NCT00950742|81779713|FG000|Overall Study|Progressive Disease|6|||
27985655|NCT00950742|81779714|FG001|Overall Study|Progressive Disease|2|||
27795654|NCT00408005|81082158|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
27795655|NCT00408005|81082159|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
27795656|NCT00408005|81082160|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
27795657|NCT00408005|81082161|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
27795658|NCT00408005|81082162|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
27985656|NCT00950742|81779713|FG000|Overall Study|Dose limiting toxicity|6|||
27985657|NCT00950742|81779714|FG001|Overall Study|Dose limiting toxicity|0|||
27985658|NCT02478255|81779716|FG000|Overall Study|Physician Decision|6|||
27985659|NCT02478255|81779717|FG001|Overall Study|Physician Decision|0|||
27985660|NCT02478255|81779716|FG000|Overall Study|Withdrawal by Subject|2|||
27985661|NCT02478255|81779717|FG001|Overall Study|Withdrawal by Subject|0|||
27985662|NCT01345682|81779718|FG000|Overall Study|Progressive disease per RECIST|226|||
27985663|NCT01345682|81779719|FG001|Overall Study|Progressive disease per RECIST|93|||
27985664|NCT01345682|81779718|FG000|Overall Study|Worsening of underlying cancer disease|23|||
27985665|NCT01345682|81779719|FG001|Overall Study|Worsening of underlying cancer disease|12|||
27985666|NCT01345682|81779718|FG000|Overall Study|Adverse Event|51|||
27985667|NCT01345682|81779719|FG001|Overall Study|Adverse Event|41|||
27985668|NCT01345682|81779718|FG000|Overall Study|Non-compliance with protocol|0|||
27985669|NCT01345682|81779719|FG001|Overall Study|Non-compliance with protocol|1|||
27985670|NCT01345682|81779718|FG000|Overall Study|Lost to Follow-up|0|||
27985671|NCT01345682|81779719|FG001|Overall Study|Lost to Follow-up|1|||
27985672|NCT01345682|81779718|FG000|Overall Study|Refused to continue trial medication|16|||
27985673|NCT01345682|81779719|FG001|Overall Study|Refused to continue trial medication|9|||
27985674|NCT01345682|81779718|FG000|Overall Study|Not treated|2|||
27985675|NCT01345682|81779719|FG001|Overall Study|Not treated|1|||
27985676|NCT01345682|81779718|FG000|Overall Study|Reason other than those specified above|4|||
27985677|NCT01345682|81779719|FG001|Overall Study|Reason other than those specified above|3|||
27985678|NCT03157037|81779720|FG000|Overall Study|Death|1|||
27985679|NCT01825941|81779721|FG000|Overall Study|Lost to Follow-up|4|||
27985680|NCT01825941|81779722|FG001|Overall Study|Lost to Follow-up|1|||
27985681|NCT02301624|81779726|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
27985682|NCT02301624|81779727|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
27985683|NCT02301624|81779726|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
27985684|NCT02301624|81779727|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
27985685|NCT02301624|81779726|FG000|Open-label Maintenance Phase|Adverse Event|2|||
27985686|NCT02301624|81779727|FG001|Open-label Maintenance Phase|Adverse Event|5|||
27985687|NCT02301624|81779726|FG000|Open-label Maintenance Phase|Physician Decision|3|||
27985688|NCT02301624|81779727|FG001|Open-label Maintenance Phase|Physician Decision|3|||
27985689|NCT02301624|81779726|FG000|Open-label Maintenance Phase|Death|2|||
27985690|NCT02301624|81779727|FG001|Open-label Maintenance Phase|Death|1|||
27985691|NCT02301624|81779726|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
27985692|NCT02301624|81779727|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
27985693|NCT02895945|81779729|FG000|Overall Study|Physician Decision|2|||
27985694|NCT02895945|81779730|FG001|Overall Study|Physician Decision|1|||
27985695|NCT02277119|81779731|FG000|Overall Study|Lack of Efficacy|1|||
27985696|NCT02277119|81779732|FG001|Overall Study|Lack of Efficacy|1|||
27985697|NCT02277119|81779733|FG002|Overall Study|Lack of Efficacy|1|||
27985698|NCT02277119|81779731|FG000|Overall Study|Protocol Violation|2|||
27985699|NCT02277119|81779732|FG001|Overall Study|Protocol Violation|3|||
27578454|NCT03064126|80299522|FG002|Overall Study|Missed Visit|0|||
27985700|NCT02277119|81779733|FG002|Overall Study|Protocol Violation|7|||
27985701|NCT03657095|81779735|FG000|Overall Study|Withdrawal by Subject|1|||
27985702|NCT03657095|81779736|FG001|Overall Study|Withdrawal by Subject|1|||
27985703|NCT03657095|81779735|FG000|Overall Study|Adverse Event|0|||
27985704|NCT03657095|81779736|FG001|Overall Study|Adverse Event|3|||
27985705|NCT03657095|81779735|FG000|Overall Study|Study Terminated by Sponsor|58|||
27985706|NCT03657095|81779736|FG001|Overall Study|Study Terminated by Sponsor|49|||
27985707|NCT00559988|81779739|FG000|Overall Study|Death|147|||
27985708|NCT00559988|81779740|FG001|Overall Study|Death|140|||
27985709|NCT00559988|81779739|FG000|Overall Study|Withdrawal by Subject|152|||
27985710|NCT00559988|81779740|FG001|Overall Study|Withdrawal by Subject|139|||
27985711|NCT00559988|81779739|FG000|Overall Study|Lost to Follow-up|42|||
27985712|NCT00559988|81779740|FG001|Overall Study|Lost to Follow-up|56|||
27985713|NCT00559988|81779739|FG000|Overall Study|ICD device explanted|10|||
27985714|NCT00559988|81779740|FG001|Overall Study|ICD device explanted|17|||
27985715|NCT00737633|81779742|FG000|Overall Study|Study terminated by sponsor|44|||
27985716|NCT00737633|81779743|FG001|Overall Study|Study terminated by sponsor|55|||
27985717|NCT00737633|81779742|FG000|Overall Study|Lost to Follow-up|0|||
27985718|NCT00737633|81779743|FG001|Overall Study|Lost to Follow-up|1|||
27985719|NCT00737633|81779742|FG000|Overall Study|protocol non-compliance|0|||
27985720|NCT00737633|81779743|FG001|Overall Study|protocol non-compliance|1|||
27985721|NCT03006887|81779744|FG000|Overall Study|Adverse Event|1|||
27985722|NCT02554981|81779747|FG000|Overall Study|Adverse Event|1|||
27985723|NCT02554981|81779747|FG000|Overall Study|Administrative Reasons|1|||
27985724|NCT02554981|81779747|FG000|Overall Study|Other Miscellaneous Reasons|3|||
27985725|NCT04311463|81779748|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
27985726|NCT04311463|81779749|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
27985727|NCT04311463|81779748|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
27985728|NCT04311463|81779749|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
27985729|NCT04311463|81779748|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
27985730|NCT04311463|81779749|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
27985731|NCT03194438|81779752|FG000|Overall Study|Withdrawal by Subject|2|||
27985732|NCT02905006|81779753|FG000|Overall Study|Adverse Event|1|||
27985733|NCT02905006|81779754|FG001|Overall Study|Adverse Event|1|||
27985734|NCT02905006|81779755|FG002|Overall Study|Adverse Event|1|||
27985735|NCT02905006|81779756|FG003|Overall Study|Adverse Event|1|||
27985736|NCT02905006|81779757|FG004|Overall Study|Adverse Event|0|||
27985737|NCT02905006|81779758|FG005|Overall Study|Adverse Event|1|||
27985738|NCT02905006|81779753|FG000|Overall Study|Lack of Efficacy|1|||
27985739|NCT02905006|81779754|FG001|Overall Study|Lack of Efficacy|0|||
27985740|NCT02905006|81779755|FG002|Overall Study|Lack of Efficacy|0|||
27985741|NCT02905006|81779756|FG003|Overall Study|Lack of Efficacy|0|||
27985742|NCT02905006|81779757|FG004|Overall Study|Lack of Efficacy|0|||
27985743|NCT02905006|81779758|FG005|Overall Study|Lack of Efficacy|0|||
27985744|NCT02905006|81779753|FG000|Overall Study|Protocol Violation|2|||
27985745|NCT02905006|81779754|FG001|Overall Study|Protocol Violation|0|||
27985746|NCT02905006|81779755|FG002|Overall Study|Protocol Violation|0|||
27985747|NCT02905006|81779756|FG003|Overall Study|Protocol Violation|0|||
27985748|NCT02905006|81779757|FG004|Overall Study|Protocol Violation|0|||
27985749|NCT02905006|81779758|FG005|Overall Study|Protocol Violation|0|||
27985750|NCT02905006|81779753|FG000|Overall Study|Lost to Follow-up|0|||
27985751|NCT02905006|81779754|FG001|Overall Study|Lost to Follow-up|0|||
27795659|NCT00408005|81082155|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
27795660|NCT00408005|81082156|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
27985752|NCT02905006|81779755|FG002|Overall Study|Lost to Follow-up|0|||
27985753|NCT02905006|81779756|FG003|Overall Study|Lost to Follow-up|1|||
27985754|NCT02905006|81779757|FG004|Overall Study|Lost to Follow-up|1|||
27985755|NCT02905006|81779758|FG005|Overall Study|Lost to Follow-up|0|||
27985756|NCT02905006|81779753|FG000|Overall Study|Withdrawal by Subject|0|||
27985757|NCT02905006|81779754|FG001|Overall Study|Withdrawal by Subject|0|||
27985758|NCT02905006|81779755|FG002|Overall Study|Withdrawal by Subject|1|||
27985759|NCT02905006|81779756|FG003|Overall Study|Withdrawal by Subject|1|||
27985760|NCT02905006|81779757|FG004|Overall Study|Withdrawal by Subject|0|||
27985761|NCT02905006|81779758|FG005|Overall Study|Withdrawal by Subject|1|||
27985762|NCT02905006|81779753|FG000|Overall Study|Screening exclusion criteria met|1|||
27985763|NCT02905006|81779754|FG001|Overall Study|Screening exclusion criteria met|0|||
27985764|NCT02905006|81779755|FG002|Overall Study|Screening exclusion criteria met|0|||
27985765|NCT02905006|81779756|FG003|Overall Study|Screening exclusion criteria met|0|||
27985766|NCT02905006|81779757|FG004|Overall Study|Screening exclusion criteria met|0|||
27985767|NCT02905006|81779758|FG005|Overall Study|Screening exclusion criteria met|0|||
27985768|NCT02905006|81779753|FG000|Overall Study|Lab withdrawal criterion met|0|||
27985769|NCT02905006|81779754|FG001|Overall Study|Lab withdrawal criterion met|1|||
27795661|NCT00408005|81082157|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
27985770|NCT02905006|81779755|FG002|Overall Study|Lab withdrawal criterion met|2|||
27985771|NCT02905006|81779756|FG003|Overall Study|Lab withdrawal criterion met|2|||
27985772|NCT02905006|81779757|FG004|Overall Study|Lab withdrawal criterion met|2|||
27985773|NCT02905006|81779758|FG005|Overall Study|Lab withdrawal criterion met|1|||
27985774|NCT02905006|81779753|FG000|Overall Study|Positive for Tuberculosis|0|||
27985775|NCT02905006|81779754|FG001|Overall Study|Positive for Tuberculosis|1|||
27985776|NCT02905006|81779755|FG002|Overall Study|Positive for Tuberculosis|0|||
27985777|NCT02905006|81779756|FG003|Overall Study|Positive for Tuberculosis|0|||
27985778|NCT02905006|81779757|FG004|Overall Study|Positive for Tuberculosis|0|||
27985779|NCT02905006|81779758|FG005|Overall Study|Positive for Tuberculosis|0|||
27985780|NCT02905006|81779753|FG000|Overall Study|Subject positive for Hep B|0|||
27985781|NCT02905006|81779754|FG001|Overall Study|Subject positive for Hep B|0|||
27985782|NCT02905006|81779755|FG002|Overall Study|Subject positive for Hep B|1|||
27985783|NCT02905006|81779756|FG003|Overall Study|Subject positive for Hep B|0|||
27985784|NCT02905006|81779757|FG004|Overall Study|Subject positive for Hep B|0|||
27985785|NCT02905006|81779758|FG005|Overall Study|Subject positive for Hep B|0|||
27985786|NCT02905006|81779753|FG000|Overall Study|Patient moved abroad|0|||
27985787|NCT02905006|81779754|FG001|Overall Study|Patient moved abroad|0|||
27985788|NCT02905006|81779755|FG002|Overall Study|Patient moved abroad|0|||
27985789|NCT02905006|81779756|FG003|Overall Study|Patient moved abroad|1|||
27985790|NCT02905006|81779757|FG004|Overall Study|Patient moved abroad|0|||
27985791|NCT02905006|81779758|FG005|Overall Study|Patient moved abroad|0|||
27578455|NCT03064126|80299523|FG003|Overall Study|Missed Visit|0|||
27578456|NCT01336738|80299531|FG000|Overall Study|Adverse Event|0|||
27578457|NCT01336738|80299532|FG001|Overall Study|Adverse Event|3|||
27578458|NCT01336738|80299533|FG002|Overall Study|Adverse Event|2|||
27578459|NCT01336738|80299534|FG003|Overall Study|Adverse Event|1|||
27578460|NCT01336738|80299535|FG004|Overall Study|Adverse Event|3|||
27578461|NCT01336738|80299531|FG000|Overall Study|Lost to Follow-up|2|||
27578462|NCT01336738|80299532|FG001|Overall Study|Lost to Follow-up|1|||
27578463|NCT01336738|80299533|FG002|Overall Study|Lost to Follow-up|2|||
27578464|NCT01336738|80299534|FG003|Overall Study|Lost to Follow-up|2|||
27578465|NCT01336738|80299535|FG004|Overall Study|Lost to Follow-up|2|||
27578466|NCT01336738|80299531|FG000|Overall Study|Did not meet entrance criteria|0|||
27578467|NCT01336738|80299532|FG001|Overall Study|Did not meet entrance criteria|1|||
27578468|NCT01336738|80299533|FG002|Overall Study|Did not meet entrance criteria|0|||
27578469|NCT01336738|80299534|FG003|Overall Study|Did not meet entrance criteria|0|||
27578470|NCT01336738|80299535|FG004|Overall Study|Did not meet entrance criteria|0|||
27578471|NCT01336738|80299531|FG000|Overall Study|Protocol Violation|0|||
27578472|NCT01336738|80299532|FG001|Overall Study|Protocol Violation|1|||
27578473|NCT01336738|80299533|FG002|Overall Study|Protocol Violation|0|||
27985792|NCT02905006|81779753|FG000|Overall Study|Patient randomized by mistake|0|||
27985793|NCT02905006|81779754|FG001|Overall Study|Patient randomized by mistake|0|||
27578474|NCT01336738|80299534|FG003|Overall Study|Protocol Violation|0|||
27985794|NCT02905006|81779755|FG002|Overall Study|Patient randomized by mistake|0|||
27985795|NCT02905006|81779756|FG003|Overall Study|Patient randomized by mistake|0|||
27985796|NCT02905006|81779757|FG004|Overall Study|Patient randomized by mistake|0|||
27985797|NCT02905006|81779758|FG005|Overall Study|Patient randomized by mistake|1|||
27985798|NCT00931801|81779759|FG000|Overall Study|Adverse Event|0|||
27985799|NCT00931801|81779760|FG001|Overall Study|Adverse Event|0|||
27985800|NCT00931801|81779761|FG002|Overall Study|Adverse Event|1|||
27985801|NCT00931801|81779759|FG000|Overall Study|Lost to Follow-up|0|||
27985802|NCT00931801|81779760|FG001|Overall Study|Lost to Follow-up|1|||
27985803|NCT00931801|81779761|FG002|Overall Study|Lost to Follow-up|0|||
27985804|NCT00931801|81779759|FG000|Overall Study|Withdrawal by Subject|1|||
27985805|NCT00931801|81779760|FG001|Overall Study|Withdrawal by Subject|0|||
27985806|NCT00931801|81779761|FG002|Overall Study|Withdrawal by Subject|0|||
27985807|NCT00931801|81779759|FG000|Overall Study|Confirmed Virologic Failure|0|||
27985808|NCT00931801|81779760|FG001|Overall Study|Confirmed Virologic Failure|0|||
27985809|NCT00931801|81779761|FG002|Overall Study|Confirmed Virologic Failure|3|||
27985810|NCT02032407|81779762|FG000|Overall Study|Lost to Follow-up|2|||
27578475|NCT01336738|80299535|FG004|Overall Study|Protocol Violation|0|||
27578476|NCT01336738|80299531|FG000|Overall Study|Withdrawal by Subject|2|||
27578477|NCT01336738|80299532|FG001|Overall Study|Withdrawal by Subject|0|||
27985811|NCT02032407|81779762|FG000|Overall Study|Pregnancy|1|||
27985812|NCT02032407|81779762|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27985813|NCT00694304|81779763|FG000|Overall Study|Adverse Event|42|||
27985814|NCT00694304|81779763|FG000|Overall Study|Lack of Efficacy|35|||
27985815|NCT00694304|81779763|FG000|Overall Study|Non-compliance With Study Product|16|||
27985816|NCT00694304|81779763|FG000|Overall Study|Protocol Violation|6|||
27985817|NCT00694304|81779763|FG000|Overall Study|Withdrawal of Consent|61|||
27985818|NCT00694304|81779763|FG000|Overall Study|Lost to Follow-up|15|||
27985819|NCT00694304|81779763|FG000|Overall Study|Administrative or Other Reasons|32|||
27985820|NCT01092663|81779773|FG000|Overall Study|Withdrawal by Subject|3|||
27985821|NCT01092663|81779774|FG001|Overall Study|Withdrawal by Subject|2|||
27985822|NCT01092663|81779773|FG000|Overall Study|Glucose >300mg/dL|1|||
27985823|NCT01092663|81779774|FG001|Overall Study|Glucose >300mg/dL|0|||
27985824|NCT01092663|81779773|FG000|Overall Study|High fasting triglyceride|2|||
27985825|NCT01092663|81779774|FG001|Overall Study|High fasting triglyceride|0|||
27985826|NCT01092663|81779773|FG000|Overall Study|Adverse Event|1|||
27985827|NCT01092663|81779774|FG001|Overall Study|Adverse Event|1|||
27985828|NCT01092663|81779773|FG000|Overall Study|Protocol Violation|0|||
27985829|NCT01092663|81779774|FG001|Overall Study|Protocol Violation|1|||
27985830|NCT00172042|81779775|FG000|Overall Study|Adverse Event|27|||
27985831|NCT00172042|81779776|FG001|Overall Study|Adverse Event|13|||
27985832|NCT00172042|81779775|FG000|Overall Study|Abnormal laboratory value(s)|5|||
27985833|NCT00172042|81779776|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27985834|NCT00172042|81779775|FG000|Overall Study|Abnormal test procedure(s)|0|||
27985835|NCT00172042|81779776|FG001|Overall Study|Abnormal test procedure(s)|3|||
27985836|NCT00172042|81779775|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
27985837|NCT00172042|81779776|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
27985838|NCT00172042|81779775|FG000|Overall Study|Patient no longer requires study drug|10|||
27985839|NCT00172042|81779776|FG001|Overall Study|Patient no longer requires study drug|8|||
27985840|NCT00172042|81779775|FG000|Overall Study|Protocol Violation|8|||
27985841|NCT00172042|81779776|FG001|Overall Study|Protocol Violation|7|||
27985842|NCT00172042|81779775|FG000|Overall Study|Withdrawal by Subject|37|||
27985843|NCT00172042|81779776|FG001|Overall Study|Withdrawal by Subject|25|||
27985844|NCT00172042|81779775|FG000|Overall Study|Lost to Follow-up|3|||
27985845|NCT00172042|81779776|FG001|Overall Study|Lost to Follow-up|5|||
27985846|NCT00172042|81779775|FG000|Overall Study|Administrative problems|13|||
27985847|NCT00172042|81779776|FG001|Overall Study|Administrative problems|10|||
27985848|NCT00172042|81779775|FG000|Overall Study|Death|42|||
27985849|NCT00172042|81779776|FG001|Overall Study|Death|42|||
27985850|NCT03652675|81779778|FG000|Overall Study|Lost to Follow-up|4|||
27985851|NCT03652675|81779779|FG001|Overall Study|Lost to Follow-up|4|||
27985852|NCT01789606|81779782|FG000|Overall Study|Participant not Purchased the Product|0|||
27985853|NCT01789606|81779783|FG001|Overall Study|Participant not Purchased the Product|20|||
27985854|NCT01789606|81779782|FG000|Overall Study|Withdrawal by Subject|0|||
27985855|NCT01789606|81779783|FG001|Overall Study|Withdrawal by Subject|1|||
27985856|NCT01789606|81779782|FG000|Overall Study|Ineligible|6|||
27985857|NCT01789606|81779783|FG001|Overall Study|Ineligible|2|||
27578478|NCT01336738|80299533|FG002|Overall Study|Withdrawal by Subject|2|||
27578479|NCT01336738|80299534|FG003|Overall Study|Withdrawal by Subject|1|||
27985858|NCT01789606|81779782|FG000|Overall Study|Administrative Reasons|17|||
27985859|NCT01789606|81779783|FG001|Overall Study|Administrative Reasons|6|||
27985860|NCT01789606|81779782|FG000|Overall Study|No Study Medication Taken|0|||
27985861|NCT01789606|81779783|FG001|Overall Study|No Study Medication Taken|1|||
27985862|NCT01789606|81779782|FG000|Overall Study|Protocol Violation|0|||
27985863|NCT01789606|81779783|FG001|Overall Study|Protocol Violation|55|||
27985864|NCT01789606|81779782|FG000|Overall Study|Adverse Event|0|||
27985865|NCT01789606|81779783|FG001|Overall Study|Adverse Event|3|||
27985866|NCT01789606|81779782|FG000|Overall Study|Lost to Follow-up|0|||
27985867|NCT01789606|81779783|FG001|Overall Study|Lost to Follow-up|14|||
27985868|NCT01789606|81779782|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
27985869|NCT01789606|81779783|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
27985870|NCT03316950|81779790|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
27985871|NCT03316950|81779791|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
27985872|NCT03316950|81779792|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
27985873|NCT03316950|81779793|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
27985874|NCT03316950|81779790|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
27985875|NCT03316950|81779791|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
27985876|NCT03316950|81779792|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
27985877|NCT03316950|81779793|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
27985878|NCT03316950|81779790|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
27985879|NCT03316950|81779791|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
27985880|NCT03316950|81779792|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
27985881|NCT03316950|81779793|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
27985882|NCT00490776|81779794|FG000|Overall Study|Withdrawal by Subject|1|||
27985883|NCT00490776|81779794|FG000|Overall Study|Administrative Problems|1|||
27985884|NCT00490776|81779794|FG000|Overall Study|Death|1|||
27985885|NCT00490776|81779794|FG000|Overall Study|New Cancer Therapy|1|||
27985886|NCT00490776|81779794|FG000|Overall Study|Disease Progression|5|||
27985887|NCT03890367|81779795|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27985888|NCT03890367|81779796|FG001|Overall Study|Withdrawal by parent/guardian|3|||
27985889|NCT03890367|81779797|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27985890|NCT03890367|81779795|FG000|Overall Study|Protocol deviation|2|||
27985891|NCT03890367|81779796|FG001|Overall Study|Protocol deviation|2|||
27985892|NCT03890367|81779797|FG002|Overall Study|Protocol deviation|1|||
27985893|NCT03890367|81779795|FG000|Overall Study|Lost to Follow-up|1|||
27985894|NCT03890367|81779796|FG001|Overall Study|Lost to Follow-up|1|||
27985895|NCT03890367|81779797|FG002|Overall Study|Lost to Follow-up|0|||
27985896|NCT02540265|81779798|FG000|Overall Study|Lost to Follow-up|0|||
27985897|NCT02540265|81779799|FG001|Overall Study|Lost to Follow-up|0|||
27985898|NCT02540265|81779800|FG002|Overall Study|Lost to Follow-up|1|||
27985899|NCT00772109|81779801|FG000|Overall Study|Serious adverse event|1|||
27985900|NCT00772109|81779802|FG001|Overall Study|Serious adverse event|0|||
27985901|NCT00772109|81779803|FG002|Overall Study|Serious adverse event|1|||
27985902|NCT00772109|81779804|FG003|Overall Study|Serious adverse event|0|||
27985903|NCT00772109|81779801|FG000|Overall Study|Protocol Violation|5|||
27985904|NCT00772109|81779802|FG001|Overall Study|Protocol Violation|8|||
27674733|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
27985905|NCT00772109|81779803|FG002|Overall Study|Protocol Violation|7|||
27985906|NCT00772109|81779804|FG003|Overall Study|Protocol Violation|6|||
27985907|NCT00772109|81779801|FG000|Overall Study|Lost to Follow-up|7|||
27985908|NCT00772109|81779802|FG001|Overall Study|Lost to Follow-up|3|||
27985909|NCT00772109|81779803|FG002|Overall Study|Lost to Follow-up|5|||
27985910|NCT00772109|81779804|FG003|Overall Study|Lost to Follow-up|9|||
27985911|NCT00772109|81779801|FG000|Overall Study|Withdrawal by Subject|8|||
27985912|NCT00772109|81779802|FG001|Overall Study|Withdrawal by Subject|8|||
27985913|NCT00772109|81779803|FG002|Overall Study|Withdrawal by Subject|6|||
27985914|NCT00772109|81779804|FG003|Overall Study|Withdrawal by Subject|16|||
27985915|NCT02322190|81779807|FG000|Overall Study|Death on study|1|||
27985916|NCT02322190|81779808|FG001|Overall Study|Death on study|0|||
27985917|NCT00330681|81779809|FG000|Overall Study|Adverse Event|3|||
27985918|NCT00330681|81779810|FG001|Overall Study|Adverse Event|6|||
27985919|NCT00330681|81779809|FG000|Overall Study|Protocol Violation|0|||
27985920|NCT00330681|81779810|FG001|Overall Study|Protocol Violation|1|||
27985921|NCT00330681|81779809|FG000|Overall Study|Withdrawal by Subject|5|||
27985922|NCT00330681|81779810|FG001|Overall Study|Withdrawal by Subject|5|||
27985923|NCT00330681|81779809|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
27985924|NCT00330681|81779810|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
27985925|NCT03834220|81779812|FG000|Overall Study|Adverse Event|1|||
27985926|NCT03834220|81779813|FG001|Overall Study|Adverse Event|0|||
27985927|NCT03834220|81779814|FG002|Overall Study|Adverse Event|0|||
27985928|NCT03834220|81779812|FG000|Overall Study|Death|8|||
27985929|NCT03834220|81779813|FG001|Overall Study|Death|1|||
27985930|NCT03834220|81779814|FG002|Overall Study|Death|17|||
27985931|NCT03834220|81779812|FG000|Overall Study|Reason not Specified|9|||
27985932|NCT03834220|81779813|FG001|Overall Study|Reason not Specified|0|||
27985933|NCT03834220|81779814|FG002|Overall Study|Reason not Specified|6|||
27985934|NCT03834220|81779812|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
27985935|NCT03834220|81779813|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
27985936|NCT03834220|81779814|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
27985937|NCT03834220|81779812|FG000|Overall Study|Withdrawal of Consent|2|||
27985938|NCT03834220|81779813|FG001|Overall Study|Withdrawal of Consent|2|||
27985939|NCT03834220|81779814|FG002|Overall Study|Withdrawal of Consent|2|||
27985940|NCT02126839|81779815|FG000|Overall Study|Adverse Event|0|||
27674734|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
27985941|NCT02126839|81779816|FG001|Overall Study|Adverse Event|1|||
27985942|NCT02126839|81779815|FG000|Overall Study|Withdrawal by Subject|1|||
27985943|NCT02126839|81779816|FG001|Overall Study|Withdrawal by Subject|0|||
27985944|NCT02126839|81779815|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27985945|NCT02126839|81779816|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27985946|NCT02126839|81779815|FG000|Overall Study|Protocol Violation|2|||
27985947|NCT02126839|81779816|FG001|Overall Study|Protocol Violation|3|||
27985948|NCT02126839|81779815|FG000|Overall Study|Sponsor request|0|||
27985949|NCT02126839|81779816|FG001|Overall Study|Sponsor request|1|||
27985950|NCT02126839|81779815|FG000|Overall Study|Lost to Follow-up|1|||
27985951|NCT02126839|81779816|FG001|Overall Study|Lost to Follow-up|4|||
27985952|NCT02126839|81779815|FG000|Overall Study|Other|5|||
27985953|NCT02126839|81779816|FG001|Overall Study|Other|5|||
27985954|NCT02305238|81779839|FG000|Overall Study|Death|2|||
27985955|NCT02305238|81779840|FG001|Overall Study|Death|1|||
27985956|NCT02305238|81779841|FG002|Overall Study|Death|0|||
27985957|NCT02305238|81779839|FG000|Overall Study|Progressive disease|4|||
27985958|NCT02305238|81779840|FG001|Overall Study|Progressive disease|4|||
27985959|NCT02305238|81779841|FG002|Overall Study|Progressive disease|0|||
27985960|NCT02305238|81779839|FG000|Overall Study|Logistical difficulties|1|||
27985961|NCT02305238|81779840|FG001|Overall Study|Logistical difficulties|3|||
27985962|NCT02305238|81779841|FG002|Overall Study|Logistical difficulties|0|||
27985963|NCT02305238|81779839|FG000|Overall Study|Protocol Violation|0|||
27985964|NCT02305238|81779840|FG001|Overall Study|Protocol Violation|3|||
27985965|NCT02305238|81779841|FG002|Overall Study|Protocol Violation|0|||
27985966|NCT02305238|81779839|FG000|Overall Study|Physician Decision|2|||
27985967|NCT02305238|81779840|FG001|Overall Study|Physician Decision|1|||
27985968|NCT02305238|81779841|FG002|Overall Study|Physician Decision|0|||
27985969|NCT02305238|81779839|FG000|Overall Study|Adverse Event|4|||
27985970|NCT02305238|81779840|FG001|Overall Study|Adverse Event|2|||
27985971|NCT02305238|81779841|FG002|Overall Study|Adverse Event|0|||
27985972|NCT02305238|81779839|FG000|Overall Study|Withdrawal by Subject|3|||
27985973|NCT02305238|81779840|FG001|Overall Study|Withdrawal by Subject|4|||
27985974|NCT02305238|81779841|FG002|Overall Study|Withdrawal by Subject|0|||
27985975|NCT02305238|81779839|FG000|Overall Study|Randomized failure|0|||
27985976|NCT02305238|81779840|FG001|Overall Study|Randomized failure|0|||
27985977|NCT02305238|81779841|FG002|Overall Study|Randomized failure|8|||
27985978|NCT02305238|81779839|FG000|Overall Study|Required procedure failed|0|||
27985979|NCT02305238|81779840|FG001|Overall Study|Required procedure failed|1|||
27985980|NCT02305238|81779841|FG002|Overall Study|Required procedure failed|0|||
27985981|NCT01504204|81779845|FG000|Overall Study|Lost to Follow-up|1|||
27985982|NCT01504204|81779846|FG001|Overall Study|Lost to Follow-up|1|||
27985983|NCT00527319|81779847|FG000|Overall Study|Withdrawal by Subject|5|||
27985984|NCT00527319|81779848|FG001|Overall Study|Withdrawal by Subject|0|||
27985985|NCT00527319|81779849|FG002|Overall Study|Withdrawal by Subject|1|||
27985986|NCT00527319|81779847|FG000|Overall Study|Lost to Follow-up|1|||
27985987|NCT00527319|81779848|FG001|Overall Study|Lost to Follow-up|0|||
27985988|NCT00527319|81779849|FG002|Overall Study|Lost to Follow-up|0|||
27985989|NCT00527319|81779847|FG000|Overall Study|Death|0|||
27985990|NCT00527319|81779848|FG001|Overall Study|Death|3|||
27985991|NCT00527319|81779849|FG002|Overall Study|Death|1|||
27985992|NCT00527319|81779847|FG000|Overall Study|Intercurrent Medical Illness|0|||
27985993|NCT00527319|81779848|FG001|Overall Study|Intercurrent Medical Illness|1|||
27985994|NCT00527319|81779849|FG002|Overall Study|Intercurrent Medical Illness|3|||
27985995|NCT00527319|81779847|FG000|Overall Study|Adverse Event|0|||
27985996|NCT00527319|81779848|FG001|Overall Study|Adverse Event|0|||
27985997|NCT00527319|81779849|FG002|Overall Study|Adverse Event|1|||
27985998|NCT03508609|81779852|FG000|Overall Study|Withdrawal by Subject|1|||
27985999|NCT01403116|81779855|FG000|Overall Study|Adverse Event|7|||
27986000|NCT01403116|81779856|FG001|Overall Study|Adverse Event|4|||
27986001|NCT01403116|81779855|FG000|Overall Study|Lost to Follow-up|7|||
27986002|NCT01403116|81779856|FG001|Overall Study|Lost to Follow-up|5|||
27986003|NCT01403116|81779855|FG000|Overall Study|Withdrawal by Subject|12|||
27986004|NCT01403116|81779856|FG001|Overall Study|Withdrawal by Subject|15|||
27986005|NCT01403116|81779855|FG000|Overall Study|Non-compliance of study drug|3|||
27986006|NCT01403116|81779856|FG001|Overall Study|Non-compliance of study drug|0|||
27986007|NCT01403116|81779855|FG000|Overall Study|Protocol Violation|0|||
27986008|NCT01403116|81779856|FG001|Overall Study|Protocol Violation|1|||
27986009|NCT01403116|81779855|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
27986010|NCT01403116|81779856|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
27986011|NCT01403116|81779855|FG000|Overall Study|Hct >54%|2|||
27986012|NCT01403116|81779856|FG001|Overall Study|Hct >54%|0|||
27986013|NCT01403116|81779855|FG000|Overall Study|unable to keep appointments|0|||
27986014|NCT01403116|81779856|FG001|Overall Study|unable to keep appointments|2|||
27986015|NCT00528996|81779857|FG000|Overall Study|Other reasons than listing|6|||
27986016|NCT00528996|81779858|FG001|Overall Study|Other reasons than listing|7|||
27986017|NCT00528996|81779859|FG002|Overall Study|Other reasons than listing|14|||
27986018|NCT00528996|81779860|FG003|Overall Study|Other reasons than listing|11|||
27986019|NCT00528996|81779861|FG004|Overall Study|Other reasons than listing|5|||
27986020|NCT00528996|81779857|FG000|Overall Study|Refused continue medication|16|||
27795662|NCT00408005|81082158|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
27795663|NCT00408005|81082159|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
27795664|NCT00408005|81082160|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
27795665|NCT00408005|81082161|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
27795666|NCT00408005|81082162|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
27795667|NCT00408005|81082155|FG000|Induction|Progressive Disease|0|||
27986021|NCT00528996|81779858|FG001|Overall Study|Refused continue medication|0|||
27986022|NCT00528996|81779859|FG002|Overall Study|Refused continue medication|3|||
27986023|NCT00528996|81779860|FG003|Overall Study|Refused continue medication|3|||
27795668|NCT00408005|81082156|FG001|Induction|Progressive Disease|1|||
27795669|NCT00408005|81082157|FG002|Induction|Progressive Disease|0|||
27986024|NCT00528996|81779861|FG004|Overall Study|Refused continue medication|6|||
27986025|NCT00528996|81779857|FG000|Overall Study|Lost to Follow-up|2|||
27986026|NCT00528996|81779858|FG001|Overall Study|Lost to Follow-up|0|||
27986027|NCT00528996|81779859|FG002|Overall Study|Lost to Follow-up|4|||
27986028|NCT00528996|81779860|FG003|Overall Study|Lost to Follow-up|1|||
27986029|NCT00528996|81779861|FG004|Overall Study|Lost to Follow-up|3|||
27986030|NCT00528996|81779857|FG000|Overall Study|Protocol Violation|1|||
27986031|NCT00528996|81779858|FG001|Overall Study|Protocol Violation|2|||
27986032|NCT00528996|81779859|FG002|Overall Study|Protocol Violation|3|||
27986033|NCT00528996|81779860|FG003|Overall Study|Protocol Violation|3|||
27986034|NCT00528996|81779861|FG004|Overall Study|Protocol Violation|2|||
27986035|NCT00528996|81779857|FG000|Overall Study|Lack of Efficacy|7|||
27986036|NCT00528996|81779858|FG001|Overall Study|Lack of Efficacy|2|||
27986037|NCT00528996|81779859|FG002|Overall Study|Lack of Efficacy|1|||
27986038|NCT00528996|81779860|FG003|Overall Study|Lack of Efficacy|3|||
27986039|NCT00528996|81779861|FG004|Overall Study|Lack of Efficacy|3|||
27986040|NCT00528996|81779857|FG000|Overall Study|Adverse Event|32|||
27986041|NCT00528996|81779858|FG001|Overall Study|Adverse Event|13|||
27986042|NCT00528996|81779859|FG002|Overall Study|Adverse Event|18|||
27986043|NCT00528996|81779860|FG003|Overall Study|Adverse Event|29|||
27986044|NCT00528996|81779861|FG004|Overall Study|Adverse Event|18|||
27795670|NCT00408005|81082158|FG003|Induction|Progressive Disease|0|||
27795671|NCT00408005|81082159|FG004|Induction|Progressive Disease|0|||
27795672|NCT00408005|81082160|FG005|Induction|Progressive Disease|0|||
27795673|NCT00408005|81082161|FG006|Induction|Progressive Disease|0|||
27986045|NCT00395850|81779864|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
27986046|NCT00395850|81779865|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
27986047|NCT00395850|81779866|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
27578480|NCT01336738|80299535|FG004|Overall Study|Withdrawal by Subject|1|||
27578481|NCT01336738|80299531|FG000|Overall Study|Other|3|||
27795674|NCT00408005|81082162|FG007|Induction|Progressive Disease|0|||
27795675|NCT00408005|81082155|FG000|Induction|Inevaluable|18|||
27795676|NCT00408005|81082156|FG001|Induction|Inevaluable|14|||
27578482|NCT01336738|80299532|FG001|Overall Study|Other|3|||
27986048|NCT00395850|81779867|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
27986049|NCT00395850|81779864|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
27986050|NCT00395850|81779865|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
27986051|NCT00395850|81779866|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
27869587|NCT03296527|81357753|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
27869588|NCT03296527|81357754|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
27869589|NCT03296527|81357753|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
27869590|NCT03296527|81357754|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
27869591|NCT03594071|81357759|FG000|Overall Study|Re-operation|3|||
27869592|NCT03594071|81357759|FG000|Overall Study|Missed visit|2|||
27869593|NCT00451204|81357768|FG000|Overall Study|Adverse Event|4|||
27869594|NCT00451204|81357769|FG001|Overall Study|Adverse Event|6|||
27869595|NCT00451204|81357768|FG000|Overall Study|Lack of Efficacy|4|||
27869596|NCT00451204|81357769|FG001|Overall Study|Lack of Efficacy|4|||
27869597|NCT00451204|81357768|FG000|Overall Study|Lost to Follow-up|4|||
27869598|NCT00451204|81357769|FG001|Overall Study|Lost to Follow-up|4|||
27869599|NCT00451204|81357768|FG000|Overall Study|Protocol Violation|1|||
27869600|NCT00451204|81357769|FG001|Overall Study|Protocol Violation|0|||
27869601|NCT00451204|81357768|FG000|Overall Study|Patient refusal|8|||
27869602|NCT00451204|81357769|FG001|Overall Study|Patient refusal|4|||
27869603|NCT00451204|81357768|FG000|Overall Study|Other|1|||
27869604|NCT00451204|81357769|FG001|Overall Study|Other|2|||
27869605|NCT00606632|81357774|FG000|Overall Study|Withdrawal by Subject|13|||
27869606|NCT00606632|81357774|FG000|Overall Study|Miscellaneous reasons|9|||
27869607|NCT01295320|81357775|FG000|Overall Study|Adverse Event|2|||
27869608|NCT01295320|81357775|FG000|Overall Study|Lost to Follow-up|4|||
27986052|NCT00395850|81779867|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
27986053|NCT00395850|81779864|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
27986054|NCT00395850|81779865|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
27986055|NCT00395850|81779866|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
27986056|NCT00395850|81779867|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
27986057|NCT00395850|81779864|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
27986058|NCT00395850|81779865|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
27986059|NCT00395850|81779866|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
27869609|NCT01295320|81357775|FG000|Overall Study|Withdrawal by Subject|2|||
27869610|NCT01295320|81357775|FG000|Overall Study|Subject was bedridden|1|||
27869611|NCT01295320|81357775|FG000|Overall Study|Unable to travel|1|||
27869612|NCT00625820|81357776|FG000|Overall Study|Withdrawal by Subject|1|||
27869613|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #1|24|||
27869614|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #1|0|||
27869615|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
27869616|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
27869617|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27869618|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27869619|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
27869620|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
27869621|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
27869622|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
27869623|NCT03888066|81357784|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27869624|NCT03888066|81357785|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27869625|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27869626|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27986060|NCT00395850|81779867|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
27986061|NCT00395850|81779864|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
27986062|NCT00395850|81779865|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
27986063|NCT00395850|81779866|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
27986064|NCT00395850|81779867|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
27986065|NCT00395850|81779864|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
27986066|NCT00395850|81779865|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
27986067|NCT00395850|81779866|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
27986068|NCT00395850|81779867|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
27986069|NCT00395850|81779864|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
27986070|NCT00395850|81779865|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
27986071|NCT00395850|81779866|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
27986072|NCT00395850|81779867|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
27986073|NCT00118430|81779871|FG000|Overall Study|Withdrawal by Subject|6|||
27986074|NCT00118430|81779872|FG001|Overall Study|Withdrawal by Subject|2|||
27986075|NCT00118430|81779873|FG002|Overall Study|Withdrawal by Subject|0|||
27986076|NCT00118430|81779871|FG000|Overall Study|Lost to Follow-up|15|||
27986077|NCT00118430|81779872|FG001|Overall Study|Lost to Follow-up|22|||
27986078|NCT00118430|81779873|FG002|Overall Study|Lost to Follow-up|28|||
27986079|NCT03565237|81779874|FG000|Overall Study|Non-compliance of Investigational Product|1|||
27986080|NCT03565237|81779874|FG000|Overall Study|Physician Decision|1|||
27986081|NCT03824587|81779878|FG000|Run-in Period|Screen Failure|0|||
27986082|NCT03824587|81779879|FG001|Run-in Period|Screen Failure|275|||
27986083|NCT03824587|81779878|FG000|Treatment Period|Adverse Event|4|||
27986084|NCT03824587|81779879|FG001|Treatment Period|Adverse Event|1|||
27986085|NCT03824587|81779878|FG000|Treatment Period|Withdrawal by Subject|0|||
27986086|NCT03824587|81779879|FG001|Treatment Period|Withdrawal by Subject|1|||
27986087|NCT03824587|81779878|FG000|Treatment Period|Kidney Transplant|1|||
27986088|NCT03824587|81779879|FG001|Treatment Period|Kidney Transplant|1|||
27986089|NCT00428844|81779880|FG000|Completed Study Drug Treatment|Adverse Event|2|||
27986090|NCT00428844|81779881|FG001|Completed Study Drug Treatment|Adverse Event|4|||
27986091|NCT00428844|81779882|FG002|Completed Study Drug Treatment|Adverse Event|4|||
27986092|NCT00428844|81779880|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
27986093|NCT00428844|81779881|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
27986094|NCT00428844|81779882|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
27986095|NCT00428844|81779880|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
27986096|NCT00428844|81779881|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
27986097|NCT00428844|81779882|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
27986098|NCT00428844|81779880|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
27986099|NCT00428844|81779881|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
27986100|NCT00428844|81779882|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
27986101|NCT00428844|81779880|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
27986102|NCT00428844|81779881|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
27986103|NCT00428844|81779882|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
27986104|NCT00428844|81779880|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
27986105|NCT00428844|81779881|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
27986106|NCT00428844|81779882|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
27986107|NCT00428844|81779880|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
27986108|NCT00428844|81779881|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
27986109|NCT00428844|81779882|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
27986110|NCT00428844|81779880|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
27986111|NCT00428844|81779881|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
27986112|NCT00428844|81779882|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
27986113|NCT00428844|81779880|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
27986114|NCT00428844|81779881|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
27986115|NCT00428844|81779882|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
27986116|NCT00844558|81779885|FG000|Overall Study|Withdrawal by Subject|9|||
27986117|NCT00844558|81779886|FG001|Overall Study|Withdrawal by Subject|2|||
27986118|NCT00844558|81779885|FG000|Overall Study|Death|1|||
27986119|NCT00844558|81779886|FG001|Overall Study|Death|0|||
27986120|NCT00844558|81779885|FG000|Overall Study|Protocol Violation|1|||
27986121|NCT00844558|81779886|FG001|Overall Study|Protocol Violation|1|||
27986122|NCT00844558|81779885|FG000|Overall Study|Lost to Follow-up|0|||
27986123|NCT00844558|81779886|FG001|Overall Study|Lost to Follow-up|1|||
27986124|NCT00844558|81779885|FG000|Overall Study|Physician Decision|1|||
27986125|NCT00844558|81779886|FG001|Overall Study|Physician Decision|0|||
27578483|NCT01336738|80299533|FG002|Overall Study|Other|2|||
27986126|NCT02202538|81779887|FG000|Overall Study|Withdrawal by Subject|5|||
27986127|NCT02202538|81779887|FG000|Overall Study|Did not meet all inclusion criteria|2|||
27986128|NCT02202538|81779887|FG000|Overall Study|Investigator Decision|1|||
27986129|NCT02540993|81779896|FG000|Overall Study|Lost to Follow-up|5|||
27986130|NCT02540993|81779897|FG001|Overall Study|Lost to Follow-up|3|||
27986131|NCT02540993|81779896|FG000|Overall Study|Withdrawal by Subject|4|||
27986132|NCT02540993|81779897|FG001|Overall Study|Withdrawal by Subject|6|||
27986133|NCT02540993|81779896|FG000|Overall Study|GCP violations|33|||
27986134|NCT02540993|81779897|FG001|Overall Study|GCP violations|27|||
27986135|NCT02891382|81779898|FG000|Overall Study|Lost to Follow-up|3|||
27986136|NCT02891382|81779899|FG001|Overall Study|Lost to Follow-up|4|||
27986137|NCT02891382|81779900|FG002|Overall Study|Lost to Follow-up|5|||
27986138|NCT02891382|81779901|FG003|Overall Study|Lost to Follow-up|3|||
27986139|NCT02891382|81779902|FG004|Overall Study|Lost to Follow-up|4|||
27986140|NCT03344172|81779905|FG000|Overall Study|Received <1 dose of treatment|1|||
27986141|NCT03344172|81779906|FG001|Overall Study|Received <1 dose of treatment|0|||
27986142|NCT00590577|81779911|FG000|Overall Study|Lack of Efficacy|31|||
27986143|NCT00590577|81779912|FG001|Overall Study|Lack of Efficacy|28|||
27986144|NCT00590577|81779913|FG002|Overall Study|Lack of Efficacy|23|||
27986145|NCT00590577|81779914|FG003|Overall Study|Lack of Efficacy|45|||
27986146|NCT00590577|81779911|FG000|Overall Study|Withdrawal by Subject|23|||
27986147|NCT00590577|81779912|FG001|Overall Study|Withdrawal by Subject|28|||
27986148|NCT00590577|81779913|FG002|Overall Study|Withdrawal by Subject|30|||
27986149|NCT00590577|81779914|FG003|Overall Study|Withdrawal by Subject|26|||
27986150|NCT00590577|81779911|FG000|Overall Study|Adverse Event|10|||
27986151|NCT00590577|81779912|FG001|Overall Study|Adverse Event|10|||
27986152|NCT00590577|81779913|FG002|Overall Study|Adverse Event|13|||
27986153|NCT00590577|81779914|FG003|Overall Study|Adverse Event|11|||
27986154|NCT00590577|81779911|FG000|Overall Study|Lost to Follow-up|12|||
27986155|NCT00590577|81779912|FG001|Overall Study|Lost to Follow-up|6|||
27986156|NCT00590577|81779913|FG002|Overall Study|Lost to Follow-up|6|||
27986157|NCT00590577|81779914|FG003|Overall Study|Lost to Follow-up|9|||
27986158|NCT00590577|81779911|FG000|Overall Study|Pregnancy|0|||
27986159|NCT00590577|81779912|FG001|Overall Study|Pregnancy|1|||
27986160|NCT00590577|81779913|FG002|Overall Study|Pregnancy|0|||
27578484|NCT01336738|80299534|FG003|Overall Study|Other|3|||
27578485|NCT01336738|80299535|FG004|Overall Study|Other|4|||
27578486|NCT01175824|80299536|FG000|Overall Study|Adverse Event|2|||
27578487|NCT01175824|80299537|FG001|Overall Study|Adverse Event|1|||
27578488|NCT01175824|80299536|FG000|Overall Study|Lack of Efficacy|2|||
27578489|NCT01175824|80299537|FG001|Overall Study|Lack of Efficacy|0|||
27578490|NCT01175824|80299536|FG000|Overall Study|Lost to Follow-up|0|||
27578491|NCT01175824|80299537|FG001|Overall Study|Lost to Follow-up|1|||
27795677|NCT00408005|81082157|FG002|Induction|Inevaluable|0|||
27795678|NCT00408005|81082158|FG003|Induction|Inevaluable|0|||
27986161|NCT00590577|81779914|FG003|Overall Study|Pregnancy|0|||
27986162|NCT00590577|81779911|FG000|Overall Study|Various reasons|1|||
27986163|NCT00590577|81779912|FG001|Overall Study|Various reasons|3|||
27986164|NCT00590577|81779913|FG002|Overall Study|Various reasons|1|||
27986165|NCT00590577|81779914|FG003|Overall Study|Various reasons|2|||
27795679|NCT00408005|81082159|FG004|Induction|Inevaluable|0|||
27795680|NCT00408005|81082160|FG005|Induction|Inevaluable|0|||
27795681|NCT00408005|81082161|FG006|Induction|Inevaluable|0|||
27795682|NCT00408005|81082162|FG007|Induction|Inevaluable|0|||
27795683|NCT00408005|81082155|FG000|Induction|Failed to Complete Randomization|3|||
27795684|NCT00408005|81082156|FG001|Induction|Failed to Complete Randomization|2|||
27795685|NCT00408005|81082157|FG002|Induction|Failed to Complete Randomization|0|||
27795686|NCT00408005|81082158|FG003|Induction|Failed to Complete Randomization|0|||
27869627|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
27869628|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
27986166|NCT00908037|81779915|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986167|NCT00908037|81779916|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986168|NCT00908037|81779917|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986169|NCT00908037|81779918|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986170|NCT00908037|81779919|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
27578492|NCT01175824|80299536|FG000|Overall Study|Physician Decision|0|||
27578493|NCT01175824|80299537|FG001|Overall Study|Physician Decision|4|||
27986171|NCT00908037|81779920|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986172|NCT00908037|81779921|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
27986173|NCT00908037|81779922|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986174|NCT00908037|81779923|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
27986175|NCT00908037|81779924|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986176|NCT00908037|81779925|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986177|NCT00908037|81779926|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
27986178|NCT00908037|81779915|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986179|NCT00908037|81779916|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986180|NCT00908037|81779917|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986181|NCT00908037|81779918|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27578494|NCT01175824|80299536|FG000|Overall Study|Protocol Violation|2|||
27578495|NCT01175824|80299537|FG001|Overall Study|Protocol Violation|5|||
27578496|NCT01175824|80299536|FG000|Overall Study|Withdrawal by Subject|3|||
27578497|NCT01175824|80299537|FG001|Overall Study|Withdrawal by Subject|7|||
27578498|NCT01175824|80299536|FG000|Overall Study|Sponsor Decision|1|||
27578499|NCT01175824|80299537|FG001|Overall Study|Sponsor Decision|0|||
27578500|NCT01175824|80299536|FG000|Overall Study|Entry Criteria Not Met|6|||
27578501|NCT01175824|80299537|FG001|Overall Study|Entry Criteria Not Met|4|||
27578502|NCT01994395|80299538|FG000|Overall Study|Withdrawal by Subject|1|||
27578503|NCT01994395|80299539|FG001|Overall Study|Withdrawal by Subject|2|||
27578504|NCT03509948|80299540|FG000|Overall Study|Protocol Violation|0|||
27578505|NCT03509948|80299541|FG001|Overall Study|Protocol Violation|1|||
27578506|NCT01079234|80299542|FG000|Main: Week 0 to 26|Adverse Event|5|||
27578507|NCT01079234|80299543|FG001|Main: Week 0 to 26|Adverse Event|4|||
27578508|NCT01079234|80299544|FG002|Main: Week 0 to 26|Adverse Event|1|||
27578509|NCT01079234|80299545|FG003|Main: Week 0 to 26|Adverse Event|0|||
27578510|NCT01079234|80299542|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
27578511|NCT01079234|80299543|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
27578512|NCT01079234|80299544|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
27578513|NCT01079234|80299545|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
27578514|NCT01079234|80299542|FG000|Main: Week 0 to 26|Protocol Violation|6|||
27578515|NCT01079234|80299543|FG001|Main: Week 0 to 26|Protocol Violation|2|||
27578516|NCT01079234|80299544|FG002|Main: Week 0 to 26|Protocol Violation|4|||
27578517|NCT01079234|80299545|FG003|Main: Week 0 to 26|Protocol Violation|0|||
27578518|NCT01079234|80299542|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
27578519|NCT01079234|80299543|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
27578520|NCT01079234|80299544|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
27578521|NCT01079234|80299545|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
27578522|NCT01079234|80299542|FG000|Main: Week 0 to 26|Unclassified|7|||
27578523|NCT01079234|80299543|FG001|Main: Week 0 to 26|Unclassified|13|||
27578524|NCT01079234|80299544|FG002|Main: Week 0 to 26|Unclassified|4|||
27578525|NCT01079234|80299545|FG003|Main: Week 0 to 26|Unclassified|0|||
27578526|NCT01079234|80299542|FG000|Extension: Week 27 to 52|Adverse Event|0|||
27578527|NCT01079234|80299543|FG001|Extension: Week 27 to 52|Adverse Event|0|||
27578528|NCT01079234|80299544|FG002|Extension: Week 27 to 52|Adverse Event|1|||
27578529|NCT01079234|80299545|FG003|Extension: Week 27 to 52|Adverse Event|0|||
27578530|NCT01079234|80299542|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
27578531|NCT01079234|80299543|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
27578532|NCT01079234|80299544|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
27578533|NCT01079234|80299545|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
27578534|NCT01079234|80299542|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
27578535|NCT01079234|80299543|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
27578536|NCT01079234|80299544|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
27578537|NCT01079234|80299545|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
27578538|NCT01079234|80299542|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
27578539|NCT01079234|80299543|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
27578540|NCT01079234|80299544|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
27578541|NCT01079234|80299545|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
27578542|NCT01079234|80299542|FG000|Extension: Week 27 to 52|Unclassified|0|||
27578543|NCT01079234|80299543|FG001|Extension: Week 27 to 52|Unclassified|0|||
27578544|NCT01079234|80299544|FG002|Extension: Week 27 to 52|Unclassified|4|||
27578545|NCT01079234|80299545|FG003|Extension: Week 27 to 52|Unclassified|7|||
27578546|NCT02383758|80299546|FG000|Overall Study|Withdrawal by Subject|0|||
27578547|NCT02383758|80299547|FG001|Overall Study|Withdrawal by Subject|2|||
27578548|NCT02583256|80299548|FG000|Overall Study|Withdrawal by Subject|0|||
27578549|NCT02583256|80299549|FG001|Overall Study|Withdrawal by Subject|1|||
27578550|NCT02583256|80299550|FG002|Overall Study|Withdrawal by Subject|1|||
27578551|NCT02583256|80299551|FG003|Overall Study|Withdrawal by Subject|0|||
27578552|NCT02583256|80299548|FG000|Overall Study|Lost to Follow-up|1|||
27986182|NCT00908037|81779919|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
27986183|NCT00908037|81779920|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27578553|NCT02583256|80299549|FG001|Overall Study|Lost to Follow-up|1|||
27578554|NCT02583256|80299550|FG002|Overall Study|Lost to Follow-up|0|||
27578555|NCT02583256|80299551|FG003|Overall Study|Lost to Follow-up|1|||
27578556|NCT02583256|80299548|FG000|Overall Study|Administrative/Other|2|||
27578557|NCT02583256|80299549|FG001|Overall Study|Administrative/Other|0|||
27578558|NCT02583256|80299550|FG002|Overall Study|Administrative/Other|1|||
27578559|NCT02583256|80299551|FG003|Overall Study|Administrative/Other|2|||
27594139|NCT02962908|80352451|FG000|Overall Study|Withdrawal by Subject|0|||
27986184|NCT00908037|81779921|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27594140|NCT02962908|80352452|FG001|Overall Study|Withdrawal by Subject|3|||
27594141|NCT02962908|80352453|FG002|Overall Study|Withdrawal by Subject|0|||
27594142|NCT02962908|80352454|FG003|Overall Study|Withdrawal by Subject|2|||
27594143|NCT02962908|80352451|FG000|Overall Study|Protocol Violation|0|||
27594144|NCT02962908|80352452|FG001|Overall Study|Protocol Violation|1|||
27594145|NCT02962908|80352453|FG002|Overall Study|Protocol Violation|0|||
27578560|NCT02984995|80302892|FG000|Overall Study|Required stem cell transplant|13|||
27578561|NCT02984995|80302893|FG001|Overall Study|Required stem cell transplant|2|||
27578562|NCT02984995|80302892|FG000|Overall Study|Progressive disease|11|||
27578563|NCT02984995|80302893|FG001|Overall Study|Progressive disease|1|||
27578564|NCT02984995|80302892|FG000|Overall Study|Adverse Event|1|||
27578565|NCT02984995|80302893|FG001|Overall Study|Adverse Event|0|||
27578566|NCT05061446|80302894|FG000|Overall Study|Adverse Event|2|||
27578567|NCT05061446|80302895|FG001|Overall Study|Adverse Event|0|||
27578568|NCT05061446|80302896|FG002|Overall Study|Adverse Event|0|||
27578569|NCT05061446|80302894|FG000|Overall Study|Participant no longer available due to personal reason|0|||
27578570|NCT05061446|80302895|FG001|Overall Study|Participant no longer available due to personal reason|1|||
27578571|NCT05061446|80302896|FG002|Overall Study|Participant no longer available due to personal reason|0|||
27578572|NCT01168999|80302897|FG000|Overall Study|Lost to Follow-up|2|||
27578573|NCT01168999|80302898|FG001|Overall Study|Lost to Follow-up|1|||
27578574|NCT01168999|80302899|FG002|Overall Study|Lost to Follow-up|0|||
27578575|NCT01168999|80302900|FG003|Overall Study|Lost to Follow-up|0|||
27578576|NCT04028388|80302901|FG000|Overall Study|Evaluations missing|3|||
27578577|NCT04028388|80302902|FG001|Overall Study|Evaluations missing|6|||
27578578|NCT04028388|80302901|FG000|Overall Study|Not started|2|||
27578579|NCT04028388|80302902|FG001|Overall Study|Not started|0|||
27578580|NCT01723904|80302903|FG000|Overall Study|Noncompliant|3|||
27578581|NCT01723904|80302903|FG000|Overall Study|Adverse Event|5|||
27578582|NCT01723904|80302903|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
27578583|NCT00699699|80302904|FG000|Overall Study|Adverse Event|36|||
27578584|NCT00699699|80302904|FG000|Overall Study|Individual different reasons|21|||
27578585|NCT03779841|80302906|FG000|Randomized Population|Did Not Receive Treatment|3|||
27578586|NCT03779841|80302907|FG001|Randomized Population|Did Not Receive Treatment|1|||
27578587|NCT03779841|80302908|FG002|Randomized Population|Did Not Receive Treatment|0|||
27578588|NCT03779841|80302906|FG000|Treated (Safety) Population|Adverse Event|1|||
27578589|NCT03779841|80302907|FG001|Treated (Safety) Population|Adverse Event|1|||
27578590|NCT03779841|80302908|FG002|Treated (Safety) Population|Adverse Event|0|||
27578591|NCT03779841|80302906|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
27578592|NCT03779841|80302907|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
27578593|NCT03779841|80302908|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
27578594|NCT03779841|80302906|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
27578595|NCT03779841|80302907|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
27578596|NCT03779841|80302908|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
27578597|NCT03779841|80302906|FG000|Treated (Safety) Population|Death|1|||
27578598|NCT03779841|80302907|FG001|Treated (Safety) Population|Death|0|||
27578599|NCT03779841|80302908|FG002|Treated (Safety) Population|Death|2|||
27578600|NCT01818336|80302909|FG000|Overall Study|Declined retest visit|0|||
27578601|NCT01818336|80302910|FG001|Overall Study|Declined retest visit|11|||
27578602|NCT01818336|80302909|FG000|Overall Study|Lost to Follow-up|0|||
27578603|NCT01818336|80302910|FG001|Overall Study|Lost to Follow-up|1|||
27578604|NCT00274716|80302913|FG000|Phase A|Other non-reported reason|4|||
27578605|NCT00274716|80302914|FG001|Phase A|Other non-reported reason|2|||
27578606|NCT00274716|80302915|FG002|Phase A|Other non-reported reason|1|||
27578607|NCT00274716|80302916|FG003|Phase A|Other non-reported reason|2|||
27578608|NCT00274716|80302917|FG004|Phase A|Other non-reported reason|0|||
27578609|NCT00274716|80302918|FG005|Phase A|Other non-reported reason|1|||
27578610|NCT00274716|80302913|FG000|Phase A|Participant moved|0|||
27578611|NCT00274716|80302914|FG001|Phase A|Participant moved|0|||
27578612|NCT00274716|80302915|FG002|Phase A|Participant moved|1|||
27578613|NCT00274716|80302916|FG003|Phase A|Participant moved|0|||
27578614|NCT00274716|80302917|FG004|Phase A|Participant moved|0|||
27578615|NCT00274716|80302918|FG005|Phase A|Participant moved|1|||
27578616|NCT00274716|80302913|FG000|Phase A|Site Terminated|0|||
27578617|NCT00274716|80302914|FG001|Phase A|Site Terminated|0|||
27578618|NCT00274716|80302915|FG002|Phase A|Site Terminated|0|||
27795687|NCT00408005|81082159|FG004|Induction|Failed to Complete Randomization|0|||
27578619|NCT00274716|80302916|FG003|Phase A|Site Terminated|1|||
27578620|NCT00274716|80302917|FG004|Phase A|Site Terminated|0|||
27578621|NCT00274716|80302918|FG005|Phase A|Site Terminated|0|||
27578622|NCT00274716|80302913|FG000|Phase A|Protocol Violation|1|||
27578623|NCT00274716|80302914|FG001|Phase A|Protocol Violation|0|||
27578624|NCT00274716|80302915|FG002|Phase A|Protocol Violation|0|||
27795688|NCT00408005|81082160|FG005|Induction|Failed to Complete Randomization|0|||
27795689|NCT00408005|81082161|FG006|Induction|Failed to Complete Randomization|0|||
27795690|NCT00408005|81082162|FG007|Induction|Failed to Complete Randomization|0|||
27578625|NCT00274716|80302916|FG003|Phase A|Protocol Violation|1|||
27578626|NCT00274716|80302917|FG004|Phase A|Protocol Violation|0|||
27795691|NCT00408005|81082155|FG000|Induction|Protocol Deviation|3|||
27795692|NCT00408005|81082156|FG001|Induction|Protocol Deviation|1|||
27578627|NCT00274716|80302918|FG005|Phase A|Protocol Violation|0|||
27578628|NCT00274716|80302913|FG000|Phase A|Met criteria for discontinuation|1|||
27578629|NCT00274716|80302914|FG001|Phase A|Met criteria for discontinuation|1|||
27578630|NCT00274716|80302915|FG002|Phase A|Met criteria for discontinuation|0|||
27578631|NCT00274716|80302916|FG003|Phase A|Met criteria for discontinuation|0|||
27578632|NCT00274716|80302917|FG004|Phase A|Met criteria for discontinuation|0|||
27578633|NCT00274716|80302918|FG005|Phase A|Met criteria for discontinuation|0|||
27578634|NCT00274716|80302913|FG000|Phase A|Withdrawal by Subject|2|||
27578635|NCT00274716|80302914|FG001|Phase A|Withdrawal by Subject|2|||
27578636|NCT00274716|80302915|FG002|Phase A|Withdrawal by Subject|1|||
27578637|NCT00274716|80302916|FG003|Phase A|Withdrawal by Subject|3|||
27578638|NCT00274716|80302917|FG004|Phase A|Withdrawal by Subject|0|||
27578639|NCT00274716|80302918|FG005|Phase A|Withdrawal by Subject|1|||
27578640|NCT00274716|80302913|FG000|Phase A|Adverse Event|2|||
27578641|NCT00274716|80302914|FG001|Phase A|Adverse Event|3|||
27578642|NCT00274716|80302915|FG002|Phase A|Adverse Event|3|||
27578643|NCT00274716|80302916|FG003|Phase A|Adverse Event|0|||
27578644|NCT00274716|80302917|FG004|Phase A|Adverse Event|2|||
27578645|NCT00274716|80302918|FG005|Phase A|Adverse Event|0|||
27578646|NCT00274716|80302913|FG000|Phase A|Completed but did not enter Phase B|1|||
27578647|NCT00274716|80302914|FG001|Phase A|Completed but did not enter Phase B|2|||
27578648|NCT00274716|80302915|FG002|Phase A|Completed but did not enter Phase B|2|||
27578649|NCT00274716|80302916|FG003|Phase A|Completed but did not enter Phase B|2|||
27578650|NCT00274716|80302917|FG004|Phase A|Completed but did not enter Phase B|1|||
27578651|NCT00274716|80302918|FG005|Phase A|Completed but did not enter Phase B|1|||
27578652|NCT00274716|80302913|FG000|Phase B|Adverse Event|0|||
27578653|NCT00274716|80302914|FG001|Phase B|Adverse Event|0|||
27578654|NCT00274716|80302915|FG002|Phase B|Adverse Event|2|||
27986185|NCT00908037|81779922|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986186|NCT00908037|81779923|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
27986187|NCT00908037|81779924|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986188|NCT00908037|81779925|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986189|NCT00908037|81779926|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
27986190|NCT00908037|81779915|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27578655|NCT00274716|80302916|FG003|Phase B|Adverse Event|0|||
27578656|NCT00274716|80302917|FG004|Phase B|Adverse Event|0|||
27578657|NCT00274716|80302918|FG005|Phase B|Adverse Event|1|||
27578658|NCT00274716|80302913|FG000|Phase B|Protocol Violation|0|||
27986191|NCT00908037|81779916|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986192|NCT00908037|81779917|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986193|NCT00908037|81779918|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
27986194|NCT00908037|81779919|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986195|NCT00908037|81779920|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986196|NCT00908037|81779921|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
27986197|NCT00908037|81779922|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986198|NCT00908037|81779923|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986199|NCT00908037|81779924|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986200|NCT00908037|81779925|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986201|NCT00908037|81779926|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
27986202|NCT00908037|81779915|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986203|NCT00908037|81779916|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986204|NCT00908037|81779917|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986205|NCT00908037|81779918|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986206|NCT00908037|81779919|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986207|NCT00908037|81779920|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986208|NCT00908037|81779921|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986209|NCT00908037|81779922|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27578659|NCT00274716|80302914|FG001|Phase B|Protocol Violation|2|||
27578660|NCT00274716|80302915|FG002|Phase B|Protocol Violation|0|||
27986210|NCT00908037|81779923|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27578661|NCT00274716|80302916|FG003|Phase B|Protocol Violation|0|||
27986211|NCT00908037|81779924|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986212|NCT00908037|81779925|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
27986213|NCT00908037|81779926|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
27986214|NCT00908037|81779915|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27578662|NCT00274716|80302917|FG004|Phase B|Protocol Violation|0|||
27578663|NCT00274716|80302918|FG005|Phase B|Protocol Violation|0|||
27578664|NCT00274716|80302913|FG000|Phase B|Withdrawal by Subject|0|||
27578665|NCT00274716|80302914|FG001|Phase B|Withdrawal by Subject|1|||
27578666|NCT00274716|80302915|FG002|Phase B|Withdrawal by Subject|0|||
27578667|NCT00274716|80302916|FG003|Phase B|Withdrawal by Subject|0|||
27578668|NCT00274716|80302917|FG004|Phase B|Withdrawal by Subject|0|||
27578669|NCT00274716|80302918|FG005|Phase B|Withdrawal by Subject|0|||
27578670|NCT00274716|80302913|FG000|Phase B|Participant moved|1|||
27578671|NCT00274716|80302914|FG001|Phase B|Participant moved|0|||
27578672|NCT00274716|80302915|FG002|Phase B|Participant moved|0|||
27578673|NCT00274716|80302916|FG003|Phase B|Participant moved|0|||
27578674|NCT00274716|80302917|FG004|Phase B|Participant moved|0|||
27578675|NCT00274716|80302918|FG005|Phase B|Participant moved|0|||
27578676|NCT00274716|80302913|FG000|Phase B|Other non-reported reason|0|||
27578677|NCT00274716|80302914|FG001|Phase B|Other non-reported reason|0|||
27578678|NCT00274716|80302915|FG002|Phase B|Other non-reported reason|1|||
27578679|NCT00274716|80302916|FG003|Phase B|Other non-reported reason|1|||
27578680|NCT00274716|80302917|FG004|Phase B|Other non-reported reason|0|||
27986215|NCT00908037|81779916|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27986216|NCT00908037|81779917|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27674735|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
27674736|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
27986217|NCT00908037|81779918|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27986218|NCT00908037|81779919|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27986219|NCT00908037|81779920|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27986220|NCT00908037|81779921|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27986221|NCT00908037|81779922|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27986222|NCT00908037|81779923|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27578681|NCT00274716|80302918|FG005|Phase B|Other non-reported reason|0|||
27578682|NCT00274716|80302913|FG000|Phase B|Lost to Follow-up|0|||
27578683|NCT00274716|80302914|FG001|Phase B|Lost to Follow-up|1|||
27578684|NCT00274716|80302915|FG002|Phase B|Lost to Follow-up|0|||
27578685|NCT00274716|80302916|FG003|Phase B|Lost to Follow-up|0|||
27578686|NCT00274716|80302917|FG004|Phase B|Lost to Follow-up|0|||
27578687|NCT00274716|80302918|FG005|Phase B|Lost to Follow-up|0|||
27578688|NCT00938431|80302925|FG000|Overall Study|Adverse Event|5|||
27578689|NCT00938431|80302926|FG001|Overall Study|Adverse Event|8|||
27578690|NCT00938431|80302927|FG002|Overall Study|Adverse Event|6|||
27578691|NCT00938431|80302925|FG000|Overall Study|Lack of Efficacy|0|||
27578692|NCT00938431|80302926|FG001|Overall Study|Lack of Efficacy|1|||
27578693|NCT00938431|80302927|FG002|Overall Study|Lack of Efficacy|0|||
27578694|NCT00938431|80302925|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
27578695|NCT00938431|80302926|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
27578696|NCT00938431|80302927|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
27578697|NCT00938431|80302925|FG000|Overall Study|Dosing compliance issue|0|||
27578698|NCT00938431|80302926|FG001|Overall Study|Dosing compliance issue|0|||
27986223|NCT00908037|81779924|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
27986224|NCT00908037|81779925|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
27674737|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
27986225|NCT00908037|81779926|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
27986226|NCT00908037|81779915|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986227|NCT00908037|81779916|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986228|NCT00908037|81779917|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986229|NCT00908037|81779918|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986230|NCT00908037|81779919|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986231|NCT00908037|81779920|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986232|NCT00908037|81779921|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986233|NCT00908037|81779922|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986234|NCT00908037|81779923|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986235|NCT00908037|81779924|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
27986236|NCT00908037|81779925|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27674738|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
27869629|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27869630|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27674739|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
27578699|NCT00938431|80302927|FG002|Overall Study|Dosing compliance issue|1|||
27578700|NCT00938431|80302925|FG000|Overall Study|Reached maximum dose early|0|||
27578701|NCT00938431|80302926|FG001|Overall Study|Reached maximum dose early|0|||
27578702|NCT00938431|80302927|FG002|Overall Study|Reached maximum dose early|1|||
27578703|NCT02752048|80302928|FG000|Overall Study|Withdrawal by Subject|0|||
27578704|NCT02752048|80302929|FG001|Overall Study|Withdrawal by Subject|0|||
27578705|NCT02752048|80302930|FG002|Overall Study|Withdrawal by Subject|3|||
27578706|NCT00818441|80302933|FG000|Overall Study|Death|69|||
27578707|NCT00818441|80302934|FG001|Overall Study|Death|26|||
27578708|NCT00818441|80302933|FG000|Overall Study|Other|5|||
27578709|NCT00818441|80302934|FG001|Overall Study|Other|0|||
27578710|NCT00818441|80302933|FG000|Overall Study|Lost to Follow-up|2|||
27578711|NCT00818441|80302934|FG001|Overall Study|Lost to Follow-up|1|||
27578712|NCT00818441|80302933|FG000|Overall Study|Withdrawal by Subject|2|||
27578713|NCT00818441|80302934|FG001|Overall Study|Withdrawal by Subject|0|||
27578714|NCT00818441|80302933|FG000|Overall Study|Adverse Event|0|||
27578715|NCT00818441|80302934|FG001|Overall Study|Adverse Event|1|||
27578716|NCT00818441|80302933|FG000|Overall Study|Study terminated by sponsor|11|||
27578717|NCT00818441|80302934|FG001|Overall Study|Study terminated by sponsor|2|||
27578718|NCT02992899|80302935|FG000|Overall Study|Withdrawal by Subject|1|||
27578719|NCT02992899|80302936|FG001|Overall Study|Withdrawal by Subject|0|||
27578720|NCT02992899|80302935|FG000|Overall Study|Lost to Follow-up|1|||
27578721|NCT02992899|80302936|FG001|Overall Study|Lost to Follow-up|3|||
27578722|NCT03251924|80302937|FG000|Overall Study|Disease Progression|6|||
27578723|NCT03251924|80302938|FG001|Overall Study|Disease Progression|6|||
27578724|NCT03251924|80302939|FG002|Overall Study|Disease Progression|7|||
27578725|NCT03251924|80302940|FG003|Overall Study|Disease Progression|8|||
27674740|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
27674741|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
27674742|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
27986237|NCT00908037|81779926|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
27986238|NCT00908037|81779915|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986239|NCT00908037|81779916|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986240|NCT00908037|81779917|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986241|NCT00908037|81779918|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27578726|NCT03251924|80302941|FG004|Overall Study|Disease Progression|8|||
27578727|NCT03251924|80302942|FG005|Overall Study|Disease Progression|7|||
27986242|NCT00908037|81779919|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986243|NCT00908037|81779920|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986244|NCT00908037|81779921|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986245|NCT00908037|81779922|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986246|NCT00908037|81779923|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986247|NCT00908037|81779924|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986248|NCT00908037|81779925|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
27986249|NCT00908037|81779926|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
27986250|NCT00908037|81779915|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27578728|NCT03251924|80302943|FG006|Overall Study|Disease Progression|6|||
27674743|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
27674744|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
27674745|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
27674746|NCT00132678|80647197|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
27674747|NCT00132678|80647198|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
27578729|NCT03251924|80302944|FG007|Overall Study|Disease Progression|10|||
27578730|NCT03251924|80302945|FG008|Overall Study|Disease Progression|6|||
27578731|NCT03251924|80302937|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
27674748|NCT00132678|80647199|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
27674749|NCT01896557|80647200|FG000|Clopidogrel Alone|Adverse Event|1|||
27886628|NCT01938430|81418139|FG003|Overall Study|Randomized but Not Treated|0|||
27795693|NCT00408005|81082157|FG002|Induction|Protocol Deviation|0|||
27795694|NCT00408005|81082158|FG003|Induction|Protocol Deviation|0|||
27795695|NCT00408005|81082159|FG004|Induction|Protocol Deviation|0|||
27986251|NCT00908037|81779916|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986252|NCT00908037|81779917|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986253|NCT00908037|81779918|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986254|NCT00908037|81779919|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986255|NCT00908037|81779920|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27578732|NCT03251924|80302938|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
27594146|NCT02962908|80352454|FG003|Overall Study|Protocol Violation|0|||
27795696|NCT00408005|81082160|FG005|Induction|Protocol Deviation|0|||
27795697|NCT00408005|81082161|FG006|Induction|Protocol Deviation|0|||
27795698|NCT00408005|81082162|FG007|Induction|Protocol Deviation|0|||
27795699|NCT00408005|81082155|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
27795700|NCT00408005|81082156|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
27795701|NCT00408005|81082157|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
27795702|NCT00408005|81082158|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
27795703|NCT00408005|81082159|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
27869631|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
27869632|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27869633|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #2|5|||
27869634|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #2|0|||
27869635|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
27869636|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
27869637|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
27795704|NCT00408005|81082160|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
27795705|NCT00408005|81082161|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
27795706|NCT00408005|81082162|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
27795707|NCT00408005|81082155|FG000|Induction|Recurrent leukemia|1|||
27795708|NCT00408005|81082156|FG001|Induction|Recurrent leukemia|0|||
27795709|NCT00408005|81082157|FG002|Induction|Recurrent leukemia|0|||
27795710|NCT00408005|81082158|FG003|Induction|Recurrent leukemia|0|||
27795711|NCT00408005|81082159|FG004|Induction|Recurrent leukemia|0|||
27795712|NCT00408005|81082160|FG005|Induction|Recurrent leukemia|0|||
27795713|NCT00408005|81082161|FG006|Induction|Recurrent leukemia|0|||
27869638|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
27869639|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
27869640|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
27869641|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #3|11|||
27869642|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #3|0|||
27869643|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
27869644|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
27869645|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
27869646|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27869647|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27869648|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27795714|NCT00408005|81082162|FG007|Induction|Recurrent leukemia|0|||
27795715|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27795716|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27795717|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
27795718|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
27795719|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
27795720|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
27795721|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
27795722|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27795723|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
27795724|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
27795725|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
27795726|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
27795727|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
27795728|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
27795729|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
27594147|NCT02962908|80352451|FG000|Overall Study|Physician Decision|0|||
27594148|NCT02962908|80352452|FG001|Overall Study|Physician Decision|1|||
27594149|NCT02962908|80352453|FG002|Overall Study|Physician Decision|0|||
27594150|NCT02962908|80352454|FG003|Overall Study|Physician Decision|0|||
27594151|NCT02137369|80352457|FG000|Overall Study|Withdrawal by Subject|3|||
27594152|NCT02137369|80352458|FG001|Overall Study|Withdrawal by Subject|2|||
27986256|NCT00908037|81779921|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986257|NCT00908037|81779922|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986258|NCT00908037|81779923|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986259|NCT00908037|81779924|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
27986260|NCT00908037|81779925|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986261|NCT00908037|81779926|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
27986262|NCT00908037|81779915|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986263|NCT00908037|81779916|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986264|NCT00908037|81779917|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986265|NCT00908037|81779918|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986266|NCT00908037|81779919|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986267|NCT00908037|81779920|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986268|NCT00908037|81779921|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986269|NCT00908037|81779922|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986270|NCT00908037|81779923|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27869649|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #4|3|||
27869650|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #4|0|||
27869651|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
27986271|NCT00908037|81779924|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986272|NCT00908037|81779925|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
27986273|NCT00908037|81779926|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
27986274|NCT01353911|81779931|FG000|Overall Study|Lost to Follow-up|2|||
27986275|NCT01353911|81779932|FG001|Overall Study|Lost to Follow-up|6|||
27986276|NCT01353911|81779933|FG002|Overall Study|Lost to Follow-up|4|||
27986277|NCT01353911|81779934|FG003|Overall Study|Lost to Follow-up|0|||
27986278|NCT01353911|81779935|FG004|Overall Study|Lost to Follow-up|4|||
27986279|NCT01353911|81779936|FG005|Overall Study|Lost to Follow-up|4|||
27986280|NCT01353911|81779937|FG006|Overall Study|Lost to Follow-up|3|||
27986281|NCT01353911|81779938|FG007|Overall Study|Lost to Follow-up|6|||
27986282|NCT01353911|81779931|FG000|Overall Study|Withdrawal by Subject|2|||
27986283|NCT01353911|81779932|FG001|Overall Study|Withdrawal by Subject|3|||
27986284|NCT01353911|81779933|FG002|Overall Study|Withdrawal by Subject|4|||
27986285|NCT01353911|81779934|FG003|Overall Study|Withdrawal by Subject|2|||
27986286|NCT01353911|81779935|FG004|Overall Study|Withdrawal by Subject|2|||
27986287|NCT01353911|81779936|FG005|Overall Study|Withdrawal by Subject|3|||
27986288|NCT01353911|81779937|FG006|Overall Study|Withdrawal by Subject|3|||
27986289|NCT01353911|81779938|FG007|Overall Study|Withdrawal by Subject|9|||
27986290|NCT01353911|81779931|FG000|Overall Study|Status Not Recorded|4|||
27986291|NCT01353911|81779932|FG001|Overall Study|Status Not Recorded|0|||
27986292|NCT01353911|81779933|FG002|Overall Study|Status Not Recorded|1|||
27986293|NCT01353911|81779934|FG003|Overall Study|Status Not Recorded|0|||
27986294|NCT01353911|81779935|FG004|Overall Study|Status Not Recorded|0|||
27986295|NCT01353911|81779936|FG005|Overall Study|Status Not Recorded|0|||
27986296|NCT01353911|81779937|FG006|Overall Study|Status Not Recorded|0|||
27578733|NCT03251924|80302939|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
27986297|NCT01353911|81779938|FG007|Overall Study|Status Not Recorded|0|||
27795730|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
27795731|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27795732|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27795733|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
27795734|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27795735|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
27795736|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27795737|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27795738|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
27795739|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
27795740|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
27795741|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
27795742|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
27795743|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
27795744|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
27795745|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
27795746|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
27795747|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27795748|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27795749|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
27986298|NCT00109577|81779939|FG000|Overall Study|Withdrawal by Subject|3|||
27986299|NCT00109577|81779940|FG001|Overall Study|Withdrawal by Subject|3|||
27986300|NCT01818284|81779941|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
27986301|NCT01818284|81779942|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
27986302|NCT01818284|81779941|FG000|Overall Study|Death|0|||
27986303|NCT01818284|81779942|FG001|Overall Study|Death|2|||
27986304|NCT01278407|81779943|FG000|Confirmatory Phase|Adverse Event|5|||
27986305|NCT01278407|81779944|FG001|Confirmatory Phase|Adverse Event|10|||
27986306|NCT01278407|81779945|FG002|Confirmatory Phase|Adverse Event|1|||
27986307|NCT01278407|81779946|FG003|Confirmatory Phase|Adverse Event|0|||
27986308|NCT01278407|81779947|FG004|Confirmatory Phase|Adverse Event|0|||
27986309|NCT01278407|81779943|FG000|Confirmatory Phase|Participant's Choice|3|||
27986310|NCT01278407|81779944|FG001|Confirmatory Phase|Participant's Choice|5|||
27986311|NCT01278407|81779945|FG002|Confirmatory Phase|Participant's Choice|3|||
27986312|NCT01278407|81779946|FG003|Confirmatory Phase|Participant's Choice|0|||
27986313|NCT01278407|81779947|FG004|Confirmatory Phase|Participant's Choice|0|||
27986314|NCT01278407|81779943|FG000|Confirmatory Phase|Other|1|||
27986315|NCT01278407|81779944|FG001|Confirmatory Phase|Other|1|||
27986316|NCT01278407|81779945|FG002|Confirmatory Phase|Other|2|||
27986317|NCT01278407|81779946|FG003|Confirmatory Phase|Other|0|||
27986318|NCT01278407|81779947|FG004|Confirmatory Phase|Other|0|||
27986319|NCT01278407|81779943|FG000|Extension Phase|Adverse Event|0|||
27986320|NCT01278407|81779944|FG001|Extension Phase|Adverse Event|0|||
27986321|NCT01278407|81779945|FG002|Extension Phase|Adverse Event|0|||
27986322|NCT01278407|81779946|FG003|Extension Phase|Adverse Event|7|||
27986323|NCT01278407|81779947|FG004|Extension Phase|Adverse Event|16|||
27986324|NCT01278407|81779943|FG000|Extension Phase|Participant's Choice|0|||
27986325|NCT01278407|81779944|FG001|Extension Phase|Participant's Choice|0|||
27986326|NCT01278407|81779945|FG002|Extension Phase|Participant's Choice|0|||
27986327|NCT01278407|81779946|FG003|Extension Phase|Participant's Choice|4|||
27986328|NCT01278407|81779947|FG004|Extension Phase|Participant's Choice|11|||
27986329|NCT01278407|81779943|FG000|Extension Phase|Other|0|||
27795750|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
27795751|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27795752|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
27795753|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27795754|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
27795755|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
27795756|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
27986330|NCT01278407|81779944|FG001|Extension Phase|Other|0|||
27986331|NCT01278407|81779945|FG002|Extension Phase|Other|0|||
27578734|NCT03251924|80302940|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
27986332|NCT01278407|81779946|FG003|Extension Phase|Other|1|||
27986333|NCT01278407|81779947|FG004|Extension Phase|Other|3|||
27986334|NCT04268173|81779948|FG000|Overall Study|Lost to Follow-up|75|||
27986335|NCT04268173|81779949|FG001|Overall Study|Lost to Follow-up|108|||
27986336|NCT00991406|81779952|FG000|Overall Study|One participant did not respond to FES.|1|||
27986337|NCT02438813|81783055|FG000|Overall Study|Patient Decision|59|||
27795757|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
27795758|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
27795759|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
27795760|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
27795761|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
27795762|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
27795763|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27986338|NCT02438813|81783055|FG000|Overall Study|Patient Lost to Follow-Up|137|||
27986339|NCT02438813|81783055|FG000|Overall Study|Study Ended by Sponsor|80|||
27986340|NCT02438813|81783055|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
27986341|NCT01729208|81783058|FG000|Baseline|Physician Decision|5|||
27986342|NCT01729208|81783059|FG001|Baseline|Physician Decision|4|||
27986343|NCT01729208|81783058|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
27795764|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27795765|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27795766|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27795767|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
27795768|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27795769|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27986344|NCT01729208|81783059|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
27986345|NCT01729208|81783058|FG000|12 Months Follow-up|Lost to Follow-up|3|||
27986346|NCT01729208|81783059|FG001|12 Months Follow-up|Lost to Follow-up|3|||
27986347|NCT01729208|81783058|FG000|24 Months Follow-up|Lost to Follow-up|3|||
27986348|NCT01729208|81783059|FG001|24 Months Follow-up|Lost to Follow-up|0|||
27986349|NCT01729208|81783058|FG000|36 Months Follow-up|Physician Decision|1|||
27986350|NCT01729208|81783059|FG001|36 Months Follow-up|Physician Decision|0|||
27986351|NCT01729208|81783058|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
27986352|NCT01729208|81783059|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
27986353|NCT01452919|81783060|FG000|Open-Label Treatment|Adverse Event|5|||
27986354|NCT01452919|81783061|FG001|Open-Label Treatment|Adverse Event|0|||
27986355|NCT01452919|81783062|FG002|Open-Label Treatment|Adverse Event|0|||
27986356|NCT01452919|81783060|FG000|Open-Label Treatment|Lost to Follow-up|4|||
27986357|NCT01452919|81783061|FG001|Open-Label Treatment|Lost to Follow-up|0|||
27986358|NCT01452919|81783062|FG002|Open-Label Treatment|Lost to Follow-up|0|||
27986359|NCT01452919|81783060|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
27986360|NCT01452919|81783061|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
27986361|NCT01452919|81783062|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
27986362|NCT01452919|81783060|FG000|Open-Label Treatment|Protocol Violation|4|||
27986363|NCT01452919|81783061|FG001|Open-Label Treatment|Protocol Violation|0|||
27986364|NCT01452919|81783062|FG002|Open-Label Treatment|Protocol Violation|0|||
27986365|NCT01452919|81783060|FG000|Open-Label Treatment|Sponsor Decision|1|||
27986366|NCT01452919|81783061|FG001|Open-Label Treatment|Sponsor Decision|0|||
27986367|NCT01452919|81783062|FG002|Open-Label Treatment|Sponsor Decision|0|||
27986368|NCT01452919|81783060|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
27986369|NCT01452919|81783061|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
27986370|NCT01452919|81783062|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
27986371|NCT01452919|81783060|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
27986372|NCT01452919|81783061|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
27986373|NCT01452919|81783062|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
27986374|NCT01452919|81783060|FG000|Randomization Treatment|Adverse Event|0|||
27986375|NCT01452919|81783061|FG001|Randomization Treatment|Adverse Event|0|||
27986376|NCT01452919|81783062|FG002|Randomization Treatment|Adverse Event|2|||
27986377|NCT01452919|81783060|FG000|Randomization Treatment|Sponsor Decision|0|||
27986378|NCT01452919|81783061|FG001|Randomization Treatment|Sponsor Decision|1|||
27986379|NCT01452919|81783062|FG002|Randomization Treatment|Sponsor Decision|0|||
27986380|NCT01452919|81783060|FG000|Randomization Treatment|Withdrawal by Subject|0|||
27986381|NCT01452919|81783061|FG001|Randomization Treatment|Withdrawal by Subject|1|||
27986382|NCT01452919|81783062|FG002|Randomization Treatment|Withdrawal by Subject|0|||
27986383|NCT01452919|81783060|FG000|Randomization Treatment|Subject is moving or has moved|0|||
27986384|NCT01452919|81783061|FG001|Randomization Treatment|Subject is moving or has moved|1|||
27986385|NCT01452919|81783062|FG002|Randomization Treatment|Subject is moving or has moved|0|||
27986386|NCT02678923|81783067|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
27986387|NCT02678923|81783068|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
27986388|NCT02678923|81783067|FG000|Overall Study|Withdrawal by Subject|3|||
27986389|NCT02678923|81783068|FG001|Overall Study|Withdrawal by Subject|2|||
27986390|NCT02678923|81783067|FG000|Overall Study|Lost to Follow-up|1|||
27986391|NCT02678923|81783068|FG001|Overall Study|Lost to Follow-up|0|||
27986392|NCT02678923|81783067|FG000|Overall Study|Did Not Return for Study Visits|1|||
27986393|NCT02678923|81783068|FG001|Overall Study|Did Not Return for Study Visits|0|||
27986394|NCT01563185|81783069|FG000|Overall Study|Withdrawal by Subject|1|||
27986395|NCT01563185|81783069|FG000|Overall Study|Non-Compliance with study drug|1|||
27986396|NCT01090063|81783070|FG000|Screen|Screen Failed|4|||
27986397|NCT01090063|81783070|FG000|Treatment|Withdrawal by Subject|4|||
27986398|NCT02607228|81783071|FG000|Overall Study|Progressive Disease|4|||
27986399|NCT02607228|81783072|FG001|Overall Study|Progressive Disease|3|||
27986400|NCT02607228|81783073|FG002|Overall Study|Progressive Disease|1|||
27986401|NCT02607228|81783074|FG003|Overall Study|Progressive Disease|5|||
27986402|NCT02607228|81783075|FG004|Overall Study|Progressive Disease|4|||
27986403|NCT02607228|81783076|FG005|Overall Study|Progressive Disease|3|||
27986404|NCT02607228|81783077|FG006|Overall Study|Progressive Disease|1|||
27986405|NCT02607228|81783071|FG000|Overall Study|Adverse Event|1|||
27986406|NCT02607228|81783072|FG001|Overall Study|Adverse Event|0|||
27986407|NCT02607228|81783073|FG002|Overall Study|Adverse Event|1|||
27986408|NCT02607228|81783074|FG003|Overall Study|Adverse Event|0|||
27986409|NCT02607228|81783075|FG004|Overall Study|Adverse Event|1|||
27986410|NCT02607228|81783076|FG005|Overall Study|Adverse Event|1|||
27986411|NCT02607228|81783077|FG006|Overall Study|Adverse Event|1|||
27986412|NCT02607228|81783071|FG000|Overall Study|Investigator's Discretion|0|||
27986413|NCT02607228|81783072|FG001|Overall Study|Investigator's Discretion|0|||
27986414|NCT02607228|81783073|FG002|Overall Study|Investigator's Discretion|1|||
27986415|NCT02607228|81783074|FG003|Overall Study|Investigator's Discretion|0|||
27986416|NCT02607228|81783075|FG004|Overall Study|Investigator's Discretion|0|||
27986417|NCT02607228|81783076|FG005|Overall Study|Investigator's Discretion|1|||
27986418|NCT02607228|81783077|FG006|Overall Study|Investigator's Discretion|0|||
27986419|NCT02607228|81783071|FG000|Overall Study|Withdrew Consent|0|||
27986420|NCT02607228|81783072|FG001|Overall Study|Withdrew Consent|1|||
27986421|NCT02607228|81783073|FG002|Overall Study|Withdrew Consent|0|||
27986422|NCT02607228|81783074|FG003|Overall Study|Withdrew Consent|0|||
27986423|NCT02607228|81783075|FG004|Overall Study|Withdrew Consent|0|||
27986424|NCT02607228|81783076|FG005|Overall Study|Withdrew Consent|1|||
27986425|NCT02607228|81783077|FG006|Overall Study|Withdrew Consent|0|||
27986426|NCT02607228|81783071|FG000|Overall Study|Study Terminated by Sponsor|0|||
27986427|NCT02607228|81783072|FG001|Overall Study|Study Terminated by Sponsor|0|||
27986428|NCT02607228|81783073|FG002|Overall Study|Study Terminated by Sponsor|0|||
27986429|NCT02607228|81783074|FG003|Overall Study|Study Terminated by Sponsor|1|||
27986430|NCT02607228|81783075|FG004|Overall Study|Study Terminated by Sponsor|0|||
27986431|NCT02607228|81783076|FG005|Overall Study|Study Terminated by Sponsor|0|||
27986432|NCT02607228|81783077|FG006|Overall Study|Study Terminated by Sponsor|0|||
27986433|NCT01424566|81783078|FG000|Single-blind Treatment|Adverse Event|71|||
27986434|NCT01424566|81783079|FG001|Single-blind Treatment|Adverse Event|0|||
27986435|NCT01424566|81783080|FG002|Single-blind Treatment|Adverse Event|0|||
27986436|NCT01424566|81783078|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
27986437|NCT01424566|81783079|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
27986438|NCT01424566|81783080|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
27986439|NCT01424566|81783078|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
27986440|NCT01424566|81783079|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
27986441|NCT01424566|81783080|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
27986442|NCT01424566|81783078|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
27986443|NCT01424566|81783079|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
27986444|NCT01424566|81783080|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
27986445|NCT01424566|81783078|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
27986446|NCT01424566|81783079|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
27986447|NCT01424566|81783080|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
27986448|NCT01424566|81783078|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
27986449|NCT01424566|81783079|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
27986450|NCT01424566|81783080|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
27986451|NCT01424566|81783078|FG000|Double-blind Treatment|Adverse Event|0|||
27986452|NCT01424566|81783079|FG001|Double-blind Treatment|Adverse Event|21|||
27986453|NCT01424566|81783080|FG002|Double-blind Treatment|Adverse Event|13|||
27986454|NCT01424566|81783078|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
27986455|NCT01424566|81783079|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
27986456|NCT01424566|81783080|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
27986457|NCT01424566|81783078|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
27986458|NCT01424566|81783079|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
27986459|NCT01424566|81783080|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
27869652|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
27869653|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
27869654|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
27869655|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
27869656|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27869657|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
27869658|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
27869659|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
27869660|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27869661|NCT03888066|81357784|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
27869662|NCT03888066|81357785|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27869663|NCT03888066|81357784|FG000|Run-in Phase|AE (Adverse Event)|17|||
27869664|NCT03888066|81357785|FG001|Run-in Phase|AE (Adverse Event)|0|||
27869665|NCT03888066|81357784|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
27869666|NCT03888066|81357785|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
27869667|NCT03888066|81357784|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27986460|NCT01424566|81783078|FG000|Double-blind Treatment|Lack of Efficacy|0|||
27986461|NCT01424566|81783079|FG001|Double-blind Treatment|Lack of Efficacy|1|||
27986462|NCT01424566|81783080|FG002|Double-blind Treatment|Lack of Efficacy|1|||
27986463|NCT03459365|81783081|FG000|Overall Study|Withdrawal by Subject|6|||
27986464|NCT03459365|81783081|FG000|Overall Study|Protocol Violation|8|||
27986465|NCT01183065|81783084|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
27795770|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
27795771|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27795772|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27795773|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
27795774|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
27795775|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
27795776|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27795777|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
27795778|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
27795779|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27795780|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27795781|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27795782|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27986466|NCT02831933|81783085|FG000|Overall Study|Physician Decision|11|||
27986467|NCT00527982|81783087|FG000|Overall Study|Physician Decision|1|||
27986468|NCT00527982|81783088|FG001|Overall Study|Physician Decision|0|||
27986469|NCT04544683|81783091|FG000|Overall Study|Lost to Follow-up|2|||
27986470|NCT04544683|81783091|FG000|Overall Study|Underwent cervical spine surgery|6|||
27986471|NCT04405076|81783092|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
27986472|NCT04405076|81783093|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
27986473|NCT04405076|81783094|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
27986474|NCT04405076|81783095|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
27986475|NCT04405076|81783096|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
27986476|NCT04405076|81783097|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
27986477|NCT04405076|81783098|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
27986478|NCT04405076|81783099|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
27986479|NCT04405076|81783100|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
27986480|NCT04405076|81783092|FG000|Part A (Blinded Phase)|Physician Decision|1|||
27986481|NCT04405076|81783093|FG001|Part A (Blinded Phase)|Physician Decision|2|||
27986482|NCT04405076|81783094|FG002|Part A (Blinded Phase)|Physician Decision|0|||
27986483|NCT04405076|81783095|FG003|Part A (Blinded Phase)|Physician Decision|0|||
27986484|NCT04405076|81783096|FG004|Part A (Blinded Phase)|Physician Decision|0|||
27986485|NCT04405076|81783097|FG005|Part A (Blinded Phase)|Physician Decision|0|||
27986486|NCT04405076|81783098|FG006|Part A (Blinded Phase)|Physician Decision|0|||
27986487|NCT04405076|81783099|FG007|Part A (Blinded Phase)|Physician Decision|0|||
27986488|NCT04405076|81783100|FG008|Part A (Blinded Phase)|Physician Decision|0|||
27986489|NCT04405076|81783092|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
27986490|NCT04405076|81783093|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
27986491|NCT04405076|81783094|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
27986492|NCT04405076|81783095|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
27986493|NCT04405076|81783096|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
27986494|NCT04405076|81783097|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
27986495|NCT04405076|81783098|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
27986496|NCT04405076|81783099|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
27986497|NCT04405076|81783100|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
27986498|NCT04405076|81783092|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
27986499|NCT04405076|81783093|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986500|NCT04405076|81783094|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986501|NCT04405076|81783095|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986502|NCT04405076|81783096|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986503|NCT04405076|81783097|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986504|NCT04405076|81783098|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986505|NCT04405076|81783099|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986506|NCT04405076|81783100|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
27986507|NCT04405076|81783092|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
27986508|NCT04405076|81783093|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
27986509|NCT04405076|81783094|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986510|NCT04405076|81783095|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986511|NCT04405076|81783096|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986512|NCT04405076|81783097|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986513|NCT04405076|81783098|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986514|NCT04405076|81783099|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986515|NCT04405076|81783100|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
27986516|NCT04405076|81783092|FG000|Part A (Blinded Phase)|Other than Specified|0|||
27986517|NCT04405076|81783093|FG001|Part A (Blinded Phase)|Other than Specified|0|||
27986518|NCT04405076|81783094|FG002|Part A (Blinded Phase)|Other than Specified|3|||
27986519|NCT04405076|81783095|FG003|Part A (Blinded Phase)|Other than Specified|0|||
27986520|NCT04405076|81783096|FG004|Part A (Blinded Phase)|Other than Specified|0|||
27986521|NCT04405076|81783097|FG005|Part A (Blinded Phase)|Other than Specified|0|||
27986522|NCT04405076|81783098|FG006|Part A (Blinded Phase)|Other than Specified|0|||
27986523|NCT04405076|81783099|FG007|Part A (Blinded Phase)|Other than Specified|0|||
27986524|NCT04405076|81783100|FG008|Part A (Blinded Phase)|Other than Specified|0|||
27986525|NCT04405076|81783092|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
27986526|NCT04405076|81783093|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
27986527|NCT04405076|81783094|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
27986528|NCT04405076|81783095|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
27986529|NCT04405076|81783096|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
27986530|NCT04405076|81783097|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
27986531|NCT04405076|81783098|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
27986532|NCT04405076|81783099|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
27986533|NCT04405076|81783100|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
27986534|NCT04405076|81783092|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986535|NCT04405076|81783093|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986536|NCT04405076|81783094|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986537|NCT04405076|81783095|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986538|NCT04405076|81783096|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
27986539|NCT04405076|81783097|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986540|NCT04405076|81783098|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986541|NCT04405076|81783099|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986542|NCT04405076|81783100|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
27986543|NCT04405076|81783092|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
27986544|NCT04405076|81783093|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
27986545|NCT04405076|81783094|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
27986546|NCT04405076|81783095|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
27986547|NCT04405076|81783096|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
27986548|NCT04405076|81783097|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
27986549|NCT04405076|81783098|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
27795783|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
27795784|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
27795785|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
27795786|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
27795787|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795788|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795789|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795790|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795791|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795792|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
27795793|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795794|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
27795795|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27795796|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27795797|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
27795798|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
27986550|NCT04405076|81783099|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
27986551|NCT04405076|81783100|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
27986552|NCT04405076|81783092|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986553|NCT04405076|81783093|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986554|NCT04405076|81783094|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986555|NCT04405076|81783095|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986556|NCT04405076|81783096|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986557|NCT04405076|81783097|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986558|NCT04405076|81783098|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
27986559|NCT04405076|81783099|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
27986560|NCT04405076|81783100|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
27986561|NCT04405076|81783092|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986562|NCT04405076|81783093|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986563|NCT04405076|81783094|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986564|NCT04405076|81783095|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986565|NCT04405076|81783096|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986566|NCT04405076|81783097|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986567|NCT04405076|81783098|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
27986568|NCT04405076|81783099|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986569|NCT04405076|81783100|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
27986570|NCT01306656|81783101|FG000|Overall Study|Lost to Follow-up|1|||
27986571|NCT01306656|81783102|FG001|Overall Study|Lost to Follow-up|0|||
27986572|NCT02666105|81783103|FG000|Overall Study|Death|1|||
27986573|NCT03088813|81783104|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
27986574|NCT03088813|81783105|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
27986575|NCT03088813|81783106|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
27986576|NCT03088813|81783107|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
27986577|NCT03088813|81783104|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
27986578|NCT03088813|81783105|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
27986579|NCT03088813|81783106|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
27986580|NCT03088813|81783107|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
27986581|NCT03088813|81783104|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
27986582|NCT03088813|81783105|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
27795799|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
27795800|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
27986583|NCT03088813|81783106|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
27986584|NCT03088813|81783107|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
27986585|NCT03088813|81783104|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
27986586|NCT03088813|81783105|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
27986587|NCT03088813|81783106|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
27986588|NCT03088813|81783107|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
27986589|NCT03088813|81783104|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
27986590|NCT03088813|81783105|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
27986591|NCT03088813|81783106|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
27986592|NCT03088813|81783107|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
27986593|NCT03088813|81783104|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
27986594|NCT03088813|81783105|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
27986595|NCT03088813|81783106|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
27986596|NCT03088813|81783107|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
27986597|NCT03088813|81783104|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
27986598|NCT03088813|81783105|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
27986599|NCT03088813|81783106|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
27986600|NCT03088813|81783107|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
27986601|NCT01990859|81783109|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
27986602|NCT01990859|81783109|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
27986603|NCT02428205|81783116|FG000|Overall Study|Lack of Efficacy|1|||
27986604|NCT02428205|81783117|FG001|Overall Study|Lack of Efficacy|0|||
27986605|NCT02428205|81783116|FG000|Overall Study|Lost to Follow-up|1|||
27986606|NCT02428205|81783117|FG001|Overall Study|Lost to Follow-up|1|||
27986607|NCT02428205|81783116|FG000|Overall Study|Worse behavior|0|||
27986608|NCT02428205|81783117|FG001|Overall Study|Worse behavior|1|||
27986609|NCT02123576|81783121|FG000|Overall Study|Adverse Event|1|||
27986610|NCT02123576|81783122|FG001|Overall Study|Adverse Event|0|||
27986611|NCT00084487|81783123|FG000|Overall Study|Death|1|||
27986612|NCT03576716|81783125|FG000|Overall Study|Withdrawal by Subject|0|||
27986613|NCT03576716|81783126|FG001|Overall Study|Withdrawal by Subject|1|||
27986614|NCT01805037|81783129|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
27986615|NCT01805037|81783130|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
27986616|NCT01805037|81783129|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
27986617|NCT01805037|81783130|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
27795801|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27795802|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
27795803|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27795804|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27795805|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27795806|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27795807|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
27795808|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
27795809|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27795810|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
27795811|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
27795812|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
27795813|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
27795814|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
27986618|NCT01805037|81783129|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
27986619|NCT01805037|81783130|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
27986620|NCT01805037|81783129|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
27986621|NCT01805037|81783130|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
27986622|NCT01805037|81783129|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
27986623|NCT01805037|81783130|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
27986624|NCT01805037|81783129|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
27986625|NCT01805037|81783130|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
27986626|NCT01805037|81783129|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
27986627|NCT01805037|81783130|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
27986628|NCT01805037|81783129|FG000|Follow Up (up to 3 Years)|Death|0|||
27986629|NCT01805037|81783130|FG001|Follow Up (up to 3 Years)|Death|2|||
27594153|NCT02137369|80352457|FG000|Overall Study|Adverse Event|2|||
27795815|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
27795816|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
27578735|NCT03251924|80302941|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
27578736|NCT03251924|80302942|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
27578737|NCT03251924|80302943|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
27578738|NCT03251924|80302944|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
27674750|NCT01896557|80647201|FG001|Clopidogrel Alone|Adverse Event|0|||
27674751|NCT01896557|80647200|FG000|Clopidogrel + GI Protector|low adherence|1|||
27674752|NCT01896557|80647201|FG001|Clopidogrel + GI Protector|low adherence|1|||
27674753|NCT01896557|80647200|FG000|Clopidogrel + GI Protector|Reading error|1|||
27674754|NCT01896557|80647201|FG001|Clopidogrel + GI Protector|Reading error|3|||
27674755|NCT03566979|80647202|FG000|Overall Study|Withdrawal by Subject|2|||
27674756|NCT03566979|80647203|FG001|Overall Study|Withdrawal by Subject|0|||
27674757|NCT03566979|80647204|FG002|Overall Study|Withdrawal by Subject|1|||
27674758|NCT03566979|80647205|FG003|Overall Study|Withdrawal by Subject|1|||
27674759|NCT03566979|80647202|FG000|Overall Study|Lost to Follow-up|2|||
27674760|NCT03566979|80647203|FG001|Overall Study|Lost to Follow-up|7|||
27674761|NCT03566979|80647204|FG002|Overall Study|Lost to Follow-up|9|||
27674762|NCT03566979|80647205|FG003|Overall Study|Lost to Follow-up|5|||
27674763|NCT03566979|80647202|FG000|Overall Study|Adverse Event|1|||
27674764|NCT03566979|80647203|FG001|Overall Study|Adverse Event|0|||
27674765|NCT03566979|80647204|FG002|Overall Study|Adverse Event|0|||
27674766|NCT03566979|80647205|FG003|Overall Study|Adverse Event|0|||
27674767|NCT03721705|80647208|FG000|Overall Study|Adverse Event|2|||
27674768|NCT03721705|80647209|FG001|Overall Study|Adverse Event|0|||
27795817|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
27795818|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
27674769|NCT03721705|80647208|FG000|Overall Study|Withdrawal by Subject|4|||
27674770|NCT03721705|80647209|FG001|Overall Study|Withdrawal by Subject|10|||
27674771|NCT03721705|80647208|FG000|Overall Study|No Suitable Study Partner|1|||
27674772|NCT03721705|80647209|FG001|Overall Study|No Suitable Study Partner|0|||
27674773|NCT03721705|80647208|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
27674774|NCT03721705|80647209|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
27674775|NCT03721705|80647208|FG000|Overall Study|Death|0|||
27674776|NCT03721705|80647209|FG001|Overall Study|Death|1|||
27795819|NCT00408005|81082155|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27795820|NCT00408005|81082156|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27795821|NCT00408005|81082157|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
27795822|NCT00408005|81082158|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
27795823|NCT00408005|81082159|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
27986630|NCT01805037|81783129|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
27986631|NCT01805037|81783130|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
27986632|NCT01805037|81783129|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
27986633|NCT01805037|81783130|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
27986634|NCT03180307|81783135|FG000|Overall Study|Lost to Follow-up|2|||
27986635|NCT03180307|81783136|FG001|Overall Study|Lost to Follow-up|0|||
27986636|NCT03180307|81783135|FG000|Overall Study|Death|1|||
27986637|NCT03180307|81783136|FG001|Overall Study|Death|0|||
27986638|NCT03180307|81783135|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
27986639|NCT03180307|81783136|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
27986640|NCT00470418|81783137|FG000|Overall Study|Withdrawal by Subject|1|||
27986641|NCT00470418|81783138|FG001|Overall Study|Withdrawal by Subject|0|||
27986642|NCT04405245|81783141|FG000|Overall Study|Adverse Event|0|||
27986643|NCT04405245|81783142|FG001|Overall Study|Adverse Event|1|||
27986644|NCT04405245|81783143|FG002|Overall Study|Adverse Event|0|||
27986645|NCT03688620|81783144|FG000|Overall Study|Other|0|||
27986646|NCT03688620|81783145|FG001|Overall Study|Other|0|||
27986647|NCT03688620|81783146|FG002|Overall Study|Other|1|||
27986648|NCT03688620|81783144|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
27986649|NCT03688620|81783145|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
27578739|NCT03251924|80302945|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
27578740|NCT03251924|80302937|FG000|Overall Study|Death|0|||
27578741|NCT03251924|80302938|FG001|Overall Study|Death|1|||
27674777|NCT00958711|80647211|FG000|Overall Study|Withdrawal by Subject|0|||
27674778|NCT00958711|80647212|FG001|Overall Study|Withdrawal by Subject|4|||
27674779|NCT00958711|80647211|FG000|Overall Study|Physician Decision|5|||
27986650|NCT03688620|81783146|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
27674780|NCT00958711|80647212|FG001|Overall Study|Physician Decision|7|||
27674781|NCT00958711|80647211|FG000|Overall Study|Lost to Follow-up|4|||
27674782|NCT00958711|80647212|FG001|Overall Study|Lost to Follow-up|1|||
27674783|NCT00958711|80647211|FG000|Overall Study|Other|2|||
27674784|NCT00958711|80647212|FG001|Overall Study|Other|5|||
27674785|NCT00958711|80647211|FG000|Overall Study|Death|1|||
27674786|NCT00958711|80647212|FG001|Overall Study|Death|2|||
27674787|NCT00958711|80647211|FG000|Overall Study|Adverse Event|1|||
27674788|NCT00958711|80647212|FG001|Overall Study|Adverse Event|2|||
27674789|NCT00967005|80647214|FG000|Overall Study|Lost to Follow-up|7|||
27674790|NCT00967005|80647215|FG001|Overall Study|Lost to Follow-up|10|||
27674791|NCT00356811|80647216|FG000|Overall Study|Death|35|||
27674792|NCT00356811|80647216|FG000|Overall Study|Lost to Follow-up|2|||
27674793|NCT00356811|80647216|FG000|Overall Study|Withdrawal by Subject|6|||
27674794|NCT00356811|80647216|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
27578742|NCT03251924|80302939|FG002|Overall Study|Death|0|||
27578743|NCT03251924|80302940|FG003|Overall Study|Death|1|||
27578744|NCT03251924|80302941|FG004|Overall Study|Death|1|||
27578745|NCT03251924|80302942|FG005|Overall Study|Death|1|||
27578746|NCT03251924|80302943|FG006|Overall Study|Death|0|||
27578747|NCT03251924|80302944|FG007|Overall Study|Death|0|||
27578748|NCT03251924|80302945|FG008|Overall Study|Death|0|||
27578749|NCT03251924|80302937|FG000|Overall Study|Study Drug Toxicity|0|||
27578750|NCT03251924|80302938|FG001|Overall Study|Study Drug Toxicity|0|||
27578751|NCT03251924|80302939|FG002|Overall Study|Study Drug Toxicity|0|||
27578752|NCT03251924|80302940|FG003|Overall Study|Study Drug Toxicity|1|||
27578753|NCT03251924|80302941|FG004|Overall Study|Study Drug Toxicity|0|||
27578754|NCT03251924|80302942|FG005|Overall Study|Study Drug Toxicity|0|||
27578755|NCT03251924|80302943|FG006|Overall Study|Study Drug Toxicity|0|||
27578756|NCT03251924|80302944|FG007|Overall Study|Study Drug Toxicity|0|||
27578757|NCT03251924|80302945|FG008|Overall Study|Study Drug Toxicity|1|||
27578758|NCT03251924|80302937|FG000|Overall Study|Other Reasons|0|||
27578759|NCT03251924|80302938|FG001|Overall Study|Other Reasons|0|||
27578760|NCT03251924|80302939|FG002|Overall Study|Other Reasons|0|||
27578761|NCT03251924|80302940|FG003|Overall Study|Other Reasons|0|||
27578762|NCT03251924|80302941|FG004|Overall Study|Other Reasons|0|||
27578763|NCT03251924|80302942|FG005|Overall Study|Other Reasons|0|||
27578764|NCT03251924|80302943|FG006|Overall Study|Other Reasons|0|||
27578765|NCT03251924|80302944|FG007|Overall Study|Other Reasons|0|||
27578766|NCT03251924|80302945|FG008|Overall Study|Other Reasons|1|||
27578767|NCT03251924|80302937|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27578768|NCT03251924|80302938|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27578769|NCT03251924|80302939|FG002|Overall Study|Participant request to discontinue study treatment|0|||
27578770|NCT03251924|80302940|FG003|Overall Study|Participant request to discontinue study treatment|0|||
27578771|NCT03251924|80302941|FG004|Overall Study|Participant request to discontinue study treatment|0|||
27578772|NCT03251924|80302942|FG005|Overall Study|Participant request to discontinue study treatment|0|||
27578773|NCT03251924|80302943|FG006|Overall Study|Participant request to discontinue study treatment|0|||
27986651|NCT03688620|81783144|FG000|Overall Study|Lost to Follow-up|16|||
27986652|NCT03688620|81783145|FG001|Overall Study|Lost to Follow-up|0|||
27986653|NCT03688620|81783146|FG002|Overall Study|Lost to Follow-up|1|||
27986654|NCT03688620|81783144|FG000|Overall Study|Withdrawal by Subject|0|||
27578774|NCT03251924|80302944|FG007|Overall Study|Participant request to discontinue study treatment|1|||
27578775|NCT03251924|80302945|FG008|Overall Study|Participant request to discontinue study treatment|0|||
27578776|NCT04442737|80302946|FG000|Overall Study|Lost to Follow-up|1|||
27578777|NCT04442737|80302947|FG001|Overall Study|Lost to Follow-up|3|||
27578778|NCT04442737|80302946|FG000|Overall Study|Withdrawal by Subject|3|||
27795824|NCT00408005|81082160|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
27578779|NCT04442737|80302947|FG001|Overall Study|Withdrawal by Subject|2|||
27578780|NCT04442737|80302946|FG000|Overall Study|Adverse Event|3|||
27578781|NCT04442737|80302947|FG001|Overall Study|Adverse Event|2|||
27578782|NCT04442737|80302946|FG000|Overall Study|Death|0|||
27578783|NCT04442737|80302947|FG001|Overall Study|Death|1|||
27578784|NCT04442737|80302946|FG000|Overall Study|Protocol Violation|0|||
27578785|NCT04442737|80302947|FG001|Overall Study|Protocol Violation|2|||
27578786|NCT04442737|80302946|FG000|Overall Study|Other|1|||
27578787|NCT04442737|80302947|FG001|Overall Study|Other|1|||
27578788|NCT02496884|80302948|FG000|Overall Study|Counted twice as enrolled|2|||
27578789|NCT02496884|80302949|FG001|Overall Study|Counted twice as enrolled|0|||
27795825|NCT00408005|81082161|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27795826|NCT00408005|81082162|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
27986655|NCT03688620|81783145|FG001|Overall Study|Withdrawal by Subject|0|||
27578790|NCT02496884|80302950|FG002|Overall Study|Counted twice as enrolled|0|||
27674795|NCT00356811|80647216|FG000|Overall Study|Study Is Terminating|3|||
27986656|NCT03688620|81783146|FG002|Overall Study|Withdrawal by Subject|6|||
27986657|NCT01276223|81783149|FG000|Overall Study|Adverse Event|7|||
27578791|NCT02496884|80302951|FG003|Overall Study|Counted twice as enrolled|0|||
27578792|NCT02496884|80302948|FG000|Overall Study|Withdrawal by Subject|0|||
27578793|NCT02496884|80302949|FG001|Overall Study|Withdrawal by Subject|3|||
27578794|NCT02496884|80302950|FG002|Overall Study|Withdrawal by Subject|0|||
27578795|NCT02496884|80302951|FG003|Overall Study|Withdrawal by Subject|0|||
27578796|NCT02473445|80302952|FG000|Overall Study|Withdrawal by Subject|2|||
27986658|NCT01276223|81783150|FG001|Overall Study|Adverse Event|4|||
27986659|NCT01276223|81783151|FG002|Overall Study|Adverse Event|1|||
27986660|NCT01276223|81783149|FG000|Overall Study|Lost to Follow-up|0|||
27986661|NCT01276223|81783150|FG001|Overall Study|Lost to Follow-up|0|||
27986662|NCT01276223|81783151|FG002|Overall Study|Lost to Follow-up|1|||
27986663|NCT01276223|81783149|FG000|Overall Study|Other|0|||
27986664|NCT01276223|81783150|FG001|Overall Study|Other|0|||
27986665|NCT01276223|81783151|FG002|Overall Study|Other|1|||
27986666|NCT01276223|81783149|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
27986667|NCT01276223|81783150|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
27986668|NCT01276223|81783151|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
27986669|NCT01276223|81783149|FG000|Overall Study|Protocol Violation|1|||
27986670|NCT01276223|81783150|FG001|Overall Study|Protocol Violation|0|||
27986671|NCT01276223|81783151|FG002|Overall Study|Protocol Violation|0|||
27986672|NCT02409719|81783157|FG000|Overall Study|Lost to Follow-up|3|||
27986673|NCT02409719|81783158|FG001|Overall Study|Lost to Follow-up|3|||
27986674|NCT03203291|81783159|FG000|Overall Study|Withdrawal by Subject|1|||
27986675|NCT02690649|81783161|FG000|Overall Study|Withdrawal by Subject|1|||
27986676|NCT02690649|81783162|FG001|Overall Study|Withdrawal by Subject|1|||
27986677|NCT02690649|81783161|FG000|Overall Study|Protocol Violation|0|||
27986678|NCT02690649|81783162|FG001|Overall Study|Protocol Violation|3|||
27986679|NCT00565136|81783163|FG000|Overall Study|Lost to Follow-up|1|||
27986680|NCT00565136|81783163|FG000|Overall Study|Withdrawal by Subject|1|||
27986681|NCT00565136|81783163|FG000|Overall Study|Protocol Violation|1|||
27986682|NCT01309269|81783165|FG000|Overall Study|Adverse Event|56|||
27986683|NCT01309269|81783165|FG000|Overall Study|Withdrawal by Subject|25|||
27986684|NCT01309269|81783165|FG000|Overall Study|Lack of Acceptance|15|||
27986685|NCT01309269|81783165|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
27986686|NCT01309269|81783165|FG000|Overall Study|Kidney Transplant|25|||
27986687|NCT01309269|81783165|FG000|Overall Study|Administrative Problems|141|||
27986688|NCT01309269|81783165|FG000|Overall Study|Other|256|||
27986689|NCT01309269|81783165|FG000|Overall Study|Other|1|||
27986690|NCT01309269|81783165|FG000|Overall Study|Study Completion Data Not Recorded|95|||
27986691|NCT01309269|81783165|FG000|Overall Study|Enrolled but not Treated|107|||
27986692|NCT00705146|81783166|FG000|Overall Study|Lost to Follow-up|1|||
27986693|NCT00705146|81783167|FG001|Overall Study|Lost to Follow-up|1|||
27986694|NCT01300260|81783169|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
27986695|NCT01300260|81783170|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
27986696|NCT01300260|81783169|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
27986697|NCT01300260|81783170|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
27986698|NCT01300260|81783169|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
27986699|NCT01300260|81783170|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
27986700|NCT03160885|81783171|FG000|Initial Treatment Period|Not dosed|2|||
27986701|NCT03160885|81783172|FG001|Initial Treatment Period|Not dosed|0|||
27986702|NCT03160885|81783173|FG002|Initial Treatment Period|Not dosed|0|||
27986703|NCT03160885|81783174|FG003|Initial Treatment Period|Not dosed|0|||
27986704|NCT03160885|81783175|FG004|Initial Treatment Period|Not dosed|0|||
27986705|NCT03160885|81783176|FG005|Initial Treatment Period|Not dosed|0|||
27986706|NCT03160885|81783177|FG006|Initial Treatment Period|Not dosed|0|||
27986707|NCT03160885|81783171|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
27986708|NCT03160885|81783172|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
27986709|NCT03160885|81783173|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27986710|NCT03160885|81783174|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27986711|NCT03160885|81783175|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27986712|NCT03160885|81783176|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27986713|NCT03160885|81783177|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27986714|NCT03160885|81783171|FG000|Open-label Treatment|Not dosed|0|||
27986715|NCT03160885|81783172|FG001|Open-label Treatment|Not dosed|0|||
27986716|NCT03160885|81783173|FG002|Open-label Treatment|Not dosed|0|||
27986717|NCT03160885|81783174|FG003|Open-label Treatment|Not dosed|0|||
27986718|NCT03160885|81783175|FG004|Open-label Treatment|Not dosed|0|||
27986719|NCT03160885|81783176|FG005|Open-label Treatment|Not dosed|0|||
27986720|NCT03160885|81783177|FG006|Open-label Treatment|Not dosed|2|||
27986721|NCT03160885|81783171|FG000|Open-label Treatment|Discontinued IMP|0|||
27986722|NCT03160885|81783172|FG001|Open-label Treatment|Discontinued IMP|0|||
27986723|NCT03160885|81783173|FG002|Open-label Treatment|Discontinued IMP|0|||
27578797|NCT02473445|80302952|FG000|Overall Study|Sponsor Decision|20|||
27986724|NCT03160885|81783174|FG003|Open-label Treatment|Discontinued IMP|0|||
27986725|NCT03160885|81783175|FG004|Open-label Treatment|Discontinued IMP|0|||
27986726|NCT03160885|81783176|FG005|Open-label Treatment|Discontinued IMP|0|||
27986727|NCT03160885|81783177|FG006|Open-label Treatment|Discontinued IMP|131|||
27986728|NCT03160885|81783171|FG000|Open-label Treatment|Completed Week 50|0|||
27578798|NCT04796610|80302953|FG000|Overall Study|Withdrawal by Subject|1|||
27578799|NCT04796610|80302954|FG001|Overall Study|Withdrawal by Subject|0|||
27578800|NCT04796610|80302955|FG002|Overall Study|Withdrawal by Subject|0|||
27578801|NCT04796610|80302956|FG003|Overall Study|Withdrawal by Subject|0|||
27578802|NCT04796610|80302953|FG000|Overall Study|Lost to Follow-up|2|||
27578803|NCT04796610|80302954|FG001|Overall Study|Lost to Follow-up|0|||
27578804|NCT04796610|80302955|FG002|Overall Study|Lost to Follow-up|1|||
27578805|NCT04796610|80302956|FG003|Overall Study|Lost to Follow-up|1|||
27578806|NCT01181895|80302957|FG000|Overall Study|Adverse Event|3|||
27578807|NCT01181895|80302958|FG001|Overall Study|Adverse Event|1|||
27578808|NCT01181895|80302959|FG002|Overall Study|Adverse Event|1|||
27578809|NCT01181895|80302957|FG000|Overall Study|Lack of Efficacy|8|||
27578810|NCT01181895|80302958|FG001|Overall Study|Lack of Efficacy|9|||
27578811|NCT01181895|80302959|FG002|Overall Study|Lack of Efficacy|9|||
27578812|NCT01181895|80302957|FG000|Overall Study|Protocol Violation|2|||
27578813|NCT01181895|80302958|FG001|Overall Study|Protocol Violation|1|||
27578814|NCT01181895|80302959|FG002|Overall Study|Protocol Violation|0|||
27578815|NCT01181895|80302957|FG000|Overall Study|Lost to Follow-up|0|||
27578816|NCT01181895|80302958|FG001|Overall Study|Lost to Follow-up|1|||
27578817|NCT01181895|80302959|FG002|Overall Study|Lost to Follow-up|2|||
27674796|NCT00356811|80647216|FG000|Overall Study|Site Closed during Follow-up|2|||
27795827|NCT04278872|81082163|FG000|Overall Study|Adverse Event|1|||
27795828|NCT04278872|81082164|FG001|Overall Study|Adverse Event|0|||
27986729|NCT03160885|81783172|FG001|Open-label Treatment|Completed Week 50|0|||
27986730|NCT03160885|81783173|FG002|Open-label Treatment|Completed Week 50|0|||
27795829|NCT04278872|81082163|FG000|Overall Study|Protocol Violation|0|||
27795830|NCT04278872|81082164|FG001|Overall Study|Protocol Violation|1|||
27869668|NCT03888066|81357785|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27869669|NCT03888066|81357784|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
27869670|NCT03888066|81357785|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27869671|NCT03888066|81357784|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
27869672|NCT03888066|81357785|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27869673|NCT03888066|81357784|FG000|Run-in Phase|Withdrawal by Subject|43|||
27869674|NCT03888066|81357785|FG001|Run-in Phase|Withdrawal by Subject|0|||
27869675|NCT03888066|81357784|FG000|Run-in Phase|AE; Physician Decision|1|||
27986731|NCT03160885|81783174|FG003|Open-label Treatment|Completed Week 50|0|||
27986732|NCT03160885|81783175|FG004|Open-label Treatment|Completed Week 50|0|||
27986733|NCT03160885|81783176|FG005|Open-label Treatment|Completed Week 50|0|||
27795831|NCT04278872|81082163|FG000|Overall Study|Study Termination|2|||
27795832|NCT04278872|81082164|FG001|Overall Study|Study Termination|0|||
27795833|NCT01100073|81082165|FG000|Overall Study|Lack of Efficacy|4|||
27795834|NCT01100073|81082165|FG000|Overall Study|Insufficient Tolerability|21|||
27869676|NCT03888066|81357785|FG001|Run-in Phase|AE; Physician Decision|0|||
27869677|NCT03888066|81357784|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
27986734|NCT03160885|81783177|FG006|Open-label Treatment|Completed Week 50|4|||
27986735|NCT03160885|81783171|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
27986736|NCT03160885|81783172|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
27986737|NCT03160885|81783173|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
27986738|NCT03160885|81783174|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
27986739|NCT03160885|81783175|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
27986740|NCT03160885|81783176|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
27578818|NCT01181895|80302957|FG000|Overall Study|Investigator Discretion|1|||
27674797|NCT00978562|80647221|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
27674798|NCT00425607|80647222|FG000|Overall Study|Death|1|||
27674799|NCT00425607|80647222|FG000|Overall Study|Withdrawal by Subject|1|||
27674800|NCT02344342|80647239|FG000|Overall Study|Industry partner dropped out|11|||
27674801|NCT02344342|80647240|FG001|Overall Study|Industry partner dropped out|9|||
27674802|NCT02344342|80647241|FG002|Overall Study|Industry partner dropped out|14|||
27674803|NCT02344342|80647242|FG003|Overall Study|Industry partner dropped out|10|||
27795835|NCT01100073|81082165|FG000|Overall Study|Withdrawal by Subject|13|||
27795836|NCT01100073|81082165|FG000|Overall Study|Lost to Follow-up|39|||
27869678|NCT03888066|81357785|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
27578819|NCT01181895|80302958|FG001|Overall Study|Investigator Discretion|2|||
27578820|NCT01181895|80302959|FG002|Overall Study|Investigator Discretion|1|||
27578821|NCT01181895|80302957|FG000|Overall Study|Withdrawal by Subject|3|||
27578822|NCT01181895|80302958|FG001|Overall Study|Withdrawal by Subject|0|||
27578823|NCT01181895|80302959|FG002|Overall Study|Withdrawal by Subject|5|||
27578824|NCT00132769|80302960|FG000|Overall Study|Withdrawal by Subject|1|||
27674804|NCT04547023|80647243|FG000|Overall Study|Did Not Receive Intervention|3|||
27795837|NCT01100073|81082165|FG000|Overall Study|Lack of effect + patient's wish|2|||
27795838|NCT01100073|81082165|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
27795839|NCT01100073|81082165|FG000|Overall Study|Other|8|||
27795840|NCT01100073|81082165|FG000|Overall Study|Missing|5|||
27795841|NCT04980391|81082166|FG000|Overall Study|Death|0|||
27795842|NCT04980391|81082167|FG001|Overall Study|Death|0|||
27795843|NCT04980391|81082168|FG002|Overall Study|Death|1|||
27795844|NCT04980391|81082169|FG003|Overall Study|Death|1|||
27795845|NCT04980391|81082166|FG000|Overall Study|Lost to Follow-up|3|||
27795846|NCT04980391|81082167|FG001|Overall Study|Lost to Follow-up|3|||
27795847|NCT04980391|81082168|FG002|Overall Study|Lost to Follow-up|2|||
27795848|NCT04980391|81082169|FG003|Overall Study|Lost to Follow-up|3|||
27795849|NCT04980391|81082166|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
27795850|NCT04980391|81082167|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
27795851|NCT04980391|81082168|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
27795852|NCT04980391|81082169|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
27795853|NCT04980391|81082166|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27795854|NCT04980391|81082167|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27795855|NCT04980391|81082168|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
27795856|NCT04980391|81082169|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27795857|NCT04980391|81082166|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
27795858|NCT04980391|81082167|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
27795859|NCT04980391|81082168|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
27795860|NCT04980391|81082169|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
27795861|NCT01211613|81082170|FG000|Overall Study|Lost to Follow-up|2|||
27795862|NCT01211613|81082171|FG001|Overall Study|Lost to Follow-up|2|||
27795863|NCT01211613|81082172|FG002|Overall Study|Lost to Follow-up|2|||
27795864|NCT01211613|81082170|FG000|Overall Study|Withdrawal by Subject|1|||
27795865|NCT01211613|81082171|FG001|Overall Study|Withdrawal by Subject|0|||
27795866|NCT01211613|81082172|FG002|Overall Study|Withdrawal by Subject|0|||
27795867|NCT01414062|81082173|FG000|Overall Study|Lost to Follow-up|3|||
27795868|NCT01414062|81082174|FG001|Overall Study|Lost to Follow-up|2|||
27795869|NCT01414062|81082173|FG000|Overall Study|Left Country|1|||
27795870|NCT01414062|81082174|FG001|Overall Study|Left Country|1|||
27795871|NCT01414062|81082173|FG000|Overall Study|Family Disapproval|1|||
27795872|NCT01414062|81082174|FG001|Overall Study|Family Disapproval|0|||
27795873|NCT01414062|81082173|FG000|Overall Study|Withdrawal by Subject|0|||
27795874|NCT01414062|81082174|FG001|Overall Study|Withdrawal by Subject|1|||
27795875|NCT01833897|81082176|FG000|Overall Study|Lack of Efficacy|1|||
27795876|NCT03130777|81082179|FG000|Overall Study|Death|0|||
27795877|NCT03130777|81082180|FG001|Overall Study|Death|1|||
27795878|NCT03130777|81082179|FG000|Overall Study|Did not meet eligibility criteria|1|||
27795879|NCT03130777|81082180|FG001|Overall Study|Did not meet eligibility criteria|0|||
27795880|NCT04484805|81082181|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
27795881|NCT04484805|81082182|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
27795882|NCT04484805|81082181|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
27795883|NCT04484805|81082182|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
27795884|NCT04163991|81082188|FG000|Overall Study|Adverse Event|0|||
27795885|NCT04163991|81082189|FG001|Overall Study|Adverse Event|0|||
27795886|NCT04163991|81082190|FG002|Overall Study|Adverse Event|0|||
27795887|NCT04163991|81082191|FG003|Overall Study|Adverse Event|1|||
27795888|NCT04163991|81082192|FG004|Overall Study|Adverse Event|0|||
27795889|NCT04163991|81082188|FG000|Overall Study|Death|0|||
27795890|NCT04163991|81082189|FG001|Overall Study|Death|0|||
27986741|NCT03160885|81783177|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
27986742|NCT03160885|81783171|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
27986743|NCT03160885|81783172|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
27986744|NCT03160885|81783173|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
27986745|NCT03160885|81783174|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
27986746|NCT03160885|81783175|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
27795891|NCT04163991|81082190|FG002|Overall Study|Death|1|||
27795892|NCT04163991|81082191|FG003|Overall Study|Death|0|||
27986747|NCT03160885|81783176|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
27795893|NCT04163991|81082192|FG004|Overall Study|Death|0|||
27795894|NCT04163991|81082188|FG000|Overall Study|Lost to Follow-up|0|||
27795895|NCT04163991|81082189|FG001|Overall Study|Lost to Follow-up|1|||
27795896|NCT04163991|81082190|FG002|Overall Study|Lost to Follow-up|0|||
27986748|NCT03160885|81783177|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
27795897|NCT04163991|81082191|FG003|Overall Study|Lost to Follow-up|0|||
27795898|NCT04163991|81082192|FG004|Overall Study|Lost to Follow-up|0|||
27795899|NCT04163991|81082188|FG000|Overall Study|Withdrawal by Subject|1|||
27795900|NCT04163991|81082189|FG001|Overall Study|Withdrawal by Subject|1|||
27795901|NCT04163991|81082190|FG002|Overall Study|Withdrawal by Subject|3|||
27795902|NCT04163991|81082191|FG003|Overall Study|Withdrawal by Subject|1|||
27986749|NCT03160885|81783171|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27986750|NCT03160885|81783172|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27986751|NCT03160885|81783173|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
27986752|NCT03160885|81783174|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
27986753|NCT03160885|81783175|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
27986754|NCT03160885|81783176|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
27986755|NCT03160885|81783177|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27986756|NCT03160885|81783171|FG000|Maintenance Treatment Period|Completed Week 50|0|||
27986757|NCT03160885|81783172|FG001|Maintenance Treatment Period|Completed Week 50|0|||
27986758|NCT03160885|81783173|FG002|Maintenance Treatment Period|Completed Week 50|1|||
27795903|NCT04163991|81082192|FG004|Overall Study|Withdrawal by Subject|1|||
27795904|NCT04163991|81082188|FG000|Overall Study|Other, Not Specified|0|||
27795905|NCT04163991|81082189|FG001|Overall Study|Other, Not Specified|1|||
27795906|NCT04163991|81082190|FG002|Overall Study|Other, Not Specified|1|||
27795907|NCT04163991|81082191|FG003|Overall Study|Other, Not Specified|1|||
27795908|NCT04163991|81082192|FG004|Overall Study|Other, Not Specified|0|||
27795909|NCT01023815|81082196|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
27795910|NCT01023815|81082197|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
27795911|NCT01023815|81082198|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
27795912|NCT01023815|81082199|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
27795913|NCT01023815|81082196|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
27795914|NCT01023815|81082197|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
27795915|NCT01023815|81082198|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
27795916|NCT01023815|81082199|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
27795917|NCT01023815|81082196|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
27795918|NCT01023815|81082197|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
27795919|NCT01023815|81082198|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
27795920|NCT01023815|81082199|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
27795921|NCT01023815|81082196|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
27795922|NCT01023815|81082197|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
27795923|NCT01023815|81082198|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
27795924|NCT01023815|81082199|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
27795925|NCT01023815|81082196|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
27795926|NCT01023815|81082197|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
27795927|NCT01023815|81082198|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
27795928|NCT01023815|81082199|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
27795929|NCT04639310|81082208|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
27795930|NCT04639310|81082209|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
27795931|NCT00891527|81082210|FG000|Overall Study|Withdrawal by Subject|2|||
27795932|NCT00440193|81082211|FG000|Treatment Period|Adverse Event|74|||
27795933|NCT00440193|81082212|FG001|Treatment Period|Adverse Event|67|||
27795934|NCT00440193|81082211|FG000|Treatment Period|Death|19|||
27795935|NCT00440193|81082212|FG001|Treatment Period|Death|22|||
27795936|NCT00440193|81082211|FG000|Treatment Period|Lack of Efficacy|0|||
27795937|NCT00440193|81082212|FG001|Treatment Period|Lack of Efficacy|1|||
27795938|NCT00440193|81082211|FG000|Treatment Period|Lost to Follow-up|12|||
27795939|NCT00440193|81082212|FG001|Treatment Period|Lost to Follow-up|18|||
27795940|NCT00440193|81082211|FG000|Treatment Period|Physician Decision|3|||
27795941|NCT00440193|81082212|FG001|Treatment Period|Physician Decision|6|||
27795942|NCT00440193|81082211|FG000|Treatment Period|Protocol Violation|16|||
27795943|NCT00440193|81082212|FG001|Treatment Period|Protocol Violation|19|||
27795944|NCT00440193|81082211|FG000|Treatment Period|Withdrawal by Subject|36|||
27795945|NCT00440193|81082212|FG001|Treatment Period|Withdrawal by Subject|77|||
27795946|NCT00440193|81082211|FG000|Treatment Period|Clinical endpoint reached|28|||
27795947|NCT00440193|81082212|FG001|Treatment Period|Clinical endpoint reached|25|||
27795948|NCT00440193|81082211|FG000|Treatment Period|Study terminated by sponsor|102|||
27795949|NCT00440193|81082212|FG001|Treatment Period|Study terminated by sponsor|94|||
27795950|NCT00440193|81082211|FG000|Treatment Period|Protocol driven decision point|2|||
27795951|NCT00440193|81082212|FG001|Treatment Period|Protocol driven decision point|2|||
27795952|NCT00440193|81082211|FG000|Treatment Period|Switch to commercial drug|0|||
27986759|NCT03160885|81783174|FG003|Maintenance Treatment Period|Completed Week 50|0|||
27986760|NCT03160885|81783175|FG004|Maintenance Treatment Period|Completed Week 50|0|||
27578825|NCT00132769|80302961|FG001|Overall Study|Withdrawal by Subject|3|||
27578826|NCT00132769|80302960|FG000|Overall Study|Lack of Efficacy|7|||
27578827|NCT00132769|80302961|FG001|Overall Study|Lack of Efficacy|6|||
27578828|NCT00132769|80302960|FG000|Overall Study|Adverse Event|2|||
27986761|NCT03160885|81783176|FG005|Maintenance Treatment Period|Completed Week 50|0|||
27986762|NCT03160885|81783177|FG006|Maintenance Treatment Period|Completed Week 50|0|||
27986763|NCT01140061|81783185|FG000|Part I|Adverse Event|1|||
27986764|NCT01140061|81783186|FG001|Part I|Adverse Event|0|||
27986765|NCT01140061|81783187|FG002|Part I|Adverse Event|0|||
27986766|NCT01140061|81783188|FG003|Part I|Adverse Event|0|||
27986767|NCT01140061|81783189|FG004|Part I|Adverse Event|0|||
27986768|NCT01140061|81783190|FG005|Part I|Adverse Event|0|||
27986769|NCT01140061|81783191|FG006|Part I|Adverse Event|0|||
27986770|NCT01140061|81783192|FG007|Part I|Adverse Event|0|||
27986771|NCT01140061|81783193|FG008|Part I|Adverse Event|0|||
27986772|NCT01140061|81783194|FG009|Part I|Adverse Event|0|||
27986773|NCT01140061|81783185|FG000|Extension|Laboratory Adverse Event|0|||
27674805|NCT04547023|80647244|FG001|Overall Study|Did Not Receive Intervention|2|||
27795953|NCT00440193|81082212|FG001|Treatment Period|Switch to commercial drug|2|||
27795954|NCT00440193|81082211|FG000|Treatment Period|Technical problems|1|||
27795955|NCT00440193|81082212|FG001|Treatment Period|Technical problems|1|||
27795956|NCT00440193|81082211|FG000|Treatment Period|Participant convenience|5|||
27795957|NCT00440193|81082212|FG001|Treatment Period|Participant convenience|2|||
27795958|NCT00440193|81082211|FG000|Treatment Period|Participant did not receive treatment|7|||
27795959|NCT00440193|81082212|FG001|Treatment Period|Participant did not receive treatment|13|||
27795960|NCT00440193|81082211|FG000|Treatment Period|Site closed by investigator|0|||
27795961|NCT00440193|81082212|FG001|Treatment Period|Site closed by investigator|2|||
27795962|NCT00440193|81082211|FG000|Observational Period|Adverse Event|2|||
27795963|NCT00440193|81082212|FG001|Observational Period|Adverse Event|2|||
27795964|NCT00440193|81082211|FG000|Observational Period|Death|15|||
27795965|NCT00440193|81082212|FG001|Observational Period|Death|20|||
27795966|NCT00440193|81082211|FG000|Observational Period|Lost to Follow-up|12|||
27795967|NCT00440193|81082212|FG001|Observational Period|Lost to Follow-up|8|||
27795968|NCT00440193|81082211|FG000|Observational Period|Protocol Violation|1|||
27795969|NCT00440193|81082212|FG001|Observational Period|Protocol Violation|0|||
27795970|NCT00440193|81082211|FG000|Observational Period|Withdrawal by Subject|11|||
27795971|NCT00440193|81082212|FG001|Observational Period|Withdrawal by Subject|8|||
27795972|NCT00440193|81082211|FG000|Observational Period|Physician Decision|1|||
27986774|NCT01140061|81783186|FG001|Extension|Laboratory Adverse Event|0|||
27986775|NCT01140061|81783187|FG002|Extension|Laboratory Adverse Event|0|||
27986776|NCT01140061|81783188|FG003|Extension|Laboratory Adverse Event|0|||
27674806|NCT04547023|80647243|FG000|Overall Study|Lost to Follow-up|1|||
27674807|NCT04547023|80647244|FG001|Overall Study|Lost to Follow-up|1|||
27674808|NCT02232399|80647245|FG000|Overall Study|Adverse Event|1|||
27674809|NCT02232399|80647246|FG001|Overall Study|Adverse Event|0|||
27674810|NCT02232399|80647245|FG000|Overall Study|Withdrawal by Subject|0|||
27674811|NCT02232399|80647246|FG001|Overall Study|Withdrawal by Subject|1|||
27674812|NCT02358668|80647256|FG000|Overall Study|Adverse Event|2|||
27674813|NCT02358668|80647257|FG001|Overall Study|Adverse Event|0|||
27674814|NCT02358668|80647258|FG002|Overall Study|Adverse Event|0|||
27674815|NCT02358668|80647256|FG000|Overall Study|Withdrawal by Subject|0|||
27674816|NCT02358668|80647257|FG001|Overall Study|Withdrawal by Subject|1|||
27674817|NCT02358668|80647258|FG002|Overall Study|Withdrawal by Subject|0|||
27674818|NCT02786004|80647259|FG000|Overall Study|Withdrawal by Subject|0|||
27674819|NCT02786004|80647260|FG001|Overall Study|Withdrawal by Subject|1|||
27674820|NCT01867047|80647261|FG000|Overall Study|Lost to Follow-up|3|||
27674821|NCT01867047|80647262|FG001|Overall Study|Lost to Follow-up|3|||
27674822|NCT01867047|80647261|FG000|Overall Study|Withdrawal by Subject|2|||
27674823|NCT01867047|80647262|FG001|Overall Study|Withdrawal by Subject|0|||
27674824|NCT01867047|80647261|FG000|Overall Study|Physician Decision|2|||
27674825|NCT01867047|80647262|FG001|Overall Study|Physician Decision|0|||
27674826|NCT01867047|80647261|FG000|Overall Study|surgery not indicated in protocol|1|||
27674827|NCT01867047|80647262|FG001|Overall Study|surgery not indicated in protocol|2|||
27674828|NCT00208325|80647263|FG000|Overall Study|Death|18|||
27674829|NCT00208325|80647264|FG001|Overall Study|Death|19|||
27674830|NCT00208325|80647265|FG002|Overall Study|Death|7|||
27674831|NCT00208325|80647266|FG003|Overall Study|Death|5|||
27674832|NCT00208325|80647263|FG000|Overall Study|Withdrawal by Subject|0|||
27674833|NCT00208325|80647264|FG001|Overall Study|Withdrawal by Subject|1|||
27674834|NCT00208325|80647265|FG002|Overall Study|Withdrawal by Subject|0|||
27674835|NCT00208325|80647266|FG003|Overall Study|Withdrawal by Subject|0|||
27674836|NCT00208325|80647263|FG000|Overall Study|Revision|4|||
27674837|NCT00208325|80647264|FG001|Overall Study|Revision|1|||
27674838|NCT00208325|80647265|FG002|Overall Study|Revision|0|||
27674839|NCT00208325|80647266|FG003|Overall Study|Revision|4|||
27674840|NCT00208325|80647263|FG000|Overall Study|Lost to Follow-up|1|||
27674841|NCT00208325|80647264|FG001|Overall Study|Lost to Follow-up|0|||
27674842|NCT00208325|80647265|FG002|Overall Study|Lost to Follow-up|2|||
27674843|NCT00208325|80647266|FG003|Overall Study|Lost to Follow-up|0|||
27795973|NCT00440193|81082212|FG001|Observational Period|Physician Decision|0|||
27986777|NCT01140061|81783189|FG004|Extension|Laboratory Adverse Event|0|||
27986778|NCT01140061|81783190|FG005|Extension|Laboratory Adverse Event|0|||
27578829|NCT00132769|80302961|FG001|Overall Study|Adverse Event|1|||
27578830|NCT00132769|80302960|FG000|Overall Study|Protocol Violation|1|||
27578831|NCT00132769|80302961|FG001|Overall Study|Protocol Violation|1|||
27578832|NCT01709318|80302962|FG000|Overall Study|Adverse Event|3|||
27578833|NCT01709318|80302963|FG001|Overall Study|Adverse Event|4|||
27578834|NCT01709318|80302964|FG002|Overall Study|Adverse Event|2|||
27578835|NCT01709318|80302965|FG003|Overall Study|Adverse Event|2|||
27578836|NCT01709318|80302966|FG004|Overall Study|Adverse Event|0|||
27674844|NCT00208325|80647263|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
27674845|NCT00208325|80647264|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
27674846|NCT00208325|80647265|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
27674847|NCT00208325|80647266|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
27674848|NCT00208325|80647263|FG000|Overall Study|Does not wish to Continue in Study|5|||
27674849|NCT00208325|80647264|FG001|Overall Study|Does not wish to Continue in Study|8|||
27674850|NCT00208325|80647265|FG002|Overall Study|Does not wish to Continue in Study|3|||
27674851|NCT00208325|80647266|FG003|Overall Study|Does not wish to Continue in Study|2|||
27674852|NCT00208325|80647263|FG000|Overall Study|Other|2|||
27674853|NCT00208325|80647264|FG001|Overall Study|Other|1|||
27674854|NCT00208325|80647265|FG002|Overall Study|Other|1|||
27674855|NCT00208325|80647266|FG003|Overall Study|Other|0|||
27674856|NCT00208325|80647263|FG000|Overall Study|Mis-Randomized|17|||
27674857|NCT00208325|80647264|FG001|Overall Study|Mis-Randomized|20|||
27674858|NCT00208325|80647265|FG002|Overall Study|Mis-Randomized|0|||
27674859|NCT00208325|80647266|FG003|Overall Study|Mis-Randomized|0|||
27674860|NCT03898700|80647267|FG000|Overall Study|Withdrawal by Subject|2|||
27674861|NCT00903760|80647268|FG000|Overall Study|Disease Progression/Death|8|||
27674862|NCT00903760|80647269|FG001|Overall Study|Disease Progression/Death|6|||
27674863|NCT00903760|80647268|FG000|Overall Study|Stem Cell Transplant|8|||
27674864|NCT00903760|80647269|FG001|Overall Study|Stem Cell Transplant|4|||
27674865|NCT00903760|80647268|FG000|Overall Study|Physician Decision|1|||
27674866|NCT00903760|80647269|FG001|Overall Study|Physician Decision|2|||
27674867|NCT00903760|80647268|FG000|Overall Study|Death|0|||
27674868|NCT00903760|80647269|FG001|Overall Study|Death|1|||
27674869|NCT00903760|80647268|FG000|Overall Study|Lost to Follow-up|1|||
27674870|NCT00903760|80647269|FG001|Overall Study|Lost to Follow-up|0|||
27795974|NCT00440193|81082211|FG000|Observational Period|Clinical endpoint reached|1|||
27795975|NCT00440193|81082212|FG001|Observational Period|Clinical endpoint reached|0|||
27795976|NCT00440193|81082211|FG000|Observational Period|Participant convenience|2|||
27578837|NCT01709318|80302967|FG005|Overall Study|Adverse Event|1|||
27578838|NCT01709318|80302968|FG006|Overall Study|Adverse Event|2|||
27674871|NCT00903760|80647268|FG000|Overall Study|Withdrawal by Subject|1|||
27674872|NCT00903760|80647269|FG001|Overall Study|Withdrawal by Subject|2|||
27674873|NCT00903760|80647268|FG000|Overall Study|Off treatment for long period|0|||
27674874|NCT00903760|80647269|FG001|Overall Study|Off treatment for long period|1|||
27674875|NCT03933462|80647270|FG000|Overall Study|Adverse Event|2|||
27578839|NCT01709318|80302962|FG000|Overall Study|Lost to Follow-up|2|||
27578840|NCT01709318|80302963|FG001|Overall Study|Lost to Follow-up|0|||
27674876|NCT03933462|80647271|FG001|Overall Study|Adverse Event|0|||
27578841|NCT01709318|80302964|FG002|Overall Study|Lost to Follow-up|0|||
27578842|NCT01709318|80302965|FG003|Overall Study|Lost to Follow-up|0|||
27578843|NCT01709318|80302966|FG004|Overall Study|Lost to Follow-up|1|||
27578844|NCT01709318|80302967|FG005|Overall Study|Lost to Follow-up|1|||
27578845|NCT01709318|80302968|FG006|Overall Study|Lost to Follow-up|1|||
27578846|NCT01709318|80302962|FG000|Overall Study|Non-compliance with Study Drug|0|||
27795977|NCT00440193|81082212|FG001|Observational Period|Participant convenience|0|||
27795978|NCT00537056|81082213|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
27795979|NCT03205163|81082214|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
27795980|NCT03205163|81082215|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
27795981|NCT04611152|81082218|FG000|Overall Study|Adverse Event|9|||
27795982|NCT04611152|81082219|FG001|Overall Study|Adverse Event|8|||
27795983|NCT04611152|81082218|FG000|Overall Study|Non-compliance with study schedule|1|||
27795984|NCT04611152|81082219|FG001|Overall Study|Non-compliance with study schedule|3|||
27795985|NCT04611152|81082218|FG000|Overall Study|Withdrawal by Subject|5|||
27795986|NCT04611152|81082219|FG001|Overall Study|Withdrawal by Subject|6|||
27795987|NCT04611152|81082218|FG000|Overall Study|Lost to Follow-up|11|||
27795988|NCT04611152|81082219|FG001|Overall Study|Lost to Follow-up|2|||
27795989|NCT00244881|81082222|FG000|Overall Study|Withdrawal by Subject|3|||
27795990|NCT02395536|81082223|FG000|Overall Study|Lost to Follow-up|4|||
27578847|NCT01709318|80302963|FG001|Overall Study|Non-compliance with Study Drug|2|||
27578848|NCT01709318|80302964|FG002|Overall Study|Non-compliance with Study Drug|1|||
27578849|NCT01709318|80302965|FG003|Overall Study|Non-compliance with Study Drug|1|||
27578850|NCT01709318|80302966|FG004|Overall Study|Non-compliance with Study Drug|0|||
27578851|NCT01709318|80302967|FG005|Overall Study|Non-compliance with Study Drug|0|||
27578852|NCT01709318|80302968|FG006|Overall Study|Non-compliance with Study Drug|2|||
27578853|NCT01709318|80302962|FG000|Overall Study|Physician Decision|0|||
27578854|NCT01709318|80302963|FG001|Overall Study|Physician Decision|0|||
27578855|NCT01709318|80302964|FG002|Overall Study|Physician Decision|0|||
27578856|NCT01709318|80302965|FG003|Overall Study|Physician Decision|0|||
27578857|NCT01709318|80302966|FG004|Overall Study|Physician Decision|0|||
27578858|NCT01709318|80302967|FG005|Overall Study|Physician Decision|0|||
27578859|NCT01709318|80302968|FG006|Overall Study|Physician Decision|1|||
27578860|NCT01709318|80302962|FG000|Overall Study|Pregnancy|0|||
27578861|NCT01709318|80302963|FG001|Overall Study|Pregnancy|0|||
27578862|NCT01709318|80302964|FG002|Overall Study|Pregnancy|0|||
27578863|NCT01709318|80302965|FG003|Overall Study|Pregnancy|0|||
27578864|NCT01709318|80302966|FG004|Overall Study|Pregnancy|1|||
27578865|NCT01709318|80302967|FG005|Overall Study|Pregnancy|0|||
27578866|NCT01709318|80302968|FG006|Overall Study|Pregnancy|0|||
27578867|NCT01709318|80302962|FG000|Overall Study|Protocol Violation|0|||
27795991|NCT02395536|81082224|FG001|Overall Study|Lost to Follow-up|4|||
27578868|NCT01709318|80302963|FG001|Overall Study|Protocol Violation|0|||
27578869|NCT01709318|80302964|FG002|Overall Study|Protocol Violation|0|||
27578870|NCT01709318|80302965|FG003|Overall Study|Protocol Violation|0|||
27578871|NCT01709318|80302966|FG004|Overall Study|Protocol Violation|2|||
27578872|NCT01709318|80302967|FG005|Overall Study|Protocol Violation|0|||
27578873|NCT01709318|80302968|FG006|Overall Study|Protocol Violation|1|||
27578874|NCT01709318|80302962|FG000|Overall Study|Technical Problems|1|||
27578875|NCT01709318|80302963|FG001|Overall Study|Technical Problems|0|||
27986779|NCT01140061|81783191|FG006|Extension|Laboratory Adverse Event|0|||
27986780|NCT01140061|81783192|FG007|Extension|Laboratory Adverse Event|0|||
27986781|NCT01140061|81783193|FG008|Extension|Laboratory Adverse Event|0|||
27986782|NCT01140061|81783194|FG009|Extension|Laboratory Adverse Event|1|||
27986783|NCT01959243|81783195|FG000|Overall Study|Investigator Decision|3|||
27986784|NCT01959243|81783196|FG001|Overall Study|Investigator Decision|0|||
27986785|NCT01959243|81783195|FG000|Overall Study|Adverse Event|5|||
27986786|NCT01959243|81783196|FG001|Overall Study|Adverse Event|2|||
27986787|NCT01959243|81783195|FG000|Overall Study|Administrative reasons|2|||
27986788|NCT01959243|81783196|FG001|Overall Study|Administrative reasons|1|||
27986789|NCT01959243|81783195|FG000|Overall Study|Lost to Follow-up|3|||
27986790|NCT01959243|81783196|FG001|Overall Study|Lost to Follow-up|1|||
27986791|NCT05327361|81783197|FG000|Overall Study|Lost to Follow-up|4|||
27986792|NCT03369236|81783198|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
27986793|NCT03369236|81783199|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
27986794|NCT03369236|81783198|FG000|Open-label Extension Period|Lack of Efficacy|2|||
27986795|NCT03369236|81783199|FG001|Open-label Extension Period|Lack of Efficacy|1|||
27986796|NCT03369236|81783198|FG000|Open-label Extension Period|Adverse Event|0|||
27986797|NCT03369236|81783199|FG001|Open-label Extension Period|Adverse Event|1|||
27986798|NCT03369236|81783198|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
27986799|NCT03369236|81783199|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
27986800|NCT04046250|81783202|FG000|Overall Study|Death|0|||
27986801|NCT04046250|81783203|FG001|Overall Study|Death|1|||
27986802|NCT04046250|81783202|FG000|Overall Study|Withdrawal by Subject|3|||
27986803|NCT04046250|81783203|FG001|Overall Study|Withdrawal by Subject|3|||
27986804|NCT05079477|81783204|FG000|Overall Study|Lost to Follow-up|2|||
27986805|NCT05079477|81783205|FG001|Overall Study|Lost to Follow-up|0|||
27986806|NCT05079477|81783204|FG000|Overall Study|Withdrawal by Subject|1|||
27986807|NCT05079477|81783205|FG001|Overall Study|Withdrawal by Subject|0|||
27986808|NCT05079477|81783204|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
27986809|NCT05079477|81783205|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
27986810|NCT05079477|81783204|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
27986811|NCT05079477|81783205|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
27986812|NCT00902174|81783211|FG000|Overall Study|Adverse Event|27|||
27986813|NCT00902174|81783212|FG001|Overall Study|Adverse Event|7|||
27986814|NCT00902174|81783211|FG000|Overall Study|Lack of Efficacy|1|||
27986815|NCT00902174|81783212|FG001|Overall Study|Lack of Efficacy|5|||
27986816|NCT00902174|81783211|FG000|Overall Study|Death|2|||
27986817|NCT00902174|81783212|FG001|Overall Study|Death|2|||
27986818|NCT00902174|81783211|FG000|Overall Study|Withdrawal by Subject|2|||
27986819|NCT00902174|81783212|FG001|Overall Study|Withdrawal by Subject|1|||
27986820|NCT00902174|81783211|FG000|Overall Study|Abnormal labs|1|||
27986821|NCT00902174|81783212|FG001|Overall Study|Abnormal labs|1|||
27986822|NCT00902174|81783211|FG000|Overall Study|Protocol Violation|1|||
27986823|NCT00902174|81783212|FG001|Overall Study|Protocol Violation|1|||
27986824|NCT00902174|81783211|FG000|Overall Study|Administration problem|0|||
27986825|NCT00902174|81783212|FG001|Overall Study|Administration problem|1|||
27986826|NCT01543776|81783217|FG000|Overall Study|Withdrawal by Subject|2|||
27578876|NCT01709318|80302964|FG002|Overall Study|Technical Problems|0|||
27578877|NCT01709318|80302965|FG003|Overall Study|Technical Problems|0|||
27578878|NCT01709318|80302966|FG004|Overall Study|Technical Problems|0|||
27578879|NCT01709318|80302967|FG005|Overall Study|Technical Problems|0|||
27578880|NCT01709318|80302968|FG006|Overall Study|Technical Problems|0|||
27578881|NCT01709318|80302962|FG000|Overall Study|Withdrawal by Subject|3|||
27578882|NCT01709318|80302963|FG001|Overall Study|Withdrawal by Subject|0|||
27578883|NCT01709318|80302964|FG002|Overall Study|Withdrawal by Subject|3|||
27578884|NCT01709318|80302965|FG003|Overall Study|Withdrawal by Subject|3|||
27578885|NCT01709318|80302966|FG004|Overall Study|Withdrawal by Subject|0|||
27578886|NCT01709318|80302967|FG005|Overall Study|Withdrawal by Subject|2|||
27578887|NCT01709318|80302968|FG006|Overall Study|Withdrawal by Subject|4|||
27578888|NCT01709318|80302962|FG000|Overall Study|Other Protocol Specified Criteria|0|||
27578889|NCT01709318|80302963|FG001|Overall Study|Other Protocol Specified Criteria|1|||
27578890|NCT01709318|80302964|FG002|Overall Study|Other Protocol Specified Criteria|0|||
27578891|NCT01709318|80302965|FG003|Overall Study|Other Protocol Specified Criteria|0|||
27578892|NCT01709318|80302966|FG004|Overall Study|Other Protocol Specified Criteria|0|||
27578893|NCT01709318|80302967|FG005|Overall Study|Other Protocol Specified Criteria|0|||
27674877|NCT00882115|80647272|FG000|Overall Study|Withdrawal by Subject|3|||
27674878|NCT00882115|80647272|FG000|Overall Study|did not respond to DEP challe|6|||
27674879|NCT02820597|80647275|FG000|Overall Study|Lost to Follow-up|12|||
27674880|NCT00633945|80647278|FG000|Overall Study|Physician Decision|2|||
27986827|NCT01543776|81783218|FG001|Overall Study|Withdrawal by Subject|2|||
27986828|NCT02453555|81783219|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
27578894|NCT01709318|80302968|FG006|Overall Study|Other Protocol Specified Criteria|0|||
27578895|NCT01229436|80302969|FG000|Overall Study|Withdrawal by Subject|2|||
27674881|NCT04351269|80647279|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
27674882|NCT04351269|80647280|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
27674883|NCT04351269|80647281|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
27674884|NCT04351269|80647279|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
27674885|NCT04351269|80647280|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
27674886|NCT04351269|80647281|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
27674887|NCT04351269|80647279|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
27578896|NCT01229436|80302969|FG000|Overall Study|Lost to Follow-up|3|||
27674888|NCT04351269|80647280|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
27674889|NCT04351269|80647281|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
27674890|NCT04351269|80647279|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
27674891|NCT04351269|80647280|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
27674892|NCT04351269|80647281|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
27674893|NCT04351269|80647279|FG000|Overall Study|Lost to Follow-up|1|||
27795992|NCT02395536|81082223|FG000|Overall Study|Death|2|||
27795993|NCT02395536|81082224|FG001|Overall Study|Death|0|||
27795994|NCT02395536|81082223|FG000|Overall Study|Physician Decision|4|||
27795995|NCT02395536|81082224|FG001|Overall Study|Physician Decision|6|||
27795996|NCT02395536|81082223|FG000|Overall Study|Withdrawal by Subject|9|||
27795997|NCT02395536|81082224|FG001|Overall Study|Withdrawal by Subject|17|||
27795998|NCT02395536|81082223|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
27795999|NCT02395536|81082224|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
27796000|NCT02395536|81082223|FG000|Overall Study|Insurance issue|0|||
27796001|NCT02395536|81082224|FG001|Overall Study|Insurance issue|1|||
27796002|NCT02332655|81082226|FG000|Overall Study|Lack of Efficacy|1|||
27796003|NCT01266642|81082229|FG000|Overall Study|Protocol Violation|0|||
27796004|NCT01266642|81082230|FG001|Overall Study|Protocol Violation|1|||
27796005|NCT02181634|81082231|FG000|Overall Study|Lack of Efficacy|33|||
27796006|NCT02181634|81082231|FG000|Overall Study|Adverse Event|17|||
27796007|NCT02181634|81082231|FG000|Overall Study|Physician Decision|8|||
27796008|NCT02181634|81082231|FG000|Overall Study|Withdrawal by Subject|5|||
27796009|NCT02181634|81082231|FG000|Overall Study|Death|2|||
27796010|NCT02181634|81082231|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
27796011|NCT02181634|81082231|FG000|Overall Study|Ineligible|1|||
27796012|NCT02181634|81082231|FG000|Overall Study|Max number of dose reduction|1|||
27796013|NCT02181634|81082231|FG000|Overall Study|Symptomatic progression|1|||
27796014|NCT02181634|81082231|FG000|Overall Study|Patient opted to proceed to surgery|1|||
27986829|NCT02453555|81783220|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
27986830|NCT02453555|81783221|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
27986831|NCT02453555|81783222|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
27986832|NCT02453555|81783223|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
27578897|NCT01018264|80302970|FG000|Overall Study|Withdrawal by Subject|1|||
27578898|NCT01018264|80302971|FG001|Overall Study|Withdrawal by Subject|0|||
27578899|NCT01018264|80302970|FG000|Overall Study|Lost to Follow-up|0|||
27796015|NCT01988337|81082232|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
27986833|NCT02453555|81783224|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
27986834|NCT02453555|81783219|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
27986835|NCT02453555|81783220|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27986836|NCT02453555|81783221|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27986837|NCT02453555|81783222|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27986838|NCT02453555|81783223|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27986839|NCT02453555|81783224|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
27986840|NCT02453555|81783219|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
27986841|NCT02453555|81783220|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
27986842|NCT02453555|81783221|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27986843|NCT02453555|81783222|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27986844|NCT02453555|81783223|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27986845|NCT02453555|81783224|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27986846|NCT02453555|81783219|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
27986847|NCT02453555|81783220|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
27986848|NCT02453555|81783221|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
27986849|NCT02453555|81783222|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
27986850|NCT02453555|81783223|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
27986851|NCT02453555|81783224|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
27986852|NCT02453555|81783219|FG000|Extension Period|Adverse Event|0|||
27986853|NCT02453555|81783220|FG001|Extension Period|Adverse Event|0|||
27986854|NCT02453555|81783221|FG002|Extension Period|Adverse Event|1|||
27986855|NCT02453555|81783222|FG003|Extension Period|Adverse Event|2|||
27986856|NCT02453555|81783223|FG004|Extension Period|Adverse Event|1|||
27986857|NCT02453555|81783224|FG005|Extension Period|Adverse Event|1|||
27986858|NCT02453555|81783219|FG000|Extension Period|Protocol Violation|0|||
27986859|NCT02453555|81783220|FG001|Extension Period|Protocol Violation|0|||
27986860|NCT02453555|81783221|FG002|Extension Period|Protocol Violation|1|||
27986861|NCT02453555|81783222|FG003|Extension Period|Protocol Violation|0|||
27986862|NCT02453555|81783223|FG004|Extension Period|Protocol Violation|0|||
27986863|NCT02453555|81783224|FG005|Extension Period|Protocol Violation|0|||
27986864|NCT02453555|81783219|FG000|Extension Period|Withdrawal by Subject|0|||
27986865|NCT02453555|81783220|FG001|Extension Period|Withdrawal by Subject|0|||
27986866|NCT02453555|81783221|FG002|Extension Period|Withdrawal by Subject|1|||
27986867|NCT02453555|81783222|FG003|Extension Period|Withdrawal by Subject|0|||
27986868|NCT02453555|81783223|FG004|Extension Period|Withdrawal by Subject|0|||
27986869|NCT02453555|81783224|FG005|Extension Period|Withdrawal by Subject|0|||
27986870|NCT00400569|81783227|FG000|Overall Study|Death|1|||
27986871|NCT00488826|81783232|FG000|Overall Study|Withdrawal by Subject|40|||
27986872|NCT00488826|81783233|FG001|Overall Study|Withdrawal by Subject|35|||
27986873|NCT00488826|81783234|FG002|Overall Study|Withdrawal by Subject|19|||
27986874|NCT00488826|81783232|FG000|Overall Study|Protocol Violation|0|||
27986875|NCT00488826|81783233|FG001|Overall Study|Protocol Violation|0|||
27986876|NCT00488826|81783234|FG002|Overall Study|Protocol Violation|2|||
27986877|NCT00488826|81783232|FG000|Overall Study|Adverse Event|9|||
27986878|NCT00488826|81783233|FG001|Overall Study|Adverse Event|15|||
27986879|NCT00488826|81783234|FG002|Overall Study|Adverse Event|4|||
27986880|NCT00488826|81783232|FG000|Overall Study|Lost to Follow-up|5|||
27986881|NCT00488826|81783233|FG001|Overall Study|Lost to Follow-up|1|||
27986882|NCT00488826|81783234|FG002|Overall Study|Lost to Follow-up|0|||
27986883|NCT00488826|81783232|FG000|Overall Study|Protocol Deviations|2|||
27986884|NCT00488826|81783233|FG001|Overall Study|Protocol Deviations|1|||
27986885|NCT00488826|81783234|FG002|Overall Study|Protocol Deviations|1|||
27986886|NCT01026220|81783235|FG000|Induction|Death|1|||
27986887|NCT01026220|81783236|FG001|Induction|Death|0|||
27986888|NCT01026220|81783237|FG002|Induction|Death|0|||
27986889|NCT01026220|81783235|FG000|Induction|Lack of Efficacy|2|||
27986890|NCT01026220|81783236|FG001|Induction|Lack of Efficacy|0|||
27986891|NCT01026220|81783237|FG002|Induction|Lack of Efficacy|0|||
27986892|NCT01026220|81783235|FG000|Induction|Physician Decision|12|||
27986893|NCT01026220|81783236|FG001|Induction|Physician Decision|0|||
27986894|NCT01026220|81783237|FG002|Induction|Physician Decision|0|||
27986895|NCT01026220|81783235|FG000|Induction|Withdrawal by Subject|9|||
27986896|NCT01026220|81783236|FG001|Induction|Withdrawal by Subject|0|||
27986897|NCT01026220|81783237|FG002|Induction|Withdrawal by Subject|0|||
27986898|NCT01026220|81783235|FG000|Induction|Ineligible|1|||
27869679|NCT03888066|81357784|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
27869680|NCT03888066|81357785|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
27869681|NCT03888066|81357784|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
27986899|NCT01026220|81783236|FG001|Induction|Ineligible|0|||
27986900|NCT01026220|81783237|FG002|Induction|Ineligible|0|||
27986901|NCT01026220|81783235|FG000|Consolidation Maintenance|Death|0|||
27986902|NCT01026220|81783236|FG001|Consolidation Maintenance|Death|1|||
27869682|NCT03888066|81357785|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
27986903|NCT01026220|81783237|FG002|Consolidation Maintenance|Death|0|||
27986904|NCT01026220|81783235|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
27986905|NCT01026220|81783236|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
27986906|NCT01026220|81783237|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
27986907|NCT01026220|81783235|FG000|Consolidation Maintenance|Physician Decision|0|||
27986908|NCT01026220|81783236|FG001|Consolidation Maintenance|Physician Decision|2|||
27986909|NCT01026220|81783237|FG002|Consolidation Maintenance|Physician Decision|7|||
27986910|NCT01026220|81783235|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
27986911|NCT01026220|81783236|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
27986912|NCT01026220|81783237|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
27986913|NCT00932165|81783238|FG000|Overall Study|Lost to Follow-up|1|||
27986914|NCT02999633|81783239|FG000|Overall Study|Adverse Event|2|||
27986915|NCT02999633|81783239|FG000|Overall Study|Progressive disease|12|||
27986916|NCT01012323|81783242|FG000|Overall Study|Investigator Judgment|1|||
27986917|NCT00924443|81783245|FG000|Overall Study|Physician Decision|2|||
27986918|NCT00924443|81783245|FG000|Overall Study|Protocol Violation|1|||
27986919|NCT03320330|81783246|FG000|Overall Study|Lack of Efficacy|5|||
27986920|NCT03320330|81783247|FG001|Overall Study|Lack of Efficacy|5|||
27986921|NCT03320330|81783248|FG002|Overall Study|Lack of Efficacy|14|||
27986922|NCT03320330|81783246|FG000|Overall Study|Physician Decision|1|||
27986923|NCT03320330|81783247|FG001|Overall Study|Physician Decision|0|||
27986924|NCT03320330|81783248|FG002|Overall Study|Physician Decision|0|||
27986925|NCT01953913|81783249|FG000|Overall Study|Disease Progression|349|||
27986926|NCT01953913|81783249|FG000|Overall Study|Worsening of underlying cancer|22|||
27986927|NCT01953913|81783249|FG000|Overall Study|Adverse Event|20|||
27986928|NCT01953913|81783249|FG000|Overall Study|Protocol Violation|6|||
27986929|NCT01953913|81783249|FG000|Overall Study|Lost to Follow-up|4|||
27986930|NCT01953913|81783249|FG000|Overall Study|Withdrawal by Subject|32|||
27796016|NCT03022799|81082233|FG000|Overall Study|Adverse Event|0|||
27796017|NCT03022799|81082234|FG001|Overall Study|Adverse Event|0|||
27796018|NCT03022799|81082235|FG002|Overall Study|Adverse Event|0|||
27796019|NCT03022799|81082236|FG003|Overall Study|Adverse Event|0|||
27796020|NCT03022799|81082237|FG004|Overall Study|Adverse Event|0|||
27796021|NCT03022799|81082238|FG005|Overall Study|Adverse Event|0|||
27796022|NCT03022799|81082239|FG006|Overall Study|Adverse Event|0|||
27796023|NCT03022799|81082240|FG007|Overall Study|Adverse Event|0|||
27796024|NCT03022799|81082241|FG008|Overall Study|Adverse Event|0|||
27796025|NCT03022799|81082242|FG009|Overall Study|Adverse Event|1|||
27796026|NCT03022799|81082243|FG010|Overall Study|Adverse Event|1|||
27796027|NCT03022799|81082244|FG011|Overall Study|Adverse Event|0|||
27796028|NCT03022799|81082245|FG012|Overall Study|Adverse Event|0|||
27796029|NCT02545868|81082246|FG000|Overall Study|Lack of Efficacy|1|||
27796030|NCT02545868|81082247|FG001|Overall Study|Lack of Efficacy|1|||
27796031|NCT02545868|81082248|FG002|Overall Study|Lack of Efficacy|0|||
27796032|NCT02545868|81082246|FG000|Overall Study|Lost to Follow-up|1|||
27796033|NCT02545868|81082247|FG001|Overall Study|Lost to Follow-up|5|||
27796034|NCT02545868|81082248|FG002|Overall Study|Lost to Follow-up|1|||
27796035|NCT02545868|81082246|FG000|Overall Study|Non-compliance|1|||
27796036|NCT02545868|81082247|FG001|Overall Study|Non-compliance|1|||
27796037|NCT02545868|81082248|FG002|Overall Study|Non-compliance|1|||
27796038|NCT02545868|81082246|FG000|Overall Study|Treatment change|21|||
27796039|NCT02545868|81082247|FG001|Overall Study|Treatment change|19|||
27796040|NCT02545868|81082248|FG002|Overall Study|Treatment change|22|||
27796041|NCT02545868|81082246|FG000|Overall Study|Physician Decision|1|||
27796042|NCT02545868|81082247|FG001|Overall Study|Physician Decision|1|||
27796043|NCT02545868|81082248|FG002|Overall Study|Physician Decision|1|||
27796044|NCT02545868|81082246|FG000|Overall Study|Withdrawal by Subject|6|||
27796045|NCT02545868|81082247|FG001|Overall Study|Withdrawal by Subject|7|||
27986931|NCT01953913|81783249|FG000|Overall Study|Other than listed|108|||
27986932|NCT01953913|81783249|FG000|Overall Study|Not Treated|1|||
27986933|NCT00837759|81783251|FG000|Overall Study|Protocol Violation|3|||
27986934|NCT00837759|81783251|FG000|Overall Study|Lost to Follow-up|1|||
27986935|NCT00447122|81783252|FG000|Overall Study|worsening medical condition -came off|0|||
27986936|NCT00447122|81783253|FG001|Overall Study|worsening medical condition -came off|1|||
27578900|NCT01018264|80302971|FG001|Overall Study|Lost to Follow-up|1|||
27578901|NCT03160703|80302972|FG000|Overall Study|Withdrawal by Subject|0|||
27796046|NCT02545868|81082248|FG002|Overall Study|Withdrawal by Subject|9|||
27796047|NCT01017731|81082254|FG000|Overall Study|Lost to Follow-up|2|||
27796048|NCT01017731|81082254|FG000|Overall Study|Withdrawal by Subject|3|||
27796049|NCT01017731|81082254|FG000|Overall Study|Physician Decision|2|||
27578902|NCT03160703|80302973|FG001|Overall Study|Withdrawal by Subject|0|||
27594154|NCT02137369|80352458|FG001|Overall Study|Adverse Event|0|||
27796050|NCT01017731|81082254|FG000|Overall Study|Adverse Event|1|||
27796051|NCT03867500|81082255|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
27796052|NCT04362761|81082261|FG000|Part A (48 Weeks)|Adverse Event|2|||
27796053|NCT04362761|81082261|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
27986937|NCT00447122|81783254|FG002|Overall Study|worsening medical condition -came off|0|||
27986938|NCT00447122|81783255|FG003|Overall Study|worsening medical condition -came off|0|||
27986939|NCT01431963|81783256|FG000|Overall Study|Adverse Event|18|||
27986940|NCT01431963|81783256|FG000|Overall Study|Lack of Efficacy|7|||
27986941|NCT01431963|81783256|FG000|Overall Study|Protocol Violation|1|||
27986942|NCT01431963|81783256|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
27986943|NCT01431963|81783256|FG000|Overall Study|Physician Decision|4|||
27986944|NCT01431963|81783256|FG000|Overall Study|Withdrawal by Subject|3|||
27986945|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
27986946|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
27986947|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
27986948|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
27986949|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
27986950|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
27986951|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
27986952|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
27986953|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
27986954|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
27986955|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
27986956|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
27986957|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
27986958|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
27986959|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
27986960|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
27986961|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
27986962|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
27986963|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
27986964|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
27986965|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
27986966|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
27986967|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
27986968|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
27986969|NCT01532869|81783257|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
27986970|NCT01532869|81783258|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
27986971|NCT01532869|81783257|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
27986972|NCT01532869|81783258|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
27986973|NCT01532869|81783257|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
27986974|NCT01532869|81783258|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
27986975|NCT01532869|81783257|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
27986976|NCT01532869|81783258|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
27986977|NCT01532869|81783257|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
27986978|NCT01532869|81783258|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
27986979|NCT03667690|81783260|FG000|Overall Study|Adverse Event|0|||
27986980|NCT03667690|81783261|FG001|Overall Study|Adverse Event|3|||
27986981|NCT03667690|81783260|FG000|Overall Study|Death|22|||
27986982|NCT03667690|81783261|FG001|Overall Study|Death|21|||
27986983|NCT03667690|81783260|FG000|Overall Study|Lost to Follow-up|4|||
27986984|NCT03667690|81783261|FG001|Overall Study|Lost to Follow-up|5|||
27986985|NCT03667690|81783260|FG000|Overall Study|Withdrawal by Subject|7|||
27986986|NCT03667690|81783261|FG001|Overall Study|Withdrawal by Subject|8|||
27986987|NCT03667690|81783260|FG000|Overall Study|Subject could not return for additional investigational product|1|||
27986988|NCT03667690|81783261|FG001|Overall Study|Subject could not return for additional investigational product|0|||
27986989|NCT03667690|81783260|FG000|Overall Study|Subject discharged to hospice care|2|||
27986990|NCT03667690|81783261|FG001|Overall Study|Subject discharged to hospice care|0|||
27986991|NCT03667690|81783260|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
27986992|NCT03667690|81783261|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
27986993|NCT03667690|81783260|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
27986994|NCT03667690|81783261|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
27986995|NCT03667690|81783260|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
27986996|NCT03667690|81783261|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
27796054|NCT04362761|81082261|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
27796055|NCT04362761|81082261|FG000|Part A (48 Weeks)|Other|5|||
27796056|NCT04362761|81082261|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
27869683|NCT03888066|81357784|FG000|Run-in Phase|Death|1|||
27796057|NCT04362761|81082261|FG000|Part B (86 Weeks)|Other|4|||
27986997|NCT03667690|81783260|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
27986998|NCT03667690|81783261|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
27986999|NCT03667690|81783260|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
27987000|NCT03667690|81783261|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
27987001|NCT01438177|81783263|FG000|Overall Study|Withdrawal by Subject|1|||
27796058|NCT01856257|81082265|FG000|Overall Study|Death|2|||
27987002|NCT01438177|81783263|FG000|Overall Study|Initiation of new therapy|1|||
27987003|NCT01374178|81783267|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
27987004|NCT01374178|81783268|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
27987005|NCT01374178|81783267|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
27987006|NCT01374178|81783268|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
27987007|NCT01983774|81783269|FG000|Overall Study|Lung Transplant|0|||
27987008|NCT01983774|81783270|FG001|Overall Study|Lung Transplant|1|||
27987009|NCT01983774|81783269|FG000|Overall Study|Lost to Follow-up|1|||
27987010|NCT01983774|81783270|FG001|Overall Study|Lost to Follow-up|0|||
27987011|NCT03689855|81783271|FG000|Overall Study|Adverse Event|3|||
27987012|NCT03689855|81783271|FG000|Overall Study|Withdrawal by Subject|1|||
27987013|NCT01549873|81783272|FG000|Overall Study|Physician Decision|0|||
27987014|NCT01549873|81783273|FG001|Overall Study|Physician Decision|1|||
27987015|NCT03238924|81783274|FG000|Overall Study|Withdrawal by Subject|2|||
27987016|NCT03238924|81783275|FG001|Overall Study|Withdrawal by Subject|2|||
27987017|NCT02252965|81783276|FG000|Overall Study|Adverse Event|9|||
27987018|NCT02252965|81783277|FG001|Overall Study|Adverse Event|14|||
27987019|NCT02252965|81783276|FG000|Overall Study|Lost to Follow-up|16|||
27987020|NCT02252965|81783277|FG001|Overall Study|Lost to Follow-up|8|||
27987021|NCT02252965|81783276|FG000|Overall Study|Protocol Violation|4|||
27987022|NCT02252965|81783277|FG001|Overall Study|Protocol Violation|5|||
27987023|NCT02252965|81783276|FG000|Overall Study|Lack of Efficacy|0|||
27987024|NCT02252965|81783277|FG001|Overall Study|Lack of Efficacy|2|||
27987025|NCT02252965|81783276|FG000|Overall Study|Withdrawal by Subject|7|||
27987026|NCT02252965|81783277|FG001|Overall Study|Withdrawal by Subject|9|||
27987027|NCT02252965|81783276|FG000|Overall Study|Other|4|||
27987028|NCT02252965|81783277|FG001|Overall Study|Other|5|||
27987029|NCT03624127|81783280|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
27987030|NCT03624127|81783281|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
27987031|NCT03624127|81783282|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
27987032|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
27987033|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
27987034|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
27987035|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Death|0|||
27987036|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Death|1|||
27987037|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Death|0|||
27987038|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
27987039|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
27987040|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
27987041|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
27987042|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
27987043|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
27987044|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
27987045|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
27987046|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
27987047|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
27987048|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
27987049|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
27987050|NCT03624127|81783280|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
27987051|NCT03624127|81783281|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
27987052|NCT03624127|81783282|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
27987053|NCT03624127|81783280|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
27987054|NCT03624127|81783281|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
27987055|NCT03624127|81783282|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
27987056|NCT03624127|81783280|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
27987057|NCT03624127|81783281|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
27674894|NCT04351269|80647280|FG001|Overall Study|Lost to Follow-up|3|||
27987058|NCT03624127|81783282|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
27987059|NCT03624127|81783280|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27987060|NCT03624127|81783281|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27987061|NCT03624127|81783282|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
27987062|NCT03624127|81783280|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
27987063|NCT03624127|81783281|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
27987064|NCT03624127|81783282|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
27987065|NCT03624127|81783280|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
27987066|NCT03624127|81783281|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
27987067|NCT03624127|81783282|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
27987068|NCT03624127|81783280|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
27987069|NCT03624127|81783281|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
27987070|NCT03624127|81783282|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
27987071|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
27987072|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
27987073|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
27987074|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
27987075|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
27987076|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
27987077|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
27987078|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
27987079|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
27987080|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
27987081|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
27987082|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
27987083|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
27987084|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
27987085|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
27987086|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
27987087|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
27987088|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
27987089|NCT03624127|81783280|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
27987090|NCT03624127|81783281|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
27987091|NCT03624127|81783282|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
27987092|NCT03052816|81783284|FG000|Overall Study|Withdrawal by Subject|1|||
27987093|NCT03052816|81783285|FG001|Overall Study|Withdrawal by Subject|0|||
27987094|NCT03052816|81783284|FG000|Overall Study|Desired opioids|2|||
27987095|NCT03052816|81783285|FG001|Overall Study|Desired opioids|0|||
27987096|NCT01555125|81783288|FG000|Induction Period|Lost to Follow-up|0|||
27987097|NCT01555125|81783289|FG001|Induction Period|Lost to Follow-up|2|||
27987098|NCT01555125|81783290|FG002|Induction Period|Lost to Follow-up|0|||
27987099|NCT01555125|81783291|FG003|Induction Period|Lost to Follow-up|0|||
27987100|NCT01555125|81783292|FG004|Induction Period|Lost to Follow-up|0|||
27987101|NCT01555125|81783288|FG000|Induction Period|Adverse Event|0|||
27987102|NCT01555125|81783289|FG001|Induction Period|Adverse Event|1|||
27987103|NCT01555125|81783290|FG002|Induction Period|Adverse Event|0|||
27987104|NCT01555125|81783291|FG003|Induction Period|Adverse Event|0|||
27987105|NCT01555125|81783292|FG004|Induction Period|Adverse Event|1|||
27987106|NCT01555125|81783288|FG000|Induction Period|Subject / guardian decision|0|||
27987107|NCT01555125|81783289|FG001|Induction Period|Subject / guardian decision|0|||
27987108|NCT01555125|81783290|FG002|Induction Period|Subject / guardian decision|0|||
27987109|NCT01555125|81783291|FG003|Induction Period|Subject / guardian decision|0|||
27987110|NCT01555125|81783292|FG004|Induction Period|Subject / guardian decision|2|||
27987111|NCT01555125|81783288|FG000|Induction Period|Death|1|||
27987112|NCT01555125|81783289|FG001|Induction Period|Death|0|||
27987113|NCT01555125|81783290|FG002|Induction Period|Death|0|||
27987114|NCT01555125|81783291|FG003|Induction Period|Death|0|||
27987115|NCT01555125|81783292|FG004|Induction Period|Death|0|||
27987116|NCT01555125|81783288|FG000|Maintenance Period|Adverse Event|1|||
27987117|NCT01555125|81783289|FG001|Maintenance Period|Adverse Event|1|||
27987118|NCT01555125|81783290|FG002|Maintenance Period|Adverse Event|0|||
27987119|NCT01555125|81783291|FG003|Maintenance Period|Adverse Event|0|||
27987120|NCT01555125|81783292|FG004|Maintenance Period|Adverse Event|0|||
27987121|NCT01555125|81783288|FG000|Maintenance Period|Subject / guardian decision|1|||
27987122|NCT01555125|81783289|FG001|Maintenance Period|Subject / guardian decision|2|||
27987123|NCT01555125|81783290|FG002|Maintenance Period|Subject / guardian decision|0|||
27987124|NCT01555125|81783291|FG003|Maintenance Period|Subject / guardian decision|0|||
27987125|NCT01555125|81783292|FG004|Maintenance Period|Subject / guardian decision|0|||
27987126|NCT01555125|81783288|FG000|Maintenance Period|Lost to Follow-up|2|||
27987127|NCT01555125|81783289|FG001|Maintenance Period|Lost to Follow-up|0|||
27987128|NCT01555125|81783290|FG002|Maintenance Period|Lost to Follow-up|0|||
27987129|NCT01555125|81783291|FG003|Maintenance Period|Lost to Follow-up|1|||
27987130|NCT01555125|81783292|FG004|Maintenance Period|Lost to Follow-up|0|||
27987131|NCT01555125|81783288|FG000|Maintenance Period|Lack of Efficacy|6|||
27987132|NCT01555125|81783289|FG001|Maintenance Period|Lack of Efficacy|1|||
27987133|NCT01555125|81783290|FG002|Maintenance Period|Lack of Efficacy|3|||
27987134|NCT01555125|81783291|FG003|Maintenance Period|Lack of Efficacy|0|||
27987135|NCT01555125|81783292|FG004|Maintenance Period|Lack of Efficacy|0|||
27674895|NCT04351269|80647281|FG002|Overall Study|Lost to Follow-up|0|||
27674896|NCT03784820|80647282|FG000|Overall Study|Lost to Follow-up|5|||
27674897|NCT03784820|80647283|FG001|Overall Study|Lost to Follow-up|5|||
27674898|NCT03784820|80647284|FG002|Overall Study|Lost to Follow-up|3|||
27674899|NCT03784820|80647285|FG003|Overall Study|Lost to Follow-up|3|||
27674900|NCT00940875|80647286|FG000|Treatment Phase|Adverse Event|9|||
27674901|NCT00940875|80647287|FG001|Treatment Phase|Adverse Event|3|||
27674902|NCT00940875|80647286|FG000|Treatment Phase|Death|3|||
27674903|NCT00940875|80647287|FG001|Treatment Phase|Death|5|||
27674904|NCT00940875|80647286|FG000|Treatment Phase|Lack of Efficacy|1|||
27674905|NCT00940875|80647287|FG001|Treatment Phase|Lack of Efficacy|0|||
27674906|NCT00940875|80647286|FG000|Treatment Phase|Withdrawal by Subject|3|||
27674907|NCT00940875|80647287|FG001|Treatment Phase|Withdrawal by Subject|0|||
27674908|NCT00940875|80647286|FG000|Treatment Phase|Disease progression|9|||
27674909|NCT00940875|80647287|FG001|Treatment Phase|Disease progression|11|||
27674910|NCT00940875|80647286|FG000|Treatment Phase|Physician Decision|1|||
27674911|NCT00940875|80647287|FG001|Treatment Phase|Physician Decision|0|||
27674912|NCT00940875|80647286|FG000|Post-Study Treatment|Death|0|||
27674913|NCT00940875|80647287|FG001|Post-Study Treatment|Death|1|||
27674914|NCT00940875|80647286|FG000|Post-Study Treatment|Disease Progression|0|||
27674915|NCT00940875|80647287|FG001|Post-Study Treatment|Disease Progression|2|||
27674916|NCT03054337|80647290|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
27674917|NCT03054337|80647291|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
27674918|NCT03054337|80647292|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
27674919|NCT03054337|80647293|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
27674920|NCT03054337|80647294|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
27674921|NCT03054337|80647295|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
27674922|NCT02388347|80647296|FG000|Overall Study|Withdrawal by Subject|0|||
27674923|NCT02388347|80647297|FG001|Overall Study|Withdrawal by Subject|0|||
27674924|NCT02388347|80647298|FG002|Overall Study|Withdrawal by Subject|1|||
27674925|NCT02388347|80647299|FG003|Overall Study|Withdrawal by Subject|0|||
27674926|NCT02388347|80647300|FG004|Overall Study|Withdrawal by Subject|0|||
27674927|NCT02763215|80647301|FG000|Overall Study|Participants withdrew from study|3|||
27674928|NCT02763215|80647301|FG000|Overall Study|Missed visit|1|||
27674929|NCT02763215|80647301|FG000|Overall Study|Visit outside visit-window|1|||
27674930|NCT02763215|80647301|FG000|Overall Study|Death|1|||
27674931|NCT02763215|80647301|FG000|Overall Study|Lost to Follow-up|1|||
27674932|NCT02586415|80647302|FG000|Overall Study|Death|13|||
27869684|NCT03888066|81357785|FG001|Run-in Phase|Death|0|||
27869685|NCT03888066|81357784|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
27987136|NCT01555125|81783288|FG000|Maintenance Period|Physician Decision|0|||
27987137|NCT01555125|81783289|FG001|Maintenance Period|Physician Decision|0|||
27987138|NCT01555125|81783290|FG002|Maintenance Period|Physician Decision|1|||
27987139|NCT01555125|81783291|FG003|Maintenance Period|Physician Decision|0|||
27987140|NCT01555125|81783292|FG004|Maintenance Period|Physician Decision|0|||
27987141|NCT01555125|81783288|FG000|Maintenance Period|Death|0|||
27987142|NCT01555125|81783289|FG001|Maintenance Period|Death|0|||
27987143|NCT01555125|81783290|FG002|Maintenance Period|Death|0|||
27987144|NCT01555125|81783291|FG003|Maintenance Period|Death|1|||
27987145|NCT01555125|81783292|FG004|Maintenance Period|Death|0|||
27987146|NCT01555125|81783288|FG000|Extension|Adverse Event|1|||
27987147|NCT01555125|81783289|FG001|Extension|Adverse Event|2|||
27987148|NCT01555125|81783290|FG002|Extension|Adverse Event|1|||
27987149|NCT01555125|81783291|FG003|Extension|Adverse Event|1|||
27987150|NCT01555125|81783292|FG004|Extension|Adverse Event|0|||
27987151|NCT01555125|81783288|FG000|Extension|Protocol deviation|1|||
27987152|NCT01555125|81783289|FG001|Extension|Protocol deviation|0|||
27987153|NCT01555125|81783290|FG002|Extension|Protocol deviation|0|||
27987154|NCT01555125|81783291|FG003|Extension|Protocol deviation|0|||
27987155|NCT01555125|81783292|FG004|Extension|Protocol deviation|0|||
27987156|NCT01555125|81783288|FG000|Extension|Lack of Efficacy|7|||
27987157|NCT01555125|81783289|FG001|Extension|Lack of Efficacy|6|||
27987158|NCT01555125|81783290|FG002|Extension|Lack of Efficacy|3|||
27987159|NCT01555125|81783291|FG003|Extension|Lack of Efficacy|0|||
27987160|NCT01555125|81783292|FG004|Extension|Lack of Efficacy|0|||
27674933|NCT02586415|80647303|FG001|Overall Study|Death|23|||
27674934|NCT02586415|80647302|FG000|Overall Study|Lost to Follow-up|1|||
27674935|NCT02586415|80647303|FG001|Overall Study|Lost to Follow-up|2|||
27674936|NCT00762476|80647306|FG000|Overall Study|Adverse Event|7|||
27674937|NCT00762476|80647307|FG001|Overall Study|Adverse Event|1|||
27674938|NCT00762476|80647306|FG000|Overall Study|Lost to Follow-up|2|||
27674939|NCT00762476|80647307|FG001|Overall Study|Lost to Follow-up|0|||
27674940|NCT00762476|80647306|FG000|Overall Study|Protocol Violation|5|||
27674941|NCT00762476|80647307|FG001|Overall Study|Protocol Violation|6|||
27987161|NCT01555125|81783288|FG000|Extension|Lost to Follow-up|2|||
27987162|NCT01555125|81783289|FG001|Extension|Lost to Follow-up|1|||
27987163|NCT01555125|81783290|FG002|Extension|Lost to Follow-up|2|||
27987164|NCT01555125|81783291|FG003|Extension|Lost to Follow-up|0|||
27674942|NCT00762476|80647306|FG000|Overall Study|Physician Decision|2|||
27674943|NCT00762476|80647307|FG001|Overall Study|Physician Decision|14|||
27674944|NCT00762476|80647306|FG000|Overall Study|Withdrawal by Subject|6|||
27674945|NCT00762476|80647307|FG001|Overall Study|Withdrawal by Subject|12|||
27674946|NCT00762476|80647306|FG000|Overall Study|antibiotic use|0|||
27674947|NCT00762476|80647307|FG001|Overall Study|antibiotic use|1|||
27674948|NCT00762476|80647306|FG000|Overall Study|non-compliance with study visits|0|||
27674949|NCT00762476|80647307|FG001|Overall Study|non-compliance with study visits|2|||
27674950|NCT00762476|80647306|FG000|Overall Study|Seasonal allergies|1|||
27674951|NCT00762476|80647307|FG001|Overall Study|Seasonal allergies|0|||
27674952|NCT01131104|80647308|FG000|Overall Study|Withdrawal by Subject|3|||
27796059|NCT01856257|81082266|FG001|Overall Study|Death|0|||
27796060|NCT01856257|81082267|FG002|Overall Study|Death|0|||
27796061|NCT01856257|81082268|FG003|Overall Study|Death|0|||
27796062|NCT01856257|81082265|FG000|Overall Study|Physician Decision|0|||
27796063|NCT01856257|81082266|FG001|Overall Study|Physician Decision|0|||
27796064|NCT01856257|81082267|FG002|Overall Study|Physician Decision|0|||
27796065|NCT01856257|81082268|FG003|Overall Study|Physician Decision|1|||
27674953|NCT01131104|80647308|FG000|Overall Study|Physician Decision|4|||
27674954|NCT01131104|80647308|FG000|Overall Study|Information Not Available|5|||
27796066|NCT01856257|81082265|FG000|Overall Study|Withdrawal by Subject|1|||
27796067|NCT01856257|81082266|FG001|Overall Study|Withdrawal by Subject|1|||
27796068|NCT01856257|81082267|FG002|Overall Study|Withdrawal by Subject|0|||
27796069|NCT01856257|81082268|FG003|Overall Study|Withdrawal by Subject|0|||
27796070|NCT01856257|81082265|FG000|Overall Study|Donor complication|0|||
27987165|NCT01555125|81783292|FG004|Extension|Lost to Follow-up|0|||
27987166|NCT01555125|81783288|FG000|Extension|Study terminated by sponsor|32|||
27987167|NCT01555125|81783289|FG001|Extension|Study terminated by sponsor|33|||
27987168|NCT01555125|81783290|FG002|Extension|Study terminated by sponsor|16|||
27987169|NCT01555125|81783291|FG003|Extension|Study terminated by sponsor|20|||
27987170|NCT01555125|81783292|FG004|Extension|Study terminated by sponsor|0|||
27987171|NCT01555125|81783288|FG000|Extension|Subject/guardian decision|1|||
27987172|NCT01555125|81783289|FG001|Extension|Subject/guardian decision|9|||
27987173|NCT01555125|81783290|FG002|Extension|Subject/guardian decision|1|||
27987174|NCT01555125|81783291|FG003|Extension|Subject/guardian decision|0|||
27987175|NCT01555125|81783292|FG004|Extension|Subject/guardian decision|0|||
27987176|NCT01555125|81783288|FG000|Extension|Technical Problems|1|||
27987177|NCT01555125|81783289|FG001|Extension|Technical Problems|0|||
27987178|NCT01555125|81783290|FG002|Extension|Technical Problems|0|||
27987179|NCT01555125|81783291|FG003|Extension|Technical Problems|1|||
27987180|NCT01555125|81783292|FG004|Extension|Technical Problems|0|||
27987181|NCT01555125|81783288|FG000|Follow-Up Period|Lost to Follow-up|1|||
27987182|NCT01555125|81783289|FG001|Follow-Up Period|Lost to Follow-up|0|||
27987183|NCT01555125|81783290|FG002|Follow-Up Period|Lost to Follow-up|0|||
27987184|NCT01555125|81783291|FG003|Follow-Up Period|Lost to Follow-up|0|||
27987185|NCT01555125|81783292|FG004|Follow-Up Period|Lost to Follow-up|0|||
27987186|NCT01555125|81783288|FG000|Follow-Up Period|Subject / guardian decision|3|||
27987187|NCT01555125|81783289|FG001|Follow-Up Period|Subject / guardian decision|1|||
27987188|NCT01555125|81783290|FG002|Follow-Up Period|Subject / guardian decision|1|||
27987189|NCT01555125|81783291|FG003|Follow-Up Period|Subject / guardian decision|1|||
27987190|NCT01555125|81783292|FG004|Follow-Up Period|Subject / guardian decision|0|||
27987191|NCT02726022|81783293|FG000|Overall Study|Adverse Event|14|||
27987192|NCT02726022|81783293|FG000|Overall Study|Treatment Failure|8|||
27987193|NCT02726022|81783293|FG000|Overall Study|Poor Compliance|13|||
27987194|NCT02726022|81783293|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
27987195|NCT00812565|81783294|FG000|Overall Study|Did Not Receive Study Medication|1|||
27987196|NCT00812565|81783295|FG001|Overall Study|Did Not Receive Study Medication|1|||
27987197|NCT00812565|81783296|FG002|Overall Study|Did Not Receive Study Medication|0|||
27987198|NCT00812565|81783297|FG003|Overall Study|Did Not Receive Study Medication|0|||
27987199|NCT00812565|81783298|FG004|Overall Study|Did Not Receive Study Medication|0|||
27987200|NCT00812565|81783299|FG005|Overall Study|Did Not Receive Study Medication|0|||
27987201|NCT00812565|81783300|FG006|Overall Study|Did Not Receive Study Medication|0|||
27987202|NCT00812565|81783301|FG007|Overall Study|Did Not Receive Study Medication|0|||
27987203|NCT00812565|81783294|FG000|Overall Study|Adverse Event|0|||
27987204|NCT00812565|81783295|FG001|Overall Study|Adverse Event|0|||
27987205|NCT00812565|81783296|FG002|Overall Study|Adverse Event|0|||
27987206|NCT00812565|81783297|FG003|Overall Study|Adverse Event|2|||
27987207|NCT00812565|81783298|FG004|Overall Study|Adverse Event|0|||
27987208|NCT00812565|81783299|FG005|Overall Study|Adverse Event|0|||
27987209|NCT00812565|81783300|FG006|Overall Study|Adverse Event|0|||
27987210|NCT00812565|81783301|FG007|Overall Study|Adverse Event|1|||
27987211|NCT00812565|81783294|FG000|Overall Study|Did Not Come to Study Visit|1|||
27987212|NCT00812565|81783295|FG001|Overall Study|Did Not Come to Study Visit|0|||
27987213|NCT00812565|81783296|FG002|Overall Study|Did Not Come to Study Visit|0|||
27987214|NCT00812565|81783297|FG003|Overall Study|Did Not Come to Study Visit|0|||
27987215|NCT00812565|81783298|FG004|Overall Study|Did Not Come to Study Visit|0|||
27987216|NCT00812565|81783299|FG005|Overall Study|Did Not Come to Study Visit|0|||
27987217|NCT00812565|81783300|FG006|Overall Study|Did Not Come to Study Visit|0|||
27987218|NCT00812565|81783301|FG007|Overall Study|Did Not Come to Study Visit|0|||
27987219|NCT00812565|81783294|FG000|Overall Study|Withdrawal of Consent|1|||
27987220|NCT00812565|81783295|FG001|Overall Study|Withdrawal of Consent|0|||
27987221|NCT00812565|81783296|FG002|Overall Study|Withdrawal of Consent|0|||
27987222|NCT00812565|81783297|FG003|Overall Study|Withdrawal of Consent|0|||
27987223|NCT00812565|81783298|FG004|Overall Study|Withdrawal of Consent|1|||
27987224|NCT00812565|81783299|FG005|Overall Study|Withdrawal of Consent|0|||
27987225|NCT00812565|81783300|FG006|Overall Study|Withdrawal of Consent|0|||
27987226|NCT00812565|81783301|FG007|Overall Study|Withdrawal of Consent|0|||
27987227|NCT00812565|81783294|FG000|Overall Study|Reason Not Specified|0|||
27987228|NCT00812565|81783295|FG001|Overall Study|Reason Not Specified|0|||
27796071|NCT01856257|81082266|FG001|Overall Study|Donor complication|0|||
27987229|NCT00812565|81783296|FG002|Overall Study|Reason Not Specified|0|||
27987230|NCT00812565|81783297|FG003|Overall Study|Reason Not Specified|0|||
27578903|NCT03160703|80302974|FG002|Overall Study|Withdrawal by Subject|0|||
27796072|NCT01856257|81082267|FG002|Overall Study|Donor complication|0|||
27796073|NCT01856257|81082268|FG003|Overall Study|Donor complication|1|||
27987231|NCT00812565|81783298|FG004|Overall Study|Reason Not Specified|0|||
27987232|NCT00812565|81783299|FG005|Overall Study|Reason Not Specified|1|||
27987233|NCT00812565|81783300|FG006|Overall Study|Reason Not Specified|0|||
27987234|NCT00812565|81783301|FG007|Overall Study|Reason Not Specified|0|||
27987235|NCT00148941|81783304|FG000|Overall Study|Lost to Follow-up|17|||
27987236|NCT00148941|81783305|FG001|Overall Study|Lost to Follow-up|24|||
27987237|NCT00148941|81783306|FG002|Overall Study|Lost to Follow-up|18|||
27987238|NCT00148941|81783307|FG003|Overall Study|Lost to Follow-up|22|||
27987239|NCT00148941|81783304|FG000|Overall Study|Withdrawal by Subject|1|||
27987240|NCT00148941|81783305|FG001|Overall Study|Withdrawal by Subject|0|||
27674955|NCT01131104|80647308|FG000|Overall Study|No Information on Index Date of Onset|1|||
27674956|NCT02514551|80647309|FG000|Overall Study|Lost to Follow-up|0|||
27869686|NCT03888066|81357785|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
27987241|NCT00148941|81783306|FG002|Overall Study|Withdrawal by Subject|1|||
27987242|NCT00148941|81783307|FG003|Overall Study|Withdrawal by Subject|0|||
27987243|NCT00148941|81783304|FG000|Overall Study|Other|0|||
27987244|NCT00148941|81783305|FG001|Overall Study|Other|0|||
27987245|NCT00148941|81783306|FG002|Overall Study|Other|1|||
27987246|NCT00148941|81783307|FG003|Overall Study|Other|2|||
27987247|NCT01147848|81783310|FG000|Run-in Period|Screen Failure|623|||
27987248|NCT01147848|81783311|FG001|Run-in Period|Screen Failure|0|||
27987249|NCT01147848|81783312|FG002|Run-in Period|Screen Failure|0|||
27987250|NCT01147848|81783310|FG000|Run-in Period|Run-in Failure|135|||
27987251|NCT01147848|81783311|FG001|Run-in Period|Run-in Failure|0|||
27987252|NCT01147848|81783312|FG002|Run-in Period|Run-in Failure|0|||
27987253|NCT01147848|81783310|FG000|Randomized Phase|Adverse Event|0|||
27987254|NCT01147848|81783311|FG001|Randomized Phase|Adverse Event|6|||
27987255|NCT01147848|81783312|FG002|Randomized Phase|Adverse Event|8|||
27987256|NCT01147848|81783310|FG000|Randomized Phase|Lack of Efficacy|0|||
27987257|NCT01147848|81783311|FG001|Randomized Phase|Lack of Efficacy|20|||
27987258|NCT01147848|81783312|FG002|Randomized Phase|Lack of Efficacy|11|||
27987259|NCT01147848|81783310|FG000|Randomized Phase|Protocol Violation|0|||
27987260|NCT01147848|81783311|FG001|Randomized Phase|Protocol Violation|7|||
27987261|NCT01147848|81783312|FG002|Randomized Phase|Protocol Violation|10|||
27987262|NCT01147848|81783310|FG000|Randomized Phase|Lost to Follow-up|0|||
27987263|NCT01147848|81783311|FG001|Randomized Phase|Lost to Follow-up|5|||
27987264|NCT01147848|81783312|FG002|Randomized Phase|Lost to Follow-up|7|||
27987265|NCT01147848|81783310|FG000|Randomized Phase|Physician Decision|0|||
27987266|NCT01147848|81783311|FG001|Randomized Phase|Physician Decision|0|||
27987267|NCT01147848|81783312|FG002|Randomized Phase|Physician Decision|1|||
27987268|NCT01147848|81783310|FG000|Randomized Phase|Withdrawal by Subject|0|||
27987269|NCT01147848|81783311|FG001|Randomized Phase|Withdrawal by Subject|7|||
27987270|NCT01147848|81783312|FG002|Randomized Phase|Withdrawal by Subject|9|||
27987271|NCT03040986|81783313|FG000|Overall Study|Hospice|1|||
27987272|NCT03040986|81783314|FG001|Overall Study|Hospice|0|||
27987273|NCT03040986|81783313|FG000|Overall Study|Adverse Event|2|||
27987274|NCT03040986|81783314|FG001|Overall Study|Adverse Event|1|||
27987275|NCT03040986|81783313|FG000|Overall Study|Disease progression on study|3|||
27987276|NCT03040986|81783314|FG001|Overall Study|Disease progression on study|1|||
27987277|NCT03244826|81783319|FG000|Overall Study|Withdrawal by Subject|2|||
27987278|NCT03244826|81783320|FG001|Overall Study|Withdrawal by Subject|0|||
27987279|NCT03244826|81783319|FG000|Overall Study|Transplant delayed or withdrawn|12|||
27987280|NCT03244826|81783320|FG001|Overall Study|Transplant delayed or withdrawn|10|||
27987281|NCT01008904|81783321|FG000|Overall Study|Lost to Follow-up|1|||
27987282|NCT01008904|81783321|FG000|Overall Study|Adverse Event|2|||
27987283|NCT01008904|81783321|FG000|Overall Study|unexpected unrelated surgery|1|||
27987284|NCT00079677|81783322|FG000|Overall Study|Adverse Event|5|||
27987285|NCT00079677|81783323|FG001|Overall Study|Adverse Event|6|||
27987286|NCT00079677|81783322|FG000|Overall Study|Lack of Efficacy|1|||
27987287|NCT00079677|81783323|FG001|Overall Study|Lack of Efficacy|0|||
27987288|NCT00079677|81783322|FG000|Overall Study|Lost to Follow-up|2|||
27987289|NCT00079677|81783323|FG001|Overall Study|Lost to Follow-up|2|||
27987290|NCT00079677|81783322|FG000|Overall Study|Physician Decision|3|||
27987291|NCT00079677|81783323|FG001|Overall Study|Physician Decision|0|||
27987292|NCT00079677|81783322|FG000|Overall Study|Protocol Violation|2|||
27987293|NCT00079677|81783323|FG001|Overall Study|Protocol Violation|3|||
27987294|NCT00079677|81783322|FG000|Overall Study|Withdrawal by Subject|5|||
27987295|NCT00079677|81783323|FG001|Overall Study|Withdrawal by Subject|3|||
27987296|NCT00079677|81783322|FG000|Overall Study|Miscellaneous|2|||
27796074|NCT01257737|81082269|FG000|Overall Study|Lost to Follow-up|1|||
27796075|NCT01257737|81082270|FG001|Overall Study|Lost to Follow-up|2|||
27987297|NCT00079677|81783323|FG001|Overall Study|Miscellaneous|0|||
27674957|NCT02514551|80647310|FG001|Overall Study|Lost to Follow-up|1|||
27987298|NCT00498355|81783324|FG000|Overall Study|Lost to Follow-up|1|||
27987299|NCT02516228|81783325|FG000|Overall Study|Lost to Follow-up|1|||
27987300|NCT02516228|81783325|FG000|Overall Study|Withdrawal by Subject|1|||
27987301|NCT02516228|81783325|FG000|Overall Study|Physician Decision|1|||
27987302|NCT02039856|81783328|FG000|Overall Study|Death|5|||
27987303|NCT02039856|81783329|FG001|Overall Study|Death|3|||
27987304|NCT02039856|81783328|FG000|Overall Study|Partial survey completion|61|||
27987305|NCT02039856|81783329|FG001|Overall Study|Partial survey completion|26|||
27987306|NCT02039856|81783328|FG000|Overall Study|Lost to Follow-up|388|||
27987307|NCT02039856|81783329|FG001|Overall Study|Lost to Follow-up|206|||
27987308|NCT02039856|81783328|FG000|Overall Study|Withdrawal by Subject|1573|||
27987309|NCT02039856|81783329|FG001|Overall Study|Withdrawal by Subject|618|||
27987310|NCT00383162|81783330|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
27987311|NCT00383162|81783331|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
27987312|NCT00383162|81783330|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
27987313|NCT00383162|81783331|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
27987314|NCT00383162|81783330|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
27987315|NCT00383162|81783331|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
27987316|NCT00383162|81783330|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
27987317|NCT00383162|81783331|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
27987318|NCT00383162|81783330|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
27987319|NCT00383162|81783331|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
27987320|NCT00383162|81783330|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
27987321|NCT00383162|81783331|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
27987322|NCT00383162|81783330|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
27987323|NCT00383162|81783331|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
27987324|NCT00383162|81783330|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
27987325|NCT00383162|81783331|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
27987326|NCT00383162|81783330|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
27987327|NCT00383162|81783331|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
27578904|NCT03160703|80302975|FG003|Overall Study|Withdrawal by Subject|1|||
27987328|NCT04006392|81783332|FG000|Overall Study|Lost to Follow-up|0|||
27987329|NCT04006392|81783333|FG001|Overall Study|Lost to Follow-up|1|||
27578905|NCT01263873|80302979|FG000|Overall Study|One provider unable to complete numbers|1|||
27987330|NCT01264770|81783334|FG000|Overall Study|Not reported|0|||
27987331|NCT01264770|81783335|FG001|Overall Study|Not reported|0|||
27987332|NCT01264770|81783336|FG002|Overall Study|Not reported|1|||
27987333|NCT01264770|81783337|FG003|Overall Study|Not reported|0|||
27987334|NCT01264770|81783338|FG004|Overall Study|Not reported|0|||
27987335|NCT01264770|81783339|FG005|Overall Study|Not reported|0|||
27987336|NCT01264770|81783334|FG000|Overall Study|e.g., change in circumstances|8|||
27987337|NCT01264770|81783335|FG001|Overall Study|e.g., change in circumstances|3|||
27987338|NCT01264770|81783336|FG002|Overall Study|e.g., change in circumstances|3|||
27987339|NCT01264770|81783337|FG003|Overall Study|e.g., change in circumstances|3|||
27987340|NCT01264770|81783338|FG004|Overall Study|e.g., change in circumstances|4|||
27987341|NCT01264770|81783339|FG005|Overall Study|e.g., change in circumstances|4|||
27987342|NCT01264770|81783334|FG000|Overall Study|Severe non-compliance to protocol|0|||
27578906|NCT01263873|80302980|FG001|Overall Study|One provider unable to complete numbers|1|||
27796076|NCT01257737|81082269|FG000|Overall Study|Liver transplant|1|||
27796077|NCT01257737|81082270|FG001|Overall Study|Liver transplant|0|||
27796078|NCT01257737|81082269|FG000|Overall Study|Relocation out of the country|0|||
27796079|NCT01257737|81082270|FG001|Overall Study|Relocation out of the country|1|||
27796080|NCT01257737|81082269|FG000|Overall Study|Withdrew from study|0|||
27796081|NCT01257737|81082270|FG001|Overall Study|Withdrew from study|1|||
27796082|NCT00962013|81082271|FG000|Overall Study|Did not have surgery|1|||
27796083|NCT00962013|81082271|FG000|Overall Study|Death|8|||
27796084|NCT00962013|81082271|FG000|Overall Study|Lost to Follow-up|12|||
27796085|NCT00962013|81082271|FG000|Overall Study|Unable/Unwilling to return|6|||
27796086|NCT00962013|81082271|FG000|Overall Study|Withdrawal by Subject|8|||
27796087|NCT00962013|81082271|FG000|Overall Study|Removal of study device|3|||
27796088|NCT00962013|81082271|FG000|Overall Study|Site Termination|24|||
27796089|NCT00962013|81082271|FG000|Overall Study|No 5 year evaluation|6|||
27796090|NCT00558831|81082272|FG000|Overall Study|Lost to Follow-up|1|||
27987343|NCT01264770|81783335|FG001|Overall Study|Severe non-compliance to protocol|0|||
27578907|NCT00555438|80302983|FG000|10 Days Post-operative|Death|4|||
27796091|NCT03901352|81085931|FG000|Double-blind Phase|Adverse Event|6|||
27796092|NCT03901352|81085932|FG001|Double-blind Phase|Adverse Event|4|||
27796093|NCT03901352|81085931|FG000|Double-blind Phase|Death|1|||
27796094|NCT03901352|81085932|FG001|Double-blind Phase|Death|0|||
27796095|NCT03901352|81085931|FG000|Double-blind Phase|Lack of Efficacy|0|||
27796096|NCT03901352|81085932|FG001|Double-blind Phase|Lack of Efficacy|1|||
27796097|NCT03901352|81085931|FG000|Double-blind Phase|Protocol Violation|0|||
27796098|NCT03901352|81085932|FG001|Double-blind Phase|Protocol Violation|1|||
27796099|NCT03901352|81085931|FG000|Double-blind Phase|Withdrawal by Subject|10|||
27796100|NCT03901352|81085932|FG001|Double-blind Phase|Withdrawal by Subject|8|||
27796101|NCT03901352|81085931|FG000|Open-label Extension Phase|Adverse Event|24|||
27796102|NCT03901352|81085932|FG001|Open-label Extension Phase|Adverse Event|0|||
27796103|NCT03901352|81085931|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
27796104|NCT03901352|81085932|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
27796105|NCT03901352|81085931|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
27796106|NCT03901352|81085932|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
27796107|NCT03901352|81085931|FG000|Open-label Extension Phase|Other|1|||
27796108|NCT03901352|81085932|FG001|Open-label Extension Phase|Other|0|||
27796109|NCT04935931|81085936|FG000|Overall Study|Withdrawal by Subject|1|||
27796110|NCT02866695|81085937|FG000|Overall Study|Adverse Event|1|||
27796111|NCT02866695|81085937|FG000|Overall Study|Lost to Follow-up|1|||
27796112|NCT00605839|81085938|FG000|Overall Study|Protocol Violation|1|||
27796113|NCT00605839|81085939|FG001|Overall Study|Protocol Violation|0|||
27796114|NCT00605839|81085940|FG002|Overall Study|Protocol Violation|0|||
27796115|NCT03256526|81085945|FG000|Overall Study|Adverse Event|1|||
27796116|NCT03256526|81085946|FG001|Overall Study|Adverse Event|0|||
27796117|NCT03256526|81085947|FG002|Overall Study|Adverse Event|1|||
27796118|NCT03256526|81085945|FG000|Overall Study|Lost to Follow-up|1|||
27796119|NCT03256526|81085946|FG001|Overall Study|Lost to Follow-up|0|||
27796120|NCT03256526|81085947|FG002|Overall Study|Lost to Follow-up|2|||
27796121|NCT01186744|81085948|FG000|Overall Study|Lack of Efficacy|156|||
27578908|NCT00555438|80302983|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
27796122|NCT01186744|81085949|FG001|Overall Study|Lack of Efficacy|99|||
27796123|NCT01186744|81085950|FG002|Overall Study|Lack of Efficacy|0|||
27796124|NCT01186744|81085951|FG003|Overall Study|Lack of Efficacy|2|||
27796125|NCT01186744|81085952|FG004|Overall Study|Lack of Efficacy|2|||
27796126|NCT01186744|81085953|FG005|Overall Study|Lack of Efficacy|5|||
27796127|NCT01186744|81085948|FG000|Overall Study|Protocol Violation|1|||
27796128|NCT01186744|81085949|FG001|Overall Study|Protocol Violation|2|||
27796129|NCT01186744|81085950|FG002|Overall Study|Protocol Violation|0|||
27796130|NCT01186744|81085951|FG003|Overall Study|Protocol Violation|1|||
27987344|NCT01264770|81783336|FG002|Overall Study|Severe non-compliance to protocol|1|||
27987345|NCT01264770|81783337|FG003|Overall Study|Severe non-compliance to protocol|1|||
27987346|NCT01264770|81783338|FG004|Overall Study|Severe non-compliance to protocol|0|||
27987347|NCT01264770|81783339|FG005|Overall Study|Severe non-compliance to protocol|0|||
27796131|NCT01186744|81085952|FG004|Overall Study|Protocol Violation|1|||
27796132|NCT01186744|81085953|FG005|Overall Study|Protocol Violation|2|||
27796133|NCT01186744|81085948|FG000|Overall Study|Lost to Follow-up|15|||
27796134|NCT01186744|81085949|FG001|Overall Study|Lost to Follow-up|16|||
27987348|NCT01264770|81783334|FG000|Overall Study|Lack of therapeutic response|1|||
27987349|NCT01264770|81783335|FG001|Overall Study|Lack of therapeutic response|0|||
27987350|NCT01264770|81783336|FG002|Overall Study|Lack of therapeutic response|2|||
27987351|NCT01264770|81783337|FG003|Overall Study|Lack of therapeutic response|1|||
27987352|NCT01264770|81783338|FG004|Overall Study|Lack of therapeutic response|1|||
27987353|NCT01264770|81783339|FG005|Overall Study|Lack of therapeutic response|0|||
27987354|NCT01264770|81783334|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
27987355|NCT01264770|81783335|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
27987356|NCT01264770|81783336|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
27987357|NCT01264770|81783337|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
27987358|NCT01264770|81783338|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
27987359|NCT01264770|81783339|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
27987360|NCT01264770|81783334|FG000|Overall Study|Lost to Follow-up|0|||
27987361|NCT01264770|81783335|FG001|Overall Study|Lost to Follow-up|0|||
27987362|NCT01264770|81783336|FG002|Overall Study|Lost to Follow-up|1|||
27987363|NCT01264770|81783337|FG003|Overall Study|Lost to Follow-up|1|||
27987364|NCT01264770|81783338|FG004|Overall Study|Lost to Follow-up|0|||
27987365|NCT01264770|81783339|FG005|Overall Study|Lost to Follow-up|0|||
27987366|NCT01264770|81783334|FG000|Overall Study|Adverse Event|7|||
27987367|NCT01264770|81783335|FG001|Overall Study|Adverse Event|7|||
27987368|NCT01264770|81783336|FG002|Overall Study|Adverse Event|8|||
27987369|NCT01264770|81783337|FG003|Overall Study|Adverse Event|0|||
27987370|NCT01264770|81783338|FG004|Overall Study|Adverse Event|2|||
27987371|NCT01264770|81783339|FG005|Overall Study|Adverse Event|1|||
27987372|NCT01439373|81783340|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
27987373|NCT01439373|81783341|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
27987374|NCT01439373|81783340|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
27987375|NCT01439373|81783341|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
27987376|NCT02160145|81783342|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
27987377|NCT02160145|81783343|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
27987378|NCT02160145|81783344|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
27987379|NCT02160145|81783342|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
27987380|NCT02160145|81783343|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
27987381|NCT02160145|81783344|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
27987382|NCT02160145|81783342|FG000|Randomized Double-blind Period|Subject decision|0|||
27987383|NCT02160145|81783343|FG001|Randomized Double-blind Period|Subject decision|21|||
27987384|NCT02160145|81783344|FG002|Randomized Double-blind Period|Subject decision|20|||
27987385|NCT02160145|81783342|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
27987386|NCT02160145|81783343|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
27987387|NCT02160145|81783344|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
27796135|NCT01186744|81085950|FG002|Overall Study|Lost to Follow-up|2|||
27796136|NCT01186744|81085951|FG003|Overall Study|Lost to Follow-up|1|||
27796137|NCT01186744|81085952|FG004|Overall Study|Lost to Follow-up|1|||
27796138|NCT01186744|81085953|FG005|Overall Study|Lost to Follow-up|4|||
27796139|NCT01186744|81085948|FG000|Overall Study|Screen failure|1|||
27796140|NCT01186744|81085949|FG001|Overall Study|Screen failure|1|||
27987388|NCT02160145|81783342|FG000|Randomized Double-blind Period|Physician Decision|0|||
27987389|NCT02160145|81783343|FG001|Randomized Double-blind Period|Physician Decision|7|||
27987390|NCT02160145|81783344|FG002|Randomized Double-blind Period|Physician Decision|5|||
27987391|NCT00699335|81783345|FG000|Overall Study|Combination of multiple reasons|176|||
27987392|NCT00699335|81783345|FG000|Overall Study|Missing data|52|||
27987393|NCT02175368|81783348|FG000|Overall Study|Lost to Follow-up|1|||
27987394|NCT02915978|81787161|FG000|Overall Study|Adverse Event|2|||
27987395|NCT02915978|81787162|FG001|Overall Study|Adverse Event|1|||
27796141|NCT01186744|81085950|FG002|Overall Study|Screen failure|0|||
27796142|NCT01186744|81085951|FG003|Overall Study|Screen failure|1|||
27987396|NCT02915978|81787163|FG002|Overall Study|Adverse Event|0|||
27987397|NCT00167310|81787164|FG000|Overall Study|Protocol Violation|5|||
27987398|NCT00167310|81787165|FG001|Overall Study|Protocol Violation|3|||
27987399|NCT00167310|81787164|FG000|Overall Study|Withdrawal by Subject|3|||
27987400|NCT00167310|81787165|FG001|Overall Study|Withdrawal by Subject|7|||
27578909|NCT02788175|80302986|FG000|Overall Study|Protocol Violation|3|||
27578910|NCT02788175|80302986|FG000|Overall Study|Withdrawal by Subject|4|||
27796143|NCT01186744|81085952|FG004|Overall Study|Screen failure|0|||
27987401|NCT01041287|81787166|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
27987402|NCT01041287|81787167|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
27987403|NCT01041287|81787166|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
27987404|NCT01041287|81787167|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
27987405|NCT05096312|81787168|FG000|Overall Study|Lost to Follow-up|2|||
27796144|NCT01186744|81085953|FG005|Overall Study|Screen failure|0|||
27796145|NCT01186744|81085948|FG000|Overall Study|Withdrawal by Subject|14|||
27796146|NCT01186744|81085949|FG001|Overall Study|Withdrawal by Subject|10|||
27987406|NCT05096312|81787169|FG001|Overall Study|Lost to Follow-up|4|||
27987407|NCT05096312|81787168|FG000|Overall Study|Adverse Event|1|||
27987408|NCT05096312|81787169|FG001|Overall Study|Adverse Event|0|||
27987409|NCT00895310|81787173|FG000|Overall Study|Withdrawal by Subject|1|||
27987410|NCT02461745|81787177|FG000|Overall Study|Lack of Efficacy|9|||
27987411|NCT02461745|81787178|FG001|Overall Study|Lack of Efficacy|1|||
27987412|NCT02461745|81787177|FG000|Overall Study|Lost to Follow-up|2|||
27987413|NCT02461745|81787178|FG001|Overall Study|Lost to Follow-up|2|||
27987414|NCT02461745|81787177|FG000|Overall Study|Withdrawal by Subject|3|||
27987415|NCT02461745|81787178|FG001|Overall Study|Withdrawal by Subject|1|||
27987416|NCT02540668|81787192|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
27987417|NCT02540668|81787193|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
27987418|NCT00599638|81787194|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
27987419|NCT00599638|81787195|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
27987420|NCT00599638|81787196|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
27987421|NCT00599638|81787197|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
27987422|NCT00599638|81787194|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
27987423|NCT00599638|81787195|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
27987424|NCT00599638|81787196|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
27987425|NCT00599638|81787197|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
27987426|NCT00599638|81787194|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
27987427|NCT00599638|81787195|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
27987428|NCT00599638|81787196|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
27987429|NCT00599638|81787197|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
27987430|NCT00599638|81787194|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
27987431|NCT00599638|81787195|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
27987432|NCT00599638|81787196|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
27987433|NCT00599638|81787197|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
27987434|NCT00599638|81787194|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
27987435|NCT00599638|81787195|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
27987436|NCT00599638|81787196|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
27987437|NCT00599638|81787197|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
27987438|NCT00599638|81787194|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
27987439|NCT00599638|81787195|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
27987440|NCT00599638|81787196|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
27987441|NCT00599638|81787197|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
27987442|NCT00599638|81787194|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
27987443|NCT00599638|81787195|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
27987444|NCT00599638|81787196|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
27987445|NCT00599638|81787197|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
27987446|NCT00599638|81787194|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
27987447|NCT00599638|81787195|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
27987448|NCT00599638|81787196|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
27987449|NCT00599638|81787197|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
27987450|NCT00599638|81787194|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
27987451|NCT00599638|81787195|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
27987452|NCT00599638|81787196|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
27987453|NCT00599638|81787197|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
27987454|NCT03208088|81787198|FG000|Period 2|Withdrawal by Subject|0|||
27987455|NCT03208088|81787199|FG001|Period 2|Withdrawal by Subject|0|||
27987456|NCT03208088|81787200|FG002|Period 2|Withdrawal by Subject|0|||
27987457|NCT03208088|81787201|FG003|Period 2|Withdrawal by Subject|0|||
27987458|NCT03208088|81787202|FG004|Period 2|Withdrawal by Subject|0|||
27987459|NCT03208088|81787203|FG005|Period 2|Withdrawal by Subject|0|||
27987460|NCT03208088|81787204|FG006|Period 2|Withdrawal by Subject|0|||
27987461|NCT03208088|81787205|FG007|Period 2|Withdrawal by Subject|0|||
27987462|NCT03208088|81787206|FG008|Period 2|Withdrawal by Subject|1|||
27987463|NCT03208088|81787207|FG009|Period 2|Withdrawal by Subject|0|||
27987464|NCT03208088|81787198|FG000|Period 3|Unsatisfactory Test Article|0|||
27987465|NCT03208088|81787199|FG001|Period 3|Unsatisfactory Test Article|0|||
27987466|NCT03208088|81787200|FG002|Period 3|Unsatisfactory Test Article|0|||
27987467|NCT03208088|81787201|FG003|Period 3|Unsatisfactory Test Article|1|||
27987468|NCT03208088|81787202|FG004|Period 3|Unsatisfactory Test Article|0|||
27987469|NCT03208088|81787203|FG005|Period 3|Unsatisfactory Test Article|0|||
27987470|NCT03208088|81787204|FG006|Period 3|Unsatisfactory Test Article|0|||
27987471|NCT03208088|81787205|FG007|Period 3|Unsatisfactory Test Article|0|||
27987472|NCT03208088|81787206|FG008|Period 3|Unsatisfactory Test Article|0|||
27987473|NCT03208088|81787207|FG009|Period 3|Unsatisfactory Test Article|0|||
27987474|NCT03208088|81787198|FG000|Period 4|Unsatisfactory Test Article|0|||
27987475|NCT03208088|81787199|FG001|Period 4|Unsatisfactory Test Article|0|||
27987476|NCT03208088|81787200|FG002|Period 4|Unsatisfactory Test Article|0|||
27987477|NCT03208088|81787201|FG003|Period 4|Unsatisfactory Test Article|1|||
27987478|NCT03208088|81787202|FG004|Period 4|Unsatisfactory Test Article|0|||
27987479|NCT03208088|81787203|FG005|Period 4|Unsatisfactory Test Article|0|||
27987480|NCT03208088|81787204|FG006|Period 4|Unsatisfactory Test Article|0|||
27987481|NCT03208088|81787205|FG007|Period 4|Unsatisfactory Test Article|0|||
27987482|NCT03208088|81787206|FG008|Period 4|Unsatisfactory Test Article|0|||
27987483|NCT03208088|81787207|FG009|Period 4|Unsatisfactory Test Article|0|||
27987484|NCT02409342|81787208|FG000|Overall Study|Death|211|||
27987485|NCT02409342|81787209|FG001|Overall Study|Death|201|||
27987486|NCT02409342|81787208|FG000|Overall Study|Withdrawal by Subject|24|||
27987487|NCT02409342|81787209|FG001|Overall Study|Withdrawal by Subject|17|||
27987488|NCT02409342|81787208|FG000|Overall Study|Study Terminated By Sponsor|48|||
27987489|NCT02409342|81787209|FG001|Overall Study|Study Terminated By Sponsor|59|||
27987490|NCT02409342|81787208|FG000|Overall Study|Lost to Follow-up|3|||
27987491|NCT02409342|81787209|FG001|Overall Study|Lost to Follow-up|5|||
27987492|NCT02409342|81787208|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
27987493|NCT02409342|81787209|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
27987494|NCT02409342|81787208|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
27987495|NCT02409342|81787209|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
27987496|NCT02409342|81787208|FG000|Overall Study|Sponsor Decision|1|||
27987497|NCT02409342|81787209|FG001|Overall Study|Sponsor Decision|0|||
27987498|NCT02220712|81787211|FG000|Overall Study|Adverse Event|1|||
27987499|NCT02220712|81787211|FG000|Overall Study|Withdrawal by Subject|2|||
27987500|NCT02220712|81787211|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
27987501|NCT02986854|81787212|FG000|Overall Study|Withdrawal by Subject|0|||
27987502|NCT02986854|81787213|FG001|Overall Study|Withdrawal by Subject|1|||
27987503|NCT02986854|81787214|FG002|Overall Study|Withdrawal by Subject|1|||
27987504|NCT02986854|81787212|FG000|Overall Study|Lost to Follow-up|3|||
27987505|NCT02986854|81787213|FG001|Overall Study|Lost to Follow-up|11|||
27987506|NCT02986854|81787214|FG002|Overall Study|Lost to Follow-up|2|||
27987507|NCT02353728|81787218|FG000|Overall Study|Subject non-compliance|1|||
27987508|NCT00238238|81787219|FG000|Overall Study|Withdrawal by Subject|0|||
27987509|NCT00238238|81787220|FG001|Overall Study|Withdrawal by Subject|3|||
27987510|NCT00238238|81787221|FG002|Overall Study|Withdrawal by Subject|0|||
27987511|NCT00545103|81787222|FG000|Overall Study|Lack of Efficacy|48|||
27987512|NCT00545103|81787223|FG001|Overall Study|Lack of Efficacy|45|||
27796147|NCT01186744|81085950|FG002|Overall Study|Withdrawal by Subject|2|||
27796148|NCT01186744|81085951|FG003|Overall Study|Withdrawal by Subject|5|||
27796149|NCT01186744|81085952|FG004|Overall Study|Withdrawal by Subject|0|||
27796150|NCT01186744|81085953|FG005|Overall Study|Withdrawal by Subject|6|||
27796151|NCT01186744|81085948|FG000|Overall Study|Study terminated by Sponsor|1|||
27796152|NCT01186744|81085949|FG001|Overall Study|Study terminated by Sponsor|0|||
27796153|NCT01186744|81085950|FG002|Overall Study|Study terminated by Sponsor|0|||
27796154|NCT01186744|81085951|FG003|Overall Study|Study terminated by Sponsor|0|||
27796155|NCT01186744|81085952|FG004|Overall Study|Study terminated by Sponsor|0|||
27796156|NCT01186744|81085953|FG005|Overall Study|Study terminated by Sponsor|0|||
27796157|NCT01186744|81085948|FG000|Overall Study|Other|9|||
27796158|NCT01186744|81085949|FG001|Overall Study|Other|10|||
27796159|NCT01186744|81085950|FG002|Overall Study|Other|1|||
27796160|NCT01186744|81085951|FG003|Overall Study|Other|2|||
27796161|NCT01186744|81085952|FG004|Overall Study|Other|1|||
27796162|NCT01186744|81085953|FG005|Overall Study|Other|5|||
27796163|NCT01186744|81085948|FG000|Overall Study|Adverse Event|10|||
27796164|NCT01186744|81085949|FG001|Overall Study|Adverse Event|14|||
27796165|NCT01186744|81085950|FG002|Overall Study|Adverse Event|1|||
27796166|NCT01186744|81085951|FG003|Overall Study|Adverse Event|0|||
27796167|NCT01186744|81085952|FG004|Overall Study|Adverse Event|1|||
27796168|NCT01186744|81085953|FG005|Overall Study|Adverse Event|4|||
27796169|NCT01186744|81085948|FG000|Overall Study|Death|1|||
27796170|NCT01186744|81085949|FG001|Overall Study|Death|0|||
27796171|NCT01186744|81085950|FG002|Overall Study|Death|0|||
27796172|NCT01186744|81085951|FG003|Overall Study|Death|0|||
27869687|NCT03888066|81357784|FG000|Run-in Phase|Physician Decision|1|||
27987513|NCT00545103|81787224|FG002|Overall Study|Lack of Efficacy|31|||
27987514|NCT00545103|81787225|FG003|Overall Study|Lack of Efficacy|27|||
27987515|NCT00545103|81787222|FG000|Overall Study|Withdrawal by Subject|6|||
27987516|NCT00545103|81787223|FG001|Overall Study|Withdrawal by Subject|10|||
27987517|NCT00545103|81787224|FG002|Overall Study|Withdrawal by Subject|18|||
27987518|NCT00545103|81787225|FG003|Overall Study|Withdrawal by Subject|22|||
27796173|NCT01186744|81085952|FG004|Overall Study|Death|0|||
27796174|NCT01186744|81085953|FG005|Overall Study|Death|0|||
27987519|NCT00545103|81787222|FG000|Overall Study|Adverse Event|11|||
27987520|NCT00545103|81787223|FG001|Overall Study|Adverse Event|12|||
27987521|NCT00545103|81787224|FG002|Overall Study|Adverse Event|17|||
27796175|NCT01721200|81085954|FG000|Overall Study|Lost to Follow-up|3|||
27796176|NCT01721200|81085955|FG001|Overall Study|Lost to Follow-up|5|||
27796177|NCT00518531|81085956|FG000|Treatment Period 1|Adverse Event|5|||
27796178|NCT00518531|81085957|FG001|Treatment Period 1|Adverse Event|0|||
27987522|NCT00545103|81787225|FG003|Overall Study|Adverse Event|10|||
27987523|NCT00545103|81787222|FG000|Overall Study|Lost to Follow-up|4|||
27987524|NCT00545103|81787223|FG001|Overall Study|Lost to Follow-up|6|||
27987525|NCT00545103|81787224|FG002|Overall Study|Lost to Follow-up|3|||
27987526|NCT00545103|81787225|FG003|Overall Study|Lost to Follow-up|4|||
27987527|NCT00545103|81787222|FG000|Overall Study|Protocol Violation|1|||
27987528|NCT00545103|81787223|FG001|Overall Study|Protocol Violation|2|||
27987529|NCT00545103|81787224|FG002|Overall Study|Protocol Violation|3|||
27987530|NCT00545103|81787225|FG003|Overall Study|Protocol Violation|0|||
27987531|NCT00545103|81787222|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
27987532|NCT00545103|81787223|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
27987533|NCT00545103|81787224|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
27987534|NCT00545103|81787225|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
27987535|NCT00545103|81787222|FG000|Overall Study|Difficult to open package|0|||
27987536|NCT00545103|81787223|FG001|Overall Study|Difficult to open package|0|||
27987537|NCT00545103|81787224|FG002|Overall Study|Difficult to open package|0|||
27987538|NCT00545103|81787225|FG003|Overall Study|Difficult to open package|1|||
27987539|NCT00545103|81787222|FG000|Overall Study|Investigational product not taken|1|||
27987540|NCT00545103|81787223|FG001|Overall Study|Investigational product not taken|0|||
27987541|NCT00545103|81787224|FG002|Overall Study|Investigational product not taken|0|||
27987542|NCT00545103|81787225|FG003|Overall Study|Investigational product not taken|1|||
27987543|NCT00545103|81787222|FG000|Overall Study|Wish to start a family|0|||
27987544|NCT00545103|81787223|FG001|Overall Study|Wish to start a family|0|||
27987545|NCT00545103|81787224|FG002|Overall Study|Wish to start a family|0|||
27987546|NCT00545103|81787225|FG003|Overall Study|Wish to start a family|1|||
27987547|NCT00545103|81787222|FG000|Overall Study|Diverticulitis crisis|0|||
27987548|NCT00545103|81787223|FG001|Overall Study|Diverticulitis crisis|0|||
27987549|NCT00545103|81787224|FG002|Overall Study|Diverticulitis crisis|0|||
27987550|NCT00545103|81787225|FG003|Overall Study|Diverticulitis crisis|1|||
27987551|NCT00545103|81787222|FG000|Overall Study|Personal reasons|1|||
27987552|NCT00545103|81787223|FG001|Overall Study|Personal reasons|0|||
27987553|NCT00545103|81787224|FG002|Overall Study|Personal reasons|0|||
27987554|NCT00545103|81787225|FG003|Overall Study|Personal reasons|0|||
27987555|NCT00545103|81787222|FG000|Overall Study|Subject's decision|1|||
27987556|NCT00545103|81787223|FG001|Overall Study|Subject's decision|0|||
27987557|NCT00545103|81787224|FG002|Overall Study|Subject's decision|0|||
27987558|NCT00545103|81787225|FG003|Overall Study|Subject's decision|0|||
27987559|NCT00545103|81787222|FG000|Overall Study|Noncompliance|0|||
27987560|NCT00545103|81787223|FG001|Overall Study|Noncompliance|1|||
27987561|NCT00545103|81787224|FG002|Overall Study|Noncompliance|0|||
27987562|NCT00545103|81787225|FG003|Overall Study|Noncompliance|0|||
27987563|NCT00545103|81787222|FG000|Overall Study|Investigator decision|0|||
27987564|NCT00545103|81787223|FG001|Overall Study|Investigator decision|0|||
27987565|NCT00545103|81787224|FG002|Overall Study|Investigator decision|1|||
27987566|NCT00545103|81787225|FG003|Overall Study|Investigator decision|0|||
27987567|NCT00545103|81787222|FG000|Overall Study|Subject moved|0|||
27987568|NCT00545103|81787223|FG001|Overall Study|Subject moved|1|||
27674958|NCT02514551|80647309|FG000|Overall Study|Participant Never Treated|0|||
27674959|NCT02514551|80647310|FG001|Overall Study|Participant Never Treated|2|||
27674960|NCT00664534|80647311|FG000|Overall Study|Adverse Event|2|||
27674961|NCT00664534|80647312|FG001|Overall Study|Adverse Event|3|||
27674962|NCT00664534|80647311|FG000|Overall Study|Lost to Follow-up|6|||
27674963|NCT00664534|80647312|FG001|Overall Study|Lost to Follow-up|10|||
27674964|NCT00664534|80647311|FG000|Overall Study|Protocol Violation|10|||
27674965|NCT00664534|80647312|FG001|Overall Study|Protocol Violation|8|||
27674966|NCT00664534|80647311|FG000|Overall Study|Withdrawal by Subject|7|||
27674967|NCT00664534|80647312|FG001|Overall Study|Withdrawal by Subject|6|||
27674968|NCT00664534|80647311|FG000|Overall Study|Physician Decision|8|||
27674969|NCT00664534|80647312|FG001|Overall Study|Physician Decision|0|||
27674970|NCT00664534|80647311|FG000|Overall Study|Sponsor decision|8|||
27674971|NCT00664534|80647312|FG001|Overall Study|Sponsor decision|6|||
27674972|NCT02638103|80647313|FG000|Overall Study|Adverse Event|13|||
27674973|NCT02638103|80647314|FG001|Overall Study|Adverse Event|12|||
27987569|NCT00545103|81787224|FG002|Overall Study|Subject moved|0|||
27987570|NCT00545103|81787225|FG003|Overall Study|Subject moved|0|||
27987571|NCT00545103|81787222|FG000|Overall Study|Use of prohibited medication|0|||
27987572|NCT00545103|81787223|FG001|Overall Study|Use of prohibited medication|0|||
27674974|NCT02638103|80647315|FG002|Overall Study|Adverse Event|19|||
27674975|NCT02638103|80647316|FG003|Overall Study|Adverse Event|12|||
27674976|NCT02638103|80647313|FG000|Overall Study|Withdrawal by Subject|43|||
27674977|NCT02638103|80647314|FG001|Overall Study|Withdrawal by Subject|53|||
27674978|NCT02638103|80647315|FG002|Overall Study|Withdrawal by Subject|30|||
27674979|NCT02638103|80647316|FG003|Overall Study|Withdrawal by Subject|61|||
27674980|NCT02638103|80647313|FG000|Overall Study|Protocol Violation|1|||
27674981|NCT02638103|80647314|FG001|Overall Study|Protocol Violation|2|||
27674982|NCT02638103|80647315|FG002|Overall Study|Protocol Violation|1|||
27674983|NCT02638103|80647316|FG003|Overall Study|Protocol Violation|4|||
27578911|NCT02788175|80302986|FG000|Overall Study|Ineligible prior to study agent|6|||
27578912|NCT01310413|80302987|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
27796179|NCT00518531|81085956|FG000|Treatment Period 1|Lost to Follow-up|5|||
27796180|NCT00518531|81085957|FG001|Treatment Period 1|Lost to Follow-up|3|||
27796181|NCT00518531|81085956|FG000|Treatment Period 1|Physician Decision|1|||
27796182|NCT00518531|81085957|FG001|Treatment Period 1|Physician Decision|0|||
27796183|NCT00518531|81085956|FG000|Treatment Period 1|Protocol Violation|2|||
27796184|NCT00518531|81085957|FG001|Treatment Period 1|Protocol Violation|0|||
27796185|NCT00518531|81085956|FG000|Treatment Period 1|Withdrawal by Subject|4|||
27796186|NCT00518531|81085957|FG001|Treatment Period 1|Withdrawal by Subject|6|||
27796187|NCT00518531|81085956|FG000|Treatment Period 1|Early crossover|1|||
27796188|NCT00518531|81085957|FG001|Treatment Period 1|Early crossover|3|||
27796189|NCT00518531|81085956|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27796190|NCT00518531|81085957|FG001|Treatment Period 2|Withdrawal by Subject|8|||
27796191|NCT00518531|81085956|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
27796192|NCT00518531|81085957|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
27796193|NCT00518531|81085956|FG000|Treatment Period 2|Adverse Event|1|||
27796194|NCT00518531|81085957|FG001|Treatment Period 2|Adverse Event|7|||
27796195|NCT00518531|81085956|FG000|Treatment Period 2|Protocol-specified criteria|0|||
27796196|NCT00518531|81085957|FG001|Treatment Period 2|Protocol-specified criteria|1|||
27796197|NCT00518531|81085956|FG000|Treatment Period 2|Non-compliance|1|||
27796198|NCT00518531|81085957|FG001|Treatment Period 2|Non-compliance|2|||
27796199|NCT02998645|81085958|FG000|Treatment Period 1|Adverse Event|6|||
27796200|NCT02998645|81085958|FG000|Treatment Period 1|Death|5|||
27796201|NCT02998645|81085958|FG000|Treatment Period 1|Technical Problems|4|||
27796202|NCT02998645|81085958|FG000|Treatment Period 1|Lack of Efficacy|2|||
27796203|NCT02998645|81085958|FG000|Treatment Period 1|Progressive disease|1|||
27869688|NCT03888066|81357785|FG001|Run-in Phase|Physician Decision|0|||
27869689|NCT03888066|81357784|FG000|Run-in Phase|Protocol Violation|13|||
27869690|NCT03888066|81357785|FG001|Run-in Phase|Protocol Violation|0|||
27674984|NCT02638103|80647313|FG000|Overall Study|Pregnancy|2|||
27674985|NCT02638103|80647314|FG001|Overall Study|Pregnancy|3|||
27869691|NCT03888066|81357784|FG000|Run-in Phase|Sponsor Request|34|||
27869692|NCT03888066|81357785|FG001|Run-in Phase|Sponsor Request|0|||
27796204|NCT02998645|81085958|FG000|Treatment Period 1|Subject/guardian decision|1|||
27796205|NCT02998645|81085958|FG000|Treatment Period 2|Lack of Efficacy|5|||
27796206|NCT02998645|81085958|FG000|Treatment Period 2|Adverse Event|2|||
27796207|NCT02998645|81085958|FG000|Treatment Period 2|Progressive disease|2|||
27796208|NCT02998645|81085958|FG000|Treatment Period 2|Physician Decision|1|||
27869693|NCT03888066|81357784|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
27796209|NCT01126359|81085959|FG000|First Intervention (20-minutes)|Physician Decision|0|||
27796210|NCT01126359|81085960|FG001|First Intervention (20-minutes)|Physician Decision|1|||
27796211|NCT02641730|81085961|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
27796212|NCT02641730|81085962|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27796213|NCT02641730|81085963|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27796214|NCT02641730|81085964|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
27796215|NCT02641730|81085965|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
27796216|NCT02641730|81085961|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27796217|NCT02641730|81085962|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
27796218|NCT02641730|81085963|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
27796219|NCT02641730|81085964|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
27796220|NCT02641730|81085965|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
27796221|NCT02641730|81085961|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
27796222|NCT02641730|81085962|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
27796223|NCT02641730|81085963|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
27796224|NCT02641730|81085964|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
27987573|NCT00545103|81787224|FG002|Overall Study|Use of prohibited medication|1|||
27987574|NCT00545103|81787225|FG003|Overall Study|Use of prohibited medication|0|||
27987575|NCT00545103|81787222|FG000|Overall Study|Does not want to take study drug anymore|1|||
27987576|NCT00545103|81787223|FG001|Overall Study|Does not want to take study drug anymore|0|||
27987577|NCT00545103|81787224|FG002|Overall Study|Does not want to take study drug anymore|1|||
27987578|NCT00545103|81787225|FG003|Overall Study|Does not want to take study drug anymore|0|||
27987579|NCT00545103|81787222|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
27987580|NCT00545103|81787223|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
27987581|NCT00545103|81787224|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
27987582|NCT00545103|81787225|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
27987583|NCT00545103|81787222|FG000|Overall Study|Death|0|||
27987584|NCT00545103|81787223|FG001|Overall Study|Death|1|||
27987585|NCT00545103|81787224|FG002|Overall Study|Death|0|||
27987586|NCT00545103|81787225|FG003|Overall Study|Death|0|||
27987587|NCT01918332|81787226|FG000|Overall Study|Adverse Event|0|||
27987588|NCT01918332|81787227|FG001|Overall Study|Adverse Event|0|||
27987589|NCT01918332|81787228|FG002|Overall Study|Adverse Event|0|||
27987590|NCT01918332|81787229|FG003|Overall Study|Adverse Event|1|||
27987591|NCT01918332|81787226|FG000|Overall Study|Withdrawal by Subject|2|||
27987592|NCT01918332|81787227|FG001|Overall Study|Withdrawal by Subject|3|||
27987593|NCT01918332|81787228|FG002|Overall Study|Withdrawal by Subject|2|||
27987594|NCT01918332|81787229|FG003|Overall Study|Withdrawal by Subject|3|||
27987595|NCT01918332|81787226|FG000|Overall Study|Protocol Violation|6|||
27987596|NCT01918332|81787227|FG001|Overall Study|Protocol Violation|2|||
27987597|NCT01918332|81787228|FG002|Overall Study|Protocol Violation|6|||
27987598|NCT01918332|81787229|FG003|Overall Study|Protocol Violation|3|||
27987599|NCT01918332|81787226|FG000|Overall Study|lipid result by central lab did not meet|0|||
27987600|NCT01918332|81787227|FG001|Overall Study|lipid result by central lab did not meet|0|||
27987601|NCT01918332|81787228|FG002|Overall Study|lipid result by central lab did not meet|1|||
27987602|NCT01918332|81787229|FG003|Overall Study|lipid result by central lab did not meet|0|||
27796225|NCT02641730|81085965|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
27796226|NCT02641730|81085961|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27796227|NCT02641730|81085962|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27796228|NCT02641730|81085963|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27796229|NCT02641730|81085964|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
27796230|NCT02641730|81085965|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
27796231|NCT02641730|81085961|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
27796232|NCT02641730|81085962|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
27796233|NCT02641730|81085963|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
27796234|NCT02641730|81085964|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
27796235|NCT02641730|81085965|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
27796236|NCT02641730|81085961|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
27796237|NCT02641730|81085962|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
27796238|NCT02641730|81085963|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
27796239|NCT02641730|81085964|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
27869694|NCT03888066|81357785|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
27796240|NCT02641730|81085965|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
27869695|NCT03888066|81357784|FG000|Run-in Phase|Withdrawal Of Consent|1|||
27987603|NCT02708485|81787230|FG000|Overall Study|Withdrawal by Subject|3|||
27987604|NCT02708485|81787231|FG001|Overall Study|Withdrawal by Subject|2|||
27987605|NCT02104947|81787232|FG000|Overall Study|Withdrawal by Subject|10|||
27987606|NCT02104947|81787233|FG001|Overall Study|Withdrawal by Subject|3|||
27987607|NCT02104947|81787232|FG000|Overall Study|Lost to Follow-up|4|||
27796241|NCT01977482|81085966|FG000|Overall Study|Adverse Event|0|||
27796242|NCT01977482|81085967|FG001|Overall Study|Adverse Event|1|||
27796243|NCT01977482|81085968|FG002|Overall Study|Adverse Event|1|||
27796244|NCT01977482|81085969|FG003|Overall Study|Adverse Event|0|||
27796245|NCT01977482|81085970|FG004|Overall Study|Adverse Event|2|||
27796246|NCT01977482|81085971|FG005|Overall Study|Adverse Event|0|||
27796247|NCT01977482|81085966|FG000|Overall Study|Lost to Follow-up|1|||
27796248|NCT01977482|81085967|FG001|Overall Study|Lost to Follow-up|0|||
27796249|NCT01977482|81085968|FG002|Overall Study|Lost to Follow-up|0|||
27796250|NCT01977482|81085969|FG003|Overall Study|Lost to Follow-up|0|||
27796251|NCT01977482|81085970|FG004|Overall Study|Lost to Follow-up|0|||
27796252|NCT01977482|81085971|FG005|Overall Study|Lost to Follow-up|0|||
27796253|NCT01977482|81085966|FG000|Overall Study|Physician Decision|0|||
27987608|NCT02104947|81787233|FG001|Overall Study|Lost to Follow-up|4|||
27987609|NCT02104947|81787232|FG000|Overall Study|Protocol Violation|6|||
27987610|NCT02104947|81787233|FG001|Overall Study|Protocol Violation|8|||
27987611|NCT02104947|81787232|FG000|Overall Study|Adverse Event|57|||
27987612|NCT02104947|81787233|FG001|Overall Study|Adverse Event|38|||
27987613|NCT02104947|81787232|FG000|Overall Study|Other than stated above|2|||
27987614|NCT02104947|81787233|FG001|Overall Study|Other than stated above|3|||
27987615|NCT02725866|81787238|FG000|Overall Study|Failure to return|6|||
27987616|NCT02725866|81787238|FG000|Overall Study|Withdrew consent|3|||
27987617|NCT02725866|81787238|FG000|Overall Study|Insufficient virological response|1|||
27987618|NCT02725866|81787238|FG000|Overall Study|Other, not specified|4|||
27796254|NCT01977482|81085967|FG001|Overall Study|Physician Decision|1|||
27869696|NCT03888066|81357785|FG001|Run-in Phase|Withdrawal Of Consent|0|||
27869697|NCT03888066|81357784|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
27869698|NCT03888066|81357785|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
27869699|NCT03888066|81357784|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
27869700|NCT03888066|81357785|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
27869701|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
27869702|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
27869703|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
27869704|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
27987619|NCT01620944|81787239|FG000|Overall Study|Early termination of Study|2|||
27987620|NCT01620944|81787240|FG001|Overall Study|Early termination of Study|1|||
27796255|NCT01977482|81085968|FG002|Overall Study|Physician Decision|0|||
27796256|NCT01977482|81085969|FG003|Overall Study|Physician Decision|0|||
27796257|NCT01977482|81085970|FG004|Overall Study|Physician Decision|0|||
27869705|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
27869706|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
27987621|NCT01229449|81787241|FG000|Overall Study|Withdrawal by Subject|0|||
27987622|NCT01229449|81787242|FG001|Overall Study|Withdrawal by Subject|3|||
27796258|NCT01977482|81085971|FG005|Overall Study|Physician Decision|0|||
27796259|NCT01977482|81085966|FG000|Overall Study|Protocol Violation|0|||
27796260|NCT01977482|81085967|FG001|Overall Study|Protocol Violation|0|||
27796261|NCT01977482|81085968|FG002|Overall Study|Protocol Violation|1|||
27869707|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
27869708|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
27869709|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
27869710|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
27869711|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
27869712|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
27869713|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
27869714|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
27869715|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
27869716|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
27869717|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
27869718|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
27869719|NCT03888066|81357784|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
27869720|NCT03888066|81357785|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
27869721|NCT04113018|81357786|FG000|Overall Study|Death|2|||
27869722|NCT04113018|81357786|FG000|Overall Study|Lost to Follow-up|1|||
27869723|NCT04113018|81357786|FG000|Overall Study|Still On Study (on study treatment)|24|||
27869724|NCT04113018|81357786|FG000|Overall Study|Still On Study (in follow up)|12|||
27869725|NCT00362336|81357793|FG000|Overall Study|Serious Adverse Event|1|||
27869726|NCT00362336|81357794|FG001|Overall Study|Serious Adverse Event|0|||
27869727|NCT00362336|81357795|FG002|Overall Study|Serious Adverse Event|1|||
27869728|NCT00362336|81357793|FG000|Overall Study|Protocol Violation|0|||
27869729|NCT00362336|81357794|FG001|Overall Study|Protocol Violation|0|||
27869730|NCT00362336|81357795|FG002|Overall Study|Protocol Violation|1|||
27869731|NCT00362336|81357793|FG000|Overall Study|Lost to Follow-up|6|||
27869732|NCT00362336|81357794|FG001|Overall Study|Lost to Follow-up|4|||
27796262|NCT01977482|81085969|FG003|Overall Study|Protocol Violation|0|||
27796263|NCT01977482|81085970|FG004|Overall Study|Protocol Violation|0|||
27796264|NCT01977482|81085971|FG005|Overall Study|Protocol Violation|0|||
27796265|NCT01977482|81085966|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
27796266|NCT01977482|81085967|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
27796267|NCT01977482|81085968|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
27796268|NCT01977482|81085969|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
27796269|NCT01977482|81085970|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
27796270|NCT01977482|81085971|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
27796271|NCT01977482|81085966|FG000|Overall Study|Withdrawal by Subject|2|||
27796272|NCT01977482|81085967|FG001|Overall Study|Withdrawal by Subject|4|||
27796273|NCT01977482|81085968|FG002|Overall Study|Withdrawal by Subject|1|||
27796274|NCT01977482|81085969|FG003|Overall Study|Withdrawal by Subject|3|||
27796275|NCT01977482|81085970|FG004|Overall Study|Withdrawal by Subject|1|||
27869733|NCT00362336|81357795|FG002|Overall Study|Lost to Follow-up|0|||
27869734|NCT00362336|81357793|FG000|Overall Study|Withdrawal by Subject|3|||
27796276|NCT01977482|81085971|FG005|Overall Study|Withdrawal by Subject|5|||
27796277|NCT00447265|81085972|FG000|Overall Study|Physician Decision|1|||
27869735|NCT00362336|81357794|FG001|Overall Study|Withdrawal by Subject|3|||
27869736|NCT00362336|81357795|FG002|Overall Study|Withdrawal by Subject|1|||
27869737|NCT00711243|81357796|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
27869738|NCT00711243|81357797|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
27869739|NCT00711243|81357798|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
27869740|NCT00711243|81357799|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
27869741|NCT00711243|81357800|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
27869742|NCT00711243|81357801|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
27869743|NCT00711243|81357796|FG000|Reached First Response/4 Cycles|Death|0|||
27869744|NCT00711243|81357797|FG001|Reached First Response/4 Cycles|Death|0|||
27869745|NCT00711243|81357798|FG002|Reached First Response/4 Cycles|Death|0|||
27869746|NCT00711243|81357799|FG003|Reached First Response/4 Cycles|Death|0|||
27869747|NCT00711243|81357800|FG004|Reached First Response/4 Cycles|Death|0|||
27869748|NCT00711243|81357801|FG005|Reached First Response/4 Cycles|Death|2|||
27796278|NCT00447265|81085973|FG001|Overall Study|Physician Decision|0|||
27796279|NCT00557830|81085977|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
27796280|NCT00557830|81085978|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
27796281|NCT00557830|81085979|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
27796282|NCT00557830|81085977|FG000|Screening Treatment Phase|Adverse Event|2|||
27796283|NCT00557830|81085978|FG001|Screening Treatment Phase|Adverse Event|0|||
27796284|NCT00557830|81085979|FG002|Screening Treatment Phase|Adverse Event|0|||
27987623|NCT01229449|81787243|FG002|Overall Study|Withdrawal by Subject|0|||
27987624|NCT01229449|81787244|FG003|Overall Study|Withdrawal by Subject|1|||
27987625|NCT01229449|81787245|FG004|Overall Study|Withdrawal by Subject|1|||
27987626|NCT01229449|81787241|FG000|Overall Study|Lost to Follow-up|1|||
27987627|NCT01229449|81787242|FG001|Overall Study|Lost to Follow-up|1|||
27987628|NCT01229449|81787243|FG002|Overall Study|Lost to Follow-up|1|||
27987629|NCT01229449|81787244|FG003|Overall Study|Lost to Follow-up|0|||
27796285|NCT00557830|81085977|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
27796286|NCT00557830|81085978|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
27796287|NCT00557830|81085979|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
27796288|NCT02842086|81085980|FG000|Overall Study|Randomized but Never Treated|6|||
27987630|NCT01229449|81787245|FG004|Overall Study|Lost to Follow-up|0|||
27987631|NCT01229449|81787241|FG000|Overall Study|Physician Decision|0|||
27987632|NCT01229449|81787242|FG001|Overall Study|Physician Decision|0|||
27987633|NCT01229449|81787243|FG002|Overall Study|Physician Decision|1|||
27987634|NCT01229449|81787244|FG003|Overall Study|Physician Decision|0|||
27674986|NCT02638103|80647315|FG002|Overall Study|Pregnancy|0|||
27796289|NCT02842086|81085981|FG001|Overall Study|Randomized but Never Treated|6|||
27796290|NCT02842086|81085980|FG000|Overall Study|Still in Double-Blind Phase|7|||
27796291|NCT02842086|81085981|FG001|Overall Study|Still in Double-Blind Phase|3|||
27796292|NCT02842086|81085980|FG000|Overall Study|Adverse Event|18|||
27796293|NCT02842086|81085981|FG001|Overall Study|Adverse Event|20|||
27869749|NCT00711243|81357796|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
27869750|NCT00711243|81357797|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
27869751|NCT00711243|81357798|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
27869752|NCT00711243|81357799|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
27869753|NCT00711243|81357800|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
27869754|NCT00711243|81357801|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
27869755|NCT00711243|81357796|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
27869756|NCT00711243|81357797|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
27869757|NCT00711243|81357798|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
27869758|NCT00711243|81357799|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
27987635|NCT01229449|81787245|FG004|Overall Study|Physician Decision|0|||
27987636|NCT01113580|81787246|FG000|Overall Study|Protocol Violation|1|||
27987637|NCT01113580|81787247|FG001|Overall Study|Protocol Violation|0|||
27796294|NCT02842086|81085980|FG000|Overall Study|Death|3|||
27796295|NCT02842086|81085981|FG001|Overall Study|Death|3|||
27796296|NCT02842086|81085980|FG000|Overall Study|Investigator's Discretion|9|||
27987638|NCT02974842|81787248|FG000|Overall Study|Withdrawal by Subject|4|||
27987639|NCT02974842|81787248|FG000|Overall Study|Screen failures|4|||
27987640|NCT00852241|81787249|FG000|Overall Study|Physician Decision|18|||
27987641|NCT03916484|81787250|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
27674987|NCT02638103|80647316|FG003|Overall Study|Pregnancy|1|||
27796297|NCT02842086|81085981|FG001|Overall Study|Investigator's Discretion|13|||
27796298|NCT02842086|81085980|FG000|Overall Study|Non-Compliance with Study Drug|9|||
27796299|NCT02842086|81085981|FG001|Overall Study|Non-Compliance with Study Drug|8|||
27796300|NCT02842086|81085980|FG000|Overall Study|Protocol Violation|8|||
27796301|NCT02842086|81085981|FG001|Overall Study|Protocol Violation|4|||
27796302|NCT02842086|81085980|FG000|Overall Study|Withdrew Consent|205|||
27796303|NCT02842086|81085981|FG001|Overall Study|Withdrew Consent|194|||
27796304|NCT02842086|81085980|FG000|Overall Study|Lost to Follow-up|274|||
27796305|NCT02842086|81085981|FG001|Overall Study|Lost to Follow-up|236|||
27796306|NCT02842086|81085980|FG000|Overall Study|HIV-1 Infection|5|||
27796307|NCT02842086|81085981|FG001|Overall Study|HIV-1 Infection|6|||
27796308|NCT00806416|81085982|FG000|Period 1 - Part I|Adverse Event|0|||
27869759|NCT00711243|81357800|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
27869760|NCT00711243|81357801|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
27869761|NCT00711243|81357796|FG000|Treated Cycle 5 After First Response|Death|0|||
27869762|NCT00711243|81357797|FG001|Treated Cycle 5 After First Response|Death|0|||
27869763|NCT00711243|81357798|FG002|Treated Cycle 5 After First Response|Death|0|||
27869764|NCT00711243|81357799|FG003|Treated Cycle 5 After First Response|Death|0|||
27869765|NCT00711243|81357800|FG004|Treated Cycle 5 After First Response|Death|0|||
27869766|NCT00711243|81357801|FG005|Treated Cycle 5 After First Response|Death|2|||
27869767|NCT00711243|81357796|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
27869768|NCT00711243|81357797|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
27869769|NCT00711243|81357798|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
27869770|NCT00711243|81357799|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
27869771|NCT00711243|81357800|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
27869772|NCT00711243|81357801|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
27869773|NCT00711243|81357796|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
27796309|NCT00806416|81085983|FG001|Period 1 - Part I|Adverse Event|1|||
27796310|NCT00806416|81085984|FG002|Period 1 - Part I|Adverse Event|0|||
27796311|NCT00806416|81085985|FG003|Period 1 - Part I|Adverse Event|0|||
27796312|NCT00806416|81085982|FG000|Period 1 - Part I|Lost to Follow-up|0|||
27796313|NCT00806416|81085983|FG001|Period 1 - Part I|Lost to Follow-up|2|||
27796314|NCT00806416|81085984|FG002|Period 1 - Part I|Lost to Follow-up|0|||
27796315|NCT00806416|81085985|FG003|Period 1 - Part I|Lost to Follow-up|0|||
27796316|NCT00806416|81085982|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
27796317|NCT00806416|81085983|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
27796318|NCT00806416|81085984|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
27796319|NCT00806416|81085985|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
27796320|NCT00806416|81085982|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
27796321|NCT00806416|81085983|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
27796322|NCT00806416|81085984|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
27796323|NCT00806416|81085985|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
27796324|NCT00826176|81085986|FG000|Overall Study|Lost to Follow-up|1|||
27796325|NCT00826176|81085987|FG001|Overall Study|Lost to Follow-up|0|||
27796326|NCT00826176|81085986|FG000|Overall Study|Subject Withdrew Consent|3|||
27796327|NCT00826176|81085987|FG001|Overall Study|Subject Withdrew Consent|0|||
27796328|NCT00826176|81085986|FG000|Overall Study|Administrative|9|||
27796329|NCT00826176|81085987|FG001|Overall Study|Administrative|0|||
27796330|NCT04797637|81085988|FG000|Overall Study|Lost to Follow-up|23|||
27796331|NCT04797637|81085989|FG001|Overall Study|Lost to Follow-up|32|||
27796332|NCT04797637|81085988|FG000|Overall Study|Withdrawal by Subject|0|||
27796333|NCT04797637|81085989|FG001|Overall Study|Withdrawal by Subject|1|||
27796334|NCT00518011|81085996|FG000|Overall Study|Death|1|||
27796335|NCT00518011|81085997|FG001|Overall Study|Death|1|||
27796336|NCT00518011|81085996|FG000|Overall Study|Adverse Event|2|||
27796337|NCT00518011|81085997|FG001|Overall Study|Adverse Event|3|||
27869774|NCT00711243|81357797|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
27869775|NCT00711243|81357798|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
27869776|NCT00711243|81357799|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
27987642|NCT03916484|81787251|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
27987643|NCT03916484|81787252|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
27987644|NCT03916484|81787253|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
27987645|NCT03916484|81787250|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
27987646|NCT03916484|81787251|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
27987647|NCT03916484|81787252|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
27987648|NCT03916484|81787253|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
27674988|NCT02638103|80647313|FG000|Overall Study|Non-compliance to Study Procedures|2|||
27796338|NCT00518011|81085996|FG000|Overall Study|Disease Progression|2|||
27796339|NCT00518011|81085997|FG001|Overall Study|Disease Progression|2|||
27796340|NCT00518011|81085996|FG000|Overall Study|Other Reasons|3|||
27796341|NCT00518011|81085997|FG001|Overall Study|Other Reasons|2|||
27796342|NCT00518011|81085996|FG000|Overall Study|Withdrawal by Subject|1|||
27796343|NCT00518011|81085997|FG001|Overall Study|Withdrawal by Subject|0|||
27796344|NCT03606109|81085998|FG000|Overall Study|Lost to Follow-up|2|||
27796345|NCT03606109|81085999|FG001|Overall Study|Lost to Follow-up|1|||
27796346|NCT02803138|81086000|FG000|Overall Study|Failure to return|38|||
27796347|NCT02803138|81086000|FG000|Overall Study|Insufficient virological response|2|||
27796348|NCT02803138|81086000|FG000|Overall Study|Withdrawn consent|1|||
27796349|NCT02803138|81086000|FG000|Overall Study|Death|1|||
27796350|NCT02803138|81086000|FG000|Overall Study|Other, not specified|28|||
27796351|NCT03252015|81086001|FG000|Overall Study|Withdrawal by Subject|0|||
27796352|NCT03252015|81086002|FG001|Overall Study|Withdrawal by Subject|1|||
27796353|NCT03252015|81086003|FG002|Overall Study|Withdrawal by Subject|1|||
27796354|NCT03252015|81086004|FG003|Overall Study|Withdrawal by Subject|0|||
27796355|NCT03252015|81086001|FG000|Overall Study|Adverse Event|1|||
27796356|NCT03252015|81086002|FG001|Overall Study|Adverse Event|0|||
27796357|NCT03252015|81086003|FG002|Overall Study|Adverse Event|0|||
27796358|NCT03252015|81086004|FG003|Overall Study|Adverse Event|1|||
27796359|NCT04449354|81086005|FG000|Overall Study|Withdrawal by Subject|1|||
27796360|NCT04682639|81086006|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
27796361|NCT04682639|81086007|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
27796362|NCT04682639|81086008|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
27796363|NCT04682639|81086009|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
27796364|NCT04682639|81086010|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
27796365|NCT04682639|81086006|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
27796366|NCT04682639|81086007|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
27796367|NCT04682639|81086008|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
27796368|NCT04682639|81086009|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27796369|NCT04682639|81086010|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27796370|NCT04682639|81086006|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
27796371|NCT04682639|81086007|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27869777|NCT00711243|81357800|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
27869778|NCT00711243|81357801|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
27869779|NCT01937871|81357804|FG000|Overall Study|Adverse Event|6|||
27869780|NCT01937871|81357805|FG001|Overall Study|Adverse Event|6|||
27869781|NCT01937871|81357806|FG002|Overall Study|Adverse Event|2|||
27869782|NCT01937871|81357804|FG000|Overall Study|Lost to Follow-up|8|||
27869783|NCT01937871|81357805|FG001|Overall Study|Lost to Follow-up|2|||
27869784|NCT01937871|81357806|FG002|Overall Study|Lost to Follow-up|4|||
27869785|NCT01937871|81357804|FG000|Overall Study|Withdrawal by Subject|9|||
27869786|NCT01937871|81357805|FG001|Overall Study|Withdrawal by Subject|6|||
27869787|NCT01937871|81357806|FG002|Overall Study|Withdrawal by Subject|4|||
27869788|NCT01937871|81357804|FG000|Overall Study|Physician Decision|0|||
27869789|NCT01937871|81357805|FG001|Overall Study|Physician Decision|1|||
27869790|NCT01937871|81357806|FG002|Overall Study|Physician Decision|0|||
27869791|NCT01937871|81357804|FG000|Overall Study|Entry Criteria Not Met|1|||
27869792|NCT01937871|81357805|FG001|Overall Study|Entry Criteria Not Met|2|||
27869793|NCT01937871|81357806|FG002|Overall Study|Entry Criteria Not Met|1|||
27869794|NCT01982955|81357807|FG000|Overall Study|Randomized but not treated|0|||
27869795|NCT01982955|81357808|FG001|Overall Study|Randomized but not treated|0|||
27869796|NCT01982955|81357809|FG002|Overall Study|Randomized but not treated|0|||
27869797|NCT01982955|81357810|FG003|Overall Study|Randomized but not treated|1|||
27869798|NCT01982955|81357811|FG004|Overall Study|Randomized but not treated|0|||
27869799|NCT03541317|81357819|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
27869800|NCT03541317|81357820|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
27869801|NCT03541317|81357821|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
27869802|NCT03541317|81357822|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
27869803|NCT03541317|81357823|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
27869804|NCT03541317|81357824|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
27869805|NCT00185588|81357828|FG000|Overall Study|Adverse Event|3|||
27796372|NCT04682639|81086008|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27796373|NCT04682639|81086009|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27796374|NCT04682639|81086010|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27796375|NCT04682639|81086006|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
27796376|NCT04682639|81086007|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
27869806|NCT00185588|81357829|FG001|Overall Study|Adverse Event|1|||
27869807|NCT00185588|81357830|FG002|Overall Study|Adverse Event|4|||
27796377|NCT04682639|81086008|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
27796378|NCT04682639|81086009|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
27796379|NCT04682639|81086010|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
27796380|NCT04682639|81086006|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
27796381|NCT04682639|81086007|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
27869808|NCT00185588|81357831|FG003|Overall Study|Adverse Event|2|||
27869809|NCT00185588|81357828|FG000|Overall Study|Lost to Follow-up|0|||
27869810|NCT00185588|81357829|FG001|Overall Study|Lost to Follow-up|0|||
27869811|NCT00185588|81357830|FG002|Overall Study|Lost to Follow-up|1|||
27869812|NCT00185588|81357831|FG003|Overall Study|Lost to Follow-up|2|||
27796382|NCT04682639|81086008|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
27869813|NCT00185588|81357828|FG000|Overall Study|Withdrawal by Subject|0|||
27987649|NCT01371305|81787254|FG000|Overall Study|Adverse Event|0|||
27987650|NCT01371305|81787255|FG001|Overall Study|Adverse Event|0|||
27987651|NCT01371305|81787256|FG002|Overall Study|Adverse Event|0|||
27987652|NCT01371305|81787257|FG003|Overall Study|Adverse Event|2|||
27987653|NCT01371305|81787258|FG004|Overall Study|Adverse Event|1|||
27987654|NCT01371305|81787259|FG005|Overall Study|Adverse Event|0|||
27987655|NCT01371305|81787254|FG000|Overall Study|Study terminated by sponsor|0|||
27987656|NCT01371305|81787255|FG001|Overall Study|Study terminated by sponsor|0|||
27987657|NCT01371305|81787256|FG002|Overall Study|Study terminated by sponsor|0|||
27987658|NCT01371305|81787257|FG003|Overall Study|Study terminated by sponsor|0|||
27987659|NCT01371305|81787258|FG004|Overall Study|Study terminated by sponsor|3|||
27987660|NCT01371305|81787259|FG005|Overall Study|Study terminated by sponsor|1|||
27987661|NCT01371305|81787254|FG000|Overall Study|Subject request|0|||
27987662|NCT01371305|81787255|FG001|Overall Study|Subject request|0|||
27987663|NCT01371305|81787256|FG002|Overall Study|Subject request|0|||
27987664|NCT01371305|81787257|FG003|Overall Study|Subject request|0|||
27987665|NCT01371305|81787258|FG004|Overall Study|Subject request|0|||
27987666|NCT01371305|81787259|FG005|Overall Study|Subject request|1|||
27987667|NCT00428389|81787260|FG000|Core Phase|Adverse Event|6|||
27987668|NCT00428389|81787261|FG001|Core Phase|Adverse Event|4|||
27987669|NCT00428389|81787260|FG000|Core Phase|Lack of Efficacy|2|||
27674989|NCT02638103|80647314|FG001|Overall Study|Non-compliance to Study Procedures|1|||
27987670|NCT00428389|81787261|FG001|Core Phase|Lack of Efficacy|0|||
27674990|NCT02638103|80647315|FG002|Overall Study|Non-compliance to Study Procedures|1|||
27674991|NCT02638103|80647316|FG003|Overall Study|Non-compliance to Study Procedures|1|||
27674992|NCT02638103|80647313|FG000|Overall Study|Lost to Follow-up|26|||
27674993|NCT02638103|80647314|FG001|Overall Study|Lost to Follow-up|33|||
27674994|NCT02638103|80647315|FG002|Overall Study|Lost to Follow-up|20|||
27674995|NCT02638103|80647316|FG003|Overall Study|Lost to Follow-up|37|||
27674996|NCT02638103|80647313|FG000|Overall Study|Lack of Efficacy|14|||
27674997|NCT02638103|80647314|FG001|Overall Study|Lack of Efficacy|10|||
27674998|NCT02638103|80647315|FG002|Overall Study|Lack of Efficacy|12|||
27674999|NCT02638103|80647316|FG003|Overall Study|Lack of Efficacy|22|||
27675000|NCT02638103|80647313|FG000|Overall Study|Other than specified|5|||
27675001|NCT02638103|80647314|FG001|Overall Study|Other than specified|4|||
27675002|NCT02638103|80647315|FG002|Overall Study|Other than specified|2|||
27675003|NCT02638103|80647316|FG003|Overall Study|Other than specified|4|||
27675004|NCT02094898|80647317|FG000|Overall Study|Clinical Worsening|2|||
27675005|NCT02094898|80647317|FG000|Overall Study|Adverse Event|2|||
27675006|NCT02094898|80647317|FG000|Overall Study|Lack of Efficacy|1|||
27675007|NCT01485120|80647318|FG000|Overall Study|Withdrawal by Subject|2|||
27675008|NCT03325777|80647319|FG000|Overall Study|Lost to Follow-up|9|||
27675009|NCT03325777|80647320|FG001|Overall Study|Lost to Follow-up|12|||
27675010|NCT03358238|80647324|FG000|Overall Study|Withdrawal by Subject|0|||
27675011|NCT03358238|80647325|FG001|Overall Study|Withdrawal by Subject|1|||
27675012|NCT00350727|80647326|FG000|Phase I: Dose Escalation|Adverse Event|4|||
27675013|NCT00350727|80647327|FG001|Phase I: Dose Escalation|Adverse Event|0|||
27675014|NCT00350727|80647328|FG002|Phase I: Dose Escalation|Adverse Event|0|||
27675015|NCT00350727|80647326|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
27675016|NCT00350727|80647327|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
27987671|NCT00428389|81787260|FG000|Core Phase|Abnormal test procedure result(s)|0|||
27987672|NCT00428389|81787261|FG001|Core Phase|Abnormal test procedure result(s)|1|||
27987673|NCT00428389|81787260|FG000|Core Phase|Withdrawal by Subject|3|||
27675017|NCT00350727|80647328|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
27675018|NCT00350727|80647326|FG000|Phase I: Dose Escalation|Death|1|||
27675019|NCT00350727|80647327|FG001|Phase I: Dose Escalation|Death|0|||
27675020|NCT00350727|80647328|FG002|Phase I: Dose Escalation|Death|0|||
27675021|NCT00350727|80647326|FG000|Phase I: Dose Escalation|Physician Decision|1|||
27987674|NCT00428389|81787261|FG001|Core Phase|Withdrawal by Subject|4|||
27987675|NCT00428389|81787260|FG000|Core Phase|Protocol deviation|0|||
27869814|NCT00185588|81357829|FG001|Overall Study|Withdrawal by Subject|1|||
27869815|NCT00185588|81357830|FG002|Overall Study|Withdrawal by Subject|0|||
27869816|NCT00185588|81357831|FG003|Overall Study|Withdrawal by Subject|0|||
27869817|NCT00185588|81357828|FG000|Overall Study|Physician Decision|0|||
27869818|NCT00185588|81357829|FG001|Overall Study|Physician Decision|0|||
27869819|NCT00185588|81357830|FG002|Overall Study|Physician Decision|1|||
27869820|NCT00185588|81357831|FG003|Overall Study|Physician Decision|0|||
27869821|NCT00233948|81357832|FG000|Overall Study|Adverse Event|1|||
27869822|NCT00233948|81357833|FG001|Overall Study|Adverse Event|0|||
27869823|NCT00233948|81357834|FG002|Overall Study|Adverse Event|0|||
27869824|NCT00233948|81357835|FG003|Overall Study|Adverse Event|0|||
27869825|NCT00233948|81357836|FG004|Overall Study|Adverse Event|0|||
27869826|NCT00233948|81357837|FG005|Overall Study|Adverse Event|0|||
27869827|NCT00444587|81357838|FG000|Overall Study|Death|2|||
27869828|NCT00444587|81357839|FG001|Overall Study|Death|1|||
27869829|NCT00444587|81357838|FG000|Overall Study|Progression of the disease|73|||
27869830|NCT00444587|81357839|FG001|Overall Study|Progression of the disease|8|||
27869831|NCT00444587|81357838|FG000|Overall Study|Refused treatment/did not cooperate|4|||
27869832|NCT00444587|81357839|FG001|Overall Study|Refused treatment/did not cooperate|1|||
27869833|NCT00444587|81357838|FG000|Overall Study|Investigator decision|3|||
27675022|NCT00350727|80647327|FG001|Phase I: Dose Escalation|Physician Decision|0|||
27869834|NCT00444587|81357839|FG001|Overall Study|Investigator decision|0|||
27869835|NCT00444587|81357838|FG000|Overall Study|Protocol Violation|1|||
27869836|NCT00444587|81357839|FG001|Overall Study|Protocol Violation|0|||
27869837|NCT00444587|81357838|FG000|Overall Study|Missing|0|||
27869838|NCT00444587|81357839|FG001|Overall Study|Missing|5|||
27869839|NCT04607135|81357840|FG000|Overall Study|Physician Decision|1|||
27869840|NCT04607135|81357840|FG000|Overall Study|Withdrawal by Subject|1|||
27869841|NCT04607135|81357840|FG000|Overall Study|Equipment not working|3|||
27869842|NCT02135614|81357842|FG000|Overall Study|Randomized but Not Treated|2|||
27869843|NCT02135614|81357843|FG001|Overall Study|Randomized but Not Treated|1|||
27869844|NCT02135614|81357842|FG000|Overall Study|Adverse Event|0|||
27869845|NCT02135614|81357843|FG001|Overall Study|Adverse Event|1|||
27869846|NCT02135614|81357842|FG000|Overall Study|Death|1|||
27869847|NCT02135614|81357843|FG001|Overall Study|Death|0|||
27869848|NCT02135614|81357842|FG000|Overall Study|Investigator's Discretion|0|||
27869849|NCT02135614|81357843|FG001|Overall Study|Investigator's Discretion|1|||
27869850|NCT02135614|81357842|FG000|Overall Study|Withdrew Consent|2|||
27869851|NCT02135614|81357843|FG001|Overall Study|Withdrew Consent|2|||
27869852|NCT02135614|81357842|FG000|Overall Study|Lost to Follow-up|3|||
27869853|NCT02135614|81357843|FG001|Overall Study|Lost to Follow-up|0|||
27869854|NCT05024747|81357847|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
27869855|NCT05024747|81357848|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
27869856|NCT05024747|81357847|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
27869857|NCT05024747|81357848|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
27987676|NCT00428389|81787261|FG001|Core Phase|Protocol deviation|2|||
27987677|NCT00428389|81787260|FG000|Extension Phase|Adverse Event|17|||
27987678|NCT00428389|81787261|FG001|Extension Phase|Adverse Event|11|||
27987679|NCT00428389|81787260|FG000|Extension Phase|Lack of Efficacy|4|||
27987680|NCT00428389|81787261|FG001|Extension Phase|Lack of Efficacy|3|||
27987681|NCT00428389|81787260|FG000|Extension Phase|Withdrawal by Subject|6|||
27987682|NCT00428389|81787261|FG001|Extension Phase|Withdrawal by Subject|6|||
27987683|NCT00428389|81787260|FG000|Extension Phase|Lost to Follow-up|0|||
27987684|NCT00428389|81787261|FG001|Extension Phase|Lost to Follow-up|3|||
27987685|NCT00428389|81787260|FG000|Extension Phase|Death|1|||
27578913|NCT01310413|80302988|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
27578914|NCT01310413|80302989|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
27675023|NCT00350727|80647328|FG002|Phase I: Dose Escalation|Physician Decision|0|||
27675024|NCT00350727|80647326|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
27675025|NCT00350727|80647327|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
27675026|NCT00350727|80647328|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
27675027|NCT00350727|80647326|FG000|Phase II|Disease Progression|0|||
27675028|NCT00350727|80647327|FG001|Phase II|Disease Progression|15|||
27675029|NCT00350727|80647328|FG002|Phase II|Disease Progression|16|||
27869858|NCT05024747|81357847|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
27869859|NCT05024747|81357848|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
27869860|NCT00866359|81357852|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
27869861|NCT00866359|81357853|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
27869862|NCT00866359|81357854|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
27869863|NCT00866359|81357855|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
27869864|NCT00866359|81357852|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
27987686|NCT00428389|81787261|FG001|Extension Phase|Death|0|||
27987687|NCT00428389|81787260|FG000|Extension Phase|Protocol Violation|3|||
27578915|NCT01310413|80302990|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
27578916|NCT01310413|80302991|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
27578917|NCT01310413|80302992|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
27987688|NCT00428389|81787261|FG001|Extension Phase|Protocol Violation|2|||
27987689|NCT00428389|81787260|FG000|Extension Phase|Administrative problems|1|||
27987690|NCT00428389|81787261|FG001|Extension Phase|Administrative problems|1|||
27987691|NCT00082381|81787262|FG000|Overall Study|Adverse Event|27|||
27987692|NCT00082381|81787263|FG001|Overall Study|Adverse Event|2|||
27987693|NCT00082381|81787262|FG000|Overall Study|Lost to Follow-up|5|||
27987694|NCT00082381|81787263|FG001|Overall Study|Lost to Follow-up|7|||
27987695|NCT00082381|81787262|FG000|Overall Study|Patient Decision|8|||
27987696|NCT00082381|81787263|FG001|Overall Study|Patient Decision|4|||
27987697|NCT00082381|81787262|FG000|Overall Study|Physician Decision|1|||
27987698|NCT00082381|81787263|FG001|Overall Study|Physician Decision|2|||
27987699|NCT00082381|81787262|FG000|Overall Study|Protocol Violation|10|||
27987700|NCT00082381|81787263|FG001|Overall Study|Protocol Violation|11|||
27987701|NCT00082381|81787262|FG000|Overall Study|Loss of Glucose Control|4|||
27987702|NCT00082381|81787263|FG001|Overall Study|Loss of Glucose Control|0|||
27987703|NCT03761810|81787266|FG000|Overall Study|Adverse Event|12|||
27987704|NCT03761810|81787267|FG001|Overall Study|Adverse Event|0|||
27987705|NCT03761810|81787266|FG000|Overall Study|Lost to Follow-up|15|||
27987706|NCT03761810|81787267|FG001|Overall Study|Lost to Follow-up|7|||
27987707|NCT03761810|81787266|FG000|Overall Study|Pregnancy|1|||
27987708|NCT03761810|81787267|FG001|Overall Study|Pregnancy|0|||
27578918|NCT01310413|80302993|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
27578919|NCT01310413|80302987|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
27578920|NCT01310413|80302988|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
27578921|NCT01310413|80302989|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
27578922|NCT01310413|80302990|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
27578923|NCT01310413|80302991|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
27578924|NCT01310413|80302992|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
27578925|NCT01310413|80302993|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
27987709|NCT03761810|81787266|FG000|Overall Study|Withdrawal by Subject|14|||
27987710|NCT03761810|81787267|FG001|Overall Study|Withdrawal by Subject|5|||
27987711|NCT03761810|81787266|FG000|Overall Study|Physician Decision|1|||
27987712|NCT03761810|81787267|FG001|Overall Study|Physician Decision|0|||
27987713|NCT03761810|81787266|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
27987714|NCT03761810|81787267|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27987715|NCT03761810|81787266|FG000|Overall Study|Other Than Specified|1|||
27987716|NCT03761810|81787267|FG001|Overall Study|Other Than Specified|0|||
27987717|NCT05392803|81787269|FG000|Overall Study|Lost to Follow-up|0|||
27578926|NCT01310413|80302987|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
27578927|NCT01310413|80302988|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
27578928|NCT01310413|80302989|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
27987718|NCT05392803|81787270|FG001|Overall Study|Lost to Follow-up|2|||
27578929|NCT01310413|80302990|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
27987719|NCT01406015|81787271|FG000|Overall Study|Withdrawal by Subject|3|||
27987720|NCT01406015|81787272|FG001|Overall Study|Withdrawal by Subject|3|||
27987721|NCT02337634|81787275|FG000|Overall Study|Protocol Violation|3|||
27987722|NCT02337634|81787276|FG001|Overall Study|Protocol Violation|1|||
27987723|NCT02337634|81787275|FG000|Overall Study|Lost to Follow-up|1|||
27987724|NCT02337634|81787276|FG001|Overall Study|Lost to Follow-up|0|||
27987725|NCT03235089|81787277|FG000|Overall Study|Lost to Follow-up|1|||
27987726|NCT03235089|81787278|FG001|Overall Study|Lost to Follow-up|1|||
27987727|NCT03235089|81787277|FG000|Overall Study|Physician Decision|2|||
27987728|NCT03235089|81787278|FG001|Overall Study|Physician Decision|2|||
27869865|NCT00866359|81357853|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
27869866|NCT00866359|81357854|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
27869867|NCT00866359|81357855|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
27869868|NCT00866359|81357852|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
27869869|NCT00866359|81357853|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
27869870|NCT00866359|81357854|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
27869871|NCT00866359|81357855|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
27869872|NCT00866359|81357852|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
27869873|NCT00866359|81357853|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
27869874|NCT00866359|81357854|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
27987729|NCT01299116|81787279|FG000|Overall Study|Lost to Follow-up|65|||
27987730|NCT01299116|81787280|FG001|Overall Study|Lost to Follow-up|9|||
27987731|NCT01299116|81787281|FG002|Overall Study|Lost to Follow-up|11|||
27987732|NCT04038567|81787282|FG000|Overall Study|Lost to Follow-up|6|||
27987733|NCT04038567|81787283|FG001|Overall Study|Lost to Follow-up|4|||
27987734|NCT04038567|81787284|FG002|Overall Study|Lost to Follow-up|5|||
27987735|NCT04038567|81787285|FG003|Overall Study|Lost to Follow-up|4|||
27987736|NCT04038567|81787286|FG004|Overall Study|Lost to Follow-up|6|||
27987737|NCT04038567|81787287|FG005|Overall Study|Lost to Follow-up|4|||
27987738|NCT04038567|81787288|FG006|Overall Study|Lost to Follow-up|4|||
27987739|NCT04038567|81787289|FG007|Overall Study|Lost to Follow-up|1|||
27987740|NCT04038567|81787282|FG000|Overall Study|Withdrawal by Subject|2|||
27987741|NCT04038567|81787283|FG001|Overall Study|Withdrawal by Subject|1|||
27987742|NCT04038567|81787284|FG002|Overall Study|Withdrawal by Subject|1|||
27987743|NCT04038567|81787285|FG003|Overall Study|Withdrawal by Subject|1|||
27987744|NCT04038567|81787286|FG004|Overall Study|Withdrawal by Subject|4|||
27987745|NCT04038567|81787287|FG005|Overall Study|Withdrawal by Subject|1|||
27987746|NCT04038567|81787288|FG006|Overall Study|Withdrawal by Subject|1|||
27578930|NCT01310413|80302991|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
27987747|NCT04038567|81787289|FG007|Overall Study|Withdrawal by Subject|1|||
27987748|NCT04038567|81787282|FG000|Overall Study|missed survey window|1|||
27987749|NCT04038567|81787283|FG001|Overall Study|missed survey window|2|||
27987750|NCT04038567|81787284|FG002|Overall Study|missed survey window|0|||
27987751|NCT04038567|81787285|FG003|Overall Study|missed survey window|0|||
27987752|NCT04038567|81787286|FG004|Overall Study|missed survey window|1|||
27987753|NCT04038567|81787287|FG005|Overall Study|missed survey window|1|||
27987754|NCT04038567|81787288|FG006|Overall Study|missed survey window|2|||
27987755|NCT04038567|81787289|FG007|Overall Study|missed survey window|2|||
27987756|NCT04038567|81787282|FG000|Overall Study|technical issues|0|||
27987757|NCT04038567|81787283|FG001|Overall Study|technical issues|0|||
27987758|NCT04038567|81787284|FG002|Overall Study|technical issues|0|||
27987759|NCT04038567|81787285|FG003|Overall Study|technical issues|0|||
27987760|NCT04038567|81787286|FG004|Overall Study|technical issues|0|||
27987761|NCT04038567|81787287|FG005|Overall Study|technical issues|0|||
27987762|NCT04038567|81787288|FG006|Overall Study|technical issues|1|||
27987763|NCT04038567|81787289|FG007|Overall Study|technical issues|0|||
27987764|NCT04038567|81787282|FG000|Overall Study|Medical issues (i.e., illness)|0|||
27987765|NCT04038567|81787283|FG001|Overall Study|Medical issues (i.e., illness)|1|||
27987766|NCT04038567|81787284|FG002|Overall Study|Medical issues (i.e., illness)|2|||
27987767|NCT04038567|81787285|FG003|Overall Study|Medical issues (i.e., illness)|1|||
27987768|NCT04038567|81787286|FG004|Overall Study|Medical issues (i.e., illness)|1|||
27987769|NCT04038567|81787287|FG005|Overall Study|Medical issues (i.e., illness)|1|||
27987770|NCT04038567|81787288|FG006|Overall Study|Medical issues (i.e., illness)|0|||
27987771|NCT04038567|81787289|FG007|Overall Study|Medical issues (i.e., illness)|0|||
27987772|NCT04038567|81787282|FG000|Overall Study|Death|0|||
27675030|NCT00350727|80647326|FG000|Phase II|Clinical Deterioration|0|||
27796383|NCT04682639|81086009|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
27796384|NCT04682639|81086010|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
27796385|NCT04682639|81086006|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
27796386|NCT04682639|81086007|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
27796387|NCT04682639|81086008|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
27796388|NCT04682639|81086009|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27796389|NCT04682639|81086010|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27987773|NCT04038567|81787283|FG001|Overall Study|Death|0|||
27987774|NCT04038567|81787284|FG002|Overall Study|Death|0|||
27987775|NCT04038567|81787285|FG003|Overall Study|Death|1|||
27987776|NCT04038567|81787286|FG004|Overall Study|Death|1|||
27987777|NCT04038567|81787287|FG005|Overall Study|Death|0|||
27987778|NCT04038567|81787288|FG006|Overall Study|Death|0|||
27796390|NCT04682639|81086006|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
27796391|NCT04682639|81086007|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
27987779|NCT04038567|81787289|FG007|Overall Study|Death|1|||
27987780|NCT01772576|81787290|FG000|Overall Study|Death|15|||
27987781|NCT01772576|81787290|FG000|Overall Study|Protocol Violation|1|||
27987782|NCT01772576|81787290|FG000|Overall Study|Lost to Follow-up|3|||
27987783|NCT01772576|81787290|FG000|Overall Study|Study device not used|3|||
27987784|NCT01772576|81787290|FG000|Overall Study|Adverse Event|6|||
27987785|NCT01772576|81787290|FG000|Overall Study|Withdrawal by Subject|6|||
27987786|NCT01717326|81787291|FG000|Overall Study|Death|0|||
27987787|NCT01717326|81787292|FG001|Overall Study|Death|0|||
27987788|NCT01717326|81787293|FG002|Overall Study|Death|0|||
27987789|NCT01717326|81787294|FG003|Overall Study|Death|0|||
27987790|NCT01717326|81787295|FG004|Overall Study|Death|0|||
27987791|NCT01717326|81787296|FG005|Overall Study|Death|0|||
27987792|NCT01717326|81787297|FG006|Overall Study|Death|0|||
27987793|NCT01717326|81787298|FG007|Overall Study|Death|0|||
27987794|NCT01717326|81787299|FG008|Overall Study|Death|0|||
27987795|NCT01717326|81787300|FG009|Overall Study|Death|0|||
27987796|NCT01717326|81787301|FG010|Overall Study|Death|1|||
27987797|NCT01717326|81787302|FG011|Overall Study|Death|0|||
27796392|NCT04682639|81086008|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
27796393|NCT04682639|81086009|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
27796394|NCT04682639|81086010|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
27796395|NCT04682639|81086006|FG000|OLE Period (28 Weeks)|Other|1|||
27796396|NCT04682639|81086007|FG001|OLE Period (28 Weeks)|Other|2|||
27796397|NCT04682639|81086008|FG002|OLE Period (28 Weeks)|Other|0|||
27796398|NCT04682639|81086009|FG003|OLE Period (28 Weeks)|Other|0|||
27796399|NCT04682639|81086010|FG004|OLE Period (28 Weeks)|Other|1|||
27796400|NCT04682639|81086006|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
27796401|NCT04682639|81086007|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
27796402|NCT04682639|81086008|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
27796403|NCT04682639|81086009|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
27796404|NCT04682639|81086010|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
27796405|NCT04682639|81086006|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
27796406|NCT04682639|81086007|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
27796407|NCT04682639|81086008|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27796408|NCT04682639|81086009|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27796409|NCT04682639|81086010|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27796410|NCT04682639|81086006|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
27796411|NCT04682639|81086007|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
27987798|NCT01717326|81787303|FG012|Overall Study|Death|0|||
27987799|NCT01717326|81787304|FG013|Overall Study|Death|0|||
27987800|NCT01717326|81787305|FG014|Overall Study|Death|0|||
27987801|NCT01717326|81787306|FG015|Overall Study|Death|0|||
27987802|NCT01717326|81787307|FG016|Overall Study|Death|0|||
27987803|NCT01717326|81787308|FG017|Overall Study|Death|0|||
27987804|NCT01717326|81787309|FG018|Overall Study|Death|0|||
27987805|NCT01717326|81787310|FG019|Overall Study|Death|0|||
27987806|NCT01717326|81787291|FG000|Overall Study|Lost to Follow-up|3|||
27987807|NCT01717326|81787292|FG001|Overall Study|Lost to Follow-up|0|||
27987808|NCT01717326|81787293|FG002|Overall Study|Lost to Follow-up|0|||
27987809|NCT01717326|81787294|FG003|Overall Study|Lost to Follow-up|2|||
27987810|NCT01717326|81787295|FG004|Overall Study|Lost to Follow-up|1|||
27987811|NCT01717326|81787296|FG005|Overall Study|Lost to Follow-up|0|||
27987812|NCT01717326|81787297|FG006|Overall Study|Lost to Follow-up|1|||
27987813|NCT01717326|81787298|FG007|Overall Study|Lost to Follow-up|0|||
27987814|NCT01717326|81787299|FG008|Overall Study|Lost to Follow-up|0|||
27987815|NCT01717326|81787300|FG009|Overall Study|Lost to Follow-up|0|||
27987816|NCT01717326|81787301|FG010|Overall Study|Lost to Follow-up|1|||
27987817|NCT01717326|81787302|FG011|Overall Study|Lost to Follow-up|0|||
27987818|NCT01717326|81787303|FG012|Overall Study|Lost to Follow-up|0|||
27987819|NCT01717326|81787304|FG013|Overall Study|Lost to Follow-up|0|||
27987820|NCT01717326|81787305|FG014|Overall Study|Lost to Follow-up|0|||
27987821|NCT01717326|81787306|FG015|Overall Study|Lost to Follow-up|2|||
27987822|NCT01717326|81787307|FG016|Overall Study|Lost to Follow-up|1|||
27987823|NCT01717326|81787308|FG017|Overall Study|Lost to Follow-up|0|||
27987824|NCT01717326|81787309|FG018|Overall Study|Lost to Follow-up|2|||
27987825|NCT01717326|81787310|FG019|Overall Study|Lost to Follow-up|3|||
27987826|NCT01717326|81787291|FG000|Overall Study|Physician Decision|0|||
27987827|NCT01717326|81787292|FG001|Overall Study|Physician Decision|0|||
27987828|NCT01717326|81787293|FG002|Overall Study|Physician Decision|0|||
27578931|NCT01310413|80302992|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
27796412|NCT04682639|81086008|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27987829|NCT01717326|81787294|FG003|Overall Study|Physician Decision|0|||
27987830|NCT01717326|81787295|FG004|Overall Study|Physician Decision|0|||
27987831|NCT01717326|81787296|FG005|Overall Study|Physician Decision|0|||
27987832|NCT01717326|81787297|FG006|Overall Study|Physician Decision|0|||
27796413|NCT04682639|81086009|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27796414|NCT04682639|81086010|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27987833|NCT01717326|81787298|FG007|Overall Study|Physician Decision|0|||
27987834|NCT01717326|81787299|FG008|Overall Study|Physician Decision|0|||
27987835|NCT01717326|81787300|FG009|Overall Study|Physician Decision|1|||
27869875|NCT00866359|81357855|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
27869876|NCT00866359|81357852|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
27869877|NCT00866359|81357853|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
27987836|NCT01717326|81787301|FG010|Overall Study|Physician Decision|0|||
27987837|NCT01717326|81787302|FG011|Overall Study|Physician Decision|0|||
27987838|NCT01717326|81787303|FG012|Overall Study|Physician Decision|0|||
27987839|NCT01717326|81787304|FG013|Overall Study|Physician Decision|0|||
27987840|NCT01717326|81787305|FG014|Overall Study|Physician Decision|0|||
27987841|NCT01717326|81787306|FG015|Overall Study|Physician Decision|0|||
27987842|NCT01717326|81787307|FG016|Overall Study|Physician Decision|0|||
27987843|NCT01717326|81787308|FG017|Overall Study|Physician Decision|0|||
27987844|NCT01717326|81787309|FG018|Overall Study|Physician Decision|0|||
27987845|NCT01717326|81787310|FG019|Overall Study|Physician Decision|0|||
27987846|NCT01717326|81787291|FG000|Overall Study|Protocol Violation|0|||
27987847|NCT01717326|81787292|FG001|Overall Study|Protocol Violation|0|||
27987848|NCT01717326|81787293|FG002|Overall Study|Protocol Violation|0|||
27987849|NCT01717326|81787294|FG003|Overall Study|Protocol Violation|0|||
27987850|NCT01717326|81787295|FG004|Overall Study|Protocol Violation|1|||
27987851|NCT01717326|81787296|FG005|Overall Study|Protocol Violation|0|||
27987852|NCT01717326|81787297|FG006|Overall Study|Protocol Violation|0|||
27987853|NCT01717326|81787298|FG007|Overall Study|Protocol Violation|0|||
27987854|NCT01717326|81787299|FG008|Overall Study|Protocol Violation|0|||
27987855|NCT01717326|81787300|FG009|Overall Study|Protocol Violation|0|||
27987856|NCT01717326|81787301|FG010|Overall Study|Protocol Violation|0|||
27987857|NCT01717326|81787302|FG011|Overall Study|Protocol Violation|0|||
27987858|NCT01717326|81787303|FG012|Overall Study|Protocol Violation|0|||
27987859|NCT01717326|81787304|FG013|Overall Study|Protocol Violation|0|||
27987860|NCT01717326|81787305|FG014|Overall Study|Protocol Violation|0|||
27987861|NCT01717326|81787306|FG015|Overall Study|Protocol Violation|0|||
27987862|NCT01717326|81787307|FG016|Overall Study|Protocol Violation|0|||
27987863|NCT01717326|81787308|FG017|Overall Study|Protocol Violation|0|||
27987864|NCT01717326|81787309|FG018|Overall Study|Protocol Violation|0|||
27987865|NCT01717326|81787310|FG019|Overall Study|Protocol Violation|0|||
27987866|NCT01717326|81787291|FG000|Overall Study|Withdrawal by Subject|0|||
27987867|NCT01717326|81787292|FG001|Overall Study|Withdrawal by Subject|1|||
27987868|NCT01717326|81787293|FG002|Overall Study|Withdrawal by Subject|0|||
27987869|NCT01717326|81787294|FG003|Overall Study|Withdrawal by Subject|0|||
27987870|NCT01717326|81787295|FG004|Overall Study|Withdrawal by Subject|0|||
27987871|NCT01717326|81787296|FG005|Overall Study|Withdrawal by Subject|0|||
27987872|NCT01717326|81787297|FG006|Overall Study|Withdrawal by Subject|0|||
27987873|NCT01717326|81787298|FG007|Overall Study|Withdrawal by Subject|0|||
27987874|NCT01717326|81787299|FG008|Overall Study|Withdrawal by Subject|0|||
27987875|NCT01717326|81787300|FG009|Overall Study|Withdrawal by Subject|1|||
27987876|NCT01717326|81787301|FG010|Overall Study|Withdrawal by Subject|0|||
27987877|NCT01717326|81787302|FG011|Overall Study|Withdrawal by Subject|0|||
27578932|NCT01310413|80302993|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
27869878|NCT00866359|81357854|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
27869879|NCT00866359|81357855|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
27869880|NCT00866359|81357852|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
27869881|NCT00866359|81357853|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
27869882|NCT00866359|81357854|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
27869883|NCT00866359|81357855|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
27869884|NCT01074944|81357856|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
27869885|NCT01074944|81357857|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27869886|NCT01074944|81357858|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27869887|NCT01074944|81357859|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27869888|NCT01074944|81357860|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
27869889|NCT01074944|81357856|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
27987878|NCT01717326|81787303|FG012|Overall Study|Withdrawal by Subject|1|||
27987879|NCT01717326|81787304|FG013|Overall Study|Withdrawal by Subject|0|||
27987880|NCT01717326|81787305|FG014|Overall Study|Withdrawal by Subject|0|||
27987881|NCT01717326|81787306|FG015|Overall Study|Withdrawal by Subject|1|||
27987882|NCT01717326|81787307|FG016|Overall Study|Withdrawal by Subject|0|||
27987883|NCT01717326|81787308|FG017|Overall Study|Withdrawal by Subject|0|||
27578933|NCT01310413|80302987|FG000|Day 0 to Day 385|Other|1|||
27675031|NCT00350727|80647327|FG001|Phase II|Clinical Deterioration|1|||
27869890|NCT01074944|81357857|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27987884|NCT01717326|81787309|FG018|Overall Study|Withdrawal by Subject|2|||
27987885|NCT01717326|81787310|FG019|Overall Study|Withdrawal by Subject|3|||
27987886|NCT04667104|81787311|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
27987887|NCT04667104|81787312|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
27987888|NCT04667104|81787313|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
27987889|NCT00861471|81787314|FG000|Overall Study|Withdrawal by Subject|1|||
27987890|NCT00861471|81787314|FG000|Overall Study|Adverse Event|2|||
27987891|NCT00861471|81787314|FG000|Overall Study|Lack of Efficacy|3|||
27578934|NCT01310413|80302988|FG001|Day 0 to Day 385|Other|0|||
27987892|NCT00861471|81787314|FG000|Overall Study|treatment for lumbar laminectomy|1|||
27987893|NCT00861471|81787314|FG000|Overall Study|Physician Decision|2|||
27987894|NCT02249182|81787317|FG000|Treatment Phase|Lost to Follow-up|4|||
27987895|NCT02249182|81787318|FG001|Treatment Phase|Lost to Follow-up|0|||
27987896|NCT02249182|81787319|FG002|Treatment Phase|Lost to Follow-up|0|||
27987897|NCT02249182|81787320|FG003|Treatment Phase|Lost to Follow-up|0|||
27987898|NCT02249182|81787321|FG004|Treatment Phase|Lost to Follow-up|0|||
27987899|NCT04856904|81787324|FG000|Overall Study|Physician Decision|1|||
27987900|NCT04856904|81787325|FG001|Overall Study|Physician Decision|1|||
27987901|NCT04856904|81787324|FG000|Overall Study|Withdrawal by Subject|13|||
27987902|NCT04856904|81787325|FG001|Overall Study|Withdrawal by Subject|13|||
27987903|NCT04856904|81787324|FG000|Overall Study|Adverse Event|1|||
27987904|NCT04856904|81787325|FG001|Overall Study|Adverse Event|1|||
27987905|NCT04856904|81787324|FG000|Overall Study|Non-compliance with study drug|1|||
27987906|NCT04856904|81787325|FG001|Overall Study|Non-compliance with study drug|1|||
27987907|NCT04856904|81787324|FG000|Overall Study|Lost to Follow-up|4|||
27987908|NCT04856904|81787325|FG001|Overall Study|Lost to Follow-up|4|||
27987909|NCT04856904|81787324|FG000|Overall Study|Withdrawal by Subject|1|||
27987910|NCT04856904|81787325|FG001|Overall Study|Withdrawal by Subject|1|||
27987911|NCT04856904|81787324|FG000|Overall Study|Protocol Violation|1|||
27987912|NCT04856904|81787325|FG001|Overall Study|Protocol Violation|1|||
27987913|NCT00687531|81787334|FG000|Overall Study|Did not meet protocol eligibility|104|||
27987914|NCT00687531|81787334|FG000|Overall Study|Adverse Event|5|||
27987915|NCT00687531|81787334|FG000|Overall Study|Lost to Follow-up|26|||
27987916|NCT02161757|81787335|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
27987917|NCT02161757|81787336|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
27987918|NCT02161757|81787337|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
27987919|NCT02161757|81787335|FG000|Treatment Through Study Completion|Adverse Event|1|||
27987920|NCT02161757|81787336|FG001|Treatment Through Study Completion|Adverse Event|1|||
27987921|NCT02161757|81787337|FG002|Treatment Through Study Completion|Adverse Event|0|||
27987922|NCT02161757|81787335|FG000|Treatment Through Study Completion|Protocol Violation|0|||
27987923|NCT02161757|81787336|FG001|Treatment Through Study Completion|Protocol Violation|1|||
27987924|NCT02161757|81787337|FG002|Treatment Through Study Completion|Protocol Violation|2|||
27987925|NCT02161757|81787335|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
27987926|NCT02161757|81787336|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
27987927|NCT02161757|81787337|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
27987928|NCT02161757|81787335|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
27987929|NCT02161757|81787336|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
27987930|NCT02161757|81787337|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
27987931|NCT02161757|81787335|FG000|Treatment Through Study Completion|Other|20|||
27987932|NCT02161757|81787336|FG001|Treatment Through Study Completion|Other|19|||
27987933|NCT02161757|81787337|FG002|Treatment Through Study Completion|Other|12|||
27987934|NCT02161757|81787335|FG000|Treatment Through Study Completion|Death|2|||
27987935|NCT02161757|81787336|FG001|Treatment Through Study Completion|Death|1|||
27987936|NCT02161757|81787337|FG002|Treatment Through Study Completion|Death|1|||
27987937|NCT03228212|81787338|FG000|Period 1|Adverse Event|1|||
27987938|NCT03228212|81787339|FG001|Period 1|Adverse Event|0|||
27987939|NCT03228212|81787338|FG000|Period 1|no longer meets eligibility criteria|0|||
27987940|NCT03228212|81787339|FG001|Period 1|no longer meets eligibility criteria|1|||
27987941|NCT03228212|81787338|FG000|Period 2|Lost to Follow-up|1|||
27987942|NCT03228212|81787339|FG001|Period 2|Lost to Follow-up|0|||
27987943|NCT00494507|81787344|FG000|Double-Blind Phase|Adverse Event|2|||
27987944|NCT00494507|81787345|FG001|Double-Blind Phase|Adverse Event|0|||
27987945|NCT00494507|81787346|FG002|Double-Blind Phase|Adverse Event|1|||
27796415|NCT04682639|81086006|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
27796416|NCT04682639|81086007|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
27796417|NCT04682639|81086008|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
27796418|NCT04682639|81086009|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
27796419|NCT04682639|81086010|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
27987946|NCT00494507|81787347|FG003|Double-Blind Phase|Adverse Event|0|||
27987947|NCT00494507|81787344|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
27987948|NCT00494507|81787345|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
27987949|NCT00494507|81787346|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27987950|NCT00494507|81787347|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27987951|NCT00494507|81787344|FG000|Double-Blind Phase|Subject Non-compliance|0|||
27987952|NCT00494507|81787345|FG001|Double-Blind Phase|Subject Non-compliance|0|||
27987953|NCT00494507|81787346|FG002|Double-Blind Phase|Subject Non-compliance|1|||
27987954|NCT00494507|81787347|FG003|Double-Blind Phase|Subject Non-compliance|0|||
27987955|NCT00494507|81787344|FG000|Double-Blind Phase|Negative DNA test|0|||
27987956|NCT00494507|81787345|FG001|Double-Blind Phase|Negative DNA test|0|||
27987957|NCT00494507|81787346|FG002|Double-Blind Phase|Negative DNA test|0|||
27987958|NCT00494507|81787347|FG003|Double-Blind Phase|Negative DNA test|1|||
27987959|NCT00494507|81787344|FG000|Open-Label Phase|Adverse Event|0|||
27987960|NCT00494507|81787345|FG001|Open-Label Phase|Adverse Event|1|||
27987961|NCT00494507|81787346|FG002|Open-Label Phase|Adverse Event|5|||
27987962|NCT00494507|81787347|FG003|Open-Label Phase|Adverse Event|3|||
27796420|NCT02815540|81086011|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
27796421|NCT04342390|81086012|FG000|Overall Study|Lost to Follow-up|3|||
27796422|NCT04342390|81086013|FG001|Overall Study|Lost to Follow-up|0|||
27796423|NCT01525407|81086014|FG000|Overall Study|Change in recipient treatment plan|2|||
27796424|NCT01525407|81086015|FG001|Overall Study|Change in recipient treatment plan|2|||
27796425|NCT01525407|81086014|FG000|Overall Study|Withdrawal by Subject|0|||
27796426|NCT01525407|81086015|FG001|Overall Study|Withdrawal by Subject|1|||
27796427|NCT01525407|81086014|FG000|Overall Study|Transplant was delayed|0|||
27796428|NCT01525407|81086015|FG001|Overall Study|Transplant was delayed|1|||
27796429|NCT01525407|81086014|FG000|Overall Study|Delay in Transplant|1|||
27796430|NCT01525407|81086015|FG001|Overall Study|Delay in Transplant|0|||
27796431|NCT00577031|81086016|FG000|Overall Study|Adverse Event|52|||
27796432|NCT00577031|81086016|FG000|Overall Study|Progression of disease|93|||
27796433|NCT00577031|81086016|FG000|Overall Study|Protocol Violation|5|||
27796434|NCT00577031|81086016|FG000|Overall Study|Participant withdrew consent|13|||
27796435|NCT00577031|81086016|FG000|Overall Study|Participant non-compliance|5|||
27796436|NCT00577031|81086016|FG000|Overall Study|Need for surgery|17|||
27796437|NCT00577031|81086016|FG000|Overall Study|Medical decision|14|||
27796438|NCT00577031|81086016|FG000|Overall Study|Death|6|||
27869891|NCT01074944|81357858|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27869892|NCT01074944|81357859|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27869893|NCT01074944|81357860|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
27869894|NCT01074944|81357856|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
27869895|NCT01074944|81357857|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27869896|NCT01074944|81357858|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27869897|NCT01074944|81357859|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27869898|NCT01074944|81357860|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
27869899|NCT01074944|81357856|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
27869900|NCT01074944|81357857|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27869901|NCT01074944|81357858|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27869902|NCT01074944|81357859|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27987963|NCT00494507|81787344|FG000|Open-Label Phase|Worsening Disease|0|||
27987964|NCT00494507|81787345|FG001|Open-Label Phase|Worsening Disease|0|||
27987965|NCT00494507|81787346|FG002|Open-Label Phase|Worsening Disease|0|||
27987966|NCT00494507|81787347|FG003|Open-Label Phase|Worsening Disease|2|||
27987967|NCT01123707|81787348|FG000|Overall Study|Lost to Follow-up|3|||
27987968|NCT01123707|81787349|FG001|Overall Study|Lost to Follow-up|1|||
27987969|NCT01123707|81787350|FG002|Overall Study|Lost to Follow-up|3|||
27987970|NCT01123707|81787351|FG003|Overall Study|Lost to Follow-up|2|||
27987971|NCT01123707|81787348|FG000|Overall Study|Adverse Event|5|||
27987972|NCT01123707|81787349|FG001|Overall Study|Adverse Event|7|||
27987973|NCT01123707|81787350|FG002|Overall Study|Adverse Event|5|||
27987974|NCT01123707|81787351|FG003|Overall Study|Adverse Event|3|||
27987975|NCT01123707|81787348|FG000|Overall Study|Sponsor Discontinued Study|30|||
27987976|NCT01123707|81787349|FG001|Overall Study|Sponsor Discontinued Study|24|||
27987977|NCT01123707|81787350|FG002|Overall Study|Sponsor Discontinued Study|25|||
27987978|NCT01123707|81787351|FG003|Overall Study|Sponsor Discontinued Study|40|||
27987979|NCT01123707|81787348|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27987980|NCT01123707|81787349|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
27869903|NCT01074944|81357860|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
27869904|NCT01074944|81357856|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
27869905|NCT01074944|81357857|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
27869906|NCT01074944|81357858|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
27987981|NCT01123707|81787350|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
27796439|NCT00685763|81086017|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
27796440|NCT00685763|81086017|FG000|Overall Study|Protocol Violation|1|||
27796441|NCT02594384|81086018|FG000|Overall Study|Disease Progression|3|||
27796442|NCT02594384|81086019|FG001|Overall Study|Disease Progression|7|||
27869907|NCT01074944|81357859|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
27869908|NCT01074944|81357860|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
27869909|NCT01074944|81357856|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
27869910|NCT01074944|81357857|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
27869911|NCT01074944|81357858|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
27869912|NCT01074944|81357859|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
27987982|NCT01123707|81787351|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
27987983|NCT01123707|81787348|FG000|Overall Study|Investigator Withdrew Participant|0|||
27796443|NCT02594384|81086020|FG002|Overall Study|Disease Progression|0|||
27796444|NCT02594384|81086021|FG003|Overall Study|Disease Progression|2|||
27796445|NCT02594384|81086022|FG004|Overall Study|Disease Progression|2|||
27675032|NCT00350727|80647328|FG002|Phase II|Clinical Deterioration|0|||
27675033|NCT00350727|80647326|FG000|Phase II|Withdrawal by Subject|0|||
27675034|NCT00350727|80647327|FG001|Phase II|Withdrawal by Subject|2|||
27675035|NCT00350727|80647328|FG002|Phase II|Withdrawal by Subject|1|||
27675036|NCT00350727|80647326|FG000|Phase II|Adverse Event|0|||
27675037|NCT00350727|80647327|FG001|Phase II|Adverse Event|1|||
27675038|NCT00350727|80647328|FG002|Phase II|Adverse Event|1|||
27675039|NCT00350727|80647326|FG000|Phase II|Death|0|||
27675040|NCT00350727|80647327|FG001|Phase II|Death|0|||
27675041|NCT00350727|80647328|FG002|Phase II|Death|2|||
27675042|NCT00350727|80647326|FG000|Phase II|Sponsor Terminated Study|0|||
27675043|NCT00350727|80647327|FG001|Phase II|Sponsor Terminated Study|0|||
27675044|NCT00350727|80647328|FG002|Phase II|Sponsor Terminated Study|1|||
27675045|NCT00350727|80647326|FG000|Phase II|Enrolled in Rollover Study|0|||
27675046|NCT00350727|80647327|FG001|Phase II|Enrolled in Rollover Study|0|||
27675047|NCT00350727|80647328|FG002|Phase II|Enrolled in Rollover Study|1|||
27675048|NCT02473965|80647330|FG000|Overall Study|Adverse Event|6|||
27675049|NCT02473965|80647331|FG001|Overall Study|Adverse Event|4|||
27987984|NCT01123707|81787349|FG001|Overall Study|Investigator Withdrew Participant|1|||
27987985|NCT01123707|81787350|FG002|Overall Study|Investigator Withdrew Participant|1|||
27987986|NCT01123707|81787351|FG003|Overall Study|Investigator Withdrew Participant|1|||
27987987|NCT01123707|81787348|FG000|Overall Study|Subject Withdrew Consent|4|||
27987988|NCT01123707|81787349|FG001|Overall Study|Subject Withdrew Consent|5|||
27987989|NCT01123707|81787350|FG002|Overall Study|Subject Withdrew Consent|1|||
27987990|NCT01123707|81787351|FG003|Overall Study|Subject Withdrew Consent|2|||
27987991|NCT01123707|81787348|FG000|Overall Study|Lack of Efficacy|1|||
27987992|NCT01123707|81787349|FG001|Overall Study|Lack of Efficacy|2|||
27987993|NCT01123707|81787350|FG002|Overall Study|Lack of Efficacy|1|||
27987994|NCT01123707|81787351|FG003|Overall Study|Lack of Efficacy|0|||
27987995|NCT01123707|81787348|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
27987996|NCT01123707|81787349|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
27987997|NCT01123707|81787350|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
27987998|NCT01123707|81787351|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
27987999|NCT04576897|81787356|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
27988000|NCT03916081|81787357|FG000|Overall Study|Adverse Event|1|||
27988001|NCT03916081|81787358|FG001|Overall Study|Adverse Event|0|||
27988002|NCT03916081|81787359|FG002|Overall Study|Adverse Event|0|||
27988003|NCT03916081|81787357|FG000|Overall Study|Physician Decision|0|||
27988004|NCT03916081|81787358|FG001|Overall Study|Physician Decision|0|||
27988005|NCT03916081|81787359|FG002|Overall Study|Physician Decision|1|||
27988006|NCT03916081|81787357|FG000|Overall Study|Lost to Follow-up|0|||
27988007|NCT03916081|81787358|FG001|Overall Study|Lost to Follow-up|1|||
27988008|NCT03916081|81787359|FG002|Overall Study|Lost to Follow-up|0|||
27988009|NCT03916081|81787357|FG000|Overall Study|Withdrawal by Subject|3|||
27988010|NCT03916081|81787358|FG001|Overall Study|Withdrawal by Subject|0|||
27988011|NCT03916081|81787359|FG002|Overall Study|Withdrawal by Subject|1|||
27988012|NCT03916081|81787357|FG000|Overall Study|Worsening of AD|0|||
27988013|NCT03916081|81787358|FG001|Overall Study|Worsening of AD|0|||
27988014|NCT03916081|81787359|FG002|Overall Study|Worsening of AD|1|||
27988015|NCT03995355|81787361|FG000|Overall Study|Adverse Event|1|||
27988016|NCT03995355|81787362|FG001|Overall Study|Adverse Event|0|||
27988017|NCT03995355|81787361|FG000|Overall Study|Withdrawal by Subject|1|||
27988018|NCT03995355|81787362|FG001|Overall Study|Withdrawal by Subject|0|||
27988019|NCT03995355|81787361|FG000|Overall Study|Scheduling Issues|0|||
27988020|NCT03995355|81787362|FG001|Overall Study|Scheduling Issues|1|||
27988021|NCT01736618|81787368|FG000|Overall Study|Death|294|||
27988022|NCT01736618|81787368|FG000|Overall Study|Lost to Follow-up|193|||
27988023|NCT01736618|81787368|FG000|Overall Study|Withdrawal by Subject|54|||
27988024|NCT01736618|81787368|FG000|Overall Study|Subject unable to be followed at study location|223|||
27988025|NCT01736618|81787368|FG000|Overall Study|Physician Decision|33|||
27988026|NCT01736618|81787368|FG000|Overall Study|Transplant or removal of target organ|19|||
27988027|NCT01736618|81787368|FG000|Overall Study|Change in indication or condition|78|||
27988028|NCT01736618|81787368|FG000|Overall Study|Study device explant|103|||
27988029|NCT01736618|81787368|FG000|Overall Study|Unable to complete implant|2|||
27988030|NCT02702414|81787369|FG000|Overall Study|Death|96|||
27988031|NCT02702414|81787370|FG001|Overall Study|Death|42|||
27988032|NCT02702414|81787369|FG000|Overall Study|Lost to Follow-up|0|||
27988033|NCT02702414|81787370|FG001|Overall Study|Lost to Follow-up|1|||
27675050|NCT02473965|80647330|FG000|Overall Study|MG worsening|4|||
27675051|NCT02473965|80647331|FG001|Overall Study|MG worsening|1|||
27675052|NCT02473965|80647330|FG000|Overall Study|Withdrawal by Subject|2|||
27675053|NCT02473965|80647331|FG001|Overall Study|Withdrawal by Subject|3|||
27675054|NCT02473965|80647330|FG000|Overall Study|Physician Decision|0|||
27675055|NCT02473965|80647331|FG001|Overall Study|Physician Decision|2|||
27988034|NCT02702414|81787369|FG000|Overall Study|Withdrawal by Subject|0|||
27675056|NCT00277095|80647332|FG000|Overall Study|Death|2|||
27675057|NCT00277095|80647332|FG000|Overall Study|Explanted|7|||
27675058|NCT00277095|80647332|FG000|Overall Study|Lost to Follow-up|2|||
27675059|NCT00277095|80647332|FG000|Overall Study|Missed Follow-up|9|||
27675060|NCT00277095|80647332|FG000|Overall Study|Physician Decision|1|||
27675061|NCT00520845|80647333|FG000|Overall Study|Death|3|||
27675062|NCT00520845|80647333|FG000|Overall Study|Adverse Event|4|||
27675063|NCT00520845|80647333|FG000|Overall Study|Disease Progression, relapse|13|||
27675064|NCT00520845|80647333|FG000|Overall Study|Withdrawal by Subject|1|||
27675065|NCT00520845|80647333|FG000|Overall Study|Alternative Therapy|1|||
27675066|NCT00966264|80647334|FG000|Overall Study|Lost to Follow-up|4|||
27675067|NCT00966264|80647335|FG001|Overall Study|Lost to Follow-up|3|||
27675068|NCT01850030|80647338|FG000|Overall Study|Adverse Event|64|||
27675069|NCT01850030|80647339|FG001|Overall Study|Adverse Event|82|||
27675070|NCT01850030|80647338|FG000|Overall Study|Lack of Efficacy|3|||
27675071|NCT01850030|80647339|FG001|Overall Study|Lack of Efficacy|1|||
27675072|NCT01850030|80647338|FG000|Overall Study|Lost to Follow-up|5|||
27675073|NCT01850030|80647339|FG001|Overall Study|Lost to Follow-up|5|||
27675074|NCT01850030|80647338|FG000|Overall Study|Withdrawal by Subject|3|||
27675075|NCT01850030|80647339|FG001|Overall Study|Withdrawal by Subject|4|||
27675076|NCT01850030|80647338|FG000|Overall Study|Protocol Violation|24|||
27675077|NCT01850030|80647339|FG001|Overall Study|Protocol Violation|28|||
27675078|NCT01850030|80647338|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
27675079|NCT01850030|80647339|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
27675080|NCT02366143|80647340|FG000|Overall Study|Death|307|||
27675081|NCT02366143|80647341|FG001|Overall Study|Death|278|||
27675082|NCT02366143|80647342|FG002|Overall Study|Death|280|||
27675083|NCT02366143|80647340|FG000|Overall Study|Lost to Follow-up|2|||
27675084|NCT02366143|80647341|FG001|Overall Study|Lost to Follow-up|4|||
27675085|NCT02366143|80647342|FG002|Overall Study|Lost to Follow-up|2|||
27675086|NCT02366143|80647340|FG000|Overall Study|Physician Decision|1|||
27675087|NCT02366143|80647341|FG001|Overall Study|Physician Decision|2|||
27675088|NCT02366143|80647342|FG002|Overall Study|Physician Decision|1|||
27675089|NCT02366143|80647340|FG000|Overall Study|Protocol Violation|0|||
27675090|NCT02366143|80647341|FG001|Overall Study|Protocol Violation|0|||
27675091|NCT02366143|80647342|FG002|Overall Study|Protocol Violation|2|||
27675092|NCT02366143|80647340|FG000|Overall Study|Withdrawal by Subject|16|||
27675093|NCT02366143|80647341|FG001|Overall Study|Withdrawal by Subject|17|||
27675094|NCT02366143|80647342|FG002|Overall Study|Withdrawal by Subject|22|||
27675095|NCT02366143|80647340|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
27675096|NCT02366143|80647341|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
27675097|NCT02366143|80647342|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
27675098|NCT02366143|80647340|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
27675099|NCT02366143|80647341|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
27675100|NCT02366143|80647342|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
27675101|NCT02366143|80647340|FG000|Overall Study|Randomization Error|1|||
27675102|NCT02366143|80647341|FG001|Overall Study|Randomization Error|0|||
27675103|NCT02366143|80647342|FG002|Overall Study|Randomization Error|0|||
27675104|NCT02366143|80647340|FG000|Overall Study|PI Move and Site Closure|1|||
27675105|NCT02366143|80647341|FG001|Overall Study|PI Move and Site Closure|0|||
27675106|NCT02366143|80647342|FG002|Overall Study|PI Move and Site Closure|1|||
27675107|NCT02366143|80647340|FG000|Overall Study|Study Terminated By Sponsor|0|||
27675108|NCT02366143|80647341|FG001|Overall Study|Study Terminated By Sponsor|0|||
27675109|NCT02366143|80647342|FG002|Overall Study|Study Terminated By Sponsor|2|||
27675110|NCT02366143|80647340|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
27675111|NCT02366143|80647341|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
27675112|NCT02366143|80647342|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
27675113|NCT02366143|80647340|FG000|Overall Study|Patient moved to roll-over study|1|||
27675114|NCT02366143|80647341|FG001|Overall Study|Patient moved to roll-over study|19|||
27675115|NCT02366143|80647342|FG002|Overall Study|Patient moved to roll-over study|28|||
27675116|NCT02366143|80647340|FG000|Overall Study|Patient moved to commercial stock|0|||
27675117|NCT02366143|80647341|FG001|Overall Study|Patient moved to commercial stock|0|||
27675118|NCT02366143|80647342|FG002|Overall Study|Patient moved to commercial stock|1|||
27675119|NCT02366143|80647340|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
27675120|NCT02366143|80647341|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
27675121|NCT02366143|80647342|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
27675122|NCT02366143|80647340|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
27675123|NCT02366143|80647341|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
27675124|NCT02366143|80647342|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
27675125|NCT02366143|80647340|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
27675126|NCT02366143|80647341|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
27675127|NCT02366143|80647342|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
27675128|NCT02366143|80647340|FG000|Overall Study|Requester's instructions|1|||
27675129|NCT02366143|80647341|FG001|Overall Study|Requester's instructions|1|||
27675130|NCT02366143|80647342|FG002|Overall Study|Requester's instructions|1|||
27675131|NCT02366143|80647340|FG000|Overall Study|Uneligible|0|||
27675132|NCT02366143|80647341|FG001|Overall Study|Uneligible|1|||
27675133|NCT02366143|80647342|FG002|Overall Study|Uneligible|0|||
27675134|NCT02366143|80647340|FG000|Overall Study|Post Trial Migration|0|||
27675135|NCT02366143|80647341|FG001|Overall Study|Post Trial Migration|1|||
27675136|NCT02366143|80647342|FG002|Overall Study|Post Trial Migration|0|||
27675137|NCT02366143|80647340|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
27675138|NCT02366143|80647341|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
27675139|NCT02366143|80647342|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
27675140|NCT02366143|80647340|FG000|Overall Study|Patient switched to PTAP|0|||
27675141|NCT02366143|80647341|FG001|Overall Study|Patient switched to PTAP|1|||
27675142|NCT02366143|80647342|FG002|Overall Study|Patient switched to PTAP|0|||
27675143|NCT02366143|80647340|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
27675144|NCT02366143|80647341|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
27675145|NCT02366143|80647342|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
27675146|NCT01439867|80647344|FG000|Overall Study|Non-compliance|0|||
27675147|NCT01439867|80647345|FG001|Overall Study|Non-compliance|1|||
27675148|NCT01439867|80647344|FG000|Overall Study|Withdrawal by Subject|1|||
27675149|NCT01439867|80647345|FG001|Overall Study|Withdrawal by Subject|2|||
27675150|NCT01439867|80647344|FG000|Overall Study|Administrative Decision|4|||
27675151|NCT01439867|80647345|FG001|Overall Study|Administrative Decision|5|||
27675152|NCT01439867|80647344|FG000|Overall Study|Protocol-specified Criteria|1|||
27675153|NCT01439867|80647345|FG001|Overall Study|Protocol-specified Criteria|0|||
27675154|NCT00955708|80647346|FG000|Overall Study|Death|269|||
27796446|NCT02594384|81086023|FG005|Overall Study|Disease Progression|12|||
27796447|NCT02594384|81086024|FG006|Overall Study|Disease Progression|5|||
27796448|NCT02594384|81086025|FG007|Overall Study|Disease Progression|5|||
27796449|NCT02594384|81086018|FG000|Overall Study|Adverse Event|0|||
27796450|NCT02594384|81086019|FG001|Overall Study|Adverse Event|1|||
27796451|NCT02594384|81086020|FG002|Overall Study|Adverse Event|4|||
27796452|NCT02594384|81086021|FG003|Overall Study|Adverse Event|1|||
27796453|NCT02594384|81086022|FG004|Overall Study|Adverse Event|0|||
27796454|NCT02594384|81086023|FG005|Overall Study|Adverse Event|6|||
27796455|NCT02594384|81086024|FG006|Overall Study|Adverse Event|1|||
27796456|NCT02594384|81086025|FG007|Overall Study|Adverse Event|1|||
27796457|NCT02594384|81086018|FG000|Overall Study|Withdrawal by Subject|0|||
27796458|NCT02594384|81086019|FG001|Overall Study|Withdrawal by Subject|0|||
27796459|NCT02594384|81086020|FG002|Overall Study|Withdrawal by Subject|0|||
27796460|NCT02594384|81086021|FG003|Overall Study|Withdrawal by Subject|1|||
27796461|NCT02594384|81086022|FG004|Overall Study|Withdrawal by Subject|0|||
27796462|NCT02594384|81086023|FG005|Overall Study|Withdrawal by Subject|0|||
27796463|NCT02594384|81086024|FG006|Overall Study|Withdrawal by Subject|0|||
27796464|NCT02594384|81086025|FG007|Overall Study|Withdrawal by Subject|1|||
27796465|NCT02594384|81086018|FG000|Overall Study|Physician Decision|0|||
27869913|NCT01074944|81357860|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
27988035|NCT02702414|81787370|FG001|Overall Study|Withdrawal by Subject|1|||
27988036|NCT02702414|81787369|FG000|Overall Study|Protocol Violation|1|||
27988037|NCT02702414|81787370|FG001|Overall Study|Protocol Violation|0|||
27988038|NCT02702414|81787369|FG000|Overall Study|Sponsor Decision|8|||
27988039|NCT02702414|81787370|FG001|Overall Study|Sponsor Decision|7|||
27675155|NCT00955708|80647346|FG000|Overall Study|Lost to Follow-up|72|||
27675156|NCT00955708|80647346|FG000|Overall Study|Physician Decision|36|||
27675157|NCT00955708|80647346|FG000|Overall Study|Protocol Violation|134|||
27675158|NCT00955708|80647346|FG000|Overall Study|Registry Conclusion|186|||
27675159|NCT00955708|80647346|FG000|Overall Study|Product removed from service|94|||
27675160|NCT00955708|80647346|FG000|Overall Study|Patient Refused to participate further|116|||
27796466|NCT02594384|81086019|FG001|Overall Study|Physician Decision|0|||
27796467|NCT02594384|81086020|FG002|Overall Study|Physician Decision|0|||
27796468|NCT02594384|81086021|FG003|Overall Study|Physician Decision|0|||
27796469|NCT02594384|81086022|FG004|Overall Study|Physician Decision|0|||
27796470|NCT02594384|81086023|FG005|Overall Study|Physician Decision|1|||
27796471|NCT02594384|81086024|FG006|Overall Study|Physician Decision|2|||
27796472|NCT02594384|81086025|FG007|Overall Study|Physician Decision|0|||
27796473|NCT02594384|81086018|FG000|Overall Study|Progressive Leukocytosis|0|||
27796474|NCT02594384|81086019|FG001|Overall Study|Progressive Leukocytosis|0|||
27796475|NCT02594384|81086020|FG002|Overall Study|Progressive Leukocytosis|1|||
27796476|NCT02594384|81086021|FG003|Overall Study|Progressive Leukocytosis|0|||
27796477|NCT02594384|81086022|FG004|Overall Study|Progressive Leukocytosis|0|||
27796478|NCT02594384|81086023|FG005|Overall Study|Progressive Leukocytosis|0|||
27796479|NCT02594384|81086024|FG006|Overall Study|Progressive Leukocytosis|0|||
27869914|NCT01074944|81357856|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27869915|NCT01074944|81357857|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
27869916|NCT01074944|81357858|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
27869917|NCT01074944|81357859|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27869918|NCT01074944|81357860|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
27869919|NCT01074944|81357856|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27869920|NCT01074944|81357857|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
27869921|NCT01074944|81357858|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27869922|NCT01074944|81357859|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27869923|NCT01074944|81357860|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
27869924|NCT01074944|81357856|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
27869925|NCT01074944|81357857|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
27796480|NCT02594384|81086025|FG007|Overall Study|Progressive Leukocytosis|0|||
27796481|NCT02594384|81086018|FG000|Overall Study|Lack of Efficacy|0|||
27796482|NCT02594384|81086019|FG001|Overall Study|Lack of Efficacy|0|||
27796483|NCT02594384|81086020|FG002|Overall Study|Lack of Efficacy|0|||
27796484|NCT02594384|81086021|FG003|Overall Study|Lack of Efficacy|0|||
27796485|NCT02594384|81086022|FG004|Overall Study|Lack of Efficacy|1|||
27796486|NCT02594384|81086023|FG005|Overall Study|Lack of Efficacy|0|||
27796487|NCT02594384|81086024|FG006|Overall Study|Lack of Efficacy|0|||
27796488|NCT02594384|81086025|FG007|Overall Study|Lack of Efficacy|0|||
27869926|NCT01074944|81357858|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
27869927|NCT01074944|81357859|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
27869928|NCT01074944|81357860|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
27869929|NCT01074944|81357856|FG000|Long Term Treatment|Adverse Event|0|||
27869930|NCT01074944|81357857|FG001|Long Term Treatment|Adverse Event|0|||
27869931|NCT01074944|81357858|FG002|Long Term Treatment|Adverse Event|0|||
27869932|NCT01074944|81357859|FG003|Long Term Treatment|Adverse Event|3|||
27869933|NCT01074944|81357860|FG004|Long Term Treatment|Adverse Event|0|||
27869934|NCT01074944|81357856|FG000|Long Term Treatment|Lost to Follow-up|0|||
27869935|NCT01074944|81357857|FG001|Long Term Treatment|Lost to Follow-up|0|||
27869936|NCT01074944|81357858|FG002|Long Term Treatment|Lost to Follow-up|0|||
27869937|NCT01074944|81357859|FG003|Long Term Treatment|Lost to Follow-up|2|||
27869938|NCT01074944|81357860|FG004|Long Term Treatment|Lost to Follow-up|0|||
27869939|NCT01074944|81357856|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27869940|NCT01074944|81357857|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27869941|NCT01074944|81357858|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27869942|NCT01074944|81357859|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
27869943|NCT01074944|81357860|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
27869944|NCT01074944|81357856|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
27988040|NCT02853435|81787371|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
27988041|NCT02853435|81787372|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
27988042|NCT02853435|81787373|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
27988043|NCT02853435|81787374|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
27988044|NCT02853435|81787375|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
27988045|NCT02853435|81787376|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
27988046|NCT00679172|81787382|FG000|Overall Study|Non-compliance|1|||
27988047|NCT00679172|81787383|FG001|Overall Study|Non-compliance|1|||
27988048|NCT00679172|81787384|FG002|Overall Study|Non-compliance|0|||
27988049|NCT00679172|81787385|FG003|Overall Study|Non-compliance|1|||
27988050|NCT00679172|81787386|FG004|Overall Study|Non-compliance|0|||
27796489|NCT02594384|81086018|FG000|Overall Study|Substantial noncompliance|0|||
27988051|NCT00679172|81787382|FG000|Overall Study|Other not specified|0|||
27796490|NCT02594384|81086019|FG001|Overall Study|Substantial noncompliance|0|||
27796491|NCT02594384|81086020|FG002|Overall Study|Substantial noncompliance|0|||
27869945|NCT01074944|81357857|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
27869946|NCT01074944|81357858|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
27869947|NCT01074944|81357859|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
27796492|NCT02594384|81086021|FG003|Overall Study|Substantial noncompliance|0|||
27796493|NCT02594384|81086022|FG004|Overall Study|Substantial noncompliance|0|||
27675161|NCT00955708|80647346|FG000|Overall Study|Closure of study location|60|||
27675162|NCT00955708|80647346|FG000|Overall Study|Patient changed care provider/moved|91|||
27796494|NCT02594384|81086023|FG005|Overall Study|Substantial noncompliance|0|||
27796495|NCT02594384|81086024|FG006|Overall Study|Substantial noncompliance|1|||
27796496|NCT02594384|81086025|FG007|Overall Study|Substantial noncompliance|0|||
27796497|NCT03914469|81086026|FG000|Overall Study|Lost to Follow-up|1|||
27796498|NCT03914469|81086027|FG001|Overall Study|Lost to Follow-up|4|||
27796499|NCT02628418|81086028|FG000|Overall Study|Lost to Follow-up|1|||
27796500|NCT02628418|81086029|FG001|Overall Study|Lost to Follow-up|2|||
27796501|NCT01591499|81086030|FG000|Baseline Visit|Withdrawal by Subject|0|||
27796502|NCT01591499|81086031|FG001|Baseline Visit|Withdrawal by Subject|2|||
27796503|NCT01591499|81086032|FG002|Baseline Visit|Withdrawal by Subject|0|||
27796504|NCT01591499|81086033|FG003|Baseline Visit|Withdrawal by Subject|2|||
27796505|NCT01591499|81086030|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
27796506|NCT01591499|81086031|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
27796507|NCT01591499|81086032|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
27796508|NCT01591499|81086033|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
27796509|NCT01591499|81086030|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
27796510|NCT01591499|81086031|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
27796511|NCT01591499|81086032|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
27796512|NCT01591499|81086033|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
27796513|NCT01260194|81086036|FG000|Overall Study|Withdrawal of Consent|1|||
27796514|NCT00297882|81086037|FG000|Day 14|Lack of Efficacy|12|||
27796515|NCT00297882|81086038|FG001|Day 14|Lack of Efficacy|49|||
27796516|NCT00297882|81086037|FG000|Day 28|Lost to Follow-up|13|||
27796517|NCT00297882|81086038|FG001|Day 28|Lost to Follow-up|23|||
27796518|NCT00297882|81086037|FG000|Day 28|Lack of Efficacy|3|||
27675163|NCT00243074|80647350|FG000|Overall Study|Ineligible|6|||
27675164|NCT00243074|80647350|FG000|Overall Study|Adverse Event|6|||
27675165|NCT00243074|80647350|FG000|Overall Study|Withdrawal by Subject|2|||
27675166|NCT00243074|80647350|FG000|Overall Study|Lack of Efficacy|36|||
27796519|NCT00297882|81086038|FG001|Day 28|Lack of Efficacy|0|||
27796520|NCT03425331|81086039|FG000|Overall Study|Withdrawal by Subject|1|||
27796521|NCT03425331|81086039|FG000|Overall Study|Death|1|||
27796522|NCT03425331|81086039|FG000|Overall Study|Adverse Event|1|||
27796523|NCT03425331|81086039|FG000|Overall Study|Disease Progression|2|||
27796524|NCT02531698|81086040|FG000|Overall Study|Adverse Event|2|||
27796525|NCT02531698|81086041|FG001|Overall Study|Adverse Event|1|||
27796526|NCT02531698|81086040|FG000|Overall Study|Withdrawal by Subject|6|||
27796527|NCT02531698|81086041|FG001|Overall Study|Withdrawal by Subject|1|||
27796528|NCT02531698|81086040|FG000|Overall Study|Protocol Violation|2|||
27796529|NCT02531698|81086041|FG001|Overall Study|Protocol Violation|0|||
27796530|NCT02531698|81086040|FG000|Overall Study|Lost to Follow-up|1|||
27988052|NCT00679172|81787383|FG001|Overall Study|Other not specified|0|||
27988053|NCT00679172|81787384|FG002|Overall Study|Other not specified|1|||
27988054|NCT00679172|81787385|FG003|Overall Study|Other not specified|0|||
27988055|NCT00679172|81787386|FG004|Overall Study|Other not specified|0|||
27796531|NCT02531698|81086041|FG001|Overall Study|Lost to Follow-up|0|||
27796532|NCT04635631|81086049|FG000|Overall Study|Adverse Event|1|||
27796533|NCT04635631|81086049|FG000|Overall Study|Progressive disease|13|||
27796534|NCT04635631|81086049|FG000|Overall Study|Withdrawal by Subject|1|||
27796535|NCT05083559|81086052|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
27796536|NCT05083559|81086053|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
27988056|NCT03178669|81787391|FG000|Overall Study|Adverse Event|4|||
27988057|NCT03178669|81787392|FG001|Overall Study|Adverse Event|1|||
27988058|NCT03178669|81787393|FG002|Overall Study|Adverse Event|4|||
27988059|NCT03178669|81787394|FG003|Overall Study|Adverse Event|2|||
27988060|NCT03178669|81787395|FG004|Overall Study|Adverse Event|2|||
27988061|NCT03178669|81787391|FG000|Overall Study|Lack of Efficacy|0|||
27796537|NCT05083559|81086052|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
27796538|NCT05083559|81086053|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
27988062|NCT03178669|81787392|FG001|Overall Study|Lack of Efficacy|0|||
27988063|NCT03178669|81787393|FG002|Overall Study|Lack of Efficacy|2|||
27988064|NCT03178669|81787394|FG003|Overall Study|Lack of Efficacy|0|||
27988065|NCT03178669|81787395|FG004|Overall Study|Lack of Efficacy|1|||
27988066|NCT03178669|81787391|FG000|Overall Study|Physician Decision|0|||
27988067|NCT03178669|81787392|FG001|Overall Study|Physician Decision|0|||
27988068|NCT03178669|81787393|FG002|Overall Study|Physician Decision|0|||
27988069|NCT03178669|81787394|FG003|Overall Study|Physician Decision|0|||
27988070|NCT03178669|81787395|FG004|Overall Study|Physician Decision|1|||
27675167|NCT00243074|80647350|FG000|Overall Study|Death|2|||
27796539|NCT05083559|81086052|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
27796540|NCT05083559|81086053|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
27796541|NCT03286426|81086054|FG000|Overall Study|Physician Decision|3|||
27796542|NCT00299546|81086055|FG000|Overall Study|Death|3|||
27988071|NCT03178669|81787391|FG000|Overall Study|Withdrawal by Subject|1|||
27675168|NCT00243074|80647350|FG000|Overall Study|not protocol specified|1|||
27796543|NCT00299546|81086056|FG001|Overall Study|Death|2|||
27796544|NCT00299546|81086057|FG002|Overall Study|Death|0|||
27796545|NCT00299546|81086055|FG000|Overall Study|Lost to Follow-up|2|||
27796546|NCT00299546|81086056|FG001|Overall Study|Lost to Follow-up|2|||
27796547|NCT00299546|81086057|FG002|Overall Study|Lost to Follow-up|5|||
27796548|NCT00299546|81086055|FG000|Overall Study|Adverse Event|37|||
27796549|NCT00299546|81086056|FG001|Overall Study|Adverse Event|22|||
27796550|NCT00299546|81086057|FG002|Overall Study|Adverse Event|27|||
27578935|NCT01310413|80302989|FG002|Day 0 to Day 385|Other|3|||
27796551|NCT00299546|81086055|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
27796552|NCT00299546|81086056|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
27796553|NCT00299546|81086057|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
27796554|NCT00299546|81086055|FG000|Overall Study|Other|24|||
27796555|NCT00299546|81086056|FG001|Overall Study|Other|26|||
27796556|NCT00299546|81086057|FG002|Overall Study|Other|19|||
27796557|NCT00299546|81086055|FG000|Overall Study|Not treated|0|||
27796558|NCT00299546|81086056|FG001|Overall Study|Not treated|1|||
27796559|NCT00299546|81086057|FG002|Overall Study|Not treated|1|||
27796560|NCT00503035|81086061|FG000|Overall Study|Lost to Follow-up|2|||
27796561|NCT00503035|81086061|FG000|Overall Study|Physician Decision|3|||
27796562|NCT00503035|81086061|FG000|Overall Study|Ineligible|15|||
27796563|NCT04101721|81086063|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
27796564|NCT04101721|81086064|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
27796565|NCT04101721|81086063|FG000|Overall Study|Death|0|||
27796566|NCT04101721|81086064|FG001|Overall Study|Death|1|||
27796567|NCT04101721|81086063|FG000|Overall Study|Lost to Follow-up|0|||
27796568|NCT04101721|81086064|FG001|Overall Study|Lost to Follow-up|3|||
27796569|NCT02787785|81086067|FG000|Overall Study|Death|3|||
27796570|NCT02787785|81086068|FG001|Overall Study|Death|4|||
27796571|NCT02787785|81086067|FG000|Overall Study|Lost to Follow-up|1|||
27796572|NCT02787785|81086068|FG001|Overall Study|Lost to Follow-up|1|||
27796573|NCT02787785|81086067|FG000|Overall Study|Withdrawal by Subject|0|||
27988072|NCT03178669|81787392|FG001|Overall Study|Withdrawal by Subject|0|||
27988073|NCT03178669|81787393|FG002|Overall Study|Withdrawal by Subject|1|||
27988074|NCT03178669|81787394|FG003|Overall Study|Withdrawal by Subject|1|||
27988075|NCT03178669|81787395|FG004|Overall Study|Withdrawal by Subject|0|||
27988076|NCT03178669|81787391|FG000|Overall Study|Lost to Follow-up|0|||
27988077|NCT03178669|81787392|FG001|Overall Study|Lost to Follow-up|0|||
27988078|NCT03178669|81787393|FG002|Overall Study|Lost to Follow-up|0|||
27988079|NCT03178669|81787394|FG003|Overall Study|Lost to Follow-up|1|||
27988080|NCT03178669|81787395|FG004|Overall Study|Lost to Follow-up|0|||
27988081|NCT03262441|81787396|FG000|Overall Study|Withdrawal by Subject|1|||
27988082|NCT04186871|81787397|FG000|Overall Study|Lack of Efficacy|0|||
27988083|NCT04186871|81787398|FG001|Overall Study|Lack of Efficacy|1|||
27796574|NCT02787785|81086068|FG001|Overall Study|Withdrawal by Subject|5|||
27796575|NCT00499252|81086070|FG000|Overall Study|Adverse Event|3|||
27796576|NCT00499252|81086070|FG000|Overall Study|Refused further treatment|2|||
27796577|NCT00499252|81086070|FG000|Overall Study|Ineligible|4|||
27796578|NCT00499252|81086070|FG000|Overall Study|<no further label>|3|||
27796579|NCT02086968|81086071|FG000|Overall Study|Adverse Event|1|||
27796580|NCT02086968|81086072|FG001|Overall Study|Adverse Event|5|||
27796581|NCT02086968|81086071|FG000|Overall Study|Lost to Follow-up|2|||
27796582|NCT02086968|81086072|FG001|Overall Study|Lost to Follow-up|3|||
27796583|NCT02086968|81086071|FG000|Overall Study|Study drug received outside protocol|0|||
27796584|NCT02086968|81086072|FG001|Overall Study|Study drug received outside protocol|1|||
27796585|NCT02086968|81086071|FG000|Overall Study|Physician Decision|4|||
27796586|NCT02086968|81086072|FG001|Overall Study|Physician Decision|0|||
27796587|NCT02086968|81086071|FG000|Overall Study|Withdrawal by Subject|1|||
27796588|NCT02086968|81086072|FG001|Overall Study|Withdrawal by Subject|4|||
27796589|NCT03020966|81086073|FG000|Overall Study|Withdrawal by Subject|2|||
27796590|NCT03020966|81086074|FG001|Overall Study|Withdrawal by Subject|0|||
27988084|NCT04186871|81787399|FG002|Overall Study|Lack of Efficacy|0|||
27988085|NCT04186871|81787400|FG003|Overall Study|Lack of Efficacy|0|||
27988086|NCT04186871|81787401|FG004|Overall Study|Lack of Efficacy|1|||
27796591|NCT03224234|81086078|FG000|Main Study|Lost to Follow-up|5|||
27796592|NCT03224234|81086079|FG001|Main Study|Lost to Follow-up|5|||
27796593|NCT01473589|81086080|FG000|Overall Study|Adverse Event|1|||
27796594|NCT01473589|81086081|FG001|Overall Study|Adverse Event|1|||
27796595|NCT01473589|81086080|FG000|Overall Study|Death|2|||
27796596|NCT01473589|81086081|FG001|Overall Study|Death|0|||
27796597|NCT01473589|81086080|FG000|Overall Study|Lost to Follow-up|2|||
27796598|NCT01473589|81086081|FG001|Overall Study|Lost to Follow-up|2|||
27796599|NCT01473589|81086080|FG000|Overall Study|Protocol Violation|1|||
27796600|NCT01473589|81086081|FG001|Overall Study|Protocol Violation|0|||
27796601|NCT01473589|81086080|FG000|Overall Study|Withdrawal by Subject|5|||
27988087|NCT04186871|81787402|FG005|Overall Study|Lack of Efficacy|1|||
27675169|NCT00243074|80647350|FG000|Overall Study|Did not receive any treatment|1|||
27675170|NCT02838134|80647351|FG000|Overall Study|Lost to Follow-up|1|||
27988088|NCT04186871|81787397|FG000|Overall Study|Adverse Event|1|||
27988089|NCT04186871|81787398|FG001|Overall Study|Adverse Event|1|||
27988090|NCT04186871|81787399|FG002|Overall Study|Adverse Event|0|||
27988091|NCT04186871|81787400|FG003|Overall Study|Adverse Event|0|||
27988092|NCT04186871|81787401|FG004|Overall Study|Adverse Event|0|||
27988093|NCT04186871|81787402|FG005|Overall Study|Adverse Event|2|||
27675171|NCT02838134|80647352|FG001|Overall Study|Lost to Follow-up|2|||
27675172|NCT02838134|80647351|FG000|Overall Study|logistic problems|1|||
27675173|NCT02838134|80647352|FG001|Overall Study|logistic problems|1|||
27675174|NCT00738283|80647353|FG000|Overall Study|Death|1|||
27675175|NCT00738283|80647353|FG000|Overall Study|Transfer to another facility|2|||
27675176|NCT00738283|80647353|FG000|Overall Study|Discharge home prior to end of study|1|||
27675177|NCT00666198|80647354|FG000|Overall Study|Protocol Violation|10|||
27988094|NCT04186871|81787397|FG000|Overall Study|Study terminated by sponsor|1|||
27988095|NCT04186871|81787398|FG001|Overall Study|Study terminated by sponsor|2|||
27988096|NCT04186871|81787399|FG002|Overall Study|Study terminated by sponsor|0|||
27988097|NCT04186871|81787400|FG003|Overall Study|Study terminated by sponsor|1|||
27988098|NCT04186871|81787401|FG004|Overall Study|Study terminated by sponsor|0|||
27988099|NCT04186871|81787402|FG005|Overall Study|Study terminated by sponsor|0|||
27988100|NCT04186871|81787397|FG000|Overall Study|Other reasons|0|||
27988101|NCT04186871|81787398|FG001|Overall Study|Other reasons|0|||
27988102|NCT04186871|81787399|FG002|Overall Study|Other reasons|0|||
27988103|NCT04186871|81787400|FG003|Overall Study|Other reasons|0|||
27988104|NCT04186871|81787401|FG004|Overall Study|Other reasons|0|||
27988105|NCT04186871|81787402|FG005|Overall Study|Other reasons|1|||
27988106|NCT04186871|81787397|FG000|Overall Study|Withdrawal by Subject|0|||
27988107|NCT04186871|81787398|FG001|Overall Study|Withdrawal by Subject|0|||
27988108|NCT04186871|81787399|FG002|Overall Study|Withdrawal by Subject|0|||
27988109|NCT04186871|81787400|FG003|Overall Study|Withdrawal by Subject|0|||
27988110|NCT04186871|81787401|FG004|Overall Study|Withdrawal by Subject|0|||
27675178|NCT00666198|80647354|FG000|Overall Study|No Visit After First Day of Treatment|13|||
27675179|NCT00666198|80647354|FG000|Overall Study|Safety Not Assessable|6|||
27675180|NCT00666198|80647354|FG000|Overall Study|No Drug Administration|4|||
27675181|NCT02844777|80647355|FG000|Overall Study|Withdrawal by Subject|2|||
27675182|NCT02844777|80647356|FG001|Overall Study|Withdrawal by Subject|0|||
27675183|NCT02844777|80647357|FG002|Overall Study|Withdrawal by Subject|0|||
27675184|NCT02579772|80647358|FG000|Overall Study|Withdrawal by Subject|0|||
27675185|NCT02579772|80647359|FG001|Overall Study|Withdrawal by Subject|1|||
27675186|NCT02579772|80647358|FG000|Overall Study|Usage of additional antioxidants|1|||
27675187|NCT02579772|80647359|FG001|Overall Study|Usage of additional antioxidants|0|||
27675188|NCT02579772|80647358|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
27675189|NCT02579772|80647359|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
27675190|NCT01080300|80647363|FG000|Overall Study|Adverse Event|49|||
27796602|NCT01473589|81086081|FG001|Overall Study|Withdrawal by Subject|11|||
27796603|NCT01473589|81086080|FG000|Overall Study|Physician Decision|0|||
27796604|NCT01473589|81086081|FG001|Overall Study|Physician Decision|1|||
27796605|NCT01473589|81086080|FG000|Overall Study|Entry criteria not met|0|||
27796606|NCT01473589|81086081|FG001|Overall Study|Entry criteria not met|1|||
27988111|NCT04186871|81787402|FG005|Overall Study|Withdrawal by Subject|1|||
27988112|NCT04186871|81787397|FG000|Overall Study|Lost to Follow-up|0|||
27988113|NCT04186871|81787398|FG001|Overall Study|Lost to Follow-up|0|||
27988114|NCT04186871|81787399|FG002|Overall Study|Lost to Follow-up|0|||
27988115|NCT04186871|81787400|FG003|Overall Study|Lost to Follow-up|0|||
27988116|NCT04186871|81787401|FG004|Overall Study|Lost to Follow-up|0|||
27988117|NCT04186871|81787402|FG005|Overall Study|Lost to Follow-up|1|||
27988118|NCT02936284|81787403|FG000|Overall Study|Withdrawal by Subject|3|||
27988119|NCT02936284|81787404|FG001|Overall Study|Withdrawal by Subject|1|||
27988120|NCT02936284|81787403|FG000|Overall Study|Lost to Follow-up|7|||
27988121|NCT02936284|81787404|FG001|Overall Study|Lost to Follow-up|8|||
27988122|NCT04058886|81787405|FG000|Overall Study|Withdrawal by Subject|4|||
27675191|NCT01080300|80647364|FG001|Overall Study|Adverse Event|35|||
27675192|NCT01080300|80647363|FG000|Overall Study|Lack of Efficacy|12|||
27675193|NCT01080300|80647364|FG001|Overall Study|Lack of Efficacy|15|||
27675194|NCT01080300|80647363|FG000|Overall Study|Protocol Violation|7|||
27675195|NCT01080300|80647364|FG001|Overall Study|Protocol Violation|13|||
27675196|NCT01080300|80647363|FG000|Overall Study|Lost to Follow-up|10|||
27675197|NCT01080300|80647364|FG001|Overall Study|Lost to Follow-up|6|||
27675198|NCT01080300|80647363|FG000|Overall Study|Death|0|||
27675199|NCT01080300|80647364|FG001|Overall Study|Death|1|||
27675200|NCT01080300|80647363|FG000|Overall Study|Withdrawal by Subject|12|||
27988123|NCT04058886|81787405|FG000|Overall Study|Inadequate deafness interpreter service|1|||
27796607|NCT00463385|81086088|FG000|Overall Study|Other|4|||
27796608|NCT00463385|81086089|FG001|Overall Study|Other|3|||
27796609|NCT00463385|81086090|FG002|Overall Study|Other|6|||
27796610|NCT00463385|81086091|FG003|Overall Study|Other|4|||
27796611|NCT00463385|81086088|FG000|Overall Study|Adverse Event|5|||
27796612|NCT00463385|81086089|FG001|Overall Study|Adverse Event|8|||
27796613|NCT00463385|81086090|FG002|Overall Study|Adverse Event|4|||
27796614|NCT00463385|81086091|FG003|Overall Study|Adverse Event|2|||
27796615|NCT00463385|81086088|FG000|Overall Study|Lack of Efficacy|6|||
27869948|NCT01074944|81357860|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
27869949|NCT01074944|81357856|FG000|Long Term Treatment|Withdrawal by Subject|0|||
27796616|NCT00463385|81086089|FG001|Overall Study|Lack of Efficacy|6|||
27796617|NCT00463385|81086090|FG002|Overall Study|Lack of Efficacy|7|||
27578936|NCT01310413|80302990|FG003|Day 0 to Day 385|Other|0|||
27796618|NCT00463385|81086091|FG003|Overall Study|Lack of Efficacy|9|||
27796619|NCT00463385|81086088|FG000|Overall Study|Withdrawal by Subject|3|||
27796620|NCT00463385|81086089|FG001|Overall Study|Withdrawal by Subject|3|||
27796621|NCT00463385|81086090|FG002|Overall Study|Withdrawal by Subject|3|||
27796622|NCT00463385|81086091|FG003|Overall Study|Withdrawal by Subject|4|||
27796623|NCT00463385|81086088|FG000|Overall Study|Lost to Follow-up|0|||
27796624|NCT00463385|81086089|FG001|Overall Study|Lost to Follow-up|0|||
27796625|NCT00463385|81086090|FG002|Overall Study|Lost to Follow-up|0|||
27796626|NCT00463385|81086091|FG003|Overall Study|Lost to Follow-up|1|||
27796627|NCT00463385|81086088|FG000|Overall Study|Death|2|||
27796628|NCT00463385|81086089|FG001|Overall Study|Death|1|||
27869950|NCT01074944|81357857|FG001|Long Term Treatment|Withdrawal by Subject|0|||
27869951|NCT01074944|81357858|FG002|Long Term Treatment|Withdrawal by Subject|0|||
27869952|NCT01074944|81357859|FG003|Long Term Treatment|Withdrawal by Subject|2|||
27869953|NCT01074944|81357860|FG004|Long Term Treatment|Withdrawal by Subject|0|||
27869954|NCT01074944|81357856|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27869955|NCT01074944|81357857|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27869956|NCT01074944|81357858|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27869957|NCT01074944|81357859|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
27869958|NCT01074944|81357860|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
27869959|NCT01074944|81357856|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27869960|NCT01074944|81357857|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27869961|NCT01074944|81357858|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27869962|NCT01074944|81357859|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
27869963|NCT01074944|81357860|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
27869964|NCT02094417|81357861|FG000|Overall Study|Adverse Event|0|||
27869965|NCT02094417|81357862|FG001|Overall Study|Adverse Event|0|||
27869966|NCT02094417|81357863|FG002|Overall Study|Adverse Event|0|||
27869967|NCT02094417|81357864|FG003|Overall Study|Adverse Event|1|||
27869968|NCT02094417|81357861|FG000|Overall Study|Eligibility criteria|0|||
27869969|NCT02094417|81357862|FG001|Overall Study|Eligibility criteria|1|||
27869970|NCT02094417|81357863|FG002|Overall Study|Eligibility criteria|0|||
27869971|NCT02094417|81357864|FG003|Overall Study|Eligibility criteria|0|||
27796629|NCT00463385|81086090|FG002|Overall Study|Death|2|||
27796630|NCT00463385|81086091|FG003|Overall Study|Death|0|||
27796631|NCT00463385|81086088|FG000|Overall Study|Missing|2|||
27796632|NCT00463385|81086089|FG001|Overall Study|Missing|0|||
27796633|NCT00463385|81086090|FG002|Overall Study|Missing|0|||
27796634|NCT00463385|81086091|FG003|Overall Study|Missing|2|||
27796635|NCT00463385|81086088|FG000|Overall Study|1 participant received commercial drug|0|||
27796636|NCT00463385|81086089|FG001|Overall Study|1 participant received commercial drug|1|||
27796637|NCT00463385|81086090|FG002|Overall Study|1 participant received commercial drug|0|||
27796638|NCT00463385|81086091|FG003|Overall Study|1 participant received commercial drug|0|||
27796639|NCT05144477|81086097|FG000|Overall Study|Withdrawal by Subject|1|||
27869972|NCT02094417|81357861|FG000|Overall Study|No responder|4|||
27796640|NCT05144477|81086098|FG001|Overall Study|Withdrawal by Subject|1|||
27796641|NCT02453282|81086099|FG000|Overall Study|Death|275|||
27796642|NCT02453282|81086100|FG001|Overall Study|Death|277|||
27796643|NCT02453282|81086101|FG002|Overall Study|Death|296|||
27796644|NCT02453282|81086099|FG000|Overall Study|Lost to Follow-up|1|||
27796645|NCT02453282|81086100|FG001|Overall Study|Lost to Follow-up|0|||
27796646|NCT02453282|81086101|FG002|Overall Study|Lost to Follow-up|2|||
27796647|NCT02453282|81086099|FG000|Overall Study|Withdrawal by Subject|12|||
27869973|NCT02094417|81357862|FG001|Overall Study|No responder|4|||
27796648|NCT02453282|81086100|FG001|Overall Study|Withdrawal by Subject|10|||
27796649|NCT02453282|81086101|FG002|Overall Study|Withdrawal by Subject|11|||
27869974|NCT02094417|81357863|FG002|Overall Study|No responder|4|||
27988124|NCT00620113|81787406|FG000|Overall Study|Adverse Event|3|||
27578937|NCT01310413|80302991|FG004|Day 0 to Day 385|Other|0|||
27796650|NCT02453282|81086099|FG000|Overall Study|Participants ongoing at data cut-off|85|||
27796651|NCT02453282|81086100|FG001|Overall Study|Participants ongoing at data cut-off|84|||
27796652|NCT02453282|81086101|FG002|Overall Study|Participants ongoing at data cut-off|62|||
27796653|NCT02453282|81086099|FG000|Overall Study|Other|1|||
27796654|NCT02453282|81086100|FG001|Overall Study|Other|1|||
27796655|NCT02453282|81086101|FG002|Overall Study|Other|1|||
27796656|NCT03862807|81086102|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
27796657|NCT00242567|81086103|FG000|Overall Study|Adverse Event|70|||
27796658|NCT00242567|81086104|FG001|Overall Study|Adverse Event|43|||
27796659|NCT00242567|81086103|FG000|Overall Study|Disease Progression|17|||
27796660|NCT00242567|81086104|FG001|Overall Study|Disease Progression|22|||
27796661|NCT00242567|81086103|FG000|Overall Study|Symptomatic deterioration|9|||
27796662|NCT00242567|81086104|FG001|Overall Study|Symptomatic deterioration|3|||
27796663|NCT00242567|81086103|FG000|Overall Study|Lack of Efficacy|2|||
27796664|NCT00242567|81086104|FG001|Overall Study|Lack of Efficacy|2|||
27796665|NCT00242567|81086103|FG000|Overall Study|Lost to Follow-up|9|||
27796666|NCT00242567|81086104|FG001|Overall Study|Lost to Follow-up|19|||
27796667|NCT00242567|81086103|FG000|Overall Study|Withdrawal by Subject|33|||
27796668|NCT00242567|81086104|FG001|Overall Study|Withdrawal by Subject|28|||
27796669|NCT00242567|81086103|FG000|Overall Study|Protocol Violation|12|||
27796670|NCT00242567|81086104|FG001|Overall Study|Protocol Violation|12|||
27796671|NCT00242567|81086103|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
27796672|NCT00242567|81086104|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
27796673|NCT00242567|81086103|FG000|Overall Study|Other|14|||
27796674|NCT00242567|81086104|FG001|Overall Study|Other|9|||
27796675|NCT02949219|81086105|FG000|Overall Study|Withdrawal by Subject|1|||
27796676|NCT00560573|81086106|FG000|Overall Study|Death|4|||
27796677|NCT00560573|81086107|FG001|Overall Study|Death|1|||
27796678|NCT00560573|81086108|FG002|Overall Study|Death|4|||
27796679|NCT00560573|81086109|FG003|Overall Study|Death|5|||
27796680|NCT00560573|81086110|FG004|Overall Study|Death|1|||
27796681|NCT00560573|81086111|FG005|Overall Study|Death|10|||
27796682|NCT00560573|81086106|FG000|Overall Study|Lost to Follow-up|0|||
27796683|NCT00560573|81086107|FG001|Overall Study|Lost to Follow-up|0|||
27796684|NCT00560573|81086108|FG002|Overall Study|Lost to Follow-up|0|||
27796685|NCT00560573|81086109|FG003|Overall Study|Lost to Follow-up|1|||
27796686|NCT00560573|81086110|FG004|Overall Study|Lost to Follow-up|1|||
27796687|NCT00560573|81086111|FG005|Overall Study|Lost to Follow-up|0|||
27796688|NCT00560573|81086106|FG000|Overall Study|Withdrawal by Subject|0|||
27869975|NCT02094417|81357864|FG003|Overall Study|No responder|3|||
27869976|NCT02094417|81357861|FG000|Overall Study|Unable to conduct observations or assess|0|||
27869977|NCT02094417|81357862|FG001|Overall Study|Unable to conduct observations or assess|1|||
27869978|NCT02094417|81357863|FG002|Overall Study|Unable to conduct observations or assess|0|||
27869979|NCT02094417|81357864|FG003|Overall Study|Unable to conduct observations or assess|0|||
27988125|NCT00620113|81787407|FG001|Overall Study|Adverse Event|2|||
27988126|NCT00620113|81787408|FG002|Overall Study|Adverse Event|2|||
27988127|NCT00620113|81787409|FG003|Overall Study|Adverse Event|1|||
27988128|NCT00620113|81787406|FG000|Overall Study|Lack of Efficacy|2|||
27988129|NCT00620113|81787407|FG001|Overall Study|Lack of Efficacy|3|||
27988130|NCT00620113|81787408|FG002|Overall Study|Lack of Efficacy|0|||
27988131|NCT00620113|81787409|FG003|Overall Study|Lack of Efficacy|2|||
27988132|NCT00620113|81787406|FG000|Overall Study|Physician Decision|1|||
27988133|NCT00620113|81787407|FG001|Overall Study|Physician Decision|0|||
27988134|NCT00620113|81787408|FG002|Overall Study|Physician Decision|0|||
27988135|NCT00620113|81787409|FG003|Overall Study|Physician Decision|2|||
27988136|NCT00620113|81787406|FG000|Overall Study|Protocol Violation|2|||
27988137|NCT00620113|81787407|FG001|Overall Study|Protocol Violation|1|||
27988138|NCT00620113|81787408|FG002|Overall Study|Protocol Violation|0|||
27988139|NCT00620113|81787409|FG003|Overall Study|Protocol Violation|0|||
27988140|NCT00620113|81787406|FG000|Overall Study|Withdrawal by Subject|5|||
27988141|NCT00620113|81787407|FG001|Overall Study|Withdrawal by Subject|1|||
27796689|NCT00560573|81086107|FG001|Overall Study|Withdrawal by Subject|0|||
27796690|NCT00560573|81086108|FG002|Overall Study|Withdrawal by Subject|0|||
27796691|NCT00560573|81086109|FG003|Overall Study|Withdrawal by Subject|1|||
27796692|NCT00560573|81086110|FG004|Overall Study|Withdrawal by Subject|1|||
27796693|NCT00560573|81086111|FG005|Overall Study|Withdrawal by Subject|0|||
27796694|NCT00560573|81086106|FG000|Overall Study|Other|2|||
27869980|NCT02094417|81357861|FG000|Overall Study|Withdrawal by Subject|1|||
27869981|NCT02094417|81357862|FG001|Overall Study|Withdrawal by Subject|2|||
27869982|NCT02094417|81357863|FG002|Overall Study|Withdrawal by Subject|1|||
27988142|NCT00620113|81787408|FG002|Overall Study|Withdrawal by Subject|3|||
27988143|NCT00620113|81787409|FG003|Overall Study|Withdrawal by Subject|5|||
27796695|NCT00560573|81086107|FG001|Overall Study|Other|2|||
27796696|NCT00560573|81086108|FG002|Overall Study|Other|2|||
27796697|NCT00560573|81086109|FG003|Overall Study|Other|3|||
27988144|NCT01069705|81787410|FG000|Overall Study|Adverse Event|1|||
27796698|NCT00560573|81086110|FG004|Overall Study|Other|3|||
27796699|NCT00560573|81086111|FG005|Overall Study|Other|3|||
27796700|NCT00560573|81086106|FG000|Overall Study|Enrolled, not treated|0|||
27796701|NCT00560573|81086107|FG001|Overall Study|Enrolled, not treated|0|||
27796702|NCT00560573|81086108|FG002|Overall Study|Enrolled, not treated|0|||
27869983|NCT02094417|81357864|FG003|Overall Study|Withdrawal by Subject|3|||
27675201|NCT01080300|80647364|FG001|Overall Study|Withdrawal by Subject|28|||
27675202|NCT01080300|80647363|FG000|Overall Study|Reasons not specified|4|||
27675203|NCT01080300|80647364|FG001|Overall Study|Reasons not specified|6|||
27988145|NCT01069705|81787410|FG000|Overall Study|Withdrawal by Subject|2|||
27988146|NCT01844778|81787415|FG000|Overall Study|Protocol deviation|0|||
27988147|NCT01844778|81787416|FG001|Overall Study|Protocol deviation|1|||
27988148|NCT01844778|81787417|FG002|Overall Study|Protocol deviation|2|||
27988149|NCT01844778|81787415|FG000|Overall Study|Withdrawal by Subject|2|||
27988150|NCT01844778|81787416|FG001|Overall Study|Withdrawal by Subject|0|||
27988151|NCT01844778|81787417|FG002|Overall Study|Withdrawal by Subject|0|||
27988152|NCT01844778|81787415|FG000|Overall Study|Adverse Event|0|||
27988153|NCT01844778|81787416|FG001|Overall Study|Adverse Event|2|||
27988154|NCT01844778|81787417|FG002|Overall Study|Adverse Event|2|||
27988155|NCT03172130|81787418|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
27988156|NCT03172130|81787419|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
27988157|NCT01052077|81787420|FG000|Phase A|Lost to Follow-up|22|||
27988158|NCT01052077|81787421|FG001|Phase A|Lost to Follow-up|0|||
27988159|NCT01052077|81787422|FG002|Phase A|Lost to Follow-up|0|||
27988160|NCT01052077|81787423|FG003|Phase A|Lost to Follow-up|0|||
27988161|NCT01052077|81787420|FG000|Phase A|Adverse Event|32|||
27988162|NCT01052077|81787421|FG001|Phase A|Adverse Event|0|||
27988163|NCT01052077|81787422|FG002|Phase A|Adverse Event|0|||
27988164|NCT01052077|81787423|FG003|Phase A|Adverse Event|0|||
27988165|NCT01052077|81787420|FG000|Phase A|Met Withdrawal Criteria|26|||
27988166|NCT01052077|81787421|FG001|Phase A|Met Withdrawal Criteria|0|||
27988167|NCT01052077|81787422|FG002|Phase A|Met Withdrawal Criteria|0|||
27988168|NCT01052077|81787423|FG003|Phase A|Met Withdrawal Criteria|0|||
27988169|NCT01052077|81787420|FG000|Phase A|Physician Decision|10|||
27988170|NCT01052077|81787421|FG001|Phase A|Physician Decision|0|||
27988171|NCT01052077|81787422|FG002|Phase A|Physician Decision|0|||
27988172|NCT01052077|81787423|FG003|Phase A|Physician Decision|0|||
27988173|NCT01052077|81787420|FG000|Phase A|Withdrawal by Subject|29|||
27988174|NCT01052077|81787421|FG001|Phase A|Withdrawal by Subject|0|||
27988175|NCT01052077|81787422|FG002|Phase A|Withdrawal by Subject|0|||
27988176|NCT01052077|81787423|FG003|Phase A|Withdrawal by Subject|0|||
27988177|NCT01052077|81787420|FG000|Phase A|Protocol Deviation|27|||
27988178|NCT01052077|81787421|FG001|Phase A|Protocol Deviation|0|||
27988179|NCT01052077|81787422|FG002|Phase A|Protocol Deviation|0|||
27988180|NCT01052077|81787423|FG003|Phase A|Protocol Deviation|0|||
27988181|NCT01052077|81787420|FG000|Phase B|Lost to Follow-up|0|||
27988182|NCT01052077|81787421|FG001|Phase B|Lost to Follow-up|2|||
27988183|NCT01052077|81787422|FG002|Phase B|Lost to Follow-up|3|||
27988184|NCT01052077|81787423|FG003|Phase B|Lost to Follow-up|0|||
27988185|NCT01052077|81787420|FG000|Phase B|Adverse Event|0|||
27675204|NCT02406248|80647365|FG000|Overall Study|Death|7|||
27675205|NCT02406248|80647365|FG000|Overall Study|Withdrawal by Subject|2|||
27675206|NCT00706654|80647371|FG000|Conversion Phase|Lost to Follow-up|4|||
27675207|NCT00706654|80647372|FG001|Conversion Phase|Lost to Follow-up|0|||
27675208|NCT00706654|80647373|FG002|Conversion Phase|Lost to Follow-up|0|||
27675209|NCT00706654|80647374|FG003|Conversion Phase|Lost to Follow-up|0|||
27675210|NCT00706654|80647371|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
27675211|NCT00706654|80647372|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
27675212|NCT00706654|80647373|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
27675213|NCT00706654|80647374|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
27796703|NCT00560573|81086109|FG003|Overall Study|Enrolled, not treated|0|||
27869984|NCT01245283|81357866|FG000|Overall Study|Lost to Follow-up|14|||
27988186|NCT01052077|81787421|FG001|Phase B|Adverse Event|9|||
27988187|NCT01052077|81787422|FG002|Phase B|Adverse Event|2|||
27988188|NCT01052077|81787423|FG003|Phase B|Adverse Event|0|||
27988189|NCT01052077|81787420|FG000|Phase B|Met Withdrawal Criteria|0|||
27988190|NCT01052077|81787421|FG001|Phase B|Met Withdrawal Criteria|2|||
27988191|NCT01052077|81787422|FG002|Phase B|Met Withdrawal Criteria|1|||
27988192|NCT01052077|81787423|FG003|Phase B|Met Withdrawal Criteria|0|||
27988193|NCT01052077|81787420|FG000|Phase B|Physician Decision|0|||
27988194|NCT01052077|81787421|FG001|Phase B|Physician Decision|1|||
27988195|NCT01052077|81787422|FG002|Phase B|Physician Decision|1|||
27988196|NCT01052077|81787423|FG003|Phase B|Physician Decision|0|||
27988197|NCT01052077|81787420|FG000|Phase B|Withdrawal by Subject|0|||
27988198|NCT01052077|81787421|FG001|Phase B|Withdrawal by Subject|0|||
27988199|NCT01052077|81787422|FG002|Phase B|Withdrawal by Subject|5|||
27988200|NCT01052077|81787423|FG003|Phase B|Withdrawal by Subject|0|||
27988201|NCT01052077|81787420|FG000|Phase B|Protocol Deviation|0|||
27988202|NCT01052077|81787421|FG001|Phase B|Protocol Deviation|3|||
27675214|NCT00706654|80647371|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
27675215|NCT00706654|80647372|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
27675216|NCT00706654|80647373|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
27675217|NCT00706654|80647374|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
27796704|NCT00560573|81086110|FG004|Overall Study|Enrolled, not treated|1|||
27988203|NCT01052077|81787422|FG002|Phase B|Protocol Deviation|4|||
27988204|NCT01052077|81787423|FG003|Phase B|Protocol Deviation|0|||
27988205|NCT01052077|81787420|FG000|Phase B|Lack of Efficacy|0|||
27988206|NCT01052077|81787421|FG001|Phase B|Lack of Efficacy|1|||
27988207|NCT01052077|81787422|FG002|Phase B|Lack of Efficacy|0|||
27988208|NCT01052077|81787423|FG003|Phase B|Lack of Efficacy|0|||
27988209|NCT01052077|81787420|FG000|Phase A+|Lost to Follow-up|0|||
27988210|NCT01052077|81787421|FG001|Phase A+|Lost to Follow-up|0|||
27988211|NCT01052077|81787422|FG002|Phase A+|Lost to Follow-up|0|||
27988212|NCT01052077|81787423|FG003|Phase A+|Lost to Follow-up|8|||
27988213|NCT01052077|81787420|FG000|Phase A+|Adverse Event|0|||
27988214|NCT01052077|81787421|FG001|Phase A+|Adverse Event|0|||
27988215|NCT01052077|81787422|FG002|Phase A+|Adverse Event|0|||
27988216|NCT01052077|81787423|FG003|Phase A+|Adverse Event|4|||
27988217|NCT01052077|81787420|FG000|Phase A+|Met Withdrawal Criteria|0|||
27988218|NCT01052077|81787421|FG001|Phase A+|Met Withdrawal Criteria|0|||
27988219|NCT01052077|81787422|FG002|Phase A+|Met Withdrawal Criteria|0|||
27988220|NCT01052077|81787423|FG003|Phase A+|Met Withdrawal Criteria|2|||
27988221|NCT01052077|81787420|FG000|Phase A+|Withdrawal by Subject|0|||
27988222|NCT01052077|81787421|FG001|Phase A+|Withdrawal by Subject|0|||
27988223|NCT01052077|81787422|FG002|Phase A+|Withdrawal by Subject|0|||
27988224|NCT01052077|81787423|FG003|Phase A+|Withdrawal by Subject|7|||
27988225|NCT00619307|81787428|FG000|Overall Study|Adverse Event|0|||
27988226|NCT00619307|81787429|FG001|Overall Study|Adverse Event|1|||
27988227|NCT00619307|81787428|FG000|Overall Study|Lost to Follow-up|0|||
27988228|NCT00619307|81787429|FG001|Overall Study|Lost to Follow-up|1|||
27988229|NCT00619307|81787428|FG000|Overall Study|Protocol Violation|3|||
27988230|NCT00619307|81787429|FG001|Overall Study|Protocol Violation|0|||
27988231|NCT00619307|81787428|FG000|Overall Study|Withdrew consent|1|||
27988232|NCT00619307|81787429|FG001|Overall Study|Withdrew consent|0|||
27988233|NCT00619307|81787428|FG000|Overall Study|Severe migraine|0|||
27988234|NCT00619307|81787429|FG001|Overall Study|Severe migraine|1|||
27988235|NCT00619307|81787428|FG000|Overall Study|MS attack plus steroids|0|||
27988236|NCT00619307|81787429|FG001|Overall Study|MS attack plus steroids|1|||
27988237|NCT00788710|81787432|FG000|Overall Study|Adverse Event|1|||
27988238|NCT00788710|81787433|FG001|Overall Study|Adverse Event|3|||
27988239|NCT00788710|81787434|FG002|Overall Study|Adverse Event|4|||
27988240|NCT00788710|81787432|FG000|Overall Study|Lack of Efficacy|0|||
27988241|NCT00788710|81787433|FG001|Overall Study|Lack of Efficacy|0|||
27988242|NCT00788710|81787434|FG002|Overall Study|Lack of Efficacy|1|||
27988243|NCT00788710|81787432|FG000|Overall Study|Lost to Follow-up|0|||
27988244|NCT00788710|81787433|FG001|Overall Study|Lost to Follow-up|1|||
27988245|NCT00788710|81787434|FG002|Overall Study|Lost to Follow-up|0|||
27988246|NCT00788710|81787432|FG000|Overall Study|Physician Decision|2|||
27988247|NCT00788710|81787433|FG001|Overall Study|Physician Decision|1|||
27988248|NCT00788710|81787434|FG002|Overall Study|Physician Decision|0|||
27988249|NCT00788710|81787432|FG000|Overall Study|Protocol Violation|0|||
27988250|NCT00788710|81787433|FG001|Overall Study|Protocol Violation|1|||
27988251|NCT00788710|81787434|FG002|Overall Study|Protocol Violation|1|||
27988252|NCT00788710|81787432|FG000|Overall Study|Withdrawal by Subject|2|||
27988253|NCT00788710|81787433|FG001|Overall Study|Withdrawal by Subject|2|||
27988254|NCT00788710|81787434|FG002|Overall Study|Withdrawal by Subject|0|||
27988255|NCT03170193|81787437|FG000|Overall Study|Withdrawal by Subject|0|||
27988256|NCT03170193|81787438|FG001|Overall Study|Withdrawal by Subject|0|||
27988257|NCT03170193|81787439|FG002|Overall Study|Withdrawal by Subject|0|||
27988258|NCT03170193|81787440|FG003|Overall Study|Withdrawal by Subject|1|||
27988259|NCT03170193|81787441|FG004|Overall Study|Withdrawal by Subject|0|||
27988260|NCT03170193|81787442|FG005|Overall Study|Withdrawal by Subject|0|||
27988261|NCT03170193|81787443|FG006|Overall Study|Withdrawal by Subject|0|||
27988262|NCT03170193|81787437|FG000|Overall Study|Lost to Follow-up|1|||
27578938|NCT01310413|80302992|FG005|Day 0 to Day 385|Other|0|||
27578939|NCT01310413|80302993|FG006|Day 0 to Day 385|Other|0|||
27578940|NCT01310413|80302987|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
27578941|NCT01310413|80302988|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
27988263|NCT03170193|81787438|FG001|Overall Study|Lost to Follow-up|1|||
27988264|NCT03170193|81787439|FG002|Overall Study|Lost to Follow-up|0|||
27988265|NCT03170193|81787440|FG003|Overall Study|Lost to Follow-up|0|||
27988266|NCT03170193|81787441|FG004|Overall Study|Lost to Follow-up|0|||
27988267|NCT03170193|81787442|FG005|Overall Study|Lost to Follow-up|0|||
27988268|NCT03170193|81787443|FG006|Overall Study|Lost to Follow-up|0|||
27988269|NCT01183468|81787447|FG000|Overall Study|Lost to Follow-up|2|||
27988270|NCT01183468|81787448|FG001|Overall Study|Lost to Follow-up|1|||
27988271|NCT01183468|81787449|FG002|Overall Study|Lost to Follow-up|0|||
27988272|NCT01183468|81787450|FG003|Overall Study|Lost to Follow-up|0|||
27988273|NCT01183468|81787447|FG000|Overall Study|Physician Decision|1|||
27988274|NCT01183468|81787448|FG001|Overall Study|Physician Decision|0|||
27988275|NCT01183468|81787449|FG002|Overall Study|Physician Decision|0|||
27988276|NCT01183468|81787450|FG003|Overall Study|Physician Decision|0|||
27988277|NCT01183468|81787447|FG000|Overall Study|Withdrawal by Subject|0|||
27988278|NCT01183468|81787448|FG001|Overall Study|Withdrawal by Subject|1|||
27988279|NCT01183468|81787449|FG002|Overall Study|Withdrawal by Subject|0|||
27988280|NCT01183468|81787450|FG003|Overall Study|Withdrawal by Subject|0|||
27675218|NCT00706654|80647371|FG000|Conversion Phase|Withdrawn by Investigator|14|||
27675219|NCT00706654|80647372|FG001|Conversion Phase|Withdrawn by Investigator|0|||
27675220|NCT00706654|80647373|FG002|Conversion Phase|Withdrawn by Investigator|0|||
27675221|NCT00706654|80647374|FG003|Conversion Phase|Withdrawn by Investigator|0|||
27988281|NCT03615066|81787451|FG000|Main Study|Withdrew Consent|0|||
27988282|NCT03615066|81787452|FG001|Main Study|Withdrew Consent|1|||
27675222|NCT00706654|80647371|FG000|Conversion Phase|Withdrew Consent|38|||
27675223|NCT00706654|80647372|FG001|Conversion Phase|Withdrew Consent|0|||
27675224|NCT00706654|80647373|FG002|Conversion Phase|Withdrew Consent|0|||
27675225|NCT00706654|80647374|FG003|Conversion Phase|Withdrew Consent|0|||
27675226|NCT00706654|80647371|FG000|Conversion Phase|Adverse Event|18|||
27675227|NCT00706654|80647372|FG001|Conversion Phase|Adverse Event|0|||
27675228|NCT00706654|80647373|FG002|Conversion Phase|Adverse Event|0|||
27675229|NCT00706654|80647374|FG003|Conversion Phase|Adverse Event|0|||
27675230|NCT00706654|80647371|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
27675231|NCT00706654|80647372|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27675232|NCT00706654|80647373|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27675233|NCT00706654|80647374|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27675234|NCT00706654|80647371|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
27675235|NCT00706654|80647372|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27675236|NCT00706654|80647373|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27675237|NCT00706654|80647374|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27675238|NCT00706654|80647371|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
27675239|NCT00706654|80647372|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
27675240|NCT00706654|80647373|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
27675241|NCT00706654|80647374|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
27675242|NCT00706654|80647371|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
27675243|NCT00706654|80647372|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
27675244|NCT00706654|80647373|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
27675245|NCT00706654|80647374|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
27675246|NCT00706654|80647371|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
27988283|NCT03615066|81787453|FG002|Main Study|Withdrew Consent|1|||
27988284|NCT03615066|81787451|FG000|Main Study|Lost to Follow-up|0|||
27988285|NCT03615066|81787452|FG001|Main Study|Lost to Follow-up|0|||
27988286|NCT03615066|81787453|FG002|Main Study|Lost to Follow-up|1|||
27988287|NCT03615066|81787451|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
27988288|NCT03615066|81787452|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
27988289|NCT03615066|81787453|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
27988290|NCT03615066|81787451|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
27988291|NCT03615066|81787452|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
27988292|NCT03615066|81787453|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
27988293|NCT03615066|81787451|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
27988294|NCT03615066|81787452|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
27988295|NCT03615066|81787453|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
27988296|NCT02081599|81787454|FG000|Period 1：Double-blind Period|Adverse Event|3|||
27988297|NCT02081599|81787455|FG001|Period 1：Double-blind Period|Adverse Event|0|||
27988298|NCT02081599|81787454|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
27988299|NCT02081599|81787455|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
27988300|NCT02081599|81787454|FG000|Period 1：Double-blind Period|Physician Decision|1|||
27988301|NCT02081599|81787455|FG001|Period 1：Double-blind Period|Physician Decision|0|||
27988302|NCT02081599|81787454|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
27988303|NCT02081599|81787455|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
27988304|NCT02081599|81787454|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
27675247|NCT00706654|80647372|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27675248|NCT00706654|80647373|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27675249|NCT00706654|80647374|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27675250|NCT00706654|80647371|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
27675251|NCT00706654|80647372|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27675252|NCT00706654|80647373|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27675253|NCT00706654|80647374|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27675254|NCT00706654|80647371|FG000|Oral Stabilization Phase|Withdrew consent|55|||
27675255|NCT00706654|80647372|FG001|Oral Stabilization Phase|Withdrew consent|0|||
27675256|NCT00706654|80647373|FG002|Oral Stabilization Phase|Withdrew consent|0|||
27675257|NCT00706654|80647374|FG003|Oral Stabilization Phase|Withdrew consent|0|||
27675258|NCT00706654|80647371|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
27675259|NCT00706654|80647372|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
27675260|NCT00706654|80647373|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
27675261|NCT00706654|80647374|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
27988305|NCT02081599|81787455|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
27988306|NCT02081599|81787454|FG000|Period 1：Double-blind Period|stopping criteria|1|||
27988307|NCT02081599|81787455|FG001|Period 1：Double-blind Period|stopping criteria|0|||
27988308|NCT02081599|81787454|FG000|Period 2：Open-label Period|Adverse Event|1|||
27988309|NCT02081599|81787455|FG001|Period 2：Open-label Period|Adverse Event|0|||
27988310|NCT02081599|81787454|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
27988311|NCT02081599|81787455|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
27988312|NCT02081599|81787454|FG000|Period 2：Open-label Period|Physician Decision|1|||
27988313|NCT02081599|81787455|FG001|Period 2：Open-label Period|Physician Decision|0|||
27988314|NCT02081599|81787454|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
27988315|NCT02081599|81787455|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
27988316|NCT04079114|81787456|FG000|Overall Study|Study prematuely terminated.|166|||
27988317|NCT02798471|81787459|FG000|Overall Study|Adverse Event|7|||
27988318|NCT02798471|81787460|FG001|Overall Study|Adverse Event|2|||
27988319|NCT02798471|81787459|FG000|Overall Study|Physician Decision|3|||
27988320|NCT02798471|81787460|FG001|Overall Study|Physician Decision|7|||
27988321|NCT02798471|81787459|FG000|Overall Study|Death|2|||
27988322|NCT02798471|81787460|FG001|Overall Study|Death|3|||
27988323|NCT02798471|81787459|FG000|Overall Study|Lost to Follow-up|0|||
27988324|NCT02798471|81787460|FG001|Overall Study|Lost to Follow-up|1|||
27988325|NCT02798471|81787459|FG000|Overall Study|Other|5|||
27988326|NCT02798471|81787460|FG001|Overall Study|Other|3|||
27988327|NCT02798471|81787459|FG000|Overall Study|Subject withdrew consent|0|||
27988328|NCT02798471|81787460|FG001|Overall Study|Subject withdrew consent|6|||
27988329|NCT02798471|81787459|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
27988330|NCT02798471|81787460|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
27988331|NCT02798471|81787459|FG000|Overall Study|Randomized, but not treated|0|||
27988332|NCT02798471|81787460|FG001|Overall Study|Randomized, but not treated|2|||
27988333|NCT01019369|81787461|FG000|Overall Study|Lost to Follow-up|10|||
27988334|NCT01019369|81787462|FG001|Overall Study|Lost to Follow-up|6|||
27988335|NCT01019369|81787461|FG000|Overall Study|Withdrawal by Subject|0|||
27988336|NCT01019369|81787462|FG001|Overall Study|Withdrawal by Subject|1|||
27988337|NCT00095173|81787467|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
27988338|NCT00095173|81787468|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27988339|NCT00095173|81787469|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27988340|NCT00095173|81787470|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27988341|NCT00095173|81787471|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27988342|NCT00095173|81787472|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
27988343|NCT00095173|81787467|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
27988344|NCT00095173|81787468|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
27988345|NCT00095173|81787469|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
27988346|NCT00095173|81787470|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
27988347|NCT00095173|81787471|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
27988348|NCT00095173|81787472|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
27988349|NCT00095173|81787467|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
27988350|NCT00095173|81787468|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
27988351|NCT00095173|81787469|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
27988352|NCT00095173|81787470|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
27988353|NCT00095173|81787471|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
27988354|NCT00095173|81787472|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
27988355|NCT00095173|81787467|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
27988356|NCT00095173|81787468|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
27988357|NCT00095173|81787469|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
27988358|NCT00095173|81787470|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
27988359|NCT00095173|81787471|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
27988360|NCT00095173|81787472|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
27988361|NCT00095173|81787467|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
27988362|NCT00095173|81787468|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
27988363|NCT00095173|81787469|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
27988364|NCT00095173|81787470|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
27988365|NCT00095173|81787471|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
27988366|NCT00095173|81787472|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
27988367|NCT00095173|81787467|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
27988368|NCT00095173|81787468|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
27988369|NCT00095173|81787469|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
27988370|NCT00095173|81787470|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
27988371|NCT00095173|81787471|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
27988372|NCT00095173|81787472|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
27988373|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Death|0|||
27988374|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Death|0|||
27988375|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Death|0|||
27988376|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Death|0|||
27988377|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Death|0|||
27988378|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Death|1|||
27988379|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
27988380|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
27988381|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
27988382|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
27988383|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
27988384|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
27988385|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
27988386|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
27988387|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
27988388|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
27988389|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
27988390|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
27988391|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
27988392|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
27988393|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
27988394|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
27988395|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
27988396|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
27988397|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
27988398|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
27988399|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
27988400|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
27988401|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
27988402|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
27988403|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
27988404|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
27988405|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
27988406|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
27988407|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
27988408|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
27988409|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
27988410|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
27988411|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
27988412|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
27675262|NCT00706654|80647371|FG000|Oral Stabilization Phase|Adverse Event|21|||
27675263|NCT00706654|80647372|FG001|Oral Stabilization Phase|Adverse Event|0|||
27675264|NCT00706654|80647373|FG002|Oral Stabilization Phase|Adverse Event|0|||
27675265|NCT00706654|80647374|FG003|Oral Stabilization Phase|Adverse Event|0|||
27675266|NCT00706654|80647371|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
27675267|NCT00706654|80647372|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27796705|NCT00560573|81086111|FG005|Overall Study|Enrolled, not treated|0|||
27796706|NCT00398632|81086124|FG000|Overall Study|Withdrawal by Subject|1|||
27988413|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
27988414|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
27988415|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
27988416|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
27675268|NCT00706654|80647373|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27675269|NCT00706654|80647374|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27988417|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
27988418|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
27988419|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
27988420|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
27988421|NCT00095173|81787467|FG000|Open-Label Extension Phase (Period C)|Other|0|||
27988422|NCT00095173|81787468|FG001|Open-Label Extension Phase (Period C)|Other|0|||
27988423|NCT00095173|81787469|FG002|Open-Label Extension Phase (Period C)|Other|0|||
27988424|NCT00095173|81787470|FG003|Open-Label Extension Phase (Period C)|Other|4|||
27988425|NCT00095173|81787471|FG004|Open-Label Extension Phase (Period C)|Other|6|||
27988426|NCT00095173|81787472|FG005|Open-Label Extension Phase (Period C)|Other|8|||
27988427|NCT03675737|81787477|FG000|Overall Study|Death|593|||
27988428|NCT03675737|81787478|FG001|Overall Study|Death|660|||
27988429|NCT03675737|81787477|FG000|Overall Study|Lost to Follow-up|1|||
27988430|NCT03675737|81787478|FG001|Overall Study|Lost to Follow-up|5|||
27988431|NCT03675737|81787477|FG000|Overall Study|Physician Decision|1|||
27988432|NCT03675737|81787478|FG001|Overall Study|Physician Decision|0|||
27988433|NCT03675737|81787477|FG000|Overall Study|Withdrawal by Subject|14|||
27988434|NCT03675737|81787478|FG001|Overall Study|Withdrawal by Subject|12|||
27988435|NCT03675737|81787477|FG000|Overall Study|Ongoing in Study|181|||
27988436|NCT03675737|81787478|FG001|Overall Study|Ongoing in Study|112|||
27988437|NCT04356352|81787479|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
27988438|NCT04356352|81787480|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
27988439|NCT04356352|81787481|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
27988440|NCT04356352|81787479|FG000|Overall Study|Protocol Violation|0|||
27988441|NCT04356352|81787480|FG001|Overall Study|Protocol Violation|3|||
27988442|NCT04356352|81787481|FG002|Overall Study|Protocol Violation|1|||
27988443|NCT00835341|81787482|FG000|Overall Study|Lost to Follow-up|3|||
27988444|NCT00835341|81787483|FG001|Overall Study|Lost to Follow-up|12|||
27988445|NCT05320393|81787484|FG000|Overall Study|Withdrawal by Subject|1|||
27988446|NCT05320393|81787485|FG001|Overall Study|Withdrawal by Subject|0|||
27988447|NCT05320393|81787486|FG002|Overall Study|Withdrawal by Subject|2|||
27988448|NCT05320393|81787484|FG000|Overall Study|Lost to Follow-up|1|||
27988449|NCT05320393|81787485|FG001|Overall Study|Lost to Follow-up|2|||
27988450|NCT05320393|81787486|FG002|Overall Study|Lost to Follow-up|1|||
27988451|NCT05320393|81787484|FG000|Overall Study|Moved; too much driving|0|||
27988452|NCT05320393|81787485|FG001|Overall Study|Moved; too much driving|0|||
27988453|NCT05320393|81787486|FG002|Overall Study|Moved; too much driving|2|||
27988454|NCT05320393|81787484|FG000|Overall Study|Did not receive treatment|0|||
27988455|NCT05320393|81787485|FG001|Overall Study|Did not receive treatment|0|||
27988456|NCT05320393|81787486|FG002|Overall Study|Did not receive treatment|1|||
27988457|NCT02294734|81787488|FG000|Overall Study|Adverse Event|5|||
27988458|NCT02294734|81787489|FG001|Overall Study|Adverse Event|5|||
27988459|NCT02294734|81787488|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
27988460|NCT02294734|81787489|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
27988461|NCT02294734|81787488|FG000|Overall Study|Lost to Follow-up|2|||
27796707|NCT00398632|81086124|FG000|Overall Study|Lack of Efficacy|1|||
27796708|NCT00391092|81086125|FG000|Overall Study|Death|78|||
27796709|NCT00391092|81086126|FG001|Overall Study|Death|81|||
27796710|NCT00391092|81086125|FG000|Overall Study|Lost to Follow-up|13|||
27796711|NCT00391092|81086126|FG001|Overall Study|Lost to Follow-up|18|||
27796712|NCT00391092|81086125|FG000|Overall Study|Alive on treatment|29|||
27796713|NCT00391092|81086126|FG001|Overall Study|Alive on treatment|33|||
27796714|NCT00391092|81086125|FG000|Overall Study|Alive in follow-up|88|||
27796715|NCT00391092|81086126|FG001|Overall Study|Alive in follow-up|84|||
27796716|NCT00390572|81086127|FG000|Overall Study|Lost to Follow-up|8|||
27796717|NCT00390572|81086128|FG001|Overall Study|Lost to Follow-up|4|||
27796718|NCT00390572|81086127|FG000|Overall Study|health condition|0|||
27796719|NCT00390572|81086128|FG001|Overall Study|health condition|1|||
27796720|NCT00433771|81086131|FG000|Overall Study|screen fail|14|||
27988462|NCT02294734|81787489|FG001|Overall Study|Lost to Follow-up|0|||
27988463|NCT02294734|81787488|FG000|Overall Study|Physician Decision|2|||
27988464|NCT02294734|81787489|FG001|Overall Study|Physician Decision|1|||
27578942|NCT01310413|80302989|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
27796721|NCT00433771|81086131|FG000|Overall Study|Treated and later found to be ineligible|2|||
27869985|NCT01245283|81357867|FG001|Overall Study|Lost to Follow-up|11|||
27869986|NCT01245283|81357868|FG002|Overall Study|Lost to Follow-up|11|||
27988465|NCT02294734|81787488|FG000|Overall Study|Withdrawal by Subject|4|||
27988466|NCT02294734|81787489|FG001|Overall Study|Withdrawal by Subject|2|||
27988467|NCT01153698|81787496|FG000|Overall Study|Adverse Event|12|||
27988468|NCT01153698|81787496|FG000|Overall Study|Lost to Follow-up|4|||
27988469|NCT01153698|81787496|FG000|Overall Study|Withdrawal by Subject|2|||
27578943|NCT01310413|80302990|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
27796722|NCT00433771|81086131|FG000|Overall Study|Death|2|||
27796723|NCT00433771|81086131|FG000|Overall Study|Failure to deploy stent|1|||
27796724|NCT03099265|81086132|FG000|Overall Study|Adverse Event|1|||
27869987|NCT03410056|81357870|FG000|Overall Study|Decision by Sponsor|0|||
27796725|NCT03494816|81086133|FG000|Overall Study|Protocol Violation|2|||
27796726|NCT03494816|81086133|FG000|Overall Study|Physician Decision|2|||
27796727|NCT03494816|81086133|FG000|Overall Study|Did not start trial treatment|1|||
27796728|NCT03494816|81086133|FG000|Overall Study|Adverse Event|1|||
27796729|NCT00203892|81086134|FG000|Overall Study|Physician Decision|1|||
27796730|NCT00203892|81086135|FG001|Overall Study|Physician Decision|2|||
27796731|NCT00203892|81086136|FG002|Overall Study|Physician Decision|0|||
27796732|NCT00203892|81086134|FG000|Overall Study|Death|1|||
27796733|NCT00203892|81086135|FG001|Overall Study|Death|0|||
27796734|NCT00203892|81086136|FG002|Overall Study|Death|0|||
27796735|NCT00455923|81086137|FG000|Overall Study|Pregnancy|0|||
27796736|NCT00455923|81086138|FG001|Overall Study|Pregnancy|2|||
27988470|NCT01153698|81787496|FG000|Overall Study|Switch to other anticoagulants|4|||
27988471|NCT01153698|81787496|FG000|Overall Study|Other|2|||
27988472|NCT01153698|81787496|FG000|Overall Study|Not treated with Pradaxa|5|||
27988473|NCT01571453|81787497|FG000|Overall Study|Adverse Event|14|||
27675270|NCT00706654|80647371|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
27675271|NCT00706654|80647372|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27675272|NCT00706654|80647373|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27675273|NCT00706654|80647374|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27675274|NCT00706654|80647371|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
27675275|NCT00706654|80647372|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
27675276|NCT00706654|80647373|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
27675277|NCT00706654|80647374|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
27675278|NCT00706654|80647371|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
27675279|NCT00706654|80647372|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
27675280|NCT00706654|80647373|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
27675281|NCT00706654|80647374|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
27675282|NCT00706654|80647371|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
27675283|NCT00706654|80647372|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
27675284|NCT00706654|80647373|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
27675285|NCT00706654|80647374|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
27675286|NCT00706654|80647371|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
27675287|NCT00706654|80647372|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
27675288|NCT00706654|80647373|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
27675289|NCT00706654|80647374|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
27675290|NCT00706654|80647371|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
27675291|NCT00706654|80647372|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
27675292|NCT00706654|80647373|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
27675293|NCT00706654|80647374|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
27675294|NCT00706654|80647371|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
27675295|NCT00706654|80647372|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
27675296|NCT00706654|80647373|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
27675297|NCT00706654|80647374|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
27675298|NCT00706654|80647371|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
27675299|NCT00706654|80647372|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
27675300|NCT00706654|80647373|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
27675301|NCT00706654|80647374|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
27675302|NCT00706654|80647371|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
27675303|NCT00706654|80647372|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
27675304|NCT00706654|80647373|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
27675305|NCT00706654|80647374|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
27675306|NCT02615509|80647375|FG000|Overall Study|Lost to Follow-up|134|||
27675307|NCT02615509|80647375|FG000|Overall Study|Death|4|||
27675308|NCT02615509|80647375|FG000|Overall Study|Withdrawal by Subject|8|||
27675309|NCT00839956|80647378|FG000|Overall Study|Adverse Event|2|||
27796737|NCT00455923|81086137|FG000|Overall Study|Other|3|||
27796738|NCT00455923|81086138|FG001|Overall Study|Other|1|||
27796739|NCT03926728|81086139|FG000|Overall Study|Withdrawal by Subject|0|||
27796740|NCT03926728|81086140|FG001|Overall Study|Withdrawal by Subject|1|||
27988474|NCT01571453|81787498|FG001|Overall Study|Adverse Event|32|||
27675310|NCT00839956|80647378|FG000|Overall Study|Lack of Efficacy|6|||
27675311|NCT00839956|80647378|FG000|Overall Study|Physician Decision|1|||
27796741|NCT03926728|81086141|FG002|Overall Study|Withdrawal by Subject|1|||
27675312|NCT00839956|80647378|FG000|Overall Study|Withdrawal by Subject|3|||
27675313|NCT01646385|80647381|FG000|Overall Study|Death|202|||
27675314|NCT01646385|80647382|FG001|Overall Study|Death|222|||
27675315|NCT01646385|80647381|FG000|Overall Study|Switched to alternate biologic|636|||
27675316|NCT01646385|80647382|FG001|Overall Study|Switched to alternate biologic|649|||
27796742|NCT03926728|81086142|FG003|Overall Study|Withdrawal by Subject|0|||
27796743|NCT03926728|81086143|FG004|Overall Study|Withdrawal by Subject|0|||
27796744|NCT03926728|81086144|FG005|Overall Study|Withdrawal by Subject|1|||
27796745|NCT03926728|81086145|FG006|Overall Study|Withdrawal by Subject|1|||
27675317|NCT03194867|80647383|FG000|Overall Study|Incorrect completion of end of study form|0|||
27675318|NCT03194867|80647384|FG001|Overall Study|Incorrect completion of end of study form|0|||
27675319|NCT03194867|80647385|FG002|Overall Study|Incorrect completion of end of study form|1|||
27675320|NCT03194867|80647386|FG003|Overall Study|Incorrect completion of end of study form|0|||
27675321|NCT01721954|80647388|FG000|Overall Study|Death|58|||
27675322|NCT01721954|80647389|FG001|Overall Study|Death|64|||
27675323|NCT01721954|80647388|FG000|Overall Study|Withdrawal by Subject|8|||
27675324|NCT01721954|80647389|FG001|Overall Study|Withdrawal by Subject|4|||
27675325|NCT01721954|80647388|FG000|Overall Study|Adverse Event|2|||
27675326|NCT01721954|80647389|FG001|Overall Study|Adverse Event|0|||
27675327|NCT01721954|80647388|FG000|Overall Study|Lost to Follow-up|2|||
27675328|NCT01721954|80647389|FG001|Overall Study|Lost to Follow-up|1|||
27675329|NCT01081886|80647390|FG000|Overall Study|Study termination|11|||
27675330|NCT01081886|80647391|FG001|Overall Study|Study termination|13|||
27675331|NCT01986114|80647393|FG000|Overall Study|Adverse Event|59|||
27675332|NCT01986114|80647393|FG000|Overall Study|Lack of Efficacy|23|||
27675333|NCT01986114|80647393|FG000|Overall Study|Withdrawal by Subject|58|||
27675334|NCT01986114|80647393|FG000|Overall Study|Noncompliance|3|||
27675335|NCT01986114|80647393|FG000|Overall Study|Protocol Violation|1|||
27675336|NCT01986114|80647393|FG000|Overall Study|Lost to Follow-up|5|||
27675337|NCT01986114|80647393|FG000|Overall Study|Other reason|7|||
27675338|NCT00681668|80647394|FG000|Overall Study|Protocol Violation|1|||
27675339|NCT00681668|80647394|FG000|Overall Study|Withdrawal by Subject|1|||
27675340|NCT02125279|80647395|FG000|Overall Study|Lack of Efficacy|2|||
27988475|NCT01571453|81787497|FG000|Overall Study|Lack of Efficacy|8|||
27988476|NCT01571453|81787498|FG001|Overall Study|Lack of Efficacy|3|||
27988477|NCT01571453|81787497|FG000|Overall Study|Non-compliance|2|||
27988478|NCT01571453|81787498|FG001|Overall Study|Non-compliance|4|||
27988479|NCT01571453|81787497|FG000|Overall Study|Protocol Violation|1|||
27988480|NCT01571453|81787498|FG001|Overall Study|Protocol Violation|5|||
27988481|NCT01571453|81787497|FG000|Overall Study|Withdrawal of consent|5|||
27988482|NCT01571453|81787498|FG001|Overall Study|Withdrawal of consent|13|||
27988483|NCT01571453|81787497|FG000|Overall Study|Lost to Follow-up|4|||
27675341|NCT02125279|80647395|FG000|Overall Study|Withdrawal by Subject|6|||
27675342|NCT02125279|80647395|FG000|Overall Study|Protocol Violation|1|||
27675343|NCT02125279|80647395|FG000|Overall Study|Lost to Follow-up|4|||
27675344|NCT02975102|80647396|FG000|Overall Study|Adverse Event|2|||
27675345|NCT02975102|80647397|FG001|Overall Study|Adverse Event|1|||
27675346|NCT02567708|80647400|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
27675347|NCT02567708|80647401|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
27675348|NCT02567708|80647400|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
27675349|NCT02567708|80647401|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
27675350|NCT02567708|80647400|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
27675351|NCT02567708|80647401|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
27675352|NCT02567708|80647400|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
27675353|NCT02567708|80647401|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
27675354|NCT01516749|80647402|FG000|Active Therapy|Lost to Follow-up|1|||
27675355|NCT01516749|80647402|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
27675356|NCT00108745|80647403|FG000|Overall Study|Withdrawal by Subject|19|||
27675357|NCT00108745|80647404|FG001|Overall Study|Withdrawal by Subject|12|||
27675358|NCT00108745|80647405|FG002|Overall Study|Withdrawal by Subject|12|||
27675359|NCT00108745|80647403|FG000|Overall Study|Never Treated|8|||
27675360|NCT00108745|80647404|FG001|Overall Study|Never Treated|10|||
27675361|NCT00108745|80647405|FG002|Overall Study|Never Treated|12|||
27675362|NCT00108745|80647403|FG000|Overall Study|Ineligible|7|||
27675363|NCT00108745|80647404|FG001|Overall Study|Ineligible|13|||
27675364|NCT00108745|80647405|FG002|Overall Study|Ineligible|13|||
27675365|NCT02034162|80650112|FG000|Double-blind|Lost to Follow-up|3|||
27675366|NCT02034162|80650113|FG001|Double-blind|Lost to Follow-up|0|||
27675367|NCT02034162|80650114|FG002|Double-blind|Lost to Follow-up|0|||
27675368|NCT02034162|80650112|FG000|Double-blind|Physician Decision|1|||
27675369|NCT02034162|80650113|FG001|Double-blind|Physician Decision|0|||
27675370|NCT02034162|80650114|FG002|Double-blind|Physician Decision|0|||
27675371|NCT02034162|80650112|FG000|Double-blind|Protocol Violation|0|||
27675372|NCT02034162|80650113|FG001|Double-blind|Protocol Violation|1|||
27675373|NCT02034162|80650114|FG002|Double-blind|Protocol Violation|0|||
27988484|NCT01571453|81787498|FG001|Overall Study|Lost to Follow-up|2|||
27675374|NCT02034162|80650112|FG000|Double-blind|Withdrawal by Subject|5|||
27675375|NCT02034162|80650113|FG001|Double-blind|Withdrawal by Subject|7|||
27675376|NCT02034162|80650114|FG002|Double-blind|Withdrawal by Subject|0|||
27675377|NCT01736189|80650117|FG000|Overall Study|Violation of registration criteria|41|||
27675378|NCT01736189|80650117|FG000|Overall Study|Protocol Violation|4|||
27675379|NCT01736189|80650117|FG000|Overall Study|Criteria and protocol violations|1|||
27675380|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
27675381|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
27675382|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
27675383|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
27675384|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
27675385|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
27675386|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
27675387|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
27675388|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
27675389|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
27675390|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
27675391|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
27675392|NCT01216072|80650118|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
27675393|NCT01216072|80650119|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
27675394|NCT01216072|80650118|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
27675395|NCT01216072|80650119|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
27675396|NCT01216072|80650118|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
27675397|NCT01216072|80650119|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
27675398|NCT01216072|80650118|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
27675399|NCT01216072|80650119|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
27675400|NCT02172911|80650120|FG000|Overall Study|Serious Adverse Event|0|||
27675401|NCT02172911|80650121|FG001|Overall Study|Serious Adverse Event|1|||
27675402|NCT02172911|80650120|FG000|Overall Study|Progression of Disease|0|||
27675403|NCT02172911|80650121|FG001|Overall Study|Progression of Disease|1|||
27675404|NCT02172911|80650120|FG000|Overall Study|Loss of insurance coverage|1|||
27675405|NCT02172911|80650121|FG001|Overall Study|Loss of insurance coverage|0|||
27675406|NCT03614676|80650124|FG000|Overall Study|Delivery before planned visit|2|||
27675407|NCT03614676|80650125|FG001|Overall Study|Delivery before planned visit|0|||
27675408|NCT03614676|80650124|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
27675409|NCT03614676|80650125|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
27675410|NCT03614676|80650124|FG000|Overall Study|Migrated / moved from the study area|30|||
27675411|NCT03614676|80650125|FG001|Overall Study|Migrated / moved from the study area|22|||
27675412|NCT03614676|80650124|FG000|Overall Study|Lost to Follow-up|17|||
27675413|NCT03614676|80650125|FG001|Overall Study|Lost to Follow-up|42|||
27675414|NCT03614676|80650124|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
27675415|NCT03614676|80650125|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
27675416|NCT03614676|80650124|FG000|Overall Study|Other|16|||
27675417|NCT03614676|80650125|FG001|Overall Study|Other|47|||
27675418|NCT03614676|80650124|FG000|Overall Study|Protocol Violation|0|||
27675419|NCT03614676|80650125|FG001|Overall Study|Protocol Violation|2|||
27675420|NCT03614676|80650124|FG000|Overall Study|Neonatal event of interest|0|||
27675421|NCT03614676|80650125|FG001|Overall Study|Neonatal event of interest|6|||
27675422|NCT03614676|80650124|FG000|Overall Study|Death in infant greater than 28 days old|0|||
27675423|NCT03614676|80650125|FG001|Overall Study|Death in infant greater than 28 days old|12|||
27675424|NCT03614676|80650124|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
27675425|NCT03614676|80650125|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
27675426|NCT01432626|80650126|FG000|Overall Study|LV function recovered|2|||
27675427|NCT01432626|80650126|FG000|Overall Study|Withdrawal by Subject|2|||
27675428|NCT01432626|80650126|FG000|Overall Study|Only 1 image competed|2|||
27675429|NCT01432626|80650126|FG000|Overall Study|Imaging agent not available|1|||
27675430|NCT02127125|80650127|FG000|Overall Study|Lost to Follow-up|0|||
27675431|NCT02127125|80650128|FG001|Overall Study|Lost to Follow-up|0|||
27675432|NCT02127125|80650129|FG002|Overall Study|Lost to Follow-up|0|||
27675433|NCT02127125|80650130|FG003|Overall Study|Lost to Follow-up|0|||
27675434|NCT02127125|80650131|FG004|Overall Study|Lost to Follow-up|2|||
27675435|NCT02127125|80650132|FG005|Overall Study|Lost to Follow-up|1|||
27675436|NCT02127125|80650133|FG006|Overall Study|Lost to Follow-up|0|||
27675437|NCT02127125|80650134|FG007|Overall Study|Lost to Follow-up|0|||
27675438|NCT02127125|80650135|FG008|Overall Study|Lost to Follow-up|0|||
27675439|NCT02127125|80650127|FG000|Overall Study|Withdrawal by Subject|0|||
27675440|NCT02127125|80650128|FG001|Overall Study|Withdrawal by Subject|0|||
27675441|NCT02127125|80650129|FG002|Overall Study|Withdrawal by Subject|0|||
27675442|NCT02127125|80650130|FG003|Overall Study|Withdrawal by Subject|1|||
27675443|NCT02127125|80650131|FG004|Overall Study|Withdrawal by Subject|0|||
27675444|NCT02127125|80650132|FG005|Overall Study|Withdrawal by Subject|0|||
27675445|NCT02127125|80650133|FG006|Overall Study|Withdrawal by Subject|0|||
27675446|NCT02127125|80650134|FG007|Overall Study|Withdrawal by Subject|0|||
27675447|NCT02127125|80650135|FG008|Overall Study|Withdrawal by Subject|0|||
27796746|NCT03926728|81086146|FG007|Overall Study|Withdrawal by Subject|0|||
27796747|NCT03926728|81086147|FG008|Overall Study|Withdrawal by Subject|0|||
27796748|NCT03926728|81086148|FG009|Overall Study|Withdrawal by Subject|1|||
27796749|NCT03926728|81086149|FG010|Overall Study|Withdrawal by Subject|0|||
27796750|NCT03926728|81086150|FG011|Overall Study|Withdrawal by Subject|0|||
27796751|NCT03875235|81086153|FG000|Overall Study|Ongoing study treatment|63|||
27796752|NCT03875235|81086154|FG001|Overall Study|Ongoing study treatment|20|||
27796753|NCT03875235|81086153|FG000|Overall Study|Off treatment|77|||
27796754|NCT03875235|81086154|FG001|Overall Study|Off treatment|91|||
27796755|NCT03875235|81086153|FG000|Overall Study|Withdrawal by Subject|3|||
27796756|NCT03875235|81086154|FG001|Overall Study|Withdrawal by Subject|10|||
27796757|NCT03875235|81086153|FG000|Overall Study|Death|198|||
27796758|NCT03875235|81086154|FG001|Overall Study|Death|223|||
27796759|NCT00265239|81086157|FG000|Overall Study|Adverse Event|2|||
27796760|NCT00265239|81086158|FG001|Overall Study|Adverse Event|1|||
27796761|NCT00742859|81086159|FG000|Overall Study|Adverse Event|5|||
27796762|NCT00742859|81086160|FG001|Overall Study|Adverse Event|6|||
27796763|NCT00742859|81086161|FG002|Overall Study|Adverse Event|3|||
27796764|NCT00742859|81086162|FG003|Overall Study|Adverse Event|1|||
27796765|NCT00742859|81086159|FG000|Overall Study|Death|1|||
27796766|NCT00742859|81086160|FG001|Overall Study|Death|0|||
27796767|NCT00742859|81086161|FG002|Overall Study|Death|0|||
27796768|NCT00742859|81086162|FG003|Overall Study|Death|1|||
27796769|NCT00742859|81086159|FG000|Overall Study|Physician Decision|1|||
27796770|NCT00742859|81086160|FG001|Overall Study|Physician Decision|2|||
27796771|NCT00742859|81086161|FG002|Overall Study|Physician Decision|0|||
27796772|NCT00742859|81086162|FG003|Overall Study|Physician Decision|0|||
27796773|NCT00742859|81086159|FG000|Overall Study|Withdrawal by Subject|4|||
27796774|NCT00742859|81086160|FG001|Overall Study|Withdrawal by Subject|2|||
27796775|NCT00742859|81086161|FG002|Overall Study|Withdrawal by Subject|4|||
27796776|NCT00742859|81086162|FG003|Overall Study|Withdrawal by Subject|1|||
27796777|NCT00742859|81086159|FG000|Overall Study|Endpoint|0|||
27796778|NCT00742859|81086160|FG001|Overall Study|Endpoint|1|||
27796779|NCT00742859|81086161|FG002|Overall Study|Endpoint|1|||
27796780|NCT00742859|81086162|FG003|Overall Study|Endpoint|2|||
27796781|NCT00742859|81086159|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
27796782|NCT00742859|81086160|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
27796783|NCT00742859|81086161|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
27796784|NCT00742859|81086162|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
27796785|NCT00742859|81086159|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
27796786|NCT00742859|81086160|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
27796787|NCT00742859|81086161|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
27796788|NCT00742859|81086162|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
27796789|NCT00742859|81086159|FG000|Overall Study|Sponsor request patient out of town|0|||
27796790|NCT00742859|81086160|FG001|Overall Study|Sponsor request patient out of town|0|||
27796791|NCT00742859|81086161|FG002|Overall Study|Sponsor request patient out of town|1|||
27796792|NCT00742859|81086162|FG003|Overall Study|Sponsor request patient out of town|1|||
27796793|NCT00742859|81086159|FG000|Overall Study|Site error|0|||
27796794|NCT00742859|81086160|FG001|Overall Study|Site error|0|||
27796795|NCT00742859|81086161|FG002|Overall Study|Site error|1|||
27796796|NCT00742859|81086162|FG003|Overall Study|Site error|1|||
27796797|NCT03069365|81086164|FG000|Overall Study|Adverse Event|1|||
27796798|NCT00424632|81086167|FG000|Overall Study|Death|0|||
27796799|NCT00424632|81086168|FG001|Overall Study|Death|0|||
27796800|NCT00424632|81086169|FG002|Overall Study|Death|0|||
27796801|NCT00424632|81086170|FG003|Overall Study|Death|0|||
27796802|NCT00424632|81086171|FG004|Overall Study|Death|0|||
27578944|NCT01310413|80302991|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
27578945|NCT01310413|80302992|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
27578946|NCT01310413|80302993|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
27578947|NCT01310413|80302987|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
27578948|NCT01310413|80302988|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
27578949|NCT01310413|80302989|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
27578950|NCT01310413|80302990|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
27578951|NCT01310413|80302991|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
27578952|NCT01310413|80302992|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
27578953|NCT01310413|80302993|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
27578954|NCT02104557|80302994|FG000|Overall Study|Adverse Event|24|||
27578955|NCT02104557|80302994|FG000|Overall Study|Lost to Follow-up|34|||
27796803|NCT00424632|81086172|FG005|Overall Study|Death|2|||
27988485|NCT01571453|81787497|FG000|Overall Study|Administrative or other reason(s)|4|||
27594155|NCT02137369|80352457|FG000|Overall Study|Lost to Follow-up|1|||
27796804|NCT00424632|81086173|FG006|Overall Study|Death|0|||
27796805|NCT00424632|81086174|FG007|Overall Study|Death|0|||
27796806|NCT00424632|81086175|FG008|Overall Study|Death|0|||
27796807|NCT00424632|81086176|FG009|Overall Study|Death|0|||
27796808|NCT00424632|81086167|FG000|Overall Study|Adverse Event|0|||
27796809|NCT00424632|81086168|FG001|Overall Study|Adverse Event|0|||
27578956|NCT02104557|80302994|FG000|Overall Study|Violated the usage and dosage|14|||
27578957|NCT02104557|80302994|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
27578958|NCT02104557|80302994|FG000|Overall Study|Administered Sayana prior to the contract|1|||
27578959|NCT02104557|80302994|FG000|Overall Study|Other|17|||
27578960|NCT02104557|80302994|FG000|Overall Study|Change to other contraception methods|5|||
27796810|NCT00424632|81086169|FG002|Overall Study|Adverse Event|0|||
27796811|NCT00424632|81086170|FG003|Overall Study|Adverse Event|0|||
27796812|NCT00424632|81086171|FG004|Overall Study|Adverse Event|0|||
27796813|NCT00424632|81086172|FG005|Overall Study|Adverse Event|0|||
27796814|NCT00424632|81086173|FG006|Overall Study|Adverse Event|0|||
27796815|NCT00424632|81086174|FG007|Overall Study|Adverse Event|0|||
27796816|NCT00424632|81086175|FG008|Overall Study|Adverse Event|3|||
27796817|NCT00424632|81086176|FG009|Overall Study|Adverse Event|2|||
27796818|NCT00424632|81086167|FG000|Overall Study|Global deterioration of health status|0|||
27796819|NCT00424632|81086168|FG001|Overall Study|Global deterioration of health status|0|||
27796820|NCT00424632|81086169|FG002|Overall Study|Global deterioration of health status|0|||
27796821|NCT00424632|81086170|FG003|Overall Study|Global deterioration of health status|1|||
27796822|NCT00424632|81086171|FG004|Overall Study|Global deterioration of health status|1|||
27796823|NCT00424632|81086172|FG005|Overall Study|Global deterioration of health status|0|||
27796824|NCT00424632|81086173|FG006|Overall Study|Global deterioration of health status|0|||
27796825|NCT00424632|81086174|FG007|Overall Study|Global deterioration of health status|0|||
27796826|NCT00424632|81086175|FG008|Overall Study|Global deterioration of health status|0|||
27796827|NCT00424632|81086176|FG009|Overall Study|Global deterioration of health status|0|||
27796828|NCT00424632|81086167|FG000|Overall Study|Objective progression or relapse|1|||
27796829|NCT00424632|81086168|FG001|Overall Study|Objective progression or relapse|1|||
27796830|NCT00424632|81086169|FG002|Overall Study|Objective progression or relapse|1|||
27796831|NCT00424632|81086170|FG003|Overall Study|Objective progression or relapse|2|||
27796832|NCT00424632|81086171|FG004|Overall Study|Objective progression or relapse|2|||
27796833|NCT00424632|81086172|FG005|Overall Study|Objective progression or relapse|13|||
27796834|NCT00424632|81086173|FG006|Overall Study|Objective progression or relapse|7|||
27796835|NCT00424632|81086174|FG007|Overall Study|Objective progression or relapse|3|||
27796836|NCT00424632|81086175|FG008|Overall Study|Objective progression or relapse|12|||
27796837|NCT00424632|81086176|FG009|Overall Study|Objective progression or relapse|4|||
27796838|NCT00424632|81086167|FG000|Overall Study|Other|0|||
27796839|NCT00424632|81086168|FG001|Overall Study|Other|0|||
27988486|NCT01571453|81787498|FG001|Overall Study|Administrative or other reason(s)|3|||
27988487|NCT01174173|81787499|FG000|Overall Study|drug-drug interaction|1|||
27988488|NCT01440881|81787500|FG000|Overall Study|Death|0|||
27988489|NCT01440881|81787501|FG001|Overall Study|Death|1|||
27988490|NCT03216746|81787502|FG000|Overall Study|Lost to Follow-up|6|||
27796840|NCT00424632|81086169|FG002|Overall Study|Other|0|||
27796841|NCT00424632|81086170|FG003|Overall Study|Other|1|||
27796842|NCT00424632|81086171|FG004|Overall Study|Other|0|||
27796843|NCT00424632|81086172|FG005|Overall Study|Other|0|||
27796844|NCT00424632|81086173|FG006|Overall Study|Other|0|||
27796845|NCT00424632|81086174|FG007|Overall Study|Other|0|||
27796846|NCT00424632|81086175|FG008|Overall Study|Other|1|||
27796847|NCT00424632|81086176|FG009|Overall Study|Other|0|||
27796848|NCT03033069|81086179|FG000|Overall Study|Adverse Event|6|||
27796849|NCT03033069|81086180|FG001|Overall Study|Adverse Event|7|||
27796850|NCT03033069|81086181|FG002|Overall Study|Adverse Event|4|||
27796851|NCT03033069|81086182|FG003|Overall Study|Adverse Event|6|||
27796852|NCT03033069|81086179|FG000|Overall Study|Lack of Efficacy|0|||
27796853|NCT03033069|81086180|FG001|Overall Study|Lack of Efficacy|0|||
27796854|NCT03033069|81086181|FG002|Overall Study|Lack of Efficacy|1|||
27796855|NCT03033069|81086182|FG003|Overall Study|Lack of Efficacy|0|||
27796856|NCT03033069|81086179|FG000|Overall Study|Lost to Follow-up|6|||
27796857|NCT03033069|81086180|FG001|Overall Study|Lost to Follow-up|5|||
27796858|NCT03033069|81086181|FG002|Overall Study|Lost to Follow-up|5|||
27796859|NCT03033069|81086182|FG003|Overall Study|Lost to Follow-up|6|||
27796860|NCT03033069|81086179|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27796861|NCT03033069|81086180|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27796862|NCT03033069|81086181|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27796863|NCT03033069|81086182|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27796864|NCT03033069|81086179|FG000|Overall Study|Protocol Deviation|0|||
27796865|NCT03033069|81086180|FG001|Overall Study|Protocol Deviation|1|||
27796866|NCT03033069|81086181|FG002|Overall Study|Protocol Deviation|0|||
27988491|NCT03216746|81787503|FG001|Overall Study|Lost to Follow-up|8|||
27796867|NCT03033069|81086182|FG003|Overall Study|Protocol Deviation|0|||
27796868|NCT03033069|81086179|FG000|Overall Study|Withdrawal by Subject|10|||
27796869|NCT03033069|81086180|FG001|Overall Study|Withdrawal by Subject|10|||
27988492|NCT03216746|81787504|FG002|Overall Study|Lost to Follow-up|5|||
27578961|NCT02104557|80302994|FG000|Overall Study|Discontinuation due to no pain|1|||
27578962|NCT02104557|80302994|FG000|Overall Study|Withdrawal consent|2|||
27796870|NCT03033069|81086181|FG002|Overall Study|Withdrawal by Subject|11|||
27988493|NCT03216746|81787505|FG003|Overall Study|Lost to Follow-up|6|||
27796871|NCT03033069|81086182|FG003|Overall Study|Withdrawal by Subject|6|||
27796872|NCT03033069|81086179|FG000|Overall Study|Withdrawal By Caregiver|1|||
27796873|NCT03033069|81086180|FG001|Overall Study|Withdrawal By Caregiver|0|||
27796874|NCT03033069|81086181|FG002|Overall Study|Withdrawal By Caregiver|0|||
27796875|NCT03033069|81086182|FG003|Overall Study|Withdrawal By Caregiver|0|||
27796876|NCT03033069|81086179|FG000|Overall Study|Reason not Specified|0|||
27796877|NCT03033069|81086180|FG001|Overall Study|Reason not Specified|1|||
27796878|NCT03033069|81086181|FG002|Overall Study|Reason not Specified|0|||
27796879|NCT03033069|81086182|FG003|Overall Study|Reason not Specified|1|||
27796880|NCT00138658|81086183|FG000|Overall Study|Adverse Event|23|||
27796881|NCT00138658|81086183|FG000|Overall Study|Death|1|||
27796882|NCT00138658|81086183|FG000|Overall Study|Disease Progression|21|||
27796883|NCT00138658|81086183|FG000|Overall Study|Physician Decision|11|||
27796884|NCT00138658|81086183|FG000|Overall Study|Withdrawal by Subject|5|||
27796885|NCT01788163|81086192|FG000|Overall Study|Other|53|||
27796886|NCT01788163|81086193|FG001|Overall Study|Other|0|||
27796887|NCT01788163|81086194|FG002|Overall Study|Other|0|||
27796888|NCT01788163|81086195|FG003|Overall Study|Other|0|||
27796889|NCT01788163|81086196|FG004|Overall Study|Other|0|||
27796890|NCT01788163|81086197|FG005|Overall Study|Other|7|||
27796891|NCT01788163|81086198|FG006|Overall Study|Other|1|||
27796892|NCT01788163|81086199|FG007|Overall Study|Other|48|||
27796893|NCT01788163|81086200|FG008|Overall Study|Other|15|||
27796894|NCT01788163|81086192|FG000|Overall Study|Withdrawal by Subject|2|||
27796895|NCT01788163|81086193|FG001|Overall Study|Withdrawal by Subject|0|||
27796896|NCT01788163|81086194|FG002|Overall Study|Withdrawal by Subject|0|||
27796897|NCT01788163|81086195|FG003|Overall Study|Withdrawal by Subject|0|||
27796898|NCT01788163|81086196|FG004|Overall Study|Withdrawal by Subject|0|||
27796899|NCT01788163|81086197|FG005|Overall Study|Withdrawal by Subject|0|||
27796900|NCT01788163|81086198|FG006|Overall Study|Withdrawal by Subject|0|||
27796901|NCT01788163|81086199|FG007|Overall Study|Withdrawal by Subject|0|||
27796902|NCT01788163|81086200|FG008|Overall Study|Withdrawal by Subject|1|||
27796903|NCT01215955|81086202|FG000|Overall Study|Adverse Event|1|||
27796904|NCT01215955|81086203|FG001|Overall Study|Adverse Event|4|||
27796905|NCT01215955|81086204|FG002|Overall Study|Adverse Event|2|||
27796906|NCT01215955|81086205|FG003|Overall Study|Adverse Event|3|||
27796907|NCT01215955|81086202|FG000|Overall Study|Death|2|||
27796908|NCT01215955|81086203|FG001|Overall Study|Death|0|||
27796909|NCT01215955|81086204|FG002|Overall Study|Death|1|||
27796910|NCT01215955|81086205|FG003|Overall Study|Death|3|||
27796911|NCT01215955|81086202|FG000|Overall Study|Entry Criteria Not Met|1|||
27796912|NCT01215955|81086203|FG001|Overall Study|Entry Criteria Not Met|3|||
27796913|NCT01215955|81086204|FG002|Overall Study|Entry Criteria Not Met|4|||
27578963|NCT02104557|80302994|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
27578964|NCT02104557|80302994|FG000|Overall Study|Discontinuation of contraception|9|||
27578965|NCT02822794|80302995|FG000|Overall Study|Withdrew Consent|1|||
27578966|NCT02822794|80302996|FG001|Overall Study|Withdrew Consent|0|||
27578967|NCT00459134|80302997|FG000|Overall Study|Physician Decision|1|||
27578968|NCT00459134|80302998|FG001|Overall Study|Physician Decision|1|||
27578969|NCT00459134|80302997|FG000|Overall Study|Withdrawal by Subject|8|||
27578970|NCT00459134|80302998|FG001|Overall Study|Withdrawal by Subject|7|||
27578971|NCT00459134|80302997|FG000|Overall Study|Lost to Follow-up|6|||
27578972|NCT00459134|80302998|FG001|Overall Study|Lost to Follow-up|7|||
27578973|NCT00459134|80302997|FG000|Overall Study|Surgery|1|||
27796914|NCT01215955|81086205|FG003|Overall Study|Entry Criteria Not Met|7|||
27796915|NCT01215955|81086202|FG000|Overall Study|Lack of Efficacy|1|||
27796916|NCT01215955|81086203|FG001|Overall Study|Lack of Efficacy|2|||
27988494|NCT01078168|81787506|FG000|Overall Study|Physician Decision|0|||
27988495|NCT01078168|81787507|FG001|Overall Study|Physician Decision|1|||
27988496|NCT01123395|81787508|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
27988497|NCT01123395|81787509|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
27988498|NCT03659136|81787517|FG000|Overall Study|Not treated|2|||
27988499|NCT03659136|81787518|FG001|Overall Study|Not treated|0|||
27988500|NCT03659136|81787517|FG000|Overall Study|Covid-19 related|1|||
27988501|NCT03659136|81787518|FG001|Overall Study|Covid-19 related|1|||
27988502|NCT03659136|81787517|FG000|Overall Study|Withdrawal by Subject|1|||
27988503|NCT03659136|81787518|FG001|Overall Study|Withdrawal by Subject|6|||
27988504|NCT03659136|81787517|FG000|Overall Study|Adverse Event|4|||
27988505|NCT03659136|81787518|FG001|Overall Study|Adverse Event|6|||
27988506|NCT03659136|81787517|FG000|Overall Study|Progressive disease|37|||
27578974|NCT00459134|80302998|FG001|Overall Study|Surgery|2|||
27796917|NCT01215955|81086204|FG002|Overall Study|Lack of Efficacy|1|||
27796918|NCT01215955|81086205|FG003|Overall Study|Lack of Efficacy|0|||
27796919|NCT01215955|81086202|FG000|Overall Study|Lost to Follow-up|4|||
27796920|NCT01215955|81086203|FG001|Overall Study|Lost to Follow-up|4|||
27578975|NCT00459134|80302997|FG000|Overall Study|Toxicity|4|||
27796921|NCT01215955|81086204|FG002|Overall Study|Lost to Follow-up|8|||
27796922|NCT01215955|81086205|FG003|Overall Study|Lost to Follow-up|9|||
27796923|NCT01215955|81086202|FG000|Overall Study|Physician Decision|4|||
27988507|NCT03659136|81787518|FG001|Overall Study|Progressive disease|31|||
27796924|NCT01215955|81086203|FG001|Overall Study|Physician Decision|10|||
27796925|NCT01215955|81086204|FG002|Overall Study|Physician Decision|8|||
27796926|NCT01215955|81086205|FG003|Overall Study|Physician Decision|11|||
27796927|NCT01215955|81086202|FG000|Overall Study|Protocol Violation|17|||
27796928|NCT01215955|81086203|FG001|Overall Study|Protocol Violation|13|||
27796929|NCT01215955|81086204|FG002|Overall Study|Protocol Violation|8|||
27796930|NCT01215955|81086205|FG003|Overall Study|Protocol Violation|8|||
27796931|NCT01215955|81086202|FG000|Overall Study|Sponsor Decision|1|||
27796932|NCT01215955|81086203|FG001|Overall Study|Sponsor Decision|2|||
27796933|NCT01215955|81086204|FG002|Overall Study|Sponsor Decision|0|||
27796934|NCT01215955|81086205|FG003|Overall Study|Sponsor Decision|1|||
27796935|NCT01215955|81086202|FG000|Overall Study|Withdrawal by Subject|14|||
27796936|NCT01215955|81086203|FG001|Overall Study|Withdrawal by Subject|15|||
27796937|NCT01215955|81086204|FG002|Overall Study|Withdrawal by Subject|13|||
27796938|NCT01215955|81086205|FG003|Overall Study|Withdrawal by Subject|9|||
27796939|NCT01215955|81086202|FG000|Overall Study|Quality Issues|0|||
27796940|NCT01215955|81086203|FG001|Overall Study|Quality Issues|0|||
27796941|NCT01215955|81086204|FG002|Overall Study|Quality Issues|3|||
27796942|NCT01215955|81086205|FG003|Overall Study|Quality Issues|2|||
27796943|NCT00798707|81086208|FG000|Overall Study|Adverse Event|6|||
27796944|NCT00798707|81086209|FG001|Overall Study|Adverse Event|8|||
27796945|NCT00798707|81086210|FG002|Overall Study|Adverse Event|8|||
27796946|NCT00798707|81086208|FG000|Overall Study|Failed to return|2|||
27796947|NCT00798707|81086209|FG001|Overall Study|Failed to return|2|||
27796948|NCT00798707|81086210|FG002|Overall Study|Failed to return|0|||
27796949|NCT00798707|81086208|FG000|Overall Study|Investigator|0|||
27796950|NCT00798707|81086209|FG001|Overall Study|Investigator|1|||
27796951|NCT00798707|81086210|FG002|Overall Study|Investigator|2|||
27796952|NCT00798707|81086208|FG000|Overall Study|Lack of Efficacy|2|||
27796953|NCT00798707|81086209|FG001|Overall Study|Lack of Efficacy|2|||
27796954|NCT00798707|81086210|FG002|Overall Study|Lack of Efficacy|1|||
27796955|NCT00798707|81086208|FG000|Overall Study|Lost to Follow-up|5|||
27796956|NCT00798707|81086209|FG001|Overall Study|Lost to Follow-up|6|||
27796957|NCT00798707|81086210|FG002|Overall Study|Lost to Follow-up|6|||
27796958|NCT00798707|81086208|FG000|Overall Study|Other|0|||
27796959|NCT00798707|81086209|FG001|Overall Study|Other|1|||
27796960|NCT00798707|81086210|FG002|Overall Study|Other|0|||
27796961|NCT00798707|81086208|FG000|Overall Study|Protocol Violation|4|||
27796962|NCT00798707|81086209|FG001|Overall Study|Protocol Violation|0|||
27988508|NCT03659136|81787517|FG000|Overall Study|Study closure|2|||
27578976|NCT00459134|80302998|FG001|Overall Study|Toxicity|5|||
27578977|NCT00459134|80302997|FG000|Overall Study|Progression|1|||
27578978|NCT00459134|80302998|FG001|Overall Study|Progression|0|||
27578979|NCT00459134|80302997|FG000|Overall Study|Multiple Reasons|2|||
27578980|NCT00459134|80302998|FG001|Overall Study|Multiple Reasons|3|||
27578981|NCT01126541|80303005|FG000|Overall Study|Adverse Event|0|||
27578982|NCT01126541|80303006|FG001|Overall Study|Adverse Event|2|||
27578983|NCT01126541|80303007|FG002|Overall Study|Adverse Event|4|||
27578984|NCT01126541|80303005|FG000|Overall Study|Death|0|||
27578985|NCT01126541|80303006|FG001|Overall Study|Death|1|||
27578986|NCT01126541|80303007|FG002|Overall Study|Death|0|||
27578987|NCT01126541|80303005|FG000|Overall Study|Lack of Efficacy|6|||
27578988|NCT01126541|80303006|FG001|Overall Study|Lack of Efficacy|1|||
27578989|NCT01126541|80303007|FG002|Overall Study|Lack of Efficacy|11|||
27578990|NCT01126541|80303005|FG000|Overall Study|Lost to Follow-up|1|||
27578991|NCT01126541|80303006|FG001|Overall Study|Lost to Follow-up|2|||
27578992|NCT01126541|80303007|FG002|Overall Study|Lost to Follow-up|2|||
27578993|NCT01126541|80303005|FG000|Overall Study|Withdrawal by Subject|2|||
27578994|NCT01126541|80303006|FG001|Overall Study|Withdrawal by Subject|5|||
27578995|NCT01126541|80303007|FG002|Overall Study|Withdrawal by Subject|6|||
27988509|NCT03659136|81787518|FG001|Overall Study|Study closure|2|||
27988510|NCT03659136|81787517|FG000|Overall Study|Sponsor decision/recommendation|3|||
27988511|NCT03659136|81787518|FG001|Overall Study|Sponsor decision/recommendation|2|||
27988512|NCT03659136|81787517|FG000|Overall Study|Switched to other drug/therapy|2|||
27988513|NCT03659136|81787518|FG001|Overall Study|Switched to other drug/therapy|2|||
27988514|NCT03659136|81787517|FG000|Overall Study|Lack of clinical benefit|0|||
27578996|NCT01126541|80303005|FG000|Overall Study|Protocol Violation|0|||
27988515|NCT03659136|81787518|FG001|Overall Study|Lack of clinical benefit|1|||
27578997|NCT01126541|80303006|FG001|Overall Study|Protocol Violation|0|||
27796963|NCT00798707|81086210|FG002|Overall Study|Protocol Violation|2|||
27796964|NCT00798707|81086208|FG000|Overall Study|Withdrawal by Subject|3|||
27796965|NCT00798707|81086209|FG001|Overall Study|Withdrawal by Subject|8|||
27796966|NCT00798707|81086210|FG002|Overall Study|Withdrawal by Subject|2|||
27578998|NCT01126541|80303007|FG002|Overall Study|Protocol Violation|1|||
27578999|NCT01126541|80303005|FG000|Overall Study|Administrative reason or other|1|||
27579000|NCT01126541|80303006|FG001|Overall Study|Administrative reason or other|1|||
27796967|NCT00798707|81086208|FG000|Overall Study|Randomized not treated|4|||
27796968|NCT00798707|81086209|FG001|Overall Study|Randomized not treated|5|||
27796969|NCT00798707|81086210|FG002|Overall Study|Randomized not treated|1|||
27988516|NCT00659230|81787519|FG000|Overall Study|Lost to Follow-up|2|||
27988517|NCT00659230|81787520|FG001|Overall Study|Lost to Follow-up|5|||
27988518|NCT00659230|81787519|FG000|Overall Study|Lost source documentation|5|||
27988519|NCT00659230|81787520|FG001|Overall Study|Lost source documentation|4|||
27988520|NCT00659230|81787519|FG000|Overall Study|Did not return post-randomization|2|||
27988521|NCT00659230|81787520|FG001|Overall Study|Did not return post-randomization|3|||
27869988|NCT03410056|81357871|FG001|Overall Study|Decision by Sponsor|0|||
27869989|NCT03410056|81357872|FG002|Overall Study|Decision by Sponsor|3|||
27869990|NCT03410056|81357873|FG003|Overall Study|Decision by Sponsor|0|||
27869991|NCT03410056|81357874|FG004|Overall Study|Decision by Sponsor|0|||
27869992|NCT03410056|81357875|FG005|Overall Study|Decision by Sponsor|0|||
27869993|NCT03410056|81357876|FG006|Overall Study|Decision by Sponsor|0|||
27869994|NCT03410056|81357870|FG000|Overall Study|Withdrawal by Subject|0|||
27869995|NCT03410056|81357871|FG001|Overall Study|Withdrawal by Subject|2|||
27869996|NCT03410056|81357872|FG002|Overall Study|Withdrawal by Subject|5|||
27869997|NCT03410056|81357873|FG003|Overall Study|Withdrawal by Subject|5|||
27869998|NCT03410056|81357874|FG004|Overall Study|Withdrawal by Subject|0|||
27869999|NCT03410056|81357875|FG005|Overall Study|Withdrawal by Subject|0|||
27870000|NCT03410056|81357876|FG006|Overall Study|Withdrawal by Subject|0|||
27870001|NCT01547390|81357877|FG000|Overall Study|Withdrawal by Subject|10|||
27870002|NCT01547390|81357878|FG001|Overall Study|Withdrawal by Subject|7|||
27870003|NCT01547390|81357877|FG000|Overall Study|termination of pregnancy|0|||
27870004|NCT01547390|81357878|FG001|Overall Study|termination of pregnancy|1|||
27870005|NCT01547390|81357877|FG000|Overall Study|Lost to Follow-up|0|||
27870006|NCT01547390|81357878|FG001|Overall Study|Lost to Follow-up|2|||
27870007|NCT01547390|81357877|FG000|Overall Study|Adverse Event|3|||
27870008|NCT01547390|81357878|FG001|Overall Study|Adverse Event|0|||
27870009|NCT00247676|81357884|FG000|Overall Study|Death|5|||
27870010|NCT00247676|81357884|FG000|Overall Study|Adverse Event|11|||
27870011|NCT00247676|81357884|FG000|Overall Study|Lack of Efficacy|15|||
27870012|NCT00247676|81357884|FG000|Overall Study|Other|3|||
27870013|NCT00247676|81357884|FG000|Overall Study|Withdrawal by Subject|2|||
27870014|NCT02553772|81357885|FG000|Overall Study|Adverse Event|2|||
27870015|NCT02553772|81357886|FG001|Overall Study|Adverse Event|3|||
27870016|NCT02553772|81357885|FG000|Overall Study|Lost to Follow-up|2|||
27870017|NCT02553772|81357886|FG001|Overall Study|Lost to Follow-up|1|||
27870018|NCT02553772|81357885|FG000|Overall Study|Withdrawal of Consent|1|||
27870019|NCT02553772|81357886|FG001|Overall Study|Withdrawal of Consent|1|||
27988522|NCT04167137|81787525|FG000|Overall Study|Disease progression|1|||
27988523|NCT04167137|81787526|FG001|Overall Study|Disease progression|1|||
27988524|NCT04167137|81787527|FG002|Overall Study|Disease progression|3|||
27988525|NCT04167137|81787528|FG003|Overall Study|Disease progression|3|||
27988526|NCT04167137|81787529|FG004|Overall Study|Disease progression|2|||
27594156|NCT02137369|80352458|FG001|Overall Study|Lost to Follow-up|0|||
27594157|NCT02137369|80352457|FG000|Overall Study|Moved away|2|||
27594158|NCT02137369|80352458|FG001|Overall Study|Moved away|0|||
27594159|NCT03561090|80352459|FG000|Overall Study|Adverse Event|11|||
27594160|NCT03561090|80352460|FG001|Overall Study|Adverse Event|7|||
27594161|NCT03561090|80352459|FG000|Overall Study|Non-Compliance With Study Drug|2|||
27870020|NCT02553772|81357885|FG000|Overall Study|Lack of Efficacy|1|||
27594162|NCT03561090|80352460|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27594163|NCT03561090|80352459|FG000|Overall Study|Protocol Violation|2|||
27870021|NCT02553772|81357886|FG001|Overall Study|Lack of Efficacy|0|||
27870022|NCT02553772|81357885|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27988527|NCT04167137|81787530|FG005|Overall Study|Disease progression|3|||
27988528|NCT04167137|81787531|FG006|Overall Study|Disease progression|2|||
27988529|NCT04167137|81787532|FG007|Overall Study|Disease progression|2|||
27988530|NCT04167137|81787525|FG000|Overall Study|Withdrawal by Subject|1|||
27988531|NCT04167137|81787526|FG001|Overall Study|Withdrawal by Subject|0|||
27988532|NCT04167137|81787527|FG002|Overall Study|Withdrawal by Subject|0|||
27988533|NCT04167137|81787528|FG003|Overall Study|Withdrawal by Subject|1|||
27988534|NCT04167137|81787529|FG004|Overall Study|Withdrawal by Subject|0|||
27988535|NCT04167137|81787530|FG005|Overall Study|Withdrawal by Subject|2|||
27988536|NCT04167137|81787531|FG006|Overall Study|Withdrawal by Subject|1|||
27988537|NCT04167137|81787532|FG007|Overall Study|Withdrawal by Subject|0|||
27675448|NCT02127125|80650127|FG000|Overall Study|Physician Decision|0|||
27675449|NCT02127125|80650128|FG001|Overall Study|Physician Decision|0|||
27675450|NCT02127125|80650129|FG002|Overall Study|Physician Decision|1|||
27675451|NCT02127125|80650130|FG003|Overall Study|Physician Decision|0|||
27675452|NCT02127125|80650131|FG004|Overall Study|Physician Decision|1|||
27675453|NCT02127125|80650132|FG005|Overall Study|Physician Decision|2|||
27870023|NCT02553772|81357886|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27870024|NCT00196326|81357887|FG000|Overall Study|Did not meet protocol requirements|64|||
27870025|NCT00196326|81357887|FG000|Overall Study|Non-compliance with the protocol|81|||
27988538|NCT04167137|81787525|FG000|Overall Study|Adverse Event|0|||
27988539|NCT04167137|81787526|FG001|Overall Study|Adverse Event|0|||
27988540|NCT04167137|81787527|FG002|Overall Study|Adverse Event|0|||
27988541|NCT04167137|81787528|FG003|Overall Study|Adverse Event|0|||
27988542|NCT04167137|81787529|FG004|Overall Study|Adverse Event|0|||
27988543|NCT04167137|81787530|FG005|Overall Study|Adverse Event|1|||
27988544|NCT04167137|81787531|FG006|Overall Study|Adverse Event|0|||
27988545|NCT04167137|81787532|FG007|Overall Study|Adverse Event|1|||
27988546|NCT04167137|81787525|FG000|Overall Study|Physician Decision|0|||
27988547|NCT04167137|81787526|FG001|Overall Study|Physician Decision|0|||
27988548|NCT04167137|81787527|FG002|Overall Study|Physician Decision|0|||
27988549|NCT04167137|81787528|FG003|Overall Study|Physician Decision|1|||
27988550|NCT04167137|81787529|FG004|Overall Study|Physician Decision|0|||
27988551|NCT04167137|81787530|FG005|Overall Study|Physician Decision|0|||
27988552|NCT04167137|81787531|FG006|Overall Study|Physician Decision|1|||
27988553|NCT04167137|81787532|FG007|Overall Study|Physician Decision|0|||
27988554|NCT04167137|81787525|FG000|Overall Study|Death|0|||
27988555|NCT04167137|81787526|FG001|Overall Study|Death|1|||
27988556|NCT04167137|81787527|FG002|Overall Study|Death|0|||
27988557|NCT04167137|81787528|FG003|Overall Study|Death|0|||
27988558|NCT04167137|81787529|FG004|Overall Study|Death|0|||
27988559|NCT04167137|81787530|FG005|Overall Study|Death|0|||
27988560|NCT04167137|81787531|FG006|Overall Study|Death|0|||
27988561|NCT04167137|81787532|FG007|Overall Study|Death|0|||
27988562|NCT04167137|81787525|FG000|Overall Study|Study terminated by Sponsor|0|||
27988563|NCT04167137|81787526|FG001|Overall Study|Study terminated by Sponsor|0|||
27988564|NCT04167137|81787527|FG002|Overall Study|Study terminated by Sponsor|0|||
27988565|NCT04167137|81787528|FG003|Overall Study|Study terminated by Sponsor|0|||
27988566|NCT04167137|81787529|FG004|Overall Study|Study terminated by Sponsor|0|||
27988567|NCT04167137|81787530|FG005|Overall Study|Study terminated by Sponsor|0|||
27988568|NCT04167137|81787531|FG006|Overall Study|Study terminated by Sponsor|0|||
27988569|NCT04167137|81787532|FG007|Overall Study|Study terminated by Sponsor|1|||
27988570|NCT00547521|81787533|FG000|Short Term Study (4 Months)|Adverse Event|1|||
27988571|NCT00547521|81787534|FG001|Short Term Study (4 Months)|Adverse Event|0|||
27579001|NCT01126541|80303007|FG002|Overall Study|Administrative reason or other|2|||
27579002|NCT00600821|80303013|FG000|Overall Study|Death|45|||
27675454|NCT02127125|80650133|FG006|Overall Study|Physician Decision|0|||
27675455|NCT02127125|80650134|FG007|Overall Study|Physician Decision|0|||
27870026|NCT00196326|81357887|FG000|Overall Study|Physician Decision|3|||
27988572|NCT00547521|81787533|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
27988573|NCT00547521|81787534|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
27988574|NCT00547521|81787533|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
27988575|NCT00547521|81787534|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
27988576|NCT00547521|81787533|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
27988577|NCT00547521|81787534|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
27988578|NCT00547521|81787533|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
27675456|NCT02127125|80650135|FG008|Overall Study|Physician Decision|0|||
27796970|NCT01870921|81086213|FG000|Overall Study|Subject decision|80|||
27988579|NCT00547521|81787534|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
27988580|NCT00547521|81787533|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
27988581|NCT00547521|81787534|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
27988582|NCT00547521|81787533|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
27988583|NCT00547521|81787534|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
27988584|NCT00547521|81787533|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
27988585|NCT00547521|81787534|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
27988586|NCT00547521|81787533|FG000|Long Term Extension (LTE) Study|Other|0|||
27988587|NCT00547521|81787534|FG001|Long Term Extension (LTE) Study|Other|2|||
27988588|NCT00547521|81787533|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
27988589|NCT00547521|81787534|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
27796971|NCT01870921|81086213|FG000|Overall Study|Severe non-compliance to protocol|7|||
27796972|NCT01870921|81086213|FG000|Overall Study|Subject Lost to Follow up|2|||
27796973|NCT01870921|81086213|FG000|Overall Study|Other|1|||
27796974|NCT00185731|81086217|FG000|Overall Study|Withdrawal by Subject|1|||
27796975|NCT00185731|81086217|FG000|Overall Study|Not Eligible|1|||
27796976|NCT04854707|81086218|FG000|Overall Study|Lack of Efficacy|78|||
27796977|NCT04854707|81086219|FG001|Overall Study|Lack of Efficacy|59|||
27796978|NCT04854707|81086220|FG002|Overall Study|Lack of Efficacy|30|||
27796979|NCT02392559|81086225|FG000|Overall Study|Withdrawal by Subject|0|||
27796980|NCT02392559|81086226|FG001|Overall Study|Withdrawal by Subject|1|||
27796981|NCT02662556|81086227|FG000|Overall Study|Adverse Event|4|||
27796982|NCT02662556|81086227|FG000|Overall Study|Lack of Efficacy|4|||
27796983|NCT01876082|81086236|FG000|Overall Study|Withdrawal by Subject|0|||
27796984|NCT01876082|81086237|FG001|Overall Study|Withdrawal by Subject|2|||
27796985|NCT01876082|81086236|FG000|Overall Study|Protocol Violation|1|||
27796986|NCT01876082|81086237|FG001|Overall Study|Protocol Violation|0|||
27796987|NCT01876082|81086236|FG000|Overall Study|Adverse Event|1|||
27796988|NCT01876082|81086237|FG001|Overall Study|Adverse Event|1|||
27796989|NCT01876082|81086236|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
27796990|NCT01876082|81086237|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
27796991|NCT01817764|81086238|FG000|Overall Study|Adverse Event|7|||
27796992|NCT01817764|81086239|FG001|Overall Study|Adverse Event|10|||
27796993|NCT01817764|81086238|FG000|Overall Study|Lack of Efficacy|9|||
27796994|NCT01817764|81086239|FG001|Overall Study|Lack of Efficacy|7|||
27796995|NCT01817764|81086238|FG000|Overall Study|Protocol Violation|7|||
27796996|NCT01817764|81086239|FG001|Overall Study|Protocol Violation|5|||
27796997|NCT01817764|81086238|FG000|Overall Study|Lost to Follow-up|1|||
27796998|NCT01817764|81086239|FG001|Overall Study|Lost to Follow-up|4|||
27796999|NCT01817764|81086238|FG000|Overall Study|Withdrawal by Subject|10|||
27797000|NCT01817764|81086239|FG001|Overall Study|Withdrawal by Subject|12|||
27797001|NCT02610842|81086240|FG000|Overall Study|Lost to Follow-up|5|||
27988590|NCT01368081|81791459|FG000|Overall Study|Adverse Event|4|||
27988591|NCT01368081|81791460|FG001|Overall Study|Adverse Event|4|||
27797002|NCT04527549|81086241|FG000|Overall Study|Withdrawal by Subject|1|||
27797003|NCT04527549|81086242|FG001|Overall Study|Withdrawal by Subject|1|||
27797004|NCT03457727|81089176|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
27797005|NCT03457727|81089177|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
27797006|NCT03457727|81089178|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
27797007|NCT03457727|81089179|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
27797008|NCT02856282|81089185|FG000|Overall Study|Withdrawal by Subject|1|||
27797009|NCT01248130|81089186|FG000|Overall Study|Protocol Violation|1|||
27797010|NCT01248130|81089187|FG001|Overall Study|Protocol Violation|0|||
27797011|NCT01248130|81089186|FG000|Overall Study|Ineligible|1|||
27797012|NCT01248130|81089187|FG001|Overall Study|Ineligible|0|||
27797013|NCT04764669|81089191|FG000|Overall Study|Adverse Event|1|||
27797014|NCT04764669|81089192|FG001|Overall Study|Adverse Event|0|||
27797015|NCT04764669|81089193|FG002|Overall Study|Adverse Event|1|||
27797016|NCT04764669|81089194|FG003|Overall Study|Adverse Event|0|||
27797017|NCT04764669|81089191|FG000|Overall Study|Subject Choice|0|||
27988592|NCT01368081|81791461|FG002|Overall Study|Adverse Event|3|||
27579003|NCT00600821|80303014|FG001|Overall Study|Death|46|||
27579004|NCT00600821|80303013|FG000|Overall Study|Lost to Follow-up|2|||
27870027|NCT00196326|81357887|FG000|Overall Study|Withdrawal by Subject|225|||
27870028|NCT00196326|81357887|FG000|Overall Study|Adverse Event|253|||
27870029|NCT00196326|81357887|FG000|Overall Study|Pregnancy|34|||
27870030|NCT00196326|81357887|FG000|Overall Study|Lost to Follow-up|304|||
27797018|NCT04764669|81089192|FG001|Overall Study|Subject Choice|0|||
27797019|NCT04764669|81089193|FG002|Overall Study|Subject Choice|1|||
27797020|NCT04764669|81089194|FG003|Overall Study|Subject Choice|0|||
27797021|NCT04764669|81089191|FG000|Overall Study|Withdrawal by Subject|2|||
27797022|NCT04764669|81089192|FG001|Overall Study|Withdrawal by Subject|0|||
27797023|NCT04764669|81089193|FG002|Overall Study|Withdrawal by Subject|0|||
27797024|NCT04764669|81089194|FG003|Overall Study|Withdrawal by Subject|0|||
27797025|NCT01861717|81089199|FG000|Overall Study|Lost to Follow-up|1|||
27797026|NCT01861717|81089199|FG000|Overall Study|Withdrawal by Subject|1|||
27797027|NCT03981614|81089200|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
27797028|NCT03981614|81089201|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
27797029|NCT03981614|81089202|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
27797030|NCT03751124|81089203|FG000|Overall Study|Adverse Event|4|||
27797031|NCT03751124|81089204|FG001|Overall Study|Adverse Event|3|||
27797032|NCT03751124|81089203|FG000|Overall Study|Protocol Deviation|0|||
27797033|NCT03751124|81089204|FG001|Overall Study|Protocol Deviation|1|||
27797034|NCT03751124|81089203|FG000|Overall Study|Lost to Follow-up|6|||
27797035|NCT03751124|81089204|FG001|Overall Study|Lost to Follow-up|4|||
27797036|NCT03751124|81089203|FG000|Overall Study|Withdrawal by Subject|6|||
27797037|NCT03751124|81089204|FG001|Overall Study|Withdrawal by Subject|8|||
27797038|NCT03751124|81089203|FG000|Overall Study|Lack of Efficacy|1|||
27870031|NCT00196326|81357887|FG000|Overall Study|Other|22|||
27870032|NCT02207634|81357889|FG000|Overall Study|Withdrawal by Subject|21|||
27870033|NCT02207634|81357890|FG001|Overall Study|Withdrawal by Subject|31|||
27870034|NCT02207634|81357889|FG000|Overall Study|Lost to Follow-up|1|||
27870035|NCT02207634|81357890|FG001|Overall Study|Lost to Follow-up|0|||
27870036|NCT03889886|81357891|FG000|Overall Study|Other|0|||
27870037|NCT03889886|81357892|FG001|Overall Study|Other|1|||
27870038|NCT03889886|81357893|FG002|Overall Study|Other|0|||
27988593|NCT01368081|81791462|FG003|Overall Study|Adverse Event|2|||
27988594|NCT01368081|81791463|FG004|Overall Study|Adverse Event|2|||
27988595|NCT01368081|81791464|FG005|Overall Study|Adverse Event|5|||
27988596|NCT01368081|81791465|FG006|Overall Study|Adverse Event|6|||
27988597|NCT01368081|81791466|FG007|Overall Study|Adverse Event|2|||
27579005|NCT00600821|80303014|FG001|Overall Study|Lost to Follow-up|2|||
27579006|NCT00600821|80303013|FG000|Overall Study|Withdrawal by Subject|1|||
27797039|NCT03751124|81089204|FG001|Overall Study|Lack of Efficacy|1|||
27797040|NCT03751124|81089203|FG000|Overall Study|Pregnancy|0|||
27579007|NCT00600821|80303014|FG001|Overall Study|Withdrawal by Subject|1|||
27797041|NCT03751124|81089204|FG001|Overall Study|Pregnancy|1|||
27870039|NCT03889886|81357894|FG003|Overall Study|Other|1|||
27870040|NCT03889886|81357891|FG000|Overall Study|Withdrawal by Subject|0|||
27870041|NCT03889886|81357892|FG001|Overall Study|Withdrawal by Subject|0|||
27579008|NCT00600821|80303013|FG000|Overall Study|Terminated by sponsor|8|||
27870042|NCT03889886|81357893|FG002|Overall Study|Withdrawal by Subject|1|||
27579009|NCT00600821|80303014|FG001|Overall Study|Terminated by sponsor|6|||
27579010|NCT00600821|80303013|FG000|Overall Study|Objective progression or relapse|0|||
27579011|NCT00600821|80303014|FG001|Overall Study|Objective progression or relapse|1|||
27579012|NCT00600821|80303013|FG000|Overall Study|Randomized but not treated|0|||
27797042|NCT03751124|81089203|FG000|Overall Study|Other|9|||
27797043|NCT03751124|81089204|FG001|Overall Study|Other|9|||
27870043|NCT03889886|81357894|FG003|Overall Study|Withdrawal by Subject|0|||
27870044|NCT03889886|81357891|FG000|Overall Study|Adverse Event|0|||
27988598|NCT01368081|81791467|FG008|Overall Study|Adverse Event|3|||
27579013|NCT00600821|80303014|FG001|Overall Study|Randomized but not treated|1|||
27579014|NCT00600821|80303013|FG000|Overall Study|Other|2|||
27579015|NCT00600821|80303014|FG001|Overall Study|Other|3|||
27579016|NCT00503685|80303021|FG000|Overall Study|Adverse Event|0|||
27579017|NCT00503685|80303022|FG001|Overall Study|Adverse Event|0|||
27797044|NCT03751124|81089203|FG000|Overall Study|Participants who did not receive any study drug|0|||
27797045|NCT03751124|81089204|FG001|Overall Study|Participants who did not receive any study drug|1|||
27579018|NCT00503685|80303023|FG002|Overall Study|Adverse Event|2|||
27579019|NCT00503685|80303021|FG000|Overall Study|Withdrawal by Subject|0|||
27579020|NCT00503685|80303022|FG001|Overall Study|Withdrawal by Subject|1|||
27579021|NCT00503685|80303023|FG002|Overall Study|Withdrawal by Subject|0|||
27797046|NCT03273712|81089208|FG000|Overall Study|Death|5|||
27797047|NCT03273712|81089208|FG000|Overall Study|Adverse Event|1|||
27797048|NCT03273712|81089208|FG000|Overall Study|Disease Progression|1|||
27797049|NCT03664024|81089209|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
27797050|NCT03664024|81089209|FG000|Overall Study|Lost to Follow-up|2|||
27797051|NCT03664024|81089209|FG000|Overall Study|Withdrawal by Subject|2|||
27797052|NCT03664024|81089209|FG000|Overall Study|Death|80|||
27797053|NCT02617446|81089210|FG000|Overall Study|Withdrawal by Subject|0|||
27797054|NCT02617446|81089211|FG001|Overall Study|Withdrawal by Subject|2|||
27797055|NCT02617446|81089212|FG002|Overall Study|Withdrawal by Subject|0|||
27797056|NCT02617446|81089210|FG000|Overall Study|Adverse Event|1|||
27797057|NCT02617446|81089211|FG001|Overall Study|Adverse Event|0|||
27797058|NCT02617446|81089212|FG002|Overall Study|Adverse Event|5|||
27797059|NCT02617446|81089210|FG000|Overall Study|Lost to Follow-up|3|||
27797060|NCT02617446|81089211|FG001|Overall Study|Lost to Follow-up|0|||
27797061|NCT02617446|81089212|FG002|Overall Study|Lost to Follow-up|0|||
27797062|NCT02617446|81089210|FG000|Overall Study|Death|0|||
27797063|NCT02617446|81089211|FG001|Overall Study|Death|0|||
27797064|NCT02617446|81089212|FG002|Overall Study|Death|2|||
27797065|NCT01102972|81089216|FG000|Overall Study|Adverse Event|8|||
27797066|NCT01102972|81089217|FG001|Overall Study|Adverse Event|2|||
27797067|NCT01102972|81089216|FG000|Overall Study|Lack of Efficacy|2|||
27797068|NCT01102972|81089217|FG001|Overall Study|Lack of Efficacy|1|||
27797069|NCT01102972|81089216|FG000|Overall Study|Protocol Violation|1|||
27797070|NCT01102972|81089217|FG001|Overall Study|Protocol Violation|0|||
27797071|NCT01102972|81089216|FG000|Overall Study|Lost to Follow-up|10|||
27797072|NCT01102972|81089217|FG001|Overall Study|Lost to Follow-up|5|||
27797073|NCT01102972|81089216|FG000|Overall Study|Investigator Discretion|2|||
27797074|NCT01102972|81089217|FG001|Overall Study|Investigator Discretion|0|||
27988599|NCT01368081|81791468|FG009|Overall Study|Adverse Event|5|||
27988600|NCT01368081|81791469|FG010|Overall Study|Adverse Event|6|||
27988601|NCT01368081|81791470|FG011|Overall Study|Adverse Event|1|||
27988602|NCT01368081|81791471|FG012|Overall Study|Adverse Event|3|||
27988603|NCT01368081|81791459|FG000|Overall Study|Lack of Efficacy|0|||
27988604|NCT01368081|81791460|FG001|Overall Study|Lack of Efficacy|1|||
27988605|NCT01368081|81791461|FG002|Overall Study|Lack of Efficacy|0|||
27988606|NCT01368081|81791462|FG003|Overall Study|Lack of Efficacy|1|||
27988607|NCT01368081|81791463|FG004|Overall Study|Lack of Efficacy|0|||
27988608|NCT01368081|81791464|FG005|Overall Study|Lack of Efficacy|0|||
27988609|NCT01368081|81791465|FG006|Overall Study|Lack of Efficacy|0|||
27988610|NCT01368081|81791466|FG007|Overall Study|Lack of Efficacy|2|||
27988611|NCT01368081|81791467|FG008|Overall Study|Lack of Efficacy|0|||
27988612|NCT01368081|81791468|FG009|Overall Study|Lack of Efficacy|0|||
27988613|NCT01368081|81791469|FG010|Overall Study|Lack of Efficacy|0|||
27988614|NCT01368081|81791470|FG011|Overall Study|Lack of Efficacy|0|||
27988615|NCT01368081|81791471|FG012|Overall Study|Lack of Efficacy|0|||
27988616|NCT01368081|81791459|FG000|Overall Study|Protocol Violation|0|||
27988617|NCT01368081|81791460|FG001|Overall Study|Protocol Violation|0|||
27988618|NCT01368081|81791461|FG002|Overall Study|Protocol Violation|0|||
27988619|NCT01368081|81791462|FG003|Overall Study|Protocol Violation|0|||
27988620|NCT01368081|81791463|FG004|Overall Study|Protocol Violation|0|||
27988621|NCT01368081|81791464|FG005|Overall Study|Protocol Violation|1|||
27988622|NCT01368081|81791465|FG006|Overall Study|Protocol Violation|0|||
27797075|NCT01102972|81089216|FG000|Overall Study|Withdrawal by Subject|6|||
27870045|NCT03889886|81357892|FG001|Overall Study|Adverse Event|0|||
27870046|NCT03889886|81357893|FG002|Overall Study|Adverse Event|0|||
27579022|NCT00503685|80303021|FG000|Overall Study|Protocol Violation|0|||
27797076|NCT01102972|81089217|FG001|Overall Study|Withdrawal by Subject|6|||
27797077|NCT01741259|81089222|FG000|Overall Study|Protocol Violation|6|||
27797078|NCT01741259|81089223|FG001|Overall Study|Protocol Violation|4|||
27988623|NCT01368081|81791466|FG007|Overall Study|Protocol Violation|1|||
27988624|NCT01368081|81791467|FG008|Overall Study|Protocol Violation|0|||
27988625|NCT01368081|81791468|FG009|Overall Study|Protocol Violation|0|||
27988626|NCT01368081|81791469|FG010|Overall Study|Protocol Violation|0|||
27579023|NCT00503685|80303022|FG001|Overall Study|Protocol Violation|1|||
27579024|NCT00503685|80303023|FG002|Overall Study|Protocol Violation|0|||
27870047|NCT03889886|81357894|FG003|Overall Study|Adverse Event|6|||
27988627|NCT01368081|81791470|FG011|Overall Study|Protocol Violation|0|||
27988628|NCT01368081|81791471|FG012|Overall Study|Protocol Violation|0|||
27579025|NCT00503685|80303021|FG000|Overall Study|Eligibility Criteria Not Met|0|||
27579026|NCT00503685|80303022|FG001|Overall Study|Eligibility Criteria Not Met|1|||
27579027|NCT00503685|80303023|FG002|Overall Study|Eligibility Criteria Not Met|0|||
27579028|NCT03952039|80303030|FG000|Overall Study|Adverse Event|22|||
27579029|NCT03952039|80303031|FG001|Overall Study|Adverse Event|8|||
27579030|NCT03952039|80303030|FG000|Overall Study|Withdrawal by Participant|17|||
27579031|NCT03952039|80303031|FG001|Overall Study|Withdrawal by Participant|12|||
27579032|NCT03952039|80303030|FG000|Overall Study|Death|13|||
27579033|NCT03952039|80303031|FG001|Overall Study|Death|6|||
27579034|NCT03952039|80303030|FG000|Overall Study|Lack of Efficacy|12|||
27579035|NCT03952039|80303031|FG001|Overall Study|Lack of Efficacy|2|||
27579036|NCT03952039|80303030|FG000|Overall Study|Physician Decision|9|||
27579037|NCT03952039|80303031|FG001|Overall Study|Physician Decision|3|||
27579038|NCT03952039|80303030|FG000|Overall Study|Progressive Disease|6|||
27675457|NCT05144945|80650136|FG000|Overall Study|Withdrawal by Subject|1|||
27675458|NCT05144945|80650137|FG001|Overall Study|Withdrawal by Subject|0|||
27579039|NCT03952039|80303031|FG001|Overall Study|Progressive Disease|4|||
27579040|NCT03952039|80303030|FG000|Overall Study|Other Reasons|12|||
27579041|NCT03952039|80303031|FG001|Overall Study|Other Reasons|4|||
27579042|NCT00162136|80303033|FG000|Overall Study|Adverse Event|1|||
27579043|NCT00162136|80303033|FG000|Overall Study|Death|1|||
27579044|NCT00162136|80303033|FG000|Overall Study|Disease Progression/Relapse|23|||
27579045|NCT00162136|80303033|FG000|Overall Study|Investigator Request|5|||
27579046|NCT00162136|80303033|FG000|Overall Study|Study Drug Toxicity|4|||
27579047|NCT00162136|80303033|FG000|Overall Study|Withdrawal by Subject|1|||
27579048|NCT03880578|80303040|FG000|Overall Study|Withdrawal by Subject|0|||
27579049|NCT03880578|80303041|FG001|Overall Study|Withdrawal by Subject|3|||
27579050|NCT03880578|80303042|FG002|Overall Study|Withdrawal by Subject|1|||
27579051|NCT03880578|80303040|FG000|Overall Study|Death|0|||
27579052|NCT03880578|80303041|FG001|Overall Study|Death|1|||
27579053|NCT03880578|80303042|FG002|Overall Study|Death|0|||
27579054|NCT02738775|80303043|FG000|Overall Study|Withdrawal by Subject|0|||
27579055|NCT02738775|80303044|FG001|Overall Study|Withdrawal by Subject|1|||
27579056|NCT02738775|80303045|FG002|Overall Study|Withdrawal by Subject|0|||
27579057|NCT02738775|80303046|FG003|Overall Study|Withdrawal by Subject|0|||
27579058|NCT02738775|80303047|FG004|Overall Study|Withdrawal by Subject|0|||
27579059|NCT02738775|80303048|FG005|Overall Study|Withdrawal by Subject|0|||
27579060|NCT02738775|80303043|FG000|Overall Study|Adverse Event|0|||
27579061|NCT02738775|80303044|FG001|Overall Study|Adverse Event|0|||
27579062|NCT02738775|80303045|FG002|Overall Study|Adverse Event|0|||
27579063|NCT02738775|80303046|FG003|Overall Study|Adverse Event|1|||
27579064|NCT02738775|80303047|FG004|Overall Study|Adverse Event|0|||
27579065|NCT02738775|80303048|FG005|Overall Study|Adverse Event|0|||
27579066|NCT02738775|80303043|FG000|Overall Study|Pregnancy|0|||
27579067|NCT02738775|80303044|FG001|Overall Study|Pregnancy|1|||
27579068|NCT02738775|80303045|FG002|Overall Study|Pregnancy|0|||
27579069|NCT02738775|80303046|FG003|Overall Study|Pregnancy|0|||
27579070|NCT02738775|80303047|FG004|Overall Study|Pregnancy|0|||
27579071|NCT02738775|80303048|FG005|Overall Study|Pregnancy|0|||
27579072|NCT02738775|80303043|FG000|Overall Study|Missing|0|||
27579073|NCT02738775|80303044|FG001|Overall Study|Missing|0|||
27579074|NCT02738775|80303045|FG002|Overall Study|Missing|0|||
27579075|NCT02738775|80303046|FG003|Overall Study|Missing|0|||
27579076|NCT02738775|80303047|FG004|Overall Study|Missing|0|||
27579077|NCT02738775|80303048|FG005|Overall Study|Missing|1|||
27579078|NCT02047604|80303049|FG000|Overall Study|Withdrawal by Subject|0|||
27579079|NCT02047604|80303050|FG001|Overall Study|Withdrawal by Subject|0|||
27579080|NCT02047604|80303051|FG002|Overall Study|Withdrawal by Subject|0|||
27579081|NCT02047604|80303052|FG003|Overall Study|Withdrawal by Subject|0|||
27988629|NCT01368081|81791459|FG000|Overall Study|Lost to Follow-up|0|||
27988630|NCT01368081|81791460|FG001|Overall Study|Lost to Follow-up|0|||
27988631|NCT01368081|81791461|FG002|Overall Study|Lost to Follow-up|0|||
27988632|NCT01368081|81791462|FG003|Overall Study|Lost to Follow-up|0|||
27988633|NCT01368081|81791463|FG004|Overall Study|Lost to Follow-up|0|||
27988634|NCT01368081|81791464|FG005|Overall Study|Lost to Follow-up|0|||
27988635|NCT01368081|81791465|FG006|Overall Study|Lost to Follow-up|0|||
27988636|NCT01368081|81791466|FG007|Overall Study|Lost to Follow-up|0|||
27988637|NCT01368081|81791467|FG008|Overall Study|Lost to Follow-up|0|||
27988638|NCT01368081|81791468|FG009|Overall Study|Lost to Follow-up|0|||
27988639|NCT01368081|81791469|FG010|Overall Study|Lost to Follow-up|0|||
27988640|NCT01368081|81791470|FG011|Overall Study|Lost to Follow-up|0|||
27988641|NCT01368081|81791471|FG012|Overall Study|Lost to Follow-up|1|||
27988642|NCT01368081|81791459|FG000|Overall Study|Withdrawal by Subject|4|||
27988643|NCT01368081|81791460|FG001|Overall Study|Withdrawal by Subject|4|||
27988644|NCT01368081|81791461|FG002|Overall Study|Withdrawal by Subject|1|||
27988645|NCT01368081|81791462|FG003|Overall Study|Withdrawal by Subject|1|||
27988646|NCT01368081|81791463|FG004|Overall Study|Withdrawal by Subject|0|||
27988647|NCT01368081|81791464|FG005|Overall Study|Withdrawal by Subject|3|||
27988648|NCT01368081|81791465|FG006|Overall Study|Withdrawal by Subject|4|||
27988649|NCT01368081|81791466|FG007|Overall Study|Withdrawal by Subject|2|||
27988650|NCT01368081|81791467|FG008|Overall Study|Withdrawal by Subject|5|||
27988651|NCT01368081|81791468|FG009|Overall Study|Withdrawal by Subject|4|||
27988652|NCT01368081|81791469|FG010|Overall Study|Withdrawal by Subject|3|||
27988653|NCT01368081|81791470|FG011|Overall Study|Withdrawal by Subject|2|||
27988654|NCT01368081|81791471|FG012|Overall Study|Withdrawal by Subject|0|||
27988655|NCT01368081|81791459|FG000|Overall Study|Other reason not defined above|2|||
27988656|NCT01368081|81791460|FG001|Overall Study|Other reason not defined above|0|||
27988657|NCT01368081|81791461|FG002|Overall Study|Other reason not defined above|0|||
27988658|NCT01368081|81791462|FG003|Overall Study|Other reason not defined above|1|||
27988659|NCT01368081|81791463|FG004|Overall Study|Other reason not defined above|0|||
27988660|NCT01368081|81791464|FG005|Overall Study|Other reason not defined above|1|||
27988661|NCT01368081|81791465|FG006|Overall Study|Other reason not defined above|2|||
27988662|NCT01368081|81791466|FG007|Overall Study|Other reason not defined above|0|||
27797079|NCT01741259|81089222|FG000|Overall Study|Withdrawal by Subject|0|||
27797080|NCT01741259|81089223|FG001|Overall Study|Withdrawal by Subject|2|||
27797081|NCT01071083|81089226|FG000|Overall Study|Adverse Event|1|||
27797082|NCT01071083|81089227|FG001|Overall Study|Adverse Event|0|||
27797083|NCT01071083|81089228|FG002|Overall Study|Adverse Event|1|||
27797084|NCT01071083|81089229|FG003|Overall Study|Adverse Event|0|||
27797085|NCT01071083|81089230|FG004|Overall Study|Adverse Event|1|||
27797086|NCT01071083|81089226|FG000|Overall Study|Withdrawal by Subject|3|||
27797087|NCT01071083|81089227|FG001|Overall Study|Withdrawal by Subject|0|||
27988663|NCT01368081|81791467|FG008|Overall Study|Other reason not defined above|0|||
27988664|NCT01368081|81791468|FG009|Overall Study|Other reason not defined above|1|||
27988665|NCT01368081|81791469|FG010|Overall Study|Other reason not defined above|0|||
27988666|NCT01368081|81791470|FG011|Overall Study|Other reason not defined above|0|||
27988667|NCT01368081|81791471|FG012|Overall Study|Other reason not defined above|3|||
27988668|NCT01620762|81791472|FG000|Overall Study|Protocol Violation|1|||
27988669|NCT01620762|81791473|FG001|Overall Study|Protocol Violation|1|||
27988670|NCT01620762|81791474|FG002|Overall Study|Protocol Violation|1|||
27988671|NCT01620762|81791472|FG000|Overall Study|Adverse Event|9|||
27988672|NCT01620762|81791473|FG001|Overall Study|Adverse Event|5|||
27988673|NCT01620762|81791474|FG002|Overall Study|Adverse Event|2|||
27988674|NCT01620762|81791472|FG000|Overall Study|Withdrawal by Subject|23|||
27988675|NCT01620762|81791473|FG001|Overall Study|Withdrawal by Subject|26|||
27988676|NCT01620762|81791474|FG002|Overall Study|Withdrawal by Subject|27|||
27988677|NCT01620762|81791472|FG000|Overall Study|Lost to Follow-up|11|||
27988678|NCT01620762|81791473|FG001|Overall Study|Lost to Follow-up|17|||
27988679|NCT01620762|81791474|FG002|Overall Study|Lost to Follow-up|10|||
27988680|NCT01620762|81791472|FG000|Overall Study|Protocol deviation|1|||
27988681|NCT01620762|81791473|FG001|Overall Study|Protocol deviation|1|||
27988682|NCT01620762|81791474|FG002|Overall Study|Protocol deviation|6|||
27988683|NCT01620762|81791472|FG000|Overall Study|Subject deterioration|0|||
27988684|NCT01620762|81791473|FG001|Overall Study|Subject deterioration|1|||
27988685|NCT01620762|81791474|FG002|Overall Study|Subject deterioration|1|||
27579082|NCT02047604|80303053|FG004|Overall Study|Withdrawal by Subject|1|||
27675459|NCT02947100|80650138|FG000|Overall Study|study terminated early|3|||
27988686|NCT01620762|81791472|FG000|Overall Study|Non-specified|3|||
27988687|NCT01620762|81791473|FG001|Overall Study|Non-specified|6|||
27988688|NCT01620762|81791474|FG002|Overall Study|Non-specified|5|||
27988689|NCT01620762|81791472|FG000|Overall Study|Use of prohibted therapies|0|||
27988690|NCT01620762|81791473|FG001|Overall Study|Use of prohibted therapies|1|||
27988691|NCT01620762|81791474|FG002|Overall Study|Use of prohibted therapies|1|||
27797088|NCT01071083|81089228|FG002|Overall Study|Withdrawal by Subject|2|||
27797089|NCT01071083|81089229|FG003|Overall Study|Withdrawal by Subject|0|||
27797090|NCT01071083|81089230|FG004|Overall Study|Withdrawal by Subject|3|||
27988692|NCT00695864|81791475|FG000|Placebo|Withdrawal by Subject|1|||
27988693|NCT00695864|81791475|FG000|Placebo|Physician Decision|4|||
27988694|NCT00455143|81791478|FG000|Overall Study|Physician Decision|1|||
27988695|NCT00455143|81791478|FG000|Overall Study|Withdrawal by Subject|1|||
27988696|NCT00455143|81791478|FG000|Overall Study|Staff was not avail to follow patient|2|||
27988697|NCT00455143|81791478|FG000|Overall Study|No longer met Inclusion Criteria|1|||
27988698|NCT00455143|81791478|FG000|Overall Study|Surgical time, staff not available|1|||
27988699|NCT02651220|81791490|FG000|Overall Study|Adverse Event|1|||
27988700|NCT02651220|81791491|FG001|Overall Study|Adverse Event|5|||
27988701|NCT02651220|81791492|FG002|Overall Study|Adverse Event|1|||
27988702|NCT02651220|81791490|FG000|Overall Study|Lost to Follow-up|8|||
27988703|NCT02651220|81791491|FG001|Overall Study|Lost to Follow-up|14|||
27988704|NCT02651220|81791492|FG002|Overall Study|Lost to Follow-up|14|||
27988705|NCT02651220|81791490|FG000|Overall Study|Non-Compliance with Study Drug|4|||
27988706|NCT02651220|81791491|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27988707|NCT02651220|81791492|FG002|Overall Study|Non-Compliance with Study Drug|1|||
27988708|NCT02651220|81791490|FG000|Overall Study|Pregnancy|1|||
27988709|NCT02651220|81791491|FG001|Overall Study|Pregnancy|0|||
27988710|NCT02651220|81791492|FG002|Overall Study|Pregnancy|1|||
27988711|NCT02651220|81791490|FG000|Overall Study|Protocol Violation|0|||
27988712|NCT02651220|81791491|FG001|Overall Study|Protocol Violation|0|||
27988713|NCT02651220|81791492|FG002|Overall Study|Protocol Violation|1|||
27988714|NCT02651220|81791490|FG000|Overall Study|Withdrawal by Subject|5|||
27988715|NCT02651220|81791491|FG001|Overall Study|Withdrawal by Subject|6|||
27988716|NCT02651220|81791492|FG002|Overall Study|Withdrawal by Subject|8|||
27988717|NCT02651220|81791490|FG000|Overall Study|Miscellaneous|4|||
27988718|NCT02651220|81791491|FG001|Overall Study|Miscellaneous|1|||
27988719|NCT02651220|81791492|FG002|Overall Study|Miscellaneous|2|||
27988720|NCT02651220|81791490|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27988721|NCT02651220|81791491|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27988722|NCT02651220|81791492|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
27988723|NCT01730586|81791494|FG000|Overall Study|Progressive Disease|2|||
27988724|NCT01730586|81791494|FG000|Overall Study|Inadequate Trial|8|||
27988725|NCT01730586|81791494|FG000|Overall Study|Adverse Event|2|||
27988726|NCT01730586|81791494|FG000|Overall Study|Hospice|1|||
27988727|NCT02777827|81791496|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
27988728|NCT02777827|81791497|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
27988729|NCT02777827|81791498|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
27988730|NCT02777827|81791499|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
27988731|NCT02777827|81791500|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
27988732|NCT02777827|81791501|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
27988733|NCT01673620|81791505|FG000|Overall Study|Adverse Event|1|||
27988734|NCT01673620|81791506|FG001|Overall Study|Adverse Event|0|||
27988735|NCT02921087|81791507|FG000|Overall Study|Withdrawal by Subject|0|||
27988736|NCT02921087|81791508|FG001|Overall Study|Withdrawal by Subject|1|||
27988737|NCT04230213|81791509|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
27988738|NCT04230213|81791510|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
27988739|NCT04230213|81791511|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
27988740|NCT04230213|81791509|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
27988741|NCT04230213|81791510|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
27988742|NCT04230213|81791511|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
27988743|NCT04230213|81791509|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
27988744|NCT04230213|81791510|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
27988745|NCT04230213|81791511|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
27988746|NCT04230213|81791509|FG000|TP2: Week 10 to Week 16|Other|0|||
27988747|NCT04230213|81791510|FG001|TP2: Week 10 to Week 16|Other|2|||
27988748|NCT04230213|81791511|FG002|TP2: Week 10 to Week 16|Other|1|||
27988749|NCT04230213|81791509|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
27988750|NCT04230213|81791510|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
27988751|NCT04230213|81791511|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
27988752|NCT04230213|81791509|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
27988753|NCT04230213|81791510|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
27797091|NCT01071083|81089226|FG000|Overall Study|Physician Decision|1|||
27988754|NCT04230213|81791511|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
27988755|NCT04230213|81791509|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
27988756|NCT04230213|81791510|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
27988757|NCT04230213|81791511|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
27988758|NCT04230213|81791509|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
27988759|NCT04230213|81791510|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
27988760|NCT04230213|81791511|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
27988761|NCT04230213|81791509|FG000|TP3: Week 16 to Week 22|Other|0|||
27988762|NCT04230213|81791510|FG001|TP3: Week 16 to Week 22|Other|1|||
27988763|NCT04230213|81791511|FG002|TP3: Week 16 to Week 22|Other|3|||
27988764|NCT04230213|81791509|FG000|TP4: Week 22 to Week 32|Other|0|||
27988765|NCT04230213|81791510|FG001|TP4: Week 22 to Week 32|Other|5|||
27988766|NCT04230213|81791511|FG002|TP4: Week 22 to Week 32|Other|5|||
27988767|NCT04230213|81791509|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
27988768|NCT04230213|81791510|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
27988769|NCT04230213|81791511|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
27988770|NCT04230213|81791509|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
27988771|NCT04230213|81791510|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
27988772|NCT04230213|81791511|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
27988773|NCT04230213|81791509|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
27988774|NCT04230213|81791510|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
27988775|NCT04230213|81791511|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
27797092|NCT01071083|81089227|FG001|Overall Study|Physician Decision|0|||
27797093|NCT01071083|81089228|FG002|Overall Study|Physician Decision|0|||
27797094|NCT01071083|81089229|FG003|Overall Study|Physician Decision|1|||
27988776|NCT04230213|81791509|FG000|Follow up: Week 32 to Week 36|Other|0|||
27988777|NCT04230213|81791510|FG001|Follow up: Week 32 to Week 36|Other|1|||
27988778|NCT04230213|81791511|FG002|Follow up: Week 32 to Week 36|Other|1|||
27988779|NCT00293020|81791515|FG000|Overall Study|Withdrawal by Subject|34|||
27988780|NCT00293020|81791515|FG000|Overall Study|Adverse Event|30|||
27988781|NCT00293020|81791515|FG000|Overall Study|Death|32|||
27988782|NCT00293020|81791515|FG000|Overall Study|Lack of Efficacy|12|||
27797095|NCT01071083|81089230|FG004|Overall Study|Physician Decision|1|||
27797096|NCT01071083|81089226|FG000|Overall Study|Early Rescue|1|||
27988783|NCT00293020|81791515|FG000|Overall Study|Lost to Follow-up|4|||
27988784|NCT00293020|81791515|FG000|Overall Study|Protocol Violation|6|||
27988785|NCT00293020|81791515|FG000|Overall Study|Physician Decision|21|||
27988786|NCT00293020|81791515|FG000|Overall Study|Other Reason|22|||
27988787|NCT00293020|81791515|FG000|Overall Study|No dose taken|1|||
27988788|NCT02873338|81791516|FG000|Overall Study|Adverse Event|0|||
27797097|NCT01071083|81089227|FG001|Overall Study|Early Rescue|0|||
27988789|NCT02873338|81791517|FG001|Overall Study|Adverse Event|2|||
27988790|NCT02873338|81791518|FG002|Overall Study|Adverse Event|1|||
27988791|NCT02873338|81791516|FG000|Overall Study|Death|2|||
27988792|NCT02873338|81791517|FG001|Overall Study|Death|1|||
27988793|NCT02873338|81791518|FG002|Overall Study|Death|1|||
27988794|NCT02873338|81791516|FG000|Overall Study|Withdrawal by Subject|2|||
27988795|NCT02873338|81791517|FG001|Overall Study|Withdrawal by Subject|1|||
27988796|NCT02873338|81791518|FG002|Overall Study|Withdrawal by Subject|3|||
27988797|NCT02873338|81791516|FG000|Overall Study|Lack of Efficacy|0|||
27988798|NCT02873338|81791517|FG001|Overall Study|Lack of Efficacy|2|||
27797098|NCT01071083|81089228|FG002|Overall Study|Early Rescue|0|||
27797099|NCT01071083|81089229|FG003|Overall Study|Early Rescue|0|||
27797100|NCT01071083|81089230|FG004|Overall Study|Early Rescue|1|||
27797101|NCT01071083|81089226|FG000|Overall Study|Subject Moved|0|||
27797102|NCT01071083|81089227|FG001|Overall Study|Subject Moved|1|||
27797103|NCT01071083|81089228|FG002|Overall Study|Subject Moved|0|||
27797104|NCT01071083|81089229|FG003|Overall Study|Subject Moved|0|||
27797105|NCT01071083|81089230|FG004|Overall Study|Subject Moved|0|||
27797106|NCT01071083|81089226|FG000|Overall Study|Images Not Usable (Motion)|0|||
27797107|NCT01071083|81089227|FG001|Overall Study|Images Not Usable (Motion)|1|||
27797108|NCT01071083|81089228|FG002|Overall Study|Images Not Usable (Motion)|0|||
27797109|NCT01071083|81089229|FG003|Overall Study|Images Not Usable (Motion)|0|||
27797110|NCT01071083|81089230|FG004|Overall Study|Images Not Usable (Motion)|0|||
27797111|NCT01071083|81089226|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
27797112|NCT01071083|81089227|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
27988799|NCT02873338|81791518|FG002|Overall Study|Lack of Efficacy|0|||
27988800|NCT02873338|81791516|FG000|Overall Study|Other or Missing|14|||
27988801|NCT02873338|81791517|FG001|Overall Study|Other or Missing|15|||
27988802|NCT02873338|81791518|FG002|Overall Study|Other or Missing|13|||
27988803|NCT01073930|81791522|FG000|Overall Study|Withdrawal by Subject|3|||
27988804|NCT01073930|81791523|FG001|Overall Study|Withdrawal by Subject|2|||
27988805|NCT01073930|81791522|FG000|Overall Study|Lost to Follow-up|0|||
27797113|NCT01071083|81089228|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
27797114|NCT01071083|81089229|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
27797115|NCT01071083|81089230|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
27797116|NCT01071083|81089226|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
27988806|NCT01073930|81791523|FG001|Overall Study|Lost to Follow-up|1|||
27988807|NCT01073930|81791522|FG000|Overall Study|Adverse Event|0|||
27988808|NCT01073930|81791523|FG001|Overall Study|Adverse Event|1|||
27988809|NCT01073930|81791522|FG000|Overall Study|Noncompliance with study drug|0|||
27988810|NCT01073930|81791523|FG001|Overall Study|Noncompliance with study drug|1|||
27988811|NCT01073930|81791522|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
27870048|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
27870049|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
27870050|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
27870051|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
27870052|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
27870053|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
27870054|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
27988812|NCT01073930|81791523|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
27988813|NCT00377364|81791524|FG000|Overall Study|Lost to Follow-up|1|||
27988814|NCT00377364|81791525|FG001|Overall Study|Lost to Follow-up|0|||
27988815|NCT00377364|81791524|FG000|Overall Study|Withdrawal by Subject|1|||
27988816|NCT00377364|81791525|FG001|Overall Study|Withdrawal by Subject|0|||
27988817|NCT03997825|81791528|FG000|Overall Study|Death|3|||
27988818|NCT03997825|81791528|FG000|Overall Study|Lost to Follow-up|10|||
27988819|NCT03997825|81791528|FG000|Overall Study|Withdrawal by Subject|3|||
27988820|NCT03997825|81791528|FG000|Overall Study|Refused participation|1|||
27988821|NCT01008449|81791529|FG000|Overall Study|Lost to Follow-up|29|||
27988822|NCT01008449|81791530|FG001|Overall Study|Lost to Follow-up|19|||
27988823|NCT01300572|81791531|FG000|Overall Study|HAMA + post dosimetry|1|||
27988824|NCT00477152|81791532|FG000|Overall Study|Parent withdrew consent|2|||
27988825|NCT00477152|81791532|FG000|Overall Study|Adverse Event|1|||
27988826|NCT00666965|81791533|FG000|Overall Study|Adverse Event|0|||
27988827|NCT00666965|81791534|FG001|Overall Study|Adverse Event|2|||
27988828|NCT00666965|81791535|FG002|Overall Study|Adverse Event|1|||
27988829|NCT00666965|81791536|FG003|Overall Study|Adverse Event|9|||
27988830|NCT00666965|81791533|FG000|Overall Study|Lack of Efficacy|1|||
27988831|NCT00666965|81791534|FG001|Overall Study|Lack of Efficacy|1|||
27988832|NCT00666965|81791535|FG002|Overall Study|Lack of Efficacy|0|||
27988833|NCT00666965|81791536|FG003|Overall Study|Lack of Efficacy|0|||
27988834|NCT00666965|81791533|FG000|Overall Study|Protocol Violation|0|||
27988835|NCT00666965|81791534|FG001|Overall Study|Protocol Violation|0|||
27988836|NCT00666965|81791535|FG002|Overall Study|Protocol Violation|0|||
27988837|NCT00666965|81791536|FG003|Overall Study|Protocol Violation|2|||
27988838|NCT00666965|81791533|FG000|Overall Study|Discontinuation criteria|2|||
27988839|NCT00666965|81791534|FG001|Overall Study|Discontinuation criteria|1|||
27988840|NCT00666965|81791535|FG002|Overall Study|Discontinuation criteria|1|||
27988841|NCT00666965|81791536|FG003|Overall Study|Discontinuation criteria|2|||
27988842|NCT00666965|81791533|FG000|Overall Study|Withdrawal by Subject|0|||
27988843|NCT00666965|81791534|FG001|Overall Study|Withdrawal by Subject|0|||
27988844|NCT00666965|81791535|FG002|Overall Study|Withdrawal by Subject|0|||
27988845|NCT00666965|81791536|FG003|Overall Study|Withdrawal by Subject|2|||
27988846|NCT01912339|81791537|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
27988847|NCT01912339|81791538|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
27988848|NCT01912339|81791539|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
27579083|NCT02047604|80303054|FG005|Overall Study|Withdrawal by Subject|1|||
27579084|NCT03455855|80303055|FG000|Overall Study|Lost to Follow-up|4|||
27579085|NCT03455855|80303056|FG001|Overall Study|Lost to Follow-up|2|||
27579086|NCT00298896|80303057|FG000|Overall Study|Death|3|||
27579087|NCT00298896|80303057|FG000|Overall Study|Physician Decision|2|||
27797117|NCT01071083|81089227|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
27797118|NCT01071083|81089228|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
27797119|NCT01071083|81089229|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
27797120|NCT01071083|81089230|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
27797121|NCT01071083|81089226|FG000|Overall Study|Subject Refused to Continue|1|||
27797122|NCT01071083|81089227|FG001|Overall Study|Subject Refused to Continue|0|||
27797123|NCT01071083|81089228|FG002|Overall Study|Subject Refused to Continue|0|||
27797124|NCT01071083|81089229|FG003|Overall Study|Subject Refused to Continue|0|||
27797125|NCT01071083|81089230|FG004|Overall Study|Subject Refused to Continue|0|||
27797126|NCT03533608|81089231|FG000|Overall Study|Withdrawal by Subject|3|||
27797127|NCT03533608|81089231|FG000|Overall Study|Physician Decision|2|||
27797128|NCT00630994|81089232|FG000|Overall Study|Adverse Event|1|||
27797129|NCT00630994|81089232|FG000|Overall Study|Disease Progression|1|||
27797130|NCT00630994|81089232|FG000|Overall Study|Lack of Efficacy|1|||
27797131|NCT00630994|81089232|FG000|Overall Study|Other|1|||
27797132|NCT03387735|81089233|FG000|Overall Study|Lost to Follow-up|4|||
27988849|NCT01912339|81791537|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
27797133|NCT03387735|81089234|FG001|Overall Study|Lost to Follow-up|8|||
27797134|NCT03387735|81089233|FG000|Overall Study|Death|4|||
27797135|NCT03387735|81089234|FG001|Overall Study|Death|8|||
27797136|NCT00555399|81089243|FG000|Overall Study|Withdrawal by Subject|0|||
27988850|NCT01912339|81791538|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
27988851|NCT01912339|81791539|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
27988852|NCT01912339|81791537|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
27579088|NCT00298896|80303057|FG000|Overall Study|Intercurrent Illness|1|||
27988853|NCT01912339|81791538|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
27988854|NCT01912339|81791539|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
27988855|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
27675460|NCT02947100|80650138|FG000|Overall Study|did not meet inclusion criteria|1|||
27675461|NCT00879775|80650141|FG000|Overall Study|Lost to Follow-up|2|||
27675462|NCT00879775|80650142|FG001|Overall Study|Lost to Follow-up|1|||
27675463|NCT03994731|80650146|FG000|Pegloticase + IMM Period|Death|2|||
27675464|NCT03994731|80650147|FG001|Pegloticase + IMM Period|Death|0|||
27675465|NCT03994731|80650146|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
27675466|NCT03994731|80650147|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
27675467|NCT03994731|80650146|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
27675468|NCT03994731|80650147|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
27797137|NCT00555399|81089244|FG001|Overall Study|Withdrawal by Subject|0|||
27797138|NCT00555399|81089245|FG002|Overall Study|Withdrawal by Subject|1|||
27797139|NCT00555399|81089246|FG003|Overall Study|Withdrawal by Subject|0|||
27797140|NCT00555399|81089247|FG004|Overall Study|Withdrawal by Subject|0|||
27797141|NCT00555399|81089248|FG005|Overall Study|Withdrawal by Subject|0|||
27797142|NCT00555399|81089249|FG006|Overall Study|Withdrawal by Subject|0|||
27797143|NCT00555399|81089250|FG007|Overall Study|Withdrawal by Subject|0|||
27797144|NCT00555399|81089251|FG008|Overall Study|Withdrawal by Subject|0|||
27797145|NCT00555399|81089252|FG009|Overall Study|Withdrawal by Subject|0|||
27797146|NCT00555399|81089253|FG010|Overall Study|Withdrawal by Subject|0|||
27797147|NCT00555399|81089254|FG011|Overall Study|Withdrawal by Subject|1|||
27797148|NCT00555399|81089243|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
27797149|NCT00555399|81089244|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
27797150|NCT00555399|81089245|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
27797151|NCT00555399|81089246|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
27797152|NCT00555399|81089247|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
27797153|NCT00555399|81089248|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
27797154|NCT00555399|81089249|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
27797155|NCT00555399|81089250|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
27797156|NCT00555399|81089251|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
27797157|NCT00555399|81089252|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
27797158|NCT00555399|81089253|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
27797159|NCT00555399|81089254|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
27797160|NCT00396318|81089255|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
27797161|NCT00902278|81089256|FG000|Overall Study|Physician Decision|1|||
27797162|NCT00902278|81089257|FG001|Overall Study|Physician Decision|0|||
27797163|NCT00902278|81089258|FG002|Overall Study|Physician Decision|2|||
27797164|NCT00902278|81089259|FG003|Overall Study|Physician Decision|0|||
27797165|NCT00902278|81089260|FG004|Overall Study|Physician Decision|1|||
27797166|NCT00902278|81089256|FG000|Overall Study|Lost to Follow-up|3|||
27797167|NCT00902278|81089257|FG001|Overall Study|Lost to Follow-up|2|||
27797168|NCT00902278|81089258|FG002|Overall Study|Lost to Follow-up|3|||
27797169|NCT00902278|81089259|FG003|Overall Study|Lost to Follow-up|0|||
27797170|NCT00902278|81089260|FG004|Overall Study|Lost to Follow-up|1|||
27988856|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
27988857|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
27988858|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
27988859|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
27988860|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
27988861|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
27797171|NCT02076113|81089263|FG000|Overall Study|Lost to Follow-up|4|||
27988862|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
27988863|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
27988864|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
27870055|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
27797172|NCT02076113|81089264|FG001|Overall Study|Lost to Follow-up|1|||
27797173|NCT02076113|81089263|FG000|Overall Study|Withdrawal by Subject|2|||
27797174|NCT02076113|81089264|FG001|Overall Study|Withdrawal by Subject|3|||
27797175|NCT02076113|81089263|FG000|Overall Study|Death|1|||
27675469|NCT00334542|80650148|FG000|Overall Study|Adverse Event|3|||
27797176|NCT02076113|81089264|FG001|Overall Study|Death|3|||
27797177|NCT04311411|81089268|FG000|Overall Study|Adverse Event|2|||
27797178|NCT04311411|81089269|FG001|Overall Study|Adverse Event|3|||
27797179|NCT04311411|81089270|FG002|Overall Study|Adverse Event|2|||
27797180|NCT04311411|81089268|FG000|Overall Study|Withdrawal by Subject|3|||
27797181|NCT04311411|81089269|FG001|Overall Study|Withdrawal by Subject|3|||
27797182|NCT04311411|81089270|FG002|Overall Study|Withdrawal by Subject|0|||
27797183|NCT03123120|81089273|FG000|Overall Study|Lost to Follow-up|0|||
27797184|NCT03123120|81089274|FG001|Overall Study|Lost to Follow-up|1|||
27797185|NCT03123120|81089273|FG000|Overall Study|Withdrawal by Subject|0|||
27797186|NCT03123120|81089274|FG001|Overall Study|Withdrawal by Subject|1|||
27797187|NCT01652872|81089275|FG000|Overall Study|Death|36|||
27870056|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
27870057|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
27988865|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
27988866|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
27988867|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
27988868|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
27988869|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
27988870|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
27988871|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
27988872|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
27988873|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
27988874|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
27988875|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
27988876|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
27988877|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
27988878|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
27988879|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
27988880|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
27988881|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
27988882|NCT01912339|81791537|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
27988883|NCT01912339|81791538|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
27988884|NCT01912339|81791539|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
27988885|NCT02479139|81791541|FG000|Overall Study|Lost to Follow-up|2|||
27988886|NCT02479139|81791542|FG001|Overall Study|Lost to Follow-up|4|||
27988887|NCT02479139|81791543|FG002|Overall Study|Lost to Follow-up|4|||
27988888|NCT02479139|81791544|FG003|Overall Study|Lost to Follow-up|2|||
27988889|NCT02479139|81791545|FG004|Overall Study|Lost to Follow-up|3|||
27988890|NCT02479139|81791546|FG005|Overall Study|Lost to Follow-up|5|||
27988891|NCT02479139|81791541|FG000|Overall Study|Withdrew Consent|5|||
27988892|NCT02479139|81791542|FG001|Overall Study|Withdrew Consent|6|||
27988893|NCT02479139|81791543|FG002|Overall Study|Withdrew Consent|1|||
27988894|NCT02479139|81791544|FG003|Overall Study|Withdrew Consent|4|||
27988895|NCT02479139|81791545|FG004|Overall Study|Withdrew Consent|1|||
27988896|NCT02479139|81791546|FG005|Overall Study|Withdrew Consent|1|||
27988897|NCT02479139|81791541|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27988898|NCT02479139|81791542|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27988899|NCT02479139|81791543|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
27988900|NCT02479139|81791544|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27988901|NCT02479139|81791545|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27988902|NCT02479139|81791546|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
27988903|NCT02479139|81791541|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27988904|NCT02479139|81791542|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27988905|NCT02479139|81791543|FG002|Overall Study|Other Miscellaneous Reasons|1|||
27988906|NCT02479139|81791544|FG003|Overall Study|Other Miscellaneous Reasons|1|||
27988907|NCT02479139|81791545|FG004|Overall Study|Other Miscellaneous Reasons|1|||
27988908|NCT02479139|81791546|FG005|Overall Study|Other Miscellaneous Reasons|0|||
27988909|NCT02292706|81791549|FG000|Overall Study|Lost to Follow-up|20|||
27797188|NCT01652872|81089276|FG001|Overall Study|Death|39|||
27870058|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
27988910|NCT02292706|81791550|FG001|Overall Study|Lost to Follow-up|44|||
27988911|NCT02292706|81791551|FG002|Overall Study|Lost to Follow-up|24|||
27988912|NCT02292706|81791552|FG003|Overall Study|Lost to Follow-up|61|||
27579089|NCT00298896|80303057|FG000|Overall Study|Disease Progression|41|||
27797189|NCT01652872|81089275|FG000|Overall Study|Lost to Follow-up|28|||
27797190|NCT01652872|81089276|FG001|Overall Study|Lost to Follow-up|23|||
27797191|NCT01652872|81089275|FG000|Overall Study|Decision by sponsor|5|||
27797192|NCT01652872|81089276|FG001|Overall Study|Decision by sponsor|7|||
27797193|NCT01652872|81089275|FG000|Overall Study|Withdrawal by Subject|76|||
27797194|NCT01652872|81089276|FG001|Overall Study|Withdrawal by Subject|84|||
27797195|NCT03332212|81089277|FG000|Overall Study|Not treated|0|||
27797196|NCT03332212|81089278|FG001|Overall Study|Not treated|1|||
27797197|NCT03332212|81089279|FG002|Overall Study|Not treated|0|||
27797198|NCT03332212|81089280|FG003|Overall Study|Not treated|0|||
27797199|NCT03332212|81089277|FG000|Overall Study|Adverse Event|0|||
27797200|NCT03332212|81089278|FG001|Overall Study|Adverse Event|0|||
27797201|NCT03332212|81089279|FG002|Overall Study|Adverse Event|0|||
27797202|NCT03332212|81089280|FG003|Overall Study|Adverse Event|1|||
27797203|NCT03332212|81089277|FG000|Overall Study|worsening of disease under study|1|||
27797204|NCT03332212|81089278|FG001|Overall Study|worsening of disease under study|1|||
27797205|NCT03332212|81089279|FG002|Overall Study|worsening of disease under study|0|||
27797206|NCT03332212|81089280|FG003|Overall Study|worsening of disease under study|0|||
27797207|NCT03125915|81089281|FG000|1 Month Follow up|Lost to Follow-up|3|||
27797208|NCT03125915|81089282|FG001|1 Month Follow up|Lost to Follow-up|3|||
27797209|NCT03125915|81089283|FG002|1 Month Follow up|Lost to Follow-up|2|||
27797210|NCT03125915|81089284|FG003|1 Month Follow up|Lost to Follow-up|3|||
27797211|NCT03125915|81089281|FG000|3 Month Follow-up|Lost to Follow-up|6|||
27797212|NCT03125915|81089282|FG001|3 Month Follow-up|Lost to Follow-up|4|||
27797213|NCT03125915|81089283|FG002|3 Month Follow-up|Lost to Follow-up|4|||
27797214|NCT03125915|81089284|FG003|3 Month Follow-up|Lost to Follow-up|2|||
27797215|NCT03125915|81089281|FG000|6 Month Follow-up|Lost to Follow-up|7|||
27797216|NCT03125915|81089282|FG001|6 Month Follow-up|Lost to Follow-up|3|||
27797217|NCT03125915|81089283|FG002|6 Month Follow-up|Lost to Follow-up|6|||
27797218|NCT03125915|81089284|FG003|6 Month Follow-up|Lost to Follow-up|3|||
27797219|NCT02487979|81089285|FG000|Overall Study|Physician Decision|2|||
27797220|NCT02487979|81089285|FG000|Overall Study|Withdrawal by Subject|2|||
27797221|NCT02487979|81089285|FG000|Overall Study|Progressive Disease|17|||
27797222|NCT01311505|81089286|FG000|First Intervention Period|Protocol Violation|0|||
27797223|NCT01311505|81089287|FG001|First Intervention Period|Protocol Violation|1|||
27797224|NCT00447694|81089288|FG000|Overall Study|Adverse Event|2|||
27797225|NCT00447694|81089288|FG000|Overall Study|Abnormal laboratory value|1|||
27870059|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
27988913|NCT02292706|81791553|FG004|Overall Study|Lost to Follow-up|21|||
27594164|NCT03561090|80352460|FG001|Overall Study|Protocol Violation|2|||
27594165|NCT03561090|80352459|FG000|Overall Study|Withdrawal by Subject|7|||
27594166|NCT03561090|80352460|FG001|Overall Study|Withdrawal by Subject|7|||
27594167|NCT03561090|80352459|FG000|Overall Study|Lost to Follow-up|7|||
27594168|NCT03561090|80352460|FG001|Overall Study|Lost to Follow-up|2|||
27594169|NCT03561090|80352459|FG000|Overall Study|Study Terminated by Sponsor|10|||
27594170|NCT03561090|80352460|FG001|Overall Study|Study Terminated by Sponsor|15|||
27594171|NCT03561090|80352459|FG000|Overall Study|Randomized by Mistake|1|||
27594172|NCT03561090|80352460|FG001|Overall Study|Randomized by Mistake|1|||
27594173|NCT03561090|80352459|FG000|Overall Study|Other Not Specified|0|||
27594174|NCT03561090|80352460|FG001|Overall Study|Other Not Specified|2|||
27594175|NCT00636610|80352461|FG000|Overall Study|Adverse Event|4|||
27594176|NCT00636610|80352462|FG001|Overall Study|Adverse Event|4|||
27594177|NCT00636610|80352461|FG000|Overall Study|Death|6|||
27594178|NCT00636610|80352462|FG001|Overall Study|Death|3|||
27594179|NCT00636610|80352461|FG000|Overall Study|Physician decision to withdraw patient|15|||
27594180|NCT00636610|80352462|FG001|Overall Study|Physician decision to withdraw patient|9|||
27594181|NCT00636610|80352461|FG000|Overall Study|Subject decision to withdraw|15|||
27594182|NCT00636610|80352462|FG001|Overall Study|Subject decision to withdraw|11|||
27594183|NCT00636610|80352461|FG000|Overall Study|Disease progression - radiographic|41|||
27594184|NCT00636610|80352462|FG001|Overall Study|Disease progression - radiographic|51|||
27594185|NCT00636610|80352461|FG000|Overall Study|Disease progression - clinical|8|||
27594186|NCT00636610|80352462|FG001|Overall Study|Disease progression - clinical|3|||
27594187|NCT00636610|80352461|FG000|Overall Study|Reason for discontinuation not available|3|||
27594188|NCT00636610|80352462|FG001|Overall Study|Reason for discontinuation not available|2|||
27594189|NCT00729833|80352465|FG000|Overall Study|Death|5|||
27594190|NCT00729833|80352466|FG001|Overall Study|Death|1|||
27594191|NCT00729833|80352467|FG002|Overall Study|Death|3|||
27594192|NCT00729833|80352468|FG003|Overall Study|Death|5|||
27594193|NCT00729833|80352465|FG000|Overall Study|Study Terminated by Sponsor|0|||
27594194|NCT00729833|80352466|FG001|Overall Study|Study Terminated by Sponsor|0|||
27594195|NCT00729833|80352467|FG002|Overall Study|Study Terminated by Sponsor|1|||
27594196|NCT00729833|80352468|FG003|Overall Study|Study Terminated by Sponsor|0|||
27594197|NCT00729833|80352465|FG000|Overall Study|Lost to Follow-up|1|||
27579090|NCT00298896|80303057|FG000|Overall Study|Withdrawal by Subject|2|||
27579091|NCT00298896|80303057|FG000|Overall Study|Assigned to treatment in error|1|||
27579092|NCT01038778|80303065|FG000|Overall Study|Withdrawal by Subject|0|||
27579093|NCT01038778|80303066|FG001|Overall Study|Withdrawal by Subject|2|||
27579094|NCT01038778|80303067|FG002|Overall Study|Withdrawal by Subject|3|||
27579095|NCT02838420|80303068|FG000|Overall Study|Ongoing in Study|113|||
27579096|NCT02838420|80303069|FG001|Overall Study|Ongoing in Study|45|||
27579097|NCT02838420|80303068|FG000|Overall Study|Lost to Follow-up|1|||
27579098|NCT02838420|80303069|FG001|Overall Study|Lost to Follow-up|0|||
27579099|NCT02838420|80303068|FG000|Overall Study|Withdrawal by Subject|3|||
27797226|NCT00447694|81089288|FG000|Overall Study|Abnormal test procedure result|1|||
27797227|NCT00447694|81089288|FG000|Overall Study|Withdrawal by Subject|2|||
27797228|NCT00960687|81089292|FG000|Washout Period of 7 Days|Adverse Event|3|||
27797229|NCT00960687|81089293|FG001|Washout Period of 7 Days|Adverse Event|2|||
27797230|NCT00960687|81089292|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27797231|NCT00960687|81089293|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27797232|NCT01500434|81089294|FG000|Overall Study|Death|1|||
27797233|NCT01500434|81089294|FG000|Overall Study|Withdrawal by Subject|1|||
27797234|NCT01500434|81089294|FG000|Overall Study|Missed 12-month follow-up|5|||
27797235|NCT03047031|81089296|FG000|Overall Study|Other than listed|1|||
27797236|NCT03047031|81089297|FG001|Overall Study|Other than listed|0|||
27797237|NCT03047031|81089298|FG002|Overall Study|Other than listed|0|||
27870060|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
27988914|NCT02292706|81791554|FG005|Overall Study|Lost to Follow-up|52|||
27988915|NCT02292706|81791555|FG006|Overall Study|Lost to Follow-up|25|||
27988916|NCT02292706|81791556|FG007|Overall Study|Lost to Follow-up|0|||
27988917|NCT02292706|81791549|FG000|Overall Study|Withdrew consent|15|||
27988918|NCT02292706|81791550|FG001|Overall Study|Withdrew consent|56|||
27579100|NCT02838420|80303069|FG001|Overall Study|Withdrawal by Subject|4|||
27579101|NCT02838420|80303068|FG000|Overall Study|Death|8|||
27579102|NCT02838420|80303069|FG001|Overall Study|Death|13|||
27579103|NCT02057757|80303072|FG000|Overall Study|Withdrawal by Subject|3|||
27579104|NCT02057757|80303073|FG001|Overall Study|Withdrawal by Subject|5|||
27579105|NCT02057757|80303072|FG000|Overall Study|Death|2|||
27579106|NCT02057757|80303073|FG001|Overall Study|Death|0|||
27579107|NCT02057757|80303072|FG000|Overall Study|Lost to Follow-up|8|||
27579108|NCT02057757|80303073|FG001|Overall Study|Lost to Follow-up|3|||
27579109|NCT02057757|80303072|FG000|Overall Study|Non-compliance|1|||
27579110|NCT02057757|80303073|FG001|Overall Study|Non-compliance|0|||
27579111|NCT01312467|80303079|FG000|Overall Study|Adverse Event|4|||
27579112|NCT01312467|80303079|FG000|Overall Study|Lost to Follow-up|1|||
27579113|NCT01312467|80303079|FG000|Overall Study|Withdrawal by Subject|2|||
27579114|NCT01312467|80303079|FG000|Overall Study|Deported to country of origin|1|||
27579115|NCT01312467|80303079|FG000|Overall Study|Another medical condition|1|||
27579116|NCT01312467|80303079|FG000|Overall Study|Ineligible|4|||
27579117|NCT00961259|80303087|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
27579118|NCT00961259|80303088|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
27579119|NCT00961259|80303089|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
27579120|NCT03285477|80303090|FG000|Treatment and Response Assessment Period|Death|1|||
27988919|NCT02292706|81791551|FG002|Overall Study|Withdrew consent|43|||
27988920|NCT02292706|81791552|FG003|Overall Study|Withdrew consent|36|||
27988921|NCT02292706|81791553|FG004|Overall Study|Withdrew consent|13|||
27579121|NCT03285477|80303091|FG001|Treatment and Response Assessment Period|Death|0|||
27579122|NCT03285477|80303090|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
27579123|NCT03285477|80303091|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
27579124|NCT03285477|80303090|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
27579125|NCT03285477|80303091|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
27579126|NCT03285477|80303090|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
27579127|NCT03285477|80303091|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
27579128|NCT03285477|80303090|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
27579129|NCT03285477|80303091|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
27988922|NCT02292706|81791554|FG005|Overall Study|Withdrew consent|51|||
27988923|NCT02292706|81791555|FG006|Overall Study|Withdrew consent|20|||
27579130|NCT00534352|80303092|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
27579131|NCT00534352|80303092|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
27579132|NCT00534352|80303092|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
27579133|NCT00534352|80303092|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
27797238|NCT03047031|81089296|FG000|Overall Study|Lost to Follow-up|4|||
27797239|NCT03047031|81089297|FG001|Overall Study|Lost to Follow-up|0|||
27797240|NCT03047031|81089298|FG002|Overall Study|Lost to Follow-up|0|||
27988924|NCT02292706|81791556|FG007|Overall Study|Withdrew consent|0|||
27988925|NCT02292706|81791549|FG000|Overall Study|Death|3|||
27579134|NCT00534352|80303092|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
27579135|NCT00534352|80303092|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
27579136|NCT03285646|80303095|FG000|Overall Study|Adverse Event|1|||
27579137|NCT03285646|80303096|FG001|Overall Study|Adverse Event|0|||
27579138|NCT03285646|80303095|FG000|Overall Study|Withdrawal by Subject|10|||
27579139|NCT03285646|80303096|FG001|Overall Study|Withdrawal by Subject|2|||
27579140|NCT03285646|80303095|FG000|Overall Study|Lost to Follow-up|2|||
27579141|NCT03285646|80303096|FG001|Overall Study|Lost to Follow-up|1|||
27579142|NCT03285646|80303095|FG000|Overall Study|Investigator/Sponsor Decision|0|||
27579143|NCT03285646|80303096|FG001|Overall Study|Investigator/Sponsor Decision|1|||
27579144|NCT01328002|80303097|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
27579145|NCT01328002|80303098|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
27579146|NCT01328002|80303097|FG000|Open-Label Period|Adverse Event|8|||
27579147|NCT01328002|80303098|FG001|Open-Label Period|Adverse Event|0|||
27579148|NCT01328002|80303097|FG000|Open-Label Period|Lack of Efficacy|3|||
27579149|NCT01328002|80303098|FG001|Open-Label Period|Lack of Efficacy|0|||
27579150|NCT01328002|80303097|FG000|Open-Label Period|Protocol Violation|2|||
27579151|NCT01328002|80303098|FG001|Open-Label Period|Protocol Violation|0|||
27579152|NCT01328002|80303097|FG000|Open-Label Period|Withdrawal by Subject|9|||
27579153|NCT01328002|80303098|FG001|Open-Label Period|Withdrawal by Subject|0|||
27579154|NCT01328002|80303097|FG000|Open-Label Period|Lost to Follow-up|6|||
27579155|NCT01328002|80303098|FG001|Open-Label Period|Lost to Follow-up|0|||
27579156|NCT01328002|80303097|FG000|Open-Label Period|Other Reason|2|||
27579157|NCT01328002|80303098|FG001|Open-Label Period|Other Reason|0|||
27579158|NCT01328002|80303097|FG000|Double-Blind Period|Adverse Event|1|||
27988926|NCT02292706|81791550|FG001|Overall Study|Death|11|||
27988927|NCT02292706|81791551|FG002|Overall Study|Death|16|||
27579159|NCT01328002|80303098|FG001|Double-Blind Period|Adverse Event|0|||
27579160|NCT01328002|80303097|FG000|Double-Blind Period|Lack of Efficacy|1|||
27675470|NCT00334542|80650148|FG000|Overall Study|Withdrawal by Subject|1|||
27675471|NCT00334542|80650148|FG000|Overall Study|New cancer diagnosis|1|||
27870061|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
27870062|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
27870063|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
27870064|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
27870065|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
27870066|NCT00261443|81357895|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
27870067|NCT00261443|81357896|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
27870068|NCT00261443|81357897|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
27870069|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
27870070|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
27870071|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
27870072|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
27870073|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
27988928|NCT02292706|81791552|FG003|Overall Study|Death|22|||
27988929|NCT02292706|81791553|FG004|Overall Study|Death|8|||
27870074|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
27870075|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
27870076|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
27870077|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
27870078|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
27870079|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
27870080|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
27870081|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
27988930|NCT02292706|81791554|FG005|Overall Study|Death|17|||
27988931|NCT02292706|81791555|FG006|Overall Study|Death|3|||
27988932|NCT02292706|81791556|FG007|Overall Study|Death|0|||
27988933|NCT02292706|81791549|FG000|Overall Study|Study terminated by sponsor|0|||
27988934|NCT02292706|81791550|FG001|Overall Study|Study terminated by sponsor|9|||
27988935|NCT02292706|81791551|FG002|Overall Study|Study terminated by sponsor|4|||
27988936|NCT02292706|81791552|FG003|Overall Study|Study terminated by sponsor|21|||
27988937|NCT02292706|81791553|FG004|Overall Study|Study terminated by sponsor|11|||
27988938|NCT02292706|81791554|FG005|Overall Study|Study terminated by sponsor|13|||
27988939|NCT02292706|81791555|FG006|Overall Study|Study terminated by sponsor|3|||
27988940|NCT02292706|81791556|FG007|Overall Study|Study terminated by sponsor|0|||
27988941|NCT02292706|81791549|FG000|Overall Study|Investigator's discretion|4|||
27988942|NCT02292706|81791550|FG001|Overall Study|Investigator's discretion|9|||
27988943|NCT02292706|81791551|FG002|Overall Study|Investigator's discretion|7|||
27988944|NCT02292706|81791552|FG003|Overall Study|Investigator's discretion|11|||
27988945|NCT02292706|81791553|FG004|Overall Study|Investigator's discretion|4|||
27988946|NCT02292706|81791554|FG005|Overall Study|Investigator's discretion|10|||
27988947|NCT02292706|81791555|FG006|Overall Study|Investigator's discretion|1|||
27988948|NCT02292706|81791556|FG007|Overall Study|Investigator's discretion|0|||
27988949|NCT02292706|81791549|FG000|Overall Study|Liver transplant|1|||
27988950|NCT02292706|81791550|FG001|Overall Study|Liver transplant|1|||
27988951|NCT02292706|81791551|FG002|Overall Study|Liver transplant|11|||
27870082|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
27870083|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
27870084|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
27870085|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
27870086|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
27870087|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
27870088|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
27870089|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
27870090|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
27870091|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
27870092|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
27870093|NCT00261443|81357895|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
27870094|NCT00261443|81357896|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
27870095|NCT00261443|81357897|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
27870096|NCT00261443|81357895|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
27988952|NCT02292706|81791552|FG003|Overall Study|Liver transplant|16|||
27988953|NCT02292706|81791553|FG004|Overall Study|Liver transplant|5|||
27988954|NCT02292706|81791554|FG005|Overall Study|Liver transplant|6|||
27988955|NCT02292706|81791555|FG006|Overall Study|Liver transplant|5|||
27988956|NCT02292706|81791556|FG007|Overall Study|Liver transplant|0|||
27988957|NCT02292706|81791549|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
27988958|NCT02292706|81791550|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
27594198|NCT00729833|80352466|FG001|Overall Study|Lost to Follow-up|0|||
27797241|NCT03047031|81089296|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
27797242|NCT03047031|81089297|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
27797243|NCT03047031|81089298|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
27988959|NCT02292706|81791551|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
27797244|NCT03047031|81089296|FG000|Overall Study|Adverse Event|1|||
27797245|NCT03047031|81089297|FG001|Overall Study|Adverse Event|0|||
27988960|NCT02292706|81791552|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
27988961|NCT02292706|81791553|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
27797246|NCT03047031|81089298|FG002|Overall Study|Adverse Event|0|||
27797247|NCT03047031|81089296|FG000|Overall Study|Withdrawal by Subject|2|||
27797248|NCT03047031|81089297|FG001|Overall Study|Withdrawal by Subject|0|||
27797249|NCT03047031|81089298|FG002|Overall Study|Withdrawal by Subject|0|||
27797250|NCT03047031|81089296|FG000|Overall Study|Change to other medication|2|||
27797251|NCT03047031|81089297|FG001|Overall Study|Change to other medication|0|||
27870097|NCT00261443|81357896|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
27988962|NCT02292706|81791554|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
27870098|NCT00261443|81357897|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
27870099|NCT00261443|81357895|FG000|3: Assessment of Relapse|Adverse Event|0|||
27797252|NCT03047031|81089298|FG002|Overall Study|Change to other medication|0|||
27797253|NCT03047031|81089296|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
27870100|NCT00261443|81357896|FG001|3: Assessment of Relapse|Adverse Event|15|||
27870101|NCT00261443|81357897|FG002|3: Assessment of Relapse|Adverse Event|19|||
27870102|NCT00261443|81357895|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
27870103|NCT00261443|81357896|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
27870104|NCT00261443|81357897|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
27870105|NCT00261443|81357895|FG000|3: Assessment of Relapse|Death|0|||
27870106|NCT00261443|81357896|FG001|3: Assessment of Relapse|Death|0|||
27870107|NCT00261443|81357897|FG002|3: Assessment of Relapse|Death|1|||
27870108|NCT00261443|81357895|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
27870109|NCT00261443|81357896|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
27870110|NCT00261443|81357897|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
27870111|NCT00261443|81357895|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
27870112|NCT00261443|81357896|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
27870113|NCT00261443|81357897|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
27797254|NCT03047031|81089297|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
27797255|NCT03047031|81089298|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
27797256|NCT02058368|81089299|FG000|Overall Study|Adverse Event|15|||
27797257|NCT02058368|81089300|FG001|Overall Study|Adverse Event|20|||
27797258|NCT02058368|81089299|FG000|Overall Study|Lack of Efficacy|0|||
27797259|NCT02058368|81089300|FG001|Overall Study|Lack of Efficacy|1|||
27797260|NCT02058368|81089299|FG000|Overall Study|Protocol Violation|0|||
27797261|NCT02058368|81089300|FG001|Overall Study|Protocol Violation|4|||
27797262|NCT02058368|81089299|FG000|Overall Study|Lost to Follow-up|2|||
27797263|NCT02058368|81089300|FG001|Overall Study|Lost to Follow-up|0|||
27797264|NCT02058368|81089299|FG000|Overall Study|Physician Decision|2|||
27797265|NCT02058368|81089300|FG001|Overall Study|Physician Decision|3|||
27797266|NCT02058368|81089299|FG000|Overall Study|Withdrawal by Subject|22|||
27797267|NCT02058368|81089300|FG001|Overall Study|Withdrawal by Subject|26|||
27797268|NCT02704130|81089301|FG000|Overall Study|Physician Decision|5|||
27797269|NCT02704130|81089302|FG001|Overall Study|Physician Decision|3|||
27797270|NCT03255226|81089303|FG000|Overall Study|Adverse Event|2|||
27797271|NCT03255226|81089303|FG000|Overall Study|Physician Decision|3|||
27797272|NCT03255226|81089303|FG000|Overall Study|Withdrawal by Subject|1|||
27797273|NCT03255226|81089303|FG000|Overall Study|Serum or blood sodium increased|4|||
27797274|NCT03255226|81089303|FG000|Overall Study|Serum or blood potassium increased|4|||
27797275|NCT00567996|81089310|FG000|Overall Study|Adverse Event|18|||
27797276|NCT00567996|81089311|FG001|Overall Study|Adverse Event|16|||
27797277|NCT00567996|81089312|FG002|Overall Study|Adverse Event|13|||
27797278|NCT00567996|81089310|FG000|Overall Study|Protocol Deviation|9|||
27797279|NCT00567996|81089311|FG001|Overall Study|Protocol Deviation|11|||
27797280|NCT00567996|81089312|FG002|Overall Study|Protocol Deviation|13|||
27797281|NCT00567996|81089310|FG000|Overall Study|Withdrawal by Subject|8|||
27797282|NCT00567996|81089311|FG001|Overall Study|Withdrawal by Subject|12|||
27797283|NCT00567996|81089312|FG002|Overall Study|Withdrawal by Subject|22|||
27797284|NCT00567996|81089310|FG000|Overall Study|Abnormal Lab value(s)|2|||
27797285|NCT00567996|81089311|FG001|Overall Study|Abnormal Lab value(s)|1|||
27797286|NCT00567996|81089312|FG002|Overall Study|Abnormal Lab value(s)|2|||
27797287|NCT00567996|81089310|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27797288|NCT00567996|81089311|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27797289|NCT00567996|81089312|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27797290|NCT00567996|81089310|FG000|Overall Study|Lost to Follow-up|2|||
27797291|NCT00567996|81089311|FG001|Overall Study|Lost to Follow-up|5|||
27797292|NCT00567996|81089312|FG002|Overall Study|Lost to Follow-up|2|||
27797293|NCT00567996|81089310|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27797294|NCT00567996|81089311|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27797295|NCT00567996|81089312|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
27797296|NCT00567996|81089310|FG000|Overall Study|Administrative problems|1|||
27870114|NCT00261443|81357895|FG000|3: Assessment of Relapse|Pregnancy|0|||
27870115|NCT00261443|81357896|FG001|3: Assessment of Relapse|Pregnancy|2|||
27797297|NCT00567996|81089311|FG001|Overall Study|Administrative problems|1|||
27797298|NCT00567996|81089312|FG002|Overall Study|Administrative problems|0|||
27797299|NCT00567996|81089310|FG000|Overall Study|Death|1|||
27870116|NCT00261443|81357897|FG002|3: Assessment of Relapse|Pregnancy|1|||
27870117|NCT00261443|81357895|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
27870118|NCT00261443|81357896|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
27797300|NCT00567996|81089311|FG001|Overall Study|Death|0|||
27797301|NCT00567996|81089312|FG002|Overall Study|Death|2|||
27797302|NCT00567996|81089310|FG000|Overall Study|Patient's inability to use the device|0|||
27797303|NCT00567996|81089311|FG001|Overall Study|Patient's inability to use the device|1|||
27870119|NCT00261443|81357897|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
27870120|NCT00261443|81357895|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
27870121|NCT00261443|81357896|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
27870122|NCT00261443|81357897|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
27870123|NCT00261443|81357895|FG000|3: Assessment of Relapse|Other Reasons|0|||
27870124|NCT00261443|81357896|FG001|3: Assessment of Relapse|Other Reasons|4|||
27870125|NCT00261443|81357897|FG002|3: Assessment of Relapse|Other Reasons|3|||
27870126|NCT00261443|81357895|FG000|4: Extension Phase|Adverse Event|0|||
27870127|NCT00261443|81357896|FG001|4: Extension Phase|Adverse Event|1|||
27870128|NCT00261443|81357897|FG002|4: Extension Phase|Adverse Event|0|||
27870129|NCT00261443|81357895|FG000|4: Extension Phase|Withdrawal by Subject|0|||
27870130|NCT00261443|81357896|FG001|4: Extension Phase|Withdrawal by Subject|1|||
27870131|NCT00261443|81357897|FG002|4: Extension Phase|Withdrawal by Subject|2|||
27870132|NCT00261443|81357895|FG000|4: Extension Phase|Lost to Follow-up|0|||
27870133|NCT00261443|81357896|FG001|4: Extension Phase|Lost to Follow-up|1|||
27870134|NCT00261443|81357897|FG002|4: Extension Phase|Lost to Follow-up|0|||
27870135|NCT03993379|81357898|FG000|Overall Study|The study was terminated early due to business decision.|0|||
27870136|NCT03993379|81357899|FG001|Overall Study|The study was terminated early due to business decision.|2|||
27870137|NCT03993379|81357900|FG002|Overall Study|The study was terminated early due to business decision.|0|||
27870138|NCT03993379|81357901|FG003|Overall Study|The study was terminated early due to business decision.|0|||
27870139|NCT03993379|81357898|FG000|Overall Study|Withdrawal by Subject|0|||
27870140|NCT03993379|81357899|FG001|Overall Study|Withdrawal by Subject|1|||
27870141|NCT03993379|81357900|FG002|Overall Study|Withdrawal by Subject|0|||
27870142|NCT03993379|81357901|FG003|Overall Study|Withdrawal by Subject|0|||
27870143|NCT00925704|81357903|FG000|First Intervention|Withdrew consent|0|||
27870144|NCT00925704|81357904|FG001|First Intervention|Withdrew consent|0|||
27870145|NCT00925704|81357905|FG002|First Intervention|Withdrew consent|0|||
27870146|NCT00925704|81357906|FG003|First Intervention|Withdrew consent|1|||
27870147|NCT00925704|81357907|FG004|First Intervention|Withdrew consent|1|||
27870148|NCT00925704|81357908|FG005|First Intervention|Withdrew consent|0|||
27870149|NCT00925704|81357903|FG000|Second Intervention|Withdrawal by Subject|1|||
27870150|NCT00925704|81357904|FG001|Second Intervention|Withdrawal by Subject|0|||
27870151|NCT00925704|81357905|FG002|Second Intervention|Withdrawal by Subject|0|||
27870152|NCT00925704|81357906|FG003|Second Intervention|Withdrawal by Subject|0|||
27870153|NCT00925704|81357907|FG004|Second Intervention|Withdrawal by Subject|1|||
27870154|NCT00925704|81357908|FG005|Second Intervention|Withdrawal by Subject|0|||
27870155|NCT00925704|81357903|FG000|Third Intervention|Withdrew consent|0|||
27870156|NCT00925704|81357904|FG001|Third Intervention|Withdrew consent|0|||
27870157|NCT00925704|81357905|FG002|Third Intervention|Withdrew consent|0|||
27870158|NCT00925704|81357906|FG003|Third Intervention|Withdrew consent|0|||
27870159|NCT00925704|81357907|FG004|Third Intervention|Withdrew consent|0|||
27870160|NCT00925704|81357908|FG005|Third Intervention|Withdrew consent|1|||
27870161|NCT01197911|81357911|FG000|Overall Study|Adverse Event|0|||
27870162|NCT01197911|81357912|FG001|Overall Study|Adverse Event|0|||
27870163|NCT01197911|81357913|FG002|Overall Study|Adverse Event|1|||
27870164|NCT02685735|81357914|FG000|Overall Study|Missing construct or pain data|23|||
27870165|NCT02685735|81357915|FG001|Overall Study|Missing construct or pain data|22|||
27870166|NCT00246324|81357916|FG000|Overall Study|Withdrawal by Subject|1|||
27870167|NCT00064987|81357919|FG000|Overall Study|Physician Decision|3|||
27870168|NCT00064987|81357920|FG001|Overall Study|Physician Decision|0|||
27870169|NCT02501928|81357923|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27870170|NCT02501928|81357924|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
27870171|NCT02501928|81357925|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
27870172|NCT02501928|81357926|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
27870173|NCT02501928|81357927|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
27870174|NCT02501928|81357928|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
27870175|NCT01090414|81357935|FG000|Study 101-99|Progressive Disease|28|||
27870176|NCT01090414|81357936|FG001|Study 101-99|Progressive Disease|48|||
27870177|NCT01090414|81357937|FG002|Study 101-99|Progressive Disease|10|||
27870178|NCT01090414|81357938|FG003|Study 101-99|Progressive Disease|4|||
27870179|NCT01090414|81357935|FG000|Study 101-99|Adverse Event|10|||
27675472|NCT01228175|80650149|FG000|Overall Study|Lost to Follow-up|64|||
27675473|NCT01228175|80650150|FG001|Overall Study|Lost to Follow-up|50|||
27675474|NCT01228175|80650149|FG000|Overall Study|Withdrawal by Subject|1|||
27675475|NCT01228175|80650150|FG001|Overall Study|Withdrawal by Subject|2|||
27870180|NCT01090414|81357936|FG001|Study 101-99|Adverse Event|28|||
27870181|NCT01090414|81357937|FG002|Study 101-99|Adverse Event|18|||
27870182|NCT01090414|81357938|FG003|Study 101-99|Adverse Event|0|||
27675476|NCT01228175|80650149|FG000|Overall Study|Physician Decision|1|||
27870183|NCT01090414|81357935|FG000|Study 101-99|Investigator Request|1|||
27870184|NCT01090414|81357936|FG001|Study 101-99|Investigator Request|11|||
27870185|NCT01090414|81357937|FG002|Study 101-99|Investigator Request|4|||
27870186|NCT01090414|81357938|FG003|Study 101-99|Investigator Request|0|||
27675477|NCT01228175|80650150|FG001|Overall Study|Physician Decision|1|||
27870187|NCT01090414|81357935|FG000|Study 101-99|Death|3|||
27870188|NCT01090414|81357936|FG001|Study 101-99|Death|8|||
27797304|NCT00567996|81089312|FG002|Overall Study|Patient's inability to use the device|0|||
27797305|NCT00595127|81089321|FG000|Overall Study|Death|6|||
27797306|NCT00595127|81089321|FG000|Overall Study|Relapsed|3|||
27797307|NCT00595127|81089321|FG000|Overall Study|joined another trial|1|||
27797308|NCT01306968|81089322|FG000|Overall Study|Lost to Follow-up|1|||
27797309|NCT01306968|81089323|FG001|Overall Study|Lost to Follow-up|1|||
27797310|NCT01306968|81089324|FG002|Overall Study|Lost to Follow-up|0|||
27797311|NCT01306968|81089325|FG003|Overall Study|Lost to Follow-up|0|||
27797312|NCT01306968|81089322|FG000|Overall Study|Physician Decision|0|||
27797313|NCT01306968|81089323|FG001|Overall Study|Physician Decision|1|||
27797314|NCT01306968|81089324|FG002|Overall Study|Physician Decision|0|||
27797315|NCT01306968|81089325|FG003|Overall Study|Physician Decision|0|||
27675478|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
27797316|NCT01306968|81089322|FG000|Overall Study|Relocated and left active duty|0|||
27797317|NCT01306968|81089323|FG001|Overall Study|Relocated and left active duty|1|||
27797318|NCT01306968|81089324|FG002|Overall Study|Relocated and left active duty|1|||
27797319|NCT01306968|81089325|FG003|Overall Study|Relocated and left active duty|1|||
27797320|NCT01306968|81089322|FG000|Overall Study|Withdrew - time commitment|0|||
27797321|NCT01306968|81089323|FG001|Overall Study|Withdrew - time commitment|0|||
27797322|NCT01306968|81089324|FG002|Overall Study|Withdrew - time commitment|0|||
27797323|NCT01306968|81089325|FG003|Overall Study|Withdrew - time commitment|2|||
27797324|NCT01306968|81089322|FG000|Overall Study|Withdrew over privacy concerns|0|||
27797325|NCT01306968|81089323|FG001|Overall Study|Withdrew over privacy concerns|0|||
27797326|NCT01306968|81089324|FG002|Overall Study|Withdrew over privacy concerns|0|||
27797327|NCT01306968|81089325|FG003|Overall Study|Withdrew over privacy concerns|1|||
27797328|NCT02525627|81089326|FG000|Overall Study|Revision|1|||
27797329|NCT02525627|81089327|FG001|Overall Study|Revision|1|||
27797330|NCT02525627|81089326|FG000|Overall Study|Withdrawal by Subject|1|||
27797331|NCT02525627|81089327|FG001|Overall Study|Withdrawal by Subject|2|||
27797332|NCT02525627|81089326|FG000|Overall Study|Death|1|||
27797333|NCT02525627|81089327|FG001|Overall Study|Death|0|||
27797334|NCT02525627|81089326|FG000|Overall Study|Site terminated|11|||
27797335|NCT02525627|81089327|FG001|Overall Study|Site terminated|10|||
27797336|NCT01643928|81089331|FG000|Overall Study|Lost to Follow-up|1|||
27797337|NCT01643928|81089332|FG001|Overall Study|Lost to Follow-up|0|||
27797338|NCT01643928|81089333|FG002|Overall Study|Lost to Follow-up|2|||
27797339|NCT01643928|81089334|FG003|Overall Study|Lost to Follow-up|0|||
27797340|NCT01643928|81089335|FG004|Overall Study|Lost to Follow-up|0|||
27797341|NCT01643928|81089331|FG000|Overall Study|Withdrawal by Subject|2|||
27797342|NCT01643928|81089332|FG001|Overall Study|Withdrawal by Subject|0|||
27797343|NCT01643928|81089333|FG002|Overall Study|Withdrawal by Subject|0|||
27797344|NCT01643928|81089334|FG003|Overall Study|Withdrawal by Subject|1|||
27797345|NCT01643928|81089335|FG004|Overall Study|Withdrawal by Subject|0|||
27797346|NCT01643928|81089331|FG000|Overall Study|Pregnancy|0|||
27797347|NCT01643928|81089332|FG001|Overall Study|Pregnancy|0|||
27797348|NCT01643928|81089333|FG002|Overall Study|Pregnancy|0|||
27797349|NCT01643928|81089334|FG003|Overall Study|Pregnancy|1|||
27797350|NCT01643928|81089335|FG004|Overall Study|Pregnancy|0|||
27797351|NCT01643928|81089331|FG000|Overall Study|Other|5|||
27797352|NCT01643928|81089332|FG001|Overall Study|Other|1|||
27797353|NCT01643928|81089333|FG002|Overall Study|Other|1|||
27797354|NCT01643928|81089334|FG003|Overall Study|Other|0|||
27797355|NCT01643928|81089335|FG004|Overall Study|Other|0|||
27797356|NCT01643928|81089331|FG000|Overall Study|Adverse Event|2|||
27797357|NCT01643928|81089332|FG001|Overall Study|Adverse Event|1|||
27797358|NCT01643928|81089333|FG002|Overall Study|Adverse Event|0|||
27797359|NCT01643928|81089334|FG003|Overall Study|Adverse Event|1|||
27797360|NCT01643928|81089335|FG004|Overall Study|Adverse Event|2|||
27797361|NCT02886494|81089336|FG000|Overall Study|Adverse Event|1|||
27797362|NCT02886494|81089337|FG001|Overall Study|Adverse Event|0|||
27797363|NCT02886494|81089336|FG000|Overall Study|Withdrawal by Subject|12|||
27797364|NCT02886494|81089337|FG001|Overall Study|Withdrawal by Subject|3|||
27797365|NCT02886494|81089336|FG000|Overall Study|Protocol Violation|4|||
27797366|NCT02886494|81089337|FG001|Overall Study|Protocol Violation|1|||
27797367|NCT00996918|81089340|FG000|Overall Study|Lack of Efficacy|1|||
27797368|NCT00996918|81089341|FG001|Overall Study|Lack of Efficacy|1|||
27797369|NCT00996918|81089342|FG002|Overall Study|Lack of Efficacy|2|||
27797370|NCT00996918|81089343|FG003|Overall Study|Lack of Efficacy|2|||
27797371|NCT00996918|81089344|FG004|Overall Study|Lack of Efficacy|0|||
27797372|NCT00996918|81089340|FG000|Overall Study|Adverse Event|2|||
27797373|NCT00996918|81089341|FG001|Overall Study|Adverse Event|5|||
27797374|NCT00996918|81089342|FG002|Overall Study|Adverse Event|2|||
27797375|NCT00996918|81089343|FG003|Overall Study|Adverse Event|6|||
27797376|NCT00996918|81089344|FG004|Overall Study|Adverse Event|0|||
27797377|NCT00996918|81089340|FG000|Overall Study|Withdrawal by Subject|1|||
27797378|NCT00996918|81089341|FG001|Overall Study|Withdrawal by Subject|4|||
27797379|NCT00996918|81089342|FG002|Overall Study|Withdrawal by Subject|3|||
27797380|NCT00996918|81089343|FG003|Overall Study|Withdrawal by Subject|3|||
27797381|NCT00996918|81089344|FG004|Overall Study|Withdrawal by Subject|2|||
27797382|NCT00996918|81089340|FG000|Overall Study|Physician Decision|1|||
27797383|NCT00996918|81089341|FG001|Overall Study|Physician Decision|0|||
27797384|NCT00996918|81089342|FG002|Overall Study|Physician Decision|0|||
27797385|NCT00996918|81089343|FG003|Overall Study|Physician Decision|0|||
27797386|NCT00996918|81089344|FG004|Overall Study|Physician Decision|0|||
27797387|NCT00996918|81089340|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
27797388|NCT00996918|81089341|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
27797389|NCT00996918|81089342|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
27797390|NCT00996918|81089343|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
27797391|NCT00996918|81089344|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
27797392|NCT00996918|81089340|FG000|Overall Study|Loss of Caregiver|0|||
27870189|NCT01090414|81357937|FG002|Study 101-99|Death|1|||
27797393|NCT00996918|81089341|FG001|Overall Study|Loss of Caregiver|1|||
27870190|NCT01090414|81357938|FG003|Study 101-99|Death|0|||
27870191|NCT01090414|81357935|FG000|Study 101-99|Sponsor Discontinued Study|0|||
27870192|NCT01090414|81357936|FG001|Study 101-99|Sponsor Discontinued Study|7|||
27870193|NCT01090414|81357937|FG002|Study 101-99|Sponsor Discontinued Study|5|||
27870194|NCT01090414|81357938|FG003|Study 101-99|Sponsor Discontinued Study|0|||
27870195|NCT01090414|81357935|FG000|Study 101-99|Other (Unknown Reasons)|3|||
27870196|NCT01090414|81357936|FG001|Study 101-99|Other (Unknown Reasons)|3|||
27870197|NCT01090414|81357937|FG002|Study 101-99|Other (Unknown Reasons)|0|||
27870198|NCT01090414|81357938|FG003|Study 101-99|Other (Unknown Reasons)|0|||
27870199|NCT01090414|81357935|FG000|Study 101-99|Withdrew Consent|0|||
27870200|NCT01090414|81357936|FG001|Study 101-99|Withdrew Consent|2|||
27870201|NCT01090414|81357937|FG002|Study 101-99|Withdrew Consent|3|||
27870202|NCT01090414|81357938|FG003|Study 101-99|Withdrew Consent|1|||
27870203|NCT01090414|81357935|FG000|Study 101-99|Participant Request|3|||
27870204|NCT01090414|81357936|FG001|Study 101-99|Participant Request|1|||
27870205|NCT01090414|81357937|FG002|Study 101-99|Participant Request|0|||
27870206|NCT01090414|81357938|FG003|Study 101-99|Participant Request|0|||
27870207|NCT01640249|81357939|FG000|Period 1|Withdrawal by Subject|1|||
27870208|NCT01640249|81357940|FG001|Period 1|Withdrawal by Subject|0|||
27870209|NCT01640249|81357941|FG002|Period 1|Withdrawal by Subject|0|||
27870210|NCT01640249|81357942|FG003|Period 1|Withdrawal by Subject|0|||
27870211|NCT01640249|81357943|FG004|Period 1|Withdrawal by Subject|0|||
27870212|NCT01640249|81357944|FG005|Period 1|Withdrawal by Subject|1|||
27870213|NCT01640249|81357945|FG006|Period 1|Withdrawal by Subject|0|||
27870214|NCT02370238|81357946|FG000|Overall Study|Death|42|||
27870215|NCT02370238|81357947|FG001|Overall Study|Death|35|||
27870216|NCT02370238|81357946|FG000|Overall Study|Lost to Follow-up|1|||
27870217|NCT02370238|81357947|FG001|Overall Study|Lost to Follow-up|3|||
27870218|NCT02370238|81357946|FG000|Overall Study|Withdrawal by Subject|2|||
27870219|NCT02370238|81357947|FG001|Overall Study|Withdrawal by Subject|6|||
27870220|NCT02370238|81357946|FG000|Overall Study|Other|2|||
27870221|NCT02370238|81357947|FG001|Overall Study|Other|1|||
27870222|NCT02245412|81357948|FG000|Treatment Period|Death|1|||
27870223|NCT02245412|81357949|FG001|Treatment Period|Death|1|||
27870224|NCT02245412|81357950|FG002|Treatment Period|Death|0|||
27870225|NCT02245412|81357948|FG000|Treatment Period|Physician Decision|1|||
27870226|NCT02245412|81357949|FG001|Treatment Period|Physician Decision|1|||
27870227|NCT02245412|81357950|FG002|Treatment Period|Physician Decision|0|||
27870228|NCT02245412|81357948|FG000|Treatment Period|Withdrawal by Subject|2|||
27870229|NCT02245412|81357949|FG001|Treatment Period|Withdrawal by Subject|1|||
27870230|NCT02245412|81357950|FG002|Treatment Period|Withdrawal by Subject|0|||
27988963|NCT02292706|81791555|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
27988964|NCT02292706|81791556|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
27988965|NCT02292706|81791549|FG000|Overall Study|Subject terminated by sponsor|1|||
27988966|NCT02292706|81791550|FG001|Overall Study|Subject terminated by sponsor|0|||
27988967|NCT02292706|81791551|FG002|Overall Study|Subject terminated by sponsor|0|||
27988968|NCT02292706|81791552|FG003|Overall Study|Subject terminated by sponsor|2|||
27988969|NCT02292706|81791553|FG004|Overall Study|Subject terminated by sponsor|1|||
27988970|NCT02292706|81791554|FG005|Overall Study|Subject terminated by sponsor|0|||
27988971|NCT02292706|81791555|FG006|Overall Study|Subject terminated by sponsor|0|||
27988972|NCT02292706|81791556|FG007|Overall Study|Subject terminated by sponsor|0|||
27988973|NCT02292706|81791549|FG000|Overall Study|Missing|0|||
27988974|NCT02292706|81791550|FG001|Overall Study|Missing|0|||
27988975|NCT02292706|81791551|FG002|Overall Study|Missing|1|||
27988976|NCT02292706|81791552|FG003|Overall Study|Missing|1|||
27988977|NCT02292706|81791553|FG004|Overall Study|Missing|0|||
27988978|NCT02292706|81791554|FG005|Overall Study|Missing|1|||
27797394|NCT00996918|81089342|FG002|Overall Study|Loss of Caregiver|0|||
27797395|NCT00996918|81089343|FG003|Overall Study|Loss of Caregiver|0|||
27870231|NCT02245412|81357948|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
27870232|NCT02245412|81357949|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
27870233|NCT02245412|81357950|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
27870234|NCT02245412|81357948|FG000|Follow-Up Period|Death|4|||
27870235|NCT02245412|81357949|FG001|Follow-Up Period|Death|2|||
27870236|NCT02245412|81357950|FG002|Follow-Up Period|Death|1|||
27988979|NCT02292706|81791555|FG006|Overall Study|Missing|0|||
27988980|NCT02292706|81791556|FG007|Overall Study|Missing|0|||
27988981|NCT02292706|81791549|FG000|Overall Study|Virologic relapse or reinfection|1|||
27988982|NCT02292706|81791550|FG001|Overall Study|Virologic relapse or reinfection|0|||
27988983|NCT02292706|81791551|FG002|Overall Study|Virologic relapse or reinfection|0|||
27988984|NCT02292706|81791552|FG003|Overall Study|Virologic relapse or reinfection|1|||
27797396|NCT00996918|81089344|FG004|Overall Study|Loss of Caregiver|0|||
27797397|NCT00996918|81089340|FG000|Overall Study|Other|3|||
27797398|NCT00996918|81089341|FG001|Overall Study|Other|1|||
27797399|NCT00996918|81089342|FG002|Overall Study|Other|0|||
27797400|NCT00996918|81089343|FG003|Overall Study|Other|0|||
27988985|NCT02292706|81791553|FG004|Overall Study|Virologic relapse or reinfection|0|||
27988986|NCT02292706|81791554|FG005|Overall Study|Virologic relapse or reinfection|1|||
27988987|NCT02292706|81791555|FG006|Overall Study|Virologic relapse or reinfection|0|||
27988988|NCT02292706|81791556|FG007|Overall Study|Virologic relapse or reinfection|0|||
27988989|NCT01192412|81791559|FG000|Overall Study|Lost to Follow-up|2|||
27988990|NCT01192412|81791560|FG001|Overall Study|Lost to Follow-up|1|||
27988991|NCT01192412|81791559|FG000|Overall Study|Withdrawal by Subject|2|||
27988992|NCT01192412|81791560|FG001|Overall Study|Withdrawal by Subject|1|||
27988993|NCT01196416|81791564|FG000|Overall Study|Withdrawal by Subject|2|||
27988994|NCT01336023|81791565|FG000|Week 0 to Week 26|Adverse Event|8|||
27988995|NCT01336023|81791566|FG001|Week 0 to Week 26|Adverse Event|10|||
27988996|NCT01336023|81791567|FG002|Week 0 to Week 26|Adverse Event|24|||
27988997|NCT01336023|81791565|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
27988998|NCT01336023|81791566|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
27988999|NCT01336023|81791567|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
27989000|NCT01336023|81791565|FG000|Week 0 to Week 26|Protocol Violation|1|||
27989001|NCT01336023|81791566|FG001|Week 0 to Week 26|Protocol Violation|2|||
27989002|NCT01336023|81791567|FG002|Week 0 to Week 26|Protocol Violation|0|||
27989003|NCT01336023|81791565|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
27989004|NCT01336023|81791566|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
27989005|NCT01336023|81791567|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
27797401|NCT00996918|81089344|FG004|Overall Study|Other|0|||
27797402|NCT02362646|81089345|FG000|Overall Study|Death|15|||
27797403|NCT02362646|81089346|FG001|Overall Study|Death|8|||
27797404|NCT02362646|81089345|FG000|Overall Study|Withdrawal by Subject|2|||
27797405|NCT02362646|81089346|FG001|Overall Study|Withdrawal by Subject|2|||
27797406|NCT02362646|81089345|FG000|Overall Study|received transplant|21|||
27797407|NCT02362646|81089346|FG001|Overall Study|received transplant|14|||
27797408|NCT01612780|81089349|FG000|Overall Study|Treatment not completed|1|||
27797409|NCT01612780|81089349|FG000|Overall Study|Withdrawal by Subject|5|||
27797410|NCT01491737|81089359|FG000|Overall Study|Withdrawal by Subject|20|||
27797411|NCT01491737|81089360|FG001|Overall Study|Withdrawal by Subject|17|||
27797412|NCT01491737|81089359|FG000|Overall Study|Lost to Follow-up|2|||
27797413|NCT01491737|81089360|FG001|Overall Study|Lost to Follow-up|10|||
27797414|NCT01491737|81089359|FG000|Overall Study|Death|63|||
27989006|NCT01336023|81791565|FG000|Week 0 to Week 26|Unclassified|5|||
27594199|NCT00729833|80352467|FG002|Overall Study|Lost to Follow-up|0|||
27797415|NCT01491737|81089360|FG001|Overall Study|Death|57|||
27797416|NCT01491737|81089359|FG000|Overall Study|Study Termination by Sponsor|36|||
27797417|NCT01491737|81089360|FG001|Overall Study|Study Termination by Sponsor|36|||
27797418|NCT01491737|81089359|FG000|Overall Study|Reason Not Specified|8|||
27989007|NCT01336023|81791566|FG001|Week 0 to Week 26|Unclassified|16|||
27989008|NCT01336023|81791567|FG002|Week 0 to Week 26|Unclassified|9|||
27797419|NCT01491737|81089360|FG001|Overall Study|Reason Not Specified|9|||
27870237|NCT02245412|81357948|FG000|Follow-Up Period|Physician Decision|1|||
27870238|NCT02245412|81357949|FG001|Follow-Up Period|Physician Decision|0|||
27989009|NCT01336023|81791565|FG000|Week 27 to 52|Adverse Event|1|||
27989010|NCT01336023|81791566|FG001|Week 27 to 52|Adverse Event|5|||
27989011|NCT01336023|81791567|FG002|Week 27 to 52|Adverse Event|2|||
27989012|NCT01336023|81791565|FG000|Week 27 to 52|Protocol Violation|0|||
27989013|NCT01336023|81791566|FG001|Week 27 to 52|Protocol Violation|2|||
27989014|NCT01336023|81791567|FG002|Week 27 to 52|Protocol Violation|1|||
27989015|NCT01336023|81791565|FG000|Week 27 to 52|Withdrawal Criteria|14|||
27989016|NCT01336023|81791566|FG001|Week 27 to 52|Withdrawal Criteria|19|||
27989017|NCT01336023|81791567|FG002|Week 27 to 52|Withdrawal Criteria|16|||
27989018|NCT01336023|81791565|FG000|Week 27 to 52|Unclassified|13|||
27989019|NCT01336023|81791566|FG001|Week 27 to 52|Unclassified|18|||
27989020|NCT01336023|81791567|FG002|Week 27 to 52|Unclassified|9|||
27989021|NCT00994643|81791569|FG000|Overall Study|Withdrawal by Subject|1|||
27989022|NCT03188510|81791570|FG000|Overall Study|Inappropriate behavior with site staff|0|||
27989023|NCT03188510|81791571|FG001|Overall Study|Inappropriate behavior with site staff|1|||
27989024|NCT03188510|81791572|FG002|Overall Study|Inappropriate behavior with site staff|0|||
27989025|NCT00320424|81791573|FG000|Overall Study|Adverse Event|3|||
27989026|NCT00320424|81791573|FG000|Overall Study|Other|3|||
27989027|NCT03270891|81791574|FG000|Overall Study|Lost to Follow-up|3|||
27989028|NCT03270891|81791575|FG001|Overall Study|Lost to Follow-up|6|||
27989029|NCT03270891|81791576|FG002|Overall Study|Lost to Follow-up|0|||
27989030|NCT03270891|81791574|FG000|Overall Study|Withdrawal by Subject|1|||
27989031|NCT03270891|81791575|FG001|Overall Study|Withdrawal by Subject|0|||
27989032|NCT03270891|81791576|FG002|Overall Study|Withdrawal by Subject|0|||
27989033|NCT03270891|81791574|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
27989034|NCT03270891|81791575|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
27989035|NCT03270891|81791576|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
27797420|NCT00903409|81089361|FG000|Overall Study|Adverse Event|11|||
27797421|NCT00903409|81089362|FG001|Overall Study|Adverse Event|9|||
27797422|NCT00903409|81089361|FG000|Overall Study|Non-compliance with Protocol|1|||
27797423|NCT00903409|81089362|FG001|Overall Study|Non-compliance with Protocol|1|||
27797424|NCT00903409|81089361|FG000|Overall Study|Laboratory Abnormality|2|||
27797425|NCT00903409|81089362|FG001|Overall Study|Laboratory Abnormality|0|||
27797426|NCT00903409|81089361|FG000|Overall Study|Withdrawal by Subject|8|||
27797427|NCT00903409|81089362|FG001|Overall Study|Withdrawal by Subject|8|||
27797428|NCT00903409|81089361|FG000|Overall Study|Other|2|||
27797429|NCT00903409|81089362|FG001|Overall Study|Other|3|||
27797430|NCT00903409|81089361|FG000|Overall Study|Lost to Follow-up|2|||
27797431|NCT00903409|81089362|FG001|Overall Study|Lost to Follow-up|6|||
27797432|NCT01777191|81089365|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
27797433|NCT01777191|81089366|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
27797434|NCT01777191|81089365|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
27797435|NCT01777191|81089366|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
27797436|NCT01777191|81089365|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
27797437|NCT01777191|81089366|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
27797438|NCT01777191|81089365|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
27797439|NCT01777191|81089366|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
27797440|NCT01777191|81089365|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
27797441|NCT01777191|81089366|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
27797442|NCT01777191|81089365|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
27797443|NCT01777191|81089366|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
27797444|NCT01777191|81089365|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
27797445|NCT01777191|81089366|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
27797446|NCT01777191|81089365|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
27797447|NCT01777191|81089366|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
27797448|NCT01777191|81089365|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
27797449|NCT01777191|81089366|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
27797450|NCT01777191|81089365|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
27797451|NCT01777191|81089366|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
27797452|NCT01777191|81089365|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
27797453|NCT01777191|81089366|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
27797454|NCT03992456|81089369|FG000|Overall Study|Withdrawal by Subject|1|||
27797455|NCT03992456|81089370|FG001|Overall Study|Withdrawal by Subject|0|||
27797456|NCT03992456|81089369|FG000|Overall Study|Disease progression|4|||
27797457|NCT03992456|81089370|FG001|Overall Study|Disease progression|5|||
27989036|NCT01298765|81791592|FG000|Titration Period|Adverse Event|26|||
27989037|NCT01298765|81791592|FG000|Titration Period|Death|1|||
27989038|NCT01298765|81791592|FG000|Titration Period|Lack of Efficacy|21|||
27989039|NCT01298765|81791592|FG000|Titration Period|Lost to Follow-up|9|||
27989040|NCT01298765|81791592|FG000|Titration Period|Physician Decision|1|||
27594200|NCT00729833|80352468|FG003|Overall Study|Lost to Follow-up|0|||
27797458|NCT03992456|81089369|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
27989041|NCT01298765|81791592|FG000|Titration Period|Withdrawal by Subject|10|||
27989042|NCT01298765|81791592|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
27989043|NCT01298765|81791592|FG000|Long-Term Treatment Period|Adverse Event|19|||
27989044|NCT01298765|81791592|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
27989045|NCT01298765|81791592|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
27989046|NCT01298765|81791592|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
27989047|NCT01298765|81791592|FG000|Long-Term Treatment Period|Physician Decision|1|||
27989048|NCT01298765|81791592|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
27989049|NCT00250276|81791595|FG000|Overall Study|Serious Adverse Event|0|||
27989050|NCT00250276|81791596|FG001|Overall Study|Serious Adverse Event|0|||
27989051|NCT00250276|81791597|FG002|Overall Study|Serious Adverse Event|1|||
27989052|NCT00250276|81791598|FG003|Overall Study|Serious Adverse Event|0|||
27989053|NCT00250276|81791595|FG000|Overall Study|Non-serious Adverse Event|2|||
27989054|NCT00250276|81791596|FG001|Overall Study|Non-serious Adverse Event|0|||
27989055|NCT00250276|81791597|FG002|Overall Study|Non-serious Adverse Event|0|||
27989056|NCT00250276|81791598|FG003|Overall Study|Non-serious Adverse Event|2|||
27989057|NCT00250276|81791595|FG000|Overall Study|Protocol Violation|0|||
27989058|NCT00250276|81791596|FG001|Overall Study|Protocol Violation|1|||
27989059|NCT00250276|81791597|FG002|Overall Study|Protocol Violation|0|||
27989060|NCT00250276|81791598|FG003|Overall Study|Protocol Violation|0|||
27989061|NCT00250276|81791595|FG000|Overall Study|Withdrawal by Subject|1|||
27989062|NCT00250276|81791596|FG001|Overall Study|Withdrawal by Subject|2|||
27797459|NCT03992456|81089370|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
27989063|NCT00250276|81791597|FG002|Overall Study|Withdrawal by Subject|3|||
27989064|NCT00250276|81791598|FG003|Overall Study|Withdrawal by Subject|2|||
27989065|NCT00250276|81791595|FG000|Overall Study|Migrated/moved from study area|3|||
27989066|NCT00250276|81791596|FG001|Overall Study|Migrated/moved from study area|0|||
27989067|NCT00250276|81791597|FG002|Overall Study|Migrated/moved from study area|2|||
27989068|NCT00250276|81791598|FG003|Overall Study|Migrated/moved from study area|7|||
27989069|NCT00250276|81791595|FG000|Overall Study|Lost to Follow-up|11|||
27989070|NCT00250276|81791596|FG001|Overall Study|Lost to Follow-up|18|||
27989071|NCT00250276|81791597|FG002|Overall Study|Lost to Follow-up|13|||
27989072|NCT00250276|81791598|FG003|Overall Study|Lost to Follow-up|8|||
27989073|NCT02834247|81791599|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
27989074|NCT02834247|81791600|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
27989075|NCT02834247|81791601|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
27989076|NCT02834247|81791602|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
27989077|NCT02834247|81791599|FG000|Dose Escalation Phase|Death|5|||
27989078|NCT02834247|81791600|FG001|Dose Escalation Phase|Death|6|||
27989079|NCT02834247|81791601|FG002|Dose Escalation Phase|Death|5|||
27989080|NCT02834247|81791602|FG003|Dose Escalation Phase|Death|0|||
27989081|NCT02834247|81791599|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
27989082|NCT02834247|81791600|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
27989083|NCT02834247|81791601|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
27989084|NCT02834247|81791602|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
27989085|NCT02834247|81791599|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
27989086|NCT02834247|81791600|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
27989087|NCT02834247|81791601|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27989088|NCT02834247|81791602|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27989089|NCT02834247|81791599|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
27989090|NCT02834247|81791600|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
27989091|NCT02834247|81791601|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
27989092|NCT02834247|81791602|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
27989093|NCT02834247|81791599|FG000|Dose Expansion Phase|Death|0|||
27989094|NCT02834247|81791600|FG001|Dose Expansion Phase|Death|0|||
27989095|NCT02834247|81791601|FG002|Dose Expansion Phase|Death|0|||
27989096|NCT02834247|81791602|FG003|Dose Expansion Phase|Death|8|||
27989097|NCT02834247|81791599|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
27989098|NCT02834247|81791600|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
27989099|NCT02834247|81791601|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
27989100|NCT02834247|81791602|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
27989101|NCT02834247|81791599|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
27989102|NCT02834247|81791600|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
27989103|NCT02834247|81791601|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
27989104|NCT02834247|81791602|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
27989105|NCT02429791|81791603|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
27989106|NCT02429791|81791604|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
27989107|NCT02429791|81791603|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
27989108|NCT02429791|81791604|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
27989109|NCT02429791|81791603|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
27989110|NCT02429791|81791604|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
27989111|NCT02429791|81791603|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
27989112|NCT02429791|81791604|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
27989113|NCT02429791|81791603|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
27989114|NCT02429791|81791604|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
27989115|NCT02429791|81791603|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
27989116|NCT02429791|81791604|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
27989117|NCT02429791|81791603|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
27989118|NCT02429791|81791604|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
27989119|NCT02429791|81791603|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
27989120|NCT02429791|81791604|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
27989121|NCT02429791|81791603|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
27989122|NCT02429791|81791604|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
27989123|NCT02429791|81791603|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
27989124|NCT02429791|81791604|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
27989125|NCT02429791|81791603|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
27989126|NCT02429791|81791604|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
27989127|NCT02429791|81791603|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
27989128|NCT02429791|81791604|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
27989129|NCT02429791|81791603|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
27989130|NCT02429791|81791604|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
27989131|NCT02429791|81791603|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
27989132|NCT02429791|81791604|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
27989133|NCT02429791|81791603|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
27989134|NCT02429791|81791604|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
27989135|NCT02429791|81791603|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
27989136|NCT02429791|81791604|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
27989137|NCT02429791|81791603|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
27989138|NCT02429791|81791604|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
27989139|NCT02429791|81791603|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
27989140|NCT02429791|81791604|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
27989141|NCT03129360|81791605|FG000|Overall Study|Did not meet entry criteria|0|||
27989142|NCT03129360|81791606|FG001|Overall Study|Did not meet entry criteria|2|||
27989143|NCT03129360|81791607|FG002|Overall Study|Did not meet entry criteria|1|||
27989144|NCT03129360|81791605|FG000|Overall Study|Excluded due to motion in scanner|1|||
27989145|NCT03129360|81791606|FG001|Overall Study|Excluded due to motion in scanner|0|||
27989146|NCT03129360|81791607|FG002|Overall Study|Excluded due to motion in scanner|0|||
27989147|NCT00923845|81791608|FG000|Induction Therapy|Poor performance status|0|||
27989148|NCT00923845|81791609|FG001|Induction Therapy|Poor performance status|2|||
27989149|NCT00410605|81791610|FG000|Overall Study|Adverse Event|12|||
27989150|NCT00410605|81791610|FG000|Overall Study|Physician Decision|3|||
27989151|NCT00410605|81791610|FG000|Overall Study|Withdrawal by Subject|5|||
27989152|NCT00410605|81791610|FG000|Overall Study|Started Non-Protocol Therapy|3|||
27989153|NCT00410605|81791610|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
27989154|NCT00410605|81791610|FG000|Overall Study|Transferred to another Institution|1|||
27989155|NCT01564732|81791619|FG000|Overall Study|Early termination by the study sponsor|6|||
27989156|NCT01564732|81791620|FG001|Overall Study|Early termination by the study sponsor|5|||
27989157|NCT02879578|81791633|FG000|Overall Study|Adverse Event|1|||
27989158|NCT02879578|81791634|FG001|Overall Study|Adverse Event|2|||
27989159|NCT02879578|81791635|FG002|Overall Study|Adverse Event|14|||
27989160|NCT02879578|81791633|FG000|Overall Study|Protocol Violation|0|||
27989161|NCT02879578|81791634|FG001|Overall Study|Protocol Violation|1|||
27989162|NCT02879578|81791635|FG002|Overall Study|Protocol Violation|1|||
27989163|NCT02879578|81791633|FG000|Overall Study|Withdrawal by Subject|8|||
27989164|NCT02879578|81791634|FG001|Overall Study|Withdrawal by Subject|6|||
27989165|NCT02879578|81791635|FG002|Overall Study|Withdrawal by Subject|9|||
27989166|NCT02879578|81791633|FG000|Overall Study|Lost to Follow-up|1|||
27989167|NCT02879578|81791634|FG001|Overall Study|Lost to Follow-up|0|||
27989168|NCT02879578|81791635|FG002|Overall Study|Lost to Follow-up|4|||
27989169|NCT02879578|81791633|FG000|Overall Study|Physician Decision|0|||
27989170|NCT02879578|81791634|FG001|Overall Study|Physician Decision|0|||
27989171|NCT02879578|81791635|FG002|Overall Study|Physician Decision|4|||
27989172|NCT02669121|81791636|FG000|Overall Study|Adverse Event|4|||
27989173|NCT02669121|81791637|FG001|Overall Study|Adverse Event|5|||
27989174|NCT02669121|81791636|FG000|Overall Study|Lost to Follow-up|15|||
27989175|NCT02669121|81791637|FG001|Overall Study|Lost to Follow-up|27|||
27989176|NCT02669121|81791636|FG000|Overall Study|Withdrawal by Subject|132|||
27989177|NCT02669121|81791637|FG001|Overall Study|Withdrawal by Subject|140|||
27870239|NCT02245412|81357950|FG002|Follow-Up Period|Physician Decision|0|||
27797460|NCT01125358|81089373|FG000|Overall Study|Adverse Event|3|||
27797461|NCT01125358|81089374|FG001|Overall Study|Adverse Event|0|||
27797462|NCT01125358|81089375|FG002|Overall Study|Adverse Event|0|||
27797463|NCT01125358|81089376|FG003|Overall Study|Adverse Event|2|||
27797464|NCT01125358|81089373|FG000|Overall Study|Perceived Lack of Efficacy|6|||
27797465|NCT01125358|81089374|FG001|Overall Study|Perceived Lack of Efficacy|3|||
27797466|NCT01125358|81089375|FG002|Overall Study|Perceived Lack of Efficacy|7|||
27797467|NCT01125358|81089376|FG003|Overall Study|Perceived Lack of Efficacy|4|||
27797468|NCT01125358|81089373|FG000|Overall Study|Protocol Violation|1|||
27797469|NCT01125358|81089374|FG001|Overall Study|Protocol Violation|0|||
27797470|NCT01125358|81089375|FG002|Overall Study|Protocol Violation|0|||
27797471|NCT01125358|81089376|FG003|Overall Study|Protocol Violation|0|||
27797472|NCT01125358|81089373|FG000|Overall Study|Sponsor Decision|0|||
27797473|NCT01125358|81089374|FG001|Overall Study|Sponsor Decision|0|||
27870240|NCT02245412|81357948|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
27870241|NCT02245412|81357949|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
27870242|NCT02245412|81357950|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
27870243|NCT01168427|81357951|FG000|Overall Study|Patient exited prior to implant|1|||
27870244|NCT01200069|81357952|FG000|Overall Study|Withdrawal by Subject|0|||
27870245|NCT01200069|81357953|FG001|Overall Study|Withdrawal by Subject|1|||
27870246|NCT00545714|81357964|FG000|Induction Phase (6 Months)|Physician Decision|3|||
27870247|NCT00545714|81357964|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
27870248|NCT00545714|81357964|FG000|Induction Phase (6 Months)|Disease Progression|1|||
27870249|NCT00545714|81357964|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
27870250|NCT00545714|81357964|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
27870251|NCT00545714|81357964|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
27870252|NCT00545714|81357964|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
27870253|NCT00545714|81357964|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
27870254|NCT00545714|81357964|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
27870255|NCT00545714|81357964|FG000|Maintenance Phase (36 Months)|Death|2|||
27870256|NCT02189837|81357969|FG000|Overall Study|Withdrawal by Subject|2|||
27870257|NCT02189837|81357970|FG001|Overall Study|Withdrawal by Subject|1|||
27870258|NCT02189837|81357971|FG002|Overall Study|Withdrawal by Subject|3|||
27870259|NCT02189837|81357972|FG003|Overall Study|Withdrawal by Subject|1|||
27870260|NCT02189837|81357969|FG000|Overall Study|Sponsor Decision|0|||
27870261|NCT02189837|81357970|FG001|Overall Study|Sponsor Decision|0|||
27870262|NCT02189837|81357971|FG002|Overall Study|Sponsor Decision|0|||
27989178|NCT02669121|81791636|FG000|Overall Study|Pregnancy|0|||
27989179|NCT02669121|81791637|FG001|Overall Study|Pregnancy|1|||
27989180|NCT02669121|81791636|FG000|Overall Study|Discharged from US Military Active Service|117|||
27989181|NCT02669121|81791637|FG001|Overall Study|Discharged from US Military Active Service|91|||
27989182|NCT02669121|81791636|FG000|Overall Study|Reason not Specified|22|||
27989183|NCT02669121|81791637|FG001|Overall Study|Reason not Specified|18|||
27989184|NCT00186901|81791638|FG000|Overall Study|Pregnancy|6|||
27989185|NCT00186901|81791639|FG001|Overall Study|Pregnancy|3|||
27989186|NCT00186901|81791640|FG002|Overall Study|Pregnancy|0|||
27989187|NCT00186901|81791638|FG000|Overall Study|Lost to Follow-up|6|||
27989188|NCT00186901|81791639|FG001|Overall Study|Lost to Follow-up|3|||
27797474|NCT01125358|81089375|FG002|Overall Study|Sponsor Decision|1|||
27870263|NCT02189837|81357972|FG003|Overall Study|Sponsor Decision|1|||
27870264|NCT02016183|81357973|FG000|Overall Study|Case Report Forms Uncollected|13|||
27989189|NCT00186901|81791640|FG002|Overall Study|Lost to Follow-up|0|||
27989190|NCT00186901|81791638|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
27989191|NCT00186901|81791639|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
27797475|NCT01125358|81089376|FG003|Overall Study|Sponsor Decision|1|||
27797476|NCT01125358|81089373|FG000|Overall Study|Withdrawal by Subject|2|||
27870265|NCT02016183|81357973|FG000|Overall Study|Protocol Violation|52|||
27989192|NCT00186901|81791640|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
27989193|NCT00186901|81791638|FG000|Overall Study|ALL relapse or second malignancy|1|||
27989194|NCT00186901|81791639|FG001|Overall Study|ALL relapse or second malignancy|2|||
27989195|NCT00186901|81791640|FG002|Overall Study|ALL relapse or second malignancy|0|||
27797477|NCT01125358|81089374|FG001|Overall Study|Withdrawal by Subject|1|||
27989196|NCT00186901|81791638|FG000|Overall Study|Withdrawal by Subject|4|||
27989197|NCT00186901|81791639|FG001|Overall Study|Withdrawal by Subject|5|||
27989198|NCT00186901|81791640|FG002|Overall Study|Withdrawal by Subject|0|||
27989199|NCT00186901|81791638|FG000|Overall Study|Open label|3|||
27989200|NCT00186901|81791639|FG001|Overall Study|Open label|2|||
27989201|NCT00186901|81791640|FG002|Overall Study|Open label|0|||
27989202|NCT00186901|81791638|FG000|Overall Study|Limited adherence to study requirements|20|||
27989203|NCT00186901|81791639|FG001|Overall Study|Limited adherence to study requirements|23|||
27989204|NCT00186901|81791640|FG002|Overall Study|Limited adherence to study requirements|0|||
27989205|NCT00186901|81791638|FG000|Overall Study|Bone Mineral Density > 0|0|||
27989206|NCT00186901|81791639|FG001|Overall Study|Bone Mineral Density > 0|0|||
27989207|NCT00186901|81791640|FG002|Overall Study|Bone Mineral Density > 0|149|||
27989208|NCT00411632|81791641|FG000|Overall Study|Death|1|||
27989209|NCT01630889|81791642|FG000|Overall Study|Death|2|||
27989210|NCT01630889|81791642|FG000|Overall Study|Withdrawal by Subject|1|||
27989211|NCT01630889|81791642|FG000|Overall Study|Other than Specified|2|||
27989212|NCT01630889|81791642|FG000|Overall Study|Lost to Follow-up|4|||
27989213|NCT01630889|81791642|FG000|Overall Study|Other|1|||
27989214|NCT00999518|81791645|FG000|Overall Study|Adverse Event|1|||
27989215|NCT00999518|81791646|FG001|Overall Study|Adverse Event|6|||
27797478|NCT01125358|81089375|FG002|Overall Study|Withdrawal by Subject|1|||
27797479|NCT01125358|81089376|FG003|Overall Study|Withdrawal by Subject|1|||
27797480|NCT01216319|81089382|FG000|Overall Study|Lost to Follow-up|2|||
27797481|NCT01216319|81089382|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
27797482|NCT00414011|81089383|FG000|Overall Study|Physician Decision|3|||
27797483|NCT00414011|81089383|FG000|Overall Study|Withdrawal by Subject|2|||
27989216|NCT00999518|81791647|FG002|Overall Study|Adverse Event|3|||
27989217|NCT00999518|81791648|FG003|Overall Study|Adverse Event|1|||
27989218|NCT00999518|81791649|FG004|Overall Study|Adverse Event|2|||
27989219|NCT00999518|81791645|FG000|Overall Study|Lack of Efficacy|2|||
27989220|NCT00999518|81791646|FG001|Overall Study|Lack of Efficacy|0|||
27989221|NCT00999518|81791647|FG002|Overall Study|Lack of Efficacy|0|||
27989222|NCT00999518|81791648|FG003|Overall Study|Lack of Efficacy|2|||
27989223|NCT00999518|81791649|FG004|Overall Study|Lack of Efficacy|2|||
27989224|NCT00999518|81791645|FG000|Overall Study|Lost to Follow-up|0|||
27989225|NCT00999518|81791646|FG001|Overall Study|Lost to Follow-up|0|||
27989226|NCT00999518|81791647|FG002|Overall Study|Lost to Follow-up|0|||
27989227|NCT00999518|81791648|FG003|Overall Study|Lost to Follow-up|4|||
27989228|NCT00999518|81791649|FG004|Overall Study|Lost to Follow-up|1|||
27989229|NCT00999518|81791645|FG000|Overall Study|Did not meet entrance criteria|0|||
27989230|NCT00999518|81791646|FG001|Overall Study|Did not meet entrance criteria|0|||
27989231|NCT00999518|81791647|FG002|Overall Study|Did not meet entrance criteria|0|||
27989232|NCT00999518|81791648|FG003|Overall Study|Did not meet entrance criteria|0|||
27989233|NCT00999518|81791649|FG004|Overall Study|Did not meet entrance criteria|1|||
27989234|NCT00999518|81791645|FG000|Overall Study|Study terminated by sponsor|10|||
27989235|NCT00999518|81791646|FG001|Overall Study|Study terminated by sponsor|6|||
27989236|NCT00999518|81791647|FG002|Overall Study|Study terminated by sponsor|5|||
27989237|NCT00999518|81791648|FG003|Overall Study|Study terminated by sponsor|5|||
27989238|NCT00999518|81791649|FG004|Overall Study|Study terminated by sponsor|9|||
27989239|NCT00999518|81791645|FG000|Overall Study|Pregnancy|0|||
27989240|NCT00999518|81791646|FG001|Overall Study|Pregnancy|0|||
27797484|NCT01610284|81089384|FG000|Randomization Phase|Adverse Event|1|||
27797485|NCT01610284|81089385|FG001|Randomization Phase|Adverse Event|0|||
27870266|NCT00591773|81357977|FG000|Overall Study|Adverse Event|9|||
27870267|NCT00591773|81357978|FG001|Overall Study|Adverse Event|9|||
27989241|NCT00999518|81791647|FG002|Overall Study|Pregnancy|1|||
27989242|NCT00999518|81791648|FG003|Overall Study|Pregnancy|0|||
27989243|NCT00999518|81791649|FG004|Overall Study|Pregnancy|0|||
27989244|NCT00999518|81791645|FG000|Overall Study|Protocol Violation|0|||
27989245|NCT00999518|81791646|FG001|Overall Study|Protocol Violation|1|||
27989246|NCT00999518|81791647|FG002|Overall Study|Protocol Violation|0|||
27989247|NCT00999518|81791648|FG003|Overall Study|Protocol Violation|0|||
27989248|NCT00999518|81791649|FG004|Overall Study|Protocol Violation|2|||
27989249|NCT00999518|81791645|FG000|Overall Study|Withdrawal by Subject|5|||
27989250|NCT00999518|81791646|FG001|Overall Study|Withdrawal by Subject|4|||
27797486|NCT01610284|81089384|FG000|Randomization Phase|Physician Decision|1|||
27797487|NCT01610284|81089385|FG001|Randomization Phase|Physician Decision|1|||
27989251|NCT00999518|81791647|FG002|Overall Study|Withdrawal by Subject|10|||
27989252|NCT00999518|81791648|FG003|Overall Study|Withdrawal by Subject|6|||
27989253|NCT00999518|81791649|FG004|Overall Study|Withdrawal by Subject|1|||
27989254|NCT00999518|81791645|FG000|Overall Study|Other|5|||
27989255|NCT00999518|81791646|FG001|Overall Study|Other|7|||
27989256|NCT00999518|81791647|FG002|Overall Study|Other|1|||
27989257|NCT00999518|81791648|FG003|Overall Study|Other|4|||
27989258|NCT00999518|81791649|FG004|Overall Study|Other|5|||
27797488|NCT01610284|81089384|FG000|Randomization Phase|Death|0|||
27870268|NCT00591773|81357979|FG002|Overall Study|Adverse Event|6|||
27989259|NCT00999518|81791645|FG000|Overall Study|Randomized but not Treated|1|||
27989260|NCT00999518|81791646|FG001|Overall Study|Randomized but not Treated|1|||
27989261|NCT00999518|81791647|FG002|Overall Study|Randomized but not Treated|2|||
27989262|NCT00999518|81791648|FG003|Overall Study|Randomized but not Treated|0|||
27989263|NCT00999518|81791649|FG004|Overall Study|Randomized but not Treated|1|||
27989264|NCT02508428|81791650|FG000|Overall Study|Death|32|||
27989265|NCT02508428|81791651|FG001|Overall Study|Death|33|||
27989266|NCT02508428|81791650|FG000|Overall Study|Liner revised|3|||
27989267|NCT02508428|81791651|FG001|Overall Study|Liner revised|19|||
27989268|NCT02508428|81791650|FG000|Overall Study|Incomplete follow-up|17|||
27989269|NCT02508428|81791651|FG001|Overall Study|Incomplete follow-up|15|||
27989270|NCT01209078|81791653|FG000|Overall Study|Adverse Event|5|||
27989271|NCT01209078|81791654|FG001|Overall Study|Adverse Event|0|||
27989272|NCT01209078|81791653|FG000|Overall Study|Lost to Follow-up|4|||
27989273|NCT01209078|81791654|FG001|Overall Study|Lost to Follow-up|0|||
27989274|NCT01209078|81791653|FG000|Overall Study|Physician Decision|5|||
27989275|NCT01209078|81791654|FG001|Overall Study|Physician Decision|2|||
27989276|NCT01209078|81791653|FG000|Overall Study|Withdrawal by Subject|2|||
27989277|NCT01209078|81791654|FG001|Overall Study|Withdrawal by Subject|1|||
27989278|NCT02332291|81791655|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
27989279|NCT02332291|81791656|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
27989280|NCT02332291|81791655|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
27989281|NCT02332291|81791656|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
27989282|NCT02332291|81791655|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
27989283|NCT02332291|81791656|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
27989284|NCT02332291|81791655|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
27989285|NCT02332291|81791656|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
27989286|NCT02332291|81791655|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
27989287|NCT02332291|81791656|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
27989288|NCT02332291|81791655|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
27989289|NCT02332291|81791656|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
27989290|NCT00392990|81791657|FG000|Treatment on Study|Adverse Event|3|||
27989291|NCT00392990|81791658|FG001|Treatment on Study|Adverse Event|1|||
27989292|NCT00392990|81791657|FG000|Follow up for 2 Years|Death|4|||
27989293|NCT00392990|81791658|FG001|Follow up for 2 Years|Death|0|||
27989294|NCT00417963|81791663|FG000|Overall Study|Lost to Follow-up|3|||
27989295|NCT00417963|81791663|FG000|Overall Study|Withdrawal by Subject|18|||
27989296|NCT00417963|81791663|FG000|Overall Study|Death|17|||
27989297|NCT00417963|81791663|FG000|Overall Study|Study device could not be deployed|3|||
27989298|NCT01727336|81791664|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27989299|NCT01727336|81791665|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
27989300|NCT01727336|81791666|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
27989301|NCT01727336|81791667|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27989302|NCT01727336|81791668|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27989303|NCT01727336|81791669|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
27989304|NCT01727336|81791664|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
27989305|NCT01727336|81791665|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
27989306|NCT01727336|81791666|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
27989307|NCT01727336|81791667|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
27989308|NCT01727336|81791668|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
27989309|NCT01727336|81791669|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
27989310|NCT01727336|81791664|FG000|Part 2 Blinded|Death|0|||
27989311|NCT01727336|81791665|FG001|Part 2 Blinded|Death|0|||
27989312|NCT01727336|81791666|FG002|Part 2 Blinded|Death|0|||
27989313|NCT01727336|81791667|FG003|Part 2 Blinded|Death|0|||
27989314|NCT01727336|81791668|FG004|Part 2 Blinded|Death|20|||
27989315|NCT01727336|81791669|FG005|Part 2 Blinded|Death|16|||
27989316|NCT01727336|81791664|FG000|Part 2 Blinded|Lack of Efficacy|0|||
27989317|NCT01727336|81791665|FG001|Part 2 Blinded|Lack of Efficacy|0|||
27989318|NCT01727336|81791666|FG002|Part 2 Blinded|Lack of Efficacy|0|||
27989319|NCT01727336|81791667|FG003|Part 2 Blinded|Lack of Efficacy|0|||
27989320|NCT01727336|81791668|FG004|Part 2 Blinded|Lack of Efficacy|42|||
27989321|NCT01727336|81791669|FG005|Part 2 Blinded|Lack of Efficacy|44|||
27989322|NCT01727336|81791664|FG000|Part 2 Blinded|Lost to Follow-up|0|||
27989323|NCT01727336|81791665|FG001|Part 2 Blinded|Lost to Follow-up|0|||
27989324|NCT01727336|81791666|FG002|Part 2 Blinded|Lost to Follow-up|0|||
27989325|NCT01727336|81791667|FG003|Part 2 Blinded|Lost to Follow-up|0|||
27989326|NCT01727336|81791668|FG004|Part 2 Blinded|Lost to Follow-up|0|||
27989327|NCT01727336|81791669|FG005|Part 2 Blinded|Lost to Follow-up|1|||
27989328|NCT01727336|81791664|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
27989329|NCT01727336|81791665|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
27989330|NCT01727336|81791666|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
27989331|NCT01727336|81791667|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
27989332|NCT01727336|81791668|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
27989333|NCT01727336|81791669|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
27989334|NCT01727336|81791664|FG000|Part 2 Blinded|use of prohibited medications|0|||
27989335|NCT01727336|81791665|FG001|Part 2 Blinded|use of prohibited medications|0|||
27989336|NCT01727336|81791666|FG002|Part 2 Blinded|use of prohibited medications|0|||
27989337|NCT01727336|81791667|FG003|Part 2 Blinded|use of prohibited medications|0|||
27797489|NCT01610284|81089385|FG001|Randomization Phase|Death|1|||
27797490|NCT01610284|81089384|FG000|Treatment Phase|Adverse Event|80|||
27989338|NCT01727336|81791668|FG004|Part 2 Blinded|use of prohibited medications|1|||
27797491|NCT01610284|81089385|FG001|Treatment Phase|Adverse Event|12|||
27797492|NCT01610284|81089384|FG000|Treatment Phase|Lost to Follow-up|1|||
27797493|NCT01610284|81089385|FG001|Treatment Phase|Lost to Follow-up|0|||
27797494|NCT01610284|81089384|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
27797495|NCT01610284|81089385|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
27797496|NCT01610284|81089384|FG000|Treatment Phase|Physician Decision|27|||
27797497|NCT01610284|81089385|FG001|Treatment Phase|Physician Decision|24|||
27797498|NCT01610284|81089384|FG000|Treatment Phase|Progressive Disease|377|||
27797499|NCT01610284|81089385|FG001|Treatment Phase|Progressive Disease|486|||
27797500|NCT01610284|81089384|FG000|Treatment Phase|Protocol Deviation|2|||
27797501|NCT01610284|81089385|FG001|Treatment Phase|Protocol Deviation|3|||
27797502|NCT01610284|81089384|FG000|Treatment Phase|Study terminated by Sponsor|18|||
27797503|NCT01610284|81089385|FG001|Treatment Phase|Study terminated by Sponsor|15|||
27797504|NCT01610284|81089384|FG000|Treatment Phase|Subject/Guardian Decision|55|||
27797505|NCT01610284|81089385|FG001|Treatment Phase|Subject/Guardian Decision|23|||
27797506|NCT01610284|81089384|FG000|Treatment Phase|Death|6|||
27797507|NCT01610284|81089385|FG001|Treatment Phase|Death|5|||
27797508|NCT01610284|81089384|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
27797509|NCT01610284|81089385|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27797510|NCT01610284|81089384|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
27797511|NCT01610284|81089385|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
27797512|NCT01610284|81089384|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
27797513|NCT01610284|81089385|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
27797514|NCT01610284|81089384|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
27797515|NCT01610284|81089385|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
27797516|NCT01610284|81089384|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
27797517|NCT01610284|81089385|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
27797518|NCT01610284|81089384|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
27797519|NCT01610284|81089385|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
27797520|NCT00038467|81089386|FG000|Overall Study|Adverse Event|170|||
27797521|NCT00038467|81089387|FG001|Overall Study|Adverse Event|145|||
27989339|NCT01727336|81791669|FG005|Part 2 Blinded|use of prohibited medications|3|||
27989340|NCT01364389|81791670|FG000|Overall Study|Withdrawal by Subject|0|||
27989341|NCT01364389|81791671|FG001|Overall Study|Withdrawal by Subject|1|||
27989342|NCT01364389|81791672|FG002|Overall Study|Withdrawal by Subject|0|||
27989343|NCT01364389|81791670|FG000|Overall Study|Protocol deviation|0|||
27989344|NCT01364389|81791671|FG001|Overall Study|Protocol deviation|0|||
27989345|NCT01364389|81791672|FG002|Overall Study|Protocol deviation|1|||
27989346|NCT01364389|81791670|FG000|Overall Study|Administrative problems|1|||
27989347|NCT01364389|81791671|FG001|Overall Study|Administrative problems|0|||
27989348|NCT01364389|81791672|FG002|Overall Study|Administrative problems|0|||
27989349|NCT01364389|81791670|FG000|Overall Study|Adverse Event|1|||
27989350|NCT01364389|81791671|FG001|Overall Study|Adverse Event|0|||
27989351|NCT01364389|81791672|FG002|Overall Study|Adverse Event|0|||
27989352|NCT00986362|81791678|FG000|Overall Study|Death|2|||
27989353|NCT00986362|81791679|FG001|Overall Study|Death|0|||
27989354|NCT00986362|81791678|FG000|Overall Study|Lost to Follow-up|0|||
27989355|NCT00986362|81791679|FG001|Overall Study|Lost to Follow-up|1|||
27989356|NCT01879072|81791686|FG000|Overall Study|Withdrawal by Subject|121|||
27989357|NCT01879072|81791686|FG000|Overall Study|Not Transplanted|30|||
27989358|NCT02188849|81791687|FG000|Overall Study|Lost to Follow-up|3|||
27989359|NCT02188849|81791688|FG001|Overall Study|Lost to Follow-up|8|||
27989360|NCT00391625|81791689|FG000|Month 14|Withdrawal by Subject|1|||
27989361|NCT00391625|81791689|FG000|Month 50|Physician Decision|1|||
27989362|NCT01329939|81791690|FG000|Overall Study|Lost to Follow-up|3|||
27989363|NCT01329939|81791691|FG001|Overall Study|Lost to Follow-up|0|||
27989364|NCT01329939|81791692|FG002|Overall Study|Lost to Follow-up|1|||
27989365|NCT01329939|81791693|FG003|Overall Study|Lost to Follow-up|2|||
27675479|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
27797522|NCT00038467|81089386|FG000|Overall Study|Withdrawal by Subject|150|||
27797523|NCT00038467|81089387|FG001|Overall Study|Withdrawal by Subject|107|||
27797524|NCT00038467|81089386|FG000|Overall Study|Protocol Violation|19|||
27989366|NCT01329939|81791690|FG000|Overall Study|Withdrawal by Subject|0|||
27989367|NCT01329939|81791691|FG001|Overall Study|Withdrawal by Subject|1|||
27989368|NCT01329939|81791692|FG002|Overall Study|Withdrawal by Subject|0|||
27989369|NCT01329939|81791693|FG003|Overall Study|Withdrawal by Subject|0|||
27989370|NCT01329939|81791690|FG000|Overall Study|Adverse Event|0|||
27989371|NCT01329939|81791691|FG001|Overall Study|Adverse Event|0|||
27989372|NCT01329939|81791692|FG002|Overall Study|Adverse Event|0|||
27989373|NCT01329939|81791693|FG003|Overall Study|Adverse Event|3|||
27989374|NCT02335424|81791694|FG000|Overall Study|Withdrawal by Subject|19|||
27989375|NCT02335424|81791694|FG000|Overall Study|Adverse Event|25|||
27989376|NCT02335424|81791694|FG000|Overall Study|Death|273|||
27989377|NCT02335424|81791694|FG000|Overall Study|Lost to Follow-up|3|||
27989378|NCT02335424|81791694|FG000|Overall Study|Physician Decision|13|||
27989379|NCT02335424|81791694|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
27989380|NCT02335424|81791694|FG000|Overall Study|Protocol Violation|1|||
27989381|NCT02335424|81791694|FG000|Overall Study|Screen failure|1|||
27989382|NCT02476006|81791695|FG000|Overall Study|Death|4|||
27989383|NCT02476006|81791695|FG000|Overall Study|Lack of treatment efficacy|2|||
27989384|NCT02476006|81791695|FG000|Overall Study|Pregnancy|1|||
27989385|NCT02476006|81791695|FG000|Overall Study|Participant did not wish to continue|39|||
27989386|NCT02476006|81791695|FG000|Overall Study|Adverse Event|41|||
27989387|NCT02476006|81791695|FG000|Overall Study|Poor compliance to study protocol|3|||
27989388|NCT02476006|81791695|FG000|Overall Study|Sponsor decision|6|||
27989389|NCT02476006|81791695|FG000|Overall Study|Lost to Follow-up|5|||
27989390|NCT02476006|81791695|FG000|Overall Study|Physician Decision|5|||
27989391|NCT02476006|81791695|FG000|Overall Study|Study ended treatment not available|4|||
27989392|NCT02476006|81791695|FG000|Overall Study|Switched to commercial drug|4|||
27989393|NCT02476006|81791695|FG000|Overall Study|Excluded from study|1|||
27989394|NCT02476006|81791695|FG000|Overall Study|Protocol Violation|1|||
27989395|NCT02476006|81791695|FG000|Overall Study|Enrolled but not treated|4|||
27989396|NCT02596945|81791696|FG000|Overall Study|No documentation of study drug dosing|3|||
27989397|NCT02596945|81791696|FG000|Overall Study|Other|32|||
27989398|NCT02596945|81791696|FG000|Overall Study|Change to hemodialysis|15|||
27989399|NCT02596945|81791696|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
27989400|NCT02596945|81791696|FG000|Overall Study|Withdrawal by Subject|1|||
27989401|NCT02596945|81791696|FG000|Overall Study|Missing|1|||
27989402|NCT01023672|81791698|FG000|Overall Study|Worsening disease|2|||
27989403|NCT01023672|81791698|FG000|Overall Study|Death|1|||
27989404|NCT03422536|81791699|FG000|Randomized|Physician Decision|1|||
27989405|NCT03422536|81791700|FG001|Randomized|Physician Decision|1|||
27989406|NCT03422536|81791699|FG000|Allocation - Received Intervention|Disease progression|19|||
27989407|NCT03422536|81791700|FG001|Allocation - Received Intervention|Disease progression|25|||
27989408|NCT03422536|81791699|FG000|Allocation - Received Intervention|Death|1|||
27989409|NCT03422536|81791700|FG001|Allocation - Received Intervention|Death|3|||
27989410|NCT03422536|81791699|FG000|Allocation - Received Intervention|Adverse Event|1|||
27989411|NCT03422536|81791700|FG001|Allocation - Received Intervention|Adverse Event|0|||
27989412|NCT03422536|81791699|FG000|Allocation - Received Intervention|Physician Decision|1|||
27989413|NCT03422536|81791700|FG001|Allocation - Received Intervention|Physician Decision|1|||
27989414|NCT03422536|81791699|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
27989415|NCT03422536|81791700|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
27989416|NCT03422536|81791699|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
27989417|NCT03422536|81791700|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
27989418|NCT01534195|81791703|FG000|Overall Study|Withdrawal by Subject|1|||
27989419|NCT01534195|81791704|FG001|Overall Study|Withdrawal by Subject|1|||
27989420|NCT01105377|81791705|FG000|Overall Study|Withdrawal by Subject|0|||
27989421|NCT01105377|81791706|FG001|Overall Study|Withdrawal by Subject|1|||
27989422|NCT04378114|81791709|FG000|Overall Study|Withdrawal by Subject|5|||
27989423|NCT02868229|81791710|FG000|Overall Study|Adverse Event|1|||
27989424|NCT02868229|81791711|FG001|Overall Study|Adverse Event|0|||
27989425|NCT02868229|81791712|FG002|Overall Study|Adverse Event|0|||
27989426|NCT02868229|81791713|FG003|Overall Study|Adverse Event|1|||
27989427|NCT02868229|81791710|FG000|Overall Study|Death|0|||
27989428|NCT02868229|81791711|FG001|Overall Study|Death|0|||
27989429|NCT02868229|81791712|FG002|Overall Study|Death|1|||
27989430|NCT02868229|81791713|FG003|Overall Study|Death|1|||
27989431|NCT02868229|81791710|FG000|Overall Study|Missed dose|0|||
27989432|NCT02868229|81791711|FG001|Overall Study|Missed dose|0|||
27989433|NCT02868229|81791712|FG002|Overall Study|Missed dose|0|||
27989434|NCT02868229|81791713|FG003|Overall Study|Missed dose|3|||
27989435|NCT01868477|81791718|FG000|Overall Study|Adverse Event|2|||
27989436|NCT01868477|81791719|FG001|Overall Study|Adverse Event|4|||
27989437|NCT01868477|81791718|FG000|Overall Study|Disease progression|1|||
27797525|NCT00038467|81089387|FG001|Overall Study|Protocol Violation|22|||
27989438|NCT01868477|81791719|FG001|Overall Study|Disease progression|1|||
27989439|NCT01868477|81791718|FG000|Overall Study|Withdrawal by Subject|1|||
27989440|NCT01868477|81791719|FG001|Overall Study|Withdrawal by Subject|0|||
27989441|NCT00445770|81791721|FG000|Overall Study|Adverse Event|9|||
27989442|NCT00445770|81791722|FG001|Overall Study|Adverse Event|15|||
27797526|NCT00038467|81089386|FG000|Overall Study|Death|22|||
27989443|NCT00445770|81791723|FG002|Overall Study|Adverse Event|19|||
27989444|NCT00445770|81791721|FG000|Overall Study|Lack of Efficacy|38|||
27797527|NCT00038467|81089387|FG001|Overall Study|Death|16|||
27797528|NCT00038467|81089386|FG000|Overall Study|Lost to Follow-up|15|||
27675480|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
27675481|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
27675482|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
27675483|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
27675484|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
27675485|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
27675486|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
27675487|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
27675488|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
27675489|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
27675490|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
27675491|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
27797529|NCT00038467|81089387|FG001|Overall Study|Lost to Follow-up|10|||
27797530|NCT00038467|81089386|FG000|Overall Study|Recurrence|109|||
27989445|NCT00445770|81791722|FG001|Overall Study|Lack of Efficacy|13|||
27989446|NCT00445770|81791723|FG002|Overall Study|Lack of Efficacy|6|||
27989447|NCT00445770|81791721|FG000|Overall Study|Lost to Follow-up|0|||
27797531|NCT00038467|81089387|FG001|Overall Study|Recurrence|179|||
27989448|NCT00445770|81791722|FG001|Overall Study|Lost to Follow-up|2|||
27989449|NCT00445770|81791723|FG002|Overall Study|Lost to Follow-up|0|||
27989450|NCT00445770|81791721|FG000|Overall Study|Other|6|||
27989451|NCT00445770|81791722|FG001|Overall Study|Other|5|||
27989452|NCT00445770|81791723|FG002|Overall Study|Other|6|||
27989453|NCT01894022|81791724|FG000|Overall Study|Death|1|||
27989454|NCT01894022|81791725|FG001|Overall Study|Death|0|||
27989455|NCT01894022|81791724|FG000|Overall Study|Adverse Event, non-fatal|1|||
27989456|NCT01894022|81791725|FG001|Overall Study|Adverse Event, non-fatal|0|||
27579161|NCT01328002|80303098|FG001|Double-Blind Period|Lack of Efficacy|0|||
27797532|NCT00038467|81089386|FG000|Overall Study|Randomized, but not treated|31|||
27797533|NCT00038467|81089387|FG001|Overall Study|Randomized, but not treated|35|||
27797534|NCT00038467|81089386|FG000|Overall Study|Other|26|||
27797535|NCT00038467|81089387|FG001|Overall Study|Other|28|||
27797536|NCT02032823|81089399|FG000|Overall Study|Death|75|||
27797537|NCT02032823|81089400|FG001|Overall Study|Death|109|||
27797538|NCT02032823|81089399|FG000|Overall Study|Lost to Follow-up|18|||
27797539|NCT02032823|81089400|FG001|Overall Study|Lost to Follow-up|17|||
27797540|NCT02032823|81089399|FG000|Overall Study|Withdrawal by Subject|70|||
27797541|NCT02032823|81089400|FG001|Overall Study|Withdrawal by Subject|53|||
27797542|NCT02032823|81089399|FG000|Overall Study|Ongoing study at data cut-off|755|||
27797543|NCT02032823|81089400|FG001|Overall Study|Ongoing study at data cut-off|731|||
27797544|NCT02032823|81089399|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
27797545|NCT02032823|81089400|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
27797546|NCT01447628|81089401|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
27797547|NCT01447628|81089402|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
27797548|NCT01447628|81089403|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
27797549|NCT01447628|81089404|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
27797550|NCT02204449|81089405|FG000|Overall Study|Lost to Follow-up|7|||
27797551|NCT02204449|81089406|FG001|Overall Study|Lost to Follow-up|9|||
27797552|NCT02204449|81089405|FG000|Overall Study|Death|0|||
27797553|NCT02204449|81089406|FG001|Overall Study|Death|1|||
27797554|NCT02204449|81089405|FG000|Overall Study|Withdrawal by Subject|0|||
27797555|NCT02204449|81089406|FG001|Overall Study|Withdrawal by Subject|1|||
27797556|NCT03701516|81089407|FG000|Period 1|Lost to Follow-up|0|||
27797557|NCT03701516|81089408|FG001|Period 1|Lost to Follow-up|1|||
27797558|NCT03701516|81089407|FG000|Period 1|Adverse Event|0|||
27797559|NCT03701516|81089408|FG001|Period 1|Adverse Event|2|||
27797560|NCT03701516|81089407|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
27797561|NCT03701516|81089408|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
27797562|NCT03701516|81089407|FG000|Period 1|Non Compliance to Protocol|2|||
27797563|NCT03701516|81089408|FG001|Period 1|Non Compliance to Protocol|1|||
27797564|NCT03701516|81089407|FG000|Period 1|Withdrawal by Subject|0|||
27989457|NCT01894022|81791724|FG000|Overall Study|Study Closed/terminated|7|||
27989458|NCT01894022|81791725|FG001|Overall Study|Study Closed/terminated|10|||
27579162|NCT00533949|80303100|FG000|Overall Study|Protocol Violation|12|||
27675492|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
27797565|NCT03701516|81089408|FG001|Period 1|Withdrawal by Subject|1|||
27797566|NCT03701516|81089407|FG000|Period 2|failed to meet all eligibility creiteria|1|||
27797567|NCT03701516|81089408|FG001|Period 2|failed to meet all eligibility creiteria|0|||
27989459|NCT04439318|81791726|FG000|Overall Study|Ineligible|1|||
27579163|NCT00533949|80303101|FG001|Overall Study|Protocol Violation|12|||
27797568|NCT03701516|81089407|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
27797569|NCT03701516|81089408|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
27797570|NCT00424515|81089423|FG000|Overall Study|Progressive Disease|10|||
27797571|NCT00424515|81089424|FG001|Overall Study|Progressive Disease|11|||
27989460|NCT04439318|81791726|FG000|Overall Study|Never Started Treatment|3|||
27797572|NCT00424515|81089423|FG000|Overall Study|Adverse Event|0|||
27797573|NCT00424515|81089424|FG001|Overall Study|Adverse Event|1|||
27797574|NCT00424515|81089423|FG000|Overall Study|Intercurrent Illness|0|||
27797575|NCT00424515|81089424|FG001|Overall Study|Intercurrent Illness|1|||
27797576|NCT00424515|81089423|FG000|Overall Study|Withdrawal by Subject|1|||
27797577|NCT00424515|81089424|FG001|Overall Study|Withdrawal by Subject|0|||
27797578|NCT04856917|81089426|FG000|Overall Study|Withdrawal by Subject|4|||
27797579|NCT04856917|81089427|FG001|Overall Study|Withdrawal by Subject|3|||
27797580|NCT04856917|81089428|FG002|Overall Study|Withdrawal by Subject|1|||
27797581|NCT04856917|81089426|FG000|Overall Study|Lost to Follow-up|3|||
27797582|NCT04856917|81089427|FG001|Overall Study|Lost to Follow-up|1|||
27797583|NCT04856917|81089428|FG002|Overall Study|Lost to Follow-up|1|||
27797584|NCT04856917|81089426|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
27797585|NCT04856917|81089427|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
27797586|NCT04856917|81089428|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
27797587|NCT04856917|81089426|FG000|Overall Study|Other|1|||
27797588|NCT04856917|81089427|FG001|Overall Study|Other|1|||
27870269|NCT00591773|81357977|FG000|Overall Study|Protocol Violation|2|||
27870270|NCT00591773|81357978|FG001|Overall Study|Protocol Violation|3|||
27870271|NCT00591773|81357979|FG002|Overall Study|Protocol Violation|0|||
27870272|NCT00591773|81357977|FG000|Overall Study|Lost to Follow-up|1|||
27870273|NCT00591773|81357978|FG001|Overall Study|Lost to Follow-up|4|||
27870274|NCT00591773|81357979|FG002|Overall Study|Lost to Follow-up|1|||
27870275|NCT00591773|81357977|FG000|Overall Study|Withdrawal by Subject|2|||
27870276|NCT00591773|81357978|FG001|Overall Study|Withdrawal by Subject|5|||
27797589|NCT04856917|81089428|FG002|Overall Study|Other|0|||
27797590|NCT02181842|81089429|FG000|Overall Study|Case Report Forms Uncollected|2|||
27797591|NCT00865306|81089432|FG000|Controlled Trial|Lost to Follow-up|1|||
27797592|NCT00865306|81089433|FG001|Controlled Trial|Lost to Follow-up|1|||
27797593|NCT00865306|81089432|FG000|Controlled Trial|Difficulty commuting|2|||
27797594|NCT00865306|81089433|FG001|Controlled Trial|Difficulty commuting|0|||
27797595|NCT00865306|81089432|FG000|Controlled Trial|Improved btw baseline and first session|1|||
27797596|NCT00865306|81089433|FG001|Controlled Trial|Improved btw baseline and first session|0|||
27797597|NCT00865306|81089432|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
27797598|NCT00865306|81089433|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
27797599|NCT00865306|81089432|FG000|Controlled Trial|Withdrawal by Subject|0|||
27797600|NCT00865306|81089433|FG001|Controlled Trial|Withdrawal by Subject|1|||
27797601|NCT04578548|81089436|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
27797602|NCT04578548|81089437|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
27797603|NCT04578548|81089436|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
27797604|NCT04578548|81089437|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
27797605|NCT04578548|81089436|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
27797606|NCT04578548|81089437|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
27797607|NCT04578548|81089436|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
27797608|NCT04578548|81089437|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
27797609|NCT04578548|81089436|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
27797610|NCT04578548|81089437|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
27797611|NCT04578548|81089436|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
27797612|NCT04578548|81089437|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
27797613|NCT00457418|81089438|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
27797614|NCT00457418|81089438|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
27797615|NCT00457418|81089438|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
27797616|NCT00457418|81089438|FG000|Post PK Maintenance|Adverse Event|10|||
27797617|NCT00457418|81089438|FG000|Post PK Maintenance|Progression of Disease|6|||
27797618|NCT00457418|81089438|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
27797619|NCT00457418|81089438|FG000|Post PK Maintenance|Lost to Follow-up|1|||
27797620|NCT00532779|81089445|FG000|Overall Study|Adverse Event|122|||
27797621|NCT00532779|81089446|FG001|Overall Study|Adverse Event|112|||
27797622|NCT00532779|81089447|FG002|Overall Study|Adverse Event|56|||
27870277|NCT00591773|81357979|FG002|Overall Study|Withdrawal by Subject|3|||
27797623|NCT00532779|81089445|FG000|Overall Study|Lost to Follow-up|76|||
27797624|NCT00532779|81089446|FG001|Overall Study|Lost to Follow-up|65|||
27797625|NCT00532779|81089447|FG002|Overall Study|Lost to Follow-up|66|||
27797626|NCT00532779|81089445|FG000|Overall Study|Withdrawal by Subject|63|||
27797627|NCT00532779|81089446|FG001|Overall Study|Withdrawal by Subject|60|||
27797628|NCT00532779|81089447|FG002|Overall Study|Withdrawal by Subject|90|||
27797629|NCT00532779|81089445|FG000|Overall Study|Lack of Efficacy|12|||
27797630|NCT00532779|81089446|FG001|Overall Study|Lack of Efficacy|12|||
27797631|NCT00532779|81089447|FG002|Overall Study|Lack of Efficacy|40|||
27797632|NCT00532779|81089445|FG000|Overall Study|Protocol Violation|5|||
27870278|NCT00591773|81357977|FG000|Overall Study|Lack of Efficacy|1|||
27797633|NCT00532779|81089446|FG001|Overall Study|Protocol Violation|9|||
27797634|NCT00532779|81089447|FG002|Overall Study|Protocol Violation|7|||
27797635|NCT00532779|81089445|FG000|Overall Study|Pregnancy|2|||
27797636|NCT00532779|81089446|FG001|Overall Study|Pregnancy|5|||
27797637|NCT00532779|81089447|FG002|Overall Study|Pregnancy|3|||
27797638|NCT00532779|81089445|FG000|Overall Study|Death|0|||
27797639|NCT00532779|81089446|FG001|Overall Study|Death|1|||
27797640|NCT00532779|81089447|FG002|Overall Study|Death|0|||
27797641|NCT00532779|81089445|FG000|Overall Study|Drug noncompliance, moved, other|14|||
27797642|NCT00532779|81089446|FG001|Overall Study|Drug noncompliance, moved, other|23|||
27797643|NCT00532779|81089447|FG002|Overall Study|Drug noncompliance, moved, other|29|||
27797644|NCT00005879|81089448|FG000|Overall Study|Withdrawal by Subject|8|||
27797645|NCT00005879|81089449|FG001|Overall Study|Withdrawal by Subject|10|||
27833055|NCT03131895|81219442|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
27833056|NCT03131895|81219443|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
27833057|NCT03131895|81219444|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
27833058|NCT03602339|81219445|FG000|Overall Study|Withdrawal by Subject|9|||
27833059|NCT03602339|81219445|FG000|Overall Study|Physician Decision|2|||
27833060|NCT03602339|81219445|FG000|Overall Study|Other reason|4|||
27833061|NCT00849797|81219446|FG000|First Intervention|bad veins|1|||
27833062|NCT00849797|81219447|FG001|First Intervention|bad veins|0|||
27833063|NCT00849797|81219446|FG000|First Intervention|Adverse Event|0|||
27833064|NCT00849797|81219447|FG001|First Intervention|Adverse Event|1|||
27989461|NCT04439318|81791726|FG000|Overall Study|Adverse Event|10|||
27833065|NCT00849797|81219446|FG000|Washout: One Week|Withdrawal by Subject|0|||
27833066|NCT00849797|81219447|FG001|Washout: One Week|Withdrawal by Subject|2|||
27833067|NCT03599193|81219448|FG000|Overall Study|Adverse Event|0|||
27833068|NCT03599193|81219449|FG001|Overall Study|Adverse Event|2|||
27833069|NCT03599193|81219448|FG000|Overall Study|Withdrawal by Subject|1|||
27833070|NCT03599193|81219449|FG001|Overall Study|Withdrawal by Subject|0|||
27833071|NCT03599193|81219448|FG000|Overall Study|Protocol Violation|1|||
27989462|NCT04439318|81791726|FG000|Overall Study|Death|2|||
27833072|NCT03599193|81219449|FG001|Overall Study|Protocol Violation|0|||
27833073|NCT03599193|81219448|FG000|Overall Study|Lost to Follow-up|0|||
27833074|NCT03599193|81219449|FG001|Overall Study|Lost to Follow-up|1|||
27833075|NCT01609257|81219450|FG000|Overall Study|Lost to Follow-up|2|||
27833076|NCT01609257|81219451|FG001|Overall Study|Lost to Follow-up|1|||
27833077|NCT01609257|81219450|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
27833078|NCT01609257|81219451|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
27833079|NCT01609257|81219450|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
27833080|NCT01609257|81219451|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
27833081|NCT01993186|81219452|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
27833082|NCT01993186|81219453|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
27833083|NCT01993186|81219452|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
27833084|NCT01993186|81219453|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
27833085|NCT01993186|81219452|FG000|Open-Label Extension Period|Other, Not Specified|0|||
27833086|NCT01993186|81219453|FG001|Open-Label Extension Period|Other, Not Specified|1|||
27989463|NCT04439318|81791726|FG000|Overall Study|Disease Progression|25|||
27989464|NCT04439318|81791726|FG000|Overall Study|Other Complicating Disease|2|||
27989465|NCT04439318|81791726|FG000|Overall Study|Withdrawal by Subject|4|||
27989466|NCT04439318|81791726|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
27989467|NCT04439318|81791726|FG000|Overall Study|Non-Compliance|1|||
27989468|NCT04439318|81791726|FG000|Overall Study|Still on Treatment|1|||
27989469|NCT00367835|81791727|FG000|Overall Study|Adverse Event|14|||
27989470|NCT00367835|81791728|FG001|Overall Study|Adverse Event|1|||
27989471|NCT00367835|81791727|FG000|Overall Study|Protocol Violation|1|||
27989472|NCT00367835|81791728|FG001|Overall Study|Protocol Violation|7|||
27989473|NCT00367835|81791727|FG000|Overall Study|Withdrawal by Subject|7|||
27989474|NCT00367835|81791728|FG001|Overall Study|Withdrawal by Subject|6|||
27833087|NCT01993186|81219452|FG000|Open-Label Extension Period|Adverse Event|1|||
27833088|NCT01993186|81219453|FG001|Open-Label Extension Period|Adverse Event|0|||
27833089|NCT01993186|81219452|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
27833090|NCT01993186|81219453|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
27833091|NCT01993186|81219452|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
27833092|NCT01993186|81219453|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
27989475|NCT00367835|81791727|FG000|Overall Study|Lost to Follow-up|1|||
27833093|NCT01993186|81219452|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
27833094|NCT01993186|81219453|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
27833095|NCT00807495|81219454|FG000|Overall Study|Adverse Event|6|||
27833096|NCT00807495|81219455|FG001|Overall Study|Adverse Event|3|||
27833097|NCT00807495|81219456|FG002|Overall Study|Adverse Event|1|||
27833098|NCT00807495|81219457|FG003|Overall Study|Adverse Event|1|||
27989476|NCT00367835|81791728|FG001|Overall Study|Lost to Follow-up|4|||
27989477|NCT00367835|81791727|FG000|Overall Study|Lack of Efficacy|3|||
27989478|NCT00367835|81791728|FG001|Overall Study|Lack of Efficacy|12|||
27989479|NCT00367835|81791727|FG000|Overall Study|Subject in juvenile detention center|1|||
27989480|NCT00367835|81791728|FG001|Overall Study|Subject in juvenile detention center|0|||
27870279|NCT00591773|81357978|FG001|Overall Study|Lack of Efficacy|2|||
27870280|NCT00591773|81357979|FG002|Overall Study|Lack of Efficacy|2|||
27870281|NCT00591773|81357977|FG000|Overall Study|Other|1|||
27870282|NCT00591773|81357978|FG001|Overall Study|Other|1|||
27870283|NCT00591773|81357979|FG002|Overall Study|Other|4|||
27870284|NCT02524847|81361408|FG000|Overall Study|Adverse Event|4|||
27870285|NCT02524847|81361408|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
27870286|NCT02524847|81361408|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
27870287|NCT02524847|81361408|FG000|Overall Study|Death|1|||
27870288|NCT02524847|81361408|FG000|Overall Study|Reason not Specified|1|||
27870289|NCT03288714|81361409|FG000|Overall Study|Lost to Follow-up|2|||
27870290|NCT03288714|81361410|FG001|Overall Study|Lost to Follow-up|1|||
27870291|NCT03288714|81361409|FG000|Overall Study|Non-compliance with study schedule|2|||
27870292|NCT03288714|81361410|FG001|Overall Study|Non-compliance with study schedule|0|||
27870293|NCT03288714|81361409|FG000|Overall Study|Withdrawal by Subject|3|||
27870294|NCT03288714|81361410|FG001|Overall Study|Withdrawal by Subject|1|||
27870295|NCT03288714|81361409|FG000|Overall Study|Clinical Worsening|2|||
27870296|NCT03288714|81361410|FG001|Overall Study|Clinical Worsening|1|||
27870297|NCT03288714|81361409|FG000|Overall Study|Adverse Event|1|||
27870298|NCT03288714|81361410|FG001|Overall Study|Adverse Event|0|||
27870299|NCT01807065|81361419|FG000|Overall Study|Receive no sip-T due to IV access|1|||
27870300|NCT01807065|81361420|FG001|Overall Study|Receive no sip-T due to IV access|1|||
27870301|NCT04352101|81361423|FG000|Overall Study|Physician Decision|2|||
27870302|NCT04352101|81361424|FG001|Overall Study|Physician Decision|1|||
27870303|NCT02493660|81361430|FG000|Overall Study|Physician Decision|0|||
27870304|NCT02493660|81361431|FG001|Overall Study|Physician Decision|1|||
27870305|NCT02493660|81361430|FG000|Overall Study|Adverse Event|4|||
27870306|NCT02493660|81361431|FG001|Overall Study|Adverse Event|2|||
27870307|NCT02493660|81361430|FG000|Overall Study|Withdrawal by Subject|2|||
27870308|NCT02493660|81361431|FG001|Overall Study|Withdrawal by Subject|3|||
27870309|NCT02493660|81361430|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
27870310|NCT02493660|81361431|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
27870311|NCT02493660|81361430|FG000|Overall Study|Protocol Violation|0|||
27870312|NCT02493660|81361431|FG001|Overall Study|Protocol Violation|1|||
27870313|NCT02493660|81361430|FG000|Overall Study|Death|0|||
27870314|NCT02493660|81361431|FG001|Overall Study|Death|1|||
27870315|NCT02493660|81361430|FG000|Overall Study|Lost to Follow-up|2|||
27870316|NCT02493660|81361431|FG001|Overall Study|Lost to Follow-up|4|||
27870317|NCT04428034|81361433|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
27870318|NCT04583735|81361434|FG000|Double-masked Treatment Period|Adverse Event|0|||
27870319|NCT04583735|81361435|FG001|Double-masked Treatment Period|Adverse Event|1|||
27870320|NCT04583735|81361434|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
27870321|NCT04583735|81361435|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
27870322|NCT04583735|81361434|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
27870323|NCT04583735|81361435|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
27870324|NCT04583735|81361434|FG000|Open-label Treatment Period|Adverse Event|1|||
27870325|NCT04583735|81361435|FG001|Open-label Treatment Period|Adverse Event|1|||
27870326|NCT04583735|81361434|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
27870327|NCT04583735|81361435|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27870328|NCT04583735|81361434|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27870329|NCT04583735|81361435|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
27870330|NCT04747470|81361438|FG000|Overall Study|Death|0|||
27870331|NCT04747470|81361439|FG001|Overall Study|Death|3|||
27870332|NCT04747470|81361440|FG002|Overall Study|Death|2|||
27870333|NCT04747470|81361441|FG003|Overall Study|Death|2|||
27870334|NCT04747470|81361442|FG004|Overall Study|Death|2|||
27870335|NCT04747470|81361443|FG005|Overall Study|Death|0|||
27870336|NCT04747470|81361444|FG006|Overall Study|Death|0|||
27870337|NCT04747470|81361445|FG007|Overall Study|Death|0|||
27870338|NCT04747470|81361446|FG008|Overall Study|Death|0|||
27870339|NCT04747470|81361447|FG009|Overall Study|Death|0|||
27870340|NCT04747470|81361448|FG010|Overall Study|Death|0|||
27870341|NCT04747470|81361438|FG000|Overall Study|Withdrew Consent|0|||
27870342|NCT04747470|81361439|FG001|Overall Study|Withdrew Consent|0|||
27870343|NCT04747470|81361440|FG002|Overall Study|Withdrew Consent|0|||
27870344|NCT04747470|81361441|FG003|Overall Study|Withdrew Consent|1|||
27870345|NCT04747470|81361442|FG004|Overall Study|Withdrew Consent|0|||
27870346|NCT04747470|81361443|FG005|Overall Study|Withdrew Consent|0|||
27870347|NCT04747470|81361444|FG006|Overall Study|Withdrew Consent|0|||
27870348|NCT04747470|81361445|FG007|Overall Study|Withdrew Consent|0|||
27870349|NCT04747470|81361446|FG008|Overall Study|Withdrew Consent|0|||
27870350|NCT04747470|81361447|FG009|Overall Study|Withdrew Consent|0|||
27870351|NCT04747470|81361448|FG010|Overall Study|Withdrew Consent|0|||
27870352|NCT04747470|81361438|FG000|Overall Study|Study Terminated by Sponsor|0|||
27579164|NCT00533949|80303102|FG002|Overall Study|Protocol Violation|9|||
27870353|NCT04747470|81361439|FG001|Overall Study|Study Terminated by Sponsor|0|||
27870354|NCT04747470|81361440|FG002|Overall Study|Study Terminated by Sponsor|1|||
27870355|NCT04747470|81361441|FG003|Overall Study|Study Terminated by Sponsor|0|||
27870356|NCT04747470|81361442|FG004|Overall Study|Study Terminated by Sponsor|2|||
27870357|NCT04747470|81361443|FG005|Overall Study|Study Terminated by Sponsor|0|||
27989481|NCT00367835|81791727|FG000|Overall Study|refused blood collection|1|||
27989482|NCT00367835|81791728|FG001|Overall Study|refused blood collection|0|||
27989483|NCT00367835|81791727|FG000|Overall Study|Did not respond to calls|1|||
27989484|NCT00367835|81791728|FG001|Overall Study|Did not respond to calls|0|||
27870358|NCT04747470|81361444|FG006|Overall Study|Study Terminated by Sponsor|0|||
27870359|NCT04747470|81361445|FG007|Overall Study|Study Terminated by Sponsor|0|||
27870360|NCT04747470|81361446|FG008|Overall Study|Study Terminated by Sponsor|0|||
27797646|NCT04816877|81091420|FG000|Overall Study|Withdrawal by Subject|1|||
27870361|NCT04747470|81361447|FG009|Overall Study|Study Terminated by Sponsor|0|||
27870362|NCT04747470|81361448|FG010|Overall Study|Study Terminated by Sponsor|0|||
27870363|NCT01197534|81361449|FG000|Overall Study|Not reported|16|||
27870364|NCT01197534|81361450|FG001|Overall Study|Not reported|10|||
27870365|NCT01197534|81361451|FG002|Overall Study|Not reported|16|||
27870366|NCT01197534|81361449|FG000|Overall Study|Enrolment in long term extension|57|||
27870367|NCT01197534|81361450|FG001|Overall Study|Enrolment in long term extension|66|||
27870368|NCT01197534|81361451|FG002|Overall Study|Enrolment in long term extension|119|||
27870369|NCT01197534|81361449|FG000|Overall Study|Severe non-compliance to protocol|3|||
27870370|NCT01197534|81361450|FG001|Overall Study|Severe non-compliance to protocol|4|||
27870371|NCT01197534|81361451|FG002|Overall Study|Severe non-compliance to protocol|1|||
27870372|NCT01197534|81361449|FG000|Overall Study|Lack of therapeutic response|9|||
27870373|NCT01197534|81361450|FG001|Overall Study|Lack of therapeutic response|4|||
27870374|NCT01197534|81361451|FG002|Overall Study|Lack of therapeutic response|9|||
27870375|NCT01197534|81361449|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
27870376|NCT01197534|81361450|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
27989485|NCT00367835|81791727|FG000|Overall Study|History of lead poisoning|0|||
27989486|NCT00367835|81791728|FG001|Overall Study|History of lead poisoning|1|||
27989487|NCT02927938|81791731|FG000|Overall Study|Death|0|||
27989488|NCT02927938|81791732|FG001|Overall Study|Death|1|||
27579165|NCT00533949|80303103|FG003|Overall Study|Protocol Violation|9|||
27797647|NCT04816877|81091421|FG001|Overall Study|Withdrawal by Subject|0|||
27797648|NCT03330847|81091422|FG000|Overall Study|Patients ongoing study|62|||
27797649|NCT03330847|81091423|FG001|Overall Study|Patients ongoing study|65|||
27797650|NCT03330847|81091424|FG002|Overall Study|Patients ongoing study|15|||
27797651|NCT05004181|81091426|FG000|Overall Study|Withdrawal of consent|0|||
27797652|NCT05004181|81091427|FG001|Overall Study|Withdrawal of consent|0|||
27797653|NCT05004181|81091428|FG002|Overall Study|Withdrawal of consent|1|||
27797654|NCT05004181|81091429|FG003|Overall Study|Withdrawal of consent|3|||
27797655|NCT05004181|81091430|FG004|Overall Study|Withdrawal of consent|3|||
27797656|NCT05004181|81091431|FG005|Overall Study|Withdrawal of consent|0|||
27797657|NCT05004181|81091432|FG006|Overall Study|Withdrawal of consent|30|||
27797658|NCT05004181|81091433|FG007|Overall Study|Withdrawal of consent|9|||
27797659|NCT05004181|81091434|FG008|Overall Study|Withdrawal of consent|3|||
27797660|NCT05004181|81091435|FG009|Overall Study|Withdrawal of consent|2|||
27797661|NCT05004181|81091436|FG010|Overall Study|Withdrawal of consent|5|||
27797662|NCT05004181|81091437|FG011|Overall Study|Withdrawal of consent|1|||
27797663|NCT05004181|81091426|FG000|Overall Study|Lost to Follow-up|2|||
27579166|NCT00533949|80303100|FG000|Overall Study|Withdrawal by Subject|3|||
27579167|NCT00533949|80303101|FG001|Overall Study|Withdrawal by Subject|2|||
27579168|NCT00533949|80303102|FG002|Overall Study|Withdrawal by Subject|1|||
27579169|NCT00533949|80303103|FG003|Overall Study|Withdrawal by Subject|1|||
27579170|NCT03662750|80303109|FG000|Overall Study|Withdrawal by Subject|1|||
27797664|NCT05004181|81091427|FG001|Overall Study|Lost to Follow-up|4|||
27797665|NCT05004181|81091428|FG002|Overall Study|Lost to Follow-up|2|||
27797666|NCT05004181|81091429|FG003|Overall Study|Lost to Follow-up|3|||
27797667|NCT05004181|81091430|FG004|Overall Study|Lost to Follow-up|5|||
27797668|NCT05004181|81091431|FG005|Overall Study|Lost to Follow-up|2|||
27797669|NCT05004181|81091432|FG006|Overall Study|Lost to Follow-up|15|||
27797670|NCT05004181|81091433|FG007|Overall Study|Lost to Follow-up|12|||
27870377|NCT01197534|81361451|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
27870378|NCT01197534|81361449|FG000|Overall Study|Lost to Follow-up|1|||
27870379|NCT01197534|81361450|FG001|Overall Study|Lost to Follow-up|4|||
27579171|NCT04537715|80303124|FG000|Overall Study|Death|3|||
27797671|NCT05004181|81091434|FG008|Overall Study|Lost to Follow-up|38|||
27797672|NCT05004181|81091435|FG009|Overall Study|Lost to Follow-up|6|||
27870380|NCT01197534|81361451|FG002|Overall Study|Lost to Follow-up|2|||
27579172|NCT04537715|80303125|FG001|Overall Study|Death|1|||
27797673|NCT05004181|81091436|FG010|Overall Study|Lost to Follow-up|6|||
27797674|NCT05004181|81091437|FG011|Overall Study|Lost to Follow-up|0|||
27797675|NCT05004181|81091426|FG000|Overall Study|Death|0|||
27797676|NCT05004181|81091427|FG001|Overall Study|Death|0|||
27870381|NCT01197534|81361449|FG000|Overall Study|Adverse Event|35|||
27579173|NCT04537715|80303124|FG000|Overall Study|Withdrawal by Subject|3|||
27989489|NCT02927938|81791733|FG002|Overall Study|Death|0|||
27797677|NCT05004181|81091428|FG002|Overall Study|Death|0|||
27797678|NCT05004181|81091429|FG003|Overall Study|Death|0|||
27797679|NCT05004181|81091430|FG004|Overall Study|Death|0|||
27797680|NCT05004181|81091431|FG005|Overall Study|Death|0|||
27797681|NCT05004181|81091432|FG006|Overall Study|Death|1|||
27797682|NCT05004181|81091433|FG007|Overall Study|Death|0|||
27870382|NCT01197534|81361450|FG001|Overall Study|Adverse Event|36|||
27870383|NCT01197534|81361451|FG002|Overall Study|Adverse Event|24|||
27870384|NCT02174627|81361452|FG000|Overall Study|Missing|0|||
27870385|NCT02174627|81361453|FG001|Overall Study|Missing|1|||
27870386|NCT02174627|81361452|FG000|Overall Study|Incorrect enrolment before randomization|0|||
27870387|NCT02174627|81361453|FG001|Overall Study|Incorrect enrolment before randomization|1|||
27870388|NCT02174627|81361452|FG000|Overall Study|Participant decision|84|||
27870389|NCT02174627|81361453|FG001|Overall Study|Participant decision|128|||
27870390|NCT02288312|81361454|FG000|Overall Study|Pregnancy|1|||
27870391|NCT02288312|81361455|FG001|Overall Study|Pregnancy|0|||
27870392|NCT02288312|81361456|FG002|Overall Study|Pregnancy|0|||
27870393|NCT03345420|81361457|FG000|Overall Study|Withdrawal by Subject|1|||
27870394|NCT04067050|81361458|FG000|One Month|Lost to Follow-up|4|||
27870395|NCT04067050|81361459|FG001|One Month|Lost to Follow-up|0|||
27797683|NCT05004181|81091434|FG008|Overall Study|Death|2|||
27797684|NCT05004181|81091435|FG009|Overall Study|Death|0|||
27797685|NCT05004181|81091436|FG010|Overall Study|Death|0|||
27797686|NCT05004181|81091437|FG011|Overall Study|Death|0|||
27797687|NCT05004181|81091426|FG000|Overall Study|Physician Decision|0|||
27797688|NCT05004181|81091427|FG001|Overall Study|Physician Decision|0|||
27797689|NCT05004181|81091428|FG002|Overall Study|Physician Decision|0|||
27797690|NCT05004181|81091429|FG003|Overall Study|Physician Decision|0|||
27797691|NCT05004181|81091430|FG004|Overall Study|Physician Decision|0|||
27797692|NCT05004181|81091431|FG005|Overall Study|Physician Decision|0|||
27797693|NCT05004181|81091432|FG006|Overall Study|Physician Decision|2|||
27797694|NCT05004181|81091433|FG007|Overall Study|Physician Decision|0|||
27797695|NCT05004181|81091434|FG008|Overall Study|Physician Decision|7|||
27870396|NCT04067050|81361458|FG000|Two Month|Lost to Follow-up|1|||
27797696|NCT05004181|81091435|FG009|Overall Study|Physician Decision|0|||
27797697|NCT05004181|81091436|FG010|Overall Study|Physician Decision|0|||
27797698|NCT05004181|81091437|FG011|Overall Study|Physician Decision|0|||
27797699|NCT05004181|81091426|FG000|Overall Study|Withdrawal by Subject|2|||
27797700|NCT05004181|81091427|FG001|Overall Study|Withdrawal by Subject|3|||
27797701|NCT05004181|81091428|FG002|Overall Study|Withdrawal by Subject|2|||
27797702|NCT05004181|81091429|FG003|Overall Study|Withdrawal by Subject|2|||
27797703|NCT05004181|81091430|FG004|Overall Study|Withdrawal by Subject|4|||
27797704|NCT05004181|81091431|FG005|Overall Study|Withdrawal by Subject|2|||
27797705|NCT05004181|81091432|FG006|Overall Study|Withdrawal by Subject|4|||
27797706|NCT05004181|81091433|FG007|Overall Study|Withdrawal by Subject|22|||
27797707|NCT05004181|81091434|FG008|Overall Study|Withdrawal by Subject|8|||
27870397|NCT04067050|81361459|FG001|Two Month|Lost to Follow-up|0|||
27870398|NCT04067050|81361458|FG000|Two Month|Adverse Event|1|||
27870399|NCT04067050|81361459|FG001|Two Month|Adverse Event|0|||
27870400|NCT03305848|81361460|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
27870401|NCT03305848|81361460|FG000|Overall Study|Physician Decision|2|||
27989490|NCT02927938|81791734|FG003|Overall Study|Death|4|||
27989491|NCT02927938|81791731|FG000|Overall Study|Early Study Termination|1|||
27989492|NCT02927938|81791732|FG001|Overall Study|Early Study Termination|5|||
27989493|NCT02927938|81791733|FG002|Overall Study|Early Study Termination|4|||
27989494|NCT02927938|81791734|FG003|Overall Study|Early Study Termination|3|||
27989495|NCT00924508|81791735|FG000|Overall Study|Withdrawal by Subject|3|||
27989496|NCT01743040|81791740|FG000|Overall Study|Death|1|||
27989497|NCT01743040|81791740|FG000|Overall Study|Lost to Follow-up|66|||
27989498|NCT01743040|81791740|FG000|Overall Study|Physician Decision|40|||
27989499|NCT01743040|81791740|FG000|Overall Study|Protocol Violation|1|||
27675493|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
27675494|NCT04210843|80650152|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
27675495|NCT04210843|80650153|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
27675496|NCT04210843|80650152|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
27675497|NCT04210843|80650153|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
27675498|NCT04210843|80650152|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
27675499|NCT04210843|80650153|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
27675500|NCT04210843|80650152|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
27675501|NCT04210843|80650153|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
27675502|NCT04210843|80650152|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
27989500|NCT01743040|81791740|FG000|Overall Study|Withdrawal by Subject|121|||
27989501|NCT00269633|81791741|FG000|Overall Study|Withdrawal by Subject|1|||
27989502|NCT00269633|81791742|FG001|Overall Study|Withdrawal by Subject|0|||
27989503|NCT02593318|81791743|FG000|Overall Study|Withdrawal by Subject|1|||
27989504|NCT02593318|81791744|FG001|Overall Study|Withdrawal by Subject|1|||
27989505|NCT02828020|81791750|FG000|Treatment Period|Adverse Event|3|||
27989506|NCT02828020|81791751|FG001|Treatment Period|Adverse Event|1|||
27989507|NCT02828020|81791752|FG002|Treatment Period|Adverse Event|1|||
27989508|NCT02828020|81791750|FG000|Treatment Period|Withdrawal of Consent|10|||
27989509|NCT02828020|81791751|FG001|Treatment Period|Withdrawal of Consent|14|||
27989510|NCT02828020|81791752|FG002|Treatment Period|Withdrawal of Consent|9|||
27989511|NCT02828020|81791750|FG000|Treatment Period|Lost to Follow-up|21|||
27989512|NCT02828020|81791751|FG001|Treatment Period|Lost to Follow-up|24|||
27579174|NCT04537715|80303125|FG001|Overall Study|Withdrawal by Subject|1|||
27579175|NCT04537715|80303124|FG000|Overall Study|Other|4|||
27579176|NCT04537715|80303125|FG001|Overall Study|Other|3|||
27579177|NCT04537715|80303124|FG000|Overall Study|Progressive disease|1|||
27579178|NCT04537715|80303125|FG001|Overall Study|Progressive disease|0|||
27833099|NCT00807495|81219458|FG004|Overall Study|Adverse Event|2|||
27989513|NCT02828020|81791752|FG002|Treatment Period|Lost to Follow-up|18|||
27989514|NCT02828020|81791750|FG000|Treatment Period|Lack of Qualifying Event|44|||
27989515|NCT02828020|81791751|FG001|Treatment Period|Lack of Qualifying Event|53|||
27989516|NCT02828020|81791752|FG002|Treatment Period|Lack of Qualifying Event|43|||
27989517|NCT02828020|81791750|FG000|Treatment Period|Pregnancy|0|||
27989518|NCT02828020|81791751|FG001|Treatment Period|Pregnancy|2|||
27989519|NCT02828020|81791752|FG002|Treatment Period|Pregnancy|0|||
27989520|NCT02828020|81791750|FG000|Treatment Period|Protocol Violation|2|||
27989521|NCT02828020|81791751|FG001|Treatment Period|Protocol Violation|4|||
27989522|NCT02828020|81791752|FG002|Treatment Period|Protocol Violation|7|||
27989523|NCT02828020|81791750|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
27989524|NCT02828020|81791751|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
27989525|NCT02828020|81791752|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
27989526|NCT02828020|81791750|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
27989527|NCT02828020|81791751|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
27989528|NCT02828020|81791752|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
27989529|NCT02828020|81791750|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
27989530|NCT02828020|81791751|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
27989531|NCT02828020|81791752|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
27989532|NCT02828020|81791750|FG000|Safety Follow-up Period|Protocol Violation|0|||
27989533|NCT02828020|81791751|FG001|Safety Follow-up Period|Protocol Violation|2|||
27989534|NCT02828020|81791752|FG002|Safety Follow-up Period|Protocol Violation|1|||
27989535|NCT02828020|81791750|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
27989536|NCT02828020|81791751|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
27989537|NCT02828020|81791752|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
27989538|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Adverse Event|33|||
27989539|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
27989540|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
27989541|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
27989542|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Physician Decision|6|||
27989543|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
27989544|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
27989545|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
27989546|NCT00965419|81791753|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
27989547|NCT00965419|81791753|FG000|Follow-up Phase|Adverse Event|9|||
27989548|NCT00965419|81791753|FG000|Follow-up Phase|Protocol Violation|4|||
27989549|NCT00965419|81791753|FG000|Follow-up Phase|Withdrawal by Subject|8|||
27989550|NCT00965419|81791753|FG000|Follow-up Phase|Physician Decision|4|||
27989551|NCT00965419|81791753|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
27989552|NCT00965419|81791753|FG000|Follow-up Phase|Lack of Efficacy|28|||
27989553|NCT03182907|81791754|FG000|Overall Study|Death|3|||
27989554|NCT03182907|81791755|FG001|Overall Study|Death|0|||
27989555|NCT03182907|81791754|FG000|Overall Study|Protocol Violation|4|||
27989556|NCT03182907|81791755|FG001|Overall Study|Protocol Violation|0|||
27989557|NCT03182907|81791754|FG000|Overall Study|Lost to Follow-up|1|||
27989558|NCT03182907|81791755|FG001|Overall Study|Lost to Follow-up|0|||
27989559|NCT03182907|81791754|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27989560|NCT03182907|81791755|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27989561|NCT04407234|81791756|FG000|Overall Study|Adverse Event|3|||
27989562|NCT04407234|81791757|FG001|Overall Study|Adverse Event|3|||
27989563|NCT01099397|81791761|FG000|Overall Study|Lost to Follow-up|4|||
27989564|NCT01099397|81791761|FG000|Overall Study|Protocol Violation|4|||
27989565|NCT01099397|81791761|FG000|Overall Study|Withdrawal by Subject|5|||
27989566|NCT00615030|81791763|FG000|Period I|Administrative problem|0|||
27989567|NCT00615030|81791764|FG001|Period I|Administrative problem|0|||
27989568|NCT00615030|81791765|FG002|Period I|Administrative problem|0|||
27989569|NCT00615030|81791766|FG003|Period I|Administrative problem|0|||
27989570|NCT00615030|81791767|FG004|Period I|Administrative problem|1|||
27989571|NCT00615030|81791768|FG005|Period I|Administrative problem|0|||
27989572|NCT00615030|81791769|FG006|Period I|Administrative problem|0|||
27989573|NCT00615030|81791770|FG007|Period I|Administrative problem|0|||
27989574|NCT00615030|81791771|FG008|Period I|Administrative problem|0|||
27989575|NCT00615030|81791772|FG009|Period I|Administrative problem|0|||
27989576|NCT00615030|81791773|FG010|Period I|Administrative problem|0|||
27989577|NCT00615030|81791774|FG011|Period I|Administrative problem|0|||
27989578|NCT00615030|81791763|FG000|Period I|Protocol deviation|1|||
27989579|NCT00615030|81791764|FG001|Period I|Protocol deviation|0|||
27989580|NCT00615030|81791765|FG002|Period I|Protocol deviation|0|||
27989581|NCT00615030|81791766|FG003|Period I|Protocol deviation|0|||
27989582|NCT00615030|81791767|FG004|Period I|Protocol deviation|0|||
27989583|NCT00615030|81791768|FG005|Period I|Protocol deviation|0|||
27989584|NCT00615030|81791769|FG006|Period I|Protocol deviation|0|||
27989585|NCT00615030|81791770|FG007|Period I|Protocol deviation|0|||
27989586|NCT00615030|81791771|FG008|Period I|Protocol deviation|0|||
27989587|NCT00615030|81791772|FG009|Period I|Protocol deviation|0|||
27797708|NCT05004181|81091435|FG009|Overall Study|Withdrawal by Subject|1|||
27797709|NCT05004181|81091436|FG010|Overall Study|Withdrawal by Subject|3|||
27797710|NCT05004181|81091437|FG011|Overall Study|Withdrawal by Subject|2|||
27797711|NCT05004181|81091426|FG000|Overall Study|Protocol Violation|2|||
27797712|NCT05004181|81091427|FG001|Overall Study|Protocol Violation|3|||
27797713|NCT05004181|81091428|FG002|Overall Study|Protocol Violation|0|||
27989588|NCT00615030|81791773|FG010|Period I|Protocol deviation|0|||
27989589|NCT00615030|81791774|FG011|Period I|Protocol deviation|0|||
27989590|NCT00615030|81791763|FG000|Period I|Subject withdrew consent|0|||
27989591|NCT00615030|81791764|FG001|Period I|Subject withdrew consent|0|||
27989592|NCT00615030|81791765|FG002|Period I|Subject withdrew consent|0|||
27989593|NCT00615030|81791766|FG003|Period I|Subject withdrew consent|0|||
27989594|NCT00615030|81791767|FG004|Period I|Subject withdrew consent|0|||
27989595|NCT00615030|81791768|FG005|Period I|Subject withdrew consent|0|||
27989596|NCT00615030|81791769|FG006|Period I|Subject withdrew consent|0|||
27989597|NCT00615030|81791770|FG007|Period I|Subject withdrew consent|0|||
27989598|NCT00615030|81791771|FG008|Period I|Subject withdrew consent|1|||
27989599|NCT00615030|81791772|FG009|Period I|Subject withdrew consent|0|||
27989600|NCT00615030|81791773|FG010|Period I|Subject withdrew consent|1|||
27989601|NCT00615030|81791774|FG011|Period I|Subject withdrew consent|1|||
27989602|NCT00615030|81791763|FG000|Period I|Abnormal laboratory value(s)|0|||
27989603|NCT00615030|81791764|FG001|Period I|Abnormal laboratory value(s)|0|||
27989604|NCT00615030|81791765|FG002|Period I|Abnormal laboratory value(s)|0|||
27989605|NCT00615030|81791766|FG003|Period I|Abnormal laboratory value(s)|0|||
27989606|NCT00615030|81791767|FG004|Period I|Abnormal laboratory value(s)|0|||
27989607|NCT00615030|81791768|FG005|Period I|Abnormal laboratory value(s)|1|||
27989608|NCT00615030|81791769|FG006|Period I|Abnormal laboratory value(s)|0|||
27989609|NCT00615030|81791770|FG007|Period I|Abnormal laboratory value(s)|0|||
27989610|NCT00615030|81791771|FG008|Period I|Abnormal laboratory value(s)|0|||
27989611|NCT00615030|81791772|FG009|Period I|Abnormal laboratory value(s)|0|||
27989612|NCT00615030|81791773|FG010|Period I|Abnormal laboratory value(s)|0|||
27989613|NCT00615030|81791774|FG011|Period I|Abnormal laboratory value(s)|0|||
27989614|NCT00615030|81791763|FG000|Period II|Adverse Event|0|||
27989615|NCT00615030|81791764|FG001|Period II|Adverse Event|0|||
27989616|NCT00615030|81791765|FG002|Period II|Adverse Event|1|||
27989617|NCT00615030|81791766|FG003|Period II|Adverse Event|0|||
27989618|NCT00615030|81791767|FG004|Period II|Adverse Event|0|||
27989619|NCT00615030|81791768|FG005|Period II|Adverse Event|0|||
27989620|NCT00615030|81791769|FG006|Period II|Adverse Event|0|||
27989621|NCT00615030|81791770|FG007|Period II|Adverse Event|0|||
27989622|NCT00615030|81791771|FG008|Period II|Adverse Event|1|||
27989623|NCT00615030|81791772|FG009|Period II|Adverse Event|0|||
27989624|NCT00615030|81791773|FG010|Period II|Adverse Event|0|||
27989625|NCT00615030|81791774|FG011|Period II|Adverse Event|0|||
27989626|NCT00615030|81791763|FG000|Period II|Subject withdrew consent|0|||
27989627|NCT00615030|81791764|FG001|Period II|Subject withdrew consent|0|||
27989628|NCT00615030|81791765|FG002|Period II|Subject withdrew consent|0|||
27989629|NCT00615030|81791766|FG003|Period II|Subject withdrew consent|1|||
27989630|NCT00615030|81791767|FG004|Period II|Subject withdrew consent|0|||
27989631|NCT00615030|81791768|FG005|Period II|Subject withdrew consent|0|||
27989632|NCT00615030|81791769|FG006|Period II|Subject withdrew consent|1|||
27989633|NCT00615030|81791770|FG007|Period II|Subject withdrew consent|0|||
27989634|NCT00615030|81791771|FG008|Period II|Subject withdrew consent|0|||
27989635|NCT00615030|81791772|FG009|Period II|Subject withdrew consent|0|||
27989636|NCT00615030|81791773|FG010|Period II|Subject withdrew consent|0|||
27989637|NCT00615030|81791774|FG011|Period II|Subject withdrew consent|0|||
27989638|NCT00615030|81791763|FG000|Period III|Administrative problems|1|||
27989639|NCT00615030|81791764|FG001|Period III|Administrative problems|0|||
27989640|NCT00615030|81791765|FG002|Period III|Administrative problems|0|||
27989641|NCT00615030|81791766|FG003|Period III|Administrative problems|1|||
27989642|NCT00615030|81791767|FG004|Period III|Administrative problems|0|||
27989643|NCT00615030|81791768|FG005|Period III|Administrative problems|0|||
27989644|NCT00615030|81791769|FG006|Period III|Administrative problems|0|||
27989645|NCT00615030|81791770|FG007|Period III|Administrative problems|0|||
27989646|NCT00615030|81791771|FG008|Period III|Administrative problems|0|||
27989647|NCT00615030|81791772|FG009|Period III|Administrative problems|0|||
27989648|NCT00615030|81791773|FG010|Period III|Administrative problems|0|||
27579179|NCT03433456|80303128|FG000|Overall Study|Death|1|||
27989649|NCT00615030|81791774|FG011|Period III|Administrative problems|0|||
27989650|NCT04369950|81791775|FG000|Overall Study|Protocol Violation|2|||
27579180|NCT03433456|80303129|FG001|Overall Study|Death|1|||
27579181|NCT03433456|80303128|FG000|Overall Study|Lost to Follow-up|14|||
27797714|NCT05004181|81091429|FG003|Overall Study|Protocol Violation|0|||
27989651|NCT04369950|81791776|FG001|Overall Study|Protocol Violation|2|||
27989652|NCT05198843|81791781|FG000|Overall Study|Lack of Efficacy|1|||
27989653|NCT03245398|81791782|FG000|Overall Study|Travelled to another island|1|||
27989654|NCT03245398|81791783|FG001|Overall Study|Travelled to another island|0|||
27989655|NCT02687581|81791784|FG000|Overall Study|Withdrawal by Subject|1|||
27989656|NCT02687581|81791785|FG001|Overall Study|Withdrawal by Subject|0|||
27989657|NCT02687581|81791786|FG002|Overall Study|Withdrawal by Subject|0|||
27989658|NCT02687581|81791787|FG003|Overall Study|Withdrawal by Subject|1|||
27989659|NCT02687581|81791784|FG000|Overall Study|Lost to Follow-up|2|||
27989660|NCT02687581|81791785|FG001|Overall Study|Lost to Follow-up|2|||
27989661|NCT02687581|81791786|FG002|Overall Study|Lost to Follow-up|0|||
27989662|NCT02687581|81791787|FG003|Overall Study|Lost to Follow-up|0|||
27989663|NCT02687581|81791784|FG000|Overall Study|the device is too small for the patient.|1|||
27989664|NCT02687581|81791785|FG001|Overall Study|the device is too small for the patient.|0|||
27989665|NCT02687581|81791786|FG002|Overall Study|the device is too small for the patient.|0|||
27989666|NCT02687581|81791787|FG003|Overall Study|the device is too small for the patient.|0|||
27989667|NCT02513472|81791788|FG000|Overall Study|Radiological Disease Progression|45|||
27989668|NCT02513472|81791789|FG001|Overall Study|Radiological Disease Progression|57|||
27989669|NCT02513472|81791788|FG000|Overall Study|Clinical Disease Progression|5|||
27989670|NCT02513472|81791789|FG001|Overall Study|Clinical Disease Progression|13|||
27989671|NCT02513472|81791788|FG000|Overall Study|Adverse Event|8|||
27989672|NCT02513472|81791789|FG001|Overall Study|Adverse Event|11|||
27989673|NCT02513472|81791788|FG000|Overall Study|Withdrawal by Subject|0|||
27989674|NCT02513472|81791789|FG001|Overall Study|Withdrawal by Subject|4|||
27989675|NCT02513472|81791788|FG000|Overall Study|Subject Choice|2|||
27989676|NCT02513472|81791789|FG001|Overall Study|Subject Choice|7|||
27989677|NCT02513472|81791788|FG000|Overall Study|Treatment Completed as per Protocol|3|||
27989678|NCT02513472|81791789|FG001|Overall Study|Treatment Completed as per Protocol|3|||
27989679|NCT02513472|81791788|FG000|Overall Study|Other|3|||
27989680|NCT02513472|81791789|FG001|Overall Study|Other|6|||
27989681|NCT00483938|81791792|FG000|Overall Study|Protocol Violation|0|||
27989682|NCT00483938|81791793|FG001|Overall Study|Protocol Violation|0|||
27989683|NCT00483938|81791794|FG002|Overall Study|Protocol Violation|0|||
27989684|NCT00483938|81791795|FG003|Overall Study|Protocol Violation|0|||
27989685|NCT00483938|81791796|FG004|Overall Study|Protocol Violation|0|||
27989686|NCT00483938|81791797|FG005|Overall Study|Protocol Violation|0|||
27989687|NCT00483938|81791798|FG006|Overall Study|Protocol Violation|3|||
27989688|NCT00483938|81791792|FG000|Overall Study|Withdrawal by Subject|1|||
27989689|NCT00483938|81791793|FG001|Overall Study|Withdrawal by Subject|6|||
27989690|NCT00483938|81791794|FG002|Overall Study|Withdrawal by Subject|0|||
27989691|NCT00483938|81791795|FG003|Overall Study|Withdrawal by Subject|0|||
27989692|NCT00483938|81791796|FG004|Overall Study|Withdrawal by Subject|1|||
27989693|NCT00483938|81791797|FG005|Overall Study|Withdrawal by Subject|3|||
27989694|NCT00483938|81791798|FG006|Overall Study|Withdrawal by Subject|2|||
27989695|NCT00483938|81791792|FG000|Overall Study|Lost to Follow-up|1|||
27989696|NCT00483938|81791793|FG001|Overall Study|Lost to Follow-up|2|||
27989697|NCT00483938|81791794|FG002|Overall Study|Lost to Follow-up|0|||
27989698|NCT00483938|81791795|FG003|Overall Study|Lost to Follow-up|2|||
27989699|NCT00483938|81791796|FG004|Overall Study|Lost to Follow-up|1|||
27989700|NCT00483938|81791797|FG005|Overall Study|Lost to Follow-up|1|||
27989701|NCT00483938|81791798|FG006|Overall Study|Lost to Follow-up|3|||
27989702|NCT00483938|81791792|FG000|Overall Study|Death|0|||
27989703|NCT00483938|81791793|FG001|Overall Study|Death|2|||
27989704|NCT00483938|81791794|FG002|Overall Study|Death|0|||
27989705|NCT00483938|81791795|FG003|Overall Study|Death|0|||
27989706|NCT00483938|81791796|FG004|Overall Study|Death|0|||
27989707|NCT00483938|81791797|FG005|Overall Study|Death|0|||
27989708|NCT00483938|81791798|FG006|Overall Study|Death|0|||
27989709|NCT00483938|81791792|FG000|Overall Study|Other|3|||
27989710|NCT00483938|81791793|FG001|Overall Study|Other|9|||
27989711|NCT00483938|81791794|FG002|Overall Study|Other|0|||
27579182|NCT03433456|80303129|FG001|Overall Study|Lost to Follow-up|11|||
27989712|NCT00483938|81791795|FG003|Overall Study|Other|4|||
27989713|NCT00483938|81791796|FG004|Overall Study|Other|0|||
27989714|NCT00483938|81791797|FG005|Overall Study|Other|4|||
27989715|NCT00483938|81791798|FG006|Overall Study|Other|32|||
27989716|NCT02487030|81791799|FG000|Overall Study|Lack of Efficacy|2|||
27989717|NCT02487030|81791800|FG001|Overall Study|Lack of Efficacy|4|||
27675503|NCT04210843|80650153|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
27675504|NCT04210843|80650152|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
27675505|NCT04210843|80650153|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
27675506|NCT04210843|80650152|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
27675507|NCT04210843|80650153|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
27675508|NCT04210843|80650152|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
27675509|NCT04210843|80650153|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
27675510|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
27675511|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
27675512|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
27675513|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
27675514|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
27675515|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
27675516|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
27675517|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
27675518|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
27675519|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
27675520|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
27675521|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
27675522|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
27675523|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
27675524|NCT04210843|80650152|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
27675525|NCT04210843|80650153|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
27675526|NCT01736540|80650154|FG000|Overall Study|Did not complete scan within 45 days|2|||
27675527|NCT01736540|80650154|FG000|Overall Study|Death|1|||
27675528|NCT01736540|80650154|FG000|Overall Study|Abnormal test procedure|1|||
27675529|NCT01736540|80650154|FG000|Overall Study|Withdrawal by Subject|5|||
27675530|NCT01736540|80650154|FG000|Overall Study|Protocol Violation|1|||
27675531|NCT01736540|80650154|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
27675532|NCT01736540|80650154|FG000|Overall Study|No show for MRI appointment|1|||
27675533|NCT01736540|80650154|FG000|Overall Study|Unable to make MRI appointment|3|||
27675534|NCT01053247|80650155|FG000|Overall Study|Withdrawal by Subject|9|||
27675535|NCT01053247|80650156|FG001|Overall Study|Withdrawal by Subject|4|||
27675536|NCT01053247|80650157|FG002|Overall Study|Withdrawal by Subject|15|||
27675537|NCT01053247|80650155|FG000|Overall Study|Lack of Efficacy|1|||
27675538|NCT01053247|80650156|FG001|Overall Study|Lack of Efficacy|0|||
27675539|NCT01053247|80650157|FG002|Overall Study|Lack of Efficacy|1|||
27675540|NCT01053247|80650155|FG000|Overall Study|Protocol Violation|2|||
27675541|NCT01053247|80650156|FG001|Overall Study|Protocol Violation|1|||
27675542|NCT01053247|80650157|FG002|Overall Study|Protocol Violation|2|||
27675543|NCT01053247|80650155|FG000|Overall Study|Lost to Follow-up|8|||
27675544|NCT01053247|80650156|FG001|Overall Study|Lost to Follow-up|5|||
27675545|NCT01053247|80650157|FG002|Overall Study|Lost to Follow-up|7|||
27675546|NCT01053247|80650155|FG000|Overall Study|Adverse Event|0|||
27675547|NCT01053247|80650156|FG001|Overall Study|Adverse Event|9|||
27675548|NCT01053247|80650157|FG002|Overall Study|Adverse Event|3|||
27675549|NCT02229578|80650158|FG000|Overall Study|Withdrawal by Subject|1|||
27675550|NCT02229578|80650159|FG001|Overall Study|Withdrawal by Subject|3|||
27675551|NCT02229578|80650158|FG000|Overall Study|Protocol Violation|2|||
27675552|NCT02229578|80650159|FG001|Overall Study|Protocol Violation|0|||
27675553|NCT02878603|80650160|FG000|Overall Study|Lost to Follow-up|4|||
27675554|NCT02878603|80650161|FG001|Overall Study|Lost to Follow-up|1|||
27675555|NCT02878603|80650160|FG000|Overall Study|Withdrawal by Subject|1|||
27675556|NCT02878603|80650161|FG001|Overall Study|Withdrawal by Subject|1|||
27675557|NCT02878603|80650160|FG000|Overall Study|Death|1|||
27675558|NCT02878603|80650161|FG001|Overall Study|Death|0|||
27675559|NCT02878603|80650160|FG000|Overall Study|Physician Decision|0|||
27675560|NCT02878603|80650161|FG001|Overall Study|Physician Decision|3|||
27675561|NCT00193479|80650162|FG000|Induction Chemotherapy|Adverse Event|2|||
27675562|NCT00193479|80650162|FG000|Induction Chemotherapy|Disease Progression|1|||
27675563|NCT00193479|80650162|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
27675564|NCT00193479|80650162|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
27675565|NCT00658606|80650163|FG000|Overall Study|Adverse Event|2|||
27675566|NCT00658606|80650164|FG001|Overall Study|Adverse Event|1|||
27675567|NCT00658606|80650163|FG000|Overall Study|Lack of Efficacy|6|||
27675568|NCT00658606|80650164|FG001|Overall Study|Lack of Efficacy|3|||
27675569|NCT00658606|80650163|FG000|Overall Study|Lost to Follow-up|1|||
27675570|NCT00658606|80650164|FG001|Overall Study|Lost to Follow-up|0|||
27675571|NCT00658606|80650163|FG000|Overall Study|Withdrawal by Subject|7|||
27870402|NCT01288079|81361461|FG000|Overall Study|Withdrawal by Subject|2|||
27870403|NCT01288079|81361462|FG001|Overall Study|Withdrawal by Subject|4|||
27797715|NCT05004181|81091430|FG004|Overall Study|Protocol Violation|1|||
27797716|NCT05004181|81091431|FG005|Overall Study|Protocol Violation|0|||
27797717|NCT05004181|81091432|FG006|Overall Study|Protocol Violation|16|||
27797718|NCT05004181|81091433|FG007|Overall Study|Protocol Violation|18|||
27797719|NCT05004181|81091434|FG008|Overall Study|Protocol Violation|2|||
27797720|NCT05004181|81091435|FG009|Overall Study|Protocol Violation|2|||
27797721|NCT05004181|81091436|FG010|Overall Study|Protocol Violation|2|||
27797722|NCT05004181|81091437|FG011|Overall Study|Protocol Violation|1|||
27797723|NCT05004181|81091426|FG000|Overall Study|Not further specified|1|||
27797724|NCT05004181|81091427|FG001|Overall Study|Not further specified|0|||
27797725|NCT05004181|81091428|FG002|Overall Study|Not further specified|0|||
27797726|NCT05004181|81091429|FG003|Overall Study|Not further specified|0|||
27797727|NCT05004181|81091430|FG004|Overall Study|Not further specified|0|||
27797728|NCT05004181|81091431|FG005|Overall Study|Not further specified|0|||
27797729|NCT05004181|81091432|FG006|Overall Study|Not further specified|1|||
27797730|NCT05004181|81091433|FG007|Overall Study|Not further specified|0|||
27797731|NCT05004181|81091434|FG008|Overall Study|Not further specified|2|||
27797732|NCT05004181|81091435|FG009|Overall Study|Not further specified|1|||
27797733|NCT05004181|81091436|FG010|Overall Study|Not further specified|0|||
27797734|NCT05004181|81091437|FG011|Overall Study|Not further specified|1|||
27797735|NCT04736576|81091439|FG000|Overall Study|Progressive disease|3|||
27797736|NCT04736576|81091440|FG001|Overall Study|Progressive disease|1|||
27797737|NCT04736576|81091439|FG000|Overall Study|Death|1|||
27797738|NCT04736576|81091440|FG001|Overall Study|Death|0|||
27797739|NCT05981365|81091452|FG000|Period 1|Adverse Event|1|||
27797740|NCT05981365|81091453|FG001|Period 1|Adverse Event|0|||
27797741|NCT04732728|81091454|FG000|Overall Study|Death|12|||
27797742|NCT04732728|81091454|FG000|Overall Study|Withdrawn|136|||
27797743|NCT04647253|81091456|FG000|Overall Study|Death ≤ 365 Days|16|||
27797744|NCT04647253|81091457|FG001|Overall Study|Death ≤ 365 Days|7|||
27797745|NCT04647253|81091456|FG000|Overall Study|Physician Decision|0|||
27797746|NCT04647253|81091457|FG001|Overall Study|Physician Decision|1|||
27797747|NCT04647253|81091456|FG000|Overall Study|Withdrawal by Subject|7|||
27797748|NCT04647253|81091457|FG001|Overall Study|Withdrawal by Subject|2|||
27797749|NCT04647253|81091456|FG000|Overall Study|Missed 12-Month Visit|9|||
27797750|NCT04647253|81091457|FG001|Overall Study|Missed 12-Month Visit|7|||
27797751|NCT04647253|81091456|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
27797752|NCT04647253|81091457|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
27797753|NCT05788237|81091458|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
27797754|NCT05788237|81091459|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
27797755|NCT05788237|81091460|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
27797756|NCT05788237|81091461|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
27797757|NCT05788237|81091458|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
27797758|NCT05788237|81091459|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
27797759|NCT05788237|81091460|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
27797760|NCT05788237|81091461|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
27797761|NCT05788237|81091458|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
27797762|NCT05788237|81091459|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
27797763|NCT05788237|81091460|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
27797764|NCT05788237|81091461|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
27797765|NCT05788237|81091458|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
27797766|NCT05788237|81091459|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
27797767|NCT05788237|81091460|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
27797768|NCT05788237|81091461|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
27797769|NCT05788237|81091458|FG000|SSA (Approximately 2 Months)|Death|0|||
27797770|NCT05788237|81091459|FG001|SSA (Approximately 2 Months)|Death|1|||
27797771|NCT05788237|81091460|FG002|SSA (Approximately 2 Months)|Death|0|||
27797772|NCT05788237|81091461|FG003|SSA (Approximately 2 Months)|Death|0|||
27797773|NCT05788237|81091458|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
27797774|NCT05788237|81091459|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
27797775|NCT05788237|81091460|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
27797776|NCT05788237|81091461|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
27797777|NCT05788237|81091458|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
27797778|NCT05788237|81091459|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
27797779|NCT05788237|81091460|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
27797780|NCT05788237|81091461|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
27797781|NCT05788237|81091458|FG000|SSB (Approximately 1 Month)|Other|0|||
27797782|NCT05788237|81091459|FG001|SSB (Approximately 1 Month)|Other|0|||
27870404|NCT01288079|81361463|FG002|Overall Study|Withdrawal by Subject|1|||
27870405|NCT01288079|81361464|FG003|Overall Study|Withdrawal by Subject|0|||
27675572|NCT00658606|80650164|FG001|Overall Study|Withdrawal by Subject|16|||
27675573|NCT00658606|80650163|FG000|Overall Study|Lack of Compliance|0|||
27675574|NCT00658606|80650164|FG001|Overall Study|Lack of Compliance|3|||
27675575|NCT00725712|80650165|FG000|Overall Study|Withdrawal by Subject|2|||
27675576|NCT00725712|80650166|FG001|Overall Study|Withdrawal by Subject|1|||
27675577|NCT00725712|80650165|FG000|Overall Study|Protocol Violation|1|||
27675578|NCT00725712|80650166|FG001|Overall Study|Protocol Violation|0|||
27675579|NCT00725712|80650165|FG000|Overall Study|Progressive disease|37|||
27675580|NCT00725712|80650166|FG001|Overall Study|Progressive disease|16|||
27675581|NCT00725712|80650165|FG000|Overall Study|Clinical progression not based on RECIST|0|||
27675582|NCT00725712|80650166|FG001|Overall Study|Clinical progression not based on RECIST|3|||
27675583|NCT00725712|80650165|FG000|Overall Study|Adverse Event|5|||
27675584|NCT00725712|80650166|FG001|Overall Study|Adverse Event|5|||
27675585|NCT00725712|80650165|FG000|Overall Study|Death|2|||
27675586|NCT00725712|80650166|FG001|Overall Study|Death|0|||
27675587|NCT00725712|80650165|FG000|Overall Study|Other: Death|1|||
27675588|NCT00725712|80650166|FG001|Overall Study|Other: Death|0|||
27675589|NCT00725712|80650165|FG000|Overall Study|Hospitalized, unable to continue|0|||
27675590|NCT00725712|80650166|FG001|Overall Study|Hospitalized, unable to continue|1|||
27675591|NCT02242643|80650170|FG000|Overall Study|Protocol Violation|1|||
27675592|NCT02242643|80650171|FG001|Overall Study|Protocol Violation|2|||
27675593|NCT02242643|80650170|FG000|Overall Study|Withdrawal by Subject|15|||
27675594|NCT02242643|80650171|FG001|Overall Study|Withdrawal by Subject|10|||
27675595|NCT02242643|80650170|FG000|Overall Study|Migrated/moved from study area|1|||
27675596|NCT02242643|80650171|FG001|Overall Study|Migrated/moved from study area|3|||
27675597|NCT02242643|80650170|FG000|Overall Study|Lost to Follow-up|54|||
27675598|NCT02242643|80650171|FG001|Overall Study|Lost to Follow-up|61|||
27675599|NCT02242643|80650170|FG000|Overall Study|Child placed in foster care by family|0|||
27675600|NCT02242643|80650171|FG001|Overall Study|Child placed in foster care by family|1|||
27675601|NCT02242643|80650170|FG000|Overall Study|Non-compliance|1|||
27675602|NCT02242643|80650171|FG001|Overall Study|Non-compliance|0|||
27675603|NCT02242643|80650170|FG000|Overall Study|Consent withdrawal by parent|1|||
27675604|NCT02242643|80650171|FG001|Overall Study|Consent withdrawal by parent|0|||
27675605|NCT02242643|80650170|FG000|Overall Study|Protocol requirements not followed|1|||
27675606|NCT02242643|80650171|FG001|Overall Study|Protocol requirements not followed|0|||
27675607|NCT02242643|80650170|FG000|Overall Study|Language barrier|1|||
27675608|NCT02242643|80650171|FG001|Overall Study|Language barrier|0|||
27675609|NCT02242643|80650170|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
27675610|NCT02242643|80650171|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
27675611|NCT01907906|80650172|FG000|Overall Study|Withdrawal by Subject|1|||
27675612|NCT01907906|80650173|FG001|Overall Study|Withdrawal by Subject|0|||
27675613|NCT01907906|80650172|FG000|Overall Study|Physician Decision|3|||
27797783|NCT05788237|81091460|FG002|SSB (Approximately 1 Month)|Other|0|||
27797784|NCT05788237|81091461|FG003|SSB (Approximately 1 Month)|Other|1|||
27797785|NCT05458895|81091462|FG000|Overall Study|Withdrawal by Subject|8|||
27797786|NCT05458895|81091462|FG000|Overall Study|Lost to Follow-up|17|||
27797787|NCT05458895|81091462|FG000|Overall Study|Pregnancy|2|||
27797788|NCT05458895|81091462|FG000|Overall Study|Withdrawal by Study Team|1|||
27797789|NCT04317053|81091463|FG000|Overall Study|Withdrawn (screen failure)|4|||
27675614|NCT01907906|80650173|FG001|Overall Study|Physician Decision|1|||
27675615|NCT00694109|80650176|FG000|Overall Study|Physician Decision|3|||
27675616|NCT00694109|80650176|FG000|Overall Study|Adverse Event|74|||
27675617|NCT00694109|80650176|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
27675618|NCT00694109|80650176|FG000|Overall Study|Lack of Efficacy|2|||
27675619|NCT00694109|80650176|FG000|Overall Study|Withdrawal by Subject|13|||
27675620|NCT00694109|80650176|FG000|Overall Study|Pregnancy|1|||
27675621|NCT00694109|80650176|FG000|Overall Study|Enrolled but not treated|1|||
27675622|NCT00694109|80650176|FG000|Overall Study|Other|2|||
27675623|NCT00694109|80650176|FG000|Overall Study|Consented but no additional treatment|3|||
27675624|NCT00983749|80650177|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
27675625|NCT00983749|80650178|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
27675626|NCT02417441|80650180|FG000|Overall Study|Inconclusive due to missing data|52|||
27675627|NCT02417441|80650181|FG001|Overall Study|Inconclusive due to missing data|19|||
27675628|NCT01174446|80650182|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
27675629|NCT01174446|80650183|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
27675630|NCT01174446|80650184|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
27675631|NCT01174446|80650185|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
27675632|NCT01174446|80650182|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
27675633|NCT01174446|80650183|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
27675634|NCT01174446|80650184|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
27675635|NCT01174446|80650185|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
27870406|NCT01288079|81361461|FG000|Overall Study|Adverse Event|2|||
27675636|NCT01174446|80650182|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
27675637|NCT01174446|80650183|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
27675638|NCT01174446|80650184|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
27797790|NCT04317053|81091464|FG001|Overall Study|Withdrawn (screen failure)|2|||
27797791|NCT04136626|81091465|FG000|Treatment Phase|Withdrawal by Subject|1|||
27797792|NCT04136626|81091466|FG001|Treatment Phase|Withdrawal by Subject|9|||
27797793|NCT04136626|81091465|FG000|Treatment Phase|Adverse Event|1|||
27797794|NCT04136626|81091466|FG001|Treatment Phase|Adverse Event|0|||
27797795|NCT04136626|81091465|FG000|Treatment Phase|Lost to Follow-up|1|||
27797796|NCT04136626|81091466|FG001|Treatment Phase|Lost to Follow-up|5|||
27797797|NCT04136626|81091465|FG000|12-month Follow-up|Lost to Follow-up|8|||
27797798|NCT04136626|81091466|FG001|12-month Follow-up|Lost to Follow-up|7|||
27797799|NCT00628745|81091467|FG000|Overall Study|Withdrawal by Subject|63|||
27797800|NCT00628745|81091468|FG001|Overall Study|Withdrawal by Subject|3|||
27797801|NCT00628745|81091469|FG002|Overall Study|Withdrawal by Subject|9|||
27797802|NCT00628745|81091470|FG003|Overall Study|Withdrawal by Subject|2|||
27797803|NCT00628745|81091471|FG004|Overall Study|Withdrawal by Subject|69|||
27675639|NCT01174446|80650185|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
27675640|NCT01174446|80650182|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
27797804|NCT00628745|81091467|FG000|Overall Study|Does not meet inclusion criteria|0|||
27797805|NCT00628745|81091468|FG001|Overall Study|Does not meet inclusion criteria|12|||
27989718|NCT02487030|81791801|FG002|Overall Study|Lack of Efficacy|1|||
27989719|NCT02487030|81791802|FG003|Overall Study|Lack of Efficacy|0|||
27989720|NCT02487030|81791803|FG004|Overall Study|Lack of Efficacy|1|||
27989721|NCT02487030|81791804|FG005|Overall Study|Lack of Efficacy|0|||
27989722|NCT02487030|81791805|FG006|Overall Study|Lack of Efficacy|0|||
27989723|NCT02487030|81791799|FG000|Overall Study|Lost to Follow-up|0|||
27989724|NCT02487030|81791800|FG001|Overall Study|Lost to Follow-up|0|||
27989725|NCT02487030|81791801|FG002|Overall Study|Lost to Follow-up|1|||
27989726|NCT02487030|81791802|FG003|Overall Study|Lost to Follow-up|1|||
27989727|NCT02487030|81791803|FG004|Overall Study|Lost to Follow-up|0|||
27989728|NCT02487030|81791804|FG005|Overall Study|Lost to Follow-up|1|||
27797806|NCT00628745|81091469|FG002|Overall Study|Does not meet inclusion criteria|0|||
27797807|NCT00628745|81091470|FG003|Overall Study|Does not meet inclusion criteria|0|||
27797808|NCT00628745|81091471|FG004|Overall Study|Does not meet inclusion criteria|18|||
27797809|NCT00628745|81091467|FG000|Overall Study|Participation in an interventional clinical trial|81|||
27797810|NCT00628745|81091468|FG001|Overall Study|Participation in an interventional clinical trial|4|||
27797811|NCT00628745|81091469|FG002|Overall Study|Participation in an interventional clinical trial|7|||
27797812|NCT00628745|81091470|FG003|Overall Study|Participation in an interventional clinical trial|0|||
27797813|NCT00628745|81091471|FG004|Overall Study|Participation in an interventional clinical trial|63|||
27797814|NCT00628745|81091467|FG000|Overall Study|Physician Decision|8|||
27797815|NCT00628745|81091468|FG001|Overall Study|Physician Decision|4|||
27797816|NCT00628745|81091469|FG002|Overall Study|Physician Decision|3|||
27797817|NCT00628745|81091470|FG003|Overall Study|Physician Decision|0|||
27797818|NCT00628745|81091471|FG004|Overall Study|Physician Decision|30|||
27797819|NCT00628745|81091467|FG000|Overall Study|Lost to Follow-up|109|||
27579183|NCT03433456|80303128|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
27579184|NCT03433456|80303129|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
27797820|NCT00628745|81091468|FG001|Overall Study|Lost to Follow-up|7|||
27870407|NCT01288079|81361462|FG001|Overall Study|Adverse Event|1|||
27870408|NCT01288079|81361463|FG002|Overall Study|Adverse Event|2|||
27870409|NCT01288079|81361464|FG003|Overall Study|Adverse Event|3|||
27870410|NCT01288079|81361461|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
27989729|NCT02487030|81791805|FG006|Overall Study|Lost to Follow-up|0|||
27870411|NCT01288079|81361462|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
27870412|NCT01288079|81361463|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
27870413|NCT01288079|81361464|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
27870414|NCT01288079|81361461|FG000|Overall Study|Condition under Investigation Worsened|0|||
27989730|NCT02487030|81791799|FG000|Overall Study|Adverse Event|0|||
27989731|NCT02487030|81791800|FG001|Overall Study|Adverse Event|0|||
27579185|NCT01208233|80303130|FG000|Overall Study|Adverse Event|0|||
27989732|NCT02487030|81791801|FG002|Overall Study|Adverse Event|0|||
27797821|NCT00628745|81091469|FG002|Overall Study|Lost to Follow-up|7|||
27797822|NCT00628745|81091470|FG003|Overall Study|Lost to Follow-up|0|||
27797823|NCT00628745|81091471|FG004|Overall Study|Lost to Follow-up|498|||
27797824|NCT00628745|81091467|FG000|Overall Study|Death|197|||
27989733|NCT02487030|81791802|FG003|Overall Study|Adverse Event|1|||
27989734|NCT02487030|81791803|FG004|Overall Study|Adverse Event|0|||
27989735|NCT02487030|81791804|FG005|Overall Study|Adverse Event|0|||
27989736|NCT02487030|81791805|FG006|Overall Study|Adverse Event|0|||
27989737|NCT02487030|81791799|FG000|Overall Study|Death|0|||
27989738|NCT02487030|81791800|FG001|Overall Study|Death|0|||
27989739|NCT02487030|81791801|FG002|Overall Study|Death|0|||
27989740|NCT02487030|81791802|FG003|Overall Study|Death|0|||
27989741|NCT02487030|81791803|FG004|Overall Study|Death|1|||
27989742|NCT02487030|81791804|FG005|Overall Study|Death|0|||
27989743|NCT02487030|81791805|FG006|Overall Study|Death|0|||
27989744|NCT00828750|81791806|FG000|Overall Study|Lack of Efficacy|3|||
27989745|NCT00828750|81791806|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
27989746|NCT00408434|81791807|FG000|Overall Study|Adverse Event|0|||
27989747|NCT00408434|81791808|FG001|Overall Study|Adverse Event|0|||
27989748|NCT00408434|81791809|FG002|Overall Study|Adverse Event|1|||
27797825|NCT00628745|81091468|FG001|Overall Study|Death|81|||
27797826|NCT00628745|81091469|FG002|Overall Study|Death|12|||
27797827|NCT00628745|81091470|FG003|Overall Study|Death|4|||
27797828|NCT00628745|81091471|FG004|Overall Study|Death|939|||
27797829|NCT00628745|81091467|FG000|Overall Study|Participant transferred to another THAOS site|6|||
27797830|NCT00628745|81091468|FG001|Overall Study|Participant transferred to another THAOS site|0|||
27797831|NCT00628745|81091469|FG002|Overall Study|Participant transferred to another THAOS site|0|||
27989749|NCT00408434|81791810|FG003|Overall Study|Adverse Event|0|||
27989750|NCT00408434|81791811|FG004|Overall Study|Adverse Event|0|||
27989751|NCT00408434|81791812|FG005|Overall Study|Adverse Event|0|||
27989752|NCT00408434|81791813|FG006|Overall Study|Adverse Event|0|||
27989753|NCT00408434|81791807|FG000|Overall Study|Progressive disease|6|||
27675641|NCT01174446|80650183|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
27989754|NCT00408434|81791808|FG001|Overall Study|Progressive disease|3|||
27797832|NCT00628745|81091470|FG003|Overall Study|Participant transferred to another THAOS site|0|||
27797833|NCT00628745|81091471|FG004|Overall Study|Participant transferred to another THAOS site|7|||
27989755|NCT00408434|81791809|FG002|Overall Study|Progressive disease|4|||
27989756|NCT00408434|81791810|FG003|Overall Study|Progressive disease|3|||
27989757|NCT00408434|81791811|FG004|Overall Study|Progressive disease|3|||
27989758|NCT00408434|81791812|FG005|Overall Study|Progressive disease|1|||
27989759|NCT00408434|81791813|FG006|Overall Study|Progressive disease|4|||
27989760|NCT00408434|81791807|FG000|Overall Study|Other|0|||
27989761|NCT00408434|81791808|FG001|Overall Study|Other|0|||
27989762|NCT00408434|81791809|FG002|Overall Study|Other|1|||
27989763|NCT00408434|81791810|FG003|Overall Study|Other|0|||
27989764|NCT00408434|81791811|FG004|Overall Study|Other|2|||
27989765|NCT00408434|81791812|FG005|Overall Study|Other|1|||
27989766|NCT00408434|81791813|FG006|Overall Study|Other|0|||
27989767|NCT00408434|81791807|FG000|Overall Study|Terminated by Investigator|0|||
27989768|NCT00408434|81791808|FG001|Overall Study|Terminated by Investigator|0|||
27989769|NCT00408434|81791809|FG002|Overall Study|Terminated by Investigator|0|||
27989770|NCT00408434|81791810|FG003|Overall Study|Terminated by Investigator|0|||
27989771|NCT00408434|81791811|FG004|Overall Study|Terminated by Investigator|1|||
27989772|NCT00408434|81791812|FG005|Overall Study|Terminated by Investigator|1|||
27989773|NCT00408434|81791813|FG006|Overall Study|Terminated by Investigator|0|||
27989774|NCT04384523|81791814|FG000|Overall Study|Lost to Follow-up|0|||
27989775|NCT04384523|81791815|FG001|Overall Study|Lost to Follow-up|0|||
27989776|NCT04384523|81791816|FG002|Overall Study|Lost to Follow-up|0|||
27989777|NCT04384523|81791817|FG003|Overall Study|Lost to Follow-up|0|||
27989778|NCT04384523|81791818|FG004|Overall Study|Lost to Follow-up|0|||
27989779|NCT04384523|81791819|FG005|Overall Study|Lost to Follow-up|1|||
27989780|NCT04384523|81791814|FG000|Overall Study|Protocol Violation|0|||
27989781|NCT04384523|81791815|FG001|Overall Study|Protocol Violation|1|||
27989782|NCT04384523|81791816|FG002|Overall Study|Protocol Violation|0|||
27989783|NCT04384523|81791817|FG003|Overall Study|Protocol Violation|0|||
27989784|NCT04384523|81791818|FG004|Overall Study|Protocol Violation|0|||
27989785|NCT04384523|81791819|FG005|Overall Study|Protocol Violation|0|||
27989786|NCT04384523|81791814|FG000|Overall Study|Withdrawal by Subject|1|||
27989787|NCT04384523|81791815|FG001|Overall Study|Withdrawal by Subject|0|||
27989788|NCT04384523|81791816|FG002|Overall Study|Withdrawal by Subject|0|||
27989789|NCT04384523|81791817|FG003|Overall Study|Withdrawal by Subject|0|||
27989790|NCT04384523|81791818|FG004|Overall Study|Withdrawal by Subject|0|||
27989791|NCT04384523|81791819|FG005|Overall Study|Withdrawal by Subject|0|||
27989792|NCT01853878|81791820|FG000|Overall Study|Recurrence|2|||
27989793|NCT01853878|81791821|FG001|Overall Study|Recurrence|0|||
27989794|NCT01853878|81791820|FG000|Overall Study|Adverse Event|2|||
27797834|NCT00628745|81091467|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
27797835|NCT00628745|81091468|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
27797836|NCT00628745|81091469|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
27797837|NCT00628745|81091470|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
27797838|NCT00628745|81091471|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
27797839|NCT00628745|81091467|FG000|Overall Study|Site closure|152|||
27797840|NCT00628745|81091468|FG001|Overall Study|Site closure|146|||
27797841|NCT00628745|81091469|FG002|Overall Study|Site closure|6|||
27797842|NCT00628745|81091470|FG003|Overall Study|Site closure|8|||
27797843|NCT00628745|81091471|FG004|Overall Study|Site closure|691|||
27797844|NCT00628745|81091467|FG000|Overall Study|Duplicate participant|0|||
27797845|NCT00628745|81091468|FG001|Overall Study|Duplicate participant|0|||
27797846|NCT00628745|81091469|FG002|Overall Study|Duplicate participant|0|||
27870415|NCT01288079|81361462|FG001|Overall Study|Condition under Investigation Worsened|0|||
27989795|NCT01853878|81791821|FG001|Overall Study|Adverse Event|0|||
27989796|NCT01853878|81791820|FG000|Overall Study|Withdrawal by Subject|3|||
27989797|NCT01853878|81791821|FG001|Overall Study|Withdrawal by Subject|1|||
27989798|NCT01853878|81791820|FG000|Overall Study|Migrated/moved from the study area|1|||
27989799|NCT01853878|81791821|FG001|Overall Study|Migrated/moved from the study area|0|||
27989800|NCT01853878|81791820|FG000|Overall Study|Other|55|||
27989801|NCT01853878|81791821|FG001|Overall Study|Other|43|||
27989802|NCT02673684|81791822|FG000|Overall Study|Study not completed d/t loss of funding|9|||
27989803|NCT02673684|81791823|FG001|Overall Study|Study not completed d/t loss of funding|8|||
27989804|NCT04078152|81791826|FG000|Overall Study|Other|83|||
27797847|NCT00628745|81091470|FG003|Overall Study|Duplicate participant|0|||
27797848|NCT00628745|81091471|FG004|Overall Study|Duplicate participant|1|||
27675642|NCT01174446|80650184|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
27675643|NCT01174446|80650185|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
27989805|NCT04078152|81791827|FG001|Overall Study|Other|22|||
27989806|NCT04078152|81791828|FG002|Overall Study|Other|25|||
27989807|NCT04078152|81791826|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
27989808|NCT04078152|81791827|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
27989809|NCT04078152|81791828|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
27989810|NCT04078152|81791826|FG000|Overall Study|Withdrawal by Subject|5|||
27989811|NCT04078152|81791827|FG001|Overall Study|Withdrawal by Subject|0|||
27989812|NCT04078152|81791828|FG002|Overall Study|Withdrawal by Subject|1|||
27989813|NCT04078152|81791826|FG000|Overall Study|Death|10|||
27989814|NCT04078152|81791827|FG001|Overall Study|Death|2|||
27989815|NCT04078152|81791828|FG002|Overall Study|Death|12|||
27989816|NCT04078152|81791826|FG000|Overall Study|Adverse Event|1|||
27989817|NCT04078152|81791827|FG001|Overall Study|Adverse Event|0|||
27989818|NCT04078152|81791828|FG002|Overall Study|Adverse Event|0|||
27989819|NCT02697435|81794658|FG000|Overall Study|Withdrawal by Subject|1|||
27989820|NCT02697435|81794659|FG001|Overall Study|Withdrawal by Subject|0|||
27989821|NCT02697435|81794658|FG000|Overall Study|Physician Decision|0|||
27870416|NCT01288079|81361463|FG002|Overall Study|Condition under Investigation Worsened|0|||
27870417|NCT01288079|81361464|FG003|Overall Study|Condition under Investigation Worsened|1|||
27870418|NCT01288079|81361461|FG000|Overall Study|Lack of Efficacy|2|||
27870419|NCT01288079|81361462|FG001|Overall Study|Lack of Efficacy|2|||
27675644|NCT02353468|80650186|FG000|Overall Study|Study terminated|3|||
27675645|NCT04887506|80650187|FG000|Overall Study|Death|1|||
27675646|NCT04887506|80650188|FG001|Overall Study|Death|1|||
27675647|NCT04887506|80650187|FG000|Overall Study|Withdrawal by Subject|0|||
27675648|NCT04887506|80650188|FG001|Overall Study|Withdrawal by Subject|3|||
27675649|NCT04887506|80650187|FG000|Overall Study|Adverse Event|4|||
27870420|NCT01288079|81361463|FG002|Overall Study|Lack of Efficacy|0|||
27870421|NCT01288079|81361464|FG003|Overall Study|Lack of Efficacy|2|||
27870422|NCT01288079|81361461|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
27989822|NCT02697435|81794659|FG001|Overall Study|Physician Decision|4|||
27989823|NCT00764673|81794662|FG000|Overall Study|Death|1|||
27989824|NCT00764673|81794662|FG000|Overall Study|Lost to Follow-up|3|||
27989825|NCT00764673|81794662|FG000|Overall Study|Withdrawal by Subject|6|||
27989826|NCT00764673|81794662|FG000|Overall Study|Revision of Device|2|||
27989827|NCT01793883|81794669|FG000|Overall Study|Withdrawal by Subject|3|||
27989828|NCT01793883|81794670|FG001|Overall Study|Withdrawal by Subject|7|||
27989829|NCT01793883|81794671|FG002|Overall Study|Withdrawal by Subject|3|||
27989830|NCT01793883|81794669|FG000|Overall Study|Subject noncompliance|0|||
27989831|NCT01793883|81794670|FG001|Overall Study|Subject noncompliance|1|||
27675650|NCT04887506|80650188|FG001|Overall Study|Adverse Event|3|||
27675651|NCT04887506|80650187|FG000|Overall Study|Other - Not Reported|1|||
27675652|NCT04887506|80650188|FG001|Overall Study|Other - Not Reported|1|||
27675653|NCT02375347|80650190|FG000|Overall Study|Protocol Violation|1|||
27675654|NCT02493946|80650192|FG000|DB Period|Withdrawal by Subject|8|||
27675655|NCT02493946|80650193|FG001|DB Period|Withdrawal by Subject|5|||
27675656|NCT02493946|80650194|FG002|DB Period|Withdrawal by Subject|0|||
27675657|NCT02493946|80650192|FG000|Open Label Period|Withdrawal by Subject|0|||
27797849|NCT00628745|81091467|FG000|Overall Study|Missing|4|||
27797850|NCT00628745|81091468|FG001|Overall Study|Missing|3|||
27797851|NCT00628745|81091469|FG002|Overall Study|Missing|0|||
27797852|NCT00628745|81091470|FG003|Overall Study|Missing|0|||
27797853|NCT00628745|81091471|FG004|Overall Study|Missing|10|||
27797854|NCT00628745|81091467|FG000|Overall Study|Othe reasons|987|||
27797855|NCT00628745|81091468|FG001|Overall Study|Othe reasons|373|||
27870423|NCT01288079|81361462|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27989832|NCT01793883|81794671|FG002|Overall Study|Subject noncompliance|1|||
27989833|NCT01793883|81794669|FG000|Overall Study|Lost to Follow-up|5|||
27989834|NCT01793883|81794670|FG001|Overall Study|Lost to Follow-up|1|||
27989835|NCT01793883|81794671|FG002|Overall Study|Lost to Follow-up|3|||
27797856|NCT00628745|81091469|FG002|Overall Study|Othe reasons|105|||
27797857|NCT00628745|81091470|FG003|Overall Study|Othe reasons|1|||
27797858|NCT00628745|81091471|FG004|Overall Study|Othe reasons|1772|||
27989836|NCT01793883|81794669|FG000|Overall Study|Randomized in error|1|||
27989837|NCT01793883|81794670|FG001|Overall Study|Randomized in error|0|||
27989838|NCT01793883|81794671|FG002|Overall Study|Randomized in error|0|||
27989839|NCT01793883|81794669|FG000|Overall Study|Unable to complete spriometry|1|||
27989840|NCT01793883|81794670|FG001|Overall Study|Unable to complete spriometry|0|||
27989841|NCT01793883|81794671|FG002|Overall Study|Unable to complete spriometry|0|||
27989842|NCT01793883|81794669|FG000|Overall Study|Unable to complete measurements|1|||
27989843|NCT01793883|81794670|FG001|Overall Study|Unable to complete measurements|0|||
27989844|NCT01793883|81794671|FG002|Overall Study|Unable to complete measurements|0|||
27989845|NCT01793883|81794669|FG000|Overall Study|Met exclusion criteria|1|||
27989846|NCT01793883|81794670|FG001|Overall Study|Met exclusion criteria|0|||
27989847|NCT01793883|81794671|FG002|Overall Study|Met exclusion criteria|0|||
27989848|NCT01793883|81794669|FG000|Overall Study|Dosing error|0|||
27989849|NCT01793883|81794670|FG001|Overall Study|Dosing error|1|||
27989850|NCT01793883|81794671|FG002|Overall Study|Dosing error|0|||
27989851|NCT01793883|81794669|FG000|Overall Study|Respiratory distress during spirometry|0|||
27989852|NCT01793883|81794670|FG001|Overall Study|Respiratory distress during spirometry|0|||
27989853|NCT01793883|81794671|FG002|Overall Study|Respiratory distress during spirometry|1|||
27989854|NCT00856297|81794673|FG000|Overall Study|Unable to classify|2|||
27675658|NCT02493946|80650193|FG001|Open Label Period|Withdrawal by Subject|0|||
27675659|NCT02493946|80650194|FG002|Open Label Period|Withdrawal by Subject|74|||
27675660|NCT02493946|80650192|FG000|Open Label Period|Adverse Event|0|||
27675661|NCT02493946|80650193|FG001|Open Label Period|Adverse Event|0|||
27675662|NCT02493946|80650194|FG002|Open Label Period|Adverse Event|4|||
27797859|NCT05166421|81091472|FG000|Overall Study|Other|3|||
27797860|NCT05166421|81091473|FG001|Overall Study|Other|1|||
27797861|NCT05166421|81091474|FG002|Overall Study|Other|1|||
27797862|NCT05166421|81091472|FG000|Overall Study|Withdrawal by Subject|5|||
27579186|NCT01208233|80303131|FG001|Overall Study|Adverse Event|1|||
27675663|NCT02493946|80650192|FG000|Open Label Period|Lost to Follow-up|0|||
27675664|NCT02493946|80650193|FG001|Open Label Period|Lost to Follow-up|0|||
27675665|NCT02493946|80650194|FG002|Open Label Period|Lost to Follow-up|1|||
27675666|NCT02493946|80650192|FG000|Open Label Period|Investigator decision, non-compliance|0|||
27797863|NCT05166421|81091473|FG001|Overall Study|Withdrawal by Subject|3|||
27675667|NCT02493946|80650193|FG001|Open Label Period|Investigator decision, non-compliance|0|||
27675668|NCT02493946|80650194|FG002|Open Label Period|Investigator decision, non-compliance|2|||
27675669|NCT02493946|80650192|FG000|Open Label Period|Investigator decision, non-availability|0|||
27675670|NCT02493946|80650193|FG001|Open Label Period|Investigator decision, non-availability|0|||
27675671|NCT02493946|80650194|FG002|Open Label Period|Investigator decision, non-availability|1|||
27675672|NCT02493946|80650192|FG000|Open Label Period|Pregnancy|0|||
27675673|NCT02493946|80650193|FG001|Open Label Period|Pregnancy|0|||
27675674|NCT02493946|80650194|FG002|Open Label Period|Pregnancy|3|||
27675675|NCT02493946|80650192|FG000|Open Label Period|Site error|0|||
27675676|NCT02493946|80650193|FG001|Open Label Period|Site error|0|||
27675677|NCT02493946|80650194|FG002|Open Label Period|Site error|1|||
27675678|NCT01099917|80650195|FG000|Overall Study|Adverse Event|3|||
27675679|NCT01099917|80650195|FG000|Overall Study|Not Treated|24|||
27675680|NCT03682185|80650196|FG000|Overall Study|Lost to Follow-up|4|||
27675681|NCT03682185|80650197|FG001|Overall Study|Lost to Follow-up|7|||
27675682|NCT03682185|80650198|FG002|Overall Study|Lost to Follow-up|4|||
27675683|NCT03682185|80650199|FG003|Overall Study|Lost to Follow-up|7|||
27675684|NCT03682185|80650200|FG004|Overall Study|Lost to Follow-up|1|||
27675685|NCT03682185|80650196|FG000|Overall Study|Withdrawal by Subject|7|||
27675686|NCT03682185|80650197|FG001|Overall Study|Withdrawal by Subject|3|||
27675687|NCT03682185|80650198|FG002|Overall Study|Withdrawal by Subject|7|||
27675688|NCT03682185|80650199|FG003|Overall Study|Withdrawal by Subject|3|||
27675689|NCT03682185|80650200|FG004|Overall Study|Withdrawal by Subject|0|||
27675690|NCT00731133|80650201|FG000|Overall Study|Withdrawal by Subject|10|||
27675691|NCT03690427|80650202|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
27675692|NCT03690427|80650203|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
27675693|NCT01261000|80650204|FG000|Overall Study|Screen failure|1|||
27675694|NCT01411241|80650205|FG000|Overall Study|Protocol Violation|0|||
27675695|NCT01411241|80650206|FG001|Overall Study|Protocol Violation|5|||
27675696|NCT01411241|80650205|FG000|Overall Study|Withdrawal by Subject|9|||
27675697|NCT01411241|80650206|FG001|Overall Study|Withdrawal by Subject|10|||
27675698|NCT01411241|80650205|FG000|Overall Study|Serious Adverse Event|0|||
27675699|NCT01411241|80650206|FG001|Overall Study|Serious Adverse Event|3|||
27675700|NCT01411241|80650205|FG000|Overall Study|Lost to Follow-up|2|||
27675701|NCT01411241|80650206|FG001|Overall Study|Lost to Follow-up|4|||
27675702|NCT02601209|80650207|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
27675703|NCT02601209|80650208|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
27675704|NCT02601209|80650209|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
27675705|NCT02601209|80650210|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27675706|NCT02601209|80650211|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27675707|NCT02601209|80650212|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27675708|NCT02601209|80650213|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27675709|NCT02601209|80650214|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27675710|NCT02601209|80650215|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
27675711|NCT02601209|80650207|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27675712|NCT02601209|80650208|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27675713|NCT02601209|80650209|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27675714|NCT02601209|80650210|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27675715|NCT02601209|80650211|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
27675716|NCT02601209|80650212|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
27675717|NCT02601209|80650213|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
27675718|NCT02601209|80650214|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27675719|NCT02601209|80650215|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
27675720|NCT01592045|80650216|FG000|Overall Study|Disease Progression|1|||
27675721|NCT01592045|80650217|FG001|Overall Study|Disease Progression|1|||
27675722|NCT01592045|80650216|FG000|Overall Study|Adverse Event|1|||
27675723|NCT01592045|80650217|FG001|Overall Study|Adverse Event|1|||
27675724|NCT01592045|80650216|FG000|Overall Study|Withdrawal by Subject|1|||
27675725|NCT01592045|80650217|FG001|Overall Study|Withdrawal by Subject|0|||
27675726|NCT01592045|80650216|FG000|Overall Study|Moved out of country|2|||
27675727|NCT01592045|80650217|FG001|Overall Study|Moved out of country|0|||
27675728|NCT00632502|80650218|FG000|Overall Study|Adverse Event|0|||
27675729|NCT00632502|80650219|FG001|Overall Study|Adverse Event|1|||
27675730|NCT00632502|80650218|FG000|Overall Study|Randomized not treated|3|||
27675731|NCT00632502|80650219|FG001|Overall Study|Randomized not treated|0|||
27675732|NCT00979953|80650220|FG000|Overall Study|Adverse Event|5|||
27675733|NCT00979953|80650221|FG001|Overall Study|Adverse Event|2|||
27675734|NCT00979953|80650222|FG002|Overall Study|Adverse Event|17|||
27675735|NCT00979953|80650223|FG003|Overall Study|Adverse Event|4|||
27675736|NCT00979953|80650220|FG000|Overall Study|Lack of Efficacy|1|||
27675737|NCT00979953|80650221|FG001|Overall Study|Lack of Efficacy|2|||
27675738|NCT00979953|80650222|FG002|Overall Study|Lack of Efficacy|0|||
27675739|NCT00979953|80650223|FG003|Overall Study|Lack of Efficacy|0|||
27675740|NCT00979953|80650220|FG000|Overall Study|Lost to Follow-up|1|||
27675741|NCT00979953|80650221|FG001|Overall Study|Lost to Follow-up|1|||
27675742|NCT00979953|80650222|FG002|Overall Study|Lost to Follow-up|1|||
27675743|NCT00979953|80650223|FG003|Overall Study|Lost to Follow-up|0|||
27675744|NCT00979953|80650220|FG000|Overall Study|Withdrawal by Subject|0|||
27675745|NCT00979953|80650221|FG001|Overall Study|Withdrawal by Subject|0|||
27675746|NCT00979953|80650222|FG002|Overall Study|Withdrawal by Subject|2|||
27675747|NCT00979953|80650223|FG003|Overall Study|Withdrawal by Subject|1|||
27675748|NCT00979953|80650220|FG000|Overall Study|Protocol Violation|1|||
27675749|NCT00979953|80650221|FG001|Overall Study|Protocol Violation|0|||
27675750|NCT00979953|80650222|FG002|Overall Study|Protocol Violation|2|||
27675751|NCT00979953|80650223|FG003|Overall Study|Protocol Violation|2|||
27675752|NCT00953147|80650224|FG000|Overall Study|Adverse Event|8|||
27675753|NCT00953147|80650225|FG001|Overall Study|Adverse Event|16|||
27675754|NCT00953147|80650226|FG002|Overall Study|Adverse Event|6|||
27675755|NCT00953147|80650224|FG000|Overall Study|Protocol Violation|2|||
27675756|NCT00953147|80650225|FG001|Overall Study|Protocol Violation|8|||
27675757|NCT00953147|80650226|FG002|Overall Study|Protocol Violation|4|||
27675758|NCT00953147|80650224|FG000|Overall Study|Withdrawal by Subject|13|||
27675759|NCT00953147|80650225|FG001|Overall Study|Withdrawal by Subject|15|||
27675760|NCT00953147|80650226|FG002|Overall Study|Withdrawal by Subject|12|||
27675761|NCT00953147|80650224|FG000|Overall Study|Lost to Follow-up|8|||
27675762|NCT00953147|80650225|FG001|Overall Study|Lost to Follow-up|9|||
27675763|NCT00953147|80650226|FG002|Overall Study|Lost to Follow-up|4|||
27675764|NCT00953147|80650224|FG000|Overall Study|Physician Decision|2|||
27675765|NCT00953147|80650225|FG001|Overall Study|Physician Decision|7|||
27675766|NCT00953147|80650226|FG002|Overall Study|Physician Decision|3|||
27675767|NCT00953147|80650224|FG000|Overall Study|Other|4|||
27675768|NCT00953147|80650225|FG001|Overall Study|Other|11|||
27675769|NCT00953147|80650226|FG002|Overall Study|Other|13|||
27675770|NCT01154140|80650227|FG000|Overall Study|Death|71|||
27675771|NCT01154140|80650228|FG001|Overall Study|Death|81|||
27675772|NCT01154140|80650227|FG000|Overall Study|Lost to Follow-up|4|||
27675773|NCT01154140|80650228|FG001|Overall Study|Lost to Follow-up|5|||
27675774|NCT01154140|80650227|FG000|Overall Study|Withdrawal by Subject|12|||
27675775|NCT01154140|80650228|FG001|Overall Study|Withdrawal by Subject|13|||
27675776|NCT01154140|80650227|FG000|Overall Study|Other|3|||
27675777|NCT01154140|80650228|FG001|Overall Study|Other|1|||
27675778|NCT01154140|80650227|FG000|Overall Study|Randomized but not treated|1|||
27675779|NCT01154140|80650228|FG001|Overall Study|Randomized but not treated|2|||
27675780|NCT01183390|80650230|FG000|First Intervention|Adverse Event|0|||
27675781|NCT01183390|80650231|FG001|First Intervention|Adverse Event|1|||
27675782|NCT00794924|80650235|FG000|Overall Study|Lost to Follow-up|6|||
27675783|NCT00794924|80650236|FG001|Overall Study|Lost to Follow-up|8|||
27675784|NCT00794924|80650235|FG000|Overall Study|Withdrawal by Subject|48|||
27675785|NCT00794924|80650236|FG001|Overall Study|Withdrawal by Subject|60|||
27675786|NCT00794924|80650235|FG000|Overall Study|Adverse Event|6|||
27675787|NCT00794924|80650236|FG001|Overall Study|Adverse Event|2|||
27675788|NCT01784523|80650237|FG000|Overall Study|Study closed early|7|||
27675789|NCT01784523|80650238|FG001|Overall Study|Study closed early|4|||
27675790|NCT03445533|80650241|FG000|Overall Study|Progressive Disease|48|||
27675791|NCT03445533|80650242|FG001|Overall Study|Progressive Disease|81|||
27675792|NCT03445533|80650241|FG000|Overall Study|Adverse Event|60|||
27675793|NCT03445533|80650242|FG001|Overall Study|Adverse Event|64|||
27675794|NCT03445533|80650241|FG000|Overall Study|Death|9|||
27675795|NCT03445533|80650242|FG001|Overall Study|Death|19|||
27675796|NCT03445533|80650241|FG000|Overall Study|Miscellaneous|0|||
27675797|NCT03445533|80650242|FG001|Overall Study|Miscellaneous|16|||
27675798|NCT03445533|80650241|FG000|Overall Study|Withdrawal by Subject|3|||
27675799|NCT03445533|80650242|FG001|Overall Study|Withdrawal by Subject|4|||
27675800|NCT03445533|80650241|FG000|Overall Study|Physician Decision|1|||
27675801|NCT03445533|80650242|FG001|Overall Study|Physician Decision|3|||
27675802|NCT03445533|80650241|FG000|Overall Study|Sponsor Decision|0|||
27675803|NCT03445533|80650242|FG001|Overall Study|Sponsor Decision|1|||
27989855|NCT00856297|81794674|FG001|Overall Study|Unable to classify|0|||
27675804|NCT03445533|80650241|FG000|Overall Study|Lost to Follow-up|0|||
27675805|NCT03445533|80650242|FG001|Overall Study|Lost to Follow-up|1|||
27675806|NCT03445533|80650241|FG000|Overall Study|Never Received any Study Treatment|7|||
27675807|NCT03445533|80650242|FG001|Overall Study|Never Received any Study Treatment|4|||
27675808|NCT01843777|80650243|FG000|Overall Study|Withdrawal by Subject|1|||
27675809|NCT01843777|80650244|FG001|Overall Study|Withdrawal by Subject|0|||
27675810|NCT01327612|80650245|FG000|Overall Study|Withdrawal by Subject|0|||
27675811|NCT01327612|80650246|FG001|Overall Study|Withdrawal by Subject|0|||
27675812|NCT01327612|80650247|FG002|Overall Study|Withdrawal by Subject|0|||
27675813|NCT01327612|80650248|FG003|Overall Study|Withdrawal by Subject|0|||
27675814|NCT01327612|80650249|FG004|Overall Study|Withdrawal by Subject|0|||
27675815|NCT01327612|80650250|FG005|Overall Study|Withdrawal by Subject|1|||
27675816|NCT01327612|80650251|FG006|Overall Study|Withdrawal by Subject|0|||
27675817|NCT01327612|80650245|FG000|Overall Study|Disease Progression|1|||
27675818|NCT01327612|80650246|FG001|Overall Study|Disease Progression|1|||
27675819|NCT01327612|80650247|FG002|Overall Study|Disease Progression|1|||
27675820|NCT01327612|80650248|FG003|Overall Study|Disease Progression|0|||
27675821|NCT01327612|80650249|FG004|Overall Study|Disease Progression|1|||
27675822|NCT01327612|80650250|FG005|Overall Study|Disease Progression|2|||
27675823|NCT01327612|80650251|FG006|Overall Study|Disease Progression|2|||
27675824|NCT01327612|80650245|FG000|Overall Study|Administrative Decision|0|||
27675825|NCT01327612|80650246|FG001|Overall Study|Administrative Decision|0|||
27675826|NCT01327612|80650247|FG002|Overall Study|Administrative Decision|0|||
27675827|NCT01327612|80650248|FG003|Overall Study|Administrative Decision|1|||
27675828|NCT01327612|80650249|FG004|Overall Study|Administrative Decision|0|||
27675829|NCT01327612|80650250|FG005|Overall Study|Administrative Decision|0|||
27675830|NCT01327612|80650251|FG006|Overall Study|Administrative Decision|0|||
27675831|NCT01327612|80650245|FG000|Overall Study|Death|0|||
27675832|NCT01327612|80650246|FG001|Overall Study|Death|0|||
27675833|NCT01327612|80650247|FG002|Overall Study|Death|0|||
27675834|NCT01327612|80650248|FG003|Overall Study|Death|0|||
27675835|NCT01327612|80650249|FG004|Overall Study|Death|1|||
27675836|NCT01327612|80650250|FG005|Overall Study|Death|0|||
27675837|NCT01327612|80650251|FG006|Overall Study|Death|0|||
27675838|NCT00983853|80650252|FG000|Overall Study|Lost to Follow-up|1|||
27675839|NCT00983853|80650253|FG001|Overall Study|Lost to Follow-up|1|||
27675840|NCT00983853|80650254|FG002|Overall Study|Lost to Follow-up|2|||
27675841|NCT00983853|80650255|FG003|Overall Study|Lost to Follow-up|2|||
27797864|NCT05166421|81091474|FG002|Overall Study|Withdrawal by Subject|6|||
27797865|NCT05166421|81091472|FG000|Overall Study|Lost to Follow-up|4|||
27675842|NCT00983853|80650256|FG004|Overall Study|Lost to Follow-up|2|||
27675843|NCT00983853|80650257|FG005|Overall Study|Lost to Follow-up|1|||
27675844|NCT00983853|80650252|FG000|Overall Study|Withdrawal by Subject|0|||
27675845|NCT00983853|80650253|FG001|Overall Study|Withdrawal by Subject|0|||
27675846|NCT00983853|80650254|FG002|Overall Study|Withdrawal by Subject|1|||
27675847|NCT00983853|80650255|FG003|Overall Study|Withdrawal by Subject|0|||
27675848|NCT00983853|80650256|FG004|Overall Study|Withdrawal by Subject|1|||
27675849|NCT00983853|80650257|FG005|Overall Study|Withdrawal by Subject|0|||
27675850|NCT00983853|80650252|FG000|Overall Study|Unable to come to study follow-up visits|0|||
27675851|NCT00983853|80650253|FG001|Overall Study|Unable to come to study follow-up visits|1|||
27675852|NCT00983853|80650254|FG002|Overall Study|Unable to come to study follow-up visits|0|||
27797866|NCT05166421|81091473|FG001|Overall Study|Lost to Follow-up|1|||
27797867|NCT05166421|81091474|FG002|Overall Study|Lost to Follow-up|7|||
27675853|NCT00983853|80650255|FG003|Overall Study|Unable to come to study follow-up visits|0|||
27675854|NCT00983853|80650256|FG004|Overall Study|Unable to come to study follow-up visits|0|||
27675855|NCT00983853|80650257|FG005|Overall Study|Unable to come to study follow-up visits|0|||
27675856|NCT03080493|80650258|FG000|Overall Study|Did not provide NRS pain results|1|||
27675857|NCT03080493|80650259|FG001|Overall Study|Did not provide NRS pain results|0|||
27675858|NCT03080493|80650258|FG000|Overall Study|Adverse Event|0|||
27675859|NCT03080493|80650259|FG001|Overall Study|Adverse Event|1|||
27675860|NCT03080493|80650258|FG000|Overall Study|Randomization error (parity group)|0|||
27675861|NCT03080493|80650259|FG001|Overall Study|Randomization error (parity group)|1|||
27675862|NCT01250509|80650264|FG000|Overall Study|Lost to Follow-up|5|||
27675863|NCT01250509|80650265|FG001|Overall Study|Lost to Follow-up|2|||
27675864|NCT02227992|80650266|FG000|Overall Study|Lost to Follow-up|1|||
27675865|NCT02227992|80650267|FG001|Overall Study|Lost to Follow-up|1|||
27675866|NCT02807883|80650268|FG000|Overall Study|Withdrawal by Subject|2|||
27675867|NCT03819634|80650269|FG000|Overall Study|Physician Decision|2|||
27675868|NCT01250925|80650270|FG000|Overall Study|Lost to Follow-up|1|||
27675869|NCT01250925|80650271|FG001|Overall Study|Lost to Follow-up|1|||
27675870|NCT01250925|80650272|FG002|Overall Study|Lost to Follow-up|0|||
27675871|NCT01250925|80650270|FG000|Overall Study|Withdrawal by Subject|2|||
27675872|NCT01250925|80650271|FG001|Overall Study|Withdrawal by Subject|0|||
27675873|NCT01250925|80650272|FG002|Overall Study|Withdrawal by Subject|0|||
27675874|NCT01250925|80650270|FG000|Overall Study|Protocol Violation|2|||
27675875|NCT01250925|80650271|FG001|Overall Study|Protocol Violation|0|||
27675876|NCT01250925|80650272|FG002|Overall Study|Protocol Violation|0|||
27675877|NCT01250925|80650270|FG000|Overall Study|Physician Decision|0|||
27675878|NCT01250925|80650271|FG001|Overall Study|Physician Decision|2|||
27989856|NCT00856297|81794675|FG002|Overall Study|Unable to classify|0|||
27989857|NCT00856297|81794676|FG003|Overall Study|Unable to classify|0|||
27989858|NCT00856297|81794677|FG004|Overall Study|Unable to classify|0|||
27989859|NCT00605345|81794685|FG000|Overall Study|Withdrawal by Subject|1|||
27989860|NCT00605345|81794686|FG001|Overall Study|Withdrawal by Subject|0|||
27989861|NCT00605345|81794685|FG000|Overall Study|Adverse Event|0|||
27989862|NCT00605345|81794686|FG001|Overall Study|Adverse Event|1|||
27989863|NCT00605345|81794685|FG000|Overall Study|Protocol Violation|0|||
27989864|NCT00605345|81794686|FG001|Overall Study|Protocol Violation|2|||
27989865|NCT05513053|81794688|FG000|Overall Study|Lost to Follow-up|9|||
27989866|NCT05513053|81794689|FG001|Overall Study|Lost to Follow-up|11|||
27989867|NCT05513053|81794688|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27989868|NCT05513053|81794689|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27989869|NCT05513053|81794688|FG000|Overall Study|Withdrawal by Subject|2|||
27989870|NCT05513053|81794689|FG001|Overall Study|Withdrawal by Subject|9|||
27989871|NCT05513053|81794688|FG000|Overall Study|Protocol Violation|6|||
27989872|NCT05513053|81794689|FG001|Overall Study|Protocol Violation|3|||
27989873|NCT05513053|81794688|FG000|Overall Study|Adverse Event|0|||
27989874|NCT05513053|81794689|FG001|Overall Study|Adverse Event|2|||
27989875|NCT00866814|81794690|FG000|Overall Study|Lost to Follow-up|12|||
27675879|NCT01250925|80650272|FG002|Overall Study|Physician Decision|1|||
27675880|NCT01250925|80650270|FG000|Overall Study|Adverse Event|0|||
27675881|NCT01250925|80650271|FG001|Overall Study|Adverse Event|0|||
27675882|NCT01250925|80650272|FG002|Overall Study|Adverse Event|1|||
27675883|NCT01240551|80650273|FG000|Overall Study|Refused further treatment|3|||
27675884|NCT01240551|80650274|FG001|Overall Study|Refused further treatment|2|||
27675885|NCT01240551|80650273|FG000|Overall Study|Lost to Follow-up|1|||
27675886|NCT01240551|80650274|FG001|Overall Study|Lost to Follow-up|1|||
27675887|NCT00634842|80650279|FG000|Overall Study|Adverse Event|2|||
27675888|NCT00634842|80650280|FG001|Overall Study|Adverse Event|3|||
27675889|NCT00634842|80650279|FG000|Overall Study|Protocol Violation|8|||
27675890|NCT00634842|80650280|FG001|Overall Study|Protocol Violation|4|||
27989876|NCT00866814|81794690|FG000|Overall Study|Adverse Event|2|||
27989877|NCT00866814|81794690|FG000|Overall Study|Physician Decision|1|||
27989878|NCT00866814|81794690|FG000|Overall Study|Death|1|||
27675891|NCT00634842|80650279|FG000|Overall Study|Move to another state|1|||
27675892|NCT00634842|80650280|FG001|Overall Study|Move to another state|0|||
27675893|NCT00634842|80650279|FG000|Overall Study|Inclusion criteria were not met|1|||
27675894|NCT00634842|80650280|FG001|Overall Study|Inclusion criteria were not met|0|||
27675895|NCT00634842|80650279|FG000|Overall Study|Lost to Follow-up|1|||
27675896|NCT00634842|80650280|FG001|Overall Study|Lost to Follow-up|2|||
27675897|NCT00634842|80650279|FG000|Overall Study|Physician Decision|1|||
27797868|NCT05013749|81091478|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
27797869|NCT05013749|81091479|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
27797870|NCT05013749|81091478|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
27797871|NCT05013749|81091479|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
27797872|NCT04038957|81091483|FG000|Overall Study|Withdrawal by Subject|1|||
27797873|NCT04038957|81091483|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
27797874|NCT03692078|81091484|FG000|Overall Study|Adverse Event|0|||
27797875|NCT03692078|81091485|FG001|Overall Study|Adverse Event|0|||
27989879|NCT00866814|81794690|FG000|Overall Study|No longer wished to participate|1|||
27989880|NCT00866814|81794690|FG000|Overall Study|Unable to meet follow-up requirements|2|||
27675898|NCT00634842|80650280|FG001|Overall Study|Physician Decision|0|||
27675899|NCT00634842|80650279|FG000|Overall Study|Withdrawal by Subject|1|||
27675900|NCT00634842|80650280|FG001|Overall Study|Withdrawal by Subject|3|||
27675901|NCT00634842|80650279|FG000|Overall Study|Lack of time and intolerance to drug|0|||
27675902|NCT00634842|80650280|FG001|Overall Study|Lack of time and intolerance to drug|1|||
27675903|NCT00634842|80650279|FG000|Overall Study|Discontinued due to injection|0|||
27989881|NCT00866814|81794690|FG000|Overall Study|Moved to area without study site|1|||
27989882|NCT01887353|81794696|FG000|Overall Study|Study stopped early|4|||
27989883|NCT01887353|81794697|FG001|Overall Study|Study stopped early|3|||
27675904|NCT00634842|80650280|FG001|Overall Study|Discontinued due to injection|2|||
27675905|NCT00634842|80650279|FG000|Overall Study|No need of study drug to treat diabetes|0|||
27675906|NCT00634842|80650280|FG001|Overall Study|No need of study drug to treat diabetes|1|||
27675907|NCT00634842|80650279|FG000|Overall Study|No wish to keep taking Avandia|0|||
27675908|NCT00634842|80650280|FG001|Overall Study|No wish to keep taking Avandia|1|||
27675909|NCT00634842|80650279|FG000|Overall Study|Subject off study drug for too long|0|||
27675910|NCT00634842|80650280|FG001|Overall Study|Subject off study drug for too long|1|||
27675911|NCT03210519|80650281|FG000|Overall Study|Adverse Event|2|||
27675912|NCT03210519|80650282|FG001|Overall Study|Adverse Event|0|||
27675913|NCT05071313|80650285|FG000|Overall Study|Lost to Follow-up|17|||
27675914|NCT05071313|80650286|FG001|Overall Study|Lost to Follow-up|10|||
27675915|NCT05071313|80650285|FG000|Overall Study|Physician Decision|1|||
27675916|NCT05071313|80650286|FG001|Overall Study|Physician Decision|6|||
27675917|NCT05071313|80650285|FG000|Overall Study|Death|1|||
27675918|NCT05071313|80650286|FG001|Overall Study|Death|0|||
27675919|NCT05071313|80650285|FG000|Overall Study|Withdrawal by Subject|10|||
27675920|NCT05071313|80650286|FG001|Overall Study|Withdrawal by Subject|15|||
27797876|NCT03692078|81091486|FG002|Overall Study|Adverse Event|0|||
27797877|NCT03692078|81091487|FG003|Overall Study|Adverse Event|0|||
27797878|NCT03692078|81091488|FG004|Overall Study|Adverse Event|0|||
27797879|NCT03692078|81091489|FG005|Overall Study|Adverse Event|1|||
27797880|NCT03692078|81091490|FG006|Overall Study|Adverse Event|0|||
27797881|NCT03692078|81091484|FG000|Overall Study|Enrollment Closed|5|||
27989884|NCT03364738|81794698|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
27989885|NCT03364738|81794698|FG000|Overall Study|Withdrawal by Subject|1|||
27989886|NCT03364738|81794698|FG000|Overall Study|Adverse Event|1|||
27989887|NCT04072887|81794702|FG000|Overall Study|Withdrawal by Subject|3|||
27989888|NCT04072887|81794703|FG001|Overall Study|Withdrawal by Subject|8|||
27675921|NCT05071313|80650285|FG000|Overall Study|Other|1|||
27675922|NCT05071313|80650286|FG001|Overall Study|Other|0|||
27675923|NCT05071313|80650285|FG000|Overall Study|Randomized but not vaccinated|4|||
27989889|NCT04072887|81794704|FG002|Overall Study|Withdrawal by Subject|1|||
27989890|NCT04072887|81794705|FG003|Overall Study|Withdrawal by Subject|3|||
27989891|NCT04072887|81794706|FG004|Overall Study|Withdrawal by Subject|3|||
27989892|NCT04072887|81794707|FG005|Overall Study|Withdrawal by Subject|13|||
27989893|NCT04072887|81794702|FG000|Overall Study|Adverse Event|2|||
27989894|NCT04072887|81794703|FG001|Overall Study|Adverse Event|4|||
27989895|NCT04072887|81794704|FG002|Overall Study|Adverse Event|1|||
27989896|NCT04072887|81794705|FG003|Overall Study|Adverse Event|4|||
27989897|NCT04072887|81794706|FG004|Overall Study|Adverse Event|0|||
27989898|NCT04072887|81794707|FG005|Overall Study|Adverse Event|1|||
27989899|NCT04072887|81794702|FG000|Overall Study|Physician Decision|2|||
27989900|NCT04072887|81794703|FG001|Overall Study|Physician Decision|0|||
27989901|NCT04072887|81794704|FG002|Overall Study|Physician Decision|0|||
27989902|NCT04072887|81794705|FG003|Overall Study|Physician Decision|0|||
27989903|NCT04072887|81794706|FG004|Overall Study|Physician Decision|0|||
27989904|NCT04072887|81794707|FG005|Overall Study|Physician Decision|1|||
27989905|NCT04072887|81794702|FG000|Overall Study|Lost to Follow-up|1|||
27989906|NCT04072887|81794703|FG001|Overall Study|Lost to Follow-up|3|||
27989907|NCT04072887|81794704|FG002|Overall Study|Lost to Follow-up|0|||
27989908|NCT04072887|81794705|FG003|Overall Study|Lost to Follow-up|0|||
27989909|NCT04072887|81794706|FG004|Overall Study|Lost to Follow-up|0|||
27989910|NCT04072887|81794707|FG005|Overall Study|Lost to Follow-up|0|||
27989911|NCT04072887|81794702|FG000|Overall Study|Death|0|||
27989912|NCT04072887|81794703|FG001|Overall Study|Death|2|||
27989913|NCT04072887|81794704|FG002|Overall Study|Death|0|||
27989914|NCT04072887|81794705|FG003|Overall Study|Death|2|||
27797882|NCT03692078|81091485|FG001|Overall Study|Enrollment Closed|0|||
27797883|NCT03692078|81091486|FG002|Overall Study|Enrollment Closed|0|||
27797884|NCT03692078|81091487|FG003|Overall Study|Enrollment Closed|0|||
27797885|NCT03692078|81091488|FG004|Overall Study|Enrollment Closed|0|||
27797886|NCT03692078|81091489|FG005|Overall Study|Enrollment Closed|0|||
27797887|NCT03692078|81091490|FG006|Overall Study|Enrollment Closed|0|||
27797888|NCT03692078|81091484|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
27989915|NCT04072887|81794706|FG004|Overall Study|Death|3|||
27989916|NCT04072887|81794707|FG005|Overall Study|Death|0|||
27989917|NCT00372697|81794708|FG000|Overall Study|Protocol Violation|1|||
27989918|NCT00372697|81794709|FG001|Overall Study|Protocol Violation|1|||
27989919|NCT00830180|81794710|FG000|Overall Study|Adverse Event|6|||
27989920|NCT00830180|81794710|FG000|Overall Study|Death|11|||
27675924|NCT05071313|80650286|FG001|Overall Study|Randomized but not vaccinated|2|||
27675925|NCT00422734|80650287|FG000|Overall Study|Physician Decision|1|||
27675926|NCT00422734|80650288|FG001|Overall Study|Physician Decision|1|||
27675927|NCT00422734|80650287|FG000|Overall Study|Protocol Violation|1|||
27675928|NCT00422734|80650288|FG001|Overall Study|Protocol Violation|6|||
27989921|NCT00830180|81794710|FG000|Overall Study|Insufficient clinical response|1|||
27989922|NCT00830180|81794710|FG000|Overall Study|Withdrawal by Subject|5|||
27675929|NCT00422734|80650287|FG000|Overall Study|Withdrawal by Subject|12|||
27675930|NCT00422734|80650288|FG001|Overall Study|Withdrawal by Subject|8|||
27675931|NCT00422734|80650287|FG000|Overall Study|Adverse Event|0|||
27675932|NCT00422734|80650288|FG001|Overall Study|Adverse Event|3|||
27675933|NCT00422734|80650287|FG000|Overall Study|Partner Decision|0|||
27675934|NCT00422734|80650288|FG001|Overall Study|Partner Decision|3|||
27675935|NCT04147858|80650289|FG000|Overall Study|Adverse Event|6|||
27675936|NCT04147858|80650290|FG001|Overall Study|Adverse Event|6|||
27675937|NCT04147858|80650291|FG002|Overall Study|Adverse Event|6|||
27675938|NCT04147858|80650289|FG000|Overall Study|Lack of Efficacy|3|||
27675939|NCT04147858|80650290|FG001|Overall Study|Lack of Efficacy|3|||
27675940|NCT04147858|80650291|FG002|Overall Study|Lack of Efficacy|1|||
27675941|NCT04147858|80650289|FG000|Overall Study|Lost to Follow-up|1|||
27675942|NCT04147858|80650290|FG001|Overall Study|Lost to Follow-up|6|||
27675943|NCT04147858|80650291|FG002|Overall Study|Lost to Follow-up|2|||
27675944|NCT04147858|80650289|FG000|Overall Study|Withdrawal by Subject|3|||
27675945|NCT04147858|80650290|FG001|Overall Study|Withdrawal by Subject|4|||
27675946|NCT04147858|80650291|FG002|Overall Study|Withdrawal by Subject|10|||
27675947|NCT04147858|80650289|FG000|Overall Study|Subject Noncompliance, Other|4|||
27675948|NCT04147858|80650290|FG001|Overall Study|Subject Noncompliance, Other|3|||
27675949|NCT04147858|80650291|FG002|Overall Study|Subject Noncompliance, Other|1|||
27675950|NCT01263509|80650295|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
27675951|NCT01263509|80650296|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
27675952|NCT01263509|80650297|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
27675953|NCT01263509|80650298|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
27675954|NCT01263509|80650295|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27675955|NCT01263509|80650296|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
27675956|NCT01263509|80650297|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27675957|NCT01263509|80650298|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27675958|NCT01263509|80650295|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27675959|NCT01263509|80650296|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27675960|NCT01263509|80650297|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27675961|NCT01263509|80650298|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27675962|NCT01263509|80650295|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
27675963|NCT01263509|80650296|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
27675964|NCT01263509|80650297|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27675965|NCT01263509|80650298|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27675966|NCT01263509|80650295|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
27675967|NCT01263509|80650296|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
27675968|NCT01263509|80650297|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
27675969|NCT01263509|80650298|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
27675970|NCT01777334|80650299|FG000|Overall Study|Adverse Event|18|||
27675971|NCT01777334|80650300|FG001|Overall Study|Adverse Event|14|||
27675972|NCT01777334|80650299|FG000|Overall Study|Lack of Efficacy|15|||
27675973|NCT01777334|80650300|FG001|Overall Study|Lack of Efficacy|29|||
27675974|NCT01777334|80650299|FG000|Overall Study|Protocol Violation|3|||
27675975|NCT01777334|80650300|FG001|Overall Study|Protocol Violation|7|||
27675976|NCT01777334|80650299|FG000|Overall Study|Lost to Follow-up|3|||
27675977|NCT01777334|80650300|FG001|Overall Study|Lost to Follow-up|2|||
27675978|NCT01777334|80650299|FG000|Overall Study|Withdrawal by Subject|14|||
27675979|NCT01777334|80650300|FG001|Overall Study|Withdrawal by Subject|11|||
27797889|NCT03692078|81091485|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
27797890|NCT03692078|81091486|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
27989923|NCT00830180|81794710|FG000|Overall Study|Progressive disease|2|||
27989924|NCT00830180|81794710|FG000|Overall Study|Other - Unspecified|1|||
27989925|NCT01320202|81794712|FG000|Overall Study|Adverse Event|5|||
27989926|NCT01320202|81794713|FG001|Overall Study|Adverse Event|5|||
27989927|NCT01320202|81794712|FG000|Overall Study|Death|5|||
27989928|NCT01320202|81794713|FG001|Overall Study|Death|3|||
27989929|NCT01320202|81794712|FG000|Overall Study|Lost to Follow-up|1|||
27989930|NCT01320202|81794713|FG001|Overall Study|Lost to Follow-up|0|||
27989931|NCT01320202|81794712|FG000|Overall Study|Physician Decision|3|||
27989932|NCT01320202|81794713|FG001|Overall Study|Physician Decision|1|||
27989933|NCT01320202|81794712|FG000|Overall Study|Protocol Violation|2|||
27579187|NCT01208233|80303132|FG002|Overall Study|Adverse Event|2|||
27579188|NCT01208233|80303133|FG003|Overall Study|Adverse Event|0|||
27675980|NCT01931098|80650301|FG000|Overall Study|Withdrawal by Subject|0|||
27675981|NCT01931098|80650302|FG001|Overall Study|Withdrawal by Subject|1|||
27675982|NCT01931098|80650301|FG000|Overall Study|Enrolled in different protocol|0|||
27675983|NCT01931098|80650302|FG001|Overall Study|Enrolled in different protocol|1|||
27989934|NCT01320202|81794713|FG001|Overall Study|Protocol Violation|1|||
27989935|NCT01320202|81794712|FG000|Overall Study|Withdrawal by Subject|10|||
27989936|NCT01320202|81794713|FG001|Overall Study|Withdrawal by Subject|3|||
27989937|NCT01320202|81794712|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
27675984|NCT01931098|80650301|FG000|Overall Study|Unable to begin trmt:active infection|0|||
27797891|NCT03692078|81091487|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
27989938|NCT01320202|81794713|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
27989939|NCT01320202|81794712|FG000|Overall Study|kidney transplant|1|||
27989940|NCT01320202|81794713|FG001|Overall Study|kidney transplant|2|||
27989941|NCT01320202|81794712|FG000|Overall Study|blood transfusion|1|||
27989942|NCT01320202|81794713|FG001|Overall Study|blood transfusion|7|||
27989943|NCT01320202|81794712|FG000|Overall Study|moved/changed dialysis|5|||
27989944|NCT01320202|81794713|FG001|Overall Study|moved/changed dialysis|2|||
27989945|NCT01320202|81794712|FG000|Overall Study|sponsor request|2|||
27797892|NCT03692078|81091488|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
27797893|NCT03692078|81091489|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
27797894|NCT03692078|81091490|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
27797895|NCT03692078|81091484|FG000|Overall Study|Withdrawal by Subject|0|||
27797896|NCT03692078|81091485|FG001|Overall Study|Withdrawal by Subject|2|||
27797897|NCT03692078|81091486|FG002|Overall Study|Withdrawal by Subject|0|||
27797898|NCT03692078|81091487|FG003|Overall Study|Withdrawal by Subject|1|||
27797899|NCT03692078|81091488|FG004|Overall Study|Withdrawal by Subject|5|||
27797900|NCT03692078|81091489|FG005|Overall Study|Withdrawal by Subject|3|||
27797901|NCT03692078|81091490|FG006|Overall Study|Withdrawal by Subject|3|||
27797902|NCT03370276|81091491|FG000|Overall Study|Death|0|||
27797903|NCT03370276|81091492|FG001|Overall Study|Death|2|||
27797904|NCT03370276|81091493|FG002|Overall Study|Death|5|||
27797905|NCT04840901|81091505|FG000|Overall Study|Lost to Follow-up|3|||
27797906|NCT04840901|81091506|FG001|Overall Study|Lost to Follow-up|1|||
27797907|NCT04840901|81091505|FG000|Overall Study|Moved|1|||
27797908|NCT04840901|81091506|FG001|Overall Study|Moved|0|||
27797909|NCT04840901|81091505|FG000|Overall Study|Unable to comply with study schedule|0|||
27797910|NCT04840901|81091506|FG001|Overall Study|Unable to comply with study schedule|1|||
27797911|NCT04840901|81091505|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
27797912|NCT04840901|81091506|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
27797913|NCT04152200|81091507|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
27797914|NCT04152200|81091508|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
27797915|NCT01268683|81091509|FG000|Overall Study|Lost to Follow-up|1|||
27797916|NCT01268683|81091509|FG000|Overall Study|Death|1|||
27797917|NCT02216214|81091510|FG000|Overall Study|Randomized Never Received Study Drug|1|||
27797918|NCT02216214|81091511|FG001|Overall Study|Randomized Never Received Study Drug|0|||
27797919|NCT02216214|81091510|FG000|Overall Study|Adverse Event|10|||
27797920|NCT02216214|81091511|FG001|Overall Study|Adverse Event|8|||
27797921|NCT02216214|81091510|FG000|Overall Study|Lack of Efficacy|2|||
27989946|NCT01320202|81794713|FG001|Overall Study|sponsor request|0|||
27675985|NCT01931098|80650302|FG001|Overall Study|Unable to begin trmt:active infection|1|||
27989947|NCT01320202|81794712|FG000|Overall Study|ineligible|3|||
27989948|NCT01320202|81794713|FG001|Overall Study|ineligible|0|||
27989949|NCT01320202|81794712|FG000|Overall Study|regained renal function|1|||
27989950|NCT01320202|81794713|FG001|Overall Study|regained renal function|0|||
27989951|NCT01380834|81794714|FG000|Overall Study|Physician Decision|1|||
27989952|NCT01380834|81794715|FG001|Overall Study|Physician Decision|0|||
27989953|NCT03722524|81794716|FG000|Overall Study|Protocol Violation|86|||
27989954|NCT03722524|81794716|FG000|Overall Study|Adverse Event|7|||
27989955|NCT03722524|81794716|FG000|Overall Study|Lost to Follow-up|1|||
27989956|NCT03722524|81794716|FG000|Overall Study|Reason is not stated|1|||
27989957|NCT03722524|81794716|FG000|Overall Study|Physician Decision|1|||
27989958|NCT03722524|81794716|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
27989959|NCT00799591|81794717|FG000|Overall Study|De-escalation of doses|20|||
27989960|NCT00799591|81794717|FG000|Overall Study|Death|14|||
27989961|NCT00799591|81794717|FG000|Overall Study|Technical failure|12|||
27989962|NCT00799591|81794717|FG000|Overall Study|Resistant germ|11|||
27989963|NCT00799591|81794717|FG000|Overall Study|New infection|4|||
27989964|NCT00799591|81794717|FG000|Overall Study|Resistance germ and technical failure|2|||
27989965|NCT00799591|81794717|FG000|Overall Study|Persistance of fever undetermined origin|1|||
27989966|NCT00799591|81794717|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
27989967|NCT00799591|81794717|FG000|Overall Study|Infectious origin not probable|1|||
27989968|NCT02516592|81794722|FG000|Overall Study|Patient withdrew consent|5|||
27989969|NCT02516592|81794723|FG001|Overall Study|Patient withdrew consent|2|||
27989970|NCT02516592|81794722|FG000|Overall Study|Protocol deviation|4|||
27989971|NCT02516592|81794723|FG001|Overall Study|Protocol deviation|4|||
27989972|NCT02516592|81794722|FG000|Overall Study|Lost to Follow-up|2|||
27989973|NCT02516592|81794723|FG001|Overall Study|Lost to Follow-up|3|||
27989974|NCT02516592|81794722|FG000|Overall Study|Patient/guardian decision|2|||
27989975|NCT02516592|81794723|FG001|Overall Study|Patient/guardian decision|1|||
27989976|NCT02516592|81794722|FG000|Overall Study|Adverse Event|1|||
27989977|NCT02516592|81794723|FG001|Overall Study|Adverse Event|2|||
27989978|NCT02516592|81794722|FG000|Overall Study|Abnormal test procedure result|1|||
27989979|NCT02516592|81794723|FG001|Overall Study|Abnormal test procedure result|0|||
27989980|NCT02516592|81794722|FG000|Overall Study|Death|1|||
27989981|NCT02516592|81794723|FG001|Overall Study|Death|1|||
27989982|NCT04541628|81794724|FG000|Overall Study|Study Terminated|1|||
27989983|NCT04541628|81794725|FG001|Overall Study|Study Terminated|1|||
27989984|NCT04541628|81794726|FG002|Overall Study|Study Terminated|1|||
27989985|NCT01811186|81794727|FG000|Overall Study|Adverse Event|54|||
27989986|NCT01811186|81794728|FG001|Overall Study|Adverse Event|38|||
27989987|NCT01811186|81794727|FG000|Overall Study|Protocol Violation|5|||
27989988|NCT01811186|81794728|FG001|Overall Study|Protocol Violation|6|||
27989989|NCT01811186|81794727|FG000|Overall Study|Withdrawal by Subject|5|||
27989990|NCT01811186|81794728|FG001|Overall Study|Withdrawal by Subject|10|||
27989991|NCT01811186|81794727|FG000|Overall Study|Lack of Efficacy|3|||
27989992|NCT01811186|81794728|FG001|Overall Study|Lack of Efficacy|6|||
27989993|NCT01811186|81794727|FG000|Overall Study|Lost to Follow-up|4|||
27989994|NCT01811186|81794728|FG001|Overall Study|Lost to Follow-up|2|||
27989995|NCT02038075|81794729|FG000|Overall Study|Withdrawal by Subject|3|||
27989996|NCT02038075|81794730|FG001|Overall Study|Withdrawal by Subject|0|||
27989997|NCT01496846|81794731|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
27989998|NCT01496846|81794732|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
27989999|NCT01496846|81794733|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27990000|NCT01496846|81794734|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27797922|NCT02216214|81091511|FG001|Overall Study|Lack of Efficacy|2|||
27797923|NCT02216214|81091510|FG000|Overall Study|Lost to Follow-up|3|||
27579189|NCT01208233|80303134|FG004|Overall Study|Adverse Event|3|||
27990001|NCT01496846|81794735|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27990002|NCT01496846|81794736|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
27990003|NCT01846741|81794738|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
27990004|NCT00859937|81794745|FG000|Overall Study|Protocol Violation|1|||
27990005|NCT00859937|81794746|FG001|Overall Study|Protocol Violation|0|||
27990006|NCT00802893|81794747|FG000|Overall Study|study terminated|3|||
27990007|NCT01870726|81794750|FG000|Overall Study|Withdrawal of informed consent|0|||
27990008|NCT01870726|81794751|FG001|Overall Study|Withdrawal of informed consent|0|||
27870424|NCT01288079|81361463|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
27990009|NCT01870726|81794752|FG002|Overall Study|Withdrawal of informed consent|0|||
27990010|NCT01870726|81794753|FG003|Overall Study|Withdrawal of informed consent|1|||
27990011|NCT01870726|81794754|FG004|Overall Study|Withdrawal of informed consent|0|||
27990012|NCT01870726|81794755|FG005|Overall Study|Withdrawal of informed consent|0|||
27990013|NCT01870726|81794756|FG006|Overall Study|Withdrawal of informed consent|0|||
27990014|NCT01870726|81794750|FG000|Overall Study|Withdrawal by Subject|0|||
27990015|NCT01870726|81794751|FG001|Overall Study|Withdrawal by Subject|1|||
27990016|NCT01870726|81794752|FG002|Overall Study|Withdrawal by Subject|0|||
27990017|NCT01870726|81794753|FG003|Overall Study|Withdrawal by Subject|0|||
27990018|NCT01870726|81794754|FG004|Overall Study|Withdrawal by Subject|0|||
27990019|NCT01870726|81794755|FG005|Overall Study|Withdrawal by Subject|0|||
27990020|NCT01870726|81794756|FG006|Overall Study|Withdrawal by Subject|0|||
27870425|NCT01288079|81361464|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
27870426|NCT01288079|81361461|FG000|Overall Study|Lost to Follow-up|1|||
27870427|NCT01288079|81361462|FG001|Overall Study|Lost to Follow-up|1|||
27870428|NCT01288079|81361463|FG002|Overall Study|Lost to Follow-up|1|||
27870429|NCT01288079|81361464|FG003|Overall Study|Lost to Follow-up|0|||
27870430|NCT01288079|81361461|FG000|Overall Study|Other or Study Termination|11|||
27870431|NCT01288079|81361462|FG001|Overall Study|Other or Study Termination|15|||
27870432|NCT01288079|81361463|FG002|Overall Study|Other or Study Termination|14|||
27870433|NCT01288079|81361464|FG003|Overall Study|Other or Study Termination|8|||
27870434|NCT00100828|81361465|FG000|Overall Study|Physician Decision|6|||
27870435|NCT03536884|81361467|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
27870436|NCT03536884|81361468|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
27870437|NCT03536884|81361469|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27990021|NCT01870726|81794750|FG000|Overall Study|Adverse Event|0|||
27990022|NCT01870726|81794751|FG001|Overall Study|Adverse Event|0|||
27990023|NCT01870726|81794752|FG002|Overall Study|Adverse Event|0|||
27990024|NCT01870726|81794753|FG003|Overall Study|Adverse Event|0|||
27990025|NCT01870726|81794754|FG004|Overall Study|Adverse Event|1|||
27990026|NCT01870726|81794755|FG005|Overall Study|Adverse Event|1|||
27990027|NCT01870726|81794756|FG006|Overall Study|Adverse Event|0|||
27990028|NCT01870726|81794750|FG000|Overall Study|Progressive disease|5|||
27990029|NCT01870726|81794751|FG001|Overall Study|Progressive disease|5|||
27990030|NCT01870726|81794752|FG002|Overall Study|Progressive disease|4|||
27990031|NCT01870726|81794753|FG003|Overall Study|Progressive disease|5|||
27990032|NCT01870726|81794754|FG004|Overall Study|Progressive disease|6|||
27990033|NCT01870726|81794755|FG005|Overall Study|Progressive disease|4|||
27990034|NCT01870726|81794756|FG006|Overall Study|Progressive disease|10|||
27990035|NCT00534976|81794757|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
27990036|NCT00534976|81794758|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
27990037|NCT00534976|81794757|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
27797924|NCT02216214|81091511|FG001|Overall Study|Lost to Follow-up|2|||
27797925|NCT02216214|81091510|FG000|Overall Study|Protocol Violation|4|||
27797926|NCT02216214|81091511|FG001|Overall Study|Protocol Violation|2|||
27797927|NCT02216214|81091510|FG000|Overall Study|Withdrawal by Subject|22|||
27797928|NCT02216214|81091511|FG001|Overall Study|Withdrawal by Subject|20|||
27797929|NCT02216214|81091510|FG000|Overall Study|Study Terminated By Sponsor|0|||
27797930|NCT02216214|81091511|FG001|Overall Study|Study Terminated By Sponsor|1|||
27797931|NCT02216214|81091510|FG000|Overall Study|Miscellaneous|1|||
27797932|NCT02216214|81091511|FG001|Overall Study|Miscellaneous|1|||
27797933|NCT03954041|81091512|FG000|Overall Study|Lost to Follow-up|3|||
27797934|NCT03954041|81091513|FG001|Overall Study|Lost to Follow-up|3|||
27797935|NCT03954041|81091514|FG002|Overall Study|Lost to Follow-up|6|||
27797936|NCT03954041|81091512|FG000|Overall Study|Death|4|||
27797937|NCT03954041|81091513|FG001|Overall Study|Death|0|||
27797938|NCT03954041|81091514|FG002|Overall Study|Death|1|||
27797939|NCT03954041|81091512|FG000|Overall Study|Death by neurologic criteria|0|||
27870438|NCT03536884|81361470|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870439|NCT03536884|81361471|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870440|NCT03536884|81361472|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870441|NCT03536884|81361473|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27990038|NCT00534976|81794758|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
27990039|NCT00534976|81794757|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
27675986|NCT01931098|80650301|FG000|Overall Study|Refused further treatment|0|||
27797940|NCT03954041|81091513|FG001|Overall Study|Death by neurologic criteria|0|||
27797941|NCT03954041|81091514|FG002|Overall Study|Death by neurologic criteria|1|||
27797942|NCT03954041|81091512|FG000|Overall Study|Reason not specified|7|||
27990040|NCT00534976|81794758|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
27870442|NCT03536884|81361474|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870443|NCT03536884|81361475|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27675987|NCT01931098|80650302|FG001|Overall Study|Refused further treatment|1|||
27675988|NCT01999972|80650303|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
27675989|NCT01999972|80650304|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
27675990|NCT01999972|80650305|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
27675991|NCT01999972|80650306|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
27675992|NCT01999972|80650307|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
27675993|NCT01999972|80650308|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
27675994|NCT01999972|80650303|FG000|Dose Escalation Part|Death|0|||
27870444|NCT03536884|81361476|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870445|NCT03536884|81361477|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870446|NCT03536884|81361478|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
27870447|NCT03536884|81361467|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27675995|NCT01999972|80650304|FG001|Dose Escalation Part|Death|1|||
27675996|NCT01999972|80650305|FG002|Dose Escalation Part|Death|0|||
27675997|NCT01999972|80650306|FG003|Dose Escalation Part|Death|0|||
27675998|NCT01999972|80650307|FG004|Dose Escalation Part|Death|0|||
27675999|NCT01999972|80650308|FG005|Dose Escalation Part|Death|0|||
27676000|NCT01999972|80650303|FG000|Dose Escalation Part|Enrolled but not treated|0|||
27676001|NCT01999972|80650304|FG001|Dose Escalation Part|Enrolled but not treated|0|||
27676002|NCT01999972|80650305|FG002|Dose Escalation Part|Enrolled but not treated|1|||
27676003|NCT01999972|80650306|FG003|Dose Escalation Part|Enrolled but not treated|1|||
27676004|NCT01999972|80650307|FG004|Dose Escalation Part|Enrolled but not treated|0|||
27676005|NCT01999972|80650308|FG005|Dose Escalation Part|Enrolled but not treated|0|||
27870448|NCT03536884|81361468|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
27579190|NCT01208233|80303135|FG005|Overall Study|Adverse Event|5|||
27579191|NCT01208233|80303130|FG000|Overall Study|Death|0|||
27579192|NCT01208233|80303131|FG001|Overall Study|Death|0|||
27579193|NCT01208233|80303132|FG002|Overall Study|Death|0|||
27579194|NCT01208233|80303133|FG003|Overall Study|Death|0|||
27579195|NCT01208233|80303134|FG004|Overall Study|Death|3|||
27579196|NCT01208233|80303135|FG005|Overall Study|Death|5|||
27579197|NCT01208233|80303130|FG000|Overall Study|Did not meet entrance criteria|2|||
27579198|NCT01208233|80303131|FG001|Overall Study|Did not meet entrance criteria|1|||
27579199|NCT01208233|80303132|FG002|Overall Study|Did not meet entrance criteria|1|||
27579200|NCT01208233|80303133|FG003|Overall Study|Did not meet entrance criteria|0|||
27579201|NCT01208233|80303134|FG004|Overall Study|Did not meet entrance criteria|1|||
27579202|NCT01208233|80303135|FG005|Overall Study|Did not meet entrance criteria|0|||
27579203|NCT01208233|80303130|FG000|Overall Study|Medication error without adverse event|0|||
27579204|NCT01208233|80303131|FG001|Overall Study|Medication error without adverse event|0|||
27579205|NCT01208233|80303132|FG002|Overall Study|Medication error without adverse event|0|||
27579206|NCT01208233|80303133|FG003|Overall Study|Medication error without adverse event|0|||
27579207|NCT01208233|80303134|FG004|Overall Study|Medication error without adverse event|0|||
27579208|NCT01208233|80303135|FG005|Overall Study|Medication error without adverse event|1|||
27579209|NCT01208233|80303130|FG000|Overall Study|Study terminated by sponsor|0|||
27579210|NCT01208233|80303131|FG001|Overall Study|Study terminated by sponsor|0|||
27579211|NCT01208233|80303132|FG002|Overall Study|Study terminated by sponsor|0|||
27579212|NCT01208233|80303133|FG003|Overall Study|Study terminated by sponsor|0|||
27579213|NCT01208233|80303134|FG004|Overall Study|Study terminated by sponsor|10|||
27579214|NCT01208233|80303135|FG005|Overall Study|Study terminated by sponsor|7|||
27579215|NCT01208233|80303130|FG000|Overall Study|Protocol Violation|0|||
27579216|NCT01208233|80303131|FG001|Overall Study|Protocol Violation|0|||
27579217|NCT01208233|80303132|FG002|Overall Study|Protocol Violation|0|||
27579218|NCT01208233|80303133|FG003|Overall Study|Protocol Violation|0|||
27579219|NCT01208233|80303134|FG004|Overall Study|Protocol Violation|3|||
27579220|NCT01208233|80303135|FG005|Overall Study|Protocol Violation|0|||
27579221|NCT01208233|80303130|FG000|Overall Study|Other|2|||
27579222|NCT01208233|80303131|FG001|Overall Study|Other|1|||
27579223|NCT01208233|80303132|FG002|Overall Study|Other|0|||
27579224|NCT01208233|80303133|FG003|Overall Study|Other|0|||
27579225|NCT01208233|80303134|FG004|Overall Study|Other|0|||
27579226|NCT01208233|80303135|FG005|Overall Study|Other|1|||
27579227|NCT01208233|80303130|FG000|Overall Study|Withdrawal by Subject|1|||
27579228|NCT01208233|80303131|FG001|Overall Study|Withdrawal by Subject|0|||
27579229|NCT01208233|80303132|FG002|Overall Study|Withdrawal by Subject|1|||
27579230|NCT01208233|80303133|FG003|Overall Study|Withdrawal by Subject|1|||
27579231|NCT01208233|80303134|FG004|Overall Study|Withdrawal by Subject|4|||
27579232|NCT01208233|80303135|FG005|Overall Study|Withdrawal by Subject|2|||
27579233|NCT02663128|80303136|FG000|Period 2|Physician Decision|0|||
27579234|NCT02663128|80303137|FG001|Period 2|Physician Decision|0|||
27579235|NCT02663128|80303138|FG002|Period 2|Physician Decision|0|||
27579236|NCT02663128|80303139|FG003|Period 2|Physician Decision|0|||
27579237|NCT02663128|80303140|FG004|Period 2|Physician Decision|1|||
27676006|NCT01999972|80650303|FG000|Dose Escalation Part|Disease progression|3|||
27676007|NCT01999972|80650304|FG001|Dose Escalation Part|Disease progression|2|||
27676008|NCT01999972|80650305|FG002|Dose Escalation Part|Disease progression|3|||
27676009|NCT01999972|80650306|FG003|Dose Escalation Part|Disease progression|6|||
27676010|NCT01999972|80650307|FG004|Dose Escalation Part|Disease progression|0|||
27676011|NCT01999972|80650308|FG005|Dose Escalation Part|Disease progression|0|||
27676012|NCT01999972|80650303|FG000|Dose Escalation Part|Adverse Event|0|||
27676013|NCT01999972|80650304|FG001|Dose Escalation Part|Adverse Event|0|||
27676014|NCT01999972|80650305|FG002|Dose Escalation Part|Adverse Event|0|||
27676015|NCT01999972|80650306|FG003|Dose Escalation Part|Adverse Event|2|||
27676016|NCT01999972|80650307|FG004|Dose Escalation Part|Adverse Event|0|||
27676017|NCT01999972|80650308|FG005|Dose Escalation Part|Adverse Event|0|||
27676018|NCT01999972|80650303|FG000|Dose Escalation Part|Global deterioration of health status|1|||
27676019|NCT01999972|80650304|FG001|Dose Escalation Part|Global deterioration of health status|0|||
27676020|NCT01999972|80650305|FG002|Dose Escalation Part|Global deterioration of health status|0|||
27676021|NCT01999972|80650306|FG003|Dose Escalation Part|Global deterioration of health status|1|||
27676022|NCT01999972|80650307|FG004|Dose Escalation Part|Global deterioration of health status|0|||
27676023|NCT01999972|80650308|FG005|Dose Escalation Part|Global deterioration of health status|0|||
27676024|NCT01999972|80650303|FG000|Dose Expansion Part|Death|0|||
27676025|NCT01999972|80650304|FG001|Dose Expansion Part|Death|0|||
27676026|NCT01999972|80650305|FG002|Dose Expansion Part|Death|0|||
27676027|NCT01999972|80650306|FG003|Dose Expansion Part|Death|0|||
27676028|NCT01999972|80650307|FG004|Dose Expansion Part|Death|2|||
27676029|NCT01999972|80650308|FG005|Dose Expansion Part|Death|1|||
27676030|NCT01999972|80650303|FG000|Dose Expansion Part|Disease progression|0|||
27676031|NCT01999972|80650304|FG001|Dose Expansion Part|Disease progression|0|||
27676032|NCT01999972|80650305|FG002|Dose Expansion Part|Disease progression|0|||
27676033|NCT01999972|80650306|FG003|Dose Expansion Part|Disease progression|0|||
27676034|NCT01999972|80650307|FG004|Dose Expansion Part|Disease progression|9|||
27676035|NCT01999972|80650308|FG005|Dose Expansion Part|Disease progression|3|||
27676036|NCT01999972|80650303|FG000|Dose Expansion Part|Sponsor decision|0|||
27676037|NCT01999972|80650304|FG001|Dose Expansion Part|Sponsor decision|0|||
27676038|NCT01999972|80650305|FG002|Dose Expansion Part|Sponsor decision|0|||
27676039|NCT01999972|80650306|FG003|Dose Expansion Part|Sponsor decision|0|||
27676040|NCT01999972|80650307|FG004|Dose Expansion Part|Sponsor decision|1|||
27676041|NCT01999972|80650308|FG005|Dose Expansion Part|Sponsor decision|0|||
27676042|NCT01999972|80650303|FG000|Dose Expansion Part|Adverse Event|0|||
27676043|NCT01999972|80650304|FG001|Dose Expansion Part|Adverse Event|0|||
27676044|NCT01999972|80650305|FG002|Dose Expansion Part|Adverse Event|0|||
27676045|NCT01999972|80650306|FG003|Dose Expansion Part|Adverse Event|0|||
27676046|NCT01999972|80650307|FG004|Dose Expansion Part|Adverse Event|4|||
27676047|NCT01999972|80650308|FG005|Dose Expansion Part|Adverse Event|2|||
27676048|NCT01999972|80650303|FG000|Dose Expansion Part|Participant's non-compliance|0|||
27676049|NCT01999972|80650304|FG001|Dose Expansion Part|Participant's non-compliance|0|||
27676050|NCT01999972|80650305|FG002|Dose Expansion Part|Participant's non-compliance|0|||
27676051|NCT01999972|80650306|FG003|Dose Expansion Part|Participant's non-compliance|0|||
27797943|NCT03954041|81091513|FG001|Overall Study|Reason not specified|4|||
27797944|NCT03954041|81091514|FG002|Overall Study|Reason not specified|2|||
27797945|NCT03954041|81091512|FG000|Overall Study|Withdrew prior to dosing|4|||
27797946|NCT03954041|81091513|FG001|Overall Study|Withdrew prior to dosing|2|||
27797947|NCT03954041|81091514|FG002|Overall Study|Withdrew prior to dosing|0|||
27797948|NCT05354206|81091515|FG000|Overall Study|Withdrawal by Subject|1|||
27797949|NCT05354206|81091516|FG001|Overall Study|Withdrawal by Subject|0|||
27797950|NCT03526679|81092464|FG000|Overall Study|still under treatment|2|||
27676052|NCT01999972|80650307|FG004|Dose Expansion Part|Participant's non-compliance|0|||
27676053|NCT01999972|80650308|FG005|Dose Expansion Part|Participant's non-compliance|1|||
27797951|NCT03515837|81092465|FG000|Overall Study|Death|219|||
27676054|NCT01999972|80650303|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
27676055|NCT01999972|80650304|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
27676056|NCT01999972|80650305|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
27676057|NCT01999972|80650306|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
27676058|NCT01999972|80650307|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
27676059|NCT01999972|80650308|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
27676060|NCT01999972|80650303|FG000|Dose Expansion Part|Changed to standard of care|0|||
27676061|NCT01999972|80650304|FG001|Dose Expansion Part|Changed to standard of care|0|||
27676062|NCT01999972|80650305|FG002|Dose Expansion Part|Changed to standard of care|0|||
27676063|NCT01999972|80650306|FG003|Dose Expansion Part|Changed to standard of care|0|||
27676064|NCT01999972|80650307|FG004|Dose Expansion Part|Changed to standard of care|1|||
27870449|NCT03536884|81361469|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870450|NCT03536884|81361470|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27990041|NCT00588354|81794759|FG000|Baseline to 2 Weeks|Adverse Event|1|||
27990042|NCT00588354|81794760|FG001|Baseline to 2 Weeks|Adverse Event|0|||
27990043|NCT00588354|81794759|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
27990044|NCT00588354|81794760|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
27990045|NCT00588354|81794759|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
27990046|NCT00588354|81794760|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
27990047|NCT02396589|81794768|FG000|Intervention|Lost to Follow-up|1|||
27990048|NCT02396589|81794769|FG001|Intervention|Lost to Follow-up|0|||
27990049|NCT02396589|81794768|FG000|6 Month Follow-up|change in health status|0|||
27990050|NCT02396589|81794769|FG001|6 Month Follow-up|change in health status|1|||
27990051|NCT02396589|81794768|FG000|9 Month Follow-up|Death|0|||
27990052|NCT02396589|81794769|FG001|9 Month Follow-up|Death|1|||
27676065|NCT01999972|80650308|FG005|Dose Expansion Part|Changed to standard of care|0|||
27676066|NCT01246999|80650311|FG000|Overall Study|Lost to Follow-up|0|||
27676067|NCT01246999|80650312|FG001|Overall Study|Lost to Follow-up|1|||
27676068|NCT01246999|80650313|FG002|Overall Study|Lost to Follow-up|0|||
27676069|NCT01246999|80650314|FG003|Overall Study|Lost to Follow-up|0|||
27676070|NCT01246999|80650311|FG000|Overall Study|Withdrawal by Subject|0|||
27676071|NCT01246999|80650312|FG001|Overall Study|Withdrawal by Subject|0|||
27870451|NCT03536884|81361471|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870452|NCT03536884|81361472|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870453|NCT03536884|81361473|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870454|NCT03536884|81361474|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870455|NCT03536884|81361475|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870456|NCT03536884|81361476|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870457|NCT03536884|81361477|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870458|NCT03536884|81361478|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
27870459|NCT03536884|81361467|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
27870460|NCT03536884|81361468|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
27676072|NCT01246999|80650313|FG002|Overall Study|Withdrawal by Subject|0|||
27676073|NCT01246999|80650314|FG003|Overall Study|Withdrawal by Subject|2|||
27676074|NCT01151215|80650316|FG000|Overall Study|Worsening of condition under study|1|||
27676075|NCT01151215|80650317|FG001|Overall Study|Worsening of condition under study|1|||
27676076|NCT01151215|80650318|FG002|Overall Study|Worsening of condition under study|1|||
27676077|NCT01151215|80650316|FG000|Overall Study|Death|16|||
27676078|NCT01151215|80650317|FG001|Overall Study|Death|20|||
27676079|NCT01151215|80650318|FG002|Overall Study|Death|11|||
27676080|NCT01151215|80650316|FG000|Overall Study|Lost to Follow-up|0|||
27676081|NCT01151215|80650317|FG001|Overall Study|Lost to Follow-up|0|||
27676082|NCT01151215|80650318|FG002|Overall Study|Lost to Follow-up|3|||
27676083|NCT01151215|80650316|FG000|Overall Study|Withdrawal by Subject|3|||
27676084|NCT01151215|80650317|FG001|Overall Study|Withdrawal by Subject|1|||
27676085|NCT01151215|80650318|FG002|Overall Study|Withdrawal by Subject|2|||
27676086|NCT01151215|80650316|FG000|Overall Study|Disease progression|0|||
27676087|NCT01151215|80650317|FG001|Overall Study|Disease progression|1|||
27676088|NCT01151215|80650318|FG002|Overall Study|Disease progression|1|||
27676089|NCT01151215|80650316|FG000|Overall Study|Safety as judged by the investigator|0|||
27676090|NCT01151215|80650317|FG001|Overall Study|Safety as judged by the investigator|0|||
27676091|NCT01151215|80650318|FG002|Overall Study|Safety as judged by the investigator|1|||
27676092|NCT01040169|80650321|FG000|Overall Study|Lost to Follow-up|3|||
27676093|NCT01040169|80650322|FG001|Overall Study|Lost to Follow-up|8|||
27676094|NCT02370251|80650323|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
27676095|NCT02370251|80650323|FG000|Overall Study|Death|4|||
27676096|NCT01939353|80650330|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
27676097|NCT01939353|80650330|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
27676098|NCT01939353|80650330|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
27676099|NCT01939353|80650330|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
27676100|NCT01939353|80650330|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
27676101|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Adverse Event|10|||
27870461|NCT03536884|81361469|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870462|NCT03536884|81361470|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27990053|NCT02396589|81794768|FG000|12 Month Follow up|Lost to Follow-up|0|||
27990054|NCT02396589|81794769|FG001|12 Month Follow up|Lost to Follow-up|2|||
27990055|NCT01832532|81794770|FG000|Overall Study|Withdrawal by Subject|5|||
27990056|NCT01832532|81794771|FG001|Overall Study|Withdrawal by Subject|2|||
27870463|NCT03536884|81361471|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870464|NCT03536884|81361472|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870465|NCT03536884|81361473|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870466|NCT03536884|81361474|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870467|NCT03536884|81361475|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870468|NCT03536884|81361476|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870469|NCT03536884|81361477|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870470|NCT03536884|81361478|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
27870471|NCT03536884|81361467|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870472|NCT03536884|81361468|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
27870473|NCT03536884|81361469|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870474|NCT03536884|81361470|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870475|NCT03536884|81361471|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870476|NCT03536884|81361472|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870477|NCT03536884|81361473|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870478|NCT03536884|81361474|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870479|NCT03536884|81361475|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27676102|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Adverse Event|9|||
27676103|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Adverse Event|7|||
27676104|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
27676105|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
27797952|NCT03515837|81092466|FG001|Overall Study|Death|227|||
27870480|NCT03536884|81361476|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870481|NCT03536884|81361477|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870482|NCT03536884|81361478|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
27870483|NCT03536884|81361467|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27797953|NCT03515837|81092465|FG000|Overall Study|Lost to Follow-up|0|||
27797954|NCT03515837|81092466|FG001|Overall Study|Lost to Follow-up|1|||
27870484|NCT03536884|81361468|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
27990057|NCT00398320|81794777|FG000|Overall Study|Death|1|||
27990058|NCT00398320|81794777|FG000|Overall Study|Adverse Event|4|||
27990059|NCT00398320|81794777|FG000|Overall Study|Physician Decision|1|||
27990060|NCT01990612|81794778|FG000|Overall Study|Lost to Follow-up|2|||
27990061|NCT01990612|81794779|FG001|Overall Study|Lost to Follow-up|1|||
27990062|NCT01990612|81794778|FG000|Overall Study|Withdrawal by Subject|5|||
27990063|NCT01990612|81794779|FG001|Overall Study|Withdrawal by Subject|2|||
27990064|NCT01345669|81794780|FG000|Overall Study|Primary tumour recurrence|53|||
27990065|NCT01345669|81794781|FG001|Overall Study|Primary tumour recurrence|32|||
27579238|NCT02663128|80303141|FG005|Period 2|Physician Decision|0|||
27579239|NCT01581593|80303152|FG000|Overall Study|Withdrawal by Subject|1|||
27676106|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
27676107|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
27676108|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
27797955|NCT03515837|81092465|FG000|Overall Study|Withdrawal by Subject|0|||
27797956|NCT03515837|81092466|FG001|Overall Study|Withdrawal by Subject|4|||
27797957|NCT03515837|81092465|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
27797958|NCT03515837|81092466|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
27797959|NCT02118896|81092467|FG000|Overall Study|Death|4|||
27797960|NCT02118896|81092468|FG001|Overall Study|Death|0|||
27797961|NCT02118896|81092469|FG002|Overall Study|Death|4|||
27797962|NCT02118896|81092470|FG003|Overall Study|Death|6|||
27797963|NCT02118896|81092471|FG004|Overall Study|Death|3|||
27676109|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
27676110|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Physician Decision|7|||
27676111|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Physician Decision|3|||
27676112|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Physician Decision|2|||
27676113|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Pregnancy|2|||
27676114|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Pregnancy|1|||
27676115|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Pregnancy|3|||
27676116|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
27797964|NCT02118896|81092472|FG005|Overall Study|Death|1|||
27797965|NCT02118896|81092473|FG006|Overall Study|Death|0|||
27797966|NCT02118896|81092474|FG007|Overall Study|Death|0|||
27797967|NCT02118896|81092475|FG008|Overall Study|Death|0|||
27797968|NCT02118896|81092476|FG009|Overall Study|Death|0|||
27797969|NCT02118896|81092467|FG000|Overall Study|Adverse Event|5|||
27990066|NCT01345669|81794780|FG000|Overall Study|Second primary tumour|4|||
27990067|NCT01345669|81794781|FG001|Overall Study|Second primary tumour|3|||
27990068|NCT01345669|81794780|FG000|Overall Study|Adverse Event|63|||
27990069|NCT01345669|81794781|FG001|Overall Study|Adverse Event|9|||
27990070|NCT01345669|81794780|FG000|Overall Study|Protocol Violation|3|||
27990071|NCT01345669|81794781|FG001|Overall Study|Protocol Violation|1|||
27990072|NCT01345669|81794780|FG000|Overall Study|Lost to Follow-up|1|||
27990073|NCT01345669|81794781|FG001|Overall Study|Lost to Follow-up|1|||
27990074|NCT01345669|81794780|FG000|Overall Study|Withdrawal by Subject|52|||
27990075|NCT01345669|81794781|FG001|Overall Study|Withdrawal by Subject|13|||
27990076|NCT01345669|81794780|FG000|Overall Study|Other Reasons|111|||
27990077|NCT01345669|81794781|FG001|Overall Study|Other Reasons|60|||
27990078|NCT02504580|81794782|FG000|Overall Study|Other|1|||
27990079|NCT02504580|81794783|FG001|Overall Study|Other|0|||
27990080|NCT02504580|81794784|FG002|Overall Study|Other|0|||
27990081|NCT02504580|81794785|FG003|Overall Study|Other|2|||
27990082|NCT02504580|81794786|FG004|Overall Study|Other|1|||
27990083|NCT02504580|81794787|FG005|Overall Study|Other|1|||
27990084|NCT02504580|81794788|FG006|Overall Study|Other|1|||
27990085|NCT02504580|81794789|FG007|Overall Study|Other|2|||
27990086|NCT02504580|81794790|FG008|Overall Study|Other|0|||
27990087|NCT02504580|81794791|FG009|Overall Study|Other|0|||
27990088|NCT02504580|81794792|FG010|Overall Study|Other|0|||
27990089|NCT02504580|81794793|FG011|Overall Study|Other|2|||
27990090|NCT02504580|81794782|FG000|Overall Study|Subject refusal to continue|0|||
27990091|NCT02504580|81794783|FG001|Overall Study|Subject refusal to continue|1|||
27990092|NCT02504580|81794784|FG002|Overall Study|Subject refusal to continue|0|||
27990093|NCT02504580|81794785|FG003|Overall Study|Subject refusal to continue|0|||
27990094|NCT02504580|81794786|FG004|Overall Study|Subject refusal to continue|0|||
27990095|NCT02504580|81794787|FG005|Overall Study|Subject refusal to continue|0|||
27990096|NCT02504580|81794788|FG006|Overall Study|Subject refusal to continue|0|||
27990097|NCT02504580|81794789|FG007|Overall Study|Subject refusal to continue|0|||
27990098|NCT02504580|81794790|FG008|Overall Study|Subject refusal to continue|0|||
27990099|NCT02504580|81794791|FG009|Overall Study|Subject refusal to continue|0|||
27990100|NCT02504580|81794792|FG010|Overall Study|Subject refusal to continue|0|||
27990101|NCT02504580|81794793|FG011|Overall Study|Subject refusal to continue|0|||
27990102|NCT00042991|81794794|FG000|Overall Study|Adverse Event|1|||
27990103|NCT00042991|81794795|FG001|Overall Study|Adverse Event|4|||
27990104|NCT00042991|81794796|FG002|Overall Study|Adverse Event|2|||
27990105|NCT00042991|81794797|FG003|Overall Study|Adverse Event|0|||
27990106|NCT00042991|81794798|FG004|Overall Study|Adverse Event|0|||
27990107|NCT00042991|81794799|FG005|Overall Study|Adverse Event|1|||
27990108|NCT00042991|81794800|FG006|Overall Study|Adverse Event|0|||
27990109|NCT00042991|81794794|FG000|Overall Study|Withdrawal by Subject|0|||
27990110|NCT00042991|81794795|FG001|Overall Study|Withdrawal by Subject|7|||
27990111|NCT00042991|81794796|FG002|Overall Study|Withdrawal by Subject|2|||
27990112|NCT00042991|81794797|FG003|Overall Study|Withdrawal by Subject|0|||
27990113|NCT00042991|81794798|FG004|Overall Study|Withdrawal by Subject|1|||
27990114|NCT00042991|81794799|FG005|Overall Study|Withdrawal by Subject|0|||
27990115|NCT00042991|81794800|FG006|Overall Study|Withdrawal by Subject|0|||
27990116|NCT00042991|81794794|FG000|Overall Study|Disease Progression|5|||
27579240|NCT03403634|80303153|FG000|Overall Study|Disease progression|3|||
27579241|NCT03403634|80303153|FG000|Overall Study|Did not meet eligibility criteria|4|||
27579242|NCT03495908|80303154|FG000|Overall Study|Withdrawal by Subject|3|||
27579243|NCT03495908|80303155|FG001|Overall Study|Withdrawal by Subject|1|||
27579244|NCT03495908|80303154|FG000|Overall Study|Lost to Follow-up|1|||
27579245|NCT03495908|80303155|FG001|Overall Study|Lost to Follow-up|4|||
27579246|NCT03495908|80303154|FG000|Overall Study|Adverse Event|0|||
27579247|NCT03495908|80303155|FG001|Overall Study|Adverse Event|2|||
27676117|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
27797970|NCT02118896|81092468|FG001|Overall Study|Adverse Event|4|||
27797971|NCT02118896|81092469|FG002|Overall Study|Adverse Event|4|||
27797972|NCT02118896|81092470|FG003|Overall Study|Adverse Event|5|||
27797973|NCT02118896|81092471|FG004|Overall Study|Adverse Event|5|||
27797974|NCT02118896|81092472|FG005|Overall Study|Adverse Event|9|||
27797975|NCT02118896|81092473|FG006|Overall Study|Adverse Event|1|||
27797976|NCT02118896|81092474|FG007|Overall Study|Adverse Event|1|||
27797977|NCT02118896|81092475|FG008|Overall Study|Adverse Event|4|||
27990117|NCT00042991|81794795|FG001|Overall Study|Disease Progression|29|||
27990118|NCT00042991|81794796|FG002|Overall Study|Disease Progression|2|||
27579248|NCT03495908|80303154|FG000|Overall Study|Death|1|||
27579249|NCT03495908|80303155|FG001|Overall Study|Death|0|||
27579250|NCT03495908|80303154|FG000|Overall Study|Physician Decision|5|||
27797978|NCT02118896|81092476|FG009|Overall Study|Adverse Event|0|||
27990119|NCT00042991|81794797|FG003|Overall Study|Disease Progression|2|||
27990120|NCT00042991|81794798|FG004|Overall Study|Disease Progression|1|||
27990121|NCT00042991|81794799|FG005|Overall Study|Disease Progression|4|||
27990122|NCT00042991|81794800|FG006|Overall Study|Disease Progression|2|||
27990123|NCT00042991|81794794|FG000|Overall Study|Alternative Therapy|0|||
27990124|NCT00042991|81794795|FG001|Overall Study|Alternative Therapy|0|||
27990125|NCT00042991|81794796|FG002|Overall Study|Alternative Therapy|0|||
27990126|NCT00042991|81794797|FG003|Overall Study|Alternative Therapy|0|||
27990127|NCT00042991|81794798|FG004|Overall Study|Alternative Therapy|1|||
27990128|NCT00042991|81794799|FG005|Overall Study|Alternative Therapy|0|||
27990129|NCT00042991|81794800|FG006|Overall Study|Alternative Therapy|0|||
27990130|NCT01192568|81794805|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
27990131|NCT01192568|81794806|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
27990132|NCT01192568|81794807|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
27797979|NCT02118896|81092467|FG000|Overall Study|Consent withdrawn|2|||
27797980|NCT02118896|81092468|FG001|Overall Study|Consent withdrawn|0|||
27797981|NCT02118896|81092469|FG002|Overall Study|Consent withdrawn|3|||
27797982|NCT02118896|81092470|FG003|Overall Study|Consent withdrawn|4|||
27797983|NCT02118896|81092471|FG004|Overall Study|Consent withdrawn|1|||
27797984|NCT02118896|81092472|FG005|Overall Study|Consent withdrawn|4|||
27797985|NCT02118896|81092473|FG006|Overall Study|Consent withdrawn|0|||
27797986|NCT02118896|81092474|FG007|Overall Study|Consent withdrawn|0|||
27797987|NCT02118896|81092475|FG008|Overall Study|Consent withdrawn|0|||
27797988|NCT02118896|81092476|FG009|Overall Study|Consent withdrawn|0|||
27797989|NCT02118896|81092467|FG000|Overall Study|Non-compliance|2|||
27797990|NCT02118896|81092468|FG001|Overall Study|Non-compliance|1|||
27797991|NCT02118896|81092469|FG002|Overall Study|Non-compliance|1|||
27797992|NCT02118896|81092470|FG003|Overall Study|Non-compliance|5|||
27797993|NCT02118896|81092471|FG004|Overall Study|Non-compliance|0|||
27797994|NCT02118896|81092472|FG005|Overall Study|Non-compliance|1|||
27797995|NCT02118896|81092473|FG006|Overall Study|Non-compliance|0|||
27797996|NCT02118896|81092474|FG007|Overall Study|Non-compliance|1|||
27797997|NCT02118896|81092475|FG008|Overall Study|Non-compliance|0|||
27797998|NCT02118896|81092476|FG009|Overall Study|Non-compliance|0|||
27990133|NCT01192568|81794808|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
27990134|NCT01192568|81794805|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
27990135|NCT01192568|81794806|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
27990136|NCT01192568|81794807|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
27990137|NCT01192568|81794808|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
27990138|NCT00211887|81794809|FG000|Overall Study|Adverse Event|8|||
27990139|NCT00211887|81794810|FG001|Overall Study|Adverse Event|4|||
27990140|NCT00211887|81794811|FG002|Overall Study|Adverse Event|6|||
27990141|NCT00211887|81794809|FG000|Overall Study|Death|1|||
27990142|NCT00211887|81794810|FG001|Overall Study|Death|1|||
27797999|NCT02118896|81092467|FG000|Overall Study|Pregnancy|1|||
27798000|NCT02118896|81092468|FG001|Overall Study|Pregnancy|1|||
27798001|NCT02118896|81092469|FG002|Overall Study|Pregnancy|0|||
27798002|NCT02118896|81092470|FG003|Overall Study|Pregnancy|0|||
27798003|NCT02118896|81092471|FG004|Overall Study|Pregnancy|1|||
27798004|NCT02118896|81092472|FG005|Overall Study|Pregnancy|3|||
27798005|NCT02118896|81092473|FG006|Overall Study|Pregnancy|1|||
27798006|NCT02118896|81092474|FG007|Overall Study|Pregnancy|0|||
27798007|NCT02118896|81092475|FG008|Overall Study|Pregnancy|0|||
27798008|NCT02118896|81092476|FG009|Overall Study|Pregnancy|0|||
27798009|NCT02118896|81092467|FG000|Overall Study|Lost to Follow-up|1|||
27798010|NCT02118896|81092468|FG001|Overall Study|Lost to Follow-up|2|||
27870485|NCT03536884|81361469|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870486|NCT03536884|81361470|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870487|NCT03536884|81361471|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870488|NCT03536884|81361472|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870489|NCT03536884|81361473|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870490|NCT03536884|81361474|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870491|NCT03536884|81361475|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27990143|NCT00211887|81794811|FG002|Overall Study|Death|1|||
27990144|NCT00211887|81794809|FG000|Overall Study|Lost to Follow-up|28|||
27990145|NCT00211887|81794810|FG001|Overall Study|Lost to Follow-up|13|||
27990146|NCT00211887|81794811|FG002|Overall Study|Lost to Follow-up|9|||
27990147|NCT00211887|81794809|FG000|Overall Study|Non-medical reason|31|||
27990148|NCT00211887|81794810|FG001|Overall Study|Non-medical reason|14|||
27676118|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
27676119|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
27676120|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
27798011|NCT02118896|81092469|FG002|Overall Study|Lost to Follow-up|1|||
27798012|NCT02118896|81092470|FG003|Overall Study|Lost to Follow-up|0|||
27798013|NCT02118896|81092471|FG004|Overall Study|Lost to Follow-up|2|||
27798014|NCT02118896|81092472|FG005|Overall Study|Lost to Follow-up|1|||
27798015|NCT02118896|81092473|FG006|Overall Study|Lost to Follow-up|0|||
27798016|NCT02118896|81092474|FG007|Overall Study|Lost to Follow-up|0|||
27798017|NCT02118896|81092475|FG008|Overall Study|Lost to Follow-up|0|||
27798018|NCT02118896|81092476|FG009|Overall Study|Lost to Follow-up|0|||
27798019|NCT02118896|81092467|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
27798020|NCT02118896|81092468|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
27990149|NCT00211887|81794811|FG002|Overall Study|Non-medical reason|8|||
27990150|NCT00211887|81794809|FG000|Overall Study|Other medical reason|15|||
27990151|NCT00211887|81794810|FG001|Overall Study|Other medical reason|11|||
27990152|NCT00211887|81794811|FG002|Overall Study|Other medical reason|7|||
27990153|NCT00211887|81794809|FG000|Overall Study|Side effects|19|||
27990154|NCT00211887|81794810|FG001|Overall Study|Side effects|13|||
27990155|NCT00211887|81794811|FG002|Overall Study|Side effects|5|||
27990156|NCT02413489|81794813|FG000|Overall Study|Death|11|||
27990157|NCT02413489|81794814|FG001|Overall Study|Death|3|||
27990158|NCT02413489|81794815|FG002|Overall Study|Death|4|||
27990159|NCT02413489|81794813|FG000|Overall Study|Withdrawal by Subject|2|||
27990160|NCT02413489|81794814|FG001|Overall Study|Withdrawal by Subject|0|||
27990161|NCT02413489|81794815|FG002|Overall Study|Withdrawal by Subject|0|||
27990162|NCT02413489|81794813|FG000|Overall Study|Study Terminated By Sponsor|2|||
27990163|NCT02413489|81794814|FG001|Overall Study|Study Terminated By Sponsor|13|||
27990164|NCT02413489|81794815|FG002|Overall Study|Study Terminated By Sponsor|1|||
27990165|NCT02593825|81794819|FG000|Intervention|Lost to Follow-up|10|||
27990166|NCT02593825|81794820|FG001|Intervention|Lost to Follow-up|12|||
27990167|NCT03043651|81794829|FG000|Overall Study|Death|1|||
27990168|NCT03043651|81794829|FG000|Overall Study|Progressive Disease|2|||
27990169|NCT03043651|81794829|FG000|Overall Study|Adverse Event|2|||
27990170|NCT03043651|81794829|FG000|Overall Study|Withdrawal by Subject|4|||
27990171|NCT03043651|81794829|FG000|Overall Study|Study Terminated by Sponsor|39|||
27990172|NCT00622388|81794830|FG000|Overall Study|Disease Progression|47|||
27990173|NCT00622388|81794830|FG000|Overall Study|Adverse Event|6|||
27990174|NCT00622388|81794830|FG000|Overall Study|Protocol Violation|3|||
27990175|NCT00622388|81794830|FG000|Overall Study|Participant Refusal|1|||
27990176|NCT00622388|81794830|FG000|Overall Study|Death|3|||
27676121|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
27676122|NCT02614183|80650331|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
27676123|NCT02614183|80650332|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
27676124|NCT02614183|80650333|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
27676125|NCT02614183|80650331|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
27676126|NCT02614183|80650332|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
27676127|NCT02614183|80650333|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
27676128|NCT02614183|80650331|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
27676129|NCT02614183|80650332|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
27676130|NCT02614183|80650333|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
27676131|NCT02614183|80650331|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
27676132|NCT02614183|80650332|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
27676133|NCT02614183|80650333|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
27676134|NCT02614183|80650331|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
27676135|NCT02614183|80650332|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
27798021|NCT02118896|81092469|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
27798022|NCT02118896|81092470|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
27798023|NCT02118896|81092471|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
27798024|NCT02118896|81092472|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
27798025|NCT02118896|81092473|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
27798026|NCT02118896|81092474|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
27798027|NCT02118896|81092475|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
27798028|NCT02118896|81092476|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
27798029|NCT02118896|81092467|FG000|Overall Study|Prohibited medication|0|||
27798030|NCT02118896|81092468|FG001|Overall Study|Prohibited medication|0|||
27798031|NCT02118896|81092469|FG002|Overall Study|Prohibited medication|0|||
27870492|NCT03536884|81361476|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870493|NCT03536884|81361477|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870494|NCT03536884|81361478|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
27870495|NCT03536884|81361467|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870496|NCT03536884|81361468|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
27870497|NCT03536884|81361469|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870498|NCT03536884|81361470|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870499|NCT03536884|81361471|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870500|NCT03536884|81361472|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870501|NCT03536884|81361473|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27676136|NCT02614183|80650333|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
27676137|NCT00126659|80650334|FG000|Overall Study|Adverse Event|0|||
27676138|NCT00126659|80650335|FG001|Overall Study|Adverse Event|0|||
27798032|NCT02118896|81092470|FG003|Overall Study|Prohibited medication|0|||
27798033|NCT02118896|81092471|FG004|Overall Study|Prohibited medication|1|||
27798034|NCT02118896|81092472|FG005|Overall Study|Prohibited medication|3|||
27990177|NCT00622388|81794830|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
27990178|NCT00622388|81794830|FG000|Overall Study|Took Prohibited Medication|2|||
27990179|NCT00622388|81794830|FG000|Overall Study|Withdrew Consent|1|||
27990180|NCT00622388|81794830|FG000|Overall Study|Insurance Expired|1|||
27990181|NCT04302545|81794831|FG000|Overall Study|Lost to Follow-up|3|||
27676139|NCT00126659|80650336|FG002|Overall Study|Adverse Event|2|||
27870502|NCT03536884|81361474|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870503|NCT03536884|81361475|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27798035|NCT02118896|81092473|FG006|Overall Study|Prohibited medication|0|||
27798036|NCT02118896|81092474|FG007|Overall Study|Prohibited medication|0|||
27798037|NCT02118896|81092475|FG008|Overall Study|Prohibited medication|0|||
27798038|NCT02118896|81092476|FG009|Overall Study|Prohibited medication|0|||
27870504|NCT03536884|81361476|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870505|NCT03536884|81361477|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870506|NCT03536884|81361478|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
27870507|NCT03536884|81361467|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870508|NCT03536884|81361468|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870509|NCT03536884|81361469|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
27870510|NCT03536884|81361470|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870511|NCT03536884|81361471|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
27870512|NCT03536884|81361472|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870513|NCT03536884|81361473|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870514|NCT03536884|81361474|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870515|NCT03536884|81361475|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870516|NCT03536884|81361476|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870517|NCT03536884|81361477|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
27870518|NCT03536884|81361478|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
27798039|NCT02118896|81092467|FG000|Overall Study|Miscellaneous|1|||
27798040|NCT02118896|81092468|FG001|Overall Study|Miscellaneous|2|||
27798041|NCT02118896|81092469|FG002|Overall Study|Miscellaneous|0|||
27798042|NCT02118896|81092470|FG003|Overall Study|Miscellaneous|2|||
27798043|NCT02118896|81092471|FG004|Overall Study|Miscellaneous|0|||
27798044|NCT02118896|81092472|FG005|Overall Study|Miscellaneous|4|||
27798045|NCT02118896|81092473|FG006|Overall Study|Miscellaneous|0|||
27798046|NCT02118896|81092474|FG007|Overall Study|Miscellaneous|0|||
27798047|NCT02118896|81092475|FG008|Overall Study|Miscellaneous|0|||
27798048|NCT02118896|81092476|FG009|Overall Study|Miscellaneous|0|||
27798049|NCT04991311|81092477|FG000|Overall Study|Adverse Event|1|||
27798050|NCT03927989|81092478|FG000|Overall Study|Withdrawal by Subject|0|||
27798051|NCT03927989|81092479|FG001|Overall Study|Withdrawal by Subject|1|||
27798052|NCT02864953|81092482|FG000|Overall Study|Adverse Event|22|||
27798053|NCT02864953|81092483|FG001|Overall Study|Adverse Event|19|||
27798054|NCT02864953|81092482|FG000|Overall Study|Withdrawal by Subject|1|||
27798055|NCT02864953|81092483|FG001|Overall Study|Withdrawal by Subject|0|||
27798056|NCT02864953|81092482|FG000|Overall Study|Physician Decision|4|||
27798057|NCT02864953|81092483|FG001|Overall Study|Physician Decision|2|||
27798058|NCT02864953|81092482|FG000|Overall Study|Death|3|||
27798059|NCT02864953|81092483|FG001|Overall Study|Death|13|||
27798060|NCT02864953|81092482|FG000|Overall Study|Reason not specified|14|||
27798061|NCT02864953|81092483|FG001|Overall Study|Reason not specified|12|||
27798062|NCT02864953|81092482|FG000|Overall Study|Withdrew Prior to Dosing|9|||
27798063|NCT02864953|81092483|FG001|Overall Study|Withdrew Prior to Dosing|8|||
27798064|NCT05604521|81092484|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
27798065|NCT05604521|81092485|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
27798066|NCT05604521|81092484|FG000|Overall Study|Adverse Event|1|||
27798067|NCT05604521|81092485|FG001|Overall Study|Adverse Event|0|||
27798068|NCT06371079|81092488|FG000|Overall Study|Missing data|88|||
27798069|NCT06371079|81092489|FG001|Overall Study|Missing data|247|||
27798070|NCT05302414|81092492|FG000|Pretest to Posttest|Lost to Follow-up|12|||
27798071|NCT05302414|81092493|FG001|Pretest to Posttest|Lost to Follow-up|8|||
27798072|NCT05302414|81092494|FG002|Pretest to Posttest|Lost to Follow-up|8|||
27798073|NCT05302414|81092492|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
27870519|NCT03536884|81361467|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870520|NCT03536884|81361468|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870521|NCT03536884|81361469|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
27676140|NCT03809039|80650339|FG000|Part 1|Withdrawal by Subject|1|||
27798074|NCT05302414|81092493|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
27798075|NCT05302414|81092494|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
27798076|NCT04930536|81092495|FG000|Overall Study|Adverse Event|1|||
27798077|NCT04930536|81092496|FG001|Overall Study|Adverse Event|0|||
27870522|NCT03536884|81361470|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
27870523|NCT03536884|81361471|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
27798078|NCT04930536|81092495|FG000|Overall Study|Disease Progression|2|||
27798079|NCT04930536|81092496|FG001|Overall Study|Disease Progression|0|||
27798080|NCT04930536|81092495|FG000|Overall Study|Patient Decision|4|||
27798081|NCT04930536|81092496|FG001|Overall Study|Patient Decision|2|||
27798082|NCT04930536|81092495|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
27798083|NCT04930536|81092496|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
27798084|NCT01933932|81092499|FG000|Overall Study|Death|173|||
27798085|NCT01933932|81092500|FG001|Overall Study|Death|163|||
27870524|NCT03536884|81361472|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870525|NCT03536884|81361473|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870526|NCT03536884|81361474|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870527|NCT03536884|81361475|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870528|NCT03536884|81361476|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870529|NCT03536884|81361477|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870530|NCT03536884|81361478|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
27870531|NCT03536884|81361467|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27676141|NCT03809039|80650340|FG001|Part 1|Withdrawal by Subject|0|||
27676142|NCT03809039|80650341|FG002|Part 1|Withdrawal by Subject|0|||
27798086|NCT01933932|81092499|FG000|Overall Study|Withdrawal by Subject|11|||
27798087|NCT01933932|81092500|FG001|Overall Study|Withdrawal by Subject|14|||
27798088|NCT01933932|81092499|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27798089|NCT01933932|81092500|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27798090|NCT05166512|81092510|FG000|Randomized|Lost to Follow-up|2|||
27798091|NCT05166512|81092511|FG001|Randomized|Lost to Follow-up|0|||
27870532|NCT03536884|81361468|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870533|NCT03536884|81361469|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870534|NCT03536884|81361470|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
27870535|NCT03536884|81361471|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
27870536|NCT03536884|81361472|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870537|NCT03536884|81361473|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870538|NCT03536884|81361474|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870539|NCT03536884|81361475|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27990182|NCT04302545|81794832|FG001|Overall Study|Lost to Follow-up|4|||
27990183|NCT02147288|81794833|FG000|Overall Study|post-operative hematoma|1|||
27870540|NCT03536884|81361476|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870541|NCT03536884|81361477|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27990184|NCT02147288|81794834|FG001|Overall Study|post-operative hematoma|1|||
27870542|NCT03536884|81361478|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
27870543|NCT03536884|81361467|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870544|NCT03536884|81361468|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870545|NCT03536884|81361469|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
27870546|NCT03536884|81361470|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
27870547|NCT03536884|81361471|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
27870548|NCT03536884|81361472|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870549|NCT03536884|81361473|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870550|NCT03536884|81361474|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870551|NCT03536884|81361475|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870552|NCT03536884|81361476|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870553|NCT03536884|81361477|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870554|NCT03536884|81361478|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
27870555|NCT03536884|81361467|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870556|NCT03536884|81361468|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27990185|NCT02147288|81794835|FG002|Overall Study|post-operative hematoma|0|||
27870557|NCT03536884|81361469|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
27870558|NCT03536884|81361470|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
27870559|NCT03536884|81361471|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
27870560|NCT03536884|81361472|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870561|NCT03536884|81361473|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870562|NCT03536884|81361474|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870563|NCT03536884|81361475|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870564|NCT03536884|81361476|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870565|NCT03536884|81361477|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870566|NCT03536884|81361478|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
27870567|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870568|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870569|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870570|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870571|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
27990186|NCT02147288|81794836|FG003|Overall Study|post-operative hematoma|0|||
27990187|NCT02147288|81794837|FG004|Overall Study|post-operative hematoma|0|||
27676143|NCT03809039|80650342|FG003|Part 1|Withdrawal by Subject|1|||
27798092|NCT05166512|81092510|FG000|Randomized|Withdrawal by Subject|1|||
27870572|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
27990188|NCT02147288|81794838|FG005|Overall Study|post-operative hematoma|0|||
27676144|NCT03809039|80650343|FG004|Part 1|Withdrawal by Subject|0|||
27676145|NCT03809039|80650344|FG005|Part 1|Withdrawal by Subject|0|||
27798093|NCT05166512|81092511|FG001|Randomized|Withdrawal by Subject|0|||
27990189|NCT02147288|81794839|FG006|Overall Study|post-operative hematoma|0|||
27990190|NCT02147288|81794840|FG007|Overall Study|post-operative hematoma|0|||
27990191|NCT02147288|81794841|FG008|Overall Study|post-operative hematoma|0|||
27990192|NCT02147288|81794842|FG009|Overall Study|post-operative hematoma|0|||
27990193|NCT02147288|81794833|FG000|Overall Study|complications from concurrent hernia rep|0|||
27990194|NCT02147288|81794834|FG001|Overall Study|complications from concurrent hernia rep|1|||
27990195|NCT02147288|81794835|FG002|Overall Study|complications from concurrent hernia rep|0|||
27990196|NCT02147288|81794836|FG003|Overall Study|complications from concurrent hernia rep|0|||
27990197|NCT02147288|81794837|FG004|Overall Study|complications from concurrent hernia rep|0|||
27990198|NCT02147288|81794838|FG005|Overall Study|complications from concurrent hernia rep|0|||
27990199|NCT02147288|81794839|FG006|Overall Study|complications from concurrent hernia rep|0|||
27990200|NCT02147288|81794840|FG007|Overall Study|complications from concurrent hernia rep|0|||
27990201|NCT02147288|81794841|FG008|Overall Study|complications from concurrent hernia rep|0|||
27990202|NCT02147288|81794842|FG009|Overall Study|complications from concurrent hernia rep|0|||
27990203|NCT01088399|81794847|FG000|Overall Study|Adverse Event|211|||
27990204|NCT01088399|81794848|FG001|Overall Study|Adverse Event|16|||
27990205|NCT01088399|81794849|FG002|Overall Study|Adverse Event|0|||
27990206|NCT01088399|81794847|FG000|Overall Study|Death|204|||
27990207|NCT01088399|81794848|FG001|Overall Study|Death|45|||
27990208|NCT01088399|81794849|FG002|Overall Study|Death|0|||
27990209|NCT01088399|81794847|FG000|Overall Study|Lack of Efficacy|298|||
27990210|NCT01088399|81794848|FG001|Overall Study|Lack of Efficacy|7|||
27990211|NCT01088399|81794849|FG002|Overall Study|Lack of Efficacy|5|||
27990212|NCT01088399|81794847|FG000|Overall Study|Lost to Follow-up|1070|||
27990213|NCT01088399|81794848|FG001|Overall Study|Lost to Follow-up|278|||
27990214|NCT01088399|81794849|FG002|Overall Study|Lost to Follow-up|58|||
27990215|NCT01088399|81794847|FG000|Overall Study|Physician Decision|531|||
27990216|NCT01088399|81794848|FG001|Overall Study|Physician Decision|88|||
27990217|NCT01088399|81794849|FG002|Overall Study|Physician Decision|16|||
27990218|NCT01088399|81794847|FG000|Overall Study|Withdrawal by Subject|544|||
27990219|NCT01088399|81794848|FG001|Overall Study|Withdrawal by Subject|195|||
27990220|NCT01088399|81794849|FG002|Overall Study|Withdrawal by Subject|33|||
27990221|NCT01088399|81794847|FG000|Overall Study|Change to or start of somatropin therapy|234|||
27990222|NCT01088399|81794848|FG001|Overall Study|Change to or start of somatropin therapy|17|||
27990223|NCT01088399|81794849|FG002|Overall Study|Change to or start of somatropin therapy|12|||
27990224|NCT01088399|81794847|FG000|Overall Study|Sponsor decision|1573|||
27990225|NCT01088399|81794848|FG001|Overall Study|Sponsor decision|298|||
27990226|NCT01088399|81794849|FG002|Overall Study|Sponsor decision|7|||
27990227|NCT01088399|81794847|FG000|Overall Study|Protocol Violation|10|||
27990228|NCT01088399|81794848|FG001|Overall Study|Protocol Violation|1|||
27990229|NCT01088399|81794849|FG002|Overall Study|Protocol Violation|0|||
27990230|NCT01088399|81794847|FG000|Overall Study|Enrollment criteria not met|48|||
27990231|NCT01088399|81794848|FG001|Overall Study|Enrollment criteria not met|119|||
27990232|NCT01088399|81794849|FG002|Overall Study|Enrollment criteria not met|70|||
27990233|NCT01088399|81794847|FG000|Overall Study|Study summary visit not completed|2398|||
27990234|NCT01088399|81794848|FG001|Overall Study|Study summary visit not completed|283|||
27990235|NCT01088399|81794849|FG002|Overall Study|Study summary visit not completed|80|||
27798094|NCT05166512|81092510|FG000|Baseline Data Collection|Lost to Follow-up|0|||
27798095|NCT05166512|81092511|FG001|Baseline Data Collection|Lost to Follow-up|3|||
27798096|NCT05166512|81092510|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
27798097|NCT05166512|81092511|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
27798098|NCT05166512|81092510|FG000|Baseline Data Collection|Protocol Violation|2|||
27798099|NCT05166512|81092511|FG001|Baseline Data Collection|Protocol Violation|0|||
27990236|NCT00061633|81794856|FG000|Overall Study|Adverse Event|1|||
27990237|NCT00061633|81794857|FG001|Overall Study|Adverse Event|2|||
27990238|NCT00061633|81794856|FG000|Overall Study|Withdrawal by Subject|2|||
27990239|NCT00061633|81794857|FG001|Overall Study|Withdrawal by Subject|2|||
27990240|NCT00061633|81794856|FG000|Overall Study|Lost to Follow-up|1|||
27990241|NCT00061633|81794857|FG001|Overall Study|Lost to Follow-up|4|||
27990242|NCT00061633|81794856|FG000|Overall Study|Other|1|||
27990243|NCT00061633|81794857|FG001|Overall Study|Other|1|||
27990244|NCT00061633|81794856|FG000|Overall Study|Never received study treatment|0|||
27990245|NCT00061633|81794857|FG001|Overall Study|Never received study treatment|2|||
27990246|NCT00064792|81794858|FG000|Overall Study|Withdrawal by Subject|2|||
27990247|NCT00064792|81794859|FG001|Overall Study|Withdrawal by Subject|0|||
27990248|NCT00064792|81794858|FG000|Overall Study|Adverse Event|3|||
27990249|NCT00064792|81794859|FG001|Overall Study|Adverse Event|0|||
27990250|NCT00375518|81794864|FG000|Overall Study|Withdrawal by Subject|2|||
27990251|NCT00375518|81794865|FG001|Overall Study|Withdrawal by Subject|10|||
27990252|NCT00375518|81794864|FG000|Overall Study|Patient Not Treated|6|||
27990253|NCT00375518|81794865|FG001|Overall Study|Patient Not Treated|6|||
27990254|NCT00375518|81794864|FG000|Overall Study|Death|0|||
27990255|NCT00375518|81794865|FG001|Overall Study|Death|1|||
27990256|NCT02008773|81794866|FG000|Overall Study|Adverse Event|3|||
27990257|NCT02008773|81794867|FG001|Overall Study|Adverse Event|3|||
27990258|NCT02008773|81794868|FG002|Overall Study|Adverse Event|1|||
27990259|NCT02008773|81794869|FG003|Overall Study|Adverse Event|2|||
27990260|NCT02008773|81794866|FG000|Overall Study|Medication Non-compliance|2|||
27990261|NCT02008773|81794867|FG001|Overall Study|Medication Non-compliance|1|||
27990262|NCT02008773|81794868|FG002|Overall Study|Medication Non-compliance|3|||
27990263|NCT02008773|81794869|FG003|Overall Study|Medication Non-compliance|2|||
27990264|NCT02008773|81794866|FG000|Overall Study|Withdrawal by Subject|8|||
27990265|NCT02008773|81794867|FG001|Overall Study|Withdrawal by Subject|4|||
27990266|NCT02008773|81794868|FG002|Overall Study|Withdrawal by Subject|7|||
27990267|NCT02008773|81794869|FG003|Overall Study|Withdrawal by Subject|6|||
27990268|NCT02008773|81794866|FG000|Overall Study|Lost to Follow-up|0|||
27990269|NCT02008773|81794867|FG001|Overall Study|Lost to Follow-up|1|||
27990270|NCT02008773|81794868|FG002|Overall Study|Lost to Follow-up|3|||
27990271|NCT02008773|81794869|FG003|Overall Study|Lost to Follow-up|2|||
27990272|NCT01628965|81794874|FG000|Overall Study|Adverse Event|30|||
27990273|NCT01628965|81794874|FG000|Overall Study|Lack of Efficacy|7|||
27990274|NCT01628965|81794874|FG000|Overall Study|Withdrawal by Subject|3|||
27990275|NCT01628965|81794874|FG000|Overall Study|Lost to Follow-up|1|||
27990276|NCT01628965|81794874|FG000|Overall Study|Discontinuation criteria|8|||
27990277|NCT04390841|81794875|FG000|Overall Study|Withdrawal by Subject|2|||
27990278|NCT01114438|81794879|FG000|Overall Study|Adverse Event|10|||
27990279|NCT01114438|81794879|FG000|Overall Study|concomitant medication|1|||
27990280|NCT01114438|81794879|FG000|Overall Study|Physician Decision|1|||
27990281|NCT01114438|81794879|FG000|Overall Study|Withdrawal by Subject|2|||
27990282|NCT00621140|81794880|FG000|Overall Study|Adverse Event|4|||
27990283|NCT00621140|81794881|FG001|Overall Study|Adverse Event|5|||
27990284|NCT00621140|81794880|FG000|Overall Study|Lost to Follow-up|1|||
27990285|NCT00621140|81794881|FG001|Overall Study|Lost to Follow-up|2|||
27990286|NCT00621140|81794880|FG000|Overall Study|Withdrawal by Subject|4|||
27990287|NCT00621140|81794881|FG001|Overall Study|Withdrawal by Subject|6|||
27990288|NCT00621140|81794880|FG000|Overall Study|Other incl. lack of efficacy|6|||
27990289|NCT00621140|81794881|FG001|Overall Study|Other incl. lack of efficacy|5|||
27990290|NCT01563172|81794882|FG000|Overall Study|Adverse Event|5|||
27990291|NCT01563172|81794882|FG000|Overall Study|Lost to Follow-up|2|||
27990292|NCT01563172|81794882|FG000|Overall Study|Other (Protocol deviation)|5|||
27990293|NCT01563172|81794882|FG000|Overall Study|Other (Not specified)|1|||
27990294|NCT01068158|81794887|FG000|Overall Study|Withdrawal by Subject|1|||
27990295|NCT01068158|81794888|FG001|Overall Study|Withdrawal by Subject|2|||
27990296|NCT01068158|81794887|FG000|Overall Study|Lost to Follow-up|7|||
27990297|NCT01068158|81794888|FG001|Overall Study|Lost to Follow-up|0|||
27990298|NCT01068158|81794887|FG000|Overall Study|Protocol Violation|0|||
27990299|NCT01068158|81794888|FG001|Overall Study|Protocol Violation|2|||
27990300|NCT00761527|81794891|FG000|Overall Study|Adverse Event|3|||
27990301|NCT00761527|81794891|FG000|Overall Study|Poor Compliance|8|||
27990302|NCT00761527|81794891|FG000|Overall Study|Lost to Follow-up|9|||
27990303|NCT00761527|81794891|FG000|Overall Study|Unknown reason|2|||
27990304|NCT00528801|81794892|FG000|Overall Study|Withdrawal by Subject|1|||
27990305|NCT00528801|81794893|FG001|Overall Study|Withdrawal by Subject|1|||
27990306|NCT00528801|81794892|FG000|Overall Study|Protocol Violation|11|||
27990307|NCT00528801|81794893|FG001|Overall Study|Protocol Violation|5|||
27990308|NCT00528801|81794892|FG000|Overall Study|Lost to Follow-up|15|||
27990309|NCT00528801|81794893|FG001|Overall Study|Lost to Follow-up|4|||
27990310|NCT00528801|81794892|FG000|Overall Study|Administrative Reasons|0|||
27990311|NCT00528801|81794893|FG001|Overall Study|Administrative Reasons|1|||
27990312|NCT04371666|81794894|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
27990313|NCT04371666|81794895|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
27990314|NCT04371666|81794894|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
27990315|NCT04371666|81794895|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
27990316|NCT04371666|81794894|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
27990317|NCT04371666|81794895|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
27579251|NCT03495908|80303155|FG001|Overall Study|Physician Decision|4|||
27798100|NCT05166512|81092510|FG000|4 Month Data Collection|Lost to Follow-up|1|||
27798101|NCT05166512|81092511|FG001|4 Month Data Collection|Lost to Follow-up|0|||
27798102|NCT05166512|81092510|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
27798103|NCT05166512|81092511|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
27798104|NCT05166512|81092510|FG000|12 Month Data Collection|Lost to Follow-up|3|||
27798105|NCT05166512|81092511|FG001|12 Month Data Collection|Lost to Follow-up|1|||
27798106|NCT05166512|81092510|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
27798107|NCT05166512|81092511|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
27798108|NCT03889197|81092514|FG000|Overall Study|Withdrawal by Subject|1|||
27798109|NCT03889197|81092515|FG001|Overall Study|Withdrawal by Subject|0|||
27798110|NCT03889197|81092514|FG000|Overall Study|Physician Decision|0|||
27798111|NCT03889197|81092515|FG001|Overall Study|Physician Decision|1|||
27798112|NCT03889197|81092514|FG000|Overall Study|met exclusion criteria|0|||
27676146|NCT03809039|80650345|FG006|Part 1|Withdrawal by Subject|0|||
27798113|NCT03889197|81092515|FG001|Overall Study|met exclusion criteria|1|||
27990318|NCT04371666|81794894|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
27990319|NCT04371666|81794895|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
27990320|NCT04371666|81794894|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
27798114|NCT03889197|81092514|FG000|Overall Study|Protocol Violation|1|||
27798115|NCT03889197|81092515|FG001|Overall Study|Protocol Violation|0|||
27798116|NCT05789420|81092516|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
27798117|NCT05789420|81092516|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
27798118|NCT02720094|81092517|FG000|Overall Study|Scheduled exit visit/end of study|2|||
27798119|NCT02720094|81092518|FG001|Overall Study|Scheduled exit visit/end of study|1|||
27798120|NCT02720094|81092517|FG000|Overall Study|Death|4|||
27798121|NCT02720094|81092518|FG001|Overall Study|Death|7|||
27798122|NCT02720094|81092517|FG000|Overall Study|Withdrawal by Subject|55|||
27798123|NCT02720094|81092518|FG001|Overall Study|Withdrawal by Subject|56|||
27798124|NCT02720094|81092517|FG000|Overall Study|Lost to Follow-up|2|||
27798125|NCT02720094|81092518|FG001|Overall Study|Lost to Follow-up|7|||
27798126|NCT02720094|81092517|FG000|Overall Study|Physician Decision|1|||
27798127|NCT02720094|81092518|FG001|Overall Study|Physician Decision|3|||
27798128|NCT02720094|81092517|FG000|Overall Study|Inappropriate enrollment|1|||
27798129|NCT02720094|81092518|FG001|Overall Study|Inappropriate enrollment|3|||
27798130|NCT02720094|81092517|FG000|Overall Study|Ongoing|2210|||
27798131|NCT02720094|81092518|FG001|Overall Study|Ongoing|2203|||
27798132|NCT02720094|81092517|FG000|Overall Study|Relocation|1|||
27798133|NCT02720094|81092518|FG001|Overall Study|Relocation|1|||
27798134|NCT05048342|81092519|FG000|Overall Study|Adverse Event|1|||
27798135|NCT05048342|81092519|FG000|Overall Study|Subject decision|2|||
27798136|NCT01668719|81092520|FG000|Phase I|On treatment|1|||
27798137|NCT01668719|81092521|FG001|Phase I|On treatment|0|||
27798138|NCT01668719|81092522|FG002|Phase I|On treatment|0|||
27798139|NCT01668719|81092520|FG000|Phase I|Adverse Event|2|||
27798140|NCT01668719|81092521|FG001|Phase I|Adverse Event|0|||
27798141|NCT01668719|81092522|FG002|Phase I|Adverse Event|0|||
27798142|NCT01668719|81092520|FG000|Phase I|Progression/relapse|1|||
27990321|NCT04371666|81794895|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
27990322|NCT04371666|81794894|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
27990323|NCT04371666|81794895|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
27990324|NCT03691571|81794896|FG000|Overall Study|Withdrawal by Subject|9|||
27990325|NCT03691571|81794897|FG001|Overall Study|Withdrawal by Subject|2|||
27990326|NCT03772665|81794898|FG000|Overall Study|Protocol Violation|1|||
27990327|NCT03772665|81794899|FG001|Overall Study|Protocol Violation|0|||
27990328|NCT02980133|81794900|FG000|Overall Study|Other than specified|1|||
27990329|NCT02980133|81794901|FG001|Overall Study|Other than specified|1|||
27990330|NCT02980133|81794902|FG002|Overall Study|Other than specified|2|||
27990331|NCT02980133|81794903|FG003|Overall Study|Other than specified|2|||
27990332|NCT02980133|81794900|FG000|Overall Study|Lost to Follow-up|0|||
27990333|NCT02980133|81794901|FG001|Overall Study|Lost to Follow-up|0|||
27990334|NCT02980133|81794902|FG002|Overall Study|Lost to Follow-up|1|||
27990335|NCT02980133|81794903|FG003|Overall Study|Lost to Follow-up|3|||
27990336|NCT02980133|81794900|FG000|Overall Study|Protocol Violation|0|||
27990337|NCT02980133|81794901|FG001|Overall Study|Protocol Violation|1|||
27990338|NCT02980133|81794902|FG002|Overall Study|Protocol Violation|0|||
27990339|NCT02980133|81794903|FG003|Overall Study|Protocol Violation|0|||
27990340|NCT02980133|81794900|FG000|Overall Study|Withdrawal by parent/guardian|6|||
27798143|NCT01668719|81092521|FG001|Phase I|Progression/relapse|0|||
27990341|NCT02980133|81794901|FG001|Overall Study|Withdrawal by parent/guardian|3|||
27798144|NCT01668719|81092522|FG002|Phase I|Progression/relapse|0|||
27798145|NCT01668719|81092520|FG000|Phase I|not protocol specified|2|||
27798146|NCT01668719|81092521|FG001|Phase I|not protocol specified|0|||
27798147|NCT01668719|81092522|FG002|Phase I|not protocol specified|0|||
27798148|NCT01668719|81092520|FG000|Phase II|On treatment|0|||
27798149|NCT01668719|81092521|FG001|Phase II|On treatment|4|||
27798150|NCT01668719|81092522|FG002|Phase II|On treatment|3|||
27798151|NCT01668719|81092520|FG000|Phase II|Adverse Event|0|||
27798152|NCT01668719|81092521|FG001|Phase II|Adverse Event|18|||
27798153|NCT01668719|81092522|FG002|Phase II|Adverse Event|18|||
27798154|NCT01668719|81092520|FG000|Phase II|Refusal unrelated to adverse event|0|||
27798155|NCT01668719|81092521|FG001|Phase II|Refusal unrelated to adverse event|4|||
27798156|NCT01668719|81092522|FG002|Phase II|Refusal unrelated to adverse event|1|||
27798157|NCT01668719|81092520|FG000|Phase II|Progression/relapse|0|||
27798158|NCT01668719|81092521|FG001|Phase II|Progression/relapse|13|||
27798159|NCT01668719|81092522|FG002|Phase II|Progression/relapse|17|||
27990342|NCT02980133|81794902|FG002|Overall Study|Withdrawal by parent/guardian|3|||
27990343|NCT02980133|81794903|FG003|Overall Study|Withdrawal by parent/guardian|1|||
27990344|NCT02980133|81794900|FG000|Overall Study|Withdrawal by Subject|0|||
27990345|NCT02980133|81794901|FG001|Overall Study|Withdrawal by Subject|0|||
27990346|NCT02980133|81794902|FG002|Overall Study|Withdrawal by Subject|1|||
27990347|NCT02980133|81794903|FG003|Overall Study|Withdrawal by Subject|0|||
27990348|NCT02283788|81794904|FG000|Overall Study|Adverse Event|1|||
27990349|NCT02283788|81794905|FG001|Overall Study|Adverse Event|3|||
27990350|NCT02283788|81794906|FG002|Overall Study|Adverse Event|5|||
27990351|NCT02283788|81794907|FG003|Overall Study|Adverse Event|1|||
27990352|NCT02283788|81794904|FG000|Overall Study|Withdrawal by Subject|0|||
27990353|NCT02283788|81794905|FG001|Overall Study|Withdrawal by Subject|1|||
27990354|NCT02283788|81794906|FG002|Overall Study|Withdrawal by Subject|0|||
27990355|NCT02283788|81794907|FG003|Overall Study|Withdrawal by Subject|1|||
27990356|NCT00384332|81794908|FG000|Overall Study|Lost to Follow-up|4|||
27990357|NCT00384332|81794909|FG001|Overall Study|Lost to Follow-up|0|||
27990358|NCT01894243|81794913|FG000|Overall Study|Adverse Event|0|||
27990359|NCT01894243|81794914|FG001|Overall Study|Adverse Event|1|||
27990360|NCT01894243|81794915|FG002|Overall Study|Adverse Event|2|||
27990361|NCT01894243|81794913|FG000|Overall Study|Death|0|||
27990362|NCT01894243|81794914|FG001|Overall Study|Death|0|||
27990363|NCT01894243|81794915|FG002|Overall Study|Death|3|||
27990364|NCT01894243|81794913|FG000|Overall Study|Lack of Efficacy|3|||
27990365|NCT01894243|81794914|FG001|Overall Study|Lack of Efficacy|3|||
27990366|NCT01894243|81794915|FG002|Overall Study|Lack of Efficacy|1|||
27990367|NCT01894243|81794913|FG000|Overall Study|Condition under investigation worsened|8|||
27990368|NCT01894243|81794914|FG001|Overall Study|Condition under investigation worsened|6|||
27990369|NCT01894243|81794915|FG002|Overall Study|Condition under investigation worsened|2|||
27990370|NCT01894243|81794913|FG000|Overall Study|Subject decision|1|||
27990371|NCT01894243|81794914|FG001|Overall Study|Subject decision|0|||
27990372|NCT01894243|81794915|FG002|Overall Study|Subject decision|0|||
27990373|NCT01894243|81794913|FG000|Overall Study|Other|1|||
27990374|NCT01894243|81794914|FG001|Overall Study|Other|0|||
27990375|NCT01894243|81794915|FG002|Overall Study|Other|0|||
27990376|NCT00847197|81794918|FG000|Overall Study|Adverse Event|21|||
27990377|NCT00847197|81794919|FG001|Overall Study|Adverse Event|3|||
27990378|NCT00847197|81794918|FG000|Overall Study|Protocol Violation|0|||
27990379|NCT00847197|81794919|FG001|Overall Study|Protocol Violation|1|||
27990380|NCT00847197|81794918|FG000|Overall Study|Withdrawal by Subject|3|||
27990381|NCT00847197|81794919|FG001|Overall Study|Withdrawal by Subject|1|||
27990382|NCT03319212|81794920|FG000|Overall Study|Discontinued as moving out of local area|0|||
27990383|NCT03319212|81794921|FG001|Overall Study|Discontinued as moving out of local area|1|||
27990384|NCT03319212|81794920|FG000|Overall Study|Adverse Event|2|||
27990385|NCT03319212|81794921|FG001|Overall Study|Adverse Event|2|||
27990386|NCT03319212|81794920|FG000|Overall Study|Withdrawal by Subject|0|||
27990387|NCT03319212|81794921|FG001|Overall Study|Withdrawal by Subject|1|||
27990388|NCT03319212|81794920|FG000|Overall Study|Lost to Follow-up|0|||
27990389|NCT03319212|81794921|FG001|Overall Study|Lost to Follow-up|1|||
27990390|NCT03319212|81794920|FG000|Overall Study|Physician Decision|1|||
27990391|NCT03319212|81794921|FG001|Overall Study|Physician Decision|0|||
27990392|NCT02713828|81794922|FG000|Overall Study|Death|2|||
27990393|NCT02713828|81794923|FG001|Overall Study|Death|0|||
27990394|NCT02713828|81794922|FG000|Overall Study|Withdrawal by Subject|1|||
27798160|NCT01668719|81092520|FG000|Phase II|Death|0|||
27990395|NCT02713828|81794923|FG001|Overall Study|Withdrawal by Subject|0|||
27990396|NCT02713828|81794922|FG000|Overall Study|study terminated but patient allowed to|2|||
27990397|NCT02713828|81794923|FG001|Overall Study|study terminated but patient allowed to|0|||
27990398|NCT01748825|81794924|FG000|Dose Escalation|Refused further treatment|2|||
27990399|NCT01748825|81794925|FG001|Dose Escalation|Refused further treatment|2|||
27990400|NCT01748825|81794926|FG002|Dose Escalation|Refused further treatment|0|||
27990401|NCT01748825|81794927|FG003|Dose Escalation|Refused further treatment|0|||
27990402|NCT01748825|81794928|FG004|Dose Escalation|Refused further treatment|1|||
27990403|NCT01748825|81794929|FG005|Dose Escalation|Refused further treatment|2|||
27798161|NCT01668719|81092521|FG001|Phase II|Death|0|||
27798162|NCT01668719|81092522|FG002|Phase II|Death|2|||
27990404|NCT01748825|81794930|FG006|Dose Escalation|Refused further treatment|0|||
27990405|NCT01748825|81794931|FG007|Dose Escalation|Refused further treatment|0|||
27990406|NCT01748825|81794932|FG008|Dose Escalation|Refused further treatment|0|||
27990407|NCT01748825|81794933|FG009|Dose Escalation|Refused further treatment|0|||
27798163|NCT01668719|81092520|FG000|Phase II|not protocol specified|0|||
27798164|NCT01668719|81092521|FG001|Phase II|not protocol specified|13|||
27798165|NCT01668719|81092522|FG002|Phase II|not protocol specified|7|||
27798166|NCT05899218|81092523|FG000|Overall Study|Lost to Follow-up|2|||
27798167|NCT05899218|81092524|FG001|Overall Study|Lost to Follow-up|2|||
27798168|NCT05899218|81092523|FG000|Overall Study|deemed ineligible out of country|1|||
27798169|NCT05899218|81092524|FG001|Overall Study|deemed ineligible out of country|0|||
27798170|NCT05246111|81092526|FG000|Period 01|NOT ELIGIBLE IC5|1|||
27798171|NCT05246111|81092527|FG001|Period 01|NOT ELIGIBLE IC5|0|||
27798172|NCT05293743|81092528|FG000|Overall Study|Withdrawal by Subject|1|||
27798173|NCT05293743|81092529|FG001|Overall Study|Withdrawal by Subject|0|||
27798174|NCT02587325|81092530|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
27798175|NCT02587325|81092531|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
27990408|NCT01748825|81794924|FG000|Dose Escalation|Switched to alternative treatment|0|||
27990409|NCT01748825|81794925|FG001|Dose Escalation|Switched to alternative treatment|0|||
27990410|NCT01748825|81794926|FG002|Dose Escalation|Switched to alternative treatment|0|||
27676147|NCT03809039|80650346|FG007|Part 1|Withdrawal by Subject|0|||
27676148|NCT03809039|80650347|FG008|Part 1|Withdrawal by Subject|0|||
27990411|NCT01748825|81794927|FG003|Dose Escalation|Switched to alternative treatment|1|||
27990412|NCT01748825|81794928|FG004|Dose Escalation|Switched to alternative treatment|0|||
27990413|NCT01748825|81794929|FG005|Dose Escalation|Switched to alternative treatment|0|||
27990414|NCT01748825|81794930|FG006|Dose Escalation|Switched to alternative treatment|0|||
27990415|NCT01748825|81794931|FG007|Dose Escalation|Switched to alternative treatment|0|||
27676149|NCT03809039|80650339|FG000|Part 3|Withdrawn by study termination|0|||
27676150|NCT03809039|80650340|FG001|Part 3|Withdrawn by study termination|0|||
27676151|NCT03809039|80650341|FG002|Part 3|Withdrawn by study termination|0|||
27676152|NCT03809039|80650342|FG003|Part 3|Withdrawn by study termination|0|||
27676153|NCT03809039|80650343|FG004|Part 3|Withdrawn by study termination|0|||
27676154|NCT03809039|80650344|FG005|Part 3|Withdrawn by study termination|0|||
27676155|NCT03809039|80650345|FG006|Part 3|Withdrawn by study termination|0|||
27676156|NCT03809039|80650346|FG007|Part 3|Withdrawn by study termination|2|||
27676157|NCT03809039|80650347|FG008|Part 3|Withdrawn by study termination|6|||
27676158|NCT01732549|80650352|FG000|Overall Study|Adverse Event|13|||
27676159|NCT01732549|80650353|FG001|Overall Study|Adverse Event|3|||
27676160|NCT01732549|80650352|FG000|Overall Study|Consent withdrawn|13|||
27676161|NCT01732549|80650353|FG001|Overall Study|Consent withdrawn|6|||
27676162|NCT01732549|80650352|FG000|Overall Study|Disease progression|37|||
27676163|NCT01732549|80650353|FG001|Overall Study|Disease progression|50|||
27676164|NCT01732549|80650352|FG000|Overall Study|Other|8|||
27676165|NCT01732549|80650353|FG001|Overall Study|Other|14|||
27676166|NCT00203047|80650356|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
27676167|NCT00203047|80650357|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
27676168|NCT00203047|80650356|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
27676169|NCT00203047|80650357|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
27676170|NCT00203047|80650356|FG000|Overall Study|Withdrawal by Subject|13|||
27676171|NCT00203047|80650357|FG001|Overall Study|Withdrawal by Subject|47|||
27676172|NCT00203047|80650356|FG000|Overall Study|Teva requested participant withdrawal|1|||
27676173|NCT00203047|80650357|FG001|Overall Study|Teva requested participant withdrawal|1|||
27676174|NCT00203047|80650356|FG000|Overall Study|Physician Decision|8|||
27676175|NCT00203047|80650357|FG001|Overall Study|Physician Decision|7|||
27676176|NCT00203047|80650356|FG000|Overall Study|Non-compliance|4|||
27676177|NCT00203047|80650357|FG001|Overall Study|Non-compliance|8|||
27676178|NCT00203047|80650356|FG000|Overall Study|Protocol Violation|1|||
27676179|NCT00203047|80650357|FG001|Overall Study|Protocol Violation|0|||
27676180|NCT00203047|80650356|FG000|Overall Study|Lost to Follow-up|11|||
27676181|NCT00203047|80650357|FG001|Overall Study|Lost to Follow-up|5|||
27676182|NCT00203047|80650356|FG000|Overall Study|Adverse Event|8|||
27676183|NCT00203047|80650357|FG001|Overall Study|Adverse Event|18|||
27676184|NCT00203047|80650356|FG000|Overall Study|Death|1|||
27798176|NCT02587325|81092532|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
27798177|NCT02587325|81092533|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
27798178|NCT02587325|81092534|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
27990416|NCT01748825|81794932|FG008|Dose Escalation|Switched to alternative treatment|0|||
27676185|NCT00203047|80650357|FG001|Overall Study|Death|2|||
27676186|NCT00203047|80650356|FG000|Overall Study|Pregnancy|3|||
27990417|NCT01748825|81794933|FG009|Dose Escalation|Switched to alternative treatment|0|||
27990418|NCT01748825|81794924|FG000|Dose Escalation|Adverse Event|0|||
27990419|NCT01748825|81794925|FG001|Dose Escalation|Adverse Event|0|||
27990420|NCT01748825|81794926|FG002|Dose Escalation|Adverse Event|0|||
27990421|NCT01748825|81794927|FG003|Dose Escalation|Adverse Event|0|||
27990422|NCT01748825|81794928|FG004|Dose Escalation|Adverse Event|0|||
27990423|NCT01748825|81794929|FG005|Dose Escalation|Adverse Event|0|||
27990424|NCT01748825|81794930|FG006|Dose Escalation|Adverse Event|1|||
27990425|NCT01748825|81794931|FG007|Dose Escalation|Adverse Event|0|||
27990426|NCT01748825|81794932|FG008|Dose Escalation|Adverse Event|0|||
27990427|NCT01748825|81794933|FG009|Dose Escalation|Adverse Event|0|||
27990428|NCT01748825|81794924|FG000|Dose Expansion|Refused further treatment|0|||
27990429|NCT01748825|81794925|FG001|Dose Expansion|Refused further treatment|0|||
27990430|NCT01748825|81794926|FG002|Dose Expansion|Refused further treatment|0|||
27990431|NCT01748825|81794927|FG003|Dose Expansion|Refused further treatment|0|||
27990432|NCT01748825|81794928|FG004|Dose Expansion|Refused further treatment|0|||
27990433|NCT01748825|81794929|FG005|Dose Expansion|Refused further treatment|0|||
27990434|NCT01748825|81794930|FG006|Dose Expansion|Refused further treatment|0|||
27990435|NCT01748825|81794931|FG007|Dose Expansion|Refused further treatment|0|||
27990436|NCT01748825|81794932|FG008|Dose Expansion|Refused further treatment|1|||
27990437|NCT01748825|81794933|FG009|Dose Expansion|Refused further treatment|1|||
27990438|NCT01748825|81794924|FG000|Dose Expansion|Switched to alternative treatment|0|||
27990439|NCT01748825|81794925|FG001|Dose Expansion|Switched to alternative treatment|0|||
27990440|NCT01748825|81794926|FG002|Dose Expansion|Switched to alternative treatment|0|||
27990441|NCT01748825|81794927|FG003|Dose Expansion|Switched to alternative treatment|0|||
27990442|NCT01748825|81794928|FG004|Dose Expansion|Switched to alternative treatment|0|||
27870573|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
27870574|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
27870575|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
27870576|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870577|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870578|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
27870579|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870580|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870581|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870582|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870583|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870584|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
27870585|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
27870586|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
27870587|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
27870588|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870589|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870590|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
27870591|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870592|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870593|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870594|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870595|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27990443|NCT01748825|81794929|FG005|Dose Expansion|Switched to alternative treatment|0|||
27990444|NCT01748825|81794930|FG006|Dose Expansion|Switched to alternative treatment|0|||
27990445|NCT01748825|81794931|FG007|Dose Expansion|Switched to alternative treatment|0|||
27990446|NCT01748825|81794932|FG008|Dose Expansion|Switched to alternative treatment|0|||
27990447|NCT01748825|81794933|FG009|Dose Expansion|Switched to alternative treatment|1|||
27870596|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
27990448|NCT01748825|81794924|FG000|Dose Expansion|Adverse Event|0|||
27990449|NCT01748825|81794925|FG001|Dose Expansion|Adverse Event|0|||
27990450|NCT01748825|81794926|FG002|Dose Expansion|Adverse Event|0|||
27990451|NCT01748825|81794927|FG003|Dose Expansion|Adverse Event|0|||
27990452|NCT01748825|81794928|FG004|Dose Expansion|Adverse Event|0|||
27990453|NCT01748825|81794929|FG005|Dose Expansion|Adverse Event|0|||
27990454|NCT01748825|81794930|FG006|Dose Expansion|Adverse Event|0|||
27990455|NCT01748825|81794931|FG007|Dose Expansion|Adverse Event|0|||
27990456|NCT01748825|81794932|FG008|Dose Expansion|Adverse Event|0|||
27990457|NCT01748825|81794933|FG009|Dose Expansion|Adverse Event|3|||
27990458|NCT01748825|81794924|FG000|Dose Expansion|Physician Decision|0|||
27990459|NCT01748825|81794925|FG001|Dose Expansion|Physician Decision|0|||
27798179|NCT02587325|81092530|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
27798180|NCT02587325|81092531|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
27798181|NCT02587325|81092532|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
27990460|NCT01748825|81794926|FG002|Dose Expansion|Physician Decision|0|||
27990461|NCT01748825|81794927|FG003|Dose Expansion|Physician Decision|0|||
27990462|NCT01748825|81794928|FG004|Dose Expansion|Physician Decision|0|||
27990463|NCT01748825|81794929|FG005|Dose Expansion|Physician Decision|0|||
27990464|NCT01748825|81794930|FG006|Dose Expansion|Physician Decision|0|||
27990465|NCT01748825|81794931|FG007|Dose Expansion|Physician Decision|0|||
27990466|NCT01748825|81794932|FG008|Dose Expansion|Physician Decision|1|||
27870597|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870598|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
27870599|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870600|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870601|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870602|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
27870603|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870604|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870605|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870606|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870607|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870608|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
27990467|NCT01748825|81794933|FG009|Dose Expansion|Physician Decision|0|||
27990468|NCT02161380|81794934|FG000|Overall Study|Lost to Follow-up|0|||
27990469|NCT02161380|81794935|FG001|Overall Study|Lost to Follow-up|1|||
27990470|NCT02161380|81794936|FG002|Overall Study|Lost to Follow-up|0|||
27990471|NCT02161380|81794937|FG003|Overall Study|Lost to Follow-up|0|||
27990472|NCT03887221|81794941|FG000|Overall Study|Protocol Violation|1|||
27798182|NCT02587325|81092533|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
27798183|NCT02587325|81092534|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
27798184|NCT02587325|81092530|FG000|32-Week Optional Extension Part|Adverse Event|0|||
27798185|NCT02587325|81092531|FG001|32-Week Optional Extension Part|Adverse Event|0|||
27798186|NCT02587325|81092532|FG002|32-Week Optional Extension Part|Adverse Event|1|||
27798187|NCT02587325|81092533|FG003|32-Week Optional Extension Part|Adverse Event|0|||
27798188|NCT02587325|81092534|FG004|32-Week Optional Extension Part|Adverse Event|0|||
27798189|NCT02587325|81092530|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
27798190|NCT02587325|81092531|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
27798191|NCT02587325|81092532|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
27870609|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27990473|NCT03887221|81794942|FG001|Overall Study|Protocol Violation|0|||
27870610|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
27990474|NCT03405818|81794943|FG000|Overall Study|Withdrawal by Subject|4|||
27990475|NCT03405818|81794943|FG000|Overall Study|Lost to Follow-up|4|||
27990476|NCT03245775|81794948|FG000|Overall Study|Lost to Follow-up|25|||
27990477|NCT03245775|81794949|FG001|Overall Study|Lost to Follow-up|26|||
27990478|NCT03245775|81794950|FG002|Overall Study|Lost to Follow-up|16|||
27990479|NCT03245775|81794951|FG003|Overall Study|Lost to Follow-up|16|||
27990480|NCT02328027|81794952|FG000|Overall Study|Withdrawal by Subject|0|||
27990481|NCT02328027|81794953|FG001|Overall Study|Withdrawal by Subject|1|||
27990482|NCT00106353|81794954|FG000|Part 1|Disease progression|3|||
27990483|NCT00106353|81794955|FG001|Part 1|Disease progression|4|||
27990484|NCT00106353|81794956|FG002|Part 1|Disease progression|1|||
27990485|NCT00106353|81794957|FG003|Part 1|Disease progression|3|||
27990486|NCT00106353|81794958|FG004|Part 1|Disease progression|0|||
27990487|NCT00106353|81794959|FG005|Part 1|Disease progression|0|||
27990488|NCT00106353|81794960|FG006|Part 1|Disease progression|0|||
27990489|NCT00106353|81794954|FG000|Part 1|Withdrawal by Subject|0|||
27798192|NCT02587325|81092533|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
27870611|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
27798193|NCT02587325|81092534|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
27870612|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27990490|NCT00106353|81794955|FG001|Part 1|Withdrawal by Subject|0|||
27990491|NCT00106353|81794956|FG002|Part 1|Withdrawal by Subject|1|||
27990492|NCT00106353|81794957|FG003|Part 1|Withdrawal by Subject|2|||
27990493|NCT00106353|81794958|FG004|Part 1|Withdrawal by Subject|0|||
27990494|NCT00106353|81794959|FG005|Part 1|Withdrawal by Subject|0|||
27990495|NCT00106353|81794960|FG006|Part 1|Withdrawal by Subject|0|||
27990496|NCT00106353|81794954|FG000|Part 1|Symptomatic deterioration|0|||
27990497|NCT00106353|81794955|FG001|Part 1|Symptomatic deterioration|0|||
27990498|NCT00106353|81794956|FG002|Part 1|Symptomatic deterioration|1|||
27990499|NCT00106353|81794957|FG003|Part 1|Symptomatic deterioration|0|||
27990500|NCT00106353|81794958|FG004|Part 1|Symptomatic deterioration|0|||
27990501|NCT00106353|81794959|FG005|Part 1|Symptomatic deterioration|0|||
27990502|NCT00106353|81794960|FG006|Part 1|Symptomatic deterioration|0|||
27990503|NCT00106353|81794954|FG000|Part 1|Entered follow-up phase|1|||
27990504|NCT00106353|81794955|FG001|Part 1|Entered follow-up phase|1|||
27990505|NCT00106353|81794956|FG002|Part 1|Entered follow-up phase|0|||
27990506|NCT00106353|81794957|FG003|Part 1|Entered follow-up phase|1|||
27990507|NCT00106353|81794958|FG004|Part 1|Entered follow-up phase|0|||
27990508|NCT00106353|81794959|FG005|Part 1|Entered follow-up phase|0|||
27990509|NCT00106353|81794960|FG006|Part 1|Entered follow-up phase|0|||
27990510|NCT00106353|81794954|FG000|Part 1|Adverse Event|0|||
27990511|NCT00106353|81794955|FG001|Part 1|Adverse Event|0|||
27990512|NCT00106353|81794956|FG002|Part 1|Adverse Event|0|||
27990513|NCT00106353|81794957|FG003|Part 1|Adverse Event|1|||
27990514|NCT00106353|81794958|FG004|Part 1|Adverse Event|0|||
27990515|NCT00106353|81794959|FG005|Part 1|Adverse Event|0|||
27990516|NCT00106353|81794960|FG006|Part 1|Adverse Event|0|||
27990517|NCT00106353|81794954|FG000|Part 2|Disease progression|0|||
27990518|NCT00106353|81794955|FG001|Part 2|Disease progression|0|||
27990519|NCT00106353|81794956|FG002|Part 2|Disease progression|0|||
27990520|NCT00106353|81794957|FG003|Part 2|Disease progression|0|||
27990521|NCT00106353|81794958|FG004|Part 2|Disease progression|8|||
27798194|NCT03514121|81092539|FG000|Overall Study|Withdrawal by Subject|0|||
27798195|NCT03514121|81092540|FG001|Overall Study|Withdrawal by Subject|0|||
27798196|NCT03514121|81092541|FG002|Overall Study|Withdrawal by Subject|0|||
27798197|NCT03514121|81092542|FG003|Overall Study|Withdrawal by Subject|0|||
27798198|NCT03514121|81092543|FG004|Overall Study|Withdrawal by Subject|1|||
27798199|NCT03514121|81092544|FG005|Overall Study|Withdrawal by Subject|2|||
27798200|NCT03514121|81092545|FG006|Overall Study|Withdrawal by Subject|1|||
27870613|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870614|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
27870615|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870616|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870617|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870618|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870619|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27798201|NCT03514121|81092546|FG007|Overall Study|Withdrawal by Subject|1|||
27798202|NCT03514121|81092547|FG008|Overall Study|Withdrawal by Subject|7|||
27798203|NCT03514121|81092548|FG009|Overall Study|Withdrawal by Subject|2|||
27798204|NCT03514121|81092539|FG000|Overall Study|Death|0|||
27870620|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
27870621|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
27870622|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
27990522|NCT00106353|81794959|FG005|Part 2|Disease progression|14|||
27990523|NCT00106353|81794960|FG006|Part 2|Disease progression|13|||
27990524|NCT00106353|81794954|FG000|Part 2|Death|0|||
27676187|NCT00203047|80650357|FG001|Overall Study|Pregnancy|0|||
27798205|NCT03514121|81092540|FG001|Overall Study|Death|0|||
27990525|NCT00106353|81794955|FG001|Part 2|Death|0|||
27798206|NCT03514121|81092541|FG002|Overall Study|Death|0|||
27798207|NCT03514121|81092542|FG003|Overall Study|Death|0|||
27798208|NCT03514121|81092543|FG004|Overall Study|Death|0|||
27990526|NCT00106353|81794956|FG002|Part 2|Death|0|||
27990527|NCT00106353|81794957|FG003|Part 2|Death|0|||
27990528|NCT00106353|81794958|FG004|Part 2|Death|3|||
27990529|NCT00106353|81794959|FG005|Part 2|Death|0|||
27990530|NCT00106353|81794960|FG006|Part 2|Death|1|||
27990531|NCT00106353|81794954|FG000|Part 2|Symptomatic deterioration|0|||
27990532|NCT00106353|81794955|FG001|Part 2|Symptomatic deterioration|0|||
27798209|NCT03514121|81092544|FG005|Overall Study|Death|3|||
27798210|NCT03514121|81092545|FG006|Overall Study|Death|2|||
27798211|NCT03514121|81092546|FG007|Overall Study|Death|1|||
27798212|NCT03514121|81092547|FG008|Overall Study|Death|26|||
27798213|NCT03514121|81092548|FG009|Overall Study|Death|3|||
27798214|NCT03514121|81092539|FG000|Overall Study|Lost to Follow-up|0|||
27990533|NCT00106353|81794956|FG002|Part 2|Symptomatic deterioration|0|||
27990534|NCT00106353|81794957|FG003|Part 2|Symptomatic deterioration|0|||
27990535|NCT00106353|81794958|FG004|Part 2|Symptomatic deterioration|3|||
27990536|NCT00106353|81794959|FG005|Part 2|Symptomatic deterioration|0|||
27990537|NCT00106353|81794960|FG006|Part 2|Symptomatic deterioration|0|||
27990538|NCT00106353|81794954|FG000|Part 2|Adverse Event|0|||
27990539|NCT00106353|81794955|FG001|Part 2|Adverse Event|0|||
27990540|NCT00106353|81794956|FG002|Part 2|Adverse Event|0|||
27990541|NCT00106353|81794957|FG003|Part 2|Adverse Event|0|||
27676188|NCT00203047|80650356|FG000|Overall Study|Other|5|||
27676189|NCT00203047|80650357|FG001|Overall Study|Other|5|||
27676190|NCT01234883|80650359|FG000|Overall Study|Early treatment release|8|||
27676191|NCT01234883|80650360|FG001|Overall Study|Early treatment release|10|||
27676192|NCT01234883|80650359|FG000|Overall Study|Parent/guardian withdrew consent|1|||
27798215|NCT03514121|81092540|FG001|Overall Study|Lost to Follow-up|0|||
27798216|NCT03514121|81092541|FG002|Overall Study|Lost to Follow-up|1|||
27798217|NCT03514121|81092542|FG003|Overall Study|Lost to Follow-up|0|||
27798218|NCT03514121|81092543|FG004|Overall Study|Lost to Follow-up|0|||
27798219|NCT03514121|81092544|FG005|Overall Study|Lost to Follow-up|0|||
27990542|NCT00106353|81794958|FG004|Part 2|Adverse Event|0|||
27990543|NCT00106353|81794959|FG005|Part 2|Adverse Event|2|||
27990544|NCT00106353|81794960|FG006|Part 2|Adverse Event|1|||
27990545|NCT00106353|81794954|FG000|Part 2|Other|0|||
27990546|NCT00106353|81794955|FG001|Part 2|Other|0|||
27990547|NCT00106353|81794956|FG002|Part 2|Other|0|||
27990548|NCT00106353|81794957|FG003|Part 2|Other|0|||
27990549|NCT00106353|81794958|FG004|Part 2|Other|1|||
27990550|NCT00106353|81794959|FG005|Part 2|Other|1|||
27990551|NCT00106353|81794960|FG006|Part 2|Other|1|||
27990552|NCT00106353|81794954|FG000|Part 2|Withdrawal by Subject|0|||
27990553|NCT00106353|81794955|FG001|Part 2|Withdrawal by Subject|0|||
27990554|NCT00106353|81794956|FG002|Part 2|Withdrawal by Subject|0|||
27990555|NCT00106353|81794957|FG003|Part 2|Withdrawal by Subject|0|||
27990556|NCT00106353|81794958|FG004|Part 2|Withdrawal by Subject|1|||
27990557|NCT00106353|81794959|FG005|Part 2|Withdrawal by Subject|0|||
27990558|NCT00106353|81794960|FG006|Part 2|Withdrawal by Subject|0|||
27990559|NCT00106353|81794954|FG000|Part 2|Physician Decision|0|||
27990560|NCT00106353|81794955|FG001|Part 2|Physician Decision|0|||
27990561|NCT00106353|81794956|FG002|Part 2|Physician Decision|0|||
27990562|NCT00106353|81794957|FG003|Part 2|Physician Decision|0|||
27990563|NCT00106353|81794958|FG004|Part 2|Physician Decision|0|||
27990564|NCT00106353|81794959|FG005|Part 2|Physician Decision|1|||
27990565|NCT00106353|81794960|FG006|Part 2|Physician Decision|0|||
27990566|NCT00360568|81794961|FG000|Overall Study|Adverse Event|1|||
27990567|NCT00360568|81794962|FG001|Overall Study|Adverse Event|2|||
27990568|NCT00360568|81794961|FG000|Overall Study|Lack of Efficacy|1|||
27990569|NCT00360568|81794962|FG001|Overall Study|Lack of Efficacy|0|||
27990570|NCT00360568|81794961|FG000|Overall Study|Withdrawal by Subject|0|||
27990571|NCT00360568|81794962|FG001|Overall Study|Withdrawal by Subject|3|||
27990572|NCT00151372|81794963|FG000|Overall Study|Death|12|||
27990573|NCT00151372|81794964|FG001|Overall Study|Death|11|||
27990574|NCT00151372|81794963|FG000|Overall Study|Lost to Follow-up|5|||
27990575|NCT00151372|81794964|FG001|Overall Study|Lost to Follow-up|5|||
27990576|NCT00151372|81794963|FG000|Overall Study|Too sick medically to continue|5|||
27990577|NCT00151372|81794964|FG001|Overall Study|Too sick medically to continue|6|||
27990578|NCT00151372|81794963|FG000|Overall Study|Withdrawal by Subject|7|||
27990579|NCT00151372|81794964|FG001|Overall Study|Withdrawal by Subject|7|||
27579252|NCT03495908|80303154|FG000|Overall Study|No documented reason|0|||
27990580|NCT02241343|81794969|FG000|Overall Study|Adverse Event|1|||
27990581|NCT01138501|81794972|FG000|Overall Study|Protocol Violation|2|||
27990582|NCT01138501|81794972|FG000|Overall Study|Withdrawal by Subject|3|||
27990583|NCT04294147|81794973|FG000|Overall Study|Protocol Violation|2|||
27990584|NCT04294147|81794974|FG001|Overall Study|Protocol Violation|0|||
27990585|NCT03078855|81798228|FG000|Overall Study|Lack of Efficacy|62|||
27990586|NCT03078855|81798229|FG001|Overall Study|Lack of Efficacy|31|||
27990587|NCT03078855|81798228|FG000|Overall Study|Death|1|||
27990588|NCT03078855|81798229|FG001|Overall Study|Death|0|||
27990589|NCT03078855|81798228|FG000|Overall Study|Withdrawal by Subject|12|||
27579253|NCT03495908|80303155|FG001|Overall Study|No documented reason|2|||
27579254|NCT03003520|80303156|FG000|Overall Study|Adverse Event|9|||
27579255|NCT03003520|80303157|FG001|Overall Study|Adverse Event|0|||
27579256|NCT03003520|80303156|FG000|Overall Study|Death|1|||
27579257|NCT03003520|80303157|FG001|Overall Study|Death|0|||
27579258|NCT03003520|80303156|FG000|Overall Study|Other reasons|4|||
27990590|NCT03078855|81798229|FG001|Overall Study|Withdrawal by Subject|6|||
27990591|NCT03078855|81798228|FG000|Overall Study|Physician Decision|3|||
27990592|NCT03078855|81798229|FG001|Overall Study|Physician Decision|2|||
27676193|NCT01234883|80650360|FG001|Overall Study|Parent/guardian withdrew consent|2|||
27798220|NCT03514121|81092545|FG006|Overall Study|Lost to Follow-up|0|||
27798221|NCT03514121|81092546|FG007|Overall Study|Lost to Follow-up|0|||
27798222|NCT03514121|81092547|FG008|Overall Study|Lost to Follow-up|1|||
27798223|NCT03514121|81092548|FG009|Overall Study|Lost to Follow-up|0|||
27798224|NCT03514121|81092539|FG000|Overall Study|Adverse Event|0|||
27798225|NCT03514121|81092540|FG001|Overall Study|Adverse Event|0|||
27798226|NCT03514121|81092541|FG002|Overall Study|Adverse Event|0|||
27798227|NCT03514121|81092542|FG003|Overall Study|Adverse Event|0|||
27676194|NCT01234883|80650359|FG000|Overall Study|Technical difficulties with IV infusion|0|||
27676195|NCT01234883|80650360|FG001|Overall Study|Technical difficulties with IV infusion|1|||
27676196|NCT01234883|80650359|FG000|Overall Study|Inclusion/exclusion failure|1|||
27676197|NCT01234883|80650360|FG001|Overall Study|Inclusion/exclusion failure|0|||
27676198|NCT01647542|80650361|FG000|Overall Study|Major Protocol Deviation|1|||
27676199|NCT01647542|80650362|FG001|Overall Study|Major Protocol Deviation|0|||
27676200|NCT01647542|80650363|FG002|Overall Study|Major Protocol Deviation|0|||
27676201|NCT01647542|80650361|FG000|Overall Study|Adverse Event|4|||
27676202|NCT01647542|80650362|FG001|Overall Study|Adverse Event|5|||
27676203|NCT01647542|80650363|FG002|Overall Study|Adverse Event|4|||
27798228|NCT03514121|81092543|FG004|Overall Study|Adverse Event|0|||
27798229|NCT03514121|81092544|FG005|Overall Study|Adverse Event|0|||
27990593|NCT03078855|81798228|FG000|Overall Study|Second Malignancy|4|||
27990594|NCT03078855|81798229|FG001|Overall Study|Second Malignancy|0|||
27990595|NCT03078855|81798228|FG000|Overall Study|Ineligible|2|||
27990596|NCT03078855|81798229|FG001|Overall Study|Ineligible|0|||
27990597|NCT03078855|81798228|FG000|Overall Study|Withdrew before day 1 treatment|2|||
27990598|NCT03078855|81798229|FG001|Overall Study|Withdrew before day 1 treatment|1|||
27990599|NCT00983385|81798230|FG000|Observation Period|Not eligible to be dosed|20|||
27990600|NCT00983385|81798230|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
27990601|NCT01114828|81798231|FG000|Overall Study|Adverse Event|1|||
27990602|NCT01114828|81798232|FG001|Overall Study|Adverse Event|1|||
27798230|NCT03514121|81092545|FG006|Overall Study|Adverse Event|1|||
27798231|NCT03514121|81092546|FG007|Overall Study|Adverse Event|0|||
27798232|NCT03514121|81092547|FG008|Overall Study|Adverse Event|0|||
27798233|NCT03514121|81092548|FG009|Overall Study|Adverse Event|0|||
27798234|NCT03514121|81092539|FG000|Overall Study|Other|0|||
27798235|NCT03514121|81092540|FG001|Overall Study|Other|1|||
27798236|NCT03514121|81092541|FG002|Overall Study|Other|1|||
27990603|NCT01114828|81798231|FG000|Overall Study|Lack of Efficacy|0|||
27990604|NCT01114828|81798232|FG001|Overall Study|Lack of Efficacy|2|||
27990605|NCT01114828|81798231|FG000|Overall Study|Protocol Violation|2|||
27798237|NCT03514121|81092542|FG003|Overall Study|Other|0|||
27798238|NCT03514121|81092543|FG004|Overall Study|Other|1|||
27798239|NCT03514121|81092544|FG005|Overall Study|Other|2|||
27798240|NCT03514121|81092545|FG006|Overall Study|Other|3|||
27798241|NCT03514121|81092546|FG007|Overall Study|Other|2|||
27798242|NCT03514121|81092547|FG008|Overall Study|Other|7|||
27798243|NCT03514121|81092548|FG009|Overall Study|Other|3|||
27798244|NCT03514121|81092539|FG000|Overall Study|Study termination by Sponsor|0|||
27798245|NCT03514121|81092540|FG001|Overall Study|Study termination by Sponsor|0|||
27798246|NCT03514121|81092541|FG002|Overall Study|Study termination by Sponsor|0|||
27798247|NCT03514121|81092542|FG003|Overall Study|Study termination by Sponsor|0|||
27798248|NCT03514121|81092543|FG004|Overall Study|Study termination by Sponsor|0|||
27798249|NCT03514121|81092544|FG005|Overall Study|Study termination by Sponsor|0|||
27798250|NCT03514121|81092545|FG006|Overall Study|Study termination by Sponsor|0|||
27798251|NCT03514121|81092546|FG007|Overall Study|Study termination by Sponsor|0|||
27798252|NCT03514121|81092547|FG008|Overall Study|Study termination by Sponsor|11|||
27798253|NCT03514121|81092548|FG009|Overall Study|Study termination by Sponsor|3|||
27798254|NCT03514121|81092539|FG000|Overall Study|Investigator decision|0|||
27798255|NCT03514121|81092540|FG001|Overall Study|Investigator decision|0|||
27990606|NCT01114828|81798232|FG001|Overall Study|Protocol Violation|0|||
27990607|NCT01114828|81798231|FG000|Overall Study|Withdrawal by Subject|0|||
27990608|NCT01114828|81798232|FG001|Overall Study|Withdrawal by Subject|1|||
27990609|NCT04000581|81798233|FG000|Overall Study|Withdrawal by Subject|0|||
27990610|NCT04000581|81798234|FG001|Overall Study|Withdrawal by Subject|1|||
27798256|NCT03514121|81092541|FG002|Overall Study|Investigator decision|0|||
27798257|NCT03514121|81092542|FG003|Overall Study|Investigator decision|0|||
27798258|NCT03514121|81092543|FG004|Overall Study|Investigator decision|0|||
27798259|NCT03514121|81092544|FG005|Overall Study|Investigator decision|0|||
27990611|NCT00604695|81798235|FG000|Overall Study|Did not receive first bolus.|0|||
27990612|NCT00604695|81798236|FG001|Overall Study|Did not receive first bolus.|4|||
27990613|NCT00245037|81798249|FG000|Overall Study|Death|17|||
27798260|NCT03514121|81092545|FG006|Overall Study|Investigator decision|0|||
27798261|NCT03514121|81092546|FG007|Overall Study|Investigator decision|0|||
27798262|NCT03514121|81092547|FG008|Overall Study|Investigator decision|1|||
27798263|NCT03514121|81092548|FG009|Overall Study|Investigator decision|0|||
27798264|NCT02421939|81092551|FG000|Overall Study|Progressive disease|70|||
27990614|NCT03304873|81798250|FG000|Overall Study|Lost to Follow-up|1|||
27990615|NCT03304873|81798251|FG001|Overall Study|Lost to Follow-up|8|||
27990616|NCT02577016|81798252|FG000|Overall Study|Adverse Event|2|||
27990617|NCT02577016|81798253|FG001|Overall Study|Adverse Event|1|||
27990618|NCT02577016|81798252|FG000|Overall Study|Physician Decision|0|||
27990619|NCT02577016|81798253|FG001|Overall Study|Physician Decision|1|||
27990620|NCT02092025|81798254|FG000|Overall Study|Case Report Forms Uncollected|44|||
27990621|NCT02092025|81798254|FG000|Overall Study|Protocol Deviation|24|||
27990622|NCT02783599|81798257|FG000|Overall Study|Progressive disease|23|||
27990623|NCT02783599|81798257|FG000|Overall Study|Surgical Resection|10|||
27990624|NCT02783599|81798257|FG000|Overall Study|Adverse Event|4|||
27990625|NCT02783599|81798257|FG000|Overall Study|Physician Decision|2|||
27990626|NCT02783599|81798257|FG000|Overall Study|Death|1|||
27990627|NCT02485704|81798258|FG000|Overall Study|Lost to Follow-up|4|||
27990628|NCT02485704|81798259|FG001|Overall Study|Lost to Follow-up|5|||
27990629|NCT02485704|81798258|FG000|Overall Study|Withdrawal by Subject|0|||
27990630|NCT02485704|81798259|FG001|Overall Study|Withdrawal by Subject|3|||
27990631|NCT02485704|81798258|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
27990632|NCT02485704|81798259|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
27990633|NCT00900029|81798264|FG000|Overall Study|Lost to Follow-up|0|||
27990634|NCT00900029|81798265|FG001|Overall Study|Lost to Follow-up|2|||
27990635|NCT00900029|81798266|FG002|Overall Study|Lost to Follow-up|1|||
27990636|NCT00900029|81798267|FG003|Overall Study|Lost to Follow-up|4|||
27990637|NCT00900029|81798268|FG004|Overall Study|Lost to Follow-up|4|||
27990638|NCT00900029|81798264|FG000|Overall Study|Withdrawal by Subject|2|||
27990639|NCT00900029|81798265|FG001|Overall Study|Withdrawal by Subject|2|||
27990640|NCT00900029|81798266|FG002|Overall Study|Withdrawal by Subject|1|||
27990641|NCT00900029|81798267|FG003|Overall Study|Withdrawal by Subject|1|||
27990642|NCT00900029|81798268|FG004|Overall Study|Withdrawal by Subject|1|||
27990643|NCT00900029|81798264|FG000|Overall Study|Adverse Event|0|||
27990644|NCT00900029|81798265|FG001|Overall Study|Adverse Event|0|||
27990645|NCT00900029|81798266|FG002|Overall Study|Adverse Event|1|||
27990646|NCT00900029|81798267|FG003|Overall Study|Adverse Event|1|||
27990647|NCT00900029|81798268|FG004|Overall Study|Adverse Event|1|||
27990648|NCT00900029|81798264|FG000|Overall Study|Death|1|||
27676204|NCT01647542|80650361|FG000|Overall Study|Lost to Follow-up|0|||
27676205|NCT01647542|80650362|FG001|Overall Study|Lost to Follow-up|2|||
27676206|NCT01647542|80650363|FG002|Overall Study|Lost to Follow-up|2|||
27798265|NCT02421939|81092552|FG001|Overall Study|Progressive disease|16|||
27990649|NCT00900029|81798265|FG001|Overall Study|Death|0|||
27990650|NCT00900029|81798266|FG002|Overall Study|Death|0|||
27990651|NCT00900029|81798267|FG003|Overall Study|Death|1|||
27990652|NCT00900029|81798268|FG004|Overall Study|Death|0|||
27990653|NCT03647267|81798270|FG000|Overall Study|Lost to Follow-up|1|||
27990654|NCT03647267|81798271|FG001|Overall Study|Lost to Follow-up|0|||
27798266|NCT02421939|81092551|FG000|Overall Study|Lack of Efficacy|21|||
27798267|NCT02421939|81092552|FG001|Overall Study|Lack of Efficacy|31|||
27798268|NCT02421939|81092551|FG000|Overall Study|Death|36|||
27798269|NCT02421939|81092552|FG001|Overall Study|Death|10|||
27798270|NCT02421939|81092551|FG000|Overall Study|Disease relapse|33|||
27798271|NCT02421939|81092552|FG001|Overall Study|Disease relapse|2|||
27798272|NCT02421939|81092551|FG000|Overall Study|Adverse Event|28|||
27798273|NCT02421939|81092552|FG001|Overall Study|Adverse Event|5|||
27798274|NCT02421939|81092551|FG000|Overall Study|Withdrawal by Subject|5|||
27798275|NCT02421939|81092552|FG001|Overall Study|Withdrawal by Subject|24|||
27798276|NCT02421939|81092551|FG000|Overall Study|Physician Decision|11|||
27798277|NCT02421939|81092552|FG001|Overall Study|Physician Decision|11|||
27798278|NCT02421939|81092551|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
27798279|NCT02421939|81092552|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
27798280|NCT02421939|81092551|FG000|Overall Study|Miscellaneous|4|||
27798281|NCT02421939|81092552|FG001|Overall Study|Miscellaneous|5|||
27798282|NCT02421939|81092551|FG000|Overall Study|Protocol deviation|1|||
27798283|NCT02421939|81092552|FG001|Overall Study|Protocol deviation|1|||
27990655|NCT00306527|81798272|FG000|Overall Study|Lost to Follow-up|3|||
27990656|NCT00306527|81798273|FG001|Overall Study|Lost to Follow-up|4|||
27990657|NCT00306527|81798274|FG002|Overall Study|Lost to Follow-up|3|||
27990658|NCT00306527|81798275|FG003|Overall Study|Lost to Follow-up|0|||
27990659|NCT00306527|81798272|FG000|Overall Study|Withdrawal by Subject|2|||
27990660|NCT00306527|81798273|FG001|Overall Study|Withdrawal by Subject|3|||
27990661|NCT00306527|81798274|FG002|Overall Study|Withdrawal by Subject|0|||
27990662|NCT00306527|81798275|FG003|Overall Study|Withdrawal by Subject|3|||
27990663|NCT00306527|81798272|FG000|Overall Study|Adverse Event|0|||
27990664|NCT00306527|81798273|FG001|Overall Study|Adverse Event|0|||
27990665|NCT00306527|81798274|FG002|Overall Study|Adverse Event|1|||
27990666|NCT00306527|81798275|FG003|Overall Study|Adverse Event|1|||
27990667|NCT00306527|81798272|FG000|Overall Study|Death|1|||
27990668|NCT00306527|81798273|FG001|Overall Study|Death|0|||
27798284|NCT05473247|81092553|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
27798285|NCT01831596|81092554|FG000|Overall Study|Other|8|||
27798286|NCT03663205|81092555|FG000|Overall Study|Death|144|||
27798287|NCT03663205|81092556|FG001|Overall Study|Death|69|||
27798288|NCT03663205|81092555|FG000|Overall Study|Sponsor decision|53|||
27798289|NCT03663205|81092556|FG001|Overall Study|Sponsor decision|19|||
27798290|NCT03663205|81092555|FG000|Overall Study|Withdrawal by Subject|8|||
27798291|NCT03663205|81092556|FG001|Overall Study|Withdrawal by Subject|11|||
27798292|NCT03663205|81092555|FG000|Overall Study|Lost to Follow-up|7|||
27798293|NCT03663205|81092556|FG001|Overall Study|Lost to Follow-up|9|||
27798294|NCT03663205|81092555|FG000|Overall Study|Transferred to long term extension study|11|||
27798295|NCT03663205|81092556|FG001|Overall Study|Transferred to long term extension study|3|||
27798296|NCT04489888|81092741|FG000|Overall Study|Death|61|||
27798297|NCT04489888|81092741|FG000|Overall Study|Participant On-going|40|||
27990669|NCT00306527|81798274|FG002|Overall Study|Death|1|||
27990670|NCT00306527|81798275|FG003|Overall Study|Death|2|||
27990671|NCT01103063|81798276|FG000|Overall Study|Adverse Event|3|||
27990672|NCT01103063|81798277|FG001|Overall Study|Adverse Event|1|||
27990673|NCT01103063|81798276|FG000|Overall Study|Lost to Follow-up|68|||
27990674|NCT01103063|81798277|FG001|Overall Study|Lost to Follow-up|51|||
27990675|NCT01103063|81798276|FG000|Overall Study|Withdrawal by Subject|60|||
27990676|NCT01103063|81798277|FG001|Overall Study|Withdrawal by Subject|15|||
27990677|NCT01103063|81798276|FG000|Overall Study|Other|16|||
27990678|NCT01103063|81798277|FG001|Overall Study|Other|11|||
27990679|NCT01103063|81798276|FG000|Overall Study|Protocol Violation|1|||
27990680|NCT01103063|81798277|FG001|Overall Study|Protocol Violation|0|||
27990681|NCT01103063|81798276|FG000|Overall Study|Study terminated by Sponsor|326|||
27990682|NCT01103063|81798277|FG001|Overall Study|Study terminated by Sponsor|342|||
27990683|NCT01103063|81798276|FG000|Overall Study|Death|3|||
27990684|NCT01103063|81798277|FG001|Overall Study|Death|1|||
27990685|NCT00429169|81798279|FG000|Overall Study|Lost to Follow-up|0|||
27990686|NCT00429169|81798280|FG001|Overall Study|Lost to Follow-up|1|||
27990687|NCT00429169|81798279|FG000|Overall Study|Ineligibility discovered after entry|2|||
27990688|NCT00429169|81798280|FG001|Overall Study|Ineligibility discovered after entry|1|||
27990689|NCT00296140|81798281|FG000|Overall Study|Lost to Follow-up|1|||
27990690|NCT00296140|81798282|FG001|Overall Study|Lost to Follow-up|0|||
27990691|NCT00296140|81798281|FG000|Overall Study|Withdrawal by Subject|1|||
27990692|NCT00296140|81798282|FG001|Overall Study|Withdrawal by Subject|0|||
27990693|NCT00296140|81798281|FG000|Overall Study|Discharge to Nursing Home|1|||
27990694|NCT00296140|81798282|FG001|Overall Study|Discharge to Nursing Home|0|||
27990695|NCT00151476|81798284|FG000|FAP Identified Subjects|Protocol Violation|0|||
27990696|NCT00151476|81798285|FG001|FAP Identified Subjects|Protocol Violation|1|||
27990697|NCT00151476|81798284|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
27676207|NCT01647542|80650361|FG000|Overall Study|Withdrawal by Subject|6|||
27676208|NCT01647542|80650362|FG001|Overall Study|Withdrawal by Subject|4|||
27798298|NCT05307692|81092742|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
27798299|NCT05307692|81092743|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
27870623|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
27870624|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870625|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870626|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
27870627|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870628|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870629|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870630|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870631|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870632|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
27870633|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27990698|NCT00151476|81798285|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
27798300|NCT05307692|81092744|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
27798301|NCT05307692|81092745|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
27798302|NCT05307692|81092742|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
27798303|NCT05307692|81092743|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
27798304|NCT05307692|81092744|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
27798305|NCT05307692|81092745|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
27990699|NCT00151476|81798284|FG000|FAP Analyzed Subjects|Other study participation|0|||
27990700|NCT00151476|81798285|FG001|FAP Analyzed Subjects|Other study participation|1|||
27990701|NCT02503501|81798293|FG000|Overall Study|Physician Decision|1|||
27990702|NCT02503501|81798294|FG001|Overall Study|Physician Decision|0|||
27990703|NCT02503501|81798293|FG000|Overall Study|Protocol Violation|0|||
27990704|NCT02503501|81798294|FG001|Overall Study|Protocol Violation|1|||
27990705|NCT02503501|81798293|FG000|Overall Study|Withdrawal by Subject|0|||
27870634|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870635|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27798306|NCT05307692|81092742|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
27798307|NCT05307692|81092743|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
27798308|NCT05307692|81092744|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
27798309|NCT05307692|81092745|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
27798310|NCT05307692|81092742|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
27798311|NCT05307692|81092743|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
27798312|NCT05307692|81092744|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
27798313|NCT05307692|81092745|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
27798314|NCT05307692|81092742|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
27798315|NCT05307692|81092743|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
27798316|NCT05307692|81092744|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
27798317|NCT05307692|81092745|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
27798318|NCT05307692|81092742|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
27990706|NCT02503501|81798294|FG001|Overall Study|Withdrawal by Subject|2|||
27990707|NCT01629953|81798295|FG000|Overall Study|Death|3|||
27990708|NCT01629953|81798296|FG001|Overall Study|Death|1|||
27990709|NCT01629953|81798295|FG000|Overall Study|Lost to Follow-up|10|||
27990710|NCT01629953|81798296|FG001|Overall Study|Lost to Follow-up|14|||
27990711|NCT03193736|81798297|FG000|Overall Study|Death|2|||
27990712|NCT03193736|81798297|FG000|Overall Study|Withdrawal by Subject|1|||
27990713|NCT03193736|81798297|FG000|Overall Study|Lost to Follow-up|1|||
27990714|NCT03193736|81798297|FG000|Overall Study|implant not received|1|||
27990715|NCT01971008|81798300|FG000|Overall Study|Protocol Violation|2|||
27990716|NCT01971008|81798301|FG001|Overall Study|Protocol Violation|1|||
27990717|NCT04752358|81798302|FG000|Overall Study|Death|2|||
27990718|NCT04752358|81798303|FG001|Overall Study|Death|1|||
27990719|NCT01817959|81798304|FG000|Overall Study|Graft loss|1|||
27990720|NCT01817959|81798305|FG001|Overall Study|Graft loss|1|||
27870636|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870637|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27870638|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
27990721|NCT01817959|81798304|FG000|Overall Study|forbidden medication|1|||
27798319|NCT05307692|81092743|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
27798320|NCT05307692|81092744|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
27990722|NCT01817959|81798305|FG001|Overall Study|forbidden medication|1|||
27990723|NCT01817959|81798304|FG000|Overall Study|Adverse Event|1|||
27990724|NCT01817959|81798305|FG001|Overall Study|Adverse Event|0|||
27990725|NCT01817959|81798304|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
27990726|NCT01817959|81798305|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
27798321|NCT05307692|81092745|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
27990727|NCT02421588|81798308|FG000|Overall Study|Non-treatment-related AE|8|||
27990728|NCT02421588|81798309|FG001|Overall Study|Non-treatment-related AE|8|||
27990729|NCT02421588|81798308|FG000|Overall Study|Progressive disease|152|||
27990730|NCT02421588|81798309|FG001|Overall Study|Progressive disease|135|||
27990731|NCT02421588|81798308|FG000|Overall Study|Death|11|||
27990732|NCT02421588|81798309|FG001|Overall Study|Death|3|||
27990733|NCT02421588|81798308|FG000|Overall Study|Physician Decision|8|||
27990734|NCT02421588|81798309|FG001|Overall Study|Physician Decision|17|||
27990735|NCT02421588|81798308|FG000|Overall Study|Other reason not specified|3|||
27990736|NCT02421588|81798309|FG001|Overall Study|Other reason not specified|1|||
27990737|NCT02421588|81798308|FG000|Overall Study|Symptomatic deterioration|13|||
27990738|NCT02421588|81798309|FG001|Overall Study|Symptomatic deterioration|19|||
27990739|NCT02421588|81798308|FG000|Overall Study|Treatment-related AE|10|||
27990740|NCT02421588|81798309|FG001|Overall Study|Treatment-related AE|14|||
27990741|NCT02421588|81798308|FG000|Overall Study|Withdrawal by Subject|14|||
27798322|NCT05307692|81092742|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
27990742|NCT02421588|81798309|FG001|Overall Study|Withdrawal by Subject|16|||
27990743|NCT02421588|81798308|FG000|Overall Study|Not treated|2|||
27990744|NCT02421588|81798309|FG001|Overall Study|Not treated|8|||
27990745|NCT00077649|81798310|FG000|Overall Study|Adverse Event|5|||
27990746|NCT00077649|81798311|FG001|Overall Study|Adverse Event|1|||
27990747|NCT00077649|81798312|FG002|Overall Study|Adverse Event|7|||
27990748|NCT00077649|81798313|FG003|Overall Study|Adverse Event|9|||
27798323|NCT05307692|81092743|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
27798324|NCT05307692|81092744|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
27798325|NCT05307692|81092745|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
27798326|NCT05307692|81092742|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
27798327|NCT05307692|81092743|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
27798328|NCT05307692|81092744|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
27798329|NCT05307692|81092745|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
27798330|NCT03909971|81092746|FG000|Overall Study|Other Reasons Not Specified|0|||
27798331|NCT03909971|81092747|FG001|Overall Study|Other Reasons Not Specified|1|||
27798332|NCT03909971|81092746|FG000|Overall Study|Global Deterioration of Health Status|2|||
27798333|NCT03909971|81092747|FG001|Overall Study|Global Deterioration of Health Status|1|||
27798334|NCT03909971|81092746|FG000|Overall Study|Progressive Disease|6|||
27798335|NCT03909971|81092747|FG001|Overall Study|Progressive Disease|14|||
27798336|NCT03909971|81092746|FG000|Overall Study|Death|2|||
27798337|NCT03909971|81092747|FG001|Overall Study|Death|6|||
27833100|NCT00807495|81219454|FG000|Overall Study|Withdrawal by Patient|2|||
27833101|NCT00807495|81219455|FG001|Overall Study|Withdrawal by Patient|0|||
27833102|NCT00807495|81219456|FG002|Overall Study|Withdrawal by Patient|1|||
27833103|NCT00807495|81219457|FG003|Overall Study|Withdrawal by Patient|0|||
27833104|NCT00807495|81219458|FG004|Overall Study|Withdrawal by Patient|0|||
27833105|NCT00807495|81219454|FG000|Overall Study|Reason Not Specified|0|||
27990749|NCT00077649|81798310|FG000|Overall Study|Lack of Efficacy|5|||
27990750|NCT00077649|81798311|FG001|Overall Study|Lack of Efficacy|3|||
27990751|NCT00077649|81798312|FG002|Overall Study|Lack of Efficacy|3|||
27990752|NCT00077649|81798313|FG003|Overall Study|Lack of Efficacy|2|||
27990753|NCT00077649|81798310|FG000|Overall Study|Withdrawal by Subject|0|||
27990754|NCT00077649|81798311|FG001|Overall Study|Withdrawal by Subject|1|||
27870639|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870640|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870641|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870642|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27990755|NCT00077649|81798312|FG002|Overall Study|Withdrawal by Subject|1|||
27990756|NCT00077649|81798313|FG003|Overall Study|Withdrawal by Subject|2|||
27833106|NCT00807495|81219455|FG001|Overall Study|Reason Not Specified|3|||
27833107|NCT00807495|81219456|FG002|Overall Study|Reason Not Specified|2|||
27833108|NCT00807495|81219457|FG003|Overall Study|Reason Not Specified|0|||
27833109|NCT00807495|81219458|FG004|Overall Study|Reason Not Specified|3|||
27833110|NCT03531827|81219459|FG000|Overall Study|Adverse Event|2|||
27833111|NCT03531827|81219460|FG001|Overall Study|Adverse Event|0|||
27833112|NCT03531827|81219459|FG000|Overall Study|Progressive disease|1|||
27833113|NCT03531827|81219460|FG001|Overall Study|Progressive disease|0|||
27833114|NCT01750294|81219461|FG000|Overall Study|Withdrawal by Subject|1|||
27833115|NCT01750294|81219461|FG000|Overall Study|Safety Endpoint|1|||
27990757|NCT00077649|81798310|FG000|Overall Study|Lost to Follow-up|2|||
27990758|NCT00077649|81798311|FG001|Overall Study|Lost to Follow-up|2|||
27833116|NCT04281472|81219493|FG000|Stage A|Lack of Efficacy|8|||
27833117|NCT04281472|81219494|FG001|Stage A|Lack of Efficacy|0|||
27833118|NCT04281472|81219495|FG002|Stage A|Lack of Efficacy|0|||
27833119|NCT04281472|81219493|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
27833120|NCT04281472|81219494|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
27833121|NCT04281472|81219495|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
27833122|NCT04281472|81219493|FG000|Stage A|Adverse Event|20|||
27833123|NCT04281472|81219494|FG001|Stage A|Adverse Event|0|||
27833124|NCT04281472|81219495|FG002|Stage A|Adverse Event|0|||
27833125|NCT04281472|81219493|FG000|Stage A|Death|1|||
27833126|NCT04281472|81219494|FG001|Stage A|Death|0|||
27833127|NCT04281472|81219495|FG002|Stage A|Death|0|||
27833128|NCT04281472|81219493|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
27833129|NCT04281472|81219494|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
27833130|NCT04281472|81219495|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
27833131|NCT04281472|81219493|FG000|Stage A|Lost to Follow-up|2|||
27833132|NCT04281472|81219494|FG001|Stage A|Lost to Follow-up|0|||
27833133|NCT04281472|81219495|FG002|Stage A|Lost to Follow-up|0|||
27990759|NCT00077649|81798312|FG002|Overall Study|Lost to Follow-up|3|||
27833134|NCT04281472|81219493|FG000|Stage A|Non-compliance with study drug|1|||
27833135|NCT04281472|81219494|FG001|Stage A|Non-compliance with study drug|0|||
27833136|NCT04281472|81219495|FG002|Stage A|Non-compliance with study drug|0|||
27833137|NCT04281472|81219493|FG000|Stage A|Physician Decision|1|||
27833138|NCT04281472|81219494|FG001|Stage A|Physician Decision|0|||
27833139|NCT04281472|81219495|FG002|Stage A|Physician Decision|0|||
27833140|NCT04281472|81219493|FG000|Stage A|Prohibited medications|2|||
27579259|NCT03003520|80303157|FG001|Overall Study|Other reasons|0|||
27833141|NCT04281472|81219494|FG001|Stage A|Prohibited medications|0|||
27833142|NCT04281472|81219495|FG002|Stage A|Prohibited medications|0|||
27833143|NCT04281472|81219493|FG000|Stage A|Withdrawal by Subject|11|||
27798338|NCT00720304|81095514|FG000|Overall Study|Withdrawal by Subject|14|||
27798339|NCT00720304|81095515|FG001|Overall Study|Withdrawal by Subject|1|||
27798340|NCT00720304|81095514|FG000|Overall Study|Death|1|||
27798341|NCT00720304|81095515|FG001|Overall Study|Death|0|||
27798342|NCT00720304|81095514|FG000|Overall Study|Physician Decision|5|||
27798343|NCT00720304|81095515|FG001|Overall Study|Physician Decision|2|||
27798344|NCT00720304|81095514|FG000|Overall Study|Adverse Event|3|||
27798345|NCT00720304|81095515|FG001|Overall Study|Adverse Event|1|||
27798346|NCT00720304|81095514|FG000|Overall Study|Disease progression|6|||
27798347|NCT00720304|81095515|FG001|Overall Study|Disease progression|1|||
27798348|NCT03333382|81095516|FG000|Overall Study|Lost to Follow-up|1|||
27798349|NCT03333382|81095517|FG001|Overall Study|Lost to Follow-up|0|||
27798350|NCT02996448|81095518|FG000|Overall Study|Study terminated due to adverse effects|3|||
27798351|NCT03286400|81095519|FG000|Overall Study|Death|10|||
27798352|NCT03286400|81095519|FG000|Overall Study|Lost to Follow-up|10|||
27798353|NCT03286400|81095519|FG000|Overall Study|Physician Decision|1|||
27798354|NCT03286400|81095519|FG000|Overall Study|Scheduling difficulty|4|||
27798355|NCT00689273|81095522|FG000|Overall Study|Adverse Event|3|||
27798356|NCT00689273|81095523|FG001|Overall Study|Adverse Event|1|||
27798357|NCT00689273|81095522|FG000|Overall Study|Lack of Efficacy|3|||
27798358|NCT00689273|81095523|FG001|Overall Study|Lack of Efficacy|0|||
27798359|NCT00689273|81095522|FG000|Overall Study|Lost to Follow-up|0|||
27798360|NCT00689273|81095523|FG001|Overall Study|Lost to Follow-up|2|||
27798361|NCT00689273|81095522|FG000|Overall Study|Other|6|||
27870643|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870644|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870645|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
27870646|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870647|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27990760|NCT00077649|81798313|FG003|Overall Study|Lost to Follow-up|2|||
27990761|NCT00077649|81798310|FG000|Overall Study|Abnormality of Laboratory Test|1|||
27990762|NCT00077649|81798311|FG001|Overall Study|Abnormality of Laboratory Test|2|||
27990763|NCT00077649|81798312|FG002|Overall Study|Abnormality of Laboratory Test|1|||
27990764|NCT00077649|81798313|FG003|Overall Study|Abnormality of Laboratory Test|2|||
27676209|NCT01647542|80650363|FG002|Overall Study|Withdrawal by Subject|0|||
27798362|NCT00689273|81095523|FG001|Overall Study|Other|2|||
27990765|NCT00077649|81798310|FG000|Overall Study|Randomized but never dosed|1|||
27990766|NCT00077649|81798311|FG001|Overall Study|Randomized but never dosed|0|||
27990767|NCT00077649|81798312|FG002|Overall Study|Randomized but never dosed|0|||
27990768|NCT00077649|81798313|FG003|Overall Study|Randomized but never dosed|0|||
27990769|NCT04039217|81798316|FG000|Overall Study|Lost to Follow-up|1|||
27990770|NCT00940498|81798317|FG000|Overall Study|Death|2|||
27990771|NCT00940498|81798318|FG001|Overall Study|Death|0|||
27990772|NCT00940498|81798319|FG002|Overall Study|Death|0|||
27990773|NCT00940498|81798320|FG003|Overall Study|Death|1|||
27990774|NCT00940498|81798321|FG004|Overall Study|Death|5|||
27990775|NCT00940498|81798322|FG005|Overall Study|Death|0|||
27990776|NCT00940498|81798323|FG006|Overall Study|Death|1|||
27990777|NCT00940498|81798324|FG007|Overall Study|Death|0|||
27990778|NCT00940498|81798317|FG000|Overall Study|Lost to Follow-up|1|||
27990779|NCT00940498|81798318|FG001|Overall Study|Lost to Follow-up|1|||
27990780|NCT00940498|81798319|FG002|Overall Study|Lost to Follow-up|2|||
27990781|NCT00940498|81798320|FG003|Overall Study|Lost to Follow-up|0|||
27990782|NCT00940498|81798321|FG004|Overall Study|Lost to Follow-up|1|||
27990783|NCT00940498|81798322|FG005|Overall Study|Lost to Follow-up|0|||
27990784|NCT00940498|81798323|FG006|Overall Study|Lost to Follow-up|0|||
27990785|NCT00940498|81798324|FG007|Overall Study|Lost to Follow-up|1|||
27990786|NCT00940498|81798317|FG000|Overall Study|Disease Progression|0|||
27990787|NCT00940498|81798318|FG001|Overall Study|Disease Progression|0|||
27990788|NCT00940498|81798319|FG002|Overall Study|Disease Progression|1|||
27990789|NCT00940498|81798320|FG003|Overall Study|Disease Progression|1|||
27990790|NCT00940498|81798321|FG004|Overall Study|Disease Progression|0|||
27990791|NCT00940498|81798322|FG005|Overall Study|Disease Progression|1|||
27798363|NCT00689273|81095522|FG000|Overall Study|Randomized but not Treated|1|||
27798364|NCT00689273|81095523|FG001|Overall Study|Randomized but not Treated|0|||
27798365|NCT03402126|81095524|FG000|Overall Study|Lost to Follow-up|6|||
27798366|NCT03402126|81095524|FG000|Overall Study|Protocol Violation|10|||
27798367|NCT03402126|81095524|FG000|Overall Study|Sponsor request/Study termination|29|||
27798368|NCT03402126|81095524|FG000|Overall Study|Study product no longer in use|1|||
27990792|NCT00940498|81798323|FG006|Overall Study|Disease Progression|0|||
27990793|NCT00940498|81798324|FG007|Overall Study|Disease Progression|0|||
27990794|NCT00940498|81798317|FG000|Overall Study|Physician Decision|0|||
27990795|NCT00940498|81798318|FG001|Overall Study|Physician Decision|0|||
27798369|NCT03402126|81095524|FG000|Overall Study|Technical problems|1|||
27990796|NCT00940498|81798319|FG002|Overall Study|Physician Decision|0|||
27990797|NCT00940498|81798320|FG003|Overall Study|Physician Decision|0|||
27990798|NCT00940498|81798321|FG004|Overall Study|Physician Decision|2|||
27990799|NCT00940498|81798322|FG005|Overall Study|Physician Decision|0|||
27798370|NCT03402126|81095524|FG000|Overall Study|Withdrawal by Subject|6|||
27798371|NCT03402126|81095524|FG000|Overall Study|Physician Decision|2|||
27798372|NCT03402126|81095524|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
27798373|NCT03402126|81095524|FG000|Overall Study|Death|4|||
27798374|NCT03725722|81095527|FG000|Overall Study|Lack of Efficacy|2|||
27990800|NCT00940498|81798323|FG006|Overall Study|Physician Decision|0|||
27798375|NCT03725722|81095528|FG001|Overall Study|Lack of Efficacy|1|||
27798376|NCT03725722|81095529|FG002|Overall Study|Lack of Efficacy|2|||
27798377|NCT03725722|81095530|FG003|Overall Study|Lack of Efficacy|0|||
27798378|NCT03725722|81095531|FG004|Overall Study|Lack of Efficacy|2|||
27798379|NCT03725722|81095527|FG000|Overall Study|Adverse Event|2|||
27798380|NCT03725722|81095528|FG001|Overall Study|Adverse Event|2|||
27798381|NCT03725722|81095529|FG002|Overall Study|Adverse Event|1|||
27798382|NCT03725722|81095530|FG003|Overall Study|Adverse Event|0|||
27798383|NCT03725722|81095531|FG004|Overall Study|Adverse Event|6|||
27798384|NCT03725722|81095527|FG000|Overall Study|Withdrawal by Subject|4|||
27798385|NCT03725722|81095528|FG001|Overall Study|Withdrawal by Subject|1|||
27798386|NCT03725722|81095529|FG002|Overall Study|Withdrawal by Subject|0|||
27798387|NCT03725722|81095530|FG003|Overall Study|Withdrawal by Subject|4|||
27798388|NCT03725722|81095531|FG004|Overall Study|Withdrawal by Subject|4|||
27798389|NCT03725722|81095527|FG000|Overall Study|Lost to Follow-up|3|||
27990801|NCT00940498|81798324|FG007|Overall Study|Physician Decision|0|||
27990802|NCT00940498|81798317|FG000|Overall Study|Not treated due to disease related pain|0|||
27990803|NCT00940498|81798318|FG001|Overall Study|Not treated due to disease related pain|0|||
27990804|NCT00940498|81798319|FG002|Overall Study|Not treated due to disease related pain|0|||
27990805|NCT00940498|81798320|FG003|Overall Study|Not treated due to disease related pain|0|||
27990806|NCT00940498|81798321|FG004|Overall Study|Not treated due to disease related pain|1|||
27990807|NCT00940498|81798322|FG005|Overall Study|Not treated due to disease related pain|0|||
27990808|NCT00940498|81798323|FG006|Overall Study|Not treated due to disease related pain|0|||
27990809|NCT00940498|81798324|FG007|Overall Study|Not treated due to disease related pain|0|||
27990810|NCT01611194|81798328|FG000|Overall Study|Lost to Follow-up|0|||
27990811|NCT01611194|81798329|FG001|Overall Study|Lost to Follow-up|1|||
27990812|NCT01611194|81798328|FG000|Overall Study|Withdrawal by Subject|0|||
27990813|NCT01611194|81798329|FG001|Overall Study|Withdrawal by Subject|1|||
27990814|NCT01611194|81798328|FG000|Overall Study|drug use|0|||
27990815|NCT01611194|81798329|FG001|Overall Study|drug use|1|||
27990816|NCT03878758|81798331|FG000|Overall Study|Withdrawal by Subject|1|||
27990817|NCT03878758|81798331|FG000|Overall Study|Protocol defined|2|||
27990818|NCT03878758|81798331|FG000|Overall Study|Improper consent documentation|1|||
27579260|NCT03003520|80303156|FG000|Overall Study|Withdrawal by Subject|6|||
27579261|NCT03003520|80303157|FG001|Overall Study|Withdrawal by Subject|0|||
27579262|NCT03003520|80303156|FG000|Overall Study|Progressive disease|9|||
27798390|NCT03725722|81095528|FG001|Overall Study|Lost to Follow-up|1|||
27798391|NCT03725722|81095529|FG002|Overall Study|Lost to Follow-up|2|||
27798392|NCT03725722|81095530|FG003|Overall Study|Lost to Follow-up|2|||
27798393|NCT03725722|81095531|FG004|Overall Study|Lost to Follow-up|1|||
27798394|NCT03725722|81095527|FG000|Overall Study|Personal reasons|0|||
27798395|NCT03725722|81095528|FG001|Overall Study|Personal reasons|0|||
27990819|NCT00527904|81798332|FG000|Overall Study|Adverse Event|45|||
27990820|NCT00527904|81798332|FG000|Overall Study|Withdrawal by Subject|21|||
27990821|NCT00527904|81798332|FG000|Overall Study|Lost to Follow-up|8|||
27990822|NCT00527904|81798332|FG000|Overall Study|misc|22|||
27798396|NCT03725722|81095529|FG002|Overall Study|Personal reasons|1|||
27990823|NCT00348309|81798333|FG000|Overall Study|Adverse Event|56|||
27798397|NCT03725722|81095530|FG003|Overall Study|Personal reasons|0|||
27990824|NCT00348309|81798334|FG001|Overall Study|Adverse Event|28|||
27990825|NCT00348309|81798335|FG002|Overall Study|Adverse Event|63|||
27990826|NCT00348309|81798333|FG000|Overall Study|Lost to Follow-up|6|||
27990827|NCT00348309|81798334|FG001|Overall Study|Lost to Follow-up|7|||
27990828|NCT00348309|81798335|FG002|Overall Study|Lost to Follow-up|4|||
27990829|NCT00348309|81798333|FG000|Overall Study|Protocol Violation|7|||
27990830|NCT00348309|81798334|FG001|Overall Study|Protocol Violation|12|||
27990831|NCT00348309|81798335|FG002|Overall Study|Protocol Violation|7|||
27990832|NCT00348309|81798333|FG000|Overall Study|Withdrawal by Subject|33|||
27990833|NCT00348309|81798334|FG001|Overall Study|Withdrawal by Subject|37|||
27990834|NCT00348309|81798335|FG002|Overall Study|Withdrawal by Subject|40|||
27990835|NCT00348309|81798333|FG000|Overall Study|Non-compliance|8|||
27990836|NCT00348309|81798334|FG001|Overall Study|Non-compliance|6|||
27990837|NCT00348309|81798335|FG002|Overall Study|Non-compliance|8|||
27990838|NCT00348309|81798333|FG000|Overall Study|Death of caregiver|1|||
27990839|NCT00348309|81798334|FG001|Overall Study|Death of caregiver|0|||
27990840|NCT00348309|81798335|FG002|Overall Study|Death of caregiver|1|||
27990841|NCT00348309|81798333|FG000|Overall Study|Lack of insight, dementia|1|||
27990842|NCT00348309|81798334|FG001|Overall Study|Lack of insight, dementia|0|||
27990843|NCT00348309|81798335|FG002|Overall Study|Lack of insight, dementia|0|||
27990844|NCT00348309|81798333|FG000|Overall Study|Wrong bottle allocated|1|||
27990845|NCT00348309|81798334|FG001|Overall Study|Wrong bottle allocated|0|||
27990846|NCT00348309|81798335|FG002|Overall Study|Wrong bottle allocated|0|||
27990847|NCT00348309|81798333|FG000|Overall Study|Caregiver sick|1|||
27990848|NCT00348309|81798334|FG001|Overall Study|Caregiver sick|0|||
27990849|NCT00348309|81798335|FG002|Overall Study|Caregiver sick|0|||
27990850|NCT00348309|81798333|FG000|Overall Study|Use of prohibited medication|5|||
27990851|NCT00348309|81798334|FG001|Overall Study|Use of prohibited medication|2|||
27990852|NCT00348309|81798335|FG002|Overall Study|Use of prohibited medication|2|||
27990853|NCT00348309|81798333|FG000|Overall Study|Caregiver withdrawal|3|||
27990854|NCT00348309|81798334|FG001|Overall Study|Caregiver withdrawal|0|||
27990855|NCT00348309|81798335|FG002|Overall Study|Caregiver withdrawal|7|||
27990856|NCT00348309|81798333|FG000|Overall Study|Unable to complete ET visit|1|||
27990857|NCT00348309|81798334|FG001|Overall Study|Unable to complete ET visit|0|||
27990858|NCT00348309|81798335|FG002|Overall Study|Unable to complete ET visit|0|||
27990859|NCT00348309|81798333|FG000|Overall Study|PI closing medical practice|1|||
27990860|NCT00348309|81798334|FG001|Overall Study|PI closing medical practice|0|||
27990861|NCT00348309|81798335|FG002|Overall Study|PI closing medical practice|0|||
27990862|NCT00348309|81798333|FG000|Overall Study|Principal investigator's decision|1|||
27990863|NCT00348309|81798334|FG001|Overall Study|Principal investigator's decision|0|||
27990864|NCT00348309|81798335|FG002|Overall Study|Principal investigator's decision|0|||
27990865|NCT00348309|81798333|FG000|Overall Study|No disponibility of medication|1|||
27990866|NCT00348309|81798334|FG001|Overall Study|No disponibility of medication|0|||
27990867|NCT00348309|81798335|FG002|Overall Study|No disponibility of medication|0|||
27990868|NCT00348309|81798333|FG000|Overall Study|Worsened neurodegenerative disease|1|||
27990869|NCT00348309|81798334|FG001|Overall Study|Worsened neurodegenerative disease|0|||
27990870|NCT00348309|81798335|FG002|Overall Study|Worsened neurodegenerative disease|0|||
27990871|NCT00348309|81798333|FG000|Overall Study|Cognitive and behaviour worsening|2|||
27990872|NCT00348309|81798334|FG001|Overall Study|Cognitive and behaviour worsening|0|||
27990873|NCT00348309|81798335|FG002|Overall Study|Cognitive and behaviour worsening|0|||
27579263|NCT03003520|80303157|FG001|Overall Study|Progressive disease|1|||
27579264|NCT01532687|80303158|FG000|Overall Study|Death|2|||
27579265|NCT01532687|80303159|FG001|Overall Study|Death|0|||
27990874|NCT00348309|81798333|FG000|Overall Study|Worsening of alzheimer|1|||
27990875|NCT00348309|81798334|FG001|Overall Study|Worsening of alzheimer|0|||
27990876|NCT00348309|81798335|FG002|Overall Study|Worsening of alzheimer|1|||
27990877|NCT00348309|81798333|FG000|Overall Study|Did not appear in time for Visit 3|1|||
27990878|NCT00348309|81798334|FG001|Overall Study|Did not appear in time for Visit 3|0|||
27990879|NCT00348309|81798335|FG002|Overall Study|Did not appear in time for Visit 3|0|||
27990880|NCT00348309|81798333|FG000|Overall Study|Participant died|2|||
27990881|NCT00348309|81798334|FG001|Overall Study|Participant died|1|||
27870648|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27990882|NCT00348309|81798335|FG002|Overall Study|Participant died|1|||
27990883|NCT00348309|81798333|FG000|Overall Study|Decision of sponsor|1|||
27990884|NCT00348309|81798334|FG001|Overall Study|Decision of sponsor|0|||
27990885|NCT00348309|81798335|FG002|Overall Study|Decision of sponsor|0|||
27990886|NCT00348309|81798333|FG000|Overall Study|Ineffectiveness of treatment|0|||
27990887|NCT00348309|81798334|FG001|Overall Study|Ineffectiveness of treatment|1|||
27870649|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870650|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
27870651|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27870652|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27870653|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27870654|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27676210|NCT01647542|80650361|FG000|Overall Study|Study Termination|64|||
27676211|NCT01647542|80650362|FG001|Overall Study|Study Termination|61|||
27798398|NCT03725722|81095531|FG004|Overall Study|Personal reasons|1|||
27798399|NCT03725722|81095527|FG000|Overall Study|COVID-19 situation|0|||
27798400|NCT03725722|81095528|FG001|Overall Study|COVID-19 situation|1|||
27798401|NCT03725722|81095529|FG002|Overall Study|COVID-19 situation|0|||
27798402|NCT03725722|81095530|FG003|Overall Study|COVID-19 situation|0|||
27990888|NCT00348309|81798335|FG002|Overall Study|Ineffectiveness of treatment|0|||
27990889|NCT00348309|81798333|FG000|Overall Study|A foul of exclusion criteria|0|||
27676212|NCT01647542|80650363|FG002|Overall Study|Study Termination|65|||
27798403|NCT03725722|81095531|FG004|Overall Study|COVID-19 situation|0|||
27798404|NCT01976663|81095532|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
27579266|NCT01532687|80303158|FG000|Overall Study|Adverse Event|6|||
27798405|NCT01976663|81095532|FG000|Overall Study|Personal Reasons|6|||
27798406|NCT01976663|81095532|FG000|Overall Study|Withdrawal by Subject|4|||
27798407|NCT01976663|81095532|FG000|Overall Study|Screen Failure|3|||
27798408|NCT01976663|81095532|FG000|Overall Study|Adverse Event|2|||
27870655|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27579267|NCT01532687|80303159|FG001|Overall Study|Adverse Event|1|||
27798409|NCT01976663|81095532|FG000|Overall Study|Lost to Follow-up|3|||
27990890|NCT00348309|81798334|FG001|Overall Study|A foul of exclusion criteria|1|||
27798410|NCT00435825|81095533|FG000|Overall Study|Abnormality of Laboratory Test|0|||
27990891|NCT00348309|81798335|FG002|Overall Study|A foul of exclusion criteria|0|||
27990892|NCT00348309|81798333|FG000|Overall Study|Participant was hospitalized|0|||
27990893|NCT00348309|81798334|FG001|Overall Study|Participant was hospitalized|1|||
27990894|NCT00348309|81798335|FG002|Overall Study|Participant was hospitalized|0|||
27990895|NCT00348309|81798333|FG000|Overall Study|Sponsor refuseal|0|||
27990896|NCT00348309|81798334|FG001|Overall Study|Sponsor refuseal|1|||
27990897|NCT00348309|81798335|FG002|Overall Study|Sponsor refuseal|1|||
27990898|NCT00348309|81798333|FG000|Overall Study|Forgot often medication|0|||
27990899|NCT00348309|81798334|FG001|Overall Study|Forgot often medication|1|||
27990900|NCT00348309|81798335|FG002|Overall Study|Forgot often medication|0|||
27990901|NCT00348309|81798333|FG000|Overall Study|Medical Monitor decision|0|||
27990902|NCT00348309|81798334|FG001|Overall Study|Medical Monitor decision|0|||
27990903|NCT00348309|81798335|FG002|Overall Study|Medical Monitor decision|1|||
27990904|NCT00348309|81798333|FG000|Overall Study|Increased dose of Aricept|0|||
27990905|NCT00348309|81798334|FG001|Overall Study|Increased dose of Aricept|0|||
27990906|NCT00348309|81798335|FG002|Overall Study|Increased dose of Aricept|1|||
27990907|NCT00348309|81798333|FG000|Overall Study|Site closure|0|||
27990908|NCT00348309|81798334|FG001|Overall Study|Site closure|0|||
27990909|NCT00348309|81798335|FG002|Overall Study|Site closure|1|||
27990910|NCT00348309|81798333|FG000|Overall Study|Adverse event not attended|0|||
27990911|NCT00348309|81798334|FG001|Overall Study|Adverse event not attended|0|||
27990912|NCT00348309|81798335|FG002|Overall Study|Adverse event not attended|1|||
27990913|NCT00348309|81798333|FG000|Overall Study|ECG abnormal|0|||
27990914|NCT00348309|81798334|FG001|Overall Study|ECG abnormal|0|||
27990915|NCT00348309|81798335|FG002|Overall Study|ECG abnormal|2|||
27990916|NCT00348309|81798333|FG000|Overall Study|Cardiologist recommendations|0|||
27990917|NCT00348309|81798334|FG001|Overall Study|Cardiologist recommendations|0|||
27990918|NCT00348309|81798335|FG002|Overall Study|Cardiologist recommendations|1|||
27990919|NCT00348309|81798333|FG000|Overall Study|HCV career|0|||
27990920|NCT00348309|81798334|FG001|Overall Study|HCV career|0|||
27990921|NCT00348309|81798335|FG002|Overall Study|HCV career|1|||
27990922|NCT03922620|81798341|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
27990923|NCT03922620|81798342|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
27990924|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
27798411|NCT00435825|81095534|FG001|Overall Study|Abnormality of Laboratory Test|1|||
27798412|NCT00435825|81095535|FG002|Overall Study|Abnormality of Laboratory Test|0|||
27798413|NCT00435825|81095536|FG003|Overall Study|Abnormality of Laboratory Test|0|||
27798414|NCT00435825|81095533|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27798415|NCT00435825|81095534|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27798416|NCT00435825|81095535|FG002|Overall Study|Insufficient Therapeutic Response|0|||
27798417|NCT00435825|81095536|FG003|Overall Study|Insufficient Therapeutic Response|3|||
27798418|NCT00435825|81095533|FG000|Overall Study|Other Protocol Violation|1|||
27798419|NCT00435825|81095534|FG001|Overall Study|Other Protocol Violation|0|||
27798420|NCT00435825|81095535|FG002|Overall Study|Other Protocol Violation|0|||
27798421|NCT00435825|81095536|FG003|Overall Study|Other Protocol Violation|0|||
27798422|NCT00435825|81095533|FG000|Overall Study|Refused treatment|2|||
27798423|NCT00435825|81095534|FG001|Overall Study|Refused treatment|0|||
27798424|NCT00435825|81095535|FG002|Overall Study|Refused treatment|0|||
27798425|NCT00435825|81095536|FG003|Overall Study|Refused treatment|5|||
27798426|NCT00435825|81095533|FG000|Overall Study|Failure to return|5|||
27798427|NCT00435825|81095534|FG001|Overall Study|Failure to return|0|||
27798428|NCT00435825|81095535|FG002|Overall Study|Failure to return|4|||
27798429|NCT00435825|81095536|FG003|Overall Study|Failure to return|0|||
27798430|NCT00435825|81095533|FG000|Overall Study|Did not receive study drug|1|||
27798431|NCT00435825|81095534|FG001|Overall Study|Did not receive study drug|0|||
27798432|NCT00435825|81095535|FG002|Overall Study|Did not receive study drug|2|||
27798433|NCT00435825|81095536|FG003|Overall Study|Did not receive study drug|0|||
27798434|NCT00435825|81095533|FG000|Overall Study|Did not enter follow-up|0|||
27798435|NCT00435825|81095534|FG001|Overall Study|Did not enter follow-up|4|||
27798436|NCT00435825|81095535|FG002|Overall Study|Did not enter follow-up|1|||
27798437|NCT00435825|81095536|FG003|Overall Study|Did not enter follow-up|3|||
27798438|NCT00435825|81095533|FG000|Overall Study|Did not complete full follow-up period|6|||
27798439|NCT00435825|81095534|FG001|Overall Study|Did not complete full follow-up period|6|||
27798440|NCT00435825|81095535|FG002|Overall Study|Did not complete full follow-up period|4|||
27798441|NCT00435825|81095536|FG003|Overall Study|Did not complete full follow-up period|5|||
27798442|NCT03674827|81095538|FG000|Treatment Phase|Adverse Event|0|||
27798443|NCT03674827|81095539|FG001|Treatment Phase|Adverse Event|0|||
27798444|NCT03674827|81095540|FG002|Treatment Phase|Adverse Event|0|||
27798445|NCT03674827|81095541|FG003|Treatment Phase|Adverse Event|0|||
27798446|NCT03674827|81095542|FG004|Treatment Phase|Adverse Event|0|||
27990925|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
27990926|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
27990927|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Death|0|||
27990928|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Death|2|||
27870656|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27870657|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
27990929|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Death|0|||
27990930|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
27990931|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
27990932|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
27798447|NCT03674827|81095543|FG005|Treatment Phase|Adverse Event|2|||
27798448|NCT03674827|81095538|FG000|Treatment Phase|Death|2|||
27798449|NCT03674827|81095539|FG001|Treatment Phase|Death|0|||
27798450|NCT03674827|81095540|FG002|Treatment Phase|Death|0|||
27798451|NCT03674827|81095541|FG003|Treatment Phase|Death|0|||
27798452|NCT03674827|81095542|FG004|Treatment Phase|Death|1|||
27798453|NCT03674827|81095543|FG005|Treatment Phase|Death|0|||
27798454|NCT03674827|81095538|FG000|Treatment Phase|Progressive Disease|0|||
27798455|NCT03674827|81095539|FG001|Treatment Phase|Progressive Disease|4|||
27798456|NCT03674827|81095540|FG002|Treatment Phase|Progressive Disease|3|||
27798457|NCT03674827|81095541|FG003|Treatment Phase|Progressive Disease|4|||
27798458|NCT03674827|81095542|FG004|Treatment Phase|Progressive Disease|4|||
27798459|NCT03674827|81095543|FG005|Treatment Phase|Progressive Disease|9|||
27990933|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
27990934|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
27990935|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
27990936|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
27990937|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
27990938|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
27990939|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
27990940|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
27990941|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
27990942|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
27990943|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
27990944|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
27798460|NCT03674827|81095538|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
27798461|NCT03674827|81095539|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
27798462|NCT03674827|81095540|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
27798463|NCT03674827|81095541|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
27798464|NCT03674827|81095542|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
27798465|NCT03674827|81095543|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
27798466|NCT03674827|81095538|FG000|Treatment Phase|Withdrawal by Subject|0|||
27798467|NCT03674827|81095539|FG001|Treatment Phase|Withdrawal by Subject|0|||
27798468|NCT03674827|81095540|FG002|Treatment Phase|Withdrawal by Subject|0|||
27798469|NCT03674827|81095541|FG003|Treatment Phase|Withdrawal by Subject|0|||
27798470|NCT03674827|81095542|FG004|Treatment Phase|Withdrawal by Subject|0|||
27798471|NCT03674827|81095543|FG005|Treatment Phase|Withdrawal by Subject|1|||
27798472|NCT03674827|81095538|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
27798473|NCT03674827|81095539|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
27798474|NCT03674827|81095540|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
27798475|NCT03674827|81095541|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
27798476|NCT03674827|81095542|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
27798477|NCT03674827|81095543|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
27798478|NCT03674827|81095538|FG000|Treatment Phase|Other|0|||
27798479|NCT03674827|81095539|FG001|Treatment Phase|Other|1|||
27870658|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27990945|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Recovery|1|||
27990946|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Recovery|0|||
27990947|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Recovery|1|||
27990948|NCT00195663|81798343|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
27990949|NCT00195663|81798344|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
27990950|NCT00195663|81798345|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
27990951|NCT00195663|81798343|FG000|Open-Label Extension Period|Adverse Event|21|||
27990952|NCT00195663|81798344|FG001|Open-Label Extension Period|Adverse Event|32|||
27990953|NCT00195663|81798345|FG002|Open-Label Extension Period|Adverse Event|36|||
27990954|NCT00195663|81798343|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
27990955|NCT00195663|81798344|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
27990956|NCT00195663|81798345|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
27990957|NCT00195663|81798343|FG000|Open-Label Extension Period|Recovery|0|||
27798480|NCT03674827|81095540|FG002|Treatment Phase|Other|0|||
27798481|NCT03674827|81095541|FG003|Treatment Phase|Other|0|||
27798482|NCT03674827|81095542|FG004|Treatment Phase|Other|0|||
27798483|NCT03674827|81095543|FG005|Treatment Phase|Other|1|||
27798484|NCT03674827|81095538|FG000|Long-Term Follow-up Phase|Death|2|||
27798485|NCT03674827|81095539|FG001|Long-Term Follow-up Phase|Death|4|||
27798486|NCT03674827|81095540|FG002|Long-Term Follow-up Phase|Death|2|||
27798487|NCT03674827|81095541|FG003|Long-Term Follow-up Phase|Death|3|||
27798488|NCT03674827|81095542|FG004|Long-Term Follow-up Phase|Death|2|||
27798489|NCT03674827|81095543|FG005|Long-Term Follow-up Phase|Death|6|||
27798490|NCT03674827|81095538|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
27798491|NCT03674827|81095539|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
27798492|NCT03674827|81095540|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
27990958|NCT00195663|81798344|FG001|Open-Label Extension Period|Recovery|2|||
27990959|NCT00195663|81798345|FG002|Open-Label Extension Period|Recovery|2|||
27990960|NCT00195663|81798343|FG000|Open-Label Extension Period|Protocol Violation|3|||
27990961|NCT00195663|81798344|FG001|Open-Label Extension Period|Protocol Violation|4|||
27990962|NCT00195663|81798345|FG002|Open-Label Extension Period|Protocol Violation|4|||
27990963|NCT00195663|81798343|FG000|Open-Label Extension Period|Death|2|||
27990964|NCT00195663|81798344|FG001|Open-Label Extension Period|Death|2|||
27990965|NCT00195663|81798345|FG002|Open-Label Extension Period|Death|2|||
27990966|NCT00195663|81798343|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
27990967|NCT00195663|81798344|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
27990968|NCT00195663|81798345|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
27990969|NCT00195663|81798343|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
27990970|NCT00195663|81798344|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
27990971|NCT00195663|81798345|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
27990972|NCT00195663|81798343|FG000|Open-Label Extension Period|Administrative reasons|11|||
27990973|NCT00195663|81798344|FG001|Open-Label Extension Period|Administrative reasons|11|||
27990974|NCT00195663|81798345|FG002|Open-Label Extension Period|Administrative reasons|13|||
27990975|NCT00811174|81798346|FG000|Overall Study|Protocol Violation|2|||
27990976|NCT00811174|81798346|FG000|Overall Study|Sponsors Decision|1|||
27990977|NCT00448747|81798347|FG000|Overall Study|collapsed veins|1|||
27990978|NCT00448747|81798348|FG001|Overall Study|collapsed veins|0|||
27990979|NCT02578186|81798349|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
27990980|NCT02578186|81798350|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
27990981|NCT02578186|81798349|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
27990982|NCT02578186|81798350|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
27990983|NCT03781778|81798358|FG000|Overall Study|Withdrawal by Subject|2|||
27990984|NCT03781778|81798359|FG001|Overall Study|Withdrawal by Subject|2|||
27990985|NCT03052049|81798360|FG000|Overall Study|Withdrawal by Subject|2|||
27990986|NCT01223183|81798361|FG000|Imaging Day 1|Physician Decision|0|||
27990987|NCT01223183|81798362|FG001|Imaging Day 1|Physician Decision|1|||
27990988|NCT01223183|81798361|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
27990989|NCT01223183|81798362|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
27990990|NCT01223183|81798361|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
27990991|NCT01223183|81798362|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
27990992|NCT01022424|81798363|FG000|Overall Study|Adverse Event|1|||
27990993|NCT01022424|81798363|FG000|Overall Study|Physician Decision|1|||
27990994|NCT01022424|81798363|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
27990995|NCT04207060|81798368|FG000|Overall Study|Lost to Follow-up|2|||
27990996|NCT04207060|81798369|FG001|Overall Study|Lost to Follow-up|0|||
27990997|NCT03197376|81798370|FG000|Primary and Booster Phase|Adverse Event|0|||
27990998|NCT03197376|81798371|FG001|Primary and Booster Phase|Adverse Event|0|||
27798493|NCT03674827|81095541|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
27798494|NCT03674827|81095542|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
27990999|NCT03197376|81798372|FG002|Primary and Booster Phase|Adverse Event|0|||
27991000|NCT03197376|81798373|FG003|Primary and Booster Phase|Adverse Event|1|||
27991001|NCT03197376|81798370|FG000|Primary and Booster Phase|Death|1|||
27991002|NCT03197376|81798371|FG001|Primary and Booster Phase|Death|0|||
27991003|NCT03197376|81798372|FG002|Primary and Booster Phase|Death|0|||
27991004|NCT03197376|81798373|FG003|Primary and Booster Phase|Death|2|||
27991005|NCT03197376|81798370|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
27991006|NCT03197376|81798371|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
27991007|NCT03197376|81798372|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
27798495|NCT03674827|81095543|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
27991008|NCT03197376|81798373|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
27991009|NCT03197376|81798370|FG000|Primary and Booster Phase|Physician Decision|1|||
27991010|NCT03197376|81798371|FG001|Primary and Booster Phase|Physician Decision|0|||
27798496|NCT03674827|81095538|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
27798497|NCT03674827|81095539|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
27798498|NCT03674827|81095540|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
27991011|NCT03197376|81798372|FG002|Primary and Booster Phase|Physician Decision|1|||
27991012|NCT03197376|81798373|FG003|Primary and Booster Phase|Physician Decision|3|||
27991013|NCT03197376|81798370|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
27991014|NCT03197376|81798371|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
27991015|NCT03197376|81798372|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
27991016|NCT03197376|81798373|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
27991017|NCT03197376|81798370|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
27991018|NCT03197376|81798371|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
27991019|NCT03197376|81798372|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
27991020|NCT03197376|81798373|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
27991021|NCT03197376|81798370|FG000|Primary and Booster Phase|Not vaccine related|1|||
27991022|NCT03197376|81798371|FG001|Primary and Booster Phase|Not vaccine related|2|||
27991023|NCT03197376|81798372|FG002|Primary and Booster Phase|Not vaccine related|0|||
27991024|NCT03197376|81798373|FG003|Primary and Booster Phase|Not vaccine related|6|||
27991025|NCT03197376|81798370|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
27991026|NCT03197376|81798371|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
27991027|NCT03197376|81798372|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
27991028|NCT03197376|81798373|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
27991029|NCT03197376|81798370|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
27991030|NCT03197376|81798371|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
27991031|NCT03197376|81798372|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
27991032|NCT03197376|81798373|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
27991033|NCT03197376|81798370|FG000|Immune Persistence Phase|Not vaccine related|1|||
27991034|NCT03197376|81798371|FG001|Immune Persistence Phase|Not vaccine related|0|||
27991035|NCT03197376|81798372|FG002|Immune Persistence Phase|Not vaccine related|1|||
27991036|NCT03197376|81798373|FG003|Immune Persistence Phase|Not vaccine related|1|||
27991037|NCT01161537|81798374|FG000|Part B|Withdrawal by Subject|2|||
27991038|NCT05090852|81798377|FG000|Overall Study|Physician Decision|5|||
27991039|NCT03214406|81798378|FG000|Overall Study|did not meet enrollment criteria|9|||
27991040|NCT03214406|81798379|FG001|Overall Study|did not meet enrollment criteria|13|||
27991041|NCT03214406|81798378|FG000|Overall Study|Withdrawal by Subject|1|||
27991042|NCT03214406|81798379|FG001|Overall Study|Withdrawal by Subject|0|||
27991043|NCT03214406|81798378|FG000|Overall Study|Lost to Follow-up|0|||
27991044|NCT03214406|81798379|FG001|Overall Study|Lost to Follow-up|2|||
27991045|NCT01792115|81798380|FG000|Overall Study|Lost to Follow-up|0|||
27991046|NCT01792115|81798381|FG001|Overall Study|Lost to Follow-up|1|||
27991047|NCT01792115|81798382|FG002|Overall Study|Lost to Follow-up|0|||
27991048|NCT02560012|81798385|FG000|Overall Study|Study Terminated|2|||
27991049|NCT01153724|81798386|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27991050|NCT01153724|81798386|FG000|Treatment Period 2|Adverse Event|1|||
27991051|NCT01153724|81798386|FG000|Treatment Period 2|Other reason not defined above|1|||
27991052|NCT00416455|81798387|FG000|Overall Study|PET / CT not done|3|||
27991053|NCT00416455|81798388|FG001|Overall Study|PET / CT not done|5|||
27991054|NCT00416455|81798387|FG000|Overall Study|PET / CT poor quality|2|||
27991055|NCT00416455|81798388|FG001|Overall Study|PET / CT poor quality|1|||
27991056|NCT00416455|81798387|FG000|Overall Study|Inadequate pathology|11|||
27991057|NCT00416455|81798388|FG001|Overall Study|Inadequate pathology|2|||
27991058|NCT01007838|81798397|FG000|Overall Study|Withdrawal by Subject|1|||
27991059|NCT01007838|81798398|FG001|Overall Study|Withdrawal by Subject|0|||
27991060|NCT01007838|81798399|FG002|Overall Study|Withdrawal by Subject|0|||
27991061|NCT01007838|81798400|FG003|Overall Study|Withdrawal by Subject|0|||
27991062|NCT01007838|81798397|FG000|Overall Study|Physician Decision|1|||
27991063|NCT01007838|81798398|FG001|Overall Study|Physician Decision|0|||
27991064|NCT01007838|81798399|FG002|Overall Study|Physician Decision|0|||
27991065|NCT01007838|81798400|FG003|Overall Study|Physician Decision|0|||
27991066|NCT01007838|81798397|FG000|Overall Study|Started home haemodialysis|1|||
27991067|NCT01007838|81798398|FG001|Overall Study|Started home haemodialysis|0|||
27991068|NCT01007838|81798399|FG002|Overall Study|Started home haemodialysis|0|||
27991069|NCT01007838|81798400|FG003|Overall Study|Started home haemodialysis|0|||
27991070|NCT02587819|81798406|FG000|Overall Study|Adverse Event|1|||
27991071|NCT02587819|81798406|FG000|Overall Study|Lost to Follow-up|1|||
27991072|NCT00782483|81798408|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
27991073|NCT00880191|81798409|FG000|Overall Study|Refused further treatment|4|||
27676213|NCT01647542|80650361|FG000|Overall Study|Lack of Efficacy|1|||
27991074|NCT00880191|81798410|FG001|Overall Study|Refused further treatment|1|||
27991075|NCT00880191|81798409|FG000|Overall Study|Adverse Event|8|||
27991076|NCT00880191|81798410|FG001|Overall Study|Adverse Event|6|||
27991077|NCT00880191|81798409|FG000|Overall Study|Hospitalization/efficacy|1|||
27991078|NCT00880191|81798410|FG001|Overall Study|Hospitalization/efficacy|1|||
27991079|NCT02218008|81798413|FG000|Stage 1 (S1)|Adverse Event|6|||
27991080|NCT02218008|81798414|FG001|Stage 1 (S1)|Adverse Event|5|||
27991081|NCT02218008|81798415|FG002|Stage 1 (S1)|Adverse Event|11|||
27676214|NCT01647542|80650362|FG001|Overall Study|Lack of Efficacy|1|||
27991082|NCT02218008|81798416|FG003|Stage 1 (S1)|Adverse Event|0|||
27991083|NCT02218008|81798417|FG004|Stage 1 (S1)|Adverse Event|0|||
27991084|NCT02218008|81798418|FG005|Stage 1 (S1)|Adverse Event|0|||
27991085|NCT02218008|81798413|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
27991086|NCT02218008|81798414|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
27991087|NCT02218008|81798415|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
27991088|NCT02218008|81798416|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
27676215|NCT01647542|80650363|FG002|Overall Study|Lack of Efficacy|0|||
27798499|NCT03674827|81095541|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
27798500|NCT03674827|81095542|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
27798501|NCT03674827|81095543|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
27798502|NCT01333475|81095544|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
27798503|NCT01333475|81095545|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
27991089|NCT02218008|81798417|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
27991090|NCT02218008|81798418|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
27991091|NCT02218008|81798413|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
27991092|NCT02218008|81798414|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
27991093|NCT02218008|81798415|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
27991094|NCT02218008|81798416|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
27991095|NCT02218008|81798417|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
27991096|NCT02218008|81798418|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
27991097|NCT02218008|81798413|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
27991098|NCT02218008|81798414|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
27991099|NCT02218008|81798415|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
27991100|NCT02218008|81798416|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
27991101|NCT02218008|81798417|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
27991102|NCT02218008|81798418|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
27991103|NCT02218008|81798413|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
27991104|NCT02218008|81798414|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
27991105|NCT02218008|81798415|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27991106|NCT02218008|81798416|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27991107|NCT02218008|81798417|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27991108|NCT02218008|81798418|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
27991109|NCT02218008|81798413|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
27991110|NCT02218008|81798414|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
27991111|NCT02218008|81798415|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
27991112|NCT02218008|81798416|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
27991113|NCT02218008|81798417|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
27991114|NCT02218008|81798418|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
27991115|NCT02218008|81798413|FG000|Stage 1 (S1)|Pregnancy|0|||
27991116|NCT02218008|81798414|FG001|Stage 1 (S1)|Pregnancy|0|||
27991117|NCT02218008|81798415|FG002|Stage 1 (S1)|Pregnancy|1|||
27991118|NCT02218008|81798416|FG003|Stage 1 (S1)|Pregnancy|0|||
27991119|NCT02218008|81798417|FG004|Stage 1 (S1)|Pregnancy|0|||
27991120|NCT02218008|81798418|FG005|Stage 1 (S1)|Pregnancy|0|||
27991121|NCT02218008|81798413|FG000|Stage 1 (S1)|Protocol Violation|0|||
27991122|NCT02218008|81798414|FG001|Stage 1 (S1)|Protocol Violation|0|||
27991123|NCT02218008|81798415|FG002|Stage 1 (S1)|Protocol Violation|1|||
27991124|NCT02218008|81798416|FG003|Stage 1 (S1)|Protocol Violation|0|||
27991125|NCT02218008|81798417|FG004|Stage 1 (S1)|Protocol Violation|0|||
27991126|NCT02218008|81798418|FG005|Stage 1 (S1)|Protocol Violation|0|||
27991127|NCT02218008|81798413|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
27991128|NCT02218008|81798414|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27991129|NCT02218008|81798415|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27991130|NCT02218008|81798416|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27676216|NCT01647542|80650361|FG000|Overall Study|Death|0|||
27676217|NCT01647542|80650362|FG001|Overall Study|Death|0|||
27676218|NCT01647542|80650363|FG002|Overall Study|Death|1|||
27676219|NCT00401258|80650366|FG000|Overall Study|Adverse Event|7|||
27676220|NCT04463680|80650367|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
27676221|NCT04463680|80650367|FG000|Overall Study|Not eligible due to implant duration of use|1|||
27991131|NCT02218008|81798417|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27676222|NCT04463680|80650367|FG000|Overall Study|Withdrawal by Subject|3|||
27676223|NCT01667926|80650368|FG000|Overall Study|Withdrawal by Subject|1|||
27676224|NCT01667926|80650369|FG001|Overall Study|Withdrawal by Subject|2|||
27676225|NCT01667926|80650370|FG002|Overall Study|Withdrawal by Subject|2|||
27798504|NCT01333475|81095544|FG000|Overall Study|Toxicity|1|||
27798505|NCT01333475|81095545|FG001|Overall Study|Toxicity|3|||
27798506|NCT00883740|81095552|FG000|First Intervention|Lost to Follow-up|1|||
27798507|NCT00883740|81095553|FG001|First Intervention|Lost to Follow-up|0|||
27870659|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27991132|NCT02218008|81798418|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
27991133|NCT02218008|81798413|FG000|Stage 2 (S2)|Adverse Event|0|||
27991134|NCT02218008|81798414|FG001|Stage 2 (S2)|Adverse Event|0|||
27991135|NCT02218008|81798415|FG002|Stage 2 (S2)|Adverse Event|0|||
27991136|NCT02218008|81798416|FG003|Stage 2 (S2)|Adverse Event|2|||
27991137|NCT02218008|81798417|FG004|Stage 2 (S2)|Adverse Event|3|||
27991138|NCT02218008|81798418|FG005|Stage 2 (S2)|Adverse Event|3|||
27676226|NCT01667926|80650368|FG000|Overall Study|Physician Decision|0|||
27676227|NCT01667926|80650369|FG001|Overall Study|Physician Decision|0|||
27991139|NCT02218008|81798413|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
27991140|NCT02218008|81798414|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
27991141|NCT02218008|81798415|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
27991142|NCT02218008|81798416|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
27991143|NCT02218008|81798417|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
27991144|NCT02218008|81798418|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
27991145|NCT02218008|81798413|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
27991146|NCT02218008|81798414|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
27991147|NCT02218008|81798415|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
27991148|NCT02218008|81798416|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
27991149|NCT02218008|81798417|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
27991150|NCT02218008|81798418|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
27991151|NCT02218008|81798413|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27991152|NCT02218008|81798414|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27991153|NCT02218008|81798415|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27991154|NCT02218008|81798416|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
27991155|NCT02218008|81798417|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27991156|NCT02218008|81798418|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
27991157|NCT02218008|81798413|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
27991158|NCT02218008|81798414|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
27991159|NCT02218008|81798415|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
27991160|NCT02218008|81798416|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
27991161|NCT02218008|81798417|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
27991162|NCT02218008|81798418|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
27991163|NCT04677504|81798419|FG000|Overall Study|Death|51|||
27991164|NCT04677504|81798420|FG001|Overall Study|Death|49|||
27991165|NCT04677504|81798419|FG000|Overall Study|Progressive Disease|1|||
27991166|NCT04677504|81798420|FG001|Overall Study|Progressive Disease|0|||
27991167|NCT04677504|81798419|FG000|Overall Study|Symptomatic Deterioration|1|||
27991168|NCT04677504|81798420|FG001|Overall Study|Symptomatic Deterioration|0|||
27991169|NCT04677504|81798419|FG000|Overall Study|Withdrawal by Subject|2|||
27991170|NCT04677504|81798420|FG001|Overall Study|Withdrawal by Subject|5|||
27991171|NCT04677504|81798419|FG000|Overall Study|Study Terminated By Sponsor|28|||
27991172|NCT04677504|81798420|FG001|Overall Study|Study Terminated By Sponsor|24|||
27991173|NCT04677504|81798419|FG000|Overall Study|Adverse Event|0|||
27991174|NCT04677504|81798420|FG001|Overall Study|Adverse Event|1|||
27991175|NCT02106403|81798435|FG000|Follow-Up Visit 3|Other Reason|0|||
27991176|NCT02106403|81798436|FG001|Follow-Up Visit 3|Other Reason|0|||
27991177|NCT02106403|81798437|FG002|Follow-Up Visit 3|Other Reason|0|||
27991178|NCT02106403|81798438|FG003|Follow-Up Visit 3|Other Reason|0|||
27991179|NCT02106403|81798439|FG004|Follow-Up Visit 3|Other Reason|0|||
27991180|NCT02106403|81798440|FG005|Follow-Up Visit 3|Other Reason|1|||
27676228|NCT01667926|80650370|FG002|Overall Study|Physician Decision|1|||
27676229|NCT01667926|80650368|FG000|Overall Study|Time committment|0|||
27676230|NCT01667926|80650369|FG001|Overall Study|Time committment|0|||
27676231|NCT01667926|80650370|FG002|Overall Study|Time committment|2|||
27676232|NCT01667926|80650368|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
27676233|NCT01667926|80650369|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
27676234|NCT01667926|80650370|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
27676235|NCT01667926|80650368|FG000|Overall Study|Lost to Follow-up|1|||
27676236|NCT01667926|80650369|FG001|Overall Study|Lost to Follow-up|2|||
27676237|NCT01667926|80650370|FG002|Overall Study|Lost to Follow-up|1|||
27676238|NCT01667926|80650368|FG000|Overall Study|Side effects|3|||
27676239|NCT01667926|80650369|FG001|Overall Study|Side effects|0|||
27676240|NCT01667926|80650370|FG002|Overall Study|Side effects|0|||
27676241|NCT02035696|80650371|FG000|Overall Study|Lost to Follow-up|0|||
27676242|NCT02035696|80650372|FG001|Overall Study|Lost to Follow-up|3|||
27676243|NCT02035696|80650373|FG002|Overall Study|Lost to Follow-up|1|||
27676244|NCT02035696|80650374|FG003|Overall Study|Lost to Follow-up|2|||
27676245|NCT02035696|80650371|FG000|Overall Study|Withdrawal by Subject|3|||
27676246|NCT02035696|80650372|FG001|Overall Study|Withdrawal by Subject|0|||
27676247|NCT02035696|80650373|FG002|Overall Study|Withdrawal by Subject|2|||
27991181|NCT00699660|81798441|FG000|Overall Study|Lost to Follow-up|4|||
27991182|NCT00699660|81798442|FG001|Overall Study|Lost to Follow-up|2|||
27991183|NCT00699660|81798441|FG000|Overall Study|missing reports and recording failures|10|||
27991184|NCT00699660|81798442|FG001|Overall Study|missing reports and recording failures|6|||
27991185|NCT01180296|81798443|FG000|Overall Study|Protocol Violation|1|||
27991186|NCT01180296|81798444|FG001|Overall Study|Protocol Violation|2|||
27991187|NCT02465203|81798446|FG000|Overall Study|Protocol Violation|1|||
27991188|NCT02465203|81798447|FG001|Overall Study|Protocol Violation|1|||
27676248|NCT02035696|80650374|FG003|Overall Study|Withdrawal by Subject|1|||
27676249|NCT04367480|80650378|FG000|Overall Study|Adverse Event|1|||
27676250|NCT04367480|80650379|FG001|Overall Study|Adverse Event|1|||
27676251|NCT04367480|80650378|FG000|Overall Study|Death|1|||
27676252|NCT04367480|80650379|FG001|Overall Study|Death|0|||
27676253|NCT04367480|80650378|FG000|Overall Study|Lost to Follow-up|1|||
27833144|NCT04281472|81219494|FG001|Stage A|Withdrawal by Subject|0|||
27991189|NCT02465203|81798448|FG002|Overall Study|Protocol Violation|1|||
27991190|NCT02465203|81798446|FG000|Overall Study|Study terminated by sponsor|50|||
27991191|NCT02465203|81798447|FG001|Overall Study|Study terminated by sponsor|34|||
27991192|NCT02465203|81798448|FG002|Overall Study|Study terminated by sponsor|11|||
27676254|NCT04367480|80650379|FG001|Overall Study|Lost to Follow-up|1|||
27676255|NCT04367480|80650378|FG000|Overall Study|Withdrawal by Subject|0|||
27676256|NCT04367480|80650379|FG001|Overall Study|Withdrawal by Subject|3|||
27676257|NCT04367480|80650378|FG000|Overall Study|App glitch during the study|1|||
27676258|NCT04367480|80650379|FG001|Overall Study|App glitch during the study|0|||
27676259|NCT04367480|80650378|FG000|Overall Study|Device Distribution Error|0|||
27798508|NCT00883740|81095552|FG000|First Intervention|No longer willing to participate|2|||
27798509|NCT00883740|81095553|FG001|First Intervention|No longer willing to participate|0|||
27798510|NCT00883740|81095552|FG000|First Intervention|Protocol Violation|3|||
27798511|NCT00883740|81095553|FG001|First Intervention|Protocol Violation|6|||
27798512|NCT00883740|81095552|FG000|First Intervention|Adverse Event|1|||
27798513|NCT00883740|81095553|FG001|First Intervention|Adverse Event|2|||
27798514|NCT00883740|81095552|FG000|Second Intervention|Protocol Violation|1|||
27798515|NCT00883740|81095553|FG001|Second Intervention|Protocol Violation|0|||
27798516|NCT00883740|81095552|FG000|Second Intervention|No longer willing to participate|0|||
27798517|NCT00883740|81095553|FG001|Second Intervention|No longer willing to participate|1|||
27798518|NCT00929201|81095554|FG000|Period 1|Withdrawal by Subject|0|||
27798519|NCT00929201|81095555|FG001|Period 1|Withdrawal by Subject|1|||
27798520|NCT01548573|81095556|FG000|Overall Study|Death|3|||
27798521|NCT01548573|81095556|FG000|Overall Study|Withdrawal by Subject|2|||
27798522|NCT03576131|81095557|FG000|Overall Study|Investigator decision|0|||
27798523|NCT03576131|81095558|FG001|Overall Study|Investigator decision|0|||
27798524|NCT03576131|81095559|FG002|Overall Study|Investigator decision|0|||
27870660|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27870661|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27870662|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
27798525|NCT03576131|81095560|FG003|Overall Study|Investigator decision|1|||
27870663|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870664|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
27991193|NCT02465203|81798446|FG000|Overall Study|New therapy for study indication|4|||
27991194|NCT02465203|81798447|FG001|Overall Study|New therapy for study indication|0|||
27991195|NCT02465203|81798448|FG002|Overall Study|New therapy for study indication|0|||
27991196|NCT02465203|81798446|FG000|Overall Study|Patient/guardian decision|1|||
27991197|NCT02465203|81798447|FG001|Overall Study|Patient/guardian decision|1|||
27991198|NCT02465203|81798448|FG002|Overall Study|Patient/guardian decision|1|||
27991199|NCT01371734|81798449|FG000|Overall Study|Other|2|||
27991200|NCT01371734|81798450|FG001|Overall Study|Other|1|||
27991201|NCT01371734|81798451|FG002|Overall Study|Other|2|||
27991202|NCT01371734|81798449|FG000|Overall Study|Withdrawal by Subject|3|||
27991203|NCT01371734|81798450|FG001|Overall Study|Withdrawal by Subject|4|||
27991204|NCT01371734|81798451|FG002|Overall Study|Withdrawal by Subject|9|||
27991205|NCT01371734|81798449|FG000|Overall Study|Lost to Follow-up|5|||
27991206|NCT01371734|81798450|FG001|Overall Study|Lost to Follow-up|3|||
27991207|NCT01371734|81798451|FG002|Overall Study|Lost to Follow-up|1|||
27991208|NCT01371734|81798449|FG000|Overall Study|Protocol Violation|3|||
27991209|NCT01371734|81798450|FG001|Overall Study|Protocol Violation|1|||
27991210|NCT01371734|81798451|FG002|Overall Study|Protocol Violation|2|||
27991211|NCT01371734|81798449|FG000|Overall Study|Adverse Event|8|||
27991212|NCT01371734|81798450|FG001|Overall Study|Adverse Event|8|||
27991213|NCT01371734|81798451|FG002|Overall Study|Adverse Event|3|||
27991214|NCT01371734|81798449|FG000|Overall Study|Lack of Efficacy|2|||
27991215|NCT01371734|81798450|FG001|Overall Study|Lack of Efficacy|2|||
27991216|NCT01371734|81798451|FG002|Overall Study|Lack of Efficacy|0|||
27991217|NCT01108523|81798455|FG000|Overall Study|Protocol Violation|4|||
27991218|NCT02663622|81798458|FG000|Overall Study|Death|3|||
27991219|NCT02663622|81798459|FG001|Overall Study|Death|1|||
27991220|NCT02663622|81798460|FG002|Overall Study|Death|1|||
27991221|NCT02663622|81798461|FG003|Overall Study|Death|8|||
27991222|NCT02663622|81798458|FG000|Overall Study|Protocol Violation|0|||
27991223|NCT02663622|81798459|FG001|Overall Study|Protocol Violation|0|||
27676260|NCT04367480|80650379|FG001|Overall Study|Device Distribution Error|2|||
27798526|NCT03576131|81095561|FG004|Overall Study|Investigator decision|0|||
27798527|NCT03576131|81095562|FG005|Overall Study|Investigator decision|1|||
27798528|NCT03576131|81095563|FG006|Overall Study|Investigator decision|0|||
27798529|NCT03576131|81095564|FG007|Overall Study|Investigator decision|0|||
27798530|NCT03576131|81095557|FG000|Overall Study|Withdrawal by Subject|1|||
27991224|NCT02663622|81798460|FG002|Overall Study|Protocol Violation|0|||
27991225|NCT02663622|81798461|FG003|Overall Study|Protocol Violation|1|||
27991226|NCT01754493|81798462|FG000|Overall Study|Adverse Event|1|||
27991227|NCT01754493|81798462|FG000|Overall Study|Lost to Follow-up|3|||
27991228|NCT01754493|81798462|FG000|Overall Study|Withdrawal by Subject|1|||
27991229|NCT01754493|81798462|FG000|Overall Study|Moved out of town|1|||
27676261|NCT04367480|80650378|FG000|Overall Study|Ineligible after Randomization|0|||
27676262|NCT04367480|80650379|FG001|Overall Study|Ineligible after Randomization|1|||
27676263|NCT04367480|80650378|FG000|Overall Study|Other Medical Reasons|0|||
27676264|NCT04367480|80650379|FG001|Overall Study|Other Medical Reasons|2|||
27676265|NCT04596995|80650380|FG000|Overall Study|Lack of Efficacy|8|||
27676266|NCT04596995|80650380|FG000|Overall Study|Lost to Follow-up|3|||
27676267|NCT04596995|80650380|FG000|Overall Study|Withdrawal by Subject|12|||
27676268|NCT04596995|80650380|FG000|Overall Study|Sponsor decision|3|||
27676269|NCT04596995|80650380|FG000|Overall Study|Enrolled in managed access program|3|||
27676270|NCT02833077|80650383|FG000|Overall Study|Adverse Event|1|||
27676271|NCT02833077|80650384|FG001|Overall Study|Adverse Event|2|||
27676272|NCT02833077|80650383|FG000|Overall Study|Lost to Follow-up|10|||
27676273|NCT02833077|80650384|FG001|Overall Study|Lost to Follow-up|1|||
27676274|NCT02833077|80650383|FG000|Overall Study|Personal Reasons|6|||
27676275|NCT02833077|80650384|FG001|Overall Study|Personal Reasons|4|||
27676276|NCT02833077|80650383|FG000|Overall Study|Protocol Deviation|0|||
27676277|NCT02833077|80650384|FG001|Overall Study|Protocol Deviation|1|||
27798531|NCT03576131|81095558|FG001|Overall Study|Withdrawal by Subject|1|||
27798532|NCT03576131|81095559|FG002|Overall Study|Withdrawal by Subject|0|||
27798533|NCT03576131|81095560|FG003|Overall Study|Withdrawal by Subject|1|||
27798534|NCT03576131|81095561|FG004|Overall Study|Withdrawal by Subject|2|||
27798535|NCT03576131|81095562|FG005|Overall Study|Withdrawal by Subject|3|||
27798536|NCT03576131|81095563|FG006|Overall Study|Withdrawal by Subject|1|||
27798537|NCT03576131|81095564|FG007|Overall Study|Withdrawal by Subject|0|||
27798538|NCT03576131|81095557|FG000|Overall Study|Death|3|||
27798539|NCT03576131|81095558|FG001|Overall Study|Death|3|||
27798540|NCT03576131|81095559|FG002|Overall Study|Death|1|||
27798541|NCT03576131|81095560|FG003|Overall Study|Death|5|||
27798542|NCT03576131|81095561|FG004|Overall Study|Death|4|||
27798543|NCT03576131|81095562|FG005|Overall Study|Death|1|||
27798544|NCT03576131|81095563|FG006|Overall Study|Death|0|||
27798545|NCT03576131|81095564|FG007|Overall Study|Death|1|||
27798546|NCT03576131|81095557|FG000|Overall Study|New anti-cancer treatment|5|||
27798547|NCT03576131|81095558|FG001|Overall Study|New anti-cancer treatment|1|||
27798548|NCT03576131|81095559|FG002|Overall Study|New anti-cancer treatment|2|||
27798549|NCT03576131|81095560|FG003|Overall Study|New anti-cancer treatment|3|||
27798550|NCT03576131|81095561|FG004|Overall Study|New anti-cancer treatment|0|||
27798551|NCT03576131|81095562|FG005|Overall Study|New anti-cancer treatment|0|||
27798552|NCT03576131|81095563|FG006|Overall Study|New anti-cancer treatment|0|||
27798553|NCT03576131|81095564|FG007|Overall Study|New anti-cancer treatment|0|||
27798554|NCT03576131|81095557|FG000|Overall Study|Unspecified reason|0|||
27798555|NCT03576131|81095558|FG001|Overall Study|Unspecified reason|0|||
27798556|NCT03576131|81095559|FG002|Overall Study|Unspecified reason|1|||
27798557|NCT03576131|81095560|FG003|Overall Study|Unspecified reason|1|||
27798558|NCT03576131|81095561|FG004|Overall Study|Unspecified reason|1|||
27798559|NCT03576131|81095562|FG005|Overall Study|Unspecified reason|1|||
27798560|NCT03576131|81095563|FG006|Overall Study|Unspecified reason|0|||
27798561|NCT03576131|81095564|FG007|Overall Study|Unspecified reason|0|||
27798562|NCT03576131|81095557|FG000|Overall Study|Subject non-compliance|0|||
27798563|NCT03576131|81095558|FG001|Overall Study|Subject non-compliance|0|||
27798564|NCT03576131|81095559|FG002|Overall Study|Subject non-compliance|0|||
27798565|NCT03576131|81095560|FG003|Overall Study|Subject non-compliance|0|||
27798566|NCT03576131|81095561|FG004|Overall Study|Subject non-compliance|0|||
27798567|NCT03576131|81095562|FG005|Overall Study|Subject non-compliance|1|||
27798568|NCT03576131|81095563|FG006|Overall Study|Subject non-compliance|0|||
27798569|NCT03576131|81095564|FG007|Overall Study|Subject non-compliance|0|||
27798570|NCT03911960|81095566|FG000|Overall Study|Lost to Follow-up|5|||
27798571|NCT03911960|81095567|FG001|Overall Study|Lost to Follow-up|3|||
27798572|NCT02989610|81095568|FG000|Overall Study|Withdrawal by Subject|20|||
27798573|NCT02989610|81095568|FG000|Overall Study|Departure of PI from Site|8|||
27798574|NCT02989610|81095568|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
27798575|NCT02989610|81095568|FG000|Overall Study|Lost to Follow-up|3|||
27798576|NCT02989610|81095568|FG000|Overall Study|Death|3|||
27798577|NCT02989610|81095568|FG000|Overall Study|System Explant|3|||
27991230|NCT01754493|81798462|FG000|Overall Study|Scheduling conflict|1|||
27991231|NCT01278797|81798463|FG000|Period 1|Adverse Event|0|||
27798578|NCT02989610|81095568|FG000|Overall Study|Subject Non-Compliance|2|||
27991232|NCT01278797|81798464|FG001|Period 1|Adverse Event|1|||
27676278|NCT00513708|80653332|FG000|Overall Study|Lost to Follow-up|4|||
27676279|NCT00513708|80653333|FG001|Overall Study|Lost to Follow-up|4|||
27676280|NCT00513708|80653334|FG002|Overall Study|Lost to Follow-up|4|||
27798579|NCT02989610|81095568|FG000|Overall Study|System Revision|2|||
27798580|NCT02989610|81095568|FG000|Overall Study|PI Left, Study Closing|1|||
27798581|NCT02989610|81095568|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
27676281|NCT03023722|80653336|FG000|Overall Study|No follow-up assessment|4|||
27676282|NCT00848484|80653337|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
27798582|NCT02989610|81095568|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
27991233|NCT01278797|81798463|FG000|Period 1|Protocol Violation|1|||
27798583|NCT04723173|81095569|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
27798584|NCT02125734|81095570|FG000|Period 2|Adverse Event|0|||
27798585|NCT02125734|81095571|FG001|Period 2|Adverse Event|1|||
27798586|NCT04057118|81095572|FG000|Overall Study|Adverse Event|1|||
27798587|NCT04057118|81095573|FG001|Overall Study|Adverse Event|0|||
27798588|NCT04057118|81095574|FG002|Overall Study|Adverse Event|1|||
27798589|NCT04057118|81095575|FG003|Overall Study|Adverse Event|1|||
27798590|NCT04057118|81095572|FG000|Overall Study|Physician Decision|0|||
27798591|NCT04057118|81095573|FG001|Overall Study|Physician Decision|0|||
27798592|NCT04057118|81095574|FG002|Overall Study|Physician Decision|1|||
27798593|NCT04057118|81095575|FG003|Overall Study|Physician Decision|1|||
27798594|NCT04057118|81095572|FG000|Overall Study|Withdrawal by Subject|2|||
27798595|NCT04057118|81095573|FG001|Overall Study|Withdrawal by Subject|2|||
27798596|NCT04057118|81095574|FG002|Overall Study|Withdrawal by Subject|0|||
27798597|NCT04057118|81095575|FG003|Overall Study|Withdrawal by Subject|2|||
27798598|NCT04057118|81095572|FG000|Overall Study|Not Specific|0|||
27798599|NCT04057118|81095573|FG001|Overall Study|Not Specific|0|||
27798600|NCT04057118|81095574|FG002|Overall Study|Not Specific|1|||
27798601|NCT04057118|81095575|FG003|Overall Study|Not Specific|1|||
27798602|NCT03428217|81095580|FG000|Overall Study|Death|89|||
27798603|NCT03428217|81095581|FG001|Overall Study|Death|93|||
27798604|NCT03428217|81095580|FG000|Overall Study|Withdrawal by Subject|8|||
27798605|NCT03428217|81095581|FG001|Overall Study|Withdrawal by Subject|7|||
27798606|NCT03428217|81095580|FG000|Overall Study|Lost to Follow-up|1|||
27798607|NCT03428217|81095581|FG001|Overall Study|Lost to Follow-up|3|||
27798608|NCT03428217|81095580|FG000|Overall Study|Study terminated by sponsor|124|||
27798609|NCT03428217|81095581|FG001|Overall Study|Study terminated by sponsor|118|||
27798610|NCT03428217|81095580|FG000|Overall Study|Other, Not Specified|1|||
27798611|NCT03428217|81095581|FG001|Overall Study|Other, Not Specified|0|||
27798612|NCT00981019|81095582|FG000|Overall Study|Did not respond|65|||
27798613|NCT00981019|81095582|FG000|Overall Study|Did not match target population|94|||
27798614|NCT00981019|81095582|FG000|Overall Study|Inadvertent exclusion|239|||
27798615|NCT00981019|81095582|FG000|Overall Study|Hit the survey after closure|79|||
27798616|NCT00061945|81095583|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
27798617|NCT00061945|81095584|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
27798618|NCT00061945|81095583|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
27798619|NCT00061945|81095584|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
27798620|NCT00061945|81095583|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
27798621|NCT00061945|81095584|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
27798622|NCT00061945|81095583|FG000|Course IV: Alemtuzumab|Early exits|6|||
27798623|NCT00061945|81095584|FG001|Course IV: Alemtuzumab|Early exits|15|||
27798624|NCT03993288|81095585|FG000|Overall Study|Lost to Follow-up|2|||
27798625|NCT03993288|81095586|FG001|Overall Study|Lost to Follow-up|1|||
27798626|NCT03993288|81095585|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
27798627|NCT03993288|81095586|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
27798628|NCT03993288|81095585|FG000|Overall Study|wrong randomization|0|||
27798629|NCT03993288|81095586|FG001|Overall Study|wrong randomization|1|||
27798630|NCT03993288|81095585|FG000|Overall Study|improper enrollment|0|||
27798631|NCT03993288|81095586|FG001|Overall Study|improper enrollment|1|||
27798632|NCT03993288|81095585|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
27798633|NCT03993288|81095586|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
27798634|NCT03993288|81095585|FG000|Overall Study|developed SAE|2|||
27798635|NCT03993288|81095586|FG001|Overall Study|developed SAE|0|||
27798636|NCT03993288|81095585|FG000|Overall Study|consent withdrawal|1|||
27798637|NCT03993288|81095586|FG001|Overall Study|consent withdrawal|0|||
27798638|NCT03993288|81095585|FG000|Overall Study|did not follow the treatment schedule|1|||
27798639|NCT03993288|81095586|FG001|Overall Study|did not follow the treatment schedule|0|||
27798640|NCT03993288|81095585|FG000|Overall Study|did not follow the treatment regimen|1|||
27798641|NCT03993288|81095586|FG001|Overall Study|did not follow the treatment regimen|0|||
27991234|NCT01278797|81798464|FG001|Period 1|Protocol Violation|0|||
27991235|NCT01835223|81798465|FG000|Overall Study|Adverse Event|1|||
27991236|NCT01835223|81798466|FG001|Overall Study|Adverse Event|0|||
27991237|NCT01835223|81798465|FG000|Overall Study|Withdrawal by Subject|2|||
27991238|NCT01835223|81798466|FG001|Overall Study|Withdrawal by Subject|0|||
27991239|NCT01835223|81798465|FG000|Overall Study|Disease progression|2|||
27991240|NCT01835223|81798466|FG001|Overall Study|Disease progression|1|||
27579268|NCT01532687|80303158|FG000|Overall Study|Withdrawal by Subject|1|||
27798642|NCT03993288|81095585|FG000|Overall Study|Adverse Event|1|||
27798643|NCT03993288|81095586|FG001|Overall Study|Adverse Event|0|||
27798644|NCT03993288|81095585|FG000|Overall Study|Withdrawal by Subject|1|||
27798645|NCT03993288|81095586|FG001|Overall Study|Withdrawal by Subject|1|||
27798646|NCT01556165|81095590|FG000|Overall Study|Adverse Event|5|||
27798647|NCT01556165|81095591|FG001|Overall Study|Adverse Event|3|||
27991241|NCT01835223|81798465|FG000|Overall Study|Became Inelligible|4|||
27798648|NCT01556165|81095590|FG000|Overall Study|Protocol Violation|0|||
27798649|NCT01556165|81095591|FG001|Overall Study|Protocol Violation|3|||
27991242|NCT01835223|81798466|FG001|Overall Study|Became Inelligible|0|||
27991243|NCT03803683|81798467|FG000|Overall Study|Lost to Follow-up|41|||
27798650|NCT01556165|81095590|FG000|Overall Study|Withdrawal of Consent|7|||
27798651|NCT01556165|81095591|FG001|Overall Study|Withdrawal of Consent|1|||
27798652|NCT00411762|81095594|FG000|Overall Study|Withdrawal by Subject|5|||
27798653|NCT01988493|81095595|FG000|Overall Study|Randomized but not treated|0|||
27798654|NCT01988493|81095596|FG001|Overall Study|Randomized but not treated|0|||
27798655|NCT01988493|81095597|FG002|Overall Study|Randomized but not treated|0|||
27798656|NCT01988493|81095598|FG003|Overall Study|Randomized but not treated|0|||
27991244|NCT03803683|81798468|FG001|Overall Study|Lost to Follow-up|18|||
27991245|NCT03803683|81798469|FG002|Overall Study|Lost to Follow-up|12|||
27991246|NCT03803683|81798467|FG000|Overall Study|Withdrawal by Subject|9|||
27991247|NCT03803683|81798468|FG001|Overall Study|Withdrawal by Subject|1|||
27991248|NCT03803683|81798469|FG002|Overall Study|Withdrawal by Subject|4|||
27991249|NCT00842543|81798474|FG000|Overall Study|Withdrawal by Subject|2|||
27991250|NCT00842543|81798475|FG001|Overall Study|Withdrawal by Subject|0|||
27991251|NCT00842543|81798476|FG002|Overall Study|Withdrawal by Subject|3|||
27991252|NCT00842543|81798477|FG003|Overall Study|Withdrawal by Subject|4|||
27991253|NCT04725500|81798478|FG000|Screening|Screen Failure|26|||
27991254|NCT04725500|81798478|FG000|Screening|Withdrawal by Subject|1|||
27991255|NCT04725500|81798478|FG000|2 Week Take Home|Screen Fail|5|||
27991256|NCT02207491|81798479|FG000|Overall Study|Adverse Event|20|||
27991257|NCT02207491|81798480|FG001|Overall Study|Adverse Event|4|||
27991258|NCT02207491|81798479|FG000|Overall Study|Withdrawal by Subject|3|||
27991259|NCT02207491|81798480|FG001|Overall Study|Withdrawal by Subject|2|||
27991260|NCT02207491|81798479|FG000|Overall Study|Non-compliant|0|||
27991261|NCT02207491|81798480|FG001|Overall Study|Non-compliant|1|||
27991262|NCT02207491|81798479|FG000|Overall Study|Lost to Follow-up|0|||
27991263|NCT02207491|81798480|FG001|Overall Study|Lost to Follow-up|1|||
27991264|NCT02207491|81798479|FG000|Overall Study|Lack of Efficacy|3|||
27991265|NCT02207491|81798480|FG001|Overall Study|Lack of Efficacy|0|||
27991266|NCT02207491|81798479|FG000|Overall Study|Physician Decision|2|||
27991267|NCT02207491|81798480|FG001|Overall Study|Physician Decision|0|||
27991268|NCT02207491|81798479|FG000|Overall Study|Protocol Violation|3|||
27991269|NCT02207491|81798480|FG001|Overall Study|Protocol Violation|5|||
27991270|NCT03068767|81798485|FG000|Overall Study|Lost to Follow-up|7|||
27991271|NCT03068767|81798486|FG001|Overall Study|Lost to Follow-up|3|||
27991272|NCT03068767|81798485|FG000|Overall Study|Protocol Violation|3|||
27991273|NCT03068767|81798486|FG001|Overall Study|Protocol Violation|0|||
27991274|NCT00387725|81798487|FG000|Overall Study|Adverse Event|0|||
27991275|NCT00387725|81798488|FG001|Overall Study|Adverse Event|0|||
27991276|NCT00387725|81798489|FG002|Overall Study|Adverse Event|0|||
27798657|NCT01988493|81095599|FG004|Overall Study|Randomized but not treated|1|||
27798658|NCT00915473|81095600|FG000|Screening|Withdrawal by Subject|1|||
27798659|NCT00915473|81095601|FG001|Screening|Withdrawal by Subject|0|||
27798660|NCT00915473|81095600|FG000|4-week Follow Up|Lost to Follow-up|1|||
27798661|NCT00915473|81095601|FG001|4-week Follow Up|Lost to Follow-up|5|||
27991277|NCT00387725|81798490|FG003|Overall Study|Adverse Event|1|||
27991278|NCT00387725|81798487|FG000|Overall Study|Protocol Violation|0|||
27991279|NCT00387725|81798488|FG001|Overall Study|Protocol Violation|1|||
27991280|NCT00387725|81798489|FG002|Overall Study|Protocol Violation|0|||
27991281|NCT00387725|81798490|FG003|Overall Study|Protocol Violation|0|||
27991282|NCT00387725|81798487|FG000|Overall Study|Withdrawal by Subject|1|||
27991283|NCT00387725|81798488|FG001|Overall Study|Withdrawal by Subject|0|||
27991284|NCT00387725|81798489|FG002|Overall Study|Withdrawal by Subject|1|||
27991285|NCT00387725|81798490|FG003|Overall Study|Withdrawal by Subject|0|||
27991286|NCT00387725|81798487|FG000|Overall Study|Parent/legal guardian request|0|||
27991287|NCT00387725|81798488|FG001|Overall Study|Parent/legal guardian request|0|||
27991288|NCT00387725|81798489|FG002|Overall Study|Parent/legal guardian request|1|||
27991289|NCT00387725|81798490|FG003|Overall Study|Parent/legal guardian request|1|||
27991290|NCT04680975|81798491|FG000|Overall Study|Adverse Event|3|||
27991291|NCT04680975|81798491|FG000|Overall Study|Death|1|||
27991292|NCT04680975|81798491|FG000|Overall Study|Progressive Disease|1|||
27991293|NCT04680975|81798491|FG000|Overall Study|Withdrawal by Subject|1|||
27991294|NCT00794950|81798492|FG000|BCG Induction|Withdrawal by Subject|2|||
27991295|NCT00794950|81798492|FG000|BCG Induction|ineligible|3|||
27991296|NCT00794950|81798492|FG000|BCG Induction|noncompliant w. BCG|1|||
27991297|NCT00794950|81798492|FG000|BCG Induction|Adverse Event|1|||
27991298|NCT00794950|81798492|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
27991299|NCT00794950|81798492|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
27991300|NCT00794950|81798492|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
27991301|NCT00794950|81798492|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
27991302|NCT00310817|81798493|FG000|Overall Study|AE or Death|3|||
27991303|NCT00310817|81798494|FG001|Overall Study|AE or Death|1|||
27991304|NCT00310817|81798495|FG002|Overall Study|AE or Death|0|||
27991305|NCT00310817|81798496|FG003|Overall Study|AE or Death|0|||
27991306|NCT00310817|81798493|FG000|Overall Study|Withdrawal by Subject|1|||
27991307|NCT00310817|81798494|FG001|Overall Study|Withdrawal by Subject|4|||
27991308|NCT00310817|81798495|FG002|Overall Study|Withdrawal by Subject|6|||
27991309|NCT00310817|81798496|FG003|Overall Study|Withdrawal by Subject|7|||
27991310|NCT00310817|81798493|FG000|Overall Study|Lost to Follow-up|2|||
27991311|NCT00310817|81798494|FG001|Overall Study|Lost to Follow-up|1|||
27991312|NCT00310817|81798495|FG002|Overall Study|Lost to Follow-up|0|||
27991313|NCT00310817|81798496|FG003|Overall Study|Lost to Follow-up|0|||
27991314|NCT00310817|81798493|FG000|Overall Study|Inappropriate Enrollment|1|||
27991315|NCT00310817|81798494|FG001|Overall Study|Inappropriate Enrollment|0|||
27991316|NCT00310817|81798495|FG002|Overall Study|Inappropriate Enrollment|1|||
27991317|NCT00310817|81798496|FG003|Overall Study|Inappropriate Enrollment|0|||
27991318|NCT00310817|81798493|FG000|Overall Study|Protocol Violation|1|||
27991319|NCT00310817|81798494|FG001|Overall Study|Protocol Violation|1|||
27991320|NCT00310817|81798495|FG002|Overall Study|Protocol Violation|1|||
27991321|NCT00310817|81798496|FG003|Overall Study|Protocol Violation|1|||
27991322|NCT00310817|81798493|FG000|Overall Study|Unable to classify|3|||
27991323|NCT00310817|81798494|FG001|Overall Study|Unable to classify|1|||
27991324|NCT00310817|81798495|FG002|Overall Study|Unable to classify|0|||
27870665|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870666|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870667|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870668|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
27870669|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870670|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870671|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870672|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870673|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870674|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
27870675|NCT03536884|81361467|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27991325|NCT00310817|81798496|FG003|Overall Study|Unable to classify|0|||
27991326|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27991327|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27991328|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
27991329|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
27991330|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
27991331|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27676283|NCT00848484|80653338|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
27676284|NCT00848484|80653337|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
27676285|NCT00848484|80653338|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
27676286|NCT00848484|80653337|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
27676287|NCT00848484|80653338|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
27676288|NCT00848484|80653337|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
27676289|NCT00848484|80653338|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
27676290|NCT00848484|80653337|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
27676291|NCT00848484|80653338|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
27676292|NCT02336451|80653339|FG000|Overall Study|Adverse Event|1|||
27676293|NCT02336451|80653340|FG001|Overall Study|Adverse Event|2|||
27676294|NCT02336451|80653341|FG002|Overall Study|Adverse Event|0|||
27676295|NCT02336451|80653342|FG003|Overall Study|Adverse Event|6|||
27676296|NCT02336451|80653343|FG004|Overall Study|Adverse Event|4|||
27676297|NCT02336451|80653339|FG000|Overall Study|Death|6|||
27676298|NCT02336451|80653340|FG001|Overall Study|Death|2|||
27676299|NCT02336451|80653341|FG002|Overall Study|Death|3|||
27676300|NCT02336451|80653342|FG003|Overall Study|Death|6|||
27676301|NCT02336451|80653343|FG004|Overall Study|Death|6|||
27676302|NCT02336451|80653339|FG000|Overall Study|Physician Decision|9|||
27676303|NCT02336451|80653340|FG001|Overall Study|Physician Decision|6|||
27676304|NCT02336451|80653341|FG002|Overall Study|Physician Decision|7|||
27676305|NCT02336451|80653342|FG003|Overall Study|Physician Decision|16|||
27676306|NCT02336451|80653343|FG004|Overall Study|Physician Decision|3|||
27676307|NCT02336451|80653339|FG000|Overall Study|Progressive disease|23|||
27676308|NCT02336451|80653340|FG001|Overall Study|Progressive disease|26|||
27676309|NCT02336451|80653341|FG002|Overall Study|Progressive disease|2|||
27676310|NCT02336451|80653342|FG003|Overall Study|Progressive disease|14|||
27676311|NCT02336451|80653343|FG004|Overall Study|Progressive disease|4|||
27676312|NCT02336451|80653339|FG000|Overall Study|Protocol Violation|1|||
27676313|NCT02336451|80653340|FG001|Overall Study|Protocol Violation|0|||
27676314|NCT02336451|80653341|FG002|Overall Study|Protocol Violation|0|||
27676315|NCT02336451|80653342|FG003|Overall Study|Protocol Violation|0|||
27676316|NCT02336451|80653343|FG004|Overall Study|Protocol Violation|0|||
27676317|NCT02336451|80653339|FG000|Overall Study|Patient/guardian decision|2|||
27676318|NCT02336451|80653340|FG001|Overall Study|Patient/guardian decision|4|||
27676319|NCT02336451|80653341|FG002|Overall Study|Patient/guardian decision|0|||
27676320|NCT02336451|80653342|FG003|Overall Study|Patient/guardian decision|2|||
27676321|NCT02336451|80653343|FG004|Overall Study|Patient/guardian decision|1|||
27676322|NCT01747551|80653346|FG000|Overall Study|Progressive Disease|24|||
27676323|NCT01747551|80653347|FG001|Overall Study|Progressive Disease|17|||
27676324|NCT01747551|80653346|FG000|Overall Study|Death|3|||
27676325|NCT01747551|80653347|FG001|Overall Study|Death|1|||
27676326|NCT01747551|80653346|FG000|Overall Study|Adverse Event|7|||
27676327|NCT01747551|80653347|FG001|Overall Study|Adverse Event|1|||
27676328|NCT01747551|80653346|FG000|Overall Study|Prolonged Treatment Delay|2|||
27676329|NCT01747551|80653347|FG001|Overall Study|Prolonged Treatment Delay|0|||
27676330|NCT01747551|80653346|FG000|Overall Study|Withdrawal by Subject|3|||
27676331|NCT01747551|80653347|FG001|Overall Study|Withdrawal by Subject|1|||
27676332|NCT01747551|80653346|FG000|Overall Study|Physician Decision|2|||
27676333|NCT01747551|80653347|FG001|Overall Study|Physician Decision|1|||
27676334|NCT01747551|80653346|FG000|Overall Study|Other|2|||
27676335|NCT01747551|80653347|FG001|Overall Study|Other|0|||
27676336|NCT00572533|80653350|FG000|Overall Study|Death|4|||
27676337|NCT00572533|80653351|FG001|Overall Study|Death|1|||
27676338|NCT00572533|80653350|FG000|Overall Study|Received Kidney Transplant|2|||
27676339|NCT00572533|80653351|FG001|Overall Study|Received Kidney Transplant|1|||
27676340|NCT00572533|80653350|FG000|Overall Study|Social Issues|1|||
27676341|NCT00572533|80653351|FG001|Overall Study|Social Issues|0|||
27676342|NCT00572533|80653350|FG000|Overall Study|Transfer out of Facility|0|||
27991332|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
27991333|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
27991334|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
27991335|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27991336|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27676343|NCT00572533|80653351|FG001|Overall Study|Transfer out of Facility|1|||
27676344|NCT01200290|80653352|FG000|Treatment Period|Adverse Event|1|||
27676345|NCT01200290|80653352|FG000|Post-Treatment Follow-Up Period|Death|2|||
27676346|NCT00547534|80653353|FG000|Overall Study|Adverse Event|7|||
27676347|NCT00547534|80653353|FG000|Overall Study|Disease Progression|4|||
27676348|NCT01144377|80653354|FG000|52 Week Treatment Period|Adverse Event|0|||
27676349|NCT01144377|80653355|FG001|52 Week Treatment Period|Adverse Event|0|||
27676350|NCT01144377|80653356|FG002|52 Week Treatment Period|Adverse Event|3|||
27676351|NCT01144377|80653357|FG003|52 Week Treatment Period|Adverse Event|2|||
27676352|NCT01144377|80653358|FG004|52 Week Treatment Period|Adverse Event|1|||
27991337|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27991338|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
27798662|NCT03443973|81095602|FG000|Double-blind Treatment Period|Adverse Event|5|||
27798663|NCT03443973|81095603|FG001|Double-blind Treatment Period|Adverse Event|19|||
27798664|NCT03443973|81095604|FG002|Double-blind Treatment Period|Adverse Event|0|||
27798665|NCT03443973|81095605|FG003|Double-blind Treatment Period|Adverse Event|0|||
27798666|NCT03443973|81095602|FG000|Double-blind Treatment Period|Death|5|||
27798667|NCT03443973|81095603|FG001|Double-blind Treatment Period|Death|7|||
27798668|NCT03443973|81095604|FG002|Double-blind Treatment Period|Death|0|||
27798669|NCT03443973|81095605|FG003|Double-blind Treatment Period|Death|0|||
27798670|NCT03443973|81095602|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
27798671|NCT03443973|81095603|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
27798672|NCT03443973|81095604|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27798673|NCT03443973|81095605|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
27798674|NCT03443973|81095602|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27798675|NCT03443973|81095603|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27798676|NCT03443973|81095604|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27798677|NCT03443973|81095605|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27798678|NCT03443973|81095602|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
27798679|NCT03443973|81095603|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
27798680|NCT03443973|81095604|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
27798681|NCT03443973|81095605|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
27798682|NCT03443973|81095602|FG000|Double-blind Treatment Period|Physician Decision|5|||
27798683|NCT03443973|81095603|FG001|Double-blind Treatment Period|Physician Decision|6|||
27798684|NCT03443973|81095604|FG002|Double-blind Treatment Period|Physician Decision|0|||
27798685|NCT03443973|81095605|FG003|Double-blind Treatment Period|Physician Decision|0|||
27798686|NCT03443973|81095602|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
27798687|NCT03443973|81095603|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
27798688|NCT03443973|81095604|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
27798689|NCT03443973|81095605|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
27798690|NCT03443973|81095602|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
27798691|NCT03443973|81095603|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
27798692|NCT03443973|81095604|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27798693|NCT03443973|81095605|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
27798694|NCT03443973|81095602|FG000|Open-label Extension Period|Reason Not Specified|0|||
27798695|NCT03443973|81095603|FG001|Open-label Extension Period|Reason Not Specified|0|||
27991339|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
27991340|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
27991341|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
27991342|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
27991343|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
27991344|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
27991345|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
27991346|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
27991347|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
27991348|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
27991349|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
27991350|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
27991351|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
27991352|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991353|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
27991354|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
27991355|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991356|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991357|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
27991358|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
27991359|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991360|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991361|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991362|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991363|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991364|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
27991365|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991366|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
27798696|NCT03443973|81095604|FG002|Open-label Extension Period|Reason Not Specified|3|||
27798697|NCT03443973|81095605|FG003|Open-label Extension Period|Reason Not Specified|0|||
27798698|NCT03443973|81095602|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
27798699|NCT03443973|81095603|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
27798700|NCT03443973|81095604|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
27798701|NCT03443973|81095605|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
27798702|NCT01856686|81095606|FG000|Overall Study|Lost to Follow-up|5|||
27798703|NCT01856686|81095607|FG001|Overall Study|Lost to Follow-up|11|||
27798704|NCT03237481|81095608|FG000|Overall Study|Lost to Follow-up|1|||
27798705|NCT03237481|81095609|FG001|Overall Study|Lost to Follow-up|0|||
27798706|NCT03237481|81095610|FG002|Overall Study|Lost to Follow-up|0|||
27798707|NCT03237481|81095608|FG000|Overall Study|Protocol Violation|1|||
27798708|NCT03237481|81095609|FG001|Overall Study|Protocol Violation|0|||
27798709|NCT03237481|81095610|FG002|Overall Study|Protocol Violation|0|||
27798710|NCT03237481|81095608|FG000|Overall Study|Withdrawal by Subject|3|||
27798711|NCT03237481|81095609|FG001|Overall Study|Withdrawal by Subject|2|||
27798712|NCT03237481|81095610|FG002|Overall Study|Withdrawal by Subject|1|||
27798713|NCT01956123|81095615|FG000|COS Cycle 2|Protocol Violation|8|||
27798714|NCT01956123|81095616|FG001|COS Cycle 2|Protocol Violation|3|||
27798715|NCT01956123|81095617|FG002|COS Cycle 2|Protocol Violation|0|||
27798716|NCT01956123|81095618|FG003|COS Cycle 2|Protocol Violation|0|||
27798717|NCT01956123|81095615|FG000|COS Cycle 2|Adverse Event|3|||
27798718|NCT01956123|81095616|FG001|COS Cycle 2|Adverse Event|4|||
27798719|NCT01956123|81095617|FG002|COS Cycle 2|Adverse Event|0|||
27798720|NCT01956123|81095618|FG003|COS Cycle 2|Adverse Event|0|||
27798721|NCT01956123|81095615|FG000|COS Cycle 2|Personal Reasons|2|||
27798722|NCT01956123|81095616|FG001|COS Cycle 2|Personal Reasons|0|||
27798723|NCT01956123|81095617|FG002|COS Cycle 2|Personal Reasons|0|||
27798724|NCT01956123|81095618|FG003|COS Cycle 2|Personal Reasons|0|||
27798725|NCT01956123|81095615|FG000|COS Cycle 2|Withdrawal by Subject|1|||
27798726|NCT01956123|81095616|FG001|COS Cycle 2|Withdrawal by Subject|0|||
27798727|NCT01956123|81095617|FG002|COS Cycle 2|Withdrawal by Subject|0|||
27798728|NCT01956123|81095618|FG003|COS Cycle 2|Withdrawal by Subject|0|||
27798729|NCT01956123|81095615|FG000|COS Cycle 3|Protocol Violation|0|||
27870676|NCT03536884|81361468|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870677|NCT03536884|81361469|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870678|NCT03536884|81361470|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870679|NCT03536884|81361471|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870680|NCT03536884|81361472|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870681|NCT03536884|81361473|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870682|NCT03536884|81361474|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870683|NCT03536884|81361475|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
27870684|NCT03536884|81361476|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870685|NCT03536884|81361477|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27870686|NCT03536884|81361478|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
27991367|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
27991368|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991369|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991370|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991371|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
27991372|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991373|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
27991374|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991375|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991376|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991377|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
27991378|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991379|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991380|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991381|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
27991382|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991383|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991384|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991385|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
27991386|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991387|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991388|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991389|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27798730|NCT01956123|81095616|FG001|COS Cycle 3|Protocol Violation|0|||
27798731|NCT01956123|81095617|FG002|COS Cycle 3|Protocol Violation|2|||
27798732|NCT01956123|81095618|FG003|COS Cycle 3|Protocol Violation|1|||
27798733|NCT01956123|81095615|FG000|COS Cycle 3|Adverse Event|0|||
27798734|NCT01956123|81095616|FG001|COS Cycle 3|Adverse Event|0|||
27798735|NCT01956123|81095617|FG002|COS Cycle 3|Adverse Event|3|||
27798736|NCT01956123|81095618|FG003|COS Cycle 3|Adverse Event|0|||
27798737|NCT01956123|81095615|FG000|COS Cycle 3|Personal Reasons|0|||
27798738|NCT01956123|81095616|FG001|COS Cycle 3|Personal Reasons|0|||
27798739|NCT01956123|81095617|FG002|COS Cycle 3|Personal Reasons|1|||
27798740|NCT01956123|81095618|FG003|COS Cycle 3|Personal Reasons|0|||
27991390|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
27991391|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991392|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991393|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991394|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
27991395|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991396|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991397|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
27676353|NCT01144377|80653354|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
27676354|NCT01144377|80653355|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
27676355|NCT01144377|80653356|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
27676356|NCT01144377|80653357|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
27676357|NCT01144377|80653358|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
27676358|NCT01144377|80653354|FG000|52 Week Treatment Period|Protocol Violation|0|||
27676359|NCT01144377|80653355|FG001|52 Week Treatment Period|Protocol Violation|0|||
27991398|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991399|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991400|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991401|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991402|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27579269|NCT01532687|80303159|FG001|Overall Study|Withdrawal by Subject|0|||
27579270|NCT01532687|80303158|FG000|Overall Study|Physician Decision|2|||
27579271|NCT01532687|80303159|FG001|Overall Study|Physician Decision|1|||
27579272|NCT01532687|80303158|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
27579273|NCT01532687|80303159|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
27579274|NCT00110266|80303160|FG000|Overall Study|Adverse Event|27|||
27579275|NCT00110266|80303160|FG000|Overall Study|Abnormal laboratory value|15|||
27579276|NCT00110266|80303160|FG000|Overall Study|Withdrawal by Subject|16|||
27579277|NCT00110266|80303160|FG000|Overall Study|Death|17|||
27579278|NCT00110266|80303160|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27579279|NCT00110266|80303160|FG000|Overall Study|Participant condition no longer requires study drug|1|||
27579280|NCT04369469|80303161|FG000|Overall Study|Lost to Follow-up|2|||
27579281|NCT04369469|80303162|FG001|Overall Study|Lost to Follow-up|4|||
27579282|NCT04369469|80303161|FG000|Overall Study|Physician Decision|2|||
27579283|NCT04369469|80303162|FG001|Overall Study|Physician Decision|1|||
27579284|NCT04369469|80303161|FG000|Overall Study|Withdrawal by Subject|2|||
27579285|NCT04369469|80303162|FG001|Overall Study|Withdrawal by Subject|3|||
27579286|NCT04369469|80303161|FG000|Overall Study|Adverse Event|1|||
27579287|NCT04369469|80303162|FG001|Overall Study|Adverse Event|0|||
27579288|NCT04369469|80303161|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
27579289|NCT04369469|80303162|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
27579290|NCT04369469|80303161|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
27579291|NCT04369469|80303162|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
27579292|NCT04369469|80303161|FG000|Overall Study|Unable to Provide Consent|0|||
27579293|NCT04369469|80303162|FG001|Overall Study|Unable to Provide Consent|1|||
27579294|NCT01083433|80303165|FG000|Overall Study|Lost to Follow-up|2|||
27579295|NCT01083433|80303166|FG001|Overall Study|Lost to Follow-up|1|||
27579296|NCT01083433|80303167|FG002|Overall Study|Lost to Follow-up|1|||
27579297|NCT01083433|80303165|FG000|Overall Study|Withdrawal by Subject|0|||
27579298|NCT01083433|80303166|FG001|Overall Study|Withdrawal by Subject|5|||
27579299|NCT01083433|80303167|FG002|Overall Study|Withdrawal by Subject|3|||
27991403|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
27991404|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991405|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
27579300|NCT01083433|80303165|FG000|Overall Study|Pregnancy|0|||
27579301|NCT01083433|80303166|FG001|Overall Study|Pregnancy|0|||
27579302|NCT01083433|80303167|FG002|Overall Study|Pregnancy|1|||
27579303|NCT01663636|80303170|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
27579304|NCT01663636|80303171|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
27676360|NCT01144377|80653356|FG002|52 Week Treatment Period|Protocol Violation|0|||
27579305|NCT01049919|80303172|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
27798741|NCT01956123|81095615|FG000|COS Cycle 3|Withdrawal by Subject|0|||
27579306|NCT01049919|80303173|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
27798742|NCT01956123|81095616|FG001|COS Cycle 3|Withdrawal by Subject|0|||
27798743|NCT01956123|81095617|FG002|COS Cycle 3|Withdrawal by Subject|0|||
27798744|NCT01956123|81095618|FG003|COS Cycle 3|Withdrawal by Subject|1|||
27798745|NCT02748616|81095621|FG000|Overall Study|Lost to Follow-up|1|||
27798746|NCT02748616|81095621|FG000|Overall Study|Withdrawal by Subject|2|||
27798747|NCT02748616|81095621|FG000|Overall Study|Physician Decision|2|||
27798748|NCT02748616|81095621|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
27798749|NCT04508621|81095624|FG000|Overall Study|Adverse Event|39|||
27798750|NCT04508621|81095625|FG001|Overall Study|Adverse Event|16|||
27991406|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991407|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991408|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27870687|NCT03536884|81361467|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870688|NCT03536884|81361468|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870689|NCT03536884|81361469|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870690|NCT03536884|81361470|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870691|NCT03536884|81361471|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870692|NCT03536884|81361472|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870693|NCT03536884|81361473|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870694|NCT03536884|81361474|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870695|NCT03536884|81361475|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
27870696|NCT03536884|81361476|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
27870697|NCT03536884|81361477|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
27870698|NCT03536884|81361478|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
27870699|NCT03536884|81361467|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870700|NCT03536884|81361468|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870701|NCT03536884|81361469|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870702|NCT03536884|81361470|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870703|NCT03536884|81361471|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870704|NCT03536884|81361472|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870705|NCT03536884|81361473|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870706|NCT03536884|81361474|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870707|NCT03536884|81361475|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
27870708|NCT03536884|81361476|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
27870709|NCT03536884|81361477|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
27870710|NCT03536884|81361478|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
27870711|NCT03536884|81361467|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870712|NCT03536884|81361468|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870713|NCT03536884|81361469|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870714|NCT03536884|81361470|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870715|NCT03536884|81361471|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870716|NCT03536884|81361472|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870717|NCT03536884|81361473|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870718|NCT03536884|81361474|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870719|NCT03536884|81361475|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870720|NCT03536884|81361476|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870721|NCT03536884|81361477|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
27870722|NCT03536884|81361478|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
27870723|NCT03536884|81361467|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870724|NCT03536884|81361468|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870725|NCT03536884|81361469|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870726|NCT03536884|81361470|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870727|NCT03536884|81361471|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870728|NCT03536884|81361472|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870729|NCT03536884|81361473|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870730|NCT03536884|81361474|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870731|NCT03536884|81361475|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870732|NCT03536884|81361476|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870733|NCT03536884|81361477|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
27870734|NCT03536884|81361478|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
27870735|NCT03536884|81361467|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870736|NCT03536884|81361468|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870737|NCT03536884|81361469|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870738|NCT03536884|81361470|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870739|NCT03536884|81361471|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870740|NCT03536884|81361472|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870741|NCT03536884|81361473|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27991409|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27579307|NCT01049919|80303172|FG000|Overall Study|Withdrawal by Subject|5|||
27579308|NCT01049919|80303173|FG001|Overall Study|Withdrawal by Subject|0|||
27991410|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991411|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991412|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991413|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991414|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991415|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991416|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
27991417|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
27991418|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991419|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991420|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991421|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991422|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991423|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991424|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991425|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991426|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991427|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991428|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991429|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
27991430|NCT03100058|81798501|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991431|NCT03100058|81798502|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991432|NCT03100058|81798503|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991433|NCT03100058|81798504|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991434|NCT03100058|81798505|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991435|NCT03100058|81798506|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991436|NCT03100058|81798507|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
27991437|NCT03100058|81798508|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991438|NCT03100058|81798509|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991439|NCT03100058|81798510|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991440|NCT03100058|81798511|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991441|NCT03100058|81798512|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991442|NCT03100058|81798513|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
27991443|NCT03100058|81798501|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991444|NCT03100058|81798502|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991445|NCT03100058|81798503|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991446|NCT03100058|81798504|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991447|NCT03100058|81798505|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991448|NCT03100058|81798506|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991449|NCT03100058|81798507|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27798751|NCT04508621|81095624|FG000|Overall Study|Lack of Efficacy|2|||
27798752|NCT04508621|81095625|FG001|Overall Study|Lack of Efficacy|8|||
27798753|NCT04508621|81095624|FG000|Overall Study|Physician Decision|0|||
27798754|NCT04508621|81095625|FG001|Overall Study|Physician Decision|1|||
27798755|NCT04508621|81095624|FG000|Overall Study|Withdrawal by Subject|10|||
27798756|NCT04508621|81095625|FG001|Overall Study|Withdrawal by Subject|14|||
27798757|NCT04508621|81095624|FG000|Overall Study|Lost to Follow-up|12|||
27798758|NCT04508621|81095625|FG001|Overall Study|Lost to Follow-up|9|||
27798759|NCT04508621|81095624|FG000|Overall Study|COVID-19 related crisis|3|||
27798760|NCT04508621|81095625|FG001|Overall Study|COVID-19 related crisis|0|||
27798761|NCT04508621|81095624|FG000|Overall Study|Subject non-compliance|1|||
27798762|NCT04508621|81095625|FG001|Overall Study|Subject non-compliance|0|||
27798763|NCT02426125|81095626|FG000|Overall Study|Lost to Follow-up|14|||
27798764|NCT02426125|81095627|FG001|Overall Study|Lost to Follow-up|12|||
27991450|NCT03100058|81798508|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991451|NCT03100058|81798509|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991452|NCT03100058|81798510|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
27991453|NCT03100058|81798511|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
27991454|NCT03100058|81798512|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
27991455|NCT03100058|81798513|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
27991456|NCT03100058|81798501|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991457|NCT03100058|81798502|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991458|NCT03100058|81798503|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991459|NCT03100058|81798504|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991460|NCT03100058|81798505|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991461|NCT03100058|81798506|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991462|NCT03100058|81798507|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991463|NCT03100058|81798508|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991464|NCT03100058|81798509|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991465|NCT03100058|81798510|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27991466|NCT03100058|81798511|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
27991467|NCT03100058|81798512|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
27991468|NCT03100058|81798513|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
27579309|NCT01049919|80303172|FG000|Overall Study|Lost to Follow-up|6|||
27579310|NCT01049919|80303173|FG001|Overall Study|Lost to Follow-up|1|||
27676361|NCT01144377|80653357|FG003|52 Week Treatment Period|Protocol Violation|0|||
27676362|NCT01144377|80653358|FG004|52 Week Treatment Period|Protocol Violation|1|||
27676363|NCT01144377|80653354|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
27676364|NCT01144377|80653355|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
27676365|NCT01144377|80653356|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
27676366|NCT01144377|80653357|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
27676367|NCT01144377|80653358|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
27676368|NCT01144377|80653354|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
27676369|NCT01144377|80653355|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
27676370|NCT01144377|80653356|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
27676371|NCT01144377|80653357|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
27991469|NCT03100058|81798501|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991470|NCT03100058|81798502|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991471|NCT03100058|81798503|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991472|NCT03100058|81798504|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991473|NCT03100058|81798505|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991474|NCT03100058|81798506|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991475|NCT03100058|81798507|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27676372|NCT01144377|80653358|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
27676373|NCT01144377|80653354|FG000|52 Week Treatment Period|Sponsor Decision|0|||
27676374|NCT01144377|80653355|FG001|52 Week Treatment Period|Sponsor Decision|0|||
27676375|NCT01144377|80653356|FG002|52 Week Treatment Period|Sponsor Decision|0|||
27676376|NCT01144377|80653357|FG003|52 Week Treatment Period|Sponsor Decision|0|||
27676377|NCT01144377|80653358|FG004|52 Week Treatment Period|Sponsor Decision|1|||
27676378|NCT01144377|80653354|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
27676379|NCT01144377|80653355|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
27676380|NCT01144377|80653356|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
27676381|NCT01144377|80653357|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
27676382|NCT01144377|80653358|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
27676383|NCT01144377|80653354|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27579311|NCT01049919|80303172|FG000|Overall Study|Physician Decision|2|||
27676384|NCT01144377|80653355|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27676385|NCT01144377|80653356|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27676386|NCT01144377|80653357|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
27798765|NCT02426125|81095626|FG000|Overall Study|Withdrawal by Subject|13|||
27798766|NCT02426125|81095627|FG001|Overall Study|Withdrawal by Subject|14|||
27798767|NCT02426125|81095626|FG000|Overall Study|Death|185|||
27798768|NCT02426125|81095627|FG001|Overall Study|Death|200|||
27798769|NCT02426125|81095626|FG000|Overall Study|Randomized, But Never Treated|5|||
27798770|NCT02426125|81095627|FG001|Overall Study|Randomized, But Never Treated|2|||
27798771|NCT01466673|81095628|FG000|Overall Study|Non-compliance with study treatment|2|||
27798772|NCT01466673|81095629|FG001|Overall Study|Non-compliance with study treatment|0|||
27798773|NCT01466673|81095628|FG000|Overall Study|Lost to Follow-up|3|||
27798774|NCT01466673|81095629|FG001|Overall Study|Lost to Follow-up|5|||
27798775|NCT01466673|81095628|FG000|Overall Study|Adverse Event|2|||
27798776|NCT01466673|81095629|FG001|Overall Study|Adverse Event|1|||
27798777|NCT02367781|81095630|FG000|Overall Study|Withdrawal by Subject|20|||
27798778|NCT02367781|81095631|FG001|Overall Study|Withdrawal by Subject|13|||
27798779|NCT02367781|81095630|FG000|Overall Study|Protocol Violation|0|||
27798780|NCT02367781|81095631|FG001|Overall Study|Protocol Violation|1|||
27991476|NCT03100058|81798508|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991477|NCT03100058|81798509|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27676387|NCT01144377|80653358|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
27991478|NCT03100058|81798510|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
27991479|NCT03100058|81798511|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
27991480|NCT03100058|81798512|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
27991481|NCT03100058|81798513|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
27991482|NCT03100058|81798501|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991483|NCT03100058|81798502|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27676388|NCT01144377|80653354|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
27676389|NCT01144377|80653355|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27676390|NCT01144377|80653356|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27798781|NCT02367781|81095630|FG000|Overall Study|Physician Decision|7|||
27798782|NCT02367781|81095631|FG001|Overall Study|Physician Decision|0|||
27991484|NCT03100058|81798503|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991485|NCT03100058|81798504|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991486|NCT03100058|81798505|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991487|NCT03100058|81798506|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991488|NCT03100058|81798507|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991489|NCT03100058|81798508|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991490|NCT03100058|81798509|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991491|NCT03100058|81798510|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991492|NCT03100058|81798511|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
27991493|NCT03100058|81798512|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27991494|NCT03100058|81798513|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
27798783|NCT02367781|81095630|FG000|Overall Study|Randomized in Error|5|||
27798784|NCT02367781|81095631|FG001|Overall Study|Randomized in Error|4|||
27798785|NCT02367781|81095630|FG000|Overall Study|Non-Compliance|1|||
27798786|NCT02367781|81095631|FG001|Overall Study|Non-Compliance|0|||
27798787|NCT02367781|81095630|FG000|Overall Study|Lost to Follow-up|1|||
27798788|NCT02367781|81095631|FG001|Overall Study|Lost to Follow-up|2|||
27798789|NCT02367781|81095630|FG000|Overall Study|Death|330|||
27798790|NCT02367781|81095631|FG001|Overall Study|Death|176|||
27798791|NCT02367781|81095630|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
27798792|NCT02367781|81095631|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
27798793|NCT02367781|81095630|FG000|Overall Study|Prolonged Hospitalization|1|||
27798794|NCT02367781|81095631|FG001|Overall Study|Prolonged Hospitalization|0|||
27798795|NCT02367781|81095630|FG000|Overall Study|Death Prior First Dose|1|||
27798796|NCT02367781|81095631|FG001|Overall Study|Death Prior First Dose|0|||
27798797|NCT02367781|81095630|FG000|Overall Study|Administrative-Change Facility|1|||
27798798|NCT02367781|81095631|FG001|Overall Study|Administrative-Change Facility|0|||
27798799|NCT02367781|81095630|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
27798800|NCT02367781|81095631|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
27798801|NCT02367781|81095630|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
27798802|NCT02367781|81095631|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
27798803|NCT02367781|81095630|FG000|Overall Study|Study Terminated by Sponsor|3|||
27798804|NCT02367781|81095631|FG001|Overall Study|Study Terminated by Sponsor|1|||
27798805|NCT02367781|81095630|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
27798806|NCT02367781|81095631|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
27798807|NCT02367781|81095630|FG000|Overall Study|Sponsor Decision|2|||
27798808|NCT02367781|81095631|FG001|Overall Study|Sponsor Decision|0|||
27798809|NCT02367781|81095630|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
27798810|NCT02367781|81095631|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
27798811|NCT00996632|81095632|FG000|Overall Study|Physician Decision|0|||
27798812|NCT00996632|81095633|FG001|Overall Study|Physician Decision|0|||
27798813|NCT05674721|81095634|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
27798814|NCT05674721|81095635|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
27798815|NCT05674721|81095634|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
27798816|NCT05674721|81095635|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
27798817|NCT01682512|81095637|FG000|Overall Study|Adverse Event|6|||
27798818|NCT01682512|81095638|FG001|Overall Study|Adverse Event|5|||
27798819|NCT01682512|81095639|FG002|Overall Study|Adverse Event|2|||
27798820|NCT01682512|81095637|FG000|Overall Study|Withdrawal by Subject|2|||
27798821|NCT01682512|81095638|FG001|Overall Study|Withdrawal by Subject|6|||
27798822|NCT01682512|81095639|FG002|Overall Study|Withdrawal by Subject|3|||
27798823|NCT01682512|81095637|FG000|Overall Study|Physician Decision|0|||
27798824|NCT01682512|81095638|FG001|Overall Study|Physician Decision|2|||
27798825|NCT01682512|81095639|FG002|Overall Study|Physician Decision|0|||
27798826|NCT01682512|81095637|FG000|Overall Study|Study terminated by sponsor|46|||
27833145|NCT04281472|81219495|FG002|Stage A|Withdrawal by Subject|0|||
27676391|NCT01144377|80653357|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27676392|NCT01144377|80653358|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
27676393|NCT00971997|80653363|FG000|Overall Study|Adverse Event|2|||
27676394|NCT00971997|80653363|FG000|Overall Study|Death|1|||
27676395|NCT00971997|80653363|FG000|Overall Study|Protocol Violation|4|||
27676396|NCT00971997|80653363|FG000|Overall Study|Withdrawal by Subject|5|||
27991495|NCT03100058|81798501|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991496|NCT03100058|81798502|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991497|NCT03100058|81798503|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27676397|NCT00971997|80653363|FG000|Overall Study|Physician Decision|7|||
27676398|NCT00862836|80653364|FG000|Overall Study|Withdrawal by Subject|1|||
27676399|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27991498|NCT03100058|81798504|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991499|NCT03100058|81798505|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991500|NCT03100058|81798506|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27676400|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27991501|NCT03100058|81798507|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991502|NCT03100058|81798508|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991503|NCT03100058|81798509|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991504|NCT03100058|81798510|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27676401|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
27676402|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
27676403|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
27676404|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
27676405|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
27991505|NCT03100058|81798511|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27991506|NCT03100058|81798512|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
27676406|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
27676407|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
27676408|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
27676409|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
27676410|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
27676411|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
27676412|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
27676413|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27676414|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27676415|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27676416|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27676417|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27676418|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
27676419|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
27991507|NCT03100058|81798513|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
27991508|NCT03100058|81798501|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991509|NCT03100058|81798502|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27676420|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27676421|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
27676422|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
27676423|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
27886629|NCT01938430|81418140|FG004|Overall Study|Randomized but Not Treated|0|||
27991510|NCT03100058|81798503|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27676424|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
27676425|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
27676426|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27676427|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27676428|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27676429|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27676430|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27676431|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
27676432|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27676433|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27676434|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27676435|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
27676436|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27676437|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27798827|NCT01682512|81095638|FG001|Overall Study|Study terminated by sponsor|43|||
27798828|NCT01682512|81095639|FG002|Overall Study|Study terminated by sponsor|0|||
27798829|NCT01682512|81095637|FG000|Overall Study|Lost to Follow-up|3|||
27798830|NCT01682512|81095638|FG001|Overall Study|Lost to Follow-up|0|||
27798831|NCT01682512|81095639|FG002|Overall Study|Lost to Follow-up|2|||
27798832|NCT01682512|81095637|FG000|Overall Study|Protocol Violation|2|||
27991511|NCT03100058|81798504|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991512|NCT03100058|81798505|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991513|NCT03100058|81798506|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991514|NCT03100058|81798507|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991515|NCT03100058|81798508|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991516|NCT03100058|81798509|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991517|NCT03100058|81798510|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
27991518|NCT03100058|81798511|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991519|NCT03100058|81798512|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991520|NCT03100058|81798513|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
27991521|NCT02464410|81798514|FG000|Overall Study|Death|3|||
27991522|NCT02464410|81798515|FG001|Overall Study|Death|4|||
27991523|NCT02464410|81798514|FG000|Overall Study|Lost to Follow-up|7|||
27991524|NCT02464410|81798515|FG001|Overall Study|Lost to Follow-up|9|||
27991525|NCT02464410|81798514|FG000|Overall Study|Withdrawal by Subject|12|||
27991526|NCT02464410|81798515|FG001|Overall Study|Withdrawal by Subject|3|||
27991527|NCT01357551|81798516|FG000|Overall Study|Withdrawal by Subject|6|||
27991528|NCT01357551|81798517|FG001|Overall Study|Withdrawal by Subject|4|||
27991529|NCT01357551|81798516|FG000|Overall Study|Death|0|||
27991530|NCT01357551|81798517|FG001|Overall Study|Death|1|||
27991531|NCT01357551|81798516|FG000|Overall Study|Lost to Follow-up|16|||
27991532|NCT01357551|81798517|FG001|Overall Study|Lost to Follow-up|6|||
27991533|NCT04177212|81798518|FG000|Overall Study|Withdrawal by Subject|9|||
27991534|NCT04177212|81798519|FG001|Overall Study|Withdrawal by Subject|7|||
27991535|NCT04177212|81798518|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
27991536|NCT04177212|81798519|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
27991537|NCT04177212|81798518|FG000|Overall Study|Physician Decision|1|||
27991538|NCT04177212|81798519|FG001|Overall Study|Physician Decision|0|||
27991539|NCT04177212|81798518|FG000|Overall Study|Lost to Follow-up|0|||
27991540|NCT04177212|81798519|FG001|Overall Study|Lost to Follow-up|3|||
27991541|NCT04177212|81798518|FG000|Overall Study|Adverse Event|0|||
27991542|NCT04177212|81798519|FG001|Overall Study|Adverse Event|1|||
27991543|NCT04177212|81798518|FG000|Overall Study|Other|1|||
27991544|NCT04177212|81798519|FG001|Overall Study|Other|2|||
27991545|NCT01240135|81798523|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
27991546|NCT01240135|81798524|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
27991547|NCT01240135|81798523|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
27991548|NCT01240135|81798524|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
27991549|NCT01098305|81798525|FG000|Overall Study|Lost to Follow-up|31|||
27991550|NCT01098305|81798526|FG001|Overall Study|Lost to Follow-up|33|||
27991551|NCT00793325|81798527|FG000|Overall Study|Protocol Violation|18|||
27991552|NCT00793325|81798527|FG000|Overall Study|Lost to Follow-up|1|||
27991553|NCT00869518|81798528|FG000|Overall Study|Lost to Follow-up|1|||
27991554|NCT00869518|81798529|FG001|Overall Study|Lost to Follow-up|1|||
27991555|NCT00958165|81798530|FG000|Overall Study|Lost to Follow-up|5|||
27991556|NCT00958165|81798530|FG000|Overall Study|Not eligible|9|||
27991557|NCT00465647|81798539|FG000|Overall Study|Administrative|2|||
27991558|NCT00465647|81798540|FG001|Overall Study|Administrative|2|||
27798833|NCT01682512|81095638|FG001|Overall Study|Protocol Violation|3|||
27798834|NCT01682512|81095639|FG002|Overall Study|Protocol Violation|2|||
27798835|NCT01682512|81095637|FG000|Overall Study|Primary lack of efficacy|10|||
27991559|NCT00465647|81798541|FG002|Overall Study|Administrative|3|||
27991560|NCT00465647|81798542|FG003|Overall Study|Administrative|2|||
27991561|NCT00465647|81798539|FG000|Overall Study|Adverse Event|2|||
27991562|NCT00465647|81798540|FG001|Overall Study|Adverse Event|0|||
27870742|NCT03536884|81361474|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870743|NCT03536884|81361475|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870744|NCT03536884|81361476|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870745|NCT03536884|81361477|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
27870746|NCT03536884|81361478|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
27870747|NCT02269098|81361479|FG000|Overall Study|Lost to Follow-up|14|||
27870748|NCT02269098|81361480|FG001|Overall Study|Lost to Follow-up|9|||
27870749|NCT01569295|81361481|FG000|Overall Study|Progressive Disease|75|||
27870750|NCT01569295|81361482|FG001|Overall Study|Progressive Disease|139|||
27870751|NCT01569295|81361481|FG000|Overall Study|Adverse Event|39|||
27870752|NCT01569295|81361482|FG001|Overall Study|Adverse Event|14|||
27870753|NCT01569295|81361481|FG000|Overall Study|Withdrawal by Subject|25|||
27870754|NCT01569295|81361482|FG001|Overall Study|Withdrawal by Subject|12|||
27870755|NCT01569295|81361481|FG000|Overall Study|Death|19|||
27870756|NCT01569295|81361482|FG001|Overall Study|Death|15|||
27870757|NCT01569295|81361481|FG000|Overall Study|Physician Decision|13|||
27870758|NCT01569295|81361482|FG001|Overall Study|Physician Decision|18|||
27870759|NCT01569295|81361481|FG000|Overall Study|Study Terminated by Sponsor|24|||
27991563|NCT00465647|81798541|FG002|Overall Study|Adverse Event|3|||
27991564|NCT00465647|81798542|FG003|Overall Study|Adverse Event|2|||
27991565|NCT00465647|81798539|FG000|Overall Study|Withdrawal by Subject|1|||
27991566|NCT00465647|81798540|FG001|Overall Study|Withdrawal by Subject|2|||
27991567|NCT00465647|81798541|FG002|Overall Study|Withdrawal by Subject|2|||
27991568|NCT00465647|81798542|FG003|Overall Study|Withdrawal by Subject|7|||
27991569|NCT00465647|81798539|FG000|Overall Study|"The other reasons included loss of IV"|8|||
27991570|NCT00465647|81798540|FG001|Overall Study|"The other reasons included loss of IV"|4|||
27991571|NCT00465647|81798541|FG002|Overall Study|"The other reasons included loss of IV"|3|||
27991572|NCT00465647|81798542|FG003|Overall Study|"The other reasons included loss of IV"|2|||
27991573|NCT00947115|81798544|FG000|Overall Study|Missed reporting interval|3|||
27991574|NCT00947115|81798545|FG001|Overall Study|Missed reporting interval|4|||
27991575|NCT00947115|81798546|FG002|Overall Study|Missed reporting interval|2|||
27991576|NCT00947115|81798544|FG000|Overall Study|Physician Decision|0|||
27991577|NCT00947115|81798545|FG001|Overall Study|Physician Decision|2|||
27676438|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27676439|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27676440|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
27676441|NCT01888874|80653368|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27676442|NCT01888874|80653369|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
27676443|NCT01888874|80653370|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27676444|NCT01888874|80653371|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27676445|NCT01888874|80653372|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27676446|NCT01888874|80653373|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
27798836|NCT01682512|81095638|FG001|Overall Study|Primary lack of efficacy|7|||
27991578|NCT00947115|81798546|FG002|Overall Study|Physician Decision|0|||
27991579|NCT00947115|81798544|FG000|Overall Study|Death|0|||
27991580|NCT00947115|81798545|FG001|Overall Study|Death|1|||
27991581|NCT00947115|81798546|FG002|Overall Study|Death|1|||
27991582|NCT00947115|81798544|FG000|Overall Study|Migrated from study area|2|||
27991583|NCT00947115|81798545|FG001|Overall Study|Migrated from study area|0|||
27991584|NCT00947115|81798546|FG002|Overall Study|Migrated from study area|0|||
27991585|NCT00947115|81798544|FG000|Overall Study|Withdrawal by Subject|1|||
27798837|NCT01682512|81095639|FG002|Overall Study|Primary lack of efficacy|7|||
27798838|NCT01682512|81095637|FG000|Overall Study|Secondary lack of efficacy|1|||
27798839|NCT01682512|81095638|FG001|Overall Study|Secondary lack of efficacy|1|||
27798840|NCT01682512|81095639|FG002|Overall Study|Secondary lack of efficacy|0|||
27798841|NCT01682512|81095637|FG000|Overall Study|Other than stated above|2|||
27798842|NCT01682512|81095638|FG001|Overall Study|Other than stated above|4|||
27798843|NCT01682512|81095639|FG002|Overall Study|Other than stated above|2|||
27798844|NCT00759759|81095640|FG000|Overall Study|didn't return for period 2|1|||
27798845|NCT00759759|81095641|FG001|Overall Study|didn't return for period 2|0|||
27676447|NCT01888874|80653374|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
27676448|NCT01888874|80653368|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
27676449|NCT01888874|80653369|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
27798846|NCT00759759|81095640|FG000|Overall Study|Didn't receive drug in period 2|1|||
27991586|NCT00947115|81798545|FG001|Overall Study|Withdrawal by Subject|3|||
27991587|NCT00947115|81798546|FG002|Overall Study|Withdrawal by Subject|4|||
27798847|NCT00759759|81095641|FG001|Overall Study|Didn't receive drug in period 2|0|||
27798848|NCT00759759|81095640|FG000|Overall Study|Withdrawal by Subject|2|||
27991588|NCT00947115|81798544|FG000|Overall Study|Lost to Follow-up|11|||
27991589|NCT00947115|81798545|FG001|Overall Study|Lost to Follow-up|12|||
27991590|NCT00947115|81798546|FG002|Overall Study|Lost to Follow-up|8|||
27991591|NCT00231413|81801900|FG000|Overall Study|Non-serious AE|0|||
27991592|NCT00231413|81801901|FG001|Overall Study|Non-serious AE|0|||
27991593|NCT00231413|81801902|FG002|Overall Study|Non-serious AE|1|||
27991594|NCT00231413|81801903|FG003|Overall Study|Non-serious AE|0|||
27991595|NCT00231413|81801904|FG004|Overall Study|Non-serious AE|0|||
27991596|NCT00231413|81801905|FG005|Overall Study|Non-serious AE|0|||
27991597|NCT00231413|81801906|FG006|Overall Study|Non-serious AE|1|||
27991598|NCT00231413|81801900|FG000|Overall Study|Withdrawal by Subject|3|||
27991599|NCT00231413|81801901|FG001|Overall Study|Withdrawal by Subject|1|||
27991600|NCT00231413|81801902|FG002|Overall Study|Withdrawal by Subject|4|||
27991601|NCT00231413|81801903|FG003|Overall Study|Withdrawal by Subject|2|||
27991602|NCT00231413|81801904|FG004|Overall Study|Withdrawal by Subject|2|||
27991603|NCT00231413|81801905|FG005|Overall Study|Withdrawal by Subject|0|||
27991604|NCT00231413|81801906|FG006|Overall Study|Withdrawal by Subject|3|||
27991605|NCT00231413|81801900|FG000|Overall Study|Migrated/moved from study area|0|||
27991606|NCT00231413|81801901|FG001|Overall Study|Migrated/moved from study area|0|||
27991607|NCT00231413|81801902|FG002|Overall Study|Migrated/moved from study area|1|||
27991608|NCT00231413|81801903|FG003|Overall Study|Migrated/moved from study area|0|||
27991609|NCT00231413|81801904|FG004|Overall Study|Migrated/moved from study area|0|||
27991610|NCT00231413|81801905|FG005|Overall Study|Migrated/moved from study area|1|||
27991611|NCT00231413|81801906|FG006|Overall Study|Migrated/moved from study area|0|||
27991612|NCT00231413|81801900|FG000|Overall Study|Lost to Follow-up|4|||
27991613|NCT00231413|81801901|FG001|Overall Study|Lost to Follow-up|4|||
27991614|NCT00231413|81801902|FG002|Overall Study|Lost to Follow-up|1|||
27991615|NCT00231413|81801903|FG003|Overall Study|Lost to Follow-up|1|||
27991616|NCT00231413|81801904|FG004|Overall Study|Lost to Follow-up|1|||
27991617|NCT00231413|81801905|FG005|Overall Study|Lost to Follow-up|4|||
27991618|NCT00231413|81801906|FG006|Overall Study|Lost to Follow-up|0|||
27991619|NCT00231413|81801900|FG000|Overall Study|Pregnancy|1|||
27991620|NCT00231413|81801901|FG001|Overall Study|Pregnancy|0|||
27991621|NCT00231413|81801902|FG002|Overall Study|Pregnancy|0|||
27991622|NCT00231413|81801903|FG003|Overall Study|Pregnancy|0|||
27991623|NCT00231413|81801904|FG004|Overall Study|Pregnancy|0|||
27991624|NCT00231413|81801905|FG005|Overall Study|Pregnancy|0|||
27991625|NCT00231413|81801906|FG006|Overall Study|Pregnancy|0|||
27991626|NCT00650845|81801907|FG000|Overall Study|Withdrawal by Subject|5|||
27991627|NCT00650845|81801908|FG001|Overall Study|Withdrawal by Subject|0|||
27991628|NCT00650845|81801907|FG000|Overall Study|Protocol Violation|0|||
27991629|NCT00650845|81801908|FG001|Overall Study|Protocol Violation|13|||
27991630|NCT00779025|81801909|FG000|Overall Study|Withdrawal by Subject|1|||
27991631|NCT03775512|81801910|FG000|Overall Study|Death|1|||
27991632|NCT03775512|81801911|FG001|Overall Study|Death|1|||
27991633|NCT03775512|81801910|FG000|Overall Study|Withdrawal by Subject|7|||
27991634|NCT03775512|81801911|FG001|Overall Study|Withdrawal by Subject|4|||
27991635|NCT03775512|81801910|FG000|Overall Study|Lost to Follow-up|5|||
27991636|NCT03775512|81801911|FG001|Overall Study|Lost to Follow-up|5|||
27991637|NCT03775512|81801910|FG000|Overall Study|Excluded before Catheter insertion|14|||
27991638|NCT03775512|81801911|FG001|Overall Study|Excluded before Catheter insertion|5|||
27991639|NCT03775512|81801910|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
27991640|NCT03775512|81801911|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
27991641|NCT03775512|81801910|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
27991642|NCT03775512|81801911|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
27798849|NCT00759759|81095641|FG001|Overall Study|Withdrawal by Subject|1|||
27798850|NCT03976076|81095646|FG000|Overall Study|Withdrawal by Subject|2|||
27798851|NCT00782275|81095647|FG000|Overall Study|Adverse Event|11|||
27798852|NCT00782275|81095647|FG000|Overall Study|Withdrawal by Subject|1|||
27798853|NCT00782275|81095647|FG000|Overall Study|Progressive Disease|21|||
27798854|NCT00782275|81095647|FG000|Overall Study|Physician Decision|4|||
27991643|NCT04310566|81801914|FG000|Period 1|Study Termination due to COVID-19|15|||
27991644|NCT04310566|81801915|FG001|Period 1|Study Termination due to COVID-19|17|||
27991645|NCT04310566|81801914|FG000|Period 1|Protocol Violation|0|||
27991646|NCT04310566|81801915|FG001|Period 1|Protocol Violation|1|||
27991647|NCT04310566|81801914|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
27991648|NCT04310566|81801915|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
27991649|NCT04310566|81801914|FG000|Period 1|Lost to Follow-up|1|||
27991650|NCT04310566|81801915|FG001|Period 1|Lost to Follow-up|0|||
27991651|NCT04310566|81801914|FG000|Period 1|Withdrawal by Subject|0|||
27991652|NCT04310566|81801915|FG001|Period 1|Withdrawal by Subject|1|||
27991653|NCT04310566|81801914|FG000|Period 2|Study Termination|7|||
27991654|NCT04310566|81801915|FG001|Period 2|Study Termination|5|||
27991655|NCT01815840|81801916|FG000|Overall Study|Missing|1|||
27991656|NCT01815840|81801917|FG001|Overall Study|Missing|0|||
27798855|NCT00782275|81095647|FG000|Overall Study|Not started treatment|1|||
27991657|NCT01815840|81801916|FG000|Overall Study|Withdrew Consent|31|||
27991658|NCT01815840|81801917|FG001|Overall Study|Withdrew Consent|30|||
27991659|NCT01815840|81801916|FG000|Overall Study|Administrative/Other|1|||
27991660|NCT01815840|81801917|FG001|Overall Study|Administrative/Other|3|||
27676450|NCT01888874|80653370|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
27676451|NCT01888874|80653371|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27676452|NCT01888874|80653372|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
27676453|NCT01888874|80653373|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27676454|NCT01888874|80653374|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27676455|NCT01888874|80653368|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27676456|NCT01888874|80653369|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27676457|NCT01888874|80653370|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27676458|NCT01888874|80653371|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27676459|NCT01888874|80653372|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
27676460|NCT01888874|80653373|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27676461|NCT01888874|80653374|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
27676462|NCT01888874|80653368|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27676463|NCT01888874|80653369|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27676464|NCT01888874|80653370|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
27676465|NCT01888874|80653371|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27676466|NCT01888874|80653372|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27676467|NCT01888874|80653373|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
27676468|NCT01888874|80653374|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
27676469|NCT01888874|80653368|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27676470|NCT01888874|80653369|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27676471|NCT01888874|80653370|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
27676472|NCT01888874|80653371|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27798856|NCT00782275|81095647|FG000|Overall Study|Other|3|||
27798857|NCT00430638|81095648|FG000|Overall Study|Adverse Event|15|||
27798858|NCT00430638|81095649|FG001|Overall Study|Adverse Event|15|||
27798859|NCT00430638|81095648|FG000|Overall Study|Uncontrolled blood pressure|48|||
27798860|NCT00430638|81095649|FG001|Overall Study|Uncontrolled blood pressure|13|||
27798861|NCT00430638|81095648|FG000|Overall Study|Lost to Follow-up|1|||
27798862|NCT00430638|81095649|FG001|Overall Study|Lost to Follow-up|7|||
27676473|NCT01888874|80653372|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27676474|NCT01888874|80653373|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27798863|NCT00430638|81095648|FG000|Overall Study|Protocol Violation|6|||
27798864|NCT00430638|81095649|FG001|Overall Study|Protocol Violation|4|||
27798865|NCT00430638|81095648|FG000|Overall Study|Withdrawal by Subject|4|||
27798866|NCT00430638|81095649|FG001|Overall Study|Withdrawal by Subject|6|||
27991661|NCT01815840|81801916|FG000|Overall Study|Adverse Event|10|||
27991662|NCT01815840|81801917|FG001|Overall Study|Adverse Event|16|||
27991663|NCT01815840|81801916|FG000|Overall Study|Death|2|||
27991664|NCT01815840|81801917|FG001|Overall Study|Death|2|||
27991665|NCT01815840|81801916|FG000|Overall Study|Disease progression|3|||
27991666|NCT01815840|81801917|FG001|Overall Study|Disease progression|2|||
27991667|NCT01815840|81801916|FG000|Overall Study|Investigators Decision|2|||
27991668|NCT01815840|81801917|FG001|Overall Study|Investigators Decision|3|||
27991669|NCT01815840|81801916|FG000|Overall Study|Lost to Follow-up|3|||
27991670|NCT01815840|81801917|FG001|Overall Study|Lost to Follow-up|6|||
27991671|NCT01815840|81801916|FG000|Overall Study|Refused Treatment|5|||
27798867|NCT00430638|81095648|FG000|Overall Study|Non-compliant|2|||
27798868|NCT00430638|81095649|FG001|Overall Study|Non-compliant|1|||
27991672|NCT01815840|81801917|FG001|Overall Study|Refused Treatment|1|||
27991673|NCT01815840|81801916|FG000|Overall Study|Sponsor Termination Treatment|1|||
27991674|NCT01815840|81801917|FG001|Overall Study|Sponsor Termination Treatment|0|||
27991675|NCT04440813|81801923|FG000|Overall Study|Lost to Follow-up|5|||
27991676|NCT04440813|81801924|FG001|Overall Study|Lost to Follow-up|5|||
27991677|NCT02942485|81801925|FG000|Overall Study|Lost to Follow-up|1|||
27991678|NCT02942485|81801926|FG001|Overall Study|Lost to Follow-up|0|||
27991679|NCT06359080|81801928|FG000|Overall Study|Withdrawal by Subject|3|||
27991680|NCT00615992|81801929|FG000|Overall Study|Protocol Violation|67|||
27991681|NCT01279681|81801930|FG000|Overall Study|Disease Progression|9|||
27991682|NCT01279681|81801931|FG001|Overall Study|Disease Progression|6|||
27991683|NCT01279681|81801930|FG000|Overall Study|Withdrawal by Subject|3|||
27991684|NCT01279681|81801931|FG001|Overall Study|Withdrawal by Subject|4|||
27991685|NCT01279681|81801930|FG000|Overall Study|Adverse Event|2|||
27991686|NCT01279681|81801931|FG001|Overall Study|Adverse Event|3|||
27991687|NCT01279681|81801930|FG000|Overall Study|Death|0|||
27991688|NCT01279681|81801931|FG001|Overall Study|Death|1|||
27991689|NCT01279681|81801930|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
27991690|NCT01279681|81801931|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
27991691|NCT01279681|81801930|FG000|Overall Study|Physician Decision|1|||
27991692|NCT01279681|81801931|FG001|Overall Study|Physician Decision|0|||
27991693|NCT01279681|81801930|FG000|Overall Study|Other Reason|0|||
27991694|NCT01279681|81801931|FG001|Overall Study|Other Reason|2|||
27991695|NCT00176462|81801934|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
27991696|NCT00176462|81801935|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
27991697|NCT00176462|81801934|FG000|Induction (4 Weeks)|Death|1|||
27991698|NCT00176462|81801935|FG001|Induction (4 Weeks)|Death|2|||
27991699|NCT00176462|81801934|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
27991700|NCT00176462|81801935|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
27991701|NCT00176462|81801934|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
27991702|NCT00176462|81801935|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
27798869|NCT00430638|81095648|FG000|Overall Study|Other|2|||
27798870|NCT00430638|81095649|FG001|Overall Study|Other|2|||
27798871|NCT02703454|81095650|FG000|Overall Study|Not treated|1|||
27798872|NCT02703454|81095651|FG001|Overall Study|Not treated|3|||
27798873|NCT02703454|81095650|FG000|Overall Study|Withdrawal by Subject|4|||
27991703|NCT00176462|81801934|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
27991704|NCT00176462|81801935|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
27991705|NCT00176462|81801934|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
27991706|NCT00176462|81801935|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
27991707|NCT00176462|81801934|FG000|Consolidation (12 Weeks)|Not documented|0|||
27991708|NCT00176462|81801935|FG001|Consolidation (12 Weeks)|Not documented|1|||
27991709|NCT00176462|81801934|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
27991710|NCT00176462|81801935|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
27991711|NCT00176462|81801934|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
27991712|NCT00176462|81801935|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
27991713|NCT04565951|81801936|FG000|Overall Study|Lost to Follow-up|66|||
27991714|NCT04565951|81801937|FG001|Overall Study|Lost to Follow-up|38|||
27991715|NCT04565951|81801936|FG000|Overall Study|Withdrawal by Subject|14|||
27991716|NCT04565951|81801937|FG001|Overall Study|Withdrawal by Subject|7|||
27991717|NCT04565951|81801936|FG000|Overall Study|Death|0|||
27991718|NCT04565951|81801937|FG001|Overall Study|Death|1|||
27798874|NCT02703454|81095651|FG001|Overall Study|Withdrawal by Subject|3|||
27991719|NCT00646399|81801938|FG000|Overall Study|Death|63|||
27991720|NCT00646399|81801939|FG001|Overall Study|Death|53|||
27991721|NCT00646399|81801938|FG000|Overall Study|Withdrawal by Subject|9|||
27991722|NCT00646399|81801939|FG001|Overall Study|Withdrawal by Subject|10|||
27991723|NCT00646399|81801938|FG000|Overall Study|Other Reason|11|||
27991724|NCT00646399|81801939|FG001|Overall Study|Other Reason|11|||
27798875|NCT02703454|81095650|FG000|Overall Study|Lost to Follow-up|1|||
27991725|NCT04698993|81801942|FG000|Overall Study|PCR results not accessible|2|||
27991726|NCT04698993|81801943|FG001|Overall Study|PCR results not accessible|7|||
27676475|NCT01888874|80653374|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
27676476|NCT01888874|80653368|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
27676477|NCT01888874|80653369|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
27676478|NCT01888874|80653370|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
27676479|NCT01888874|80653371|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
27676480|NCT01888874|80653372|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
27676481|NCT01888874|80653373|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
27798876|NCT02703454|81095651|FG001|Overall Study|Lost to Follow-up|2|||
27991727|NCT04698993|81801942|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
27991728|NCT04698993|81801943|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
27991729|NCT01657292|81801945|FG000|Overall Study|Adverse Event|6|||
27991730|NCT01657292|81801945|FG000|Overall Study|Withdrawal by Subject|2|||
27991731|NCT01657292|81801945|FG000|Overall Study|Violation of eligibility criteria|1|||
27991732|NCT01657292|81801945|FG000|Overall Study|Change of therapy|1|||
27798877|NCT02703454|81095650|FG000|Overall Study|Study discontinuation|5|||
27798878|NCT02703454|81095651|FG001|Overall Study|Study discontinuation|8|||
27798879|NCT00445458|81095652|FG000|Overall Study|Disease Progression|3|||
27798880|NCT00445458|81095653|FG001|Overall Study|Disease Progression|4|||
27798881|NCT00445458|81095654|FG002|Overall Study|Disease Progression|54|||
27676482|NCT01888874|80653374|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
27798882|NCT00445458|81095655|FG003|Overall Study|Disease Progression|27|||
27798883|NCT00445458|81095652|FG000|Overall Study|Withdrawal by Subject|0|||
27798884|NCT00445458|81095653|FG001|Overall Study|Withdrawal by Subject|0|||
27798885|NCT00445458|81095654|FG002|Overall Study|Withdrawal by Subject|7|||
27798886|NCT00445458|81095655|FG003|Overall Study|Withdrawal by Subject|0|||
27798887|NCT00445458|81095652|FG000|Overall Study|Adverse Event|0|||
27991733|NCT00856544|81801946|FG000|Overall Study|Randomized but not treated|3|||
27991734|NCT00856544|81801947|FG001|Overall Study|Randomized but not treated|0|||
27991735|NCT00856544|81801948|FG002|Overall Study|Randomized but not treated|0|||
27991736|NCT00856544|81801949|FG003|Overall Study|Randomized but not treated|0|||
27798888|NCT00445458|81095653|FG001|Overall Study|Adverse Event|0|||
27798889|NCT00445458|81095654|FG002|Overall Study|Adverse Event|3|||
27991737|NCT00856544|81801946|FG000|Overall Study|Death|0|||
27991738|NCT00856544|81801947|FG001|Overall Study|Death|2|||
27991739|NCT00856544|81801948|FG002|Overall Study|Death|0|||
27991740|NCT00856544|81801949|FG003|Overall Study|Death|0|||
27991741|NCT00856544|81801946|FG000|Overall Study|Adverse Event|20|||
27991742|NCT00856544|81801947|FG001|Overall Study|Adverse Event|29|||
27991743|NCT00856544|81801948|FG002|Overall Study|Adverse Event|2|||
27991744|NCT00856544|81801949|FG003|Overall Study|Adverse Event|3|||
27991745|NCT00856544|81801946|FG000|Overall Study|Lack of Efficacy|16|||
27991746|NCT00856544|81801947|FG001|Overall Study|Lack of Efficacy|12|||
27991747|NCT00856544|81801948|FG002|Overall Study|Lack of Efficacy|3|||
27991748|NCT00856544|81801949|FG003|Overall Study|Lack of Efficacy|3|||
27991749|NCT00856544|81801946|FG000|Overall Study|Other|9|||
27991750|NCT00856544|81801947|FG001|Overall Study|Other|16|||
27991751|NCT00856544|81801948|FG002|Overall Study|Other|1|||
27798890|NCT00445458|81095655|FG003|Overall Study|Adverse Event|0|||
27798891|NCT00445458|81095652|FG000|Overall Study|Death|0|||
27798892|NCT00445458|81095653|FG001|Overall Study|Death|1|||
27798893|NCT00445458|81095654|FG002|Overall Study|Death|2|||
27798894|NCT00445458|81095655|FG003|Overall Study|Death|0|||
27798895|NCT00445458|81095652|FG000|Overall Study|Physician Decision|0|||
27798896|NCT00445458|81095653|FG001|Overall Study|Physician Decision|0|||
27798897|NCT00445458|81095654|FG002|Overall Study|Physician Decision|1|||
27798898|NCT00445458|81095655|FG003|Overall Study|Physician Decision|1|||
27798899|NCT00445458|81095652|FG000|Overall Study|Surgery|0|||
27798900|NCT00445458|81095653|FG001|Overall Study|Surgery|0|||
27798901|NCT00445458|81095654|FG002|Overall Study|Surgery|1|||
27798902|NCT00445458|81095655|FG003|Overall Study|Surgery|0|||
27798903|NCT01227954|81095657|FG000|Overall Study|Protocol Violation|6|||
27798904|NCT01227954|81095657|FG000|Overall Study|No protocol treatment|7|||
27798905|NCT00953927|81095662|FG000|Overall Study|Lost to Follow-up|61|||
27798906|NCT00953927|81095663|FG001|Overall Study|Lost to Follow-up|65|||
27991752|NCT00856544|81801949|FG003|Overall Study|Other|6|||
27991753|NCT00856544|81801946|FG000|Overall Study|Lost to Follow-up|1|||
27991754|NCT00856544|81801947|FG001|Overall Study|Lost to Follow-up|2|||
27991755|NCT00856544|81801948|FG002|Overall Study|Lost to Follow-up|2|||
27991756|NCT00856544|81801949|FG003|Overall Study|Lost to Follow-up|0|||
27991757|NCT00856544|81801946|FG000|Overall Study|Withdrawal by Subject|8|||
27991758|NCT00856544|81801947|FG001|Overall Study|Withdrawal by Subject|5|||
27991759|NCT00856544|81801948|FG002|Overall Study|Withdrawal by Subject|0|||
27991760|NCT00856544|81801949|FG003|Overall Study|Withdrawal by Subject|1|||
27991761|NCT02397057|81801954|FG000|Overall Study|Withdrawal by Subject|6|||
27991762|NCT02397057|81801955|FG001|Overall Study|Withdrawal by Subject|7|||
27991763|NCT02397057|81801954|FG000|Overall Study|Lost to Follow-up|4|||
27991764|NCT02397057|81801955|FG001|Overall Study|Lost to Follow-up|3|||
27991765|NCT02397057|81801954|FG000|Overall Study|Death|1|||
27991766|NCT02397057|81801955|FG001|Overall Study|Death|0|||
27991767|NCT02397057|81801954|FG000|Overall Study|Adverse Event|0|||
27991768|NCT02397057|81801955|FG001|Overall Study|Adverse Event|1|||
27798907|NCT00953927|81095662|FG000|Overall Study|Withdrawal by Subject|36|||
27798908|NCT00953927|81095663|FG001|Overall Study|Withdrawal by Subject|25|||
27798909|NCT00953927|81095662|FG000|Overall Study|Death|7|||
27798910|NCT00953927|81095663|FG001|Overall Study|Death|4|||
27798911|NCT00953927|81095662|FG000|Overall Study|Other study discontinuation|1|||
27798912|NCT00953927|81095663|FG001|Overall Study|Other study discontinuation|1|||
27798913|NCT01342367|81095666|FG000|Overall Study|Death|1|||
27798914|NCT01342367|81095667|FG001|Overall Study|Death|0|||
27798915|NCT01342367|81095666|FG000|Overall Study|Withdrawal by Subject|1|||
27798916|NCT01342367|81095667|FG001|Overall Study|Withdrawal by Subject|2|||
27798917|NCT00765999|81095668|FG000|Overall Study|Adverse Event|203|||
27798918|NCT00765999|81095668|FG000|Overall Study|Insufficient Therapeutic Response|100|||
27798919|NCT00765999|81095668|FG000|Overall Study|Protocol Violation|95|||
27798920|NCT00765999|81095668|FG000|Overall Study|Consent Withdrawn|202|||
27798921|NCT00765999|81095668|FG000|Overall Study|Lost to Follow-up|131|||
27798922|NCT00765999|81095668|FG000|Overall Study|Study Terminated by Sponsor|2|||
27798923|NCT00765999|81095668|FG000|Overall Study|Other Miscellaneous Reasons|51|||
27798924|NCT03159611|81095671|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
27798925|NCT03159611|81095672|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
27798926|NCT03159611|81095671|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
27798927|NCT03159611|81095672|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
27798928|NCT03159611|81095671|FG000|Overall Study|Protocol Violation|7|||
27798929|NCT03159611|81095672|FG001|Overall Study|Protocol Violation|4|||
27798930|NCT03159611|81095671|FG000|Overall Study|Adverse Event|1|||
27798931|NCT03159611|81095672|FG001|Overall Study|Adverse Event|0|||
27676483|NCT01888874|80653368|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27676484|NCT01888874|80653369|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
27579312|NCT01049919|80303173|FG001|Overall Study|Physician Decision|0|||
27798932|NCT03159611|81095671|FG000|Overall Study|Withdrawal by Subject|1|||
27991769|NCT02397057|81801954|FG000|Overall Study|Physician Decision|0|||
27991770|NCT02397057|81801955|FG001|Overall Study|Physician Decision|1|||
27991771|NCT02397057|81801954|FG000|Overall Study|Subject did not receive study drug|0|||
27991772|NCT02397057|81801955|FG001|Overall Study|Subject did not receive study drug|1|||
27991773|NCT01408459|81801956|FG000|Overall Study|Withdrawal by Subject|1|||
27991774|NCT01408459|81801957|FG001|Overall Study|Withdrawal by Subject|1|||
27991775|NCT00989963|81801960|FG000|Overall Study|Adverse Event|1|||
27991776|NCT00989963|81801961|FG001|Overall Study|Adverse Event|1|||
27991777|NCT00989963|81801962|FG002|Overall Study|Adverse Event|1|||
27991778|NCT01266590|81801967|FG000|Overall Study|Adverse Event|3|||
27991779|NCT01266590|81801967|FG000|Overall Study|Lost to Follow-up|1|||
27991780|NCT01266590|81801967|FG000|Overall Study|Withdrawal by Subject|1|||
27991781|NCT01266590|81801967|FG000|Overall Study|Physician Decision|1|||
27991782|NCT03857542|81801970|FG000|Overall Study|Adverse Event|1|||
27991783|NCT03857542|81801971|FG001|Overall Study|Adverse Event|3|||
27991784|NCT03857542|81801970|FG000|Overall Study|Withdrawal by Subject|2|||
27991785|NCT03857542|81801971|FG001|Overall Study|Withdrawal by Subject|1|||
27991786|NCT03857542|81801970|FG000|Overall Study|Lost to Follow-up|2|||
27991787|NCT03857542|81801971|FG001|Overall Study|Lost to Follow-up|1|||
27991788|NCT03857542|81801970|FG000|Overall Study|Reason not Specified|1|||
27991789|NCT03857542|81801971|FG001|Overall Study|Reason not Specified|0|||
27991790|NCT02718716|81801972|FG000|Overall Study|Lack of Efficacy|1|||
27991791|NCT02718716|81801973|FG001|Overall Study|Lack of Efficacy|0|||
27991792|NCT02718716|81801974|FG002|Overall Study|Lack of Efficacy|0|||
27991793|NCT02718716|81801975|FG003|Overall Study|Lack of Efficacy|0|||
27991794|NCT02718716|81801976|FG004|Overall Study|Lack of Efficacy|0|||
27991795|NCT01867086|81801977|FG000|Overall Study|Disease Progression|1|||
27991796|NCT03364309|81801979|FG000|Induction Period|Adverse Event|4|||
27991797|NCT03364309|81801980|FG001|Induction Period|Adverse Event|0|||
27991798|NCT03364309|81801981|FG002|Induction Period|Adverse Event|1|||
27991799|NCT03364309|81801982|FG003|Induction Period|Adverse Event|0|||
27991800|NCT03364309|81801983|FG004|Induction Period|Adverse Event|0|||
27991801|NCT03364309|81801984|FG005|Induction Period|Adverse Event|0|||
27991802|NCT03364309|81801985|FG006|Induction Period|Adverse Event|0|||
27991803|NCT03364309|81801986|FG007|Induction Period|Adverse Event|0|||
27991804|NCT03364309|81801987|FG008|Induction Period|Adverse Event|0|||
27991805|NCT03364309|81801988|FG009|Induction Period|Adverse Event|0|||
27991806|NCT03364309|81801989|FG010|Induction Period|Adverse Event|0|||
27991807|NCT03364309|81801990|FG011|Induction Period|Adverse Event|0|||
27991808|NCT03364309|81801991|FG012|Induction Period|Adverse Event|0|||
27991809|NCT03364309|81801992|FG013|Induction Period|Adverse Event|0|||
27991810|NCT03364309|81801993|FG014|Induction Period|Adverse Event|0|||
27991811|NCT03364309|81801994|FG015|Induction Period|Adverse Event|0|||
27991812|NCT03364309|81801995|FG016|Induction Period|Adverse Event|0|||
27991813|NCT03364309|81801996|FG017|Induction Period|Adverse Event|0|||
27991814|NCT03364309|81801997|FG018|Induction Period|Adverse Event|0|||
27991815|NCT03364309|81801979|FG000|Induction Period|Withdrawal by Subject|1|||
27991816|NCT03364309|81801980|FG001|Induction Period|Withdrawal by Subject|3|||
27991817|NCT03364309|81801981|FG002|Induction Period|Withdrawal by Subject|0|||
27991818|NCT03364309|81801982|FG003|Induction Period|Withdrawal by Subject|0|||
27991819|NCT03364309|81801983|FG004|Induction Period|Withdrawal by Subject|0|||
27991820|NCT03364309|81801984|FG005|Induction Period|Withdrawal by Subject|0|||
27991821|NCT03364309|81801985|FG006|Induction Period|Withdrawal by Subject|0|||
27798933|NCT03159611|81095672|FG001|Overall Study|Withdrawal by Subject|1|||
27798934|NCT03159611|81095671|FG000|Overall Study|Non-compliance with protocol requirement|3|||
27991822|NCT03364309|81801986|FG007|Induction Period|Withdrawal by Subject|0|||
27991823|NCT03364309|81801987|FG008|Induction Period|Withdrawal by Subject|0|||
27991824|NCT03364309|81801988|FG009|Induction Period|Withdrawal by Subject|0|||
27991825|NCT03364309|81801989|FG010|Induction Period|Withdrawal by Subject|0|||
27991826|NCT03364309|81801990|FG011|Induction Period|Withdrawal by Subject|0|||
27991827|NCT03364309|81801991|FG012|Induction Period|Withdrawal by Subject|0|||
27676485|NCT01888874|80653370|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27991828|NCT03364309|81801992|FG013|Induction Period|Withdrawal by Subject|0|||
27991829|NCT03364309|81801993|FG014|Induction Period|Withdrawal by Subject|0|||
27991830|NCT03364309|81801994|FG015|Induction Period|Withdrawal by Subject|0|||
27579313|NCT01049919|80303172|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
27870760|NCT01569295|81361482|FG001|Overall Study|Study Terminated by Sponsor|2|||
27870761|NCT01569295|81361481|FG000|Overall Study|Other Reason not Specified|3|||
27870762|NCT01569295|81361482|FG001|Overall Study|Other Reason not Specified|5|||
27870763|NCT01569295|81361481|FG000|Overall Study|Non-Compliance with Study Drug|6|||
27870764|NCT01569295|81361482|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27870765|NCT01569295|81361481|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
27870766|NCT01569295|81361482|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
27870767|NCT01569295|81361481|FG000|Overall Study|Lost to Follow-up|1|||
27870768|NCT01569295|81361482|FG001|Overall Study|Lost to Follow-up|1|||
27870769|NCT01459783|81361483|FG000|Baseline to 6 Months|Death|1|||
27870770|NCT01459783|81361484|FG001|Baseline to 6 Months|Death|0|||
27579314|NCT01049919|80303173|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
27798935|NCT03159611|81095672|FG001|Overall Study|Non-compliance with protocol requirement|2|||
27798936|NCT03159611|81095671|FG000|Overall Study|Inability to perform procedures|1|||
27798937|NCT03159611|81095672|FG001|Overall Study|Inability to perform procedures|0|||
27798938|NCT03338673|81095673|FG000|Overall Study|Lost to Follow-up|1|||
27798939|NCT03338673|81095674|FG001|Overall Study|Lost to Follow-up|1|||
27798940|NCT00572156|81095676|FG000|Overall Study|Adverse Event|3|||
27798941|NCT00572156|81095677|FG001|Overall Study|Adverse Event|1|||
27798942|NCT00572156|81095678|FG002|Overall Study|Adverse Event|5|||
27798943|NCT00572156|81095679|FG003|Overall Study|Adverse Event|1|||
27798944|NCT00572156|81095676|FG000|Overall Study|Lost to Follow-up|1|||
27798945|NCT00572156|81095677|FG001|Overall Study|Lost to Follow-up|1|||
27798946|NCT00572156|81095678|FG002|Overall Study|Lost to Follow-up|1|||
27798947|NCT00572156|81095679|FG003|Overall Study|Lost to Follow-up|0|||
27798948|NCT00572156|81095676|FG000|Overall Study|Protocol Violation|1|||
27798949|NCT00572156|81095677|FG001|Overall Study|Protocol Violation|2|||
27798950|NCT00572156|81095678|FG002|Overall Study|Protocol Violation|0|||
27798951|NCT00572156|81095679|FG003|Overall Study|Protocol Violation|2|||
27798952|NCT00572156|81095676|FG000|Overall Study|Patient/Parent Decision|1|||
27798953|NCT00572156|81095677|FG001|Overall Study|Patient/Parent Decision|6|||
27798954|NCT00572156|81095678|FG002|Overall Study|Patient/Parent Decision|4|||
27798955|NCT00572156|81095679|FG003|Overall Study|Patient/Parent Decision|3|||
27798956|NCT00572156|81095676|FG000|Overall Study|Sponsor Decision|20|||
27798957|NCT00572156|81095677|FG001|Overall Study|Sponsor Decision|16|||
27798958|NCT00572156|81095678|FG002|Overall Study|Sponsor Decision|17|||
27798959|NCT00572156|81095679|FG003|Overall Study|Sponsor Decision|19|||
27798960|NCT03669640|81095682|FG000|Overall Study|Study Terminated by Sponsor|0|||
27798961|NCT03669640|81095683|FG001|Overall Study|Study Terminated by Sponsor|0|||
27798962|NCT03669640|81095684|FG002|Overall Study|Study Terminated by Sponsor|0|||
27798963|NCT03669640|81095685|FG003|Overall Study|Study Terminated by Sponsor|0|||
27798964|NCT03669640|81095686|FG004|Overall Study|Study Terminated by Sponsor|1|||
27798965|NCT03669640|81095687|FG005|Overall Study|Study Terminated by Sponsor|0|||
27798966|NCT03669640|81095682|FG000|Overall Study|Lost to Follow-up|0|||
27798967|NCT03669640|81095683|FG001|Overall Study|Lost to Follow-up|0|||
27798968|NCT03669640|81095684|FG002|Overall Study|Lost to Follow-up|2|||
27798969|NCT03669640|81095685|FG003|Overall Study|Lost to Follow-up|0|||
27798970|NCT03669640|81095686|FG004|Overall Study|Lost to Follow-up|0|||
27798971|NCT03669640|81095687|FG005|Overall Study|Lost to Follow-up|0|||
27798972|NCT03669640|81095682|FG000|Overall Study|Death|0|||
27798973|NCT03669640|81095683|FG001|Overall Study|Death|0|||
27798974|NCT03669640|81095684|FG002|Overall Study|Death|1|||
27798975|NCT03669640|81095685|FG003|Overall Study|Death|0|||
27870771|NCT01459783|81361483|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
27870772|NCT01459783|81361484|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
27870773|NCT01459783|81361483|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
27870774|NCT01459783|81361484|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
27798976|NCT03669640|81095686|FG004|Overall Study|Death|0|||
27798977|NCT03669640|81095687|FG005|Overall Study|Death|0|||
27798978|NCT03669640|81095682|FG000|Overall Study|Withdrawal by Subject|1|||
27798979|NCT03669640|81095683|FG001|Overall Study|Withdrawal by Subject|2|||
27579315|NCT01049919|80303172|FG000|Overall Study|Early study termination by sponsor.|2|||
27798980|NCT03669640|81095684|FG002|Overall Study|Withdrawal by Subject|1|||
27798981|NCT03669640|81095685|FG003|Overall Study|Withdrawal by Subject|0|||
27798982|NCT03669640|81095686|FG004|Overall Study|Withdrawal by Subject|1|||
27798983|NCT03669640|81095687|FG005|Overall Study|Withdrawal by Subject|3|||
27798984|NCT03669640|81095682|FG000|Overall Study|Protocol Violation|1|||
27798985|NCT03669640|81095683|FG001|Overall Study|Protocol Violation|0|||
27870775|NCT01459783|81361483|FG000|6 Months to 12 Months|Death|0|||
27798986|NCT03669640|81095684|FG002|Overall Study|Protocol Violation|0|||
27798987|NCT03669640|81095685|FG003|Overall Study|Protocol Violation|0|||
27798988|NCT03669640|81095686|FG004|Overall Study|Protocol Violation|0|||
27798989|NCT03669640|81095687|FG005|Overall Study|Protocol Violation|0|||
27798990|NCT03669640|81095682|FG000|Overall Study|Physician Decision|0|||
27798991|NCT03669640|81095683|FG001|Overall Study|Physician Decision|2|||
27798992|NCT03669640|81095684|FG002|Overall Study|Physician Decision|0|||
27798993|NCT03669640|81095685|FG003|Overall Study|Physician Decision|0|||
27798994|NCT03669640|81095686|FG004|Overall Study|Physician Decision|0|||
27798995|NCT03669640|81095687|FG005|Overall Study|Physician Decision|0|||
27798996|NCT03669640|81095682|FG000|Overall Study|Disease Relapse|1|||
27798997|NCT03669640|81095683|FG001|Overall Study|Disease Relapse|0|||
27798998|NCT03669640|81095684|FG002|Overall Study|Disease Relapse|0|||
27798999|NCT03669640|81095685|FG003|Overall Study|Disease Relapse|0|||
27799000|NCT03669640|81095686|FG004|Overall Study|Disease Relapse|0|||
27799001|NCT03669640|81095687|FG005|Overall Study|Disease Relapse|0|||
27799002|NCT03669640|81095682|FG000|Overall Study|Adverse Event|2|||
27799003|NCT03669640|81095683|FG001|Overall Study|Adverse Event|1|||
27799004|NCT03669640|81095684|FG002|Overall Study|Adverse Event|0|||
27799005|NCT03669640|81095685|FG003|Overall Study|Adverse Event|0|||
27799006|NCT03669640|81095686|FG004|Overall Study|Adverse Event|1|||
27799007|NCT03669640|81095687|FG005|Overall Study|Adverse Event|0|||
27799008|NCT01875991|81095698|FG000|Overall Study|Withdrawal by Subject|6|||
27799009|NCT01875991|81095699|FG001|Overall Study|Withdrawal by Subject|6|||
27799010|NCT01875991|81095698|FG000|Overall Study|Sponsor Decision|1|||
27799011|NCT01875991|81095699|FG001|Overall Study|Sponsor Decision|0|||
27799012|NCT00828516|81095700|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
27799013|NCT00981409|81095701|FG000|Overall Study|Adverse Event|4|||
27799014|NCT00981409|81095702|FG001|Overall Study|Adverse Event|0|||
27799015|NCT00981409|81095701|FG000|Overall Study|Protocol Violation|0|||
27799016|NCT00981409|81095702|FG001|Overall Study|Protocol Violation|1|||
27799017|NCT00981409|81095701|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
27799018|NCT00981409|81095702|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
27799019|NCT02163694|81095703|FG000|Overall Study|Adverse event- related to progression|3|||
27799020|NCT02163694|81095704|FG001|Overall Study|Adverse event- related to progression|8|||
27799021|NCT02163694|81095703|FG000|Overall Study|Adverse event- not related to progression|7|||
27799022|NCT02163694|81095704|FG001|Overall Study|Adverse event- not related to progression|17|||
27799023|NCT02163694|81095703|FG000|Overall Study|Withdrew consent|8|||
27799024|NCT02163694|81095704|FG001|Overall Study|Withdrew consent|21|||
27799025|NCT02163694|81095703|FG000|Overall Study|Lost to Follow-up|1|||
27799026|NCT02163694|81095704|FG001|Overall Study|Lost to Follow-up|2|||
27799027|NCT02163694|81095703|FG000|Overall Study|Progressive disease per protocol|122|||
27799028|NCT02163694|81095704|FG001|Overall Study|Progressive disease per protocol|197|||
27799029|NCT02163694|81095703|FG000|Overall Study|Other, not specified|13|||
27799030|NCT02163694|81095704|FG001|Overall Study|Other, not specified|22|||
27799031|NCT00358670|81095708|FG000|Overall Study|Adverse Event|26|||
27799032|NCT00358670|81095709|FG001|Overall Study|Adverse Event|29|||
27799033|NCT00358670|81095708|FG000|Overall Study|Lack of Efficacy|20|||
27799034|NCT00358670|81095709|FG001|Overall Study|Lack of Efficacy|23|||
27799035|NCT00358670|81095708|FG000|Overall Study|Protocol Violation|6|||
27799036|NCT00358670|81095709|FG001|Overall Study|Protocol Violation|9|||
27799037|NCT00358670|81095708|FG000|Overall Study|Lost to Follow-up|4|||
27799038|NCT00358670|81095709|FG001|Overall Study|Lost to Follow-up|5|||
27799039|NCT00358670|81095708|FG000|Overall Study|Withdrawal by Subject|13|||
27799040|NCT00358670|81095709|FG001|Overall Study|Withdrawal by Subject|24|||
27870776|NCT01459783|81361484|FG001|6 Months to 12 Months|Death|1|||
27870777|NCT01459783|81361483|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
27870778|NCT01459783|81361484|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
27870779|NCT01459783|81361483|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
27799041|NCT00358670|81095708|FG000|Overall Study|Protocol Defined Clinical Event|0|||
27799042|NCT00358670|81095709|FG001|Overall Study|Protocol Defined Clinical Event|1|||
27870780|NCT01459783|81361484|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
27870781|NCT01459783|81361483|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
27799043|NCT00358670|81095708|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27799044|NCT00358670|81095709|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
27799045|NCT00358670|81095708|FG000|Overall Study|Administrative|153|||
27799046|NCT00358670|81095709|FG001|Overall Study|Administrative|125|||
27799047|NCT01220128|81095716|FG000|Overall Study|Progressive disease|0|||
27799048|NCT01220128|81095717|FG001|Overall Study|Progressive disease|0|||
27799049|NCT01220128|81095718|FG002|Overall Study|Progressive disease|2|||
27799050|NCT01220128|81095719|FG003|Overall Study|Progressive disease|0|||
27799051|NCT01220128|81095720|FG004|Overall Study|Progressive disease|0|||
27870782|NCT01459783|81361484|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
27870783|NCT00908544|81361485|FG000|Overall Study|Withdrawal by Subject|2|||
27870784|NCT00908544|81361486|FG001|Overall Study|Withdrawal by Subject|4|||
27991831|NCT03364309|81801995|FG016|Induction Period|Withdrawal by Subject|0|||
27991832|NCT03364309|81801996|FG017|Induction Period|Withdrawal by Subject|0|||
27991833|NCT03364309|81801997|FG018|Induction Period|Withdrawal by Subject|0|||
27991834|NCT03364309|81801979|FG000|Induction Period|Lost to Follow-up|1|||
27991835|NCT03364309|81801980|FG001|Induction Period|Lost to Follow-up|0|||
27991836|NCT03364309|81801981|FG002|Induction Period|Lost to Follow-up|0|||
27870785|NCT00908544|81361485|FG000|Overall Study|Lack of Efficacy|0|||
27870786|NCT00908544|81361486|FG001|Overall Study|Lack of Efficacy|1|||
27991837|NCT03364309|81801982|FG003|Induction Period|Lost to Follow-up|0|||
27799052|NCT01220128|81095721|FG005|Overall Study|Progressive disease|0|||
27799053|NCT01220128|81095722|FG006|Overall Study|Progressive disease|0|||
27799054|NCT01220128|81095716|FG000|Overall Study|Sponsor study termination|0|||
27799055|NCT01220128|81095717|FG001|Overall Study|Sponsor study termination|1|||
27799056|NCT01220128|81095718|FG002|Overall Study|Sponsor study termination|0|||
27799057|NCT01220128|81095719|FG003|Overall Study|Sponsor study termination|0|||
27799058|NCT01220128|81095720|FG004|Overall Study|Sponsor study termination|0|||
27799059|NCT01220128|81095721|FG005|Overall Study|Sponsor study termination|0|||
27799060|NCT01220128|81095722|FG006|Overall Study|Sponsor study termination|1|||
27870787|NCT00908544|81361485|FG000|Overall Study|Pregnancy|1|||
27991838|NCT03364309|81801983|FG004|Induction Period|Lost to Follow-up|0|||
27991839|NCT03364309|81801984|FG005|Induction Period|Lost to Follow-up|0|||
27991840|NCT03364309|81801985|FG006|Induction Period|Lost to Follow-up|0|||
27991841|NCT03364309|81801986|FG007|Induction Period|Lost to Follow-up|0|||
27991842|NCT03364309|81801987|FG008|Induction Period|Lost to Follow-up|0|||
27991843|NCT03364309|81801988|FG009|Induction Period|Lost to Follow-up|0|||
27991844|NCT03364309|81801989|FG010|Induction Period|Lost to Follow-up|0|||
27991845|NCT03364309|81801990|FG011|Induction Period|Lost to Follow-up|0|||
27991846|NCT03364309|81801991|FG012|Induction Period|Lost to Follow-up|0|||
27991847|NCT03364309|81801992|FG013|Induction Period|Lost to Follow-up|0|||
27991848|NCT03364309|81801993|FG014|Induction Period|Lost to Follow-up|0|||
27799061|NCT01220128|81095716|FG000|Overall Study|Adverse event, serious fatal|2|||
27870788|NCT00908544|81361486|FG001|Overall Study|Pregnancy|0|||
27870789|NCT00908544|81361485|FG000|Overall Study|Relocation abroad|1|||
27870790|NCT00908544|81361486|FG001|Overall Study|Relocation abroad|1|||
27870791|NCT00908544|81361485|FG000|Overall Study|Unable to visit sutdy center|1|||
27870792|NCT00908544|81361486|FG001|Overall Study|Unable to visit sutdy center|0|||
27870793|NCT04108299|81361488|FG000|Overall Study|Not interested in participating|2|||
27870794|NCT04108299|81361489|FG001|Overall Study|Not interested in participating|1|||
27870795|NCT04108299|81361490|FG002|Overall Study|Not interested in participating|2|||
27870796|NCT04108299|81361491|FG003|Overall Study|Not interested in participating|1|||
27870797|NCT03593395|81361492|FG000|Overall Study|Lost to Follow-up|48|||
27870798|NCT03593395|81361493|FG001|Overall Study|Lost to Follow-up|3|||
27870799|NCT03593395|81361492|FG000|Overall Study|Withdrawal by Subject|5|||
27870800|NCT03593395|81361493|FG001|Overall Study|Withdrawal by Subject|24|||
27870801|NCT03593395|81361492|FG000|Overall Study|Death|2|||
27991849|NCT03364309|81801994|FG015|Induction Period|Lost to Follow-up|0|||
27799062|NCT01220128|81095717|FG001|Overall Study|Adverse event, serious fatal|0|||
27799063|NCT01220128|81095718|FG002|Overall Study|Adverse event, serious fatal|0|||
27870802|NCT03593395|81361493|FG001|Overall Study|Death|3|||
27870803|NCT03593395|81361492|FG000|Overall Study|Physician Decision|0|||
27991850|NCT03364309|81801995|FG016|Induction Period|Lost to Follow-up|0|||
27991851|NCT03364309|81801996|FG017|Induction Period|Lost to Follow-up|0|||
27991852|NCT03364309|81801997|FG018|Induction Period|Lost to Follow-up|0|||
27579316|NCT01049919|80303173|FG001|Overall Study|Early study termination by sponsor.|0|||
27799064|NCT01220128|81095719|FG003|Overall Study|Adverse event, serious fatal|0|||
27870804|NCT03593395|81361493|FG001|Overall Study|Physician Decision|6|||
27991853|NCT03364309|81801979|FG000|Induction Period|Physician Decision|0|||
27991854|NCT03364309|81801980|FG001|Induction Period|Physician Decision|1|||
27991855|NCT03364309|81801981|FG002|Induction Period|Physician Decision|0|||
27991856|NCT03364309|81801982|FG003|Induction Period|Physician Decision|0|||
27991857|NCT03364309|81801983|FG004|Induction Period|Physician Decision|0|||
27991858|NCT03364309|81801984|FG005|Induction Period|Physician Decision|0|||
27991859|NCT03364309|81801985|FG006|Induction Period|Physician Decision|0|||
27991860|NCT03364309|81801986|FG007|Induction Period|Physician Decision|0|||
27991861|NCT03364309|81801987|FG008|Induction Period|Physician Decision|0|||
27799065|NCT01220128|81095720|FG004|Overall Study|Adverse event, serious fatal|0|||
27676486|NCT01888874|80653371|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27676487|NCT01888874|80653372|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27676488|NCT01888874|80653373|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
27676489|NCT01888874|80653374|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
27676490|NCT00609947|80653375|FG000|Overall Study|Death|1|||
27676491|NCT01067846|80653380|FG000|Overall Study|Lost to Follow-up|17|||
27676492|NCT01067846|80653381|FG001|Overall Study|Lost to Follow-up|19|||
27676493|NCT01067846|80653380|FG000|Overall Study|Withdrawal by Subject|1|||
27676494|NCT01067846|80653381|FG001|Overall Study|Withdrawal by Subject|0|||
27676495|NCT01067846|80653380|FG000|Overall Study|participation in other tx study|1|||
27870805|NCT03593395|81361492|FG000|Overall Study|Participant Relocated|19|||
27870806|NCT03593395|81361493|FG001|Overall Study|Participant Relocated|3|||
27870807|NCT03593395|81361492|FG000|Overall Study|No Information|1|||
27870808|NCT03593395|81361493|FG001|Overall Study|No Information|7|||
27870809|NCT03122886|81361494|FG000|Overall Study|Withdrawal by Subject|1|||
27870810|NCT03122886|81361495|FG001|Overall Study|Withdrawal by Subject|2|||
27870811|NCT01810302|81361496|FG000|Overall Study|Death|1|||
27870812|NCT01810302|81361497|FG001|Overall Study|Death|0|||
27870813|NCT01810302|81361496|FG000|Overall Study|Physician Decision|0|||
27870814|NCT01810302|81361497|FG001|Overall Study|Physician Decision|1|||
27870815|NCT01207583|81361498|FG000|Overall Study|Withdrawal by Subject|0|||
27870816|NCT01207583|81361499|FG001|Overall Study|Withdrawal by Subject|3|||
27991862|NCT03364309|81801988|FG009|Induction Period|Physician Decision|0|||
27991863|NCT03364309|81801989|FG010|Induction Period|Physician Decision|0|||
27870817|NCT01207583|81361500|FG002|Overall Study|Withdrawal by Subject|1|||
27870818|NCT01207583|81361498|FG000|Overall Study|Participant failed to return|1|||
27676496|NCT01067846|80653381|FG001|Overall Study|participation in other tx study|0|||
27799066|NCT01220128|81095721|FG005|Overall Study|Adverse event, serious fatal|0|||
27799067|NCT01220128|81095722|FG006|Overall Study|Adverse event, serious fatal|1|||
27799068|NCT01220128|81095716|FG000|Overall Study|Adverse event, non-fatal|1|||
27799069|NCT01220128|81095717|FG001|Overall Study|Adverse event, non-fatal|0|||
27799070|NCT01220128|81095718|FG002|Overall Study|Adverse event, non-fatal|0|||
27799071|NCT01220128|81095719|FG003|Overall Study|Adverse event, non-fatal|0|||
27799072|NCT01220128|81095720|FG004|Overall Study|Adverse event, non-fatal|0|||
27799073|NCT01220128|81095721|FG005|Overall Study|Adverse event, non-fatal|0|||
27799074|NCT01220128|81095722|FG006|Overall Study|Adverse event, non-fatal|3|||
27870819|NCT01207583|81361499|FG001|Overall Study|Participant failed to return|0|||
27870820|NCT01207583|81361500|FG002|Overall Study|Participant failed to return|0|||
27991864|NCT03364309|81801990|FG011|Induction Period|Physician Decision|0|||
27799075|NCT01220128|81095716|FG000|Overall Study|Other|0|||
27799076|NCT01220128|81095717|FG001|Overall Study|Other|0|||
27991865|NCT03364309|81801991|FG012|Induction Period|Physician Decision|0|||
27991866|NCT03364309|81801992|FG013|Induction Period|Physician Decision|0|||
27991867|NCT03364309|81801993|FG014|Induction Period|Physician Decision|0|||
27991868|NCT03364309|81801994|FG015|Induction Period|Physician Decision|0|||
27991869|NCT03364309|81801995|FG016|Induction Period|Physician Decision|0|||
27991870|NCT03364309|81801996|FG017|Induction Period|Physician Decision|0|||
27799077|NCT01220128|81095718|FG002|Overall Study|Other|1|||
27870821|NCT01207583|81361498|FG000|Overall Study|Lost to Follow-up|0|||
27991871|NCT03364309|81801997|FG018|Induction Period|Physician Decision|0|||
27799078|NCT01220128|81095719|FG003|Overall Study|Other|0|||
27799079|NCT01220128|81095720|FG004|Overall Study|Other|0|||
27799080|NCT01220128|81095721|FG005|Overall Study|Other|0|||
27870822|NCT01207583|81361499|FG001|Overall Study|Lost to Follow-up|2|||
27870823|NCT01207583|81361500|FG002|Overall Study|Lost to Follow-up|0|||
27870824|NCT02456740|81361505|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
27799081|NCT01220128|81095722|FG006|Overall Study|Other|0|||
27799082|NCT01220128|81095716|FG000|Overall Study|Consent withdrawn by subject|1|||
27799083|NCT01220128|81095717|FG001|Overall Study|Consent withdrawn by subject|0|||
27991872|NCT03364309|81801979|FG000|Maintenance Period|Withdrawal by Subject|0|||
27991873|NCT03364309|81801980|FG001|Maintenance Period|Withdrawal by Subject|0|||
27991874|NCT03364309|81801981|FG002|Maintenance Period|Withdrawal by Subject|0|||
27991875|NCT03364309|81801982|FG003|Maintenance Period|Withdrawal by Subject|1|||
27991876|NCT03364309|81801983|FG004|Maintenance Period|Withdrawal by Subject|3|||
27991877|NCT03364309|81801984|FG005|Maintenance Period|Withdrawal by Subject|1|||
27991878|NCT03364309|81801985|FG006|Maintenance Period|Withdrawal by Subject|3|||
27991879|NCT03364309|81801986|FG007|Maintenance Period|Withdrawal by Subject|0|||
27991880|NCT03364309|81801987|FG008|Maintenance Period|Withdrawal by Subject|1|||
27991881|NCT03364309|81801988|FG009|Maintenance Period|Withdrawal by Subject|1|||
27991882|NCT03364309|81801989|FG010|Maintenance Period|Withdrawal by Subject|2|||
27991883|NCT03364309|81801990|FG011|Maintenance Period|Withdrawal by Subject|0|||
27991884|NCT03364309|81801991|FG012|Maintenance Period|Withdrawal by Subject|0|||
27579317|NCT00087568|80303174|FG000|Overall Study|Adverse Event|4|||
27799084|NCT01220128|81095718|FG002|Overall Study|Consent withdrawn by subject|0|||
27799085|NCT01220128|81095719|FG003|Overall Study|Consent withdrawn by subject|0|||
27799086|NCT01220128|81095720|FG004|Overall Study|Consent withdrawn by subject|0|||
27799087|NCT01220128|81095721|FG005|Overall Study|Consent withdrawn by subject|0|||
27799088|NCT01220128|81095722|FG006|Overall Study|Consent withdrawn by subject|0|||
27799089|NCT01966107|81095723|FG000|Overall Study|excluded from FAS|21|||
27799090|NCT01966107|81095724|FG001|Overall Study|excluded from FAS|20|||
27799091|NCT01966107|81095723|FG000|Overall Study|discontinued treatment|345|||
27799092|NCT01966107|81095724|FG001|Overall Study|discontinued treatment|372|||
27799093|NCT01966107|81095723|FG000|Overall Study|due to study closure|164|||
27799094|NCT01966107|81095724|FG001|Overall Study|due to study closure|186|||
27799095|NCT01966107|81095723|FG000|Overall Study|withdrew from the study|272|||
27799096|NCT01966107|81095724|FG001|Overall Study|withdrew from the study|303|||
27799097|NCT00928135|81095725|FG000|Overall Study|Withdrawal by Subject|1|||
27799098|NCT00928135|81095726|FG001|Overall Study|Withdrawal by Subject|0|||
27799099|NCT01610167|81095736|FG000|Overall Study|Scheduling conflict.|0|||
27799100|NCT01610167|81095737|FG001|Overall Study|Scheduling conflict.|0|||
27799101|NCT01610167|81095738|FG002|Overall Study|Scheduling conflict.|2|||
27799102|NCT03853213|81095739|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
27799103|NCT03853213|81095740|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
27799104|NCT03853213|81095739|FG000|Overall Study|Other (e.g., too busy)|0|||
27799105|NCT03853213|81095740|FG001|Overall Study|Other (e.g., too busy)|2|||
27799106|NCT01393626|81095741|FG000|Overall Study|Adverse Event|2|||
27799107|NCT01393626|81095742|FG001|Overall Study|Adverse Event|1|||
27799108|NCT01393626|81095743|FG002|Overall Study|Adverse Event|5|||
27799109|NCT01393626|81095744|FG003|Overall Study|Adverse Event|0|||
27799110|NCT01393626|81095741|FG000|Overall Study|Did not meet entrance criteria|1|||
27799111|NCT01393626|81095742|FG001|Overall Study|Did not meet entrance criteria|0|||
27799112|NCT01393626|81095743|FG002|Overall Study|Did not meet entrance criteria|0|||
27799113|NCT01393626|81095744|FG003|Overall Study|Did not meet entrance criteria|0|||
27799114|NCT01393626|81095741|FG000|Overall Study|Lack of Efficacy|6|||
27799115|NCT01393626|81095742|FG001|Overall Study|Lack of Efficacy|6|||
27799116|NCT01393626|81095743|FG002|Overall Study|Lack of Efficacy|4|||
27799117|NCT01393626|81095744|FG003|Overall Study|Lack of Efficacy|1|||
27799118|NCT01393626|81095741|FG000|Overall Study|Lost to Follow-up|1|||
27799119|NCT01393626|81095742|FG001|Overall Study|Lost to Follow-up|1|||
27799120|NCT01393626|81095743|FG002|Overall Study|Lost to Follow-up|1|||
27799121|NCT01393626|81095744|FG003|Overall Study|Lost to Follow-up|0|||
27799122|NCT01393626|81095741|FG000|Overall Study|Withdrawal by Subject|6|||
27799123|NCT01393626|81095742|FG001|Overall Study|Withdrawal by Subject|4|||
27799124|NCT01393626|81095743|FG002|Overall Study|Withdrawal by Subject|0|||
27799125|NCT01393626|81095744|FG003|Overall Study|Withdrawal by Subject|0|||
27799126|NCT01393626|81095741|FG000|Overall Study|Other|1|||
27799127|NCT01393626|81095742|FG001|Overall Study|Other|0|||
27799128|NCT01393626|81095743|FG002|Overall Study|Other|0|||
27799129|NCT01393626|81095744|FG003|Overall Study|Other|0|||
27799130|NCT01393626|81095741|FG000|Overall Study|Protocol Violation|1|||
27799131|NCT01393626|81095742|FG001|Overall Study|Protocol Violation|0|||
27799132|NCT01393626|81095743|FG002|Overall Study|Protocol Violation|2|||
27799133|NCT01393626|81095744|FG003|Overall Study|Protocol Violation|0|||
27799134|NCT00378482|81095745|FG000|Overall Study|Lost to Follow-up|1|||
27991885|NCT03364309|81801992|FG013|Maintenance Period|Withdrawal by Subject|0|||
27799135|NCT00378482|81095745|FG000|Overall Study|Lack of Efficacy|8|||
27833146|NCT04281472|81219493|FG000|Stage A|Other|5|||
27991886|NCT03364309|81801993|FG014|Maintenance Period|Withdrawal by Subject|0|||
27991887|NCT03364309|81801994|FG015|Maintenance Period|Withdrawal by Subject|0|||
27991888|NCT03364309|81801995|FG016|Maintenance Period|Withdrawal by Subject|0|||
27991889|NCT03364309|81801996|FG017|Maintenance Period|Withdrawal by Subject|0|||
27991890|NCT03364309|81801997|FG018|Maintenance Period|Withdrawal by Subject|0|||
27991891|NCT03364309|81801979|FG000|Maintenance Period|Adverse Event|0|||
27991892|NCT03364309|81801980|FG001|Maintenance Period|Adverse Event|0|||
27991893|NCT03364309|81801981|FG002|Maintenance Period|Adverse Event|0|||
27991894|NCT03364309|81801982|FG003|Maintenance Period|Adverse Event|0|||
27991895|NCT03364309|81801983|FG004|Maintenance Period|Adverse Event|2|||
27799136|NCT00378482|81095745|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
27799137|NCT00378482|81095745|FG000|Overall Study|Withdrawal by Subject|4|||
27799138|NCT00378482|81095745|FG000|Overall Study|Adverse Event|9|||
27799139|NCT03151226|81095747|FG000|Overall Study|Withdrawal by Subject|2|||
27799140|NCT03151226|81095747|FG000|Overall Study|not wear device correctly|1|||
27799141|NCT02494583|81095755|FG000|Overall Study|Death|224|||
27799142|NCT02494583|81095756|FG001|Overall Study|Death|214|||
27799143|NCT02494583|81095757|FG002|Overall Study|Death|225|||
27799144|NCT02494583|81095755|FG000|Overall Study|Lost to Follow-up|1|||
27799145|NCT02494583|81095756|FG001|Overall Study|Lost to Follow-up|0|||
27799146|NCT02494583|81095757|FG002|Overall Study|Lost to Follow-up|0|||
27799147|NCT02494583|81095755|FG000|Overall Study|Protocol Violation|1|||
27799148|NCT02494583|81095756|FG001|Overall Study|Protocol Violation|2|||
27799149|NCT02494583|81095757|FG002|Overall Study|Protocol Violation|0|||
27799150|NCT02494583|81095755|FG000|Overall Study|Screen Failure|0|||
27799151|NCT02494583|81095756|FG001|Overall Study|Screen Failure|1|||
27799152|NCT02494583|81095757|FG002|Overall Study|Screen Failure|0|||
27676497|NCT02920970|80653387|FG000|First Intervention|Protocol Violation|0|||
27799153|NCT02494583|81095755|FG000|Overall Study|Transferred to Extension Study|15|||
27799154|NCT02494583|81095756|FG001|Overall Study|Transferred to Extension Study|15|||
27799155|NCT02494583|81095757|FG002|Overall Study|Transferred to Extension Study|6|||
27799156|NCT02494583|81095755|FG000|Overall Study|Did Not Continue on Extension Study|8|||
27799157|NCT02494583|81095756|FG001|Overall Study|Did Not Continue on Extension Study|10|||
27799158|NCT02494583|81095757|FG002|Overall Study|Did Not Continue on Extension Study|4|||
27799159|NCT02494583|81095755|FG000|Overall Study|Withdrawal by Subject|7|||
27799160|NCT02494583|81095756|FG001|Overall Study|Withdrawal by Subject|15|||
27799161|NCT02494583|81095757|FG002|Overall Study|Withdrawal by Subject|15|||
27799162|NCT01965431|81095762|FG000|Overall Study|Adverse Event|0|||
27799163|NCT01965431|81095763|FG001|Overall Study|Adverse Event|1|||
27799164|NCT01965431|81095764|FG002|Overall Study|Adverse Event|0|||
27799165|NCT01965431|81095765|FG003|Overall Study|Adverse Event|0|||
27799166|NCT01965431|81095766|FG004|Overall Study|Adverse Event|0|||
27799167|NCT01965431|81095767|FG005|Overall Study|Adverse Event|0|||
27799168|NCT01965431|81095762|FG000|Overall Study|Other than stated above|6|||
27799169|NCT01965431|81095763|FG001|Overall Study|Other than stated above|5|||
27991896|NCT03364309|81801984|FG005|Maintenance Period|Adverse Event|0|||
27579318|NCT00087568|80303175|FG001|Overall Study|Adverse Event|0|||
27579319|NCT00087568|80303174|FG000|Overall Study|Withdrawal by Subject|1|||
27579320|NCT00087568|80303175|FG001|Overall Study|Withdrawal by Subject|1|||
27579321|NCT00087568|80303174|FG000|Overall Study|Lost to Follow-up|1|||
27676498|NCT02920970|80653388|FG001|First Intervention|Protocol Violation|1|||
27676499|NCT02920970|80653387|FG000|First Intervention|Adverse Event|0|||
27799170|NCT01965431|81095764|FG002|Overall Study|Other than stated above|6|||
27799171|NCT01965431|81095765|FG003|Overall Study|Other than stated above|6|||
27799172|NCT01965431|81095766|FG004|Overall Study|Other than stated above|6|||
27799173|NCT01965431|81095767|FG005|Overall Study|Other than stated above|6|||
27799174|NCT00965263|81095768|FG000|Overall Study|Physician Decision|2|||
27799175|NCT00965263|81095769|FG001|Overall Study|Physician Decision|0|||
27799176|NCT00965263|81095768|FG000|Overall Study|Family emergency|0|||
27799177|NCT00965263|81095769|FG001|Overall Study|Family emergency|1|||
27799178|NCT00965263|81095768|FG000|Overall Study|Protocol Violation|0|||
27799179|NCT00965263|81095769|FG001|Overall Study|Protocol Violation|2|||
27799180|NCT02050373|81095770|FG000|Overall Study|Adverse Event|4|||
27799181|NCT02050373|81095771|FG001|Overall Study|Adverse Event|7|||
27991897|NCT03364309|81801985|FG006|Maintenance Period|Adverse Event|3|||
27991898|NCT03364309|81801986|FG007|Maintenance Period|Adverse Event|0|||
27799182|NCT02050373|81095770|FG000|Overall Study|Death|3|||
27799183|NCT02050373|81095771|FG001|Overall Study|Death|3|||
27799184|NCT01066039|81095773|FG000|Overall Study|Adverse Event|6|||
27799185|NCT01066039|81095773|FG000|Overall Study|Withdrawal by Subject|17|||
27799186|NCT01066039|81095773|FG000|Overall Study|Protocol Violation|2|||
27799187|NCT01066039|81095773|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
27799188|NCT01066039|81095773|FG000|Overall Study|Investigator's Request|1|||
27799189|NCT01066039|81095773|FG000|Overall Study|Dropout due to Insulin Administration|1|||
27799190|NCT01066039|81095773|FG000|Overall Study|Additional Antihypertensive Required|4|||
27799191|NCT01066039|81095773|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
27799192|NCT01066039|81095773|FG000|Overall Study|Failure to Control Blood Pressure|1|||
27799193|NCT01066039|81095773|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
27799194|NCT00656019|81095774|FG000|Overall Study|Not Eligible|10|||
27799195|NCT00656019|81095775|FG001|Overall Study|Not Eligible|0|||
27799196|NCT00656019|81095776|FG002|Overall Study|Not Eligible|0|||
27799197|NCT00656019|81095777|FG003|Overall Study|Not Eligible|0|||
27799198|NCT00656019|81095774|FG000|Overall Study|Withdrawal by Subject|2|||
27799199|NCT00656019|81095775|FG001|Overall Study|Withdrawal by Subject|0|||
27870825|NCT02456740|81361506|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
27870826|NCT02456740|81361507|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
27579322|NCT00087568|80303175|FG001|Overall Study|Lost to Follow-up|0|||
27579323|NCT00087568|80303174|FG000|Overall Study|Lack of Efficacy|24|||
27579324|NCT00087568|80303175|FG001|Overall Study|Lack of Efficacy|1|||
27579325|NCT01968434|80303180|FG000|Overall Study|Lost to Follow-up|3|||
27579326|NCT01968434|80303181|FG001|Overall Study|Lost to Follow-up|6|||
27579327|NCT03120624|80303182|FG000|Overall Study|Withdrawal by Subject|0|||
27799200|NCT00656019|81095776|FG002|Overall Study|Withdrawal by Subject|0|||
27799201|NCT00656019|81095777|FG003|Overall Study|Withdrawal by Subject|0|||
27799202|NCT00656019|81095774|FG000|Overall Study|Lost to Follow-up|2|||
27799203|NCT00656019|81095775|FG001|Overall Study|Lost to Follow-up|1|||
27579328|NCT03120624|80303183|FG001|Overall Study|Withdrawal by Subject|1|||
27579329|NCT03120624|80303184|FG002|Overall Study|Withdrawal by Subject|0|||
27579330|NCT03120624|80303185|FG003|Overall Study|Withdrawal by Subject|0|||
27799204|NCT00656019|81095776|FG002|Overall Study|Lost to Follow-up|0|||
27799205|NCT00656019|81095777|FG003|Overall Study|Lost to Follow-up|0|||
27799206|NCT03343054|81095780|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
27799207|NCT03343054|81095781|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
27799208|NCT03343054|81095782|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
27799209|NCT03343054|81095780|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
27799210|NCT03343054|81095781|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
27799211|NCT03343054|81095782|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
27799212|NCT03343054|81095780|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
27991899|NCT03364309|81801987|FG008|Maintenance Period|Adverse Event|1|||
27991900|NCT03364309|81801988|FG009|Maintenance Period|Adverse Event|0|||
27799213|NCT03343054|81095781|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
27799214|NCT03343054|81095782|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
27799215|NCT03343054|81095780|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
27799216|NCT03343054|81095781|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
27991901|NCT03364309|81801989|FG010|Maintenance Period|Adverse Event|2|||
27991902|NCT03364309|81801990|FG011|Maintenance Period|Adverse Event|0|||
27991903|NCT03364309|81801991|FG012|Maintenance Period|Adverse Event|0|||
27991904|NCT03364309|81801992|FG013|Maintenance Period|Adverse Event|0|||
27991905|NCT03364309|81801993|FG014|Maintenance Period|Adverse Event|0|||
27991906|NCT03364309|81801994|FG015|Maintenance Period|Adverse Event|0|||
27991907|NCT03364309|81801995|FG016|Maintenance Period|Adverse Event|0|||
27991908|NCT03364309|81801996|FG017|Maintenance Period|Adverse Event|0|||
27991909|NCT03364309|81801997|FG018|Maintenance Period|Adverse Event|0|||
27991910|NCT03364309|81801979|FG000|Maintenance Period|Relapsed|0|||
27991911|NCT03364309|81801980|FG001|Maintenance Period|Relapsed|0|||
27991912|NCT03364309|81801981|FG002|Maintenance Period|Relapsed|0|||
27991913|NCT03364309|81801982|FG003|Maintenance Period|Relapsed|43|||
27991914|NCT03364309|81801983|FG004|Maintenance Period|Relapsed|7|||
27991915|NCT03364309|81801984|FG005|Maintenance Period|Relapsed|45|||
27991916|NCT03364309|81801985|FG006|Maintenance Period|Relapsed|10|||
27991917|NCT03364309|81801986|FG007|Maintenance Period|Relapsed|2|||
27991918|NCT03364309|81801987|FG008|Maintenance Period|Relapsed|0|||
27991919|NCT03364309|81801988|FG009|Maintenance Period|Relapsed|0|||
27991920|NCT03364309|81801989|FG010|Maintenance Period|Relapsed|0|||
27991921|NCT03364309|81801990|FG011|Maintenance Period|Relapsed|0|||
27991922|NCT03364309|81801991|FG012|Maintenance Period|Relapsed|0|||
27991923|NCT03364309|81801992|FG013|Maintenance Period|Relapsed|0|||
27579331|NCT03120624|80303186|FG004|Overall Study|Withdrawal by Subject|0|||
27799217|NCT03343054|81095782|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
27991924|NCT03364309|81801993|FG014|Maintenance Period|Relapsed|0|||
27991925|NCT03364309|81801994|FG015|Maintenance Period|Relapsed|0|||
27991926|NCT03364309|81801995|FG016|Maintenance Period|Relapsed|0|||
27991927|NCT03364309|81801996|FG017|Maintenance Period|Relapsed|0|||
27991928|NCT03364309|81801997|FG018|Maintenance Period|Relapsed|0|||
27870827|NCT02456740|81361508|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27870828|NCT02456740|81361509|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27870829|NCT02456740|81361510|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27870830|NCT02456740|81361511|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27870831|NCT02456740|81361512|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27870832|NCT02456740|81361513|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
27870833|NCT02456740|81361505|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
27870834|NCT02456740|81361506|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
27870835|NCT02456740|81361507|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
27870836|NCT02456740|81361508|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27991929|NCT03364309|81801979|FG000|Maintenance Period|Lack of Efficacy|0|||
27991930|NCT03364309|81801980|FG001|Maintenance Period|Lack of Efficacy|0|||
27991931|NCT03364309|81801981|FG002|Maintenance Period|Lack of Efficacy|0|||
27991932|NCT03364309|81801982|FG003|Maintenance Period|Lack of Efficacy|0|||
27991933|NCT03364309|81801983|FG004|Maintenance Period|Lack of Efficacy|0|||
27991934|NCT03364309|81801984|FG005|Maintenance Period|Lack of Efficacy|0|||
27991935|NCT03364309|81801985|FG006|Maintenance Period|Lack of Efficacy|0|||
27991936|NCT03364309|81801986|FG007|Maintenance Period|Lack of Efficacy|0|||
27991937|NCT03364309|81801987|FG008|Maintenance Period|Lack of Efficacy|1|||
27991938|NCT03364309|81801988|FG009|Maintenance Period|Lack of Efficacy|3|||
27991939|NCT03364309|81801989|FG010|Maintenance Period|Lack of Efficacy|2|||
27991940|NCT03364309|81801990|FG011|Maintenance Period|Lack of Efficacy|0|||
27991941|NCT03364309|81801991|FG012|Maintenance Period|Lack of Efficacy|0|||
27991942|NCT03364309|81801992|FG013|Maintenance Period|Lack of Efficacy|0|||
27991943|NCT03364309|81801993|FG014|Maintenance Period|Lack of Efficacy|0|||
27991944|NCT03364309|81801994|FG015|Maintenance Period|Lack of Efficacy|0|||
27991945|NCT03364309|81801995|FG016|Maintenance Period|Lack of Efficacy|0|||
27991946|NCT03364309|81801996|FG017|Maintenance Period|Lack of Efficacy|0|||
27991947|NCT03364309|81801997|FG018|Maintenance Period|Lack of Efficacy|0|||
27991948|NCT03364309|81801979|FG000|Maintenance Period|Death|0|||
27991949|NCT03364309|81801980|FG001|Maintenance Period|Death|0|||
27991950|NCT03364309|81801981|FG002|Maintenance Period|Death|0|||
27991951|NCT03364309|81801982|FG003|Maintenance Period|Death|0|||
27991952|NCT03364309|81801983|FG004|Maintenance Period|Death|0|||
27991953|NCT03364309|81801984|FG005|Maintenance Period|Death|0|||
27991954|NCT03364309|81801985|FG006|Maintenance Period|Death|0|||
27991955|NCT03364309|81801986|FG007|Maintenance Period|Death|0|||
27991956|NCT03364309|81801987|FG008|Maintenance Period|Death|1|||
27991957|NCT03364309|81801988|FG009|Maintenance Period|Death|0|||
27991958|NCT03364309|81801989|FG010|Maintenance Period|Death|0|||
27991959|NCT03364309|81801990|FG011|Maintenance Period|Death|0|||
27991960|NCT03364309|81801991|FG012|Maintenance Period|Death|0|||
27991961|NCT03364309|81801992|FG013|Maintenance Period|Death|0|||
27676500|NCT02920970|80653388|FG001|First Intervention|Adverse Event|1|||
27676501|NCT02920970|80653387|FG000|Second Intervention|Poor Lens Fit|1|||
27870837|NCT02456740|81361509|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27870838|NCT02456740|81361510|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27870839|NCT02456740|81361511|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27870840|NCT02456740|81361512|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27870841|NCT02456740|81361513|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
27870842|NCT02456740|81361505|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
27870843|NCT02456740|81361506|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
27870844|NCT02456740|81361507|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
27870845|NCT02456740|81361508|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27870846|NCT02456740|81361509|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27870847|NCT02456740|81361510|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27870848|NCT02456740|81361511|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27870849|NCT02456740|81361512|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27870850|NCT02456740|81361513|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
27870851|NCT02456740|81361505|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27870852|NCT02456740|81361506|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27886630|NCT01938430|81418141|FG005|Overall Study|Randomized but Not Treated|0|||
27991962|NCT03364309|81801993|FG014|Maintenance Period|Death|0|||
27991963|NCT03364309|81801994|FG015|Maintenance Period|Death|0|||
27991964|NCT03364309|81801995|FG016|Maintenance Period|Death|0|||
27991965|NCT03364309|81801996|FG017|Maintenance Period|Death|0|||
27991966|NCT03364309|81801997|FG018|Maintenance Period|Death|0|||
27991967|NCT03364309|81801979|FG000|Maintenance Period|Lost to Follow-up|0|||
27991968|NCT03364309|81801980|FG001|Maintenance Period|Lost to Follow-up|0|||
27991969|NCT03364309|81801981|FG002|Maintenance Period|Lost to Follow-up|0|||
27991970|NCT03364309|81801982|FG003|Maintenance Period|Lost to Follow-up|0|||
27991971|NCT03364309|81801983|FG004|Maintenance Period|Lost to Follow-up|0|||
27991972|NCT03364309|81801984|FG005|Maintenance Period|Lost to Follow-up|0|||
27676502|NCT02920970|80653388|FG001|Second Intervention|Poor Lens Fit|0|||
27676503|NCT03019640|80653391|FG000|Overall Study|Screen Failures|4|||
27676504|NCT03019640|80653391|FG000|Overall Study|Adverse Event|3|||
27676505|NCT03019640|80653391|FG000|Overall Study|Participant Relapsed|1|||
27676506|NCT01483144|80653395|FG000|Overall Study|Adverse Event|9|||
27676507|NCT01483144|80653396|FG001|Overall Study|Adverse Event|4|||
27676508|NCT01483144|80653397|FG002|Overall Study|Adverse Event|6|||
27676509|NCT01483144|80653395|FG000|Overall Study|Withdrawal by Subject|0|||
27676510|NCT01483144|80653396|FG001|Overall Study|Withdrawal by Subject|2|||
27676511|NCT01483144|80653397|FG002|Overall Study|Withdrawal by Subject|5|||
27676512|NCT01483144|80653395|FG000|Overall Study|Physician Decision|1|||
27676513|NCT01483144|80653396|FG001|Overall Study|Physician Decision|0|||
27676514|NCT01483144|80653397|FG002|Overall Study|Physician Decision|0|||
27676515|NCT01483144|80653395|FG000|Overall Study|Lost to Follow-up|2|||
27676516|NCT01483144|80653396|FG001|Overall Study|Lost to Follow-up|4|||
27676517|NCT01483144|80653397|FG002|Overall Study|Lost to Follow-up|1|||
27676518|NCT01483144|80653395|FG000|Overall Study|Protocol Violation|3|||
27676519|NCT01483144|80653396|FG001|Overall Study|Protocol Violation|3|||
27676520|NCT01483144|80653397|FG002|Overall Study|Protocol Violation|3|||
27676521|NCT01754753|80653398|FG000|Overall Study|Study close|43|||
27676522|NCT01754753|80653399|FG001|Overall Study|Study close|44|||
27676523|NCT01754753|80653398|FG000|Overall Study|Lost to Follow-up|9|||
27676524|NCT01754753|80653399|FG001|Overall Study|Lost to Follow-up|5|||
27799218|NCT04939701|81095786|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
27799219|NCT04939701|81095787|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
27799220|NCT04939701|81095788|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
27799221|NCT04939701|81095786|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
27799222|NCT04939701|81095787|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
27870853|NCT02456740|81361507|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27870854|NCT02456740|81361508|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
27870855|NCT02456740|81361509|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
27870856|NCT02456740|81361510|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27870857|NCT02456740|81361511|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27870858|NCT02456740|81361512|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
27870859|NCT02456740|81361513|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
27870860|NCT02456740|81361505|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27870861|NCT02456740|81361506|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27870862|NCT02456740|81361507|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27870863|NCT02456740|81361508|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
27870864|NCT02456740|81361509|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
27870865|NCT02456740|81361510|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
27870866|NCT02456740|81361511|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
27870867|NCT02456740|81361512|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
27870868|NCT02456740|81361513|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
27870869|NCT02456740|81361505|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27870870|NCT02456740|81361506|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27870871|NCT02456740|81361507|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27870872|NCT02456740|81361508|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27870873|NCT02456740|81361509|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27870874|NCT02456740|81361510|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27991973|NCT03364309|81801985|FG006|Maintenance Period|Lost to Follow-up|0|||
27676525|NCT00757627|80653403|FG000|Overall Study|Adverse Event|15|||
27799223|NCT04939701|81095788|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
27799224|NCT04939701|81095786|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
27799225|NCT04939701|81095787|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
27799226|NCT04939701|81095788|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
27799227|NCT04939701|81095786|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
27799228|NCT04939701|81095787|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
27870875|NCT02456740|81361511|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27991974|NCT03364309|81801986|FG007|Maintenance Period|Lost to Follow-up|0|||
27676526|NCT00757627|80653403|FG000|Overall Study|Lack of Efficacy|10|||
27676527|NCT00757627|80653403|FG000|Overall Study|Lost to Follow-up|28|||
27676528|NCT00757627|80653403|FG000|Overall Study|Withdrawal by Subject|27|||
27676529|NCT00757627|80653403|FG000|Overall Study|Other|1|||
27676530|NCT03197766|80653414|FG000|Overall Study|Withdrawal by Subject|2|||
27676531|NCT03197766|80653415|FG001|Overall Study|Withdrawal by Subject|0|||
27676532|NCT00581477|80653419|FG000|Overall Study|Physician Decision|2|||
27799229|NCT04939701|81095788|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
27799230|NCT04939701|81095786|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
27676533|NCT01454739|80653420|FG000|Overall Study|Protocol Violation|2|||
27676534|NCT01454739|80653421|FG001|Overall Study|Protocol Violation|3|||
27676535|NCT01454739|80653420|FG000|Overall Study|Withdrawal by Subject|2|||
27676536|NCT01454739|80653421|FG001|Overall Study|Withdrawal by Subject|6|||
27676537|NCT01454739|80653420|FG000|Overall Study|Other|3|||
27676538|NCT01454739|80653421|FG001|Overall Study|Other|5|||
27676539|NCT01454739|80653420|FG000|Overall Study|Physician Decision|0|||
27676540|NCT01454739|80653421|FG001|Overall Study|Physician Decision|5|||
27676541|NCT01454739|80653420|FG000|Overall Study|Lost to Follow-up|0|||
27676542|NCT01454739|80653421|FG001|Overall Study|Lost to Follow-up|1|||
27676543|NCT01454739|80653420|FG000|Overall Study|Adverse Event|0|||
27676544|NCT01454739|80653421|FG001|Overall Study|Adverse Event|1|||
27676545|NCT03834519|80653424|FG000|Overall Study|Ongoing|234|||
27676546|NCT03834519|80653425|FG001|Overall Study|Ongoing|111|||
27676547|NCT03834519|80653424|FG000|Overall Study|Withdrawal by Subject|4|||
27676548|NCT03834519|80653425|FG001|Overall Study|Withdrawal by Subject|7|||
27799231|NCT04939701|81095787|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
27799232|NCT04939701|81095788|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
27799233|NCT04939701|81095786|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
27799234|NCT04939701|81095787|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
27799235|NCT04939701|81095788|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
27799236|NCT04939701|81095786|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
27799237|NCT04939701|81095787|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
27799238|NCT04939701|81095788|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
27799239|NCT05553600|81095789|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
27799240|NCT05553600|81095790|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
27799241|NCT05553600|81095791|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
27799242|NCT05553600|81095792|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
27799243|NCT05553600|81095789|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
27799244|NCT05553600|81095790|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
27799245|NCT05553600|81095791|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
27799246|NCT05553600|81095792|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
27799247|NCT05553600|81095789|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
27799248|NCT05553600|81095790|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
27991975|NCT03364309|81801987|FG008|Maintenance Period|Lost to Follow-up|1|||
27991976|NCT03364309|81801988|FG009|Maintenance Period|Lost to Follow-up|0|||
27991977|NCT03364309|81801989|FG010|Maintenance Period|Lost to Follow-up|0|||
27991978|NCT03364309|81801990|FG011|Maintenance Period|Lost to Follow-up|0|||
27991979|NCT03364309|81801991|FG012|Maintenance Period|Lost to Follow-up|0|||
27991980|NCT03364309|81801992|FG013|Maintenance Period|Lost to Follow-up|0|||
27991981|NCT03364309|81801993|FG014|Maintenance Period|Lost to Follow-up|0|||
27991982|NCT03364309|81801994|FG015|Maintenance Period|Lost to Follow-up|0|||
27991983|NCT03364309|81801995|FG016|Maintenance Period|Lost to Follow-up|0|||
27991984|NCT03364309|81801996|FG017|Maintenance Period|Lost to Follow-up|0|||
27991985|NCT03364309|81801997|FG018|Maintenance Period|Lost to Follow-up|0|||
27991986|NCT03364309|81801979|FG000|Maintenance Period|Miscellaneous|0|||
27676549|NCT03834519|80653424|FG000|Overall Study|Death|291|||
27676550|NCT03834519|80653425|FG001|Overall Study|Death|146|||
27676551|NCT01217437|80653426|FG000|Overall Study|Adverse Event|0|||
27676552|NCT01217437|80653427|FG001|Overall Study|Adverse Event|8|||
27676553|NCT01217437|80653426|FG000|Overall Study|Death|5|||
27676554|NCT01217437|80653427|FG001|Overall Study|Death|0|||
27676555|NCT01217437|80653426|FG000|Overall Study|Lack of Efficacy|29|||
27676556|NCT01217437|80653427|FG001|Overall Study|Lack of Efficacy|25|||
27676557|NCT01217437|80653426|FG000|Overall Study|Physician Decision|8|||
27676558|NCT01217437|80653427|FG001|Overall Study|Physician Decision|5|||
27676559|NCT01217437|80653426|FG000|Overall Study|Withdrawal by Subject|0|||
27676560|NCT01217437|80653427|FG001|Overall Study|Withdrawal by Subject|2|||
27676561|NCT01217437|80653426|FG000|Overall Study|Ineligible|1|||
27676562|NCT01217437|80653427|FG001|Overall Study|Ineligible|1|||
27676563|NCT03274453|80653428|FG000|Overall Study|Lost to Follow-up|2|||
27676564|NCT03274453|80653429|FG001|Overall Study|Lost to Follow-up|5|||
27676565|NCT03274453|80653430|FG002|Overall Study|Lost to Follow-up|4|||
27676566|NCT03274453|80653431|FG003|Overall Study|Lost to Follow-up|1|||
27676567|NCT03274453|80653428|FG000|Overall Study|Physician Decision|2|||
27799249|NCT05553600|81095791|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
27676568|NCT03274453|80653429|FG001|Overall Study|Physician Decision|0|||
27676569|NCT03274453|80653430|FG002|Overall Study|Physician Decision|0|||
27676570|NCT03274453|80653431|FG003|Overall Study|Physician Decision|3|||
27676571|NCT03274453|80653428|FG000|Overall Study|Surgery Cancelled|0|||
27676572|NCT03274453|80653429|FG001|Overall Study|Surgery Cancelled|1|||
27676573|NCT03274453|80653430|FG002|Overall Study|Surgery Cancelled|0|||
27676574|NCT03274453|80653431|FG003|Overall Study|Surgery Cancelled|0|||
27676575|NCT03238963|80653434|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
27676576|NCT03238963|80653435|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
27676577|NCT03238963|80653434|FG000|Overall Study|Withdrawal by Subject|1|||
27833147|NCT04281472|81219494|FG001|Stage A|Other|0|||
27676578|NCT03238963|80653435|FG001|Overall Study|Withdrawal by Subject|1|||
27676579|NCT03238963|80653434|FG000|Overall Study|Lost to Follow-up|1|||
27676580|NCT03238963|80653435|FG001|Overall Study|Lost to Follow-up|0|||
27676581|NCT03238963|80653434|FG000|Overall Study|Protocol Violation|1|||
27676582|NCT03238963|80653435|FG001|Overall Study|Protocol Violation|1|||
27676583|NCT03238963|80653434|FG000|Overall Study|Adverse Event|1|||
27676584|NCT03238963|80653435|FG001|Overall Study|Adverse Event|0|||
27799250|NCT05553600|81095792|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
27799251|NCT05553600|81095789|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
27799252|NCT05553600|81095790|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
27799253|NCT05553600|81095791|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
27870876|NCT02456740|81361512|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
27870877|NCT02456740|81361513|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
27870878|NCT02456740|81361505|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27870879|NCT02456740|81361506|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27870880|NCT02456740|81361507|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27870881|NCT02456740|81361508|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
27870882|NCT02456740|81361509|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
27870883|NCT02456740|81361510|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
27870884|NCT02456740|81361511|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
27870885|NCT02456740|81361512|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
27870886|NCT02456740|81361513|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
27870887|NCT02548832|81361517|FG000|Overall Study|Lost to Follow-up|2|||
27870888|NCT02548832|81361518|FG001|Overall Study|Lost to Follow-up|2|||
27870889|NCT02548832|81361519|FG002|Overall Study|Lost to Follow-up|2|||
27870890|NCT01289678|81361520|FG000|Overall Study|Physician Decision|6|||
27870891|NCT01626690|81361521|FG000|Overall Study|Protocol Violation|1|||
27799254|NCT05553600|81095792|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
27799255|NCT05553600|81095789|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
27870892|NCT01626690|81361522|FG001|Overall Study|Protocol Violation|0|||
27870893|NCT01626690|81361521|FG000|Overall Study|Adverse Event|1|||
27870894|NCT01626690|81361522|FG001|Overall Study|Adverse Event|0|||
27870895|NCT02126826|81361523|FG000|Overall Study|Withdrawal by Subject|0|||
27870896|NCT02126826|81361524|FG001|Overall Study|Withdrawal by Subject|0|||
27870897|NCT02126826|81361525|FG002|Overall Study|Withdrawal by Subject|0|||
27870898|NCT02126826|81361526|FG003|Overall Study|Withdrawal by Subject|1|||
27870899|NCT02126826|81361527|FG004|Overall Study|Withdrawal by Subject|0|||
27870900|NCT02126826|81361528|FG005|Overall Study|Withdrawal by Subject|0|||
27870901|NCT02126826|81361529|FG006|Overall Study|Withdrawal by Subject|0|||
27991987|NCT03364309|81801980|FG001|Maintenance Period|Miscellaneous|0|||
27991988|NCT03364309|81801981|FG002|Maintenance Period|Miscellaneous|0|||
27991989|NCT03364309|81801982|FG003|Maintenance Period|Miscellaneous|0|||
27991990|NCT03364309|81801983|FG004|Maintenance Period|Miscellaneous|0|||
27991991|NCT03364309|81801984|FG005|Maintenance Period|Miscellaneous|0|||
27991992|NCT03364309|81801985|FG006|Maintenance Period|Miscellaneous|0|||
27991993|NCT03364309|81801986|FG007|Maintenance Period|Miscellaneous|0|||
27991994|NCT03364309|81801987|FG008|Maintenance Period|Miscellaneous|1|||
27676585|NCT01658020|80653436|FG000|Overall Study|Adverse Event|3|||
27799256|NCT05553600|81095790|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
27799257|NCT05553600|81095791|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
27799258|NCT05553600|81095792|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
27799259|NCT05553600|81095789|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
27799260|NCT05553600|81095790|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
27799261|NCT05553600|81095791|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
27799262|NCT05553600|81095792|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
27799263|NCT05553600|81095789|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
27799264|NCT05553600|81095790|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
27799265|NCT05553600|81095791|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
27799266|NCT05553600|81095792|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
27799267|NCT05553600|81095789|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
27799268|NCT05553600|81095790|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
27991995|NCT03364309|81801988|FG009|Maintenance Period|Miscellaneous|0|||
27991996|NCT03364309|81801989|FG010|Maintenance Period|Miscellaneous|0|||
27991997|NCT03364309|81801990|FG011|Maintenance Period|Miscellaneous|0|||
27676586|NCT01658020|80653437|FG001|Overall Study|Adverse Event|3|||
27799269|NCT05553600|81095791|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
27799270|NCT05553600|81095792|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
27870902|NCT00768248|81361530|FG000|Overall Study|Research coordinator didn't collect data|1|||
27870903|NCT00768248|81361531|FG001|Overall Study|Research coordinator didn't collect data|1|||
27870904|NCT01153425|81361544|FG000|Overall Study|Withdrawal by Subject|3|||
27870905|NCT01153425|81361545|FG001|Overall Study|Withdrawal by Subject|3|||
27676587|NCT01658020|80653436|FG000|Overall Study|Lost to Follow-up|1|||
27676588|NCT01658020|80653437|FG001|Overall Study|Lost to Follow-up|0|||
27676589|NCT01658020|80653436|FG000|Overall Study|Withdrawal by Subject|4|||
27676590|NCT01658020|80653437|FG001|Overall Study|Withdrawal by Subject|5|||
27676591|NCT01658020|80653436|FG000|Overall Study|Protocol Violation|0|||
27676592|NCT01658020|80653437|FG001|Overall Study|Protocol Violation|1|||
27676593|NCT03768336|80653438|FG000|Overall Study|Lost to Follow-up|3|||
27676594|NCT03768336|80653439|FG001|Overall Study|Lost to Follow-up|2|||
27676595|NCT03768336|80653438|FG000|Overall Study|Became Ineligible|2|||
27676596|NCT03768336|80653439|FG001|Overall Study|Became Ineligible|0|||
27676597|NCT03768336|80653438|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
27676598|NCT03768336|80653439|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
27676599|NCT03768336|80653438|FG000|Overall Study|Missed final survey (post-treatment|0|||
27676600|NCT03768336|80653439|FG001|Overall Study|Missed final survey (post-treatment|1|||
27676601|NCT00935532|80653440|FG000|Overall Study|Adverse Event|11|||
27676602|NCT00935532|80653441|FG001|Overall Study|Adverse Event|6|||
27676603|NCT00935532|80653440|FG000|Overall Study|Death|1|||
27676604|NCT00935532|80653441|FG001|Overall Study|Death|0|||
27676605|NCT00935532|80653440|FG000|Overall Study|Lost to Follow-up|1|||
27676606|NCT00935532|80653441|FG001|Overall Study|Lost to Follow-up|0|||
27676607|NCT00935532|80653440|FG000|Overall Study|Physician Decision|1|||
27676608|NCT00935532|80653441|FG001|Overall Study|Physician Decision|2|||
27676609|NCT00935532|80653440|FG000|Overall Study|Protocol Violation|2|||
27676610|NCT00935532|80653441|FG001|Overall Study|Protocol Violation|1|||
27676611|NCT00935532|80653440|FG000|Overall Study|Subject Decision|2|||
27676612|NCT00935532|80653441|FG001|Overall Study|Subject Decision|1|||
27676613|NCT00935532|80653440|FG000|Overall Study|Sponsor Decision|0|||
27676614|NCT00935532|80653441|FG001|Overall Study|Sponsor Decision|1|||
27676615|NCT00935532|80653440|FG000|Overall Study|Loss Glucose Control|4|||
27676616|NCT00935532|80653441|FG001|Overall Study|Loss Glucose Control|0|||
27676617|NCT02879383|80653442|FG000|First 24 Weeks|Physician Decision|0|||
27676618|NCT02879383|80653443|FG001|First 24 Weeks|Physician Decision|1|||
27676619|NCT02879383|80653444|FG002|First 24 Weeks|Physician Decision|0|||
27676620|NCT02879383|80653445|FG003|First 24 Weeks|Physician Decision|0|||
27676621|NCT05186311|80653446|FG000|Part A: Serum|Withdrawal by Subject|1|||
27676622|NCT00486252|80653452|FG000|Overall Study|Adverse Event|7|||
27676623|NCT00486252|80653452|FG000|Overall Study|Lack of Efficacy|9|||
27676624|NCT00486252|80653452|FG000|Overall Study|Lost to Follow-up|24|||
27676625|NCT00486252|80653452|FG000|Overall Study|Other|18|||
27676626|NCT01825798|80653456|FG000|Overall Study|Adverse Event|1|||
27676627|NCT01825798|80653457|FG001|Overall Study|Adverse Event|5|||
27676628|NCT01825798|80653456|FG000|Overall Study|Lost to Follow-up|1|||
27676629|NCT01825798|80653457|FG001|Overall Study|Lost to Follow-up|0|||
27676630|NCT01564277|80653460|FG000|Overall Study|Protocol Violation|0|||
27676631|NCT01564277|80653461|FG001|Overall Study|Protocol Violation|1|||
27676632|NCT01564277|80653460|FG000|Overall Study|Physician Decision|1|||
27676633|NCT01564277|80653461|FG001|Overall Study|Physician Decision|0|||
27676634|NCT00402051|80653462|FG000|Overall Study|Progressive Disease|13|||
27676635|NCT00402051|80653463|FG001|Overall Study|Progressive Disease|20|||
27676636|NCT00402051|80653462|FG000|Overall Study|Adverse Event|11|||
27676637|NCT00402051|80653463|FG001|Overall Study|Adverse Event|4|||
27676638|NCT00402051|80653462|FG000|Overall Study|Physician Decision|7|||
27676639|NCT00402051|80653463|FG001|Overall Study|Physician Decision|3|||
27676640|NCT00402051|80653462|FG000|Overall Study|Withdrawal by Subject|3|||
27676641|NCT00402051|80653463|FG001|Overall Study|Withdrawal by Subject|3|||
27676642|NCT00402051|80653462|FG000|Overall Study|Death - Related to Study Drug|1|||
27676643|NCT00402051|80653463|FG001|Overall Study|Death - Related to Study Drug|2|||
27676644|NCT00402051|80653462|FG000|Overall Study|Death Due to Study Disease|2|||
27676645|NCT00402051|80653463|FG001|Overall Study|Death Due to Study Disease|1|||
27676646|NCT00402051|80653462|FG000|Overall Study|Death Due to Adverse Event|0|||
27676647|NCT00402051|80653463|FG001|Overall Study|Death Due to Adverse Event|2|||
27676648|NCT00402051|80653462|FG000|Overall Study|Lost to Follow-up|1|||
27676649|NCT00402051|80653463|FG001|Overall Study|Lost to Follow-up|0|||
27676650|NCT00121667|80653465|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
27676651|NCT00121667|80653466|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
27676652|NCT00121667|80653467|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
27676653|NCT00121667|80653468|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
27676654|NCT00121667|80653465|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
27676655|NCT00121667|80653466|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
27676656|NCT00121667|80653467|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
27676657|NCT00121667|80653468|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
27676658|NCT00121667|80653465|FG000|Short Term (ST) Period|Adverse Event|5|||
27676659|NCT00121667|80653466|FG001|Short Term (ST) Period|Adverse Event|6|||
27676660|NCT00121667|80653467|FG002|Short Term (ST) Period|Adverse Event|5|||
27676661|NCT00121667|80653468|FG003|Short Term (ST) Period|Adverse Event|3|||
27676662|NCT00121667|80653465|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
27676663|NCT00121667|80653466|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
27676664|NCT00121667|80653467|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
27676665|NCT00121667|80653468|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
27676666|NCT00121667|80653465|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
27676667|NCT00121667|80653466|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
27676668|NCT00121667|80653467|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
27676669|NCT00121667|80653468|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
27676670|NCT00121667|80653465|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
27676671|NCT00121667|80653466|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
27676672|NCT00121667|80653467|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
27676673|NCT00121667|80653468|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
27676674|NCT00121667|80653465|FG000|Short Term (ST) Period|Other Reason|3|||
27676675|NCT00121667|80653466|FG001|Short Term (ST) Period|Other Reason|0|||
27676676|NCT00121667|80653467|FG002|Short Term (ST) Period|Other Reason|0|||
27676677|NCT00121667|80653468|FG003|Short Term (ST) Period|Other Reason|0|||
27676678|NCT00121667|80653465|FG000|Short Term (ST) Period|Death|0|||
27676679|NCT00121667|80653466|FG001|Short Term (ST) Period|Death|0|||
27676680|NCT00121667|80653467|FG002|Short Term (ST) Period|Death|0|||
27676681|NCT00121667|80653468|FG003|Short Term (ST) Period|Death|1|||
27676682|NCT00121667|80653465|FG000|Short Term (ST) Period|Pregnancy|0|||
27676683|NCT00121667|80653466|FG001|Short Term (ST) Period|Pregnancy|0|||
27676684|NCT00121667|80653467|FG002|Short Term (ST) Period|Pregnancy|0|||
27676685|NCT00121667|80653468|FG003|Short Term (ST) Period|Pregnancy|1|||
27676686|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
27676687|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
27676688|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
27676689|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
27676690|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
27991998|NCT03364309|81801991|FG012|Maintenance Period|Miscellaneous|0|||
27991999|NCT03364309|81801992|FG013|Maintenance Period|Miscellaneous|0|||
27992000|NCT03364309|81801993|FG014|Maintenance Period|Miscellaneous|0|||
27992001|NCT03364309|81801994|FG015|Maintenance Period|Miscellaneous|0|||
27992002|NCT03364309|81801995|FG016|Maintenance Period|Miscellaneous|0|||
27992003|NCT03364309|81801996|FG017|Maintenance Period|Miscellaneous|0|||
27992004|NCT03364309|81801997|FG018|Maintenance Period|Miscellaneous|0|||
27992005|NCT03364309|81801979|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992006|NCT03364309|81801980|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992007|NCT03364309|81801981|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992008|NCT03364309|81801982|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992009|NCT03364309|81801983|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992010|NCT03364309|81801984|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992011|NCT03364309|81801985|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992012|NCT03364309|81801986|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992013|NCT03364309|81801987|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27676691|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
27676692|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
27676693|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
27676694|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
27676695|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
27799271|NCT05553600|81095789|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
27799272|NCT05553600|81095790|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
27799273|NCT05553600|81095791|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
27799274|NCT05553600|81095792|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
27799275|NCT05553600|81095789|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
27799276|NCT05553600|81095790|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
27799277|NCT05553600|81095791|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
27799278|NCT05553600|81095792|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
27799279|NCT05553600|81095789|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
27799280|NCT05553600|81095790|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
27799281|NCT05553600|81095791|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
27799282|NCT05553600|81095792|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
27799283|NCT05553600|81095789|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
27799284|NCT05553600|81095790|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
27799285|NCT05553600|81095791|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
27799286|NCT05553600|81095792|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
27799287|NCT02094573|81098795|FG000|Overall Study|Adverse Event|4|||
27799288|NCT02094573|81098796|FG001|Overall Study|Adverse Event|14|||
27833148|NCT04281472|81219495|FG002|Stage A|Other|0|||
27992014|NCT03364309|81801988|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992015|NCT03364309|81801989|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27676696|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
27992016|NCT03364309|81801990|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992017|NCT03364309|81801991|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992018|NCT03364309|81801992|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
27992019|NCT03364309|81801993|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
27992020|NCT03364309|81801994|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
27992021|NCT03364309|81801995|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992022|NCT03364309|81801996|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992023|NCT03364309|81801997|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
27992024|NCT03364309|81801979|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992025|NCT03364309|81801980|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992026|NCT03364309|81801981|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992027|NCT03364309|81801982|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992028|NCT03364309|81801983|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992029|NCT03364309|81801984|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992030|NCT03364309|81801985|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992031|NCT03364309|81801986|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992032|NCT03364309|81801987|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992033|NCT03364309|81801988|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992034|NCT03364309|81801989|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992035|NCT03364309|81801990|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992036|NCT03364309|81801991|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992037|NCT03364309|81801992|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992038|NCT03364309|81801993|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
27992039|NCT03364309|81801994|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992040|NCT03364309|81801995|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992041|NCT03364309|81801996|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992042|NCT03364309|81801997|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
27992043|NCT03364309|81801979|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
27992044|NCT03364309|81801980|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
27992045|NCT03364309|81801981|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
27992046|NCT03364309|81801982|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
27992047|NCT03364309|81801983|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
27992048|NCT03364309|81801984|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
27992049|NCT03364309|81801985|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
27992050|NCT03364309|81801986|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
27799289|NCT02094573|81098795|FG000|Overall Study|Clinical Progressive Disease|9|||
27799290|NCT02094573|81098796|FG001|Overall Study|Clinical Progressive Disease|13|||
27799291|NCT02094573|81098795|FG000|Overall Study|Death|11|||
27799292|NCT02094573|81098796|FG001|Overall Study|Death|3|||
27799293|NCT02094573|81098795|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
27799294|NCT02094573|81098796|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
27799295|NCT02094573|81098795|FG000|Overall Study|Non-compliance with Study Drug|1|||
27799296|NCT02094573|81098796|FG001|Overall Study|Non-compliance with Study Drug|1|||
27799297|NCT02094573|81098795|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
27799298|NCT02094573|81098796|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
27799299|NCT02094573|81098795|FG000|Overall Study|Physician Decision|4|||
27799300|NCT02094573|81098796|FG001|Overall Study|Physician Decision|4|||
27799301|NCT02094573|81098795|FG000|Overall Study|Site Terminated by Sponsor|10|||
27799302|NCT02094573|81098796|FG001|Overall Study|Site Terminated by Sponsor|17|||
27799303|NCT02094573|81098795|FG000|Overall Study|Withdrawal by Subject|6|||
27799304|NCT02094573|81098796|FG001|Overall Study|Withdrawal by Subject|8|||
27799305|NCT02094573|81098795|FG000|Overall Study|Randomized but not Treated|3|||
27799306|NCT02094573|81098796|FG001|Overall Study|Randomized but not Treated|0|||
27799307|NCT01652573|81098798|FG000|Overall Study|Adverse Event|0|||
27799308|NCT01652573|81098799|FG001|Overall Study|Adverse Event|1|||
27799309|NCT00759174|81098800|FG000|Overall Study|Other|0|||
27799310|NCT00759174|81098801|FG001|Overall Study|Other|2|||
27799311|NCT01162135|81098807|FG000|Overall Study|Withdrawal by Subject|1|||
27799312|NCT01162135|81098807|FG000|Overall Study|Severe back pain|1|||
27799313|NCT01162135|81098807|FG000|Overall Study|Ineligible|1|||
27799314|NCT01238172|81098808|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
27799315|NCT01238172|81098809|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
27799316|NCT01238172|81098808|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
27799317|NCT01238172|81098809|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
27799318|NCT00530088|81098810|FG000|Overall Study|Disease Progression|4|||
27799319|NCT00530088|81098810|FG000|Overall Study|Physician Decision|4|||
27799320|NCT00530088|81098810|FG000|Overall Study|Other Not Specified|2|||
27799321|NCT02602080|81098811|FG000|Overall Study|Protocol Violation|6|||
27799322|NCT02602080|81098812|FG001|Overall Study|Protocol Violation|1|||
27799323|NCT02602080|81098813|FG002|Overall Study|Protocol Violation|3|||
27799324|NCT02411110|81098816|FG000|Treatment Period 1|Adverse Event|4|||
27992051|NCT03364309|81801987|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
27992052|NCT03364309|81801988|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
27676697|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
27676698|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
27676699|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
27676700|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
27676701|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
27676702|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
27676703|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
27676704|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
27676705|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
27676706|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
27676707|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
27676708|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
27676709|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
27676710|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
27676711|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
27676712|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
27676713|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
27676714|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
27676715|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
27676716|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
27676717|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
27676718|NCT00121667|80653465|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
27676719|NCT00121667|80653466|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
27676720|NCT00121667|80653467|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
27676721|NCT00121667|80653468|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
27676722|NCT03041792|80653469|FG000|Overall Study|Adverse Event|4|||
27676723|NCT03041792|80653470|FG001|Overall Study|Adverse Event|0|||
27676724|NCT03041792|80653469|FG000|Overall Study|Death in the family|0|||
27676725|NCT03041792|80653470|FG001|Overall Study|Death in the family|2|||
27676726|NCT03041792|80653469|FG000|Overall Study|Randomized but not treated|0|||
27676727|NCT03041792|80653470|FG001|Overall Study|Randomized but not treated|1|||
27676728|NCT00340704|80653471|FG000|PK Study|Adverse Event|0|||
27676729|NCT00340704|80653472|FG001|PK Study|Adverse Event|1|||
27676730|NCT00340704|80653473|FG002|PK Study|Adverse Event|0|||
27676731|NCT00340704|80653474|FG003|PK Study|Adverse Event|0|||
27676732|NCT00340704|80653475|FG004|PK Study|Adverse Event|0|||
27799325|NCT02411110|81098817|FG001|Treatment Period 1|Adverse Event|2|||
27799326|NCT02411110|81098816|FG000|Treatment Period 1|Lost to Follow-up|1|||
27799327|NCT02411110|81098817|FG001|Treatment Period 1|Lost to Follow-up|0|||
27799328|NCT02411110|81098816|FG000|Treatment Period 1|Personal Reasons|2|||
27799329|NCT02411110|81098817|FG001|Treatment Period 1|Personal Reasons|5|||
27799330|NCT02411110|81098816|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
27799331|NCT02411110|81098817|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
27799332|NCT02411110|81098816|FG000|Treatment Period 2|Adverse Event|1|||
27799333|NCT02411110|81098817|FG001|Treatment Period 2|Adverse Event|0|||
27799334|NCT02411110|81098816|FG000|Treatment Period 2|Lost to Follow-up|0|||
27799335|NCT02411110|81098817|FG001|Treatment Period 2|Lost to Follow-up|2|||
27799336|NCT02411110|81098816|FG000|Treatment Period 2|Personal Reasons|0|||
27799337|NCT02411110|81098817|FG001|Treatment Period 2|Personal Reasons|2|||
27992053|NCT03364309|81801989|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
27992054|NCT03364309|81801990|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
27992055|NCT03364309|81801991|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
27992056|NCT03364309|81801992|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
27992057|NCT03364309|81801993|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
27992058|NCT03364309|81801994|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
27992059|NCT03364309|81801995|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
27992060|NCT03364309|81801996|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
27676733|NCT00340704|80653476|FG005|PK Study|Adverse Event|0|||
27799338|NCT00743119|81098818|FG000|Overall Study|unreliable|3|||
27799339|NCT00743119|81098818|FG000|Overall Study|Withdrawal by Subject|1|||
27799340|NCT00550420|81098819|FG000|Overall Study|Adverse Event|28|||
27799341|NCT00550420|81098819|FG000|Overall Study|Lost to Follow-up|8|||
27992061|NCT03364309|81801997|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
27992062|NCT03364309|81801979|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27676734|NCT00340704|80653477|FG006|PK Study|Adverse Event|0|||
27676735|NCT00340704|80653478|FG007|PK Study|Adverse Event|0|||
27676736|NCT00340704|80653479|FG008|PK Study|Adverse Event|0|||
27676737|NCT00340704|80653471|FG000|PK Study|Not treated|0|||
27676738|NCT00340704|80653472|FG001|PK Study|Not treated|0|||
27676739|NCT00340704|80653473|FG002|PK Study|Not treated|1|||
27676740|NCT00340704|80653474|FG003|PK Study|Not treated|0|||
27676741|NCT00340704|80653475|FG004|PK Study|Not treated|0|||
27676742|NCT00340704|80653476|FG005|PK Study|Not treated|0|||
27676743|NCT00340704|80653477|FG006|PK Study|Not treated|0|||
27676744|NCT00340704|80653478|FG007|PK Study|Not treated|0|||
27676745|NCT00340704|80653479|FG008|PK Study|Not treated|0|||
27676746|NCT00340704|80653471|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
27676747|NCT00340704|80653472|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
27676748|NCT00340704|80653473|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
27676749|NCT00340704|80653474|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
27676750|NCT00340704|80653475|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
27676751|NCT00340704|80653476|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
27676752|NCT00340704|80653477|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
27676753|NCT00340704|80653478|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
27676754|NCT00340704|80653479|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
27676755|NCT00340704|80653471|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27799342|NCT00550420|81098819|FG000|Overall Study|Protocol Violation|11|||
27799343|NCT00550420|81098819|FG000|Overall Study|Withdrawal by Subject|30|||
27799344|NCT00550420|81098819|FG000|Overall Study|Still in study at termination|206|||
27799345|NCT00550420|81098819|FG000|Overall Study|Missing|2|||
27799346|NCT00550420|81098819|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
27676756|NCT00340704|80653472|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676757|NCT00340704|80653473|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676758|NCT00340704|80653474|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676759|NCT00340704|80653475|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676760|NCT00340704|80653476|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
27676761|NCT00340704|80653477|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676762|NCT00340704|80653478|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676763|NCT00340704|80653479|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
27676764|NCT00340704|80653471|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676765|NCT00340704|80653472|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676766|NCT00340704|80653473|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676767|NCT00340704|80653474|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676768|NCT00340704|80653475|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
27676769|NCT00340704|80653476|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
27676770|NCT00340704|80653477|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676771|NCT00340704|80653478|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676772|NCT00340704|80653479|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
27676773|NCT00340704|80653471|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
27676774|NCT00340704|80653472|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
27676775|NCT00340704|80653473|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
27676776|NCT00340704|80653474|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
27676777|NCT00340704|80653475|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
27676778|NCT00340704|80653476|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
27676779|NCT00340704|80653477|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
27676780|NCT00340704|80653478|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
27676781|NCT00340704|80653479|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
27676782|NCT00267098|80653485|FG000|Overall Study|Death|0|||
27676783|NCT00267098|80653486|FG001|Overall Study|Death|0|||
27676784|NCT00267098|80653487|FG002|Overall Study|Death|57|||
27676785|NCT00267098|80653488|FG003|Overall Study|Death|66|||
27676786|NCT00267098|80653489|FG004|Overall Study|Death|14|||
27676787|NCT00267098|80653490|FG005|Overall Study|Death|23|||
27676788|NCT00267098|80653491|FG006|Overall Study|Death|28|||
27676789|NCT00267098|80653492|FG007|Overall Study|Death|9|||
27676790|NCT00267098|80653485|FG000|Overall Study|Lost to Follow-up|0|||
27676791|NCT00267098|80653486|FG001|Overall Study|Lost to Follow-up|0|||
27676792|NCT00267098|80653487|FG002|Overall Study|Lost to Follow-up|6|||
27676793|NCT00267098|80653488|FG003|Overall Study|Lost to Follow-up|5|||
27676794|NCT00267098|80653489|FG004|Overall Study|Lost to Follow-up|2|||
27799347|NCT00550420|81098819|FG000|Overall Study|Investigators opinion|1|||
27799348|NCT00550420|81098819|FG000|Overall Study|Lack of curative effect|1|||
27799349|NCT00550420|81098819|FG000|Overall Study|Unethical stop of enrollment|2|||
27676795|NCT00267098|80653490|FG005|Overall Study|Lost to Follow-up|3|||
27676796|NCT00267098|80653491|FG006|Overall Study|Lost to Follow-up|1|||
27676797|NCT00267098|80653492|FG007|Overall Study|Lost to Follow-up|1|||
27676798|NCT00267098|80653485|FG000|Overall Study|Withdrawal by Subject|8|||
27676799|NCT00267098|80653486|FG001|Overall Study|Withdrawal by Subject|0|||
27676800|NCT00267098|80653487|FG002|Overall Study|Withdrawal by Subject|24|||
27676801|NCT00267098|80653488|FG003|Overall Study|Withdrawal by Subject|21|||
27676802|NCT00267098|80653489|FG004|Overall Study|Withdrawal by Subject|12|||
27676803|NCT00267098|80653490|FG005|Overall Study|Withdrawal by Subject|9|||
27676804|NCT00267098|80653491|FG006|Overall Study|Withdrawal by Subject|12|||
27676805|NCT00267098|80653492|FG007|Overall Study|Withdrawal by Subject|5|||
27676806|NCT00267098|80653485|FG000|Overall Study|Physician Decision|5|||
27676807|NCT00267098|80653486|FG001|Overall Study|Physician Decision|0|||
27676808|NCT00267098|80653487|FG002|Overall Study|Physician Decision|7|||
27676809|NCT00267098|80653488|FG003|Overall Study|Physician Decision|11|||
27676810|NCT00267098|80653489|FG004|Overall Study|Physician Decision|5|||
27676811|NCT00267098|80653490|FG005|Overall Study|Physician Decision|4|||
27676812|NCT00267098|80653491|FG006|Overall Study|Physician Decision|3|||
27676813|NCT00267098|80653492|FG007|Overall Study|Physician Decision|0|||
27676814|NCT00267098|80653485|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
27676815|NCT00267098|80653486|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27676816|NCT00267098|80653487|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27676817|NCT00267098|80653488|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27676818|NCT00267098|80653489|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
27676819|NCT00267098|80653490|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27676820|NCT00267098|80653491|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27676821|NCT00267098|80653492|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27676822|NCT00267098|80653485|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676823|NCT00267098|80653486|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
27676824|NCT00267098|80653487|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676825|NCT00267098|80653488|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676826|NCT00267098|80653489|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676827|NCT00267098|80653490|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676828|NCT00267098|80653491|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676829|NCT00267098|80653492|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
27676830|NCT00267098|80653485|FG000|Overall Study|Site closure|0|||
27676831|NCT00267098|80653486|FG001|Overall Study|Site closure|0|||
27676832|NCT00267098|80653487|FG002|Overall Study|Site closure|0|||
27676833|NCT00267098|80653488|FG003|Overall Study|Site closure|1|||
27676834|NCT00267098|80653489|FG004|Overall Study|Site closure|0|||
27676835|NCT00267098|80653490|FG005|Overall Study|Site closure|1|||
27676836|NCT00267098|80653491|FG006|Overall Study|Site closure|1|||
27676837|NCT00267098|80653492|FG007|Overall Study|Site closure|0|||
27676838|NCT00267098|80653485|FG000|Overall Study|Explanted Medtronic device|0|||
27676839|NCT00267098|80653486|FG001|Overall Study|Explanted Medtronic device|0|||
27676840|NCT00267098|80653487|FG002|Overall Study|Explanted Medtronic device|0|||
27676841|NCT00267098|80653488|FG003|Overall Study|Explanted Medtronic device|1|||
27676842|NCT00267098|80653489|FG004|Overall Study|Explanted Medtronic device|0|||
27676843|NCT00267098|80653490|FG005|Overall Study|Explanted Medtronic device|0|||
27676844|NCT00267098|80653491|FG006|Overall Study|Explanted Medtronic device|0|||
27676845|NCT00267098|80653492|FG007|Overall Study|Explanted Medtronic device|0|||
27676846|NCT00267098|80653485|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27676847|NCT00267098|80653486|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27676848|NCT00267098|80653487|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27676849|NCT00267098|80653488|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27676850|NCT00267098|80653489|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
27676851|NCT00267098|80653490|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27676852|NCT00267098|80653491|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27676853|NCT00267098|80653492|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
27870906|NCT00580788|81361546|FG000|Overall Study|Adverse Event|0|||
27870907|NCT00580788|81361547|FG001|Overall Study|Adverse Event|0|||
27870908|NCT00580788|81361548|FG002|Overall Study|Adverse Event|0|||
27676854|NCT00267098|80653485|FG000|Overall Study|Subject listed for heart transplant|0|||
27676855|NCT00267098|80653486|FG001|Overall Study|Subject listed for heart transplant|0|||
27676856|NCT00267098|80653487|FG002|Overall Study|Subject listed for heart transplant|0|||
27676857|NCT00267098|80653488|FG003|Overall Study|Subject listed for heart transplant|0|||
27870909|NCT00580788|81361549|FG003|Overall Study|Adverse Event|1|||
27870910|NCT00369941|81361550|FG000|Overall Study|Never Treated|1|||
27676858|NCT00267098|80653489|FG004|Overall Study|Subject listed for heart transplant|0|||
27676859|NCT00267098|80653490|FG005|Overall Study|Subject listed for heart transplant|0|||
27676860|NCT00267098|80653491|FG006|Overall Study|Subject listed for heart transplant|1|||
27676861|NCT00267098|80653492|FG007|Overall Study|Subject listed for heart transplant|0|||
27870911|NCT00369941|81361551|FG001|Overall Study|Never Treated|2|||
27870912|NCT00369941|81361550|FG000|Overall Study|Adverse Event|14|||
27870913|NCT00369941|81361551|FG001|Overall Study|Adverse Event|28|||
27870914|NCT00369941|81361550|FG000|Overall Study|Lack of Efficacy|6|||
27870915|NCT00369941|81361551|FG001|Overall Study|Lack of Efficacy|10|||
27870916|NCT00369941|81361550|FG000|Overall Study|Lost to Follow-up|12|||
27992063|NCT03364309|81801980|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27676862|NCT00267098|80653485|FG000|Overall Study|Sponsor withdrew subject|0|||
27676863|NCT00267098|80653486|FG001|Overall Study|Sponsor withdrew subject|0|||
27676864|NCT00267098|80653487|FG002|Overall Study|Sponsor withdrew subject|0|||
27676865|NCT00267098|80653488|FG003|Overall Study|Sponsor withdrew subject|1|||
27676866|NCT00267098|80653489|FG004|Overall Study|Sponsor withdrew subject|0|||
27676867|NCT00267098|80653490|FG005|Overall Study|Sponsor withdrew subject|0|||
27676868|NCT00267098|80653491|FG006|Overall Study|Sponsor withdrew subject|0|||
27992064|NCT03364309|81801981|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992065|NCT03364309|81801982|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992066|NCT03364309|81801983|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992067|NCT03364309|81801984|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992068|NCT03364309|81801985|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992069|NCT03364309|81801986|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992070|NCT03364309|81801987|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992071|NCT03364309|81801988|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27676869|NCT00267098|80653492|FG007|Overall Study|Sponsor withdrew subject|0|||
27676870|NCT03057847|80653493|FG000|Overall Study|Lost to Follow-up|16|||
27676871|NCT00570908|80653494|FG000|Overall Study|Adverse Event|5|||
27676872|NCT00570908|80653494|FG000|Overall Study|Withdrawal by Subject|2|||
27676873|NCT01435772|80653495|FG000|Overall Study|Adverse Event|1|||
27676874|NCT01435772|80653496|FG001|Overall Study|Adverse Event|0|||
27676875|NCT01435772|80653497|FG002|Overall Study|Adverse Event|2|||
27676876|NCT01435772|80653495|FG000|Overall Study|Withdrawal by Subject|0|||
27676877|NCT01435772|80653496|FG001|Overall Study|Withdrawal by Subject|1|||
27676878|NCT01435772|80653497|FG002|Overall Study|Withdrawal by Subject|3|||
27676879|NCT01435772|80653495|FG000|Overall Study|Other - study termination|2|||
27676880|NCT01435772|80653496|FG001|Overall Study|Other - study termination|2|||
27676881|NCT01435772|80653497|FG002|Overall Study|Other - study termination|10|||
27676882|NCT00820170|80653498|FG000|Overall Study|Adverse Event|0|||
27676883|NCT00820170|80653499|FG001|Overall Study|Adverse Event|0|||
27676884|NCT00820170|80653500|FG002|Overall Study|Adverse Event|0|||
27676885|NCT00820170|80653501|FG003|Overall Study|Adverse Event|0|||
27676886|NCT00820170|80653502|FG004|Overall Study|Adverse Event|2|||
27676887|NCT00820170|80653498|FG000|Overall Study|Progressive Disease|0|||
27676888|NCT00820170|80653499|FG001|Overall Study|Progressive Disease|0|||
27676889|NCT00820170|80653500|FG002|Overall Study|Progressive Disease|0|||
27676890|NCT00820170|80653501|FG003|Overall Study|Progressive Disease|0|||
27676891|NCT00820170|80653502|FG004|Overall Study|Progressive Disease|2|||
27676892|NCT00129935|80653508|FG000|Overall Study|Adverse Event|18|||
27676893|NCT00129935|80653509|FG001|Overall Study|Adverse Event|56|||
27676894|NCT00129935|80653508|FG000|Overall Study|Death|1|||
27676895|NCT00129935|80653509|FG001|Overall Study|Death|1|||
27676896|NCT00129935|80653508|FG000|Overall Study|Withdrawal by Subject|7|||
27676897|NCT00129935|80653509|FG001|Overall Study|Withdrawal by Subject|20|||
27676898|NCT00129935|80653508|FG000|Overall Study|Protocol Violation|0|||
27676899|NCT00129935|80653509|FG001|Overall Study|Protocol Violation|4|||
27799350|NCT00550420|81098819|FG000|Overall Study|Caregiver's decision to withdraw|1|||
27799351|NCT00550420|81098819|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
27799352|NCT00550420|81098819|FG000|Overall Study|Exclusion criteria|1|||
27799353|NCT00550420|81098819|FG000|Overall Study|Prohibited medicine|1|||
27799354|NCT04523831|81098820|FG000|Overall Study|Lost to Follow-up|15|||
27799355|NCT04523831|81098821|FG001|Overall Study|Lost to Follow-up|17|||
27799356|NCT04523831|81098820|FG000|Overall Study|Death|0|||
27799357|NCT04523831|81098821|FG001|Overall Study|Death|3|||
27799358|NCT04523831|81098820|FG000|Overall Study|Adverse Event|2|||
27799359|NCT04523831|81098821|FG001|Overall Study|Adverse Event|0|||
27799360|NCT01289990|81098822|FG000|Overall Study|Death|0|||
27992072|NCT03364309|81801989|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27676900|NCT00129935|80653508|FG000|Overall Study|Physician Decision|3|||
27676901|NCT00129935|80653509|FG001|Overall Study|Physician Decision|4|||
27676902|NCT00129935|80653508|FG000|Overall Study|Recurrence|1|||
27676903|NCT00129935|80653509|FG001|Overall Study|Recurrence|3|||
27676904|NCT00129935|80653508|FG000|Overall Study|Second primary|0|||
27676905|NCT00129935|80653509|FG001|Overall Study|Second primary|1|||
27799361|NCT01289990|81098823|FG001|Overall Study|Death|0|||
27676906|NCT00129935|80653508|FG000|Overall Study|Other|3|||
27676907|NCT00129935|80653509|FG001|Overall Study|Other|2|||
27676908|NCT00129935|80653508|FG000|Overall Study|Crossed to the other arm|2|||
27676909|NCT00129935|80653509|FG001|Overall Study|Crossed to the other arm|1|||
27799362|NCT01289990|81098824|FG002|Overall Study|Death|0|||
27799363|NCT01289990|81098825|FG003|Overall Study|Death|1|||
27870917|NCT00369941|81361551|FG001|Overall Study|Lost to Follow-up|22|||
27676910|NCT00129935|80653508|FG000|Overall Study|Incorrect study treatment|1|||
27676911|NCT00129935|80653509|FG001|Overall Study|Incorrect study treatment|0|||
27676912|NCT00701909|80653514|FG000|Overall Study|Withdrawal by Subject|0|||
27676913|NCT00701909|80653515|FG001|Overall Study|Withdrawal by Subject|1|||
27676914|NCT01031628|80653522|FG000|Overall Study|Study terminated early|0|||
27676915|NCT01031628|80653523|FG001|Overall Study|Study terminated early|1|||
27676916|NCT01031628|80653524|FG002|Overall Study|Study terminated early|3|||
27676917|NCT01031628|80653525|FG003|Overall Study|Study terminated early|0|||
27676918|NCT01932762|80653530|FG000|Overall Study|Withdrawal by Subject|1|||
27676919|NCT01932762|80653531|FG001|Overall Study|Withdrawal by Subject|2|||
27676920|NCT01932762|80653532|FG002|Overall Study|Withdrawal by Subject|0|||
27676921|NCT01932762|80653533|FG003|Overall Study|Withdrawal by Subject|0|||
27676922|NCT01932762|80653530|FG000|Overall Study|Lost to Follow-up|4|||
27676923|NCT01932762|80653531|FG001|Overall Study|Lost to Follow-up|0|||
27676924|NCT01932762|80653532|FG002|Overall Study|Lost to Follow-up|0|||
27676925|NCT01932762|80653533|FG003|Overall Study|Lost to Follow-up|1|||
27676926|NCT01932762|80653530|FG000|Overall Study|Physician Decision|1|||
27676927|NCT01932762|80653531|FG001|Overall Study|Physician Decision|0|||
27676928|NCT01932762|80653532|FG002|Overall Study|Physician Decision|0|||
27676929|NCT01932762|80653533|FG003|Overall Study|Physician Decision|0|||
27676930|NCT00667459|80653536|FG000|Overall Study|Death|0|||
27676931|NCT00667459|80653537|FG001|Overall Study|Death|2|||
27676932|NCT00667459|80653536|FG000|Overall Study|Lost to Follow-up|8|||
27676933|NCT00667459|80653537|FG001|Overall Study|Lost to Follow-up|43|||
27676934|NCT00895895|80653543|FG000|Period 1|Adverse Event|7|||
27676935|NCT00895895|80653544|FG001|Period 1|Adverse Event|6|||
27992073|NCT03364309|81801990|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27676936|NCT00895895|80653545|FG002|Period 1|Adverse Event|4|||
27676937|NCT00895895|80653546|FG003|Period 1|Adverse Event|6|||
27676938|NCT00895895|80653547|FG004|Period 1|Adverse Event|7|||
27676939|NCT00895895|80653543|FG000|Period 1|Death|0|||
27676940|NCT00895895|80653544|FG001|Period 1|Death|0|||
27676941|NCT00895895|80653545|FG002|Period 1|Death|0|||
27676942|NCT00895895|80653546|FG003|Period 1|Death|0|||
27676943|NCT00895895|80653547|FG004|Period 1|Death|1|||
27676944|NCT00895895|80653543|FG000|Period 1|discontinued by sponsor|2|||
27676945|NCT00895895|80653544|FG001|Period 1|discontinued by sponsor|1|||
27676946|NCT00895895|80653545|FG002|Period 1|discontinued by sponsor|2|||
27676947|NCT00895895|80653546|FG003|Period 1|discontinued by sponsor|1|||
27676948|NCT00895895|80653547|FG004|Period 1|discontinued by sponsor|1|||
27676949|NCT00895895|80653543|FG000|Period 1|failed to return|0|||
27676950|NCT00895895|80653544|FG001|Period 1|failed to return|0|||
27676951|NCT00895895|80653545|FG002|Period 1|failed to return|1|||
27676952|NCT00895895|80653546|FG003|Period 1|failed to return|0|||
27676953|NCT00895895|80653547|FG004|Period 1|failed to return|1|||
27676954|NCT00895895|80653543|FG000|Period 1|investigator request|0|||
27676955|NCT00895895|80653544|FG001|Period 1|investigator request|1|||
27676956|NCT00895895|80653545|FG002|Period 1|investigator request|0|||
27676957|NCT00895895|80653546|FG003|Period 1|investigator request|0|||
27676958|NCT00895895|80653547|FG004|Period 1|investigator request|0|||
27676959|NCT00895895|80653543|FG000|Period 1|Lost to Follow-up|2|||
27676960|NCT00895895|80653544|FG001|Period 1|Lost to Follow-up|1|||
27676961|NCT00895895|80653545|FG002|Period 1|Lost to Follow-up|3|||
27870918|NCT00369941|81361550|FG000|Overall Study|Protocol Violation|5|||
27870919|NCT00369941|81361551|FG001|Overall Study|Protocol Violation|3|||
27870920|NCT00369941|81361550|FG000|Overall Study|Withdrawal by Subject|5|||
27870921|NCT00369941|81361551|FG001|Overall Study|Withdrawal by Subject|18|||
27870922|NCT00369941|81361550|FG000|Overall Study|Pregnancy|4|||
27870923|NCT00369941|81361551|FG001|Overall Study|Pregnancy|2|||
27870924|NCT00369941|81361550|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
27870925|NCT00369941|81361551|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
27870926|NCT00369941|81361550|FG000|Overall Study|Moved|11|||
27992074|NCT03364309|81801991|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992075|NCT03364309|81801992|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992076|NCT03364309|81801993|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27870927|NCT00369941|81361551|FG001|Overall Study|Moved|5|||
27870928|NCT00369941|81361550|FG000|Overall Study|Treatment with Prohibited Medication|3|||
27870929|NCT00369941|81361551|FG001|Overall Study|Treatment with Prohibited Medication|1|||
27870930|NCT00369941|81361550|FG000|Overall Study|Employment Interfered with Study Visits|1|||
27676962|NCT00895895|80653546|FG003|Period 1|Lost to Follow-up|2|||
27676963|NCT00895895|80653547|FG004|Period 1|Lost to Follow-up|3|||
27676964|NCT00895895|80653543|FG000|Period 1|Other|1|||
27676965|NCT00895895|80653544|FG001|Period 1|Other|2|||
27676966|NCT00895895|80653545|FG002|Period 1|Other|1|||
27676967|NCT00895895|80653546|FG003|Period 1|Other|1|||
27676968|NCT00895895|80653547|FG004|Period 1|Other|1|||
27676969|NCT00895895|80653543|FG000|Period 1|Protocol Violation|0|||
27676970|NCT00895895|80653544|FG001|Period 1|Protocol Violation|1|||
27676971|NCT00895895|80653545|FG002|Period 1|Protocol Violation|0|||
27870931|NCT00369941|81361551|FG001|Overall Study|Employment Interfered with Study Visits|0|||
27870932|NCT00369941|81361550|FG000|Overall Study|Study Site Terminated|2|||
27992077|NCT03364309|81801994|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27992078|NCT03364309|81801995|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
27579332|NCT03120624|80303187|FG005|Overall Study|Withdrawal by Subject|0|||
27579333|NCT03120624|80303188|FG006|Overall Study|Withdrawal by Subject|0|||
27676972|NCT00895895|80653546|FG003|Period 1|Protocol Violation|0|||
27992079|NCT03364309|81801996|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
27992080|NCT03364309|81801997|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
27992081|NCT03364309|81801979|FG000|Post-Treatment Followup Period|Adverse Event|0|||
27992082|NCT03364309|81801980|FG001|Post-Treatment Followup Period|Adverse Event|0|||
27992083|NCT03364309|81801981|FG002|Post-Treatment Followup Period|Adverse Event|0|||
27992084|NCT03364309|81801982|FG003|Post-Treatment Followup Period|Adverse Event|0|||
27992085|NCT03364309|81801983|FG004|Post-Treatment Followup Period|Adverse Event|0|||
27992086|NCT03364309|81801984|FG005|Post-Treatment Followup Period|Adverse Event|0|||
27992087|NCT03364309|81801985|FG006|Post-Treatment Followup Period|Adverse Event|0|||
27992088|NCT03364309|81801986|FG007|Post-Treatment Followup Period|Adverse Event|0|||
27992089|NCT03364309|81801987|FG008|Post-Treatment Followup Period|Adverse Event|0|||
27992090|NCT03364309|81801988|FG009|Post-Treatment Followup Period|Adverse Event|0|||
27992091|NCT03364309|81801989|FG010|Post-Treatment Followup Period|Adverse Event|0|||
27992092|NCT03364309|81801990|FG011|Post-Treatment Followup Period|Adverse Event|0|||
27992093|NCT03364309|81801991|FG012|Post-Treatment Followup Period|Adverse Event|0|||
27992094|NCT03364309|81801992|FG013|Post-Treatment Followup Period|Adverse Event|0|||
27992095|NCT03364309|81801993|FG014|Post-Treatment Followup Period|Adverse Event|0|||
27992096|NCT03364309|81801994|FG015|Post-Treatment Followup Period|Adverse Event|0|||
27992097|NCT03364309|81801995|FG016|Post-Treatment Followup Period|Adverse Event|2|||
27992098|NCT03364309|81801996|FG017|Post-Treatment Followup Period|Adverse Event|6|||
27992099|NCT03364309|81801997|FG018|Post-Treatment Followup Period|Adverse Event|1|||
27992100|NCT03364309|81801979|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992101|NCT03364309|81801980|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992102|NCT03364309|81801981|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992103|NCT03364309|81801982|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992104|NCT03364309|81801983|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992105|NCT03364309|81801984|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992106|NCT03364309|81801985|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992107|NCT03364309|81801986|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992108|NCT03364309|81801987|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992109|NCT03364309|81801988|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992110|NCT03364309|81801989|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992111|NCT03364309|81801990|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992112|NCT03364309|81801991|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992113|NCT03364309|81801992|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992114|NCT03364309|81801993|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992115|NCT03364309|81801994|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992116|NCT03364309|81801995|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992117|NCT03364309|81801996|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
27992118|NCT03364309|81801997|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
27992119|NCT03364309|81801979|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
27992120|NCT03364309|81801980|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
27992121|NCT03364309|81801981|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
27992122|NCT03364309|81801982|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
27992123|NCT03364309|81801983|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
27992124|NCT03364309|81801984|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
27579334|NCT03120624|80303189|FG007|Overall Study|Withdrawal by Subject|0|||
27870933|NCT00369941|81361551|FG001|Overall Study|Study Site Terminated|0|||
27992125|NCT03364309|81801985|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
27992126|NCT03364309|81801986|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
27992127|NCT03364309|81801987|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
27992128|NCT03364309|81801988|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
27992129|NCT03364309|81801989|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
27992130|NCT03364309|81801990|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
27992131|NCT03364309|81801991|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
27992132|NCT03364309|81801992|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
27992133|NCT03364309|81801993|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
27992134|NCT03364309|81801994|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
27992135|NCT03364309|81801995|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
27992136|NCT03364309|81801996|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
27992137|NCT03364309|81801997|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
27992138|NCT02006979|81801998|FG000|Overall Study|Withdrawal by Subject|1|||
27992139|NCT02006979|81801999|FG001|Overall Study|Withdrawal by Subject|1|||
27992140|NCT02006979|81801998|FG000|Overall Study|Protocol Violation|0|||
27992141|NCT02006979|81801999|FG001|Overall Study|Protocol Violation|1|||
27992142|NCT01235234|81802000|FG000|Overall Study|Adverse Event|2|||
27992143|NCT01235234|81802001|FG001|Overall Study|Adverse Event|2|||
27992144|NCT01235234|81802002|FG002|Overall Study|Adverse Event|1|||
27992145|NCT01393639|81802003|FG000|Overall Study|Protocol Violation|0|||
27992146|NCT01393639|81802004|FG001|Overall Study|Protocol Violation|0|||
27992147|NCT01393639|81802005|FG002|Overall Study|Protocol Violation|0|||
27992148|NCT01393639|81802006|FG003|Overall Study|Protocol Violation|1|||
27992149|NCT01393639|81802007|FG004|Overall Study|Protocol Violation|0|||
27870934|NCT00369941|81361550|FG000|Overall Study|Miscellaneous|3|||
27992150|NCT01393639|81802008|FG005|Overall Study|Protocol Violation|0|||
27992151|NCT01393639|81802009|FG006|Overall Study|Protocol Violation|0|||
27992152|NCT01393639|81802003|FG000|Overall Study|Other|0|||
27992153|NCT01393639|81802004|FG001|Overall Study|Other|2|||
27992154|NCT01393639|81802005|FG002|Overall Study|Other|0|||
27992155|NCT01393639|81802006|FG003|Overall Study|Other|2|||
27992156|NCT01393639|81802007|FG004|Overall Study|Other|1|||
27992157|NCT01393639|81802008|FG005|Overall Study|Other|0|||
27992158|NCT01393639|81802009|FG006|Overall Study|Other|1|||
27992159|NCT01393639|81802003|FG000|Overall Study|Withdrawal by Subject|1|||
27992160|NCT01393639|81802004|FG001|Overall Study|Withdrawal by Subject|1|||
27992161|NCT01393639|81802005|FG002|Overall Study|Withdrawal by Subject|0|||
27992162|NCT01393639|81802006|FG003|Overall Study|Withdrawal by Subject|0|||
27992163|NCT01393639|81802007|FG004|Overall Study|Withdrawal by Subject|0|||
27992164|NCT01393639|81802008|FG005|Overall Study|Withdrawal by Subject|0|||
27992165|NCT01393639|81802009|FG006|Overall Study|Withdrawal by Subject|1|||
27992166|NCT01393639|81802003|FG000|Overall Study|Medication error without associated AE|0|||
27992167|NCT01393639|81802004|FG001|Overall Study|Medication error without associated AE|0|||
27992168|NCT01393639|81802005|FG002|Overall Study|Medication error without associated AE|0|||
27992169|NCT01393639|81802006|FG003|Overall Study|Medication error without associated AE|0|||
27992170|NCT01393639|81802007|FG004|Overall Study|Medication error without associated AE|0|||
27992171|NCT01393639|81802008|FG005|Overall Study|Medication error without associated AE|0|||
27992172|NCT01393639|81802009|FG006|Overall Study|Medication error without associated AE|1|||
27992173|NCT01393639|81802003|FG000|Overall Study|Lost to Follow-up|0|||
27992174|NCT01393639|81802004|FG001|Overall Study|Lost to Follow-up|1|||
27992175|NCT01393639|81802005|FG002|Overall Study|Lost to Follow-up|0|||
27992176|NCT01393639|81802006|FG003|Overall Study|Lost to Follow-up|0|||
27992177|NCT01393639|81802007|FG004|Overall Study|Lost to Follow-up|0|||
27992178|NCT01393639|81802008|FG005|Overall Study|Lost to Follow-up|0|||
27992179|NCT01393639|81802009|FG006|Overall Study|Lost to Follow-up|1|||
27992180|NCT01393639|81802003|FG000|Overall Study|Lack of Efficacy|0|||
27992181|NCT01393639|81802004|FG001|Overall Study|Lack of Efficacy|0|||
27992182|NCT01393639|81802005|FG002|Overall Study|Lack of Efficacy|0|||
27992183|NCT01393639|81802006|FG003|Overall Study|Lack of Efficacy|0|||
27992184|NCT01393639|81802007|FG004|Overall Study|Lack of Efficacy|0|||
27992185|NCT01393639|81802008|FG005|Overall Study|Lack of Efficacy|0|||
27992186|NCT01393639|81802009|FG006|Overall Study|Lack of Efficacy|1|||
27992187|NCT01393639|81802003|FG000|Overall Study|Adverse Event|2|||
27992188|NCT01393639|81802004|FG001|Overall Study|Adverse Event|3|||
27992189|NCT01393639|81802005|FG002|Overall Study|Adverse Event|1|||
27992190|NCT01393639|81802006|FG003|Overall Study|Adverse Event|2|||
27799364|NCT01289990|81098826|FG004|Overall Study|Death|2|||
27799365|NCT01289990|81098827|FG005|Overall Study|Death|1|||
27799366|NCT01289990|81098828|FG006|Overall Study|Death|0|||
27799367|NCT01289990|81098829|FG007|Overall Study|Death|0|||
27799368|NCT01289990|81098830|FG008|Overall Study|Death|0|||
27799369|NCT01289990|81098831|FG009|Overall Study|Death|0|||
27799370|NCT01289990|81098832|FG010|Overall Study|Death|0|||
27799371|NCT01289990|81098833|FG011|Overall Study|Death|1|||
27799372|NCT01289990|81098834|FG012|Overall Study|Death|0|||
27799373|NCT01289990|81098822|FG000|Overall Study|Lost to Follow-up|3|||
27799374|NCT01289990|81098823|FG001|Overall Study|Lost to Follow-up|2|||
27799375|NCT01289990|81098824|FG002|Overall Study|Lost to Follow-up|5|||
27799376|NCT01289990|81098825|FG003|Overall Study|Lost to Follow-up|5|||
27799377|NCT01289990|81098826|FG004|Overall Study|Lost to Follow-up|3|||
27870935|NCT00369941|81361551|FG001|Overall Study|Miscellaneous|3|||
27870936|NCT04981717|81361554|FG000|Overall Study|Protocol Violation|0|||
27870937|NCT04981717|81361555|FG001|Overall Study|Protocol Violation|3|||
27870938|NCT04981717|81361554|FG000|Overall Study|Adverse Event|1|||
27870939|NCT04981717|81361555|FG001|Overall Study|Adverse Event|3|||
27870940|NCT04981717|81361554|FG000|Overall Study|Pregnancy|1|||
27992191|NCT01393639|81802007|FG004|Overall Study|Adverse Event|0|||
27992192|NCT01393639|81802008|FG005|Overall Study|Adverse Event|2|||
27992193|NCT01393639|81802009|FG006|Overall Study|Adverse Event|3|||
27992194|NCT00193180|81802012|FG000|Overall Study|Lack of Efficacy|1|||
27799378|NCT01289990|81098827|FG005|Overall Study|Lost to Follow-up|4|||
27992195|NCT00193180|81802012|FG000|Overall Study|Adverse Event|8|||
27992196|NCT00193180|81802012|FG000|Overall Study|Protocol Violation|1|||
27992197|NCT00652951|81802015|FG000|Booster Phase|Adverse event, non-fatal|0|||
27992198|NCT00652951|81802016|FG001|Booster Phase|Adverse event, non-fatal|1|||
27992199|NCT00652951|81802017|FG002|Booster Phase|Adverse event, non-fatal|0|||
27992200|NCT00652951|81802015|FG000|Booster Phase|Other|1|||
27992201|NCT00652951|81802016|FG001|Booster Phase|Other|0|||
27799379|NCT01289990|81098828|FG006|Overall Study|Lost to Follow-up|2|||
27799380|NCT01289990|81098829|FG007|Overall Study|Lost to Follow-up|2|||
27870941|NCT04981717|81361555|FG001|Overall Study|Pregnancy|0|||
27870942|NCT04981717|81361554|FG000|Overall Study|Physician Decision|1|||
27992202|NCT00652951|81802017|FG002|Booster Phase|Other|0|||
27992203|NCT02141360|81802022|FG000|Overall Study|Withdrawal by Subject|6|||
27870943|NCT04981717|81361555|FG001|Overall Study|Physician Decision|0|||
27870944|NCT04981717|81361554|FG000|Overall Study|Sponsor Request|157|||
27870945|NCT04981717|81361555|FG001|Overall Study|Sponsor Request|172|||
27992204|NCT02141360|81802023|FG001|Overall Study|Withdrawal by Subject|0|||
27992205|NCT02141360|81802024|FG002|Overall Study|Withdrawal by Subject|0|||
27992206|NCT02141360|81802022|FG000|Overall Study|Study Terminated before Visit|1|||
27992207|NCT02141360|81802023|FG001|Overall Study|Study Terminated before Visit|0|||
27799381|NCT01289990|81098830|FG008|Overall Study|Lost to Follow-up|1|||
27676973|NCT00895895|80653547|FG004|Period 1|Protocol Violation|0|||
27676974|NCT00895895|80653543|FG000|Period 1|Withdrawal by Subject|6|||
27676975|NCT00895895|80653544|FG001|Period 1|Withdrawal by Subject|6|||
27676976|NCT00895895|80653545|FG002|Period 1|Withdrawal by Subject|8|||
27676977|NCT00895895|80653546|FG003|Period 1|Withdrawal by Subject|2|||
27676978|NCT00895895|80653547|FG004|Period 1|Withdrawal by Subject|4|||
27799382|NCT01289990|81098831|FG009|Overall Study|Lost to Follow-up|4|||
27799383|NCT01289990|81098832|FG010|Overall Study|Lost to Follow-up|2|||
27676979|NCT00895895|80653543|FG000|Period 1|unsatisfactory response-efficacy|2|||
27676980|NCT00895895|80653544|FG001|Period 1|unsatisfactory response-efficacy|0|||
27676981|NCT00895895|80653545|FG002|Period 1|unsatisfactory response-efficacy|0|||
27676982|NCT00895895|80653546|FG003|Period 1|unsatisfactory response-efficacy|0|||
27799384|NCT01289990|81098833|FG011|Overall Study|Lost to Follow-up|1|||
27799385|NCT01289990|81098834|FG012|Overall Study|Lost to Follow-up|2|||
27992208|NCT02141360|81802024|FG002|Overall Study|Study Terminated before Visit|0|||
27992209|NCT01771250|81802025|FG000|Period 1|Met exclusion criteria|1|||
27992210|NCT01771250|81802026|FG001|Period 1|Met exclusion criteria|0|||
27992211|NCT02315560|81802031|FG000|Overall Study|noncompliance by subjects|3|||
27992212|NCT03688074|81802032|FG000|Overall Study|Adverse Event|0|||
27992213|NCT03688074|81802033|FG001|Overall Study|Adverse Event|1|||
27992214|NCT03688074|81802032|FG000|Overall Study|Other|1|||
27992215|NCT03688074|81802033|FG001|Overall Study|Other|0|||
27992216|NCT00781859|81802036|FG000|Overall Study|Adverse Event|2|||
27992217|NCT00781859|81802037|FG001|Overall Study|Adverse Event|2|||
27992218|NCT00781859|81802036|FG000|Overall Study|Withdrawal by Subject|8|||
27992219|NCT00781859|81802037|FG001|Overall Study|Withdrawal by Subject|4|||
27992220|NCT00781859|81802036|FG000|Overall Study|Lost to Follow-up|6|||
27992221|NCT00781859|81802037|FG001|Overall Study|Lost to Follow-up|3|||
27799386|NCT01289990|81098822|FG000|Overall Study|Withdrawal by Subject|15|||
27799387|NCT01289990|81098823|FG001|Overall Study|Withdrawal by Subject|14|||
27799388|NCT01289990|81098824|FG002|Overall Study|Withdrawal by Subject|12|||
27799389|NCT01289990|81098825|FG003|Overall Study|Withdrawal by Subject|13|||
27799390|NCT01289990|81098826|FG004|Overall Study|Withdrawal by Subject|8|||
27799391|NCT01289990|81098827|FG005|Overall Study|Withdrawal by Subject|7|||
27799392|NCT01289990|81098828|FG006|Overall Study|Withdrawal by Subject|13|||
27799393|NCT01289990|81098829|FG007|Overall Study|Withdrawal by Subject|9|||
27799394|NCT01289990|81098830|FG008|Overall Study|Withdrawal by Subject|12|||
27799395|NCT01289990|81098831|FG009|Overall Study|Withdrawal by Subject|13|||
27799396|NCT01289990|81098832|FG010|Overall Study|Withdrawal by Subject|11|||
27799397|NCT01289990|81098833|FG011|Overall Study|Withdrawal by Subject|13|||
27799398|NCT01289990|81098834|FG012|Overall Study|Withdrawal by Subject|16|||
27799399|NCT01289990|81098822|FG000|Overall Study|discontinued in preceding trial|18|||
27992222|NCT00781859|81802036|FG000|Overall Study|Death|3|||
27992223|NCT00781859|81802037|FG001|Overall Study|Death|0|||
27992224|NCT02679287|81802038|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
27992225|NCT02679287|81802039|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
27992226|NCT02679287|81802038|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
27992227|NCT02679287|81802039|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
27992228|NCT02679287|81802038|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
27992229|NCT02679287|81802039|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
27992230|NCT02679287|81802038|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
27799400|NCT01289990|81098823|FG001|Overall Study|discontinued in preceding trial|20|||
27799401|NCT01289990|81098824|FG002|Overall Study|discontinued in preceding trial|41|||
27799402|NCT01289990|81098825|FG003|Overall Study|discontinued in preceding trial|17|||
27799403|NCT01289990|81098826|FG004|Overall Study|discontinued in preceding trial|11|||
27799404|NCT01289990|81098827|FG005|Overall Study|discontinued in preceding trial|12|||
27992231|NCT02679287|81802039|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
27676983|NCT00895895|80653547|FG004|Period 1|unsatisfactory response-efficacy|0|||
27676984|NCT00895895|80653543|FG000|Period 1|randomized and not treated|1|||
27799405|NCT01289990|81098828|FG006|Overall Study|discontinued in preceding trial|18|||
27799406|NCT01289990|81098829|FG007|Overall Study|discontinued in preceding trial|8|||
27799407|NCT01289990|81098830|FG008|Overall Study|discontinued in preceding trial|17|||
27799408|NCT01289990|81098831|FG009|Overall Study|discontinued in preceding trial|21|||
27799409|NCT01289990|81098832|FG010|Overall Study|discontinued in preceding trial|17|||
27870946|NCT04981717|81361554|FG000|Overall Study|Lost to Follow-up|4|||
27676985|NCT00895895|80653544|FG001|Period 1|randomized and not treated|3|||
27676986|NCT00895895|80653545|FG002|Period 1|randomized and not treated|1|||
27676987|NCT00895895|80653546|FG003|Period 1|randomized and not treated|1|||
27676988|NCT00895895|80653547|FG004|Period 1|randomized and not treated|2|||
27676989|NCT00895895|80653543|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
27676990|NCT00895895|80653544|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
27676991|NCT00895895|80653545|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
27676992|NCT00895895|80653546|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
27676993|NCT00895895|80653547|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
27676994|NCT00895895|80653543|FG000|After Period 1, Prior to Period 2|Other|0|||
27676995|NCT00895895|80653544|FG001|After Period 1, Prior to Period 2|Other|0|||
27676996|NCT00895895|80653545|FG002|After Period 1, Prior to Period 2|Other|1|||
27676997|NCT00895895|80653546|FG003|After Period 1, Prior to Period 2|Other|0|||
27676998|NCT00895895|80653547|FG004|After Period 1, Prior to Period 2|Other|0|||
27676999|NCT00895895|80653543|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
27677000|NCT00895895|80653544|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
27677001|NCT00895895|80653545|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
27677002|NCT00895895|80653546|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
27677003|NCT00895895|80653547|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
27677004|NCT00895895|80653543|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27677005|NCT00895895|80653544|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27677006|NCT00895895|80653545|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27677007|NCT00895895|80653546|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
27677008|NCT00895895|80653547|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
27677009|NCT00895895|80653543|FG000|Period 2|Adverse Event|3|||
27799410|NCT01289990|81098833|FG011|Overall Study|discontinued in preceding trial|17|||
27992232|NCT02679287|81802038|FG000|Period 2|Work/Scheduling Conflict|1|||
27992233|NCT02679287|81802039|FG001|Period 2|Work/Scheduling Conflict|0|||
27992234|NCT02679287|81802038|FG000|Period 2|Disliked Mobile System|2|||
27992235|NCT02679287|81802039|FG001|Period 2|Disliked Mobile System|0|||
27992236|NCT02679287|81802038|FG000|Period 3|Work/Scheduling Conflict|0|||
27992237|NCT02679287|81802039|FG001|Period 3|Work/Scheduling Conflict|1|||
27992238|NCT02279095|81802044|FG000|Overall Study|Non-Compliance|1|||
27992239|NCT02279095|81802044|FG000|Overall Study|Withdrawal by Subject|8|||
27992240|NCT02279095|81802044|FG000|Overall Study|Adverse Event|2|||
27992241|NCT02279095|81802044|FG000|Overall Study|Other|7|||
27992242|NCT02279095|81802044|FG000|Overall Study|Lost to Follow-up|1|||
27992243|NCT00950248|81802053|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
27992244|NCT00950248|81802054|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
27579335|NCT02334748|80303194|FG000|Overall Study|Adverse Event|1|||
27579336|NCT02334748|80303194|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
27579337|NCT02334748|80303194|FG000|Overall Study|Patient no longer required study drug|2|||
27579338|NCT02334748|80303194|FG000|Overall Study|Lack of Efficacy|4|||
27579339|NCT01513317|80303197|FG000|Overall Study|Withdrawal by Subject|15|||
27579340|NCT01513317|80303198|FG001|Overall Study|Withdrawal by Subject|4|||
27579341|NCT01513317|80303197|FG000|Overall Study|Death|1|||
27579342|NCT01513317|80303198|FG001|Overall Study|Death|1|||
27579343|NCT01513317|80303197|FG000|Overall Study|Study terminated by sponsor|18|||
27579344|NCT01513317|80303198|FG001|Overall Study|Study terminated by sponsor|18|||
27579345|NCT01513317|80303197|FG000|Overall Study|Other|0|||
27579346|NCT01513317|80303198|FG001|Overall Study|Other|1|||
27579347|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Adverse Event|41|||
27579348|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Adverse Event|24|||
27579349|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
27579350|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
27579351|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
27579352|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
27579353|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Physician Decision|0|||
27579354|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Physician Decision|6|||
27579355|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
27579356|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
27579357|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
27579358|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
27579359|NCT00673452|80303199|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
27579360|NCT00673452|80303200|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
27579361|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
27579362|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
27579363|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
27579364|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
27579365|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
27579366|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
27579367|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
27677010|NCT00895895|80653544|FG001|Period 2|Adverse Event|3|||
27677011|NCT00895895|80653545|FG002|Period 2|Adverse Event|5|||
27677012|NCT00895895|80653546|FG003|Period 2|Adverse Event|2|||
27677013|NCT00895895|80653547|FG004|Period 2|Adverse Event|5|||
27677014|NCT00895895|80653543|FG000|Period 2|Death|0|||
27677015|NCT00895895|80653544|FG001|Period 2|Death|0|||
27677016|NCT00895895|80653545|FG002|Period 2|Death|1|||
27677017|NCT00895895|80653546|FG003|Period 2|Death|0|||
27677018|NCT00895895|80653547|FG004|Period 2|Death|0|||
27677019|NCT00895895|80653543|FG000|Period 2|discontinued by sponsor|44|||
27677020|NCT00895895|80653544|FG001|Period 2|discontinued by sponsor|44|||
27677021|NCT00895895|80653545|FG002|Period 2|discontinued by sponsor|38|||
27677022|NCT00895895|80653546|FG003|Period 2|discontinued by sponsor|46|||
27677023|NCT00895895|80653547|FG004|Period 2|discontinued by sponsor|37|||
27677024|NCT00895895|80653543|FG000|Period 2|failed to return|2|||
27677025|NCT00895895|80653544|FG001|Period 2|failed to return|0|||
27677026|NCT00895895|80653545|FG002|Period 2|failed to return|0|||
27677027|NCT00895895|80653546|FG003|Period 2|failed to return|0|||
27677028|NCT00895895|80653547|FG004|Period 2|failed to return|0|||
27677029|NCT00895895|80653543|FG000|Period 2|investigator request|2|||
27677030|NCT00895895|80653544|FG001|Period 2|investigator request|0|||
27677031|NCT00895895|80653545|FG002|Period 2|investigator request|0|||
27677032|NCT00895895|80653546|FG003|Period 2|investigator request|0|||
27677033|NCT00895895|80653547|FG004|Period 2|investigator request|0|||
27677034|NCT00895895|80653543|FG000|Period 2|Lost to Follow-up|1|||
27677035|NCT00895895|80653544|FG001|Period 2|Lost to Follow-up|2|||
27677036|NCT00895895|80653545|FG002|Period 2|Lost to Follow-up|1|||
27677037|NCT00895895|80653546|FG003|Period 2|Lost to Follow-up|1|||
27677038|NCT00895895|80653547|FG004|Period 2|Lost to Follow-up|0|||
27677039|NCT00895895|80653543|FG000|Period 2|Other|1|||
27677040|NCT00895895|80653544|FG001|Period 2|Other|1|||
27677041|NCT00895895|80653545|FG002|Period 2|Other|3|||
27677042|NCT00895895|80653546|FG003|Period 2|Other|1|||
27677043|NCT00895895|80653547|FG004|Period 2|Other|1|||
27677044|NCT00895895|80653543|FG000|Period 2|Protocol Violation|1|||
27677045|NCT00895895|80653544|FG001|Period 2|Protocol Violation|0|||
27677046|NCT00895895|80653545|FG002|Period 2|Protocol Violation|1|||
27677047|NCT00895895|80653546|FG003|Period 2|Protocol Violation|1|||
27677048|NCT00895895|80653547|FG004|Period 2|Protocol Violation|1|||
27677049|NCT00895895|80653543|FG000|Period 2|Withdrawal by Subject|0|||
27677050|NCT00895895|80653544|FG001|Period 2|Withdrawal by Subject|2|||
27677051|NCT00895895|80653545|FG002|Period 2|Withdrawal by Subject|0|||
27677052|NCT00895895|80653546|FG003|Period 2|Withdrawal by Subject|3|||
27677053|NCT00895895|80653547|FG004|Period 2|Withdrawal by Subject|5|||
27677054|NCT00895895|80653543|FG000|Period 2|unsatisfactory response-efficacy|2|||
27677055|NCT00895895|80653544|FG001|Period 2|unsatisfactory response-efficacy|1|||
27677056|NCT00895895|80653545|FG002|Period 2|unsatisfactory response-efficacy|0|||
27677057|NCT00895895|80653546|FG003|Period 2|unsatisfactory response-efficacy|0|||
27677058|NCT00895895|80653547|FG004|Period 2|unsatisfactory response-efficacy|0|||
27677059|NCT02980042|80653549|FG000|Overall Study|Lost to Follow-up|5|||
27677060|NCT02980042|80653550|FG001|Overall Study|Lost to Follow-up|0|||
27677061|NCT02980042|80653549|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
27677062|NCT02980042|80653550|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
27677063|NCT02336425|80653555|FG000|Overall Study|Study terminated.|2|||
27677064|NCT02336425|80653556|FG001|Overall Study|Study terminated.|2|||
27677065|NCT02336425|80653557|FG002|Overall Study|Study terminated.|3|||
27677066|NCT02336425|80653558|FG003|Overall Study|Study terminated.|3|||
27677067|NCT01967069|80653559|FG000|Overall Study|Adverse Event|2|||
27677068|NCT01967069|80653560|FG001|Overall Study|Adverse Event|2|||
27677069|NCT01967069|80653559|FG000|Overall Study|Lost to Follow-up|5|||
27677070|NCT01967069|80653560|FG001|Overall Study|Lost to Follow-up|2|||
27677071|NCT01967069|80653559|FG000|Overall Study|Withdrawal by Subject|1|||
27677072|NCT01967069|80653560|FG001|Overall Study|Withdrawal by Subject|3|||
27677073|NCT01967069|80653559|FG000|Overall Study|Lack of Efficacy|0|||
27677074|NCT01967069|80653560|FG001|Overall Study|Lack of Efficacy|1|||
27677075|NCT01162486|80653561|FG000|Overall Study|low ANC|1|||
27677076|NCT01162486|80653562|FG001|Overall Study|low ANC|0|||
27677077|NCT01162486|80653563|FG002|Overall Study|low ANC|0|||
27677078|NCT01162486|80653564|FG003|Overall Study|low ANC|0|||
27677079|NCT01162486|80653565|FG004|Overall Study|low ANC|0|||
27677080|NCT01162486|80653561|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
27677081|NCT01162486|80653562|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27677082|NCT01162486|80653563|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27677083|NCT01162486|80653564|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27677084|NCT01162486|80653565|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
27677085|NCT01162486|80653561|FG000|Overall Study|elevated LFTs|0|||
27677086|NCT01162486|80653562|FG001|Overall Study|elevated LFTs|0|||
27677087|NCT01162486|80653563|FG002|Overall Study|elevated LFTs|1|||
27677088|NCT01162486|80653564|FG003|Overall Study|elevated LFTs|0|||
27677089|NCT01162486|80653565|FG004|Overall Study|elevated LFTs|0|||
27677090|NCT01162486|80653561|FG000|Overall Study|Pregnancy|0|||
27677091|NCT01162486|80653562|FG001|Overall Study|Pregnancy|0|||
27677092|NCT01162486|80653563|FG002|Overall Study|Pregnancy|0|||
27677093|NCT01162486|80653564|FG003|Overall Study|Pregnancy|1|||
27677094|NCT01162486|80653565|FG004|Overall Study|Pregnancy|0|||
27677095|NCT01607476|80653566|FG000|Overall Study|Withdrawal by Subject|1|||
27677096|NCT01607476|80653567|FG001|Overall Study|Withdrawal by Subject|0|||
27677097|NCT01607476|80653568|FG002|Overall Study|Withdrawal by Subject|1|||
27677098|NCT01607476|80653566|FG000|Overall Study|Lost to Follow-up|0|||
27677099|NCT01607476|80653567|FG001|Overall Study|Lost to Follow-up|0|||
27677100|NCT01607476|80653568|FG002|Overall Study|Lost to Follow-up|2|||
27677101|NCT04829747|80653569|FG000|Overall Study|Protocol Violation|1|||
27677102|NCT01987895|80653570|FG000|Overall Study|Withdrawal by Subject|12|||
27677103|NCT01987895|80653571|FG001|Overall Study|Withdrawal by Subject|7|||
27677104|NCT01987895|80653570|FG000|Overall Study|Physician Decision|8|||
27677105|NCT01987895|80653571|FG001|Overall Study|Physician Decision|10|||
27677106|NCT01987895|80653570|FG000|Overall Study|Death|7|||
27677107|NCT01987895|80653571|FG001|Overall Study|Death|7|||
27677108|NCT01987895|80653570|FG000|Overall Study|Lost to Follow-up|3|||
27677109|NCT01987895|80653571|FG001|Overall Study|Lost to Follow-up|5|||
27677110|NCT01987895|80653570|FG000|Overall Study|randomized before giving IC|0|||
27677111|NCT01987895|80653571|FG001|Overall Study|randomized before giving IC|1|||
27799411|NCT01289990|81098834|FG012|Overall Study|discontinued in preceding trial|24|||
27799412|NCT01289990|81098822|FG000|Overall Study|did not continue in extension|41|||
27799413|NCT01289990|81098823|FG001|Overall Study|did not continue in extension|45|||
27799414|NCT01289990|81098824|FG002|Overall Study|did not continue in extension|51|||
27799415|NCT01289990|81098825|FG003|Overall Study|did not continue in extension|51|||
27799416|NCT01289990|81098826|FG004|Overall Study|did not continue in extension|48|||
27799417|NCT01289990|81098827|FG005|Overall Study|did not continue in extension|50|||
27799418|NCT01289990|81098828|FG006|Overall Study|did not continue in extension|54|||
27799419|NCT01289990|81098829|FG007|Overall Study|did not continue in extension|36|||
27799420|NCT01289990|81098830|FG008|Overall Study|did not continue in extension|44|||
27799421|NCT01289990|81098831|FG009|Overall Study|did not continue in extension|48|||
27799422|NCT01289990|81098832|FG010|Overall Study|did not continue in extension|45|||
27799423|NCT01289990|81098833|FG011|Overall Study|did not continue in extension|34|||
27799424|NCT01289990|81098834|FG012|Overall Study|did not continue in extension|56|||
27799425|NCT01289990|81098822|FG000|Overall Study|Not treated|0|||
27799426|NCT01289990|81098823|FG001|Overall Study|Not treated|0|||
27799427|NCT01289990|81098824|FG002|Overall Study|Not treated|0|||
27799428|NCT01289990|81098825|FG003|Overall Study|Not treated|0|||
27799429|NCT01289990|81098826|FG004|Overall Study|Not treated|0|||
27799430|NCT01289990|81098827|FG005|Overall Study|Not treated|0|||
27799431|NCT01289990|81098828|FG006|Overall Study|Not treated|1|||
27799432|NCT01289990|81098829|FG007|Overall Study|Not treated|0|||
27799433|NCT01289990|81098830|FG008|Overall Study|Not treated|1|||
27799434|NCT01289990|81098831|FG009|Overall Study|Not treated|0|||
27799435|NCT01289990|81098832|FG010|Overall Study|Not treated|1|||
27799436|NCT01289990|81098833|FG011|Overall Study|Not treated|2|||
27799437|NCT01289990|81098834|FG012|Overall Study|Not treated|0|||
27579368|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
27677112|NCT02870972|80653572|FG000|Overall Study|Adverse Event|1|||
27677113|NCT02870972|80653573|FG001|Overall Study|Adverse Event|0|||
27677114|NCT02870972|80653574|FG002|Overall Study|Adverse Event|0|||
27677115|NCT02870972|80653575|FG003|Overall Study|Adverse Event|0|||
27677116|NCT02870972|80653576|FG004|Overall Study|Adverse Event|0|||
27677117|NCT00996606|80653589|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
27677118|NCT00996606|80653589|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27677119|NCT00996606|80653589|FG000|Overall Study|Protocol Violation|1|||
27677120|NCT00996606|80653589|FG000|Overall Study|Withdrawal by Subject|3|||
27677121|NCT00965497|80653591|FG000|Overall Study|Physician Decision|1|||
27677122|NCT00351377|80653592|FG000|Overall Study|Adverse Event|5|||
27677123|NCT00351377|80653592|FG000|Overall Study|Death|1|||
27677124|NCT00351377|80653592|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27677125|NCT00245960|80653595|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
27677126|NCT00245960|80653596|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
27799438|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
27799439|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
27799440|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
27799441|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
27579369|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
27799442|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
27579370|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
27579371|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
27579372|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
27579373|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
27579374|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
27579375|NCT00673452|80303199|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
27677127|NCT00245960|80653595|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
27677128|NCT00245960|80653596|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
27677129|NCT00245960|80653595|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
27677130|NCT00245960|80653596|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
27677131|NCT00245960|80653595|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
27677132|NCT00245960|80653596|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
27677133|NCT00245960|80653595|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
27677134|NCT00245960|80653596|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
27677135|NCT00245960|80653595|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
27677136|NCT00245960|80653596|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
27677137|NCT00245960|80653595|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
27677138|NCT00245960|80653596|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
27677139|NCT00245960|80653595|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
27677140|NCT00245960|80653596|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
27677141|NCT00245960|80653595|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
27677142|NCT00245960|80653596|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
27677143|NCT00245960|80653595|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
27677144|NCT00245960|80653596|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
27677145|NCT00245960|80653595|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
27677146|NCT00245960|80653596|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
27677147|NCT00245960|80653595|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
27677148|NCT00245960|80653596|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
27677149|NCT00953615|80653599|FG000|Overall Study|Adverse Event|1|||
27677150|NCT03510455|80653600|FG000|Overall Study|Physician Decision|1|||
27677151|NCT03721172|80653601|FG000|Placebo-controlled Phase|Adverse Event|7|||
27677152|NCT03721172|80653602|FG001|Placebo-controlled Phase|Adverse Event|7|||
27677153|NCT03721172|80653603|FG002|Placebo-controlled Phase|Adverse Event|0|||
27677154|NCT03721172|80653601|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
27677155|NCT03721172|80653602|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
27677156|NCT03721172|80653603|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
27677157|NCT03721172|80653601|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
27677158|NCT03721172|80653602|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
27677159|NCT03721172|80653603|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
27677160|NCT03721172|80653601|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
27677161|NCT03721172|80653602|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
27677162|NCT03721172|80653603|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
27677163|NCT03721172|80653601|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
27677164|NCT03721172|80653602|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
27677165|NCT03721172|80653603|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
27677166|NCT03721172|80653601|FG000|Placebo-controlled Phase|Other|3|||
27677167|NCT03721172|80653602|FG001|Placebo-controlled Phase|Other|0|||
27677168|NCT03721172|80653603|FG002|Placebo-controlled Phase|Other|0|||
27677169|NCT03721172|80653601|FG000|Apremilast Extension Phase|Adverse Event|0|||
27677170|NCT03721172|80653602|FG001|Apremilast Extension Phase|Adverse Event|0|||
27677171|NCT03721172|80653603|FG002|Apremilast Extension Phase|Adverse Event|10|||
27677172|NCT03721172|80653601|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
27677173|NCT03721172|80653602|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
27677174|NCT03721172|80653603|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
27677175|NCT03721172|80653601|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
27677176|NCT03721172|80653602|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
27677177|NCT03721172|80653603|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
27677178|NCT03721172|80653601|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
27677179|NCT03721172|80653602|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
27677180|NCT03721172|80653603|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
27677181|NCT03721172|80653601|FG000|Apremilast Extension Phase|Protocol Violation|0|||
27677182|NCT03721172|80653602|FG001|Apremilast Extension Phase|Protocol Violation|0|||
27677183|NCT03721172|80653603|FG002|Apremilast Extension Phase|Protocol Violation|1|||
27677184|NCT03721172|80653601|FG000|Apremilast Extension Phase|Physician Decision|0|||
27677185|NCT03721172|80653602|FG001|Apremilast Extension Phase|Physician Decision|0|||
27677186|NCT03721172|80653603|FG002|Apremilast Extension Phase|Physician Decision|1|||
27677187|NCT03721172|80653601|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
27677188|NCT03721172|80653602|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
27677189|NCT03721172|80653603|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
27677190|NCT03721172|80653601|FG000|Apremilast Extension Phase|Other|0|||
27677191|NCT03721172|80653602|FG001|Apremilast Extension Phase|Other|0|||
27677192|NCT03721172|80653603|FG002|Apremilast Extension Phase|Other|3|||
27677193|NCT03721172|80653601|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
27677194|NCT03721172|80653602|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
27677195|NCT03721172|80653603|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
27677196|NCT00600613|80653609|FG000|Overall Study|Protocol Deviation|1|||
27677197|NCT03548220|80653610|FG000|Overall Study|Lost to Follow-up|1|||
27677198|NCT03548220|80653611|FG001|Overall Study|Lost to Follow-up|0|||
27677199|NCT03548220|80653612|FG002|Overall Study|Lost to Follow-up|0|||
27677200|NCT03548220|80653613|FG003|Overall Study|Lost to Follow-up|0|||
27677201|NCT02053610|80653614|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
27677202|NCT02053610|80653615|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
27677203|NCT02053610|80653614|FG000|Overall Study|Withdrew Consent|2|||
27677204|NCT02053610|80653615|FG001|Overall Study|Withdrew Consent|9|||
27677205|NCT02053610|80653614|FG000|Overall Study|Death|5|||
27677206|NCT02053610|80653615|FG001|Overall Study|Death|5|||
27677207|NCT02053610|80653614|FG000|Overall Study|Administrative/Other|1|||
27677208|NCT02053610|80653615|FG001|Overall Study|Administrative/Other|1|||
27992245|NCT00950248|81802055|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
27992246|NCT00950248|81802053|FG000|Year 1: Baseline|worsening of symptoms|2|||
27992247|NCT00950248|81802054|FG001|Year 1: Baseline|worsening of symptoms|0|||
27992248|NCT00950248|81802055|FG002|Year 1: Baseline|worsening of symptoms|0|||
27992249|NCT00950248|81802053|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
27677209|NCT02053610|80653614|FG000|Overall Study|Disease Progression|2|||
27677210|NCT02053610|80653615|FG001|Overall Study|Disease Progression|3|||
27677211|NCT02053610|80653614|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
27677212|NCT02053610|80653615|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
27677213|NCT02053610|80653614|FG000|Overall Study|Did not Receive Treatment|4|||
27677214|NCT02053610|80653615|FG001|Overall Study|Did not Receive Treatment|2|||
27677215|NCT02053610|80653614|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27677216|NCT02053610|80653615|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27677217|NCT02053610|80653614|FG000|Overall Study|Violation of Selection Criteria|1|||
27677218|NCT02053610|80653615|FG001|Overall Study|Violation of Selection Criteria|0|||
27799443|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
27799444|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
27799445|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
27799446|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27799447|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27799448|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27799449|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
27799450|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
27799451|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27799452|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27799453|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
27799454|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
27799455|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
27799456|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
27799457|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
27799458|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
27799459|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
27799460|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
27799461|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
27799462|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
27870947|NCT04981717|81361555|FG001|Overall Study|Lost to Follow-up|5|||
27870948|NCT04981717|81361554|FG000|Overall Study|Withdrawal by Subject|50|||
27870949|NCT04981717|81361555|FG001|Overall Study|Withdrawal by Subject|37|||
27870950|NCT02286843|81361556|FG000|Overall Study|Not Treated|4|||
27870951|NCT02286843|81361556|FG000|Overall Study|Protocol Violation|1|||
27870952|NCT02286843|81361556|FG000|Overall Study|Withdrawal by Subject|1|||
27870953|NCT00577863|81361557|FG000|Overall Study|Adverse Event|4|||
27870954|NCT00577863|81361558|FG001|Overall Study|Adverse Event|2|||
27870955|NCT00577863|81361557|FG000|Overall Study|Death|1|||
27992250|NCT00950248|81802054|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
27992251|NCT00950248|81802055|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
27677219|NCT04206085|80653616|FG000|Overall Study|Lost to Follow-up|0|||
27677220|NCT04206085|80653617|FG001|Overall Study|Lost to Follow-up|1|||
27677221|NCT04206085|80653618|FG002|Overall Study|Lost to Follow-up|0|||
27677222|NCT04206085|80653616|FG000|Overall Study|Lost to Follow-up|0|||
27677223|NCT04206085|80653617|FG001|Overall Study|Lost to Follow-up|0|||
27677224|NCT04206085|80653618|FG002|Overall Study|Lost to Follow-up|1|||
27677225|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
27677226|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
27799463|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27799464|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
27799465|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27799466|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
27799467|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27799468|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27799469|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
27799470|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
27799471|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27799472|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
27799473|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
27799474|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27799475|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27799476|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
27799477|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
27799478|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
27799479|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
27799480|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
27799481|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
27799482|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
27799483|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
27799484|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
27799485|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
27799486|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
27799487|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
27799488|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27799489|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
27799490|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27799491|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27799492|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27799493|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
27799494|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
27799495|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
27799496|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
27799497|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
27799498|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
27799499|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
27799500|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
27799501|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
27799502|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
27799503|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
27799504|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
27799505|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
27799506|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
27799507|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
27799508|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
27799509|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
27799510|NCT04440163|81098835|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
27799511|NCT04440163|81098836|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
27799512|NCT04440163|81098837|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
27799513|NCT04440163|81098838|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
27799514|NCT04440163|81098839|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
27799515|NCT04440163|81098840|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
27677227|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
27677228|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
27677229|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
27677230|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
27677231|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
27677232|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
27677233|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
27677234|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
27677235|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
27677236|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
27677237|NCT00790400|80653619|FG000|Double-blind Period (Core Phase)|Death|1|||
27677238|NCT00790400|80653620|FG001|Double-blind Period (Core Phase)|Death|0|||
27677239|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
27677240|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
27677241|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
27677242|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
27677243|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
27677244|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
27677245|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
27677246|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
27677247|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
27677248|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
27677249|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Death|1|||
27677250|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Death|0|||
27677251|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
27677252|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
27677253|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
27677254|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
27677255|NCT00790400|80653619|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
27677256|NCT00790400|80653620|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
27677257|NCT00623805|80653623|FG000|Overall Study|Adverse Event|9|||
27677258|NCT00623805|80653624|FG001|Overall Study|Adverse Event|6|||
27677259|NCT00623805|80653623|FG000|Overall Study|Death|2|||
27677260|NCT00623805|80653624|FG001|Overall Study|Death|0|||
27677261|NCT00623805|80653623|FG000|Overall Study|Lack of Efficacy|3|||
27799516|NCT04440163|81098841|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
27799517|NCT04440163|81098842|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
27799518|NCT04440163|81098835|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
27799519|NCT04440163|81098836|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
27799520|NCT04440163|81098837|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
27799521|NCT04440163|81098838|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
27799522|NCT04440163|81098839|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
27799523|NCT04440163|81098840|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
27870956|NCT00577863|81361558|FG001|Overall Study|Death|0|||
27992252|NCT00950248|81802053|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
27992253|NCT00950248|81802054|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
27992254|NCT00950248|81802055|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
27992255|NCT00950248|81802053|FG000|Year 2&3 Treatment Randomization|Death|0|||
27992256|NCT00950248|81802054|FG001|Year 2&3 Treatment Randomization|Death|0|||
27992257|NCT00950248|81802055|FG002|Year 2&3 Treatment Randomization|Death|1|||
27992258|NCT00950248|81802053|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
27992259|NCT00950248|81802054|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
27992260|NCT00950248|81802055|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
27992261|NCT04158583|81802058|FG000|Overall Study|Withdrawal by Subject|1|||
27992262|NCT04158583|81802059|FG001|Overall Study|Withdrawal by Subject|1|||
27992263|NCT04158583|81802060|FG002|Overall Study|Withdrawal by Subject|0|||
27992264|NCT04158583|81802061|FG003|Overall Study|Withdrawal by Subject|0|||
27992265|NCT04158583|81802062|FG004|Overall Study|Withdrawal by Subject|1|||
27992266|NCT04158583|81802063|FG005|Overall Study|Withdrawal by Subject|0|||
27992267|NCT04158583|81802064|FG006|Overall Study|Withdrawal by Subject|0|||
27992268|NCT04158583|81802065|FG007|Overall Study|Withdrawal by Subject|0|||
27992269|NCT04158583|81802066|FG008|Overall Study|Withdrawal by Subject|2|||
27992270|NCT04158583|81802067|FG009|Overall Study|Withdrawal by Subject|0|||
27992271|NCT04158583|81802058|FG000|Overall Study|Study Terminated by Sponsor|0|||
27677262|NCT00623805|80653624|FG001|Overall Study|Lack of Efficacy|7|||
27677263|NCT00623805|80653623|FG000|Overall Study|Lost to Follow-up|2|||
27677264|NCT00623805|80653624|FG001|Overall Study|Lost to Follow-up|2|||
27677265|NCT00623805|80653623|FG000|Overall Study|Protocol Violation|1|||
27992272|NCT04158583|81802059|FG001|Overall Study|Study Terminated by Sponsor|0|||
27992273|NCT04158583|81802060|FG002|Overall Study|Study Terminated by Sponsor|0|||
27677266|NCT00623805|80653624|FG001|Overall Study|Protocol Violation|1|||
27677267|NCT00623805|80653623|FG000|Overall Study|Reason not Specified|3|||
27677268|NCT00623805|80653624|FG001|Overall Study|Reason not Specified|6|||
27677269|NCT04843579|80653626|FG000|Overall Study|Adverse Event|1|||
27677270|NCT04843579|80653626|FG000|Overall Study|Disease Progression|1|||
27677271|NCT02637323|80656628|FG000|Overall Study|Lost to Follow-up|2|||
27677272|NCT02637323|80656629|FG001|Overall Study|Lost to Follow-up|0|||
27677273|NCT02637323|80656628|FG000|Overall Study|Protocol Violation|0|||
27677274|NCT02637323|80656629|FG001|Overall Study|Protocol Violation|1|||
27677275|NCT01465763|80656630|FG000|Overall Study|Withdrawal by Subject|4|||
27677276|NCT01465763|80656631|FG001|Overall Study|Withdrawal by Subject|0|||
27677277|NCT01465763|80656632|FG002|Overall Study|Withdrawal by Subject|1|||
27677278|NCT01465763|80656630|FG000|Overall Study|Insufficient Clinical Response|11|||
27677279|NCT01465763|80656631|FG001|Overall Study|Insufficient Clinical Response|0|||
27677280|NCT01465763|80656632|FG002|Overall Study|Insufficient Clinical Response|1|||
27677281|NCT01465763|80656630|FG000|Overall Study|Adverse Event|9|||
27677282|NCT01465763|80656631|FG001|Overall Study|Adverse Event|0|||
27677283|NCT01465763|80656632|FG002|Overall Study|Adverse Event|1|||
27677284|NCT01465763|80656630|FG000|Overall Study|Other|2|||
27677285|NCT01465763|80656631|FG001|Overall Study|Other|0|||
27677286|NCT01465763|80656632|FG002|Overall Study|Other|0|||
27677287|NCT01465763|80656630|FG000|Overall Study|Protocol Violation|4|||
27677288|NCT01465763|80656631|FG001|Overall Study|Protocol Violation|1|||
27677289|NCT01465763|80656632|FG002|Overall Study|Protocol Violation|1|||
27677290|NCT01465763|80656630|FG000|Overall Study|Death|1|||
27677291|NCT01465763|80656631|FG001|Overall Study|Death|0|||
27677292|NCT01465763|80656632|FG002|Overall Study|Death|0|||
27677293|NCT01245374|80656633|FG000|Overall Study|Protocol Violation|1|||
27677294|NCT01245374|80656633|FG000|Overall Study|Withdrawal by Subject|3|||
27677295|NCT00246090|80656636|FG000|Overall Study|Adverse Event|25|||
27677296|NCT00246090|80656636|FG000|Overall Study|Withdrawal by Subject|7|||
27677297|NCT00246090|80656636|FG000|Overall Study|Progressive Disease|212|||
27677298|NCT00246090|80656636|FG000|Overall Study|Clinical Progression|30|||
27677299|NCT00246090|80656636|FG000|Overall Study|Physician Decision|11|||
27677300|NCT00246090|80656636|FG000|Overall Study|Not Otherwise Specified|10|||
27677301|NCT03559062|80656637|FG000|Overall Study|Other|0|||
27677302|NCT03559062|80656638|FG001|Overall Study|Other|1|||
27677303|NCT03559062|80656639|FG002|Overall Study|Other|0|||
27677304|NCT02631577|80656642|FG000|Overall Study|Death|1|||
27677305|NCT02631577|80656643|FG001|Overall Study|Death|7|||
27677306|NCT02631577|80656642|FG000|Overall Study|Withdrawal by Subject|0|||
27677307|NCT02631577|80656643|FG001|Overall Study|Withdrawal by Subject|3|||
27677308|NCT00611975|80656645|FG000|Overall Study|Withdrawal by Subject|3|||
27677309|NCT00611975|80656646|FG001|Overall Study|Withdrawal by Subject|7|||
27677310|NCT00611975|80656645|FG000|Overall Study|Pregnancy|2|||
27677311|NCT00611975|80656646|FG001|Overall Study|Pregnancy|1|||
27677312|NCT01920477|80656648|FG000|Overall Study|Adverse Event|0|||
27799524|NCT04440163|81098841|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
27799525|NCT04440163|81098842|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
27799526|NCT04440163|81098835|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27799527|NCT04440163|81098836|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27799528|NCT04440163|81098837|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27992274|NCT04158583|81802061|FG003|Overall Study|Study Terminated by Sponsor|1|||
27992275|NCT04158583|81802062|FG004|Overall Study|Study Terminated by Sponsor|0|||
27677313|NCT01920477|80656649|FG001|Overall Study|Adverse Event|1|||
27677314|NCT01920477|80656648|FG000|Overall Study|Lack of Efficacy|1|||
27677315|NCT01920477|80656649|FG001|Overall Study|Lack of Efficacy|0|||
27677316|NCT01920477|80656648|FG000|Overall Study|Study closed/terminated|14|||
27677317|NCT01920477|80656649|FG001|Overall Study|Study closed/terminated|15|||
27677318|NCT01920477|80656648|FG000|Overall Study|Withdrawal by Subject|0|||
27799529|NCT04440163|81098838|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
27799530|NCT04440163|81098839|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27992276|NCT04158583|81802063|FG005|Overall Study|Study Terminated by Sponsor|0|||
27677319|NCT01920477|80656649|FG001|Overall Study|Withdrawal by Subject|1|||
27677320|NCT01417104|80656653|FG000|Overall Study|Withdrawal by Subject|5|||
27677321|NCT01417104|80656654|FG001|Overall Study|Withdrawal by Subject|1|||
27677322|NCT01417104|80656653|FG000|Overall Study|Failure to make contact|0|||
27677323|NCT01417104|80656654|FG001|Overall Study|Failure to make contact|1|||
27677324|NCT01417104|80656653|FG000|Overall Study|Adverse Event|1|||
27799531|NCT04440163|81098840|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27677325|NCT01417104|80656654|FG001|Overall Study|Adverse Event|0|||
27677326|NCT01730378|80656657|FG000|Overall Study|Lost to Follow-up|1|||
27677327|NCT01730378|80656658|FG001|Overall Study|Lost to Follow-up|0|||
27677328|NCT00643617|80656659|FG000|Overall Study|Death|6|||
27677329|NCT00643617|80656660|FG001|Overall Study|Death|9|||
27677330|NCT00643617|80656659|FG000|Overall Study|Lost to Follow-up|42|||
27677331|NCT00643617|80656660|FG001|Overall Study|Lost to Follow-up|51|||
27677332|NCT00384397|80656661|FG000|Overall Study|Adverse Event|0|||
27677333|NCT00384397|80656662|FG001|Overall Study|Adverse Event|1|||
27677334|NCT00384397|80656663|FG002|Overall Study|Adverse Event|2|||
27677335|NCT00384397|80656661|FG000|Overall Study|Protocol Violation|7|||
27677336|NCT00384397|80656662|FG001|Overall Study|Protocol Violation|15|||
27677337|NCT00384397|80656663|FG002|Overall Study|Protocol Violation|13|||
27677338|NCT00384397|80656661|FG000|Overall Study|Lost to Follow-up|11|||
27677339|NCT00384397|80656662|FG001|Overall Study|Lost to Follow-up|13|||
27677340|NCT00384397|80656663|FG002|Overall Study|Lost to Follow-up|3|||
27677341|NCT00384397|80656661|FG000|Overall Study|Withdrawal by Subject|14|||
27677342|NCT00384397|80656662|FG001|Overall Study|Withdrawal by Subject|17|||
27677343|NCT00384397|80656663|FG002|Overall Study|Withdrawal by Subject|15|||
27677344|NCT04343976|80656666|FG000|Overall Study|Withdrawal by Subject|0|||
27677345|NCT04343976|80656667|FG001|Overall Study|Withdrawal by Subject|1|||
27677346|NCT04949802|80656668|FG000|Overall Study|Lost to Follow-up|3|||
27677347|NCT03406078|80656669|FG000|Overall Study|Death|1|||
27677348|NCT03406078|80656670|FG001|Overall Study|Death|0|||
27677349|NCT03406078|80656669|FG000|Overall Study|Lost to Follow-up|0|||
27677350|NCT03406078|80656670|FG001|Overall Study|Lost to Follow-up|1|||
27677351|NCT03406078|80656669|FG000|Overall Study|Withdrawal by Subject|5|||
27677352|NCT03406078|80656670|FG001|Overall Study|Withdrawal by Subject|2|||
27677353|NCT00412607|80656671|FG000|Overall Study|Withdrawal by Subject|9|||
27677354|NCT00412607|80656671|FG000|Overall Study|Lost to Follow-up|19|||
27677355|NCT00412607|80656671|FG000|Overall Study|Death|61|||
27677356|NCT00412607|80656671|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
27677357|NCT01252355|80656676|FG000|Overall Study|Adverse Event|9|||
27677358|NCT01252355|80656677|FG001|Overall Study|Adverse Event|17|||
27677359|NCT01252355|80656678|FG002|Overall Study|Adverse Event|22|||
27677360|NCT01252355|80656676|FG000|Overall Study|Lack of Efficacy|6|||
27677361|NCT01252355|80656677|FG001|Overall Study|Lack of Efficacy|4|||
27677362|NCT01252355|80656678|FG002|Overall Study|Lack of Efficacy|2|||
27677363|NCT01252355|80656676|FG000|Overall Study|Lost to Follow-up|0|||
27677364|NCT01252355|80656677|FG001|Overall Study|Lost to Follow-up|0|||
27677365|NCT01252355|80656678|FG002|Overall Study|Lost to Follow-up|1|||
27677366|NCT01252355|80656676|FG000|Overall Study|Poor Compliance to Protocol|1|||
27677367|NCT01252355|80656677|FG001|Overall Study|Poor Compliance to Protocol|1|||
27677368|NCT01252355|80656678|FG002|Overall Study|Poor Compliance to Protocol|1|||
27677369|NCT01252355|80656676|FG000|Overall Study|Progressive Disease|2|||
27677370|NCT01252355|80656677|FG001|Overall Study|Progressive Disease|0|||
27677371|NCT01252355|80656678|FG002|Overall Study|Progressive Disease|0|||
27677372|NCT01252355|80656676|FG000|Overall Study|Sponsor Early Termination of Study|149|||
27677373|NCT01252355|80656677|FG001|Overall Study|Sponsor Early Termination of Study|149|||
27677374|NCT01252355|80656678|FG002|Overall Study|Sponsor Early Termination of Study|146|||
27677375|NCT01252355|80656676|FG000|Overall Study|Randomized but not Treated|2|||
27677376|NCT01252355|80656677|FG001|Overall Study|Randomized but not Treated|0|||
27677377|NCT01252355|80656678|FG002|Overall Study|Randomized but not Treated|0|||
27677378|NCT01252355|80656676|FG000|Overall Study|Other Than Above|8|||
27677379|NCT01252355|80656677|FG001|Overall Study|Other Than Above|7|||
27677380|NCT01252355|80656678|FG002|Overall Study|Other Than Above|7|||
27677381|NCT03519204|80656679|FG000|Overall Study|Lost to Follow-up|3|||
27677382|NCT03519204|80656680|FG001|Overall Study|Lost to Follow-up|8|||
27677383|NCT03519204|80656679|FG000|Overall Study|Withdrawal by Subject|9|||
27677384|NCT03519204|80656680|FG001|Overall Study|Withdrawal by Subject|7|||
27677385|NCT03519204|80656679|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27677386|NCT03519204|80656680|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27677387|NCT02609672|80656683|FG000|Overall Study|Lost to Follow-up|3|||
27677388|NCT02609672|80656684|FG001|Overall Study|Lost to Follow-up|1|||
27677389|NCT02271984|80656685|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677390|NCT02271984|80656686|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677391|NCT02271984|80656687|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677392|NCT02271984|80656688|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677393|NCT02271984|80656689|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677394|NCT02271984|80656690|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
27677395|NCT02271984|80656691|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677396|NCT02271984|80656692|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
27677397|NCT02271984|80656693|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677398|NCT02271984|80656694|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677399|NCT02271984|80656695|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677400|NCT02271984|80656696|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27677401|NCT00594880|80656697|FG000|Overall Study|Withdrawal by Subject|1|||
27677402|NCT00594880|80656698|FG001|Overall Study|Withdrawal by Subject|1|||
27677403|NCT00594880|80656697|FG000|Overall Study|Lost to Follow-up|1|||
27992277|NCT04158583|81802064|FG006|Overall Study|Study Terminated by Sponsor|0|||
27677404|NCT00594880|80656698|FG001|Overall Study|Lost to Follow-up|0|||
27677405|NCT01191008|80656699|FG000|Overall Study|Protocol Violation|7|||
27677406|NCT01191008|80656699|FG000|Overall Study|Lost to Follow-up|8|||
27677407|NCT01681992|80656700|FG000|Overall Study|Adverse Event|3|||
27677408|NCT01681992|80656701|FG001|Overall Study|Adverse Event|2|||
27799532|NCT04440163|81098841|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27799533|NCT04440163|81098842|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
27799534|NCT00874757|81098843|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
27799535|NCT03891875|81098846|FG000|Overall Study|Withdrawal by Subject|20|||
27799536|NCT03891875|81098847|FG001|Overall Study|Withdrawal by Subject|3|||
27799537|NCT03891875|81098846|FG000|Overall Study|Adverse Event|10|||
27799538|NCT03891875|81098847|FG001|Overall Study|Adverse Event|4|||
27677409|NCT01681992|80656702|FG002|Overall Study|Adverse Event|3|||
27677410|NCT01681992|80656700|FG000|Overall Study|Lost to Follow-up|36|||
27677411|NCT01681992|80656701|FG001|Overall Study|Lost to Follow-up|38|||
27677412|NCT01681992|80656702|FG002|Overall Study|Lost to Follow-up|53|||
27677413|NCT01681992|80656700|FG000|Overall Study|As Per Sponsor Decision|0|||
27677414|NCT01681992|80656701|FG001|Overall Study|As Per Sponsor Decision|0|||
27677415|NCT01681992|80656702|FG002|Overall Study|As Per Sponsor Decision|1|||
27677416|NCT01681992|80656700|FG000|Overall Study|Protocol Violation|0|||
27677417|NCT01681992|80656701|FG001|Overall Study|Protocol Violation|0|||
27677418|NCT01681992|80656702|FG002|Overall Study|Protocol Violation|1|||
27677419|NCT01681992|80656700|FG000|Overall Study|Withdrawal by Subject|27|||
27799539|NCT03891875|81098846|FG000|Overall Study|Physician Decision|1|||
27799540|NCT03891875|81098847|FG001|Overall Study|Physician Decision|1|||
27799541|NCT03891875|81098846|FG000|Overall Study|Protocol Violation|1|||
27799542|NCT03891875|81098847|FG001|Overall Study|Protocol Violation|0|||
27799543|NCT03891875|81098846|FG000|Overall Study|Lost to Follow-up|1|||
27799544|NCT03891875|81098847|FG001|Overall Study|Lost to Follow-up|0|||
27799545|NCT03891875|81098846|FG000|Overall Study|COVID-19 infection|1|||
27799546|NCT03891875|81098847|FG001|Overall Study|COVID-19 infection|0|||
27799547|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Adverse Event|2|||
27799548|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Adverse Event|0|||
27799549|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Adverse Event|0|||
27799550|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Adverse Event|0|||
27799551|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
27799552|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
27799553|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
27799554|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
27799555|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
27799556|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
27799557|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
27799558|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
27799559|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Physician Decision|1|||
27799560|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Physician Decision|0|||
27799561|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Physician Decision|0|||
27799562|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Physician Decision|0|||
27799563|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Pregnancy|1|||
27799564|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Pregnancy|0|||
27799565|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Pregnancy|0|||
27799566|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Pregnancy|0|||
27799567|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
27799568|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
27799569|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
27799570|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
27799571|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
27992278|NCT04158583|81802065|FG007|Overall Study|Study Terminated by Sponsor|0|||
27992279|NCT04158583|81802066|FG008|Overall Study|Study Terminated by Sponsor|0|||
27992280|NCT04158583|81802067|FG009|Overall Study|Study Terminated by Sponsor|0|||
27992281|NCT04158583|81802058|FG000|Overall Study|Progressive Disease|1|||
27992282|NCT04158583|81802059|FG001|Overall Study|Progressive Disease|0|||
27992283|NCT04158583|81802060|FG002|Overall Study|Progressive Disease|3|||
27992284|NCT04158583|81802061|FG003|Overall Study|Progressive Disease|5|||
27992285|NCT04158583|81802062|FG004|Overall Study|Progressive Disease|0|||
27992286|NCT04158583|81802063|FG005|Overall Study|Progressive Disease|1|||
27992287|NCT04158583|81802064|FG006|Overall Study|Progressive Disease|6|||
27992288|NCT04158583|81802065|FG007|Overall Study|Progressive Disease|2|||
27677420|NCT01681992|80656701|FG001|Overall Study|Withdrawal by Subject|30|||
27799572|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
27799573|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
27799574|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
27799575|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
27992289|NCT04158583|81802066|FG008|Overall Study|Progressive Disease|1|||
27992290|NCT04158583|81802067|FG009|Overall Study|Progressive Disease|2|||
27677421|NCT01681992|80656702|FG002|Overall Study|Withdrawal by Subject|25|||
27799576|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
27799577|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
27799578|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
27799579|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
27799580|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
27799581|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
27799582|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
27799583|NCT04057573|81098848|FG000|24-Week Double-Blind Period|Not Treated|1|||
27799584|NCT04057573|81098849|FG001|24-Week Double-Blind Period|Not Treated|0|||
27799585|NCT04057573|81098850|FG002|24-Week Double-Blind Period|Not Treated|0|||
27799586|NCT04057573|81098851|FG003|24-Week Double-Blind Period|Not Treated|0|||
27799587|NCT04057573|81098848|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
27799588|NCT04057573|81098849|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
27799589|NCT04057573|81098850|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
27799590|NCT04057573|81098851|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
27799591|NCT04057573|81098848|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
27992291|NCT04158583|81802058|FG000|Overall Study|Lost to Follow-up|0|||
27992292|NCT04158583|81802059|FG001|Overall Study|Lost to Follow-up|0|||
27799592|NCT04057573|81098849|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
27799593|NCT04057573|81098850|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
27799594|NCT04057573|81098851|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
27799595|NCT04057573|81098848|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
27799596|NCT04057573|81098849|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
27799597|NCT04057573|81098850|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
27799598|NCT04057573|81098851|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
27799599|NCT04057573|81098848|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
27799600|NCT04057573|81098849|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
27799601|NCT04057573|81098850|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
27799602|NCT04057573|81098851|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
27799603|NCT04057573|81098848|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
27799604|NCT04057573|81098849|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
27799605|NCT04057573|81098850|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
27799606|NCT04057573|81098851|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
27799607|NCT00817778|81098852|FG000|Overall Study|Adverse Event|1|||
27799608|NCT00817778|81098853|FG001|Overall Study|Adverse Event|0|||
27799609|NCT00817778|81098852|FG000|Overall Study|Withdrawal by Subject|1|||
27799610|NCT00817778|81098853|FG001|Overall Study|Withdrawal by Subject|1|||
27799611|NCT00817778|81098852|FG000|Overall Study|Protocol Violation|0|||
27799612|NCT00817778|81098853|FG001|Overall Study|Protocol Violation|1|||
27799613|NCT00817778|81098852|FG000|Overall Study|Study-specific discontinuation criteria|0|||
27799614|NCT00817778|81098853|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27799615|NCT00817778|81098852|FG000|Overall Study|Poor venous access|1|||
27799616|NCT00817778|81098853|FG001|Overall Study|Poor venous access|0|||
27799617|NCT01346501|81098856|FG000|Overall Study|Initiated Other Biological Agents|3|||
27799618|NCT01346501|81098857|FG001|Overall Study|Initiated Other Biological Agents|1|||
27799619|NCT01346501|81098856|FG000|Overall Study|Other|8|||
27799620|NCT01346501|81098857|FG001|Overall Study|Other|12|||
27799621|NCT02983227|81098858|FG000|Overall Study|Adverse Event|21|||
27799622|NCT02983227|81098859|FG001|Overall Study|Adverse Event|3|||
27799623|NCT02983227|81098858|FG000|Overall Study|Death|3|||
27799624|NCT02983227|81098859|FG001|Overall Study|Death|0|||
27799625|NCT02983227|81098858|FG000|Overall Study|Lack of Efficacy|8|||
27799626|NCT02983227|81098859|FG001|Overall Study|Lack of Efficacy|1|||
27799627|NCT02983227|81098858|FG000|Overall Study|Lost to Follow-up|3|||
27992293|NCT04158583|81802060|FG002|Overall Study|Lost to Follow-up|1|||
27992294|NCT04158583|81802061|FG003|Overall Study|Lost to Follow-up|1|||
27992295|NCT04158583|81802062|FG004|Overall Study|Lost to Follow-up|1|||
27799628|NCT02983227|81098859|FG001|Overall Study|Lost to Follow-up|0|||
27799629|NCT02983227|81098858|FG000|Overall Study|Multiple Reasons|2|||
27799630|NCT02983227|81098859|FG001|Overall Study|Multiple Reasons|1|||
27799631|NCT02983227|81098858|FG000|Overall Study|Physician Decision|3|||
27799632|NCT02983227|81098859|FG001|Overall Study|Physician Decision|1|||
27799633|NCT02983227|81098858|FG000|Overall Study|Withdrawal by Subject|19|||
27799634|NCT02983227|81098859|FG001|Overall Study|Withdrawal by Subject|8|||
27992296|NCT04158583|81802063|FG005|Overall Study|Lost to Follow-up|0|||
27992297|NCT04158583|81802064|FG006|Overall Study|Lost to Follow-up|0|||
27799635|NCT00833976|81098860|FG000|Overall Study|Withdrawal by Subject|5|||
27799636|NCT00833976|81098860|FG000|Overall Study|Lost to Follow-up|4|||
27799637|NCT00833976|81098860|FG000|Overall Study|Did not meet eligibility criteria|41|||
27799638|NCT00833976|81098860|FG000|Overall Study|Physician Decision|1|||
27992298|NCT04158583|81802065|FG007|Overall Study|Lost to Follow-up|0|||
27992299|NCT04158583|81802066|FG008|Overall Study|Lost to Follow-up|0|||
27799639|NCT00450177|81098861|FG000|Overall Study|Adverse Event|7|||
27799640|NCT00450177|81098862|FG001|Overall Study|Adverse Event|4|||
27799641|NCT00450177|81098861|FG000|Overall Study|Withdrawal by Subject|1|||
27799642|NCT00450177|81098862|FG001|Overall Study|Withdrawal by Subject|6|||
27799643|NCT00450177|81098861|FG000|Overall Study|Withdrawal by Primary Team|1|||
27799644|NCT00450177|81098862|FG001|Overall Study|Withdrawal by Primary Team|1|||
27799645|NCT00797316|81098865|FG000|Overall Study|Administrative problems|1|||
27799646|NCT00797316|81098866|FG001|Overall Study|Administrative problems|0|||
27870957|NCT00577863|81361557|FG000|Overall Study|Lost to Follow-up|2|||
27870958|NCT00577863|81361558|FG001|Overall Study|Lost to Follow-up|2|||
27870959|NCT00577863|81361557|FG000|Overall Study|Entry Criteria Exclusion|1|||
27870960|NCT00577863|81361558|FG001|Overall Study|Entry Criteria Exclusion|0|||
27870961|NCT00577863|81361557|FG000|Overall Study|Withdrawal by Subject|0|||
27870962|NCT00577863|81361558|FG001|Overall Study|Withdrawal by Subject|2|||
27870963|NCT00577863|81361557|FG000|Overall Study|Sponsor Decision|2|||
27870964|NCT00577863|81361558|FG001|Overall Study|Sponsor Decision|7|||
27870965|NCT00577863|81361557|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
27870966|NCT00577863|81361558|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
27870967|NCT00754650|81361567|FG000|Overall Study|Disease Progression|2|||
27870968|NCT00344448|81361570|FG000|Screening|Withdrawal by Subject|0|||
27870969|NCT00344448|81361571|FG001|Screening|Withdrawal by Subject|1|||
27870970|NCT00344448|81361570|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
27870971|NCT00344448|81361571|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
27870972|NCT00344448|81361570|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
27870973|NCT00344448|81361571|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
27870974|NCT00344448|81361570|FG000|Open Label|Withdrawal by Subject|1|||
27870975|NCT00344448|81361571|FG001|Open Label|Withdrawal by Subject|1|||
27870976|NCT00344448|81361570|FG000|Open Label|Study terminated|1|||
27870977|NCT00344448|81361571|FG001|Open Label|Study terminated|0|||
27870978|NCT00742209|81361572|FG000|Overall Study|Adverse Event|11|||
27870979|NCT00742209|81361573|FG001|Overall Study|Adverse Event|4|||
27870980|NCT00742209|81361574|FG002|Overall Study|Adverse Event|17|||
27870981|NCT00742209|81361575|FG003|Overall Study|Adverse Event|16|||
27870982|NCT00742209|81361576|FG004|Overall Study|Adverse Event|13|||
27870983|NCT00742209|81361572|FG000|Overall Study|Participant Withdrew Consent|8|||
27870984|NCT00742209|81361573|FG001|Overall Study|Participant Withdrew Consent|4|||
27870985|NCT00742209|81361574|FG002|Overall Study|Participant Withdrew Consent|14|||
27870986|NCT00742209|81361575|FG003|Overall Study|Participant Withdrew Consent|7|||
27870987|NCT00742209|81361576|FG004|Overall Study|Participant Withdrew Consent|4|||
27870988|NCT00742209|81361572|FG000|Overall Study|Protocol Violation|6|||
27870989|NCT00742209|81361573|FG001|Overall Study|Protocol Violation|5|||
27799647|NCT00797316|81098865|FG000|Overall Study|Adverse Event|5|||
27799648|NCT00797316|81098866|FG001|Overall Study|Adverse Event|3|||
27799649|NCT00797316|81098865|FG000|Overall Study|Lost to Follow-up|4|||
27799650|NCT00797316|81098866|FG001|Overall Study|Lost to Follow-up|8|||
27799651|NCT00797316|81098865|FG000|Overall Study|Protocol Deviation|1|||
27799652|NCT00797316|81098866|FG001|Overall Study|Protocol Deviation|2|||
27799653|NCT00797316|81098865|FG000|Overall Study|Patient withdrew consent|12|||
27870990|NCT00742209|81361574|FG002|Overall Study|Protocol Violation|4|||
27870991|NCT00742209|81361575|FG003|Overall Study|Protocol Violation|5|||
27870992|NCT00742209|81361576|FG004|Overall Study|Protocol Violation|3|||
27870993|NCT00742209|81361572|FG000|Overall Study|Lost to Follow-up|3|||
27870994|NCT00742209|81361573|FG001|Overall Study|Lost to Follow-up|4|||
27870995|NCT00742209|81361574|FG002|Overall Study|Lost to Follow-up|5|||
27870996|NCT00742209|81361575|FG003|Overall Study|Lost to Follow-up|5|||
27870997|NCT00742209|81361576|FG004|Overall Study|Lost to Follow-up|3|||
27870998|NCT00742209|81361572|FG000|Overall Study|Lack of Efficacy|6|||
27870999|NCT00742209|81361573|FG001|Overall Study|Lack of Efficacy|1|||
27992300|NCT04158583|81802067|FG009|Overall Study|Lost to Follow-up|0|||
27992301|NCT04158583|81802058|FG000|Overall Study|Due To Patient Status|0|||
27992302|NCT04158583|81802059|FG001|Overall Study|Due To Patient Status|0|||
27992303|NCT04158583|81802060|FG002|Overall Study|Due To Patient Status|0|||
27992304|NCT04158583|81802061|FG003|Overall Study|Due To Patient Status|0|||
27992305|NCT04158583|81802062|FG004|Overall Study|Due To Patient Status|0|||
27992306|NCT04158583|81802063|FG005|Overall Study|Due To Patient Status|0|||
27992307|NCT04158583|81802064|FG006|Overall Study|Due To Patient Status|0|||
27992308|NCT04158583|81802065|FG007|Overall Study|Due To Patient Status|0|||
27992309|NCT04158583|81802066|FG008|Overall Study|Due To Patient Status|1|||
27677422|NCT01727505|80656706|FG000|First 24 Hours|Adverse Event|0|||
27799654|NCT00797316|81098866|FG001|Overall Study|Patient withdrew consent|6|||
27871000|NCT00742209|81361574|FG002|Overall Study|Lack of Efficacy|1|||
27871001|NCT00742209|81361575|FG003|Overall Study|Lack of Efficacy|3|||
27871002|NCT00742209|81361576|FG004|Overall Study|Lack of Efficacy|1|||
27992310|NCT04158583|81802067|FG009|Overall Study|Due To Patient Status|0|||
27799655|NCT00797316|81098865|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27992311|NCT04158583|81802058|FG000|Overall Study|Death|3|||
27799656|NCT00797316|81098866|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27799657|NCT05180630|81098877|FG000|First Intervention|Physician Decision|0|||
27799658|NCT05180630|81098878|FG001|First Intervention|Physician Decision|0|||
27799659|NCT05180630|81098879|FG002|First Intervention|Physician Decision|3|||
27799660|NCT00728988|81098880|FG000|Overall Study|Not Treated|2|||
27799661|NCT00728988|81098881|FG001|Overall Study|Not Treated|2|||
27799662|NCT00728988|81098880|FG000|Overall Study|Death|1|||
27799663|NCT00728988|81098881|FG001|Overall Study|Death|1|||
27799664|NCT00728988|81098880|FG000|Overall Study|Adverse Event|3|||
27799665|NCT00728988|81098881|FG001|Overall Study|Adverse Event|2|||
27799666|NCT00728988|81098880|FG000|Overall Study|Other|85|||
27799667|NCT00728988|81098881|FG001|Overall Study|Other|77|||
27799668|NCT00728988|81098880|FG000|Overall Study|Withdrawal by Subject|2|||
27799669|NCT00728988|81098881|FG001|Overall Study|Withdrawal by Subject|6|||
27799670|NCT01977625|81098884|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
27799671|NCT01977625|81098885|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27799672|NCT01977625|81098884|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27799673|NCT01977625|81098885|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27799674|NCT01850108|81098886|FG000|Overall Study|Lost to Follow-up|4|||
27799675|NCT01850108|81098886|FG000|Overall Study|Not eligible|1|||
27799676|NCT01850108|81098886|FG000|Overall Study|Failed engraftment|2|||
27799677|NCT01850108|81098886|FG000|Overall Study|Physician Decision|1|||
27799678|NCT03594175|81098887|FG000|Overall Study|Not treated|8|||
27799679|NCT03594175|81098888|FG001|Overall Study|Not treated|1|||
27799680|NCT03594175|81098889|FG002|Overall Study|Not treated|5|||
27799681|NCT03594175|81098887|FG000|Overall Study|Adverse Event|3|||
27799682|NCT03594175|81098888|FG001|Overall Study|Adverse Event|0|||
27799683|NCT03594175|81098889|FG002|Overall Study|Adverse Event|0|||
27992312|NCT04158583|81802059|FG001|Overall Study|Death|4|||
27992313|NCT04158583|81802060|FG002|Overall Study|Death|2|||
27992314|NCT04158583|81802061|FG003|Overall Study|Death|2|||
27992315|NCT04158583|81802062|FG004|Overall Study|Death|4|||
27992316|NCT04158583|81802063|FG005|Overall Study|Death|3|||
27992317|NCT04158583|81802064|FG006|Overall Study|Death|5|||
27992318|NCT04158583|81802065|FG007|Overall Study|Death|2|||
27992319|NCT04158583|81802066|FG008|Overall Study|Death|0|||
27992320|NCT04158583|81802067|FG009|Overall Study|Death|1|||
27992321|NCT04158583|81802058|FG000|Overall Study|Clinical Progression Disease|0|||
27992322|NCT04158583|81802059|FG001|Overall Study|Clinical Progression Disease|0|||
27992323|NCT04158583|81802060|FG002|Overall Study|Clinical Progression Disease|0|||
27992324|NCT04158583|81802061|FG003|Overall Study|Clinical Progression Disease|1|||
27992325|NCT04158583|81802062|FG004|Overall Study|Clinical Progression Disease|0|||
27992326|NCT04158583|81802063|FG005|Overall Study|Clinical Progression Disease|0|||
27992327|NCT04158583|81802064|FG006|Overall Study|Clinical Progression Disease|0|||
27992328|NCT04158583|81802065|FG007|Overall Study|Clinical Progression Disease|0|||
27992329|NCT04158583|81802066|FG008|Overall Study|Clinical Progression Disease|0|||
27992330|NCT04158583|81802067|FG009|Overall Study|Clinical Progression Disease|0|||
27992331|NCT04158583|81802058|FG000|Overall Study|Clinical Progression|0|||
27992332|NCT04158583|81802059|FG001|Overall Study|Clinical Progression|0|||
27992333|NCT04158583|81802060|FG002|Overall Study|Clinical Progression|0|||
27992334|NCT04158583|81802061|FG003|Overall Study|Clinical Progression|0|||
27992335|NCT04158583|81802062|FG004|Overall Study|Clinical Progression|1|||
27992336|NCT04158583|81802063|FG005|Overall Study|Clinical Progression|0|||
27992337|NCT04158583|81802064|FG006|Overall Study|Clinical Progression|2|||
27992338|NCT04158583|81802065|FG007|Overall Study|Clinical Progression|0|||
27992339|NCT04158583|81802066|FG008|Overall Study|Clinical Progression|0|||
27992340|NCT04158583|81802067|FG009|Overall Study|Clinical Progression|0|||
27992341|NCT04158583|81802058|FG000|Overall Study|Clinical Deterioration|0|||
27992342|NCT04158583|81802059|FG001|Overall Study|Clinical Deterioration|0|||
27992343|NCT04158583|81802060|FG002|Overall Study|Clinical Deterioration|0|||
27992344|NCT04158583|81802061|FG003|Overall Study|Clinical Deterioration|1|||
27992345|NCT04158583|81802062|FG004|Overall Study|Clinical Deterioration|0|||
27992346|NCT04158583|81802063|FG005|Overall Study|Clinical Deterioration|0|||
27992347|NCT04158583|81802064|FG006|Overall Study|Clinical Deterioration|0|||
27992348|NCT04158583|81802065|FG007|Overall Study|Clinical Deterioration|0|||
27992349|NCT04158583|81802066|FG008|Overall Study|Clinical Deterioration|0|||
27992350|NCT04158583|81802067|FG009|Overall Study|Clinical Deterioration|1|||
27992351|NCT01440816|81802068|FG000|Overall Study|Disease Progression|0|||
27992352|NCT01440816|81802069|FG001|Overall Study|Disease Progression|9|||
27992353|NCT01440816|81802068|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
27992354|NCT01440816|81802069|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
27992355|NCT03679624|81802072|FG000|Overall Study|Adverse Event|1|||
27992356|NCT03679624|81802073|FG001|Overall Study|Adverse Event|0|||
27992357|NCT02473367|81802084|FG000|Wait 1|Withdrawal by Subject|1|||
27992358|NCT02473367|81802084|FG000|Period 4|Lost to Follow-up|1|||
27992359|NCT00517361|81802087|FG000|Overall Study|Death|6|||
27992360|NCT00517361|81802087|FG000|Overall Study|The study was terminated|5|||
27992361|NCT00422383|81802088|FG000|Overall Study|Adverse Event|5|||
27992362|NCT00422383|81802089|FG001|Overall Study|Adverse Event|3|||
27799684|NCT03594175|81098887|FG000|Overall Study|Withdrawal by Subject|3|||
27799685|NCT03594175|81098888|FG001|Overall Study|Withdrawal by Subject|0|||
27799686|NCT03594175|81098889|FG002|Overall Study|Withdrawal by Subject|0|||
27799687|NCT03594175|81098887|FG000|Overall Study|Protocol Violation|2|||
27799688|NCT03594175|81098888|FG001|Overall Study|Protocol Violation|2|||
27799689|NCT03594175|81098889|FG002|Overall Study|Protocol Violation|2|||
27799690|NCT02609178|81098890|FG000|First Crown|Withdrawal by Subject|0|||
27799691|NCT02609178|81098891|FG001|First Crown|Withdrawal by Subject|0|||
27799692|NCT02609178|81098892|FG002|First Crown|Withdrawal by Subject|1|||
27799693|NCT02609178|81098893|FG003|First Crown|Withdrawal by Subject|1|||
27799694|NCT02609178|81098894|FG004|First Crown|Withdrawal by Subject|0|||
27799695|NCT02609178|81098895|FG005|First Crown|Withdrawal by Subject|0|||
27799696|NCT04440007|81098896|FG000|Overall Study|Adverse Event|0|||
27799697|NCT04440007|81098897|FG001|Overall Study|Adverse Event|1|||
27799698|NCT04440007|81098896|FG000|Overall Study|Lost to Follow-up|1|||
27799699|NCT04440007|81098897|FG001|Overall Study|Lost to Follow-up|3|||
27992363|NCT00422383|81802090|FG002|Overall Study|Adverse Event|1|||
27992364|NCT00422383|81802091|FG003|Overall Study|Adverse Event|1|||
27992365|NCT00422383|81802092|FG004|Overall Study|Adverse Event|0|||
27992366|NCT00422383|81802088|FG000|Overall Study|Lack of Efficacy|4|||
27992367|NCT00422383|81802089|FG001|Overall Study|Lack of Efficacy|4|||
27992368|NCT00422383|81802090|FG002|Overall Study|Lack of Efficacy|2|||
27992369|NCT00422383|81802091|FG003|Overall Study|Lack of Efficacy|1|||
27992370|NCT00422383|81802092|FG004|Overall Study|Lack of Efficacy|1|||
27799700|NCT04440007|81098896|FG000|Overall Study|Death|7|||
27799701|NCT04440007|81098897|FG001|Overall Study|Death|2|||
27799702|NCT04440007|81098896|FG000|Overall Study|Physician Decision|1|||
27799703|NCT04440007|81098897|FG001|Overall Study|Physician Decision|1|||
27799704|NCT04440007|81098896|FG000|Overall Study|Withdrawal by Subject|2|||
27799705|NCT04440007|81098897|FG001|Overall Study|Withdrawal by Subject|1|||
27799706|NCT04440007|81098896|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
27799707|NCT04440007|81098897|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
27799708|NCT04440007|81098896|FG000|Overall Study|Discontinued prior to dosing|0|||
27992371|NCT00422383|81802088|FG000|Overall Study|Lost to Follow-up|0|||
27992372|NCT00422383|81802089|FG001|Overall Study|Lost to Follow-up|1|||
27992373|NCT00422383|81802090|FG002|Overall Study|Lost to Follow-up|0|||
27992374|NCT00422383|81802091|FG003|Overall Study|Lost to Follow-up|0|||
27992375|NCT00422383|81802092|FG004|Overall Study|Lost to Follow-up|1|||
27992376|NCT00422383|81802088|FG000|Overall Study|Protocol Violation|1|||
27992377|NCT00422383|81802089|FG001|Overall Study|Protocol Violation|1|||
27992378|NCT00422383|81802090|FG002|Overall Study|Protocol Violation|1|||
27992379|NCT00422383|81802091|FG003|Overall Study|Protocol Violation|0|||
27992380|NCT00422383|81802092|FG004|Overall Study|Protocol Violation|0|||
27992381|NCT00422383|81802088|FG000|Overall Study|Withdrawal by Subject|5|||
27992382|NCT00422383|81802089|FG001|Overall Study|Withdrawal by Subject|5|||
27992383|NCT00422383|81802090|FG002|Overall Study|Withdrawal by Subject|0|||
27992384|NCT00422383|81802091|FG003|Overall Study|Withdrawal by Subject|0|||
27992385|NCT00422383|81802092|FG004|Overall Study|Withdrawal by Subject|1|||
27992386|NCT01063153|81802093|FG000|Overall Study|Found Ineligible During Screening|2|||
27992387|NCT01063153|81802094|FG001|Overall Study|Found Ineligible During Screening|0|||
27992388|NCT01063153|81802093|FG000|Overall Study|Lost to Follow-up|0|||
27992389|NCT01063153|81802094|FG001|Overall Study|Lost to Follow-up|7|||
27992390|NCT01063153|81802093|FG000|Overall Study|Withdrawal by Subject|0|||
27992391|NCT01063153|81802094|FG001|Overall Study|Withdrawal by Subject|1|||
27992392|NCT01063153|81802093|FG000|Overall Study|Physician Decision|0|||
27992393|NCT01063153|81802094|FG001|Overall Study|Physician Decision|4|||
27992394|NCT00235716|81802095|FG000|Overall Study|Death|26|||
27992395|NCT00235716|81802096|FG001|Overall Study|Death|39|||
27992396|NCT00235716|81802097|FG002|Overall Study|Death|32|||
27992397|NCT00235716|81802098|FG003|Overall Study|Death|31|||
27992398|NCT00235716|81802095|FG000|Overall Study|Withdrawal by Subject|23|||
27992399|NCT00235716|81802096|FG001|Overall Study|Withdrawal by Subject|19|||
27992400|NCT00235716|81802097|FG002|Overall Study|Withdrawal by Subject|17|||
27992401|NCT00235716|81802098|FG003|Overall Study|Withdrawal by Subject|18|||
27677423|NCT01727505|80656707|FG001|First 24 Hours|Adverse Event|1|||
27992402|NCT00235716|81802095|FG000|Overall Study|Lost to Follow-up|12|||
27992403|NCT00235716|81802096|FG001|Overall Study|Lost to Follow-up|7|||
27799709|NCT04440007|81098897|FG001|Overall Study|Discontinued prior to dosing|2|||
27799710|NCT03496207|81098901|FG000|Base Study|Adverse Event|0|||
27799711|NCT03496207|81098902|FG001|Base Study|Adverse Event|0|||
27799712|NCT03496207|81098903|FG002|Base Study|Adverse Event|1|||
27992404|NCT00235716|81802097|FG002|Overall Study|Lost to Follow-up|14|||
27992405|NCT00235716|81802098|FG003|Overall Study|Lost to Follow-up|10|||
27799713|NCT03496207|81098904|FG003|Base Study|Adverse Event|1|||
27799714|NCT03496207|81098905|FG004|Base Study|Adverse Event|4|||
27992406|NCT00235716|81802095|FG000|Overall Study|Adverse Event|1|||
27992407|NCT00235716|81802096|FG001|Overall Study|Adverse Event|1|||
27992408|NCT00235716|81802097|FG002|Overall Study|Adverse Event|1|||
27992409|NCT00235716|81802098|FG003|Overall Study|Adverse Event|0|||
27799715|NCT03496207|81098901|FG000|Base Study|Death|0|||
27799716|NCT03496207|81098902|FG001|Base Study|Death|0|||
27799717|NCT03496207|81098903|FG002|Base Study|Death|0|||
27799718|NCT03496207|81098904|FG003|Base Study|Death|0|||
27799719|NCT03496207|81098905|FG004|Base Study|Death|1|||
27799720|NCT03496207|81098901|FG000|Base Study|Withdrawal by Subject|0|||
27799721|NCT03496207|81098902|FG001|Base Study|Withdrawal by Subject|0|||
27799722|NCT03496207|81098903|FG002|Base Study|Withdrawal by Subject|1|||
27799723|NCT03496207|81098904|FG003|Base Study|Withdrawal by Subject|0|||
27799724|NCT03496207|81098905|FG004|Base Study|Withdrawal by Subject|1|||
27799725|NCT03496207|81098901|FG000|Extension Period|Adverse Event|0|||
27799726|NCT03496207|81098902|FG001|Extension Period|Adverse Event|0|||
27799727|NCT03496207|81098903|FG002|Extension Period|Adverse Event|0|||
27799728|NCT03496207|81098904|FG003|Extension Period|Adverse Event|1|||
27799729|NCT03496207|81098905|FG004|Extension Period|Adverse Event|1|||
27799730|NCT03496207|81098901|FG000|Extension Period|Death|1|||
27799731|NCT03496207|81098902|FG001|Extension Period|Death|0|||
27799732|NCT03496207|81098903|FG002|Extension Period|Death|0|||
27799733|NCT03496207|81098904|FG003|Extension Period|Death|1|||
27799734|NCT03496207|81098905|FG004|Extension Period|Death|2|||
27799735|NCT03496207|81098901|FG000|Extension Period|Withdrawal by Subject|1|||
27799736|NCT03496207|81098902|FG001|Extension Period|Withdrawal by Subject|0|||
27799737|NCT03496207|81098903|FG002|Extension Period|Withdrawal by Subject|0|||
27799738|NCT03496207|81098904|FG003|Extension Period|Withdrawal by Subject|1|||
27799739|NCT03496207|81098905|FG004|Extension Period|Withdrawal by Subject|1|||
27799740|NCT03496207|81098901|FG000|Extension Period|Elevated hemoglobin levels|0|||
27799741|NCT03496207|81098902|FG001|Extension Period|Elevated hemoglobin levels|0|||
27799742|NCT03496207|81098903|FG002|Extension Period|Elevated hemoglobin levels|0|||
27799743|NCT03496207|81098904|FG003|Extension Period|Elevated hemoglobin levels|0|||
27799744|NCT03496207|81098905|FG004|Extension Period|Elevated hemoglobin levels|1|||
27799745|NCT01010230|81098906|FG000|Overall Study|Withdrawal by Subject|6|||
27799746|NCT01010230|81098907|FG001|Overall Study|Withdrawal by Subject|5|||
27799747|NCT01010230|81098906|FG000|Overall Study|Lost to Follow-up|4|||
27799748|NCT01010230|81098907|FG001|Overall Study|Lost to Follow-up|2|||
27799749|NCT01791127|81098908|FG000|Overall Study|Death|356|||
27799750|NCT01791127|81098908|FG000|Overall Study|Patient has withdrawn from study|293|||
27799751|NCT01791127|81098908|FG000|Overall Study|Lost to Follow-up|42|||
27799752|NCT01791127|81098908|FG000|Overall Study|All Siello leads are explanted|31|||
27799753|NCT01791127|81098908|FG000|Overall Study|Completion of 30 day safety registry|1|||
27799754|NCT01791127|81098908|FG000|Overall Study|Study terminated for EP Passion|749|||
27799755|NCT01785472|81098909|FG000|Overall Study|Adverse Event|5|||
27799756|NCT01785472|81098910|FG001|Overall Study|Adverse Event|4|||
27799757|NCT01785472|81098911|FG002|Overall Study|Adverse Event|6|||
27799758|NCT01785472|81098909|FG000|Overall Study|Lack of Efficacy|2|||
27799759|NCT01785472|81098910|FG001|Overall Study|Lack of Efficacy|0|||
27799760|NCT01785472|81098911|FG002|Overall Study|Lack of Efficacy|1|||
27799761|NCT01785472|81098909|FG000|Overall Study|Lost to Follow-up|1|||
27799762|NCT01785472|81098910|FG001|Overall Study|Lost to Follow-up|2|||
27799763|NCT01785472|81098911|FG002|Overall Study|Lost to Follow-up|0|||
27799764|NCT01785472|81098909|FG000|Overall Study|Physician Decision|1|||
27799765|NCT01785472|81098910|FG001|Overall Study|Physician Decision|1|||
27799766|NCT01785472|81098911|FG002|Overall Study|Physician Decision|1|||
27799767|NCT01785472|81098909|FG000|Overall Study|Protocol deviation|0|||
27799768|NCT01785472|81098910|FG001|Overall Study|Protocol deviation|2|||
27799769|NCT01785472|81098911|FG002|Overall Study|Protocol deviation|2|||
27799770|NCT01785472|81098909|FG000|Overall Study|Subject/guardian decision|15|||
27799771|NCT01785472|81098910|FG001|Overall Study|Subject/guardian decision|10|||
27799772|NCT01785472|81098911|FG002|Overall Study|Subject/guardian decision|11|||
27799773|NCT01785472|81098909|FG000|Overall Study|Technical problems|0|||
27799774|NCT01785472|81098910|FG001|Overall Study|Technical problems|0|||
27799775|NCT01785472|81098911|FG002|Overall Study|Technical problems|1|||
27799776|NCT03746080|81098912|FG000|Overall Study|In follow up|2|||
27799777|NCT03746080|81098912|FG000|Overall Study|Death|15|||
27799778|NCT04388527|81098915|FG000|Overall Study|Death|14|||
27799779|NCT04388527|81098915|FG000|Overall Study|Withdrawal by Subject|2|||
27799780|NCT04388527|81098915|FG000|Overall Study|Lost to Follow-up|1|||
27799781|NCT00975884|81098919|FG000|Overall Study|Adverse Event|1|||
27799782|NCT00975884|81098920|FG001|Overall Study|Adverse Event|0|||
27799783|NCT00975884|81098919|FG000|Overall Study|Lost to Follow-up|5|||
27799784|NCT00975884|81098920|FG001|Overall Study|Lost to Follow-up|3|||
27799785|NCT00975884|81098919|FG000|Overall Study|Withdrawal by Subject|9|||
27799786|NCT00975884|81098920|FG001|Overall Study|Withdrawal by Subject|9|||
27799787|NCT00975884|81098919|FG000|Overall Study|Other|1|||
27799788|NCT00975884|81098920|FG001|Overall Study|Other|3|||
27799789|NCT00791154|81098921|FG000|Overall Study|Noncompliance|0|||
27799790|NCT00791154|81098922|FG001|Overall Study|Noncompliance|1|||
27799791|NCT00791154|81098923|FG002|Overall Study|Noncompliance|0|||
27799792|NCT00791154|81098924|FG003|Overall Study|Noncompliance|0|||
27799793|NCT00791154|81098925|FG004|Overall Study|Noncompliance|1|||
27799794|NCT00791154|81098926|FG005|Overall Study|Noncompliance|1|||
27799795|NCT00791154|81098927|FG006|Overall Study|Noncompliance|1|||
27799796|NCT00791154|81098921|FG000|Overall Study|Adverse Event|0|||
27799797|NCT00791154|81098922|FG001|Overall Study|Adverse Event|0|||
27799798|NCT00791154|81098923|FG002|Overall Study|Adverse Event|0|||
27799799|NCT00791154|81098924|FG003|Overall Study|Adverse Event|0|||
27799800|NCT00791154|81098925|FG004|Overall Study|Adverse Event|2|||
27799801|NCT00791154|81098926|FG005|Overall Study|Adverse Event|0|||
27799802|NCT00791154|81098927|FG006|Overall Study|Adverse Event|1|||
27799803|NCT00791154|81098921|FG000|Overall Study|Full Consent withdrawn|1|||
27799804|NCT00791154|81098922|FG001|Overall Study|Full Consent withdrawn|3|||
27799805|NCT00791154|81098923|FG002|Overall Study|Full Consent withdrawn|0|||
27799806|NCT00791154|81098924|FG003|Overall Study|Full Consent withdrawn|0|||
27799807|NCT00791154|81098925|FG004|Overall Study|Full Consent withdrawn|1|||
27799808|NCT00791154|81098926|FG005|Overall Study|Full Consent withdrawn|3|||
27799809|NCT00791154|81098927|FG006|Overall Study|Full Consent withdrawn|1|||
27799810|NCT00791154|81098921|FG000|Overall Study|Lost to Follow-up|0|||
27799811|NCT00791154|81098922|FG001|Overall Study|Lost to Follow-up|0|||
27799812|NCT00791154|81098923|FG002|Overall Study|Lost to Follow-up|0|||
27799813|NCT00791154|81098924|FG003|Overall Study|Lost to Follow-up|1|||
27799814|NCT00791154|81098925|FG004|Overall Study|Lost to Follow-up|2|||
27799815|NCT00791154|81098926|FG005|Overall Study|Lost to Follow-up|0|||
27799816|NCT00791154|81098927|FG006|Overall Study|Lost to Follow-up|4|||
27799817|NCT00791154|81098921|FG000|Overall Study|Death|5|||
27799818|NCT00791154|81098922|FG001|Overall Study|Death|4|||
27799819|NCT00791154|81098923|FG002|Overall Study|Death|4|||
27799820|NCT00791154|81098924|FG003|Overall Study|Death|7|||
27799821|NCT00791154|81098925|FG004|Overall Study|Death|54|||
27799822|NCT00791154|81098926|FG005|Overall Study|Death|54|||
27799823|NCT00791154|81098927|FG006|Overall Study|Death|52|||
27799824|NCT00791154|81098921|FG000|Overall Study|Other event|0|||
27799825|NCT00791154|81098922|FG001|Overall Study|Other event|0|||
27799826|NCT00791154|81098923|FG002|Overall Study|Other event|2|||
27799827|NCT00791154|81098924|FG003|Overall Study|Other event|0|||
27799828|NCT00791154|81098925|FG004|Overall Study|Other event|2|||
27799829|NCT00791154|81098926|FG005|Overall Study|Other event|4|||
27799830|NCT00791154|81098927|FG006|Overall Study|Other event|2|||
27799839|NCT04333199|81098930|FG000|Evaluated Patients|Lost to Follow-up|0|||
27677424|NCT01727505|80656706|FG000|Second 24 Hours|Missing data|0|||
27799840|NCT04333199|81098931|FG001|Evaluated Patients|Lost to Follow-up|1|||
27799841|NCT04333199|81098932|FG002|Evaluated Patients|Lost to Follow-up|2|||
27799842|NCT03591107|81098933|FG000|Overall Study|Same patient in both arms|1|||
27799843|NCT03591107|81098934|FG001|Overall Study|Same patient in both arms|1|||
27799844|NCT03591107|81098933|FG000|Overall Study|Sought care at other clinics|0|||
27799845|NCT03591107|81098934|FG001|Overall Study|Sought care at other clinics|2|||
27799846|NCT03591107|81098933|FG000|Overall Study|Discharged from clinic|0|||
27799847|NCT03591107|81098934|FG001|Overall Study|Discharged from clinic|1|||
27799848|NCT03591107|81098933|FG000|Overall Study|Withdrawal by Subject|0|||
27799849|NCT03591107|81098934|FG001|Overall Study|Withdrawal by Subject|1|||
27799850|NCT01563029|81098938|FG000|Overall Study|Adverse Event|1|||
27799851|NCT01563029|81098939|FG001|Overall Study|Adverse Event|0|||
27799852|NCT01563029|81098940|FG002|Overall Study|Adverse Event|1|||
27799853|NCT01563029|81098941|FG003|Overall Study|Adverse Event|2|||
27799854|NCT01563029|81098942|FG004|Overall Study|Adverse Event|1|||
27799855|NCT01563029|81098938|FG000|Overall Study|Lack of Efficacy|42|||
27799856|NCT01563029|81098939|FG001|Overall Study|Lack of Efficacy|16|||
27799857|NCT01563029|81098940|FG002|Overall Study|Lack of Efficacy|23|||
27799858|NCT01563029|81098941|FG003|Overall Study|Lack of Efficacy|21|||
27799859|NCT01563029|81098942|FG004|Overall Study|Lack of Efficacy|19|||
27799860|NCT01563029|81098938|FG000|Overall Study|Protocol Violation|1|||
27799861|NCT01563029|81098939|FG001|Overall Study|Protocol Violation|2|||
27799862|NCT01563029|81098940|FG002|Overall Study|Protocol Violation|3|||
27799863|NCT01563029|81098941|FG003|Overall Study|Protocol Violation|1|||
27799864|NCT01563029|81098942|FG004|Overall Study|Protocol Violation|3|||
27799865|NCT01563029|81098938|FG000|Overall Study|Protocol defined stopping criteria|1|||
27799866|NCT01563029|81098939|FG001|Overall Study|Protocol defined stopping criteria|0|||
27799867|NCT01563029|81098940|FG002|Overall Study|Protocol defined stopping criteria|0|||
27799868|NCT01563029|81098941|FG003|Overall Study|Protocol defined stopping criteria|0|||
27799869|NCT01563029|81098942|FG004|Overall Study|Protocol defined stopping criteria|0|||
27799870|NCT01563029|81098938|FG000|Overall Study|Lost to Follow-up|1|||
27799871|NCT01563029|81098939|FG001|Overall Study|Lost to Follow-up|0|||
27799872|NCT01563029|81098940|FG002|Overall Study|Lost to Follow-up|1|||
27799873|NCT01563029|81098941|FG003|Overall Study|Lost to Follow-up|1|||
27799874|NCT01563029|81098942|FG004|Overall Study|Lost to Follow-up|1|||
27799875|NCT01563029|81098938|FG000|Overall Study|Physician Decision|3|||
27799876|NCT01563029|81098939|FG001|Overall Study|Physician Decision|5|||
27799877|NCT01563029|81098940|FG002|Overall Study|Physician Decision|2|||
27799878|NCT01563029|81098941|FG003|Overall Study|Physician Decision|4|||
27992410|NCT00235716|81802095|FG000|Overall Study|Physician Decision|0|||
27992411|NCT00235716|81802096|FG001|Overall Study|Physician Decision|1|||
27992412|NCT00235716|81802097|FG002|Overall Study|Physician Decision|1|||
27992413|NCT00235716|81802098|FG003|Overall Study|Physician Decision|3|||
27992414|NCT02881762|81802099|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27992415|NCT02881762|81802100|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27992416|NCT01371552|81802101|FG000|Part 1, First 3 Days|Inconvenience|0|||
27992417|NCT01371552|81802102|FG001|Part 1, First 3 Days|Inconvenience|0|||
27992418|NCT01371552|81802103|FG002|Part 1, First 3 Days|Inconvenience|1|||
27992419|NCT01371552|81802104|FG003|Part 1, First 3 Days|Inconvenience|0|||
27992420|NCT01371552|81802105|FG004|Part 1, First 3 Days|Inconvenience|0|||
27992421|NCT01371552|81802106|FG005|Part 1, First 3 Days|Inconvenience|0|||
27992422|NCT00048347|81802110|FG000|Overall Study|Screen failure|2|||
27992423|NCT01206582|81802111|FG000|Overall Study|Withdrew prior to study|1|||
27992424|NCT01206582|81802112|FG001|Overall Study|Withdrew prior to study|0|||
27992425|NCT01206582|81802111|FG000|Overall Study|Discontinued intervention before week 8|1|||
27992426|NCT01206582|81802112|FG001|Overall Study|Discontinued intervention before week 8|2|||
27992427|NCT00704288|81802113|FG000|Overall Treatment Period|Adverse Event|11|||
27992428|NCT00704288|81802114|FG001|Overall Treatment Period|Adverse Event|8|||
27992429|NCT00704288|81802115|FG002|Overall Treatment Period|Adverse Event|22|||
27992430|NCT00704288|81802113|FG000|Overall Treatment Period|Death|0|||
27992431|NCT00704288|81802114|FG001|Overall Treatment Period|Death|0|||
27992432|NCT00704288|81802115|FG002|Overall Treatment Period|Death|1|||
27992433|NCT00704288|81802113|FG000|Overall Treatment Period|Physician Decision|0|||
27992434|NCT00704288|81802114|FG001|Overall Treatment Period|Physician Decision|2|||
27992435|NCT00704288|81802115|FG002|Overall Treatment Period|Physician Decision|0|||
27992436|NCT00704288|81802113|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
27992437|NCT00704288|81802114|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
27992438|NCT00704288|81802115|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
27992439|NCT00704288|81802113|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
27992440|NCT00704288|81802114|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
27992441|NCT00704288|81802115|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
27992442|NCT00704288|81802113|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
27992443|NCT00704288|81802114|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
27992444|NCT00704288|81802115|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
27992445|NCT00704288|81802113|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
27992446|NCT00704288|81802114|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
27992447|NCT00704288|81802115|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
27992448|NCT00704288|81802113|FG000|Overall Treatment Period|Roll-over to another study|1|||
27992449|NCT00704288|81802114|FG001|Overall Treatment Period|Roll-over to another study|0|||
27992450|NCT00704288|81802115|FG002|Overall Treatment Period|Roll-over to another study|4|||
27992451|NCT00704288|81802113|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
27992452|NCT00704288|81802114|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
27992453|NCT00704288|81802115|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
27992454|NCT00704288|81802113|FG000|Extended Post Treatment Follow Up Period|Death|41|||
27992455|NCT00704288|81802114|FG001|Extended Post Treatment Follow Up Period|Death|50|||
27799879|NCT01563029|81098942|FG004|Overall Study|Physician Decision|2|||
27799880|NCT01563029|81098938|FG000|Overall Study|Withdrawal by Subject|4|||
27799881|NCT01563029|81098939|FG001|Overall Study|Withdrawal by Subject|1|||
27799882|NCT01563029|81098940|FG002|Overall Study|Withdrawal by Subject|3|||
27799883|NCT01563029|81098941|FG003|Overall Study|Withdrawal by Subject|4|||
27799884|NCT01563029|81098942|FG004|Overall Study|Withdrawal by Subject|3|||
27799885|NCT00808015|81098943|FG000|Overall Study|Death|1|||
27677425|NCT01727505|80656707|FG001|Second 24 Hours|Missing data|1|||
27677426|NCT02666664|80656708|FG000|Overall Study|Physician Decision|0|||
27677427|NCT02666664|80656709|FG001|Overall Study|Physician Decision|1|||
27677428|NCT02666664|80656708|FG000|Overall Study|Protocol Violation|0|||
27677429|NCT02666664|80656709|FG001|Overall Study|Protocol Violation|2|||
27677430|NCT02666664|80656708|FG000|Overall Study|Other|0|||
27677431|NCT02666664|80656709|FG001|Overall Study|Other|1|||
27677432|NCT02666664|80656708|FG000|Overall Study|Adverse Event|12|||
27677433|NCT02666664|80656709|FG001|Overall Study|Adverse Event|37|||
27677434|NCT02666664|80656708|FG000|Overall Study|Withdrawal by participant|23|||
27677435|NCT02666664|80656709|FG001|Overall Study|Withdrawal by participant|40|||
27677436|NCT02666664|80656708|FG000|Overall Study|Sponsor decision|0|||
27677437|NCT02666664|80656709|FG001|Overall Study|Sponsor decision|1|||
27677438|NCT02666664|80656708|FG000|Overall Study|Lost to Follow-up|1|||
27677439|NCT02666664|80656709|FG001|Overall Study|Lost to Follow-up|2|||
27677440|NCT00968526|80656711|FG000|Overall Study|Adverse Event|2|||
27799886|NCT00808015|81098943|FG000|Overall Study|Lack of Efficacy|58|||
27799887|NCT00808015|81098943|FG000|Overall Study|Lost to Follow-up|76|||
27799888|NCT00808015|81098943|FG000|Overall Study|Participants not willing to participate|158|||
27799889|NCT00808015|81098943|FG000|Overall Study|Adverse Event|22|||
27799890|NCT00808015|81098943|FG000|Overall Study|Other|25|||
27799891|NCT00808015|81098943|FG000|Overall Study|Enrolled but not treated|4|||
27799892|NCT00000135|81098944|FG000|Overall Study|Death|27|||
27799893|NCT00000135|81098945|FG001|Overall Study|Death|14|||
27799894|NCT04701658|81098946|FG000|Overall Study|Lost to Follow-up|6|||
27799895|NCT00756652|81098947|FG000|Original Phase|Withdrawal by Subject|864|||
27799896|NCT00756652|81098948|FG001|Original Phase|Withdrawal by Subject|23|||
27799897|NCT00756652|81098947|FG000|Original Phase|Lost to Follow-up|601|||
27799898|NCT00756652|81098948|FG001|Original Phase|Lost to Follow-up|0|||
27799899|NCT00756652|81098947|FG000|Original Phase|Other Discontinuation|797|||
27799900|NCT00756652|81098948|FG001|Original Phase|Other Discontinuation|5|||
27799901|NCT00756652|81098947|FG000|Original Phase|Participant Noncompliance|18622|||
27799902|NCT00756652|81098948|FG001|Original Phase|Participant Noncompliance|424|||
27799903|NCT00756652|81098947|FG000|Original Phase|Unknown Discontinuation Reason|2|||
27799904|NCT00756652|81098948|FG001|Original Phase|Unknown Discontinuation Reason|0|||
27871003|NCT00742209|81361572|FG000|Overall Study|Investigator Discretion|0|||
27871004|NCT00742209|81361573|FG001|Overall Study|Investigator Discretion|0|||
27871005|NCT00742209|81361574|FG002|Overall Study|Investigator Discretion|5|||
27871006|NCT00742209|81361575|FG003|Overall Study|Investigator Discretion|1|||
27871007|NCT00742209|81361576|FG004|Overall Study|Investigator Discretion|1|||
27871008|NCT00065156|81361577|FG000|Overall Study|Adverse Event|37|||
27871009|NCT00065156|81361577|FG000|Overall Study|Lack of Efficacy|52|||
27871010|NCT00065156|81361577|FG000|Overall Study|Withdrawal by Subject|8|||
27871011|NCT00065156|81361577|FG000|Overall Study|Lost to Follow-up|1|||
27871012|NCT00065156|81361577|FG000|Overall Study|Death|11|||
27992456|NCT00704288|81802115|FG002|Extended Post Treatment Follow Up Period|Death|93|||
27992457|NCT00704288|81802113|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
27992458|NCT00704288|81802114|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
27992459|NCT00704288|81802115|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
27677441|NCT00968526|80656712|FG001|Overall Study|Adverse Event|0|||
27677442|NCT00968526|80656711|FG000|Overall Study|Migrated/moved from study area|1|||
27677443|NCT00968526|80656712|FG001|Overall Study|Migrated/moved from study area|0|||
27677444|NCT03192462|80656719|FG000|Overall Study|Death|13|||
27677445|NCT03192462|80656720|FG001|Overall Study|Death|11|||
27677446|NCT03192462|80656721|FG002|Overall Study|Death|9|||
27677447|NCT03192462|80656719|FG000|Overall Study|Lost to Follow-up|0|||
27799905|NCT00756652|81098947|FG000|Original Phase|Participants without data|3259|||
27992460|NCT00704288|81802113|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
27992461|NCT00704288|81802114|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
27992462|NCT00704288|81802115|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
27992463|NCT00704288|81802113|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
27992464|NCT00704288|81802114|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
27992465|NCT00704288|81802115|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
27992466|NCT01504841|81802116|FG000|Overall Study|Withdrawal by Subject|1|||
27992467|NCT01504841|81802117|FG001|Overall Study|Withdrawal by Subject|1|||
27992468|NCT01504841|81802118|FG002|Overall Study|Withdrawal by Subject|0|||
27992469|NCT04736628|81802119|FG000|Overall Study|Not treated|0|||
27992470|NCT04736628|81802120|FG001|Overall Study|Not treated|0|||
27992471|NCT04736628|81802121|FG002|Overall Study|Not treated|0|||
27992472|NCT04736628|81802122|FG003|Overall Study|Not treated|2|||
27871013|NCT00065156|81361577|FG000|Overall Study|Study Closed by Sponsor|2|||
27871014|NCT00065156|81361577|FG000|Overall Study|Disease Progression|7|||
27871015|NCT00065156|81361577|FG000|Overall Study|Investigator Decision|2|||
27677448|NCT03192462|80656720|FG001|Overall Study|Lost to Follow-up|1|||
27677449|NCT03192462|80656721|FG002|Overall Study|Lost to Follow-up|0|||
27871016|NCT00065156|81361577|FG000|Overall Study|Non-Compliance|2|||
27677450|NCT03192462|80656719|FG000|Overall Study|On follow up|0|||
27871017|NCT00065156|81361577|FG000|Overall Study|Loss of Response|1|||
27871018|NCT00065156|81361577|FG000|Overall Study|Secondary Malign Disease|1|||
27871019|NCT03154125|81361578|FG000|Overall Study|Lost to Follow-up|11|||
27871020|NCT03154125|81361579|FG001|Overall Study|Lost to Follow-up|11|||
27871021|NCT03154125|81361580|FG002|Overall Study|Lost to Follow-up|0|||
27871022|NCT03154125|81361578|FG000|Overall Study|Withdrawal by Subject|49|||
27871023|NCT03154125|81361579|FG001|Overall Study|Withdrawal by Subject|55|||
27871024|NCT03154125|81361580|FG002|Overall Study|Withdrawal by Subject|8|||
27871025|NCT03154125|81361578|FG000|Overall Study|Physician Decision|13|||
27871026|NCT03154125|81361579|FG001|Overall Study|Physician Decision|6|||
27871027|NCT03154125|81361580|FG002|Overall Study|Physician Decision|0|||
27871028|NCT03154125|81361578|FG000|Overall Study|Protocol Violation|3|||
27871029|NCT03154125|81361579|FG001|Overall Study|Protocol Violation|5|||
27871030|NCT03154125|81361580|FG002|Overall Study|Protocol Violation|0|||
27871031|NCT03452943|81361581|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
27871032|NCT03452943|81361582|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
27871033|NCT03452943|81361581|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
27871034|NCT03452943|81361582|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
27871035|NCT03452943|81361581|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
27871036|NCT03452943|81361582|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
27871037|NCT03452943|81361581|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
27871038|NCT03452943|81361582|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
27871039|NCT03452943|81361581|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
27871040|NCT03452943|81361582|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
27871041|NCT03452943|81361581|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
27799906|NCT00756652|81098948|FG001|Original Phase|Participants without data|466|||
27799907|NCT00756652|81098947|FG000|Original Phase|Death|168|||
27799908|NCT00756652|81098948|FG001|Original Phase|Death|1|||
27799909|NCT00756652|81098947|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
27799910|NCT00756652|81098948|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
27799911|NCT00756652|81098947|FG000|Re-Op Phase|Withdrawal by Subject|62|||
27799912|NCT00756652|81098948|FG001|Re-Op Phase|Withdrawal by Subject|0|||
27799913|NCT00756652|81098947|FG000|Re-Op Phase|Death|6|||
27799914|NCT00756652|81098948|FG001|Re-Op Phase|Death|0|||
27799915|NCT00756652|81098947|FG000|Re-Op Phase|Lost to Follow-up|340|||
27799916|NCT00756652|81098948|FG001|Re-Op Phase|Lost to Follow-up|0|||
27799917|NCT00756652|81098947|FG000|Re-Op Phase|Site Closed|2454|||
27799918|NCT00756652|81098948|FG001|Re-Op Phase|Site Closed|0|||
27799919|NCT00756652|81098947|FG000|Re-Op Phase|Withdrawn after explant|14|||
27799920|NCT00756652|81098948|FG001|Re-Op Phase|Withdrawn after explant|0|||
27799921|NCT03174925|81098949|FG000|Overall Study|Elastographic images not retrievable|2|||
27799922|NCT03174925|81098949|FG000|Overall Study|Elastography image not interpretable|1|||
27799923|NCT01383954|81098950|FG000|Overall Study|Lack of Efficacy|2|||
27799924|NCT01383954|81098950|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
27799925|NCT01383954|81098950|FG000|Overall Study|Adverse Event|1|||
27799926|NCT01383954|81098950|FG000|Overall Study|Reason Not Specified|9|||
27799927|NCT01999322|81098951|FG000|Overall Study|Adverse Event|1|||
27799928|NCT01999322|81098952|FG001|Overall Study|Adverse Event|0|||
27799929|NCT00337129|81098953|FG000|Overall Study|Adverse Event|4|||
27799930|NCT00337129|81098953|FG000|Overall Study|Withdrawal by Subject|1|||
27871042|NCT03452943|81361582|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
27871043|NCT00615199|81361583|FG000|Overall Study|Adverse Event|3|||
27871044|NCT00615199|81361584|FG001|Overall Study|Adverse Event|1|||
27871045|NCT00615199|81361585|FG002|Overall Study|Adverse Event|1|||
27871046|NCT00615199|81361586|FG003|Overall Study|Adverse Event|0|||
27799931|NCT00337129|81098953|FG000|Overall Study|Lack of Efficacy|32|||
27799932|NCT00337129|81098953|FG000|Overall Study|Death|2|||
27799933|NCT00337129|81098953|FG000|Overall Study|not protocol specified|1|||
27799934|NCT02773446|81098954|FG000|First Admission|Withdrawal by Subject|0|||
27799935|NCT02773446|81098955|FG001|First Admission|Withdrawal by Subject|0|||
27799936|NCT02773446|81098956|FG002|First Admission|Withdrawal by Subject|0|||
27799937|NCT02773446|81098957|FG003|First Admission|Withdrawal by Subject|1|||
27799938|NCT02773446|81098958|FG004|First Admission|Withdrawal by Subject|0|||
27799939|NCT02773446|81098959|FG005|First Admission|Withdrawal by Subject|0|||
27799940|NCT02773446|81098954|FG000|First Admission|Lost to Follow-up|1|||
27799941|NCT02773446|81098955|FG001|First Admission|Lost to Follow-up|0|||
27799942|NCT02773446|81098956|FG002|First Admission|Lost to Follow-up|0|||
27799943|NCT02773446|81098957|FG003|First Admission|Lost to Follow-up|0|||
27799944|NCT02773446|81098958|FG004|First Admission|Lost to Follow-up|0|||
27799945|NCT02773446|81098959|FG005|First Admission|Lost to Follow-up|0|||
27799946|NCT00666718|81098960|FG000|Overall Study|Adverse Event|0|||
27799947|NCT00666718|81098961|FG001|Overall Study|Adverse Event|1|||
27992473|NCT04736628|81802119|FG000|Overall Study|Other reason than listed|1|||
27992474|NCT04736628|81802120|FG001|Overall Study|Other reason than listed|2|||
27992475|NCT04736628|81802121|FG002|Overall Study|Other reason than listed|2|||
27992476|NCT04736628|81802122|FG003|Overall Study|Other reason than listed|3|||
27992477|NCT04736628|81802119|FG000|Overall Study|Protocol deviation|0|||
27992478|NCT04736628|81802120|FG001|Overall Study|Protocol deviation|0|||
27992479|NCT04736628|81802121|FG002|Overall Study|Protocol deviation|0|||
27992480|NCT04736628|81802122|FG003|Overall Study|Protocol deviation|1|||
27992481|NCT04736628|81802119|FG000|Overall Study|Burden of study procedures|1|||
27992482|NCT04736628|81802120|FG001|Overall Study|Burden of study procedures|0|||
27992483|NCT04736628|81802121|FG002|Overall Study|Burden of study procedures|0|||
27992484|NCT04736628|81802122|FG003|Overall Study|Burden of study procedures|1|||
27992485|NCT04736628|81802119|FG000|Overall Study|Change of residence|0|||
27992486|NCT04736628|81802120|FG001|Overall Study|Change of residence|1|||
27992487|NCT04736628|81802121|FG002|Overall Study|Change of residence|0|||
27992488|NCT04736628|81802122|FG003|Overall Study|Change of residence|0|||
27992489|NCT04736628|81802119|FG000|Overall Study|Perceived lack of efficacy|1|||
27992490|NCT04736628|81802120|FG001|Overall Study|Perceived lack of efficacy|0|||
27992491|NCT04736628|81802121|FG002|Overall Study|Perceived lack of efficacy|0|||
27992492|NCT04736628|81802122|FG003|Overall Study|Perceived lack of efficacy|1|||
27992493|NCT04736628|81802119|FG000|Overall Study|Adverse Event|3|||
27992494|NCT04736628|81802120|FG001|Overall Study|Adverse Event|2|||
27992495|NCT04736628|81802121|FG002|Overall Study|Adverse Event|4|||
27992496|NCT04736628|81802122|FG003|Overall Study|Adverse Event|3|||
27992497|NCT04412707|81802123|FG000|Cycle 1|Death|0|||
27992498|NCT04412707|81802124|FG001|Cycle 1|Death|3|||
27992499|NCT04412707|81802123|FG000|Cycle 1|Disease progression|1|||
27992500|NCT04412707|81802124|FG001|Cycle 1|Disease progression|2|||
27992501|NCT04412707|81802123|FG000|Cycle 2|Death|0|||
27992502|NCT04412707|81802124|FG001|Cycle 2|Death|1|||
27992503|NCT04412707|81802123|FG000|Cycle 2|Disease progression|3|||
27992504|NCT04412707|81802124|FG001|Cycle 2|Disease progression|0|||
27992505|NCT04412707|81802123|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
27992506|NCT04412707|81802124|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
27992507|NCT04412707|81802123|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
27992508|NCT04412707|81802124|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
27992509|NCT04412707|81802123|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
27992510|NCT04412707|81802124|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
27992511|NCT04412707|81802123|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
27992512|NCT04412707|81802124|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
27992513|NCT01546688|81802125|FG000|Overall Study|Adverse Event|0|||
27992514|NCT01546688|81802126|FG001|Overall Study|Adverse Event|4|||
27992515|NCT01546688|81802125|FG000|Overall Study|Withdrawal by Subject|2|||
27992516|NCT01546688|81802126|FG001|Overall Study|Withdrawal by Subject|1|||
27992517|NCT01546688|81802125|FG000|Overall Study|Lack of Efficacy|1|||
27992518|NCT01546688|81802126|FG001|Overall Study|Lack of Efficacy|0|||
27992519|NCT00539305|81802129|FG000|Overall Study|Adverse Event|1|||
27992520|NCT00539305|81802130|FG001|Overall Study|Adverse Event|0|||
27992521|NCT00539305|81802129|FG000|Overall Study|Substance Use|0|||
27992522|NCT00539305|81802130|FG001|Overall Study|Substance Use|1|||
27992523|NCT00539305|81802129|FG000|Overall Study|Withdrawal by Subject|0|||
27992524|NCT00539305|81802130|FG001|Overall Study|Withdrawal by Subject|1|||
27871047|NCT00615199|81361583|FG000|Overall Study|Lack of Efficacy|2|||
27799948|NCT00666718|81098960|FG000|Overall Study|Death|1|||
27799949|NCT00666718|81098961|FG001|Overall Study|Death|0|||
27799950|NCT00666718|81098960|FG000|Overall Study|Lost to Follow-up|1|||
27992525|NCT04343755|81802132|FG000|Overall Study|Death|11|||
27992526|NCT04343755|81802132|FG000|Overall Study|Screen Failure|1|||
27992527|NCT00774800|81802133|FG000|Intervention 4|Withdrawal by Subject|1|||
27992528|NCT03927144|81802137|FG000|Core Phase|Adverse Event|9|||
27992529|NCT03927144|81802138|FG001|Core Phase|Adverse Event|5|||
27992530|NCT03927144|81802137|FG000|Core Phase|Lost to Follow-up|3|||
27871048|NCT00615199|81361584|FG001|Overall Study|Lack of Efficacy|0|||
27871049|NCT00615199|81361585|FG002|Overall Study|Lack of Efficacy|0|||
27871050|NCT00615199|81361586|FG003|Overall Study|Lack of Efficacy|1|||
27871051|NCT00615199|81361583|FG000|Overall Study|Lost to Follow-up|1|||
27871052|NCT00615199|81361584|FG001|Overall Study|Lost to Follow-up|0|||
27871053|NCT00615199|81361585|FG002|Overall Study|Lost to Follow-up|0|||
27871054|NCT00615199|81361586|FG003|Overall Study|Lost to Follow-up|0|||
27871055|NCT00615199|81361583|FG000|Overall Study|Other|0|||
27871056|NCT00615199|81361584|FG001|Overall Study|Other|0|||
27871057|NCT00615199|81361585|FG002|Overall Study|Other|0|||
27871058|NCT00615199|81361586|FG003|Overall Study|Other|1|||
27871059|NCT00615199|81361583|FG000|Overall Study|Withdrawal by Subject|2|||
27871060|NCT00615199|81361584|FG001|Overall Study|Withdrawal by Subject|1|||
27871061|NCT00615199|81361585|FG002|Overall Study|Withdrawal by Subject|0|||
27871062|NCT00615199|81361586|FG003|Overall Study|Withdrawal by Subject|0|||
27871063|NCT02860546|81361591|FG000|Overall Study|Clinical Progression|6|||
27871064|NCT02860546|81361591|FG000|Overall Study|Radiological Progression|12|||
27871065|NCT04447040|81361592|FG000|Overall Study|Lost to Follow-up|2|||
27992531|NCT03927144|81802138|FG001|Core Phase|Lost to Follow-up|2|||
27992532|NCT03927144|81802137|FG000|Core Phase|New Therapy for Study Indication|0|||
27992533|NCT03927144|81802138|FG001|Core Phase|New Therapy for Study Indication|1|||
27992534|NCT03927144|81802137|FG000|Core Phase|No Longer Clinically Benefiting|4|||
27992535|NCT03927144|81802138|FG001|Core Phase|No Longer Clinically Benefiting|4|||
27992536|NCT03927144|81802137|FG000|Core Phase|Physician Decision|2|||
27992537|NCT03927144|81802138|FG001|Core Phase|Physician Decision|8|||
27799951|NCT00666718|81098961|FG001|Overall Study|Lost to Follow-up|0|||
27799952|NCT00666718|81098960|FG000|Overall Study|Entry Criteria Not Met|2|||
27799953|NCT00666718|81098961|FG001|Overall Study|Entry Criteria Not Met|0|||
27799954|NCT00666718|81098960|FG000|Overall Study|Protocol Violation|1|||
27799955|NCT00666718|81098961|FG001|Overall Study|Protocol Violation|3|||
27799956|NCT00666718|81098960|FG000|Overall Study|Withdrawal by Subject|7|||
27799957|NCT00666718|81098961|FG001|Overall Study|Withdrawal by Subject|12|||
27799958|NCT00666718|81098960|FG000|Overall Study|Physician Decision|0|||
27799959|NCT00666718|81098961|FG001|Overall Study|Physician Decision|2|||
27799960|NCT01494649|81098964|FG000|Overall Study|Lost to Follow-up|0|||
27799961|NCT01494649|81098965|FG001|Overall Study|Lost to Follow-up|1|||
27871066|NCT04447040|81361593|FG001|Overall Study|Lost to Follow-up|1|||
27871067|NCT04447040|81361594|FG002|Overall Study|Lost to Follow-up|3|||
27871068|NCT04447040|81361595|FG003|Overall Study|Lost to Follow-up|3|||
27992538|NCT03927144|81802137|FG000|Core Phase|Protocol Violation|2|||
27992539|NCT03927144|81802138|FG001|Core Phase|Protocol Violation|2|||
27992540|NCT03927144|81802137|FG000|Core Phase|Withdrawal by Subject|16|||
27992541|NCT03927144|81802138|FG001|Core Phase|Withdrawal by Subject|40|||
27992542|NCT03927144|81802137|FG000|Extension Phase|Adverse Event|2|||
27992543|NCT03927144|81802138|FG001|Extension Phase|Adverse Event|1|||
27992544|NCT03927144|81802137|FG000|Extension Phase|No longer clinically benefiting|4|||
27992545|NCT03927144|81802138|FG001|Extension Phase|No longer clinically benefiting|5|||
27992546|NCT03927144|81802137|FG000|Extension Phase|Pregnancy|1|||
27992547|NCT03927144|81802138|FG001|Extension Phase|Pregnancy|0|||
27992548|NCT03927144|81802137|FG000|Extension Phase|Protocol Violation|0|||
27992549|NCT03927144|81802138|FG001|Extension Phase|Protocol Violation|1|||
27992550|NCT03927144|81802137|FG000|Extension Phase|Withdrawal by Subject|8|||
27992551|NCT03927144|81802138|FG001|Extension Phase|Withdrawal by Subject|3|||
27992552|NCT02152761|81802139|FG000|Epoch: Treatment Epoch|Technical problems|0|||
27992553|NCT02152761|81802140|FG001|Epoch: Treatment Epoch|Technical problems|0|||
27992554|NCT02152761|81802141|FG002|Epoch: Treatment Epoch|Technical problems|0|||
27992555|NCT02152761|81802142|FG003|Epoch: Treatment Epoch|Technical problems|1|||
27992556|NCT02152761|81802139|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
27992557|NCT02152761|81802140|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
27677451|NCT03192462|80656720|FG001|Overall Study|On follow up|0|||
27871069|NCT04447040|81361596|FG004|Overall Study|Lost to Follow-up|1|||
27871070|NCT04447040|81361597|FG005|Overall Study|Lost to Follow-up|3|||
27871071|NCT04447040|81361592|FG000|Overall Study|Withdrawal by Subject|0|||
27992558|NCT02152761|81802141|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
27992559|NCT02152761|81802142|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
27992560|NCT02152761|81802139|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
27992561|NCT02152761|81802140|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
27992562|NCT02152761|81802141|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
27992563|NCT02152761|81802142|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
27992564|NCT02152761|81802139|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
27992565|NCT02152761|81802140|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
27992566|NCT02152761|81802141|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
27992567|NCT02152761|81802142|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
27799962|NCT01106352|81098966|FG000|Overall Study|Subjects untreated|0|||
27799963|NCT01106352|81098967|FG001|Overall Study|Subjects untreated|0|||
27799964|NCT01106352|81098968|FG002|Overall Study|Subjects untreated|0|||
27871072|NCT04447040|81361593|FG001|Overall Study|Withdrawal by Subject|1|||
27871073|NCT04447040|81361594|FG002|Overall Study|Withdrawal by Subject|1|||
27799965|NCT01106352|81098969|FG003|Overall Study|Subjects untreated|3|||
27799966|NCT01106352|81098970|FG004|Overall Study|Subjects untreated|4|||
27799967|NCT01106352|81098966|FG000|Overall Study|Sponsor Decision|1|||
27799968|NCT01106352|81098967|FG001|Overall Study|Sponsor Decision|0|||
27799969|NCT01106352|81098968|FG002|Overall Study|Sponsor Decision|0|||
27992568|NCT02152761|81802139|FG000|Epoch: Treatment Epoch|Death|0|||
27992569|NCT02152761|81802140|FG001|Epoch: Treatment Epoch|Death|3|||
27992570|NCT02152761|81802141|FG002|Epoch: Treatment Epoch|Death|1|||
27992571|NCT02152761|81802142|FG003|Epoch: Treatment Epoch|Death|0|||
27992572|NCT02152761|81802139|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
27992573|NCT02152761|81802140|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
27992574|NCT02152761|81802141|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
27992575|NCT02152761|81802142|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
27992576|NCT02152761|81802139|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
27992577|NCT02152761|81802140|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
27992578|NCT02152761|81802141|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
27992579|NCT02152761|81802142|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
27992580|NCT02152761|81802139|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
27992581|NCT02152761|81802140|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
27992582|NCT02152761|81802141|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
27992583|NCT02152761|81802142|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
27992584|NCT02152761|81802139|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
27992585|NCT02152761|81802140|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
27992586|NCT02152761|81802141|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
27992587|NCT02152761|81802142|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
27992588|NCT02152761|81802139|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
27992589|NCT02152761|81802140|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
27992590|NCT02152761|81802141|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
27992591|NCT02152761|81802142|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
27992592|NCT03517228|81802143|FG000|Overall Study|Withdrawal by Subject|2|||
27992593|NCT03517228|81802143|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
27992594|NCT03517228|81802143|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
27992595|NCT03517228|81802143|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
27992596|NCT03517228|81802143|FG000|Overall Study|Canceled due to device being updated|1|||
27992597|NCT03517228|81802143|FG000|Overall Study|No V Cares in stock|1|||
27992598|NCT03517228|81802143|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
27992599|NCT02119663|81802144|FG000|Overall Study|Disease progression|26|||
27992600|NCT02119663|81802145|FG001|Overall Study|Disease progression|27|||
27992601|NCT02119663|81802144|FG000|Overall Study|Adverse Event|5|||
27992602|NCT02119663|81802145|FG001|Overall Study|Adverse Event|5|||
27992603|NCT02119663|81802144|FG000|Overall Study|Death|3|||
27992604|NCT02119663|81802145|FG001|Overall Study|Death|2|||
27992605|NCT02119663|81802144|FG000|Overall Study|Physician Decision|1|||
27992606|NCT02119663|81802145|FG001|Overall Study|Physician Decision|2|||
27992607|NCT02119663|81802144|FG000|Overall Study|Other unspecified|2|||
27992608|NCT02119663|81802145|FG001|Overall Study|Other unspecified|0|||
27992609|NCT02119663|81802144|FG000|Overall Study|Subject decision|0|||
27992610|NCT02119663|81802145|FG001|Overall Study|Subject decision|1|||
27992611|NCT02119663|81802144|FG000|Overall Study|Study Terminated by the Sponsor|3|||
27992612|NCT02119663|81802145|FG001|Overall Study|Study Terminated by the Sponsor|4|||
27992613|NCT01746225|81802148|FG000|Overall Study|Death|1|||
27992614|NCT01746225|81802149|FG001|Overall Study|Death|0|||
27992615|NCT01746225|81802150|FG002|Overall Study|Death|1|||
27992616|NCT01746225|81802148|FG000|Overall Study|Withdrawal by Subject|5|||
27992617|NCT01746225|81802149|FG001|Overall Study|Withdrawal by Subject|15|||
27992618|NCT01746225|81802150|FG002|Overall Study|Withdrawal by Subject|19|||
27992619|NCT01746225|81802148|FG000|Overall Study|Physician Decision|14|||
27992620|NCT01746225|81802149|FG001|Overall Study|Physician Decision|11|||
27992621|NCT01746225|81802150|FG002|Overall Study|Physician Decision|3|||
27992622|NCT01746225|81802148|FG000|Overall Study|Adverse Event|15|||
27992623|NCT01746225|81802149|FG001|Overall Study|Adverse Event|12|||
27992624|NCT01746225|81802150|FG002|Overall Study|Adverse Event|17|||
27992625|NCT01746225|81802148|FG000|Overall Study|Continuing Treatment|5|||
27992626|NCT01746225|81802149|FG001|Overall Study|Continuing Treatment|8|||
27992627|NCT01746225|81802150|FG002|Overall Study|Continuing Treatment|3|||
27992628|NCT00319254|81802151|FG000|Overall Study|Withdrawal by Subject|4|||
27677452|NCT03192462|80656721|FG002|Overall Study|On follow up|3|||
27799970|NCT01106352|81098969|FG003|Overall Study|Sponsor Decision|0|||
27799971|NCT01106352|81098970|FG004|Overall Study|Sponsor Decision|0|||
27799972|NCT01106352|81098966|FG000|Overall Study|Too ill to come in for the visit|0|||
27799973|NCT01106352|81098967|FG001|Overall Study|Too ill to come in for the visit|0|||
27799974|NCT01106352|81098968|FG002|Overall Study|Too ill to come in for the visit|1|||
27799975|NCT01106352|81098969|FG003|Overall Study|Too ill to come in for the visit|0|||
27799976|NCT01106352|81098970|FG004|Overall Study|Too ill to come in for the visit|0|||
27799977|NCT01106352|81098966|FG000|Overall Study|Lost to Follow-up|0|||
27799978|NCT01106352|81098967|FG001|Overall Study|Lost to Follow-up|0|||
27799979|NCT01106352|81098968|FG002|Overall Study|Lost to Follow-up|0|||
27799980|NCT01106352|81098969|FG003|Overall Study|Lost to Follow-up|0|||
27799981|NCT01106352|81098970|FG004|Overall Study|Lost to Follow-up|1|||
27799982|NCT01106352|81098966|FG000|Overall Study|Death|0|||
27799983|NCT01106352|81098967|FG001|Overall Study|Death|0|||
27799984|NCT01106352|81098968|FG002|Overall Study|Death|1|||
27799985|NCT01106352|81098969|FG003|Overall Study|Death|3|||
27799986|NCT01106352|81098970|FG004|Overall Study|Death|1|||
27799987|NCT01106352|81098966|FG000|Overall Study|Disease progression|0|||
27799988|NCT01106352|81098967|FG001|Overall Study|Disease progression|0|||
27799989|NCT01106352|81098968|FG002|Overall Study|Disease progression|0|||
27799990|NCT01106352|81098969|FG003|Overall Study|Disease progression|1|||
27799991|NCT01106352|81098970|FG004|Overall Study|Disease progression|0|||
27799992|NCT01106352|81098966|FG000|Overall Study|Withdrawal by Subject|0|||
27799993|NCT01106352|81098967|FG001|Overall Study|Withdrawal by Subject|0|||
27799994|NCT01106352|81098968|FG002|Overall Study|Withdrawal by Subject|0|||
27799995|NCT01106352|81098969|FG003|Overall Study|Withdrawal by Subject|3|||
27799996|NCT01106352|81098970|FG004|Overall Study|Withdrawal by Subject|2|||
27799997|NCT01106352|81098966|FG000|Overall Study|Went on hospice|0|||
27799998|NCT01106352|81098967|FG001|Overall Study|Went on hospice|0|||
27799999|NCT01106352|81098968|FG002|Overall Study|Went on hospice|0|||
27800000|NCT01106352|81098969|FG003|Overall Study|Went on hospice|1|||
27800001|NCT01106352|81098970|FG004|Overall Study|Went on hospice|0|||
27800002|NCT01106352|81098966|FG000|Overall Study|Subject entered hospice|0|||
27800003|NCT01106352|81098967|FG001|Overall Study|Subject entered hospice|0|||
27800004|NCT01106352|81098968|FG002|Overall Study|Subject entered hospice|0|||
27800005|NCT01106352|81098969|FG003|Overall Study|Subject entered hospice|1|||
27800006|NCT01106352|81098970|FG004|Overall Study|Subject entered hospice|0|||
27800007|NCT01106352|81098966|FG000|Overall Study|Home hospice since July 2013|0|||
27800008|NCT01106352|81098967|FG001|Overall Study|Home hospice since July 2013|0|||
27800009|NCT01106352|81098968|FG002|Overall Study|Home hospice since July 2013|0|||
27800010|NCT01106352|81098969|FG003|Overall Study|Home hospice since July 2013|1|||
27800011|NCT01106352|81098970|FG004|Overall Study|Home hospice since July 2013|0|||
27800012|NCT01508325|81098971|FG000|Overall Study|Withdrawal by Subject|8|||
27800013|NCT01508325|81098972|FG001|Overall Study|Withdrawal by Subject|9|||
27800014|NCT01508325|81098971|FG000|Overall Study|Protocol Violation|0|||
27800015|NCT01508325|81098972|FG001|Overall Study|Protocol Violation|3|||
27992629|NCT00319254|81802151|FG000|Overall Study|Death|46|||
27992630|NCT00319254|81802151|FG000|Overall Study|Lost to Follow-up|2|||
27992631|NCT00319254|81802151|FG000|Overall Study|Enrolled, Not Treated|2|||
27992632|NCT00286429|81802152|FG000|Overall Study|Adverse Event|4|||
27992633|NCT00286429|81802153|FG001|Overall Study|Adverse Event|1|||
27992634|NCT00286429|81802154|FG002|Overall Study|Adverse Event|6|||
27992635|NCT00286429|81802152|FG000|Overall Study|Lack of Efficacy|52|||
27992636|NCT00286429|81802153|FG001|Overall Study|Lack of Efficacy|27|||
27992637|NCT00286429|81802154|FG002|Overall Study|Lack of Efficacy|25|||
27992638|NCT00286429|81802152|FG000|Overall Study|Lost to Follow-up|2|||
27992639|NCT00286429|81802153|FG001|Overall Study|Lost to Follow-up|4|||
27992640|NCT00286429|81802154|FG002|Overall Study|Lost to Follow-up|3|||
27800016|NCT01508325|81098971|FG000|Overall Study|Physician Decision|2|||
27800017|NCT01508325|81098972|FG001|Overall Study|Physician Decision|1|||
27800018|NCT01508325|81098971|FG000|Overall Study|Adverse Event|1|||
27800019|NCT01508325|81098972|FG001|Overall Study|Adverse Event|0|||
27800020|NCT01508325|81098971|FG000|Overall Study|Lost to Follow-up|5|||
27800021|NCT01508325|81098972|FG001|Overall Study|Lost to Follow-up|6|||
27800022|NCT01508325|81098971|FG000|Overall Study|Other|2|||
27800023|NCT01508325|81098972|FG001|Overall Study|Other|2|||
27800024|NCT03543046|81098973|FG000|Overall Study|Adverse Event|1|||
27992641|NCT00286429|81802152|FG000|Overall Study|Physician Decision|10|||
27992642|NCT00286429|81802153|FG001|Overall Study|Physician Decision|7|||
27992643|NCT00286429|81802154|FG002|Overall Study|Physician Decision|7|||
27800025|NCT03543046|81098974|FG001|Overall Study|Adverse Event|1|||
27800026|NCT03543046|81098973|FG000|Overall Study|Physician Decision|1|||
27800027|NCT03543046|81098974|FG001|Overall Study|Physician Decision|1|||
27800028|NCT03543046|81098973|FG000|Overall Study|Protocol Violation|1|||
27992644|NCT00286429|81802152|FG000|Overall Study|Protocol Violation|3|||
27800029|NCT03543046|81098974|FG001|Overall Study|Protocol Violation|0|||
27800030|NCT03087773|81098976|FG000|Overall Study|Withdrawal by Subject|8|||
27800031|NCT03087773|81098977|FG001|Overall Study|Withdrawal by Subject|4|||
27800032|NCT03087773|81098976|FG000|Overall Study|Lost to Follow-up|12|||
27800033|NCT03087773|81098977|FG001|Overall Study|Lost to Follow-up|8|||
27992645|NCT00286429|81802153|FG001|Overall Study|Protocol Violation|5|||
27992646|NCT00286429|81802154|FG002|Overall Study|Protocol Violation|4|||
27992647|NCT00286429|81802152|FG000|Overall Study|Withdrawal by Subject|3|||
27992648|NCT00286429|81802153|FG001|Overall Study|Withdrawal by Subject|2|||
27992649|NCT00286429|81802154|FG002|Overall Study|Withdrawal by Subject|6|||
27800034|NCT03575325|81098979|FG000|Overall Study|Death|1|||
27800035|NCT00854607|81098982|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
27800036|NCT02284373|81098983|FG000|Overall Study|Withdrawal by Subject|0|||
27800037|NCT02284373|81098984|FG001|Overall Study|Withdrawal by Subject|1|||
27800038|NCT02284373|81098985|FG002|Overall Study|Withdrawal by Subject|0|||
27800039|NCT02284373|81098983|FG000|Overall Study|Other|0|||
27800040|NCT02284373|81098984|FG001|Overall Study|Other|1|||
27800041|NCT02284373|81098985|FG002|Overall Study|Other|0|||
27992650|NCT00286429|81802152|FG000|Overall Study|Administrative Error|1|||
27992651|NCT00286429|81802153|FG001|Overall Study|Administrative Error|1|||
27992652|NCT00286429|81802154|FG002|Overall Study|Administrative Error|1|||
27992653|NCT00286429|81802152|FG000|Overall Study|Administrative Decision|0|||
27992654|NCT00286429|81802153|FG001|Overall Study|Administrative Decision|1|||
27992655|NCT00286429|81802154|FG002|Overall Study|Administrative Decision|0|||
27800042|NCT02284373|81098983|FG000|Overall Study|Lost to Follow-up|0|||
27992656|NCT01769196|81802155|FG000|Overall Study|Adverse Event|24|||
27992657|NCT01769196|81802156|FG001|Overall Study|Adverse Event|20|||
27992658|NCT01769196|81802155|FG000|Overall Study|Death|21|||
27992659|NCT01769196|81802156|FG001|Overall Study|Death|26|||
27992660|NCT01769196|81802155|FG000|Overall Study|Investigator Discretion|7|||
27992661|NCT01769196|81802156|FG001|Overall Study|Investigator Discretion|3|||
27800043|NCT02284373|81098984|FG001|Overall Study|Lost to Follow-up|1|||
27800044|NCT02284373|81098985|FG002|Overall Study|Lost to Follow-up|0|||
27800045|NCT01467570|81098988|FG000|Overall Study|Lost to Follow-up|8|||
27800046|NCT01467570|81098989|FG001|Overall Study|Lost to Follow-up|9|||
27800047|NCT01020773|81098990|FG000|Overall Study|Withdrawal by Subject|4|||
27800048|NCT01020773|81098991|FG001|Overall Study|Withdrawal by Subject|3|||
27992662|NCT01769196|81802155|FG000|Overall Study|Lack of Efficacy|3|||
27992663|NCT01769196|81802156|FG001|Overall Study|Lack of Efficacy|2|||
27992664|NCT01769196|81802155|FG000|Overall Study|Progressive disease|11|||
27992665|NCT01769196|81802156|FG001|Overall Study|Progressive disease|6|||
27992666|NCT01769196|81802155|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
27992667|NCT01769196|81802156|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
27992668|NCT01769196|81802155|FG000|Overall Study|Protocol Violation|0|||
27992669|NCT01769196|81802156|FG001|Overall Study|Protocol Violation|3|||
27992670|NCT01769196|81802155|FG000|Overall Study|Study terminated by sponsor|160|||
27992671|NCT01769196|81802156|FG001|Overall Study|Study terminated by sponsor|161|||
27992672|NCT01769196|81802155|FG000|Overall Study|Participant never dosed with study drug|1|||
27677453|NCT01077518|80656727|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
27677454|NCT01077518|80656728|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
27677455|NCT01077518|80656729|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
27677456|NCT01077518|80656727|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
27800049|NCT03349437|81098997|FG000|Screening|Screen Fail|4|||
27800050|NCT03349437|81098998|FG001|Screening|Screen Fail|0|||
27800051|NCT03349437|81098999|FG002|Screening|Screen Fail|0|||
27800052|NCT03349437|81098997|FG000|Screening|Withdrawn|1|||
27800053|NCT03349437|81098998|FG001|Screening|Withdrawn|0|||
27800054|NCT03349437|81098999|FG002|Screening|Withdrawn|0|||
27800055|NCT00589693|81099000|FG000|Overall Study|randomized in error|12|||
27800056|NCT00589693|81099001|FG001|Overall Study|randomized in error|6|||
27800057|NCT00589693|81099000|FG000|Overall Study|Adverse Event|4|||
27800058|NCT00589693|81099001|FG001|Overall Study|Adverse Event|4|||
27800059|NCT00589693|81099000|FG000|Overall Study|Death|26|||
27800060|NCT00589693|81099001|FG001|Overall Study|Death|16|||
27800061|NCT00589693|81099000|FG000|Overall Study|Lack of Efficacy|0|||
27800062|NCT00589693|81099001|FG001|Overall Study|Lack of Efficacy|1|||
27800063|NCT00589693|81099000|FG000|Overall Study|Lost to Follow-up|1|||
27800064|NCT00589693|81099001|FG001|Overall Study|Lost to Follow-up|0|||
27800065|NCT00589693|81099000|FG000|Overall Study|Physician Decision|0|||
27800066|NCT00589693|81099001|FG001|Overall Study|Physician Decision|1|||
27800067|NCT00589693|81099000|FG000|Overall Study|Protocol Violation|1|||
27800068|NCT00589693|81099001|FG001|Overall Study|Protocol Violation|1|||
27800069|NCT03722849|81099002|FG000|Overall Study|Withdrawal by Subject|1|||
27800070|NCT03722849|81099003|FG001|Overall Study|Withdrawal by Subject|1|||
27800071|NCT01396161|81099005|FG000|Overall Study|Withdrawal by Subject|0|||
27800072|NCT01396161|81099006|FG001|Overall Study|Withdrawal by Subject|0|||
27800073|NCT01396161|81099007|FG002|Overall Study|Withdrawal by Subject|0|||
27800074|NCT01396161|81099008|FG003|Overall Study|Withdrawal by Subject|0|||
27800075|NCT01396161|81099009|FG004|Overall Study|Withdrawal by Subject|1|||
27800076|NCT01396161|81099010|FG005|Overall Study|Withdrawal by Subject|0|||
27800077|NCT01396161|81099011|FG006|Overall Study|Withdrawal by Subject|0|||
27800078|NCT01396161|81099005|FG000|Overall Study|Other|0|||
27800079|NCT01396161|81099006|FG001|Overall Study|Other|0|||
27800080|NCT01396161|81099007|FG002|Overall Study|Other|0|||
27800081|NCT01396161|81099008|FG003|Overall Study|Other|0|||
27800082|NCT01396161|81099009|FG004|Overall Study|Other|0|||
27800083|NCT01396161|81099010|FG005|Overall Study|Other|0|||
27800084|NCT01396161|81099011|FG006|Overall Study|Other|1|||
27800085|NCT05478603|81099018|FG000|Overall Study|Withdrawal by Subject|0|||
27800086|NCT05478603|81099019|FG001|Overall Study|Withdrawal by Subject|1|||
27800087|NCT05478603|81099020|FG002|Overall Study|Withdrawal by Subject|0|||
27800088|NCT05478603|81099021|FG003|Overall Study|Withdrawal by Subject|0|||
27800089|NCT01256398|81099024|FG000|Overall Study|Withdrawal by Subject|1|||
27800090|NCT01890109|81099026|FG000|Overall Study|Withdrawal by Subject|0|||
27800091|NCT01890109|81099027|FG001|Overall Study|Withdrawal by Subject|3|||
27800092|NCT01890109|81099026|FG000|Overall Study|Lost to Follow-up|1|||
27800093|NCT01890109|81099027|FG001|Overall Study|Lost to Follow-up|2|||
27800094|NCT01154673|81099028|FG000|Overall Study|Lost to Follow-up|1|||
27800095|NCT01154673|81099029|FG001|Overall Study|Lost to Follow-up|0|||
27800096|NCT01154673|81099028|FG000|Overall Study|moved out of province|1|||
27800097|NCT01154673|81099029|FG001|Overall Study|moved out of province|0|||
27992673|NCT01769196|81802156|FG001|Overall Study|Participant never dosed with study drug|0|||
27992674|NCT01769196|81802155|FG000|Overall Study|Withdrew consent|36|||
27800098|NCT00530439|81099030|FG000|Overall Study|GDM|9|||
27800099|NCT00530439|81099031|FG001|Overall Study|GDM|3|||
27800100|NCT00530439|81099030|FG000|Overall Study|Withdraw|18|||
27992675|NCT01769196|81802156|FG001|Overall Study|Withdrew consent|40|||
27992676|NCT01045694|81802159|FG000|Overall Study|Withdrawal by Subject|2|||
27800101|NCT00530439|81099031|FG001|Overall Study|Withdraw|14|||
27800102|NCT00530439|81099030|FG000|Overall Study|Missed abortion|1|||
27800103|NCT00530439|81099031|FG001|Overall Study|Missed abortion|4|||
27992677|NCT00320515|81802165|FG000|Overall Study|Death|33|||
27677457|NCT01077518|80656728|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
27677458|NCT01077518|80656729|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
27677459|NCT01077518|80656727|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
27677460|NCT01077518|80656728|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
27800104|NCT00530439|81099030|FG000|Overall Study|Misclassification|2|||
27800105|NCT00530439|81099031|FG001|Overall Study|Misclassification|0|||
27800106|NCT00530439|81099030|FG000|Overall Study|Twin pregnancy|0|||
27800107|NCT00530439|81099031|FG001|Overall Study|Twin pregnancy|2|||
27800108|NCT00530439|81099030|FG000|Overall Study|Severe malformation/abortion|0|||
27800109|NCT00530439|81099031|FG001|Overall Study|Severe malformation/abortion|3|||
27800110|NCT00585039|81099035|FG000|Overall Study|medication spilled|2|||
27800111|NCT00585039|81099036|FG001|Overall Study|medication spilled|0|||
27800112|NCT01179191|81099039|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
27800113|NCT01179191|81099039|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
27800114|NCT01179191|81099039|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
27800115|NCT01179191|81099039|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
27800116|NCT01179191|81099039|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
27800117|NCT01179191|81099039|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
27800118|NCT01179191|81099039|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
27800119|NCT01179191|81099039|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
27800120|NCT01179191|81099039|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
27992678|NCT00320515|81802165|FG000|Overall Study|Lost to Follow-up|6|||
27992679|NCT00320515|81802165|FG000|Overall Study|Physician Decision|2|||
27992680|NCT00320515|81802165|FG000|Overall Study|Withdrawal by Subject|8|||
27992681|NCT01068769|81802168|FG000|Overall Study|Ineligible|1|||
27992682|NCT00163020|81802172|FG000|Overall Study|Lost to Follow-up|0|||
27992683|NCT00163020|81802173|FG001|Overall Study|Lost to Follow-up|2|||
27992684|NCT01843023|81802188|FG000|Overall Study|Death|1|||
27992685|NCT01843023|81802189|FG001|Overall Study|Death|0|||
27992686|NCT01843023|81802188|FG000|Overall Study|Lost to Follow-up|24|||
27992687|NCT01843023|81802189|FG001|Overall Study|Lost to Follow-up|29|||
27992688|NCT01843023|81802188|FG000|Overall Study|Withdrawal by Subject|8|||
27992689|NCT01843023|81802189|FG001|Overall Study|Withdrawal by Subject|6|||
27992690|NCT00850538|81802190|FG000|Overall Study|unable/unwilling to complete MRI|13|||
27992691|NCT00850538|81802190|FG000|Overall Study|specimen missed due to scheduling error|14|||
27992692|NCT00850538|81802190|FG000|Overall Study|specimen unusable|7|||
27992693|NCT00850538|81802190|FG000|Overall Study|Withdrawal by Subject|3|||
27992694|NCT00850538|81802190|FG000|Overall Study|radiology error|2|||
27992695|NCT00850538|81802190|FG000|Overall Study|Protocol Violation|2|||
27992696|NCT00753454|81802191|FG000|Overall Study|Adverse Event|4|||
27992697|NCT00753454|81802191|FG000|Overall Study|Lack of Efficacy|1|||
27992698|NCT00753454|81802191|FG000|Overall Study|Lost to Follow-up|3|||
27992699|NCT00753454|81802191|FG000|Overall Study|Withdrawal by Subject|5|||
27992700|NCT00753454|81802191|FG000|Overall Study|Investigator Decision|1|||
27992701|NCT00555217|81802194|FG000|Overall Study|Withdrawal by Subject|35|||
27992702|NCT00555217|81802195|FG001|Overall Study|Withdrawal by Subject|31|||
27992703|NCT00555217|81802194|FG000|Overall Study|Lost to Follow-up|19|||
27992704|NCT00555217|81802195|FG001|Overall Study|Lost to Follow-up|20|||
27992705|NCT00555217|81802194|FG000|Overall Study|close out sites|21|||
27992706|NCT00555217|81802195|FG001|Overall Study|close out sites|17|||
27992707|NCT03268941|81802198|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
27992708|NCT03268941|81802199|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
27992709|NCT03268941|81802200|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
27992710|NCT03268941|81802201|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
27992711|NCT03268941|81802202|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
27992712|NCT03268941|81802203|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
27992713|NCT03268941|81802204|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
27992714|NCT03268941|81802198|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
27677461|NCT01077518|80656729|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
27677462|NCT01077518|80656727|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
27677463|NCT01077518|80656728|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
27800121|NCT01179191|81099039|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
27992715|NCT03268941|81802199|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
27992716|NCT03268941|81802200|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
27992717|NCT03268941|81802201|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
27992718|NCT03268941|81802202|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
27992719|NCT03268941|81802203|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
27992720|NCT03268941|81802204|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
27992721|NCT03268941|81802198|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
27992722|NCT03268941|81802199|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
27992723|NCT03268941|81802200|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
27992724|NCT03268941|81802201|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
27992725|NCT03268941|81802202|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
27992726|NCT03268941|81802203|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
27992727|NCT03268941|81802204|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
27992728|NCT03268941|81802198|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
27992729|NCT03268941|81802199|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
27992730|NCT03268941|81802200|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
27992731|NCT03268941|81802201|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
27800122|NCT01179191|81099039|FG000|Maintenance Phase (8 Weeks)|Other|66|||
27800123|NCT02173301|81099040|FG000|Overall Study|Adverse Event|7|||
27800124|NCT02173301|81099041|FG001|Overall Study|Adverse Event|8|||
27800125|NCT02173301|81099042|FG002|Overall Study|Adverse Event|13|||
27871074|NCT04447040|81361595|FG003|Overall Study|Withdrawal by Subject|1|||
27800126|NCT02173301|81099043|FG003|Overall Study|Adverse Event|5|||
27800127|NCT02173301|81099040|FG000|Overall Study|Withdrawal by Subject|8|||
27800128|NCT02173301|81099041|FG001|Overall Study|Withdrawal by Subject|10|||
27800129|NCT02173301|81099042|FG002|Overall Study|Withdrawal by Subject|4|||
27800130|NCT02173301|81099043|FG003|Overall Study|Withdrawal by Subject|8|||
27800131|NCT02173301|81099040|FG000|Overall Study|Lost to Follow-up|4|||
27800132|NCT02173301|81099041|FG001|Overall Study|Lost to Follow-up|4|||
27800133|NCT02173301|81099042|FG002|Overall Study|Lost to Follow-up|2|||
27800134|NCT02173301|81099043|FG003|Overall Study|Lost to Follow-up|2|||
27800135|NCT02173301|81099040|FG000|Overall Study|Protocol Violation|0|||
27800136|NCT02173301|81099041|FG001|Overall Study|Protocol Violation|1|||
27800137|NCT02173301|81099042|FG002|Overall Study|Protocol Violation|0|||
27800138|NCT02173301|81099043|FG003|Overall Study|Protocol Violation|0|||
27800139|NCT02173301|81099040|FG000|Overall Study|Physician Decision|0|||
27800140|NCT02173301|81099041|FG001|Overall Study|Physician Decision|0|||
27800141|NCT02173301|81099042|FG002|Overall Study|Physician Decision|1|||
27800142|NCT02173301|81099043|FG003|Overall Study|Physician Decision|0|||
27800143|NCT02173301|81099040|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
27800144|NCT02173301|81099041|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
27800145|NCT02173301|81099042|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
27800146|NCT02173301|81099043|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
27800147|NCT04199104|81099045|FG000|Overall Study|Death|148|||
27800148|NCT04199104|81099046|FG001|Overall Study|Death|134|||
27800149|NCT04199104|81099045|FG000|Overall Study|Lost to Follow-up|1|||
27800150|NCT04199104|81099046|FG001|Overall Study|Lost to Follow-up|1|||
27800151|NCT04199104|81099045|FG000|Overall Study|Withdrawal by Subject|4|||
27800152|NCT04199104|81099046|FG001|Overall Study|Withdrawal by Subject|4|||
27800153|NCT04199104|81099045|FG000|Overall Study|Participants Ongoing|103|||
27871075|NCT04447040|81361596|FG004|Overall Study|Withdrawal by Subject|0|||
27871076|NCT04447040|81361597|FG005|Overall Study|Withdrawal by Subject|0|||
27871077|NCT02698163|81361598|FG000|Overall Study|Lost to Follow-up|0|||
27871078|NCT02698163|81361599|FG001|Overall Study|Lost to Follow-up|1|||
27871079|NCT02601014|81361600|FG000|Overall Study|Adverse Event|3|||
27871080|NCT02601014|81361601|FG001|Overall Study|Adverse Event|3|||
27871081|NCT02601014|81361600|FG000|Overall Study|Death|3|||
27871082|NCT02601014|81361601|FG001|Overall Study|Death|1|||
27871083|NCT02601014|81361600|FG000|Overall Study|Disease progression|4|||
27871084|NCT02601014|81361601|FG001|Overall Study|Disease progression|8|||
27871085|NCT01371747|81361602|FG000|Overall Study|Adverse Event|4|||
27871086|NCT01371747|81361603|FG001|Overall Study|Adverse Event|2|||
27871087|NCT01371747|81361604|FG002|Overall Study|Adverse Event|7|||
27871088|NCT01371747|81361605|FG003|Overall Study|Adverse Event|2|||
27871089|NCT01371747|81361606|FG004|Overall Study|Adverse Event|2|||
27871090|NCT01371747|81361607|FG005|Overall Study|Adverse Event|2|||
27871091|NCT01371747|81361602|FG000|Overall Study|Death|1|||
27871092|NCT01371747|81361603|FG001|Overall Study|Death|0|||
27871093|NCT01371747|81361604|FG002|Overall Study|Death|4|||
27871094|NCT01371747|81361605|FG003|Overall Study|Death|1|||
27871095|NCT01371747|81361606|FG004|Overall Study|Death|2|||
27871096|NCT01371747|81361607|FG005|Overall Study|Death|0|||
27871097|NCT01371747|81361602|FG000|Overall Study|Abnormal Renal Function|0|||
27800154|NCT04199104|81099046|FG001|Overall Study|Participants Ongoing|116|||
27800155|NCT02380248|81099047|FG000|Overall Study|Lost to Follow-up|11|||
27800156|NCT02380248|81099047|FG000|Overall Study|Withdrawal by Subject|3|||
27800157|NCT02499406|81099048|FG000|Overall Study|missed 3 treatment sessions|4|||
27871098|NCT01371747|81361603|FG001|Overall Study|Abnormal Renal Function|2|||
27871099|NCT01371747|81361604|FG002|Overall Study|Abnormal Renal Function|0|||
27871100|NCT01371747|81361605|FG003|Overall Study|Abnormal Renal Function|1|||
27992732|NCT03268941|81802202|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
27871101|NCT01371747|81361606|FG004|Overall Study|Abnormal Renal Function|0|||
27992733|NCT03268941|81802203|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
27800158|NCT03869684|81099055|FG000|Overall Study|Adverse Event|0|||
27800159|NCT03869684|81099056|FG001|Overall Study|Adverse Event|3|||
27800160|NCT03869684|81099057|FG002|Overall Study|Adverse Event|1|||
27800161|NCT03869684|81099055|FG000|Overall Study|Withdrawal by Subject|1|||
27800162|NCT03869684|81099056|FG001|Overall Study|Withdrawal by Subject|0|||
27800163|NCT03869684|81099057|FG002|Overall Study|Withdrawal by Subject|0|||
27800164|NCT03869684|81099055|FG000|Overall Study|Lost to Follow-up|1|||
27800165|NCT03869684|81099056|FG001|Overall Study|Lost to Follow-up|0|||
27800166|NCT03869684|81099057|FG002|Overall Study|Lost to Follow-up|0|||
27800167|NCT03869684|81099055|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
27800168|NCT03869684|81099056|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
27800169|NCT03869684|81099057|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
27800170|NCT01374906|81099058|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27800171|NCT01374906|81099059|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27800172|NCT01374906|81099058|FG000|Overall Study|Administrative problems|2|||
27800173|NCT01374906|81099059|FG001|Overall Study|Administrative problems|2|||
27800174|NCT01374906|81099058|FG000|Overall Study|Adverse Event|10|||
27800175|NCT01374906|81099059|FG001|Overall Study|Adverse Event|11|||
27800176|NCT01374906|81099058|FG000|Overall Study|Death|0|||
27800177|NCT01374906|81099059|FG001|Overall Study|Death|2|||
27800178|NCT01374906|81099058|FG000|Overall Study|Protocol Violation|2|||
27800179|NCT01374906|81099059|FG001|Overall Study|Protocol Violation|2|||
27800180|NCT01374906|81099058|FG000|Overall Study|Withdrawal by Subject|15|||
27800181|NCT01374906|81099059|FG001|Overall Study|Withdrawal by Subject|9|||
27800182|NCT01374906|81099058|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
27800183|NCT01374906|81099059|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
27800184|NCT04476017|81099060|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
27800185|NCT04476017|81099061|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
27800186|NCT02564952|81099062|FG000|Overall Study|Adverse Event|6|||
27800187|NCT02564952|81099062|FG000|Overall Study|Lost to Follow-up|1|||
27800188|NCT02564952|81099062|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
27800189|NCT02564952|81099062|FG000|Overall Study|Withdrawal by Subject|1|||
27800190|NCT02564952|81099062|FG000|Overall Study|Low Efficacy|1|||
27800191|NCT02564952|81099062|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27800192|NCT00478673|81099063|FG000|30-Days Post-Procedure|Death|2|||
27800193|NCT00478673|81099063|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
27800194|NCT00478673|81099063|FG000|30-Days Post-Procedure|Missed Visit|7|||
27800195|NCT00478673|81099063|FG000|12-Months Post-Procedure|Death|23|||
27800196|NCT00478673|81099063|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
27800197|NCT00478673|81099063|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
27800198|NCT00478673|81099063|FG000|12-Months Post-Procedure|Missed Visit|25|||
27800199|NCT00478673|81099063|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
27800200|NCT00602979|81099066|FG000|Overall Study|Lost to Follow-up|3|||
27800201|NCT00602979|81099067|FG001|Overall Study|Lost to Follow-up|2|||
27800202|NCT00602979|81099068|FG002|Overall Study|Lost to Follow-up|3|||
27800203|NCT00602979|81099069|FG003|Overall Study|Lost to Follow-up|2|||
27800204|NCT00602979|81099070|FG004|Overall Study|Lost to Follow-up|3|||
27800205|NCT00602979|81099066|FG000|Overall Study|Failed Intubation|0|||
27800206|NCT00602979|81099067|FG001|Overall Study|Failed Intubation|1|||
27800207|NCT00602979|81099068|FG002|Overall Study|Failed Intubation|0|||
27800208|NCT00602979|81099069|FG003|Overall Study|Failed Intubation|1|||
27800209|NCT00602979|81099070|FG004|Overall Study|Failed Intubation|0|||
27800210|NCT01461369|81099071|FG000|Overall Study|Lack of Efficacy|2|||
27800211|NCT01461369|81099072|FG001|Overall Study|Lack of Efficacy|0|||
27800212|NCT01461369|81099073|FG002|Overall Study|Lack of Efficacy|6|||
27800213|NCT01461369|81099071|FG000|Overall Study|Lost to Follow-up|0|||
27800214|NCT01461369|81099072|FG001|Overall Study|Lost to Follow-up|0|||
27800215|NCT01461369|81099073|FG002|Overall Study|Lost to Follow-up|3|||
27800216|NCT01461369|81099071|FG000|Overall Study|Adverse Event|9|||
27800217|NCT01461369|81099072|FG001|Overall Study|Adverse Event|12|||
27800218|NCT01461369|81099073|FG002|Overall Study|Adverse Event|4|||
27800219|NCT01461369|81099071|FG000|Overall Study|Protocol Violation|1|||
27800220|NCT01461369|81099072|FG001|Overall Study|Protocol Violation|2|||
27800221|NCT01461369|81099073|FG002|Overall Study|Protocol Violation|2|||
27800222|NCT01461369|81099071|FG000|Overall Study|Withdrawal by Subject|1|||
27800223|NCT01461369|81099072|FG001|Overall Study|Withdrawal by Subject|3|||
27800224|NCT01461369|81099073|FG002|Overall Study|Withdrawal by Subject|2|||
27800225|NCT04465916|81099075|FG000|Overall Study|Withdrawal by Subject|0|||
27800226|NCT04465916|81099076|FG001|Overall Study|Withdrawal by Subject|1|||
27800227|NCT03120520|81099077|FG000|Overall Study|Lost to Follow-up|1|||
27800228|NCT03120520|81099078|FG001|Overall Study|Lost to Follow-up|1|||
27800229|NCT03120520|81099079|FG002|Overall Study|Lost to Follow-up|1|||
27800230|NCT03120520|81099080|FG003|Overall Study|Lost to Follow-up|1|||
27800231|NCT03120520|81099077|FG000|Overall Study|Withdrawal by Subject|3|||
27800232|NCT03120520|81099078|FG001|Overall Study|Withdrawal by Subject|2|||
27871102|NCT01371747|81361607|FG005|Overall Study|Abnormal Renal Function|1|||
27871103|NCT01371747|81361602|FG000|Overall Study|High Serum Potassium Results|1|||
27992734|NCT03268941|81802204|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
27992735|NCT03268941|81802198|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
27992736|NCT03268941|81802199|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
27992737|NCT03268941|81802200|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
27992738|NCT03268941|81802201|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
27992739|NCT03268941|81802202|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
27992740|NCT03268941|81802203|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
27992741|NCT03268941|81802204|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
27992742|NCT00707954|81802205|FG000|Overall Study|Physician Decision|0|||
27992743|NCT00707954|81802206|FG001|Overall Study|Physician Decision|0|||
27992744|NCT00707954|81802207|FG002|Overall Study|Physician Decision|0|||
27992745|NCT00707954|81802208|FG003|Overall Study|Physician Decision|0|||
27992746|NCT00707954|81802209|FG004|Overall Study|Physician Decision|1|||
27992747|NCT02863328|81802210|FG000|Overall Study|Lost to Follow-up|4|||
27992748|NCT02863328|81802211|FG001|Overall Study|Lost to Follow-up|10|||
27992749|NCT02863328|81802210|FG000|Overall Study|Withdrawal by Subject|7|||
27992750|NCT02863328|81802211|FG001|Overall Study|Withdrawal by Subject|12|||
27992751|NCT02863328|81802210|FG000|Overall Study|Died|0|||
27992752|NCT02863328|81802211|FG001|Overall Study|Died|1|||
27992753|NCT00773747|81802212|FG000|Overall Study|Lack of Efficacy|112|||
27992754|NCT00773747|81802213|FG001|Overall Study|Lack of Efficacy|144|||
27992755|NCT00773747|81802212|FG000|Overall Study|Physician Decision|26|||
27992756|NCT00773747|81802213|FG001|Overall Study|Physician Decision|18|||
27992757|NCT00773747|81802212|FG000|Overall Study|Lost to Follow-up|0|||
27992758|NCT00773747|81802213|FG001|Overall Study|Lost to Follow-up|1|||
27992759|NCT00773747|81802212|FG000|Overall Study|Protocol Violation|2|||
27992760|NCT00773747|81802213|FG001|Overall Study|Protocol Violation|2|||
27992761|NCT00773747|81802212|FG000|Overall Study|Withdrawal by Subject|89|||
27992762|NCT00773747|81802213|FG001|Overall Study|Withdrawal by Subject|61|||
27992763|NCT00773747|81802212|FG000|Overall Study|Adverse Event|61|||
27992764|NCT00773747|81802213|FG001|Overall Study|Adverse Event|62|||
27992765|NCT00773747|81802212|FG000|Overall Study|Death|5|||
27992766|NCT00773747|81802213|FG001|Overall Study|Death|8|||
27992767|NCT00773747|81802212|FG000|Overall Study|Not Treated|2|||
27677464|NCT01077518|80656729|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
27677465|NCT01077518|80656727|FG000|Optional Ofa Phase|Physician Decision|0|||
27677466|NCT01077518|80656728|FG001|Optional Ofa Phase|Physician Decision|0|||
27677467|NCT01077518|80656729|FG002|Optional Ofa Phase|Physician Decision|1|||
27677468|NCT01077518|80656727|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
27677469|NCT01077518|80656728|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
27677470|NCT01077518|80656729|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
27677471|NCT01077518|80656727|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
27677472|NCT01077518|80656728|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
27871104|NCT01371747|81361603|FG001|Overall Study|High Serum Potassium Results|1|||
27992768|NCT00773747|81802213|FG001|Overall Study|Not Treated|0|||
27992769|NCT02775916|81802214|FG000|Overall Study|Adverse Event|1|||
27992770|NCT02775916|81802215|FG001|Overall Study|Adverse Event|0|||
27992771|NCT02775916|81802214|FG000|Overall Study|Subject/Guardian Decision|2|||
27992772|NCT02775916|81802215|FG001|Overall Study|Subject/Guardian Decision|0|||
27992773|NCT02227199|81802216|FG000|Overall Study|Physician Decision|0|||
27992774|NCT02227199|81802217|FG001|Overall Study|Physician Decision|0|||
27992775|NCT02227199|81802218|FG002|Overall Study|Physician Decision|1|||
27992776|NCT02227199|81802216|FG000|Overall Study|Adverse Event|0|||
27992777|NCT02227199|81802217|FG001|Overall Study|Adverse Event|0|||
27992778|NCT02227199|81802218|FG002|Overall Study|Adverse Event|3|||
27992779|NCT04090242|81802219|FG000|Overall Study|Withdrawal by Subject|1|||
27677473|NCT01077518|80656729|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
27677474|NCT02808975|80656730|FG000|Overall Study|Adverse Event|3|||
27677475|NCT02808975|80656731|FG001|Overall Study|Adverse Event|4|||
27677476|NCT02808975|80656730|FG000|Overall Study|Withdrew consent|9|||
27677477|NCT02808975|80656731|FG001|Overall Study|Withdrew consent|8|||
27677478|NCT02808975|80656730|FG000|Overall Study|Lost to Follow-up|4|||
27677479|NCT02808975|80656731|FG001|Overall Study|Lost to Follow-up|6|||
27677480|NCT02808975|80656730|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
27677481|NCT02808975|80656731|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
27677482|NCT02808975|80656730|FG000|Overall Study|Other, not specified|5|||
27677483|NCT02808975|80656731|FG001|Overall Study|Other, not specified|1|||
27677484|NCT03392168|80656732|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
27677485|NCT03392168|80656733|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
27677486|NCT03392168|80656734|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
27677487|NCT03392168|80656735|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
27677488|NCT03392168|80656732|FG000|Period 2: Cohort 2|Other|0|||
27677489|NCT03392168|80656733|FG001|Period 2: Cohort 2|Other|1|||
27677490|NCT03392168|80656734|FG002|Period 2: Cohort 2|Other|0|||
27677491|NCT03392168|80656735|FG003|Period 2: Cohort 2|Other|0|||
27677492|NCT01254747|80656737|FG000|Overall Study|Unacceptable subjective vision|0|||
27677493|NCT01254747|80656738|FG001|Overall Study|Unacceptable subjective vision|0|||
27677494|NCT01254747|80656739|FG002|Overall Study|Unacceptable subjective vision|0|||
27677495|NCT01254747|80656740|FG003|Overall Study|Unacceptable subjective vision|2|||
27677496|NCT01254747|80656737|FG000|Overall Study|Difficult removal handling|0|||
27677497|NCT01254747|80656738|FG001|Overall Study|Difficult removal handling|0|||
27677498|NCT01254747|80656739|FG002|Overall Study|Difficult removal handling|1|||
27677499|NCT01254747|80656740|FG003|Overall Study|Difficult removal handling|0|||
27677500|NCT01254747|80656737|FG000|Overall Study|Symptoms and problems|0|||
27677501|NCT01254747|80656738|FG001|Overall Study|Symptoms and problems|2|||
27677502|NCT01254747|80656739|FG002|Overall Study|Symptoms and problems|1|||
27677503|NCT01254747|80656740|FG003|Overall Study|Symptoms and problems|0|||
27677504|NCT01254747|80656737|FG000|Overall Study|Lost to Follow-up|0|||
27677505|NCT01254747|80656738|FG001|Overall Study|Lost to Follow-up|0|||
27677506|NCT01254747|80656739|FG002|Overall Study|Lost to Follow-up|1|||
27677507|NCT01254747|80656740|FG003|Overall Study|Lost to Follow-up|0|||
27677508|NCT01254747|80656737|FG000|Overall Study|Biomicroscopy|0|||
27677509|NCT01254747|80656738|FG001|Overall Study|Biomicroscopy|0|||
27677510|NCT01254747|80656739|FG002|Overall Study|Biomicroscopy|1|||
27677511|NCT01254747|80656740|FG003|Overall Study|Biomicroscopy|0|||
27677512|NCT01254747|80656737|FG000|Overall Study|Discomfort|0|||
27677513|NCT01254747|80656738|FG001|Overall Study|Discomfort|4|||
27677514|NCT01254747|80656739|FG002|Overall Study|Discomfort|0|||
27677515|NCT01254747|80656740|FG003|Overall Study|Discomfort|0|||
27677516|NCT01441635|80656741|FG000|Overall Study|Adverse Event|4|||
27677517|NCT01441635|80656742|FG001|Overall Study|Adverse Event|3|||
27677518|NCT01441635|80656743|FG002|Overall Study|Adverse Event|1|||
27677519|NCT01441635|80656744|FG003|Overall Study|Adverse Event|5|||
27677520|NCT01441635|80656745|FG004|Overall Study|Adverse Event|1|||
27677521|NCT01441635|80656746|FG005|Overall Study|Adverse Event|2|||
27677522|NCT01441635|80656747|FG006|Overall Study|Adverse Event|2|||
27677523|NCT01441635|80656748|FG007|Overall Study|Adverse Event|2|||
27677524|NCT01441635|80656749|FG008|Overall Study|Adverse Event|1|||
27677525|NCT01441635|80656750|FG009|Overall Study|Adverse Event|0|||
27677526|NCT01441635|80656741|FG000|Overall Study|Withdrawal by Subject|1|||
27677527|NCT01441635|80656742|FG001|Overall Study|Withdrawal by Subject|1|||
27677528|NCT01441635|80656743|FG002|Overall Study|Withdrawal by Subject|0|||
27677529|NCT01441635|80656744|FG003|Overall Study|Withdrawal by Subject|1|||
27677530|NCT01441635|80656745|FG004|Overall Study|Withdrawal by Subject|0|||
27677531|NCT01441635|80656746|FG005|Overall Study|Withdrawal by Subject|0|||
27677532|NCT01441635|80656747|FG006|Overall Study|Withdrawal by Subject|2|||
27677533|NCT01441635|80656748|FG007|Overall Study|Withdrawal by Subject|0|||
27992780|NCT04090242|81802220|FG001|Overall Study|Withdrawal by Subject|0|||
27992781|NCT01128946|81802221|FG000|Period I|Protocol Violation|0|||
27677534|NCT01441635|80656749|FG008|Overall Study|Withdrawal by Subject|1|||
27677535|NCT01441635|80656750|FG009|Overall Study|Withdrawal by Subject|1|||
27677536|NCT01441635|80656741|FG000|Overall Study|Lost to Follow-up|0|||
27677537|NCT01441635|80656742|FG001|Overall Study|Lost to Follow-up|1|||
27677538|NCT01441635|80656743|FG002|Overall Study|Lost to Follow-up|1|||
27677539|NCT01441635|80656744|FG003|Overall Study|Lost to Follow-up|1|||
27677540|NCT01441635|80656745|FG004|Overall Study|Lost to Follow-up|1|||
27677541|NCT01441635|80656746|FG005|Overall Study|Lost to Follow-up|3|||
27677542|NCT01441635|80656747|FG006|Overall Study|Lost to Follow-up|1|||
27677543|NCT01441635|80656748|FG007|Overall Study|Lost to Follow-up|1|||
27677544|NCT01441635|80656749|FG008|Overall Study|Lost to Follow-up|0|||
27677545|NCT01441635|80656750|FG009|Overall Study|Lost to Follow-up|1|||
27677546|NCT01441635|80656741|FG000|Overall Study|Noncompliance|0|||
27677547|NCT01441635|80656742|FG001|Overall Study|Noncompliance|1|||
27992782|NCT01128946|81802222|FG001|Period I|Protocol Violation|1|||
27992783|NCT01128946|81802223|FG002|Period I|Protocol Violation|0|||
27992784|NCT01128946|81802224|FG003|Period I|Protocol Violation|0|||
27992785|NCT01128946|81802221|FG000|Period I|Withdrawal by Subject|0|||
27992786|NCT01128946|81802222|FG001|Period I|Withdrawal by Subject|0|||
27992787|NCT01128946|81802223|FG002|Period I|Withdrawal by Subject|1|||
27992788|NCT01128946|81802224|FG003|Period I|Withdrawal by Subject|1|||
27992789|NCT01128946|81802221|FG000|Period II|Protocol Violation|0|||
27992790|NCT01128946|81802222|FG001|Period II|Protocol Violation|1|||
27992791|NCT01128946|81802223|FG002|Period II|Protocol Violation|0|||
27992792|NCT01128946|81802224|FG003|Period II|Protocol Violation|0|||
27992793|NCT01128946|81802221|FG000|Period II|Withdrawal by Subject|0|||
27992794|NCT01128946|81802222|FG001|Period II|Withdrawal by Subject|0|||
27992795|NCT01128946|81802223|FG002|Period II|Withdrawal by Subject|0|||
27992796|NCT01128946|81802224|FG003|Period II|Withdrawal by Subject|1|||
27992797|NCT01128946|81802221|FG000|Period III|Protocol Violation|1|||
27992798|NCT01128946|81802222|FG001|Period III|Protocol Violation|0|||
27992799|NCT01128946|81802223|FG002|Period III|Protocol Violation|0|||
27992800|NCT01128946|81802224|FG003|Period III|Protocol Violation|0|||
27992801|NCT01712204|81805349|FG000|Overall Study|Adverse Event|3|||
27992802|NCT01712204|81805350|FG001|Overall Study|Adverse Event|1|||
27992803|NCT01712204|81805349|FG000|Overall Study|Withdrawal by Subject|3|||
27992804|NCT01712204|81805350|FG001|Overall Study|Withdrawal by Subject|3|||
27992805|NCT01712204|81805349|FG000|Overall Study|Lost to Follow-up|1|||
27992806|NCT01712204|81805350|FG001|Overall Study|Lost to Follow-up|0|||
27992807|NCT01712204|81805349|FG000|Overall Study|Protocol Violation|1|||
27992808|NCT01712204|81805350|FG001|Overall Study|Protocol Violation|1|||
27992809|NCT00511238|81805367|FG000|Overall Study|Adverse Event|13|||
27992810|NCT00511238|81805368|FG001|Overall Study|Adverse Event|33|||
27992811|NCT00511238|81805367|FG000|Overall Study|Withdrawal by Subject|2|||
27992812|NCT00511238|81805368|FG001|Overall Study|Withdrawal by Subject|22|||
27992813|NCT00511238|81805367|FG000|Overall Study|Progressive Disease|23|||
27992814|NCT00511238|81805368|FG001|Overall Study|Progressive Disease|157|||
27992815|NCT00511238|81805367|FG000|Overall Study|various reasons|4|||
27992816|NCT00511238|81805368|FG001|Overall Study|various reasons|14|||
27992817|NCT00595478|81805369|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
27992818|NCT00595478|81805370|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
27992819|NCT00595478|81805369|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
27992820|NCT00595478|81805370|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
27992821|NCT00858637|81805373|FG000|Active Comparison Phase|Adverse Event|14|||
27992822|NCT00858637|81805374|FG001|Active Comparison Phase|Adverse Event|0|||
27992823|NCT00858637|81805375|FG002|Active Comparison Phase|Adverse Event|0|||
27992824|NCT00858637|81805376|FG003|Active Comparison Phase|Adverse Event|9|||
27992825|NCT00858637|81805377|FG004|Active Comparison Phase|Adverse Event|0|||
27992826|NCT00858637|81805378|FG005|Active Comparison Phase|Adverse Event|0|||
27992827|NCT00858637|81805373|FG000|Active Comparison Phase|Death|1|||
27594201|NCT00729833|80352465|FG000|Overall Study|Withdrawal by Subject|3|||
27871105|NCT01371747|81361604|FG002|Overall Study|High Serum Potassium Results|1|||
27871106|NCT01371747|81361605|FG003|Overall Study|High Serum Potassium Results|2|||
27992828|NCT00858637|81805374|FG001|Active Comparison Phase|Death|0|||
27992829|NCT00858637|81805375|FG002|Active Comparison Phase|Death|0|||
27992830|NCT00858637|81805376|FG003|Active Comparison Phase|Death|1|||
27992831|NCT00858637|81805377|FG004|Active Comparison Phase|Death|0|||
27992832|NCT00858637|81805378|FG005|Active Comparison Phase|Death|0|||
27992833|NCT00858637|81805373|FG000|Active Comparison Phase|Physician Decision|1|||
27992834|NCT00858637|81805374|FG001|Active Comparison Phase|Physician Decision|0|||
27992835|NCT00858637|81805375|FG002|Active Comparison Phase|Physician Decision|0|||
27992836|NCT00858637|81805376|FG003|Active Comparison Phase|Physician Decision|1|||
27992837|NCT00858637|81805377|FG004|Active Comparison Phase|Physician Decision|0|||
27992838|NCT00858637|81805378|FG005|Active Comparison Phase|Physician Decision|0|||
27992839|NCT00858637|81805373|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
27992840|NCT00858637|81805374|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
27992841|NCT00858637|81805375|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
27992842|NCT00858637|81805376|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
27992843|NCT00858637|81805377|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
27992844|NCT00858637|81805378|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
27992845|NCT00858637|81805373|FG000|Active Comparison Phase|Other Reasons|1|||
27992846|NCT00858637|81805374|FG001|Active Comparison Phase|Other Reasons|0|||
27992847|NCT00858637|81805375|FG002|Active Comparison Phase|Other Reasons|0|||
27992848|NCT00858637|81805376|FG003|Active Comparison Phase|Other Reasons|1|||
27992849|NCT00858637|81805377|FG004|Active Comparison Phase|Other Reasons|0|||
27992850|NCT00858637|81805378|FG005|Active Comparison Phase|Other Reasons|0|||
27992851|NCT00858637|81805373|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
27992852|NCT00858637|81805374|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
27992853|NCT00858637|81805375|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
27992854|NCT00858637|81805376|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
27992855|NCT00858637|81805377|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
27992856|NCT00858637|81805378|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
27992857|NCT00858637|81805373|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27992858|NCT00858637|81805374|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27992859|NCT00858637|81805375|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27992860|NCT00858637|81805376|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27992861|NCT00858637|81805377|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
27992862|NCT00858637|81805378|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
27992863|NCT03221842|81805381|FG000|Period 1 (Open-label)|Adverse Event|4|||
27677548|NCT01441635|80656743|FG002|Overall Study|Noncompliance|0|||
27677549|NCT01441635|80656744|FG003|Overall Study|Noncompliance|0|||
27677550|NCT01441635|80656745|FG004|Overall Study|Noncompliance|0|||
27677551|NCT01441635|80656746|FG005|Overall Study|Noncompliance|0|||
27677552|NCT01441635|80656747|FG006|Overall Study|Noncompliance|1|||
27677553|NCT01441635|80656748|FG007|Overall Study|Noncompliance|0|||
27677554|NCT01441635|80656749|FG008|Overall Study|Noncompliance|0|||
27677555|NCT01441635|80656750|FG009|Overall Study|Noncompliance|0|||
27677556|NCT01441635|80656741|FG000|Overall Study|Surgery or Invasive Intervention|0|||
27677557|NCT01441635|80656742|FG001|Overall Study|Surgery or Invasive Intervention|0|||
27677558|NCT01441635|80656743|FG002|Overall Study|Surgery or Invasive Intervention|1|||
27677559|NCT01441635|80656744|FG003|Overall Study|Surgery or Invasive Intervention|0|||
27677560|NCT01441635|80656745|FG004|Overall Study|Surgery or Invasive Intervention|0|||
27677561|NCT01441635|80656746|FG005|Overall Study|Surgery or Invasive Intervention|0|||
27677562|NCT01441635|80656747|FG006|Overall Study|Surgery or Invasive Intervention|0|||
27677563|NCT01441635|80656748|FG007|Overall Study|Surgery or Invasive Intervention|0|||
27677564|NCT01441635|80656749|FG008|Overall Study|Surgery or Invasive Intervention|0|||
27677565|NCT01441635|80656750|FG009|Overall Study|Surgery or Invasive Intervention|0|||
27677566|NCT01441635|80656741|FG000|Overall Study|Received Exclusionary Medication|1|||
27677567|NCT01441635|80656742|FG001|Overall Study|Received Exclusionary Medication|0|||
27677568|NCT01441635|80656743|FG002|Overall Study|Received Exclusionary Medication|0|||
27677569|NCT01441635|80656744|FG003|Overall Study|Received Exclusionary Medication|0|||
27677570|NCT01441635|80656745|FG004|Overall Study|Received Exclusionary Medication|0|||
27677571|NCT01441635|80656746|FG005|Overall Study|Received Exclusionary Medication|0|||
27677572|NCT01441635|80656747|FG006|Overall Study|Received Exclusionary Medication|0|||
27677573|NCT01441635|80656748|FG007|Overall Study|Received Exclusionary Medication|0|||
27677574|NCT01441635|80656749|FG008|Overall Study|Received Exclusionary Medication|0|||
27677575|NCT01441635|80656750|FG009|Overall Study|Received Exclusionary Medication|0|||
27677576|NCT01441635|80656741|FG000|Overall Study|Other|0|||
27677577|NCT01441635|80656742|FG001|Overall Study|Other|0|||
27677578|NCT01441635|80656743|FG002|Overall Study|Other|0|||
27677579|NCT01441635|80656744|FG003|Overall Study|Other|0|||
27677580|NCT01441635|80656745|FG004|Overall Study|Other|0|||
27677581|NCT01441635|80656746|FG005|Overall Study|Other|0|||
27677582|NCT01441635|80656747|FG006|Overall Study|Other|0|||
27677583|NCT01441635|80656748|FG007|Overall Study|Other|1|||
27677584|NCT01441635|80656749|FG008|Overall Study|Other|0|||
27677585|NCT01441635|80656750|FG009|Overall Study|Other|0|||
27677586|NCT01132820|80656751|FG000|Overall Study|Ineligible: wrong cell type|1|||
27677587|NCT01132820|80656751|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
27677588|NCT01132820|80656751|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
27677589|NCT01132820|80656751|FG000|Overall Study|Never treated|1|||
27677590|NCT01132820|80656751|FG000|Overall Study|Inadequate data|1|||
27677591|NCT00567567|80656756|FG000|Overall Study|Adverse Event|0|||
27677592|NCT00567567|80656757|FG001|Overall Study|Adverse Event|2|||
27677593|NCT00567567|80656758|FG002|Overall Study|Adverse Event|5|||
27677594|NCT00567567|80656756|FG000|Overall Study|Death|8|||
27677595|NCT00567567|80656757|FG001|Overall Study|Death|1|||
27677596|NCT00567567|80656758|FG002|Overall Study|Death|5|||
27677597|NCT00567567|80656756|FG000|Overall Study|Lack of Efficacy|16|||
27677598|NCT00567567|80656757|FG001|Overall Study|Lack of Efficacy|17|||
27677599|NCT00567567|80656758|FG002|Overall Study|Lack of Efficacy|48|||
27677600|NCT00567567|80656756|FG000|Overall Study|Lost to Follow-up|0|||
27677601|NCT00567567|80656757|FG001|Overall Study|Lost to Follow-up|0|||
27677602|NCT00567567|80656758|FG002|Overall Study|Lost to Follow-up|1|||
27677603|NCT00567567|80656756|FG000|Overall Study|Physician Decision|16|||
27677604|NCT00567567|80656757|FG001|Overall Study|Physician Decision|18|||
27677605|NCT00567567|80656758|FG002|Overall Study|Physician Decision|84|||
27800233|NCT03120520|81099079|FG002|Overall Study|Withdrawal by Subject|3|||
27800234|NCT03120520|81099080|FG003|Overall Study|Withdrawal by Subject|2|||
27677606|NCT00567567|80656756|FG000|Overall Study|Withdrawal by Subject|0|||
27677607|NCT00567567|80656757|FG001|Overall Study|Withdrawal by Subject|0|||
27677608|NCT00567567|80656758|FG002|Overall Study|Withdrawal by Subject|2|||
27677609|NCT00567567|80656756|FG000|Overall Study|Ineligible|4|||
27677610|NCT00567567|80656757|FG001|Overall Study|Ineligible|0|||
27800235|NCT03120520|81099077|FG000|Overall Study|Other|0|||
27992864|NCT03221842|81805382|FG001|Period 1 (Open-label)|Adverse Event|0|||
27992865|NCT03221842|81805381|FG000|Period 1 (Open-label)|Physician Decision|2|||
27992866|NCT03221842|81805382|FG001|Period 1 (Open-label)|Physician Decision|0|||
27992867|NCT03221842|81805381|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
27677611|NCT00567567|80656758|FG002|Overall Study|Ineligible|9|||
27677612|NCT00567567|80656756|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
27677613|NCT00567567|80656757|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
27677614|NCT00567567|80656758|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
27677615|NCT00567567|80656756|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
27677616|NCT00567567|80656757|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
27677617|NCT00567567|80656758|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
27677618|NCT00567567|80656756|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
27677619|NCT00567567|80656757|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
27677620|NCT00567567|80656758|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
27677621|NCT01358331|80656759|FG000|Overall Study|Lost to Follow-up|0|||
27677622|NCT01358331|80656760|FG001|Overall Study|Lost to Follow-up|0|||
27677623|NCT01358331|80656761|FG002|Overall Study|Lost to Follow-up|0|||
27677624|NCT01358331|80656762|FG003|Overall Study|Lost to Follow-up|1|||
27677625|NCT01358331|80656763|FG004|Overall Study|Lost to Follow-up|0|||
27677626|NCT01358331|80656764|FG005|Overall Study|Lost to Follow-up|0|||
27677627|NCT01358331|80656759|FG000|Overall Study|Withdrawal by Subject|0|||
27677628|NCT01358331|80656760|FG001|Overall Study|Withdrawal by Subject|0|||
27677629|NCT01358331|80656761|FG002|Overall Study|Withdrawal by Subject|0|||
27677630|NCT01358331|80656762|FG003|Overall Study|Withdrawal by Subject|1|||
27677631|NCT01358331|80656763|FG004|Overall Study|Withdrawal by Subject|1|||
27677632|NCT01358331|80656764|FG005|Overall Study|Withdrawal by Subject|1|||
27677633|NCT01358331|80656759|FG000|Overall Study|Adverse Events|1|||
27677634|NCT01358331|80656760|FG001|Overall Study|Adverse Events|1|||
27677635|NCT01358331|80656761|FG002|Overall Study|Adverse Events|1|||
27871107|NCT01371747|81361606|FG004|Overall Study|High Serum Potassium Results|0|||
27871108|NCT01371747|81361607|FG005|Overall Study|High Serum Potassium Results|2|||
27992868|NCT03221842|81805382|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
27992869|NCT03221842|81805381|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
27992870|NCT03221842|81805382|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
27992871|NCT03221842|81805381|FG000|Period 1 (Open-label)|Other|2|||
27992872|NCT03221842|81805382|FG001|Period 1 (Open-label)|Other|0|||
27992873|NCT03221842|81805381|FG000|Period 2 (Randomized, Blinded)|Death|0|||
27871109|NCT01371747|81361602|FG000|Overall Study|Low Serum Potassium Results|1|||
27871110|NCT01371747|81361603|FG001|Overall Study|Low Serum Potassium Results|1|||
27992874|NCT03221842|81805382|FG001|Period 2 (Randomized, Blinded)|Death|1|||
27677636|NCT01358331|80656762|FG003|Overall Study|Adverse Events|0|||
27677637|NCT01358331|80656763|FG004|Overall Study|Adverse Events|1|||
27677638|NCT01358331|80656764|FG005|Overall Study|Adverse Events|5|||
27677639|NCT01358331|80656759|FG000|Overall Study|Symptomatic Deterioration|0|||
27677640|NCT01358331|80656760|FG001|Overall Study|Symptomatic Deterioration|0|||
27992875|NCT03221842|81805381|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
27992876|NCT03221842|81805382|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
27992877|NCT01196026|81805383|FG000|Overall Study|Withdrawal by Subject|1|||
27992878|NCT01196026|81805384|FG001|Overall Study|Withdrawal by Subject|4|||
27677641|NCT01358331|80656761|FG002|Overall Study|Symptomatic Deterioration|0|||
27677642|NCT01358331|80656762|FG003|Overall Study|Symptomatic Deterioration|0|||
27677643|NCT01358331|80656763|FG004|Overall Study|Symptomatic Deterioration|1|||
27677644|NCT01358331|80656764|FG005|Overall Study|Symptomatic Deterioration|0|||
27677645|NCT01358331|80656759|FG000|Overall Study|Participants did not wish to continue|0|||
27677646|NCT01358331|80656760|FG001|Overall Study|Participants did not wish to continue|0|||
27677647|NCT01358331|80656761|FG002|Overall Study|Participants did not wish to continue|0|||
27677648|NCT01358331|80656762|FG003|Overall Study|Participants did not wish to continue|0|||
27677649|NCT01358331|80656763|FG004|Overall Study|Participants did not wish to continue|1|||
27677650|NCT01358331|80656764|FG005|Overall Study|Participants did not wish to continue|0|||
27677651|NCT01358331|80656759|FG000|Overall Study|Progress of disease under investigation|1|||
27677652|NCT01358331|80656760|FG001|Overall Study|Progress of disease under investigation|2|||
27677653|NCT01358331|80656761|FG002|Overall Study|Progress of disease under investigation|3|||
27677654|NCT01358331|80656762|FG003|Overall Study|Progress of disease under investigation|1|||
27677655|NCT01358331|80656763|FG004|Overall Study|Progress of disease under investigation|3|||
27677656|NCT01358331|80656764|FG005|Overall Study|Progress of disease under investigation|0|||
27677657|NCT00911768|80656765|FG000|Overall Study|Protocol Violation|5|||
27677658|NCT00911768|80656766|FG001|Overall Study|Protocol Violation|4|||
27677659|NCT00911768|80656765|FG000|Overall Study|Withdrawal by Subject|1|||
27677660|NCT00911768|80656766|FG001|Overall Study|Withdrawal by Subject|0|||
27677661|NCT01371825|80656768|FG000|Overall Study|Death|4|||
27677662|NCT02963090|80656771|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
27677663|NCT02963090|80656772|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
27677664|NCT00487825|80656776|FG000|Overall Study|Adverse Event|2|||
27677665|NCT00487825|80656777|FG001|Overall Study|Adverse Event|2|||
27677666|NCT00487825|80656776|FG000|Overall Study|Lack of Efficacy|1|||
27677667|NCT00487825|80656777|FG001|Overall Study|Lack of Efficacy|1|||
27677668|NCT00487825|80656776|FG000|Overall Study|Other|3|||
27677669|NCT00487825|80656777|FG001|Overall Study|Other|2|||
27677670|NCT02688530|80656778|FG000|Overall Study|Withdrawal by Subject|0|||
27677671|NCT02688530|80656779|FG001|Overall Study|Withdrawal by Subject|1|||
27677672|NCT02688530|80656780|FG002|Overall Study|Withdrawal by Subject|0|||
27677673|NCT02688530|80656781|FG003|Overall Study|Withdrawal by Subject|0|||
27677674|NCT02688530|80656778|FG000|Overall Study|Lost to Follow-up|0|||
27677675|NCT02688530|80656779|FG001|Overall Study|Lost to Follow-up|0|||
27677676|NCT02688530|80656780|FG002|Overall Study|Lost to Follow-up|2|||
27677677|NCT02688530|80656781|FG003|Overall Study|Lost to Follow-up|0|||
27677678|NCT00504777|80656785|FG000|Overall Study|Adverse Event|1|||
27677679|NCT01810939|80656786|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
27677680|NCT01810939|80656787|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
27677681|NCT01810939|80656788|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
27677682|NCT01810939|80656786|FG000|Part A Treatment Period|Protocol Violation|2|||
27677683|NCT01810939|80656787|FG001|Part A Treatment Period|Protocol Violation|0|||
27677684|NCT01810939|80656788|FG002|Part A Treatment Period|Protocol Violation|0|||
27677685|NCT01810939|80656786|FG000|Part A Treatment Period|Adverse Event|10|||
27677686|NCT01810939|80656787|FG001|Part A Treatment Period|Adverse Event|0|||
27677687|NCT01810939|80656788|FG002|Part A Treatment Period|Adverse Event|0|||
27677688|NCT01810939|80656786|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
27677689|NCT01810939|80656787|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
27677690|NCT01810939|80656788|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
27677691|NCT01810939|80656786|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
27677692|NCT01810939|80656787|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
27677693|NCT01810939|80656788|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
27677694|NCT01810939|80656786|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
27677695|NCT01810939|80656787|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
27677696|NCT01810939|80656788|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
27677697|NCT01810939|80656786|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
27677698|NCT01810939|80656787|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
27677699|NCT01810939|80656788|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
27677700|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
27677701|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
27800236|NCT03120520|81099078|FG001|Overall Study|Other|1|||
27800237|NCT03120520|81099079|FG002|Overall Study|Other|0|||
27800238|NCT03120520|81099080|FG003|Overall Study|Other|0|||
27800239|NCT02149199|81099083|FG000|Overall Study|Study specific withdrawal criteria|4|||
27677702|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
27677703|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
27677704|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
27677705|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
27800240|NCT02149199|81099084|FG001|Overall Study|Study specific withdrawal criteria|21|||
27800241|NCT02149199|81099085|FG002|Overall Study|Study specific withdrawal criteria|6|||
27800242|NCT02149199|81099083|FG000|Overall Study|Other|20|||
27800243|NCT02149199|81099084|FG001|Overall Study|Other|25|||
27800244|NCT02149199|81099085|FG002|Overall Study|Other|20|||
27800245|NCT02149199|81099083|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
27800246|NCT02149199|81099084|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
27800247|NCT02149199|81099085|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
27800248|NCT02149199|81099083|FG000|Overall Study|Withdrawal by Subject|75|||
27800249|NCT02149199|81099084|FG001|Overall Study|Withdrawal by Subject|93|||
27677706|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
27677707|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
27800250|NCT02149199|81099085|FG002|Overall Study|Withdrawal by Subject|77|||
27800251|NCT02149199|81099083|FG000|Overall Study|Protocol Violation|16|||
27677708|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
27800252|NCT02149199|81099084|FG001|Overall Study|Protocol Violation|13|||
27800253|NCT02149199|81099085|FG002|Overall Study|Protocol Violation|15|||
27800254|NCT02149199|81099083|FG000|Overall Study|Lost to Follow-up|3|||
27800255|NCT02149199|81099084|FG001|Overall Study|Lost to Follow-up|12|||
27800256|NCT02149199|81099085|FG002|Overall Study|Lost to Follow-up|11|||
27800257|NCT02149199|81099083|FG000|Overall Study|Death|0|||
27800258|NCT02149199|81099084|FG001|Overall Study|Death|0|||
27800259|NCT02149199|81099085|FG002|Overall Study|Death|1|||
27800260|NCT02149199|81099083|FG000|Overall Study|Adverse Event|6|||
27800261|NCT02149199|81099084|FG001|Overall Study|Adverse Event|15|||
27800262|NCT02149199|81099085|FG002|Overall Study|Adverse Event|9|||
27800263|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
27800264|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
27800265|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
27800266|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
27871111|NCT01371747|81361604|FG002|Overall Study|Low Serum Potassium Results|1|||
27871112|NCT01371747|81361605|FG003|Overall Study|Low Serum Potassium Results|1|||
27871113|NCT01371747|81361606|FG004|Overall Study|Low Serum Potassium Results|0|||
27800267|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
27800268|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
27800269|NCT00566631|81099088|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
27800270|NCT00566631|81099088|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
27800271|NCT00566631|81099088|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
27871114|NCT01371747|81361607|FG005|Overall Study|Low Serum Potassium Results|3|||
27871115|NCT01371747|81361602|FG000|Overall Study|Protocol Violation|0|||
27800272|NCT00566631|81099088|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
27800273|NCT00566631|81099088|FG000|Part 2: Extension Phase|Adverse Event|11|||
27800274|NCT00566631|81099088|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
27800275|NCT00566631|81099088|FG000|Part 2: Extension Phase|Death|1|||
27800276|NCT00566631|81099088|FG000|Part 2: Extension Phase|Other|5|||
27800277|NCT01286207|81099089|FG000|Overall Study|Adverse Event|27|||
27800278|NCT01286207|81099090|FG001|Overall Study|Adverse Event|41|||
27800279|NCT01286207|81099091|FG002|Overall Study|Adverse Event|8|||
27800280|NCT01286207|81099089|FG000|Overall Study|Lost to Follow-up|49|||
27871116|NCT01371747|81361603|FG001|Overall Study|Protocol Violation|0|||
27871117|NCT01371747|81361604|FG002|Overall Study|Protocol Violation|1|||
27871118|NCT01371747|81361605|FG003|Overall Study|Protocol Violation|0|||
27871119|NCT01371747|81361606|FG004|Overall Study|Protocol Violation|0|||
27871120|NCT01371747|81361607|FG005|Overall Study|Protocol Violation|0|||
27871121|NCT01371747|81361602|FG000|Overall Study|Non-Compliance|3|||
27871122|NCT01371747|81361603|FG001|Overall Study|Non-Compliance|4|||
27871123|NCT01371747|81361604|FG002|Overall Study|Non-Compliance|3|||
27800281|NCT01286207|81099090|FG001|Overall Study|Lost to Follow-up|43|||
27800282|NCT01286207|81099091|FG002|Overall Study|Lost to Follow-up|20|||
27800283|NCT01286207|81099089|FG000|Overall Study|Withdrawal by Subject|93|||
27800284|NCT01286207|81099090|FG001|Overall Study|Withdrawal by Subject|79|||
27800285|NCT01286207|81099091|FG002|Overall Study|Withdrawal by Subject|41|||
27871124|NCT01371747|81361605|FG003|Overall Study|Non-Compliance|0|||
27594202|NCT00729833|80352466|FG001|Overall Study|Withdrawal by Subject|1|||
27871125|NCT01371747|81361606|FG004|Overall Study|Non-Compliance|0|||
27594203|NCT00729833|80352467|FG002|Overall Study|Withdrawal by Subject|3|||
27800286|NCT01286207|81099089|FG000|Overall Study|Lack of Response|92|||
27800287|NCT01286207|81099090|FG001|Overall Study|Lack of Response|38|||
27800288|NCT01286207|81099091|FG002|Overall Study|Lack of Response|8|||
27800289|NCT01286207|81099089|FG000|Overall Study|Other|37|||
27992879|NCT01196026|81805385|FG002|Overall Study|Withdrawal by Subject|0|||
27992880|NCT01196026|81805386|FG003|Overall Study|Withdrawal by Subject|0|||
27992881|NCT01196026|81805387|FG004|Overall Study|Withdrawal by Subject|0|||
27992882|NCT01196026|81805388|FG005|Overall Study|Withdrawal by Subject|0|||
27992883|NCT01196026|81805383|FG000|Overall Study|Lost to Follow-up|0|||
27992884|NCT01196026|81805384|FG001|Overall Study|Lost to Follow-up|3|||
27992885|NCT01196026|81805385|FG002|Overall Study|Lost to Follow-up|0|||
27992886|NCT01196026|81805386|FG003|Overall Study|Lost to Follow-up|0|||
27992887|NCT01196026|81805387|FG004|Overall Study|Lost to Follow-up|1|||
27992888|NCT01196026|81805388|FG005|Overall Study|Lost to Follow-up|0|||
27992889|NCT01196026|81805383|FG000|Overall Study|Other|0|||
27992890|NCT01196026|81805384|FG001|Overall Study|Other|1|||
27992891|NCT01196026|81805385|FG002|Overall Study|Other|0|||
27992892|NCT01196026|81805386|FG003|Overall Study|Other|0|||
27992893|NCT01196026|81805387|FG004|Overall Study|Other|0|||
27992894|NCT01196026|81805388|FG005|Overall Study|Other|0|||
27992895|NCT02478164|81805395|FG000|Overall Study|Lack of Efficacy|13|||
27992896|NCT02478164|81805395|FG000|Overall Study|Adverse Event|1|||
27992897|NCT02478164|81805395|FG000|Overall Study|Withdrawal by Subject|1|||
27992898|NCT00423449|81805396|FG000|Overall Study|Clinical Adverse Event|1|||
27992899|NCT00423449|81805397|FG001|Overall Study|Clinical Adverse Event|0|||
27992900|NCT00423449|81805398|FG002|Overall Study|Clinical Adverse Event|1|||
27992901|NCT00423449|81805399|FG003|Overall Study|Clinical Adverse Event|8|||
27992902|NCT00423449|81805400|FG004|Overall Study|Clinical Adverse Event|2|||
27992903|NCT00423449|81805396|FG000|Overall Study|Death|1|||
27800290|NCT01286207|81099090|FG001|Overall Study|Other|47|||
27800291|NCT01286207|81099091|FG002|Overall Study|Other|13|||
27800292|NCT02367729|81099094|FG000|Overall Study|Organic disorder diagnosed|2|||
27800293|NCT02367729|81099095|FG001|Overall Study|Organic disorder diagnosed|1|||
27800294|NCT02367729|81099094|FG000|Overall Study|Adverse Event|1|||
27800295|NCT02367729|81099095|FG001|Overall Study|Adverse Event|2|||
27800296|NCT02367729|81099094|FG000|Overall Study|Withdrawal by Subject|0|||
27800297|NCT02367729|81099095|FG001|Overall Study|Withdrawal by Subject|5|||
27800298|NCT00343642|81099098|FG000|Overall Study|Lost to Follow-up|0|||
27800299|NCT00343642|81099099|FG001|Overall Study|Lost to Follow-up|1|||
27800300|NCT00343642|81099100|FG002|Overall Study|Lost to Follow-up|0|||
27800301|NCT00343642|81099098|FG000|Overall Study|Pregnancy|1|||
27800302|NCT00343642|81099099|FG001|Overall Study|Pregnancy|0|||
27800303|NCT00343642|81099100|FG002|Overall Study|Pregnancy|2|||
27800304|NCT00343642|81099098|FG000|Overall Study|Withdrawal by Subject|2|||
27800305|NCT00343642|81099099|FG001|Overall Study|Withdrawal by Subject|3|||
27800306|NCT00343642|81099100|FG002|Overall Study|Withdrawal by Subject|4|||
27800307|NCT00343642|81099098|FG000|Overall Study|Adverse Event|0|||
27800308|NCT00343642|81099099|FG001|Overall Study|Adverse Event|0|||
27800309|NCT00343642|81099100|FG002|Overall Study|Adverse Event|1|||
27800310|NCT00343642|81099098|FG000|Overall Study|Flare up|6|||
27800311|NCT00343642|81099099|FG001|Overall Study|Flare up|4|||
27800312|NCT00343642|81099100|FG002|Overall Study|Flare up|0|||
27800313|NCT01892020|81099103|FG000|Period 1|Adverse Event|1|||
27800314|NCT01892020|81099104|FG001|Period 1|Adverse Event|1|||
27800315|NCT01892020|81099103|FG000|Period 1|Protocol Violation|2|||
27800316|NCT01892020|81099104|FG001|Period 1|Protocol Violation|4|||
27800317|NCT01892020|81099103|FG000|Period 1|Unclassified|0|||
27800318|NCT01892020|81099104|FG001|Period 1|Unclassified|1|||
27800319|NCT01892020|81099103|FG000|Period 2|Protocol Violation|1|||
27800320|NCT01892020|81099104|FG001|Period 2|Protocol Violation|0|||
27800321|NCT03284424|81099105|FG000|Overall Study|Death|70|||
27800322|NCT03284424|81099106|FG001|Overall Study|Death|24|||
27800323|NCT03284424|81099105|FG000|Overall Study|Lost to Follow-up|3|||
27800324|NCT03284424|81099106|FG001|Overall Study|Lost to Follow-up|1|||
27800325|NCT03284424|81099105|FG000|Overall Study|Physician Decision|1|||
27800326|NCT03284424|81099106|FG001|Overall Study|Physician Decision|2|||
27800327|NCT03284424|81099105|FG000|Overall Study|Withdrawal by Subject|4|||
27800328|NCT03284424|81099106|FG001|Overall Study|Withdrawal by Subject|5|||
27871126|NCT01371747|81361607|FG005|Overall Study|Non-Compliance|1|||
27992904|NCT00423449|81805397|FG001|Overall Study|Death|0|||
27992905|NCT00423449|81805398|FG002|Overall Study|Death|2|||
27800329|NCT03284424|81099105|FG000|Overall Study|Sponsor's decision|27|||
27800330|NCT03284424|81099106|FG001|Overall Study|Sponsor's decision|22|||
27800331|NCT00434148|81099107|FG000|Overall Study|Adverse Event|18|||
27800332|NCT00434148|81099108|FG001|Overall Study|Adverse Event|18|||
27871127|NCT01371747|81361602|FG000|Overall Study|Physician Decision|0|||
27800333|NCT00434148|81099107|FG000|Overall Study|Lack of Efficacy|25|||
27800334|NCT00434148|81099108|FG001|Overall Study|Lack of Efficacy|28|||
27992906|NCT00423449|81805399|FG003|Overall Study|Death|1|||
27992907|NCT00423449|81805400|FG004|Overall Study|Death|1|||
27992908|NCT00423449|81805396|FG000|Overall Study|Progressive Disease|1|||
27992909|NCT00423449|81805397|FG001|Overall Study|Progressive Disease|3|||
27871128|NCT01371747|81361603|FG001|Overall Study|Physician Decision|0|||
27871129|NCT01371747|81361604|FG002|Overall Study|Physician Decision|0|||
27871130|NCT01371747|81361605|FG003|Overall Study|Physician Decision|0|||
27871131|NCT01371747|81361606|FG004|Overall Study|Physician Decision|1|||
27871132|NCT01371747|81361607|FG005|Overall Study|Physician Decision|0|||
27871133|NCT01371747|81361602|FG000|Overall Study|Withdrawal by Subject|6|||
27992910|NCT00423449|81805398|FG002|Overall Study|Progressive Disease|8|||
27992911|NCT00423449|81805399|FG003|Overall Study|Progressive Disease|11|||
27992912|NCT00423449|81805400|FG004|Overall Study|Progressive Disease|4|||
27992913|NCT00423449|81805396|FG000|Overall Study|Laboratory Adverse Event|0|||
27992914|NCT00423449|81805397|FG001|Overall Study|Laboratory Adverse Event|1|||
27992915|NCT00423449|81805398|FG002|Overall Study|Laboratory Adverse Event|2|||
27992916|NCT00423449|81805399|FG003|Overall Study|Laboratory Adverse Event|0|||
27992917|NCT00423449|81805400|FG004|Overall Study|Laboratory Adverse Event|0|||
27992918|NCT00423449|81805396|FG000|Overall Study|Other|0|||
27992919|NCT00423449|81805397|FG001|Overall Study|Other|0|||
27992920|NCT00423449|81805398|FG002|Overall Study|Other|0|||
27992921|NCT00423449|81805399|FG003|Overall Study|Other|1|||
27992922|NCT00423449|81805400|FG004|Overall Study|Other|0|||
27992923|NCT00423449|81805396|FG000|Overall Study|Protocol Violation|0|||
27992924|NCT00423449|81805397|FG001|Overall Study|Protocol Violation|0|||
27992925|NCT00423449|81805398|FG002|Overall Study|Protocol Violation|2|||
27992926|NCT00423449|81805399|FG003|Overall Study|Protocol Violation|1|||
27992927|NCT00423449|81805400|FG004|Overall Study|Protocol Violation|0|||
27992928|NCT01248949|81805401|FG000|Overall Study|Lost to Follow-up|2|||
27677709|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
27677710|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
27677711|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
27677712|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
27677713|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
27677714|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
27677715|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
27677716|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
27677717|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
27677718|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
27677719|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
27677720|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
27677721|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
27677722|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
27677723|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
27677724|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
27677725|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
27677726|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
27677727|NCT01810939|80656786|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
27677728|NCT01810939|80656787|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
27677729|NCT01810939|80656788|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
27677730|NCT00607724|80656789|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
27677731|NCT00607724|80656790|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
27677732|NCT00607724|80656791|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
27677733|NCT00607724|80656792|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
27677734|NCT00607724|80656793|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
27677735|NCT00607724|80656794|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
27677736|NCT00607724|80656795|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
27677737|NCT00607724|80656789|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
27677738|NCT00607724|80656790|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
27677739|NCT00607724|80656791|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
27677740|NCT00607724|80656792|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
27677741|NCT00607724|80656793|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
27677742|NCT00607724|80656794|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
27677743|NCT00607724|80656795|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
27677744|NCT00607724|80656789|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
27677745|NCT00607724|80656790|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
27871134|NCT01371747|81361603|FG001|Overall Study|Withdrawal by Subject|12|||
27871135|NCT01371747|81361604|FG002|Overall Study|Withdrawal by Subject|5|||
27992929|NCT01248949|81805402|FG001|Overall Study|Lost to Follow-up|2|||
27992930|NCT01248949|81805403|FG002|Overall Study|Lost to Follow-up|2|||
27992931|NCT01248949|81805404|FG003|Overall Study|Lost to Follow-up|1|||
27992932|NCT01248949|81805405|FG004|Overall Study|Lost to Follow-up|0|||
27992933|NCT01248949|81805401|FG000|Overall Study|Withdrawal by Subject|5|||
27992934|NCT01248949|81805402|FG001|Overall Study|Withdrawal by Subject|3|||
27992935|NCT01248949|81805403|FG002|Overall Study|Withdrawal by Subject|11|||
27800335|NCT00434148|81099107|FG000|Overall Study|Withdrawal by Subject|15|||
27800336|NCT00434148|81099108|FG001|Overall Study|Withdrawal by Subject|15|||
27871136|NCT01371747|81361605|FG003|Overall Study|Withdrawal by Subject|2|||
27871137|NCT01371747|81361606|FG004|Overall Study|Withdrawal by Subject|2|||
27871138|NCT01371747|81361607|FG005|Overall Study|Withdrawal by Subject|4|||
27800337|NCT00434148|81099107|FG000|Overall Study|Protocol Violation|4|||
27800338|NCT00434148|81099108|FG001|Overall Study|Protocol Violation|0|||
27800339|NCT00434148|81099107|FG000|Overall Study|Administrative problems|6|||
27800340|NCT00434148|81099108|FG001|Overall Study|Administrative problems|10|||
27800341|NCT00434148|81099107|FG000|Overall Study|Lost to Follow-up|0|||
27800342|NCT00434148|81099108|FG001|Overall Study|Lost to Follow-up|1|||
27800343|NCT00434148|81099107|FG000|Overall Study|Condition no longer requires study drug|1|||
27800344|NCT00434148|81099108|FG001|Overall Study|Condition no longer requires study drug|0|||
27800345|NCT00434148|81099107|FG000|Overall Study|Abnormal test procedure result|0|||
27800346|NCT00434148|81099108|FG001|Overall Study|Abnormal test procedure result|1|||
27800347|NCT00190684|81099109|FG000|Overall Study|Adverse Event|86|||
27800348|NCT00190684|81099109|FG000|Overall Study|Satisfactory response|80|||
27800349|NCT00190684|81099109|FG000|Overall Study|Lack of efficacy|204|||
27800350|NCT00190684|81099109|FG000|Overall Study|Lost to Follow-up|232|||
27800351|NCT00190684|81099109|FG000|Overall Study|Patient moved|60|||
27800352|NCT00190684|81099109|FG000|Overall Study|Patient Decision|432|||
27800353|NCT00190684|81099109|FG000|Overall Study|Clinical relapse|67|||
27800354|NCT00190684|81099109|FG000|Overall Study|Sponsor's decision|17|||
27800355|NCT00190684|81099109|FG000|Overall Study|Physician Decision|84|||
27800356|NCT00190684|81099109|FG000|Overall Study|Protocol Violation|123|||
27800357|NCT00190684|81099109|FG000|Overall Study|Study Period III Completed|103|||
27800358|NCT00190684|81099109|FG000|Overall Study|Study Period V Completed|1|||
27800359|NCT00068406|81101875|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
27800360|NCT00068406|81101875|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
27800361|NCT01244516|81101876|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
27800362|NCT01244516|81101877|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
27800363|NCT01244516|81101878|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
27800364|NCT01244516|81101876|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
27800365|NCT01244516|81101877|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
27992936|NCT01248949|81805404|FG003|Overall Study|Withdrawal by Subject|3|||
27992937|NCT01248949|81805405|FG004|Overall Study|Withdrawal by Subject|1|||
27992938|NCT01248949|81805401|FG000|Overall Study|Death|22|||
27992939|NCT01248949|81805402|FG001|Overall Study|Death|7|||
27992940|NCT01248949|81805403|FG002|Overall Study|Death|21|||
27992941|NCT01248949|81805404|FG003|Overall Study|Death|6|||
27992942|NCT01248949|81805405|FG004|Overall Study|Death|2|||
27992943|NCT01248949|81805401|FG000|Overall Study|Alternative Therapy|1|||
27992944|NCT01248949|81805402|FG001|Overall Study|Alternative Therapy|0|||
27871139|NCT01371747|81361602|FG000|Overall Study|Other Reasons|2|||
27871140|NCT01371747|81361603|FG001|Overall Study|Other Reasons|1|||
27871141|NCT01371747|81361604|FG002|Overall Study|Other Reasons|2|||
27871142|NCT01371747|81361605|FG003|Overall Study|Other Reasons|0|||
27871143|NCT01371747|81361606|FG004|Overall Study|Other Reasons|0|||
27992945|NCT01248949|81805403|FG002|Overall Study|Alternative Therapy|0|||
27800366|NCT01244516|81101878|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
27992946|NCT01248949|81805404|FG003|Overall Study|Alternative Therapy|0|||
27992947|NCT01248949|81805405|FG004|Overall Study|Alternative Therapy|0|||
27992948|NCT01248949|81805401|FG000|Overall Study|Alternative Therapy.|1|||
27992949|NCT01248949|81805402|FG001|Overall Study|Alternative Therapy.|0|||
27992950|NCT01248949|81805403|FG002|Overall Study|Alternative Therapy.|0|||
27800367|NCT01244516|81101876|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
27800368|NCT01244516|81101877|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
27800369|NCT01244516|81101878|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
27800370|NCT01244516|81101876|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
27800371|NCT01244516|81101877|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
27800372|NCT01244516|81101878|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
27800373|NCT01244516|81101876|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
27800374|NCT01244516|81101877|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
27800375|NCT01244516|81101878|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
27800376|NCT01244516|81101876|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
27800377|NCT01244516|81101877|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
27871144|NCT01371747|81361607|FG005|Overall Study|Other Reasons|1|||
27871145|NCT03552380|81361615|FG000|Study Treatment|Disease Progression|3|||
27871146|NCT03552380|81361616|FG001|Study Treatment|Disease Progression|4|||
27871147|NCT03552380|81361615|FG000|Study Treatment|Adverse Event|2|||
27992951|NCT01248949|81805404|FG003|Overall Study|Alternative Therapy.|0|||
27992952|NCT01248949|81805405|FG004|Overall Study|Alternative Therapy.|0|||
27992953|NCT01248949|81805401|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
27992954|NCT01248949|81805402|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
27992955|NCT01248949|81805403|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
27992956|NCT01248949|81805404|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
27992957|NCT01248949|81805405|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
27992958|NCT01248949|81805401|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
27992959|NCT01248949|81805402|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
27992960|NCT01248949|81805403|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
27992961|NCT01248949|81805404|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
27992962|NCT01248949|81805405|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
27992963|NCT01248949|81805401|FG000|Overall Study|Participant Went To Hospice|0|||
27992964|NCT01248949|81805402|FG001|Overall Study|Participant Went To Hospice|0|||
27992965|NCT01248949|81805403|FG002|Overall Study|Participant Went To Hospice|1|||
27992966|NCT01248949|81805404|FG003|Overall Study|Participant Went To Hospice|0|||
27992967|NCT01248949|81805405|FG004|Overall Study|Participant Went To Hospice|0|||
27992968|NCT01248949|81805401|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
27992969|NCT01248949|81805402|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27992970|NCT01248949|81805403|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27992971|NCT01248949|81805404|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27992972|NCT01248949|81805405|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
27992973|NCT01248949|81805401|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
27992974|NCT01248949|81805402|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
27992975|NCT01248949|81805403|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
27992976|NCT01248949|81805404|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
27992977|NCT01248949|81805405|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
27992978|NCT01248949|81805401|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27992979|NCT01248949|81805402|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
27992980|NCT01248949|81805403|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27992981|NCT01248949|81805404|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27992982|NCT01248949|81805405|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
27992983|NCT01248949|81805401|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27992984|NCT01248949|81805402|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27992985|NCT01248949|81805403|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
27992986|NCT01248949|81805404|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27992987|NCT01248949|81805405|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
27992988|NCT02564978|81805406|FG000|Overall Study|Adverse Event|8|||
27992989|NCT02564978|81805406|FG000|Overall Study|Death|1|||
27992990|NCT02564978|81805406|FG000|Overall Study|Lost to Follow-up|1|||
27992991|NCT02564978|81805406|FG000|Overall Study|Withdrawal by Subject|15|||
27992992|NCT02564978|81805406|FG000|Overall Study|Early Study Closure|2|||
27992993|NCT02564978|81805406|FG000|Overall Study|Other Reason|5|||
27992994|NCT00766051|81805407|FG000|Overall Study|Withdrawal by Subject|2|||
27992995|NCT00766051|81805408|FG001|Overall Study|Withdrawal by Subject|0|||
27992996|NCT00787189|81805409|FG000|Overall Study|Lost to Follow-up|2|||
27992997|NCT00787189|81805410|FG001|Overall Study|Lost to Follow-up|2|||
27992998|NCT00770601|81805412|FG000|Overall Study|Withdrawal by Subject|1|||
27992999|NCT01067144|81805415|FG000|Treatment|Did not receive allocated intervention|4|||
27993000|NCT01067144|81805416|FG001|Treatment|Did not receive allocated intervention|7|||
27993001|NCT01067144|81805415|FG000|Follow-up|Lost to Follow-up|22|||
27993002|NCT01067144|81805416|FG001|Follow-up|Lost to Follow-up|12|||
27993003|NCT01067144|81805415|FG000|Follow-up|Censored owing to second surgery|19|||
27993004|NCT01067144|81805416|FG001|Follow-up|Censored owing to second surgery|28|||
27993005|NCT01067144|81805415|FG000|Follow-up|Withdrawal by Subject|18|||
27993006|NCT01067144|81805416|FG001|Follow-up|Withdrawal by Subject|14|||
27993007|NCT01067144|81805415|FG000|Follow-up|Surgery cancelled|0|||
27993008|NCT01067144|81805416|FG001|Follow-up|Surgery cancelled|1|||
27993009|NCT01067144|81805415|FG000|Follow-up|Death|0|||
27993010|NCT01067144|81805416|FG001|Follow-up|Death|1|||
27993011|NCT01943591|81805417|FG000|Overall Study|Lost to Follow-up|3|||
27993012|NCT01943591|81805418|FG001|Overall Study|Lost to Follow-up|4|||
27993013|NCT01943591|81805417|FG000|Overall Study|Death|2|||
27993014|NCT01943591|81805418|FG001|Overall Study|Death|7|||
27993015|NCT03302247|81805419|FG000|Overall Study|the study has closed prematurely|2|||
27993016|NCT03302247|81805419|FG000|Overall Study|Death|1|||
27993017|NCT01777776|81805421|FG000|Overall Study|Adverse Event|2|||
27677746|NCT00607724|80656791|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
27677747|NCT00607724|80656792|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
27871148|NCT03552380|81361616|FG001|Study Treatment|Adverse Event|2|||
27993018|NCT01777776|81805422|FG001|Overall Study|Adverse Event|4|||
27993019|NCT01777776|81805423|FG002|Overall Study|Adverse Event|0|||
27993020|NCT01777776|81805424|FG003|Overall Study|Adverse Event|0|||
27993021|NCT01777776|81805421|FG000|Overall Study|Disease Progression|4|||
27993022|NCT01777776|81805422|FG001|Overall Study|Disease Progression|8|||
27993023|NCT01777776|81805423|FG002|Overall Study|Disease Progression|6|||
27993024|NCT01777776|81805424|FG003|Overall Study|Disease Progression|3|||
27993025|NCT01777776|81805421|FG000|Overall Study|Withdrawal by Subject|0|||
27993026|NCT01777776|81805422|FG001|Overall Study|Withdrawal by Subject|0|||
27993027|NCT01777776|81805423|FG002|Overall Study|Withdrawal by Subject|0|||
27993028|NCT01777776|81805424|FG003|Overall Study|Withdrawal by Subject|1|||
27993029|NCT00874848|81805428|FG000|Overall Study|Adverse Event|13|||
27993030|NCT00874848|81805429|FG001|Overall Study|Adverse Event|2|||
27993031|NCT00874848|81805428|FG000|Overall Study|Progressive neoplastic disease|38|||
27993032|NCT00874848|81805429|FG001|Overall Study|Progressive neoplastic disease|18|||
27993033|NCT00874848|81805428|FG000|Overall Study|Withdrawal by Subject|7|||
27993034|NCT00874848|81805429|FG001|Overall Study|Withdrawal by Subject|4|||
27993035|NCT00874848|81805428|FG000|Overall Study|Noncompliance|1|||
27993036|NCT00874848|81805429|FG001|Overall Study|Noncompliance|1|||
27993037|NCT00874848|81805428|FG000|Overall Study|Failure to comply with protocol|0|||
27993038|NCT00874848|81805429|FG001|Overall Study|Failure to comply with protocol|1|||
27993039|NCT00874848|81805428|FG000|Overall Study|Physician Decision|0|||
27993040|NCT00874848|81805429|FG001|Overall Study|Physician Decision|2|||
27677748|NCT00607724|80656793|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
27800378|NCT01244516|81101878|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
27800379|NCT01244516|81101876|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
27800380|NCT01244516|81101877|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
27800381|NCT01244516|81101878|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
27800382|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
27800383|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
27800384|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
27800385|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
27800386|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
27800387|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
27800388|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
27800389|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
27800390|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
27800391|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
27800392|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
27800393|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
27800394|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
27800395|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
27800396|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
27800397|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
27800398|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
27800399|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
27800400|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
27800401|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
27800402|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
27800403|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
27800404|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
27800405|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
27800406|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
27800407|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
27800408|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
27800409|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
27800410|NCT01299272|81101879|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
27800411|NCT01299272|81101880|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
27800412|NCT01299272|81101881|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
27800413|NCT01299272|81101882|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
27800414|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
27800415|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
27800416|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
27800417|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
27800418|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
27800419|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
27800420|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
27993041|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Death|113|||
27993042|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Death|189|||
27993043|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
27677749|NCT00607724|80656794|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
27800421|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
27800422|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
27800423|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
27800424|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
27800425|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
27800426|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
27800427|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
27800428|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
27800429|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
27800430|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
27800431|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
27800432|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
27800433|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
27800434|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
27800435|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
27800436|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
27800437|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
27800438|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
27800439|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
27800440|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
27800441|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
27800442|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
27800443|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
27800444|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
27800445|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
27800446|NCT01299272|81101879|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
27800447|NCT01299272|81101880|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
27800448|NCT01299272|81101881|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
27800449|NCT01299272|81101882|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
27800450|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
27800451|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
27871149|NCT03552380|81361615|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
27871150|NCT03552380|81361616|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
27871151|NCT03552380|81361615|FG000|Follow up|Death|3|||
27871152|NCT03552380|81361616|FG001|Follow up|Death|4|||
27800452|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
27800453|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
27800454|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
27800455|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
27871153|NCT03552380|81361615|FG000|Follow up|Site IRB terminated|0|||
27871154|NCT03552380|81361616|FG001|Follow up|Site IRB terminated|1|||
27800456|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
27800457|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
27800458|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
27800459|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
27800460|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
27800461|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
27800462|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
27800463|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
27800464|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
27800465|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
27800466|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
27800467|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
27800468|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
27871155|NCT03301649|81361617|FG000|Overall Study|Need alternate therapy due to live lice|17|||
27871156|NCT03301649|81361618|FG001|Overall Study|Need alternate therapy due to live lice|25|||
27993044|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
27993045|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
27993046|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
27993047|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
27993048|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
27993049|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
27993050|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
27993051|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
27993052|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
27993053|NCT02677896|81805430|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
27993054|NCT02677896|81805431|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
27993055|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
27993056|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
27993057|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
27993058|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
27993059|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
27993060|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
27993061|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
27993062|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
27993063|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
27993064|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
27993065|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
27993066|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
27993067|NCT02677896|81805430|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
27993068|NCT02677896|81805431|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
27993069|NCT00635882|81805432|FG000|Overall Study|Protocol Violation|1|||
27993070|NCT00635882|81805433|FG001|Overall Study|Protocol Violation|0|||
27993071|NCT00635882|81805434|FG002|Overall Study|Protocol Violation|0|||
27993072|NCT00635882|81805435|FG003|Overall Study|Protocol Violation|0|||
27993073|NCT00635882|81805436|FG004|Overall Study|Protocol Violation|0|||
27993074|NCT00635882|81805437|FG005|Overall Study|Protocol Violation|0|||
27993075|NCT01301833|81805440|FG000|Overall Study|Adverse Event|7|||
27993076|NCT01301833|81805441|FG001|Overall Study|Adverse Event|5|||
27993077|NCT01301833|81805442|FG002|Overall Study|Adverse Event|5|||
27993078|NCT01301833|81805443|FG003|Overall Study|Adverse Event|5|||
27993079|NCT01301833|81805440|FG000|Overall Study|Lack of Efficacy|1|||
27993080|NCT01301833|81805441|FG001|Overall Study|Lack of Efficacy|1|||
27993081|NCT01301833|81805442|FG002|Overall Study|Lack of Efficacy|0|||
27993082|NCT01301833|81805443|FG003|Overall Study|Lack of Efficacy|0|||
27993083|NCT01301833|81805440|FG000|Overall Study|Physician Decision|3|||
27993084|NCT01301833|81805441|FG001|Overall Study|Physician Decision|1|||
27993085|NCT01301833|81805442|FG002|Overall Study|Physician Decision|1|||
27993086|NCT01301833|81805443|FG003|Overall Study|Physician Decision|0|||
27993087|NCT01301833|81805440|FG000|Overall Study|Withdrawal by Subject|3|||
27993088|NCT01301833|81805441|FG001|Overall Study|Withdrawal by Subject|1|||
27993089|NCT01301833|81805442|FG002|Overall Study|Withdrawal by Subject|1|||
27993090|NCT01301833|81805443|FG003|Overall Study|Withdrawal by Subject|2|||
27993091|NCT01301833|81805440|FG000|Overall Study|Personal matter|1|||
27993092|NCT01301833|81805441|FG001|Overall Study|Personal matter|0|||
27993093|NCT01301833|81805442|FG002|Overall Study|Personal matter|0|||
27993094|NCT01301833|81805443|FG003|Overall Study|Personal matter|0|||
27993095|NCT03915470|81805446|FG000|Overall Study|Death|3|||
27800469|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
27993096|NCT03915470|81805447|FG001|Overall Study|Death|1|||
27993097|NCT03915470|81805446|FG000|Overall Study|Adverse Event|1|||
27993098|NCT03915470|81805447|FG001|Overall Study|Adverse Event|0|||
27993099|NCT03915470|81805446|FG000|Overall Study|Physician Decision|1|||
27993100|NCT03915470|81805447|FG001|Overall Study|Physician Decision|0|||
27993101|NCT03915470|81805446|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
27993102|NCT03915470|81805447|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
27993103|NCT00892775|81805448|FG000|Overall Study|Protocol Violation|1|||
27993104|NCT00892775|81805449|FG001|Overall Study|Protocol Violation|0|||
27993105|NCT00892775|81805448|FG000|Overall Study|Subject difficulties with blood drawing|1|||
27993106|NCT00892775|81805449|FG001|Overall Study|Subject difficulties with blood drawing|0|||
27993107|NCT00892775|81805448|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
27800470|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
27800471|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
27800472|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
27800473|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
27800474|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
27800475|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
27800476|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
27800477|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
27800478|NCT01299272|81101879|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
27800479|NCT01299272|81101880|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
27800480|NCT01299272|81101881|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
27800481|NCT01299272|81101882|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
27800482|NCT02406742|81101883|FG000|Overall Study|Progression of Disease|5|||
27800483|NCT02406742|81101884|FG001|Overall Study|Progression of Disease|1|||
27800484|NCT02406742|81101885|FG002|Overall Study|Progression of Disease|6|||
27800485|NCT02406742|81101883|FG000|Overall Study|Adverse Event|3|||
27993108|NCT00892775|81805449|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
27993109|NCT00892775|81805448|FG000|Overall Study|Migrated/ moved from study area|1|||
27677750|NCT00607724|80656795|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
27993110|NCT00892775|81805449|FG001|Overall Study|Migrated/ moved from study area|0|||
27993111|NCT00892775|81805448|FG000|Overall Study|Withdrawal by Subject|0|||
27993112|NCT00892775|81805449|FG001|Overall Study|Withdrawal by Subject|1|||
27993113|NCT00892775|81805448|FG000|Overall Study|Lost to Follow-up|1|||
27993114|NCT00892775|81805449|FG001|Overall Study|Lost to Follow-up|0|||
27993115|NCT00825812|81805450|FG000|Overall Study|Never entered follow up|0|||
27993116|NCT00825812|81805451|FG001|Overall Study|Never entered follow up|0|||
27993117|NCT00825812|81805452|FG002|Overall Study|Never entered follow up|0|||
27993118|NCT00825812|81805453|FG003|Overall Study|Never entered follow up|1|||
27993119|NCT00825812|81805450|FG000|Overall Study|Adverse Event|0|||
27993120|NCT00825812|81805451|FG001|Overall Study|Adverse Event|0|||
27800486|NCT02406742|81101884|FG001|Overall Study|Adverse Event|0|||
27800487|NCT02406742|81101885|FG002|Overall Study|Adverse Event|2|||
27800488|NCT02406742|81101883|FG000|Overall Study|Death|1|||
27800489|NCT02406742|81101884|FG001|Overall Study|Death|0|||
27800490|NCT02406742|81101885|FG002|Overall Study|Death|0|||
27800491|NCT02406742|81101883|FG000|Overall Study|Lack of Efficacy|0|||
27800492|NCT02406742|81101884|FG001|Overall Study|Lack of Efficacy|0|||
27800493|NCT02406742|81101885|FG002|Overall Study|Lack of Efficacy|1|||
27800494|NCT02406742|81101883|FG000|Overall Study|Withdrawal by Participant|1|||
27800495|NCT02406742|81101884|FG001|Overall Study|Withdrawal by Participant|2|||
27800496|NCT02406742|81101885|FG002|Overall Study|Withdrawal by Participant|0|||
27800497|NCT02406742|81101883|FG000|Overall Study|Physician Decision|1|||
27800498|NCT02406742|81101884|FG001|Overall Study|Physician Decision|2|||
27800499|NCT02406742|81101885|FG002|Overall Study|Physician Decision|1|||
27993121|NCT00825812|81805452|FG002|Overall Study|Adverse Event|0|||
27993122|NCT00825812|81805453|FG003|Overall Study|Adverse Event|1|||
27993123|NCT00825812|81805450|FG000|Overall Study|Subject withdrew consent|0|||
27993124|NCT00825812|81805451|FG001|Overall Study|Subject withdrew consent|0|||
27993125|NCT00825812|81805452|FG002|Overall Study|Subject withdrew consent|3|||
27993126|NCT00825812|81805453|FG003|Overall Study|Subject withdrew consent|2|||
27993127|NCT00825812|81805450|FG000|Overall Study|Non-compliance with protocol|0|||
27993128|NCT00825812|81805451|FG001|Overall Study|Non-compliance with protocol|0|||
27993129|NCT00825812|81805452|FG002|Overall Study|Non-compliance with protocol|0|||
27993130|NCT00825812|81805453|FG003|Overall Study|Non-compliance with protocol|1|||
27993131|NCT00825812|81805450|FG000|Overall Study|Administrative|0|||
27993132|NCT00825812|81805451|FG001|Overall Study|Administrative|1|||
27993133|NCT00825812|81805452|FG002|Overall Study|Administrative|3|||
27993134|NCT00825812|81805453|FG003|Overall Study|Administrative|5|||
27993135|NCT03543137|81805454|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
27993136|NCT03543137|81805455|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
27993137|NCT03543137|81805454|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
27993138|NCT03543137|81805455|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
27993139|NCT03543137|81805454|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
27993140|NCT03543137|81805455|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
27993141|NCT01740401|81805456|FG000|Overall Study|Progression of disease|6|||
27993142|NCT01740401|81805456|FG000|Overall Study|Adverse Event|2|||
27993143|NCT01740401|81805456|FG000|Overall Study|Did not reach primary endpoint|2|||
27993144|NCT01957202|81805457|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993145|NCT01957202|81805458|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
27993146|NCT01957202|81805459|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993147|NCT01957202|81805460|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993148|NCT01957202|81805461|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27800500|NCT02406742|81101883|FG000|Overall Study|Transition to other treatment|2|||
27993149|NCT01957202|81805462|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993150|NCT01957202|81805463|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993151|NCT01957202|81805464|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993152|NCT01957202|81805465|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993153|NCT01957202|81805466|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27800501|NCT02406742|81101884|FG001|Overall Study|Transition to other treatment|0|||
27800502|NCT02406742|81101885|FG002|Overall Study|Transition to other treatment|1|||
27800503|NCT02406742|81101883|FG000|Overall Study|Other Reasons|1|||
27800504|NCT02406742|81101884|FG001|Overall Study|Other Reasons|11|||
27800505|NCT02406742|81101885|FG002|Overall Study|Other Reasons|5|||
27800506|NCT00810615|81101887|FG000|Overall Study|Withdrawal by Subject|1|||
27800507|NCT00810615|81101888|FG001|Overall Study|Withdrawal by Subject|1|||
27800508|NCT00386100|81101890|FG000|Overall Study|Did not receive study medication|6|||
27993154|NCT01957202|81805467|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993155|NCT01957202|81805468|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993156|NCT01957202|81805469|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993157|NCT01957202|81805470|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27800509|NCT00386100|81101891|FG001|Overall Study|Did not receive study medication|4|||
27800510|NCT00386100|81101890|FG000|Overall Study|Adverse Event|15|||
27993158|NCT01957202|81805471|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993159|NCT01957202|81805472|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993160|NCT01957202|81805473|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
27993161|NCT01957202|81805474|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
27993162|NCT01957202|81805457|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993163|NCT01957202|81805458|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993164|NCT01957202|81805459|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993165|NCT01957202|81805460|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993166|NCT01957202|81805461|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993167|NCT01957202|81805462|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993168|NCT01957202|81805463|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993169|NCT01957202|81805464|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993170|NCT01957202|81805465|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993171|NCT01957202|81805466|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993172|NCT01957202|81805467|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993173|NCT01957202|81805468|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993174|NCT01957202|81805469|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993175|NCT01957202|81805470|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993176|NCT01957202|81805471|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993177|NCT01957202|81805472|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993178|NCT01957202|81805473|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
27993179|NCT01957202|81805474|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
27993180|NCT03932760|81805477|FG000|Overall Study|Became Ineligible|2|||
27993181|NCT03932760|81805478|FG001|Overall Study|Became Ineligible|5|||
27993182|NCT03932760|81805477|FG000|Overall Study|Withdrawal by Subject|6|||
27993183|NCT03932760|81805478|FG001|Overall Study|Withdrawal by Subject|6|||
27993184|NCT00166439|81805484|FG000|Overall Study|Ineligible|5|||
27993185|NCT02649894|81805491|FG000|Overall Study|Adverse Event|1|||
27993186|NCT02649894|81805492|FG001|Overall Study|Adverse Event|0|||
27993187|NCT02649894|81805491|FG000|Overall Study|Physician Decision|0|||
27993188|NCT02649894|81805492|FG001|Overall Study|Physician Decision|1|||
27993189|NCT02649894|81805491|FG000|Overall Study|Withdrawal by Subject|5|||
27993190|NCT02649894|81805492|FG001|Overall Study|Withdrawal by Subject|2|||
27993191|NCT02649894|81805491|FG000|Overall Study|Lost to Follow-up|2|||
27993192|NCT02649894|81805492|FG001|Overall Study|Lost to Follow-up|1|||
27993193|NCT02649894|81805491|FG000|Overall Study|Death|30|||
27993194|NCT02649894|81805492|FG001|Overall Study|Death|7|||
27993195|NCT02649894|81805491|FG000|Overall Study|Other, not specified|6|||
27993196|NCT02649894|81805492|FG001|Overall Study|Other, not specified|0|||
27993197|NCT01610336|81805493|FG000|Overall Study|Progressive Disease|4|||
27993198|NCT01610336|81805494|FG001|Overall Study|Progressive Disease|6|||
27993199|NCT01610336|81805495|FG002|Overall Study|Progressive Disease|6|||
27993200|NCT01610336|81805496|FG003|Overall Study|Progressive Disease|5|||
27993201|NCT01610336|81805497|FG004|Overall Study|Progressive Disease|3|||
27993202|NCT01610336|81805498|FG005|Overall Study|Progressive Disease|10|||
27993203|NCT01610336|81805499|FG006|Overall Study|Progressive Disease|1|||
27993204|NCT01610336|81805500|FG007|Overall Study|Progressive Disease|6|||
27993205|NCT01610336|81805501|FG008|Overall Study|Progressive Disease|6|||
27993206|NCT01610336|81805502|FG009|Overall Study|Progressive Disease|40|||
27993207|NCT01610336|81805503|FG010|Overall Study|Progressive Disease|36|||
27993208|NCT01610336|81805493|FG000|Overall Study|Adverse Event|0|||
27993209|NCT01610336|81805494|FG001|Overall Study|Adverse Event|0|||
27993210|NCT01610336|81805495|FG002|Overall Study|Adverse Event|0|||
27993211|NCT01610336|81805496|FG003|Overall Study|Adverse Event|1|||
27993212|NCT01610336|81805497|FG004|Overall Study|Adverse Event|1|||
27993213|NCT01610336|81805498|FG005|Overall Study|Adverse Event|1|||
27993214|NCT01610336|81805499|FG006|Overall Study|Adverse Event|0|||
27993215|NCT01610336|81805500|FG007|Overall Study|Adverse Event|0|||
27993216|NCT01610336|81805501|FG008|Overall Study|Adverse Event|2|||
27993217|NCT01610336|81805502|FG009|Overall Study|Adverse Event|8|||
27993218|NCT01610336|81805503|FG010|Overall Study|Adverse Event|6|||
27993219|NCT01610336|81805493|FG000|Overall Study|Subject/Guardian decision|1|||
27993220|NCT01610336|81805494|FG001|Overall Study|Subject/Guardian decision|1|||
27993221|NCT01610336|81805495|FG002|Overall Study|Subject/Guardian decision|0|||
27993222|NCT01610336|81805496|FG003|Overall Study|Subject/Guardian decision|1|||
27993223|NCT01610336|81805497|FG004|Overall Study|Subject/Guardian decision|0|||
27993224|NCT01610336|81805498|FG005|Overall Study|Subject/Guardian decision|0|||
27993225|NCT01610336|81805499|FG006|Overall Study|Subject/Guardian decision|0|||
27993226|NCT01610336|81805500|FG007|Overall Study|Subject/Guardian decision|1|||
27993227|NCT01610336|81805501|FG008|Overall Study|Subject/Guardian decision|0|||
27993228|NCT01610336|81805502|FG009|Overall Study|Subject/Guardian decision|2|||
27993229|NCT01610336|81805503|FG010|Overall Study|Subject/Guardian decision|2|||
27993230|NCT01610336|81805493|FG000|Overall Study|Death|0|||
27993231|NCT01610336|81805494|FG001|Overall Study|Death|0|||
27993232|NCT01610336|81805495|FG002|Overall Study|Death|0|||
27993233|NCT01610336|81805496|FG003|Overall Study|Death|0|||
27993234|NCT01610336|81805497|FG004|Overall Study|Death|0|||
27993235|NCT01610336|81805498|FG005|Overall Study|Death|1|||
27993236|NCT01610336|81805499|FG006|Overall Study|Death|3|||
27993237|NCT01610336|81805500|FG007|Overall Study|Death|0|||
27993238|NCT01610336|81805501|FG008|Overall Study|Death|0|||
27993239|NCT01610336|81805502|FG009|Overall Study|Death|1|||
27993240|NCT01610336|81805503|FG010|Overall Study|Death|2|||
27993241|NCT01610336|81805493|FG000|Overall Study|Non-Compliance with study treatment|0|||
27993242|NCT01610336|81805494|FG001|Overall Study|Non-Compliance with study treatment|0|||
27800511|NCT00386100|81101891|FG001|Overall Study|Adverse Event|25|||
27800512|NCT00386100|81101890|FG000|Overall Study|Death|0|||
27800513|NCT00386100|81101891|FG001|Overall Study|Death|1|||
27800514|NCT00386100|81101890|FG000|Overall Study|Insufficient therapeutic effect|30|||
27800515|NCT00386100|81101891|FG001|Overall Study|Insufficient therapeutic effect|6|||
27800516|NCT00386100|81101890|FG000|Overall Study|Lost to Follow-up|29|||
27800517|NCT00386100|81101891|FG001|Overall Study|Lost to Follow-up|29|||
27800518|NCT00386100|81101890|FG000|Overall Study|Non-compliance|18|||
27800519|NCT00386100|81101891|FG001|Overall Study|Non-compliance|19|||
27800520|NCT00386100|81101890|FG000|Overall Study|Protocol Violation|5|||
27800521|NCT00386100|81101891|FG001|Overall Study|Protocol Violation|3|||
27800522|NCT00386100|81101890|FG000|Overall Study|Withdrawal by Subject|32|||
27800523|NCT00386100|81101891|FG001|Overall Study|Withdrawal by Subject|31|||
27800524|NCT00386100|81101890|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
27800525|NCT00386100|81101891|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
27800526|NCT00386100|81101890|FG000|Overall Study|BMD <2.5|1|||
27800527|NCT00386100|81101891|FG001|Overall Study|BMD <2.5|0|||
27800528|NCT00386100|81101890|FG000|Overall Study|Consecutive elevated Hba1C|1|||
27800529|NCT00386100|81101891|FG001|Overall Study|Consecutive elevated Hba1C|0|||
27800530|NCT00386100|81101890|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
27800531|NCT00386100|81101891|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
27800532|NCT00386100|81101890|FG000|Overall Study|Laboratory findings|1|||
27800533|NCT00386100|81101891|FG001|Overall Study|Laboratory findings|0|||
27800534|NCT00386100|81101890|FG000|Overall Study|Participant's concern due to CPK levels|1|||
27800535|NCT00386100|81101891|FG001|Overall Study|Participant's concern due to CPK levels|0|||
27800536|NCT00386100|81101890|FG000|Overall Study|Participant moving out of state|2|||
27800537|NCT00386100|81101891|FG001|Overall Study|Participant moving out of state|0|||
27800538|NCT00386100|81101890|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
27800539|NCT00386100|81101891|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
27800540|NCT00386100|81101890|FG000|Overall Study|Didn't meet entry criteria|1|||
27800541|NCT00386100|81101891|FG001|Overall Study|Didn't meet entry criteria|1|||
27800542|NCT00386100|81101890|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
27800543|NCT00386100|81101891|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
27800544|NCT00386100|81101890|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
27800545|NCT00386100|81101891|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
27800546|NCT00386100|81101890|FG000|Overall Study|Bad metabolic control & patient security|1|||
27800547|NCT00386100|81101891|FG001|Overall Study|Bad metabolic control & patient security|0|||
27800548|NCT00386100|81101890|FG000|Overall Study|Bone loss by DXA bone scan|1|||
27800549|NCT00386100|81101891|FG001|Overall Study|Bone loss by DXA bone scan|0|||
27800550|NCT00386100|81101890|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
27800551|NCT00386100|81101891|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
27800552|NCT00386100|81101890|FG000|Overall Study|7.6% bone loss|1|||
27800553|NCT00386100|81101891|FG001|Overall Study|7.6% bone loss|0|||
27800554|NCT00386100|81101890|FG000|Overall Study|Osteoporosis|0|||
27800555|NCT00386100|81101891|FG001|Overall Study|Osteoporosis|1|||
27800556|NCT00386100|81101890|FG000|Overall Study|Positive pregnancy test|1|||
27800557|NCT00386100|81101891|FG001|Overall Study|Positive pregnancy test|3|||
27800558|NCT00386100|81101890|FG000|Overall Study|Out of country for 5 months|1|||
27800559|NCT00386100|81101891|FG001|Overall Study|Out of country for 5 months|0|||
27800560|NCT00386100|81101890|FG000|Overall Study|Hb1Ac >8%|0|||
27800561|NCT00386100|81101891|FG001|Overall Study|Hb1Ac >8%|1|||
27800562|NCT00386100|81101890|FG000|Overall Study|Participant randomized in error|1|||
27800563|NCT00386100|81101891|FG001|Overall Study|Participant randomized in error|0|||
27993243|NCT01610336|81805495|FG002|Overall Study|Non-Compliance with study treatment|0|||
27993244|NCT01610336|81805496|FG003|Overall Study|Non-Compliance with study treatment|0|||
27993245|NCT01610336|81805497|FG004|Overall Study|Non-Compliance with study treatment|0|||
27800564|NCT03079869|81101892|FG000|Overall Study|Adverse Event|6|||
27800565|NCT03079869|81101893|FG001|Overall Study|Adverse Event|8|||
27800566|NCT03079869|81101892|FG000|Overall Study|Withdrawal by Subject|4|||
27800567|NCT03079869|81101893|FG001|Overall Study|Withdrawal by Subject|1|||
27800568|NCT03079869|81101892|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
27800569|NCT03079869|81101893|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
27800570|NCT00763269|81101894|FG000|Overall Study|Lost to Follow-up|12|||
27993246|NCT01610336|81805498|FG005|Overall Study|Non-Compliance with study treatment|0|||
27993247|NCT01610336|81805499|FG006|Overall Study|Non-Compliance with study treatment|0|||
27993248|NCT01610336|81805500|FG007|Overall Study|Non-Compliance with study treatment|0|||
27993249|NCT01610336|81805501|FG008|Overall Study|Non-Compliance with study treatment|0|||
27993250|NCT01610336|81805502|FG009|Overall Study|Non-Compliance with study treatment|1|||
27993251|NCT01610336|81805503|FG010|Overall Study|Non-Compliance with study treatment|0|||
27993252|NCT01610336|81805493|FG000|Overall Study|Physician Decision|0|||
27993253|NCT01610336|81805494|FG001|Overall Study|Physician Decision|0|||
27993254|NCT01610336|81805495|FG002|Overall Study|Physician Decision|0|||
27993255|NCT01610336|81805496|FG003|Overall Study|Physician Decision|0|||
27993256|NCT01610336|81805497|FG004|Overall Study|Physician Decision|0|||
27993257|NCT01610336|81805498|FG005|Overall Study|Physician Decision|0|||
27993258|NCT01610336|81805499|FG006|Overall Study|Physician Decision|1|||
27993259|NCT01610336|81805500|FG007|Overall Study|Physician Decision|0|||
27993260|NCT01610336|81805501|FG008|Overall Study|Physician Decision|0|||
27993261|NCT01610336|81805502|FG009|Overall Study|Physician Decision|0|||
27993262|NCT01610336|81805503|FG010|Overall Study|Physician Decision|0|||
27993263|NCT01610336|81805493|FG000|Overall Study|Protocol Deviation|0|||
27993264|NCT01610336|81805494|FG001|Overall Study|Protocol Deviation|0|||
27993265|NCT01610336|81805495|FG002|Overall Study|Protocol Deviation|0|||
27993266|NCT01610336|81805496|FG003|Overall Study|Protocol Deviation|0|||
27993267|NCT01610336|81805497|FG004|Overall Study|Protocol Deviation|0|||
27993268|NCT01610336|81805498|FG005|Overall Study|Protocol Deviation|0|||
27993269|NCT01610336|81805499|FG006|Overall Study|Protocol Deviation|0|||
27993270|NCT01610336|81805500|FG007|Overall Study|Protocol Deviation|0|||
27677751|NCT00607724|80656789|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
27677752|NCT00607724|80656790|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
27677753|NCT00607724|80656791|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
27677754|NCT00607724|80656792|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
27677755|NCT00607724|80656793|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
27677756|NCT00607724|80656794|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
27677757|NCT00607724|80656795|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
27677758|NCT00607724|80656789|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
27677759|NCT00607724|80656790|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
27579376|NCT00673452|80303200|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
27579377|NCT01110239|80303201|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
27579378|NCT01110239|80303202|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
27579379|NCT01110239|80303203|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
27579380|NCT01110239|80303204|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
27579381|NCT01110239|80303201|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
27579382|NCT01110239|80303202|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
27579383|NCT01110239|80303203|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
27579384|NCT01110239|80303204|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
27677760|NCT00607724|80656791|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
27677761|NCT00607724|80656792|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
27677762|NCT00607724|80656793|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
27677763|NCT00607724|80656794|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
27677764|NCT00607724|80656795|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
27993271|NCT01610336|81805501|FG008|Overall Study|Protocol Deviation|0|||
27993272|NCT01610336|81805502|FG009|Overall Study|Protocol Deviation|1|||
27993273|NCT01610336|81805503|FG010|Overall Study|Protocol Deviation|0|||
27993274|NCT01610336|81805493|FG000|Overall Study|Transfer to another trial|0|||
27993275|NCT01610336|81805494|FG001|Overall Study|Transfer to another trial|0|||
27993276|NCT01610336|81805495|FG002|Overall Study|Transfer to another trial|0|||
27993277|NCT01610336|81805496|FG003|Overall Study|Transfer to another trial|0|||
27993278|NCT01610336|81805497|FG004|Overall Study|Transfer to another trial|0|||
27993279|NCT01610336|81805498|FG005|Overall Study|Transfer to another trial|0|||
27993280|NCT01610336|81805499|FG006|Overall Study|Transfer to another trial|0|||
27993281|NCT01610336|81805500|FG007|Overall Study|Transfer to another trial|0|||
27993282|NCT01610336|81805501|FG008|Overall Study|Transfer to another trial|0|||
27993283|NCT01610336|81805502|FG009|Overall Study|Transfer to another trial|0|||
27993284|NCT01610336|81805503|FG010|Overall Study|Transfer to another trial|1|||
27579385|NCT00563797|80303207|FG000|Overall Study|Lost to Follow-up|7|||
27579386|NCT00563797|80303208|FG001|Overall Study|Lost to Follow-up|2|||
27677765|NCT00203268|80656796|FG000|Early Treatment|only treated one headache|2|||
27677766|NCT00203268|80656796|FG000|Early Treatment|Lost to Follow-up|1|||
27677767|NCT00203268|80656796|FG000|Early Treatment|Withdrawal by Subject|1|||
27677768|NCT02628028|80656798|FG000|Dosing Period|Withdrawal by Subject|0|||
27677769|NCT02628028|80656799|FG001|Dosing Period|Withdrawal by Subject|0|||
27993285|NCT01463306|81805504|FG000|Overall Study|Adverse Event|6|||
27993286|NCT01463306|81805505|FG001|Overall Study|Adverse Event|9|||
27993287|NCT01463306|81805506|FG002|Overall Study|Adverse Event|3|||
27993288|NCT01463306|81805504|FG000|Overall Study|Death|3|||
27993289|NCT01463306|81805505|FG001|Overall Study|Death|3|||
27993290|NCT01463306|81805506|FG002|Overall Study|Death|0|||
27993291|NCT01463306|81805504|FG000|Overall Study|Lack of Efficacy|22|||
27993292|NCT01463306|81805505|FG001|Overall Study|Lack of Efficacy|16|||
27993293|NCT01463306|81805506|FG002|Overall Study|Lack of Efficacy|1|||
27993294|NCT01463306|81805504|FG000|Overall Study|Lost to Follow-up|5|||
27579387|NCT01513291|80303209|FG000|Treatment Period|Adverse Event|8|||
27677770|NCT02628028|80656800|FG002|Dosing Period|Withdrawal by Subject|1|||
27677771|NCT02628028|80656801|FG003|Dosing Period|Withdrawal by Subject|0|||
27677772|NCT02628028|80656802|FG004|Dosing Period|Withdrawal by Subject|2|||
27677773|NCT02628028|80656803|FG005|Dosing Period|Withdrawal by Subject|4|||
27677774|NCT02628028|80656804|FG006|Dosing Period|Withdrawal by Subject|1|||
27677775|NCT02628028|80656805|FG007|Dosing Period|Withdrawal by Subject|1|||
27677776|NCT02628028|80656798|FG000|Dosing Period|Adverse Event|0|||
27677777|NCT02628028|80656799|FG001|Dosing Period|Adverse Event|0|||
27677778|NCT02628028|80656800|FG002|Dosing Period|Adverse Event|0|||
27677779|NCT02628028|80656801|FG003|Dosing Period|Adverse Event|0|||
27677780|NCT02628028|80656802|FG004|Dosing Period|Adverse Event|2|||
27677781|NCT02628028|80656803|FG005|Dosing Period|Adverse Event|1|||
27677782|NCT02628028|80656804|FG006|Dosing Period|Adverse Event|3|||
27677783|NCT02628028|80656805|FG007|Dosing Period|Adverse Event|2|||
27677784|NCT02628028|80656798|FG000|Dosing Period|Death|0|||
27677785|NCT02628028|80656799|FG001|Dosing Period|Death|0|||
27677786|NCT02628028|80656800|FG002|Dosing Period|Death|0|||
27677787|NCT02628028|80656801|FG003|Dosing Period|Death|0|||
27677788|NCT02628028|80656802|FG004|Dosing Period|Death|0|||
27677789|NCT02628028|80656803|FG005|Dosing Period|Death|0|||
27677790|NCT02628028|80656804|FG006|Dosing Period|Death|0|||
27677791|NCT02628028|80656805|FG007|Dosing Period|Death|1|||
27677792|NCT02628028|80656798|FG000|Dosing Period|Lack of Efficacy|0|||
27677793|NCT02628028|80656799|FG001|Dosing Period|Lack of Efficacy|0|||
27677794|NCT02628028|80656800|FG002|Dosing Period|Lack of Efficacy|0|||
27677795|NCT02628028|80656801|FG003|Dosing Period|Lack of Efficacy|0|||
27677796|NCT02628028|80656802|FG004|Dosing Period|Lack of Efficacy|3|||
27677797|NCT02628028|80656803|FG005|Dosing Period|Lack of Efficacy|0|||
27677798|NCT02628028|80656804|FG006|Dosing Period|Lack of Efficacy|1|||
27677799|NCT02628028|80656805|FG007|Dosing Period|Lack of Efficacy|0|||
27677800|NCT02628028|80656798|FG000|Dosing Period|Study Terminated by Sponsor|0|||
27677801|NCT02628028|80656799|FG001|Dosing Period|Study Terminated by Sponsor|0|||
27677802|NCT02628028|80656800|FG002|Dosing Period|Study Terminated by Sponsor|0|||
27677803|NCT02628028|80656801|FG003|Dosing Period|Study Terminated by Sponsor|0|||
27677804|NCT02628028|80656802|FG004|Dosing Period|Study Terminated by Sponsor|7|||
27800571|NCT00763269|81101895|FG001|Overall Study|Lost to Follow-up|13|||
27800572|NCT05349188|81101904|FG000|Overall Study|Withdrawal by Subject|1|||
27579388|NCT01513291|80303210|FG001|Treatment Period|Adverse Event|4|||
27579389|NCT01513291|80303211|FG002|Treatment Period|Adverse Event|0|||
27579390|NCT01513291|80303212|FG003|Treatment Period|Adverse Event|0|||
27579391|NCT01513291|80303213|FG004|Treatment Period|Adverse Event|0|||
27579392|NCT01513291|80303209|FG000|Treatment Period|Lack of Efficacy|3|||
27579393|NCT01513291|80303210|FG001|Treatment Period|Lack of Efficacy|0|||
27579394|NCT01513291|80303211|FG002|Treatment Period|Lack of Efficacy|0|||
27579395|NCT01513291|80303212|FG003|Treatment Period|Lack of Efficacy|0|||
27579396|NCT01513291|80303213|FG004|Treatment Period|Lack of Efficacy|0|||
27579397|NCT01513291|80303209|FG000|Treatment Period|Lost to Follow-up|2|||
27579398|NCT01513291|80303210|FG001|Treatment Period|Lost to Follow-up|3|||
27579399|NCT01513291|80303211|FG002|Treatment Period|Lost to Follow-up|0|||
27579400|NCT01513291|80303212|FG003|Treatment Period|Lost to Follow-up|0|||
27579401|NCT01513291|80303213|FG004|Treatment Period|Lost to Follow-up|0|||
27579402|NCT01513291|80303209|FG000|Treatment Period|Physician Decision|1|||
27579403|NCT01513291|80303210|FG001|Treatment Period|Physician Decision|0|||
27579404|NCT01513291|80303211|FG002|Treatment Period|Physician Decision|0|||
27579405|NCT01513291|80303212|FG003|Treatment Period|Physician Decision|0|||
27579406|NCT01513291|80303213|FG004|Treatment Period|Physician Decision|0|||
27579407|NCT01513291|80303209|FG000|Treatment Period|Protocol Violation|1|||
27579408|NCT01513291|80303210|FG001|Treatment Period|Protocol Violation|2|||
27579409|NCT01513291|80303211|FG002|Treatment Period|Protocol Violation|0|||
27579410|NCT01513291|80303212|FG003|Treatment Period|Protocol Violation|0|||
27579411|NCT01513291|80303213|FG004|Treatment Period|Protocol Violation|0|||
27579412|NCT01513291|80303209|FG000|Treatment Period|Withdrawal by Subject|8|||
27677805|NCT02628028|80656803|FG005|Dosing Period|Study Terminated by Sponsor|6|||
27677806|NCT02628028|80656804|FG006|Dosing Period|Study Terminated by Sponsor|7|||
27677807|NCT02628028|80656805|FG007|Dosing Period|Study Terminated by Sponsor|7|||
27677808|NCT02628028|80656798|FG000|Dosing Period|Physician Decision|0|||
27677809|NCT02628028|80656799|FG001|Dosing Period|Physician Decision|0|||
27677810|NCT02628028|80656800|FG002|Dosing Period|Physician Decision|0|||
27677811|NCT02628028|80656801|FG003|Dosing Period|Physician Decision|0|||
27800573|NCT05349188|81101905|FG001|Overall Study|Withdrawal by Subject|0|||
27800574|NCT03499249|81101912|FG000|Overall Study|Physician Decision|1|||
27579413|NCT01513291|80303210|FG001|Treatment Period|Withdrawal by Subject|5|||
27579414|NCT01513291|80303211|FG002|Treatment Period|Withdrawal by Subject|0|||
27579415|NCT01513291|80303212|FG003|Treatment Period|Withdrawal by Subject|0|||
27579416|NCT01513291|80303213|FG004|Treatment Period|Withdrawal by Subject|0|||
27579417|NCT01513291|80303209|FG000|Treatment Period|Randomized not treated|0|||
27677812|NCT02628028|80656802|FG004|Dosing Period|Physician Decision|0|||
27677813|NCT02628028|80656803|FG005|Dosing Period|Physician Decision|1|||
27677814|NCT02628028|80656804|FG006|Dosing Period|Physician Decision|0|||
27677815|NCT02628028|80656805|FG007|Dosing Period|Physician Decision|0|||
27677816|NCT02628028|80656798|FG000|Dosing Period|Site Terminated by Sponsor|0|||
27677817|NCT02628028|80656799|FG001|Dosing Period|Site Terminated by Sponsor|0|||
27677818|NCT02628028|80656800|FG002|Dosing Period|Site Terminated by Sponsor|0|||
27677819|NCT02628028|80656801|FG003|Dosing Period|Site Terminated by Sponsor|0|||
27677820|NCT02628028|80656802|FG004|Dosing Period|Site Terminated by Sponsor|0|||
27677821|NCT02628028|80656803|FG005|Dosing Period|Site Terminated by Sponsor|1|||
27677822|NCT02628028|80656804|FG006|Dosing Period|Site Terminated by Sponsor|1|||
27677823|NCT02628028|80656805|FG007|Dosing Period|Site Terminated by Sponsor|0|||
27677824|NCT02628028|80656798|FG000|Dosing Period|Lost to Follow-up|0|||
27677825|NCT02628028|80656799|FG001|Dosing Period|Lost to Follow-up|0|||
27677826|NCT02628028|80656800|FG002|Dosing Period|Lost to Follow-up|0|||
27677827|NCT02628028|80656801|FG003|Dosing Period|Lost to Follow-up|0|||
27677828|NCT02628028|80656802|FG004|Dosing Period|Lost to Follow-up|0|||
27677829|NCT02628028|80656803|FG005|Dosing Period|Lost to Follow-up|0|||
27677830|NCT02628028|80656804|FG006|Dosing Period|Lost to Follow-up|1|||
27677831|NCT02628028|80656805|FG007|Dosing Period|Lost to Follow-up|0|||
27677832|NCT02628028|80656798|FG000|Dosing Period|Other|0|||
27677833|NCT02628028|80656799|FG001|Dosing Period|Other|0|||
27677834|NCT02628028|80656800|FG002|Dosing Period|Other|0|||
27677835|NCT02628028|80656801|FG003|Dosing Period|Other|0|||
27677836|NCT02628028|80656802|FG004|Dosing Period|Other|2|||
27677837|NCT02628028|80656803|FG005|Dosing Period|Other|1|||
27677838|NCT02628028|80656804|FG006|Dosing Period|Other|2|||
27677839|NCT02628028|80656805|FG007|Dosing Period|Other|4|||
27677840|NCT02628028|80656798|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
27677841|NCT02628028|80656799|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
27677842|NCT02628028|80656800|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
27677843|NCT02628028|80656801|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
27677844|NCT02628028|80656802|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
27677845|NCT02628028|80656803|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
27677846|NCT02628028|80656804|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
27677847|NCT02628028|80656805|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
27677848|NCT02628028|80656798|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
27677849|NCT02628028|80656799|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
27677850|NCT02628028|80656800|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
27677851|NCT02628028|80656801|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
27677852|NCT02628028|80656802|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
27677853|NCT02628028|80656803|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
27677854|NCT02628028|80656804|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
27677855|NCT02628028|80656805|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
27677856|NCT02628028|80656798|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
27677857|NCT02628028|80656799|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
27677858|NCT02628028|80656800|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
27677859|NCT02628028|80656801|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
27677860|NCT02628028|80656802|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
27677861|NCT02628028|80656803|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
27677862|NCT02628028|80656804|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
27677863|NCT02628028|80656805|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
27677864|NCT02628028|80656798|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
27677865|NCT02628028|80656799|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
27677866|NCT02628028|80656800|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
27677867|NCT02628028|80656801|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
27677868|NCT02628028|80656802|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
27677869|NCT02628028|80656803|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
27677870|NCT02628028|80656804|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
27677871|NCT02628028|80656805|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
27677872|NCT02628028|80656798|FG000|Long-term Extension (LTE) Period|Other|0|||
27677873|NCT02628028|80656799|FG001|Long-term Extension (LTE) Period|Other|0|||
27677874|NCT02628028|80656800|FG002|Long-term Extension (LTE) Period|Other|0|||
27677875|NCT02628028|80656801|FG003|Long-term Extension (LTE) Period|Other|0|||
27677876|NCT02628028|80656802|FG004|Long-term Extension (LTE) Period|Other|0|||
27677877|NCT02628028|80656803|FG005|Long-term Extension (LTE) Period|Other|3|||
27677878|NCT02628028|80656804|FG006|Long-term Extension (LTE) Period|Other|4|||
27677879|NCT02628028|80656805|FG007|Long-term Extension (LTE) Period|Other|3|||
27677880|NCT02354651|80656810|FG000|Overall Study|Withdrawal by Subject|2|||
27677881|NCT02354651|80656810|FG000|Overall Study|Physician Decision|1|||
27677882|NCT03603639|80656811|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
27677883|NCT03603639|80656812|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
27677884|NCT03603639|80656813|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
27800575|NCT02046369|81101917|FG000|Overall Study|Adverse Event|3|||
27800576|NCT02046369|81101918|FG001|Overall Study|Adverse Event|3|||
27677885|NCT03603639|80656814|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
27677886|NCT03603639|80656815|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
27677887|NCT03603639|80656816|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
27677888|NCT03603639|80656811|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
27677889|NCT03603639|80656812|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
27677890|NCT03603639|80656813|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
27677891|NCT03603639|80656814|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
27677892|NCT03603639|80656815|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
27677893|NCT03603639|80656816|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
27677894|NCT01989169|80656819|FG000|Period 2|Adverse Event|0|||
27677895|NCT01989169|80656820|FG001|Period 2|Adverse Event|1|||
27677896|NCT01594970|80656825|FG000|Overall Study|Non-Adverse Event Related|4|||
27677897|NCT01594970|80656826|FG001|Overall Study|Non-Adverse Event Related|5|||
27677898|NCT01594970|80656827|FG002|Overall Study|Non-Adverse Event Related|6|||
27677899|NCT01594970|80656825|FG000|Overall Study|Adverse Event|17|||
27677900|NCT01594970|80656826|FG001|Overall Study|Adverse Event|23|||
27677901|NCT01594970|80656827|FG002|Overall Study|Adverse Event|23|||
27677902|NCT01594970|80656825|FG000|Overall Study|Lost to Follow-up|54|||
27677903|NCT01594970|80656826|FG001|Overall Study|Lost to Follow-up|54|||
27677904|NCT01594970|80656827|FG002|Overall Study|Lost to Follow-up|37|||
27677905|NCT03838731|80656828|FG000|Overall Study|Pregnancy|0|||
27677906|NCT03838731|80656829|FG001|Overall Study|Pregnancy|1|||
27677907|NCT03838731|80656828|FG000|Overall Study|Withdrawal of consent|1|||
27677908|NCT03838731|80656829|FG001|Overall Study|Withdrawal of consent|0|||
27677909|NCT01575873|80656833|FG000|Overall Study|Withdrawal by Subject|15|||
27677910|NCT01575873|80656834|FG001|Overall Study|Withdrawal by Subject|20|||
27677911|NCT01575873|80656835|FG002|Overall Study|Withdrawal by Subject|34|||
27677912|NCT01575873|80656836|FG003|Overall Study|Withdrawal by Subject|34|||
27800577|NCT02046369|81101917|FG000|Overall Study|Lack of Efficacy|3|||
27677913|NCT01575873|80656833|FG000|Overall Study|Adverse Event|7|||
27677914|NCT01575873|80656834|FG001|Overall Study|Adverse Event|7|||
27677915|NCT01575873|80656835|FG002|Overall Study|Adverse Event|9|||
27677916|NCT01575873|80656836|FG003|Overall Study|Adverse Event|12|||
27677917|NCT01575873|80656833|FG000|Overall Study|Lost to Follow-up|1|||
27677918|NCT01575873|80656834|FG001|Overall Study|Lost to Follow-up|3|||
27677919|NCT01575873|80656835|FG002|Overall Study|Lost to Follow-up|13|||
27677920|NCT01575873|80656836|FG003|Overall Study|Lost to Follow-up|5|||
27677921|NCT01575873|80656833|FG000|Overall Study|Death|3|||
27677922|NCT01575873|80656834|FG001|Overall Study|Death|2|||
27677923|NCT01575873|80656835|FG002|Overall Study|Death|8|||
27677924|NCT01575873|80656836|FG003|Overall Study|Death|9|||
27677925|NCT01575873|80656833|FG000|Overall Study|Noncompliance|1|||
27677926|NCT01575873|80656834|FG001|Overall Study|Noncompliance|2|||
27677927|NCT01575873|80656835|FG002|Overall Study|Noncompliance|4|||
27677928|NCT01575873|80656836|FG003|Overall Study|Noncompliance|3|||
27677929|NCT01575873|80656833|FG000|Overall Study|Administrative decision|1|||
27677930|NCT01575873|80656834|FG001|Overall Study|Administrative decision|1|||
27677931|NCT01575873|80656835|FG002|Overall Study|Administrative decision|1|||
27677932|NCT01575873|80656836|FG003|Overall Study|Administrative decision|0|||
27677933|NCT01575873|80656833|FG000|Overall Study|Protocol deviation|0|||
27677934|NCT01575873|80656834|FG001|Overall Study|Protocol deviation|1|||
27677935|NCT01575873|80656835|FG002|Overall Study|Protocol deviation|0|||
27677936|NCT01575873|80656836|FG003|Overall Study|Protocol deviation|1|||
27677937|NCT01575873|80656833|FG000|Overall Study|Requirement for Alternative Therapy|0|||
27677938|NCT01575873|80656834|FG001|Overall Study|Requirement for Alternative Therapy|0|||
27800578|NCT02046369|81101918|FG001|Overall Study|Lack of Efficacy|3|||
27800579|NCT02046369|81101917|FG000|Overall Study|Lost to Follow-up|3|||
27677939|NCT01575873|80656835|FG002|Overall Study|Requirement for Alternative Therapy|1|||
27677940|NCT01575873|80656836|FG003|Overall Study|Requirement for Alternative Therapy|1|||
27677941|NCT01575873|80656833|FG000|Overall Study|Other|0|||
27677942|NCT01575873|80656834|FG001|Overall Study|Other|0|||
27677943|NCT01575873|80656835|FG002|Overall Study|Other|4|||
27677944|NCT01575873|80656836|FG003|Overall Study|Other|2|||
27677945|NCT01735175|80656837|FG000|Overall Study|Withdrawal by Subject|9|||
27677946|NCT01735175|80656838|FG001|Overall Study|Withdrawal by Subject|2|||
27677947|NCT01735175|80656837|FG000|Overall Study|Lost to Follow-up|4|||
27677948|NCT01735175|80656838|FG001|Overall Study|Lost to Follow-up|2|||
27677949|NCT01735175|80656837|FG000|Overall Study|Death|3|||
27677950|NCT01735175|80656838|FG001|Overall Study|Death|2|||
27677951|NCT01735175|80656837|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
27677952|NCT01735175|80656838|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
27800580|NCT02046369|81101918|FG001|Overall Study|Lost to Follow-up|3|||
27800581|NCT02046369|81101917|FG000|Overall Study|Protocol Violation|1|||
27800582|NCT02046369|81101918|FG001|Overall Study|Protocol Violation|2|||
27993295|NCT01463306|81805505|FG001|Overall Study|Lost to Follow-up|2|||
27677953|NCT02671500|80656843|FG000|Overall Study|Lack of Efficacy|12|||
27677954|NCT02671500|80656843|FG000|Overall Study|Lost to Follow-up|2|||
27993296|NCT01463306|81805506|FG002|Overall Study|Lost to Follow-up|0|||
27677955|NCT01377389|80656844|FG000|Overall Study|Withdrawal by Subject|1|||
27677956|NCT01377389|80656844|FG000|Overall Study|Screen failure|2|||
27677957|NCT00416195|80656845|FG000|Overall Study|Adverse Event|1|||
27677958|NCT00416195|80656846|FG001|Overall Study|Adverse Event|2|||
27677959|NCT00416195|80656845|FG000|Overall Study|Protocol Violation|1|||
27677960|NCT00416195|80656846|FG001|Overall Study|Protocol Violation|1|||
27677961|NCT00416195|80656845|FG000|Overall Study|Other|0|||
27677962|NCT00416195|80656846|FG001|Overall Study|Other|1|||
27677963|NCT01294397|80656849|FG000|Overall Study|Withdrawal by Subject|1|||
27677964|NCT01294397|80656849|FG000|Overall Study|Administrative Decision|1|||
27677965|NCT01011868|80656853|FG000|After Week 18 Follow-up|Adverse Event|8|||
27677966|NCT01011868|80656854|FG001|After Week 18 Follow-up|Adverse Event|6|||
27677967|NCT01011868|80656855|FG002|After Week 18 Follow-up|Adverse Event|13|||
27677968|NCT01011868|80656853|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
27677969|NCT01011868|80656854|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
27677970|NCT01011868|80656855|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
27677971|NCT01011868|80656853|FG000|After Week 18 Follow-up|Protocol Violation|1|||
27677972|NCT01011868|80656854|FG001|After Week 18 Follow-up|Protocol Violation|1|||
27677973|NCT01011868|80656855|FG002|After Week 18 Follow-up|Protocol Violation|1|||
27677974|NCT01011868|80656853|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
27677975|NCT01011868|80656854|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
27677976|NCT01011868|80656855|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
27677977|NCT01011868|80656853|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
27677978|NCT01011868|80656854|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
27677979|NCT01011868|80656855|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
27677980|NCT01011868|80656853|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
27677981|NCT01011868|80656854|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
27677982|NCT01011868|80656855|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
27677983|NCT01011868|80656853|FG000|After Week 78 Follow-up|Adverse Event|14|||
27677984|NCT01011868|80656854|FG001|After Week 78 Follow-up|Adverse Event|18|||
27677985|NCT01011868|80656855|FG002|After Week 78 Follow-up|Adverse Event|21|||
27677986|NCT01011868|80656853|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
27677987|NCT01011868|80656854|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
27677988|NCT01011868|80656855|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
27677989|NCT01011868|80656853|FG000|After Week 78 Follow-up|Protocol Violation|9|||
27677990|NCT01011868|80656854|FG001|After Week 78 Follow-up|Protocol Violation|1|||
27677991|NCT01011868|80656855|FG002|After Week 78 Follow-up|Protocol Violation|2|||
27677992|NCT01011868|80656853|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
27677993|NCT01011868|80656854|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
27677994|NCT01011868|80656855|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
27677995|NCT01011868|80656853|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
27677996|NCT01011868|80656854|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
27677997|NCT01011868|80656855|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
27677998|NCT01011868|80656853|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
27677999|NCT01011868|80656854|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
27678000|NCT01011868|80656855|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
27678001|NCT03017742|80656858|FG000|Overall Study|Protocol Violation|36|||
27678002|NCT03017742|80656858|FG000|Overall Study|Withdrawal by Subject|37|||
27678003|NCT01375673|80656859|FG000|Overall Study|Withdrawal by Subject|0|||
27678004|NCT01375673|80656860|FG001|Overall Study|Withdrawal by Subject|1|||
27678005|NCT00426127|80656861|FG000|Overall Study|Adverse Event|1|||
27678006|NCT00426127|80656861|FG000|Overall Study|Removed due to disease progression|1|||
27678007|NCT01370655|80656867|FG000|Period 1|Adverse Event|2|||
27800583|NCT02046369|81101917|FG000|Overall Study|Withdrawal by Subject|3|||
27800584|NCT02046369|81101918|FG001|Overall Study|Withdrawal by Subject|6|||
27800585|NCT02046369|81101917|FG000|Overall Study|never received study drug|0|||
27800586|NCT02046369|81101918|FG001|Overall Study|never received study drug|1|||
27800587|NCT02046369|81101917|FG000|Overall Study|non compliance|1|||
27800588|NCT02046369|81101918|FG001|Overall Study|non compliance|0|||
27800589|NCT00423488|81101922|FG000|Overall Study|No evidence of study drug intake|2|||
27800590|NCT00423488|81101923|FG001|Overall Study|No evidence of study drug intake|1|||
27800591|NCT00423488|81101922|FG000|Overall Study|No post baseline data|3|||
27800592|NCT00423488|81101923|FG001|Overall Study|No post baseline data|0|||
27800593|NCT00701558|81101926|FG000|Overall Study|Death|7|||
27800594|NCT00701558|81101926|FG000|Overall Study|Lost to Follow-up|8|||
27800595|NCT00479765|81101927|FG000|Overall Study|study terminated|4|||
27678008|NCT01370655|80656868|FG001|Period 1|Adverse Event|0|||
27678009|NCT01370655|80656869|FG002|Period 1|Adverse Event|0|||
27678010|NCT01370655|80656870|FG003|Period 1|Adverse Event|0|||
27678011|NCT01370655|80656871|FG004|Period 1|Adverse Event|0|||
27800596|NCT01005680|81101928|FG000|Overall Study|Lost to Follow-up|4|||
27800597|NCT01005680|81101929|FG001|Overall Study|Lost to Follow-up|6|||
27800598|NCT01005680|81101928|FG000|Overall Study|Withdrawal by Subject|1|||
27993297|NCT01463306|81805504|FG000|Overall Study|Protocol Violation|4|||
27800599|NCT01005680|81101929|FG001|Overall Study|Withdrawal by Subject|4|||
27800600|NCT01005680|81101928|FG000|Overall Study|Physician Decision|1|||
27800601|NCT01005680|81101929|FG001|Overall Study|Physician Decision|1|||
27800602|NCT02923115|81101934|FG000|Overall Study|Lost to Follow-up|0|||
27800603|NCT02923115|81101935|FG001|Overall Study|Lost to Follow-up|0|||
27800604|NCT02923115|81101936|FG002|Overall Study|Lost to Follow-up|0|||
27800605|NCT02923115|81101937|FG003|Overall Study|Lost to Follow-up|1|||
27800606|NCT02923115|81101938|FG004|Overall Study|Lost to Follow-up|0|||
27800607|NCT02923115|81101939|FG005|Overall Study|Lost to Follow-up|0|||
27800608|NCT02923115|81101934|FG000|Overall Study|Withdrawal by Subject|0|||
27800609|NCT02923115|81101935|FG001|Overall Study|Withdrawal by Subject|1|||
27800610|NCT02923115|81101936|FG002|Overall Study|Withdrawal by Subject|0|||
27800611|NCT02923115|81101937|FG003|Overall Study|Withdrawal by Subject|0|||
27800612|NCT02923115|81101938|FG004|Overall Study|Withdrawal by Subject|0|||
27800613|NCT02923115|81101939|FG005|Overall Study|Withdrawal by Subject|0|||
27800614|NCT02923115|81101934|FG000|Overall Study|Randomized, but not dosed|0|||
27800615|NCT02923115|81101935|FG001|Overall Study|Randomized, but not dosed|0|||
27800616|NCT02923115|81101936|FG002|Overall Study|Randomized, but not dosed|3|||
27800617|NCT02923115|81101937|FG003|Overall Study|Randomized, but not dosed|1|||
27800618|NCT02923115|81101938|FG004|Overall Study|Randomized, but not dosed|5|||
27800619|NCT02923115|81101939|FG005|Overall Study|Randomized, but not dosed|0|||
27871157|NCT03301649|81361619|FG002|Overall Study|Need alternate therapy due to live lice|81|||
27871158|NCT03301649|81361617|FG000|Overall Study|Lost to Follow-up|11|||
27871159|NCT03301649|81361618|FG001|Overall Study|Lost to Follow-up|11|||
27871160|NCT03301649|81361619|FG002|Overall Study|Lost to Follow-up|3|||
27871161|NCT03301649|81361617|FG000|Overall Study|Protocol Violation|0|||
27800620|NCT02239692|81101940|FG000|Overall Study|Incomplete colonoscopy|1|||
27800621|NCT02239692|81101941|FG001|Overall Study|Incomplete colonoscopy|2|||
27800622|NCT02239692|81101940|FG000|Overall Study|Adverse Event|0|||
27800623|NCT02239692|81101941|FG001|Overall Study|Adverse Event|1|||
27800624|NCT02239692|81101940|FG000|Overall Study|Physician Decision|0|||
27800625|NCT02239692|81101941|FG001|Overall Study|Physician Decision|1|||
27800626|NCT02239692|81101940|FG000|Overall Study|Lost to Follow-up|1|||
27800627|NCT02239692|81101941|FG001|Overall Study|Lost to Follow-up|4|||
27800628|NCT02239692|81101940|FG000|Overall Study|Withdrawal by Subject|3|||
27800629|NCT02239692|81101941|FG001|Overall Study|Withdrawal by Subject|5|||
27800630|NCT02239692|81101940|FG000|Overall Study|Other reason|1|||
27800631|NCT02239692|81101941|FG001|Overall Study|Other reason|0|||
27871162|NCT03301649|81361618|FG001|Overall Study|Protocol Violation|1|||
27871163|NCT03301649|81361619|FG002|Overall Study|Protocol Violation|1|||
27871164|NCT03301649|81361617|FG000|Overall Study|Withdrawal by Subject|10|||
27871165|NCT03301649|81361618|FG001|Overall Study|Withdrawal by Subject|4|||
27871166|NCT03301649|81361619|FG002|Overall Study|Withdrawal by Subject|0|||
27871167|NCT03301649|81361617|FG000|Overall Study|Other than specified|5|||
27871168|NCT03301649|81361618|FG001|Overall Study|Other than specified|3|||
27871169|NCT03301649|81361619|FG002|Overall Study|Other than specified|0|||
27871170|NCT01522456|81361629|FG000|Overall Study|Adverse Event|2|||
27871171|NCT01522456|81361629|FG000|Overall Study|Lost to Follow-up|2|||
27871172|NCT01522456|81361629|FG000|Overall Study|Withdrawal by Subject|2|||
27871173|NCT01522456|81361629|FG000|Overall Study|Pregnancy|1|||
27871174|NCT01522456|81361629|FG000|Overall Study|Tolerability Assessment|1|||
27871175|NCT00124748|81361630|FG000|Overall Study|Adverse Event|8|||
27871176|NCT00124748|81361631|FG001|Overall Study|Adverse Event|39|||
27871177|NCT00124748|81361630|FG000|Overall Study|Abnormal laboratory Value|2|||
27871178|NCT00124748|81361631|FG001|Overall Study|Abnormal laboratory Value|2|||
27871179|NCT00124748|81361630|FG000|Overall Study|Abnormal Procedure|0|||
27871180|NCT00124748|81361631|FG001|Overall Study|Abnormal Procedure|1|||
27871181|NCT00124748|81361630|FG000|Overall Study|Lack of Efficacy|20|||
27871182|NCT00124748|81361631|FG001|Overall Study|Lack of Efficacy|41|||
27871183|NCT00124748|81361630|FG000|Overall Study|No longer requires study drug|1|||
27871184|NCT00124748|81361631|FG001|Overall Study|No longer requires study drug|1|||
27871185|NCT00124748|81361630|FG000|Overall Study|Protocol Violation|3|||
27871186|NCT00124748|81361631|FG001|Overall Study|Protocol Violation|1|||
27871187|NCT00124748|81361630|FG000|Overall Study|Withdrawal by Subject|5|||
27871188|NCT00124748|81361631|FG001|Overall Study|Withdrawal by Subject|15|||
27800632|NCT03506425|81101946|FG000|Overall Study|Adverse Event|1|||
27800633|NCT03506425|81101947|FG001|Overall Study|Adverse Event|3|||
27800634|NCT03506425|81101948|FG002|Overall Study|Adverse Event|0|||
27800635|NCT03506425|81101946|FG000|Overall Study|Death|1|||
27800636|NCT03506425|81101947|FG001|Overall Study|Death|0|||
27800637|NCT03506425|81101948|FG002|Overall Study|Death|0|||
27871189|NCT00124748|81361630|FG000|Overall Study|Lost to Follow-up|2|||
27871190|NCT00124748|81361631|FG001|Overall Study|Lost to Follow-up|7|||
27871191|NCT00124748|81361630|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
27871192|NCT00124748|81361631|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
27800638|NCT03506425|81101946|FG000|Overall Study|Withdrawal by Subject|0|||
27800639|NCT03506425|81101947|FG001|Overall Study|Withdrawal by Subject|0|||
27800640|NCT03506425|81101948|FG002|Overall Study|Withdrawal by Subject|1|||
27871193|NCT00124748|81361630|FG000|Overall Study|Death|1|||
27871194|NCT00124748|81361631|FG001|Overall Study|Death|3|||
27871195|NCT02492867|81361632|FG000|Overall Study|Alternate therapy|1|||
27871196|NCT02492867|81361632|FG000|Overall Study|Withdrawal by Subject|2|||
27871197|NCT02492867|81361632|FG000|Overall Study|Disease progression after treatment started|1|||
27871198|NCT02492867|81361632|FG000|Overall Study|Death|1|||
27871199|NCT02115607|81361633|FG000|Overall Study|Withdrawal by Subject|1|||
27871200|NCT01495000|81361634|FG000|Overall Study|Lost to Follow-up|2|||
27871201|NCT01495000|81361635|FG001|Overall Study|Lost to Follow-up|2|||
27871202|NCT01495000|81361634|FG000|Overall Study|Protocol Violation|1|||
27871203|NCT01495000|81361635|FG001|Overall Study|Protocol Violation|0|||
27871204|NCT01495000|81361634|FG000|Overall Study|Withdrawal by Subject|10|||
27871205|NCT01495000|81361635|FG001|Overall Study|Withdrawal by Subject|10|||
27871206|NCT03125798|81361636|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
27871207|NCT03125798|81361637|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
27871208|NCT03125798|81361636|FG000|Overall Study|Conversion to thoracotomy|7|||
27871209|NCT03125798|81361637|FG001|Overall Study|Conversion to thoracotomy|7|||
27871210|NCT00280735|81361638|FG000|Overall Study|Adverse Event|5|||
27871211|NCT00280735|81361638|FG000|Overall Study|Lack of Efficacy|3|||
27871212|NCT00280735|81361638|FG000|Overall Study|Withdrawal by Subject|8|||
27871213|NCT00280735|81361638|FG000|Overall Study|Intercurrent Illness|2|||
27800641|NCT04247594|81101949|FG000|Overall Study|Withdrawal by Subject|4|||
27800642|NCT00934622|81101956|FG000|Overall Study|Lost to Follow-up|7|||
27800643|NCT00934622|81101956|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
27800644|NCT00929864|81101957|FG000|Overall Study|Death|1|||
27871214|NCT01651117|81361639|FG000|Overall Study|Death|2|||
27871215|NCT01651117|81361640|FG001|Overall Study|Death|3|||
27871216|NCT01651117|81361641|FG002|Overall Study|Death|2|||
27871217|NCT01651117|81361642|FG003|Overall Study|Death|2|||
27871218|NCT04342819|81361647|FG000|Overall Study|Declined|4|||
27871219|NCT04342819|81361647|FG000|Overall Study|Not meeeting selection criteria|1|||
27800645|NCT00929864|81101958|FG001|Overall Study|Death|1|||
27800646|NCT00929864|81101957|FG000|Overall Study|Adverse Event|11|||
27800647|NCT00929864|81101958|FG001|Overall Study|Adverse Event|30|||
27800648|NCT00929864|81101957|FG000|Overall Study|Lack of Efficacy|19|||
27871220|NCT01811472|81361648|FG000|Overall Study|Adverse Event|1|||
27871221|NCT01811472|81361649|FG001|Overall Study|Adverse Event|0|||
27871222|NCT01811472|81361650|FG002|Overall Study|Adverse Event|4|||
27871223|NCT01811472|81361648|FG000|Overall Study|Lost to Follow-up|0|||
27871224|NCT01811472|81361649|FG001|Overall Study|Lost to Follow-up|0|||
27871225|NCT01811472|81361650|FG002|Overall Study|Lost to Follow-up|1|||
27871226|NCT01811472|81361648|FG000|Overall Study|Subject/guardian decision|1|||
27871227|NCT01811472|81361649|FG001|Overall Study|Subject/guardian decision|0|||
27871228|NCT01811472|81361650|FG002|Overall Study|Subject/guardian decision|0|||
27871229|NCT00182325|81361657|FG000|Overall Study|Lost to Follow-up|7|||
27871230|NCT00182325|81361658|FG001|Overall Study|Lost to Follow-up|7|||
27871231|NCT00182325|81361657|FG000|Overall Study|Miscarriage|5|||
27871232|NCT00182325|81361658|FG001|Overall Study|Miscarriage|3|||
27871233|NCT00182325|81361657|FG000|Overall Study|Did not complete survey|22|||
27871234|NCT00182325|81361658|FG001|Overall Study|Did not complete survey|43|||
27871235|NCT03333941|81361659|FG000|Overall Study|Lost to Follow-up|10|||
27871236|NCT03333941|81361659|FG000|Overall Study|Death|2|||
27871237|NCT03333941|81361659|FG000|Overall Study|Adverse Event|1|||
27871238|NCT00638508|81361660|FG000|Overall Study|Physician Decision|5|||
27871239|NCT00638508|81361661|FG001|Overall Study|Physician Decision|2|||
27871240|NCT01524978|81361662|FG000|Overall Study|Other|16|||
27871241|NCT01524978|81361663|FG001|Overall Study|Other|2|||
27871242|NCT01524978|81361664|FG002|Overall Study|Other|1|||
27871243|NCT01524978|81361665|FG003|Overall Study|Other|2|||
27871244|NCT01524978|81361666|FG004|Overall Study|Other|1|||
27871245|NCT01524978|81361667|FG005|Overall Study|Other|3|||
27579418|NCT01513291|80303210|FG001|Treatment Period|Randomized not treated|2|||
27678012|NCT01370655|80656872|FG005|Period 1|Adverse Event|0|||
27871246|NCT01524978|81361668|FG006|Overall Study|Other|17|||
27871247|NCT01524978|81361669|FG007|Overall Study|Other|1|||
27871248|NCT01524978|81361670|FG008|Overall Study|Other|2|||
27871249|NCT01524978|81361671|FG009|Overall Study|Other|2|||
27871250|NCT01524978|81361672|FG010|Overall Study|Other|5|||
27871251|NCT01524978|81361662|FG000|Overall Study|Withdrawal by Subject|12|||
27871252|NCT01524978|81361663|FG001|Overall Study|Withdrawal by Subject|0|||
27871253|NCT01524978|81361664|FG002|Overall Study|Withdrawal by Subject|1|||
27800649|NCT00929864|81101958|FG001|Overall Study|Lack of Efficacy|16|||
27800650|NCT00929864|81101957|FG000|Overall Study|Lost to Follow-up|7|||
27800651|NCT00929864|81101958|FG001|Overall Study|Lost to Follow-up|12|||
27871254|NCT01524978|81361665|FG003|Overall Study|Withdrawal by Subject|1|||
27871255|NCT01524978|81361666|FG004|Overall Study|Withdrawal by Subject|3|||
27871256|NCT01524978|81361667|FG005|Overall Study|Withdrawal by Subject|1|||
27871257|NCT01524978|81361668|FG006|Overall Study|Withdrawal by Subject|6|||
27871258|NCT01524978|81361669|FG007|Overall Study|Withdrawal by Subject|2|||
27871259|NCT01524978|81361670|FG008|Overall Study|Withdrawal by Subject|4|||
27678013|NCT01370655|80656873|FG006|Period 1|Adverse Event|1|||
27678014|NCT01370655|80656874|FG007|Period 1|Adverse Event|0|||
27678015|NCT01370655|80656875|FG008|Period 1|Adverse Event|0|||
27678016|NCT01370655|80656876|FG009|Period 1|Adverse Event|0|||
27678017|NCT01370655|80656877|FG010|Period 1|Adverse Event|0|||
27678018|NCT01370655|80656878|FG011|Period 1|Adverse Event|0|||
27678019|NCT01370655|80656867|FG000|Period 2|Adverse Event|0|||
27678020|NCT01370655|80656868|FG001|Period 2|Adverse Event|0|||
27678021|NCT01370655|80656869|FG002|Period 2|Adverse Event|1|||
27678022|NCT01370655|80656870|FG003|Period 2|Adverse Event|0|||
27678023|NCT01370655|80656871|FG004|Period 2|Adverse Event|1|||
27678024|NCT01370655|80656872|FG005|Period 2|Adverse Event|0|||
27678025|NCT01370655|80656873|FG006|Period 2|Adverse Event|0|||
27678026|NCT01370655|80656874|FG007|Period 2|Adverse Event|1|||
27678027|NCT01370655|80656875|FG008|Period 2|Adverse Event|0|||
27678028|NCT01370655|80656876|FG009|Period 2|Adverse Event|0|||
27678029|NCT01370655|80656877|FG010|Period 2|Adverse Event|0|||
27678030|NCT01370655|80656878|FG011|Period 2|Adverse Event|0|||
27678031|NCT01370655|80656867|FG000|Period 2|met protocol specified stopping criteria|0|||
27678032|NCT01370655|80656868|FG001|Period 2|met protocol specified stopping criteria|0|||
27678033|NCT01370655|80656869|FG002|Period 2|met protocol specified stopping criteria|1|||
27678034|NCT01370655|80656870|FG003|Period 2|met protocol specified stopping criteria|0|||
27678035|NCT01370655|80656871|FG004|Period 2|met protocol specified stopping criteria|0|||
27678036|NCT01370655|80656872|FG005|Period 2|met protocol specified stopping criteria|0|||
27678037|NCT01370655|80656873|FG006|Period 2|met protocol specified stopping criteria|1|||
27678038|NCT01370655|80656874|FG007|Period 2|met protocol specified stopping criteria|0|||
27678039|NCT01370655|80656875|FG008|Period 2|met protocol specified stopping criteria|1|||
27678040|NCT01370655|80656876|FG009|Period 2|met protocol specified stopping criteria|0|||
27678041|NCT01370655|80656877|FG010|Period 2|met protocol specified stopping criteria|1|||
27678042|NCT01370655|80656878|FG011|Period 2|met protocol specified stopping criteria|0|||
27678043|NCT01370655|80656867|FG000|Period 2|Withdrawal by Subject|0|||
27678044|NCT01370655|80656868|FG001|Period 2|Withdrawal by Subject|0|||
27678045|NCT01370655|80656869|FG002|Period 2|Withdrawal by Subject|0|||
27678046|NCT01370655|80656870|FG003|Period 2|Withdrawal by Subject|0|||
27678047|NCT01370655|80656871|FG004|Period 2|Withdrawal by Subject|0|||
27678048|NCT01370655|80656872|FG005|Period 2|Withdrawal by Subject|0|||
27678049|NCT01370655|80656873|FG006|Period 2|Withdrawal by Subject|0|||
27678050|NCT01370655|80656874|FG007|Period 2|Withdrawal by Subject|0|||
27678051|NCT01370655|80656875|FG008|Period 2|Withdrawal by Subject|1|||
27678052|NCT01370655|80656876|FG009|Period 2|Withdrawal by Subject|0|||
27678053|NCT01370655|80656877|FG010|Period 2|Withdrawal by Subject|0|||
27678054|NCT01370655|80656878|FG011|Period 2|Withdrawal by Subject|0|||
27678055|NCT04707664|80656879|FG000|Overall Study|Adverse Event|2|||
27678056|NCT04707664|80656880|FG001|Overall Study|Adverse Event|0|||
27678057|NCT04707664|80656879|FG000|Overall Study|Death|1|||
27678058|NCT04707664|80656880|FG001|Overall Study|Death|2|||
27800652|NCT00929864|81101957|FG000|Overall Study|Withdrawal by Subject|20|||
27800653|NCT00929864|81101958|FG001|Overall Study|Withdrawal by Subject|9|||
27800654|NCT00929864|81101957|FG000|Overall Study|No longer met criteria|2|||
27800655|NCT00929864|81101958|FG001|Overall Study|No longer met criteria|1|||
27800656|NCT00929864|81101957|FG000|Overall Study|Poor or non-compliance|3|||
27800657|NCT00929864|81101958|FG001|Overall Study|Poor or non-compliance|3|||
27800658|NCT00929864|81101957|FG000|Overall Study|Pregnancy|0|||
27800659|NCT00929864|81101958|FG001|Overall Study|Pregnancy|3|||
27871260|NCT01524978|81361671|FG009|Overall Study|Withdrawal by Subject|0|||
27871261|NCT01524978|81361672|FG010|Overall Study|Withdrawal by Subject|5|||
27800660|NCT00929864|81101957|FG000|Overall Study|Administrative reason by Sponsor|1|||
27800661|NCT00929864|81101958|FG001|Overall Study|Administrative reason by Sponsor|1|||
27800662|NCT00929864|81101957|FG000|Overall Study|Non-specified|2|||
27871262|NCT01524978|81361662|FG000|Overall Study|Lost to Follow-up|0|||
27871263|NCT01524978|81361663|FG001|Overall Study|Lost to Follow-up|0|||
27871264|NCT01524978|81361664|FG002|Overall Study|Lost to Follow-up|3|||
27678059|NCT04707664|80656879|FG000|Overall Study|Withdrawal by Subject|13|||
27678060|NCT04707664|80656880|FG001|Overall Study|Withdrawal by Subject|21|||
27678061|NCT04707664|80656879|FG000|Overall Study|Lost to Follow-up|11|||
27678062|NCT04707664|80656880|FG001|Overall Study|Lost to Follow-up|13|||
27678063|NCT04707664|80656879|FG000|Overall Study|Not treated|2|||
27678064|NCT04707664|80656880|FG001|Overall Study|Not treated|0|||
27678065|NCT00972322|80656881|FG000|Overall Study|Adverse Event|2|||
27678066|NCT00972322|80656882|FG001|Overall Study|Adverse Event|1|||
27678067|NCT00972322|80656881|FG000|Overall Study|Positive drug screen|0|||
27678068|NCT00972322|80656882|FG001|Overall Study|Positive drug screen|1|||
27678069|NCT00972322|80656881|FG000|Overall Study|Lost to Follow-up|0|||
27800663|NCT00929864|81101958|FG001|Overall Study|Non-specified|7|||
27871265|NCT01524978|81361665|FG003|Overall Study|Lost to Follow-up|0|||
27678070|NCT00972322|80656882|FG001|Overall Study|Lost to Follow-up|1|||
27800664|NCT01529749|81101968|FG000|Overall Study|Lost to Follow-up|0|||
27800665|NCT01529749|81101969|FG001|Overall Study|Lost to Follow-up|1|||
27678071|NCT00972322|80656881|FG000|Overall Study|Consistently high glucose values|1|||
27871266|NCT01524978|81361666|FG004|Overall Study|Lost to Follow-up|1|||
27871267|NCT01524978|81361667|FG005|Overall Study|Lost to Follow-up|1|||
27800666|NCT01529749|81101970|FG002|Overall Study|Lost to Follow-up|1|||
27800667|NCT01529749|81101971|FG003|Overall Study|Lost to Follow-up|0|||
27800668|NCT01529749|81101968|FG000|Overall Study|Physician Decision|0|||
27800669|NCT01529749|81101969|FG001|Overall Study|Physician Decision|0|||
27800670|NCT01529749|81101970|FG002|Overall Study|Physician Decision|0|||
27800671|NCT01529749|81101971|FG003|Overall Study|Physician Decision|1|||
27871268|NCT01524978|81361668|FG006|Overall Study|Lost to Follow-up|2|||
27871269|NCT01524978|81361669|FG007|Overall Study|Lost to Follow-up|0|||
27871270|NCT01524978|81361670|FG008|Overall Study|Lost to Follow-up|1|||
27871271|NCT01524978|81361671|FG009|Overall Study|Lost to Follow-up|1|||
27871272|NCT01524978|81361672|FG010|Overall Study|Lost to Follow-up|1|||
27871273|NCT01524978|81361662|FG000|Overall Study|Death|34|||
27871274|NCT01524978|81361663|FG001|Overall Study|Death|2|||
27871275|NCT01524978|81361664|FG002|Overall Study|Death|5|||
27800672|NCT01529749|81101968|FG000|Overall Study|Withdrawal by Subject|0|||
27800673|NCT01529749|81101969|FG001|Overall Study|Withdrawal by Subject|1|||
27800674|NCT01529749|81101970|FG002|Overall Study|Withdrawal by Subject|1|||
27800675|NCT01529749|81101971|FG003|Overall Study|Withdrawal by Subject|0|||
27800676|NCT01529749|81101968|FG000|Overall Study|Protocol Violation|0|||
27800677|NCT01529749|81101969|FG001|Overall Study|Protocol Violation|0|||
27800678|NCT01529749|81101970|FG002|Overall Study|Protocol Violation|0|||
27800679|NCT01529749|81101971|FG003|Overall Study|Protocol Violation|1|||
27800680|NCT00306852|81101980|FG000|Overall Study|Death|14|||
27800681|NCT00306852|81101981|FG001|Overall Study|Death|14|||
27800682|NCT00306852|81101980|FG000|Overall Study|Lost to Follow-up|15|||
27800683|NCT00306852|81101981|FG001|Overall Study|Lost to Follow-up|24|||
27871276|NCT01524978|81361665|FG003|Overall Study|Death|24|||
27871277|NCT01524978|81361666|FG004|Overall Study|Death|4|||
27871278|NCT01524978|81361667|FG005|Overall Study|Death|4|||
27871279|NCT01524978|81361668|FG006|Overall Study|Death|1|||
27871280|NCT01524978|81361669|FG007|Overall Study|Death|9|||
27871281|NCT01524978|81361670|FG008|Overall Study|Death|5|||
27871282|NCT01524978|81361671|FG009|Overall Study|Death|6|||
27871283|NCT01524978|81361672|FG010|Overall Study|Death|17|||
27871284|NCT02121652|81361673|FG000|Overall Study|Lost to Follow-up|2|||
27871285|NCT02121652|81361674|FG001|Overall Study|Lost to Follow-up|1|||
27871286|NCT02121652|81361673|FG000|Overall Study|Death|1|||
27871287|NCT02121652|81361674|FG001|Overall Study|Death|0|||
27871288|NCT02121652|81361673|FG000|Overall Study|Withdrawal by Subject|3|||
27871289|NCT02121652|81361674|FG001|Overall Study|Withdrawal by Subject|3|||
27871290|NCT00618371|81361675|FG000|Overall Study|Withdrawal by Subject|2|||
27871291|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
27871292|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
27871293|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
27871294|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
27871295|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
27871296|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871297|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871298|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871299|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871300|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871301|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871302|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871303|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871304|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871305|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
27871306|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
27993298|NCT01463306|81805505|FG001|Overall Study|Protocol Violation|0|||
27800684|NCT00647426|81101982|FG000|Overall Study|Withdrawal by Subject|2|||
27800685|NCT02567266|81101983|FG000|Overall Study|Withdrawal by Subject|10|||
27800686|NCT02567266|81101984|FG001|Overall Study|Withdrawal by Subject|7|||
27800687|NCT02567266|81101985|FG002|Overall Study|Withdrawal by Subject|6|||
27800688|NCT02567266|81101983|FG000|Overall Study|Lost to Follow-up|13|||
27800689|NCT02567266|81101984|FG001|Overall Study|Lost to Follow-up|8|||
27871307|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
27871308|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
27871309|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
27871310|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
27871311|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871312|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871313|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871314|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871315|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871316|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871317|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871318|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871319|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871320|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
27871321|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
27871322|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
27871323|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
27871324|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
27871325|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
27871326|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871327|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871328|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871329|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871330|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871331|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871332|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871333|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871334|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871335|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
27871336|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
27871337|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
27871338|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
27871339|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
27871340|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
27871341|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871342|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871343|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871344|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871345|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871346|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871347|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871348|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871349|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871350|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
27871351|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
27871352|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871353|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
27871354|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
27871355|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
27800690|NCT02567266|81101985|FG002|Overall Study|Lost to Follow-up|10|||
27800691|NCT01959230|81101986|FG000|Overall Study|Failure to follow study procedures|0|||
27800692|NCT01959230|81101987|FG001|Overall Study|Failure to follow study procedures|1|||
27800693|NCT01959230|81101986|FG000|Overall Study|Administrative reasons|2|||
27800694|NCT01959230|81101987|FG001|Overall Study|Administrative reasons|0|||
27871356|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871357|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871358|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27800695|NCT01959230|81101986|FG000|Overall Study|Withdrawal by Subject|2|||
27800696|NCT01959230|81101987|FG001|Overall Study|Withdrawal by Subject|0|||
27800697|NCT02756078|81101992|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
27800698|NCT02756078|81101993|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
27800699|NCT02756078|81101992|FG000|Period 1|Lost to Follow-up|0|||
27800700|NCT02756078|81101993|FG001|Period 1|Lost to Follow-up|2|||
27800701|NCT02756078|81101992|FG000|Period 1|Protocol Violation|0|||
27800702|NCT02756078|81101993|FG001|Period 1|Protocol Violation|1|||
27800703|NCT02756078|81101992|FG000|Period 1|Adverse Event|1|||
27800704|NCT02756078|81101993|FG001|Period 1|Adverse Event|10|||
27800705|NCT02756078|81101992|FG000|Period 1|Withdrawal by Subject|6|||
27800706|NCT02756078|81101993|FG001|Period 1|Withdrawal by Subject|6|||
27800707|NCT02756078|81101992|FG000|Period 1|Lens Discomfort|2|||
27800708|NCT02756078|81101993|FG001|Period 1|Lens Discomfort|2|||
27800709|NCT02756078|81101992|FG000|Period 2|Adverse Event|3|||
27800710|NCT02756078|81101993|FG001|Period 2|Adverse Event|5|||
27800711|NCT02756078|81101992|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
27800712|NCT02756078|81101993|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
27800713|NCT02756078|81101992|FG000|Period 2|Withdrawal by Subject|3|||
27800714|NCT02756078|81101993|FG001|Period 2|Withdrawal by Subject|1|||
27800715|NCT02858076|81101994|FG000|Overall Study|Death|6|||
27871359|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871360|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871361|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871362|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871363|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871364|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871365|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
27871366|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871367|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871368|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871369|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
27871370|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871371|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871372|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871373|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871374|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871375|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871376|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871377|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871378|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871379|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871380|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
27871381|NCT03334435|81361677|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871382|NCT03334435|81361678|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
27871383|NCT03334435|81361679|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
27871384|NCT03334435|81361680|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
27871385|NCT03334435|81361681|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
27871386|NCT03334435|81361682|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871387|NCT03334435|81361683|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871388|NCT03334435|81361684|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871389|NCT03334435|81361685|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871390|NCT03334435|81361686|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871391|NCT03334435|81361687|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871392|NCT03334435|81361688|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871393|NCT03334435|81361689|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871394|NCT03334435|81361690|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
27871395|NCT03334435|81361691|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
27993299|NCT01463306|81805506|FG002|Overall Study|Protocol Violation|0|||
27993300|NCT01463306|81805504|FG000|Overall Study|Withdrawal by Subject|19|||
27993301|NCT01463306|81805505|FG001|Overall Study|Withdrawal by Subject|9|||
27871396|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
27993302|NCT01463306|81805506|FG002|Overall Study|Withdrawal by Subject|1|||
27993303|NCT01463306|81805504|FG000|Overall Study|Other|26|||
27993304|NCT01463306|81805505|FG001|Overall Study|Other|13|||
27993305|NCT01463306|81805506|FG002|Overall Study|Other|0|||
27993306|NCT01463306|81805504|FG000|Overall Study|Approval expiry at site|1|||
27993307|NCT01463306|81805505|FG001|Overall Study|Approval expiry at site|0|||
27993308|NCT01463306|81805506|FG002|Overall Study|Approval expiry at site|0|||
27993309|NCT04599465|81805507|FG000|Overall Study|Physician Decision|1|||
27993310|NCT04599465|81805507|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
27800716|NCT02858076|81101995|FG001|Overall Study|Death|3|||
27800717|NCT02858076|81101994|FG000|Overall Study|Withdrawal by Subject|1|||
27871397|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
27993311|NCT03698019|81805511|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
27993312|NCT03698019|81805512|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
27993313|NCT03698019|81805511|FG000|Step 1: Registration|Withdrawal by Subject|7|||
27993314|NCT03698019|81805512|FG001|Step 1: Registration|Withdrawal by Subject|2|||
27579419|NCT01513291|80303211|FG002|Treatment Period|Randomized not treated|0|||
27579420|NCT01513291|80303212|FG003|Treatment Period|Randomized not treated|0|||
27871398|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
27871399|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
27871400|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
27993315|NCT03698019|81805511|FG000|Step 1: Registration|Toxicity|0|||
27993316|NCT03698019|81805512|FG001|Step 1: Registration|Toxicity|1|||
27993317|NCT03698019|81805511|FG000|Step 1: Registration|Disease Progression|0|||
27993318|NCT03698019|81805512|FG001|Step 1: Registration|Disease Progression|12|||
27993319|NCT03698019|81805511|FG000|Step 1: Registration|Co-morbidities|0|||
27993320|NCT03698019|81805512|FG001|Step 1: Registration|Co-morbidities|1|||
27993321|NCT03698019|81805511|FG000|Step 1: Registration|Scheduling Issues|1|||
27993322|NCT03698019|81805512|FG001|Step 1: Registration|Scheduling Issues|0|||
27993323|NCT03698019|81805511|FG000|Step 1: Registration|Participant Refusal|0|||
27993324|NCT03698019|81805512|FG001|Step 1: Registration|Participant Refusal|1|||
27993325|NCT03698019|81805511|FG000|Step 2: Surgery|Participant Refusal|2|||
27993326|NCT03698019|81805512|FG001|Step 2: Surgery|Participant Refusal|1|||
27993327|NCT03698019|81805511|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
27579421|NCT01513291|80303213|FG004|Treatment Period|Randomized not treated|0|||
27993328|NCT03698019|81805512|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
27993329|NCT03698019|81805511|FG000|Step 2: Surgery|Metastatic Disease|16|||
27993330|NCT03698019|81805512|FG001|Step 2: Surgery|Metastatic Disease|9|||
27993331|NCT03698019|81805511|FG000|Step 2: Surgery|Residual Disease|2|||
27993332|NCT03698019|81805512|FG001|Step 2: Surgery|Residual Disease|1|||
27993333|NCT03698019|81805511|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
27993334|NCT03698019|81805512|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
27993335|NCT03698019|81805511|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
27993336|NCT03698019|81805512|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
27993337|NCT03698019|81805511|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
27993338|NCT03698019|81805512|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
27993339|NCT03698019|81805511|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
27993340|NCT03698019|81805512|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
27993341|NCT03698019|81805511|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
27993342|NCT03698019|81805512|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
27993343|NCT03698019|81805511|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
27993344|NCT03698019|81805512|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
27993345|NCT03698019|81805511|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
27993346|NCT03698019|81805512|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
27993347|NCT03698019|81805511|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
27993348|NCT03698019|81805512|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
27993349|NCT00934128|81805513|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
27993350|NCT00934128|81805514|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
27993351|NCT00934128|81805513|FG000|First Intervention (2 Hours)|Adverse Event|4|||
27993352|NCT00934128|81805514|FG001|First Intervention (2 Hours)|Adverse Event|1|||
27993353|NCT00934128|81805513|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
27993354|NCT00934128|81805514|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
27993355|NCT00934128|81805513|FG000|Washout Period (1 Hour)|Patient preference|1|||
27800718|NCT02858076|81101995|FG001|Overall Study|Withdrawal by Subject|5|||
27800719|NCT02858076|81101994|FG000|Overall Study|Lost to Follow-up|2|||
27800720|NCT02858076|81101995|FG001|Overall Study|Lost to Follow-up|7|||
27800721|NCT02858076|81101994|FG000|Overall Study|Completed Out of Window|1|||
27800722|NCT02858076|81101995|FG001|Overall Study|Completed Out of Window|3|||
27800723|NCT00289731|81101996|FG000|Overall Study|Adverse Event|1|||
27800724|NCT00289731|81101997|FG001|Overall Study|Adverse Event|2|||
27800725|NCT00289731|81101998|FG002|Overall Study|Adverse Event|2|||
27800726|NCT00289731|81101996|FG000|Overall Study|Other|1|||
27800727|NCT00289731|81101997|FG001|Overall Study|Other|0|||
27800728|NCT00289731|81101998|FG002|Overall Study|Other|0|||
27800729|NCT03454672|81102001|FG000|Overall Study|Adverse Event|1|||
27800730|NCT03454672|81102002|FG001|Overall Study|Adverse Event|1|||
27800731|NCT03454672|81102001|FG000|Overall Study|Lost to Follow-up|1|||
27800732|NCT03454672|81102002|FG001|Overall Study|Lost to Follow-up|3|||
27800733|NCT03454672|81102001|FG000|Overall Study|painful|1|||
27800734|NCT03454672|81102002|FG001|Overall Study|painful|2|||
27800735|NCT03454672|81102001|FG000|Overall Study|Non-compliance|2|||
27800736|NCT03454672|81102002|FG001|Overall Study|Non-compliance|4|||
27800737|NCT03454672|81102001|FG000|Overall Study|personal reasons|3|||
27800738|NCT03454672|81102002|FG001|Overall Study|personal reasons|2|||
27800739|NCT03454672|81102001|FG000|Overall Study|Withdrawal by Subject|1|||
27800740|NCT03454672|81102002|FG001|Overall Study|Withdrawal by Subject|0|||
27800741|NCT03091400|81102003|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
27678072|NCT00972322|80656882|FG001|Overall Study|Consistently high glucose values|0|||
27678073|NCT00737477|80656883|FG000|Overall Study|Adverse Event|9|||
27678074|NCT00737477|80656883|FG000|Overall Study|Death|9|||
27678075|NCT00737477|80656883|FG000|Overall Study|Treatment Refusal|1|||
27800742|NCT03091400|81102004|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
27800743|NCT02237118|81102007|FG000|Overall Study|Protocol Violation|0|||
27800744|NCT02237118|81102008|FG001|Overall Study|Protocol Violation|1|||
27800745|NCT02237118|81102007|FG000|Overall Study|consent withdrawn|1|||
27800746|NCT02237118|81102008|FG001|Overall Study|consent withdrawn|0|||
27800747|NCT00319020|81102009|FG000|Overall Study|Death|2|||
27800748|NCT00319020|81102010|FG001|Overall Study|Death|2|||
27579422|NCT01513291|80303209|FG000|Run-out Period|Lost to Follow-up|0|||
27800749|NCT00319020|81102009|FG000|Overall Study|Withdrawal by Subject|4|||
27800750|NCT00319020|81102010|FG001|Overall Study|Withdrawal by Subject|1|||
27800751|NCT00319020|81102009|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
27800752|NCT00319020|81102010|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
27579423|NCT01513291|80303210|FG001|Run-out Period|Lost to Follow-up|0|||
27678076|NCT00737477|80656883|FG000|Overall Study|Withdrawal by Subject|1|||
27800753|NCT00319020|81102009|FG000|Overall Study|Administrative reason|0|||
27800754|NCT00319020|81102010|FG001|Overall Study|Administrative reason|5|||
27800755|NCT00319020|81102009|FG000|Overall Study|Disease progression|0|||
27800756|NCT00319020|81102010|FG001|Overall Study|Disease progression|2|||
27800757|NCT00319020|81102009|FG000|Overall Study|Transplant|0|||
27993356|NCT00934128|81805514|FG001|Washout Period (1 Hour)|Patient preference|3|||
27993357|NCT00934128|81805513|FG000|Washout Period (1 Hour)|Pain|1|||
27993358|NCT00934128|81805514|FG001|Washout Period (1 Hour)|Pain|0|||
27993359|NCT00934128|81805513|FG000|Washout Period (1 Hour)|Too tired|1|||
27993360|NCT00934128|81805514|FG001|Washout Period (1 Hour)|Too tired|0|||
27678077|NCT00737477|80656883|FG000|Overall Study|Renal Transplantation|10|||
27678078|NCT00737477|80656883|FG000|Overall Study|Other|4|||
27871401|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
27871402|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
27871403|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
27871404|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
27871405|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
27871406|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
27871407|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
27871408|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
27871409|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
27871410|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
27871411|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
27871412|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
27871413|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
27871414|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
27871415|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
27871416|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
27871417|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
27871418|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
27871419|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
27871420|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
27871421|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
27871422|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
27871423|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
27871424|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
27871425|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
27871426|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
27871427|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
27871428|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
27871429|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
27871430|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
27871431|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
27871432|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
27871433|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
27871434|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
27871435|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
27871436|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
27871437|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
27871438|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
27993361|NCT00934128|81805513|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
27993362|NCT00934128|81805514|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
27993363|NCT00934128|81805513|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
27993364|NCT00934128|81805514|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
27993365|NCT00206440|81805515|FG000|Overall Study|Protocol Violation|1|||
27993366|NCT00206440|81805516|FG001|Overall Study|Protocol Violation|2|||
27993367|NCT00206440|81805515|FG000|Overall Study|Adverse Event|4|||
27993368|NCT00206440|81805516|FG001|Overall Study|Adverse Event|2|||
27993369|NCT04829916|81805520|FG000|Overall Study|Withdrawal by Subject|1|||
27993370|NCT04829916|81805521|FG001|Overall Study|Withdrawal by Subject|0|||
27993371|NCT03477838|81805522|FG000|Overall Study|Lost to Follow-up|14|||
27993372|NCT00568126|81805523|FG000|Overall Study|Adverse Event|3|||
27993373|NCT00568126|81805524|FG001|Overall Study|Adverse Event|0|||
27993374|NCT00568126|81805523|FG000|Overall Study|Withdrawal by Subject|2|||
27993375|NCT00568126|81805524|FG001|Overall Study|Withdrawal by Subject|3|||
27993376|NCT00568126|81805523|FG000|Overall Study|Lost to Follow-up|4|||
27993377|NCT00568126|81805524|FG001|Overall Study|Lost to Follow-up|3|||
27993378|NCT00568126|81805523|FG000|Overall Study|Lack of Efficacy|0|||
27993379|NCT00568126|81805524|FG001|Overall Study|Lack of Efficacy|1|||
27993380|NCT00568126|81805523|FG000|Overall Study|Physician Decision|2|||
27993381|NCT00568126|81805524|FG001|Overall Study|Physician Decision|2|||
27993382|NCT03056339|81805525|FG000|Overall Study|Failed Requirements|0|||
27678079|NCT03332784|80656884|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27993383|NCT03056339|81805526|FG001|Overall Study|Failed Requirements|2|||
27993384|NCT03056339|81805527|FG002|Overall Study|Failed Requirements|7|||
27993385|NCT03056339|81805528|FG003|Overall Study|Failed Requirements|1|||
27993386|NCT01832155|81805533|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
27993387|NCT01832155|81805534|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
27993388|NCT01832155|81805533|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
27993389|NCT01832155|81805534|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
27800758|NCT00319020|81102010|FG001|Overall Study|Transplant|1|||
27800759|NCT00319020|81102009|FG000|Overall Study|Treatment failure|0|||
27800760|NCT00319020|81102010|FG001|Overall Study|Treatment failure|1|||
27800761|NCT00319020|81102009|FG000|Overall Study|Adverse Event|0|||
27800762|NCT00319020|81102010|FG001|Overall Study|Adverse Event|1|||
27800763|NCT01488071|81102012|FG000|Overall Study|Adverse Event|15|||
27800764|NCT01488071|81102013|FG001|Overall Study|Adverse Event|23|||
27993390|NCT01711645|81805536|FG000|Overall Study|Withdrawal by Subject|8|||
27800765|NCT01488071|81102012|FG000|Overall Study|Lack of Efficacy|11|||
27800766|NCT01488071|81102013|FG001|Overall Study|Lack of Efficacy|17|||
27800767|NCT01488071|81102012|FG000|Overall Study|Non-compliance with study drug|2|||
27800768|NCT01488071|81102013|FG001|Overall Study|Non-compliance with study drug|0|||
27800769|NCT01488071|81102012|FG000|Overall Study|Protocol Violation|5|||
27800770|NCT01488071|81102013|FG001|Overall Study|Protocol Violation|7|||
27800771|NCT01488071|81102012|FG000|Overall Study|Withdrawal of Consent|14|||
27800772|NCT01488071|81102013|FG001|Overall Study|Withdrawal of Consent|12|||
27800773|NCT01488071|81102012|FG000|Overall Study|Lost to Follow-up|1|||
27993391|NCT01711645|81805536|FG000|Overall Study|Lost to Follow-up|6|||
27993392|NCT01711645|81805536|FG000|Overall Study|Physician Decision|5|||
27993393|NCT00847886|81805537|FG000|Overall Study|Adverse Event|0|||
27993394|NCT00847886|81805538|FG001|Overall Study|Adverse Event|1|||
27993395|NCT01240200|81805539|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
27993396|NCT01240200|81805540|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
27993397|NCT02688985|81805541|FG000|Overall Study|Adverse Event|1|||
27678080|NCT03332784|80656885|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
27800774|NCT01488071|81102013|FG001|Overall Study|Lost to Follow-up|0|||
27800775|NCT01488071|81102012|FG000|Overall Study|Administrative or Other Reason(s)|5|||
27800776|NCT01488071|81102013|FG001|Overall Study|Administrative or Other Reason(s)|4|||
27800777|NCT03876873|81102020|FG000|Overall Study|Physician Decision|0|||
27800778|NCT03876873|81102021|FG001|Overall Study|Physician Decision|1|||
27993398|NCT02688985|81805542|FG001|Overall Study|Adverse Event|2|||
27993399|NCT02688985|81805543|FG002|Overall Study|Adverse Event|2|||
27993400|NCT02688985|81805544|FG003|Overall Study|Adverse Event|0|||
27993401|NCT02688985|81805545|FG004|Overall Study|Adverse Event|0|||
27993402|NCT02688985|81805541|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
27800779|NCT00683904|81102031|FG000|Dose Level 1|Disease progression|2|||
27800780|NCT00683904|81102032|FG001|Dose Level 1|Disease progression|0|||
27800781|NCT00683904|81102031|FG000|Dose Level 1|Adverse Event|1|||
27800782|NCT00683904|81102032|FG001|Dose Level 1|Adverse Event|0|||
27800783|NCT00683904|81102031|FG000|Dose Level 2|Adverse Event|0|||
27800784|NCT00683904|81102032|FG001|Dose Level 2|Adverse Event|2|||
27800785|NCT00545441|81102035|FG000|Overall Study|Fistula draining at 6 months|2|||
27800786|NCT00545441|81102036|FG001|Overall Study|Fistula draining at 6 months|4|||
27800787|NCT00545441|81102035|FG000|Overall Study|Lost to Follow-up|9|||
27800788|NCT00545441|81102036|FG001|Overall Study|Lost to Follow-up|5|||
27800789|NCT00545441|81102035|FG000|Overall Study|Technical failure|0|||
27800790|NCT00545441|81102036|FG001|Overall Study|Technical failure|1|||
27993403|NCT02688985|81805542|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
27800791|NCT00545441|81102035|FG000|Overall Study|Withdrawal by Subject|1|||
27993404|NCT02688985|81805543|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
27800792|NCT00545441|81102036|FG001|Overall Study|Withdrawal by Subject|1|||
27800793|NCT00545441|81102035|FG000|Overall Study|Persistence or recurrence of fistula|5|||
27800794|NCT00545441|81102036|FG001|Overall Study|Persistence or recurrence of fistula|2|||
27800795|NCT00545441|81102035|FG000|Overall Study|Patients were not treated|1|||
27800796|NCT00545441|81102036|FG001|Overall Study|Patients were not treated|3|||
27800797|NCT00734617|81102039|FG000|Overall Study|Adverse Event|4|||
27800798|NCT00734617|81102040|FG001|Overall Study|Adverse Event|7|||
27800799|NCT00734617|81102039|FG000|Overall Study|Withdrawal by Subject|103|||
27800800|NCT00734617|81102040|FG001|Overall Study|Withdrawal by Subject|95|||
27800801|NCT02742818|81102041|FG000|Overall Study|Adverse Event|0|||
27800802|NCT02742818|81102042|FG001|Overall Study|Adverse Event|1|||
27800803|NCT02742818|81102041|FG000|Overall Study|Protocol Violation|0|||
27800804|NCT02742818|81102042|FG001|Overall Study|Protocol Violation|1|||
27800805|NCT04347161|81102043|FG000|Overall Study|Death|0|||
27800806|NCT04347161|81102044|FG001|Overall Study|Death|2|||
27800807|NCT04347161|81102043|FG000|Overall Study|Withdrawal by Subject|1|||
27800808|NCT04347161|81102044|FG001|Overall Study|Withdrawal by Subject|0|||
27800809|NCT04347161|81102043|FG000|Overall Study|Lost to Follow-up|0|||
27800810|NCT04347161|81102044|FG001|Overall Study|Lost to Follow-up|1|||
27800811|NCT04347161|81102043|FG000|Overall Study|No longer on study medication|1|||
27800812|NCT04347161|81102044|FG001|Overall Study|No longer on study medication|1|||
27800813|NCT00665626|81102050|FG000|Overall Study|Lack of Efficacy|8|||
27800814|NCT00665626|81102051|FG001|Overall Study|Lack of Efficacy|5|||
27800815|NCT00665626|81102050|FG000|Overall Study|Lost to Follow-up|0|||
27800816|NCT00665626|81102051|FG001|Overall Study|Lost to Follow-up|2|||
27800817|NCT00665626|81102050|FG000|Overall Study|Withdrawal by Subject|0|||
27800818|NCT00665626|81102051|FG001|Overall Study|Withdrawal by Subject|1|||
27800819|NCT00665626|81102050|FG000|Overall Study|Protocol Violation|0|||
27800820|NCT00665626|81102051|FG001|Overall Study|Protocol Violation|2|||
27800821|NCT00665626|81102050|FG000|Overall Study|Adverse Event|1|||
27800822|NCT00665626|81102051|FG001|Overall Study|Adverse Event|9|||
27800823|NCT00665626|81102050|FG000|Overall Study|Due to exclusion criteria|0|||
27800824|NCT00665626|81102051|FG001|Overall Study|Due to exclusion criteria|1|||
27800825|NCT00665626|81102050|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
27800826|NCT00665626|81102051|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
27800827|NCT00665626|81102050|FG000|Overall Study|Unably to comply with dosing regimen|0|||
27800828|NCT00665626|81102051|FG001|Overall Study|Unably to comply with dosing regimen|1|||
27800829|NCT00665626|81102050|FG000|Overall Study|Death|1|||
27800830|NCT00665626|81102051|FG001|Overall Study|Death|0|||
27800831|NCT01123980|81102052|FG000|Overall Study|Adverse Event|1|||
27800832|NCT01123980|81102053|FG001|Overall Study|Adverse Event|1|||
27800833|NCT01123980|81102052|FG000|Overall Study|Lack of Efficacy|1|||
27800834|NCT01123980|81102053|FG001|Overall Study|Lack of Efficacy|0|||
27800835|NCT01123980|81102052|FG000|Overall Study|Physician Decision|0|||
27800836|NCT01123980|81102053|FG001|Overall Study|Physician Decision|1|||
27800837|NCT01123980|81102052|FG000|Overall Study|Lost to Follow-up|0|||
27800838|NCT01123980|81102053|FG001|Overall Study|Lost to Follow-up|6|||
27800839|NCT01123980|81102052|FG000|Overall Study|Protocol Violation|6|||
27800840|NCT01123980|81102053|FG001|Overall Study|Protocol Violation|6|||
27800841|NCT01123980|81102052|FG000|Overall Study|Withdrawal by Subject|5|||
27800842|NCT01123980|81102053|FG001|Overall Study|Withdrawal by Subject|3|||
27800843|NCT01123980|81102052|FG000|Overall Study|Unclassified|6|||
27993405|NCT02688985|81805544|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
27993406|NCT02688985|81805545|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
27993407|NCT02688985|81805541|FG000|Overall Study|Death|0|||
27993408|NCT02688985|81805542|FG001|Overall Study|Death|0|||
27993409|NCT02688985|81805543|FG002|Overall Study|Death|0|||
27993410|NCT02688985|81805544|FG003|Overall Study|Death|0|||
27993411|NCT02688985|81805545|FG004|Overall Study|Death|1|||
27993412|NCT02688985|81805541|FG000|Overall Study|Lack of Efficacy|0|||
27993413|NCT02688985|81805542|FG001|Overall Study|Lack of Efficacy|0|||
27993414|NCT02688985|81805543|FG002|Overall Study|Lack of Efficacy|0|||
27993415|NCT02688985|81805544|FG003|Overall Study|Lack of Efficacy|0|||
27993416|NCT02688985|81805545|FG004|Overall Study|Lack of Efficacy|1|||
27800844|NCT01123980|81102053|FG001|Overall Study|Unclassified|7|||
27800845|NCT03634488|81102056|FG000|Overall Study|Death|1|||
27800846|NCT03634488|81102057|FG001|Overall Study|Death|0|||
27993417|NCT02688985|81805541|FG000|Overall Study|Lost to Follow-up|2|||
27993418|NCT02688985|81805542|FG001|Overall Study|Lost to Follow-up|0|||
27993419|NCT02688985|81805543|FG002|Overall Study|Lost to Follow-up|1|||
27993420|NCT02688985|81805544|FG003|Overall Study|Lost to Follow-up|1|||
27993421|NCT02688985|81805545|FG004|Overall Study|Lost to Follow-up|1|||
27800847|NCT03634488|81102058|FG002|Overall Study|Death|0|||
27800848|NCT03634488|81102056|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
27800849|NCT03634488|81102057|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
27800850|NCT03634488|81102058|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
27800851|NCT00291330|81102059|FG000|Overall Study|Adverse Event|47|||
27800852|NCT00291330|81102060|FG001|Overall Study|Adverse Event|40|||
27993422|NCT02688985|81805541|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27993423|NCT02688985|81805542|FG001|Overall Study|Non-Compliance With Study Drug|3|||
27993424|NCT02688985|81805543|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27993425|NCT02688985|81805544|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27993426|NCT02688985|81805545|FG004|Overall Study|Non-Compliance With Study Drug|1|||
27993427|NCT02688985|81805541|FG000|Overall Study|Other|3|||
27993428|NCT02688985|81805542|FG001|Overall Study|Other|4|||
27993429|NCT02688985|81805543|FG002|Overall Study|Other|1|||
27993430|NCT02688985|81805544|FG003|Overall Study|Other|0|||
27993431|NCT02688985|81805545|FG004|Overall Study|Other|0|||
27993432|NCT02688985|81805541|FG000|Overall Study|Physician Decision|2|||
27993433|NCT02688985|81805542|FG001|Overall Study|Physician Decision|2|||
27993434|NCT02688985|81805543|FG002|Overall Study|Physician Decision|0|||
27993435|NCT02688985|81805544|FG003|Overall Study|Physician Decision|0|||
27993436|NCT02688985|81805545|FG004|Overall Study|Physician Decision|1|||
27993437|NCT02688985|81805541|FG000|Overall Study|Pregnancy|0|||
27993438|NCT02688985|81805542|FG001|Overall Study|Pregnancy|0|||
27993439|NCT02688985|81805543|FG002|Overall Study|Pregnancy|2|||
27993440|NCT02688985|81805544|FG003|Overall Study|Pregnancy|1|||
27993441|NCT02688985|81805545|FG004|Overall Study|Pregnancy|0|||
27993442|NCT02688985|81805541|FG000|Overall Study|Study Terminated By Sponsor|0|||
27993443|NCT02688985|81805542|FG001|Overall Study|Study Terminated By Sponsor|0|||
27993444|NCT02688985|81805543|FG002|Overall Study|Study Terminated By Sponsor|0|||
27993445|NCT02688985|81805544|FG003|Overall Study|Study Terminated By Sponsor|1|||
27993446|NCT02688985|81805545|FG004|Overall Study|Study Terminated By Sponsor|0|||
27993447|NCT02688985|81805541|FG000|Overall Study|Withdrawal by Subject|2|||
27993448|NCT02688985|81805542|FG001|Overall Study|Withdrawal by Subject|8|||
27993449|NCT02688985|81805543|FG002|Overall Study|Withdrawal by Subject|7|||
27993450|NCT02688985|81805544|FG003|Overall Study|Withdrawal by Subject|1|||
27993451|NCT02688985|81805545|FG004|Overall Study|Withdrawal by Subject|4|||
27993452|NCT01574651|81805546|FG000|Overall Study|Lost to Follow-up|2|||
27993453|NCT01574651|81805547|FG001|Overall Study|Lost to Follow-up|4|||
27800853|NCT00291330|81102059|FG000|Overall Study|Protocol Violation|13|||
27800854|NCT00291330|81102060|FG001|Overall Study|Protocol Violation|20|||
27800855|NCT00291330|81102059|FG000|Overall Study|Lost to Follow-up|16|||
27800856|NCT00291330|81102060|FG001|Overall Study|Lost to Follow-up|11|||
27800857|NCT00291330|81102059|FG000|Overall Study|Withdrawal by Subject|22|||
27800858|NCT00291330|81102060|FG001|Overall Study|Withdrawal by Subject|25|||
27800859|NCT00291330|81102059|FG000|Overall Study|Other|3|||
27800860|NCT00291330|81102060|FG001|Overall Study|Other|1|||
27800861|NCT04651218|81102061|FG000|Overall Study|Withdrawal by Subject|0|||
27800862|NCT04651218|81102062|FG001|Overall Study|Withdrawal by Subject|2|||
27800863|NCT02261974|81102063|FG000|Overall Study|Withdrawal by Subject|3|||
27800864|NCT02261974|81102064|FG001|Overall Study|Withdrawal by Subject|2|||
27800865|NCT02261974|81102063|FG000|Overall Study|Pregnancy|0|||
27800866|NCT02261974|81102064|FG001|Overall Study|Pregnancy|1|||
27800867|NCT02261974|81102063|FG000|Overall Study|Missed treatment cut-off date|6|||
27800868|NCT02261974|81102064|FG001|Overall Study|Missed treatment cut-off date|3|||
27800869|NCT02261974|81102063|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
27800870|NCT02261974|81102064|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
27800871|NCT02261974|81102063|FG000|Overall Study|Lost to Follow-up|2|||
27800872|NCT02261974|81102064|FG001|Overall Study|Lost to Follow-up|0|||
27800873|NCT02261974|81102063|FG000|Overall Study|Adverse Event|1|||
27800874|NCT02261974|81102064|FG001|Overall Study|Adverse Event|0|||
27871439|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
27871440|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
27871441|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
27871442|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
27871443|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
27871444|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
27871445|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
27871446|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
27871447|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
27871448|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
27993454|NCT01574651|81805546|FG000|Overall Study|Administrative problems|0|||
27993455|NCT01574651|81805547|FG001|Overall Study|Administrative problems|1|||
27993456|NCT01574651|81805546|FG000|Overall Study|Death|3|||
27993457|NCT01574651|81805547|FG001|Overall Study|Death|3|||
27800875|NCT00755937|81102065|FG000|Recruitment|Unknown if infliximab received|164|||
27993458|NCT01574651|81805546|FG000|Overall Study|Patient's inability to use the device|0|||
27800876|NCT00755937|81102065|FG000|Observational Follow-up|Lost to Follow-up|148|||
27800877|NCT01246986|81102066|FG000|Overall Study|Lost to Follow-up|0|||
27993459|NCT01574651|81805547|FG001|Overall Study|Patient's inability to use the device|1|||
27993460|NCT01574651|81805546|FG000|Overall Study|Adverse Event|36|||
27993461|NCT01574651|81805547|FG001|Overall Study|Adverse Event|27|||
27800878|NCT01246986|81102067|FG001|Overall Study|Lost to Follow-up|1|||
27800879|NCT01246986|81102068|FG002|Overall Study|Lost to Follow-up|3|||
27800880|NCT01246986|81102069|FG003|Overall Study|Lost to Follow-up|0|||
27800881|NCT01246986|81102070|FG004|Overall Study|Lost to Follow-up|0|||
27800882|NCT01246986|81102071|FG005|Overall Study|Lost to Follow-up|1|||
27800883|NCT01246986|81102072|FG006|Overall Study|Lost to Follow-up|0|||
27993462|NCT01574651|81805546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27993463|NCT01574651|81805547|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27993464|NCT01574651|81805546|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27993465|NCT01574651|81805547|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27993466|NCT01574651|81805546|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27993467|NCT01574651|81805547|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27993468|NCT01574651|81805546|FG000|Overall Study|Protocol Violation|3|||
27993469|NCT01574651|81805547|FG001|Overall Study|Protocol Violation|5|||
27993470|NCT01574651|81805546|FG000|Overall Study|Withdrawal by Subject|9|||
27993471|NCT01574651|81805547|FG001|Overall Study|Withdrawal by Subject|10|||
27993472|NCT01221350|81805548|FG000|Overall Study|Discontinued intervention (GERD)|1|||
27993473|NCT01221350|81805549|FG001|Overall Study|Discontinued intervention (GERD)|0|||
27993474|NCT01221350|81805548|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
27993475|NCT01221350|81805549|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
27993476|NCT01221350|81805548|FG000|Overall Study|Withdrawal by Subject|4|||
27993477|NCT01221350|81805549|FG001|Overall Study|Withdrawal by Subject|2|||
27800884|NCT01246986|81102066|FG000|Overall Study|Withdrawal by Subject|3|||
27800885|NCT01246986|81102067|FG001|Overall Study|Withdrawal by Subject|4|||
27800886|NCT01246986|81102068|FG002|Overall Study|Withdrawal by Subject|3|||
27800887|NCT01246986|81102069|FG003|Overall Study|Withdrawal by Subject|0|||
27800888|NCT01246986|81102070|FG004|Overall Study|Withdrawal by Subject|4|||
27800889|NCT01246986|81102071|FG005|Overall Study|Withdrawal by Subject|0|||
27800890|NCT01246986|81102072|FG006|Overall Study|Withdrawal by Subject|0|||
27800891|NCT00995930|81102075|FG000|Overall Study|Protocol deviation|2|||
27800892|NCT00995930|81102076|FG001|Overall Study|Protocol deviation|5|||
27800893|NCT00995930|81102075|FG000|Overall Study|Death|0|||
27800894|NCT00995930|81102076|FG001|Overall Study|Death|1|||
27800895|NCT00995930|81102075|FG000|Overall Study|Administrative problems|4|||
27800896|NCT00995930|81102076|FG001|Overall Study|Administrative problems|2|||
27800897|NCT00995930|81102075|FG000|Overall Study|Lost to Follow-up|1|||
27800898|NCT00995930|81102076|FG001|Overall Study|Lost to Follow-up|2|||
27800899|NCT00995930|81102075|FG000|Overall Study|Withdrawal by Subject|3|||
27800900|NCT00995930|81102076|FG001|Overall Study|Withdrawal by Subject|4|||
27800901|NCT00995930|81102075|FG000|Overall Study|Adverse Event|11|||
27800902|NCT00995930|81102076|FG001|Overall Study|Adverse Event|14|||
27800903|NCT02862535|81102077|FG000|Overall Study|Death|7|||
27800904|NCT02862535|81102078|FG001|Overall Study|Death|3|||
27800905|NCT02862535|81102079|FG002|Overall Study|Death|2|||
27800906|NCT02862535|81102080|FG003|Overall Study|Death|5|||
27800907|NCT02862535|81102077|FG000|Overall Study|Study Terminated by Sponsor|1|||
27800908|NCT02862535|81102078|FG001|Overall Study|Study Terminated by Sponsor|3|||
27800909|NCT02862535|81102079|FG002|Overall Study|Study Terminated by Sponsor|8|||
27800910|NCT02862535|81102080|FG003|Overall Study|Study Terminated by Sponsor|5|||
27800911|NCT02862535|81102077|FG000|Overall Study|Enrolled, not Treated|1|||
27800912|NCT02862535|81102078|FG001|Overall Study|Enrolled, not Treated|0|||
27993478|NCT01361178|81805550|FG000|Overall Study|Death|13|||
27993479|NCT01361178|81805551|FG001|Overall Study|Death|0|||
27993480|NCT01807299|81805552|FG000|Overall Study|Protocol Violation|3|||
27993481|NCT01807299|81805553|FG001|Overall Study|Protocol Violation|1|||
27678081|NCT03332784|80656886|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27800913|NCT02862535|81102079|FG002|Overall Study|Enrolled, not Treated|0|||
27800914|NCT02862535|81102080|FG003|Overall Study|Enrolled, not Treated|1|||
27800915|NCT04380701|81102084|FG000|Overall Study|Pregnancy|0|||
27800916|NCT04380701|81102085|FG001|Overall Study|Pregnancy|0|||
27800917|NCT04380701|81102086|FG002|Overall Study|Pregnancy|0|||
27800918|NCT04380701|81102087|FG003|Overall Study|Pregnancy|0|||
27800919|NCT04380701|81102088|FG004|Overall Study|Pregnancy|0|||
27800920|NCT04380701|81102089|FG005|Overall Study|Pregnancy|0|||
27800921|NCT04380701|81102090|FG006|Overall Study|Pregnancy|0|||
27800922|NCT04380701|81102091|FG007|Overall Study|Pregnancy|0|||
27993482|NCT01807299|81805554|FG002|Overall Study|Protocol Violation|0|||
27993483|NCT01807299|81805555|FG003|Overall Study|Protocol Violation|2|||
27993484|NCT02058563|81805556|FG000|Overall Study|Lost to Follow-up|26|||
27800923|NCT04380701|81102092|FG008|Overall Study|Pregnancy|0|||
27993485|NCT02058563|81805557|FG001|Overall Study|Lost to Follow-up|22|||
27993486|NCT02058563|81805556|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
27993487|NCT02058563|81805557|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
27678082|NCT03332784|80656887|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27800924|NCT04380701|81102093|FG009|Overall Study|Pregnancy|0|||
27800925|NCT04380701|81102094|FG010|Overall Study|Pregnancy|0|||
27800926|NCT04380701|81102095|FG011|Overall Study|Pregnancy|0|||
27800927|NCT04380701|81102096|FG012|Overall Study|Pregnancy|0|||
27800928|NCT04380701|81102097|FG013|Overall Study|Pregnancy|0|||
27800929|NCT04380701|81102098|FG014|Overall Study|Pregnancy|0|||
27993488|NCT02058563|81805556|FG000|Overall Study|Consent Withdrawal|1|||
27993489|NCT02058563|81805557|FG001|Overall Study|Consent Withdrawal|1|||
27993490|NCT02058563|81805556|FG000|Overall Study|Other (patient incarcerated)|0|||
27993491|NCT02058563|81805557|FG001|Overall Study|Other (patient incarcerated)|1|||
27993492|NCT01843062|81805558|FG000|Overall Study|Protocol Violation|1|||
27993493|NCT01843062|81805559|FG001|Overall Study|Protocol Violation|0|||
27993494|NCT01843062|81805558|FG000|Overall Study|New treatment following progression|2|||
27993495|NCT01843062|81805559|FG001|Overall Study|New treatment following progression|0|||
27800930|NCT04380701|81102099|FG015|Overall Study|Pregnancy|0|||
27800931|NCT04380701|81102100|FG016|Overall Study|Pregnancy|0|||
27800932|NCT04380701|81102101|FG017|Overall Study|Pregnancy|0|||
27800933|NCT04380701|81102102|FG018|Overall Study|Pregnancy|0|||
27800934|NCT04380701|81102103|FG019|Overall Study|Pregnancy|0|||
27800935|NCT04380701|81102104|FG020|Overall Study|Pregnancy|0|||
27800936|NCT04380701|81102105|FG021|Overall Study|Pregnancy|0|||
27800937|NCT04380701|81102106|FG022|Overall Study|Pregnancy|0|||
27800938|NCT04380701|81102107|FG023|Overall Study|Pregnancy|0|||
27800939|NCT04380701|81102108|FG024|Overall Study|Pregnancy|0|||
27800940|NCT04380701|81102109|FG025|Overall Study|Pregnancy|0|||
27993496|NCT01843062|81805558|FG000|Overall Study|Pregnancy|1|||
27993497|NCT01843062|81805559|FG001|Overall Study|Pregnancy|0|||
27993498|NCT01843062|81805558|FG000|Overall Study|Adverse Event|2|||
27993499|NCT01843062|81805559|FG001|Overall Study|Adverse Event|0|||
27993500|NCT01843062|81805558|FG000|Overall Study|Incorrect randomisation|1|||
27993501|NCT01843062|81805559|FG001|Overall Study|Incorrect randomisation|0|||
27993502|NCT01843062|81805558|FG000|Overall Study|Withdrawal by Subject|12|||
27800941|NCT04380701|81102110|FG026|Overall Study|Pregnancy|0|||
27800942|NCT04380701|81102111|FG027|Overall Study|Pregnancy|0|||
27800943|NCT04380701|81102112|FG028|Overall Study|Pregnancy|0|||
27800944|NCT04380701|81102113|FG029|Overall Study|Pregnancy|0|||
27800945|NCT04380701|81102114|FG030|Overall Study|Pregnancy|0|||
27800946|NCT04380701|81102115|FG031|Overall Study|Pregnancy|0|||
27800947|NCT04380701|81102116|FG032|Overall Study|Pregnancy|1|||
27800948|NCT04380701|81102117|FG033|Overall Study|Pregnancy|0|||
27800949|NCT04380701|81102084|FG000|Overall Study|Lost to Follow-up|0|||
27800950|NCT04380701|81102085|FG001|Overall Study|Lost to Follow-up|0|||
27800951|NCT04380701|81102086|FG002|Overall Study|Lost to Follow-up|0|||
27800952|NCT04380701|81102087|FG003|Overall Study|Lost to Follow-up|0|||
27800953|NCT04380701|81102088|FG004|Overall Study|Lost to Follow-up|0|||
27800954|NCT04380701|81102089|FG005|Overall Study|Lost to Follow-up|0|||
27800955|NCT04380701|81102090|FG006|Overall Study|Lost to Follow-up|0|||
27800956|NCT04380701|81102091|FG007|Overall Study|Lost to Follow-up|0|||
27800957|NCT04380701|81102092|FG008|Overall Study|Lost to Follow-up|0|||
27800958|NCT04380701|81102093|FG009|Overall Study|Lost to Follow-up|0|||
27800959|NCT04380701|81102094|FG010|Overall Study|Lost to Follow-up|0|||
27800960|NCT04380701|81102095|FG011|Overall Study|Lost to Follow-up|0|||
27800961|NCT04380701|81102096|FG012|Overall Study|Lost to Follow-up|0|||
27800962|NCT04380701|81102097|FG013|Overall Study|Lost to Follow-up|0|||
27800963|NCT04380701|81102098|FG014|Overall Study|Lost to Follow-up|0|||
27800964|NCT04380701|81102099|FG015|Overall Study|Lost to Follow-up|0|||
27800965|NCT04380701|81102100|FG016|Overall Study|Lost to Follow-up|0|||
27800966|NCT04380701|81102101|FG017|Overall Study|Lost to Follow-up|0|||
27800967|NCT04380701|81102102|FG018|Overall Study|Lost to Follow-up|0|||
27800968|NCT04380701|81102103|FG019|Overall Study|Lost to Follow-up|0|||
27800969|NCT04380701|81102104|FG020|Overall Study|Lost to Follow-up|1|||
27800970|NCT04380701|81102105|FG021|Overall Study|Lost to Follow-up|0|||
27800971|NCT04380701|81102106|FG022|Overall Study|Lost to Follow-up|0|||
27800972|NCT04380701|81102107|FG023|Overall Study|Lost to Follow-up|1|||
27800973|NCT04380701|81102108|FG024|Overall Study|Lost to Follow-up|0|||
27800974|NCT04380701|81102109|FG025|Overall Study|Lost to Follow-up|0|||
27800975|NCT04380701|81102110|FG026|Overall Study|Lost to Follow-up|0|||
27800976|NCT04380701|81102111|FG027|Overall Study|Lost to Follow-up|0|||
27800977|NCT04380701|81102112|FG028|Overall Study|Lost to Follow-up|0|||
27800978|NCT04380701|81102113|FG029|Overall Study|Lost to Follow-up|1|||
27800979|NCT04380701|81102114|FG030|Overall Study|Lost to Follow-up|0|||
27800980|NCT04380701|81102115|FG031|Overall Study|Lost to Follow-up|0|||
27993503|NCT01843062|81805559|FG001|Overall Study|Withdrawal by Subject|3|||
27993504|NCT01843062|81805558|FG000|Overall Study|Death|1|||
27800981|NCT04380701|81102116|FG032|Overall Study|Lost to Follow-up|0|||
27871449|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
27993505|NCT01843062|81805559|FG001|Overall Study|Death|2|||
27993506|NCT01843062|81805558|FG000|Overall Study|Lost to Follow-up|2|||
27993507|NCT01843062|81805559|FG001|Overall Study|Lost to Follow-up|4|||
27800982|NCT04380701|81102117|FG033|Overall Study|Lost to Follow-up|1|||
27800983|NCT04380701|81102084|FG000|Overall Study|Private reason(s)|0|||
27800984|NCT04380701|81102085|FG001|Overall Study|Private reason(s)|0|||
27800985|NCT04380701|81102086|FG002|Overall Study|Private reason(s)|0|||
27800986|NCT04380701|81102087|FG003|Overall Study|Private reason(s)|0|||
27800987|NCT04380701|81102088|FG004|Overall Study|Private reason(s)|0|||
27800988|NCT04380701|81102089|FG005|Overall Study|Private reason(s)|0|||
27800989|NCT04380701|81102090|FG006|Overall Study|Private reason(s)|1|||
27993508|NCT00851786|81805560|FG000|Overall Study|Withdrawal by Subject|0|||
27800990|NCT04380701|81102091|FG007|Overall Study|Private reason(s)|0|||
27993509|NCT00851786|81805561|FG001|Overall Study|Withdrawal by Subject|1|||
27993510|NCT00851786|81805560|FG000|Overall Study|Protocol Violation|0|||
27993511|NCT00851786|81805561|FG001|Overall Study|Protocol Violation|1|||
27993512|NCT00851786|81805560|FG000|Overall Study|Lost to Follow-up|1|||
27993513|NCT00851786|81805561|FG001|Overall Study|Lost to Follow-up|0|||
27993514|NCT00851786|81805560|FG000|Overall Study|Incarceration|1|||
27993515|NCT00851786|81805561|FG001|Overall Study|Incarceration|0|||
27993516|NCT00851786|81805560|FG000|Overall Study|Site Closure|1|||
27993517|NCT00851786|81805561|FG001|Overall Study|Site Closure|0|||
27800991|NCT04380701|81102092|FG008|Overall Study|Private reason(s)|1|||
27800992|NCT04380701|81102093|FG009|Overall Study|Private reason(s)|1|||
27800993|NCT04380701|81102094|FG010|Overall Study|Private reason(s)|0|||
27800994|NCT04380701|81102095|FG011|Overall Study|Private reason(s)|0|||
27800995|NCT04380701|81102096|FG012|Overall Study|Private reason(s)|0|||
27800996|NCT04380701|81102097|FG013|Overall Study|Private reason(s)|0|||
27800997|NCT04380701|81102098|FG014|Overall Study|Private reason(s)|0|||
27800998|NCT04380701|81102099|FG015|Overall Study|Private reason(s)|0|||
27800999|NCT04380701|81102100|FG016|Overall Study|Private reason(s)|0|||
27801000|NCT04380701|81102101|FG017|Overall Study|Private reason(s)|0|||
27801001|NCT04380701|81102102|FG018|Overall Study|Private reason(s)|0|||
27801002|NCT04380701|81102103|FG019|Overall Study|Private reason(s)|0|||
27801003|NCT04380701|81102104|FG020|Overall Study|Private reason(s)|0|||
27801004|NCT04380701|81102105|FG021|Overall Study|Private reason(s)|0|||
27801005|NCT04380701|81102106|FG022|Overall Study|Private reason(s)|0|||
27801006|NCT04380701|81102107|FG023|Overall Study|Private reason(s)|1|||
27801007|NCT04380701|81102108|FG024|Overall Study|Private reason(s)|0|||
27801008|NCT04380701|81102109|FG025|Overall Study|Private reason(s)|0|||
27801009|NCT04380701|81102110|FG026|Overall Study|Private reason(s)|0|||
27801010|NCT04380701|81102111|FG027|Overall Study|Private reason(s)|0|||
27801011|NCT04380701|81102112|FG028|Overall Study|Private reason(s)|0|||
27801012|NCT04380701|81102113|FG029|Overall Study|Private reason(s)|1|||
27801013|NCT04380701|81102114|FG030|Overall Study|Private reason(s)|0|||
27801014|NCT04380701|81102115|FG031|Overall Study|Private reason(s)|0|||
27801015|NCT04380701|81102116|FG032|Overall Study|Private reason(s)|0|||
27801016|NCT04380701|81102117|FG033|Overall Study|Private reason(s)|0|||
27801017|NCT04380701|81102084|FG000|Overall Study|Withdrawal by Subject|0|||
27801018|NCT04380701|81102085|FG001|Overall Study|Withdrawal by Subject|0|||
27801019|NCT04380701|81102086|FG002|Overall Study|Withdrawal by Subject|0|||
27801020|NCT04380701|81102087|FG003|Overall Study|Withdrawal by Subject|0|||
27801021|NCT04380701|81102088|FG004|Overall Study|Withdrawal by Subject|0|||
27801022|NCT04380701|81102089|FG005|Overall Study|Withdrawal by Subject|0|||
27801023|NCT04380701|81102090|FG006|Overall Study|Withdrawal by Subject|1|||
27801024|NCT04380701|81102091|FG007|Overall Study|Withdrawal by Subject|1|||
27801025|NCT04380701|81102092|FG008|Overall Study|Withdrawal by Subject|0|||
27801026|NCT04380701|81102093|FG009|Overall Study|Withdrawal by Subject|0|||
27801027|NCT04380701|81102094|FG010|Overall Study|Withdrawal by Subject|0|||
27801028|NCT04380701|81102095|FG011|Overall Study|Withdrawal by Subject|1|||
27801029|NCT04380701|81102096|FG012|Overall Study|Withdrawal by Subject|0|||
27801030|NCT04380701|81102097|FG013|Overall Study|Withdrawal by Subject|1|||
27801031|NCT04380701|81102098|FG014|Overall Study|Withdrawal by Subject|0|||
27801032|NCT04380701|81102099|FG015|Overall Study|Withdrawal by Subject|0|||
27801033|NCT04380701|81102100|FG016|Overall Study|Withdrawal by Subject|1|||
27801034|NCT04380701|81102101|FG017|Overall Study|Withdrawal by Subject|0|||
27993518|NCT00851786|81805560|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
27993519|NCT00851786|81805561|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
27993520|NCT04618744|81805564|FG000|Overall Study|Adverse Event|0|||
27993521|NCT04618744|81805565|FG001|Overall Study|Adverse Event|1|||
27993522|NCT04618744|81805564|FG000|Overall Study|Withdrawal by Subject|0|||
27993523|NCT04618744|81805565|FG001|Overall Study|Withdrawal by Subject|1|||
27993524|NCT00434109|81805566|FG000|Overall Study|Physician Decision|9|||
27993525|NCT00434109|81805566|FG000|Overall Study|Adverse Event|5|||
27993526|NCT00434109|81805566|FG000|Overall Study|Protocol Violation|1|||
27993527|NCT00434109|81805566|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
27993528|NCT01865448|81805573|FG000|Overall Study|Adverse Event|1|||
27993529|NCT01865448|81805574|FG001|Overall Study|Adverse Event|1|||
27801035|NCT04380701|81102102|FG018|Overall Study|Withdrawal by Subject|0|||
27993530|NCT01865448|81805573|FG000|Overall Study|Pregnancy|0|||
27993531|NCT01865448|81805574|FG001|Overall Study|Pregnancy|1|||
27993532|NCT01865448|81805573|FG000|Overall Study|dropout unrelated to study|1|||
27801036|NCT04380701|81102103|FG019|Overall Study|Withdrawal by Subject|0|||
27801037|NCT04380701|81102104|FG020|Overall Study|Withdrawal by Subject|0|||
27801038|NCT04380701|81102105|FG021|Overall Study|Withdrawal by Subject|0|||
27801039|NCT04380701|81102106|FG022|Overall Study|Withdrawal by Subject|2|||
27801040|NCT04380701|81102107|FG023|Overall Study|Withdrawal by Subject|2|||
27801041|NCT04380701|81102108|FG024|Overall Study|Withdrawal by Subject|1|||
27801042|NCT04380701|81102109|FG025|Overall Study|Withdrawal by Subject|1|||
27993533|NCT01865448|81805574|FG001|Overall Study|dropout unrelated to study|1|||
27993534|NCT03437577|81805576|FG000|Pre-Randomization|Withdrawal by Subject|0|||
27993535|NCT03437577|81805577|FG001|Pre-Randomization|Withdrawal by Subject|0|||
27993536|NCT03437577|81805578|FG002|Pre-Randomization|Withdrawal by Subject|10|||
27993537|NCT03437577|81805576|FG000|Post-Randomization|Physician Decision|0|||
27993538|NCT03437577|81805577|FG001|Post-Randomization|Physician Decision|2|||
27993539|NCT03437577|81805578|FG002|Post-Randomization|Physician Decision|0|||
27993540|NCT02806960|81805579|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
27993541|NCT02806960|81805580|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
27993542|NCT02806960|81805581|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
27993543|NCT02806960|81805582|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
27993544|NCT03472586|81805585|FG000|Overall Study|Physician Decision|6|||
27993545|NCT03472586|81805585|FG000|Overall Study|Death|6|||
27993546|NCT03472586|81805585|FG000|Overall Study|Adverse Event|1|||
27993547|NCT00543387|81805594|FG000|Panel 1 + Panel 2|Adverse Event|0|||
27993548|NCT00543387|81805595|FG001|Panel 1 + Panel 2|Adverse Event|1|||
27993549|NCT00543387|81805596|FG002|Panel 1 + Panel 2|Adverse Event|0|||
27993550|NCT00543387|81805597|FG003|Panel 1 + Panel 2|Adverse Event|0|||
27993551|NCT00543387|81805598|FG004|Panel 1 + Panel 2|Adverse Event|0|||
27993552|NCT00543387|81805599|FG005|Panel 1 + Panel 2|Adverse Event|0|||
27993553|NCT00543387|81805600|FG006|Panel 1 + Panel 2|Adverse Event|0|||
27993554|NCT00543387|81805601|FG007|Panel 1 + Panel 2|Adverse Event|1|||
27993555|NCT00543387|81805602|FG008|Panel 1 + Panel 2|Adverse Event|1|||
27993556|NCT00543387|81805603|FG009|Panel 1 + Panel 2|Adverse Event|0|||
27993557|NCT00543387|81805604|FG010|Panel 1 + Panel 2|Adverse Event|0|||
27993558|NCT00543387|81805594|FG000|Panel 1 + Panel 2|Physician Decision|0|||
27993559|NCT00543387|81805595|FG001|Panel 1 + Panel 2|Physician Decision|0|||
27993560|NCT00543387|81805596|FG002|Panel 1 + Panel 2|Physician Decision|1|||
27993561|NCT00543387|81805597|FG003|Panel 1 + Panel 2|Physician Decision|0|||
27993562|NCT00543387|81805598|FG004|Panel 1 + Panel 2|Physician Decision|0|||
27993563|NCT00543387|81805599|FG005|Panel 1 + Panel 2|Physician Decision|0|||
27993564|NCT00543387|81805600|FG006|Panel 1 + Panel 2|Physician Decision|0|||
27993565|NCT00543387|81805601|FG007|Panel 1 + Panel 2|Physician Decision|1|||
27993566|NCT00543387|81805602|FG008|Panel 1 + Panel 2|Physician Decision|0|||
27993567|NCT00543387|81805603|FG009|Panel 1 + Panel 2|Physician Decision|0|||
27993568|NCT00543387|81805604|FG010|Panel 1 + Panel 2|Physician Decision|0|||
27993569|NCT00543387|81805594|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
27993570|NCT00543387|81805595|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
27993571|NCT00543387|81805596|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
27993572|NCT00543387|81805597|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
27993573|NCT00543387|81805598|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
27993574|NCT00543387|81805599|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
27993575|NCT00543387|81805600|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
27993576|NCT00543387|81805601|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
27993577|NCT00543387|81805602|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
27993578|NCT00543387|81805603|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
27678083|NCT03332784|80656888|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678084|NCT03332784|80656889|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678085|NCT03332784|80656890|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678086|NCT03332784|80656891|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678087|NCT03332784|80656892|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678088|NCT03332784|80656893|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678089|NCT03332784|80656894|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678090|NCT03332784|80656895|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678091|NCT03332784|80656896|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678092|NCT03332784|80656897|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678093|NCT03332784|80656898|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
27678094|NCT03332784|80656899|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678095|NCT03332784|80656900|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678096|NCT03332784|80656901|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678097|NCT03332784|80656902|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678098|NCT03332784|80656903|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
27678099|NCT00078377|80656910|FG000|Overall Study|Adverse Event|2|||
27871450|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
27993579|NCT00543387|81805604|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
27993580|NCT00543387|81805594|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993581|NCT00543387|81805595|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993582|NCT00543387|81805596|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993583|NCT00543387|81805597|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993584|NCT00543387|81805598|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993585|NCT00543387|81805599|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27678100|NCT00078377|80656911|FG001|Overall Study|Adverse Event|5|||
27678101|NCT00078377|80656912|FG002|Overall Study|Adverse Event|1|||
27993586|NCT00543387|81805600|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
27678102|NCT00078377|80656910|FG000|Overall Study|Lack of Efficacy|2|||
27678103|NCT00078377|80656911|FG001|Overall Study|Lack of Efficacy|0|||
27678104|NCT00078377|80656912|FG002|Overall Study|Lack of Efficacy|2|||
27678105|NCT00078377|80656910|FG000|Overall Study|Lost to Follow-up|0|||
27678106|NCT00078377|80656911|FG001|Overall Study|Lost to Follow-up|1|||
27678107|NCT00078377|80656912|FG002|Overall Study|Lost to Follow-up|1|||
27678108|NCT00078377|80656910|FG000|Overall Study|Physician Decision|2|||
27678109|NCT00078377|80656911|FG001|Overall Study|Physician Decision|0|||
27678110|NCT00078377|80656912|FG002|Overall Study|Physician Decision|0|||
27678111|NCT00078377|80656910|FG000|Overall Study|Withdrawal by Subject|3|||
27678112|NCT00078377|80656911|FG001|Overall Study|Withdrawal by Subject|4|||
27678113|NCT00078377|80656912|FG002|Overall Study|Withdrawal by Subject|4|||
27678114|NCT00078377|80656910|FG000|Overall Study|Miscellaneous|2|||
27678115|NCT00078377|80656911|FG001|Overall Study|Miscellaneous|6|||
27678116|NCT00078377|80656912|FG002|Overall Study|Miscellaneous|1|||
27678117|NCT00565773|80656914|FG000|Overall Study|Withdrawal by Subject|1|||
27678118|NCT00565773|80656914|FG000|Overall Study|Physician Decision|1|||
27678119|NCT02979249|80656915|FG000|Overall Study|Lost to Follow-up|2|||
27678120|NCT02979249|80656915|FG000|Overall Study|Withdrawal by Subject|4|||
27678121|NCT00822770|80656918|FG000|Overall Study|Not treated|1|||
27678122|NCT00822770|80656919|FG001|Overall Study|Not treated|0|||
27678123|NCT00822770|80656918|FG000|Overall Study|Complication/Incomplete treatment|1|||
27678124|NCT00822770|80656919|FG001|Overall Study|Complication/Incomplete treatment|0|||
27678125|NCT00822770|80656918|FG000|Overall Study|Death|1|||
27678126|NCT00822770|80656919|FG001|Overall Study|Death|1|||
27678127|NCT01850589|80656920|FG000|Overall Study|Withdrawal by Subject|8|||
27678128|NCT01850589|80656921|FG001|Overall Study|Withdrawal by Subject|0|||
27678129|NCT02993406|80656924|FG000|Overall Study|Withdrawal by Subject|170|||
27801043|NCT04380701|81102110|FG026|Overall Study|Withdrawal by Subject|0|||
27993587|NCT00543387|81805601|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993588|NCT00543387|81805602|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993589|NCT00543387|81805603|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993590|NCT00543387|81805604|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
27993591|NCT00543387|81805594|FG000|Crossover Participants|Progressive Disease|0|||
27993592|NCT00543387|81805595|FG001|Crossover Participants|Progressive Disease|0|||
27993593|NCT00543387|81805596|FG002|Crossover Participants|Progressive Disease|0|||
27993594|NCT00543387|81805597|FG003|Crossover Participants|Progressive Disease|0|||
27993595|NCT00543387|81805598|FG004|Crossover Participants|Progressive Disease|0|||
27993596|NCT00543387|81805599|FG005|Crossover Participants|Progressive Disease|0|||
27993597|NCT00543387|81805600|FG006|Crossover Participants|Progressive Disease|0|||
27993598|NCT00543387|81805601|FG007|Crossover Participants|Progressive Disease|0|||
27993599|NCT00543387|81805602|FG008|Crossover Participants|Progressive Disease|0|||
27993600|NCT00543387|81805603|FG009|Crossover Participants|Progressive Disease|1|||
27993601|NCT00543387|81805604|FG010|Crossover Participants|Progressive Disease|2|||
27993602|NCT00543387|81805594|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
27993603|NCT00543387|81805595|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
27993604|NCT00543387|81805596|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
27993605|NCT00543387|81805597|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
27993606|NCT00543387|81805598|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
27801044|NCT04380701|81102111|FG027|Overall Study|Withdrawal by Subject|0|||
27801045|NCT04380701|81102112|FG028|Overall Study|Withdrawal by Subject|0|||
27801046|NCT04380701|81102113|FG029|Overall Study|Withdrawal by Subject|0|||
27801047|NCT04380701|81102114|FG030|Overall Study|Withdrawal by Subject|0|||
27801048|NCT04380701|81102115|FG031|Overall Study|Withdrawal by Subject|0|||
27801049|NCT04380701|81102116|FG032|Overall Study|Withdrawal by Subject|0|||
27801050|NCT04380701|81102117|FG033|Overall Study|Withdrawal by Subject|0|||
27993607|NCT00543387|81805599|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
27993608|NCT00543387|81805600|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
27993609|NCT00543387|81805601|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
27993610|NCT00543387|81805602|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
27801051|NCT04380701|81102084|FG000|Overall Study|Adverse Event|0|||
27801052|NCT04380701|81102085|FG001|Overall Study|Adverse Event|0|||
27993611|NCT00543387|81805603|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
27993612|NCT00543387|81805604|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
27993613|NCT01445080|81805605|FG000|Overall Study|Adverse Event|5|||
27579424|NCT01513291|80303211|FG002|Run-out Period|Lost to Follow-up|0|||
27678130|NCT02993406|80656925|FG001|Overall Study|Withdrawal by Subject|196|||
27678131|NCT02993406|80656924|FG000|Overall Study|Physician Decision|3|||
27678132|NCT02993406|80656925|FG001|Overall Study|Physician Decision|5|||
27678133|NCT02993406|80656924|FG000|Overall Study|Lost to Follow-up|12|||
27678134|NCT02993406|80656925|FG001|Overall Study|Lost to Follow-up|13|||
27678135|NCT02993406|80656924|FG000|Overall Study|Unclassifiable Response|105|||
27801053|NCT04380701|81102086|FG002|Overall Study|Adverse Event|0|||
27678136|NCT02993406|80656925|FG001|Overall Study|Unclassifiable Response|139|||
27678137|NCT02993406|80656924|FG000|Overall Study|Administrative decision|1|||
27801054|NCT04380701|81102087|FG003|Overall Study|Adverse Event|0|||
27801055|NCT04380701|81102088|FG004|Overall Study|Adverse Event|0|||
27801056|NCT04380701|81102089|FG005|Overall Study|Adverse Event|1|||
27801057|NCT04380701|81102090|FG006|Overall Study|Adverse Event|0|||
27801058|NCT04380701|81102091|FG007|Overall Study|Adverse Event|0|||
27801059|NCT04380701|81102092|FG008|Overall Study|Adverse Event|0|||
27871451|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
27871452|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
27871453|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
27871454|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
27993614|NCT01445080|81805606|FG001|Overall Study|Adverse Event|3|||
27871455|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
27871456|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871457|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871458|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871459|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871460|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871461|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871462|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
27871463|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
27871464|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
27871465|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
27871466|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
27871467|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
27871468|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
27871469|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
27871470|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
27871471|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871472|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871473|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27579425|NCT01513291|80303212|FG003|Run-out Period|Lost to Follow-up|1|||
27579426|NCT01513291|80303213|FG004|Run-out Period|Lost to Follow-up|0|||
27871474|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871475|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871476|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871477|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871478|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871479|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871480|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871481|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871482|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
27871483|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871484|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
27871485|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
27871486|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871487|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871488|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871489|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871490|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871491|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
27871492|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871493|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871494|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
27993615|NCT01445080|81805607|FG002|Overall Study|Adverse Event|11|||
27993616|NCT01445080|81805608|FG003|Overall Study|Adverse Event|6|||
27993617|NCT01445080|81805609|FG004|Overall Study|Adverse Event|2|||
27993618|NCT01445080|81805610|FG005|Overall Study|Adverse Event|3|||
27579427|NCT01513291|80303209|FG000|Run-out Period|Withdrawal by Subject|0|||
27678138|NCT02993406|80656925|FG001|Overall Study|Administrative decision|0|||
27678139|NCT02993406|80656924|FG000|Overall Study|Sponsor decision|4|||
27801060|NCT04380701|81102093|FG009|Overall Study|Adverse Event|0|||
27801061|NCT04380701|81102094|FG010|Overall Study|Adverse Event|0|||
27801062|NCT04380701|81102095|FG011|Overall Study|Adverse Event|0|||
27801063|NCT04380701|81102096|FG012|Overall Study|Adverse Event|0|||
27678140|NCT02993406|80656925|FG001|Overall Study|Sponsor decision|5|||
27579428|NCT01513291|80303210|FG001|Run-out Period|Withdrawal by Subject|0|||
27801064|NCT04380701|81102097|FG013|Overall Study|Adverse Event|0|||
27801065|NCT04380701|81102098|FG014|Overall Study|Adverse Event|0|||
27801066|NCT04380701|81102099|FG015|Overall Study|Adverse Event|1|||
27801067|NCT04380701|81102100|FG016|Overall Study|Adverse Event|0|||
27801068|NCT04380701|81102101|FG017|Overall Study|Adverse Event|0|||
27801069|NCT04380701|81102102|FG018|Overall Study|Adverse Event|0|||
27801070|NCT04380701|81102103|FG019|Overall Study|Adverse Event|1|||
27801071|NCT04380701|81102104|FG020|Overall Study|Adverse Event|0|||
27801072|NCT04380701|81102105|FG021|Overall Study|Adverse Event|0|||
27801073|NCT04380701|81102106|FG022|Overall Study|Adverse Event|0|||
27993619|NCT01445080|81805611|FG006|Overall Study|Adverse Event|0|||
27993620|NCT01445080|81805612|FG007|Overall Study|Adverse Event|3|||
27993621|NCT01445080|81805613|FG008|Overall Study|Adverse Event|10|||
27993622|NCT01445080|81805605|FG000|Overall Study|Physician Decision|0|||
27993623|NCT01445080|81805606|FG001|Overall Study|Physician Decision|0|||
27993624|NCT01445080|81805607|FG002|Overall Study|Physician Decision|1|||
27993625|NCT01445080|81805608|FG003|Overall Study|Physician Decision|0|||
27993626|NCT01445080|81805609|FG004|Overall Study|Physician Decision|0|||
27993627|NCT01445080|81805610|FG005|Overall Study|Physician Decision|3|||
27993628|NCT01445080|81805611|FG006|Overall Study|Physician Decision|2|||
27993629|NCT01445080|81805612|FG007|Overall Study|Physician Decision|2|||
27993630|NCT01445080|81805613|FG008|Overall Study|Physician Decision|0|||
27993631|NCT01445080|81805605|FG000|Overall Study|Withdrawal by Subject|1|||
27993632|NCT01445080|81805606|FG001|Overall Study|Withdrawal by Subject|0|||
27993633|NCT01445080|81805607|FG002|Overall Study|Withdrawal by Subject|0|||
27993634|NCT01445080|81805608|FG003|Overall Study|Withdrawal by Subject|1|||
27993635|NCT01445080|81805609|FG004|Overall Study|Withdrawal by Subject|0|||
27993636|NCT01445080|81805610|FG005|Overall Study|Withdrawal by Subject|0|||
27801074|NCT04380701|81102107|FG023|Overall Study|Adverse Event|0|||
27801075|NCT04380701|81102108|FG024|Overall Study|Adverse Event|0|||
27801076|NCT04380701|81102109|FG025|Overall Study|Adverse Event|0|||
27801077|NCT04380701|81102110|FG026|Overall Study|Adverse Event|0|||
27801078|NCT04380701|81102111|FG027|Overall Study|Adverse Event|0|||
27801079|NCT04380701|81102112|FG028|Overall Study|Adverse Event|0|||
27801080|NCT04380701|81102113|FG029|Overall Study|Adverse Event|0|||
27801081|NCT04380701|81102114|FG030|Overall Study|Adverse Event|0|||
27801082|NCT04380701|81102115|FG031|Overall Study|Adverse Event|0|||
27801083|NCT04380701|81102116|FG032|Overall Study|Adverse Event|0|||
27801084|NCT04380701|81102117|FG033|Overall Study|Adverse Event|0|||
27801085|NCT04380701|81102084|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
27801086|NCT04380701|81102085|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
27801087|NCT04380701|81102086|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
27801088|NCT04380701|81102087|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
27801089|NCT04380701|81102088|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
27801090|NCT04380701|81102089|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
27993637|NCT01445080|81805611|FG006|Overall Study|Withdrawal by Subject|0|||
27993638|NCT01445080|81805612|FG007|Overall Study|Withdrawal by Subject|0|||
27801091|NCT04380701|81102090|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
27801092|NCT04380701|81102091|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
27993639|NCT01445080|81805613|FG008|Overall Study|Withdrawal by Subject|2|||
27801093|NCT04380701|81102092|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
27801094|NCT04380701|81102093|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
27801095|NCT04380701|81102094|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
27801096|NCT04380701|81102095|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
27801097|NCT04380701|81102096|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
27801098|NCT04380701|81102097|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
27801099|NCT04380701|81102098|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
27801100|NCT04380701|81102099|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
27801101|NCT04380701|81102100|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
27801102|NCT04380701|81102101|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
27801103|NCT04380701|81102102|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
27801104|NCT04380701|81102103|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
27801105|NCT04380701|81102104|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
27993640|NCT01445080|81805605|FG000|Overall Study|Ineligible/Inevaluable|1|||
27993641|NCT01445080|81805606|FG001|Overall Study|Ineligible/Inevaluable|2|||
27993642|NCT01445080|81805607|FG002|Overall Study|Ineligible/Inevaluable|0|||
27993643|NCT01445080|81805608|FG003|Overall Study|Ineligible/Inevaluable|1|||
27801106|NCT04380701|81102105|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
27801107|NCT04380701|81102106|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
27801108|NCT04380701|81102107|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
27801109|NCT04380701|81102108|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
27993644|NCT01445080|81805609|FG004|Overall Study|Ineligible/Inevaluable|2|||
27993645|NCT01445080|81805610|FG005|Overall Study|Ineligible/Inevaluable|3|||
27993646|NCT01445080|81805611|FG006|Overall Study|Ineligible/Inevaluable|0|||
27993647|NCT01445080|81805612|FG007|Overall Study|Ineligible/Inevaluable|0|||
27871495|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871496|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871497|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
27871498|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
27993648|NCT01445080|81805613|FG008|Overall Study|Ineligible/Inevaluable|6|||
27993649|NCT02720692|81805614|FG000|Overall Study|Withdrawal by Subject|3|||
27993650|NCT02720692|81805615|FG001|Overall Study|Withdrawal by Subject|0|||
27993651|NCT02720692|81805614|FG000|Overall Study|Physician Decision|1|||
27993652|NCT02720692|81805615|FG001|Overall Study|Physician Decision|0|||
27993653|NCT02720692|81805614|FG000|Overall Study|Lost to Follow-up|8|||
27993654|NCT02720692|81805615|FG001|Overall Study|Lost to Follow-up|3|||
27993655|NCT02720692|81805614|FG000|Overall Study|Subject unable to return for visit|1|||
27993656|NCT02720692|81805615|FG001|Overall Study|Subject unable to return for visit|0|||
27993657|NCT00988091|81805618|FG000|Double-blind Period|Withdrawal by Subject|15|||
27993658|NCT00988091|81805619|FG001|Double-blind Period|Withdrawal by Subject|13|||
27993659|NCT00988091|81805618|FG000|Double-blind Period|Lost to Follow-up|12|||
27993660|NCT00988091|81805619|FG001|Double-blind Period|Lost to Follow-up|14|||
27993661|NCT00988091|81805618|FG000|Double-blind Period|Other|8|||
27993662|NCT00988091|81805619|FG001|Double-blind Period|Other|8|||
27993663|NCT00988091|81805618|FG000|Double-blind Period|Adverse Event|6|||
27993664|NCT00988091|81805619|FG001|Double-blind Period|Adverse Event|9|||
27993665|NCT00988091|81805618|FG000|Double-blind Period|Use of exclusionary medication|2|||
27993666|NCT00988091|81805619|FG001|Double-blind Period|Use of exclusionary medication|3|||
27993667|NCT00988091|81805618|FG000|Open-label Period|Adverse Event|4|||
27993668|NCT00988091|81805619|FG001|Open-label Period|Adverse Event|7|||
27993669|NCT00988091|81805618|FG000|Open-label Period|Use of exclusionary medication|1|||
27993670|NCT00988091|81805619|FG001|Open-label Period|Use of exclusionary medication|1|||
27993671|NCT00988091|81805618|FG000|Open-label Period|Protocol Violation|1|||
27993672|NCT00988091|81805619|FG001|Open-label Period|Protocol Violation|1|||
27993673|NCT00988091|81805618|FG000|Open-label Period|Withdrawal by Subject|10|||
27993674|NCT00988091|81805619|FG001|Open-label Period|Withdrawal by Subject|16|||
27993675|NCT00988091|81805618|FG000|Open-label Period|Lost to Follow-up|3|||
27993676|NCT00988091|81805619|FG001|Open-label Period|Lost to Follow-up|5|||
27993677|NCT00988091|81805618|FG000|Open-label Period|Other|2|||
27993678|NCT00988091|81805619|FG001|Open-label Period|Other|3|||
27993679|NCT01286740|81805620|FG000|Overall Study|Enrolled but not treated|1|||
27993680|NCT01286740|81805620|FG000|Overall Study|Protocol Violation|1|||
27993681|NCT02703324|81805621|FG000|Period Two|Withdrawal by Subject|0|||
27993682|NCT02703324|81805622|FG001|Period Two|Withdrawal by Subject|0|||
27993683|NCT02703324|81805623|FG002|Period Two|Withdrawal by Subject|1|||
27993684|NCT02703324|81805624|FG003|Period Two|Withdrawal by Subject|0|||
27993685|NCT02703324|81805625|FG004|Period Two|Withdrawal by Subject|0|||
27993686|NCT02703324|81805626|FG005|Period Two|Withdrawal by Subject|0|||
27993687|NCT01059318|81805627|FG000|Core Study (26 Week)|Adverse Event|3|||
27993688|NCT01059318|81805627|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
27993689|NCT01059318|81805627|FG000|Extension (36 Week)|Adverse Event|3|||
27993690|NCT00549445|81805628|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
27993691|NCT00549445|81805629|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
27993692|NCT02522325|81805631|FG000|Overall Study|Adverse Event|0|||
27993693|NCT02522325|81805632|FG001|Overall Study|Adverse Event|1|||
27993694|NCT02519595|81805637|FG000|Overall Study|Protocol Violation|8|||
27993695|NCT02519595|81805638|FG001|Overall Study|Protocol Violation|22|||
27993696|NCT02519595|81805639|FG002|Overall Study|Protocol Violation|16|||
27993697|NCT00495625|81805640|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
27993698|NCT01055314|81805641|FG000|Overall Study|Adverse Event|7|||
27993699|NCT01055314|81805642|FG001|Overall Study|Adverse Event|4|||
27993700|NCT01055314|81805641|FG000|Overall Study|Death|2|||
27993701|NCT01055314|81805642|FG001|Overall Study|Death|1|||
27993702|NCT01055314|81805641|FG000|Overall Study|Lack of Efficacy|11|||
27993703|NCT01055314|81805642|FG001|Overall Study|Lack of Efficacy|19|||
27993704|NCT01055314|81805641|FG000|Overall Study|Physician Decision|10|||
27993705|NCT01055314|81805642|FG001|Overall Study|Physician Decision|5|||
27871499|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
27993706|NCT01055314|81805641|FG000|Overall Study|Withdrawal by Subject|1|||
27993707|NCT01055314|81805642|FG001|Overall Study|Withdrawal by Subject|0|||
27993708|NCT01055314|81805641|FG000|Overall Study|Ineligible|3|||
27993709|NCT01055314|81805642|FG001|Overall Study|Ineligible|5|||
27993710|NCT01055314|81805641|FG000|Overall Study|Refusal of further protocol therapy|10|||
27993711|NCT01055314|81805642|FG001|Overall Study|Refusal of further protocol therapy|4|||
27993712|NCT01055314|81805641|FG000|Overall Study|No treatment|1|||
27993713|NCT01055314|81805642|FG001|Overall Study|No treatment|0|||
27678141|NCT01696955|80656926|FG000|Main Study|Protocol Violation|1|||
27993714|NCT00264537|81805647|FG000|Overall Study|Death|0|||
27993715|NCT00264537|81805648|FG001|Overall Study|Death|3|||
27993716|NCT00264537|81805649|FG002|Overall Study|Death|3|||
27993717|NCT00264537|81805650|FG003|Overall Study|Death|2|||
27993718|NCT00264537|81805647|FG000|Overall Study|Lost to Follow-up|3|||
27993719|NCT00264537|81805648|FG001|Overall Study|Lost to Follow-up|4|||
27993720|NCT00264537|81805649|FG002|Overall Study|Lost to Follow-up|7|||
27993721|NCT00264537|81805650|FG003|Overall Study|Lost to Follow-up|6|||
27993722|NCT00264537|81805647|FG000|Overall Study|Adverse Event|21|||
27993723|NCT00264537|81805648|FG001|Overall Study|Adverse Event|32|||
27993724|NCT00264537|81805649|FG002|Overall Study|Adverse Event|24|||
27993725|NCT00264537|81805650|FG003|Overall Study|Adverse Event|34|||
27993726|NCT00264537|81805647|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27993727|NCT00264537|81805648|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
27993728|NCT00264537|81805649|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
27993729|NCT00264537|81805650|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
27993730|NCT00264537|81805647|FG000|Overall Study|Other|21|||
27993731|NCT00264537|81805648|FG001|Overall Study|Other|11|||
27993732|NCT00264537|81805649|FG002|Overall Study|Other|10|||
27993733|NCT00264537|81805650|FG003|Overall Study|Other|11|||
27993734|NCT00264537|81805647|FG000|Overall Study|Not treated|0|||
27993735|NCT00264537|81805648|FG001|Overall Study|Not treated|2|||
27993736|NCT00264537|81805649|FG002|Overall Study|Not treated|1|||
27993737|NCT00264537|81805650|FG003|Overall Study|Not treated|0|||
27871500|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
27871501|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27871502|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27993738|NCT01635855|81805655|FG000|Overall Study|Withdrawal by Subject|4|||
27993739|NCT00767819|81805658|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
27993740|NCT00767819|81805659|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
27993741|NCT00767819|81805660|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27993742|NCT00767819|81805658|FG000|Overall Study|Withdrawal by Subject|1|||
27993743|NCT00767819|81805659|FG001|Overall Study|Withdrawal by Subject|1|||
27871503|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27871504|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27871505|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27993744|NCT00767819|81805660|FG002|Overall Study|Withdrawal by Subject|0|||
27993745|NCT00767819|81805658|FG000|Overall Study|Administrative problems|0|||
27993746|NCT00767819|81805659|FG001|Overall Study|Administrative problems|1|||
27993747|NCT00767819|81805660|FG002|Overall Study|Administrative problems|0|||
27993748|NCT00767819|81805658|FG000|Overall Study|Death|2|||
27993749|NCT00767819|81805659|FG001|Overall Study|Death|3|||
27993750|NCT00767819|81805660|FG002|Overall Study|Death|0|||
27993751|NCT00767819|81805658|FG000|Overall Study|Adverse Event|2|||
27993752|NCT00767819|81805659|FG001|Overall Study|Adverse Event|0|||
27993753|NCT00767819|81805660|FG002|Overall Study|Adverse Event|0|||
27993754|NCT00767819|81805658|FG000|Overall Study|Abnormal lab values|1|||
27993755|NCT00767819|81805659|FG001|Overall Study|Abnormal lab values|0|||
27993756|NCT00767819|81805660|FG002|Overall Study|Abnormal lab values|0|||
27993757|NCT00767819|81805658|FG000|Overall Study|Lost to Follow-up|1|||
27993758|NCT00767819|81805659|FG001|Overall Study|Lost to Follow-up|0|||
27993759|NCT00767819|81805660|FG002|Overall Study|Lost to Follow-up|0|||
27993760|NCT01900652|81805661|FG000|Overall Study|Progressive Disease|1|||
27993761|NCT01900652|81805662|FG001|Overall Study|Progressive Disease|0|||
27993762|NCT01900652|81805661|FG000|Overall Study|Consent withdrawn by subject|1|||
27993763|NCT01900652|81805662|FG001|Overall Study|Consent withdrawn by subject|1|||
27993764|NCT01900652|81805661|FG000|Overall Study|Death|3|||
27993765|NCT01900652|81805662|FG001|Overall Study|Death|0|||
27993766|NCT01900652|81805661|FG000|Overall Study|Adverse Event|2|||
27993767|NCT01900652|81805662|FG001|Overall Study|Adverse Event|1|||
27993768|NCT01900652|81805661|FG000|Overall Study|Physician Decision|1|||
27993769|NCT01900652|81805662|FG001|Overall Study|Physician Decision|1|||
27993770|NCT03671304|81805682|FG000|Overall Study|study terminated|7|||
27678142|NCT01696955|80656927|FG001|Main Study|Protocol Violation|0|||
27678143|NCT01696955|80656926|FG000|Main Study|Withdrawal by Subject|1|||
27801110|NCT04380701|81102109|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
27801111|NCT04380701|81102110|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
27801112|NCT04380701|81102111|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
27801113|NCT04380701|81102112|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
27801114|NCT04380701|81102113|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
27801115|NCT04380701|81102114|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
27801116|NCT04380701|81102115|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
27993771|NCT00379912|81805683|FG000|Overall Study|Lack of Efficacy|1|||
27993772|NCT00379912|81805684|FG001|Overall Study|Lack of Efficacy|0|||
27801117|NCT04380701|81102116|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
27993773|NCT00887926|81805688|FG000|Overall Study|Withdrawal by Subject|0|||
27993774|NCT00887926|81805689|FG001|Overall Study|Withdrawal by Subject|1|||
27993775|NCT00887926|81805690|FG002|Overall Study|Withdrawal by Subject|0|||
27993776|NCT00887926|81805691|FG003|Overall Study|Withdrawal by Subject|0|||
27993777|NCT00145574|81805692|FG000|Double Blind|Adverse Event|0|||
27993778|NCT00145574|81805693|FG001|Double Blind|Adverse Event|3|||
27993779|NCT00145574|81805694|FG002|Double Blind|Adverse Event|1|||
27993780|NCT00145574|81805692|FG000|Double Blind|Withdrawal by Subject|1|||
27993781|NCT00145574|81805693|FG001|Double Blind|Withdrawal by Subject|1|||
27993782|NCT00145574|81805694|FG002|Double Blind|Withdrawal by Subject|1|||
27993783|NCT00145574|81805692|FG000|Double Blind|required restricted medicine|0|||
27993784|NCT00145574|81805693|FG001|Double Blind|required restricted medicine|1|||
27993785|NCT00145574|81805694|FG002|Double Blind|required restricted medicine|0|||
27993786|NCT00145574|81805692|FG000|Open Label Long-term Extension|Adverse Event|0|||
27801118|NCT04380701|81102117|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
27801119|NCT04380701|81102084|FG000|Overall Study|Physician Decision|0|||
27801120|NCT04380701|81102085|FG001|Overall Study|Physician Decision|0|||
27801121|NCT04380701|81102086|FG002|Overall Study|Physician Decision|0|||
27801122|NCT04380701|81102087|FG003|Overall Study|Physician Decision|0|||
27801123|NCT04380701|81102088|FG004|Overall Study|Physician Decision|0|||
27801124|NCT04380701|81102089|FG005|Overall Study|Physician Decision|0|||
27801125|NCT04380701|81102090|FG006|Overall Study|Physician Decision|0|||
27801126|NCT04380701|81102091|FG007|Overall Study|Physician Decision|0|||
27801127|NCT04380701|81102092|FG008|Overall Study|Physician Decision|0|||
27871506|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
27871507|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
27871508|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
27871509|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
27871510|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
27871511|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
27871512|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
27871513|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27871514|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27871515|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
27871516|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871517|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27801128|NCT04380701|81102093|FG009|Overall Study|Physician Decision|0|||
27993787|NCT00145574|81805693|FG001|Open Label Long-term Extension|Adverse Event|0|||
27993788|NCT00145574|81805694|FG002|Open Label Long-term Extension|Adverse Event|5|||
27993789|NCT00145574|81805692|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
27993790|NCT00145574|81805693|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
27993791|NCT00145574|81805694|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
27993792|NCT00145574|81805692|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
27993793|NCT00145574|81805693|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
27993794|NCT00145574|81805694|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
27993795|NCT00145574|81805692|FG000|Open Label Long-term Extension|required restricted medicine|0|||
27993796|NCT00145574|81805693|FG001|Open Label Long-term Extension|required restricted medicine|0|||
27801129|NCT04380701|81102094|FG010|Overall Study|Physician Decision|0|||
27801130|NCT04380701|81102095|FG011|Overall Study|Physician Decision|0|||
27801131|NCT04380701|81102096|FG012|Overall Study|Physician Decision|0|||
27801132|NCT04380701|81102097|FG013|Overall Study|Physician Decision|0|||
27801133|NCT04380701|81102098|FG014|Overall Study|Physician Decision|0|||
27801134|NCT04380701|81102099|FG015|Overall Study|Physician Decision|0|||
27801135|NCT04380701|81102100|FG016|Overall Study|Physician Decision|0|||
27801136|NCT04380701|81102101|FG017|Overall Study|Physician Decision|0|||
27801137|NCT04380701|81102102|FG018|Overall Study|Physician Decision|0|||
27801138|NCT04380701|81102103|FG019|Overall Study|Physician Decision|0|||
27801139|NCT04380701|81102104|FG020|Overall Study|Physician Decision|0|||
27801140|NCT04380701|81102105|FG021|Overall Study|Physician Decision|0|||
27801141|NCT04380701|81102106|FG022|Overall Study|Physician Decision|0|||
27871518|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871519|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871520|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871521|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
27871522|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
27871523|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871524|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27993797|NCT00145574|81805694|FG002|Open Label Long-term Extension|required restricted medicine|1|||
27993798|NCT03992846|81805695|FG000|Overall Study|Adverse Event|8|||
27993799|NCT03992846|81805696|FG001|Overall Study|Adverse Event|6|||
27993800|NCT03992846|81805697|FG002|Overall Study|Adverse Event|3|||
27801142|NCT04380701|81102107|FG023|Overall Study|Physician Decision|0|||
27801143|NCT04380701|81102108|FG024|Overall Study|Physician Decision|2|||
27801144|NCT04380701|81102109|FG025|Overall Study|Physician Decision|0|||
27801145|NCT04380701|81102110|FG026|Overall Study|Physician Decision|0|||
27801146|NCT04380701|81102111|FG027|Overall Study|Physician Decision|0|||
27801147|NCT04380701|81102112|FG028|Overall Study|Physician Decision|0|||
27801148|NCT04380701|81102113|FG029|Overall Study|Physician Decision|0|||
27871525|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871526|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
27871527|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
27871528|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
27871529|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
27871530|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
27871531|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871532|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871533|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871534|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871535|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27993801|NCT03992846|81805695|FG000|Overall Study|Lost to Follow-up|0|||
27993802|NCT03992846|81805696|FG001|Overall Study|Lost to Follow-up|1|||
27993803|NCT03992846|81805697|FG002|Overall Study|Lost to Follow-up|1|||
27993804|NCT03992846|81805695|FG000|Overall Study|Pregnancy|2|||
27871536|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
27871537|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871538|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871539|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871540|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871541|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
27871542|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27993805|NCT03992846|81805696|FG001|Overall Study|Pregnancy|0|||
27993806|NCT03992846|81805697|FG002|Overall Study|Pregnancy|1|||
27993807|NCT03992846|81805695|FG000|Overall Study|Protocol Violation|1|||
27993808|NCT03992846|81805696|FG001|Overall Study|Protocol Violation|2|||
27993809|NCT03992846|81805697|FG002|Overall Study|Protocol Violation|0|||
27993810|NCT03992846|81805695|FG000|Overall Study|Withdrawal by Subject|8|||
27993811|NCT03992846|81805696|FG001|Overall Study|Withdrawal by Subject|10|||
27871543|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871544|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
27871545|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
27871546|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871547|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871548|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871549|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871550|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871551|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27993812|NCT03992846|81805697|FG002|Overall Study|Withdrawal by Subject|20|||
27993813|NCT03992846|81805695|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
27993814|NCT03992846|81805696|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
27993815|NCT03992846|81805697|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
27993816|NCT01529034|81805698|FG000|Overall Study|Discontinued prior to study treatment|14|||
27993817|NCT01529034|81805698|FG000|Overall Study|Site closure|62|||
27993818|NCT01529034|81805698|FG000|Overall Study|Study termination|29|||
27993819|NCT01529034|81805698|FG000|Overall Study|Withdrawal by Subject|25|||
27993820|NCT01529034|81805698|FG000|Overall Study|No treated SCs within protocol window|13|||
27993821|NCT01529034|81805698|FG000|Overall Study|Noncompliance|8|||
27993822|NCT01529034|81805698|FG000|Overall Study|Caregiver no longer available|7|||
27993823|NCT01529034|81805698|FG000|Overall Study|Adverse Event|4|||
27993824|NCT01529034|81805698|FG000|Overall Study|Protocol Violation|4|||
27993825|NCT01529034|81805698|FG000|Overall Study|Lack of Efficacy|4|||
27993826|NCT01529034|81805698|FG000|Overall Study|Investigator no longer available|2|||
27993827|NCT01529034|81805698|FG000|Overall Study|Study drug not available|2|||
27993828|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
27993829|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
27993830|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
27993831|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
27993832|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
27993833|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
27993834|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Death|7|||
27871552|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27993835|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Death|5|||
27993836|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Death|6|||
27993837|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
27993838|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
27993839|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
27801149|NCT04380701|81102114|FG030|Overall Study|Physician Decision|0|||
27993840|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
27993841|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
27993842|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
27993843|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Other|1|||
27993844|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Other|0|||
27993845|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Other|0|||
27993846|NCT00104650|81805704|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
27993847|NCT00104650|81805705|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
27993848|NCT00104650|81805706|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
27993849|NCT00104650|81805704|FG000|Follow-up Period|Physician Decision|1|||
27993850|NCT00104650|81805705|FG001|Follow-up Period|Physician Decision|1|||
27678144|NCT01696955|80656927|FG001|Main Study|Withdrawal by Subject|1|||
27678145|NCT03149042|80656928|FG000|Overall Study|Invasive FFR not performed|21|||
27678146|NCT03149042|80656928|FG000|Overall Study|Poor CT Image Quality|1|||
27678147|NCT03149042|80656928|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
27678148|NCT01711853|80656929|FG000|Overall Study|Not treated|3|||
27678149|NCT01825577|80656930|FG000|Overall Study|Physician Decision|2|||
27678150|NCT01825577|80656930|FG000|Overall Study|Withdrawal by Subject|1|||
27678151|NCT01825577|80656930|FG000|Overall Study|Withdrawn by family members|2|||
27678152|NCT01825577|80656930|FG000|Overall Study|Lack of Efficacy|3|||
27678153|NCT01241604|80656936|FG000|Screening Period|Screen Failure|3|||
27678154|NCT01241604|80656937|FG001|Screening Period|Screen Failure|0|||
27678155|NCT01241604|80656938|FG002|Screening Period|Screen Failure|0|||
27678156|NCT00368875|80656939|FG000|Overall Study|Adverse Event|0|||
27801150|NCT04380701|81102115|FG031|Overall Study|Physician Decision|0|||
27801151|NCT04380701|81102116|FG032|Overall Study|Physician Decision|0|||
27801152|NCT04380701|81102117|FG033|Overall Study|Physician Decision|0|||
27801153|NCT04380701|81102084|FG000|Overall Study|Death|0|||
27801154|NCT04380701|81102085|FG001|Overall Study|Death|0|||
27801155|NCT04380701|81102086|FG002|Overall Study|Death|0|||
27801156|NCT04380701|81102087|FG003|Overall Study|Death|0|||
27801157|NCT04380701|81102088|FG004|Overall Study|Death|0|||
27801158|NCT04380701|81102089|FG005|Overall Study|Death|0|||
27801159|NCT04380701|81102090|FG006|Overall Study|Death|0|||
27801160|NCT04380701|81102091|FG007|Overall Study|Death|0|||
27801161|NCT04380701|81102092|FG008|Overall Study|Death|0|||
27801162|NCT04380701|81102093|FG009|Overall Study|Death|0|||
27801163|NCT04380701|81102094|FG010|Overall Study|Death|0|||
27801164|NCT04380701|81102095|FG011|Overall Study|Death|0|||
27801165|NCT04380701|81102096|FG012|Overall Study|Death|0|||
27801166|NCT04380701|81102097|FG013|Overall Study|Death|0|||
27801167|NCT04380701|81102098|FG014|Overall Study|Death|0|||
27801168|NCT04380701|81102099|FG015|Overall Study|Death|0|||
27801169|NCT04380701|81102100|FG016|Overall Study|Death|0|||
27801170|NCT04380701|81102101|FG017|Overall Study|Death|0|||
27801171|NCT04380701|81102102|FG018|Overall Study|Death|0|||
27801172|NCT04380701|81102103|FG019|Overall Study|Death|0|||
27801173|NCT04380701|81102104|FG020|Overall Study|Death|0|||
27801174|NCT04380701|81102105|FG021|Overall Study|Death|0|||
27801175|NCT04380701|81102106|FG022|Overall Study|Death|0|||
27801176|NCT04380701|81102107|FG023|Overall Study|Death|0|||
27801177|NCT04380701|81102108|FG024|Overall Study|Death|1|||
27801178|NCT04380701|81102109|FG025|Overall Study|Death|0|||
27801179|NCT04380701|81102110|FG026|Overall Study|Death|0|||
27801180|NCT04380701|81102111|FG027|Overall Study|Death|0|||
27801181|NCT04380701|81102112|FG028|Overall Study|Death|0|||
27801182|NCT04380701|81102113|FG029|Overall Study|Death|0|||
27801183|NCT04380701|81102114|FG030|Overall Study|Death|0|||
27801184|NCT04380701|81102115|FG031|Overall Study|Death|0|||
27801185|NCT04380701|81102116|FG032|Overall Study|Death|0|||
27801186|NCT04380701|81102117|FG033|Overall Study|Death|0|||
27801187|NCT04380701|81102084|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27993851|NCT00104650|81805706|FG002|Follow-up Period|Physician Decision|0|||
27678157|NCT00368875|80656940|FG001|Overall Study|Adverse Event|12|||
27678158|NCT00368875|80656939|FG000|Overall Study|Progressive disease|3|||
27678159|NCT00368875|80656940|FG001|Overall Study|Progressive disease|27|||
27871553|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
27678160|NCT00368875|80656939|FG000|Overall Study|Withdrawal by Subject|2|||
27801188|NCT04380701|81102085|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801189|NCT04380701|81102086|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801190|NCT04380701|81102087|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801191|NCT04380701|81102088|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801192|NCT04380701|81102089|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801193|NCT04380701|81102090|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801194|NCT04380701|81102091|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801195|NCT04380701|81102092|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801196|NCT04380701|81102093|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27993852|NCT00104650|81805704|FG000|Follow-up Period|Adverse Event|1|||
27993853|NCT00104650|81805705|FG001|Follow-up Period|Adverse Event|0|||
27993854|NCT00104650|81805706|FG002|Follow-up Period|Adverse Event|1|||
27993855|NCT00104650|81805704|FG000|Follow-up Period|Withdrawal by Subject|0|||
27993856|NCT00104650|81805705|FG001|Follow-up Period|Withdrawal by Subject|3|||
27993857|NCT00104650|81805706|FG002|Follow-up Period|Withdrawal by Subject|3|||
27993858|NCT00104650|81805704|FG000|Follow-up Period|Death|6|||
27579429|NCT01513291|80303211|FG002|Run-out Period|Withdrawal by Subject|0|||
27579430|NCT01513291|80303212|FG003|Run-out Period|Withdrawal by Subject|1|||
27871554|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
27871555|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871556|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
27801197|NCT04380701|81102094|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801198|NCT04380701|81102095|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801199|NCT04380701|81102096|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801200|NCT04380701|81102097|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801201|NCT04380701|81102098|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801202|NCT04380701|81102099|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801203|NCT04380701|81102100|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801204|NCT04380701|81102101|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801205|NCT04380701|81102102|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801206|NCT04380701|81102103|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801207|NCT04380701|81102104|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801208|NCT04380701|81102105|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
27801209|NCT04380701|81102106|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
27801210|NCT04380701|81102107|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
27801211|NCT04380701|81102108|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
27801212|NCT04380701|81102109|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801213|NCT04380701|81102110|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801214|NCT04380701|81102111|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801215|NCT04380701|81102112|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801216|NCT04380701|81102113|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801217|NCT04380701|81102114|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801218|NCT04380701|81102115|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801219|NCT04380701|81102116|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801220|NCT04380701|81102117|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
27801221|NCT04088734|81102122|FG000|Overall Study|Other, Not Specified|5|||
27801222|NCT04529096|81102125|FG000|Overall Study|Adverse Event|6|||
27801223|NCT04529096|81102126|FG001|Overall Study|Adverse Event|1|||
27801224|NCT04529096|81102125|FG000|Overall Study|Lack of Efficacy|1|||
27801225|NCT04529096|81102126|FG001|Overall Study|Lack of Efficacy|0|||
27801226|NCT04529096|81102125|FG000|Overall Study|Lost to Follow-up|1|||
27801227|NCT04529096|81102126|FG001|Overall Study|Lost to Follow-up|1|||
27801228|NCT04529096|81102125|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27801229|NCT04529096|81102126|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27801230|NCT04529096|81102125|FG000|Overall Study|Physician Decision|1|||
27801231|NCT04529096|81102126|FG001|Overall Study|Physician Decision|3|||
27801232|NCT04529096|81102125|FG000|Overall Study|Withdrawal by Subject|5|||
27801233|NCT04529096|81102126|FG001|Overall Study|Withdrawal by Subject|0|||
27801234|NCT02913261|81102127|FG000|Overall Study|Technical problems|0|||
27801235|NCT02913261|81102128|FG001|Overall Study|Technical problems|1|||
27801236|NCT02913261|81102127|FG000|Overall Study|Lack of Efficacy|32|||
27801237|NCT02913261|81102128|FG001|Overall Study|Lack of Efficacy|69|||
27801238|NCT02913261|81102127|FG000|Overall Study|Adverse Event|27|||
27801239|NCT02913261|81102128|FG001|Overall Study|Adverse Event|5|||
27801240|NCT02913261|81102127|FG000|Overall Study|Death|25|||
27801241|NCT02913261|81102128|FG001|Overall Study|Death|22|||
27801242|NCT02913261|81102127|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
27801243|NCT02913261|81102128|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
27801244|NCT02913261|81102127|FG000|Overall Study|Disease relapse|8|||
27801245|NCT02913261|81102128|FG001|Overall Study|Disease relapse|13|||
27993859|NCT00104650|81805705|FG001|Follow-up Period|Death|6|||
27993860|NCT00104650|81805706|FG002|Follow-up Period|Death|4|||
27993861|NCT00104650|81805704|FG000|Follow-up Period|Disease progression|3|||
27579431|NCT01513291|80303213|FG004|Run-out Period|Withdrawal by Subject|0|||
27579432|NCT04027686|80303214|FG000|Overall Study|Lost to Follow-up|2|||
27993862|NCT00104650|81805705|FG001|Follow-up Period|Disease progression|1|||
27993863|NCT00104650|81805706|FG002|Follow-up Period|Disease progression|0|||
27801246|NCT02913261|81102127|FG000|Overall Study|Physician Decision|8|||
27801247|NCT02913261|81102128|FG001|Overall Study|Physician Decision|9|||
27801248|NCT02913261|81102127|FG000|Overall Study|Subject/guardian decision|4|||
27871557|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
27871558|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
27871559|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871560|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
27871561|NCT03334435|81361677|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871562|NCT03334435|81361678|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871563|NCT03334435|81361679|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871564|NCT03334435|81361680|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871565|NCT03334435|81361681|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871566|NCT03334435|81361682|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871567|NCT03334435|81361683|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871568|NCT03334435|81361684|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871569|NCT03334435|81361685|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871570|NCT03334435|81361686|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871571|NCT03334435|81361687|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871572|NCT03334435|81361688|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
27871573|NCT03334435|81361689|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
27871574|NCT03334435|81361690|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
27871575|NCT03334435|81361691|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
27871576|NCT01276041|81361693|FG000|Overall Study|Adverse Event|2|||
27871577|NCT01276041|81361693|FG000|Overall Study|Protocol Violation|1|||
27871578|NCT02864992|81361694|FG000|Overall Study|still on treatment|15|||
27871579|NCT02864992|81361695|FG001|Overall Study|still on treatment|1|||
27871580|NCT02864992|81361696|FG002|Overall Study|still on treatment|33|||
27871581|NCT02324582|81361699|FG000|Overall Study|Screen Failures|0|||
27871582|NCT02324582|81361700|FG001|Overall Study|Screen Failures|5|||
27871583|NCT02585778|81361701|FG000|Overall Study|Adverse Event|17|||
27871584|NCT02585778|81361702|FG001|Overall Study|Adverse Event|4|||
27871585|NCT02585778|81361701|FG000|Overall Study|Participant did not wish to continue|9|||
27871586|NCT02585778|81361702|FG001|Overall Study|Participant did not wish to continue|4|||
27871587|NCT02585778|81361701|FG000|Overall Study|Poor compliance to study protocol|0|||
27871588|NCT02585778|81361702|FG001|Overall Study|Poor compliance to study protocol|2|||
27871589|NCT02585778|81361701|FG000|Overall Study|Death|0|||
27871590|NCT02585778|81361702|FG001|Overall Study|Death|1|||
27871591|NCT02585778|81361701|FG000|Overall Study|Randomized but not treated|1|||
27871592|NCT02585778|81361702|FG001|Overall Study|Randomized but not treated|2|||
27871593|NCT02585778|81361701|FG000|Overall Study|Other than specified above|6|||
27871594|NCT02585778|81361702|FG001|Overall Study|Other than specified above|2|||
27871595|NCT00729937|81361703|FG000|Overall Study|Lost to Follow-up|49|||
27871596|NCT00729937|81361704|FG001|Overall Study|Lost to Follow-up|58|||
27871597|NCT00729937|81361705|FG002|Overall Study|Lost to Follow-up|18|||
27871598|NCT00729937|81361706|FG003|Overall Study|Lost to Follow-up|33|||
27871599|NCT00729937|81361707|FG004|Overall Study|Lost to Follow-up|18|||
27871600|NCT00729937|81361708|FG005|Overall Study|Lost to Follow-up|23|||
27871601|NCT00729937|81361703|FG000|Overall Study|Physician Decision|7|||
27871602|NCT00729937|81361704|FG001|Overall Study|Physician Decision|16|||
27871603|NCT00729937|81361705|FG002|Overall Study|Physician Decision|2|||
27871604|NCT00729937|81361706|FG003|Overall Study|Physician Decision|0|||
27871605|NCT00729937|81361707|FG004|Overall Study|Physician Decision|5|||
27871606|NCT00729937|81361708|FG005|Overall Study|Physician Decision|8|||
27871607|NCT00729937|81361703|FG000|Overall Study|Death|1|||
27871608|NCT00729937|81361704|FG001|Overall Study|Death|0|||
27871609|NCT00729937|81361705|FG002|Overall Study|Death|1|||
27871610|NCT00729937|81361706|FG003|Overall Study|Death|0|||
27871611|NCT00729937|81361707|FG004|Overall Study|Death|0|||
27871612|NCT00729937|81361708|FG005|Overall Study|Death|1|||
27871613|NCT00729937|81361703|FG000|Overall Study|Withdrawal by Subject|3|||
27801249|NCT02913261|81102128|FG001|Overall Study|Subject/guardian decision|6|||
27801250|NCT02913261|81102127|FG000|Overall Study|Graft loss|2|||
27801251|NCT02913261|81102128|FG001|Overall Study|Graft loss|0|||
27801252|NCT03078192|81102129|FG000|Overall Study|Withdrawal by Subject|2|||
27801253|NCT03078192|81102130|FG001|Overall Study|Withdrawal by Subject|1|||
27801254|NCT03078192|81102129|FG000|Overall Study|screen failure|0|||
27801255|NCT03078192|81102130|FG001|Overall Study|screen failure|3|||
27871614|NCT00729937|81361704|FG001|Overall Study|Withdrawal by Subject|5|||
27871615|NCT00729937|81361705|FG002|Overall Study|Withdrawal by Subject|6|||
27871616|NCT00729937|81361706|FG003|Overall Study|Withdrawal by Subject|0|||
27871617|NCT00729937|81361707|FG004|Overall Study|Withdrawal by Subject|4|||
27871618|NCT00729937|81361708|FG005|Overall Study|Withdrawal by Subject|2|||
27871619|NCT00729937|81361703|FG000|Overall Study|Randomized but not treated|12|||
27871620|NCT00729937|81361704|FG001|Overall Study|Randomized but not treated|6|||
27871621|NCT00729937|81361705|FG002|Overall Study|Randomized but not treated|1|||
27871622|NCT00729937|81361706|FG003|Overall Study|Randomized but not treated|0|||
27871623|NCT00729937|81361707|FG004|Overall Study|Randomized but not treated|1|||
27871624|NCT00729937|81361708|FG005|Overall Study|Randomized but not treated|3|||
27801256|NCT00758706|81102133|FG000|Overall Study|Adverse Event|4|||
27993864|NCT00104650|81805704|FG000|Follow-up Period|Lost to Follow-up|0|||
27993865|NCT00104650|81805705|FG001|Follow-up Period|Lost to Follow-up|1|||
27993866|NCT00104650|81805706|FG002|Follow-up Period|Lost to Follow-up|2|||
27993867|NCT00104650|81805704|FG000|Follow-up Period|Other|0|||
27993868|NCT00104650|81805705|FG001|Follow-up Period|Other|1|||
27993869|NCT00104650|81805706|FG002|Follow-up Period|Other|0|||
27993870|NCT00003199|81805707|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
27993871|NCT00003199|81805707|FG000|Overall Study|Lack of insurance clearance|2|||
27993872|NCT00003199|81805707|FG000|Overall Study|Screen fail|15|||
27993873|NCT02069392|81805708|FG000|Overall Study|Withdrawal by Subject|4|||
27993874|NCT02069392|81805709|FG001|Overall Study|Withdrawal by Subject|2|||
27993875|NCT02728089|81805710|FG000|Overall Study|Physician Decision|2|||
27993876|NCT02728089|81805710|FG000|Overall Study|Withdrawal by Subject|1|||
27993877|NCT00765063|81808153|FG000|Overall Study|Lack of Efficacy|5|||
27993878|NCT00765063|81808153|FG000|Overall Study|Withdrawal by Subject|1|||
27993879|NCT00765063|81808153|FG000|Overall Study|Other|16|||
27993880|NCT00765063|81808153|FG000|Overall Study|Protocol Violation|6|||
27801257|NCT00758706|81102134|FG001|Overall Study|Adverse Event|4|||
27801258|NCT03959137|81102135|FG000|Overall Study|Protocol Violation|6|||
27801259|NCT01325701|81102136|FG000|Overall Study|Adverse Event|12|||
27801260|NCT01325701|81102137|FG001|Overall Study|Adverse Event|0|||
27801261|NCT01325701|81102136|FG000|Overall Study|Protocol Violation|1|||
27801262|NCT01325701|81102137|FG001|Overall Study|Protocol Violation|0|||
27801263|NCT01325701|81102136|FG000|Overall Study|Physician Decision|2|||
27801264|NCT01325701|81102137|FG001|Overall Study|Physician Decision|2|||
27801265|NCT01325701|81102136|FG000|Overall Study|Withdrawal by Subject|2|||
27801266|NCT01325701|81102137|FG001|Overall Study|Withdrawal by Subject|1|||
27801267|NCT01325701|81102136|FG000|Overall Study|Rollerover Extension Study|4|||
27801268|NCT01325701|81102137|FG001|Overall Study|Rollerover Extension Study|0|||
27801269|NCT00943384|81102140|FG000|Overall Study|Dispositioned prior to treatment|23|||
27801270|NCT00943384|81102140|FG000|Overall Study|Treated off protocol-protocol violation|5|||
27801271|NCT00943384|81102140|FG000|Overall Study|Lost to Follow-up|16|||
27801272|NCT00943384|81102140|FG000|Overall Study|Withdrawal by Subject|5|||
27801273|NCT01345058|81102143|FG000|Overall Study|Withdrawal by Subject|1|||
27801274|NCT01345058|81102144|FG001|Overall Study|Withdrawal by Subject|0|||
27801275|NCT01345058|81102143|FG000|Overall Study|Participant Reported Increase in Events|1|||
27801276|NCT01345058|81102144|FG001|Overall Study|Participant Reported Increase in Events|0|||
27801277|NCT01345058|81102143|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
27801278|NCT01345058|81102144|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
27801279|NCT01345058|81102143|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
27801280|NCT01345058|81102144|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
27801281|NCT01345058|81102143|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
27801282|NCT01345058|81102144|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
27801283|NCT03944707|81102150|FG000|Overall Study|Adverse Event|0|||
27801284|NCT03944707|81102151|FG001|Overall Study|Adverse Event|2|||
27801285|NCT03944707|81102150|FG000|Overall Study|Study terminated by sponsor|12|||
27801286|NCT03944707|81102151|FG001|Overall Study|Study terminated by sponsor|7|||
27801287|NCT03944707|81102150|FG000|Overall Study|Subject decision|0|||
27801288|NCT03944707|81102151|FG001|Overall Study|Subject decision|1|||
27801289|NCT02574260|81102152|FG000|Overall Study|Disease Progression|1|||
27801290|NCT01458132|81102153|FG000|Overall Study|Other|15|||
27801291|NCT01458132|81102154|FG001|Overall Study|Other|3|||
27801292|NCT02525562|81102155|FG000|Overall Study|Death|9|||
27801293|NCT02525562|81102156|FG001|Overall Study|Death|0|||
27801294|NCT02525562|81102157|FG002|Overall Study|Death|0|||
27801295|NCT02525562|81102155|FG000|Overall Study|Lost to Follow-up|19|||
27801296|NCT02525562|81102156|FG001|Overall Study|Lost to Follow-up|0|||
27801297|NCT02525562|81102157|FG002|Overall Study|Lost to Follow-up|0|||
27801298|NCT02525562|81102155|FG000|Overall Study|Withdrawal by Subject|37|||
27801299|NCT02525562|81102156|FG001|Overall Study|Withdrawal by Subject|0|||
27801300|NCT02525562|81102157|FG002|Overall Study|Withdrawal by Subject|0|||
27801301|NCT02525562|81102155|FG000|Overall Study|Revision/Removal of Study Device|4|||
27801302|NCT02525562|81102156|FG001|Overall Study|Revision/Removal of Study Device|0|||
27801303|NCT02525562|81102157|FG002|Overall Study|Revision/Removal of Study Device|0|||
27801304|NCT02525562|81102155|FG000|Overall Study|Study Closed by Sponsor|154|||
27801305|NCT02525562|81102156|FG001|Overall Study|Study Closed by Sponsor|0|||
27801306|NCT02525562|81102157|FG002|Overall Study|Study Closed by Sponsor|0|||
27801307|NCT02962739|81102160|FG000|Overall Study|Withdrawal by Subject|0|||
27801308|NCT02962739|81102161|FG001|Overall Study|Withdrawal by Subject|1|||
27801309|NCT02962739|81102162|FG002|Overall Study|Withdrawal by Subject|0|||
27801310|NCT02962739|81102163|FG003|Overall Study|Withdrawal by Subject|0|||
27801311|NCT02962739|81102164|FG004|Overall Study|Withdrawal by Subject|0|||
27801312|NCT02962739|81102165|FG005|Overall Study|Withdrawal by Subject|0|||
27801313|NCT02962739|81102160|FG000|Overall Study|Protocol Violation|0|||
27993881|NCT00765063|81808153|FG000|Overall Study|Adverse Event|4|||
27993882|NCT02451124|81808155|FG000|Overall Study|Withdrawal by Subject|1|||
27993883|NCT02429830|81808157|FG000|Overall Study|Lost to Follow-up|1|||
27993884|NCT02429830|81808157|FG000|Overall Study|Device Explant|2|||
27993885|NCT01339897|81808162|FG000|Overall Study|Adverse Event|1|||
27993886|NCT01339897|81808163|FG001|Overall Study|Adverse Event|0|||
27993887|NCT01339897|81808164|FG002|Overall Study|Adverse Event|0|||
27993888|NCT01339897|81808165|FG003|Overall Study|Adverse Event|1|||
27993889|NCT01433172|81808166|FG000|Overall Study|Withdrawal by Subject|0|||
27993890|NCT01433172|81808167|FG001|Overall Study|Withdrawal by Subject|1|||
27993891|NCT01433172|81808168|FG002|Overall Study|Withdrawal by Subject|0|||
27993892|NCT01433172|81808166|FG000|Overall Study|Disease Progression|0|||
27993893|NCT01433172|81808167|FG001|Overall Study|Disease Progression|0|||
27993894|NCT01433172|81808168|FG002|Overall Study|Disease Progression|1|||
27993895|NCT01433172|81808166|FG000|Overall Study|Death|0|||
27993896|NCT01433172|81808167|FG001|Overall Study|Death|2|||
27993897|NCT01433172|81808168|FG002|Overall Study|Death|0|||
27993898|NCT00709618|81808169|FG000|Overall Study|Withdrawal by Subject|4|||
27993899|NCT00709618|81808169|FG000|Overall Study|Lost to Follow-up|1|||
27993900|NCT00709618|81808169|FG000|Overall Study|Study Closed/Terminated|25|||
27993901|NCT00741013|81808170|FG000|Overall Study|Adverse Event|1|||
27993902|NCT00741013|81808171|FG001|Overall Study|Adverse Event|0|||
27993903|NCT00741013|81808172|FG002|Overall Study|Adverse Event|0|||
27993904|NCT00741013|81808170|FG000|Overall Study|Withdrawal by Subject|0|||
27993905|NCT00741013|81808171|FG001|Overall Study|Withdrawal by Subject|0|||
27993906|NCT00741013|81808172|FG002|Overall Study|Withdrawal by Subject|1|||
27993907|NCT00741013|81808170|FG000|Overall Study|Discovered failed screen after enrolled|0|||
27993908|NCT00741013|81808171|FG001|Overall Study|Discovered failed screen after enrolled|2|||
27993909|NCT00741013|81808172|FG002|Overall Study|Discovered failed screen after enrolled|0|||
27993910|NCT02709330|81808183|FG000|Overall Study|Death|5|||
27993911|NCT02709330|81808184|FG001|Overall Study|Death|0|||
27993912|NCT02709330|81808183|FG000|Overall Study|Lost to Follow-up|2|||
27993913|NCT02709330|81808184|FG001|Overall Study|Lost to Follow-up|0|||
27993914|NCT02709330|81808183|FG000|Overall Study|Physician Decision|2|||
27993915|NCT02709330|81808184|FG001|Overall Study|Physician Decision|0|||
27993916|NCT02709330|81808183|FG000|Overall Study|Withdrawal by Subject|4|||
27993917|NCT02709330|81808184|FG001|Overall Study|Withdrawal by Subject|0|||
27993918|NCT00302211|81808189|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
27993919|NCT00302211|81808190|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
27993920|NCT00302211|81808191|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
27993921|NCT00302211|81808192|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
27993922|NCT00302211|81808193|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
27993923|NCT00302211|81808189|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
27993924|NCT00302211|81808190|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
27993925|NCT00302211|81808191|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
27993926|NCT00302211|81808192|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
27993927|NCT00302211|81808193|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
27993928|NCT00302211|81808189|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
27993929|NCT00302211|81808190|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
27993930|NCT00302211|81808191|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
27993931|NCT00302211|81808192|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
27993932|NCT00302211|81808193|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
27993933|NCT00302211|81808189|FG000|Double Blind Period (New Patients)|Disease progression|0|||
27993934|NCT00302211|81808190|FG001|Double Blind Period (New Patients)|Disease progression|1|||
27993935|NCT00302211|81808191|FG002|Double Blind Period (New Patients)|Disease progression|1|||
27993936|NCT00302211|81808192|FG003|Double Blind Period (New Patients)|Disease progression|0|||
27993937|NCT00302211|81808193|FG004|Double Blind Period (New Patients)|Disease progression|0|||
27993938|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
27993939|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
27993940|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
27993941|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
27993942|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
27993943|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
27993944|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
27993945|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
27993946|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
27993947|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
27993948|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
27993949|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
27579433|NCT04027686|80303215|FG001|Overall Study|Lost to Follow-up|0|||
27801314|NCT02962739|81102161|FG001|Overall Study|Protocol Violation|0|||
27993950|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
27993951|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
27993952|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
27993953|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
27993954|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
27993955|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
27993956|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
27993957|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
27993958|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Death|0|||
27993959|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Death|0|||
27993960|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Death|0|||
27993961|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Death|1|||
27993962|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Death|1|||
27993963|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
27993964|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
27993965|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
27993966|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
27993967|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
27993968|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
27993969|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
27993970|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
27993971|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
27993972|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
27993973|NCT00302211|81808189|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
27993974|NCT00302211|81808190|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
27993975|NCT00302211|81808191|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
27993976|NCT00302211|81808192|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
27993977|NCT00302211|81808193|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
27993978|NCT01510158|81808195|FG000|Overall Study|Adverse Event|7|||
27993979|NCT01510158|81808196|FG001|Overall Study|Adverse Event|8|||
27871625|NCT00729937|81361703|FG000|Overall Study|Did not meet eligibility criteria|2|||
27993980|NCT01510158|81808197|FG002|Overall Study|Adverse Event|5|||
27993981|NCT01510158|81808195|FG000|Overall Study|Gout flare|1|||
27993982|NCT01510158|81808196|FG001|Overall Study|Gout flare|0|||
27993983|NCT01510158|81808197|FG002|Overall Study|Gout flare|0|||
27993984|NCT01510158|81808195|FG000|Overall Study|Protocol Violation|17|||
27993985|NCT01510158|81808196|FG001|Overall Study|Protocol Violation|16|||
27993986|NCT01510158|81808197|FG002|Overall Study|Protocol Violation|24|||
27801315|NCT02962739|81102162|FG002|Overall Study|Protocol Violation|1|||
27801316|NCT02962739|81102163|FG003|Overall Study|Protocol Violation|0|||
27801317|NCT02962739|81102164|FG004|Overall Study|Protocol Violation|1|||
27801318|NCT02962739|81102165|FG005|Overall Study|Protocol Violation|0|||
27801319|NCT00295620|81105029|FG000|Overall Study|Lost to Follow-up|9|||
27801320|NCT00295620|81105030|FG001|Overall Study|Lost to Follow-up|5|||
27801321|NCT00295620|81105029|FG000|Overall Study|Withdrawal by Subject|37|||
27801322|NCT00295620|81105030|FG001|Overall Study|Withdrawal by Subject|50|||
27801323|NCT00295620|81105029|FG000|Overall Study|Death|206|||
27801324|NCT00295620|81105030|FG001|Overall Study|Death|207|||
27801325|NCT00295620|81105029|FG000|Overall Study|Other reasons|10|||
27801326|NCT00295620|81105030|FG001|Overall Study|Other reasons|9|||
27801327|NCT00295620|81105029|FG000|Overall Study|Discontinuation by sponsor|580|||
27801328|NCT00295620|81105030|FG001|Overall Study|Discontinuation by sponsor|593|||
27801329|NCT00295620|81105029|FG000|Overall Study|Protocol Violation|30|||
27801330|NCT00295620|81105030|FG001|Overall Study|Protocol Violation|32|||
27801331|NCT01629693|81105033|FG000|Overall Study|Lost to Follow-up|2|||
27801332|NCT01629693|81105034|FG001|Overall Study|Lost to Follow-up|4|||
27801333|NCT01629693|81105033|FG000|Overall Study|Withdrawal by Subject|2|||
27871626|NCT00729937|81361704|FG001|Overall Study|Did not meet eligibility criteria|1|||
27871627|NCT00729937|81361705|FG002|Overall Study|Did not meet eligibility criteria|0|||
27871628|NCT00729937|81361706|FG003|Overall Study|Did not meet eligibility criteria|0|||
27871629|NCT00729937|81361707|FG004|Overall Study|Did not meet eligibility criteria|0|||
27871630|NCT00729937|81361708|FG005|Overall Study|Did not meet eligibility criteria|0|||
27871631|NCT00729937|81361703|FG000|Overall Study|Incarcerated|0|||
27871632|NCT00729937|81361704|FG001|Overall Study|Incarcerated|2|||
27993987|NCT01510158|81808195|FG000|Overall Study|Sponsor terminated study.|2|||
27993988|NCT01510158|81808196|FG001|Overall Study|Sponsor terminated study.|0|||
27993989|NCT01510158|81808197|FG002|Overall Study|Sponsor terminated study.|2|||
27801334|NCT01629693|81105034|FG001|Overall Study|Withdrawal by Subject|2|||
27801335|NCT01629693|81105033|FG000|Overall Study|Adverse Event|1|||
27801336|NCT01629693|81105034|FG001|Overall Study|Adverse Event|0|||
27801337|NCT01629693|81105033|FG000|Overall Study|Investigator decision|0|||
27993990|NCT01510158|81808195|FG000|Overall Study|Lost to Follow-up|13|||
27993991|NCT01510158|81808196|FG001|Overall Study|Lost to Follow-up|16|||
27993992|NCT01510158|81808197|FG002|Overall Study|Lost to Follow-up|9|||
27993993|NCT01510158|81808195|FG000|Overall Study|Withdrawal by Subject|10|||
27993994|NCT01510158|81808196|FG001|Overall Study|Withdrawal by Subject|13|||
27993995|NCT01510158|81808197|FG002|Overall Study|Withdrawal by Subject|10|||
27993996|NCT01510158|81808195|FG000|Overall Study|Death|1|||
27993997|NCT01510158|81808196|FG001|Overall Study|Death|0|||
27993998|NCT01510158|81808197|FG002|Overall Study|Death|0|||
27993999|NCT00599755|81808198|FG000|Overall Study|Adverse Event|11|||
27994000|NCT00599755|81808198|FG000|Overall Study|Withdrawal by Subject|2|||
27994001|NCT00599755|81808198|FG000|Overall Study|Progression of Disease|3|||
27994002|NCT00599755|81808198|FG000|Overall Study|Other Reason|2|||
27994003|NCT00599755|81808198|FG000|Overall Study|No data available|1|||
27994004|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
27994005|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
27994006|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
27994007|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
27994008|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Death|2|||
27994009|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Death|2|||
27994010|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Death|0|||
27994011|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Death|0|||
27994012|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
27994013|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
27994014|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
27994015|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
27994016|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
27994017|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
27994018|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
27994019|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
27994020|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
27994021|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
27994022|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
27994023|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
27994024|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
27994025|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
27994026|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
27994027|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
27994028|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
27994029|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
27994030|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
27994031|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
27994032|NCT03068754|81808199|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
27994033|NCT03068754|81808200|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
27994034|NCT03068754|81808201|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
27994035|NCT03068754|81808202|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
27678161|NCT00368875|80656940|FG001|Overall Study|Withdrawal by Subject|6|||
27678162|NCT00368875|80656939|FG000|Overall Study|Other Reason|0|||
27678163|NCT00368875|80656940|FG001|Overall Study|Other Reason|2|||
27994036|NCT03068754|81808199|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
27994037|NCT03068754|81808200|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
27994038|NCT03068754|81808201|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
27994039|NCT03068754|81808202|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
27994040|NCT03068754|81808199|FG000|Open Label Extension Period (OLE)|Death|0|||
27994041|NCT03068754|81808200|FG001|Open Label Extension Period (OLE)|Death|0|||
27994042|NCT03068754|81808201|FG002|Open Label Extension Period (OLE)|Death|0|||
27994043|NCT03068754|81808202|FG003|Open Label Extension Period (OLE)|Death|1|||
27994044|NCT03068754|81808199|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
27994045|NCT03068754|81808200|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
27994046|NCT03068754|81808201|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
27994047|NCT03068754|81808202|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
27994048|NCT03068754|81808199|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
27994049|NCT03068754|81808200|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
27994050|NCT03068754|81808201|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
27994051|NCT03068754|81808202|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
27678164|NCT00368875|80656939|FG000|Overall Study|Alternative Therapy|1|||
27678165|NCT00368875|80656940|FG001|Overall Study|Alternative Therapy|1|||
27678166|NCT03853551|80656941|FG000|Overall Study|Death|2|||
27871633|NCT00729937|81361705|FG002|Overall Study|Incarcerated|1|||
27994052|NCT03068754|81808199|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
27994053|NCT03068754|81808200|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
27994054|NCT03068754|81808201|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
27994055|NCT03068754|81808202|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
27994056|NCT03068754|81808199|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
27994057|NCT03068754|81808200|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
27994058|NCT03068754|81808201|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
27994059|NCT03068754|81808202|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
27994060|NCT01858740|81808204|FG000|Overall Study|Death|4|||
27994061|NCT00103740|81808205|FG000|Period 1 - Core|Adverse Event|1|||
27994062|NCT00103740|81808206|FG001|Period 1 - Core|Adverse Event|0|||
27994063|NCT00103740|81808205|FG000|Period 1 - Core|Protocol Violation|3|||
27994064|NCT00103740|81808206|FG001|Period 1 - Core|Protocol Violation|2|||
27994065|NCT00103740|81808205|FG000|Period 1 - Core|Patient withdrew consent|3|||
27994066|NCT00103740|81808206|FG001|Period 1 - Core|Patient withdrew consent|2|||
27994067|NCT00103740|81808205|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
27994068|NCT00103740|81808206|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
27994069|NCT00103740|81808205|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
27994070|NCT00103740|81808206|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
27994071|NCT00103740|81808205|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
27994072|NCT00103740|81808206|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
27994073|NCT00103740|81808205|FG000|Period 2 - Extended Observation Period|Death|6|||
27994074|NCT00103740|81808206|FG001|Period 2 - Extended Observation Period|Death|2|||
27994075|NCT00103740|81808205|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
27994076|NCT00103740|81808206|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
27994077|NCT01934010|81808213|FG000|Overall Study|Adverse Event|1|||
27994078|NCT01934010|81808214|FG001|Overall Study|Adverse Event|1|||
27994079|NCT01934010|81808215|FG002|Overall Study|Adverse Event|0|||
27994080|NCT01934010|81808213|FG000|Overall Study|Withdrawal by Subject|15|||
27994081|NCT01934010|81808214|FG001|Overall Study|Withdrawal by Subject|6|||
27994082|NCT01934010|81808215|FG002|Overall Study|Withdrawal by Subject|2|||
27994083|NCT01934010|81808213|FG000|Overall Study|Lost to Follow-up|7|||
27994084|NCT01934010|81808214|FG001|Overall Study|Lost to Follow-up|4|||
27994085|NCT01934010|81808215|FG002|Overall Study|Lost to Follow-up|0|||
27994086|NCT01286077|81808218|FG000|Overall Study|Adverse Event|2|||
27994087|NCT01286077|81808219|FG001|Overall Study|Adverse Event|0|||
27994088|NCT01286077|81808218|FG000|Overall Study|Death|1|||
27994089|NCT01286077|81808219|FG001|Overall Study|Death|0|||
27994090|NCT01286077|81808218|FG000|Overall Study|Protocol Violation|1|||
27994091|NCT01286077|81808219|FG001|Overall Study|Protocol Violation|1|||
27994092|NCT01286077|81808218|FG000|Overall Study|Withdrawal by Subject|0|||
27994093|NCT01286077|81808219|FG001|Overall Study|Withdrawal by Subject|2|||
27994094|NCT01286077|81808218|FG000|Overall Study|Intercurrent illness|1|||
27994095|NCT01286077|81808219|FG001|Overall Study|Intercurrent illness|0|||
27994096|NCT01286077|81808218|FG000|Overall Study|Non-compliance|1|||
27994097|NCT01286077|81808219|FG001|Overall Study|Non-compliance|0|||
27994098|NCT01286077|81808218|FG000|Overall Study|The subject starts with alternative MMY|0|||
27678167|NCT03853551|80656941|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
27678168|NCT01008553|80656942|FG000|Period 1 (Titration Period)|Physician Decision|2|||
27678169|NCT01008553|80656943|FG001|Period 1 (Titration Period)|Physician Decision|0|||
27678170|NCT01008553|80656944|FG002|Period 1 (Titration Period)|Physician Decision|0|||
27678171|NCT01008553|80656942|FG000|Period 1 (Titration Period)|Adverse Event|33|||
27678172|NCT01008553|80656943|FG001|Period 1 (Titration Period)|Adverse Event|0|||
27678173|NCT01008553|80656944|FG002|Period 1 (Titration Period)|Adverse Event|0|||
27678174|NCT01008553|80656942|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
27678175|NCT01008553|80656943|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27678176|NCT01008553|80656944|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27678177|NCT01008553|80656942|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
27678178|NCT01008553|80656943|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
27678179|NCT01008553|80656944|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
27678180|NCT01008553|80656942|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
27678181|NCT01008553|80656943|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27871634|NCT00729937|81361706|FG003|Overall Study|Incarcerated|1|||
27994099|NCT01286077|81808219|FG001|Overall Study|The subject starts with alternative MMY|3|||
27678182|NCT01008553|80656944|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27994100|NCT01286077|81808218|FG000|Overall Study|Patient's decision to stop treatment|3|||
27994101|NCT01286077|81808219|FG001|Overall Study|Patient's decision to stop treatment|0|||
27871635|NCT00729937|81361707|FG004|Overall Study|Incarcerated|0|||
27678183|NCT01008553|80656942|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
27994102|NCT01286077|81808218|FG000|Overall Study|Progression of disease|0|||
27994103|NCT01286077|81808219|FG001|Overall Study|Progression of disease|1|||
27994104|NCT01286077|81808218|FG000|Overall Study|refill medication not received in time|1|||
27994105|NCT01286077|81808219|FG001|Overall Study|refill medication not received in time|0|||
27579434|NCT04027686|80303214|FG000|Overall Study|Withdrawal by Subject|0|||
27579435|NCT04027686|80303215|FG001|Overall Study|Withdrawal by Subject|1|||
27994106|NCT01856582|81808222|FG000|Overall Study|Died prior to Boost infusion|1|||
27994107|NCT01807598|81808226|FG000|Overall Study|Withdrawal by Subject|4|||
27994108|NCT01807598|81808226|FG000|Overall Study|Adverse Event|1|||
27994109|NCT01807598|81808226|FG000|Overall Study|Other Physician Decision|1|||
27994110|NCT00994422|81808227|FG000|Overall Study|Lost to Follow-up|7|||
27994111|NCT00994422|81808228|FG001|Overall Study|Lost to Follow-up|1|||
27994112|NCT00291486|81808231|FG000|Overall Study|Adverse Event|0|||
27994113|NCT00291486|81808232|FG001|Overall Study|Adverse Event|3|||
27994114|NCT00291486|81808233|FG002|Overall Study|Adverse Event|0|||
27994115|NCT00291486|81808234|FG003|Overall Study|Adverse Event|1|||
27994116|NCT00291486|81808235|FG004|Overall Study|Adverse Event|0|||
27994117|NCT00291486|81808231|FG000|Overall Study|Withdrawal by Subject|0|||
27994118|NCT00291486|81808232|FG001|Overall Study|Withdrawal by Subject|0|||
27994119|NCT00291486|81808233|FG002|Overall Study|Withdrawal by Subject|0|||
27994120|NCT00291486|81808234|FG003|Overall Study|Withdrawal by Subject|0|||
27994121|NCT00291486|81808235|FG004|Overall Study|Withdrawal by Subject|1|||
27994122|NCT00291486|81808231|FG000|Overall Study|Disease progression|1|||
27994123|NCT00291486|81808232|FG001|Overall Study|Disease progression|0|||
27994124|NCT00291486|81808233|FG002|Overall Study|Disease progression|1|||
27994125|NCT00291486|81808234|FG003|Overall Study|Disease progression|0|||
27994126|NCT00291486|81808235|FG004|Overall Study|Disease progression|0|||
27994127|NCT02008227|81808241|FG000|Overall Study|Lost to Follow-up|7|||
27994128|NCT02008227|81808242|FG001|Overall Study|Lost to Follow-up|9|||
27994129|NCT02008227|81808241|FG000|Overall Study|Death|494|||
27994130|NCT02008227|81808242|FG001|Overall Study|Death|485|||
27994131|NCT02008227|81808241|FG000|Overall Study|Withdrawal by Subject|67|||
27994132|NCT02008227|81808242|FG001|Overall Study|Withdrawal by Subject|36|||
27994133|NCT02008227|81808241|FG000|Overall Study|Study Terminated By Sponsor|44|||
27994134|NCT02008227|81808242|FG001|Overall Study|Study Terminated By Sponsor|83|||
27994135|NCT03614325|81808247|FG000|Overall Study|Withdrawal by Subject|0|||
27994136|NCT03614325|81808248|FG001|Overall Study|Withdrawal by Subject|2|||
27994137|NCT03614325|81808247|FG000|Overall Study|Surgery Cancelled|2|||
27994138|NCT03614325|81808248|FG001|Overall Study|Surgery Cancelled|1|||
27994139|NCT03614325|81808247|FG000|Overall Study|Lost to Follow-up|2|||
27678184|NCT01008553|80656943|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
27678185|NCT01008553|80656944|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
27678186|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
27678187|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
27678188|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
27678189|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
27678190|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
27994140|NCT03614325|81808248|FG001|Overall Study|Lost to Follow-up|1|||
27994141|NCT03614325|81808247|FG000|Overall Study|Surgery never scheduled|1|||
27994142|NCT03614325|81808248|FG001|Overall Study|Surgery never scheduled|0|||
27994143|NCT03790917|81808249|FG000|Overall Study|Death|1|||
27994144|NCT02452424|81808250|FG000|Overall Study|Death|2|||
27994145|NCT02452424|81808251|FG001|Overall Study|Death|2|||
27994146|NCT02452424|81808252|FG002|Overall Study|Death|2|||
27579436|NCT00048724|80306602|FG000|Overall Study|Adverse Event|53|||
27579437|NCT00048724|80306603|FG001|Overall Study|Adverse Event|12|||
27579438|NCT00048724|80306602|FG000|Overall Study|Withdrawal by Subject|34|||
27579439|NCT00048724|80306603|FG001|Overall Study|Withdrawal by Subject|54|||
27678191|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
27678192|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
27678193|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
27579440|NCT00048724|80306602|FG000|Overall Study|Lost to Follow-up|5|||
27678194|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
27994147|NCT02452424|81808253|FG003|Overall Study|Death|6|||
27994148|NCT02452424|81808254|FG004|Overall Study|Death|2|||
27994149|NCT02452424|81808255|FG005|Overall Study|Death|0|||
27994150|NCT02452424|81808256|FG006|Overall Study|Death|5|||
27994151|NCT02452424|81808257|FG007|Overall Study|Death|1|||
27994152|NCT02452424|81808258|FG008|Overall Study|Death|3|||
27994153|NCT02452424|81808259|FG009|Overall Study|Death|1|||
27994154|NCT02452424|81808260|FG010|Overall Study|Death|0|||
27994155|NCT02452424|81808250|FG000|Overall Study|Lost to Follow-up|0|||
27994156|NCT02452424|81808251|FG001|Overall Study|Lost to Follow-up|1|||
27994157|NCT02452424|81808252|FG002|Overall Study|Lost to Follow-up|1|||
27994158|NCT02452424|81808253|FG003|Overall Study|Lost to Follow-up|0|||
27994159|NCT02452424|81808254|FG004|Overall Study|Lost to Follow-up|0|||
27994160|NCT02452424|81808255|FG005|Overall Study|Lost to Follow-up|0|||
27994161|NCT02452424|81808256|FG006|Overall Study|Lost to Follow-up|0|||
27994162|NCT02452424|81808257|FG007|Overall Study|Lost to Follow-up|0|||
27994163|NCT02452424|81808258|FG008|Overall Study|Lost to Follow-up|0|||
27994164|NCT02452424|81808259|FG009|Overall Study|Lost to Follow-up|0|||
27994165|NCT02452424|81808260|FG010|Overall Study|Lost to Follow-up|0|||
27994166|NCT02452424|81808250|FG000|Overall Study|Withdrawal by Subject|0|||
27994167|NCT02452424|81808251|FG001|Overall Study|Withdrawal by Subject|0|||
27994168|NCT02452424|81808252|FG002|Overall Study|Withdrawal by Subject|3|||
27994169|NCT02452424|81808253|FG003|Overall Study|Withdrawal by Subject|2|||
27994170|NCT02452424|81808254|FG004|Overall Study|Withdrawal by Subject|0|||
27994171|NCT02452424|81808255|FG005|Overall Study|Withdrawal by Subject|0|||
27994172|NCT02452424|81808256|FG006|Overall Study|Withdrawal by Subject|1|||
27994173|NCT02452424|81808257|FG007|Overall Study|Withdrawal by Subject|0|||
27994174|NCT02452424|81808258|FG008|Overall Study|Withdrawal by Subject|1|||
27994175|NCT02452424|81808259|FG009|Overall Study|Withdrawal by Subject|1|||
27994176|NCT02452424|81808260|FG010|Overall Study|Withdrawal by Subject|0|||
27994177|NCT02452424|81808250|FG000|Overall Study|Other|0|||
27994178|NCT02452424|81808251|FG001|Overall Study|Other|0|||
27994179|NCT02452424|81808252|FG002|Overall Study|Other|1|||
27994180|NCT02452424|81808253|FG003|Overall Study|Other|0|||
27994181|NCT02452424|81808254|FG004|Overall Study|Other|0|||
27994182|NCT02452424|81808255|FG005|Overall Study|Other|1|||
27994183|NCT02452424|81808256|FG006|Overall Study|Other|4|||
27994184|NCT02452424|81808257|FG007|Overall Study|Other|3|||
27994185|NCT02452424|81808258|FG008|Overall Study|Other|0|||
27994186|NCT02452424|81808259|FG009|Overall Study|Other|0|||
27994187|NCT02452424|81808260|FG010|Overall Study|Other|1|||
27994188|NCT02452424|81808250|FG000|Overall Study|Progressive disease (per RECIST)|0|||
27994189|NCT02452424|81808251|FG001|Overall Study|Progressive disease (per RECIST)|0|||
27994190|NCT02452424|81808252|FG002|Overall Study|Progressive disease (per RECIST)|0|||
27994191|NCT02452424|81808253|FG003|Overall Study|Progressive disease (per RECIST)|0|||
27994192|NCT02452424|81808254|FG004|Overall Study|Progressive disease (per RECIST)|0|||
27994193|NCT02452424|81808255|FG005|Overall Study|Progressive disease (per RECIST)|0|||
27994194|NCT02452424|81808256|FG006|Overall Study|Progressive disease (per RECIST)|0|||
27994195|NCT02452424|81808257|FG007|Overall Study|Progressive disease (per RECIST)|0|||
27994196|NCT02452424|81808258|FG008|Overall Study|Progressive disease (per RECIST)|2|||
27994197|NCT02452424|81808259|FG009|Overall Study|Progressive disease (per RECIST)|0|||
27994198|NCT02452424|81808260|FG010|Overall Study|Progressive disease (per RECIST)|0|||
27994199|NCT02452424|81808250|FG000|Overall Study|Adverse Event|0|||
27994200|NCT02452424|81808251|FG001|Overall Study|Adverse Event|0|||
27994201|NCT02452424|81808252|FG002|Overall Study|Adverse Event|0|||
27994202|NCT02452424|81808253|FG003|Overall Study|Adverse Event|0|||
27994203|NCT02452424|81808254|FG004|Overall Study|Adverse Event|0|||
27994204|NCT02452424|81808255|FG005|Overall Study|Adverse Event|0|||
27994205|NCT02452424|81808256|FG006|Overall Study|Adverse Event|0|||
27994206|NCT02452424|81808257|FG007|Overall Study|Adverse Event|0|||
27994207|NCT02452424|81808258|FG008|Overall Study|Adverse Event|0|||
27994208|NCT02452424|81808259|FG009|Overall Study|Adverse Event|0|||
27994209|NCT02452424|81808260|FG010|Overall Study|Adverse Event|1|||
27994210|NCT00930930|81808263|FG000|Overall Study|Death|1|||
27994211|NCT00930930|81808264|FG001|Overall Study|Death|0|||
27994212|NCT00930930|81808263|FG000|Overall Study|Physician Decision|1|||
27994213|NCT00930930|81808264|FG001|Overall Study|Physician Decision|0|||
27994214|NCT00930930|81808263|FG000|Overall Study|Adverse Event|13|||
27871636|NCT00729937|81361708|FG005|Overall Study|Incarcerated|0|||
27994215|NCT00930930|81808264|FG001|Overall Study|Adverse Event|3|||
27994216|NCT00930930|81808263|FG000|Overall Study|Withdrawal by Subject|3|||
27994217|NCT00930930|81808264|FG001|Overall Study|Withdrawal by Subject|1|||
27994218|NCT00930930|81808263|FG000|Overall Study|Disease progression|2|||
27994219|NCT00930930|81808264|FG001|Overall Study|Disease progression|3|||
27994220|NCT00930930|81808263|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
27871637|NCT00916383|81361711|FG000|Overall Study|Adverse Event|1|||
27994221|NCT00930930|81808264|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
27994222|NCT00930930|81808263|FG000|Overall Study|patients not compliant|1|||
27994223|NCT00930930|81808264|FG001|Overall Study|patients not compliant|1|||
27994224|NCT00303485|81808269|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
27994225|NCT00303485|81808270|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
27994226|NCT00303485|81808269|FG000|Overall Study|Failure to return|0|||
27994227|NCT00303485|81808270|FG001|Overall Study|Failure to return|1|||
27994228|NCT00303485|81808269|FG000|Overall Study|Withdrawal by Subject|1|||
27994229|NCT00303485|81808270|FG001|Overall Study|Withdrawal by Subject|0|||
27994230|NCT00571038|81808271|FG000|Overall Study|Lost to Follow-up|1|||
27994231|NCT00571038|81808272|FG001|Overall Study|Lost to Follow-up|4|||
27994232|NCT00571038|81808271|FG000|Overall Study|Death|7|||
27994233|NCT00571038|81808272|FG001|Overall Study|Death|5|||
27994234|NCT00571038|81808271|FG000|Overall Study|Withdrawal by Subject|1|||
27994235|NCT00571038|81808272|FG001|Overall Study|Withdrawal by Subject|3|||
27994236|NCT00571038|81808271|FG000|Overall Study|Moved out of state|2|||
27994237|NCT00571038|81808272|FG001|Overall Study|Moved out of state|2|||
27994238|NCT02969356|81808273|FG000|Overall Study|Adverse Event|7|||
27994239|NCT02969356|81808273|FG000|Overall Study|Consent withdrawn|2|||
27994240|NCT02969356|81808273|FG000|Overall Study|Lost to Follow-up|3|||
27994241|NCT02969356|81808273|FG000|Overall Study|Did not need to be reinjected|6|||
27994242|NCT02969356|81808273|FG000|Overall Study|Personal reasons|5|||
27994243|NCT03566082|81808274|FG000|Overall Study|Death|7|||
27994244|NCT03566082|81808274|FG000|Overall Study|Failures (revision required)|2|||
27994245|NCT03566082|81808274|FG000|Overall Study|Lost to Follow-up|8|||
27994246|NCT00350844|81808283|FG000|Overall Study|Lost to Follow-up|1|||
27994247|NCT02100969|81808284|FG000|Overall Study|Did not pass screening phase|1|||
27994248|NCT02926638|81808285|FG000|Overall Study|Progression|2|||
27994249|NCT02926638|81808286|FG001|Overall Study|Progression|5|||
27994250|NCT02926638|81808285|FG000|Overall Study|Ineligible|1|||
27994251|NCT02926638|81808286|FG001|Overall Study|Ineligible|0|||
27994252|NCT02926638|81808285|FG000|Overall Study|Not protocol specified|1|||
27994253|NCT02926638|81808286|FG001|Overall Study|Not protocol specified|0|||
27994254|NCT03387020|81808287|FG000|Overall Study|Adverse Event|0|||
27994255|NCT03387020|81808288|FG001|Overall Study|Adverse Event|2|||
27994256|NCT03387020|81808289|FG002|Overall Study|Adverse Event|0|||
27994257|NCT03387020|81808287|FG000|Overall Study|Withdrawal by Subject|2|||
27994258|NCT03387020|81808288|FG001|Overall Study|Withdrawal by Subject|0|||
27994259|NCT03387020|81808289|FG002|Overall Study|Withdrawal by Subject|0|||
27994260|NCT02702180|81808300|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27994261|NCT02702180|81808301|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27994262|NCT02702180|81808302|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27994263|NCT02702180|81808300|FG000|Double-blind Treatment Period|Adverse Event|0|||
27994264|NCT02702180|81808301|FG001|Double-blind Treatment Period|Adverse Event|0|||
27994265|NCT02702180|81808302|FG002|Double-blind Treatment Period|Adverse Event|1|||
27994266|NCT02702180|81808300|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27994267|NCT02702180|81808301|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
27994268|NCT02702180|81808302|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
27994269|NCT02702180|81808300|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27994270|NCT02702180|81808301|FG001|Double-blind Treatment Period|Protocol Violation|0|||
27994271|NCT02702180|81808302|FG002|Double-blind Treatment Period|Protocol Violation|2|||
27994272|NCT02702180|81808300|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
27994273|NCT02702180|81808301|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
27994274|NCT02702180|81808302|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
27994275|NCT02702180|81808300|FG000|Open-label Treatment Period|Withdrawn in error|0|||
27994276|NCT02702180|81808301|FG001|Open-label Treatment Period|Withdrawn in error|0|||
27994277|NCT02702180|81808302|FG002|Open-label Treatment Period|Withdrawn in error|1|||
27994278|NCT00630344|81808305|FG000|Overall Study|Adverse Event|5|||
27994279|NCT00630344|81808305|FG000|Overall Study|Progressive Disease|19|||
27994280|NCT00630344|81808305|FG000|Overall Study|Physician Decision|9|||
27994281|NCT00630344|81808305|FG000|Overall Study|Withdrawal by Subject|1|||
27994282|NCT00630344|81808305|FG000|Overall Study|Intercurrent Illness|1|||
27994283|NCT00630344|81808305|FG000|Overall Study|Other|1|||
27994284|NCT03416127|81808306|FG000|Overall Study|Withdrawal by Subject|0|||
27994285|NCT03416127|81808307|FG001|Overall Study|Withdrawal by Subject|1|||
27994286|NCT03416127|81808308|FG002|Overall Study|Withdrawal by Subject|1|||
27994287|NCT02669212|81808312|FG000|Overall Study|Lost to Follow-up|1|||
27994288|NCT02669212|81808313|FG001|Overall Study|Lost to Follow-up|0|||
27994289|NCT02669212|81808312|FG000|Overall Study|Medical Condition|3|||
27994290|NCT02669212|81808313|FG001|Overall Study|Medical Condition|4|||
27994291|NCT02669212|81808312|FG000|Overall Study|Withdrawal by Subject|0|||
27994292|NCT02669212|81808313|FG001|Overall Study|Withdrawal by Subject|2|||
27994293|NCT02669212|81808312|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
27994294|NCT02669212|81808313|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
27994295|NCT04522141|81808314|FG000|Overall Study|Withdrawal by Subject|1|||
27994296|NCT04522141|81808315|FG001|Overall Study|Withdrawal by Subject|0|||
27994297|NCT02287467|81808316|FG000|Overall Study|Protocol Violation|12|||
27994298|NCT02287467|81808317|FG001|Overall Study|Protocol Violation|9|||
27994299|NCT01959139|81808318|FG000|Phase II|Disease progression|0|||
27994300|NCT01959139|81808319|FG001|Phase II|Disease progression|0|||
27994301|NCT01959139|81808320|FG002|Phase II|Disease progression|26|||
27994302|NCT01959139|81808321|FG003|Phase II|Disease progression|34|||
27994303|NCT01959139|81808318|FG000|Phase II|Adverse Event|0|||
27994304|NCT01959139|81808319|FG001|Phase II|Adverse Event|0|||
27994305|NCT01959139|81808320|FG002|Phase II|Adverse Event|10|||
27994306|NCT01959139|81808321|FG003|Phase II|Adverse Event|11|||
27994307|NCT01959139|81808318|FG000|Phase II|Patient Refusal|0|||
27994308|NCT01959139|81808319|FG001|Phase II|Patient Refusal|0|||
27678195|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
27678196|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
27678197|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
27678198|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
27678199|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
27678200|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
27994309|NCT01959139|81808320|FG002|Phase II|Patient Refusal|5|||
27994310|NCT01959139|81808321|FG003|Phase II|Patient Refusal|4|||
27994311|NCT01959139|81808318|FG000|Phase II|Death|0|||
27994312|NCT01959139|81808319|FG001|Phase II|Death|0|||
27994313|NCT01959139|81808320|FG002|Phase II|Death|3|||
27994314|NCT01959139|81808321|FG003|Phase II|Death|1|||
27994315|NCT01959139|81808318|FG000|Phase II|Other/Unknown|0|||
27678201|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
27678202|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
27678203|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
27678204|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27678205|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27678206|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
27678207|NCT01008553|80656942|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
27678208|NCT01008553|80656943|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
27678209|NCT01008553|80656944|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
27678210|NCT02737826|80656947|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
27678211|NCT02737826|80656948|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
27678212|NCT02737826|80656949|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
27678213|NCT00527787|80660319|FG000|Overall Study|Adverse Event|14|||
27678214|NCT00527787|80660320|FG001|Overall Study|Adverse Event|24|||
27678215|NCT00527787|80660319|FG000|Overall Study|Withdrawal by Subject|13|||
27678216|NCT00527787|80660320|FG001|Overall Study|Withdrawal by Subject|25|||
27678217|NCT00527787|80660319|FG000|Overall Study|Lost to Follow-up|5|||
27678218|NCT00527787|80660320|FG001|Overall Study|Lost to Follow-up|2|||
27678219|NCT00527787|80660319|FG000|Overall Study|Duodenal Ulcer|1|||
27678220|NCT00527787|80660320|FG001|Overall Study|Duodenal Ulcer|10|||
27579441|NCT00048724|80306603|FG001|Overall Study|Lost to Follow-up|5|||
27678221|NCT00527787|80660319|FG000|Overall Study|misc|5|||
27994316|NCT01959139|81808319|FG001|Phase II|Other/Unknown|0|||
27994317|NCT01959139|81808320|FG002|Phase II|Other/Unknown|8|||
27994318|NCT01959139|81808321|FG003|Phase II|Other/Unknown|5|||
27994319|NCT01959139|81808318|FG000|Phase II|On treatment|0|||
27994320|NCT01959139|81808319|FG001|Phase II|On treatment|0|||
27579442|NCT00048724|80306602|FG000|Overall Study|Protocol-defined Clinical Event|17|||
27678222|NCT00527787|80660320|FG001|Overall Study|misc|2|||
27678223|NCT00552929|80660333|FG000|Overall Study|Lost to Follow-up|0|||
27678224|NCT00552929|80660334|FG001|Overall Study|Lost to Follow-up|0|||
27678225|NCT00552929|80660335|FG002|Overall Study|Lost to Follow-up|0|||
27678226|NCT00552929|80660336|FG003|Overall Study|Lost to Follow-up|0|||
27678227|NCT00552929|80660337|FG004|Overall Study|Lost to Follow-up|0|||
27678228|NCT00552929|80660338|FG005|Overall Study|Lost to Follow-up|0|||
27678229|NCT00552929|80660339|FG006|Overall Study|Lost to Follow-up|0|||
27678230|NCT00552929|80660340|FG007|Overall Study|Lost to Follow-up|0|||
27678231|NCT00552929|80660341|FG008|Overall Study|Lost to Follow-up|1|||
27678232|NCT00552929|80660342|FG009|Overall Study|Lost to Follow-up|0|||
27678233|NCT00552929|80660333|FG000|Overall Study|Not Eligible|0|||
27678234|NCT00552929|80660334|FG001|Overall Study|Not Eligible|0|||
27678235|NCT00552929|80660335|FG002|Overall Study|Not Eligible|0|||
27678236|NCT00552929|80660336|FG003|Overall Study|Not Eligible|0|||
27678237|NCT00552929|80660337|FG004|Overall Study|Not Eligible|0|||
27678238|NCT00552929|80660338|FG005|Overall Study|Not Eligible|1|||
27678239|NCT00552929|80660339|FG006|Overall Study|Not Eligible|0|||
27678240|NCT00552929|80660340|FG007|Overall Study|Not Eligible|0|||
27678241|NCT00552929|80660341|FG008|Overall Study|Not Eligible|0|||
27678242|NCT00552929|80660342|FG009|Overall Study|Not Eligible|0|||
27678243|NCT02416453|80660343|FG000|Overall Study|Adverse Event|0|||
27678244|NCT02416453|80660344|FG001|Overall Study|Adverse Event|0|||
27678245|NCT02416453|80660345|FG002|Overall Study|Adverse Event|0|||
27678246|NCT02416453|80660346|FG003|Overall Study|Adverse Event|2|||
27678247|NCT02416453|80660347|FG004|Overall Study|Adverse Event|0|||
27678248|NCT02416453|80660348|FG005|Overall Study|Adverse Event|1|||
27678249|NCT02416453|80660349|FG006|Overall Study|Adverse Event|0|||
27678250|NCT02416453|80660350|FG007|Overall Study|Adverse Event|0|||
27678251|NCT02416453|80660351|FG008|Overall Study|Adverse Event|0|||
27678252|NCT02416453|80660352|FG009|Overall Study|Adverse Event|0|||
27678253|NCT02416453|80660353|FG010|Overall Study|Adverse Event|0|||
27678254|NCT02416453|80660343|FG000|Overall Study|Lost to Follow-up|1|||
27678255|NCT02416453|80660344|FG001|Overall Study|Lost to Follow-up|3|||
27801338|NCT01629693|81105034|FG001|Overall Study|Investigator decision|1|||
27801339|NCT01629693|81105033|FG000|Overall Study|Poor comfort of study lenses|0|||
27801340|NCT01629693|81105034|FG001|Overall Study|Poor comfort of study lenses|2|||
27801341|NCT01629693|81105033|FG000|Overall Study|Subject decision unrelated to AE|0|||
27801342|NCT01629693|81105034|FG001|Overall Study|Subject decision unrelated to AE|1|||
27801343|NCT02702271|81105035|FG000|Overall Study|Death|36|||
27801344|NCT02702271|81105036|FG001|Overall Study|Death|7|||
27801345|NCT02702271|81105035|FG000|Overall Study|Lost to Follow-up|12|||
27801346|NCT02702271|81105036|FG001|Overall Study|Lost to Follow-up|0|||
27801347|NCT02702271|81105035|FG000|Overall Study|Withdrawal by Subject|8|||
27801348|NCT02702271|81105036|FG001|Overall Study|Withdrawal by Subject|1|||
27801349|NCT02702271|81105035|FG000|Overall Study|Physician Decision|2|||
27801350|NCT02702271|81105036|FG001|Overall Study|Physician Decision|0|||
27801351|NCT02702271|81105035|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
27801352|NCT02702271|81105036|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
27801353|NCT03547531|81105039|FG000|Overall Study|not coming in data collection : sick|2|||
27801354|NCT03547531|81105040|FG001|Overall Study|not coming in data collection : sick|2|||
27801355|NCT03547531|81105039|FG000|Overall Study|having family occasion|0|||
27801356|NCT03547531|81105040|FG001|Overall Study|having family occasion|2|||
27801357|NCT01678924|81105041|FG000|Overall Study|Adverse Event|1|||
27801358|NCT01678924|81105042|FG001|Overall Study|Adverse Event|1|||
27801359|NCT01678924|81105043|FG002|Overall Study|Adverse Event|0|||
27801360|NCT01678924|81105044|FG003|Overall Study|Adverse Event|1|||
27801361|NCT01678924|81105041|FG000|Overall Study|Lack of Efficacy|7|||
27801362|NCT01678924|81105042|FG001|Overall Study|Lack of Efficacy|2|||
27801363|NCT01678924|81105043|FG002|Overall Study|Lack of Efficacy|0|||
27801364|NCT01678924|81105044|FG003|Overall Study|Lack of Efficacy|5|||
27801365|NCT01678924|81105041|FG000|Overall Study|Lost to Follow-up|0|||
27801366|NCT01678924|81105042|FG001|Overall Study|Lost to Follow-up|4|||
27678256|NCT02416453|80660345|FG002|Overall Study|Lost to Follow-up|0|||
27678257|NCT02416453|80660346|FG003|Overall Study|Lost to Follow-up|8|||
27678258|NCT02416453|80660347|FG004|Overall Study|Lost to Follow-up|0|||
27678259|NCT02416453|80660348|FG005|Overall Study|Lost to Follow-up|5|||
27678260|NCT02416453|80660349|FG006|Overall Study|Lost to Follow-up|1|||
27678261|NCT02416453|80660350|FG007|Overall Study|Lost to Follow-up|3|||
27678262|NCT02416453|80660351|FG008|Overall Study|Lost to Follow-up|1|||
27678263|NCT02416453|80660352|FG009|Overall Study|Lost to Follow-up|0|||
27678264|NCT02416453|80660353|FG010|Overall Study|Lost to Follow-up|0|||
27678265|NCT02416453|80660343|FG000|Overall Study|Physician Decision|0|||
27678266|NCT02416453|80660344|FG001|Overall Study|Physician Decision|0|||
27801367|NCT01678924|81105043|FG002|Overall Study|Lost to Follow-up|0|||
27801368|NCT01678924|81105044|FG003|Overall Study|Lost to Follow-up|2|||
27801369|NCT01678924|81105041|FG000|Overall Study|Personal Reasons|2|||
27801370|NCT01678924|81105042|FG001|Overall Study|Personal Reasons|2|||
27801371|NCT01678924|81105043|FG002|Overall Study|Personal Reasons|2|||
27801372|NCT01678924|81105044|FG003|Overall Study|Personal Reasons|7|||
27678267|NCT02416453|80660345|FG002|Overall Study|Physician Decision|0|||
27678268|NCT02416453|80660346|FG003|Overall Study|Physician Decision|0|||
27871638|NCT00916383|81361711|FG000|Overall Study|Death|1|||
27871639|NCT00916383|81361711|FG000|Overall Study|Protocol Violation|1|||
27871640|NCT02556801|81361714|FG000|Overall Study|Lost to Follow-up|1|||
27871641|NCT02556801|81361715|FG001|Overall Study|Lost to Follow-up|0|||
27871642|NCT02556801|81361716|FG002|Overall Study|Lost to Follow-up|2|||
27871643|NCT02556801|81361717|FG003|Overall Study|Lost to Follow-up|0|||
27871644|NCT02556801|81361714|FG000|Overall Study|Withdrawal by Subject|1|||
27871645|NCT02556801|81361715|FG001|Overall Study|Withdrawal by Subject|1|||
27871646|NCT02556801|81361716|FG002|Overall Study|Withdrawal by Subject|1|||
27871647|NCT02556801|81361717|FG003|Overall Study|Withdrawal by Subject|0|||
27871648|NCT02556801|81361714|FG000|Overall Study|Protocol Violation|0|||
27871649|NCT02556801|81361715|FG001|Overall Study|Protocol Violation|3|||
27871650|NCT02556801|81361716|FG002|Overall Study|Protocol Violation|1|||
27871651|NCT02556801|81361717|FG003|Overall Study|Protocol Violation|1|||
27871652|NCT02556801|81361714|FG000|Overall Study|Adverse Event|0|||
27871653|NCT02556801|81361715|FG001|Overall Study|Adverse Event|2|||
27871654|NCT02556801|81361716|FG002|Overall Study|Adverse Event|0|||
27871655|NCT02556801|81361717|FG003|Overall Study|Adverse Event|3|||
27871656|NCT02556801|81361714|FG000|Overall Study|Pregnancy|0|||
27871657|NCT02556801|81361715|FG001|Overall Study|Pregnancy|1|||
27871658|NCT02556801|81361716|FG002|Overall Study|Pregnancy|0|||
27871659|NCT02556801|81361717|FG003|Overall Study|Pregnancy|0|||
27871660|NCT02556801|81361714|FG000|Overall Study|Personal reasons patient|0|||
27871661|NCT02556801|81361715|FG001|Overall Study|Personal reasons patient|0|||
27871662|NCT02556801|81361716|FG002|Overall Study|Personal reasons patient|0|||
27871663|NCT02556801|81361717|FG003|Overall Study|Personal reasons patient|1|||
27871664|NCT02208089|81361718|FG000|Overall Study|Withdrawal by Subject|1|||
27871665|NCT02208089|81361719|FG001|Overall Study|Withdrawal by Subject|0|||
27871666|NCT02208089|81361718|FG000|Overall Study|Lost to Follow-up|6|||
27871667|NCT02208089|81361719|FG001|Overall Study|Lost to Follow-up|0|||
27871668|NCT00879086|81365036|FG000|Overall Study|Adverse Event|3|||
27871669|NCT00879086|81365037|FG001|Overall Study|Adverse Event|15|||
27871670|NCT00879086|81365036|FG000|Overall Study|Participant choice|2|||
27871671|NCT00879086|81365037|FG001|Overall Study|Participant choice|2|||
27871672|NCT00879086|81365036|FG000|Overall Study|Progression of disease|40|||
27871673|NCT00879086|81365037|FG001|Overall Study|Progression of disease|26|||
27871674|NCT00879086|81365036|FG000|Overall Study|Withdrawal of consent|2|||
27871675|NCT00879086|81365037|FG001|Overall Study|Withdrawal of consent|1|||
27871676|NCT00879086|81365036|FG000|Overall Study|Other|4|||
27871677|NCT00879086|81365037|FG001|Overall Study|Other|6|||
27871678|NCT00879086|81365036|FG000|Overall Study|Death|1|||
27871679|NCT00879086|81365037|FG001|Overall Study|Death|2|||
27871680|NCT01326845|81365044|FG000|Overall Study|Administrative Problems|5|||
27871681|NCT01326845|81365045|FG001|Overall Study|Administrative Problems|2|||
27871682|NCT01326845|81365044|FG000|Overall Study|Adverse Event|1|||
27871683|NCT01326845|81365045|FG001|Overall Study|Adverse Event|0|||
27871684|NCT01326845|81365044|FG000|Overall Study|Misisng|1|||
27871685|NCT01326845|81365045|FG001|Overall Study|Misisng|3|||
27871686|NCT00443729|81365049|FG000|Overall Study|Never Treated|0|||
27871687|NCT00443729|81365050|FG001|Overall Study|Never Treated|1|||
27871688|NCT00443729|81365049|FG000|Overall Study|Lack of Efficacy|4|||
27871689|NCT00443729|81365050|FG001|Overall Study|Lack of Efficacy|2|||
27871690|NCT00443729|81365049|FG000|Overall Study|Lost to Follow-up|0|||
27994321|NCT01959139|81808320|FG002|Phase II|On treatment|4|||
27994322|NCT01959139|81808321|FG003|Phase II|On treatment|0|||
27994323|NCT01450098|81808322|FG000|Period 3|Protocol Violation|0|||
27994324|NCT01450098|81808323|FG001|Period 3|Protocol Violation|1|||
27994325|NCT01450098|81808322|FG000|Period 3|Withdrawal by Subject|0|||
27994326|NCT01450098|81808323|FG001|Period 3|Withdrawal by Subject|2|||
27871691|NCT00443729|81365050|FG001|Overall Study|Lost to Follow-up|1|||
27871692|NCT00443729|81365049|FG000|Overall Study|Physician Decision|2|||
27871693|NCT00443729|81365050|FG001|Overall Study|Physician Decision|1|||
27871694|NCT00443729|81365049|FG000|Overall Study|Protocol Violation|1|||
27871695|NCT00443729|81365050|FG001|Overall Study|Protocol Violation|1|||
27871696|NCT00443729|81365049|FG000|Overall Study|Withdrawal by Subject|3|||
27871697|NCT00443729|81365050|FG001|Overall Study|Withdrawal by Subject|1|||
27871698|NCT02072980|81365051|FG000|Period 2, Second Wear|Adverse Event|0|||
27871699|NCT02072980|81365052|FG001|Period 2, Second Wear|Adverse Event|1|||
27871700|NCT01564537|81365057|FG000|Overall Study|Site Terminated by Sponsor|1|||
27871701|NCT01564537|81365058|FG001|Overall Study|Site Terminated by Sponsor|0|||
27678269|NCT02416453|80660347|FG004|Overall Study|Physician Decision|0|||
27871702|NCT01564537|81365057|FG000|Overall Study|Withdrawal by Subject|12|||
27871703|NCT01564537|81365058|FG001|Overall Study|Withdrawal by Subject|14|||
27994327|NCT03301350|81808326|FG000|Overall Study|Withdrawal by Subject|4|||
27678270|NCT02416453|80660348|FG005|Overall Study|Physician Decision|1|||
27871704|NCT01564537|81365057|FG000|Overall Study|Lost to Follow-up|7|||
27871705|NCT01564537|81365058|FG001|Overall Study|Lost to Follow-up|3|||
27871706|NCT01564537|81365057|FG000|Overall Study|Reason not specified|81|||
27801373|NCT01678924|81105041|FG000|Overall Study|Withdrawal by Subject|0|||
27801374|NCT01678924|81105042|FG001|Overall Study|Withdrawal by Subject|3|||
27994328|NCT03301350|81808326|FG000|Overall Study|Adverse Event|1|||
27994329|NCT03301350|81808326|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
27801375|NCT01678924|81105043|FG002|Overall Study|Withdrawal by Subject|0|||
27801376|NCT01678924|81105044|FG003|Overall Study|Withdrawal by Subject|2|||
27801377|NCT01678924|81105041|FG000|Overall Study|Unable to attend scheduled visits|0|||
27801378|NCT01678924|81105042|FG001|Overall Study|Unable to attend scheduled visits|0|||
27801379|NCT01678924|81105043|FG002|Overall Study|Unable to attend scheduled visits|0|||
27801380|NCT01678924|81105044|FG003|Overall Study|Unable to attend scheduled visits|1|||
27801381|NCT00829439|81105045|FG000|Overall Study|Adverse Event|0|||
27801382|NCT00829439|81105046|FG001|Overall Study|Adverse Event|0|||
27801383|NCT00829439|81105047|FG002|Overall Study|Adverse Event|1|||
27801384|NCT00829439|81105048|FG003|Overall Study|Adverse Event|0|||
27801385|NCT04128696|81105052|FG000|Overall Study|Lost to Follow-up|3|||
27801386|NCT04128696|81105053|FG001|Overall Study|Lost to Follow-up|7|||
27801387|NCT04128696|81105052|FG000|Overall Study|Withdrawal by Subject|12|||
27801388|NCT04128696|81105053|FG001|Overall Study|Withdrawal by Subject|11|||
27801389|NCT04128696|81105052|FG000|Overall Study|Study Closed/Terminated|26|||
27801390|NCT04128696|81105053|FG001|Overall Study|Study Closed/Terminated|38|||
27801391|NCT04128696|81105052|FG000|Overall Study|Physician Decision|2|||
27801392|NCT04128696|81105053|FG001|Overall Study|Physician Decision|3|||
27801393|NCT00402779|81105054|FG000|Overall Study|Screen Failure|77|||
27801394|NCT00402779|81105055|FG001|Overall Study|Screen Failure|76|||
27801395|NCT02476851|81105056|FG000|Overall Study|Protocol Violation|1|||
27801396|NCT02476851|81105057|FG001|Overall Study|Protocol Violation|1|||
27801397|NCT00344305|81105058|FG000|Overall Study|Lost to Follow-up|2|||
27801398|NCT00344305|81105059|FG001|Overall Study|Lost to Follow-up|0|||
27801399|NCT00344305|81105058|FG000|Overall Study|Participant was not contacted in window|0|||
27801400|NCT00344305|81105059|FG001|Overall Study|Participant was not contacted in window|1|||
27801401|NCT03672396|81105062|FG000|Overall Study|Withdrawal by Subject|4|||
27801402|NCT03672396|81105062|FG000|Overall Study|Physician Decision|1|||
27801403|NCT03672396|81105062|FG000|Overall Study|Adverse Event|1|||
27801404|NCT00529802|81105064|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
27801405|NCT00529802|81105064|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
27801406|NCT00529802|81105064|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
27801407|NCT00529802|81105064|FG000|Evaluable for Primary Endpoint|Death|1|||
27801408|NCT00529802|81105064|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
27801409|NCT00529802|81105064|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
27801410|NCT00529802|81105064|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
27801411|NCT01835470|81105065|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
27801412|NCT01835470|81105065|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
27801413|NCT03940586|81105066|FG000|Overall Study|Death|3|||
27801414|NCT03940586|81105067|FG001|Overall Study|Death|2|||
27801415|NCT03940586|81105068|FG002|Overall Study|Death|0|||
27994330|NCT03301350|81808326|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
27994331|NCT03301350|81808326|FG000|Overall Study|no detail provided|1|||
27994332|NCT00719355|81808338|FG000|Overall Study|Death|0|||
27994333|NCT00719355|81808339|FG001|Overall Study|Death|1|||
27994334|NCT00719355|81808338|FG000|Overall Study|Medical|14|||
27994335|NCT00719355|81808339|FG001|Overall Study|Medical|5|||
27994336|NCT00719355|81808338|FG000|Overall Study|Compliance|4|||
27994337|NCT00719355|81808339|FG001|Overall Study|Compliance|6|||
27994338|NCT00719355|81808338|FG000|Overall Study|Moved|0|||
27994339|NCT00719355|81808339|FG001|Overall Study|Moved|1|||
27994340|NCT02629822|81808340|FG000|Base Study|Lost to Follow-up|2|||
27994341|NCT02629822|81808340|FG000|Base Study|Non-Compliance With Study Drug|1|||
27994342|NCT02629822|81808340|FG000|Extension Study|Adverse Event|1|||
27994343|NCT02629822|81808340|FG000|Extension Study|Lost to Follow-up|1|||
27994344|NCT00344500|81808341|FG000|Overall Study|Adverse Event|6|||
27994345|NCT00344500|81808342|FG001|Overall Study|Adverse Event|2|||
27994346|NCT00344500|81808343|FG002|Overall Study|Adverse Event|0|||
27994347|NCT00344500|81808341|FG000|Overall Study|Lost to Follow-up|5|||
27994348|NCT00344500|81808342|FG001|Overall Study|Lost to Follow-up|13|||
27994349|NCT00344500|81808343|FG002|Overall Study|Lost to Follow-up|1|||
27994350|NCT00344500|81808341|FG000|Overall Study|Withdrawal by Subject|7|||
27801416|NCT03940586|81105066|FG000|Overall Study|Physician Decision|1|||
27801417|NCT03940586|81105067|FG001|Overall Study|Physician Decision|0|||
27801418|NCT03940586|81105068|FG002|Overall Study|Physician Decision|1|||
27801419|NCT03940586|81105066|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
27801420|NCT03940586|81105067|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
27801421|NCT03940586|81105068|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
27801422|NCT03940586|81105066|FG000|Overall Study|Not Treated|0|||
27994351|NCT00344500|81808342|FG001|Overall Study|Withdrawal by Subject|10|||
27994352|NCT00344500|81808343|FG002|Overall Study|Withdrawal by Subject|0|||
27994353|NCT00344500|81808341|FG000|Overall Study|Protocol Violation|4|||
27871707|NCT01564537|81365058|FG001|Overall Study|Reason not specified|82|||
27871708|NCT02152605|81365059|FG000|Overall Study|Adverse Event|6|||
27871709|NCT02152605|81365060|FG001|Overall Study|Adverse Event|8|||
27871710|NCT02152605|81365059|FG000|Overall Study|Lack of Efficacy|7|||
27871711|NCT02152605|81365060|FG001|Overall Study|Lack of Efficacy|4|||
27871712|NCT02152605|81365059|FG000|Overall Study|Protocol deviation|1|||
27871713|NCT02152605|81365060|FG001|Overall Study|Protocol deviation|4|||
27871714|NCT02152605|81365059|FG000|Overall Study|Lost to Follow-up|1|||
27871715|NCT02152605|81365060|FG001|Overall Study|Lost to Follow-up|0|||
27871716|NCT02152605|81365059|FG000|Overall Study|Withdrew consent|4|||
27871717|NCT02152605|81365060|FG001|Overall Study|Withdrew consent|2|||
27871718|NCT00529373|81365061|FG000|Base Study|Adverse Event|525|||
27871719|NCT00529373|81365062|FG001|Base Study|Adverse Event|470|||
27871720|NCT00529373|81365061|FG000|Base Study|Lack of Efficacy|16|||
27871721|NCT00529373|81365062|FG001|Base Study|Lack of Efficacy|75|||
27871722|NCT00529373|81365061|FG000|Base Study|Lost to Follow-up|221|||
27871723|NCT00529373|81365062|FG001|Base Study|Lost to Follow-up|208|||
27871724|NCT00529373|81365061|FG000|Base Study|Other Protocol Specified Criteria|19|||
27871725|NCT00529373|81365062|FG001|Base Study|Other Protocol Specified Criteria|20|||
27871726|NCT00529373|81365061|FG000|Base Study|Physician Decision|60|||
27871727|NCT00529373|81365062|FG001|Base Study|Physician Decision|52|||
27871728|NCT00529373|81365061|FG000|Base Study|Protocol Violation|48|||
27871729|NCT00529373|81365062|FG001|Base Study|Protocol Violation|38|||
27871730|NCT00529373|81365061|FG000|Base Study|Withdrawal by Subject|1062|||
27871731|NCT00529373|81365062|FG001|Base Study|Withdrawal by Subject|967|||
27871732|NCT00529373|81365061|FG000|Base Study|Did not continue into Extension|1795|||
27871733|NCT00529373|81365062|FG001|Base Study|Did not continue into Extension|2238|||
27801423|NCT03940586|81105067|FG001|Overall Study|Not Treated|2|||
27801424|NCT03940586|81105068|FG002|Overall Study|Not Treated|0|||
27801425|NCT02766088|81105069|FG000|Overall Study|Sponsor study termination|498|||
27801426|NCT02766088|81105069|FG000|Overall Study|Migrated/moved from the study area|1|||
27801427|NCT02766088|81105069|FG000|Overall Study|Lost to Follow-up|5|||
27801428|NCT02766088|81105069|FG000|Overall Study|Other|1|||
27801429|NCT02766088|81105069|FG000|Overall Study|Death|1|||
27801430|NCT00563524|81105070|FG000|Overall Study|Adverse Event|0|||
27801431|NCT00563524|81105071|FG001|Overall Study|Adverse Event|1|||
27801432|NCT00563524|81105072|FG002|Overall Study|Adverse Event|0|||
27801433|NCT00563524|81105073|FG003|Overall Study|Adverse Event|0|||
27801434|NCT00563524|81105074|FG004|Overall Study|Adverse Event|2|||
27801435|NCT00563524|81105075|FG005|Overall Study|Adverse Event|0|||
27871734|NCT00529373|81365061|FG000|First Extension Study|Adverse Event|162|||
27871735|NCT00529373|81365062|FG001|First Extension Study|Adverse Event|142|||
27871736|NCT00529373|81365061|FG000|First Extension Study|Lack of Efficacy|65|||
27871737|NCT00529373|81365062|FG001|First Extension Study|Lack of Efficacy|427|||
27871738|NCT00529373|81365061|FG000|First Extension Study|Lost to Follow-up|41|||
27871739|NCT00529373|81365062|FG001|First Extension Study|Lost to Follow-up|37|||
27871740|NCT00529373|81365061|FG000|First Extension Study|Other|27|||
27871741|NCT00529373|81365062|FG001|First Extension Study|Other|47|||
27871742|NCT00529373|81365061|FG000|First Extension Study|Physician Decision|50|||
27871743|NCT00529373|81365062|FG001|First Extension Study|Physician Decision|45|||
27871744|NCT00529373|81365061|FG000|First Extension Study|Protocol Violation|16|||
27871745|NCT00529373|81365062|FG001|First Extension Study|Protocol Violation|13|||
27871746|NCT00529373|81365061|FG000|First Extension Study|Withdrawal by Subject|296|||
27871747|NCT00529373|81365062|FG001|First Extension Study|Withdrawal by Subject|287|||
27871748|NCT00529373|81365061|FG000|First Extension Study|Disposition record non-existing|0|||
27871749|NCT00529373|81365062|FG001|First Extension Study|Disposition record non-existing|1|||
27871750|NCT00529373|81365061|FG000|First Extension Study|Discontinued after 5 years completion|208|||
27871751|NCT00529373|81365062|FG001|First Extension Study|Discontinued after 5 years completion|346|||
27871752|NCT00529373|81365061|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
27871753|NCT00529373|81365062|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
27871754|NCT00529373|81365061|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
27871755|NCT00529373|81365062|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
27871756|NCT00529373|81365061|FG000|Second Extension Study|Adverse Event|101|||
27871757|NCT00529373|81365062|FG001|Second Extension Study|Adverse Event|51|||
27871758|NCT00529373|81365061|FG000|Second Extension Study|Lack of Efficacy|7|||
27871759|NCT00529373|81365062|FG001|Second Extension Study|Lack of Efficacy|15|||
27871760|NCT00529373|81365061|FG000|Second Extension Study|Lost to Follow-up|18|||
27871761|NCT00529373|81365062|FG001|Second Extension Study|Lost to Follow-up|12|||
27871762|NCT00529373|81365061|FG000|Second Extension Study|Other|7|||
27871763|NCT00529373|81365062|FG001|Second Extension Study|Other|12|||
27801436|NCT00563524|81105070|FG000|Overall Study|Lost to Follow-up|1|||
27871764|NCT00529373|81365061|FG000|Second Extension Study|Physician Decision|63|||
27801437|NCT00563524|81105071|FG001|Overall Study|Lost to Follow-up|0|||
27871765|NCT00529373|81365062|FG001|Second Extension Study|Physician Decision|26|||
27871766|NCT00529373|81365061|FG000|Second Extension Study|Protocol Violation|2|||
27801438|NCT00563524|81105072|FG002|Overall Study|Lost to Follow-up|0|||
27801439|NCT00563524|81105073|FG003|Overall Study|Lost to Follow-up|0|||
27801440|NCT00563524|81105074|FG004|Overall Study|Lost to Follow-up|0|||
27801441|NCT00563524|81105075|FG005|Overall Study|Lost to Follow-up|0|||
27801442|NCT00563524|81105070|FG000|Overall Study|Protocol Violation|0|||
27801443|NCT00563524|81105071|FG001|Overall Study|Protocol Violation|1|||
27801444|NCT00563524|81105072|FG002|Overall Study|Protocol Violation|0|||
27801445|NCT00563524|81105073|FG003|Overall Study|Protocol Violation|0|||
27801446|NCT00563524|81105074|FG004|Overall Study|Protocol Violation|0|||
27801447|NCT00563524|81105075|FG005|Overall Study|Protocol Violation|0|||
27801448|NCT00563524|81105070|FG000|Overall Study|Withdrawal by Subject|1|||
27801449|NCT00563524|81105071|FG001|Overall Study|Withdrawal by Subject|1|||
27801450|NCT00563524|81105072|FG002|Overall Study|Withdrawal by Subject|3|||
27801451|NCT00563524|81105073|FG003|Overall Study|Withdrawal by Subject|0|||
27801452|NCT00563524|81105074|FG004|Overall Study|Withdrawal by Subject|0|||
27801453|NCT00563524|81105075|FG005|Overall Study|Withdrawal by Subject|1|||
27801454|NCT02156466|81105076|FG000|Overall Study|Adverse Event|0|||
27801455|NCT02156466|81105077|FG001|Overall Study|Adverse Event|0|||
27801456|NCT02156466|81105078|FG002|Overall Study|Adverse Event|1|||
27801457|NCT02156466|81105079|FG003|Overall Study|Adverse Event|1|||
27801458|NCT02156466|81105080|FG004|Overall Study|Adverse Event|0|||
27801459|NCT02156466|81105076|FG000|Overall Study|Quantiferon Positivity|0|||
27801460|NCT02156466|81105077|FG001|Overall Study|Quantiferon Positivity|0|||
27801461|NCT02156466|81105078|FG002|Overall Study|Quantiferon Positivity|0|||
27801462|NCT02156466|81105079|FG003|Overall Study|Quantiferon Positivity|1|||
27801463|NCT02156466|81105080|FG004|Overall Study|Quantiferon Positivity|0|||
27801464|NCT00272961|81105081|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
27801465|NCT00272961|81105082|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
27801466|NCT00272961|81105083|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
27871767|NCT00529373|81365062|FG001|Second Extension Study|Protocol Violation|1|||
27801467|NCT00272961|81105084|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
27801468|NCT00272961|81105085|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
27801469|NCT00272961|81105081|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
27801470|NCT00272961|81105082|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
27871768|NCT00529373|81365061|FG000|Second Extension Study|Withdrawal by Subject|97|||
27871769|NCT00529373|81365062|FG001|Second Extension Study|Withdrawal by Subject|75|||
27871770|NCT00529373|81365061|FG000|Second Extension Study|Status Missing|5|||
27871771|NCT00529373|81365062|FG001|Second Extension Study|Status Missing|5|||
27871772|NCT01742897|81365063|FG000|Overall Study|Adverse Event|3|||
27871773|NCT01742897|81365063|FG000|Overall Study|Withdrawal by Subject|1|||
27871774|NCT01742897|81365063|FG000|Overall Study|Other|1|||
27871775|NCT01786993|81365064|FG000|Overall Study|Death|6|||
27871776|NCT01786993|81365065|FG001|Overall Study|Death|7|||
27871777|NCT01786993|81365064|FG000|Overall Study|Withdrawal by Subject|3|||
27871778|NCT01786993|81365065|FG001|Overall Study|Withdrawal by Subject|2|||
27871779|NCT01786993|81365064|FG000|Overall Study|Lost to Follow-up|0|||
27801471|NCT00272961|81105083|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
27801472|NCT00272961|81105084|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
27801473|NCT00272961|81105085|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
27801474|NCT00272961|81105081|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
27871780|NCT01786993|81365065|FG001|Overall Study|Lost to Follow-up|1|||
27801475|NCT00272961|81105082|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
27801476|NCT00272961|81105083|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
27801477|NCT00272961|81105084|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
27801478|NCT00272961|81105085|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
27801479|NCT00272961|81105081|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
27801480|NCT00272961|81105082|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
27801481|NCT00272961|81105083|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
27801482|NCT00272961|81105084|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
27801483|NCT00272961|81105085|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
27871781|NCT01786993|81365064|FG000|Overall Study|Subject Non-Compliance|1|||
27871782|NCT01786993|81365065|FG001|Overall Study|Subject Non-Compliance|0|||
27871783|NCT01786993|81365064|FG000|Overall Study|System Explant|1|||
27801484|NCT00272961|81105081|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
27871784|NCT01786993|81365065|FG001|Overall Study|System Explant|0|||
27801485|NCT00272961|81105082|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
27801486|NCT00272961|81105083|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
27801487|NCT00272961|81105084|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
27871785|NCT01786993|81365064|FG000|Overall Study|Hospice Admission|1|||
27871786|NCT01786993|81365065|FG001|Overall Study|Hospice Admission|0|||
27801488|NCT00272961|81105085|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
27801489|NCT00272961|81105081|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
27871787|NCT02235454|81365066|FG000|Overall Study|Withdrawal by Subject|2|||
27871788|NCT01762800|81365075|FG000|Overall Study|Adverse Event|8|||
27801490|NCT00272961|81105082|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
27801491|NCT00272961|81105083|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
27801492|NCT00272961|81105084|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
27801493|NCT00272961|81105085|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
27801494|NCT00272961|81105081|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
27801495|NCT00272961|81105082|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
27801496|NCT00272961|81105083|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
27801497|NCT00272961|81105084|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
27801498|NCT00272961|81105085|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
27801499|NCT00272961|81105081|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
27801500|NCT00272961|81105082|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
27801501|NCT00272961|81105083|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
27801502|NCT00272961|81105084|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
27801503|NCT00272961|81105085|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
27801504|NCT01766310|81105087|FG000|Overall Study|Lost to Follow-up|1|||
27801505|NCT01766310|81105088|FG001|Overall Study|Lost to Follow-up|3|||
27801506|NCT00096200|81105089|FG000|Overall Study|Adverse Event|0|||
27801507|NCT00096200|81105090|FG001|Overall Study|Adverse Event|4|||
27801508|NCT00096200|81105091|FG002|Overall Study|Adverse Event|0|||
27801509|NCT00096200|81105089|FG000|Overall Study|Withdrawal by Subject|1|||
27801510|NCT00096200|81105090|FG001|Overall Study|Withdrawal by Subject|2|||
27801511|NCT00096200|81105091|FG002|Overall Study|Withdrawal by Subject|0|||
27801512|NCT00096200|81105089|FG000|Overall Study|Ineligible pathology|0|||
27801513|NCT00096200|81105090|FG001|Overall Study|Ineligible pathology|1|||
27801514|NCT00096200|81105091|FG002|Overall Study|Ineligible pathology|0|||
27801515|NCT04098068|81105095|FG000|Overall Study|Disease Progression|7|||
27801516|NCT04098068|81105095|FG000|Overall Study|Withdrawal by Subject|2|||
27801517|NCT04098068|81105095|FG000|Overall Study|New Cancer Diagnosis|1|||
27801518|NCT03056001|81105096|FG000|Overall Study|Death|24|||
27801519|NCT01050673|81105097|FG000|Overall Study|Physician Decision|4|||
27801520|NCT01050673|81105098|FG001|Overall Study|Physician Decision|5|||
27801521|NCT01174368|81105099|FG000|Overall Study|Withdrawal by Subject|1|||
27801522|NCT02643394|81105100|FG000|Overall Study|Protocol Violation|4|||
27801523|NCT02643394|81105101|FG001|Overall Study|Protocol Violation|5|||
27801524|NCT00267007|81105107|FG000|Overall Study|Withdrawal by Subject|6|||
27801525|NCT00267007|81105108|FG001|Overall Study|Withdrawal by Subject|0|||
27801526|NCT00267007|81105107|FG000|Overall Study|Lost to Follow-up|1|||
27871789|NCT01762800|81365076|FG001|Overall Study|Adverse Event|13|||
27871790|NCT01762800|81365075|FG000|Overall Study|Lack of Efficacy|3|||
27871791|NCT01762800|81365076|FG001|Overall Study|Lack of Efficacy|2|||
27871792|NCT01762800|81365075|FG000|Overall Study|Study Closed/Terminated|0|||
27871793|NCT01762800|81365076|FG001|Overall Study|Study Closed/Terminated|1|||
27871794|NCT01762800|81365075|FG000|Overall Study|Physician Decision|1|||
27871795|NCT01762800|81365076|FG001|Overall Study|Physician Decision|1|||
27871796|NCT01762800|81365075|FG000|Overall Study|Withdrawal by Subject|7|||
27871797|NCT01762800|81365076|FG001|Overall Study|Withdrawal by Subject|4|||
27871798|NCT00214383|81365079|FG000|Overall Study|Lost to Follow-up|16|||
27871799|NCT00214383|81365080|FG001|Overall Study|Lost to Follow-up|26|||
27871800|NCT00124917|81365081|FG000|Overall Study|Physician Decision|3|||
27871801|NCT02064296|81365082|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
27871802|NCT02064296|81365083|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
27871803|NCT02064296|81365084|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
27871804|NCT02064296|81365082|FG000|Intervention|Withdrawal by Subject|0|||
27871805|NCT02064296|81365083|FG001|Intervention|Withdrawal by Subject|1|||
27871806|NCT02064296|81365084|FG002|Intervention|Withdrawal by Subject|2|||
27871807|NCT02676882|81365087|FG000|Overall Study|Adverse Event|1|||
27871808|NCT02676882|81365088|FG001|Overall Study|Adverse Event|0|||
27871809|NCT02676882|81365087|FG000|Overall Study|Lost to Follow-up|1|||
27871810|NCT02676882|81365088|FG001|Overall Study|Lost to Follow-up|0|||
27871811|NCT02676882|81365087|FG000|Overall Study|Withdrawal by Subject|1|||
27871812|NCT02676882|81365088|FG001|Overall Study|Withdrawal by Subject|2|||
27871813|NCT03668808|81365090|FG000|First Intervention|Withdrawal by Subject|2|||
27871814|NCT03668808|81365091|FG001|First Intervention|Withdrawal by Subject|2|||
27801527|NCT00267007|81105108|FG001|Overall Study|Lost to Follow-up|0|||
27801528|NCT00267007|81105107|FG000|Overall Study|Non-compliance|0|||
27801529|NCT00267007|81105108|FG001|Overall Study|Non-compliance|1|||
27871815|NCT02899962|81365102|FG000|Open-label Phase|Adverse Event|2|||
27871816|NCT02899962|81365103|FG001|Open-label Phase|Adverse Event|0|||
27871817|NCT02899962|81365104|FG002|Open-label Phase|Adverse Event|0|||
27871818|NCT02899962|81365102|FG000|Open-label Phase|Lost to Follow-up|9|||
27801530|NCT00267007|81105107|FG000|Overall Study|Adverse Event|1|||
27801531|NCT00267007|81105108|FG001|Overall Study|Adverse Event|0|||
27801532|NCT02524665|81105109|FG000|Overall Study|Lost to Follow-up|1|||
27871819|NCT02899962|81365103|FG001|Open-label Phase|Lost to Follow-up|0|||
27871820|NCT02899962|81365104|FG002|Open-label Phase|Lost to Follow-up|0|||
27801533|NCT00078312|81105110|FG000|Overall Study|Adverse Event|43|||
27801534|NCT00078312|81105110|FG000|Overall Study|Lack of Efficacy|15|||
27801535|NCT00078312|81105110|FG000|Overall Study|Lost to Follow-up|41|||
27801536|NCT00078312|81105110|FG000|Overall Study|Physician Decision|9|||
27801537|NCT00078312|81105110|FG000|Overall Study|Protocol Violation|3|||
27801538|NCT00078312|81105110|FG000|Overall Study|Withdrawal by Subject|33|||
27801539|NCT00078312|81105110|FG000|Overall Study|Miscellaneous|33|||
27801540|NCT02176642|81105113|FG000|Overall Study|Withdrawal by Subject|0|||
27801541|NCT02176642|81105114|FG001|Overall Study|Withdrawal by Subject|1|||
27801542|NCT01559818|81105115|FG000|Overall Study|Physician Decision|1|||
27801543|NCT01559818|81105115|FG000|Overall Study|Pregnancy|1|||
27801544|NCT01559818|81105115|FG000|Overall Study|Study terminated by Sponsor|4|||
27801545|NCT01559818|81105115|FG000|Overall Study|Withdrawal by Subject|1|||
27801546|NCT00640614|81105116|FG000|Overall Study|Lost to Follow-up|1|||
27801547|NCT00640614|81105117|FG001|Overall Study|Lost to Follow-up|0|||
27801548|NCT01858558|81105118|FG000|Overall Study|Death|1|||
27801549|NCT01858558|81105119|FG001|Overall Study|Death|1|||
27801550|NCT01858558|81105118|FG000|Overall Study|Lost to Follow-up|1|||
27801551|NCT01858558|81105119|FG001|Overall Study|Lost to Follow-up|0|||
27801552|NCT01858558|81105118|FG000|Overall Study|Disease progression|3|||
27801553|NCT01858558|81105119|FG001|Overall Study|Disease progression|1|||
27871821|NCT02899962|81365102|FG000|Open-label Phase|Other reasons|9|||
27801554|NCT01858558|81105118|FG000|Overall Study|Product contamination|2|||
27871822|NCT02899962|81365103|FG001|Open-label Phase|Other reasons|0|||
27871823|NCT02899962|81365104|FG002|Open-label Phase|Other reasons|0|||
27871824|NCT02899962|81365102|FG000|Open-label Phase|Withdrawal by Subject|7|||
27871825|NCT02899962|81365103|FG001|Open-label Phase|Withdrawal by Subject|0|||
27871826|NCT02899962|81365104|FG002|Open-label Phase|Withdrawal by Subject|0|||
27871827|NCT02899962|81365102|FG000|Maintenance Phase|Adverse Event|0|||
27871828|NCT02899962|81365103|FG001|Maintenance Phase|Adverse Event|2|||
27871829|NCT02899962|81365104|FG002|Maintenance Phase|Adverse Event|1|||
27871830|NCT02899962|81365102|FG000|Maintenance Phase|Death|0|||
27871831|NCT02899962|81365103|FG001|Maintenance Phase|Death|0|||
27871832|NCT02899962|81365104|FG002|Maintenance Phase|Death|1|||
27871833|NCT02899962|81365102|FG000|Maintenance Phase|Lack of Efficacy|0|||
27871834|NCT02899962|81365103|FG001|Maintenance Phase|Lack of Efficacy|20|||
27871835|NCT02899962|81365104|FG002|Maintenance Phase|Lack of Efficacy|16|||
27871836|NCT02899962|81365102|FG000|Maintenance Phase|Lost to Follow-up|0|||
27871837|NCT02899962|81365103|FG001|Maintenance Phase|Lost to Follow-up|12|||
27871838|NCT02899962|81365104|FG002|Maintenance Phase|Lost to Follow-up|14|||
27871839|NCT02899962|81365102|FG000|Maintenance Phase|Other reasons|0|||
27871840|NCT02899962|81365103|FG001|Maintenance Phase|Other reasons|9|||
27871841|NCT02899962|81365104|FG002|Maintenance Phase|Other reasons|13|||
27871842|NCT02899962|81365102|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
27871843|NCT02899962|81365103|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
27871844|NCT02899962|81365104|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
27871845|NCT02899962|81365102|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
27871846|NCT02899962|81365103|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
27871847|NCT02899962|81365104|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
27871848|NCT02899962|81365102|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27871849|NCT02899962|81365103|FG001|Maintenance Phase|Withdrawal by Subject|30|||
27871850|NCT02899962|81365104|FG002|Maintenance Phase|Withdrawal by Subject|36|||
27871851|NCT02955212|81365106|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
27871852|NCT02955212|81365107|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
27994354|NCT00344500|81808342|FG001|Overall Study|Protocol Violation|7|||
27994355|NCT00344500|81808343|FG002|Overall Study|Protocol Violation|1|||
27994356|NCT00344500|81808341|FG000|Overall Study|Not Noted|1|||
27994357|NCT00344500|81808342|FG001|Overall Study|Not Noted|3|||
27994358|NCT00344500|81808343|FG002|Overall Study|Not Noted|0|||
27994359|NCT00126776|81808344|FG000|Overall Study|follow up complete on all patients|0|||
27994360|NCT00126776|81808345|FG001|Overall Study|follow up complete on all patients|0|||
27994361|NCT00555672|81808346|FG000|Overall Study|Death|0|||
27994362|NCT00555672|81808347|FG001|Overall Study|Death|2|||
27994363|NCT00555672|81808346|FG000|Overall Study|Adverse Event|8|||
27801555|NCT01858558|81105119|FG001|Overall Study|Product contamination|0|||
27801556|NCT01858558|81105118|FG000|Overall Study|Failed expansion of cell product|2|||
27871853|NCT02955212|81365106|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
27871854|NCT02955212|81365107|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
27871855|NCT02955212|81365106|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
27871856|NCT02955212|81365107|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
27801557|NCT01858558|81105119|FG001|Overall Study|Failed expansion of cell product|0|||
27994364|NCT00555672|81808347|FG001|Overall Study|Adverse Event|2|||
27801558|NCT02162511|81105123|FG000|Overall Study|Lack of Efficacy|0|||
27801559|NCT02162511|81105124|FG001|Overall Study|Lack of Efficacy|0|||
27801560|NCT02162511|81105125|FG002|Overall Study|Lack of Efficacy|2|||
27801561|NCT01422720|81105126|FG000|Overall Study|Adverse Event|16|||
27678271|NCT02416453|80660349|FG006|Overall Study|Physician Decision|1|||
27678272|NCT02416453|80660350|FG007|Overall Study|Physician Decision|1|||
27678273|NCT02416453|80660351|FG008|Overall Study|Physician Decision|0|||
27678274|NCT02416453|80660352|FG009|Overall Study|Physician Decision|0|||
27678275|NCT02416453|80660353|FG010|Overall Study|Physician Decision|0|||
27801562|NCT01422720|81105126|FG000|Overall Study|Lack of Efficacy|1|||
27801563|NCT01422720|81105126|FG000|Overall Study|Withdrawal by Subject|4|||
27801564|NCT01422720|81105126|FG000|Overall Study|Ineligibility|1|||
27801565|NCT00725725|81105127|FG000|Overall Study|Adverse Event|1|||
27801566|NCT00725725|81105128|FG001|Overall Study|Adverse Event|3|||
27801567|NCT00725725|81105129|FG002|Overall Study|Adverse Event|2|||
27678276|NCT02416453|80660343|FG000|Overall Study|Withdrawal by Subject|2|||
27678277|NCT02416453|80660344|FG001|Overall Study|Withdrawal by Subject|0|||
27801568|NCT00725725|81105127|FG000|Overall Study|Lost to Follow-up|2|||
27801569|NCT00725725|81105128|FG001|Overall Study|Lost to Follow-up|0|||
27801570|NCT00725725|81105129|FG002|Overall Study|Lost to Follow-up|2|||
27801571|NCT00725725|81105127|FG000|Overall Study|Withdrawal by Subject|1|||
27678278|NCT02416453|80660345|FG002|Overall Study|Withdrawal by Subject|0|||
27678279|NCT02416453|80660346|FG003|Overall Study|Withdrawal by Subject|5|||
27678280|NCT02416453|80660347|FG004|Overall Study|Withdrawal by Subject|1|||
27678281|NCT02416453|80660348|FG005|Overall Study|Withdrawal by Subject|8|||
27678282|NCT02416453|80660349|FG006|Overall Study|Withdrawal by Subject|0|||
27678283|NCT02416453|80660350|FG007|Overall Study|Withdrawal by Subject|8|||
27678284|NCT02416453|80660351|FG008|Overall Study|Withdrawal by Subject|4|||
27678285|NCT02416453|80660352|FG009|Overall Study|Withdrawal by Subject|0|||
27678286|NCT02416453|80660353|FG010|Overall Study|Withdrawal by Subject|0|||
27678287|NCT02416453|80660343|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678288|NCT02416453|80660344|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678289|NCT02416453|80660345|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
27678290|NCT02416453|80660346|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678291|NCT02416453|80660347|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678292|NCT02416453|80660348|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678293|NCT02416453|80660349|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678294|NCT02416453|80660350|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678295|NCT02416453|80660351|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678296|NCT02416453|80660352|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678297|NCT02416453|80660353|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
27678298|NCT02416453|80660343|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678299|NCT02416453|80660344|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678300|NCT02416453|80660345|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678301|NCT02416453|80660346|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678302|NCT02416453|80660347|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678303|NCT02416453|80660348|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
27678304|NCT02416453|80660349|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678305|NCT02416453|80660350|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678306|NCT02416453|80660351|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678307|NCT02416453|80660352|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678308|NCT02416453|80660353|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
27678309|NCT01199068|80660355|FG000|Overall Study|Unacceptable toxicity|0|||
27801572|NCT00725725|81105128|FG001|Overall Study|Withdrawal by Subject|0|||
27801573|NCT00725725|81105129|FG002|Overall Study|Withdrawal by Subject|1|||
27801574|NCT00725725|81105127|FG000|Overall Study|Protocol Violation|0|||
27678310|NCT01199068|80660356|FG001|Overall Study|Unacceptable toxicity|0|||
27678311|NCT01199068|80660357|FG002|Overall Study|Unacceptable toxicity|2|||
27678312|NCT01199068|80660355|FG000|Overall Study|Progressive disease|3|||
27801575|NCT00725725|81105128|FG001|Overall Study|Protocol Violation|1|||
27801576|NCT00725725|81105129|FG002|Overall Study|Protocol Violation|0|||
27801577|NCT00963599|81105139|FG000|Overall Study|Adverse Event|2|||
27801578|NCT00963599|81105140|FG001|Overall Study|Adverse Event|0|||
27678313|NCT01199068|80660356|FG001|Overall Study|Progressive disease|3|||
27678314|NCT01199068|80660357|FG002|Overall Study|Progressive disease|6|||
27678315|NCT01199068|80660355|FG000|Overall Study|Withdrawal by Subject|0|||
27678316|NCT01199068|80660356|FG001|Overall Study|Withdrawal by Subject|0|||
27678317|NCT01199068|80660357|FG002|Overall Study|Withdrawal by Subject|1|||
27678318|NCT00589303|80660358|FG000|Overall Study|Withdrawal by Subject|2|||
27801579|NCT00963599|81105141|FG002|Overall Study|Adverse Event|1|||
27801580|NCT00963599|81105142|FG003|Overall Study|Adverse Event|2|||
27801581|NCT00963599|81105139|FG000|Overall Study|Lack of Efficacy|0|||
27801582|NCT00963599|81105140|FG001|Overall Study|Lack of Efficacy|2|||
27801583|NCT00963599|81105141|FG002|Overall Study|Lack of Efficacy|1|||
27801584|NCT00963599|81105142|FG003|Overall Study|Lack of Efficacy|4|||
27801585|NCT00963599|81105139|FG000|Overall Study|Lost to Follow-up|0|||
27801586|NCT00963599|81105140|FG001|Overall Study|Lost to Follow-up|1|||
27801587|NCT00963599|81105141|FG002|Overall Study|Lost to Follow-up|1|||
27801588|NCT00963599|81105142|FG003|Overall Study|Lost to Follow-up|1|||
27801589|NCT00963599|81105139|FG000|Overall Study|Protocol Violation|2|||
27801590|NCT00963599|81105140|FG001|Overall Study|Protocol Violation|2|||
27678319|NCT00589303|80660359|FG001|Overall Study|Withdrawal by Subject|1|||
27678320|NCT00842244|80660362|FG000|Overall Study|Death|3|||
27678321|NCT00842244|80660362|FG000|Overall Study|Withdrawal by Subject|1|||
27678322|NCT00842244|80660362|FG000|Overall Study|Other|17|||
27678323|NCT00078338|80660363|FG000|Overall Study|Adverse Event|31|||
27678324|NCT00078338|80660364|FG001|Overall Study|Adverse Event|24|||
27678325|NCT00078338|80660363|FG000|Overall Study|Lost to Follow-up|17|||
27678326|NCT00078338|80660364|FG001|Overall Study|Lost to Follow-up|2|||
27678327|NCT00078338|80660363|FG000|Overall Study|Protocol Violation|2|||
27678328|NCT00078338|80660364|FG001|Overall Study|Protocol Violation|2|||
27801591|NCT00963599|81105141|FG002|Overall Study|Protocol Violation|3|||
27801592|NCT00963599|81105142|FG003|Overall Study|Protocol Violation|4|||
27801593|NCT00963599|81105139|FG000|Overall Study|Withdrawal by Subject|2|||
27801594|NCT00963599|81105140|FG001|Overall Study|Withdrawal by Subject|1|||
27801595|NCT00963599|81105141|FG002|Overall Study|Withdrawal by Subject|3|||
27801596|NCT00963599|81105142|FG003|Overall Study|Withdrawal by Subject|3|||
27801597|NCT02956005|81105143|FG000|Overall Study|Not eligible|1|||
27801598|NCT02956005|81105143|FG000|Overall Study|Withdrawal by Subject|3|||
27801599|NCT02956005|81105143|FG000|Overall Study|Physician Decision|12|||
27801600|NCT00068445|81105144|FG000|Randomization|Cancel|1|||
27801601|NCT00068445|81105145|FG001|Randomization|Cancel|3|||
27801602|NCT00068445|81105144|FG000|Randomization|Ineligible|1|||
27801603|NCT00068445|81105145|FG001|Randomization|Ineligible|1|||
27801604|NCT00068445|81105144|FG000|Treatment|Refused Further Treatment|13|||
27801605|NCT00068445|81105145|FG001|Treatment|Refused Further Treatment|10|||
27801606|NCT00068445|81105144|FG000|Treatment|Adverse Event|7|||
27801607|NCT00068445|81105145|FG001|Treatment|Adverse Event|1|||
27801608|NCT00068445|81105144|FG000|Treatment|Other (Specifics not available)|9|||
27801609|NCT00068445|81105145|FG001|Treatment|Other (Specifics not available)|5|||
27801610|NCT03467971|81105149|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27801611|NCT03467971|81105150|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27801612|NCT02038959|81105151|FG000|Overall Study|Withdrawal by Subject|6|||
27801613|NCT02038959|81105152|FG001|Overall Study|Withdrawal by Subject|8|||
27801614|NCT02953262|81105153|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
27801615|NCT02953262|81105154|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
27801616|NCT02953262|81105155|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
27801617|NCT02953262|81105156|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
27801618|NCT02239601|81105157|FG000|Overall Study|Withdrawal by Subject|3|||
27801619|NCT02239601|81105158|FG001|Overall Study|Withdrawal by Subject|4|||
27801620|NCT02239601|81105157|FG000|Overall Study|Protocol Violation|4|||
27801621|NCT02239601|81105158|FG001|Overall Study|Protocol Violation|2|||
27801622|NCT02200614|81105165|FG000|Double Blind Treatment|Adverse Event|86|||
27801623|NCT02200614|81105166|FG001|Double Blind Treatment|Adverse Event|48|||
27801624|NCT02200614|81105165|FG000|Double Blind Treatment|Confirmed metastasis|120|||
27801625|NCT02200614|81105166|FG001|Double Blind Treatment|Confirmed metastasis|140|||
27801626|NCT02200614|81105165|FG000|Double Blind Treatment|Judgment of the investigator|59|||
27801627|NCT02200614|81105166|FG001|Double Blind Treatment|Judgment of the investigator|99|||
27801628|NCT02200614|81105165|FG000|Double Blind Treatment|Metastasis by local reading|1|||
27801629|NCT02200614|81105166|FG001|Double Blind Treatment|Metastasis by local reading|3|||
27801630|NCT02200614|81105165|FG000|Double Blind Treatment|Other reason|6|||
27801631|NCT02200614|81105166|FG001|Double Blind Treatment|Other reason|2|||
27801632|NCT02200614|81105165|FG000|Double Blind Treatment|Personal reason|77|||
27801633|NCT02200614|81105166|FG001|Double Blind Treatment|Personal reason|85|||
27801634|NCT02200614|81105165|FG000|Double Blind Treatment|Protocol deviation|14|||
27801635|NCT02200614|81105166|FG001|Double Blind Treatment|Protocol deviation|7|||
27801636|NCT02200614|81105165|FG000|Double Blind Treatment|Not treated|1|||
27801637|NCT02200614|81105166|FG001|Double Blind Treatment|Not treated|0|||
27801638|NCT02200614|81105165|FG000|Open Label|Adverse Event|41|||
27801639|NCT02200614|81105166|FG001|Open Label|Adverse Event|11|||
27801640|NCT02200614|81105165|FG000|Open Label|Confirmed metastasis|1|||
27801641|NCT02200614|81105166|FG001|Open Label|Confirmed metastasis|0|||
27801642|NCT02200614|81105165|FG000|Open Label|Judgment of the investigator|29|||
27801643|NCT02200614|81105166|FG001|Open Label|Judgment of the investigator|2|||
27801644|NCT02200614|81105165|FG000|Open Label|Metastasis by local reading|138|||
27678329|NCT00078338|80660363|FG000|Overall Study|Disease Progression|4|||
27678330|NCT00078338|80660364|FG001|Overall Study|Disease Progression|7|||
27678331|NCT00078338|80660363|FG000|Overall Study|Other|28|||
27801645|NCT02200614|81105166|FG001|Open Label|Metastasis by local reading|27|||
27801646|NCT02200614|81105165|FG000|Open Label|Other reason|22|||
27801647|NCT02200614|81105166|FG001|Open Label|Other reason|4|||
27801648|NCT02200614|81105165|FG000|Open Label|Personal reason|60|||
27801649|NCT02200614|81105166|FG001|Open Label|Personal reason|8|||
27801650|NCT02200614|81105165|FG000|Open Label|Protocol deviation|3|||
27801651|NCT02200614|81105166|FG001|Open Label|Protocol deviation|2|||
27801652|NCT02200614|81105165|FG000|Open Label|Missing|2|||
27801653|NCT02200614|81105166|FG001|Open Label|Missing|2|||
27801654|NCT04056299|81105167|FG000|Overall Study|Sponsor discontinued study|3|||
27801655|NCT04056299|81105168|FG001|Overall Study|Sponsor discontinued study|3|||
27801656|NCT00366678|81105169|FG000|Infant Series|Withdrawal by Subject|8|||
27801657|NCT00366678|81105170|FG001|Infant Series|Withdrawal by Subject|6|||
27801658|NCT00366678|81105171|FG002|Infant Series|Withdrawal by Subject|0|||
27801659|NCT00366678|81105169|FG000|Infant Series|Protocol Violation|4|||
27801660|NCT00366678|81105170|FG001|Infant Series|Protocol Violation|3|||
27801661|NCT00366678|81105171|FG002|Infant Series|Protocol Violation|0|||
27801662|NCT00366678|81105169|FG000|Infant Series|Failed to return|1|||
27801663|NCT00366678|81105170|FG001|Infant Series|Failed to return|1|||
27801664|NCT00366678|81105171|FG002|Infant Series|Failed to return|0|||
27801665|NCT00366678|81105169|FG000|Infant Series|Adverse Event|1|||
27801666|NCT00366678|81105170|FG001|Infant Series|Adverse Event|0|||
27801667|NCT00366678|81105171|FG002|Infant Series|Adverse Event|0|||
27801668|NCT00366678|81105169|FG000|After Infant|Withdrawal by Subject|8|||
27801669|NCT00366678|81105170|FG001|After Infant|Withdrawal by Subject|4|||
27801670|NCT00366678|81105171|FG002|After Infant|Withdrawal by Subject|0|||
27801671|NCT00366678|81105169|FG000|After Infant|Lost to Follow-up|2|||
27801672|NCT00366678|81105170|FG001|After Infant|Lost to Follow-up|1|||
27801673|NCT00366678|81105171|FG002|After Infant|Lost to Follow-up|0|||
27801674|NCT00366678|81105169|FG000|After Infant|Failed to return|5|||
27801675|NCT00366678|81105170|FG001|After Infant|Failed to return|5|||
27801676|NCT00366678|81105171|FG002|After Infant|Failed to return|0|||
27801677|NCT00366678|81105169|FG000|After Infant|Adverse Event|1|||
27801678|NCT00366678|81105170|FG001|After Infant|Adverse Event|0|||
27801679|NCT00366678|81105171|FG002|After Infant|Adverse Event|0|||
27801680|NCT00366678|81105169|FG000|After Infant|Protocol Violation|1|||
27801681|NCT00366678|81105170|FG001|After Infant|Protocol Violation|0|||
27801682|NCT00366678|81105171|FG002|After Infant|Protocol Violation|0|||
27801683|NCT00366678|81105169|FG000|Toddler Dose|Protocol Violation|2|||
27801684|NCT00366678|81105170|FG001|Toddler Dose|Protocol Violation|1|||
27801685|NCT00366678|81105171|FG002|Toddler Dose|Protocol Violation|0|||
27801686|NCT00366678|81105169|FG000|Toddler Dose|Failed to return|1|||
27801687|NCT00366678|81105170|FG001|Toddler Dose|Failed to return|0|||
27801688|NCT00366678|81105171|FG002|Toddler Dose|Failed to return|0|||
27801689|NCT00366678|81105169|FG000|Toddler Dose|Withdrawal by Subject|1|||
27801690|NCT00366678|81105170|FG001|Toddler Dose|Withdrawal by Subject|0|||
27801691|NCT00366678|81105171|FG002|Toddler Dose|Withdrawal by Subject|0|||
27801692|NCT00366678|81105169|FG000|Toddler Dose|protocol deviation|1|||
27801693|NCT00366678|81105170|FG001|Toddler Dose|protocol deviation|0|||
27801694|NCT00366678|81105171|FG002|Toddler Dose|protocol deviation|0|||
27801695|NCT00740480|81105172|FG000|Overall Study|Adverse Event|1|||
27801696|NCT00740480|81105172|FG000|Overall Study|Physician Decision|1|||
27801697|NCT01896700|81105175|FG000|Overall Study|Adverse Event|4|||
27801698|NCT01896700|81105176|FG001|Overall Study|Adverse Event|5|||
27801699|NCT01896700|81105175|FG000|Overall Study|Withdrawal by Subject|0|||
27801700|NCT01896700|81105176|FG001|Overall Study|Withdrawal by Subject|1|||
27801701|NCT00827359|81105177|FG000|Overall Study|Progressive Diseas|19|||
27801702|NCT00827359|81105177|FG000|Overall Study|Unacceptable Toxicity|5|||
27801703|NCT00827359|81105177|FG000|Overall Study|Ineligible|1|||
27801704|NCT00990093|81105178|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
27801705|NCT00990093|81105179|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
27871857|NCT02955212|81365106|FG000|Period 1: Double-blind Treatment Period|Other|3|||
27871858|NCT02955212|81365107|FG001|Period 1: Double-blind Treatment Period|Other|2|||
27871859|NCT02955212|81365106|FG000|Period 2: Open-label Extension|Adverse Event|11|||
27871860|NCT02955212|81365107|FG001|Period 2: Open-label Extension|Adverse Event|7|||
27871861|NCT02955212|81365106|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
27801706|NCT00990093|81105178|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
27801707|NCT00990093|81105179|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
27801708|NCT00990093|81105178|FG000|Test Period 1 (1-14 Days)|Other|1|||
27801709|NCT00990093|81105179|FG001|Test Period 1 (1-14 Days)|Other|0|||
27801710|NCT00990093|81105178|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
27801711|NCT00990093|81105179|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
27801712|NCT00990093|81105178|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
27801713|NCT00990093|81105179|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
27801714|NCT00990093|81105178|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
27801715|NCT00990093|81105179|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
27801716|NCT00990093|81105178|FG000|Test Period 2 (15-28 Days)|Other|0|||
27871862|NCT02955212|81365107|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
27994365|NCT00555672|81808346|FG000|Overall Study|Objective progression or relapse|11|||
27994366|NCT00555672|81808347|FG001|Overall Study|Objective progression or relapse|5|||
27994367|NCT00555672|81808346|FG000|Overall Study|Other|3|||
27994368|NCT00555672|81808347|FG001|Overall Study|Other|1|||
27994369|NCT00555672|81808346|FG000|Overall Study|Participant refused|2|||
27994370|NCT00555672|81808347|FG001|Overall Study|Participant refused|0|||
27801717|NCT00990093|81105179|FG001|Test Period 2 (15-28 Days)|Other|1|||
27801718|NCT00449930|81105180|FG000|Overall Study|Adverse Event|9|||
27801719|NCT00449930|81105181|FG001|Overall Study|Adverse Event|19|||
27801720|NCT00449930|81105180|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
27801721|NCT00449930|81105181|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
27801722|NCT00449930|81105180|FG000|Overall Study|Lack of Efficacy|10|||
27801723|NCT00449930|81105181|FG001|Overall Study|Lack of Efficacy|1|||
27801724|NCT00449930|81105180|FG000|Overall Study|Lost to Follow-up|9|||
27801725|NCT00449930|81105181|FG001|Overall Study|Lost to Follow-up|14|||
27801726|NCT00449930|81105180|FG000|Overall Study|Physician Decision|1|||
27801727|NCT00449930|81105181|FG001|Overall Study|Physician Decision|2|||
27801728|NCT00449930|81105180|FG000|Overall Study|Protocol Violation|14|||
27801729|NCT00449930|81105181|FG001|Overall Study|Protocol Violation|15|||
27801730|NCT00449930|81105180|FG000|Overall Study|Withdrawal by Subject|16|||
27801731|NCT00449930|81105181|FG001|Overall Study|Withdrawal by Subject|23|||
27801732|NCT00449930|81105180|FG000|Overall Study|Glycemic discontinuation criteria|1|||
27801733|NCT00449930|81105181|FG001|Overall Study|Glycemic discontinuation criteria|1|||
27801734|NCT02441179|81105186|FG000|Overall Study|Withdrawal by Subject|1|||
27801735|NCT02441179|81105187|FG001|Overall Study|Withdrawal by Subject|1|||
27801736|NCT00021229|81105188|FG000|Overall Study|Adverse Event|10|||
27801737|NCT00021229|81105189|FG001|Overall Study|Adverse Event|5|||
27801738|NCT00021229|81105190|FG002|Overall Study|Adverse Event|2|||
27801739|NCT00021229|81105188|FG000|Overall Study|Death|0|||
27801740|NCT00021229|81105189|FG001|Overall Study|Death|1|||
27801741|NCT00021229|81105190|FG002|Overall Study|Death|0|||
27801742|NCT00021229|81105188|FG000|Overall Study|Withdrawal by Subject|7|||
27801743|NCT00021229|81105189|FG001|Overall Study|Withdrawal by Subject|7|||
27801744|NCT00021229|81105190|FG002|Overall Study|Withdrawal by Subject|1|||
27801745|NCT00021229|81105188|FG000|Overall Study|Progressive Disease|15|||
27801746|NCT00021229|81105189|FG001|Overall Study|Progressive Disease|19|||
27801747|NCT00021229|81105190|FG002|Overall Study|Progressive Disease|12|||
27801748|NCT00021229|81105188|FG000|Overall Study|Protocol Violation|1|||
27801749|NCT00021229|81105189|FG001|Overall Study|Protocol Violation|1|||
27801750|NCT00021229|81105190|FG002|Overall Study|Protocol Violation|0|||
27801751|NCT00021229|81105188|FG000|Overall Study|Physician Decision|0|||
27801752|NCT00021229|81105189|FG001|Overall Study|Physician Decision|0|||
27801753|NCT00021229|81105190|FG002|Overall Study|Physician Decision|1|||
27801754|NCT00021229|81105188|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
27801755|NCT00021229|81105189|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
27801756|NCT00021229|81105190|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
27801757|NCT01120600|81105195|FG000|Overall Study|Adverse Event|7|||
27801758|NCT01120600|81105196|FG001|Overall Study|Adverse Event|7|||
27994371|NCT02828436|81808348|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
27678332|NCT00078338|80660364|FG001|Overall Study|Other|16|||
27678333|NCT00078338|80660363|FG000|Overall Study|Subjects randomized, but not treated|3|||
27678334|NCT00078338|80660364|FG001|Overall Study|Subjects randomized, but not treated|3|||
27678335|NCT00335140|80660367|FG000|Overall Study|Ineligible|1|||
27678336|NCT02807272|80660368|FG000|Overall Study|Death|9|||
27678337|NCT02807272|80660369|FG001|Overall Study|Death|5|||
27678338|NCT02807272|80660370|FG002|Overall Study|Death|2|||
27678339|NCT02807272|80660371|FG003|Overall Study|Death|0|||
27678340|NCT02807272|80660372|FG004|Overall Study|Death|1|||
27678341|NCT02807272|80660368|FG000|Overall Study|Lost to Follow-up|1|||
27678342|NCT02807272|80660369|FG001|Overall Study|Lost to Follow-up|0|||
27678343|NCT02807272|80660370|FG002|Overall Study|Lost to Follow-up|0|||
27678344|NCT02807272|80660371|FG003|Overall Study|Lost to Follow-up|0|||
27678345|NCT02807272|80660372|FG004|Overall Study|Lost to Follow-up|0|||
27678346|NCT02807272|80660368|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
27801759|NCT01120600|81105195|FG000|Overall Study|Excessive Bone Loss|0|||
27994372|NCT02828436|81808349|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
27801760|NCT01120600|81105196|FG001|Overall Study|Excessive Bone Loss|4|||
27801761|NCT01120600|81105195|FG000|Overall Study|Lost to Follow-up|1|||
27801762|NCT01120600|81105196|FG001|Overall Study|Lost to Follow-up|3|||
27801763|NCT01120600|81105195|FG000|Overall Study|Physician Decision|1|||
27801764|NCT01120600|81105196|FG001|Overall Study|Physician Decision|3|||
27801765|NCT01120600|81105195|FG000|Overall Study|Protocol Violation|0|||
27678347|NCT02807272|80660369|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
27678348|NCT02807272|80660370|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
27678349|NCT02807272|80660371|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
27678350|NCT02807272|80660372|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
27801766|NCT01120600|81105196|FG001|Overall Study|Protocol Violation|4|||
27994373|NCT02828436|81808348|FG000|Period 1|Lost to Follow-up|0|||
27801767|NCT01120600|81105195|FG000|Overall Study|Withdrawal by Subject|10|||
27801768|NCT01120600|81105196|FG001|Overall Study|Withdrawal by Subject|11|||
27801769|NCT00858234|81105200|FG000|Overall Study|Adverse Event|6|||
27801770|NCT00858234|81105200|FG000|Overall Study|Progressive disease|2|||
27801771|NCT00858234|81105200|FG000|Overall Study|Status unknown|1|||
27801772|NCT01052038|81105201|FG000|Overall Study|Lost to Follow-up|2|||
27801773|NCT01052038|81105202|FG001|Overall Study|Lost to Follow-up|3|||
27801774|NCT01052038|81105203|FG002|Overall Study|Lost to Follow-up|1|||
27801775|NCT01052038|81105201|FG000|Overall Study|Protocol Violation|2|||
27801776|NCT01052038|81105202|FG001|Overall Study|Protocol Violation|3|||
27801777|NCT01052038|81105203|FG002|Overall Study|Protocol Violation|3|||
27801778|NCT00835068|81105204|FG000|Overall Study|Death|1|||
27801779|NCT00835068|81105205|FG001|Overall Study|Death|0|||
27801780|NCT00835068|81105204|FG000|Overall Study|Adverse Event|0|||
27801781|NCT00835068|81105205|FG001|Overall Study|Adverse Event|1|||
27801782|NCT00835068|81105204|FG000|Overall Study|Other|8|||
27801783|NCT00835068|81105205|FG001|Overall Study|Other|0|||
27801784|NCT00835068|81105204|FG000|Overall Study|Withdrawal by Subject|1|||
27801785|NCT00835068|81105205|FG001|Overall Study|Withdrawal by Subject|0|||
27801786|NCT02295280|81105208|FG000|Overall Study|Adverse Event|0|||
27801787|NCT02295280|81105209|FG001|Overall Study|Adverse Event|1|||
27801788|NCT03276962|81105210|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
27801789|NCT03276962|81105211|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
27994374|NCT02828436|81808349|FG001|Period 1|Lost to Follow-up|1|||
27994375|NCT02828436|81808348|FG000|Period 2|Withdrawal by Subject|4|||
27994376|NCT02828436|81808349|FG001|Period 2|Withdrawal by Subject|0|||
27994377|NCT02828436|81808348|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
27994378|NCT02828436|81808349|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
27994379|NCT02828436|81808348|FG000|Period 2|Lost to Follow-up|1|||
27994380|NCT02828436|81808349|FG001|Period 2|Lost to Follow-up|0|||
27994381|NCT01279616|81808351|FG000|Overall Study|donor could not be located|5|||
27994382|NCT01279616|81808351|FG000|Overall Study|no signs of sickle cell disease|2|||
27994383|NCT01359943|81808354|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
27994384|NCT01359943|81808355|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
27994385|NCT01359943|81808356|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
27994386|NCT01359943|81808354|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
27994387|NCT01359943|81808355|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
27994388|NCT01359943|81808356|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
27994389|NCT01359943|81808354|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
27994390|NCT01359943|81808355|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
27994391|NCT01359943|81808356|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
27994392|NCT01359943|81808354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
27994393|NCT01359943|81808355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
27994394|NCT01359943|81808356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
27994395|NCT01359943|81808354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
27994396|NCT01359943|81808355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
27994397|NCT01359943|81808356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
27579443|NCT00048724|80306603|FG001|Overall Study|Protocol-defined Clinical Event|32|||
27579444|NCT00048724|80306602|FG000|Overall Study|Noncompliance With Protocol|4|||
27579445|NCT00048724|80306603|FG001|Overall Study|Noncompliance With Protocol|12|||
27579446|NCT00048724|80306602|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
27579447|NCT00048724|80306603|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
27579448|NCT00048724|80306602|FG000|Overall Study|Administrative|1|||
27579449|NCT00048724|80306603|FG001|Overall Study|Administrative|1|||
27579450|NCT04121962|80306604|FG000|Overall Study|Lost to Follow-up|42|||
27579451|NCT04121962|80306605|FG001|Overall Study|Lost to Follow-up|39|||
27579452|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
27579453|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
27579454|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
27579455|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
27579456|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
27801790|NCT03276962|81105212|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
27801791|NCT03276962|81105213|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
27801792|NCT03276962|81105214|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
27801793|NCT03276962|81105210|FG000|Overall Study|Protocol Deviation|2|||
27801794|NCT03276962|81105211|FG001|Overall Study|Protocol Deviation|0|||
27801795|NCT03276962|81105212|FG002|Overall Study|Protocol Deviation|1|||
27801796|NCT03276962|81105213|FG003|Overall Study|Protocol Deviation|2|||
27579457|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
27579458|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
27801797|NCT03276962|81105214|FG004|Overall Study|Protocol Deviation|1|||
27801798|NCT03276962|81105210|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
27994398|NCT01359943|81808354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
27994399|NCT01359943|81808355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
27994400|NCT01359943|81808356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
27994401|NCT01359943|81808354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
27994402|NCT01359943|81808355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
27994403|NCT01359943|81808356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
27994404|NCT01359943|81808354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
27994405|NCT01359943|81808355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
27994406|NCT01359943|81808356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
27994407|NCT01359943|81808354|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
27994408|NCT01359943|81808355|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
27994409|NCT01359943|81808356|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
27994410|NCT01359943|81808354|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
27994411|NCT01359943|81808355|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
27994412|NCT01359943|81808356|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
27994413|NCT01359943|81808354|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
27994414|NCT01359943|81808355|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
27994415|NCT01359943|81808356|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
27994416|NCT01359943|81808354|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
27678351|NCT02807272|80660368|FG000|Overall Study|Protocol-defined Disease Progression|0|||
27678352|NCT02807272|80660369|FG001|Overall Study|Protocol-defined Disease Progression|1|||
27678353|NCT02807272|80660370|FG002|Overall Study|Protocol-defined Disease Progression|0|||
27678354|NCT02807272|80660371|FG003|Overall Study|Protocol-defined Disease Progression|0|||
27678355|NCT02807272|80660372|FG004|Overall Study|Protocol-defined Disease Progression|1|||
27678356|NCT02807272|80660368|FG000|Overall Study|Study Terminated by Sponsor|1|||
27678357|NCT02807272|80660369|FG001|Overall Study|Study Terminated by Sponsor|0|||
27678358|NCT02807272|80660370|FG002|Overall Study|Study Terminated by Sponsor|0|||
27678359|NCT02807272|80660371|FG003|Overall Study|Study Terminated by Sponsor|1|||
27678360|NCT02807272|80660372|FG004|Overall Study|Study Terminated by Sponsor|0|||
27678361|NCT02807272|80660368|FG000|Overall Study|Other|1|||
27678362|NCT02807272|80660369|FG001|Overall Study|Other|0|||
27678363|NCT02807272|80660370|FG002|Overall Study|Other|0|||
27678364|NCT02807272|80660371|FG003|Overall Study|Other|0|||
27678365|NCT02807272|80660372|FG004|Overall Study|Other|1|||
27678366|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
27678367|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
27678368|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27678369|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
27678370|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27678371|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27678372|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
27678373|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
27678374|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27678375|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27678376|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
27678377|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27678378|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
27678379|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
27678380|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27678381|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
27678382|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
27678383|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
27678384|NCT00603525|80660373|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
27678385|NCT00603525|80660374|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
27678386|NCT00603525|80660375|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
27678387|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27678388|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
27678389|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27678390|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27678391|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
27678392|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27678393|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27678394|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
27678395|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27678396|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27678397|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
27678398|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27678399|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27678400|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
27678401|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27994417|NCT01359943|81808355|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
27678402|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27678403|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
27678404|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27678405|NCT00603525|80660373|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27678406|NCT00603525|80660374|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
27678407|NCT00603525|80660375|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27678408|NCT00603525|80660373|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
27678409|NCT00603525|80660374|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
27678410|NCT00603525|80660375|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
27678411|NCT01609062|80660378|FG000|Extension Phase|Terminated by Sponsor|14|||
27678412|NCT01609062|80660379|FG001|Extension Phase|Terminated by Sponsor|9|||
27678413|NCT01609062|80660378|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
27678414|NCT01609062|80660379|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
27678415|NCT01609062|80660378|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
27678416|NCT01609062|80660379|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
27678417|NCT01016262|80660386|FG000|Double-blind Phase|Adverse Event|0|||
27678418|NCT01016262|80660387|FG001|Double-blind Phase|Adverse Event|0|||
27678419|NCT01016262|80660388|FG002|Double-blind Phase|Adverse Event|1|||
27678420|NCT01016262|80660389|FG003|Double-blind Phase|Adverse Event|0|||
27678421|NCT01016262|80660390|FG004|Double-blind Phase|Adverse Event|0|||
27678422|NCT01016262|80660391|FG005|Double-blind Phase|Adverse Event|0|||
27678423|NCT01016262|80660386|FG000|Double-blind Phase|Lack of Efficacy|1|||
27678424|NCT01016262|80660387|FG001|Double-blind Phase|Lack of Efficacy|0|||
27678425|NCT01016262|80660388|FG002|Double-blind Phase|Lack of Efficacy|5|||
27678426|NCT01016262|80660389|FG003|Double-blind Phase|Lack of Efficacy|0|||
27801799|NCT03276962|81105211|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
27801800|NCT03276962|81105212|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
27801801|NCT03276962|81105213|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
27994418|NCT01359943|81808356|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
27994419|NCT01359943|81808354|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
27994420|NCT01359943|81808355|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
27994421|NCT01359943|81808356|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
27994422|NCT01359943|81808354|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
27579459|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
27579460|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
27579461|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
27579462|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
27579463|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
27579464|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
27579465|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
27994423|NCT01359943|81808355|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
27994424|NCT01359943|81808356|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
27994425|NCT01359943|81808354|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
27994426|NCT01359943|81808355|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
27994427|NCT01359943|81808356|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
27994428|NCT03785964|81808357|FG000|Overall Study|Adverse Event|14|||
27994429|NCT03785964|81808358|FG001|Overall Study|Adverse Event|1|||
27579466|NCT02464969|80306606|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
27579467|NCT02464969|80306607|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
27579468|NCT02464969|80306606|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
27579469|NCT02464969|80306607|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
27579470|NCT02464969|80306606|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
27994430|NCT03785964|81808357|FG000|Overall Study|Unqualified Clinical Progression|1|||
27994431|NCT03785964|81808358|FG001|Overall Study|Unqualified Clinical Progression|1|||
27994432|NCT03785964|81808357|FG000|Overall Study|Participant non-compliance|1|||
27994433|NCT03785964|81808358|FG001|Overall Study|Participant non-compliance|1|||
27579471|NCT02464969|80306607|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
27579472|NCT02464969|80306606|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
27579473|NCT02464969|80306607|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
27579474|NCT01519518|80306608|FG000|Overall Study|Consent not available|7|||
27579475|NCT01519518|80306609|FG001|Overall Study|Consent not available|10|||
27579476|NCT04317586|80306612|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
27678427|NCT01016262|80660390|FG004|Double-blind Phase|Lack of Efficacy|0|||
27678428|NCT01016262|80660391|FG005|Double-blind Phase|Lack of Efficacy|0|||
27678429|NCT01016262|80660386|FG000|Double-blind Phase|Disease Progression|0|||
27678430|NCT01016262|80660387|FG001|Double-blind Phase|Disease Progression|1|||
27678431|NCT01016262|80660388|FG002|Double-blind Phase|Disease Progression|2|||
27678432|NCT01016262|80660389|FG003|Double-blind Phase|Disease Progression|0|||
27678433|NCT01016262|80660390|FG004|Double-blind Phase|Disease Progression|0|||
27579477|NCT04317586|80306612|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
27579478|NCT04116229|80306617|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
27579479|NCT04116229|80306618|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
27579480|NCT04116229|80306617|FG000|Overall Study|Scheduling not possible.|0|||
27579481|NCT04116229|80306618|FG001|Overall Study|Scheduling not possible.|1|||
27579482|NCT03586869|80306619|FG000|Overall Study|Progressive Disease|3|||
27579483|NCT01813019|80306620|FG000|Overall Study|Adverse Event|0|||
27579484|NCT01813019|80306621|FG001|Overall Study|Adverse Event|3|||
27579485|NCT01813019|80306620|FG000|Overall Study|Withdrawal by Subject|3|||
27579486|NCT01813019|80306621|FG001|Overall Study|Withdrawal by Subject|2|||
27579487|NCT01813019|80306620|FG000|Overall Study|administrative problems|2|||
27579488|NCT01813019|80306621|FG001|Overall Study|administrative problems|0|||
27678434|NCT01016262|80660391|FG005|Double-blind Phase|Disease Progression|0|||
27871863|NCT02955212|81365106|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
27871864|NCT02955212|81365107|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
27871865|NCT02955212|81365106|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
27871866|NCT02955212|81365107|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
27871867|NCT02955212|81365106|FG000|Period 2: Open-label Extension|Other|2|||
27871868|NCT02955212|81365107|FG001|Period 2: Open-label Extension|Other|4|||
27871869|NCT03380429|81365108|FG000|Overall Study|Physician Decision|0|||
27871870|NCT03380429|81365109|FG001|Overall Study|Physician Decision|1|||
27871871|NCT03380429|81365110|FG002|Overall Study|Physician Decision|0|||
27871872|NCT03380429|81365111|FG003|Overall Study|Physician Decision|1|||
27871873|NCT03380429|81365112|FG004|Overall Study|Physician Decision|1|||
27871874|NCT03380429|81365108|FG000|Overall Study|Withdrawal by Subject|3|||
27871875|NCT03380429|81365109|FG001|Overall Study|Withdrawal by Subject|3|||
27871876|NCT03380429|81365110|FG002|Overall Study|Withdrawal by Subject|5|||
27871877|NCT03380429|81365111|FG003|Overall Study|Withdrawal by Subject|2|||
27871878|NCT03380429|81365112|FG004|Overall Study|Withdrawal by Subject|1|||
27871879|NCT03380429|81365108|FG000|Overall Study|Lost to Follow-up|0|||
27871880|NCT03380429|81365109|FG001|Overall Study|Lost to Follow-up|2|||
27871881|NCT03380429|81365110|FG002|Overall Study|Lost to Follow-up|4|||
27871882|NCT03380429|81365111|FG003|Overall Study|Lost to Follow-up|3|||
27871883|NCT03380429|81365112|FG004|Overall Study|Lost to Follow-up|1|||
27871884|NCT03380429|81365108|FG000|Overall Study|Protocol Violation|1|||
27871885|NCT03380429|81365109|FG001|Overall Study|Protocol Violation|0|||
27871886|NCT03380429|81365110|FG002|Overall Study|Protocol Violation|1|||
27871887|NCT03380429|81365111|FG003|Overall Study|Protocol Violation|0|||
27871888|NCT03380429|81365112|FG004|Overall Study|Protocol Violation|1|||
27871889|NCT03380429|81365108|FG000|Overall Study|Lack of Efficacy|0|||
27871890|NCT03380429|81365109|FG001|Overall Study|Lack of Efficacy|0|||
27871891|NCT03380429|81365110|FG002|Overall Study|Lack of Efficacy|0|||
27871892|NCT03380429|81365111|FG003|Overall Study|Lack of Efficacy|2|||
27871893|NCT03380429|81365112|FG004|Overall Study|Lack of Efficacy|1|||
27871894|NCT03380429|81365108|FG000|Overall Study|Adverse Event|1|||
27871895|NCT03380429|81365109|FG001|Overall Study|Adverse Event|1|||
27871896|NCT03380429|81365110|FG002|Overall Study|Adverse Event|1|||
27871897|NCT03380429|81365111|FG003|Overall Study|Adverse Event|2|||
27871898|NCT03380429|81365112|FG004|Overall Study|Adverse Event|0|||
27871899|NCT03875508|81365113|FG000|Overall Study|Adverse Event|1|||
27871900|NCT03875508|81365113|FG000|Overall Study|Lost to Follow-up|8|||
27871901|NCT03875508|81365113|FG000|Overall Study|Lack of Efficacy|1|||
27871902|NCT03875508|81365113|FG000|Overall Study|Other, not specified|2|||
27871903|NCT00974922|81365117|FG000|Overall Study|study terminated|24|||
27871904|NCT02618759|81365118|FG000|Overall Study|Lost to Follow-up|0|||
27871905|NCT02618759|81365119|FG001|Overall Study|Lost to Follow-up|1|||
27871906|NCT02618759|81365118|FG000|Overall Study|Withdrawal by Subject|1|||
27994434|NCT03785964|81808357|FG000|Overall Study|Not treated|1|||
27994435|NCT03785964|81808358|FG001|Overall Study|Not treated|0|||
27994436|NCT03785964|81808357|FG000|Overall Study|Other reason|5|||
27994437|NCT03785964|81808358|FG001|Overall Study|Other reason|11|||
27994438|NCT03785964|81808357|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
27994439|NCT03785964|81808358|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
27994440|NCT01732770|81808360|FG000|Overall Study|Lost to Follow-up|2|||
27579489|NCT01813019|80306620|FG000|Overall Study|Protocol Deviation|2|||
27871907|NCT02618759|81365119|FG001|Overall Study|Withdrawal by Subject|0|||
27871908|NCT02618759|81365118|FG000|Overall Study|Other Reasons|1|||
27579490|NCT01813019|80306621|FG001|Overall Study|Protocol Deviation|1|||
27579491|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
27579492|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27871909|NCT02618759|81365119|FG001|Overall Study|Other Reasons|4|||
27871910|NCT02789137|81365120|FG000|Overall Study|Dropped out/Died|58|||
27871911|NCT02847260|81365121|FG000|Overall Study|Adverse Event|3|||
27871912|NCT02847260|81365121|FG000|Overall Study|Withdrawal by Subject|2|||
27871913|NCT02847260|81365121|FG000|Overall Study|Clinical Deterioration|1|||
27994441|NCT01732770|81808361|FG001|Overall Study|Lost to Follow-up|3|||
27994442|NCT01732770|81808360|FG000|Overall Study|Withdrawal by Subject|5|||
27994443|NCT01732770|81808361|FG001|Overall Study|Withdrawal by Subject|3|||
27994444|NCT01732770|81808360|FG000|Overall Study|Decision by Sponsor|2|||
27871914|NCT02847260|81365121|FG000|Overall Study|Physician Decision|1|||
27871915|NCT00322712|81365122|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
27871916|NCT01026194|81365123|FG000|Period 1：Double Blind Period|Adverse Event|2|||
27871917|NCT01026194|81365124|FG001|Period 1：Double Blind Period|Adverse Event|1|||
27871918|NCT01026194|81365123|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
27871919|NCT01026194|81365124|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
27871920|NCT01026194|81365123|FG000|Period 1：Double Blind Period|Physician Decision|0|||
27871921|NCT01026194|81365124|FG001|Period 1：Double Blind Period|Physician Decision|4|||
27871922|NCT01026194|81365123|FG000|Period 2：Open-label Period|Adverse Event|4|||
27871923|NCT01026194|81365124|FG001|Period 2：Open-label Period|Adverse Event|5|||
27871924|NCT01026194|81365123|FG000|Period 2：Open-label Period|Physician Decision|3|||
27871925|NCT01026194|81365124|FG001|Period 2：Open-label Period|Physician Decision|1|||
27871926|NCT01026194|81365123|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
27871927|NCT01026194|81365124|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
27871928|NCT00652340|81365125|FG000|Overall Study|Had not progressed.|4|||
27871929|NCT00652340|81365126|FG001|Overall Study|Had not progressed.|3|||
27871930|NCT01127256|81365127|FG000|Overall Study|Adverse Event|13|||
27871931|NCT01127256|81365128|FG001|Overall Study|Adverse Event|13|||
27871932|NCT01127256|81365127|FG000|Overall Study|Lack of Efficacy|4|||
27871933|NCT01127256|81365128|FG001|Overall Study|Lack of Efficacy|0|||
27871934|NCT01127256|81365127|FG000|Overall Study|Lost to Follow-up|16|||
27871935|NCT01127256|81365128|FG001|Overall Study|Lost to Follow-up|17|||
27871936|NCT01127256|81365127|FG000|Overall Study|Withdrawal by Subject|5|||
27871937|NCT01127256|81365128|FG001|Overall Study|Withdrawal by Subject|9|||
27871938|NCT01127256|81365127|FG000|Overall Study|Protocol Violation|1|||
27871939|NCT01127256|81365128|FG001|Overall Study|Protocol Violation|0|||
27871940|NCT03238651|81365130|FG000|Overall Study|Other|0|||
27871941|NCT03238651|81365131|FG001|Overall Study|Other|0|||
27871942|NCT03238651|81365132|FG002|Overall Study|Other|0|||
27871943|NCT03238651|81365133|FG003|Overall Study|Other|0|||
27871944|NCT03238651|81365134|FG004|Overall Study|Other|1|||
27871945|NCT03238651|81365130|FG000|Overall Study|Progressive Disease|2|||
27871946|NCT03238651|81365131|FG001|Overall Study|Progressive Disease|2|||
27871947|NCT03238651|81365132|FG002|Overall Study|Progressive Disease|2|||
27871948|NCT03238651|81365133|FG003|Overall Study|Progressive Disease|2|||
27871949|NCT03238651|81365134|FG004|Overall Study|Progressive Disease|0|||
27871950|NCT03238651|81365130|FG000|Overall Study|Withdrawal by Subject|0|||
27871951|NCT03238651|81365131|FG001|Overall Study|Withdrawal by Subject|1|||
27871952|NCT03238651|81365132|FG002|Overall Study|Withdrawal by Subject|0|||
27871953|NCT03238651|81365133|FG003|Overall Study|Withdrawal by Subject|1|||
27871954|NCT03238651|81365134|FG004|Overall Study|Withdrawal by Subject|0|||
27994445|NCT01732770|81808361|FG001|Overall Study|Decision by Sponsor|2|||
27994446|NCT01732770|81808360|FG000|Overall Study|Death|1|||
27871955|NCT03238651|81365130|FG000|Overall Study|Adverse Event|1|||
27871956|NCT03238651|81365131|FG001|Overall Study|Adverse Event|3|||
27994447|NCT01732770|81808361|FG001|Overall Study|Death|0|||
27994448|NCT03282097|81808362|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
27994449|NCT03282097|81808363|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
27871957|NCT03238651|81365132|FG002|Overall Study|Adverse Event|2|||
27871958|NCT03238651|81365133|FG003|Overall Study|Adverse Event|0|||
27871959|NCT03238651|81365134|FG004|Overall Study|Adverse Event|0|||
27871960|NCT02500043|81365135|FG000|Overall Study|Randomized, but not Treated|2|||
27871961|NCT02500043|81365136|FG001|Overall Study|Randomized, but not Treated|2|||
27871962|NCT02500043|81365135|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
27871963|NCT02500043|81365136|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
27871964|NCT02500043|81365135|FG000|Overall Study|Adverse Event|33|||
27871965|NCT02500043|81365136|FG001|Overall Study|Adverse Event|11|||
27994450|NCT03282097|81808362|FG000|Intervention Visit Complete|Patient Death|13|||
27994451|NCT03282097|81808363|FG001|Intervention Visit Complete|Patient Death|15|||
27994452|NCT03282097|81808362|FG000|Intervention Visit Complete|Caregiver Death|0|||
27994453|NCT03282097|81808363|FG001|Intervention Visit Complete|Caregiver Death|3|||
27994454|NCT03282097|81808362|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
27871966|NCT02500043|81365135|FG000|Overall Study|Clinical Progression|54|||
27994455|NCT03282097|81808363|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
27994456|NCT03282097|81808362|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
27994457|NCT03282097|81808363|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
27871967|NCT02500043|81365136|FG001|Overall Study|Clinical Progression|35|||
27871968|NCT02500043|81365135|FG000|Overall Study|Radiological Progression|192|||
27871969|NCT02500043|81365136|FG001|Overall Study|Radiological Progression|110|||
27871970|NCT02500043|81365135|FG000|Overall Study|Physician's Decision|11|||
27871971|NCT02500043|81365136|FG001|Overall Study|Physician's Decision|3|||
27871972|NCT02500043|81365135|FG000|Overall Study|Withdrawal by Subject|14|||
27871973|NCT02500043|81365136|FG001|Overall Study|Withdrawal by Subject|4|||
27871974|NCT02500043|81365135|FG000|Overall Study|Death|11|||
27871975|NCT02500043|81365136|FG001|Overall Study|Death|2|||
27871976|NCT02500043|81365135|FG000|Overall Study|Protocol Deviation|1|||
27871977|NCT02500043|81365136|FG001|Overall Study|Protocol Deviation|0|||
27871978|NCT02792517|81365137|FG000|Overall Study|Withdrawal by Subject|10|||
27871979|NCT02792517|81365137|FG000|Overall Study|Decision by Sponsor|7|||
27871980|NCT02792517|81365137|FG000|Overall Study|Lost to Follow-up|3|||
27871981|NCT00560391|81365139|FG000|Overall Study|Still on treatment|0|||
27871982|NCT00560391|81365140|FG001|Overall Study|Still on treatment|0|||
27871983|NCT00560391|81365141|FG002|Overall Study|Still on treatment|0|||
27871984|NCT00560391|81365142|FG003|Overall Study|Still on treatment|1|||
27871985|NCT00560391|81365143|FG004|Overall Study|Still on treatment|2|||
27871986|NCT02719184|81365145|FG000|Overall Study|Other than listed|1|||
27871987|NCT02719184|81365146|FG001|Overall Study|Other than listed|12|||
27871988|NCT02719184|81365147|FG002|Overall Study|Other than listed|13|||
27871989|NCT02719184|81365148|FG003|Overall Study|Other than listed|22|||
27871990|NCT02719184|81365149|FG004|Overall Study|Other than listed|9|||
27871991|NCT02719184|81365145|FG000|Overall Study|Withdrawal by Subject|5|||
27994458|NCT03282097|81808362|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
27994459|NCT03282097|81808363|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
27994460|NCT03282097|81808362|FG000|Primary Outcome Data Collection Complete|Missing|2|||
27994461|NCT03282097|81808363|FG001|Primary Outcome Data Collection Complete|Missing|3|||
27994462|NCT03282097|81808362|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
27994463|NCT03282097|81808363|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
27994464|NCT03282097|81808362|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
27994465|NCT03282097|81808363|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
27994466|NCT03282097|81808362|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
27994467|NCT03282097|81808363|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
27579493|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27579494|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27579495|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27579496|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27801802|NCT03276962|81105214|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
27801803|NCT03276962|81105210|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
27801804|NCT03276962|81105211|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
27801805|NCT03276962|81105212|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
27801806|NCT03276962|81105213|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
27801807|NCT03276962|81105214|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
27801808|NCT03276962|81105210|FG000|Overall Study|Lost to Follow-up|10|||
27801809|NCT03276962|81105211|FG001|Overall Study|Lost to Follow-up|10|||
27801810|NCT03276962|81105212|FG002|Overall Study|Lost to Follow-up|4|||
27801811|NCT03276962|81105213|FG003|Overall Study|Lost to Follow-up|6|||
27801812|NCT03276962|81105214|FG004|Overall Study|Lost to Follow-up|10|||
27801813|NCT03276962|81105210|FG000|Overall Study|Other|0|||
27801814|NCT03276962|81105211|FG001|Overall Study|Other|2|||
27801815|NCT03276962|81105212|FG002|Overall Study|Other|0|||
27801816|NCT03276962|81105213|FG003|Overall Study|Other|2|||
27801817|NCT03276962|81105214|FG004|Overall Study|Other|1|||
27801818|NCT00388674|81105223|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
27801819|NCT00388674|81105224|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
27801820|NCT00388674|81105223|FG000|Initial Treatment|Adverse Event|22|||
27801821|NCT00388674|81105224|FG001|Initial Treatment|Adverse Event|87|||
27801822|NCT00388674|81105223|FG000|Initial Treatment|Death|215|||
27801823|NCT00388674|81105224|FG001|Initial Treatment|Death|216|||
27801824|NCT00388674|81105223|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
27801825|NCT00388674|81105224|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
27801826|NCT00388674|81105223|FG000|Initial Treatment|HCC|12|||
27801827|NCT00388674|81105224|FG001|Initial Treatment|HCC|20|||
27801828|NCT00388674|81105223|FG000|Initial Treatment|Lost to Follow-up|526|||
27801829|NCT00388674|81105224|FG001|Initial Treatment|Lost to Follow-up|624|||
27801830|NCT00388674|81105223|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
27801831|NCT00388674|81105224|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
27801832|NCT00388674|81105223|FG000|Initial Treatment|Never Treated with Study Medication|1|||
27871992|NCT02719184|81365146|FG001|Overall Study|Withdrawal by Subject|3|||
27871993|NCT02719184|81365147|FG002|Overall Study|Withdrawal by Subject|6|||
27871994|NCT02719184|81365148|FG003|Overall Study|Withdrawal by Subject|6|||
27871995|NCT02719184|81365149|FG004|Overall Study|Withdrawal by Subject|0|||
27871996|NCT02719184|81365145|FG000|Overall Study|Lost to Follow-up|0|||
27801833|NCT00388674|81105224|FG001|Initial Treatment|Never Treated with Study Medication|7|||
27801834|NCT00388674|81105223|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
27801835|NCT00388674|81105224|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
27871997|NCT02719184|81365146|FG001|Overall Study|Lost to Follow-up|4|||
27871998|NCT02719184|81365147|FG002|Overall Study|Lost to Follow-up|1|||
27801836|NCT00388674|81105223|FG000|Initial Treatment|Not Defined|125|||
27801837|NCT00388674|81105224|FG001|Initial Treatment|Not Defined|172|||
27801838|NCT00388674|81105223|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
27801839|NCT00388674|81105224|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
27801840|NCT00388674|81105223|FG000|Initial Treatment|Pregnancy|26|||
27801841|NCT00388674|81105224|FG001|Initial Treatment|Pregnancy|16|||
27801842|NCT00388674|81105223|FG000|Initial Treatment|Study Drug Toxicity|5|||
27801843|NCT00388674|81105224|FG001|Initial Treatment|Study Drug Toxicity|92|||
27801844|NCT00388674|81105223|FG000|Initial Treatment|Participant Request|501|||
27801845|NCT00388674|81105224|FG001|Initial Treatment|Participant Request|673|||
27801846|NCT00388674|81105223|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
27801847|NCT00388674|81105224|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
27801848|NCT00388674|81105223|FG000|Initial Treatment|Not Reported|10|||
27801849|NCT00388674|81105224|FG001|Initial Treatment|Not Reported|12|||
27801850|NCT00388674|81105223|FG000|End of Study|Administrative Reason By Sponsor|299|||
27801851|NCT00388674|81105224|FG001|End of Study|Administrative Reason By Sponsor|253|||
27801852|NCT00388674|81105223|FG000|End of Study|Death|239|||
27801853|NCT00388674|81105224|FG001|End of Study|Death|262|||
27801854|NCT00388674|81105223|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
27801855|NCT00388674|81105224|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
27801856|NCT00388674|81105223|FG000|End of Study|HCC|8|||
27801857|NCT00388674|81105224|FG001|End of Study|HCC|7|||
27801858|NCT00388674|81105223|FG000|End of Study|Lost to Follow-up|587|||
27801859|NCT00388674|81105224|FG001|End of Study|Lost to Follow-up|715|||
27801860|NCT00388674|81105223|FG000|End of Study|Malignancy (Non-HCC)|1|||
27801861|NCT00388674|81105224|FG001|End of Study|Malignancy (Non-HCC)|1|||
27801862|NCT00388674|81105223|FG000|End of Study|Non-Study Related Comorbidities|3|||
27801863|NCT00388674|81105224|FG001|End of Study|Non-Study Related Comorbidities|4|||
27994468|NCT01824355|81808369|FG000|Overall Study|Adverse Event|2|||
27994469|NCT01824355|81808369|FG000|Overall Study|unevaluable reference method results per|1|||
27994470|NCT01919801|81808370|FG000|Overall Study|Withdrawal by Subject|1|||
27994471|NCT01919801|81808371|FG001|Overall Study|Withdrawal by Subject|0|||
27994472|NCT01919801|81808370|FG000|Overall Study|Physician Decision|0|||
27994473|NCT01919801|81808371|FG001|Overall Study|Physician Decision|1|||
27994474|NCT01919801|81808370|FG000|Overall Study|Lost to Follow-up|0|||
27994475|NCT01919801|81808371|FG001|Overall Study|Lost to Follow-up|1|||
27994476|NCT01919801|81808370|FG000|Overall Study|Other|0|||
27994477|NCT01919801|81808371|FG001|Overall Study|Other|1|||
27994478|NCT00826618|81808372|FG000|Overall Study|Withdrawal by Subject|1|||
27994479|NCT00596830|81808375|FG000|Overall Study|Death|258|||
27994480|NCT00596830|81808376|FG001|Overall Study|Death|247|||
27994481|NCT00596830|81808375|FG000|Overall Study|Lost to Follow-up|7|||
27994482|NCT00596830|81808376|FG001|Overall Study|Lost to Follow-up|11|||
27994483|NCT00596830|81808375|FG000|Overall Study|Withdrawal by Subject|22|||
27994484|NCT00596830|81808376|FG001|Overall Study|Withdrawal by Subject|12|||
27994485|NCT00596830|81808375|FG000|Overall Study|Study terminated by sponsor|51|||
27994486|NCT00596830|81808376|FG001|Overall Study|Study terminated by sponsor|62|||
27801864|NCT00388674|81105223|FG000|End of Study|Not Defined|135|||
27994487|NCT00596830|81808375|FG000|Overall Study|Follow-up was discontinued|1|||
27994488|NCT00596830|81808376|FG001|Overall Study|Follow-up was discontinued|0|||
27994489|NCT00596830|81808375|FG000|Overall Study|Randomized but not treated|3|||
27579497|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
27801865|NCT00388674|81105224|FG001|End of Study|Not Defined|214|||
27801866|NCT00388674|81105223|FG000|End of Study|Participant Withdrew Consent|437|||
27801867|NCT00388674|81105224|FG001|End of Study|Participant Withdrew Consent|673|||
27801868|NCT00388674|81105223|FG000|End of Study|No Off-Treatment Status Data|22|||
27801869|NCT00388674|81105224|FG001|End of Study|No Off-Treatment Status Data|30|||
27994490|NCT00596830|81808376|FG001|Overall Study|Randomized but not treated|7|||
27994491|NCT03521141|81808377|FG000|Overall Study|Death|1|||
27994492|NCT03521141|81808378|FG001|Overall Study|Death|0|||
27994493|NCT03521141|81808379|FG002|Overall Study|Death|1|||
27994494|NCT02097030|81808383|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
27994495|NCT02097030|81808384|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
27994496|NCT02097030|81808383|FG000|First Intervention (3 Days)|Visual Acuity|0|||
27994497|NCT02097030|81808384|FG001|First Intervention (3 Days)|Visual Acuity|1|||
27994498|NCT03654885|81808385|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
27994499|NCT03654885|81808386|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
27994500|NCT03654885|81808385|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
27994501|NCT03654885|81808386|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
27994502|NCT03654885|81808385|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
27994503|NCT03654885|81808386|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
27994504|NCT03654885|81808385|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
27994505|NCT03654885|81808386|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
27994506|NCT03654885|81808385|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
27994507|NCT03654885|81808386|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
27994508|NCT03654885|81808385|FG000|Overall Study|Adverse Event in Study Eye|3|||
27994509|NCT03654885|81808386|FG001|Overall Study|Adverse Event in Study Eye|0|||
27994510|NCT03654885|81808385|FG000|Overall Study|Consent Withdrawn|1|||
27994511|NCT03654885|81808386|FG001|Overall Study|Consent Withdrawn|0|||
27994512|NCT03654885|81808385|FG000|Overall Study|Death|3|||
27994513|NCT03654885|81808386|FG001|Overall Study|Death|1|||
27994514|NCT03654885|81808385|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
27994515|NCT03654885|81808386|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
27801870|NCT00388674|81105223|FG000|End of Study|Not Reported|0|||
27801871|NCT00388674|81105224|FG001|End of Study|Not Reported|1|||
27801872|NCT02444182|81105225|FG000|Overall Study|non-compliance|2|||
27801873|NCT02444182|81105226|FG001|Overall Study|non-compliance|1|||
27801874|NCT02444182|81105225|FG000|Overall Study|Lost to Follow-up|0|||
27801875|NCT02444182|81105226|FG001|Overall Study|Lost to Follow-up|4|||
27801876|NCT04318535|81105227|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
27801877|NCT04318535|81105228|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
27801878|NCT04318535|81105229|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
27801879|NCT03471182|81105230|FG000|Overall Study|Withdrawal by Subject|1|||
27801880|NCT03471182|81105231|FG001|Overall Study|Withdrawal by Subject|1|||
27994516|NCT03654885|81808385|FG000|Overall Study|Lost to Follow-up|3|||
27994517|NCT03654885|81808386|FG001|Overall Study|Lost to Follow-up|3|||
27994518|NCT00532298|81808387|FG000|Overall Study|Adverse Event|1|||
27994519|NCT00532298|81808388|FG001|Overall Study|Adverse Event|0|||
27994520|NCT00532298|81808389|FG002|Overall Study|Adverse Event|0|||
27994521|NCT00532298|81808390|FG003|Overall Study|Adverse Event|0|||
27994522|NCT00532298|81808391|FG004|Overall Study|Adverse Event|1|||
27994523|NCT00532298|81808392|FG005|Overall Study|Adverse Event|1|||
27994524|NCT00532298|81808387|FG000|Overall Study|Lost to Follow-up|1|||
27994525|NCT00532298|81808388|FG001|Overall Study|Lost to Follow-up|1|||
27994526|NCT00532298|81808389|FG002|Overall Study|Lost to Follow-up|1|||
27994527|NCT00532298|81808390|FG003|Overall Study|Lost to Follow-up|0|||
27994528|NCT00532298|81808391|FG004|Overall Study|Lost to Follow-up|0|||
27994529|NCT00532298|81808392|FG005|Overall Study|Lost to Follow-up|1|||
27994530|NCT02206035|81808396|FG000|Overall Study|Physician Decision|10|||
27678435|NCT01016262|80660386|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
27871999|NCT02719184|81365148|FG003|Overall Study|Lost to Follow-up|3|||
27994531|NCT02206035|81808397|FG001|Overall Study|Physician Decision|0|||
27994532|NCT02206035|81808398|FG002|Overall Study|Physician Decision|175|||
27994533|NCT01677858|81808399|FG000|Overall Study|Adverse Event|0|||
27994534|NCT01677858|81808400|FG001|Overall Study|Adverse Event|0|||
27994535|NCT01677858|81808401|FG002|Overall Study|Adverse Event|2|||
27678436|NCT01016262|80660387|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
27801881|NCT03471182|81105232|FG002|Overall Study|Withdrawal by Subject|0|||
27872000|NCT02719184|81365149|FG004|Overall Study|Lost to Follow-up|0|||
27872001|NCT02719184|81365145|FG000|Overall Study|Protocol Violation|0|||
27872002|NCT02719184|81365146|FG001|Overall Study|Protocol Violation|3|||
27872003|NCT02719184|81365147|FG002|Overall Study|Protocol Violation|0|||
27872004|NCT02719184|81365148|FG003|Overall Study|Protocol Violation|2|||
27872005|NCT02719184|81365149|FG004|Overall Study|Protocol Violation|0|||
27872006|NCT02719184|81365145|FG000|Overall Study|Adverse Event|0|||
27872007|NCT02719184|81365146|FG001|Overall Study|Adverse Event|0|||
27994536|NCT01677858|81808402|FG003|Overall Study|Adverse Event|3|||
27994537|NCT01677858|81808403|FG004|Overall Study|Adverse Event|13|||
27994538|NCT01677858|81808399|FG000|Overall Study|Death|0|||
27994539|NCT01677858|81808400|FG001|Overall Study|Death|0|||
27801882|NCT03471182|81105230|FG000|Overall Study|Technical failure|2|||
27801883|NCT03471182|81105231|FG001|Overall Study|Technical failure|0|||
27801884|NCT03471182|81105232|FG002|Overall Study|Technical failure|0|||
27801885|NCT01954082|81105233|FG000|Overall Study|Study Suspension|42|||
27801886|NCT01954082|81105234|FG001|Overall Study|Study Suspension|36|||
27801887|NCT01954082|81105233|FG000|Overall Study|Adverse Event|10|||
27801888|NCT01954082|81105234|FG001|Overall Study|Adverse Event|4|||
27801889|NCT01954082|81105233|FG000|Overall Study|Intolerance|0|||
27801890|NCT01954082|81105234|FG001|Overall Study|Intolerance|1|||
27801891|NCT01954082|81105233|FG000|Overall Study|Non-compliance|6|||
27801892|NCT01954082|81105234|FG001|Overall Study|Non-compliance|4|||
27801893|NCT01954082|81105233|FG000|Overall Study|Physician Decision|2|||
27801894|NCT01954082|81105234|FG001|Overall Study|Physician Decision|0|||
27994540|NCT01677858|81808401|FG002|Overall Study|Death|0|||
27994541|NCT01677858|81808402|FG003|Overall Study|Death|0|||
27994542|NCT01677858|81808403|FG004|Overall Study|Death|1|||
27994543|NCT01677858|81808399|FG000|Overall Study|Physician Decision|1|||
27994544|NCT01677858|81808400|FG001|Overall Study|Physician Decision|0|||
27994545|NCT01677858|81808401|FG002|Overall Study|Physician Decision|2|||
27994546|NCT01677858|81808402|FG003|Overall Study|Physician Decision|0|||
27994547|NCT01677858|81808403|FG004|Overall Study|Physician Decision|12|||
27994548|NCT01677858|81808399|FG000|Overall Study|Progressive Disease|2|||
27994549|NCT01677858|81808400|FG001|Overall Study|Progressive Disease|1|||
27994550|NCT01677858|81808401|FG002|Overall Study|Progressive Disease|9|||
27994551|NCT01677858|81808402|FG003|Overall Study|Progressive Disease|3|||
27994552|NCT01677858|81808403|FG004|Overall Study|Progressive Disease|43|||
27994553|NCT01677858|81808399|FG000|Overall Study|Withdrawal by Subject|0|||
27994554|NCT01677858|81808400|FG001|Overall Study|Withdrawal by Subject|1|||
27994555|NCT01677858|81808401|FG002|Overall Study|Withdrawal by Subject|1|||
27994556|NCT01677858|81808402|FG003|Overall Study|Withdrawal by Subject|0|||
27994557|NCT01677858|81808403|FG004|Overall Study|Withdrawal by Subject|15|||
27994558|NCT01677858|81808399|FG000|Overall Study|Lost to Follow-up|0|||
27994559|NCT01677858|81808400|FG001|Overall Study|Lost to Follow-up|0|||
27994560|NCT01677858|81808401|FG002|Overall Study|Lost to Follow-up|0|||
27994561|NCT01677858|81808402|FG003|Overall Study|Lost to Follow-up|0|||
27994562|NCT01677858|81808403|FG004|Overall Study|Lost to Follow-up|1|||
27994563|NCT00466921|81808406|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
27994564|NCT00466921|81808406|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
27994565|NCT00466921|81808406|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
27994566|NCT00466921|81808406|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
27994567|NCT00466921|81808406|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
27994568|NCT00466921|81808406|FG000|Follow up for a Minimum of 1 Year|Death|6|||
27678437|NCT01016262|80660388|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
27801895|NCT01954082|81105233|FG000|Overall Study|Parent Decision|1|||
27801896|NCT01954082|81105234|FG001|Overall Study|Parent Decision|0|||
27801897|NCT01954082|81105233|FG000|Overall Study|Withdrawal by Subject|0|||
27872008|NCT02719184|81365147|FG002|Overall Study|Adverse Event|0|||
27872009|NCT02719184|81365148|FG003|Overall Study|Adverse Event|3|||
27994569|NCT04178720|81808407|FG000|Overall Study|Withdrawal by Subject|2|||
27994570|NCT04178720|81808408|FG001|Overall Study|Withdrawal by Subject|0|||
27994571|NCT04178720|81808407|FG000|Overall Study|Relocation|0|||
27994572|NCT04178720|81808408|FG001|Overall Study|Relocation|1|||
27994573|NCT01625000|81808411|FG000|Overall Study|Physician Decision|15|||
27801898|NCT01954082|81105234|FG001|Overall Study|Withdrawal by Subject|1|||
27872010|NCT02719184|81365149|FG004|Overall Study|Adverse Event|0|||
27994574|NCT01625000|81808412|FG001|Overall Study|Physician Decision|7|||
27994575|NCT01625000|81808413|FG002|Overall Study|Physician Decision|7|||
27872011|NCT02392481|81365150|FG000|Overall Study|Adverse Event|0|||
27872012|NCT02392481|81365151|FG001|Overall Study|Adverse Event|0|||
27872013|NCT02392481|81365152|FG002|Overall Study|Adverse Event|1|||
27872014|NCT02392481|81365153|FG003|Overall Study|Adverse Event|2|||
27872015|NCT02392481|81365150|FG000|Overall Study|Withdrawal by Subject|0|||
27872016|NCT02392481|81365151|FG001|Overall Study|Withdrawal by Subject|0|||
27872017|NCT02392481|81365152|FG002|Overall Study|Withdrawal by Subject|1|||
27872018|NCT02392481|81365153|FG003|Overall Study|Withdrawal by Subject|0|||
27872019|NCT05373108|81365154|FG000|Overall Study|Withdrawal by Subject|2|||
27872020|NCT02163057|81365155|FG000|Overall Study|Participant Refusal to Continue|2|||
27872021|NCT02163057|81365156|FG001|Overall Study|Participant Refusal to Continue|2|||
27872022|NCT02163057|81365155|FG000|Overall Study|Participant Significant Noncompliance|0|||
27872023|NCT02163057|81365156|FG001|Overall Study|Participant Significant Noncompliance|1|||
27872024|NCT02163057|81365155|FG000|Overall Study|Progression of Disease|1|||
27872025|NCT02163057|81365156|FG001|Overall Study|Progression of Disease|2|||
27872026|NCT01176513|81365157|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
27872027|NCT01565889|81365163|FG000|Part A|Withdrawal by Subject|1|||
27872028|NCT01565889|81365164|FG001|Part A|Withdrawal by Subject|0|||
27872029|NCT01565889|81365165|FG002|Part A|Withdrawal by Subject|0|||
27872030|NCT01565889|81365166|FG003|Part A|Withdrawal by Subject|0|||
27872031|NCT01565889|81365167|FG004|Part A|Withdrawal by Subject|0|||
27872032|NCT01565889|81365168|FG005|Part A|Withdrawal by Subject|0|||
27872033|NCT01565889|81365163|FG000|Part B|Withdrawal by Subject|0|||
27872034|NCT01565889|81365164|FG001|Part B|Withdrawal by Subject|0|||
27872035|NCT01565889|81365165|FG002|Part B|Withdrawal by Subject|0|||
27872036|NCT01565889|81365166|FG003|Part B|Withdrawal by Subject|0|||
27872037|NCT01565889|81365167|FG004|Part B|Withdrawal by Subject|0|||
27872038|NCT01565889|81365168|FG005|Part B|Withdrawal by Subject|1|||
27872039|NCT01565889|81365163|FG000|Part B|Lack of Efficacy|0|||
27872040|NCT01565889|81365164|FG001|Part B|Lack of Efficacy|0|||
27872041|NCT01565889|81365165|FG002|Part B|Lack of Efficacy|0|||
27872042|NCT01565889|81365166|FG003|Part B|Lack of Efficacy|0|||
27872043|NCT01565889|81365167|FG004|Part B|Lack of Efficacy|0|||
27872044|NCT01565889|81365168|FG005|Part B|Lack of Efficacy|2|||
27872045|NCT01565889|81365163|FG000|Part B|Lost to Follow-up|0|||
27872046|NCT01565889|81365164|FG001|Part B|Lost to Follow-up|0|||
27872047|NCT01565889|81365165|FG002|Part B|Lost to Follow-up|0|||
27872048|NCT01565889|81365166|FG003|Part B|Lost to Follow-up|0|||
27872049|NCT01565889|81365167|FG004|Part B|Lost to Follow-up|0|||
27872050|NCT01565889|81365168|FG005|Part B|Lost to Follow-up|1|||
27872051|NCT00711087|81365173|FG000|Overall Study|Lost to Follow-up|1|||
27872052|NCT00711087|81365174|FG001|Overall Study|Lost to Follow-up|0|||
27872053|NCT00927589|81365175|FG000|Overall Study|Death|1|||
27872054|NCT00927589|81365175|FG000|Overall Study|Physician Decision|1|||
27872055|NCT00927589|81365175|FG000|Overall Study|Withdrawal by Subject|3|||
27872056|NCT00927589|81365175|FG000|Overall Study|Adverse Event|2|||
27872057|NCT00927589|81365175|FG000|Overall Study|Disease Progression|8|||
27872058|NCT00927589|81365175|FG000|Overall Study|Non-compliance|1|||
27872059|NCT01027702|81365176|FG000|Overall Study|Received subsequent therapy|1|||
27872060|NCT01027702|81365177|FG001|Overall Study|Received subsequent therapy|2|||
27872061|NCT01027702|81365178|FG002|Overall Study|Received subsequent therapy|0|||
27872062|NCT01027702|81365179|FG003|Overall Study|Received subsequent therapy|4|||
27872063|NCT01027702|81365180|FG004|Overall Study|Received subsequent therapy|1|||
27872064|NCT01027702|81365181|FG005|Overall Study|Received subsequent therapy|0|||
27994576|NCT01625000|81808414|FG003|Overall Study|Physician Decision|2|||
27994577|NCT01625000|81808415|FG004|Overall Study|Physician Decision|15|||
27994578|NCT01625000|81808411|FG000|Overall Study|Protocol Violation|3|||
27994579|NCT01625000|81808412|FG001|Overall Study|Protocol Violation|10|||
27872065|NCT01027702|81365182|FG006|Overall Study|Received subsequent therapy|1|||
27872066|NCT01027702|81365176|FG000|Overall Study|Death|0|||
27872067|NCT01027702|81365177|FG001|Overall Study|Death|0|||
27872068|NCT01027702|81365178|FG002|Overall Study|Death|1|||
27872069|NCT01027702|81365179|FG003|Overall Study|Death|0|||
27994580|NCT01625000|81808413|FG002|Overall Study|Protocol Violation|4|||
27872070|NCT01027702|81365180|FG004|Overall Study|Death|0|||
27872071|NCT01027702|81365181|FG005|Overall Study|Death|0|||
27872072|NCT01027702|81365182|FG006|Overall Study|Death|0|||
27872073|NCT03830333|81365183|FG000|Overall Study|Death|0|||
27872074|NCT03830333|81365184|FG001|Overall Study|Death|1|||
27872075|NCT03830333|81365183|FG000|Overall Study|Withdrawal by Subject|5|||
27994581|NCT01625000|81808414|FG003|Overall Study|Protocol Violation|1|||
27872076|NCT03830333|81365184|FG001|Overall Study|Withdrawal by Subject|1|||
27872077|NCT03830333|81365183|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
27872078|NCT03830333|81365184|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
27872079|NCT03644342|81365185|FG000|Overall Study|Adverse Event|2|||
27872080|NCT03644342|81365186|FG001|Overall Study|Adverse Event|0|||
27872081|NCT03644342|81365185|FG000|Overall Study|Protocol Violation|0|||
27872082|NCT03644342|81365186|FG001|Overall Study|Protocol Violation|1|||
27872083|NCT01526655|81365189|FG000|Overall Study|Withdrawal by Subject|0|||
27872084|NCT01526655|81365190|FG001|Overall Study|Withdrawal by Subject|1|||
27872085|NCT02906670|81365191|FG000|Cohort 1, QW|Radiological Progression|1|||
27872086|NCT02906670|81365192|FG001|Cohort 1, QW|Radiological Progression|0|||
27872087|NCT02906670|81365193|FG002|Cohort 1, QW|Radiological Progression|0|||
27872088|NCT02906670|81365194|FG003|Cohort 1, QW|Radiological Progression|0|||
27872089|NCT02906670|81365195|FG004|Cohort 1, QW|Radiological Progression|0|||
27872090|NCT02906670|81365196|FG005|Cohort 1, QW|Radiological Progression|0|||
27872091|NCT02906670|81365197|FG006|Cohort 1, QW|Radiological Progression|0|||
27872092|NCT02906670|81365198|FG007|Cohort 1, QW|Radiological Progression|0|||
27872093|NCT02906670|81365199|FG008|Cohort 1, QW|Radiological Progression|0|||
27872094|NCT02906670|81365200|FG009|Cohort 1, QW|Radiological Progression|0|||
27872095|NCT02906670|81365191|FG000|Cohort 2, QW|Radiological Progression|0|||
27872096|NCT02906670|81365192|FG001|Cohort 2, QW|Radiological Progression|1|||
27872097|NCT02906670|81365193|FG002|Cohort 2, QW|Radiological Progression|0|||
27872098|NCT02906670|81365194|FG003|Cohort 2, QW|Radiological Progression|0|||
27872099|NCT02906670|81365195|FG004|Cohort 2, QW|Radiological Progression|0|||
27994582|NCT01625000|81808415|FG004|Overall Study|Protocol Violation|2|||
27994583|NCT01625000|81808411|FG000|Overall Study|Withdrawal by Subject|19|||
27994584|NCT01625000|81808412|FG001|Overall Study|Withdrawal by Subject|16|||
27994585|NCT01625000|81808413|FG002|Overall Study|Withdrawal by Subject|11|||
27994586|NCT01625000|81808414|FG003|Overall Study|Withdrawal by Subject|9|||
27994587|NCT01625000|81808415|FG004|Overall Study|Withdrawal by Subject|17|||
27994588|NCT01625000|81808411|FG000|Overall Study|Adverse Event (including Death)|15|||
27994589|NCT01625000|81808412|FG001|Overall Study|Adverse Event (including Death)|19|||
27994590|NCT01625000|81808413|FG002|Overall Study|Adverse Event (including Death)|11|||
27994591|NCT01625000|81808414|FG003|Overall Study|Adverse Event (including Death)|7|||
27994592|NCT01625000|81808415|FG004|Overall Study|Adverse Event (including Death)|21|||
27994593|NCT02799745|81808416|FG000|Overall Study|Participant moved out of state|1|||
27994594|NCT02799745|81808417|FG001|Overall Study|Participant moved out of state|0|||
27994595|NCT02799745|81808416|FG000|Overall Study|Discontinued due to planned surgery|1|||
27994596|NCT02799745|81808417|FG001|Overall Study|Discontinued due to planned surgery|0|||
27994597|NCT02799745|81808416|FG000|Overall Study|Withdrawal by Subject|16|||
27994598|NCT02799745|81808417|FG001|Overall Study|Withdrawal by Subject|25|||
27994599|NCT02799745|81808416|FG000|Overall Study|Protocol Deviation|4|||
27994600|NCT02799745|81808417|FG001|Overall Study|Protocol Deviation|5|||
27994601|NCT02799745|81808416|FG000|Overall Study|Progressive Disease|28|||
27994602|NCT02799745|81808417|FG001|Overall Study|Progressive Disease|38|||
27994603|NCT02799745|81808416|FG000|Overall Study|Lost to Follow-up|3|||
27994604|NCT02799745|81808417|FG001|Overall Study|Lost to Follow-up|2|||
27801899|NCT01954082|81105233|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
27801900|NCT01954082|81105234|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
27801901|NCT01954082|81105233|FG000|Overall Study|Redirection of Care|0|||
27801902|NCT01954082|81105234|FG001|Overall Study|Redirection of Care|2|||
27801903|NCT01954082|81105233|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
27801904|NCT01954082|81105234|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
27801905|NCT01954082|81105233|FG000|Overall Study|Comfort Care|0|||
27801906|NCT01954082|81105234|FG001|Overall Study|Comfort Care|1|||
27801907|NCT01954082|81105233|FG000|Overall Study|Infant Moved|0|||
27801908|NCT01954082|81105234|FG001|Overall Study|Infant Moved|1|||
27801909|NCT01954082|81105233|FG000|Overall Study|Randomized not Treated|4|||
27801910|NCT01954082|81105234|FG001|Overall Study|Randomized not Treated|2|||
27801911|NCT01339000|81105235|FG000|Overall Study|study closed due to lack of drug supply|1|||
27801912|NCT01339000|81105236|FG001|Overall Study|study closed due to lack of drug supply|0|||
27801913|NCT00597207|81105237|FG000|Overall Study|Lost to Follow-up|5|||
27801914|NCT00597207|81105238|FG001|Overall Study|Lost to Follow-up|7|||
27801915|NCT01542736|81105239|FG000|Overall Study|Death|1|||
27801916|NCT02072174|81105241|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
27801917|NCT02072174|81105242|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
27801918|NCT02072174|81105241|FG000|Overall Study|Protocol Violation|16|||
27801919|NCT02072174|81105242|FG001|Overall Study|Protocol Violation|23|||
27994605|NCT02799745|81808416|FG000|Overall Study|Death|3|||
27579498|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27801920|NCT02072174|81105241|FG000|Overall Study|Physician Decision|0|||
27801921|NCT02072174|81105242|FG001|Overall Study|Physician Decision|1|||
27801922|NCT02072174|81105241|FG000|Overall Study|Non-compliance with protocol requirement|2|||
27801923|NCT02072174|81105242|FG001|Overall Study|Non-compliance with protocol requirement|0|||
27801924|NCT02428231|81105243|FG000|Overall Study|Other|10|||
27872100|NCT02906670|81365196|FG005|Cohort 2, QW|Radiological Progression|0|||
27872101|NCT02906670|81365197|FG006|Cohort 2, QW|Radiological Progression|0|||
27872102|NCT02906670|81365198|FG007|Cohort 2, QW|Radiological Progression|0|||
27872103|NCT02906670|81365199|FG008|Cohort 2, QW|Radiological Progression|0|||
27872104|NCT02906670|81365200|FG009|Cohort 2, QW|Radiological Progression|0|||
27872105|NCT02906670|81365191|FG000|Cohort 3, QW|Radiological Progression|0|||
27872106|NCT02906670|81365192|FG001|Cohort 3, QW|Radiological Progression|0|||
27872107|NCT02906670|81365193|FG002|Cohort 3, QW|Radiological Progression|2|||
27994606|NCT02799745|81808417|FG001|Overall Study|Death|0|||
27994607|NCT02799745|81808416|FG000|Overall Study|Adverse Event|0|||
27994608|NCT02799745|81808417|FG001|Overall Study|Adverse Event|1|||
27994609|NCT01363661|81808418|FG000|Overall Study|Adverse Event|9|||
27994610|NCT01363661|81808419|FG001|Overall Study|Adverse Event|2|||
27994611|NCT01363661|81808418|FG000|Overall Study|Withdrawal by Subject|1|||
27994612|NCT01363661|81808419|FG001|Overall Study|Withdrawal by Subject|1|||
27994613|NCT01363661|81808418|FG000|Overall Study|Protocol Violation|1|||
27994614|NCT01363661|81808419|FG001|Overall Study|Protocol Violation|0|||
27994615|NCT01363661|81808418|FG000|Overall Study|Lost to Follow-up|3|||
27801925|NCT02428231|81105244|FG001|Overall Study|Other|16|||
27801926|NCT02428231|81105243|FG000|Overall Study|Required Symptomatic Therapy|0|||
27801927|NCT02428231|81105244|FG001|Overall Study|Required Symptomatic Therapy|1|||
27801928|NCT02428231|81105243|FG000|Overall Study|Adverse Event|3|||
27801929|NCT02428231|81105244|FG001|Overall Study|Adverse Event|0|||
27801930|NCT00738920|81105245|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
27801931|NCT00738920|81105246|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
27801932|NCT00738920|81105247|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
27801933|NCT00738920|81105245|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
27801934|NCT00738920|81105246|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
27994616|NCT01363661|81808419|FG001|Overall Study|Lost to Follow-up|1|||
27994617|NCT04124705|81808420|FG000|Titration Period|Adverse Event|9|||
27994618|NCT04124705|81808421|FG001|Titration Period|Adverse Event|5|||
27994619|NCT04124705|81808420|FG000|Titration Period|Withdrawal by Subject|6|||
27994620|NCT04124705|81808421|FG001|Titration Period|Withdrawal by Subject|3|||
27994621|NCT04124705|81808420|FG000|Titration Period|Lost to Follow-up|0|||
27994622|NCT04124705|81808421|FG001|Titration Period|Lost to Follow-up|1|||
27994623|NCT04124705|81808420|FG000|Titration Period|Death|1|||
27994624|NCT04124705|81808421|FG001|Titration Period|Death|1|||
27994625|NCT04124705|81808420|FG000|Titration Period|Lack of Efficacy|2|||
27994626|NCT04124705|81808421|FG001|Titration Period|Lack of Efficacy|0|||
27994627|NCT04124705|81808420|FG000|Titration Period|Physician Decision|2|||
27994628|NCT04124705|81808421|FG001|Titration Period|Physician Decision|0|||
27994629|NCT04124705|81808420|FG000|Titration Period|Non-compliance with Study Drug|2|||
27994630|NCT04124705|81808421|FG001|Titration Period|Non-compliance with Study Drug|0|||
27994631|NCT04124705|81808420|FG000|Titration Period|Other|4|||
27994632|NCT04124705|81808421|FG001|Titration Period|Other|9|||
27994633|NCT04124705|81808420|FG000|Stabilization Period|Adverse Event|4|||
27994634|NCT04124705|81808421|FG001|Stabilization Period|Adverse Event|2|||
27994635|NCT04124705|81808420|FG000|Stabilization Period|Withdrawal by Subject|1|||
27994636|NCT04124705|81808421|FG001|Stabilization Period|Withdrawal by Subject|1|||
27994637|NCT04124705|81808420|FG000|Stabilization Period|Lost to Follow-up|0|||
27994638|NCT04124705|81808421|FG001|Stabilization Period|Lost to Follow-up|1|||
27994639|NCT04124705|81808420|FG000|Stabilization Period|Lack of Efficacy|4|||
27994640|NCT04124705|81808421|FG001|Stabilization Period|Lack of Efficacy|2|||
27994641|NCT04124705|81808420|FG000|Stabilization Period|Protocol Deviation|0|||
27994642|NCT04124705|81808421|FG001|Stabilization Period|Protocol Deviation|2|||
27994643|NCT04124705|81808420|FG000|Stabilization Period|Other|2|||
27994644|NCT04124705|81808421|FG001|Stabilization Period|Other|2|||
27994645|NCT00720343|81808422|FG000|Overall Study|Lost to Follow-up|1|||
27994646|NCT00720343|81808423|FG001|Overall Study|Lost to Follow-up|0|||
27994647|NCT00720343|81808422|FG000|Overall Study|Protocol Violation|0|||
27994648|NCT00720343|81808423|FG001|Overall Study|Protocol Violation|2|||
27994649|NCT00381693|81808424|FG000|Overall Study|Death|1|||
27994650|NCT00381693|81808424|FG000|Overall Study|Adverse Event|4|||
27994651|NCT00381693|81808424|FG000|Overall Study|Patient Choice|1|||
27994652|NCT00381693|81808424|FG000|Overall Study|Progression|2|||
27994653|NCT01687101|81808425|FG000|Overall Study|Lost to Follow-up|7|||
27994654|NCT00279916|81808429|FG000|Overall Study|Withdrawal by Subject|4|||
27994655|NCT00279916|81808430|FG001|Overall Study|Withdrawal by Subject|3|||
27994656|NCT00279916|81808429|FG000|Overall Study|Lost to Follow-up|3|||
27994657|NCT00279916|81808430|FG001|Overall Study|Lost to Follow-up|2|||
27994658|NCT02363959|81811087|FG000|Overall Study|Medical instability|1|||
27801935|NCT00738920|81105247|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
27994659|NCT02363959|81811088|FG001|Overall Study|Medical instability|0|||
27801936|NCT00738920|81105245|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
27801937|NCT00738920|81105246|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
27801938|NCT00738920|81105247|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
27994660|NCT01618695|81811091|FG000|Core Phase|Adverse Event|4|||
27994661|NCT01618695|81811092|FG001|Core Phase|Adverse Event|5|||
27994662|NCT01618695|81811093|FG002|Core Phase|Adverse Event|15|||
27994663|NCT01618695|81811094|FG003|Core Phase|Adverse Event|20|||
27994664|NCT01618695|81811091|FG000|Core Phase|Lost to Follow-up|0|||
27994665|NCT01618695|81811092|FG001|Core Phase|Lost to Follow-up|0|||
27994666|NCT01618695|81811093|FG002|Core Phase|Lost to Follow-up|1|||
27994667|NCT01618695|81811094|FG003|Core Phase|Lost to Follow-up|0|||
27678438|NCT01016262|80660389|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
27678439|NCT01016262|80660390|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
27678440|NCT01016262|80660391|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
27678441|NCT01016262|80660386|FG000|Open-Label Phase|Adverse Event|0|||
27678442|NCT01016262|80660387|FG001|Open-Label Phase|Adverse Event|0|||
27678443|NCT01016262|80660388|FG002|Open-Label Phase|Adverse Event|0|||
27678444|NCT01016262|80660389|FG003|Open-Label Phase|Adverse Event|1|||
27678445|NCT01016262|80660390|FG004|Open-Label Phase|Adverse Event|0|||
27678446|NCT01016262|80660391|FG005|Open-Label Phase|Adverse Event|0|||
27678447|NCT01016262|80660386|FG000|Open-Label Phase|Lost to Follow-up|0|||
27678448|NCT01016262|80660387|FG001|Open-Label Phase|Lost to Follow-up|0|||
27801939|NCT00738920|81105245|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
27801940|NCT00738920|81105246|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
27801941|NCT00738920|81105247|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
27801942|NCT00738920|81105245|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
27801943|NCT00738920|81105246|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
27801944|NCT00738920|81105247|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
27801945|NCT00738920|81105245|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
27801946|NCT00738920|81105246|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
27801947|NCT00738920|81105247|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
27801948|NCT00738920|81105245|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
27801949|NCT00738920|81105246|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
27801950|NCT00738920|81105247|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
27801951|NCT00738920|81105245|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
27801952|NCT00738920|81105246|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
27801953|NCT00738920|81105247|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
27801954|NCT00738920|81105245|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
27801955|NCT00738920|81105246|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
27801956|NCT00738920|81105247|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
27801957|NCT00738920|81105245|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
27801958|NCT00738920|81105246|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
27801959|NCT00738920|81105247|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
27801960|NCT01787188|81105251|FG000|Overall Study|Adverse Event|2|||
27801961|NCT01787188|81105252|FG001|Overall Study|Adverse Event|4|||
27801962|NCT01787188|81105253|FG002|Overall Study|Adverse Event|6|||
27801963|NCT01787188|81105251|FG000|Overall Study|Lack of Efficacy|7|||
27801964|NCT01787188|81105252|FG001|Overall Study|Lack of Efficacy|3|||
27801965|NCT01787188|81105253|FG002|Overall Study|Lack of Efficacy|5|||
27801966|NCT01787188|81105251|FG000|Overall Study|Non-compliance with Study Drug|0|||
27801967|NCT01787188|81105252|FG001|Overall Study|Non-compliance with Study Drug|1|||
27801968|NCT01787188|81105253|FG002|Overall Study|Non-compliance with Study Drug|0|||
27801969|NCT01787188|81105251|FG000|Overall Study|Withdrawal by Subject|4|||
27801970|NCT01787188|81105252|FG001|Overall Study|Withdrawal by Subject|3|||
27801971|NCT01787188|81105253|FG002|Overall Study|Withdrawal by Subject|2|||
27801972|NCT01787188|81105251|FG000|Overall Study|Protocol Violation|3|||
27801973|NCT01787188|81105252|FG001|Overall Study|Protocol Violation|2|||
27801974|NCT01787188|81105253|FG002|Overall Study|Protocol Violation|3|||
27801975|NCT01787188|81105251|FG000|Overall Study|Lost to Follow-up|1|||
27801976|NCT01787188|81105252|FG001|Overall Study|Lost to Follow-up|2|||
27801977|NCT01787188|81105253|FG002|Overall Study|Lost to Follow-up|2|||
27801978|NCT01787188|81105251|FG000|Overall Study|Other, including patient moved|0|||
27801979|NCT01787188|81105252|FG001|Overall Study|Other, including patient moved|3|||
27801980|NCT01787188|81105253|FG002|Overall Study|Other, including patient moved|0|||
27801981|NCT00886782|81105254|FG000|Overall Study|Disease progression|3|||
27801982|NCT00886782|81105255|FG001|Overall Study|Disease progression|3|||
27801983|NCT00886782|81105256|FG002|Overall Study|Disease progression|3|||
27801984|NCT00886782|81105254|FG000|Overall Study|Study drug toxicity|0|||
27801985|NCT00886782|81105255|FG001|Overall Study|Study drug toxicity|0|||
27801986|NCT00886782|81105256|FG002|Overall Study|Study drug toxicity|1|||
27801987|NCT00886782|81105254|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
27801988|NCT00886782|81105255|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
27801989|NCT00886782|81105256|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
27994668|NCT01618695|81811091|FG000|Core Phase|Withdrawal by Subject|16|||
27994669|NCT01618695|81811092|FG001|Core Phase|Withdrawal by Subject|11|||
27801990|NCT00709735|81105261|FG000|Overall Study|Lost to Follow-up|1|||
27801991|NCT00709735|81105262|FG001|Overall Study|Lost to Follow-up|1|||
27801992|NCT00709735|81105261|FG000|Overall Study|Relapse into Opioid Abuse|0|||
27801993|NCT00709735|81105262|FG001|Overall Study|Relapse into Opioid Abuse|1|||
27801994|NCT00709735|81105261|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
27994670|NCT01618695|81811093|FG002|Core Phase|Withdrawal by Subject|9|||
27994671|NCT01618695|81811094|FG003|Core Phase|Withdrawal by Subject|13|||
27678449|NCT01016262|80660388|FG002|Open-Label Phase|Lost to Follow-up|0|||
27994672|NCT01618695|81811091|FG000|Core Phase|Pregnancy|2|||
27994673|NCT01618695|81811092|FG001|Core Phase|Pregnancy|0|||
27994674|NCT01618695|81811093|FG002|Core Phase|Pregnancy|0|||
27994675|NCT01618695|81811094|FG003|Core Phase|Pregnancy|0|||
27994676|NCT01618695|81811091|FG000|Core Phase|Lack of Efficacy|1|||
27994677|NCT01618695|81811092|FG001|Core Phase|Lack of Efficacy|2|||
27994678|NCT01618695|81811093|FG002|Core Phase|Lack of Efficacy|1|||
27994679|NCT01618695|81811094|FG003|Core Phase|Lack of Efficacy|1|||
27994680|NCT01618695|81811091|FG000|Core Phase|Other than specified|1|||
27994681|NCT01618695|81811092|FG001|Core Phase|Other than specified|2|||
27994682|NCT01618695|81811093|FG002|Core Phase|Other than specified|2|||
27994683|NCT01618695|81811094|FG003|Core Phase|Other than specified|2|||
27994684|NCT01618695|81811091|FG000|Core Phase|Not treated|1|||
27994685|NCT01618695|81811092|FG001|Core Phase|Not treated|0|||
27994686|NCT01618695|81811093|FG002|Core Phase|Not treated|2|||
27994687|NCT01618695|81811094|FG003|Core Phase|Not treated|0|||
27994688|NCT01618695|81811091|FG000|Extension Phase|Lack of Efficacy|17|||
27994689|NCT01618695|81811092|FG001|Extension Phase|Lack of Efficacy|33|||
27994690|NCT01618695|81811093|FG002|Extension Phase|Lack of Efficacy|26|||
27994691|NCT01618695|81811094|FG003|Extension Phase|Lack of Efficacy|24|||
27994692|NCT01618695|81811091|FG000|Extension Phase|Pregnancy|2|||
27994693|NCT01618695|81811092|FG001|Extension Phase|Pregnancy|0|||
27994694|NCT01618695|81811093|FG002|Extension Phase|Pregnancy|1|||
27994695|NCT01618695|81811094|FG003|Extension Phase|Pregnancy|1|||
27994696|NCT01618695|81811091|FG000|Extension Phase|Withdrawal by Subject|43|||
27994697|NCT01618695|81811092|FG001|Extension Phase|Withdrawal by Subject|48|||
27994698|NCT01618695|81811093|FG002|Extension Phase|Withdrawal by Subject|42|||
27994699|NCT01618695|81811094|FG003|Extension Phase|Withdrawal by Subject|33|||
27994700|NCT01618695|81811091|FG000|Extension Phase|Adverse Event|18|||
27994701|NCT01618695|81811092|FG001|Extension Phase|Adverse Event|16|||
27994702|NCT01618695|81811093|FG002|Extension Phase|Adverse Event|9|||
27994703|NCT01618695|81811094|FG003|Extension Phase|Adverse Event|20|||
27994704|NCT01618695|81811091|FG000|Extension Phase|Lost to Follow-up|2|||
27994705|NCT01618695|81811092|FG001|Extension Phase|Lost to Follow-up|1|||
27994706|NCT01618695|81811093|FG002|Extension Phase|Lost to Follow-up|1|||
27994707|NCT01618695|81811094|FG003|Extension Phase|Lost to Follow-up|1|||
27994708|NCT01618695|81811091|FG000|Extension Phase|Other than specified|13|||
27994709|NCT01618695|81811092|FG001|Extension Phase|Other than specified|18|||
27994710|NCT01618695|81811093|FG002|Extension Phase|Other than specified|13|||
27994711|NCT01618695|81811094|FG003|Extension Phase|Other than specified|18|||
27994712|NCT02333799|81811097|FG000|Treatment Period|Withdrawal by Subject|1|||
27994713|NCT02333799|81811097|FG000|Treatment Period|Death|6|||
27994714|NCT02333799|81811097|FG000|6 Month Follow Up Period|Physician Decision|1|||
27994715|NCT02333799|81811097|FG000|6 Month Follow Up Period|Death|1|||
27994716|NCT02333799|81811097|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
27994717|NCT02333799|81811097|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
27994718|NCT01363908|81811098|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
27994719|NCT01363908|81811099|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
27994720|NCT01363908|81811098|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
27994721|NCT01363908|81811099|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
27994722|NCT01363908|81811098|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
27994723|NCT01363908|81811099|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
27994724|NCT01363908|81811098|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
27994725|NCT01363908|81811099|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
27994726|NCT02978833|81811106|FG000|Overall Study|Study terminated|1|||
27994727|NCT02978833|81811107|FG001|Overall Study|Study terminated|1|||
27994728|NCT03305770|81811108|FG000|Overall Study|Physician Decision - prior to dispense|0|||
27994729|NCT03305770|81811109|FG001|Overall Study|Physician Decision - prior to dispense|1|||
27994730|NCT03305770|81811108|FG000|Overall Study|Subject moved|1|||
27994731|NCT03305770|81811109|FG001|Overall Study|Subject moved|0|||
27994732|NCT01461707|81811110|FG000|Overall Study|Withdrawal by Subject|1|||
27994733|NCT01461707|81811111|FG001|Overall Study|Withdrawal by Subject|0|||
27994734|NCT02837029|81811119|FG000|Screening|Failed to meet screening requirements.|7|||
27994735|NCT02837029|81811120|FG001|Screening|Failed to meet screening requirements.|3|||
27994736|NCT02837029|81811121|FG002|Screening|Failed to meet screening requirements.|0|||
27994737|NCT02837029|81811119|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
27994738|NCT02837029|81811120|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
27994739|NCT02837029|81811121|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
27994740|NCT02837029|81811119|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
27994741|NCT02837029|81811120|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
27994742|NCT02837029|81811121|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
27994743|NCT02837029|81811119|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
27994744|NCT02837029|81811120|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
27994745|NCT02837029|81811121|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
27994746|NCT02837029|81811119|FG000|Cycle 2 and Beyond|Adverse Event|1|||
27994747|NCT02837029|81811120|FG001|Cycle 2 and Beyond|Adverse Event|0|||
27994748|NCT02837029|81811121|FG002|Cycle 2 and Beyond|Adverse Event|0|||
27994749|NCT02837029|81811119|FG000|2 Year Follow-up|Death|6|||
27994750|NCT02837029|81811120|FG001|2 Year Follow-up|Death|7|||
27994751|NCT02837029|81811121|FG002|2 Year Follow-up|Death|0|||
27994752|NCT00358436|81811122|FG000|Overall Study|Adverse Event|29|||
27994753|NCT00358436|81811123|FG001|Overall Study|Adverse Event|13|||
27994754|NCT00358436|81811122|FG000|Overall Study|Lack of Efficacy|34|||
27994755|NCT00358436|81811123|FG001|Overall Study|Lack of Efficacy|36|||
27994756|NCT00358436|81811122|FG000|Overall Study|Lost to Follow-up|11|||
27994757|NCT00358436|81811123|FG001|Overall Study|Lost to Follow-up|6|||
27994758|NCT00358436|81811122|FG000|Overall Study|Protocol Violation|8|||
27994759|NCT00358436|81811123|FG001|Overall Study|Protocol Violation|3|||
27994760|NCT00358436|81811122|FG000|Overall Study|Withdrawal by Subject|40|||
27994761|NCT00358436|81811123|FG001|Overall Study|Withdrawal by Subject|17|||
27994762|NCT00358436|81811122|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
27994763|NCT00358436|81811123|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
27994764|NCT00358436|81811122|FG000|Overall Study|COPD exacerbation|22|||
27994765|NCT00358436|81811123|FG001|Overall Study|COPD exacerbation|10|||
27994766|NCT00358436|81811122|FG000|Overall Study|Other|6|||
27994767|NCT00358436|81811123|FG001|Overall Study|Other|1|||
27994768|NCT00705367|81811127|FG000|Long-term Extension Period|Adverse Event|2|||
27994769|NCT00705367|81811128|FG001|Long-term Extension Period|Adverse Event|0|||
27994770|NCT00705367|81811127|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
27994771|NCT00705367|81811128|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
27994772|NCT00705367|81811127|FG000|Long-term Extension Period|Lack of Efficacy|1|||
27994773|NCT00705367|81811128|FG001|Long-term Extension Period|Lack of Efficacy|0|||
27994774|NCT00705367|81811127|FG000|Long-term Extension Period|No longer met study criteria|1|||
27994775|NCT00705367|81811128|FG001|Long-term Extension Period|No longer met study criteria|0|||
27994776|NCT00705367|81811127|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
27994777|NCT00705367|81811128|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
27994778|NCT01378325|81811129|FG000|Overall Study|Protocol Violation|0|||
27994779|NCT01378325|81811130|FG001|Overall Study|Protocol Violation|1|||
27994780|NCT00348673|81811131|FG000|Stage 1|Randomized but not Treated|0|||
27994781|NCT00348673|81811132|FG001|Stage 1|Randomized but not Treated|0|||
27801995|NCT00709735|81105262|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
27801996|NCT03550794|81105263|FG000|Overall Study|No longer met inclusion criteria|1|||
27801997|NCT03550794|81105264|FG001|Overall Study|No longer met inclusion criteria|2|||
27801998|NCT03550794|81105263|FG000|Overall Study|Goals of care changed|1|||
27801999|NCT03550794|81105264|FG001|Overall Study|Goals of care changed|0|||
27802000|NCT03550794|81105263|FG000|Overall Study|Withdrawal by Subject|2|||
27802001|NCT03550794|81105264|FG001|Overall Study|Withdrawal by Subject|0|||
27802002|NCT03550794|81105263|FG000|Overall Study|Death|0|||
27802003|NCT03550794|81105264|FG001|Overall Study|Death|1|||
27802004|NCT00267020|81105265|FG000|Overall Study|Adverse Event|22|||
27802005|NCT00267020|81105266|FG001|Overall Study|Adverse Event|5|||
27802006|NCT00267020|81105265|FG000|Overall Study|Death|2|||
27802007|NCT00267020|81105266|FG001|Overall Study|Death|1|||
27802008|NCT00267020|81105265|FG000|Overall Study|Withdrawal by Subject|17|||
27802009|NCT00267020|81105266|FG001|Overall Study|Withdrawal by Subject|7|||
27802010|NCT00267020|81105265|FG000|Overall Study|Physician Decision|3|||
27802011|NCT00267020|81105266|FG001|Overall Study|Physician Decision|2|||
27802012|NCT00267020|81105265|FG000|Overall Study|Disease Progression|39|||
27994782|NCT00348673|81811133|FG002|Stage 1|Randomized but not Treated|1|||
27994783|NCT00348673|81811134|FG003|Stage 1|Randomized but not Treated|0|||
27994784|NCT00348673|81811135|FG004|Stage 1|Randomized but not Treated|0|||
27994785|NCT00348673|81811136|FG005|Stage 1|Randomized but not Treated|0|||
27994786|NCT00348673|81811137|FG006|Stage 1|Randomized but not Treated|0|||
27994787|NCT00348673|81811138|FG007|Stage 1|Randomized but not Treated|0|||
27994788|NCT00348673|81811139|FG008|Stage 1|Randomized but not Treated|0|||
27994789|NCT03350815|81811140|FG000|Period 1|Adverse Event|10|||
27994790|NCT03350815|81811141|FG001|Period 1|Adverse Event|0|||
27994791|NCT03350815|81811142|FG002|Period 1|Adverse Event|0|||
27994792|NCT03350815|81811143|FG003|Period 1|Adverse Event|0|||
27994793|NCT03350815|81811140|FG000|Period 1|Technical problems|1|||
27994794|NCT03350815|81811141|FG001|Period 1|Technical problems|0|||
27994795|NCT03350815|81811142|FG002|Period 1|Technical problems|0|||
27994796|NCT03350815|81811143|FG003|Period 1|Technical problems|0|||
27994797|NCT03350815|81811140|FG000|Period 1|Lost to Follow-up|3|||
27994798|NCT03350815|81811141|FG001|Period 1|Lost to Follow-up|0|||
27994799|NCT03350815|81811142|FG002|Period 1|Lost to Follow-up|0|||
27994800|NCT03350815|81811143|FG003|Period 1|Lost to Follow-up|0|||
27994801|NCT03350815|81811140|FG000|Period 1|Physician Decision|1|||
27802013|NCT00267020|81105266|FG001|Overall Study|Disease Progression|25|||
27802014|NCT00267020|81105265|FG000|Overall Study|Unrelated Complication|1|||
27994802|NCT03350815|81811141|FG001|Period 1|Physician Decision|0|||
27994803|NCT03350815|81811142|FG002|Period 1|Physician Decision|0|||
27802015|NCT00267020|81105266|FG001|Overall Study|Unrelated Complication|1|||
27802016|NCT00267020|81105265|FG000|Overall Study|Sponsor Request|1|||
27802017|NCT00267020|81105266|FG001|Overall Study|Sponsor Request|0|||
27994804|NCT03350815|81811143|FG003|Period 1|Physician Decision|0|||
27994805|NCT03350815|81811140|FG000|Period 1|Withdrawal by Subject|8|||
27994806|NCT03350815|81811141|FG001|Period 1|Withdrawal by Subject|0|||
27994807|NCT03350815|81811142|FG002|Period 1|Withdrawal by Subject|0|||
27994808|NCT03350815|81811143|FG003|Period 1|Withdrawal by Subject|0|||
27994809|NCT03350815|81811140|FG000|Period 1|Lack of Efficacy|15|||
27994810|NCT03350815|81811141|FG001|Period 1|Lack of Efficacy|0|||
27994811|NCT03350815|81811142|FG002|Period 1|Lack of Efficacy|0|||
27994812|NCT03350815|81811143|FG003|Period 1|Lack of Efficacy|0|||
27994813|NCT03350815|81811140|FG000|Period 1|Non-compliance with study treatment|2|||
27994814|NCT03350815|81811141|FG001|Period 1|Non-compliance with study treatment|0|||
27994815|NCT03350815|81811142|FG002|Period 1|Non-compliance with study treatment|0|||
27994816|NCT03350815|81811143|FG003|Period 1|Non-compliance with study treatment|0|||
27994817|NCT03350815|81811140|FG000|Period 1|Protocol Violation|3|||
27994818|NCT03350815|81811141|FG001|Period 1|Protocol Violation|0|||
27994819|NCT03350815|81811142|FG002|Period 1|Protocol Violation|0|||
27994820|NCT03350815|81811143|FG003|Period 1|Protocol Violation|0|||
27994821|NCT03350815|81811140|FG000|Period 2|Adverse Event|0|||
27994822|NCT03350815|81811141|FG001|Period 2|Adverse Event|3|||
27994823|NCT03350815|81811142|FG002|Period 2|Adverse Event|5|||
27994824|NCT03350815|81811143|FG003|Period 2|Adverse Event|0|||
27994825|NCT03350815|81811140|FG000|Period 2|Technical problem|0|||
27994826|NCT03350815|81811141|FG001|Period 2|Technical problem|1|||
27994827|NCT03350815|81811142|FG002|Period 2|Technical problem|0|||
27994828|NCT03350815|81811143|FG003|Period 2|Technical problem|0|||
27994829|NCT03350815|81811140|FG000|Period 2|Lost to Follow-up|0|||
27994830|NCT03350815|81811141|FG001|Period 2|Lost to Follow-up|3|||
27994831|NCT03350815|81811142|FG002|Period 2|Lost to Follow-up|3|||
27994832|NCT03350815|81811143|FG003|Period 2|Lost to Follow-up|0|||
27994833|NCT03350815|81811140|FG000|Period 2|Physician Decision|0|||
27802018|NCT00267020|81105265|FG000|Overall Study|Other|1|||
27802019|NCT00267020|81105266|FG001|Overall Study|Other|2|||
27802020|NCT01185639|81105270|FG000|Overall Study|Progressed and didn't receive therapy|2|||
27802021|NCT02729545|81105273|FG000|Overall Study|Pregnancy|1|||
27802022|NCT02729545|81105274|FG001|Overall Study|Pregnancy|1|||
27802023|NCT02729545|81105273|FG000|Overall Study|Lost to Follow-up|0|||
27802024|NCT02729545|81105274|FG001|Overall Study|Lost to Follow-up|1|||
27802025|NCT02729545|81105273|FG000|Overall Study|Withdrawal by Subject|2|||
27802026|NCT02729545|81105274|FG001|Overall Study|Withdrawal by Subject|3|||
27802027|NCT00964223|81105275|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
27802028|NCT01418352|81105276|FG000|Overall Study|Lost to Follow-up|2|||
27802029|NCT01418352|81105277|FG001|Overall Study|Lost to Follow-up|0|||
27802030|NCT01418352|81105278|FG002|Overall Study|Lost to Follow-up|0|||
27802031|NCT01418352|81105279|FG003|Overall Study|Lost to Follow-up|0|||
27802032|NCT01418352|81105276|FG000|Overall Study|Adverse Event|0|||
27802033|NCT01418352|81105277|FG001|Overall Study|Adverse Event|1|||
27802034|NCT01418352|81105278|FG002|Overall Study|Adverse Event|0|||
27802035|NCT01418352|81105279|FG003|Overall Study|Adverse Event|0|||
27802036|NCT01418352|81105276|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
27994834|NCT03350815|81811141|FG001|Period 2|Physician Decision|0|||
27994835|NCT03350815|81811142|FG002|Period 2|Physician Decision|1|||
27994836|NCT03350815|81811143|FG003|Period 2|Physician Decision|0|||
27994837|NCT03350815|81811140|FG000|Period 2|Withdrawal by Subject|0|||
27802037|NCT01418352|81105277|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
27802038|NCT01418352|81105278|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
27802039|NCT01418352|81105279|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
27802040|NCT01418352|81105276|FG000|Overall Study|Subject Withdrew Consent|0|||
27802041|NCT01418352|81105277|FG001|Overall Study|Subject Withdrew Consent|1|||
27994838|NCT03350815|81811141|FG001|Period 2|Withdrawal by Subject|3|||
27994839|NCT03350815|81811142|FG002|Period 2|Withdrawal by Subject|4|||
27994840|NCT03350815|81811143|FG003|Period 2|Withdrawal by Subject|0|||
27994841|NCT03350815|81811140|FG000|Period 2|Lack of Efficacy|0|||
27994842|NCT03350815|81811141|FG001|Period 2|Lack of Efficacy|6|||
27994843|NCT03350815|81811142|FG002|Period 2|Lack of Efficacy|2|||
27802042|NCT01418352|81105278|FG002|Overall Study|Subject Withdrew Consent|2|||
27802043|NCT01418352|81105279|FG003|Overall Study|Subject Withdrew Consent|1|||
27802044|NCT01418352|81105276|FG000|Overall Study|Protocol Deviation|0|||
27802045|NCT01418352|81105277|FG001|Overall Study|Protocol Deviation|0|||
27994844|NCT03350815|81811143|FG003|Period 2|Lack of Efficacy|0|||
27802046|NCT01418352|81105278|FG002|Overall Study|Protocol Deviation|1|||
27802047|NCT01418352|81105279|FG003|Overall Study|Protocol Deviation|0|||
27994845|NCT03350815|81811140|FG000|Period 2|Protocol Violation|0|||
27994846|NCT03350815|81811141|FG001|Period 2|Protocol Violation|0|||
27994847|NCT03350815|81811142|FG002|Period 2|Protocol Violation|1|||
27994848|NCT03350815|81811143|FG003|Period 2|Protocol Violation|0|||
27994849|NCT03350815|81811140|FG000|Period 2|New therapy for study indication|0|||
27994850|NCT03350815|81811141|FG001|Period 2|New therapy for study indication|0|||
27802048|NCT01418352|81105276|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
27802049|NCT01418352|81105277|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
27802050|NCT01418352|81105278|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
27994851|NCT03350815|81811142|FG002|Period 2|New therapy for study indication|1|||
27994852|NCT03350815|81811143|FG003|Period 2|New therapy for study indication|0|||
27994853|NCT03499314|81811144|FG000|Overall Study|Time Commitment|1|||
27994854|NCT03499314|81811145|FG001|Overall Study|Time Commitment|2|||
27994855|NCT03499314|81811144|FG000|Overall Study|Medical issue unrelated to research study|1|||
27994856|NCT03499314|81811145|FG001|Overall Study|Medical issue unrelated to research study|1|||
27994857|NCT00256724|81811148|FG000|Overall Study|Physician Decision|2|||
27994858|NCT00256724|81811149|FG001|Overall Study|Physician Decision|5|||
27994859|NCT00256724|81811148|FG000|Overall Study|Protocol Violation|3|||
27994860|NCT00256724|81811149|FG001|Overall Study|Protocol Violation|3|||
27994861|NCT00546000|81811159|FG000|Overall Study|Adverse Event|1|||
27994862|NCT00546000|81811159|FG000|Overall Study|Lost to Follow-up|1|||
27802051|NCT01418352|81105279|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
27802052|NCT04330482|81105280|FG000|Overall Study|Lost to Follow-up|2|||
27802053|NCT04330482|81105281|FG001|Overall Study|Lost to Follow-up|1|||
27802054|NCT04330482|81105280|FG000|Overall Study|Withdrawal by Subject|0|||
27802055|NCT04330482|81105281|FG001|Overall Study|Withdrawal by Subject|3|||
27802056|NCT01977352|81105282|FG000|Overall Study|Lost to Follow-up|1|||
27802057|NCT01977352|81105283|FG001|Overall Study|Lost to Follow-up|2|||
27802058|NCT02561000|81105284|FG000|Overall Study|Withdrawal by Subject|2|||
27802059|NCT02561000|81105285|FG001|Overall Study|Withdrawal by Subject|3|||
27802060|NCT02561000|81105286|FG002|Overall Study|Withdrawal by Subject|0|||
27802061|NCT02561000|81105284|FG000|Overall Study|Adverse Event|0|||
27802062|NCT02561000|81105285|FG001|Overall Study|Adverse Event|1|||
27802063|NCT02561000|81105286|FG002|Overall Study|Adverse Event|0|||
27802064|NCT03611751|81107760|FG000|Pre-treatment|Randomized but not treated|1|||
27802065|NCT03611751|81107761|FG001|Pre-treatment|Randomized but not treated|1|||
27802066|NCT03611751|81107762|FG002|Pre-treatment|Randomized but not treated|0|||
27802067|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
27802068|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
27802069|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
27802070|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
27802071|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
27802072|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
27802073|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
27802074|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
27994863|NCT00546000|81811159|FG000|Overall Study|Baseline HPA Axis Supression|2|||
27994864|NCT02134925|81811160|FG000|Overall Study|Withdrawal by Subject|1|||
27994865|NCT02134925|81811161|FG001|Overall Study|Withdrawal by Subject|0|||
27994866|NCT02134925|81811160|FG000|Overall Study|Cancel|1|||
27994867|NCT02134925|81811161|FG001|Overall Study|Cancel|6|||
27994868|NCT00742417|81811163|FG000|Randomized|Withdrawal by legal representative|0|||
27802075|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
27802076|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
27802077|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
27802078|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
27802079|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
27802080|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
27678450|NCT01016262|80660389|FG003|Open-Label Phase|Lost to Follow-up|0|||
27678451|NCT01016262|80660390|FG004|Open-Label Phase|Lost to Follow-up|1|||
27678452|NCT01016262|80660391|FG005|Open-Label Phase|Lost to Follow-up|0|||
27802081|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
27802082|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
27802083|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
27802084|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
27802085|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
27802086|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
27802087|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
27994869|NCT00742417|81811164|FG001|Randomized|Withdrawal by legal representative|1|||
27994870|NCT00742417|81811163|FG000|Randomized|Withdrawal by Subject|1|||
27994871|NCT00742417|81811164|FG001|Randomized|Withdrawal by Subject|0|||
27678453|NCT01016262|80660386|FG000|Open-Label Phase|Lack of Efficacy|0|||
27678454|NCT01016262|80660387|FG001|Open-Label Phase|Lack of Efficacy|0|||
27678455|NCT01016262|80660388|FG002|Open-Label Phase|Lack of Efficacy|0|||
27678456|NCT01016262|80660389|FG003|Open-Label Phase|Lack of Efficacy|1|||
27802088|NCT03611751|81107760|FG000|Treatment Week 0 - Week 16|Death|0|||
27802089|NCT03611751|81107761|FG001|Treatment Week 0 - Week 16|Death|0|||
27994872|NCT00742417|81811163|FG000|Randomized|Physician Decision|1|||
27994873|NCT00742417|81811164|FG001|Randomized|Physician Decision|0|||
27678457|NCT01016262|80660390|FG004|Open-Label Phase|Lack of Efficacy|0|||
27994874|NCT00742417|81811163|FG000|Intensive Period|Withdrawal by Subject|1|||
27994875|NCT00742417|81811164|FG001|Intensive Period|Withdrawal by Subject|1|||
27994876|NCT00742417|81811163|FG000|Intensive Period|Adverse Event|2|||
27994877|NCT00742417|81811164|FG001|Intensive Period|Adverse Event|0|||
27994878|NCT01036321|81811165|FG000|Overall Study|Ineligible after randomization|0|||
27994879|NCT01036321|81811166|FG001|Overall Study|Ineligible after randomization|1|||
27994880|NCT01036321|81811165|FG000|Overall Study|Withdrawal by Subject|3|||
27994881|NCT01036321|81811166|FG001|Overall Study|Withdrawal by Subject|2|||
27678458|NCT01016262|80660391|FG005|Open-Label Phase|Lack of Efficacy|0|||
27678459|NCT01016262|80660386|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
27678460|NCT01016262|80660387|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
27678461|NCT01016262|80660388|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
27678462|NCT01016262|80660389|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
27678463|NCT01016262|80660390|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
27678464|NCT01016262|80660391|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
27678465|NCT01475461|80660397|FG000|Run-in Period|Not meet eligibility criteria|16|||
27678466|NCT01475461|80660398|FG001|Run-in Period|Not meet eligibility criteria|0|||
27678467|NCT01475461|80660399|FG002|Run-in Period|Not meet eligibility criteria|0|||
27678468|NCT01475461|80660400|FG003|Run-in Period|Not meet eligibility criteria|0|||
27802090|NCT03611751|81107762|FG002|Treatment Week 0 - Week 16|Death|1|||
27678469|NCT01475461|80660401|FG004|Run-in Period|Not meet eligibility criteria|0|||
27678470|NCT01475461|80660402|FG005|Run-in Period|Not meet eligibility criteria|0|||
27678471|NCT01475461|80660403|FG006|Run-in Period|Not meet eligibility criteria|0|||
27678472|NCT01475461|80660397|FG000|Run-in Period|Lost to Follow-up|7|||
27678473|NCT01475461|80660398|FG001|Run-in Period|Lost to Follow-up|0|||
27678474|NCT01475461|80660399|FG002|Run-in Period|Lost to Follow-up|0|||
27678475|NCT01475461|80660400|FG003|Run-in Period|Lost to Follow-up|0|||
27678476|NCT01475461|80660401|FG004|Run-in Period|Lost to Follow-up|0|||
27678477|NCT01475461|80660402|FG005|Run-in Period|Lost to Follow-up|0|||
27678478|NCT01475461|80660403|FG006|Run-in Period|Lost to Follow-up|0|||
27678479|NCT01475461|80660397|FG000|Run-in Period|Withdrawal by Subject|11|||
27678480|NCT01475461|80660398|FG001|Run-in Period|Withdrawal by Subject|0|||
27678481|NCT01475461|80660399|FG002|Run-in Period|Withdrawal by Subject|0|||
27678482|NCT01475461|80660400|FG003|Run-in Period|Withdrawal by Subject|0|||
27678483|NCT01475461|80660401|FG004|Run-in Period|Withdrawal by Subject|0|||
27678484|NCT01475461|80660402|FG005|Run-in Period|Withdrawal by Subject|0|||
27678485|NCT01475461|80660403|FG006|Run-in Period|Withdrawal by Subject|0|||
27678486|NCT01475461|80660397|FG000|Run-in Period|Other|3|||
27678487|NCT01475461|80660398|FG001|Run-in Period|Other|0|||
27678488|NCT01475461|80660399|FG002|Run-in Period|Other|0|||
27678489|NCT01475461|80660400|FG003|Run-in Period|Other|0|||
27678490|NCT01475461|80660401|FG004|Run-in Period|Other|0|||
27678491|NCT01475461|80660402|FG005|Run-in Period|Other|0|||
27678492|NCT01475461|80660403|FG006|Run-in Period|Other|0|||
27678493|NCT01475461|80660397|FG000|Run-in Period|Protocol Violation|4|||
27678494|NCT01475461|80660398|FG001|Run-in Period|Protocol Violation|0|||
27678495|NCT01475461|80660399|FG002|Run-in Period|Protocol Violation|0|||
27678496|NCT01475461|80660400|FG003|Run-in Period|Protocol Violation|0|||
27678497|NCT01475461|80660401|FG004|Run-in Period|Protocol Violation|0|||
27678498|NCT01475461|80660402|FG005|Run-in Period|Protocol Violation|0|||
27678499|NCT01475461|80660403|FG006|Run-in Period|Protocol Violation|0|||
27678500|NCT01475461|80660397|FG000|Treatment Period|Death|0|||
27678501|NCT01475461|80660398|FG001|Treatment Period|Death|0|||
27678502|NCT01475461|80660399|FG002|Treatment Period|Death|0|||
27678503|NCT01475461|80660400|FG003|Treatment Period|Death|1|||
27678504|NCT01475461|80660401|FG004|Treatment Period|Death|0|||
27802091|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
27994882|NCT01036321|81811165|FG000|Overall Study|Adverse Event|2|||
27994883|NCT01036321|81811166|FG001|Overall Study|Adverse Event|1|||
27994884|NCT00711971|81811167|FG000|Overall Study|Lost to Follow-up|3|||
27678505|NCT01475461|80660402|FG005|Treatment Period|Death|0|||
27678506|NCT01475461|80660403|FG006|Treatment Period|Death|0|||
27678507|NCT01475461|80660397|FG000|Treatment Period|Lost to Follow-up|0|||
27678508|NCT01475461|80660398|FG001|Treatment Period|Lost to Follow-up|3|||
27678509|NCT01475461|80660399|FG002|Treatment Period|Lost to Follow-up|2|||
27678510|NCT01475461|80660400|FG003|Treatment Period|Lost to Follow-up|3|||
27678511|NCT01475461|80660401|FG004|Treatment Period|Lost to Follow-up|1|||
27678512|NCT01475461|80660402|FG005|Treatment Period|Lost to Follow-up|2|||
27678513|NCT01475461|80660403|FG006|Treatment Period|Lost to Follow-up|1|||
27678514|NCT01475461|80660397|FG000|Treatment Period|Withdrawal by Subject|0|||
27678515|NCT01475461|80660398|FG001|Treatment Period|Withdrawal by Subject|2|||
27678516|NCT01475461|80660399|FG002|Treatment Period|Withdrawal by Subject|2|||
27678517|NCT01475461|80660400|FG003|Treatment Period|Withdrawal by Subject|0|||
27994885|NCT00711971|81811168|FG001|Overall Study|Lost to Follow-up|4|||
27678518|NCT01475461|80660401|FG004|Treatment Period|Withdrawal by Subject|2|||
27678519|NCT01475461|80660402|FG005|Treatment Period|Withdrawal by Subject|2|||
27678520|NCT01475461|80660403|FG006|Treatment Period|Withdrawal by Subject|0|||
27678521|NCT01475461|80660397|FG000|Treatment Period|Other|0|||
27678522|NCT01475461|80660398|FG001|Treatment Period|Other|1|||
27678523|NCT01475461|80660399|FG002|Treatment Period|Other|0|||
27678524|NCT01475461|80660400|FG003|Treatment Period|Other|0|||
27678525|NCT01475461|80660401|FG004|Treatment Period|Other|0|||
27678526|NCT01475461|80660402|FG005|Treatment Period|Other|0|||
27678527|NCT01475461|80660403|FG006|Treatment Period|Other|0|||
27678528|NCT01475461|80660397|FG000|Treatment Period|Protocol Violation|0|||
27678529|NCT01475461|80660398|FG001|Treatment Period|Protocol Violation|1|||
27678530|NCT01475461|80660399|FG002|Treatment Period|Protocol Violation|0|||
27678531|NCT01475461|80660400|FG003|Treatment Period|Protocol Violation|0|||
27678532|NCT01475461|80660401|FG004|Treatment Period|Protocol Violation|0|||
27678533|NCT01475461|80660402|FG005|Treatment Period|Protocol Violation|0|||
27678534|NCT01475461|80660403|FG006|Treatment Period|Protocol Violation|1|||
27678535|NCT01475461|80660397|FG000|Treatment Period|Lack of Efficacy|0|||
27678536|NCT01475461|80660398|FG001|Treatment Period|Lack of Efficacy|2|||
27678537|NCT01475461|80660399|FG002|Treatment Period|Lack of Efficacy|0|||
27678538|NCT01475461|80660400|FG003|Treatment Period|Lack of Efficacy|2|||
27678539|NCT01475461|80660401|FG004|Treatment Period|Lack of Efficacy|1|||
27678540|NCT01475461|80660402|FG005|Treatment Period|Lack of Efficacy|1|||
27678541|NCT01475461|80660403|FG006|Treatment Period|Lack of Efficacy|0|||
27678542|NCT01475461|80660397|FG000|Treatment Period|Medication Error|0|||
27678543|NCT01475461|80660398|FG001|Treatment Period|Medication Error|0|||
27678544|NCT01475461|80660399|FG002|Treatment Period|Medication Error|0|||
27678545|NCT01475461|80660400|FG003|Treatment Period|Medication Error|1|||
27678546|NCT01475461|80660401|FG004|Treatment Period|Medication Error|0|||
27678547|NCT01475461|80660402|FG005|Treatment Period|Medication Error|0|||
27678548|NCT01475461|80660403|FG006|Treatment Period|Medication Error|0|||
27678549|NCT01475461|80660397|FG000|Treatment Period|Adverse Event|0|||
27678550|NCT01475461|80660398|FG001|Treatment Period|Adverse Event|0|||
27678551|NCT01475461|80660399|FG002|Treatment Period|Adverse Event|0|||
27678552|NCT01475461|80660400|FG003|Treatment Period|Adverse Event|1|||
27678553|NCT01475461|80660401|FG004|Treatment Period|Adverse Event|0|||
27678554|NCT01475461|80660402|FG005|Treatment Period|Adverse Event|0|||
27678555|NCT01475461|80660403|FG006|Treatment Period|Adverse Event|0|||
27678556|NCT03301155|80660404|FG000|Overall Study|Сompliance with exclusion criteria|8|||
27678557|NCT03301155|80660405|FG001|Overall Study|Сompliance with exclusion criteria|7|||
27678558|NCT01509547|80660406|FG000|Overall Study|Lost to Follow-up|24|||
27678559|NCT01509547|80660407|FG001|Overall Study|Lost to Follow-up|14|||
27678560|NCT01509547|80660406|FG000|Overall Study|Withdrawal by Subject|11|||
27678561|NCT01509547|80660407|FG001|Overall Study|Withdrawal by Subject|24|||
27678562|NCT01509547|80660406|FG000|Overall Study|Physician Decision|0|||
27678563|NCT01509547|80660407|FG001|Overall Study|Physician Decision|1|||
27678564|NCT00709228|80660409|FG000|Overall Study|Not treated|14|||
27678565|NCT00709228|80660409|FG000|Overall Study|Eligibility criteria not met|281|||
27678566|NCT00709228|80660409|FG000|Overall Study|Adverse events|2|||
27678567|NCT00709228|80660409|FG000|Overall Study|Discontinued treatment|14|||
27678568|NCT00709228|80660409|FG000|Overall Study|Did not enter follow-up|4|||
27678569|NCT00709228|80660409|FG000|Overall Study|Discontinued follow-up|5|||
27678570|NCT00709228|80660409|FG000|Overall Study|Disease progression|1|||
27678571|NCT00709228|80660409|FG000|Overall Study|Lost to Follow-up|6|||
27678572|NCT00709228|80660409|FG000|Overall Study|Non-compliance|5|||
27678573|NCT00737698|80660416|FG000|Overall Study|Withdrawal by Subject|6|||
27678574|NCT00737698|80660417|FG001|Overall Study|Withdrawal by Subject|5|||
27678575|NCT00737698|80660418|FG002|Overall Study|Withdrawal by Subject|3|||
27678576|NCT00737698|80660416|FG000|Overall Study|Death|0|||
27678577|NCT00737698|80660417|FG001|Overall Study|Death|0|||
27678578|NCT00737698|80660418|FG002|Overall Study|Death|1|||
27678579|NCT03101462|80660421|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
27678580|NCT03101462|80660422|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
27678581|NCT01110408|80660429|FG000|Overall Study|Protocol Violation|1|||
27872108|NCT02906670|81365194|FG003|Cohort 3, QW|Radiological Progression|0|||
27678582|NCT01110408|80660430|FG001|Overall Study|Protocol Violation|0|||
27678583|NCT03552523|80660431|FG000|Overall Study|Withdrawal by Subject|1|||
27678584|NCT03552523|80660432|FG001|Overall Study|Withdrawal by Subject|1|||
27678585|NCT01661205|80660445|FG000|Overall Study|Physician Decision|2|||
27678586|NCT01381575|80660452|FG000|Overall Study|Serious Adverse Event|1|||
27678587|NCT01381575|80660453|FG001|Overall Study|Serious Adverse Event|0|||
27678588|NCT01381575|80660454|FG002|Overall Study|Serious Adverse Event|0|||
27678589|NCT01381575|80660452|FG000|Overall Study|Non-Serious Adverse Event|0|||
27678590|NCT01381575|80660453|FG001|Overall Study|Non-Serious Adverse Event|0|||
27678591|NCT01381575|80660454|FG002|Overall Study|Non-Serious Adverse Event|1|||
27678592|NCT01381575|80660452|FG000|Overall Study|Protocol Violation|0|||
27678593|NCT01381575|80660453|FG001|Overall Study|Protocol Violation|1|||
27678594|NCT01381575|80660454|FG002|Overall Study|Protocol Violation|1|||
27678595|NCT01381575|80660452|FG000|Overall Study|Withdrawal by Subject|15|||
27678596|NCT01381575|80660453|FG001|Overall Study|Withdrawal by Subject|9|||
27678597|NCT01381575|80660454|FG002|Overall Study|Withdrawal by Subject|7|||
27678598|NCT01381575|80660452|FG000|Overall Study|Migrated/moved from study area|2|||
27678599|NCT01381575|80660453|FG001|Overall Study|Migrated/moved from study area|12|||
27678600|NCT01381575|80660454|FG002|Overall Study|Migrated/moved from study area|2|||
27678601|NCT01381575|80660452|FG000|Overall Study|Lost to Follow-up|8|||
27678602|NCT01381575|80660453|FG001|Overall Study|Lost to Follow-up|17|||
27678603|NCT01381575|80660454|FG002|Overall Study|Lost to Follow-up|9|||
27678604|NCT03284203|80660455|FG000|Overall Study|Lost to Follow-up|3|||
27678605|NCT01299480|80660456|FG000|Overall Study|No longer willing to participate|19|||
27678606|NCT01299480|80660457|FG001|Overall Study|No longer willing to participate|17|||
27678607|NCT01299480|80660458|FG002|Overall Study|No longer willing to participate|14|||
27678608|NCT01299480|80660459|FG003|Overall Study|No longer willing to participate|13|||
27678609|NCT01299480|80660460|FG004|Overall Study|No longer willing to participate|10|||
27678610|NCT01299480|80660456|FG000|Overall Study|Protocol Violation|7|||
27678611|NCT01299480|80660457|FG001|Overall Study|Protocol Violation|5|||
27678612|NCT01299480|80660458|FG002|Overall Study|Protocol Violation|8|||
27678613|NCT01299480|80660459|FG003|Overall Study|Protocol Violation|1|||
27678614|NCT01299480|80660460|FG004|Overall Study|Protocol Violation|1|||
27678615|NCT01299480|80660456|FG000|Overall Study|Withdrawal by Subject|3|||
27678616|NCT01299480|80660457|FG001|Overall Study|Withdrawal by Subject|4|||
27678617|NCT01299480|80660458|FG002|Overall Study|Withdrawal by Subject|7|||
27678618|NCT01299480|80660459|FG003|Overall Study|Withdrawal by Subject|3|||
27678619|NCT01299480|80660460|FG004|Overall Study|Withdrawal by Subject|4|||
27678620|NCT01299480|80660456|FG000|Overall Study|Adverse Event|6|||
27678621|NCT01299480|80660457|FG001|Overall Study|Adverse Event|4|||
27678622|NCT01299480|80660458|FG002|Overall Study|Adverse Event|5|||
27678623|NCT01299480|80660459|FG003|Overall Study|Adverse Event|4|||
27678624|NCT01299480|80660460|FG004|Overall Study|Adverse Event|0|||
27678625|NCT01299480|80660456|FG000|Overall Study|Withdrawal due to pregnancy|0|||
27678626|NCT01299480|80660457|FG001|Overall Study|Withdrawal due to pregnancy|1|||
27678627|NCT01299480|80660458|FG002|Overall Study|Withdrawal due to pregnancy|1|||
27678628|NCT01299480|80660459|FG003|Overall Study|Withdrawal due to pregnancy|0|||
27678629|NCT01299480|80660460|FG004|Overall Study|Withdrawal due to pregnancy|0|||
27678630|NCT01299480|80660456|FG000|Overall Study|Physician Decision|1|||
27678631|NCT01299480|80660457|FG001|Overall Study|Physician Decision|1|||
27678632|NCT01299480|80660458|FG002|Overall Study|Physician Decision|0|||
27678633|NCT01299480|80660459|FG003|Overall Study|Physician Decision|2|||
27678634|NCT01299480|80660460|FG004|Overall Study|Physician Decision|0|||
27678635|NCT01299480|80660456|FG000|Overall Study|Lost to Follow-up|3|||
27678636|NCT01299480|80660457|FG001|Overall Study|Lost to Follow-up|1|||
27678637|NCT01299480|80660458|FG002|Overall Study|Lost to Follow-up|2|||
27678638|NCT01299480|80660459|FG003|Overall Study|Lost to Follow-up|1|||
27678639|NCT01299480|80660460|FG004|Overall Study|Lost to Follow-up|2|||
27678640|NCT01299480|80660456|FG000|Overall Study|Other|3|||
27678641|NCT01299480|80660457|FG001|Overall Study|Other|2|||
27678642|NCT01299480|80660458|FG002|Overall Study|Other|3|||
27678643|NCT01299480|80660459|FG003|Overall Study|Other|0|||
27678644|NCT01299480|80660460|FG004|Overall Study|Other|3|||
27678645|NCT01299480|80660456|FG000|Overall Study|Started, but not vaccinated|0|||
27678646|NCT01299480|80660457|FG001|Overall Study|Started, but not vaccinated|0|||
27678647|NCT01299480|80660458|FG002|Overall Study|Started, but not vaccinated|1|||
27678648|NCT01299480|80660459|FG003|Overall Study|Started, but not vaccinated|1|||
27678649|NCT01299480|80660460|FG004|Overall Study|Started, but not vaccinated|0|||
27678650|NCT00863512|80660461|FG000|Overall Study|Adverse Event|2|||
27678651|NCT00863512|80660462|FG001|Overall Study|Adverse Event|0|||
27678652|NCT00863512|80660461|FG000|Overall Study|Withdrawal by Subject|11|||
27678653|NCT00863512|80660462|FG001|Overall Study|Withdrawal by Subject|0|||
27678654|NCT00863512|80660461|FG000|Overall Study|Physician Decision|1|||
27678655|NCT00863512|80660462|FG001|Overall Study|Physician Decision|0|||
27678656|NCT01367847|80660463|FG000|Overall Study|Withdrawal by Subject|2|||
27678657|NCT01367847|80660464|FG001|Overall Study|Withdrawal by Subject|2|||
27678658|NCT04942366|80660466|FG000|Overall Study|Withdrawal by Subject|5|||
27802092|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
27802093|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
27802094|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
27802095|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
27802096|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
27678659|NCT04942366|80660467|FG001|Overall Study|Withdrawal by Subject|5|||
27678660|NCT01413503|80660474|FG000|Overall Study|Lost to Follow-up|1|||
27678661|NCT00680992|80660477|FG000|Overall Study|Complete Resection (as per protocol)|25|||
27678662|NCT00680992|80660478|FG001|Overall Study|Complete Resection (as per protocol)|121|||
27802097|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
27678663|NCT00680992|80660479|FG002|Overall Study|Complete Resection (as per protocol)|0|||
27678664|NCT00680992|80660477|FG000|Overall Study|Administrative Decision|83|||
27678665|NCT00680992|80660478|FG001|Overall Study|Administrative Decision|42|||
27802098|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27678666|NCT00680992|80660479|FG002|Overall Study|Administrative Decision|5|||
27678667|NCT00680992|80660477|FG000|Overall Study|End of Trial|32|||
27678668|NCT00680992|80660478|FG001|Overall Study|End of Trial|12|||
27678669|NCT00680992|80660479|FG002|Overall Study|End of Trial|3|||
27678670|NCT00680992|80660477|FG000|Overall Study|Withdrawal by Subject|33|||
27678671|NCT00680992|80660478|FG001|Overall Study|Withdrawal by Subject|11|||
27678672|NCT00680992|80660479|FG002|Overall Study|Withdrawal by Subject|1|||
27678673|NCT00680992|80660477|FG000|Overall Study|Adverse Event|21|||
27678674|NCT00680992|80660478|FG001|Overall Study|Adverse Event|19|||
27678675|NCT00680992|80660479|FG002|Overall Study|Adverse Event|1|||
27678676|NCT00680992|80660477|FG000|Overall Study|Other|19|||
27678677|NCT00680992|80660478|FG001|Overall Study|Other|14|||
27678678|NCT00680992|80660479|FG002|Overall Study|Other|1|||
27678679|NCT00680992|80660477|FG000|Overall Study|Disease Progression|21|||
27678680|NCT00680992|80660478|FG001|Overall Study|Disease Progression|9|||
27678681|NCT00680992|80660479|FG002|Overall Study|Disease Progression|0|||
27678682|NCT00680992|80660477|FG000|Overall Study|Lost to Follow-up|12|||
27678683|NCT00680992|80660478|FG001|Overall Study|Lost to Follow-up|14|||
27678684|NCT00680992|80660479|FG002|Overall Study|Lost to Follow-up|0|||
27678685|NCT00680992|80660477|FG000|Overall Study|Noncompliance|4|||
27678686|NCT00680992|80660478|FG001|Overall Study|Noncompliance|6|||
27678687|NCT00680992|80660479|FG002|Overall Study|Noncompliance|0|||
27678688|NCT00680992|80660477|FG000|Overall Study|Requirement for Alternative Therapy|8|||
27678689|NCT00680992|80660478|FG001|Overall Study|Requirement for Alternative Therapy|2|||
27678690|NCT00680992|80660479|FG002|Overall Study|Requirement for Alternative Therapy|0|||
27678691|NCT00680992|80660477|FG000|Overall Study|Pregnancy|5|||
27678692|NCT00680992|80660478|FG001|Overall Study|Pregnancy|0|||
27678693|NCT00680992|80660479|FG002|Overall Study|Pregnancy|1|||
27678694|NCT00680992|80660477|FG000|Overall Study|Death|5|||
27678695|NCT00680992|80660478|FG001|Overall Study|Death|1|||
27678696|NCT00680992|80660479|FG002|Overall Study|Death|0|||
27678697|NCT00680992|80660477|FG000|Overall Study|Ineligibility Determined|0|||
27678698|NCT00680992|80660478|FG001|Overall Study|Ineligibility Determined|1|||
27678699|NCT00680992|80660479|FG002|Overall Study|Ineligibility Determined|0|||
27678700|NCT04954326|80660480|FG000|Overall Study|Protocol Violation|0|||
27678701|NCT04954326|80660481|FG001|Overall Study|Protocol Violation|1|||
27678702|NCT04954326|80660480|FG000|Overall Study|Death|0|||
27678703|NCT04954326|80660481|FG001|Overall Study|Death|2|||
27678704|NCT04954326|80660480|FG000|Overall Study|Physician Decision|0|||
27678705|NCT04954326|80660481|FG001|Overall Study|Physician Decision|1|||
27678706|NCT01572740|80660489|FG000|Overall Study|Adverse Event|1|||
27678707|NCT01572740|80660490|FG001|Overall Study|Adverse Event|1|||
27678708|NCT01572740|80660489|FG000|Overall Study|Withdrawal by Subject|1|||
27678709|NCT01572740|80660490|FG001|Overall Study|Withdrawal by Subject|1|||
27678710|NCT01572740|80660489|FG000|Overall Study|unclassified|4|||
27802099|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
27802100|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
27802101|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
27802102|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
27802103|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
27802104|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
27802105|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
27802106|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
27802107|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
27802108|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
27802109|NCT03611751|81107760|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
27802110|NCT03611751|81107761|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
27802111|NCT03611751|81107762|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
27802112|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
27872109|NCT02906670|81365195|FG004|Cohort 3, QW|Radiological Progression|0|||
27994886|NCT00711971|81811169|FG002|Overall Study|Lost to Follow-up|1|||
27678711|NCT01572740|80660490|FG001|Overall Study|unclassified|3|||
27994887|NCT01949090|81811170|FG000|Overall Study|Serious Adverse Event|0|||
27994888|NCT01949090|81811171|FG001|Overall Study|Serious Adverse Event|1|||
27994889|NCT01949090|81811172|FG002|Overall Study|Serious Adverse Event|2|||
27678712|NCT01934790|80660491|FG000|Treatment|Adverse Event|3|||
27678713|NCT01934790|80660491|FG000|Treatment|Clinical progression|6|||
27678714|NCT01934790|80660491|FG000|Treatment|Radiological progression|4|||
27678715|NCT01934790|80660491|FG000|Treatment|Withdrawal by Subject|2|||
27678716|NCT01934790|80660491|FG000|Treatment|Study drug never administered|1|||
27678717|NCT01934790|80660491|FG000|Active Follow up|Death|20|||
27678718|NCT01934790|80660491|FG000|Active Follow up|Physician Decision|2|||
27678719|NCT01934790|80660491|FG000|Active Follow up|Progressive disease|1|||
27678720|NCT01934790|80660491|FG000|Active Follow up|Other reason|1|||
27678721|NCT01436253|80660492|FG000|Overall Study|Lost to Follow-up|182|||
27678722|NCT01436253|80660492|FG000|Overall Study|Not meeting all eligibility criteria|117|||
27678723|NCT00332462|80660493|FG000|Overall Study|Adverse Event|5|||
27678724|NCT00332462|80660493|FG000|Overall Study|Abnormal Lab Value|1|||
27994890|NCT01949090|81811173|FG003|Overall Study|Serious Adverse Event|0|||
27994891|NCT01949090|81811174|FG004|Overall Study|Serious Adverse Event|1|||
27994892|NCT01949090|81811170|FG000|Overall Study|Withdrawal by Subject|2|||
27994893|NCT01949090|81811171|FG001|Overall Study|Withdrawal by Subject|0|||
27994894|NCT01949090|81811172|FG002|Overall Study|Withdrawal by Subject|0|||
27994895|NCT01949090|81811173|FG003|Overall Study|Withdrawal by Subject|0|||
27994896|NCT01949090|81811174|FG004|Overall Study|Withdrawal by Subject|1|||
27994897|NCT01949090|81811170|FG000|Overall Study|Protocol non-compliance|0|||
27994898|NCT01949090|81811171|FG001|Overall Study|Protocol non-compliance|0|||
27994899|NCT01949090|81811172|FG002|Overall Study|Protocol non-compliance|0|||
27994900|NCT01949090|81811173|FG003|Overall Study|Protocol non-compliance|0|||
27994901|NCT01949090|81811174|FG004|Overall Study|Protocol non-compliance|1|||
27994902|NCT01949090|81811170|FG000|Overall Study|Lost to Follow-up|2|||
27994903|NCT01949090|81811171|FG001|Overall Study|Lost to Follow-up|1|||
27994904|NCT01949090|81811172|FG002|Overall Study|Lost to Follow-up|0|||
27994905|NCT01949090|81811173|FG003|Overall Study|Lost to Follow-up|1|||
27994906|NCT01949090|81811174|FG004|Overall Study|Lost to Follow-up|1|||
27994907|NCT03539601|81811175|FG000|Overall Study|Withdraw by parent/guardian|1|||
27994908|NCT03539601|81811176|FG001|Overall Study|Withdraw by parent/guardian|0|||
27994909|NCT03539601|81811177|FG002|Overall Study|Withdraw by parent/guardian|1|||
27994910|NCT03539601|81811178|FG003|Overall Study|Withdraw by parent/guardian|0|||
27994911|NCT03539601|81811175|FG000|Overall Study|Adverse Event|0|||
27994912|NCT03539601|81811176|FG001|Overall Study|Adverse Event|2|||
27994913|NCT03539601|81811177|FG002|Overall Study|Adverse Event|0|||
27994914|NCT03539601|81811178|FG003|Overall Study|Adverse Event|0|||
27994915|NCT03539601|81811175|FG000|Overall Study|Lost to Follow-up|2|||
27994916|NCT03539601|81811176|FG001|Overall Study|Lost to Follow-up|4|||
27994917|NCT03539601|81811177|FG002|Overall Study|Lost to Follow-up|5|||
27994918|NCT03539601|81811178|FG003|Overall Study|Lost to Follow-up|0|||
27994919|NCT03539601|81811175|FG000|Overall Study|Withdrawal by Subject|2|||
27994920|NCT03539601|81811176|FG001|Overall Study|Withdrawal by Subject|0|||
27994921|NCT03539601|81811177|FG002|Overall Study|Withdrawal by Subject|0|||
27994922|NCT03539601|81811178|FG003|Overall Study|Withdrawal by Subject|1|||
27994923|NCT03539601|81811175|FG000|Overall Study|Randomized but not treated|1|||
27994924|NCT03539601|81811176|FG001|Overall Study|Randomized but not treated|1|||
27994925|NCT03539601|81811177|FG002|Overall Study|Randomized but not treated|0|||
27994926|NCT03539601|81811178|FG003|Overall Study|Randomized but not treated|0|||
27994927|NCT02524158|81811179|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
27994928|NCT02524158|81811180|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
27994929|NCT02524158|81811179|FG000|12-weeks Assessment|Lost to Follow-up|18|||
27994930|NCT02524158|81811180|FG001|12-weeks Assessment|Lost to Follow-up|12|||
27994931|NCT02524158|81811179|FG000|6-month Assessment|Withdrawal by Subject|1|||
27994932|NCT02524158|81811180|FG001|6-month Assessment|Withdrawal by Subject|1|||
27994933|NCT02524158|81811179|FG000|6-month Assessment|Lost to Follow-up|21|||
27994934|NCT02524158|81811180|FG001|6-month Assessment|Lost to Follow-up|20|||
27994935|NCT00203424|81811184|FG000|Treatment Period|Withdrawal by Subject|4|||
27994936|NCT00203424|81811184|FG000|Treatment Period|Adverse Event|5|||
27994937|NCT00203424|81811184|FG000|Treatment Period|progressive disease|2|||
27994938|NCT00203424|81811184|FG000|Follow-up Period|Withdrawal by Subject|1|||
27994939|NCT00203424|81811184|FG000|Follow-up Period|progressive disease|4|||
27994940|NCT00203424|81811184|FG000|Follow-up Period|Lost to Follow-up|1|||
27994941|NCT00992459|81811185|FG000|Overall Study|Withdrawal by Subject|0|||
27994942|NCT00992459|81811186|FG001|Overall Study|Withdrawal by Subject|1|||
27994943|NCT00992459|81811185|FG000|Overall Study|Adverse Event|1|||
27994944|NCT00992459|81811186|FG001|Overall Study|Adverse Event|0|||
27994945|NCT00548145|81811187|FG000|Overall Study|Death|0|||
27994946|NCT00548145|81811188|FG001|Overall Study|Death|1|||
27994947|NCT00548145|81811187|FG000|Overall Study|Withdrawal by Subject|0|||
27994948|NCT00548145|81811188|FG001|Overall Study|Withdrawal by Subject|2|||
27994949|NCT00548145|81811187|FG000|Overall Study|Physician Decision|1|||
27994950|NCT00548145|81811188|FG001|Overall Study|Physician Decision|1|||
27994951|NCT00607087|81811189|FG000|Overall Study|Withdrawal by Subject|9|||
27994952|NCT00607087|81811190|FG001|Overall Study|Withdrawal by Subject|4|||
27994953|NCT00607087|81811191|FG002|Overall Study|Withdrawal by Subject|4|||
27994954|NCT00607087|81811189|FG000|Overall Study|Adverse Event|3|||
27994955|NCT00607087|81811190|FG001|Overall Study|Adverse Event|2|||
27994956|NCT00607087|81811191|FG002|Overall Study|Adverse Event|3|||
27994957|NCT00607087|81811189|FG000|Overall Study|Other reason|1|||
27994958|NCT00607087|81811190|FG001|Overall Study|Other reason|5|||
27994959|NCT00607087|81811191|FG002|Overall Study|Other reason|2|||
27994960|NCT00607087|81811189|FG000|Overall Study|Poor compliance to protocol|1|||
27994961|NCT00607087|81811190|FG001|Overall Study|Poor compliance to protocol|0|||
27994962|NCT00607087|81811191|FG002|Overall Study|Poor compliance to protocol|1|||
27994963|NCT00607087|81811189|FG000|Overall Study|Lost to Follow-up|1|||
27994964|NCT00607087|81811190|FG001|Overall Study|Lost to Follow-up|0|||
27994965|NCT00607087|81811191|FG002|Overall Study|Lost to Follow-up|0|||
27994966|NCT00607087|81811189|FG000|Period 1|Withdrawal by Subject|7|||
27994967|NCT00607087|81811190|FG001|Period 1|Withdrawal by Subject|2|||
27802113|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
27802114|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
27802115|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
27802116|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
27802117|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
27802118|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
27802119|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
27802120|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
27802121|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
27802122|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
27994968|NCT00607087|81811191|FG002|Period 1|Withdrawal by Subject|3|||
27994969|NCT00607087|81811189|FG000|Period 1|Adverse Event|3|||
27994970|NCT00607087|81811190|FG001|Period 1|Adverse Event|0|||
27994971|NCT00607087|81811191|FG002|Period 1|Adverse Event|0|||
27802123|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
27802124|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
27802125|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
27802126|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
27802127|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
27802128|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
27802129|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
27802130|NCT03611751|81107760|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
27802131|NCT03611751|81107761|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
27802132|NCT03611751|81107762|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
27802133|NCT03724916|81107763|FG000|Overall Study|Withdrawal by Subject|0|||
27802134|NCT03724916|81107764|FG001|Overall Study|Withdrawal by Subject|1|||
27802135|NCT03724916|81107765|FG002|Overall Study|Withdrawal by Subject|1|||
27802136|NCT03724916|81107766|FG003|Overall Study|Withdrawal by Subject|2|||
27802137|NCT03724916|81107763|FG000|Overall Study|Randomized but not Treated|1|||
27802138|NCT03724916|81107764|FG001|Overall Study|Randomized but not Treated|0|||
27802139|NCT03724916|81107765|FG002|Overall Study|Randomized but not Treated|0|||
27802140|NCT03724916|81107766|FG003|Overall Study|Randomized but not Treated|0|||
27802141|NCT00078819|81107771|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
27802142|NCT00078819|81107772|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
27802143|NCT00078819|81107773|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
27802144|NCT00078819|81107774|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
27802145|NCT00078819|81107771|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
27802146|NCT00078819|81107772|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
27802147|NCT00078819|81107773|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
27802148|NCT00078819|81107774|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
27802149|NCT00078819|81107771|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
27802150|NCT00078819|81107772|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
27802151|NCT00078819|81107773|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
27994972|NCT00607087|81811189|FG000|Period 1|Poor compliance to protocol|1|||
27994973|NCT00607087|81811190|FG001|Period 1|Poor compliance to protocol|0|||
27994974|NCT00607087|81811191|FG002|Period 1|Poor compliance to protocol|0|||
27994975|NCT00607087|81811189|FG000|Period 1|Lost to Follow-up|1|||
27994976|NCT00607087|81811190|FG001|Period 1|Lost to Follow-up|0|||
27994977|NCT00607087|81811191|FG002|Period 1|Lost to Follow-up|0|||
27994978|NCT00607087|81811189|FG000|Period 1|Other reason|0|||
27994979|NCT00607087|81811190|FG001|Period 1|Other reason|4|||
27994980|NCT00607087|81811191|FG002|Period 1|Other reason|2|||
27994981|NCT00607087|81811189|FG000|Period 2|Withdrawal by Subject|0|||
27994982|NCT00607087|81811190|FG001|Period 2|Withdrawal by Subject|1|||
27994983|NCT00607087|81811191|FG002|Period 2|Withdrawal by Subject|1|||
27994984|NCT00607087|81811189|FG000|Period 2|Other reason|1|||
27994985|NCT00607087|81811190|FG001|Period 2|Other reason|1|||
27994986|NCT00607087|81811191|FG002|Period 2|Other reason|0|||
27994987|NCT00607087|81811189|FG000|Period 2|Adverse Event|0|||
27802152|NCT00078819|81107774|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
27802153|NCT00078819|81107771|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
27802154|NCT00078819|81107772|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
27994988|NCT00607087|81811190|FG001|Period 2|Adverse Event|1|||
27994989|NCT00607087|81811191|FG002|Period 2|Adverse Event|3|||
27994990|NCT00607087|81811189|FG000|Period 2|Poor compliance to protocol|0|||
27994991|NCT00607087|81811190|FG001|Period 2|Poor compliance to protocol|0|||
27994992|NCT00607087|81811191|FG002|Period 2|Poor compliance to protocol|1|||
27802155|NCT00078819|81107773|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
27802156|NCT00078819|81107774|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
27802157|NCT00078819|81107771|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
27802158|NCT00078819|81107772|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
27994993|NCT00607087|81811189|FG000|Period 3|Withdrawal by Subject|2|||
27994994|NCT00607087|81811190|FG001|Period 3|Withdrawal by Subject|1|||
27994995|NCT00607087|81811191|FG002|Period 3|Withdrawal by Subject|0|||
27994996|NCT00607087|81811189|FG000|Period 3|Adverse Event|0|||
27994997|NCT00607087|81811190|FG001|Period 3|Adverse Event|1|||
27994998|NCT00607087|81811191|FG002|Period 3|Adverse Event|0|||
27994999|NCT00660179|81811194|FG000|Overall Study|Death|44|||
27995000|NCT00660179|81811195|FG001|Overall Study|Death|47|||
27995001|NCT00660179|81811196|FG002|Overall Study|Death|34|||
27995002|NCT00660179|81811194|FG000|Overall Study|Withdrawal of consent|4|||
27995003|NCT00660179|81811195|FG001|Overall Study|Withdrawal of consent|6|||
27995004|NCT00660179|81811196|FG002|Overall Study|Withdrawal of consent|4|||
27995005|NCT00660179|81811194|FG000|Overall Study|Lost to Follow-up|7|||
27995006|NCT00660179|81811195|FG001|Overall Study|Lost to Follow-up|5|||
27995007|NCT00660179|81811196|FG002|Overall Study|Lost to Follow-up|2|||
27995008|NCT00660179|81811194|FG000|Overall Study|Administrative reason|0|||
27995009|NCT00660179|81811195|FG001|Overall Study|Administrative reason|0|||
27995010|NCT00660179|81811196|FG002|Overall Study|Administrative reason|1|||
27995011|NCT00660179|81811194|FG000|Overall Study|Incorrect randomization|1|||
27995012|NCT00660179|81811195|FG001|Overall Study|Incorrect randomization|0|||
27995013|NCT00660179|81811196|FG002|Overall Study|Incorrect randomization|0|||
27995014|NCT00719680|81811197|FG000|Overall Study|Adverse Event|1|||
27995015|NCT00719680|81811197|FG000|Overall Study|Lost to Follow-up|1|||
27995016|NCT00719680|81811197|FG000|Overall Study|Withdrawal by Subject|3|||
27995017|NCT02717494|81811204|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
27995018|NCT02717494|81811205|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
27995019|NCT02717494|81811206|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
27995020|NCT02717494|81811204|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
27995021|NCT02717494|81811205|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
27995022|NCT02717494|81811206|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
27995023|NCT02717494|81811204|FG000|First Intervention (Step 1)|Death|0|||
27995024|NCT02717494|81811205|FG001|First Intervention (Step 1)|Death|0|||
27995025|NCT02717494|81811206|FG002|First Intervention (Step 1)|Death|1|||
27995026|NCT02717494|81811204|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
27995027|NCT02717494|81811205|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
27995028|NCT02717494|81811206|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
27802159|NCT00078819|81107773|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
27802160|NCT00078819|81107774|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
27802161|NCT00078819|81107771|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
27802162|NCT00078819|81107772|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
27802163|NCT00078819|81107773|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
27802164|NCT00078819|81107774|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
27802165|NCT00078819|81107771|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
27802166|NCT00078819|81107772|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
27802167|NCT00078819|81107773|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
27995029|NCT00991939|81811207|FG000|Overall Study|Lost to Follow-up|0|||
27995030|NCT00991939|81811208|FG001|Overall Study|Lost to Follow-up|1|||
27995031|NCT00991939|81811207|FG000|Overall Study|Withdrawal by Subject|1|||
27995032|NCT00991939|81811208|FG001|Overall Study|Withdrawal by Subject|0|||
27995033|NCT00991939|81811207|FG000|Overall Study|Entire study terminated|4|||
27995034|NCT00991939|81811208|FG001|Overall Study|Entire study terminated|1|||
27995035|NCT01505374|81811209|FG000|Overall Study|Lost to Follow-up|1|||
27995036|NCT01505374|81811210|FG001|Overall Study|Lost to Follow-up|0|||
27995037|NCT02360228|81811212|FG000|Overall Study|Withdrawal by Subject|1|||
27995038|NCT02360228|81811213|FG001|Overall Study|Withdrawal by Subject|0|||
27995039|NCT02360228|81811214|FG002|Overall Study|Withdrawal by Subject|0|||
27995040|NCT02360228|81811212|FG000|Overall Study|Self-discontinued medication|0|||
27995041|NCT02360228|81811213|FG001|Overall Study|Self-discontinued medication|1|||
27995042|NCT02360228|81811214|FG002|Overall Study|Self-discontinued medication|0|||
27995043|NCT02360228|81811212|FG000|Overall Study|Unstable symptoms during screening|0|||
27995044|NCT02360228|81811213|FG001|Overall Study|Unstable symptoms during screening|0|||
27995045|NCT02360228|81811214|FG002|Overall Study|Unstable symptoms during screening|1|||
27995046|NCT03386487|81811217|FG000|Overall Study|Lost to Follow-up|5|||
27802168|NCT00078819|81107774|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
27802169|NCT00078819|81107771|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
27802170|NCT00078819|81107772|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
27995047|NCT03386487|81811218|FG001|Overall Study|Lost to Follow-up|6|||
27995048|NCT03386487|81811217|FG000|Overall Study|Withdrawal by Subject|11|||
27995049|NCT03386487|81811218|FG001|Overall Study|Withdrawal by Subject|7|||
27995050|NCT03386487|81811217|FG000|Overall Study|Physician Decision|11|||
27995051|NCT03386487|81811218|FG001|Overall Study|Physician Decision|8|||
27995052|NCT01641601|81811219|FG000|Overall Study|Study discontinued.|3|||
27995053|NCT01641601|81811220|FG001|Overall Study|Study discontinued.|5|||
27995054|NCT02586727|81811224|FG000|Overall Study|Lost to Follow-up|1|||
27995055|NCT02586727|81811225|FG001|Overall Study|Lost to Follow-up|0|||
27802171|NCT00078819|81107773|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
27995056|NCT01504412|81811228|FG000|Overall Study|Adverse Event|1|||
27995057|NCT01504412|81811229|FG001|Overall Study|Adverse Event|8|||
27995058|NCT01504412|81811230|FG002|Overall Study|Adverse Event|1|||
27995059|NCT01504412|81811231|FG003|Overall Study|Adverse Event|7|||
27802172|NCT00078819|81107774|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
27802173|NCT01586624|81107775|FG000|Overall Study|Adverse Event|3|||
27802174|NCT01586624|81107776|FG001|Overall Study|Adverse Event|0|||
27802175|NCT01586624|81107777|FG002|Overall Study|Adverse Event|2|||
27802176|NCT01586624|81107778|FG003|Overall Study|Adverse Event|1|||
27802177|NCT01586624|81107779|FG004|Overall Study|Adverse Event|3|||
27802178|NCT01586624|81107780|FG005|Overall Study|Adverse Event|3|||
27802179|NCT01586624|81107781|FG006|Overall Study|Adverse Event|2|||
27802180|NCT01586624|81107782|FG007|Overall Study|Adverse Event|3|||
27802181|NCT01586624|81107775|FG000|Overall Study|Physician Decision|0|||
27802182|NCT01586624|81107776|FG001|Overall Study|Physician Decision|1|||
27802183|NCT01586624|81107777|FG002|Overall Study|Physician Decision|1|||
27802184|NCT01586624|81107778|FG003|Overall Study|Physician Decision|0|||
27802185|NCT01586624|81107779|FG004|Overall Study|Physician Decision|2|||
27802186|NCT01586624|81107780|FG005|Overall Study|Physician Decision|0|||
27802187|NCT01586624|81107781|FG006|Overall Study|Physician Decision|1|||
27802188|NCT01586624|81107782|FG007|Overall Study|Physician Decision|1|||
27802189|NCT01586624|81107775|FG000|Overall Study|Withdrawal by Subject|0|||
27802190|NCT01586624|81107776|FG001|Overall Study|Withdrawal by Subject|0|||
27802191|NCT01586624|81107777|FG002|Overall Study|Withdrawal by Subject|0|||
27802192|NCT01586624|81107778|FG003|Overall Study|Withdrawal by Subject|1|||
27802193|NCT01586624|81107779|FG004|Overall Study|Withdrawal by Subject|0|||
27802194|NCT01586624|81107780|FG005|Overall Study|Withdrawal by Subject|0|||
27802195|NCT01586624|81107781|FG006|Overall Study|Withdrawal by Subject|0|||
27802196|NCT01586624|81107782|FG007|Overall Study|Withdrawal by Subject|0|||
27802197|NCT01586624|81107775|FG000|Overall Study|Evidence of disease progression|1|||
27802198|NCT01586624|81107776|FG001|Overall Study|Evidence of disease progression|3|||
27802199|NCT01586624|81107777|FG002|Overall Study|Evidence of disease progression|2|||
27802200|NCT01586624|81107778|FG003|Overall Study|Evidence of disease progression|5|||
27802201|NCT01586624|81107779|FG004|Overall Study|Evidence of disease progression|3|||
27802202|NCT01586624|81107780|FG005|Overall Study|Evidence of disease progression|5|||
27802203|NCT01586624|81107781|FG006|Overall Study|Evidence of disease progression|4|||
27802204|NCT01586624|81107782|FG007|Overall Study|Evidence of disease progression|6|||
27802205|NCT01586624|81107775|FG000|Overall Study|Screen failure (no treatment received)|0|||
27802206|NCT01586624|81107776|FG001|Overall Study|Screen failure (no treatment received)|0|||
27802207|NCT01586624|81107777|FG002|Overall Study|Screen failure (no treatment received)|0|||
27802208|NCT01586624|81107778|FG003|Overall Study|Screen failure (no treatment received)|0|||
27802209|NCT01586624|81107779|FG004|Overall Study|Screen failure (no treatment received)|0|||
27802210|NCT01586624|81107780|FG005|Overall Study|Screen failure (no treatment received)|0|||
27802211|NCT01586624|81107781|FG006|Overall Study|Screen failure (no treatment received)|1|||
27802212|NCT01586624|81107782|FG007|Overall Study|Screen failure (no treatment received)|0|||
27802213|NCT01656967|81107785|FG000|Overall Study|faulty monitor|1|||
27802214|NCT01656967|81107786|FG001|Overall Study|faulty monitor|0|||
27802215|NCT01656967|81107785|FG000|Overall Study|unsuccessful ETT insertion|3|||
27802216|NCT01656967|81107786|FG001|Overall Study|unsuccessful ETT insertion|2|||
27802217|NCT01715415|81107787|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
27802218|NCT01715415|81107788|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
27802219|NCT01715415|81107787|FG000|Double-blind Treatment|Adverse Event|3|||
27802220|NCT01715415|81107788|FG001|Double-blind Treatment|Adverse Event|0|||
27802221|NCT01715415|81107787|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
27802222|NCT01715415|81107788|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
27802223|NCT01715415|81107787|FG000|Double-blind Treatment|Other|1|||
27995060|NCT01504412|81811232|FG004|Overall Study|Adverse Event|10|||
27995061|NCT01504412|81811228|FG000|Overall Study|Withdrawal by Subject|2|||
27995062|NCT01504412|81811229|FG001|Overall Study|Withdrawal by Subject|1|||
27995063|NCT01504412|81811230|FG002|Overall Study|Withdrawal by Subject|1|||
27995064|NCT01504412|81811231|FG003|Overall Study|Withdrawal by Subject|5|||
27995065|NCT01504412|81811232|FG004|Overall Study|Withdrawal by Subject|1|||
27995066|NCT01504412|81811228|FG000|Overall Study|Other|2|||
27802224|NCT01715415|81107788|FG001|Double-blind Treatment|Other|0|||
27802225|NCT01715415|81107787|FG000|Open-label Treatment|Adverse Event|0|||
27802226|NCT01715415|81107788|FG001|Open-label Treatment|Adverse Event|1|||
27802227|NCT01715415|81107787|FG000|Open-label Treatment|Subject Noncompliant|0|||
27995067|NCT01504412|81811229|FG001|Overall Study|Other|1|||
27995068|NCT01504412|81811230|FG002|Overall Study|Other|1|||
27995069|NCT01504412|81811231|FG003|Overall Study|Other|6|||
27579499|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27995070|NCT01504412|81811232|FG004|Overall Study|Other|1|||
27995071|NCT01504412|81811228|FG000|Overall Study|Lost to Follow-up|0|||
27802228|NCT01715415|81107788|FG001|Open-label Treatment|Subject Noncompliant|1|||
27802229|NCT00520494|81107789|FG000|Overall Study|Withdrawal by Subject|1|||
27995072|NCT01504412|81811229|FG001|Overall Study|Lost to Follow-up|2|||
27802230|NCT01335399|81107792|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
27802231|NCT01335399|81107793|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
27802232|NCT01335399|81107792|FG000|Pre-treatment Period|Participant request to discontinue|0|||
27802233|NCT01335399|81107793|FG001|Pre-treatment Period|Participant request to discontinue|1|||
27802234|NCT01335399|81107792|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
27802235|NCT01335399|81107793|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
27802236|NCT01335399|81107792|FG000|Pre-treatment Period|Consent withdrawal|3|||
27802237|NCT01335399|81107793|FG001|Pre-treatment Period|Consent withdrawal|0|||
27802238|NCT01335399|81107792|FG000|Treatment Period|Disease progression|117|||
27802239|NCT01335399|81107793|FG001|Treatment Period|Disease progression|145|||
27802240|NCT01335399|81107792|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
27802241|NCT01335399|81107793|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
27802242|NCT01335399|81107792|FG000|Treatment Period|Study drug toxicity|52|||
27802243|NCT01335399|81107793|FG001|Treatment Period|Study drug toxicity|64|||
27802244|NCT01335399|81107792|FG000|Treatment Period|Participant request to discontinue|30|||
27802245|NCT01335399|81107793|FG001|Treatment Period|Participant request to discontinue|22|||
27802246|NCT01335399|81107792|FG000|Treatment Period|Other reasons|30|||
27802247|NCT01335399|81107793|FG001|Treatment Period|Other reasons|30|||
27802248|NCT01335399|81107792|FG000|Treatment Period|Consent withdrawal|10|||
27802249|NCT01335399|81107793|FG001|Treatment Period|Consent withdrawal|7|||
27802250|NCT01335399|81107792|FG000|Treatment Period|Death|7|||
27802251|NCT01335399|81107793|FG001|Treatment Period|Death|6|||
27802252|NCT01335399|81107792|FG000|Treatment Period|Poor/Non-compliance|3|||
27802253|NCT01335399|81107793|FG001|Treatment Period|Poor/Non-compliance|4|||
27802254|NCT01335399|81107792|FG000|Treatment Period|Lost to Follow-up|2|||
27802255|NCT01335399|81107793|FG001|Treatment Period|Lost to Follow-up|2|||
27802256|NCT01335399|81107792|FG000|Treatment Period|Maximum clinical benefit|1|||
27802257|NCT01335399|81107793|FG001|Treatment Period|Maximum clinical benefit|1|||
27802258|NCT01335399|81107792|FG000|Treatment Period|No longer meet study criteria|1|||
27802259|NCT01335399|81107793|FG001|Treatment Period|No longer meet study criteria|1|||
27802260|NCT01335399|81107792|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
27802261|NCT01335399|81107793|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
27802262|NCT01364298|81107794|FG000|Overall Study|Adverse Event|3|||
27802263|NCT01364298|81107795|FG001|Overall Study|Adverse Event|4|||
27802264|NCT01364298|81107794|FG000|Overall Study|Lack of adherence to treatment|1|||
27802265|NCT01364298|81107795|FG001|Overall Study|Lack of adherence to treatment|3|||
27802266|NCT01364298|81107794|FG000|Overall Study|Lack of Efficacy|1|||
27802267|NCT01364298|81107795|FG001|Overall Study|Lack of Efficacy|0|||
27802268|NCT01364298|81107794|FG000|Overall Study|Lost to Follow-up|5|||
27802269|NCT01364298|81107795|FG001|Overall Study|Lost to Follow-up|10|||
27802270|NCT01364298|81107794|FG000|Overall Study|Withdrawal by Subject|3|||
27802271|NCT01364298|81107795|FG001|Overall Study|Withdrawal by Subject|3|||
27802272|NCT01364298|81107794|FG000|Overall Study|Other|1|||
27802273|NCT01364298|81107795|FG001|Overall Study|Other|3|||
27802274|NCT01825876|81107796|FG000|Period 2|Withdrawal by Subject|0|||
27802275|NCT01825876|81107797|FG001|Period 2|Withdrawal by Subject|1|||
27802276|NCT01625286|81107798|FG000|Overall Study|Adverse Event|0|||
27802277|NCT01625286|81107799|FG001|Overall Study|Adverse Event|0|||
27802278|NCT01625286|81107800|FG002|Overall Study|Adverse Event|0|||
27802279|NCT01625286|81107801|FG003|Overall Study|Adverse Event|0|||
27802280|NCT01625286|81107802|FG004|Overall Study|Adverse Event|1|||
27995073|NCT01504412|81811230|FG002|Overall Study|Lost to Follow-up|0|||
27995074|NCT01504412|81811231|FG003|Overall Study|Lost to Follow-up|0|||
27995075|NCT01504412|81811232|FG004|Overall Study|Lost to Follow-up|0|||
27995076|NCT01504412|81811228|FG000|Overall Study|Lack of Efficacy|0|||
27995077|NCT01504412|81811229|FG001|Overall Study|Lack of Efficacy|0|||
27995078|NCT01504412|81811230|FG002|Overall Study|Lack of Efficacy|1|||
27995079|NCT01504412|81811231|FG003|Overall Study|Lack of Efficacy|0|||
27995080|NCT01504412|81811232|FG004|Overall Study|Lack of Efficacy|1|||
27802281|NCT01625286|81107803|FG005|Overall Study|Adverse Event|2|||
27802282|NCT01625286|81107804|FG006|Overall Study|Adverse Event|1|||
27802283|NCT01625286|81107798|FG000|Overall Study|Death|0|||
27802284|NCT01625286|81107799|FG001|Overall Study|Death|0|||
27995081|NCT01504412|81811228|FG000|Overall Study|Death|0|||
27995082|NCT01504412|81811229|FG001|Overall Study|Death|0|||
27802285|NCT01625286|81107800|FG002|Overall Study|Death|1|||
27995083|NCT01504412|81811230|FG002|Overall Study|Death|0|||
27995084|NCT01504412|81811231|FG003|Overall Study|Death|1|||
27802286|NCT01625286|81107801|FG003|Overall Study|Death|1|||
27802287|NCT01625286|81107802|FG004|Overall Study|Death|0|||
27802288|NCT01625286|81107803|FG005|Overall Study|Death|11|||
27802289|NCT01625286|81107804|FG006|Overall Study|Death|16|||
27802290|NCT01625286|81107798|FG000|Overall Study|Withdrawal by Subject|0|||
27802291|NCT01625286|81107799|FG001|Overall Study|Withdrawal by Subject|1|||
27802292|NCT01625286|81107800|FG002|Overall Study|Withdrawal by Subject|0|||
27995085|NCT01504412|81811232|FG004|Overall Study|Death|0|||
27995086|NCT01702246|81811235|FG000|Overall Study|Lost to Follow-up|2|||
27579500|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27579501|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27579502|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27579503|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
27579504|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27579505|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27579506|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27579507|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27579508|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27579509|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
27579510|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27579511|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27678725|NCT00332462|80660493|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27678726|NCT00332462|80660493|FG000|Overall Study|no longer requires study drug|1|||
27678727|NCT00332462|80660493|FG000|Overall Study|Death|3|||
27678728|NCT00332462|80660493|FG000|Overall Study|Graft Loss|2|||
27995087|NCT01702246|81811235|FG000|Overall Study|Withdrawal by Subject|2|||
27995088|NCT01702246|81811235|FG000|Overall Study|Physician Decision|1|||
27678729|NCT02817906|80660494|FG000|Overall Study|Adverse Event|3|||
27678730|NCT02817906|80660495|FG001|Overall Study|Adverse Event|0|||
27678731|NCT02817906|80660494|FG000|Overall Study|Lack of Efficacy|1|||
27678732|NCT02817906|80660495|FG001|Overall Study|Lack of Efficacy|0|||
27678733|NCT02817906|80660494|FG000|Overall Study|Protocol Violation|1|||
27678734|NCT02817906|80660495|FG001|Overall Study|Protocol Violation|1|||
27678735|NCT02817906|80660494|FG000|Overall Study|Study Terminated by Sponsor|2|||
27995089|NCT00479856|81811236|FG000|Overall Study|Adverse Event|1|||
27678736|NCT02817906|80660495|FG001|Overall Study|Study Terminated by Sponsor|2|||
27678737|NCT02817906|80660494|FG000|Overall Study|Withdrawal by Subject|7|||
27678738|NCT02817906|80660495|FG001|Overall Study|Withdrawal by Subject|0|||
27995090|NCT00479856|81811236|FG000|Overall Study|Withdrawal by Subject|1|||
27995091|NCT00479856|81811236|FG000|Overall Study|Physician Decision|1|||
27995092|NCT04639219|81811237|FG000|Overall Study|Withdrawal by Subject|8|||
27579512|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27579513|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27678739|NCT02817906|80660494|FG000|Overall Study|Other|2|||
27678740|NCT02817906|80660495|FG001|Overall Study|Other|2|||
27678741|NCT01271504|80660496|FG000|Overall Study|Death|7|||
27678742|NCT01271504|80660497|FG001|Overall Study|Death|6|||
27678743|NCT01271504|80660498|FG002|Overall Study|Death|32|||
27678744|NCT01271504|80660499|FG003|Overall Study|Death|32|||
27678745|NCT01271504|80660496|FG000|Overall Study|Lost to Follow-up|0|||
27678746|NCT01271504|80660497|FG001|Overall Study|Lost to Follow-up|1|||
27678747|NCT01271504|80660498|FG002|Overall Study|Lost to Follow-up|3|||
27678748|NCT01271504|80660499|FG003|Overall Study|Lost to Follow-up|1|||
27678749|NCT01271504|80660496|FG000|Overall Study|Protocol Violation|0|||
27678750|NCT01271504|80660497|FG001|Overall Study|Protocol Violation|0|||
27678751|NCT01271504|80660498|FG002|Overall Study|Protocol Violation|0|||
27678752|NCT01271504|80660499|FG003|Overall Study|Protocol Violation|2|||
27678753|NCT01271504|80660496|FG000|Overall Study|Administrative Reasons|0|||
27678754|NCT01271504|80660497|FG001|Overall Study|Administrative Reasons|0|||
27678755|NCT01271504|80660498|FG002|Overall Study|Administrative Reasons|6|||
27678756|NCT01271504|80660499|FG003|Overall Study|Administrative Reasons|5|||
27678757|NCT01271504|80660496|FG000|Overall Study|Withdrawal by Subject|0|||
27678758|NCT01271504|80660497|FG001|Overall Study|Withdrawal by Subject|0|||
27995093|NCT04639219|81811237|FG000|Overall Study|Lost to Follow-up|6|||
27995094|NCT04639219|81811237|FG000|Overall Study|Death|55|||
27995095|NCT02652156|81811238|FG000|Overall Study|Physician Decision|1|||
27579514|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27579515|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
27579516|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27579517|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27579518|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27579519|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27678759|NCT01271504|80660498|FG002|Overall Study|Withdrawal by Subject|1|||
27995096|NCT02652156|81811239|FG001|Overall Study|Physician Decision|0|||
27678760|NCT01271504|80660499|FG003|Overall Study|Withdrawal by Subject|3|||
27678761|NCT01271504|80660496|FG000|Overall Study|Other|0|||
27678762|NCT01271504|80660497|FG001|Overall Study|Other|1|||
27678763|NCT01271504|80660498|FG002|Overall Study|Other|2|||
27678764|NCT01271504|80660499|FG003|Overall Study|Other|0|||
27678765|NCT04071301|80660502|FG000|Overall Study|Withdrawal by Subject|6|||
27678766|NCT04071301|80660502|FG000|Overall Study|Death|1|||
27678767|NCT01195623|80660503|FG000|Overall Study|Lost to Follow-up|35|||
27678768|NCT01195623|80660504|FG001|Overall Study|Lost to Follow-up|37|||
27678769|NCT01513330|80660506|FG000|SenSura Mio First,|Adverse Event|2|||
27678770|NCT01513330|80660507|FG001|SenSura Mio First,|Adverse Event|0|||
27579520|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27678771|NCT01513330|80660506|FG000|SenSura Mio First,|Lack of Efficacy|0|||
27678772|NCT01513330|80660507|FG001|SenSura Mio First,|Lack of Efficacy|1|||
27678773|NCT01513330|80660506|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
27678774|NCT01513330|80660507|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
27678775|NCT01513330|80660506|FG000|SenSura Mio First,|Other|1|||
27678776|NCT01513330|80660507|FG001|SenSura Mio First,|Other|0|||
27678777|NCT01513330|80660506|FG000|Standard Care First,|Lack of Efficacy|2|||
27678778|NCT01513330|80660507|FG001|Standard Care First,|Lack of Efficacy|2|||
27678779|NCT01513330|80660506|FG000|Standard Care First,|Withdrawal by Subject|1|||
27678780|NCT01513330|80660507|FG001|Standard Care First,|Withdrawal by Subject|2|||
27678781|NCT01513330|80660506|FG000|Standard Care First,|Other|1|||
27678782|NCT01513330|80660507|FG001|Standard Care First,|Other|0|||
27678783|NCT02206061|80660512|FG000|Overall Study|Withdrawal by Subject|4|||
27678784|NCT02206061|80660513|FG001|Overall Study|Withdrawal by Subject|7|||
27678785|NCT02206061|80660514|FG002|Overall Study|Withdrawal by Subject|1|||
27678786|NCT02206061|80660512|FG000|Overall Study|Lost to Follow-up|14|||
27678787|NCT02206061|80660513|FG001|Overall Study|Lost to Follow-up|7|||
27678788|NCT02206061|80660514|FG002|Overall Study|Lost to Follow-up|20|||
27678789|NCT04497389|80660515|FG000|Overall Study|Withdrawal by Subject|1|||
27678790|NCT04497389|80660516|FG001|Overall Study|Withdrawal by Subject|0|||
27678791|NCT04458922|80660517|FG000|Overall Study|Withdrawal by Subject|1|||
27678792|NCT04458922|80660518|FG001|Overall Study|Withdrawal by Subject|0|||
27678793|NCT04458922|80660519|FG002|Overall Study|Withdrawal by Subject|2|||
27678794|NCT04458922|80660517|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
27678795|NCT04458922|80660518|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
27678796|NCT04458922|80660519|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
27678797|NCT04458922|80660517|FG000|Overall Study|Adverse Event|1|||
27678798|NCT04458922|80660518|FG001|Overall Study|Adverse Event|0|||
27678799|NCT04458922|80660519|FG002|Overall Study|Adverse Event|0|||
27678800|NCT04458922|80660517|FG000|Overall Study|Started new study|0|||
27678801|NCT04458922|80660518|FG001|Overall Study|Started new study|0|||
27678802|NCT04458922|80660519|FG002|Overall Study|Started new study|1|||
27678803|NCT04458922|80660517|FG000|Overall Study|Progressive disease|6|||
27678804|NCT04458922|80660518|FG001|Overall Study|Progressive disease|8|||
27678805|NCT04458922|80660519|FG002|Overall Study|Progressive disease|2|||
27678806|NCT04458922|80660517|FG000|Overall Study|Death|1|||
27678807|NCT04458922|80660518|FG001|Overall Study|Death|0|||
27678808|NCT04458922|80660519|FG002|Overall Study|Death|2|||
27678809|NCT04458922|80660517|FG000|Overall Study|Participant started chemotherapy|0|||
27678810|NCT04458922|80660518|FG001|Overall Study|Participant started chemotherapy|1|||
27678811|NCT04458922|80660519|FG002|Overall Study|Participant started chemotherapy|0|||
27678812|NCT00943852|80660520|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678813|NCT00943852|80660521|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678814|NCT00943852|80660522|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678815|NCT00943852|80660523|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
27678816|NCT00943852|80660524|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678817|NCT00943852|80660525|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678818|NCT00943852|80660526|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678819|NCT00943852|80660527|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678820|NCT00943852|80660528|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678821|NCT00943852|80660529|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
27678822|NCT00943852|80660520|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678823|NCT00943852|80660521|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678824|NCT00943852|80660522|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678825|NCT00943852|80660523|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678826|NCT00943852|80660524|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678827|NCT00943852|80660525|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
27678828|NCT00943852|80660526|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678829|NCT00943852|80660527|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678830|NCT00943852|80660528|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678831|NCT00943852|80660529|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
27678832|NCT00943852|80660520|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678833|NCT00943852|80660521|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678834|NCT00943852|80660522|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678835|NCT00943852|80660523|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678836|NCT00943852|80660524|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678837|NCT00943852|80660525|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678838|NCT00943852|80660526|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
27678839|NCT00943852|80660527|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678840|NCT00943852|80660528|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678841|NCT00943852|80660529|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
27678842|NCT00943852|80660520|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678843|NCT00943852|80660521|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678844|NCT00943852|80660522|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678845|NCT00943852|80660523|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678846|NCT00943852|80660524|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678847|NCT00943852|80660525|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678848|NCT00943852|80660526|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678849|NCT00943852|80660527|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
27678850|NCT00943852|80660528|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678851|NCT00943852|80660529|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
27678852|NCT00943852|80660520|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27678853|NCT00943852|80660521|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27678854|NCT00943852|80660522|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27678855|NCT00943852|80660523|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27802293|NCT01625286|81107801|FG003|Overall Study|Withdrawal by Subject|1|||
27802294|NCT01625286|81107802|FG004|Overall Study|Withdrawal by Subject|0|||
27802295|NCT01625286|81107803|FG005|Overall Study|Withdrawal by Subject|0|||
27802296|NCT01625286|81107804|FG006|Overall Study|Withdrawal by Subject|1|||
27802297|NCT01625286|81107798|FG000|Overall Study|Any reason not specifically recorded|0|||
27802298|NCT01625286|81107799|FG001|Overall Study|Any reason not specifically recorded|0|||
27802299|NCT01625286|81107800|FG002|Overall Study|Any reason not specifically recorded|0|||
27802300|NCT01625286|81107801|FG003|Overall Study|Any reason not specifically recorded|0|||
27802301|NCT01625286|81107802|FG004|Overall Study|Any reason not specifically recorded|0|||
27678856|NCT00943852|80660524|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27678857|NCT00943852|80660525|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27678858|NCT00943852|80660526|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
27678859|NCT00943852|80660527|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27678860|NCT00943852|80660528|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27678861|NCT00943852|80660529|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
27678862|NCT01912404|80660530|FG000|Overall Study|Due to personal reasons|1|||
27678863|NCT01912404|80660531|FG001|Overall Study|Due to personal reasons|0|||
27678864|NCT05383508|80660537|FG000|Overall Study|Withdrawal by Subject|1|||
27678865|NCT05383508|80660538|FG001|Overall Study|Withdrawal by Subject|0|||
27678866|NCT05383508|80660539|FG002|Overall Study|Withdrawal by Subject|1|||
27678867|NCT05383508|80660540|FG003|Overall Study|Withdrawal by Subject|1|||
27678868|NCT05383508|80660541|FG004|Overall Study|Withdrawal by Subject|2|||
27678869|NCT05383508|80660542|FG005|Overall Study|Withdrawal by Subject|0|||
27678870|NCT01156376|80660543|FG000|Overall Study|Adverse Event|1|||
27678871|NCT01156376|80660544|FG001|Overall Study|Adverse Event|0|||
27678872|NCT01156376|80660545|FG002|Overall Study|Adverse Event|1|||
27678873|NCT01156376|80660543|FG000|Overall Study|Withdrawal by Subject|0|||
27678874|NCT01156376|80660544|FG001|Overall Study|Withdrawal by Subject|0|||
27678875|NCT01156376|80660545|FG002|Overall Study|Withdrawal by Subject|3|||
27678876|NCT00633880|80660547|FG000|Open Label Titration|Lack of Efficacy|1|||
27678877|NCT00633880|80660548|FG001|Open Label Titration|Lack of Efficacy|0|||
27678878|NCT00633880|80660549|FG002|Open Label Titration|Lack of Efficacy|0|||
27678879|NCT00633880|80660547|FG000|Open Label Titration|Adverse Event|13|||
27678880|NCT00633880|80660548|FG001|Open Label Titration|Adverse Event|0|||
27678881|NCT00633880|80660549|FG002|Open Label Titration|Adverse Event|0|||
27678882|NCT00633880|80660547|FG000|Open Label Titration|Treatment Failure|55|||
27678883|NCT00633880|80660548|FG001|Open Label Titration|Treatment Failure|0|||
27678884|NCT00633880|80660549|FG002|Open Label Titration|Treatment Failure|0|||
27678885|NCT00633880|80660547|FG000|Open Label Titration|Protocol Violation|6|||
27678886|NCT00633880|80660548|FG001|Open Label Titration|Protocol Violation|0|||
27678887|NCT00633880|80660549|FG002|Open Label Titration|Protocol Violation|0|||
27802302|NCT01625286|81107803|FG005|Overall Study|Any reason not specifically recorded|1|||
27802303|NCT01625286|81107804|FG006|Overall Study|Any reason not specifically recorded|0|||
27802304|NCT01625286|81107798|FG000|Overall Study|Progressive disease|6|||
27802305|NCT01625286|81107799|FG001|Overall Study|Progressive disease|3|||
27678888|NCT00633880|80660547|FG000|Open Label Titration|Physician Decision|1|||
27678889|NCT00633880|80660548|FG001|Open Label Titration|Physician Decision|0|||
27678890|NCT00633880|80660549|FG002|Open Label Titration|Physician Decision|0|||
27678891|NCT00633880|80660547|FG000|Open Label Titration|Withdrawal by Subject|4|||
27678892|NCT00633880|80660548|FG001|Open Label Titration|Withdrawal by Subject|0|||
27678893|NCT00633880|80660549|FG002|Open Label Titration|Withdrawal by Subject|0|||
27678894|NCT02956837|80660550|FG000|Overall Study|Serious Adverse Events|0|||
27678895|NCT02956837|80660551|FG001|Overall Study|Serious Adverse Events|1|||
27678896|NCT02956837|80660552|FG002|Overall Study|Serious Adverse Events|0|||
27678897|NCT02956837|80660553|FG003|Overall Study|Serious Adverse Events|0|||
27678898|NCT02956837|80660550|FG000|Overall Study|Withdrawal by Subject|0|||
27678899|NCT02956837|80660551|FG001|Overall Study|Withdrawal by Subject|1|||
27678900|NCT02956837|80660552|FG002|Overall Study|Withdrawal by Subject|0|||
27678901|NCT02956837|80660553|FG003|Overall Study|Withdrawal by Subject|3|||
27678902|NCT02956837|80660550|FG000|Overall Study|Lost to Follow-up|0|||
27678903|NCT02956837|80660551|FG001|Overall Study|Lost to Follow-up|1|||
27678904|NCT02956837|80660552|FG002|Overall Study|Lost to Follow-up|2|||
27678905|NCT02956837|80660553|FG003|Overall Study|Lost to Follow-up|0|||
27678906|NCT01443403|80660558|FG000|Overall Study|Adverse Event|1|||
27678907|NCT01443403|80660559|FG001|Overall Study|Adverse Event|1|||
27678908|NCT01443403|80660560|FG002|Overall Study|Adverse Event|4|||
27678909|NCT01443403|80660561|FG003|Overall Study|Adverse Event|5|||
27678910|NCT01443403|80660558|FG000|Overall Study|Withdrawal by Subject|0|||
27678911|NCT01443403|80660559|FG001|Overall Study|Withdrawal by Subject|1|||
27678912|NCT01443403|80660560|FG002|Overall Study|Withdrawal by Subject|2|||
27678913|NCT01443403|80660561|FG003|Overall Study|Withdrawal by Subject|1|||
27678914|NCT01443403|80660558|FG000|Overall Study|Lost to Follow-up|0|||
27678915|NCT01443403|80660559|FG001|Overall Study|Lost to Follow-up|0|||
27678916|NCT01443403|80660560|FG002|Overall Study|Lost to Follow-up|0|||
27678917|NCT01443403|80660561|FG003|Overall Study|Lost to Follow-up|1|||
27678918|NCT01443403|80660558|FG000|Overall Study|Protocol Violation|2|||
27678919|NCT01443403|80660559|FG001|Overall Study|Protocol Violation|1|||
27678920|NCT01443403|80660560|FG002|Overall Study|Protocol Violation|1|||
27678921|NCT01443403|80660561|FG003|Overall Study|Protocol Violation|1|||
27678922|NCT01443403|80660558|FG000|Overall Study|Use of Prohibited Treatment|2|||
27678923|NCT01443403|80660559|FG001|Overall Study|Use of Prohibited Treatment|3|||
27678924|NCT01443403|80660560|FG002|Overall Study|Use of Prohibited Treatment|0|||
27678925|NCT01443403|80660561|FG003|Overall Study|Use of Prohibited Treatment|0|||
27678926|NCT01443403|80660558|FG000|Overall Study|Other - Miscellaneous|1|||
27678927|NCT01443403|80660559|FG001|Overall Study|Other - Miscellaneous|0|||
27678928|NCT01443403|80660560|FG002|Overall Study|Other - Miscellaneous|0|||
27678929|NCT01443403|80660561|FG003|Overall Study|Other - Miscellaneous|1|||
27678930|NCT01251770|80660562|FG000|Overall Study|Protocol Violation|13|||
27678931|NCT01251770|80660563|FG001|Overall Study|Protocol Violation|7|||
27678932|NCT02145468|80660564|FG000|Overall Study|Withdrawal by Subject|5|||
27678933|NCT02145468|80660565|FG001|Overall Study|Withdrawal by Subject|8|||
27678934|NCT04148651|80660568|FG000|Overall Study|Lost to Follow-up|2|||
27678935|NCT04577001|80660569|FG000|Overall Study|Subject became ineligible|0|||
27678936|NCT04577001|80660570|FG001|Overall Study|Subject became ineligible|1|||
27678937|NCT02056626|80660573|FG000|Overall Study|patient did not follow directions|3|||
27678938|NCT02056626|80660574|FG001|Overall Study|patient did not follow directions|1|||
27678939|NCT02056626|80660575|FG002|Overall Study|patient did not follow directions|0|||
27678940|NCT02056626|80660576|FG003|Overall Study|patient did not follow directions|0|||
27678941|NCT02568397|80660580|FG000|Period 2|Withdrawal by Subject|0|||
27678942|NCT02568397|80660581|FG001|Period 2|Withdrawal by Subject|1|||
27678943|NCT02568397|80660580|FG000|Period 2|Physician Decision|0|||
27802306|NCT01625286|81107800|FG002|Overall Study|Progressive disease|4|||
27802307|NCT01625286|81107801|FG003|Overall Study|Progressive disease|5|||
27802308|NCT01625286|81107802|FG004|Overall Study|Progressive disease|5|||
27802309|NCT01625286|81107803|FG005|Overall Study|Progressive disease|0|||
27802310|NCT01625286|81107804|FG006|Overall Study|Progressive disease|0|||
27678944|NCT02568397|80660581|FG001|Period 2|Physician Decision|1|||
27678945|NCT01681277|80660583|FG000|Overall Study|Adverse Event|1|||
27802311|NCT01625286|81107798|FG000|Overall Study|Lost to Follow-up|0|||
27678946|NCT01681277|80660584|FG001|Overall Study|Adverse Event|0|||
27678947|NCT01681277|80660585|FG002|Overall Study|Adverse Event|0|||
27802312|NCT01625286|81107799|FG001|Overall Study|Lost to Follow-up|0|||
27802313|NCT01625286|81107800|FG002|Overall Study|Lost to Follow-up|0|||
27579521|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
27678948|NCT01681277|80660586|FG003|Overall Study|Adverse Event|0|||
27678949|NCT01681277|80660587|FG004|Overall Study|Adverse Event|0|||
27678950|NCT01886287|80660588|FG000|Overall Study|Radiographic disease progression|1|||
27678951|NCT01886287|80660588|FG000|Overall Study|Clinical progression due to disease|1|||
27678952|NCT00702962|80660589|FG000|Overall Study|Progressive disease|0|||
27678953|NCT00702962|80660590|FG001|Overall Study|Progressive disease|1|||
27678954|NCT00702962|80660589|FG000|Overall Study|Hospitalized for other health disorder|1|||
27802314|NCT01625286|81107801|FG003|Overall Study|Lost to Follow-up|0|||
27802315|NCT01625286|81107802|FG004|Overall Study|Lost to Follow-up|0|||
27802316|NCT01625286|81107803|FG005|Overall Study|Lost to Follow-up|0|||
27802317|NCT01625286|81107804|FG006|Overall Study|Lost to Follow-up|1|||
27802318|NCT02164539|81107805|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
27802319|NCT02164539|81107806|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
27802320|NCT02164539|81107807|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
27802321|NCT02164539|81107808|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
27802322|NCT02164539|81107809|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
27995097|NCT02652156|81811240|FG002|Overall Study|Physician Decision|0|||
27995098|NCT01427933|81811244|FG000|Overall Study|Withdrawal by Subject|5|||
27995099|NCT01427933|81811245|FG001|Overall Study|Withdrawal by Subject|8|||
27995100|NCT01427933|81811244|FG000|Overall Study|Lost to Follow-up|1|||
27995101|NCT01427933|81811245|FG001|Overall Study|Lost to Follow-up|5|||
27995102|NCT01427933|81811244|FG000|Overall Study|Other|1|||
27995103|NCT01427933|81811245|FG001|Overall Study|Other|0|||
27995104|NCT01427933|81811244|FG000|Overall Study|Investigator's Decision|1|||
27995105|NCT01427933|81811245|FG001|Overall Study|Investigator's Decision|0|||
27995106|NCT01483183|81811248|FG000|Overall Study|Physician Decision|0|||
27995107|NCT01483183|81811249|FG001|Overall Study|Physician Decision|0|||
27579522|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
27579523|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
27579524|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
27579525|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
27579526|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
27579527|NCT02139644|80306624|FG000|Run-In Period (Pre-assignment)|Other|6|||
27579528|NCT02139644|80306625|FG001|Run-In Period (Pre-assignment)|Other|0|||
27579529|NCT02139644|80306626|FG002|Run-In Period (Pre-assignment)|Other|0|||
27579530|NCT02139644|80306627|FG003|Run-In Period (Pre-assignment)|Other|0|||
27579531|NCT02139644|80306628|FG004|Run-In Period (Pre-assignment)|Other|0|||
27579532|NCT02139644|80306629|FG005|Run-In Period (Pre-assignment)|Other|0|||
27802323|NCT02164539|81107810|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
27579533|NCT02139644|80306624|FG000|Treatment Period|Adverse Event|0|||
27579534|NCT02139644|80306625|FG001|Treatment Period|Adverse Event|0|||
27802324|NCT02164539|81107811|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
27802325|NCT02164539|81107805|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
27995108|NCT01483183|81811250|FG002|Overall Study|Physician Decision|0|||
27995109|NCT01483183|81811251|FG003|Overall Study|Physician Decision|0|||
27995110|NCT01483183|81811252|FG004|Overall Study|Physician Decision|0|||
27995111|NCT01483183|81811253|FG005|Overall Study|Physician Decision|0|||
27802326|NCT02164539|81107806|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
27802327|NCT02164539|81107807|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
27802328|NCT02164539|81107808|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
27802329|NCT02164539|81107809|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
27802330|NCT02164539|81107810|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
27995112|NCT01483183|81811254|FG006|Overall Study|Physician Decision|2|||
27995113|NCT01483183|81811255|FG007|Overall Study|Physician Decision|0|||
27995114|NCT01483183|81811256|FG008|Overall Study|Physician Decision|0|||
27995115|NCT01483183|81811257|FG009|Overall Study|Physician Decision|0|||
27802331|NCT02164539|81107811|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
27802332|NCT02164539|81107805|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
27802333|NCT02164539|81107806|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
27802334|NCT02164539|81107807|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
27995116|NCT01483183|81811248|FG000|Overall Study|Withdrawal by Subject|0|||
27995117|NCT01483183|81811249|FG001|Overall Study|Withdrawal by Subject|0|||
27995118|NCT01483183|81811250|FG002|Overall Study|Withdrawal by Subject|0|||
27579535|NCT02139644|80306626|FG002|Treatment Period|Adverse Event|3|||
27802335|NCT02164539|81107808|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
27802336|NCT02164539|81107809|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
27802337|NCT02164539|81107810|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
27802338|NCT02164539|81107811|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
27802339|NCT02164539|81107805|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
27802340|NCT02164539|81107806|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27802341|NCT02164539|81107807|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27802342|NCT02164539|81107808|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27802343|NCT02164539|81107809|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27995119|NCT01483183|81811251|FG003|Overall Study|Withdrawal by Subject|0|||
27995120|NCT01483183|81811252|FG004|Overall Study|Withdrawal by Subject|0|||
27995121|NCT01483183|81811253|FG005|Overall Study|Withdrawal by Subject|0|||
27995122|NCT01483183|81811254|FG006|Overall Study|Withdrawal by Subject|0|||
27995123|NCT01483183|81811255|FG007|Overall Study|Withdrawal by Subject|0|||
27995124|NCT01483183|81811256|FG008|Overall Study|Withdrawal by Subject|0|||
27995125|NCT01483183|81811257|FG009|Overall Study|Withdrawal by Subject|1|||
27995126|NCT03710642|81811258|FG000|Overall Study|Adverse Event|5|||
27995127|NCT03710642|81811259|FG001|Overall Study|Adverse Event|1|||
27995128|NCT03710642|81811258|FG000|Overall Study|non-site physician recommendation|1|||
27802344|NCT02164539|81107810|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27802345|NCT02164539|81107811|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
27802346|NCT02164539|81107805|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
27995129|NCT03710642|81811259|FG001|Overall Study|non-site physician recommendation|0|||
27995130|NCT03710642|81811258|FG000|Overall Study|Participant unwilling or unable to participate|1|||
27995131|NCT03710642|81811259|FG001|Overall Study|Participant unwilling or unable to participate|1|||
27995132|NCT03710642|81811258|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
27995133|NCT03710642|81811259|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
27995134|NCT03710642|81811258|FG000|Overall Study|NA-no code provided|1|||
27995135|NCT03710642|81811259|FG001|Overall Study|NA-no code provided|0|||
27995136|NCT03710642|81811258|FG000|Overall Study|Withdrawal by Subject|1|||
27995137|NCT03710642|81811259|FG001|Overall Study|Withdrawal by Subject|0|||
27995138|NCT02352753|81811260|FG000|6-Month Dosing Period|Decision by sponsor|2|||
27995139|NCT02352753|81811260|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
27995140|NCT02352753|81811260|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
27995141|NCT02352753|81811260|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
27995142|NCT02352753|81811260|FG000|3-Month Dosing Period|Decision by sponsor|14|||
27995143|NCT02352753|81811260|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
27995144|NCT04034004|81811262|FG000|Overall Study|Withdrawal by Subject|1|||
27995145|NCT04034004|81811263|FG001|Overall Study|Withdrawal by Subject|2|||
27995146|NCT04034004|81811264|FG002|Overall Study|Withdrawal by Subject|2|||
27995147|NCT04034004|81811265|FG003|Overall Study|Withdrawal by Subject|3|||
27995148|NCT04034004|81811262|FG000|Overall Study|could not find vein to administer IV|2|||
27995149|NCT04034004|81811263|FG001|Overall Study|could not find vein to administer IV|1|||
27995150|NCT04034004|81811264|FG002|Overall Study|could not find vein to administer IV|0|||
27995151|NCT04034004|81811265|FG003|Overall Study|could not find vein to administer IV|0|||
27995152|NCT04034004|81811262|FG000|Overall Study|nurse accidentally unblinded subject|0|||
27995153|NCT04034004|81811263|FG001|Overall Study|nurse accidentally unblinded subject|0|||
27995154|NCT04034004|81811264|FG002|Overall Study|nurse accidentally unblinded subject|0|||
27995155|NCT04034004|81811265|FG003|Overall Study|nurse accidentally unblinded subject|1|||
27995156|NCT00637416|81811266|FG000|Overall Study|Lost to Follow-up|1|||
27995157|NCT00637416|81811267|FG001|Overall Study|Lost to Follow-up|1|||
27995158|NCT00637416|81811266|FG000|Overall Study|Unable to take study drug|0|||
27995159|NCT00637416|81811267|FG001|Overall Study|Unable to take study drug|1|||
27995160|NCT00566852|81811273|FG000|Overall Study|Protocol Violation|22|||
27995161|NCT00566852|81811274|FG001|Overall Study|Protocol Violation|24|||
27995162|NCT00566852|81811273|FG000|Overall Study|Death|95|||
27995163|NCT00566852|81811274|FG001|Overall Study|Death|78|||
27995164|NCT00566852|81811273|FG000|Overall Study|Withdrawal by Subject|30|||
27995165|NCT00566852|81811274|FG001|Overall Study|Withdrawal by Subject|25|||
27995166|NCT00566852|81811273|FG000|Overall Study|Patient refusal|37|||
27995167|NCT00566852|81811274|FG001|Overall Study|Patient refusal|37|||
27995168|NCT00566852|81811273|FG000|Overall Study|Not tested due to disability|6|||
27995169|NCT00566852|81811274|FG001|Overall Study|Not tested due to disability|12|||
27802347|NCT02164539|81107806|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
27995170|NCT00566852|81811273|FG000|Overall Study|Missing reason not specified|1|||
27579536|NCT02139644|80306627|FG003|Treatment Period|Adverse Event|2|||
27579537|NCT02139644|80306628|FG004|Treatment Period|Adverse Event|1|||
27579538|NCT02139644|80306629|FG005|Treatment Period|Adverse Event|6|||
27802348|NCT02164539|81107807|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
27802349|NCT02164539|81107808|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
27995171|NCT00566852|81811274|FG001|Overall Study|Missing reason not specified|2|||
27995172|NCT00566852|81811273|FG000|Overall Study|Missing reason not reported|16|||
27995173|NCT00566852|81811274|FG001|Overall Study|Missing reason not reported|20|||
27678955|NCT00702962|80660590|FG001|Overall Study|Hospitalized for other health disorder|0|||
27678956|NCT03015129|80660594|FG000|Overall Study|Death|2|||
27678957|NCT03015129|80660595|FG001|Overall Study|Death|2|||
27678958|NCT03015129|80660594|FG000|Overall Study|Lost to Follow-up|0|||
27678959|NCT03015129|80660595|FG001|Overall Study|Lost to Follow-up|1|||
27678960|NCT03015129|80660594|FG000|Overall Study|Progression of disease|38|||
27678961|NCT03015129|80660595|FG001|Overall Study|Progression of disease|33|||
27678962|NCT03015129|80660594|FG000|Overall Study|Adverse Event|0|||
27678963|NCT03015129|80660595|FG001|Overall Study|Adverse Event|4|||
27678964|NCT03551691|80660596|FG000|Overall Study|Withdrawal by Subject|3|||
27678965|NCT03551691|80660597|FG001|Overall Study|Withdrawal by Subject|3|||
27678966|NCT00846807|80660598|FG000|Overall Study|Adverse Event|270|||
27678967|NCT00846807|80660598|FG000|Overall Study|Lost to Follow-up|94|||
27678968|NCT00846807|80660598|FG000|Overall Study|Withdrawal by Subject|56|||
27678969|NCT00846807|80660598|FG000|Overall Study|Non compliant with European label|7|||
27678970|NCT00846807|80660598|FG000|Overall Study|Switch to other anticoagulants|89|||
27678971|NCT00846807|80660598|FG000|Overall Study|No prescription after hospital discharge|56|||
27678972|NCT00846807|80660598|FG000|Overall Study|Other|60|||
27995174|NCT01272635|81811276|FG000|Overall Study|Lost to Follow-up|31|||
27995175|NCT01272635|81811277|FG001|Overall Study|Lost to Follow-up|20|||
27995176|NCT01272635|81811278|FG002|Overall Study|Lost to Follow-up|31|||
27995177|NCT01272635|81811279|FG003|Overall Study|Lost to Follow-up|23|||
27995178|NCT01670721|81811280|FG000|Overall Study|Participant's decision|15|||
27995179|NCT01670721|81811280|FG000|Overall Study|Other than specified above|38|||
27995180|NCT01636986|81811283|FG000|Overall Study|Withdrawal by Subject|0|||
27995181|NCT01636986|81811284|FG001|Overall Study|Withdrawal by Subject|1|||
27995182|NCT01636986|81811283|FG000|Overall Study|Corneal Staining|0|||
27678973|NCT01677767|80660599|FG000|Overall Study|Adverse Event|1|||
27678974|NCT01677767|80660599|FG000|Overall Study|Death|4|||
27678975|NCT01677767|80660599|FG000|Overall Study|Protocol Violation|4|||
27678976|NCT01677767|80660599|FG000|Overall Study|Withdrawal by Subject|10|||
27678977|NCT01677767|80660599|FG000|Overall Study|Non-compliance by the participants|3|||
27678978|NCT00756457|80660600|FG000|Overall Study|Lost to Follow-up|1|||
27678979|NCT00756457|80660601|FG001|Overall Study|Lost to Follow-up|2|||
27678980|NCT00863681|80660602|FG000|Overall Study|Other|2|||
27678981|NCT00863681|80660603|FG001|Overall Study|Other|0|||
27678982|NCT00863681|80660604|FG002|Overall Study|Other|0|||
27678983|NCT00863681|80660602|FG000|Overall Study|Missing|1|||
27678984|NCT00863681|80660603|FG001|Overall Study|Missing|0|||
27678985|NCT00863681|80660604|FG002|Overall Study|Missing|0|||
27678986|NCT00863681|80660602|FG000|Overall Study|Death|40|||
27678987|NCT00863681|80660603|FG001|Overall Study|Death|23|||
27678988|NCT00863681|80660604|FG002|Overall Study|Death|6|||
27678989|NCT00863681|80660602|FG000|Overall Study|Withdrawal by Subject|12|||
27678990|NCT00863681|80660603|FG001|Overall Study|Withdrawal by Subject|5|||
27678991|NCT00863681|80660604|FG002|Overall Study|Withdrawal by Subject|2|||
27678992|NCT00863681|80660602|FG000|Overall Study|Protocol Violation|2|||
27678993|NCT00863681|80660603|FG001|Overall Study|Protocol Violation|0|||
27678994|NCT00863681|80660604|FG002|Overall Study|Protocol Violation|0|||
27678995|NCT00863681|80660602|FG000|Overall Study|Lost to Follow-up|3|||
27678996|NCT00863681|80660603|FG001|Overall Study|Lost to Follow-up|0|||
27678997|NCT00863681|80660604|FG002|Overall Study|Lost to Follow-up|3|||
27678998|NCT00863681|80660602|FG000|Overall Study|Adverse Event|28|||
27678999|NCT00863681|80660603|FG001|Overall Study|Adverse Event|10|||
27679000|NCT00863681|80660604|FG002|Overall Study|Adverse Event|6|||
27802350|NCT02164539|81107809|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
27995183|NCT01636986|81811284|FG001|Overall Study|Corneal Staining|1|||
27579539|NCT02139644|80306624|FG000|Treatment Period|Withdrawal by Subject|0|||
27579540|NCT02139644|80306625|FG001|Treatment Period|Withdrawal by Subject|0|||
27579541|NCT02139644|80306626|FG002|Treatment Period|Withdrawal by Subject|2|||
27579542|NCT02139644|80306627|FG003|Treatment Period|Withdrawal by Subject|2|||
27579543|NCT02139644|80306628|FG004|Treatment Period|Withdrawal by Subject|3|||
27579544|NCT02139644|80306629|FG005|Treatment Period|Withdrawal by Subject|2|||
27579545|NCT02139644|80306624|FG000|Treatment Period|Non-compliance|0|||
27579546|NCT02139644|80306625|FG001|Treatment Period|Non-compliance|0|||
27579547|NCT02139644|80306626|FG002|Treatment Period|Non-compliance|0|||
27579548|NCT02139644|80306627|FG003|Treatment Period|Non-compliance|1|||
27579549|NCT02139644|80306628|FG004|Treatment Period|Non-compliance|0|||
27579550|NCT02139644|80306629|FG005|Treatment Period|Non-compliance|0|||
27579551|NCT02139644|80306624|FG000|Treatment Period|Protocol Violation|0|||
27579552|NCT02139644|80306625|FG001|Treatment Period|Protocol Violation|0|||
27579553|NCT02139644|80306626|FG002|Treatment Period|Protocol Violation|0|||
27579554|NCT02139644|80306627|FG003|Treatment Period|Protocol Violation|1|||
27579555|NCT02139644|80306628|FG004|Treatment Period|Protocol Violation|1|||
27579556|NCT02139644|80306629|FG005|Treatment Period|Protocol Violation|1|||
27579557|NCT02139644|80306624|FG000|Treatment Period|Disease progression|0|||
27579558|NCT02139644|80306625|FG001|Treatment Period|Disease progression|0|||
27579559|NCT02139644|80306626|FG002|Treatment Period|Disease progression|0|||
27995184|NCT01415401|81811285|FG000|Overall Study|Adverse Event|5|||
27995185|NCT01415401|81811285|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
27995186|NCT01415401|81811285|FG000|Overall Study|Terminated by Sponsor|1|||
27995187|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Death|0|||
27995188|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Death|0|||
27995189|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Death|0|||
27995190|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Death|0|||
27995191|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Death|1|||
27995192|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Death|0|||
27995193|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Death|0|||
27995194|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Death|0|||
27995195|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
27995196|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
27995197|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
27995198|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
27995199|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
27995200|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
27995201|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
27995202|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
27995203|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
27995204|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27995205|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27995206|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
27995207|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27995208|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
27995209|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27995210|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
27995211|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
27995212|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
27995213|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
27995214|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
27995215|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
27679001|NCT00863681|80660602|FG000|Overall Study|Lack of Efficacy|2|||
27679002|NCT00863681|80660603|FG001|Overall Study|Lack of Efficacy|2|||
27679003|NCT00863681|80660604|FG002|Overall Study|Lack of Efficacy|1|||
27679004|NCT00863681|80660602|FG000|Overall Study|Non-compliance with study drug|1|||
27679005|NCT00863681|80660603|FG001|Overall Study|Non-compliance with study drug|3|||
27679006|NCT00863681|80660604|FG002|Overall Study|Non-compliance with study drug|0|||
27679007|NCT00214019|80660606|FG000|Overall Study|Lost to Follow-up|11|||
27679008|NCT00214019|80660606|FG000|Overall Study|Withdrawal by Subject|2|||
27679009|NCT00214019|80660606|FG000|Overall Study|Screen Failed prior to randomization|17|||
27679010|NCT00604708|80660607|FG000|Overall Study|Withdrawal by Subject|9|||
27679011|NCT00604708|80660608|FG001|Overall Study|Withdrawal by Subject|10|||
27679012|NCT00604708|80660607|FG000|Overall Study|Protocol Violation|2|||
27679013|NCT00604708|80660608|FG001|Overall Study|Protocol Violation|8|||
27679014|NCT00604708|80660607|FG000|Overall Study|Lost to Follow-up|5|||
27679015|NCT00604708|80660608|FG001|Overall Study|Lost to Follow-up|5|||
27679016|NCT00604708|80660607|FG000|Overall Study|administrative reasons|9|||
27679017|NCT00604708|80660608|FG001|Overall Study|administrative reasons|11|||
27679018|NCT00604708|80660607|FG000|Overall Study|Adverse Event|6|||
27679019|NCT00604708|80660608|FG001|Overall Study|Adverse Event|6|||
27679020|NCT00763451|80660609|FG000|Overall Study|Adverse Event|4|||
27679021|NCT00763451|80660610|FG001|Overall Study|Adverse Event|6|||
27679022|NCT00763451|80660611|FG002|Overall Study|Adverse Event|19|||
27679023|NCT00763451|80660612|FG003|Overall Study|Adverse Event|14|||
27679024|NCT00763451|80660609|FG000|Overall Study|Lack of Efficacy|1|||
27679025|NCT00763451|80660610|FG001|Overall Study|Lack of Efficacy|4|||
27679026|NCT00763451|80660611|FG002|Overall Study|Lack of Efficacy|3|||
27679027|NCT00763451|80660612|FG003|Overall Study|Lack of Efficacy|2|||
27679028|NCT00763451|80660609|FG000|Overall Study|Withdrawal by Subject|1|||
27679029|NCT00763451|80660610|FG001|Overall Study|Withdrawal by Subject|6|||
27579560|NCT02139644|80306627|FG003|Treatment Period|Disease progression|1|||
27579561|NCT02139644|80306628|FG004|Treatment Period|Disease progression|1|||
27579562|NCT02139644|80306629|FG005|Treatment Period|Disease progression|2|||
27579563|NCT02139644|80306624|FG000|Treatment Period|Lost to Follow-up|0|||
27679030|NCT00763451|80660611|FG002|Overall Study|Withdrawal by Subject|9|||
27679031|NCT00763451|80660612|FG003|Overall Study|Withdrawal by Subject|7|||
27679032|NCT00763451|80660609|FG000|Overall Study|Protocol Violation|0|||
27679033|NCT00763451|80660610|FG001|Overall Study|Protocol Violation|0|||
27679034|NCT00763451|80660611|FG002|Overall Study|Protocol Violation|1|||
27679035|NCT00763451|80660612|FG003|Overall Study|Protocol Violation|0|||
27679036|NCT00763451|80660609|FG000|Overall Study|Poor Compliance to Protocol|1|||
27995216|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
27579564|NCT02139644|80306625|FG001|Treatment Period|Lost to Follow-up|0|||
27679037|NCT00763451|80660610|FG001|Overall Study|Poor Compliance to Protocol|1|||
27679038|NCT00763451|80660611|FG002|Overall Study|Poor Compliance to Protocol|2|||
27679039|NCT00763451|80660612|FG003|Overall Study|Poor Compliance to Protocol|2|||
27679040|NCT00763451|80660609|FG000|Overall Study|Familial and Personal Reasons|5|||
27679041|NCT00763451|80660610|FG001|Overall Study|Familial and Personal Reasons|3|||
27679042|NCT00763451|80660611|FG002|Overall Study|Familial and Personal Reasons|5|||
27679043|NCT00763451|80660612|FG003|Overall Study|Familial and Personal Reasons|4|||
27679044|NCT00763451|80660609|FG000|Overall Study|Randomized but not Treated|1|||
27679045|NCT00763451|80660610|FG001|Overall Study|Randomized but not Treated|1|||
27679046|NCT00763451|80660611|FG002|Overall Study|Randomized but not Treated|0|||
27679047|NCT00763451|80660612|FG003|Overall Study|Randomized but not Treated|0|||
27679048|NCT00763451|80660609|FG000|Overall Study|Study Site Reason|0|||
27679049|NCT00763451|80660610|FG001|Overall Study|Study Site Reason|1|||
27679050|NCT00763451|80660611|FG002|Overall Study|Study Site Reason|1|||
27679051|NCT00763451|80660612|FG003|Overall Study|Study Site Reason|1|||
27679052|NCT00667394|80660613|FG000|Overall Study|Adverse Event|3|||
27679053|NCT00667394|80660614|FG001|Overall Study|Adverse Event|0|||
27679054|NCT00667394|80660613|FG000|Overall Study|Progressive disease|1|||
27679055|NCT00667394|80660614|FG001|Overall Study|Progressive disease|0|||
27679056|NCT01646177|80660617|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
27679057|NCT01646177|80660618|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
27679058|NCT01646177|80660619|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
27679059|NCT01646177|80660620|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
27679060|NCT01646177|80660621|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679061|NCT01646177|80660622|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679062|NCT01646177|80660623|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679063|NCT01646177|80660624|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679064|NCT01646177|80660625|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679065|NCT01646177|80660626|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679066|NCT01646177|80660627|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679067|NCT01646177|80660628|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
27679068|NCT01646177|80660617|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
27679069|NCT01646177|80660618|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
27679070|NCT01646177|80660619|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
27679071|NCT01646177|80660620|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
27679072|NCT01646177|80660621|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679073|NCT01646177|80660622|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679074|NCT01646177|80660623|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679075|NCT01646177|80660624|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679076|NCT01646177|80660625|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679077|NCT01646177|80660626|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679078|NCT01646177|80660627|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679079|NCT01646177|80660628|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
27679080|NCT01646177|80660617|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
27679081|NCT01646177|80660618|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
27679082|NCT01646177|80660619|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
27679083|NCT01646177|80660620|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
27679084|NCT01646177|80660621|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679085|NCT01646177|80660622|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679086|NCT01646177|80660623|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679087|NCT01646177|80660624|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679088|NCT01646177|80660625|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679089|NCT01646177|80660626|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679090|NCT01646177|80660627|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679091|NCT01646177|80660628|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
27679092|NCT01646177|80660617|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
27679093|NCT01646177|80660618|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
27679094|NCT01646177|80660619|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
27679095|NCT01646177|80660620|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
27679096|NCT01646177|80660621|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27802351|NCT02164539|81107810|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
27679097|NCT01646177|80660622|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27679098|NCT01646177|80660623|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27679099|NCT01646177|80660624|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27679100|NCT01646177|80660625|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27679101|NCT01646177|80660626|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27802352|NCT02164539|81107811|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
27802353|NCT02164539|81107805|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
27679102|NCT01646177|80660627|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27679103|NCT01646177|80660628|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
27679104|NCT01646177|80660617|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679105|NCT01646177|80660618|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679106|NCT01646177|80660619|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
27679107|NCT01646177|80660620|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
27679108|NCT01646177|80660621|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679109|NCT01646177|80660622|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679110|NCT01646177|80660623|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679111|NCT01646177|80660624|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679112|NCT01646177|80660625|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679113|NCT01646177|80660626|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679114|NCT01646177|80660627|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679115|NCT01646177|80660628|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
27679116|NCT01646177|80660617|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
27679117|NCT01646177|80660618|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
27679118|NCT01646177|80660619|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
27679119|NCT01646177|80660620|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679120|NCT01646177|80660621|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679121|NCT01646177|80660622|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679122|NCT01646177|80660623|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679123|NCT01646177|80660624|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679124|NCT01646177|80660625|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679125|NCT01646177|80660626|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679126|NCT01646177|80660627|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679127|NCT01646177|80660628|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
27679128|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679129|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679130|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679131|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679132|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
27679133|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
27679134|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
27679135|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
27679136|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679137|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679138|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679139|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
27679140|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679141|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679142|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679143|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679144|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
27679145|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
27679146|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
27679147|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
27679148|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679149|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679150|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679151|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
27679152|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679153|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679154|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679155|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679156|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
27802354|NCT02164539|81107806|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
27802355|NCT02164539|81107807|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
27802356|NCT02164539|81107808|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
27995217|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
27995218|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
27995219|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
27995220|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
27995221|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
27995222|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
27679157|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
27679158|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
27679159|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
27679160|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679161|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679162|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679163|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
27679164|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679165|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679166|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679167|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679168|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
27679169|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
27679170|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
27679171|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
27679172|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679173|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679174|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679175|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
27679176|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679177|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679178|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679179|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679180|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
27679181|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
27679182|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
27679183|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
27679184|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679185|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679186|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679187|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
27679188|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679189|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679190|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679191|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679192|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
27679193|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
27679194|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679195|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
27679196|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679197|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679198|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679199|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
27679200|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679201|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679202|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679203|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679204|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
27679205|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
27679206|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
27802357|NCT02164539|81107809|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
27802358|NCT02164539|81107810|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
27802359|NCT02164539|81107811|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
27802360|NCT01571635|81107813|FG000|Overall Study|Adverse Event|3|||
27802361|NCT01571635|81107814|FG001|Overall Study|Adverse Event|0|||
27802362|NCT01571635|81107815|FG002|Overall Study|Adverse Event|2|||
27802363|NCT01571635|81107816|FG003|Overall Study|Adverse Event|3|||
27802364|NCT01571635|81107817|FG004|Overall Study|Adverse Event|5|||
27802365|NCT01571635|81107813|FG000|Overall Study|Other reasons|2|||
27802366|NCT01571635|81107814|FG001|Overall Study|Other reasons|1|||
27802367|NCT01571635|81107815|FG002|Overall Study|Other reasons|2|||
27679207|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
27679208|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27802368|NCT01571635|81107816|FG003|Overall Study|Other reasons|2|||
27802369|NCT01571635|81107817|FG004|Overall Study|Other reasons|1|||
27802370|NCT01571635|81107813|FG000|Overall Study|Study terminated by sponsor|0|||
27679209|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679210|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679211|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
27679212|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
27679213|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
27679214|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
27679215|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
27679216|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
27679217|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
27679218|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
27679219|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
27679220|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
27679221|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
27679222|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
27679223|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
27679224|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679225|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679226|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679227|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679228|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
27679229|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
27679230|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
27679231|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
27679232|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679233|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679234|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679235|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
27679236|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679237|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679238|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679239|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679240|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679241|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679242|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679243|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
27679244|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679245|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679246|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679247|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
27679248|NCT01646177|80660617|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679249|NCT01646177|80660618|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679250|NCT01646177|80660619|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679251|NCT01646177|80660620|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679252|NCT01646177|80660621|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679253|NCT01646177|80660622|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
27679254|NCT01646177|80660623|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
27679255|NCT01646177|80660624|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
27679256|NCT01646177|80660625|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679257|NCT01646177|80660626|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679258|NCT01646177|80660627|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679259|NCT01646177|80660628|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
27679260|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27679261|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27679262|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27679263|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27679264|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27679265|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27579565|NCT02139644|80306626|FG002|Treatment Period|Lost to Follow-up|1|||
27579566|NCT02139644|80306627|FG003|Treatment Period|Lost to Follow-up|1|||
27579567|NCT02139644|80306628|FG004|Treatment Period|Lost to Follow-up|1|||
27579568|NCT02139644|80306629|FG005|Treatment Period|Lost to Follow-up|1|||
27679266|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27579569|NCT02139644|80306624|FG000|Treatment Period|Lack of Efficacy|0|||
27995223|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
27679267|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
27679268|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
27679269|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
27679270|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
27679271|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
27679272|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27995224|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
27995225|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
27995226|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
27679273|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679274|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679275|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679276|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679277|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679278|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679279|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
27679280|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
27679281|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
27679282|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
27679283|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
27679284|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679285|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679286|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679287|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679288|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27579570|NCT02139644|80306625|FG001|Treatment Period|Lack of Efficacy|0|||
27579571|NCT02139644|80306626|FG002|Treatment Period|Lack of Efficacy|1|||
27579572|NCT02139644|80306627|FG003|Treatment Period|Lack of Efficacy|0|||
27579573|NCT02139644|80306628|FG004|Treatment Period|Lack of Efficacy|1|||
27579574|NCT02139644|80306629|FG005|Treatment Period|Lack of Efficacy|4|||
27579575|NCT02139644|80306624|FG000|Treatment Period|Other|0|||
27579576|NCT02139644|80306625|FG001|Treatment Period|Other|3|||
27579577|NCT02139644|80306626|FG002|Treatment Period|Other|1|||
27579578|NCT02139644|80306627|FG003|Treatment Period|Other|1|||
27679289|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679290|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679291|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
27679292|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
27679293|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
27679294|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
27679295|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
27679296|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679297|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679298|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679299|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679300|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679301|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679302|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679303|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
27679304|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
27679305|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
27679306|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
27679307|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
27802371|NCT01571635|81107814|FG001|Overall Study|Study terminated by sponsor|4|||
27802372|NCT01571635|81107815|FG002|Overall Study|Study terminated by sponsor|1|||
27802373|NCT01571635|81107816|FG003|Overall Study|Study terminated by sponsor|3|||
27802374|NCT01571635|81107817|FG004|Overall Study|Study terminated by sponsor|1|||
27995227|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
27995228|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27995229|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27579579|NCT02139644|80306628|FG004|Treatment Period|Other|0|||
27579580|NCT02139644|80306629|FG005|Treatment Period|Other|1|||
27679308|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679309|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679310|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679311|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27802375|NCT01571635|81107813|FG000|Overall Study|Withdrew consent|1|||
27679312|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679313|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679314|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679315|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
27679316|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
27679317|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
27679318|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
27679319|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
27679320|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679321|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679322|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679323|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679324|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679325|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679326|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679327|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
27679328|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
27679329|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
27802376|NCT01571635|81107814|FG001|Overall Study|Withdrew consent|1|||
27802377|NCT01571635|81107815|FG002|Overall Study|Withdrew consent|2|||
27802378|NCT01571635|81107816|FG003|Overall Study|Withdrew consent|3|||
27802379|NCT01571635|81107817|FG004|Overall Study|Withdrew consent|0|||
27802380|NCT01571635|81107813|FG000|Overall Study|Lack of Efficacy|0|||
27802381|NCT01571635|81107814|FG001|Overall Study|Lack of Efficacy|2|||
27802382|NCT01571635|81107815|FG002|Overall Study|Lack of Efficacy|0|||
27802383|NCT01571635|81107816|FG003|Overall Study|Lack of Efficacy|1|||
27802384|NCT01571635|81107817|FG004|Overall Study|Lack of Efficacy|2|||
27802385|NCT03044431|81107819|FG000|Overall Study|Lost to Follow-up|59|||
27802386|NCT01205529|81107822|FG000|Overall Study|Procedure Cancelled|4|||
27802387|NCT01205529|81107822|FG000|Overall Study|Withdrawal by Subject|2|||
27802388|NCT01205529|81107822|FG000|Overall Study|Physician Decision|4|||
27802389|NCT01205529|81107822|FG000|Overall Study|Unstable post op|15|||
27802390|NCT01205529|81107822|FG000|Overall Study|No longer met criteria|30|||
27802391|NCT00033631|81107825|FG000|Overall Study|Protocol Violation|14|||
27802392|NCT00033631|81107826|FG001|Overall Study|Protocol Violation|11|||
27802393|NCT00033631|81107825|FG000|Overall Study|Withdrawal by Subject|4|||
27802394|NCT00033631|81107826|FG001|Overall Study|Withdrawal by Subject|4|||
27802395|NCT03734679|81107827|FG000|Overall Study|Missed Visit|1|||
27802396|NCT02598622|81107828|FG000|Overall Study|Withdrawal by Subject|3|||
27802397|NCT02598622|81107829|FG001|Overall Study|Withdrawal by Subject|0|||
27802398|NCT02598622|81107828|FG000|Overall Study|Physician Decision|3|||
27802399|NCT02598622|81107829|FG001|Overall Study|Physician Decision|0|||
27802400|NCT01963676|81107835|FG000|Overall Study|Withdrawal by Subject|1|||
27802401|NCT01963676|81107836|FG001|Overall Study|Withdrawal by Subject|0|||
27802402|NCT01614925|81107837|FG000|Overall Study|Withdrawal by Subject|1|||
27802403|NCT01614925|81107838|FG001|Overall Study|Withdrawal by Subject|0|||
27802404|NCT01614925|81107837|FG000|Overall Study|Protocol Violation|3|||
27802405|NCT01614925|81107838|FG001|Overall Study|Protocol Violation|2|||
27802406|NCT05003167|81107839|FG000|Overall Study|Withdrawal by Subject|1|||
27802407|NCT02875067|81107847|FG000|Overall Study|Withdrawal by Subject|1|||
27802408|NCT02875067|81107847|FG000|Overall Study|Withdrawal by Termination of Study|5|||
27802409|NCT01238211|81107848|FG000|Overall Study|Continues active treatment|31|||
27802410|NCT01238211|81107848|FG000|Overall Study|Adverse Event|7|||
27679330|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
27802411|NCT01238211|81107848|FG000|Overall Study|Death|4|||
27802412|NCT01238211|81107848|FG000|Overall Study|Relapse/Progression|2|||
27802413|NCT01238211|81107848|FG000|Overall Study|Withdrawal by Subject|7|||
27802414|NCT01238211|81107848|FG000|Overall Study|Non-protocol treatment|4|||
27995230|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
27995231|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
27995232|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
27679331|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
27679332|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679333|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679334|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679335|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27802415|NCT01238211|81107848|FG000|Overall Study|Investigator/Patient Decision|3|||
27802416|NCT02018042|81107849|FG000|Overall Study|Withdrawal by Subject|1|||
27802417|NCT03726437|81107851|FG000|Overall Study|Lost to Follow-up|85|||
27802418|NCT03726437|81107852|FG001|Overall Study|Lost to Follow-up|76|||
27802419|NCT03296553|81107859|FG000|Overall Study|Withdrawal by Subject|1|||
27802420|NCT03296553|81107860|FG001|Overall Study|Withdrawal by Subject|1|||
27802421|NCT03296553|81107859|FG000|Overall Study|Death|1|||
27679336|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679337|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679338|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679339|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679340|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
27679341|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
27679342|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
27679343|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
27679344|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679345|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679346|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679347|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679348|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679349|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679350|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679351|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679352|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
27679353|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
27679354|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
27679355|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
27679356|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27995233|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27995234|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
27995235|NCT00726232|81811286|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
27995236|NCT00726232|81811287|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995237|NCT00726232|81811288|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995238|NCT00726232|81811289|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995239|NCT00726232|81811290|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995240|NCT00726232|81811291|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995241|NCT00726232|81811292|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995242|NCT00726232|81811293|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
27995243|NCT00726232|81811286|FG000|Expansion Phase|Death|0|||
27995244|NCT00726232|81811287|FG001|Expansion Phase|Death|0|||
27995245|NCT00726232|81811288|FG002|Expansion Phase|Death|0|||
27995246|NCT00726232|81811289|FG003|Expansion Phase|Death|0|||
27995247|NCT00726232|81811290|FG004|Expansion Phase|Death|0|||
27995248|NCT00726232|81811291|FG005|Expansion Phase|Death|0|||
27995249|NCT00726232|81811292|FG006|Expansion Phase|Death|0|||
27995250|NCT00726232|81811293|FG007|Expansion Phase|Death|1|||
27995251|NCT00726232|81811286|FG000|Expansion Phase|Adverse Event|0|||
27679357|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27679358|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27679359|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27679360|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27995252|NCT00726232|81811287|FG001|Expansion Phase|Adverse Event|0|||
27995253|NCT00726232|81811288|FG002|Expansion Phase|Adverse Event|0|||
27995254|NCT00726232|81811289|FG003|Expansion Phase|Adverse Event|0|||
27995255|NCT00726232|81811290|FG004|Expansion Phase|Adverse Event|0|||
27679361|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27995256|NCT00726232|81811291|FG005|Expansion Phase|Adverse Event|0|||
27802422|NCT03296553|81107860|FG001|Overall Study|Death|0|||
27802423|NCT00995488|81107861|FG000|Overall Study|Withdrawal by Subject|1|||
27802424|NCT00383019|81107862|FG000|Overall Study|Adverse Event|5|||
27802425|NCT00383019|81107863|FG001|Overall Study|Adverse Event|1|||
27802426|NCT00383019|81107862|FG000|Overall Study|Withdrawal by Subject|0|||
27802427|NCT00383019|81107863|FG001|Overall Study|Withdrawal by Subject|1|||
27802428|NCT01128153|81107864|FG000|Overall Study|Adverse Event|1|||
27802429|NCT01128153|81107865|FG001|Overall Study|Adverse Event|3|||
27802430|NCT01128153|81107864|FG000|Overall Study|Condition under investigation worsened|8|||
27802431|NCT01128153|81107865|FG001|Overall Study|Condition under investigation worsened|7|||
27802432|NCT01128153|81107864|FG000|Overall Study|Withdrawal by Subject|2|||
27802433|NCT01128153|81107865|FG001|Overall Study|Withdrawal by Subject|3|||
27802434|NCT01128153|81107864|FG000|Overall Study|Incorrect enrolment to study|2|||
27802435|NCT01128153|81107865|FG001|Overall Study|Incorrect enrolment to study|1|||
27802436|NCT01128153|81107864|FG000|Overall Study|Protocol Violation|2|||
27802437|NCT01128153|81107865|FG001|Overall Study|Protocol Violation|0|||
27802438|NCT01128153|81107864|FG000|Overall Study|Developed discontinuation criteria|1|||
27802439|NCT01128153|81107865|FG001|Overall Study|Developed discontinuation criteria|1|||
27802440|NCT01355523|81107866|FG000|Overall Study|Withdrawal by Subject|1|||
27802441|NCT01355523|81107867|FG001|Overall Study|Withdrawal by Subject|4|||
27802442|NCT01355523|81107866|FG000|Overall Study|Lost to Follow-up|0|||
27802443|NCT01355523|81107867|FG001|Overall Study|Lost to Follow-up|2|||
27802444|NCT01355523|81107866|FG000|Overall Study|Protocol Violation|0|||
27802445|NCT01355523|81107867|FG001|Overall Study|Protocol Violation|2|||
27802446|NCT01355523|81107866|FG000|Overall Study|Adverse Event|0|||
27802447|NCT01355523|81107867|FG001|Overall Study|Adverse Event|2|||
27802448|NCT01984229|81107871|FG000|Safety Follow-up Period|Adverse Event|1|||
27802449|NCT01984229|81107872|FG001|Safety Follow-up Period|Adverse Event|1|||
27802450|NCT01984229|81107871|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
27802451|NCT01984229|81107872|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
27802452|NCT02475980|81107873|FG000|Overall Study|Lost to Follow-up|4|||
27802453|NCT02475980|81107873|FG000|Overall Study|Withdrawal by Subject|1|||
27802454|NCT01154127|81107899|FG000|Period 1 (21 Days)|Adverse Event|3|||
27802455|NCT01154127|81107900|FG001|Period 1 (21 Days)|Adverse Event|4|||
27802456|NCT01154127|81107899|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
27802457|NCT01154127|81107900|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
27802458|NCT01154127|81107899|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
27802459|NCT01154127|81107900|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
27802460|NCT01154127|81107899|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
27802461|NCT01154127|81107900|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
27802462|NCT01154127|81107899|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
27802463|NCT01154127|81107900|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
27802464|NCT00331773|81107902|FG000|Overall Study|Withdrawal by Subject|6|||
27802465|NCT00331773|81107903|FG001|Overall Study|Withdrawal by Subject|4|||
27802466|NCT00331773|81107902|FG000|Overall Study|Protocol Violation|10|||
27802467|NCT00331773|81107903|FG001|Overall Study|Protocol Violation|3|||
27802468|NCT00552617|81107904|FG000|Overall Study|Not Treated|0|||
27802469|NCT00552617|81107905|FG001|Overall Study|Not Treated|0|||
27802470|NCT00552617|81107906|FG002|Overall Study|Not Treated|1|||
27802471|NCT00552617|81107907|FG003|Overall Study|Not Treated|0|||
27802472|NCT00552617|81107908|FG004|Overall Study|Not Treated|0|||
27802473|NCT00552617|81107909|FG005|Overall Study|Not Treated|0|||
27802474|NCT00552617|81107910|FG006|Overall Study|Not Treated|0|||
27872110|NCT02906670|81365196|FG005|Cohort 3, QW|Radiological Progression|0|||
27995257|NCT00726232|81811292|FG006|Expansion Phase|Adverse Event|6|||
27995258|NCT00726232|81811293|FG007|Expansion Phase|Adverse Event|11|||
27995259|NCT00726232|81811286|FG000|Expansion Phase|Withdrawal by Subject|0|||
27995260|NCT00726232|81811287|FG001|Expansion Phase|Withdrawal by Subject|0|||
27995261|NCT00726232|81811288|FG002|Expansion Phase|Withdrawal by Subject|0|||
27802475|NCT00552617|81107911|FG007|Overall Study|Not Treated|0|||
27802476|NCT00552617|81107912|FG008|Overall Study|Not Treated|0|||
27802477|NCT00552617|81107913|FG009|Overall Study|Not Treated|1|||
27802478|NCT00552617|81107904|FG000|Overall Study|Lost to Follow-up|0|||
27802479|NCT00552617|81107905|FG001|Overall Study|Lost to Follow-up|0|||
27802480|NCT00552617|81107906|FG002|Overall Study|Lost to Follow-up|0|||
27802481|NCT00552617|81107907|FG003|Overall Study|Lost to Follow-up|1|||
27802482|NCT00552617|81107908|FG004|Overall Study|Lost to Follow-up|0|||
27802483|NCT00552617|81107909|FG005|Overall Study|Lost to Follow-up|2|||
27802484|NCT00552617|81107910|FG006|Overall Study|Lost to Follow-up|0|||
27872111|NCT02906670|81365197|FG006|Cohort 3, QW|Radiological Progression|0|||
27872112|NCT02906670|81365198|FG007|Cohort 3, QW|Radiological Progression|0|||
27872113|NCT02906670|81365199|FG008|Cohort 3, QW|Radiological Progression|0|||
27802485|NCT00552617|81107911|FG007|Overall Study|Lost to Follow-up|0|||
27802486|NCT00552617|81107912|FG008|Overall Study|Lost to Follow-up|2|||
27802487|NCT00552617|81107913|FG009|Overall Study|Lost to Follow-up|0|||
27872114|NCT02906670|81365200|FG009|Cohort 3, QW|Radiological Progression|0|||
27802488|NCT00265083|81107914|FG000|Overall Study|Adverse Event|5|||
27802489|NCT00265083|81107915|FG001|Overall Study|Adverse Event|13|||
27802490|NCT00265083|81107916|FG002|Overall Study|Adverse Event|15|||
27802491|NCT00265083|81107914|FG000|Overall Study|Lost to Follow-up|3|||
27802492|NCT00265083|81107915|FG001|Overall Study|Lost to Follow-up|4|||
27802493|NCT00265083|81107916|FG002|Overall Study|Lost to Follow-up|4|||
27802494|NCT00265083|81107914|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
27802495|NCT00265083|81107915|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27802496|NCT00265083|81107916|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
27802497|NCT00265083|81107914|FG000|Overall Study|Other|1|||
27802498|NCT00265083|81107915|FG001|Overall Study|Other|12|||
27802499|NCT00265083|81107916|FG002|Overall Study|Other|9|||
27802500|NCT01399125|81107917|FG000|Overall Study|Adverse Event|32|||
27802501|NCT01399125|81107918|FG001|Overall Study|Adverse Event|30|||
27802502|NCT01399125|81107917|FG000|Overall Study|Abnormal Lab values|0|||
27802503|NCT01399125|81107918|FG001|Overall Study|Abnormal Lab values|1|||
27802504|NCT01399125|81107917|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27802505|NCT01399125|81107918|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
27802506|NCT01399125|81107917|FG000|Overall Study|Withdrawal by Subject|5|||
27802507|NCT01399125|81107918|FG001|Overall Study|Withdrawal by Subject|8|||
27802508|NCT01399125|81107917|FG000|Overall Study|Lost to Follow-up|2|||
27802509|NCT01399125|81107918|FG001|Overall Study|Lost to Follow-up|3|||
27802510|NCT01399125|81107917|FG000|Overall Study|Administrative Problems|7|||
27802511|NCT01399125|81107918|FG001|Overall Study|Administrative Problems|11|||
27802512|NCT01399125|81107917|FG000|Overall Study|Death|0|||
27802513|NCT01399125|81107918|FG001|Overall Study|Death|1|||
27802514|NCT01399125|81107917|FG000|Overall Study|Protocol Deviation|5|||
27802515|NCT01399125|81107918|FG001|Overall Study|Protocol Deviation|2|||
27802516|NCT00837577|81107921|FG000|Double-blind Period|Clinical Adverse Event|1|||
27802517|NCT00837577|81107922|FG001|Double-blind Period|Clinical Adverse Event|0|||
27802518|NCT00837577|81107921|FG000|Double-blind Period|Withdrawal by Subject|1|||
27802519|NCT00837577|81107922|FG001|Double-blind Period|Withdrawal by Subject|0|||
27802520|NCT00837577|81107921|FG000|Open-label Period|Clinical Adverse Event|2|||
27802521|NCT00837577|81107922|FG001|Open-label Period|Clinical Adverse Event|2|||
27802522|NCT00837577|81107921|FG000|Open-label Period|Laboratory Adverse Event|0|||
27802523|NCT00837577|81107922|FG001|Open-label Period|Laboratory Adverse Event|1|||
27802524|NCT00837577|81107921|FG000|Open-label Period|Lack of Efficacy|4|||
27802525|NCT00837577|81107922|FG001|Open-label Period|Lack of Efficacy|3|||
27802526|NCT00837577|81107921|FG000|Open-label Period|Withdrawal by Subject|1|||
27802527|NCT00837577|81107922|FG001|Open-label Period|Withdrawal by Subject|2|||
27802528|NCT00837577|81107921|FG000|Open-label Period|Other Reason|1|||
27802529|NCT00837577|81107922|FG001|Open-label Period|Other Reason|1|||
27802530|NCT03707522|81107925|FG000|Overall Study|Lost to Follow-up|24|||
27802531|NCT03707522|81107926|FG001|Overall Study|Lost to Follow-up|27|||
27802532|NCT03707522|81107927|FG002|Overall Study|Lost to Follow-up|41|||
27802533|NCT03707522|81107928|FG003|Overall Study|Lost to Follow-up|36|||
27802534|NCT01697449|81107929|FG000|Overall Study|Disease progression|47|||
27802535|NCT01697449|81107929|FG000|Overall Study|Adverse Event|7|||
27802536|NCT01697449|81107929|FG000|Overall Study|Lost to Follow-up|5|||
27802537|NCT01697449|81107929|FG000|Overall Study|Withdrawal by Subject|2|||
27802538|NCT01697449|81107929|FG000|Overall Study|Physician Decision|1|||
27802539|NCT01697449|81107929|FG000|Overall Study|Death|2|||
27802540|NCT01697449|81107929|FG000|Overall Study|Other|1|||
27802541|NCT01697449|81107929|FG000|Overall Study|Missing|25|||
27802542|NCT01169844|81107932|FG000|Overall Study|Adverse Event|0|||
27802543|NCT01169844|81107933|FG001|Overall Study|Adverse Event|1|||
27802544|NCT01169844|81107932|FG000|Overall Study|Patient withdrew consent|4|||
27872115|NCT02906670|81365191|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872116|NCT02906670|81365192|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872117|NCT02906670|81365193|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
27872118|NCT02906670|81365194|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872119|NCT02906670|81365195|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872120|NCT02906670|81365196|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872121|NCT02906670|81365197|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872122|NCT02906670|81365198|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
27802545|NCT01169844|81107933|FG001|Overall Study|Patient withdrew consent|0|||
27802546|NCT01169844|81107932|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27802547|NCT01169844|81107933|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27802548|NCT02124746|81107934|FG000|Overall Study|Adverse Event|2|||
27802549|NCT02124746|81107935|FG001|Overall Study|Adverse Event|1|||
27802550|NCT02124746|81107936|FG002|Overall Study|Adverse Event|2|||
27802551|NCT02124746|81107934|FG000|Overall Study|Death|2|||
27802552|NCT02124746|81107935|FG001|Overall Study|Death|1|||
27802553|NCT02124746|81107936|FG002|Overall Study|Death|3|||
27872123|NCT02906670|81365199|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
27802554|NCT02124746|81107934|FG000|Overall Study|Lack of Efficacy|3|||
27802555|NCT02124746|81107935|FG001|Overall Study|Lack of Efficacy|2|||
27802556|NCT02124746|81107936|FG002|Overall Study|Lack of Efficacy|2|||
27802557|NCT02124746|81107934|FG000|Overall Study|Physician Decision|6|||
27802558|NCT02124746|81107935|FG001|Overall Study|Physician Decision|4|||
27679362|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27679363|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27679364|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
27679365|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
27679366|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
27679367|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
27679368|NCT01646177|80660617|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679369|NCT01646177|80660618|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679370|NCT01646177|80660619|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679371|NCT01646177|80660620|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679372|NCT01646177|80660621|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679373|NCT01646177|80660622|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679374|NCT01646177|80660623|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27802559|NCT02124746|81107936|FG002|Overall Study|Physician Decision|5|||
27802560|NCT02124746|81107934|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27802561|NCT02124746|81107935|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27802562|NCT02124746|81107936|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27802563|NCT02124746|81107934|FG000|Overall Study|Withdrawal by Subject|3|||
27802564|NCT02124746|81107935|FG001|Overall Study|Withdrawal by Subject|3|||
27802565|NCT02124746|81107936|FG002|Overall Study|Withdrawal by Subject|0|||
27802566|NCT02124746|81107934|FG000|Overall Study|Study Terminated by Sponsor|0|||
27802567|NCT02124746|81107935|FG001|Overall Study|Study Terminated by Sponsor|0|||
27802568|NCT02124746|81107936|FG002|Overall Study|Study Terminated by Sponsor|6|||
27802569|NCT02124746|81107934|FG000|Overall Study|Disease Progression|3|||
27802570|NCT02124746|81107935|FG001|Overall Study|Disease Progression|6|||
27802571|NCT02124746|81107936|FG002|Overall Study|Disease Progression|4|||
27802572|NCT00849524|81107937|FG000|Overall Study|Lack of Efficacy|3|||
27802573|NCT00627458|81107938|FG000|Overall Study|Migrated from study area|1|||
27802574|NCT00627458|81107939|FG001|Overall Study|Migrated from study area|0|||
27802575|NCT00627458|81107940|FG002|Overall Study|Migrated from study area|1|||
27802576|NCT00627458|81107938|FG000|Overall Study|Withdrawal by Subject|2|||
27995262|NCT00726232|81811289|FG003|Expansion Phase|Withdrawal by Subject|0|||
27995263|NCT00726232|81811290|FG004|Expansion Phase|Withdrawal by Subject|0|||
27802577|NCT00627458|81107939|FG001|Overall Study|Withdrawal by Subject|6|||
27995264|NCT00726232|81811291|FG005|Expansion Phase|Withdrawal by Subject|0|||
27995265|NCT00726232|81811292|FG006|Expansion Phase|Withdrawal by Subject|2|||
27995266|NCT00726232|81811293|FG007|Expansion Phase|Withdrawal by Subject|3|||
27995267|NCT00726232|81811286|FG000|Expansion Phase|Disease progression|0|||
27995268|NCT00726232|81811287|FG001|Expansion Phase|Disease progression|0|||
27995269|NCT00726232|81811288|FG002|Expansion Phase|Disease progression|0|||
27995270|NCT00726232|81811289|FG003|Expansion Phase|Disease progression|0|||
27995271|NCT00726232|81811290|FG004|Expansion Phase|Disease progression|0|||
27995272|NCT00726232|81811291|FG005|Expansion Phase|Disease progression|0|||
27995273|NCT00726232|81811292|FG006|Expansion Phase|Disease progression|4|||
27995274|NCT00726232|81811293|FG007|Expansion Phase|Disease progression|0|||
27995275|NCT00726232|81811286|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
27995276|NCT00726232|81811287|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
27995277|NCT00726232|81811288|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
27995278|NCT00726232|81811289|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
27995279|NCT00726232|81811290|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
27995280|NCT00726232|81811291|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
27995281|NCT00726232|81811292|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
27995282|NCT00726232|81811293|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
27995283|NCT00726232|81811286|FG000|Expansion Phase|Per Investigator: lack of response|0|||
27995284|NCT00726232|81811287|FG001|Expansion Phase|Per Investigator: lack of response|0|||
27995285|NCT00726232|81811288|FG002|Expansion Phase|Per Investigator: lack of response|0|||
27995286|NCT00726232|81811289|FG003|Expansion Phase|Per Investigator: lack of response|0|||
27995287|NCT00726232|81811290|FG004|Expansion Phase|Per Investigator: lack of response|0|||
27995288|NCT00726232|81811291|FG005|Expansion Phase|Per Investigator: lack of response|0|||
27995289|NCT00726232|81811292|FG006|Expansion Phase|Per Investigator: lack of response|1|||
27995290|NCT00726232|81811293|FG007|Expansion Phase|Per Investigator: lack of response|7|||
27995291|NCT00726232|81811286|FG000|Expansion Phase|Unspecified reason|0|||
27995292|NCT00726232|81811287|FG001|Expansion Phase|Unspecified reason|0|||
27995293|NCT00726232|81811288|FG002|Expansion Phase|Unspecified reason|0|||
27802578|NCT00627458|81107940|FG002|Overall Study|Withdrawal by Subject|5|||
27802579|NCT00627458|81107938|FG000|Overall Study|Lost to Follow-up|1|||
27802580|NCT00627458|81107939|FG001|Overall Study|Lost to Follow-up|1|||
27802581|NCT00627458|81107940|FG002|Overall Study|Lost to Follow-up|0|||
27802582|NCT04603937|81107943|FG000|Overall Study|Adverse Event|9|||
27995294|NCT00726232|81811289|FG003|Expansion Phase|Unspecified reason|0|||
27995295|NCT00726232|81811290|FG004|Expansion Phase|Unspecified reason|0|||
27802583|NCT04603937|81107944|FG001|Overall Study|Adverse Event|10|||
27802584|NCT04603937|81107943|FG000|Overall Study|Withdrawal by Subject|7|||
27802585|NCT04603937|81107944|FG001|Overall Study|Withdrawal by Subject|6|||
27802586|NCT04603937|81107943|FG000|Overall Study|Lost to Follow-up|5|||
27802587|NCT04603937|81107944|FG001|Overall Study|Lost to Follow-up|6|||
27802588|NCT04603937|81107943|FG000|Overall Study|Physician Decision|0|||
27802589|NCT04603937|81107944|FG001|Overall Study|Physician Decision|1|||
27802590|NCT04603937|81107943|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
27802591|NCT04603937|81107944|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
27679375|NCT01646177|80660624|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679376|NCT01646177|80660625|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679377|NCT01646177|80660626|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
27679378|NCT01646177|80660627|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
27679379|NCT01646177|80660628|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
27679380|NCT00747227|80660637|FG000|Overall Study|Death|3|||
27679381|NCT00747227|80660638|FG001|Overall Study|Death|1|||
27679382|NCT00747227|80660637|FG000|Overall Study|Withdrawal by Subject|1|||
27679383|NCT00747227|80660638|FG001|Overall Study|Withdrawal by Subject|0|||
27679384|NCT00747227|80660637|FG000|Overall Study|Lost to Follow-up|1|||
27679385|NCT00747227|80660638|FG001|Overall Study|Lost to Follow-up|2|||
27679386|NCT00747227|80660637|FG000|Overall Study|Illness|1|||
27679387|NCT00747227|80660638|FG001|Overall Study|Illness|1|||
27679388|NCT03192475|80660639|FG000|Overall Study|Death|0|||
27679389|NCT03192475|80660640|FG001|Overall Study|Death|1|||
27679390|NCT03192475|80660639|FG000|Overall Study|Lost to Follow-up|13|||
27679391|NCT03192475|80660640|FG001|Overall Study|Lost to Follow-up|8|||
27679392|NCT01068665|80660641|FG000|Overall Study|Adverse Event|5|||
27679393|NCT01068665|80660642|FG001|Overall Study|Adverse Event|4|||
27679394|NCT01068665|80660641|FG000|Overall Study|Lack of Efficacy|0|||
27679395|NCT01068665|80660642|FG001|Overall Study|Lack of Efficacy|2|||
27679396|NCT01068665|80660641|FG000|Overall Study|Protocol Violation|5|||
27679397|NCT01068665|80660642|FG001|Overall Study|Protocol Violation|2|||
27679398|NCT01068665|80660641|FG000|Overall Study|Withdrawal Criteria|3|||
27679399|NCT01068665|80660642|FG001|Overall Study|Withdrawal Criteria|9|||
27679400|NCT01068665|80660641|FG000|Overall Study|Other|17|||
27679401|NCT01068665|80660642|FG001|Overall Study|Other|12|||
27679402|NCT00941070|80660644|FG000|Overall Study|Patient non-compliant|1|||
27679403|NCT00387426|80660645|FG000|Overall Study|Lack of Response|7|||
27679404|NCT00387426|80660645|FG000|Overall Study|Toxicities|4|||
27679405|NCT00387426|80660645|FG000|Overall Study|Disease Progression|3|||
27679406|NCT00945672|80660648|FG000|Overall Study|Withdrawal by Subject|0|||
27679407|NCT00945672|80660649|FG001|Overall Study|Withdrawal by Subject|0|||
27679408|NCT00945672|80660650|FG002|Overall Study|Withdrawal by Subject|0|||
27679409|NCT00945672|80660651|FG003|Overall Study|Withdrawal by Subject|1|||
27679410|NCT03232931|80660653|FG000|Overall Study|Physician Decision|1|||
27679411|NCT03232931|80660654|FG001|Overall Study|Physician Decision|1|||
27679412|NCT03232931|80660653|FG000|Overall Study|Withdrawal by Subject|6|||
27679413|NCT03232931|80660654|FG001|Overall Study|Withdrawal by Subject|0|||
27679414|NCT03232931|80660653|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
27679415|NCT03232931|80660654|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
27679416|NCT03232931|80660653|FG000|Overall Study|Parent did not record voice|1|||
27679417|NCT03232931|80660654|FG001|Overall Study|Parent did not record voice|2|||
27679418|NCT03232931|80660653|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
27679419|NCT03232931|80660654|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
27679420|NCT03752970|80660655|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
27679421|NCT03752970|80660656|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
27679422|NCT03752970|80660657|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
27679423|NCT03752970|80660655|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
27679424|NCT03752970|80660656|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
27679425|NCT03752970|80660657|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
27679426|NCT03752970|80660655|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
27679427|NCT03752970|80660656|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
27679428|NCT03752970|80660657|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
27679429|NCT03752970|80660655|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
27679430|NCT03752970|80660656|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
27802592|NCT03797222|81107948|FG000|Overall Study|Withdrawal by Subject|1|||
27802593|NCT04288115|81107949|FG000|Overall Study|Withdrawal by Subject|0|||
27802594|NCT04288115|81107950|FG001|Overall Study|Withdrawal by Subject|1|||
27579581|NCT02348489|80306630|FG000|Overall Study|Death|336|||
27579582|NCT02348489|80306631|FG001|Overall Study|Death|335|||
27579583|NCT02348489|80306630|FG000|Overall Study|Withdrawal by Subject|14|||
27579584|NCT02348489|80306631|FG001|Overall Study|Withdrawal by Subject|27|||
27579585|NCT02348489|80306630|FG000|Overall Study|Lost to Follow-up|3|||
27579586|NCT02348489|80306631|FG001|Overall Study|Lost to Follow-up|5|||
27579587|NCT00575588|80306635|FG000|Overall Study|Adverse Event|11|||
27579588|NCT00575588|80306636|FG001|Overall Study|Adverse Event|13|||
27579589|NCT00575588|80306635|FG000|Overall Study|Withdrawal by Subject|27|||
27872124|NCT02906670|81365200|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
27872125|NCT02906670|81365191|FG000|Cohort 4, Q2W|Radiological Progression|0|||
27872126|NCT02906670|81365192|FG001|Cohort 4, Q2W|Radiological Progression|0|||
27872127|NCT02906670|81365193|FG002|Cohort 4, Q2W|Radiological Progression|0|||
27872128|NCT02906670|81365194|FG003|Cohort 4, Q2W|Radiological Progression|0|||
27872129|NCT02906670|81365195|FG004|Cohort 4, Q2W|Radiological Progression|0|||
27872130|NCT02906670|81365196|FG005|Cohort 4, Q2W|Radiological Progression|1|||
27802595|NCT04288115|81107949|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
27802596|NCT04288115|81107950|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
27802597|NCT03670537|81107953|FG000|Overall Study|Protocol Violation|1|||
27802598|NCT02209454|81107955|FG000|Second Period|Adverse Event|1|||
27802599|NCT02209454|81107956|FG001|Second Period|Adverse Event|0|||
27802600|NCT01864525|81107957|FG000|Overall Study|Adverse Event|1|||
27872131|NCT02906670|81365197|FG006|Cohort 4, Q2W|Radiological Progression|0|||
27872132|NCT02906670|81365198|FG007|Cohort 4, Q2W|Radiological Progression|0|||
27872133|NCT02906670|81365199|FG008|Cohort 4, Q2W|Radiological Progression|0|||
27872134|NCT02906670|81365200|FG009|Cohort 4, Q2W|Radiological Progression|0|||
27872135|NCT02906670|81365191|FG000|Cohort 4, Q2W|Clinical Progression|0|||
27872136|NCT02906670|81365192|FG001|Cohort 4, Q2W|Clinical Progression|0|||
27872137|NCT02906670|81365193|FG002|Cohort 4, Q2W|Clinical Progression|0|||
27872138|NCT02906670|81365194|FG003|Cohort 4, Q2W|Clinical Progression|0|||
27872139|NCT02906670|81365195|FG004|Cohort 4, Q2W|Clinical Progression|0|||
27872140|NCT02906670|81365196|FG005|Cohort 4, Q2W|Clinical Progression|2|||
27872141|NCT02906670|81365197|FG006|Cohort 4, Q2W|Clinical Progression|0|||
27802601|NCT01864525|81107958|FG001|Overall Study|Adverse Event|0|||
27872142|NCT02906670|81365198|FG007|Cohort 4, Q2W|Clinical Progression|0|||
27802602|NCT03840135|81107959|FG000|Overall Study|Protocol Violation|6|||
27802603|NCT03840135|81107960|FG001|Overall Study|Protocol Violation|1|||
27802604|NCT03840135|81107959|FG000|Overall Study|Withdrawal by Subject|1|||
27802605|NCT03840135|81107960|FG001|Overall Study|Withdrawal by Subject|0|||
27802606|NCT00895583|81107961|FG000|Overall Study|Adverse Event|28|||
27802607|NCT00895583|81107962|FG001|Overall Study|Adverse Event|4|||
27802608|NCT00895583|81107961|FG000|Overall Study|Death|2|||
27802609|NCT00895583|81107962|FG001|Overall Study|Death|1|||
27802610|NCT00895583|81107961|FG000|Overall Study|Physician Decision|3|||
27802611|NCT00895583|81107962|FG001|Overall Study|Physician Decision|1|||
27802612|NCT00895583|81107961|FG000|Overall Study|Lost to Follow-up|1|||
27802613|NCT00895583|81107962|FG001|Overall Study|Lost to Follow-up|3|||
27802614|NCT00895583|81107961|FG000|Overall Study|Protocol Violation|1|||
27802615|NCT00895583|81107962|FG001|Overall Study|Protocol Violation|0|||
27802616|NCT00895583|81107961|FG000|Overall Study|Withdrawal by Subject|4|||
27802617|NCT00895583|81107962|FG001|Overall Study|Withdrawal by Subject|2|||
27802618|NCT00895583|81107961|FG000|Overall Study|Lack of Efficacy|5|||
27802619|NCT00895583|81107962|FG001|Overall Study|Lack of Efficacy|0|||
27802620|NCT00895583|81107961|FG000|Overall Study|Other|0|||
27802621|NCT00895583|81107962|FG001|Overall Study|Other|1|||
27802622|NCT04529499|81107963|FG000|Overall Study|Withdrawal by Subject|9|||
27802623|NCT04529499|81107964|FG001|Overall Study|Withdrawal by Subject|11|||
27802624|NCT04529499|81107963|FG000|Overall Study|Physician Decision|1|||
27802625|NCT04529499|81107964|FG001|Overall Study|Physician Decision|2|||
27802626|NCT04529499|81107963|FG000|Overall Study|Adverse Event|4|||
27802627|NCT04529499|81107964|FG001|Overall Study|Adverse Event|4|||
27802628|NCT04529499|81107963|FG000|Overall Study|Death|14|||
27802629|NCT04529499|81107964|FG001|Overall Study|Death|11|||
27802630|NCT04529499|81107963|FG000|Overall Study|Lost to Follow-up|1|||
27872143|NCT02906670|81365199|FG008|Cohort 4, Q2W|Clinical Progression|0|||
27995296|NCT00726232|81811291|FG005|Expansion Phase|Unspecified reason|0|||
27995297|NCT00726232|81811292|FG006|Expansion Phase|Unspecified reason|1|||
27995298|NCT00726232|81811293|FG007|Expansion Phase|Unspecified reason|0|||
27995299|NCT01031979|81811294|FG000|Overall Study|Lost to Follow-up|5|||
27995300|NCT01031979|81811295|FG001|Overall Study|Lost to Follow-up|4|||
27995301|NCT03472326|81811296|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
27995302|NCT03472326|81811297|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
27995303|NCT03472326|81811298|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
27579590|NCT00575588|80306636|FG001|Overall Study|Withdrawal by Subject|31|||
27802631|NCT04529499|81107964|FG001|Overall Study|Lost to Follow-up|1|||
27995304|NCT03472326|81811299|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
27995305|NCT03472326|81811296|FG000|Part 2: Combination Therapy|Pregnancy|0|||
27802632|NCT04529499|81107963|FG000|Overall Study|Others|7|||
27802633|NCT04529499|81107964|FG001|Overall Study|Others|11|||
27802634|NCT03182686|81107965|FG000|Overall Study|Lost to Follow-up|2|||
27802635|NCT03182686|81107966|FG001|Overall Study|Lost to Follow-up|0|||
27579591|NCT00575588|80306635|FG000|Overall Study|Lost to Follow-up|1|||
27802636|NCT03182686|81107965|FG000|Overall Study|Adverse Event|2|||
27872144|NCT02906670|81365200|FG009|Cohort 4, Q2W|Clinical Progression|0|||
27872145|NCT02906670|81365191|FG000|Cohort 5, Q2W|Radiological Progression|0|||
27802637|NCT03182686|81107966|FG001|Overall Study|Adverse Event|0|||
27802638|NCT03182686|81107965|FG000|Overall Study|Withdrawal by Subject|3|||
27802639|NCT03182686|81107966|FG001|Overall Study|Withdrawal by Subject|0|||
27802640|NCT00468312|81107968|FG000|Overall Study|Adverse Event|2|||
27802641|NCT00468312|81107969|FG001|Overall Study|Adverse Event|1|||
27802642|NCT00468312|81107968|FG000|Overall Study|Lack of Efficacy|0|||
27802643|NCT00468312|81107969|FG001|Overall Study|Lack of Efficacy|1|||
27802644|NCT00468312|81107968|FG000|Overall Study|Withdrawal by Subject|0|||
27802645|NCT00468312|81107969|FG001|Overall Study|Withdrawal by Subject|1|||
27802646|NCT00468312|81107968|FG000|Overall Study|Protocol Violation|2|||
27802647|NCT00468312|81107969|FG001|Overall Study|Protocol Violation|1|||
27802648|NCT00468312|81107968|FG000|Overall Study|Did not meet protocol eligibility|0|||
27802649|NCT00468312|81107969|FG001|Overall Study|Did not meet protocol eligibility|1|||
27802650|NCT00568776|81107970|FG000|Overall Study|Adverse Event|8|||
27802651|NCT00568776|81107971|FG001|Overall Study|Adverse Event|8|||
27802652|NCT00568776|81107972|FG002|Overall Study|Adverse Event|10|||
27802653|NCT00568776|81107973|FG003|Overall Study|Adverse Event|8|||
27802654|NCT00568776|81107970|FG000|Overall Study|Death|0|||
27802655|NCT00568776|81107971|FG001|Overall Study|Death|1|||
27802656|NCT00568776|81107972|FG002|Overall Study|Death|4|||
27802657|NCT00568776|81107973|FG003|Overall Study|Death|3|||
27802658|NCT00568776|81107970|FG000|Overall Study|Physician Decision|0|||
27802659|NCT00568776|81107971|FG001|Overall Study|Physician Decision|2|||
27802660|NCT00568776|81107972|FG002|Overall Study|Physician Decision|0|||
27802661|NCT00568776|81107973|FG003|Overall Study|Physician Decision|0|||
27802662|NCT00568776|81107970|FG000|Overall Study|Lack of Efficacy|2|||
27802663|NCT00568776|81107971|FG001|Overall Study|Lack of Efficacy|2|||
27802664|NCT00568776|81107972|FG002|Overall Study|Lack of Efficacy|2|||
27802665|NCT00568776|81107973|FG003|Overall Study|Lack of Efficacy|4|||
27802666|NCT00568776|81107970|FG000|Overall Study|Lost to Follow-up|1|||
27679431|NCT03752970|80660657|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
27679432|NCT03752970|80660655|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
27802667|NCT00568776|81107971|FG001|Overall Study|Lost to Follow-up|1|||
27802668|NCT00568776|81107972|FG002|Overall Study|Lost to Follow-up|1|||
27802669|NCT00568776|81107973|FG003|Overall Study|Lost to Follow-up|1|||
27802670|NCT00568776|81107970|FG000|Overall Study|Protocol Violation|1|||
27802671|NCT00568776|81107971|FG001|Overall Study|Protocol Violation|0|||
27802672|NCT00568776|81107972|FG002|Overall Study|Protocol Violation|1|||
27802673|NCT00568776|81107973|FG003|Overall Study|Protocol Violation|1|||
27802674|NCT00568776|81107970|FG000|Overall Study|Withdrawal by Subject|13|||
27802675|NCT00568776|81107971|FG001|Overall Study|Withdrawal by Subject|15|||
27802676|NCT00568776|81107972|FG002|Overall Study|Withdrawal by Subject|13|||
27802677|NCT00568776|81107973|FG003|Overall Study|Withdrawal by Subject|7|||
27802678|NCT00568776|81107970|FG000|Overall Study|Loss of Caregiver|0|||
27802679|NCT00568776|81107971|FG001|Overall Study|Loss of Caregiver|2|||
27802680|NCT00568776|81107972|FG002|Overall Study|Loss of Caregiver|1|||
27802681|NCT00568776|81107973|FG003|Overall Study|Loss of Caregiver|2|||
27802682|NCT00568776|81107970|FG000|Overall Study|Sponsor Decision|2|||
27802683|NCT00568776|81107971|FG001|Overall Study|Sponsor Decision|2|||
27802684|NCT00568776|81107972|FG002|Overall Study|Sponsor Decision|41|||
27802685|NCT00568776|81107973|FG003|Overall Study|Sponsor Decision|42|||
27802686|NCT00568776|81107970|FG000|Overall Study|Miscellaeneous|3|||
27802687|NCT00568776|81107971|FG001|Overall Study|Miscellaeneous|3|||
27802688|NCT00568776|81107972|FG002|Overall Study|Miscellaeneous|1|||
27802689|NCT00568776|81107973|FG003|Overall Study|Miscellaeneous|4|||
27802690|NCT01296152|81107980|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
27802691|NCT00619619|81107982|FG000|Overall Study|Physician Decision|0|||
27802692|NCT00619619|81107983|FG001|Overall Study|Physician Decision|0|||
27802693|NCT00619619|81107984|FG002|Overall Study|Physician Decision|1|||
27802694|NCT00619619|81107985|FG003|Overall Study|Physician Decision|0|||
27995306|NCT03472326|81811297|FG001|Part 2: Combination Therapy|Pregnancy|0|||
27802695|NCT00619619|81107986|FG004|Overall Study|Physician Decision|0|||
27802696|NCT00619619|81107987|FG005|Overall Study|Physician Decision|0|||
27802697|NCT00619619|81107988|FG006|Overall Study|Physician Decision|0|||
27802698|NCT00619619|81107989|FG007|Overall Study|Physician Decision|0|||
27802699|NCT00619619|81107982|FG000|Overall Study|Protocol Violation|0|||
27802700|NCT00619619|81107983|FG001|Overall Study|Protocol Violation|0|||
27802701|NCT00619619|81107984|FG002|Overall Study|Protocol Violation|0|||
27802702|NCT00619619|81107985|FG003|Overall Study|Protocol Violation|1|||
27802703|NCT00619619|81107986|FG004|Overall Study|Protocol Violation|0|||
27802704|NCT00619619|81107987|FG005|Overall Study|Protocol Violation|0|||
27802705|NCT00619619|81107988|FG006|Overall Study|Protocol Violation|1|||
27802706|NCT00619619|81107989|FG007|Overall Study|Protocol Violation|1|||
27995307|NCT03472326|81811298|FG002|Part 2: Combination Therapy|Pregnancy|0|||
27995308|NCT03472326|81811299|FG003|Part 2: Combination Therapy|Pregnancy|1|||
27995309|NCT02114606|81811300|FG000|Overall Study|Unable to swallow Cytosponge|6|||
27579592|NCT00575588|80306636|FG001|Overall Study|Lost to Follow-up|3|||
27802707|NCT00619619|81107982|FG000|Overall Study|Adverse Event|0|||
27802708|NCT00619619|81107983|FG001|Overall Study|Adverse Event|0|||
27802709|NCT00619619|81107984|FG002|Overall Study|Adverse Event|0|||
27802710|NCT00619619|81107985|FG003|Overall Study|Adverse Event|0|||
27802711|NCT00619619|81107986|FG004|Overall Study|Adverse Event|2|||
27802712|NCT00619619|81107987|FG005|Overall Study|Adverse Event|0|||
27802713|NCT00619619|81107988|FG006|Overall Study|Adverse Event|0|||
27802714|NCT00619619|81107989|FG007|Overall Study|Adverse Event|2|||
27802715|NCT02713243|81107992|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
27802716|NCT02713243|81107993|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
27802717|NCT02713243|81107992|FG000|Overall Study|Administrative problems|0|||
27802718|NCT02713243|81107993|FG001|Overall Study|Administrative problems|1|||
27802719|NCT02713243|81107992|FG000|Overall Study|Protocol deviation|0|||
27802720|NCT02713243|81107993|FG001|Overall Study|Protocol deviation|1|||
27802721|NCT02595528|81107994|FG000|Overall Study|Withdrawal by Subject|1|||
27802722|NCT02595528|81107995|FG001|Overall Study|Withdrawal by Subject|2|||
27802723|NCT02595528|81107996|FG002|Overall Study|Withdrawal by Subject|1|||
27802724|NCT02595528|81107997|FG003|Overall Study|Withdrawal by Subject|3|||
27802725|NCT02595528|81107994|FG000|Overall Study|Lost to Follow-up|1|||
27802726|NCT02595528|81107995|FG001|Overall Study|Lost to Follow-up|1|||
27802727|NCT02595528|81107996|FG002|Overall Study|Lost to Follow-up|0|||
27802728|NCT02595528|81107997|FG003|Overall Study|Lost to Follow-up|1|||
27802729|NCT01027884|81107999|FG000|Overall Study|Adverse Event|2|||
27802730|NCT01027884|81108000|FG001|Overall Study|Adverse Event|1|||
27579593|NCT00575588|80306635|FG000|Overall Study|Death|4|||
27872146|NCT02906670|81365192|FG001|Cohort 5, Q2W|Radiological Progression|0|||
27872147|NCT02906670|81365193|FG002|Cohort 5, Q2W|Radiological Progression|0|||
27872148|NCT02906670|81365194|FG003|Cohort 5, Q2W|Radiological Progression|0|||
27872149|NCT02906670|81365195|FG004|Cohort 5, Q2W|Radiological Progression|0|||
27872150|NCT02906670|81365196|FG005|Cohort 5, Q2W|Radiological Progression|0|||
27872151|NCT02906670|81365197|FG006|Cohort 5, Q2W|Radiological Progression|4|||
27872152|NCT02906670|81365198|FG007|Cohort 5, Q2W|Radiological Progression|0|||
27872153|NCT02906670|81365199|FG008|Cohort 5, Q2W|Radiological Progression|0|||
27679433|NCT03752970|80660656|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
27679434|NCT03752970|80660657|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
27679435|NCT04276051|80660658|FG000|Overall Study|Lost to Follow-up|0|||
27679436|NCT04276051|80660659|FG001|Overall Study|Lost to Follow-up|1|||
27679437|NCT04276051|80660658|FG000|Overall Study|Physician Decision|0|||
27679438|NCT04276051|80660659|FG001|Overall Study|Physician Decision|1|||
27872154|NCT02906670|81365200|FG009|Cohort 5, Q2W|Radiological Progression|0|||
27872155|NCT02906670|81365191|FG000|Cohort 5, Q2W|Clinical Progression|0|||
27872156|NCT02906670|81365192|FG001|Cohort 5, Q2W|Clinical Progression|0|||
27872157|NCT02906670|81365193|FG002|Cohort 5, Q2W|Clinical Progression|0|||
27872158|NCT02906670|81365194|FG003|Cohort 5, Q2W|Clinical Progression|0|||
27872159|NCT02906670|81365195|FG004|Cohort 5, Q2W|Clinical Progression|0|||
27872160|NCT02906670|81365196|FG005|Cohort 5, Q2W|Clinical Progression|0|||
27872161|NCT02906670|81365197|FG006|Cohort 5, Q2W|Clinical Progression|1|||
27872162|NCT02906670|81365198|FG007|Cohort 5, Q2W|Clinical Progression|0|||
27872163|NCT02906670|81365199|FG008|Cohort 5, Q2W|Clinical Progression|0|||
27872164|NCT02906670|81365200|FG009|Cohort 5, Q2W|Clinical Progression|0|||
27872165|NCT02906670|81365191|FG000|Cohort 5, Q2W|Adverse Event|0|||
27872166|NCT02906670|81365192|FG001|Cohort 5, Q2W|Adverse Event|0|||
27872167|NCT02906670|81365193|FG002|Cohort 5, Q2W|Adverse Event|0|||
27872168|NCT02906670|81365194|FG003|Cohort 5, Q2W|Adverse Event|0|||
27872169|NCT02906670|81365195|FG004|Cohort 5, Q2W|Adverse Event|0|||
27679439|NCT04276051|80660658|FG000|Overall Study|Withdrawal by Subject|1|||
27679440|NCT04276051|80660659|FG001|Overall Study|Withdrawal by Subject|1|||
27679441|NCT03812029|80660660|FG000|Overall Study|Protocol Violation|1|||
27802731|NCT01027884|81107999|FG000|Overall Study|Protocol Violation|1|||
27802732|NCT01027884|81108000|FG001|Overall Study|Protocol Violation|0|||
27802733|NCT01027884|81107999|FG000|Overall Study|Non-compliance|1|||
27802734|NCT01027884|81108000|FG001|Overall Study|Non-compliance|1|||
27802735|NCT01027884|81107999|FG000|Overall Study|Withdrawal by Subject|0|||
27802736|NCT01027884|81108000|FG001|Overall Study|Withdrawal by Subject|1|||
27802737|NCT01027884|81107999|FG000|Overall Study|Lost to Follow-up|0|||
27802738|NCT01027884|81108000|FG001|Overall Study|Lost to Follow-up|1|||
27802739|NCT01027884|81107999|FG000|Overall Study|Spinal fixation surgery|0|||
27802740|NCT01027884|81108000|FG001|Overall Study|Spinal fixation surgery|3|||
27802741|NCT02016755|81108001|FG000|Overall Study|Major amputation of index limb|2|||
27802742|NCT02016755|81108001|FG000|Overall Study|Adverse Event|2|||
27872170|NCT02906670|81365196|FG005|Cohort 5, Q2W|Adverse Event|0|||
27872171|NCT02906670|81365197|FG006|Cohort 5, Q2W|Adverse Event|1|||
27679442|NCT03812029|80660661|FG001|Overall Study|Protocol Violation|0|||
27872172|NCT02906670|81365198|FG007|Cohort 5, Q2W|Adverse Event|0|||
27872173|NCT02906670|81365199|FG008|Cohort 5, Q2W|Adverse Event|0|||
27802743|NCT02016755|81108001|FG000|Overall Study|Physician Decision|1|||
27579594|NCT00575588|80306636|FG001|Overall Study|Death|2|||
27802744|NCT02016755|81108001|FG000|Overall Study|Death|2|||
27802745|NCT00127192|81108002|FG000|Overall Study|Adverse Event|0|||
27802746|NCT00127192|81108003|FG001|Overall Study|Adverse Event|1|||
27802747|NCT00127192|81108004|FG002|Overall Study|Adverse Event|1|||
27679443|NCT03812029|80660662|FG002|Overall Study|Protocol Violation|0|||
27679444|NCT03812029|80660663|FG003|Overall Study|Protocol Violation|1|||
27679445|NCT03812029|80660664|FG004|Overall Study|Protocol Violation|0|||
27679446|NCT03812029|80660660|FG000|Overall Study|Withdrawal by Subject|1|||
27579595|NCT00575588|80306635|FG000|Overall Study|Incorrect enrollment|8|||
27579596|NCT00575588|80306636|FG001|Overall Study|Incorrect enrollment|4|||
27579597|NCT00575588|80306635|FG000|Overall Study|Study specific discontinuation criteria|203|||
27579598|NCT00575588|80306636|FG001|Overall Study|Study specific discontinuation criteria|218|||
27579599|NCT00575588|80306635|FG000|Overall Study|Severe non-compliance to protocol|5|||
27579600|NCT00575588|80306636|FG001|Overall Study|Severe non-compliance to protocol|7|||
27579601|NCT00575588|80306635|FG000|Overall Study|Safety reasons|2|||
27579602|NCT00575588|80306636|FG001|Overall Study|Safety reasons|1|||
27579603|NCT00575588|80306635|FG000|Overall Study|Elevated triglyceride|1|||
27579604|NCT00575588|80306636|FG001|Overall Study|Elevated triglyceride|0|||
27579605|NCT00575588|80306635|FG000|Overall Study|Patient moved|1|||
27579606|NCT00575588|80306636|FG001|Overall Study|Patient moved|3|||
27679447|NCT03812029|80660661|FG001|Overall Study|Withdrawal by Subject|0|||
27679448|NCT03812029|80660662|FG002|Overall Study|Withdrawal by Subject|0|||
27679449|NCT03812029|80660663|FG003|Overall Study|Withdrawal by Subject|2|||
27679450|NCT03812029|80660664|FG004|Overall Study|Withdrawal by Subject|2|||
27679451|NCT03812029|80660660|FG000|Overall Study|Stopping rules|0|||
27679452|NCT03812029|80660661|FG001|Overall Study|Stopping rules|1|||
27679453|NCT03812029|80660662|FG002|Overall Study|Stopping rules|0|||
27679454|NCT03812029|80660663|FG003|Overall Study|Stopping rules|0|||
27679455|NCT03812029|80660664|FG004|Overall Study|Stopping rules|0|||
27679456|NCT03812029|80660660|FG000|Overall Study|Adverse Event|0|||
27679457|NCT03812029|80660661|FG001|Overall Study|Adverse Event|9|||
27679458|NCT03812029|80660662|FG002|Overall Study|Adverse Event|0|||
27679459|NCT03812029|80660663|FG003|Overall Study|Adverse Event|3|||
27679460|NCT03812029|80660664|FG004|Overall Study|Adverse Event|5|||
27679461|NCT03812029|80660660|FG000|Overall Study|Lost to Follow-up|0|||
27679462|NCT03812029|80660661|FG001|Overall Study|Lost to Follow-up|0|||
27679463|NCT03812029|80660662|FG002|Overall Study|Lost to Follow-up|0|||
27679464|NCT03812029|80660663|FG003|Overall Study|Lost to Follow-up|0|||
27679465|NCT03812029|80660664|FG004|Overall Study|Lost to Follow-up|3|||
27679466|NCT03381339|80660666|FG000|Overall Study|Protocol Violation|4|||
27679467|NCT03381339|80660667|FG001|Overall Study|Protocol Violation|3|||
27679468|NCT03381339|80660666|FG000|Overall Study|Lost to Follow-up|0|||
27679469|NCT03381339|80660667|FG001|Overall Study|Lost to Follow-up|1|||
27679470|NCT01424813|80664349|FG000|Overall Study|Withdrawal by Subject|3|||
27679471|NCT01424813|80664350|FG001|Overall Study|Withdrawal by Subject|0|||
27679472|NCT01424813|80664349|FG000|Overall Study|Protocol Violation|1|||
27679473|NCT01424813|80664350|FG001|Overall Study|Protocol Violation|0|||
27679474|NCT01424813|80664349|FG000|Overall Study|Other|1|||
27679475|NCT01424813|80664350|FG001|Overall Study|Other|2|||
27679476|NCT03149549|80664351|FG000|Study Discontinuation--Treatment Period|Death|0|||
27679477|NCT03149549|80664352|FG001|Study Discontinuation--Treatment Period|Death|0|||
27679478|NCT03149549|80664353|FG002|Study Discontinuation--Treatment Period|Death|0|||
27679479|NCT03149549|80664354|FG003|Study Discontinuation--Treatment Period|Death|1|||
27802748|NCT00127192|81108005|FG003|Overall Study|Adverse Event|1|||
27802749|NCT00127192|81108006|FG004|Overall Study|Adverse Event|0|||
27802750|NCT00127192|81108002|FG000|Overall Study|Lack of Efficacy|2|||
27802751|NCT00127192|81108003|FG001|Overall Study|Lack of Efficacy|0|||
27802752|NCT00127192|81108004|FG002|Overall Study|Lack of Efficacy|0|||
27995310|NCT00082407|81811303|FG000|Overall Study|Adverse Event|20|||
27995311|NCT00082407|81811304|FG001|Overall Study|Adverse Event|0|||
27995312|NCT00082407|81811303|FG000|Overall Study|Protocol Violation|14|||
27995313|NCT00082407|81811304|FG001|Overall Study|Protocol Violation|12|||
27579607|NCT00575588|80306635|FG000|Overall Study|Impossible to determine HbA1c|0|||
27579608|NCT00575588|80306636|FG001|Overall Study|Impossible to determine HbA1c|1|||
27579609|NCT00403455|80306637|FG000|Overall Study|Withdrawal by Subject|1|||
27579610|NCT00194012|80306638|FG000|Randomized Phase|Lack of Efficacy|8|||
27679480|NCT03149549|80664355|FG004|Study Discontinuation--Treatment Period|Death|2|||
27679481|NCT03149549|80664356|FG005|Study Discontinuation--Treatment Period|Death|1|||
27679482|NCT03149549|80664357|FG006|Study Discontinuation--Treatment Period|Death|1|||
27679483|NCT03149549|80664358|FG007|Study Discontinuation--Treatment Period|Death|2|||
27679484|NCT03149549|80664359|FG008|Study Discontinuation--Treatment Period|Death|4|||
27679485|NCT03149549|80664360|FG009|Study Discontinuation--Treatment Period|Death|1|||
27679486|NCT03149549|80664361|FG010|Study Discontinuation--Treatment Period|Death|0|||
27579611|NCT00194012|80306639|FG001|Randomized Phase|Lack of Efficacy|18|||
27679487|NCT03149549|80664362|FG011|Study Discontinuation--Treatment Period|Death|0|||
27679488|NCT03149549|80664363|FG012|Study Discontinuation--Treatment Period|Death|1|||
27802753|NCT00127192|81108005|FG003|Overall Study|Lack of Efficacy|0|||
27802754|NCT00127192|81108006|FG004|Overall Study|Lack of Efficacy|2|||
27802755|NCT00127192|81108002|FG000|Overall Study|Withdrawal by Subject|0|||
27802756|NCT00127192|81108003|FG001|Overall Study|Withdrawal by Subject|0|||
27802757|NCT00127192|81108004|FG002|Overall Study|Withdrawal by Subject|1|||
27802758|NCT00127192|81108005|FG003|Overall Study|Withdrawal by Subject|0|||
27802759|NCT00127192|81108006|FG004|Overall Study|Withdrawal by Subject|3|||
27802760|NCT00127192|81108002|FG000|Overall Study|Adverse event in pre-treatment period|1|||
27802761|NCT00127192|81108003|FG001|Overall Study|Adverse event in pre-treatment period|0|||
27802762|NCT00127192|81108004|FG002|Overall Study|Adverse event in pre-treatment period|0|||
27802763|NCT00127192|81108005|FG003|Overall Study|Adverse event in pre-treatment period|0|||
27802764|NCT00127192|81108006|FG004|Overall Study|Adverse event in pre-treatment period|0|||
27802765|NCT01946282|81108008|FG000|Year 1|Did not return FIT kit|4186|||
27802766|NCT01946282|81108009|FG001|Year 1|Did not return FIT kit|608|||
27802767|NCT01946282|81108010|FG002|Year 1|Did not return FIT kit|654|||
27802768|NCT01946282|81108008|FG000|Year 2|Did not return FIT kit|803|||
27802769|NCT01946282|81108009|FG001|Year 2|Did not return FIT kit|131|||
27802770|NCT01946282|81108010|FG002|Year 2|Did not return FIT kit|115|||
27802771|NCT01946282|81108008|FG000|Year 3|Did not return FIT kit|288|||
27802772|NCT01946282|81108009|FG001|Year 3|Did not return FIT kit|43|||
27802773|NCT01946282|81108010|FG002|Year 3|Did not return FIT kit|30|||
27802774|NCT01901146|81108011|FG000|Neoadjuvant Phase|Death|1|||
27802775|NCT01901146|81108012|FG001|Neoadjuvant Phase|Death|2|||
27802776|NCT01901146|81108013|FG002|Neoadjuvant Phase|Death|0|||
27802777|NCT01901146|81108014|FG003|Neoadjuvant Phase|Death|0|||
27802778|NCT01901146|81108015|FG004|Neoadjuvant Phase|Death|0|||
27802779|NCT01901146|81108011|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
27802780|NCT01901146|81108012|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
27802781|NCT01901146|81108013|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
27802782|NCT01901146|81108014|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
27802783|NCT01901146|81108015|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
27802784|NCT01901146|81108011|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
27802785|NCT01901146|81108012|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
27802786|NCT01901146|81108013|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
27802787|NCT01901146|81108014|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
27802788|NCT01901146|81108015|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
27995314|NCT00082407|81811303|FG000|Overall Study|Patient Decision|13|||
27995315|NCT00082407|81811304|FG001|Overall Study|Patient Decision|6|||
27995316|NCT00082407|81811303|FG000|Overall Study|Physician Decision|5|||
27995317|NCT00082407|81811304|FG001|Overall Study|Physician Decision|3|||
27995318|NCT00082407|81811303|FG000|Overall Study|Loss of Glucose Control|2|||
27995319|NCT00082407|81811304|FG001|Overall Study|Loss of Glucose Control|2|||
27995320|NCT00082407|81811303|FG000|Overall Study|Death|2|||
27995321|NCT00082407|81811304|FG001|Overall Study|Death|1|||
27995322|NCT00082407|81811303|FG000|Overall Study|Lost to Follow-up|0|||
27802789|NCT01901146|81108011|FG000|Neoadjuvant Phase|Physician Decision|1|||
27802790|NCT01901146|81108012|FG001|Neoadjuvant Phase|Physician Decision|2|||
27802791|NCT01901146|81108013|FG002|Neoadjuvant Phase|Physician Decision|0|||
27802792|NCT01901146|81108014|FG003|Neoadjuvant Phase|Physician Decision|0|||
27802793|NCT01901146|81108015|FG004|Neoadjuvant Phase|Physician Decision|0|||
27802794|NCT01901146|81108011|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
27802795|NCT01901146|81108012|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
27802796|NCT01901146|81108013|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
27802797|NCT01901146|81108014|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
27802798|NCT01901146|81108015|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
27802799|NCT01901146|81108011|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27802800|NCT01901146|81108012|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
27802801|NCT01901146|81108013|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27802802|NCT01901146|81108014|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27802803|NCT01901146|81108015|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
27802804|NCT01901146|81108011|FG000|Adjuvant Phase|Other|0|||
27802805|NCT01901146|81108012|FG001|Adjuvant Phase|Other|0|||
27802806|NCT01901146|81108013|FG002|Adjuvant Phase|Other|1|||
27802807|NCT01901146|81108014|FG003|Adjuvant Phase|Other|0|||
27802808|NCT01901146|81108015|FG004|Adjuvant Phase|Other|0|||
27802809|NCT01901146|81108011|FG000|Adjuvant Phase|Death|0|||
27802810|NCT01901146|81108012|FG001|Adjuvant Phase|Death|0|||
27802811|NCT01901146|81108013|FG002|Adjuvant Phase|Death|0|||
27995323|NCT00082407|81811304|FG001|Overall Study|Lost to Follow-up|3|||
27995324|NCT02292446|81811307|FG000|Overall Study|Adverse Event|12|||
27802812|NCT01901146|81108014|FG003|Adjuvant Phase|Death|0|||
27802813|NCT01901146|81108015|FG004|Adjuvant Phase|Death|3|||
27802814|NCT01901146|81108011|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
27802815|NCT01901146|81108012|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
27872174|NCT02906670|81365200|FG009|Cohort 5, Q2W|Adverse Event|0|||
27995325|NCT02292446|81811307|FG000|Overall Study|Death|1|||
27679489|NCT03149549|80664351|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679490|NCT03149549|80664352|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27579612|NCT00194012|80306638|FG000|Randomized Phase|Study nonadherence|2|||
27579613|NCT00194012|80306639|FG001|Randomized Phase|Study nonadherence|1|||
27995326|NCT02292446|81811307|FG000|Overall Study|Disease progression|2|||
27995327|NCT02292446|81811307|FG000|Overall Study|Subject/guardian decision|2|||
27995328|NCT02292446|81811307|FG000|Overall Study|Withdrawal by Subject|3|||
27995329|NCT00965575|81811308|FG000|Overall Study|subject unwillingness to swallow study c|1|||
27995330|NCT00965575|81811309|FG001|Overall Study|subject unwillingness to swallow study c|0|||
27995331|NCT01835158|81811310|FG000|Overall Study|Withdrawal by Subject|1|||
27995332|NCT01835158|81811311|FG001|Overall Study|Withdrawal by Subject|6|||
27995333|NCT00577824|81811319|FG000|Overall Study|Adverse Event|6|||
27995334|NCT00577824|81811320|FG001|Overall Study|Adverse Event|18|||
27679491|NCT03149549|80664353|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679492|NCT03149549|80664354|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679493|NCT03149549|80664355|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679494|NCT03149549|80664356|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679495|NCT03149549|80664357|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679496|NCT03149549|80664358|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
27679497|NCT03149549|80664359|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27872175|NCT02906670|81365191|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872176|NCT02906670|81365192|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872177|NCT02906670|81365193|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872178|NCT02906670|81365194|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872179|NCT02906670|81365195|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27995335|NCT00577824|81811321|FG002|Overall Study|Adverse Event|1|||
27995336|NCT00577824|81811319|FG000|Overall Study|Patient decision|0|||
27995337|NCT00577824|81811320|FG001|Overall Study|Patient decision|1|||
27995338|NCT00577824|81811321|FG002|Overall Study|Patient decision|1|||
27995339|NCT00577824|81811319|FG000|Overall Study|Protocol Violation|1|||
27995340|NCT00577824|81811320|FG001|Overall Study|Protocol Violation|1|||
27995341|NCT00577824|81811321|FG002|Overall Study|Protocol Violation|0|||
27995342|NCT05274269|81811323|FG000|Overall Study|Adverse Event|0|||
27995343|NCT05274269|81811324|FG001|Overall Study|Adverse Event|3|||
27995344|NCT05274269|81811323|FG000|Overall Study|Death|0|||
27995345|NCT05274269|81811324|FG001|Overall Study|Death|1|||
27995346|NCT05274269|81811323|FG000|Overall Study|Other|0|||
27995347|NCT05274269|81811324|FG001|Overall Study|Other|2|||
27995348|NCT05274269|81811323|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
27995349|NCT05274269|81811324|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
27995350|NCT03948334|81811331|FG000|Overall Study|Adverse Event|1|||
27579614|NCT00194012|80306638|FG000|Randomized Phase|Withdrawal by Subject|3|||
27579615|NCT00194012|80306639|FG001|Randomized Phase|Withdrawal by Subject|3|||
27579616|NCT00194012|80306638|FG000|Randomized Phase|Adverse Event|2|||
27579617|NCT00194012|80306639|FG001|Randomized Phase|Adverse Event|1|||
27579618|NCT00194012|80306638|FG000|Randomized Phase|Participant reported having a rash|1|||
27579619|NCT00194012|80306639|FG001|Randomized Phase|Participant reported having a rash|0|||
27579620|NCT00194012|80306638|FG000|Randomized Phase|Emesis and enuresis|0|||
27579621|NCT00194012|80306639|FG001|Randomized Phase|Emesis and enuresis|1|||
27579622|NCT00194012|80306638|FG000|Randomized Phase|Oral/nasal twitching|0|||
27679498|NCT03149549|80664360|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27872180|NCT02906670|81365196|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872181|NCT02906670|81365197|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
27872182|NCT02906670|81365198|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872183|NCT02906670|81365199|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27872184|NCT02906670|81365200|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
27995351|NCT03948334|81811332|FG001|Overall Study|Adverse Event|4|||
27995352|NCT03948334|81811331|FG000|Overall Study|Lack of Efficacy|2|||
27679499|NCT03149549|80664361|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679500|NCT03149549|80664362|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
27679501|NCT03149549|80664363|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
27872185|NCT02906670|81365191|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
27995353|NCT03948334|81811332|FG001|Overall Study|Lack of Efficacy|0|||
27995354|NCT03948334|81811331|FG000|Overall Study|Lost to Follow-up|1|||
27995355|NCT03948334|81811332|FG001|Overall Study|Lost to Follow-up|0|||
27995356|NCT03948334|81811331|FG000|Overall Study|Physician Decision|1|||
27995357|NCT03948334|81811332|FG001|Overall Study|Physician Decision|0|||
27995358|NCT03948334|81811331|FG000|Overall Study|Pregnancy|0|||
27995359|NCT03948334|81811332|FG001|Overall Study|Pregnancy|1|||
27995360|NCT03948334|81811331|FG000|Overall Study|Protocol Deviation|1|||
27995361|NCT03948334|81811332|FG001|Overall Study|Protocol Deviation|0|||
27995362|NCT03948334|81811331|FG000|Overall Study|Study terminated by Sponsor|50|||
27995363|NCT03948334|81811332|FG001|Overall Study|Study terminated by Sponsor|51|||
27579623|NCT00194012|80306639|FG001|Randomized Phase|Oral/nasal twitching|1|||
27579624|NCT00194012|80306638|FG000|Open Label Extension (OLE)|Weight Gain|1|||
27872186|NCT02906670|81365192|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
27872187|NCT02906670|81365193|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
27579625|NCT00194012|80306639|FG001|Open Label Extension (OLE)|Weight Gain|0|||
27995364|NCT03948334|81811331|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
27995365|NCT03948334|81811332|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
27995366|NCT00649428|81811333|FG000|Overall Study|Adverse Event|2|||
27995367|NCT00649428|81811334|FG001|Overall Study|Adverse Event|2|||
27995368|NCT00649428|81811333|FG000|Overall Study|Withdrawal by Subject|6|||
27679502|NCT03149549|80664351|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679503|NCT03149549|80664352|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679504|NCT03149549|80664353|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679505|NCT03149549|80664354|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
27679506|NCT03149549|80664355|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
27679507|NCT03149549|80664356|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
27679508|NCT03149549|80664357|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
27995369|NCT00649428|81811334|FG001|Overall Study|Withdrawal by Subject|6|||
27995370|NCT00649428|81811333|FG000|Overall Study|Lost to Follow-up|1|||
27995371|NCT00649428|81811334|FG001|Overall Study|Lost to Follow-up|3|||
27679509|NCT03149549|80664358|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679510|NCT03149549|80664359|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
27679511|NCT03149549|80664360|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679512|NCT03149549|80664361|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679513|NCT03149549|80664362|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679514|NCT03149549|80664363|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
27679515|NCT03149549|80664351|FG000|Study Discontinuation--Treatment Period|Other|0|||
27679516|NCT03149549|80664352|FG001|Study Discontinuation--Treatment Period|Other|0|||
27679517|NCT03149549|80664353|FG002|Study Discontinuation--Treatment Period|Other|0|||
27679518|NCT03149549|80664354|FG003|Study Discontinuation--Treatment Period|Other|0|||
27679519|NCT03149549|80664355|FG004|Study Discontinuation--Treatment Period|Other|0|||
27679520|NCT03149549|80664356|FG005|Study Discontinuation--Treatment Period|Other|0|||
27679521|NCT03149549|80664357|FG006|Study Discontinuation--Treatment Period|Other|0|||
27679522|NCT03149549|80664358|FG007|Study Discontinuation--Treatment Period|Other|1|||
27679523|NCT03149549|80664359|FG008|Study Discontinuation--Treatment Period|Other|0|||
27679524|NCT03149549|80664360|FG009|Study Discontinuation--Treatment Period|Other|1|||
27679525|NCT03149549|80664361|FG010|Study Discontinuation--Treatment Period|Other|0|||
27679526|NCT03149549|80664362|FG011|Study Discontinuation--Treatment Period|Other|0|||
27679527|NCT03149549|80664363|FG012|Study Discontinuation--Treatment Period|Other|0|||
27679528|NCT03149549|80664351|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679529|NCT03149549|80664352|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679530|NCT03149549|80664353|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679531|NCT03149549|80664354|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679532|NCT03149549|80664355|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679533|NCT03149549|80664356|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
27679534|NCT03149549|80664357|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
27995372|NCT00649428|81811333|FG000|Overall Study|Insufficient manufacturing yield|5|||
27995373|NCT00649428|81811334|FG001|Overall Study|Insufficient manufacturing yield|1|||
27995374|NCT00649428|81811333|FG000|Overall Study|Protocol Violation|6|||
27995375|NCT00649428|81811334|FG001|Overall Study|Protocol Violation|2|||
27995376|NCT00649428|81811333|FG000|Overall Study|Physician Decision|0|||
27995377|NCT00649428|81811334|FG001|Overall Study|Physician Decision|1|||
27995378|NCT02462720|81811335|FG000|Part 2|Withdrawal by Subject|1|||
27995379|NCT02462720|81811336|FG001|Part 2|Withdrawal by Subject|0|||
27995380|NCT02462720|81811335|FG000|Part 2|Protocol Violation|0|||
27995381|NCT02462720|81811336|FG001|Part 2|Protocol Violation|1|||
27679535|NCT03149549|80664358|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679536|NCT03149549|80664359|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
27995382|NCT02343406|81811337|FG000|Overall Study|Progressive disease|72|||
27995383|NCT02343406|81811338|FG001|Overall Study|Progressive disease|70|||
27995384|NCT02343406|81811339|FG002|Overall Study|Progressive disease|43|||
27995385|NCT02343406|81811340|FG003|Overall Study|Progressive disease|15|||
27995386|NCT02343406|81811341|FG004|Overall Study|Progressive disease|5|||
27579626|NCT00194012|80306638|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
27579627|NCT00194012|80306639|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
27679537|NCT03149549|80664360|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27802816|NCT01901146|81108013|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
27995387|NCT02343406|81811337|FG000|Overall Study|Adverse Event|6|||
27995388|NCT02343406|81811338|FG001|Overall Study|Adverse Event|8|||
27995389|NCT02343406|81811339|FG002|Overall Study|Adverse Event|6|||
27995390|NCT02343406|81811340|FG003|Overall Study|Adverse Event|3|||
27995391|NCT02343406|81811341|FG004|Overall Study|Adverse Event|0|||
27995392|NCT02343406|81811337|FG000|Overall Study|Withdrawal by Subject|6|||
27995393|NCT02343406|81811338|FG001|Overall Study|Withdrawal by Subject|4|||
27995394|NCT02343406|81811339|FG002|Overall Study|Withdrawal by Subject|8|||
27995395|NCT02343406|81811340|FG003|Overall Study|Withdrawal by Subject|3|||
27802817|NCT01901146|81108014|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
27802818|NCT01901146|81108015|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
27802819|NCT01901146|81108011|FG000|Adjuvant Phase|Physician Decision|0|||
27802820|NCT01901146|81108012|FG001|Adjuvant Phase|Physician Decision|0|||
27802821|NCT01901146|81108013|FG002|Adjuvant Phase|Physician Decision|9|||
27802822|NCT01901146|81108014|FG003|Adjuvant Phase|Physician Decision|2|||
27802823|NCT01901146|81108015|FG004|Adjuvant Phase|Physician Decision|4|||
27802824|NCT01901146|81108011|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
27802825|NCT01901146|81108012|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
27802826|NCT01901146|81108013|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
27802827|NCT01901146|81108014|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
27802828|NCT01901146|81108015|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
27802829|NCT03085485|81108016|FG000|Overall Study|Death|1|||
27802830|NCT03085485|81108017|FG001|Overall Study|Death|0|||
27802831|NCT03085485|81108016|FG000|Overall Study|Lost to Follow-up|1|||
27802832|NCT03085485|81108017|FG001|Overall Study|Lost to Follow-up|0|||
27802833|NCT03001011|81108020|FG000|Overall Study|Adverse Event|9|||
27802834|NCT03001011|81108021|FG001|Overall Study|Adverse Event|3|||
27802835|NCT03001011|81108020|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
27802836|NCT03001011|81108021|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
27802837|NCT03001011|81108020|FG000|Overall Study|Other than specified above|3|||
27802838|NCT03001011|81108021|FG001|Overall Study|Other than specified above|8|||
27802839|NCT01392170|81108022|FG000|Overall Study|Withdrawal by Subject|1|||
27802840|NCT01392170|81108022|FG000|Overall Study|Ineligible|1|||
27802841|NCT01585831|81108023|FG000|Overall Study|Physician Decision|0|||
27802842|NCT01585831|81108024|FG001|Overall Study|Physician Decision|1|||
27802843|NCT01585831|81108023|FG000|Overall Study|Withdrawal by Subject|2|||
27802844|NCT01585831|81108024|FG001|Overall Study|Withdrawal by Subject|1|||
27802845|NCT03724968|81108025|FG000|Overall Study|Insurance issues|0|||
27802846|NCT03724968|81108026|FG001|Overall Study|Insurance issues|1|||
27802847|NCT03724968|81108025|FG000|Overall Study|Study closed|0|||
27802848|NCT03724968|81108026|FG001|Overall Study|Study closed|1|||
27802849|NCT02059187|81108027|FG000|Overall Study|Adverse Event|0|||
27802850|NCT02059187|81108028|FG001|Overall Study|Adverse Event|3|||
27802851|NCT02059187|81108027|FG000|Overall Study|Death|1|||
27995396|NCT02343406|81811341|FG004|Overall Study|Withdrawal by Subject|0|||
27995397|NCT02343406|81811337|FG000|Overall Study|Death|2|||
27995398|NCT02343406|81811338|FG001|Overall Study|Death|1|||
27995399|NCT02343406|81811339|FG002|Overall Study|Death|0|||
27995400|NCT02343406|81811340|FG003|Overall Study|Death|0|||
27995401|NCT02343406|81811341|FG004|Overall Study|Death|0|||
27995402|NCT02343406|81811337|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
27802852|NCT02059187|81108028|FG001|Overall Study|Death|1|||
27995403|NCT02343406|81811338|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
27995404|NCT02343406|81811339|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
27995405|NCT02343406|81811340|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
27995406|NCT02343406|81811341|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
27995407|NCT02343406|81811337|FG000|Overall Study|Other primary malignancy|0|||
27995408|NCT02343406|81811338|FG001|Overall Study|Other primary malignancy|1|||
27995409|NCT02343406|81811339|FG002|Overall Study|Other primary malignancy|0|||
27995410|NCT02343406|81811340|FG003|Overall Study|Other primary malignancy|0|||
27995411|NCT02343406|81811341|FG004|Overall Study|Other primary malignancy|0|||
27995412|NCT02343406|81811337|FG000|Overall Study|Other, not specified|2|||
27995413|NCT02343406|81811338|FG001|Overall Study|Other, not specified|1|||
27995414|NCT02343406|81811339|FG002|Overall Study|Other, not specified|1|||
27995415|NCT02343406|81811340|FG003|Overall Study|Other, not specified|4|||
27995416|NCT02343406|81811341|FG004|Overall Study|Other, not specified|0|||
27995417|NCT04170543|81811344|FG000|Overall Study|Death|1|||
27995418|NCT04170543|81811345|FG001|Overall Study|Death|1|||
27995419|NCT04170543|81811346|FG002|Overall Study|Death|1|||
27995420|NCT04170543|81811347|FG003|Overall Study|Death|1|||
27995421|NCT04170543|81811348|FG004|Overall Study|Death|1|||
27995422|NCT04170543|81811344|FG000|Overall Study|Lost to Follow-up|3|||
27995423|NCT04170543|81811345|FG001|Overall Study|Lost to Follow-up|3|||
27995424|NCT04170543|81811346|FG002|Overall Study|Lost to Follow-up|0|||
27995425|NCT04170543|81811347|FG003|Overall Study|Lost to Follow-up|3|||
27995426|NCT04170543|81811348|FG004|Overall Study|Lost to Follow-up|1|||
27995427|NCT04170543|81811344|FG000|Overall Study|Withdrawal by Subject|13|||
27995428|NCT04170543|81811345|FG001|Overall Study|Withdrawal by Subject|6|||
27995429|NCT04170543|81811346|FG002|Overall Study|Withdrawal by Subject|5|||
27995430|NCT04170543|81811347|FG003|Overall Study|Withdrawal by Subject|4|||
27995431|NCT04170543|81811348|FG004|Overall Study|Withdrawal by Subject|9|||
27995432|NCT04170543|81811344|FG000|Overall Study|Not able to transition to phase 2b|8|||
27995433|NCT04170543|81811345|FG001|Overall Study|Not able to transition to phase 2b|0|||
27995434|NCT04170543|81811346|FG002|Overall Study|Not able to transition to phase 2b|10|||
27995435|NCT04170543|81811347|FG003|Overall Study|Not able to transition to phase 2b|0|||
27995436|NCT04170543|81811348|FG004|Overall Study|Not able to transition to phase 2b|6|||
27995437|NCT04170543|81811344|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
27995438|NCT04170543|81811345|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
27995439|NCT04170543|81811346|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
27995440|NCT04170543|81811347|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
27995441|NCT04170543|81811348|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
27995442|NCT04170543|81811344|FG000|Overall Study|Not Treated|0|||
27995443|NCT04170543|81811345|FG001|Overall Study|Not Treated|0|||
27995444|NCT04170543|81811346|FG002|Overall Study|Not Treated|0|||
27995445|NCT04170543|81811347|FG003|Overall Study|Not Treated|0|||
27995446|NCT04170543|81811348|FG004|Overall Study|Not Treated|2|||
27995447|NCT04170543|81811344|FG000|Overall Study|(CRF)|16|||
27995448|NCT04170543|81811345|FG001|Overall Study|(CRF)|15|||
27995449|NCT04170543|81811346|FG002|Overall Study|(CRF)|12|||
27995450|NCT04170543|81811347|FG003|Overall Study|(CRF)|17|||
27995451|NCT04170543|81811348|FG004|Overall Study|(CRF)|17|||
27995452|NCT04170543|81811344|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
27995453|NCT04170543|81811345|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
27995454|NCT04170543|81811346|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
27802853|NCT02059187|81108027|FG000|Overall Study|Lost to Follow-up|9|||
27995455|NCT04170543|81811347|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
27995456|NCT04170543|81811348|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
27995457|NCT00713544|81811351|FG000|Overall Study|Adverse Event|5|||
27802854|NCT02059187|81108028|FG001|Overall Study|Lost to Follow-up|8|||
27802855|NCT02059187|81108027|FG000|Overall Study|Non-compliance with study drug|1|||
27802856|NCT02059187|81108028|FG001|Overall Study|Non-compliance with study drug|0|||
27802857|NCT02059187|81108027|FG000|Overall Study|Physician Decision|1|||
27995458|NCT00713544|81811352|FG001|Overall Study|Adverse Event|3|||
27802858|NCT02059187|81108028|FG001|Overall Study|Physician Decision|2|||
27995459|NCT00713544|81811353|FG002|Overall Study|Adverse Event|7|||
27995460|NCT00713544|81811354|FG003|Overall Study|Adverse Event|7|||
27995461|NCT00713544|81811355|FG004|Overall Study|Adverse Event|3|||
27872188|NCT02906670|81365194|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
27872189|NCT02906670|81365195|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
27872190|NCT02906670|81365196|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
27872191|NCT02906670|81365197|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
27872192|NCT02906670|81365198|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
27872193|NCT02906670|81365199|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
27872194|NCT02906670|81365200|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
27872195|NCT02906670|81365191|FG000|Cohort 5P, Q2W|Adverse Event|0|||
27872196|NCT02906670|81365192|FG001|Cohort 5P, Q2W|Adverse Event|0|||
27872197|NCT02906670|81365193|FG002|Cohort 5P, Q2W|Adverse Event|0|||
27872198|NCT02906670|81365194|FG003|Cohort 5P, Q2W|Adverse Event|0|||
27872199|NCT02906670|81365195|FG004|Cohort 5P, Q2W|Adverse Event|0|||
27872200|NCT02906670|81365196|FG005|Cohort 5P, Q2W|Adverse Event|0|||
27872201|NCT02906670|81365197|FG006|Cohort 5P, Q2W|Adverse Event|0|||
27872202|NCT02906670|81365198|FG007|Cohort 5P, Q2W|Adverse Event|1|||
27872203|NCT02906670|81365199|FG008|Cohort 5P, Q2W|Adverse Event|0|||
27872204|NCT02906670|81365200|FG009|Cohort 5P, Q2W|Adverse Event|0|||
27872205|NCT02906670|81365191|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
27872206|NCT02906670|81365192|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
27872207|NCT02906670|81365193|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
27872208|NCT02906670|81365194|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
27872209|NCT02906670|81365195|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
27872210|NCT02906670|81365196|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
27872211|NCT02906670|81365197|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
27872212|NCT02906670|81365198|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
27872213|NCT02906670|81365199|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
27872214|NCT02906670|81365200|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
27872215|NCT02906670|81365191|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
27872216|NCT02906670|81365192|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
27872217|NCT02906670|81365193|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
27872218|NCT02906670|81365194|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
27872219|NCT02906670|81365195|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
27872220|NCT02906670|81365196|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
27679538|NCT03149549|80664361|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27679539|NCT03149549|80664362|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27872221|NCT02906670|81365197|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
27872222|NCT02906670|81365198|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
27872223|NCT02906670|81365199|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
27872224|NCT02906670|81365200|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
27872225|NCT02906670|81365191|FG000|Cohort 4P, QW|Radiological Progression|0|||
27872226|NCT02906670|81365192|FG001|Cohort 4P, QW|Radiological Progression|0|||
27872227|NCT02906670|81365193|FG002|Cohort 4P, QW|Radiological Progression|0|||
27872228|NCT02906670|81365194|FG003|Cohort 4P, QW|Radiological Progression|3|||
27872229|NCT02906670|81365195|FG004|Cohort 4P, QW|Radiological Progression|0|||
27995462|NCT00713544|81811356|FG005|Overall Study|Adverse Event|5|||
27995463|NCT00713544|81811351|FG000|Overall Study|Withdrawal by Subject|2|||
27995464|NCT00713544|81811352|FG001|Overall Study|Withdrawal by Subject|0|||
27995465|NCT00713544|81811353|FG002|Overall Study|Withdrawal by Subject|3|||
27995466|NCT00713544|81811354|FG003|Overall Study|Withdrawal by Subject|2|||
27995467|NCT00713544|81811355|FG004|Overall Study|Withdrawal by Subject|3|||
27995468|NCT00713544|81811356|FG005|Overall Study|Withdrawal by Subject|1|||
27995469|NCT00713544|81811351|FG000|Overall Study|Protocol Violation|0|||
27995470|NCT00713544|81811352|FG001|Overall Study|Protocol Violation|0|||
27995471|NCT00713544|81811353|FG002|Overall Study|Protocol Violation|0|||
27995472|NCT00713544|81811354|FG003|Overall Study|Protocol Violation|0|||
27995473|NCT00713544|81811355|FG004|Overall Study|Protocol Violation|0|||
27995474|NCT00713544|81811356|FG005|Overall Study|Protocol Violation|1|||
27995475|NCT00713544|81811351|FG000|Overall Study|Physician Decision|0|||
27995476|NCT00713544|81811352|FG001|Overall Study|Physician Decision|0|||
27995477|NCT00713544|81811353|FG002|Overall Study|Physician Decision|0|||
27995478|NCT00713544|81811354|FG003|Overall Study|Physician Decision|0|||
27995479|NCT00713544|81811355|FG004|Overall Study|Physician Decision|0|||
27995480|NCT00713544|81811356|FG005|Overall Study|Physician Decision|2|||
27679540|NCT03149549|80664363|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
27872230|NCT02906670|81365196|FG005|Cohort 4P, QW|Radiological Progression|0|||
27872231|NCT02906670|81365197|FG006|Cohort 4P, QW|Radiological Progression|0|||
27872232|NCT02906670|81365198|FG007|Cohort 4P, QW|Radiological Progression|0|||
27872233|NCT02906670|81365199|FG008|Cohort 4P, QW|Radiological Progression|0|||
27995481|NCT00713544|81811351|FG000|Overall Study|Lack of Efficacy|0|||
27995482|NCT00713544|81811352|FG001|Overall Study|Lack of Efficacy|1|||
27579628|NCT00194012|80306638|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
27872234|NCT02906670|81365200|FG009|Cohort 4P, QW|Radiological Progression|0|||
27995483|NCT00713544|81811353|FG002|Overall Study|Lack of Efficacy|0|||
27995484|NCT00713544|81811354|FG003|Overall Study|Lack of Efficacy|1|||
27995485|NCT00713544|81811355|FG004|Overall Study|Lack of Efficacy|1|||
27995486|NCT00713544|81811356|FG005|Overall Study|Lack of Efficacy|0|||
27995487|NCT00713544|81811351|FG000|Overall Study|Lost to Follow-up|0|||
27579629|NCT00194012|80306639|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
27579630|NCT00194012|80306638|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
27802859|NCT02059187|81108027|FG000|Overall Study|Protocol Violation|1|||
27802860|NCT02059187|81108028|FG001|Overall Study|Protocol Violation|0|||
27995488|NCT00713544|81811352|FG001|Overall Study|Lost to Follow-up|0|||
27995489|NCT00713544|81811353|FG002|Overall Study|Lost to Follow-up|1|||
27995490|NCT00713544|81811354|FG003|Overall Study|Lost to Follow-up|0|||
27995491|NCT00713544|81811355|FG004|Overall Study|Lost to Follow-up|0|||
27995492|NCT00713544|81811356|FG005|Overall Study|Lost to Follow-up|0|||
27995493|NCT00713544|81811351|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
27995494|NCT00713544|81811352|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
27995495|NCT00713544|81811353|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
27995496|NCT00713544|81811354|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
27995497|NCT00713544|81811355|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
27995498|NCT00713544|81811356|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
27995499|NCT00713544|81811351|FG000|Overall Study|Incorrect enrollment|0|||
27995500|NCT00713544|81811352|FG001|Overall Study|Incorrect enrollment|1|||
27995501|NCT00713544|81811353|FG002|Overall Study|Incorrect enrollment|0|||
27995502|NCT00713544|81811354|FG003|Overall Study|Incorrect enrollment|0|||
27995503|NCT00713544|81811355|FG004|Overall Study|Incorrect enrollment|0|||
27995504|NCT00713544|81811356|FG005|Overall Study|Incorrect enrollment|0|||
27995505|NCT00713544|81811351|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
27995506|NCT00713544|81811352|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
27995507|NCT00713544|81811353|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
27995508|NCT00713544|81811354|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
27995509|NCT00713544|81811355|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
27995510|NCT00713544|81811356|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
27995511|NCT01685697|81811357|FG000|Overall Study|Protocol Violation|3|||
27995512|NCT01685697|81811358|FG001|Overall Study|Protocol Violation|3|||
27995513|NCT01502228|81811359|FG000|Overall Study|Death|1|||
27995514|NCT00132808|81811362|FG000|Stratum I|Adverse Event|2|||
27995515|NCT00132808|81811363|FG001|Stratum I|Adverse Event|1|||
27995516|NCT00132808|81811364|FG002|Stratum I|Adverse Event|0|||
27995517|NCT00132808|81811362|FG000|Stratum I|Lost to Follow-up|3|||
27995518|NCT00132808|81811363|FG001|Stratum I|Lost to Follow-up|4|||
27995519|NCT00132808|81811364|FG002|Stratum I|Lost to Follow-up|1|||
27995520|NCT00132808|81811362|FG000|Stratum I|Withdrawal by Subject|4|||
27995521|NCT00132808|81811363|FG001|Stratum I|Withdrawal by Subject|7|||
27995522|NCT00132808|81811364|FG002|Stratum I|Withdrawal by Subject|3|||
27802861|NCT02059187|81108027|FG000|Overall Study|Withdrawal by Subject|12|||
27802862|NCT02059187|81108028|FG001|Overall Study|Withdrawal by Subject|8|||
27802863|NCT01358708|81108031|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
27802864|NCT01358708|81108032|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27802865|NCT01358708|81108031|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
27802866|NCT01358708|81108032|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
27802867|NCT01160198|81108035|FG000|Overall Study|Withdrawal by Subject|2|||
27802868|NCT01160198|81108036|FG001|Overall Study|Withdrawal by Subject|1|||
27802869|NCT01160198|81108037|FG002|Overall Study|Withdrawal by Subject|0|||
27802870|NCT01160198|81108035|FG000|Overall Study|Adverse Event|0|||
27802871|NCT01160198|81108036|FG001|Overall Study|Adverse Event|1|||
27802872|NCT01160198|81108037|FG002|Overall Study|Adverse Event|0|||
27802873|NCT01160198|81108035|FG000|Overall Study|Lost to Follow-up|0|||
27802874|NCT01160198|81108036|FG001|Overall Study|Lost to Follow-up|1|||
27802875|NCT01160198|81108037|FG002|Overall Study|Lost to Follow-up|0|||
27802876|NCT01160198|81108035|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
27802877|NCT01160198|81108036|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
27995523|NCT00132808|81811362|FG000|Stratum I|Abnormal test procedure result (s)|0|||
27802878|NCT01160198|81108037|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
27802879|NCT01829295|81108038|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
27995524|NCT00132808|81811363|FG001|Stratum I|Abnormal test procedure result (s)|0|||
27995525|NCT00132808|81811364|FG002|Stratum I|Abnormal test procedure result (s)|1|||
27995526|NCT00132808|81811362|FG000|Stratum II|Adverse Event|1|||
27995527|NCT00132808|81811363|FG001|Stratum II|Adverse Event|2|||
27995528|NCT00132808|81811364|FG002|Stratum II|Adverse Event|1|||
27802880|NCT01829295|81108039|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
27802881|NCT01829295|81108040|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
27802882|NCT01829295|81108041|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
27802883|NCT01829295|81108038|FG000|6-12 Months|Adverse Event|0|||
27802884|NCT01829295|81108039|FG001|6-12 Months|Adverse Event|0|||
27802885|NCT01829295|81108040|FG002|6-12 Months|Adverse Event|3|||
27802886|NCT01829295|81108041|FG003|6-12 Months|Adverse Event|2|||
27802887|NCT01829295|81108038|FG000|6-12 Months|Lost to Follow-up|2|||
27995529|NCT00132808|81811362|FG000|Stratum II|Death|1|||
27995530|NCT00132808|81811363|FG001|Stratum II|Death|0|||
27995531|NCT00132808|81811364|FG002|Stratum II|Death|0|||
27995532|NCT00132808|81811362|FG000|Stratum II|Lost to Follow-up|2|||
27995533|NCT00132808|81811363|FG001|Stratum II|Lost to Follow-up|2|||
27995534|NCT00132808|81811364|FG002|Stratum II|Lost to Follow-up|1|||
27995535|NCT00132808|81811362|FG000|Stratum II|Protocol Violation|0|||
27995536|NCT00132808|81811363|FG001|Stratum II|Protocol Violation|2|||
27995537|NCT00132808|81811364|FG002|Stratum II|Protocol Violation|1|||
27995538|NCT00132808|81811362|FG000|Stratum II|Withdrawal by Subject|4|||
27995539|NCT00132808|81811363|FG001|Stratum II|Withdrawal by Subject|9|||
27995540|NCT00132808|81811364|FG002|Stratum II|Withdrawal by Subject|6|||
27995541|NCT02652260|81811365|FG000|Overall Study|Pregnancy|0|||
27995542|NCT02652260|81811366|FG001|Overall Study|Pregnancy|1|||
27995543|NCT02652260|81811365|FG000|Overall Study|Withdrawal by Subject|0|||
27995544|NCT02652260|81811366|FG001|Overall Study|Withdrawal by Subject|1|||
27995545|NCT03831100|81811369|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
27995546|NCT03831100|81811370|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
27995547|NCT00434642|81811371|FG000|Blinded Treatment Phase|Adverse Event|12|||
27802888|NCT01829295|81108039|FG001|6-12 Months|Lost to Follow-up|0|||
27872235|NCT02906670|81365191|FG000|Cohort 7P, Q2W|Adverse Event|0|||
27995548|NCT00434642|81811372|FG001|Blinded Treatment Phase|Adverse Event|58|||
27802889|NCT01829295|81108040|FG002|6-12 Months|Lost to Follow-up|0|||
27802890|NCT01829295|81108041|FG003|6-12 Months|Lost to Follow-up|0|||
27995549|NCT00434642|81811371|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
27995550|NCT00434642|81811372|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
27995551|NCT00434642|81811371|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
27995552|NCT00434642|81811372|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
27802891|NCT01829295|81108038|FG000|6-12 Months|Withdrawal by Subject|2|||
27802892|NCT01829295|81108039|FG001|6-12 Months|Withdrawal by Subject|2|||
27802893|NCT01829295|81108040|FG002|6-12 Months|Withdrawal by Subject|0|||
27802894|NCT01829295|81108041|FG003|6-12 Months|Withdrawal by Subject|0|||
27802895|NCT01493531|81108042|FG000|Overall Study|Adverse Event|4|||
27802896|NCT01493531|81108043|FG001|Overall Study|Adverse Event|12|||
27802897|NCT01493531|81108044|FG002|Overall Study|Adverse Event|9|||
27802898|NCT01493531|81108042|FG000|Overall Study|Gout flare|3|||
27802899|NCT01493531|81108043|FG001|Overall Study|Gout flare|0|||
27802900|NCT01493531|81108044|FG002|Overall Study|Gout flare|2|||
27802901|NCT01493531|81108042|FG000|Overall Study|Protocol Violation|8|||
27802902|NCT01493531|81108043|FG001|Overall Study|Protocol Violation|15|||
27802903|NCT01493531|81108044|FG002|Overall Study|Protocol Violation|12|||
27802904|NCT01493531|81108042|FG000|Overall Study|Sponsor terminated study|5|||
27802905|NCT01493531|81108043|FG001|Overall Study|Sponsor terminated study|2|||
27802906|NCT01493531|81108044|FG002|Overall Study|Sponsor terminated study|3|||
27802907|NCT01493531|81108042|FG000|Overall Study|Lost to Follow-up|5|||
27802908|NCT01493531|81108043|FG001|Overall Study|Lost to Follow-up|7|||
27802909|NCT01493531|81108044|FG002|Overall Study|Lost to Follow-up|11|||
27802910|NCT01493531|81108042|FG000|Overall Study|Withdrawal by Subject|16|||
27802911|NCT01493531|81108043|FG001|Overall Study|Withdrawal by Subject|13|||
27995553|NCT00434642|81811371|FG000|Blinded Treatment Phase|Physician Decision|19|||
27995554|NCT00434642|81811372|FG001|Blinded Treatment Phase|Physician Decision|27|||
27995555|NCT00434642|81811371|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
27995556|NCT00434642|81811372|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
27995557|NCT00434642|81811371|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
27995558|NCT00434642|81811372|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
27995559|NCT00434642|81811371|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
27995560|NCT00434642|81811372|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
27995561|NCT00434642|81811371|FG000|Open-label Treatment Phase|Adverse Event|0|||
27995562|NCT00434642|81811372|FG001|Open-label Treatment Phase|Adverse Event|5|||
27995563|NCT00434642|81811371|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
27995564|NCT00434642|81811372|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
27995565|NCT02291419|81811375|FG000|Overall Study|Early study termination|1|||
27995566|NCT02291419|81811376|FG001|Overall Study|Early study termination|5|||
27995567|NCT01550757|81811377|FG000|Overall Study|Lost to Follow-up|21|||
27995568|NCT01550757|81811378|FG001|Overall Study|Lost to Follow-up|14|||
27995569|NCT01550757|81811379|FG002|Overall Study|Lost to Follow-up|42|||
27995570|NCT01550757|81811380|FG003|Overall Study|Lost to Follow-up|53|||
27802912|NCT01493531|81108044|FG002|Overall Study|Withdrawal by Subject|11|||
27995571|NCT01550757|81811377|FG000|Overall Study|Withdrawal by Subject|2|||
27579631|NCT00194012|80306639|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
27802913|NCT01493531|81108042|FG000|Overall Study|Death|0|||
27802914|NCT01493531|81108043|FG001|Overall Study|Death|1|||
27802915|NCT01493531|81108044|FG002|Overall Study|Death|0|||
27802916|NCT02766400|81108051|FG000|Overall Study|Death|1|||
27802917|NCT02766400|81108052|FG001|Overall Study|Death|2|||
27802918|NCT02766400|81108051|FG000|Overall Study|Withdrawal by Subject|1|||
27802919|NCT02766400|81108052|FG001|Overall Study|Withdrawal by Subject|0|||
27802920|NCT00283686|81111334|FG000|Overall Study|Death|1|||
27802921|NCT00283686|81111335|FG001|Overall Study|Death|1|||
27802922|NCT00283686|81111336|FG002|Overall Study|Death|1|||
27802923|NCT00283686|81111337|FG003|Overall Study|Death|0|||
27579632|NCT01312961|80306642|FG000|Overall Study|Adverse Event|3|||
27872236|NCT02906670|81365192|FG001|Cohort 7P, Q2W|Adverse Event|0|||
27579633|NCT01312961|80306643|FG001|Overall Study|Adverse Event|3|||
27802924|NCT00283686|81111334|FG000|Overall Study|Lost to Follow-up|21|||
27802925|NCT00283686|81111335|FG001|Overall Study|Lost to Follow-up|31|||
27802926|NCT00283686|81111336|FG002|Overall Study|Lost to Follow-up|26|||
27802927|NCT00283686|81111337|FG003|Overall Study|Lost to Follow-up|20|||
27802928|NCT00283686|81111334|FG000|Overall Study|Less than full participation|7|||
27802929|NCT00283686|81111335|FG001|Overall Study|Less than full participation|9|||
27802930|NCT00283686|81111336|FG002|Overall Study|Less than full participation|6|||
27802931|NCT00283686|81111337|FG003|Overall Study|Less than full participation|12|||
27802932|NCT00569231|81111338|FG000|Overall Study|Study unrelated surgery|1|||
27802933|NCT00569231|81111338|FG000|Overall Study|Airfare expense|2|||
27802934|NCT00569231|81111338|FG000|Overall Study|Withdrawal by Subject|1|||
27802935|NCT00569231|81111338|FG000|Overall Study|Car accident injury|1|||
27872237|NCT02906670|81365193|FG002|Cohort 7P, Q2W|Adverse Event|0|||
27872238|NCT02906670|81365194|FG003|Cohort 7P, Q2W|Adverse Event|0|||
27872239|NCT02906670|81365195|FG004|Cohort 7P, Q2W|Adverse Event|0|||
27872240|NCT02906670|81365196|FG005|Cohort 7P, Q2W|Adverse Event|0|||
27872241|NCT02906670|81365197|FG006|Cohort 7P, Q2W|Adverse Event|0|||
27872242|NCT02906670|81365198|FG007|Cohort 7P, Q2W|Adverse Event|0|||
27872243|NCT02906670|81365199|FG008|Cohort 7P, Q2W|Adverse Event|0|||
27872244|NCT02906670|81365200|FG009|Cohort 7P, Q2W|Adverse Event|1|||
27872245|NCT02906670|81365191|FG000|Cohort 7P, Q2W|Physician Decision|0|||
27872246|NCT02906670|81365192|FG001|Cohort 7P, Q2W|Physician Decision|0|||
27872247|NCT02906670|81365193|FG002|Cohort 7P, Q2W|Physician Decision|0|||
27872248|NCT02906670|81365194|FG003|Cohort 7P, Q2W|Physician Decision|0|||
27995572|NCT01550757|81811378|FG001|Overall Study|Withdrawal by Subject|0|||
27995573|NCT01550757|81811379|FG002|Overall Study|Withdrawal by Subject|3|||
27995574|NCT01550757|81811380|FG003|Overall Study|Withdrawal by Subject|1|||
27995575|NCT03755882|81811381|FG000|Period 1|Protocol Violation|1|||
27995576|NCT03755882|81811382|FG001|Period 1|Protocol Violation|0|||
27995577|NCT03755882|81811381|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
27995578|NCT03755882|81811382|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
27995579|NCT01391663|81815426|FG000|Overall Study|Withdrawal by Subject|0|||
27802936|NCT00569231|81111338|FG000|Overall Study|Non-compliance|2|||
27802937|NCT01612702|81111340|FG000|Overall Study|Protocol Violation|11|||
27802938|NCT01612702|81111341|FG001|Overall Study|Protocol Violation|11|||
27802939|NCT01328054|81111342|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
27802940|NCT01328054|81111343|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
27802941|NCT01328054|81111342|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
27802942|NCT01328054|81111343|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
27802943|NCT01328054|81111342|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
27802944|NCT01328054|81111343|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
27802945|NCT00833547|81111348|FG000|Overall Study|Withdrawal by Subject|2|||
27802946|NCT00833547|81111349|FG001|Overall Study|Withdrawal by Subject|2|||
27802947|NCT01142466|81111352|FG000|Overall Study|Adverse Event|2|||
27802948|NCT01142466|81111353|FG001|Overall Study|Adverse Event|1|||
27802949|NCT01142466|81111352|FG000|Overall Study|Withdrawal by Subject|1|||
27802950|NCT01142466|81111353|FG001|Overall Study|Withdrawal by Subject|1|||
27802951|NCT00972153|81111360|FG000|Overall Study|Equipment malfunction during case|0|||
27995580|NCT01391663|81815427|FG001|Overall Study|Withdrawal by Subject|0|||
27995581|NCT01391663|81815428|FG002|Overall Study|Withdrawal by Subject|1|||
27995582|NCT01391663|81815429|FG003|Overall Study|Withdrawal by Subject|0|||
27579634|NCT01312961|80306642|FG000|Overall Study|Lack of Efficacy|11|||
27579635|NCT01312961|80306643|FG001|Overall Study|Lack of Efficacy|1|||
27802952|NCT00972153|81111361|FG001|Overall Study|Equipment malfunction during case|1|||
27802953|NCT00972153|81111362|FG002|Overall Study|Equipment malfunction during case|0|||
27802954|NCT04385199|81111369|FG000|Overall Study|Withdrawal by Subject|1|||
27802955|NCT04385199|81111370|FG001|Overall Study|Withdrawal by Subject|0|||
27802956|NCT01784419|81111371|FG000|Overall Study|Adverse Event|3|||
27872249|NCT02906670|81365195|FG004|Cohort 7P, Q2W|Physician Decision|0|||
27872250|NCT02906670|81365196|FG005|Cohort 7P, Q2W|Physician Decision|0|||
27872251|NCT02906670|81365197|FG006|Cohort 7P, Q2W|Physician Decision|0|||
27872252|NCT02906670|81365198|FG007|Cohort 7P, Q2W|Physician Decision|0|||
27872253|NCT02906670|81365199|FG008|Cohort 7P, Q2W|Physician Decision|0|||
27872254|NCT02906670|81365200|FG009|Cohort 7P, Q2W|Physician Decision|1|||
27802957|NCT01076166|81111376|FG000|Overall Study|Adverse Event|3|||
27872255|NCT02906670|81365191|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872256|NCT02906670|81365192|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27995583|NCT02489942|81815430|FG000|Overall Study|Request by patient|602|||
27995584|NCT02489942|81815430|FG000|Overall Study|Improvement/remission|157|||
27579636|NCT01312961|80306642|FG000|Overall Study|Poor compliance to protocol|1|||
27872257|NCT02906670|81365193|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872258|NCT02906670|81365194|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872259|NCT02906670|81365195|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872260|NCT02906670|81365196|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872261|NCT02906670|81365197|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872262|NCT02906670|81365198|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27872263|NCT02906670|81365199|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
27995585|NCT02489942|81815430|FG000|Overall Study|No change/Progressive disease|263|||
27995586|NCT02489942|81815430|FG000|Overall Study|Adverse Event|522|||
27995587|NCT02489942|81815430|FG000|Overall Study|Other personal reasons|1218|||
27995588|NCT02489942|81815430|FG000|Overall Study|Lost to Follow-up|456|||
27802958|NCT01076166|81111376|FG000|Overall Study|Symptoms improved/resolved|6|||
27802959|NCT00736099|81111377|FG000|Overall Study|Adverse Event|61|||
27802960|NCT00736099|81111378|FG001|Overall Study|Adverse Event|18|||
27802961|NCT00736099|81111377|FG000|Overall Study|Protocol Violation|10|||
27802962|NCT00736099|81111378|FG001|Overall Study|Protocol Violation|4|||
27802963|NCT00736099|81111377|FG000|Overall Study|Lost to Follow-up|12|||
27802964|NCT00736099|81111378|FG001|Overall Study|Lost to Follow-up|5|||
27802965|NCT00736099|81111377|FG000|Overall Study|Withdrawal by Subject|42|||
27802966|NCT00736099|81111378|FG001|Overall Study|Withdrawal by Subject|13|||
27802967|NCT00736099|81111377|FG000|Overall Study|Lack of Efficacy|15|||
27802968|NCT00736099|81111378|FG001|Overall Study|Lack of Efficacy|8|||
27802969|NCT00736099|81111377|FG000|Overall Study|Other reason|43|||
27802970|NCT00736099|81111378|FG001|Overall Study|Other reason|10|||
27995589|NCT02489942|81815430|FG000|Overall Study|Not continuously investigated|7|||
27995590|NCT02489942|81815430|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
27995591|NCT02489942|81815430|FG000|Overall Study|Multiple registration|1|||
27995592|NCT02489942|81815430|FG000|Overall Study|No patient visit after entry|100|||
27995593|NCT02489942|81815430|FG000|Overall Study|No treatment with Jardiance|2|||
27995594|NCT02489942|81815430|FG000|Overall Study|Patient received Jardiance before registration|1|||
27995595|NCT02489942|81815430|FG000|Overall Study|No CRF collected|86|||
27995596|NCT02644343|81815435|FG000|Overall Study|Withdrawal by Subject|1|||
27995597|NCT01136408|81815436|FG000|Overall Study|Adverse Event|4|||
27995598|NCT01136408|81815437|FG001|Overall Study|Adverse Event|8|||
27995599|NCT01136408|81815438|FG002|Overall Study|Adverse Event|4|||
27995600|NCT01136408|81815436|FG000|Overall Study|Protocol Violation|1|||
27995601|NCT01136408|81815437|FG001|Overall Study|Protocol Violation|1|||
27995602|NCT01136408|81815438|FG002|Overall Study|Protocol Violation|1|||
27995603|NCT00226811|81815439|FG000|Overall Study|Death|8|||
27995604|NCT00226811|81815439|FG000|Overall Study|Adverse Event|11|||
27995605|NCT00226811|81815439|FG000|Overall Study|Lack of Efficacy|55|||
27995606|NCT00226811|81815439|FG000|Overall Study|Withdrawal by Subject|2|||
27995607|NCT00853151|81815440|FG000|Overall Study|Adverse Event|1|||
27995608|NCT00853151|81815441|FG001|Overall Study|Adverse Event|4|||
27995609|NCT00853151|81815442|FG002|Overall Study|Adverse Event|2|||
27995610|NCT00853151|81815443|FG003|Overall Study|Adverse Event|0|||
27995611|NCT00853151|81815440|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27995612|NCT00853151|81815441|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27995613|NCT00853151|81815442|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27995614|NCT00853151|81815443|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27995615|NCT00853151|81815440|FG000|Overall Study|Lost to Follow-up|2|||
27995616|NCT00853151|81815441|FG001|Overall Study|Lost to Follow-up|0|||
27995617|NCT00853151|81815442|FG002|Overall Study|Lost to Follow-up|3|||
27995618|NCT00853151|81815443|FG003|Overall Study|Lost to Follow-up|0|||
27995619|NCT00853151|81815440|FG000|Overall Study|Death|1|||
27995620|NCT00853151|81815441|FG001|Overall Study|Death|0|||
27995621|NCT00853151|81815442|FG002|Overall Study|Death|0|||
27995622|NCT00853151|81815443|FG003|Overall Study|Death|1|||
27995623|NCT00853151|81815440|FG000|Overall Study|Protocol Violation|0|||
27995624|NCT00853151|81815441|FG001|Overall Study|Protocol Violation|0|||
27995625|NCT00853151|81815442|FG002|Overall Study|Protocol Violation|0|||
27995626|NCT00853151|81815443|FG003|Overall Study|Protocol Violation|1|||
27995627|NCT00853151|81815440|FG000|Overall Study|Withdrawal by Subject|5|||
27995628|NCT00853151|81815441|FG001|Overall Study|Withdrawal by Subject|4|||
27579637|NCT01312961|80306643|FG001|Overall Study|Poor compliance to protocol|0|||
27579638|NCT01312961|80306642|FG000|Overall Study|Other than specified above|2|||
27995629|NCT00853151|81815442|FG002|Overall Study|Withdrawal by Subject|2|||
27995630|NCT00853151|81815443|FG003|Overall Study|Withdrawal by Subject|1|||
27802971|NCT04060654|81111379|FG000|Overall Study|Withdrawal by Subject|1|||
27802972|NCT04060654|81111379|FG000|Overall Study|Lost to Follow-up|5|||
27802973|NCT02482571|81111380|FG000|Overall Study|Adverse Event|1|||
27802974|NCT02482571|81111380|FG000|Overall Study|Scanner or Respiract failure|3|||
27995631|NCT00853151|81815440|FG000|Overall Study|Physician Decision|0|||
27995632|NCT00853151|81815441|FG001|Overall Study|Physician Decision|2|||
27995633|NCT00853151|81815442|FG002|Overall Study|Physician Decision|1|||
27995634|NCT00853151|81815443|FG003|Overall Study|Physician Decision|0|||
27802975|NCT02482571|81111380|FG000|Overall Study|Withdrawal by Subject|4|||
27802976|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
27802977|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
27802978|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
27802979|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
27802980|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
27802981|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
27679541|NCT03149549|80664351|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679542|NCT03149549|80664352|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679543|NCT03149549|80664353|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679544|NCT03149549|80664354|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27802982|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
27802983|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
27802984|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
27679545|NCT03149549|80664355|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
27679546|NCT03149549|80664356|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679547|NCT03149549|80664357|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679548|NCT03149549|80664358|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
27802985|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
27802986|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
27802987|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
27802988|NCT01600014|81111381|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
27802989|NCT01600014|81111382|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
27802990|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
27802991|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
27802992|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
27802993|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
27802994|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
27802995|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
27802996|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
27802997|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
27802998|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
27802999|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
27803000|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
27803001|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
27803002|NCT01600014|81111381|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
27803003|NCT01600014|81111382|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
27803004|NCT01600014|81111381|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
27803005|NCT01600014|81111382|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
27803006|NCT01600014|81111381|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
27803007|NCT01600014|81111382|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
27803008|NCT01600014|81111381|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
27803009|NCT01600014|81111382|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
27803010|NCT01255722|81111386|FG000|Overall Study|Adverse Event|0|||
27995635|NCT00853151|81815440|FG000|Overall Study|Sponsor Decision|0|||
27995636|NCT00853151|81815441|FG001|Overall Study|Sponsor Decision|3|||
27995637|NCT00853151|81815442|FG002|Overall Study|Sponsor Decision|0|||
27803011|NCT01255722|81111387|FG001|Overall Study|Adverse Event|1|||
27995638|NCT00853151|81815443|FG003|Overall Study|Sponsor Decision|0|||
27995639|NCT04327024|81815446|FG000|Overall Study|Death|1|||
27995640|NCT04327024|81815447|FG001|Overall Study|Death|2|||
27995641|NCT04327024|81815448|FG002|Overall Study|Death|1|||
27995642|NCT04327024|81815446|FG000|Overall Study|Non-compliance with study drug|0|||
27995643|NCT04327024|81815447|FG001|Overall Study|Non-compliance with study drug|1|||
27803012|NCT01255722|81111388|FG002|Overall Study|Adverse Event|1|||
27803013|NCT01255722|81111386|FG000|Overall Study|asymptomatic patient|1|||
27803014|NCT01255722|81111387|FG001|Overall Study|asymptomatic patient|0|||
27803015|NCT01255722|81111388|FG002|Overall Study|asymptomatic patient|0|||
27803016|NCT01255722|81111386|FG000|Overall Study|beta-blocker contraindicated|2|||
27803017|NCT01255722|81111387|FG001|Overall Study|beta-blocker contraindicated|0|||
27803018|NCT01255722|81111388|FG002|Overall Study|beta-blocker contraindicated|0|||
27803019|NCT00457665|81111389|FG000|12 Months|Drug allergy|1|||
27872264|NCT02906670|81365200|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
27995644|NCT04327024|81815448|FG002|Overall Study|Non-compliance with study drug|0|||
27579639|NCT01312961|80306643|FG001|Overall Study|Other than specified above|3|||
27579640|NCT02041429|80306644|FG000|Overall Study|Progressive Disease|2|||
27579641|NCT02041429|80306645|FG001|Overall Study|Progressive Disease|2|||
27579642|NCT02041429|80306646|FG002|Overall Study|Progressive Disease|3|||
27579643|NCT02041429|80306647|FG003|Overall Study|Progressive Disease|2|||
27579644|NCT02041429|80306644|FG000|Overall Study|Toxicity|0|||
27579645|NCT02041429|80306645|FG001|Overall Study|Toxicity|1|||
27579646|NCT02041429|80306646|FG002|Overall Study|Toxicity|4|||
27579647|NCT02041429|80306647|FG003|Overall Study|Toxicity|2|||
27579648|NCT02041429|80306644|FG000|Overall Study|Withdrawal by Subject|0|||
27579649|NCT02041429|80306645|FG001|Overall Study|Withdrawal by Subject|1|||
27579650|NCT02041429|80306646|FG002|Overall Study|Withdrawal by Subject|0|||
27579651|NCT02041429|80306647|FG003|Overall Study|Withdrawal by Subject|0|||
27579652|NCT02041429|80306644|FG000|Overall Study|On Maintenance Therapy|1|||
27579653|NCT02041429|80306645|FG001|Overall Study|On Maintenance Therapy|0|||
27579654|NCT02041429|80306646|FG002|Overall Study|On Maintenance Therapy|0|||
27579655|NCT02041429|80306647|FG003|Overall Study|On Maintenance Therapy|2|||
27579656|NCT03169153|80306650|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
27579657|NCT03169153|80306651|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
27579658|NCT03169153|80306650|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
27579659|NCT03169153|80306651|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
27579660|NCT03169153|80306650|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
27579661|NCT03169153|80306651|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
27579662|NCT03169153|80306650|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
27579663|NCT03169153|80306651|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
27579664|NCT02664038|80306658|FG000|13 Week|Lost to Follow-up|7|||
27579665|NCT02664038|80306659|FG001|13 Week|Lost to Follow-up|14|||
27579666|NCT02664038|80306658|FG000|13 Week|Withdrawal by Subject|1|||
27579667|NCT02664038|80306659|FG001|13 Week|Withdrawal by Subject|0|||
27579668|NCT02664038|80306658|FG000|26 Week|Lost to Follow-up|5|||
27579669|NCT02664038|80306659|FG001|26 Week|Lost to Follow-up|4|||
27579670|NCT04394351|80306660|FG000|Part A (16 Weeks)|Adverse Event|1|||
27579671|NCT04394351|80306661|FG001|Part A (16 Weeks)|Adverse Event|0|||
27579672|NCT04394351|80306662|FG002|Part A (16 Weeks)|Adverse Event|0|||
27579673|NCT04394351|80306663|FG003|Part A (16 Weeks)|Adverse Event|0|||
27579674|NCT04394351|80306664|FG004|Part A (16 Weeks)|Adverse Event|0|||
27579675|NCT04394351|80306665|FG005|Part A (16 Weeks)|Adverse Event|0|||
27579676|NCT04394351|80306666|FG006|Part A (16 Weeks)|Adverse Event|0|||
27579677|NCT04394351|80306667|FG007|Part A (16 Weeks)|Adverse Event|0|||
27579678|NCT04394351|80306660|FG000|Part A (16 Weeks)|Physician Decision|0|||
27579679|NCT04394351|80306661|FG001|Part A (16 Weeks)|Physician Decision|1|||
27579680|NCT04394351|80306662|FG002|Part A (16 Weeks)|Physician Decision|0|||
27579681|NCT04394351|80306663|FG003|Part A (16 Weeks)|Physician Decision|0|||
27579682|NCT04394351|80306664|FG004|Part A (16 Weeks)|Physician Decision|0|||
27579683|NCT04394351|80306665|FG005|Part A (16 Weeks)|Physician Decision|0|||
27579684|NCT04394351|80306666|FG006|Part A (16 Weeks)|Physician Decision|0|||
27579685|NCT04394351|80306667|FG007|Part A (16 Weeks)|Physician Decision|0|||
27579686|NCT04394351|80306660|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579687|NCT04394351|80306661|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
27803020|NCT00457665|81111390|FG001|12 Months|Drug allergy|1|||
27803021|NCT00457665|81111389|FG000|12 Months|High HIV viral load|5|||
27803022|NCT00457665|81111390|FG001|12 Months|High HIV viral load|1|||
27803023|NCT00457665|81111389|FG000|12 Months|Lipodystrophy|2|||
27995645|NCT04327024|81815446|FG000|Overall Study|Withdrawal by Subject|1|||
27995646|NCT04327024|81815447|FG001|Overall Study|Withdrawal by Subject|1|||
27995647|NCT04327024|81815448|FG002|Overall Study|Withdrawal by Subject|2|||
27995648|NCT02223715|81815449|FG000|Overall Study|Death|31|||
27995649|NCT02223715|81815449|FG000|Overall Study|Lost to Follow-up|73|||
27995650|NCT02630472|81815450|FG000|Overall Study|Physician Decision|10|||
27995651|NCT02630472|81815451|FG001|Overall Study|Physician Decision|0|||
27995652|NCT01514201|81815452|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
27995653|NCT01514201|81815453|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27995654|NCT01514201|81815454|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27995655|NCT01514201|81815455|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27995656|NCT01514201|81815452|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27995657|NCT01514201|81815453|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
27579688|NCT04394351|80306662|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579689|NCT04394351|80306663|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579690|NCT04394351|80306664|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579691|NCT04394351|80306665|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579692|NCT04394351|80306666|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579693|NCT04394351|80306667|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
27579694|NCT04394351|80306660|FG000|Part B (36 Weeks)|Adverse Event|0|||
27579695|NCT04394351|80306661|FG001|Part B (36 Weeks)|Adverse Event|0|||
27579696|NCT04394351|80306662|FG002|Part B (36 Weeks)|Adverse Event|0|||
27579697|NCT04394351|80306663|FG003|Part B (36 Weeks)|Adverse Event|0|||
27579698|NCT04394351|80306664|FG004|Part B (36 Weeks)|Adverse Event|0|||
27579699|NCT04394351|80306665|FG005|Part B (36 Weeks)|Adverse Event|0|||
27579700|NCT04394351|80306666|FG006|Part B (36 Weeks)|Adverse Event|1|||
27579701|NCT04394351|80306667|FG007|Part B (36 Weeks)|Adverse Event|0|||
27579702|NCT00774787|80306668|FG000|Overall Study|Lost to Follow-up|1|||
27579703|NCT01243944|80306675|FG000|Overall Study|Adverse Event|15|||
27579704|NCT01243944|80306676|FG001|Overall Study|Adverse Event|13|||
27579705|NCT01243944|80306675|FG000|Overall Study|Lost to Follow-up|2|||
27579706|NCT01243944|80306676|FG001|Overall Study|Lost to Follow-up|1|||
27579707|NCT01243944|80306675|FG000|Overall Study|Physician Decision|2|||
27579708|NCT01243944|80306676|FG001|Overall Study|Physician Decision|7|||
27579709|NCT01243944|80306675|FG000|Overall Study|Disease progression|12|||
27579710|NCT01243944|80306676|FG001|Overall Study|Disease progression|11|||
27579711|NCT01243944|80306675|FG000|Overall Study|Protocol deviation|1|||
27579712|NCT01243944|80306676|FG001|Overall Study|Protocol deviation|1|||
27579713|NCT01243944|80306675|FG000|Overall Study|Participant decision|10|||
27579714|NCT01243944|80306676|FG001|Overall Study|Participant decision|15|||
27579715|NCT01243944|80306675|FG000|Overall Study|Death|2|||
27579716|NCT01243944|80306676|FG001|Overall Study|Death|3|||
27579717|NCT01243944|80306675|FG000|Overall Study|Non-compliance with study treatment|1|||
27579718|NCT01243944|80306676|FG001|Overall Study|Non-compliance with study treatment|0|||
27579719|NCT01816139|80306678|FG000|Overall Study|Adverse Event|6|||
27579720|NCT01816139|80306679|FG001|Overall Study|Adverse Event|8|||
27995658|NCT01514201|81815454|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
27995659|NCT01514201|81815455|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27995660|NCT01514201|81815452|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
27995661|NCT01514201|81815453|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
27995662|NCT01514201|81815454|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
27995663|NCT01514201|81815455|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27995664|NCT01514201|81815452|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
27995665|NCT01514201|81815453|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
27995666|NCT01514201|81815454|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27995667|NCT01514201|81815455|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27995668|NCT01514201|81815452|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
27995669|NCT01514201|81815453|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
27995670|NCT01514201|81815454|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
27995671|NCT01514201|81815455|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
27995672|NCT01514201|81815452|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
27995673|NCT01514201|81815453|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
27995674|NCT01514201|81815454|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
27579721|NCT01816139|80306678|FG000|Overall Study|Lack of Efficacy|1|||
27579722|NCT01816139|80306679|FG001|Overall Study|Lack of Efficacy|2|||
27579723|NCT01816139|80306678|FG000|Overall Study|Lost to Follow-up|5|||
27579724|NCT01816139|80306679|FG001|Overall Study|Lost to Follow-up|3|||
27579725|NCT01816139|80306678|FG000|Overall Study|Withdrew Consent|6|||
27579726|NCT01816139|80306679|FG001|Overall Study|Withdrew Consent|4|||
27579727|NCT01816139|80306678|FG000|Overall Study|Protocol Violation|6|||
27579728|NCT01816139|80306679|FG001|Overall Study|Protocol Violation|3|||
27579729|NCT01816139|80306678|FG000|Overall Study|Reason not Specified|4|||
27579730|NCT01816139|80306679|FG001|Overall Study|Reason not Specified|2|||
27803024|NCT00457665|81111390|FG001|12 Months|Lipodystrophy|0|||
27803025|NCT00457665|81111389|FG000|12 Months|Withdrawal by Subject|0|||
27803026|NCT00457665|81111390|FG001|12 Months|Withdrawal by Subject|2|||
27995675|NCT01514201|81815455|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
27995676|NCT01514201|81815452|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
27995677|NCT01514201|81815453|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
27995678|NCT01514201|81815454|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
27995679|NCT01514201|81815455|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
27995680|NCT01514201|81815452|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27995681|NCT01514201|81815453|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27995682|NCT01514201|81815454|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
27995683|NCT01514201|81815455|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
27995684|NCT01514201|81815452|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
27995685|NCT01514201|81815453|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
27995686|NCT01514201|81815454|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
27995687|NCT01514201|81815455|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
27995688|NCT01514201|81815452|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27995689|NCT01514201|81815453|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27995690|NCT01514201|81815454|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
27995691|NCT01514201|81815455|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
27995692|NCT01514201|81815452|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27995693|NCT01514201|81815453|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27995694|NCT01514201|81815454|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
27995695|NCT01514201|81815455|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
27995696|NCT01514201|81815452|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27995697|NCT01514201|81815453|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27995698|NCT01514201|81815454|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
27995699|NCT01514201|81815455|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
27995700|NCT01487265|81815456|FG000|Overall Study|Adverse Event|8|||
27995701|NCT01487265|81815456|FG000|Overall Study|Withdrawal by Subject|5|||
27803027|NCT00457665|81111389|FG000|12 Months|Abnormal Liver function tests|0|||
27803028|NCT00457665|81111390|FG001|12 Months|Abnormal Liver function tests|5|||
27995702|NCT01487265|81815456|FG000|Overall Study|Disease Progression|21|||
27995703|NCT01487265|81815456|FG000|Overall Study|Death|2|||
27995704|NCT01487265|81815456|FG000|Overall Study|Still on Treatment|1|||
27803029|NCT00457665|81111389|FG000|24 Months|Withdrawal by Subject|3|||
27803030|NCT00457665|81111390|FG001|24 Months|Withdrawal by Subject|2|||
27995705|NCT02255461|81815459|FG000|Overall Study|Adverse Event|0|||
27579731|NCT01940705|80306680|FG000|Overall Study|Lost to Follow-up|1|||
27995706|NCT02255461|81815460|FG001|Overall Study|Adverse Event|1|||
27803031|NCT00457665|81111389|FG000|24 Months|Lipodystrophy|1|||
27803032|NCT00457665|81111390|FG001|24 Months|Lipodystrophy|1|||
27803033|NCT00457665|81111389|FG000|24 Months|Abnormal liver function tests|1|||
27803034|NCT00457665|81111390|FG001|24 Months|Abnormal liver function tests|5|||
27803035|NCT03056352|81111391|FG000|Overall Study|Lost to Follow-up|1|||
27803036|NCT02555618|81111392|FG000|Overall Study|Sponsor's Circumstances|1|||
27803037|NCT02555618|81111393|FG001|Overall Study|Sponsor's Circumstances|0|||
27803038|NCT00789828|81111394|FG000|Core Period (48 Weeks)|Administrative problems|0|||
27803039|NCT00789828|81111395|FG001|Core Period (48 Weeks)|Administrative problems|1|||
27803040|NCT00789828|81111394|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
27803041|NCT00789828|81111395|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
27803042|NCT00789828|81111394|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
27803043|NCT00789828|81111395|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
27803044|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
27803045|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
27803046|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
27995707|NCT02255461|81815461|FG002|Overall Study|Adverse Event|0|||
27803047|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
27803048|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
27995708|NCT02255461|81815462|FG003|Overall Study|Adverse Event|0|||
27803049|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
27803050|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
27995709|NCT02255461|81815463|FG004|Overall Study|Adverse Event|1|||
27995710|NCT02255461|81815459|FG000|Overall Study|Withdrawal by Subject|0|||
27995711|NCT02255461|81815460|FG001|Overall Study|Withdrawal by Subject|0|||
27995712|NCT02255461|81815461|FG002|Overall Study|Withdrawal by Subject|1|||
27995713|NCT02255461|81815462|FG003|Overall Study|Withdrawal by Subject|0|||
27995714|NCT02255461|81815463|FG004|Overall Study|Withdrawal by Subject|1|||
27995715|NCT02255461|81815459|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
27995716|NCT02255461|81815460|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
27995717|NCT02255461|81815461|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
27995718|NCT02255461|81815462|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
27872265|NCT02906670|81365191|FG000|Cohort 5P, QW|Radiological Progression|0|||
27995719|NCT02255461|81815463|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
27995720|NCT01797263|81815466|FG000|Overall Study|Withdrawal by Subject|21|||
27995721|NCT01797263|81815467|FG001|Overall Study|Withdrawal by Subject|25|||
27995722|NCT01797263|81815466|FG000|Overall Study|Death|1|||
27995723|NCT01797263|81815467|FG001|Overall Study|Death|0|||
27995724|NCT01797263|81815466|FG000|Overall Study|Lost to Follow-up|15|||
27995725|NCT01797263|81815467|FG001|Overall Study|Lost to Follow-up|15|||
27995726|NCT00871338|81815468|FG000|Prior to Booster|Withdrawal by Subject|1|||
27995727|NCT00871338|81815469|FG001|Prior to Booster|Withdrawal by Subject|3|||
27995728|NCT00871338|81815468|FG000|Prior to Booster|Lost to Follow-up|1|||
27995729|NCT00871338|81815469|FG001|Prior to Booster|Lost to Follow-up|0|||
27995730|NCT03600740|81815470|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
27995731|NCT01010971|81815471|FG000|Overall Study|Adverse Event|2|||
27995732|NCT01010971|81815472|FG001|Overall Study|Adverse Event|4|||
27995733|NCT01010971|81815473|FG002|Overall Study|Adverse Event|3|||
27995734|NCT01010971|81815471|FG000|Overall Study|Withdrawal by Subject|0|||
27995735|NCT01010971|81815472|FG001|Overall Study|Withdrawal by Subject|2|||
27995736|NCT01010971|81815473|FG002|Overall Study|Withdrawal by Subject|5|||
27995737|NCT01010971|81815471|FG000|Overall Study|Lost to Follow-up|0|||
27995738|NCT01010971|81815472|FG001|Overall Study|Lost to Follow-up|2|||
27995739|NCT01010971|81815473|FG002|Overall Study|Lost to Follow-up|3|||
27995740|NCT01010971|81815471|FG000|Overall Study|Other|1|||
27995741|NCT01010971|81815472|FG001|Overall Study|Other|0|||
27995742|NCT01010971|81815473|FG002|Overall Study|Other|2|||
27872266|NCT02906670|81365192|FG001|Cohort 5P, QW|Radiological Progression|0|||
27995743|NCT00891228|81815474|FG000|Overall Study|Adverse Event|0|||
27579732|NCT01940705|80306681|FG001|Overall Study|Lost to Follow-up|3|||
27803051|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
27803052|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|Death|1|||
27872267|NCT02906670|81365193|FG002|Cohort 5P, QW|Radiological Progression|0|||
27995744|NCT00891228|81815475|FG001|Overall Study|Adverse Event|2|||
27995745|NCT00891228|81815476|FG002|Overall Study|Adverse Event|3|||
27995746|NCT00891228|81815474|FG000|Overall Study|Withdrawal by Subject|2|||
27995747|NCT00891228|81815475|FG001|Overall Study|Withdrawal by Subject|4|||
27803053|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|Death|0|||
27803054|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
27803055|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
27803056|NCT00789828|81111394|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
27803057|NCT00789828|81111395|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
27803058|NCT03216954|81111397|FG000|Overall Study|Adverse Event|0|||
27803059|NCT03216954|81111398|FG001|Overall Study|Adverse Event|0|||
27803060|NCT03216954|81111399|FG002|Overall Study|Adverse Event|1|||
27803061|NCT03216954|81111400|FG003|Overall Study|Adverse Event|0|||
27803062|NCT03216954|81111401|FG004|Overall Study|Adverse Event|1|||
27803063|NCT03216954|81111397|FG000|Overall Study|Withdrawal by Subject|2|||
27803064|NCT03216954|81111398|FG001|Overall Study|Withdrawal by Subject|0|||
27803065|NCT03216954|81111399|FG002|Overall Study|Withdrawal by Subject|0|||
27803066|NCT03216954|81111400|FG003|Overall Study|Withdrawal by Subject|0|||
27995748|NCT00891228|81815476|FG002|Overall Study|Withdrawal by Subject|5|||
27995749|NCT00891228|81815474|FG000|Overall Study|Protocol Violation|3|||
27995750|NCT00891228|81815475|FG001|Overall Study|Protocol Violation|1|||
27995751|NCT00891228|81815476|FG002|Overall Study|Protocol Violation|2|||
27995752|NCT00891228|81815474|FG000|Overall Study|Physician Decision|2|||
27995753|NCT00891228|81815475|FG001|Overall Study|Physician Decision|1|||
27995754|NCT00891228|81815476|FG002|Overall Study|Physician Decision|0|||
27995755|NCT00891228|81815474|FG000|Overall Study|Lost to Follow-up|4|||
27995756|NCT00891228|81815475|FG001|Overall Study|Lost to Follow-up|4|||
27995757|NCT00891228|81815476|FG002|Overall Study|Lost to Follow-up|5|||
27995758|NCT00891228|81815474|FG000|Overall Study|Pregnancy|0|||
27995759|NCT00891228|81815475|FG001|Overall Study|Pregnancy|1|||
27995760|NCT00891228|81815476|FG002|Overall Study|Pregnancy|0|||
27995761|NCT01858766|81815477|FG000|Overall Study|Randomized but Never Treated|0|||
27995762|NCT01858766|81815478|FG001|Overall Study|Randomized but Never Treated|0|||
27995763|NCT01858766|81815479|FG002|Overall Study|Randomized but Never Treated|0|||
27803067|NCT03216954|81111401|FG004|Overall Study|Withdrawal by Subject|0|||
27803068|NCT03216954|81111397|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
27803069|NCT03216954|81111398|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
27803070|NCT03216954|81111399|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
27803071|NCT03216954|81111400|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
27803072|NCT03216954|81111401|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
27995764|NCT01858766|81815480|FG003|Overall Study|Randomized but Never Treated|0|||
27995765|NCT01858766|81815481|FG004|Overall Study|Randomized but Never Treated|0|||
27995766|NCT01858766|81815482|FG005|Overall Study|Randomized but Never Treated|1|||
27803073|NCT03264066|81111408|FG000|Overall Study|Adverse Event|1|||
27803074|NCT03264066|81111409|FG001|Overall Study|Adverse Event|1|||
27803075|NCT03264066|81111410|FG002|Overall Study|Adverse Event|0|||
27803076|NCT03264066|81111411|FG003|Overall Study|Adverse Event|0|||
27803077|NCT03264066|81111412|FG004|Overall Study|Adverse Event|0|||
27679549|NCT03149549|80664359|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
27679550|NCT03149549|80664360|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679551|NCT03149549|80664361|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
27679552|NCT03149549|80664362|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
27679553|NCT03149549|80664363|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
27679554|NCT03149549|80664351|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679555|NCT03149549|80664352|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679556|NCT03149549|80664353|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679557|NCT03149549|80664354|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679558|NCT03149549|80664355|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
27679559|NCT03149549|80664356|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679560|NCT03149549|80664357|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679561|NCT03149549|80664358|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
27679562|NCT03149549|80664359|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
27679563|NCT03149549|80664360|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
27679564|NCT03149549|80664361|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
27803078|NCT03264066|81111413|FG005|Overall Study|Adverse Event|0|||
27995767|NCT01858766|81815483|FG006|Overall Study|Randomized but Never Treated|0|||
27995768|NCT01858766|81815484|FG007|Overall Study|Randomized but Never Treated|0|||
27803079|NCT03264066|81111408|FG000|Overall Study|Death|12|||
27803080|NCT03264066|81111409|FG001|Overall Study|Death|12|||
27995769|NCT01858766|81815485|FG008|Overall Study|Randomized but Never Treated|0|||
27995770|NCT01858766|81815486|FG009|Overall Study|Randomized but Never Treated|0|||
27995771|NCT01858766|81815487|FG010|Overall Study|Randomized but Never Treated|0|||
27803081|NCT03264066|81111410|FG002|Overall Study|Death|8|||
27803082|NCT03264066|81111411|FG003|Overall Study|Death|10|||
27803083|NCT03264066|81111412|FG004|Overall Study|Death|6|||
27803084|NCT03264066|81111413|FG005|Overall Study|Death|1|||
27803085|NCT03264066|81111408|FG000|Overall Study|Lost to Follow-up|1|||
27803086|NCT03264066|81111409|FG001|Overall Study|Lost to Follow-up|0|||
27803087|NCT03264066|81111410|FG002|Overall Study|Lost to Follow-up|0|||
27803088|NCT03264066|81111411|FG003|Overall Study|Lost to Follow-up|0|||
27803089|NCT03264066|81111412|FG004|Overall Study|Lost to Follow-up|0|||
27803090|NCT03264066|81111413|FG005|Overall Study|Lost to Follow-up|0|||
27803091|NCT03264066|81111408|FG000|Overall Study|Progressive Disease|0|||
27803092|NCT03264066|81111409|FG001|Overall Study|Progressive Disease|2|||
27803093|NCT03264066|81111410|FG002|Overall Study|Progressive Disease|1|||
27803094|NCT03264066|81111411|FG003|Overall Study|Progressive Disease|0|||
27803095|NCT03264066|81111412|FG004|Overall Study|Progressive Disease|0|||
27803096|NCT03264066|81111413|FG005|Overall Study|Progressive Disease|0|||
27803097|NCT03264066|81111408|FG000|Overall Study|Study Terminated by Sponsor|5|||
27803098|NCT03264066|81111409|FG001|Overall Study|Study Terminated by Sponsor|5|||
27803099|NCT03264066|81111410|FG002|Overall Study|Study Terminated by Sponsor|8|||
27803100|NCT03264066|81111411|FG003|Overall Study|Study Terminated by Sponsor|5|||
27803101|NCT03264066|81111412|FG004|Overall Study|Study Terminated by Sponsor|1|||
27803102|NCT03264066|81111413|FG005|Overall Study|Study Terminated by Sponsor|2|||
27803103|NCT03264066|81111408|FG000|Overall Study|Withdrawal by Subject|1|||
27803104|NCT03264066|81111409|FG001|Overall Study|Withdrawal by Subject|0|||
27803105|NCT03264066|81111410|FG002|Overall Study|Withdrawal by Subject|0|||
27803106|NCT03264066|81111411|FG003|Overall Study|Withdrawal by Subject|5|||
27803107|NCT03264066|81111412|FG004|Overall Study|Withdrawal by Subject|0|||
27803108|NCT03264066|81111413|FG005|Overall Study|Withdrawal by Subject|0|||
27803109|NCT01246973|81111414|FG000|Overall Study|Other|38|||
27803110|NCT01246973|81111415|FG001|Overall Study|Other|25|||
27803111|NCT01246973|81111414|FG000|Overall Study|Adverse Event|16|||
27803112|NCT01246973|81111415|FG001|Overall Study|Adverse Event|9|||
27803113|NCT01246973|81111414|FG000|Overall Study|Withdrawal by Subject|7|||
27803114|NCT01246973|81111415|FG001|Overall Study|Withdrawal by Subject|13|||
27803115|NCT03302299|81111416|FG000|Overall Study|Protocol Violation|1|||
27803116|NCT01964898|81111419|FG000|Overall Study|ineligible post-randomization|1|||
27803117|NCT01964898|81111420|FG001|Overall Study|ineligible post-randomization|1|||
27803118|NCT01964898|81111419|FG000|Overall Study|did not receive the allocated interventi|2|||
27803119|NCT01964898|81111420|FG001|Overall Study|did not receive the allocated interventi|1|||
27995772|NCT01858766|81815488|FG011|Overall Study|Randomized but Never Treated|0|||
27995773|NCT01858766|81815489|FG012|Overall Study|Randomized but Never Treated|0|||
27995774|NCT01858766|81815490|FG013|Overall Study|Randomized but Never Treated|0|||
27995775|NCT01858766|81815491|FG014|Overall Study|Randomized but Never Treated|0|||
27995776|NCT01858766|81815492|FG015|Overall Study|Randomized but Never Treated|0|||
27995777|NCT01858766|81815493|FG016|Overall Study|Randomized but Never Treated|0|||
27995778|NCT01858766|81815494|FG017|Overall Study|Randomized but Never Treated|1|||
27995779|NCT01858766|81815495|FG018|Overall Study|Randomized but Never Treated|0|||
27995780|NCT01858766|81815477|FG000|Overall Study|Death|0|||
27995781|NCT01858766|81815478|FG001|Overall Study|Death|0|||
27995782|NCT01858766|81815479|FG002|Overall Study|Death|1|||
27995783|NCT01858766|81815480|FG003|Overall Study|Death|0|||
27995784|NCT01858766|81815481|FG004|Overall Study|Death|0|||
27995785|NCT01858766|81815482|FG005|Overall Study|Death|0|||
27995786|NCT01858766|81815483|FG006|Overall Study|Death|0|||
27995787|NCT01858766|81815484|FG007|Overall Study|Death|0|||
27995788|NCT01858766|81815485|FG008|Overall Study|Death|0|||
27995789|NCT01858766|81815486|FG009|Overall Study|Death|0|||
27995790|NCT01858766|81815487|FG010|Overall Study|Death|0|||
27995791|NCT01858766|81815488|FG011|Overall Study|Death|0|||
27995792|NCT01858766|81815489|FG012|Overall Study|Death|0|||
27995793|NCT01858766|81815490|FG013|Overall Study|Death|0|||
27995794|NCT01858766|81815491|FG014|Overall Study|Death|0|||
27995795|NCT01858766|81815492|FG015|Overall Study|Death|0|||
27995796|NCT01858766|81815493|FG016|Overall Study|Death|0|||
27995797|NCT01858766|81815494|FG017|Overall Study|Death|0|||
27995798|NCT01858766|81815495|FG018|Overall Study|Death|0|||
27995799|NCT01858766|81815477|FG000|Overall Study|Lack of Efficacy|1|||
27995800|NCT01858766|81815478|FG001|Overall Study|Lack of Efficacy|0|||
27995801|NCT01858766|81815479|FG002|Overall Study|Lack of Efficacy|0|||
27995802|NCT01858766|81815480|FG003|Overall Study|Lack of Efficacy|0|||
27995803|NCT01858766|81815481|FG004|Overall Study|Lack of Efficacy|1|||
27995804|NCT01858766|81815482|FG005|Overall Study|Lack of Efficacy|2|||
27995805|NCT01858766|81815483|FG006|Overall Study|Lack of Efficacy|0|||
27995806|NCT01858766|81815484|FG007|Overall Study|Lack of Efficacy|0|||
27995807|NCT01858766|81815485|FG008|Overall Study|Lack of Efficacy|0|||
27995808|NCT01858766|81815486|FG009|Overall Study|Lack of Efficacy|0|||
27995809|NCT01858766|81815487|FG010|Overall Study|Lack of Efficacy|0|||
27995810|NCT01858766|81815488|FG011|Overall Study|Lack of Efficacy|3|||
27995811|NCT01858766|81815489|FG012|Overall Study|Lack of Efficacy|5|||
27995812|NCT01858766|81815490|FG013|Overall Study|Lack of Efficacy|3|||
27679565|NCT03149549|80664362|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
27679566|NCT03149549|80664363|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
27679567|NCT03149549|80664351|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
27679568|NCT03149549|80664352|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
27679569|NCT03149549|80664353|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
27679570|NCT03149549|80664354|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
27679571|NCT03149549|80664355|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
27679572|NCT03149549|80664356|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
27679573|NCT03149549|80664357|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
27679574|NCT03149549|80664358|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
27679575|NCT03149549|80664359|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
27679576|NCT03149549|80664360|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
27679577|NCT03149549|80664361|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
27679578|NCT03149549|80664362|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
27679579|NCT03149549|80664363|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
27679580|NCT03149549|80664351|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
27679581|NCT03149549|80664352|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
27679582|NCT03149549|80664353|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
27679583|NCT03149549|80664354|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
27679584|NCT03149549|80664355|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
27679585|NCT03149549|80664356|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
27679586|NCT03149549|80664357|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
27679587|NCT03149549|80664358|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
27679588|NCT03149549|80664359|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
27679589|NCT03149549|80664360|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
27679590|NCT03149549|80664361|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
27679591|NCT03149549|80664362|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
27679592|NCT03149549|80664363|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
27679593|NCT01214642|80664368|FG000|Overall Study|Progressive Disease|3|||
27679594|NCT01214642|80664369|FG001|Overall Study|Progressive Disease|2|||
27679595|NCT01214642|80664370|FG002|Overall Study|Progressive Disease|3|||
27679596|NCT01214642|80664371|FG003|Overall Study|Progressive Disease|5|||
27679597|NCT01214642|80664372|FG004|Overall Study|Progressive Disease|5|||
27679598|NCT01214642|80664373|FG005|Overall Study|Progressive Disease|3|||
27679599|NCT01214642|80664374|FG006|Overall Study|Progressive Disease|5|||
27679600|NCT01214642|80664375|FG007|Overall Study|Progressive Disease|3|||
27679601|NCT01214642|80664376|FG008|Overall Study|Progressive Disease|10|||
27679602|NCT01214642|80664377|FG009|Overall Study|Progressive Disease|2|||
27679603|NCT01214642|80664378|FG010|Overall Study|Progressive Disease|1|||
27679604|NCT01214642|80664379|FG011|Overall Study|Progressive Disease|4|||
27679605|NCT01214642|80664368|FG000|Overall Study|Adverse Event|0|||
27679606|NCT01214642|80664369|FG001|Overall Study|Adverse Event|1|||
27679607|NCT01214642|80664370|FG002|Overall Study|Adverse Event|0|||
27679608|NCT01214642|80664371|FG003|Overall Study|Adverse Event|0|||
27679609|NCT01214642|80664372|FG004|Overall Study|Adverse Event|0|||
27679610|NCT01214642|80664373|FG005|Overall Study|Adverse Event|0|||
27679611|NCT01214642|80664374|FG006|Overall Study|Adverse Event|1|||
27679612|NCT01214642|80664375|FG007|Overall Study|Adverse Event|0|||
27679613|NCT01214642|80664376|FG008|Overall Study|Adverse Event|0|||
27679614|NCT01214642|80664377|FG009|Overall Study|Adverse Event|1|||
27679615|NCT01214642|80664378|FG010|Overall Study|Adverse Event|1|||
27679616|NCT01214642|80664379|FG011|Overall Study|Adverse Event|0|||
27872268|NCT02906670|81365194|FG003|Cohort 5P, QW|Radiological Progression|0|||
27679617|NCT01214642|80664368|FG000|Overall Study|Death|0|||
27679618|NCT01214642|80664369|FG001|Overall Study|Death|0|||
27679619|NCT01214642|80664370|FG002|Overall Study|Death|1|||
27679620|NCT01214642|80664371|FG003|Overall Study|Death|0|||
27679621|NCT01214642|80664372|FG004|Overall Study|Death|0|||
27995813|NCT01858766|81815491|FG014|Overall Study|Lack of Efficacy|5|||
27803120|NCT01964898|81111419|FG000|Overall Study|Lost to Follow-up|3|||
27803121|NCT01964898|81111420|FG001|Overall Study|Lost to Follow-up|5|||
27803122|NCT01964898|81111419|FG000|Overall Study|Withdrawal by Subject|1|||
27803123|NCT01964898|81111420|FG001|Overall Study|Withdrawal by Subject|0|||
27803124|NCT03053622|81111423|FG000|Overall Study|Lost to Follow-up|0|||
27803125|NCT03053622|81111424|FG001|Overall Study|Lost to Follow-up|0|||
27803126|NCT03053622|81111425|FG002|Overall Study|Lost to Follow-up|0|||
27803127|NCT03053622|81111426|FG003|Overall Study|Lost to Follow-up|1|||
27803128|NCT01155284|81111427|FG000|Overall Study|Withdrawal by Subject|4|||
27803129|NCT01155284|81111428|FG001|Overall Study|Withdrawal by Subject|3|||
27803130|NCT01155284|81111427|FG000|Overall Study|Lost to Follow-up|1|||
27803131|NCT01155284|81111428|FG001|Overall Study|Lost to Follow-up|2|||
27803132|NCT01155284|81111427|FG000|Overall Study|Physician Decision|1|||
27803133|NCT01155284|81111428|FG001|Overall Study|Physician Decision|0|||
27803134|NCT01155284|81111427|FG000|Overall Study|Adverse Event|1|||
27803135|NCT01155284|81111428|FG001|Overall Study|Adverse Event|0|||
27803136|NCT01726335|81111431|FG000|Overall Study|Lost to Follow-up|2|||
27803137|NCT01726335|81111431|FG000|Overall Study|Withdrawal by Subject|15|||
27803138|NCT01726335|81111431|FG000|Overall Study|Adverse Event|4|||
27803139|NCT01726335|81111431|FG000|Overall Study|Lost to Follow-up|2|||
27803140|NCT01726335|81111431|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
27803141|NCT02236754|81111432|FG000|Overall Study|Withdrawal by Subject|1|||
27803142|NCT02236754|81111433|FG001|Overall Study|Withdrawal by Subject|0|||
27803143|NCT00871728|81111435|FG000|Overall Study|Adverse Event|1|||
27803144|NCT00871728|81111435|FG000|Overall Study|Protocol Violation|7|||
27803145|NCT00871728|81111435|FG000|Overall Study|Lost to Follow-up|2|||
27803146|NCT00871728|81111435|FG000|Overall Study|Failed to Visit Hospital|4|||
27803147|NCT00871728|81111435|FG000|Overall Study|Participant Non-compliance|1|||
27803148|NCT00871728|81111435|FG000|Overall Study|Withdrawal of Informed Consent|5|||
27803149|NCT00766506|81111436|FG000|Overall Study|Use rescue medication after 3 hours|3|||
27803150|NCT00766506|81111437|FG001|Overall Study|Use rescue medication after 3 hours|0|||
27803151|NCT00766506|81111436|FG000|Overall Study|Other|2|||
27803152|NCT00766506|81111437|FG001|Overall Study|Other|2|||
27803153|NCT03548207|81111438|FG000|Overall Study|Death|10|||
27803154|NCT03548207|81111439|FG001|Overall Study|Death|23|||
27803155|NCT03548207|81111440|FG002|Overall Study|Death|3|||
27803156|NCT03548207|81111438|FG000|Overall Study|Lost to Follow-up|0|||
27803157|NCT03548207|81111439|FG001|Overall Study|Lost to Follow-up|2|||
27803158|NCT03548207|81111440|FG002|Overall Study|Lost to Follow-up|0|||
27803159|NCT03548207|81111438|FG000|Overall Study|Withdrawal by Subject|0|||
27803160|NCT03548207|81111439|FG001|Overall Study|Withdrawal by Subject|3|||
27803161|NCT03548207|81111440|FG002|Overall Study|Withdrawal by Subject|0|||
27803162|NCT03548207|81111438|FG000|Overall Study|Sponsor decision|19|||
27803163|NCT03548207|81111439|FG001|Overall Study|Sponsor decision|40|||
27803164|NCT03548207|81111440|FG002|Overall Study|Sponsor decision|6|||
27803165|NCT03548207|81111438|FG000|Overall Study|Randomized but not treated|6|||
27803166|NCT03548207|81111439|FG001|Overall Study|Randomized but not treated|10|||
27803167|NCT03548207|81111440|FG002|Overall Study|Randomized but not treated|4|||
27803168|NCT02556632|81111444|FG000|Overall Study|Lost to Follow-up|1|||
27803169|NCT02556632|81111445|FG001|Overall Study|Lost to Follow-up|0|||
27803170|NCT02556632|81111446|FG002|Overall Study|Lost to Follow-up|0|||
27803171|NCT02556632|81111444|FG000|Overall Study|Disliked Intervention|1|||
27803172|NCT02556632|81111445|FG001|Overall Study|Disliked Intervention|1|||
27803173|NCT02556632|81111446|FG002|Overall Study|Disliked Intervention|1|||
27803174|NCT02556632|81111444|FG000|Overall Study|No Reason|1|||
27803175|NCT02556632|81111445|FG001|Overall Study|No Reason|0|||
27803176|NCT02556632|81111446|FG002|Overall Study|No Reason|1|||
27803177|NCT02556632|81111444|FG000|Overall Study|Personal Issues|0|||
27995814|NCT01858766|81815492|FG015|Overall Study|Lack of Efficacy|5|||
27995815|NCT01858766|81815493|FG016|Overall Study|Lack of Efficacy|2|||
27995816|NCT01858766|81815494|FG017|Overall Study|Lack of Efficacy|3|||
27995817|NCT01858766|81815495|FG018|Overall Study|Lack of Efficacy|3|||
27803178|NCT02556632|81111445|FG001|Overall Study|Personal Issues|1|||
27803179|NCT02556632|81111446|FG002|Overall Study|Personal Issues|1|||
27803180|NCT02556632|81111444|FG000|Overall Study|Changed Mind|0|||
27803181|NCT02556632|81111445|FG001|Overall Study|Changed Mind|1|||
27803182|NCT02556632|81111446|FG002|Overall Study|Changed Mind|0|||
27803183|NCT02556632|81111444|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
27803184|NCT02556632|81111445|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
27803185|NCT02556632|81111446|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
27803186|NCT02556632|81111444|FG000|Overall Study|Unrelated Adverse Event|1|||
27803187|NCT02556632|81111445|FG001|Overall Study|Unrelated Adverse Event|0|||
27803188|NCT02556632|81111446|FG002|Overall Study|Unrelated Adverse Event|3|||
27803189|NCT02556632|81111444|FG000|Overall Study|Related Adverse Event|0|||
27803190|NCT02556632|81111445|FG001|Overall Study|Related Adverse Event|1|||
27803191|NCT02556632|81111446|FG002|Overall Study|Related Adverse Event|0|||
27803192|NCT02556632|81111444|FG000|Overall Study|Possibly Related Adverse Event|0|||
27995818|NCT01858766|81815477|FG000|Overall Study|Lost to Follow-up|0|||
27995819|NCT01858766|81815478|FG001|Overall Study|Lost to Follow-up|0|||
27995820|NCT01858766|81815479|FG002|Overall Study|Lost to Follow-up|0|||
27995821|NCT01858766|81815480|FG003|Overall Study|Lost to Follow-up|0|||
27995822|NCT01858766|81815481|FG004|Overall Study|Lost to Follow-up|0|||
27995823|NCT01858766|81815482|FG005|Overall Study|Lost to Follow-up|1|||
27995824|NCT01858766|81815483|FG006|Overall Study|Lost to Follow-up|0|||
27995825|NCT01858766|81815484|FG007|Overall Study|Lost to Follow-up|2|||
27995826|NCT01858766|81815485|FG008|Overall Study|Lost to Follow-up|0|||
27995827|NCT01858766|81815486|FG009|Overall Study|Lost to Follow-up|0|||
27995828|NCT01858766|81815487|FG010|Overall Study|Lost to Follow-up|0|||
27995829|NCT01858766|81815488|FG011|Overall Study|Lost to Follow-up|1|||
27995830|NCT01858766|81815489|FG012|Overall Study|Lost to Follow-up|0|||
27995831|NCT01858766|81815490|FG013|Overall Study|Lost to Follow-up|0|||
27995832|NCT01858766|81815491|FG014|Overall Study|Lost to Follow-up|3|||
27995833|NCT01858766|81815492|FG015|Overall Study|Lost to Follow-up|1|||
27995834|NCT01858766|81815493|FG016|Overall Study|Lost to Follow-up|1|||
27995835|NCT01858766|81815494|FG017|Overall Study|Lost to Follow-up|0|||
27995836|NCT01858766|81815495|FG018|Overall Study|Lost to Follow-up|1|||
27995837|NCT01858766|81815477|FG000|Overall Study|Withdrew Consent|0|||
27995838|NCT01858766|81815478|FG001|Overall Study|Withdrew Consent|0|||
27995839|NCT01858766|81815479|FG002|Overall Study|Withdrew Consent|0|||
27679622|NCT01214642|80664373|FG005|Overall Study|Death|0|||
27803193|NCT02556632|81111445|FG001|Overall Study|Possibly Related Adverse Event|0|||
27803194|NCT02556632|81111446|FG002|Overall Study|Possibly Related Adverse Event|1|||
27803195|NCT02556632|81111444|FG000|Overall Study|Did Not Start RT|0|||
27803196|NCT02556632|81111445|FG001|Overall Study|Did Not Start RT|1|||
27803197|NCT02556632|81111446|FG002|Overall Study|Did Not Start RT|0|||
27803198|NCT02556632|81111444|FG000|Overall Study|Ineligible|0|||
27803199|NCT02556632|81111445|FG001|Overall Study|Ineligible|1|||
27803200|NCT02556632|81111446|FG002|Overall Study|Ineligible|0|||
27803201|NCT02556632|81111444|FG000|Overall Study|Disliked Study Procedures|0|||
27803202|NCT02556632|81111445|FG001|Overall Study|Disliked Study Procedures|0|||
27803203|NCT02556632|81111446|FG002|Overall Study|Disliked Study Procedures|1|||
27803204|NCT02556632|81111444|FG000|Overall Study|Treatment or Change Delay|0|||
27803205|NCT02556632|81111445|FG001|Overall Study|Treatment or Change Delay|0|||
27803206|NCT02556632|81111446|FG002|Overall Study|Treatment or Change Delay|1|||
27803207|NCT00751998|81111457|FG000|Overall Study|Lost to Follow-up|7|||
27803208|NCT00751998|81111457|FG000|Overall Study|Death|11|||
27803209|NCT00751998|81111457|FG000|Overall Study|Withdrawal by Subject|2|||
27803210|NCT01309828|81111458|FG000|Overall Study|Adverse Event|10|||
27803211|NCT01309828|81111459|FG001|Overall Study|Adverse Event|11|||
27803212|NCT01309828|81111458|FG000|Overall Study|Voluntary Withdrawal|5|||
27803213|NCT01309828|81111459|FG001|Overall Study|Voluntary Withdrawal|4|||
27803214|NCT01309828|81111458|FG000|Overall Study|Major Protocol Deviation|0|||
27803215|NCT01309828|81111459|FG001|Overall Study|Major Protocol Deviation|1|||
27803216|NCT01309828|81111458|FG000|Overall Study|Other|1|||
27803217|NCT01309828|81111459|FG001|Overall Study|Other|0|||
27803218|NCT00802529|81111460|FG000|Overall Study|Lost to Follow-up|0|||
27803219|NCT00802529|81111461|FG001|Overall Study|Lost to Follow-up|1|||
27803220|NCT01336608|81111465|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
27803221|NCT01336608|81111466|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27803222|NCT01336608|81111467|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27803223|NCT01336608|81111468|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27803224|NCT01336608|81111465|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
27995840|NCT01858766|81815480|FG003|Overall Study|Withdrew Consent|0|||
27995841|NCT01858766|81815481|FG004|Overall Study|Withdrew Consent|0|||
27803225|NCT01336608|81111466|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27995842|NCT01858766|81815482|FG005|Overall Study|Withdrew Consent|0|||
27995843|NCT01858766|81815483|FG006|Overall Study|Withdrew Consent|0|||
27679623|NCT01214642|80664374|FG006|Overall Study|Death|0|||
27803226|NCT01336608|81111467|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27803227|NCT01336608|81111468|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27803228|NCT01336608|81111465|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
27995844|NCT01858766|81815484|FG007|Overall Study|Withdrew Consent|0|||
27995845|NCT01858766|81815485|FG008|Overall Study|Withdrew Consent|0|||
27995846|NCT01858766|81815486|FG009|Overall Study|Withdrew Consent|0|||
27995847|NCT01858766|81815487|FG010|Overall Study|Withdrew Consent|0|||
27995848|NCT01858766|81815488|FG011|Overall Study|Withdrew Consent|1|||
27995849|NCT01858766|81815489|FG012|Overall Study|Withdrew Consent|0|||
27995850|NCT01858766|81815490|FG013|Overall Study|Withdrew Consent|0|||
27995851|NCT01858766|81815491|FG014|Overall Study|Withdrew Consent|0|||
27995852|NCT01858766|81815492|FG015|Overall Study|Withdrew Consent|0|||
27579733|NCT01940705|80306682|FG002|Overall Study|Lost to Follow-up|2|||
27579734|NCT01940705|80306683|FG003|Overall Study|Lost to Follow-up|2|||
27579735|NCT01940705|80306680|FG000|Overall Study|Withdrawal by Subject|2|||
27579736|NCT01940705|80306681|FG001|Overall Study|Withdrawal by Subject|2|||
27679624|NCT01214642|80664375|FG007|Overall Study|Death|0|||
27679625|NCT01214642|80664376|FG008|Overall Study|Death|0|||
27679626|NCT01214642|80664377|FG009|Overall Study|Death|0|||
27679627|NCT01214642|80664378|FG010|Overall Study|Death|1|||
27679628|NCT01214642|80664379|FG011|Overall Study|Death|0|||
27679629|NCT01214642|80664368|FG000|Overall Study|Withdrawal by Subject|0|||
27679630|NCT01214642|80664369|FG001|Overall Study|Withdrawal by Subject|0|||
27995853|NCT01858766|81815493|FG016|Overall Study|Withdrew Consent|0|||
27995854|NCT01858766|81815494|FG017|Overall Study|Withdrew Consent|0|||
27995855|NCT01858766|81815495|FG018|Overall Study|Withdrew Consent|0|||
27995856|NCT01053988|81815498|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
27995857|NCT01053988|81815499|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27995858|NCT01053988|81815500|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27995859|NCT01053988|81815501|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27995860|NCT01053988|81815502|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27995861|NCT01053988|81815503|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27579737|NCT01940705|80306682|FG002|Overall Study|Withdrawal by Subject|3|||
27579738|NCT01940705|80306683|FG003|Overall Study|Withdrawal by Subject|2|||
27679631|NCT01214642|80664370|FG002|Overall Study|Withdrawal by Subject|1|||
27679632|NCT01214642|80664371|FG003|Overall Study|Withdrawal by Subject|0|||
27679633|NCT01214642|80664372|FG004|Overall Study|Withdrawal by Subject|0|||
27679634|NCT01214642|80664373|FG005|Overall Study|Withdrawal by Subject|0|||
27679635|NCT01214642|80664374|FG006|Overall Study|Withdrawal by Subject|0|||
27679636|NCT01214642|80664375|FG007|Overall Study|Withdrawal by Subject|0|||
27803229|NCT01336608|81111466|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
27803230|NCT01336608|81111467|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
27803231|NCT01336608|81111468|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
27803232|NCT01336608|81111465|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
27803233|NCT01336608|81111466|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
27803234|NCT01336608|81111467|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
27803235|NCT01336608|81111468|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
27803236|NCT01336608|81111465|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
27803237|NCT01336608|81111466|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27803238|NCT01336608|81111467|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27803239|NCT01336608|81111468|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27803240|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27803241|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
27679637|NCT01214642|80664376|FG008|Overall Study|Withdrawal by Subject|3|||
27579739|NCT01940705|80306680|FG000|Overall Study|Intervention not given|0|||
27995862|NCT01053988|81815498|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
27995863|NCT01053988|81815499|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27995864|NCT01053988|81815500|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27995865|NCT01053988|81815501|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27995866|NCT01053988|81815502|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27995867|NCT01053988|81815503|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27995868|NCT01053988|81815498|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
27995869|NCT01053988|81815499|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27803242|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
27803243|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
27803244|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27803245|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
27995870|NCT01053988|81815500|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27995871|NCT01053988|81815501|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27995872|NCT01053988|81815502|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27995873|NCT01053988|81815503|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27995874|NCT01053988|81815498|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
27995875|NCT01053988|81815499|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
27995876|NCT01053988|81815500|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
27995877|NCT01053988|81815501|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
27995878|NCT01053988|81815502|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
27995879|NCT01053988|81815503|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
27995880|NCT01053988|81815498|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
27995881|NCT01053988|81815499|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
27995882|NCT01053988|81815500|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
27995883|NCT01053988|81815501|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
27995884|NCT01053988|81815502|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
27995885|NCT01053988|81815503|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
27995886|NCT01053988|81815498|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
27995887|NCT01053988|81815499|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27995888|NCT01053988|81815500|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27995889|NCT01053988|81815501|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27803246|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27803247|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27803248|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
27803249|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
27803250|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
27803251|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
27803252|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27803253|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27803254|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
27803255|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
27803256|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
27803257|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
27803258|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
27803259|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
27803260|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27803261|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
27803262|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27803263|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27803264|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27803265|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
27803266|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
27803267|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
27803268|NCT01336608|81111465|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27803269|NCT01336608|81111466|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
27803270|NCT01336608|81111467|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
27803271|NCT01336608|81111468|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
27803272|NCT00579254|81111469|FG000|Overall Study|Lost to Follow-up|39|||
27803273|NCT00579254|81111469|FG000|Overall Study|Discontinued when study terminated|73|||
27803274|NCT01389024|81111472|FG000|Overall Study|Withdrawal by Subject|0|||
27803275|NCT01389024|81111473|FG001|Overall Study|Withdrawal by Subject|1|||
27803276|NCT01389024|81111472|FG000|Overall Study|Lost to Follow-up|1|||
27995890|NCT01053988|81815502|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27872269|NCT02906670|81365195|FG004|Cohort 5P, QW|Radiological Progression|3|||
27872270|NCT02906670|81365196|FG005|Cohort 5P, QW|Radiological Progression|0|||
27872271|NCT02906670|81365197|FG006|Cohort 5P, QW|Radiological Progression|0|||
27995891|NCT01053988|81815503|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27995892|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27579740|NCT01940705|80306681|FG001|Overall Study|Intervention not given|3|||
27579741|NCT01940705|80306682|FG002|Overall Study|Intervention not given|3|||
27679638|NCT01214642|80664377|FG009|Overall Study|Withdrawal by Subject|1|||
27995893|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
27995894|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
27995895|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
27995896|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
27579742|NCT01940705|80306683|FG003|Overall Study|Intervention not given|0|||
27679639|NCT01214642|80664378|FG010|Overall Study|Withdrawal by Subject|1|||
27679640|NCT01214642|80664379|FG011|Overall Study|Withdrawal by Subject|0|||
27679641|NCT01214642|80664368|FG000|Overall Study|Physician Decision|0|||
27679642|NCT01214642|80664369|FG001|Overall Study|Physician Decision|0|||
27679643|NCT01214642|80664370|FG002|Overall Study|Physician Decision|1|||
27803277|NCT01389024|81111473|FG001|Overall Study|Lost to Follow-up|0|||
27803278|NCT00678379|81111483|FG000|Overall Study|Injection performed after tonsillectomy|2|||
27803279|NCT00678379|81111484|FG001|Overall Study|Injection performed after tonsillectomy|0|||
27803280|NCT00678379|81111485|FG002|Overall Study|Injection performed after tonsillectomy|1|||
27803281|NCT00678379|81111483|FG000|Overall Study|Incomplete Data|4|||
27803282|NCT00678379|81111484|FG001|Overall Study|Incomplete Data|3|||
27803283|NCT00678379|81111485|FG002|Overall Study|Incomplete Data|3|||
27803284|NCT01169987|81111488|FG000|Overall Study|Withdrawal by Subject|3|||
27803285|NCT01169987|81111488|FG000|Overall Study|Lost to Follow-up|24|||
27803286|NCT01169987|81111488|FG000|Overall Study|Other|4|||
27803287|NCT00123487|81111492|FG000|Randomized|Death prior to starting treatment|0|||
27803288|NCT00123487|81111493|FG001|Randomized|Death prior to starting treatment|1|||
27803289|NCT00123487|81111492|FG000|Randomized|SAE prior to starting treatment|1|||
27803290|NCT00123487|81111493|FG001|Randomized|SAE prior to starting treatment|0|||
27803291|NCT00123487|81111492|FG000|Treated With Study Drug|Adverse Event|23|||
27803292|NCT00123487|81111493|FG001|Treated With Study Drug|Adverse Event|22|||
27803293|NCT00123487|81111492|FG000|Treated With Study Drug|Disease Progression|141|||
27803294|NCT00123487|81111493|FG001|Treated With Study Drug|Disease Progression|122|||
27803295|NCT00123487|81111492|FG000|Treated With Study Drug|Physician Decision|8|||
27803296|NCT00123487|81111493|FG001|Treated With Study Drug|Physician Decision|9|||
27803297|NCT00123487|81111492|FG000|Treated With Study Drug|Other|59|||
27803298|NCT00123487|81111493|FG001|Treated With Study Drug|Other|58|||
27803299|NCT00123487|81111492|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
27803300|NCT00123487|81111493|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
27803301|NCT00123487|81111492|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
27803302|NCT00123487|81111493|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
27803303|NCT00123487|81111492|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
27803304|NCT00123487|81111493|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
27872272|NCT02906670|81365198|FG007|Cohort 5P, QW|Radiological Progression|0|||
27995897|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
27995898|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27579743|NCT01940705|80306680|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
27579744|NCT01940705|80306681|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
27579745|NCT01940705|80306682|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
27579746|NCT01940705|80306683|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
27579747|NCT00120042|80306684|FG000|Overall Study|all completed protocl|0|||
27579748|NCT00120042|80306685|FG001|Overall Study|all completed protocl|0|||
27579749|NCT00120042|80306686|FG002|Overall Study|all completed protocl|0|||
27579750|NCT00298038|80306688|FG000|Overall Study|Lost to Follow-up|0|||
27679644|NCT01214642|80664371|FG003|Overall Study|Physician Decision|1|||
27803305|NCT03836729|81111494|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
27803306|NCT00420290|81111495|FG000|Overall Study|Adverse Event|3|||
27803307|NCT00420290|81111496|FG001|Overall Study|Adverse Event|1|||
27803308|NCT00420290|81111495|FG000|Overall Study|Withdrawal by Subject|0|||
27803309|NCT00420290|81111496|FG001|Overall Study|Withdrawal by Subject|2|||
27579751|NCT00298038|80306689|FG001|Overall Study|Lost to Follow-up|1|||
27872273|NCT02906670|81365199|FG008|Cohort 5P, QW|Radiological Progression|0|||
27872274|NCT02906670|81365200|FG009|Cohort 5P, QW|Radiological Progression|0|||
27872275|NCT02635984|81365201|FG000|Overall Study|Lost to Follow-up|2|||
27872276|NCT02635984|81365202|FG001|Overall Study|Lost to Follow-up|4|||
27872277|NCT02635984|81365201|FG000|Overall Study|Study Arm Closed|1|||
27872278|NCT02635984|81365202|FG001|Overall Study|Study Arm Closed|0|||
27995899|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
27995900|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
27995901|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
27995902|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
27803310|NCT00420290|81111495|FG000|Overall Study|did not meet inclusion/exclusion|1|||
27803311|NCT00420290|81111496|FG001|Overall Study|did not meet inclusion/exclusion|1|||
27803312|NCT00529568|81111497|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
27803313|NCT00529568|81111498|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
27803314|NCT00529568|81111499|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
27803315|NCT00529568|81111497|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
27803316|NCT00529568|81111498|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
27803317|NCT00529568|81111499|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
27803318|NCT00529568|81111497|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
27803319|NCT00529568|81111498|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
27803320|NCT00529568|81111499|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
27803321|NCT00529568|81111497|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
27803322|NCT00529568|81111498|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
27995903|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27995904|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
27995905|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
27995906|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
27995907|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
27803323|NCT00529568|81111499|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
27803324|NCT00529568|81111497|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
27803325|NCT00529568|81111498|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
27803326|NCT00529568|81111499|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
27803327|NCT00529568|81111497|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
27803328|NCT00529568|81111498|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
27803329|NCT00529568|81111499|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
27803330|NCT00529568|81111497|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
27803331|NCT00529568|81111498|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
27803332|NCT00529568|81111499|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
27803333|NCT00529568|81111497|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
27803334|NCT00529568|81111498|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
27803335|NCT00529568|81111499|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
27803336|NCT00529568|81111497|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
27803337|NCT00529568|81111498|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
27803338|NCT00529568|81111499|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
27803339|NCT00529568|81111497|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
27803340|NCT00529568|81111498|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
27803341|NCT00529568|81111499|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
27803342|NCT00529568|81111497|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
27803343|NCT00529568|81111498|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
27803344|NCT00529568|81111499|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
27803345|NCT04147611|81111522|FG000|Overall Study|Physician Decision|0|||
27803346|NCT04147611|81111523|FG001|Overall Study|Physician Decision|1|||
27803347|NCT00479401|81111526|FG000|Overall Study|Adverse Event|24|||
27803348|NCT00479401|81111527|FG001|Overall Study|Adverse Event|20|||
27803349|NCT00479401|81111528|FG002|Overall Study|Adverse Event|4|||
27803350|NCT00479401|81111526|FG000|Overall Study|Lack of Efficacy|2|||
27803351|NCT00479401|81111527|FG001|Overall Study|Lack of Efficacy|2|||
27872279|NCT00289848|81365203|FG000|Overall Study|Adverse Event|6|||
27872280|NCT00289848|81365204|FG001|Overall Study|Adverse Event|4|||
27872281|NCT00289848|81365203|FG000|Overall Study|Death|1|||
27872282|NCT00289848|81365204|FG001|Overall Study|Death|0|||
27872283|NCT00289848|81365203|FG000|Overall Study|Lack of Efficacy|20|||
27803352|NCT00479401|81111528|FG002|Overall Study|Lack of Efficacy|4|||
27803353|NCT00479401|81111526|FG000|Overall Study|Protocol Violation|2|||
27803354|NCT00479401|81111527|FG001|Overall Study|Protocol Violation|1|||
27803355|NCT00479401|81111528|FG002|Overall Study|Protocol Violation|1|||
27803356|NCT00479401|81111526|FG000|Overall Study|Lost to Follow-up|1|||
27803357|NCT00479401|81111527|FG001|Overall Study|Lost to Follow-up|1|||
27803358|NCT00479401|81111528|FG002|Overall Study|Lost to Follow-up|1|||
27803359|NCT00479401|81111526|FG000|Overall Study|Withdrawal by Subject|16|||
27803360|NCT00479401|81111527|FG001|Overall Study|Withdrawal by Subject|10|||
27803361|NCT00479401|81111528|FG002|Overall Study|Withdrawal by Subject|2|||
27803362|NCT00479401|81111526|FG000|Overall Study|Exclusion criteria, relocation|4|||
27803363|NCT00479401|81111527|FG001|Overall Study|Exclusion criteria, relocation|3|||
27803364|NCT00479401|81111528|FG002|Overall Study|Exclusion criteria, relocation|0|||
27803365|NCT00869089|81111529|FG000|Overall Study|Lost to Follow-up|1|||
27803366|NCT00869089|81111529|FG000|Overall Study|Withdrawal by Subject|1|||
27803367|NCT00869089|81111529|FG000|Overall Study|Screen Fail|1|||
27803368|NCT01271933|81111530|FG000|Single-Blind Phase|Lack of Efficacy|37|||
27803369|NCT01271933|81111531|FG001|Single-Blind Phase|Lack of Efficacy|0|||
27803370|NCT01271933|81111532|FG002|Single-Blind Phase|Lack of Efficacy|0|||
27803371|NCT01271933|81111530|FG000|Single-Blind Phase|Lost to Follow-up|10|||
27803372|NCT01271933|81111531|FG001|Single-Blind Phase|Lost to Follow-up|0|||
27803373|NCT01271933|81111532|FG002|Single-Blind Phase|Lost to Follow-up|0|||
27803374|NCT01271933|81111530|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
27803375|NCT01271933|81111531|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
27803376|NCT01271933|81111532|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
27803377|NCT01271933|81111530|FG000|Single-Blind Phase|Protocol Violation|3|||
27803378|NCT01271933|81111531|FG001|Single-Blind Phase|Protocol Violation|0|||
27803379|NCT01271933|81111532|FG002|Single-Blind Phase|Protocol Violation|0|||
27803380|NCT01271933|81111530|FG000|Single-Blind Phase|Adverse Event|52|||
27803381|NCT01271933|81111531|FG001|Single-Blind Phase|Adverse Event|0|||
27803382|NCT01271933|81111532|FG002|Single-Blind Phase|Adverse Event|0|||
27803383|NCT01271933|81111530|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
27803384|NCT01271933|81111531|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
27803385|NCT01271933|81111532|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
27803386|NCT01271933|81111530|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
27803387|NCT01271933|81111531|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
27803388|NCT01271933|81111532|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
27803389|NCT01271933|81111530|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
27803390|NCT01271933|81111531|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
27803391|NCT01271933|81111532|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
27803392|NCT01271933|81111530|FG000|Double-Blind Phase|Randomized but not treated|0|||
27803393|NCT01271933|81111531|FG001|Double-Blind Phase|Randomized but not treated|0|||
27803394|NCT01271933|81111532|FG002|Double-Blind Phase|Randomized but not treated|1|||
27803395|NCT01271933|81111530|FG000|Double-Blind Phase|Lack of Efficacy|0|||
27803396|NCT01271933|81111531|FG001|Double-Blind Phase|Lack of Efficacy|6|||
27803397|NCT01271933|81111532|FG002|Double-Blind Phase|Lack of Efficacy|9|||
27803398|NCT01271933|81111530|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27803399|NCT01271933|81111531|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27803400|NCT01271933|81111532|FG002|Double-Blind Phase|Lost to Follow-up|1|||
27803401|NCT01271933|81111530|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27803402|NCT01271933|81111531|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
27803403|NCT01271933|81111532|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
27803404|NCT01271933|81111530|FG000|Double-Blind Phase|Adverse Event|0|||
27803405|NCT01271933|81111531|FG001|Double-Blind Phase|Adverse Event|3|||
27803406|NCT01271933|81111532|FG002|Double-Blind Phase|Adverse Event|0|||
27803407|NCT01271933|81111530|FG000|Double-Blind Phase|Participant request-personal reason|0|||
27803408|NCT01271933|81111531|FG001|Double-Blind Phase|Participant request-personal reason|1|||
27803409|NCT01271933|81111532|FG002|Double-Blind Phase|Participant request-personal reason|0|||
27803410|NCT02030834|81111533|FG000|Overall Study|Death|4|||
27803411|NCT02030834|81111534|FG001|Overall Study|Death|0|||
27803412|NCT02030834|81111535|FG002|Overall Study|Death|0|||
27803413|NCT02030834|81111533|FG000|Overall Study|Manufacturing failure|2|||
27803414|NCT02030834|81111534|FG001|Overall Study|Manufacturing failure|0|||
27803415|NCT02030834|81111535|FG002|Overall Study|Manufacturing failure|1|||
27995908|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
27995909|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
27995910|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27803416|NCT02030834|81111533|FG000|Overall Study|Disease progression|2|||
27803417|NCT02030834|81111534|FG001|Overall Study|Disease progression|0|||
27803418|NCT02030834|81111535|FG002|Overall Study|Disease progression|2|||
27803419|NCT02030834|81111533|FG000|Overall Study|Lost to Follow-up|1|||
27803420|NCT02030834|81111534|FG001|Overall Study|Lost to Follow-up|0|||
27803421|NCT02030834|81111535|FG002|Overall Study|Lost to Follow-up|0|||
27803422|NCT02030834|81111533|FG000|Overall Study|Withdrawal by Subject|1|||
27803423|NCT02030834|81111534|FG001|Overall Study|Withdrawal by Subject|0|||
27803424|NCT02030834|81111535|FG002|Overall Study|Withdrawal by Subject|0|||
27803425|NCT02030834|81111533|FG000|Overall Study|Lack of funding|1|||
27803426|NCT02030834|81111534|FG001|Overall Study|Lack of funding|0|||
27995911|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
27679645|NCT01214642|80664372|FG004|Overall Study|Physician Decision|1|||
27679646|NCT01214642|80664373|FG005|Overall Study|Physician Decision|0|||
27679647|NCT01214642|80664374|FG006|Overall Study|Physician Decision|0|||
27679648|NCT01214642|80664375|FG007|Overall Study|Physician Decision|0|||
27679649|NCT01214642|80664376|FG008|Overall Study|Physician Decision|0|||
27679650|NCT01214642|80664377|FG009|Overall Study|Physician Decision|0|||
27679651|NCT01214642|80664378|FG010|Overall Study|Physician Decision|0|||
27679652|NCT01214642|80664379|FG011|Overall Study|Physician Decision|2|||
27679653|NCT00438672|80664385|FG000|Overall Study|Lost to Follow-up|7|||
27679654|NCT00438672|80664386|FG001|Overall Study|Lost to Follow-up|9|||
27679655|NCT00233480|80664387|FG000|Overall Study|Underwent status II heart transplant|0|||
27679656|NCT00233480|80664388|FG001|Overall Study|Underwent status II heart transplant|1|||
27679657|NCT01782690|80664390|FG000|Overall Study|Not reported|7|||
27679658|NCT01782690|80664390|FG000|Overall Study|Toxicity of gemcitabine|1|||
27679659|NCT01782690|80664390|FG000|Overall Study|Toxicity of erlotinib|1|||
27679660|NCT01782690|80664390|FG000|Overall Study|Lost to Follow-up|31|||
27679661|NCT01782690|80664390|FG000|Overall Study|Withdrawal of informed consent|2|||
27679662|NCT01782690|80664390|FG000|Overall Study|Absent rash|9|||
27679663|NCT01782690|80664390|FG000|Overall Study|Physician Decision|13|||
27679664|NCT01782690|80664390|FG000|Overall Study|Patient's wish|21|||
27679665|NCT01782690|80664390|FG000|Overall Study|Tumor progression|74|||
27679666|NCT01782690|80664390|FG000|Overall Study|Death|133|||
27679667|NCT01782690|80664390|FG000|Overall Study|Study completion unknown|7|||
27679668|NCT01840410|80664391|FG000|Overall Study|Physician Decision|1|||
27679669|NCT01840410|80664392|FG001|Overall Study|Physician Decision|2|||
27679670|NCT01840410|80664391|FG000|Overall Study|Pregnancy|1|||
27679671|NCT01840410|80664392|FG001|Overall Study|Pregnancy|0|||
27679672|NCT01840410|80664391|FG000|Overall Study|Protocol deviation|1|||
27679673|NCT01840410|80664392|FG001|Overall Study|Protocol deviation|0|||
27679674|NCT01840410|80664391|FG000|Overall Study|Lost to Follow-up|1|||
27679675|NCT01840410|80664392|FG001|Overall Study|Lost to Follow-up|0|||
27679676|NCT01840410|80664391|FG000|Overall Study|Withdrawal by Subject|2|||
27679677|NCT01840410|80664392|FG001|Overall Study|Withdrawal by Subject|1|||
27679678|NCT01840410|80664391|FG000|Overall Study|Adverse Event|1|||
27679679|NCT01840410|80664392|FG001|Overall Study|Adverse Event|1|||
27679680|NCT01923467|80664396|FG000|Overall Study|Lost to Follow-up|62|||
27679681|NCT01923467|80664396|FG000|Overall Study|Subject non-interest|479|||
27679682|NCT01637077|80664399|FG000|Overall Study|Cancel|1|||
27679683|NCT01637077|80664400|FG001|Overall Study|Cancel|1|||
27679684|NCT01637077|80664399|FG000|Overall Study|Withdrawal by Subject|1|||
27679685|NCT01637077|80664400|FG001|Overall Study|Withdrawal by Subject|0|||
27679686|NCT01637077|80664399|FG000|Overall Study|No cycle 1 questionnaire data|2|||
27679687|NCT01637077|80664400|FG001|Overall Study|No cycle 1 questionnaire data|0|||
27679688|NCT01638390|80664404|FG000|Overall Study|screening failures|21|||
27995912|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27995913|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27995914|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
27679689|NCT01208103|80664408|FG000|Overall Study|Adverse Event|1|||
27679690|NCT01208103|80664408|FG000|Overall Study|Withdrawal by Subject|1|||
27679691|NCT02406677|80664409|FG000|Overall Study|Death|16|||
27679692|NCT02406677|80664410|FG001|Overall Study|Death|8|||
27679693|NCT02406677|80664409|FG000|Overall Study|Discharged without P2Y12|1|||
27679694|NCT02406677|80664410|FG001|Overall Study|Discharged without P2Y12|3|||
27679695|NCT02406677|80664409|FG000|Overall Study|Discharged on prasugrel|283|||
27995915|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27995916|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27995917|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
27995918|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
27995919|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
27995920|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
27679696|NCT02406677|80664410|FG001|Overall Study|Discharged on prasugrel|587|||
27679697|NCT02406677|80664409|FG000|Overall Study|Withdrawal by Subject|1|||
27679698|NCT02406677|80664410|FG001|Overall Study|Withdrawal by Subject|0|||
27679699|NCT04157400|80664411|FG000|Overall Study|Withdrawal by Subject|1|||
27679700|NCT04157400|80664411|FG000|Overall Study|Lost to Follow-up|3|||
27679701|NCT02071290|80664412|FG000|Overall Study|Death|1|||
27679702|NCT02071290|80664413|FG001|Overall Study|Death|0|||
27679703|NCT02071290|80664412|FG000|Overall Study|Withdrawal by Subject|0|||
27679704|NCT02071290|80664413|FG001|Overall Study|Withdrawal by Subject|1|||
27679705|NCT02071290|80664412|FG000|Overall Study|Protocol Violation|3|||
27679706|NCT02071290|80664413|FG001|Overall Study|Protocol Violation|5|||
27679707|NCT02071290|80664412|FG000|Overall Study|Physician Decision|0|||
27679708|NCT02071290|80664413|FG001|Overall Study|Physician Decision|1|||
27679709|NCT02815579|80664415|FG000|Overall Study|Non-payment of loan down-payment|16|||
27679710|NCT02815579|80664416|FG001|Overall Study|Non-payment of loan down-payment|0|||
27803427|NCT02030834|81111535|FG002|Overall Study|Lack of funding|0|||
27803428|NCT01011907|81111536|FG000|Overall Study|Withdrawal by Subject|13|||
27803429|NCT01011907|81111537|FG001|Overall Study|Withdrawal by Subject|11|||
27803430|NCT01011907|81111536|FG000|Overall Study|Adverse Event|1|||
27679711|NCT02815579|80664415|FG000|Overall Study|Withdrawal by Subject|7|||
27872284|NCT00289848|81365204|FG001|Overall Study|Lack of Efficacy|24|||
27872285|NCT00289848|81365203|FG000|Overall Study|Lost to Follow-up|3|||
27872286|NCT00289848|81365204|FG001|Overall Study|Lost to Follow-up|1|||
27872287|NCT00289848|81365203|FG000|Overall Study|Protocol Violation|5|||
27872288|NCT00289848|81365204|FG001|Overall Study|Protocol Violation|2|||
27872289|NCT00289848|81365203|FG000|Overall Study|Withdrawal by Subject|5|||
27872290|NCT00289848|81365204|FG001|Overall Study|Withdrawal by Subject|11|||
27872291|NCT00289848|81365203|FG000|Overall Study|Patient Moved|6|||
27872292|NCT00289848|81365204|FG001|Overall Study|Patient Moved|2|||
27872293|NCT00289848|81365203|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
27872294|NCT00289848|81365204|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
27995921|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
27995922|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27995923|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
27995924|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27995925|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27679712|NCT02815579|80664416|FG001|Overall Study|Withdrawal by Subject|1|||
27679713|NCT02815579|80664415|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
27679714|NCT02815579|80664416|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
27679715|NCT02815579|80664415|FG000|Overall Study|Lost to Follow-up|7|||
27679716|NCT02815579|80664416|FG001|Overall Study|Lost to Follow-up|4|||
27679717|NCT02815579|80664415|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
27803431|NCT01011907|81111537|FG001|Overall Study|Adverse Event|4|||
27803432|NCT00051636|81111538|FG000|Period 1 - Core|Adverse Event|2|||
27803433|NCT00051636|81111539|FG001|Period 1 - Core|Adverse Event|2|||
27803434|NCT00051636|81111538|FG000|Period 1 - Core|Protocol Violation|1|||
27803435|NCT00051636|81111539|FG001|Period 1 - Core|Protocol Violation|0|||
27803436|NCT00051636|81111538|FG000|Period 1 - Core|Withdrawal by Subject|1|||
27995926|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27995927|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
27803437|NCT00051636|81111539|FG001|Period 1 - Core|Withdrawal by Subject|2|||
27803438|NCT00051636|81111538|FG000|Period 1 - Core|Lost to Follow-up|0|||
27803439|NCT00051636|81111539|FG001|Period 1 - Core|Lost to Follow-up|2|||
27803440|NCT00051636|81111538|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
27803441|NCT00051636|81111539|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
27995928|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27679718|NCT02815579|80664416|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
27679719|NCT02815579|80664415|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
27679720|NCT02815579|80664416|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
27679721|NCT02815579|80664415|FG000|Overall Study|Death|5|||
27803442|NCT00051636|81111538|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
27803443|NCT00051636|81111539|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
27803444|NCT00051636|81111538|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
27872295|NCT01368497|81365205|FG000|Overall Study|Lost to Follow-up|2|||
27872296|NCT01720225|81365208|FG000|Overall Study|Withdrawal by Subject|0|||
27872297|NCT01720225|81365209|FG001|Overall Study|Withdrawal by Subject|1|||
27872298|NCT01720225|81365208|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
27872299|NCT01720225|81365209|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
27803445|NCT00051636|81111539|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
27995929|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
27995930|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
27995931|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
27995932|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
27995933|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
27995934|NCT01053988|81815498|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27995935|NCT01053988|81815499|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
27995936|NCT01053988|81815500|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27995937|NCT01053988|81815501|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
27995938|NCT01053988|81815502|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
27995939|NCT01053988|81815503|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27995940|NCT02488005|81815504|FG000|Overall Study|Lost to Follow-up|2|||
27995941|NCT02128724|81815505|FG000|Overall Study|Death|1|||
27995942|NCT02128724|81815506|FG001|Overall Study|Death|0|||
27995943|NCT02128724|81815507|FG002|Overall Study|Death|0|||
27872300|NCT02040805|81365215|FG000|Overall Study|Lost to Follow-up|14|||
27872301|NCT02040805|81365216|FG001|Overall Study|Lost to Follow-up|9|||
27995944|NCT02128724|81815508|FG003|Overall Study|Death|0|||
27995945|NCT02128724|81815505|FG000|Overall Study|Adverse Event|0|||
27995946|NCT02128724|81815506|FG001|Overall Study|Adverse Event|1|||
27995947|NCT02128724|81815507|FG002|Overall Study|Adverse Event|0|||
27995948|NCT02128724|81815508|FG003|Overall Study|Adverse Event|0|||
27995949|NCT02128724|81815505|FG000|Overall Study|Physician Decision|0|||
27995950|NCT02128724|81815506|FG001|Overall Study|Physician Decision|0|||
27679722|NCT02815579|80664416|FG001|Overall Study|Death|4|||
27679723|NCT02815579|80664415|FG000|Overall Study|Imprisoned|0|||
27679724|NCT02815579|80664416|FG001|Overall Study|Imprisoned|2|||
27679725|NCT02815579|80664415|FG000|Overall Study|Did not meet enrollment criteria|0|||
27679726|NCT02815579|80664416|FG001|Overall Study|Did not meet enrollment criteria|1|||
27679727|NCT00685698|80664418|FG000|Overall Study|Withdrawal by Subject|1|||
27679728|NCT00685698|80664418|FG000|Overall Study|Protocol Violation|6|||
27679729|NCT00685698|80664418|FG000|Overall Study|Adverse Event|3|||
27679730|NCT00685698|80664418|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
27679731|NCT00685698|80664418|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
27679732|NCT00685698|80664418|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
27679733|NCT00874731|80664425|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
27679734|NCT00874731|80664426|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
27679735|NCT00874731|80664427|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
27679736|NCT00874731|80664425|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
27679737|NCT00874731|80664426|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
27679738|NCT00874731|80664427|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
27679739|NCT00874731|80664425|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
27679740|NCT00874731|80664426|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
27679741|NCT00874731|80664427|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
27679742|NCT02489968|80664428|FG000|Open-label Treatment Period|Adverse Event|14|||
27679743|NCT02489968|80664429|FG001|Open-label Treatment Period|Adverse Event|7|||
27872302|NCT02040805|81365215|FG000|Overall Study|Withdrawal by Subject|28|||
27995951|NCT02128724|81815507|FG002|Overall Study|Physician Decision|0|||
27995952|NCT02128724|81815508|FG003|Overall Study|Physician Decision|2|||
27995953|NCT02128724|81815505|FG000|Overall Study|Withdrawal by Subject|0|||
27995954|NCT02128724|81815506|FG001|Overall Study|Withdrawal by Subject|0|||
27995955|NCT02128724|81815507|FG002|Overall Study|Withdrawal by Subject|0|||
27995956|NCT02128724|81815508|FG003|Overall Study|Withdrawal by Subject|1|||
27995957|NCT01973998|81815509|FG000|Overall Study|Death|2|||
27995958|NCT01973998|81815510|FG001|Overall Study|Death|2|||
27995959|NCT05011513|81815511|FG000|Overall Study|Death|0|||
27995960|NCT05011513|81815512|FG001|Overall Study|Death|1|||
27995961|NCT05011513|81815511|FG000|Overall Study|Lost to Follow-up|4|||
27872303|NCT02040805|81365216|FG001|Overall Study|Withdrawal by Subject|41|||
27995962|NCT05011513|81815512|FG001|Overall Study|Lost to Follow-up|0|||
27995963|NCT05011513|81815511|FG000|Overall Study|Withdrawal by Subject|18|||
27995964|NCT05011513|81815512|FG001|Overall Study|Withdrawal by Subject|17|||
27679744|NCT02489968|80664430|FG002|Open-label Treatment Period|Adverse Event|0|||
27679745|NCT02489968|80664431|FG003|Open-label Treatment Period|Adverse Event|0|||
27679746|NCT02489968|80664432|FG004|Open-label Treatment Period|Adverse Event|0|||
27679747|NCT02489968|80664433|FG005|Open-label Treatment Period|Adverse Event|0|||
27872304|NCT01050530|81365217|FG000|Overall Study|Adverse Event|6|||
27995965|NCT05011513|81815511|FG000|Overall Study|Other|4|||
27995966|NCT05011513|81815512|FG001|Overall Study|Other|2|||
27995967|NCT00391027|81815518|FG000|Overall Study|Adverse Event|8|||
27995968|NCT00391027|81815519|FG001|Overall Study|Adverse Event|8|||
27995969|NCT00391027|81815518|FG000|Overall Study|Lack of Efficacy|3|||
27995970|NCT00391027|81815519|FG001|Overall Study|Lack of Efficacy|0|||
27995971|NCT00391027|81815518|FG000|Overall Study|Withdrawal by Subject|10|||
27995972|NCT00391027|81815519|FG001|Overall Study|Withdrawal by Subject|1|||
27995973|NCT00391027|81815518|FG000|Overall Study|Other|4|||
27995974|NCT00391027|81815519|FG001|Overall Study|Other|3|||
27995975|NCT04089761|81815520|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
27995976|NCT04089761|81815520|FG000|"Run In Phase"|Lost to Follow-up|1|||
27995977|NCT04089761|81815520|FG000|"Treatment Phase"|No evaluable data|5|||
27995978|NCT04089761|81815520|FG000|"Treatment Phase"|Lost to Follow-up|1|||
27995979|NCT02735343|81815521|FG000|Overall Study|screen fail|0|||
27995980|NCT02735343|81815522|FG001|Overall Study|screen fail|2|||
27995981|NCT03116685|81815526|FG000|Overall Study|Physician Decision|0|||
27995982|NCT03116685|81815527|FG001|Overall Study|Physician Decision|1|||
27995983|NCT01132313|81815531|FG000|Overall Study|Lack of Efficacy|1|||
27995984|NCT01132313|81815532|FG001|Overall Study|Lack of Efficacy|0|||
27995985|NCT01132313|81815533|FG002|Overall Study|Lack of Efficacy|0|||
27995986|NCT01132313|81815534|FG003|Overall Study|Lack of Efficacy|0|||
27995987|NCT01132313|81815535|FG004|Overall Study|Lack of Efficacy|0|||
27995988|NCT01132313|81815536|FG005|Overall Study|Lack of Efficacy|0|||
27995989|NCT01132313|81815537|FG006|Overall Study|Lack of Efficacy|0|||
27803446|NCT00051636|81111538|FG000|Period 2- Extended Observation Period|Death|4|||
27803447|NCT00051636|81111539|FG001|Period 2- Extended Observation Period|Death|5|||
27803448|NCT00051636|81111538|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
27803449|NCT00051636|81111539|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
27803450|NCT00350519|81111544|FG000|Overall Study|Death|0|||
27803451|NCT00350519|81111545|FG001|Overall Study|Death|1|||
27803452|NCT00350519|81111544|FG000|Overall Study|Physician Decision|0|||
27803453|NCT00350519|81111545|FG001|Overall Study|Physician Decision|1|||
27803454|NCT00350519|81111544|FG000|Overall Study|Protocol Violation|1|||
27803455|NCT00350519|81111545|FG001|Overall Study|Protocol Violation|2|||
27803456|NCT00350519|81111544|FG000|Overall Study|Withdrawal by Subject|3|||
27803457|NCT00350519|81111545|FG001|Overall Study|Withdrawal by Subject|2|||
27803458|NCT00370396|81111546|FG000|Overall Study|Withdrawal by Subject|0|||
27803459|NCT00370396|81111547|FG001|Overall Study|Withdrawal by Subject|0|||
27803460|NCT00370396|81111548|FG002|Overall Study|Withdrawal by Subject|1|||
27803461|NCT00370396|81111546|FG000|Overall Study|Lost to Follow-up|11|||
27803462|NCT00370396|81111547|FG001|Overall Study|Lost to Follow-up|1|||
27995990|NCT01132313|81815538|FG007|Overall Study|Lack of Efficacy|3|||
27995991|NCT01132313|81815539|FG008|Overall Study|Lack of Efficacy|14|||
27995992|NCT01132313|81815540|FG009|Overall Study|Lack of Efficacy|16|||
27995993|NCT01132313|81815541|FG010|Overall Study|Lack of Efficacy|0|||
27995994|NCT01132313|81815542|FG011|Overall Study|Lack of Efficacy|0|||
27995995|NCT01132313|81815531|FG000|Overall Study|Not treated|2|||
27995996|NCT01132313|81815532|FG001|Overall Study|Not treated|0|||
27995997|NCT01132313|81815533|FG002|Overall Study|Not treated|0|||
27995998|NCT01132313|81815534|FG003|Overall Study|Not treated|0|||
27995999|NCT01132313|81815535|FG004|Overall Study|Not treated|2|||
27996000|NCT01132313|81815536|FG005|Overall Study|Not treated|1|||
27996001|NCT01132313|81815537|FG006|Overall Study|Not treated|3|||
27996002|NCT01132313|81815538|FG007|Overall Study|Not treated|0|||
27996003|NCT01132313|81815539|FG008|Overall Study|Not treated|0|||
27996004|NCT01132313|81815540|FG009|Overall Study|Not treated|0|||
27996005|NCT01132313|81815541|FG010|Overall Study|Not treated|0|||
27996006|NCT01132313|81815542|FG011|Overall Study|Not treated|0|||
27996007|NCT01132313|81815531|FG000|Overall Study|Adverse Event|0|||
27996008|NCT01132313|81815532|FG001|Overall Study|Adverse Event|0|||
27996009|NCT01132313|81815533|FG002|Overall Study|Adverse Event|4|||
27996010|NCT01132313|81815534|FG003|Overall Study|Adverse Event|10|||
27996011|NCT01132313|81815535|FG004|Overall Study|Adverse Event|19|||
27996012|NCT01132313|81815536|FG005|Overall Study|Adverse Event|6|||
27996013|NCT01132313|81815537|FG006|Overall Study|Adverse Event|5|||
27996014|NCT01132313|81815538|FG007|Overall Study|Adverse Event|3|||
27996015|NCT01132313|81815539|FG008|Overall Study|Adverse Event|7|||
27996016|NCT01132313|81815540|FG009|Overall Study|Adverse Event|2|||
27996017|NCT01132313|81815541|FG010|Overall Study|Adverse Event|0|||
27996018|NCT01132313|81815542|FG011|Overall Study|Adverse Event|0|||
27579752|NCT00298038|80306688|FG000|Overall Study|Liver Transplant|0|||
27679748|NCT02489968|80664428|FG000|Open-label Treatment Period|Protocol Violation|2|||
27803463|NCT00370396|81111548|FG002|Overall Study|Lost to Follow-up|0|||
27996019|NCT01132313|81815531|FG000|Overall Study|Protocol Violation|0|||
27996020|NCT01132313|81815532|FG001|Overall Study|Protocol Violation|0|||
27679749|NCT02489968|80664429|FG001|Open-label Treatment Period|Protocol Violation|2|||
27803464|NCT01749033|81111552|FG000|Overall Study|Did not receive allocated intervention|3|||
27803465|NCT01749033|81111553|FG001|Overall Study|Did not receive allocated intervention|3|||
27803466|NCT01749033|81111554|FG002|Overall Study|Did not receive allocated intervention|0|||
27996021|NCT01132313|81815533|FG002|Overall Study|Protocol Violation|0|||
27996022|NCT01132313|81815534|FG003|Overall Study|Protocol Violation|1|||
27996023|NCT01132313|81815535|FG004|Overall Study|Protocol Violation|0|||
27996024|NCT01132313|81815536|FG005|Overall Study|Protocol Violation|0|||
27996025|NCT01132313|81815537|FG006|Overall Study|Protocol Violation|0|||
27996026|NCT01132313|81815538|FG007|Overall Study|Protocol Violation|0|||
27996027|NCT01132313|81815539|FG008|Overall Study|Protocol Violation|0|||
27996028|NCT01132313|81815540|FG009|Overall Study|Protocol Violation|0|||
27679750|NCT02489968|80664430|FG002|Open-label Treatment Period|Protocol Violation|0|||
27996029|NCT01132313|81815541|FG010|Overall Study|Protocol Violation|0|||
27996030|NCT01132313|81815542|FG011|Overall Study|Protocol Violation|0|||
27679751|NCT02489968|80664431|FG003|Open-label Treatment Period|Protocol Violation|0|||
27679752|NCT02489968|80664432|FG004|Open-label Treatment Period|Protocol Violation|0|||
27679753|NCT02489968|80664433|FG005|Open-label Treatment Period|Protocol Violation|0|||
27679754|NCT02489968|80664428|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27679755|NCT02489968|80664429|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
27679756|NCT02489968|80664430|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
27679757|NCT02489968|80664431|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
27679758|NCT02489968|80664432|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
27679759|NCT02489968|80664433|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
27679760|NCT02489968|80664428|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
27679761|NCT02489968|80664429|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
27679762|NCT02489968|80664430|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
27679763|NCT02489968|80664431|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
27679764|NCT02489968|80664432|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
27679765|NCT02489968|80664433|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
27679766|NCT02489968|80664428|FG000|Open-label Treatment Period|Other than specified above|204|||
27679767|NCT02489968|80664429|FG001|Open-label Treatment Period|Other than specified above|189|||
27679768|NCT02489968|80664430|FG002|Open-label Treatment Period|Other than specified above|0|||
27679769|NCT02489968|80664431|FG003|Open-label Treatment Period|Other than specified above|0|||
27679770|NCT02489968|80664432|FG004|Open-label Treatment Period|Other than specified above|0|||
27679771|NCT02489968|80664433|FG005|Open-label Treatment Period|Other than specified above|0|||
27679772|NCT02489968|80664428|FG000|Double-blind Treatment Period|Adverse Event|0|||
27679773|NCT02489968|80664429|FG001|Double-blind Treatment Period|Adverse Event|0|||
27679774|NCT02489968|80664430|FG002|Double-blind Treatment Period|Adverse Event|2|||
27679775|NCT02489968|80664431|FG003|Double-blind Treatment Period|Adverse Event|6|||
27679776|NCT02489968|80664432|FG004|Double-blind Treatment Period|Adverse Event|4|||
27679777|NCT02489968|80664433|FG005|Double-blind Treatment Period|Adverse Event|5|||
27679778|NCT02489968|80664428|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27996031|NCT01132313|81815531|FG000|Overall Study|Lost to Follow-up|0|||
27996032|NCT01132313|81815532|FG001|Overall Study|Lost to Follow-up|0|||
27996033|NCT01132313|81815533|FG002|Overall Study|Lost to Follow-up|1|||
27996034|NCT01132313|81815534|FG003|Overall Study|Lost to Follow-up|0|||
27996035|NCT01132313|81815535|FG004|Overall Study|Lost to Follow-up|0|||
27996036|NCT01132313|81815536|FG005|Overall Study|Lost to Follow-up|0|||
27996037|NCT01132313|81815537|FG006|Overall Study|Lost to Follow-up|0|||
27996038|NCT01132313|81815538|FG007|Overall Study|Lost to Follow-up|1|||
27996039|NCT01132313|81815539|FG008|Overall Study|Lost to Follow-up|0|||
27996040|NCT01132313|81815540|FG009|Overall Study|Lost to Follow-up|0|||
27996041|NCT01132313|81815541|FG010|Overall Study|Lost to Follow-up|0|||
27996042|NCT01132313|81815542|FG011|Overall Study|Lost to Follow-up|0|||
27996043|NCT01132313|81815531|FG000|Overall Study|Withdrawal by Subject|0|||
27996044|NCT01132313|81815532|FG001|Overall Study|Withdrawal by Subject|0|||
27996045|NCT01132313|81815533|FG002|Overall Study|Withdrawal by Subject|3|||
27996046|NCT01132313|81815534|FG003|Overall Study|Withdrawal by Subject|3|||
27996047|NCT01132313|81815535|FG004|Overall Study|Withdrawal by Subject|6|||
27996048|NCT01132313|81815536|FG005|Overall Study|Withdrawal by Subject|0|||
27996049|NCT01132313|81815537|FG006|Overall Study|Withdrawal by Subject|1|||
27996050|NCT01132313|81815538|FG007|Overall Study|Withdrawal by Subject|0|||
27996051|NCT01132313|81815539|FG008|Overall Study|Withdrawal by Subject|0|||
27996052|NCT01132313|81815540|FG009|Overall Study|Withdrawal by Subject|2|||
27996053|NCT01132313|81815541|FG010|Overall Study|Withdrawal by Subject|0|||
27996054|NCT01132313|81815542|FG011|Overall Study|Withdrawal by Subject|0|||
27996055|NCT01132313|81815531|FG000|Overall Study|Lack of antiviral response|0|||
27996056|NCT01132313|81815532|FG001|Overall Study|Lack of antiviral response|0|||
27996057|NCT01132313|81815533|FG002|Overall Study|Lack of antiviral response|12|||
27996058|NCT01132313|81815534|FG003|Overall Study|Lack of antiviral response|18|||
27996059|NCT01132313|81815535|FG004|Overall Study|Lack of antiviral response|18|||
27996060|NCT01132313|81815536|FG005|Overall Study|Lack of antiviral response|18|||
27996061|NCT01132313|81815537|FG006|Overall Study|Lack of antiviral response|21|||
27996062|NCT01132313|81815538|FG007|Overall Study|Lack of antiviral response|0|||
27996063|NCT01132313|81815539|FG008|Overall Study|Lack of antiviral response|0|||
27996064|NCT01132313|81815540|FG009|Overall Study|Lack of antiviral response|0|||
27679779|NCT02489968|80664429|FG001|Double-blind Treatment Period|Protocol Violation|0|||
27679780|NCT02489968|80664430|FG002|Double-blind Treatment Period|Protocol Violation|0|||
27803467|NCT01749033|81111552|FG000|Overall Study|Lost to Follow-up|0|||
27803468|NCT01749033|81111553|FG001|Overall Study|Lost to Follow-up|2|||
27996065|NCT01132313|81815541|FG010|Overall Study|Lack of antiviral response|1|||
27996066|NCT01132313|81815542|FG011|Overall Study|Lack of antiviral response|0|||
27996067|NCT01132313|81815531|FG000|Overall Study|Other reason not defined above|0|||
27996068|NCT01132313|81815532|FG001|Overall Study|Other reason not defined above|0|||
27996069|NCT01132313|81815533|FG002|Overall Study|Other reason not defined above|0|||
27996070|NCT01132313|81815534|FG003|Overall Study|Other reason not defined above|0|||
27996071|NCT01132313|81815535|FG004|Overall Study|Other reason not defined above|0|||
27996072|NCT01132313|81815536|FG005|Overall Study|Other reason not defined above|0|||
27996073|NCT01132313|81815537|FG006|Overall Study|Other reason not defined above|0|||
27996074|NCT01132313|81815538|FG007|Overall Study|Other reason not defined above|1|||
27996075|NCT01132313|81815539|FG008|Overall Study|Other reason not defined above|0|||
27996076|NCT01132313|81815540|FG009|Overall Study|Other reason not defined above|0|||
27996077|NCT01132313|81815541|FG010|Overall Study|Other reason not defined above|0|||
27996078|NCT01132313|81815542|FG011|Overall Study|Other reason not defined above|0|||
27996079|NCT01369784|81815546|FG000|Overall Study|Protocol Violation|12|||
27996080|NCT01979952|81815547|FG000|Overall Study|Adverse Event|4|||
27996081|NCT01979952|81815548|FG001|Overall Study|Adverse Event|5|||
27996082|NCT01979952|81815547|FG000|Overall Study|Protocol Violation|1|||
27996083|NCT01979952|81815548|FG001|Overall Study|Protocol Violation|0|||
27996084|NCT01979952|81815547|FG000|Overall Study|Withdrawal by Subject|2|||
27996085|NCT01979952|81815548|FG001|Overall Study|Withdrawal by Subject|1|||
27996086|NCT01979952|81815547|FG000|Overall Study|Other than specified above|1|||
27996087|NCT01979952|81815548|FG001|Overall Study|Other than specified above|0|||
27996088|NCT00742183|81815549|FG000|Overall Study|Adverse Event|2|||
27996089|NCT00742183|81815550|FG001|Overall Study|Adverse Event|2|||
27996090|NCT00742183|81815549|FG000|Overall Study|Death|1|||
27996091|NCT00742183|81815550|FG001|Overall Study|Death|0|||
27996092|NCT00742183|81815549|FG000|Overall Study|Physician Decision|0|||
27996093|NCT00742183|81815550|FG001|Overall Study|Physician Decision|2|||
27996094|NCT00742183|81815549|FG000|Overall Study|Lost to Follow-up|4|||
27996095|NCT00742183|81815550|FG001|Overall Study|Lost to Follow-up|4|||
27996096|NCT00742183|81815549|FG000|Overall Study|Required skin-graft|1|||
27996097|NCT00742183|81815550|FG001|Overall Study|Required skin-graft|1|||
27996098|NCT00742183|81815549|FG000|Overall Study|Withdrawal by Subject|1|||
27996099|NCT00742183|81815550|FG001|Overall Study|Withdrawal by Subject|0|||
27996100|NCT00742183|81815549|FG000|Overall Study|Lack of Efficacy|0|||
27996101|NCT00742183|81815550|FG001|Overall Study|Lack of Efficacy|3|||
27996102|NCT04531241|81815560|FG000|Period 1|Withdrawal by Subject|2|||
27996103|NCT04531241|81815561|FG001|Period 1|Withdrawal by Subject|0|||
27996104|NCT04531241|81815560|FG000|Period 1|Dispesed incorrect lens power|1|||
27996105|NCT04531241|81815561|FG001|Period 1|Dispesed incorrect lens power|0|||
27996106|NCT04531241|81815560|FG000|Period 1|Protocol Violation|1|||
27996107|NCT04531241|81815561|FG001|Period 1|Protocol Violation|0|||
27803469|NCT01749033|81111554|FG002|Overall Study|Lost to Follow-up|1|||
27803470|NCT01201356|81111555|FG000|Overall Study|Adverse Event|170|||
27803471|NCT01201356|81111555|FG000|Overall Study|Abnormal laboratory value(s)|51|||
27803472|NCT01201356|81111555|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27803473|NCT01201356|81111555|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
27803474|NCT01201356|81111555|FG000|Overall Study|Condition no longer requires study drug|12|||
27803475|NCT01201356|81111555|FG000|Overall Study|Withdrawal by Subject|144|||
27803476|NCT01201356|81111555|FG000|Overall Study|Lost to Follow-up|50|||
27803477|NCT01201356|81111555|FG000|Overall Study|administrative problems|74|||
27803478|NCT01201356|81111555|FG000|Overall Study|Death|16|||
27803479|NCT01201356|81111555|FG000|Overall Study|Protocol Violation|12|||
27803480|NCT00297492|81111556|FG000|Set Quit Date|Lost to Follow-up|7|||
27803481|NCT00297492|81111557|FG001|Set Quit Date|Lost to Follow-up|13|||
27803482|NCT00297492|81111558|FG002|Set Quit Date|Lost to Follow-up|5|||
27803483|NCT00297492|81111556|FG000|6 Month Follow-up|Lost to Follow-up|63|||
27803484|NCT00297492|81111557|FG001|6 Month Follow-up|Lost to Follow-up|49|||
27803485|NCT00297492|81111558|FG002|6 Month Follow-up|Lost to Follow-up|27|||
27803486|NCT02419469|81111561|FG000|Overall Study|Withdrawal by Subject|1|||
27803487|NCT00096486|81111562|FG000|Overall Study|Withdrawal by Subject|0|||
27803488|NCT00096486|81111563|FG001|Overall Study|Withdrawal by Subject|0|||
27803489|NCT00096486|81111564|FG002|Overall Study|Withdrawal by Subject|1|||
27872305|NCT01050530|81365218|FG001|Overall Study|Adverse Event|3|||
27803490|NCT00096486|81111565|FG003|Overall Study|Withdrawal by Subject|1|||
27803491|NCT00096486|81111562|FG000|Overall Study|Not Treated|0|||
27803492|NCT00096486|81111563|FG001|Overall Study|Not Treated|0|||
27803493|NCT00096486|81111564|FG002|Overall Study|Not Treated|1|||
27803494|NCT00096486|81111565|FG003|Overall Study|Not Treated|1|||
27803495|NCT00700310|81111566|FG000|Overall Study|Adverse Event|6|||
27803496|NCT00700310|81111567|FG001|Overall Study|Adverse Event|10|||
27872306|NCT01050530|81365217|FG000|Overall Study|Lack of Efficacy|1|||
27872307|NCT01050530|81365218|FG001|Overall Study|Lack of Efficacy|4|||
27803497|NCT00700310|81111568|FG002|Overall Study|Adverse Event|5|||
27803498|NCT00700310|81111569|FG003|Overall Study|Adverse Event|11|||
27803499|NCT00700310|81111566|FG000|Overall Study|Lost to Follow-up|4|||
27803500|NCT00700310|81111567|FG001|Overall Study|Lost to Follow-up|1|||
27872308|NCT01050530|81365217|FG000|Overall Study|Withdrawal by Subject|0|||
27996108|NCT04531241|81815560|FG000|Period 1|No longer eligible|0|||
27996109|NCT04531241|81815561|FG001|Period 1|No longer eligible|1|||
27996110|NCT04531241|81815560|FG000|Period 1|Lens Discomfort|0|||
27803501|NCT00700310|81111568|FG002|Overall Study|Lost to Follow-up|0|||
27803502|NCT00700310|81111569|FG003|Overall Study|Lost to Follow-up|1|||
27803503|NCT00700310|81111566|FG000|Overall Study|Withdrawal by Subject|8|||
27803504|NCT00700310|81111567|FG001|Overall Study|Withdrawal by Subject|9|||
27679781|NCT02489968|80664431|FG003|Double-blind Treatment Period|Protocol Violation|0|||
27679782|NCT02489968|80664432|FG004|Double-blind Treatment Period|Protocol Violation|1|||
27679783|NCT02489968|80664433|FG005|Double-blind Treatment Period|Protocol Violation|1|||
27679784|NCT02489968|80664428|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27679785|NCT02489968|80664429|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27679786|NCT02489968|80664430|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27679787|NCT02489968|80664431|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
27679788|NCT02489968|80664432|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
27679789|NCT02489968|80664433|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
27679790|NCT02489968|80664428|FG000|Double-blind Treatment Period|Other than specified above|0|||
27679791|NCT02489968|80664429|FG001|Double-blind Treatment Period|Other than specified above|0|||
27679792|NCT02489968|80664430|FG002|Double-blind Treatment Period|Other than specified above|0|||
27679793|NCT02489968|80664431|FG003|Double-blind Treatment Period|Other than specified above|0|||
27679794|NCT02489968|80664432|FG004|Double-blind Treatment Period|Other than specified above|1|||
27679795|NCT02489968|80664433|FG005|Double-blind Treatment Period|Other than specified above|0|||
27679796|NCT01725126|80664434|FG000|Overall Study|Protocol Violation|0|||
27679797|NCT01725126|80664435|FG001|Overall Study|Protocol Violation|1|||
27679798|NCT01725126|80664436|FG002|Overall Study|Protocol Violation|0|||
27679799|NCT01725126|80664437|FG003|Overall Study|Protocol Violation|0|||
27679800|NCT01725126|80664438|FG004|Overall Study|Protocol Violation|0|||
27679801|NCT01725126|80664439|FG005|Overall Study|Protocol Violation|0|||
27679802|NCT01725126|80664434|FG000|Overall Study|Withdrawal by Subject|0|||
27679803|NCT01725126|80664435|FG001|Overall Study|Withdrawal by Subject|0|||
27679804|NCT01725126|80664436|FG002|Overall Study|Withdrawal by Subject|0|||
27679805|NCT01725126|80664437|FG003|Overall Study|Withdrawal by Subject|1|||
27872309|NCT01050530|81365218|FG001|Overall Study|Withdrawal by Subject|3|||
27803505|NCT00700310|81111568|FG002|Overall Study|Withdrawal by Subject|8|||
27803506|NCT00700310|81111569|FG003|Overall Study|Withdrawal by Subject|8|||
27803507|NCT00700310|81111566|FG000|Overall Study|Lack of Efficacy|0|||
27803508|NCT00700310|81111567|FG001|Overall Study|Lack of Efficacy|3|||
27803509|NCT00700310|81111568|FG002|Overall Study|Lack of Efficacy|0|||
27803510|NCT00700310|81111569|FG003|Overall Study|Lack of Efficacy|1|||
27803511|NCT00700310|81111566|FG000|Overall Study|Administrative/Other|1|||
27803512|NCT00700310|81111567|FG001|Overall Study|Administrative/Other|3|||
27803513|NCT00700310|81111568|FG002|Overall Study|Administrative/Other|1|||
27803514|NCT00700310|81111569|FG003|Overall Study|Administrative/Other|3|||
27803515|NCT00700310|81111566|FG000|Overall Study|Randomized, Not Treated|2|||
27803516|NCT00700310|81111567|FG001|Overall Study|Randomized, Not Treated|0|||
27803517|NCT00700310|81111568|FG002|Overall Study|Randomized, Not Treated|2|||
27803518|NCT00700310|81111569|FG003|Overall Study|Randomized, Not Treated|2|||
27803519|NCT01074307|81111570|FG000|Overall Study|No primary endpoint evaluation|14|||
27803520|NCT01074307|81111571|FG001|Overall Study|No primary endpoint evaluation|6|||
27803521|NCT01074307|81111570|FG000|Overall Study|Exclusion criterion|0|||
27803522|NCT01074307|81111571|FG001|Overall Study|Exclusion criterion|1|||
27803523|NCT01074307|81111570|FG000|Overall Study|Protocol Violation|8|||
27803524|NCT01074307|81111571|FG001|Overall Study|Protocol Violation|5|||
27803525|NCT00103259|81111574|FG000|Overall Study|Death|3|||
27803526|NCT00103259|81111575|FG001|Overall Study|Death|2|||
27803527|NCT00103259|81111574|FG000|Overall Study|Withdrawal by Subject|2|||
27803528|NCT00103259|81111575|FG001|Overall Study|Withdrawal by Subject|3|||
27803529|NCT00103259|81111574|FG000|Overall Study|alternative therapy|1|||
27803530|NCT00103259|81111575|FG001|Overall Study|alternative therapy|0|||
27803531|NCT00103259|81111574|FG000|Overall Study|other (reasons were not specified)|2|||
27803532|NCT00103259|81111575|FG001|Overall Study|other (reasons were not specified)|1|||
27803533|NCT00103259|81111574|FG000|Overall Study|ineligible/no protocol therapy|4|||
27803534|NCT00103259|81111575|FG001|Overall Study|ineligible/no protocol therapy|6|||
27803535|NCT04444752|81111576|FG000|Overall Study|Adverse Event|1|||
27803536|NCT04444752|81111577|FG001|Overall Study|Adverse Event|0|||
27803537|NCT04444752|81111578|FG002|Overall Study|Adverse Event|0|||
27803538|NCT04444752|81111579|FG003|Overall Study|Adverse Event|2|||
27803539|NCT04444752|81111576|FG000|Overall Study|Lost to Follow-up|2|||
27803540|NCT04444752|81111577|FG001|Overall Study|Lost to Follow-up|6|||
27803541|NCT04444752|81111578|FG002|Overall Study|Lost to Follow-up|2|||
27679806|NCT01725126|80664438|FG004|Overall Study|Withdrawal by Subject|0|||
27679807|NCT01725126|80664439|FG005|Overall Study|Withdrawal by Subject|0|||
27679808|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
27803542|NCT04444752|81111579|FG003|Overall Study|Lost to Follow-up|5|||
27803543|NCT04444752|81111576|FG000|Overall Study|Physician Decision|0|||
27803544|NCT04444752|81111577|FG001|Overall Study|Physician Decision|0|||
27803545|NCT04444752|81111578|FG002|Overall Study|Physician Decision|0|||
27803546|NCT04444752|81111579|FG003|Overall Study|Physician Decision|2|||
27679809|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
27679810|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
27679811|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
27679812|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
27679813|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
27679814|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
27679815|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
27679816|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
27679817|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
27679818|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
27679819|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
27679820|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
27679821|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
27679822|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
27679823|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
27679824|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
27679825|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
27679826|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
27679827|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
27679828|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
27679829|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
27679830|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
27679831|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
27679832|NCT00479882|80664440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
27679833|NCT00479882|80664441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
27679834|NCT00479882|80664442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
27679835|NCT00479882|80664443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
27679836|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
27679837|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
27679838|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
27679839|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
27679840|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
27679841|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
27679842|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
27679843|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
27679844|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
27679845|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
27803547|NCT04444752|81111576|FG000|Overall Study|Pregnancy|0|||
27803548|NCT04444752|81111577|FG001|Overall Study|Pregnancy|0|||
27803549|NCT04444752|81111578|FG002|Overall Study|Pregnancy|0|||
27803550|NCT04444752|81111579|FG003|Overall Study|Pregnancy|1|||
27803551|NCT04444752|81111576|FG000|Overall Study|Withdrawal by Subject|6|||
27803552|NCT04444752|81111577|FG001|Overall Study|Withdrawal by Subject|5|||
27803553|NCT04444752|81111578|FG002|Overall Study|Withdrawal by Subject|3|||
27803554|NCT04444752|81111579|FG003|Overall Study|Withdrawal by Subject|4|||
27803555|NCT04444752|81111576|FG000|Overall Study|Protocol Violation|1|||
27803556|NCT04444752|81111577|FG001|Overall Study|Protocol Violation|1|||
27803557|NCT04444752|81111578|FG002|Overall Study|Protocol Violation|0|||
27803558|NCT04444752|81111579|FG003|Overall Study|Protocol Violation|0|||
27803559|NCT04444752|81111576|FG000|Overall Study|Patient moving out of town|1|||
27803560|NCT04444752|81111577|FG001|Overall Study|Patient moving out of town|0|||
27803561|NCT04444752|81111578|FG002|Overall Study|Patient moving out of town|0|||
27803562|NCT04444752|81111579|FG003|Overall Study|Patient moving out of town|1|||
27803563|NCT04444752|81111576|FG000|Overall Study|Lack of Efficacy|0|||
27803564|NCT04444752|81111577|FG001|Overall Study|Lack of Efficacy|0|||
27803565|NCT04444752|81111578|FG002|Overall Study|Lack of Efficacy|0|||
27803566|NCT04444752|81111579|FG003|Overall Study|Lack of Efficacy|1|||
27803567|NCT04444752|81111576|FG000|Overall Study|Death|0|||
27872310|NCT01050530|81365217|FG000|Overall Study|Protocol Violation|1|||
27803568|NCT04444752|81111577|FG001|Overall Study|Death|0|||
27803569|NCT04444752|81111578|FG002|Overall Study|Death|1|||
27803570|NCT04444752|81111579|FG003|Overall Study|Death|0|||
27803571|NCT01039584|81111582|FG000|Overall Study|Withdrawal by Subject|4|||
27803572|NCT01039584|81111583|FG001|Overall Study|Withdrawal by Subject|2|||
27872311|NCT01050530|81365218|FG001|Overall Study|Protocol Violation|0|||
27803573|NCT01039584|81111584|FG002|Overall Study|Withdrawal by Subject|1|||
27803574|NCT01039584|81111582|FG000|Overall Study|Protocol Violation|10|||
27803575|NCT01039584|81111583|FG001|Overall Study|Protocol Violation|4|||
27803576|NCT01039584|81111584|FG002|Overall Study|Protocol Violation|6|||
27803577|NCT01039584|81111582|FG000|Overall Study|Lost to Follow-up|5|||
27803578|NCT01039584|81111583|FG001|Overall Study|Lost to Follow-up|3|||
27803579|NCT01039584|81111584|FG002|Overall Study|Lost to Follow-up|4|||
27803580|NCT01039584|81111582|FG000|Overall Study|Negative Baseline culture for Candida|59|||
27803581|NCT01039584|81111583|FG001|Overall Study|Negative Baseline culture for Candida|59|||
27803582|NCT01039584|81111584|FG002|Overall Study|Negative Baseline culture for Candida|24|||
27803583|NCT01039584|81111582|FG000|Overall Study|Lack of Efficacy|7|||
27803584|NCT01039584|81111583|FG001|Overall Study|Lack of Efficacy|6|||
27803585|NCT01039584|81111584|FG002|Overall Study|Lack of Efficacy|10|||
27803586|NCT01039584|81111582|FG000|Overall Study|other|1|||
27803587|NCT01039584|81111583|FG001|Overall Study|other|3|||
27803588|NCT01039584|81111584|FG002|Overall Study|other|1|||
27803589|NCT01039584|81111582|FG000|Overall Study|Pap smear with significant pathology|10|||
27803590|NCT01039584|81111583|FG001|Overall Study|Pap smear with significant pathology|10|||
27803591|NCT01039584|81111584|FG002|Overall Study|Pap smear with significant pathology|3|||
27803592|NCT01039584|81111582|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
27803593|NCT01039584|81111583|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
27803594|NCT01039584|81111584|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
27803595|NCT05028751|81111589|FG000|Overall Study|Study Terminated by Sponsor|3|||
27803596|NCT05028751|81111590|FG001|Overall Study|Study Terminated by Sponsor|0|||
27803597|NCT05028751|81111591|FG002|Overall Study|Study Terminated by Sponsor|0|||
27803598|NCT05028751|81111592|FG003|Overall Study|Study Terminated by Sponsor|0|||
27803599|NCT05028751|81111589|FG000|Overall Study|Death|9|||
27803600|NCT05028751|81111590|FG001|Overall Study|Death|3|||
27803601|NCT05028751|81111591|FG002|Overall Study|Death|2|||
27803602|NCT05028751|81111592|FG003|Overall Study|Death|4|||
27803603|NCT05028751|81111589|FG000|Overall Study|Withdrawal by Subject|0|||
27803604|NCT05028751|81111590|FG001|Overall Study|Withdrawal by Subject|0|||
27803605|NCT05028751|81111591|FG002|Overall Study|Withdrawal by Subject|1|||
27803606|NCT05028751|81111592|FG003|Overall Study|Withdrawal by Subject|0|||
27803607|NCT05028751|81111589|FG000|Overall Study|Miscellaneous|2|||
27803608|NCT05028751|81111590|FG001|Overall Study|Miscellaneous|0|||
27803609|NCT05028751|81111591|FG002|Overall Study|Miscellaneous|0|||
27803610|NCT05028751|81111592|FG003|Overall Study|Miscellaneous|0|||
27803611|NCT03118765|81111593|FG000|Overall Study|Withdrawal by Subject|0|||
27803612|NCT03118765|81111594|FG001|Overall Study|Withdrawal by Subject|0|||
27803613|NCT03118765|81111595|FG002|Overall Study|Withdrawal by Subject|1|||
27803614|NCT03118765|81111596|FG003|Overall Study|Withdrawal by Subject|0|||
27803615|NCT03118765|81111597|FG004|Overall Study|Withdrawal by Subject|0|||
27996111|NCT04531241|81815561|FG001|Period 1|Lens Discomfort|1|||
27996112|NCT04531241|81815560|FG000|Period 2|Covid-19 Related|1|||
27996113|NCT04531241|81815561|FG001|Period 2|Covid-19 Related|1|||
27996114|NCT00536471|81815562|FG000|Overall Study|Lost to Follow-up|48|||
27996115|NCT00536471|81815563|FG001|Overall Study|Lost to Follow-up|23|||
27996116|NCT00536471|81815564|FG002|Overall Study|Lost to Follow-up|48|||
27996117|NCT00536471|81815565|FG003|Overall Study|Lost to Follow-up|22|||
27996118|NCT00536471|81815562|FG000|Overall Study|Adverse Event|32|||
27996119|NCT00536471|81815563|FG001|Overall Study|Adverse Event|16|||
27996120|NCT00536471|81815564|FG002|Overall Study|Adverse Event|28|||
27996121|NCT00536471|81815565|FG003|Overall Study|Adverse Event|13|||
27996122|NCT00536471|81815562|FG000|Overall Study|Withdrawal by Subject|40|||
27996123|NCT00536471|81815563|FG001|Overall Study|Withdrawal by Subject|24|||
27996124|NCT00536471|81815564|FG002|Overall Study|Withdrawal by Subject|43|||
27996125|NCT00536471|81815565|FG003|Overall Study|Withdrawal by Subject|21|||
27996126|NCT00536471|81815562|FG000|Overall Study|Lack of Efficacy|17|||
27996127|NCT00536471|81815563|FG001|Overall Study|Lack of Efficacy|18|||
27996128|NCT00536471|81815564|FG002|Overall Study|Lack of Efficacy|11|||
27996129|NCT00536471|81815565|FG003|Overall Study|Lack of Efficacy|9|||
27996130|NCT00536471|81815562|FG000|Overall Study|Protocol Violation|8|||
27996131|NCT00536471|81815563|FG001|Overall Study|Protocol Violation|1|||
27996132|NCT00536471|81815564|FG002|Overall Study|Protocol Violation|2|||
27996133|NCT00536471|81815565|FG003|Overall Study|Protocol Violation|3|||
27996134|NCT00536471|81815562|FG000|Overall Study|Physician Decision|11|||
27996135|NCT00536471|81815563|FG001|Overall Study|Physician Decision|1|||
27996136|NCT00536471|81815564|FG002|Overall Study|Physician Decision|3|||
27579753|NCT00298038|80306689|FG001|Overall Study|Liver Transplant|1|||
27996137|NCT00536471|81815565|FG003|Overall Study|Physician Decision|2|||
27996138|NCT00536471|81815562|FG000|Overall Study|Death|0|||
27579754|NCT00298038|80306688|FG000|Overall Study|Protocol Violation|1|||
27803616|NCT03118765|81111593|FG000|Overall Study|Adverse Event|1|||
27803617|NCT03118765|81111594|FG001|Overall Study|Adverse Event|1|||
27803618|NCT03118765|81111595|FG002|Overall Study|Adverse Event|1|||
27803619|NCT03118765|81111596|FG003|Overall Study|Adverse Event|1|||
27803620|NCT03118765|81111597|FG004|Overall Study|Adverse Event|1|||
27803621|NCT03118765|81111593|FG000|Overall Study|Non compliance with Study Procedures|0|||
27803622|NCT03118765|81111594|FG001|Overall Study|Non compliance with Study Procedures|0|||
27803623|NCT03118765|81111595|FG002|Overall Study|Non compliance with Study Procedures|0|||
27996139|NCT00536471|81815563|FG001|Overall Study|Death|0|||
27996140|NCT00536471|81815564|FG002|Overall Study|Death|1|||
27996141|NCT00536471|81815565|FG003|Overall Study|Death|2|||
27996142|NCT00536471|81815562|FG000|Overall Study|Sponsor Decision|0|||
27996143|NCT00536471|81815563|FG001|Overall Study|Sponsor Decision|1|||
27996144|NCT00536471|81815564|FG002|Overall Study|Sponsor Decision|3|||
27996145|NCT00536471|81815565|FG003|Overall Study|Sponsor Decision|2|||
27996146|NCT04395690|81815566|FG000|Overall Study|Lost to Follow-up|1|||
27996147|NCT04395690|81815567|FG001|Overall Study|Lost to Follow-up|1|||
27996148|NCT01388907|81815568|FG000|Overall Study|Adverse Event|2|||
27996149|NCT01388907|81815569|FG001|Overall Study|Adverse Event|0|||
27996150|NCT03464019|81815570|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
27996151|NCT03464019|81815571|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
27996152|NCT03464019|81815572|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
27996153|NCT03464019|81815570|FG000|NODE-301 Part 1|Ablation|0|||
27996154|NCT03464019|81815571|FG001|NODE-301 Part 1|Ablation|0|||
27996155|NCT03464019|81815572|FG002|NODE-301 Part 1|Ablation|16|||
27996156|NCT03464019|81815570|FG000|NODE-301 Part 1|Test Dose Failure|0|||
27996157|NCT03464019|81815571|FG001|NODE-301 Part 1|Test Dose Failure|0|||
27996158|NCT03464019|81815572|FG002|NODE-301 Part 1|Test Dose Failure|8|||
27996159|NCT03464019|81815570|FG000|NODE-301 Part 1|Adverse Event|0|||
27996160|NCT03464019|81815571|FG001|NODE-301 Part 1|Adverse Event|0|||
27996161|NCT03464019|81815572|FG002|NODE-301 Part 1|Adverse Event|5|||
27996162|NCT03464019|81815570|FG000|NODE-301 Part 1|Physician Decision|0|||
27996163|NCT03464019|81815571|FG001|NODE-301 Part 1|Physician Decision|0|||
27996164|NCT03464019|81815572|FG002|NODE-301 Part 1|Physician Decision|4|||
27996165|NCT03464019|81815570|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
27996166|NCT03464019|81815571|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
27579755|NCT00298038|80306689|FG001|Overall Study|Protocol Violation|3|||
27579756|NCT00298038|80306688|FG000|Overall Study|Death|6|||
27579757|NCT00298038|80306689|FG001|Overall Study|Death|3|||
27579758|NCT00298038|80306688|FG000|Overall Study|Withdrawal by Subject|6|||
27579759|NCT00298038|80306689|FG001|Overall Study|Withdrawal by Subject|9|||
27803624|NCT03118765|81111596|FG003|Overall Study|Non compliance with Study Procedures|1|||
27803625|NCT03118765|81111597|FG004|Overall Study|Non compliance with Study Procedures|0|||
27803626|NCT03118765|81111593|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
27803627|NCT03118765|81111594|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
27803628|NCT03118765|81111595|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
27803629|NCT03118765|81111596|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
27803630|NCT03118765|81111597|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
27803631|NCT03118765|81111593|FG000|Overall Study|COPD Exacerbation|1|||
27803632|NCT03118765|81111594|FG001|Overall Study|COPD Exacerbation|0|||
27803633|NCT03118765|81111595|FG002|Overall Study|COPD Exacerbation|0|||
27803634|NCT03118765|81111596|FG003|Overall Study|COPD Exacerbation|1|||
27803635|NCT03118765|81111597|FG004|Overall Study|COPD Exacerbation|0|||
27803636|NCT03118765|81111593|FG000|Overall Study|Lost to Follow-up|1|||
27803637|NCT03118765|81111594|FG001|Overall Study|Lost to Follow-up|0|||
27803638|NCT03118765|81111595|FG002|Overall Study|Lost to Follow-up|1|||
27803639|NCT03118765|81111596|FG003|Overall Study|Lost to Follow-up|0|||
27803640|NCT03118765|81111597|FG004|Overall Study|Lost to Follow-up|0|||
27803641|NCT03118765|81111593|FG000|Overall Study|Sponsor Decision|1|||
27803642|NCT03118765|81111594|FG001|Overall Study|Sponsor Decision|0|||
27803643|NCT03118765|81111595|FG002|Overall Study|Sponsor Decision|1|||
27803644|NCT03118765|81111596|FG003|Overall Study|Sponsor Decision|0|||
27803645|NCT03118765|81111597|FG004|Overall Study|Sponsor Decision|1|||
27803646|NCT03811249|81111598|FG000|Overall Study|Withdrawal by Subject|44|||
27803647|NCT03811249|81111598|FG000|Overall Study|Missed Visit|24|||
27803648|NCT02496221|81111599|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
27803649|NCT02496221|81111600|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
27803650|NCT02496221|81111599|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
27803651|NCT02496221|81111600|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
27803652|NCT02496221|81111599|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
27803653|NCT02496221|81111600|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
27803654|NCT02576054|81111604|FG000|Overall Study|Withdrawal by Subject|1|||
27803655|NCT00729365|81111609|FG000|Overall Study|Physician Decision|33|||
27803656|NCT00729365|81111610|FG001|Overall Study|Physician Decision|6|||
27996167|NCT03464019|81815572|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
27679846|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
27803657|NCT00729365|81111611|FG002|Overall Study|Physician Decision|7|||
27803658|NCT00481871|81111616|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
27803659|NCT00481871|81111617|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
27803660|NCT00481871|81111618|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
27803661|NCT00481871|81111619|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
27996168|NCT03464019|81815570|FG000|NODE-301 Part 1|Protocol Violation|0|||
27996169|NCT03464019|81815571|FG001|NODE-301 Part 1|Protocol Violation|0|||
27996170|NCT03464019|81815572|FG002|NODE-301 Part 1|Protocol Violation|2|||
27996171|NCT03464019|81815570|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
27996172|NCT03464019|81815571|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
27579760|NCT00298038|80306688|FG000|Overall Study|Adverse Event|8|||
27803662|NCT00481871|81111620|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
27803663|NCT02643966|81111623|FG000|First Screening Round|ineligible|1|||
27803664|NCT02643966|81111623|FG000|First Screening Round|excluded from analysis|2|||
27803665|NCT02643966|81111623|FG000|First Screening Round|Lost to Follow-up|56|||
27803666|NCT02643966|81111623|FG000|First Screening Round|Withdrawal by Subject|28|||
27803667|NCT02643966|81111623|FG000|First Screening Round|Death|1|||
27803668|NCT02643966|81111623|FG000|Between First and Second Screening|Lost to Follow-up|65|||
27803669|NCT02643966|81111623|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
27803670|NCT02643966|81111623|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
27803671|NCT02643966|81111623|FG000|Second Screening Round|Withdrawal by Subject|20|||
27803672|NCT02643966|81111623|FG000|Second Screening Round|Lost to Follow-up|57|||
27803673|NCT02643966|81111623|FG000|Second Screening Round|Physician Decision|2|||
27803674|NCT02643966|81111623|FG000|Second Screening Round|Death|4|||
27803675|NCT02643966|81111623|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
27803676|NCT02643966|81111623|FG000|Between Second and Third Screening|Death|1|||
27803677|NCT02643966|81111623|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
27803678|NCT02643966|81111623|FG000|Third Screening Round|PI excluded|2|||
27803679|NCT02643966|81111623|FG000|Third Screening Round|Lost to Follow-up|241|||
27803680|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803681|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803682|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803683|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
27803684|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803685|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803686|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803687|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803688|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803689|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
27803690|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27803691|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27803692|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Adverse Event|1|||
27803693|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Adverse Event|1|||
27803694|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Adverse Event|1|||
27803695|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Adverse Event|1|||
27872312|NCT00262028|81365219|FG000|Overall Study|Withdrawal by Subject|6|||
27872313|NCT00262028|81365220|FG001|Overall Study|Withdrawal by Subject|3|||
27872314|NCT00262028|81365221|FG002|Overall Study|Withdrawal by Subject|6|||
27872315|NCT00262028|81365222|FG003|Overall Study|Withdrawal by Subject|5|||
27872316|NCT00262028|81365223|FG004|Overall Study|Withdrawal by Subject|2|||
27872317|NCT00262028|81365224|FG005|Overall Study|Withdrawal by Subject|3|||
27872318|NCT00262028|81365225|FG006|Overall Study|Withdrawal by Subject|5|||
27872319|NCT00262028|81365226|FG007|Overall Study|Withdrawal by Subject|7|||
27872320|NCT00262028|81365227|FG008|Overall Study|Withdrawal by Subject|2|||
27872321|NCT00262028|81365219|FG000|Overall Study|Lost to Follow-up|7|||
27872322|NCT00262028|81365220|FG001|Overall Study|Lost to Follow-up|7|||
27803696|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Adverse Event|0|||
27803697|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Adverse Event|0|||
27803698|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Adverse Event|0|||
27803699|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Adverse Event|0|||
27803700|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
27803701|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
27803702|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
27803703|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
27803704|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
27803705|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
27803706|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
27803707|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
27803708|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
27803709|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
27803710|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27803711|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
27803712|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
27872323|NCT00262028|81365221|FG002|Overall Study|Lost to Follow-up|5|||
27872324|NCT00262028|81365222|FG003|Overall Study|Lost to Follow-up|5|||
27872325|NCT00262028|81365223|FG004|Overall Study|Lost to Follow-up|4|||
27872326|NCT00262028|81365224|FG005|Overall Study|Lost to Follow-up|3|||
27872327|NCT00262028|81365225|FG006|Overall Study|Lost to Follow-up|3|||
27996173|NCT03464019|81815572|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
27996174|NCT03464019|81815570|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
27996175|NCT03464019|81815571|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
27872328|NCT00262028|81365226|FG007|Overall Study|Lost to Follow-up|5|||
27872329|NCT00262028|81365227|FG008|Overall Study|Lost to Follow-up|6|||
27872330|NCT00262028|81365219|FG000|Overall Study|Administrative Reason|11|||
27872331|NCT00262028|81365220|FG001|Overall Study|Administrative Reason|14|||
27803713|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
27803714|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
27803715|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
27803716|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
27803717|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
27803718|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
27872332|NCT00262028|81365221|FG002|Overall Study|Administrative Reason|9|||
27579761|NCT00298038|80306689|FG001|Overall Study|Adverse Event|7|||
27579762|NCT00298038|80306688|FG000|Overall Study|Breakthrough overt HE episode|28|||
27803719|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
27803720|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
27803721|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
27803722|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27996176|NCT03464019|81815572|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
27579763|NCT00298038|80306689|FG001|Overall Study|Breakthrough overt HE episode|69|||
27803723|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27996177|NCT03464019|81815570|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
27996178|NCT03464019|81815571|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
27996179|NCT03464019|81815572|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
27996180|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
27996181|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
27996182|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
27996183|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
27996184|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
27579764|NCT00298038|80306688|FG000|Overall Study|Noncompliance|1|||
27872333|NCT00262028|81365222|FG003|Overall Study|Administrative Reason|12|||
27996185|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
27996186|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
27579765|NCT00298038|80306689|FG001|Overall Study|Noncompliance|0|||
27579766|NCT00298038|80306688|FG000|Overall Study|Cocaine Abuse|1|||
27872334|NCT00262028|81365223|FG004|Overall Study|Administrative Reason|6|||
27872335|NCT00262028|81365224|FG005|Overall Study|Administrative Reason|7|||
27872336|NCT00262028|81365225|FG006|Overall Study|Administrative Reason|4|||
27872337|NCT00262028|81365226|FG007|Overall Study|Administrative Reason|6|||
27872338|NCT00262028|81365227|FG008|Overall Study|Administrative Reason|10|||
27872339|NCT00262028|81365219|FG000|Overall Study|Protocol Violation|0|||
27872340|NCT00262028|81365220|FG001|Overall Study|Protocol Violation|0|||
27872341|NCT00262028|81365221|FG002|Overall Study|Protocol Violation|0|||
27872342|NCT00262028|81365222|FG003|Overall Study|Protocol Violation|1|||
27872343|NCT00262028|81365223|FG004|Overall Study|Protocol Violation|0|||
27872344|NCT00262028|81365224|FG005|Overall Study|Protocol Violation|0|||
27872345|NCT00262028|81365225|FG006|Overall Study|Protocol Violation|0|||
27872346|NCT00262028|81365226|FG007|Overall Study|Protocol Violation|0|||
27872347|NCT00262028|81365227|FG008|Overall Study|Protocol Violation|0|||
27872348|NCT00262028|81365219|FG000|Overall Study|Unable to classify|0|||
27872349|NCT00262028|81365220|FG001|Overall Study|Unable to classify|3|||
27872350|NCT00262028|81365221|FG002|Overall Study|Unable to classify|0|||
27872351|NCT00262028|81365222|FG003|Overall Study|Unable to classify|0|||
27872352|NCT00262028|81365223|FG004|Overall Study|Unable to classify|0|||
27872353|NCT00262028|81365224|FG005|Overall Study|Unable to classify|0|||
27872354|NCT00262028|81365225|FG006|Overall Study|Unable to classify|0|||
27872355|NCT00262028|81365226|FG007|Overall Study|Unable to classify|0|||
27872356|NCT00262028|81365227|FG008|Overall Study|Unable to classify|1|||
27872357|NCT02071225|81365228|FG000|Overall Study|Withdrawal of Consent|2|||
27872358|NCT02071225|81365228|FG000|Overall Study|Protocol Deviation|1|||
27996187|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
27996188|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
27996189|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
27996190|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
27996191|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
27996192|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
27996193|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
27996194|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
27996195|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
27996196|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
27996197|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
27996198|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
27996199|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
27996200|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
27996201|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
27996202|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
27996203|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
27996204|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
27996205|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
27996206|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
27996207|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
27996208|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
27996209|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
27996210|NCT03464019|81815570|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
27996211|NCT03464019|81815571|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
27996212|NCT03464019|81815572|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
27996213|NCT02596230|81815573|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
27996214|NCT02596230|81815574|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
27996215|NCT02596230|81815575|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
27996216|NCT02596230|81815576|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
27996217|NCT02596230|81815577|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
27996218|NCT02596230|81815573|FG000|Objective 2, One Year|Lost to Follow-up|0|||
27996219|NCT02596230|81815574|FG001|Objective 2, One Year|Lost to Follow-up|41|||
27996220|NCT02596230|81815575|FG002|Objective 2, One Year|Lost to Follow-up|41|||
27996221|NCT02596230|81815576|FG003|Objective 2, One Year|Lost to Follow-up|32|||
27996222|NCT02596230|81815577|FG004|Objective 2, One Year|Lost to Follow-up|46|||
27996223|NCT02596230|81815573|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
27872359|NCT02071225|81365228|FG000|Overall Study|Lost to Follow-up|2|||
27872360|NCT02071225|81365228|FG000|Overall Study|Death|25|||
27872361|NCT03499067|81365229|FG000|First Intervention|Physician Decision|2|||
27872362|NCT03499067|81365230|FG001|First Intervention|Physician Decision|1|||
27679847|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
27872363|NCT03499067|81365229|FG000|First Intervention|Withdrawal by Subject|3|||
27872364|NCT03499067|81365230|FG001|First Intervention|Withdrawal by Subject|6|||
27872365|NCT00370552|81365231|FG000|Overall Study|Adverse Event|2|||
27872366|NCT00370552|81365232|FG001|Overall Study|Adverse Event|2|||
27872367|NCT00370552|81365233|FG002|Overall Study|Adverse Event|2|||
27872368|NCT00370552|81365231|FG000|Overall Study|Disease progression|23|||
27872369|NCT00370552|81365232|FG001|Overall Study|Disease progression|23|||
27872370|NCT00370552|81365233|FG002|Overall Study|Disease progression|15|||
27872371|NCT00370552|81365231|FG000|Overall Study|Maximum clinical benefit|3|||
27803724|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27803725|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27803726|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27872372|NCT00370552|81365232|FG001|Overall Study|Maximum clinical benefit|5|||
27872373|NCT00370552|81365233|FG002|Overall Study|Maximum clinical benefit|5|||
27872374|NCT00370552|81365231|FG000|Overall Study|Poor or noncompliance|0|||
27872375|NCT00370552|81365232|FG001|Overall Study|Poor or noncompliance|0|||
27872376|NCT00370552|81365233|FG002|Overall Study|Poor or noncompliance|1|||
27872377|NCT00370552|81365231|FG000|Overall Study|Study drug toxicity|11|||
27872378|NCT00370552|81365232|FG001|Overall Study|Study drug toxicity|8|||
27872379|NCT00370552|81365233|FG002|Overall Study|Study drug toxicity|6|||
27872380|NCT00370552|81365231|FG000|Overall Study|Withdrawal by Subject|2|||
27872381|NCT00370552|81365232|FG001|Overall Study|Withdrawal by Subject|0|||
27872382|NCT00370552|81365233|FG002|Overall Study|Withdrawal by Subject|1|||
27872383|NCT00370552|81365231|FG000|Overall Study|Still on treatment|1|||
27872384|NCT00370552|81365232|FG001|Overall Study|Still on treatment|3|||
27872385|NCT00370552|81365233|FG002|Overall Study|Still on treatment|2|||
27872386|NCT00370552|81365231|FG000|Overall Study|Never treated|1|||
27872387|NCT00370552|81365232|FG001|Overall Study|Never treated|0|||
27803727|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
27803728|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27803729|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
27803730|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803731|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803732|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803733|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803734|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
27803735|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
27803736|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803737|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803738|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803739|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
27803740|NCT00950599|81111626|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
27803741|NCT00950599|81111627|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
27803742|NCT00950599|81111628|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
27803743|NCT00950599|81111629|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
27872388|NCT00370552|81365233|FG002|Overall Study|Never treated|0|||
27872389|NCT00370552|81365231|FG000|Overall Study|Physician Decision|1|||
27872390|NCT00370552|81365232|FG001|Overall Study|Physician Decision|1|||
27872391|NCT00370552|81365233|FG002|Overall Study|Physician Decision|0|||
27872392|NCT00370552|81365231|FG000|Overall Study|Investigator decision|2|||
27803744|NCT00950599|81111630|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
27803745|NCT00950599|81111631|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
27803746|NCT00950599|81111632|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
27803747|NCT00950599|81111633|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
27803748|NCT00950599|81111634|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
27803749|NCT00950599|81111635|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
27803750|NCT00950599|81111626|FG000|Follow-Up Period|Adverse Event|0|||
27803751|NCT00950599|81111627|FG001|Follow-Up Period|Adverse Event|0|||
27803752|NCT00950599|81111628|FG002|Follow-Up Period|Adverse Event|0|||
27803753|NCT00950599|81111629|FG003|Follow-Up Period|Adverse Event|0|||
27803754|NCT00950599|81111630|FG004|Follow-Up Period|Adverse Event|0|||
27803755|NCT00950599|81111631|FG005|Follow-Up Period|Adverse Event|0|||
27803756|NCT00950599|81111632|FG006|Follow-Up Period|Adverse Event|0|||
27803757|NCT00950599|81111633|FG007|Follow-Up Period|Adverse Event|0|||
27803758|NCT00950599|81111634|FG008|Follow-Up Period|Adverse Event|1|||
27803759|NCT00950599|81111635|FG009|Follow-Up Period|Adverse Event|0|||
27803760|NCT00950599|81111626|FG000|Follow-Up Period|Lack of Efficacy|0|||
27996224|NCT02596230|81815574|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
27996225|NCT02596230|81815575|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
27996226|NCT02596230|81815576|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
27996227|NCT02596230|81815577|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
27996228|NCT02596230|81815573|FG000|Objective 2, One Year|Adverse drug reaction|0|||
27996229|NCT02596230|81815574|FG001|Objective 2, One Year|Adverse drug reaction|1|||
27996230|NCT02596230|81815575|FG002|Objective 2, One Year|Adverse drug reaction|0|||
27996231|NCT02596230|81815576|FG003|Objective 2, One Year|Adverse drug reaction|0|||
27996232|NCT02596230|81815577|FG004|Objective 2, One Year|Adverse drug reaction|0|||
27996233|NCT02596230|81815573|FG000|Objective 2, One Year|Death|0|||
27996234|NCT02596230|81815574|FG001|Objective 2, One Year|Death|12|||
27996235|NCT02596230|81815575|FG002|Objective 2, One Year|Death|41|||
27996236|NCT02596230|81815576|FG003|Objective 2, One Year|Death|21|||
27996237|NCT02596230|81815577|FG004|Objective 2, One Year|Death|30|||
27996238|NCT02596230|81815573|FG000|Objective 2, One Year|Other|0|||
27996239|NCT02596230|81815574|FG001|Objective 2, One Year|Other|3|||
27996240|NCT02596230|81815575|FG002|Objective 2, One Year|Other|2|||
27996241|NCT02596230|81815576|FG003|Objective 2, One Year|Other|0|||
27996242|NCT02596230|81815577|FG004|Objective 2, One Year|Other|0|||
27996243|NCT01012258|81815578|FG000|Overall Study|Death|14|||
27996244|NCT01012258|81815578|FG000|Overall Study|Lost to Follow-up|1|||
27996245|NCT01012258|81815578|FG000|Overall Study|Adverse Event|1|||
27996246|NCT01012258|81815578|FG000|Overall Study|Progressive Disease (PD)|18|||
27996247|NCT01012258|81815578|FG000|Overall Study|Symptomatic Deterioration|1|||
27996248|NCT01012258|81815578|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
27996249|NCT01012258|81815578|FG000|Overall Study|Another Tumor Discovered|1|||
27996250|NCT01012258|81815578|FG000|Overall Study|Ongoing|29|||
27996251|NCT01397461|81815579|FG000|Overall Study|Withdrawal by Subject|2|||
27996252|NCT01397461|81815580|FG001|Overall Study|Withdrawal by Subject|1|||
27996253|NCT01397461|81815581|FG002|Overall Study|Withdrawal by Subject|0|||
27996254|NCT01397461|81815579|FG000|Overall Study|Lost to Follow-up|0|||
27996255|NCT01397461|81815580|FG001|Overall Study|Lost to Follow-up|2|||
27996256|NCT01397461|81815581|FG002|Overall Study|Lost to Follow-up|1|||
27996257|NCT01397461|81815579|FG000|Overall Study|Lack of Efficacy|0|||
27996258|NCT01397461|81815580|FG001|Overall Study|Lack of Efficacy|3|||
27996259|NCT01397461|81815581|FG002|Overall Study|Lack of Efficacy|0|||
27996260|NCT01397461|81815579|FG000|Overall Study|Not treated|0|||
27996261|NCT01397461|81815580|FG001|Overall Study|Not treated|0|||
27996262|NCT01397461|81815581|FG002|Overall Study|Not treated|1|||
27996263|NCT00930553|81815585|FG000|Overall Study|Adverse Event|1|||
27996264|NCT00930553|81815585|FG000|Overall Study|Lack of Efficacy|7|||
27996265|NCT00930553|81815585|FG000|Overall Study|Physician Decision|39|||
27996266|NCT00930553|81815585|FG000|Overall Study|Protocol Violation|1|||
27996267|NCT00930553|81815585|FG000|Overall Study|Pregnancy|1|||
27996268|NCT00930553|81815585|FG000|Overall Study|Withdrawal by Subject|88|||
27996269|NCT00930553|81815585|FG000|Overall Study|Lost to Follow-up|25|||
27996270|NCT00930553|81815585|FG000|Overall Study|Death|9|||
27996271|NCT00930553|81815585|FG000|Overall Study|Study terminated by sponsor|24|||
27996272|NCT00930553|81815585|FG000|Overall Study|Other than specified above|28|||
27803761|NCT00950599|81111627|FG001|Follow-Up Period|Lack of Efficacy|0|||
27803762|NCT00950599|81111628|FG002|Follow-Up Period|Lack of Efficacy|0|||
27872393|NCT00370552|81365232|FG001|Overall Study|Investigator decision|1|||
27803763|NCT00950599|81111629|FG003|Follow-Up Period|Lack of Efficacy|0|||
27803764|NCT00950599|81111630|FG004|Follow-Up Period|Lack of Efficacy|0|||
27996273|NCT00780416|81815588|FG000|Overall Study|Physician Decision|3|||
27996274|NCT00780416|81815589|FG001|Overall Study|Physician Decision|3|||
27996275|NCT00780416|81815588|FG000|Overall Study|Protocol Violation|1|||
27996276|NCT00780416|81815589|FG001|Overall Study|Protocol Violation|0|||
27996277|NCT00780416|81815588|FG000|Overall Study|Withdrawal by Subject|8|||
27579767|NCT00298038|80306689|FG001|Overall Study|Cocaine Abuse|0|||
27996278|NCT00780416|81815589|FG001|Overall Study|Withdrawal by Subject|6|||
27996279|NCT00413036|81815590|FG000|Overall Study|Adverse Event|44|||
27996280|NCT00413036|81815590|FG000|Overall Study|Lack of Efficacy|129|||
27996281|NCT00413036|81815590|FG000|Overall Study|Withdrawal by Subject|7|||
27996282|NCT00413036|81815590|FG000|Overall Study|Death|9|||
27996283|NCT00413036|81815590|FG000|Overall Study|Other|26|||
27996284|NCT00413036|81815590|FG000|Overall Study|Missing|2|||
27996285|NCT00291018|81815591|FG000|Overall Study|Not Consented or Declined PAS|12|||
27996286|NCT00291018|81815592|FG001|Overall Study|Not Consented or Declined PAS|15|||
27996287|NCT00291018|81815593|FG002|Overall Study|Not Consented or Declined PAS|15|||
27996288|NCT00291018|81815591|FG000|Overall Study|Death|3|||
27996289|NCT00291018|81815592|FG001|Overall Study|Death|3|||
27996290|NCT00291018|81815593|FG002|Overall Study|Death|4|||
27996291|NCT00291018|81815591|FG000|Overall Study|Withdrawal by Subject|2|||
27996292|NCT00291018|81815592|FG001|Overall Study|Withdrawal by Subject|8|||
27996293|NCT00291018|81815593|FG002|Overall Study|Withdrawal by Subject|1|||
27803765|NCT00950599|81111631|FG005|Follow-Up Period|Lack of Efficacy|0|||
27803766|NCT00950599|81111632|FG006|Follow-Up Period|Lack of Efficacy|0|||
27803767|NCT00950599|81111633|FG007|Follow-Up Period|Lack of Efficacy|0|||
27803768|NCT00950599|81111634|FG008|Follow-Up Period|Lack of Efficacy|3|||
27803769|NCT00950599|81111635|FG009|Follow-Up Period|Lack of Efficacy|0|||
27996294|NCT00291018|81815591|FG000|Overall Study|Failures|5|||
27996295|NCT00291018|81815592|FG001|Overall Study|Failures|12|||
27996296|NCT00291018|81815593|FG002|Overall Study|Failures|5|||
27996297|NCT00291018|81815591|FG000|Overall Study|Lost to Follow-up|3|||
27996298|NCT00291018|81815592|FG001|Overall Study|Lost to Follow-up|4|||
27996299|NCT00291018|81815593|FG002|Overall Study|Lost to Follow-up|18|||
27996300|NCT03088917|81815601|FG000|Overall Study|In care/cured elsewhere|15|||
27996301|NCT03088917|81815601|FG000|Overall Study|Refuse re-evaluation|13|||
27996302|NCT03088917|81815601|FG000|Overall Study|Contact not established|13|||
27996303|NCT03088917|81815601|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
27996304|NCT03088917|81815601|FG000|Overall Study|Moved outside study region|50|||
27996305|NCT02598297|81815602|FG000|Overall Study|Study terminated by Sponsor|21|||
27996306|NCT02598297|81815603|FG001|Overall Study|Study terminated by Sponsor|23|||
27996307|NCT02598297|81815602|FG000|Overall Study|Adverse Event|1|||
27996308|NCT02598297|81815603|FG001|Overall Study|Adverse Event|1|||
27996309|NCT02598297|81815602|FG000|Overall Study|Physician Decision|1|||
27996310|NCT02598297|81815603|FG001|Overall Study|Physician Decision|0|||
27996311|NCT02598297|81815602|FG000|Overall Study|Subject/guardian decision|1|||
27996312|NCT02598297|81815603|FG001|Overall Study|Subject/guardian decision|0|||
27996313|NCT02598297|81815602|FG000|Overall Study|Followed for survival|1|||
27996314|NCT02598297|81815603|FG001|Overall Study|Followed for survival|0|||
27996315|NCT02525588|81815608|FG000|Overall Study|Death|3|||
27579768|NCT00298038|80306688|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
27996316|NCT02525588|81815609|FG001|Overall Study|Death|1|||
27996317|NCT02525588|81815608|FG000|Overall Study|Lost to Follow-up|2|||
27996318|NCT02525588|81815609|FG001|Overall Study|Lost to Follow-up|0|||
27996319|NCT02525588|81815608|FG000|Overall Study|Withdrawal by Subject|1|||
27996320|NCT02525588|81815609|FG001|Overall Study|Withdrawal by Subject|1|||
27996321|NCT02525588|81815608|FG000|Overall Study|Adverse Event|0|||
27996322|NCT02525588|81815609|FG001|Overall Study|Adverse Event|1|||
27996323|NCT02454478|81815610|FG000|Overall Study|Incomplete DLT Evaluation|1|||
27996324|NCT04207749|81815611|FG000|Overall Study|Lost to Follow-up|0|||
27996325|NCT04207749|81815612|FG001|Overall Study|Lost to Follow-up|2|||
27579769|NCT00298038|80306689|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
27579770|NCT02809976|80306690|FG000|Overall Study|Lost to Follow-up|1|||
27803770|NCT00950599|81111626|FG000|Follow-Up Period|Lost to Follow-up|0|||
27803771|NCT00950599|81111627|FG001|Follow-Up Period|Lost to Follow-up|0|||
27803772|NCT00950599|81111628|FG002|Follow-Up Period|Lost to Follow-up|0|||
27803773|NCT00950599|81111629|FG003|Follow-Up Period|Lost to Follow-up|0|||
27803774|NCT00950599|81111630|FG004|Follow-Up Period|Lost to Follow-up|0|||
27872394|NCT00370552|81365233|FG002|Overall Study|Investigator decision|0|||
27996326|NCT04207749|81815611|FG000|Overall Study|Protocol Violation|0|||
27996327|NCT04207749|81815612|FG001|Overall Study|Protocol Violation|1|||
27996328|NCT04207749|81815611|FG000|Overall Study|Withdrawal by Subject|3|||
27996329|NCT04207749|81815612|FG001|Overall Study|Withdrawal by Subject|0|||
27996330|NCT04207749|81815611|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
27996331|NCT04207749|81815612|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
27996332|NCT04071158|81815616|FG000|Overall Study|Lost to Follow-up|1|||
27996333|NCT04071158|81815617|FG001|Overall Study|Lost to Follow-up|2|||
27996334|NCT04071158|81815618|FG002|Overall Study|Lost to Follow-up|3|||
27996335|NCT04071158|81815619|FG003|Overall Study|Lost to Follow-up|3|||
27996336|NCT04071158|81815620|FG004|Overall Study|Lost to Follow-up|5|||
27996337|NCT04071158|81815616|FG000|Overall Study|Randomized but not treated|2|||
27579771|NCT02809976|80306690|FG000|Overall Study|Withdrawal by Subject|1|||
27996338|NCT04071158|81815617|FG001|Overall Study|Randomized but not treated|2|||
27996339|NCT04071158|81815618|FG002|Overall Study|Randomized but not treated|0|||
27872395|NCT00370552|81365231|FG000|Overall Study|High risk of allergic reaction|0|||
27872396|NCT00370552|81365232|FG001|Overall Study|High risk of allergic reaction|1|||
27872397|NCT00370552|81365233|FG002|Overall Study|High risk of allergic reaction|0|||
27872398|NCT00370552|81365231|FG000|Overall Study|Planned radiation for palliation|0|||
27872399|NCT00370552|81365232|FG001|Overall Study|Planned radiation for palliation|1|||
27872400|NCT00370552|81365233|FG002|Overall Study|Planned radiation for palliation|0|||
27872401|NCT00153179|81365234|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
27872402|NCT00153179|81365235|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
27872403|NCT00153179|81365236|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
27872404|NCT00153179|81365237|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
27803775|NCT00950599|81111631|FG005|Follow-Up Period|Lost to Follow-up|0|||
27579772|NCT01412424|80306691|FG000|Core Treatment Period|Treatment Failure|24|||
27579773|NCT01412424|80306691|FG000|Core Treatment Period|Adverse Event|21|||
27579774|NCT01412424|80306691|FG000|Core Treatment Period|Patient Request|5|||
27803776|NCT00950599|81111632|FG006|Follow-Up Period|Lost to Follow-up|0|||
27803777|NCT00950599|81111633|FG007|Follow-Up Period|Lost to Follow-up|0|||
27803778|NCT00950599|81111634|FG008|Follow-Up Period|Lost to Follow-up|5|||
27803779|NCT00950599|81111635|FG009|Follow-Up Period|Lost to Follow-up|1|||
27803780|NCT00950599|81111626|FG000|Follow-Up Period|Physician Decision|0|||
27803781|NCT00950599|81111627|FG001|Follow-Up Period|Physician Decision|0|||
27803782|NCT00950599|81111628|FG002|Follow-Up Period|Physician Decision|0|||
27803783|NCT00950599|81111629|FG003|Follow-Up Period|Physician Decision|0|||
27803784|NCT00950599|81111630|FG004|Follow-Up Period|Physician Decision|0|||
27803785|NCT00950599|81111631|FG005|Follow-Up Period|Physician Decision|0|||
27803786|NCT00950599|81111632|FG006|Follow-Up Period|Physician Decision|0|||
27803787|NCT00950599|81111633|FG007|Follow-Up Period|Physician Decision|0|||
27803788|NCT00950599|81111634|FG008|Follow-Up Period|Physician Decision|1|||
27803789|NCT00950599|81111635|FG009|Follow-Up Period|Physician Decision|0|||
27803790|NCT00950599|81111626|FG000|Follow-Up Period|Poor/Noncompliance|0|||
27803791|NCT00950599|81111627|FG001|Follow-Up Period|Poor/Noncompliance|0|||
27803792|NCT00950599|81111628|FG002|Follow-Up Period|Poor/Noncompliance|0|||
27803793|NCT00950599|81111629|FG003|Follow-Up Period|Poor/Noncompliance|0|||
27803794|NCT00950599|81111630|FG004|Follow-Up Period|Poor/Noncompliance|0|||
27803795|NCT00950599|81111631|FG005|Follow-Up Period|Poor/Noncompliance|0|||
27803796|NCT00950599|81111632|FG006|Follow-Up Period|Poor/Noncompliance|0|||
27803797|NCT00950599|81111633|FG007|Follow-Up Period|Poor/Noncompliance|0|||
27803798|NCT00950599|81111634|FG008|Follow-Up Period|Poor/Noncompliance|1|||
27803799|NCT00950599|81111635|FG009|Follow-Up Period|Poor/Noncompliance|0|||
27803800|NCT00950599|81111626|FG000|Follow-Up Period|Subject withdrew Consent|0|||
27803801|NCT00950599|81111627|FG001|Follow-Up Period|Subject withdrew Consent|0|||
27803802|NCT00950599|81111628|FG002|Follow-Up Period|Subject withdrew Consent|0|||
27803803|NCT00950599|81111629|FG003|Follow-Up Period|Subject withdrew Consent|0|||
27803804|NCT00950599|81111630|FG004|Follow-Up Period|Subject withdrew Consent|0|||
27803805|NCT00950599|81111631|FG005|Follow-Up Period|Subject withdrew Consent|0|||
27803806|NCT00950599|81111632|FG006|Follow-Up Period|Subject withdrew Consent|0|||
27803807|NCT00950599|81111633|FG007|Follow-Up Period|Subject withdrew Consent|0|||
27803808|NCT00950599|81111634|FG008|Follow-Up Period|Subject withdrew Consent|2|||
27803809|NCT00950599|81111635|FG009|Follow-Up Period|Subject withdrew Consent|1|||
27803810|NCT02683187|81111636|FG000|Overall Study|Failed IV access|3|||
27803811|NCT02683187|81111636|FG000|Overall Study|Withdrawal by Subject|5|||
27803812|NCT00931385|81111637|FG000|Overall Study|Adverse Event|2|||
27803813|NCT00931385|81111638|FG001|Overall Study|Adverse Event|1|||
27803814|NCT00931385|81111639|FG002|Overall Study|Adverse Event|0|||
27803815|NCT00931385|81111640|FG003|Overall Study|Adverse Event|3|||
27803816|NCT00931385|81111637|FG000|Overall Study|Protocol Violation|0|||
27803817|NCT00931385|81111638|FG001|Overall Study|Protocol Violation|0|||
27803818|NCT00931385|81111639|FG002|Overall Study|Protocol Violation|1|||
27872405|NCT01112059|81365238|FG000|Overall Study|Withdrawal by Subject|1|||
27872406|NCT01112059|81365239|FG001|Overall Study|Withdrawal by Subject|0|||
27872407|NCT04700137|81365241|FG000|Overall Study|Lost to Follow-up|1|||
27579775|NCT01412424|80306691|FG000|Core Treatment Period|Lost to Follow-up|2|||
27579776|NCT01412424|80306691|FG000|Core Treatment Period|Sponsor Request|1|||
27803819|NCT00931385|81111640|FG003|Overall Study|Protocol Violation|0|||
27803820|NCT00931385|81111637|FG000|Overall Study|Withdrawal by Subject|0|||
27803821|NCT00931385|81111638|FG001|Overall Study|Withdrawal by Subject|1|||
27803822|NCT00931385|81111639|FG002|Overall Study|Withdrawal by Subject|0|||
27872408|NCT04700137|81365242|FG001|Overall Study|Lost to Follow-up|6|||
27872409|NCT04700137|81365243|FG002|Overall Study|Lost to Follow-up|1|||
27872410|NCT04700137|81365244|FG003|Overall Study|Lost to Follow-up|1|||
27872411|NCT04700137|81365241|FG000|Overall Study|Withdrawal by Subject|0|||
27872412|NCT04700137|81365242|FG001|Overall Study|Withdrawal by Subject|0|||
27872413|NCT04700137|81365243|FG002|Overall Study|Withdrawal by Subject|1|||
27872414|NCT04700137|81365244|FG003|Overall Study|Withdrawal by Subject|0|||
27872415|NCT04700137|81365241|FG000|Overall Study|Death|0|||
27872416|NCT04700137|81365242|FG001|Overall Study|Death|0|||
27872417|NCT04700137|81365243|FG002|Overall Study|Death|1|||
27872418|NCT04700137|81365244|FG003|Overall Study|Death|0|||
27872419|NCT03022370|81365245|FG000|Overall Study|Death|6|||
27872420|NCT03022370|81365246|FG001|Overall Study|Death|12|||
27872421|NCT03022370|81365245|FG000|Overall Study|Lost to Follow-up|174|||
27679848|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
27679849|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
27679850|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
27679851|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
27679852|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
27679853|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
27679854|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
27679855|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
27679856|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
27679857|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
27679858|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
27803823|NCT00931385|81111640|FG003|Overall Study|Withdrawal by Subject|1|||
27803824|NCT00931385|81111637|FG000|Overall Study|Lost to Follow-up|0|||
27803825|NCT00931385|81111638|FG001|Overall Study|Lost to Follow-up|0|||
27803826|NCT00931385|81111639|FG002|Overall Study|Lost to Follow-up|0|||
27803827|NCT00931385|81111640|FG003|Overall Study|Lost to Follow-up|1|||
27803828|NCT03255031|81113757|FG000|Overall Study|Adverse Event|5|||
27803829|NCT03255031|81113758|FG001|Overall Study|Adverse Event|3|||
27803830|NCT03255031|81113757|FG000|Overall Study|Physician Decision|2|||
27803831|NCT03255031|81113758|FG001|Overall Study|Physician Decision|1|||
27803832|NCT03255031|81113757|FG000|Overall Study|Withdrawal by Subject|9|||
27803833|NCT03255031|81113758|FG001|Overall Study|Withdrawal by Subject|3|||
27803834|NCT02092961|81113759|FG000|Overall Study|Not reported|1|||
27803835|NCT02092961|81113760|FG001|Overall Study|Not reported|0|||
27803836|NCT02092961|81113761|FG002|Overall Study|Not reported|1|||
27803837|NCT02092961|81113759|FG000|Overall Study|Study stopped|13|||
27803838|NCT02092961|81113760|FG001|Overall Study|Study stopped|9|||
27803839|NCT02092961|81113761|FG002|Overall Study|Study stopped|12|||
27803840|NCT02092961|81113759|FG000|Overall Study|Lack of therapeutic response|2|||
27803841|NCT02092961|81113760|FG001|Overall Study|Lack of therapeutic response|1|||
27803842|NCT02092961|81113761|FG002|Overall Study|Lack of therapeutic response|3|||
27803843|NCT02092961|81113759|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
27803844|NCT02092961|81113760|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
27803845|NCT02092961|81113761|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
27803846|NCT02092961|81113759|FG000|Overall Study|Adverse Event|2|||
27803847|NCT02092961|81113760|FG001|Overall Study|Adverse Event|4|||
27803848|NCT02092961|81113761|FG002|Overall Study|Adverse Event|0|||
27803849|NCT02280356|81113762|FG000|Overall Study|Not Treated|2|||
27803850|NCT02280356|81113762|FG000|Overall Study|Withdrawal by Subject|1|||
27803851|NCT02280356|81113762|FG000|Overall Study|Not evaluable|2|||
27679859|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
27679860|NCT00479882|80664440|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
27803852|NCT03125629|81113763|FG000|Overall Study|Withdrawal by Subject|2|||
27803853|NCT03125629|81113763|FG000|Overall Study|Equipment malfunction|1|||
27803854|NCT03031431|81113764|FG000|Overall Study|Infant removed by maternal request|1|||
27803855|NCT01401478|81113765|FG000|Overall Study|Study drug not available|6|||
27872422|NCT03022370|81365246|FG001|Overall Study|Lost to Follow-up|109|||
27872423|NCT02854527|81365248|FG000|Overall Study|Adverse Event|0|||
27872424|NCT02854527|81365249|FG001|Overall Study|Adverse Event|0|||
27872425|NCT02854527|81365250|FG002|Overall Study|Adverse Event|0|||
27872426|NCT02854527|81365251|FG003|Overall Study|Adverse Event|0|||
27872427|NCT02854527|81365252|FG004|Overall Study|Adverse Event|1|||
27803856|NCT01401478|81113765|FG000|Overall Study|Adverse Event|5|||
27803857|NCT01401478|81113765|FG000|Overall Study|Hyperphosphatemia|5|||
27872428|NCT02854527|81365253|FG005|Overall Study|Adverse Event|0|||
27803858|NCT01401478|81113765|FG000|Overall Study|Lost to Follow-up|5|||
27803859|NCT01401478|81113765|FG000|Overall Study|Kidney transplantation|3|||
27803860|NCT01401478|81113765|FG000|Overall Study|Withdrawal by Subject|3|||
27803861|NCT01401478|81113765|FG000|Overall Study|Blood samples not available|1|||
27803862|NCT01401478|81113765|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
27803863|NCT01401478|81113765|FG000|Overall Study|Low intact parathyroid hormone|1|||
27803864|NCT01401478|81113765|FG000|Overall Study|Serious adverse event|1|||
27803865|NCT01440595|81113768|FG000|Overall Study|Lost to Follow-up|0|||
27803866|NCT01440595|81113769|FG001|Overall Study|Lost to Follow-up|1|||
27803867|NCT01440595|81113770|FG002|Overall Study|Lost to Follow-up|0|||
27803868|NCT01440595|81113768|FG000|Overall Study|Study terminated by sponsor.|1|||
27803869|NCT01440595|81113769|FG001|Overall Study|Study terminated by sponsor.|2|||
27803870|NCT01440595|81113770|FG002|Overall Study|Study terminated by sponsor.|1|||
27803871|NCT03456726|81113773|FG000|Overall Study|Disease Progression|6|||
27803872|NCT03456726|81113774|FG001|Overall Study|Disease Progression|1|||
27803873|NCT03456726|81113773|FG000|Overall Study|Adverse Event|4|||
27803874|NCT03456726|81113774|FG001|Overall Study|Adverse Event|2|||
27803875|NCT03456726|81113773|FG000|Overall Study|Withdrawal by Subject|1|||
27803876|NCT03456726|81113774|FG001|Overall Study|Withdrawal by Subject|0|||
27803877|NCT03456726|81113773|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
27803878|NCT03456726|81113774|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
27803879|NCT00363129|81113775|FG000|Overall Study|Withdrawal by Subject|11|||
27803880|NCT00363129|81113776|FG001|Overall Study|Withdrawal by Subject|18|||
27803881|NCT00363129|81113775|FG000|Overall Study|Adverse Event|8|||
27803882|NCT00363129|81113776|FG001|Overall Study|Adverse Event|3|||
27803883|NCT00363129|81113775|FG000|Overall Study|Alternate Treatment|2|||
27803884|NCT00363129|81113776|FG001|Overall Study|Alternate Treatment|4|||
27803885|NCT00363129|81113775|FG000|Overall Study|Other Medical Problems|2|||
27803886|NCT00363129|81113776|FG001|Overall Study|Other Medical Problems|4|||
27803887|NCT00363129|81113775|FG000|Overall Study|Death|0|||
27803888|NCT00363129|81113776|FG001|Overall Study|Death|1|||
27803889|NCT00363129|81113775|FG000|Overall Study|Other Reasons|6|||
27803890|NCT00363129|81113776|FG001|Overall Study|Other Reasons|3|||
27803891|NCT00854620|81113777|FG000|Overall Study|Adverse Event|1|||
27803892|NCT01462695|81113778|FG000|Overall Study|Adverse Event|1|||
27803893|NCT01462695|81113779|FG001|Overall Study|Adverse Event|1|||
27803894|NCT01462695|81113778|FG000|Overall Study|Death|2|||
27872429|NCT02854527|81365254|FG006|Overall Study|Adverse Event|0|||
27872430|NCT02854527|81365255|FG007|Overall Study|Adverse Event|0|||
27579777|NCT01412424|80306691|FG000|Extension Treatment Period|Adverse Event|2|||
27803895|NCT01462695|81113779|FG001|Overall Study|Death|0|||
27803896|NCT01462695|81113778|FG000|Overall Study|Lack of Efficacy|6|||
27803897|NCT01462695|81113779|FG001|Overall Study|Lack of Efficacy|12|||
27803898|NCT01462695|81113778|FG000|Overall Study|Physician Decision|5|||
27803899|NCT01462695|81113779|FG001|Overall Study|Physician Decision|0|||
27803900|NCT01462695|81113778|FG000|Overall Study|Withdrawal by Subject|2|||
27996340|NCT04071158|81815619|FG003|Overall Study|Randomized but not treated|0|||
27996341|NCT04071158|81815620|FG004|Overall Study|Randomized but not treated|0|||
27996342|NCT01219985|81815621|FG000|Overall Study|Physician Decision|20|||
27996343|NCT00394706|81815622|FG000|Overall Study|Withdrawal by Subject|2|||
27996344|NCT00394706|81815623|FG001|Overall Study|Withdrawal by Subject|0|||
27996345|NCT00394706|81815624|FG002|Overall Study|Withdrawal by Subject|1|||
27996346|NCT00394706|81815625|FG003|Overall Study|Withdrawal by Subject|0|||
27996347|NCT00394706|81815626|FG004|Overall Study|Withdrawal by Subject|0|||
27996348|NCT00394706|81815627|FG005|Overall Study|Withdrawal by Subject|2|||
27996349|NCT00394706|81815628|FG006|Overall Study|Withdrawal by Subject|1|||
27579778|NCT01412424|80306691|FG000|Extension Treatment Period|Treatment Failure|2|||
27579779|NCT01412424|80306691|FG000|Extension Treatment Period|Patient Request|2|||
27579780|NCT00733824|80306706|FG000|Phase I|Withdrawal by Subject|1|||
27579781|NCT00733824|80306707|FG001|Phase I|Withdrawal by Subject|0|||
27579782|NCT00733824|80306708|FG002|Phase I|Withdrawal by Subject|0|||
27579783|NCT00733824|80306709|FG003|Phase I|Withdrawal by Subject|0|||
27579784|NCT00733824|80306710|FG004|Phase I|Withdrawal by Subject|0|||
27579785|NCT02742103|80306711|FG000|Overall Study|Protocol Violation|1|||
27579786|NCT02742103|80306712|FG001|Overall Study|Protocol Violation|0|||
27579787|NCT02742103|80306711|FG000|Overall Study|Death|2|||
27579788|NCT02742103|80306712|FG001|Overall Study|Death|2|||
27579789|NCT02742103|80306711|FG000|Overall Study|Adverse Event|1|||
27579790|NCT02742103|80306712|FG001|Overall Study|Adverse Event|0|||
27579791|NCT02742103|80306711|FG000|Overall Study|Moved to another town|0|||
27579792|NCT02742103|80306712|FG001|Overall Study|Moved to another town|1|||
27996350|NCT00394706|81815629|FG007|Overall Study|Withdrawal by Subject|0|||
27996351|NCT00394706|81815622|FG000|Overall Study|Lost to Follow-up|2|||
27996352|NCT00394706|81815623|FG001|Overall Study|Lost to Follow-up|2|||
27996353|NCT00394706|81815624|FG002|Overall Study|Lost to Follow-up|8|||
27996354|NCT00394706|81815625|FG003|Overall Study|Lost to Follow-up|1|||
27996355|NCT00394706|81815626|FG004|Overall Study|Lost to Follow-up|2|||
27996356|NCT00394706|81815627|FG005|Overall Study|Lost to Follow-up|5|||
27996357|NCT00394706|81815628|FG006|Overall Study|Lost to Follow-up|2|||
27996358|NCT00394706|81815629|FG007|Overall Study|Lost to Follow-up|0|||
27579793|NCT02742103|80306711|FG000|Overall Study|Withdrawal by Subject|5|||
27679861|NCT00479882|80664441|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
27996359|NCT04079816|81815630|FG000|Overall Study|Request of Subject|2|||
27996360|NCT04079816|81815630|FG000|Overall Study|Unable to draw samples|1|||
27996361|NCT00650767|81815631|FG000|Overall Study|Adverse Event|0|||
27996362|NCT00650767|81815632|FG001|Overall Study|Adverse Event|3|||
27996363|NCT00650767|81815633|FG002|Overall Study|Adverse Event|10|||
27996364|NCT00650767|81815634|FG003|Overall Study|Adverse Event|8|||
27579794|NCT02742103|80306712|FG001|Overall Study|Withdrawal by Subject|2|||
27579795|NCT00377676|80306717|FG000|Overall Study|Adverse Event|498|||
27579796|NCT00377676|80306718|FG001|Overall Study|Adverse Event|107|||
27579797|NCT00377676|80306717|FG000|Overall Study|Protocol Violation|33|||
27679862|NCT00479882|80664442|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
27579798|NCT00377676|80306718|FG001|Overall Study|Protocol Violation|27|||
27803901|NCT01462695|81113779|FG001|Overall Study|Withdrawal by Subject|0|||
27803902|NCT01462695|81113778|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
27803903|NCT01462695|81113779|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
27803904|NCT02082912|81113785|FG000|Overall Study|Physician Decision|0|||
27803905|NCT02082912|81113786|FG001|Overall Study|Physician Decision|1|||
27803906|NCT01537549|81113793|FG000|Overall Study|Lost to Follow-up|1|||
27803907|NCT01537549|81113793|FG000|Overall Study|Withdrawal by Subject|2|||
27803908|NCT00305110|81113796|FG000|Overall Study|Missing data|29|||
27803909|NCT01902134|81113797|FG000|Overall Study|Adverse Event|3|||
27803910|NCT01902134|81113798|FG001|Overall Study|Adverse Event|1|||
27803911|NCT01902134|81113799|FG002|Overall Study|Adverse Event|2|||
27803912|NCT01902134|81113800|FG003|Overall Study|Adverse Event|1|||
27803913|NCT01902134|81113801|FG004|Overall Study|Adverse Event|1|||
27803914|NCT01902134|81113802|FG005|Overall Study|Adverse Event|3|||
27803915|NCT01902134|81113797|FG000|Overall Study|Lack of Efficacy|0|||
27803916|NCT01902134|81113798|FG001|Overall Study|Lack of Efficacy|0|||
27803917|NCT01902134|81113799|FG002|Overall Study|Lack of Efficacy|2|||
27803918|NCT01902134|81113800|FG003|Overall Study|Lack of Efficacy|0|||
27803919|NCT01902134|81113801|FG004|Overall Study|Lack of Efficacy|0|||
27803920|NCT01902134|81113802|FG005|Overall Study|Lack of Efficacy|1|||
27803921|NCT01902134|81113797|FG000|Overall Study|Physician Decision|0|||
27803922|NCT01902134|81113798|FG001|Overall Study|Physician Decision|1|||
27803923|NCT01902134|81113799|FG002|Overall Study|Physician Decision|0|||
27803924|NCT01902134|81113800|FG003|Overall Study|Physician Decision|0|||
27803925|NCT01902134|81113801|FG004|Overall Study|Physician Decision|0|||
27803926|NCT01902134|81113802|FG005|Overall Study|Physician Decision|0|||
27803927|NCT01902134|81113797|FG000|Overall Study|Protocol Violation|0|||
27803928|NCT01902134|81113798|FG001|Overall Study|Protocol Violation|0|||
27803929|NCT01902134|81113799|FG002|Overall Study|Protocol Violation|0|||
27803930|NCT01902134|81113800|FG003|Overall Study|Protocol Violation|0|||
27803931|NCT01902134|81113801|FG004|Overall Study|Protocol Violation|0|||
27803932|NCT01902134|81113802|FG005|Overall Study|Protocol Violation|1|||
27803933|NCT01902134|81113797|FG000|Overall Study|Withdrawal by Subject|4|||
27803934|NCT01902134|81113798|FG001|Overall Study|Withdrawal by Subject|8|||
27803935|NCT01902134|81113799|FG002|Overall Study|Withdrawal by Subject|9|||
27803936|NCT01902134|81113800|FG003|Overall Study|Withdrawal by Subject|1|||
27803937|NCT01902134|81113801|FG004|Overall Study|Withdrawal by Subject|5|||
27803938|NCT01902134|81113802|FG005|Overall Study|Withdrawal by Subject|4|||
27803939|NCT01902134|81113797|FG000|Overall Study|no compliance|1|||
27803940|NCT01902134|81113798|FG001|Overall Study|no compliance|0|||
27803941|NCT01902134|81113799|FG002|Overall Study|no compliance|0|||
27803942|NCT01902134|81113800|FG003|Overall Study|no compliance|0|||
27803943|NCT01902134|81113801|FG004|Overall Study|no compliance|0|||
27803944|NCT01902134|81113802|FG005|Overall Study|no compliance|0|||
27803945|NCT01902134|81113797|FG000|Overall Study|Other|0|||
27803946|NCT01902134|81113798|FG001|Overall Study|Other|1|||
27803947|NCT01902134|81113799|FG002|Overall Study|Other|2|||
27803948|NCT01902134|81113800|FG003|Overall Study|Other|0|||
27803949|NCT01902134|81113801|FG004|Overall Study|Other|1|||
27803950|NCT01902134|81113802|FG005|Overall Study|Other|0|||
27803951|NCT01190098|81113803|FG000|Overall Study|Adverse Event|2|||
27803952|NCT01190098|81113804|FG001|Overall Study|Adverse Event|0|||
27803953|NCT01190098|81113803|FG000|Overall Study|Patient coomorbidity|0|||
27803954|NCT01190098|81113804|FG001|Overall Study|Patient coomorbidity|1|||
27803955|NCT01190098|81113803|FG000|Overall Study|Lack of transportation|1|||
27803956|NCT01190098|81113804|FG001|Overall Study|Lack of transportation|0|||
27803957|NCT01190098|81113803|FG000|Overall Study|Other|0|||
27803958|NCT01190098|81113804|FG001|Overall Study|Other|1|||
27579799|NCT00377676|80306717|FG000|Overall Study|Death|5|||
27803959|NCT01463683|81113808|FG000|Overall Study|Adverse Event|2|||
27803960|NCT01463683|81113809|FG001|Overall Study|Adverse Event|0|||
27803961|NCT01463683|81113810|FG002|Overall Study|Adverse Event|0|||
27803962|NCT01463683|81113808|FG000|Overall Study|Lost to Follow-up|10|||
27803963|NCT01463683|81113809|FG001|Overall Study|Lost to Follow-up|9|||
27803964|NCT01463683|81113810|FG002|Overall Study|Lost to Follow-up|7|||
27803965|NCT01463683|81113808|FG000|Overall Study|Physician Decision|0|||
27803966|NCT01463683|81113809|FG001|Overall Study|Physician Decision|3|||
27803967|NCT01463683|81113810|FG002|Overall Study|Physician Decision|1|||
27803968|NCT01463683|81113808|FG000|Overall Study|Pregnancy|2|||
27803969|NCT01463683|81113809|FG001|Overall Study|Pregnancy|2|||
27803970|NCT01463683|81113810|FG002|Overall Study|Pregnancy|1|||
27803971|NCT01463683|81113808|FG000|Overall Study|Withdrawal by Subject|5|||
27803972|NCT01463683|81113809|FG001|Overall Study|Withdrawal by Subject|17|||
27803973|NCT01463683|81113810|FG002|Overall Study|Withdrawal by Subject|2|||
27803974|NCT00304954|81113811|FG000|Overall Study|Withdrawal by Subject|0|||
27803975|NCT00304954|81113812|FG001|Overall Study|Withdrawal by Subject|0|||
27803976|NCT00304954|81113813|FG002|Overall Study|Withdrawal by Subject|1|||
27803977|NCT00304954|81113814|FG003|Overall Study|Withdrawal by Subject|0|||
27803978|NCT00304954|81113811|FG000|Overall Study|Adverse Event|1|||
27803979|NCT00304954|81113812|FG001|Overall Study|Adverse Event|0|||
27803980|NCT00304954|81113813|FG002|Overall Study|Adverse Event|0|||
27803981|NCT00304954|81113814|FG003|Overall Study|Adverse Event|0|||
27803982|NCT02746705|81113818|FG000|Overall Study|Physician Decision|1|||
27803983|NCT02746705|81113819|FG001|Overall Study|Physician Decision|1|||
27803984|NCT02746705|81113818|FG000|Overall Study|Lost to Follow-up|1|||
27803985|NCT02746705|81113819|FG001|Overall Study|Lost to Follow-up|0|||
27803986|NCT02746705|81113818|FG000|Overall Study|outlier scores deemed not valid|0|||
27579800|NCT00377676|80306718|FG001|Overall Study|Death|2|||
27579801|NCT00377676|80306717|FG000|Overall Study|Withdrawal by Subject|187|||
27579802|NCT00377676|80306718|FG001|Overall Study|Withdrawal by Subject|72|||
27579803|NCT00377676|80306717|FG000|Overall Study|Lost to Follow-up|120|||
27803987|NCT02746705|81113819|FG001|Overall Study|outlier scores deemed not valid|1|||
27803988|NCT02623426|81113827|FG000|Overall Study|Lost to Follow-up|0|||
27803989|NCT02623426|81113828|FG001|Overall Study|Lost to Follow-up|0|||
27803990|NCT02623426|81113829|FG002|Overall Study|Lost to Follow-up|1|||
27803991|NCT02623426|81113827|FG000|Overall Study|Withdrawal by Subject|1|||
27803992|NCT02623426|81113828|FG001|Overall Study|Withdrawal by Subject|2|||
27803993|NCT02623426|81113829|FG002|Overall Study|Withdrawal by Subject|2|||
27803994|NCT00591253|81113830|FG000|Overall Study|Adverse Event|3|||
27803995|NCT00591253|81113831|FG001|Overall Study|Adverse Event|3|||
27803996|NCT00591253|81113832|FG002|Overall Study|Adverse Event|1|||
27803997|NCT00591253|81113830|FG000|Overall Study|Protocol Violation|2|||
27803998|NCT00591253|81113831|FG001|Overall Study|Protocol Violation|2|||
27803999|NCT00591253|81113832|FG002|Overall Study|Protocol Violation|2|||
27804000|NCT00591253|81113830|FG000|Overall Study|Lost to Follow-up|2|||
27804001|NCT00591253|81113831|FG001|Overall Study|Lost to Follow-up|4|||
27872431|NCT02854527|81365256|FG008|Overall Study|Adverse Event|0|||
27872432|NCT02854527|81365257|FG009|Overall Study|Adverse Event|0|||
27872433|NCT02854527|81365248|FG000|Overall Study|Lost to Follow-up|0|||
27996365|NCT00650767|81815631|FG000|Overall Study|Death|1|||
27804002|NCT00591253|81113832|FG002|Overall Study|Lost to Follow-up|0|||
27804003|NCT00591253|81113830|FG000|Overall Study|Withdrawal by Subject|1|||
27804004|NCT00591253|81113831|FG001|Overall Study|Withdrawal by Subject|7|||
27804005|NCT00591253|81113832|FG002|Overall Study|Withdrawal by Subject|6|||
27804006|NCT00591253|81113830|FG000|Overall Study|Lack of Efficacy|1|||
27872434|NCT02854527|81365249|FG001|Overall Study|Lost to Follow-up|0|||
27996366|NCT00650767|81815632|FG001|Overall Study|Death|0|||
27996367|NCT00650767|81815633|FG002|Overall Study|Death|0|||
27996368|NCT00650767|81815634|FG003|Overall Study|Death|0|||
27996369|NCT00650767|81815631|FG000|Overall Study|Withdrawal by Subject|2|||
27996370|NCT00650767|81815632|FG001|Overall Study|Withdrawal by Subject|4|||
27996371|NCT00650767|81815633|FG002|Overall Study|Withdrawal by Subject|3|||
27996372|NCT00650767|81815634|FG003|Overall Study|Withdrawal by Subject|3|||
27996373|NCT00650767|81815631|FG000|Overall Study|Lost to Follow-up|1|||
27579804|NCT00377676|80306718|FG001|Overall Study|Lost to Follow-up|56|||
27804007|NCT00591253|81113831|FG001|Overall Study|Lack of Efficacy|0|||
27804008|NCT00591253|81113832|FG002|Overall Study|Lack of Efficacy|3|||
27804009|NCT00591253|81113830|FG000|Overall Study|Other|5|||
27804010|NCT00591253|81113831|FG001|Overall Study|Other|5|||
27804011|NCT00591253|81113832|FG002|Overall Study|Other|3|||
27872435|NCT02854527|81365250|FG002|Overall Study|Lost to Follow-up|0|||
27872436|NCT02854527|81365251|FG003|Overall Study|Lost to Follow-up|1|||
27804012|NCT02629965|81113833|FG000|Period 1|Adverse Event|1|||
27804013|NCT02629965|81113834|FG001|Period 1|Adverse Event|0|||
27996374|NCT00650767|81815632|FG001|Overall Study|Lost to Follow-up|1|||
27579805|NCT00377676|80306717|FG000|Overall Study|Other|118|||
27804014|NCT02629965|81113833|FG000|Period 1|Unexpected worsening of disease|2|||
27804015|NCT02629965|81113834|FG001|Period 1|Unexpected worsening of disease|0|||
27804016|NCT02629965|81113833|FG000|Period 1|Other than listed above|1|||
27804017|NCT02629965|81113834|FG001|Period 1|Other than listed above|2|||
27804018|NCT02629965|81113833|FG000|Period 2|Adverse Event|1|||
27804019|NCT02629965|81113834|FG001|Period 2|Adverse Event|0|||
27804020|NCT00543439|81113835|FG000|Period 1|Adverse Event|0|||
27804021|NCT00543439|81113836|FG001|Period 1|Adverse Event|2|||
27804022|NCT00543439|81113837|FG002|Period 1|Adverse Event|1|||
27804023|NCT00543439|81113835|FG000|Period 1|Withdrawal by Subject|1|||
27804024|NCT00543439|81113836|FG001|Period 1|Withdrawal by Subject|1|||
27804025|NCT00543439|81113837|FG002|Period 1|Withdrawal by Subject|0|||
27804026|NCT00543439|81113835|FG000|Period 1|Physician Decision|0|||
27804027|NCT00543439|81113836|FG001|Period 1|Physician Decision|0|||
27804028|NCT00543439|81113837|FG002|Period 1|Physician Decision|1|||
27804029|NCT00543439|81113835|FG000|Period 2|Protocol Violation|1|||
27804030|NCT00543439|81113836|FG001|Period 2|Protocol Violation|0|||
27804031|NCT00543439|81113837|FG002|Period 2|Protocol Violation|1|||
27804032|NCT00543439|81113835|FG000|Period 2|Adverse Event|0|||
27804033|NCT00543439|81113836|FG001|Period 2|Adverse Event|1|||
27804034|NCT00543439|81113837|FG002|Period 2|Adverse Event|1|||
27804035|NCT00080288|81113838|FG000|Overall Study|Adverse Event|7|||
27804036|NCT00080288|81113839|FG001|Overall Study|Adverse Event|4|||
27804037|NCT00080288|81113838|FG000|Overall Study|Lost to Follow-up|3|||
27804038|NCT00080288|81113839|FG001|Overall Study|Lost to Follow-up|5|||
27804039|NCT00080288|81113838|FG000|Overall Study|Physician Decision|6|||
27804040|NCT00080288|81113839|FG001|Overall Study|Physician Decision|2|||
27804041|NCT00080288|81113838|FG000|Overall Study|Withdrawal by Subject|3|||
27804042|NCT00080288|81113839|FG001|Overall Study|Withdrawal by Subject|16|||
27804043|NCT00080288|81113838|FG000|Overall Study|Miscellaneous|11|||
27804044|NCT00080288|81113839|FG001|Overall Study|Miscellaneous|11|||
27804045|NCT00860574|81113843|FG000|Overall Study|Death|2|||
27804046|NCT00860574|81113843|FG000|Overall Study|Relapse|1|||
27804047|NCT02217345|81113844|FG000|Overall Study|Lost to Follow-up|2|||
27804048|NCT02217345|81113845|FG001|Overall Study|Lost to Follow-up|1|||
27804049|NCT02217345|81113844|FG000|Overall Study|Withdrawal by Subject|3|||
27804050|NCT02217345|81113845|FG001|Overall Study|Withdrawal by Subject|2|||
27804051|NCT02217345|81113844|FG000|Overall Study|Adverse Event|2|||
27804052|NCT02217345|81113845|FG001|Overall Study|Adverse Event|1|||
27804053|NCT02217345|81113844|FG000|Overall Study|Physician Decision|0|||
27804054|NCT02217345|81113845|FG001|Overall Study|Physician Decision|1|||
27804055|NCT01408576|81113846|FG000|Overall Study|Lack of Efficacy|17|||
27804056|NCT01408576|81113847|FG001|Overall Study|Lack of Efficacy|30|||
27804057|NCT01408576|81113848|FG002|Overall Study|Lack of Efficacy|48|||
27804058|NCT01408576|81113846|FG000|Overall Study|Protocol Violation|1|||
27872437|NCT02854527|81365252|FG004|Overall Study|Lost to Follow-up|0|||
27872438|NCT02854527|81365253|FG005|Overall Study|Lost to Follow-up|0|||
27872439|NCT02854527|81365254|FG006|Overall Study|Lost to Follow-up|0|||
27872440|NCT02854527|81365255|FG007|Overall Study|Lost to Follow-up|0|||
27804059|NCT01408576|81113847|FG001|Overall Study|Protocol Violation|2|||
27804060|NCT01408576|81113848|FG002|Overall Study|Protocol Violation|2|||
27804061|NCT01408576|81113846|FG000|Overall Study|Lost to Follow-up|10|||
27872441|NCT02854527|81365256|FG008|Overall Study|Lost to Follow-up|0|||
27872442|NCT02854527|81365257|FG009|Overall Study|Lost to Follow-up|0|||
27872443|NCT02932462|81365258|FG000|Overall Study|Adverse Event|1|||
27872444|NCT02932462|81365259|FG001|Overall Study|Adverse Event|2|||
27872445|NCT02932462|81365258|FG000|Overall Study|Lost to Follow-up|4|||
27872446|NCT02932462|81365259|FG001|Overall Study|Lost to Follow-up|1|||
27872447|NCT02932462|81365258|FG000|Overall Study|Protocol Violation|0|||
27872448|NCT02932462|81365259|FG001|Overall Study|Protocol Violation|5|||
27872449|NCT02932462|81365258|FG000|Overall Study|Withdrawal by Subject|1|||
27872450|NCT02932462|81365259|FG001|Overall Study|Withdrawal by Subject|4|||
27872451|NCT02932462|81365258|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27804062|NCT01408576|81113847|FG001|Overall Study|Lost to Follow-up|9|||
27872452|NCT02932462|81365259|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27804063|NCT01408576|81113848|FG002|Overall Study|Lost to Follow-up|17|||
27804064|NCT01408576|81113846|FG000|Overall Study|Withdrawal by Subject|34|||
27804065|NCT01408576|81113847|FG001|Overall Study|Withdrawal by Subject|60|||
27804066|NCT01408576|81113848|FG002|Overall Study|Withdrawal by Subject|66|||
27804067|NCT01408576|81113846|FG000|Overall Study|Sponsor terminated study|89|||
27804068|NCT01408576|81113847|FG001|Overall Study|Sponsor terminated study|333|||
27804069|NCT01408576|81113848|FG002|Overall Study|Sponsor terminated study|330|||
27804070|NCT01408576|81113846|FG000|Overall Study|AE, serious fatal|4|||
27872453|NCT02932462|81365258|FG000|Overall Study|Progressive Disease|1|||
27804071|NCT01408576|81113847|FG001|Overall Study|AE, serious fatal|4|||
27804072|NCT01408576|81113848|FG002|Overall Study|AE, serious fatal|1|||
27804073|NCT01408576|81113846|FG000|Overall Study|SAE, non-fatal|11|||
27804074|NCT01408576|81113847|FG001|Overall Study|SAE, non-fatal|23|||
27804075|NCT01408576|81113848|FG002|Overall Study|SAE, non-fatal|14|||
27804076|NCT01408576|81113846|FG000|Overall Study|AE, non-serious non-fatal|12|||
27872454|NCT02932462|81365259|FG001|Overall Study|Progressive Disease|0|||
27872455|NCT03203473|81365264|FG000|Induction Phase|Never started primary treatment|2|||
27872456|NCT03203473|81365265|FG001|Induction Phase|Never started primary treatment|0|||
27872457|NCT03203473|81365266|FG002|Induction Phase|Never started primary treatment|0|||
27872458|NCT03203473|81365264|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
27872459|NCT03203473|81365265|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
27872460|NCT03203473|81365266|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
27872461|NCT03203473|81365264|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
27872462|NCT03203473|81365265|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
27804077|NCT01408576|81113847|FG001|Overall Study|AE, non-serious non-fatal|19|||
27804078|NCT01408576|81113848|FG002|Overall Study|AE, non-serious non-fatal|11|||
27804079|NCT01408576|81113846|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27804080|NCT01408576|81113847|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27804081|NCT01408576|81113848|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27804082|NCT01408576|81113846|FG000|Overall Study|AE, unknown type|0|||
27804083|NCT01408576|81113847|FG001|Overall Study|AE, unknown type|1|||
27804084|NCT01408576|81113848|FG002|Overall Study|AE, unknown type|0|||
27804085|NCT01408576|81113846|FG000|Overall Study|Other|10|||
27804086|NCT01408576|81113847|FG001|Overall Study|Other|16|||
27804087|NCT01408576|81113848|FG002|Overall Study|Other|18|||
27804088|NCT01092702|81113852|FG000|Overall Study|Withdrawal by Subject|7|||
27804089|NCT01092702|81113852|FG000|Overall Study|Lost to Follow-up|2|||
27804090|NCT00382291|81113853|FG000|Overall Study|Adverse Event|1|||
27804091|NCT00382291|81113854|FG001|Overall Study|Adverse Event|2|||
27804092|NCT00382291|81113855|FG002|Overall Study|Adverse Event|2|||
27804093|NCT00382291|81113853|FG000|Overall Study|Protocol Violation|1|||
27804094|NCT00382291|81113854|FG001|Overall Study|Protocol Violation|0|||
27804095|NCT00382291|81113855|FG002|Overall Study|Protocol Violation|0|||
27804096|NCT00382291|81113853|FG000|Overall Study|Temporary study suspension|2|||
27804097|NCT00382291|81113854|FG001|Overall Study|Temporary study suspension|2|||
27804098|NCT00382291|81113855|FG002|Overall Study|Temporary study suspension|5|||
27804099|NCT00382291|81113853|FG000|Overall Study|Withdrawal by Subject|0|||
27804100|NCT00382291|81113854|FG001|Overall Study|Withdrawal by Subject|2|||
27804101|NCT00382291|81113855|FG002|Overall Study|Withdrawal by Subject|0|||
27804102|NCT00382291|81113853|FG000|Overall Study|Physician Decision|0|||
27804103|NCT00382291|81113854|FG001|Overall Study|Physician Decision|1|||
27804104|NCT00382291|81113855|FG002|Overall Study|Physician Decision|0|||
27804105|NCT00382291|81113853|FG000|Overall Study|Lack of Efficacy|0|||
27872463|NCT03203473|81365266|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
27872464|NCT03203473|81365264|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
27872465|NCT03203473|81365265|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
27804106|NCT00382291|81113854|FG001|Overall Study|Lack of Efficacy|0|||
27804107|NCT00382291|81113855|FG002|Overall Study|Lack of Efficacy|1|||
27804108|NCT01440647|81113856|FG000|Overall Study|Death|2|||
27804109|NCT01440647|81113857|FG001|Overall Study|Death|3|||
27804110|NCT01430104|81113859|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
27804111|NCT01406873|81113864|FG000|Overall Study|Withdrawal by Subject|1|||
27579806|NCT00377676|80306718|FG001|Overall Study|Other|58|||
27804112|NCT01406873|81113865|FG001|Overall Study|Withdrawal by Subject|1|||
27804113|NCT00084617|81113866|FG000|Overall Study|Withdrawal by Subject|7|||
27804114|NCT00084617|81113866|FG000|Overall Study|Lack of Efficacy|1|||
27804115|NCT00084617|81113866|FG000|Overall Study|Protocol Violation|1|||
27804116|NCT00328783|81113869|FG000|Overall Study|Could not tolerate ABC|21|||
27804117|NCT00328783|81113869|FG000|Overall Study|No heart in RT field|4|||
27804118|NCT00328783|81113869|FG000|Overall Study|Withdrawal by Subject|1|||
27804119|NCT00667719|81113873|FG000|Overall Study|Adverse Event|39|||
27804120|NCT00667719|81113873|FG000|Overall Study|Abnormal Test Procedure|1|||
27804121|NCT00667719|81113873|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27804122|NCT00667719|81113873|FG000|Overall Study|Protocol Violation|3|||
27872466|NCT03203473|81365266|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
27872467|NCT03203473|81365264|FG000|Arm Allocation Phase|started salvage therapy|0|||
27872468|NCT03203473|81365265|FG001|Arm Allocation Phase|started salvage therapy|5|||
27872469|NCT03203473|81365266|FG002|Arm Allocation Phase|started salvage therapy|0|||
27872470|NCT03203473|81365264|FG000|Arm Allocation Phase|Disease progression|0|||
27804123|NCT00667719|81113873|FG000|Overall Study|Withdrawal by Subject|17|||
27804124|NCT00667719|81113873|FG000|Overall Study|Lost to Follow-up|8|||
27804125|NCT00606801|81113879|FG000|Intervention|Protocol Violation|3|||
27804126|NCT00606801|81113880|FG001|Intervention|Protocol Violation|3|||
27804127|NCT01796860|81113881|FG000|Overall Study|Withdrawal by Subject|3|||
27804128|NCT01613131|81113882|FG000|Overall Study|Withdrawal by Subject|3|||
27804129|NCT01613131|81113883|FG001|Overall Study|Withdrawal by Subject|5|||
27804130|NCT02290028|81113887|FG000|Overall Study|Death|217|||
27804131|NCT02290028|81113887|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
27804132|NCT02290028|81113887|FG000|Overall Study|No longer under care of study physician|76|||
27804133|NCT02290028|81113887|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
27804134|NCT02290028|81113887|FG000|Overall Study|Withdrawal by Subject|52|||
27804135|NCT02290028|81113887|FG000|Overall Study|Study site closure|44|||
27804136|NCT02290028|81113887|FG000|Overall Study|Lost to Follow-up|34|||
27804137|NCT02290028|81113887|FG000|Overall Study|Miscellaneous|10|||
27804138|NCT02290028|81113887|FG000|Overall Study|Transition to EP PASSION|1295|||
27804139|NCT02290028|81113887|FG000|Overall Study|Planned study completion at 12 months|257|||
27804140|NCT01783730|81113888|FG000|Overall Study|Failed to meet inclusion criteria|6|||
27804141|NCT03412019|81113889|FG000|Overall Study|Withdrawal by Subject|1|||
27804142|NCT03412019|81113890|FG001|Overall Study|Withdrawal by Subject|1|||
27804143|NCT00320593|81113891|FG000|Overall Study|Lost to Follow-up|3|||
27804144|NCT00320593|81113892|FG001|Overall Study|Lost to Follow-up|0|||
27872471|NCT03203473|81365265|FG001|Arm Allocation Phase|Disease progression|0|||
27872472|NCT03203473|81365266|FG002|Arm Allocation Phase|Disease progression|37|||
27872473|NCT03203473|81365264|FG000|Arm Allocation Phase|Adverse Event|0|||
27872474|NCT03203473|81365265|FG001|Arm Allocation Phase|Adverse Event|0|||
27872475|NCT03203473|81365266|FG002|Arm Allocation Phase|Adverse Event|11|||
27872476|NCT03203473|81365264|FG000|Arm Allocation Phase|Physician Decision|0|||
27872477|NCT03203473|81365265|FG001|Arm Allocation Phase|Physician Decision|0|||
27872478|NCT03203473|81365266|FG002|Arm Allocation Phase|Physician Decision|3|||
27872479|NCT03203473|81365264|FG000|Arm Allocation Phase|Death|0|||
27872480|NCT03203473|81365265|FG001|Arm Allocation Phase|Death|0|||
27804145|NCT00320593|81113891|FG000|Overall Study|Moved to another state|1|||
27804146|NCT00320593|81113892|FG001|Overall Study|Moved to another state|0|||
27804147|NCT00320593|81113891|FG000|Overall Study|Withdrawal by Subject|2|||
27804148|NCT00320593|81113892|FG001|Overall Study|Withdrawal by Subject|1|||
27804149|NCT00320593|81113891|FG000|Overall Study|Withdrawal by clinical center|1|||
27804150|NCT00320593|81113892|FG001|Overall Study|Withdrawal by clinical center|0|||
27804151|NCT03012815|81113893|FG000|Overall Study|Lost to Follow-up|1|||
27804152|NCT03012815|81113894|FG001|Overall Study|Lost to Follow-up|0|||
27804153|NCT03012815|81113893|FG000|Overall Study|Physician Decision|3|||
27804154|NCT03012815|81113894|FG001|Overall Study|Physician Decision|2|||
27804155|NCT03012815|81113893|FG000|Overall Study|Adverse Event|1|||
27804156|NCT03012815|81113894|FG001|Overall Study|Adverse Event|0|||
27804157|NCT01964105|81113895|FG000|Overall Study|Lost to Follow-up|2|||
27804158|NCT01964105|81113896|FG001|Overall Study|Lost to Follow-up|13|||
27804159|NCT01964105|81113897|FG002|Overall Study|Lost to Follow-up|0|||
27804160|NCT05016765|81113900|FG000|Overall Study|Lost to Follow-up|4|||
27804161|NCT01222715|81113901|FG000|Overall Study|Adverse Event|0|||
27804162|NCT01222715|81113902|FG001|Overall Study|Adverse Event|4|||
27804163|NCT01222715|81113901|FG000|Overall Study|Death|0|||
27804164|NCT01222715|81113902|FG001|Overall Study|Death|1|||
27804165|NCT01222715|81113901|FG000|Overall Study|Lack of Efficacy|22|||
27804166|NCT01222715|81113902|FG001|Overall Study|Lack of Efficacy|14|||
27804167|NCT01222715|81113901|FG000|Overall Study|Physician Decision|12|||
27804168|NCT01222715|81113902|FG001|Overall Study|Physician Decision|2|||
27804169|NCT01222715|81113901|FG000|Overall Study|Refusal of further protocol therapy|0|||
27804170|NCT01222715|81113902|FG001|Overall Study|Refusal of further protocol therapy|4|||
27804171|NCT01222715|81113901|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
27804172|NCT01222715|81113902|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
27804173|NCT01222715|81113901|FG000|Overall Study|Ineligible|0|||
27804174|NCT01222715|81113902|FG001|Overall Study|Ineligible|1|||
27804175|NCT01222715|81113901|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
27804176|NCT01222715|81113902|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
27804177|NCT00681824|81113916|FG000|Overall Study|withdrawn by investigator|0|||
27804178|NCT00681824|81113917|FG001|Overall Study|withdrawn by investigator|0|||
27804179|NCT00681824|81113918|FG002|Overall Study|withdrawn by investigator|1|||
27804180|NCT00681824|81113916|FG000|Overall Study|scheduling conflict|1|||
27804181|NCT00681824|81113917|FG001|Overall Study|scheduling conflict|0|||
27804182|NCT00681824|81113918|FG002|Overall Study|scheduling conflict|0|||
27804183|NCT00681824|81113916|FG000|Overall Study|Death|0|||
27804184|NCT00681824|81113917|FG001|Overall Study|Death|1|||
27804185|NCT00681824|81113918|FG002|Overall Study|Death|0|||
27996375|NCT00650767|81815633|FG002|Overall Study|Lost to Follow-up|1|||
27996376|NCT00650767|81815634|FG003|Overall Study|Lost to Follow-up|0|||
27996377|NCT00650767|81815631|FG000|Overall Study|Other|1|||
27996378|NCT00650767|81815632|FG001|Overall Study|Other|1|||
27996379|NCT00650767|81815633|FG002|Overall Study|Other|0|||
27996380|NCT00650767|81815634|FG003|Overall Study|Other|0|||
27996381|NCT02073682|81815636|FG000|Overall Study|Low Creatinine Clearance|1|||
27996382|NCT02073682|81815637|FG001|Overall Study|Low Creatinine Clearance|2|||
27996383|NCT02073682|81815636|FG000|Overall Study|Death|86|||
27996384|NCT02073682|81815637|FG001|Overall Study|Death|100|||
27996385|NCT02073682|81815636|FG000|Overall Study|Cancer Cured|10|||
27996386|NCT02073682|81815637|FG001|Overall Study|Cancer Cured|15|||
27996387|NCT02073682|81815636|FG000|Overall Study|ID: Patient Noncompliance|1|||
27996388|NCT02073682|81815637|FG001|Overall Study|ID: Patient Noncompliance|2|||
27996389|NCT02073682|81815636|FG000|Overall Study|ID: Palliative Treatment Only|10|||
27996390|NCT02073682|81815637|FG001|Overall Study|ID: Palliative Treatment Only|7|||
27996391|NCT02073682|81815636|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
27996392|NCT02073682|81815637|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
27996393|NCT02073682|81815636|FG000|Overall Study|Platelet Count <50,000/mL|1|||
27996394|NCT02073682|81815637|FG001|Overall Study|Platelet Count <50,000/mL|2|||
27996395|NCT02073682|81815636|FG000|Overall Study|Surgery/Medical Procedure|3|||
27996396|NCT02073682|81815637|FG001|Overall Study|Surgery/Medical Procedure|1|||
27996397|NCT02073682|81815636|FG000|Overall Study|Withdrawal by Subject|6|||
27996398|NCT02073682|81815637|FG001|Overall Study|Withdrawal by Subject|8|||
27996399|NCT02073682|81815636|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
27996400|NCT02073682|81815637|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
27996401|NCT02073682|81815636|FG000|Overall Study|Cancer Progression|53|||
27996402|NCT02073682|81815637|FG001|Overall Study|Cancer Progression|33|||
27996403|NCT02073682|81815636|FG000|Overall Study|Protocol Violation|1|||
27996404|NCT02073682|81815637|FG001|Overall Study|Protocol Violation|0|||
27996405|NCT02073682|81815636|FG000|Overall Study|Adverse Event|79|||
27996406|NCT02073682|81815637|FG001|Overall Study|Adverse Event|62|||
27996407|NCT02073682|81815636|FG000|Overall Study|No reason provided|11|||
27996408|NCT02073682|81815637|FG001|Overall Study|No reason provided|9|||
27996409|NCT02073682|81815636|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
27996410|NCT02073682|81815637|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
27679863|NCT00479882|80664443|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
27804186|NCT01890785|81113919|FG000|Third Intervention|Withdrawal by Subject|0|||
27804187|NCT01890785|81113920|FG001|Third Intervention|Withdrawal by Subject|1|||
27804188|NCT01890785|81113921|FG002|Third Intervention|Withdrawal by Subject|0|||
27804189|NCT01890785|81113922|FG003|Third Intervention|Withdrawal by Subject|0|||
27804190|NCT01890785|81113923|FG004|Third Intervention|Withdrawal by Subject|0|||
27804191|NCT01890785|81113924|FG005|Third Intervention|Withdrawal by Subject|0|||
27804192|NCT04556838|81113925|FG000|Overall Study|Withdrawal by Subject|3|||
27804193|NCT04556838|81113926|FG001|Overall Study|Withdrawal by Subject|1|||
27579807|NCT01274637|80306719|FG000|Overall Study|Withdrawal by Subject|0|||
27579808|NCT01274637|80306720|FG001|Overall Study|Withdrawal by Subject|1|||
27579809|NCT01274637|80306719|FG000|Overall Study|Lost to Follow-up|0|||
27579810|NCT01274637|80306720|FG001|Overall Study|Lost to Follow-up|1|||
27579811|NCT02052466|80306723|FG000|Overall Study|Withdrawal by Subject|1|||
27579812|NCT02052466|80306723|FG000|Overall Study|Acromial fracture|1|||
27579813|NCT02167035|80306724|FG000|Overall Study|Adverse Event|2|||
27579814|NCT02167035|80306725|FG001|Overall Study|Adverse Event|2|||
27872481|NCT03203473|81365266|FG002|Arm Allocation Phase|Death|1|||
27872482|NCT03203473|81365264|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
27872483|NCT03203473|81365265|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
27872484|NCT03203473|81365266|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
27872485|NCT03203473|81365264|FG000|Arm Allocation Phase|Intercurrent illness|0|||
27872486|NCT03203473|81365265|FG001|Arm Allocation Phase|Intercurrent illness|0|||
27872487|NCT03203473|81365266|FG002|Arm Allocation Phase|Intercurrent illness|1|||
27872488|NCT03203473|81365264|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
27872489|NCT03203473|81365265|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
27872490|NCT03203473|81365266|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
27872491|NCT02009722|81365267|FG000|Overall Study|Protocol Violation|1|||
27872492|NCT02009722|81365268|FG001|Overall Study|Protocol Violation|2|||
27872493|NCT02009722|81365267|FG000|Overall Study|Did not receive intervention|0|||
27872494|NCT02009722|81365268|FG001|Overall Study|Did not receive intervention|1|||
27872495|NCT03639779|81365269|FG000|Overall Study|Lost to Follow-up|1|||
27872496|NCT01396512|81365270|FG000|Overall Study|Withdrawal by Subject|0|||
27872497|NCT01396512|81365271|FG001|Overall Study|Withdrawal by Subject|1|||
27872498|NCT01042093|81365274|FG000|Overall Study|Protocol Violation|2|||
27872499|NCT01042093|81365275|FG001|Overall Study|Protocol Violation|2|||
27872500|NCT01042093|81365276|FG002|Overall Study|Protocol Violation|2|||
27996411|NCT02073682|81815636|FG000|Overall Study|Lost to Follow-up|1|||
27996412|NCT02073682|81815637|FG001|Overall Study|Lost to Follow-up|1|||
27996413|NCT02073682|81815636|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
27996414|NCT02073682|81815637|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
27996415|NCT03738618|81815640|FG000|Overall Study|Protocol deviation|23|||
27996416|NCT03738618|81815641|FG001|Overall Study|Protocol deviation|0|||
27996417|NCT03738618|81815640|FG000|Overall Study|Adverse Event|4|||
27996418|NCT03738618|81815641|FG001|Overall Study|Adverse Event|0|||
27996419|NCT03738618|81815640|FG000|Overall Study|Lost to Follow-up|2|||
27996420|NCT03738618|81815641|FG001|Overall Study|Lost to Follow-up|0|||
27996421|NCT03738618|81815640|FG000|Overall Study|Randomization failure|1|||
27996422|NCT03738618|81815641|FG001|Overall Study|Randomization failure|0|||
27996423|NCT03738618|81815640|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
27996424|NCT03738618|81815641|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
27996425|NCT03738618|81815640|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
27996426|NCT03738618|81815641|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
27996427|NCT01587040|81815642|FG000|Overall Study|Protocol Violation|0|||
27996428|NCT01587040|81815643|FG001|Overall Study|Protocol Violation|0|||
27996429|NCT01587040|81815644|FG002|Overall Study|Protocol Violation|1|||
27996430|NCT01587040|81815645|FG003|Overall Study|Protocol Violation|0|||
27996431|NCT01587040|81815642|FG000|Overall Study|Adverse Event|0|||
27996432|NCT01587040|81815643|FG001|Overall Study|Adverse Event|1|||
27996433|NCT01587040|81815644|FG002|Overall Study|Adverse Event|10|||
27996434|NCT01587040|81815645|FG003|Overall Study|Adverse Event|0|||
27996435|NCT01587040|81815642|FG000|Overall Study|Disease progression|12|||
27996436|NCT01587040|81815643|FG001|Overall Study|Disease progression|1|||
27996437|NCT01587040|81815644|FG002|Overall Study|Disease progression|15|||
27996438|NCT01587040|81815645|FG003|Overall Study|Disease progression|3|||
27996439|NCT01587040|81815642|FG000|Overall Study|Other than specified|5|||
27996440|NCT01587040|81815643|FG001|Overall Study|Other than specified|1|||
27996441|NCT01587040|81815644|FG002|Overall Study|Other than specified|11|||
27579815|NCT02167035|80306724|FG000|Overall Study|Lost to Follow-up|3|||
27579816|NCT02167035|80306725|FG001|Overall Study|Lost to Follow-up|3|||
27579817|NCT02167035|80306724|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
27679864|NCT02922023|80664444|FG000|Overall Study|Lost to Follow-up|2|||
27679865|NCT02922023|80664445|FG001|Overall Study|Lost to Follow-up|0|||
27872501|NCT01042093|81365277|FG003|Overall Study|Protocol Violation|3|||
27872502|NCT01042093|81365274|FG000|Overall Study|Withdrawal by Subject|0|||
27872503|NCT01042093|81365275|FG001|Overall Study|Withdrawal by Subject|0|||
27872504|NCT01042093|81365276|FG002|Overall Study|Withdrawal by Subject|0|||
27872505|NCT01042093|81365277|FG003|Overall Study|Withdrawal by Subject|1|||
27996442|NCT01587040|81815645|FG003|Overall Study|Other than specified|1|||
27579818|NCT02167035|80306725|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
27872506|NCT02387840|81365278|FG000|Overall Study|Death|0|||
27872507|NCT02387840|81365279|FG001|Overall Study|Death|0|||
27996443|NCT00786799|81815648|FG000|Overall Study|Lost to Follow-up|1|||
27996444|NCT00786799|81815649|FG001|Overall Study|Lost to Follow-up|1|||
27996445|NCT02396212|81815650|FG000|Overall Study|Adverse Event|1|||
27996446|NCT02396212|81815650|FG000|Overall Study|Lack of Efficacy|2|||
27804194|NCT04556838|81113927|FG002|Overall Study|Withdrawal by Subject|2|||
27804195|NCT04556838|81113925|FG000|Overall Study|Adverse Event|0|||
27804196|NCT04556838|81113926|FG001|Overall Study|Adverse Event|1|||
27804197|NCT04556838|81113927|FG002|Overall Study|Adverse Event|1|||
27804198|NCT04556838|81113925|FG000|Overall Study|Lost to Follow-up|0|||
27804199|NCT04556838|81113926|FG001|Overall Study|Lost to Follow-up|0|||
27804200|NCT04556838|81113927|FG002|Overall Study|Lost to Follow-up|2|||
27804201|NCT04556838|81113925|FG000|Overall Study|Subject travel|0|||
27804202|NCT04556838|81113926|FG001|Overall Study|Subject travel|1|||
27804203|NCT04556838|81113927|FG002|Overall Study|Subject travel|0|||
27804204|NCT04556838|81113925|FG000|Overall Study|Physician Decision|1|||
27872508|NCT02387840|81365280|FG002|Overall Study|Death|0|||
27996447|NCT01919229|81815651|FG000|Overall Study|Subject/guardian decision|0|||
27996448|NCT01919229|81815652|FG001|Overall Study|Subject/guardian decision|0|||
27996449|NCT01919229|81815653|FG002|Overall Study|Subject/guardian decision|1|||
27996450|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
27996451|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
27996452|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
27996453|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
27579819|NCT04067141|80306731|FG000|First Intervention|Withdrawal by Subject|0|||
27579820|NCT04067141|80306732|FG001|First Intervention|Withdrawal by Subject|1|||
27996454|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
27996455|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
27996456|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
27996457|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
27996458|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
27996459|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
27996460|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
27996461|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
27579821|NCT04067141|80306731|FG000|Second Intervention|Adverse Event|0|||
27579822|NCT04067141|80306732|FG001|Second Intervention|Adverse Event|2|||
27996462|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
27996463|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
27996464|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
27996465|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
27996466|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
27996467|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
27996468|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
27996469|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
27996470|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
27996471|NCT00550407|81815654|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
27996472|NCT00550407|81815655|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
27996473|NCT00550407|81815656|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
27996474|NCT00550407|81815654|FG000|26-Week Randomized Phase|Adverse Event|0|||
27996475|NCT00550407|81815655|FG001|26-Week Randomized Phase|Adverse Event|5|||
27996476|NCT00550407|81815656|FG002|26-Week Randomized Phase|Adverse Event|2|||
27996477|NCT00550407|81815654|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
27996478|NCT00550407|81815655|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
27579823|NCT01575561|80306735|FG000|Overall Study|Adverse Event|9|||
27679866|NCT04531904|80664446|FG000|Overall Study|Lost to Follow-up|1|||
27679867|NCT04531904|80664446|FG000|Overall Study|Death|14|||
27679868|NCT03995316|80664452|FG000|Overall Study|Lost to Follow-up|10|||
27679869|NCT03995316|80664453|FG001|Overall Study|Lost to Follow-up|3|||
27679870|NCT01643044|80664458|FG000|Overall Study|Lost to Follow-up|1|||
27679871|NCT01643044|80664459|FG001|Overall Study|Lost to Follow-up|1|||
27679872|NCT01643044|80664458|FG000|Overall Study|Miscarried baby|2|||
27679873|NCT01643044|80664459|FG001|Overall Study|Miscarried baby|2|||
27679874|NCT01643044|80664458|FG000|Overall Study|Delivered outside of hospital|1|||
27679875|NCT01643044|80664459|FG001|Overall Study|Delivered outside of hospital|2|||
27679876|NCT01585155|80664460|FG000|Overall Study|Adverse Event|1|||
27679877|NCT01585155|80664460|FG000|Overall Study|Lack of Efficacy|2|||
27679878|NCT01585155|80664460|FG000|Overall Study|Worsening ulcerative colitis|2|||
27804205|NCT04556838|81113926|FG001|Overall Study|Physician Decision|0|||
27872509|NCT02387840|81365281|FG003|Overall Study|Death|0|||
27679879|NCT00677534|80664462|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
27804206|NCT04556838|81113927|FG002|Overall Study|Physician Decision|0|||
27679880|NCT00677534|80664462|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
27804207|NCT02253654|81113928|FG000|Overall Study|Withdrawal by Subject|12|||
27804208|NCT02253654|81113929|FG001|Overall Study|Withdrawal by Subject|4|||
27804209|NCT02253654|81113928|FG000|Overall Study|Decision by Sponsor|1|||
27804210|NCT02253654|81113929|FG001|Overall Study|Decision by Sponsor|1|||
27872510|NCT02387840|81365282|FG004|Overall Study|Death|0|||
27579824|NCT01575561|80306735|FG000|Overall Study|Lack of Efficacy|8|||
27579825|NCT01575561|80306735|FG000|Overall Study|Lost to Follow-up|6|||
27579826|NCT01575561|80306735|FG000|Overall Study|Protocol Violation|4|||
27579827|NCT01575561|80306735|FG000|Overall Study|Withdrawal by Subject|11|||
27579828|NCT01575561|80306735|FG000|Overall Study|administration|1|||
27579829|NCT00844545|80306736|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
27579830|NCT00844545|80306736|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
27579831|NCT00844545|80306736|FG000|Extension Treatment Period|Adverse Event|2|||
27579832|NCT00844545|80306736|FG000|Post Treatment Period|Withdrawal by Subject|1|||
27872511|NCT02387840|81365283|FG005|Overall Study|Death|1|||
27872512|NCT01870778|81365284|FG000|Overall Study|Withdrawal by Subject|8|||
27579833|NCT01416805|80306737|FG000|Overall Study|Lost to Follow-up|4|||
27579834|NCT01416805|80306738|FG001|Overall Study|Lost to Follow-up|4|||
27679881|NCT00677534|80664462|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
27804211|NCT02253654|81113928|FG000|Overall Study|Lost to Follow-up|2|||
27804212|NCT02253654|81113929|FG001|Overall Study|Lost to Follow-up|5|||
27804213|NCT02253654|81113928|FG000|Overall Study|Death|4|||
27804214|NCT02253654|81113929|FG001|Overall Study|Death|7|||
27804215|NCT02253654|81113928|FG000|Overall Study|Did Not Receive Study Treatment|4|||
27804216|NCT02253654|81113929|FG001|Overall Study|Did Not Receive Study Treatment|1|||
27804217|NCT02414854|81113932|FG000|Overall Study|Adverse Event|9|||
27804218|NCT02414854|81113933|FG001|Overall Study|Adverse Event|7|||
27804219|NCT02414854|81113934|FG002|Overall Study|Adverse Event|1|||
27804220|NCT02414854|81113935|FG003|Overall Study|Adverse Event|12|||
27804221|NCT02414854|81113932|FG000|Overall Study|Poor compliance to protocol|1|||
27804222|NCT02414854|81113933|FG001|Overall Study|Poor compliance to protocol|1|||
27804223|NCT02414854|81113934|FG002|Overall Study|Poor compliance to protocol|2|||
27804224|NCT02414854|81113935|FG003|Overall Study|Poor compliance to protocol|2|||
27804225|NCT02414854|81113932|FG000|Overall Study|Other than specified above|12|||
27804226|NCT02414854|81113933|FG001|Overall Study|Other than specified above|37|||
27804227|NCT02414854|81113934|FG002|Overall Study|Other than specified above|17|||
27804228|NCT02414854|81113935|FG003|Overall Study|Other than specified above|37|||
27804229|NCT00986154|81113936|FG000|Overall Study|Death|136|||
27804230|NCT00986154|81113937|FG001|Overall Study|Death|127|||
27804231|NCT00986154|81113936|FG000|Overall Study|Lost to Follow-up|7|||
27804232|NCT00986154|81113937|FG001|Overall Study|Lost to Follow-up|4|||
27804233|NCT00986154|81113936|FG000|Overall Study|Withdrawal by Subject|32|||
27804234|NCT00986154|81113937|FG001|Overall Study|Withdrawal by Subject|33|||
27804235|NCT00986154|81113936|FG000|Overall Study|investigator/subject decide not continue|6|||
27804236|NCT00986154|81113937|FG001|Overall Study|investigator/subject decide not continue|3|||
27804237|NCT00986154|81113936|FG000|Overall Study|never received study drug|25|||
27804238|NCT00986154|81113937|FG001|Overall Study|never received study drug|27|||
27804239|NCT03077828|81113938|FG000|Treatment Cycles|Death|1|||
27872513|NCT01870778|81365285|FG001|Overall Study|Withdrawal by Subject|7|||
27872514|NCT01870778|81365284|FG000|Overall Study|Lost to Follow-up|0|||
27579835|NCT02266381|80306739|FG000|Overall Study|Physician Decision|3|||
27804240|NCT03077828|81113938|FG000|Treatment Cycles|Withdrawal by Subject|1|||
27804241|NCT03077828|81113938|FG000|Treatment Cycles|Screen Fail|2|||
27804242|NCT03077828|81113938|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
27804243|NCT03077828|81113938|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
27804244|NCT03077828|81113938|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
27804245|NCT03077828|81113938|FG000|Follow-up|Patients still in follow-up|15|||
27804246|NCT03066440|81113943|FG000|Overall Study|Physician Decision|1|||
27804247|NCT03066440|81113944|FG001|Overall Study|Physician Decision|1|||
27804248|NCT03066440|81113943|FG000|Overall Study|Protocol Violation|0|||
27804249|NCT03066440|81113944|FG001|Overall Study|Protocol Violation|2|||
27804250|NCT02063698|81113945|FG000|Overall Study|did not complete booklet for days 2-8|1|||
27804251|NCT02063698|81113946|FG001|Overall Study|did not complete booklet for days 2-8|2|||
27804252|NCT02402933|81113949|FG000|Overall Study|Withdrawal by Subject|4|||
27804253|NCT02402933|81113949|FG000|Overall Study|Discontinued; Site Termination|10|||
27804254|NCT03586830|81113950|FG000|Overall Study|Site terminated by Sponsor|1|||
27804255|NCT03586830|81113951|FG001|Overall Study|Site terminated by Sponsor|4|||
27804256|NCT03586830|81113952|FG002|Overall Study|Site terminated by Sponsor|3|||
27804257|NCT03586830|81113953|FG003|Overall Study|Site terminated by Sponsor|3|||
27804258|NCT03586830|81113950|FG000|Overall Study|Lost to Follow-up|0|||
27804259|NCT03586830|81113951|FG001|Overall Study|Lost to Follow-up|2|||
27804260|NCT03586830|81113952|FG002|Overall Study|Lost to Follow-up|2|||
27804261|NCT03586830|81113953|FG003|Overall Study|Lost to Follow-up|1|||
27804262|NCT03586830|81113950|FG000|Overall Study|Withdrawal by Subject|1|||
27804263|NCT03586830|81113951|FG001|Overall Study|Withdrawal by Subject|0|||
27804264|NCT03586830|81113952|FG002|Overall Study|Withdrawal by Subject|3|||
27804265|NCT03586830|81113953|FG003|Overall Study|Withdrawal by Subject|1|||
27804266|NCT00936884|81113957|FG000|Double-blind|Withdrawal by Subject|6|||
27804267|NCT00936884|81113958|FG001|Double-blind|Withdrawal by Subject|4|||
27804268|NCT00936884|81113959|FG002|Double-blind|Withdrawal by Subject|0|||
27804269|NCT00936884|81113957|FG000|Double-blind|Death|2|||
27804270|NCT00936884|81113958|FG001|Double-blind|Death|1|||
27804271|NCT00936884|81113959|FG002|Double-blind|Death|0|||
27804272|NCT00936884|81113957|FG000|Double-blind|Lack of Efficacy|1|||
27804273|NCT00936884|81113958|FG001|Double-blind|Lack of Efficacy|1|||
27804274|NCT00936884|81113959|FG002|Double-blind|Lack of Efficacy|0|||
27804275|NCT00936884|81113957|FG000|Double-blind|Adverse Event|1|||
27804276|NCT00936884|81113958|FG001|Double-blind|Adverse Event|0|||
27804277|NCT00936884|81113959|FG002|Double-blind|Adverse Event|0|||
27804278|NCT00936884|81113957|FG000|Double-blind|Physician Decision|1|||
27804279|NCT00936884|81113958|FG001|Double-blind|Physician Decision|0|||
27804280|NCT00936884|81113959|FG002|Double-blind|Physician Decision|0|||
27804281|NCT00936884|81113957|FG000|Double-blind|No post baseline diary entry|1|||
27804282|NCT00936884|81113958|FG001|Double-blind|No post baseline diary entry|0|||
27804283|NCT00936884|81113959|FG002|Double-blind|No post baseline diary entry|0|||
27804284|NCT00936884|81113957|FG000|Double-blind|Did not receive study drug|0|||
27804285|NCT00936884|81113958|FG001|Double-blind|Did not receive study drug|1|||
27872515|NCT01870778|81365285|FG001|Overall Study|Lost to Follow-up|2|||
27996479|NCT00550407|81815656|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
27996480|NCT00550407|81815654|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
27996481|NCT00550407|81815655|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
27996482|NCT00550407|81815656|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
27996483|NCT00550407|81815654|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
27996484|NCT00550407|81815655|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
27996485|NCT00550407|81815656|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
27996486|NCT03549104|81815657|FG000|Overall Study|Withdrawal by Subject|5|||
27996487|NCT03549104|81815658|FG001|Overall Study|Withdrawal by Subject|2|||
27996488|NCT03549104|81815657|FG000|Overall Study|Covid shelter in place|1|||
27996489|NCT03549104|81815658|FG001|Overall Study|Covid shelter in place|2|||
27996490|NCT01518374|81815659|FG000|Overall Study|Withdrawal by Subject|2|||
27996491|NCT01518374|81815659|FG000|Overall Study|Protocol Violation|3|||
27996492|NCT01518374|81815659|FG000|Overall Study|Lost to Follow-up|2|||
27996493|NCT05249569|81815664|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
27996494|NCT00767806|81815667|FG000|Overall Study|Adverse Event|30|||
27804286|NCT00936884|81113959|FG002|Double-blind|Did not receive study drug|0|||
27804287|NCT02868281|81113967|FG000|Overall Study|Adverse Event|2|||
27996495|NCT00767806|81815668|FG001|Overall Study|Adverse Event|11|||
27996496|NCT00767806|81815667|FG000|Overall Study|Withdrawal by Subject|8|||
27996497|NCT00767806|81815668|FG001|Overall Study|Withdrawal by Subject|13|||
27804288|NCT02868281|81113968|FG001|Overall Study|Adverse Event|2|||
27804289|NCT02868281|81113967|FG000|Overall Study|Protocol Violation|13|||
27804290|NCT02868281|81113968|FG001|Overall Study|Protocol Violation|10|||
27804291|NCT02868281|81113967|FG000|Overall Study|Lost to Follow-up|3|||
27804292|NCT02868281|81113968|FG001|Overall Study|Lost to Follow-up|6|||
27804293|NCT02868281|81113967|FG000|Overall Study|Withdrawal by Subject|11|||
27804294|NCT02868281|81113968|FG001|Overall Study|Withdrawal by Subject|15|||
27804295|NCT02868281|81113967|FG000|Overall Study|Physician Decision|2|||
27804296|NCT02868281|81113968|FG001|Overall Study|Physician Decision|0|||
27872516|NCT01707290|81365289|FG000|Overall Study|Adverse event (AE)|1|||
27804297|NCT02868281|81113967|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
27996498|NCT00767806|81815667|FG000|Overall Study|Protocol Violation|6|||
27996499|NCT00767806|81815668|FG001|Overall Study|Protocol Violation|5|||
27996500|NCT00767806|81815667|FG000|Overall Study|Lack of Efficacy|1|||
27996501|NCT00767806|81815668|FG001|Overall Study|Lack of Efficacy|9|||
27996502|NCT00767806|81815667|FG000|Overall Study|Physician Decision|4|||
27996503|NCT00767806|81815668|FG001|Overall Study|Physician Decision|3|||
27996504|NCT00767806|81815667|FG000|Overall Study|Lost to Follow-up|1|||
27996505|NCT00767806|81815668|FG001|Overall Study|Lost to Follow-up|4|||
27996506|NCT00767806|81815667|FG000|Overall Study|Entry Criteria Not Met|1|||
27996507|NCT00767806|81815668|FG001|Overall Study|Entry Criteria Not Met|1|||
27996508|NCT00767806|81815667|FG000|Overall Study|Sponsor Decision|0|||
27996509|NCT00767806|81815668|FG001|Overall Study|Sponsor Decision|1|||
27996510|NCT00714415|81815669|FG000|Overall Study|Lack of Efficacy|1|||
27996511|NCT00714415|81815670|FG001|Overall Study|Lack of Efficacy|0|||
27996512|NCT00714415|81815669|FG000|Overall Study|Death|1|||
27804298|NCT02868281|81113968|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
27804299|NCT02868281|81113967|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
27804300|NCT02868281|81113968|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
27804301|NCT02868281|81113967|FG000|Overall Study|Long journey/moving away|1|||
27804302|NCT02868281|81113968|FG001|Overall Study|Long journey/moving away|1|||
27804303|NCT03101293|81113972|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
27804304|NCT03101293|81113973|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
27804305|NCT01484028|81113974|FG000|Period 1|Lost to Follow-up|0|||
27804306|NCT01484028|81113975|FG001|Period 1|Lost to Follow-up|1|||
27804307|NCT01484028|81113976|FG002|Period 1|Lost to Follow-up|0|||
27804308|NCT01484028|81113977|FG003|Period 1|Lost to Follow-up|0|||
27804309|NCT01484028|81113974|FG000|Period 1|Non-Compliance to Protocol|0|||
27804310|NCT01484028|81113975|FG001|Period 1|Non-Compliance to Protocol|1|||
27804311|NCT01484028|81113976|FG002|Period 1|Non-Compliance to Protocol|0|||
27804312|NCT01484028|81113977|FG003|Period 1|Non-Compliance to Protocol|1|||
27804313|NCT01484028|81113974|FG000|Period 1|Lens Discomfort|0|||
27804314|NCT01484028|81113975|FG001|Period 1|Lens Discomfort|1|||
27804315|NCT01484028|81113976|FG002|Period 1|Lens Discomfort|0|||
27804316|NCT01484028|81113977|FG003|Period 1|Lens Discomfort|0|||
27804317|NCT01507831|81113978|FG000|Overall Study|Randomized but not treated|0|||
27804318|NCT01507831|81113979|FG001|Overall Study|Randomized but not treated|3|||
27804319|NCT01507831|81113978|FG000|Overall Study|Adverse Event|48|||
27804320|NCT01507831|81113979|FG001|Overall Study|Adverse Event|113|||
27804321|NCT01507831|81113978|FG000|Overall Study|Death|6|||
27804322|NCT01507831|81113979|FG001|Overall Study|Death|2|||
27804323|NCT01507831|81113978|FG000|Overall Study|Poor compliance to protocol|38|||
27804324|NCT01507831|81113979|FG001|Overall Study|Poor compliance to protocol|60|||
27804325|NCT01507831|81113978|FG000|Overall Study|Physician Decision|0|||
27996513|NCT00714415|81815670|FG001|Overall Study|Death|0|||
27996514|NCT00622505|81815671|FG000|Overall Study|Adverse Event|9|||
27996515|NCT00622505|81815672|FG001|Overall Study|Adverse Event|7|||
27996516|NCT00622505|81815671|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
27996517|NCT00622505|81815672|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
27996518|NCT00622505|81815671|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
27804326|NCT01507831|81113979|FG001|Overall Study|Physician Decision|4|||
27804327|NCT01507831|81113978|FG000|Overall Study|Participant moved|5|||
27804328|NCT01507831|81113979|FG001|Overall Study|Participant moved|19|||
27804329|NCT01507831|81113978|FG000|Overall Study|Consent withdrawn by participant|34|||
27804330|NCT01507831|81113979|FG001|Overall Study|Consent withdrawn by participant|72|||
27804331|NCT01507831|81113978|FG000|Overall Study|Related to study drug administration|5|||
27804332|NCT01507831|81113979|FG001|Overall Study|Related to study drug administration|14|||
27804333|NCT01507831|81113978|FG000|Overall Study|Last visit outside protocol visit window|51|||
27872517|NCT01707290|81365290|FG001|Overall Study|Adverse event (AE)|0|||
27872518|NCT01707290|81365289|FG000|Overall Study|Physician Decision|1|||
27872519|NCT01707290|81365290|FG001|Overall Study|Physician Decision|0|||
27872520|NCT01707290|81365289|FG000|Overall Study|Lost to Follow-up|3|||
27872521|NCT01707290|81365290|FG001|Overall Study|Lost to Follow-up|0|||
27872522|NCT01707290|81365289|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
27872523|NCT01707290|81365290|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
27872524|NCT01707290|81365289|FG000|Overall Study|Commercial drug available|60|||
27872525|NCT01707290|81365290|FG001|Overall Study|Commercial drug available|1|||
27872526|NCT01707290|81365289|FG000|Overall Study|Other unspecified|17|||
27872527|NCT01707290|81365290|FG001|Overall Study|Other unspecified|0|||
27872528|NCT01866826|81365291|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
27872529|NCT01866826|81365292|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
27872530|NCT01866826|81365291|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
27872531|NCT01866826|81365292|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
27872532|NCT01866826|81365291|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
27872533|NCT01866826|81365292|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
27872534|NCT00312338|81365293|FG000|Overall Study|Adverse Event|7|||
27872535|NCT00312338|81365294|FG001|Overall Study|Adverse Event|2|||
27872536|NCT00312338|81365293|FG000|Overall Study|Lost to Follow-up|9|||
27872537|NCT00312338|81365294|FG001|Overall Study|Lost to Follow-up|1|||
27872538|NCT00312338|81365293|FG000|Overall Study|Withdrawal by Subject|4|||
27872539|NCT00312338|81365294|FG001|Overall Study|Withdrawal by Subject|0|||
27872540|NCT00312338|81365293|FG000|Overall Study|Subsequent infection|2|||
27872541|NCT00312338|81365294|FG001|Overall Study|Subsequent infection|0|||
27872542|NCT01610492|81365295|FG000|Overall Study|Adverse Event|1|||
27872543|NCT01610492|81365295|FG000|Overall Study|Lack of Efficacy|3|||
27872544|NCT01610492|81365295|FG000|Overall Study|Other: Reached stopping criteria|1|||
27872545|NCT01610492|81365295|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
27872546|NCT02414958|81365296|FG000|Overall Study|Adverse Event|6|||
27872547|NCT02414958|81365297|FG001|Overall Study|Adverse Event|6|||
27872548|NCT02414958|81365298|FG002|Overall Study|Adverse Event|3|||
27872549|NCT02414958|81365296|FG000|Overall Study|Protocol Violation|10|||
27872550|NCT02414958|81365297|FG001|Overall Study|Protocol Violation|3|||
27872551|NCT02414958|81365298|FG002|Overall Study|Protocol Violation|1|||
27872552|NCT02414958|81365296|FG000|Overall Study|Lost to Follow-up|7|||
27872553|NCT02414958|81365297|FG001|Overall Study|Lost to Follow-up|4|||
27872554|NCT02414958|81365298|FG002|Overall Study|Lost to Follow-up|0|||
27872555|NCT02414958|81365296|FG000|Overall Study|Withdrawal by Subject|5|||
27872556|NCT02414958|81365297|FG001|Overall Study|Withdrawal by Subject|3|||
27872557|NCT02414958|81365298|FG002|Overall Study|Withdrawal by Subject|5|||
27872558|NCT02414958|81365296|FG000|Overall Study|Other than specified|4|||
27872559|NCT02414958|81365297|FG001|Overall Study|Other than specified|4|||
27872560|NCT02414958|81365298|FG002|Overall Study|Other than specified|5|||
27872561|NCT01895777|81365300|FG000|Overall Study|Adverse Event|1|||
27872562|NCT01895777|81365301|FG001|Overall Study|Adverse Event|2|||
27872563|NCT01895777|81365300|FG000|Overall Study|Lost to Follow-up|2|||
27872564|NCT01895777|81365301|FG001|Overall Study|Lost to Follow-up|0|||
27872565|NCT01895777|81365300|FG000|Overall Study|Not treated|1|||
27872566|NCT01895777|81365301|FG001|Overall Study|Not treated|0|||
27872567|NCT01895777|81365300|FG000|Overall Study|Other reasons|3|||
27872568|NCT01895777|81365301|FG001|Overall Study|Other reasons|2|||
27872569|NCT01895777|81365300|FG000|Overall Study|Non-compliance with the CTP|2|||
27872570|NCT01895777|81365301|FG001|Overall Study|Non-compliance with the CTP|1|||
27872571|NCT02203357|81365306|FG000|Overall Study|Lost to Follow-up|58|||
27872572|NCT02203357|81365307|FG001|Overall Study|Lost to Follow-up|66|||
27872573|NCT02203357|81365308|FG002|Overall Study|Lost to Follow-up|70|||
27872574|NCT04479787|81365313|FG000|Overall Study|Withdrawal by Subject|19|||
27872575|NCT04479787|81365314|FG001|Overall Study|Withdrawal by Subject|27|||
27872576|NCT04479787|81365313|FG000|Overall Study|Unsuccessful Trial|17|||
27872577|NCT04479787|81365314|FG001|Overall Study|Unsuccessful Trial|7|||
27872578|NCT04479787|81365313|FG000|Overall Study|Subject Participation Terminated By Investigator|14|||
27872579|NCT04479787|81365314|FG001|Overall Study|Subject Participation Terminated By Investigator|5|||
27872580|NCT04479787|81365313|FG000|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
27872581|NCT04479787|81365314|FG001|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
27872582|NCT04479787|81365313|FG000|Overall Study|Lost to Follow-up|3|||
27996519|NCT00622505|81815672|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27996520|NCT00622505|81815671|FG000|Overall Study|Withdrawal by Subject|12|||
27996521|NCT00622505|81815672|FG001|Overall Study|Withdrawal by Subject|5|||
27996522|NCT00622505|81815671|FG000|Overall Study|Administrative Problems|2|||
27996523|NCT00622505|81815672|FG001|Overall Study|Administrative Problems|4|||
27996524|NCT00622505|81815671|FG000|Overall Study|Death|2|||
27996525|NCT00622505|81815672|FG001|Overall Study|Death|2|||
27996526|NCT00567359|81815673|FG000|Overall Study|Withdrawal by Subject|1|||
27996527|NCT03592368|81815674|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
27996528|NCT03592368|81815675|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
27996529|NCT03592368|81815676|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
27996530|NCT03592368|81815677|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
27996531|NCT03592368|81815674|FG000|Overall Study|Adverse Event|0|||
27996532|NCT03592368|81815675|FG001|Overall Study|Adverse Event|0|||
27996533|NCT03592368|81815676|FG002|Overall Study|Adverse Event|0|||
27679882|NCT00951015|80664463|FG000|Randomization Phase 96 Week|Adverse Event|1|||
27679883|NCT00951015|80664464|FG001|Randomization Phase 96 Week|Adverse Event|1|||
27679884|NCT00951015|80664465|FG002|Randomization Phase 96 Week|Adverse Event|2|||
27679885|NCT00951015|80664466|FG003|Randomization Phase 96 Week|Adverse Event|5|||
27804334|NCT01507831|81113979|FG001|Overall Study|Last visit outside protocol visit window|143|||
27804335|NCT01507831|81113978|FG000|Overall Study|Selection criteria finally not met|0|||
27804336|NCT01507831|81113979|FG001|Overall Study|Selection criteria finally not met|1|||
27872583|NCT04479787|81365314|FG001|Overall Study|Lost to Follow-up|3|||
27872584|NCT04479787|81365313|FG000|Overall Study|Death|4|||
27872585|NCT04479787|81365314|FG001|Overall Study|Death|0|||
27872586|NCT04479787|81365313|FG000|Overall Study|Inclusion/Exclusion|2|||
27872587|NCT04479787|81365314|FG001|Overall Study|Inclusion/Exclusion|1|||
27872588|NCT04479787|81365313|FG000|Overall Study|Subject Became Pregnant|1|||
27872589|NCT04479787|81365314|FG001|Overall Study|Subject Became Pregnant|1|||
27872590|NCT04479787|81365313|FG000|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
27996534|NCT03592368|81815677|FG003|Overall Study|Adverse Event|1|||
27996535|NCT03592368|81815674|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
27996536|NCT03592368|81815675|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
27996537|NCT03592368|81815676|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
27996538|NCT03592368|81815677|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
27996539|NCT01008943|81815685|FG000|Overall Study|Withdrawal by Subject|1|||
27996540|NCT03852719|81815688|FG000|Overall Study|Still on study after Week 144|49|||
27804337|NCT01507831|81113978|FG000|Overall Study|Site closure|0|||
27804338|NCT01507831|81113979|FG001|Overall Study|Site closure|3|||
27804339|NCT01507831|81113978|FG000|Overall Study|Potential lost to follow-up|3|||
27804340|NCT01507831|81113979|FG001|Overall Study|Potential lost to follow-up|0|||
27872591|NCT04479787|81365314|FG001|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
27872592|NCT04479787|81365313|FG000|Overall Study|Patient's Health Significantly Declined|0|||
27872593|NCT04479787|81365314|FG001|Overall Study|Patient's Health Significantly Declined|1|||
27872594|NCT04479787|81365313|FG000|Overall Study|Subject Had Back Surgery On March 1st|0|||
27872595|NCT04479787|81365314|FG001|Overall Study|Subject Had Back Surgery On March 1st|1|||
27872596|NCT04479787|81365313|FG000|Overall Study|Withdrawn At Sponsor's Request|1|||
27872597|NCT04479787|81365314|FG001|Overall Study|Withdrawn At Sponsor's Request|0|||
27872598|NCT04479787|81365313|FG000|Overall Study|Subject Failed To Comply With The Protocol Requirements|1|||
27872599|NCT04479787|81365314|FG001|Overall Study|Subject Failed To Comply With The Protocol Requirements|0|||
27872600|NCT02969382|81365319|FG000|Overall Study|Adverse Event|8|||
27872601|NCT02969382|81365320|FG001|Overall Study|Adverse Event|10|||
27872602|NCT02969382|81365319|FG000|Overall Study|Lack of Efficacy|4|||
27872603|NCT02969382|81365320|FG001|Overall Study|Lack of Efficacy|5|||
27872604|NCT02969382|81365319|FG000|Overall Study|Death|0|||
27804341|NCT01507831|81113978|FG000|Overall Study|Other|3|||
27804342|NCT01507831|81113979|FG001|Overall Study|Other|6|||
27804343|NCT00771901|81113980|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
27804344|NCT00771901|81113981|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
27804345|NCT00771901|81113982|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
27804346|NCT02464059|81113983|FG000|Overall Study|Lost to Follow-up|6|||
27804347|NCT01416142|81113984|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
27804348|NCT01416142|81113985|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
27872605|NCT02969382|81365320|FG001|Overall Study|Death|1|||
27872606|NCT02969382|81365319|FG000|Overall Study|PROTOCOL DEVIATION|0|||
27872607|NCT02969382|81365320|FG001|Overall Study|PROTOCOL DEVIATION|1|||
27996541|NCT03852719|81815689|FG001|Overall Study|Still on study after Week 144|44|||
27804349|NCT01416142|81113986|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
27872608|NCT02969382|81365319|FG000|Overall Study|Withdrawal by Subject|14|||
27872609|NCT02969382|81365320|FG001|Overall Study|Withdrawal by Subject|9|||
27579836|NCT02266381|80306740|FG001|Overall Study|Physician Decision|5|||
27996542|NCT03852719|81815690|FG002|Overall Study|Still on study after Week 144|44|||
27996543|NCT03852719|81815688|FG000|Overall Study|Withdrawal of consent|0|||
27996544|NCT03852719|81815689|FG001|Overall Study|Withdrawal of consent|4|||
27996545|NCT03852719|81815690|FG002|Overall Study|Withdrawal of consent|5|||
27996546|NCT03852719|81815688|FG000|Overall Study|Physician Decision|0|||
27579837|NCT02266381|80306741|FG002|Overall Study|Physician Decision|4|||
27579838|NCT00304070|80306742|FG000|Overall Study|Death|0|||
27579839|NCT00304070|80306743|FG001|Overall Study|Death|0|||
27579840|NCT00304070|80306744|FG002|Overall Study|Death|3|||
27579841|NCT00304070|80306742|FG000|Overall Study|Lost to Follow-up|0|||
27579842|NCT00304070|80306743|FG001|Overall Study|Lost to Follow-up|0|||
27579843|NCT00304070|80306744|FG002|Overall Study|Lost to Follow-up|1|||
27579844|NCT00304070|80306742|FG000|Overall Study|Physician Decision|0|||
27579845|NCT00304070|80306743|FG001|Overall Study|Physician Decision|0|||
27579846|NCT00304070|80306744|FG002|Overall Study|Physician Decision|3|||
27579847|NCT00304070|80306742|FG000|Overall Study|Withdrawal by Subject|0|||
27579848|NCT00304070|80306743|FG001|Overall Study|Withdrawal by Subject|0|||
27579849|NCT00304070|80306744|FG002|Overall Study|Withdrawal by Subject|1|||
27579850|NCT00304070|80306742|FG000|Overall Study|Progressive Disease|3|||
27579851|NCT00304070|80306743|FG001|Overall Study|Progressive Disease|7|||
27579852|NCT00304070|80306744|FG002|Overall Study|Progressive Disease|4|||
27579853|NCT00653224|80306745|FG000|Overall Study|Adverse Event|2|||
27579854|NCT00653224|80306746|FG001|Overall Study|Adverse Event|1|||
27579855|NCT00653224|80306745|FG000|Overall Study|Lack of Efficacy|1|||
27579856|NCT00653224|80306746|FG001|Overall Study|Lack of Efficacy|2|||
27579857|NCT00653224|80306745|FG000|Overall Study|Loss of efficacy|1|||
27579858|NCT00653224|80306746|FG001|Overall Study|Loss of efficacy|0|||
27579859|NCT00653224|80306745|FG000|Overall Study|Lost to Follow-up|1|||
27579860|NCT00653224|80306746|FG001|Overall Study|Lost to Follow-up|0|||
27579861|NCT00653224|80306745|FG000|Overall Study|Other|2|||
27579862|NCT00653224|80306746|FG001|Overall Study|Other|4|||
27579863|NCT01896895|80306747|FG000|Double-blind MP|Physician Decision|0|||
27579864|NCT01896895|80306748|FG001|Double-blind MP|Physician Decision|0|||
27579865|NCT01896895|80306749|FG002|Double-blind MP|Physician Decision|1|||
27579866|NCT01896895|80306750|FG003|Double-blind MP|Physician Decision|0|||
27579867|NCT01896895|80306747|FG000|Double-blind MP|Withdrawal by Subject|0|||
27579868|NCT01896895|80306748|FG001|Double-blind MP|Withdrawal by Subject|2|||
27579869|NCT01896895|80306749|FG002|Double-blind MP|Withdrawal by Subject|1|||
27579870|NCT01896895|80306750|FG003|Double-blind MP|Withdrawal by Subject|0|||
27579871|NCT01896895|80306747|FG000|Double-blind MP|Lost to Follow-up|1|||
27579872|NCT01896895|80306748|FG001|Double-blind MP|Lost to Follow-up|0|||
27996547|NCT03852719|81815689|FG001|Overall Study|Physician Decision|0|||
27996548|NCT03852719|81815690|FG002|Overall Study|Physician Decision|1|||
27996549|NCT03852719|81815688|FG000|Overall Study|Pregnancy|1|||
27996550|NCT03852719|81815689|FG001|Overall Study|Pregnancy|1|||
27996551|NCT03852719|81815690|FG002|Overall Study|Pregnancy|0|||
27996552|NCT03852719|81815688|FG000|Overall Study|Death|1|||
27996553|NCT03852719|81815689|FG001|Overall Study|Death|0|||
27996554|NCT03852719|81815690|FG002|Overall Study|Death|0|||
27996555|NCT03386721|81815695|FG000|Overall Study|Death|12|||
27996556|NCT03386721|81815696|FG001|Overall Study|Death|21|||
27996557|NCT03386721|81815697|FG002|Overall Study|Death|2|||
27996558|NCT03386721|81815698|FG003|Overall Study|Death|5|||
27996559|NCT03386721|81815699|FG004|Overall Study|Death|1|||
27996560|NCT03386721|81815700|FG005|Overall Study|Death|12|||
27996561|NCT03386721|81815701|FG006|Overall Study|Death|1|||
27996562|NCT03386721|81815702|FG007|Overall Study|Death|1|||
27996563|NCT03386721|81815703|FG008|Overall Study|Death|12|||
27996564|NCT03386721|81815704|FG009|Overall Study|Death|20|||
27996565|NCT03386721|81815705|FG010|Overall Study|Death|21|||
27579873|NCT01896895|80306749|FG002|Double-blind MP|Lost to Follow-up|1|||
27579874|NCT01896895|80306750|FG003|Double-blind MP|Lost to Follow-up|0|||
27579875|NCT01993719|80306755|FG000|First Drug Administration|Not treated|1|||
27579876|NCT01993719|80306756|FG001|First Drug Administration|Not treated|0|||
27579877|NCT01993719|80306757|FG002|First Drug Administration|Not treated|0|||
27996566|NCT03386721|81815706|FG011|Overall Study|Death|21|||
27996567|NCT03386721|81815707|FG012|Overall Study|Death|14|||
27996568|NCT03386721|81815708|FG013|Overall Study|Death|2|||
27996569|NCT03386721|81815709|FG014|Overall Study|Death|1|||
27996570|NCT03386721|81815695|FG000|Overall Study|Lost to Follow-up|1|||
27996571|NCT03386721|81815696|FG001|Overall Study|Lost to Follow-up|3|||
27996572|NCT03386721|81815697|FG002|Overall Study|Lost to Follow-up|0|||
27996573|NCT03386721|81815698|FG003|Overall Study|Lost to Follow-up|0|||
27996574|NCT03386721|81815699|FG004|Overall Study|Lost to Follow-up|0|||
27996575|NCT03386721|81815700|FG005|Overall Study|Lost to Follow-up|2|||
27579878|NCT01993719|80306758|FG003|First Drug Administration|Not treated|0|||
27579879|NCT01993719|80306759|FG004|First Drug Administration|Not treated|0|||
27579880|NCT02660359|80306760|FG000|Overall Study|Protocol Deviation|0|||
27579881|NCT02660359|80306761|FG001|Overall Study|Protocol Deviation|0|||
27579882|NCT02660359|80306762|FG002|Overall Study|Protocol Deviation|1|||
27996576|NCT03386721|81815701|FG006|Overall Study|Lost to Follow-up|1|||
27996577|NCT03386721|81815702|FG007|Overall Study|Lost to Follow-up|0|||
27579883|NCT02660359|80306760|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
27579884|NCT02660359|80306761|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
27579885|NCT02660359|80306762|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
27579886|NCT02660359|80306760|FG000|Overall Study|Lack of Efficacy|1|||
27804350|NCT03262233|81113987|FG000|Overall Study|Withdrawal by Subject|12|||
27996578|NCT03386721|81815703|FG008|Overall Study|Lost to Follow-up|1|||
27996579|NCT03386721|81815704|FG009|Overall Study|Lost to Follow-up|2|||
27996580|NCT03386721|81815705|FG010|Overall Study|Lost to Follow-up|1|||
27996581|NCT03386721|81815706|FG011|Overall Study|Lost to Follow-up|0|||
27996582|NCT03386721|81815707|FG012|Overall Study|Lost to Follow-up|0|||
27996583|NCT03386721|81815708|FG013|Overall Study|Lost to Follow-up|0|||
27996584|NCT03386721|81815709|FG014|Overall Study|Lost to Follow-up|0|||
27996585|NCT03386721|81815695|FG000|Overall Study|Reason not specified|3|||
27996586|NCT03386721|81815696|FG001|Overall Study|Reason not specified|0|||
27996587|NCT03386721|81815697|FG002|Overall Study|Reason not specified|0|||
27996588|NCT03386721|81815698|FG003|Overall Study|Reason not specified|0|||
27996589|NCT03386721|81815699|FG004|Overall Study|Reason not specified|0|||
27996590|NCT03386721|81815700|FG005|Overall Study|Reason not specified|3|||
27996591|NCT03386721|81815701|FG006|Overall Study|Reason not specified|1|||
27996592|NCT03386721|81815702|FG007|Overall Study|Reason not specified|0|||
27996593|NCT03386721|81815703|FG008|Overall Study|Reason not specified|0|||
27996594|NCT03386721|81815704|FG009|Overall Study|Reason not specified|1|||
27996595|NCT03386721|81815705|FG010|Overall Study|Reason not specified|2|||
27996596|NCT03386721|81815706|FG011|Overall Study|Reason not specified|6|||
27996597|NCT03386721|81815707|FG012|Overall Study|Reason not specified|1|||
27996598|NCT03386721|81815708|FG013|Overall Study|Reason not specified|0|||
27996599|NCT03386721|81815709|FG014|Overall Study|Reason not specified|0|||
27996600|NCT03386721|81815695|FG000|Overall Study|Progressive Disease|0|||
27996601|NCT03386721|81815696|FG001|Overall Study|Progressive Disease|0|||
27996602|NCT03386721|81815697|FG002|Overall Study|Progressive Disease|1|||
27996603|NCT03386721|81815698|FG003|Overall Study|Progressive Disease|0|||
27996604|NCT03386721|81815699|FG004|Overall Study|Progressive Disease|0|||
27996605|NCT03386721|81815700|FG005|Overall Study|Progressive Disease|1|||
27996606|NCT03386721|81815701|FG006|Overall Study|Progressive Disease|0|||
27996607|NCT03386721|81815702|FG007|Overall Study|Progressive Disease|0|||
27996608|NCT03386721|81815703|FG008|Overall Study|Progressive Disease|2|||
27996609|NCT03386721|81815704|FG009|Overall Study|Progressive Disease|1|||
27996610|NCT03386721|81815705|FG010|Overall Study|Progressive Disease|1|||
27996611|NCT03386721|81815706|FG011|Overall Study|Progressive Disease|0|||
27996612|NCT03386721|81815707|FG012|Overall Study|Progressive Disease|1|||
27996613|NCT03386721|81815708|FG013|Overall Study|Progressive Disease|0|||
27996614|NCT03386721|81815709|FG014|Overall Study|Progressive Disease|0|||
27996615|NCT03386721|81815695|FG000|Overall Study|Site Terminated by Sponsor|5|||
27996616|NCT03386721|81815696|FG001|Overall Study|Site Terminated by Sponsor|5|||
27996617|NCT03386721|81815697|FG002|Overall Study|Site Terminated by Sponsor|0|||
27996618|NCT03386721|81815698|FG003|Overall Study|Site Terminated by Sponsor|0|||
27996619|NCT03386721|81815699|FG004|Overall Study|Site Terminated by Sponsor|1|||
27996620|NCT03386721|81815700|FG005|Overall Study|Site Terminated by Sponsor|3|||
27996621|NCT03386721|81815701|FG006|Overall Study|Site Terminated by Sponsor|0|||
27996622|NCT03386721|81815702|FG007|Overall Study|Site Terminated by Sponsor|1|||
27996623|NCT03386721|81815703|FG008|Overall Study|Site Terminated by Sponsor|4|||
27996624|NCT03386721|81815704|FG009|Overall Study|Site Terminated by Sponsor|5|||
27996625|NCT03386721|81815705|FG010|Overall Study|Site Terminated by Sponsor|3|||
27996626|NCT03386721|81815706|FG011|Overall Study|Site Terminated by Sponsor|11|||
27996627|NCT03386721|81815707|FG012|Overall Study|Site Terminated by Sponsor|6|||
27996628|NCT03386721|81815708|FG013|Overall Study|Site Terminated by Sponsor|0|||
27996629|NCT03386721|81815709|FG014|Overall Study|Site Terminated by Sponsor|0|||
27996630|NCT03386721|81815695|FG000|Overall Study|Symptomatic Deterioration|0|||
27996631|NCT03386721|81815696|FG001|Overall Study|Symptomatic Deterioration|0|||
27579887|NCT02660359|80306761|FG001|Overall Study|Lack of Efficacy|1|||
27804351|NCT03262233|81113988|FG001|Overall Study|Withdrawal by Subject|8|||
27996632|NCT03386721|81815697|FG002|Overall Study|Symptomatic Deterioration|0|||
27996633|NCT03386721|81815698|FG003|Overall Study|Symptomatic Deterioration|0|||
27579888|NCT02660359|80306762|FG002|Overall Study|Lack of Efficacy|1|||
27996634|NCT03386721|81815699|FG004|Overall Study|Symptomatic Deterioration|0|||
27996635|NCT03386721|81815700|FG005|Overall Study|Symptomatic Deterioration|0|||
27996636|NCT03386721|81815701|FG006|Overall Study|Symptomatic Deterioration|0|||
27996637|NCT03386721|81815702|FG007|Overall Study|Symptomatic Deterioration|0|||
27996638|NCT03386721|81815703|FG008|Overall Study|Symptomatic Deterioration|1|||
27996639|NCT03386721|81815704|FG009|Overall Study|Symptomatic Deterioration|0|||
27996640|NCT03386721|81815705|FG010|Overall Study|Symptomatic Deterioration|0|||
27996641|NCT03386721|81815706|FG011|Overall Study|Symptomatic Deterioration|1|||
27996642|NCT03386721|81815707|FG012|Overall Study|Symptomatic Deterioration|0|||
27996643|NCT03386721|81815708|FG013|Overall Study|Symptomatic Deterioration|0|||
27679886|NCT00951015|80664467|FG004|Randomization Phase 96 Week|Adverse Event|0|||
27804352|NCT03262233|81113989|FG002|Overall Study|Withdrawal by Subject|21|||
27996644|NCT03386721|81815709|FG014|Overall Study|Symptomatic Deterioration|0|||
27996645|NCT03386721|81815695|FG000|Overall Study|Withdrawal by Subject|1|||
27996646|NCT03386721|81815696|FG001|Overall Study|Withdrawal by Subject|2|||
27996647|NCT03386721|81815697|FG002|Overall Study|Withdrawal by Subject|0|||
27996648|NCT03386721|81815698|FG003|Overall Study|Withdrawal by Subject|0|||
27996649|NCT03386721|81815699|FG004|Overall Study|Withdrawal by Subject|0|||
27996650|NCT03386721|81815700|FG005|Overall Study|Withdrawal by Subject|0|||
27996651|NCT03386721|81815701|FG006|Overall Study|Withdrawal by Subject|0|||
27804353|NCT03262233|81113990|FG003|Overall Study|Withdrawal by Subject|13|||
27804354|NCT03262233|81113987|FG000|Overall Study|Declined due to shock|1|||
27804355|NCT03262233|81113988|FG001|Overall Study|Declined due to shock|2|||
27804356|NCT03262233|81113989|FG002|Overall Study|Declined due to shock|2|||
27804357|NCT03262233|81113990|FG003|Overall Study|Declined due to shock|3|||
27804358|NCT03262233|81113987|FG000|Overall Study|Protocol Violation|5|||
27804359|NCT03262233|81113988|FG001|Overall Study|Protocol Violation|10|||
27804360|NCT03262233|81113989|FG002|Overall Study|Protocol Violation|2|||
27804361|NCT03262233|81113990|FG003|Overall Study|Protocol Violation|13|||
27804362|NCT03262233|81113987|FG000|Overall Study|data collection artifact|0|||
27804363|NCT03262233|81113988|FG001|Overall Study|data collection artifact|1|||
27804364|NCT03262233|81113989|FG002|Overall Study|data collection artifact|0|||
27804365|NCT03262233|81113990|FG003|Overall Study|data collection artifact|0|||
27804366|NCT00926289|81113991|FG000|Overall Study|Adverse Event|9|||
27804367|NCT00926289|81113992|FG001|Overall Study|Adverse Event|11|||
27996652|NCT03386721|81815702|FG007|Overall Study|Withdrawal by Subject|0|||
27996653|NCT03386721|81815703|FG008|Overall Study|Withdrawal by Subject|2|||
27996654|NCT03386721|81815704|FG009|Overall Study|Withdrawal by Subject|1|||
27996655|NCT03386721|81815705|FG010|Overall Study|Withdrawal by Subject|3|||
27996656|NCT03386721|81815706|FG011|Overall Study|Withdrawal by Subject|2|||
27996657|NCT03386721|81815707|FG012|Overall Study|Withdrawal by Subject|3|||
27872610|NCT03633825|81365325|FG000|Enrollment|Did not post on network|5066|||
27872611|NCT03633825|81365326|FG001|Enrollment|Did not post on network|5080|||
27996658|NCT03386721|81815708|FG013|Overall Study|Withdrawal by Subject|0|||
27996659|NCT03386721|81815709|FG014|Overall Study|Withdrawal by Subject|0|||
27996660|NCT01970306|81815710|FG000|Overall Study|Not eligible|3|||
27996661|NCT01970306|81815710|FG000|Overall Study|Not able to be treated|9|||
27996662|NCT01442714|81815711|FG000|Overall Study|Death|11|||
27996663|NCT01442714|81815711|FG000|Overall Study|Withdrawal by Subject|1|||
27996664|NCT03259087|81815715|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
27996665|NCT03259087|81815716|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
27996666|NCT03259087|81815717|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
27996667|NCT03259087|81815718|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
27996668|NCT03259087|81815719|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
27996669|NCT03259087|81815715|FG000|Period 2 of Part 2|Adverse Event|0|||
27996670|NCT03259087|81815716|FG001|Period 2 of Part 2|Adverse Event|0|||
27996671|NCT03259087|81815717|FG002|Period 2 of Part 2|Adverse Event|0|||
27996672|NCT03259087|81815718|FG003|Period 2 of Part 2|Adverse Event|0|||
27996673|NCT03259087|81815719|FG004|Period 2 of Part 2|Adverse Event|1|||
27996674|NCT01080807|81815720|FG000|Overall Study|Adverse Event|9|||
27996675|NCT01080807|81815721|FG001|Overall Study|Adverse Event|1|||
27996676|NCT01080807|81815720|FG000|Overall Study|Lack of Efficacy|0|||
27996677|NCT01080807|81815721|FG001|Overall Study|Lack of Efficacy|1|||
27996678|NCT01080807|81815720|FG000|Overall Study|Withdrawal by Subject|7|||
27996679|NCT01080807|81815721|FG001|Overall Study|Withdrawal by Subject|2|||
27996680|NCT01080807|81815720|FG000|Overall Study|Protocol Violation|7|||
27996681|NCT01080807|81815721|FG001|Overall Study|Protocol Violation|6|||
27996682|NCT01080807|81815720|FG000|Overall Study|Lost to Follow-up|6|||
27996683|NCT01080807|81815721|FG001|Overall Study|Lost to Follow-up|4|||
27996684|NCT01080807|81815720|FG000|Overall Study|Noncompliance with drug administration|1|||
27996685|NCT01080807|81815721|FG001|Overall Study|Noncompliance with drug administration|1|||
27996686|NCT01080807|81815720|FG000|Overall Study|Noncompliance to study procedures|1|||
27996687|NCT01080807|81815721|FG001|Overall Study|Noncompliance to study procedures|1|||
27996688|NCT01080807|81815720|FG000|Overall Study|Began working day shift|0|||
27804368|NCT00926289|81113991|FG000|Overall Study|Protocol Violation|8|||
27872612|NCT03633825|81365325|FG000|Enrollment|Post not classified as crisis|13967|||
27996689|NCT01080807|81815721|FG001|Overall Study|Began working day shift|2|||
27996690|NCT01080807|81815720|FG000|Overall Study|Laid off or terminated from job|1|||
27996691|NCT01080807|81815721|FG001|Overall Study|Laid off or terminated from job|2|||
27996692|NCT01080807|81815720|FG000|Overall Study|Stopped working consistent night shifts|0|||
27996693|NCT01080807|81815721|FG001|Overall Study|Stopped working consistent night shifts|1|||
27996694|NCT01080807|81815720|FG000|Overall Study|Work schedule changing|1|||
27579889|NCT02660359|80306760|FG000|Overall Study|Adverse Event|0|||
27804369|NCT00926289|81113992|FG001|Overall Study|Protocol Violation|12|||
27804370|NCT00926289|81113991|FG000|Overall Study|Lost to Follow-up|3|||
27804371|NCT00926289|81113992|FG001|Overall Study|Lost to Follow-up|6|||
27996695|NCT01080807|81815721|FG001|Overall Study|Work schedule changing|1|||
27872613|NCT03633825|81365326|FG001|Enrollment|Post not classified as crisis|13757|||
27996696|NCT01080807|81815720|FG000|Overall Study|Work schedule and travel|0|||
27996697|NCT01080807|81815721|FG001|Overall Study|Work schedule and travel|1|||
27996698|NCT01080807|81815720|FG000|Overall Study|Switched to first shift|1|||
27996699|NCT01080807|81815721|FG001|Overall Study|Switched to first shift|0|||
27996700|NCT01080807|81815720|FG000|Overall Study|Moved away without notifying center|1|||
27996701|NCT01080807|81815721|FG001|Overall Study|Moved away without notifying center|0|||
27996702|NCT01331109|81815722|FG000|Overall Study|Adverse Event|6|||
27996703|NCT01331109|81815722|FG000|Overall Study|Lack of Efficacy|2|||
27996704|NCT01331109|81815722|FG000|Overall Study|Protocol Violation|3|||
27996705|NCT01331109|81815722|FG000|Overall Study|Withdrawal by Subject|7|||
27679887|NCT00951015|80664463|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
27679888|NCT00951015|80664464|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
27679889|NCT00951015|80664465|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
27679890|NCT00951015|80664466|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
27679891|NCT00951015|80664467|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
27679892|NCT00951015|80664463|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
27679893|NCT00951015|80664464|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
27679894|NCT00951015|80664465|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
27679895|NCT00951015|80664466|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
27679896|NCT00951015|80664467|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
27679897|NCT00951015|80664463|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27679898|NCT00951015|80664464|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27679899|NCT00951015|80664465|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27679900|NCT00951015|80664466|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
27679901|NCT00951015|80664467|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
27679902|NCT00951015|80664463|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
27679903|NCT00951015|80664464|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
27679904|NCT00951015|80664465|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
27679905|NCT00951015|80664466|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
27679906|NCT00951015|80664467|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
27679907|NCT00951015|80664463|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
27679908|NCT00951015|80664464|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
27679909|NCT00951015|80664465|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
27679910|NCT00951015|80664466|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
27679911|NCT00951015|80664467|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
27679912|NCT00951015|80664463|FG000|Open-label Phase|Adverse Event|0|||
27679913|NCT00951015|80664464|FG001|Open-label Phase|Adverse Event|0|||
27996706|NCT01331109|81815722|FG000|Overall Study|Lost to Follow-up|1|||
27996707|NCT01331109|81815722|FG000|Overall Study|Study Terminated by Sponsor|38|||
27804372|NCT00926289|81113991|FG000|Overall Study|Withdrawal by Subject|4|||
27804373|NCT00926289|81113992|FG001|Overall Study|Withdrawal by Subject|4|||
27804374|NCT00926289|81113991|FG000|Overall Study|Other|1|||
27804375|NCT00926289|81113992|FG001|Overall Study|Other|3|||
27804376|NCT00971204|81117036|FG000|Overall Study|Did not meet all criteria-not treated|14|||
27804377|NCT00971204|81117036|FG000|Overall Study|Lost to Follow-up|10|||
27996708|NCT03040674|81815723|FG000|Overall Study|Lost to Follow-up|225|||
27996709|NCT03040674|81815723|FG000|Overall Study|Death|23|||
27996710|NCT00837213|81815724|FG000|Overall Study|Lost to Follow-up|3|||
27996711|NCT00837213|81815725|FG001|Overall Study|Lost to Follow-up|2|||
27679914|NCT00951015|80664465|FG002|Open-label Phase|Adverse Event|0|||
27679915|NCT00951015|80664466|FG003|Open-label Phase|Adverse Event|0|||
27679916|NCT00951015|80664467|FG004|Open-label Phase|Adverse Event|3|||
27679917|NCT00951015|80664463|FG000|Open-label Phase|Lack of Efficacy|0|||
27679918|NCT00951015|80664464|FG001|Open-label Phase|Lack of Efficacy|0|||
27679919|NCT00951015|80664465|FG002|Open-label Phase|Lack of Efficacy|0|||
27679920|NCT00951015|80664466|FG003|Open-label Phase|Lack of Efficacy|0|||
27804378|NCT02278952|81117037|FG000|Overall Study|Insufficient Sample|6|||
27804379|NCT02984683|81117038|FG000|Overall Study|Adverse Event|3|||
27996712|NCT00837213|81815724|FG000|Overall Study|Withdrawal by Subject|2|||
27996713|NCT00837213|81815725|FG001|Overall Study|Withdrawal by Subject|2|||
27996714|NCT00837213|81815724|FG000|Overall Study|not stated|1|||
27996715|NCT00837213|81815725|FG001|Overall Study|not stated|1|||
27679921|NCT00951015|80664467|FG004|Open-label Phase|Lack of Efficacy|1|||
27679922|NCT00951015|80664463|FG000|Open-label Phase|Protocol Violation|0|||
27804380|NCT02984683|81117039|FG001|Overall Study|Adverse Event|3|||
27804381|NCT02984683|81117038|FG000|Overall Study|Withdrawal by Subject|1|||
27679923|NCT00951015|80664464|FG001|Open-label Phase|Protocol Violation|0|||
27804382|NCT02984683|81117039|FG001|Overall Study|Withdrawal by Subject|0|||
27872614|NCT03633825|81365325|FG000|Follow up|Lost to Follow-up|478|||
27996716|NCT04303572|81815728|FG000|Overall Study|Study closed due to poor enrollment|1|||
27996717|NCT02814175|81815729|FG000|Part 1|Adverse Event|2|||
27872615|NCT03633825|81365326|FG001|Follow up|Lost to Follow-up|450|||
27996718|NCT02814175|81815730|FG001|Part 1|Adverse Event|3|||
27679924|NCT00951015|80664465|FG002|Open-label Phase|Protocol Violation|0|||
27679925|NCT00951015|80664466|FG003|Open-label Phase|Protocol Violation|0|||
27679926|NCT00951015|80664467|FG004|Open-label Phase|Protocol Violation|12|||
27679927|NCT00951015|80664463|FG000|Open-label Phase|Lost to Follow-up|0|||
27804383|NCT02984683|81117038|FG000|Overall Study|Disease progression|7|||
27996719|NCT02814175|81815731|FG002|Part 1|Adverse Event|0|||
27996720|NCT02814175|81815732|FG003|Part 1|Adverse Event|0|||
27996721|NCT02814175|81815733|FG004|Part 1|Adverse Event|0|||
27996722|NCT02814175|81815734|FG005|Part 1|Adverse Event|0|||
27996723|NCT02814175|81815729|FG000|Part 1|Withdrawal Consent|8|||
27996724|NCT02814175|81815730|FG001|Part 1|Withdrawal Consent|1|||
27996725|NCT02814175|81815731|FG002|Part 1|Withdrawal Consent|0|||
27996726|NCT02814175|81815732|FG003|Part 1|Withdrawal Consent|0|||
27996727|NCT02814175|81815733|FG004|Part 1|Withdrawal Consent|0|||
27996728|NCT02814175|81815734|FG005|Part 1|Withdrawal Consent|0|||
27996729|NCT02814175|81815729|FG000|Part 1|Lost to Follow-up|1|||
27996730|NCT02814175|81815730|FG001|Part 1|Lost to Follow-up|0|||
27996731|NCT02814175|81815731|FG002|Part 1|Lost to Follow-up|0|||
27996732|NCT02814175|81815732|FG003|Part 1|Lost to Follow-up|0|||
27996733|NCT02814175|81815733|FG004|Part 1|Lost to Follow-up|0|||
27996734|NCT02814175|81815734|FG005|Part 1|Lost to Follow-up|0|||
27996735|NCT02814175|81815729|FG000|Part 1|Lack of Efficacy|1|||
27996736|NCT02814175|81815730|FG001|Part 1|Lack of Efficacy|2|||
27996737|NCT02814175|81815731|FG002|Part 1|Lack of Efficacy|0|||
27996738|NCT02814175|81815732|FG003|Part 1|Lack of Efficacy|0|||
27996739|NCT02814175|81815733|FG004|Part 1|Lack of Efficacy|0|||
27996740|NCT02814175|81815734|FG005|Part 1|Lack of Efficacy|0|||
27996741|NCT02814175|81815729|FG000|Part 2|Adverse Event|0|||
27996742|NCT02814175|81815730|FG001|Part 2|Adverse Event|0|||
27996743|NCT02814175|81815731|FG002|Part 2|Adverse Event|0|||
27996744|NCT02814175|81815732|FG003|Part 2|Adverse Event|1|||
27996745|NCT02814175|81815733|FG004|Part 2|Adverse Event|1|||
27996746|NCT02814175|81815734|FG005|Part 2|Adverse Event|2|||
27996747|NCT02814175|81815729|FG000|Part 2|Withdrawal Consent|0|||
27996748|NCT02814175|81815730|FG001|Part 2|Withdrawal Consent|0|||
27996749|NCT02814175|81815731|FG002|Part 2|Withdrawal Consent|0|||
27996750|NCT02814175|81815732|FG003|Part 2|Withdrawal Consent|2|||
27996751|NCT02814175|81815733|FG004|Part 2|Withdrawal Consent|1|||
27996752|NCT02814175|81815734|FG005|Part 2|Withdrawal Consent|1|||
27996753|NCT02814175|81815729|FG000|Part 2|Lost to Follow-up|0|||
27996754|NCT02814175|81815730|FG001|Part 2|Lost to Follow-up|0|||
27996755|NCT02814175|81815731|FG002|Part 2|Lost to Follow-up|0|||
27996756|NCT02814175|81815732|FG003|Part 2|Lost to Follow-up|1|||
27996757|NCT02814175|81815733|FG004|Part 2|Lost to Follow-up|0|||
27996758|NCT02814175|81815734|FG005|Part 2|Lost to Follow-up|0|||
27996759|NCT02814175|81815729|FG000|Part 2|Lack of Efficacy|0|||
27996760|NCT02814175|81815730|FG001|Part 2|Lack of Efficacy|0|||
27996761|NCT02814175|81815731|FG002|Part 2|Lack of Efficacy|0|||
27996762|NCT02814175|81815732|FG003|Part 2|Lack of Efficacy|0|||
27996763|NCT02814175|81815733|FG004|Part 2|Lack of Efficacy|0|||
27996764|NCT02814175|81815734|FG005|Part 2|Lack of Efficacy|3|||
27996765|NCT00080301|81815736|FG000|Overall Study|Randomized but Never Treated|5|||
27996766|NCT00080301|81815737|FG001|Overall Study|Randomized but Never Treated|10|||
27996767|NCT00080301|81815736|FG000|Overall Study|Still on Treatment as of CSR date|0|||
27996768|NCT00080301|81815737|FG001|Overall Study|Still on Treatment as of CSR date|1|||
27996769|NCT02678351|81815738|FG000|Overall Study|Withdrawal by Subject|1|||
27996770|NCT00799903|81815739|FG000|Overall Study|Investigator Site Closed|25|||
27996771|NCT00799903|81815740|FG001|Overall Study|Investigator Site Closed|23|||
27996772|NCT00799903|81815739|FG000|Overall Study|Withdrawal by Subject|179|||
27996773|NCT00799903|81815740|FG001|Overall Study|Withdrawal by Subject|175|||
27996774|NCT00799903|81815739|FG000|Overall Study|Lost to Follow-up|69|||
27996775|NCT00799903|81815740|FG001|Overall Study|Lost to Follow-up|80|||
27996776|NCT05258149|81819621|FG000|Period 1|Protocol Deviation|1|||
27996777|NCT05258149|81819622|FG001|Period 1|Protocol Deviation|0|||
27996778|NCT05258149|81819621|FG000|Period 1|Adverse Event|0|||
27996779|NCT05258149|81819622|FG001|Period 1|Adverse Event|1|||
27996780|NCT05258149|81819621|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
27996781|NCT05258149|81819622|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
27996782|NCT05258149|81819621|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
27996783|NCT05258149|81819622|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
27996784|NCT05258149|81819621|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
27996785|NCT05258149|81819622|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
27996786|NCT03792256|81819623|FG000|Overall Study|Death|0|||
27996787|NCT03792256|81819624|FG001|Overall Study|Death|1|||
27996788|NCT03792256|81819623|FG000|Overall Study|Lack of Efficacy|0|||
27996789|NCT03792256|81819624|FG001|Overall Study|Lack of Efficacy|1|||
27996790|NCT03792256|81819623|FG000|Overall Study|Withdrawal by Subject|0|||
27996791|NCT03792256|81819624|FG001|Overall Study|Withdrawal by Subject|1|||
27996792|NCT03210961|81819627|FG000|Overall Study|Adverse Event|0|||
27996793|NCT03210961|81819628|FG001|Overall Study|Adverse Event|0|||
27996794|NCT03210961|81819629|FG002|Overall Study|Adverse Event|0|||
27996795|NCT03210961|81819630|FG003|Overall Study|Adverse Event|0|||
27996796|NCT03210961|81819631|FG004|Overall Study|Adverse Event|0|||
27996797|NCT03210961|81819632|FG005|Overall Study|Adverse Event|0|||
27996798|NCT03210961|81819633|FG006|Overall Study|Adverse Event|0|||
27996799|NCT03210961|81819634|FG007|Overall Study|Adverse Event|0|||
27996800|NCT03210961|81819635|FG008|Overall Study|Adverse Event|0|||
27996801|NCT03210961|81819636|FG009|Overall Study|Adverse Event|0|||
27996802|NCT03210961|81819637|FG010|Overall Study|Adverse Event|0|||
27996803|NCT03210961|81819638|FG011|Overall Study|Adverse Event|0|||
27996804|NCT03210961|81819639|FG012|Overall Study|Adverse Event|0|||
27996805|NCT03210961|81819640|FG013|Overall Study|Adverse Event|1|||
27996806|NCT03210961|81819641|FG014|Overall Study|Adverse Event|0|||
27996807|NCT03210961|81819627|FG000|Overall Study|Lost to Follow-up|0|||
27996808|NCT03210961|81819628|FG001|Overall Study|Lost to Follow-up|0|||
27996809|NCT03210961|81819629|FG002|Overall Study|Lost to Follow-up|0|||
27996810|NCT03210961|81819630|FG003|Overall Study|Lost to Follow-up|0|||
27996811|NCT03210961|81819631|FG004|Overall Study|Lost to Follow-up|0|||
27996812|NCT03210961|81819632|FG005|Overall Study|Lost to Follow-up|0|||
27996813|NCT03210961|81819633|FG006|Overall Study|Lost to Follow-up|0|||
27679928|NCT00951015|80664464|FG001|Open-label Phase|Lost to Follow-up|0|||
27679929|NCT00951015|80664465|FG002|Open-label Phase|Lost to Follow-up|0|||
27679930|NCT00951015|80664466|FG003|Open-label Phase|Lost to Follow-up|0|||
27679931|NCT00951015|80664467|FG004|Open-label Phase|Lost to Follow-up|12|||
27679932|NCT00951015|80664463|FG000|Open-label Phase|Withdrawal by Subject|0|||
27679933|NCT00951015|80664464|FG001|Open-label Phase|Withdrawal by Subject|0|||
27679934|NCT00951015|80664465|FG002|Open-label Phase|Withdrawal by Subject|0|||
27679935|NCT00951015|80664466|FG003|Open-label Phase|Withdrawal by Subject|0|||
27679936|NCT00951015|80664467|FG004|Open-label Phase|Withdrawal by Subject|14|||
27679937|NCT00951015|80664463|FG000|Open-label Phase|Physician Decision|0|||
27679938|NCT00951015|80664464|FG001|Open-label Phase|Physician Decision|0|||
27679939|NCT00951015|80664465|FG002|Open-label Phase|Physician Decision|0|||
27679940|NCT00951015|80664466|FG003|Open-label Phase|Physician Decision|0|||
27679941|NCT00951015|80664467|FG004|Open-label Phase|Physician Decision|8|||
27679942|NCT02687035|80664468|FG000|Overall Study|Withdrawal by Subject|1|||
27679943|NCT02687035|80664468|FG000|Overall Study|Death|87|||
27679944|NCT02687035|80664468|FG000|Overall Study|Lost to Follow-up|1|||
27679945|NCT02687035|80664468|FG000|Overall Study|Missed Visit|87|||
27679946|NCT02687035|80664468|FG000|Overall Study|Did not receive Study Device|8|||
27679947|NCT00604825|80664469|FG000|Overall Study|Adverse Event|2|||
27679948|NCT00604825|80664470|FG001|Overall Study|Adverse Event|6|||
27679949|NCT00604825|80664471|FG002|Overall Study|Adverse Event|7|||
27679950|NCT00604825|80664472|FG003|Overall Study|Adverse Event|4|||
27679951|NCT00604825|80664469|FG000|Overall Study|Lost to Follow-up|0|||
27679952|NCT00604825|80664470|FG001|Overall Study|Lost to Follow-up|3|||
27679953|NCT00604825|80664471|FG002|Overall Study|Lost to Follow-up|1|||
27679954|NCT00604825|80664472|FG003|Overall Study|Lost to Follow-up|0|||
27679955|NCT00604825|80664469|FG000|Overall Study|Protocol Violation|0|||
27679956|NCT00604825|80664470|FG001|Overall Study|Protocol Violation|1|||
27679957|NCT00604825|80664471|FG002|Overall Study|Protocol Violation|0|||
27996814|NCT03210961|81819634|FG007|Overall Study|Lost to Follow-up|0|||
27996815|NCT03210961|81819635|FG008|Overall Study|Lost to Follow-up|0|||
27996816|NCT03210961|81819636|FG009|Overall Study|Lost to Follow-up|0|||
27996817|NCT03210961|81819637|FG010|Overall Study|Lost to Follow-up|0|||
27996818|NCT03210961|81819638|FG011|Overall Study|Lost to Follow-up|0|||
27996819|NCT03210961|81819639|FG012|Overall Study|Lost to Follow-up|0|||
27996820|NCT03210961|81819640|FG013|Overall Study|Lost to Follow-up|0|||
27996821|NCT03210961|81819641|FG014|Overall Study|Lost to Follow-up|1|||
27679958|NCT00604825|80664472|FG003|Overall Study|Protocol Violation|0|||
27679959|NCT00604825|80664469|FG000|Overall Study|Withdrawal by Subject|4|||
27679960|NCT00604825|80664470|FG001|Overall Study|Withdrawal by Subject|3|||
27679961|NCT00604825|80664471|FG002|Overall Study|Withdrawal by Subject|5|||
27679962|NCT00604825|80664472|FG003|Overall Study|Withdrawal by Subject|5|||
27679963|NCT00604825|80664469|FG000|Overall Study|Lack of Efficacy|3|||
27804384|NCT02984683|81117039|FG001|Overall Study|Disease progression|9|||
27996822|NCT03210961|81819627|FG000|Overall Study|Withdrawal by Subject|0|||
27996823|NCT03210961|81819628|FG001|Overall Study|Withdrawal by Subject|0|||
27804385|NCT01270841|81117040|FG000|Overall Study|Adverse Event|0|||
27996824|NCT03210961|81819629|FG002|Overall Study|Withdrawal by Subject|0|||
27996825|NCT03210961|81819630|FG003|Overall Study|Withdrawal by Subject|0|||
27679964|NCT00604825|80664470|FG001|Overall Study|Lack of Efficacy|2|||
27679965|NCT00604825|80664471|FG002|Overall Study|Lack of Efficacy|1|||
27679966|NCT00604825|80664472|FG003|Overall Study|Lack of Efficacy|0|||
27679967|NCT00604825|80664469|FG000|Overall Study|Did not meet eligibility criteria|0|||
27679968|NCT00604825|80664470|FG001|Overall Study|Did not meet eligibility criteria|0|||
27679969|NCT00604825|80664471|FG002|Overall Study|Did not meet eligibility criteria|2|||
27679970|NCT00604825|80664472|FG003|Overall Study|Did not meet eligibility criteria|0|||
27679971|NCT00604825|80664469|FG000|Overall Study|Physician Decision|0|||
27679972|NCT00604825|80664470|FG001|Overall Study|Physician Decision|0|||
27679973|NCT00604825|80664471|FG002|Overall Study|Physician Decision|0|||
27679974|NCT00604825|80664472|FG003|Overall Study|Physician Decision|1|||
27679975|NCT00604825|80664469|FG000|Overall Study|Exclusion criterion met|0|||
27679976|NCT00604825|80664470|FG001|Overall Study|Exclusion criterion met|0|||
27679977|NCT00604825|80664471|FG002|Overall Study|Exclusion criterion met|0|||
27679978|NCT00604825|80664472|FG003|Overall Study|Exclusion criterion met|1|||
27804386|NCT01270841|81117041|FG001|Overall Study|Adverse Event|1|||
27804387|NCT01270841|81117042|FG002|Overall Study|Adverse Event|0|||
27996826|NCT03210961|81819631|FG004|Overall Study|Withdrawal by Subject|0|||
27996827|NCT03210961|81819632|FG005|Overall Study|Withdrawal by Subject|0|||
27996828|NCT03210961|81819633|FG006|Overall Study|Withdrawal by Subject|0|||
27996829|NCT03210961|81819634|FG007|Overall Study|Withdrawal by Subject|0|||
27996830|NCT03210961|81819635|FG008|Overall Study|Withdrawal by Subject|0|||
27996831|NCT03210961|81819636|FG009|Overall Study|Withdrawal by Subject|0|||
27679979|NCT02597712|80664474|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
27679980|NCT02597712|80664475|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
27804388|NCT01270841|81117043|FG003|Overall Study|Adverse Event|3|||
27804389|NCT01270841|81117040|FG000|Overall Study|Withdrawal by Subject|3|||
27804390|NCT01270841|81117041|FG001|Overall Study|Withdrawal by Subject|2|||
27804391|NCT01270841|81117042|FG002|Overall Study|Withdrawal by Subject|3|||
27804392|NCT01270841|81117043|FG003|Overall Study|Withdrawal by Subject|3|||
27804393|NCT01270841|81117040|FG000|Overall Study|Lost to Follow-up|3|||
27804394|NCT01270841|81117041|FG001|Overall Study|Lost to Follow-up|1|||
27804395|NCT01270841|81117042|FG002|Overall Study|Lost to Follow-up|4|||
27804396|NCT01270841|81117043|FG003|Overall Study|Lost to Follow-up|2|||
27804397|NCT01270841|81117040|FG000|Overall Study|Physician Decision|0|||
27804398|NCT01270841|81117041|FG001|Overall Study|Physician Decision|1|||
27804399|NCT01270841|81117042|FG002|Overall Study|Physician Decision|0|||
27804400|NCT01270841|81117043|FG003|Overall Study|Physician Decision|0|||
27804401|NCT01270841|81117040|FG000|Overall Study|Did not qualify|6|||
27804402|NCT01270841|81117041|FG001|Overall Study|Did not qualify|3|||
27804403|NCT01270841|81117042|FG002|Overall Study|Did not qualify|4|||
27804404|NCT01270841|81117043|FG003|Overall Study|Did not qualify|5|||
27804405|NCT01270841|81117040|FG000|Overall Study|Protocol Violation|1|||
27804406|NCT01270841|81117041|FG001|Overall Study|Protocol Violation|5|||
27804407|NCT01270841|81117042|FG002|Overall Study|Protocol Violation|0|||
27804408|NCT01270841|81117043|FG003|Overall Study|Protocol Violation|0|||
27804409|NCT01270841|81117040|FG000|Overall Study|Enrolled in error|0|||
27804410|NCT01270841|81117041|FG001|Overall Study|Enrolled in error|1|||
27804411|NCT01270841|81117042|FG002|Overall Study|Enrolled in error|0|||
27804412|NCT01270841|81117043|FG003|Overall Study|Enrolled in error|0|||
27804413|NCT01716754|81117045|FG000|Overall Study|Death|0|||
27804414|NCT01716754|81117046|FG001|Overall Study|Death|0|||
27804415|NCT01716754|81117047|FG002|Overall Study|Death|0|||
27804416|NCT01716754|81117048|FG003|Overall Study|Death|1|||
27804417|NCT01716754|81117045|FG000|Overall Study|Protocol deviation|0|||
27804418|NCT01716754|81117046|FG001|Overall Study|Protocol deviation|2|||
27804419|NCT01716754|81117047|FG002|Overall Study|Protocol deviation|7|||
27804420|NCT01716754|81117048|FG003|Overall Study|Protocol deviation|2|||
27804421|NCT01716754|81117045|FG000|Overall Study|Non-compliance with study treatment|0|||
27804422|NCT01716754|81117046|FG001|Overall Study|Non-compliance with study treatment|0|||
27996832|NCT03210961|81819637|FG010|Overall Study|Withdrawal by Subject|0|||
27996833|NCT03210961|81819638|FG011|Overall Study|Withdrawal by Subject|0|||
27996834|NCT03210961|81819639|FG012|Overall Study|Withdrawal by Subject|0|||
27804423|NCT01716754|81117047|FG002|Overall Study|Non-compliance with study treatment|1|||
27804424|NCT01716754|81117048|FG003|Overall Study|Non-compliance with study treatment|0|||
27804425|NCT01716754|81117045|FG000|Overall Study|Physician Decision|1|||
27804426|NCT01716754|81117046|FG001|Overall Study|Physician Decision|0|||
27804427|NCT01716754|81117047|FG002|Overall Study|Physician Decision|0|||
27804428|NCT01716754|81117048|FG003|Overall Study|Physician Decision|0|||
27804429|NCT01716754|81117045|FG000|Overall Study|Lost to Follow-up|1|||
27804430|NCT01716754|81117046|FG001|Overall Study|Lost to Follow-up|0|||
27804431|NCT01716754|81117047|FG002|Overall Study|Lost to Follow-up|0|||
27679981|NCT02597712|80664474|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
27804432|NCT01716754|81117048|FG003|Overall Study|Lost to Follow-up|1|||
27804433|NCT01716754|81117045|FG000|Overall Study|Adverse Event|4|||
27996835|NCT03210961|81819640|FG013|Overall Study|Withdrawal by Subject|0|||
27804434|NCT01716754|81117046|FG001|Overall Study|Adverse Event|2|||
27804435|NCT01716754|81117047|FG002|Overall Study|Adverse Event|2|||
27804436|NCT01716754|81117048|FG003|Overall Study|Adverse Event|1|||
27804437|NCT01716754|81117045|FG000|Overall Study|Withdrawal by Subject|5|||
27804438|NCT01716754|81117046|FG001|Overall Study|Withdrawal by Subject|0|||
27804439|NCT01716754|81117047|FG002|Overall Study|Withdrawal by Subject|4|||
27804440|NCT01716754|81117048|FG003|Overall Study|Withdrawal by Subject|3|||
27804441|NCT03372083|81117049|FG000|Overall Study|Adverse Event|3|||
27804442|NCT03372083|81117049|FG000|Overall Study|Physician Decision|1|||
27804443|NCT03372083|81117049|FG000|Overall Study|Withdrawal by Subject|1|||
27804444|NCT03636542|81117050|FG000|Overall Study|Lost to Follow-up|1|||
27804445|NCT03636542|81117051|FG001|Overall Study|Lost to Follow-up|1|||
27804446|NCT03636542|81117050|FG000|Overall Study|Physician Decision|0|||
27804447|NCT03636542|81117051|FG001|Overall Study|Physician Decision|1|||
27804448|NCT03636542|81117050|FG000|Overall Study|Withdrawal by Subject|1|||
27804449|NCT03636542|81117051|FG001|Overall Study|Withdrawal by Subject|0|||
27804450|NCT00379587|81117054|FG000|Overall Study|Lost to Follow-up|2|||
27804451|NCT02626182|81117055|FG000|Overall Study|Adverse Event|2|||
27804452|NCT02626182|81117056|FG001|Overall Study|Adverse Event|0|||
27804453|NCT00616928|81117057|FG000|Overall Study|Adverse Event|6|||
27804454|NCT00616928|81117058|FG001|Overall Study|Adverse Event|3|||
27804455|NCT00616928|81117059|FG002|Overall Study|Adverse Event|2|||
27804456|NCT00616928|81117060|FG003|Overall Study|Adverse Event|2|||
27804457|NCT00616928|81117057|FG000|Overall Study|Other|51|||
27804458|NCT00616928|81117058|FG001|Overall Study|Other|8|||
27804459|NCT00616928|81117059|FG002|Overall Study|Other|15|||
27804460|NCT00616928|81117060|FG003|Overall Study|Other|5|||
27804461|NCT00616928|81117057|FG000|Overall Study|Lost to Follow-up|5|||
27804462|NCT00616928|81117058|FG001|Overall Study|Lost to Follow-up|7|||
27996836|NCT03210961|81819641|FG014|Overall Study|Withdrawal by Subject|1|||
27996837|NCT03210961|81819627|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996838|NCT03210961|81819628|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996839|NCT03210961|81819629|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996840|NCT03210961|81819630|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996841|NCT03210961|81819631|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996842|NCT03210961|81819632|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996843|NCT03210961|81819633|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996844|NCT03210961|81819634|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996845|NCT03210961|81819635|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996846|NCT03210961|81819636|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996847|NCT03210961|81819637|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996848|NCT03210961|81819638|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996849|NCT03210961|81819639|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996850|NCT03210961|81819640|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
27996851|NCT03210961|81819641|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
27996852|NCT03210961|81819627|FG000|Overall Study|Other|0|||
27996853|NCT03210961|81819628|FG001|Overall Study|Other|0|||
27996854|NCT03210961|81819629|FG002|Overall Study|Other|0|||
27996855|NCT03210961|81819630|FG003|Overall Study|Other|1|||
27996856|NCT03210961|81819631|FG004|Overall Study|Other|0|||
27996857|NCT03210961|81819632|FG005|Overall Study|Other|0|||
27996858|NCT03210961|81819633|FG006|Overall Study|Other|1|||
27579890|NCT02660359|80306761|FG001|Overall Study|Adverse Event|1|||
27804463|NCT00616928|81117059|FG002|Overall Study|Lost to Follow-up|0|||
27804464|NCT00616928|81117060|FG003|Overall Study|Lost to Follow-up|0|||
27804465|NCT01325532|81117061|FG000|Overall Study|Withdrawal by Subject|2|||
27804466|NCT01325532|81117062|FG001|Overall Study|Withdrawal by Subject|0|||
27804467|NCT04130919|81117065|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
27804468|NCT04130919|81117066|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
27804469|NCT04130919|81117067|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
27804470|NCT04130919|81117068|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
27804471|NCT04130919|81117069|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
27804472|NCT04130919|81117070|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
27804473|NCT04130919|81117065|FG000|Blinded Treatment Phase|Adverse Event|0|||
27804474|NCT04130919|81117066|FG001|Blinded Treatment Phase|Adverse Event|0|||
27996859|NCT03210961|81819634|FG007|Overall Study|Other|0|||
27996860|NCT03210961|81819635|FG008|Overall Study|Other|0|||
27579891|NCT02660359|80306762|FG002|Overall Study|Adverse Event|0|||
27679982|NCT02597712|80664475|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
27996861|NCT03210961|81819636|FG009|Overall Study|Other|0|||
27996862|NCT03210961|81819637|FG010|Overall Study|Other|1|||
27996863|NCT03210961|81819638|FG011|Overall Study|Other|0|||
27996864|NCT03210961|81819639|FG012|Overall Study|Other|2|||
27996865|NCT03210961|81819640|FG013|Overall Study|Other|2|||
27579892|NCT02660359|80306760|FG000|Overall Study|Other|2|||
27679983|NCT02597712|80664474|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
27804475|NCT04130919|81117067|FG002|Blinded Treatment Phase|Adverse Event|1|||
27804476|NCT04130919|81117068|FG003|Blinded Treatment Phase|Adverse Event|0|||
27804477|NCT04130919|81117069|FG004|Blinded Treatment Phase|Adverse Event|0|||
27804478|NCT04130919|81117070|FG005|Blinded Treatment Phase|Adverse Event|0|||
27804479|NCT04130919|81117065|FG000|Blinded Treatment Phase|Disease worsening|0|||
27804480|NCT04130919|81117066|FG001|Blinded Treatment Phase|Disease worsening|0|||
27804481|NCT04130919|81117067|FG002|Blinded Treatment Phase|Disease worsening|1|||
27804482|NCT04130919|81117068|FG003|Blinded Treatment Phase|Disease worsening|0|||
27804483|NCT04130919|81117069|FG004|Blinded Treatment Phase|Disease worsening|0|||
27804484|NCT04130919|81117070|FG005|Blinded Treatment Phase|Disease worsening|0|||
27804485|NCT04130919|81117065|FG000|Blinded Treatment Phase|Investigator's decision|0|||
27804486|NCT04130919|81117066|FG001|Blinded Treatment Phase|Investigator's decision|1|||
27804487|NCT04130919|81117067|FG002|Blinded Treatment Phase|Investigator's decision|0|||
27804488|NCT04130919|81117068|FG003|Blinded Treatment Phase|Investigator's decision|0|||
27996866|NCT03210961|81819641|FG014|Overall Study|Other|0|||
27996867|NCT01327599|81819652|FG000|Overall Study|Adverse Event|1|||
27996868|NCT01327599|81819652|FG000|Overall Study|Could Not Attend Visit|1|||
27996869|NCT01327599|81819652|FG000|Overall Study|Withdrawal of Consent|1|||
27996870|NCT02021643|81819659|FG000|Overall Study|Enrolled but Never Treated|1|||
27996871|NCT02021643|81819660|FG001|Overall Study|Enrolled but Never Treated|0|||
27996872|NCT02021643|81819661|FG002|Overall Study|Enrolled but Never Treated|0|||
27996873|NCT02021643|81819662|FG003|Overall Study|Enrolled but Never Treated|0|||
27996874|NCT02021643|81819659|FG000|Overall Study|Adverse Event|0|||
27996875|NCT02021643|81819660|FG001|Overall Study|Adverse Event|1|||
27996876|NCT02021643|81819661|FG002|Overall Study|Adverse Event|0|||
27996877|NCT02021643|81819662|FG003|Overall Study|Adverse Event|0|||
27996878|NCT02021643|81819659|FG000|Overall Study|Death|0|||
27996879|NCT02021643|81819660|FG001|Overall Study|Death|1|||
27996880|NCT02021643|81819661|FG002|Overall Study|Death|0|||
27996881|NCT02021643|81819662|FG003|Overall Study|Death|0|||
27996882|NCT02021643|81819659|FG000|Overall Study|Investigator's Discretion|1|||
27996883|NCT02021643|81819660|FG001|Overall Study|Investigator's Discretion|0|||
27996884|NCT02021643|81819661|FG002|Overall Study|Investigator's Discretion|0|||
27996885|NCT02021643|81819662|FG003|Overall Study|Investigator's Discretion|0|||
27996886|NCT02021643|81819659|FG000|Overall Study|Lack of Efficacy|7|||
27996887|NCT02021643|81819660|FG001|Overall Study|Lack of Efficacy|6|||
27996888|NCT02021643|81819661|FG002|Overall Study|Lack of Efficacy|0|||
27804489|NCT04130919|81117069|FG004|Blinded Treatment Phase|Investigator's decision|0|||
27872616|NCT00931411|81365330|FG000|First Intervention - 42 Days|Adverse Event|2|||
27996889|NCT02021643|81819662|FG003|Overall Study|Lack of Efficacy|12|||
27996890|NCT02021643|81819659|FG000|Overall Study|Lost to Follow-up|0|||
27996891|NCT02021643|81819660|FG001|Overall Study|Lost to Follow-up|1|||
27996892|NCT02021643|81819661|FG002|Overall Study|Lost to Follow-up|0|||
27996893|NCT02021643|81819662|FG003|Overall Study|Lost to Follow-up|0|||
27804490|NCT04130919|81117070|FG005|Blinded Treatment Phase|Investigator's decision|0|||
27804491|NCT04130919|81117065|FG000|Blinded Treatment Phase|Withdrew consent|1|||
27996894|NCT02021643|81819659|FG000|Overall Study|Withdrew Consent|0|||
27996895|NCT02021643|81819660|FG001|Overall Study|Withdrew Consent|1|||
27996896|NCT02021643|81819661|FG002|Overall Study|Withdrew Consent|0|||
27996897|NCT02021643|81819662|FG003|Overall Study|Withdrew Consent|0|||
27996898|NCT01456169|81819663|FG000|Overall Study|Adverse Event|1|||
27996899|NCT01456169|81819664|FG001|Overall Study|Adverse Event|2|||
27996900|NCT01456169|81819665|FG002|Overall Study|Adverse Event|7|||
27996901|NCT01456169|81819663|FG000|Overall Study|Major Protocol Deviation|3|||
27996902|NCT01456169|81819664|FG001|Overall Study|Major Protocol Deviation|2|||
27996903|NCT01456169|81819665|FG002|Overall Study|Major Protocol Deviation|3|||
27996904|NCT01456169|81819663|FG000|Overall Study|Voluntary Withdrawal|3|||
27996905|NCT01456169|81819664|FG001|Overall Study|Voluntary Withdrawal|0|||
27996906|NCT01456169|81819665|FG002|Overall Study|Voluntary Withdrawal|2|||
27996907|NCT01456169|81819663|FG000|Overall Study|Lack of Efficacy|2|||
27996908|NCT01456169|81819664|FG001|Overall Study|Lack of Efficacy|0|||
27996909|NCT01456169|81819665|FG002|Overall Study|Lack of Efficacy|0|||
27996910|NCT01456169|81819663|FG000|Overall Study|Other|1|||
27996911|NCT01456169|81819664|FG001|Overall Study|Other|1|||
27996912|NCT01456169|81819665|FG002|Overall Study|Other|0|||
27996913|NCT01559675|81819667|FG000|Overall Study|Protocol Violation|1|||
27996914|NCT01559675|81819668|FG001|Overall Study|Protocol Violation|2|||
27996915|NCT01559675|81819667|FG000|Overall Study|2nd operation on same patient excluded|14|||
27996916|NCT01559675|81819668|FG001|Overall Study|2nd operation on same patient excluded|12|||
27996917|NCT03160898|81819669|FG000|Overall Study|Adverse Event|4|||
27996918|NCT03160898|81819670|FG001|Overall Study|Adverse Event|8|||
27996919|NCT03160898|81819671|FG002|Overall Study|Adverse Event|7|||
27996920|NCT03160898|81819672|FG003|Overall Study|Adverse Event|10|||
27996921|NCT03160898|81819669|FG000|Overall Study|Death|1|||
27996922|NCT03160898|81819670|FG001|Overall Study|Death|0|||
27996923|NCT03160898|81819671|FG002|Overall Study|Death|0|||
27996924|NCT03160898|81819672|FG003|Overall Study|Death|1|||
27996925|NCT03160898|81819669|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
27996926|NCT03160898|81819670|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
27996927|NCT03160898|81819671|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
27996928|NCT03160898|81819672|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
27996929|NCT03160898|81819669|FG000|Overall Study|Lost to Follow-up|1|||
27996930|NCT03160898|81819670|FG001|Overall Study|Lost to Follow-up|1|||
27996931|NCT03160898|81819671|FG002|Overall Study|Lost to Follow-up|1|||
27996932|NCT03160898|81819672|FG003|Overall Study|Lost to Follow-up|2|||
27996933|NCT03160898|81819669|FG000|Overall Study|Physician Decision|1|||
27996934|NCT03160898|81819670|FG001|Overall Study|Physician Decision|0|||
27996935|NCT03160898|81819671|FG002|Overall Study|Physician Decision|0|||
27996936|NCT03160898|81819672|FG003|Overall Study|Physician Decision|1|||
27996937|NCT03160898|81819669|FG000|Overall Study|Progressive Disease|4|||
27996938|NCT03160898|81819670|FG001|Overall Study|Progressive Disease|1|||
27996939|NCT03160898|81819671|FG002|Overall Study|Progressive Disease|2|||
27996940|NCT03160898|81819672|FG003|Overall Study|Progressive Disease|1|||
27996941|NCT03160898|81819669|FG000|Overall Study|Protocol Violation|1|||
27996942|NCT03160898|81819670|FG001|Overall Study|Protocol Violation|0|||
27996943|NCT03160898|81819671|FG002|Overall Study|Protocol Violation|2|||
27996944|NCT03160898|81819672|FG003|Overall Study|Protocol Violation|0|||
27996945|NCT03160898|81819669|FG000|Overall Study|Sponsor Discretion|2|||
27996946|NCT03160898|81819670|FG001|Overall Study|Sponsor Discretion|0|||
27996947|NCT03160898|81819671|FG002|Overall Study|Sponsor Discretion|0|||
27996948|NCT03160898|81819672|FG003|Overall Study|Sponsor Discretion|0|||
27996949|NCT03160898|81819669|FG000|Overall Study|Withdrawal by Subject|1|||
27804492|NCT04130919|81117066|FG001|Blinded Treatment Phase|Withdrew consent|0|||
27804493|NCT04130919|81117067|FG002|Blinded Treatment Phase|Withdrew consent|0|||
27804494|NCT04130919|81117068|FG003|Blinded Treatment Phase|Withdrew consent|0|||
27804495|NCT04130919|81117069|FG004|Blinded Treatment Phase|Withdrew consent|0|||
27804496|NCT04130919|81117070|FG005|Blinded Treatment Phase|Withdrew consent|0|||
27804497|NCT04130919|81117065|FG000|Open-label Treatment Phase|Withdrew consent|0|||
27804498|NCT04130919|81117066|FG001|Open-label Treatment Phase|Withdrew consent|0|||
27996950|NCT03160898|81819670|FG001|Overall Study|Withdrawal by Subject|3|||
27804499|NCT04130919|81117067|FG002|Open-label Treatment Phase|Withdrew consent|0|||
27872617|NCT00931411|81365331|FG001|First Intervention - 42 Days|Adverse Event|3|||
27996951|NCT03160898|81819671|FG002|Overall Study|Withdrawal by Subject|2|||
27996952|NCT03160898|81819672|FG003|Overall Study|Withdrawal by Subject|1|||
27996953|NCT03160898|81819669|FG000|Overall Study|Other|2|||
27996954|NCT03160898|81819670|FG001|Overall Study|Other|0|||
27996955|NCT03160898|81819671|FG002|Overall Study|Other|2|||
27996956|NCT03160898|81819672|FG003|Overall Study|Other|2|||
27996957|NCT03250182|81819674|FG000|Overall Study|Withdrawal by Subject|1|||
27996958|NCT00731679|81819679|FG000|Overall Study|Adverse Event|7|||
27996959|NCT00731679|81819680|FG001|Overall Study|Adverse Event|8|||
27996960|NCT00731679|81819679|FG000|Overall Study|Withdrawal by Subject|8|||
27996961|NCT00731679|81819680|FG001|Overall Study|Withdrawal by Subject|8|||
27996962|NCT00731679|81819679|FG000|Overall Study|Lost to Follow-up|7|||
27996963|NCT00731679|81819680|FG001|Overall Study|Lost to Follow-up|8|||
27996964|NCT00731679|81819679|FG000|Overall Study|Noncompliance|0|||
27996965|NCT00731679|81819680|FG001|Overall Study|Noncompliance|1|||
27996966|NCT00731679|81819679|FG000|Overall Study|Pregnancy|0|||
27996967|NCT00731679|81819680|FG001|Overall Study|Pregnancy|1|||
27996968|NCT01076036|81819685|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
27996969|NCT01178099|81819686|FG000|Overall Study|Physician Decision|0|||
27996970|NCT01178099|81819687|FG001|Overall Study|Physician Decision|1|||
27996971|NCT03801174|81819688|FG000|Overall Study|Withdrawal by Subject|14|||
27996972|NCT03801174|81819689|FG001|Overall Study|Withdrawal by Subject|15|||
27996973|NCT03801174|81819688|FG000|Overall Study|Death|1|||
27996974|NCT03801174|81819689|FG001|Overall Study|Death|0|||
27996975|NCT03801174|81819688|FG000|Overall Study|Pregnancy|2|||
27996976|NCT03801174|81819689|FG001|Overall Study|Pregnancy|2|||
27804500|NCT04130919|81117068|FG003|Open-label Treatment Phase|Withdrew consent|1|||
27804501|NCT04130919|81117069|FG004|Open-label Treatment Phase|Withdrew consent|1|||
27804502|NCT04130919|81117070|FG005|Open-label Treatment Phase|Withdrew consent|1|||
27804503|NCT04130919|81117065|FG000|Open-label Treatment Phase|Disease worsening|0|||
27804504|NCT04130919|81117066|FG001|Open-label Treatment Phase|Disease worsening|0|||
27804505|NCT04130919|81117067|FG002|Open-label Treatment Phase|Disease worsening|0|||
27804506|NCT04130919|81117068|FG003|Open-label Treatment Phase|Disease worsening|1|||
27804507|NCT04130919|81117069|FG004|Open-label Treatment Phase|Disease worsening|0|||
27804508|NCT04130919|81117070|FG005|Open-label Treatment Phase|Disease worsening|1|||
27804509|NCT04130919|81117065|FG000|Open-label Treatment Phase|Investigator's decision|0|||
27804510|NCT04130919|81117066|FG001|Open-label Treatment Phase|Investigator's decision|0|||
27804511|NCT04130919|81117067|FG002|Open-label Treatment Phase|Investigator's decision|0|||
27804512|NCT04130919|81117068|FG003|Open-label Treatment Phase|Investigator's decision|1|||
27804513|NCT04130919|81117069|FG004|Open-label Treatment Phase|Investigator's decision|0|||
27804514|NCT04130919|81117070|FG005|Open-label Treatment Phase|Investigator's decision|0|||
27804515|NCT04130919|81117065|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
27804516|NCT04130919|81117066|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
27804517|NCT04130919|81117067|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
27804518|NCT04130919|81117068|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
27804519|NCT04130919|81117069|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
27804520|NCT04130919|81117070|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
27804521|NCT04130919|81117065|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
27804522|NCT04130919|81117066|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
27804523|NCT04130919|81117067|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
27804524|NCT04130919|81117068|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
27804525|NCT04130919|81117069|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
27804526|NCT04130919|81117070|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
27804527|NCT04575038|81117071|FG000|Overall Study|Withdrawal by Subject|1|||
27804528|NCT04575038|81117072|FG001|Overall Study|Withdrawal by Subject|1|||
27804529|NCT00856778|81117075|FG000|Overall Study|Adverse Event|7|||
27804530|NCT00856778|81117075|FG000|Overall Study|Withdrawal by Subject|10|||
27804531|NCT00856778|81117075|FG000|Overall Study|Study deviation|2|||
27804532|NCT00856778|81117075|FG000|Overall Study|Lost to Follow-up|5|||
27804533|NCT01225991|81117080|FG000|Overall Study|Withdrawal by Subject|6|||
27804534|NCT03361956|81117083|FG000|Overall Study|Adverse Event|1|||
27804535|NCT03361956|81117084|FG001|Overall Study|Adverse Event|0|||
27804536|NCT03361956|81117085|FG002|Overall Study|Adverse Event|1|||
27804537|NCT03361956|81117086|FG003|Overall Study|Adverse Event|1|||
27804538|NCT03361956|81117087|FG004|Overall Study|Adverse Event|0|||
27804539|NCT03361956|81117083|FG000|Overall Study|Other|0|||
27804540|NCT03361956|81117084|FG001|Overall Study|Other|0|||
27804541|NCT03361956|81117085|FG002|Overall Study|Other|0|||
27804542|NCT03361956|81117086|FG003|Overall Study|Other|1|||
27804543|NCT03361956|81117087|FG004|Overall Study|Other|0|||
27804544|NCT03361956|81117083|FG000|Overall Study|Withdrawal by Subject|2|||
27804545|NCT03361956|81117084|FG001|Overall Study|Withdrawal by Subject|2|||
27804546|NCT03361956|81117085|FG002|Overall Study|Withdrawal by Subject|2|||
27804547|NCT03361956|81117086|FG003|Overall Study|Withdrawal by Subject|0|||
27804548|NCT03361956|81117087|FG004|Overall Study|Withdrawal by Subject|3|||
27804549|NCT03361956|81117083|FG000|Overall Study|Disease Relapse|0|||
27804550|NCT03361956|81117084|FG001|Overall Study|Disease Relapse|0|||
27804551|NCT03361956|81117085|FG002|Overall Study|Disease Relapse|1|||
27804552|NCT03361956|81117086|FG003|Overall Study|Disease Relapse|0|||
27996977|NCT03801174|81819688|FG000|Overall Study|Lost to Follow-up|19|||
27804553|NCT03361956|81117087|FG004|Overall Study|Disease Relapse|0|||
27804554|NCT03361956|81117083|FG000|Overall Study|Physician Decision|0|||
27996978|NCT03801174|81819689|FG001|Overall Study|Lost to Follow-up|10|||
27804555|NCT03361956|81117084|FG001|Overall Study|Physician Decision|2|||
27804556|NCT03361956|81117085|FG002|Overall Study|Physician Decision|0|||
27804557|NCT03361956|81117086|FG003|Overall Study|Physician Decision|1|||
27804558|NCT03361956|81117087|FG004|Overall Study|Physician Decision|0|||
27804559|NCT03361956|81117083|FG000|Overall Study|Lost to Follow-up|0|||
27804560|NCT03361956|81117084|FG001|Overall Study|Lost to Follow-up|0|||
27804561|NCT03361956|81117085|FG002|Overall Study|Lost to Follow-up|1|||
27996979|NCT03801174|81819688|FG000|Overall Study|Other|4|||
27996980|NCT03801174|81819689|FG001|Overall Study|Other|3|||
27996981|NCT03801174|81819688|FG000|Overall Study|Lack of Efficacy|4|||
27872618|NCT00931411|81365330|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
27872619|NCT00931411|81365331|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
27872620|NCT00931411|81365330|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
27872621|NCT00931411|81365331|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
27872622|NCT00445432|81365336|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
27872623|NCT00445432|81365337|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
27872624|NCT00445432|81365338|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
27872625|NCT00445432|81365339|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
27872626|NCT00445432|81365336|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
27872627|NCT00445432|81365337|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
27872628|NCT00445432|81365338|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
27872629|NCT00445432|81365339|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
27872630|NCT00445432|81365336|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
27872631|NCT00445432|81365337|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
27872632|NCT00445432|81365338|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
27872633|NCT00445432|81365339|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
27872634|NCT00445432|81365336|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
27872635|NCT00445432|81365337|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
27872636|NCT00445432|81365338|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
27872637|NCT00445432|81365339|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
27872638|NCT00445432|81365336|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
27872639|NCT00445432|81365337|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
27872640|NCT00445432|81365338|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
27872641|NCT00445432|81365339|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
27872642|NCT00445432|81365336|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
27872643|NCT00445432|81365337|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
27872644|NCT00445432|81365338|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
27872645|NCT00445432|81365339|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
27872646|NCT00445432|81365336|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
27872647|NCT00445432|81365337|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
27872648|NCT00445432|81365338|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
27872649|NCT00445432|81365339|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
27872650|NCT03657797|81365340|FG000|Overall Study|Lost to Follow-up|0|||
27872651|NCT03657797|81365341|FG001|Overall Study|Lost to Follow-up|1|||
27872652|NCT03657797|81365342|FG002|Overall Study|Lost to Follow-up|1|||
27872653|NCT03657797|81365343|FG003|Overall Study|Lost to Follow-up|0|||
27872654|NCT03657797|81365340|FG000|Overall Study|Physician Decision|0|||
27996982|NCT03801174|81819689|FG001|Overall Study|Lack of Efficacy|0|||
27996983|NCT03801174|81819688|FG000|Overall Study|Unwilling to complete activities|5|||
27996984|NCT03801174|81819689|FG001|Overall Study|Unwilling to complete activities|6|||
27996985|NCT03801174|81819688|FG000|Overall Study|Moved out of area|3|||
27996986|NCT03801174|81819689|FG001|Overall Study|Moved out of area|0|||
27996987|NCT01922271|81819694|FG000|WASHOUT Period|Withdrawal by Subject|1|||
27996988|NCT01922271|81819695|FG001|WASHOUT Period|Withdrawal by Subject|0|||
27996989|NCT02737475|81819696|FG000|Overall Study|Other reasons|0|||
27996990|NCT02737475|81819697|FG001|Overall Study|Other reasons|0|||
27996991|NCT02737475|81819698|FG002|Overall Study|Other reasons|0|||
27996992|NCT02737475|81819699|FG003|Overall Study|Other reasons|0|||
27996993|NCT02737475|81819700|FG004|Overall Study|Other reasons|1|||
27996994|NCT02737475|81819701|FG005|Overall Study|Other reasons|1|||
27996995|NCT02737475|81819702|FG006|Overall Study|Other reasons|0|||
27804562|NCT03361956|81117086|FG003|Overall Study|Lost to Follow-up|1|||
27804563|NCT03361956|81117087|FG004|Overall Study|Lost to Follow-up|2|||
27804564|NCT02729194|81117092|FG000|Overall Study|Withdrawal by Subject|3|||
27804565|NCT00299728|81117093|FG000|Overall Study|Lost to Follow-up|0|||
27804566|NCT00299728|81117094|FG001|Overall Study|Lost to Follow-up|1|||
27804567|NCT00299728|81117093|FG000|Overall Study|Withdrawal by Subject|0|||
27804568|NCT00299728|81117094|FG001|Overall Study|Withdrawal by Subject|1|||
27804569|NCT00299728|81117093|FG000|Overall Study|Progressive disease|0|||
27804570|NCT00299728|81117094|FG001|Overall Study|Progressive disease|1|||
27804571|NCT00345683|81117100|FG000|Overall Study|Lost to Follow-up|19|||
27872655|NCT03657797|81365341|FG001|Overall Study|Physician Decision|1|||
27872656|NCT03657797|81365342|FG002|Overall Study|Physician Decision|0|||
27996996|NCT02737475|81819703|FG007|Overall Study|Other reasons|0|||
27996997|NCT02737475|81819704|FG008|Overall Study|Other reasons|1|||
27996998|NCT02737475|81819705|FG009|Overall Study|Other reasons|0|||
27804572|NCT00345683|81117101|FG001|Overall Study|Lost to Follow-up|7|||
27996999|NCT02737475|81819706|FG010|Overall Study|Other reasons|1|||
27804573|NCT00345683|81117100|FG000|Overall Study|Other|6|||
27997000|NCT02737475|81819707|FG011|Overall Study|Other reasons|0|||
27997001|NCT02737475|81819708|FG012|Overall Study|Other reasons|0|||
27997002|NCT02737475|81819709|FG013|Overall Study|Other reasons|0|||
27679984|NCT02597712|80664475|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
27997003|NCT02737475|81819710|FG014|Overall Study|Other reasons|0|||
27997004|NCT02737475|81819711|FG015|Overall Study|Other reasons|0|||
27997005|NCT02737475|81819712|FG016|Overall Study|Other reasons|0|||
27997006|NCT02737475|81819713|FG017|Overall Study|Other reasons|0|||
27997007|NCT02737475|81819714|FG018|Overall Study|Other reasons|0|||
27997008|NCT02737475|81819715|FG019|Overall Study|Other reasons|0|||
27997009|NCT02737475|81819716|FG020|Overall Study|Other reasons|0|||
27997010|NCT02737475|81819717|FG021|Overall Study|Other reasons|1|||
27997011|NCT02737475|81819718|FG022|Overall Study|Other reasons|0|||
27997012|NCT02737475|81819719|FG023|Overall Study|Other reasons|1|||
27997013|NCT02737475|81819720|FG024|Overall Study|Other reasons|1|||
27997014|NCT02737475|81819721|FG025|Overall Study|Other reasons|1|||
27997015|NCT02737475|81819722|FG026|Overall Study|Other reasons|0|||
27997016|NCT02737475|81819696|FG000|Overall Study|Death|1|||
27997017|NCT02737475|81819697|FG001|Overall Study|Death|0|||
27997018|NCT02737475|81819698|FG002|Overall Study|Death|0|||
27997019|NCT02737475|81819699|FG003|Overall Study|Death|1|||
27997020|NCT02737475|81819700|FG004|Overall Study|Death|0|||
27997021|NCT02737475|81819701|FG005|Overall Study|Death|0|||
27997022|NCT02737475|81819702|FG006|Overall Study|Death|0|||
27997023|NCT02737475|81819703|FG007|Overall Study|Death|2|||
27997024|NCT02737475|81819704|FG008|Overall Study|Death|0|||
27997025|NCT02737475|81819705|FG009|Overall Study|Death|0|||
27997026|NCT02737475|81819706|FG010|Overall Study|Death|0|||
27997027|NCT02737475|81819707|FG011|Overall Study|Death|4|||
27997028|NCT02737475|81819708|FG012|Overall Study|Death|2|||
27997029|NCT02737475|81819709|FG013|Overall Study|Death|2|||
27997030|NCT02737475|81819710|FG014|Overall Study|Death|0|||
27997031|NCT02737475|81819711|FG015|Overall Study|Death|2|||
27997032|NCT02737475|81819712|FG016|Overall Study|Death|2|||
27997033|NCT02737475|81819713|FG017|Overall Study|Death|2|||
27997034|NCT02737475|81819714|FG018|Overall Study|Death|1|||
27997035|NCT02737475|81819715|FG019|Overall Study|Death|0|||
27997036|NCT02737475|81819716|FG020|Overall Study|Death|0|||
27997037|NCT02737475|81819717|FG021|Overall Study|Death|0|||
27997038|NCT02737475|81819718|FG022|Overall Study|Death|0|||
27997039|NCT02737475|81819719|FG023|Overall Study|Death|0|||
27997040|NCT02737475|81819720|FG024|Overall Study|Death|0|||
27997041|NCT02737475|81819721|FG025|Overall Study|Death|0|||
27997042|NCT02737475|81819722|FG026|Overall Study|Death|0|||
27997043|NCT02737475|81819696|FG000|Overall Study|Participant withdrew consent|0|||
27997044|NCT02737475|81819697|FG001|Overall Study|Participant withdrew consent|0|||
27997045|NCT02737475|81819698|FG002|Overall Study|Participant withdrew consent|0|||
27997046|NCT02737475|81819699|FG003|Overall Study|Participant withdrew consent|0|||
27997047|NCT02737475|81819700|FG004|Overall Study|Participant withdrew consent|0|||
27997048|NCT02737475|81819701|FG005|Overall Study|Participant withdrew consent|2|||
27997049|NCT02737475|81819702|FG006|Overall Study|Participant withdrew consent|0|||
27997050|NCT02737475|81819703|FG007|Overall Study|Participant withdrew consent|0|||
27997051|NCT02737475|81819704|FG008|Overall Study|Participant withdrew consent|0|||
27872657|NCT03657797|81365343|FG003|Overall Study|Physician Decision|0|||
27872658|NCT03657797|81365340|FG000|Overall Study|Withdrawal by Subject|0|||
27872659|NCT03657797|81365341|FG001|Overall Study|Withdrawal by Subject|1|||
27997052|NCT02737475|81819705|FG009|Overall Study|Participant withdrew consent|0|||
27997053|NCT02737475|81819706|FG010|Overall Study|Participant withdrew consent|0|||
27997054|NCT02737475|81819707|FG011|Overall Study|Participant withdrew consent|0|||
27997055|NCT02737475|81819708|FG012|Overall Study|Participant withdrew consent|0|||
27997056|NCT02737475|81819709|FG013|Overall Study|Participant withdrew consent|0|||
27997057|NCT02737475|81819710|FG014|Overall Study|Participant withdrew consent|1|||
27997058|NCT02737475|81819711|FG015|Overall Study|Participant withdrew consent|0|||
27997059|NCT02737475|81819712|FG016|Overall Study|Participant withdrew consent|0|||
27997060|NCT02737475|81819713|FG017|Overall Study|Participant withdrew consent|2|||
27997061|NCT02737475|81819714|FG018|Overall Study|Participant withdrew consent|1|||
27997062|NCT02737475|81819715|FG019|Overall Study|Participant withdrew consent|0|||
27997063|NCT02737475|81819716|FG020|Overall Study|Participant withdrew consent|2|||
27997064|NCT02737475|81819717|FG021|Overall Study|Participant withdrew consent|0|||
27997065|NCT02737475|81819718|FG022|Overall Study|Participant withdrew consent|0|||
27997066|NCT02737475|81819719|FG023|Overall Study|Participant withdrew consent|0|||
27997067|NCT02737475|81819720|FG024|Overall Study|Participant withdrew consent|0|||
27997068|NCT02737475|81819721|FG025|Overall Study|Participant withdrew consent|0|||
27997069|NCT02737475|81819722|FG026|Overall Study|Participant withdrew consent|0|||
27997070|NCT02737475|81819696|FG000|Overall Study|Lost to Follow-up|0|||
27997071|NCT02737475|81819697|FG001|Overall Study|Lost to Follow-up|0|||
27997072|NCT02737475|81819698|FG002|Overall Study|Lost to Follow-up|0|||
27997073|NCT02737475|81819699|FG003|Overall Study|Lost to Follow-up|0|||
27997074|NCT02737475|81819700|FG004|Overall Study|Lost to Follow-up|0|||
27997075|NCT02737475|81819701|FG005|Overall Study|Lost to Follow-up|0|||
27997076|NCT02737475|81819702|FG006|Overall Study|Lost to Follow-up|0|||
27997077|NCT02737475|81819703|FG007|Overall Study|Lost to Follow-up|0|||
27997078|NCT02737475|81819704|FG008|Overall Study|Lost to Follow-up|0|||
27997079|NCT02737475|81819705|FG009|Overall Study|Lost to Follow-up|0|||
27997080|NCT02737475|81819706|FG010|Overall Study|Lost to Follow-up|0|||
27997081|NCT02737475|81819707|FG011|Overall Study|Lost to Follow-up|0|||
27997082|NCT02737475|81819708|FG012|Overall Study|Lost to Follow-up|0|||
27997083|NCT02737475|81819709|FG013|Overall Study|Lost to Follow-up|0|||
27997084|NCT02737475|81819710|FG014|Overall Study|Lost to Follow-up|0|||
27997085|NCT02737475|81819711|FG015|Overall Study|Lost to Follow-up|1|||
27997086|NCT02737475|81819712|FG016|Overall Study|Lost to Follow-up|0|||
27997087|NCT02737475|81819713|FG017|Overall Study|Lost to Follow-up|0|||
27997088|NCT02737475|81819714|FG018|Overall Study|Lost to Follow-up|0|||
27997089|NCT02737475|81819715|FG019|Overall Study|Lost to Follow-up|0|||
27997090|NCT02737475|81819716|FG020|Overall Study|Lost to Follow-up|0|||
27997091|NCT02737475|81819717|FG021|Overall Study|Lost to Follow-up|0|||
27997092|NCT02737475|81819718|FG022|Overall Study|Lost to Follow-up|0|||
27997093|NCT02737475|81819719|FG023|Overall Study|Lost to Follow-up|0|||
27997094|NCT02737475|81819720|FG024|Overall Study|Lost to Follow-up|0|||
27997095|NCT02737475|81819721|FG025|Overall Study|Lost to Follow-up|0|||
27997096|NCT02737475|81819722|FG026|Overall Study|Lost to Follow-up|0|||
27997097|NCT02737475|81819696|FG000|Overall Study|Disease Progression|0|||
27997098|NCT02737475|81819697|FG001|Overall Study|Disease Progression|0|||
27997099|NCT02737475|81819698|FG002|Overall Study|Disease Progression|0|||
27804574|NCT00345683|81117101|FG001|Overall Study|Other|2|||
27804575|NCT00420849|81117105|FG000|Overall Study|Lack of Efficacy|154|||
27997100|NCT02737475|81819699|FG003|Overall Study|Disease Progression|0|||
27997101|NCT02737475|81819700|FG004|Overall Study|Disease Progression|0|||
27997102|NCT02737475|81819701|FG005|Overall Study|Disease Progression|0|||
27997103|NCT02737475|81819702|FG006|Overall Study|Disease Progression|0|||
27997104|NCT02737475|81819703|FG007|Overall Study|Disease Progression|0|||
27997105|NCT02737475|81819704|FG008|Overall Study|Disease Progression|0|||
27997106|NCT02737475|81819705|FG009|Overall Study|Disease Progression|0|||
27997107|NCT02737475|81819706|FG010|Overall Study|Disease Progression|0|||
27997108|NCT02737475|81819707|FG011|Overall Study|Disease Progression|0|||
27997109|NCT02737475|81819708|FG012|Overall Study|Disease Progression|0|||
27997110|NCT02737475|81819709|FG013|Overall Study|Disease Progression|0|||
27997111|NCT02737475|81819710|FG014|Overall Study|Disease Progression|0|||
27997112|NCT02737475|81819711|FG015|Overall Study|Disease Progression|0|||
27997113|NCT02737475|81819712|FG016|Overall Study|Disease Progression|0|||
27997114|NCT02737475|81819713|FG017|Overall Study|Disease Progression|0|||
27997115|NCT02737475|81819714|FG018|Overall Study|Disease Progression|0|||
27997116|NCT02737475|81819715|FG019|Overall Study|Disease Progression|0|||
27997117|NCT02737475|81819716|FG020|Overall Study|Disease Progression|0|||
27997118|NCT02737475|81819717|FG021|Overall Study|Disease Progression|0|||
27997119|NCT02737475|81819718|FG022|Overall Study|Disease Progression|0|||
27997120|NCT02737475|81819719|FG023|Overall Study|Disease Progression|0|||
27997121|NCT02737475|81819720|FG024|Overall Study|Disease Progression|0|||
27997122|NCT02737475|81819721|FG025|Overall Study|Disease Progression|0|||
27997123|NCT02737475|81819722|FG026|Overall Study|Disease Progression|1|||
27804576|NCT00420849|81117105|FG000|Overall Study|Adverse Event|107|||
27997124|NCT02326597|81819725|FG000|Overall Study|Lost to Follow-up|42|||
27997125|NCT02326597|81819726|FG001|Overall Study|Lost to Follow-up|32|||
27804577|NCT00420849|81117105|FG000|Overall Study|Withdrawal by Subject|28|||
27804578|NCT00420849|81117105|FG000|Overall Study|Death|18|||
27804579|NCT00420849|81117105|FG000|Overall Study|Other|14|||
27804580|NCT00420849|81117105|FG000|Overall Study|Transplant|8|||
27804581|NCT00420849|81117105|FG000|Overall Study|Protocol Violation|1|||
27804582|NCT00420849|81117105|FG000|Overall Study|Lost to Follow-up|1|||
27997126|NCT01946152|81819727|FG000|Overall Study|Adverse Event|1|||
27997127|NCT01946152|81819728|FG001|Overall Study|Adverse Event|0|||
27997128|NCT01946152|81819729|FG002|Overall Study|Adverse Event|0|||
27997129|NCT01946152|81819730|FG003|Overall Study|Adverse Event|0|||
27997130|NCT01946152|81819727|FG000|Overall Study|Withdrawal by Subject|0|||
27997131|NCT01946152|81819728|FG001|Overall Study|Withdrawal by Subject|2|||
27997132|NCT01946152|81819729|FG002|Overall Study|Withdrawal by Subject|0|||
27997133|NCT01946152|81819730|FG003|Overall Study|Withdrawal by Subject|0|||
27997134|NCT01946152|81819727|FG000|Overall Study|Progression|0|||
27997135|NCT01946152|81819728|FG001|Overall Study|Progression|1|||
27997136|NCT01946152|81819729|FG002|Overall Study|Progression|4|||
27997137|NCT01946152|81819730|FG003|Overall Study|Progression|7|||
27804583|NCT01021137|81117109|FG000|Overall Study|Lost to Follow-up|9|||
27997138|NCT01946152|81819727|FG000|Overall Study|Physician Decision|0|||
27997139|NCT01946152|81819728|FG001|Overall Study|Physician Decision|0|||
27997140|NCT01946152|81819729|FG002|Overall Study|Physician Decision|1|||
27997141|NCT01946152|81819730|FG003|Overall Study|Physician Decision|0|||
27997142|NCT01946152|81819727|FG000|Overall Study|Second malignancy|0|||
27997143|NCT01946152|81819728|FG001|Overall Study|Second malignancy|0|||
27997144|NCT01946152|81819729|FG002|Overall Study|Second malignancy|1|||
27997145|NCT01946152|81819730|FG003|Overall Study|Second malignancy|0|||
27997146|NCT01946152|81819727|FG000|Overall Study|Adverse Event|0|||
27997147|NCT01946152|81819728|FG001|Overall Study|Adverse Event|0|||
27997148|NCT01946152|81819729|FG002|Overall Study|Adverse Event|0|||
27997149|NCT01946152|81819730|FG003|Overall Study|Adverse Event|1|||
27997150|NCT02274792|81819731|FG000|Overall Study|Withdrawal by Subject|13|||
27997151|NCT02274792|81819731|FG000|Overall Study|Lost to Follow-up|8|||
27997152|NCT02274792|81819731|FG000|Overall Study|Protocol Specified Criteria|2|||
27997153|NCT02274792|81819731|FG000|Overall Study|Sponsor Decision|2|||
27997154|NCT00479713|81819736|FG000|Overall Study|Adverse Event|8|||
27997155|NCT00479713|81819737|FG001|Overall Study|Adverse Event|6|||
27997156|NCT00479713|81819736|FG000|Overall Study|Death|1|||
27997157|NCT00479713|81819737|FG001|Overall Study|Death|0|||
27997158|NCT00479713|81819736|FG000|Overall Study|Lost to Follow-up|0|||
27997159|NCT00479713|81819737|FG001|Overall Study|Lost to Follow-up|1|||
27997160|NCT00479713|81819736|FG000|Overall Study|Protocol Violation|0|||
27997161|NCT00479713|81819737|FG001|Overall Study|Protocol Violation|1|||
27997162|NCT00479713|81819736|FG000|Overall Study|Withdrawal by Subject|4|||
27804584|NCT01021137|81117110|FG001|Overall Study|Lost to Follow-up|4|||
27804585|NCT01021137|81117111|FG002|Overall Study|Lost to Follow-up|2|||
27804586|NCT01021137|81117112|FG003|Overall Study|Lost to Follow-up|6|||
27997163|NCT00479713|81819737|FG001|Overall Study|Withdrawal by Subject|1|||
27997164|NCT01726582|81819740|FG000|Overall Study|Physician Decision|99|||
27997165|NCT01726582|81819740|FG000|Overall Study|Death|85|||
27997166|NCT00193206|81819741|FG000|Preoperative Therapy|Lack of Efficacy|2|||
27997167|NCT00193206|81819741|FG000|Preoperative Therapy|Adverse Event|2|||
27997168|NCT00193206|81819741|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
27997169|NCT00193206|81819741|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
27997170|NCT00193206|81819741|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
27997171|NCT00193206|81819741|FG000|Postoperative Therapy|Physician Decision|3|||
27997172|NCT00193206|81819741|FG000|Postoperative Therapy|Intercurrent Illness|2|||
27997173|NCT00193206|81819741|FG000|Postoperative Therapy|Lack of Efficacy|1|||
27997174|NCT00193206|81819741|FG000|Postoperative Therapy|Protocol Violation|1|||
27997175|NCT00592904|81819742|FG000|Overall Study|Adverse Event|15|||
27997176|NCT00592904|81819743|FG001|Overall Study|Adverse Event|25|||
27997177|NCT00592904|81819744|FG002|Overall Study|Adverse Event|13|||
27997178|NCT00592904|81819745|FG003|Overall Study|Adverse Event|5|||
27997179|NCT00592904|81819742|FG000|Overall Study|Protocol Violation|1|||
27997180|NCT00592904|81819743|FG001|Overall Study|Protocol Violation|1|||
27997181|NCT00592904|81819744|FG002|Overall Study|Protocol Violation|0|||
27997182|NCT00592904|81819745|FG003|Overall Study|Protocol Violation|1|||
27997183|NCT00592904|81819742|FG000|Overall Study|Withdrawal by Subject|4|||
27997184|NCT00592904|81819743|FG001|Overall Study|Withdrawal by Subject|16|||
27997185|NCT00592904|81819744|FG002|Overall Study|Withdrawal by Subject|1|||
27997186|NCT00592904|81819745|FG003|Overall Study|Withdrawal by Subject|2|||
27997187|NCT00592904|81819742|FG000|Overall Study|Lack of Efficacy|2|||
27997188|NCT00592904|81819743|FG001|Overall Study|Lack of Efficacy|7|||
27997189|NCT00592904|81819744|FG002|Overall Study|Lack of Efficacy|2|||
27997190|NCT00592904|81819745|FG003|Overall Study|Lack of Efficacy|3|||
27997191|NCT00592904|81819742|FG000|Overall Study|Physician Decision|0|||
27997192|NCT00592904|81819743|FG001|Overall Study|Physician Decision|3|||
27997193|NCT00592904|81819744|FG002|Overall Study|Physician Decision|1|||
27997194|NCT00592904|81819745|FG003|Overall Study|Physician Decision|0|||
27804587|NCT01021137|81117109|FG000|Overall Study|Withdrawal by Subject|1|||
27997195|NCT00592904|81819742|FG000|Overall Study|Other|3|||
27997196|NCT00592904|81819743|FG001|Overall Study|Other|3|||
27997197|NCT00592904|81819744|FG002|Overall Study|Other|0|||
27997198|NCT00592904|81819745|FG003|Overall Study|Other|0|||
27997199|NCT01128244|81819747|FG000|Overall Study|Adverse Event|1|||
27997200|NCT01128244|81819747|FG000|Overall Study|Scheduling conflict|2|||
27997201|NCT02391363|81819750|FG000|Overall Study|Lost to Follow-up|5|||
27997202|NCT02391363|81819751|FG001|Overall Study|Lost to Follow-up|5|||
27997203|NCT02391363|81819750|FG000|Overall Study|Withdrawal by Subject|6|||
27997204|NCT02391363|81819751|FG001|Overall Study|Withdrawal by Subject|3|||
27997205|NCT01928927|81819756|FG000|Overall Study|Lost to Follow-up|1|||
27997206|NCT01928927|81819757|FG001|Overall Study|Lost to Follow-up|0|||
27997207|NCT01928927|81819756|FG000|Overall Study|Withdrawal by Subject|1|||
27997208|NCT01928927|81819757|FG001|Overall Study|Withdrawal by Subject|1|||
27997209|NCT01525615|81819758|FG000|Overall Study|Adverse Event|11|||
27997210|NCT01525615|81819759|FG001|Overall Study|Adverse Event|7|||
27997211|NCT01525615|81819760|FG002|Overall Study|Adverse Event|5|||
27804588|NCT01021137|81117110|FG001|Overall Study|Withdrawal by Subject|0|||
27804589|NCT01021137|81117111|FG002|Overall Study|Withdrawal by Subject|0|||
27997212|NCT01525615|81819758|FG000|Overall Study|Lost to Follow-up|1|||
27997213|NCT01525615|81819759|FG001|Overall Study|Lost to Follow-up|0|||
27997214|NCT01525615|81819760|FG002|Overall Study|Lost to Follow-up|0|||
27997215|NCT01525615|81819758|FG000|Overall Study|Withdrawal by Subject|1|||
27997216|NCT01525615|81819759|FG001|Overall Study|Withdrawal by Subject|0|||
27997217|NCT01525615|81819760|FG002|Overall Study|Withdrawal by Subject|0|||
27997218|NCT01525615|81819758|FG000|Overall Study|Other reason not described above|1|||
27997219|NCT01525615|81819759|FG001|Overall Study|Other reason not described above|0|||
27997220|NCT01525615|81819760|FG002|Overall Study|Other reason not described above|1|||
27997221|NCT00773513|81819761|FG000|Overall Study|Renal Transplant|254|||
27997222|NCT00773513|81819762|FG001|Overall Study|Renal Transplant|263|||
27997223|NCT00773513|81819761|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
27997224|NCT00773513|81819762|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
27997225|NCT00773513|81819761|FG000|Overall Study|Withdrew Consent|68|||
27997226|NCT00773513|81819762|FG001|Overall Study|Withdrew Consent|69|||
27997227|NCT00773513|81819761|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
27997228|NCT00773513|81819762|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
27997229|NCT00773513|81819761|FG000|Overall Study|Failure to Return|22|||
27997230|NCT00773513|81819762|FG001|Overall Study|Failure to Return|8|||
27997231|NCT00773513|81819761|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27997232|NCT00773513|81819762|FG001|Overall Study|Insufficient Therapeutic Response|18|||
27997233|NCT00773513|81819761|FG000|Overall Study|Reason Not Specified|159|||
27997234|NCT00773513|81819762|FG001|Overall Study|Reason Not Specified|126|||
27997235|NCT00773513|81819761|FG000|Overall Study|Death|531|||
27997236|NCT00773513|81819762|FG001|Overall Study|Death|545|||
27997237|NCT01858363|81819763|FG000|Overall Study|Death|35|||
27997238|NCT01858363|81819764|FG001|Overall Study|Death|9|||
27997239|NCT01858363|81819763|FG000|Overall Study|Withdrawal by Subject|28|||
27997240|NCT01858363|81819764|FG001|Overall Study|Withdrawal by Subject|14|||
27997241|NCT01858363|81819763|FG000|Overall Study|Lost to Follow-up|13|||
27997242|NCT01858363|81819764|FG001|Overall Study|Lost to Follow-up|3|||
27997243|NCT00894361|81819765|FG000|Overall Study|deaths and less than 2 years followup|24|||
27997244|NCT00894361|81819766|FG001|Overall Study|deaths and less than 2 years followup|64|||
27997245|NCT00782717|81819767|FG000|Overall Study|Adverse Event|2|||
27997246|NCT00782717|81819768|FG001|Overall Study|Adverse Event|5|||
27997247|NCT00782717|81819767|FG000|Overall Study|Patient decision unrelated to AE|6|||
27997248|NCT00782717|81819768|FG001|Overall Study|Patient decision unrelated to AE|3|||
27997249|NCT00782717|81819767|FG000|Overall Study|Noncompliance|2|||
27997250|NCT00782717|81819768|FG001|Overall Study|Noncompliance|1|||
27997251|NCT00782717|81819767|FG000|Overall Study|Treatment failure|3|||
27997252|NCT00782717|81819768|FG001|Overall Study|Treatment failure|14|||
27997253|NCT00782717|81819767|FG000|Overall Study|Enrollment close prior to surgery|1|||
27997254|NCT00782717|81819768|FG001|Overall Study|Enrollment close prior to surgery|0|||
27997255|NCT00782717|81819767|FG000|Overall Study|Did not meet entrance criteria|1|||
27997256|NCT00782717|81819768|FG001|Overall Study|Did not meet entrance criteria|3|||
27997257|NCT00782717|81819767|FG000|Overall Study|Exited in error|0|||
27997258|NCT00782717|81819768|FG001|Overall Study|Exited in error|2|||
27997259|NCT00596752|81819776|FG000|Overall Study|Other Reason|44|||
27997260|NCT00596752|81819777|FG001|Overall Study|Other Reason|49|||
27997261|NCT00596752|81819776|FG000|Overall Study|Adverse Event|34|||
27997262|NCT00596752|81819777|FG001|Overall Study|Adverse Event|34|||
27997263|NCT00596752|81819776|FG000|Overall Study|Lost to Follow-up|22|||
27997264|NCT00596752|81819777|FG001|Overall Study|Lost to Follow-up|38|||
27997265|NCT00596752|81819776|FG000|Overall Study|Withdrawal by Subject|12|||
27997266|NCT00596752|81819777|FG001|Overall Study|Withdrawal by Subject|9|||
27997267|NCT00596752|81819776|FG000|Overall Study|Unsatisfactory Compliance|9|||
27997268|NCT00596752|81819777|FG001|Overall Study|Unsatisfactory Compliance|6|||
27997269|NCT00596752|81819776|FG000|Overall Study|Lack of Efficacy|4|||
27997270|NCT00596752|81819777|FG001|Overall Study|Lack of Efficacy|7|||
27997271|NCT00596752|81819776|FG000|Overall Study|Protocol Violation|1|||
27997272|NCT00596752|81819777|FG001|Overall Study|Protocol Violation|0|||
27997273|NCT01420926|81819778|FG000|Overall Study|Adverse Event|6|||
27997274|NCT01420926|81819779|FG001|Overall Study|Adverse Event|4|||
27997275|NCT01420926|81819778|FG000|Overall Study|Death|18|||
27997276|NCT01420926|81819779|FG001|Overall Study|Death|17|||
27997277|NCT01420926|81819778|FG000|Overall Study|Withdrawal by Subject|11|||
27997278|NCT01420926|81819779|FG001|Overall Study|Withdrawal by Subject|17|||
27997279|NCT01420926|81819778|FG000|Overall Study|Non-protocol treatment|17|||
27997280|NCT01420926|81819779|FG001|Overall Study|Non-protocol treatment|20|||
27679985|NCT02269423|80664478|FG000|Overall Study|Discontinued due to change in residence|0|||
27997281|NCT01420926|81819778|FG000|Overall Study|Physician Decision|8|||
27997282|NCT01420926|81819779|FG001|Overall Study|Physician Decision|5|||
27997283|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
27997284|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
27997285|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
27997286|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
27997287|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
27997288|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
27997289|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
27997290|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
27997291|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
27997292|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
27679986|NCT02269423|80664479|FG001|Overall Study|Discontinued due to change in residence|1|||
27679987|NCT02269423|80664480|FG002|Overall Study|Discontinued due to change in residence|0|||
27679988|NCT02269423|80664481|FG003|Overall Study|Discontinued due to change in residence|1|||
27679989|NCT02138786|80664486|FG000|Overall Study|Adverse Event|0|||
27872660|NCT03657797|81365342|FG002|Overall Study|Withdrawal by Subject|2|||
27872661|NCT03657797|81365343|FG003|Overall Study|Withdrawal by Subject|0|||
27872662|NCT03657797|81365340|FG000|Overall Study|Adverse Event|0|||
27872663|NCT03657797|81365341|FG001|Overall Study|Adverse Event|0|||
27872664|NCT03657797|81365342|FG002|Overall Study|Adverse Event|2|||
27872665|NCT03657797|81365343|FG003|Overall Study|Adverse Event|0|||
27872666|NCT03170544|81365344|FG000|Part 1|Lost to Follow-up|1|||
27872667|NCT03170544|81365345|FG001|Part 1|Lost to Follow-up|0|||
27872668|NCT03170544|81365346|FG002|Part 1|Lost to Follow-up|0|||
27872669|NCT03170544|81365347|FG003|Part 1|Lost to Follow-up|0|||
27679990|NCT02138786|80664487|FG001|Overall Study|Adverse Event|2|||
27679991|NCT02138786|80664488|FG002|Overall Study|Adverse Event|1|||
27679992|NCT02138786|80664486|FG000|Overall Study|Death|1|||
27679993|NCT02138786|80664487|FG001|Overall Study|Death|7|||
27679994|NCT02138786|80664488|FG002|Overall Study|Death|2|||
27679995|NCT02138786|80664486|FG000|Overall Study|Disease Progression|1|||
27679996|NCT02138786|80664487|FG001|Overall Study|Disease Progression|1|||
27679997|NCT02138786|80664488|FG002|Overall Study|Disease Progression|3|||
27679998|NCT02138786|80664486|FG000|Overall Study|Withdrawal by Subject|1|||
27679999|NCT02138786|80664487|FG001|Overall Study|Withdrawal by Subject|2|||
27680000|NCT02138786|80664488|FG002|Overall Study|Withdrawal by Subject|0|||
27680001|NCT02138786|80664486|FG000|Overall Study|Patient's Wish|0|||
27680002|NCT02138786|80664487|FG001|Overall Study|Patient's Wish|2|||
27680003|NCT02138786|80664488|FG002|Overall Study|Patient's Wish|0|||
27680004|NCT02138786|80664486|FG000|Overall Study|Sponsor Terminated Study|0|||
27680005|NCT02138786|80664487|FG001|Overall Study|Sponsor Terminated Study|1|||
27680006|NCT02138786|80664488|FG002|Overall Study|Sponsor Terminated Study|1|||
27680007|NCT02138786|80664486|FG000|Overall Study|Non-Compliance|0|||
27680008|NCT02138786|80664487|FG001|Overall Study|Non-Compliance|0|||
27680009|NCT02138786|80664488|FG002|Overall Study|Non-Compliance|1|||
27680010|NCT01525238|80664489|FG000|Overall Study|Withdrawal by Subject|1|||
27680011|NCT01525238|80664490|FG001|Overall Study|Withdrawal by Subject|0|||
27680012|NCT01525238|80664491|FG002|Overall Study|Withdrawal by Subject|0|||
27680013|NCT01401153|80664492|FG000|First Test Day|Learning disabilities; illness|1|||
27680014|NCT01401153|80664493|FG001|First Test Day|Learning disabilities; illness|10|||
27680015|NCT01401153|80664492|FG000|Second Test Day|illness|0|||
27680016|NCT01401153|80664493|FG001|Second Test Day|illness|5|||
27680017|NCT03738475|80664494|FG000|Overall Study|Participant Non-Compliance|1|||
27680018|NCT03738475|80664495|FG001|Overall Study|Participant Non-Compliance|0|||
27680019|NCT00734591|80664496|FG000|Screening for Prospective Period|Site did not participate|1604|||
27680020|NCT00734591|80664497|FG001|Screening for Prospective Period|Site did not participate|1488|||
27680021|NCT00734591|80664496|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
27680022|NCT00734591|80664497|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
27680023|NCT00734591|80664496|FG000|Prospective Period|Withdrawal by Subject|11|||
27680024|NCT00734591|80664497|FG001|Prospective Period|Withdrawal by Subject|9|||
27680025|NCT00734591|80664496|FG000|Prospective Period|Lost to Follow-up|37|||
27680026|NCT00734591|80664497|FG001|Prospective Period|Lost to Follow-up|33|||
27680027|NCT00734591|80664496|FG000|Prospective Period|Study Terminated|1|||
27680028|NCT00734591|80664497|FG001|Prospective Period|Study Terminated|0|||
27680029|NCT00734591|80664496|FG000|Prospective Period|Other|2|||
27872670|NCT03170544|81365348|FG004|Part 1|Lost to Follow-up|0|||
27872671|NCT03170544|81365349|FG005|Part 1|Lost to Follow-up|0|||
27997293|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
27997294|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
27997295|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
27872672|NCT03170544|81365350|FG006|Part 1|Lost to Follow-up|0|||
27997296|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
27680030|NCT00734591|80664497|FG001|Prospective Period|Other|2|||
27680031|NCT02440425|80664498|FG000|Overall Study|Death likely due to disease progression|1|||
27680032|NCT02440425|80664498|FG000|Overall Study|Withdrawal by Subject|2|||
27680033|NCT02440425|80664498|FG000|Overall Study|Adverse Event|1|||
27680034|NCT02440425|80664498|FG000|Overall Study|Adverse Event/Ineligible|1|||
27680035|NCT01200342|80664499|FG000|Overall Study|Disease Progression|1|||
27872673|NCT03170544|81365351|FG007|Part 1|Lost to Follow-up|0|||
27680036|NCT01685229|80664502|FG000|Overall Study|Subjects missing Study Exit form|3|||
27680037|NCT01685229|80664503|FG001|Overall Study|Subjects missing Study Exit form|1|||
27872674|NCT03170544|81365352|FG008|Part 1|Lost to Follow-up|0|||
27680038|NCT01685229|80664502|FG000|Overall Study|Lost to Follow-up|16|||
27680039|NCT01685229|80664503|FG001|Overall Study|Lost to Follow-up|10|||
27680040|NCT01685229|80664502|FG000|Overall Study|Withdrawal by Subject|6|||
27680041|NCT01685229|80664503|FG001|Overall Study|Withdrawal by Subject|5|||
27680042|NCT01685229|80664502|FG000|Overall Study|Death|1|||
27680043|NCT01685229|80664503|FG001|Overall Study|Death|0|||
27680044|NCT03167151|80664506|FG000|Overall Study|Withdrawal by Subject|1|||
27680045|NCT03167151|80664507|FG001|Overall Study|Withdrawal by Subject|0|||
27680046|NCT03167151|80664508|FG002|Overall Study|Withdrawal by Subject|0|||
27680047|NCT03167151|80664506|FG000|Overall Study|No evidence of tumour at surgery|0|||
27680048|NCT03167151|80664507|FG001|Overall Study|No evidence of tumour at surgery|1|||
27680049|NCT03167151|80664508|FG002|Overall Study|No evidence of tumour at surgery|1|||
27680050|NCT01689857|80664509|FG000|Overall Study|Lost to Follow-up|5|||
27680051|NCT01689857|80664510|FG001|Overall Study|Lost to Follow-up|2|||
27680052|NCT01245140|80664511|FG000|Overall Study|Adverse Event|1|||
27680053|NCT01245140|80664512|FG001|Overall Study|Adverse Event|3|||
27680054|NCT01245140|80664511|FG000|Overall Study|Lack of Efficacy|2|||
27680055|NCT01245140|80664512|FG001|Overall Study|Lack of Efficacy|4|||
27680056|NCT01245140|80664511|FG000|Overall Study|Protocol Violation|0|||
27680057|NCT01245140|80664512|FG001|Overall Study|Protocol Violation|1|||
27680058|NCT01245140|80664511|FG000|Overall Study|Withdrawal by Subject|0|||
27680059|NCT01245140|80664512|FG001|Overall Study|Withdrawal by Subject|1|||
27680060|NCT01245140|80664511|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
27680061|NCT01245140|80664512|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
27680062|NCT02473289|80664513|FG000|Overall Study|Adverse Event|2|||
27680063|NCT02473289|80664514|FG001|Overall Study|Adverse Event|3|||
27680064|NCT02473289|80664513|FG000|Overall Study|Lost to Follow-up|1|||
27680065|NCT02473289|80664514|FG001|Overall Study|Lost to Follow-up|1|||
27680066|NCT02473289|80664513|FG000|Overall Study|Protocol Violation|0|||
27680067|NCT02473289|80664514|FG001|Overall Study|Protocol Violation|1|||
27680068|NCT02473289|80664513|FG000|Overall Study|Withdrawal of consent|6|||
27680069|NCT02473289|80664514|FG001|Overall Study|Withdrawal of consent|7|||
27680070|NCT02473289|80664513|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
27680071|NCT02473289|80664514|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
27997297|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
27680072|NCT02473289|80664513|FG000|Overall Study|Other|2|||
27680073|NCT02473289|80664514|FG001|Overall Study|Other|0|||
27680074|NCT01385748|80664515|FG000|Overall Study|Withdrawal by Subject|7|||
27680075|NCT01385748|80664516|FG001|Overall Study|Withdrawal by Subject|4|||
27680076|NCT01385748|80664517|FG002|Overall Study|Withdrawal by Subject|5|||
27680077|NCT01385748|80664515|FG000|Overall Study|Noncompliance|3|||
27680078|NCT01385748|80664516|FG001|Overall Study|Noncompliance|1|||
27680079|NCT01385748|80664517|FG002|Overall Study|Noncompliance|6|||
27680080|NCT01385748|80664515|FG000|Overall Study|Other|1|||
27680081|NCT01385748|80664516|FG001|Overall Study|Other|7|||
27680082|NCT01385748|80664517|FG002|Overall Study|Other|1|||
27680083|NCT01385748|80664515|FG000|Overall Study|Adverse Event|4|||
27680084|NCT01385748|80664516|FG001|Overall Study|Adverse Event|2|||
27680085|NCT01385748|80664517|FG002|Overall Study|Adverse Event|1|||
27680086|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
27680087|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
27680088|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
27680089|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
27680090|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
27680091|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
27680092|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
27680093|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
27680094|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
27680095|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
27680096|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27680097|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27680098|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
27680099|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
27680100|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27680101|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27680102|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27680103|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
27680104|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
27680105|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
27680106|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
27680107|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
27680108|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
27680109|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
27680110|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
27680111|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
27997298|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
27680112|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
27680113|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
27680114|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
27680115|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
27680116|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
27680117|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
27680118|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27680119|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27680120|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27680121|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
27680122|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
27680123|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
27680124|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
27680125|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
27680126|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
27680127|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27680128|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27680129|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27680130|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
27680131|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
27680132|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
27680133|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
27680134|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
27680135|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
27680136|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
27680137|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
27872675|NCT03170544|81365353|FG009|Part 1|Lost to Follow-up|0|||
27872676|NCT03170544|81365354|FG010|Part 1|Lost to Follow-up|0|||
27872677|NCT03170544|81365355|FG011|Part 1|Lost to Follow-up|0|||
27872678|NCT03170544|81365344|FG000|Part 1|Not treated|0|||
27872679|NCT03170544|81365345|FG001|Part 1|Not treated|0|||
27872680|NCT03170544|81365346|FG002|Part 1|Not treated|0|||
27997299|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
27997300|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
27997301|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
27997302|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
27997303|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
27997304|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
27997305|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
27997306|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
27997307|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
27997308|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
27997309|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
27997310|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
27997311|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
27997312|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
27680138|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
27872681|NCT03170544|81365347|FG003|Part 1|Not treated|1|||
27680139|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
27680140|NCT00477490|80664518|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
27872682|NCT03170544|81365348|FG004|Part 1|Not treated|0|||
27872683|NCT03170544|81365349|FG005|Part 1|Not treated|0|||
27804590|NCT01021137|81117112|FG003|Overall Study|Withdrawal by Subject|3|||
27804591|NCT04313283|81117113|FG000|Overall Study|did not complete intervention|4|||
27804592|NCT00845026|81117116|FG000|Study Period III|Adverse Event|23|||
27804593|NCT00845026|81117117|FG001|Study Period III|Adverse Event|19|||
27804594|NCT00845026|81117116|FG000|Study Period III|Perceived lack of efficacy|27|||
27997313|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
27997314|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
27804595|NCT00845026|81117117|FG001|Study Period III|Perceived lack of efficacy|15|||
27804596|NCT00845026|81117116|FG000|Study Period III|Withdrawal by Subject|19|||
27804597|NCT00845026|81117117|FG001|Study Period III|Withdrawal by Subject|15|||
27804598|NCT00845026|81117116|FG000|Study Period III|Entry Criteria not met|8|||
27804599|NCT00845026|81117117|FG001|Study Period III|Entry Criteria not met|11|||
27804600|NCT00845026|81117116|FG000|Study Period III|Lost to Follow-up|4|||
27804601|NCT00845026|81117117|FG001|Study Period III|Lost to Follow-up|5|||
27804602|NCT00845026|81117116|FG000|Study Period III|Protocol Violation|8|||
27804603|NCT00845026|81117117|FG001|Study Period III|Protocol Violation|1|||
27804604|NCT00845026|81117116|FG000|Study Period III|Scheduled conflict|3|||
27997315|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
27997316|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
27997317|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
27997318|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
27997319|NCT02586623|81819780|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
27997320|NCT02586623|81819781|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
27997321|NCT02586623|81819782|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
27997322|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
27579893|NCT02660359|80306761|FG001|Overall Study|Other|1|||
27804605|NCT00845026|81117117|FG001|Study Period III|Scheduled conflict|1|||
27804606|NCT00845026|81117116|FG000|Study Period III|Subject is moving or has moved|2|||
27804607|NCT00845026|81117117|FG001|Study Period III|Subject is moving or has moved|4|||
27804608|NCT00845026|81117116|FG000|Study Period III|Transportation issues|1|||
27804609|NCT00845026|81117117|FG001|Study Period III|Transportation issues|1|||
27804610|NCT00845026|81117116|FG000|Study Period IV|Adverse Event|4|||
27997323|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
27997324|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
27997325|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
27997326|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
27997327|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
27997328|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
27997329|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
27997330|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
27997331|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
27997332|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
27997333|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
27997334|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
27997335|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
27997336|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
27997337|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
27997338|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
27997339|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
27579894|NCT02660359|80306762|FG002|Overall Study|Other|3|||
27579895|NCT02660359|80306760|FG000|Overall Study|Withdrawal by Subject|7|||
27579896|NCT02660359|80306761|FG001|Overall Study|Withdrawal by Subject|5|||
27579897|NCT02660359|80306762|FG002|Overall Study|Withdrawal by Subject|8|||
27872684|NCT03170544|81365350|FG006|Part 1|Not treated|0|||
27804611|NCT00845026|81117117|FG001|Study Period IV|Adverse Event|0|||
27804612|NCT00845026|81117116|FG000|Study Period IV|Perceived lack of efficacy|2|||
27804613|NCT00845026|81117117|FG001|Study Period IV|Perceived lack of efficacy|1|||
27804614|NCT00845026|81117116|FG000|Study Period IV|Protocol Violation|3|||
27804615|NCT00845026|81117117|FG001|Study Period IV|Protocol Violation|1|||
27804616|NCT00845026|81117116|FG000|Study Period IV|Lost to Follow-up|1|||
27804617|NCT00845026|81117117|FG001|Study Period IV|Lost to Follow-up|0|||
27804618|NCT00845026|81117116|FG000|Study Period IV|Withdrawal by Subject|4|||
27804619|NCT00845026|81117117|FG001|Study Period IV|Withdrawal by Subject|1|||
27804620|NCT00845026|81117116|FG000|Study Period IV|Entry Criteria Not Met|1|||
27804621|NCT00845026|81117117|FG001|Study Period IV|Entry Criteria Not Met|0|||
27804622|NCT00845026|81117116|FG000|Study Period IV|Subject is moving or has moved|0|||
27804623|NCT00845026|81117117|FG001|Study Period IV|Subject is moving or has moved|1|||
27804624|NCT00845026|81117116|FG000|Study Period IV|Scheduling conflict|1|||
27804625|NCT00845026|81117117|FG001|Study Period IV|Scheduling conflict|0|||
27804626|NCT00558519|81117121|FG000|Overall Study|Ph+|20|||
27804627|NCT00558519|81117121|FG000|Overall Study|Ineligible|1|||
27804628|NCT00558519|81117121|FG000|Overall Study|Insufficient data|1|||
27804629|NCT00558519|81117121|FG000|Overall Study|Never received treatment|1|||
27804630|NCT02410837|81117122|FG000|Overall Study|Death|387|||
27804631|NCT02410837|81117122|FG000|Overall Study|Lost to Follow-up|50|||
27804632|NCT02410837|81117122|FG000|Overall Study|Withdrawal by Subject|44|||
27804633|NCT02410837|81117122|FG000|Overall Study|Physician Decision|6|||
27804634|NCT02410837|81117122|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
27804635|NCT00525031|81117123|FG000|Overall Study|Disease Progression|1|||
27804636|NCT00525031|81117124|FG001|Overall Study|Disease Progression|1|||
27804637|NCT02117479|81117125|FG000|Overall Study|Death|13|||
27804638|NCT02117479|81117126|FG001|Overall Study|Death|8|||
27804639|NCT02117479|81117125|FG000|Overall Study|Adverse Event|8|||
27804640|NCT02117479|81117126|FG001|Overall Study|Adverse Event|16|||
27804641|NCT02117479|81117125|FG000|Overall Study|Subject decision|8|||
27804642|NCT02117479|81117126|FG001|Overall Study|Subject decision|9|||
27804643|NCT02117479|81117125|FG000|Overall Study|Disease progression|104|||
27804644|NCT02117479|81117126|FG001|Overall Study|Disease progression|108|||
27804645|NCT02117479|81117125|FG000|Overall Study|Noncompliance with study treatment|1|||
27804646|NCT02117479|81117126|FG001|Overall Study|Noncompliance with study treatment|0|||
27804647|NCT02117479|81117125|FG000|Overall Study|Study terminated by the sponsor|4|||
27804648|NCT02117479|81117126|FG001|Overall Study|Study terminated by the sponsor|6|||
27804649|NCT02117479|81117125|FG000|Overall Study|Physician Decision|7|||
27804650|NCT02117479|81117126|FG001|Overall Study|Physician Decision|2|||
27804651|NCT02117479|81117125|FG000|Overall Study|Other unspecified|11|||
27804652|NCT02117479|81117126|FG001|Overall Study|Other unspecified|7|||
27804653|NCT03740100|81117127|FG000|Overall Study|Adverse Event|1|||
27804654|NCT03740100|81117127|FG000|Overall Study|Death|1|||
27804655|NCT02340078|81117128|FG000|Overall Study|Protocol Violation|1|||
27804656|NCT00124449|81117129|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
27804657|NCT00124449|81117130|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
27804658|NCT00124449|81117129|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
27804659|NCT00124449|81117130|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
27804660|NCT00124449|81117129|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
27804661|NCT00124449|81117130|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
27804662|NCT00124449|81117129|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
27872685|NCT03170544|81365351|FG007|Part 1|Not treated|0|||
27804663|NCT00124449|81117130|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
27804664|NCT00124449|81117129|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
27804665|NCT00124449|81117130|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
27804666|NCT00124449|81117129|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
27804667|NCT00124449|81117130|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
27804668|NCT00124449|81117129|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
27872686|NCT03170544|81365352|FG008|Part 1|Not treated|0|||
27872687|NCT03170544|81365353|FG009|Part 1|Not treated|0|||
27579898|NCT02660359|80306760|FG000|Overall Study|Lost to Follow-up|3|||
27997340|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
27997341|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
27997342|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
27997343|NCT02586623|81819780|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
27997344|NCT02586623|81819781|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
27997345|NCT02586623|81819782|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
27997346|NCT02034877|81819783|FG000|Overall Study|Lost to Follow-up|0|||
27997347|NCT02034877|81819784|FG001|Overall Study|Lost to Follow-up|3|||
27997348|NCT02034877|81819783|FG000|Overall Study|No Longer Willing to Participate|0|||
27997349|NCT02034877|81819784|FG001|Overall Study|No Longer Willing to Participate|3|||
27997350|NCT00684996|81819787|FG000|Overall Study|Adverse Event|1|||
27997351|NCT00684996|81819787|FG000|Overall Study|Refusal unrelated to adverse event|1|||
27997352|NCT00684996|81819787|FG000|Overall Study|Progression/relapse|2|||
27997353|NCT00684996|81819787|FG000|Overall Study|Other reasons not protocol specified|1|||
27997354|NCT02855268|81819793|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
27997355|NCT02855268|81819794|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
27997356|NCT02855268|81819793|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
27997357|NCT02855268|81819794|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
27997358|NCT02855268|81819793|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
27997359|NCT02855268|81819794|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
27997360|NCT02855268|81819793|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
27997361|NCT02855268|81819794|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
27997362|NCT02855268|81819793|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
27997363|NCT02855268|81819794|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
27997364|NCT02855268|81819793|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
27997365|NCT02855268|81819794|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
27997366|NCT00687804|81819799|FG000|Core Study|Adverse Event|5|||
27997367|NCT00687804|81819800|FG001|Core Study|Adverse Event|3|||
27997368|NCT00687804|81819801|FG002|Core Study|Adverse Event|3|||
27997369|NCT00687804|81819799|FG000|Core Study|Abnormal laboratory value(s)|1|||
27997370|NCT00687804|81819800|FG001|Core Study|Abnormal laboratory value(s)|0|||
27997371|NCT00687804|81819801|FG002|Core Study|Abnormal laboratory value(s)|0|||
27997372|NCT00687804|81819799|FG000|Core Study|Lack of Efficacy|1|||
27997373|NCT00687804|81819800|FG001|Core Study|Lack of Efficacy|1|||
27997374|NCT00687804|81819801|FG002|Core Study|Lack of Efficacy|1|||
27997375|NCT00687804|81819799|FG000|Core Study|Withdrawal by Subject|4|||
27997376|NCT00687804|81819800|FG001|Core Study|Withdrawal by Subject|7|||
27997377|NCT00687804|81819801|FG002|Core Study|Withdrawal by Subject|7|||
27997378|NCT00687804|81819799|FG000|Core Study|Lost to Follow-up|0|||
27997379|NCT00687804|81819800|FG001|Core Study|Lost to Follow-up|1|||
27997380|NCT00687804|81819801|FG002|Core Study|Lost to Follow-up|0|||
27997381|NCT00687804|81819799|FG000|Core Study|Death|2|||
27997382|NCT00687804|81819800|FG001|Core Study|Death|2|||
27997383|NCT00687804|81819801|FG002|Core Study|Death|2|||
27997384|NCT00687804|81819799|FG000|Core Study|Protocol Violation|1|||
27997385|NCT00687804|81819800|FG001|Core Study|Protocol Violation|1|||
27997386|NCT00687804|81819801|FG002|Core Study|Protocol Violation|0|||
27997387|NCT00687804|81819799|FG000|Open-Label Extension Study|Adverse Event|2|||
27997388|NCT00687804|81819800|FG001|Open-Label Extension Study|Adverse Event|2|||
27997389|NCT00687804|81819801|FG002|Open-Label Extension Study|Adverse Event|2|||
27997390|NCT00687804|81819799|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
27997391|NCT00687804|81819800|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
27997392|NCT00687804|81819801|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
27997393|NCT00687804|81819799|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
27997394|NCT00687804|81819800|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
27997395|NCT00687804|81819801|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
27997396|NCT00687804|81819799|FG000|Open-Label Extension Study|Administrative problems|1|||
27997397|NCT00687804|81819800|FG001|Open-Label Extension Study|Administrative problems|1|||
27997398|NCT00687804|81819801|FG002|Open-Label Extension Study|Administrative problems|0|||
27997399|NCT00687804|81819799|FG000|Open-Label Extension Study|Death|2|||
27997400|NCT00687804|81819800|FG001|Open-Label Extension Study|Death|3|||
27997401|NCT00687804|81819801|FG002|Open-Label Extension Study|Death|3|||
27997402|NCT01818596|81819802|FG000|Overall Study|Enrolled but Not Treated|4|||
27997403|NCT01818596|81819803|FG001|Overall Study|Enrolled but Not Treated|0|||
27579899|NCT02660359|80306761|FG001|Overall Study|Lost to Follow-up|3|||
27579900|NCT02660359|80306762|FG002|Overall Study|Lost to Follow-up|0|||
27997404|NCT01818596|81819802|FG000|Overall Study|Adverse Event|7|||
27997405|NCT01818596|81819803|FG001|Overall Study|Adverse Event|0|||
27997406|NCT01818596|81819802|FG000|Overall Study|Death|3|||
27997407|NCT01818596|81819803|FG001|Overall Study|Death|0|||
27579901|NCT01933334|80306763|FG000|Overall Study|Adverse Event|5|||
27997408|NCT01818596|81819802|FG000|Overall Study|Investigator's Discretion|4|||
27997409|NCT01818596|81819803|FG001|Overall Study|Investigator's Discretion|0|||
27997410|NCT01818596|81819802|FG000|Overall Study|Protocol Violation|1|||
27997411|NCT01818596|81819803|FG001|Overall Study|Protocol Violation|0|||
27872688|NCT03170544|81365354|FG010|Part 1|Not treated|0|||
27579902|NCT01933334|80306764|FG001|Overall Study|Adverse Event|1|||
27579903|NCT01933334|80306763|FG000|Overall Study|Withdrawal by Subject|0|||
27872689|NCT03170544|81365355|FG011|Part 1|Not treated|0|||
27872690|NCT00235755|81365358|FG000|4-Week Titration Phase|Adverse Event|6|||
27872691|NCT00235755|81365359|FG001|4-Week Titration Phase|Adverse Event|14|||
27872692|NCT00235755|81365360|FG002|4-Week Titration Phase|Adverse Event|20|||
27872693|NCT00235755|81365358|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
27872694|NCT00235755|81365359|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
27872695|NCT00235755|81365360|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
27872696|NCT00235755|81365358|FG000|4-Week Titration Phase|Protocol Violation|2|||
27872697|NCT00235755|81365359|FG001|4-Week Titration Phase|Protocol Violation|2|||
27872698|NCT00235755|81365360|FG002|4-Week Titration Phase|Protocol Violation|1|||
27872699|NCT00235755|81365358|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
27872700|NCT00235755|81365359|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
27872701|NCT00235755|81365360|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
27997412|NCT01818596|81819802|FG000|Overall Study|Withdrew Consent|5|||
27997413|NCT01818596|81819803|FG001|Overall Study|Withdrew Consent|0|||
27997414|NCT01818596|81819802|FG000|Overall Study|Lost to Follow-up|7|||
27997415|NCT01818596|81819803|FG001|Overall Study|Lost to Follow-up|0|||
27997416|NCT02292719|81819807|FG000|Overall Study|Withdrawal by Subject|0|||
27997417|NCT02292719|81819808|FG001|Overall Study|Withdrawal by Subject|0|||
27997418|NCT02292719|81819809|FG002|Overall Study|Withdrawal by Subject|0|||
27997419|NCT02292719|81819810|FG003|Overall Study|Withdrawal by Subject|1|||
27997420|NCT02292719|81819811|FG004|Overall Study|Withdrawal by Subject|1|||
27997421|NCT02292719|81819812|FG005|Overall Study|Withdrawal by Subject|0|||
27997422|NCT02292719|81819807|FG000|Overall Study|Subject enrolled in new study.|0|||
27997423|NCT02292719|81819808|FG001|Overall Study|Subject enrolled in new study.|0|||
27997424|NCT02292719|81819809|FG002|Overall Study|Subject enrolled in new study.|1|||
27997425|NCT02292719|81819810|FG003|Overall Study|Subject enrolled in new study.|0|||
27997426|NCT02292719|81819811|FG004|Overall Study|Subject enrolled in new study.|0|||
27997427|NCT02292719|81819812|FG005|Overall Study|Subject enrolled in new study.|0|||
27997428|NCT01288989|81819813|FG000|Overall Study|Death|0|||
27997429|NCT01288989|81819814|FG001|Overall Study|Death|0|||
27997430|NCT01288989|81819815|FG002|Overall Study|Death|0|||
27997431|NCT01288989|81819816|FG003|Overall Study|Death|1|||
27997432|NCT01288989|81819817|FG004|Overall Study|Death|0|||
27997433|NCT01288989|81819813|FG000|Overall Study|Dose limiting toxicity|1|||
27997434|NCT01288989|81819814|FG001|Overall Study|Dose limiting toxicity|0|||
27997435|NCT01288989|81819815|FG002|Overall Study|Dose limiting toxicity|0|||
27997436|NCT01288989|81819816|FG003|Overall Study|Dose limiting toxicity|0|||
27997437|NCT01288989|81819817|FG004|Overall Study|Dose limiting toxicity|0|||
27997438|NCT01288989|81819813|FG000|Overall Study|Adverse Event|0|||
27997439|NCT01288989|81819814|FG001|Overall Study|Adverse Event|0|||
27997440|NCT01288989|81819815|FG002|Overall Study|Adverse Event|0|||
27997441|NCT01288989|81819816|FG003|Overall Study|Adverse Event|0|||
27997442|NCT01288989|81819817|FG004|Overall Study|Adverse Event|2|||
27997443|NCT01288989|81819813|FG000|Overall Study|Physician Decision|0|||
27997444|NCT01288989|81819814|FG001|Overall Study|Physician Decision|0|||
27997445|NCT01288989|81819815|FG002|Overall Study|Physician Decision|0|||
27872702|NCT00235755|81365358|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
27997446|NCT01288989|81819816|FG003|Overall Study|Physician Decision|0|||
27997447|NCT01288989|81819817|FG004|Overall Study|Physician Decision|1|||
27997448|NCT01288989|81819813|FG000|Overall Study|Withdrawal by Subject|0|||
27997449|NCT01288989|81819814|FG001|Overall Study|Withdrawal by Subject|0|||
27997450|NCT01288989|81819815|FG002|Overall Study|Withdrawal by Subject|0|||
27997451|NCT01288989|81819816|FG003|Overall Study|Withdrawal by Subject|0|||
27997452|NCT01288989|81819817|FG004|Overall Study|Withdrawal by Subject|3|||
27872703|NCT00235755|81365359|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
27997453|NCT00931606|81819818|FG000|Overall Study|Death|1|||
27872704|NCT00235755|81365360|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
27872705|NCT00235755|81365358|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
27872706|NCT00235755|81365359|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
27872707|NCT00235755|81365360|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
27872708|NCT00235755|81365358|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
27872709|NCT00235755|81365359|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
27997454|NCT00931606|81819819|FG001|Overall Study|Death|3|||
27997455|NCT00931606|81819820|FG002|Overall Study|Death|2|||
27997456|NCT00931606|81819821|FG003|Overall Study|Death|0|||
27680141|NCT00477490|80664519|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
27680142|NCT00477490|80664520|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
27680143|NCT00477490|80664521|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
27680144|NCT00477490|80664522|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
27680145|NCT00477490|80664523|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
27680146|NCT00477490|80664524|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
27997457|NCT00931606|81819818|FG000|Overall Study|Lost to Follow-up|0|||
27997458|NCT00931606|81819819|FG001|Overall Study|Lost to Follow-up|1|||
27997459|NCT00931606|81819820|FG002|Overall Study|Lost to Follow-up|0|||
27997460|NCT00931606|81819821|FG003|Overall Study|Lost to Follow-up|0|||
27804669|NCT00124449|81117130|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
27804670|NCT00124449|81117129|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
27804671|NCT00124449|81117130|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
27804672|NCT00124449|81117129|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
27804673|NCT00124449|81117130|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
27804674|NCT00124449|81117129|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
27804675|NCT00124449|81117130|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
27804676|NCT00124449|81117129|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
27804677|NCT00124449|81117130|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
27804678|NCT00124449|81117129|FG000|18-Month Untreated Observation Period|Relocated|1|||
27997461|NCT00931606|81819818|FG000|Overall Study|Physician Decision|0|||
27997462|NCT00931606|81819819|FG001|Overall Study|Physician Decision|0|||
27997463|NCT00931606|81819820|FG002|Overall Study|Physician Decision|3|||
27997464|NCT00931606|81819821|FG003|Overall Study|Physician Decision|0|||
27997465|NCT00931606|81819818|FG000|Overall Study|Sponsor Decision|1|||
27997466|NCT00931606|81819819|FG001|Overall Study|Sponsor Decision|4|||
27997467|NCT00931606|81819820|FG002|Overall Study|Sponsor Decision|0|||
27997468|NCT00931606|81819821|FG003|Overall Study|Sponsor Decision|2|||
27997469|NCT00931606|81819818|FG000|Overall Study|Withdrawal by Subject|3|||
27680147|NCT00477490|80664525|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
27997470|NCT00931606|81819819|FG001|Overall Study|Withdrawal by Subject|1|||
27997471|NCT00931606|81819820|FG002|Overall Study|Withdrawal by Subject|1|||
27997472|NCT00931606|81819821|FG003|Overall Study|Withdrawal by Subject|1|||
27997473|NCT03672292|81819822|FG000|Overall Study|Adverse Event|3|||
27997474|NCT03672292|81819823|FG001|Overall Study|Adverse Event|1|||
27997475|NCT03672292|81819822|FG000|Overall Study|Physician Decision|0|||
27997476|NCT03672292|81819823|FG001|Overall Study|Physician Decision|1|||
27997477|NCT03672292|81819822|FG000|Overall Study|Withdrawal by Subject|1|||
27997478|NCT03672292|81819823|FG001|Overall Study|Withdrawal by Subject|2|||
27997479|NCT03018691|81819824|FG000|Overall Study|Adverse Event|1|||
27997480|NCT03018691|81819825|FG001|Overall Study|Adverse Event|1|||
27997481|NCT03018691|81819826|FG002|Overall Study|Adverse Event|4|||
27997482|NCT03018691|81819824|FG000|Overall Study|Lack of Efficacy|0|||
27997483|NCT03018691|81819825|FG001|Overall Study|Lack of Efficacy|0|||
27997484|NCT03018691|81819826|FG002|Overall Study|Lack of Efficacy|1|||
27997485|NCT03018691|81819824|FG000|Overall Study|Withdrawal by Subject|0|||
27997486|NCT03018691|81819825|FG001|Overall Study|Withdrawal by Subject|0|||
27997487|NCT03018691|81819826|FG002|Overall Study|Withdrawal by Subject|1|||
27997488|NCT03018691|81819824|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27997489|NCT03018691|81819825|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27997490|NCT03018691|81819826|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27997491|NCT03551626|81819827|FG000|Overall Study|Adverse Event|88|||
27680148|NCT00477490|80664526|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
27997492|NCT03551626|81819827|FG000|Overall Study|Disease relapse|18|||
27680149|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
27804679|NCT00124449|81117130|FG001|18-Month Untreated Observation Period|Relocated|0|||
27804680|NCT01689974|81117131|FG000|Overall Study|Termination of Study|5|||
27804681|NCT01689974|81117132|FG001|Overall Study|Termination of Study|5|||
27804682|NCT00185211|81117134|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
27804683|NCT00185211|81117135|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
27997493|NCT03551626|81819827|FG000|Overall Study|Withdrawal of informed consent|6|||
27997494|NCT03551626|81819827|FG000|Overall Study|Patient decision|5|||
27997495|NCT03551626|81819827|FG000|Overall Study|Physician Decision|4|||
27997496|NCT03551626|81819827|FG000|Overall Study|Lost to Follow-up|3|||
27997497|NCT03551626|81819827|FG000|Overall Study|Pregnancy|1|||
27997498|NCT03551626|81819827|FG000|Overall Study|Protocol deviation|1|||
27804684|NCT00185211|81117134|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
27997499|NCT03551626|81819827|FG000|Overall Study|Technical problems|1|||
27997500|NCT00855816|81819828|FG000|Overall Study|Withdrawal by Subject|22|||
27997501|NCT00855816|81819829|FG001|Overall Study|Withdrawal by Subject|15|||
27997502|NCT00855816|81819828|FG000|Overall Study|Lost to Follow-up|3|||
27997503|NCT00855816|81819829|FG001|Overall Study|Lost to Follow-up|5|||
27997504|NCT00855816|81819828|FG000|Overall Study|Death|1|||
27997505|NCT00855816|81819829|FG001|Overall Study|Death|0|||
27997506|NCT00855816|81819828|FG000|Overall Study|Became ineligible|0|||
27997507|NCT00855816|81819829|FG001|Overall Study|Became ineligible|1|||
27997508|NCT03155724|81819830|FG000|Overall Study|Death|3|||
27997509|NCT03155724|81819830|FG000|Overall Study|Physician Decision|1|||
27997510|NCT03155724|81819830|FG000|Overall Study|Study closure|7|||
27997511|NCT03359174|81819831|FG000|Overall Study|Adverse Event|1|||
27997512|NCT00183625|81819832|FG000|Overall Study|Withdrawal by Subject|18|||
27997513|NCT00183625|81819833|FG001|Overall Study|Withdrawal by Subject|18|||
27997514|NCT00183625|81819834|FG002|Overall Study|Withdrawal by Subject|19|||
27997515|NCT00183625|81819835|FG003|Overall Study|Withdrawal by Subject|14|||
27997516|NCT03712787|81819836|FG000|Overall Study|Adverse Event|2|||
27997517|NCT03712787|81819837|FG001|Overall Study|Adverse Event|3|||
27997518|NCT03712787|81819838|FG002|Overall Study|Adverse Event|0|||
27997519|NCT03712787|81819839|FG003|Overall Study|Adverse Event|4|||
27997520|NCT03712787|81819836|FG000|Overall Study|Withdrawal by Subject|4|||
27997521|NCT03712787|81819837|FG001|Overall Study|Withdrawal by Subject|14|||
27997522|NCT03712787|81819838|FG002|Overall Study|Withdrawal by Subject|12|||
27997523|NCT03712787|81819839|FG003|Overall Study|Withdrawal by Subject|8|||
27997524|NCT03712787|81819836|FG000|Overall Study|Lost to Follow-up|1|||
27997525|NCT03712787|81819837|FG001|Overall Study|Lost to Follow-up|1|||
27997526|NCT03712787|81819838|FG002|Overall Study|Lost to Follow-up|2|||
27997527|NCT03712787|81819839|FG003|Overall Study|Lost to Follow-up|1|||
27997528|NCT03712787|81819836|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
27997529|NCT03712787|81819837|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
27997530|NCT03712787|81819838|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
27997531|NCT03712787|81819839|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
27997532|NCT03712787|81819836|FG000|Overall Study|COVID-19 Infection|0|||
27997533|NCT03712787|81819837|FG001|Overall Study|COVID-19 Infection|1|||
27997534|NCT03712787|81819838|FG002|Overall Study|COVID-19 Infection|0|||
27997535|NCT03712787|81819839|FG003|Overall Study|COVID-19 Infection|0|||
27997536|NCT03712787|81819836|FG000|Overall Study|Other, Not Specified|79|||
27997537|NCT03712787|81819837|FG001|Overall Study|Other, Not Specified|77|||
27997538|NCT03712787|81819838|FG002|Overall Study|Other, Not Specified|74|||
27997539|NCT03712787|81819839|FG003|Overall Study|Other, Not Specified|78|||
27997540|NCT00732875|81819840|FG000|Overall Study|Adverse Event|16|||
27997541|NCT00732875|81819840|FG000|Overall Study|Withdrawal by Subject|6|||
27997542|NCT00732875|81819840|FG000|Overall Study|Lack of Efficacy|13|||
27997543|NCT03077542|81819841|FG000|Overall Study|Death|4|||
27997544|NCT03077542|81819842|FG001|Overall Study|Death|0|||
27997545|NCT03077542|81819841|FG000|Overall Study|Physician Decision|6|||
27997546|NCT03077542|81819842|FG001|Overall Study|Physician Decision|1|||
27997547|NCT03077542|81819841|FG000|Overall Study|Withdrawal by Subject|0|||
27997548|NCT03077542|81819842|FG001|Overall Study|Withdrawal by Subject|1|||
27997549|NCT01292187|81819843|FG000|Overall Study|Adverse Event|10|||
27997550|NCT01292187|81819844|FG001|Overall Study|Adverse Event|5|||
27997551|NCT01292187|81819843|FG000|Overall Study|Withdrawal by Subject|6|||
27997552|NCT01292187|81819844|FG001|Overall Study|Withdrawal by Subject|5|||
27997553|NCT01292187|81819843|FG000|Overall Study|All other reasons|1|||
27997554|NCT01292187|81819844|FG001|Overall Study|All other reasons|3|||
27997555|NCT00832416|81819845|FG000|Overall Study|Lack of Efficacy|17|||
27997556|NCT00832416|81819846|FG001|Overall Study|Lack of Efficacy|15|||
27997557|NCT00832416|81819847|FG002|Overall Study|Lack of Efficacy|13|||
27997558|NCT00832416|81819848|FG003|Overall Study|Lack of Efficacy|52|||
27680150|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
27997559|NCT00832416|81819845|FG000|Overall Study|Withdrawal by Subject|5|||
27680151|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
27680152|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
27680153|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
27997560|NCT00832416|81819846|FG001|Overall Study|Withdrawal by Subject|7|||
27997561|NCT00832416|81819847|FG002|Overall Study|Withdrawal by Subject|2|||
27997562|NCT00832416|81819848|FG003|Overall Study|Withdrawal by Subject|10|||
27997563|NCT00832416|81819845|FG000|Overall Study|Physician Decision|2|||
27997564|NCT00832416|81819846|FG001|Overall Study|Physician Decision|12|||
27997565|NCT00832416|81819847|FG002|Overall Study|Physician Decision|5|||
27997566|NCT00832416|81819848|FG003|Overall Study|Physician Decision|10|||
27997567|NCT00832416|81819845|FG000|Overall Study|Administrative|0|||
27997568|NCT00832416|81819846|FG001|Overall Study|Administrative|0|||
27997569|NCT00832416|81819847|FG002|Overall Study|Administrative|0|||
27997570|NCT00832416|81819848|FG003|Overall Study|Administrative|1|||
27997571|NCT00832416|81819845|FG000|Overall Study|Adverse Event|21|||
27997572|NCT00832416|81819846|FG001|Overall Study|Adverse Event|19|||
27997573|NCT00832416|81819847|FG002|Overall Study|Adverse Event|41|||
27997574|NCT00832416|81819848|FG003|Overall Study|Adverse Event|10|||
27997575|NCT00832416|81819845|FG000|Overall Study|Death|1|||
27997576|NCT00832416|81819846|FG001|Overall Study|Death|0|||
27997577|NCT00832416|81819847|FG002|Overall Study|Death|0|||
27997578|NCT00832416|81819848|FG003|Overall Study|Death|0|||
27997579|NCT01959841|81819851|FG000|Overall Study|Adverse Event|1|||
27997580|NCT01959841|81819852|FG001|Overall Study|Adverse Event|3|||
27997581|NCT01959841|81819853|FG002|Overall Study|Adverse Event|2|||
27997582|NCT01959841|81819851|FG000|Overall Study|Lack of Efficacy|5|||
27997583|NCT01959841|81819852|FG001|Overall Study|Lack of Efficacy|0|||
27997584|NCT01959841|81819853|FG002|Overall Study|Lack of Efficacy|0|||
27997585|NCT01959841|81819851|FG000|Overall Study|Lost to Follow-up|1|||
27997586|NCT01959841|81819852|FG001|Overall Study|Lost to Follow-up|1|||
27997587|NCT01959841|81819853|FG002|Overall Study|Lost to Follow-up|0|||
27997588|NCT01959841|81819851|FG000|Overall Study|Physician Decision|0|||
27997589|NCT01959841|81819852|FG001|Overall Study|Physician Decision|2|||
27997590|NCT01959841|81819853|FG002|Overall Study|Physician Decision|3|||
27997591|NCT01959841|81819851|FG000|Overall Study|Protocol Violation|16|||
27680154|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
27997592|NCT01959841|81819852|FG001|Overall Study|Protocol Violation|23|||
27997593|NCT01959841|81819853|FG002|Overall Study|Protocol Violation|16|||
27997594|NCT01959841|81819851|FG000|Overall Study|Withdrawal by Subject|7|||
27997595|NCT01959841|81819852|FG001|Overall Study|Withdrawal by Subject|7|||
27997596|NCT01959841|81819853|FG002|Overall Study|Withdrawal by Subject|5|||
27997597|NCT01959841|81819851|FG000|Overall Study|Clinical laboratory value|2|||
27997598|NCT01959841|81819852|FG001|Overall Study|Clinical laboratory value|6|||
27997599|NCT01959841|81819853|FG002|Overall Study|Clinical laboratory value|6|||
27997600|NCT01959841|81819851|FG000|Overall Study|Platelet count below on day1 or 4|11|||
27997601|NCT01959841|81819852|FG001|Overall Study|Platelet count below on day1 or 4|15|||
27997602|NCT01959841|81819853|FG002|Overall Study|Platelet count below on day1 or 4|11|||
27997603|NCT02100475|81819859|FG000|Overall Study|Unclassified|1|||
27997604|NCT02100475|81819860|FG001|Overall Study|Unclassified|2|||
27997605|NCT02100475|81819859|FG000|Overall Study|Withdrawal criteria|1|||
27997606|NCT02100475|81819860|FG001|Overall Study|Withdrawal criteria|0|||
27997607|NCT00785980|81819861|FG000|7 Day Washout Period|Protocol Violation|3|||
27997608|NCT01217463|81819862|FG000|Overall Study|Adverse Event|8|||
27804685|NCT00185211|81117135|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
27579904|NCT01933334|80306764|FG001|Overall Study|Withdrawal by Subject|1|||
27579905|NCT02863354|80306765|FG000|Year 1|Lost to Follow-up|1|||
27804686|NCT00185211|81117134|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
27804687|NCT00185211|81117135|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
27804688|NCT00185211|81117134|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
27997609|NCT01217463|81819863|FG001|Overall Study|Adverse Event|5|||
27804689|NCT00185211|81117135|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
27804690|NCT00185211|81117134|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
27804691|NCT00185211|81117135|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
27804692|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
27804693|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
27804694|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
27804695|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
27804696|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
27579906|NCT02863354|80306766|FG001|Year 1|Lost to Follow-up|1|||
27579907|NCT02863354|80306765|FG000|Year 1|Withdrawal by Subject|3|||
27579908|NCT02863354|80306766|FG001|Year 1|Withdrawal by Subject|0|||
27579909|NCT02863354|80306765|FG000|Year 1|Death|0|||
27579910|NCT02863354|80306766|FG001|Year 1|Death|1|||
27579911|NCT02863354|80306765|FG000|Year 2|Lost to Follow-up|2|||
27579912|NCT02863354|80306766|FG001|Year 2|Lost to Follow-up|2|||
27579913|NCT03286140|80306775|FG000|Overall Study|Withdrawal by Subject|10|||
27579914|NCT03286140|80306776|FG001|Overall Study|Withdrawal by Subject|5|||
27579915|NCT03286140|80306775|FG000|Overall Study|Lost to Follow-up|5|||
27579916|NCT03286140|80306776|FG001|Overall Study|Lost to Follow-up|10|||
27579917|NCT03286140|80306775|FG000|Overall Study|Failure to comply|0|||
27579918|NCT03286140|80306776|FG001|Overall Study|Failure to comply|1|||
27579919|NCT03766009|80306777|FG000|Usual Care|Death|0|||
27579920|NCT03766009|80306778|FG001|Usual Care|Death|0|||
27579921|NCT03766009|80306779|FG002|Usual Care|Death|0|||
27579922|NCT03766009|80306780|FG003|Usual Care|Death|1|||
27579923|NCT03766009|80306781|FG004|Usual Care|Death|0|||
27579924|NCT03766009|80306782|FG005|Usual Care|Death|0|||
27579925|NCT03766009|80306777|FG000|Usual Care|Lost to Follow-up|0|||
27579926|NCT03766009|80306778|FG001|Usual Care|Lost to Follow-up|0|||
27579927|NCT03766009|80306779|FG002|Usual Care|Lost to Follow-up|0|||
27579928|NCT03766009|80306780|FG003|Usual Care|Lost to Follow-up|1|||
27579929|NCT03766009|80306781|FG004|Usual Care|Lost to Follow-up|0|||
27579930|NCT03766009|80306782|FG005|Usual Care|Lost to Follow-up|0|||
27579931|NCT03766009|80306777|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
27579932|NCT03766009|80306778|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
27579933|NCT03766009|80306779|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
27579934|NCT03766009|80306780|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
27579935|NCT03766009|80306781|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
27804697|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
27804698|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
27997610|NCT01217463|81819862|FG000|Overall Study|Physician Decision|0|||
27997611|NCT01217463|81819863|FG001|Overall Study|Physician Decision|1|||
27997612|NCT01217463|81819862|FG000|Overall Study|Withdrawal by Subject|3|||
27997613|NCT01217463|81819863|FG001|Overall Study|Withdrawal by Subject|0|||
27997614|NCT01217463|81819862|FG000|Overall Study|Surgery on the Target Limb|0|||
27997615|NCT01217463|81819863|FG001|Overall Study|Surgery on the Target Limb|1|||
27579936|NCT03766009|80306782|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
27579937|NCT03766009|80306777|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
27594204|NCT00729833|80352468|FG003|Overall Study|Withdrawal by Subject|0|||
27997616|NCT01217463|81819862|FG000|Overall Study|Patient Non-compliant|1|||
27997617|NCT01217463|81819863|FG001|Overall Study|Patient Non-compliant|0|||
27997618|NCT01217463|81819862|FG000|Overall Study|Other|1|||
27997619|NCT01217463|81819863|FG001|Overall Study|Other|1|||
27997620|NCT00981461|81819870|FG000|Overall Study|Lost to Follow-up|5|||
27997621|NCT00981461|81819871|FG001|Overall Study|Lost to Follow-up|2|||
27997622|NCT00475709|81819872|FG000|Overall Study|Did not meet eligibility criteria|8|||
27997623|NCT00475709|81819872|FG000|Overall Study|Death|41|||
27997624|NCT00475709|81819872|FG000|Overall Study|Device Explant|6|||
27997625|NCT00475709|81819872|FG000|Overall Study|Lost to Follow-up|21|||
27997626|NCT03201419|81819875|FG000|Overall Study|Adverse Event|3|||
27997627|NCT03201419|81819876|FG001|Overall Study|Adverse Event|1|||
27997628|NCT03201419|81819877|FG002|Overall Study|Adverse Event|0|||
27997629|NCT03201419|81819878|FG003|Overall Study|Adverse Event|0|||
27997630|NCT03201419|81819879|FG004|Overall Study|Adverse Event|1|||
27997631|NCT03201419|81819880|FG005|Overall Study|Adverse Event|1|||
27997632|NCT03201419|81819881|FG006|Overall Study|Adverse Event|5|||
27997633|NCT03201419|81819882|FG007|Overall Study|Adverse Event|0|||
27997634|NCT03201419|81819883|FG008|Overall Study|Adverse Event|0|||
27997635|NCT03201419|81819875|FG000|Overall Study|Lost to Follow-up|1|||
27997636|NCT03201419|81819876|FG001|Overall Study|Lost to Follow-up|0|||
27997637|NCT03201419|81819877|FG002|Overall Study|Lost to Follow-up|0|||
27997638|NCT03201419|81819878|FG003|Overall Study|Lost to Follow-up|0|||
27997639|NCT03201419|81819879|FG004|Overall Study|Lost to Follow-up|0|||
27997640|NCT03201419|81819880|FG005|Overall Study|Lost to Follow-up|0|||
27997641|NCT03201419|81819881|FG006|Overall Study|Lost to Follow-up|0|||
27997642|NCT03201419|81819882|FG007|Overall Study|Lost to Follow-up|0|||
27997643|NCT03201419|81819883|FG008|Overall Study|Lost to Follow-up|0|||
27997644|NCT03201419|81819875|FG000|Overall Study|Protocol Deviation|0|||
27997645|NCT03201419|81819876|FG001|Overall Study|Protocol Deviation|0|||
27997646|NCT03201419|81819877|FG002|Overall Study|Protocol Deviation|0|||
27997647|NCT03201419|81819878|FG003|Overall Study|Protocol Deviation|0|||
27997648|NCT03201419|81819879|FG004|Overall Study|Protocol Deviation|0|||
27997649|NCT03201419|81819880|FG005|Overall Study|Protocol Deviation|0|||
27997650|NCT03201419|81819881|FG006|Overall Study|Protocol Deviation|1|||
27997651|NCT03201419|81819882|FG007|Overall Study|Protocol Deviation|0|||
27997652|NCT03201419|81819883|FG008|Overall Study|Protocol Deviation|0|||
27997653|NCT03201419|81819875|FG000|Overall Study|Withdrawal by Subject|4|||
27997654|NCT03201419|81819876|FG001|Overall Study|Withdrawal by Subject|2|||
27997655|NCT03201419|81819877|FG002|Overall Study|Withdrawal by Subject|1|||
27997656|NCT03201419|81819878|FG003|Overall Study|Withdrawal by Subject|0|||
27997657|NCT03201419|81819879|FG004|Overall Study|Withdrawal by Subject|0|||
27997658|NCT03201419|81819880|FG005|Overall Study|Withdrawal by Subject|0|||
27997659|NCT03201419|81819881|FG006|Overall Study|Withdrawal by Subject|0|||
27997660|NCT03201419|81819882|FG007|Overall Study|Withdrawal by Subject|1|||
27997661|NCT03201419|81819883|FG008|Overall Study|Withdrawal by Subject|2|||
27997662|NCT03201419|81819875|FG000|Overall Study|Other|0|||
27997663|NCT03201419|81819876|FG001|Overall Study|Other|0|||
27997664|NCT03201419|81819877|FG002|Overall Study|Other|1|||
27997665|NCT03201419|81819878|FG003|Overall Study|Other|0|||
27997666|NCT03201419|81819879|FG004|Overall Study|Other|0|||
27997667|NCT03201419|81819880|FG005|Overall Study|Other|0|||
27997668|NCT03201419|81819881|FG006|Overall Study|Other|0|||
27997669|NCT03201419|81819882|FG007|Overall Study|Other|0|||
27997670|NCT03201419|81819883|FG008|Overall Study|Other|0|||
27997671|NCT00265317|81819884|FG000|Lead-In|Objective progression or relapse|6|||
27997672|NCT00265317|81819885|FG001|Lead-In|Objective progression or relapse|11|||
27997673|NCT00265317|81819886|FG002|Lead-In|Objective progression or relapse|0|||
27997674|NCT00265317|81819887|FG003|Lead-In|Objective progression or relapse|0|||
27997675|NCT00265317|81819884|FG000|Lead-In|Adverse Event|2|||
27997676|NCT00265317|81819885|FG001|Lead-In|Adverse Event|1|||
27997677|NCT00265317|81819886|FG002|Lead-In|Adverse Event|0|||
27997678|NCT00265317|81819887|FG003|Lead-In|Adverse Event|0|||
27997679|NCT00265317|81819884|FG000|Lead-In|Death|3|||
27997680|NCT00265317|81819885|FG001|Lead-In|Death|5|||
27997681|NCT00265317|81819886|FG002|Lead-In|Death|0|||
27997682|NCT00265317|81819887|FG003|Lead-In|Death|0|||
27997683|NCT00265317|81819884|FG000|Lead-In|Withdrawal/other than adverse event|1|||
27997684|NCT00265317|81819885|FG001|Lead-In|Withdrawal/other than adverse event|0|||
27997685|NCT00265317|81819886|FG002|Lead-In|Withdrawal/other than adverse event|0|||
27997686|NCT00265317|81819887|FG003|Lead-In|Withdrawal/other than adverse event|0|||
27997687|NCT00265317|81819884|FG000|Phase 2|Objective progression or relapse|0|||
27997688|NCT00265317|81819885|FG001|Phase 2|Objective progression or relapse|0|||
27997689|NCT00265317|81819886|FG002|Phase 2|Objective progression or relapse|37|||
27997690|NCT00265317|81819887|FG003|Phase 2|Objective progression or relapse|38|||
27997691|NCT00265317|81819884|FG000|Phase 2|Global deterioration of health status|0|||
27997692|NCT00265317|81819885|FG001|Phase 2|Global deterioration of health status|0|||
27997693|NCT00265317|81819886|FG002|Phase 2|Global deterioration of health status|3|||
27997694|NCT00265317|81819887|FG003|Phase 2|Global deterioration of health status|0|||
27997695|NCT00265317|81819884|FG000|Phase 2|Adverse Event|0|||
27997696|NCT00265317|81819885|FG001|Phase 2|Adverse Event|0|||
27997697|NCT00265317|81819886|FG002|Phase 2|Adverse Event|7|||
27997698|NCT00265317|81819887|FG003|Phase 2|Adverse Event|5|||
27997699|NCT00265317|81819884|FG000|Phase 2|Death|0|||
27997700|NCT00265317|81819885|FG001|Phase 2|Death|0|||
27997701|NCT00265317|81819886|FG002|Phase 2|Death|12|||
27997702|NCT00265317|81819887|FG003|Phase 2|Death|15|||
27997703|NCT00265317|81819884|FG000|Phase 2|Protocol Violation|0|||
27997704|NCT00265317|81819885|FG001|Phase 2|Protocol Violation|0|||
27997705|NCT00265317|81819886|FG002|Phase 2|Protocol Violation|1|||
27997706|NCT00265317|81819887|FG003|Phase 2|Protocol Violation|4|||
27997707|NCT00265317|81819884|FG000|Phase 2|Lost to Follow-up|0|||
27997708|NCT00265317|81819885|FG001|Phase 2|Lost to Follow-up|0|||
27997709|NCT00265317|81819886|FG002|Phase 2|Lost to Follow-up|0|||
27997710|NCT00265317|81819887|FG003|Phase 2|Lost to Follow-up|1|||
27997711|NCT00265317|81819884|FG000|Phase 2|Withdrawal/other than adverse event|0|||
27997712|NCT00265317|81819885|FG001|Phase 2|Withdrawal/other than adverse event|0|||
27997713|NCT00265317|81819886|FG002|Phase 2|Withdrawal/other than adverse event|2|||
27997714|NCT00265317|81819887|FG003|Phase 2|Withdrawal/other than adverse event|1|||
27997715|NCT00265317|81819884|FG000|Phase 2|Study terminated by sponsor|0|||
27997716|NCT00265317|81819885|FG001|Phase 2|Study terminated by sponsor|0|||
27997717|NCT00265317|81819886|FG002|Phase 2|Study terminated by sponsor|1|||
27997718|NCT00265317|81819887|FG003|Phase 2|Study terminated by sponsor|0|||
27997719|NCT00265317|81819884|FG000|Phase 2|Other|0|||
27997720|NCT00265317|81819885|FG001|Phase 2|Other|0|||
27579938|NCT03766009|80306778|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
27579939|NCT03766009|80306779|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
27579940|NCT03766009|80306780|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
27579941|NCT03766009|80306781|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
27579942|NCT03766009|80306782|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
27579943|NCT03766009|80306777|FG000|Usual Care|No treatment or declined surgery|0|||
27680155|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
27680156|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
27680157|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
27680158|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
27680159|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
27680160|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
27680161|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27680162|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27680163|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27680164|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27680165|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
27680166|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
27680167|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27804699|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
27804700|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
27804701|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
27804702|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
27804703|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
27804704|NCT00185211|81117134|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
27804705|NCT00185211|81117135|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
27804706|NCT01200394|81117136|FG000|Overall Study|Adverse Event|0|||
27804707|NCT01200394|81117137|FG001|Overall Study|Adverse Event|14|||
27804708|NCT01200394|81117136|FG000|Overall Study|Death|1|||
27804709|NCT01200394|81117137|FG001|Overall Study|Death|0|||
27804710|NCT01200394|81117136|FG000|Overall Study|Lost to Follow-up|0|||
27804711|NCT01200394|81117137|FG001|Overall Study|Lost to Follow-up|1|||
27804712|NCT01200394|81117136|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27997721|NCT00265317|81819886|FG002|Phase 2|Other|1|||
27997722|NCT00265317|81819887|FG003|Phase 2|Other|1|||
27997723|NCT03089580|81819889|FG000|Overall Study|Lost to Follow-up|2|||
27997724|NCT03495102|81819893|FG000|Overall Study|Adverse Event|5|||
27997725|NCT03495102|81819894|FG001|Overall Study|Adverse Event|7|||
27997726|NCT03495102|81819895|FG002|Overall Study|Adverse Event|10|||
27997727|NCT03495102|81819893|FG000|Overall Study|Death|3|||
27997728|NCT03495102|81819894|FG001|Overall Study|Death|4|||
27997729|NCT03495102|81819895|FG002|Overall Study|Death|4|||
27997730|NCT03495102|81819893|FG000|Overall Study|Lost to Follow-up|15|||
27997731|NCT03495102|81819894|FG001|Overall Study|Lost to Follow-up|16|||
27997732|NCT03495102|81819895|FG002|Overall Study|Lost to Follow-up|17|||
27997733|NCT03495102|81819893|FG000|Overall Study|Physician Decision|2|||
27997734|NCT03495102|81819894|FG001|Overall Study|Physician Decision|0|||
27872710|NCT00235755|81365360|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
27872711|NCT00235755|81365358|FG000|12-Week Maintenance Phase|Adverse Event|8|||
27872712|NCT00235755|81365359|FG001|12-Week Maintenance Phase|Adverse Event|12|||
27872713|NCT00235755|81365360|FG002|12-Week Maintenance Phase|Adverse Event|26|||
27872714|NCT00235755|81365358|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
27872715|NCT00235755|81365359|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
27872716|NCT00235755|81365360|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
27872717|NCT00235755|81365358|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
27872718|NCT00235755|81365359|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
27872719|NCT00235755|81365360|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
27872720|NCT00235755|81365358|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
27872721|NCT00235755|81365359|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
27872722|NCT00235755|81365360|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
27872723|NCT00235755|81365358|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
27872724|NCT00235755|81365359|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
27997735|NCT03495102|81819895|FG002|Overall Study|Physician Decision|2|||
27997736|NCT03495102|81819893|FG000|Overall Study|Withdrawal by Subject|25|||
27997737|NCT03495102|81819894|FG001|Overall Study|Withdrawal by Subject|36|||
27872725|NCT00235755|81365360|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
27872726|NCT00235755|81365358|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
27872727|NCT00235755|81365359|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
27997738|NCT03495102|81819895|FG002|Overall Study|Withdrawal by Subject|18|||
27997739|NCT03495102|81819893|FG000|Overall Study|Protocol Violation|1|||
27997740|NCT03495102|81819894|FG001|Overall Study|Protocol Violation|1|||
27997741|NCT03495102|81819895|FG002|Overall Study|Protocol Violation|0|||
27804713|NCT01200394|81117137|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
27804714|NCT01200394|81117136|FG000|Overall Study|Protocol Violation|0|||
27804715|NCT01200394|81117137|FG001|Overall Study|Protocol Violation|3|||
27804716|NCT01200394|81117136|FG000|Overall Study|Withdrawal by Subject|0|||
27804717|NCT01200394|81117137|FG001|Overall Study|Withdrawal by Subject|5|||
27804718|NCT01200394|81117136|FG000|Overall Study|Other|0|||
27804719|NCT01200394|81117137|FG001|Overall Study|Other|1|||
27804720|NCT01458119|81117145|FG000|Overall Study|Physician Decision|4|||
27804721|NCT01458119|81117145|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
27804722|NCT01458119|81117145|FG000|Overall Study|Pregnancy|1|||
27804723|NCT01458119|81117145|FG000|Overall Study|Death|2|||
27804724|NCT01458119|81117145|FG000|Overall Study|Adverse Event|1|||
27804725|NCT01458119|81117145|FG000|Overall Study|Consent Withdrawn by Participant|8|||
27804726|NCT01458119|81117145|FG000|Overall Study|Non-compliance With Study Drug|3|||
27804727|NCT03263819|81117146|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
27804728|NCT03263819|81117147|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
27804729|NCT04126733|81117148|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
27804730|NCT04126733|81117148|FG000|Treatment Period|Adverse Event|8|||
27804731|NCT04126733|81117148|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
27804732|NCT04126733|81117148|FG000|Treatment Period|Physician Decision|5|||
27804733|NCT04126733|81117148|FG000|Treatment Period|Death|1|||
27804734|NCT04126733|81117148|FG000|Treatment Period|Other Reasons|2|||
27804735|NCT04126733|81117148|FG000|Active Follow-up Period|Death|13|||
27804736|NCT04126733|81117148|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
27804737|NCT04126733|81117148|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
27804738|NCT04126733|81117148|FG000|Active Follow-up Period|Other Reasons|1|||
27804739|NCT04126733|81117148|FG000|Long-term Follow-up Period|Death|22|||
27804740|NCT04126733|81117148|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
27804741|NCT04126733|81117148|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
27804742|NCT01098240|81117149|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
27804743|NCT01098240|81117150|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
27804744|NCT01098240|81117151|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
27804745|NCT01098240|81117149|FG000|Open-Label Phase|Protocol Violation|4|||
27804746|NCT01098240|81117150|FG001|Open-Label Phase|Protocol Violation|0|||
27804747|NCT01098240|81117151|FG002|Open-Label Phase|Protocol Violation|0|||
27804748|NCT01098240|81117149|FG000|Open-Label Phase|Lost to Follow-up|13|||
27997742|NCT03495102|81819893|FG000|Overall Study|Site Closure|3|||
27997743|NCT03495102|81819894|FG001|Overall Study|Site Closure|1|||
27804749|NCT01098240|81117150|FG001|Open-Label Phase|Lost to Follow-up|0|||
27997744|NCT03495102|81819895|FG002|Overall Study|Site Closure|2|||
27997745|NCT03495102|81819893|FG000|Overall Study|Non-compliance|1|||
27997746|NCT03495102|81819894|FG001|Overall Study|Non-compliance|0|||
27804750|NCT01098240|81117151|FG002|Open-Label Phase|Lost to Follow-up|0|||
27804751|NCT01098240|81117149|FG000|Open-Label Phase|Other|19|||
27804752|NCT01098240|81117150|FG001|Open-Label Phase|Other|0|||
27804753|NCT01098240|81117151|FG002|Open-Label Phase|Other|0|||
27872728|NCT00235755|81365360|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
27872729|NCT02232984|81365361|FG000|Overall Study|Withdrawal by Subject|5|||
27872730|NCT02232984|81365361|FG000|Overall Study|Death|1|||
27872731|NCT02232984|81365361|FG000|Overall Study|Investigator withdrawal|10|||
27872732|NCT02232984|81365361|FG000|Overall Study|Device implant unsuccessful|53|||
27872733|NCT02232984|81365361|FG000|Overall Study|not disclosed by site|7|||
27872734|NCT02232984|81365361|FG000|Overall Study|Protocol Violation|1|||
27872735|NCT00725491|81365362|FG000|Overall Study|Adverse Event|3|||
27872736|NCT00725491|81365363|FG001|Overall Study|Adverse Event|2|||
27872737|NCT00725491|81365362|FG000|Overall Study|Pregnancy|0|||
27872738|NCT00725491|81365363|FG001|Overall Study|Pregnancy|3|||
27872739|NCT00725491|81365362|FG000|Overall Study|Risk for hyperstimulation|2|||
27872740|NCT00725491|81365363|FG001|Overall Study|Risk for hyperstimulation|9|||
27872741|NCT00725491|81365362|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
27872742|NCT00725491|81365363|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
27872743|NCT00725491|81365362|FG000|Overall Study|Fertilization failure|0|||
27594205|NCT00729833|80352465|FG000|Overall Study|Unspecified Reasons|11|||
27594206|NCT00729833|80352466|FG001|Overall Study|Unspecified Reasons|5|||
27594207|NCT00729833|80352467|FG002|Overall Study|Unspecified Reasons|5|||
27594208|NCT00729833|80352468|FG003|Overall Study|Unspecified Reasons|1|||
27594209|NCT01297062|80352473|FG000|Overall Study|Adverse Event|2|||
27594210|NCT01297062|80352474|FG001|Overall Study|Adverse Event|0|||
27594211|NCT01297062|80352475|FG002|Overall Study|Adverse Event|1|||
27594212|NCT01297062|80352476|FG003|Overall Study|Adverse Event|0|||
27594213|NCT01297062|80352477|FG004|Overall Study|Adverse Event|0|||
27594214|NCT01297062|80352478|FG005|Overall Study|Adverse Event|0|||
27594215|NCT01297062|80352479|FG006|Overall Study|Adverse Event|0|||
27594216|NCT01297062|80352473|FG000|Overall Study|Physician Decision|1|||
27594217|NCT01297062|80352474|FG001|Overall Study|Physician Decision|0|||
27594218|NCT01297062|80352475|FG002|Overall Study|Physician Decision|1|||
27594219|NCT01297062|80352476|FG003|Overall Study|Physician Decision|0|||
27594220|NCT01297062|80352477|FG004|Overall Study|Physician Decision|0|||
27594221|NCT01297062|80352478|FG005|Overall Study|Physician Decision|0|||
27594222|NCT01297062|80352479|FG006|Overall Study|Physician Decision|6|||
27594223|NCT01297062|80352473|FG000|Overall Study|Protocol Violation|0|||
27594224|NCT01297062|80352474|FG001|Overall Study|Protocol Violation|0|||
27594225|NCT01297062|80352475|FG002|Overall Study|Protocol Violation|0|||
27594226|NCT01297062|80352476|FG003|Overall Study|Protocol Violation|0|||
27594227|NCT01297062|80352477|FG004|Overall Study|Protocol Violation|1|||
27594228|NCT01297062|80352478|FG005|Overall Study|Protocol Violation|0|||
27594229|NCT01297062|80352479|FG006|Overall Study|Protocol Violation|0|||
27594230|NCT01297062|80352473|FG000|Overall Study|Subject Decision|1|||
27594231|NCT01297062|80352474|FG001|Overall Study|Subject Decision|1|||
27594232|NCT01297062|80352475|FG002|Overall Study|Subject Decision|0|||
27594233|NCT01297062|80352476|FG003|Overall Study|Subject Decision|1|||
27594234|NCT01297062|80352477|FG004|Overall Study|Subject Decision|1|||
27594235|NCT01297062|80352478|FG005|Overall Study|Subject Decision|1|||
27594236|NCT01297062|80352479|FG006|Overall Study|Subject Decision|2|||
27594237|NCT03342638|80352480|FG000|Overall Study|Withdrawal by Subject|1|||
27594238|NCT03342638|80352481|FG001|Overall Study|Withdrawal by Subject|0|||
27594239|NCT03342638|80352480|FG000|Overall Study|Physician Decision|0|||
27594240|NCT03342638|80352481|FG001|Overall Study|Physician Decision|1|||
27594241|NCT00450411|80352484|FG000|Overall Study|Protocol Violation|6|||
27594242|NCT00450411|80352484|FG000|Overall Study|No protocol treatment|2|||
27594243|NCT01669629|80352485|FG000|Period 1|protocol deviation|1|||
27594244|NCT01669629|80352486|FG001|Period 1|protocol deviation|2|||
27594245|NCT00902304|80352487|FG000|Overall Study|Adverse Event|4|||
27594246|NCT00902304|80352488|FG001|Overall Study|Adverse Event|10|||
27594247|NCT00902304|80352489|FG002|Overall Study|Adverse Event|25|||
27594248|NCT00902304|80352487|FG000|Overall Study|Investigator discretion|3|||
27594249|NCT00902304|80352488|FG001|Overall Study|Investigator discretion|5|||
27594250|NCT00902304|80352489|FG002|Overall Study|Investigator discretion|13|||
27594251|NCT00902304|80352487|FG000|Overall Study|Lost to Follow-up|7|||
27594252|NCT00902304|80352488|FG001|Overall Study|Lost to Follow-up|7|||
27594253|NCT00902304|80352489|FG002|Overall Study|Lost to Follow-up|7|||
27594254|NCT00902304|80352487|FG000|Overall Study|Protocol Violation|9|||
27594255|NCT00902304|80352488|FG001|Overall Study|Protocol Violation|18|||
27594256|NCT00902304|80352489|FG002|Overall Study|Protocol Violation|20|||
27594257|NCT00902304|80352487|FG000|Overall Study|Withdrawal by Subject|32|||
27594258|NCT00902304|80352488|FG001|Overall Study|Withdrawal by Subject|22|||
27594259|NCT00902304|80352489|FG002|Overall Study|Withdrawal by Subject|43|||
27594260|NCT00902304|80352487|FG000|Overall Study|includes pregnancy|3|||
27594261|NCT00902304|80352488|FG001|Overall Study|includes pregnancy|9|||
27594262|NCT00902304|80352489|FG002|Overall Study|includes pregnancy|2|||
27594263|NCT01881126|80352490|FG000|Overall Study|Non-compliance|1|||
27594264|NCT01881126|80352491|FG001|Overall Study|Non-compliance|1|||
27594265|NCT01881126|80352490|FG000|Overall Study|Adverse Event|0|||
27804754|NCT01098240|81117149|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
27804755|NCT01098240|81117150|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27804756|NCT01098240|81117151|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27804757|NCT01098240|81117149|FG000|Open-Label Phase|Pregnancy|1|||
27804758|NCT01098240|81117150|FG001|Open-Label Phase|Pregnancy|0|||
27804759|NCT01098240|81117151|FG002|Open-Label Phase|Pregnancy|0|||
27804760|NCT01098240|81117149|FG000|Open-Label Phase|Withdrawal by Subject|9|||
27804761|NCT01098240|81117150|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27804762|NCT01098240|81117151|FG002|Open-Label Phase|Withdrawal by Subject|0|||
27804763|NCT01098240|81117149|FG000|Open-Label Phase|Adverse Event|12|||
27804764|NCT01098240|81117150|FG001|Open-Label Phase|Adverse Event|0|||
27804765|NCT01098240|81117151|FG002|Open-Label Phase|Adverse Event|0|||
27804766|NCT01098240|81117149|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
27804767|NCT01098240|81117150|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
27997747|NCT03495102|81819895|FG002|Overall Study|Non-compliance|0|||
27997748|NCT03495102|81819893|FG000|Overall Study|Participant Duplicated at Another Site|0|||
27997749|NCT03495102|81819894|FG001|Overall Study|Participant Duplicated at Another Site|0|||
27997750|NCT03495102|81819895|FG002|Overall Study|Participant Duplicated at Another Site|1|||
27804768|NCT01098240|81117151|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
27804769|NCT01098240|81117149|FG000|Double-Blind Phase|Protocol Violation|0|||
27804770|NCT01098240|81117150|FG001|Double-Blind Phase|Protocol Violation|2|||
27804771|NCT01098240|81117151|FG002|Double-Blind Phase|Protocol Violation|4|||
27804772|NCT01098240|81117149|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27804773|NCT01098240|81117150|FG001|Double-Blind Phase|Lost to Follow-up|2|||
27804774|NCT01098240|81117151|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27804775|NCT01098240|81117149|FG000|Double-Blind Phase|Other|0|||
27804776|NCT01098240|81117150|FG001|Double-Blind Phase|Other|2|||
27804777|NCT01098240|81117151|FG002|Double-Blind Phase|Other|2|||
27804778|NCT01098240|81117149|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
27804779|NCT01098240|81117150|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
27680168|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
27680169|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
27680170|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27680171|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
27804780|NCT01098240|81117151|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
27804781|NCT01098240|81117149|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
27804782|NCT01098240|81117150|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
27804783|NCT01098240|81117151|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
27804784|NCT01098240|81117149|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27804785|NCT01098240|81117150|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
27804786|NCT01098240|81117151|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
27804787|NCT01098240|81117149|FG000|Double-Blind Phase|Adverse Event|0|||
27804788|NCT01098240|81117150|FG001|Double-Blind Phase|Adverse Event|3|||
27804789|NCT01098240|81117151|FG002|Double-Blind Phase|Adverse Event|3|||
27804790|NCT00879970|81117152|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
27872744|NCT00725491|81365363|FG001|Overall Study|Fertilization failure|1|||
27997751|NCT03495102|81819893|FG000|Overall Study|Primary Care Physician Recommendation|0|||
27680172|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27997752|NCT03495102|81819894|FG001|Overall Study|Primary Care Physician Recommendation|1|||
27680173|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
27680174|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27680175|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
27680176|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27680177|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27680178|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27680179|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27680180|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
27680181|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27680182|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
27804791|NCT00879970|81117153|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
27804792|NCT00879970|81117154|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
27804793|NCT00879970|81117155|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
27804794|NCT00879970|81117156|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
27804795|NCT00879970|81117152|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
27804796|NCT00879970|81117153|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
27804797|NCT00879970|81117154|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
27804798|NCT00879970|81117155|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
27872745|NCT00725491|81365362|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
27997753|NCT03495102|81819895|FG002|Overall Study|Primary Care Physician Recommendation|0|||
27680183|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
27680184|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
27680185|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27680186|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
27680187|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27579944|NCT03766009|80306778|FG001|Usual Care|No treatment or declined surgery|0|||
27579945|NCT03766009|80306779|FG002|Usual Care|No treatment or declined surgery|0|||
27579946|NCT03766009|80306780|FG003|Usual Care|No treatment or declined surgery|2|||
27579947|NCT03766009|80306781|FG004|Usual Care|No treatment or declined surgery|0|||
27579948|NCT03766009|80306782|FG005|Usual Care|No treatment or declined surgery|0|||
27579949|NCT03766009|80306777|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
27579950|NCT03766009|80306778|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
27579951|NCT03766009|80306779|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
27579952|NCT03766009|80306780|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
27579953|NCT03766009|80306781|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
27579954|NCT03766009|80306782|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
27579955|NCT03766009|80306777|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
27579956|NCT03766009|80306778|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
27579957|NCT03766009|80306779|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
27579958|NCT03766009|80306780|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
27997754|NCT03495102|81819893|FG000|Overall Study|Relocated to Another Country|0|||
27997755|NCT03495102|81819894|FG001|Overall Study|Relocated to Another Country|1|||
27997756|NCT03495102|81819895|FG002|Overall Study|Relocated to Another Country|0|||
27997757|NCT03495102|81819893|FG000|Overall Study|Participant was in Rehabilitation|1|||
27997758|NCT03495102|81819894|FG001|Overall Study|Participant was in Rehabilitation|0|||
27997759|NCT03495102|81819895|FG002|Overall Study|Participant was in Rehabilitation|0|||
27997760|NCT04538417|81819896|FG000|Overall Study|Withdrawal by Subject|2|||
27997761|NCT04137731|81819897|FG000|Overall Study|Surgery Cancellation|1|||
27997762|NCT04137731|81819898|FG001|Overall Study|Surgery Cancellation|2|||
27997763|NCT04137731|81819897|FG000|Overall Study|Withdrawal by Subject|2|||
27997764|NCT04137731|81819898|FG001|Overall Study|Withdrawal by Subject|0|||
27997765|NCT04137731|81819897|FG000|Overall Study|Protocol Violation|0|||
27997766|NCT04137731|81819898|FG001|Overall Study|Protocol Violation|1|||
27997767|NCT01147055|81819899|FG000|First Intervention Period|Lost to Follow-up|1|||
27997768|NCT01147055|81819900|FG001|First Intervention Period|Lost to Follow-up|0|||
27997769|NCT02915263|81819901|FG000|Overall Study|Covid|3|||
27997770|NCT02915263|81819902|FG001|Overall Study|Covid|2|||
27997771|NCT00824473|81819905|FG000|Overall Study|Adverse Event|4|||
27997772|NCT00824473|81819906|FG001|Overall Study|Adverse Event|5|||
27997773|NCT00824473|81819905|FG000|Overall Study|Lack of Efficacy|2|||
27997774|NCT00824473|81819906|FG001|Overall Study|Lack of Efficacy|2|||
27997775|NCT00824473|81819905|FG000|Overall Study|Protocol Violation|2|||
27997776|NCT00824473|81819906|FG001|Overall Study|Protocol Violation|0|||
27997777|NCT00824473|81819905|FG000|Overall Study|Non-Compliance|4|||
27997778|NCT00824473|81819906|FG001|Overall Study|Non-Compliance|2|||
27997779|NCT00824473|81819905|FG000|Overall Study|Withdrawal by Subject|2|||
27997780|NCT00824473|81819906|FG001|Overall Study|Withdrawal by Subject|3|||
27997781|NCT00824473|81819905|FG000|Overall Study|Other|1|||
27997782|NCT00824473|81819906|FG001|Overall Study|Other|1|||
27997783|NCT03461146|81819907|FG000|Overall Study|Adverse Event|2|||
27997784|NCT03461146|81819907|FG000|Overall Study|Physician Decision|1|||
27997785|NCT00511134|81819908|FG000|Overall Study|Withdrawal by Subject|0|||
27997786|NCT00511134|81819909|FG001|Overall Study|Withdrawal by Subject|2|||
27997787|NCT02475278|81819910|FG000|Overall Study|Lost to Follow-up|1|||
27997788|NCT02475278|81819910|FG000|Overall Study|Reason Not Specified|1|||
27997789|NCT00858208|81819911|FG000|Overall Study|Adverse Event|3|||
27997790|NCT00858208|81819911|FG000|Overall Study|Lost to Follow-up|26|||
27997791|NCT00858208|81819911|FG000|Overall Study|Participant refused|40|||
27997792|NCT00858208|81819911|FG000|Overall Study|Other|10|||
27680188|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27997793|NCT02446717|81819912|FG000|Overall Study|Adverse Event|0|||
27579959|NCT03766009|80306781|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
27997794|NCT02446717|81819913|FG001|Overall Study|Adverse Event|0|||
27997795|NCT02446717|81819914|FG002|Overall Study|Adverse Event|1|||
27997796|NCT02446717|81819915|FG003|Overall Study|Adverse Event|0|||
27997797|NCT02446717|81819916|FG004|Overall Study|Adverse Event|0|||
27997798|NCT02446717|81819912|FG000|Overall Study|Lost to Follow-up|0|||
27997799|NCT02446717|81819913|FG001|Overall Study|Lost to Follow-up|1|||
27997800|NCT02446717|81819914|FG002|Overall Study|Lost to Follow-up|1|||
27997801|NCT02446717|81819915|FG003|Overall Study|Lost to Follow-up|0|||
27997802|NCT02446717|81819916|FG004|Overall Study|Lost to Follow-up|1|||
27997803|NCT02446717|81819912|FG000|Overall Study|Withdrew consent|0|||
27997804|NCT02446717|81819913|FG001|Overall Study|Withdrew consent|0|||
27579960|NCT03766009|80306782|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
27579961|NCT03766009|80306777|FG000|Usual Care|Ineligible|0|||
27579962|NCT03766009|80306778|FG001|Usual Care|Ineligible|1|||
27579963|NCT03766009|80306779|FG002|Usual Care|Ineligible|0|||
27579964|NCT03766009|80306780|FG003|Usual Care|Ineligible|0|||
27579965|NCT03766009|80306781|FG004|Usual Care|Ineligible|0|||
27579966|NCT03766009|80306782|FG005|Usual Care|Ineligible|0|||
27579967|NCT03766009|80306777|FG000|Usual Care|Other: Staff turnover|0|||
27579968|NCT03766009|80306778|FG001|Usual Care|Other: Staff turnover|0|||
27579969|NCT03766009|80306779|FG002|Usual Care|Other: Staff turnover|0|||
27579970|NCT03766009|80306780|FG003|Usual Care|Other: Staff turnover|0|||
27579971|NCT03766009|80306781|FG004|Usual Care|Other: Staff turnover|0|||
27579972|NCT03766009|80306782|FG005|Usual Care|Other: Staff turnover|2|||
27579973|NCT01033747|80306783|FG000|Overall Study|Adverse Event|9|||
27579974|NCT01033747|80306784|FG001|Overall Study|Adverse Event|4|||
27579975|NCT01033747|80306783|FG000|Overall Study|Abnormal Laboratory Value|1|||
27579976|NCT01033747|80306784|FG001|Overall Study|Abnormal Laboratory Value|0|||
27579977|NCT01033747|80306783|FG000|Overall Study|Abnormal test procedure|0|||
27579978|NCT01033747|80306784|FG001|Overall Study|Abnormal test procedure|1|||
27872746|NCT00725491|81365363|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
27872747|NCT04158648|81365364|FG000|Overall Study|Ongoing in the Study|69|||
27872748|NCT04158648|81365364|FG000|Overall Study|Withdrawal by Subject|4|||
27872749|NCT01330303|81365365|FG000|Period 1|Adverse Event|1|||
27579979|NCT01033747|80306783|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
27579980|NCT01033747|80306784|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27579981|NCT01033747|80306783|FG000|Overall Study|Protocol Violation|1|||
27579982|NCT01033747|80306784|FG001|Overall Study|Protocol Violation|0|||
27579983|NCT01033747|80306783|FG000|Overall Study|Withdrawal by Subject|9|||
27579984|NCT01033747|80306784|FG001|Overall Study|Withdrawal by Subject|6|||
27872750|NCT01330303|81365366|FG001|Period 1|Adverse Event|0|||
27872751|NCT01330303|81365365|FG000|Period 1|Protocol Violation|0|||
27594266|NCT01881126|80352491|FG001|Overall Study|Adverse Event|1|||
27680189|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27680190|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27680191|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27997805|NCT02446717|81819914|FG002|Overall Study|Withdrew consent|0|||
27997806|NCT02446717|81819915|FG003|Overall Study|Withdrew consent|1|||
27680192|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27680193|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
27997807|NCT02446717|81819916|FG004|Overall Study|Withdrew consent|0|||
27680194|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
27680195|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
27680196|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
27680197|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
27680198|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
27680199|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
27680200|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
27680201|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
27680202|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
27680203|NCT00477490|80664518|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27680204|NCT00477490|80664519|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
27680205|NCT00477490|80664520|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
27680206|NCT00477490|80664521|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27680207|NCT00477490|80664522|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
27680208|NCT00477490|80664523|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27680209|NCT00477490|80664524|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27680210|NCT00477490|80664525|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27997808|NCT00337207|81819917|FG000|Overall Study|Withdrawal by Subject|3|||
27997809|NCT03191630|81819923|FG000|Overall Study|Lost to Follow-up|7|||
27997810|NCT03191630|81819924|FG001|Overall Study|Lost to Follow-up|7|||
27997811|NCT01871519|81819927|FG000|Overall Study|Death|26|||
27997812|NCT01871519|81819927|FG000|Overall Study|Lost to Follow-up|15|||
27997813|NCT01871519|81819927|FG000|Overall Study|Withdrawal by Subject|49|||
27997814|NCT01156714|81823514|FG000|Overall Study|Withdrawal by Subject|9|||
27997815|NCT01156714|81823515|FG001|Overall Study|Withdrawal by Subject|4|||
27997816|NCT01156714|81823516|FG002|Overall Study|Withdrawal by Subject|3|||
27997817|NCT00867165|81823520|FG000|Overall Study|Adverse Event|3|||
27997818|NCT00867165|81823521|FG001|Overall Study|Adverse Event|0|||
27997819|NCT00867165|81823520|FG000|Overall Study|Withdrawal by Subject|1|||
27997820|NCT00867165|81823521|FG001|Overall Study|Withdrawal by Subject|0|||
27997821|NCT02950480|81823522|FG000|Overall Study|Withdrawal by Subject|1|||
27997822|NCT02950480|81823523|FG001|Overall Study|Withdrawal by Subject|0|||
27997823|NCT00452790|81823524|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
27997824|NCT00452790|81823525|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
27997825|NCT00452790|81823524|FG000|Infant Series|Parent/legal guardian request|8|||
27997826|NCT00452790|81823525|FG001|Infant Series|Parent/legal guardian request|6|||
27997827|NCT00452790|81823524|FG000|Infant Series|Failed to return|4|||
27997828|NCT00452790|81823525|FG001|Infant Series|Failed to return|1|||
27997829|NCT00452790|81823524|FG000|Infant Series|Protocol Violation|1|||
27997830|NCT00452790|81823525|FG001|Infant Series|Protocol Violation|3|||
27997831|NCT00452790|81823524|FG000|Infant Series|Lost to Follow-up|2|||
27997832|NCT00452790|81823525|FG001|Infant Series|Lost to Follow-up|2|||
27997833|NCT00452790|81823524|FG000|Infant Series|Adverse Event|1|||
27997834|NCT00452790|81823525|FG001|Infant Series|Adverse Event|2|||
27997835|NCT00452790|81823524|FG000|Infant Series|Other reasons|1|||
27997836|NCT00452790|81823525|FG001|Infant Series|Other reasons|2|||
27997837|NCT00452790|81823524|FG000|Infant Series|Investigator request|0|||
27997838|NCT00452790|81823525|FG001|Infant Series|Investigator request|1|||
27997839|NCT00452790|81823524|FG000|Infant Series|Death|0|||
27997840|NCT00452790|81823525|FG001|Infant Series|Death|1|||
27997841|NCT00452790|81823524|FG000|After Infant Series|Investigator request|10|||
27997842|NCT00452790|81823525|FG001|After Infant Series|Investigator request|10|||
27579985|NCT01033747|80306783|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
27997843|NCT00452790|81823524|FG000|After Infant Series|Adverse Event|4|||
27997844|NCT00452790|81823525|FG001|After Infant Series|Adverse Event|1|||
27579986|NCT01033747|80306784|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
27579987|NCT01033747|80306783|FG000|Overall Study|Stopped at end of Extension 1|2|||
27579988|NCT01033747|80306784|FG001|Overall Study|Stopped at end of Extension 1|0|||
27997845|NCT00452790|81823524|FG000|After Infant Series|Parent/legal guardian request|1|||
27997846|NCT00452790|81823525|FG001|After Infant Series|Parent/legal guardian request|3|||
27997847|NCT00452790|81823524|FG000|After Infant Series|Lost to Follow-up|4|||
27997848|NCT00452790|81823525|FG001|After Infant Series|Lost to Follow-up|0|||
27997849|NCT00452790|81823524|FG000|After Infant Series|Failed to return|1|||
27997850|NCT00452790|81823525|FG001|After Infant Series|Failed to return|0|||
27579989|NCT02720484|80306788|FG000|Treatment on Study|Adverse Event|1|||
27579990|NCT02720484|80306788|FG000|Treatment on Study|Withdrawal by Subject|1|||
27579991|NCT02720484|80306788|FG000|Treatment on Study|Progressive Disease|4|||
27579992|NCT02720484|80306788|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
27579993|NCT02720484|80306788|FG000|Follow Up for 2 Years|Death|3|||
27579994|NCT02720484|80306788|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
27579995|NCT03394924|80306789|FG000|Overall Study|Adverse Event|0|||
27579996|NCT03394924|80306790|FG001|Overall Study|Adverse Event|5|||
27579997|NCT03394924|80306791|FG002|Overall Study|Adverse Event|0|||
27579998|NCT03394924|80306789|FG000|Overall Study|Withdrawal by Subject|2|||
27579999|NCT03394924|80306790|FG001|Overall Study|Withdrawal by Subject|0|||
27580000|NCT03394924|80306791|FG002|Overall Study|Withdrawal by Subject|0|||
27580001|NCT03394924|80306789|FG000|Overall Study|Lost to Follow-up|0|||
27580002|NCT03394924|80306790|FG001|Overall Study|Lost to Follow-up|1|||
27580003|NCT03394924|80306791|FG002|Overall Study|Lost to Follow-up|0|||
27580004|NCT03394924|80306789|FG000|Overall Study|Did not meet all inclusion criteria|1|||
27580005|NCT03394924|80306790|FG001|Overall Study|Did not meet all inclusion criteria|0|||
27580006|NCT03394924|80306791|FG002|Overall Study|Did not meet all inclusion criteria|0|||
27680211|NCT00477490|80664526|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
27680212|NCT05262517|80664527|FG000|Overall Study|Randomized but not treated|5|||
27680213|NCT05262517|80664528|FG001|Overall Study|Randomized but not treated|11|||
27680214|NCT04531098|80664529|FG000|Stage I|Adverse Event|0|||
27680215|NCT04531098|80664530|FG001|Stage I|Adverse Event|0|||
27680216|NCT04531098|80664531|FG002|Stage I|Adverse Event|3|||
27680217|NCT04531098|80664529|FG000|Stage I|Protocol Violation|0|||
27680218|NCT04531098|80664530|FG001|Stage I|Protocol Violation|0|||
27680219|NCT04531098|80664531|FG002|Stage I|Protocol Violation|5|||
27680220|NCT04531098|80664529|FG000|Stage I|Withdrawal by Subject|0|||
27680221|NCT04531098|80664530|FG001|Stage I|Withdrawal by Subject|5|||
27580007|NCT04079933|80306792|FG000|Overall Study|Withdrawal by Subject|3|||
27580008|NCT04079933|80306793|FG001|Overall Study|Withdrawal by Subject|4|||
27580009|NCT04079933|80306792|FG000|Overall Study|Lost to Follow-up|0|||
27580010|NCT04079933|80306793|FG001|Overall Study|Lost to Follow-up|1|||
27580011|NCT02486406|80306801|FG000|Overall Study|Withdrew consent|1|||
27580012|NCT02486406|80306802|FG001|Overall Study|Withdrew consent|0|||
27580013|NCT02486406|80306803|FG002|Overall Study|Withdrew consent|0|||
27580014|NCT02486406|80306804|FG003|Overall Study|Withdrew consent|1|||
27580015|NCT02486406|80306801|FG000|Overall Study|Lost to Follow-up|1|||
27580016|NCT02486406|80306802|FG001|Overall Study|Lost to Follow-up|3|||
27580017|NCT02486406|80306803|FG002|Overall Study|Lost to Follow-up|1|||
27580018|NCT02486406|80306804|FG003|Overall Study|Lost to Follow-up|3|||
27580019|NCT02486406|80306801|FG000|Overall Study|Other, not specified|0|||
27580020|NCT02486406|80306802|FG001|Overall Study|Other, not specified|0|||
27680222|NCT04531098|80664531|FG002|Stage I|Withdrawal by Subject|10|||
27680223|NCT04531098|80664529|FG000|Stage II|Adverse Event|1|||
27680224|NCT04531098|80664530|FG001|Stage II|Adverse Event|2|||
27997851|NCT00452790|81823524|FG000|After Infant Series|Other reasons|1|||
27997852|NCT00452790|81823525|FG001|After Infant Series|Other reasons|0|||
27997853|NCT00452790|81823524|FG000|Toddler Dose|Failed to return|0|||
27997854|NCT00452790|81823525|FG001|Toddler Dose|Failed to return|1|||
27997855|NCT00452790|81823524|FG000|Toddler Dose|Parent/legal guardian request|0|||
27997856|NCT00452790|81823525|FG001|Toddler Dose|Parent/legal guardian request|1|||
27997857|NCT00602420|81823526|FG000|Overall Study|Death|1|||
27997858|NCT00602420|81823527|FG001|Overall Study|Death|4|||
27997859|NCT00602420|81823526|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
27997860|NCT00602420|81823527|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
27997861|NCT00602420|81823526|FG000|Overall Study|Withdrawal by Subject|18|||
27997862|NCT00602420|81823527|FG001|Overall Study|Withdrawal by Subject|17|||
27997863|NCT00602420|81823526|FG000|Overall Study|Adverse Event|1|||
27997864|NCT00602420|81823527|FG001|Overall Study|Adverse Event|0|||
27997865|NCT04566601|81823532|FG000|Overall Study|Other than listed|13|||
27997866|NCT04566601|81823533|FG001|Overall Study|Other than listed|4|||
27997867|NCT04566601|81823534|FG002|Overall Study|Other than listed|2|||
27997868|NCT04566601|81823535|FG003|Overall Study|Other than listed|1|||
27594267|NCT01353313|80352493|FG000|Overall Study|Lost to Follow-up|22|||
27594268|NCT01353313|80352494|FG001|Overall Study|Lost to Follow-up|23|||
27594269|NCT01353313|80352493|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
27594270|NCT01353313|80352494|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
27594271|NCT02097108|80352495|FG000|Overall Study|Adverse Event|1|||
27594272|NCT02097108|80352495|FG000|Overall Study|patient was abroad for 6 months|1|||
27594273|NCT04764396|80352496|FG000|Overall Study|Physician Decision|1|||
27594274|NCT04764396|80352497|FG001|Overall Study|Physician Decision|0|||
27594275|NCT02975973|80352498|FG000|Overall Study|Adverse Event|1|||
27594276|NCT02975973|80352499|FG001|Overall Study|Adverse Event|1|||
27594277|NCT02975973|80352500|FG002|Overall Study|Adverse Event|1|||
27594278|NCT02975973|80352501|FG003|Overall Study|Adverse Event|0|||
27594279|NCT02293538|80352502|FG000|Overall Study|Adverse Event|0|||
27594280|NCT02293538|80352503|FG001|Overall Study|Adverse Event|1|||
27594281|NCT02293538|80352502|FG000|Overall Study|Lost to Follow-up|1|||
27594282|NCT02293538|80352503|FG001|Overall Study|Lost to Follow-up|0|||
27594283|NCT02293538|80352502|FG000|Overall Study|Withdrawal by Subject|0|||
27594284|NCT02293538|80352503|FG001|Overall Study|Withdrawal by Subject|1|||
27594285|NCT01786512|80352504|FG000|Overall Study|Lost to Follow-up|0|||
27594286|NCT01786512|80352505|FG001|Overall Study|Lost to Follow-up|0|||
27594287|NCT01786512|80352506|FG002|Overall Study|Lost to Follow-up|0|||
27594288|NCT01786512|80352507|FG003|Overall Study|Lost to Follow-up|0|||
27594289|NCT01786512|80352508|FG004|Overall Study|Lost to Follow-up|0|||
27594290|NCT01786512|80352509|FG005|Overall Study|Lost to Follow-up|0|||
27594291|NCT01786512|80352510|FG006|Overall Study|Lost to Follow-up|0|||
27594292|NCT01786512|80352511|FG007|Overall Study|Lost to Follow-up|0|||
27594293|NCT01786512|80352512|FG008|Overall Study|Lost to Follow-up|0|||
27594294|NCT01786512|80352513|FG009|Overall Study|Lost to Follow-up|1|||
27594295|NCT01786512|80352514|FG010|Overall Study|Lost to Follow-up|0|||
27594296|NCT01786512|80352504|FG000|Overall Study|Decision by sponsor|0|||
27594297|NCT01786512|80352505|FG001|Overall Study|Decision by sponsor|0|||
27594298|NCT01786512|80352506|FG002|Overall Study|Decision by sponsor|0|||
27594299|NCT01786512|80352507|FG003|Overall Study|Decision by sponsor|0|||
27594300|NCT01786512|80352508|FG004|Overall Study|Decision by sponsor|0|||
27594301|NCT01786512|80352509|FG005|Overall Study|Decision by sponsor|0|||
27680225|NCT04531098|80664531|FG002|Stage II|Adverse Event|0|||
27680226|NCT04531098|80664529|FG000|Stage II|Protocol Violation|1|||
27680227|NCT04531098|80664530|FG001|Stage II|Protocol Violation|2|||
27680228|NCT04531098|80664531|FG002|Stage II|Protocol Violation|0|||
27680229|NCT04531098|80664529|FG000|Stage II|Withdrawal by Subject|3|||
27680230|NCT04531098|80664530|FG001|Stage II|Withdrawal by Subject|1|||
27680231|NCT04531098|80664531|FG002|Stage II|Withdrawal by Subject|0|||
27680232|NCT04531098|80664529|FG000|Stage II|Moved from study area|8|||
27680233|NCT04531098|80664530|FG001|Stage II|Moved from study area|5|||
27680234|NCT04531098|80664531|FG002|Stage II|Moved from study area|0|||
27680235|NCT02493062|80664532|FG000|Overall Study|Physician Decision|12|||
27680236|NCT01147536|80664533|FG000|Overall Study|Administrative study close|2|||
27680237|NCT01147536|80664533|FG000|Overall Study|Death|1|||
27680238|NCT01114880|80664534|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
27680239|NCT01114880|80664535|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
27680240|NCT01114880|80664534|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
27997869|NCT04566601|81823536|FG004|Overall Study|Other than listed|4|||
27997870|NCT04566601|81823532|FG000|Overall Study|Protocol deviation|3|||
27997871|NCT04566601|81823533|FG001|Overall Study|Protocol deviation|0|||
27997872|NCT04566601|81823534|FG002|Overall Study|Protocol deviation|1|||
27580021|NCT02486406|80306803|FG002|Overall Study|Other, not specified|1|||
27580022|NCT02486406|80306804|FG003|Overall Study|Other, not specified|0|||
27580023|NCT01827904|80306805|FG000|Main Study|Withdrawal by Subject|1|||
27580024|NCT01827904|80306806|FG001|Main Study|Withdrawal by Subject|0|||
27580025|NCT01827904|80306807|FG002|Main Study|Withdrawal by Subject|0|||
27580026|NCT01827904|80306805|FG000|Main Study|Adverse Event|1|||
27580027|NCT01827904|80306806|FG001|Main Study|Adverse Event|0|||
27580028|NCT01827904|80306807|FG002|Main Study|Adverse Event|0|||
27580029|NCT01827904|80306805|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
27580030|NCT01827904|80306806|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
27997873|NCT04566601|81823535|FG003|Overall Study|Protocol deviation|1|||
27997874|NCT04566601|81823536|FG004|Overall Study|Protocol deviation|1|||
27997875|NCT04566601|81823532|FG000|Overall Study|Technical problems|0|||
27997876|NCT04566601|81823533|FG001|Overall Study|Technical problems|0|||
27997877|NCT04566601|81823534|FG002|Overall Study|Technical problems|1|||
27997878|NCT04566601|81823535|FG003|Overall Study|Technical problems|0|||
27997879|NCT04566601|81823536|FG004|Overall Study|Technical problems|0|||
27997880|NCT04566601|81823532|FG000|Overall Study|No reason available|3|||
27997881|NCT04566601|81823533|FG001|Overall Study|No reason available|2|||
27997882|NCT04566601|81823534|FG002|Overall Study|No reason available|7|||
27997883|NCT04566601|81823535|FG003|Overall Study|No reason available|1|||
27997884|NCT04566601|81823536|FG004|Overall Study|No reason available|5|||
27997885|NCT04566601|81823532|FG000|Overall Study|Burden of study procedures|3|||
27997886|NCT04566601|81823533|FG001|Overall Study|Burden of study procedures|0|||
27997887|NCT04566601|81823534|FG002|Overall Study|Burden of study procedures|0|||
27997888|NCT04566601|81823535|FG003|Overall Study|Burden of study procedures|3|||
27580031|NCT01827904|80306807|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
27580032|NCT01827904|80306805|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
27580033|NCT01827904|80306806|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
27580034|NCT01827904|80306807|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
27580035|NCT01827904|80306805|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
27580036|NCT01827904|80306806|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
27580037|NCT01827904|80306807|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
27580038|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
27997889|NCT04566601|81823536|FG004|Overall Study|Burden of study procedures|1|||
27997890|NCT04566601|81823532|FG000|Overall Study|Change of residence|2|||
27997891|NCT04566601|81823533|FG001|Overall Study|Change of residence|2|||
27580039|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
27580040|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
27580041|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
27580042|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
27680241|NCT01114880|80664535|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
27680242|NCT01114880|80664534|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
27680243|NCT01114880|80664535|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
27680244|NCT01114880|80664534|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
27680245|NCT01114880|80664535|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
27680246|NCT01114880|80664534|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
27997892|NCT04566601|81823534|FG002|Overall Study|Change of residence|0|||
27997893|NCT04566601|81823535|FG003|Overall Study|Change of residence|1|||
27997894|NCT04566601|81823536|FG004|Overall Study|Change of residence|2|||
27997895|NCT04566601|81823532|FG000|Overall Study|Perceived lack of efficacy|2|||
27997896|NCT04566601|81823533|FG001|Overall Study|Perceived lack of efficacy|0|||
27997897|NCT04566601|81823534|FG002|Overall Study|Perceived lack of efficacy|1|||
27997898|NCT04566601|81823535|FG003|Overall Study|Perceived lack of efficacy|1|||
27997899|NCT04566601|81823536|FG004|Overall Study|Perceived lack of efficacy|2|||
27680247|NCT01114880|80664535|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
27680248|NCT01114880|80664534|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
27680249|NCT01114880|80664535|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
27680250|NCT03480932|80664538|FG000|Overall Study|Death|1|||
27872752|NCT01330303|81365366|FG001|Period 1|Protocol Violation|1|||
27872753|NCT01330303|81365365|FG000|Period 1|Withdrawal by Subject|0|||
27872754|NCT01330303|81365366|FG001|Period 1|Withdrawal by Subject|1|||
27872755|NCT00276484|81365367|FG000|Overall Study|Adverse Event|4|||
27872756|NCT00276484|81365368|FG001|Overall Study|Adverse Event|7|||
27872757|NCT00276484|81365367|FG000|Overall Study|Lost to Follow-up|1|||
27872758|NCT00276484|81365368|FG001|Overall Study|Lost to Follow-up|1|||
27872759|NCT00276484|81365367|FG000|Overall Study|Protocol Violation|0|||
27872760|NCT00276484|81365368|FG001|Overall Study|Protocol Violation|1|||
27872761|NCT00276484|81365367|FG000|Overall Study|Withdrawal by Subject|4|||
27872762|NCT00276484|81365368|FG001|Overall Study|Withdrawal by Subject|3|||
27580043|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
27580044|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
27872763|NCT00276484|81365367|FG000|Overall Study|Could not take time off work|0|||
27872764|NCT00276484|81365368|FG001|Overall Study|Could not take time off work|1|||
27872765|NCT02762929|81365375|FG000|Overall Study|Adverse Event|0|||
27872766|NCT02762929|81365376|FG001|Overall Study|Adverse Event|0|||
27872767|NCT02762929|81365377|FG002|Overall Study|Adverse Event|0|||
27872768|NCT02762929|81365378|FG003|Overall Study|Adverse Event|1|||
27872769|NCT02762929|81365379|FG004|Overall Study|Adverse Event|0|||
27872770|NCT02762929|81365380|FG005|Overall Study|Adverse Event|0|||
27872771|NCT02762929|81365375|FG000|Overall Study|Lost to Follow-up|1|||
27872772|NCT02762929|81365376|FG001|Overall Study|Lost to Follow-up|2|||
27872773|NCT02762929|81365377|FG002|Overall Study|Lost to Follow-up|0|||
27872774|NCT02762929|81365378|FG003|Overall Study|Lost to Follow-up|1|||
27872775|NCT02762929|81365379|FG004|Overall Study|Lost to Follow-up|0|||
27872776|NCT02762929|81365380|FG005|Overall Study|Lost to Follow-up|0|||
27872777|NCT02762929|81365375|FG000|Overall Study|Withdrawal by Subject|0|||
27872778|NCT02762929|81365376|FG001|Overall Study|Withdrawal by Subject|1|||
27872779|NCT02762929|81365377|FG002|Overall Study|Withdrawal by Subject|0|||
27872780|NCT02762929|81365378|FG003|Overall Study|Withdrawal by Subject|0|||
27872781|NCT02762929|81365379|FG004|Overall Study|Withdrawal by Subject|0|||
27872782|NCT02762929|81365380|FG005|Overall Study|Withdrawal by Subject|0|||
27872783|NCT02762929|81365375|FG000|Overall Study|exclusionary medication disclosed late|0|||
27872784|NCT02762929|81365376|FG001|Overall Study|exclusionary medication disclosed late|0|||
27872785|NCT02762929|81365377|FG002|Overall Study|exclusionary medication disclosed late|0|||
27872786|NCT02762929|81365378|FG003|Overall Study|exclusionary medication disclosed late|1|||
27872787|NCT02762929|81365379|FG004|Overall Study|exclusionary medication disclosed late|0|||
27872788|NCT02762929|81365380|FG005|Overall Study|exclusionary medication disclosed late|0|||
27872789|NCT02790437|81365381|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
27872790|NCT02790437|81365382|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
27872791|NCT02790437|81365381|FG000|Overall Study|Adverse Event|1|||
27872792|NCT02790437|81365382|FG001|Overall Study|Adverse Event|0|||
27580045|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
27580046|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
27580047|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
27580048|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
27580049|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
27580050|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Physician Decision|1|||
27580051|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Physician Decision|0|||
27580052|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Physician Decision|0|||
27580053|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
27580054|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
27580055|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
27580056|NCT01827904|80306805|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
27580057|NCT01827904|80306806|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
27580058|NCT01827904|80306807|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
27580059|NCT00142909|80306808|FG000|Randomization|Various Reasons|7|||
27580060|NCT00142909|80306809|FG001|Randomization|Various Reasons|10|||
27580061|NCT00142909|80306808|FG000|Medications Begin|Protocol Violation|2|||
27580062|NCT00142909|80306809|FG001|Medications Begin|Protocol Violation|0|||
27580063|NCT00142909|80306808|FG000|Medications Begin|Withdrawal by Subject|5|||
27580064|NCT00142909|80306809|FG001|Medications Begin|Withdrawal by Subject|3|||
27580065|NCT00142909|80306808|FG000|Medications Begin|Withdrawal by Subject|2|||
27580066|NCT00142909|80306809|FG001|Medications Begin|Withdrawal by Subject|0|||
27580067|NCT01431508|80306813|FG000|Overall Study|Lack of Efficacy|1|||
27580068|NCT01431508|80306813|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
27580069|NCT02610192|80306814|FG000|Overall Study|Received other treatment|8|||
27580070|NCT02610192|80306814|FG000|Overall Study|Physician Decision|1|||
27580071|NCT00968617|80306815|FG000|Overall Study|Study terminated by sponsor|6|||
27580072|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
27580073|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
27580074|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
27580075|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
27580076|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
27580077|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
27580078|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
27580079|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
27580080|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
27580081|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
27580082|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
27804799|NCT00879970|81117156|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
27804800|NCT00879970|81117152|FG000|Period 1 TZD Randomization|Death|2|||
27804801|NCT00879970|81117153|FG001|Period 1 TZD Randomization|Death|1|||
27804802|NCT00879970|81117154|FG002|Period 1 TZD Randomization|Death|0|||
27804803|NCT00879970|81117155|FG003|Period 1 TZD Randomization|Death|0|||
27804804|NCT00879970|81117156|FG004|Period 1 TZD Randomization|Death|0|||
27580083|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
27580084|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
27580085|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
27580086|NCT03732638|80306816|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
27580087|NCT03732638|80306817|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
27580088|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
27580089|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
27580090|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
27804805|NCT00879970|81117152|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
27804806|NCT00879970|81117153|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
27804807|NCT00879970|81117154|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
27804808|NCT00879970|81117155|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
27804809|NCT00879970|81117156|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
27804810|NCT00879970|81117152|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
27804811|NCT00879970|81117153|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
27804812|NCT00879970|81117154|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
27804813|NCT00879970|81117155|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
27804814|NCT00879970|81117156|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
27804815|NCT00879970|81117152|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27804816|NCT00879970|81117153|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27804817|NCT00879970|81117154|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27804818|NCT00879970|81117155|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
27804819|NCT00879970|81117156|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
27804820|NCT00879970|81117152|FG000|Period 2 Vitamin D Randomization|Death|0|||
27804821|NCT00879970|81117153|FG001|Period 2 Vitamin D Randomization|Death|0|||
27804822|NCT00879970|81117154|FG002|Period 2 Vitamin D Randomization|Death|0|||
27804823|NCT00879970|81117155|FG003|Period 2 Vitamin D Randomization|Death|2|||
27804824|NCT00879970|81117156|FG004|Period 2 Vitamin D Randomization|Death|0|||
27804825|NCT01155063|81117158|FG000|Overall Study|Adverse Event|1|||
27804826|NCT01155063|81117158|FG000|Overall Study|Withdrawal by Subject|1|||
27804827|NCT01155063|81117158|FG000|Overall Study|Study terminated by sponsor|87|||
27804828|NCT00515073|81117159|FG000|Overall Study|Withdrawal by Subject|1|||
27804829|NCT00515073|81117159|FG000|Overall Study|Physician Decision|1|||
27804830|NCT04470622|81117162|FG000|Overall Study|Withdrawal by Subject|0|||
27580091|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
27594302|NCT01786512|80352510|FG006|Overall Study|Decision by sponsor|0|||
27594303|NCT01786512|80352511|FG007|Overall Study|Decision by sponsor|0|||
27594304|NCT01786512|80352512|FG008|Overall Study|Decision by sponsor|0|||
27594305|NCT01786512|80352513|FG009|Overall Study|Decision by sponsor|0|||
27594306|NCT01786512|80352514|FG010|Overall Study|Decision by sponsor|2|||
27594307|NCT01786512|80352504|FG000|Overall Study|Withdrawal by Subject|0|||
27594308|NCT01786512|80352505|FG001|Overall Study|Withdrawal by Subject|1|||
27594309|NCT01786512|80352506|FG002|Overall Study|Withdrawal by Subject|0|||
27594310|NCT01786512|80352507|FG003|Overall Study|Withdrawal by Subject|0|||
27594311|NCT01786512|80352508|FG004|Overall Study|Withdrawal by Subject|0|||
27594312|NCT01786512|80352509|FG005|Overall Study|Withdrawal by Subject|0|||
27594313|NCT01786512|80352510|FG006|Overall Study|Withdrawal by Subject|1|||
27594314|NCT01786512|80352511|FG007|Overall Study|Withdrawal by Subject|0|||
27594315|NCT01786512|80352512|FG008|Overall Study|Withdrawal by Subject|0|||
27594316|NCT01786512|80352513|FG009|Overall Study|Withdrawal by Subject|3|||
27594317|NCT01786512|80352514|FG010|Overall Study|Withdrawal by Subject|7|||
27594318|NCT01786512|80352504|FG000|Overall Study|Death|0|||
27680251|NCT03480932|80664539|FG001|Overall Study|Death|1|||
27680252|NCT03480932|80664540|FG002|Overall Study|Death|0|||
27872793|NCT02790437|81365381|FG000|Overall Study|Withdrawal by Subject|1|||
27872794|NCT02790437|81365382|FG001|Overall Study|Withdrawal by Subject|0|||
27872795|NCT01403051|81368265|FG000|Overall Study|Protocol Violation|2|||
27872796|NCT01403051|81368266|FG001|Overall Study|Protocol Violation|0|||
27872797|NCT01403051|81368265|FG000|Overall Study|Death|1|||
27872798|NCT01403051|81368266|FG001|Overall Study|Death|0|||
27872799|NCT01403051|81368265|FG000|Overall Study|Withdrawal by Subject|2|||
27872800|NCT01403051|81368266|FG001|Overall Study|Withdrawal by Subject|1|||
27580092|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
27580093|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
27580094|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
27580095|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
27580096|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
27580097|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
27580098|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
27580099|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
27580100|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
27580101|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
27580102|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
27680253|NCT03480932|80664538|FG000|Overall Study|Lost to Follow-up|0|||
27580103|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
27872801|NCT01403051|81368265|FG000|Overall Study|Lost to Follow-up|5|||
27872802|NCT01403051|81368266|FG001|Overall Study|Lost to Follow-up|5|||
27997900|NCT04566601|81823532|FG000|Overall Study|Adverse Event|7|||
27997901|NCT04566601|81823533|FG001|Overall Study|Adverse Event|4|||
27997902|NCT04566601|81823534|FG002|Overall Study|Adverse Event|6|||
27997903|NCT04566601|81823535|FG003|Overall Study|Adverse Event|5|||
27680254|NCT03480932|80664539|FG001|Overall Study|Lost to Follow-up|2|||
27680255|NCT03480932|80664540|FG002|Overall Study|Lost to Follow-up|3|||
27680256|NCT03480932|80664538|FG000|Overall Study|Incarcerated|2|||
27680257|NCT03480932|80664539|FG001|Overall Study|Incarcerated|2|||
27680258|NCT03480932|80664540|FG002|Overall Study|Incarcerated|2|||
27680259|NCT01133418|80664541|FG000|Overall Study|Lost to Follow-up|5|||
27997904|NCT04566601|81823536|FG004|Overall Study|Adverse Event|12|||
27997905|NCT03077919|81823543|FG000|Overall Study|Lost to Follow-up|4|||
27997906|NCT03077919|81823544|FG001|Overall Study|Lost to Follow-up|1|||
27680260|NCT01133418|80664542|FG001|Overall Study|Lost to Follow-up|6|||
27680261|NCT03433677|80664543|FG000|Period 1|Protocol Violation|1|||
27680262|NCT03433677|80664544|FG001|Period 1|Protocol Violation|0|||
27680263|NCT03433677|80664543|FG000|Period 2|Withdrawal by Subject|1|||
27680264|NCT03433677|80664544|FG001|Period 2|Withdrawal by Subject|1|||
27680265|NCT04674189|80664545|FG000|Overall Study|Adverse Event|0|||
27680266|NCT04674189|80664546|FG001|Overall Study|Adverse Event|0|||
27580104|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
27580105|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
27580106|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
27580107|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
27580108|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
27680267|NCT04674189|80664547|FG002|Overall Study|Adverse Event|1|||
27997907|NCT00191308|81823555|FG000|Overall Study|Adverse Event|1|||
27997908|NCT05066165|81823556|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
27997909|NCT05066165|81823557|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
27997910|NCT05066165|81823556|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
27580109|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
27580110|NCT03732638|80306816|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
27580111|NCT03732638|80306817|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
27680268|NCT04674189|80664545|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
27680269|NCT04674189|80664546|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
27680270|NCT04674189|80664547|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
27680271|NCT04674189|80664545|FG000|Overall Study|Physician Decision|1|||
27680272|NCT04674189|80664546|FG001|Overall Study|Physician Decision|0|||
27680273|NCT04674189|80664547|FG002|Overall Study|Physician Decision|0|||
27997911|NCT05066165|81823557|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
27997912|NCT01220167|81823564|FG000|Period 3|Urine positive for substance abuse|0|||
27680274|NCT04674189|80664545|FG000|Overall Study|Withdrawal by Participant|83|||
27680275|NCT04674189|80664546|FG001|Overall Study|Withdrawal by Participant|71|||
27680276|NCT04674189|80664547|FG002|Overall Study|Withdrawal by Participant|142|||
27680277|NCT04674189|80664545|FG000|Overall Study|Lost to Follow-up|55|||
27680278|NCT04674189|80664546|FG001|Overall Study|Lost to Follow-up|53|||
27680279|NCT04674189|80664547|FG002|Overall Study|Lost to Follow-up|44|||
27680280|NCT04674189|80664545|FG000|Overall Study|Miscellaneous|27|||
27680281|NCT04674189|80664546|FG001|Overall Study|Miscellaneous|23|||
27580112|NCT03732638|80306816|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
27580113|NCT03732638|80306817|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
27580114|NCT03732638|80306816|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
27580115|NCT03732638|80306817|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
27580116|NCT03732638|80306816|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
27580117|NCT03732638|80306817|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
27680282|NCT04674189|80664547|FG002|Overall Study|Miscellaneous|207|||
27997913|NCT01220167|81823565|FG001|Period 3|Urine positive for substance abuse|1|||
27997914|NCT01220167|81823566|FG002|Period 3|Urine positive for substance abuse|0|||
27997915|NCT02756338|81823568|FG000|Overall Study|Withdrawn by Investigator|1|||
27997916|NCT02756338|81823568|FG000|Overall Study|Device Replaced with Pacemaker|4|||
27997917|NCT00239928|81823569|FG000|Overall Study|Lack of Efficacy|1|||
27997918|NCT00239928|81823569|FG000|Overall Study|Adverse Event|4|||
27997919|NCT00239928|81823569|FG000|Overall Study|Not need to continue study|3|||
27997920|NCT00239928|81823569|FG000|Overall Study|Withdrawal by Subject|2|||
27997921|NCT05274958|81823570|FG000|Overall Study|Only completed 1 set of PROMs|22|||
27997922|NCT05274958|81823571|FG001|Overall Study|Only completed 1 set of PROMs|35|||
27997923|NCT00377858|81823572|FG000|Overall Study|Withdrawal by Subject|12|||
27997924|NCT00377858|81823573|FG001|Overall Study|Withdrawal by Subject|11|||
27997925|NCT00377858|81823572|FG000|Overall Study|Lost to Follow-up|6|||
27997926|NCT00377858|81823573|FG001|Overall Study|Lost to Follow-up|1|||
27997927|NCT00377858|81823572|FG000|Overall Study|Physician Decision|5|||
27997928|NCT00377858|81823573|FG001|Overall Study|Physician Decision|5|||
27997929|NCT00377858|81823572|FG000|Overall Study|Protocol Violation|3|||
27997930|NCT00377858|81823573|FG001|Overall Study|Protocol Violation|4|||
27997931|NCT00377858|81823572|FG000|Overall Study|Adverse Event|2|||
27997932|NCT00377858|81823573|FG001|Overall Study|Adverse Event|1|||
27997933|NCT00377858|81823572|FG000|Overall Study|Entry Criteria Not Met|2|||
27997934|NCT00377858|81823573|FG001|Overall Study|Entry Criteria Not Met|0|||
27997935|NCT00377858|81823572|FG000|Overall Study|Sponsor Decision|1|||
27997936|NCT00377858|81823573|FG001|Overall Study|Sponsor Decision|2|||
27997937|NCT00377858|81823572|FG000|Overall Study|Death|0|||
27997938|NCT00377858|81823573|FG001|Overall Study|Death|3|||
27997939|NCT00584415|81823576|FG000|Overall Study|Adverse Event|7|||
27997940|NCT02657889|81823578|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
27997941|NCT02657889|81823579|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
27997942|NCT02657889|81823580|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
27997943|NCT02657889|81823581|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
27997944|NCT02657889|81823578|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
27997945|NCT02657889|81823579|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
27997946|NCT02657889|81823580|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
27997947|NCT02657889|81823581|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
27997948|NCT02657889|81823578|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
27997949|NCT02657889|81823579|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
27997950|NCT02657889|81823580|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
27997951|NCT02657889|81823581|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
27997952|NCT02657889|81823578|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
27997953|NCT02657889|81823579|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
27997954|NCT02657889|81823580|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
27997955|NCT02657889|81823581|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
27997956|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
27997957|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
27997958|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
27997959|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
27580118|NCT03732638|80306816|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
27580119|NCT03732638|80306817|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
27580120|NCT01344057|80306821|FG000|Overall Study|Premature Withdrawal|1|||
27680283|NCT04674189|80664545|FG000|Overall Study|Did Not Receive Treatment|3|||
27680284|NCT04674189|80664546|FG001|Overall Study|Did Not Receive Treatment|1|||
27680285|NCT04674189|80664547|FG002|Overall Study|Did Not Receive Treatment|2|||
27997960|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
27997961|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
27997962|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
27997963|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
27997964|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
27997965|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
27997966|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
27997967|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
27997968|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
27997969|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
27997970|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
27997971|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
27997972|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
27580121|NCT01465334|80306829|FG000|Overall Study|Disease Progression|1|||
27580122|NCT01465334|80306830|FG001|Overall Study|Disease Progression|0|||
27680286|NCT01607879|80664552|FG000|Overall Study|Death|1|||
27680287|NCT01607879|80664553|FG001|Overall Study|Death|0|||
27680288|NCT03361605|80664554|FG000|Overall Study|Analyzable data not available|3|||
27580123|NCT01465334|80306829|FG000|Overall Study|Adverse Event|1|||
27580124|NCT01465334|80306830|FG001|Overall Study|Adverse Event|0|||
27580125|NCT01465334|80306829|FG000|Overall Study|Richter's transformation|0|||
27580126|NCT01465334|80306830|FG001|Overall Study|Richter's transformation|3|||
27580127|NCT01465334|80306829|FG000|Overall Study|Refractory Disease|0|||
27580128|NCT01465334|80306830|FG001|Overall Study|Refractory Disease|3|||
27580129|NCT03864614|80306834|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
27580130|NCT03864614|80306835|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
27580131|NCT03864614|80306836|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
27580132|NCT03864614|80306837|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
27580133|NCT03864614|80306834|FG000|Overall Study|Withdrawal by Subject|72|||
27580134|NCT03864614|80306835|FG001|Overall Study|Withdrawal by Subject|100|||
27580135|NCT03864614|80306836|FG002|Overall Study|Withdrawal by Subject|1|||
27580136|NCT03864614|80306837|FG003|Overall Study|Withdrawal by Subject|21|||
27580137|NCT03864614|80306834|FG000|Overall Study|Lost to Follow-up|45|||
27580138|NCT03864614|80306835|FG001|Overall Study|Lost to Follow-up|54|||
27580139|NCT03864614|80306836|FG002|Overall Study|Lost to Follow-up|0|||
27580140|NCT03864614|80306837|FG003|Overall Study|Lost to Follow-up|9|||
27580141|NCT03864614|80306834|FG000|Overall Study|Adverse Event|42|||
27580142|NCT03864614|80306835|FG001|Overall Study|Adverse Event|30|||
27580143|NCT03864614|80306836|FG002|Overall Study|Adverse Event|1|||
27680289|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
27804831|NCT04470622|81117163|FG001|Overall Study|Withdrawal by Subject|1|||
27804832|NCT04470622|81117162|FG000|Overall Study|Screen Failure|0|||
27804833|NCT04470622|81117163|FG001|Overall Study|Screen Failure|1|||
27804834|NCT04470622|81117162|FG000|Overall Study|Death|0|||
27804835|NCT04470622|81117163|FG001|Overall Study|Death|1|||
27804836|NCT02270983|81117164|FG000|Overall Study|Adverse Event|3|||
27804837|NCT02270983|81117165|FG001|Overall Study|Adverse Event|2|||
27804838|NCT02270983|81117166|FG002|Overall Study|Adverse Event|6|||
27804839|NCT02270983|81117164|FG000|Overall Study|Lack of Efficacy|2|||
27804840|NCT02270983|81117165|FG001|Overall Study|Lack of Efficacy|1|||
27804841|NCT02270983|81117166|FG002|Overall Study|Lack of Efficacy|1|||
27804842|NCT02270983|81117164|FG000|Overall Study|Withdrawal by Subject|1|||
27804843|NCT02270983|81117165|FG001|Overall Study|Withdrawal by Subject|0|||
27804844|NCT02270983|81117166|FG002|Overall Study|Withdrawal by Subject|2|||
27804845|NCT02270983|81117164|FG000|Overall Study|Lost to Follow-up|1|||
27804846|NCT02270983|81117165|FG001|Overall Study|Lost to Follow-up|1|||
27804847|NCT02270983|81117166|FG002|Overall Study|Lost to Follow-up|2|||
27804848|NCT02270983|81117164|FG000|Overall Study|Protocol Violation|1|||
27804849|NCT02270983|81117165|FG001|Overall Study|Protocol Violation|1|||
27804850|NCT02270983|81117166|FG002|Overall Study|Protocol Violation|1|||
27804851|NCT02270983|81117164|FG000|Overall Study|family emergency|0|||
27804852|NCT02270983|81117165|FG001|Overall Study|family emergency|1|||
27804853|NCT02270983|81117166|FG002|Overall Study|family emergency|0|||
27804854|NCT02270983|81117164|FG000|Overall Study|study procedure non-compliance|1|||
27804855|NCT02270983|81117165|FG001|Overall Study|study procedure non-compliance|0|||
27580144|NCT03864614|80306837|FG003|Overall Study|Adverse Event|9|||
27580145|NCT03864614|80306834|FG000|Overall Study|Protocol Deviation|6|||
27580146|NCT03864614|80306835|FG001|Overall Study|Protocol Deviation|26|||
27580147|NCT03864614|80306836|FG002|Overall Study|Protocol Deviation|0|||
27580148|NCT03864614|80306837|FG003|Overall Study|Protocol Deviation|1|||
27804856|NCT02270983|81117166|FG002|Overall Study|study procedure non-compliance|0|||
27580149|NCT03864614|80306834|FG000|Overall Study|Physician Decision|7|||
27580150|NCT03864614|80306835|FG001|Overall Study|Physician Decision|10|||
27580151|NCT03864614|80306836|FG002|Overall Study|Physician Decision|1|||
27804857|NCT02270983|81117164|FG000|Overall Study|moved away from study site|0|||
27997973|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
27997974|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
27997975|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
27997976|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
27997977|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
27997978|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
27997979|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
27997980|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
27997981|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
27997982|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
27997983|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
27997984|NCT02657889|81823578|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
27997985|NCT02657889|81823579|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
27997986|NCT02657889|81823580|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
27997987|NCT02657889|81823581|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
27997988|NCT01359904|81823582|FG000|Overall Study|Withdrawal by Subject|1|||
27997989|NCT01359904|81823583|FG001|Overall Study|Withdrawal by Subject|0|||
27997990|NCT01150097|81823584|FG000|Months 24 to 36 Post-transplantation|Death|2|||
27997991|NCT01150097|81823585|FG001|Months 24 to 36 Post-transplantation|Death|0|||
27997992|NCT01150097|81823586|FG002|Months 24 to 36 Post-transplantation|Death|0|||
27997993|NCT01150097|81823584|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
27997994|NCT01150097|81823585|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
27997995|NCT01150097|81823586|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
27997996|NCT01150097|81823584|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
27997997|NCT01150097|81823585|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
27997998|NCT01150097|81823586|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
27997999|NCT01150097|81823584|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
27998000|NCT01150097|81823585|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
27998001|NCT01150097|81823586|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
27998002|NCT01150097|81823584|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
27580152|NCT03864614|80306837|FG003|Overall Study|Physician Decision|5|||
27580153|NCT03864614|80306834|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
27580154|NCT03864614|80306835|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
27580155|NCT03864614|80306836|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
27998003|NCT01150097|81823585|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
27998004|NCT01150097|81823586|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
27998005|NCT01150097|81823584|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
27998006|NCT01150097|81823585|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
27998007|NCT01150097|81823586|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
27998008|NCT01150097|81823584|FG000|Months 24 to 48 Post-transplantation|Death|2|||
27998009|NCT01150097|81823585|FG001|Months 24 to 48 Post-transplantation|Death|0|||
27998010|NCT01150097|81823586|FG002|Months 24 to 48 Post-transplantation|Death|0|||
27998011|NCT03500640|81823593|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
27998012|NCT03500640|81823594|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
27998013|NCT03500640|81823595|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
27998014|NCT03500640|81823593|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
27998015|NCT03500640|81823594|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
27998016|NCT03500640|81823595|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
27998017|NCT03500640|81823593|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
27998018|NCT03500640|81823594|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
27998019|NCT03500640|81823595|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
27998020|NCT03500640|81823593|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
27998021|NCT03500640|81823594|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
27998022|NCT03500640|81823595|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
27998023|NCT03500640|81823593|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
27998024|NCT03500640|81823594|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
27998025|NCT03500640|81823595|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
27998026|NCT03500640|81823593|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
27998027|NCT03500640|81823594|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
27998028|NCT03500640|81823595|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
27998029|NCT03500640|81823593|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
27998030|NCT03500640|81823594|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
27998031|NCT03500640|81823595|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
27580156|NCT03864614|80306837|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
27998032|NCT03500640|81823593|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
27998033|NCT03500640|81823594|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
27998034|NCT03500640|81823595|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
27998035|NCT03500640|81823593|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
27998036|NCT03500640|81823594|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
27998037|NCT03500640|81823595|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
27998038|NCT03500640|81823593|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
27998039|NCT03500640|81823594|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
27998040|NCT03500640|81823595|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
27998041|NCT00872599|81823597|FG000|Second Washout Period|Adverse Event|1|||
27998042|NCT00872599|81823598|FG001|Second Washout Period|Adverse Event|1|||
27998043|NCT02698826|81823599|FG000|Overall Study|Death|13|||
27998044|NCT02698826|81823599|FG000|Overall Study|Adverse Event|1|||
27998045|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
27998046|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
27998047|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
27998048|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
27998049|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
27998050|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
27998051|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
27998052|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
27998053|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
27998054|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
27998055|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
27998056|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
27998057|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
27998058|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
27998059|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
27998060|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
27998061|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
27998062|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
27998063|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
27998064|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
27998065|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
27998066|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
27998067|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
27680290|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
27680291|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
27680292|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Death|4|||
27680293|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Death|2|||
27680294|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Death|3|||
27680295|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
27680296|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
27680297|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
27680298|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
27680299|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
27680300|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
27680301|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
27680302|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
27680303|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
27680304|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
27680305|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
27680306|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
27680307|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
27680308|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
27804858|NCT02270983|81117165|FG001|Overall Study|moved away from study site|1|||
27804859|NCT02270983|81117166|FG002|Overall Study|moved away from study site|0|||
27804860|NCT03451331|81117174|FG000|Overall Study|Withdrawal by Subject|1|||
27804861|NCT03451331|81117175|FG001|Overall Study|Withdrawal by Subject|0|||
27804862|NCT03451331|81117174|FG000|Overall Study|Unable to start treatment.|1|||
27804863|NCT03451331|81117175|FG001|Overall Study|Unable to start treatment.|1|||
27804864|NCT05288673|81117176|FG000|Overall Study|Consent withdrawn by subject|0|||
27804865|NCT05288673|81117177|FG001|Overall Study|Consent withdrawn by subject|0|||
27804866|NCT05288673|81117178|FG002|Overall Study|Consent withdrawn by subject|1|||
27998068|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
27998069|NCT03777059|81823602|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
27998070|NCT03777059|81823603|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
27998071|NCT03777059|81823604|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
27804867|NCT00686374|81117179|FG000|Overall Study|Lack of Efficacy|10|||
27804868|NCT00686374|81117179|FG000|Overall Study|Adverse Event|8|||
27804869|NCT00686374|81117179|FG000|Overall Study|Withdrew consent|5|||
27804870|NCT00686374|81117179|FG000|Overall Study|Lost to Follow-up|1|||
27804871|NCT00686374|81117179|FG000|Overall Study|Missing reason|33|||
27804872|NCT00686374|81117179|FG000|Overall Study|Other, not specified|4|||
27804873|NCT00096382|81117180|FG000|Overall Study|Not treated|1|||
27804874|NCT00096382|81117181|FG001|Overall Study|Not treated|0|||
27804875|NCT00096382|81117180|FG000|Overall Study|Death during treatment|1|||
27804876|NCT00096382|81117181|FG001|Overall Study|Death during treatment|0|||
27804877|NCT01706770|81117188|FG000|Overall Study|Lost to Follow-up|1|||
27804878|NCT01706770|81117189|FG001|Overall Study|Lost to Follow-up|0|||
27804879|NCT01706770|81117188|FG000|Overall Study|Physician Decision|1|||
27804880|NCT01706770|81117189|FG001|Overall Study|Physician Decision|0|||
27804881|NCT03877237|81117190|FG000|Overall Study|Adverse Event|1|||
27804882|NCT03877237|81117191|FG001|Overall Study|Adverse Event|2|||
27804883|NCT03877237|81117190|FG000|Overall Study|Death|3|||
27804884|NCT03877237|81117191|FG001|Overall Study|Death|2|||
27804885|NCT03877237|81117190|FG000|Overall Study|Physician Decision|1|||
27804886|NCT03877237|81117191|FG001|Overall Study|Physician Decision|0|||
27804887|NCT03877237|81117190|FG000|Overall Study|Withdrawal by Subject|0|||
27804888|NCT03877237|81117191|FG001|Overall Study|Withdrawal by Subject|2|||
27804889|NCT04023994|81117192|FG000|Overall Study|Lost to Follow-up|0|||
27804890|NCT04023994|81117193|FG001|Overall Study|Lost to Follow-up|1|||
27804891|NCT04023994|81117194|FG002|Overall Study|Lost to Follow-up|2|||
27804892|NCT04023994|81117195|FG003|Overall Study|Lost to Follow-up|0|||
27804893|NCT04023994|81117196|FG004|Overall Study|Lost to Follow-up|0|||
27804894|NCT04023994|81117197|FG005|Overall Study|Lost to Follow-up|0|||
27804895|NCT04023994|81117192|FG000|Overall Study|Withdrawal by Subject|0|||
27998072|NCT03777059|81823605|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
27998073|NCT03777059|81823602|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
27998074|NCT03777059|81823603|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
27998075|NCT03777059|81823604|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
27998076|NCT03777059|81823605|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
27580157|NCT03864614|80306834|FG000|Overall Study|Sponsor Decision|1|||
27804896|NCT04023994|81117193|FG001|Overall Study|Withdrawal by Subject|0|||
27804897|NCT04023994|81117194|FG002|Overall Study|Withdrawal by Subject|0|||
27804898|NCT04023994|81117195|FG003|Overall Study|Withdrawal by Subject|1|||
27804899|NCT04023994|81117196|FG004|Overall Study|Withdrawal by Subject|0|||
27804900|NCT04023994|81117197|FG005|Overall Study|Withdrawal by Subject|0|||
27804901|NCT04363736|81117198|FG000|Overall Study|Withdrawal by Subject|1|||
27804902|NCT04363736|81117199|FG001|Overall Study|Withdrawal by Subject|0|||
27804903|NCT04363736|81117198|FG000|Overall Study|Lost to Follow-up|10|||
27804904|NCT04363736|81117199|FG001|Overall Study|Lost to Follow-up|7|||
27804905|NCT04363736|81117198|FG000|Overall Study|Death|8|||
27804906|NCT04363736|81117199|FG001|Overall Study|Death|6|||
27872803|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
27872804|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Death|1|||
27872805|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
27872806|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
27872807|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
27872808|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
27872809|NCT02001987|81368267|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
27872810|NCT02001987|81368267|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
27872811|NCT02001987|81368267|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
27872812|NCT02001987|81368267|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
27872813|NCT02001987|81368267|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
27872814|NCT02001987|81368267|FG000|LTE Period (52 Weeks)|Other|3|||
27872815|NCT01062425|81368268|FG000|Overall Study|Protocol Violation|3|||
27872816|NCT01062425|81368269|FG001|Overall Study|Protocol Violation|6|||
27872817|NCT02115269|81368278|FG000|Overall Study|Lost to Follow-up|43|||
27872818|NCT02115269|81368278|FG000|Overall Study|Did not complete patient diary|3|||
27872819|NCT02115269|81368278|FG000|Overall Study|Moved to another city|7|||
27872820|NCT02115269|81368278|FG000|Overall Study|Withdrawal by Subject|2|||
27872821|NCT02115269|81368278|FG000|Overall Study|Didn't take study drug|2|||
27872822|NCT02892331|81368281|FG000|Overall Study|Withdrawal by Subject|0|||
27872823|NCT02892331|81368282|FG001|Overall Study|Withdrawal by Subject|1|||
27804907|NCT00527397|81117202|FG000|Overall Study|Adverse Event|3|||
27872824|NCT02892331|81368283|FG002|Overall Study|Withdrawal by Subject|1|||
27872825|NCT02892331|81368281|FG000|Overall Study|Sick family member|0|||
27804908|NCT00527397|81117202|FG000|Overall Study|Lack of Efficacy|1|||
27804909|NCT00527397|81117202|FG000|Overall Study|Protocol Violation|1|||
27998077|NCT03777059|81823602|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
27804910|NCT00527397|81117202|FG000|Overall Study|Withdrawal by Subject|6|||
27804911|NCT00527397|81117202|FG000|Overall Study|Study terminated by sponsor|13|||
27804912|NCT01272193|81117203|FG000|Overall Study|Adverse Event|1|||
27804913|NCT01272193|81117204|FG001|Overall Study|Adverse Event|1|||
27680309|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
27680310|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
27680311|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
27680312|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
27680313|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
27680314|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
27680315|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
27680316|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
27680317|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
27680318|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
27680319|NCT02783573|80664557|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
27680320|NCT02783573|80664558|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
27680321|NCT02783573|80664559|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
27680322|NCT02783573|80664557|FG000|Delayed-Start Period|Sponsor Decision|0|||
27680323|NCT02783573|80664558|FG001|Delayed-Start Period|Sponsor Decision|17|||
27680324|NCT02783573|80664559|FG002|Delayed-Start Period|Sponsor Decision|12|||
27680325|NCT01730950|80664560|FG000|Overall Study|Protocol Violation|6|||
27680326|NCT01730950|80664561|FG001|Overall Study|Protocol Violation|6|||
27680327|NCT04617275|80664565|FG000|Treatment Period|Adverse Event|1|||
27680328|NCT04617275|80664566|FG001|Treatment Period|Adverse Event|6|||
27680329|NCT04617275|80664567|FG002|Treatment Period|Adverse Event|4|||
27680330|NCT04617275|80664568|FG003|Treatment Period|Adverse Event|6|||
27680331|NCT04617275|80664569|FG004|Treatment Period|Adverse Event|7|||
27680332|NCT04617275|80664570|FG005|Treatment Period|Adverse Event|8|||
27680333|NCT04617275|80664571|FG006|Treatment Period|Adverse Event|0|||
27680334|NCT04617275|80664572|FG007|Treatment Period|Adverse Event|12|||
27680335|NCT04617275|80664565|FG000|Treatment Period|Lost to Follow-up|0|||
27680336|NCT04617275|80664566|FG001|Treatment Period|Lost to Follow-up|0|||
27680337|NCT04617275|80664567|FG002|Treatment Period|Lost to Follow-up|2|||
27680338|NCT04617275|80664568|FG003|Treatment Period|Lost to Follow-up|0|||
27680339|NCT04617275|80664569|FG004|Treatment Period|Lost to Follow-up|0|||
27680340|NCT04617275|80664570|FG005|Treatment Period|Lost to Follow-up|3|||
27680341|NCT04617275|80664571|FG006|Treatment Period|Lost to Follow-up|0|||
27680342|NCT04617275|80664572|FG007|Treatment Period|Lost to Follow-up|2|||
27680343|NCT04617275|80664565|FG000|Treatment Period|No longer meets eligibility criteria|0|||
27680344|NCT04617275|80664566|FG001|Treatment Period|No longer meets eligibility criteria|0|||
27680345|NCT04617275|80664567|FG002|Treatment Period|No longer meets eligibility criteria|0|||
27680346|NCT04617275|80664568|FG003|Treatment Period|No longer meets eligibility criteria|1|||
27680347|NCT04617275|80664569|FG004|Treatment Period|No longer meets eligibility criteria|0|||
27680348|NCT04617275|80664570|FG005|Treatment Period|No longer meets eligibility criteria|0|||
27680349|NCT04617275|80664571|FG006|Treatment Period|No longer meets eligibility criteria|0|||
27680350|NCT04617275|80664572|FG007|Treatment Period|No longer meets eligibility criteria|0|||
27680351|NCT04617275|80664565|FG000|Treatment Period|Other|0|||
27680352|NCT04617275|80664566|FG001|Treatment Period|Other|1|||
27680353|NCT04617275|80664567|FG002|Treatment Period|Other|0|||
27680354|NCT04617275|80664568|FG003|Treatment Period|Other|0|||
27680355|NCT04617275|80664569|FG004|Treatment Period|Other|0|||
27680356|NCT04617275|80664570|FG005|Treatment Period|Other|0|||
27680357|NCT04617275|80664571|FG006|Treatment Period|Other|0|||
27680358|NCT04617275|80664572|FG007|Treatment Period|Other|0|||
27680359|NCT04617275|80664565|FG000|Treatment Period|Withdrawal by Subject|2|||
27680360|NCT04617275|80664566|FG001|Treatment Period|Withdrawal by Subject|0|||
27680361|NCT04617275|80664567|FG002|Treatment Period|Withdrawal by Subject|0|||
27680362|NCT04617275|80664568|FG003|Treatment Period|Withdrawal by Subject|2|||
27680363|NCT04617275|80664569|FG004|Treatment Period|Withdrawal by Subject|2|||
27680364|NCT04617275|80664570|FG005|Treatment Period|Withdrawal by Subject|0|||
27680365|NCT04617275|80664571|FG006|Treatment Period|Withdrawal by Subject|1|||
27680366|NCT04617275|80664572|FG007|Treatment Period|Withdrawal by Subject|2|||
27998078|NCT03777059|81823603|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
27998079|NCT03777059|81823604|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
27998080|NCT03777059|81823605|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
27998081|NCT03777059|81823602|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
27998082|NCT03777059|81823603|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
27998083|NCT03777059|81823604|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
27680367|NCT04617275|80664565|FG000|Follow-up Period|Adverse Event|1|||
27680368|NCT04617275|80664566|FG001|Follow-up Period|Adverse Event|1|||
27680369|NCT04617275|80664567|FG002|Follow-up Period|Adverse Event|2|||
27680370|NCT04617275|80664568|FG003|Follow-up Period|Adverse Event|3|||
27680371|NCT04617275|80664569|FG004|Follow-up Period|Adverse Event|4|||
27998084|NCT03777059|81823605|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
27680372|NCT04617275|80664570|FG005|Follow-up Period|Adverse Event|3|||
27680373|NCT04617275|80664571|FG006|Follow-up Period|Adverse Event|0|||
27680374|NCT04617275|80664572|FG007|Follow-up Period|Adverse Event|3|||
27680375|NCT04617275|80664565|FG000|Follow-up Period|Lost to Follow-up|0|||
27680376|NCT04617275|80664566|FG001|Follow-up Period|Lost to Follow-up|1|||
27680377|NCT04617275|80664567|FG002|Follow-up Period|Lost to Follow-up|2|||
27680378|NCT04617275|80664568|FG003|Follow-up Period|Lost to Follow-up|0|||
27680379|NCT04617275|80664569|FG004|Follow-up Period|Lost to Follow-up|0|||
27680380|NCT04617275|80664570|FG005|Follow-up Period|Lost to Follow-up|4|||
27680381|NCT04617275|80664571|FG006|Follow-up Period|Lost to Follow-up|0|||
27680382|NCT04617275|80664572|FG007|Follow-up Period|Lost to Follow-up|3|||
27680383|NCT04617275|80664565|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
27680384|NCT04617275|80664566|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
27680385|NCT04617275|80664567|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
27680386|NCT04617275|80664568|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
27680387|NCT04617275|80664569|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
27680388|NCT04617275|80664570|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
27680389|NCT04617275|80664571|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
27680390|NCT04617275|80664572|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
27680391|NCT04617275|80664565|FG000|Follow-up Period|Other|0|||
27680392|NCT04617275|80664566|FG001|Follow-up Period|Other|1|||
27680393|NCT04617275|80664567|FG002|Follow-up Period|Other|0|||
27680394|NCT04617275|80664568|FG003|Follow-up Period|Other|0|||
27680395|NCT04617275|80664569|FG004|Follow-up Period|Other|0|||
27680396|NCT04617275|80664570|FG005|Follow-up Period|Other|0|||
27680397|NCT04617275|80664571|FG006|Follow-up Period|Other|0|||
27680398|NCT04617275|80664572|FG007|Follow-up Period|Other|0|||
27680399|NCT04617275|80664565|FG000|Follow-up Period|Withdrawal by Subject|2|||
27680400|NCT04617275|80664566|FG001|Follow-up Period|Withdrawal by Subject|0|||
27680401|NCT04617275|80664567|FG002|Follow-up Period|Withdrawal by Subject|0|||
27680402|NCT04617275|80664568|FG003|Follow-up Period|Withdrawal by Subject|2|||
27680403|NCT04617275|80664569|FG004|Follow-up Period|Withdrawal by Subject|2|||
27680404|NCT04617275|80664570|FG005|Follow-up Period|Withdrawal by Subject|0|||
27680405|NCT04617275|80664571|FG006|Follow-up Period|Withdrawal by Subject|1|||
27680406|NCT04617275|80664572|FG007|Follow-up Period|Withdrawal by Subject|2|||
27680407|NCT01255631|80664573|FG000|Overall Study|poor enrollment, no data analyzed|9|||
27680408|NCT01255631|80664574|FG001|Overall Study|poor enrollment, no data analyzed|6|||
27680409|NCT01080326|80664575|FG000|Overall Study|Patient deterioration prior to procedure|3|||
27680410|NCT01080326|80664575|FG000|Overall Study|Surgeon decision|1|||
27680411|NCT00534495|80664576|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
27680412|NCT00534495|80664577|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
27680413|NCT00534495|80664578|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
27680414|NCT00534495|80664576|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
27680415|NCT00534495|80664577|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
27680416|NCT00534495|80664578|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
27680417|NCT00534495|80664576|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
27680418|NCT00534495|80664577|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
27680419|NCT00534495|80664578|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
27680420|NCT00534495|80664576|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
27680421|NCT00534495|80664577|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
27680422|NCT00534495|80664578|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
27680423|NCT00534495|80664576|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
27680424|NCT00534495|80664577|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
27680425|NCT00534495|80664578|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
27680426|NCT00534495|80664576|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
27680427|NCT00534495|80664577|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
27680428|NCT00534495|80664578|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
27680429|NCT00534495|80664576|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
27680430|NCT00534495|80664577|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
27680431|NCT00534495|80664578|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
27680432|NCT00534495|80664576|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
27680433|NCT00534495|80664577|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
27680434|NCT00534495|80664578|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
27680435|NCT00534495|80664576|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
27680436|NCT00534495|80664577|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
27680437|NCT00534495|80664578|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
27680438|NCT02389764|80664579|FG000|Overall Study|Lack of Efficacy|9|||
27680439|NCT01294436|80664580|FG000|Overall Study|Adverse Event|10|||
27680440|NCT01294436|80664581|FG001|Overall Study|Adverse Event|17|||
27680441|NCT01294436|80664580|FG000|Overall Study|Withdrawal by Subject|11|||
27680442|NCT01294436|80664581|FG001|Overall Study|Withdrawal by Subject|28|||
27680443|NCT01294436|80664580|FG000|Overall Study|subject no longer meets study criteria|5|||
27680444|NCT01294436|80664581|FG001|Overall Study|subject no longer meets study criteria|20|||
27680445|NCT01294436|80664580|FG000|Overall Study|poor/non-compliance|2|||
27680446|NCT01294436|80664581|FG001|Overall Study|poor/non-compliance|5|||
27680447|NCT02993523|80664585|FG000|Overall Study|Withdrew Consent|0|||
27680448|NCT02993523|80664586|FG001|Overall Study|Withdrew Consent|0|||
27680449|NCT02993523|80664587|FG002|Overall Study|Withdrew Consent|2|||
27680450|NCT02993523|80664588|FG003|Overall Study|Withdrew Consent|9|||
27680451|NCT02993523|80664589|FG004|Overall Study|Withdrew Consent|0|||
27680452|NCT02993523|80664585|FG000|Overall Study|Lost to Follow-up|0|||
27998085|NCT03777059|81823602|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
27998086|NCT03777059|81823603|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
27580158|NCT03864614|80306835|FG001|Overall Study|Sponsor Decision|2|||
27680453|NCT02993523|80664586|FG001|Overall Study|Lost to Follow-up|0|||
27680454|NCT02993523|80664587|FG002|Overall Study|Lost to Follow-up|3|||
27680455|NCT02993523|80664588|FG003|Overall Study|Lost to Follow-up|6|||
27680456|NCT02993523|80664589|FG004|Overall Study|Lost to Follow-up|0|||
27680457|NCT02993523|80664585|FG000|Overall Study|Death|1|||
27680458|NCT02993523|80664586|FG001|Overall Study|Death|1|||
27680459|NCT02993523|80664587|FG002|Overall Study|Death|138|||
27680460|NCT02993523|80664588|FG003|Overall Study|Death|222|||
27680461|NCT02993523|80664589|FG004|Overall Study|Death|6|||
27680462|NCT02993523|80664585|FG000|Overall Study|Reason not Specified|0|||
27680463|NCT02993523|80664586|FG001|Overall Study|Reason not Specified|0|||
27680464|NCT02993523|80664587|FG002|Overall Study|Reason not Specified|1|||
27680465|NCT02993523|80664588|FG003|Overall Study|Reason not Specified|1|||
27680466|NCT02993523|80664589|FG004|Overall Study|Reason not Specified|0|||
27680467|NCT01461811|80664593|FG000|Overall Study|Adverse Event|2|||
27680468|NCT01461811|80664594|FG001|Overall Study|Adverse Event|1|||
27680469|NCT01461811|80664593|FG000|Overall Study|Subject decision unrelated to an AE|1|||
27680470|NCT01461811|80664594|FG001|Overall Study|Subject decision unrelated to an AE|1|||
27680471|NCT01461811|80664593|FG000|Overall Study|Noncompliance|1|||
27680472|NCT01461811|80664594|FG001|Overall Study|Noncompliance|1|||
27680473|NCT00288639|80664595|FG000|Overall Study|Adverse Event|5|||
27680474|NCT00288639|80664595|FG000|Overall Study|Lack of Efficacy|4|||
27680475|NCT00288639|80664595|FG000|Overall Study|Withdrawal by Subject|2|||
27680476|NCT00288639|80664595|FG000|Overall Study|Other|1|||
27804914|NCT01272193|81117203|FG000|Overall Study|Lack of Efficacy|0|||
27804915|NCT01272193|81117204|FG001|Overall Study|Lack of Efficacy|3|||
27804916|NCT01272193|81117203|FG000|Overall Study|Withdrawal Criteria|1|||
27804917|NCT01272193|81117204|FG001|Overall Study|Withdrawal Criteria|1|||
27804918|NCT01272193|81117203|FG000|Overall Study|Unclassified|8|||
27580159|NCT03864614|80306836|FG002|Overall Study|Sponsor Decision|0|||
27580160|NCT03864614|80306837|FG003|Overall Study|Sponsor Decision|0|||
27580161|NCT03864614|80306834|FG000|Overall Study|Pregnancy|0|||
27580162|NCT03864614|80306835|FG001|Overall Study|Pregnancy|1|||
27580163|NCT03864614|80306836|FG002|Overall Study|Pregnancy|0|||
27580164|NCT03864614|80306837|FG003|Overall Study|Pregnancy|0|||
27580165|NCT03864614|80306834|FG000|Overall Study|Other|7|||
27580166|NCT03864614|80306835|FG001|Overall Study|Other|9|||
27580167|NCT03864614|80306836|FG002|Overall Study|Other|1|||
27580168|NCT03864614|80306837|FG003|Overall Study|Other|4|||
27580169|NCT03864614|80306834|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
27580170|NCT03864614|80306835|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
27580171|NCT03864614|80306836|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
27580172|NCT03864614|80306837|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
27580173|NCT03221257|80306838|FG000|Overall Study|Lost to Follow-up|0|||
27580174|NCT03221257|80306839|FG001|Overall Study|Lost to Follow-up|1|||
27580175|NCT03221257|80306838|FG000|Overall Study|Withdrawal by Subject|1|||
27580176|NCT03221257|80306839|FG001|Overall Study|Withdrawal by Subject|1|||
27580177|NCT05008055|80306840|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
27580178|NCT05008055|80306841|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
27580179|NCT05008055|80306842|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
27580180|NCT03099382|80306843|FG000|Overall Study|Protocol Violation|2|||
27580181|NCT03099382|80306844|FG001|Overall Study|Protocol Violation|3|||
27580182|NCT02209324|80306845|FG000|Overall Study|Adverse Event|2|||
27804919|NCT01272193|81117204|FG001|Overall Study|Unclassified|7|||
27804920|NCT01375010|81117207|FG000|Overall Study|Lost to Follow-up|8|||
27580183|NCT02209324|80306845|FG000|Overall Study|Lack of Efficacy|1|||
27580184|NCT02209324|80306845|FG000|Overall Study|Lost to Follow-up|1|||
27680477|NCT02592876|80664596|FG000|Overall Study|Withdrawal by Subject|3|||
27680478|NCT02592876|80664597|FG001|Overall Study|Withdrawal by Subject|3|||
27680479|NCT02592876|80664596|FG000|Overall Study|Study Termination by Sponsor|32|||
27680480|NCT02592876|80664597|FG001|Overall Study|Study Termination by Sponsor|27|||
27680481|NCT02592876|80664596|FG000|Overall Study|Lost to Follow-up|0|||
27680482|NCT02592876|80664597|FG001|Overall Study|Lost to Follow-up|1|||
27680483|NCT02592876|80664596|FG000|Overall Study|Death|6|||
27998087|NCT03777059|81823604|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
27580185|NCT02209324|80306845|FG000|Overall Study|Physician Decision|3|||
27580186|NCT02209324|80306845|FG000|Overall Study|Protocol Violation|14|||
27580187|NCT02209324|80306845|FG000|Overall Study|Withdrawal by Subject|8|||
27580188|NCT02209324|80306845|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
27580189|NCT02209324|80306845|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
27998088|NCT03777059|81823605|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
27998089|NCT00086047|81823608|FG000|Overall Study|Lost to Follow-up|7|||
27998090|NCT00086047|81823609|FG001|Overall Study|Lost to Follow-up|6|||
27998091|NCT00086047|81823608|FG000|Overall Study|Physician Decision|0|||
27998092|NCT00086047|81823609|FG001|Overall Study|Physician Decision|1|||
27998093|NCT04862065|81823610|FG000|Screening|Protocol Violation|54|||
27998094|NCT04862065|81823611|FG001|Screening|Protocol Violation|0|||
27998095|NCT04862065|81823612|FG002|Screening|Protocol Violation|0|||
27998096|NCT04862065|81823610|FG000|Screening|Insufficient Sample|1|||
27998097|NCT04862065|81823611|FG001|Screening|Insufficient Sample|0|||
27998098|NCT04862065|81823612|FG002|Screening|Insufficient Sample|0|||
27998099|NCT04862065|81823610|FG000|Follow-Up|Lost to Follow-up|3|||
27998100|NCT04862065|81823611|FG001|Follow-Up|Lost to Follow-up|0|||
27998101|NCT04862065|81823612|FG002|Follow-Up|Lost to Follow-up|0|||
27998102|NCT03003962|81823613|FG000|Overall Study|Withdrawal by Subject|5|||
27998103|NCT03003962|81823614|FG001|Overall Study|Withdrawal by Subject|17|||
27998104|NCT03003962|81823613|FG000|Overall Study|Death|274|||
27998105|NCT03003962|81823614|FG001|Overall Study|Death|277|||
27998106|NCT03003962|81823613|FG000|Overall Study|Participants ongoing at DCO|55|||
27998107|NCT03003962|81823614|FG001|Overall Study|Participants ongoing at DCO|40|||
27998108|NCT00321464|81823615|FG000|Overall Study|Death|169|||
27998109|NCT00321464|81823616|FG001|Overall Study|Death|174|||
27998110|NCT00321464|81823615|FG000|Overall Study|Disease progression|124|||
27998111|NCT00321464|81823616|FG001|Overall Study|Disease progression|124|||
27998112|NCT00321464|81823615|FG000|Overall Study|Withdrawal by Subject|117|||
27998113|NCT00321464|81823616|FG001|Overall Study|Withdrawal by Subject|118|||
27998114|NCT00321464|81823615|FG000|Overall Study|Participant request|57|||
27998115|NCT00321464|81823616|FG001|Overall Study|Participant request|61|||
27580190|NCT02209324|80306845|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
27580191|NCT00861341|80306846|FG000|Overall Study|Withdrawal by Subject|2|||
27580192|NCT00812812|80306847|FG000|Overall Study|Adverse Event|2|||
27580193|NCT00812812|80306848|FG001|Overall Study|Adverse Event|1|||
27580194|NCT00812812|80306847|FG000|Overall Study|Lack of Efficacy|1|||
27580195|NCT00812812|80306848|FG001|Overall Study|Lack of Efficacy|0|||
27580196|NCT00812812|80306847|FG000|Overall Study|Lost to Follow-up|0|||
27580197|NCT00812812|80306848|FG001|Overall Study|Lost to Follow-up|1|||
27580198|NCT00812812|80306847|FG000|Overall Study|Withdrawal by Subject|0|||
27580199|NCT00812812|80306848|FG001|Overall Study|Withdrawal by Subject|2|||
27580200|NCT00690755|80306850|FG000|Overall Study|Physician Decision|2|||
27580201|NCT00690755|80306851|FG001|Overall Study|Physician Decision|0|||
27580202|NCT00690755|80306852|FG002|Overall Study|Physician Decision|46|||
27580203|NCT00690755|80306853|FG003|Overall Study|Physician Decision|5|||
27580204|NCT00690755|80306854|FG004|Overall Study|Physician Decision|0|||
27580205|NCT00690755|80306855|FG005|Overall Study|Physician Decision|4|||
27998116|NCT00321464|81823615|FG000|Overall Study|Adverse Event|43|||
27998117|NCT00321464|81823616|FG001|Overall Study|Adverse Event|28|||
27998118|NCT00321464|81823615|FG000|Overall Study|Physician Decision|15|||
27998119|NCT00321464|81823616|FG001|Overall Study|Physician Decision|14|||
27998120|NCT00321464|81823615|FG000|Overall Study|Noncompliance|4|||
27580206|NCT00690755|80306856|FG006|Overall Study|Physician Decision|0|||
27580207|NCT04354831|80306864|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
27580208|NCT04354831|80306865|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
27580209|NCT00852397|80306866|FG000|Overall Study|Adverse Event|4|||
27998121|NCT00321464|81823616|FG001|Overall Study|Noncompliance|10|||
27998122|NCT00321464|81823615|FG000|Overall Study|Lost to Follow-up|7|||
27680484|NCT02592876|80664597|FG001|Overall Study|Death|9|||
27580210|NCT00852397|80306867|FG001|Overall Study|Adverse Event|6|||
27998123|NCT00321464|81823616|FG001|Overall Study|Lost to Follow-up|8|||
27998124|NCT00321464|81823615|FG000|Overall Study|Protocol deviation|0|||
27998125|NCT00321464|81823616|FG001|Overall Study|Protocol deviation|2|||
27998126|NCT00321464|81823615|FG000|Overall Study|Ineligibility determined|2|||
27998127|NCT00321464|81823616|FG001|Overall Study|Ineligibility determined|1|||
27998128|NCT00321464|81823615|FG000|Overall Study|Other|21|||
27998129|NCT00321464|81823616|FG001|Overall Study|Other|18|||
27580211|NCT00852397|80306868|FG002|Overall Study|Adverse Event|4|||
27580212|NCT00852397|80306866|FG000|Overall Study|Death|0|||
27580213|NCT00852397|80306867|FG001|Overall Study|Death|0|||
27580214|NCT00852397|80306868|FG002|Overall Study|Death|1|||
27580215|NCT00852397|80306866|FG000|Overall Study|Withdrawal by Subject|4|||
27580216|NCT00852397|80306867|FG001|Overall Study|Withdrawal by Subject|1|||
27580217|NCT00852397|80306868|FG002|Overall Study|Withdrawal by Subject|2|||
27580218|NCT00852397|80306866|FG000|Overall Study|Study terminated by sponsor|2|||
27580219|NCT00852397|80306867|FG001|Overall Study|Study terminated by sponsor|1|||
27580220|NCT00852397|80306868|FG002|Overall Study|Study terminated by sponsor|6|||
27580221|NCT00852397|80306866|FG000|Overall Study|Difficulty in study site visit|1|||
27580222|NCT00852397|80306867|FG001|Overall Study|Difficulty in study site visit|0|||
27580223|NCT00852397|80306868|FG002|Overall Study|Difficulty in study site visit|0|||
27580224|NCT00852397|80306866|FG000|Overall Study|Protocol Violation|0|||
27580225|NCT00852397|80306867|FG001|Overall Study|Protocol Violation|0|||
27580226|NCT00852397|80306868|FG002|Overall Study|Protocol Violation|1|||
27580227|NCT04632940|80306869|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
27580228|NCT04632940|80306870|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
27580229|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
27580230|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
27580231|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
27580232|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
27580233|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
27580234|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
27580235|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
27580236|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
27580237|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
27580238|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
27580239|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Other than specified|0|||
27580240|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Other than specified|1|||
27580241|NCT04632940|80306869|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
27580242|NCT04632940|80306870|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
27580243|NCT01578551|80306871|FG000|Overall Study|Adverse Event|1|||
27580244|NCT01578551|80306872|FG001|Overall Study|Adverse Event|0|||
27580245|NCT02447991|80306874|FG000|Overall Study|Withdrawn by subject - no data|0|||
27580246|NCT02447991|80306875|FG001|Overall Study|Withdrawn by subject - no data|2|||
27580247|NCT02447991|80306874|FG000|Overall Study|Withdrawn by Subject - with data|4|||
27580248|NCT02447991|80306875|FG001|Overall Study|Withdrawn by Subject - with data|4|||
27580249|NCT02447991|80306874|FG000|Overall Study|Lost to Follow-up - no data|3|||
27580250|NCT02447991|80306875|FG001|Overall Study|Lost to Follow-up - no data|6|||
27804921|NCT01375010|81117208|FG001|Overall Study|Lost to Follow-up|2|||
27804922|NCT01375010|81117207|FG000|Overall Study|Withdrawal by Subject|4|||
27804923|NCT01375010|81117208|FG001|Overall Study|Withdrawal by Subject|2|||
27804924|NCT00409188|81117209|FG000|Overall Study|Ongoing at data cut-off|383|||
27804925|NCT00409188|81117210|FG001|Overall Study|Ongoing at data cut-off|175|||
27804926|NCT01453374|81117211|FG000|Overall Study|Adverse Event|7|||
27804927|NCT01453374|81117211|FG000|Overall Study|Lack of Efficacy|1|||
27804928|NCT01453374|81117211|FG000|Overall Study|Lost to Follow-up|3|||
27804929|NCT01453374|81117211|FG000|Overall Study|Withdrawal by Subject|5|||
27804930|NCT01453374|81117211|FG000|Overall Study|Incarcerated|2|||
27580251|NCT02447991|80306874|FG000|Overall Study|Lost to follow-up - with data|0|||
27580252|NCT02447991|80306875|FG001|Overall Study|Lost to follow-up - with data|3|||
27580253|NCT02447991|80306874|FG000|Overall Study|End of study - no treatment results|3|||
27580254|NCT02447991|80306875|FG001|Overall Study|End of study - no treatment results|6|||
27580255|NCT02447991|80306874|FG000|Overall Study|End of study - partial treatment results|0|||
27804931|NCT01619085|81117212|FG000|Overall Study|Adverse Event|231|||
27580256|NCT02447991|80306875|FG001|Overall Study|End of study - partial treatment results|9|||
27580257|NCT00530023|80306878|FG000|Overall Study|Withdrawal by Subject|0|||
27804932|NCT01619085|81117212|FG000|Overall Study|Protocol Violation|4|||
27804933|NCT01619085|81117212|FG000|Overall Study|Lost to Follow-up|3|||
27804934|NCT01619085|81117212|FG000|Overall Study|Withdrawal by Subject|45|||
27804935|NCT01619085|81117212|FG000|Overall Study|Other than specified|96|||
27804936|NCT01619085|81117212|FG000|Overall Study|Not treated|1|||
27804937|NCT01619085|81117212|FG000|Overall Study|Death|145|||
27804938|NCT01690520|81117218|FG000|Overall Study|Death|25|||
27804939|NCT01690520|81117219|FG001|Overall Study|Death|21|||
27804940|NCT01690520|81117218|FG000|Overall Study|Lost to Follow-up|2|||
27804941|NCT01690520|81117219|FG001|Overall Study|Lost to Follow-up|3|||
27804942|NCT01690520|81117218|FG000|Overall Study|Withdrawal by Subject|2|||
27804943|NCT01690520|81117219|FG001|Overall Study|Withdrawal by Subject|0|||
27804944|NCT01690520|81117218|FG000|Overall Study|Relapse|0|||
27804945|NCT01690520|81117219|FG001|Overall Study|Relapse|1|||
27804946|NCT01690520|81117218|FG000|Overall Study|Other|0|||
27804947|NCT01690520|81117219|FG001|Overall Study|Other|1|||
27804948|NCT01690520|81117218|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
27804949|NCT01690520|81117219|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
27804950|NCT01605461|81117220|FG000|Overall Study|Lost to Follow-up|3|||
27804951|NCT01605461|81117220|FG000|Overall Study|Withdrawal by Subject|1|||
27580258|NCT00530023|80306879|FG001|Overall Study|Withdrawal by Subject|1|||
27580259|NCT02602288|80306885|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
27580260|NCT02602288|80306886|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
27580261|NCT02602288|80306885|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
27580262|NCT02602288|80306886|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
27580263|NCT02602288|80306885|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
27580264|NCT02602288|80306886|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
27580265|NCT02602288|80306885|FG000|12 Month Follow-up|Lost to Follow-up|0|||
27580266|NCT02602288|80306886|FG001|12 Month Follow-up|Lost to Follow-up|4|||
27580267|NCT02602288|80306885|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
27580268|NCT02602288|80306886|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
27580269|NCT01775137|80306892|FG000|Overall Study|Death|1|||
27804952|NCT03070431|81117221|FG000|Overall Study|Withdrawal by Subject|2|||
27804953|NCT03070431|81117221|FG000|Overall Study|Lost to Follow-up|2|||
27804954|NCT02657356|81117222|FG000|Overall Study|Death|1|||
27804955|NCT02657356|81117223|FG001|Overall Study|Death|0|||
27804956|NCT02657356|81117222|FG000|Overall Study|Withdrawal by Subject|5|||
27804957|NCT02657356|81117223|FG001|Overall Study|Withdrawal by Subject|6|||
27804958|NCT02657356|81117222|FG000|Overall Study|Terminated by Sponsor|8|||
27804959|NCT02657356|81117223|FG001|Overall Study|Terminated by Sponsor|5|||
27804960|NCT02657356|81117222|FG000|Overall Study|Rolled over to EAP study|6|||
27804961|NCT02657356|81117223|FG001|Overall Study|Rolled over to EAP study|4|||
27804962|NCT00575328|81117225|FG000|Overall Study|Adverse Event|1|||
27804963|NCT00575328|81117226|FG001|Overall Study|Adverse Event|1|||
27804964|NCT00575328|81117225|FG000|Overall Study|Lost to Follow-up|2|||
27580270|NCT01775137|80306892|FG000|Overall Study|Protocol deviation|2|||
27580271|NCT01775137|80306892|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27580272|NCT01775137|80306892|FG000|Overall Study|Adverse Event|1|||
27580273|NCT01775137|80306892|FG000|Overall Study|Withdrawal by participants|5|||
27580274|NCT00887341|80306895|FG000|Overall Study|Refused treatment|1|||
27580275|NCT00887341|80306896|FG001|Overall Study|Refused treatment|0|||
27580276|NCT00887341|80306895|FG000|Overall Study|Withdrawal by Subject|1|||
27580277|NCT00887341|80306896|FG001|Overall Study|Withdrawal by Subject|1|||
27580278|NCT00887341|80306895|FG000|Overall Study|Adverse Event|0|||
27580279|NCT00887341|80306896|FG001|Overall Study|Adverse Event|1|||
27804965|NCT00575328|81117226|FG001|Overall Study|Lost to Follow-up|1|||
27804966|NCT01684722|81117227|FG000|Overall Study|Lost to Follow-up|78|||
27804967|NCT01684722|81117228|FG001|Overall Study|Lost to Follow-up|56|||
27804968|NCT01684722|81117229|FG002|Overall Study|Lost to Follow-up|75|||
27804969|NCT01684722|81117230|FG003|Overall Study|Lost to Follow-up|89|||
27804970|NCT01684722|81117227|FG000|Overall Study|Death|19|||
27804971|NCT01684722|81117228|FG001|Overall Study|Death|21|||
27580280|NCT00887341|80306895|FG000|Overall Study|Lost to Follow-up|0|||
27580281|NCT00887341|80306896|FG001|Overall Study|Lost to Follow-up|1|||
27804972|NCT01684722|81117229|FG002|Overall Study|Death|19|||
27580282|NCT01732835|80306897|FG000|6-month Primary Endpoint|Did not receive device|19|||
27580283|NCT01732835|80306897|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
27594319|NCT01786512|80352505|FG001|Overall Study|Death|0|||
27804973|NCT01684722|81117230|FG003|Overall Study|Death|21|||
27804974|NCT02437890|81117231|FG000|Overall Study|Non-compliance to study drug|0|||
27804975|NCT02437890|81117232|FG001|Overall Study|Non-compliance to study drug|1|||
27804976|NCT02437890|81117233|FG002|Overall Study|Non-compliance to study drug|0|||
27804977|NCT02437890|81117234|FG003|Overall Study|Non-compliance to study drug|0|||
27580284|NCT01732835|80306897|FG000|6-month Primary Endpoint|Adverse Event|3|||
27580285|NCT01732835|80306897|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
27580286|NCT01732835|80306897|FG000|2-year Extended Follow-up|Adverse Event|3|||
27580287|NCT01732835|80306897|FG000|2-year Extended Follow-up|Death|1|||
27580288|NCT01060384|80306898|FG000|Overall Study|Withdrawal by Subject|0|||
27580289|NCT01060384|80306899|FG001|Overall Study|Withdrawal by Subject|1|||
27580290|NCT01060384|80306900|FG002|Overall Study|Withdrawal by Subject|0|||
27580291|NCT01060384|80306901|FG003|Overall Study|Withdrawal by Subject|0|||
27580292|NCT01060384|80306902|FG004|Overall Study|Withdrawal by Subject|0|||
27580293|NCT01060384|80306898|FG000|Overall Study|Death|0|||
27804978|NCT02437890|81117235|FG004|Overall Study|Non-compliance to study drug|1|||
27804979|NCT02437890|81117231|FG000|Overall Study|Sponsor's decision|1|||
27804980|NCT02437890|81117232|FG001|Overall Study|Sponsor's decision|1|||
27804981|NCT02437890|81117233|FG002|Overall Study|Sponsor's decision|4|||
27804982|NCT02437890|81117234|FG003|Overall Study|Sponsor's decision|0|||
27804983|NCT02437890|81117235|FG004|Overall Study|Sponsor's decision|2|||
27804984|NCT02437890|81117231|FG000|Overall Study|Physician Decision|0|||
27804985|NCT02437890|81117232|FG001|Overall Study|Physician Decision|0|||
27804986|NCT02437890|81117233|FG002|Overall Study|Physician Decision|0|||
27804987|NCT02437890|81117234|FG003|Overall Study|Physician Decision|1|||
27804988|NCT02437890|81117235|FG004|Overall Study|Physician Decision|0|||
27804989|NCT02437890|81117231|FG000|Overall Study|Unable to attend visit(s)|1|||
27804990|NCT02437890|81117232|FG001|Overall Study|Unable to attend visit(s)|0|||
27804991|NCT02437890|81117233|FG002|Overall Study|Unable to attend visit(s)|0|||
27804992|NCT02437890|81117234|FG003|Overall Study|Unable to attend visit(s)|0|||
27804993|NCT02437890|81117235|FG004|Overall Study|Unable to attend visit(s)|0|||
27804994|NCT02437890|81117231|FG000|Overall Study|Lack of Efficacy|1|||
27804995|NCT02437890|81117232|FG001|Overall Study|Lack of Efficacy|3|||
27804996|NCT02437890|81117233|FG002|Overall Study|Lack of Efficacy|0|||
27804997|NCT02437890|81117234|FG003|Overall Study|Lack of Efficacy|3|||
27804998|NCT02437890|81117235|FG004|Overall Study|Lack of Efficacy|1|||
27804999|NCT02437890|81117231|FG000|Overall Study|Adverse Event|4|||
27805000|NCT02437890|81117232|FG001|Overall Study|Adverse Event|9|||
27805001|NCT02437890|81117233|FG002|Overall Study|Adverse Event|5|||
27805002|NCT02437890|81117234|FG003|Overall Study|Adverse Event|11|||
27805003|NCT02437890|81117235|FG004|Overall Study|Adverse Event|7|||
27805004|NCT02437890|81117231|FG000|Overall Study|Withdrawal by Subject|1|||
27805005|NCT02437890|81117232|FG001|Overall Study|Withdrawal by Subject|2|||
27805006|NCT02437890|81117233|FG002|Overall Study|Withdrawal by Subject|6|||
27805007|NCT02437890|81117234|FG003|Overall Study|Withdrawal by Subject|5|||
27805008|NCT02437890|81117235|FG004|Overall Study|Withdrawal by Subject|5|||
27805009|NCT02437890|81117231|FG000|Overall Study|Death|0|||
27805010|NCT02437890|81117232|FG001|Overall Study|Death|0|||
27805011|NCT02437890|81117233|FG002|Overall Study|Death|0|||
27805012|NCT02437890|81117234|FG003|Overall Study|Death|2|||
27805013|NCT02437890|81117235|FG004|Overall Study|Death|0|||
27805014|NCT01361607|81117236|FG000|Overall Study|Adverse Event|38|||
27805015|NCT01361607|81117237|FG001|Overall Study|Adverse Event|29|||
27805016|NCT01361607|81117236|FG000|Overall Study|Withdrawal by Subject|19|||
27805017|NCT01361607|81117237|FG001|Overall Study|Withdrawal by Subject|8|||
27805018|NCT01361607|81117236|FG000|Overall Study|Withdrawal by Investigator|5|||
27805019|NCT01361607|81117237|FG001|Overall Study|Withdrawal by Investigator|3|||
27805020|NCT01361607|81117236|FG000|Overall Study|Lost to Follow-up|1|||
27805021|NCT01361607|81117237|FG001|Overall Study|Lost to Follow-up|0|||
27805022|NCT01361607|81117236|FG000|Overall Study|Met Withdrawal Criteria|1|||
27872826|NCT02892331|81368282|FG001|Overall Study|Sick family member|0|||
27872827|NCT02892331|81368283|FG002|Overall Study|Sick family member|1|||
27872828|NCT02892331|81368281|FG000|Overall Study|Corona virus pandemic|1|||
27580294|NCT01060384|80306899|FG001|Overall Study|Death|0|||
27872829|NCT02892331|81368282|FG001|Overall Study|Corona virus pandemic|0|||
27872830|NCT02892331|81368283|FG002|Overall Study|Corona virus pandemic|1|||
27872831|NCT02892331|81368281|FG000|Overall Study|Lost to Follow-up|1|||
27580295|NCT01060384|80306900|FG002|Overall Study|Death|0|||
27580296|NCT01060384|80306901|FG003|Overall Study|Death|0|||
27805023|NCT01361607|81117237|FG001|Overall Study|Met Withdrawal Criteria|1|||
27805024|NCT03812679|81117239|FG000|Overall Study|Adverse Event|2|||
27805025|NCT03812679|81117239|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
27805026|NCT03812679|81117239|FG000|Overall Study|Renal transplant|1|||
27805027|NCT03812679|81117239|FG000|Overall Study|Withdrawal by Subject|1|||
27805028|NCT03812679|81117239|FG000|Overall Study|Termination of study|2|||
27805029|NCT03812679|81117239|FG000|Overall Study|Water device replacement|1|||
27805030|NCT01261325|81117247|FG000|Overall Study|Lack of Efficacy|1|||
27805031|NCT01261325|81117248|FG001|Overall Study|Lack of Efficacy|1|||
27805032|NCT01261325|81117249|FG002|Overall Study|Lack of Efficacy|0|||
27805033|NCT01261325|81117247|FG000|Overall Study|Withdrawal by Subject|2|||
27805034|NCT01261325|81117248|FG001|Overall Study|Withdrawal by Subject|2|||
27805035|NCT01261325|81117249|FG002|Overall Study|Withdrawal by Subject|4|||
27805036|NCT01261325|81117247|FG000|Overall Study|SAE, non-fatal|1|||
27680485|NCT02159040|80664600|FG000|Overall Study|Death|1|||
27680486|NCT02310100|80664601|FG000|Overall Study|Physician Decision|3|||
27680487|NCT02310100|80664601|FG000|Overall Study|Withdrawal by Subject|10|||
27680488|NCT02310100|80664601|FG000|Overall Study|Enrollment closure|1|||
27680489|NCT02310100|80664601|FG000|Overall Study|Unapproved ablation operator|1|||
27680490|NCT02310100|80664601|FG000|Overall Study|Visit compliance|1|||
27680491|NCT02310100|80664601|FG000|Overall Study|Lost to Follow-up|2|||
27680492|NCT05172050|80664604|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
27680493|NCT05172050|80664605|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
27872832|NCT02892331|81368282|FG001|Overall Study|Lost to Follow-up|0|||
27872833|NCT02892331|81368283|FG002|Overall Study|Lost to Follow-up|1|||
27872834|NCT02892331|81368281|FG000|Overall Study|Blood pressure was too elevated|0|||
27872835|NCT02892331|81368282|FG001|Overall Study|Blood pressure was too elevated|1|||
27872836|NCT02892331|81368283|FG002|Overall Study|Blood pressure was too elevated|0|||
27872837|NCT02892331|81368281|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
27872838|NCT02892331|81368282|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
27872839|NCT02892331|81368283|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
27872840|NCT02503540|81368286|FG000|Overall Study|Death|2|||
27680494|NCT05172050|80664606|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
27872841|NCT02503540|81368286|FG000|Overall Study|Withdrawal by Subject|1|||
27872842|NCT00595621|81368287|FG000|Open Label Run in|Adverse Event|1|||
27872843|NCT00595621|81368288|FG001|Open Label Run in|Adverse Event|0|||
27872844|NCT00595621|81368287|FG000|Open Label Run in|Physician Decision|1|||
27872845|NCT00595621|81368288|FG001|Open Label Run in|Physician Decision|0|||
27872846|NCT00595621|81368287|FG000|Open Label Run in|Withdrawal by Subject|1|||
27872847|NCT00595621|81368288|FG001|Open Label Run in|Withdrawal by Subject|0|||
27872848|NCT00595621|81368287|FG000|Randomization and Study|Adverse Event|2|||
27872849|NCT00595621|81368288|FG001|Randomization and Study|Adverse Event|0|||
27872850|NCT00595621|81368287|FG000|Randomization and Study|Withdrawal by Subject|0|||
27872851|NCT00595621|81368288|FG001|Randomization and Study|Withdrawal by Subject|1|||
27872852|NCT01214655|81368296|FG000|Part A|Progressive Disease|7|||
27872853|NCT01214655|81368297|FG001|Part A|Progressive Disease|0|||
27872854|NCT01214655|81368298|FG002|Part A|Progressive Disease|0|||
27872855|NCT01214655|81368296|FG000|Part A|Physician Decision|1|||
27872856|NCT01214655|81368297|FG001|Part A|Physician Decision|0|||
27805037|NCT01261325|81117248|FG001|Overall Study|SAE, non-fatal|5|||
27805038|NCT01261325|81117249|FG002|Overall Study|SAE, non-fatal|1|||
27805039|NCT01261325|81117247|FG000|Overall Study|AE, non-serious non-fatal|9|||
27805040|NCT01261325|81117248|FG001|Overall Study|AE, non-serious non-fatal|15|||
27805041|NCT01261325|81117249|FG002|Overall Study|AE, non-serious non-fatal|13|||
27805042|NCT01261325|81117247|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27805043|NCT01261325|81117248|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27805044|NCT01261325|81117249|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27805045|NCT01261325|81117247|FG000|Overall Study|Non Compliance|2|||
27805046|NCT01261325|81117248|FG001|Overall Study|Non Compliance|0|||
27805047|NCT01261325|81117249|FG002|Overall Study|Non Compliance|0|||
27805048|NCT01261325|81117247|FG000|Overall Study|Patient Randomized by Mistake|0|||
27805049|NCT01261325|81117248|FG001|Overall Study|Patient Randomized by Mistake|1|||
27805050|NCT01261325|81117249|FG002|Overall Study|Patient Randomized by Mistake|0|||
27805051|NCT01261325|81117247|FG000|Overall Study|Erroneously Randomized|1|||
27805052|NCT01261325|81117248|FG001|Overall Study|Erroneously Randomized|0|||
27805053|NCT01261325|81117249|FG002|Overall Study|Erroneously Randomized|0|||
27805054|NCT01261325|81117247|FG000|Overall Study|Screen Failure|1|||
27805055|NCT01261325|81117248|FG001|Overall Study|Screen Failure|0|||
27805056|NCT01261325|81117249|FG002|Overall Study|Screen Failure|0|||
27805057|NCT01261325|81117247|FG000|Overall Study|Randomized in Error|0|||
27805058|NCT01261325|81117248|FG001|Overall Study|Randomized in Error|0|||
27805059|NCT01261325|81117249|FG002|Overall Study|Randomized in Error|1|||
27872857|NCT01214655|81368298|FG002|Part A|Physician Decision|0|||
27872858|NCT01214655|81368296|FG000|Part B|Progressive disease|0|||
27872859|NCT01214655|81368297|FG001|Part B|Progressive disease|10|||
27872860|NCT01214655|81368298|FG002|Part B|Progressive disease|0|||
27680495|NCT05172050|80664604|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
27805060|NCT01261325|81117247|FG000|Overall Study|Protocol Violation|0|||
27805061|NCT01261325|81117248|FG001|Overall Study|Protocol Violation|3|||
27872861|NCT01214655|81368296|FG000|Part B|Death|0|||
27872862|NCT01214655|81368297|FG001|Part B|Death|1|||
27872863|NCT01214655|81368298|FG002|Part B|Death|0|||
27872864|NCT01214655|81368296|FG000|Part B|Withdrawal by Subject|0|||
27998130|NCT03081884|81823617|FG000|Overall Study|deferred prostate cancer treatment|1|||
27872865|NCT01214655|81368297|FG001|Part B|Withdrawal by Subject|2|||
27805062|NCT01261325|81117249|FG002|Overall Study|Protocol Violation|1|||
27805063|NCT01261325|81117247|FG000|Overall Study|Lost to Follow-up|0|||
27805064|NCT01261325|81117248|FG001|Overall Study|Lost to Follow-up|1|||
27805065|NCT01261325|81117249|FG002|Overall Study|Lost to Follow-up|3|||
27805066|NCT01261325|81117247|FG000|Overall Study|AE, serious fatal|0|||
27872866|NCT01214655|81368298|FG002|Part B|Withdrawal by Subject|0|||
27872867|NCT01214655|81368296|FG000|Part C|Progressive Disease|0|||
27872868|NCT01214655|81368297|FG001|Part C|Progressive Disease|0|||
27872869|NCT01214655|81368298|FG002|Part C|Progressive Disease|5|||
27872870|NCT01214655|81368296|FG000|Part C|Death|0|||
27805067|NCT01261325|81117248|FG001|Overall Study|AE, serious fatal|0|||
27805068|NCT01261325|81117249|FG002|Overall Study|AE, serious fatal|2|||
27805069|NCT00811070|81117252|FG000|Overall Study|Death|0|||
27805070|NCT00811070|81117253|FG001|Overall Study|Death|0|||
27805071|NCT00811070|81117254|FG002|Overall Study|Death|0|||
27805072|NCT00811070|81117255|FG003|Overall Study|Death|2|||
27805073|NCT00811070|81117256|FG004|Overall Study|Death|5|||
27805074|NCT00811070|81117257|FG005|Overall Study|Death|0|||
27580297|NCT01060384|80306902|FG004|Overall Study|Death|1|||
27580298|NCT01060384|80306898|FG000|Overall Study|Intercurrent illness|0|||
27580299|NCT01060384|80306899|FG001|Overall Study|Intercurrent illness|0|||
27580300|NCT01060384|80306900|FG002|Overall Study|Intercurrent illness|0|||
27580301|NCT01060384|80306901|FG003|Overall Study|Intercurrent illness|0|||
27580302|NCT01060384|80306902|FG004|Overall Study|Intercurrent illness|1|||
27580303|NCT00765245|80306906|FG000|Overall Study|disease progression|3|||
27580304|NCT00765245|80306907|FG001|Overall Study|disease progression|2|||
27580305|NCT00765245|80306906|FG000|Overall Study|Withdrawal by Subject|3|||
27805075|NCT00811070|81117252|FG000|Overall Study|Other|1|||
27805076|NCT00811070|81117253|FG001|Overall Study|Other|0|||
27805077|NCT00811070|81117254|FG002|Overall Study|Other|0|||
27872871|NCT01214655|81368297|FG001|Part C|Death|0|||
27872872|NCT01214655|81368298|FG002|Part C|Death|1|||
27872873|NCT01214655|81368296|FG000|Part C|Physician Decision|0|||
27872874|NCT01214655|81368297|FG001|Part C|Physician Decision|0|||
27872875|NCT01214655|81368298|FG002|Part C|Physician Decision|1|||
27872876|NCT02404805|81368299|FG000|Overall Study|Withdrawal by Subject|1|||
27872877|NCT02404805|81368300|FG001|Overall Study|Withdrawal by Subject|0|||
27872878|NCT02404805|81368301|FG002|Overall Study|Withdrawal by Subject|0|||
27872879|NCT02404805|81368302|FG003|Overall Study|Withdrawal by Subject|0|||
27872880|NCT02404805|81368303|FG004|Overall Study|Withdrawal by Subject|0|||
27872881|NCT02404805|81368304|FG005|Overall Study|Withdrawal by Subject|0|||
27872882|NCT01924689|81368305|FG000|Overall Study|Death|0|||
27805078|NCT00811070|81117255|FG003|Overall Study|Other|0|||
27805079|NCT00811070|81117256|FG004|Overall Study|Other|0|||
27805080|NCT00811070|81117257|FG005|Overall Study|Other|0|||
27805081|NCT00811070|81117252|FG000|Overall Study|Withdrawal by Subject|0|||
27872883|NCT01924689|81368306|FG001|Overall Study|Death|1|||
27872884|NCT01924689|81368307|FG002|Overall Study|Death|0|||
27872885|NCT01924689|81368308|FG003|Overall Study|Death|1|||
27580306|NCT00765245|80306907|FG001|Overall Study|Withdrawal by Subject|0|||
27805082|NCT00811070|81117253|FG001|Overall Study|Withdrawal by Subject|1|||
27805083|NCT00811070|81117254|FG002|Overall Study|Withdrawal by Subject|0|||
27872886|NCT01924689|81368309|FG004|Overall Study|Death|0|||
27872887|NCT01924689|81368310|FG005|Overall Study|Death|0|||
27580307|NCT00765245|80306906|FG000|Overall Study|Adverse Event|5|||
27580308|NCT00765245|80306907|FG001|Overall Study|Adverse Event|0|||
27580309|NCT00765245|80306906|FG000|Overall Study|Physician Decision|1|||
27580310|NCT00765245|80306907|FG001|Overall Study|Physician Decision|0|||
27580311|NCT00765245|80306906|FG000|Overall Study|Death|1|||
27680496|NCT05172050|80664605|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
27680497|NCT05172050|80664606|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
27872888|NCT01924689|81368305|FG000|Overall Study|Disease progression|0|||
27805084|NCT00811070|81117255|FG003|Overall Study|Withdrawal by Subject|0|||
27805085|NCT00811070|81117256|FG004|Overall Study|Withdrawal by Subject|0|||
27998131|NCT03081884|81823617|FG000|Overall Study|metastasis managed with systemic therapy|3|||
27998132|NCT01450761|81823618|FG000|Randomization|Subject no longer meets study criteria|1|||
27998133|NCT01450761|81823619|FG001|Randomization|Subject no longer meets study criteria|2|||
27998134|NCT01450761|81823618|FG000|Randomization|Withdrawal by Subject|2|||
27998135|NCT01450761|81823619|FG001|Randomization|Withdrawal by Subject|0|||
27998136|NCT01450761|81823618|FG000|Randomization|Disease progression|0|||
27998137|NCT01450761|81823619|FG001|Randomization|Disease progression|2|||
27998138|NCT01450761|81823618|FG000|Randomization|Adverse Event unrelated to study drug|1|||
27680498|NCT05172050|80664604|FG000|Overall Study|Other|2|||
27680499|NCT05172050|80664605|FG001|Overall Study|Other|2|||
27680500|NCT05172050|80664606|FG002|Overall Study|Other|1|||
27680501|NCT01305408|80664609|FG000|Overall Study|Adverse Event|10|||
27680502|NCT01305408|80664610|FG001|Overall Study|Adverse Event|7|||
27680503|NCT01305408|80664609|FG000|Overall Study|Lack of Efficacy|3|||
27680504|NCT01305408|80664610|FG001|Overall Study|Lack of Efficacy|4|||
27680505|NCT01305408|80664609|FG000|Overall Study|Withdrawal by Subject|9|||
27680506|NCT01305408|80664610|FG001|Overall Study|Withdrawal by Subject|9|||
27680507|NCT01305408|80664609|FG000|Overall Study|Protocol Violation|4|||
27680508|NCT01305408|80664610|FG001|Overall Study|Protocol Violation|6|||
27680509|NCT01305408|80664609|FG000|Overall Study|Lost to Follow-up|5|||
27680510|NCT01305408|80664610|FG001|Overall Study|Lost to Follow-up|3|||
27805086|NCT00811070|81117257|FG005|Overall Study|Withdrawal by Subject|0|||
27805087|NCT00811070|81117252|FG000|Overall Study|Physician Decision|0|||
27805088|NCT00811070|81117253|FG001|Overall Study|Physician Decision|0|||
27805089|NCT00811070|81117254|FG002|Overall Study|Physician Decision|0|||
27805090|NCT00811070|81117255|FG003|Overall Study|Physician Decision|0|||
27998139|NCT01450761|81823619|FG001|Randomization|Adverse Event unrelated to study drug|0|||
27998140|NCT01450761|81823618|FG000|Randomization|Other|0|||
27998141|NCT01450761|81823619|FG001|Randomization|Other|1|||
27998142|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Disease progression|33|||
27998143|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Disease progression|32|||
27805091|NCT00811070|81117256|FG004|Overall Study|Physician Decision|0|||
27998144|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
27998145|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
27998146|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
27998147|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
27805092|NCT00811070|81117257|FG005|Overall Study|Physician Decision|1|||
27805093|NCT03835975|81117258|FG000|Overall Study|Lost to Follow-up|1|||
27805094|NCT03835975|81117259|FG001|Overall Study|Lost to Follow-up|1|||
27805095|NCT03835975|81117260|FG002|Overall Study|Lost to Follow-up|0|||
27805096|NCT03835975|81117261|FG003|Overall Study|Lost to Follow-up|0|||
27805097|NCT03835975|81117262|FG004|Overall Study|Lost to Follow-up|0|||
27998148|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
27998149|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
27998150|NCT01450761|81823618|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
27998151|NCT01450761|81823619|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
27998152|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Death|3|||
27998153|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Death|3|||
27998154|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Other|2|||
27998155|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Other|2|||
27872889|NCT01924689|81368306|FG001|Overall Study|Disease progression|0|||
27872890|NCT01924689|81368307|FG002|Overall Study|Disease progression|2|||
27872891|NCT01924689|81368308|FG003|Overall Study|Disease progression|0|||
27680511|NCT01305408|80664609|FG000|Overall Study|Noncompliance with study medication|0|||
27680512|NCT01305408|80664610|FG001|Overall Study|Noncompliance with study medication|1|||
27680513|NCT01305408|80664609|FG000|Overall Study|Noncompliance with study procedures|0|||
27872892|NCT01924689|81368309|FG004|Overall Study|Disease progression|3|||
27872893|NCT01924689|81368310|FG005|Overall Study|Disease progression|2|||
27872894|NCT01924689|81368305|FG000|Overall Study|New therapy or study|3|||
27580312|NCT00765245|80306907|FG001|Overall Study|Death|0|||
27580313|NCT01163682|80306908|FG000|Overall Study|Lost to Follow-up|6|||
27805098|NCT03835975|81117258|FG000|Overall Study|No longer met eligibility criteria|0|||
27805099|NCT03835975|81117259|FG001|Overall Study|No longer met eligibility criteria|1|||
27805100|NCT03835975|81117260|FG002|Overall Study|No longer met eligibility criteria|0|||
27580314|NCT01163682|80306909|FG001|Overall Study|Lost to Follow-up|9|||
27580315|NCT04982029|80306910|FG000|Overall Study|Lost to Follow-up|2|||
27580316|NCT04982029|80306911|FG001|Overall Study|Lost to Follow-up|3|||
27580317|NCT02443298|80309837|FG000|Overall Study|Adverse Event|3|||
27580318|NCT02443298|80309838|FG001|Overall Study|Adverse Event|3|||
27580319|NCT02443298|80309837|FG000|Overall Study|Withdrawal by Subject|1|||
27872895|NCT01924689|81368306|FG001|Overall Study|New therapy or study|2|||
27872896|NCT01924689|81368307|FG002|Overall Study|New therapy or study|1|||
27872897|NCT01924689|81368308|FG003|Overall Study|New therapy or study|4|||
27872898|NCT01924689|81368309|FG004|Overall Study|New therapy or study|2|||
27680514|NCT01305408|80664610|FG001|Overall Study|Noncompliance with study procedures|1|||
27580320|NCT02443298|80309838|FG001|Overall Study|Withdrawal by Subject|2|||
27580321|NCT02461589|80309839|FG000|Overall Study|Withdrawal by Subject|5|||
27872899|NCT01924689|81368310|FG005|Overall Study|New therapy or study|0|||
27872900|NCT01924689|81368305|FG000|Overall Study|Withdrawal of consent|0|||
27872901|NCT01924689|81368306|FG001|Overall Study|Withdrawal of consent|0|||
27872902|NCT01924689|81368307|FG002|Overall Study|Withdrawal of consent|1|||
27872903|NCT01924689|81368308|FG003|Overall Study|Withdrawal of consent|1|||
27998156|NCT01450761|81823618|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
27998157|NCT01450761|81823619|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
27998158|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
27998159|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
27998160|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
27998161|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
27998162|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
27680515|NCT01305408|80664609|FG000|Overall Study|Other|1|||
27680516|NCT01305408|80664610|FG001|Overall Study|Other|0|||
27680517|NCT00264303|80664611|FG000|Overall Study|Adverse Event|4|||
27680518|NCT00264303|80664612|FG001|Overall Study|Adverse Event|3|||
27680519|NCT00264303|80664611|FG000|Overall Study|Lack of Efficacy|10|||
27580322|NCT02461589|80309840|FG001|Overall Study|Withdrawal by Subject|1|||
27580323|NCT02461589|80309841|FG002|Overall Study|Withdrawal by Subject|3|||
27580324|NCT02461589|80309842|FG003|Overall Study|Withdrawal by Subject|2|||
27580325|NCT02461589|80309843|FG004|Overall Study|Withdrawal by Subject|1|||
27580326|NCT02461589|80309844|FG005|Overall Study|Withdrawal by Subject|2|||
27580327|NCT02461589|80309845|FG006|Overall Study|Withdrawal by Subject|1|||
27680520|NCT00264303|80664612|FG001|Overall Study|Lack of Efficacy|13|||
27998163|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
27680521|NCT00264303|80664611|FG000|Overall Study|Lost to Follow-up|3|||
27580328|NCT02461589|80309846|FG007|Overall Study|Withdrawal by Subject|3|||
27998164|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
27998165|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
27580329|NCT02461589|80309847|FG008|Overall Study|Withdrawal by Subject|3|||
27998166|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
27998167|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
27998168|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Death|5|||
27998169|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Death|6|||
27998170|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
27998171|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
27998172|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
27998173|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
27998174|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
27998175|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
27998176|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
27998177|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
27998178|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
27998179|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
27998180|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
27998181|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
27998182|NCT01450761|81823618|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
27998183|NCT01450761|81823619|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
27998184|NCT01687296|81823620|FG000|Overall Study|Lack of Efficacy|1|||
27998185|NCT01687296|81823621|FG001|Overall Study|Lack of Efficacy|1|||
27998186|NCT01687296|81823620|FG000|Overall Study|Protocol Violation|0|||
27998187|NCT01687296|81823621|FG001|Overall Study|Protocol Violation|1|||
27998188|NCT01687296|81823620|FG000|Overall Study|Withdrawal by Subject|6|||
27998189|NCT01687296|81823621|FG001|Overall Study|Withdrawal by Subject|3|||
27998190|NCT02294058|81823624|FG000|Overall Study|Adverse Event|16|||
27998191|NCT02294058|81823625|FG001|Overall Study|Adverse Event|7|||
27580330|NCT02461589|80309848|FG009|Overall Study|Withdrawal by Subject|1|||
27998192|NCT02294058|81823626|FG002|Overall Study|Adverse Event|13|||
27998193|NCT02294058|81823624|FG000|Overall Study|Lack of Efficacy|3|||
27998194|NCT02294058|81823625|FG001|Overall Study|Lack of Efficacy|3|||
27998195|NCT02294058|81823626|FG002|Overall Study|Lack of Efficacy|0|||
27998196|NCT02294058|81823624|FG000|Overall Study|Lost to Follow-up|1|||
27998197|NCT02294058|81823625|FG001|Overall Study|Lost to Follow-up|0|||
27998198|NCT02294058|81823626|FG002|Overall Study|Lost to Follow-up|2|||
27998199|NCT02294058|81823624|FG000|Overall Study|Withdrawal by Subject|10|||
27998200|NCT02294058|81823625|FG001|Overall Study|Withdrawal by Subject|14|||
27998201|NCT02294058|81823626|FG002|Overall Study|Withdrawal by Subject|13|||
27998202|NCT02294058|81823624|FG000|Overall Study|Physician Decision|2|||
27998203|NCT02294058|81823625|FG001|Overall Study|Physician Decision|1|||
27998204|NCT02294058|81823626|FG002|Overall Study|Physician Decision|0|||
27998205|NCT02294058|81823624|FG000|Overall Study|Miscellaneous|4|||
27998206|NCT02294058|81823625|FG001|Overall Study|Miscellaneous|1|||
27998207|NCT02294058|81823626|FG002|Overall Study|Miscellaneous|1|||
27998208|NCT04854551|81823631|FG000|Overall Study|Withdrawal by Subject|1|||
27998209|NCT04854551|81823632|FG001|Overall Study|Withdrawal by Subject|1|||
27998210|NCT02219334|81823633|FG000|Overall Study|Withdrawal by Subject|1|||
27998211|NCT02219334|81823634|FG001|Overall Study|Withdrawal by Subject|0|||
27998212|NCT02219334|81823633|FG000|Overall Study|Protocol Violation|7|||
27998213|NCT02219334|81823634|FG001|Overall Study|Protocol Violation|3|||
27998214|NCT04050618|81823639|FG000|First Intervention|Withdrawal by Subject|2|||
27998215|NCT04050618|81823640|FG001|First Intervention|Withdrawal by Subject|0|||
27998216|NCT04050618|81823639|FG000|Second Intervention|Withdrawal by Subject|1|||
27998217|NCT04050618|81823640|FG001|Second Intervention|Withdrawal by Subject|0|||
27998218|NCT01496469|81823641|FG000|Overall Study|Adverse Event|1|||
27998219|NCT01496469|81823642|FG001|Overall Study|Adverse Event|0|||
27998220|NCT01496469|81823641|FG000|Overall Study|Protocol Violation|2|||
27998221|NCT01496469|81823642|FG001|Overall Study|Protocol Violation|0|||
27998222|NCT01496469|81823641|FG000|Overall Study|Lost to Follow-up|1|||
27998223|NCT01496469|81823642|FG001|Overall Study|Lost to Follow-up|1|||
27998224|NCT01496469|81823641|FG000|Overall Study|Withdrawal by Subject|4|||
27998225|NCT01496469|81823642|FG001|Overall Study|Withdrawal by Subject|4|||
27998226|NCT01496469|81823641|FG000|Overall Study|BP exceeds protocol limits|1|||
27998227|NCT01496469|81823642|FG001|Overall Study|BP exceeds protocol limits|2|||
27998228|NCT01496469|81823641|FG000|Overall Study|Other|1|||
27998229|NCT01496469|81823642|FG001|Overall Study|Other|1|||
27998230|NCT03828617|81823643|FG000|Overall Study|Lost to Follow-up|22|||
27998231|NCT03828617|81823644|FG001|Overall Study|Lost to Follow-up|12|||
27580331|NCT02461589|80309839|FG000|Overall Study|Lost to Follow-up|0|||
27998232|NCT03828617|81823645|FG002|Overall Study|Lost to Follow-up|23|||
27998233|NCT03828617|81823646|FG003|Overall Study|Lost to Follow-up|7|||
27998234|NCT03828617|81823643|FG000|Overall Study|No longer met eligibility criteria|0|||
27998235|NCT03828617|81823644|FG001|Overall Study|No longer met eligibility criteria|1|||
27998236|NCT03828617|81823645|FG002|Overall Study|No longer met eligibility criteria|1|||
27998237|NCT03828617|81823646|FG003|Overall Study|No longer met eligibility criteria|3|||
27998238|NCT03828617|81823643|FG000|Overall Study|Protocol Violation|0|||
27998239|NCT03828617|81823644|FG001|Overall Study|Protocol Violation|2|||
27998240|NCT03828617|81823645|FG002|Overall Study|Protocol Violation|0|||
27998241|NCT03828617|81823646|FG003|Overall Study|Protocol Violation|0|||
27998242|NCT03828617|81823643|FG000|Overall Study|Withdrawal by Subject|2|||
27998243|NCT03828617|81823644|FG001|Overall Study|Withdrawal by Subject|0|||
27998244|NCT03828617|81823645|FG002|Overall Study|Withdrawal by Subject|2|||
27998245|NCT03828617|81823646|FG003|Overall Study|Withdrawal by Subject|0|||
27998246|NCT02640547|81823660|FG000|Overall Study|Failure to Return|1|||
27998247|NCT02640547|81823660|FG000|Overall Study|Withdrawal by Subject|1|||
27998248|NCT02640547|81823660|FG000|Overall Study|Death|6|||
27998249|NCT02640547|81823660|FG000|Overall Study|Miscellaneous|3|||
27998250|NCT01362608|81823671|FG000|Overall Study|Protocol Violation|0|||
27998251|NCT01362608|81823672|FG001|Overall Study|Protocol Violation|1|||
27998252|NCT01362608|81823671|FG000|Overall Study|Lost to Follow-up|3|||
27998253|NCT01362608|81823672|FG001|Overall Study|Lost to Follow-up|1|||
27998254|NCT01362608|81823671|FG000|Overall Study|Withdrawal by Subject|1|||
27998255|NCT01362608|81823672|FG001|Overall Study|Withdrawal by Subject|2|||
27998256|NCT01362608|81823671|FG000|Overall Study|Lack of Efficacy|0|||
27998257|NCT01362608|81823672|FG001|Overall Study|Lack of Efficacy|2|||
27998258|NCT01362608|81823671|FG000|Overall Study|Adverse Event|0|||
27998259|NCT01362608|81823672|FG001|Overall Study|Adverse Event|2|||
27998260|NCT03826186|81823673|FG000|Overall Study|Protocol Violation|2|||
27998261|NCT03826186|81823674|FG001|Overall Study|Protocol Violation|0|||
27998262|NCT03826186|81823673|FG000|Overall Study|Withdrawal by Subject|1|||
27998263|NCT03826186|81823674|FG001|Overall Study|Withdrawal by Subject|0|||
27998264|NCT04112303|81823675|FG000|Overall Study|Death|1|||
27998265|NCT04950465|81823676|FG000|Overall Study|Lost to Follow-up|1|||
27998266|NCT04950465|81823677|FG001|Overall Study|Lost to Follow-up|0|||
27998267|NCT04950465|81823678|FG002|Overall Study|Lost to Follow-up|0|||
27998268|NCT03329846|81823681|FG000|Overall Study|Disease progression|4|||
27998269|NCT03329846|81823682|FG001|Overall Study|Disease progression|6|||
27998270|NCT03329846|81823681|FG000|Overall Study|Study drug toxicity|1|||
27998271|NCT03329846|81823682|FG001|Overall Study|Study drug toxicity|0|||
27998272|NCT03329846|81823681|FG000|Overall Study|Participant request to discontinue treatment|0|||
27998273|NCT03329846|81823682|FG001|Overall Study|Participant request to discontinue treatment|1|||
27998274|NCT03329846|81823681|FG000|Overall Study|Participant withdrew consent|1|||
27998275|NCT03329846|81823682|FG001|Overall Study|Participant withdrew consent|0|||
27998276|NCT03329846|81823681|FG000|Overall Study|Other reasons|2|||
27998277|NCT03329846|81823682|FG001|Overall Study|Other reasons|2|||
27998278|NCT02634333|81823687|FG000|Overall Study|Completed out of Window|3|||
27998279|NCT02634333|81823688|FG001|Overall Study|Completed out of Window|2|||
27998280|NCT02634333|81823687|FG000|Overall Study|Missed Visit|5|||
27998281|NCT02634333|81823688|FG001|Overall Study|Missed Visit|2|||
27998282|NCT02634333|81823687|FG000|Overall Study|Lost to Follow-up|12|||
27998283|NCT02634333|81823688|FG001|Overall Study|Lost to Follow-up|7|||
27998284|NCT02634333|81823687|FG000|Overall Study|Withdrawal by Subject|9|||
27998285|NCT02634333|81823688|FG001|Overall Study|Withdrawal by Subject|13|||
27998286|NCT02634333|81823687|FG000|Overall Study|Death|11|||
27998287|NCT02634333|81823688|FG001|Overall Study|Death|8|||
27998288|NCT00462306|81823689|FG000|Overall Study|insufficient data|0|||
27998289|NCT00462306|81823690|FG001|Overall Study|insufficient data|13|||
27998290|NCT02517541|81823695|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
27998291|NCT02517541|81823695|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
27998292|NCT02517541|81823695|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
27998293|NCT02517541|81823695|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
27998294|NCT02517541|81823695|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
27998295|NCT02517541|81823695|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
27998296|NCT00154297|81823696|FG000|Overall Study|Death|5|||
27998297|NCT00154297|81823697|FG001|Overall Study|Death|2|||
27580332|NCT02461589|80309840|FG001|Overall Study|Lost to Follow-up|0|||
27998298|NCT00154297|81823696|FG000|Overall Study|Withdrawal by Subject|0|||
27998299|NCT00154297|81823697|FG001|Overall Study|Withdrawal by Subject|5|||
27998300|NCT00154297|81823696|FG000|Overall Study|Lost to Follow-up|3|||
27998301|NCT00154297|81823697|FG001|Overall Study|Lost to Follow-up|0|||
27998302|NCT03980730|81823698|FG000|Overall Study|Study Terminated by Sponsor|0|||
27998303|NCT03980730|81823699|FG001|Overall Study|Study Terminated by Sponsor|3|||
27998304|NCT03980730|81823698|FG000|Overall Study|Adverse Event|2|||
27998305|NCT03980730|81823699|FG001|Overall Study|Adverse Event|0|||
27998306|NCT03980730|81823698|FG000|Overall Study|Sponsor Request|0|||
27998307|NCT03980730|81823699|FG001|Overall Study|Sponsor Request|1|||
27998308|NCT02910466|81823702|FG000|Overall Study|Adverse Event|1|||
27998309|NCT02910466|81823702|FG000|Overall Study|Withdrawal by Subject|3|||
27998310|NCT02910466|81823702|FG000|Overall Study|Lost to Follow-up|5|||
27998311|NCT02910466|81823702|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
27998312|NCT02910466|81823702|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
27998313|NCT01125800|81823703|FG000|Phase I|Protocol Violation|0|||
27998314|NCT01125800|81823704|FG001|Phase I|Protocol Violation|3|||
27998315|NCT01125800|81823705|FG002|Phase I|Protocol Violation|1|||
27998316|NCT01125800|81823706|FG003|Phase I|Protocol Violation|1|||
27998317|NCT01125800|81823707|FG004|Phase I|Protocol Violation|0|||
27998318|NCT01125800|81823703|FG000|Phase I|Adverse Event|2|||
27998319|NCT01125800|81823704|FG001|Phase I|Adverse Event|2|||
27998320|NCT01125800|81823705|FG002|Phase I|Adverse Event|1|||
27998321|NCT01125800|81823706|FG003|Phase I|Adverse Event|7|||
27998322|NCT01125800|81823707|FG004|Phase I|Adverse Event|0|||
27998323|NCT01125800|81823703|FG000|Phase I|Administrative problems|1|||
27998324|NCT01125800|81823704|FG001|Phase I|Administrative problems|0|||
27998325|NCT01125800|81823705|FG002|Phase I|Administrative problems|0|||
27998326|NCT01125800|81823706|FG003|Phase I|Administrative problems|0|||
27998327|NCT01125800|81823707|FG004|Phase I|Administrative problems|0|||
27998328|NCT01125800|81823703|FG000|Phase I|Withdrawal by Subject|0|||
27998329|NCT01125800|81823704|FG001|Phase I|Withdrawal by Subject|0|||
27998330|NCT01125800|81823705|FG002|Phase I|Withdrawal by Subject|1|||
27998331|NCT01125800|81823706|FG003|Phase I|Withdrawal by Subject|0|||
27998332|NCT01125800|81823707|FG004|Phase I|Withdrawal by Subject|0|||
27998333|NCT01125800|81823703|FG000|Phase I|Disease progression|5|||
27998334|NCT01125800|81823704|FG001|Phase I|Disease progression|4|||
27998335|NCT01125800|81823705|FG002|Phase I|Disease progression|1|||
27998336|NCT01125800|81823706|FG003|Phase I|Disease progression|3|||
27998337|NCT01125800|81823707|FG004|Phase I|Disease progression|0|||
27998338|NCT01125800|81823703|FG000|Phase II|Protocol Violation|0|||
27998339|NCT01125800|81823704|FG001|Phase II|Protocol Violation|0|||
27998340|NCT01125800|81823705|FG002|Phase II|Protocol Violation|0|||
27998341|NCT01125800|81823706|FG003|Phase II|Protocol Violation|0|||
27998342|NCT01125800|81823707|FG004|Phase II|Protocol Violation|1|||
27998343|NCT01125800|81823703|FG000|Phase II|Adverse Event|0|||
27998344|NCT01125800|81823704|FG001|Phase II|Adverse Event|0|||
27998345|NCT01125800|81823705|FG002|Phase II|Adverse Event|0|||
27998346|NCT01125800|81823706|FG003|Phase II|Adverse Event|0|||
27998347|NCT01125800|81823707|FG004|Phase II|Adverse Event|2|||
27998348|NCT01125800|81823703|FG000|Phase II|Disease progression|0|||
27998349|NCT01125800|81823704|FG001|Phase II|Disease progression|0|||
27998350|NCT01125800|81823705|FG002|Phase II|Disease progression|0|||
27998351|NCT01125800|81823706|FG003|Phase II|Disease progression|1|||
27998352|NCT01125800|81823707|FG004|Phase II|Disease progression|8|||
27998353|NCT00570310|81823708|FG000|Overall Study|Adverse Event|1|||
27998354|NCT00570310|81823709|FG001|Overall Study|Adverse Event|2|||
27998355|NCT00570310|81823708|FG000|Overall Study|Lack of Efficacy|1|||
27998356|NCT00570310|81823709|FG001|Overall Study|Lack of Efficacy|4|||
27998357|NCT04628780|81823710|FG000|Overall Study|Death|0|||
27998358|NCT04628780|81823711|FG001|Overall Study|Death|1|||
27998359|NCT04628780|81823712|FG002|Overall Study|Death|0|||
27998360|NCT04628780|81823713|FG003|Overall Study|Death|0|||
27998361|NCT04628780|81823714|FG004|Overall Study|Death|1|||
27998362|NCT04628780|81823715|FG005|Overall Study|Death|0|||
27998363|NCT04628780|81823710|FG000|Overall Study|Physician Decision|2|||
27998364|NCT04628780|81823711|FG001|Overall Study|Physician Decision|0|||
27998365|NCT04628780|81823712|FG002|Overall Study|Physician Decision|0|||
27998366|NCT04628780|81823713|FG003|Overall Study|Physician Decision|0|||
27998367|NCT04628780|81823714|FG004|Overall Study|Physician Decision|2|||
27998368|NCT04628780|81823715|FG005|Overall Study|Physician Decision|0|||
27998369|NCT04628780|81823710|FG000|Overall Study|Progressive disease|2|||
27998370|NCT04628780|81823711|FG001|Overall Study|Progressive disease|2|||
27998371|NCT04628780|81823712|FG002|Overall Study|Progressive disease|2|||
27998372|NCT04628780|81823713|FG003|Overall Study|Progressive disease|3|||
27998373|NCT04628780|81823714|FG004|Overall Study|Progressive disease|9|||
27998374|NCT04628780|81823715|FG005|Overall Study|Progressive disease|4|||
27998375|NCT04628780|81823710|FG000|Overall Study|Withdrawal by Subject|0|||
27998376|NCT04628780|81823711|FG001|Overall Study|Withdrawal by Subject|1|||
27998377|NCT04628780|81823712|FG002|Overall Study|Withdrawal by Subject|2|||
27998378|NCT04628780|81823713|FG003|Overall Study|Withdrawal by Subject|0|||
27998379|NCT04628780|81823714|FG004|Overall Study|Withdrawal by Subject|3|||
27998380|NCT04628780|81823715|FG005|Overall Study|Withdrawal by Subject|1|||
27998381|NCT04628780|81823710|FG000|Overall Study|Global deterioration of health status|0|||
27998382|NCT04628780|81823711|FG001|Overall Study|Global deterioration of health status|0|||
27998383|NCT04628780|81823712|FG002|Overall Study|Global deterioration of health status|0|||
27998384|NCT04628780|81823713|FG003|Overall Study|Global deterioration of health status|0|||
27998385|NCT04628780|81823714|FG004|Overall Study|Global deterioration of health status|1|||
27998386|NCT04628780|81823715|FG005|Overall Study|Global deterioration of health status|1|||
27998387|NCT02680665|81823717|FG000|Overall Study|No visit after the first prescription|5|||
27998388|NCT01200368|81823718|FG000|Infant Series|Adverse Event|2|||
27998389|NCT01200368|81823719|FG001|Infant Series|Adverse Event|2|||
27998390|NCT01200368|81823720|FG002|Infant Series|Adverse Event|3|||
27998391|NCT01200368|81823718|FG000|Infant Series|Withdrawal by Subject|0|||
27998392|NCT01200368|81823719|FG001|Infant Series|Withdrawal by Subject|2|||
27998393|NCT01200368|81823720|FG002|Infant Series|Withdrawal by Subject|2|||
27998394|NCT01200368|81823718|FG000|Infant Series|Did not meet entrance criteria|0|||
27998395|NCT01200368|81823719|FG001|Infant Series|Did not meet entrance criteria|1|||
27998396|NCT01200368|81823720|FG002|Infant Series|Did not meet entrance criteria|0|||
27998397|NCT01200368|81823718|FG000|Infant Series|Randomized, not vaccinated|0|||
27998398|NCT01200368|81823719|FG001|Infant Series|Randomized, not vaccinated|1|||
27998399|NCT01200368|81823720|FG002|Infant Series|Randomized, not vaccinated|1|||
27998400|NCT01200368|81823718|FG000|Infant Series|Other|1|||
27998401|NCT01200368|81823719|FG001|Infant Series|Other|0|||
27998402|NCT01200368|81823720|FG002|Infant Series|Other|0|||
27998403|NCT01200368|81823718|FG000|After Infant Series|Adverse Event|6|||
27998404|NCT01200368|81823719|FG001|After Infant Series|Adverse Event|6|||
27998405|NCT01200368|81823720|FG002|After Infant Series|Adverse Event|3|||
27998406|NCT01200368|81823718|FG000|After Infant Series|Withdrawal by Subject|10|||
27998407|NCT01200368|81823719|FG001|After Infant Series|Withdrawal by Subject|8|||
27998408|NCT01200368|81823720|FG002|After Infant Series|Withdrawal by Subject|4|||
27998409|NCT01200368|81823718|FG000|After Infant Series|Lost to Follow-up|1|||
27998410|NCT01200368|81823719|FG001|After Infant Series|Lost to Follow-up|0|||
27998411|NCT01200368|81823720|FG002|After Infant Series|Lost to Follow-up|0|||
27998412|NCT01200368|81823718|FG000|After Infant Series|Other|1|||
27998413|NCT01200368|81823719|FG001|After Infant Series|Other|2|||
27998414|NCT01200368|81823720|FG002|After Infant Series|Other|2|||
27998415|NCT01200368|81823718|FG000|Toddler Dose|Adverse Event|0|||
27998416|NCT01200368|81823719|FG001|Toddler Dose|Adverse Event|3|||
27998417|NCT01200368|81823720|FG002|Toddler Dose|Adverse Event|1|||
27998418|NCT02330055|81823723|FG000|Overall Study|technical issues|2|||
27998419|NCT02330055|81823724|FG001|Overall Study|technical issues|0|||
27998420|NCT02330055|81823723|FG000|Overall Study|participant forgot to wear device|5|||
27998421|NCT02330055|81823724|FG001|Overall Study|participant forgot to wear device|5|||
27998422|NCT02330055|81823723|FG000|Overall Study|data for less than 60 minutes|3|||
27998423|NCT02330055|81823724|FG001|Overall Study|data for less than 60 minutes|3|||
27998424|NCT02330055|81823723|FG000|Overall Study|participant did not sleep|0|||
27998425|NCT02330055|81823724|FG001|Overall Study|participant did not sleep|1|||
27998426|NCT00700713|81823732|FG000|Overall Study|Protocol Violation|1|||
27998427|NCT00700713|81823733|FG001|Overall Study|Protocol Violation|0|||
27998428|NCT00700713|81823734|FG002|Overall Study|Protocol Violation|1|||
27998429|NCT00700713|81823732|FG000|Overall Study|Withdrawal by Subject|0|||
27998430|NCT00700713|81823733|FG001|Overall Study|Withdrawal by Subject|0|||
27998431|NCT00700713|81823734|FG002|Overall Study|Withdrawal by Subject|1|||
27998432|NCT03571204|81823735|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
27998433|NCT03571204|81823736|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
27998434|NCT03571204|81823737|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
27998435|NCT03571204|81823735|FG000|Overall Study|Physician Decision|0|||
27998436|NCT03571204|81823736|FG001|Overall Study|Physician Decision|1|||
27998437|NCT03571204|81823737|FG002|Overall Study|Physician Decision|0|||
27998438|NCT01358825|81823738|FG000|Overall Study|Blood sample not drawn|0|||
27998439|NCT01358825|81823739|FG001|Overall Study|Blood sample not drawn|1|||
27998440|NCT02003534|81823740|FG000|Overall Study|Lost to Follow-up|47|||
27998441|NCT02342223|81823741|FG000|Overall Study|Lost to Follow-up|1|||
27998442|NCT00836186|81823745|FG000|Overall Study|Blood could not be drawn|1|||
27998443|NCT01594931|81823746|FG000|Overall Study|Adverse Event|3|||
27998444|NCT01594931|81823747|FG001|Overall Study|Adverse Event|1|||
27998445|NCT01594931|81823748|FG002|Overall Study|Adverse Event|1|||
27998446|NCT01594931|81823746|FG000|Overall Study|Withdrawal by Subject|2|||
27998447|NCT01594931|81823747|FG001|Overall Study|Withdrawal by Subject|1|||
27998448|NCT01594931|81823748|FG002|Overall Study|Withdrawal by Subject|1|||
27998449|NCT01594931|81823746|FG000|Overall Study|Lack of Efficacy|7|||
27998450|NCT01594931|81823747|FG001|Overall Study|Lack of Efficacy|2|||
27998451|NCT01594931|81823748|FG002|Overall Study|Lack of Efficacy|2|||
27998452|NCT01594931|81823746|FG000|Overall Study|Lost to Follow-up|4|||
27998453|NCT01594931|81823747|FG001|Overall Study|Lost to Follow-up|3|||
27998454|NCT01594931|81823748|FG002|Overall Study|Lost to Follow-up|3|||
27998455|NCT01594931|81823746|FG000|Overall Study|Protocol Violation|2|||
27998456|NCT01594931|81823747|FG001|Overall Study|Protocol Violation|1|||
27998457|NCT01594931|81823748|FG002|Overall Study|Protocol Violation|0|||
27998458|NCT01594931|81823746|FG000|Overall Study|No defiined|11|||
27998459|NCT01594931|81823747|FG001|Overall Study|No defiined|4|||
27998460|NCT01594931|81823748|FG002|Overall Study|No defiined|7|||
27998461|NCT02370420|81823749|FG000|Overall Study|Physician Decision|3|||
27680522|NCT00264303|80664612|FG001|Overall Study|Lost to Follow-up|3|||
27680523|NCT00264303|80664611|FG000|Overall Study|Withdrawal by Subject|2|||
27680524|NCT00264303|80664612|FG001|Overall Study|Withdrawal by Subject|3|||
27680525|NCT00264303|80664611|FG000|Overall Study|Various reasons listed in study report|6|||
27680526|NCT00264303|80664612|FG001|Overall Study|Various reasons listed in study report|7|||
27680527|NCT01827046|80664619|FG000|Overall Study|Lost to Follow-up|1|||
27680528|NCT01827046|80664620|FG001|Overall Study|Lost to Follow-up|5|||
27680529|NCT01827046|80664619|FG000|Overall Study|Withdrawal by Subject|0|||
27680530|NCT01827046|80664620|FG001|Overall Study|Withdrawal by Subject|4|||
27680531|NCT00755105|80664627|FG000|Overall Study|Withdrawal by Subject|9|||
27680532|NCT00755105|80664628|FG001|Overall Study|Withdrawal by Subject|11|||
27680533|NCT00755105|80664629|FG002|Overall Study|Withdrawal by Subject|4|||
27680534|NCT03686423|80664634|FG000|Overall Study|Withdrawal by Subject|9|||
27680535|NCT03686423|80664634|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
27872904|NCT01924689|81368309|FG004|Overall Study|Withdrawal of consent|0|||
27998462|NCT02370420|81823750|FG001|Overall Study|Physician Decision|3|||
27580333|NCT02461589|80309841|FG002|Overall Study|Lost to Follow-up|2|||
27580334|NCT02461589|80309842|FG003|Overall Study|Lost to Follow-up|3|||
27680536|NCT01606670|80664635|FG000|Overall Study|Adverse Event|6|||
27680537|NCT01606670|80664635|FG000|Overall Study|Lack of Efficacy|2|||
27680538|NCT01606670|80664635|FG000|Overall Study|Lost to Follow-up|3|||
27680539|NCT01606670|80664635|FG000|Overall Study|Withdrawal by Subject|3|||
27680540|NCT01606670|80664635|FG000|Overall Study|Other Reason|2|||
27680541|NCT00573859|80664641|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
27680542|NCT00573859|80664641|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
27680543|NCT02202785|80664642|FG000|Overall Study|Study Terminated by Sponsor|1|||
27680544|NCT02202785|80664643|FG001|Overall Study|Study Terminated by Sponsor|6|||
27580335|NCT02461589|80309843|FG004|Overall Study|Lost to Follow-up|1|||
27580336|NCT02461589|80309844|FG005|Overall Study|Lost to Follow-up|1|||
27580337|NCT02461589|80309845|FG006|Overall Study|Lost to Follow-up|3|||
27580338|NCT02461589|80309846|FG007|Overall Study|Lost to Follow-up|1|||
27580339|NCT02461589|80309847|FG008|Overall Study|Lost to Follow-up|3|||
27580340|NCT02461589|80309848|FG009|Overall Study|Lost to Follow-up|1|||
27580341|NCT02461589|80309839|FG000|Overall Study|Death|0|||
27580342|NCT02461589|80309840|FG001|Overall Study|Death|0|||
27580343|NCT02461589|80309841|FG002|Overall Study|Death|0|||
27580344|NCT02461589|80309842|FG003|Overall Study|Death|0|||
27580345|NCT02461589|80309843|FG004|Overall Study|Death|0|||
27580346|NCT02461589|80309844|FG005|Overall Study|Death|0|||
27580347|NCT02461589|80309845|FG006|Overall Study|Death|0|||
27580348|NCT02461589|80309846|FG007|Overall Study|Death|1|||
27580349|NCT02461589|80309847|FG008|Overall Study|Death|0|||
27580350|NCT02461589|80309848|FG009|Overall Study|Death|0|||
27580351|NCT02461589|80309839|FG000|Overall Study|Unclassified|0|||
27580352|NCT02461589|80309840|FG001|Overall Study|Unclassified|0|||
27580353|NCT02461589|80309841|FG002|Overall Study|Unclassified|0|||
27580354|NCT02461589|80309842|FG003|Overall Study|Unclassified|0|||
27580355|NCT02461589|80309843|FG004|Overall Study|Unclassified|0|||
27580356|NCT02461589|80309844|FG005|Overall Study|Unclassified|0|||
27580357|NCT02461589|80309845|FG006|Overall Study|Unclassified|1|||
27580358|NCT02461589|80309846|FG007|Overall Study|Unclassified|0|||
27580359|NCT02461589|80309847|FG008|Overall Study|Unclassified|0|||
27580360|NCT02461589|80309848|FG009|Overall Study|Unclassified|2|||
27580361|NCT02461589|80309839|FG000|Overall Study|Missing follow-up information|1|||
27580362|NCT02461589|80309840|FG001|Overall Study|Missing follow-up information|1|||
27580363|NCT02461589|80309841|FG002|Overall Study|Missing follow-up information|0|||
27580364|NCT02461589|80309842|FG003|Overall Study|Missing follow-up information|0|||
27580365|NCT02461589|80309843|FG004|Overall Study|Missing follow-up information|0|||
27580366|NCT02461589|80309844|FG005|Overall Study|Missing follow-up information|0|||
27580367|NCT02461589|80309845|FG006|Overall Study|Missing follow-up information|1|||
27580368|NCT02461589|80309846|FG007|Overall Study|Missing follow-up information|0|||
27580369|NCT02461589|80309847|FG008|Overall Study|Missing follow-up information|0|||
27580370|NCT02461589|80309848|FG009|Overall Study|Missing follow-up information|0|||
27680545|NCT02202785|80664644|FG002|Overall Study|Study Terminated by Sponsor|4|||
27680546|NCT02202785|80664642|FG000|Overall Study|Withdrawal by Subject|0|||
27580371|NCT02461589|80309839|FG000|Overall Study|Withdrawal from trial before exposure|0|||
27580372|NCT02461589|80309840|FG001|Overall Study|Withdrawal from trial before exposure|0|||
27580373|NCT02461589|80309841|FG002|Overall Study|Withdrawal from trial before exposure|0|||
27580374|NCT02461589|80309842|FG003|Overall Study|Withdrawal from trial before exposure|0|||
27580375|NCT02461589|80309843|FG004|Overall Study|Withdrawal from trial before exposure|0|||
27680547|NCT02202785|80664643|FG001|Overall Study|Withdrawal by Subject|1|||
27680548|NCT02202785|80664644|FG002|Overall Study|Withdrawal by Subject|0|||
27680549|NCT02202785|80664642|FG000|Overall Study|Lost to Follow-up|0|||
27580376|NCT02461589|80309844|FG005|Overall Study|Withdrawal from trial before exposure|0|||
27872905|NCT01924689|81368310|FG005|Overall Study|Withdrawal of consent|0|||
27580377|NCT02461589|80309845|FG006|Overall Study|Withdrawal from trial before exposure|0|||
27872906|NCT01924689|81368305|FG000|Overall Study|Other|0|||
27872907|NCT01924689|81368306|FG001|Overall Study|Other|0|||
27872908|NCT01924689|81368307|FG002|Overall Study|Other|0|||
27580378|NCT02461589|80309846|FG007|Overall Study|Withdrawal from trial before exposure|0|||
27580379|NCT02461589|80309847|FG008|Overall Study|Withdrawal from trial before exposure|0|||
27580380|NCT02461589|80309848|FG009|Overall Study|Withdrawal from trial before exposure|1|||
27580381|NCT03766646|80309849|FG000|Overall Study|Withdrawal by Subject|1|||
27580382|NCT03766646|80309850|FG001|Overall Study|Withdrawal by Subject|0|||
27872909|NCT01924689|81368308|FG003|Overall Study|Other|0|||
27872910|NCT01924689|81368309|FG004|Overall Study|Other|1|||
27872911|NCT01924689|81368310|FG005|Overall Study|Other|0|||
27872912|NCT00838526|81368311|FG000|Overall Study|Adverse Event|3|||
27872913|NCT00838526|81368312|FG001|Overall Study|Adverse Event|12|||
27872914|NCT00838526|81368311|FG000|Overall Study|Lost to Follow-up|4|||
27872915|NCT00838526|81368312|FG001|Overall Study|Lost to Follow-up|12|||
27872916|NCT00838526|81368311|FG000|Overall Study|Withdrawal by Subject|4|||
27998463|NCT02370420|81823749|FG000|Overall Study|Lost to Follow-up|11|||
27998464|NCT02370420|81823750|FG001|Overall Study|Lost to Follow-up|9|||
27998465|NCT03920254|81823751|FG000|Overall Study|Adverse Event|1|||
27998466|NCT03920254|81823752|FG001|Overall Study|Adverse Event|0|||
27998467|NCT03920254|81823753|FG002|Overall Study|Adverse Event|0|||
27998468|NCT03920254|81823751|FG000|Overall Study|Physician Decision|0|||
27580383|NCT03766646|80309849|FG000|Overall Study|Protocol Violation|0|||
27580384|NCT03766646|80309850|FG001|Overall Study|Protocol Violation|3|||
27580385|NCT02984020|80309853|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
27580386|NCT02984020|80309853|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
27580387|NCT02984020|80309853|FG000|Overall Study|Other significant protocol violation|2|||
27580388|NCT01040871|80309857|FG000|Overall Study|Adverse Event|6|||
27805101|NCT03835975|81117261|FG003|Overall Study|No longer met eligibility criteria|0|||
27805102|NCT03835975|81117262|FG004|Overall Study|No longer met eligibility criteria|0|||
27998469|NCT03920254|81823752|FG001|Overall Study|Physician Decision|1|||
27998470|NCT03920254|81823753|FG002|Overall Study|Physician Decision|2|||
27998471|NCT03920254|81823751|FG000|Overall Study|Study Terminated By Sponsor|12|||
27998472|NCT03920254|81823752|FG001|Overall Study|Study Terminated By Sponsor|17|||
27998473|NCT03920254|81823753|FG002|Overall Study|Study Terminated By Sponsor|12|||
27998474|NCT03920254|81823751|FG000|Overall Study|Withdrawal by Subject|0|||
27998475|NCT03920254|81823752|FG001|Overall Study|Withdrawal by Subject|0|||
27998476|NCT03920254|81823753|FG002|Overall Study|Withdrawal by Subject|1|||
27998477|NCT01632020|81823767|FG000|Overall Study|Withdrawal by Subject|1|||
27998478|NCT01632020|81823768|FG001|Overall Study|Withdrawal by Subject|0|||
27998479|NCT01632020|81823767|FG000|Overall Study|Adverse Event|1|||
27998480|NCT01632020|81823768|FG001|Overall Study|Adverse Event|0|||
27998481|NCT03354273|81823771|FG000|Overall Study|Adverse Event|5|||
27998482|NCT03354273|81823771|FG000|Overall Study|Screen Failure|21|||
27998483|NCT03354273|81823771|FG000|Overall Study|Withdrawal by Subject|34|||
27998484|NCT03354273|81823771|FG000|Overall Study|Technical Problems|30|||
27998485|NCT03354273|81823771|FG000|Overall Study|Lost to Follow-up|4|||
27998486|NCT03354273|81823771|FG000|Overall Study|Investigator Decision|3|||
27998487|NCT03354273|81823771|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
27998488|NCT03354273|81823771|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
27998489|NCT03354273|81823771|FG000|Overall Study|COVID-19 Restrictions|9|||
27998490|NCT03354273|81823771|FG000|Overall Study|Other|5|||
27998491|NCT00687739|81823772|FG000|Overall Study|Lost to Follow-up|2|||
27998492|NCT00687739|81823773|FG001|Overall Study|Lost to Follow-up|2|||
27998493|NCT00687739|81823774|FG002|Overall Study|Lost to Follow-up|1|||
27998494|NCT00687739|81823775|FG003|Overall Study|Lost to Follow-up|2|||
27998495|NCT00687739|81823772|FG000|Overall Study|Adverse Event|0|||
27998496|NCT00687739|81823773|FG001|Overall Study|Adverse Event|1|||
27998497|NCT00687739|81823774|FG002|Overall Study|Adverse Event|1|||
27580389|NCT01040871|80309858|FG001|Overall Study|Adverse Event|2|||
27580390|NCT01040871|80309857|FG000|Overall Study|Withdrawal by Subject|2|||
27580391|NCT01040871|80309858|FG001|Overall Study|Withdrawal by Subject|0|||
27805103|NCT03835975|81117258|FG000|Overall Study|Protocol Violation|1|||
27805104|NCT03835975|81117259|FG001|Overall Study|Protocol Violation|1|||
27805105|NCT03835975|81117260|FG002|Overall Study|Protocol Violation|2|||
27805106|NCT03835975|81117261|FG003|Overall Study|Protocol Violation|0|||
27805107|NCT03835975|81117262|FG004|Overall Study|Protocol Violation|0|||
27805108|NCT03835975|81117258|FG000|Overall Study|Withdrawal by Subject|1|||
27805109|NCT03835975|81117259|FG001|Overall Study|Withdrawal by Subject|0|||
27805110|NCT03835975|81117260|FG002|Overall Study|Withdrawal by Subject|1|||
27872917|NCT00838526|81368312|FG001|Overall Study|Withdrawal by Subject|5|||
27872918|NCT00838526|81368311|FG000|Overall Study|Lack of Efficacy|2|||
27872919|NCT00838526|81368312|FG001|Overall Study|Lack of Efficacy|3|||
27998498|NCT00687739|81823775|FG003|Overall Study|Adverse Event|0|||
27998499|NCT03863509|81823776|FG000|Overall Study|COVID-19 shutdown period|0|||
27805111|NCT03835975|81117261|FG003|Overall Study|Withdrawal by Subject|1|||
27872920|NCT00838526|81368311|FG000|Overall Study|Other|11|||
27580392|NCT01040871|80309857|FG000|Overall Study|Death|1|||
27580393|NCT01040871|80309858|FG001|Overall Study|Death|3|||
27580394|NCT01040871|80309857|FG000|Overall Study|Lack of Efficacy|1|||
27580395|NCT01040871|80309858|FG001|Overall Study|Lack of Efficacy|1|||
27580396|NCT01040871|80309857|FG000|Overall Study|drug supply issue|1|||
27580397|NCT01040871|80309858|FG001|Overall Study|drug supply issue|0|||
27580398|NCT01040871|80309857|FG000|Overall Study|Randomized and Not Treated|2|||
27580399|NCT01040871|80309858|FG001|Overall Study|Randomized and Not Treated|1|||
27580400|NCT01802411|80309868|FG000|Overall Study|Death|2|||
27580401|NCT01802411|80309869|FG001|Overall Study|Death|1|||
27580402|NCT01802411|80309868|FG000|Overall Study|Adverse Event|2|||
27580403|NCT01802411|80309869|FG001|Overall Study|Adverse Event|7|||
27580404|NCT01802411|80309868|FG000|Overall Study|Lack of Efficacy|8|||
27580405|NCT01802411|80309869|FG001|Overall Study|Lack of Efficacy|10|||
27580406|NCT01802411|80309868|FG000|Overall Study|Withdrawal by Subject|0|||
27580407|NCT01802411|80309869|FG001|Overall Study|Withdrawal by Subject|2|||
27580408|NCT01802411|80309868|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
27580409|NCT01802411|80309869|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
27580410|NCT01802411|80309868|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
27580411|NCT01802411|80309869|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
27580412|NCT01802411|80309868|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
27580413|NCT01802411|80309869|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
27580414|NCT02170727|80309870|FG000|Overall Study|Lost to Follow-up|1|||
27580415|NCT02170727|80309871|FG001|Overall Study|Lost to Follow-up|0|||
27580416|NCT02170727|80309870|FG000|Overall Study|Withdrawal by Subject|2|||
27580417|NCT02170727|80309871|FG001|Overall Study|Withdrawal by Subject|0|||
27580418|NCT02158039|80309872|FG000|Overall Study|Withdrawal by Subject|1|||
27580419|NCT02158039|80309872|FG000|Overall Study|Screen Failure|9|||
27580420|NCT01611259|80309873|FG000|Overall Study|Physician Decision|1|||
27580421|NCT01611259|80309873|FG000|Overall Study|Lack of Efficacy|2|||
27580422|NCT01611259|80309873|FG000|Overall Study|Adverse Event|4|||
27580423|NCT01611259|80309873|FG000|Overall Study|Withdrawal by Subject|7|||
27580424|NCT01694706|80309874|FG000|Overall Study|Adverse Event|0|||
27580425|NCT01694706|80309875|FG001|Overall Study|Adverse Event|1|||
27580426|NCT01694706|80309876|FG002|Overall Study|Adverse Event|0|||
27580427|NCT01694706|80309874|FG000|Overall Study|other reason not defined above|1|||
27580428|NCT01694706|80309875|FG001|Overall Study|other reason not defined above|0|||
27580429|NCT01694706|80309876|FG002|Overall Study|other reason not defined above|0|||
27580430|NCT01858194|80309877|FG000|Overall Study|Total Artificial Heart Implant|0|||
27580431|NCT01858194|80309878|FG001|Overall Study|Total Artificial Heart Implant|1|||
27580432|NCT01858194|80309877|FG000|Overall Study|Lost to Follow-up|0|||
27580433|NCT01858194|80309878|FG001|Overall Study|Lost to Follow-up|1|||
27580434|NCT00781326|80309879|FG000|Phase I|Adverse Event|1|||
27580435|NCT00781326|80309879|FG000|Phase I|Withdrawal by Subject|1|||
27580436|NCT00781326|80309879|FG000|Phase I|Physician Decision|2|||
27580437|NCT00113516|80309880|FG000|Part 1|Adverse Event|6|||
27580438|NCT00113516|80309881|FG001|Part 1|Adverse Event|0|||
27580439|NCT00113516|80309880|FG000|Part 1|Death|3|||
27580440|NCT00113516|80309881|FG001|Part 1|Death|0|||
27580441|NCT00113516|80309880|FG000|Part 1|Other|3|||
27580442|NCT00113516|80309881|FG001|Part 1|Other|0|||
27580443|NCT00113516|80309880|FG000|Part 1|Withdrawal by Subject|2|||
27580444|NCT00113516|80309881|FG001|Part 1|Withdrawal by Subject|0|||
27580445|NCT00113516|80309880|FG000|Part 1|Lack of Efficacy|2|||
27580446|NCT00113516|80309881|FG001|Part 1|Lack of Efficacy|0|||
27580447|NCT00113516|80309880|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
27580448|NCT00113516|80309881|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
27580449|NCT00113516|80309880|FG000|Part 1|Laboratory Abnormality|1|||
27580450|NCT00113516|80309881|FG001|Part 1|Laboratory Abnormality|0|||
27580451|NCT00113516|80309880|FG000|Part 1|Ongoing|1|||
27580452|NCT00113516|80309881|FG001|Part 1|Ongoing|0|||
27580453|NCT00113516|80309880|FG000|Part 1|Missing|65|||
27580454|NCT00113516|80309881|FG001|Part 1|Missing|0|||
27580455|NCT00113516|80309880|FG000|Part 2|Adverse Event|0|||
27580456|NCT00113516|80309881|FG001|Part 2|Adverse Event|16|||
27580457|NCT00113516|80309880|FG000|Part 2|Death|0|||
27580458|NCT00113516|80309881|FG001|Part 2|Death|5|||
27580459|NCT00113516|80309880|FG000|Part 2|Lack of Efficacy|0|||
27580460|NCT00113516|80309881|FG001|Part 2|Lack of Efficacy|37|||
27580461|NCT00113516|80309880|FG000|Part 2|Withdrawal by Subject|0|||
27580462|NCT00113516|80309881|FG001|Part 2|Withdrawal by Subject|3|||
27580463|NCT00113516|80309880|FG000|Part 2|Other|0|||
27580464|NCT00113516|80309881|FG001|Part 2|Other|3|||
27580465|NCT00113516|80309880|FG000|Part 2|Laboratory Abnormality|0|||
27580466|NCT00113516|80309881|FG001|Part 2|Laboratory Abnormality|1|||
27580467|NCT00113516|80309880|FG000|Part 2|Ongoing|0|||
27580468|NCT00113516|80309881|FG001|Part 2|Ongoing|1|||
27580469|NCT01358981|80309887|FG000|Period 1|Withdrawal by Subject|0|||
27580470|NCT01358981|80309888|FG001|Period 1|Withdrawal by Subject|0|||
27580471|NCT01358981|80309889|FG002|Period 1|Withdrawal by Subject|0|||
27580472|NCT01358981|80309890|FG003|Period 1|Withdrawal by Subject|1|||
27580473|NCT01358981|80309891|FG004|Period 1|Withdrawal by Subject|0|||
27872921|NCT00838526|81368312|FG001|Overall Study|Other|7|||
27872922|NCT05219448|81368313|FG000|Overall Study|Lost to Follow-up|9|||
27872923|NCT05219448|81368314|FG001|Overall Study|Lost to Follow-up|0|||
27872924|NCT00955617|81368315|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
27872925|NCT00955617|81368316|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
27872926|NCT00955617|81368315|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
27872927|NCT00955617|81368316|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
27872928|NCT00955617|81368315|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
27872929|NCT00955617|81368316|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
27872930|NCT00955617|81368315|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
27580474|NCT01358981|80309892|FG005|Period 1|Withdrawal by Subject|0|||
27580475|NCT01358981|80309893|FG006|Period 1|Withdrawal by Subject|0|||
27580476|NCT01459796|80309896|FG000|Overall Study|Non compliance with protocol|2|||
27580477|NCT01459796|80309897|FG001|Overall Study|Non compliance with protocol|4|||
27580478|NCT01459796|80309896|FG000|Overall Study|Adverse Event|5|||
27580479|NCT01459796|80309897|FG001|Overall Study|Adverse Event|5|||
27580480|NCT01459796|80309896|FG000|Overall Study|Withdrawal by Subject|6|||
27580481|NCT01459796|80309897|FG001|Overall Study|Withdrawal by Subject|3|||
27580482|NCT01459796|80309896|FG000|Overall Study|Lost to Follow-up|5|||
27872931|NCT00955617|81368316|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
27872932|NCT01071915|81368317|FG000|Overall Study|Adverse Event|3|||
27872933|NCT01071915|81368317|FG000|Overall Study|Physician Decision|2|||
27872934|NCT01071915|81368317|FG000|Overall Study|Withdrawal by Subject|2|||
27872935|NCT01071915|81368317|FG000|Overall Study|Miscellaneous Reasons|2|||
27872936|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
27872937|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Off-label use|283|||
27872938|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
27872939|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
27872940|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
27872941|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
27872942|NCT01070953|81368318|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
27872943|NCT01070953|81368318|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
27872944|NCT01070953|81368318|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
27872945|NCT01070953|81368318|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
27872946|NCT01439802|81368319|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
27872947|NCT01439802|81368319|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
27872948|NCT02500589|81368320|FG000|Overall Study|Withdrawal by Subject|11|||
27872949|NCT02500589|81368321|FG001|Overall Study|Withdrawal by Subject|14|||
27872950|NCT02500589|81368320|FG000|Overall Study|Lost to Follow-up|10|||
27872951|NCT02500589|81368321|FG001|Overall Study|Lost to Follow-up|12|||
27872952|NCT02500589|81368320|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
27872953|NCT02500589|81368321|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
27872954|NCT02500589|81368320|FG000|Overall Study|Death|7|||
27872955|NCT02500589|81368321|FG001|Overall Study|Death|5|||
27872956|NCT03805412|81368322|FG000|Overall Study|Lost to Follow-up|0|||
27872957|NCT03805412|81368323|FG001|Overall Study|Lost to Follow-up|1|||
27872958|NCT03055624|81368324|FG000|Overall Study|Study closed|9|||
27872959|NCT00808210|81368325|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
27872960|NCT00808210|81368326|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
27872961|NCT00808210|81368325|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
27872962|NCT00808210|81368326|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
27872963|NCT00808210|81368325|FG000|Double-Blind TX Period|Adverse Event|0|||
27872964|NCT00808210|81368326|FG001|Double-Blind TX Period|Adverse Event|1|||
27872965|NCT00808210|81368325|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
27872966|NCT00808210|81368326|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
27872967|NCT00808210|81368325|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
27872968|NCT00808210|81368326|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
27872969|NCT00808210|81368325|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
27872970|NCT00808210|81368326|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
27872971|NCT01392963|81368336|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
27998500|NCT03863509|81823777|FG001|Overall Study|COVID-19 shutdown period|4|||
27580483|NCT01459796|80309897|FG001|Overall Study|Lost to Follow-up|4|||
27872972|NCT01392963|81368337|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
27872973|NCT01392963|81368336|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
27998501|NCT03863509|81823778|FG002|Overall Study|COVID-19 shutdown period|0|||
27998502|NCT03863509|81823776|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
27580484|NCT01459796|80309896|FG000|Overall Study|Reason unspecified|1|||
27580485|NCT01459796|80309897|FG001|Overall Study|Reason unspecified|2|||
27872974|NCT01392963|81368337|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
27872975|NCT01392963|81368336|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
27872976|NCT01392963|81368337|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
27872977|NCT04263311|81368338|FG000|Overall Study|Lost to Follow-up|1|||
27872978|NCT04263311|81368339|FG001|Overall Study|Lost to Follow-up|2|||
27872979|NCT04263311|81368338|FG000|Overall Study|Health Issues|1|||
27872980|NCT04263311|81368339|FG001|Overall Study|Health Issues|0|||
27872981|NCT04263311|81368338|FG000|Overall Study|Left the country|1|||
27872982|NCT04263311|81368339|FG001|Overall Study|Left the country|0|||
27872983|NCT04263311|81368338|FG000|Overall Study|Unable to maintain time commitment|1|||
27872984|NCT04263311|81368339|FG001|Overall Study|Unable to maintain time commitment|0|||
27872985|NCT04263311|81368338|FG000|Overall Study|No longer interested|1|||
27872986|NCT04263311|81368339|FG001|Overall Study|No longer interested|0|||
27872987|NCT02454933|81368340|FG000|Overall Study|Progressive disease|10|||
27872988|NCT02454933|81368341|FG001|Overall Study|Progressive disease|7|||
27872989|NCT02454933|81368340|FG000|Overall Study|Adverse Event|1|||
27872990|NCT02454933|81368341|FG001|Overall Study|Adverse Event|1|||
27872991|NCT02454933|81368340|FG000|Overall Study|Withdrawal by Subject|0|||
27872992|NCT02454933|81368341|FG001|Overall Study|Withdrawal by Subject|3|||
27872993|NCT02454933|81368340|FG000|Overall Study|Lost to Follow-up|1|||
27872994|NCT02454933|81368341|FG001|Overall Study|Lost to Follow-up|0|||
27872995|NCT01154231|81368344|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
27872996|NCT01154231|81368344|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
27580486|NCT01459796|80309896|FG000|Overall Study|Decision by the sponsor|75|||
27580487|NCT01459796|80309897|FG001|Overall Study|Decision by the sponsor|108|||
27580488|NCT00466193|80309898|FG000|Overall Study|Adverse Event|0|||
27580489|NCT00466193|80309899|FG001|Overall Study|Adverse Event|1|||
27580490|NCT00466193|80309898|FG000|Overall Study|Lost to Follow-up|2|||
27580491|NCT00466193|80309899|FG001|Overall Study|Lost to Follow-up|4|||
27872997|NCT04728802|81368345|FG000|Overall Study|Withdrawal by Subject|4|||
27872998|NCT04728802|81368346|FG001|Overall Study|Withdrawal by Subject|20|||
27872999|NCT04728802|81368345|FG000|Overall Study|Physician Decision|7|||
27873000|NCT04728802|81368346|FG001|Overall Study|Physician Decision|7|||
27873001|NCT04728802|81368345|FG000|Overall Study|Protocol Violation|10|||
27873002|NCT04728802|81368346|FG001|Overall Study|Protocol Violation|4|||
27873003|NCT04728802|81368345|FG000|Overall Study|Transfer|1|||
27873004|NCT04728802|81368346|FG001|Overall Study|Transfer|0|||
27873005|NCT04728802|81368345|FG000|Overall Study|Death|4|||
27873006|NCT04728802|81368346|FG001|Overall Study|Death|5|||
27873007|NCT04728802|81368345|FG000|Overall Study|Other|3|||
27873008|NCT04728802|81368346|FG001|Overall Study|Other|0|||
27873009|NCT01125917|81368347|FG000|Overall Study|Adverse Event|43|||
27873010|NCT01125917|81368347|FG000|Overall Study|Lost to Follow-up|23|||
27873011|NCT01125917|81368347|FG000|Overall Study|Withdrawal by Subject|31|||
27873012|NCT01125917|81368347|FG000|Overall Study|Administrative|223|||
27998503|NCT03863509|81823777|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
27998504|NCT03863509|81823778|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
27998505|NCT03863509|81823776|FG000|Overall Study|Lost to Follow-up|8|||
27998506|NCT03863509|81823777|FG001|Overall Study|Lost to Follow-up|0|||
27998507|NCT03863509|81823778|FG002|Overall Study|Lost to Follow-up|2|||
27998508|NCT03863509|81823776|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
27998509|NCT03863509|81823777|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
27998510|NCT03863509|81823778|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
27998511|NCT03863509|81823776|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
27998512|NCT03863509|81823777|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
27998513|NCT03863509|81823778|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
27998514|NCT01453140|81823779|FG000|Overall Study|Adverse Event|3|||
27998515|NCT04303559|81823781|FG000|Overall Study|Study closed due to poor enrollment.|1|||
27998516|NCT03087513|81823782|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
27998517|NCT01684202|81823785|FG000|Dose-escalation Period|Adverse Event|0|||
27998518|NCT01684202|81823786|FG001|Dose-escalation Period|Adverse Event|1|||
27998519|NCT01684202|81823787|FG002|Dose-escalation Period|Adverse Event|0|||
27998520|NCT01684202|81823788|FG003|Dose-escalation Period|Adverse Event|0|||
27998521|NCT01684202|81823785|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
27998522|NCT01684202|81823786|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
27998523|NCT01684202|81823787|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
27998524|NCT01684202|81823788|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
27998525|NCT01684202|81823785|FG000|Maintenance Period|Adverse Event|1|||
27873013|NCT01125917|81368347|FG000|Overall Study|Lack of Efficacy|19|||
27873014|NCT01009814|81368350|FG000|Overall Study|No longer met study criteria|1|||
27873015|NCT01009814|81368351|FG001|Overall Study|No longer met study criteria|1|||
27873016|NCT01009814|81368352|FG002|Overall Study|No longer met study criteria|0|||
27873017|NCT01009814|81368353|FG003|Overall Study|No longer met study criteria|0|||
27580492|NCT00466193|80309898|FG000|Overall Study|Physician Decision|1|||
27580493|NCT00466193|80309899|FG001|Overall Study|Physician Decision|0|||
27580494|NCT00466193|80309898|FG000|Overall Study|Protocol Violation|1|||
27580495|NCT00466193|80309899|FG001|Overall Study|Protocol Violation|1|||
27580496|NCT00466193|80309898|FG000|Overall Study|Withdrawal by Subject|7|||
27580497|NCT00466193|80309899|FG001|Overall Study|Withdrawal by Subject|2|||
27580498|NCT00466193|80309898|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
27580499|NCT00466193|80309899|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
27580500|NCT01307501|80309900|FG000|Overall Study|Treatment Failure|1|||
27580501|NCT01307501|80309900|FG000|Overall Study|Death|20|||
27580502|NCT01307501|80309900|FG000|Overall Study|Lost to Follow-up|1|||
27580503|NCT01307501|80309900|FG000|Overall Study|Starting Hospice|1|||
27580504|NCT00097591|80309903|FG000|Overall Study|Withdrawal of consent|342|||
27580505|NCT00097591|80309904|FG001|Overall Study|Withdrawal of consent|323|||
27580506|NCT00097591|80309903|FG000|Overall Study|Less than 6 months on study drug|9|||
27580507|NCT00097591|80309904|FG001|Overall Study|Less than 6 months on study drug|7|||
27580508|NCT00097591|80309903|FG000|Overall Study|Unable to attend termination visit|53|||
27580509|NCT00097591|80309904|FG001|Overall Study|Unable to attend termination visit|51|||
27580510|NCT00097591|80309903|FG000|Overall Study|Lost to follow up|6|||
27580511|NCT00097591|80309904|FG001|Overall Study|Lost to follow up|10|||
27580512|NCT00097591|80309903|FG000|Overall Study|Other|0|||
27580513|NCT00097591|80309904|FG001|Overall Study|Other|3|||
27580514|NCT03525834|80309907|FG000|Overall Study|Progressive disease|1|||
27998526|NCT01684202|81823786|FG001|Maintenance Period|Adverse Event|1|||
27998527|NCT01684202|81823787|FG002|Maintenance Period|Adverse Event|1|||
27998528|NCT01684202|81823788|FG003|Maintenance Period|Adverse Event|1|||
27998529|NCT01684202|81823785|FG000|Maintenance Period|Physician Decision|0|||
27998530|NCT01684202|81823786|FG001|Maintenance Period|Physician Decision|1|||
27998531|NCT01684202|81823787|FG002|Maintenance Period|Physician Decision|0|||
27998532|NCT01684202|81823788|FG003|Maintenance Period|Physician Decision|0|||
27580515|NCT01458171|80309908|FG000|Overall Study|Adverse Event|1|||
27580516|NCT01692197|80309909|FG000|Overall Study|Failed Screening|3|||
27580517|NCT00991302|80309911|FG000|Overall Study|Death|0|||
27580518|NCT00991302|80309912|FG001|Overall Study|Death|1|||
27580519|NCT00991302|80309911|FG000|Overall Study|Lost to Follow-up|14|||
27580520|NCT00991302|80309912|FG001|Overall Study|Lost to Follow-up|12|||
27580521|NCT03219333|80309913|FG000|Overall Study|Withdrawal by Subject|9|||
27580522|NCT03219333|80309914|FG001|Overall Study|Withdrawal by Subject|4|||
27580523|NCT03219333|80309913|FG000|Overall Study|Lost to Follow-up|1|||
27580524|NCT03219333|80309914|FG001|Overall Study|Lost to Follow-up|1|||
27580525|NCT03219333|80309913|FG000|Overall Study|Death|104|||
27580526|NCT03219333|80309914|FG001|Overall Study|Death|72|||
27680550|NCT02202785|80664643|FG001|Overall Study|Lost to Follow-up|1|||
27580527|NCT03219333|80309913|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
27580528|NCT03219333|80309914|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
27580529|NCT03219333|80309913|FG000|Overall Study|Other|2|||
27580530|NCT03219333|80309914|FG001|Overall Study|Other|2|||
27580531|NCT01003249|80309918|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27580532|NCT01003249|80309919|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27580533|NCT01003249|80309918|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
27580534|NCT01003249|80309919|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
27998533|NCT01684202|81823785|FG000|Maintenance Period|Withdrawal by Subject|0|||
27998534|NCT01684202|81823786|FG001|Maintenance Period|Withdrawal by Subject|1|||
27998535|NCT01684202|81823787|FG002|Maintenance Period|Withdrawal by Subject|0|||
27998536|NCT01684202|81823788|FG003|Maintenance Period|Withdrawal by Subject|0|||
27998537|NCT01698814|81823789|FG000|Overall Study|Adverse Event|0|||
27998538|NCT01698814|81823790|FG001|Overall Study|Adverse Event|2|||
27998539|NCT01698814|81823789|FG000|Overall Study|Lost to Follow-up|0|||
27998540|NCT01698814|81823790|FG001|Overall Study|Lost to Follow-up|1|||
27998541|NCT01698814|81823789|FG000|Overall Study|Pregnancy|1|||
27998542|NCT01698814|81823790|FG001|Overall Study|Pregnancy|0|||
27998543|NCT01698814|81823789|FG000|Overall Study|Randomized in error|1|||
27998544|NCT01698814|81823790|FG001|Overall Study|Randomized in error|0|||
27998545|NCT01473732|81823791|FG000|Overall Study|Adverse Event|1|||
27998546|NCT01473732|81823792|FG001|Overall Study|Adverse Event|0|||
27998547|NCT01473732|81823791|FG000|Overall Study|Death|1|||
27998548|NCT01473732|81823792|FG001|Overall Study|Death|0|||
27998549|NCT00950846|81823795|FG000|Overall Study|Death|6|||
27998550|NCT00950846|81823795|FG000|Overall Study|Lost to Follow-up|3|||
27998551|NCT00950846|81823795|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
27580535|NCT01003249|80309918|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27580536|NCT01003249|80309919|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27580537|NCT01003249|80309918|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
27580538|NCT01003249|80309919|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
27580539|NCT04574362|80309920|FG000|Overall Study|Other|0|||
27580540|NCT04574362|80309921|FG001|Overall Study|Other|5|||
27580541|NCT04574362|80309920|FG000|Overall Study|COVID-19|0|||
27580542|NCT04574362|80309921|FG001|Overall Study|COVID-19|1|||
27580543|NCT04574362|80309920|FG000|Overall Study|Adverse Event|1|||
27580544|NCT04574362|80309921|FG001|Overall Study|Adverse Event|1|||
27580545|NCT04574362|80309920|FG000|Overall Study|Withdrawal by Subject|2|||
27680551|NCT02202785|80664644|FG002|Overall Study|Lost to Follow-up|0|||
27680552|NCT02202785|80664642|FG000|Overall Study|Reason not Specified|10|||
27680553|NCT02202785|80664643|FG001|Overall Study|Reason not Specified|7|||
27680554|NCT02202785|80664644|FG002|Overall Study|Reason not Specified|13|||
27680555|NCT00635661|80664651|FG000|Overall Study|Withdrawal by Subject|4|||
27680556|NCT01038427|80664653|FG000|Overall Study|Lost to follow up|1|||
27998552|NCT01216683|81823796|FG000|Induction|Never started treatment|0|||
27998553|NCT01216683|81823797|FG001|Induction|Never started treatment|6|||
27580546|NCT04574362|80309921|FG001|Overall Study|Withdrawal by Subject|4|||
27580547|NCT04574362|80309920|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
27998554|NCT01216683|81823798|FG002|Induction|Never started treatment|3|||
27998555|NCT01216683|81823796|FG000|Induction|Lack of Efficacy|4|||
27998556|NCT01216683|81823797|FG001|Induction|Lack of Efficacy|3|||
27998557|NCT01216683|81823798|FG002|Induction|Lack of Efficacy|7|||
27998558|NCT01216683|81823796|FG000|Induction|Adverse Event|0|||
27998559|NCT01216683|81823797|FG001|Induction|Adverse Event|5|||
27998560|NCT01216683|81823798|FG002|Induction|Adverse Event|5|||
27998561|NCT01216683|81823796|FG000|Induction|Death|0|||
27998562|NCT01216683|81823797|FG001|Induction|Death|0|||
27998563|NCT01216683|81823798|FG002|Induction|Death|2|||
27580548|NCT04574362|80309921|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
27580549|NCT04574362|80309920|FG000|Overall Study|Participant refused to come to the hospital|1|||
27580550|NCT04574362|80309921|FG001|Overall Study|Participant refused to come to the hospital|0|||
27580551|NCT04574362|80309920|FG000|Overall Study|Participant refused the visit|1|||
27680557|NCT01038427|80664654|FG001|Overall Study|Lost to follow up|1|||
27680558|NCT01038427|80664655|FG002|Overall Study|Lost to follow up|0|||
27998564|NCT01216683|81823796|FG000|Induction|Withdrawal by Subject|0|||
27680559|NCT01038427|80664653|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27998565|NCT01216683|81823797|FG001|Induction|Withdrawal by Subject|4|||
27998566|NCT01216683|81823798|FG002|Induction|Withdrawal by Subject|2|||
27580552|NCT04574362|80309921|FG001|Overall Study|Participant refused the visit|0|||
27580553|NCT04574362|80309920|FG000|Overall Study|Participant quit early because of business trip|1|||
27580554|NCT04574362|80309921|FG001|Overall Study|Participant quit early because of business trip|0|||
27580555|NCT04808609|80309922|FG000|Overall Study|Lost to Follow-up|0|||
27580556|NCT04808609|80309923|FG001|Overall Study|Lost to Follow-up|2|||
27580557|NCT04808609|80309922|FG000|Overall Study|Administrative Withdrawal|0|||
27580558|NCT04808609|80309923|FG001|Overall Study|Administrative Withdrawal|1|||
27580559|NCT02252081|80309926|FG000|Overall Study|Withdrawal by Subject|2|||
27580560|NCT02252081|80309927|FG001|Overall Study|Withdrawal by Subject|1|||
27580561|NCT02252081|80309926|FG000|Overall Study|Adverse Event|4|||
27580562|NCT02252081|80309927|FG001|Overall Study|Adverse Event|1|||
27580563|NCT02252081|80309926|FG000|Overall Study|non compliance & others|0|||
27580564|NCT02252081|80309927|FG001|Overall Study|non compliance & others|2|||
27580565|NCT00646958|80309928|FG000|Overall Study|Lack of Efficacy|1|||
27580566|NCT00646958|80309929|FG001|Overall Study|Lack of Efficacy|0|||
27580567|NCT00646958|80309930|FG002|Overall Study|Lack of Efficacy|0|||
27580568|NCT00646958|80309928|FG000|Overall Study|Adverse Event|4|||
27580569|NCT00646958|80309929|FG001|Overall Study|Adverse Event|0|||
27580570|NCT00646958|80309930|FG002|Overall Study|Adverse Event|0|||
27580571|NCT00646958|80309928|FG000|Overall Study|Lost to Follow-up|1|||
27580572|NCT00646958|80309929|FG001|Overall Study|Lost to Follow-up|5|||
27580573|NCT00646958|80309930|FG002|Overall Study|Lost to Follow-up|7|||
27580574|NCT00646958|80309928|FG000|Overall Study|Protocol Violation|1|||
27998567|NCT01216683|81823796|FG000|Induction|Other disease|0|||
27998568|NCT01216683|81823797|FG001|Induction|Other disease|1|||
27998569|NCT01216683|81823798|FG002|Induction|Other disease|2|||
27998570|NCT01216683|81823796|FG000|Continuation|Lack of Efficacy|3|||
27998571|NCT01216683|81823797|FG001|Continuation|Lack of Efficacy|2|||
27998572|NCT01216683|81823798|FG002|Continuation|Lack of Efficacy|7|||
27998573|NCT01216683|81823796|FG000|Continuation|Adverse Event|5|||
27580575|NCT00646958|80309929|FG001|Overall Study|Protocol Violation|1|||
27580576|NCT00646958|80309930|FG002|Overall Study|Protocol Violation|0|||
27580577|NCT00646958|80309928|FG000|Overall Study|Abnormal screening lab tests|1|||
27580578|NCT00646958|80309929|FG001|Overall Study|Abnormal screening lab tests|1|||
27580579|NCT00646958|80309930|FG002|Overall Study|Abnormal screening lab tests|0|||
27580580|NCT00646958|80309928|FG000|Overall Study|Withdrawal by Subject|1|||
27580581|NCT00646958|80309929|FG001|Overall Study|Withdrawal by Subject|2|||
27580582|NCT00646958|80309930|FG002|Overall Study|Withdrawal by Subject|0|||
27580583|NCT00646958|80309928|FG000|Overall Study|Did not receive study drug|2|||
27580584|NCT00646958|80309929|FG001|Overall Study|Did not receive study drug|0|||
27580585|NCT00646958|80309930|FG002|Overall Study|Did not receive study drug|2|||
27580586|NCT01959581|80309933|FG000|Overall Study|Lost to Follow-up|5|||
27580587|NCT01075321|80309934|FG000|Overall Study|Withdrawal by Subject|0|||
27580588|NCT01075321|80309935|FG001|Overall Study|Withdrawal by Subject|0|||
27580589|NCT01075321|80309936|FG002|Overall Study|Withdrawal by Subject|1|||
27580590|NCT01075321|80309937|FG003|Overall Study|Withdrawal by Subject|1|||
27580591|NCT01075321|80309934|FG000|Overall Study|Protocol Violation|0|||
27580592|NCT01075321|80309935|FG001|Overall Study|Protocol Violation|0|||
27580593|NCT01075321|80309936|FG002|Overall Study|Protocol Violation|1|||
27580594|NCT01075321|80309937|FG003|Overall Study|Protocol Violation|0|||
27580595|NCT01075321|80309934|FG000|Overall Study|Treatment Incomplete due to progression|1|||
27580596|NCT01075321|80309935|FG001|Overall Study|Treatment Incomplete due to progression|0|||
27580597|NCT01075321|80309936|FG002|Overall Study|Treatment Incomplete due to progression|0|||
27580598|NCT01075321|80309937|FG003|Overall Study|Treatment Incomplete due to progression|0|||
27580599|NCT01075321|80309934|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
27580600|NCT01075321|80309935|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
27805112|NCT03835975|81117262|FG004|Overall Study|Withdrawal by Subject|0|||
27805113|NCT01347879|81117263|FG000|Overall Study|Adverse Event|0|||
27998574|NCT01216683|81823797|FG001|Continuation|Adverse Event|3|||
27998575|NCT01216683|81823798|FG002|Continuation|Adverse Event|16|||
27998576|NCT01216683|81823796|FG000|Continuation|Death|1|||
27580601|NCT01075321|80309936|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
27580602|NCT01075321|80309937|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
27580603|NCT05789875|80309938|FG000|Overall Study|Lost to Follow-up|6|||
27580604|NCT01700946|80309939|FG000|Overall Study|Lost to Follow-up|1|||
27580605|NCT01700946|80309940|FG001|Overall Study|Lost to Follow-up|0|||
27580606|NCT01700946|80309939|FG000|Overall Study|Physician Decision|7|||
27998577|NCT01216683|81823797|FG001|Continuation|Death|0|||
27998578|NCT01216683|81823798|FG002|Continuation|Death|2|||
27580607|NCT01700946|80309940|FG001|Overall Study|Physician Decision|12|||
27580608|NCT01700946|80309939|FG000|Overall Study|Withdrawal by Subject|0|||
27580609|NCT01700946|80309940|FG001|Overall Study|Withdrawal by Subject|2|||
27580610|NCT01700946|80309939|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
27580611|NCT01700946|80309940|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
27580612|NCT01700946|80309939|FG000|Overall Study|Relapse|2|||
27580613|NCT01700946|80309940|FG001|Overall Study|Relapse|1|||
27580614|NCT01700946|80309939|FG000|Overall Study|Unacceptable toxicity|1|||
27580615|NCT01700946|80309940|FG001|Overall Study|Unacceptable toxicity|0|||
27580616|NCT02838017|80309941|FG000|Overall Study|Lost to Follow-up|14|||
27580617|NCT02838017|80309942|FG001|Overall Study|Lost to Follow-up|11|||
27580618|NCT00096941|80309946|FG000|Overall Study|disease progression|3|||
27580619|NCT02610140|80309949|FG000|Randomization and Treatment Period|Radiological progression|23|||
27580620|NCT02610140|80309950|FG001|Randomization and Treatment Period|Radiological progression|15|||
27580621|NCT02610140|80309949|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
27580622|NCT02610140|80309950|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
27580623|NCT02610140|80309949|FG000|Randomization and Treatment Period|Protocol Violation|1|||
27580624|NCT02610140|80309950|FG001|Randomization and Treatment Period|Protocol Violation|0|||
27580625|NCT02610140|80309949|FG000|Randomization and Treatment Period|Physician Decision|0|||
27580626|NCT02610140|80309950|FG001|Randomization and Treatment Period|Physician Decision|1|||
27580627|NCT02610140|80309949|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
27580628|NCT02610140|80309950|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
27580629|NCT02610140|80309949|FG000|Randomization and Treatment Period|Death|7|||
27580630|NCT02610140|80309950|FG001|Randomization and Treatment Period|Death|1|||
27580631|NCT02610140|80309949|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
27580632|NCT02610140|80309950|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
27580633|NCT02610140|80309949|FG000|Randomization and Treatment Period|Adverse Event|44|||
27580634|NCT02610140|80309950|FG001|Randomization and Treatment Period|Adverse Event|13|||
27580635|NCT02610140|80309949|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
27580636|NCT02610140|80309950|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
27580637|NCT02610140|80309949|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
27580638|NCT02610140|80309950|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
27580639|NCT02610140|80309949|FG000|Randomization and Treatment Period|Not treated|3|||
27580640|NCT02610140|80309950|FG001|Randomization and Treatment Period|Not treated|10|||
27580641|NCT02610140|80309949|FG000|Safety Follow-up|Other|0|||
27580642|NCT02610140|80309950|FG001|Safety Follow-up|Other|2|||
27580643|NCT02610140|80309949|FG000|Safety Follow-up|Lost to Follow-up|1|||
27580644|NCT02610140|80309950|FG001|Safety Follow-up|Lost to Follow-up|0|||
27580645|NCT02610140|80309949|FG000|Safety Follow-up|No follow-up|5|||
27580646|NCT02610140|80309950|FG001|Safety Follow-up|No follow-up|3|||
27580647|NCT02610140|80309949|FG000|Safety Follow-up|Death|12|||
27580648|NCT02610140|80309950|FG001|Safety Follow-up|Death|2|||
27580649|NCT02610140|80309949|FG000|Safety Follow-up|Deterioration of general conditions|15|||
27580650|NCT02610140|80309950|FG001|Safety Follow-up|Deterioration of general conditions|5|||
27580651|NCT02610140|80309949|FG000|Safety Follow-up|Withdrawal by Subject|12|||
27580652|NCT02610140|80309950|FG001|Safety Follow-up|Withdrawal by Subject|12|||
27580653|NCT02610140|80309949|FG000|Active Follow-up|Progressive disease - radiological|30|||
27580654|NCT02610140|80309950|FG001|Active Follow-up|Progressive disease - radiological|22|||
27580655|NCT02610140|80309949|FG000|Active Follow-up|Death|8|||
27580656|NCT02610140|80309950|FG001|Active Follow-up|Death|1|||
27580657|NCT02610140|80309949|FG000|Active Follow-up|Withdrawal by Subject|4|||
27580658|NCT02610140|80309950|FG001|Active Follow-up|Withdrawal by Subject|0|||
27580659|NCT02610140|80309949|FG000|Active Follow-up|Progressive disease - clinical|1|||
27580660|NCT02610140|80309950|FG001|Active Follow-up|Progressive disease - clinical|2|||
27580661|NCT02610140|80309949|FG000|Active Follow-up|Deterioration of general conditions|1|||
27580662|NCT02610140|80309950|FG001|Active Follow-up|Deterioration of general conditions|0|||
27580663|NCT02610140|80309949|FG000|Active Follow-up|Ongoing but not completed|4|||
27580664|NCT02610140|80309950|FG001|Active Follow-up|Ongoing but not completed|1|||
27580665|NCT02610140|80309949|FG000|Long-term Follow-up|Death|86|||
27580666|NCT02610140|80309950|FG001|Long-term Follow-up|Death|44|||
27580667|NCT02610140|80309949|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
27805114|NCT01347879|81117264|FG001|Overall Study|Adverse Event|12|||
27580668|NCT02610140|80309950|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
27580669|NCT02610140|80309949|FG000|Long-term Follow-up|Lost to Follow-up|1|||
27580670|NCT02610140|80309950|FG001|Long-term Follow-up|Lost to Follow-up|2|||
27580671|NCT02610140|80309949|FG000|Long-term Follow-up|Ongoing but not completed|30|||
27580672|NCT02610140|80309950|FG001|Long-term Follow-up|Ongoing but not completed|17|||
27805115|NCT01347879|81117263|FG000|Overall Study|Lost to Follow-up|2|||
27580673|NCT02031276|80309951|FG000|Period 1 Double-blind IV|Adverse Event|6|||
27580674|NCT02031276|80309952|FG001|Period 1 Double-blind IV|Adverse Event|5|||
27580675|NCT02031276|80309953|FG002|Period 1 Double-blind IV|Adverse Event|1|||
27805116|NCT01347879|81117264|FG001|Overall Study|Lost to Follow-up|0|||
27580676|NCT02031276|80309951|FG000|Period 1 Double-blind IV|Other|0|||
27580677|NCT02031276|80309952|FG001|Period 1 Double-blind IV|Other|1|||
27580678|NCT02031276|80309953|FG002|Period 1 Double-blind IV|Other|0|||
27580679|NCT02031276|80309951|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
27580680|NCT02031276|80309952|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
27580681|NCT02031276|80309953|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
27580682|NCT02031276|80309951|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
27580683|NCT02031276|80309952|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
27580684|NCT02031276|80309953|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
27580685|NCT02031276|80309951|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
27580686|NCT02031276|80309952|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
27580687|NCT02031276|80309953|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
27580688|NCT02031276|80309951|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
27580689|NCT02031276|80309952|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
27873018|NCT01009814|81368354|FG004|Overall Study|No longer met study criteria|0|||
27873019|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Other|34|||
27998579|NCT01216683|81823796|FG000|Continuation|Withdrawal by Subject|4|||
27998580|NCT01216683|81823797|FG001|Continuation|Withdrawal by Subject|5|||
27998581|NCT01216683|81823798|FG002|Continuation|Withdrawal by Subject|9|||
27998582|NCT01216683|81823796|FG000|Continuation|Other diseases|0|||
27998583|NCT01216683|81823797|FG001|Continuation|Other diseases|2|||
27998584|NCT01216683|81823798|FG002|Continuation|Other diseases|1|||
27998585|NCT01216683|81823796|FG000|Continuation|Physician Decision|1|||
27998586|NCT01216683|81823797|FG001|Continuation|Physician Decision|0|||
27998587|NCT01216683|81823798|FG002|Continuation|Physician Decision|1|||
27998588|NCT01216683|81823796|FG000|Continuation|Non-compliance|1|||
27998589|NCT01216683|81823797|FG001|Continuation|Non-compliance|0|||
27998590|NCT01216683|81823798|FG002|Continuation|Non-compliance|1|||
27998591|NCT01216683|81823796|FG000|Continuation|Insurance change|0|||
27998592|NCT01216683|81823797|FG001|Continuation|Insurance change|1|||
27998593|NCT01216683|81823798|FG002|Continuation|Insurance change|0|||
27998594|NCT01216683|81823796|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
27998595|NCT01216683|81823797|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
27998596|NCT01216683|81823798|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
27873020|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Other|0|||
27873021|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Other|0|||
27873022|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Other|0|||
27873023|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Death|14|||
27998597|NCT01216683|81823796|FG000|Continuation|Not reported|0|||
27998598|NCT01216683|81823797|FG001|Continuation|Not reported|0|||
27998599|NCT01216683|81823798|FG002|Continuation|Not reported|1|||
27998600|NCT01216683|81823796|FG000|Continuation|Never started treatment|0|||
27998601|NCT01216683|81823797|FG001|Continuation|Never started treatment|1|||
27998602|NCT01216683|81823798|FG002|Continuation|Never started treatment|5|||
27998603|NCT01964963|81823800|FG000|Overall Study|Case Report Forms Uncollected|888|||
27998604|NCT01964963|81823800|FG000|Overall Study|Protocol Deviation|50|||
27998605|NCT01964963|81823800|FG000|Overall Study|Data Reliability was not Assured|5|||
27998606|NCT03827655|81823802|FG000|Overall Study|Death|0|||
27998607|NCT03827655|81823803|FG001|Overall Study|Death|0|||
27998608|NCT03827655|81823804|FG002|Overall Study|Death|0|||
27998609|NCT03827655|81823805|FG003|Overall Study|Death|0|||
27580690|NCT02031276|80309953|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
27873024|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Death|0|||
27998610|NCT03827655|81823806|FG004|Overall Study|Death|1|||
27998611|NCT03827655|81823802|FG000|Overall Study|Protocol Deviation|1|||
27580691|NCT02031276|80309951|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
27580692|NCT02031276|80309952|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
27580693|NCT02031276|80309953|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
27998612|NCT03827655|81823803|FG001|Overall Study|Protocol Deviation|0|||
27998613|NCT03827655|81823804|FG002|Overall Study|Protocol Deviation|1|||
27998614|NCT03827655|81823805|FG003|Overall Study|Protocol Deviation|1|||
27998615|NCT03827655|81823806|FG004|Overall Study|Protocol Deviation|0|||
27998616|NCT03827655|81823802|FG000|Overall Study|Withdrawal by Subject|3|||
27998617|NCT03827655|81823803|FG001|Overall Study|Withdrawal by Subject|2|||
27998618|NCT03827655|81823804|FG002|Overall Study|Withdrawal by Subject|2|||
27998619|NCT03827655|81823805|FG003|Overall Study|Withdrawal by Subject|0|||
27998620|NCT03827655|81823806|FG004|Overall Study|Withdrawal by Subject|1|||
27998621|NCT03827655|81823802|FG000|Overall Study|Reason not Specified|3|||
27998622|NCT03827655|81823803|FG001|Overall Study|Reason not Specified|1|||
27580694|NCT02031276|80309951|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
27580695|NCT02031276|80309952|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
27580696|NCT02031276|80309953|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
27580697|NCT02031276|80309951|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
27580698|NCT02031276|80309952|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
27580699|NCT02031276|80309953|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
27580700|NCT03823651|80309958|FG000|Overall Study|Death|5|||
27580701|NCT03823651|80309959|FG001|Overall Study|Death|0|||
27580702|NCT03823651|80309958|FG000|Overall Study|Physician Decision|1|||
27580703|NCT03823651|80309959|FG001|Overall Study|Physician Decision|0|||
27580704|NCT03823651|80309958|FG000|Overall Study|Caregiver to patient who died|0|||
27580705|NCT03823651|80309959|FG001|Overall Study|Caregiver to patient who died|5|||
27580706|NCT03823651|80309958|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
27580707|NCT03823651|80309959|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
27580708|NCT00403546|80309964|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
27580709|NCT00403546|80309965|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
27580710|NCT00403546|80309966|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
27580711|NCT00403546|80309964|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
27580712|NCT00403546|80309965|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
27580713|NCT00403546|80309966|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
27580714|NCT00403546|80309964|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
27580715|NCT00403546|80309965|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
27580716|NCT00403546|80309966|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
27580717|NCT00403546|80309964|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
27580718|NCT00403546|80309965|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
27805117|NCT01347879|81117263|FG000|Overall Study|Withdrawal by Subject|3|||
27805118|NCT01347879|81117264|FG001|Overall Study|Withdrawal by Subject|2|||
27805119|NCT01347879|81117263|FG000|Overall Study|Other|2|||
27805120|NCT01347879|81117264|FG001|Overall Study|Other|3|||
27805121|NCT03578276|81117268|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
27805122|NCT03578276|81117269|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
27805123|NCT03712228|81117270|FG000|Treatment Period 1|Lack of Efficacy|0|||
27805124|NCT03712228|81117271|FG001|Treatment Period 1|Lack of Efficacy|0|||
27805125|NCT03712228|81117272|FG002|Treatment Period 1|Lack of Efficacy|0|||
27805126|NCT03712228|81117273|FG003|Treatment Period 1|Lack of Efficacy|0|||
27805127|NCT03712228|81117274|FG004|Treatment Period 1|Lack of Efficacy|0|||
27805128|NCT03712228|81117275|FG005|Treatment Period 1|Lack of Efficacy|1|||
27805129|NCT03712228|81117270|FG000|Treatment Period 2|Pregnancy|0|||
27805130|NCT03712228|81117271|FG001|Treatment Period 2|Pregnancy|0|||
27805131|NCT03712228|81117272|FG002|Treatment Period 2|Pregnancy|0|||
27805132|NCT03712228|81117273|FG003|Treatment Period 2|Pregnancy|1|||
27805133|NCT03712228|81117274|FG004|Treatment Period 2|Pregnancy|0|||
27805134|NCT03712228|81117275|FG005|Treatment Period 2|Pregnancy|0|||
27805135|NCT03712228|81117270|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27805136|NCT03712228|81117271|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27805137|NCT03712228|81117272|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27805138|NCT03712228|81117273|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27805139|NCT03712228|81117274|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27805140|NCT03712228|81117275|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27805141|NCT01504867|81117276|FG000|Overall Study|Inclusion criteria not met|2|||
27805142|NCT01504867|81117277|FG001|Overall Study|Inclusion criteria not met|2|||
27805143|NCT01504867|81117276|FG000|Overall Study|Consent revoked|5|||
27805144|NCT01504867|81117277|FG001|Overall Study|Consent revoked|1|||
27805145|NCT00520351|81117281|FG000|First Intervention|Withdrawal by Subject|1|||
27805146|NCT00520351|81117282|FG001|First Intervention|Withdrawal by Subject|1|||
27805147|NCT00437281|81117283|FG000|Overall Study|Adverse Event|0|||
27805148|NCT00437281|81117284|FG001|Overall Study|Adverse Event|0|||
27805149|NCT00437281|81117285|FG002|Overall Study|Adverse Event|0|||
27594320|NCT01786512|80352506|FG002|Overall Study|Death|0|||
27594321|NCT01786512|80352507|FG003|Overall Study|Death|0|||
27805150|NCT00437281|81117286|FG003|Overall Study|Adverse Event|1|||
27594322|NCT01786512|80352508|FG004|Overall Study|Death|0|||
27594323|NCT01786512|80352509|FG005|Overall Study|Death|0|||
27805151|NCT00437281|81117287|FG004|Overall Study|Adverse Event|0|||
27805152|NCT00437281|81117288|FG005|Overall Study|Adverse Event|1|||
27998623|NCT03827655|81823804|FG002|Overall Study|Reason not Specified|1|||
27998624|NCT03827655|81823805|FG003|Overall Study|Reason not Specified|1|||
27998625|NCT03827655|81823806|FG004|Overall Study|Reason not Specified|1|||
27998626|NCT01449006|81823807|FG000|Overall Study|Lost to Follow-up|1|||
27998627|NCT01449006|81823808|FG001|Overall Study|Lost to Follow-up|0|||
27998628|NCT01449006|81823807|FG000|Overall Study|Withdrawal by Subject|1|||
27998629|NCT01449006|81823808|FG001|Overall Study|Withdrawal by Subject|0|||
27998630|NCT01449006|81823807|FG000|Overall Study|Protocol Violation|1|||
27998631|NCT01449006|81823808|FG001|Overall Study|Protocol Violation|0|||
27998632|NCT02221674|81823809|FG000|Overall Study|Lost to Follow-up|1|||
27998633|NCT02221674|81823810|FG001|Overall Study|Lost to Follow-up|0|||
27998634|NCT02221674|81823811|FG002|Overall Study|Lost to Follow-up|0|||
27998635|NCT01395901|81823812|FG000|Overall Study|Lost to Follow-up|4|||
27998636|NCT01395901|81823813|FG001|Overall Study|Lost to Follow-up|0|||
27998637|NCT01395901|81823812|FG000|Overall Study|Randomized but not received study drug|5|||
27998638|NCT01395901|81823813|FG001|Overall Study|Randomized but not received study drug|4|||
27998639|NCT01395901|81823812|FG000|Overall Study|Adverse Event|0|||
27998640|NCT01395901|81823813|FG001|Overall Study|Adverse Event|1|||
27998641|NCT01395901|81823812|FG000|Overall Study|Withdrawal of consent|1|||
27998642|NCT01395901|81823813|FG001|Overall Study|Withdrawal of consent|0|||
27998643|NCT00666224|81823814|FG000|Double-Blind|Adverse Event|15|||
27998644|NCT00666224|81823815|FG001|Double-Blind|Adverse Event|5|||
27998645|NCT00666224|81823814|FG000|Double-Blind|Lost to Follow-up|2|||
27998646|NCT00666224|81823815|FG001|Double-Blind|Lost to Follow-up|2|||
27998647|NCT00666224|81823814|FG000|Double-Blind|Withdrawal by Subject|18|||
27998648|NCT00666224|81823815|FG001|Double-Blind|Withdrawal by Subject|14|||
27998649|NCT00666224|81823814|FG000|Double-Blind|Physician Decision|0|||
27998650|NCT00666224|81823815|FG001|Double-Blind|Physician Decision|3|||
27998651|NCT00666224|81823814|FG000|Double-Blind|Sponsor decision|1|||
27998652|NCT00666224|81823815|FG001|Double-Blind|Sponsor decision|0|||
27998653|NCT00666224|81823814|FG000|Double-Blind|Pregnancy|3|||
27998654|NCT00666224|81823815|FG001|Double-Blind|Pregnancy|2|||
27998655|NCT00666224|81823814|FG000|Double-Blind|Noncompliance|1|||
27998656|NCT00666224|81823815|FG001|Double-Blind|Noncompliance|0|||
27998657|NCT00666224|81823814|FG000|Double-Blind|Death|1|||
27998658|NCT00666224|81823815|FG001|Double-Blind|Death|0|||
27998659|NCT00666224|81823814|FG000|Double-Blind|Undefined/Unknown|4|||
27998660|NCT00666224|81823815|FG001|Double-Blind|Undefined/Unknown|1|||
27998661|NCT00666224|81823814|FG000|Open-Label|Adverse Event|8|||
27998662|NCT00666224|81823815|FG001|Open-Label|Adverse Event|43|||
27998663|NCT00666224|81823814|FG000|Open-Label|Lost to Follow-up|4|||
27998664|NCT00666224|81823815|FG001|Open-Label|Lost to Follow-up|5|||
27998665|NCT00666224|81823814|FG000|Open-Label|Withdrawal by Subject|12|||
27998666|NCT00666224|81823815|FG001|Open-Label|Withdrawal by Subject|25|||
27998667|NCT00666224|81823814|FG000|Open-Label|Physician Decision|7|||
27998668|NCT00666224|81823815|FG001|Open-Label|Physician Decision|5|||
27998669|NCT00666224|81823814|FG000|Open-Label|Pregnancy|1|||
27998670|NCT00666224|81823815|FG001|Open-Label|Pregnancy|5|||
27998671|NCT00666224|81823814|FG000|Open-Label|Noncompliance|2|||
27998672|NCT00666224|81823815|FG001|Open-Label|Noncompliance|1|||
27998673|NCT00666224|81823814|FG000|Open-Label|Undefined/Unknown|1|||
27998674|NCT00666224|81823815|FG001|Open-Label|Undefined/Unknown|1|||
27998675|NCT01367834|81823824|FG000|Overall Study|Withdrawal by Subject|2|||
27998676|NCT01367834|81823825|FG001|Overall Study|Withdrawal by Subject|2|||
27998677|NCT01367834|81823824|FG000|Overall Study|Study was ended.|0|||
27998678|NCT01367834|81823825|FG001|Overall Study|Study was ended.|1|||
27998679|NCT00685165|81823837|FG000|Washout Period of 14 Days|Adverse Event|1|||
27998680|NCT00685165|81823838|FG001|Washout Period of 14 Days|Adverse Event|0|||
27998681|NCT00699608|81823839|FG000|First Intervention|Withdrawal by Subject|0|||
27998682|NCT00699608|81823840|FG001|First Intervention|Withdrawal by Subject|0|||
27998683|NCT00699608|81823841|FG002|First Intervention|Withdrawal by Subject|1|||
27998684|NCT00699608|81823842|FG003|First Intervention|Withdrawal by Subject|0|||
27998685|NCT00699608|81823843|FG004|First Intervention|Withdrawal by Subject|0|||
27998686|NCT00699608|81823844|FG005|First Intervention|Withdrawal by Subject|0|||
27998687|NCT00699608|81823839|FG000|First Intervention|Protocol Violation|0|||
27998688|NCT00699608|81823840|FG001|First Intervention|Protocol Violation|0|||
27998689|NCT00699608|81823841|FG002|First Intervention|Protocol Violation|0|||
27998690|NCT00699608|81823842|FG003|First Intervention|Protocol Violation|0|||
27998691|NCT00699608|81823843|FG004|First Intervention|Protocol Violation|1|||
27998692|NCT00699608|81823844|FG005|First Intervention|Protocol Violation|0|||
27998693|NCT00699608|81823839|FG000|Second Intervention|Adverse Event|0|||
27998694|NCT00699608|81823840|FG001|Second Intervention|Adverse Event|0|||
27998695|NCT00699608|81823841|FG002|Second Intervention|Adverse Event|1|||
27998696|NCT00699608|81823842|FG003|Second Intervention|Adverse Event|0|||
27998697|NCT00699608|81823843|FG004|Second Intervention|Adverse Event|0|||
27998698|NCT00699608|81823844|FG005|Second Intervention|Adverse Event|0|||
27998699|NCT00699608|81823839|FG000|Second Intervention|Withdrawal by Subject|0|||
27998700|NCT00699608|81823840|FG001|Second Intervention|Withdrawal by Subject|0|||
27998701|NCT00699608|81823841|FG002|Second Intervention|Withdrawal by Subject|0|||
27998702|NCT00699608|81823842|FG003|Second Intervention|Withdrawal by Subject|1|||
27998703|NCT00699608|81823843|FG004|Second Intervention|Withdrawal by Subject|0|||
27998704|NCT00699608|81823844|FG005|Second Intervention|Withdrawal by Subject|0|||
27998705|NCT03109184|81823845|FG000|Overall Study|Lost to Follow-up|6|||
27998706|NCT03109184|81823846|FG001|Overall Study|Lost to Follow-up|6|||
27998707|NCT03109184|81823845|FG000|Overall Study|Withdrawal by Subject|1|||
27998708|NCT03109184|81823846|FG001|Overall Study|Withdrawal by Subject|1|||
27998709|NCT04816214|81823847|FG000|Overall Study|Progressive Disease|4|||
27998710|NCT04816214|81823848|FG001|Overall Study|Progressive Disease|0|||
27998711|NCT04816214|81823849|FG002|Overall Study|Progressive Disease|0|||
27998712|NCT04816214|81823847|FG000|Overall Study|Death|1|||
27998713|NCT04816214|81823848|FG001|Overall Study|Death|0|||
27998714|NCT04816214|81823849|FG002|Overall Study|Death|0|||
27998715|NCT04816214|81823847|FG000|Overall Study|Study Terminated by Sponsor|1|||
27998716|NCT04816214|81823848|FG001|Overall Study|Study Terminated by Sponsor|0|||
27998717|NCT04816214|81823849|FG002|Overall Study|Study Terminated by Sponsor|0|||
27998718|NCT02871635|81823852|FG000|Overall Study|Primary lack of efficacy|4|||
27998719|NCT02871635|81823853|FG001|Overall Study|Primary lack of efficacy|4|||
27998720|NCT02871635|81823852|FG000|Overall Study|Protocol Violation|3|||
27998721|NCT02871635|81823853|FG001|Overall Study|Protocol Violation|1|||
27998722|NCT02871635|81823852|FG000|Overall Study|Lost to Follow-up|1|||
27998723|NCT02871635|81823853|FG001|Overall Study|Lost to Follow-up|2|||
27998724|NCT02871635|81823852|FG000|Overall Study|Pregnancy|0|||
27998725|NCT02871635|81823853|FG001|Overall Study|Pregnancy|2|||
27998726|NCT02871635|81823852|FG000|Overall Study|Physician Decision|1|||
27998727|NCT02871635|81823853|FG001|Overall Study|Physician Decision|1|||
27998728|NCT02871635|81823852|FG000|Overall Study|Withdrawal by Subject|3|||
27998729|NCT02871635|81823853|FG001|Overall Study|Withdrawal by Subject|4|||
27998730|NCT02871635|81823852|FG000|Overall Study|Adverse Event|4|||
27998731|NCT02871635|81823853|FG001|Overall Study|Adverse Event|4|||
27998732|NCT02871635|81823852|FG000|Overall Study|Secondary lack of efficacy|2|||
27998733|NCT02871635|81823853|FG001|Overall Study|Secondary lack of efficacy|1|||
27998734|NCT01987102|81823854|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
27998735|NCT01987102|81823855|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
27998736|NCT01987102|81823854|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
27998737|NCT01987102|81823855|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
27998738|NCT01987102|81823854|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
27998739|NCT01987102|81823855|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
27998740|NCT01987102|81823854|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
27998741|NCT01987102|81823855|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
27998742|NCT01987102|81823854|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
27998743|NCT01987102|81823855|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
27998744|NCT01987102|81823854|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
27998745|NCT01987102|81823855|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
27998746|NCT04794270|81823858|FG000|Period 1|Non Compliance|1|||
27998747|NCT04794270|81823859|FG001|Period 1|Non Compliance|0|||
27998748|NCT04794270|81823858|FG000|Period 1|Adverse Event|1|||
27998749|NCT04794270|81823859|FG001|Period 1|Adverse Event|0|||
27998750|NCT04794270|81823858|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
27998751|NCT04794270|81823859|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
27998752|NCT03361293|81823860|FG000|Overall Study|Lost to Follow-up|0|||
27998753|NCT03361293|81823861|FG001|Overall Study|Lost to Follow-up|2|||
27998754|NCT03361293|81823860|FG000|Overall Study|Withdrawal by Subject|1|||
27998755|NCT03361293|81823861|FG001|Overall Study|Withdrawal by Subject|3|||
27998756|NCT02532465|81826813|FG000|Overall Study|Protocol Violation|1|||
27998757|NCT02532465|81826814|FG001|Overall Study|Protocol Violation|0|||
27998758|NCT02532465|81826813|FG000|Overall Study|Lack of Efficacy|0|||
27998759|NCT02532465|81826814|FG001|Overall Study|Lack of Efficacy|1|||
27998760|NCT04317040|81826817|FG000|Overall Study|Lost to Follow-up|2|||
27998761|NCT04317040|81826818|FG001|Overall Study|Lost to Follow-up|0|||
27998762|NCT04317040|81826817|FG000|Overall Study|Death|16|||
27998763|NCT04317040|81826818|FG001|Overall Study|Death|18|||
27998764|NCT04317040|81826817|FG000|Overall Study|Withdrawal by Subject|0|||
27998765|NCT04317040|81826818|FG001|Overall Study|Withdrawal by Subject|1|||
27998766|NCT04317040|81826817|FG000|Overall Study|Incomplete assessments|0|||
27680560|NCT01038427|80664654|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27998767|NCT04317040|81826818|FG001|Overall Study|Incomplete assessments|1|||
27998768|NCT01380769|81826819|FG000|Overall Study|Withdrawal by Subject|7|||
27998769|NCT01380769|81826820|FG001|Overall Study|Withdrawal by Subject|11|||
27998770|NCT01380769|81826819|FG000|Overall Study|Physician Decision|1|||
27998771|NCT01380769|81826820|FG001|Overall Study|Physician Decision|1|||
27998772|NCT01380769|81826819|FG000|Overall Study|Adverse Event|1|||
27998773|NCT01380769|81826820|FG001|Overall Study|Adverse Event|1|||
27998774|NCT01380769|81826819|FG000|Overall Study|Protocol Violation|0|||
27998775|NCT01380769|81826820|FG001|Overall Study|Protocol Violation|1|||
27998776|NCT02442349|81826821|FG000|Overall Study|Death|14|||
27998777|NCT02442349|81826821|FG000|Overall Study|Withdrawal by Subject|8|||
27680561|NCT01038427|80664655|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
27680562|NCT01038427|80664653|FG000|Overall Study|Withdrew consent|0|||
27680563|NCT01038427|80664654|FG001|Overall Study|Withdrew consent|0|||
27680564|NCT01038427|80664655|FG002|Overall Study|Withdrew consent|1|||
27805153|NCT00437281|81117289|FG006|Overall Study|Adverse Event|0|||
27805154|NCT00437281|81117290|FG007|Overall Study|Adverse Event|0|||
27805155|NCT00437281|81117291|FG008|Overall Study|Adverse Event|0|||
27805156|NCT00437281|81117292|FG009|Overall Study|Adverse Event|1|||
27805157|NCT00437281|81117293|FG010|Overall Study|Adverse Event|0|||
27805158|NCT00437281|81117294|FG011|Overall Study|Adverse Event|0|||
27580719|NCT00403546|80309966|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
27580720|NCT00403546|80309964|FG000|Screening Phase|Screening Failure|22|||
27580721|NCT00403546|80309965|FG001|Screening Phase|Screening Failure|0|||
27580722|NCT00403546|80309966|FG002|Screening Phase|Screening Failure|0|||
27805159|NCT00437281|81117295|FG012|Overall Study|Adverse Event|0|||
27805160|NCT00437281|81117296|FG013|Overall Study|Adverse Event|1|||
27805161|NCT00437281|81117297|FG014|Overall Study|Adverse Event|1|||
27805162|NCT00437281|81117298|FG015|Overall Study|Adverse Event|0|||
27805163|NCT00437281|81117299|FG016|Overall Study|Adverse Event|0|||
27805164|NCT00437281|81117300|FG017|Overall Study|Adverse Event|0|||
27805165|NCT00437281|81117301|FG018|Overall Study|Adverse Event|1|||
27805166|NCT00437281|81117302|FG019|Overall Study|Adverse Event|0|||
27580723|NCT00403546|80309964|FG000|Screening Phase|Adverse Event|1|||
27580724|NCT00403546|80309965|FG001|Screening Phase|Adverse Event|0|||
27580725|NCT00403546|80309966|FG002|Screening Phase|Adverse Event|0|||
27580726|NCT00403546|80309964|FG000|Screening Phase|Terminated Prior to Randomization|5|||
27580727|NCT00403546|80309965|FG001|Screening Phase|Terminated Prior to Randomization|0|||
27594324|NCT01786512|80352510|FG006|Overall Study|Death|0|||
27594325|NCT01786512|80352511|FG007|Overall Study|Death|0|||
27594326|NCT01786512|80352512|FG008|Overall Study|Death|4|||
27594327|NCT01786512|80352513|FG009|Overall Study|Death|1|||
27594328|NCT01786512|80352514|FG010|Overall Study|Death|3|||
27594329|NCT01381692|80352515|FG000|Overall Study|Adverse Event|1|||
27594330|NCT01381692|80352516|FG001|Overall Study|Adverse Event|0|||
27594331|NCT01381692|80352517|FG002|Overall Study|Adverse Event|0|||
27594332|NCT01381692|80352518|FG003|Overall Study|Adverse Event|0|||
27594333|NCT01381692|80352519|FG004|Overall Study|Adverse Event|0|||
27594334|NCT01381692|80352520|FG005|Overall Study|Adverse Event|0|||
27594335|NCT00201006|80352521|FG000|Overall Study|Withdrawal by Subject|7|||
27594336|NCT00201006|80352522|FG001|Overall Study|Withdrawal by Subject|2|||
27594337|NCT00201006|80352523|FG002|Overall Study|Withdrawal by Subject|3|||
27594338|NCT00201006|80352521|FG000|Overall Study|Adverse Event|1|||
27594339|NCT00201006|80352522|FG001|Overall Study|Adverse Event|0|||
27594340|NCT00201006|80352523|FG002|Overall Study|Adverse Event|1|||
27594341|NCT03966157|80352527|FG000|Overall Study|Physician Decision|1|||
27594342|NCT03966157|80352528|FG001|Overall Study|Physician Decision|0|||
27594343|NCT00726752|80352529|FG000|Overall Study|Lack of Efficacy|6|||
27594344|NCT01814371|80352530|FG000|Overall Study|Lost to Follow-up|30|||
27594345|NCT01814371|80352531|FG001|Overall Study|Lost to Follow-up|27|||
27594346|NCT01777854|80352534|FG000|Overall Study|Physician Decision|3|||
27594347|NCT01777854|80352535|FG001|Overall Study|Physician Decision|3|||
27594348|NCT01754467|80352537|FG000|Overall Study|Lost to Follow-up|1|||
27594349|NCT02862106|80352541|FG000|Overall Study|Adverse Event|4|||
27594350|NCT02862106|80352542|FG001|Overall Study|Adverse Event|0|||
27594351|NCT02862106|80352541|FG000|Overall Study|Protocol Violation|16|||
27594352|NCT02862106|80352542|FG001|Overall Study|Protocol Violation|1|||
27594353|NCT02862106|80352541|FG000|Overall Study|Lost to Follow-up|15|||
27594354|NCT02862106|80352542|FG001|Overall Study|Lost to Follow-up|5|||
27594355|NCT02862106|80352541|FG000|Overall Study|Withdrawal by Subject|2|||
27594356|NCT02862106|80352542|FG001|Overall Study|Withdrawal by Subject|0|||
27594357|NCT02862106|80352541|FG000|Overall Study|Subjects moved to other city|1|||
27594358|NCT02862106|80352542|FG001|Overall Study|Subjects moved to other city|0|||
27594359|NCT01540851|80352546|FG000|Overall Study|Lost to Follow-up|14|||
27594360|NCT01540851|80352547|FG001|Overall Study|Lost to Follow-up|15|||
27594361|NCT01540851|80352546|FG000|Overall Study|Withdrawal by Subject|7|||
27594362|NCT01540851|80352547|FG001|Overall Study|Withdrawal by Subject|3|||
27594363|NCT00175825|80356054|FG000|Overall Study|Adverse Event|3|||
27594364|NCT00175825|80356055|FG001|Overall Study|Adverse Event|2|||
27594365|NCT00175825|80356056|FG002|Overall Study|Adverse Event|1|||
27594366|NCT00175825|80356057|FG003|Overall Study|Adverse Event|1|||
27594367|NCT00175825|80356054|FG000|Overall Study|Lost to Follow-up|1|||
27594368|NCT00175825|80356055|FG001|Overall Study|Lost to Follow-up|2|||
27594369|NCT00175825|80356056|FG002|Overall Study|Lost to Follow-up|0|||
27594370|NCT00175825|80356057|FG003|Overall Study|Lost to Follow-up|0|||
27594371|NCT00175825|80356054|FG000|Overall Study|Withdrawal by Subject|1|||
27594372|NCT00175825|80356055|FG001|Overall Study|Withdrawal by Subject|0|||
27594373|NCT00175825|80356056|FG002|Overall Study|Withdrawal by Subject|0|||
27594374|NCT00175825|80356057|FG003|Overall Study|Withdrawal by Subject|0|||
27594375|NCT00522275|80356058|FG000|Overall Study|Adverse Event|35|||
27594376|NCT00522275|80356058|FG000|Overall Study|Lack of Efficacy|80|||
27594377|NCT00522275|80356058|FG000|Overall Study|Subject withdrew consent|16|||
27594378|NCT00522275|80356058|FG000|Overall Study|Protocol deviation|1|||
27580728|NCT00403546|80309966|FG002|Screening Phase|Terminated Prior to Randomization|0|||
27580729|NCT00403546|80309964|FG000|Randomized Trial|Early Terminations|0|||
27580730|NCT00403546|80309965|FG001|Randomized Trial|Early Terminations|17|||
27580731|NCT00403546|80309966|FG002|Randomized Trial|Early Terminations|16|||
27580732|NCT02732847|80309967|FG000|Overall Study|some filled early|42|||
27580733|NCT02732847|80309968|FG001|Overall Study|some filled early|42|||
27580734|NCT00634647|80309975|FG000|Overall Study|death on study|3|||
27580735|NCT00634647|80309975|FG000|Overall Study|refused further treatment|3|||
27580736|NCT00634647|80309975|FG000|Overall Study|declined to participate before treatment|1|||
27580737|NCT02530619|80309978|FG000|Registered for Study|Withdrawal by Subject|2|||
27580738|NCT02530619|80309978|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
27580739|NCT02530619|80309978|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
27580740|NCT02530619|80309978|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
27580741|NCT02530619|80309978|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
27580742|NCT02530619|80309978|FG000|Follow-up Period (6 Months)|Death|4|||
27580743|NCT02530619|80309978|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
27580744|NCT02530619|80309978|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
27580745|NCT04223856|80309984|FG000|Overall Study|Progressive disease|153|||
27580746|NCT04223856|80309985|FG001|Overall Study|Progressive disease|73|||
27580747|NCT04223856|80309984|FG000|Overall Study|Adverse Event|97|||
27998778|NCT02442349|81826821|FG000|Overall Study|On-going Study at Data Cut-off|149|||
27580748|NCT04223856|80309985|FG001|Overall Study|Adverse Event|62|||
27580749|NCT04223856|80309984|FG000|Overall Study|Physician Decision|9|||
27580750|NCT04223856|80309985|FG001|Overall Study|Physician Decision|28|||
27998779|NCT00806988|81826824|FG000|Overall Study|Death|15|||
27998780|NCT00806988|81826825|FG001|Overall Study|Death|16|||
27998781|NCT00806988|81826824|FG000|Overall Study|Withdrawal by Subject|8|||
27998782|NCT00806988|81826825|FG001|Overall Study|Withdrawal by Subject|8|||
27998783|NCT00806988|81826824|FG000|Overall Study|Lost to Follow-up|4|||
27998784|NCT00806988|81826825|FG001|Overall Study|Lost to Follow-up|19|||
27998785|NCT01633541|81826826|FG000|Overall Study|Death|1|||
27998786|NCT01633541|81826827|FG001|Overall Study|Death|0|||
27998787|NCT00410761|81826828|FG000|Overall Study|Adverse Event|29|||
27998788|NCT00410761|81826829|FG001|Overall Study|Adverse Event|3|||
27998789|NCT00410761|81826828|FG000|Overall Study|objective disease progression|71|||
27998790|NCT00410761|81826829|FG001|Overall Study|objective disease progression|55|||
27998791|NCT00410761|81826828|FG000|Overall Study|Withdrawal by Subject|8|||
27998792|NCT00410761|81826829|FG001|Overall Study|Withdrawal by Subject|4|||
27998793|NCT00410761|81826828|FG000|Overall Study|Other|12|||
27998794|NCT00410761|81826829|FG001|Overall Study|Other|9|||
27998795|NCT00410761|81826828|FG000|Overall Study|Never received randomised treatment|0|||
27998796|NCT00410761|81826829|FG001|Overall Study|Never received randomised treatment|1|||
27998797|NCT01787461|81826830|FG000|Overall Study|Adverse Event|4|||
27998798|NCT01787461|81826831|FG001|Overall Study|Adverse Event|3|||
27998799|NCT01787461|81826830|FG000|Overall Study|Lost to Follow-up|3|||
27998800|NCT01787461|81826831|FG001|Overall Study|Lost to Follow-up|2|||
27998801|NCT01787461|81826830|FG000|Overall Study|No longer met eligibility criteria|1|||
27998802|NCT01787461|81826831|FG001|Overall Study|No longer met eligibility criteria|0|||
27998803|NCT01787461|81826830|FG000|Overall Study|Withdrawal by Subject|3|||
27998804|NCT01787461|81826831|FG001|Overall Study|Withdrawal by Subject|4|||
27998805|NCT01787461|81826830|FG000|Overall Study|Protocol Violation|3|||
27998806|NCT01787461|81826831|FG001|Overall Study|Protocol Violation|0|||
27998807|NCT02045095|81826833|FG000|Overall Study|Other|0|||
27998808|NCT02045095|81826834|FG001|Overall Study|Other|0|||
27998809|NCT02045095|81826835|FG002|Overall Study|Other|1|||
27998810|NCT02045095|81826836|FG003|Overall Study|Other|0|||
27998811|NCT02045095|81826837|FG004|Overall Study|Other|0|||
27580751|NCT04223856|80309984|FG000|Overall Study|Withdrawal by Subject|22|||
27580752|NCT04223856|80309985|FG001|Overall Study|Withdrawal by Subject|24|||
27580753|NCT04223856|80309984|FG000|Overall Study|Other|7|||
27580754|NCT04223856|80309985|FG001|Overall Study|Other|2|||
27998812|NCT02045095|81826838|FG005|Overall Study|Other|2|||
27998813|NCT02045095|81826839|FG006|Overall Study|Other|0|||
27998814|NCT02045095|81826833|FG000|Overall Study|Progressive Disease|3|||
27998815|NCT02045095|81826834|FG001|Overall Study|Progressive Disease|3|||
27998816|NCT02045095|81826835|FG002|Overall Study|Progressive Disease|2|||
27680565|NCT01038427|80664653|FG000|Overall Study|Adverse Event|2|||
27680566|NCT01038427|80664654|FG001|Overall Study|Adverse Event|2|||
27680567|NCT01038427|80664655|FG002|Overall Study|Adverse Event|1|||
27680568|NCT01038427|80664653|FG000|Overall Study|Enrolled in error|0|||
27680569|NCT01038427|80664654|FG001|Overall Study|Enrolled in error|1|||
27680570|NCT01038427|80664655|FG002|Overall Study|Enrolled in error|1|||
27680571|NCT01038427|80664653|FG000|Overall Study|Other|0|||
27680572|NCT01038427|80664654|FG001|Overall Study|Other|2|||
27680573|NCT01038427|80664655|FG002|Overall Study|Other|0|||
27873025|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Death|0|||
27873026|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Death|0|||
27873027|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
27873028|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
27873029|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
27873030|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
27873031|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
27873032|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
27873033|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
27873034|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
27873035|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
27873036|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
27873037|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
27873038|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
27873039|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
27873040|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
27873041|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
27873042|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
27873043|NCT01995513|81368355|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
27873044|NCT01995513|81368356|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
27873045|NCT01995513|81368357|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
27873046|NCT01995513|81368358|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
27873047|NCT01995513|81368355|FG000|Period 1: Second Open Label Treatment|Other|0|||
27873048|NCT01995513|81368356|FG001|Period 1: Second Open Label Treatment|Other|2|||
27873049|NCT01995513|81368357|FG002|Period 1: Second Open Label Treatment|Other|0|||
27873050|NCT01995513|81368358|FG003|Period 1: Second Open Label Treatment|Other|0|||
27873051|NCT01995513|81368355|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
27873052|NCT01995513|81368356|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
27873053|NCT01995513|81368357|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
27873054|NCT01995513|81368358|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
27873055|NCT01995513|81368355|FG000|Period 2: Double Blind Treatment|Death|0|||
27580755|NCT04223856|80309984|FG000|Overall Study|Randomized but not treated|2|||
27580756|NCT04223856|80309985|FG001|Overall Study|Randomized but not treated|11|||
27580757|NCT04223856|80309984|FG000|Overall Study|On-treatment|144|||
27580758|NCT04223856|80309985|FG001|Overall Study|On-treatment|0|||
27580759|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27680574|NCT02797522|80664656|FG000|Overall Study|Study Terminated by Sponsor|0|||
27580760|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580761|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580762|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580763|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27580764|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27680575|NCT02797522|80664657|FG001|Overall Study|Study Terminated by Sponsor|0|||
27680576|NCT02797522|80664658|FG002|Overall Study|Study Terminated by Sponsor|0|||
27680577|NCT02797522|80664659|FG003|Overall Study|Study Terminated by Sponsor|0|||
27680578|NCT02797522|80664660|FG004|Overall Study|Study Terminated by Sponsor|0|||
27680579|NCT02797522|80664661|FG005|Overall Study|Study Terminated by Sponsor|0|||
27680580|NCT02797522|80664662|FG006|Overall Study|Study Terminated by Sponsor|0|||
27680581|NCT02797522|80664663|FG007|Overall Study|Study Terminated by Sponsor|4|||
27680582|NCT02797522|80664664|FG008|Overall Study|Study Terminated by Sponsor|2|||
27680583|NCT02797522|80664665|FG009|Overall Study|Study Terminated by Sponsor|4|||
27680584|NCT02797522|80664666|FG010|Overall Study|Study Terminated by Sponsor|1|||
27680585|NCT00669877|80664667|FG000|Overall Study|Disease Progression/Death|4|||
27680586|NCT01399697|80664668|FG000|Overall Study|Adverse Event|13|||
27680587|NCT01399697|80664669|FG001|Overall Study|Adverse Event|3|||
27680588|NCT01399697|80664670|FG002|Overall Study|Adverse Event|1|||
27680589|NCT01399697|80664668|FG000|Overall Study|Lost to Follow-up|2|||
27680590|NCT01399697|80664669|FG001|Overall Study|Lost to Follow-up|0|||
27680591|NCT01399697|80664670|FG002|Overall Study|Lost to Follow-up|0|||
27680592|NCT01399697|80664668|FG000|Overall Study|Withdrawal by Subject|8|||
27680593|NCT01399697|80664669|FG001|Overall Study|Withdrawal by Subject|0|||
27680594|NCT01399697|80664670|FG002|Overall Study|Withdrawal by Subject|0|||
27680595|NCT01399697|80664668|FG000|Overall Study|Investigator Decisión|1|||
27680596|NCT01399697|80664669|FG001|Overall Study|Investigator Decisión|0|||
27680597|NCT01399697|80664670|FG002|Overall Study|Investigator Decisión|2|||
27680598|NCT01399697|80664668|FG000|Overall Study|Lack of Efficacy|9|||
27680599|NCT01399697|80664669|FG001|Overall Study|Lack of Efficacy|0|||
27680600|NCT01399697|80664670|FG002|Overall Study|Lack of Efficacy|1|||
27680601|NCT01399697|80664668|FG000|Overall Study|Protocol Violation|2|||
27680602|NCT01399697|80664669|FG001|Overall Study|Protocol Violation|0|||
27680603|NCT01399697|80664670|FG002|Overall Study|Protocol Violation|0|||
27680604|NCT01399697|80664668|FG000|Overall Study|Non-Compliant|1|||
27680605|NCT01399697|80664669|FG001|Overall Study|Non-Compliant|0|||
27680606|NCT01399697|80664670|FG002|Overall Study|Non-Compliant|0|||
27680607|NCT01399697|80664668|FG000|Overall Study|Inclusion Error|2|||
27998817|NCT02045095|81826836|FG003|Overall Study|Progressive Disease|4|||
27998818|NCT02045095|81826837|FG004|Overall Study|Progressive Disease|2|||
27998819|NCT02045095|81826838|FG005|Overall Study|Progressive Disease|4|||
27998820|NCT02045095|81826839|FG006|Overall Study|Progressive Disease|1|||
27998821|NCT02045095|81826833|FG000|Overall Study|Withdrawal by Subject|0|||
27998822|NCT02045095|81826834|FG001|Overall Study|Withdrawal by Subject|0|||
27998823|NCT02045095|81826835|FG002|Overall Study|Withdrawal by Subject|0|||
27998824|NCT02045095|81826836|FG003|Overall Study|Withdrawal by Subject|0|||
27998825|NCT02045095|81826837|FG004|Overall Study|Withdrawal by Subject|3|||
27998826|NCT02045095|81826838|FG005|Overall Study|Withdrawal by Subject|0|||
27998827|NCT02045095|81826839|FG006|Overall Study|Withdrawal by Subject|0|||
27998828|NCT02045095|81826833|FG000|Overall Study|Adverse Event|0|||
27998829|NCT02045095|81826834|FG001|Overall Study|Adverse Event|1|||
27998830|NCT02045095|81826835|FG002|Overall Study|Adverse Event|1|||
27998831|NCT02045095|81826836|FG003|Overall Study|Adverse Event|0|||
27680608|NCT01399697|80664669|FG001|Overall Study|Inclusion Error|0|||
27680609|NCT01399697|80664670|FG002|Overall Study|Inclusion Error|0|||
27680610|NCT01399697|80664668|FG000|Overall Study|Positive result for hepatitis B|1|||
27680611|NCT01399697|80664669|FG001|Overall Study|Positive result for hepatitis B|0|||
27680612|NCT01399697|80664670|FG002|Overall Study|Positive result for hepatitis B|0|||
27998832|NCT02045095|81826837|FG004|Overall Study|Adverse Event|0|||
27998833|NCT02045095|81826838|FG005|Overall Study|Adverse Event|2|||
27998834|NCT02045095|81826839|FG006|Overall Study|Adverse Event|0|||
27998835|NCT01424501|81826842|FG000|Overall Study|Withdrawal by Subject|1|||
27680613|NCT01399697|80664668|FG000|Overall Study|Clinical RA remission|1|||
27680614|NCT01399697|80664669|FG001|Overall Study|Clinical RA remission|0|||
27680615|NCT01399697|80664670|FG002|Overall Study|Clinical RA remission|0|||
27680616|NCT01399697|80664668|FG000|Overall Study|Sponsor Decision|1|||
27680617|NCT01399697|80664669|FG001|Overall Study|Sponsor Decision|0|||
27680618|NCT01399697|80664670|FG002|Overall Study|Sponsor Decision|0|||
27680619|NCT02242097|80664671|FG000|Ibrutinib Treatment|Adverse Event|16|||
27680620|NCT02242097|80664671|FG000|Ibrutinib Treatment|Physician Decision|1|||
27680621|NCT02242097|80664671|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
27680622|NCT02242097|80664671|FG000|Ibrutinib Treatment|Death|1|||
27680623|NCT02242097|80664671|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
27680624|NCT02242097|80664671|FG000|Post Therapy Follow Up|Death|3|||
27680625|NCT02242097|80664671|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
27680626|NCT01277887|80664672|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
27680627|NCT01277887|80664673|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
27680628|NCT01277887|80664672|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
27680629|NCT01277887|80664673|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
27680630|NCT01277887|80664672|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
27680631|NCT01277887|80664673|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
27700931|NCT03471871|80741255|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
27700932|NCT03471871|80741251|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
27700933|NCT03471871|80741252|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
27700934|NCT03471871|80741253|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
27700935|NCT03471871|80741254|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
27700936|NCT03471871|80741255|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
27700937|NCT03471871|80741251|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
27700938|NCT03471871|80741252|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
27700939|NCT03471871|80741253|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
27700940|NCT03471871|80741254|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
27700941|NCT03471871|80741255|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
27700942|NCT03471871|80741251|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
27700943|NCT03471871|80741252|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
27700944|NCT03471871|80741253|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
27700945|NCT03471871|80741254|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
27700946|NCT03471871|80741255|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
27700947|NCT03471871|80741251|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
27700948|NCT03471871|80741252|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
27700949|NCT03471871|80741253|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
27700950|NCT03471871|80741254|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
27700951|NCT03471871|80741255|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
27700952|NCT01009203|80741256|FG000|Overall Study|Withdrawal by Subject|1|||
27700953|NCT01009203|80741256|FG000|Overall Study|Adverse Event|5|||
27700954|NCT01009203|80741256|FG000|Overall Study|Treatment-unrelated death|1|||
27700955|NCT01399190|80741280|FG000|Overall Study|Not Eligible for Final Analysis|5|||
27700956|NCT01399190|80741280|FG000|Overall Study|Adverse Event|8|||
27700957|NCT01399190|80741280|FG000|Overall Study|Participant's Request|5|||
27700958|NCT01399190|80741280|FG000|Overall Study|Physician Decision|2|||
27700959|NCT02066051|80741283|FG000|Overall Study|Subject developed active GVHD|1|||
27700960|NCT01798992|80741284|FG000|Overall Study|Administrative withdrawal|0|||
27700961|NCT01798992|80741285|FG001|Overall Study|Administrative withdrawal|1|||
27700962|NCT01798992|80741286|FG002|Overall Study|Administrative withdrawal|0|||
27700963|NCT01798992|80741287|FG003|Overall Study|Administrative withdrawal|1|||
27700964|NCT01798992|80741284|FG000|Overall Study|Lost to Follow-up|0|||
27700965|NCT01798992|80741285|FG001|Overall Study|Lost to Follow-up|1|||
27700966|NCT01798992|80741286|FG002|Overall Study|Lost to Follow-up|1|||
27700967|NCT01798992|80741287|FG003|Overall Study|Lost to Follow-up|0|||
27700968|NCT01798992|80741284|FG000|Overall Study|Insufficient biopsy tissue|0|||
27700969|NCT01798992|80741285|FG001|Overall Study|Insufficient biopsy tissue|0|||
27700970|NCT01798992|80741286|FG002|Overall Study|Insufficient biopsy tissue|1|||
27700971|NCT01798992|80741287|FG003|Overall Study|Insufficient biopsy tissue|0|||
27700972|NCT01241552|80741289|FG000|Overall Study|Lack of Efficacy|1|||
27700973|NCT01241552|80741290|FG001|Overall Study|Lack of Efficacy|0|||
27700974|NCT01241552|80741291|FG002|Overall Study|Lack of Efficacy|0|||
27700975|NCT01241552|80741292|FG003|Overall Study|Lack of Efficacy|0|||
27700976|NCT01241552|80741289|FG000|Overall Study|Death|26|||
27700977|NCT01241552|80741290|FG001|Overall Study|Death|30|||
27700978|NCT01241552|80741291|FG002|Overall Study|Death|20|||
27700979|NCT01241552|80741292|FG003|Overall Study|Death|25|||
27700980|NCT01241552|80741289|FG000|Overall Study|Adverse Event|1|||
27700981|NCT01241552|80741290|FG001|Overall Study|Adverse Event|1|||
27700982|NCT01241552|80741291|FG002|Overall Study|Adverse Event|0|||
27700983|NCT01241552|80741292|FG003|Overall Study|Adverse Event|0|||
27998836|NCT01424501|81826843|FG001|Overall Study|Withdrawal by Subject|0|||
27998837|NCT01424501|81826844|FG002|Overall Study|Withdrawal by Subject|1|||
27998838|NCT01424501|81826845|FG003|Overall Study|Withdrawal by Subject|0|||
27998839|NCT01424501|81826846|FG004|Overall Study|Withdrawal by Subject|0|||
27998840|NCT01424501|81826847|FG005|Overall Study|Withdrawal by Subject|0|||
27998841|NCT01424501|81826842|FG000|Overall Study|Lost to Follow-up|0|||
27998842|NCT01424501|81826843|FG001|Overall Study|Lost to Follow-up|1|||
27998843|NCT01424501|81826844|FG002|Overall Study|Lost to Follow-up|1|||
27998844|NCT01424501|81826845|FG003|Overall Study|Lost to Follow-up|0|||
27998845|NCT01424501|81826846|FG004|Overall Study|Lost to Follow-up|0|||
27998846|NCT01424501|81826847|FG005|Overall Study|Lost to Follow-up|0|||
27998847|NCT00844376|81826848|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
27998848|NCT00844376|81826849|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
27998849|NCT02362724|81826850|FG000|Overall Study|Withdrawal by Subject|3|||
27998850|NCT02362724|81826851|FG001|Overall Study|Withdrawal by Subject|1|||
27998851|NCT02362724|81826850|FG000|Overall Study|Adverse Event|3|||
27998852|NCT02362724|81826851|FG001|Overall Study|Adverse Event|0|||
27998853|NCT01691794|81826852|FG000|Overall Study|Poor/Non-Compliance|1|||
27998854|NCT01691794|81826853|FG001|Overall Study|Poor/Non-Compliance|4|||
27998855|NCT01691794|81826854|FG002|Overall Study|Poor/Non-Compliance|1|||
27998856|NCT01691794|81826852|FG000|Overall Study|Death|0|||
27998857|NCT01691794|81826853|FG001|Overall Study|Death|0|||
27998858|NCT01691794|81826854|FG002|Overall Study|Death|1|||
27998859|NCT01691794|81826852|FG000|Overall Study|Lack of Efficacy|0|||
27998860|NCT01691794|81826853|FG001|Overall Study|Lack of Efficacy|7|||
27998861|NCT01691794|81826854|FG002|Overall Study|Lack of Efficacy|1|||
27998862|NCT01691794|81826852|FG000|Overall Study|Participant request to discontinue|0|||
27998863|NCT01691794|81826853|FG001|Overall Study|Participant request to discontinue|1|||
27998864|NCT01691794|81826854|FG002|Overall Study|Participant request to discontinue|0|||
27998865|NCT01691794|81826852|FG000|Overall Study|Adverse Event|0|||
27998866|NCT01691794|81826853|FG001|Overall Study|Adverse Event|1|||
27998867|NCT01691794|81826854|FG002|Overall Study|Adverse Event|1|||
27998868|NCT01691794|81826852|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
27998869|NCT01691794|81826853|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
27998870|NCT01691794|81826854|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
27998871|NCT01691794|81826852|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
27998872|NCT01691794|81826853|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
27998873|NCT01691794|81826854|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
27998874|NCT01363700|81826855|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27998875|NCT01363700|81826856|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
27998876|NCT01363700|81826857|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27998877|NCT01363700|81826858|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27998878|NCT01363700|81826859|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
27998879|NCT00936702|81826862|FG000|Overall Study|Disease progression|34|||
27998880|NCT00936702|81826862|FG000|Overall Study|Adverse Event|8|||
27680632|NCT03653208|80667842|FG000|Overall Study|Withdrawal by Subject|0|||
27680633|NCT03653208|80667843|FG001|Overall Study|Withdrawal by Subject|0|||
27998881|NCT00936702|81826862|FG000|Overall Study|Withdrawal by Subject|2|||
27998882|NCT00936702|81826862|FG000|Overall Study|Alternative Treatment|1|||
27998883|NCT00936702|81826862|FG000|Overall Study|Other|1|||
27998884|NCT02260934|81826866|FG000|Overall Study|Lost to Follow-up|2|||
27998885|NCT02260934|81826867|FG001|Overall Study|Lost to Follow-up|1|||
27580765|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580766|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27580767|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27580768|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580769|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27580770|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
27680634|NCT03653208|80667844|FG002|Overall Study|Withdrawal by Subject|0|||
27680635|NCT03653208|80667845|FG003|Overall Study|Withdrawal by Subject|0|||
27680636|NCT03653208|80667846|FG004|Overall Study|Withdrawal by Subject|1|||
27680637|NCT03653208|80667847|FG005|Overall Study|Withdrawal by Subject|0|||
27680638|NCT03653208|80667848|FG006|Overall Study|Withdrawal by Subject|0|||
27680639|NCT03653208|80667849|FG007|Overall Study|Withdrawal by Subject|1|||
27680640|NCT03653208|80667850|FG008|Overall Study|Withdrawal by Subject|1|||
27680641|NCT03274895|80667851|FG000|Overall Study|Lack of Efficacy|1|||
27680642|NCT03274895|80667852|FG001|Overall Study|Lack of Efficacy|0|||
27680643|NCT03274895|80667851|FG000|Overall Study|Adverse Event|8|||
27680644|NCT03274895|80667852|FG001|Overall Study|Adverse Event|7|||
27680645|NCT03274895|80667851|FG000|Overall Study|Lost to Follow-up|1|||
27998886|NCT02260934|81826866|FG000|Overall Study|Withdrawal by Subject|0|||
27680646|NCT03274895|80667852|FG001|Overall Study|Lost to Follow-up|0|||
27680647|NCT03274895|80667851|FG000|Overall Study|Diagnosis not confirmed|3|||
27680648|NCT03274895|80667852|FG001|Overall Study|Diagnosis not confirmed|4|||
27680649|NCT02091206|80667853|FG000|Treatment Period|Adverse Event|0|||
27998887|NCT02260934|81826867|FG001|Overall Study|Withdrawal by Subject|2|||
27580771|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580772|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580773|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580774|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
27580775|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27580776|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
27580777|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
27580778|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
27580779|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
27580780|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
27580781|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
27580782|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
27580783|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
27580784|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
27580785|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
27580786|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
27580787|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27580788|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27580789|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27580790|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
27580791|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580792|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580793|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580794|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580795|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580796|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
27580797|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
27580798|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580799|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580800|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
27580801|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
27580802|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
27580803|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580804|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580805|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580806|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
27580807|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580808|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580809|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580810|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580811|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27680650|NCT02091206|80667854|FG001|Treatment Period|Adverse Event|1|||
27680651|NCT02091206|80667855|FG002|Treatment Period|Adverse Event|0|||
27680652|NCT02091206|80667856|FG003|Treatment Period|Adverse Event|0|||
27680653|NCT02091206|80667853|FG000|Treatment Period|Met withdrawal criteria|0|||
27680654|NCT02091206|80667854|FG001|Treatment Period|Met withdrawal criteria|0|||
27680655|NCT02091206|80667855|FG002|Treatment Period|Met withdrawal criteria|1|||
27998888|NCT02260934|81826866|FG000|Overall Study|Participant Relocated|1|||
27998889|NCT02260934|81826867|FG001|Overall Study|Participant Relocated|0|||
27998890|NCT02260934|81826866|FG000|Overall Study|Site error|0|||
27998891|NCT02260934|81826867|FG001|Overall Study|Site error|1|||
27998892|NCT01016600|81826868|FG000|Overall Study|Did not start treatment|1|||
27998893|NCT01016600|81826869|FG001|Overall Study|Did not start treatment|0|||
27998894|NCT01016600|81826870|FG002|Overall Study|Did not start treatment|0|||
27998895|NCT01016600|81826871|FG003|Overall Study|Did not start treatment|0|||
27998896|NCT00269919|81826872|FG000|Overall Study|Other|26|||
27998897|NCT00269919|81826872|FG000|Overall Study|Started but not treated|1|||
27998898|NCT02995980|81826873|FG000|Overall Study|Lost to Follow-up|14|||
27998899|NCT00988884|81826874|FG000|Overall Study|Adverse Event|0|||
27998900|NCT00988884|81826875|FG001|Overall Study|Adverse Event|1|||
27998901|NCT00988884|81826874|FG000|Overall Study|Lost to Follow-up|20|||
27580812|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
27680656|NCT02091206|80667856|FG003|Treatment Period|Met withdrawal criteria|0|||
27680657|NCT02091206|80667853|FG000|Taper Period|Participant refused study drug|1|||
27998902|NCT00988884|81826875|FG001|Overall Study|Lost to Follow-up|16|||
27998903|NCT00988884|81826874|FG000|Overall Study|Protocol Violation|0|||
27998904|NCT00988884|81826875|FG001|Overall Study|Protocol Violation|1|||
27998905|NCT00988884|81826874|FG000|Overall Study|Withdrawal by Subject|15|||
27998906|NCT00988884|81826875|FG001|Overall Study|Withdrawal by Subject|18|||
27998907|NCT00740584|81826876|FG000|Overall Study|Withdrawal by Subject|1|||
27580813|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580814|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580815|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580816|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580817|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580818|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
27580819|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580820|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580821|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580822|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
27580823|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580824|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27873056|NCT01995513|81368356|FG001|Period 2: Double Blind Treatment|Death|0|||
27873057|NCT01995513|81368357|FG002|Period 2: Double Blind Treatment|Death|0|||
27873058|NCT01995513|81368358|FG003|Period 2: Double Blind Treatment|Death|1|||
27873059|NCT01995513|81368355|FG000|Period 2: Double Blind Treatment|Other|0|||
27873060|NCT01995513|81368356|FG001|Period 2: Double Blind Treatment|Other|0|||
27873061|NCT01995513|81368357|FG002|Period 2: Double Blind Treatment|Other|3|||
27873062|NCT01995513|81368358|FG003|Period 2: Double Blind Treatment|Other|3|||
27873063|NCT01995513|81368355|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
27873064|NCT01995513|81368356|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
27873065|NCT01995513|81368357|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
27873066|NCT01995513|81368358|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
27873067|NCT01995513|81368355|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
27873068|NCT01995513|81368356|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
27873069|NCT01995513|81368357|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
27873070|NCT01995513|81368358|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
27873071|NCT01995513|81368355|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
27873072|NCT01995513|81368356|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
27580825|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580826|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580827|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580828|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
27580829|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580830|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580831|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27873073|NCT01995513|81368357|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
27873074|NCT01995513|81368358|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
27873075|NCT01995513|81368355|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
27873076|NCT01995513|81368356|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
27873077|NCT01995513|81368357|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
27873078|NCT01995513|81368358|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
27873079|NCT01487525|81368359|FG000|Overall Study|Withdrawal by Subject|0|||
27873080|NCT01487525|81368360|FG001|Overall Study|Withdrawal by Subject|1|||
27873081|NCT00075816|81368361|FG000|Overall Study|Did not undergo transplantation|14|||
27873082|NCT00075816|81368362|FG001|Overall Study|Did not undergo transplantation|11|||
27873083|NCT01609790|81368363|FG000|Overall Study|Protocol Violation|1|||
27873084|NCT01609790|81368364|FG001|Overall Study|Protocol Violation|7|||
27580832|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580833|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580834|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580835|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580836|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580837|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580838|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
27580839|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580840|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580841|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580842|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580843|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580844|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580845|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27700984|NCT01241552|80741289|FG000|Overall Study|Technical Problems|2|||
27873085|NCT01609790|81368365|FG002|Overall Study|Protocol Violation|8|||
27873086|NCT02968576|81368370|FG000|Overall Study|Pregnancy|0|||
27873087|NCT02968576|81368371|FG001|Overall Study|Pregnancy|1|||
27580846|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580847|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
27580848|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580849|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580850|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580851|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27873088|NCT00503698|81368372|FG000|Overall Study|Protocol Violation|5|||
27873089|NCT00503698|81368373|FG001|Overall Study|Protocol Violation|6|||
27873090|NCT00503698|81368372|FG000|Overall Study|Adverse Event|52|||
27873091|NCT00503698|81368373|FG001|Overall Study|Adverse Event|41|||
27873092|NCT00503698|81368372|FG000|Overall Study|Death|1|||
27873093|NCT00503698|81368373|FG001|Overall Study|Death|0|||
27873094|NCT00503698|81368372|FG000|Overall Study|Lack of Efficacy|3|||
27873095|NCT00503698|81368373|FG001|Overall Study|Lack of Efficacy|4|||
27873096|NCT00503698|81368372|FG000|Overall Study|Trial terminated|216|||
27873097|NCT00503698|81368373|FG001|Overall Study|Trial terminated|253|||
27873098|NCT00503698|81368372|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
27873099|NCT00503698|81368373|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
27873100|NCT00503698|81368372|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
27873101|NCT00503698|81368373|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
27873102|NCT00503698|81368372|FG000|Overall Study|Any condition in exclusion criteria|4|||
27873103|NCT00503698|81368373|FG001|Overall Study|Any condition in exclusion criteria|6|||
27873104|NCT00503698|81368372|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
27873105|NCT00503698|81368373|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
27873106|NCT00503698|81368372|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
27873107|NCT00503698|81368373|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
27873108|NCT00503698|81368372|FG000|Overall Study|Critically ill|2|||
27873109|NCT00503698|81368373|FG001|Overall Study|Critically ill|0|||
27873110|NCT00503698|81368372|FG000|Overall Study|Unclassified|48|||
27873111|NCT00503698|81368373|FG001|Overall Study|Unclassified|32|||
27873112|NCT00503698|81368372|FG000|Overall Study|Not exposed to trial drug|11|||
27873113|NCT00503698|81368373|FG001|Overall Study|Not exposed to trial drug|6|||
27873114|NCT02107131|81368374|FG000|Overall Study|Lost to Follow-up|4|||
27873115|NCT02107131|81368375|FG001|Overall Study|Lost to Follow-up|4|||
27873116|NCT02107131|81368374|FG000|Overall Study|Physician Decision|1|||
27873117|NCT02107131|81368375|FG001|Overall Study|Physician Decision|0|||
27873118|NCT02107131|81368374|FG000|Overall Study|Withdrawal by Subject|2|||
27873119|NCT02107131|81368375|FG001|Overall Study|Withdrawal by Subject|0|||
27998908|NCT01054456|81826879|FG000|Overall Study|Other|1|||
27998909|NCT02741596|81826880|FG000|Overall Study|Adverse Event|1|||
27998910|NCT02741596|81826881|FG001|Overall Study|Adverse Event|5|||
27998911|NCT02741596|81826880|FG000|Overall Study|Lost to Follow-up|1|||
27998912|NCT02741596|81826881|FG001|Overall Study|Lost to Follow-up|1|||
27998913|NCT02741596|81826880|FG000|Overall Study|Physician Decision|2|||
27998914|NCT02741596|81826881|FG001|Overall Study|Physician Decision|1|||
27998915|NCT02741596|81826880|FG000|Overall Study|Pregnancy|3|||
27998916|NCT02741596|81826881|FG001|Overall Study|Pregnancy|1|||
27998917|NCT02741596|81826880|FG000|Overall Study|Other (Unspecified)|0|||
27998918|NCT02741596|81826881|FG001|Overall Study|Other (Unspecified)|3|||
27873120|NCT02107131|81368374|FG000|Overall Study|mental instability|1|||
27998919|NCT02741596|81826880|FG000|Overall Study|Subject withdrawn-Other|17|||
27998920|NCT02741596|81826881|FG001|Overall Study|Subject withdrawn-Other|4|||
27998921|NCT02741596|81826880|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
27998922|NCT02741596|81826881|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
27873121|NCT02107131|81368375|FG001|Overall Study|mental instability|0|||
27873122|NCT02107131|81368374|FG000|Overall Study|Death|0|||
27998923|NCT03553758|81826882|FG000|Overall Study|Lost to Follow-up|1|||
27998924|NCT00398567|81826885|FG000|Overall Study|Disease Progression|3|||
27580852|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580853|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580854|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
27580855|NCT01609556|80309995|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
27680658|NCT02091206|80667854|FG001|Taper Period|Participant refused study drug|0|||
27680659|NCT02091206|80667855|FG002|Taper Period|Participant refused study drug|0|||
27680660|NCT02091206|80667856|FG003|Taper Period|Participant refused study drug|1|||
27680661|NCT02091206|80667853|FG000|Taper Period|Lost to Follow-up|0|||
27680662|NCT02091206|80667854|FG001|Taper Period|Lost to Follow-up|0|||
27680663|NCT02091206|80667855|FG002|Taper Period|Lost to Follow-up|0|||
27680664|NCT02091206|80667856|FG003|Taper Period|Lost to Follow-up|1|||
27680665|NCT00368927|80667860|FG000|Overall Study|Lost to Follow-up|2|||
27680666|NCT00368927|80667861|FG001|Overall Study|Lost to Follow-up|0|||
27680667|NCT00368927|80667860|FG000|Overall Study|Adverse Event|1|||
27680668|NCT00368927|80667861|FG001|Overall Study|Adverse Event|1|||
27680669|NCT00368927|80667860|FG000|Overall Study|Withdrawal by Subject|1|||
27680670|NCT00368927|80667861|FG001|Overall Study|Withdrawal by Subject|2|||
27680671|NCT00368927|80667860|FG000|Overall Study|Physician Decision|1|||
27580856|NCT01609556|80309996|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580857|NCT01609556|80309997|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580858|NCT01609556|80309998|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580859|NCT01609556|80309999|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580860|NCT01609556|80310000|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
27580861|NCT01609556|80310001|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580862|NCT01609556|80310002|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580863|NCT01609556|80310003|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580864|NCT01609556|80310004|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580865|NCT01609556|80310005|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
27580866|NCT01609556|80310006|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580867|NCT01609556|80310007|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27680672|NCT00368927|80667861|FG001|Overall Study|Physician Decision|0|||
27680673|NCT00790205|80667864|FG000|Overall Study|Lost to Follow-up|61|||
27680674|NCT00790205|80667865|FG001|Overall Study|Lost to Follow-up|71|||
27680675|NCT00790205|80667864|FG000|Overall Study|Withdrawal by Subject|299|||
27680676|NCT00790205|80667865|FG001|Overall Study|Withdrawal by Subject|363|||
27680677|NCT03338296|80667874|FG000|Overall Study|Adverse Event|0|||
27680678|NCT03338296|80667875|FG001|Overall Study|Adverse Event|1|||
27680679|NCT03338296|80667874|FG000|Overall Study|Withdrawal by Subject|14|||
27680680|NCT03338296|80667875|FG001|Overall Study|Withdrawal by Subject|13|||
27680681|NCT03338296|80667874|FG000|Overall Study|Lost to Follow-up|10|||
27680682|NCT03338296|80667875|FG001|Overall Study|Lost to Follow-up|10|||
27680683|NCT03338296|80667874|FG000|Overall Study|Study Terminated by Sponsor|77|||
27680684|NCT03338296|80667875|FG001|Overall Study|Study Terminated by Sponsor|76|||
27680685|NCT03338296|80667874|FG000|Overall Study|Other|2|||
27680686|NCT03338296|80667875|FG001|Overall Study|Other|7|||
27680687|NCT03338296|80667874|FG000|Overall Study|Missing|0|||
27680688|NCT03338296|80667875|FG001|Overall Study|Missing|1|||
27680689|NCT03926195|80667876|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
27680690|NCT03926195|80667877|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
27680691|NCT03926195|80667876|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
27680692|NCT03926195|80667877|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
27680693|NCT03926195|80667876|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
27680694|NCT03926195|80667877|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
27680695|NCT03926195|80667876|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
27680696|NCT03926195|80667877|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
27680697|NCT03926195|80667876|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
27680698|NCT03926195|80667877|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
27680699|NCT03926195|80667876|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
27680700|NCT03926195|80667877|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
27680701|NCT01498887|80667878|FG000|Overall Study|Administrative problems|1|||
27680702|NCT01498887|80667879|FG001|Overall Study|Administrative problems|0|||
27680703|NCT01498887|80667878|FG000|Overall Study|Lost to Follow-up|1|||
27680704|NCT01498887|80667879|FG001|Overall Study|Lost to Follow-up|1|||
27680705|NCT01498887|80667878|FG000|Overall Study|Withdrawal by Subject|1|||
27680706|NCT01498887|80667879|FG001|Overall Study|Withdrawal by Subject|0|||
27998925|NCT00398567|81826886|FG001|Overall Study|Disease Progression|4|||
27998926|NCT00398567|81826887|FG002|Overall Study|Disease Progression|27|||
27580868|NCT01609556|80310008|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580869|NCT01609556|80310009|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27680707|NCT01498887|80667878|FG000|Overall Study|Protocol Violation|1|||
27998927|NCT00398567|81826885|FG000|Overall Study|Withdrawal by Subject|1|||
27998928|NCT00398567|81826886|FG001|Overall Study|Withdrawal by Subject|0|||
27998929|NCT00398567|81826887|FG002|Overall Study|Withdrawal by Subject|4|||
27998930|NCT00398567|81826885|FG000|Overall Study|Adverse Event|0|||
27998931|NCT00398567|81826886|FG001|Overall Study|Adverse Event|0|||
27998932|NCT00398567|81826887|FG002|Overall Study|Adverse Event|2|||
27998933|NCT00398567|81826885|FG000|Overall Study|Protocol Violation|0|||
27998934|NCT00398567|81826886|FG001|Overall Study|Protocol Violation|0|||
27998935|NCT00398567|81826887|FG002|Overall Study|Protocol Violation|1|||
27998936|NCT03400852|81826888|FG000|Blinded Treatment Period|Physician Decision|0|||
27580870|NCT01609556|80310010|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
27580871|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27805167|NCT00437281|81117283|FG000|Overall Study|Lost to Follow-up|0|||
27805168|NCT00437281|81117284|FG001|Overall Study|Lost to Follow-up|0|||
27805169|NCT00437281|81117285|FG002|Overall Study|Lost to Follow-up|0|||
27998937|NCT03400852|81826889|FG001|Blinded Treatment Period|Physician Decision|1|||
27998938|NCT03400852|81826890|FG002|Blinded Treatment Period|Physician Decision|0|||
27998939|NCT03400852|81826888|FG000|Blinded Treatment Period|Adverse Event|1|||
27998940|NCT03400852|81826889|FG001|Blinded Treatment Period|Adverse Event|1|||
27998941|NCT03400852|81826890|FG002|Blinded Treatment Period|Adverse Event|0|||
27998942|NCT03400852|81826888|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
27998943|NCT03400852|81826889|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
27998944|NCT03400852|81826890|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
27998945|NCT03400852|81826888|FG000|Open Label Period|Physician Decision|0|||
27998946|NCT03400852|81826889|FG001|Open Label Period|Physician Decision|0|||
27998947|NCT03400852|81826890|FG002|Open Label Period|Physician Decision|1|||
27998948|NCT03400852|81826888|FG000|Open Label Period|Study terminated by sponsor|0|||
27998949|NCT03400852|81826889|FG001|Open Label Period|Study terminated by sponsor|0|||
27998950|NCT03400852|81826890|FG002|Open Label Period|Study terminated by sponsor|21|||
27998951|NCT03594773|81826900|FG000|Overall Study|Withdrawal by Subject|3|||
27998952|NCT03594773|81826901|FG001|Overall Study|Withdrawal by Subject|2|||
27998953|NCT03594773|81826900|FG000|Overall Study|Lost to Follow-up|3|||
27998954|NCT03594773|81826901|FG001|Overall Study|Lost to Follow-up|4|||
27998955|NCT01253291|81826907|FG000|Overall Study|Withdrawal by Subject|1|||
27998956|NCT01253291|81826908|FG001|Overall Study|Withdrawal by Subject|1|||
27998957|NCT01253291|81826909|FG002|Overall Study|Withdrawal by Subject|0|||
27998958|NCT01253291|81826910|FG003|Overall Study|Withdrawal by Subject|0|||
27998959|NCT01253291|81826911|FG004|Overall Study|Withdrawal by Subject|0|||
27998960|NCT01253291|81826907|FG000|Overall Study|Adverse Event|0|||
27998961|NCT01253291|81826908|FG001|Overall Study|Adverse Event|1|||
27998962|NCT01253291|81826909|FG002|Overall Study|Adverse Event|0|||
27998963|NCT01253291|81826910|FG003|Overall Study|Adverse Event|0|||
27998964|NCT01253291|81826911|FG004|Overall Study|Adverse Event|0|||
27998965|NCT01253291|81826907|FG000|Overall Study|Lack of Efficacy|1|||
27805170|NCT00437281|81117286|FG003|Overall Study|Lost to Follow-up|0|||
27805171|NCT00437281|81117287|FG004|Overall Study|Lost to Follow-up|0|||
27805172|NCT00437281|81117288|FG005|Overall Study|Lost to Follow-up|0|||
27805173|NCT00437281|81117289|FG006|Overall Study|Lost to Follow-up|0|||
27805174|NCT00437281|81117290|FG007|Overall Study|Lost to Follow-up|0|||
27805175|NCT00437281|81117291|FG008|Overall Study|Lost to Follow-up|0|||
27805176|NCT00437281|81117292|FG009|Overall Study|Lost to Follow-up|0|||
27805177|NCT00437281|81117293|FG010|Overall Study|Lost to Follow-up|0|||
27805178|NCT00437281|81117294|FG011|Overall Study|Lost to Follow-up|0|||
27805179|NCT00437281|81117295|FG012|Overall Study|Lost to Follow-up|0|||
27805180|NCT00437281|81117296|FG013|Overall Study|Lost to Follow-up|0|||
27805181|NCT00437281|81117297|FG014|Overall Study|Lost to Follow-up|0|||
27805182|NCT00437281|81117298|FG015|Overall Study|Lost to Follow-up|0|||
27805183|NCT00437281|81117299|FG016|Overall Study|Lost to Follow-up|0|||
27805184|NCT00437281|81117300|FG017|Overall Study|Lost to Follow-up|0|||
27805185|NCT00437281|81117301|FG018|Overall Study|Lost to Follow-up|0|||
27805186|NCT00437281|81117302|FG019|Overall Study|Lost to Follow-up|1|||
27805187|NCT02017535|81117307|FG000|Overall Study|Withdrawal by Subject|1|||
27805188|NCT02017535|81117308|FG001|Overall Study|Withdrawal by Subject|0|||
27805189|NCT02017535|81117309|FG002|Overall Study|Withdrawal by Subject|0|||
27998966|NCT01253291|81826908|FG001|Overall Study|Lack of Efficacy|0|||
27998967|NCT01253291|81826909|FG002|Overall Study|Lack of Efficacy|0|||
27998968|NCT01253291|81826910|FG003|Overall Study|Lack of Efficacy|0|||
27998969|NCT01253291|81826911|FG004|Overall Study|Lack of Efficacy|0|||
27998970|NCT01253291|81826907|FG000|Overall Study|Physician Decision|2|||
27998971|NCT01253291|81826908|FG001|Overall Study|Physician Decision|0|||
27998972|NCT01253291|81826909|FG002|Overall Study|Physician Decision|0|||
27805190|NCT02017535|81117310|FG003|Overall Study|Withdrawal by Subject|0|||
27805191|NCT02675426|81117311|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
27805192|NCT02675426|81117312|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
27805193|NCT02675426|81117313|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
27580872|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580873|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580874|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580875|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580876|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580877|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580878|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580879|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580880|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580881|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580882|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
27580883|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
27580884|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
27580885|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
27580886|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
27580887|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580888|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27805194|NCT02675426|81117314|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
27805195|NCT02675426|81117311|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
27805196|NCT02675426|81117312|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
27805197|NCT02675426|81117313|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
27805198|NCT02675426|81117314|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
27805199|NCT02675426|81117311|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
27805200|NCT02675426|81117312|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
27805201|NCT02675426|81117313|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
27805202|NCT02675426|81117314|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
27805203|NCT02675426|81117311|FG000|Period 1: Week 1 to Week 12|Other|2|||
27805204|NCT02675426|81117312|FG001|Period 1: Week 1 to Week 12|Other|1|||
27805205|NCT02675426|81117313|FG002|Period 1: Week 1 to Week 12|Other|0|||
27805206|NCT02675426|81117314|FG003|Period 1: Week 1 to Week 12|Other|2|||
27805207|NCT02675426|81117311|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
27805208|NCT02675426|81117312|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
27805209|NCT02675426|81117313|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
27805210|NCT02675426|81117314|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
27805211|NCT02675426|81117311|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
27805212|NCT02675426|81117312|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
27805213|NCT02675426|81117313|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
27805214|NCT02675426|81117314|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
27805215|NCT02675426|81117311|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
27805216|NCT02675426|81117312|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
27805217|NCT02675426|81117313|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
27805218|NCT02675426|81117314|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
27805219|NCT02675426|81117311|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
27805220|NCT02675426|81117312|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
27805221|NCT02675426|81117313|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
27805222|NCT02675426|81117314|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
27805223|NCT02675426|81117311|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
27805224|NCT02675426|81117312|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
27805225|NCT02675426|81117313|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
27805226|NCT02675426|81117314|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
27805227|NCT02675426|81117311|FG000|Period 2: Week 12 to Week 260|Other|8|||
27805228|NCT02675426|81117312|FG001|Period 2: Week 12 to Week 260|Other|12|||
27805229|NCT02675426|81117313|FG002|Period 2: Week 12 to Week 260|Other|23|||
27805230|NCT02675426|81117314|FG003|Period 2: Week 12 to Week 260|Other|15|||
27805231|NCT01722266|81117317|FG000|Overall Study|Withdrawal by Subject|1|||
27805232|NCT01722266|81117318|FG001|Overall Study|Withdrawal by Subject|2|||
27805233|NCT01722266|81117319|FG002|Overall Study|Withdrawal by Subject|0|||
27873123|NCT02107131|81368375|FG001|Overall Study|Death|1|||
27873124|NCT02107131|81368374|FG000|Overall Study|Protocol Violation|0|||
27873125|NCT02107131|81368375|FG001|Overall Study|Protocol Violation|4|||
27873126|NCT03500198|81368376|FG000|Overall Study|Lost to Follow-up|0|||
27873127|NCT03500198|81368377|FG001|Overall Study|Lost to Follow-up|1|||
27873128|NCT04495829|81368382|FG000|Overall Study|Lost to Follow-up|2|||
27873129|NCT04495829|81368382|FG000|Overall Study|Inclusion criterion not met|3|||
27873130|NCT01119859|81368384|FG000|Overall Study|Adverse Event|9|||
27873131|NCT01119859|81368385|FG001|Overall Study|Adverse Event|10|||
27873132|NCT01119859|81368384|FG000|Overall Study|Death|2|||
27873133|NCT01119859|81368385|FG001|Overall Study|Death|0|||
27873134|NCT01119859|81368384|FG000|Overall Study|Insufficient therapeutic response|7|||
27873135|NCT01119859|81368385|FG001|Overall Study|Insufficient therapeutic response|14|||
27873136|NCT01119859|81368384|FG000|Overall Study|Refused treatment|3|||
27873137|NCT01119859|81368385|FG001|Overall Study|Refused treatment|6|||
27873138|NCT01119859|81368384|FG000|Overall Study|Failure to return|3|||
27873139|NCT01119859|81368385|FG001|Overall Study|Failure to return|0|||
27873140|NCT03093259|81368388|FG000|Overall Study|Adverse Event|1|||
27873141|NCT03093259|81368389|FG001|Overall Study|Adverse Event|0|||
27873142|NCT03093259|81368388|FG000|Overall Study|Withdrawal by Subject|1|||
27873143|NCT03093259|81368389|FG001|Overall Study|Withdrawal by Subject|0|||
27580889|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580890|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580891|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580892|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580893|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580894|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580895|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580896|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580897|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27580898|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
27680708|NCT01498887|80667879|FG001|Overall Study|Protocol Violation|3|||
27873144|NCT02152137|81368390|FG000|Overall Study|Withdrawal by Subject|1|||
27873145|NCT02152137|81368390|FG000|Overall Study|Originally assigned to Arm B|3|||
27873146|NCT02857816|81368391|FG000|Overall Study|Screen Failure|33|||
27580899|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
27873147|NCT02857816|81368391|FG000|Overall Study|Withdrawal by Subject|4|||
27873148|NCT02857816|81368391|FG000|Overall Study|Lost to Follow-up|1|||
27873149|NCT04135937|81368401|FG000|Overall Study|Lost to Follow-up|2|||
27873150|NCT04135937|81368401|FG000|Overall Study|Withdrawal by Subject|1|||
27873151|NCT03103087|81368402|FG000|Overall Study|Did not receive any study drug|1|||
27873152|NCT03103087|81368403|FG001|Overall Study|Did not receive any study drug|0|||
27873153|NCT03103087|81368404|FG002|Overall Study|Did not receive any study drug|0|||
27873154|NCT03103087|81368402|FG000|Overall Study|Protocol Violation|1|||
27873155|NCT03103087|81368403|FG001|Overall Study|Protocol Violation|2|||
27873156|NCT03103087|81368404|FG002|Overall Study|Protocol Violation|1|||
27873157|NCT03103087|81368402|FG000|Overall Study|Lack of Efficacy|2|||
27873158|NCT03103087|81368403|FG001|Overall Study|Lack of Efficacy|1|||
27873159|NCT03103087|81368404|FG002|Overall Study|Lack of Efficacy|1|||
27873160|NCT03103087|81368402|FG000|Overall Study|Pregnancy|0|||
27873161|NCT03103087|81368403|FG001|Overall Study|Pregnancy|0|||
27580900|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
27873162|NCT03103087|81368404|FG002|Overall Study|Pregnancy|1|||
27873163|NCT03103087|81368402|FG000|Overall Study|Adverse Event|2|||
27873164|NCT03103087|81368403|FG001|Overall Study|Adverse Event|15|||
27580901|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
27580902|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
27580903|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580904|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580905|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580906|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580907|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580908|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580909|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580910|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580911|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580912|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580913|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580914|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
27580915|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
27580916|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
27580917|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
27580918|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
27580919|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580920|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580921|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580922|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580923|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580924|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580925|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580926|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580927|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580928|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580929|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580930|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27873165|NCT03103087|81368404|FG002|Overall Study|Adverse Event|6|||
27873166|NCT03103087|81368402|FG000|Overall Study|Withdrawal by Subject|13|||
27873167|NCT03103087|81368403|FG001|Overall Study|Withdrawal by Subject|6|||
27873168|NCT03103087|81368404|FG002|Overall Study|Withdrawal by Subject|6|||
27680709|NCT01498887|80667878|FG000|Overall Study|Lack of Efficacy|5|||
27873169|NCT03103087|81368402|FG000|Overall Study|Lost to Follow-up|4|||
27873170|NCT03103087|81368403|FG001|Overall Study|Lost to Follow-up|2|||
27873171|NCT03103087|81368404|FG002|Overall Study|Lost to Follow-up|7|||
27873172|NCT03103087|81368402|FG000|Overall Study|Other reason not reported|1|||
27873173|NCT03103087|81368403|FG001|Overall Study|Other reason not reported|3|||
27873174|NCT03103087|81368404|FG002|Overall Study|Other reason not reported|5|||
27580931|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
27580932|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580933|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580934|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
27580935|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580936|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580937|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580938|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580939|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580940|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580941|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580942|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580943|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580944|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580945|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580946|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
27580947|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
27580948|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
27580949|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
27580950|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
27580951|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580952|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580953|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580954|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580955|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580956|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580957|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580958|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580959|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580960|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580961|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580962|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580963|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580964|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580965|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
27580966|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
27580967|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
27580968|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
27580969|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
27998973|NCT01253291|81826910|FG003|Overall Study|Physician Decision|0|||
27998974|NCT01253291|81826911|FG004|Overall Study|Physician Decision|2|||
27998975|NCT02919761|81826917|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
27998976|NCT02919761|81826918|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
27998977|NCT02919761|81826919|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
27998978|NCT02919761|81826917|FG000|Part 1: Open Label|Adverse Event|1|||
27998979|NCT02919761|81826918|FG001|Part 1: Open Label|Adverse Event|0|||
27998980|NCT02919761|81826919|FG002|Part 1: Open Label|Adverse Event|0|||
27998981|NCT02919761|81826917|FG000|Part 1: Open Label|Lost to Follow-up|1|||
27998982|NCT02919761|81826918|FG001|Part 1: Open Label|Lost to Follow-up|0|||
27998983|NCT02919761|81826919|FG002|Part 1: Open Label|Lost to Follow-up|0|||
27998984|NCT02919761|81826917|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
27998985|NCT02919761|81826918|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
27998986|NCT02919761|81826919|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
27998987|NCT02919761|81826917|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
27998988|NCT02919761|81826918|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
27998989|NCT02919761|81826919|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
27998990|NCT02919761|81826917|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
27998991|NCT02919761|81826918|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
27998992|NCT02919761|81826919|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
27998993|NCT02919761|81826917|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
27998994|NCT02919761|81826918|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
27998995|NCT02919761|81826919|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
27998996|NCT02919761|81826917|FG000|Part 1: Open Label|Termination by Sponsor|1|||
27998997|NCT02919761|81826918|FG001|Part 1: Open Label|Termination by Sponsor|0|||
27998998|NCT02919761|81826919|FG002|Part 1: Open Label|Termination by Sponsor|0|||
27998999|NCT02919761|81826917|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
27999000|NCT02919761|81826918|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
27999001|NCT02919761|81826919|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
27999002|NCT02919761|81826917|FG000|Part 2: Double-blind|Adverse Event|0|||
27580970|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
27999003|NCT02919761|81826918|FG001|Part 2: Double-blind|Adverse Event|1|||
27999004|NCT02919761|81826919|FG002|Part 2: Double-blind|Adverse Event|0|||
27999005|NCT02919761|81826917|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
27999006|NCT02919761|81826918|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
27580971|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
27580972|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
27805234|NCT01722266|81117320|FG003|Overall Study|Withdrawal by Subject|0|||
27999007|NCT02919761|81826919|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
27999008|NCT02919761|81826917|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
27999009|NCT02919761|81826918|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
27999010|NCT02919761|81826919|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
27999011|NCT02919761|81826917|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
27999012|NCT02919761|81826918|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
27999013|NCT02919761|81826919|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
27999014|NCT02919761|81826917|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
27999015|NCT02919761|81826918|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
27999016|NCT02919761|81826919|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
27999017|NCT02919761|81826917|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
27999018|NCT02919761|81826918|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
27580973|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
27805235|NCT01722266|81117317|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
27805236|NCT01722266|81117318|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
27805237|NCT01722266|81117319|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
27805238|NCT01722266|81117320|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
27805239|NCT01722266|81117317|FG000|Overall Study|Dropped out due to Nausea|0|||
27805240|NCT01722266|81117318|FG001|Overall Study|Dropped out due to Nausea|0|||
27999019|NCT02919761|81826919|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
27999020|NCT02919761|81826917|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
27999021|NCT02919761|81826918|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
27999022|NCT02919761|81826919|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
27999023|NCT02587520|81826920|FG000|Overall Study|Protocol Violation|2|||
27999024|NCT02587520|81826921|FG001|Overall Study|Protocol Violation|0|||
27999025|NCT02587520|81826922|FG002|Overall Study|Protocol Violation|0|||
27999026|NCT02587520|81826923|FG003|Overall Study|Protocol Violation|2|||
27680710|NCT01498887|80667879|FG001|Overall Study|Lack of Efficacy|3|||
27680711|NCT01498887|80667878|FG000|Overall Study|Abnormal result from test procedure|1|||
27680712|NCT01498887|80667879|FG001|Overall Study|Abnormal result from test procedure|1|||
27680713|NCT01498887|80667878|FG000|Overall Study|Abnormal laboratory value|2|||
27680714|NCT01498887|80667879|FG001|Overall Study|Abnormal laboratory value|2|||
27680715|NCT01498887|80667878|FG000|Overall Study|Adverse Event|4|||
27680716|NCT01498887|80667879|FG001|Overall Study|Adverse Event|1|||
27680717|NCT01232738|80667883|FG000|Overall Study|Death|3|||
27999027|NCT02587520|81826924|FG004|Overall Study|Protocol Violation|0|||
27999028|NCT02587520|81826925|FG005|Overall Study|Protocol Violation|1|||
27999029|NCT02587520|81826926|FG006|Overall Study|Protocol Violation|1|||
27999030|NCT02587520|81826927|FG007|Overall Study|Protocol Violation|1|||
27999031|NCT02587520|81826928|FG008|Overall Study|Protocol Violation|3|||
27999032|NCT02587520|81826929|FG009|Overall Study|Protocol Violation|3|||
27999033|NCT02587520|81826930|FG010|Overall Study|Protocol Violation|1|||
27999034|NCT02587520|81826931|FG011|Overall Study|Protocol Violation|2|||
27999035|NCT02587520|81826932|FG012|Overall Study|Protocol Violation|0|||
27999036|NCT02587520|81826933|FG013|Overall Study|Protocol Violation|0|||
27999037|NCT02587520|81826934|FG014|Overall Study|Protocol Violation|0|||
27999038|NCT02587520|81826935|FG015|Overall Study|Protocol Violation|0|||
27999039|NCT02587520|81826936|FG016|Overall Study|Protocol Violation|0|||
27999040|NCT02587520|81826937|FG017|Overall Study|Protocol Violation|0|||
27999041|NCT02587520|81826920|FG000|Overall Study|Adverse Event|0|||
27999042|NCT02587520|81826921|FG001|Overall Study|Adverse Event|0|||
27999043|NCT02587520|81826922|FG002|Overall Study|Adverse Event|0|||
27999044|NCT02587520|81826923|FG003|Overall Study|Adverse Event|0|||
27999045|NCT02587520|81826924|FG004|Overall Study|Adverse Event|0|||
27999046|NCT02587520|81826925|FG005|Overall Study|Adverse Event|0|||
27999047|NCT02587520|81826926|FG006|Overall Study|Adverse Event|0|||
27999048|NCT02587520|81826927|FG007|Overall Study|Adverse Event|0|||
27999049|NCT02587520|81826928|FG008|Overall Study|Adverse Event|0|||
27999050|NCT02587520|81826929|FG009|Overall Study|Adverse Event|0|||
27999051|NCT02587520|81826930|FG010|Overall Study|Adverse Event|0|||
27999052|NCT02587520|81826931|FG011|Overall Study|Adverse Event|1|||
27999053|NCT02587520|81826932|FG012|Overall Study|Adverse Event|0|||
27999054|NCT02587520|81826933|FG013|Overall Study|Adverse Event|0|||
27999055|NCT02587520|81826934|FG014|Overall Study|Adverse Event|0|||
27999056|NCT02587520|81826935|FG015|Overall Study|Adverse Event|0|||
27999057|NCT02587520|81826936|FG016|Overall Study|Adverse Event|0|||
27999058|NCT02587520|81826937|FG017|Overall Study|Adverse Event|0|||
27680718|NCT01232738|80667883|FG000|Overall Study|Physician Decision|2|||
27580974|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
27999059|NCT02587520|81826920|FG000|Overall Study|Withdrawal by Subject|0|||
27999060|NCT02587520|81826921|FG001|Overall Study|Withdrawal by Subject|0|||
27999061|NCT02587520|81826922|FG002|Overall Study|Withdrawal by Subject|1|||
27999062|NCT02587520|81826923|FG003|Overall Study|Withdrawal by Subject|1|||
27999063|NCT02587520|81826924|FG004|Overall Study|Withdrawal by Subject|0|||
27999064|NCT02587520|81826925|FG005|Overall Study|Withdrawal by Subject|1|||
27999065|NCT02587520|81826926|FG006|Overall Study|Withdrawal by Subject|1|||
27999066|NCT02587520|81826927|FG007|Overall Study|Withdrawal by Subject|0|||
27999067|NCT02587520|81826928|FG008|Overall Study|Withdrawal by Subject|0|||
27999068|NCT02587520|81826929|FG009|Overall Study|Withdrawal by Subject|0|||
27999069|NCT02587520|81826930|FG010|Overall Study|Withdrawal by Subject|0|||
27999070|NCT02587520|81826931|FG011|Overall Study|Withdrawal by Subject|0|||
27580975|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
27680719|NCT01232738|80667883|FG000|Overall Study|Lost to Follow-up|1|||
27999071|NCT02587520|81826932|FG012|Overall Study|Withdrawal by Subject|0|||
27999072|NCT02587520|81826933|FG013|Overall Study|Withdrawal by Subject|1|||
27999073|NCT02587520|81826934|FG014|Overall Study|Withdrawal by Subject|0|||
27999074|NCT02587520|81826935|FG015|Overall Study|Withdrawal by Subject|0|||
27999075|NCT02587520|81826936|FG016|Overall Study|Withdrawal by Subject|0|||
27999076|NCT02587520|81826937|FG017|Overall Study|Withdrawal by Subject|0|||
27999077|NCT02587520|81826920|FG000|Overall Study|Lost to Follow-up|0|||
27580976|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
27680720|NCT01232738|80667883|FG000|Overall Study|Withdrawal by Subject|2|||
27999078|NCT02587520|81826921|FG001|Overall Study|Lost to Follow-up|2|||
27999079|NCT02587520|81826922|FG002|Overall Study|Lost to Follow-up|0|||
27999080|NCT02587520|81826923|FG003|Overall Study|Lost to Follow-up|2|||
27999081|NCT02587520|81826924|FG004|Overall Study|Lost to Follow-up|0|||
27580977|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
27580978|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
27580979|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
27580980|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
27580981|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
27580982|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
27580983|NCT01609556|80309995|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580984|NCT01609556|80309996|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580985|NCT01609556|80309997|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580986|NCT01609556|80309998|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580987|NCT01609556|80309999|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580988|NCT01609556|80310000|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580989|NCT01609556|80310001|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580990|NCT01609556|80310002|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580991|NCT01609556|80310003|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580992|NCT01609556|80310004|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580993|NCT01609556|80310005|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580994|NCT01609556|80310006|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580995|NCT01609556|80310007|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
27580996|NCT01609556|80310008|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580997|NCT01609556|80310009|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580998|NCT01609556|80310010|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
27580999|NCT03483623|80310011|FG000|Overall Study|43 complete sets achieved|1|||
27581000|NCT03930745|80310014|FG000|Overall Study|Lost to Follow-up|10|||
27581001|NCT03930745|80310015|FG001|Overall Study|Lost to Follow-up|5|||
27581002|NCT03930745|80310014|FG000|Overall Study|Withdrawal by Subject|1|||
27581003|NCT03930745|80310015|FG001|Overall Study|Withdrawal by Subject|2|||
27581004|NCT03930745|80310014|FG000|Overall Study|Protocol Violation|2|||
27581005|NCT03930745|80310015|FG001|Overall Study|Protocol Violation|2|||
27581006|NCT03930745|80310014|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
27873175|NCT00517881|81368405|FG000|Overall Study|Protocol Violation|2|||
27873176|NCT00517881|81368405|FG000|Overall Study|Adverse Event|1|||
27873177|NCT00517881|81368405|FG000|Overall Study|Renal transplantation|2|||
27873178|NCT02763046|81368406|FG000|Overall Study|Adverse Event|5|||
27873179|NCT02763046|81368407|FG001|Overall Study|Adverse Event|4|||
27873180|NCT02763046|81368408|FG002|Overall Study|Adverse Event|0|||
27581007|NCT03930745|80310015|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
27581008|NCT03930745|80310014|FG000|Overall Study|Adverse Event|0|||
27873181|NCT02763046|81368406|FG000|Overall Study|Lack of Efficacy|1|||
27873182|NCT02763046|81368407|FG001|Overall Study|Lack of Efficacy|1|||
27999082|NCT02587520|81826925|FG005|Overall Study|Lost to Follow-up|1|||
27999083|NCT02587520|81826926|FG006|Overall Study|Lost to Follow-up|1|||
27999084|NCT02587520|81826927|FG007|Overall Study|Lost to Follow-up|1|||
27999085|NCT02587520|81826928|FG008|Overall Study|Lost to Follow-up|0|||
27999086|NCT02587520|81826929|FG009|Overall Study|Lost to Follow-up|2|||
27999087|NCT02587520|81826930|FG010|Overall Study|Lost to Follow-up|2|||
27999088|NCT02587520|81826931|FG011|Overall Study|Lost to Follow-up|1|||
27999089|NCT02587520|81826932|FG012|Overall Study|Lost to Follow-up|0|||
27999090|NCT02587520|81826933|FG013|Overall Study|Lost to Follow-up|0|||
27999091|NCT02587520|81826934|FG014|Overall Study|Lost to Follow-up|0|||
27999092|NCT02587520|81826935|FG015|Overall Study|Lost to Follow-up|0|||
27999093|NCT02587520|81826936|FG016|Overall Study|Lost to Follow-up|0|||
27999094|NCT02587520|81826937|FG017|Overall Study|Lost to Follow-up|0|||
27999095|NCT03244917|81826942|FG000|Overall Study|Lost to Follow-up|2|||
27999096|NCT03244917|81826943|FG001|Overall Study|Lost to Follow-up|2|||
27999097|NCT00655629|81826950|FG000|Overall Study|Adverse Event|4|||
27999098|NCT00655629|81826951|FG001|Overall Study|Adverse Event|1|||
27581009|NCT03930745|80310015|FG001|Overall Study|Adverse Event|1|||
27581010|NCT03930745|80310014|FG000|Overall Study|Pregnancy|0|||
27581011|NCT03930745|80310015|FG001|Overall Study|Pregnancy|1|||
27581012|NCT00499369|80310016|FG000|Overall Study|Adverse Event|2|||
27581013|NCT00499369|80310017|FG001|Overall Study|Adverse Event|2|||
27581014|NCT00499369|80310018|FG002|Overall Study|Adverse Event|3|||
27581015|NCT00499369|80310019|FG003|Overall Study|Adverse Event|1|||
27581016|NCT00499369|80310020|FG004|Overall Study|Adverse Event|2|||
27581017|NCT00499369|80310016|FG000|Overall Study|Withdrawal by Subject|0|||
27581018|NCT00499369|80310017|FG001|Overall Study|Withdrawal by Subject|1|||
27581019|NCT00499369|80310018|FG002|Overall Study|Withdrawal by Subject|1|||
27581020|NCT00499369|80310019|FG003|Overall Study|Withdrawal by Subject|0|||
27581021|NCT00499369|80310020|FG004|Overall Study|Withdrawal by Subject|0|||
27581022|NCT00499369|80310016|FG000|Overall Study|Progression|10|||
27581023|NCT00499369|80310017|FG001|Overall Study|Progression|12|||
27581024|NCT00499369|80310018|FG002|Overall Study|Progression|9|||
27581025|NCT00499369|80310019|FG003|Overall Study|Progression|6|||
27581026|NCT00499369|80310020|FG004|Overall Study|Progression|10|||
27581027|NCT00499369|80310016|FG000|Overall Study|Death|0|||
27581028|NCT00499369|80310017|FG001|Overall Study|Death|1|||
27581029|NCT00499369|80310018|FG002|Overall Study|Death|0|||
27581030|NCT00499369|80310019|FG003|Overall Study|Death|0|||
27581031|NCT00499369|80310020|FG004|Overall Study|Death|0|||
27581032|NCT00499369|80310016|FG000|Overall Study|Not protocol specified|2|||
27581033|NCT00499369|80310017|FG001|Overall Study|Not protocol specified|0|||
27581034|NCT00499369|80310018|FG002|Overall Study|Not protocol specified|3|||
27581035|NCT00499369|80310019|FG003|Overall Study|Not protocol specified|1|||
27581036|NCT00499369|80310020|FG004|Overall Study|Not protocol specified|0|||
27581037|NCT00499369|80310016|FG000|Overall Study|Ineligible|2|||
27581038|NCT00499369|80310017|FG001|Overall Study|Ineligible|2|||
27581039|NCT00499369|80310018|FG002|Overall Study|Ineligible|1|||
27581040|NCT00499369|80310019|FG003|Overall Study|Ineligible|1|||
27581041|NCT00499369|80310020|FG004|Overall Study|Ineligible|0|||
27581042|NCT04382326|80310021|FG000|Overall Study|Adverse Event, not serious|1|||
27581043|NCT04382326|80310022|FG001|Overall Study|Adverse Event, not serious|2|||
27581044|NCT04382326|80310021|FG000|Overall Study|Other|1|||
27581045|NCT04382326|80310022|FG001|Overall Study|Other|0|||
27581046|NCT04382326|80310021|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
27581047|NCT04382326|80310022|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
27581048|NCT04382326|80310021|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
27581049|NCT04382326|80310022|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
27581050|NCT04382326|80310021|FG000|Overall Study|Protocol Violation|29|||
27581051|NCT04382326|80310022|FG001|Overall Study|Protocol Violation|23|||
27581052|NCT04382326|80310021|FG000|Overall Study|Physician Decision|0|||
27581053|NCT04382326|80310022|FG001|Overall Study|Physician Decision|1|||
27581054|NCT04382326|80310021|FG000|Overall Study|Lost to Follow-up|48|||
27581055|NCT04382326|80310022|FG001|Overall Study|Lost to Follow-up|63|||
27581056|NCT04382326|80310021|FG000|Overall Study|Adverse Event, non-fatal|1|||
27581057|NCT04382326|80310022|FG001|Overall Study|Adverse Event, non-fatal|1|||
27581058|NCT02200042|80310023|FG000|Overall Study|Withdrawal by Subject|0|||
27581059|NCT02200042|80310024|FG001|Overall Study|Withdrawal by Subject|1|||
27581060|NCT02293005|80310025|FG000|Overall Study|Adverse Event|2|||
27873183|NCT02763046|81368408|FG002|Overall Study|Lack of Efficacy|3|||
27999099|NCT00655629|81826950|FG000|Overall Study|Lack of Efficacy|2|||
27999100|NCT00655629|81826951|FG001|Overall Study|Lack of Efficacy|12|||
27999101|NCT00655629|81826950|FG000|Overall Study|Lost to Follow-up|4|||
27999102|NCT00655629|81826951|FG001|Overall Study|Lost to Follow-up|3|||
27581061|NCT02293005|80310025|FG000|Overall Study|Death|4|||
27581062|NCT02293005|80310025|FG000|Overall Study|Lost to Follow-up|1|||
27581063|NCT02293005|80310025|FG000|Overall Study|Withdrawal by Subject|2|||
27581064|NCT02293005|80310025|FG000|Overall Study|Progression|17|||
27581065|NCT01975389|80310030|FG000|Overall Study|Adverse Event|10|||
27581066|NCT01975389|80310031|FG001|Overall Study|Adverse Event|6|||
27999103|NCT00655629|81826950|FG000|Overall Study|Protocol Violation|5|||
27581067|NCT01975389|80310030|FG000|Overall Study|Death|61|||
27581068|NCT01975389|80310031|FG001|Overall Study|Death|54|||
27581069|NCT01975389|80310030|FG000|Overall Study|Lost to Follow-up|81|||
27581070|NCT01975389|80310031|FG001|Overall Study|Lost to Follow-up|86|||
27581071|NCT01975389|80310030|FG000|Overall Study|Withdrawal by Subject|90|||
27999104|NCT00655629|81826951|FG001|Overall Study|Protocol Violation|3|||
27999105|NCT00655629|81826950|FG000|Overall Study|consent withdrawn|6|||
27999106|NCT00655629|81826951|FG001|Overall Study|consent withdrawn|4|||
27999107|NCT01546857|81826956|FG000|Overall Study|Withdrawal by Subject|2|||
27999108|NCT01546857|81826957|FG001|Overall Study|Withdrawal by Subject|3|||
27999109|NCT00369577|81826958|FG000|Overall Study|Withdrawal by Subject|0|||
27999110|NCT00369577|81826959|FG001|Overall Study|Withdrawal by Subject|0|||
27999111|NCT00369577|81826960|FG002|Overall Study|Withdrawal by Subject|1|||
27999112|NCT03515824|81826961|FG000|Overall Study|Death|3|||
27999113|NCT03515824|81826962|FG001|Overall Study|Death|2|||
27999114|NCT03515824|81826963|FG002|Overall Study|Death|6|||
27999115|NCT03515824|81826964|FG003|Overall Study|Death|0|||
27999116|NCT03515824|81826961|FG000|Overall Study|Lost to Follow-up|0|||
27999117|NCT03515824|81826962|FG001|Overall Study|Lost to Follow-up|1|||
27999118|NCT03515824|81826963|FG002|Overall Study|Lost to Follow-up|1|||
27999119|NCT03515824|81826964|FG003|Overall Study|Lost to Follow-up|0|||
27999120|NCT03515824|81826961|FG000|Overall Study|Study terminated by sponsor|0|||
27999121|NCT03515824|81826962|FG001|Overall Study|Study terminated by sponsor|1|||
27999122|NCT03515824|81826963|FG002|Overall Study|Study terminated by sponsor|6|||
27999123|NCT03515824|81826964|FG003|Overall Study|Study terminated by sponsor|0|||
27999124|NCT03515824|81826961|FG000|Overall Study|Status not recorded|0|||
27999125|NCT03515824|81826962|FG001|Overall Study|Status not recorded|0|||
27999126|NCT03515824|81826963|FG002|Overall Study|Status not recorded|2|||
27999127|NCT03515824|81826964|FG003|Overall Study|Status not recorded|0|||
27999128|NCT01362348|81826965|FG000|Overall Study|Protocol-defined stopping criteria|9|||
27999129|NCT01362348|81826965|FG000|Overall Study|Study closed/terminated|5|||
27999130|NCT01101035|81826966|FG000|Overall Study|Adverse Event|191|||
27999131|NCT01101035|81826967|FG001|Overall Study|Adverse Event|172|||
27999132|NCT01101035|81826966|FG000|Overall Study|Major Protocol Deviation|52|||
27999133|NCT01101035|81826967|FG001|Overall Study|Major Protocol Deviation|46|||
27999134|NCT01101035|81826966|FG000|Overall Study|Lost to Follow-up|226|||
27999135|NCT01101035|81826967|FG001|Overall Study|Lost to Follow-up|223|||
27873184|NCT02763046|81368406|FG000|Overall Study|Physician Decision|1|||
27581072|NCT01975389|80310031|FG001|Overall Study|Withdrawal by Subject|76|||
27581073|NCT01975389|80310030|FG000|Overall Study|Other|6|||
27581074|NCT01975389|80310031|FG001|Overall Study|Other|9|||
27581075|NCT01975389|80310030|FG000|Overall Study|Randomized, not treated|4|||
27581076|NCT01975389|80310031|FG001|Overall Study|Randomized, not treated|5|||
27581077|NCT03832192|80310032|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
27581078|NCT03832192|80310033|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
27581079|NCT01427712|80310034|FG000|Overall Study|Transfer to a different hospital|2|||
27581080|NCT01427712|80310034|FG000|Overall Study|Lost to Follow-up|1|||
27581081|NCT01427712|80310034|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
27581082|NCT01427712|80310034|FG000|Overall Study|Failure to visit|1|||
27581083|NCT02091167|80310038|FG000|Overall Study|Lost to Follow-up|0|||
27581084|NCT02091167|80310039|FG001|Overall Study|Lost to Follow-up|2|||
27581085|NCT04713748|80310040|FG000|Overall Study|Not enough kits allocated|35|||
27581086|NCT01751568|80310046|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
27581087|NCT01751568|80310047|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
27581088|NCT01751568|80310048|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
27873185|NCT02763046|81368407|FG001|Overall Study|Physician Decision|0|||
27873186|NCT02763046|81368408|FG002|Overall Study|Physician Decision|1|||
27581089|NCT00718718|80310049|FG000|Prior to Week 12|Adverse Event|0|||
27873187|NCT02763046|81368406|FG000|Overall Study|Subject/guardian decision|2|||
27999136|NCT01101035|81826966|FG000|Overall Study|Voluntary Withdrawal|595|||
27999137|NCT01101035|81826967|FG001|Overall Study|Voluntary Withdrawal|587|||
27999138|NCT01101035|81826966|FG000|Overall Study|Reason not Specified|333|||
27999139|NCT01101035|81826967|FG001|Overall Study|Reason not Specified|363|||
27999140|NCT04528641|81826971|FG000|Overall Study|Withdrawal by Subject|0|||
27999141|NCT04528641|81826972|FG001|Overall Study|Withdrawal by Subject|0|||
27999142|NCT04528641|81826973|FG002|Overall Study|Withdrawal by Subject|0|||
27873188|NCT02763046|81368407|FG001|Overall Study|Subject/guardian decision|0|||
27873189|NCT02763046|81368408|FG002|Overall Study|Subject/guardian decision|4|||
27873190|NCT01662492|81368409|FG000|Overall Study|Other miscellaneous reasons.|1|||
27873191|NCT01662492|81368410|FG001|Overall Study|Other miscellaneous reasons.|0|||
27873192|NCT01662492|81368411|FG002|Overall Study|Other miscellaneous reasons.|1|||
27873193|NCT01662492|81368409|FG000|Overall Study|Withdrawal by Subject|0|||
27873194|NCT01662492|81368410|FG001|Overall Study|Withdrawal by Subject|0|||
27873195|NCT01662492|81368411|FG002|Overall Study|Withdrawal by Subject|1|||
27873196|NCT01662492|81368409|FG000|Overall Study|Protocol Violation|1|||
27873197|NCT01662492|81368410|FG001|Overall Study|Protocol Violation|0|||
27873198|NCT01662492|81368411|FG002|Overall Study|Protocol Violation|0|||
27873199|NCT01662492|81368409|FG000|Overall Study|Lost to Follow-up|0|||
27581090|NCT00718718|80310050|FG001|Prior to Week 12|Adverse Event|0|||
27680721|NCT01232738|80667883|FG000|Overall Study|Adverse Event|5|||
27680722|NCT00890695|80667886|FG000|Overall Study|Protocol Violation|1|||
27680723|NCT00890695|80667887|FG001|Overall Study|Protocol Violation|0|||
27680724|NCT01430468|80667888|FG000|Overall Study|Physician Decision|2|||
27680725|NCT01430468|80667889|FG001|Overall Study|Physician Decision|1|||
27680726|NCT01430468|80667888|FG000|Overall Study|Withdrawal by Subject|5|||
27680727|NCT01430468|80667889|FG001|Overall Study|Withdrawal by Subject|5|||
27680728|NCT02510040|80667890|FG000|Overall Study|Deemed no longer eligible|18|||
27680729|NCT02510040|80667891|FG001|Overall Study|Deemed no longer eligible|3|||
27680730|NCT02510040|80667892|FG002|Overall Study|Deemed no longer eligible|1|||
27873200|NCT01662492|81368410|FG001|Overall Study|Lost to Follow-up|0|||
27873201|NCT01662492|81368411|FG002|Overall Study|Lost to Follow-up|2|||
27873202|NCT01662492|81368409|FG000|Overall Study|Lack of Efficacy|1|||
27999143|NCT04528641|81826974|FG003|Overall Study|Withdrawal by Subject|1|||
27999144|NCT04528641|81826975|FG004|Overall Study|Withdrawal by Subject|0|||
27999145|NCT04528641|81826976|FG005|Overall Study|Withdrawal by Subject|1|||
27999146|NCT00354679|81826977|FG000|Overall Study|Patient Not Treated|1|||
27581091|NCT00718718|80310051|FG002|Prior to Week 12|Adverse Event|0|||
27581092|NCT00718718|80310052|FG003|Prior to Week 12|Adverse Event|0|||
27581093|NCT00718718|80310053|FG004|Prior to Week 12|Adverse Event|0|||
27581094|NCT00718718|80310054|FG005|Prior to Week 12|Adverse Event|0|||
27999147|NCT03010527|81826978|FG000|Overall Study|Death|0|||
27999148|NCT03010527|81826979|FG001|Overall Study|Death|0|||
27999149|NCT03010527|81826980|FG002|Overall Study|Death|1|||
27999150|NCT03010527|81826978|FG000|Overall Study|Adverse Event|0|||
27999151|NCT03010527|81826979|FG001|Overall Study|Adverse Event|4|||
27999152|NCT03010527|81826980|FG002|Overall Study|Adverse Event|2|||
27999153|NCT03010527|81826978|FG000|Overall Study|Protocol Violation|0|||
27999154|NCT03010527|81826979|FG001|Overall Study|Protocol Violation|1|||
27999155|NCT03010527|81826980|FG002|Overall Study|Protocol Violation|0|||
27999156|NCT03010527|81826978|FG000|Overall Study|Lost to Follow-up|0|||
27999157|NCT03010527|81826979|FG001|Overall Study|Lost to Follow-up|2|||
27999158|NCT03010527|81826980|FG002|Overall Study|Lost to Follow-up|1|||
27999159|NCT03010527|81826978|FG000|Overall Study|Withdrawal by Subject|0|||
27999160|NCT03010527|81826979|FG001|Overall Study|Withdrawal by Subject|3|||
27999161|NCT03010527|81826980|FG002|Overall Study|Withdrawal by Subject|4|||
27999162|NCT03010527|81826978|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
27873203|NCT01662492|81368410|FG001|Overall Study|Lack of Efficacy|1|||
27873204|NCT01662492|81368411|FG002|Overall Study|Lack of Efficacy|2|||
27873205|NCT00610129|81368412|FG000|Overall Study|Not treated since patients ineligible|3|||
27873206|NCT02002221|81368413|FG000|Overall Study|Adverse Event|2|||
27873207|NCT02002221|81368414|FG001|Overall Study|Adverse Event|1|||
27873208|NCT02002221|81368413|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27873209|NCT02002221|81368414|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27999163|NCT03010527|81826979|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
27999164|NCT03010527|81826980|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
27873210|NCT02002221|81368413|FG000|Overall Study|Patient withdrew consent|0|||
27581095|NCT00718718|80310055|FG006|Prior to Week 12|Adverse Event|0|||
27581096|NCT00718718|80310056|FG007|Prior to Week 12|Adverse Event|1|||
27581097|NCT00718718|80310057|FG008|Prior to Week 12|Adverse Event|1|||
27999165|NCT03010527|81826978|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
27999166|NCT03010527|81826979|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
27999167|NCT03010527|81826980|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
27999168|NCT03010527|81826978|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
27999169|NCT03010527|81826979|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
27999170|NCT03010527|81826980|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
27999171|NCT04549545|81826986|FG000|Initial Period|Withdrawal by Subject|4|||
27999172|NCT04549545|81826987|FG001|Initial Period|Withdrawal by Subject|0|||
27999173|NCT04549545|81826986|FG000|Initial Period|Additional ENT Procedure|3|||
27873211|NCT02002221|81368414|FG001|Overall Study|Patient withdrew consent|1|||
27873212|NCT00462904|81368416|FG000|Overall Study|Lost to Follow-up|1|||
27873213|NCT03359850|81368419|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
27581098|NCT00718718|80310058|FG009|Prior to Week 12|Adverse Event|0|||
27581099|NCT00718718|80310049|FG000|Prior to Week 12|Withdrawal by Subject|0|||
27873214|NCT03359850|81368420|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
27873215|NCT03359850|81368419|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
27873216|NCT03359850|81368420|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
27873217|NCT03359850|81368419|FG000|Extension Phase (Up to 28 Months)|Death|2|||
27873218|NCT03359850|81368420|FG001|Extension Phase (Up to 28 Months)|Death|4|||
27873219|NCT03359850|81368419|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
27873220|NCT03359850|81368420|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
27873221|NCT03359850|81368419|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
27873222|NCT03359850|81368420|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
27873223|NCT00856492|81368423|FG000|Overall Study|Ineligible or withdrew consent|1|||
27873224|NCT00856492|81368424|FG001|Overall Study|Ineligible or withdrew consent|1|||
27873225|NCT00856492|81368425|FG002|Overall Study|Ineligible or withdrew consent|2|||
27873226|NCT00668317|81368430|FG000|Overall Study|Adverse Event|2|||
27873227|NCT01349192|81368432|FG000|Overall Study|Protocol Violation|0|||
27873228|NCT01349192|81368433|FG001|Overall Study|Protocol Violation|1|||
27873229|NCT01349192|81368432|FG000|Overall Study|Withdrawal by Subject|0|||
27873230|NCT01349192|81368433|FG001|Overall Study|Withdrawal by Subject|2|||
27873231|NCT01349192|81368432|FG000|Overall Study|Lost to Follow-up|1|||
27873232|NCT01349192|81368433|FG001|Overall Study|Lost to Follow-up|3|||
27873233|NCT01349192|81368432|FG000|Overall Study|Failure to adhere to Protocol|2|||
27873234|NCT01349192|81368433|FG001|Overall Study|Failure to adhere to Protocol|0|||
27873235|NCT03565900|81368438|FG000|Overall Study|Disposition Unknown|4|||
27873236|NCT03565900|81368439|FG001|Overall Study|Disposition Unknown|1|||
27873237|NCT03565900|81368438|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27873238|NCT03565900|81368439|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
27873239|NCT03565900|81368438|FG000|Overall Study|Withdrawal by Subject|4|||
27873240|NCT03565900|81368439|FG001|Overall Study|Withdrawal by Subject|5|||
27873241|NCT03565900|81368438|FG000|Overall Study|Randomized By Mistake|0|||
27873242|NCT03565900|81368439|FG001|Overall Study|Randomized By Mistake|2|||
27873243|NCT03565900|81368438|FG000|Overall Study|Physician Decision|7|||
27873244|NCT03565900|81368439|FG001|Overall Study|Physician Decision|11|||
27873245|NCT03565900|81368438|FG000|Overall Study|Death|9|||
27873246|NCT03565900|81368439|FG001|Overall Study|Death|7|||
27873247|NCT03351608|81368440|FG000|Overall Study|Lost to Follow-up|0|||
27873248|NCT03351608|81368441|FG001|Overall Study|Lost to Follow-up|1|||
27581100|NCT00718718|80310050|FG001|Prior to Week 12|Withdrawal by Subject|0|||
27581101|NCT00718718|80310051|FG002|Prior to Week 12|Withdrawal by Subject|0|||
27873249|NCT03351608|81368442|FG002|Overall Study|Lost to Follow-up|1|||
27873250|NCT03351608|81368443|FG003|Overall Study|Lost to Follow-up|1|||
27873251|NCT03351608|81368444|FG004|Overall Study|Lost to Follow-up|1|||
27873252|NCT03351608|81368440|FG000|Overall Study|Physician Decision|1|||
27873253|NCT03351608|81368441|FG001|Overall Study|Physician Decision|0|||
27873254|NCT03351608|81368442|FG002|Overall Study|Physician Decision|0|||
27873255|NCT03351608|81368443|FG003|Overall Study|Physician Decision|2|||
27873256|NCT03351608|81368444|FG004|Overall Study|Physician Decision|1|||
27999174|NCT04549545|81826987|FG001|Initial Period|Additional ENT Procedure|0|||
27999175|NCT04549545|81826986|FG000|Initial Period|Lost to Follow-up|3|||
27999176|NCT04549545|81826987|FG001|Initial Period|Lost to Follow-up|1|||
27873257|NCT03351608|81368440|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
27873258|NCT03351608|81368441|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
27873259|NCT03351608|81368442|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
27873260|NCT03351608|81368443|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
27873261|NCT03351608|81368444|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
27873262|NCT03351608|81368440|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27873263|NCT03351608|81368441|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27873264|NCT03351608|81368442|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27873265|NCT03351608|81368443|FG003|Overall Study|Withdrawal by parent/guardian|1|||
27873266|NCT03351608|81368444|FG004|Overall Study|Withdrawal by parent/guardian|0|||
27873267|NCT03351608|81368440|FG000|Overall Study|Other|0|||
27873268|NCT03351608|81368441|FG001|Overall Study|Other|1|||
27873269|NCT03351608|81368442|FG002|Overall Study|Other|1|||
27873270|NCT03351608|81368443|FG003|Overall Study|Other|3|||
27873271|NCT03351608|81368444|FG004|Overall Study|Other|0|||
27873272|NCT01256879|81368445|FG000|Overall Study|Withdrawal by Subject|1|||
27873273|NCT02094300|81368446|FG000|Overall Study|Death|7|||
27873274|NCT02094300|81368446|FG000|Overall Study|Lost to Follow-up|10|||
27873275|NCT02094300|81368446|FG000|Overall Study|Still be eligible for follow-up|3|||
27873276|NCT00266630|81368447|FG000|Overall Study|Adverse Event|8|||
27873277|NCT00266630|81368448|FG001|Overall Study|Adverse Event|6|||
27873278|NCT00266630|81368447|FG000|Overall Study|Lack of Efficacy|1|||
27873279|NCT00266630|81368448|FG001|Overall Study|Lack of Efficacy|4|||
27873280|NCT00266630|81368447|FG000|Overall Study|Entry Criteria not met|1|||
27873281|NCT00266630|81368448|FG001|Overall Study|Entry Criteria not met|0|||
27873282|NCT00266630|81368447|FG000|Overall Study|Protocol Violation|1|||
27873283|NCT00266630|81368448|FG001|Overall Study|Protocol Violation|3|||
27873284|NCT00266630|81368447|FG000|Overall Study|Physician Decision|1|||
27873285|NCT00266630|81368448|FG001|Overall Study|Physician Decision|2|||
27873286|NCT00266630|81368447|FG000|Overall Study|Withdrawal by Subject|10|||
27873287|NCT00266630|81368448|FG001|Overall Study|Withdrawal by Subject|2|||
27873288|NCT00266630|81368447|FG000|Overall Study|Lost to Follow-up|1|||
27873289|NCT00266630|81368448|FG001|Overall Study|Lost to Follow-up|0|||
27873290|NCT00266630|81368447|FG000|Overall Study|Other|19|||
27873291|NCT00266630|81368448|FG001|Overall Study|Other|11|||
27873292|NCT04720053|81368450|FG000|Overall Study|Lost to Follow-up|12|||
27873293|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
27873294|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
27873295|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
27873296|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
27873297|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
27873298|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
27873299|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
27873300|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
27873301|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
27873302|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
27873303|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
27873304|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
27873305|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
27873306|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
27873307|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
27873308|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
27873309|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
27873310|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
27873311|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
27873312|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
27873313|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
27873314|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
27873315|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
27873316|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
27873317|NCT01130532|81368451|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
27873318|NCT01130532|81368452|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
27873319|NCT01130532|81368453|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
27873320|NCT01130532|81368454|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
27873321|NCT01130532|81368451|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
27873322|NCT01130532|81368452|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
27873323|NCT01130532|81368453|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
27873324|NCT01130532|81368454|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
27873325|NCT01130532|81368451|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
27873326|NCT01130532|81368452|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
27873327|NCT01130532|81368453|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
27873328|NCT01130532|81368454|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
27873329|NCT01130532|81368451|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
27873330|NCT01130532|81368452|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
27873331|NCT01130532|81368453|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
27873332|NCT01130532|81368454|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
27873333|NCT01130532|81368451|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
27873334|NCT01130532|81368452|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
27873335|NCT01130532|81368453|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
27873336|NCT01130532|81368454|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
27873337|NCT01350271|81368460|FG000|Overall Study|Lost to Follow-up|21|||
27873338|NCT01350271|81368461|FG001|Overall Study|Lost to Follow-up|17|||
27873339|NCT01350271|81368462|FG002|Overall Study|Lost to Follow-up|26|||
27581102|NCT00718718|80310052|FG003|Prior to Week 12|Withdrawal by Subject|0|||
27873340|NCT00349973|81368466|FG000|Overall Study|Adverse Event|3|||
27873341|NCT00349973|81368467|FG001|Overall Study|Adverse Event|3|||
27873342|NCT00349973|81368466|FG000|Overall Study|Withdrawal by Subject|1|||
27873343|NCT00349973|81368467|FG001|Overall Study|Withdrawal by Subject|0|||
27581103|NCT00718718|80310053|FG004|Prior to Week 12|Withdrawal by Subject|3|||
27581104|NCT00718718|80310054|FG005|Prior to Week 12|Withdrawal by Subject|0|||
27581105|NCT00718718|80310055|FG006|Prior to Week 12|Withdrawal by Subject|1|||
27581106|NCT00718718|80310056|FG007|Prior to Week 12|Withdrawal by Subject|1|||
27581107|NCT00718718|80310057|FG008|Prior to Week 12|Withdrawal by Subject|1|||
27581108|NCT00718718|80310058|FG009|Prior to Week 12|Withdrawal by Subject|0|||
27581109|NCT00718718|80310049|FG000|Prior to Week 12|Other|1|||
27581110|NCT00718718|80310050|FG001|Prior to Week 12|Other|0|||
27581111|NCT00718718|80310051|FG002|Prior to Week 12|Other|1|||
27581112|NCT00718718|80310052|FG003|Prior to Week 12|Other|0|||
27581113|NCT00718718|80310053|FG004|Prior to Week 12|Other|0|||
27581114|NCT00718718|80310054|FG005|Prior to Week 12|Other|0|||
27873344|NCT01622673|81368468|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27873345|NCT01622673|81368469|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27873346|NCT01622673|81368470|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27873347|NCT01622673|81368471|FG003|Treatment Period 1|Withdrawal by Subject|1|||
27999177|NCT04549545|81826986|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
27581115|NCT00718718|80310055|FG006|Prior to Week 12|Other|0|||
27581116|NCT00718718|80310056|FG007|Prior to Week 12|Other|0|||
27581117|NCT00718718|80310057|FG008|Prior to Week 12|Other|0|||
27581118|NCT00718718|80310058|FG009|Prior to Week 12|Other|0|||
27581119|NCT00718718|80310049|FG000|Week 12 to End of Study|Adverse Event|0|||
27581120|NCT00718718|80310050|FG001|Week 12 to End of Study|Adverse Event|0|||
27581121|NCT00718718|80310051|FG002|Week 12 to End of Study|Adverse Event|0|||
27581122|NCT00718718|80310052|FG003|Week 12 to End of Study|Adverse Event|0|||
27581123|NCT00718718|80310053|FG004|Week 12 to End of Study|Adverse Event|0|||
27581124|NCT00718718|80310054|FG005|Week 12 to End of Study|Adverse Event|0|||
27581125|NCT00718718|80310055|FG006|Week 12 to End of Study|Adverse Event|0|||
27581126|NCT00718718|80310056|FG007|Week 12 to End of Study|Adverse Event|1|||
27581127|NCT00718718|80310057|FG008|Week 12 to End of Study|Adverse Event|0|||
27581128|NCT00718718|80310058|FG009|Week 12 to End of Study|Adverse Event|0|||
27581129|NCT00718718|80310049|FG000|Week 12 to End of Study|Death|0|||
27581130|NCT00718718|80310050|FG001|Week 12 to End of Study|Death|0|||
27581131|NCT00718718|80310051|FG002|Week 12 to End of Study|Death|0|||
27581132|NCT00718718|80310052|FG003|Week 12 to End of Study|Death|0|||
27581133|NCT00718718|80310053|FG004|Week 12 to End of Study|Death|0|||
27581134|NCT00718718|80310054|FG005|Week 12 to End of Study|Death|1|||
27581135|NCT00718718|80310055|FG006|Week 12 to End of Study|Death|0|||
27581136|NCT00718718|80310056|FG007|Week 12 to End of Study|Death|0|||
27581137|NCT00718718|80310057|FG008|Week 12 to End of Study|Death|0|||
27581138|NCT00718718|80310058|FG009|Week 12 to End of Study|Death|0|||
27581139|NCT00718718|80310049|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
27581140|NCT00718718|80310050|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
27581141|NCT00718718|80310051|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
27581142|NCT00718718|80310052|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
27581143|NCT00718718|80310053|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
27581144|NCT00718718|80310054|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
27581145|NCT00718718|80310055|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
27581146|NCT00718718|80310056|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
27581147|NCT00718718|80310057|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
27581148|NCT00718718|80310058|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
27581149|NCT00718718|80310049|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
27581150|NCT00718718|80310050|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
27581151|NCT00718718|80310051|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
27873348|NCT01622673|81368472|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27873349|NCT01622673|81368473|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27999178|NCT04549545|81826987|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
27999179|NCT04549545|81826986|FG000|Crossover Period|Additional ENT Procedure|0|||
27873350|NCT01622673|81368468|FG000|Treatment Period 1|Protocol Violation|0|||
27581152|NCT00718718|80310052|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
27581153|NCT00718718|80310053|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
27581154|NCT00718718|80310054|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
27581155|NCT00718718|80310055|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
27581156|NCT00718718|80310056|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
27581157|NCT00718718|80310057|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
27581158|NCT00718718|80310058|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
27581159|NCT00718718|80310049|FG000|Week 12 to End of Study|Other|0|||
27873351|NCT01622673|81368469|FG001|Treatment Period 1|Protocol Violation|1|||
27873352|NCT01622673|81368470|FG002|Treatment Period 1|Protocol Violation|0|||
27873353|NCT01622673|81368471|FG003|Treatment Period 1|Protocol Violation|0|||
27873354|NCT01622673|81368472|FG004|Treatment Period 1|Protocol Violation|0|||
27873355|NCT01622673|81368473|FG005|Treatment Period 1|Protocol Violation|0|||
27873356|NCT01622673|81368468|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27873357|NCT01622673|81368469|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27873358|NCT01622673|81368470|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27873359|NCT01622673|81368471|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27999180|NCT04549545|81826987|FG001|Crossover Period|Additional ENT Procedure|6|||
27873360|NCT01622673|81368472|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27873361|NCT01622673|81368473|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27873362|NCT01622673|81368468|FG000|Treatment Period 3|Protocol Violation|0|||
27873363|NCT01622673|81368469|FG001|Treatment Period 3|Protocol Violation|1|||
27873364|NCT01622673|81368470|FG002|Treatment Period 3|Protocol Violation|0|||
27873365|NCT01622673|81368471|FG003|Treatment Period 3|Protocol Violation|0|||
27873366|NCT01622673|81368472|FG004|Treatment Period 3|Protocol Violation|0|||
27873367|NCT01622673|81368473|FG005|Treatment Period 3|Protocol Violation|0|||
27873368|NCT01841593|81368474|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
27999181|NCT04549545|81826986|FG000|Crossover Period|Lost to Follow-up|0|||
27999182|NCT04549545|81826987|FG001|Crossover Period|Lost to Follow-up|1|||
27999183|NCT04549545|81826986|FG000|Crossover Period|Withdrawal by Subject|0|||
27999184|NCT04549545|81826987|FG001|Crossover Period|Withdrawal by Subject|4|||
27999185|NCT00801229|81826988|FG000|Signed Consent|Withdrawal by Subject|2|||
27999186|NCT00801229|81826989|FG001|Signed Consent|Withdrawal by Subject|2|||
27999187|NCT00801229|81826988|FG000|Signed Consent|Found Ineligible|1|||
27999188|NCT00801229|81826989|FG001|Signed Consent|Found Ineligible|1|||
27999189|NCT00801229|81826988|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
27999190|NCT00801229|81826989|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
27999191|NCT00801229|81826988|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
27999192|NCT00801229|81826989|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
27999193|NCT00801229|81826988|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
27999194|NCT00801229|81826989|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
27999195|NCT00801229|81826988|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
27999196|NCT00801229|81826989|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
27999197|NCT00801229|81826988|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
27999198|NCT00801229|81826989|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
27999199|NCT00801229|81826988|FG000|Received Study Drug/Placebo|Adverse Event|1|||
27999200|NCT00801229|81826989|FG001|Received Study Drug/Placebo|Adverse Event|1|||
27999201|NCT01597635|81826991|FG000|Part A|Adverse Event|3|||
27999202|NCT01597635|81826992|FG001|Part A|Adverse Event|0|||
27999203|NCT01597635|81826993|FG002|Part A|Adverse Event|0|||
27999204|NCT01597635|81826991|FG000|Part B|Adverse Event|0|||
27999205|NCT01597635|81826992|FG001|Part B|Adverse Event|0|||
27999206|NCT01597635|81826993|FG002|Part B|Adverse Event|1|||
27999207|NCT01597635|81826991|FG000|Part B|Protocol Violation|0|||
27999208|NCT01597635|81826992|FG001|Part B|Protocol Violation|1|||
27999209|NCT01597635|81826993|FG002|Part B|Protocol Violation|0|||
27999210|NCT01597635|81826991|FG000|Part B|Protocol-defined stopping criteria|0|||
27999211|NCT01597635|81826992|FG001|Part B|Protocol-defined stopping criteria|4|||
27999212|NCT01597635|81826993|FG002|Part B|Protocol-defined stopping criteria|3|||
27999213|NCT01597635|81826991|FG000|Part B|Withdrawal by Subject|0|||
27999214|NCT01597635|81826992|FG001|Part B|Withdrawal by Subject|1|||
27999215|NCT01597635|81826993|FG002|Part B|Withdrawal by Subject|0|||
27999216|NCT00887549|81826996|FG000|Induction Therapy|Adverse Event|8|||
27999217|NCT00887549|81826996|FG000|Induction Therapy|Physician Decision|1|||
27581160|NCT00718718|80310050|FG001|Week 12 to End of Study|Other|1|||
27873369|NCT01841593|81368475|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
27581161|NCT00718718|80310051|FG002|Week 12 to End of Study|Other|0|||
27581162|NCT00718718|80310052|FG003|Week 12 to End of Study|Other|1|||
27581163|NCT00718718|80310053|FG004|Week 12 to End of Study|Other|0|||
27581164|NCT00718718|80310054|FG005|Week 12 to End of Study|Other|0|||
27581165|NCT00718718|80310055|FG006|Week 12 to End of Study|Other|1|||
27581166|NCT00718718|80310056|FG007|Week 12 to End of Study|Other|0|||
27581167|NCT00718718|80310057|FG008|Week 12 to End of Study|Other|0|||
27581168|NCT00718718|80310058|FG009|Week 12 to End of Study|Other|0|||
27873370|NCT01841593|81368474|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
27999218|NCT00887549|81826996|FG000|Induction Therapy|Progressive Disease|13|||
27999219|NCT00887549|81826996|FG000|Induction Therapy|Death due to Study Disease|4|||
27999220|NCT00887549|81826996|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
27999221|NCT00887549|81826996|FG000|Maintenance Therapy|Adverse Event|16|||
27999222|NCT00887549|81826996|FG000|Maintenance Therapy|Physician Decision|1|||
27999223|NCT00887549|81826996|FG000|Maintenance Therapy|Progressive Disease|25|||
27999224|NCT00887549|81826996|FG000|Maintenance Therapy|Death due to adverse event|1|||
27999225|NCT00717249|81827000|FG000|Overall Study|Lens Discomfort|4|||
27581169|NCT00660010|80310061|FG000|Overall Study|Withdrawal by Subject|2|||
27581170|NCT00660010|80310061|FG000|Overall Study|Lost to Follow-up|3|||
27581171|NCT00660010|80310061|FG000|Overall Study|Adverse Event|1|||
27581172|NCT00660010|80310061|FG000|Overall Study|Noncompliance with visit schedule|3|||
27581173|NCT03042312|80310062|FG000|Overall Study|Administrative Reason|1|||
27581174|NCT03042312|80310063|FG001|Overall Study|Administrative Reason|1|||
27581175|NCT03042312|80310062|FG000|Overall Study|Adverse Event|0|||
27581176|NCT03042312|80310063|FG001|Overall Study|Adverse Event|1|||
27581177|NCT03042312|80310062|FG000|Overall Study|Lost to Follow-up|1|||
27581178|NCT03042312|80310063|FG001|Overall Study|Lost to Follow-up|3|||
27581179|NCT03042312|80310062|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
27581180|NCT03042312|80310063|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
27581181|NCT03042312|80310062|FG000|Overall Study|Withdrawal by Subject|4|||
27581182|NCT03042312|80310063|FG001|Overall Study|Withdrawal by Subject|5|||
27581183|NCT00829621|80310067|FG000|Overall Study|Death|1|||
27581184|NCT00829621|80310068|FG001|Overall Study|Death|0|||
27581185|NCT00829621|80310067|FG000|Overall Study|Lost to Follow-up|3|||
27581186|NCT00829621|80310068|FG001|Overall Study|Lost to Follow-up|4|||
27581187|NCT00129259|80310069|FG000|Overall Study|Lost to Follow-up|1|||
27581188|NCT00129259|80310070|FG001|Overall Study|Lost to Follow-up|1|||
27581189|NCT00129259|80310069|FG000|Overall Study|Withdrawal by Subject|2|||
27581190|NCT00129259|80310070|FG001|Overall Study|Withdrawal by Subject|1|||
27581191|NCT00129259|80310069|FG000|Overall Study|Only available minimal phone assessments|0|||
27581192|NCT00129259|80310070|FG001|Overall Study|Only available minimal phone assessments|1|||
27581193|NCT00439140|80310071|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
27581194|NCT00439140|80310072|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
27581195|NCT00439140|80310073|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
27581196|NCT00439140|80310071|FG000|Treatment Cycle 1|Personal reasons|0|||
27581197|NCT00439140|80310072|FG001|Treatment Cycle 1|Personal reasons|2|||
27581198|NCT00439140|80310073|FG002|Treatment Cycle 1|Personal reasons|0|||
27581199|NCT00439140|80310071|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
27581200|NCT00439140|80310072|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
27581201|NCT00439140|80310073|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
27581202|NCT00439140|80310071|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
27581203|NCT00439140|80310072|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
27581204|NCT00439140|80310073|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
27581205|NCT00439140|80310071|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
27581206|NCT00439140|80310072|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
27581207|NCT00439140|80310073|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
27581208|NCT00803023|80310074|FG000|Overall Study|Adverse Event|5|||
27581209|NCT00803023|80310075|FG001|Overall Study|Adverse Event|4|||
27581210|NCT00803023|80310076|FG002|Overall Study|Adverse Event|8|||
27581211|NCT00803023|80310077|FG003|Overall Study|Adverse Event|6|||
27873371|NCT01841593|81368475|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
27873372|NCT00122382|81368479|FG000|Double-Blind Study|Adverse Event|9|||
27873373|NCT00122382|81368480|FG001|Double-Blind Study|Adverse Event|11|||
27999226|NCT00717249|81827001|FG001|Overall Study|Lens Discomfort|1|||
27999227|NCT00717249|81827000|FG000|Overall Study|Unsatisfactory visual Response|0|||
27999228|NCT00717249|81827001|FG001|Overall Study|Unsatisfactory visual Response|2|||
27581212|NCT00803023|80310074|FG000|Overall Study|Withdrawal by Subject|0|||
27581213|NCT00803023|80310075|FG001|Overall Study|Withdrawal by Subject|2|||
27581214|NCT00803023|80310076|FG002|Overall Study|Withdrawal by Subject|0|||
27581215|NCT00803023|80310077|FG003|Overall Study|Withdrawal by Subject|0|||
27581216|NCT00803023|80310074|FG000|Overall Study|Lost to Follow-up|0|||
27999229|NCT00717249|81827000|FG000|Overall Study|Adverse Event|4|||
27999230|NCT00717249|81827001|FG001|Overall Study|Adverse Event|2|||
27999231|NCT00717249|81827000|FG000|Overall Study|Lost to Follow-up|2|||
27999232|NCT00717249|81827001|FG001|Overall Study|Lost to Follow-up|0|||
27999233|NCT00717249|81827000|FG000|Overall Study|Withdrawal by Subject|1|||
27999234|NCT00717249|81827001|FG001|Overall Study|Withdrawal by Subject|2|||
27999235|NCT00717249|81827000|FG000|Overall Study|Pregnancy|6|||
27999236|NCT00717249|81827001|FG001|Overall Study|Pregnancy|3|||
27999237|NCT00717249|81827000|FG000|Overall Study|Protocol Violation|0|||
27999238|NCT00717249|81827001|FG001|Overall Study|Protocol Violation|2|||
27999239|NCT00717249|81827000|FG000|Overall Study|Subject became Ineligible|1|||
27999240|NCT00717249|81827001|FG001|Overall Study|Subject became Ineligible|1|||
27999241|NCT00717249|81827000|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
27999242|NCT00717249|81827001|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
27873374|NCT00122382|81368481|FG002|Double-Blind Study|Adverse Event|0|||
27873375|NCT00122382|81368479|FG000|Double-Blind Study|Death|2|||
27873376|NCT00122382|81368480|FG001|Double-Blind Study|Death|2|||
27873377|NCT00122382|81368481|FG002|Double-Blind Study|Death|0|||
27873378|NCT00122382|81368479|FG000|Double-Blind Study|Lack of Efficacy|0|||
27873379|NCT00122382|81368480|FG001|Double-Blind Study|Lack of Efficacy|8|||
27581217|NCT00803023|80310075|FG001|Overall Study|Lost to Follow-up|1|||
27581218|NCT00803023|80310076|FG002|Overall Study|Lost to Follow-up|2|||
27581219|NCT00803023|80310077|FG003|Overall Study|Lost to Follow-up|1|||
27581220|NCT00803023|80310074|FG000|Overall Study|Lack of Efficacy|0|||
27581221|NCT00803023|80310075|FG001|Overall Study|Lack of Efficacy|1|||
27581222|NCT00803023|80310076|FG002|Overall Study|Lack of Efficacy|1|||
27581223|NCT00803023|80310077|FG003|Overall Study|Lack of Efficacy|1|||
27581224|NCT03323099|80310079|FG000|Overall Study|Withdrawal by Subject|6|||
27581225|NCT03323099|80310080|FG001|Overall Study|Withdrawal by Subject|12|||
27581226|NCT03323099|80310079|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
27581227|NCT03323099|80310080|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
27581228|NCT01677195|80310081|FG000|Overall Study|Lost to Follow-up|14|||
27581229|NCT01677195|80310082|FG001|Overall Study|Lost to Follow-up|22|||
27581230|NCT01677195|80310083|FG002|Overall Study|Lost to Follow-up|22|||
27581231|NCT01677195|80310081|FG000|Overall Study|Withdrawal by Subject|1|||
27581232|NCT01677195|80310082|FG001|Overall Study|Withdrawal by Subject|0|||
27581233|NCT01677195|80310083|FG002|Overall Study|Withdrawal by Subject|1|||
27581234|NCT01677195|80310081|FG000|Overall Study|Adverse Event|6|||
27680746|NCT01706705|80667900|FG000|Overall Study|Death|1|||
27805241|NCT01722266|81117319|FG002|Overall Study|Dropped out due to Nausea|2|||
27805242|NCT01722266|81117320|FG003|Overall Study|Dropped out due to Nausea|0|||
27805243|NCT01335464|81117321|FG000|Overall Study|Adverse Event|15|||
27805244|NCT01335464|81117322|FG001|Overall Study|Adverse Event|25|||
27805245|NCT01335464|81117321|FG000|Overall Study|Non compliant with protocol|2|||
27805246|NCT01335464|81117322|FG001|Overall Study|Non compliant with protocol|0|||
27805247|NCT01335464|81117321|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
27805248|NCT01335464|81117322|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
27805249|NCT01335464|81117321|FG000|Overall Study|Not treated|2|||
27805250|NCT01335464|81117322|FG001|Overall Study|Not treated|0|||
27805251|NCT01335464|81117321|FG000|Overall Study|Reason other than those stated above|1|||
27805252|NCT01335464|81117322|FG001|Overall Study|Reason other than those stated above|1|||
27805253|NCT02957682|81117323|FG000|Overall Study|Adverse Event|64|||
27805254|NCT02957682|81117324|FG001|Overall Study|Adverse Event|67|||
27805255|NCT02957682|81117323|FG000|Overall Study|Poor Compliance to Protocol|30|||
27805256|NCT02957682|81117324|FG001|Overall Study|Poor Compliance to Protocol|26|||
27805257|NCT02957682|81117323|FG000|Overall Study|Physician Decision|4|||
27805258|NCT02957682|81117324|FG001|Overall Study|Physician Decision|4|||
27805259|NCT02957682|81117323|FG000|Overall Study|Study Terminated by Sponsor|4|||
27805260|NCT02957682|81117324|FG001|Overall Study|Study Terminated by Sponsor|3|||
27805261|NCT02957682|81117323|FG000|Overall Study|Subject Moved|10|||
27805262|NCT02957682|81117324|FG001|Overall Study|Subject Moved|16|||
27805263|NCT02957682|81117323|FG000|Overall Study|Withdrawal by Subject|64|||
27805264|NCT02957682|81117324|FG001|Overall Study|Withdrawal by Subject|33|||
27805265|NCT02957682|81117323|FG000|Overall Study|Related to IMP Administration|3|||
27805266|NCT02957682|81117324|FG001|Overall Study|Related to IMP Administration|6|||
27805267|NCT02957682|81117323|FG000|Overall Study|Non-disclosed|16|||
27805268|NCT02957682|81117324|FG001|Overall Study|Non-disclosed|12|||
27805269|NCT02957682|81117323|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
27805270|NCT02957682|81117324|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
27805271|NCT02995837|81117325|FG000|Overall Study|Lost to Follow-up|9|||
27805272|NCT02995837|81117326|FG001|Overall Study|Lost to Follow-up|8|||
27873380|NCT00122382|81368481|FG002|Double-Blind Study|Lack of Efficacy|0|||
27581235|NCT01677195|80310082|FG001|Overall Study|Adverse Event|4|||
27680747|NCT01706705|80667900|FG000|Overall Study|Lack of Efficacy|13|||
27680748|NCT01706705|80667900|FG000|Overall Study|Non-clinical|6|||
27805273|NCT02230085|81117327|FG000|Overall Study|Physician Decision|1|||
27805274|NCT02230085|81117327|FG000|Overall Study|Withdrawal by Subject|3|||
27805275|NCT00323609|81117330|FG000|Overall Study|Death|16|||
27873381|NCT00122382|81368479|FG000|Double-Blind Study|Lost to Follow-up|2|||
27581236|NCT01677195|80310083|FG002|Overall Study|Adverse Event|1|||
27581237|NCT01677195|80310081|FG000|Overall Study|Physician Decision|1|||
27581238|NCT01677195|80310082|FG001|Overall Study|Physician Decision|2|||
27581239|NCT01677195|80310083|FG002|Overall Study|Physician Decision|2|||
27581240|NCT01677195|80310081|FG000|Overall Study|Pregnancy|0|||
27581241|NCT01677195|80310082|FG001|Overall Study|Pregnancy|1|||
27581242|NCT01677195|80310083|FG002|Overall Study|Pregnancy|0|||
27581243|NCT01677195|80310081|FG000|Overall Study|Protocol Violation|7|||
27581244|NCT01677195|80310082|FG001|Overall Study|Protocol Violation|3|||
27581245|NCT01677195|80310083|FG002|Overall Study|Protocol Violation|4|||
27680749|NCT00918879|80667901|FG000|Overall Study|Withdrawal by Subject|4|||
27805276|NCT00323609|81117331|FG001|Overall Study|Death|21|||
27581246|NCT03728582|80310088|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
27581247|NCT03728582|80310089|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
27581248|NCT03728582|80310088|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
27581249|NCT03728582|80310089|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
27805277|NCT00323609|81117332|FG002|Overall Study|Death|0|||
27581250|NCT03370341|80310093|FG000|Overall Study|Lost to Follow-up|0|||
27581251|NCT03370341|80310094|FG001|Overall Study|Lost to Follow-up|1|||
27581252|NCT03653429|80310095|FG000|Overall Study|Physician Decision|4|||
27581253|NCT03653429|80310096|FG001|Overall Study|Physician Decision|10|||
27581254|NCT03238001|80310097|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
27581255|NCT03238001|80310097|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
27581256|NCT03238001|80310097|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
27581257|NCT03238001|80310097|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
27581258|NCT03238001|80310097|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
27581259|NCT03238001|80310097|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
27581260|NCT03238001|80310097|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
27581261|NCT03238001|80310097|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
27581262|NCT00320216|80310098|FG000|Overall Study|Adverse Event|0|||
27581263|NCT00320216|80310099|FG001|Overall Study|Adverse Event|6|||
27581264|NCT00320216|80310100|FG002|Overall Study|Adverse Event|0|||
27581265|NCT00320216|80310101|FG003|Overall Study|Adverse Event|2|||
27581266|NCT00320216|80310102|FG004|Overall Study|Adverse Event|2|||
27581267|NCT00320216|80310098|FG000|Overall Study|Lack of Efficacy|6|||
27581268|NCT00320216|80310099|FG001|Overall Study|Lack of Efficacy|2|||
27581269|NCT00320216|80310100|FG002|Overall Study|Lack of Efficacy|1|||
27581270|NCT00320216|80310101|FG003|Overall Study|Lack of Efficacy|0|||
27581271|NCT00320216|80310102|FG004|Overall Study|Lack of Efficacy|1|||
27581272|NCT00320216|80310098|FG000|Overall Study|Lost to Follow-up|3|||
27581273|NCT00320216|80310099|FG001|Overall Study|Lost to Follow-up|0|||
27581274|NCT00320216|80310100|FG002|Overall Study|Lost to Follow-up|0|||
27581275|NCT00320216|80310101|FG003|Overall Study|Lost to Follow-up|0|||
27581276|NCT00320216|80310102|FG004|Overall Study|Lost to Follow-up|0|||
27581277|NCT00320216|80310098|FG000|Overall Study|Other|7|||
27581278|NCT00320216|80310099|FG001|Overall Study|Other|2|||
27581279|NCT00320216|80310100|FG002|Overall Study|Other|5|||
27581280|NCT00320216|80310101|FG003|Overall Study|Other|1|||
27581281|NCT00320216|80310102|FG004|Overall Study|Other|3|||
27581282|NCT02805257|80310103|FG000|Overall Study|Lost to Follow-up|7|||
27581283|NCT02805257|80310104|FG001|Overall Study|Lost to Follow-up|6|||
27581284|NCT02805257|80310103|FG000|Overall Study|Death|0|||
27581285|NCT02805257|80310104|FG001|Overall Study|Death|1|||
27581286|NCT03603964|80310105|FG000|Overall Study|Death|9|||
27581287|NCT03603964|80310105|FG000|Overall Study|Withdrawal by participant|7|||
27581288|NCT03603964|80310105|FG000|Overall Study|Study terminated by Sponsor|19|||
27581289|NCT02647359|80310108|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
27581290|NCT02647359|80310109|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
27581291|NCT02647359|80310108|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
27581292|NCT02647359|80310109|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
27581293|NCT02647359|80310108|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
27581294|NCT02647359|80310109|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
27581295|NCT02647359|80310108|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
27581296|NCT02647359|80310109|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
27581297|NCT02647359|80310108|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
27581298|NCT02647359|80310109|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
27581299|NCT02647359|80310108|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
27581300|NCT02647359|80310109|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
27581301|NCT04535037|80310110|FG000|Overall Study|Protocol Violation|1|||
27581302|NCT04535037|80310111|FG001|Overall Study|Protocol Violation|0|||
27581303|NCT04535037|80310110|FG000|Overall Study|Withdrawal by Subject|8|||
27581304|NCT04535037|80310111|FG001|Overall Study|Withdrawal by Subject|9|||
27581305|NCT04535037|80310110|FG000|Overall Study|Migrated / moved from the study area|1|||
27581306|NCT04535037|80310111|FG001|Overall Study|Migrated / moved from the study area|4|||
27581307|NCT04535037|80310110|FG000|Overall Study|Other|2|||
27581308|NCT04535037|80310111|FG001|Overall Study|Other|5|||
27581309|NCT00982319|80310112|FG000|Overall Study|Surgery date change|1|||
27581310|NCT00982319|80310113|FG001|Overall Study|Surgery date change|0|||
27581311|NCT00982319|80310112|FG000|Overall Study|Preop values out of acceptable range|1|||
27581312|NCT00982319|80310113|FG001|Overall Study|Preop values out of acceptable range|1|||
27581313|NCT00982319|80310112|FG000|Overall Study|Pregnancy|0|||
27581314|NCT00982319|80310113|FG001|Overall Study|Pregnancy|1|||
27581315|NCT00767000|80310118|FG000|54-week Study|Adverse Event|4|||
27581316|NCT00767000|80310119|FG001|54-week Study|Adverse Event|6|||
27581317|NCT00767000|80310120|FG002|54-week Study|Adverse Event|6|||
27581318|NCT00767000|80310121|FG003|54-week Study|Adverse Event|8|||
27581319|NCT00767000|80310122|FG004|54-week Study|Adverse Event|4|||
27581320|NCT00767000|80310118|FG000|54-week Study|Creaninine/creatinine clearance|2|||
27581321|NCT00767000|80310119|FG001|54-week Study|Creaninine/creatinine clearance|1|||
27581322|NCT00767000|80310120|FG002|54-week Study|Creaninine/creatinine clearance|2|||
27581323|NCT00767000|80310121|FG003|54-week Study|Creaninine/creatinine clearance|2|||
27700985|NCT01241552|80741290|FG001|Overall Study|Technical Problems|0|||
27805278|NCT00323609|81117333|FG003|Overall Study|Death|0|||
27805279|NCT00323609|81117330|FG000|Overall Study|Lost to Follow-up|9|||
27805280|NCT00323609|81117331|FG001|Overall Study|Lost to Follow-up|10|||
27805281|NCT00323609|81117332|FG002|Overall Study|Lost to Follow-up|0|||
27581324|NCT00767000|80310122|FG004|54-week Study|Creaninine/creatinine clearance|4|||
27581325|NCT00767000|80310118|FG000|54-week Study|Hyperglycemia|0|||
27581326|NCT00767000|80310119|FG001|54-week Study|Hyperglycemia|0|||
27581327|NCT00767000|80310120|FG002|54-week Study|Hyperglycemia|1|||
27581328|NCT00767000|80310121|FG003|54-week Study|Hyperglycemia|0|||
27581329|NCT00767000|80310122|FG004|54-week Study|Hyperglycemia|1|||
27581330|NCT00767000|80310118|FG000|54-week Study|Hypoglycemia|0|||
27581331|NCT00767000|80310119|FG001|54-week Study|Hypoglycemia|1|||
27581332|NCT00767000|80310120|FG002|54-week Study|Hypoglycemia|0|||
27581333|NCT00767000|80310121|FG003|54-week Study|Hypoglycemia|0|||
27581334|NCT00767000|80310122|FG004|54-week Study|Hypoglycemia|0|||
27581335|NCT00767000|80310118|FG000|54-week Study|Interruption of study medication|0|||
27581336|NCT00767000|80310119|FG001|54-week Study|Interruption of study medication|0|||
27581337|NCT00767000|80310120|FG002|54-week Study|Interruption of study medication|1|||
27581338|NCT00767000|80310121|FG003|54-week Study|Interruption of study medication|0|||
27581339|NCT00767000|80310122|FG004|54-week Study|Interruption of study medication|0|||
27581340|NCT00767000|80310118|FG000|54-week Study|Lack of Efficacy|2|||
27581341|NCT00767000|80310119|FG001|54-week Study|Lack of Efficacy|0|||
27581342|NCT00767000|80310120|FG002|54-week Study|Lack of Efficacy|1|||
27581343|NCT00767000|80310121|FG003|54-week Study|Lack of Efficacy|0|||
27581344|NCT00767000|80310122|FG004|54-week Study|Lack of Efficacy|5|||
27581345|NCT00767000|80310118|FG000|54-week Study|Lost to Follow-up|4|||
27581346|NCT00767000|80310119|FG001|54-week Study|Lost to Follow-up|0|||
27581347|NCT00767000|80310120|FG002|54-week Study|Lost to Follow-up|1|||
27581348|NCT00767000|80310121|FG003|54-week Study|Lost to Follow-up|4|||
27581349|NCT00767000|80310122|FG004|54-week Study|Lost to Follow-up|2|||
27581350|NCT00767000|80310118|FG000|54-week Study|Physician Decision|4|||
27581351|NCT00767000|80310119|FG001|54-week Study|Physician Decision|0|||
27581352|NCT00767000|80310120|FG002|54-week Study|Physician Decision|1|||
27581353|NCT00767000|80310121|FG003|54-week Study|Physician Decision|1|||
27581354|NCT00767000|80310122|FG004|54-week Study|Physician Decision|1|||
27581355|NCT00767000|80310118|FG000|54-week Study|Progressive disease|0|||
27581356|NCT00767000|80310119|FG001|54-week Study|Progressive disease|0|||
27581357|NCT00767000|80310120|FG002|54-week Study|Progressive disease|1|||
27581358|NCT00767000|80310121|FG003|54-week Study|Progressive disease|0|||
27581359|NCT00767000|80310122|FG004|54-week Study|Progressive disease|0|||
27581360|NCT00767000|80310118|FG000|54-week Study|Protocol Violation|0|||
27581361|NCT00767000|80310119|FG001|54-week Study|Protocol Violation|0|||
27581362|NCT00767000|80310120|FG002|54-week Study|Protocol Violation|1|||
27581363|NCT00767000|80310121|FG003|54-week Study|Protocol Violation|2|||
27581364|NCT00767000|80310122|FG004|54-week Study|Protocol Violation|0|||
27581365|NCT00767000|80310118|FG000|54-week Study|Withdrawal by Subject|2|||
27581366|NCT00767000|80310119|FG001|54-week Study|Withdrawal by Subject|3|||
27805282|NCT00323609|81117333|FG003|Overall Study|Lost to Follow-up|0|||
27805283|NCT00323609|81117330|FG000|Overall Study|Physician Decision|2|||
27581367|NCT00767000|80310120|FG002|54-week Study|Withdrawal by Subject|5|||
27805284|NCT00323609|81117331|FG001|Overall Study|Physician Decision|0|||
27581368|NCT00767000|80310121|FG003|54-week Study|Withdrawal by Subject|11|||
27581369|NCT00767000|80310122|FG004|54-week Study|Withdrawal by Subject|13|||
27581370|NCT00767000|80310118|FG000|54-week Study|Study terminated by sponsor|90|||
27999243|NCT00717249|81827000|FG000|Overall Study|Gastric Surgery|0|||
27999244|NCT00717249|81827001|FG001|Overall Study|Gastric Surgery|1|||
27999245|NCT00717249|81827000|FG000|Overall Study|Diagnosed with Diabetes|1|||
27999246|NCT00717249|81827001|FG001|Overall Study|Diagnosed with Diabetes|0|||
27999247|NCT00717249|81827000|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
27999248|NCT00717249|81827001|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
27999249|NCT00717249|81827000|FG000|Overall Study|Subject relocated|1|||
27999250|NCT00717249|81827001|FG001|Overall Study|Subject relocated|0|||
27999251|NCT00717249|81827000|FG000|Overall Study|Headaches|1|||
27999252|NCT00717249|81827001|FG001|Overall Study|Headaches|0|||
27999253|NCT00411671|81827015|FG000|Overall Study|Adverse Event|15|||
27999254|NCT00411671|81827015|FG000|Overall Study|Death|2|||
27999255|NCT00411671|81827015|FG000|Overall Study|Lost to Follow-up|3|||
27999256|NCT02043938|81827026|FG000|Overall Study|Withdrawal by Subject|7|||
27999257|NCT02043938|81827026|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
27999258|NCT02043938|81827026|FG000|Overall Study|No show by subject|1|||
27999259|NCT02043938|81827026|FG000|Overall Study|Investigator decision|1|||
27999260|NCT02675231|81827030|FG000|Overall Study|Withdrawal by Subject|2|||
27999261|NCT02675231|81827031|FG001|Overall Study|Withdrawal by Subject|4|||
27999262|NCT02675231|81827032|FG002|Overall Study|Withdrawal by Subject|2|||
27999263|NCT02675231|81827030|FG000|Overall Study|Lost to Follow-up|3|||
27999264|NCT02675231|81827031|FG001|Overall Study|Lost to Follow-up|4|||
27999265|NCT02675231|81827032|FG002|Overall Study|Lost to Follow-up|3|||
27999266|NCT02487095|81827037|FG000|Dose Expansion|Unable to scan/restage participant|0|||
27999267|NCT02487095|81827038|FG001|Dose Expansion|Unable to scan/restage participant|0|||
27999268|NCT02487095|81827039|FG002|Dose Expansion|Unable to scan/restage participant|0|||
27999269|NCT02487095|81827040|FG003|Dose Expansion|Unable to scan/restage participant|0|||
27999270|NCT02487095|81827041|FG004|Dose Expansion|Unable to scan/restage participant|1|||
27999271|NCT02611479|81827049|FG000|Baseline Enrollment|Exited study|13|||
27999272|NCT02611479|81827049|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
27999273|NCT02611479|81827049|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
27999274|NCT02611479|81827049|FG000|Data Cleaning|No baseline function or pain metrics|2|||
27999275|NCT01486966|81827052|FG000|Overall Study|Adverse Event|0|||
27999276|NCT01486966|81827053|FG001|Overall Study|Adverse Event|1|||
27999277|NCT01486966|81827052|FG000|Overall Study|Withdrawal by Subject|0|||
27999278|NCT01486966|81827053|FG001|Overall Study|Withdrawal by Subject|1|||
27999279|NCT03294590|81827054|FG000|Overall Study|Lost to Follow-up|105|||
27999280|NCT03294590|81827055|FG001|Overall Study|Lost to Follow-up|107|||
27999281|NCT02792231|81827058|FG000|Overall Study|Patient/guardian decision|32|||
27999282|NCT02792231|81827059|FG001|Overall Study|Patient/guardian decision|42|||
27999283|NCT02792231|81827058|FG000|Overall Study|Adverse Event|15|||
27999284|NCT02792231|81827059|FG001|Overall Study|Adverse Event|11|||
27999285|NCT02792231|81827058|FG000|Overall Study|Physician Decision|14|||
27999286|NCT02792231|81827059|FG001|Overall Study|Physician Decision|12|||
27999287|NCT02792231|81827058|FG000|Overall Study|Lack of Efficacy|7|||
27999288|NCT02792231|81827059|FG001|Overall Study|Lack of Efficacy|9|||
27999289|NCT02792231|81827058|FG000|Overall Study|Lost to Follow-up|9|||
27999290|NCT02792231|81827059|FG001|Overall Study|Lost to Follow-up|5|||
27581371|NCT00767000|80310119|FG001|54-week Study|Study terminated by sponsor|102|||
27581372|NCT00767000|80310120|FG002|54-week Study|Study terminated by sponsor|89|||
27581373|NCT00767000|80310121|FG003|54-week Study|Study terminated by sponsor|196|||
27581374|NCT00767000|80310122|FG004|54-week Study|Study terminated by sponsor|194|||
27581375|NCT00767000|80310118|FG000|54-week Study|Reason not reported|0|||
27581376|NCT00767000|80310119|FG001|54-week Study|Reason not reported|0|||
27581377|NCT00767000|80310120|FG002|54-week Study|Reason not reported|0|||
27581378|NCT00767000|80310121|FG003|54-week Study|Reason not reported|1|||
27581379|NCT00767000|80310122|FG004|54-week Study|Reason not reported|0|||
27581380|NCT00767000|80310118|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
27581381|NCT00767000|80310119|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
27581382|NCT00767000|80310120|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
27581383|NCT00767000|80310121|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
27999291|NCT02792231|81827058|FG000|Overall Study|Pregnancy|1|||
27999292|NCT02792231|81827059|FG001|Overall Study|Pregnancy|3|||
27999293|NCT02792231|81827058|FG000|Overall Study|Non-compliance with study treatment|2|||
27581384|NCT00767000|80310122|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
27999294|NCT02792231|81827059|FG001|Overall Study|Non-compliance with study treatment|1|||
27581385|NCT00614939|80310124|FG000|Overall Study|Withdrawal by Subject|10|||
27999295|NCT02792231|81827058|FG000|Overall Study|Protocol deviation|2|||
27999296|NCT02792231|81827059|FG001|Overall Study|Protocol deviation|0|||
27700986|NCT01241552|80741291|FG002|Overall Study|Technical Problems|2|||
27999297|NCT02792231|81827058|FG000|Overall Study|Technical problems|0|||
27999298|NCT02792231|81827059|FG001|Overall Study|Technical problems|1|||
27999299|NCT00718510|81827060|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
27999300|NCT00718510|81827061|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27999301|NCT00718510|81827060|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
27999302|NCT00718510|81827061|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27999303|NCT03078556|81827066|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
27999304|NCT03078556|81827067|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
27999305|NCT03078556|81827068|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
27999306|NCT03078556|81827069|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
27999307|NCT03078556|81827066|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
27999308|NCT03078556|81827067|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
27999309|NCT03078556|81827068|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
27999310|NCT03078556|81827069|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
27999311|NCT03078556|81827066|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
27999312|NCT03078556|81827067|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
27999313|NCT03078556|81827068|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
27999314|NCT03078556|81827069|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
27999315|NCT03078556|81827066|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
27999316|NCT03078556|81827067|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
27999317|NCT03078556|81827068|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
27999318|NCT03078556|81827069|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
27999319|NCT02741635|81827070|FG000|Overall Study|Withdrawal by Subject|1|||
27999320|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
27999321|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
27999322|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
27999323|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
27999324|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
27999325|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
27999326|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
27999327|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
27999328|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
27999329|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
27999330|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
27999331|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
27999332|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
27999333|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
27999334|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
27999335|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
27999336|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
27999337|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
27999338|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
27999339|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
27999340|NCT03573323|81827071|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
27999341|NCT03573323|81827072|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
27999342|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
27999343|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
27999344|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
27999345|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
27999346|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
27999347|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
27999348|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
27999349|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
27999350|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
27581386|NCT00614939|80310125|FG001|Overall Study|Withdrawal by Subject|17|||
27581387|NCT00614939|80310124|FG000|Overall Study|Study specific discontinuation criteris|13|||
27581388|NCT00614939|80310125|FG001|Overall Study|Study specific discontinuation criteris|16|||
27581389|NCT00614939|80310124|FG000|Overall Study|Adverse Event|2|||
27581390|NCT00614939|80310125|FG001|Overall Study|Adverse Event|5|||
27581391|NCT00614939|80310124|FG000|Overall Study|Incorrect enrollment|1|||
27581392|NCT00614939|80310125|FG001|Overall Study|Incorrect enrollment|2|||
27581393|NCT00614939|80310124|FG000|Overall Study|Death|4|||
27581394|NCT00614939|80310125|FG001|Overall Study|Death|3|||
27581395|NCT00614939|80310124|FG000|Overall Study|Poor/non-compliance|4|||
27581396|NCT00614939|80310125|FG001|Overall Study|Poor/non-compliance|0|||
27581397|NCT00614939|80310124|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
27581398|NCT00614939|80310125|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
27999351|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
27581399|NCT03755765|80310126|FG000|Overall Study|Withdrawal by Subject|2|||
27581400|NCT03755765|80310127|FG001|Overall Study|Withdrawal by Subject|4|||
27581401|NCT03755765|80310128|FG002|Overall Study|Withdrawal by Subject|4|||
27581402|NCT04798586|80310129|FG000|Overall Study|Death|2|||
27581403|NCT01709227|80310135|FG000|Overall Study|Physician Decision|1|||
27581404|NCT01709227|80310136|FG001|Overall Study|Physician Decision|0|||
27581405|NCT01709227|80310135|FG000|Overall Study|Pleural Peritoneal communication|0|||
27581406|NCT01709227|80310136|FG001|Overall Study|Pleural Peritoneal communication|9|||
27581407|NCT01826825|80310137|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
27581408|NCT01826825|80310138|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
27581409|NCT02715765|80310139|FG000|Overall Study|Study Termination|3|||
27581410|NCT02715765|80310140|FG001|Overall Study|Study Termination|0|||
27581411|NCT02715765|80310141|FG002|Overall Study|Study Termination|0|||
27581412|NCT02554773|80310142|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
27581413|NCT02554773|80310143|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
27581414|NCT02554773|80310142|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
27999352|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
27999353|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
27999354|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
27999355|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
27999356|NCT03573323|81827071|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
27999357|NCT03573323|81827072|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
27999358|NCT04390243|81827073|FG000|Overall Study|Death|1|||
27999359|NCT04390243|81827073|FG000|Overall Study|Disease Progression|4|||
27999360|NCT04390243|81827073|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
27999361|NCT01370265|81827074|FG000|First Intervention|Adverse Event|1|||
27999362|NCT01370265|81827075|FG001|First Intervention|Adverse Event|1|||
27999363|NCT02741245|81827076|FG000|Overall Study|Adverse Event|0|||
27999364|NCT02741245|81827077|FG001|Overall Study|Adverse Event|0|||
27999365|NCT02741245|81827078|FG002|Overall Study|Adverse Event|0|||
27999366|NCT02741245|81827079|FG003|Overall Study|Adverse Event|2|||
27999367|NCT02741245|81827080|FG004|Overall Study|Adverse Event|2|||
27999368|NCT02741245|81827076|FG000|Overall Study|Protocol Violation|0|||
27999369|NCT02741245|81827077|FG001|Overall Study|Protocol Violation|1|||
27999370|NCT02741245|81827078|FG002|Overall Study|Protocol Violation|0|||
27999371|NCT02741245|81827079|FG003|Overall Study|Protocol Violation|1|||
27999372|NCT02741245|81827080|FG004|Overall Study|Protocol Violation|0|||
27999373|NCT02741245|81827076|FG000|Overall Study|Withdrawal by Subject|0|||
27999374|NCT02741245|81827077|FG001|Overall Study|Withdrawal by Subject|0|||
27999375|NCT02741245|81827078|FG002|Overall Study|Withdrawal by Subject|0|||
27999376|NCT02741245|81827079|FG003|Overall Study|Withdrawal by Subject|1|||
27999377|NCT02741245|81827080|FG004|Overall Study|Withdrawal by Subject|0|||
27999378|NCT02611817|81827081|FG000|Open-label Induction Phase|Reason not Specified|9|||
27999379|NCT02611817|81827082|FG001|Open-label Induction Phase|Reason not Specified|0|||
27999380|NCT02611817|81827083|FG002|Open-label Induction Phase|Reason not Specified|0|||
27999381|NCT02611817|81827081|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
27999382|NCT02611817|81827082|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
27999383|NCT02611817|81827083|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
27999384|NCT02611817|81827081|FG000|Open-label Induction Phase|Pregnancy|1|||
27999385|NCT02611817|81827082|FG001|Open-label Induction Phase|Pregnancy|0|||
27999386|NCT02611817|81827083|FG002|Open-label Induction Phase|Pregnancy|0|||
27999387|NCT02611817|81827081|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
27999388|NCT02611817|81827082|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
27999389|NCT02611817|81827083|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
27999390|NCT02611817|81827081|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
27999391|NCT02611817|81827082|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
27999392|NCT02611817|81827083|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
27999393|NCT02611817|81827081|FG000|Open-label Induction Phase|Protocol Violation|5|||
27999394|NCT02611817|81827082|FG001|Open-label Induction Phase|Protocol Violation|0|||
27999395|NCT02611817|81827083|FG002|Open-label Induction Phase|Protocol Violation|0|||
27999396|NCT02611817|81827081|FG000|Open-label Induction Phase|Adverse Event|16|||
27999397|NCT02611817|81827082|FG001|Open-label Induction Phase|Adverse Event|0|||
27999398|NCT02611817|81827083|FG002|Open-label Induction Phase|Adverse Event|0|||
27999399|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
27999400|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
27999401|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
27999402|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
27680750|NCT00918879|80667902|FG001|Overall Study|Withdrawal by Subject|4|||
27999403|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
27999404|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
27999405|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
27999406|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
27999407|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
27999408|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
27999409|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
27581415|NCT02554773|80310143|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
27581416|NCT02554773|80310142|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
27581417|NCT02554773|80310143|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
27581418|NCT02554773|80310142|FG000|Original Dose Regimen (SAS 1)|Death|1|||
27581419|NCT02554773|80310143|FG001|Original Dose Regimen (SAS 1)|Death|0|||
27581420|NCT02554773|80310142|FG000|Original Dose Regimen (SAS 1)|Other|4|||
27581421|NCT02554773|80310143|FG001|Original Dose Regimen (SAS 1)|Other|0|||
27999410|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
27999411|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
27999412|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
27999413|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
27999414|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
27999415|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
27999416|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
27999417|NCT02611817|81827081|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
27999418|NCT02611817|81827082|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
27999419|NCT02611817|81827083|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
27999420|NCT00191334|81827084|FG000|Overall Study|Adverse Event|4|||
27999421|NCT00191334|81827084|FG000|Overall Study|Disease Progression or Relapse|8|||
27999422|NCT00191334|81827084|FG000|Overall Study|Physician Decision|1|||
27999423|NCT00191334|81827084|FG000|Overall Study|Withdrawal by Subject|4|||
27999424|NCT04701333|81830657|FG000|Overall Study|Lost to Follow-up|3|||
27999425|NCT04701333|81830658|FG001|Overall Study|Lost to Follow-up|7|||
27999426|NCT04701333|81830657|FG000|Overall Study|Withdrawal by Subject|0|||
27999427|NCT04701333|81830658|FG001|Overall Study|Withdrawal by Subject|1|||
27999428|NCT01168349|81830659|FG000|Overall Study|Death|157|||
27999429|NCT01168349|81830659|FG000|Overall Study|Lost to Follow-up|34|||
27999430|NCT01168349|81830659|FG000|Overall Study|Withdrawal by Subject|9|||
27999431|NCT01168349|81830659|FG000|Overall Study|Kidney transplantation|3|||
27999432|NCT01168349|81830659|FG000|Overall Study|Other|22|||
27999433|NCT01168349|81830659|FG000|Overall Study|Protocol Violation|76|||
27999434|NCT00672555|81830660|FG000|Overall Study|Lost to Follow-up|4|||
27999435|NCT00672555|81830660|FG000|Overall Study|Did not want to answer questionnaire|2|||
27999436|NCT01508169|81830663|FG000|Overall Study|Adverse Event|1|||
27999437|NCT01508169|81830664|FG001|Overall Study|Adverse Event|0|||
27999438|NCT01508169|81830663|FG000|Overall Study|Withdrawal by Subject|1|||
27999439|NCT01508169|81830664|FG001|Overall Study|Withdrawal by Subject|0|||
27999440|NCT01508169|81830663|FG000|Overall Study|Lost to Follow-up|1|||
27999441|NCT01508169|81830664|FG001|Overall Study|Lost to Follow-up|2|||
27999442|NCT00108862|81830668|FG000|Overall Study|Death|31|||
27999443|NCT00108862|81830669|FG001|Overall Study|Death|37|||
27999444|NCT00108862|81830668|FG000|Overall Study|Withdrawal by Subject|10|||
27999445|NCT00108862|81830669|FG001|Overall Study|Withdrawal by Subject|6|||
27999446|NCT00108862|81830668|FG000|Overall Study|Lost to Follow-up|27|||
27999447|NCT00108862|81830669|FG001|Overall Study|Lost to Follow-up|19|||
27999448|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
27999449|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
27999450|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
27999451|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
27999452|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
27999453|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
27999454|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
27999455|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
27999456|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
27999457|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
27999458|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
27999459|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
27999460|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
27999461|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
27581422|NCT02554773|80310142|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
27873382|NCT00122382|81368480|FG001|Double-Blind Study|Lost to Follow-up|1|||
27999462|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
27999463|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
27999464|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
27999465|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
27999466|NCT01910402|81830670|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
27999467|NCT01910402|81830671|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
27999468|NCT01910402|81830672|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
27999469|NCT01910402|81830670|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
27999470|NCT01910402|81830671|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
27999471|NCT01910402|81830672|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
27999472|NCT01910402|81830670|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
27999473|NCT01910402|81830671|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
27999474|NCT01910402|81830672|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
27999475|NCT01910402|81830670|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
27999476|NCT01910402|81830671|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
27999477|NCT01910402|81830672|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
27999478|NCT01910402|81830670|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
27999479|NCT01910402|81830671|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
27999480|NCT01910402|81830672|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
27999481|NCT01910402|81830670|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
27999482|NCT01910402|81830671|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
27999483|NCT01910402|81830672|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
27999484|NCT01910402|81830670|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
27999485|NCT01910402|81830671|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
27999486|NCT01910402|81830672|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
27999487|NCT04492722|81830676|FG000|Overall Study|Adverse Event|7|||
27999488|NCT04492722|81830677|FG001|Overall Study|Adverse Event|2|||
27999489|NCT04492722|81830678|FG002|Overall Study|Adverse Event|3|||
27999490|NCT04492722|81830679|FG003|Overall Study|Adverse Event|0|||
27999491|NCT04492722|81830676|FG000|Overall Study|Death|0|||
27999492|NCT04492722|81830677|FG001|Overall Study|Death|0|||
27999493|NCT04492722|81830678|FG002|Overall Study|Death|0|||
27999494|NCT04492722|81830679|FG003|Overall Study|Death|1|||
27999495|NCT04492722|81830676|FG000|Overall Study|Lost to Follow-up|0|||
27999496|NCT04492722|81830677|FG001|Overall Study|Lost to Follow-up|1|||
27999497|NCT04492722|81830678|FG002|Overall Study|Lost to Follow-up|0|||
27999498|NCT04492722|81830679|FG003|Overall Study|Lost to Follow-up|1|||
27999499|NCT04492722|81830676|FG000|Overall Study|Physician Decision|0|||
27999500|NCT04492722|81830677|FG001|Overall Study|Physician Decision|3|||
27999501|NCT04492722|81830678|FG002|Overall Study|Physician Decision|1|||
27999502|NCT04492722|81830679|FG003|Overall Study|Physician Decision|1|||
27999503|NCT04492722|81830676|FG000|Overall Study|Withdrawal by Subject|6|||
27999504|NCT04492722|81830677|FG001|Overall Study|Withdrawal by Subject|6|||
27999505|NCT04492722|81830678|FG002|Overall Study|Withdrawal by Subject|0|||
27999506|NCT04492722|81830679|FG003|Overall Study|Withdrawal by Subject|3|||
27999507|NCT04492722|81830676|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
27999508|NCT04492722|81830677|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
27999509|NCT04492722|81830678|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
27999510|NCT04492722|81830679|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
27999511|NCT04492722|81830676|FG000|Overall Study|Due to Covid-19 pandemic|7|||
27999512|NCT04492722|81830677|FG001|Overall Study|Due to Covid-19 pandemic|3|||
27999513|NCT04492722|81830678|FG002|Overall Study|Due to Covid-19 pandemic|7|||
27999514|NCT04492722|81830679|FG003|Overall Study|Due to Covid-19 pandemic|6|||
27999515|NCT04492722|81830676|FG000|Overall Study|Failure to meet randomisation criteria|2|||
27999516|NCT04492722|81830677|FG001|Overall Study|Failure to meet randomisation criteria|3|||
27999517|NCT04492722|81830678|FG002|Overall Study|Failure to meet randomisation criteria|4|||
27999518|NCT04492722|81830679|FG003|Overall Study|Failure to meet randomisation criteria|2|||
27999519|NCT04492722|81830676|FG000|Overall Study|Early termination from the study|54|||
27999520|NCT04492722|81830677|FG001|Overall Study|Early termination from the study|51|||
27999521|NCT04492722|81830678|FG002|Overall Study|Early termination from the study|50|||
27999522|NCT04492722|81830679|FG003|Overall Study|Early termination from the study|50|||
27999523|NCT04492722|81830676|FG000|Overall Study|Missing|3|||
27999524|NCT04492722|81830677|FG001|Overall Study|Missing|0|||
27805285|NCT00323609|81117332|FG002|Overall Study|Physician Decision|0|||
27805286|NCT00323609|81117333|FG003|Overall Study|Physician Decision|1|||
27805287|NCT00323609|81117330|FG000|Overall Study|Withdrawal by Subject|11|||
27805288|NCT00323609|81117331|FG001|Overall Study|Withdrawal by Subject|23|||
27805289|NCT00323609|81117332|FG002|Overall Study|Withdrawal by Subject|4|||
27805290|NCT00323609|81117333|FG003|Overall Study|Withdrawal by Subject|4|||
27805291|NCT00323609|81117330|FG000|Overall Study|Other non-VCF-related medical condition|3|||
27999525|NCT04492722|81830678|FG002|Overall Study|Missing|0|||
27999526|NCT04492722|81830679|FG003|Overall Study|Missing|5|||
27999527|NCT04492722|81830676|FG000|Overall Study|Participants who did not receive treatment|0|||
27999528|NCT04492722|81830677|FG001|Overall Study|Participants who did not receive treatment|1|||
27805292|NCT00323609|81117331|FG001|Overall Study|Other non-VCF-related medical condition|2|||
27805293|NCT00323609|81117332|FG002|Overall Study|Other non-VCF-related medical condition|0|||
27805294|NCT00323609|81117333|FG003|Overall Study|Other non-VCF-related medical condition|0|||
27805295|NCT00323609|81117330|FG000|Overall Study|Sponsor discontinued trial|29|||
27805296|NCT00323609|81117331|FG001|Overall Study|Sponsor discontinued trial|29|||
27581423|NCT02554773|80310143|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
27581424|NCT02554773|80310142|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
27581425|NCT02554773|80310143|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
27581426|NCT02554773|80310142|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
27581427|NCT02554773|80310143|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
27581428|NCT02554773|80310142|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
27581429|NCT02554773|80310143|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
27581430|NCT02758236|80310144|FG000|Overall Study|Investigator discretion|43|||
27581431|NCT01529645|80310147|FG000|Overall Study|Lost to Follow-up|0|||
27581432|NCT01529645|80310148|FG001|Overall Study|Lost to Follow-up|1|||
27581433|NCT01529645|80310149|FG002|Overall Study|Lost to Follow-up|1|||
27581434|NCT01529645|80310150|FG003|Overall Study|Lost to Follow-up|1|||
27581435|NCT01529645|80310151|FG004|Overall Study|Lost to Follow-up|1|||
27581436|NCT01529645|80310152|FG005|Overall Study|Lost to Follow-up|0|||
27581437|NCT01529645|80310153|FG006|Overall Study|Lost to Follow-up|2|||
27581438|NCT01529645|80310154|FG007|Overall Study|Lost to Follow-up|0|||
27581439|NCT01529645|80310155|FG008|Overall Study|Lost to Follow-up|1|||
27581440|NCT01529645|80310156|FG009|Overall Study|Lost to Follow-up|0|||
27581441|NCT01529645|80310147|FG000|Overall Study|SAE - Premature contractions|0|||
27581442|NCT01529645|80310148|FG001|Overall Study|SAE - Premature contractions|0|||
27581443|NCT01529645|80310149|FG002|Overall Study|SAE - Premature contractions|1|||
27581444|NCT01529645|80310150|FG003|Overall Study|SAE - Premature contractions|0|||
27581445|NCT01529645|80310151|FG004|Overall Study|SAE - Premature contractions|0|||
27581446|NCT01529645|80310152|FG005|Overall Study|SAE - Premature contractions|0|||
27581447|NCT01529645|80310153|FG006|Overall Study|SAE - Premature contractions|0|||
27581448|NCT01529645|80310154|FG007|Overall Study|SAE - Premature contractions|0|||
27581449|NCT01529645|80310155|FG008|Overall Study|SAE - Premature contractions|0|||
27581450|NCT01529645|80310156|FG009|Overall Study|SAE - Premature contractions|0|||
27581451|NCT01529645|80310147|FG000|Overall Study|Withdrawal by Subject|2|||
27581452|NCT01529645|80310148|FG001|Overall Study|Withdrawal by Subject|0|||
27581453|NCT01529645|80310149|FG002|Overall Study|Withdrawal by Subject|0|||
27581454|NCT01529645|80310150|FG003|Overall Study|Withdrawal by Subject|1|||
27581455|NCT01529645|80310151|FG004|Overall Study|Withdrawal by Subject|1|||
27581456|NCT01529645|80310152|FG005|Overall Study|Withdrawal by Subject|1|||
27581457|NCT01529645|80310153|FG006|Overall Study|Withdrawal by Subject|0|||
27581458|NCT01529645|80310154|FG007|Overall Study|Withdrawal by Subject|0|||
27581459|NCT01529645|80310155|FG008|Overall Study|Withdrawal by Subject|0|||
27581460|NCT01529645|80310156|FG009|Overall Study|Withdrawal by Subject|0|||
27581461|NCT00779246|80310157|FG000|Overall Study|Missing sufficient data for analysis|33|||
27581462|NCT00779246|80310158|FG001|Overall Study|Missing sufficient data for analysis|53|||
27581463|NCT01962974|80310161|FG000|Overall Study|Study termination|7|||
27581464|NCT00608829|80310162|FG000|Overall Study|Death|6|||
27581465|NCT00608829|80310162|FG000|Overall Study|Withdrawal by Subject|4|||
27581466|NCT00608829|80310162|FG000|Overall Study|Subject refuses to follow up or return.|5|||
27873383|NCT00122382|81368481|FG002|Double-Blind Study|Lost to Follow-up|0|||
27873384|NCT00122382|81368479|FG000|Double-Blind Study|Pregnancy|2|||
27873385|NCT00122382|81368480|FG001|Double-Blind Study|Pregnancy|0|||
27581467|NCT00503841|80310163|FG000|Overall Study|All screen failures|44|||
27581468|NCT03791398|80310164|FG000|Overall Study|Progression of Disease Under Study|2|||
27873386|NCT00122382|81368481|FG002|Double-Blind Study|Pregnancy|0|||
27581469|NCT03791398|80310165|FG001|Overall Study|Progression of Disease Under Study|0|||
27581470|NCT03791398|80310166|FG002|Overall Study|Progression of Disease Under Study|0|||
27581471|NCT03732248|80310167|FG000|Overall Study|Withdrawal by Subject|1|||
27581472|NCT03732248|80310168|FG001|Overall Study|Withdrawal by Subject|0|||
27594379|NCT00522275|80356058|FG000|Overall Study|Unsatisfactory compliance|11|||
27805297|NCT00323609|81117332|FG002|Overall Study|Sponsor discontinued trial|0|||
27805298|NCT00323609|81117333|FG003|Overall Study|Sponsor discontinued trial|0|||
27805299|NCT00323609|81117330|FG000|Overall Study|Unrelenting or severe back pain|1|||
27805300|NCT00323609|81117331|FG001|Overall Study|Unrelenting or severe back pain|1|||
27805301|NCT00323609|81117332|FG002|Overall Study|Unrelenting or severe back pain|0|||
27805302|NCT00323609|81117333|FG003|Overall Study|Unrelenting or severe back pain|0|||
27805303|NCT00323609|81117330|FG000|Overall Study|Logistical withdrawal|9|||
27805304|NCT00323609|81117331|FG001|Overall Study|Logistical withdrawal|5|||
27805305|NCT00323609|81117332|FG002|Overall Study|Logistical withdrawal|0|||
27805306|NCT00323609|81117333|FG003|Overall Study|Logistical withdrawal|1|||
27805307|NCT00323609|81117330|FG000|Overall Study|Other reason|11|||
27805308|NCT00323609|81117331|FG001|Overall Study|Other reason|8|||
27805309|NCT00323609|81117332|FG002|Overall Study|Other reason|4|||
27805310|NCT00323609|81117333|FG003|Overall Study|Other reason|9|||
27805311|NCT04133519|81120238|FG000|Overall Study|Withdrawal by Subject|5|||
27805312|NCT04133519|81120239|FG001|Overall Study|Withdrawal by Subject|4|||
27805313|NCT04133519|81120238|FG000|Overall Study|Protocol Violation|0|||
27805314|NCT04133519|81120239|FG001|Overall Study|Protocol Violation|1|||
27805315|NCT04133519|81120238|FG000|Overall Study|Never started treatment|1|||
27805316|NCT04133519|81120239|FG001|Overall Study|Never started treatment|1|||
27805317|NCT01456052|81120240|FG000|Overall Study|Adverse Event|1|||
27805318|NCT01456052|81120241|FG001|Overall Study|Adverse Event|1|||
27805319|NCT01456052|81120242|FG002|Overall Study|Adverse Event|2|||
27805320|NCT01456052|81120240|FG000|Overall Study|Consent withdrawn|0|||
27805321|NCT01456052|81120241|FG001|Overall Study|Consent withdrawn|2|||
27805322|NCT01456052|81120242|FG002|Overall Study|Consent withdrawn|1|||
27805323|NCT01456052|81120240|FG000|Overall Study|Protocol Violation|0|||
27805324|NCT01456052|81120241|FG001|Overall Study|Protocol Violation|1|||
27805325|NCT01456052|81120242|FG002|Overall Study|Protocol Violation|0|||
27805326|NCT01456052|81120240|FG000|Overall Study|Physician Decision|1|||
27805327|NCT01456052|81120241|FG001|Overall Study|Physician Decision|0|||
27805328|NCT01456052|81120242|FG002|Overall Study|Physician Decision|1|||
27805329|NCT01456052|81120240|FG000|Overall Study|Treatment Failure|0|||
27805330|NCT01456052|81120241|FG001|Overall Study|Treatment Failure|1|||
27805331|NCT01456052|81120242|FG002|Overall Study|Treatment Failure|1|||
27805332|NCT00461500|81120244|FG000|Overall Study|Adverse Event|1|||
27805333|NCT00461500|81120245|FG001|Overall Study|Adverse Event|0|||
27805334|NCT00461500|81120244|FG000|Overall Study|Lack of Efficacy|0|||
27805335|NCT00461500|81120245|FG001|Overall Study|Lack of Efficacy|1|||
27805336|NCT00461500|81120244|FG000|Overall Study|Expired Drug Treatment|1|||
27805337|NCT00461500|81120245|FG001|Overall Study|Expired Drug Treatment|1|||
27805338|NCT00461500|81120244|FG000|Overall Study|Study Stopped|1|||
27805339|NCT00461500|81120245|FG001|Overall Study|Study Stopped|2|||
27805340|NCT00461500|81120244|FG000|Overall Study|Drug Treatment Misuse|1|||
27805341|NCT00461500|81120245|FG001|Overall Study|Drug Treatment Misuse|0|||
27805342|NCT00461500|81120244|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
27805343|NCT00461500|81120245|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
27805344|NCT00461500|81120244|FG000|Overall Study|Lost to Follow-up|2|||
27805345|NCT00461500|81120245|FG001|Overall Study|Lost to Follow-up|2|||
27805346|NCT00659581|81120248|FG000|Overall Study|Adverse Event|1006|||
27805347|NCT00659581|81120248|FG000|Overall Study|Lack of Efficacy|1183|||
27805348|NCT00659581|81120248|FG000|Overall Study|Other|6393|||
27805349|NCT00736333|81120285|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
27805350|NCT00736333|81120285|FG000|Overall Study|Data Missing|2|||
27999529|NCT04492722|81830678|FG002|Overall Study|Participants who did not receive treatment|4|||
27594380|NCT00522275|80356058|FG000|Overall Study|Lost to Follow-up|8|||
27594381|NCT00522275|80356058|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
27594382|NCT00522275|80356058|FG000|Overall Study|Other: Subject is pregnant|2|||
27594383|NCT00522275|80356058|FG000|Overall Study|Other: Subject relocated|2|||
27594384|NCT00522275|80356058|FG000|Overall Study|Other: Subject arrested|1|||
27594385|NCT00522275|80356058|FG000|Overall Study|Other: Site / clinic closed|4|||
27594386|NCT00522275|80356058|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
27594387|NCT00522275|80356058|FG000|Overall Study|Other: Sponsor request|2|||
27594388|NCT00522275|80356058|FG000|Overall Study|Other: Subject ran out of medication|1|||
27594389|NCT00522275|80356058|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
27594390|NCT00955357|80356063|FG000|Titration Phase|Adverse Event|9|||
27594391|NCT00955357|80356064|FG001|Titration Phase|Adverse Event|46|||
27594392|NCT00955357|80356063|FG000|Titration Phase|Lack of Efficacy|0|||
27594393|NCT00955357|80356064|FG001|Titration Phase|Lack of Efficacy|2|||
27594394|NCT00955357|80356063|FG000|Titration Phase|Protocol Violation|3|||
27594395|NCT00955357|80356064|FG001|Titration Phase|Protocol Violation|7|||
27805351|NCT00736333|81120285|FG000|Overall Study|Tumor Progression|75|||
27805352|NCT00736333|81120285|FG000|Overall Study|Toxicity|6|||
27805353|NCT00736333|81120285|FG000|Overall Study|Withdrawal by Subject|10|||
27805354|NCT00736333|81120285|FG000|Overall Study|Death|7|||
27805355|NCT00736333|81120285|FG000|Overall Study|Other|4|||
27805356|NCT03083132|81120286|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
27805357|NCT03083132|81120287|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
27805358|NCT03083132|81120286|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
27805359|NCT03083132|81120287|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
27805360|NCT03083132|81120286|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
27805361|NCT03083132|81120287|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
27805362|NCT01827371|81120291|FG000|Overall Study|Adverse Event|0|||
27805363|NCT01827371|81120292|FG001|Overall Study|Adverse Event|0|||
27805364|NCT01827371|81120293|FG002|Overall Study|Adverse Event|4|||
27805365|NCT01827371|81120294|FG003|Overall Study|Adverse Event|2|||
27805366|NCT01827371|81120291|FG000|Overall Study|Lost to Follow-up|0|||
27805367|NCT01827371|81120292|FG001|Overall Study|Lost to Follow-up|2|||
27805368|NCT01827371|81120293|FG002|Overall Study|Lost to Follow-up|0|||
27805369|NCT01827371|81120294|FG003|Overall Study|Lost to Follow-up|4|||
27805370|NCT01827371|81120291|FG000|Overall Study|Protocol Violation|1|||
27805371|NCT01827371|81120292|FG001|Overall Study|Protocol Violation|0|||
27805372|NCT01827371|81120293|FG002|Overall Study|Protocol Violation|0|||
27805373|NCT01827371|81120294|FG003|Overall Study|Protocol Violation|0|||
27805374|NCT01827371|81120291|FG000|Overall Study|Withdrawal by Subject|1|||
27805375|NCT01827371|81120292|FG001|Overall Study|Withdrawal by Subject|2|||
27805376|NCT01827371|81120293|FG002|Overall Study|Withdrawal by Subject|2|||
27805377|NCT01827371|81120294|FG003|Overall Study|Withdrawal by Subject|3|||
27805378|NCT01827371|81120291|FG000|Overall Study|Physician Decision|0|||
27805379|NCT01827371|81120292|FG001|Overall Study|Physician Decision|1|||
27805380|NCT01827371|81120293|FG002|Overall Study|Physician Decision|0|||
27805381|NCT01827371|81120294|FG003|Overall Study|Physician Decision|1|||
27805382|NCT01827371|81120291|FG000|Overall Study|Temporary study halt to vaccinations|11|||
27805383|NCT01827371|81120292|FG001|Overall Study|Temporary study halt to vaccinations|2|||
27805384|NCT01827371|81120293|FG002|Overall Study|Temporary study halt to vaccinations|5|||
27805385|NCT01827371|81120294|FG003|Overall Study|Temporary study halt to vaccinations|13|||
27805386|NCT01244815|81120296|FG000|Overall Study|Not Treated|0|||
27805387|NCT01244815|81120297|FG001|Overall Study|Not Treated|1|||
27805388|NCT01244815|81120298|FG002|Overall Study|Not Treated|0|||
27805389|NCT01244815|81120299|FG003|Overall Study|Not Treated|0|||
27805390|NCT01244815|81120296|FG000|Overall Study|Adverse Event|4|||
27805391|NCT01244815|81120297|FG001|Overall Study|Adverse Event|7|||
27805392|NCT01244815|81120298|FG002|Overall Study|Adverse Event|5|||
27805393|NCT01244815|81120299|FG003|Overall Study|Adverse Event|5|||
27805394|NCT01244815|81120296|FG000|Overall Study|Treatment Failure|0|||
27805395|NCT01244815|81120297|FG001|Overall Study|Treatment Failure|0|||
27805396|NCT01244815|81120298|FG002|Overall Study|Treatment Failure|0|||
27805397|NCT01244815|81120299|FG003|Overall Study|Treatment Failure|1|||
27805398|NCT01244815|81120296|FG000|Overall Study|Lost to Follow-up|3|||
27805399|NCT01244815|81120297|FG001|Overall Study|Lost to Follow-up|2|||
27805400|NCT01244815|81120298|FG002|Overall Study|Lost to Follow-up|3|||
27805401|NCT01244815|81120299|FG003|Overall Study|Lost to Follow-up|2|||
27873387|NCT00122382|81368479|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
27873388|NCT00122382|81368480|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
27873389|NCT00122382|81368481|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
27873390|NCT00122382|81368479|FG000|Double-Blind Study|Withdrawal of Consent|7|||
27873391|NCT00122382|81368480|FG001|Double-Blind Study|Withdrawal of Consent|3|||
27873392|NCT00122382|81368481|FG002|Double-Blind Study|Withdrawal of Consent|0|||
27873393|NCT00122382|81368479|FG000|Double-Blind Study|Protocol Violation|1|||
27873394|NCT00122382|81368480|FG001|Double-Blind Study|Protocol Violation|0|||
27873395|NCT00122382|81368481|FG002|Double-Blind Study|Protocol Violation|0|||
27873396|NCT00122382|81368479|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
27873397|NCT00122382|81368480|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
27873398|NCT00122382|81368481|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
27805402|NCT01244815|81120296|FG000|Overall Study|Withdrawal by Subject|0|||
27805403|NCT01244815|81120297|FG001|Overall Study|Withdrawal by Subject|2|||
27805404|NCT01244815|81120298|FG002|Overall Study|Withdrawal by Subject|0|||
27805405|NCT01244815|81120299|FG003|Overall Study|Withdrawal by Subject|3|||
27873399|NCT00122382|81368479|FG000|Double-Blind Study|Randomized but not treated|0|||
27805406|NCT01244815|81120296|FG000|Overall Study|Protocol Violation|7|||
27805407|NCT01244815|81120297|FG001|Overall Study|Protocol Violation|4|||
27805408|NCT01244815|81120298|FG002|Overall Study|Protocol Violation|3|||
27805409|NCT01244815|81120299|FG003|Overall Study|Protocol Violation|1|||
27805410|NCT01244815|81120296|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27805411|NCT01244815|81120297|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
27805412|NCT01244815|81120298|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
27873400|NCT00122382|81368480|FG001|Double-Blind Study|Randomized but not treated|2|||
27873401|NCT00122382|81368481|FG002|Double-Blind Study|Randomized but not treated|0|||
27873402|NCT00122382|81368479|FG000|Open-Label Study|Adverse Event|0|||
27805413|NCT01244815|81120299|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
27805414|NCT01360632|81120300|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
27805415|NCT01360632|81120301|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
27805416|NCT01360632|81120302|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
27873403|NCT00122382|81368480|FG001|Open-Label Study|Adverse Event|0|||
27873404|NCT00122382|81368481|FG002|Open-Label Study|Adverse Event|11|||
27873405|NCT00122382|81368479|FG000|Open-Label Study|Death|0|||
27873406|NCT00122382|81368480|FG001|Open-Label Study|Death|0|||
27805417|NCT01360632|81120303|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
27805418|NCT01360632|81120304|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
27805419|NCT01360632|81120300|FG000|Phase A (8 Weeks)|Adverse Event|60|||
27805420|NCT01360632|81120301|FG001|Phase A (8 Weeks)|Adverse Event|0|||
27805421|NCT01360632|81120302|FG002|Phase A (8 Weeks)|Adverse Event|0|||
27805422|NCT01360632|81120303|FG003|Phase A (8 Weeks)|Adverse Event|0|||
27805423|NCT01360632|81120304|FG004|Phase A (8 Weeks)|Adverse Event|0|||
27805424|NCT01360632|81120300|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
27805425|NCT01360632|81120301|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27805426|NCT01360632|81120302|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27805427|NCT01360632|81120303|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27805428|NCT01360632|81120304|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
27805429|NCT01360632|81120300|FG000|Phase A (8 Weeks)|Physician Decision|10|||
27805430|NCT01360632|81120301|FG001|Phase A (8 Weeks)|Physician Decision|0|||
27805431|NCT01360632|81120302|FG002|Phase A (8 Weeks)|Physician Decision|0|||
27805432|NCT01360632|81120303|FG003|Phase A (8 Weeks)|Physician Decision|0|||
27805433|NCT01360632|81120304|FG004|Phase A (8 Weeks)|Physician Decision|0|||
27805434|NCT01360632|81120300|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
27581473|NCT03283670|80313802|FG000|Placebo Gas|Withdrawal by Subject|2|||
27581474|NCT03283670|80313802|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
27581475|NCT03283670|80313802|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
27581476|NCT00153101|80313805|FG000|Overall Study|Lost to Follow-up|14|||
27581477|NCT00153101|80313806|FG001|Overall Study|Lost to Follow-up|14|||
27581478|NCT00153101|80313807|FG002|Overall Study|Lost to Follow-up|12|||
27873407|NCT00122382|81368481|FG002|Open-Label Study|Death|2|||
27999530|NCT04492722|81830679|FG003|Overall Study|Participants who did not receive treatment|0|||
27999531|NCT01426958|81830680|FG000|Overall Study|Adverse Event|2|||
27999532|NCT02354235|81830681|FG000|Overall Study|Adverse Event|2|||
27999533|NCT02354235|81830682|FG001|Overall Study|Adverse Event|2|||
27999534|NCT02354235|81830681|FG000|Overall Study|Physician Decision|0|||
27999535|NCT02354235|81830682|FG001|Overall Study|Physician Decision|1|||
27999536|NCT02354235|81830681|FG000|Overall Study|Withdrawal by Subject|1|||
27999537|NCT02354235|81830682|FG001|Overall Study|Withdrawal by Subject|3|||
27999538|NCT02354235|81830681|FG000|Overall Study|Conflict with the stopping criteria|0|||
27999539|NCT02354235|81830682|FG001|Overall Study|Conflict with the stopping criteria|1|||
27999540|NCT01774799|81830683|FG000|Overall Study|Lost to Follow-up|1|||
27999541|NCT01774799|81830684|FG001|Overall Study|Lost to Follow-up|1|||
27999542|NCT01774799|81830685|FG002|Overall Study|Lost to Follow-up|0|||
27999543|NCT01774799|81830686|FG003|Overall Study|Lost to Follow-up|0|||
27999544|NCT01061359|81830687|FG000|Overall Study|Death|32|||
27999545|NCT01061359|81830687|FG000|Overall Study|Lost to Follow-up|1072|||
27999546|NCT01061359|81830687|FG000|Overall Study|Relapse|187|||
27581479|NCT00153101|80313808|FG003|Overall Study|Lost to Follow-up|5|||
27581480|NCT00153101|80313809|FG004|Overall Study|Lost to Follow-up|5|||
27805435|NCT01360632|81120301|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27805436|NCT01360632|81120302|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27805437|NCT01360632|81120303|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27999547|NCT01061359|81830687|FG000|Overall Study|Secondary neoplasm|11|||
27999548|NCT00428948|81830688|FG000|Overall Study|Lost to Follow-up|15|||
27999549|NCT00428948|81830689|FG001|Overall Study|Lost to Follow-up|8|||
27581481|NCT00153101|80313805|FG000|Overall Study|Withdrawal by Subject|3|||
27581482|NCT00153101|80313806|FG001|Overall Study|Withdrawal by Subject|4|||
27581483|NCT00153101|80313807|FG002|Overall Study|Withdrawal by Subject|3|||
27581484|NCT00153101|80313808|FG003|Overall Study|Withdrawal by Subject|3|||
27999550|NCT00428948|81830688|FG000|Overall Study|Adverse Event|148|||
27999551|NCT00428948|81830689|FG001|Overall Study|Adverse Event|24|||
27805438|NCT01360632|81120304|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
27805439|NCT01360632|81120300|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
27873408|NCT00122382|81368479|FG000|Open-Label Study|Lack of Efficacy|0|||
27999552|NCT00428948|81830688|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
27999553|NCT00428948|81830689|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
27999554|NCT00428948|81830688|FG000|Overall Study|Investigator Withdrew Subject|3|||
27999555|NCT00428948|81830689|FG001|Overall Study|Investigator Withdrew Subject|4|||
27680751|NCT00918879|80667901|FG000|Overall Study|Lost to Follow-up|1|||
27805440|NCT01360632|81120301|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
27805441|NCT01360632|81120302|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
27581485|NCT00153101|80313809|FG004|Overall Study|Withdrawal by Subject|5|||
27581486|NCT00345579|80313812|FG000|Overall Study|Adverse Event|9|||
27581487|NCT00345579|80313813|FG001|Overall Study|Adverse Event|6|||
27999556|NCT00428948|81830688|FG000|Overall Study|Subject Withdrew Consent|50|||
27999557|NCT00428948|81830689|FG001|Overall Study|Subject Withdrew Consent|30|||
27999558|NCT00428948|81830688|FG000|Overall Study|Protocol Deviation|1|||
27999559|NCT00428948|81830689|FG001|Overall Study|Protocol Deviation|1|||
27999560|NCT02869633|81830692|FG000|Overall Study|Death|2|||
27999561|NCT02869633|81830693|FG001|Overall Study|Death|1|||
27999562|NCT02869633|81830692|FG000|Overall Study|Patient refused follow-up|1|||
27581488|NCT00345579|80313812|FG000|Overall Study|Protocol Violation|14|||
27581489|NCT00345579|80313813|FG001|Overall Study|Protocol Violation|5|||
27581490|NCT00345579|80313812|FG000|Overall Study|Withdrawal by Subject|50|||
27581491|NCT00345579|80313813|FG001|Overall Study|Withdrawal by Subject|17|||
27581492|NCT00345579|80313812|FG000|Overall Study|Lost to Follow-up|82|||
27581493|NCT00345579|80313813|FG001|Overall Study|Lost to Follow-up|36|||
27581494|NCT00345579|80313812|FG000|Overall Study|Other|9|||
27581495|NCT00345579|80313813|FG001|Overall Study|Other|1|||
27581496|NCT00612066|80313814|FG000|Overall Study|Adverse Event|1|||
27581497|NCT04726709|80313819|FG000|Overall Study|Withdrawal by Subject|2|||
27581498|NCT04726709|80313820|FG001|Overall Study|Withdrawal by Subject|2|||
27581499|NCT04666441|80313825|FG000|Overall Study|Lost to Follow-up|1|||
27581500|NCT04666441|80313826|FG001|Overall Study|Lost to Follow-up|4|||
27581501|NCT04666441|80313827|FG002|Overall Study|Lost to Follow-up|1|||
27581502|NCT04666441|80313828|FG003|Overall Study|Lost to Follow-up|3|||
27581503|NCT04666441|80313829|FG004|Overall Study|Lost to Follow-up|0|||
27999563|NCT02869633|81830693|FG001|Overall Study|Patient refused follow-up|0|||
27999564|NCT02869633|81830692|FG000|Overall Study|Provider discretion|1|||
27999565|NCT02869633|81830693|FG001|Overall Study|Provider discretion|0|||
27999566|NCT02869633|81830692|FG000|Overall Study|Investigator decision|1|||
27999567|NCT02869633|81830693|FG001|Overall Study|Investigator decision|0|||
27999568|NCT02869633|81830692|FG000|Overall Study|Lost to Follow-up|0|||
27999569|NCT02869633|81830693|FG001|Overall Study|Lost to Follow-up|1|||
27999570|NCT02869633|81830692|FG000|Overall Study|Not eligible|6|||
27999571|NCT02869633|81830693|FG001|Overall Study|Not eligible|1|||
27999572|NCT02869633|81830692|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
27999573|NCT02869633|81830693|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
27581504|NCT04666441|80313830|FG005|Overall Study|Lost to Follow-up|2|||
27581505|NCT04666441|80313831|FG006|Overall Study|Lost to Follow-up|2|||
27581506|NCT04666441|80313832|FG007|Overall Study|Lost to Follow-up|2|||
27581507|NCT04666441|80313825|FG000|Overall Study|Subject Decision|1|||
27581508|NCT04666441|80313826|FG001|Overall Study|Subject Decision|1|||
27581509|NCT04666441|80313827|FG002|Overall Study|Subject Decision|3|||
27805442|NCT01360632|81120303|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
27805443|NCT01360632|81120304|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
27805444|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
27805445|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
27805446|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
27805447|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
27805448|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
27805449|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Adverse Event|0|||
27805450|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Adverse Event|3|||
27805451|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Adverse Event|9|||
27805452|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Adverse Event|3|||
27805453|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Adverse Event|0|||
27805454|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27805455|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27805456|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
27805457|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
27805458|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27805459|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Physician Decision|0|||
27999574|NCT02869633|81830692|FG000|Overall Study|Withdrawal by Subject|0|||
27999575|NCT02869633|81830693|FG001|Overall Study|Withdrawal by Subject|1|||
27999576|NCT02913482|81830694|FG000|Overall Study|Death|0|||
27999577|NCT02913482|81830695|FG001|Overall Study|Death|2|||
27999578|NCT02913482|81830696|FG002|Overall Study|Death|2|||
27581510|NCT04666441|80313828|FG003|Overall Study|Subject Decision|1|||
27805460|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Physician Decision|0|||
27805461|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Physician Decision|0|||
27999579|NCT02913482|81830694|FG000|Overall Study|Progressive Disease|1|||
27999580|NCT02913482|81830695|FG001|Overall Study|Progressive Disease|1|||
27999581|NCT02913482|81830696|FG002|Overall Study|Progressive Disease|1|||
27581511|NCT04666441|80313829|FG004|Overall Study|Subject Decision|0|||
27581512|NCT04666441|80313830|FG005|Overall Study|Subject Decision|1|||
27581513|NCT04666441|80313831|FG006|Overall Study|Subject Decision|3|||
27581514|NCT04666441|80313832|FG007|Overall Study|Subject Decision|2|||
27999582|NCT02913482|81830694|FG000|Overall Study|Reason not specified|0|||
27999583|NCT02913482|81830695|FG001|Overall Study|Reason not specified|0|||
27999584|NCT02913482|81830696|FG002|Overall Study|Reason not specified|1|||
27805462|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Physician Decision|1|||
27805463|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Physician Decision|0|||
27805464|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27805465|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
27805466|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
27805467|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
27805468|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27805469|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
27805470|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
27805471|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
27805472|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
27805473|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
27805474|NCT01360632|81120300|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
27805475|NCT01360632|81120301|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
27805476|NCT01360632|81120302|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
27805477|NCT01360632|81120303|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
27805478|NCT01360632|81120304|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
27805479|NCT01360632|81120300|FG000|Phase A+|Lost to Follow-up|0|||
27805480|NCT01360632|81120301|FG001|Phase A+|Lost to Follow-up|0|||
27805481|NCT01360632|81120302|FG002|Phase A+|Lost to Follow-up|0|||
27805482|NCT01360632|81120303|FG003|Phase A+|Lost to Follow-up|0|||
27805483|NCT01360632|81120304|FG004|Phase A+|Lost to Follow-up|2|||
27805484|NCT01360632|81120300|FG000|Phase A+|Adverse Event|0|||
27805485|NCT01360632|81120301|FG001|Phase A+|Adverse Event|0|||
27805486|NCT01360632|81120302|FG002|Phase A+|Adverse Event|0|||
27805487|NCT01360632|81120303|FG003|Phase A+|Adverse Event|0|||
27805488|NCT01360632|81120304|FG004|Phase A+|Adverse Event|2|||
27805489|NCT01360632|81120300|FG000|Phase A+|Met Withdrawal Criteria|0|||
27805490|NCT01360632|81120301|FG001|Phase A+|Met Withdrawal Criteria|0|||
27805491|NCT01360632|81120302|FG002|Phase A+|Met Withdrawal Criteria|0|||
27805492|NCT01360632|81120303|FG003|Phase A+|Met Withdrawal Criteria|0|||
27805493|NCT01360632|81120304|FG004|Phase A+|Met Withdrawal Criteria|7|||
27805494|NCT01360632|81120300|FG000|Phase A+|Physician Decision|0|||
27805495|NCT01360632|81120301|FG001|Phase A+|Physician Decision|0|||
27805496|NCT01360632|81120302|FG002|Phase A+|Physician Decision|0|||
27805497|NCT01360632|81120303|FG003|Phase A+|Physician Decision|0|||
27805498|NCT01360632|81120304|FG004|Phase A+|Physician Decision|3|||
27805499|NCT01360632|81120300|FG000|Phase A+|Withdrawal by Subject|0|||
27805500|NCT01360632|81120301|FG001|Phase A+|Withdrawal by Subject|0|||
27805501|NCT01360632|81120302|FG002|Phase A+|Withdrawal by Subject|0|||
27805502|NCT01360632|81120303|FG003|Phase A+|Withdrawal by Subject|0|||
27805503|NCT01360632|81120304|FG004|Phase A+|Withdrawal by Subject|8|||
27805504|NCT01360632|81120300|FG000|Phase A+|Protocol Deviation|0|||
27805505|NCT01360632|81120301|FG001|Phase A+|Protocol Deviation|0|||
27805506|NCT01360632|81120302|FG002|Phase A+|Protocol Deviation|0|||
27805507|NCT01360632|81120303|FG003|Phase A+|Protocol Deviation|0|||
27805508|NCT01360632|81120304|FG004|Phase A+|Protocol Deviation|3|||
27805509|NCT04071626|81120312|FG000|Overall Study|Withdrawal by Subject|1|||
27805510|NCT04071626|81120313|FG001|Overall Study|Withdrawal by Subject|1|||
27805511|NCT04071626|81120312|FG000|Overall Study|Protocol Violation|0|||
27805512|NCT04071626|81120313|FG001|Overall Study|Protocol Violation|1|||
27805513|NCT01070394|81120314|FG000|Overall Study|Adverse Event|6|||
27805514|NCT01070394|81120314|FG000|Overall Study|Withdrawal by Subject|1|||
27805515|NCT02763579|81120318|FG000|Global Period|Death|167|||
27805516|NCT02763579|81120319|FG001|Global Period|Death|151|||
27805517|NCT02763579|81120320|FG002|Global Period|Death|0|||
27805518|NCT02763579|81120321|FG003|Global Period|Death|0|||
27805519|NCT02763579|81120318|FG000|Global Period|Lost to Follow-up|2|||
27805520|NCT02763579|81120319|FG001|Global Period|Lost to Follow-up|4|||
27805521|NCT02763579|81120320|FG002|Global Period|Lost to Follow-up|0|||
27805522|NCT02763579|81120321|FG003|Global Period|Lost to Follow-up|0|||
27805523|NCT02763579|81120318|FG000|Global Period|Physician Decision|0|||
27805524|NCT02763579|81120319|FG001|Global Period|Physician Decision|2|||
27805525|NCT02763579|81120320|FG002|Global Period|Physician Decision|0|||
27873409|NCT00122382|81368480|FG001|Open-Label Study|Lack of Efficacy|0|||
27999585|NCT02913482|81830694|FG000|Overall Study|Withdrawal by Subject|0|||
27805526|NCT02763579|81120321|FG003|Global Period|Physician Decision|0|||
27805527|NCT02763579|81120318|FG000|Global Period|Study Terminated By Sponsor|21|||
27805528|NCT02763579|81120319|FG001|Global Period|Study Terminated By Sponsor|26|||
27805529|NCT02763579|81120320|FG002|Global Period|Study Terminated By Sponsor|0|||
27805530|NCT02763579|81120321|FG003|Global Period|Study Terminated By Sponsor|0|||
27805531|NCT02763579|81120318|FG000|Global Period|Withdrawal by Subject|12|||
27805532|NCT02763579|81120319|FG001|Global Period|Withdrawal by Subject|18|||
27999586|NCT02913482|81830695|FG001|Overall Study|Withdrawal by Subject|1|||
27999587|NCT02913482|81830696|FG002|Overall Study|Withdrawal by Subject|1|||
27999588|NCT00580723|81830697|FG000|Overall Study|Did not want to participate in extension|3|||
27999589|NCT00580723|81830697|FG000|Overall Study|Lost to Follow-up|5|||
27999590|NCT02222558|81830698|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
27999591|NCT02222558|81830699|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
27805533|NCT02763579|81120320|FG002|Global Period|Withdrawal by Subject|0|||
27805534|NCT02763579|81120321|FG003|Global Period|Withdrawal by Subject|0|||
27805535|NCT02763579|81120318|FG000|China Period|Death|0|||
27805536|NCT02763579|81120319|FG001|China Period|Death|0|||
27805537|NCT02763579|81120320|FG002|China Period|Death|46|||
27805538|NCT02763579|81120321|FG003|China Period|Death|48|||
27581515|NCT01643473|80313833|FG000|Overall Study|Lost to Follow-up|1|||
27581516|NCT01643473|80313834|FG001|Overall Study|Lost to Follow-up|0|||
27581517|NCT01542528|80313835|FG000|Overall Study|Lost to Follow-up|2|||
27581518|NCT01542528|80313836|FG001|Overall Study|Lost to Follow-up|1|||
27581519|NCT01542528|80313835|FG000|Overall Study|Physician Decision|1|||
27581520|NCT01542528|80313836|FG001|Overall Study|Physician Decision|0|||
27581521|NCT01542528|80313835|FG000|Overall Study|Withdrawal by Subject|9|||
27581522|NCT01542528|80313836|FG001|Overall Study|Withdrawal by Subject|6|||
27581523|NCT00793910|80313837|FG000|Overall Study|discarded study pills|0|||
27873410|NCT00122382|81368481|FG002|Open-Label Study|Lack of Efficacy|3|||
27873411|NCT00122382|81368479|FG000|Open-Label Study|Lost to Follow-up|0|||
27873412|NCT00122382|81368480|FG001|Open-Label Study|Lost to Follow-up|0|||
27873413|NCT00122382|81368481|FG002|Open-Label Study|Lost to Follow-up|3|||
27999592|NCT02222558|81830700|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
27680752|NCT00918879|80667902|FG001|Overall Study|Lost to Follow-up|1|||
27680753|NCT00918879|80667901|FG000|Overall Study|Severe non-compliance to protocol|1|||
27805539|NCT02763579|81120318|FG000|China Period|Lost to Follow-up|0|||
27805540|NCT02763579|81120319|FG001|China Period|Lost to Follow-up|0|||
27805541|NCT02763579|81120320|FG002|China Period|Lost to Follow-up|1|||
27581524|NCT00793910|80313838|FG001|Overall Study|discarded study pills|1|||
27581525|NCT00793910|80313837|FG000|Overall Study|did not pick up medications|1|||
27805542|NCT02763579|81120321|FG003|China Period|Lost to Follow-up|1|||
27805543|NCT02763579|81120318|FG000|China Period|Physician Decision|0|||
27805544|NCT02763579|81120319|FG001|China Period|Physician Decision|0|||
27873414|NCT00122382|81368479|FG000|Open-Label Study|Pregnancy|0|||
27999593|NCT02222558|81830701|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
27999594|NCT02222558|81830702|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
27999595|NCT02222558|81830703|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
27999596|NCT02222558|81830698|FG000|Period 3|Withdrawal by Subject|0|||
27999597|NCT02222558|81830699|FG001|Period 3|Withdrawal by Subject|0|||
27999598|NCT02222558|81830700|FG002|Period 3|Withdrawal by Subject|0|||
27999599|NCT02222558|81830701|FG003|Period 3|Withdrawal by Subject|0|||
27999600|NCT02222558|81830702|FG004|Period 3|Withdrawal by Subject|0|||
27999601|NCT02222558|81830703|FG005|Period 3|Withdrawal by Subject|1|||
27999602|NCT00496080|81830704|FG000|Overall Study|Lost to Follow-up|9|||
27999603|NCT00496080|81830704|FG000|Overall Study|Surgical re-intervention|7|||
27999604|NCT00496080|81830704|FG000|Overall Study|Withdrawal by Subject|5|||
27999605|NCT00496080|81830704|FG000|Overall Study|Physician Decision|6|||
27999606|NCT02905266|81830711|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
27999607|NCT02905266|81830712|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
27999608|NCT02905266|81830711|FG000|Treatment Phase Part 1|Disease Progression|6|||
27999609|NCT02905266|81830712|FG001|Treatment Phase Part 1|Disease Progression|7|||
27999610|NCT02905266|81830711|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
27999611|NCT02905266|81830712|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
27999612|NCT02905266|81830711|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
27999613|NCT02905266|81830712|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
27999614|NCT02905266|81830711|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
27999615|NCT02905266|81830712|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
27999616|NCT02905266|81830711|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
27999617|NCT02905266|81830712|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
27999618|NCT02905266|81830711|FG000|Transition From Part 1 to Part 2|Death|0|||
27999619|NCT02905266|81830712|FG001|Transition From Part 1 to Part 2|Death|1|||
27999620|NCT02905266|81830711|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
27999621|NCT02905266|81830712|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
27999622|NCT02905266|81830711|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
27999623|NCT02905266|81830712|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
27999624|NCT02905266|81830711|FG000|Maintenance Phase Part 2|Disease Progression|9|||
27999625|NCT02905266|81830712|FG001|Maintenance Phase Part 2|Disease Progression|2|||
27999626|NCT02905266|81830711|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
27999627|NCT02905266|81830712|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
27999628|NCT02905266|81830711|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
27999629|NCT02905266|81830712|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
27999630|NCT01633788|81830713|FG000|Overall Study|Adverse Event|1|||
27999631|NCT01633788|81830714|FG001|Overall Study|Adverse Event|3|||
27581526|NCT00793910|80313838|FG001|Overall Study|did not pick up medications|1|||
27581527|NCT00793910|80313837|FG000|Overall Study|ineligible based on entry criteria|2|||
27594396|NCT00955357|80356063|FG000|Titration Phase|Lost to Follow-up|1|||
27805545|NCT02763579|81120320|FG002|China Period|Physician Decision|0|||
27999632|NCT01633788|81830715|FG002|Overall Study|Adverse Event|3|||
27999633|NCT01633788|81830716|FG003|Overall Study|Adverse Event|3|||
27999634|NCT01633788|81830713|FG000|Overall Study|Lost to Follow-up|2|||
27999635|NCT01633788|81830714|FG001|Overall Study|Lost to Follow-up|2|||
27999636|NCT01633788|81830715|FG002|Overall Study|Lost to Follow-up|2|||
27999637|NCT01633788|81830716|FG003|Overall Study|Lost to Follow-up|0|||
27581528|NCT00793910|80313838|FG001|Overall Study|ineligible based on entry criteria|3|||
27581529|NCT00793910|80313837|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
27581530|NCT00793910|80313838|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
27581531|NCT00793910|80313837|FG000|Overall Study|Withdrawal by Subject|0|||
27581532|NCT00793910|80313838|FG001|Overall Study|Withdrawal by Subject|1|||
27581533|NCT04788147|80313840|FG000|Overall Study|Screen Failure|3|||
27581534|NCT04788147|80313841|FG001|Overall Study|Screen Failure|10|||
27581535|NCT04788147|80313840|FG000|Overall Study|Incomplete RMRS image session|2|||
27581536|NCT04788147|80313841|FG001|Overall Study|Incomplete RMRS image session|0|||
27581537|NCT01038921|80313842|FG000|Overall Study|Withdrawal by Subject|1|||
27581538|NCT01038921|80313843|FG001|Overall Study|Withdrawal by Subject|0|||
27581539|NCT01038921|80313842|FG000|Overall Study|Physician Decision|1|||
27581540|NCT01038921|80313843|FG001|Overall Study|Physician Decision|0|||
27581541|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
27581542|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
27581543|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
27581544|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27581545|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27581546|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27581547|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27680754|NCT00918879|80667902|FG001|Overall Study|Severe non-compliance to protocol|1|||
27680755|NCT01559129|80667903|FG000|Treatment Phase|Adverse Event|0|||
27680756|NCT01559129|80667904|FG001|Treatment Phase|Adverse Event|2|||
27680757|NCT01559129|80667903|FG000|Treatment Phase|Progressive Disease|1|||
27680758|NCT01559129|80667904|FG001|Treatment Phase|Progressive Disease|1|||
27805546|NCT02763579|81120321|FG003|China Period|Physician Decision|1|||
27581548|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27581549|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27581550|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
27581551|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
27581552|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
27581553|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27581554|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27581555|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27581556|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27581557|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27581558|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27581559|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581560|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
27581561|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
27581562|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581563|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581564|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581565|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581566|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581567|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27581568|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
27680759|NCT01559129|80667903|FG000|Treatment Phase|Lack of Efficacy|0|||
27680760|NCT01559129|80667904|FG001|Treatment Phase|Lack of Efficacy|1|||
27680761|NCT01559129|80667903|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
27805547|NCT02763579|81120318|FG000|China Period|Study Terminated By Sponsor|0|||
27805548|NCT02763579|81120319|FG001|China Period|Study Terminated By Sponsor|0|||
27805549|NCT02763579|81120320|FG002|China Period|Study Terminated By Sponsor|3|||
27805550|NCT02763579|81120321|FG003|China Period|Study Terminated By Sponsor|4|||
27805551|NCT02763579|81120318|FG000|China Period|Withdrawal by Subject|0|||
27805552|NCT02763579|81120319|FG001|China Period|Withdrawal by Subject|0|||
27805553|NCT02763579|81120320|FG002|China Period|Withdrawal by Subject|3|||
27805554|NCT02763579|81120321|FG003|China Period|Withdrawal by Subject|3|||
27805555|NCT02354976|81120322|FG000|Overall Study|Other - reason not specified|1|||
27999638|NCT01633788|81830713|FG000|Overall Study|Personal Reasons|3|||
27999639|NCT01633788|81830714|FG001|Overall Study|Personal Reasons|1|||
27999640|NCT01633788|81830715|FG002|Overall Study|Personal Reasons|1|||
27999641|NCT01633788|81830716|FG003|Overall Study|Personal Reasons|3|||
27999642|NCT01633788|81830713|FG000|Overall Study|Protocol Violation|1|||
27873415|NCT00122382|81368480|FG001|Open-Label Study|Pregnancy|0|||
27999643|NCT01633788|81830714|FG001|Overall Study|Protocol Violation|0|||
27581569|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
27581570|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
27581571|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27581572|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27581573|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27581574|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27581575|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27581576|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27581577|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581578|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
27581579|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581580|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581581|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581582|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581583|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581584|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581585|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
27581586|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
27581587|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581588|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581589|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581590|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581591|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581592|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581593|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581594|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27581595|NCT01172938|80313844|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
27581596|NCT01172938|80313845|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
27581597|NCT01172938|80313846|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
27873416|NCT00122382|81368481|FG002|Open-Label Study|Pregnancy|2|||
27999644|NCT01633788|81830715|FG002|Overall Study|Protocol Violation|1|||
27999645|NCT01633788|81830716|FG003|Overall Study|Protocol Violation|0|||
27999646|NCT01633788|81830713|FG000|Overall Study|Other Reasons|0|||
27999647|NCT01633788|81830714|FG001|Overall Study|Other Reasons|2|||
27999648|NCT01633788|81830715|FG002|Overall Study|Other Reasons|3|||
27999649|NCT01633788|81830716|FG003|Overall Study|Other Reasons|7|||
27999650|NCT03535974|81830717|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
27999651|NCT03535974|81830718|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
27999652|NCT03535974|81830719|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
27999653|NCT03535974|81830717|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
27999654|NCT03535974|81830718|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
27999655|NCT03535974|81830719|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
27873417|NCT00122382|81368479|FG000|Open-Label Study|Poor/Non-Compliance|0|||
27873418|NCT00122382|81368480|FG001|Open-Label Study|Poor/Non-Compliance|0|||
27999656|NCT00584012|81830722|FG000|Overall Study|Withdrawal by Subject|1|||
27999657|NCT01479868|81830723|FG000|Overall Study|Adverse Event|1|||
27999658|NCT01479868|81830723|FG000|Overall Study|Lost to Follow-up|4|||
27999659|NCT01479868|81830723|FG000|Overall Study|Protocol Violation|1|||
27999660|NCT01479868|81830723|FG000|Overall Study|Withdrawal by Subject|1|||
27999661|NCT01479868|81830723|FG000|Overall Study|Sponsor's Decision|1|||
27999662|NCT01479868|81830723|FG000|Overall Study|Initiation of new HCV Therapy|1|||
27999663|NCT01980095|81830724|FG000|Overall Study|Lost to Follow-up|6|||
27999664|NCT01980095|81830725|FG001|Overall Study|Lost to Follow-up|7|||
27999665|NCT01980095|81830724|FG000|Overall Study|Withdrawal by Subject|2|||
27999666|NCT01980095|81830725|FG001|Overall Study|Withdrawal by Subject|3|||
27999667|NCT01980095|81830724|FG000|Overall Study|Poor compliance|5|||
27999668|NCT01980095|81830725|FG001|Overall Study|Poor compliance|0|||
27999669|NCT01980095|81830724|FG000|Overall Study|Safety issue|0|||
27999670|NCT01980095|81830725|FG001|Overall Study|Safety issue|1|||
27999671|NCT01980095|81830724|FG000|Overall Study|Study drug discontinued|1|||
27999672|NCT01980095|81830725|FG001|Overall Study|Study drug discontinued|0|||
27999673|NCT01980095|81830724|FG000|Overall Study|Randomized by mistake|1|||
27999674|NCT01980095|81830725|FG001|Overall Study|Randomized by mistake|0|||
27999675|NCT03343626|81830726|FG000|Overall Study|Lost to Follow-up|4|||
27999676|NCT03343626|81830727|FG001|Overall Study|Lost to Follow-up|3|||
27999677|NCT03343626|81830728|FG002|Overall Study|Lost to Follow-up|2|||
27999678|NCT03343626|81830729|FG003|Overall Study|Lost to Follow-up|5|||
27999679|NCT03343626|81830730|FG004|Overall Study|Lost to Follow-up|4|||
27999680|NCT03343626|81830731|FG005|Overall Study|Lost to Follow-up|4|||
27999681|NCT03343626|81830732|FG006|Overall Study|Lost to Follow-up|4|||
27999682|NCT03343626|81830733|FG007|Overall Study|Lost to Follow-up|7|||
27999683|NCT03343626|81830726|FG000|Overall Study|Withdrawal of Consent|2|||
27999684|NCT03343626|81830727|FG001|Overall Study|Withdrawal of Consent|1|||
27999685|NCT03343626|81830728|FG002|Overall Study|Withdrawal of Consent|0|||
27999686|NCT03343626|81830729|FG003|Overall Study|Withdrawal of Consent|3|||
27999687|NCT03343626|81830730|FG004|Overall Study|Withdrawal of Consent|3|||
27581598|NCT01172938|80313847|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
27581599|NCT01172938|80313848|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
27581600|NCT01172938|80313849|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
27581601|NCT01172938|80313850|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
27581602|NCT01172938|80313851|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
27999688|NCT03343626|81830731|FG005|Overall Study|Withdrawal of Consent|1|||
27999689|NCT03343626|81830732|FG006|Overall Study|Withdrawal of Consent|1|||
27999690|NCT03343626|81830733|FG007|Overall Study|Withdrawal of Consent|2|||
27999691|NCT03343626|81830726|FG000|Overall Study|Reason not Specified|0|||
27999692|NCT03343626|81830727|FG001|Overall Study|Reason not Specified|1|||
27999693|NCT03343626|81830728|FG002|Overall Study|Reason not Specified|0|||
27999694|NCT03343626|81830729|FG003|Overall Study|Reason not Specified|0|||
27999695|NCT03343626|81830730|FG004|Overall Study|Reason not Specified|0|||
27999696|NCT03343626|81830731|FG005|Overall Study|Reason not Specified|0|||
27999697|NCT03343626|81830732|FG006|Overall Study|Reason not Specified|0|||
27999698|NCT03343626|81830733|FG007|Overall Study|Reason not Specified|1|||
27999699|NCT03343626|81830726|FG000|Overall Study|Data Entry Error|0|||
27999700|NCT03343626|81830727|FG001|Overall Study|Data Entry Error|0|||
27999701|NCT03343626|81830728|FG002|Overall Study|Data Entry Error|0|||
27999702|NCT03343626|81830729|FG003|Overall Study|Data Entry Error|0|||
27581603|NCT01172938|80313852|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
27581604|NCT01172938|80313844|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27581605|NCT01172938|80313845|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
27581606|NCT01172938|80313846|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
27581607|NCT01172938|80313847|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
27581608|NCT01172938|80313848|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
27581609|NCT01172938|80313849|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
27581610|NCT01172938|80313850|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27581611|NCT01172938|80313851|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27581612|NCT01172938|80313852|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
27581613|NCT01172938|80313844|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27581614|NCT01172938|80313845|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
27581615|NCT01172938|80313846|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
27581616|NCT01172938|80313847|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
27581617|NCT01172938|80313848|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
27581618|NCT01172938|80313849|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
27581619|NCT01172938|80313850|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27581620|NCT01172938|80313851|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27581621|NCT01172938|80313852|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
27581622|NCT01172938|80313844|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581623|NCT01172938|80313845|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581624|NCT01172938|80313846|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
27999703|NCT03343626|81830730|FG004|Overall Study|Data Entry Error|0|||
27999704|NCT03343626|81830731|FG005|Overall Study|Data Entry Error|0|||
27999705|NCT03343626|81830732|FG006|Overall Study|Data Entry Error|0|||
27999706|NCT03343626|81830733|FG007|Overall Study|Data Entry Error|1|||
27581625|NCT01172938|80313847|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581626|NCT01172938|80313848|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581627|NCT01172938|80313849|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581628|NCT01172938|80313850|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581629|NCT01172938|80313851|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581630|NCT01172938|80313852|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
27581631|NCT01172938|80313844|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
27581632|NCT01172938|80313845|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
27581633|NCT01172938|80313846|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
27581634|NCT01172938|80313847|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
27581635|NCT01172938|80313848|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
27581636|NCT01172938|80313849|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
27581637|NCT01172938|80313850|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
27581638|NCT01172938|80313851|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
27581639|NCT01172938|80313852|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
27581640|NCT01172938|80313844|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27581641|NCT01172938|80313845|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
27581642|NCT01172938|80313846|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
27581643|NCT01172938|80313847|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
27581644|NCT01172938|80313848|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27581645|NCT01172938|80313849|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27581646|NCT01172938|80313850|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27581647|NCT01172938|80313851|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27581648|NCT01172938|80313852|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
27581649|NCT01172938|80313844|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581650|NCT01172938|80313845|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581651|NCT01172938|80313846|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581652|NCT01172938|80313847|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581653|NCT01172938|80313848|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581654|NCT01172938|80313849|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
27581655|NCT01172938|80313850|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
27581656|NCT01172938|80313851|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581657|NCT01172938|80313852|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
27581658|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27581659|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
27581660|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
27581661|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27581662|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27581663|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27581664|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
27581665|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
27581666|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
27581667|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27581668|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
27581669|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
27581670|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27581671|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27581672|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27581673|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27581674|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
27581675|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
27581676|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27581677|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27581678|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
27581679|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27999707|NCT02420093|81830734|FG000|Overall Study|Withdrawal by Subject|1|||
27999708|NCT02420093|81830735|FG001|Overall Study|Withdrawal by Subject|1|||
27581680|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27581681|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27680762|NCT01559129|80667904|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
27999709|NCT03229109|81830736|FG000|Overall Study|Withdrawal by Subject|0|||
27999710|NCT03229109|81830737|FG001|Overall Study|Withdrawal by Subject|0|||
27999711|NCT03229109|81830738|FG002|Overall Study|Withdrawal by Subject|0|||
27999712|NCT03229109|81830739|FG003|Overall Study|Withdrawal by Subject|1|||
27999713|NCT03369418|81830742|FG000|Overall Study|Withdrawal by Subject|3|||
27999714|NCT03369418|81830743|FG001|Overall Study|Withdrawal by Subject|3|||
27999715|NCT01521507|81830744|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
27999716|NCT01521507|81830745|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
27999717|NCT01521507|81830744|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
27999718|NCT01521507|81830745|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
27999719|NCT01521507|81830744|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
27999720|NCT01521507|81830745|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
27999721|NCT01521507|81830744|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
27999722|NCT01521507|81830745|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
27999723|NCT01521507|81830744|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
27999724|NCT01521507|81830745|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
27999725|NCT01521507|81830744|FG000|Stage 2: Observational Design|Physician Decision|1|||
27581682|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27581683|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27581684|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
27581685|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27873419|NCT00122382|81368481|FG002|Open-Label Study|Poor/Non-Compliance|1|||
27873420|NCT00122382|81368479|FG000|Open-Label Study|Withdrawal of Consent|0|||
27873421|NCT00122382|81368480|FG001|Open-Label Study|Withdrawal of Consent|0|||
27873422|NCT00122382|81368481|FG002|Open-Label Study|Withdrawal of Consent|4|||
27873423|NCT03022084|81368482|FG000|Overall Study|Lost to Follow-up|2|||
27873424|NCT03022084|81368483|FG001|Overall Study|Lost to Follow-up|3|||
27873425|NCT01149863|81368484|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
27873426|NCT01129557|81368487|FG000|Overall Study|Adverse Event|1|||
27873427|NCT01129557|81368488|FG001|Overall Study|Adverse Event|2|||
27873428|NCT01129557|81368489|FG002|Overall Study|Adverse Event|2|||
27873429|NCT01129557|81368487|FG000|Overall Study|Novartis terminated study early|3|||
27873430|NCT01129557|81368488|FG001|Overall Study|Novartis terminated study early|3|||
27873431|NCT01129557|81368489|FG002|Overall Study|Novartis terminated study early|2|||
27873432|NCT01891864|81368491|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
27873433|NCT01891864|81368492|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
27873434|NCT01891864|81368493|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27873435|NCT01891864|81368494|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27581686|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
27581687|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
27581688|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27581689|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27680763|NCT01559129|80667903|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
27680764|NCT01559129|80667904|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
27680765|NCT01559129|80667903|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
27680766|NCT01559129|80667904|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
27680767|NCT01559129|80667903|FG000|Open-label Extension Period|Adverse Event|1|||
27680768|NCT01559129|80667904|FG001|Open-label Extension Period|Adverse Event|0|||
27680769|NCT01559129|80667903|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
27680770|NCT01559129|80667904|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
27680771|NCT03738423|80667905|FG000|Overall Study|Withdrawal by Subject|9|||
27873436|NCT01891864|81368495|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27873437|NCT01891864|81368496|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
27873438|NCT01891864|81368491|FG000|Treatment Period 1|Physician Decision|0|||
27873439|NCT01891864|81368492|FG001|Treatment Period 1|Physician Decision|1|||
27873440|NCT01891864|81368493|FG002|Treatment Period 1|Physician Decision|0|||
27873441|NCT01891864|81368494|FG003|Treatment Period 1|Physician Decision|0|||
27873442|NCT01891864|81368495|FG004|Treatment Period 1|Physician Decision|0|||
27873443|NCT01891864|81368496|FG005|Treatment Period 1|Physician Decision|0|||
27873444|NCT01891864|81368491|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27873445|NCT01891864|81368492|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
27873446|NCT01891864|81368493|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27873447|NCT01891864|81368494|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27873448|NCT01891864|81368495|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27873449|NCT01891864|81368496|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
27873450|NCT01891864|81368491|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
27873451|NCT01891864|81368492|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
27873452|NCT01891864|81368493|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27873453|NCT01891864|81368494|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27873454|NCT01891864|81368495|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27873455|NCT01891864|81368496|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
27873456|NCT01891864|81368491|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27873457|NCT01891864|81368492|FG001|Treatment Period 1|Withdrawal by Subject|5|||
27873458|NCT01891864|81368493|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27873459|NCT01891864|81368494|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27873460|NCT01891864|81368495|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27873461|NCT01891864|81368496|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27873462|NCT01891864|81368491|FG000|Treatment Period 1|Lost to Follow-up|1|||
27680772|NCT03738423|80667906|FG001|Overall Study|Withdrawal by Subject|12|||
27680773|NCT03738423|80667907|FG002|Overall Study|Withdrawal by Subject|9|||
27680774|NCT03738423|80667908|FG003|Overall Study|Withdrawal by Subject|12|||
27680775|NCT03738423|80667909|FG004|Overall Study|Withdrawal by Subject|10|||
27581690|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27581691|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
27581692|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
27581693|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
27581694|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581695|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581696|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
27581697|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581698|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581699|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581700|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581701|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581702|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
27581703|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27581704|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
27680776|NCT03738423|80667905|FG000|Overall Study|Lack of Efficacy|3|||
27680777|NCT03738423|80667906|FG001|Overall Study|Lack of Efficacy|1|||
27873463|NCT01891864|81368492|FG001|Treatment Period 1|Lost to Follow-up|0|||
27873464|NCT01891864|81368493|FG002|Treatment Period 1|Lost to Follow-up|0|||
27581705|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
27680778|NCT03738423|80667907|FG002|Overall Study|Lack of Efficacy|1|||
27680779|NCT03738423|80667908|FG003|Overall Study|Lack of Efficacy|1|||
27581706|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27581707|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27581708|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27581709|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27680780|NCT03738423|80667909|FG004|Overall Study|Lack of Efficacy|2|||
27680781|NCT03738423|80667905|FG000|Overall Study|Lost to Follow-up|1|||
27581710|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
27581711|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
27581712|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581713|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
27581714|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581715|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581716|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581717|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581718|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581719|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
27581720|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
27581721|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581722|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
27581723|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581724|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581725|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581726|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581727|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581728|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27680782|NCT03738423|80667906|FG001|Overall Study|Lost to Follow-up|0|||
27680783|NCT03738423|80667907|FG002|Overall Study|Lost to Follow-up|1|||
27680784|NCT03738423|80667908|FG003|Overall Study|Lost to Follow-up|1|||
27680785|NCT03738423|80667909|FG004|Overall Study|Lost to Follow-up|0|||
27581729|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
27581730|NCT01172938|80313844|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27581731|NCT01172938|80313845|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27581732|NCT01172938|80313846|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27581733|NCT01172938|80313847|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27680786|NCT03738423|80667905|FG000|Overall Study|Protocol Violation|1|||
27680787|NCT03738423|80667906|FG001|Overall Study|Protocol Violation|0|||
27680788|NCT03738423|80667907|FG002|Overall Study|Protocol Violation|0|||
27680789|NCT03738423|80667908|FG003|Overall Study|Protocol Violation|0|||
27680790|NCT03738423|80667909|FG004|Overall Study|Protocol Violation|1|||
27680791|NCT03738423|80667905|FG000|Overall Study|Physician Decision|0|||
27680792|NCT03738423|80667906|FG001|Overall Study|Physician Decision|0|||
27680793|NCT03738423|80667907|FG002|Overall Study|Physician Decision|1|||
27680794|NCT03738423|80667908|FG003|Overall Study|Physician Decision|0|||
27680795|NCT03738423|80667909|FG004|Overall Study|Physician Decision|1|||
27805556|NCT02354976|81120323|FG001|Overall Study|Other - reason not specified|0|||
27805557|NCT02354976|81120324|FG002|Overall Study|Other - reason not specified|1|||
27805558|NCT02354976|81120322|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
27805559|NCT02354976|81120323|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
27805560|NCT02354976|81120324|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
27805561|NCT02354976|81120322|FG000|Overall Study|Adverse Event|1|||
27805562|NCT02354976|81120323|FG001|Overall Study|Adverse Event|0|||
27805563|NCT02354976|81120324|FG002|Overall Study|Adverse Event|2|||
27805564|NCT00947011|81120325|FG000|Overall Study|Study was terminated,PI left institution|12|||
27805565|NCT04428502|81120330|FG000|Overall Study|Did not meet entrance criteria|14|||
27805566|NCT02390219|81120335|FG000|Overall Study|Death|1|||
27805567|NCT02390219|81120335|FG000|Overall Study|Physician Decision|1|||
27805568|NCT02390219|81120335|FG000|Overall Study|Adverse Event|6|||
27805569|NCT02390219|81120335|FG000|Overall Study|Withdrawal by Subject|1|||
27805570|NCT02390219|81120335|FG000|Overall Study|Lost to Follow-up|2|||
27805571|NCT02390219|81120335|FG000|Overall Study|Other|2|||
27805572|NCT00219557|81120336|FG000|Phase 1|Lack of Efficacy|3|||
27805573|NCT00219557|81120337|FG001|Phase 1|Lack of Efficacy|0|||
27805574|NCT00219557|81120338|FG002|Phase 1|Lack of Efficacy|0|||
27873465|NCT01891864|81368494|FG003|Treatment Period 1|Lost to Follow-up|0|||
27680796|NCT03738423|80667905|FG000|Overall Study|Death|0|||
27581734|NCT01172938|80313848|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27581735|NCT01172938|80313849|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27680797|NCT03738423|80667906|FG001|Overall Study|Death|0|||
27680798|NCT03738423|80667907|FG002|Overall Study|Death|0|||
27680799|NCT03738423|80667908|FG003|Overall Study|Death|0|||
27805575|NCT00219557|81120336|FG000|Phase 1|Adverse Event|2|||
27805576|NCT00219557|81120337|FG001|Phase 1|Adverse Event|0|||
27805577|NCT00219557|81120338|FG002|Phase 1|Adverse Event|0|||
27805578|NCT00219557|81120336|FG000|Phase 1|Withdrawal by Subject|1|||
27680800|NCT03738423|80667909|FG004|Overall Study|Death|1|||
27680801|NCT03738423|80667905|FG000|Overall Study|Randomized but never treated|0|||
27680802|NCT03738423|80667906|FG001|Overall Study|Randomized but never treated|0|||
27680803|NCT03738423|80667907|FG002|Overall Study|Randomized but never treated|1|||
27680804|NCT03738423|80667908|FG003|Overall Study|Randomized but never treated|1|||
27680805|NCT03738423|80667909|FG004|Overall Study|Randomized but never treated|0|||
27680806|NCT03117998|80667910|FG000|Overall Study|Adverse Event|1|||
27680807|NCT03117998|80667911|FG001|Overall Study|Adverse Event|0|||
27680808|NCT03117998|80667912|FG002|Overall Study|Adverse Event|0|||
27680809|NCT03117998|80667913|FG003|Overall Study|Adverse Event|0|||
27680810|NCT03117998|80667914|FG004|Overall Study|Adverse Event|0|||
27680811|NCT03117998|80667915|FG005|Overall Study|Adverse Event|0|||
27680812|NCT03117998|80667910|FG000|Overall Study|Withdrawal by Subject|0|||
27680813|NCT03117998|80667911|FG001|Overall Study|Withdrawal by Subject|0|||
27680814|NCT03117998|80667912|FG002|Overall Study|Withdrawal by Subject|2|||
27680815|NCT03117998|80667913|FG003|Overall Study|Withdrawal by Subject|3|||
27680816|NCT03117998|80667914|FG004|Overall Study|Withdrawal by Subject|3|||
27680817|NCT03117998|80667915|FG005|Overall Study|Withdrawal by Subject|0|||
27680818|NCT03117998|80667910|FG000|Overall Study|Physician Decision|0|||
27680819|NCT03117998|80667911|FG001|Overall Study|Physician Decision|1|||
27680820|NCT03117998|80667912|FG002|Overall Study|Physician Decision|1|||
27680821|NCT03117998|80667913|FG003|Overall Study|Physician Decision|0|||
27999726|NCT01521507|81830745|FG001|Stage 2: Observational Design|Physician Decision|0|||
27999727|NCT03649217|81830750|FG000|Overall Study|subject had severe ataxia not initially found|1|||
27999728|NCT03649217|81830750|FG000|Overall Study|subject had cognitive issues not initially found|1|||
27999729|NCT00502671|81830751|FG000|Overall Study|Disease Progression|13|||
27581736|NCT01172938|80313850|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27581737|NCT01172938|80313851|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
27581738|NCT01172938|80313852|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
27581739|NCT01172938|80313844|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27581740|NCT01172938|80313845|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
27581741|NCT01172938|80313846|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
27999730|NCT00502671|81830751|FG000|Overall Study|Personal Reasons|22|||
27999731|NCT00502671|81830751|FG000|Overall Study|Lost to Follow-up|7|||
27999732|NCT00502671|81830751|FG000|Overall Study|Protocol Violation|16|||
27999733|NCT00502671|81830751|FG000|Overall Study|Adverse Event|19|||
27999734|NCT02524171|81830756|FG000|6-month Follow-up|Lost to Follow-up|53|||
27999735|NCT02524171|81830757|FG001|6-month Follow-up|Lost to Follow-up|45|||
27999736|NCT02524171|81830756|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
27999737|NCT02524171|81830757|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
27999738|NCT01271725|81830759|FG000|Part A|Progressive disease according to RECIST|8|||
27999739|NCT01271725|81830760|FG001|Part A|Progressive disease according to RECIST|0|||
27999740|NCT01271725|81830759|FG000|Part A|Clinical signs/symptoms of progression|2|||
27999741|NCT01271725|81830760|FG001|Part A|Clinical signs/symptoms of progression|0|||
27581742|NCT01172938|80313847|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27581743|NCT01172938|80313848|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27581744|NCT01172938|80313849|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27581745|NCT01172938|80313850|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
27581746|NCT01172938|80313851|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
27581747|NCT01172938|80313852|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
27581748|NCT01172938|80313844|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27581749|NCT01172938|80313845|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
27581750|NCT01172938|80313846|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
27581751|NCT01172938|80313847|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27680822|NCT03117998|80667914|FG004|Overall Study|Physician Decision|0|||
27680823|NCT03117998|80667915|FG005|Overall Study|Physician Decision|0|||
27680824|NCT03117998|80667910|FG000|Overall Study|Lost to Follow-up|0|||
27680825|NCT03117998|80667911|FG001|Overall Study|Lost to Follow-up|0|||
27680826|NCT03117998|80667912|FG002|Overall Study|Lost to Follow-up|0|||
27680827|NCT03117998|80667913|FG003|Overall Study|Lost to Follow-up|1|||
27680828|NCT03117998|80667914|FG004|Overall Study|Lost to Follow-up|4|||
27680829|NCT03117998|80667915|FG005|Overall Study|Lost to Follow-up|0|||
27680830|NCT03117998|80667910|FG000|Overall Study|Subject noncompliance|0|||
27680831|NCT03117998|80667911|FG001|Overall Study|Subject noncompliance|0|||
27680832|NCT03117998|80667912|FG002|Overall Study|Subject noncompliance|1|||
27680833|NCT03117998|80667913|FG003|Overall Study|Subject noncompliance|0|||
27999742|NCT01271725|81830759|FG000|Part A|Other Adverse Event|8|||
27680834|NCT03117998|80667914|FG004|Overall Study|Subject noncompliance|0|||
27999743|NCT01271725|81830760|FG001|Part A|Other Adverse Event|0|||
27999744|NCT01271725|81830759|FG000|Part A|Lost to Follow-up|1|||
27999745|NCT01271725|81830760|FG001|Part A|Lost to Follow-up|0|||
27999746|NCT01271725|81830759|FG000|Part A|Withdrawal by Subject|12|||
27999747|NCT01271725|81830760|FG001|Part A|Withdrawal by Subject|0|||
27999748|NCT01271725|81830759|FG000|Part A|Other than specified|3|||
27999749|NCT01271725|81830760|FG001|Part A|Other than specified|0|||
27999750|NCT01271725|81830759|FG000|Part A|Protocol Violation|1|||
27999751|NCT01271725|81830760|FG001|Part A|Protocol Violation|0|||
27999752|NCT01271725|81830759|FG000|Part B|Other than specified|0|||
27999753|NCT01271725|81830760|FG001|Part B|Other than specified|2|||
27999754|NCT01271725|81830759|FG000|Part B|Clinical signs/symptoms of progression|0|||
27999755|NCT01271725|81830760|FG001|Part B|Clinical signs/symptoms of progression|2|||
27999756|NCT01271725|81830759|FG000|Part B|Other Adverse Event|0|||
27680835|NCT03117998|80667915|FG005|Overall Study|Subject noncompliance|2|||
27680836|NCT03117998|80667910|FG000|Overall Study|Protocol Violation|0|||
27680837|NCT03117998|80667911|FG001|Overall Study|Protocol Violation|0|||
27680838|NCT03117998|80667912|FG002|Overall Study|Protocol Violation|0|||
27680839|NCT03117998|80667913|FG003|Overall Study|Protocol Violation|0|||
27680840|NCT03117998|80667914|FG004|Overall Study|Protocol Violation|0|||
27873466|NCT01891864|81368495|FG004|Treatment Period 1|Lost to Follow-up|0|||
27999757|NCT01271725|81830760|FG001|Part B|Other Adverse Event|1|||
27999758|NCT01271725|81830759|FG000|Part B|Protocol Violation|0|||
27999759|NCT01271725|81830760|FG001|Part B|Protocol Violation|1|||
27999760|NCT01271725|81830759|FG000|Part B|Withdrawal by Subject|0|||
27999761|NCT01271725|81830760|FG001|Part B|Withdrawal by Subject|6|||
27999762|NCT01247324|81830761|FG000|Overall Study|Death|6|||
27999763|NCT01247324|81830762|FG001|Overall Study|Death|10|||
27999764|NCT01247324|81830761|FG000|Overall Study|Physician Decision|2|||
27999765|NCT01247324|81830762|FG001|Overall Study|Physician Decision|3|||
27999766|NCT01247324|81830761|FG000|Overall Study|Non-compliance with study drug|3|||
27999767|NCT01247324|81830762|FG001|Overall Study|Non-compliance with study drug|0|||
27999768|NCT01247324|81830761|FG000|Overall Study|Lack of Efficacy|24|||
27999769|NCT01247324|81830762|FG001|Overall Study|Lack of Efficacy|14|||
27999770|NCT01247324|81830761|FG000|Overall Study|Non-compliance|3|||
27999771|NCT01247324|81830762|FG001|Overall Study|Non-compliance|2|||
27999772|NCT01247324|81830761|FG000|Overall Study|Pregnancy|5|||
27999773|NCT01247324|81830762|FG001|Overall Study|Pregnancy|10|||
27999774|NCT01247324|81830761|FG000|Overall Study|Protocol Violation|1|||
27999775|NCT01247324|81830762|FG001|Overall Study|Protocol Violation|1|||
27999776|NCT01247324|81830761|FG000|Overall Study|Reason not specified|42|||
27999777|NCT01247324|81830762|FG001|Overall Study|Reason not specified|32|||
27999778|NCT01247324|81830761|FG000|Overall Study|Consent withdrawn by participant|41|||
27999779|NCT01247324|81830762|FG001|Overall Study|Consent withdrawn by participant|56|||
27999780|NCT01247324|81830761|FG000|Overall Study|Adverse Event|49|||
27999781|NCT01247324|81830762|FG001|Overall Study|Adverse Event|35|||
27999782|NCT01247324|81830761|FG000|Overall Study|Lost to Follow-up|3|||
27999783|NCT01247324|81830762|FG001|Overall Study|Lost to Follow-up|6|||
27999784|NCT01247324|81830761|FG000|Overall Study|Study Terminated by Sponsor|4|||
27999785|NCT01247324|81830762|FG001|Overall Study|Study Terminated by Sponsor|1|||
27999786|NCT01247324|81830761|FG000|Overall Study|Missing|2|||
27999787|NCT01247324|81830762|FG001|Overall Study|Missing|1|||
27999788|NCT04972786|81830763|FG000|First Intervention (1 Day)|Adverse Event|1|||
27999789|NCT04972786|81830764|FG001|First Intervention (1 Day)|Adverse Event|0|||
27999790|NCT02614729|81830765|FG000|Overall Study|Withdrawal by Subject|1|||
27999791|NCT02614729|81830766|FG001|Overall Study|Withdrawal by Subject|0|||
27680841|NCT03117998|80667915|FG005|Overall Study|Protocol Violation|1|||
27680842|NCT02460575|80667916|FG000|Overall Study|Lost to Follow-up|1|||
27680843|NCT02460575|80667917|FG001|Overall Study|Lost to Follow-up|0|||
27873467|NCT01891864|81368496|FG005|Treatment Period 1|Lost to Follow-up|0|||
27999792|NCT01544920|81830767|FG000|Overall Study|Adverse Event|0|||
27999793|NCT01544920|81830768|FG001|Overall Study|Adverse Event|3|||
27999794|NCT01544920|81830767|FG000|Overall Study|Death|0|||
27999795|NCT01544920|81830768|FG001|Overall Study|Death|1|||
27999796|NCT01544920|81830767|FG000|Overall Study|Lost to Follow-up|11|||
27999797|NCT01544920|81830768|FG001|Overall Study|Lost to Follow-up|12|||
27999798|NCT01544920|81830767|FG000|Overall Study|Protocol Violation|0|||
27999799|NCT01544920|81830768|FG001|Overall Study|Protocol Violation|2|||
27999800|NCT01544920|81830767|FG000|Overall Study|Physician Decision|4|||
27999801|NCT01544920|81830768|FG001|Overall Study|Physician Decision|1|||
27680844|NCT01397422|80667920|FG000|Overall Study|Adverse Event|0|||
27680845|NCT01397422|80667921|FG001|Overall Study|Adverse Event|3|||
27680846|NCT01397422|80667922|FG002|Overall Study|Adverse Event|3|||
27581752|NCT01172938|80313848|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27581753|NCT01172938|80313849|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27581754|NCT01172938|80313850|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
27581755|NCT01172938|80313851|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
27999802|NCT01544920|81830767|FG000|Overall Study|Withdrawal by Subject|4|||
27999803|NCT01544920|81830768|FG001|Overall Study|Withdrawal by Subject|4|||
27999804|NCT01702025|81830769|FG000|Overall Study|Equipment failure|1|||
27999805|NCT01702025|81830770|FG001|Overall Study|Equipment failure|0|||
27999806|NCT01702025|81830771|FG002|Overall Study|Equipment failure|0|||
27999807|NCT01702025|81830772|FG003|Overall Study|Equipment failure|0|||
27999808|NCT01702025|81830769|FG000|Overall Study|Adverse Event|1|||
27999809|NCT01702025|81830770|FG001|Overall Study|Adverse Event|1|||
27999810|NCT01702025|81830771|FG002|Overall Study|Adverse Event|1|||
27999811|NCT01702025|81830772|FG003|Overall Study|Adverse Event|0|||
27999812|NCT02734693|81830773|FG000|Overall Study|Adverse Event|1|||
27999813|NCT02734693|81830774|FG001|Overall Study|Adverse Event|3|||
27999814|NCT02734693|81830775|FG002|Overall Study|Adverse Event|3|||
27999815|NCT02734693|81830773|FG000|Overall Study|Lack of Efficacy|1|||
27999816|NCT02734693|81830774|FG001|Overall Study|Lack of Efficacy|0|||
27999817|NCT02734693|81830775|FG002|Overall Study|Lack of Efficacy|0|||
27999818|NCT02734693|81830773|FG000|Overall Study|Lost to Follow-up|2|||
27999819|NCT02734693|81830774|FG001|Overall Study|Lost to Follow-up|0|||
27999820|NCT02734693|81830775|FG002|Overall Study|Lost to Follow-up|0|||
27999821|NCT02734693|81830773|FG000|Overall Study|Protocol Violation|1|||
27999822|NCT02734693|81830774|FG001|Overall Study|Protocol Violation|0|||
27999823|NCT02734693|81830775|FG002|Overall Study|Protocol Violation|0|||
27999824|NCT02734693|81830773|FG000|Overall Study|Withdrawal by Subject|1|||
27999825|NCT02734693|81830774|FG001|Overall Study|Withdrawal by Subject|0|||
27999826|NCT02734693|81830775|FG002|Overall Study|Withdrawal by Subject|0|||
27999827|NCT03956550|81830778|FG000|Overall Study|Sponsor decision|65|||
27999828|NCT03956550|81830779|FG001|Overall Study|Sponsor decision|66|||
27999829|NCT03956550|81830780|FG002|Overall Study|Sponsor decision|64|||
27999830|NCT03956550|81830778|FG000|Overall Study|Adverse Event|0|||
27999831|NCT03956550|81830779|FG001|Overall Study|Adverse Event|1|||
27999832|NCT03956550|81830780|FG002|Overall Study|Adverse Event|0|||
27581756|NCT01172938|80313852|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
27581757|NCT01172938|80313844|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581758|NCT01172938|80313845|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581759|NCT01172938|80313846|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581760|NCT01172938|80313847|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581761|NCT01172938|80313848|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581762|NCT01172938|80313849|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581763|NCT01172938|80313850|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581764|NCT01172938|80313851|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
27581765|NCT01172938|80313852|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
27581766|NCT01172938|80313844|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581767|NCT01172938|80313845|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
27581768|NCT01172938|80313846|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581769|NCT01172938|80313847|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581770|NCT01172938|80313848|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581771|NCT01172938|80313849|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581772|NCT01172938|80313850|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581773|NCT01172938|80313851|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581774|NCT01172938|80313852|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
27581775|NCT01172938|80313844|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581776|NCT01172938|80313845|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581777|NCT01172938|80313846|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
27581778|NCT01172938|80313847|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581779|NCT01172938|80313848|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581780|NCT01172938|80313849|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581781|NCT01172938|80313850|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581782|NCT01172938|80313851|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581783|NCT01172938|80313852|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
27581784|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27581785|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
27581786|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
27581787|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27581788|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27581789|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27581790|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27680847|NCT01397422|80667923|FG003|Overall Study|Adverse Event|8|||
27680848|NCT01397422|80667920|FG000|Overall Study|Withdrawal by Subject|1|||
27680849|NCT01397422|80667921|FG001|Overall Study|Withdrawal by Subject|0|||
27680850|NCT01397422|80667922|FG002|Overall Study|Withdrawal by Subject|0|||
27680851|NCT01397422|80667923|FG003|Overall Study|Withdrawal by Subject|0|||
27680852|NCT01397422|80667920|FG000|Overall Study|Increased bradykinesia related to PD|1|||
27680853|NCT01397422|80667921|FG001|Overall Study|Increased bradykinesia related to PD|0|||
27680854|NCT01397422|80667922|FG002|Overall Study|Increased bradykinesia related to PD|0|||
27680855|NCT01397422|80667923|FG003|Overall Study|Increased bradykinesia related to PD|0|||
27680856|NCT03772587|80667924|FG000|Overall Study|COVID-19|0|||
27680857|NCT03772587|80667925|FG001|Overall Study|COVID-19|0|||
27680858|NCT03772587|80667926|FG002|Overall Study|COVID-19|1|||
27680859|NCT03772587|80667927|FG003|Overall Study|COVID-19|1|||
27680860|NCT03772587|80667928|FG004|Overall Study|COVID-19|0|||
27680861|NCT03772587|80667924|FG000|Overall Study|Withdrawal by Subject|1|||
27680862|NCT03772587|80667925|FG001|Overall Study|Withdrawal by Subject|0|||
27680863|NCT03772587|80667926|FG002|Overall Study|Withdrawal by Subject|0|||
27680864|NCT03772587|80667927|FG003|Overall Study|Withdrawal by Subject|0|||
27873468|NCT01891864|81368491|FG000|Treatment Period 2|Protocol Violation|0|||
27873469|NCT01891864|81368492|FG001|Treatment Period 2|Protocol Violation|0|||
27873470|NCT01891864|81368493|FG002|Treatment Period 2|Protocol Violation|0|||
27873471|NCT01891864|81368494|FG003|Treatment Period 2|Protocol Violation|1|||
27873472|NCT01891864|81368495|FG004|Treatment Period 2|Protocol Violation|0|||
27873473|NCT01891864|81368496|FG005|Treatment Period 2|Protocol Violation|0|||
27873474|NCT01891864|81368491|FG000|Treatment Period 2|Physician Decision|0|||
27999833|NCT03956550|81830778|FG000|Overall Study|Withdrawal by Subject|5|||
27999834|NCT03956550|81830779|FG001|Overall Study|Withdrawal by Subject|5|||
27999835|NCT03956550|81830780|FG002|Overall Study|Withdrawal by Subject|6|||
27999836|NCT00799266|81830783|FG000|Overall Study|Adverse Event|0|||
27999837|NCT00799266|81830784|FG001|Overall Study|Adverse Event|1|||
27999838|NCT00799266|81830783|FG000|Overall Study|Subject withdrew consent|3|||
27999839|NCT00799266|81830784|FG001|Overall Study|Subject withdrew consent|0|||
27999840|NCT03038126|81830785|FG000|Overall Study|Death|1|||
27999841|NCT03038126|81830786|FG001|Overall Study|Death|1|||
27999842|NCT03038126|81830785|FG000|Overall Study|Withdrawal by Subject|5|||
27999843|NCT03038126|81830786|FG001|Overall Study|Withdrawal by Subject|0|||
27999844|NCT03038126|81830785|FG000|Overall Study|Lost to Follow-up|0|||
27999845|NCT03038126|81830786|FG001|Overall Study|Lost to Follow-up|1|||
27999846|NCT03038126|81830785|FG000|Overall Study|Long Term Hospitalization|2|||
27999847|NCT03038126|81830786|FG001|Overall Study|Long Term Hospitalization|0|||
27999848|NCT03038126|81830785|FG000|Overall Study|Too Ill to Participate|1|||
27999849|NCT03038126|81830786|FG001|Overall Study|Too Ill to Participate|2|||
27999850|NCT04098809|81830789|FG000|Overall Study|Withdrawal by Subject|1|||
27999851|NCT04098809|81830790|FG001|Overall Study|Withdrawal by Subject|3|||
27999852|NCT04098809|81830789|FG000|Overall Study|Physician Decision|2|||
27999853|NCT04098809|81830790|FG001|Overall Study|Physician Decision|1|||
27999854|NCT01425801|81830791|FG000|Period 1|Withdrawal by Subject|0|||
27999855|NCT01425801|81830792|FG001|Period 1|Withdrawal by Subject|0|||
27999856|NCT01425801|81830793|FG002|Period 1|Withdrawal by Subject|0|||
27999857|NCT01425801|81830794|FG003|Period 1|Withdrawal by Subject|0|||
27999858|NCT01425801|81830795|FG004|Period 1|Withdrawal by Subject|1|||
27999859|NCT01425801|81830796|FG005|Period 1|Withdrawal by Subject|0|||
27999860|NCT01425801|81830791|FG000|Period 2|Withdrawal by Subject|0|||
27999861|NCT01425801|81830792|FG001|Period 2|Withdrawal by Subject|0|||
27999862|NCT01425801|81830793|FG002|Period 2|Withdrawal by Subject|0|||
27999863|NCT01425801|81830794|FG003|Period 2|Withdrawal by Subject|0|||
27999864|NCT01425801|81830795|FG004|Period 2|Withdrawal by Subject|1|||
27999865|NCT01425801|81830796|FG005|Period 2|Withdrawal by Subject|0|||
27999866|NCT01425801|81830791|FG000|Period 3|Stability criteria not fullfilled|0|||
27999867|NCT01425801|81830792|FG001|Period 3|Stability criteria not fullfilled|0|||
27999868|NCT01425801|81830793|FG002|Period 3|Stability criteria not fullfilled|1|||
27680865|NCT03772587|80667928|FG004|Overall Study|Withdrawal by Subject|0|||
27680866|NCT00338962|80667929|FG000|Overall Study|Lost to Follow-up|3|||
27680867|NCT00338962|80667930|FG001|Overall Study|Lost to Follow-up|3|||
27999869|NCT01425801|81830794|FG003|Period 3|Stability criteria not fullfilled|0|||
27999870|NCT01425801|81830795|FG004|Period 3|Stability criteria not fullfilled|0|||
27999871|NCT01425801|81830796|FG005|Period 3|Stability criteria not fullfilled|0|||
27999872|NCT01425801|81830791|FG000|Period 4|Not able to maintain visit schedule|0|||
27999873|NCT01425801|81830792|FG001|Period 4|Not able to maintain visit schedule|0|||
27999874|NCT01425801|81830793|FG002|Period 4|Not able to maintain visit schedule|1|||
27999875|NCT01425801|81830794|FG003|Period 4|Not able to maintain visit schedule|0|||
27999876|NCT01425801|81830795|FG004|Period 4|Not able to maintain visit schedule|0|||
27999877|NCT01425801|81830796|FG005|Period 4|Not able to maintain visit schedule|0|||
27999878|NCT03187132|81830797|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
27680868|NCT00338962|80667931|FG002|Overall Study|Lost to Follow-up|2|||
27873475|NCT01891864|81368492|FG001|Treatment Period 2|Physician Decision|0|||
27999879|NCT03187132|81830798|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
27999880|NCT03187132|81830797|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
27999881|NCT03187132|81830798|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
27999882|NCT03187132|81830797|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
27999883|NCT03187132|81830798|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
27999884|NCT03187132|81830797|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
27999885|NCT03187132|81830798|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
27999886|NCT03187132|81830797|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
27999887|NCT03187132|81830798|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
27999888|NCT03187132|81830797|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
27999889|NCT03187132|81830798|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
27999890|NCT03187132|81830797|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
27999891|NCT03187132|81830798|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
27999892|NCT03187132|81830797|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
27999893|NCT03187132|81830798|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
27999894|NCT03187132|81830797|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
27999895|NCT03187132|81830798|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
27999896|NCT03187132|81830797|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
27999897|NCT03187132|81830798|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
27999898|NCT03187132|81830797|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
27999899|NCT03187132|81830798|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
27999900|NCT02079038|81830799|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
27999901|NCT02079038|81830800|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
27999902|NCT02079038|81830799|FG000|Modified Intent to Treat Population|Death|1|||
27999903|NCT02079038|81830800|FG001|Modified Intent to Treat Population|Death|0|||
27999904|NCT02079038|81830799|FG000|Completed 6 Months|Lost to Follow-up|2|||
27999905|NCT02079038|81830800|FG001|Completed 6 Months|Lost to Follow-up|1|||
27999906|NCT03058692|81830801|FG000|Overall Study|Lost to Follow-up|2|||
27999907|NCT03058692|81830802|FG001|Overall Study|Lost to Follow-up|1|||
27999908|NCT03058692|81830801|FG000|Overall Study|Withdrawal by Subject|1|||
27999909|NCT03058692|81830802|FG001|Overall Study|Withdrawal by Subject|1|||
27999910|NCT00619515|81830810|FG000|Overall Study|Study Termination by IRB|73|||
27999911|NCT05051579|81830811|FG000|Overall Study|Withdrawal by Subject|3|||
27999912|NCT05051579|81830812|FG001|Overall Study|Withdrawal by Subject|5|||
27999913|NCT05051579|81830813|FG002|Overall Study|Withdrawal by Subject|2|||
27999914|NCT05051579|81830814|FG003|Overall Study|Withdrawal by Subject|1|||
27999915|NCT05051579|81830815|FG004|Overall Study|Withdrawal by Subject|4|||
27999916|NCT05051579|81830816|FG005|Overall Study|Withdrawal by Subject|0|||
27999917|NCT05051579|81830817|FG006|Overall Study|Withdrawal by Subject|4|||
27999918|NCT05051579|81830811|FG000|Overall Study|Lost to Follow-up|1|||
27999919|NCT05051579|81830812|FG001|Overall Study|Lost to Follow-up|0|||
27999920|NCT05051579|81830813|FG002|Overall Study|Lost to Follow-up|0|||
27999921|NCT05051579|81830814|FG003|Overall Study|Lost to Follow-up|0|||
27999922|NCT05051579|81830815|FG004|Overall Study|Lost to Follow-up|1|||
27999923|NCT05051579|81830816|FG005|Overall Study|Lost to Follow-up|0|||
27999924|NCT05051579|81830817|FG006|Overall Study|Lost to Follow-up|1|||
27999925|NCT05051579|81830811|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
27999926|NCT05051579|81830812|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
27999927|NCT05051579|81830813|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
27999928|NCT05051579|81830814|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
27999929|NCT05051579|81830815|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
27999930|NCT05051579|81830816|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
27999931|NCT05051579|81830817|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
27999932|NCT05051579|81830811|FG000|Overall Study|Adverse Event|2|||
27999933|NCT05051579|81830812|FG001|Overall Study|Adverse Event|1|||
27999934|NCT05051579|81830813|FG002|Overall Study|Adverse Event|0|||
27999935|NCT05051579|81830814|FG003|Overall Study|Adverse Event|4|||
27999936|NCT05051579|81830815|FG004|Overall Study|Adverse Event|1|||
27999937|NCT05051579|81830816|FG005|Overall Study|Adverse Event|2|||
27999938|NCT05051579|81830817|FG006|Overall Study|Adverse Event|0|||
27999939|NCT05051579|81830811|FG000|Overall Study|Inadvertent Enrollment|0|||
27999940|NCT05051579|81830812|FG001|Overall Study|Inadvertent Enrollment|0|||
27999941|NCT05051579|81830813|FG002|Overall Study|Inadvertent Enrollment|0|||
27999942|NCT05051579|81830814|FG003|Overall Study|Inadvertent Enrollment|0|||
27999943|NCT05051579|81830815|FG004|Overall Study|Inadvertent Enrollment|0|||
27999944|NCT05051579|81830816|FG005|Overall Study|Inadvertent Enrollment|0|||
27999945|NCT05051579|81830817|FG006|Overall Study|Inadvertent Enrollment|1|||
27999946|NCT05051579|81830811|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
27999947|NCT05051579|81830812|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
27999948|NCT05051579|81830813|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
27999949|NCT05051579|81830814|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
27581791|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
27581792|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
27999950|NCT05051579|81830815|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
27999951|NCT05051579|81830816|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
27999952|NCT05051579|81830817|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
27999953|NCT05051579|81830811|FG000|Overall Study|Sponsor Decision|0|||
27999954|NCT05051579|81830812|FG001|Overall Study|Sponsor Decision|0|||
27999955|NCT05051579|81830813|FG002|Overall Study|Sponsor Decision|0|||
27999956|NCT05051579|81830814|FG003|Overall Study|Sponsor Decision|0|||
27999957|NCT05051579|81830815|FG004|Overall Study|Sponsor Decision|1|||
27999958|NCT05051579|81830816|FG005|Overall Study|Sponsor Decision|0|||
27999959|NCT05051579|81830817|FG006|Overall Study|Sponsor Decision|0|||
27999960|NCT05051579|81830811|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
27999961|NCT05051579|81830812|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
27999962|NCT05051579|81830813|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
27999963|NCT05051579|81830814|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
27999964|NCT05051579|81830815|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
27999965|NCT05051579|81830816|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
27999966|NCT05051579|81830817|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
27999967|NCT01076959|81830819|FG000|Overall Study|Adverse Event|767|||
27999968|NCT01076959|81830819|FG000|Overall Study|Lack of Efficacy|849|||
27999969|NCT01076959|81830819|FG000|Overall Study|Non-compliance|274|||
27999970|NCT01076959|81830819|FG000|Overall Study|Lost to Follow-up|241|||
27999971|NCT01076959|81830819|FG000|Overall Study|Other|119|||
27999972|NCT03066193|81830820|FG000|Overall Study|Withdrawal by Subject|1|||
27999973|NCT00300755|81830821|FG000|Overall Study|Adverse Event|1|||
27999974|NCT00300755|81830822|FG001|Overall Study|Adverse Event|2|||
27999975|NCT00300755|81830823|FG002|Overall Study|Adverse Event|1|||
27999976|NCT00300755|81830821|FG000|Overall Study|Withdrawal by Subject|0|||
27999977|NCT00300755|81830822|FG001|Overall Study|Withdrawal by Subject|2|||
27999978|NCT00300755|81830823|FG002|Overall Study|Withdrawal by Subject|0|||
27999979|NCT00300755|81830821|FG000|Overall Study|Protocol Violation|0|||
27999980|NCT00300755|81830822|FG001|Overall Study|Protocol Violation|0|||
27999981|NCT00300755|81830823|FG002|Overall Study|Protocol Violation|1|||
27999982|NCT04378270|81830824|FG000|Overall Study|Lack of Efficacy|1|||
27999983|NCT04378270|81830824|FG000|Overall Study|Withdrawal by Subject|1|||
27999984|NCT04378270|81830824|FG000|Overall Study|Screen Failure|1|||
27999985|NCT04378270|81830824|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
27999986|NCT00671034|81830825|FG000|Overall Study|Adverse Event|5|||
27999987|NCT00671034|81830826|FG001|Overall Study|Adverse Event|7|||
27999988|NCT00671034|81830827|FG002|Overall Study|Adverse Event|1|||
27999989|NCT00671034|81830825|FG000|Overall Study|Death|3|||
27999990|NCT00671034|81830826|FG001|Overall Study|Death|2|||
27873476|NCT01891864|81368493|FG002|Treatment Period 2|Physician Decision|1|||
27873477|NCT01891864|81368494|FG003|Treatment Period 2|Physician Decision|0|||
27873478|NCT01891864|81368495|FG004|Treatment Period 2|Physician Decision|0|||
27999991|NCT00671034|81830827|FG002|Overall Study|Death|1|||
27999992|NCT00671034|81830825|FG000|Overall Study|Physician Decision|12|||
27999993|NCT00671034|81830826|FG001|Overall Study|Physician Decision|4|||
27999994|NCT00671034|81830827|FG002|Overall Study|Physician Decision|5|||
27999995|NCT00671034|81830825|FG000|Overall Study|VHR ALL feature|8|||
27999996|NCT00671034|81830826|FG001|Overall Study|VHR ALL feature|3|||
27999997|NCT00671034|81830827|FG002|Overall Study|VHR ALL feature|5|||
27999998|NCT00671034|81830825|FG000|Overall Study|Refusal|5|||
27999999|NCT00671034|81830826|FG001|Overall Study|Refusal|3|||
28000000|NCT00671034|81830827|FG002|Overall Study|Refusal|5|||
28000001|NCT00671034|81830825|FG000|Overall Study|includes Alternative therapy, etc.|6|||
28000002|NCT00671034|81830826|FG001|Overall Study|includes Alternative therapy, etc.|1|||
28000003|NCT00671034|81830827|FG002|Overall Study|includes Alternative therapy, etc.|7|||
28000004|NCT00795704|81830828|FG000|Overall Study|Withdrawal by Subject|3|||
28000005|NCT00795704|81830829|FG001|Overall Study|Withdrawal by Subject|2|||
28000006|NCT00795704|81830828|FG000|Overall Study|Adverse Event|1|||
28000007|NCT00795704|81830829|FG001|Overall Study|Adverse Event|1|||
28000008|NCT01965704|81830830|FG000|Overall Study|Withdrawal by Subject|2|||
28000009|NCT01965704|81830831|FG001|Overall Study|Withdrawal by Subject|2|||
28000010|NCT01965704|81830832|FG002|Overall Study|Withdrawal by Subject|1|||
28000011|NCT01965704|81830833|FG003|Overall Study|Withdrawal by Subject|1|||
28000012|NCT01965704|81830830|FG000|Overall Study|Delivered at home|1|||
28000013|NCT01965704|81830831|FG001|Overall Study|Delivered at home|1|||
28000014|NCT01965704|81830832|FG002|Overall Study|Delivered at home|0|||
28000015|NCT01965704|81830833|FG003|Overall Study|Delivered at home|0|||
28000016|NCT01965704|81830830|FG000|Overall Study|Experienced complications|0|||
28000017|NCT01965704|81830831|FG001|Overall Study|Experienced complications|0|||
28000018|NCT01965704|81830832|FG002|Overall Study|Experienced complications|2|||
28000019|NCT01965704|81830833|FG003|Overall Study|Experienced complications|2|||
28000020|NCT01965704|81830830|FG000|Overall Study|Adverse Event|0|||
28000021|NCT01965704|81830831|FG001|Overall Study|Adverse Event|0|||
28000022|NCT01965704|81830832|FG002|Overall Study|Adverse Event|1|||
28000023|NCT01965704|81830833|FG003|Overall Study|Adverse Event|1|||
28000024|NCT01965704|81830830|FG000|Overall Study|Did not meet inclusion criteria|0|||
28000025|NCT01965704|81830831|FG001|Overall Study|Did not meet inclusion criteria|0|||
28000026|NCT01965704|81830832|FG002|Overall Study|Did not meet inclusion criteria|1|||
28000027|NCT01965704|81830833|FG003|Overall Study|Did not meet inclusion criteria|1|||
28000028|NCT00795535|81830834|FG000|Overall Study|incomplete data and technical problems|20|||
28000029|NCT02544503|81830838|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
28000030|NCT02544503|81830839|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
28000031|NCT02544503|81830838|FG000|Overall Study|Lost to Follow-up|9|||
28000032|NCT02544503|81830839|FG001|Overall Study|Lost to Follow-up|0|||
28000033|NCT02544503|81830838|FG000|Overall Study|Withdrawal by Subject|1|||
28000034|NCT02544503|81830839|FG001|Overall Study|Withdrawal by Subject|0|||
28000035|NCT02300259|81830846|FG000|Period 1|Adverse Event|0|||
28000036|NCT02300259|81830847|FG001|Period 1|Adverse Event|0|||
28000037|NCT02300259|81830848|FG002|Period 1|Adverse Event|1|||
28000038|NCT02300259|81830846|FG000|Period 1|Withdrawal by Subject|0|||
28000039|NCT02300259|81830847|FG001|Period 1|Withdrawal by Subject|0|||
28000040|NCT02300259|81830848|FG002|Period 1|Withdrawal by Subject|1|||
28000041|NCT02300259|81830846|FG000|Period 2|Adverse Event|1|||
28000042|NCT02300259|81830847|FG001|Period 2|Adverse Event|0|||
28000043|NCT02300259|81830848|FG002|Period 2|Adverse Event|0|||
28000044|NCT02300259|81830846|FG000|Period 2|Withdrawal by Subject|0|||
28000045|NCT02300259|81830847|FG001|Period 2|Withdrawal by Subject|0|||
28000046|NCT02300259|81830848|FG002|Period 2|Withdrawal by Subject|1|||
28000047|NCT02936635|81830849|FG000|Overall Study|Adverse Event|43|||
28000048|NCT02936635|81830850|FG001|Overall Study|Adverse Event|25|||
28000049|NCT02936635|81830849|FG000|Overall Study|Progressive Disease|10|||
28000050|NCT02936635|81830850|FG001|Overall Study|Progressive Disease|18|||
28000051|NCT02936635|81830849|FG000|Overall Study|Sponsor Discretion|10|||
28000052|NCT02936635|81830850|FG001|Overall Study|Sponsor Discretion|16|||
28000053|NCT02936635|81830849|FG000|Overall Study|Death|9|||
28000054|NCT02936635|81830850|FG001|Overall Study|Death|15|||
28000055|NCT02936635|81830849|FG000|Overall Study|Withdrawal by Subject|8|||
28000056|NCT02936635|81830850|FG001|Overall Study|Withdrawal by Subject|15|||
28000057|NCT02936635|81830849|FG000|Overall Study|Physician Decision|2|||
28000058|NCT02936635|81830850|FG001|Overall Study|Physician Decision|9|||
28000059|NCT02936635|81830849|FG000|Overall Study|Lost to Follow-up|1|||
28000060|NCT02936635|81830850|FG001|Overall Study|Lost to Follow-up|2|||
28000061|NCT02936635|81830849|FG000|Overall Study|Protocol Violation|1|||
28000062|NCT02936635|81830850|FG001|Overall Study|Protocol Violation|0|||
28000063|NCT02936635|81830849|FG000|Overall Study|Lack of effect/Entry into other study|31|||
28000064|NCT02936635|81830850|FG001|Overall Study|Lack of effect/Entry into other study|65|||
28000065|NCT04073186|81830851|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
28000066|NCT04073186|81830851|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
28000067|NCT04073186|81830851|FG000|First Wearing Cycle|Protocol Violation|1|||
28000068|NCT04073186|81830851|FG000|First Wearing Cycle|Lens Discomfort|2|||
28000069|NCT04073186|81830851|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
28000070|NCT04073186|81830851|FG000|Second Wearing Cycle|Adverse Event|1|||
28000071|NCT00181766|81830852|FG000|Overall Study|Lost to Follow-up|6|||
28000072|NCT00181766|81830852|FG000|Overall Study|Adverse Event|4|||
28000073|NCT00181766|81830852|FG000|Overall Study|non-compliance|2|||
28000074|NCT01855412|81830853|FG000|Overall Study|Death|77|||
28000075|NCT01855412|81830854|FG001|Overall Study|Death|123|||
28000076|NCT01855412|81830855|FG002|Overall Study|Death|30|||
28000077|NCT01855412|81830853|FG000|Overall Study|Lost to Follow-up|28|||
28000078|NCT01855412|81830854|FG001|Overall Study|Lost to Follow-up|46|||
27581793|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27581794|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
27581795|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
27581796|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
28000079|NCT01855412|81830855|FG002|Overall Study|Lost to Follow-up|15|||
27581797|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27581798|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27581799|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
27581800|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
27581801|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
27581802|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27581803|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
27581804|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
27581805|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27581806|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27581807|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27581808|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
27581809|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
27581810|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
27581811|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581812|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581813|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
27581814|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581815|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581816|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581817|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581818|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
27581819|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
27581820|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581821|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581822|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581823|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581824|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581825|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581826|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581827|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
27581828|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
27581829|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27581830|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27581831|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
27581832|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27581833|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27581834|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27581835|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
27581836|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
27581837|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
28000080|NCT01855412|81830853|FG000|Overall Study|Withdrawal by Subject|77|||
27581838|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
28000081|NCT01855412|81830854|FG001|Overall Study|Withdrawal by Subject|123|||
28000082|NCT01855412|81830855|FG002|Overall Study|Withdrawal by Subject|24|||
28000083|NCT01855412|81830853|FG000|Overall Study|Physician Decision|25|||
28000084|NCT01855412|81830854|FG001|Overall Study|Physician Decision|31|||
27581839|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581840|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
27581841|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581842|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581843|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581844|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581845|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581846|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
27581847|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27581848|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
27581849|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27581850|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
28000085|NCT01855412|81830855|FG002|Overall Study|Physician Decision|3|||
28000086|NCT01855412|81830853|FG000|Overall Study|Site Closure|4|||
28000087|NCT01855412|81830854|FG001|Overall Study|Site Closure|18|||
28000088|NCT01855412|81830855|FG002|Overall Study|Site Closure|1|||
28000089|NCT01855412|81830853|FG000|Overall Study|Reason not Specified|1|||
28000090|NCT01855412|81830854|FG001|Overall Study|Reason not Specified|2|||
28000091|NCT01855412|81830855|FG002|Overall Study|Reason not Specified|3|||
28000092|NCT01569841|81830859|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
28000093|NCT01569841|81830860|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
28000094|NCT00286494|81830861|FG000|Overall Study|Hyperglycemic rescue|12|||
28000095|NCT00286494|81830862|FG001|Overall Study|Hyperglycemic rescue|19|||
28000096|NCT00286494|81830863|FG002|Overall Study|Hyperglycemic rescue|18|||
28000097|NCT00286494|81830861|FG000|Overall Study|Withdrawal by Subject|2|||
28000098|NCT00286494|81830862|FG001|Overall Study|Withdrawal by Subject|10|||
28000099|NCT00286494|81830863|FG002|Overall Study|Withdrawal by Subject|9|||
28000100|NCT00286494|81830861|FG000|Overall Study|Adverse Event|3|||
28000101|NCT00286494|81830862|FG001|Overall Study|Adverse Event|8|||
27581851|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27581852|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27581853|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27581854|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
27581855|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
27581856|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27581857|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
27581858|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
27581859|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27581860|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27581861|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27581862|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27581863|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
27581864|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
27581865|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581866|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581867|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
27581868|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581869|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581870|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581871|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581872|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27581873|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
27680869|NCT00338962|80667932|FG003|Overall Study|Lost to Follow-up|3|||
27680870|NCT00338962|80667929|FG000|Overall Study|Withdrawal by Subject|1|||
27680871|NCT00338962|80667930|FG001|Overall Study|Withdrawal by Subject|0|||
27680872|NCT00338962|80667931|FG002|Overall Study|Withdrawal by Subject|0|||
27680873|NCT00338962|80667932|FG003|Overall Study|Withdrawal by Subject|0|||
27680874|NCT00338962|80667929|FG000|Overall Study|No Transportation|2|||
27680875|NCT00338962|80667930|FG001|Overall Study|No Transportation|0|||
28000102|NCT00286494|81830863|FG002|Overall Study|Adverse Event|6|||
28000103|NCT00286494|81830861|FG000|Overall Study|Physician Decision|5|||
28000104|NCT00286494|81830862|FG001|Overall Study|Physician Decision|5|||
28000105|NCT00286494|81830863|FG002|Overall Study|Physician Decision|1|||
28000106|NCT00286494|81830861|FG000|Overall Study|Lost to Follow-up|3|||
28000107|NCT00286494|81830862|FG001|Overall Study|Lost to Follow-up|1|||
27680876|NCT00338962|80667931|FG002|Overall Study|No Transportation|0|||
28000108|NCT00286494|81830863|FG002|Overall Study|Lost to Follow-up|3|||
28000109|NCT00286494|81830861|FG000|Overall Study|Protocol Violation|1|||
28000110|NCT00286494|81830862|FG001|Overall Study|Protocol Violation|1|||
28000111|NCT00286494|81830863|FG002|Overall Study|Protocol Violation|2|||
28000112|NCT04393493|81830864|FG000|First 4 Days of Intervention|Early improvement|5|||
28000113|NCT04393493|81830865|FG001|First 4 Days of Intervention|Early improvement|7|||
28000114|NCT00688259|81830869|FG000|Overall Study|Lost to Follow-up|2|||
28000115|NCT00688259|81830870|FG001|Overall Study|Lost to Follow-up|4|||
28000116|NCT00688259|81830869|FG000|Overall Study|Physician Decision|1|||
28000117|NCT00688259|81830870|FG001|Overall Study|Physician Decision|0|||
28000118|NCT00688259|81830869|FG000|Overall Study|Withdrawal by Subject|2|||
28000119|NCT00688259|81830870|FG001|Overall Study|Withdrawal by Subject|0|||
28000120|NCT00688259|81830869|FG000|Overall Study|Declined Interview|2|||
28000121|NCT00688259|81830870|FG001|Overall Study|Declined Interview|3|||
28000122|NCT00688259|81830869|FG000|Overall Study|Hospitalized at Follow-up|0|||
28000123|NCT00688259|81830870|FG001|Overall Study|Hospitalized at Follow-up|1|||
28000124|NCT02098746|81830871|FG000|Overall Study|Changes of Investigator|2|||
27581874|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581875|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581876|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
27581877|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581878|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581879|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581880|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581881|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581882|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
27581883|NCT01172938|80313844|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581884|NCT01172938|80313845|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581885|NCT01172938|80313846|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581886|NCT01172938|80313847|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581887|NCT01172938|80313848|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581888|NCT01172938|80313849|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581889|NCT01172938|80313850|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
28000125|NCT02098746|81830871|FG000|Overall Study|Other Miscellaneous Reasons|1|||
28000126|NCT02098746|81830871|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
28000127|NCT02098746|81830871|FG000|Overall Study|Data Not Available After Treatment|1|||
28000128|NCT03275740|81830884|FG000|Overall Study|Adverse Event|0|||
28000129|NCT03275740|81830885|FG001|Overall Study|Adverse Event|0|||
28000130|NCT03275740|81830886|FG002|Overall Study|Adverse Event|0|||
28000131|NCT03275740|81830887|FG003|Overall Study|Adverse Event|0|||
28000132|NCT03275740|81830888|FG004|Overall Study|Adverse Event|1|||
28000133|NCT03275740|81830889|FG005|Overall Study|Adverse Event|0|||
28000134|NCT03275740|81830890|FG006|Overall Study|Adverse Event|0|||
28000135|NCT03275740|81830891|FG007|Overall Study|Adverse Event|0|||
28000136|NCT03275740|81830892|FG008|Overall Study|Adverse Event|0|||
28000137|NCT03275740|81830893|FG009|Overall Study|Adverse Event|0|||
28000138|NCT03275740|81830894|FG010|Overall Study|Adverse Event|0|||
28000139|NCT03275740|81830895|FG011|Overall Study|Adverse Event|0|||
28000140|NCT03275740|81830884|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000141|NCT03275740|81830885|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000142|NCT03275740|81830886|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000143|NCT03275740|81830887|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000144|NCT03275740|81830888|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000145|NCT03275740|81830889|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
28000146|NCT03275740|81830890|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000147|NCT03275740|81830891|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000148|NCT03275740|81830892|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000149|NCT03275740|81830893|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000150|NCT03275740|81830894|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
27581890|NCT01172938|80313851|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
27581891|NCT01172938|80313852|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
27581892|NCT03268811|80313856|FG000|Overall Study|Adverse Event|0|||
27581893|NCT03268811|80313857|FG001|Overall Study|Adverse Event|1|||
28000151|NCT03275740|81830895|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
28000152|NCT03275740|81830884|FG000|Overall Study|Withdrawal by Subject|0|||
27680877|NCT00338962|80667932|FG003|Overall Study|No Transportation|0|||
28000153|NCT03275740|81830885|FG001|Overall Study|Withdrawal by Subject|0|||
28000154|NCT03275740|81830886|FG002|Overall Study|Withdrawal by Subject|0|||
27873479|NCT01891864|81368496|FG005|Treatment Period 2|Physician Decision|0|||
27873480|NCT01891864|81368491|FG000|Treatment Period 2|Site Termination|0|||
27873481|NCT01891864|81368492|FG001|Treatment Period 2|Site Termination|0|||
27873482|NCT01891864|81368493|FG002|Treatment Period 2|Site Termination|1|||
27873483|NCT01891864|81368494|FG003|Treatment Period 2|Site Termination|2|||
27873484|NCT01891864|81368495|FG004|Treatment Period 2|Site Termination|0|||
27873485|NCT01891864|81368496|FG005|Treatment Period 2|Site Termination|0|||
27873486|NCT01891864|81368491|FG000|Treatment Period 2|Lack of Efficacy|0|||
27873487|NCT01891864|81368492|FG001|Treatment Period 2|Lack of Efficacy|0|||
27873488|NCT01891864|81368493|FG002|Treatment Period 2|Lack of Efficacy|1|||
27873489|NCT01891864|81368494|FG003|Treatment Period 2|Lack of Efficacy|0|||
27873490|NCT01891864|81368495|FG004|Treatment Period 2|Lack of Efficacy|1|||
27873491|NCT01891864|81368496|FG005|Treatment Period 2|Lack of Efficacy|0|||
27873492|NCT01891864|81368491|FG000|Treatment Period 2|Adverse Event|0|||
27873493|NCT01891864|81368492|FG001|Treatment Period 2|Adverse Event|0|||
27873494|NCT01891864|81368493|FG002|Treatment Period 2|Adverse Event|1|||
27873495|NCT01891864|81368494|FG003|Treatment Period 2|Adverse Event|2|||
27873496|NCT01891864|81368495|FG004|Treatment Period 2|Adverse Event|0|||
27873497|NCT01891864|81368496|FG005|Treatment Period 2|Adverse Event|4|||
27873498|NCT01891864|81368491|FG000|Treatment Period 2|Termination of Site|0|||
27873499|NCT01891864|81368492|FG001|Treatment Period 2|Termination of Site|0|||
27873500|NCT01891864|81368493|FG002|Treatment Period 2|Termination of Site|0|||
27873501|NCT01891864|81368494|FG003|Treatment Period 2|Termination of Site|0|||
27873502|NCT01891864|81368495|FG004|Treatment Period 2|Termination of Site|2|||
27873503|NCT01891864|81368496|FG005|Treatment Period 2|Termination of Site|0|||
27873504|NCT01891864|81368491|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27873505|NCT01891864|81368492|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27873506|NCT01891864|81368493|FG002|Treatment Period 2|Withdrawal by Subject|3|||
27873507|NCT01891864|81368494|FG003|Treatment Period 2|Withdrawal by Subject|4|||
27873508|NCT01891864|81368495|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27873509|NCT01891864|81368496|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27873510|NCT01891864|81368491|FG000|Extension Period|Lack of Efficacy|0|||
28000155|NCT03275740|81830887|FG003|Overall Study|Withdrawal by Subject|0|||
28000156|NCT03275740|81830888|FG004|Overall Study|Withdrawal by Subject|0|||
28000157|NCT03275740|81830889|FG005|Overall Study|Withdrawal by Subject|0|||
28000158|NCT03275740|81830890|FG006|Overall Study|Withdrawal by Subject|0|||
28000159|NCT03275740|81830891|FG007|Overall Study|Withdrawal by Subject|0|||
28000160|NCT03275740|81830892|FG008|Overall Study|Withdrawal by Subject|1|||
28000161|NCT03275740|81830893|FG009|Overall Study|Withdrawal by Subject|1|||
28000162|NCT03275740|81830894|FG010|Overall Study|Withdrawal by Subject|0|||
28000163|NCT03275740|81830895|FG011|Overall Study|Withdrawal by Subject|0|||
28000164|NCT00483405|81830899|FG000|Overall Study|Adverse Event|8|||
28000165|NCT00483405|81830899|FG000|Overall Study|Lack of Efficacy|14|||
28000166|NCT00483405|81830899|FG000|Overall Study|Death|3|||
28000167|NCT00483405|81830899|FG000|Overall Study|Withdrawal by Subject|2|||
28000168|NCT00483405|81830899|FG000|Overall Study|Other complicating disease|1|||
27873511|NCT01891864|81368492|FG001|Extension Period|Lack of Efficacy|0|||
27873512|NCT01891864|81368493|FG002|Extension Period|Lack of Efficacy|0|||
28000169|NCT00920855|81830900|FG000|Overall Study|Adverse Event|1|||
27873513|NCT01891864|81368494|FG003|Extension Period|Lack of Efficacy|1|||
27873514|NCT01891864|81368495|FG004|Extension Period|Lack of Efficacy|1|||
27873515|NCT01891864|81368496|FG005|Extension Period|Lack of Efficacy|0|||
27873516|NCT01891864|81368491|FG000|Extension Period|Pregnancy|0|||
27873517|NCT01891864|81368492|FG001|Extension Period|Pregnancy|0|||
27873518|NCT01891864|81368493|FG002|Extension Period|Pregnancy|1|||
27873519|NCT01891864|81368494|FG003|Extension Period|Pregnancy|0|||
27873520|NCT01891864|81368495|FG004|Extension Period|Pregnancy|0|||
27680878|NCT00338962|80667929|FG000|Overall Study|Time Constraint|2|||
27805579|NCT00219557|81120337|FG001|Phase 1|Withdrawal by Subject|0|||
27873521|NCT01891864|81368496|FG005|Extension Period|Pregnancy|0|||
27873522|NCT01891864|81368491|FG000|Extension Period|Adverse Event|0|||
27873523|NCT01891864|81368492|FG001|Extension Period|Adverse Event|0|||
27873524|NCT01891864|81368493|FG002|Extension Period|Adverse Event|4|||
27873525|NCT01891864|81368494|FG003|Extension Period|Adverse Event|2|||
27873526|NCT01891864|81368495|FG004|Extension Period|Adverse Event|2|||
27873527|NCT01891864|81368496|FG005|Extension Period|Adverse Event|0|||
27873528|NCT01891864|81368491|FG000|Extension Period|Withdrawal by Subject|0|||
27873529|NCT01891864|81368492|FG001|Extension Period|Withdrawal by Subject|0|||
27873530|NCT01891864|81368493|FG002|Extension Period|Withdrawal by Subject|1|||
27873531|NCT01891864|81368494|FG003|Extension Period|Withdrawal by Subject|2|||
27873532|NCT01891864|81368495|FG004|Extension Period|Withdrawal by Subject|4|||
27873533|NCT01891864|81368496|FG005|Extension Period|Withdrawal by Subject|0|||
27873534|NCT01891864|81368491|FG000|Extension Period|Lost to Follow-up|0|||
27873535|NCT01891864|81368492|FG001|Extension Period|Lost to Follow-up|0|||
27873536|NCT01891864|81368493|FG002|Extension Period|Lost to Follow-up|2|||
27873537|NCT01891864|81368494|FG003|Extension Period|Lost to Follow-up|0|||
27873538|NCT01891864|81368495|FG004|Extension Period|Lost to Follow-up|0|||
27873539|NCT01891864|81368496|FG005|Extension Period|Lost to Follow-up|0|||
27873540|NCT02738138|81368497|FG000|Overall Study|Adverse Event|0|||
27873541|NCT02738138|81368498|FG001|Overall Study|Adverse Event|1|||
27873542|NCT02738138|81368497|FG000|Overall Study|Lost to Follow-up|2|||
27873543|NCT02738138|81368498|FG001|Overall Study|Lost to Follow-up|0|||
27805580|NCT00219557|81120338|FG002|Phase 1|Withdrawal by Subject|0|||
27805581|NCT00219557|81120336|FG000|Phase 1|Started chemotherapy at other institute|1|||
27805582|NCT00219557|81120337|FG001|Phase 1|Started chemotherapy at other institute|0|||
27805583|NCT00219557|81120338|FG002|Phase 1|Started chemotherapy at other institute|0|||
27805584|NCT00219557|81120336|FG000|Phase 2|Lack of Efficacy|0|||
27680879|NCT00338962|80667930|FG001|Overall Study|Time Constraint|0|||
27805585|NCT00219557|81120337|FG001|Phase 2|Lack of Efficacy|21|||
27873544|NCT02738138|81368497|FG000|Overall Study|Other - not further specified|1|||
27873545|NCT02738138|81368498|FG001|Overall Study|Other - not further specified|0|||
27873546|NCT03411863|81368499|FG000|Overall Study|Withdrawal by Subject|3|||
27873547|NCT03411863|81368500|FG001|Overall Study|Withdrawal by Subject|1|||
27873548|NCT03411863|81368499|FG000|Overall Study|Physician Decision|0|||
27873549|NCT03411863|81368500|FG001|Overall Study|Physician Decision|1|||
27805586|NCT00219557|81120338|FG002|Phase 2|Lack of Efficacy|15|||
27873550|NCT01213966|81368501|FG000|Overall Study|Protocol Violation|1|||
27873551|NCT01213966|81368502|FG001|Overall Study|Protocol Violation|0|||
27873552|NCT01213966|81368503|FG002|Overall Study|Protocol Violation|3|||
27873553|NCT01213966|81368504|FG003|Overall Study|Protocol Violation|1|||
27873554|NCT00116779|81368505|FG000|Overall Study|Adverse Event|4|||
27873555|NCT00116779|81368506|FG001|Overall Study|Adverse Event|2|||
27873556|NCT00116779|81368505|FG000|Overall Study|Protocol Violation|1|||
27873557|NCT00116779|81368506|FG001|Overall Study|Protocol Violation|4|||
27873558|NCT00116779|81368505|FG000|Overall Study|Withdrawal by Subject|4|||
27873559|NCT00116779|81368506|FG001|Overall Study|Withdrawal by Subject|1|||
27873560|NCT00116779|81368505|FG000|Overall Study|Inadequate testosterone suppression|7|||
27873561|NCT00116779|81368506|FG001|Overall Study|Inadequate testosterone suppression|9|||
27873562|NCT00116779|81368505|FG000|Overall Study|Physician Decision|3|||
27873563|NCT00116779|81368506|FG001|Overall Study|Physician Decision|1|||
27873564|NCT00116779|81368505|FG000|Overall Study|Elevated PSA levels|2|||
27873565|NCT00116779|81368506|FG001|Overall Study|Elevated PSA levels|2|||
27873566|NCT00450437|81368507|FG000|Overall Study|Withdrawal by Subject|10|||
27873567|NCT00450437|81368508|FG001|Overall Study|Withdrawal by Subject|2|||
27873568|NCT00450437|81368509|FG002|Overall Study|Withdrawal by Subject|0|||
27873569|NCT00450437|81368510|FG003|Overall Study|Withdrawal by Subject|1|||
27873570|NCT00450437|81368507|FG000|Overall Study|Lost to Follow-up|31|||
27873571|NCT00450437|81368508|FG001|Overall Study|Lost to Follow-up|12|||
27873572|NCT00450437|81368509|FG002|Overall Study|Lost to Follow-up|19|||
27873573|NCT00450437|81368510|FG003|Overall Study|Lost to Follow-up|9|||
27873574|NCT00450437|81368507|FG000|Overall Study|Protocol Violation|0|||
27873575|NCT00450437|81368508|FG001|Overall Study|Protocol Violation|1|||
27873576|NCT00450437|81368509|FG002|Overall Study|Protocol Violation|0|||
27873577|NCT00450437|81368510|FG003|Overall Study|Protocol Violation|1|||
27873578|NCT00450437|81368507|FG000|Overall Study|Inappropriate enrollment|4|||
27873579|NCT00450437|81368508|FG001|Overall Study|Inappropriate enrollment|1|||
27873580|NCT00450437|81368509|FG002|Overall Study|Inappropriate enrollment|3|||
28000170|NCT00920855|81830901|FG001|Overall Study|Adverse Event|1|||
28000171|NCT00920855|81830902|FG002|Overall Study|Adverse Event|4|||
28000172|NCT00920855|81830900|FG000|Overall Study|Withdrawal by Subject|2|||
28000173|NCT00920855|81830901|FG001|Overall Study|Withdrawal by Subject|1|||
27873581|NCT00450437|81368510|FG003|Overall Study|Inappropriate enrollment|0|||
27873582|NCT00450437|81368507|FG000|Overall Study|Administrative reason|0|||
27873583|NCT00450437|81368508|FG001|Overall Study|Administrative reason|0|||
27873584|NCT00450437|81368509|FG002|Overall Study|Administrative reason|1|||
27873585|NCT00450437|81368510|FG003|Overall Study|Administrative reason|0|||
27873586|NCT00450437|81368507|FG000|Overall Study|Unable to Classify|1|||
27873587|NCT00450437|81368508|FG001|Overall Study|Unable to Classify|0|||
27873588|NCT00450437|81368509|FG002|Overall Study|Unable to Classify|1|||
27873589|NCT00450437|81368510|FG003|Overall Study|Unable to Classify|0|||
27873590|NCT00764881|81368511|FG000|Overall Study|Adverse Event|5|||
27873591|NCT00764881|81368512|FG001|Overall Study|Adverse Event|1|||
27873592|NCT00764881|81368511|FG000|Overall Study|Withdrawal by Subject|1|||
27873593|NCT00764881|81368512|FG001|Overall Study|Withdrawal by Subject|3|||
27873594|NCT00764881|81368511|FG000|Overall Study|Protocol Violation|2|||
27873595|NCT00764881|81368512|FG001|Overall Study|Protocol Violation|2|||
27873596|NCT00764881|81368511|FG000|Overall Study|Lost to Follow-up|2|||
27873597|NCT00764881|81368512|FG001|Overall Study|Lost to Follow-up|0|||
27873598|NCT00764881|81368511|FG000|Overall Study|Noncompliant|1|||
28000174|NCT00920855|81830902|FG002|Overall Study|Withdrawal by Subject|6|||
28000175|NCT00920855|81830900|FG000|Overall Study|Disease progression|2|||
28000176|NCT00920855|81830901|FG001|Overall Study|Disease progression|1|||
28000177|NCT00920855|81830902|FG002|Overall Study|Disease progression|10|||
28000178|NCT00920855|81830900|FG000|Overall Study|Noncompliance to study medication|0|||
28000179|NCT00920855|81830901|FG001|Overall Study|Noncompliance to study medication|0|||
28000180|NCT00920855|81830902|FG002|Overall Study|Noncompliance to study medication|1|||
28000181|NCT00920855|81830900|FG000|Overall Study|Response plateau; started maintenance|0|||
28000182|NCT00920855|81830901|FG001|Overall Study|Response plateau; started maintenance|0|||
28000183|NCT00920855|81830902|FG002|Overall Study|Response plateau; started maintenance|1|||
27680880|NCT00338962|80667931|FG002|Overall Study|Time Constraint|0|||
27873599|NCT00764881|81368512|FG001|Overall Study|Noncompliant|0|||
27873600|NCT00764881|81368511|FG000|Overall Study|Accidentally discontinued study drug|1|||
27873601|NCT00764881|81368512|FG001|Overall Study|Accidentally discontinued study drug|0|||
27873602|NCT00764881|81368511|FG000|Overall Study|Wished to become pregnant|1|||
27873603|NCT00764881|81368512|FG001|Overall Study|Wished to become pregnant|0|||
27873604|NCT00764881|81368511|FG000|Overall Study|Carcinoma detected|1|||
27873605|NCT00764881|81368512|FG001|Overall Study|Carcinoma detected|0|||
27873606|NCT00764881|81368511|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
27873607|NCT00764881|81368512|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
28000184|NCT02510001|81830903|FG000|Overall Study|Early disease progression|0|||
28000185|NCT02510001|81830904|FG001|Overall Study|Early disease progression|0|||
28000186|NCT02510001|81830905|FG002|Overall Study|Early disease progression|0|||
28000187|NCT02510001|81830906|FG003|Overall Study|Early disease progression|1|||
28000188|NCT02510001|81830907|FG004|Overall Study|Early disease progression|1|||
28000189|NCT02510001|81830908|FG005|Overall Study|Early disease progression|1|||
28000190|NCT02510001|81830909|FG006|Overall Study|Early disease progression|0|||
28000191|NCT02510001|81830910|FG007|Overall Study|Early disease progression|0|||
28000192|NCT02510001|81830903|FG000|Overall Study|Adverse Event|0|||
28000193|NCT02510001|81830904|FG001|Overall Study|Adverse Event|0|||
28000194|NCT02510001|81830905|FG002|Overall Study|Adverse Event|0|||
28000195|NCT02510001|81830906|FG003|Overall Study|Adverse Event|1|||
28000196|NCT02510001|81830907|FG004|Overall Study|Adverse Event|2|||
28000197|NCT02510001|81830908|FG005|Overall Study|Adverse Event|1|||
28000198|NCT02510001|81830909|FG006|Overall Study|Adverse Event|2|||
28000199|NCT02510001|81830910|FG007|Overall Study|Adverse Event|5|||
28000200|NCT02510001|81830903|FG000|Overall Study|Physician Decision|0|||
28000201|NCT02510001|81830904|FG001|Overall Study|Physician Decision|0|||
28000202|NCT02510001|81830905|FG002|Overall Study|Physician Decision|0|||
28000203|NCT02510001|81830906|FG003|Overall Study|Physician Decision|0|||
27805587|NCT00219557|81120336|FG000|Phase 2|Adverse Event|0|||
27805588|NCT00219557|81120337|FG001|Phase 2|Adverse Event|22|||
27805589|NCT00219557|81120338|FG002|Phase 2|Adverse Event|2|||
27805590|NCT00219557|81120336|FG000|Phase 2|Death|0|||
27805591|NCT00219557|81120337|FG001|Phase 2|Death|8|||
27805592|NCT00219557|81120338|FG002|Phase 2|Death|2|||
27805593|NCT00219557|81120336|FG000|Phase 2|Other|0|||
27805594|NCT00219557|81120337|FG001|Phase 2|Other|8|||
27805595|NCT00219557|81120338|FG002|Phase 2|Other|6|||
27805596|NCT00219557|81120336|FG000|Phase 2|Withdrawal by Subject|0|||
27873608|NCT00764881|81368511|FG000|Overall Study|no treatment or no observation|2|||
27873609|NCT00764881|81368512|FG001|Overall Study|no treatment or no observation|2|||
28000204|NCT02510001|81830907|FG004|Overall Study|Physician Decision|1|||
28000205|NCT02510001|81830908|FG005|Overall Study|Physician Decision|0|||
28000206|NCT02510001|81830909|FG006|Overall Study|Physician Decision|0|||
27581894|NCT01669343|80313864|FG000|Part A: All Patients|Withdrawal by Subject|7|||
27873610|NCT00129389|81368517|FG000|Overall Study|Adverse Event|19|||
27873611|NCT00129389|81368518|FG001|Overall Study|Adverse Event|87|||
27873612|NCT00129389|81368517|FG000|Overall Study|Death|0|||
27873613|NCT00129389|81368518|FG001|Overall Study|Death|1|||
27873614|NCT00129389|81368517|FG000|Overall Study|Lost to Follow-up|2|||
27873615|NCT00129389|81368518|FG001|Overall Study|Lost to Follow-up|1|||
27873616|NCT00129389|81368517|FG000|Overall Study|Physician Decision|0|||
27873617|NCT00129389|81368518|FG001|Overall Study|Physician Decision|4|||
27873618|NCT00129389|81368517|FG000|Overall Study|Protocol Violation|0|||
27873619|NCT00129389|81368518|FG001|Overall Study|Protocol Violation|6|||
27873620|NCT00129389|81368517|FG000|Overall Study|Withdrawal by Subject|9|||
27873621|NCT00129389|81368518|FG001|Overall Study|Withdrawal by Subject|23|||
27873622|NCT00129389|81368517|FG000|Overall Study|Relapse|1|||
27873623|NCT00129389|81368518|FG001|Overall Study|Relapse|0|||
27873624|NCT00129389|81368517|FG000|Overall Study|Not eligible|1|||
27873625|NCT00129389|81368518|FG001|Overall Study|Not eligible|2|||
27873626|NCT00129389|81368517|FG000|Overall Study|Crossed to the other arm|1|||
27873627|NCT00129389|81368518|FG001|Overall Study|Crossed to the other arm|16|||
27873628|NCT00682786|81368522|FG000|Overall Study|Withdrawal by Subject|2|||
27873629|NCT00682786|81368523|FG001|Overall Study|Withdrawal by Subject|2|||
27873630|NCT00682786|81368522|FG000|Overall Study|Did not receive irinotecan|0|||
27873631|NCT00682786|81368523|FG001|Overall Study|Did not receive irinotecan|1|||
27873632|NCT01977417|81368524|FG000|Overall Study|Adverse Event|1|||
28000207|NCT02510001|81830910|FG007|Overall Study|Physician Decision|0|||
28000208|NCT02510001|81830903|FG000|Overall Study|Withdrawal by Subject|0|||
28000209|NCT02510001|81830904|FG001|Overall Study|Withdrawal by Subject|0|||
27581895|NCT01669343|80313864|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
28000210|NCT02510001|81830905|FG002|Overall Study|Withdrawal by Subject|0|||
28000211|NCT02510001|81830906|FG003|Overall Study|Withdrawal by Subject|0|||
28000212|NCT02510001|81830907|FG004|Overall Study|Withdrawal by Subject|0|||
28000213|NCT02510001|81830908|FG005|Overall Study|Withdrawal by Subject|0|||
28000214|NCT02510001|81830909|FG006|Overall Study|Withdrawal by Subject|0|||
27805597|NCT00219557|81120337|FG001|Phase 2|Withdrawal by Subject|9|||
27873633|NCT01977417|81368525|FG001|Overall Study|Adverse Event|0|||
27873634|NCT01977417|81368524|FG000|Overall Study|Withdrawal by Subject|2|||
27873635|NCT01977417|81368525|FG001|Overall Study|Withdrawal by Subject|4|||
27873636|NCT01977417|81368524|FG000|Overall Study|Female enrollment goal met|0|||
27873637|NCT01977417|81368525|FG001|Overall Study|Female enrollment goal met|2|||
27873638|NCT05317312|81368527|FG000|Overall Study|Withdrawal by Subject|0|||
27805598|NCT00219557|81120338|FG002|Phase 2|Withdrawal by Subject|5|||
27805599|NCT00219557|81120336|FG000|Phase 2|Treatment not received|0|||
27873639|NCT05317312|81368528|FG001|Overall Study|Withdrawal by Subject|1|||
27873640|NCT05317312|81368529|FG002|Overall Study|Withdrawal by Subject|0|||
27873641|NCT05317312|81368530|FG003|Overall Study|Withdrawal by Subject|0|||
27873642|NCT05317312|81368527|FG000|Overall Study|Lost to Follow-up|0|||
27873643|NCT05317312|81368528|FG001|Overall Study|Lost to Follow-up|0|||
27873644|NCT05317312|81368529|FG002|Overall Study|Lost to Follow-up|0|||
27873645|NCT05317312|81368530|FG003|Overall Study|Lost to Follow-up|1|||
27873646|NCT05317312|81368527|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
27873647|NCT05317312|81368528|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
27873648|NCT05317312|81368529|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
27873649|NCT05317312|81368530|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
27873650|NCT01431079|81368531|FG000|Overall Study|Lost to Follow-up|35|||
27873651|NCT01431079|81368532|FG001|Overall Study|Lost to Follow-up|39|||
27873652|NCT03591874|81368535|FG000|Overall Study|Adverse Event|4|||
27581896|NCT01669343|80313864|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
27581897|NCT01669343|80313864|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
27581898|NCT01669343|80313864|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
27581899|NCT01148810|80313865|FG000|Overall Study|Adverse Event|0|||
27581900|NCT01148810|80313866|FG001|Overall Study|Adverse Event|2|||
27581901|NCT01148810|80313865|FG000|Overall Study|Lack of Efficacy|0|||
27581902|NCT01148810|80313866|FG001|Overall Study|Lack of Efficacy|1|||
27581903|NCT01148810|80313865|FG000|Overall Study|Withdrawal by Subject|0|||
27581904|NCT01148810|80313866|FG001|Overall Study|Withdrawal by Subject|2|||
27581905|NCT01148810|80313865|FG000|Overall Study|Protocol Violation|1|||
27873653|NCT03591874|81368536|FG001|Overall Study|Adverse Event|0|||
27873654|NCT03591874|81368535|FG000|Overall Study|Withdrawal by Subject|2|||
27581906|NCT01148810|80313866|FG001|Overall Study|Protocol Violation|0|||
27873655|NCT03591874|81368536|FG001|Overall Study|Withdrawal by Subject|1|||
27873656|NCT03591874|81368535|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
27873657|NCT03591874|81368536|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
27873658|NCT03591874|81368535|FG000|Overall Study|On Study at Time of Study Termination|12|||
27873659|NCT03591874|81368536|FG001|Overall Study|On Study at Time of Study Termination|6|||
27873660|NCT02654054|81368537|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
27873661|NCT02654054|81368538|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
27873662|NCT02654054|81368539|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
27873663|NCT02654054|81368537|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
27873664|NCT02654054|81368538|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27873665|NCT02654054|81368539|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
27873666|NCT02654054|81368537|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
27873667|NCT02654054|81368538|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
27873668|NCT02654054|81368539|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
27873669|NCT02654054|81368537|FG000|Post-Treatment Follow-Up Period|Other|1|||
27873670|NCT02654054|81368538|FG001|Post-Treatment Follow-Up Period|Other|0|||
27873671|NCT02654054|81368539|FG002|Post-Treatment Follow-Up Period|Other|4|||
27873672|NCT02654054|81368537|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
27873673|NCT02654054|81368538|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
27873674|NCT02654054|81368539|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
27873675|NCT00882518|81371514|FG000|Overall Study|Adverse Event|9|||
27873676|NCT00882518|81371515|FG001|Overall Study|Adverse Event|18|||
27873677|NCT00882518|81371514|FG000|Overall Study|Withdrawal by Subject|9|||
27873678|NCT00882518|81371515|FG001|Overall Study|Withdrawal by Subject|13|||
27873679|NCT00882518|81371514|FG000|Overall Study|Lack of Efficacy|12|||
27873680|NCT00882518|81371515|FG001|Overall Study|Lack of Efficacy|9|||
27873681|NCT00882518|81371514|FG000|Overall Study|Severe non-compliance to protocol|3|||
27873682|NCT00882518|81371515|FG001|Overall Study|Severe non-compliance to protocol|1|||
27873683|NCT00882518|81371514|FG000|Overall Study|Incorrect enrolment|4|||
27873684|NCT00882518|81371515|FG001|Overall Study|Incorrect enrolment|2|||
27873685|NCT00882518|81371514|FG000|Overall Study|Central lab closure for National day|1|||
27873686|NCT00882518|81371515|FG001|Overall Study|Central lab closure for National day|0|||
27873687|NCT00882518|81371514|FG000|Overall Study|Allocating random number by mistake|0|||
27873688|NCT00882518|81371515|FG001|Overall Study|Allocating random number by mistake|1|||
27873689|NCT02038010|81371516|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
27873690|NCT02038010|81371517|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
27873691|NCT02038010|81371518|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
27873692|NCT02038010|81371519|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
27873693|NCT02038010|81371516|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
27873694|NCT02038010|81371517|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
27873695|NCT02038010|81371518|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
27873696|NCT02038010|81371519|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
27873697|NCT02038010|81371516|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
27873698|NCT02038010|81371517|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
27873699|NCT02038010|81371518|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
27873700|NCT02038010|81371519|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
27873701|NCT02038010|81371516|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
27873702|NCT02038010|81371517|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
27873703|NCT02038010|81371518|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
27873704|NCT02038010|81371519|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
27873705|NCT02038010|81371516|FG000|Follow Up|Death|4|||
27873706|NCT02038010|81371517|FG001|Follow Up|Death|3|||
27873707|NCT02038010|81371518|FG002|Follow Up|Death|0|||
27873708|NCT02038010|81371519|FG003|Follow Up|Death|0|||
27873709|NCT02038010|81371516|FG000|Follow Up|Other|3|||
27873710|NCT02038010|81371517|FG001|Follow Up|Other|0|||
27873711|NCT02038010|81371518|FG002|Follow Up|Other|0|||
27873712|NCT02038010|81371519|FG003|Follow Up|Other|0|||
27873713|NCT00634036|81371525|FG000|Overall Study|Lost to Follow-up|1|||
27873714|NCT00634036|81371526|FG001|Overall Study|Lost to Follow-up|1|||
27873715|NCT00634036|81371525|FG000|Overall Study|Withdrawal by Subject|1|||
27873716|NCT00634036|81371526|FG001|Overall Study|Withdrawal by Subject|1|||
27873717|NCT01753999|81371532|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
27873718|NCT01753999|81371533|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
27873719|NCT01753999|81371532|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
27581907|NCT01877421|80313867|FG000|Phase 2|Lost to Follow-up|0|||
27581908|NCT01877421|80313868|FG001|Phase 2|Lost to Follow-up|0|||
27581909|NCT01877421|80313869|FG002|Phase 2|Lost to Follow-up|0|||
27581910|NCT01877421|80313870|FG003|Phase 2|Lost to Follow-up|0|||
27581911|NCT01877421|80313871|FG004|Phase 2|Lost to Follow-up|0|||
27581912|NCT01877421|80313872|FG005|Phase 2|Lost to Follow-up|0|||
27581913|NCT01877421|80313873|FG006|Phase 2|Lost to Follow-up|1|||
27581914|NCT01877421|80313874|FG007|Phase 2|Lost to Follow-up|0|||
27581915|NCT01877421|80313875|FG008|Phase 2|Lost to Follow-up|0|||
27581916|NCT01877421|80313876|FG009|Phase 2|Lost to Follow-up|0|||
27581917|NCT01877421|80313877|FG010|Phase 2|Lost to Follow-up|0|||
27581918|NCT01877421|80313878|FG011|Phase 2|Lost to Follow-up|0|||
27581919|NCT01877421|80313879|FG012|Phase 2|Lost to Follow-up|0|||
27581920|NCT01877421|80313880|FG013|Phase 2|Lost to Follow-up|0|||
27805600|NCT00219557|81120337|FG001|Phase 2|Treatment not received|1|||
27805601|NCT00219557|81120338|FG002|Phase 2|Treatment not received|3|||
27805602|NCT01835132|81120340|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
27805603|NCT00068237|81120341|FG000|Overall Study|Ineligible|3|||
27805604|NCT00068237|81120341|FG000|Overall Study|No protocol treatment received|2|||
27805605|NCT03769181|81120342|FG000|Overall Study|Adverse Event|1|||
27805606|NCT03769181|81120343|FG001|Overall Study|Adverse Event|0|||
27805607|NCT03769181|81120344|FG002|Overall Study|Adverse Event|2|||
27805608|NCT03769181|81120345|FG003|Overall Study|Adverse Event|4|||
27581921|NCT01877421|80313881|FG014|Phase 2|Lost to Follow-up|0|||
27581922|NCT01877421|80313882|FG015|Phase 2|Lost to Follow-up|0|||
27581923|NCT01877421|80313883|FG016|Phase 2|Lost to Follow-up|0|||
27581924|NCT01877421|80313884|FG017|Phase 2|Lost to Follow-up|0|||
27581925|NCT01877421|80313867|FG000|Phase 2|Withdrawal by Subject|0|||
27805609|NCT03769181|81120342|FG000|Overall Study|Withdrawal by Subject|1|||
27805610|NCT03769181|81120343|FG001|Overall Study|Withdrawal by Subject|0|||
27805611|NCT03769181|81120344|FG002|Overall Study|Withdrawal by Subject|2|||
27805612|NCT03769181|81120345|FG003|Overall Study|Withdrawal by Subject|1|||
27805613|NCT03769181|81120342|FG000|Overall Study|Progressive disease|9|||
27805614|NCT03769181|81120343|FG001|Overall Study|Progressive disease|7|||
27805615|NCT03769181|81120344|FG002|Overall Study|Progressive disease|13|||
27805616|NCT03769181|81120345|FG003|Overall Study|Progressive disease|6|||
27805617|NCT03769181|81120342|FG000|Overall Study|Other - Unspecified|2|||
27805618|NCT03769181|81120343|FG001|Overall Study|Other - Unspecified|1|||
27805619|NCT03769181|81120344|FG002|Overall Study|Other - Unspecified|0|||
27805620|NCT03769181|81120345|FG003|Overall Study|Other - Unspecified|0|||
27805621|NCT00373685|81120350|FG000|Overall Study|Death|2|||
27805622|NCT00373685|81120351|FG001|Overall Study|Death|1|||
27805623|NCT00373685|81120350|FG000|Overall Study|Adverse Event|278|||
27805624|NCT00373685|81120351|FG001|Overall Study|Adverse Event|253|||
27805625|NCT00373685|81120350|FG000|Overall Study|Insufficient clinical response|169|||
27805626|NCT00373685|81120351|FG001|Overall Study|Insufficient clinical response|119|||
27805627|NCT00373685|81120350|FG000|Overall Study|Did not meet entrance criteria|167|||
27805628|NCT00373685|81120351|FG001|Overall Study|Did not meet entrance criteria|184|||
27805629|NCT00373685|81120350|FG000|Overall Study|Lost to follow up|83|||
27805630|NCT00373685|81120351|FG001|Overall Study|Lost to follow up|103|||
27805631|NCT00373685|81120350|FG000|Overall Study|No longer willing to participate|337|||
27805632|NCT00373685|81120351|FG001|Overall Study|No longer willing to participate|352|||
27805633|NCT00373685|81120350|FG000|Overall Study|Other|149|||
27805634|NCT00373685|81120351|FG001|Overall Study|Other|146|||
27805635|NCT00373685|81120350|FG000|Overall Study|Protocol Violation|191|||
27805636|NCT00373685|81120351|FG001|Overall Study|Protocol Violation|182|||
27805637|NCT00373685|81120350|FG000|Overall Study|Final Status Unknown|12|||
27805638|NCT00373685|81120351|FG001|Overall Study|Final Status Unknown|4|||
27805639|NCT00373685|81120350|FG000|Overall Study|Randomized, not treated|51|||
27805640|NCT00373685|81120351|FG001|Overall Study|Randomized, not treated|77|||
27581926|NCT01877421|80313868|FG001|Phase 2|Withdrawal by Subject|0|||
27581927|NCT01877421|80313869|FG002|Phase 2|Withdrawal by Subject|0|||
27581928|NCT01877421|80313870|FG003|Phase 2|Withdrawal by Subject|0|||
27581929|NCT01877421|80313871|FG004|Phase 2|Withdrawal by Subject|0|||
27581930|NCT01877421|80313872|FG005|Phase 2|Withdrawal by Subject|0|||
27581931|NCT01877421|80313873|FG006|Phase 2|Withdrawal by Subject|0|||
27805641|NCT02725671|81120355|FG000|Overall Study|Lost to Follow-up|1|||
27581932|NCT01877421|80313874|FG007|Phase 2|Withdrawal by Subject|0|||
27581933|NCT01877421|80313875|FG008|Phase 2|Withdrawal by Subject|1|||
27581934|NCT01877421|80313876|FG009|Phase 2|Withdrawal by Subject|0|||
27805642|NCT04356573|81120357|FG000|Overall Study|Didn't Qualify|1|||
27805643|NCT04356573|81120358|FG001|Overall Study|Didn't Qualify|0|||
27805644|NCT01155583|81120363|FG000|Phase I|Screen failure - did not start treatment|0|||
27581935|NCT01877421|80313877|FG010|Phase 2|Withdrawal by Subject|1|||
27581936|NCT01877421|80313878|FG011|Phase 2|Withdrawal by Subject|0|||
27581937|NCT01877421|80313879|FG012|Phase 2|Withdrawal by Subject|1|||
27581938|NCT01877421|80313880|FG013|Phase 2|Withdrawal by Subject|0|||
27581939|NCT01877421|80313881|FG014|Phase 2|Withdrawal by Subject|0|||
27581940|NCT01877421|80313882|FG015|Phase 2|Withdrawal by Subject|1|||
27581941|NCT01877421|80313883|FG016|Phase 2|Withdrawal by Subject|0|||
27581942|NCT01877421|80313884|FG017|Phase 2|Withdrawal by Subject|0|||
27581943|NCT01877421|80313867|FG000|Phase 2|Protocol Violation|0|||
27581944|NCT01877421|80313868|FG001|Phase 2|Protocol Violation|0|||
27581945|NCT01877421|80313869|FG002|Phase 2|Protocol Violation|0|||
27581946|NCT01877421|80313870|FG003|Phase 2|Protocol Violation|0|||
27581947|NCT01877421|80313871|FG004|Phase 2|Protocol Violation|0|||
27581948|NCT01877421|80313872|FG005|Phase 2|Protocol Violation|0|||
27581949|NCT01877421|80313873|FG006|Phase 2|Protocol Violation|0|||
27581950|NCT01877421|80313874|FG007|Phase 2|Protocol Violation|0|||
27581951|NCT01877421|80313875|FG008|Phase 2|Protocol Violation|0|||
27581952|NCT01877421|80313876|FG009|Phase 2|Protocol Violation|0|||
27581953|NCT01877421|80313877|FG010|Phase 2|Protocol Violation|1|||
27581954|NCT01877421|80313878|FG011|Phase 2|Protocol Violation|0|||
27581955|NCT01877421|80313879|FG012|Phase 2|Protocol Violation|0|||
27581956|NCT01877421|80313880|FG013|Phase 2|Protocol Violation|0|||
27581957|NCT01877421|80313881|FG014|Phase 2|Protocol Violation|0|||
27581958|NCT01877421|80313882|FG015|Phase 2|Protocol Violation|0|||
28000215|NCT02510001|81830910|FG007|Overall Study|Withdrawal by Subject|2|||
28000216|NCT02366312|81830914|FG000|Overall Study|Lost to Follow-up|0|||
28000217|NCT02366312|81830915|FG001|Overall Study|Lost to Follow-up|1|||
28000218|NCT02532517|81830916|FG000|Overall Study|Did not complete 24-Month visit|4|||
28000219|NCT02532517|81830916|FG000|Overall Study|Failed Angiographic eligibility|1|||
28000220|NCT02532517|81830916|FG000|Overall Study|Lost to Follow-up|4|||
28000221|NCT02532517|81830916|FG000|Overall Study|Withdrawal by Subject|4|||
28000222|NCT02532517|81830916|FG000|Overall Study|Death|4|||
28000223|NCT00549640|81830930|FG000|Overall Study|Withdrawal by Subject|6|||
27581959|NCT01877421|80313883|FG016|Phase 2|Protocol Violation|0|||
27581960|NCT01877421|80313884|FG017|Phase 2|Protocol Violation|0|||
27581961|NCT01401530|80313885|FG000|Overall Study|Disease Progression|1|||
27581962|NCT01401530|80313886|FG001|Overall Study|Disease Progression|2|||
27581963|NCT01401530|80313887|FG002|Overall Study|Disease Progression|1|||
27581964|NCT01401530|80313885|FG000|Overall Study|Adverse Event|1|||
27581965|NCT01401530|80313886|FG001|Overall Study|Adverse Event|1|||
27581966|NCT01401530|80313887|FG002|Overall Study|Adverse Event|1|||
27873720|NCT01753999|81371533|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
27873721|NCT01753999|81371532|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
27873722|NCT01753999|81371533|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
27873723|NCT01753999|81371532|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
27873724|NCT01753999|81371533|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
27873725|NCT01753999|81371532|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
27873726|NCT01753999|81371533|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
27873727|NCT01753999|81371532|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
27873728|NCT01753999|81371533|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
27873729|NCT04753216|81371534|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
27873730|NCT04753216|81371534|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
27873731|NCT04753216|81371534|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
27873732|NCT00226499|81371538|FG000|Overall Study|Adverse Event|10|||
27873733|NCT00226499|81371539|FG001|Overall Study|Adverse Event|6|||
27873734|NCT00226499|81371540|FG002|Overall Study|Adverse Event|3|||
27873735|NCT00226499|81371538|FG000|Overall Study|Others|1064|||
27873736|NCT00226499|81371539|FG001|Overall Study|Others|1066|||
27873737|NCT00226499|81371540|FG002|Overall Study|Others|356|||
27873738|NCT00942084|81371541|FG000|Overall Study|Death|2|||
27873739|NCT00765102|81371542|FG000|Overall Study|Progressive disease|18|||
27873740|NCT00765102|81371542|FG000|Overall Study|Adverse Event|6|||
27873741|NCT00765102|81371542|FG000|Overall Study|Physician Decision|4|||
27873742|NCT00765102|81371542|FG000|Overall Study|Withdrawal by Subject|2|||
27873743|NCT00765102|81371542|FG000|Overall Study|Protocol Violation|1|||
27873744|NCT00967330|81371549|FG000|Overall Study|Protocol Violation|3|||
27873745|NCT00967330|81371550|FG001|Overall Study|Protocol Violation|4|||
27873746|NCT00967330|81371549|FG000|Overall Study|Regular|10|||
27873747|NCT00967330|81371550|FG001|Overall Study|Regular|3|||
27873748|NCT00967330|81371549|FG000|Overall Study|Withdrawal by Subject|6|||
27873749|NCT00967330|81371550|FG001|Overall Study|Withdrawal by Subject|0|||
27873750|NCT00967330|81371549|FG000|Overall Study|Lost to Follow-up|1|||
27873751|NCT00967330|81371550|FG001|Overall Study|Lost to Follow-up|1|||
27873752|NCT00967330|81371549|FG000|Overall Study|Death|102|||
27873753|NCT00967330|81371550|FG001|Overall Study|Death|51|||
27873754|NCT00967330|81371549|FG000|Overall Study|Severe protocol deviation|0|||
27873755|NCT00967330|81371550|FG001|Overall Study|Severe protocol deviation|1|||
27873756|NCT01342081|81371551|FG000|Overall Study|Did not receive allocated intervention|0|||
27873757|NCT01342081|81371552|FG001|Overall Study|Did not receive allocated intervention|0|||
27873758|NCT01342081|81371553|FG002|Overall Study|Did not receive allocated intervention|1|||
27873759|NCT01342081|81371551|FG000|Overall Study|Adverse Event|1|||
27873760|NCT01342081|81371552|FG001|Overall Study|Adverse Event|0|||
27873761|NCT01342081|81371553|FG002|Overall Study|Adverse Event|0|||
27873762|NCT01342081|81371551|FG000|Overall Study|Physician Decision|0|||
27873763|NCT01342081|81371552|FG001|Overall Study|Physician Decision|1|||
27873764|NCT01342081|81371553|FG002|Overall Study|Physician Decision|0|||
27873765|NCT01342081|81371551|FG000|Overall Study|Withdrawal by Subject|1|||
27873766|NCT01342081|81371552|FG001|Overall Study|Withdrawal by Subject|1|||
27873767|NCT01342081|81371553|FG002|Overall Study|Withdrawal by Subject|0|||
27873768|NCT03832686|81371556|FG000|Overall Study|Lost to Follow-up|6|||
27873769|NCT03832686|81371557|FG001|Overall Study|Lost to Follow-up|9|||
27873770|NCT03832686|81371556|FG000|Overall Study|Discontinued Intervention|5|||
27873771|NCT03832686|81371557|FG001|Overall Study|Discontinued Intervention|4|||
27873772|NCT01383174|81371559|FG000|3 Month Assessment|Death|0|||
27873773|NCT01383174|81371560|FG001|3 Month Assessment|Death|1|||
28000224|NCT00549640|81830931|FG001|Overall Study|Withdrawal by Subject|12|||
28000225|NCT00549640|81830930|FG000|Overall Study|Adverse Event|5|||
27873774|NCT01383174|81371559|FG000|3 Month Assessment|Lost to Follow-up|2|||
27873775|NCT01383174|81371560|FG001|3 Month Assessment|Lost to Follow-up|0|||
27873776|NCT01383174|81371559|FG000|3 Month Assessment|Refused to complete|4|||
27873777|NCT01383174|81371560|FG001|3 Month Assessment|Refused to complete|0|||
27873778|NCT01383174|81371559|FG000|6 Month Assessment|Lost to Follow-up|1|||
27873779|NCT01383174|81371560|FG001|6 Month Assessment|Lost to Follow-up|1|||
27873780|NCT01383174|81371559|FG000|6 Month Assessment|Refused to complete|4|||
27873781|NCT01383174|81371560|FG001|6 Month Assessment|Refused to complete|0|||
27873782|NCT02687451|81371561|FG000|Overall Study|Withdrawal by Subject|1|||
27873783|NCT02687451|81371562|FG001|Overall Study|Withdrawal by Subject|0|||
27873784|NCT02687451|81371563|FG002|Overall Study|Withdrawal by Subject|0|||
27873785|NCT02687451|81371564|FG003|Overall Study|Withdrawal by Subject|0|||
27873786|NCT02687451|81371565|FG004|Overall Study|Withdrawal by Subject|0|||
28000226|NCT00549640|81830931|FG001|Overall Study|Adverse Event|0|||
27873787|NCT02687451|81371566|FG005|Overall Study|Withdrawal by Subject|1|||
27873788|NCT03571828|81371567|FG000|Overall Study|Withdrawal by Subject|1|||
27873789|NCT03571828|81371568|FG001|Overall Study|Withdrawal by Subject|0|||
27873790|NCT03571828|81371567|FG000|Overall Study|Decision by sponsor|5|||
27873791|NCT03571828|81371568|FG001|Overall Study|Decision by sponsor|1|||
27873792|NCT03571828|81371567|FG000|Overall Study|Death|2|||
27873793|NCT03571828|81371568|FG001|Overall Study|Death|0|||
27873794|NCT01418378|81371573|FG000|Overall Study|Death|1|||
27873795|NCT01418378|81371574|FG001|Overall Study|Death|2|||
27873796|NCT01418378|81371573|FG000|Overall Study|Physician Decision|0|||
27873797|NCT01418378|81371574|FG001|Overall Study|Physician Decision|1|||
27873798|NCT01418378|81371573|FG000|Overall Study|ligament imbalance|0|||
27873799|NCT01418378|81371574|FG001|Overall Study|ligament imbalance|1|||
27873800|NCT01418378|81371573|FG000|Overall Study|developed chronic myopathy|0|||
27873801|NCT01418378|81371574|FG001|Overall Study|developed chronic myopathy|1|||
27873802|NCT00470535|81371575|FG000|Overall Study|Disease Progression|13|||
27873803|NCT00470535|81371575|FG000|Overall Study|Withdrawal by Subject|1|||
27873804|NCT00470535|81371575|FG000|Overall Study|Adverse Event|1|||
27873805|NCT00470535|81371575|FG000|Overall Study|Death|1|||
27873806|NCT00470535|81371575|FG000|Overall Study|Other|2|||
27873807|NCT03839628|81371576|FG000|Overall Study|Withdrawal by Subject|1|||
27873808|NCT03347110|81371577|FG000|Overall Study|Other (Participant is incarcerated)|1|||
28000227|NCT00549640|81830930|FG000|Overall Study|Lost to Follow-up|7|||
28000228|NCT00549640|81830931|FG001|Overall Study|Lost to Follow-up|4|||
28000229|NCT01156480|81830937|FG000|Overall Study|change in diagnosis|0|||
28000230|NCT01156480|81830938|FG001|Overall Study|change in diagnosis|1|||
28000231|NCT02336230|81830939|FG000|Overall Study|Adverse Event|1|||
28000232|NCT02336230|81830939|FG000|Overall Study|Withdrawal of consent|1|||
28000233|NCT02336230|81830939|FG000|Overall Study|Death|9|||
28000234|NCT02336230|81830939|FG000|Overall Study|Dose not received due to shipping delay|1|||
28000235|NCT02336230|81830939|FG000|Overall Study|Discontinuation of MSC infusion|1|||
28000236|NCT01620086|81830940|FG000|Overall Study|Withdrawal by Subject|3|||
28000237|NCT01620086|81830941|FG001|Overall Study|Withdrawal by Subject|3|||
28000238|NCT01620086|81830942|FG002|Overall Study|Withdrawal by Subject|0|||
28000239|NCT01620086|81830940|FG000|Overall Study|failed study criteria|1|||
28000240|NCT01620086|81830941|FG001|Overall Study|failed study criteria|4|||
28000241|NCT01620086|81830942|FG002|Overall Study|failed study criteria|0|||
28000242|NCT01620086|81830940|FG000|Overall Study|Physician Decision|1|||
27581967|NCT01401530|80313885|FG000|Overall Study|Participant Choice|1|||
27581968|NCT01401530|80313886|FG001|Overall Study|Participant Choice|2|||
27581969|NCT01401530|80313887|FG002|Overall Study|Participant Choice|1|||
27581970|NCT01401530|80313885|FG000|Overall Study|Physician Decision|0|||
28000243|NCT01620086|81830941|FG001|Overall Study|Physician Decision|0|||
28000244|NCT01620086|81830942|FG002|Overall Study|Physician Decision|0|||
28000245|NCT02478463|81830945|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
28000246|NCT02478463|81830945|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
27805645|NCT01155583|81120364|FG001|Phase I|Screen failure - did not start treatment|0|||
27805646|NCT01155583|81120365|FG002|Phase I|Screen failure - did not start treatment|0|||
27805647|NCT01155583|81120366|FG003|Phase I|Screen failure - did not start treatment|0|||
27805648|NCT01155583|81120367|FG004|Phase I|Screen failure - did not start treatment|1|||
27805649|NCT01155583|81120368|FG005|Phase I|Screen failure - did not start treatment|0|||
27805650|NCT01155583|81120369|FG006|Phase I|Screen failure - did not start treatment|0|||
27805651|NCT01155583|81120370|FG007|Phase I|Screen failure - did not start treatment|2|||
27805652|NCT01155583|81120371|FG008|Phase I|Screen failure - did not start treatment|0|||
27805653|NCT01155583|81120363|FG000|Phase I|Withdrawal by Subject|0|||
27805654|NCT01155583|81120364|FG001|Phase I|Withdrawal by Subject|0|||
27805655|NCT01155583|81120365|FG002|Phase I|Withdrawal by Subject|0|||
27805656|NCT01155583|81120366|FG003|Phase I|Withdrawal by Subject|0|||
27805657|NCT01155583|81120367|FG004|Phase I|Withdrawal by Subject|0|||
27805658|NCT01155583|81120368|FG005|Phase I|Withdrawal by Subject|0|||
27805659|NCT01155583|81120369|FG006|Phase I|Withdrawal by Subject|0|||
27805660|NCT01155583|81120370|FG007|Phase I|Withdrawal by Subject|1|||
27805661|NCT01155583|81120371|FG008|Phase I|Withdrawal by Subject|0|||
27805662|NCT02065791|81120372|FG000|Overall Study|Closed Site|1|||
27805663|NCT02065791|81120373|FG001|Overall Study|Closed Site|1|||
27805664|NCT02065791|81120372|FG000|Overall Study|Withdrawal by Subject|11|||
27805665|NCT02065791|81120373|FG001|Overall Study|Withdrawal by Subject|5|||
27805666|NCT02065791|81120372|FG000|Overall Study|Lost to Follow-up|13|||
27805667|NCT02065791|81120373|FG001|Overall Study|Lost to Follow-up|9|||
27805668|NCT02535000|81120374|FG000|Overall Study|Cancellation of surgery.|1|||
27805669|NCT02535000|81120375|FG001|Overall Study|Cancellation of surgery.|2|||
28000247|NCT02478463|81830945|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
28000248|NCT01402817|81830946|FG000|Overall Study|Withdrawal by Subject|3|||
27581971|NCT01401530|80313886|FG001|Overall Study|Physician Decision|1|||
27873809|NCT03347110|81371577|FG000|Overall Study|Withdrawal by Subject|9|||
27873810|NCT03347110|81371577|FG000|Overall Study|Lost to Follow-up|1|||
27873811|NCT03347110|81371577|FG000|Overall Study|Lack of Efficacy|2|||
27873812|NCT03347110|81371577|FG000|Overall Study|Adverse Event, non-fatal|9|||
28000249|NCT01402817|81830946|FG000|Overall Study|Study Suspended by FDA|8|||
28000250|NCT04716426|81830947|FG000|Overall Study|Vaccination|1|||
28000251|NCT04716426|81830948|FG001|Overall Study|Vaccination|1|||
27581972|NCT01401530|80313887|FG002|Overall Study|Physician Decision|0|||
27581973|NCT02019719|80313888|FG000|Overall Study|Adverse Event|1|||
27873813|NCT01372618|81371578|FG000|Overall Study|PI Died. Study Terminated|9|||
28000252|NCT04716426|81830947|FG000|Overall Study|Contamination|1|||
28000253|NCT04716426|81830948|FG001|Overall Study|Contamination|0|||
28000254|NCT01176058|81830949|FG000|Overall Study|Adverse Event|1|||
27581974|NCT02019719|80313889|FG001|Overall Study|Adverse Event|0|||
27581975|NCT02019719|80313890|FG002|Overall Study|Adverse Event|0|||
27581976|NCT02019719|80313891|FG003|Overall Study|Adverse Event|1|||
27581977|NCT02019719|80313892|FG004|Overall Study|Adverse Event|1|||
27581978|NCT02019719|80313888|FG000|Overall Study|Protocol Violation|1|||
27581979|NCT02019719|80313889|FG001|Overall Study|Protocol Violation|1|||
27581980|NCT02019719|80313890|FG002|Overall Study|Protocol Violation|0|||
27581981|NCT02019719|80313891|FG003|Overall Study|Protocol Violation|0|||
27581982|NCT02019719|80313892|FG004|Overall Study|Protocol Violation|0|||
27581983|NCT02019719|80313888|FG000|Overall Study|Protocol defined stopping criteria|2|||
27581984|NCT02019719|80313889|FG001|Overall Study|Protocol defined stopping criteria|0|||
27581985|NCT02019719|80313890|FG002|Overall Study|Protocol defined stopping criteria|0|||
27581986|NCT02019719|80313891|FG003|Overall Study|Protocol defined stopping criteria|1|||
27581987|NCT02019719|80313892|FG004|Overall Study|Protocol defined stopping criteria|1|||
28000255|NCT01176058|81830950|FG001|Overall Study|Adverse Event|0|||
28000256|NCT01176058|81830949|FG000|Overall Study|Insufficient clinical response|2|||
28000257|NCT01176058|81830950|FG001|Overall Study|Insufficient clinical response|2|||
28000258|NCT01176058|81830949|FG000|Overall Study|Insufficient mycological response|0|||
28000259|NCT01176058|81830950|FG001|Overall Study|Insufficient mycological response|1|||
28000260|NCT01176058|81830949|FG000|Overall Study|Withdrawal by Subject|1|||
28000261|NCT01176058|81830950|FG001|Overall Study|Withdrawal by Subject|0|||
28000262|NCT01276639|81830951|FG000|Week 0 to 16|Death|1|||
28000263|NCT01276639|81830952|FG001|Week 0 to 16|Death|0|||
28000264|NCT01276639|81830953|FG002|Week 0 to 16|Death|0|||
28000265|NCT01276639|81830954|FG003|Week 0 to 16|Death|0|||
28000266|NCT01276639|81830955|FG004|Week 0 to 16|Death|0|||
28000267|NCT01276639|81830951|FG000|Week 0 to 16|Adverse Event|11|||
28000268|NCT01276639|81830952|FG001|Week 0 to 16|Adverse Event|8|||
28000269|NCT01276639|81830953|FG002|Week 0 to 16|Adverse Event|11|||
28000270|NCT01276639|81830954|FG003|Week 0 to 16|Adverse Event|0|||
28000271|NCT01276639|81830955|FG004|Week 0 to 16|Adverse Event|0|||
28000272|NCT01276639|81830951|FG000|Week 0 to 16|Lack of Efficacy|20|||
28000273|NCT01276639|81830952|FG001|Week 0 to 16|Lack of Efficacy|15|||
28000274|NCT01276639|81830953|FG002|Week 0 to 16|Lack of Efficacy|25|||
28000275|NCT01276639|81830954|FG003|Week 0 to 16|Lack of Efficacy|0|||
28000276|NCT01276639|81830955|FG004|Week 0 to 16|Lack of Efficacy|0|||
28000277|NCT01276639|81830951|FG000|Week 0 to 16|Lost to Follow-up|3|||
27581988|NCT02019719|80313888|FG000|Overall Study|Physician Decision|2|||
27581989|NCT02019719|80313889|FG001|Overall Study|Physician Decision|0|||
27581990|NCT02019719|80313890|FG002|Overall Study|Physician Decision|0|||
27581991|NCT02019719|80313891|FG003|Overall Study|Physician Decision|0|||
28000278|NCT01276639|81830952|FG001|Week 0 to 16|Lost to Follow-up|5|||
28000279|NCT01276639|81830953|FG002|Week 0 to 16|Lost to Follow-up|3|||
28000280|NCT01276639|81830954|FG003|Week 0 to 16|Lost to Follow-up|0|||
28000281|NCT01276639|81830955|FG004|Week 0 to 16|Lost to Follow-up|0|||
28000282|NCT01276639|81830951|FG000|Week 0 to 16|Withdrawal by Subject|8|||
28000283|NCT01276639|81830952|FG001|Week 0 to 16|Withdrawal by Subject|5|||
28000284|NCT01276639|81830953|FG002|Week 0 to 16|Withdrawal by Subject|4|||
28000285|NCT01276639|81830954|FG003|Week 0 to 16|Withdrawal by Subject|0|||
28000286|NCT01276639|81830955|FG004|Week 0 to 16|Withdrawal by Subject|0|||
28000287|NCT01276639|81830951|FG000|Week 0 to 16|Other|7|||
28000288|NCT01276639|81830952|FG001|Week 0 to 16|Other|7|||
28000289|NCT01276639|81830953|FG002|Week 0 to 16|Other|2|||
28000290|NCT01276639|81830954|FG003|Week 0 to 16|Other|0|||
28000291|NCT01276639|81830955|FG004|Week 0 to 16|Other|0|||
28000292|NCT01276639|81830951|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
27581992|NCT02019719|80313892|FG004|Overall Study|Physician Decision|0|||
27873814|NCT00708461|81371585|FG000|Overall Study|Lost to Follow-up|18|||
28000293|NCT01276639|81830952|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
28000294|NCT01276639|81830953|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
28000295|NCT01276639|81830954|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
28000296|NCT01276639|81830955|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
28000297|NCT01276639|81830951|FG000|Week 16 to 52|Death|1|||
28000298|NCT01276639|81830952|FG001|Week 16 to 52|Death|0|||
28000299|NCT01276639|81830953|FG002|Week 16 to 52|Death|0|||
28000300|NCT01276639|81830954|FG003|Week 16 to 52|Death|0|||
28000301|NCT01276639|81830955|FG004|Week 16 to 52|Death|0|||
28000302|NCT01276639|81830951|FG000|Week 16 to 52|Adverse Event|10|||
27581993|NCT02573324|80313893|FG000|Overall Study|Withdrawal by Subject|26|||
27581994|NCT02573324|80313894|FG001|Overall Study|Withdrawal by Subject|23|||
27581995|NCT02573324|80313895|FG002|Overall Study|Withdrawal by Subject|3|||
27581996|NCT02573324|80313893|FG000|Overall Study|Lost to Follow-up|4|||
27581997|NCT02573324|80313894|FG001|Overall Study|Lost to Follow-up|5|||
28000303|NCT01276639|81830952|FG001|Week 16 to 52|Adverse Event|13|||
28000304|NCT01276639|81830953|FG002|Week 16 to 52|Adverse Event|0|||
28000305|NCT01276639|81830954|FG003|Week 16 to 52|Adverse Event|1|||
27805670|NCT03760510|81120376|FG000|Overall Study|Not ventilated for 24 hours|105|||
27805671|NCT03760510|81120377|FG001|Overall Study|Not ventilated for 24 hours|97|||
27805672|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
27805673|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
27805674|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
27805675|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
27805676|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
27805677|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
27805678|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
27805679|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
27805680|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
27805681|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
27805682|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
27805683|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
27805684|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
27805685|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
27805686|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
27805687|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
27805688|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
27873815|NCT00708461|81371586|FG001|Overall Study|Lost to Follow-up|11|||
27873816|NCT00708461|81371585|FG000|Overall Study|Withdrawal by Subject|8|||
27873817|NCT00708461|81371586|FG001|Overall Study|Withdrawal by Subject|9|||
27873818|NCT00708461|81371585|FG000|Overall Study|left workforce|115|||
27873819|NCT00708461|81371586|FG001|Overall Study|left workforce|180|||
27873820|NCT01499095|81371587|FG000|Overall Study|Randomized But Not Treated|1|||
27873821|NCT01499095|81371588|FG001|Overall Study|Randomized But Not Treated|1|||
27873822|NCT01499095|81371587|FG000|Overall Study|Adverse Event|12|||
27873823|NCT01499095|81371588|FG001|Overall Study|Adverse Event|7|||
27873824|NCT01499095|81371587|FG000|Overall Study|Lack of Efficacy|2|||
27873825|NCT01499095|81371588|FG001|Overall Study|Lack of Efficacy|1|||
27873826|NCT01499095|81371587|FG000|Overall Study|Protocol Violation|6|||
27873827|NCT01499095|81371588|FG001|Overall Study|Protocol Violation|7|||
27873828|NCT01499095|81371587|FG000|Overall Study|Received Rescue Therapy|32|||
28000306|NCT01276639|81830955|FG004|Week 16 to 52|Adverse Event|3|||
28000307|NCT01276639|81830951|FG000|Week 16 to 52|Lack of Efficacy|99|||
28000308|NCT01276639|81830952|FG001|Week 16 to 52|Lack of Efficacy|71|||
28000309|NCT01276639|81830953|FG002|Week 16 to 52|Lack of Efficacy|0|||
28000310|NCT01276639|81830954|FG003|Week 16 to 52|Lack of Efficacy|14|||
27805689|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
27805690|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
27805691|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
27805692|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
27805693|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
27873829|NCT01499095|81371588|FG001|Overall Study|Received Rescue Therapy|40|||
28000311|NCT01276639|81830955|FG004|Week 16 to 52|Lack of Efficacy|13|||
28000312|NCT01276639|81830951|FG000|Week 16 to 52|Lost to Follow-up|3|||
28000313|NCT01276639|81830952|FG001|Week 16 to 52|Lost to Follow-up|1|||
28000314|NCT01276639|81830953|FG002|Week 16 to 52|Lost to Follow-up|0|||
28000315|NCT01276639|81830954|FG003|Week 16 to 52|Lost to Follow-up|0|||
28000316|NCT01276639|81830955|FG004|Week 16 to 52|Lost to Follow-up|1|||
28000317|NCT01276639|81830951|FG000|Week 16 to 52|Withdrawal by Subject|4|||
27873830|NCT01499095|81371587|FG000|Overall Study|Diverse Reasons|22|||
27873831|NCT01499095|81371588|FG001|Overall Study|Diverse Reasons|25|||
27873832|NCT01499095|81371587|FG000|Overall Study|Lost to Follow-up|6|||
27873833|NCT01499095|81371588|FG001|Overall Study|Lost to Follow-up|4|||
27873834|NCT01499095|81371587|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
28000318|NCT01276639|81830952|FG001|Week 16 to 52|Withdrawal by Subject|4|||
28000319|NCT01276639|81830953|FG002|Week 16 to 52|Withdrawal by Subject|0|||
28000320|NCT01276639|81830954|FG003|Week 16 to 52|Withdrawal by Subject|0|||
28000321|NCT01276639|81830955|FG004|Week 16 to 52|Withdrawal by Subject|1|||
28000322|NCT01276639|81830951|FG000|Week 16 to 52|Other|10|||
28000323|NCT01276639|81830952|FG001|Week 16 to 52|Other|12|||
27581998|NCT02573324|80313895|FG002|Overall Study|Lost to Follow-up|0|||
27581999|NCT02573324|80313893|FG000|Overall Study|Study Terminated by Sponsor|107|||
27582000|NCT02573324|80313894|FG001|Overall Study|Study Terminated by Sponsor|89|||
27805694|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
28000324|NCT01276639|81830953|FG002|Week 16 to 52|Other|0|||
27582001|NCT02573324|80313895|FG002|Overall Study|Study Terminated by Sponsor|2|||
28000325|NCT01276639|81830954|FG003|Week 16 to 52|Other|1|||
28000326|NCT01276639|81830955|FG004|Week 16 to 52|Other|3|||
28000327|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Progressive disease|50|||
28000328|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Progressive disease|110|||
28000329|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Progressive disease|0|||
28000330|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Progressive disease|0|||
28000331|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
28000332|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
28000333|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
28000334|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
28000335|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Adverse Event|7|||
28000336|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Adverse Event|7|||
28000337|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Adverse Event|0|||
28000338|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Adverse Event|0|||
28000339|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Other|1|||
28000340|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Other|3|||
28000341|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Other|0|||
28000342|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Other|0|||
28000343|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Physician Decision|6|||
28000344|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Physician Decision|3|||
28000345|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Physician Decision|0|||
28000346|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Physician Decision|0|||
28000347|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Death|1|||
28000348|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Death|1|||
27582002|NCT02573324|80313893|FG000|Overall Study|Death|182|||
27582003|NCT02573324|80313894|FG001|Overall Study|Death|200|||
27582004|NCT02573324|80313895|FG002|Overall Study|Death|1|||
27805695|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
27805696|NCT00455533|81120379|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
27805697|NCT00455533|81120380|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
28000349|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Death|0|||
28000350|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Death|0|||
28000351|NCT01695135|81830958|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
28000352|NCT01695135|81830959|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
27805698|NCT00455533|81120381|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
27805699|NCT00455533|81120379|FG000|Period Two: Randomized Period|Death|0|||
27805700|NCT00455533|81120380|FG001|Period Two: Randomized Period|Death|0|||
27805701|NCT00455533|81120381|FG002|Period Two: Randomized Period|Death|3|||
27805702|NCT00455533|81120379|FG000|Period Two: Randomized Period|Disease Progression|0|||
27805703|NCT00455533|81120380|FG001|Period Two: Randomized Period|Disease Progression|1|||
27805704|NCT00455533|81120381|FG002|Period Two: Randomized Period|Disease Progression|1|||
28000353|NCT01695135|81830960|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
27582005|NCT02573324|80313893|FG000|Overall Study|Other, Not Specified|20|||
27582006|NCT02573324|80313894|FG001|Overall Study|Other, Not Specified|27|||
27582007|NCT02573324|80313895|FG002|Overall Study|Other, Not Specified|0|||
27582008|NCT02573324|80313893|FG000|Overall Study|Unknown Reason|2|||
27582009|NCT02573324|80313894|FG001|Overall Study|Unknown Reason|0|||
27582010|NCT02573324|80313895|FG002|Overall Study|Unknown Reason|0|||
27582011|NCT03224468|80313896|FG000|Overall Study|Did not obtain MM card|53|||
27582012|NCT03224468|80313897|FG001|Overall Study|Did not obtain MM card|0|||
27582013|NCT03224468|80313896|FG000|Overall Study|Lost to Follow-up|4|||
27582014|NCT03224468|80313897|FG001|Overall Study|Lost to Follow-up|11|||
28000354|NCT01695135|81830961|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
27582015|NCT03224468|80313896|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
27582016|NCT03224468|80313897|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
27582017|NCT03892889|80313900|FG000|Overall Study|Adverse Event|17|||
27582018|NCT03892889|80313900|FG000|Overall Study|Lack of Efficacy|1|||
27582019|NCT03892889|80313900|FG000|Overall Study|Lost to Follow-up|46|||
27582020|NCT03892889|80313900|FG000|Overall Study|Non-compliance with study drug|22|||
27582021|NCT03892889|80313900|FG000|Overall Study|Pregnancy|1|||
27582022|NCT03892889|80313900|FG000|Overall Study|Protocol Deviation|3|||
27582023|NCT03892889|80313900|FG000|Overall Study|Withdrawal by Subject|50|||
27582024|NCT03892889|80313900|FG000|Overall Study|Withdrawal by Caregiver|1|||
27582025|NCT03892889|80313900|FG000|Overall Study|Study Terminated by Sponsor|50|||
27582026|NCT03892889|80313900|FG000|Overall Study|Physician Decision|8|||
27582027|NCT03892889|80313900|FG000|Overall Study|Reason not Specified|5|||
27582028|NCT00346034|80313901|FG000|Overall Study|Adverse Event|34|||
27582029|NCT00346034|80313901|FG000|Overall Study|Lack of Efficacy|8|||
27873835|NCT01499095|81371588|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
27873836|NCT01499095|81371587|FG000|Overall Study|Hypoglycemia|3|||
28000355|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
28000356|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
28000357|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
28000358|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
28000359|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
28000360|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
28000361|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
28000362|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
28000363|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
27582030|NCT00346034|80313901|FG000|Overall Study|Withdrawal by Subject|13|||
27805705|NCT00455533|81120379|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
27582031|NCT00346034|80313901|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
27582032|NCT00346034|80313901|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
27582033|NCT01040130|80313902|FG000|Overall Study|Adverse Event|1|||
27582034|NCT01040130|80313903|FG001|Overall Study|Adverse Event|1|||
27582035|NCT01040130|80313904|FG002|Overall Study|Adverse Event|0|||
27582036|NCT01040130|80313905|FG003|Overall Study|Adverse Event|5|||
27582037|NCT01040130|80313906|FG004|Overall Study|Adverse Event|0|||
27805706|NCT00455533|81120380|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
27805707|NCT00455533|81120381|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
27805708|NCT00455533|81120379|FG000|Period Two: Randomized Period|Other - need reasons|0|||
27805709|NCT00455533|81120380|FG001|Period Two: Randomized Period|Other - need reasons|1|||
27805710|NCT00455533|81120381|FG002|Period Two: Randomized Period|Other - need reasons|0|||
27805711|NCT00455533|81120379|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
27805712|NCT00455533|81120380|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
27805713|NCT00455533|81120381|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
27805714|NCT00455533|81120379|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
27805715|NCT00455533|81120380|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
27805716|NCT00455533|81120381|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
27805717|NCT00830063|81120383|FG000|Overall Study|Adverse Event|7|||
27805718|NCT00830063|81120384|FG001|Overall Study|Adverse Event|13|||
27805719|NCT00830063|81120385|FG002|Overall Study|Adverse Event|16|||
27805720|NCT00830063|81120386|FG003|Overall Study|Adverse Event|13|||
27805721|NCT00830063|81120383|FG000|Overall Study|Death|1|||
27805722|NCT00830063|81120384|FG001|Overall Study|Death|0|||
27805723|NCT00830063|81120385|FG002|Overall Study|Death|0|||
27805724|NCT00830063|81120386|FG003|Overall Study|Death|0|||
27805725|NCT00830063|81120383|FG000|Overall Study|Lost to Follow-up|0|||
27805726|NCT00830063|81120384|FG001|Overall Study|Lost to Follow-up|0|||
27805727|NCT00830063|81120385|FG002|Overall Study|Lost to Follow-up|3|||
27805728|NCT00830063|81120386|FG003|Overall Study|Lost to Follow-up|1|||
27805729|NCT00830063|81120383|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
27805730|NCT00830063|81120384|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
27805731|NCT00830063|81120385|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
27805732|NCT00830063|81120386|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
27805733|NCT00830063|81120383|FG000|Overall Study|Lack of Efficacy|51|||
27805734|NCT00830063|81120384|FG001|Overall Study|Lack of Efficacy|23|||
27805735|NCT00830063|81120385|FG002|Overall Study|Lack of Efficacy|25|||
27805736|NCT00830063|81120386|FG003|Overall Study|Lack of Efficacy|32|||
28000364|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
28000365|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
27582038|NCT01040130|80313907|FG005|Overall Study|Adverse Event|3|||
27582039|NCT01040130|80313902|FG000|Overall Study|Protocol Violation|0|||
27582040|NCT01040130|80313903|FG001|Overall Study|Protocol Violation|0|||
27582041|NCT01040130|80313904|FG002|Overall Study|Protocol Violation|2|||
27582042|NCT01040130|80313905|FG003|Overall Study|Protocol Violation|0|||
27582043|NCT01040130|80313906|FG004|Overall Study|Protocol Violation|0|||
27582044|NCT01040130|80313907|FG005|Overall Study|Protocol Violation|0|||
27582045|NCT01040130|80313902|FG000|Overall Study|Withdrawal by Subject|0|||
27582046|NCT01040130|80313903|FG001|Overall Study|Withdrawal by Subject|2|||
27582047|NCT01040130|80313904|FG002|Overall Study|Withdrawal by Subject|0|||
27582048|NCT01040130|80313905|FG003|Overall Study|Withdrawal by Subject|0|||
27582049|NCT01040130|80313906|FG004|Overall Study|Withdrawal by Subject|0|||
27582050|NCT01040130|80313907|FG005|Overall Study|Withdrawal by Subject|1|||
27582051|NCT01040130|80313902|FG000|Overall Study|Other reasons not listed above|2|||
27582052|NCT01040130|80313903|FG001|Overall Study|Other reasons not listed above|0|||
27582053|NCT01040130|80313904|FG002|Overall Study|Other reasons not listed above|0|||
27582054|NCT01040130|80313905|FG003|Overall Study|Other reasons not listed above|0|||
27582055|NCT01040130|80313906|FG004|Overall Study|Other reasons not listed above|0|||
27582056|NCT01040130|80313907|FG005|Overall Study|Other reasons not listed above|0|||
27582057|NCT01260922|80313909|FG000|First Intervention|Withdrawal by Subject|0|||
27582058|NCT01260922|80313910|FG001|First Intervention|Withdrawal by Subject|1|||
27582059|NCT01260922|80313909|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
27582060|NCT01260922|80313910|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
27805737|NCT00830063|81120383|FG000|Overall Study|Other|5|||
27805738|NCT00830063|81120384|FG001|Overall Study|Other|5|||
27805739|NCT00830063|81120385|FG002|Overall Study|Other|8|||
28000366|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
28000367|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Other|0|||
27805740|NCT00830063|81120386|FG003|Overall Study|Other|6|||
27805741|NCT00830063|81120383|FG000|Overall Study|Withdrawal by Subject|16|||
27805742|NCT00830063|81120384|FG001|Overall Study|Withdrawal by Subject|10|||
28000368|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Other|0|||
27582061|NCT01260922|80313909|FG000|Second Intervention|Emesis|0|||
27582062|NCT01260922|80313910|FG001|Second Intervention|Emesis|2|||
27582063|NCT01958918|80313924|FG000|Overall Study|Death|1|||
27582064|NCT01958918|80313925|FG001|Overall Study|Death|3|||
27582065|NCT01958918|80313924|FG000|Overall Study|Lost to Follow-up|4|||
27582066|NCT01958918|80313925|FG001|Overall Study|Lost to Follow-up|7|||
27582067|NCT01958918|80313924|FG000|Overall Study|Withdrawal by Subject|13|||
27582068|NCT01958918|80313925|FG001|Overall Study|Withdrawal by Subject|8|||
27582069|NCT01958918|80313924|FG000|Overall Study|Lack of Efficacy|13|||
27582070|NCT01958918|80313925|FG001|Overall Study|Lack of Efficacy|10|||
27582071|NCT01958918|80313924|FG000|Overall Study|Adverse Event|12|||
27805743|NCT00830063|81120385|FG002|Overall Study|Withdrawal by Subject|16|||
27805744|NCT00830063|81120386|FG003|Overall Study|Withdrawal by Subject|13|||
27805745|NCT00830063|81120383|FG000|Overall Study|Protocol Violation|1|||
27805746|NCT00830063|81120384|FG001|Overall Study|Protocol Violation|0|||
27805747|NCT00830063|81120385|FG002|Overall Study|Protocol Violation|3|||
27805748|NCT00830063|81120386|FG003|Overall Study|Protocol Violation|2|||
27805749|NCT00830063|81120383|FG000|Overall Study|Randomized But Not Treated|0|||
27805750|NCT00830063|81120384|FG001|Overall Study|Randomized But Not Treated|2|||
27805751|NCT00830063|81120385|FG002|Overall Study|Randomized But Not Treated|0|||
27805752|NCT00830063|81120386|FG003|Overall Study|Randomized But Not Treated|2|||
27805753|NCT03156270|81120387|FG000|Overall Study|Failed pre-treatment screening|1|||
27805754|NCT03156270|81120387|FG000|Overall Study|Lost to Follow-up|1|||
27805755|NCT02265952|81120395|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
27805756|NCT02265952|81120396|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
27805757|NCT02265952|81120395|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
27805758|NCT02265952|81120396|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
27805759|NCT01792284|81120397|FG000|Lead-in Period|Adverse Event|15|||
27805760|NCT01792284|81120398|FG001|Lead-in Period|Adverse Event|0|||
27805761|NCT01792284|81120399|FG002|Lead-in Period|Adverse Event|0|||
27805762|NCT01792284|81120397|FG000|Lead-in Period|Lost to Follow-up|2|||
27805763|NCT01792284|81120398|FG001|Lead-in Period|Lost to Follow-up|0|||
27805764|NCT01792284|81120399|FG002|Lead-in Period|Lost to Follow-up|0|||
27805765|NCT01792284|81120397|FG000|Lead-in Period|Protocol Violation|1|||
27805766|NCT01792284|81120398|FG001|Lead-in Period|Protocol Violation|0|||
27805767|NCT01792284|81120399|FG002|Lead-in Period|Protocol Violation|0|||
27805768|NCT01792284|81120397|FG000|Lead-in Period|Withdrawal by Subject|10|||
27805769|NCT01792284|81120398|FG001|Lead-in Period|Withdrawal by Subject|0|||
27805770|NCT01792284|81120399|FG002|Lead-in Period|Withdrawal by Subject|0|||
27805771|NCT01792284|81120397|FG000|Lead-in Period|Physician Decision|1|||
27582072|NCT01958918|80313925|FG001|Overall Study|Adverse Event|12|||
27805772|NCT01792284|81120398|FG001|Lead-in Period|Physician Decision|0|||
27805773|NCT01792284|81120399|FG002|Lead-in Period|Physician Decision|0|||
27805774|NCT01792284|81120397|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
27805775|NCT01792284|81120398|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
27805776|NCT01792284|81120399|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
27805777|NCT01792284|81120397|FG000|Randomization Period 1|Withdrawal by Subject|0|||
27805778|NCT01792284|81120398|FG001|Randomization Period 1|Withdrawal by Subject|1|||
27805779|NCT01792284|81120399|FG002|Randomization Period 1|Withdrawal by Subject|1|||
27805780|NCT01792284|81120397|FG000|Randomization Period 1|Physician Decision|0|||
27805781|NCT01792284|81120398|FG001|Randomization Period 1|Physician Decision|1|||
27805782|NCT01792284|81120399|FG002|Randomization Period 1|Physician Decision|1|||
27805783|NCT01792284|81120397|FG000|Randomization Period 1|Adverse Event|0|||
27805784|NCT01792284|81120398|FG001|Randomization Period 1|Adverse Event|0|||
27805785|NCT01792284|81120399|FG002|Randomization Period 1|Adverse Event|2|||
27805786|NCT01792284|81120397|FG000|Randomization Period 1|Lost to Follow-up|0|||
27805787|NCT01792284|81120398|FG001|Randomization Period 1|Lost to Follow-up|0|||
27805788|NCT01792284|81120399|FG002|Randomization Period 1|Lost to Follow-up|1|||
27805789|NCT01792284|81120397|FG000|Randomization Period 2|Protocol Violation|0|||
27805790|NCT01792284|81120398|FG001|Randomization Period 2|Protocol Violation|1|||
27582073|NCT01958918|80313924|FG000|Overall Study|administrative problems|0|||
27805791|NCT01792284|81120399|FG002|Randomization Period 2|Protocol Violation|0|||
27805792|NCT01792284|81120397|FG000|Randomization Period 2|Withdrawal by Subject|0|||
27805793|NCT01792284|81120398|FG001|Randomization Period 2|Withdrawal by Subject|2|||
27805794|NCT01792284|81120399|FG002|Randomization Period 2|Withdrawal by Subject|0|||
27805795|NCT02378506|81120402|FG000|Overall Study|Lack of Efficacy|3|||
27805796|NCT02378506|81120402|FG000|Overall Study|Withdrawal by Subject|4|||
27805797|NCT02378506|81120402|FG000|Overall Study|Protocol Violation|2|||
27805798|NCT02378506|81120402|FG000|Overall Study|Death|1|||
27805799|NCT02378506|81120402|FG000|Overall Study|Adverse Event|14|||
27805800|NCT02378506|81120402|FG000|Overall Study|Randomized But Not Treated|1|||
27805801|NCT02133352|81120403|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
27805802|NCT00095199|81120404|FG000|Overall Study|Adverse Event|40|||
27805803|NCT00095199|81120405|FG001|Overall Study|Adverse Event|22|||
27805804|NCT00095199|81120406|FG002|Overall Study|Adverse Event|26|||
27805805|NCT00095199|81120407|FG003|Overall Study|Adverse Event|11|||
27805806|NCT00095199|81120404|FG000|Overall Study|Progressive disease|213|||
27805807|NCT00095199|81120405|FG001|Overall Study|Progressive disease|179|||
27805808|NCT00095199|81120406|FG002|Overall Study|Progressive disease|105|||
27805809|NCT00095199|81120407|FG003|Overall Study|Progressive disease|98|||
27805810|NCT00095199|81120404|FG000|Overall Study|Death|10|||
27805811|NCT00095199|81120405|FG001|Overall Study|Death|6|||
27805812|NCT00095199|81120406|FG002|Overall Study|Death|11|||
27805813|NCT00095199|81120407|FG003|Overall Study|Death|9|||
27805814|NCT00095199|81120404|FG000|Overall Study|Withdrawal by Subject|21|||
27582074|NCT01958918|80313925|FG001|Overall Study|administrative problems|2|||
27582075|NCT02673697|80313931|FG000|Overall Study|Adverse Event|2|||
27582076|NCT02673697|80313932|FG001|Overall Study|Adverse Event|0|||
27805815|NCT00095199|81120405|FG001|Overall Study|Withdrawal by Subject|16|||
27805816|NCT00095199|81120406|FG002|Overall Study|Withdrawal by Subject|13|||
27805817|NCT00095199|81120407|FG003|Overall Study|Withdrawal by Subject|22|||
27805818|NCT00095199|81120404|FG000|Overall Study|Protocol Violation|4|||
27805819|NCT00095199|81120405|FG001|Overall Study|Protocol Violation|4|||
27805820|NCT00095199|81120406|FG002|Overall Study|Protocol Violation|2|||
27805821|NCT00095199|81120407|FG003|Overall Study|Protocol Violation|0|||
27805822|NCT00095199|81120404|FG000|Overall Study|Liver function test results elevated|0|||
27805823|NCT00095199|81120405|FG001|Overall Study|Liver function test results elevated|0|||
27805824|NCT00095199|81120406|FG002|Overall Study|Liver function test results elevated|1|||
27805825|NCT00095199|81120407|FG003|Overall Study|Liver function test results elevated|1|||
27805826|NCT00095199|81120404|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
27805827|NCT00095199|81120405|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
27805828|NCT00095199|81120406|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
27805829|NCT00095199|81120407|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
27805830|NCT00095199|81120404|FG000|Overall Study|Physician Decision|5|||
27805831|NCT00095199|81120405|FG001|Overall Study|Physician Decision|6|||
27805832|NCT00095199|81120406|FG002|Overall Study|Physician Decision|1|||
28000369|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Other|4|||
28000370|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Other|7|||
28000371|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
28000372|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
28000373|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
28000374|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
28000375|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Death|0|||
28000376|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Death|0|||
28000377|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Death|2|||
27582077|NCT02673697|80313931|FG000|Overall Study|Death|32|||
27582078|NCT02673697|80313932|FG001|Overall Study|Death|24|||
27582079|NCT02673697|80313931|FG000|Overall Study|Lost to Follow-up|5|||
27582080|NCT02673697|80313932|FG001|Overall Study|Lost to Follow-up|2|||
27582081|NCT02673697|80313931|FG000|Overall Study|Physician Decision|2|||
27805833|NCT00095199|81120407|FG003|Overall Study|Physician Decision|1|||
27805834|NCT00095199|81120404|FG000|Overall Study|Not eligible|1|||
27805835|NCT00095199|81120405|FG001|Overall Study|Not eligible|7|||
27805836|NCT00095199|81120406|FG002|Overall Study|Not eligible|0|||
27805837|NCT00095199|81120407|FG003|Overall Study|Not eligible|1|||
27805838|NCT00095199|81120404|FG000|Overall Study|Started Palliative Radiotherapy|1|||
27805839|NCT00095199|81120405|FG001|Overall Study|Started Palliative Radiotherapy|0|||
27805840|NCT00095199|81120406|FG002|Overall Study|Started Palliative Radiotherapy|0|||
28000378|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Death|7|||
28000379|NCT01695135|81830958|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
28000380|NCT01695135|81830959|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
27582082|NCT02673697|80313932|FG001|Overall Study|Physician Decision|1|||
27582083|NCT02673697|80313931|FG000|Overall Study|Withdrawal by Subject|10|||
27582084|NCT02673697|80313932|FG001|Overall Study|Withdrawal by Subject|7|||
27582085|NCT02673697|80313931|FG000|Overall Study|Change subj medical status|1|||
27582086|NCT02673697|80313932|FG001|Overall Study|Change subj medical status|2|||
27582087|NCT02673697|80313931|FG000|Overall Study|Explant|10|||
27582088|NCT02673697|80313932|FG001|Overall Study|Explant|5|||
27582089|NCT02673697|80313931|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
27582090|NCT02673697|80313932|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
27582091|NCT02199691|80313934|FG000|Overall Study|Protocol Violation|3|||
27582092|NCT02199691|80313935|FG001|Overall Study|Protocol Violation|3|||
27582093|NCT02199691|80313936|FG002|Overall Study|Protocol Violation|6|||
27582094|NCT02199691|80313937|FG003|Overall Study|Protocol Violation|7|||
27582095|NCT02199691|80313934|FG000|Overall Study|Withdrawal by Subject|5|||
27582096|NCT02199691|80313935|FG001|Overall Study|Withdrawal by Subject|3|||
27582097|NCT02199691|80313936|FG002|Overall Study|Withdrawal by Subject|12|||
27582098|NCT02199691|80313937|FG003|Overall Study|Withdrawal by Subject|13|||
27680881|NCT00338962|80667932|FG003|Overall Study|Time Constraint|0|||
27680882|NCT00338962|80667929|FG000|Overall Study|Moved|0|||
27680883|NCT00338962|80667930|FG001|Overall Study|Moved|1|||
27680884|NCT00338962|80667931|FG002|Overall Study|Moved|0|||
27680885|NCT00338962|80667932|FG003|Overall Study|Moved|0|||
27680886|NCT00338962|80667929|FG000|Overall Study|Adverse Event|0|||
27680887|NCT00338962|80667930|FG001|Overall Study|Adverse Event|0|||
27680888|NCT00338962|80667931|FG002|Overall Study|Adverse Event|2|||
27680889|NCT00338962|80667932|FG003|Overall Study|Adverse Event|0|||
27680890|NCT00338962|80667929|FG000|Overall Study|Poor Compliance|0|||
27680891|NCT00338962|80667930|FG001|Overall Study|Poor Compliance|0|||
27680892|NCT00338962|80667931|FG002|Overall Study|Poor Compliance|2|||
27680893|NCT00338962|80667932|FG003|Overall Study|Poor Compliance|0|||
27680894|NCT00821587|80667938|FG000|Overall Study|Physician Decision|0|||
27680895|NCT00821587|80667939|FG001|Overall Study|Physician Decision|1|||
27680896|NCT03258723|80667940|FG000|Overall Study|COVID Interruption of study|54|||
27680897|NCT03258723|80667940|FG000|Overall Study|Lost to Follow-up|8|||
27680898|NCT00581893|80667941|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
27680899|NCT00581893|80667942|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
27680900|NCT04655027|80667943|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
27680901|NCT04655027|80667944|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
27680902|NCT00224887|80667945|FG000|Overall Study|Pregnancy|6|||
27680903|NCT00224887|80667946|FG001|Overall Study|Pregnancy|6|||
27680904|NCT01696045|80667949|FG000|Overall Study|Study drug toxicity|1|||
27680905|NCT01696045|80667950|FG001|Overall Study|Study drug toxicity|5|||
27680906|NCT01696045|80667949|FG000|Overall Study|Disease progression|2|||
27680907|NCT01696045|80667950|FG001|Overall Study|Disease progression|2|||
27680908|NCT02683785|80667951|FG000|Overall Study|Withdrawal by Subject|1|||
27680909|NCT02683785|80667952|FG001|Overall Study|Withdrawal by Subject|1|||
27680910|NCT02683785|80667951|FG000|Overall Study|Lost to Follow-up|0|||
27680911|NCT02683785|80667952|FG001|Overall Study|Lost to Follow-up|1|||
27680912|NCT02683785|80667951|FG000|Overall Study|Adverse Event|0|||
27680913|NCT02683785|80667952|FG001|Overall Study|Adverse Event|2|||
27680914|NCT02992691|80667956|FG000|Overall Study|Adverse Event|2|||
27680915|NCT02992691|80667956|FG000|Overall Study|Withdrawal by Subject|1|||
27680916|NCT01182441|80667957|FG000|Overall Study|Patient Still in Follow-up|152|||
27680917|NCT01182441|80667958|FG001|Overall Study|Patient Still in Follow-up|72|||
27680918|NCT01182441|80667957|FG000|Overall Study|Death|37|||
27680919|NCT01182441|80667958|FG001|Overall Study|Death|25|||
27680920|NCT01182441|80667957|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
27680921|NCT01182441|80667958|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
27680922|NCT01182441|80667957|FG000|Overall Study|Lost to Follow-up|5|||
27680923|NCT01182441|80667958|FG001|Overall Study|Lost to Follow-up|8|||
27680924|NCT01182441|80667957|FG000|Overall Study|Withdrawal by Subject|6|||
27680925|NCT01182441|80667958|FG001|Overall Study|Withdrawal by Subject|13|||
27680926|NCT01182441|80667957|FG000|Overall Study|Implant Not Attempted|4|||
27680927|NCT01182441|80667958|FG001|Overall Study|Implant Not Attempted|0|||
27680928|NCT01182441|80667957|FG000|Overall Study|Adverse Event|2|||
27680929|NCT01182441|80667958|FG001|Overall Study|Adverse Event|0|||
27680930|NCT01182441|80667957|FG000|Overall Study|Physician Decision|1|||
27680931|NCT01182441|80667958|FG001|Overall Study|Physician Decision|1|||
27680932|NCT00392925|80667959|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
27680933|NCT00392925|80667960|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
27680934|NCT00392925|80667961|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
27680935|NCT00392925|80667962|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
27680936|NCT00392925|80667959|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
27680937|NCT00392925|80667960|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
27680938|NCT00392925|80667961|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
27680939|NCT00392925|80667962|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
27680940|NCT00392925|80667959|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
27680941|NCT00392925|80667960|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
28000381|NCT01695135|81830960|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
28000382|NCT01695135|81830961|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
28000383|NCT02836652|81830963|FG000|Overall Study|Death|3|||
28000384|NCT02836652|81830964|FG001|Overall Study|Death|3|||
28000385|NCT02836652|81830963|FG000|Overall Study|Transplant/Explant|3|||
28000386|NCT02836652|81830964|FG001|Overall Study|Transplant/Explant|4|||
28000387|NCT02836652|81830963|FG000|Overall Study|Withdrawn|9|||
27680942|NCT00392925|80667961|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
27680943|NCT00392925|80667962|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
28000388|NCT02836652|81830964|FG001|Overall Study|Withdrawn|9|||
27680944|NCT00392925|80667959|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
27680945|NCT00392925|80667960|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
28000389|NCT02836652|81830963|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
27680946|NCT00392925|80667961|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
27582099|NCT02199691|80313934|FG000|Overall Study|Lost to Follow-up|2|||
27582100|NCT02199691|80313935|FG001|Overall Study|Lost to Follow-up|1|||
27582101|NCT02199691|80313936|FG002|Overall Study|Lost to Follow-up|9|||
27582102|NCT02199691|80313937|FG003|Overall Study|Lost to Follow-up|10|||
27582103|NCT02338362|80313942|FG000|Overall Study|Withdrawal by Subject|1|||
27582104|NCT02338362|80313943|FG001|Overall Study|Withdrawal by Subject|1|||
27582105|NCT03073603|80313944|FG000|Overall Study|Noncompliance|3|||
27582106|NCT03073603|80313945|FG001|Overall Study|Noncompliance|1|||
27582107|NCT03073603|80313944|FG000|Overall Study|Adverse Event|5|||
27680947|NCT00392925|80667962|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
27680948|NCT00392925|80667959|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
27680949|NCT00392925|80667960|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
27680950|NCT00392925|80667961|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
27680951|NCT00392925|80667962|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
27680952|NCT00392925|80667959|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
27680953|NCT00392925|80667960|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
27680954|NCT00392925|80667961|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
27680955|NCT00392925|80667962|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
27680956|NCT00392925|80667959|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
27680957|NCT00392925|80667960|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
27680958|NCT00392925|80667961|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
27680959|NCT00392925|80667962|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
27680960|NCT00392925|80667959|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
27680961|NCT00392925|80667960|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
27680962|NCT00392925|80667961|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
27680963|NCT00392925|80667962|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
27680964|NCT00392925|80667959|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
27680965|NCT00392925|80667960|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
27680966|NCT00392925|80667961|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
27680967|NCT00392925|80667962|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
27680968|NCT00678301|80667965|FG000|Overall Study|Non-compliance with study procedures|0|||
27680969|NCT00678301|80667966|FG001|Overall Study|Non-compliance with study procedures|1|||
27680970|NCT00678301|80667965|FG000|Overall Study|Adverse Event|1|||
27680971|NCT00678301|80667966|FG001|Overall Study|Adverse Event|0|||
27680972|NCT00678301|80667965|FG000|Overall Study|Withdrawal by Subject|4|||
27680973|NCT00678301|80667966|FG001|Overall Study|Withdrawal by Subject|0|||
27680974|NCT00678301|80667965|FG000|Overall Study|Lost to Follow-up|3|||
27680975|NCT00678301|80667966|FG001|Overall Study|Lost to Follow-up|1|||
27680976|NCT02232243|80667967|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
27680977|NCT02232243|80667968|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
27680978|NCT02232243|80667969|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
27680979|NCT00406692|80667970|FG000|Overall Study|Withdrawal by Subject|4|||
27680980|NCT00406692|80667970|FG000|Overall Study|Physician Decision|1|||
27680981|NCT00406692|80667970|FG000|Overall Study|Adverse Event|1|||
27680982|NCT00406692|80667970|FG000|Overall Study|Lack of Efficacy|1|||
27680983|NCT01399918|80667976|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
27680984|NCT01023958|80667977|FG000|Overall Study|Progressive disease|48|||
27680985|NCT01023958|80667977|FG000|Overall Study|Other adverse event|1|||
27680986|NCT01023958|80667977|FG000|Overall Study|Refused to continue medication|1|||
27680987|NCT04230122|80667982|FG000|Overall Study|Lost to Follow-up|1|||
27680988|NCT04230122|80667983|FG001|Overall Study|Lost to Follow-up|0|||
27680989|NCT02088957|80667984|FG000|Overall Study|Lack of Efficacy|1|||
27680990|NCT02088957|80667985|FG001|Overall Study|Lack of Efficacy|0|||
27680991|NCT01213524|80667990|FG000|Baseline|Withdrawal by Subject|5|||
27680992|NCT01213524|80667990|FG000|Baseline|high breath alcohol levels|1|||
27680993|NCT01213524|80667990|FG000|Baseline|Physician Decision|1|||
27680994|NCT01213524|80667990|FG000|Session 2|Withdrawal by Subject|5|||
27680995|NCT01213524|80667990|FG000|Session 3|Withdrawal by Subject|4|||
27680996|NCT01213524|80667990|FG000|Session 4|Physician Decision|1|||
27873837|NCT01499095|81371588|FG001|Overall Study|Hypoglycemia|1|||
27680997|NCT01213524|80667990|FG000|Session 4|Withdrawal by Subject|2|||
27680998|NCT01152814|80667991|FG000|Overall Study|Lost to Follow-up|2|||
27680999|NCT00513305|80667992|FG000|Overall Study|Adverse Event|6|||
27681000|NCT00513305|80667993|FG001|Overall Study|Adverse Event|2|||
27681001|NCT00513305|80667992|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
27681002|NCT00513305|80667993|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
27681003|NCT00513305|80667992|FG000|Overall Study|Lack of Efficacy|8|||
27873838|NCT01499095|81371587|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
27582108|NCT03073603|80313945|FG001|Overall Study|Adverse Event|3|||
27582109|NCT03073603|80313944|FG000|Overall Study|Physician Decision|1|||
27582110|NCT03073603|80313945|FG001|Overall Study|Physician Decision|2|||
27681004|NCT00513305|80667993|FG001|Overall Study|Lack of Efficacy|13|||
27681005|NCT00513305|80667992|FG000|Overall Study|Withdrawal by Subject|1|||
27681006|NCT00513305|80667993|FG001|Overall Study|Withdrawal by Subject|2|||
27681007|NCT00513305|80667992|FG000|Overall Study|Disease progression|8|||
27681008|NCT00513305|80667993|FG001|Overall Study|Disease progression|5|||
27681009|NCT00513305|80667992|FG000|Overall Study|Eligible for stem cell transplant|1|||
27681010|NCT00513305|80667993|FG001|Overall Study|Eligible for stem cell transplant|0|||
27681011|NCT00513305|80667992|FG000|Overall Study|Hematologic counts did not recover|1|||
27681012|NCT00513305|80667993|FG001|Overall Study|Hematologic counts did not recover|0|||
27681013|NCT00513305|80667992|FG000|Overall Study|Physician Decision|1|||
27681014|NCT00513305|80667993|FG001|Overall Study|Physician Decision|0|||
27681015|NCT00513305|80667992|FG000|Overall Study|Persistent hypocellularity|0|||
27681016|NCT00513305|80667993|FG001|Overall Study|Persistent hypocellularity|1|||
27681017|NCT00513305|80667992|FG000|Overall Study|Sponsor Decision|0|||
27681018|NCT00513305|80667993|FG001|Overall Study|Sponsor Decision|2|||
27681019|NCT03248882|80667994|FG000|Overall Study|Adverse Event|3|||
27681020|NCT03248882|80667995|FG001|Overall Study|Adverse Event|3|||
27681021|NCT03248882|80667996|FG002|Overall Study|Adverse Event|2|||
27681022|NCT03248882|80667997|FG003|Overall Study|Adverse Event|6|||
27681023|NCT03248882|80667998|FG004|Overall Study|Adverse Event|9|||
27681024|NCT03248882|80667994|FG000|Overall Study|Lost to Follow-up|0|||
27681025|NCT03248882|80667995|FG001|Overall Study|Lost to Follow-up|0|||
27681026|NCT03248882|80667996|FG002|Overall Study|Lost to Follow-up|0|||
27681027|NCT03248882|80667997|FG003|Overall Study|Lost to Follow-up|0|||
27681028|NCT03248882|80667998|FG004|Overall Study|Lost to Follow-up|1|||
27681029|NCT03248882|80667994|FG000|Overall Study|Protocol Violation|2|||
27681030|NCT03248882|80667995|FG001|Overall Study|Protocol Violation|0|||
27681031|NCT03248882|80667996|FG002|Overall Study|Protocol Violation|2|||
27681032|NCT03248882|80667997|FG003|Overall Study|Protocol Violation|0|||
27681033|NCT03248882|80667998|FG004|Overall Study|Protocol Violation|1|||
27681034|NCT03248882|80667994|FG000|Overall Study|Withdrawal by Subject|2|||
27681035|NCT03248882|80667995|FG001|Overall Study|Withdrawal by Subject|2|||
27681036|NCT03248882|80667996|FG002|Overall Study|Withdrawal by Subject|3|||
27681037|NCT03248882|80667997|FG003|Overall Study|Withdrawal by Subject|4|||
27681038|NCT03248882|80667998|FG004|Overall Study|Withdrawal by Subject|2|||
27681039|NCT00667225|80668010|FG000|Overall Study|Subject had no more lesions to treat.|1|||
27681040|NCT00667225|80668011|FG001|Overall Study|Subject had no more lesions to treat.|0|||
27681041|NCT00667225|80668010|FG000|Overall Study|Lost to Follow-up|0|||
27681042|NCT00667225|80668011|FG001|Overall Study|Lost to Follow-up|1|||
27681043|NCT05330676|80668016|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
27681044|NCT05330676|80668017|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
27681045|NCT02472145|80668018|FG000|Overall Study|Death|10|||
27681046|NCT02472145|80668019|FG001|Overall Study|Death|101|||
27681047|NCT02472145|80668020|FG002|Overall Study|Death|99|||
27681048|NCT02472145|80668018|FG000|Overall Study|Lost to Follow-up|0|||
27681049|NCT02472145|80668019|FG001|Overall Study|Lost to Follow-up|1|||
27681050|NCT02472145|80668020|FG002|Overall Study|Lost to Follow-up|0|||
27681051|NCT02472145|80668018|FG000|Overall Study|Withdrawal by Subject|0|||
27681052|NCT02472145|80668019|FG001|Overall Study|Withdrawal by Subject|9|||
27681053|NCT02472145|80668020|FG002|Overall Study|Withdrawal by Subject|13|||
27681054|NCT02472145|80668018|FG000|Overall Study|Sponsor decision|0|||
27681055|NCT02472145|80668019|FG001|Overall Study|Sponsor decision|3|||
27681056|NCT02472145|80668020|FG002|Overall Study|Sponsor decision|2|||
27681057|NCT02472145|80668018|FG000|Overall Study|Other|0|||
27681058|NCT02472145|80668019|FG001|Overall Study|Other|45|||
27681059|NCT02472145|80668020|FG002|Overall Study|Other|43|||
27681060|NCT03846453|80668026|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
27681061|NCT03846453|80668027|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
27681062|NCT03846453|80668028|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
28000390|NCT02836652|81830964|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
28000391|NCT01454596|81830968|FG000|Overall Study|Death|0|||
27681063|NCT03846453|80668026|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
27681064|NCT03846453|80668027|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
27681065|NCT03846453|80668028|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
27681066|NCT03846453|80668026|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
27681067|NCT03846453|80668027|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
27681068|NCT03846453|80668028|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
27681069|NCT03846453|80668026|FG000|Placebo Run-in (14 Days)|Other|2|||
27681070|NCT03846453|80668027|FG001|Placebo Run-in (14 Days)|Other|0|||
27681071|NCT03846453|80668028|FG002|Placebo Run-in (14 Days)|Other|0|||
27681072|NCT03846453|80668026|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
27681073|NCT03846453|80668027|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
28000392|NCT01454596|81830969|FG001|Overall Study|Death|0|||
27681074|NCT03846453|80668028|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
27805841|NCT00095199|81120407|FG003|Overall Study|Started Palliative Radiotherapy|0|||
28000393|NCT01454596|81830970|FG002|Overall Study|Death|0|||
28000394|NCT01454596|81830971|FG003|Overall Study|Death|0|||
28000395|NCT01454596|81830972|FG004|Overall Study|Death|0|||
28000396|NCT01454596|81830973|FG005|Overall Study|Death|0|||
28000397|NCT01454596|81830974|FG006|Overall Study|Death|0|||
28000398|NCT01454596|81830975|FG007|Overall Study|Death|0|||
28000399|NCT01454596|81830976|FG008|Overall Study|Death|0|||
28000400|NCT01454596|81830977|FG009|Overall Study|Death|1|||
28000401|NCT01454596|81830978|FG010|Overall Study|Death|1|||
28000402|NCT01454596|81830979|FG011|Overall Study|Death|0|||
28000403|NCT00836589|81830980|FG000|Overall Study|Lost to Follow-up|246|||
27681075|NCT03846453|80668026|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
27681076|NCT03846453|80668027|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
27681077|NCT03846453|80668028|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
27681078|NCT03846453|80668026|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
27681079|NCT03846453|80668027|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
27681080|NCT03846453|80668028|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
27681081|NCT03846453|80668026|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
27681082|NCT03846453|80668027|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
27681083|NCT03846453|80668028|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
27681084|NCT03846453|80668026|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
27681085|NCT03846453|80668027|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
27681086|NCT03846453|80668028|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
27681087|NCT04076943|80668029|FG000|Overall Study|Withdrawal by Subject|12|||
27681088|NCT04076943|80668029|FG000|Overall Study|Adverse Event|1|||
27681089|NCT04076943|80668029|FG000|Overall Study|Progressive Disease|2|||
27681090|NCT04076943|80668029|FG000|Overall Study|Death|13|||
27681091|NCT04076943|80668029|FG000|Overall Study|Other than specified|6|||
27681092|NCT01818531|80668030|FG000|Overall Study|Withdrawn for case delay after block|1|||
27681093|NCT01818531|80668031|FG001|Overall Study|Withdrawn for case delay after block|0|||
27681094|NCT01818531|80668030|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
27681095|NCT01818531|80668031|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
27681096|NCT01818531|80668030|FG000|Overall Study|Withdrawn for failure to place block|0|||
27681097|NCT01818531|80668031|FG001|Overall Study|Withdrawn for failure to place block|1|||
27681098|NCT00523640|80668038|FG000|Overall Study|Death|1|||
27681099|NCT00293059|80668039|FG000|Overall Study|Adverse Event|12|||
27681100|NCT00293059|80668040|FG001|Overall Study|Adverse Event|4|||
27681101|NCT00293059|80668039|FG000|Overall Study|Lack of Efficacy|2|||
27681102|NCT00293059|80668040|FG001|Overall Study|Lack of Efficacy|0|||
27681103|NCT00293059|80668039|FG000|Overall Study|Lost to Follow-up|2|||
28000404|NCT00836589|81830980|FG000|Overall Study|Death|429|||
28000405|NCT00836589|81830980|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
28000406|NCT00217425|81834205|FG000|Overall Study|Never started treatment|2|||
28000407|NCT00217425|81834205|FG000|Overall Study|Patient ineligible|5|||
28000408|NCT00217425|81834205|FG000|Overall Study|Lack of Efficacy|13|||
27681104|NCT00293059|80668040|FG001|Overall Study|Lost to Follow-up|3|||
27681105|NCT00293059|80668039|FG000|Overall Study|Pregnancy|1|||
27681106|NCT00293059|80668040|FG001|Overall Study|Pregnancy|1|||
28000409|NCT00217425|81834205|FG000|Overall Study|Adverse Event|8|||
28000410|NCT00217425|81834205|FG000|Overall Study|Withdrawal by Subject|4|||
28000411|NCT00217425|81834205|FG000|Overall Study|Other complicating disease|1|||
28000412|NCT00217425|81834205|FG000|Overall Study|Other|4|||
28000413|NCT01693029|81834206|FG000|Overall Study|Withdrawal by Subject|15|||
28000414|NCT01693029|81834207|FG001|Overall Study|Withdrawal by Subject|22|||
27582111|NCT03073603|80313944|FG000|Overall Study|Required treatment not allowed by protocol|1|||
27582112|NCT03073603|80313945|FG001|Overall Study|Required treatment not allowed by protocol|0|||
27582113|NCT03073603|80313944|FG000|Overall Study|Financial or insurance-related|8|||
27582114|NCT03073603|80313945|FG001|Overall Study|Financial or insurance-related|0|||
27582115|NCT03073603|80313944|FG000|Overall Study|Withdrawal by Subject|0|||
27582116|NCT03073603|80313945|FG001|Overall Study|Withdrawal by Subject|1|||
27582117|NCT03073603|80313944|FG000|Overall Study|Discontinued DMT|4|||
27582118|NCT03073603|80313945|FG001|Overall Study|Discontinued DMT|0|||
27582119|NCT03073603|80313944|FG000|Overall Study|Restarted DMT|0|||
27582120|NCT03073603|80313945|FG001|Overall Study|Restarted DMT|1|||
27582121|NCT00642304|80313946|FG000|Overall Study|Adverse Event|1|||
27582122|NCT00642304|80313946|FG000|Overall Study|Death|1|||
27582123|NCT00642304|80313946|FG000|Overall Study|Blood transfusion|2|||
27582124|NCT00642304|80313946|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
27582125|NCT00642304|80313946|FG000|Overall Study|Transplantation|1|||
27582126|NCT00766415|80313947|FG000|Overall Study|Withdrawal by Subject|0|||
27582127|NCT00766415|80313948|FG001|Overall Study|Withdrawal by Subject|1|||
27582128|NCT00262834|80313949|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
27582129|NCT00262834|80313950|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
27582130|NCT04934670|80313951|FG000|Overall Study|Death|4|||
27582131|NCT04934670|80313952|FG001|Overall Study|Death|0|||
27582132|NCT04934670|80313951|FG000|Overall Study|Lost to Follow-up|1|||
27582133|NCT04934670|80313952|FG001|Overall Study|Lost to Follow-up|4|||
27582134|NCT01696032|80313953|FG000|Overall Study|Withdrawal by Subject|0|||
27582135|NCT01696032|80313954|FG001|Overall Study|Withdrawal by Subject|0|||
27582136|NCT01696032|80313955|FG002|Overall Study|Withdrawal by Subject|1|||
27582137|NCT01696032|80313956|FG003|Overall Study|Withdrawal by Subject|2|||
27582138|NCT01696032|80313953|FG000|Overall Study|Death|14|||
27582139|NCT01696032|80313954|FG001|Overall Study|Death|4|||
27582140|NCT01696032|80313955|FG002|Overall Study|Death|43|||
27582141|NCT01696032|80313956|FG003|Overall Study|Death|18|||
27582142|NCT01696032|80313953|FG000|Overall Study|Lost to Follow-up|0|||
27582143|NCT01696032|80313954|FG001|Overall Study|Lost to Follow-up|1|||
27582144|NCT01696032|80313955|FG002|Overall Study|Lost to Follow-up|0|||
27582145|NCT01696032|80313956|FG003|Overall Study|Lost to Follow-up|0|||
27582146|NCT01696032|80313953|FG000|Overall Study|Database lock|0|||
27805842|NCT00095199|81120404|FG000|Overall Study|Started radiotherapy regimen|0|||
27805843|NCT00095199|81120405|FG001|Overall Study|Started radiotherapy regimen|1|||
27805844|NCT00095199|81120406|FG002|Overall Study|Started radiotherapy regimen|0|||
27805845|NCT00095199|81120407|FG003|Overall Study|Started radiotherapy regimen|0|||
27805846|NCT00095199|81120404|FG000|Overall Study|Primary tumor removed in other surgery|0|||
27805847|NCT00095199|81120405|FG001|Overall Study|Primary tumor removed in other surgery|1|||
27805848|NCT00095199|81120406|FG002|Overall Study|Primary tumor removed in other surgery|0|||
27805849|NCT00095199|81120407|FG003|Overall Study|Primary tumor removed in other surgery|0|||
27805850|NCT00095199|81120404|FG000|Overall Study|Data inadvertently lost by site|1|||
27805851|NCT00095199|81120405|FG001|Overall Study|Data inadvertently lost by site|0|||
27805852|NCT00095199|81120406|FG002|Overall Study|Data inadvertently lost by site|0|||
27582147|NCT01696032|80313954|FG001|Overall Study|Database lock|1|||
27582148|NCT01696032|80313955|FG002|Overall Study|Database lock|7|||
27582149|NCT01696032|80313956|FG003|Overall Study|Database lock|2|||
27582150|NCT00226941|80313957|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
27582151|NCT00226941|80313958|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
27582152|NCT00226941|80313959|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
27582153|NCT00226941|80313960|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
27582154|NCT00226941|80313957|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
27582155|NCT00226941|80313958|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
27582156|NCT00226941|80313959|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
27582157|NCT00226941|80313960|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
27582158|NCT01794949|80313961|FG000|Overall Study|Lost to Follow-up|1|||
27582159|NCT01794949|80313962|FG001|Overall Study|Lost to Follow-up|0|||
27582160|NCT01438411|80313963|FG000|Overall Study|Adverse Event|8|||
27582161|NCT01438411|80313963|FG000|Overall Study|Lost to Follow-up|1|||
27582162|NCT01438411|80313963|FG000|Overall Study|Lack of Efficacy|1|||
27582163|NCT01438411|80313963|FG000|Overall Study|Withdrawal by Subject|3|||
27582164|NCT00616967|80313964|FG000|Overall Study|Withdrawal by Subject|0|||
27582165|NCT00616967|80313965|FG001|Overall Study|Withdrawal by Subject|0|||
27582166|NCT00616967|80313966|FG002|Overall Study|Withdrawal by Subject|1|||
27582167|NCT02770391|80313969|FG000|Overall Study|Lost to Follow-up|2|||
27582168|NCT02770391|80313969|FG000|Overall Study|Withdrawal by Subject|1|||
27582169|NCT02770391|80313969|FG000|Overall Study|Surgery delayed unevaluable|2|||
27582170|NCT02770391|80313969|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
27805853|NCT00095199|81120407|FG003|Overall Study|Data inadvertently lost by site|0|||
27582171|NCT03217136|80313970|FG000|Overall Study|Lost to Follow-up|2|||
27582172|NCT03217136|80313971|FG001|Overall Study|Lost to Follow-up|1|||
27582173|NCT03217136|80313970|FG000|Overall Study|Site Randomized Participant in Error|0|||
27582174|NCT03217136|80313971|FG001|Overall Study|Site Randomized Participant in Error|1|||
27582175|NCT03217136|80313970|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
27582176|NCT03217136|80313971|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
27582177|NCT03217136|80313970|FG000|Overall Study|Dispensing Error|1|||
27582178|NCT03217136|80313971|FG001|Overall Study|Dispensing Error|0|||
27582179|NCT03217136|80313970|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27582180|NCT03217136|80313971|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27582181|NCT01105533|80313972|FG000|Overall Study|Death|0|||
27582182|NCT01105533|80313973|FG001|Overall Study|Death|0|||
27582183|NCT01105533|80313974|FG002|Overall Study|Death|0|||
27582184|NCT01105533|80313975|FG003|Overall Study|Death|0|||
27582185|NCT01105533|80313976|FG004|Overall Study|Death|1|||
27582186|NCT01105533|80313977|FG005|Overall Study|Death|0|||
27582187|NCT01105533|80313978|FG006|Overall Study|Death|0|||
27582188|NCT01105533|80313979|FG007|Overall Study|Death|0|||
27582189|NCT01105533|80313980|FG008|Overall Study|Death|0|||
27582190|NCT01105533|80313972|FG000|Overall Study|Lack of Efficacy|1|||
27582191|NCT01105533|80313973|FG001|Overall Study|Lack of Efficacy|1|||
27582192|NCT01105533|80313974|FG002|Overall Study|Lack of Efficacy|3|||
27873839|NCT01499095|81371588|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
27873840|NCT01499095|81371587|FG000|Overall Study|Change in Injection Schedule|2|||
27873841|NCT01499095|81371588|FG001|Overall Study|Change in Injection Schedule|0|||
27873842|NCT01499095|81371587|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27873843|NCT01499095|81371588|FG001|Overall Study|Perceived Lack of Efficacy|1|||
27873844|NCT02383017|81371590|FG000|Overall Study|Injury Sustained Outside Study|1|||
27873845|NCT02383017|81371591|FG001|Overall Study|Injury Sustained Outside Study|0|||
27873846|NCT02383017|81371590|FG000|Overall Study|Compliance|3|||
27873847|NCT02383017|81371591|FG001|Overall Study|Compliance|2|||
27873848|NCT02383017|81371590|FG000|Overall Study|Found to be Hypogonadal|1|||
27873849|NCT02383017|81371591|FG001|Overall Study|Found to be Hypogonadal|0|||
27873850|NCT02540083|81371592|FG000|Overall Study|Withdrawal by Subject|16|||
28000415|NCT01693029|81834206|FG000|Overall Study|Kidney transplantation|7|||
28000416|NCT01693029|81834207|FG001|Overall Study|Kidney transplantation|7|||
28000417|NCT01693029|81834206|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
27582193|NCT01105533|80313975|FG003|Overall Study|Lack of Efficacy|3|||
27582194|NCT01105533|80313976|FG004|Overall Study|Lack of Efficacy|4|||
27582195|NCT01105533|80313977|FG005|Overall Study|Lack of Efficacy|5|||
27582196|NCT01105533|80313978|FG006|Overall Study|Lack of Efficacy|3|||
27582197|NCT01105533|80313979|FG007|Overall Study|Lack of Efficacy|2|||
27582198|NCT01105533|80313980|FG008|Overall Study|Lack of Efficacy|9|||
27582199|NCT01105533|80313972|FG000|Overall Study|Adverse Event|0|||
27582200|NCT01105533|80313973|FG001|Overall Study|Adverse Event|0|||
27873851|NCT04650204|81371594|FG000|Overall Study|Study was Terminated|2|||
27873852|NCT04650204|81371595|FG001|Overall Study|Study was Terminated|1|||
28000418|NCT01693029|81834207|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
27582201|NCT01105533|80313974|FG002|Overall Study|Adverse Event|0|||
27582202|NCT01105533|80313975|FG003|Overall Study|Adverse Event|0|||
27582203|NCT01105533|80313976|FG004|Overall Study|Adverse Event|1|||
27582204|NCT01105533|80313977|FG005|Overall Study|Adverse Event|2|||
27582205|NCT01105533|80313978|FG006|Overall Study|Adverse Event|2|||
27582206|NCT01105533|80313979|FG007|Overall Study|Adverse Event|0|||
27582207|NCT01105533|80313980|FG008|Overall Study|Adverse Event|1|||
27582208|NCT01105533|80313972|FG000|Overall Study|Other|0|||
27582209|NCT01105533|80313973|FG001|Overall Study|Other|0|||
27873853|NCT03871543|81371596|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
27873854|NCT03871543|81371596|FG000|Period 1|Investigator Error|1|||
28000419|NCT01693029|81834206|FG000|Overall Study|Protocol Violation|6|||
28000420|NCT01693029|81834207|FG001|Overall Study|Protocol Violation|7|||
28000421|NCT01693029|81834206|FG000|Overall Study|Change in dialysis modality|2|||
28000422|NCT01693029|81834207|FG001|Overall Study|Change in dialysis modality|1|||
28000423|NCT01693029|81834206|FG000|Overall Study|Physician Decision|0|||
28000424|NCT01693029|81834207|FG001|Overall Study|Physician Decision|2|||
28000425|NCT01693029|81834206|FG000|Overall Study|Lost to Follow-up|0|||
28000426|NCT01693029|81834207|FG001|Overall Study|Lost to Follow-up|1|||
28000427|NCT01693029|81834206|FG000|Overall Study|Adverse Event|1|||
28000428|NCT01693029|81834207|FG001|Overall Study|Adverse Event|6|||
28000429|NCT01693029|81834206|FG000|Overall Study|Death|5|||
28000430|NCT01693029|81834207|FG001|Overall Study|Death|8|||
28000431|NCT01693029|81834206|FG000|Overall Study|Non-compliance|2|||
27582210|NCT01105533|80313974|FG002|Overall Study|Other|0|||
27582211|NCT01105533|80313975|FG003|Overall Study|Other|0|||
27582212|NCT01105533|80313976|FG004|Overall Study|Other|1|||
27582213|NCT01105533|80313977|FG005|Overall Study|Other|0|||
28000432|NCT01693029|81834207|FG001|Overall Study|Non-compliance|1|||
28000433|NCT01702558|81834212|FG000|Overall Study|Withdrawal by Subject|0|||
28000434|NCT01702558|81834213|FG001|Overall Study|Withdrawal by Subject|0|||
28000435|NCT01702558|81834214|FG002|Overall Study|Withdrawal by Subject|0|||
27582214|NCT01105533|80313978|FG006|Overall Study|Other|3|||
27582215|NCT01105533|80313979|FG007|Overall Study|Other|1|||
27582216|NCT01105533|80313980|FG008|Overall Study|Other|2|||
27582217|NCT01105533|80313972|FG000|Overall Study|Physician Decision|0|||
27582218|NCT01105533|80313973|FG001|Overall Study|Physician Decision|0|||
27582219|NCT01105533|80313974|FG002|Overall Study|Physician Decision|0|||
27582220|NCT01105533|80313975|FG003|Overall Study|Physician Decision|0|||
27582221|NCT01105533|80313976|FG004|Overall Study|Physician Decision|0|||
27582222|NCT01105533|80313977|FG005|Overall Study|Physician Decision|0|||
27582223|NCT01105533|80313978|FG006|Overall Study|Physician Decision|0|||
27582224|NCT01105533|80313979|FG007|Overall Study|Physician Decision|1|||
27582225|NCT01105533|80313980|FG008|Overall Study|Physician Decision|0|||
27582226|NCT02956629|80313984|FG000|Overall Study|Adverse Event|0|||
27582227|NCT02956629|80313985|FG001|Overall Study|Adverse Event|0|||
27582228|NCT02956629|80313986|FG002|Overall Study|Adverse Event|1|||
27582229|NCT02956629|80313987|FG003|Overall Study|Adverse Event|0|||
27582230|NCT02956629|80313988|FG004|Overall Study|Adverse Event|0|||
27582231|NCT02956629|80313989|FG005|Overall Study|Adverse Event|0|||
27582232|NCT02956629|80313984|FG000|Overall Study|Lost to Follow-up|2|||
27582233|NCT02956629|80313985|FG001|Overall Study|Lost to Follow-up|5|||
27805854|NCT01664494|81120410|FG000|Overall Study|Withdrawal by Subject|27|||
27805855|NCT01664494|81120410|FG000|Overall Study|Death|18|||
27805856|NCT01664494|81120410|FG000|Overall Study|Other|49|||
27805857|NCT01664494|81120410|FG000|Overall Study|Lost to Follow-up|99|||
27805858|NCT02191579|81120411|FG000|Treatment 1|Multiple Reasons Specified|27|||
27805859|NCT02191579|81120412|FG001|Treatment 1|Multiple Reasons Specified|58|||
27805860|NCT02191579|81120411|FG000|Treatment 2|Multiple Reasons Specified|0|||
27805861|NCT02191579|81120412|FG001|Treatment 2|Multiple Reasons Specified|25|||
27805862|NCT01681771|81120413|FG000|Overall Study|Lost to Follow-up|4|||
27805863|NCT01681771|81120414|FG001|Overall Study|Lost to Follow-up|2|||
27805864|NCT04292171|81120416|FG000|Overall Study|Pharmacy error|2|||
27805865|NCT04292171|81120417|FG001|Overall Study|Pharmacy error|0|||
27805866|NCT04292171|81120416|FG000|Overall Study|Delivered prior to procedure|0|||
27805867|NCT04292171|81120417|FG001|Overall Study|Delivered prior to procedure|1|||
27805868|NCT02196506|81120418|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
27805869|NCT02196506|81120419|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
28000436|NCT01702558|81834215|FG003|Overall Study|Withdrawal by Subject|12|||
28000437|NCT01702558|81834216|FG004|Overall Study|Withdrawal by Subject|4|||
28000438|NCT01702558|81834212|FG000|Overall Study|Lost to Follow-up|0|||
28000439|NCT01702558|81834213|FG001|Overall Study|Lost to Follow-up|0|||
28000440|NCT01702558|81834214|FG002|Overall Study|Lost to Follow-up|0|||
28000441|NCT01702558|81834215|FG003|Overall Study|Lost to Follow-up|3|||
28000442|NCT01702558|81834216|FG004|Overall Study|Lost to Follow-up|0|||
28000443|NCT01702558|81834212|FG000|Overall Study|Death|4|||
28000444|NCT01702558|81834213|FG001|Overall Study|Death|3|||
28000445|NCT01702558|81834214|FG002|Overall Study|Death|3|||
28000446|NCT01702558|81834215|FG003|Overall Study|Death|16|||
28000447|NCT01702558|81834216|FG004|Overall Study|Death|20|||
28000448|NCT01702558|81834212|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
28000449|NCT01702558|81834213|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
28000450|NCT01702558|81834214|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
28000451|NCT01702558|81834215|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
28000452|NCT01702558|81834216|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
28000453|NCT01702558|81834212|FG000|Overall Study|Study Terminated by Sponsor|0|||
27582234|NCT02956629|80313986|FG002|Overall Study|Lost to Follow-up|3|||
27582235|NCT02956629|80313987|FG003|Overall Study|Lost to Follow-up|1|||
27582236|NCT02956629|80313988|FG004|Overall Study|Lost to Follow-up|0|||
27582237|NCT02956629|80313989|FG005|Overall Study|Lost to Follow-up|1|||
27582238|NCT02956629|80313984|FG000|Overall Study|Withdrawal by Subject|3|||
27582239|NCT02956629|80313985|FG001|Overall Study|Withdrawal by Subject|1|||
27582240|NCT02956629|80313986|FG002|Overall Study|Withdrawal by Subject|0|||
27582241|NCT02956629|80313987|FG003|Overall Study|Withdrawal by Subject|0|||
27582242|NCT02956629|80313988|FG004|Overall Study|Withdrawal by Subject|0|||
27582243|NCT02956629|80313989|FG005|Overall Study|Withdrawal by Subject|0|||
27582244|NCT04260191|80313990|FG000|Overall Study|Decision by Sponsor|0|||
27582245|NCT04260191|80313991|FG001|Overall Study|Decision by Sponsor|1|||
27582246|NCT04260191|80313992|FG002|Overall Study|Decision by Sponsor|0|||
28000454|NCT01702558|81834213|FG001|Overall Study|Study Terminated by Sponsor|1|||
28000455|NCT01702558|81834214|FG002|Overall Study|Study Terminated by Sponsor|0|||
27582247|NCT04260191|80313990|FG000|Overall Study|Withdrawal by Subject|1|||
27582248|NCT04260191|80313991|FG001|Overall Study|Withdrawal by Subject|0|||
27582249|NCT04260191|80313992|FG002|Overall Study|Withdrawal by Subject|3|||
27582250|NCT04260191|80313990|FG000|Overall Study|Death|4|||
27582251|NCT04260191|80313991|FG001|Overall Study|Death|3|||
27582252|NCT04260191|80313992|FG002|Overall Study|Death|2|||
27582253|NCT05101252|80314001|FG000|Overall Study|Unsatisfactory Test Article|1|||
27582254|NCT05101252|80314002|FG001|Overall Study|Unsatisfactory Test Article|0|||
27582255|NCT05101252|80314001|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
27582256|NCT05101252|80314002|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
27582257|NCT05101252|80314001|FG000|Overall Study|Withdrew Consent during study|0|||
27582258|NCT05101252|80314002|FG001|Overall Study|Withdrew Consent during study|1|||
27582259|NCT05101252|80314001|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
27582260|NCT05101252|80314002|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
27582261|NCT00812929|80314005|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
27582262|NCT00812929|80314006|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
27582263|NCT00812929|80314007|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
27582264|NCT00812929|80314008|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
27582265|NCT00812929|80314009|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
27582266|NCT00812929|80314010|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
27582267|NCT00812929|80314011|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
27582268|NCT00812929|80314012|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
27582269|NCT00812929|80314013|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
27582270|NCT00812929|80314014|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
27582271|NCT00812929|80314005|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
27582272|NCT00812929|80314006|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
27582273|NCT00812929|80314007|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
27582274|NCT00812929|80314008|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
27582275|NCT00812929|80314009|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
27582276|NCT00812929|80314010|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
28000456|NCT01702558|81834215|FG003|Overall Study|Study Terminated by Sponsor|0|||
28000457|NCT01702558|81834216|FG004|Overall Study|Study Terminated by Sponsor|1|||
28000458|NCT01702558|81834212|FG000|Overall Study|Other|0|||
28000459|NCT01702558|81834213|FG001|Overall Study|Other|0|||
28000460|NCT01702558|81834214|FG002|Overall Study|Other|0|||
28000461|NCT01702558|81834215|FG003|Overall Study|Other|16|||
28000462|NCT01702558|81834216|FG004|Overall Study|Other|17|||
28000463|NCT00764361|81834217|FG000|Overall Study|Withdrawal by Subject|2|||
28000464|NCT00764361|81834218|FG001|Overall Study|Withdrawal by Subject|3|||
28000465|NCT00764361|81834217|FG000|Overall Study|Adverse Event|0|||
28000466|NCT00764361|81834218|FG001|Overall Study|Adverse Event|1|||
28000467|NCT00148759|81834222|FG000|Overall Study|Withdrawal by Subject|1|||
28000468|NCT00148759|81834223|FG001|Overall Study|Withdrawal by Subject|1|||
28000469|NCT00148759|81834222|FG000|Overall Study|Lost to Follow-up|1|||
28000470|NCT00148759|81834223|FG001|Overall Study|Lost to Follow-up|0|||
28000471|NCT01290757|81834232|FG000|Overall Study|Adverse Event|1|||
28000472|NCT01290757|81834233|FG001|Overall Study|Adverse Event|0|||
28000473|NCT01290757|81834232|FG000|Overall Study|Protocol Violation|1|||
28000474|NCT01290757|81834233|FG001|Overall Study|Protocol Violation|1|||
28000475|NCT01290757|81834232|FG000|Overall Study|Other|0|||
28000476|NCT01290757|81834233|FG001|Overall Study|Other|1|||
28000477|NCT00703924|81834234|FG000|Overall Study|Withdrawal by Subject|1|||
28000478|NCT00703924|81834235|FG001|Overall Study|Withdrawal by Subject|1|||
28000479|NCT03259555|81834238|FG000|Overall Study|Adverse Event|6|||
28000480|NCT03259555|81834239|FG001|Overall Study|Adverse Event|4|||
28000481|NCT03259555|81834238|FG000|Overall Study|Lack of Efficacy|6|||
28000482|NCT03259555|81834239|FG001|Overall Study|Lack of Efficacy|4|||
28000483|NCT03259555|81834238|FG000|Overall Study|Lost to Follow-up|0|||
28000484|NCT03259555|81834239|FG001|Overall Study|Lost to Follow-up|2|||
28000485|NCT03259555|81834238|FG000|Overall Study|Non-Compliance With Study Drug|1|||
28000486|NCT03259555|81834239|FG001|Overall Study|Non-Compliance With Study Drug|0|||
28000487|NCT03259555|81834238|FG000|Overall Study|Progressive Disease|0|||
28000488|NCT03259555|81834239|FG001|Overall Study|Progressive Disease|2|||
28000489|NCT03259555|81834238|FG000|Overall Study|Withdrawal by Subject|19|||
28000490|NCT03259555|81834239|FG001|Overall Study|Withdrawal by Subject|16|||
27582277|NCT00812929|80314011|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
27582278|NCT00812929|80314012|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
27582279|NCT00812929|80314013|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
27582280|NCT00812929|80314014|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
27582281|NCT00812929|80314005|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
28000491|NCT03259555|81834238|FG000|Overall Study|Physician Decision|1|||
28000492|NCT03259555|81834239|FG001|Overall Study|Physician Decision|2|||
28000493|NCT03259555|81834238|FG000|Overall Study|Other|1|||
28000494|NCT03259555|81834239|FG001|Overall Study|Other|0|||
28000495|NCT03384940|81834240|FG000|Overall Study|Progressive disease|36|||
28000496|NCT03384940|81834241|FG001|Overall Study|Progressive disease|11|||
27582282|NCT00812929|80314006|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
27582283|NCT00812929|80314007|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
27582284|NCT00812929|80314008|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
27582285|NCT00812929|80314009|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
27582286|NCT00812929|80314010|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
27582287|NCT00812929|80314011|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
27582288|NCT00812929|80314012|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
27582289|NCT00812929|80314013|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
27582290|NCT00812929|80314014|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
27582291|NCT02391948|80314017|FG000|6-month Assessment|Death|0|||
27582292|NCT02391948|80314018|FG001|6-month Assessment|Death|0|||
27582293|NCT02391948|80314019|FG002|6-month Assessment|Death|0|||
28000497|NCT03384940|81834242|FG002|Overall Study|Progressive disease|13|||
28000498|NCT03384940|81834240|FG000|Overall Study|Clinical progression|4|||
27582294|NCT02391948|80314020|FG003|6-month Assessment|Death|0|||
27582295|NCT02391948|80314021|FG004|6-month Assessment|Death|1|||
28000499|NCT03384940|81834241|FG001|Overall Study|Clinical progression|0|||
28000500|NCT03384940|81834242|FG002|Overall Study|Clinical progression|3|||
28000501|NCT03384940|81834240|FG000|Overall Study|Adverse Event|7|||
28000502|NCT03384940|81834241|FG001|Overall Study|Adverse Event|1|||
27582296|NCT02391948|80314017|FG000|6-month Assessment|Withdrawal by Subject|0|||
27582297|NCT02391948|80314018|FG001|6-month Assessment|Withdrawal by Subject|0|||
27582298|NCT02391948|80314019|FG002|6-month Assessment|Withdrawal by Subject|1|||
27582299|NCT02391948|80314020|FG003|6-month Assessment|Withdrawal by Subject|2|||
27582300|NCT02391948|80314021|FG004|6-month Assessment|Withdrawal by Subject|0|||
27582301|NCT02391948|80314017|FG000|6-month Assessment|Lost to Follow-up|4|||
27582302|NCT02391948|80314018|FG001|6-month Assessment|Lost to Follow-up|5|||
27582303|NCT02391948|80314019|FG002|6-month Assessment|Lost to Follow-up|2|||
27582304|NCT02391948|80314020|FG003|6-month Assessment|Lost to Follow-up|3|||
27582305|NCT02391948|80314021|FG004|6-month Assessment|Lost to Follow-up|1|||
27582306|NCT02391948|80314017|FG000|6-month Assessment|Medical issue/illness|1|||
27681107|NCT00293059|80668039|FG000|Overall Study|Protocol Violation|2|||
28000503|NCT03384940|81834242|FG002|Overall Study|Adverse Event|1|||
28000504|NCT03384940|81834240|FG000|Overall Study|Withdrawal by Subject|3|||
28000505|NCT03384940|81834241|FG001|Overall Study|Withdrawal by Subject|1|||
28000506|NCT03384940|81834242|FG002|Overall Study|Withdrawal by Subject|0|||
28000507|NCT03384940|81834240|FG000|Overall Study|Physician Decision|1|||
28000508|NCT03384940|81834241|FG001|Overall Study|Physician Decision|1|||
28000509|NCT03384940|81834242|FG002|Overall Study|Physician Decision|0|||
27582307|NCT02391948|80314018|FG001|6-month Assessment|Medical issue/illness|1|||
27681108|NCT00293059|80668040|FG001|Overall Study|Protocol Violation|0|||
27805870|NCT02196506|81120420|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
28000510|NCT03384940|81834240|FG000|Overall Study|Death|2|||
28000511|NCT03384940|81834241|FG001|Overall Study|Death|1|||
27681109|NCT00293059|80668039|FG000|Overall Study|Withdrawal by Subject|11|||
27582308|NCT02391948|80314019|FG002|6-month Assessment|Medical issue/illness|0|||
27582309|NCT02391948|80314020|FG003|6-month Assessment|Medical issue/illness|0|||
27681110|NCT00293059|80668040|FG001|Overall Study|Withdrawal by Subject|5|||
27681111|NCT00293059|80668039|FG000|Overall Study|Participant moved out of state|1|||
27681112|NCT00293059|80668040|FG001|Overall Study|Participant moved out of state|0|||
28000512|NCT03384940|81834242|FG002|Overall Study|Death|0|||
28000513|NCT03384940|81834240|FG000|Overall Study|Other|0|||
27582310|NCT02391948|80314021|FG004|6-month Assessment|Medical issue/illness|0|||
27582311|NCT02391948|80314017|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
27582312|NCT02391948|80314018|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
27582313|NCT02391948|80314019|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
28000514|NCT03384940|81834241|FG001|Overall Study|Other|0|||
28000515|NCT03384940|81834242|FG002|Overall Study|Other|1|||
28000516|NCT03649074|81834243|FG000|Overall Study|Lost to Follow-up|2|||
28000517|NCT03649074|81834244|FG001|Overall Study|Lost to Follow-up|1|||
28000518|NCT03649074|81834243|FG000|Overall Study|Adverse Event|1|||
28000519|NCT03649074|81834244|FG001|Overall Study|Adverse Event|0|||
28000520|NCT03649074|81834243|FG000|Overall Study|Physician Decision|1|||
28000521|NCT03649074|81834244|FG001|Overall Study|Physician Decision|0|||
28000522|NCT03649074|81834243|FG000|Overall Study|Withdrawal by Subject|0|||
28000523|NCT03649074|81834244|FG001|Overall Study|Withdrawal by Subject|2|||
27582314|NCT02391948|80314020|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
27582315|NCT02391948|80314021|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
27582316|NCT02391948|80314017|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
27582317|NCT02391948|80314018|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
27582318|NCT02391948|80314019|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
27582319|NCT02391948|80314020|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
27582320|NCT02391948|80314021|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
27582321|NCT02391948|80314017|FG000|12-month Assessment|Death|0|||
27582322|NCT02391948|80314018|FG001|12-month Assessment|Death|0|||
27582323|NCT02391948|80314019|FG002|12-month Assessment|Death|0|||
27582324|NCT02391948|80314020|FG003|12-month Assessment|Death|1|||
27582325|NCT02391948|80314021|FG004|12-month Assessment|Death|0|||
27582326|NCT02391948|80314017|FG000|12-month Assessment|Withdrawal by Subject|1|||
27582327|NCT02391948|80314018|FG001|12-month Assessment|Withdrawal by Subject|0|||
27582328|NCT02391948|80314019|FG002|12-month Assessment|Withdrawal by Subject|0|||
27582329|NCT02391948|80314020|FG003|12-month Assessment|Withdrawal by Subject|1|||
27582330|NCT02391948|80314021|FG004|12-month Assessment|Withdrawal by Subject|0|||
27582331|NCT02391948|80314017|FG000|12-month Assessment|Lost to Follow-up|5|||
27582332|NCT02391948|80314018|FG001|12-month Assessment|Lost to Follow-up|4|||
27582333|NCT02391948|80314019|FG002|12-month Assessment|Lost to Follow-up|4|||
27582334|NCT02391948|80314020|FG003|12-month Assessment|Lost to Follow-up|4|||
27582335|NCT02391948|80314021|FG004|12-month Assessment|Lost to Follow-up|5|||
27582336|NCT02391948|80314017|FG000|12-month Assessment|Medical issue/illness|0|||
27582337|NCT02391948|80314018|FG001|12-month Assessment|Medical issue/illness|1|||
27582338|NCT02391948|80314019|FG002|12-month Assessment|Medical issue/illness|0|||
27582339|NCT02391948|80314020|FG003|12-month Assessment|Medical issue/illness|1|||
27582340|NCT02391948|80314021|FG004|12-month Assessment|Medical issue/illness|0|||
27582341|NCT02391948|80314017|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
27582342|NCT02391948|80314018|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
27582343|NCT02391948|80314019|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
27582344|NCT02391948|80314020|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
27582345|NCT02391948|80314021|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
27582346|NCT02391948|80314017|FG000|18-month Assessment|Death|0|||
27582347|NCT02391948|80314018|FG001|18-month Assessment|Death|0|||
27582348|NCT02391948|80314019|FG002|18-month Assessment|Death|0|||
27582349|NCT02391948|80314020|FG003|18-month Assessment|Death|1|||
27582350|NCT02391948|80314021|FG004|18-month Assessment|Death|1|||
27582351|NCT02391948|80314017|FG000|18-month Assessment|Withdrawal by Subject|1|||
27582352|NCT02391948|80314018|FG001|18-month Assessment|Withdrawal by Subject|0|||
27582353|NCT02391948|80314019|FG002|18-month Assessment|Withdrawal by Subject|0|||
27582354|NCT02391948|80314020|FG003|18-month Assessment|Withdrawal by Subject|1|||
27582355|NCT02391948|80314021|FG004|18-month Assessment|Withdrawal by Subject|0|||
27582356|NCT02391948|80314017|FG000|18-month Assessment|Lost to Follow-up|2|||
27582357|NCT02391948|80314018|FG001|18-month Assessment|Lost to Follow-up|6|||
27582358|NCT02391948|80314019|FG002|18-month Assessment|Lost to Follow-up|2|||
27582359|NCT02391948|80314020|FG003|18-month Assessment|Lost to Follow-up|2|||
27582360|NCT02391948|80314021|FG004|18-month Assessment|Lost to Follow-up|3|||
27582361|NCT02391948|80314017|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
27582362|NCT02391948|80314018|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
27582363|NCT02391948|80314019|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
27582364|NCT02391948|80314020|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
27582365|NCT02391948|80314021|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
27582366|NCT02391948|80314017|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
28000524|NCT03649074|81834243|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
28000525|NCT03649074|81834244|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
27582367|NCT02391948|80314018|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
27582368|NCT02391948|80314019|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
27582369|NCT02391948|80314020|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
28000526|NCT03649074|81834243|FG000|Overall Study|Other|1|||
27582370|NCT02391948|80314021|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
28000527|NCT03649074|81834244|FG001|Overall Study|Other|0|||
28000528|NCT01272232|81834245|FG000|Weeks 0-56|Adverse Event|39|||
27582371|NCT02391948|80314017|FG000|24-month Assessment|Death|0|||
27582372|NCT02391948|80314018|FG001|24-month Assessment|Death|0|||
27582373|NCT02391948|80314019|FG002|24-month Assessment|Death|0|||
27805871|NCT02196506|81120421|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
27805872|NCT02196506|81120418|FG000|Phase A|Withdrawal by Subject|34|||
27805873|NCT02196506|81120419|FG001|Phase A|Withdrawal by Subject|0|||
28000529|NCT01272232|81834246|FG001|Weeks 0-56|Adverse Event|18|||
28000530|NCT01272232|81834247|FG002|Weeks 0-56|Adverse Event|7|||
28000531|NCT01272232|81834245|FG000|Weeks 0-56|Lack of Efficacy|0|||
27805874|NCT02196506|81120420|FG002|Phase A|Withdrawal by Subject|0|||
27805875|NCT02196506|81120421|FG003|Phase A|Withdrawal by Subject|0|||
27805876|NCT02196506|81120418|FG000|Phase A|Adverse Event|22|||
27805877|NCT02196506|81120419|FG001|Phase A|Adverse Event|0|||
27805878|NCT02196506|81120420|FG002|Phase A|Adverse Event|0|||
27805879|NCT02196506|81120421|FG003|Phase A|Adverse Event|0|||
27805880|NCT02196506|81120418|FG000|Phase A|Lost to Follow-up|9|||
27805881|NCT02196506|81120419|FG001|Phase A|Lost to Follow-up|0|||
27805882|NCT02196506|81120420|FG002|Phase A|Lost to Follow-up|0|||
27805883|NCT02196506|81120421|FG003|Phase A|Lost to Follow-up|0|||
27805884|NCT02196506|81120418|FG000|Phase A|Protocol deviation|12|||
27805885|NCT02196506|81120419|FG001|Phase A|Protocol deviation|0|||
27805886|NCT02196506|81120420|FG002|Phase A|Protocol deviation|0|||
27805887|NCT02196506|81120421|FG003|Phase A|Protocol deviation|0|||
27805888|NCT02196506|81120418|FG000|Phase A|Participant withdrawn by investigator|10|||
27805889|NCT02196506|81120419|FG001|Phase A|Participant withdrawn by investigator|0|||
27805890|NCT02196506|81120420|FG002|Phase A|Participant withdrawn by investigator|0|||
27805891|NCT02196506|81120421|FG003|Phase A|Participant withdrawn by investigator|0|||
27805892|NCT02196506|81120418|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
27805893|NCT02196506|81120419|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
27805894|NCT02196506|81120420|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
27805895|NCT02196506|81120421|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
27805896|NCT02196506|81120418|FG000|Phase B|Lack of Efficacy|0|||
27805897|NCT02196506|81120419|FG001|Phase B|Lack of Efficacy|1|||
27805898|NCT02196506|81120420|FG002|Phase B|Lack of Efficacy|2|||
27805899|NCT02196506|81120421|FG003|Phase B|Lack of Efficacy|0|||
27805900|NCT02196506|81120418|FG000|Phase B|Withdrawal by Participant|0|||
27805901|NCT02196506|81120419|FG001|Phase B|Withdrawal by Participant|8|||
27805902|NCT02196506|81120420|FG002|Phase B|Withdrawal by Participant|1|||
27805903|NCT02196506|81120421|FG003|Phase B|Withdrawal by Participant|0|||
27805904|NCT02196506|81120418|FG000|Phase B|Adverse Event|0|||
27805905|NCT02196506|81120419|FG001|Phase B|Adverse Event|4|||
27805906|NCT02196506|81120420|FG002|Phase B|Adverse Event|1|||
27805907|NCT02196506|81120421|FG003|Phase B|Adverse Event|0|||
28000532|NCT01272232|81834246|FG001|Weeks 0-56|Lack of Efficacy|0|||
28000533|NCT01272232|81834247|FG002|Weeks 0-56|Lack of Efficacy|3|||
28000534|NCT01272232|81834245|FG000|Weeks 0-56|Protocol Violation|12|||
28000535|NCT01272232|81834246|FG001|Weeks 0-56|Protocol Violation|8|||
28000536|NCT01272232|81834247|FG002|Weeks 0-56|Protocol Violation|13|||
28000537|NCT01272232|81834245|FG000|Weeks 0-56|Withdrawal criteria|32|||
28000538|NCT01272232|81834246|FG001|Weeks 0-56|Withdrawal criteria|14|||
28000539|NCT01272232|81834247|FG002|Weeks 0-56|Withdrawal criteria|37|||
28000540|NCT01272232|81834245|FG000|Weeks 0-56|Unclassified|16|||
28000541|NCT01272232|81834246|FG001|Weeks 0-56|Unclassified|7|||
28000542|NCT01272232|81834247|FG002|Weeks 0-56|Unclassified|12|||
28000543|NCT01272232|81834245|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
28000544|NCT01272232|81834246|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
27681113|NCT00293059|80668039|FG000|Overall Study|Participant stopped study drug|1|||
27805908|NCT02196506|81120418|FG000|Phase B|Lost to Follow-up|0|||
27805909|NCT02196506|81120419|FG001|Phase B|Lost to Follow-up|2|||
27805910|NCT02196506|81120420|FG002|Phase B|Lost to Follow-up|1|||
27805911|NCT02196506|81120421|FG003|Phase B|Lost to Follow-up|0|||
27805912|NCT02196506|81120418|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
27805913|NCT02196506|81120419|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
27805914|NCT02196506|81120420|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
27805915|NCT02196506|81120421|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
27805916|NCT02196506|81120418|FG000|Phase A+|Withdrawal by Participant|0|||
27805917|NCT02196506|81120419|FG001|Phase A+|Withdrawal by Participant|0|||
27805918|NCT02196506|81120420|FG002|Phase A+|Withdrawal by Participant|0|||
27805919|NCT02196506|81120421|FG003|Phase A+|Withdrawal by Participant|5|||
27805920|NCT02196506|81120418|FG000|Phase A+|Adverse Event|0|||
27805921|NCT02196506|81120419|FG001|Phase A+|Adverse Event|0|||
27805922|NCT02196506|81120420|FG002|Phase A+|Adverse Event|0|||
28000545|NCT01272232|81834247|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
28000546|NCT01272232|81834245|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
28000547|NCT01272232|81834246|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
28000548|NCT01272232|81834247|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
27805923|NCT02196506|81120421|FG003|Phase A+|Adverse Event|1|||
27805924|NCT02196506|81120418|FG000|Phase A+|Lost to Follow-up|0|||
27805925|NCT02196506|81120419|FG001|Phase A+|Lost to Follow-up|0|||
27805926|NCT02196506|81120420|FG002|Phase A+|Lost to Follow-up|0|||
27805927|NCT02196506|81120421|FG003|Phase A+|Lost to Follow-up|6|||
27805928|NCT02196506|81120418|FG000|Phase A+|Participant withdrawn by investigator|0|||
28000549|NCT01272232|81834245|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
27805929|NCT02196506|81120419|FG001|Phase A+|Participant withdrawn by investigator|0|||
27805930|NCT02196506|81120420|FG002|Phase A+|Participant withdrawn by investigator|0|||
28000550|NCT01272232|81834246|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
27805931|NCT02196506|81120421|FG003|Phase A+|Participant withdrawn by investigator|1|||
27805932|NCT00686790|81120422|FG000|Overall Study|Adverse Event|2|||
27805933|NCT00686790|81120422|FG000|Overall Study|Withdrawal by Subject|1|||
27805934|NCT00686790|81120422|FG000|Overall Study|Death|1|||
27805935|NCT00686790|81120422|FG000|Overall Study|Lost to Follow-up|12|||
27805936|NCT00217971|81120423|FG000|Overall Study|Adverse Event|1|||
27805937|NCT00217971|81120424|FG001|Overall Study|Adverse Event|1|||
27805938|NCT00217971|81120423|FG000|Overall Study|Lost to Follow-up|15|||
27805939|NCT00217971|81120424|FG001|Overall Study|Lost to Follow-up|19|||
27805940|NCT00217971|81120423|FG000|Overall Study|Physician Decision|0|||
27805941|NCT00217971|81120424|FG001|Overall Study|Physician Decision|1|||
27873855|NCT03871543|81371596|FG000|Period 1|Protocol Violation|2|||
28000551|NCT01272232|81834247|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
28000552|NCT01272232|81834245|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
28000553|NCT01272232|81834246|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
28000554|NCT01272232|81834247|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
28000555|NCT01272232|81834245|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
28000556|NCT01272232|81834246|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
28000557|NCT01272232|81834247|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
28000558|NCT00833040|81834248|FG000|Overall Study|Adverse Event|0|||
28000559|NCT00833040|81834249|FG001|Overall Study|Adverse Event|0|||
28000560|NCT00833040|81834250|FG002|Overall Study|Adverse Event|0|||
28000561|NCT00833040|81834251|FG003|Overall Study|Adverse Event|0|||
28000562|NCT00833040|81834252|FG004|Overall Study|Adverse Event|0|||
28000563|NCT00833040|81834253|FG005|Overall Study|Adverse Event|1|||
28000564|NCT00430716|81834254|FG000|Double Blind Phase|Death|1|||
28000565|NCT00430716|81834255|FG001|Double Blind Phase|Death|0|||
28000566|NCT00430716|81834256|FG002|Double Blind Phase|Death|0|||
28000567|NCT00430716|81834254|FG000|Double Blind Phase|No longer willing to participate|2|||
28000568|NCT00430716|81834255|FG001|Double Blind Phase|No longer willing to participate|1|||
28000569|NCT00430716|81834256|FG002|Double Blind Phase|No longer willing to participate|1|||
28000570|NCT00430716|81834254|FG000|Double Blind Phase|Other|0|||
28000571|NCT00430716|81834255|FG001|Double Blind Phase|Other|2|||
28000572|NCT00430716|81834256|FG002|Double Blind Phase|Other|0|||
28000573|NCT00430716|81834254|FG000|Double Blind Phase|Study terminated by sponsor|1|||
28000574|NCT00430716|81834255|FG001|Double Blind Phase|Study terminated by sponsor|1|||
28000575|NCT00430716|81834256|FG002|Double Blind Phase|Study terminated by sponsor|2|||
28000576|NCT00430716|81834254|FG000|Double Blind Phase|Adverse Event|1|||
28000577|NCT00430716|81834255|FG001|Double Blind Phase|Adverse Event|1|||
28000578|NCT00430716|81834256|FG002|Double Blind Phase|Adverse Event|3|||
28000579|NCT00430716|81834254|FG000|Double Blind Phase|Not treated|1|||
28000580|NCT00430716|81834255|FG001|Double Blind Phase|Not treated|0|||
28000581|NCT00430716|81834256|FG002|Double Blind Phase|Not treated|0|||
28000582|NCT00430716|81834254|FG000|Open Label Phase|Lost to Follow-up|1|||
28000583|NCT00430716|81834255|FG001|Open Label Phase|Lost to Follow-up|0|||
28000584|NCT00430716|81834256|FG002|Open Label Phase|Lost to Follow-up|1|||
28000585|NCT00430716|81834254|FG000|Open Label Phase|No longer willing to participate|0|||
28000586|NCT00430716|81834255|FG001|Open Label Phase|No longer willing to participate|1|||
28000587|NCT00430716|81834256|FG002|Open Label Phase|No longer willing to participate|1|||
28000588|NCT00430716|81834254|FG000|Open Label Phase|Other|3|||
28000589|NCT00430716|81834255|FG001|Open Label Phase|Other|1|||
28000590|NCT00430716|81834256|FG002|Open Label Phase|Other|1|||
28000591|NCT00430716|81834254|FG000|Open Label Phase|Protocol Violation|1|||
28000592|NCT00430716|81834255|FG001|Open Label Phase|Protocol Violation|0|||
28000593|NCT00430716|81834256|FG002|Open Label Phase|Protocol Violation|0|||
28000594|NCT00430716|81834254|FG000|Open Label Phase|Study terminated by sponsor|4|||
28000595|NCT00430716|81834255|FG001|Open Label Phase|Study terminated by sponsor|5|||
28000596|NCT00430716|81834256|FG002|Open Label Phase|Study terminated by sponsor|4|||
28000597|NCT00286442|81834257|FG000|Overall Study|Hyperglycemic Rescue|19|||
28000598|NCT00286442|81834258|FG001|Overall Study|Hyperglycemic Rescue|17|||
28000599|NCT00286442|81834259|FG002|Overall Study|Hyperglycemic Rescue|25|||
28000600|NCT00286442|81834257|FG000|Overall Study|Adverse Event|7|||
28000601|NCT00286442|81834258|FG001|Overall Study|Adverse Event|6|||
28000602|NCT00286442|81834259|FG002|Overall Study|Adverse Event|1|||
27805942|NCT00217971|81120423|FG000|Overall Study|Withdrawal by Subject|7|||
27805943|NCT00217971|81120424|FG001|Overall Study|Withdrawal by Subject|12|||
27805944|NCT00217971|81120423|FG000|Overall Study|non compliant|1|||
28000603|NCT00286442|81834257|FG000|Overall Study|Protocol Violation|2|||
28000604|NCT00286442|81834258|FG001|Overall Study|Protocol Violation|4|||
28000605|NCT00286442|81834259|FG002|Overall Study|Protocol Violation|2|||
27873856|NCT03871543|81371596|FG000|Period 1|COVID-19 Related|1|||
27582374|NCT02391948|80314020|FG003|24-month Assessment|Death|0|||
28000606|NCT00286442|81834257|FG000|Overall Study|Lost to Follow-up|5|||
28000607|NCT00286442|81834258|FG001|Overall Study|Lost to Follow-up|2|||
28000608|NCT00286442|81834259|FG002|Overall Study|Lost to Follow-up|1|||
27681114|NCT00293059|80668040|FG001|Overall Study|Participant stopped study drug|0|||
27681115|NCT00293059|80668039|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
27681116|NCT00293059|80668040|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
27681117|NCT00293059|80668039|FG000|Overall Study|missing|3|||
27681118|NCT00293059|80668040|FG001|Overall Study|missing|5|||
27681119|NCT02949362|80668041|FG000|Retrospective Period|Inform consent not signed by participant|4|||
27681120|NCT02949362|80668042|FG001|Retrospective Period|Inform consent not signed by participant|1|||
27681121|NCT02949362|80668043|FG002|Retrospective Period|Inform consent not signed by participant|0|||
27681122|NCT02949362|80668044|FG003|Retrospective Period|Inform consent not signed by participant|0|||
27681123|NCT02949362|80668041|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
27681124|NCT02949362|80668042|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
27681125|NCT02949362|80668043|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
27681126|NCT02949362|80668044|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
27681127|NCT02949362|80668041|FG000|Prospective Period|Other|0|||
27681128|NCT02949362|80668042|FG001|Prospective Period|Other|0|||
27873857|NCT03871543|81371596|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
27873858|NCT03871543|81371596|FG000|Period 1|Withdrawal by Subject|10|||
27873859|NCT03871543|81371596|FG000|Period 2|Adverse Event|1|||
27873860|NCT03871543|81371596|FG000|Period 2|Withdrawal by Subject|1|||
27873861|NCT01306305|81371599|FG000|Overall Study|Lost to Follow-up|1|||
27873862|NCT01306305|81371600|FG001|Overall Study|Lost to Follow-up|0|||
27873863|NCT01306305|81371599|FG000|Overall Study|Withdrew consent|1|||
27873864|NCT01306305|81371600|FG001|Overall Study|Withdrew consent|0|||
27873865|NCT01147068|81371601|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
27873866|NCT01147068|81371602|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
27873867|NCT01147068|81371603|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
27873868|NCT01147068|81371604|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
27873869|NCT01147068|81371605|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
27873870|NCT01147068|81371606|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
27873871|NCT01147068|81371607|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
27873872|NCT01147068|81371601|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
27873873|NCT01147068|81371602|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
27873874|NCT01147068|81371603|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
27873875|NCT01147068|81371604|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
27873876|NCT01147068|81371605|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
27873877|NCT01147068|81371606|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
27873878|NCT01147068|81371607|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
27873879|NCT01147068|81371601|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
27873880|NCT01147068|81371602|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
27873881|NCT01147068|81371603|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
27873882|NCT01147068|81371604|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
27873883|NCT01147068|81371605|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
27873884|NCT01147068|81371606|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
27873885|NCT01147068|81371607|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
27873886|NCT01147068|81371601|FG000|Subjects That Received 2nd Dose|Other|0|||
27873887|NCT01147068|81371602|FG001|Subjects That Received 2nd Dose|Other|3|||
27873888|NCT01147068|81371603|FG002|Subjects That Received 2nd Dose|Other|3|||
27873889|NCT01147068|81371604|FG003|Subjects That Received 2nd Dose|Other|0|||
28000609|NCT00286442|81834257|FG000|Overall Study|Physician Decision|1|||
28000610|NCT00286442|81834258|FG001|Overall Study|Physician Decision|1|||
28000611|NCT00286442|81834259|FG002|Overall Study|Physician Decision|1|||
28000612|NCT00286442|81834257|FG000|Overall Study|Administrative Error|1|||
28000613|NCT00286442|81834258|FG001|Overall Study|Administrative Error|1|||
28000614|NCT00286442|81834259|FG002|Overall Study|Administrative Error|0|||
28000615|NCT00286442|81834257|FG000|Overall Study|Withdrawal by Subject|2|||
28000616|NCT00286442|81834258|FG001|Overall Study|Withdrawal by Subject|14|||
27681129|NCT02949362|80668043|FG002|Prospective Period|Other|0|||
27681130|NCT02949362|80668044|FG003|Prospective Period|Other|4|||
27681131|NCT01259089|80668049|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27681132|NCT01259089|80668050|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27873890|NCT01147068|81371605|FG004|Subjects That Received 2nd Dose|Other|1|||
27873891|NCT01147068|81371606|FG005|Subjects That Received 2nd Dose|Other|0|||
27873892|NCT01147068|81371607|FG006|Subjects That Received 2nd Dose|Other|0|||
27873893|NCT01147068|81371601|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
27873894|NCT01147068|81371602|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27873895|NCT01147068|81371603|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
28000617|NCT00286442|81834259|FG002|Overall Study|Withdrawal by Subject|2|||
28000618|NCT01384734|81834263|FG000|Overall Study|Adverse Event|0|||
27681133|NCT01259089|80668051|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27681134|NCT01259089|80668052|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27681135|NCT01259089|80668053|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
27681136|NCT01259089|80668054|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
27681137|NCT01259089|80668049|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
27681138|NCT01259089|80668050|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
27681139|NCT01259089|80668051|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
27681140|NCT01259089|80668052|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
27681141|NCT01259089|80668053|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
27681142|NCT01259089|80668054|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
27681143|NCT01259089|80668049|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27681144|NCT01259089|80668050|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27681145|NCT01259089|80668051|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27681146|NCT01259089|80668052|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27681147|NCT01259089|80668053|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
27681148|NCT01259089|80668054|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
27681149|NCT01259089|80668049|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
27681150|NCT01259089|80668050|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
27681151|NCT01259089|80668051|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
27681152|NCT01259089|80668052|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
27681153|NCT01259089|80668053|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
27681154|NCT01259089|80668054|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
27681155|NCT01259089|80668049|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
27805945|NCT00217971|81120424|FG001|Overall Study|non compliant|0|||
28000619|NCT01384734|81834264|FG001|Overall Study|Adverse Event|3|||
28000620|NCT01384734|81834265|FG002|Overall Study|Adverse Event|0|||
28000621|NCT01384734|81834266|FG003|Overall Study|Adverse Event|2|||
28000622|NCT01384734|81834267|FG004|Overall Study|Adverse Event|7|||
28000623|NCT01384734|81834263|FG000|Overall Study|Death|1|||
28000624|NCT01384734|81834264|FG001|Overall Study|Death|0|||
27582375|NCT02391948|80314021|FG004|24-month Assessment|Death|1|||
27582376|NCT02391948|80314017|FG000|24-month Assessment|Withdrawal by Subject|1|||
27582377|NCT02391948|80314018|FG001|24-month Assessment|Withdrawal by Subject|1|||
27582378|NCT02391948|80314019|FG002|24-month Assessment|Withdrawal by Subject|0|||
27582379|NCT02391948|80314020|FG003|24-month Assessment|Withdrawal by Subject|0|||
27582380|NCT02391948|80314021|FG004|24-month Assessment|Withdrawal by Subject|1|||
27582381|NCT02391948|80314017|FG000|24-month Assessment|Lost to Follow-up|5|||
27582382|NCT02391948|80314018|FG001|24-month Assessment|Lost to Follow-up|4|||
27582383|NCT02391948|80314019|FG002|24-month Assessment|Lost to Follow-up|0|||
27582384|NCT02391948|80314020|FG003|24-month Assessment|Lost to Follow-up|0|||
27582385|NCT02391948|80314021|FG004|24-month Assessment|Lost to Follow-up|0|||
27582386|NCT02391948|80314017|FG000|24-month Assessment|Medical issue/illness|0|||
27582387|NCT02391948|80314018|FG001|24-month Assessment|Medical issue/illness|0|||
27582388|NCT02391948|80314019|FG002|24-month Assessment|Medical issue/illness|1|||
28000625|NCT01384734|81834265|FG002|Overall Study|Death|1|||
28000626|NCT01384734|81834266|FG003|Overall Study|Death|0|||
28000627|NCT01384734|81834267|FG004|Overall Study|Death|0|||
28000628|NCT01384734|81834263|FG000|Overall Study|Continuation criteria not met|0|||
28000629|NCT01384734|81834264|FG001|Overall Study|Continuation criteria not met|0|||
28000630|NCT01384734|81834265|FG002|Overall Study|Continuation criteria not met|1|||
28000631|NCT01384734|81834266|FG003|Overall Study|Continuation criteria not met|1|||
27582389|NCT02391948|80314020|FG003|24-month Assessment|Medical issue/illness|0|||
27582390|NCT02391948|80314021|FG004|24-month Assessment|Medical issue/illness|0|||
27582391|NCT02391948|80314017|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
27582392|NCT02391948|80314018|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
27582393|NCT02391948|80314019|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
27582394|NCT02391948|80314020|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
27582395|NCT02391948|80314021|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
27582396|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
27582397|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
27582398|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
27582399|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
27582400|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
27582401|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
27582402|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
27582403|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
27582404|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
27681156|NCT01259089|80668050|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
27681157|NCT01259089|80668051|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
28000632|NCT01384734|81834267|FG004|Overall Study|Continuation criteria not met|0|||
28000633|NCT01384734|81834263|FG000|Overall Study|Lack of Efficacy|3|||
27582405|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
27582406|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
27582407|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
27582408|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
27582409|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
27582410|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
27582411|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
27582412|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
27582413|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
27582414|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
27582415|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
27582416|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
27582417|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
27582418|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
27582419|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
27582420|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
27582421|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
27582422|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
27582423|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
27582424|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
27582425|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
27582426|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
27582427|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
27582428|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
27582429|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
27582430|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
27582431|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
27582432|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
27582433|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
27582434|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
27582435|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
27582436|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
27582437|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
27582438|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
27582439|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
27582440|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
27582441|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
27582442|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
27582443|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
27582444|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
27582445|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
27582446|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
27805946|NCT02418910|81120425|FG000|Overall Study|Lost to Follow-up|3|||
27805947|NCT02418910|81120425|FG000|Overall Study|Withdrawal by Subject|4|||
27805948|NCT00948025|81120426|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
27805949|NCT00948025|81120427|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
27805950|NCT00948025|81120426|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
27805951|NCT00948025|81120427|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
27805952|NCT00948025|81120426|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
27873896|NCT01147068|81371604|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27873897|NCT01147068|81371605|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
27873898|NCT01147068|81371606|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
27873899|NCT01147068|81371607|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
27873900|NCT01147068|81371601|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27873901|NCT01147068|81371602|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27873902|NCT01147068|81371603|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27873903|NCT01147068|81371604|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
27873904|NCT01147068|81371605|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27873905|NCT01147068|81371606|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
27582447|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
27805953|NCT00948025|81120427|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
27873906|NCT01147068|81371607|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
28000634|NCT01384734|81834264|FG001|Overall Study|Lack of Efficacy|7|||
27582448|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
27582449|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
27582450|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
27582451|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
27582452|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
27582453|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
27582454|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
27582455|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
27582456|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
27582457|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
27582458|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
27582459|NCT01884350|80314025|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
27681158|NCT01259089|80668052|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
27681159|NCT01259089|80668053|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
27681160|NCT01259089|80668054|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
27681161|NCT01259089|80668049|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
27681162|NCT01259089|80668050|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
28000635|NCT01384734|81834265|FG002|Overall Study|Lack of Efficacy|4|||
28000636|NCT01384734|81834266|FG003|Overall Study|Lack of Efficacy|4|||
28000637|NCT01384734|81834267|FG004|Overall Study|Lack of Efficacy|2|||
28000638|NCT01384734|81834263|FG000|Overall Study|Lost to Follow-up|5|||
28000639|NCT01384734|81834264|FG001|Overall Study|Lost to Follow-up|3|||
28000640|NCT01384734|81834265|FG002|Overall Study|Lost to Follow-up|3|||
28000641|NCT01384734|81834266|FG003|Overall Study|Lost to Follow-up|8|||
28000642|NCT01384734|81834267|FG004|Overall Study|Lost to Follow-up|5|||
28000643|NCT01384734|81834263|FG000|Overall Study|Non-compliance with study drug|1|||
28000644|NCT01384734|81834264|FG001|Overall Study|Non-compliance with study drug|2|||
28000645|NCT01384734|81834265|FG002|Overall Study|Non-compliance with study drug|6|||
28000646|NCT01384734|81834266|FG003|Overall Study|Non-compliance with study drug|0|||
28000647|NCT01384734|81834267|FG004|Overall Study|Non-compliance with study drug|2|||
28000648|NCT01384734|81834263|FG000|Overall Study|Pregnancy|0|||
28000649|NCT01384734|81834264|FG001|Overall Study|Pregnancy|1|||
28000650|NCT01384734|81834265|FG002|Overall Study|Pregnancy|0|||
27681163|NCT01259089|80668051|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
28000651|NCT01384734|81834266|FG003|Overall Study|Pregnancy|0|||
28000652|NCT01384734|81834267|FG004|Overall Study|Pregnancy|1|||
28000653|NCT01384734|81834263|FG000|Overall Study|Sponsor terminated|0|||
27681164|NCT01259089|80668052|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27681165|NCT01259089|80668053|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27681166|NCT01259089|80668054|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
27681167|NCT01259089|80668049|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
27681168|NCT01259089|80668050|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
27681169|NCT01259089|80668051|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
27681170|NCT01259089|80668052|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
27681171|NCT01259089|80668053|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
27681172|NCT01259089|80668054|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
27681173|NCT01259089|80668049|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
27681174|NCT01259089|80668050|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
27681175|NCT01259089|80668051|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
27681176|NCT01259089|80668052|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
27681177|NCT01259089|80668053|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
27681178|NCT01259089|80668054|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
28000654|NCT01384734|81834264|FG001|Overall Study|Sponsor terminated|0|||
28000655|NCT01384734|81834265|FG002|Overall Study|Sponsor terminated|0|||
28000656|NCT01384734|81834266|FG003|Overall Study|Sponsor terminated|0|||
28000657|NCT01384734|81834267|FG004|Overall Study|Sponsor terminated|1|||
28000658|NCT01384734|81834263|FG000|Overall Study|Withdrawal by Subject|5|||
28000659|NCT01384734|81834264|FG001|Overall Study|Withdrawal by Subject|5|||
28000660|NCT01384734|81834265|FG002|Overall Study|Withdrawal by Subject|6|||
28000661|NCT01384734|81834266|FG003|Overall Study|Withdrawal by Subject|7|||
28000662|NCT01384734|81834267|FG004|Overall Study|Withdrawal by Subject|9|||
28000663|NCT01384734|81834263|FG000|Overall Study|Investigator relocating|0|||
28000664|NCT01384734|81834264|FG001|Overall Study|Investigator relocating|2|||
28000665|NCT01384734|81834265|FG002|Overall Study|Investigator relocating|0|||
28000666|NCT01384734|81834266|FG003|Overall Study|Investigator relocating|3|||
28000667|NCT01384734|81834267|FG004|Overall Study|Investigator relocating|1|||
28000668|NCT01384734|81834263|FG000|Overall Study|Unable to come back for visit|1|||
28000669|NCT01384734|81834264|FG001|Overall Study|Unable to come back for visit|0|||
28000670|NCT01384734|81834265|FG002|Overall Study|Unable to come back for visit|1|||
28000671|NCT01384734|81834266|FG003|Overall Study|Unable to come back for visit|1|||
27873907|NCT01147068|81371601|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
27873908|NCT01147068|81371602|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
27873909|NCT01147068|81371603|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
27873910|NCT01147068|81371604|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
27873911|NCT01147068|81371605|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
27873912|NCT01147068|81371606|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
27873913|NCT01147068|81371607|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
27873914|NCT01863667|81371612|FG000|Overall Study|Adverse Event|1|||
28000672|NCT01384734|81834267|FG004|Overall Study|Unable to come back for visit|0|||
28000673|NCT01384734|81834263|FG000|Overall Study|Prison|0|||
28000674|NCT01384734|81834264|FG001|Overall Study|Prison|0|||
27873915|NCT01863667|81371613|FG001|Overall Study|Adverse Event|0|||
27873916|NCT01863667|81371612|FG000|Overall Study|Study terminated by Sponsor|30|||
27873917|NCT01863667|81371613|FG001|Overall Study|Study terminated by Sponsor|30|||
27873918|NCT01863667|81371612|FG000|Overall Study|Withdrawal by Subject|2|||
28000675|NCT01384734|81834265|FG002|Overall Study|Prison|1|||
28000676|NCT01384734|81834266|FG003|Overall Study|Prison|0|||
27681179|NCT01259089|80668049|FG000|Survival Follow up for Two Years|Death|3|||
27681180|NCT01259089|80668050|FG001|Survival Follow up for Two Years|Death|2|||
27681181|NCT01259089|80668051|FG002|Survival Follow up for Two Years|Death|2|||
27681182|NCT01259089|80668052|FG003|Survival Follow up for Two Years|Death|3|||
27681183|NCT01259089|80668053|FG004|Survival Follow up for Two Years|Death|6|||
28000677|NCT01384734|81834267|FG004|Overall Study|Prison|0|||
28000678|NCT01384734|81834263|FG000|Overall Study|As per Exclusion criteria|0|||
27681184|NCT01259089|80668054|FG005|Survival Follow up for Two Years|Death|13|||
27681185|NCT01259089|80668049|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
28000679|NCT01384734|81834264|FG001|Overall Study|As per Exclusion criteria|1|||
28000680|NCT01384734|81834265|FG002|Overall Study|As per Exclusion criteria|0|||
27805954|NCT03439293|81120433|FG000|Overall Study|Death|22|||
27805955|NCT03439293|81120433|FG000|Overall Study|Withdrawal by Subject|8|||
27805956|NCT03439293|81120433|FG000|Overall Study|Lost to Follow-up|2|||
27805957|NCT03439293|81120433|FG000|Overall Study|Reason Not Specified|28|||
27805958|NCT03439293|81120433|FG000|Overall Study|Missing|1|||
27805959|NCT00597584|81120436|FG000|Overall Study|Adverse Event|4|||
28000681|NCT01384734|81834266|FG003|Overall Study|As per Exclusion criteria|0|||
27805960|NCT00597584|81120437|FG001|Overall Study|Adverse Event|2|||
28000682|NCT01384734|81834267|FG004|Overall Study|As per Exclusion criteria|0|||
28000683|NCT01384734|81834263|FG000|Overall Study|Missed End of treatment visit|0|||
28000684|NCT01384734|81834264|FG001|Overall Study|Missed End of treatment visit|0|||
28000685|NCT01384734|81834265|FG002|Overall Study|Missed End of treatment visit|0|||
28000686|NCT01384734|81834266|FG003|Overall Study|Missed End of treatment visit|1|||
27805961|NCT00597584|81120436|FG000|Overall Study|Death|53|||
27805962|NCT00597584|81120437|FG001|Overall Study|Death|30|||
27805963|NCT00597584|81120436|FG000|Overall Study|Lack of Efficacy|1|||
27805964|NCT00597584|81120437|FG001|Overall Study|Lack of Efficacy|0|||
27805965|NCT00597584|81120436|FG000|Overall Study|Lost to Follow-up|2|||
27805966|NCT00597584|81120437|FG001|Overall Study|Lost to Follow-up|4|||
27805967|NCT00597584|81120436|FG000|Overall Study|Physician Decision|3|||
27805968|NCT00597584|81120437|FG001|Overall Study|Physician Decision|0|||
28000687|NCT01384734|81834267|FG004|Overall Study|Missed End of treatment visit|0|||
27805969|NCT00597584|81120436|FG000|Overall Study|Pregnancy|2|||
27805970|NCT00597584|81120437|FG001|Overall Study|Pregnancy|0|||
27805971|NCT00597584|81120436|FG000|Overall Study|Withdrawal by Subject|44|||
27805972|NCT00597584|81120437|FG001|Overall Study|Withdrawal by Subject|12|||
27805973|NCT00597584|81120436|FG000|Overall Study|Discontinued Dialysis|0|||
27805974|NCT00597584|81120437|FG001|Overall Study|Discontinued Dialysis|1|||
28000688|NCT01384734|81834263|FG000|Overall Study|Adhesion problem|0|||
28000689|NCT01384734|81834264|FG001|Overall Study|Adhesion problem|0|||
28000690|NCT01384734|81834265|FG002|Overall Study|Adhesion problem|0|||
28000691|NCT01384734|81834266|FG003|Overall Study|Adhesion problem|1|||
28000692|NCT01384734|81834267|FG004|Overall Study|Adhesion problem|0|||
28000693|NCT01384734|81834263|FG000|Overall Study|Early termination|0|||
28000694|NCT01384734|81834264|FG001|Overall Study|Early termination|0|||
28000695|NCT01384734|81834265|FG002|Overall Study|Early termination|0|||
28000696|NCT01384734|81834266|FG003|Overall Study|Early termination|0|||
28000697|NCT01384734|81834267|FG004|Overall Study|Early termination|1|||
28000698|NCT01384734|81834263|FG000|Overall Study|Physician Decision|1|||
28000699|NCT01384734|81834264|FG001|Overall Study|Physician Decision|0|||
28000700|NCT01384734|81834265|FG002|Overall Study|Physician Decision|0|||
28000701|NCT01384734|81834266|FG003|Overall Study|Physician Decision|0|||
28000702|NCT01384734|81834267|FG004|Overall Study|Physician Decision|0|||
28000703|NCT00443040|81834268|FG000|Overall Study|Withdrawal by Subject|1|||
28000704|NCT00443040|81834269|FG001|Overall Study|Withdrawal by Subject|0|||
28000705|NCT00443040|81834270|FG002|Overall Study|Withdrawal by Subject|0|||
28000706|NCT00443040|81834268|FG000|Overall Study|Converted to an open laparotomy|3|||
28000707|NCT00443040|81834269|FG001|Overall Study|Converted to an open laparotomy|0|||
27681186|NCT01259089|80668050|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
27681187|NCT01259089|80668051|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
27681188|NCT01259089|80668052|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
27681189|NCT01259089|80668053|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
27681190|NCT01259089|80668054|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
27681191|NCT01259089|80668049|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27681192|NCT01259089|80668050|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27681193|NCT01259089|80668051|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27681194|NCT01259089|80668052|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
28000708|NCT00443040|81834270|FG002|Overall Study|Converted to an open laparotomy|1|||
27805975|NCT00597584|81120436|FG000|Overall Study|Lost ability to consent|1|||
27805976|NCT00597584|81120437|FG001|Overall Study|Lost ability to consent|1|||
27805977|NCT00597584|81120436|FG000|Overall Study|Never dosed|1|||
27582460|NCT01884350|80314026|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
27582461|NCT01884350|80314027|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
27582462|NCT03207750|80314031|FG000|Overall Study|Adverse Event|3|||
27582463|NCT03207750|80314032|FG001|Overall Study|Adverse Event|2|||
27582464|NCT03207750|80314031|FG000|Overall Study|Lost to Follow-up|21|||
27582465|NCT03207750|80314032|FG001|Overall Study|Lost to Follow-up|29|||
27681195|NCT01259089|80668053|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
27681196|NCT01259089|80668054|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
27681197|NCT04055090|80668055|FG000|Overall Study|screen failure|1|||
27805978|NCT00597584|81120437|FG001|Overall Study|Never dosed|0|||
27805979|NCT00597584|81120436|FG000|Overall Study|Relocation|8|||
28000709|NCT01011673|81834272|FG000|Randomized|Secondary headache|2|||
27805980|NCT00597584|81120437|FG001|Overall Study|Relocation|6|||
27582466|NCT03207750|80314031|FG000|Overall Study|Protocol Violation|0|||
27582467|NCT03207750|80314032|FG001|Overall Study|Protocol Violation|1|||
28000710|NCT01011673|81834273|FG001|Randomized|Secondary headache|1|||
27582468|NCT03207750|80314031|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
27582469|NCT03207750|80314032|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
27582470|NCT03207750|80314031|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
27582471|NCT03207750|80314032|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
27582472|NCT03207750|80314031|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
27582473|NCT03207750|80314032|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
27582474|NCT03207750|80314031|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
27582475|NCT03207750|80314032|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
27582476|NCT03207750|80314031|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
27582477|NCT03207750|80314032|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
27582478|NCT00840970|80314042|FG000|Overall Study|Adverse Event|0|||
27582479|NCT00840970|80314043|FG001|Overall Study|Adverse Event|0|||
27582480|NCT00840970|80314044|FG002|Overall Study|Adverse Event|1|||
27582481|NCT04964089|80314045|FG000|Overall Study|Adverse Event|8|||
27582482|NCT04964089|80314046|FG001|Overall Study|Adverse Event|6|||
27582483|NCT04964089|80314045|FG000|Overall Study|Non-compliance with study schedule|1|||
27582484|NCT04964089|80314046|FG001|Overall Study|Non-compliance with study schedule|0|||
27582485|NCT04964089|80314045|FG000|Overall Study|Withdrawal by Subject|6|||
27582486|NCT04964089|80314046|FG001|Overall Study|Withdrawal by Subject|5|||
27582487|NCT04964089|80314045|FG000|Overall Study|Lost to Follow-up|1|||
27582488|NCT04964089|80314046|FG001|Overall Study|Lost to Follow-up|1|||
27582489|NCT04964089|80314045|FG000|Overall Study|Progressive disease|4|||
27582490|NCT04964089|80314046|FG001|Overall Study|Progressive disease|0|||
27582491|NCT04964089|80314045|FG000|Overall Study|Physician Decision|1|||
28000711|NCT01011673|81834272|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
28000712|NCT01011673|81834273|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
28000713|NCT00604565|81834274|FG000|Overall Study|Study terminated|0|||
28000714|NCT00604565|81834275|FG001|Overall Study|Study terminated|3|||
28000715|NCT00796666|81834278|FG000|Overall Study|Death|2|||
28000716|NCT00796666|81834279|FG001|Overall Study|Death|4|||
28000717|NCT00796666|81834278|FG000|Overall Study|Withdrawal by Subject|2|||
27582492|NCT04964089|80314046|FG001|Overall Study|Physician Decision|0|||
27582493|NCT04964089|80314045|FG000|Overall Study|Participant did not want to continue study treatment|1|||
27582494|NCT04964089|80314046|FG001|Overall Study|Participant did not want to continue study treatment|0|||
27582495|NCT04964089|80314045|FG000|Overall Study|Participant moved to different state|1|||
27582496|NCT04964089|80314046|FG001|Overall Study|Participant moved to different state|0|||
27582497|NCT04964089|80314045|FG000|Overall Study|Participant decided to discontinue|0|||
27582498|NCT04964089|80314046|FG001|Overall Study|Participant decided to discontinue|1|||
27582499|NCT02117570|80314051|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
27582500|NCT02117570|80314052|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
27582501|NCT02117570|80314053|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
27582502|NCT02117570|80314051|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
27582503|NCT02117570|80314052|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
27582504|NCT02117570|80314053|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
27582505|NCT02117570|80314051|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
27582506|NCT02117570|80314052|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
27582507|NCT02117570|80314053|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
27582508|NCT02117570|80314051|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
27582509|NCT02117570|80314052|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
27582510|NCT02117570|80314053|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
27582511|NCT02117570|80314051|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
27582512|NCT02117570|80314052|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
27582513|NCT02117570|80314053|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
27582514|NCT02117570|80314051|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
27582515|NCT02117570|80314052|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
27582516|NCT02117570|80314053|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
27582517|NCT02117570|80314051|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
27582518|NCT02117570|80314052|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
27582519|NCT02117570|80314053|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
27582520|NCT03062891|80314055|FG000|Overall Study|Withdrawal by Subject|2|||
28000718|NCT00796666|81834279|FG001|Overall Study|Withdrawal by Subject|0|||
28000719|NCT00796666|81834278|FG000|Overall Study|Adverse Event|7|||
28000720|NCT00796666|81834279|FG001|Overall Study|Adverse Event|5|||
28000721|NCT00796666|81834278|FG000|Overall Study|Protocol Violation|1|||
28000722|NCT00796666|81834279|FG001|Overall Study|Protocol Violation|0|||
27582521|NCT03062891|80314056|FG001|Overall Study|Withdrawal by Subject|0|||
27582522|NCT03062891|80314055|FG000|Overall Study|Lost to Follow-up|50|||
27582523|NCT03062891|80314056|FG001|Overall Study|Lost to Follow-up|38|||
27582524|NCT00359762|80314059|FG000|Period II|Adverse Event|17|||
28000723|NCT00796666|81834278|FG000|Overall Study|Other|1|||
27582525|NCT00359762|80314060|FG001|Period II|Adverse Event|0|||
27582526|NCT00359762|80314061|FG002|Period II|Adverse Event|0|||
27582527|NCT00359762|80314062|FG003|Period II|Adverse Event|0|||
27582528|NCT00359762|80314063|FG004|Period II|Adverse Event|49|||
27582529|NCT00359762|80314059|FG000|Period II|Protocol Violation|18|||
27582530|NCT00359762|80314060|FG001|Period II|Protocol Violation|0|||
27582531|NCT00359762|80314061|FG002|Period II|Protocol Violation|0|||
27582532|NCT00359762|80314062|FG003|Period II|Protocol Violation|0|||
27582533|NCT00359762|80314063|FG004|Period II|Protocol Violation|11|||
27582534|NCT00359762|80314059|FG000|Period II|Physician Decision|17|||
27582535|NCT00359762|80314060|FG001|Period II|Physician Decision|0|||
27582536|NCT00359762|80314061|FG002|Period II|Physician Decision|0|||
27582537|NCT00359762|80314062|FG003|Period II|Physician Decision|0|||
27582538|NCT00359762|80314063|FG004|Period II|Physician Decision|23|||
27582539|NCT00359762|80314059|FG000|Period II|Death|2|||
27582540|NCT00359762|80314060|FG001|Period II|Death|0|||
27582541|NCT00359762|80314061|FG002|Period II|Death|0|||
27582542|NCT00359762|80314062|FG003|Period II|Death|0|||
27582543|NCT00359762|80314063|FG004|Period II|Death|4|||
27582544|NCT00359762|80314059|FG000|Period II|Lack of Efficacy|11|||
27582545|NCT00359762|80314060|FG001|Period II|Lack of Efficacy|0|||
27582546|NCT00359762|80314061|FG002|Period II|Lack of Efficacy|0|||
27582547|NCT00359762|80314062|FG003|Period II|Lack of Efficacy|0|||
27582548|NCT00359762|80314063|FG004|Period II|Lack of Efficacy|8|||
27582549|NCT00359762|80314059|FG000|Period II|Lost to follow up|5|||
27582550|NCT00359762|80314060|FG001|Period II|Lost to follow up|0|||
27582551|NCT00359762|80314061|FG002|Period II|Lost to follow up|0|||
27582552|NCT00359762|80314062|FG003|Period II|Lost to follow up|0|||
27582553|NCT00359762|80314063|FG004|Period II|Lost to follow up|5|||
27582554|NCT00359762|80314059|FG000|Period II|Entry Criteria Not Met|8|||
27582555|NCT00359762|80314060|FG001|Period II|Entry Criteria Not Met|0|||
27681198|NCT04055090|80668056|FG001|Overall Study|screen failure|0|||
27681199|NCT04055090|80668055|FG000|Overall Study|Withdrawal by Subject|1|||
27681200|NCT04055090|80668056|FG001|Overall Study|Withdrawal by Subject|0|||
27681201|NCT04307940|80668057|FG000|Overall Study|Adverse Event|1|||
27805981|NCT00597584|81120436|FG000|Overall Study|Renal transplant|9|||
27805982|NCT00597584|81120437|FG001|Overall Study|Renal transplant|7|||
27805983|NCT01637961|81120438|FG000|Overall Study|Ineligible: wrong primary|1|||
27805984|NCT01637961|81120438|FG000|Overall Study|Ineligible: inadequate pathology|1|||
28000724|NCT00796666|81834279|FG001|Overall Study|Other|0|||
28000725|NCT00796666|81834278|FG000|Overall Study|Terminated by sponsor|53|||
28000726|NCT00796666|81834279|FG001|Overall Study|Terminated by sponsor|55|||
28000727|NCT00796666|81834278|FG000|Overall Study|Randomized and not treated|1|||
28000728|NCT00796666|81834279|FG001|Overall Study|Randomized and not treated|0|||
28000729|NCT00292942|81834280|FG000|Overall Study|Withdrawal by Subject|0|||
28000730|NCT00292942|81834281|FG001|Overall Study|Withdrawal by Subject|0|||
28000731|NCT00292942|81834282|FG002|Overall Study|Withdrawal by Subject|1|||
28000732|NCT00292942|81834283|FG003|Overall Study|Withdrawal by Subject|0|||
28000733|NCT00292942|81834280|FG000|Overall Study|Adverse Event|0|||
28000734|NCT00292942|81834281|FG001|Overall Study|Adverse Event|0|||
27582556|NCT00359762|80314061|FG002|Period II|Entry Criteria Not Met|0|||
27582557|NCT00359762|80314062|FG003|Period II|Entry Criteria Not Met|0|||
27582558|NCT00359762|80314063|FG004|Period II|Entry Criteria Not Met|4|||
27582559|NCT00359762|80314059|FG000|Period II|Subject Decision|50|||
27582560|NCT00359762|80314060|FG001|Period II|Subject Decision|0|||
27582561|NCT00359762|80314061|FG002|Period II|Subject Decision|0|||
27582562|NCT00359762|80314062|FG003|Period II|Subject Decision|0|||
27582563|NCT00359762|80314063|FG004|Period II|Subject Decision|70|||
27582564|NCT00359762|80314059|FG000|Period III|Protocol Violation|0|||
27582565|NCT00359762|80314060|FG001|Period III|Protocol Violation|5|||
27681202|NCT04307940|80668058|FG001|Overall Study|Adverse Event|0|||
27681203|NCT04307940|80668059|FG002|Overall Study|Adverse Event|0|||
27681204|NCT04307940|80668057|FG000|Overall Study|Withdrawal by Subject|2|||
27681205|NCT04307940|80668058|FG001|Overall Study|Withdrawal by Subject|3|||
27681206|NCT04307940|80668059|FG002|Overall Study|Withdrawal by Subject|1|||
27681207|NCT04307940|80668057|FG000|Overall Study|Lost to Follow-up|2|||
28000735|NCT00292942|81834282|FG002|Overall Study|Adverse Event|0|||
28000736|NCT00292942|81834283|FG003|Overall Study|Adverse Event|1|||
28000737|NCT00763386|81834286|FG000|Overall Study|Adverse Event|43|||
28000738|NCT00763386|81834287|FG001|Overall Study|Adverse Event|33|||
28000739|NCT00763386|81834286|FG000|Overall Study|Death|1|||
28000740|NCT00763386|81834287|FG001|Overall Study|Death|2|||
28000741|NCT00763386|81834286|FG000|Overall Study|Lost to Follow-up|3|||
28000742|NCT00763386|81834287|FG001|Overall Study|Lost to Follow-up|3|||
28000743|NCT00763386|81834286|FG000|Overall Study|Withdrawal by Subject|0|||
28000744|NCT00763386|81834287|FG001|Overall Study|Withdrawal by Subject|1|||
28000745|NCT00763386|81834286|FG000|Overall Study|CRF missing|0|||
28000746|NCT00763386|81834287|FG001|Overall Study|CRF missing|1|||
28000747|NCT00763386|81834286|FG000|Overall Study|Study Prosthesis Removed|1|||
28000748|NCT00763386|81834287|FG001|Overall Study|Study Prosthesis Removed|0|||
28000749|NCT04524858|81834288|FG000|Overall Study|Adverse Event|1|||
28000750|NCT00479336|81834291|FG000|Overall Study|Adverse Event|1|||
28000751|NCT00479336|81834292|FG001|Overall Study|Adverse Event|1|||
28000752|NCT00479336|81834293|FG002|Overall Study|Adverse Event|1|||
28000753|NCT00479336|81834294|FG003|Overall Study|Adverse Event|3|||
28000754|NCT00479336|81834291|FG000|Overall Study|Lack of Efficacy|1|||
28000755|NCT00479336|81834292|FG001|Overall Study|Lack of Efficacy|0|||
28000756|NCT00479336|81834293|FG002|Overall Study|Lack of Efficacy|0|||
28000757|NCT00479336|81834294|FG003|Overall Study|Lack of Efficacy|0|||
28000758|NCT00479336|81834291|FG000|Overall Study|Protocol Violation|0|||
28000759|NCT00479336|81834292|FG001|Overall Study|Protocol Violation|1|||
28000760|NCT00479336|81834293|FG002|Overall Study|Protocol Violation|0|||
28000761|NCT00479336|81834294|FG003|Overall Study|Protocol Violation|0|||
28000762|NCT00479336|81834291|FG000|Overall Study|Withdrawal by Subject|1|||
28000763|NCT00479336|81834292|FG001|Overall Study|Withdrawal by Subject|2|||
28000764|NCT00479336|81834293|FG002|Overall Study|Withdrawal by Subject|0|||
28000765|NCT00479336|81834294|FG003|Overall Study|Withdrawal by Subject|0|||
28000766|NCT00479336|81834291|FG000|Overall Study|Physician Decision|0|||
28000767|NCT00479336|81834292|FG001|Overall Study|Physician Decision|1|||
28000768|NCT00479336|81834293|FG002|Overall Study|Physician Decision|0|||
28000769|NCT00479336|81834294|FG003|Overall Study|Physician Decision|2|||
28000770|NCT00479336|81834291|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
28000771|NCT00479336|81834292|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
28000772|NCT00479336|81834293|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
28000773|NCT00479336|81834294|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
28000774|NCT00402168|81834296|FG000|Randomized|Lost to Follow-up|1|||
28000775|NCT00402168|81834297|FG001|Randomized|Lost to Follow-up|0|||
28000776|NCT00402168|81834296|FG000|Randomized|Withdrawal by Subject|0|||
28000777|NCT00402168|81834297|FG001|Randomized|Withdrawal by Subject|1|||
28000778|NCT00402168|81834296|FG000|Treatment (up to 12 Months)|Death|0|||
28000779|NCT00402168|81834297|FG001|Treatment (up to 12 Months)|Death|1|||
28000780|NCT00402168|81834296|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
28000781|NCT00402168|81834297|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
28000782|NCT00402168|81834296|FG000|Treatment (up to 12 Months)|non-specified|0|||
28000783|NCT00402168|81834297|FG001|Treatment (up to 12 Months)|non-specified|1|||
28000784|NCT00402168|81834296|FG000|Long Term (LT)|Adverse Event|1|||
28000785|NCT00402168|81834297|FG001|Long Term (LT)|Adverse Event|5|||
28000786|NCT00402168|81834296|FG000|Long Term (LT)|Withdrawal by Subject|4|||
28000787|NCT00402168|81834297|FG001|Long Term (LT)|Withdrawal by Subject|7|||
28000788|NCT00402168|81834296|FG000|Long Term (LT)|Pregnancy|0|||
27681208|NCT04307940|80668058|FG001|Overall Study|Lost to Follow-up|0|||
27681209|NCT04307940|80668059|FG002|Overall Study|Lost to Follow-up|1|||
28000789|NCT00402168|81834297|FG001|Long Term (LT)|Pregnancy|1|||
28000790|NCT00402168|81834296|FG000|Long Term (LT)|Lost to Follow-up|1|||
28000791|NCT00402168|81834297|FG001|Long Term (LT)|Lost to Follow-up|0|||
28000792|NCT00402168|81834296|FG000|Long Term (LT)|Death|4|||
28000793|NCT00402168|81834297|FG001|Long Term (LT)|Death|0|||
28000794|NCT00402168|81834296|FG000|Long Term (LT)|Lack of Efficacy|0|||
27681210|NCT01495598|80668060|FG000|Overall Study|Death during follow up period|2|||
27681211|NCT01495598|80668060|FG000|Overall Study|Death on study|1|||
28000795|NCT00402168|81834297|FG001|Long Term (LT)|Lack of Efficacy|2|||
28000796|NCT00402168|81834296|FG000|Long Term (LT)|non-specified|1|||
28000797|NCT00402168|81834297|FG001|Long Term (LT)|non-specified|2|||
28000798|NCT00402168|81834296|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
28000799|NCT00402168|81834297|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
28000800|NCT00402168|81834296|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
28000801|NCT00402168|81834297|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
28000802|NCT03579940|81834300|FG000|Period 2|Withdrawal by Subject|0|||
27582566|NCT00359762|80314061|FG002|Period III|Protocol Violation|3|||
27805985|NCT01612156|81120439|FG000|Overall Study|Protocol Violation|2|||
27805986|NCT01612156|81120440|FG001|Overall Study|Protocol Violation|0|||
27805987|NCT00923195|81120441|FG000|Overall Study|Death|0|||
27805988|NCT00923195|81120442|FG001|Overall Study|Death|1|||
27805989|NCT00871169|81120443|FG000|Overall Study|Protocol Violation|1|||
27805990|NCT00871169|81120443|FG000|Overall Study|Patient did not receive study treatment|2|||
27805991|NCT03705169|81120446|FG000|Overall Study|Lost to Follow-up|0|||
27805992|NCT03705169|81120447|FG001|Overall Study|Lost to Follow-up|0|||
27805993|NCT03705169|81120448|FG002|Overall Study|Lost to Follow-up|0|||
27805994|NCT03705169|81120449|FG003|Overall Study|Lost to Follow-up|2|||
27805995|NCT03705169|81120450|FG004|Overall Study|Lost to Follow-up|0|||
27805996|NCT03705169|81120451|FG005|Overall Study|Lost to Follow-up|2|||
27805997|NCT03705169|81120452|FG006|Overall Study|Lost to Follow-up|1|||
27805998|NCT03705169|81120453|FG007|Overall Study|Lost to Follow-up|0|||
27805999|NCT03705169|81120454|FG008|Overall Study|Lost to Follow-up|0|||
27806000|NCT03705169|81120455|FG009|Overall Study|Lost to Follow-up|1|||
27806001|NCT03705169|81120446|FG000|Overall Study|Adverse Event|0|||
27806002|NCT03705169|81120447|FG001|Overall Study|Adverse Event|0|||
27806003|NCT03705169|81120448|FG002|Overall Study|Adverse Event|0|||
27806004|NCT03705169|81120449|FG003|Overall Study|Adverse Event|1|||
27806005|NCT03705169|81120450|FG004|Overall Study|Adverse Event|0|||
27806006|NCT03705169|81120451|FG005|Overall Study|Adverse Event|0|||
27806007|NCT03705169|81120452|FG006|Overall Study|Adverse Event|0|||
27806008|NCT03705169|81120453|FG007|Overall Study|Adverse Event|0|||
28000803|NCT03579940|81834301|FG001|Period 2|Withdrawal by Subject|0|||
28000804|NCT03579940|81834302|FG002|Period 2|Withdrawal by Subject|1|||
28000805|NCT03579940|81834303|FG003|Period 2|Withdrawal by Subject|0|||
28000806|NCT03579940|81834304|FG004|Period 2|Withdrawal by Subject|0|||
28000807|NCT03579940|81834305|FG005|Period 2|Withdrawal by Subject|0|||
28000808|NCT03579940|81834306|FG006|Period 2|Withdrawal by Subject|0|||
28000809|NCT03579940|81834307|FG007|Period 2|Withdrawal by Subject|0|||
28000810|NCT03579940|81834308|FG008|Period 2|Withdrawal by Subject|0|||
28000811|NCT03579940|81834309|FG009|Period 2|Withdrawal by Subject|0|||
28000812|NCT03579940|81834310|FG010|Period 2|Withdrawal by Subject|0|||
28000813|NCT04014062|81834311|FG000|Period I: Dosing|Medical Grounds|4|||
28000814|NCT04014062|81834312|FG001|Period I: Dosing|Medical Grounds|5|||
28000815|NCT04014062|81834311|FG000|Period I: Dosing|Withdrawal by Subject|3|||
28000816|NCT04014062|81834312|FG001|Period I: Dosing|Withdrawal by Subject|1|||
28000817|NCT05579977|81834313|FG000|Treatment Phase|Other|0|||
28000818|NCT05579977|81834314|FG001|Treatment Phase|Other|0|||
28000819|NCT05579977|81834315|FG002|Treatment Phase|Other|0|||
28000820|NCT05579977|81834316|FG003|Treatment Phase|Other|2|||
28000821|NCT05579977|81834317|FG004|Treatment Phase|Other|1|||
28000822|NCT05579977|81834318|FG005|Treatment Phase|Other|2|||
28000823|NCT05579977|81834319|FG006|Treatment Phase|Other|1|||
28000824|NCT05579977|81834320|FG007|Treatment Phase|Other|2|||
28000825|NCT05579977|81834321|FG008|Treatment Phase|Other|2|||
28000826|NCT05579977|81834322|FG009|Treatment Phase|Other|1|||
28000827|NCT05579977|81834323|FG010|Treatment Phase|Other|0|||
28000828|NCT05579977|81834324|FG011|Treatment Phase|Other|0|||
28000829|NCT05579977|81834325|FG012|Treatment Phase|Other|3|||
28000830|NCT05579977|81834313|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
28000831|NCT05579977|81834314|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
28000832|NCT05579977|81834315|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
28000833|NCT05579977|81834316|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
28000834|NCT05579977|81834317|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
27582567|NCT00359762|80314062|FG003|Period III|Protocol Violation|8|||
27806009|NCT03705169|81120454|FG008|Overall Study|Adverse Event|0|||
27806010|NCT03705169|81120455|FG009|Overall Study|Adverse Event|0|||
27806011|NCT03705169|81120446|FG000|Overall Study|Site Closure|0|||
27806012|NCT03705169|81120447|FG001|Overall Study|Site Closure|0|||
27873919|NCT01863667|81371613|FG001|Overall Study|Withdrawal by Subject|2|||
27873920|NCT00752128|81371614|FG000|Overall Study|Withdrawal by Subject|4|||
27873921|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
28000835|NCT05579977|81834318|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
28000836|NCT05579977|81834319|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
28000837|NCT05579977|81834320|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
28000838|NCT05579977|81834321|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
28000839|NCT05579977|81834322|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
28000840|NCT05579977|81834323|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
28000841|NCT05579977|81834324|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
27582568|NCT00359762|80314063|FG004|Period III|Protocol Violation|0|||
27582569|NCT00359762|80314059|FG000|Period III|Adverse Event|0|||
27806013|NCT03705169|81120448|FG002|Overall Study|Site Closure|0|||
27582570|NCT00359762|80314060|FG001|Period III|Adverse Event|3|||
27806014|NCT03705169|81120449|FG003|Overall Study|Site Closure|1|||
27582571|NCT00359762|80314061|FG002|Period III|Adverse Event|4|||
27806015|NCT03705169|81120450|FG004|Overall Study|Site Closure|0|||
27806016|NCT03705169|81120451|FG005|Overall Study|Site Closure|0|||
27806017|NCT03705169|81120452|FG006|Overall Study|Site Closure|0|||
27806018|NCT03705169|81120453|FG007|Overall Study|Site Closure|0|||
27806019|NCT03705169|81120454|FG008|Overall Study|Site Closure|0|||
27806020|NCT03705169|81120455|FG009|Overall Study|Site Closure|0|||
27806021|NCT03705169|81120446|FG000|Overall Study|Did not receive study treatment|0|||
27806022|NCT03705169|81120447|FG001|Overall Study|Did not receive study treatment|0|||
27806023|NCT03705169|81120448|FG002|Overall Study|Did not receive study treatment|0|||
27806024|NCT03705169|81120449|FG003|Overall Study|Did not receive study treatment|1|||
27806025|NCT03705169|81120450|FG004|Overall Study|Did not receive study treatment|0|||
27806026|NCT03705169|81120451|FG005|Overall Study|Did not receive study treatment|0|||
27806027|NCT03705169|81120452|FG006|Overall Study|Did not receive study treatment|0|||
27806028|NCT03705169|81120453|FG007|Overall Study|Did not receive study treatment|0|||
27806029|NCT03705169|81120454|FG008|Overall Study|Did not receive study treatment|0|||
27806030|NCT03705169|81120455|FG009|Overall Study|Did not receive study treatment|0|||
27806031|NCT03705169|81120446|FG000|Overall Study|Concerns about study visit compliance|0|||
27806032|NCT03705169|81120447|FG001|Overall Study|Concerns about study visit compliance|0|||
27806033|NCT03705169|81120448|FG002|Overall Study|Concerns about study visit compliance|0|||
27806034|NCT03705169|81120449|FG003|Overall Study|Concerns about study visit compliance|1|||
27806035|NCT03705169|81120450|FG004|Overall Study|Concerns about study visit compliance|0|||
27806036|NCT03705169|81120451|FG005|Overall Study|Concerns about study visit compliance|0|||
27806037|NCT03705169|81120452|FG006|Overall Study|Concerns about study visit compliance|0|||
27806038|NCT03705169|81120453|FG007|Overall Study|Concerns about study visit compliance|0|||
27806039|NCT03705169|81120454|FG008|Overall Study|Concerns about study visit compliance|0|||
27806040|NCT03705169|81120455|FG009|Overall Study|Concerns about study visit compliance|0|||
27806041|NCT03210259|81120458|FG000|12-Week Run-in Period|Adverse Event|1|||
28000842|NCT05579977|81834325|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
28000843|NCT05579977|81834313|FG000|Treatment Phase|Withdrawal by Subject|2|||
28000844|NCT05579977|81834314|FG001|Treatment Phase|Withdrawal by Subject|0|||
28000845|NCT05579977|81834315|FG002|Treatment Phase|Withdrawal by Subject|0|||
28000846|NCT05579977|81834316|FG003|Treatment Phase|Withdrawal by Subject|1|||
28000847|NCT05579977|81834317|FG004|Treatment Phase|Withdrawal by Subject|2|||
28000848|NCT05579977|81834318|FG005|Treatment Phase|Withdrawal by Subject|0|||
28000849|NCT05579977|81834319|FG006|Treatment Phase|Withdrawal by Subject|1|||
28000850|NCT05579977|81834320|FG007|Treatment Phase|Withdrawal by Subject|8|||
28000851|NCT05579977|81834321|FG008|Treatment Phase|Withdrawal by Subject|3|||
28000852|NCT05579977|81834322|FG009|Treatment Phase|Withdrawal by Subject|3|||
28000853|NCT05579977|81834323|FG010|Treatment Phase|Withdrawal by Subject|5|||
28000854|NCT05579977|81834324|FG011|Treatment Phase|Withdrawal by Subject|1|||
28000855|NCT05579977|81834325|FG012|Treatment Phase|Withdrawal by Subject|3|||
28000856|NCT05579977|81834313|FG000|Treatment Phase|Study terminated by sponsor|70|||
28000857|NCT05579977|81834314|FG001|Treatment Phase|Study terminated by sponsor|70|||
28000858|NCT05579977|81834315|FG002|Treatment Phase|Study terminated by sponsor|61|||
28000859|NCT05579977|81834316|FG003|Treatment Phase|Study terminated by sponsor|59|||
28000860|NCT05579977|81834317|FG004|Treatment Phase|Study terminated by sponsor|63|||
28000861|NCT05579977|81834318|FG005|Treatment Phase|Study terminated by sponsor|53|||
28000862|NCT05579977|81834319|FG006|Treatment Phase|Study terminated by sponsor|66|||
28000863|NCT05579977|81834320|FG007|Treatment Phase|Study terminated by sponsor|48|||
28000864|NCT05579977|81834321|FG008|Treatment Phase|Study terminated by sponsor|47|||
28000865|NCT05579977|81834322|FG009|Treatment Phase|Study terminated by sponsor|37|||
28000866|NCT05579977|81834323|FG010|Treatment Phase|Study terminated by sponsor|44|||
28000867|NCT05579977|81834324|FG011|Treatment Phase|Study terminated by sponsor|36|||
28000868|NCT05579977|81834325|FG012|Treatment Phase|Study terminated by sponsor|32|||
28000869|NCT05579977|81834313|FG000|Treatment Phase|Pregnancy|0|||
28000870|NCT05579977|81834314|FG001|Treatment Phase|Pregnancy|0|||
28000871|NCT05579977|81834315|FG002|Treatment Phase|Pregnancy|0|||
28000872|NCT05579977|81834316|FG003|Treatment Phase|Pregnancy|0|||
28000873|NCT05579977|81834317|FG004|Treatment Phase|Pregnancy|0|||
28000874|NCT05579977|81834318|FG005|Treatment Phase|Pregnancy|0|||
28000875|NCT05579977|81834319|FG006|Treatment Phase|Pregnancy|0|||
27582572|NCT00359762|80314062|FG003|Period III|Adverse Event|10|||
27582573|NCT00359762|80314063|FG004|Period III|Adverse Event|0|||
27806042|NCT03210259|81120459|FG001|12-Week Run-in Period|Adverse Event|0|||
28000876|NCT05579977|81834320|FG007|Treatment Phase|Pregnancy|0|||
28000877|NCT05579977|81834321|FG008|Treatment Phase|Pregnancy|0|||
28000878|NCT05579977|81834322|FG009|Treatment Phase|Pregnancy|1|||
28000879|NCT05579977|81834323|FG010|Treatment Phase|Pregnancy|0|||
28000880|NCT05579977|81834324|FG011|Treatment Phase|Pregnancy|0|||
27582574|NCT00359762|80314059|FG000|Period III|Physician Decision|0|||
27582575|NCT00359762|80314060|FG001|Period III|Physician Decision|5|||
27582576|NCT00359762|80314061|FG002|Period III|Physician Decision|9|||
27582577|NCT00359762|80314062|FG003|Period III|Physician Decision|15|||
27582578|NCT00359762|80314063|FG004|Period III|Physician Decision|0|||
27582579|NCT00359762|80314059|FG000|Period III|Lack of Efficacy|0|||
27582580|NCT00359762|80314060|FG001|Period III|Lack of Efficacy|7|||
27582581|NCT00359762|80314061|FG002|Period III|Lack of Efficacy|5|||
27582582|NCT00359762|80314062|FG003|Period III|Lack of Efficacy|9|||
27582583|NCT00359762|80314063|FG004|Period III|Lack of Efficacy|0|||
27582584|NCT00359762|80314059|FG000|Period III|Lost to follow up|0|||
27582585|NCT00359762|80314060|FG001|Period III|Lost to follow up|1|||
27582586|NCT00359762|80314061|FG002|Period III|Lost to follow up|1|||
27806043|NCT03210259|81120460|FG002|12-Week Run-in Period|Adverse Event|0|||
27806044|NCT03210259|81120458|FG000|12-Week Run-in Period|Death|1|||
27806045|NCT03210259|81120459|FG001|12-Week Run-in Period|Death|0|||
27806046|NCT03210259|81120460|FG002|12-Week Run-in Period|Death|0|||
27806047|NCT03210259|81120458|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
27806048|NCT03210259|81120459|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
27806049|NCT03210259|81120460|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
27806050|NCT03210259|81120458|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
27806051|NCT03210259|81120459|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
27806052|NCT03210259|81120460|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
27806053|NCT03210259|81120458|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
27806054|NCT03210259|81120459|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
27806055|NCT03210259|81120460|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
27806056|NCT03210259|81120458|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
27806057|NCT03210259|81120459|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
27806058|NCT03210259|81120460|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
27806059|NCT03210259|81120458|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
27806060|NCT03210259|81120459|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
27806061|NCT03210259|81120460|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
27806062|NCT03210259|81120458|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
27806063|NCT03210259|81120459|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
27806064|NCT03210259|81120460|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
27806065|NCT03210259|81120458|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
27806066|NCT03210259|81120459|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
27806067|NCT03210259|81120460|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
27806068|NCT03210259|81120458|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
27806069|NCT03210259|81120459|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
27806070|NCT03210259|81120460|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
27806071|NCT03210259|81120458|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
27806072|NCT03210259|81120459|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
27806073|NCT03210259|81120460|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
27806074|NCT02971605|81120461|FG000|Overall Study|Withdrawal by Subject|1|||
27806075|NCT02323295|81120464|FG000|Overall Study|Adverse Event|0|||
27806076|NCT02323295|81120465|FG001|Overall Study|Adverse Event|1|||
27806077|NCT02323295|81120464|FG000|Overall Study|Withdrawal by Subject|0|||
27806078|NCT02323295|81120465|FG001|Overall Study|Withdrawal by Subject|1|||
27806079|NCT02323295|81120464|FG000|Overall Study|Patient did not have surgery as planned.|0|||
27806080|NCT02323295|81120465|FG001|Overall Study|Patient did not have surgery as planned.|1|||
27806081|NCT00066807|81120466|FG000|Overall Study|Study was terminated early|14|||
27806082|NCT00066807|81120467|FG001|Overall Study|Study was terminated early|15|||
27582587|NCT00359762|80314062|FG003|Period III|Lost to follow up|2|||
27582588|NCT00359762|80314063|FG004|Period III|Lost to follow up|0|||
28000881|NCT05579977|81834325|FG012|Treatment Phase|Pregnancy|0|||
28000882|NCT05579977|81834313|FG000|Treatment Phase|Physician Decision|0|||
28000883|NCT05579977|81834314|FG001|Treatment Phase|Physician Decision|0|||
28000884|NCT05579977|81834315|FG002|Treatment Phase|Physician Decision|0|||
28000885|NCT05579977|81834316|FG003|Treatment Phase|Physician Decision|0|||
28000886|NCT05579977|81834317|FG004|Treatment Phase|Physician Decision|0|||
28000887|NCT05579977|81834318|FG005|Treatment Phase|Physician Decision|0|||
28000888|NCT05579977|81834319|FG006|Treatment Phase|Physician Decision|0|||
28000889|NCT05579977|81834320|FG007|Treatment Phase|Physician Decision|0|||
28000890|NCT05579977|81834321|FG008|Treatment Phase|Physician Decision|0|||
28000891|NCT05579977|81834322|FG009|Treatment Phase|Physician Decision|0|||
28000892|NCT05579977|81834323|FG010|Treatment Phase|Physician Decision|0|||
28000893|NCT05579977|81834324|FG011|Treatment Phase|Physician Decision|1|||
28000894|NCT05579977|81834325|FG012|Treatment Phase|Physician Decision|0|||
28000895|NCT05579977|81834313|FG000|Treatment Phase|Lost to Follow-up|0|||
28000896|NCT05579977|81834314|FG001|Treatment Phase|Lost to Follow-up|0|||
28000897|NCT05579977|81834315|FG002|Treatment Phase|Lost to Follow-up|0|||
28000898|NCT05579977|81834316|FG003|Treatment Phase|Lost to Follow-up|1|||
28000899|NCT05579977|81834317|FG004|Treatment Phase|Lost to Follow-up|1|||
28000900|NCT05579977|81834318|FG005|Treatment Phase|Lost to Follow-up|1|||
28000901|NCT05579977|81834319|FG006|Treatment Phase|Lost to Follow-up|0|||
28000902|NCT05579977|81834320|FG007|Treatment Phase|Lost to Follow-up|1|||
28000903|NCT05579977|81834321|FG008|Treatment Phase|Lost to Follow-up|2|||
28000904|NCT05579977|81834322|FG009|Treatment Phase|Lost to Follow-up|2|||
28000905|NCT05579977|81834323|FG010|Treatment Phase|Lost to Follow-up|1|||
28000906|NCT05579977|81834324|FG011|Treatment Phase|Lost to Follow-up|4|||
28000907|NCT05579977|81834325|FG012|Treatment Phase|Lost to Follow-up|3|||
28000908|NCT05579977|81834313|FG000|Treatment Phase|Death|1|||
28000909|NCT05579977|81834314|FG001|Treatment Phase|Death|0|||
28000910|NCT05579977|81834315|FG002|Treatment Phase|Death|0|||
28000911|NCT05579977|81834316|FG003|Treatment Phase|Death|0|||
28000912|NCT05579977|81834317|FG004|Treatment Phase|Death|0|||
28000913|NCT05579977|81834318|FG005|Treatment Phase|Death|0|||
27582589|NCT00359762|80314059|FG000|Period III|Entry Criteria Not Met|0|||
27582590|NCT00359762|80314060|FG001|Period III|Entry Criteria Not Met|1|||
27582591|NCT00359762|80314061|FG002|Period III|Entry Criteria Not Met|0|||
27582592|NCT00359762|80314062|FG003|Period III|Entry Criteria Not Met|1|||
27582593|NCT00359762|80314063|FG004|Period III|Entry Criteria Not Met|0|||
27582594|NCT00359762|80314059|FG000|Period III|Subject Decision|0|||
27582595|NCT00359762|80314060|FG001|Period III|Subject Decision|7|||
27582596|NCT00359762|80314061|FG002|Period III|Subject Decision|8|||
27582597|NCT00359762|80314062|FG003|Period III|Subject Decision|20|||
27582598|NCT00359762|80314063|FG004|Period III|Subject Decision|0|||
27681212|NCT01495598|80668060|FG000|Overall Study|Lost to Follow-up|3|||
27681213|NCT01495598|80668060|FG000|Overall Study|Physician Decision|8|||
27806083|NCT02962882|81120472|FG000|Overall Study|Adverse Event|2|||
27806084|NCT02962882|81120472|FG000|Overall Study|Withdrawal by Subject|2|||
27806085|NCT02962882|81120472|FG000|Overall Study|Transfer from ICU|32|||
27806086|NCT04304950|81120473|FG000|Overall Study|Lost to Follow-up|1|||
27806087|NCT04304950|81120474|FG001|Overall Study|Lost to Follow-up|1|||
27806088|NCT04741503|81120475|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
27806089|NCT04741503|81120476|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
27806090|NCT04741503|81120477|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
27806091|NCT04741503|81120475|FG000|Initial Enrollment|Overquotas removed|0|||
27806092|NCT04741503|81120476|FG001|Initial Enrollment|Overquotas removed|0|||
27806093|NCT04741503|81120477|FG002|Initial Enrollment|Overquotas removed|186|||
27806094|NCT04741503|81120475|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
27806095|NCT04741503|81120476|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
27806096|NCT04741503|81120477|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
27806097|NCT04242186|81120478|FG000|Overall Study|Death|5|||
27873922|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
27873923|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
27873924|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
27681214|NCT01605019|80668061|FG000|Overall Study|pt did not meet transplant endpoint|3|||
28000914|NCT05579977|81834319|FG006|Treatment Phase|Death|0|||
28000915|NCT05579977|81834320|FG007|Treatment Phase|Death|0|||
28000916|NCT05579977|81834321|FG008|Treatment Phase|Death|0|||
28000917|NCT05579977|81834322|FG009|Treatment Phase|Death|0|||
28000918|NCT05579977|81834323|FG010|Treatment Phase|Death|0|||
28000919|NCT05579977|81834324|FG011|Treatment Phase|Death|0|||
27582599|NCT00560833|80314064|FG000|Overall Study|Adverse Event|16|||
28000920|NCT05579977|81834325|FG012|Treatment Phase|Death|0|||
28000921|NCT05579977|81834313|FG000|Treatment Phase|Adverse Event|0|||
27582600|NCT00560833|80314065|FG001|Overall Study|Adverse Event|10|||
27582601|NCT00560833|80314066|FG002|Overall Study|Adverse Event|25|||
27582602|NCT00560833|80314067|FG003|Overall Study|Adverse Event|23|||
27806098|NCT03202511|81120479|FG000|Overall Study|Withdrawal by Subject|1|||
27806099|NCT03202511|81120480|FG001|Overall Study|Withdrawal by Subject|0|||
27806100|NCT01259401|81120481|FG000|4-month Follow-up|Death|0|||
27806101|NCT01259401|81120482|FG001|4-month Follow-up|Death|1|||
27806102|NCT01259401|81120481|FG000|4-month Follow-up|Lost to Follow-up|0|||
27806103|NCT01259401|81120482|FG001|4-month Follow-up|Lost to Follow-up|1|||
27806104|NCT00534092|81120483|FG000|Overall Study|Lost to Follow-up|1|||
27582603|NCT00560833|80314068|FG004|Overall Study|Adverse Event|35|||
27582604|NCT00560833|80314064|FG000|Overall Study|Lost to Follow-up|0|||
27582605|NCT00560833|80314065|FG001|Overall Study|Lost to Follow-up|0|||
27582606|NCT00560833|80314066|FG002|Overall Study|Lost to Follow-up|1|||
27806105|NCT00534092|81120484|FG001|Overall Study|Lost to Follow-up|0|||
27806106|NCT00534092|81120483|FG000|Overall Study|personal reasons/family concerns|1|||
27806107|NCT00534092|81120484|FG001|Overall Study|personal reasons/family concerns|0|||
27806108|NCT00446654|81120485|FG000|Overall Study|Withdrawal by Subject|1|||
27806109|NCT00446654|81120486|FG001|Overall Study|Withdrawal by Subject|0|||
27806110|NCT00446654|81120485|FG000|Overall Study|Adverse Event|1|||
27806111|NCT00446654|81120486|FG001|Overall Study|Adverse Event|0|||
27806112|NCT01348542|81120487|FG000|Overall Study|Withdrawal by Subject|3|||
27806113|NCT01348542|81120488|FG001|Overall Study|Withdrawal by Subject|0|||
27806114|NCT02770716|81120489|FG000|Overall Study|Death|101|||
28000922|NCT05579977|81834314|FG001|Treatment Phase|Adverse Event|3|||
28000923|NCT05579977|81834315|FG002|Treatment Phase|Adverse Event|11|||
28000924|NCT05579977|81834316|FG003|Treatment Phase|Adverse Event|10|||
28000925|NCT05579977|81834317|FG004|Treatment Phase|Adverse Event|5|||
28000926|NCT05579977|81834318|FG005|Treatment Phase|Adverse Event|17|||
28000927|NCT05579977|81834319|FG006|Treatment Phase|Adverse Event|5|||
28000928|NCT05579977|81834320|FG007|Treatment Phase|Adverse Event|5|||
28000929|NCT05579977|81834321|FG008|Treatment Phase|Adverse Event|12|||
28000930|NCT05579977|81834322|FG009|Treatment Phase|Adverse Event|20|||
28000931|NCT05579977|81834323|FG010|Treatment Phase|Adverse Event|15|||
28000932|NCT05579977|81834324|FG011|Treatment Phase|Adverse Event|24|||
28000933|NCT05579977|81834325|FG012|Treatment Phase|Adverse Event|23|||
28000934|NCT05579977|81834313|FG000|Treatment Phase|Randomized not treated|0|||
28000935|NCT05579977|81834314|FG001|Treatment Phase|Randomized not treated|0|||
28000936|NCT05579977|81834315|FG002|Treatment Phase|Randomized not treated|0|||
28000937|NCT05579977|81834316|FG003|Treatment Phase|Randomized not treated|0|||
28000938|NCT05579977|81834317|FG004|Treatment Phase|Randomized not treated|1|||
28000939|NCT05579977|81834318|FG005|Treatment Phase|Randomized not treated|0|||
28000940|NCT05579977|81834319|FG006|Treatment Phase|Randomized not treated|0|||
28000941|NCT05579977|81834320|FG007|Treatment Phase|Randomized not treated|0|||
28000942|NCT05579977|81834321|FG008|Treatment Phase|Randomized not treated|0|||
28000943|NCT05579977|81834322|FG009|Treatment Phase|Randomized not treated|0|||
28000944|NCT05579977|81834323|FG010|Treatment Phase|Randomized not treated|0|||
28000945|NCT05579977|81834324|FG011|Treatment Phase|Randomized not treated|0|||
28000946|NCT05579977|81834325|FG012|Treatment Phase|Randomized not treated|0|||
28000947|NCT05579977|81834313|FG000|Follow up|Death|1|||
28000948|NCT05579977|81834314|FG001|Follow up|Death|0|||
28000949|NCT05579977|81834315|FG002|Follow up|Death|0|||
28000950|NCT05579977|81834316|FG003|Follow up|Death|0|||
28000951|NCT05579977|81834317|FG004|Follow up|Death|0|||
28000952|NCT05579977|81834318|FG005|Follow up|Death|0|||
28000953|NCT05579977|81834319|FG006|Follow up|Death|0|||
28000954|NCT05579977|81834320|FG007|Follow up|Death|0|||
28000955|NCT05579977|81834321|FG008|Follow up|Death|0|||
28000956|NCT05579977|81834322|FG009|Follow up|Death|0|||
28000957|NCT05579977|81834323|FG010|Follow up|Death|0|||
28000958|NCT05579977|81834324|FG011|Follow up|Death|0|||
28000959|NCT05579977|81834325|FG012|Follow up|Death|0|||
28000960|NCT05579977|81834313|FG000|Follow up|Lost to Follow-up|0|||
28000961|NCT05579977|81834314|FG001|Follow up|Lost to Follow-up|0|||
28000962|NCT05579977|81834315|FG002|Follow up|Lost to Follow-up|0|||
28000963|NCT05579977|81834316|FG003|Follow up|Lost to Follow-up|1|||
27582607|NCT00560833|80314067|FG003|Overall Study|Lost to Follow-up|0|||
27582608|NCT00560833|80314068|FG004|Overall Study|Lost to Follow-up|0|||
27582609|NCT00560833|80314064|FG000|Overall Study|Lack of Efficacy|22|||
27806115|NCT02770716|81120490|FG001|Overall Study|Death|45|||
28000964|NCT05579977|81834317|FG004|Follow up|Lost to Follow-up|1|||
28000965|NCT05579977|81834318|FG005|Follow up|Lost to Follow-up|2|||
28000966|NCT05579977|81834319|FG006|Follow up|Lost to Follow-up|1|||
28000967|NCT05579977|81834320|FG007|Follow up|Lost to Follow-up|1|||
27582610|NCT00560833|80314065|FG001|Overall Study|Lack of Efficacy|9|||
27806116|NCT02770716|81120489|FG000|Overall Study|Withdrawal by Subject|4|||
27806117|NCT02770716|81120490|FG001|Overall Study|Withdrawal by Subject|2|||
27806118|NCT02770716|81120489|FG000|Overall Study|Lost to Follow-up|1|||
28000968|NCT05579977|81834321|FG008|Follow up|Lost to Follow-up|3|||
28000969|NCT05579977|81834322|FG009|Follow up|Lost to Follow-up|2|||
28000970|NCT05579977|81834323|FG010|Follow up|Lost to Follow-up|2|||
28000971|NCT05579977|81834324|FG011|Follow up|Lost to Follow-up|4|||
28000972|NCT05579977|81834325|FG012|Follow up|Lost to Follow-up|4|||
28000973|NCT05579977|81834313|FG000|Follow up|Withdrawal by Subject|2|||
27582611|NCT00560833|80314066|FG002|Overall Study|Lack of Efficacy|6|||
27582612|NCT00560833|80314067|FG003|Overall Study|Lack of Efficacy|4|||
27681215|NCT01605019|80668062|FG001|Overall Study|pt did not meet transplant endpoint|0|||
27681216|NCT01365481|80668063|FG000|Overall Study|Adverse Event|6|||
27681217|NCT01365481|80668064|FG001|Overall Study|Adverse Event|9|||
27681218|NCT01365481|80668065|FG002|Overall Study|Adverse Event|0|||
27681219|NCT01365481|80668066|FG003|Overall Study|Adverse Event|2|||
27582613|NCT00560833|80314068|FG004|Overall Study|Lack of Efficacy|4|||
27582614|NCT00560833|80314064|FG000|Overall Study|Participant uncooperative|5|||
27582615|NCT00560833|80314065|FG001|Overall Study|Participant uncooperative|5|||
27582616|NCT00560833|80314066|FG002|Overall Study|Participant uncooperative|4|||
27582617|NCT00560833|80314067|FG003|Overall Study|Participant uncooperative|4|||
27582618|NCT00560833|80314068|FG004|Overall Study|Participant uncooperative|2|||
27582619|NCT00560833|80314064|FG000|Overall Study|Other|1|||
27582620|NCT00560833|80314065|FG001|Overall Study|Other|1|||
27582621|NCT00560833|80314066|FG002|Overall Study|Other|3|||
27582622|NCT00560833|80314067|FG003|Overall Study|Other|0|||
27582623|NCT00560833|80314068|FG004|Overall Study|Other|0|||
27582624|NCT00560833|80314064|FG000|Overall Study|Never received drug|0|||
27582625|NCT00560833|80314065|FG001|Overall Study|Never received drug|1|||
27582626|NCT00560833|80314066|FG002|Overall Study|Never received drug|0|||
27582627|NCT00560833|80314067|FG003|Overall Study|Never received drug|0|||
27582628|NCT00560833|80314068|FG004|Overall Study|Never received drug|1|||
27582629|NCT02033889|80314072|FG000|Overall Study|Adverse Event|3|||
27582630|NCT02033889|80314073|FG001|Overall Study|Adverse Event|1|||
27582631|NCT02033889|80314074|FG002|Overall Study|Adverse Event|3|||
27582632|NCT02033889|80314072|FG000|Overall Study|Death|3|||
27582633|NCT02033889|80314073|FG001|Overall Study|Death|1|||
27582634|NCT02033889|80314074|FG002|Overall Study|Death|2|||
27582635|NCT02033889|80314072|FG000|Overall Study|Excluded Medication|1|||
27582636|NCT02033889|80314073|FG001|Overall Study|Excluded Medication|1|||
27582637|NCT02033889|80314074|FG002|Overall Study|Excluded Medication|0|||
27582638|NCT02033889|80314072|FG000|Overall Study|Lost to Follow-up|8|||
27582639|NCT02033889|80314073|FG001|Overall Study|Lost to Follow-up|5|||
27582640|NCT02033889|80314074|FG002|Overall Study|Lost to Follow-up|6|||
27582641|NCT02033889|80314072|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27582642|NCT02033889|80314073|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27582643|NCT02033889|80314074|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27582644|NCT02033889|80314072|FG000|Overall Study|Physician Decision|0|||
27582645|NCT02033889|80314073|FG001|Overall Study|Physician Decision|1|||
27582646|NCT02033889|80314074|FG002|Overall Study|Physician Decision|1|||
27582647|NCT02033889|80314072|FG000|Overall Study|Participant moved|0|||
27582648|NCT02033889|80314073|FG001|Overall Study|Participant moved|1|||
27582649|NCT02033889|80314074|FG002|Overall Study|Participant moved|0|||
27582650|NCT02033889|80314072|FG000|Overall Study|Withdrawal by Subject|18|||
27582651|NCT02033889|80314073|FG001|Overall Study|Withdrawal by Subject|10|||
27582652|NCT02033889|80314074|FG002|Overall Study|Withdrawal by Subject|13|||
27582653|NCT01969838|80314078|FG000|Double-blind Phase|Adverse Event|10|||
27582654|NCT01969838|80314079|FG001|Double-blind Phase|Adverse Event|4|||
27582655|NCT01969838|80314080|FG002|Double-blind Phase|Adverse Event|0|||
27582656|NCT01969838|80314081|FG003|Double-blind Phase|Adverse Event|0|||
27582657|NCT01969838|80314078|FG000|Double-blind Phase|Death|5|||
27582658|NCT01969838|80314079|FG001|Double-blind Phase|Death|2|||
27582659|NCT01969838|80314080|FG002|Double-blind Phase|Death|0|||
27582660|NCT01969838|80314081|FG003|Double-blind Phase|Death|0|||
27582661|NCT01969838|80314078|FG000|Double-blind Phase|Physician Decision|5|||
27582662|NCT01969838|80314079|FG001|Double-blind Phase|Physician Decision|1|||
27582663|NCT01969838|80314080|FG002|Double-blind Phase|Physician Decision|0|||
27582664|NCT01969838|80314081|FG003|Double-blind Phase|Physician Decision|0|||
27582665|NCT01969838|80314078|FG000|Double-blind Phase|Subject Decision|4|||
27582666|NCT01969838|80314079|FG001|Double-blind Phase|Subject Decision|2|||
27582667|NCT01969838|80314080|FG002|Double-blind Phase|Subject Decision|0|||
27582668|NCT01969838|80314081|FG003|Double-blind Phase|Subject Decision|0|||
27582669|NCT01969838|80314078|FG000|Double-blind Phase|Disease Progression|2|||
27582670|NCT01969838|80314079|FG001|Double-blind Phase|Disease Progression|0|||
27582671|NCT01969838|80314080|FG002|Double-blind Phase|Disease Progression|0|||
27681220|NCT01365481|80668063|FG000|Overall Study|Withdrawal by Subject|0|||
27582672|NCT01969838|80314081|FG003|Double-blind Phase|Disease Progression|0|||
27582673|NCT01969838|80314078|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
27582674|NCT01969838|80314079|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
27582675|NCT01969838|80314080|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
27681221|NCT01365481|80668064|FG001|Overall Study|Withdrawal by Subject|2|||
27681222|NCT01365481|80668065|FG002|Overall Study|Withdrawal by Subject|1|||
27582676|NCT01969838|80314081|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
27582677|NCT01969838|80314078|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
27582678|NCT01969838|80314079|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
27582679|NCT01969838|80314080|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
27582680|NCT01969838|80314081|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
27806119|NCT02770716|81120490|FG001|Overall Study|Lost to Follow-up|0|||
27806120|NCT02770716|81120489|FG000|Overall Study|Various reasons|6|||
27806121|NCT02770716|81120490|FG001|Overall Study|Various reasons|2|||
27806122|NCT03521999|81120495|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
27806123|NCT03521999|81120496|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
27806124|NCT03521999|81120495|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
27806125|NCT03521999|81120496|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
27806126|NCT03521999|81120495|FG000|Completed 3 Month Follow up|Death|0|||
27806127|NCT03521999|81120496|FG001|Completed 3 Month Follow up|Death|1|||
27806128|NCT03521999|81120495|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
27806129|NCT03521999|81120496|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
27806130|NCT02741271|81120497|FG000|Overall Study|Lost to Follow-up|2|||
27806131|NCT02741271|81120498|FG001|Overall Study|Lost to Follow-up|0|||
27806132|NCT02741271|81120497|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27806133|NCT02741271|81120498|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27806134|NCT00409578|81120499|FG000|Overall Study|Adverse Event|27|||
27806135|NCT00409578|81120500|FG001|Overall Study|Adverse Event|37|||
27806136|NCT00409578|81120501|FG002|Overall Study|Adverse Event|25|||
27806137|NCT00409578|81120502|FG003|Overall Study|Adverse Event|33|||
27806138|NCT00409578|81120499|FG000|Overall Study|Abnormal laboratory value(s)|2|||
27806139|NCT00409578|81120500|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27806140|NCT00409578|81120501|FG002|Overall Study|Abnormal laboratory value(s)|2|||
27806141|NCT00409578|81120502|FG003|Overall Study|Abnormal laboratory value(s)|4|||
27806142|NCT00409578|81120499|FG000|Overall Study|Lack of Efficacy|0|||
27806143|NCT00409578|81120500|FG001|Overall Study|Lack of Efficacy|0|||
27806144|NCT00409578|81120501|FG002|Overall Study|Lack of Efficacy|0|||
27806145|NCT00409578|81120502|FG003|Overall Study|Lack of Efficacy|2|||
27806146|NCT00409578|81120499|FG000|Overall Study|Subject no longer requires study drug|0|||
27806147|NCT00409578|81120500|FG001|Overall Study|Subject no longer requires study drug|0|||
27806148|NCT00409578|81120501|FG002|Overall Study|Subject no longer requires study drug|0|||
27806149|NCT00409578|81120502|FG003|Overall Study|Subject no longer requires study drug|1|||
27806150|NCT00409578|81120499|FG000|Overall Study|Withdrawal by Subject|8|||
27806151|NCT00409578|81120500|FG001|Overall Study|Withdrawal by Subject|15|||
27806152|NCT00409578|81120501|FG002|Overall Study|Withdrawal by Subject|16|||
27806153|NCT00409578|81120502|FG003|Overall Study|Withdrawal by Subject|17|||
27806154|NCT00409578|81120499|FG000|Overall Study|Lost to Follow-up|2|||
28000974|NCT05579977|81834314|FG001|Follow up|Withdrawal by Subject|0|||
28000975|NCT05579977|81834315|FG002|Follow up|Withdrawal by Subject|0|||
28000976|NCT05579977|81834316|FG003|Follow up|Withdrawal by Subject|0|||
28000977|NCT05579977|81834317|FG004|Follow up|Withdrawal by Subject|1|||
28000978|NCT05579977|81834318|FG005|Follow up|Withdrawal by Subject|0|||
28000979|NCT05579977|81834319|FG006|Follow up|Withdrawal by Subject|1|||
28000980|NCT05579977|81834320|FG007|Follow up|Withdrawal by Subject|4|||
28000981|NCT05579977|81834321|FG008|Follow up|Withdrawal by Subject|2|||
28000982|NCT05579977|81834322|FG009|Follow up|Withdrawal by Subject|3|||
28000983|NCT05579977|81834323|FG010|Follow up|Withdrawal by Subject|3|||
28000984|NCT05579977|81834324|FG011|Follow up|Withdrawal by Subject|1|||
28000985|NCT05579977|81834325|FG012|Follow up|Withdrawal by Subject|3|||
28000986|NCT01879683|81834326|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
28000987|NCT01400698|81834333|FG000|Overall Study|Lost to Follow-up|2|||
28000988|NCT01400698|81834334|FG001|Overall Study|Lost to Follow-up|5|||
28000989|NCT01400698|81834335|FG002|Overall Study|Lost to Follow-up|2|||
28000990|NCT01400698|81834336|FG003|Overall Study|Lost to Follow-up|1|||
28000991|NCT01400698|81834337|FG004|Overall Study|Lost to Follow-up|4|||
28000992|NCT01400698|81834338|FG005|Overall Study|Lost to Follow-up|3|||
28000993|NCT01400698|81834333|FG000|Overall Study|Withdrawal by Subject|8|||
28000994|NCT01400698|81834334|FG001|Overall Study|Withdrawal by Subject|2|||
28000995|NCT01400698|81834335|FG002|Overall Study|Withdrawal by Subject|0|||
27582681|NCT01969838|80314078|FG000|Open-label Phase|Adverse Event|0|||
27582682|NCT01969838|80314079|FG001|Open-label Phase|Adverse Event|0|||
27582683|NCT01969838|80314080|FG002|Open-label Phase|Adverse Event|37|||
27582684|NCT01969838|80314081|FG003|Open-label Phase|Adverse Event|49|||
27582685|NCT01969838|80314078|FG000|Open-label Phase|Disease Progression|0|||
27582686|NCT01969838|80314079|FG001|Open-label Phase|Disease Progression|0|||
27806155|NCT00409578|81120500|FG001|Overall Study|Lost to Follow-up|0|||
28000996|NCT01400698|81834336|FG003|Overall Study|Withdrawal by Subject|4|||
28000997|NCT01400698|81834337|FG004|Overall Study|Withdrawal by Subject|1|||
27806156|NCT00409578|81120501|FG002|Overall Study|Lost to Follow-up|2|||
27806157|NCT00409578|81120502|FG003|Overall Study|Lost to Follow-up|2|||
27806158|NCT00409578|81120499|FG000|Overall Study|Administrative problems|8|||
27806159|NCT00409578|81120500|FG001|Overall Study|Administrative problems|9|||
27806160|NCT00409578|81120501|FG002|Overall Study|Administrative problems|2|||
28000998|NCT01400698|81834338|FG005|Overall Study|Withdrawal by Subject|3|||
28000999|NCT01400698|81834333|FG000|Overall Study|Protocol Violation|0|||
28001000|NCT01400698|81834334|FG001|Overall Study|Protocol Violation|1|||
27582687|NCT01969838|80314080|FG002|Open-label Phase|Disease Progression|26|||
27582688|NCT01969838|80314081|FG003|Open-label Phase|Disease Progression|27|||
28001001|NCT01400698|81834335|FG002|Overall Study|Protocol Violation|0|||
28001002|NCT01400698|81834336|FG003|Overall Study|Protocol Violation|0|||
28001003|NCT01400698|81834337|FG004|Overall Study|Protocol Violation|1|||
28001004|NCT01400698|81834338|FG005|Overall Study|Protocol Violation|0|||
28001005|NCT01400698|81834333|FG000|Overall Study|Non-compliance|0|||
28001006|NCT01400698|81834334|FG001|Overall Study|Non-compliance|1|||
27806161|NCT00409578|81120502|FG003|Overall Study|Administrative problems|4|||
27873925|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Pregnancy|0|||
28001007|NCT01400698|81834335|FG002|Overall Study|Non-compliance|0|||
28001008|NCT01400698|81834336|FG003|Overall Study|Non-compliance|1|||
28001009|NCT01400698|81834337|FG004|Overall Study|Non-compliance|0|||
28001010|NCT01400698|81834338|FG005|Overall Study|Non-compliance|0|||
28001011|NCT01400698|81834333|FG000|Overall Study|Adverse Event|1|||
27806162|NCT00409578|81120499|FG000|Overall Study|Death|2|||
28001012|NCT01400698|81834334|FG001|Overall Study|Adverse Event|0|||
28001013|NCT01400698|81834335|FG002|Overall Study|Adverse Event|0|||
28001014|NCT01400698|81834336|FG003|Overall Study|Adverse Event|0|||
28001015|NCT01400698|81834337|FG004|Overall Study|Adverse Event|0|||
28001016|NCT01400698|81834338|FG005|Overall Study|Adverse Event|0|||
28001017|NCT01400698|81834333|FG000|Overall Study|Other|4|||
27806163|NCT00409578|81120500|FG001|Overall Study|Death|4|||
27806164|NCT00409578|81120501|FG002|Overall Study|Death|4|||
27806165|NCT00409578|81120502|FG003|Overall Study|Death|2|||
27806166|NCT00409578|81120499|FG000|Overall Study|Protocol Violation|3|||
27806167|NCT00409578|81120500|FG001|Overall Study|Protocol Violation|2|||
28001018|NCT01400698|81834334|FG001|Overall Study|Other|2|||
28001019|NCT01400698|81834335|FG002|Overall Study|Other|0|||
27806168|NCT00409578|81120501|FG002|Overall Study|Protocol Violation|3|||
27806169|NCT00409578|81120502|FG003|Overall Study|Protocol Violation|1|||
27806170|NCT00409578|81120499|FG000|Overall Study|Missing|0|||
27806171|NCT00409578|81120500|FG001|Overall Study|Missing|1|||
27806172|NCT00409578|81120501|FG002|Overall Study|Missing|0|||
27806173|NCT00409578|81120502|FG003|Overall Study|Missing|1|||
27806174|NCT01473758|81120503|FG000|Cycle 1|Adverse Event|10|||
27806175|NCT01473758|81120504|FG001|Cycle 1|Adverse Event|2|||
27806176|NCT01473758|81120505|FG002|Cycle 1|Adverse Event|0|||
27806177|NCT01473758|81120506|FG003|Cycle 1|Adverse Event|0|||
27806178|NCT01473758|81120503|FG000|Cycle 1|Withdrawal by Subject|1|||
27806179|NCT01473758|81120504|FG001|Cycle 1|Withdrawal by Subject|1|||
27806180|NCT01473758|81120505|FG002|Cycle 1|Withdrawal by Subject|0|||
27873926|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Pregnancy|1|||
27873927|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
27873928|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
27873929|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
28001020|NCT01400698|81834336|FG003|Overall Study|Other|2|||
28001021|NCT01400698|81834337|FG004|Overall Study|Other|1|||
28001022|NCT01400698|81834338|FG005|Overall Study|Other|0|||
28001023|NCT00871871|81834341|FG000|Part I|Adverse Event|0|||
28001024|NCT00871871|81834342|FG001|Part I|Adverse Event|2|||
27700987|NCT01241552|80741292|FG003|Overall Study|Technical Problems|2|||
28001025|NCT00871871|81834343|FG002|Part I|Adverse Event|0|||
27806181|NCT01473758|81120506|FG003|Cycle 1|Withdrawal by Subject|0|||
28001026|NCT00871871|81834344|FG003|Part I|Adverse Event|0|||
28001027|NCT00871871|81834341|FG000|Part I|Withdrawal by Subject|3|||
27806182|NCT01473758|81120503|FG000|Cycle 2|Adverse Event|0|||
28001028|NCT00871871|81834342|FG001|Part I|Withdrawal by Subject|0|||
28001029|NCT00871871|81834343|FG002|Part I|Withdrawal by Subject|0|||
28001030|NCT00871871|81834344|FG003|Part I|Withdrawal by Subject|0|||
28001031|NCT00871871|81834341|FG000|Part I|Laboratory abnormality|0|||
27806183|NCT01473758|81120504|FG001|Cycle 2|Adverse Event|0|||
28001032|NCT00871871|81834342|FG001|Part I|Laboratory abnormality|1|||
28001033|NCT00871871|81834343|FG002|Part I|Laboratory abnormality|0|||
28001034|NCT00871871|81834344|FG003|Part I|Laboratory abnormality|0|||
28001035|NCT00871871|81834341|FG000|Part II|Lack of Efficacy|0|||
28001036|NCT00871871|81834342|FG001|Part II|Lack of Efficacy|0|||
28001037|NCT00871871|81834343|FG002|Part II|Lack of Efficacy|1|||
28001038|NCT00871871|81834344|FG003|Part II|Lack of Efficacy|0|||
28001039|NCT00871871|81834341|FG000|Part II|Withdrawal by Subject|0|||
28001040|NCT00871871|81834342|FG001|Part II|Withdrawal by Subject|0|||
28001041|NCT00871871|81834343|FG002|Part II|Withdrawal by Subject|2|||
28001042|NCT00871871|81834344|FG003|Part II|Withdrawal by Subject|1|||
28001043|NCT00871871|81834341|FG000|Part II|Adverse Event|0|||
28001044|NCT00871871|81834342|FG001|Part II|Adverse Event|0|||
28001045|NCT00871871|81834343|FG002|Part II|Adverse Event|1|||
28001046|NCT00871871|81834344|FG003|Part II|Adverse Event|2|||
28001047|NCT00871871|81834341|FG000|Part II|Protocol Violation|0|||
28001048|NCT00871871|81834342|FG001|Part II|Protocol Violation|0|||
28001049|NCT00871871|81834343|FG002|Part II|Protocol Violation|0|||
28001050|NCT00871871|81834344|FG003|Part II|Protocol Violation|1|||
28001051|NCT01929226|81834345|FG000|Overall Study|Lost to Follow-up|4|||
28001052|NCT01929226|81834346|FG001|Overall Study|Lost to Follow-up|0|||
28001053|NCT01929226|81834345|FG000|Overall Study|Withdrawal by Subject|1|||
28001054|NCT01929226|81834346|FG001|Overall Study|Withdrawal by Subject|1|||
28001055|NCT00988598|81834347|FG000|Overall Study|Withdrawal by Subject|2|||
28001056|NCT00988598|81834348|FG001|Overall Study|Withdrawal by Subject|0|||
28001057|NCT00628030|81834351|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
27681223|NCT01365481|80668066|FG003|Overall Study|Withdrawal by Subject|1|||
27681224|NCT01365481|80668063|FG000|Overall Study|Lost to Follow-up|1|||
27681225|NCT01365481|80668064|FG001|Overall Study|Lost to Follow-up|1|||
27681226|NCT01365481|80668065|FG002|Overall Study|Lost to Follow-up|2|||
27681227|NCT01365481|80668066|FG003|Overall Study|Lost to Follow-up|3|||
27681228|NCT01365481|80668063|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27681229|NCT01365481|80668064|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27681230|NCT01365481|80668065|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27681231|NCT01365481|80668066|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27681232|NCT01365481|80668063|FG000|Overall Study|Administrative problems|0|||
27681233|NCT01365481|80668064|FG001|Overall Study|Administrative problems|1|||
27681234|NCT01365481|80668065|FG002|Overall Study|Administrative problems|0|||
27681235|NCT01365481|80668066|FG003|Overall Study|Administrative problems|0|||
27681236|NCT01365481|80668063|FG000|Overall Study|Protocol deviation|0|||
27681237|NCT01365481|80668064|FG001|Overall Study|Protocol deviation|1|||
27681238|NCT01365481|80668065|FG002|Overall Study|Protocol deviation|0|||
27681239|NCT01365481|80668066|FG003|Overall Study|Protocol deviation|1|||
27681240|NCT01365481|80668063|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27681241|NCT01365481|80668064|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27681242|NCT01365481|80668065|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27681243|NCT01365481|80668066|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27681244|NCT03174431|80668067|FG000|Overall Study|Withdrawal by Subject|14|||
27681245|NCT03174431|80668068|FG001|Overall Study|Withdrawal by Subject|11|||
27681246|NCT03174431|80668067|FG000|Overall Study|alternative treatment|2|||
27681247|NCT03174431|80668068|FG001|Overall Study|alternative treatment|0|||
27806184|NCT01473758|81120505|FG002|Cycle 2|Adverse Event|5|||
27806185|NCT01473758|81120506|FG003|Cycle 2|Adverse Event|0|||
27806186|NCT02454972|81120507|FG000|Overall Study|Progressive disease|17|||
27806187|NCT02454972|81120508|FG001|Overall Study|Progressive disease|16|||
27806188|NCT02454972|81120509|FG002|Overall Study|Progressive disease|59|||
27806189|NCT02454972|81120510|FG003|Overall Study|Progressive disease|23|||
28001058|NCT00628030|81834352|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
27681248|NCT03174431|80668067|FG000|Overall Study|Lost to Follow-up|1|||
27681249|NCT03174431|80668068|FG001|Overall Study|Lost to Follow-up|5|||
27681250|NCT05110690|80668069|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
27806190|NCT02454972|81120511|FG004|Overall Study|Progressive disease|16|||
27806191|NCT02454972|81120512|FG005|Overall Study|Progressive disease|12|||
28001059|NCT00628030|81834351|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
28001060|NCT00628030|81834352|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
28001061|NCT00628030|81834351|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
28001062|NCT00628030|81834352|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
27806192|NCT02454972|81120513|FG006|Overall Study|Progressive disease|19|||
28001063|NCT01745367|81834353|FG000|Overall Study|Death|1|||
28001064|NCT01745367|81834354|FG001|Overall Study|Death|0|||
27681251|NCT05110690|80668069|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
27681252|NCT05110690|80668069|FG000|Completion of Intervention|Lost to Follow-up|1|||
27681253|NCT05110690|80668069|FG000|Completion of Intervention|Death|1|||
27681254|NCT05110690|80668069|FG000|Completion of Intervention|Withdrawal by Subject|2|||
27806193|NCT02454972|81120514|FG007|Overall Study|Progressive disease|27|||
28001065|NCT01745367|81834353|FG000|Overall Study|Withdrawal by Subject|1|||
28001066|NCT01745367|81834354|FG001|Overall Study|Withdrawal by Subject|2|||
28001067|NCT01745367|81834353|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
28001068|NCT01745367|81834354|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
28001069|NCT01745367|81834353|FG000|Overall Study|Other Reasons Unspecified|0|||
28001070|NCT01745367|81834354|FG001|Overall Study|Other Reasons Unspecified|2|||
28001071|NCT00556894|81834356|FG000|Overall Study|Adverse Event|2|||
28001072|NCT00556894|81834357|FG001|Overall Study|Adverse Event|3|||
28001073|NCT00556894|81834358|FG002|Overall Study|Adverse Event|3|||
28001074|NCT00556894|81834356|FG000|Overall Study|Death|1|||
28001075|NCT00556894|81834357|FG001|Overall Study|Death|0|||
28001076|NCT00556894|81834358|FG002|Overall Study|Death|0|||
28001077|NCT00556894|81834356|FG000|Overall Study|regulatory decision in Bulgaria|10|||
27582689|NCT01969838|80314078|FG000|Open-label Phase|Lack of Efficacy|0|||
27582690|NCT01969838|80314079|FG001|Open-label Phase|Lack of Efficacy|0|||
27582691|NCT01969838|80314080|FG002|Open-label Phase|Lack of Efficacy|17|||
27582692|NCT01969838|80314081|FG003|Open-label Phase|Lack of Efficacy|19|||
27582693|NCT01969838|80314078|FG000|Open-label Phase|Subject Decision|0|||
27582694|NCT01969838|80314079|FG001|Open-label Phase|Subject Decision|0|||
27582695|NCT01969838|80314080|FG002|Open-label Phase|Subject Decision|14|||
27582696|NCT01969838|80314081|FG003|Open-label Phase|Subject Decision|15|||
28001078|NCT00556894|81834357|FG001|Overall Study|regulatory decision in Bulgaria|14|||
28001079|NCT00556894|81834358|FG002|Overall Study|regulatory decision in Bulgaria|13|||
28001080|NCT00556894|81834356|FG000|Overall Study|Change in therapy|2|||
28001081|NCT00556894|81834357|FG001|Overall Study|Change in therapy|1|||
28001082|NCT00556894|81834358|FG002|Overall Study|Change in therapy|2|||
28001083|NCT00556894|81834356|FG000|Overall Study|Withdrawal by Subject|1|||
28001084|NCT00556894|81834357|FG001|Overall Study|Withdrawal by Subject|1|||
28001085|NCT00556894|81834358|FG002|Overall Study|Withdrawal by Subject|1|||
28001086|NCT02730728|81834359|FG000|Overall Study|Withdrawal by Subject|0|||
28001087|NCT02730728|81834360|FG001|Overall Study|Withdrawal by Subject|1|||
28001088|NCT02730728|81834361|FG002|Overall Study|Withdrawal by Subject|0|||
28001089|NCT02730728|81834359|FG000|Overall Study|Lack of Efficacy|0|||
28001090|NCT02730728|81834360|FG001|Overall Study|Lack of Efficacy|1|||
28001091|NCT02730728|81834361|FG002|Overall Study|Lack of Efficacy|1|||
28001092|NCT02038153|81834368|FG000|Overall Study|Withdrawal by Subject|1|||
28001093|NCT02518971|81834372|FG000|Overall Study|Lost to Follow-up|0|||
28001094|NCT02518971|81834373|FG001|Overall Study|Lost to Follow-up|1|||
28001095|NCT02518971|81834372|FG000|Overall Study|Physician Decision|6|||
28001096|NCT02518971|81834373|FG001|Overall Study|Physician Decision|6|||
28001097|NCT02518971|81834372|FG000|Overall Study|Protocol Violation|6|||
28001098|NCT02518971|81834373|FG001|Overall Study|Protocol Violation|4|||
28001099|NCT02518971|81834372|FG000|Overall Study|Withdrawal by Subject|4|||
27582697|NCT01969838|80314078|FG000|Open-label Phase|Death|0|||
27582698|NCT01969838|80314079|FG001|Open-label Phase|Death|0|||
27582699|NCT01969838|80314080|FG002|Open-label Phase|Death|13|||
27582700|NCT01969838|80314081|FG003|Open-label Phase|Death|11|||
27582701|NCT01969838|80314078|FG000|Open-label Phase|Physician Decision|0|||
27582702|NCT01969838|80314079|FG001|Open-label Phase|Physician Decision|0|||
27582703|NCT01969838|80314080|FG002|Open-label Phase|Physician Decision|9|||
27582704|NCT01969838|80314081|FG003|Open-label Phase|Physician Decision|14|||
27582705|NCT01969838|80314078|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
27582706|NCT01969838|80314079|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
27582707|NCT01969838|80314080|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
27582708|NCT01969838|80314081|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
27806194|NCT02454972|81120515|FG008|Overall Study|Progressive disease|0|||
28001100|NCT02518971|81834373|FG001|Overall Study|Withdrawal by Subject|5|||
28001101|NCT02518971|81834372|FG000|Overall Study|Side effects|1|||
28001102|NCT02518971|81834373|FG001|Overall Study|Side effects|0|||
28001103|NCT02518971|81834372|FG000|Overall Study|medication lost in mail|0|||
27582709|NCT02349711|80314082|FG000|Overall Study|Withdrawal by Subject|2|||
27582710|NCT02349711|80314083|FG001|Overall Study|Withdrawal by Subject|1|||
28001104|NCT02518971|81834373|FG001|Overall Study|medication lost in mail|1|||
28001105|NCT02518971|81834372|FG000|Overall Study|eligibility criteria no longer met|6|||
28001106|NCT02518971|81834373|FG001|Overall Study|eligibility criteria no longer met|3|||
28001107|NCT02763644|81834374|FG000|Overall Study|Patient/guardian decision|1|||
28001108|NCT02763644|81834375|FG001|Overall Study|Patient/guardian decision|0|||
28001109|NCT02763644|81834374|FG000|Overall Study|Death|1|||
28001110|NCT02763644|81834375|FG001|Overall Study|Death|1|||
28001111|NCT02763644|81834374|FG000|Overall Study|Adverse Event|1|||
28001112|NCT02763644|81834375|FG001|Overall Study|Adverse Event|1|||
28001113|NCT00466440|81834377|FG000|Overall Study|Adverse Event|0|||
28001114|NCT00466440|81834378|FG001|Overall Study|Adverse Event|3|||
28001115|NCT00466440|81834379|FG002|Overall Study|Adverse Event|1|||
28001116|NCT00466440|81834377|FG000|Overall Study|Death|1|||
28001117|NCT00466440|81834378|FG001|Overall Study|Death|1|||
28001118|NCT00466440|81834379|FG002|Overall Study|Death|0|||
28001119|NCT00466440|81834377|FG000|Overall Study|Progressive disease|13|||
28001120|NCT00466440|81834378|FG001|Overall Study|Progressive disease|5|||
28001121|NCT00466440|81834379|FG002|Overall Study|Progressive disease|4|||
27582711|NCT02349711|80314082|FG000|Overall Study|Lost to Follow-up|1|||
27681255|NCT02229851|80668085|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
27681256|NCT02229851|80668086|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
27681257|NCT02229851|80668087|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
27681258|NCT02229851|80668088|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
27681259|NCT02229851|80668089|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
27681260|NCT02229851|80668090|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
28001122|NCT00466440|81834377|FG000|Overall Study|Lost to Follow-up|0|||
28001123|NCT00466440|81834378|FG001|Overall Study|Lost to Follow-up|1|||
28001124|NCT00466440|81834379|FG002|Overall Study|Lost to Follow-up|0|||
28001125|NCT00466440|81834377|FG000|Overall Study|Physician Decision|0|||
27582712|NCT02349711|80314083|FG001|Overall Study|Lost to Follow-up|1|||
27582713|NCT03588572|80314084|FG000|Visitation 1|Lack of Efficacy|1|||
27582714|NCT03588572|80314085|FG001|Visitation 1|Lack of Efficacy|1|||
27582715|NCT03588572|80314084|FG000|Visitation 2|Lost to Follow-up|1|||
27582716|NCT03588572|80314085|FG001|Visitation 2|Lost to Follow-up|1|||
27582717|NCT03588572|80314084|FG000|Visitation 2|Lack of Efficacy|0|||
27582718|NCT03588572|80314085|FG001|Visitation 2|Lack of Efficacy|1|||
27582719|NCT03588572|80314084|FG000|Visitation 2|Withdrawal by Subject|1|||
28001126|NCT00466440|81834378|FG001|Overall Study|Physician Decision|1|||
28001127|NCT00466440|81834379|FG002|Overall Study|Physician Decision|2|||
27582720|NCT03588572|80314085|FG001|Visitation 2|Withdrawal by Subject|0|||
27582721|NCT03588572|80314084|FG000|Visitation 3|Lost to Follow-up|1|||
27582722|NCT03588572|80314085|FG001|Visitation 3|Lost to Follow-up|1|||
27681261|NCT02229851|80668091|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
27681262|NCT02229851|80668085|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27681263|NCT02229851|80668086|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
28001128|NCT00466440|81834377|FG000|Overall Study|Protocol entry criteria not met|0|||
28001129|NCT00466440|81834378|FG001|Overall Study|Protocol entry criteria not met|0|||
28001130|NCT00466440|81834379|FG002|Overall Study|Protocol entry criteria not met|4|||
28001131|NCT00466440|81834377|FG000|Overall Study|Withdrawal by Subject|0|||
28001132|NCT00466440|81834378|FG001|Overall Study|Withdrawal by Subject|1|||
27582723|NCT03588572|80314084|FG000|Visitation 3|Physician Decision|1|||
28001133|NCT00466440|81834379|FG002|Overall Study|Withdrawal by Subject|0|||
27582724|NCT03588572|80314085|FG001|Visitation 3|Physician Decision|1|||
27582725|NCT03588572|80314084|FG000|Visitation 3|Withdrawal by Subject|1|||
27582726|NCT03588572|80314085|FG001|Visitation 3|Withdrawal by Subject|0|||
27681264|NCT02229851|80668087|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
28001134|NCT00466440|81834377|FG000|Overall Study|Sponsor decision|0|||
27582727|NCT01324024|80314086|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
27582728|NCT01324024|80314087|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27582729|NCT01114646|80314089|FG000|Overall Study|Withdrawal by Subject|3|||
27582730|NCT01114646|80314090|FG001|Overall Study|Withdrawal by Subject|2|||
27582731|NCT01731171|80314095|FG000|Overall Study|Withdrawal by Subject|4|||
27582732|NCT01731171|80314096|FG001|Overall Study|Withdrawal by Subject|1|||
27582733|NCT01731171|80314095|FG000|Overall Study|Lost to Follow-up|3|||
27582734|NCT01731171|80314096|FG001|Overall Study|Lost to Follow-up|2|||
27582735|NCT01731171|80314095|FG000|Overall Study|Moved out of Area|0|||
27582736|NCT01731171|80314096|FG001|Overall Study|Moved out of Area|2|||
27582737|NCT01731171|80314095|FG000|Overall Study|Terminated for Lack of Adherence|0|||
27582738|NCT01731171|80314096|FG001|Overall Study|Terminated for Lack of Adherence|1|||
27582739|NCT01731171|80314095|FG000|Overall Study|Terminated for Safety Reasons|0|||
27582740|NCT01731171|80314096|FG001|Overall Study|Terminated for Safety Reasons|1|||
27582741|NCT01313559|80314097|FG000|Overall Study|Withdrawal by Subject|1|||
27582742|NCT01313559|80314098|FG001|Overall Study|Withdrawal by Subject|2|||
27582743|NCT01313559|80314097|FG000|Overall Study|Disease progression|1|||
27582744|NCT01313559|80314098|FG001|Overall Study|Disease progression|0|||
27582745|NCT01313559|80314097|FG000|Overall Study|Rising PSA|2|||
27582746|NCT01313559|80314098|FG001|Overall Study|Rising PSA|0|||
27582747|NCT01071395|80314099|FG000|Overall Study|Withdrawal by Subject|2|||
27582748|NCT01071395|80314100|FG001|Overall Study|Withdrawal by Subject|1|||
27582749|NCT01071395|80314099|FG000|Overall Study|Adverse Event|3|||
27582750|NCT01071395|80314100|FG001|Overall Study|Adverse Event|1|||
27582751|NCT01639001|80314101|FG000|Overall Study|Refused further follow-up|9|||
27582752|NCT01639001|80314102|FG001|Overall Study|Refused further follow-up|12|||
27582753|NCT01639001|80314101|FG000|Overall Study|Lost to Follow-up|3|||
27582754|NCT01639001|80314102|FG001|Overall Study|Lost to Follow-up|0|||
27582755|NCT01639001|80314101|FG000|Overall Study|Death|62|||
27582756|NCT01639001|80314102|FG001|Overall Study|Death|61|||
27582757|NCT01639001|80314101|FG000|Overall Study|Randomized but not treated|0|||
27582758|NCT01639001|80314102|FG001|Overall Study|Randomized but not treated|2|||
27582759|NCT01639001|80314101|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
27582760|NCT01639001|80314102|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
27582761|NCT03231371|80314103|FG000|Overall Study|Withdrawal by Subject|1|||
27582762|NCT03231371|80314103|FG000|Overall Study|chose or were ineligible to have MRI|12|||
27582763|NCT05282004|80314109|FG000|Overall Study|Adverse Event|2|||
27582764|NCT02318329|80314110|FG000|Overall Study|Progressive Disease|2|||
27582765|NCT02318329|80314111|FG001|Overall Study|Progressive Disease|3|||
27582766|NCT02318329|80314112|FG002|Overall Study|Progressive Disease|2|||
27582767|NCT02318329|80314113|FG003|Overall Study|Progressive Disease|3|||
27582768|NCT02318329|80314114|FG004|Overall Study|Progressive Disease|3|||
27582769|NCT02318329|80314115|FG005|Overall Study|Progressive Disease|3|||
27582770|NCT02318329|80314116|FG006|Overall Study|Progressive Disease|1|||
27582771|NCT02318329|80314117|FG007|Overall Study|Progressive Disease|1|||
27582772|NCT02318329|80314118|FG008|Overall Study|Progressive Disease|5|||
27582773|NCT02318329|80314119|FG009|Overall Study|Progressive Disease|39|||
27582774|NCT02318329|80314110|FG000|Overall Study|Death|0|||
27582775|NCT02318329|80314111|FG001|Overall Study|Death|0|||
27582776|NCT02318329|80314112|FG002|Overall Study|Death|0|||
27582777|NCT02318329|80314113|FG003|Overall Study|Death|0|||
27582778|NCT02318329|80314114|FG004|Overall Study|Death|0|||
27582779|NCT02318329|80314115|FG005|Overall Study|Death|0|||
27582780|NCT02318329|80314116|FG006|Overall Study|Death|0|||
27582781|NCT02318329|80314117|FG007|Overall Study|Death|0|||
28001135|NCT00466440|81834378|FG001|Overall Study|Sponsor decision|0|||
28001136|NCT00466440|81834379|FG002|Overall Study|Sponsor decision|1|||
28001137|NCT00890825|81834380|FG000|Overall Study|Withdrawal by Subject|1|||
27582782|NCT02318329|80314118|FG008|Overall Study|Death|0|||
27582783|NCT02318329|80314119|FG009|Overall Study|Death|5|||
27582784|NCT02318329|80314110|FG000|Overall Study|Lost to Follow-up|0|||
27582785|NCT02318329|80314111|FG001|Overall Study|Lost to Follow-up|0|||
27681265|NCT02229851|80668088|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27681266|NCT02229851|80668089|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27582786|NCT02318329|80314112|FG002|Overall Study|Lost to Follow-up|0|||
27582787|NCT02318329|80314113|FG003|Overall Study|Lost to Follow-up|0|||
27582788|NCT02318329|80314114|FG004|Overall Study|Lost to Follow-up|0|||
28001138|NCT00890825|81834381|FG001|Overall Study|Withdrawal by Subject|0|||
27582789|NCT02318329|80314115|FG005|Overall Study|Lost to Follow-up|0|||
27582790|NCT02318329|80314116|FG006|Overall Study|Lost to Follow-up|0|||
27582791|NCT02318329|80314117|FG007|Overall Study|Lost to Follow-up|0|||
27582792|NCT02318329|80314118|FG008|Overall Study|Lost to Follow-up|0|||
27582793|NCT02318329|80314119|FG009|Overall Study|Lost to Follow-up|1|||
27582794|NCT02318329|80314110|FG000|Overall Study|Withdrawal by Subject|0|||
27582795|NCT02318329|80314111|FG001|Overall Study|Withdrawal by Subject|0|||
27582796|NCT02318329|80314112|FG002|Overall Study|Withdrawal by Subject|0|||
27582797|NCT02318329|80314113|FG003|Overall Study|Withdrawal by Subject|0|||
28001139|NCT00890825|81834380|FG000|Overall Study|Alive at data cut off (DCO)|13|||
27582798|NCT02318329|80314114|FG004|Overall Study|Withdrawal by Subject|0|||
27582799|NCT02318329|80314115|FG005|Overall Study|Withdrawal by Subject|0|||
27582800|NCT02318329|80314116|FG006|Overall Study|Withdrawal by Subject|0|||
27582801|NCT02318329|80314117|FG007|Overall Study|Withdrawal by Subject|0|||
27582802|NCT02318329|80314118|FG008|Overall Study|Withdrawal by Subject|0|||
27582803|NCT02318329|80314119|FG009|Overall Study|Withdrawal by Subject|6|||
28001140|NCT00890825|81834381|FG001|Overall Study|Alive at data cut off (DCO)|14|||
28001141|NCT00255190|81834382|FG000|Overall Study|Adverse Event|17|||
27582804|NCT02318329|80314110|FG000|Overall Study|Other|1|||
27582805|NCT02318329|80314111|FG001|Overall Study|Other|1|||
27582806|NCT02318329|80314112|FG002|Overall Study|Other|1|||
27582807|NCT02318329|80314113|FG003|Overall Study|Other|0|||
27582808|NCT02318329|80314114|FG004|Overall Study|Other|0|||
27582809|NCT02318329|80314115|FG005|Overall Study|Other|0|||
27582810|NCT02318329|80314116|FG006|Overall Study|Other|0|||
27582811|NCT02318329|80314117|FG007|Overall Study|Other|0|||
27582812|NCT02318329|80314118|FG008|Overall Study|Other|1|||
27582813|NCT02318329|80314119|FG009|Overall Study|Other|1|||
27582814|NCT02766608|80314120|FG000|Overall Study|Adverse Event|27|||
27582815|NCT02766608|80314121|FG001|Overall Study|Adverse Event|22|||
27582816|NCT02766608|80314122|FG002|Overall Study|Adverse Event|17|||
27582817|NCT02766608|80314123|FG003|Overall Study|Adverse Event|13|||
27582818|NCT02766608|80314124|FG004|Overall Study|Adverse Event|12|||
27582819|NCT02766608|80314120|FG000|Overall Study|Withdrawal by Subject|21|||
27582820|NCT02766608|80314121|FG001|Overall Study|Withdrawal by Subject|20|||
27582821|NCT02766608|80314122|FG002|Overall Study|Withdrawal by Subject|24|||
27582822|NCT02766608|80314123|FG003|Overall Study|Withdrawal by Subject|13|||
27582823|NCT02766608|80314124|FG004|Overall Study|Withdrawal by Subject|10|||
27582824|NCT02766608|80314120|FG000|Overall Study|Lack of Efficacy|16|||
27582825|NCT02766608|80314121|FG001|Overall Study|Lack of Efficacy|15|||
27582826|NCT02766608|80314122|FG002|Overall Study|Lack of Efficacy|32|||
27582827|NCT02766608|80314123|FG003|Overall Study|Lack of Efficacy|8|||
27582828|NCT02766608|80314124|FG004|Overall Study|Lack of Efficacy|2|||
27582829|NCT02766608|80314120|FG000|Overall Study|Lost to Follow-up|6|||
27582830|NCT02766608|80314121|FG001|Overall Study|Lost to Follow-up|3|||
27582831|NCT02766608|80314122|FG002|Overall Study|Lost to Follow-up|5|||
27582832|NCT02766608|80314123|FG003|Overall Study|Lost to Follow-up|2|||
27582833|NCT02766608|80314124|FG004|Overall Study|Lost to Follow-up|2|||
27582834|NCT02766608|80314120|FG000|Overall Study|Physician Decision|3|||
27582835|NCT02766608|80314121|FG001|Overall Study|Physician Decision|2|||
27582836|NCT02766608|80314122|FG002|Overall Study|Physician Decision|3|||
27582837|NCT02766608|80314123|FG003|Overall Study|Physician Decision|1|||
27582838|NCT02766608|80314124|FG004|Overall Study|Physician Decision|2|||
27582839|NCT02766608|80314120|FG000|Overall Study|Protocol disc criteria|3|||
27582840|NCT02766608|80314121|FG001|Overall Study|Protocol disc criteria|3|||
27582841|NCT02766608|80314122|FG002|Overall Study|Protocol disc criteria|4|||
27582842|NCT02766608|80314123|FG003|Overall Study|Protocol disc criteria|0|||
27582843|NCT02766608|80314124|FG004|Overall Study|Protocol disc criteria|0|||
27582844|NCT02766608|80314120|FG000|Overall Study|Protocol Violation|0|||
27582845|NCT02766608|80314121|FG001|Overall Study|Protocol Violation|4|||
27582846|NCT02766608|80314122|FG002|Overall Study|Protocol Violation|4|||
27582847|NCT02766608|80314123|FG003|Overall Study|Protocol Violation|0|||
27582848|NCT02766608|80314124|FG004|Overall Study|Protocol Violation|1|||
28001142|NCT00255190|81834383|FG001|Overall Study|Adverse Event|36|||
27582849|NCT02766608|80314120|FG000|Overall Study|Administrative Reasons|3|||
27582850|NCT02766608|80314121|FG001|Overall Study|Administrative Reasons|1|||
27582851|NCT02766608|80314122|FG002|Overall Study|Administrative Reasons|1|||
27582852|NCT02766608|80314123|FG003|Overall Study|Administrative Reasons|0|||
27582853|NCT02766608|80314124|FG004|Overall Study|Administrative Reasons|0|||
27582854|NCT03036566|80314125|FG000|Overall Study|Lost to Follow-up|3|||
27582855|NCT00889421|80314126|FG000|Overall Study|Lack of Efficacy|3|||
28001143|NCT00255190|81834382|FG000|Overall Study|Protocol Violation|2|||
28001144|NCT00255190|81834383|FG001|Overall Study|Protocol Violation|2|||
27582856|NCT02604589|80314130|FG000|Overall Study|catheter dislodgement|0|||
27582857|NCT02604589|80314131|FG001|Overall Study|catheter dislodgement|0|||
27582858|NCT02604589|80314132|FG002|Overall Study|catheter dislodgement|1|||
27582859|NCT02473952|80314133|FG000|Overall Study|Adverse Event|2|||
27582860|NCT02473952|80314134|FG001|Overall Study|Adverse Event|2|||
27582861|NCT02473952|80314133|FG000|Overall Study|Withdrawal by Subject|0|||
27582862|NCT02473952|80314134|FG001|Overall Study|Withdrawal by Subject|6|||
27582863|NCT00617240|80314139|FG000|Overall Study|Lack of Efficacy|1|||
27582864|NCT00617240|80314140|FG001|Overall Study|Lack of Efficacy|0|||
27582865|NCT01923181|80314141|FG000|Overall Study|Protocol Violation|2|||
27582866|NCT01923181|80314142|FG001|Overall Study|Protocol Violation|2|||
27582867|NCT01923181|80314143|FG002|Overall Study|Protocol Violation|0|||
27582868|NCT01923181|80314144|FG003|Overall Study|Protocol Violation|2|||
27582869|NCT01923181|80314145|FG004|Overall Study|Protocol Violation|2|||
27582870|NCT01923181|80314146|FG005|Overall Study|Protocol Violation|1|||
27582871|NCT01923181|80314147|FG006|Overall Study|Protocol Violation|1|||
28001145|NCT00255190|81834382|FG000|Overall Study|Lost to Follow-up|10|||
27582872|NCT01923181|80314148|FG007|Overall Study|Protocol Violation|2|||
27582873|NCT01923181|80314149|FG008|Overall Study|Protocol Violation|1|||
27806195|NCT02454972|81120507|FG000|Overall Study|Death|0|||
27806196|NCT02454972|81120508|FG001|Overall Study|Death|0|||
27806197|NCT02454972|81120509|FG002|Overall Study|Death|5|||
27806198|NCT02454972|81120510|FG003|Overall Study|Death|1|||
27806199|NCT02454972|81120511|FG004|Overall Study|Death|0|||
27806200|NCT02454972|81120512|FG005|Overall Study|Death|0|||
27806201|NCT02454972|81120513|FG006|Overall Study|Death|0|||
27806202|NCT02454972|81120514|FG007|Overall Study|Death|0|||
27806203|NCT02454972|81120515|FG008|Overall Study|Death|95|||
27806204|NCT02454972|81120507|FG000|Overall Study|Physician Decision|0|||
27806205|NCT02454972|81120508|FG001|Overall Study|Physician Decision|1|||
27806206|NCT02454972|81120509|FG002|Overall Study|Physician Decision|2|||
28001146|NCT00255190|81834383|FG001|Overall Study|Lost to Follow-up|27|||
28001147|NCT00255190|81834382|FG000|Overall Study|Withdrew Consent|17|||
28001148|NCT00255190|81834383|FG001|Overall Study|Withdrew Consent|48|||
28001149|NCT00255190|81834382|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
28001150|NCT00255190|81834383|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
28001151|NCT00255190|81834382|FG000|Overall Study|Erosive esophagitis not healed|0|||
28001152|NCT00255190|81834383|FG001|Overall Study|Erosive esophagitis not healed|20|||
28001153|NCT00255190|81834382|FG000|Overall Study|Various|4|||
28001154|NCT00255190|81834383|FG001|Overall Study|Various|23|||
28001155|NCT02471014|81834390|FG000|Overall Study|Lost to Follow-up|2|||
28001156|NCT02471014|81834391|FG001|Overall Study|Lost to Follow-up|2|||
28001157|NCT01601535|81834392|FG000|Phase 1|Adverse Event|1|||
28001158|NCT01601535|81834393|FG001|Phase 1|Adverse Event|0|||
28001159|NCT01601535|81834394|FG002|Phase 1|Adverse Event|2|||
28001160|NCT01601535|81834395|FG003|Phase 1|Adverse Event|1|||
28001161|NCT01601535|81834396|FG004|Phase 1|Adverse Event|0|||
28001162|NCT01601535|81834397|FG005|Phase 1|Adverse Event|0|||
28001163|NCT01601535|81834392|FG000|Phase 1|Withdrawal by Subject|2|||
28001164|NCT01601535|81834393|FG001|Phase 1|Withdrawal by Subject|1|||
28001165|NCT01601535|81834394|FG002|Phase 1|Withdrawal by Subject|1|||
28001166|NCT01601535|81834395|FG003|Phase 1|Withdrawal by Subject|2|||
28001167|NCT01601535|81834396|FG004|Phase 1|Withdrawal by Subject|0|||
28001168|NCT01601535|81834397|FG005|Phase 1|Withdrawal by Subject|0|||
28001169|NCT01601535|81834392|FG000|Phase 1|Progressive Disease|2|||
28001170|NCT01601535|81834393|FG001|Phase 1|Progressive Disease|3|||
27582874|NCT01923181|80314141|FG000|Overall Study|Withdrawal by Subject|0|||
27582875|NCT01923181|80314142|FG001|Overall Study|Withdrawal by Subject|1|||
27582876|NCT01923181|80314143|FG002|Overall Study|Withdrawal by Subject|0|||
27582877|NCT01923181|80314144|FG003|Overall Study|Withdrawal by Subject|1|||
27582878|NCT01923181|80314145|FG004|Overall Study|Withdrawal by Subject|4|||
27582879|NCT01923181|80314146|FG005|Overall Study|Withdrawal by Subject|2|||
27582880|NCT01923181|80314147|FG006|Overall Study|Withdrawal by Subject|4|||
27582881|NCT01923181|80314148|FG007|Overall Study|Withdrawal by Subject|3|||
27582882|NCT01923181|80314149|FG008|Overall Study|Withdrawal by Subject|1|||
27582883|NCT01923181|80314141|FG000|Overall Study|Other|1|||
27582884|NCT01923181|80314142|FG001|Overall Study|Other|0|||
27582885|NCT01923181|80314143|FG002|Overall Study|Other|0|||
27582886|NCT01923181|80314144|FG003|Overall Study|Other|1|||
27582887|NCT01923181|80314145|FG004|Overall Study|Other|0|||
27582888|NCT01923181|80314146|FG005|Overall Study|Other|0|||
27582889|NCT01923181|80314147|FG006|Overall Study|Other|0|||
27582890|NCT01923181|80314148|FG007|Overall Study|Other|0|||
27582891|NCT01923181|80314149|FG008|Overall Study|Other|0|||
27582892|NCT01923181|80314141|FG000|Overall Study|Lost to Follow-up|0|||
27582893|NCT01923181|80314142|FG001|Overall Study|Lost to Follow-up|3|||
27582894|NCT01923181|80314143|FG002|Overall Study|Lost to Follow-up|2|||
27582895|NCT01923181|80314144|FG003|Overall Study|Lost to Follow-up|1|||
27582896|NCT01923181|80314145|FG004|Overall Study|Lost to Follow-up|2|||
27582897|NCT01923181|80314146|FG005|Overall Study|Lost to Follow-up|1|||
27582898|NCT01923181|80314147|FG006|Overall Study|Lost to Follow-up|3|||
27582899|NCT01923181|80314148|FG007|Overall Study|Lost to Follow-up|3|||
27582900|NCT01923181|80314149|FG008|Overall Study|Lost to Follow-up|1|||
27582901|NCT00023452|80314152|FG000|Overall Study|Ineligible for Study|163|||
27582902|NCT00023452|80314153|FG001|Overall Study|Ineligible for Study|159|||
27582903|NCT00023452|80314152|FG000|Overall Study|Out of Window|129|||
27582904|NCT00023452|80314153|FG001|Overall Study|Out of Window|69|||
27582905|NCT00023452|80314152|FG000|Overall Study|Death|2|||
27582906|NCT00023452|80314153|FG001|Overall Study|Death|0|||
27582907|NCT00023452|80314152|FG000|Overall Study|Withdrawal by Subject|66|||
27582908|NCT00023452|80314153|FG001|Overall Study|Withdrawal by Subject|54|||
27582909|NCT00023452|80314152|FG000|Overall Study|Adverse Event|139|||
27582910|NCT00023452|80314153|FG001|Overall Study|Adverse Event|196|||
27582911|NCT00023452|80314152|FG000|Overall Study|Lost to Follow-up|293|||
27582912|NCT00023452|80314153|FG001|Overall Study|Lost to Follow-up|60|||
27582913|NCT00023452|80314152|FG000|Overall Study|Physician Decision|49|||
27681267|NCT02229851|80668090|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27681268|NCT02229851|80668091|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
27681269|NCT02229851|80668085|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
27681270|NCT02229851|80668086|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
27681271|NCT02229851|80668087|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
27681272|NCT02229851|80668088|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27681273|NCT02229851|80668089|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27681274|NCT02229851|80668090|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27873930|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
27873931|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
27873932|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
27681275|NCT02229851|80668091|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
27681276|NCT02229851|80668085|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27681277|NCT02229851|80668086|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27681278|NCT02229851|80668087|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
27681279|NCT02229851|80668088|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27681280|NCT02229851|80668089|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27681281|NCT02229851|80668090|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27681282|NCT02229851|80668091|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
27681283|NCT02229851|80668085|FG000|Main Phase (Double-blind Phase)|Death|1|||
27681284|NCT02229851|80668086|FG001|Main Phase (Double-blind Phase)|Death|1|||
27681285|NCT02229851|80668087|FG002|Main Phase (Double-blind Phase)|Death|0|||
27681286|NCT02229851|80668088|FG003|Main Phase (Double-blind Phase)|Death|0|||
27681287|NCT02229851|80668089|FG004|Main Phase (Double-blind Phase)|Death|0|||
27681288|NCT02229851|80668090|FG005|Main Phase (Double-blind Phase)|Death|0|||
27681289|NCT02229851|80668091|FG006|Main Phase (Double-blind Phase)|Death|0|||
27681290|NCT02229851|80668085|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
28001171|NCT01601535|81834394|FG002|Phase 1|Progressive Disease|2|||
28001172|NCT01601535|81834395|FG003|Phase 1|Progressive Disease|1|||
28001173|NCT01601535|81834396|FG004|Phase 1|Progressive Disease|0|||
28001174|NCT01601535|81834397|FG005|Phase 1|Progressive Disease|0|||
28001175|NCT01601535|81834392|FG000|Phase 1|Started Another Treatment|1|||
28001176|NCT01601535|81834393|FG001|Phase 1|Started Another Treatment|2|||
28001177|NCT01601535|81834394|FG002|Phase 1|Started Another Treatment|0|||
28001178|NCT01601535|81834395|FG003|Phase 1|Started Another Treatment|0|||
28001179|NCT01601535|81834396|FG004|Phase 1|Started Another Treatment|0|||
28001180|NCT01601535|81834397|FG005|Phase 1|Started Another Treatment|0|||
28001181|NCT01601535|81834392|FG000|Phase 2|Adverse Event|0|||
28001182|NCT01601535|81834393|FG001|Phase 2|Adverse Event|0|||
28001183|NCT01601535|81834394|FG002|Phase 2|Adverse Event|0|||
27873933|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Other|3|||
27873934|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Other|0|||
27873935|NCT01006122|81371615|FG000|First Double-blind Intervention Period|Adverse Event|0|||
27873936|NCT01006122|81371616|FG001|First Double-blind Intervention Period|Adverse Event|4|||
27873937|NCT01006122|81371615|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
27873938|NCT01006122|81371616|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
27873939|NCT01006122|81371615|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
27873940|NCT01006122|81371616|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
27873941|NCT01006122|81371615|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
27873942|NCT01006122|81371616|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
27873943|NCT01006122|81371615|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
27873944|NCT01006122|81371616|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
28001184|NCT01601535|81834395|FG003|Phase 2|Adverse Event|0|||
27681291|NCT02229851|80668086|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27681292|NCT02229851|80668087|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27681293|NCT02229851|80668088|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
27681294|NCT02229851|80668089|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
27681295|NCT02229851|80668090|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
27681296|NCT02229851|80668091|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
27681297|NCT02229851|80668085|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
27873945|NCT01006122|81371615|FG000|Second Double-blind Intervention Period|Death|0|||
27873946|NCT01006122|81371616|FG001|Second Double-blind Intervention Period|Death|1|||
27873947|NCT04515147|81371617|FG000|Overall Study|Withdrawal by Subject|1|||
28001185|NCT01601535|81834396|FG004|Phase 2|Adverse Event|5|||
28001186|NCT01601535|81834397|FG005|Phase 2|Adverse Event|1|||
28001187|NCT01601535|81834392|FG000|Phase 2|Withdrawal by Subject|0|||
28001188|NCT01601535|81834393|FG001|Phase 2|Withdrawal by Subject|0|||
28001189|NCT01601535|81834394|FG002|Phase 2|Withdrawal by Subject|0|||
28001190|NCT01601535|81834395|FG003|Phase 2|Withdrawal by Subject|0|||
27681298|NCT02229851|80668086|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
27681299|NCT02229851|80668087|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
27681300|NCT02229851|80668088|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
27681301|NCT02229851|80668089|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
27806207|NCT02454972|81120510|FG003|Overall Study|Physician Decision|1|||
27873948|NCT04515147|81371618|FG001|Overall Study|Withdrawal by Subject|0|||
27873949|NCT04515147|81371619|FG002|Overall Study|Withdrawal by Subject|10|||
27873950|NCT04515147|81371620|FG003|Overall Study|Withdrawal by Subject|18|||
27873951|NCT04515147|81371621|FG004|Overall Study|Withdrawal by Subject|1|||
27873952|NCT04515147|81371622|FG005|Overall Study|Withdrawal by Subject|8|||
27873953|NCT04515147|81371617|FG000|Overall Study|Lost to Follow-up|0|||
27873954|NCT04515147|81371618|FG001|Overall Study|Lost to Follow-up|1|||
27806208|NCT02454972|81120511|FG004|Overall Study|Physician Decision|2|||
27806209|NCT02454972|81120512|FG005|Overall Study|Physician Decision|0|||
27806210|NCT02454972|81120513|FG006|Overall Study|Physician Decision|0|||
27806211|NCT02454972|81120514|FG007|Overall Study|Physician Decision|1|||
27806212|NCT02454972|81120515|FG008|Overall Study|Physician Decision|0|||
27806213|NCT02454972|81120507|FG000|Overall Study|Non treatment-related adverse event|2|||
27806214|NCT02454972|81120508|FG001|Overall Study|Non treatment-related adverse event|0|||
27806215|NCT02454972|81120509|FG002|Overall Study|Non treatment-related adverse event|1|||
27806216|NCT02454972|81120510|FG003|Overall Study|Non treatment-related adverse event|0|||
27806217|NCT02454972|81120511|FG004|Overall Study|Non treatment-related adverse event|0|||
27806218|NCT02454972|81120512|FG005|Overall Study|Non treatment-related adverse event|1|||
27806219|NCT02454972|81120513|FG006|Overall Study|Non treatment-related adverse event|0|||
27806220|NCT02454972|81120514|FG007|Overall Study|Non treatment-related adverse event|1|||
27806221|NCT02454972|81120515|FG008|Overall Study|Non treatment-related adverse event|0|||
27806222|NCT02454972|81120507|FG000|Overall Study|Treatment-related adverse events|0|||
27806223|NCT02454972|81120508|FG001|Overall Study|Treatment-related adverse events|1|||
27806224|NCT02454972|81120509|FG002|Overall Study|Treatment-related adverse events|1|||
27806225|NCT02454972|81120510|FG003|Overall Study|Treatment-related adverse events|0|||
27806226|NCT02454972|81120511|FG004|Overall Study|Treatment-related adverse events|2|||
27806227|NCT02454972|81120512|FG005|Overall Study|Treatment-related adverse events|0|||
27806228|NCT02454972|81120513|FG006|Overall Study|Treatment-related adverse events|0|||
27806229|NCT02454972|81120514|FG007|Overall Study|Treatment-related adverse events|2|||
27806230|NCT02454972|81120515|FG008|Overall Study|Treatment-related adverse events|0|||
27806231|NCT02454972|81120507|FG000|Overall Study|Patient moves to compassionate use|0|||
27806232|NCT02454972|81120508|FG001|Overall Study|Patient moves to compassionate use|0|||
27806233|NCT02454972|81120509|FG002|Overall Study|Patient moves to compassionate use|0|||
27806234|NCT02454972|81120510|FG003|Overall Study|Patient moves to compassionate use|0|||
27806235|NCT02454972|81120511|FG004|Overall Study|Patient moves to compassionate use|0|||
27806236|NCT02454972|81120512|FG005|Overall Study|Patient moves to compassionate use|0|||
27806237|NCT02454972|81120513|FG006|Overall Study|Patient moves to compassionate use|2|||
27806238|NCT02454972|81120514|FG007|Overall Study|Patient moves to compassionate use|0|||
27806239|NCT02454972|81120515|FG008|Overall Study|Patient moves to compassionate use|0|||
27806240|NCT02454972|81120507|FG000|Overall Study|Withdrawal by Subject|0|||
27806241|NCT02454972|81120508|FG001|Overall Study|Withdrawal by Subject|1|||
27873955|NCT04515147|81371619|FG002|Overall Study|Lost to Follow-up|5|||
27873956|NCT04515147|81371620|FG003|Overall Study|Lost to Follow-up|6|||
27806242|NCT02454972|81120509|FG002|Overall Study|Withdrawal by Subject|5|||
27806243|NCT02454972|81120510|FG003|Overall Study|Withdrawal by Subject|2|||
27806244|NCT02454972|81120511|FG004|Overall Study|Withdrawal by Subject|3|||
27806245|NCT02454972|81120512|FG005|Overall Study|Withdrawal by Subject|2|||
27806246|NCT02454972|81120513|FG006|Overall Study|Withdrawal by Subject|0|||
27806247|NCT02454972|81120514|FG007|Overall Study|Withdrawal by Subject|1|||
27806248|NCT02454972|81120515|FG008|Overall Study|Withdrawal by Subject|2|||
27806249|NCT02454972|81120507|FG000|Overall Study|Multiple delay/holds on treatment|0|||
27806250|NCT02454972|81120508|FG001|Overall Study|Multiple delay/holds on treatment|0|||
27806251|NCT02454972|81120509|FG002|Overall Study|Multiple delay/holds on treatment|0|||
27806252|NCT02454972|81120510|FG003|Overall Study|Multiple delay/holds on treatment|1|||
27806253|NCT02454972|81120511|FG004|Overall Study|Multiple delay/holds on treatment|0|||
27806254|NCT02454972|81120512|FG005|Overall Study|Multiple delay/holds on treatment|0|||
27806255|NCT02454972|81120513|FG006|Overall Study|Multiple delay/holds on treatment|0|||
27806256|NCT02454972|81120514|FG007|Overall Study|Multiple delay/holds on treatment|0|||
27806257|NCT02454972|81120515|FG008|Overall Study|Multiple delay/holds on treatment|0|||
27681302|NCT02229851|80668090|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
27681303|NCT02229851|80668091|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
27873957|NCT04515147|81371621|FG004|Overall Study|Lost to Follow-up|2|||
27873958|NCT04515147|81371622|FG005|Overall Study|Lost to Follow-up|1|||
27873959|NCT04515147|81371617|FG000|Overall Study|Adverse Event|0|||
27681304|NCT02229851|80668085|FG000|Extension Phase (Open-label Phase)|Death|0|||
27806258|NCT02454972|81120507|FG000|Overall Study|Never treated|0|||
27806259|NCT02454972|81120508|FG001|Overall Study|Never treated|0|||
27873960|NCT04515147|81371618|FG001|Overall Study|Adverse Event|0|||
27873961|NCT04515147|81371619|FG002|Overall Study|Adverse Event|0|||
27873962|NCT04515147|81371620|FG003|Overall Study|Adverse Event|2|||
27806260|NCT02454972|81120509|FG002|Overall Study|Never treated|3|||
27806261|NCT02454972|81120510|FG003|Overall Study|Never treated|1|||
27806262|NCT02454972|81120511|FG004|Overall Study|Never treated|1|||
27806263|NCT02454972|81120512|FG005|Overall Study|Never treated|0|||
27806264|NCT02454972|81120513|FG006|Overall Study|Never treated|0|||
27806265|NCT02454972|81120514|FG007|Overall Study|Never treated|0|||
27806266|NCT02454972|81120515|FG008|Overall Study|Never treated|5|||
27806267|NCT02454972|81120507|FG000|Overall Study|Lost to Follow-up|0|||
27806268|NCT02454972|81120508|FG001|Overall Study|Lost to Follow-up|0|||
27873963|NCT04515147|81371621|FG004|Overall Study|Adverse Event|0|||
27873964|NCT04515147|81371622|FG005|Overall Study|Adverse Event|0|||
27873965|NCT04515147|81371617|FG000|Overall Study|Miscellaneous|0|||
28001191|NCT01601535|81834396|FG004|Phase 2|Withdrawal by Subject|8|||
27582914|NCT00023452|80314153|FG001|Overall Study|Physician Decision|21|||
27582915|NCT00023452|80314152|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
27582916|NCT00023452|80314153|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
27582917|NCT00023452|80314152|FG000|Overall Study|Pregnant|53|||
27582918|NCT00023452|80314153|FG001|Overall Study|Pregnant|20|||
27582919|NCT00023452|80314152|FG000|Overall Study|Other|204|||
27582920|NCT00023452|80314153|FG001|Overall Study|Other|69|||
27582921|NCT00406029|80318866|FG000|Overall Study|Adverse Event|12|||
27582922|NCT00406029|80318867|FG001|Overall Study|Adverse Event|2|||
27582923|NCT00406029|80318868|FG002|Overall Study|Adverse Event|5|||
27582924|NCT00406029|80318869|FG003|Overall Study|Adverse Event|10|||
28001192|NCT01601535|81834397|FG005|Phase 2|Withdrawal by Subject|2|||
28001193|NCT01601535|81834392|FG000|Phase 2|Progressive Disease|0|||
28001194|NCT01601535|81834393|FG001|Phase 2|Progressive Disease|0|||
28001195|NCT01601535|81834394|FG002|Phase 2|Progressive Disease|0|||
27582925|NCT00406029|80318870|FG004|Overall Study|Adverse Event|7|||
27582926|NCT00406029|80318866|FG000|Overall Study|Withdrawal by Subject|3|||
27582927|NCT00406029|80318867|FG001|Overall Study|Withdrawal by Subject|4|||
27582928|NCT00406029|80318868|FG002|Overall Study|Withdrawal by Subject|2|||
27582929|NCT00406029|80318869|FG003|Overall Study|Withdrawal by Subject|2|||
27582930|NCT00406029|80318870|FG004|Overall Study|Withdrawal by Subject|0|||
27582931|NCT00406029|80318866|FG000|Overall Study|Protocol Violation|1|||
27582932|NCT00406029|80318867|FG001|Overall Study|Protocol Violation|2|||
27582933|NCT00406029|80318868|FG002|Overall Study|Protocol Violation|0|||
27582934|NCT00406029|80318869|FG003|Overall Study|Protocol Violation|2|||
27582935|NCT00406029|80318870|FG004|Overall Study|Protocol Violation|0|||
27582936|NCT00406029|80318866|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
27582937|NCT00406029|80318867|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
27582938|NCT00406029|80318868|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
27582939|NCT00406029|80318869|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
27582940|NCT00406029|80318870|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
27582941|NCT00406029|80318866|FG000|Overall Study|Randomized in Error|0|||
27582942|NCT00406029|80318867|FG001|Overall Study|Randomized in Error|0|||
27582943|NCT00406029|80318868|FG002|Overall Study|Randomized in Error|2|||
27582944|NCT00406029|80318869|FG003|Overall Study|Randomized in Error|3|||
27582945|NCT00406029|80318870|FG004|Overall Study|Randomized in Error|1|||
27582946|NCT00672477|80318871|FG000|Overall Study|Adverse Event|10|||
27582947|NCT00672477|80318872|FG001|Overall Study|Adverse Event|7|||
27582948|NCT00672477|80318871|FG000|Overall Study|Death|7|||
27582949|NCT00672477|80318872|FG001|Overall Study|Death|11|||
27582950|NCT00672477|80318871|FG000|Overall Study|Physician Decision|2|||
27582951|NCT00672477|80318872|FG001|Overall Study|Physician Decision|0|||
27582952|NCT00672477|80318871|FG000|Overall Study|Protocol Violation|1|||
27582953|NCT00672477|80318872|FG001|Overall Study|Protocol Violation|1|||
27582954|NCT00672477|80318871|FG000|Overall Study|Withdrawal by Subject|5|||
27582955|NCT00672477|80318872|FG001|Overall Study|Withdrawal by Subject|3|||
27582956|NCT00672477|80318871|FG000|Overall Study|Lack of Efficacy|1|||
27806269|NCT02454972|81120509|FG002|Overall Study|Lost to Follow-up|0|||
27873966|NCT04515147|81371618|FG001|Overall Study|Miscellaneous|0|||
27582957|NCT00672477|80318872|FG001|Overall Study|Lack of Efficacy|1|||
27582958|NCT00672477|80318871|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
27582959|NCT00672477|80318872|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
27582960|NCT00630877|80318873|FG000|Overall Study|Adverse Event|11|||
27582961|NCT00630877|80318874|FG001|Overall Study|Adverse Event|8|||
27582962|NCT00630877|80318875|FG002|Overall Study|Adverse Event|7|||
28001196|NCT01601535|81834395|FG003|Phase 2|Progressive Disease|0|||
27582963|NCT00630877|80318873|FG000|Overall Study|Withdrawal by Subject|3|||
27582964|NCT00630877|80318874|FG001|Overall Study|Withdrawal by Subject|4|||
27582965|NCT00630877|80318875|FG002|Overall Study|Withdrawal by Subject|0|||
27582966|NCT00630877|80318873|FG000|Overall Study|Lost to Follow-up|2|||
27582967|NCT00630877|80318874|FG001|Overall Study|Lost to Follow-up|0|||
27582968|NCT00630877|80318875|FG002|Overall Study|Lost to Follow-up|0|||
27873967|NCT04515147|81371619|FG002|Overall Study|Miscellaneous|0|||
27873968|NCT04515147|81371620|FG003|Overall Study|Miscellaneous|1|||
27582969|NCT00630877|80318873|FG000|Overall Study|Noncompliance|2|||
28001197|NCT01601535|81834396|FG004|Phase 2|Progressive Disease|5|||
27582970|NCT00630877|80318874|FG001|Overall Study|Noncompliance|3|||
27582971|NCT00630877|80318875|FG002|Overall Study|Noncompliance|1|||
28001198|NCT01601535|81834397|FG005|Phase 2|Progressive Disease|7|||
28001199|NCT01601535|81834392|FG000|Phase 2|Started Another Treatment|0|||
28001200|NCT01601535|81834393|FG001|Phase 2|Started Another Treatment|0|||
28001201|NCT01601535|81834394|FG002|Phase 2|Started Another Treatment|0|||
28001202|NCT01601535|81834395|FG003|Phase 2|Started Another Treatment|0|||
28001203|NCT01601535|81834396|FG004|Phase 2|Started Another Treatment|1|||
28001204|NCT01601535|81834397|FG005|Phase 2|Started Another Treatment|2|||
28001205|NCT00165672|81834398|FG000|Overall Study|Adverse Event|0|||
28001206|NCT00165672|81834399|FG001|Overall Study|Adverse Event|1|||
28001207|NCT00985465|81834406|FG000|Overall Study|Withdrawal by Subject|1|||
27582972|NCT00630877|80318873|FG000|Overall Study|Protocol violation|1|||
27582973|NCT00630877|80318874|FG001|Overall Study|Protocol violation|0|||
27582974|NCT00630877|80318875|FG002|Overall Study|Protocol violation|1|||
27582975|NCT00630877|80318873|FG000|Overall Study|Personal reasons|0|||
27582976|NCT00630877|80318874|FG001|Overall Study|Personal reasons|0|||
27582977|NCT00630877|80318875|FG002|Overall Study|Personal reasons|1|||
27582978|NCT01272934|80318878|FG000|Overall Study|Adverse Event|0|||
27582979|NCT01272934|80318879|FG001|Overall Study|Adverse Event|1|||
27582980|NCT01272934|80318878|FG000|Overall Study|Abnormal Laboratory Value|0|||
27582981|NCT01272934|80318879|FG001|Overall Study|Abnormal Laboratory Value|1|||
27582982|NCT03348904|80318887|FG000|Overall Study|Administrative reason by the sponsor|0|||
27582983|NCT03348904|80318888|FG001|Overall Study|Administrative reason by the sponsor|1|||
27582984|NCT03348904|80318889|FG002|Overall Study|Administrative reason by the sponsor|0|||
27582985|NCT02080091|80318896|FG000|Overall Study|Study Terminated|22|||
27582986|NCT02080091|80318896|FG000|Overall Study|Death|1|||
27582987|NCT02080091|80318896|FG000|Overall Study|Withdrawal by Subject|1|||
27582988|NCT02080091|80318896|FG000|Overall Study|Other|1|||
27582989|NCT01978119|80318897|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
27582990|NCT01978119|80318898|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
27582991|NCT01978119|80318897|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27582992|NCT01978119|80318898|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27582993|NCT01978119|80318897|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27582994|NCT01978119|80318898|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
27582995|NCT00766376|80318902|FG000|Overall Study|Withdrawal by Subject|27|||
27582996|NCT01332305|80318903|FG000|Overall Study|Adverse Event|1|||
27582997|NCT01332305|80318904|FG001|Overall Study|Adverse Event|4|||
27582998|NCT01332305|80318905|FG002|Overall Study|Adverse Event|6|||
27582999|NCT01332305|80318906|FG003|Overall Study|Adverse Event|3|||
27583000|NCT01332305|80318907|FG004|Overall Study|Adverse Event|5|||
27583001|NCT01332305|80318903|FG000|Overall Study|Withdrawal by Subject|6|||
28001208|NCT00985465|81834407|FG001|Overall Study|Withdrawal by Subject|2|||
28001209|NCT00985465|81834406|FG000|Overall Study|Considered to be part of the other group|0|||
28001210|NCT00985465|81834407|FG001|Overall Study|Considered to be part of the other group|1|||
28001211|NCT02420379|81834408|FG000|Overall Study|Withdrawal by Subject|0|||
27583002|NCT01332305|80318904|FG001|Overall Study|Withdrawal by Subject|5|||
27583003|NCT01332305|80318905|FG002|Overall Study|Withdrawal by Subject|4|||
27583004|NCT01332305|80318906|FG003|Overall Study|Withdrawal by Subject|1|||
27583005|NCT01332305|80318907|FG004|Overall Study|Withdrawal by Subject|0|||
27583006|NCT01332305|80318903|FG000|Overall Study|Lost to Follow-up|0|||
27583007|NCT01332305|80318904|FG001|Overall Study|Lost to Follow-up|2|||
27583008|NCT01332305|80318905|FG002|Overall Study|Lost to Follow-up|3|||
27583009|NCT01332305|80318906|FG003|Overall Study|Lost to Follow-up|2|||
27583010|NCT01332305|80318907|FG004|Overall Study|Lost to Follow-up|3|||
27583011|NCT01332305|80318903|FG000|Overall Study|Protocol Violation|1|||
27583012|NCT01332305|80318904|FG001|Overall Study|Protocol Violation|2|||
27583013|NCT01332305|80318905|FG002|Overall Study|Protocol Violation|1|||
27583014|NCT01332305|80318906|FG003|Overall Study|Protocol Violation|0|||
27583015|NCT01332305|80318907|FG004|Overall Study|Protocol Violation|3|||
27583016|NCT01332305|80318903|FG000|Overall Study|Withdrawal by Sponsor|1|||
27583017|NCT01332305|80318904|FG001|Overall Study|Withdrawal by Sponsor|0|||
27583018|NCT01332305|80318905|FG002|Overall Study|Withdrawal by Sponsor|0|||
27583019|NCT01332305|80318906|FG003|Overall Study|Withdrawal by Sponsor|1|||
27583020|NCT01332305|80318907|FG004|Overall Study|Withdrawal by Sponsor|1|||
27583021|NCT01332305|80318903|FG000|Overall Study|Treatment Failure|1|||
27583022|NCT01332305|80318904|FG001|Overall Study|Treatment Failure|1|||
27583023|NCT01332305|80318905|FG002|Overall Study|Treatment Failure|0|||
27583024|NCT01332305|80318906|FG003|Overall Study|Treatment Failure|0|||
27806270|NCT02454972|81120510|FG003|Overall Study|Lost to Follow-up|0|||
28001212|NCT02420379|81834409|FG001|Overall Study|Withdrawal by Subject|3|||
28001213|NCT02420379|81834408|FG000|Overall Study|Unable to complete due to schooling|0|||
28001214|NCT02420379|81834409|FG001|Overall Study|Unable to complete due to schooling|1|||
27583025|NCT01332305|80318907|FG004|Overall Study|Treatment Failure|0|||
27583026|NCT01332305|80318903|FG000|Overall Study|Physician Decision|0|||
28001215|NCT02420379|81834408|FG000|Overall Study|Transitioned to commercial drug|1|||
27583027|NCT01332305|80318904|FG001|Overall Study|Physician Decision|0|||
27873969|NCT04515147|81371621|FG004|Overall Study|Miscellaneous|0|||
27873970|NCT04515147|81371622|FG005|Overall Study|Miscellaneous|1|||
27873971|NCT00468819|81371623|FG000|Overall Study|Withdrawal by Subject|4|||
28001216|NCT02420379|81834409|FG001|Overall Study|Transitioned to commercial drug|0|||
28001217|NCT02055898|81834410|FG000|First Intervention (5 Days)|Physician Decision|2|||
28001218|NCT02055898|81834411|FG001|First Intervention (5 Days)|Physician Decision|0|||
28001219|NCT02055898|81834410|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
28001220|NCT02055898|81834411|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
28001221|NCT02610777|81834417|FG000|Overall Study|Lost to Follow-up|1|||
28001222|NCT02610777|81834418|FG001|Overall Study|Lost to Follow-up|0|||
28001223|NCT02610777|81834417|FG000|Overall Study|Site Terminated by Sponsor|9|||
28001224|NCT02610777|81834418|FG001|Overall Study|Site Terminated by Sponsor|8|||
28001225|NCT02610777|81834417|FG000|Overall Study|Withdrawal by Subject|2|||
28001226|NCT02610777|81834418|FG001|Overall Study|Withdrawal by Subject|2|||
28001227|NCT02610777|81834417|FG000|Overall Study|Reason not Specified|0|||
28001228|NCT02610777|81834418|FG001|Overall Study|Reason not Specified|1|||
27681305|NCT02229851|80668086|FG001|Extension Phase (Open-label Phase)|Death|0|||
27583028|NCT01332305|80318905|FG002|Overall Study|Physician Decision|0|||
27583029|NCT01332305|80318906|FG003|Overall Study|Physician Decision|1|||
27583030|NCT01332305|80318907|FG004|Overall Study|Physician Decision|0|||
27583031|NCT02352493|80318908|FG000|Overall Study|Pregnancy|0|||
27583032|NCT02352493|80318909|FG001|Overall Study|Pregnancy|0|||
27583033|NCT02352493|80318910|FG002|Overall Study|Pregnancy|0|||
27583034|NCT02352493|80318911|FG003|Overall Study|Pregnancy|0|||
27583035|NCT02352493|80318912|FG004|Overall Study|Pregnancy|0|||
27583036|NCT02352493|80318913|FG005|Overall Study|Pregnancy|0|||
27583037|NCT02352493|80318914|FG006|Overall Study|Pregnancy|1|||
27583038|NCT02352493|80318915|FG007|Overall Study|Pregnancy|0|||
27583039|NCT02352493|80318916|FG008|Overall Study|Pregnancy|1|||
27583040|NCT02352493|80318917|FG009|Overall Study|Pregnancy|0|||
27806271|NCT02454972|81120511|FG004|Overall Study|Lost to Follow-up|0|||
27806272|NCT02454972|81120512|FG005|Overall Study|Lost to Follow-up|0|||
27806273|NCT02454972|81120513|FG006|Overall Study|Lost to Follow-up|0|||
27806274|NCT02454972|81120514|FG007|Overall Study|Lost to Follow-up|0|||
28001229|NCT02610777|81834417|FG000|Overall Study|Death|50|||
28001230|NCT02610777|81834418|FG001|Overall Study|Death|47|||
28001231|NCT01458639|81834421|FG000|Overall Study|Physician Decision|4|||
28001232|NCT01458639|81834421|FG000|Overall Study|Equipment issue|1|||
28001233|NCT01458639|81834421|FG000|Overall Study|Inability to obtain subject blood sample|1|||
28001234|NCT01535807|81834425|FG000|Overall Study|Withdrawal by Subject|1|||
28001235|NCT01535807|81834426|FG001|Overall Study|Withdrawal by Subject|1|||
28001236|NCT01535807|81834425|FG000|Overall Study|Data collection error|1|||
28001237|NCT01535807|81834426|FG001|Overall Study|Data collection error|1|||
28001238|NCT01721161|81834427|FG000|Overall Study|Adverse Event|2|||
28001239|NCT01721161|81834428|FG001|Overall Study|Adverse Event|3|||
27583041|NCT02352493|80318918|FG010|Overall Study|Pregnancy|0|||
27583042|NCT02352493|80318919|FG011|Overall Study|Pregnancy|0|||
27583043|NCT02352493|80318920|FG012|Overall Study|Pregnancy|0|||
27806275|NCT02454972|81120515|FG008|Overall Study|Lost to Follow-up|2|||
27806276|NCT02454972|81120507|FG000|Overall Study|Study termination|0|||
27806277|NCT02454972|81120508|FG001|Overall Study|Study termination|0|||
27806278|NCT02454972|81120509|FG002|Overall Study|Study termination|0|||
27806279|NCT02454972|81120510|FG003|Overall Study|Study termination|0|||
27806280|NCT02454972|81120511|FG004|Overall Study|Study termination|0|||
27806281|NCT02454972|81120512|FG005|Overall Study|Study termination|0|||
27806282|NCT02454972|81120513|FG006|Overall Study|Study termination|0|||
27806283|NCT02454972|81120514|FG007|Overall Study|Study termination|0|||
27806284|NCT02454972|81120515|FG008|Overall Study|Study termination|6|||
27806285|NCT03989115|81120516|FG000|Overall Study|Withdrawal by Subject|2|||
27806286|NCT03989115|81120517|FG001|Overall Study|Withdrawal by Subject|1|||
27806287|NCT03989115|81120518|FG002|Overall Study|Withdrawal by Subject|3|||
27806288|NCT03989115|81120519|FG003|Overall Study|Withdrawal by Subject|0|||
27806289|NCT03989115|81120520|FG004|Overall Study|Withdrawal by Subject|17|||
27806290|NCT03989115|81120521|FG005|Overall Study|Withdrawal by Subject|1|||
27806291|NCT03989115|81120522|FG006|Overall Study|Withdrawal by Subject|0|||
27806292|NCT03989115|81120523|FG007|Overall Study|Withdrawal by Subject|0|||
27873972|NCT00468819|81371624|FG001|Overall Study|Withdrawal by Subject|0|||
28001240|NCT01721161|81834427|FG000|Overall Study|Lost to Follow-up|1|||
27806293|NCT03989115|81120516|FG000|Overall Study|Sponsor decision to terminate the study|1|||
27806294|NCT03989115|81120517|FG001|Overall Study|Sponsor decision to terminate the study|1|||
27873973|NCT00468819|81371625|FG002|Overall Study|Withdrawal by Subject|1|||
28001241|NCT01721161|81834428|FG001|Overall Study|Lost to Follow-up|2|||
28001242|NCT01721161|81834427|FG000|Overall Study|Withdrawal by Subject|1|||
28001243|NCT01721161|81834428|FG001|Overall Study|Withdrawal by Subject|1|||
27583044|NCT02352493|80318921|FG013|Overall Study|Pregnancy|0|||
27873974|NCT00468819|81371623|FG000|Overall Study|Lost to Follow-up|0|||
27583045|NCT02352493|80318922|FG014|Overall Study|Pregnancy|0|||
27583046|NCT02352493|80318923|FG015|Overall Study|Pregnancy|0|||
27873975|NCT00468819|81371624|FG001|Overall Study|Lost to Follow-up|0|||
27873976|NCT00468819|81371625|FG002|Overall Study|Lost to Follow-up|1|||
27873977|NCT00468819|81371623|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
27873978|NCT00468819|81371624|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
27873979|NCT00468819|81371625|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
27873980|NCT01215136|81371634|FG000|Overall Study|Adverse Event|2|||
27873981|NCT01215136|81371635|FG001|Overall Study|Adverse Event|9|||
27873982|NCT01215136|81371634|FG000|Overall Study|Disease Progression|3|||
27873983|NCT01215136|81371635|FG001|Overall Study|Disease Progression|14|||
27873984|NCT01215136|81371634|FG000|Overall Study|Symptomatic Deterioration|1|||
27873985|NCT01215136|81371635|FG001|Overall Study|Symptomatic Deterioration|1|||
27873986|NCT01215136|81371634|FG000|Overall Study|Death|0|||
27873987|NCT01215136|81371635|FG001|Overall Study|Death|2|||
27873988|NCT01215136|81371634|FG000|Overall Study|Withdrawal by Subject|0|||
27873989|NCT01215136|81371635|FG001|Overall Study|Withdrawal by Subject|1|||
27873990|NCT04720105|81371636|FG000|Overall Study|Lack of Efficacy|1|||
27873991|NCT04720105|81371636|FG000|Overall Study|Lost to Follow-up|1|||
27873992|NCT04720105|81371636|FG000|Overall Study|Withdrawal by Subject|3|||
27873993|NCT04211831|81371637|FG000|Overall Study|Withdrawal by Subject|4|||
27873994|NCT04211831|81371638|FG001|Overall Study|Withdrawal by Subject|1|||
27873995|NCT04211831|81371639|FG002|Overall Study|Withdrawal by Subject|1|||
27583047|NCT02352493|80318924|FG016|Overall Study|Pregnancy|0|||
27873996|NCT04211831|81371637|FG000|Overall Study|Protocol Violation|0|||
27873997|NCT04211831|81371638|FG001|Overall Study|Protocol Violation|0|||
27873998|NCT04211831|81371639|FG002|Overall Study|Protocol Violation|1|||
27873999|NCT04211831|81371637|FG000|Overall Study|Adverse Event|0|||
28001244|NCT01721161|81834427|FG000|Overall Study|Other|0|||
28001245|NCT01721161|81834428|FG001|Overall Study|Other|1|||
28001246|NCT03914417|81834429|FG000|Overall Study|Withdrawal by Subject|2|||
28001247|NCT01307319|81834432|FG000|Overall Study|Adverse Event|2|||
28001248|NCT01307319|81834433|FG001|Overall Study|Adverse Event|2|||
28001249|NCT01307319|81834434|FG002|Overall Study|Adverse Event|1|||
28001250|NCT01307319|81834432|FG000|Overall Study|Lost to Follow-up|1|||
28001251|NCT01307319|81834433|FG001|Overall Study|Lost to Follow-up|0|||
28001252|NCT01307319|81834434|FG002|Overall Study|Lost to Follow-up|1|||
28001253|NCT01307319|81834432|FG000|Overall Study|Protocol Violation|1|||
28001254|NCT01307319|81834433|FG001|Overall Study|Protocol Violation|1|||
28001255|NCT01307319|81834434|FG002|Overall Study|Protocol Violation|0|||
28001256|NCT01307319|81834432|FG000|Overall Study|Withdrawal by Subject|0|||
28001257|NCT01307319|81834433|FG001|Overall Study|Withdrawal by Subject|1|||
28001258|NCT01307319|81834434|FG002|Overall Study|Withdrawal by Subject|2|||
28001259|NCT01307319|81834432|FG000|Overall Study|Other|0|||
28001260|NCT01307319|81834433|FG001|Overall Study|Other|4|||
28001261|NCT01307319|81834434|FG002|Overall Study|Other|3|||
28001262|NCT01751984|81834441|FG000|Overall Study|Adverse Event|5|||
28001263|NCT01751984|81834442|FG001|Overall Study|Adverse Event|3|||
28001264|NCT01751984|81834441|FG000|Overall Study|Withdrawal by Subject|0|||
28001265|NCT01751984|81834442|FG001|Overall Study|Withdrawal by Subject|1|||
28001266|NCT01751984|81834441|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
27583048|NCT02352493|80318925|FG017|Overall Study|Pregnancy|0|||
27583049|NCT02352493|80318908|FG000|Overall Study|Withdrawal by Subject|0|||
27583050|NCT02352493|80318909|FG001|Overall Study|Withdrawal by Subject|0|||
27583051|NCT02352493|80318910|FG002|Overall Study|Withdrawal by Subject|0|||
27583052|NCT02352493|80318911|FG003|Overall Study|Withdrawal by Subject|0|||
27583053|NCT02352493|80318912|FG004|Overall Study|Withdrawal by Subject|0|||
27583054|NCT02352493|80318913|FG005|Overall Study|Withdrawal by Subject|0|||
27583055|NCT02352493|80318914|FG006|Overall Study|Withdrawal by Subject|0|||
27583056|NCT02352493|80318915|FG007|Overall Study|Withdrawal by Subject|0|||
27583057|NCT02352493|80318916|FG008|Overall Study|Withdrawal by Subject|1|||
27583058|NCT02352493|80318917|FG009|Overall Study|Withdrawal by Subject|0|||
27583059|NCT02352493|80318918|FG010|Overall Study|Withdrawal by Subject|0|||
27583060|NCT02352493|80318919|FG011|Overall Study|Withdrawal by Subject|0|||
27583061|NCT02352493|80318920|FG012|Overall Study|Withdrawal by Subject|0|||
27594397|NCT00955357|80356064|FG001|Titration Phase|Lost to Follow-up|3|||
28001267|NCT01751984|81834442|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
28001268|NCT02800863|81834443|FG000|Overall Study|Adverse Event|14|||
28001269|NCT02800863|81834443|FG000|Overall Study|Another Device Implanted|1|||
28001270|NCT02800863|81834443|FG000|Overall Study|Device Explanted|1|||
27583062|NCT02352493|80318921|FG013|Overall Study|Withdrawal by Subject|0|||
27583063|NCT02352493|80318922|FG014|Overall Study|Withdrawal by Subject|1|||
27583064|NCT02352493|80318923|FG015|Overall Study|Withdrawal by Subject|0|||
27583065|NCT02352493|80318924|FG016|Overall Study|Withdrawal by Subject|0|||
27583066|NCT02352493|80318925|FG017|Overall Study|Withdrawal by Subject|0|||
27583067|NCT02352493|80318908|FG000|Overall Study|Lost to Follow-up|0|||
27583068|NCT02352493|80318909|FG001|Overall Study|Lost to Follow-up|0|||
27583069|NCT02352493|80318910|FG002|Overall Study|Lost to Follow-up|0|||
28001271|NCT02800863|81834443|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
28001272|NCT02800863|81834443|FG000|Overall Study|Health Issues|1|||
28001273|NCT02800863|81834443|FG000|Overall Study|Insurance Denial|8|||
28001274|NCT02800863|81834443|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
28001275|NCT02800863|81834443|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
28001276|NCT02800863|81834443|FG000|Overall Study|Screen Failure|1|||
28001277|NCT02800863|81834443|FG000|Overall Study|Sponsor Request|6|||
28001278|NCT02800863|81834443|FG000|Overall Study|Death|3|||
28001279|NCT02800863|81834443|FG000|Overall Study|Subject Implant at Another Facility|1|||
28001280|NCT02800863|81834443|FG000|Overall Study|Lost to Follow-up|26|||
28001281|NCT02800863|81834443|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
28001282|NCT02800863|81834443|FG000|Overall Study|Subject and/or Family Request|64|||
28001283|NCT02800863|81834443|FG000|Overall Study|Trial Failure|81|||
28001284|NCT02800863|81834443|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
28001285|NCT00412893|81834444|FG000|Overall Study|Adverse Event|31|||
28001286|NCT00412893|81834445|FG001|Overall Study|Adverse Event|53|||
28001287|NCT00412893|81834444|FG000|Overall Study|Death|17|||
28001288|NCT00412893|81834445|FG001|Overall Study|Death|21|||
28001289|NCT00412893|81834444|FG000|Overall Study|Insufficient Therapeutic Response|39|||
27583070|NCT02352493|80318911|FG003|Overall Study|Lost to Follow-up|0|||
27583071|NCT02352493|80318912|FG004|Overall Study|Lost to Follow-up|0|||
27874000|NCT04211831|81371638|FG001|Overall Study|Adverse Event|1|||
28001290|NCT00412893|81834445|FG001|Overall Study|Insufficient Therapeutic Response|23|||
28001291|NCT00412893|81834444|FG000|Overall Study|Lost to Follow-up|2|||
28001292|NCT00412893|81834445|FG001|Overall Study|Lost to Follow-up|1|||
28001293|NCT00412893|81834444|FG000|Overall Study|Violation of Selection at Entry|17|||
27583072|NCT02352493|80318913|FG005|Overall Study|Lost to Follow-up|0|||
27583073|NCT02352493|80318914|FG006|Overall Study|Lost to Follow-up|0|||
28001294|NCT00412893|81834445|FG001|Overall Study|Violation of Selection at Entry|10|||
28001295|NCT00412893|81834444|FG000|Overall Study|Other Protocol Violation|10|||
28001296|NCT00412893|81834445|FG001|Overall Study|Other Protocol Violation|6|||
28001297|NCT00412893|81834444|FG000|Overall Study|Did Not Cooperate|12|||
28001298|NCT00412893|81834445|FG001|Overall Study|Did Not Cooperate|9|||
28001299|NCT00412893|81834444|FG000|Overall Study|Administrative Reason|12|||
28001300|NCT00412893|81834445|FG001|Overall Study|Administrative Reason|15|||
28001301|NCT00412893|81834444|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
28001302|NCT00412893|81834445|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
28001303|NCT01467505|81834449|FG000|Overall Study|Adverse Event|1|||
28001304|NCT01467505|81834450|FG001|Overall Study|Adverse Event|0|||
27583074|NCT02352493|80318915|FG007|Overall Study|Lost to Follow-up|0|||
27583075|NCT02352493|80318916|FG008|Overall Study|Lost to Follow-up|0|||
27583076|NCT02352493|80318917|FG009|Overall Study|Lost to Follow-up|1|||
27583077|NCT02352493|80318918|FG010|Overall Study|Lost to Follow-up|0|||
27583078|NCT02352493|80318919|FG011|Overall Study|Lost to Follow-up|0|||
27583079|NCT02352493|80318920|FG012|Overall Study|Lost to Follow-up|1|||
27583080|NCT02352493|80318921|FG013|Overall Study|Lost to Follow-up|2|||
27583081|NCT02352493|80318922|FG014|Overall Study|Lost to Follow-up|0|||
27583082|NCT02352493|80318923|FG015|Overall Study|Lost to Follow-up|0|||
27583083|NCT02352493|80318924|FG016|Overall Study|Lost to Follow-up|0|||
27583084|NCT02352493|80318925|FG017|Overall Study|Lost to Follow-up|0|||
27583085|NCT01252251|80318926|FG000|Overall Study|Withdrawal by Subject|1|||
27583086|NCT00148343|80318927|FG000|Overall Study|Withdrawal by Subject|12|||
27681306|NCT02229851|80668087|FG002|Extension Phase (Open-label Phase)|Death|0|||
27681307|NCT02229851|80668088|FG003|Extension Phase (Open-label Phase)|Death|1|||
27681308|NCT02229851|80668089|FG004|Extension Phase (Open-label Phase)|Death|0|||
27681309|NCT02229851|80668090|FG005|Extension Phase (Open-label Phase)|Death|1|||
27681310|NCT02229851|80668091|FG006|Extension Phase (Open-label Phase)|Death|1|||
27681311|NCT01969851|80668092|FG000|Overall Study|Adverse Event|0|||
27681312|NCT01969851|80668093|FG001|Overall Study|Adverse Event|0|||
27681313|NCT01969851|80668094|FG002|Overall Study|Adverse Event|3|||
28001305|NCT01467505|81834449|FG000|Overall Study|Withdrawal by Subject|4|||
28001306|NCT01467505|81834450|FG001|Overall Study|Withdrawal by Subject|0|||
28001307|NCT01467505|81834449|FG000|Overall Study|Study Terminated by Sponsor|28|||
27681314|NCT01969851|80668092|FG000|Overall Study|Lack of Efficacy|0|||
28001308|NCT01467505|81834450|FG001|Overall Study|Study Terminated by Sponsor|3|||
28001309|NCT01946139|81834460|FG000|Overall Study|Withdrawal by Subject|8|||
28001310|NCT01946139|81834460|FG000|Overall Study|ineligible|8|||
28001311|NCT01946139|81834460|FG000|Overall Study|Specimens not available|4|||
27583087|NCT00148343|80318928|FG001|Overall Study|Withdrawal by Subject|7|||
27681315|NCT01969851|80668093|FG001|Overall Study|Lack of Efficacy|3|||
27681316|NCT01969851|80668094|FG002|Overall Study|Lack of Efficacy|1|||
27681317|NCT01969851|80668092|FG000|Overall Study|Withdrawal by Subject|1|||
27681318|NCT01969851|80668093|FG001|Overall Study|Withdrawal by Subject|0|||
27681319|NCT01969851|80668094|FG002|Overall Study|Withdrawal by Subject|1|||
27681320|NCT01969851|80668092|FG000|Overall Study|No effective dose in Titration period|0|||
27681321|NCT01969851|80668093|FG001|Overall Study|No effective dose in Titration period|0|||
27681322|NCT01969851|80668094|FG002|Overall Study|No effective dose in Titration period|1|||
27681323|NCT01969851|80668092|FG000|Overall Study|Sponsor decision|0|||
27681324|NCT01969851|80668093|FG001|Overall Study|Sponsor decision|0|||
27681325|NCT01969851|80668094|FG002|Overall Study|Sponsor decision|1|||
27681326|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
27681327|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
27681328|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
27681329|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
27681330|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Death|13|||
27681331|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Death|12|||
27681332|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Progression|257|||
27806295|NCT03989115|81120518|FG002|Overall Study|Sponsor decision to terminate the study|0|||
28001312|NCT01623115|81834465|FG000|Overall Study|Randomized but not treated|0|||
27583088|NCT00148343|80318927|FG000|Overall Study|Physician Decision|3|||
27583089|NCT00148343|80318928|FG001|Overall Study|Physician Decision|4|||
27583090|NCT01854554|80318931|FG000|Overall Study|Denial of Insurance Coverage|12|||
27583091|NCT01854554|80318932|FG001|Overall Study|Denial of Insurance Coverage|0|||
27583092|NCT01854554|80318931|FG000|Overall Study|Decided to get treatment locally|1|||
27583093|NCT01854554|80318932|FG001|Overall Study|Decided to get treatment locally|5|||
28001313|NCT01623115|81834466|FG001|Overall Study|Randomized but not treated|1|||
28001314|NCT01623115|81834465|FG000|Overall Study|Physician Decision|1|||
28001315|NCT01623115|81834466|FG001|Overall Study|Physician Decision|0|||
28001316|NCT01623115|81834465|FG000|Overall Study|Participants moved|1|||
28001317|NCT01623115|81834466|FG001|Overall Study|Participants moved|5|||
27681333|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Progression|218|||
27681334|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
27681335|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
27700988|NCT01241552|80741289|FG000|Overall Study|Progressive Disease|0|||
27806296|NCT03989115|81120519|FG003|Overall Study|Sponsor decision to terminate the study|1|||
27806297|NCT03989115|81120520|FG004|Overall Study|Sponsor decision to terminate the study|11|||
27681336|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
27681337|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
27681338|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
27681339|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
27681340|NCT01006980|80668095|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
27681341|NCT01006980|80668096|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
27681342|NCT01006980|80668095|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
27681343|NCT01006980|80668096|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
28001318|NCT01623115|81834465|FG000|Overall Study|Adverse Event|10|||
27681344|NCT01006980|80668095|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
27681345|NCT01006980|80668096|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
27681346|NCT01006980|80668095|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
27681347|NCT01006980|80668096|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
27681348|NCT01006980|80668095|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
27681349|NCT01006980|80668096|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
27681350|NCT01006980|80668095|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
27681351|NCT01006980|80668096|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
27681352|NCT02412735|80668099|FG000|Overall Study|Adverse Event|0|||
27681353|NCT02412735|80668100|FG001|Overall Study|Adverse Event|1|||
27681354|NCT02412735|80668101|FG002|Overall Study|Adverse Event|2|||
27681355|NCT02412735|80668099|FG000|Overall Study|Withdrawal by Subject|23|||
27681356|NCT02412735|80668100|FG001|Overall Study|Withdrawal by Subject|27|||
27681357|NCT02412735|80668101|FG002|Overall Study|Withdrawal by Subject|22|||
27681358|NCT02412735|80668099|FG000|Overall Study|Investigator Decision|3|||
27681359|NCT02412735|80668100|FG001|Overall Study|Investigator Decision|3|||
27681360|NCT02412735|80668101|FG002|Overall Study|Investigator Decision|2|||
27681361|NCT02412735|80668099|FG000|Overall Study|Lost to Follow-up|17|||
27681362|NCT02412735|80668100|FG001|Overall Study|Lost to Follow-up|11|||
27681363|NCT02412735|80668101|FG002|Overall Study|Lost to Follow-up|18|||
27681364|NCT02412735|80668099|FG000|Overall Study|Reason not Specified|3|||
27681365|NCT02412735|80668100|FG001|Overall Study|Reason not Specified|2|||
27681366|NCT02412735|80668101|FG002|Overall Study|Reason not Specified|2|||
27681367|NCT03762200|80668102|FG000|Overall Study|Death|2|||
27681368|NCT02574845|80668105|FG000|Overall Study|Consent withdrawn further participation|0|||
27681369|NCT02574845|80668106|FG001|Overall Study|Consent withdrawn further participation|0|||
27681370|NCT02574845|80668107|FG002|Overall Study|Consent withdrawn further participation|0|||
27681371|NCT02574845|80668108|FG003|Overall Study|Consent withdrawn further participation|0|||
27681372|NCT02574845|80668109|FG004|Overall Study|Consent withdrawn further participation|1|||
27681373|NCT02574845|80668110|FG005|Overall Study|Consent withdrawn further participation|0|||
27681374|NCT02574845|80668105|FG000|Overall Study|Adverse Event|0|||
27681375|NCT02574845|80668106|FG001|Overall Study|Adverse Event|1|||
27681376|NCT02574845|80668107|FG002|Overall Study|Adverse Event|0|||
27681377|NCT02574845|80668108|FG003|Overall Study|Adverse Event|0|||
27681378|NCT02574845|80668109|FG004|Overall Study|Adverse Event|0|||
27681379|NCT02574845|80668110|FG005|Overall Study|Adverse Event|1|||
27681380|NCT03031496|80668111|FG000|Period 1|Adverse Event|2|||
27681381|NCT03031496|80668112|FG001|Period 1|Adverse Event|0|||
27681382|NCT03031496|80668111|FG000|Period 1|Withdrawal by Subject|0|||
27681383|NCT03031496|80668112|FG001|Period 1|Withdrawal by Subject|2|||
27681384|NCT02037477|80671891|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
27681385|NCT02037477|80671892|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
28001319|NCT01623115|81834466|FG001|Overall Study|Adverse Event|13|||
28001320|NCT01623115|81834465|FG000|Overall Study|Poor compliance to protocol|4|||
27681386|NCT02037477|80671893|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
27681387|NCT02037477|80671894|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
27681388|NCT02530970|80671895|FG000|Overall Study|Adverse Event|8|||
27681389|NCT02530970|80671895|FG000|Overall Study|Lost to Follow-up|88|||
27806298|NCT03989115|81120521|FG005|Overall Study|Sponsor decision to terminate the study|0|||
27806299|NCT03989115|81120522|FG006|Overall Study|Sponsor decision to terminate the study|2|||
27806300|NCT03989115|81120523|FG007|Overall Study|Sponsor decision to terminate the study|1|||
27806301|NCT03989115|81120516|FG000|Overall Study|Lost to Follow-up|2|||
27806302|NCT03989115|81120517|FG001|Overall Study|Lost to Follow-up|0|||
27681390|NCT02530970|80671895|FG000|Overall Study|Physician Decision|5|||
27681391|NCT02530970|80671895|FG000|Overall Study|Withdrawal by Subject|14|||
28001321|NCT01623115|81834466|FG001|Overall Study|Poor compliance to protocol|10|||
27681392|NCT02530970|80671895|FG000|Overall Study|Death|6|||
27681393|NCT02530970|80671895|FG000|Overall Study|Hospitalization|1|||
27681394|NCT02530970|80671895|FG000|Overall Study|Insurance|2|||
27681395|NCT02530970|80671895|FG000|Overall Study|Explant|2|||
27681396|NCT02530970|80671895|FG000|Overall Study|Change in Provider|5|||
27681397|NCT02530970|80671895|FG000|Overall Study|Relocation|3|||
27681398|NCT01137578|80671897|FG000|Overall Study|Participant requested to Discontinue|3|||
27681399|NCT01137578|80671898|FG001|Overall Study|Participant requested to Discontinue|0|||
27806303|NCT03989115|81120518|FG002|Overall Study|Lost to Follow-up|0|||
28001322|NCT01623115|81834465|FG000|Overall Study|Consent withdrawn by participant|2|||
28001323|NCT01623115|81834466|FG001|Overall Study|Consent withdrawn by participant|6|||
28001324|NCT01623115|81834465|FG000|Overall Study|Related to study drug administration|0|||
28001325|NCT01623115|81834466|FG001|Overall Study|Related to study drug administration|2|||
28001326|NCT01623115|81834465|FG000|Overall Study|Last visit outside protocol visit window|14|||
28001327|NCT01623115|81834466|FG001|Overall Study|Last visit outside protocol visit window|26|||
28001328|NCT01623115|81834465|FG000|Overall Study|Site closure|1|||
28001329|NCT01623115|81834466|FG001|Overall Study|Site closure|7|||
28001330|NCT01623115|81834465|FG000|Overall Study|Death|0|||
28001331|NCT01623115|81834466|FG001|Overall Study|Death|4|||
28001332|NCT01623115|81834465|FG000|Overall Study|Other than specified above|0|||
27806304|NCT03989115|81120519|FG003|Overall Study|Lost to Follow-up|0|||
27806305|NCT03989115|81120520|FG004|Overall Study|Lost to Follow-up|1|||
27806306|NCT03989115|81120521|FG005|Overall Study|Lost to Follow-up|0|||
28001333|NCT01623115|81834466|FG001|Overall Study|Other than specified above|3|||
28001334|NCT02576639|81834467|FG000|Overall Study|Withdrawal by Subject|1|||
27806307|NCT03989115|81120522|FG006|Overall Study|Lost to Follow-up|0|||
27583094|NCT01854554|80318931|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
27583095|NCT01854554|80318932|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
27806308|NCT03989115|81120523|FG007|Overall Study|Lost to Follow-up|0|||
27806309|NCT03989115|81120516|FG000|Overall Study|Death|2|||
27806310|NCT03989115|81120517|FG001|Overall Study|Death|2|||
28001335|NCT02576639|81834468|FG001|Overall Study|Withdrawal by Subject|2|||
28001336|NCT02576639|81834469|FG002|Overall Study|Withdrawal by Subject|1|||
28001337|NCT02576639|81834470|FG003|Overall Study|Withdrawal by Subject|0|||
28001338|NCT02576639|81834471|FG004|Overall Study|Withdrawal by Subject|1|||
28001339|NCT02576639|81834467|FG000|Overall Study|Adverse Event|1|||
28001340|NCT02576639|81834468|FG001|Overall Study|Adverse Event|0|||
28001341|NCT02576639|81834469|FG002|Overall Study|Adverse Event|1|||
28001342|NCT02576639|81834470|FG003|Overall Study|Adverse Event|1|||
28001343|NCT02576639|81834471|FG004|Overall Study|Adverse Event|2|||
28001344|NCT02576639|81834467|FG000|Overall Study|Physician Decision|0|||
28001345|NCT02576639|81834468|FG001|Overall Study|Physician Decision|0|||
28001346|NCT02576639|81834469|FG002|Overall Study|Physician Decision|0|||
28001347|NCT02576639|81834470|FG003|Overall Study|Physician Decision|0|||
27583096|NCT01854554|80318931|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
27583097|NCT01854554|80318932|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
27874001|NCT04211831|81371639|FG002|Overall Study|Adverse Event|0|||
27806311|NCT03989115|81120518|FG002|Overall Study|Death|9|||
27806312|NCT03989115|81120519|FG003|Overall Study|Death|6|||
27806313|NCT03989115|81120520|FG004|Overall Study|Death|31|||
27806314|NCT03989115|81120521|FG005|Overall Study|Death|6|||
27806315|NCT03989115|81120522|FG006|Overall Study|Death|2|||
27806316|NCT03989115|81120523|FG007|Overall Study|Death|3|||
27806317|NCT03989115|81120516|FG000|Overall Study|Other|1|||
27806318|NCT03989115|81120517|FG001|Overall Study|Other|2|||
27806319|NCT03989115|81120518|FG002|Overall Study|Other|0|||
27874002|NCT04211831|81371637|FG000|Overall Study|Lack of Efficacy|0|||
27874003|NCT04211831|81371638|FG001|Overall Study|Lack of Efficacy|0|||
27874004|NCT04211831|81371639|FG002|Overall Study|Lack of Efficacy|1|||
27874005|NCT04211831|81371637|FG000|Overall Study|Lost to Follow-up|0|||
27874006|NCT04211831|81371638|FG001|Overall Study|Lost to Follow-up|0|||
27681400|NCT01137578|80671899|FG002|Overall Study|Participant requested to Discontinue|0|||
28001348|NCT02576639|81834471|FG004|Overall Study|Physician Decision|1|||
27583098|NCT01854554|80318931|FG000|Overall Study|Progression|0|||
27583099|NCT01854554|80318932|FG001|Overall Study|Progression|1|||
27583100|NCT01854554|80318931|FG000|Overall Study|Lost to Follow-up|0|||
27583101|NCT01854554|80318932|FG001|Overall Study|Lost to Follow-up|1|||
27583102|NCT03465540|80318933|FG000|Overall Study|Withdrawal by Subject|0|||
27681401|NCT01137578|80671897|FG000|Overall Study|Withdrawal by Subject|1|||
27806320|NCT03989115|81120519|FG003|Overall Study|Other|0|||
27806321|NCT03989115|81120520|FG004|Overall Study|Other|5|||
27806322|NCT03989115|81120521|FG005|Overall Study|Other|0|||
27806323|NCT03989115|81120522|FG006|Overall Study|Other|0|||
28001349|NCT00626275|81834473|FG000|Part A - Treatment Period 1|Adverse Event|1|||
28001350|NCT00626275|81834474|FG001|Part A - Treatment Period 1|Adverse Event|0|||
27583103|NCT03465540|80318934|FG001|Overall Study|Withdrawal by Subject|0|||
27583104|NCT03465540|80318935|FG002|Overall Study|Withdrawal by Subject|1|||
27583105|NCT03465540|80318936|FG003|Overall Study|Withdrawal by Subject|1|||
27681402|NCT01137578|80671898|FG001|Overall Study|Withdrawal by Subject|0|||
28001351|NCT00626275|81834475|FG002|Part A - Treatment Period 1|Adverse Event|0|||
28001352|NCT00626275|81834476|FG003|Part A - Treatment Period 1|Adverse Event|0|||
27874007|NCT04211831|81371639|FG002|Overall Study|Lost to Follow-up|2|||
27806324|NCT03989115|81120523|FG007|Overall Study|Other|0|||
27806325|NCT01764854|81120524|FG000|Overall Study|Adverse Event|0|||
27806326|NCT01764854|81120525|FG001|Overall Study|Adverse Event|0|||
27806327|NCT01764854|81120526|FG002|Overall Study|Adverse Event|2|||
27806328|NCT01764854|81120527|FG003|Overall Study|Adverse Event|0|||
27806329|NCT01764854|81120524|FG000|Overall Study|Withdrawal by Subject|0|||
27583106|NCT03465540|80318937|FG004|Overall Study|Withdrawal by Subject|1|||
27583107|NCT03465540|80318938|FG005|Overall Study|Withdrawal by Subject|0|||
27583108|NCT03465540|80318933|FG000|Overall Study|Lost to Follow-up|0|||
27583109|NCT03465540|80318934|FG001|Overall Study|Lost to Follow-up|1|||
27583110|NCT03465540|80318935|FG002|Overall Study|Lost to Follow-up|0|||
27583111|NCT03465540|80318936|FG003|Overall Study|Lost to Follow-up|0|||
27583112|NCT03465540|80318937|FG004|Overall Study|Lost to Follow-up|1|||
27583113|NCT03465540|80318938|FG005|Overall Study|Lost to Follow-up|0|||
27583114|NCT03465540|80318933|FG000|Overall Study|Death|1|||
27583115|NCT03465540|80318934|FG001|Overall Study|Death|1|||
27583116|NCT03465540|80318935|FG002|Overall Study|Death|0|||
27583117|NCT03465540|80318936|FG003|Overall Study|Death|2|||
27583118|NCT03465540|80318937|FG004|Overall Study|Death|0|||
27583119|NCT03465540|80318938|FG005|Overall Study|Death|2|||
27583120|NCT03465540|80318933|FG000|Overall Study|Protocol specified criteria|0|||
27583121|NCT03465540|80318934|FG001|Overall Study|Protocol specified criteria|2|||
27583122|NCT03465540|80318935|FG002|Overall Study|Protocol specified criteria|2|||
27583123|NCT03465540|80318936|FG003|Overall Study|Protocol specified criteria|0|||
27681403|NCT01137578|80671899|FG002|Overall Study|Withdrawal by Subject|0|||
27681404|NCT01137578|80671897|FG000|Overall Study|Other|12|||
27681405|NCT01137578|80671898|FG001|Overall Study|Other|2|||
27681406|NCT01137578|80671899|FG002|Overall Study|Other|6|||
28001353|NCT00626275|81834477|FG004|Part A - Treatment Period 1|Adverse Event|0|||
28001354|NCT00626275|81834478|FG005|Part A - Treatment Period 1|Adverse Event|0|||
28001355|NCT00626275|81834479|FG006|Part A - Treatment Period 1|Adverse Event|0|||
28001356|NCT00626275|81834480|FG007|Part A - Treatment Period 1|Adverse Event|0|||
28001357|NCT00626275|81834473|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27681407|NCT00964886|80671900|FG000|Overall Study|Lost to Follow-up|2|||
27806330|NCT01764854|81120525|FG001|Overall Study|Withdrawal by Subject|0|||
27806331|NCT01764854|81120526|FG002|Overall Study|Withdrawal by Subject|1|||
27806332|NCT01764854|81120527|FG003|Overall Study|Withdrawal by Subject|0|||
27806333|NCT01764854|81120524|FG000|Overall Study|relocation|0|||
27583124|NCT03465540|80318937|FG004|Overall Study|Protocol specified criteria|2|||
27583125|NCT03465540|80318938|FG005|Overall Study|Protocol specified criteria|0|||
27583126|NCT00022516|80318943|FG000|Overall Study|Adverse Event|0|||
27583127|NCT00022516|80318944|FG001|Overall Study|Adverse Event|59|||
27583128|NCT00022516|80318943|FG000|Overall Study|Lack of Efficacy|0|||
27681408|NCT00964886|80671901|FG001|Overall Study|Lost to Follow-up|2|||
28001358|NCT00626275|81834474|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27583129|NCT00022516|80318944|FG001|Overall Study|Lack of Efficacy|27|||
28001359|NCT00626275|81834475|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
28001360|NCT00626275|81834476|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
28001361|NCT00626275|81834477|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
28001362|NCT00626275|81834478|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27681409|NCT00964886|80671902|FG002|Overall Study|Lost to Follow-up|6|||
27681410|NCT00964886|80671903|FG003|Overall Study|Lost to Follow-up|4|||
28001363|NCT00626275|81834479|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
28001364|NCT00626275|81834480|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
27806334|NCT01764854|81120525|FG001|Overall Study|relocation|0|||
27806335|NCT01764854|81120526|FG002|Overall Study|relocation|2|||
27806336|NCT01764854|81120527|FG003|Overall Study|relocation|0|||
27806337|NCT01764854|81120524|FG000|Overall Study|Protocol Violation|0|||
27806338|NCT01764854|81120525|FG001|Overall Study|Protocol Violation|0|||
27806339|NCT01764854|81120526|FG002|Overall Study|Protocol Violation|1|||
27806340|NCT01764854|81120527|FG003|Overall Study|Protocol Violation|2|||
28001365|NCT00626275|81834473|FG000|Part B|Lost to Follow-up|0|||
28001366|NCT00626275|81834474|FG001|Part B|Lost to Follow-up|0|||
28001367|NCT00626275|81834475|FG002|Part B|Lost to Follow-up|0|||
28001368|NCT00626275|81834476|FG003|Part B|Lost to Follow-up|0|||
28001369|NCT00626275|81834477|FG004|Part B|Lost to Follow-up|0|||
27583130|NCT00022516|80318943|FG000|Overall Study|Physician Decision|0|||
27583131|NCT00022516|80318944|FG001|Overall Study|Physician Decision|1|||
27583132|NCT00022516|80318943|FG000|Overall Study|Protocol Violation|1|||
27583133|NCT00022516|80318944|FG001|Overall Study|Protocol Violation|3|||
27583134|NCT00022516|80318943|FG000|Overall Study|Withdrawal by Subject|2|||
27583135|NCT00022516|80318944|FG001|Overall Study|Withdrawal by Subject|113|||
28001370|NCT00626275|81834478|FG005|Part B|Lost to Follow-up|0|||
27583136|NCT00022516|80318943|FG000|Overall Study|Incomplete documentation|0|||
27583137|NCT00022516|80318944|FG001|Overall Study|Incomplete documentation|27|||
27583138|NCT04321460|80318945|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
27681411|NCT00964886|80671900|FG000|Overall Study|Withdrawal by Subject|6|||
27583139|NCT04321460|80318946|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
27681412|NCT00964886|80671901|FG001|Overall Study|Withdrawal by Subject|2|||
27681413|NCT00964886|80671902|FG002|Overall Study|Withdrawal by Subject|5|||
27806341|NCT00770315|81120533|FG000|Overall Study|Adverse Event|11|||
27806342|NCT00770315|81120534|FG001|Overall Study|Adverse Event|17|||
28001371|NCT00626275|81834479|FG006|Part B|Lost to Follow-up|1|||
28001372|NCT00626275|81834480|FG007|Part B|Lost to Follow-up|0|||
28001373|NCT00626275|81834473|FG000|Part B|Withdrawal by Subject|0|||
28001374|NCT00626275|81834474|FG001|Part B|Withdrawal by Subject|0|||
28001375|NCT00626275|81834475|FG002|Part B|Withdrawal by Subject|0|||
28001376|NCT00626275|81834476|FG003|Part B|Withdrawal by Subject|0|||
28001377|NCT00626275|81834477|FG004|Part B|Withdrawal by Subject|0|||
28001378|NCT00626275|81834478|FG005|Part B|Withdrawal by Subject|0|||
28001379|NCT00626275|81834479|FG006|Part B|Withdrawal by Subject|0|||
28001380|NCT00626275|81834480|FG007|Part B|Withdrawal by Subject|1|||
28001381|NCT01799226|81834481|FG000|Overall Study|Withdrawal by Subject|1|||
28001382|NCT01799226|81834482|FG001|Overall Study|Withdrawal by Subject|0|||
28001383|NCT01799226|81834481|FG000|Overall Study|Disqualified at Day 14|1|||
28001384|NCT01799226|81834482|FG001|Overall Study|Disqualified at Day 14|0|||
28001385|NCT02380287|81834483|FG000|Overall Study|Adverse Event|0|||
28001386|NCT02380287|81834484|FG001|Overall Study|Adverse Event|0|||
28001387|NCT02380287|81834485|FG002|Overall Study|Adverse Event|1|||
28001388|NCT02380287|81834486|FG003|Overall Study|Adverse Event|0|||
28001389|NCT02380287|81834487|FG004|Overall Study|Adverse Event|0|||
28001390|NCT02380287|81834488|FG005|Overall Study|Adverse Event|0|||
28001391|NCT02380287|81834489|FG006|Overall Study|Adverse Event|0|||
28001392|NCT02380287|81834490|FG007|Overall Study|Adverse Event|0|||
28001393|NCT00395746|81834491|FG000|Overall Study|Adverse Event|5|||
27681414|NCT00964886|80671903|FG003|Overall Study|Withdrawal by Subject|3|||
27681415|NCT00964886|80671900|FG000|Overall Study|Adverse Event|3|||
27681416|NCT00964886|80671901|FG001|Overall Study|Adverse Event|1|||
27681417|NCT00964886|80671902|FG002|Overall Study|Adverse Event|5|||
27681418|NCT00964886|80671903|FG003|Overall Study|Adverse Event|2|||
27681419|NCT00964886|80671900|FG000|Overall Study|Protocol Violation|0|||
27681420|NCT00964886|80671901|FG001|Overall Study|Protocol Violation|2|||
27681421|NCT00964886|80671902|FG002|Overall Study|Protocol Violation|0|||
27681422|NCT00964886|80671903|FG003|Overall Study|Protocol Violation|0|||
27681423|NCT03635099|80671907|FG000|Period 1|Adverse Event|1|||
27681424|NCT03635099|80671908|FG001|Period 1|Adverse Event|0|||
27681425|NCT03635099|80671909|FG002|Period 1|Adverse Event|0|||
27681426|NCT03635099|80671910|FG003|Period 1|Adverse Event|1|||
27681427|NCT03635099|80671911|FG004|Period 1|Adverse Event|0|||
27681428|NCT03635099|80671912|FG005|Period 1|Adverse Event|0|||
27681429|NCT03635099|80671913|FG006|Period 1|Adverse Event|0|||
27681430|NCT03635099|80671914|FG007|Period 1|Adverse Event|0|||
27681431|NCT03635099|80671907|FG000|Period 1|Protocol Violation|0|||
27681432|NCT03635099|80671908|FG001|Period 1|Protocol Violation|0|||
27681433|NCT03635099|80671909|FG002|Period 1|Protocol Violation|1|||
27681434|NCT03635099|80671910|FG003|Period 1|Protocol Violation|0|||
27681435|NCT03635099|80671911|FG004|Period 1|Protocol Violation|0|||
27681436|NCT03635099|80671912|FG005|Period 1|Protocol Violation|0|||
27681437|NCT03635099|80671913|FG006|Period 1|Protocol Violation|0|||
27681438|NCT03635099|80671914|FG007|Period 1|Protocol Violation|0|||
27681439|NCT03635099|80671907|FG000|Period 1|Lost to Follow-up|0|||
27681440|NCT03635099|80671908|FG001|Period 1|Lost to Follow-up|0|||
27681441|NCT03635099|80671909|FG002|Period 1|Lost to Follow-up|1|||
27681442|NCT03635099|80671910|FG003|Period 1|Lost to Follow-up|2|||
27681443|NCT03635099|80671911|FG004|Period 1|Lost to Follow-up|1|||
27681444|NCT03635099|80671912|FG005|Period 1|Lost to Follow-up|0|||
27681445|NCT03635099|80671913|FG006|Period 1|Lost to Follow-up|1|||
27681446|NCT03635099|80671914|FG007|Period 1|Lost to Follow-up|2|||
27681447|NCT03635099|80671907|FG000|Period 1|Withdrawal by Subject|3|||
27681448|NCT03635099|80671908|FG001|Period 1|Withdrawal by Subject|3|||
27681449|NCT03635099|80671909|FG002|Period 1|Withdrawal by Subject|5|||
27681450|NCT03635099|80671910|FG003|Period 1|Withdrawal by Subject|2|||
27874008|NCT04211831|81371637|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
28001394|NCT00395746|81834492|FG001|Overall Study|Adverse Event|2|||
28001395|NCT00395746|81834493|FG002|Overall Study|Adverse Event|2|||
27681451|NCT03635099|80671911|FG004|Period 1|Withdrawal by Subject|2|||
27681452|NCT03635099|80671912|FG005|Period 1|Withdrawal by Subject|0|||
28001396|NCT00395746|81834491|FG000|Overall Study|Protocol Violation|0|||
28001397|NCT00395746|81834492|FG001|Overall Study|Protocol Violation|1|||
28001398|NCT00395746|81834493|FG002|Overall Study|Protocol Violation|0|||
28001399|NCT00395746|81834491|FG000|Overall Study|Lack of Efficacy|2|||
27681453|NCT03635099|80671913|FG006|Period 1|Withdrawal by Subject|3|||
27681454|NCT03635099|80671914|FG007|Period 1|Withdrawal by Subject|0|||
27681455|NCT03635099|80671907|FG000|Period 1|History of suicidal ideation|0|||
27681456|NCT03635099|80671908|FG001|Period 1|History of suicidal ideation|0|||
27681457|NCT03635099|80671909|FG002|Period 1|History of suicidal ideation|1|||
27681458|NCT03635099|80671910|FG003|Period 1|History of suicidal ideation|0|||
27681459|NCT03635099|80671911|FG004|Period 1|History of suicidal ideation|0|||
27681460|NCT03635099|80671912|FG005|Period 1|History of suicidal ideation|0|||
27681461|NCT03635099|80671913|FG006|Period 1|History of suicidal ideation|0|||
27681462|NCT03635099|80671914|FG007|Period 1|History of suicidal ideation|0|||
27681463|NCT03635099|80671907|FG000|Period 1|pursue other treatment options|0|||
28001400|NCT00395746|81834492|FG001|Overall Study|Lack of Efficacy|0|||
27681464|NCT03635099|80671908|FG001|Period 1|pursue other treatment options|0|||
27681465|NCT03635099|80671909|FG002|Period 1|pursue other treatment options|0|||
28001401|NCT00395746|81834493|FG002|Overall Study|Lack of Efficacy|17|||
28001402|NCT00395746|81834491|FG000|Overall Study|Hypoglycaemia|2|||
28001403|NCT00395746|81834492|FG001|Overall Study|Hypoglycaemia|1|||
28001404|NCT00395746|81834493|FG002|Overall Study|Hypoglycaemia|0|||
28001405|NCT00395746|81834491|FG000|Overall Study|Subject decision|0|||
28001406|NCT00395746|81834492|FG001|Overall Study|Subject decision|0|||
28001407|NCT00395746|81834493|FG002|Overall Study|Subject decision|1|||
27681466|NCT03635099|80671910|FG003|Period 1|pursue other treatment options|0|||
27681467|NCT03635099|80671911|FG004|Period 1|pursue other treatment options|0|||
27681468|NCT03635099|80671912|FG005|Period 1|pursue other treatment options|1|||
27681469|NCT03635099|80671913|FG006|Period 1|pursue other treatment options|0|||
27681470|NCT03635099|80671914|FG007|Period 1|pursue other treatment options|0|||
27681471|NCT03635099|80671907|FG000|Not Eligible for Period 2|Pregnancy|0|||
27681472|NCT03635099|80671908|FG001|Not Eligible for Period 2|Pregnancy|0|||
27681473|NCT03635099|80671909|FG002|Not Eligible for Period 2|Pregnancy|0|||
27681474|NCT03635099|80671910|FG003|Not Eligible for Period 2|Pregnancy|1|||
27681475|NCT03635099|80671911|FG004|Not Eligible for Period 2|Pregnancy|0|||
27681476|NCT03635099|80671912|FG005|Not Eligible for Period 2|Pregnancy|0|||
27681477|NCT03635099|80671913|FG006|Not Eligible for Period 2|Pregnancy|0|||
27681478|NCT03635099|80671914|FG007|Not Eligible for Period 2|Pregnancy|0|||
27681479|NCT03635099|80671907|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
27681480|NCT03635099|80671908|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681481|NCT03635099|80671909|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681482|NCT03635099|80671910|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681483|NCT03635099|80671911|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681484|NCT03635099|80671912|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681485|NCT03635099|80671913|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681486|NCT03635099|80671914|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
27681487|NCT03635099|80671907|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
27681488|NCT03635099|80671908|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
27681489|NCT03635099|80671909|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
27681490|NCT03635099|80671910|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
27681491|NCT03635099|80671911|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
27681492|NCT03635099|80671912|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
27681493|NCT03635099|80671913|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
27681494|NCT03635099|80671914|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
27681495|NCT03635099|80671907|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
27681496|NCT03635099|80671908|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
27681497|NCT03635099|80671909|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
27681498|NCT03635099|80671910|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
27681499|NCT03635099|80671911|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
27681500|NCT03635099|80671912|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
27681501|NCT03635099|80671913|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
27681502|NCT03635099|80671914|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
27681503|NCT03635099|80671907|FG000|Period 2|Adverse Event|0|||
27681504|NCT03635099|80671908|FG001|Period 2|Adverse Event|0|||
27681505|NCT03635099|80671909|FG002|Period 2|Adverse Event|1|||
27681506|NCT03635099|80671910|FG003|Period 2|Adverse Event|0|||
27681507|NCT03635099|80671911|FG004|Period 2|Adverse Event|1|||
27681508|NCT03635099|80671912|FG005|Period 2|Adverse Event|0|||
27681509|NCT03635099|80671913|FG006|Period 2|Adverse Event|0|||
27681510|NCT03635099|80671914|FG007|Period 2|Adverse Event|0|||
27681511|NCT03635099|80671907|FG000|Period 2|Lost to Follow-up|0|||
27681512|NCT03635099|80671908|FG001|Period 2|Lost to Follow-up|0|||
27681513|NCT03635099|80671909|FG002|Period 2|Lost to Follow-up|1|||
27681514|NCT03635099|80671910|FG003|Period 2|Lost to Follow-up|0|||
27874009|NCT04211831|81371638|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
28001408|NCT00395746|81834491|FG000|Overall Study|Withdrawal of consent|0|||
28001409|NCT00395746|81834492|FG001|Overall Study|Withdrawal of consent|0|||
27681515|NCT03635099|80671911|FG004|Period 2|Lost to Follow-up|4|||
27681516|NCT03635099|80671912|FG005|Period 2|Lost to Follow-up|0|||
27681517|NCT03635099|80671913|FG006|Period 2|Lost to Follow-up|0|||
27681518|NCT03635099|80671914|FG007|Period 2|Lost to Follow-up|0|||
27681519|NCT03635099|80671907|FG000|Period 2|Withdrawal by Subject|0|||
27681520|NCT03635099|80671908|FG001|Period 2|Withdrawal by Subject|0|||
27681521|NCT03635099|80671909|FG002|Period 2|Withdrawal by Subject|7|||
27681522|NCT03635099|80671910|FG003|Period 2|Withdrawal by Subject|4|||
27681523|NCT03635099|80671911|FG004|Period 2|Withdrawal by Subject|7|||
27681524|NCT03635099|80671912|FG005|Period 2|Withdrawal by Subject|0|||
28001410|NCT00395746|81834493|FG002|Overall Study|Withdrawal of consent|1|||
27681525|NCT03635099|80671913|FG006|Period 2|Withdrawal by Subject|0|||
27681526|NCT03635099|80671914|FG007|Period 2|Withdrawal by Subject|0|||
27681527|NCT04546425|80671917|FG000|Overall Study|Protocol Violation|1|||
27681528|NCT04546425|80671918|FG001|Overall Study|Protocol Violation|1|||
27681529|NCT04546425|80671919|FG002|Overall Study|Protocol Violation|0|||
27681530|NCT04546425|80671920|FG003|Overall Study|Protocol Violation|0|||
27681531|NCT04546425|80671917|FG000|Overall Study|Adverse Event|3|||
27681532|NCT04546425|80671918|FG001|Overall Study|Adverse Event|0|||
27681533|NCT04546425|80671919|FG002|Overall Study|Adverse Event|0|||
27681534|NCT04546425|80671920|FG003|Overall Study|Adverse Event|0|||
27681535|NCT04546425|80671917|FG000|Overall Study|Lost to Follow-up|5|||
27681536|NCT04546425|80671918|FG001|Overall Study|Lost to Follow-up|4|||
27681537|NCT04546425|80671919|FG002|Overall Study|Lost to Follow-up|0|||
27681538|NCT04546425|80671920|FG003|Overall Study|Lost to Follow-up|0|||
27681539|NCT04546425|80671917|FG000|Overall Study|No Longer met eligibility criteria|3|||
27681540|NCT04546425|80671918|FG001|Overall Study|No Longer met eligibility criteria|3|||
27681541|NCT04546425|80671919|FG002|Overall Study|No Longer met eligibility criteria|1|||
27681542|NCT04546425|80671920|FG003|Overall Study|No Longer met eligibility criteria|1|||
27681543|NCT04546425|80671917|FG000|Overall Study|Withdrawal by parent/guardian|6|||
27681544|NCT04546425|80671918|FG001|Overall Study|Withdrawal by parent/guardian|5|||
27681545|NCT04546425|80671919|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27681546|NCT04546425|80671920|FG003|Overall Study|Withdrawal by parent/guardian|1|||
27681547|NCT04491877|80671922|FG000|Overall Study|Protocol Deviation|1|||
27681548|NCT04491877|80671923|FG001|Overall Study|Protocol Deviation|0|||
27681549|NCT04491877|80671924|FG002|Overall Study|Protocol Deviation|2|||
27681550|NCT04491877|80671925|FG003|Overall Study|Protocol Deviation|0|||
27681551|NCT04491877|80671926|FG004|Overall Study|Protocol Deviation|0|||
27681552|NCT04491877|80671927|FG005|Overall Study|Protocol Deviation|0|||
27681553|NCT04491877|80671928|FG006|Overall Study|Protocol Deviation|1|||
27681554|NCT04491877|80671929|FG007|Overall Study|Protocol Deviation|1|||
27681555|NCT04491877|80671930|FG008|Overall Study|Protocol Deviation|0|||
27681556|NCT04491877|80671922|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27681557|NCT04491877|80671923|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27681558|NCT04491877|80671924|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27681559|NCT04491877|80671925|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
27681560|NCT04491877|80671926|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27681561|NCT04491877|80671927|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
27681562|NCT04491877|80671928|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
27681563|NCT04491877|80671929|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
27681564|NCT04491877|80671930|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
27681565|NCT04491877|80671922|FG000|Overall Study|Lost to Follow-up|0|||
27583140|NCT01358526|80318947|FG000|Open-label Titration Period|Adverse Event|95|||
27583141|NCT01358526|80318948|FG001|Open-label Titration Period|Adverse Event|0|||
27583142|NCT01358526|80318949|FG002|Open-label Titration Period|Adverse Event|0|||
27583143|NCT01358526|80318947|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
27583144|NCT01358526|80318948|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
27583145|NCT01358526|80318949|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
27583146|NCT01358526|80318947|FG000|Open-label Titration Period|Lost to Follow-up|25|||
27583147|NCT01358526|80318948|FG001|Open-label Titration Period|Lost to Follow-up|0|||
27583148|NCT01358526|80318949|FG002|Open-label Titration Period|Lost to Follow-up|0|||
27583149|NCT01358526|80318947|FG000|Open-label Titration Period|Lack of Efficacy|107|||
27583150|NCT01358526|80318948|FG001|Open-label Titration Period|Lack of Efficacy|0|||
27583151|NCT01358526|80318949|FG002|Open-label Titration Period|Lack of Efficacy|0|||
27583152|NCT01358526|80318947|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
27583153|NCT01358526|80318948|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
27583154|NCT01358526|80318949|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
27583155|NCT01358526|80318947|FG000|Open-label Titration Period|Administrative|8|||
27583156|NCT01358526|80318948|FG001|Open-label Titration Period|Administrative|0|||
27583157|NCT01358526|80318949|FG002|Open-label Titration Period|Administrative|0|||
27583158|NCT01358526|80318947|FG000|Open-label Titration Period|Did not qualify|178|||
27583159|NCT01358526|80318948|FG001|Open-label Titration Period|Did not qualify|0|||
27583160|NCT01358526|80318949|FG002|Open-label Titration Period|Did not qualify|0|||
27583161|NCT01358526|80318947|FG000|Double-blind Phase|Adverse Event|0|||
27583162|NCT01358526|80318948|FG001|Double-blind Phase|Adverse Event|24|||
27583163|NCT01358526|80318949|FG002|Double-blind Phase|Adverse Event|23|||
27583164|NCT01358526|80318947|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27583165|NCT01358526|80318948|FG001|Double-blind Phase|Withdrawal by Subject|10|||
27583166|NCT01358526|80318949|FG002|Double-blind Phase|Withdrawal by Subject|8|||
27583167|NCT01358526|80318947|FG000|Double-blind Phase|Lost to Follow-up|0|||
27583168|NCT01358526|80318948|FG001|Double-blind Phase|Lost to Follow-up|4|||
27583169|NCT01358526|80318949|FG002|Double-blind Phase|Lost to Follow-up|1|||
27583170|NCT01358526|80318947|FG000|Double-blind Phase|Lack of Efficacy|0|||
27583171|NCT01358526|80318948|FG001|Double-blind Phase|Lack of Efficacy|31|||
27681566|NCT04491877|80671923|FG001|Overall Study|Lost to Follow-up|2|||
27681567|NCT04491877|80671924|FG002|Overall Study|Lost to Follow-up|0|||
27681568|NCT04491877|80671925|FG003|Overall Study|Lost to Follow-up|0|||
27681569|NCT04491877|80671926|FG004|Overall Study|Lost to Follow-up|0|||
27681570|NCT04491877|80671927|FG005|Overall Study|Lost to Follow-up|0|||
27681571|NCT04491877|80671928|FG006|Overall Study|Lost to Follow-up|2|||
27681572|NCT04491877|80671929|FG007|Overall Study|Lost to Follow-up|1|||
27681573|NCT04491877|80671930|FG008|Overall Study|Lost to Follow-up|1|||
27681574|NCT02233803|80671937|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
27681575|NCT02233803|80671938|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
27681576|NCT02233803|80671937|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
27681577|NCT02233803|80671938|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
27681578|NCT02233803|80671937|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
27681579|NCT02233803|80671938|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
27681580|NCT02233803|80671937|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
27681581|NCT02233803|80671938|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
27681582|NCT02233803|80671937|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
27681583|NCT02233803|80671938|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
27681584|NCT02233803|80671937|FG000|Washout Period (4-Wks)|Physician Decision|1|||
27806343|NCT00770315|81120535|FG002|Overall Study|Adverse Event|16|||
27806344|NCT00770315|81120536|FG003|Overall Study|Adverse Event|6|||
27806345|NCT00770315|81120533|FG000|Overall Study|Lost to Follow-up|9|||
27806346|NCT00770315|81120534|FG001|Overall Study|Lost to Follow-up|5|||
27806347|NCT00770315|81120535|FG002|Overall Study|Lost to Follow-up|10|||
27583172|NCT01358526|80318949|FG002|Double-blind Phase|Lack of Efficacy|73|||
27583173|NCT01358526|80318947|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
27583174|NCT01358526|80318948|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
27583175|NCT01358526|80318949|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
27583176|NCT01358526|80318947|FG000|Double-blind Phase|Administrative|0|||
27583177|NCT01358526|80318948|FG001|Double-blind Phase|Administrative|6|||
27583178|NCT01358526|80318949|FG002|Double-blind Phase|Administrative|10|||
27583179|NCT01954017|80318950|FG000|Overall Study|Adverse Event|0|||
27583180|NCT01954017|80318951|FG001|Overall Study|Adverse Event|0|||
27583181|NCT01954017|80318952|FG002|Overall Study|Adverse Event|1|||
27583182|NCT01954017|80318950|FG000|Overall Study|Death|2|||
27583183|NCT01954017|80318951|FG001|Overall Study|Death|1|||
27583184|NCT01954017|80318952|FG002|Overall Study|Death|1|||
27583185|NCT01954017|80318950|FG000|Overall Study|Withdrawal by Subject|0|||
27583186|NCT01954017|80318951|FG001|Overall Study|Withdrawal by Subject|1|||
27583187|NCT01954017|80318952|FG002|Overall Study|Withdrawal by Subject|0|||
27583188|NCT01954017|80318950|FG000|Overall Study|Protocol Violation|0|||
27583189|NCT01954017|80318951|FG001|Overall Study|Protocol Violation|3|||
27583190|NCT01954017|80318952|FG002|Overall Study|Protocol Violation|2|||
27583191|NCT01954017|80318950|FG000|Overall Study|Necrotizing enterocolitis|1|||
27583192|NCT01954017|80318951|FG001|Overall Study|Necrotizing enterocolitis|0|||
27583193|NCT01954017|80318952|FG002|Overall Study|Necrotizing enterocolitis|1|||
27583194|NCT01954017|80318950|FG000|Overall Study|Enteral intake stopped >7 days|0|||
27583195|NCT01954017|80318951|FG001|Overall Study|Enteral intake stopped >7 days|1|||
27583196|NCT01954017|80318952|FG002|Overall Study|Enteral intake stopped >7 days|1|||
27583197|NCT01954017|80318950|FG000|Overall Study|All other reasons|2|||
27583198|NCT01954017|80318951|FG001|Overall Study|All other reasons|2|||
27583199|NCT01954017|80318952|FG002|Overall Study|All other reasons|7|||
27583200|NCT00182689|80318953|FG000|Overall Study|Adverse Event|8|||
27583201|NCT00182689|80318954|FG001|Overall Study|Adverse Event|11|||
27583202|NCT00182689|80318953|FG000|Overall Study|Withdrawal by Subject|2|||
27583203|NCT00182689|80318954|FG001|Overall Study|Withdrawal by Subject|2|||
27583204|NCT00182689|80318953|FG000|Overall Study|Progression|27|||
27583205|NCT00182689|80318954|FG001|Overall Study|Progression|29|||
27583206|NCT00182689|80318953|FG000|Overall Study|Death|1|||
27583207|NCT00182689|80318954|FG001|Overall Study|Death|0|||
27583208|NCT00182689|80318953|FG000|Overall Study|not protocol specified|0|||
27583209|NCT00182689|80318954|FG001|Overall Study|not protocol specified|3|||
27583210|NCT00182689|80318953|FG000|Overall Study|Ineligible|1|||
27583211|NCT00182689|80318954|FG001|Overall Study|Ineligible|4|||
27583212|NCT00182689|80318953|FG000|Overall Study|Never received treatment|1|||
27583213|NCT00182689|80318954|FG001|Overall Study|Never received treatment|0|||
27583214|NCT00437489|80318956|FG000|Overall Study|Study terminated by sponsor|23|||
27583215|NCT00437489|80318957|FG001|Overall Study|Study terminated by sponsor|21|||
27583216|NCT00437489|80318956|FG000|Overall Study|Lost to Follow-up|0|||
27583217|NCT00437489|80318957|FG001|Overall Study|Lost to Follow-up|1|||
27583218|NCT00093145|80318958|FG000|Overall Study|Unacceptable Toxicity Only|2|||
27583219|NCT00093145|80318958|FG000|Overall Study|Physician Decision|5|||
27583220|NCT00093145|80318958|FG000|Overall Study|Withdrawal by Subject|9|||
27583221|NCT00093145|80318958|FG000|Overall Study|Other|1|||
27583222|NCT00795600|80318959|FG000|Overall Study|Adverse Event|1|||
27681585|NCT02233803|80671938|FG001|Washout Period (4-Wks)|Physician Decision|0|||
27681586|NCT02233803|80671937|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
27681587|NCT02233803|80671938|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
27681588|NCT02233803|80671937|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
27681589|NCT02233803|80671938|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
27681590|NCT02233803|80671937|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
27681591|NCT02233803|80671938|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
27681592|NCT01072630|80671947|FG000|Overall Study|Adverse Event|11|||
27681593|NCT01072630|80671948|FG001|Overall Study|Adverse Event|19|||
27681594|NCT01072630|80671949|FG002|Overall Study|Adverse Event|2|||
27681595|NCT01072630|80671947|FG000|Overall Study|Lack of Efficacy|10|||
27681596|NCT01072630|80671948|FG001|Overall Study|Lack of Efficacy|10|||
27681597|NCT01072630|80671949|FG002|Overall Study|Lack of Efficacy|1|||
27681598|NCT01072630|80671947|FG000|Overall Study|Withdrawal by Subject|8|||
27681599|NCT01072630|80671948|FG001|Overall Study|Withdrawal by Subject|7|||
27681600|NCT01072630|80671949|FG002|Overall Study|Withdrawal by Subject|2|||
27681601|NCT01072630|80671947|FG000|Overall Study|Protocol Violation|10|||
27681602|NCT01072630|80671948|FG001|Overall Study|Protocol Violation|8|||
27681603|NCT01072630|80671949|FG002|Overall Study|Protocol Violation|4|||
27681604|NCT01072630|80671947|FG000|Overall Study|Lost to Follow-up|11|||
27681605|NCT01072630|80671948|FG001|Overall Study|Lost to Follow-up|11|||
27681606|NCT01072630|80671949|FG002|Overall Study|Lost to Follow-up|1|||
27681607|NCT01072630|80671947|FG000|Overall Study|Noncompliance with study medication|1|||
27681608|NCT01072630|80671948|FG001|Overall Study|Noncompliance with study medication|1|||
27681609|NCT01072630|80671949|FG002|Overall Study|Noncompliance with study medication|1|||
27681610|NCT01072630|80671947|FG000|Overall Study|Noncompliance with study procedures|1|||
27681611|NCT01072630|80671948|FG001|Overall Study|Noncompliance with study procedures|2|||
27681612|NCT01072630|80671949|FG002|Overall Study|Noncompliance with study procedures|1|||
27681613|NCT01072630|80671947|FG000|Overall Study|Other|3|||
27681614|NCT01072630|80671948|FG001|Overall Study|Other|2|||
27681615|NCT01072630|80671949|FG002|Overall Study|Other|1|||
27681616|NCT02001064|80671950|FG000|Overall Study|Withdrawal by Subject|2|||
28001411|NCT00395746|81834491|FG000|Overall Study|Difficultulty in use of device|0|||
28001412|NCT00395746|81834492|FG001|Overall Study|Difficultulty in use of device|0|||
28001413|NCT00395746|81834493|FG002|Overall Study|Difficultulty in use of device|1|||
28001414|NCT00395746|81834491|FG000|Overall Study|Unable to visit site on schedule|1|||
28001415|NCT00395746|81834492|FG001|Overall Study|Unable to visit site on schedule|0|||
28001416|NCT00395746|81834493|FG002|Overall Study|Unable to visit site on schedule|0|||
28001417|NCT03683173|81834494|FG000|Completed Follow-up|Unavailable|235|||
28001418|NCT03683173|81834495|FG001|Completed Follow-up|Unavailable|217|||
28001419|NCT03683173|81834494|FG000|Completed Follow-up|Refused|69|||
28001420|NCT03683173|81834495|FG001|Completed Follow-up|Refused|59|||
28001421|NCT03683173|81834494|FG000|Completed Follow-up|Disconnected phone|65|||
28001422|NCT03683173|81834495|FG001|Completed Follow-up|Disconnected phone|95|||
28001423|NCT03683173|81834494|FG000|Completed Follow-up|Health issue/deceased|10|||
28001424|NCT03683173|81834495|FG001|Completed Follow-up|Health issue/deceased|4|||
28001425|NCT03683173|81834494|FG000|Completed Follow-up|Moved away|8|||
28001426|NCT03683173|81834495|FG001|Completed Follow-up|Moved away|1|||
28001427|NCT00962208|81834502|FG000|Overall Study|Could not achieve good vision|9|||
28001428|NCT00962208|81834503|FG001|Overall Study|Could not achieve good vision|0|||
28001429|NCT00962208|81834502|FG000|Overall Study|Contraindicated to continue study|5|||
28001430|NCT00962208|81834503|FG001|Overall Study|Contraindicated to continue study|1|||
28001431|NCT00962208|81834502|FG000|Overall Study|Lost to Follow-up|0|||
28001432|NCT00962208|81834503|FG001|Overall Study|Lost to Follow-up|9|||
28001433|NCT01135134|81834510|FG000|Overall Study|Adverse Event|1|||
28001434|NCT01135134|81834511|FG001|Overall Study|Adverse Event|1|||
28001435|NCT01135134|81834510|FG000|Overall Study|Did not meet protocol eligibility|1|||
28001436|NCT01135134|81834511|FG001|Overall Study|Did not meet protocol eligibility|0|||
27681617|NCT02001064|80671951|FG001|Overall Study|Withdrawal by Subject|1|||
27681618|NCT02179177|80671956|FG000|Overall Study|Lost to Follow-up|1|||
27681619|NCT02179177|80671957|FG001|Overall Study|Lost to Follow-up|1|||
27681620|NCT02179177|80671956|FG000|Overall Study|Withdrawal by Subject|1|||
27681621|NCT02179177|80671957|FG001|Overall Study|Withdrawal by Subject|1|||
27681622|NCT01865747|80671958|FG000|Overall Study (ITT)|Adverse Event|32|||
27681623|NCT01865747|80671959|FG001|Overall Study (ITT)|Adverse Event|31|||
27681624|NCT01865747|80671958|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
27681625|NCT01865747|80671959|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
27681626|NCT01865747|80671958|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
27681627|NCT01865747|80671959|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
27681628|NCT01865747|80671958|FG000|Overall Study (ITT)|Protocol Violation|1|||
27681629|NCT01865747|80671959|FG001|Overall Study (ITT)|Protocol Violation|1|||
28001437|NCT00880698|81834512|FG000|Overall Study|Death|0|||
28001438|NCT00880698|81834513|FG001|Overall Study|Death|0|||
27681630|NCT01865747|80671958|FG000|Overall Study (ITT)|Physician Decision|5|||
27681631|NCT01865747|80671959|FG001|Overall Study (ITT)|Physician Decision|2|||
27681632|NCT01865747|80671958|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
28001439|NCT00880698|81834514|FG002|Overall Study|Death|1|||
28001440|NCT00880698|81834515|FG003|Overall Study|Death|2|||
27681633|NCT01865747|80671959|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
27681634|NCT01865747|80671958|FG000|Overall Study (ITT)|Sponsor Decision|0|||
27681635|NCT01865747|80671959|FG001|Overall Study (ITT)|Sponsor Decision|1|||
27681636|NCT01865747|80671958|FG000|Overall Study (ITT)|Progressive Disease|122|||
27681637|NCT01865747|80671959|FG001|Overall Study (ITT)|Progressive Disease|158|||
27681638|NCT01865747|80671958|FG000|Overall Study (ITT)|Reason Not Provided|0|||
27681639|NCT01865747|80671959|FG001|Overall Study (ITT)|Reason Not Provided|1|||
27583223|NCT00795600|80318960|FG001|Overall Study|Adverse Event|1|||
27583224|NCT00795600|80318959|FG000|Overall Study|Protocol Violation|1|||
27583225|NCT00795600|80318960|FG001|Overall Study|Protocol Violation|2|||
27583226|NCT00795600|80318959|FG000|Overall Study|Withdrawal by Subject|1|||
27583227|NCT00795600|80318960|FG001|Overall Study|Withdrawal by Subject|0|||
27583228|NCT00795600|80318959|FG000|Overall Study|Unclassified|1|||
27583229|NCT00795600|80318960|FG001|Overall Study|Unclassified|1|||
27583230|NCT00965523|80318964|FG000|Study 221|Progressive Disease|4|||
27583231|NCT00965523|80318964|FG000|Study 221|Physician Decision|3|||
27583232|NCT00965523|80318964|FG000|Study 224|Progressive Disease|5|||
27583233|NCT00965523|80318964|FG000|Study 224|Physician Decision|1|||
27583234|NCT04193202|80318965|FG000|Overall Study|Adverse Event|2|||
27583235|NCT04193202|80318966|FG001|Overall Study|Adverse Event|1|||
27583236|NCT04193202|80318965|FG000|Overall Study|Death|0|||
27583237|NCT04193202|80318966|FG001|Overall Study|Death|1|||
27583238|NCT04193202|80318965|FG000|Overall Study|Physician Decision|1|||
27583239|NCT04193202|80318966|FG001|Overall Study|Physician Decision|1|||
27583240|NCT04193202|80318965|FG000|Overall Study|Protocol Violation|2|||
27583241|NCT04193202|80318966|FG001|Overall Study|Protocol Violation|2|||
27583242|NCT04193202|80318965|FG000|Overall Study|Withdrawal by Subject|11|||
27583243|NCT04193202|80318966|FG001|Overall Study|Withdrawal by Subject|5|||
27583244|NCT01055639|80318967|FG000|Overall Study|Adverse Event|0|||
27583245|NCT01055639|80318968|FG001|Overall Study|Adverse Event|1|||
27583246|NCT01055639|80318967|FG000|Overall Study|Lack of Efficacy|0|||
27583247|NCT01055639|80318968|FG001|Overall Study|Lack of Efficacy|1|||
27583248|NCT01055639|80318967|FG000|Overall Study|Lost to Follow-up|8|||
27583249|NCT01055639|80318968|FG001|Overall Study|Lost to Follow-up|11|||
27583250|NCT01055639|80318967|FG000|Overall Study|Protocol Violation|5|||
27583251|NCT01055639|80318968|FG001|Overall Study|Protocol Violation|5|||
27583252|NCT01055639|80318967|FG000|Overall Study|Withdrawal by Subject|8|||
27583253|NCT01055639|80318968|FG001|Overall Study|Withdrawal by Subject|11|||
27583254|NCT01143259|80318980|FG000|Overall Study|Withdrawal by Subject|3|||
27583255|NCT01143259|80318981|FG001|Overall Study|Withdrawal by Subject|2|||
27583256|NCT01143259|80318980|FG000|Overall Study|Protocol Violation|13|||
27583257|NCT01143259|80318981|FG001|Overall Study|Protocol Violation|9|||
27583258|NCT01143259|80318980|FG000|Overall Study|Screen Failure|7|||
27583259|NCT01143259|80318981|FG001|Overall Study|Screen Failure|9|||
27583260|NCT03864900|80318982|FG000|Overall Study|Withdrawal by Subject|1|||
27583261|NCT03864900|80318983|FG001|Overall Study|Withdrawal by Subject|1|||
27583262|NCT03864900|80318982|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
27583263|NCT03864900|80318983|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
27583264|NCT03893448|80318984|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
27583265|NCT03893448|80318985|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
27583266|NCT03893448|80318984|FG000|Overall Study|Physician Decision|8|||
27583267|NCT03893448|80318985|FG001|Overall Study|Physician Decision|14|||
27583268|NCT03893448|80318984|FG000|Overall Study|Lost to Follow-up|34|||
27583269|NCT03893448|80318985|FG001|Overall Study|Lost to Follow-up|27|||
27583270|NCT03893448|80318984|FG000|Overall Study|Death|1|||
27583271|NCT03893448|80318985|FG001|Overall Study|Death|0|||
27583272|NCT00558285|80318986|FG000|Overall Study|Adverse Event|1|||
27583273|NCT00558285|80318987|FG001|Overall Study|Adverse Event|1|||
27583274|NCT00558285|80318988|FG002|Overall Study|Adverse Event|4|||
27583275|NCT00558285|80318989|FG003|Overall Study|Adverse Event|1|||
27583276|NCT00558285|80318990|FG004|Overall Study|Adverse Event|2|||
27583277|NCT00558285|80318986|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27583278|NCT00558285|80318987|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27583279|NCT00558285|80318988|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27583280|NCT00558285|80318989|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27583281|NCT00558285|80318990|FG004|Overall Study|Abnormal test procedure result(s)|0|||
27583282|NCT00558285|80318986|FG000|Overall Study|Subject withdrew consent|2|||
27583283|NCT00558285|80318987|FG001|Overall Study|Subject withdrew consent|0|||
27583284|NCT00558285|80318988|FG002|Overall Study|Subject withdrew consent|1|||
27583285|NCT00558285|80318989|FG003|Overall Study|Subject withdrew consent|1|||
27583286|NCT00558285|80318990|FG004|Overall Study|Subject withdrew consent|1|||
27583287|NCT00558285|80318986|FG000|Overall Study|Lost to Follow-up|1|||
27681640|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
27681641|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
27681642|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
27583288|NCT00558285|80318987|FG001|Overall Study|Lost to Follow-up|1|||
27583289|NCT00558285|80318988|FG002|Overall Study|Lost to Follow-up|0|||
27681643|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
27681644|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
27681645|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
27681646|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
27681647|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
27681648|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
27681649|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
27681650|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
27681651|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
27681652|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
27681653|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
27681654|NCT01865747|80671958|FG000|Primary Intent to Treat (PITT)|Other|0|||
27681655|NCT01865747|80671959|FG001|Primary Intent to Treat (PITT)|Other|1|||
27681656|NCT01892540|80671967|FG000|Overall Study|Did not complete PET/MRI|0|||
27681657|NCT01892540|80671968|FG001|Overall Study|Did not complete PET/MRI|0|||
27681658|NCT01892540|80671969|FG002|Overall Study|Did not complete PET/MRI|2|||
27681659|NCT01892540|80671967|FG000|Overall Study|Did not fit in scanner|0|||
27681660|NCT01892540|80671968|FG001|Overall Study|Did not fit in scanner|0|||
27681661|NCT01892540|80671969|FG002|Overall Study|Did not fit in scanner|1|||
28001441|NCT00880698|81834512|FG000|Overall Study|Lost to Follow-up|1|||
28001442|NCT00880698|81834513|FG001|Overall Study|Lost to Follow-up|3|||
27681662|NCT00586612|80671975|FG000|Primary Phase|Protocol Violation|1|||
27681663|NCT00586612|80671976|FG001|Primary Phase|Protocol Violation|0|||
27681664|NCT00586612|80671975|FG000|Primary Phase|Lost to Follow-up|0|||
27681665|NCT00586612|80671976|FG001|Primary Phase|Lost to Follow-up|1|||
27681666|NCT00586612|80671975|FG000|Primary Phase|Withdrawal by Subject|0|||
27681667|NCT00586612|80671976|FG001|Primary Phase|Withdrawal by Subject|2|||
27681668|NCT00586612|80671975|FG000|Booster Phase|Lost to Follow-up|3|||
27681669|NCT00586612|80671976|FG001|Booster Phase|Lost to Follow-up|1|||
27681670|NCT00127205|80671977|FG000|Overall Study|Adverse Event|228|||
27681671|NCT00127205|80671978|FG001|Overall Study|Adverse Event|387|||
27681672|NCT00127205|80671979|FG002|Overall Study|Adverse Event|273|||
27681673|NCT00127205|80671977|FG000|Overall Study|Death|8|||
27681674|NCT00127205|80671978|FG001|Overall Study|Death|6|||
27681675|NCT00127205|80671979|FG002|Overall Study|Death|5|||
27681676|NCT00127205|80671977|FG000|Overall Study|Withdrawal by Subject|318|||
27681677|NCT00127205|80671978|FG001|Overall Study|Withdrawal by Subject|310|||
27681678|NCT00127205|80671979|FG002|Overall Study|Withdrawal by Subject|172|||
27681679|NCT00127205|80671977|FG000|Overall Study|Other-non protocol specified|142|||
27681680|NCT00127205|80671978|FG001|Overall Study|Other-non protocol specified|129|||
27681681|NCT00127205|80671979|FG002|Overall Study|Other-non protocol specified|77|||
27681682|NCT00127205|80671977|FG000|Overall Study|Data not reported|6|||
27681683|NCT00127205|80671978|FG001|Overall Study|Data not reported|10|||
27806348|NCT00770315|81120536|FG003|Overall Study|Lost to Follow-up|3|||
27806349|NCT00770315|81120533|FG000|Overall Study|Withdrawal by Subject|13|||
27806350|NCT00770315|81120534|FG001|Overall Study|Withdrawal by Subject|17|||
27806351|NCT00770315|81120535|FG002|Overall Study|Withdrawal by Subject|24|||
27806352|NCT00770315|81120536|FG003|Overall Study|Withdrawal by Subject|20|||
27806353|NCT00770315|81120533|FG000|Overall Study|Noncompliance with Protocol|7|||
27806354|NCT00770315|81120534|FG001|Overall Study|Noncompliance with Protocol|4|||
27806355|NCT00770315|81120535|FG002|Overall Study|Noncompliance with Protocol|7|||
27806356|NCT00770315|81120536|FG003|Overall Study|Noncompliance with Protocol|9|||
27806357|NCT01208402|81120539|FG000|Overall Study|Withdrawal by Subject|1|||
27806358|NCT01208402|81120540|FG001|Overall Study|Withdrawal by Subject|0|||
27806359|NCT01020305|81120542|FG000|Overall Study|Adverse Event|2|||
27806360|NCT02981602|81120543|FG000|Overall Study|Adverse Event|0|||
27806361|NCT02981602|81120544|FG001|Overall Study|Adverse Event|0|||
27806362|NCT02981602|81120545|FG002|Overall Study|Adverse Event|0|||
27806363|NCT02981602|81120546|FG003|Overall Study|Adverse Event|1|||
27806364|NCT02981602|81120547|FG004|Overall Study|Adverse Event|0|||
27806365|NCT04006847|81120548|FG000|Overall Study|Product issue|1|||
27806366|NCT03568500|81120549|FG000|Overall Study|Lost to Follow-up|1|||
27806367|NCT03568500|81120550|FG001|Overall Study|Lost to Follow-up|1|||
27806368|NCT03568500|81120551|FG002|Overall Study|Lost to Follow-up|2|||
27806369|NCT03568500|81120549|FG000|Overall Study|Adverse Event|1|||
27806370|NCT03568500|81120550|FG001|Overall Study|Adverse Event|1|||
27806371|NCT03568500|81120551|FG002|Overall Study|Adverse Event|2|||
27806372|NCT03568500|81120549|FG000|Overall Study|Physician Decision|1|||
27806373|NCT03568500|81120550|FG001|Overall Study|Physician Decision|0|||
27806374|NCT03568500|81120551|FG002|Overall Study|Physician Decision|0|||
27806375|NCT03568500|81120549|FG000|Overall Study|Withdrawal by Subject|4|||
27806376|NCT03568500|81120550|FG001|Overall Study|Withdrawal by Subject|2|||
27806377|NCT03568500|81120551|FG002|Overall Study|Withdrawal by Subject|0|||
28001443|NCT00880698|81834514|FG002|Overall Study|Lost to Follow-up|0|||
27681684|NCT00127205|80671979|FG002|Overall Study|Data not reported|1|||
27681685|NCT00127205|80671977|FG000|Overall Study|Progression|127|||
28001444|NCT00880698|81834515|FG003|Overall Study|Lost to Follow-up|1|||
27806378|NCT03568500|81120549|FG000|Overall Study|Technical Problems|2|||
27806379|NCT03568500|81120550|FG001|Overall Study|Technical Problems|1|||
27806380|NCT03568500|81120551|FG002|Overall Study|Technical Problems|0|||
28001445|NCT01962441|81834521|FG000|Randomized Period|Randomized but Never Treated|4|||
28001446|NCT01962441|81834522|FG001|Randomized Period|Randomized but Never Treated|2|||
28001447|NCT01962441|81834523|FG002|Randomized Period|Randomized but Never Treated|3|||
28001448|NCT01962441|81834521|FG000|Randomized Period|Lost to Follow-up|2|||
27583290|NCT00558285|80318989|FG003|Overall Study|Lost to Follow-up|0|||
27583291|NCT00558285|80318990|FG004|Overall Study|Lost to Follow-up|0|||
27583292|NCT00558285|80318986|FG000|Overall Study|Administrative problems|0|||
27583293|NCT00558285|80318987|FG001|Overall Study|Administrative problems|0|||
27583294|NCT00558285|80318988|FG002|Overall Study|Administrative problems|0|||
27583295|NCT00558285|80318989|FG003|Overall Study|Administrative problems|1|||
27583296|NCT00558285|80318990|FG004|Overall Study|Administrative problems|1|||
27583297|NCT00558285|80318986|FG000|Overall Study|Protocol deviation|1|||
27583298|NCT00558285|80318987|FG001|Overall Study|Protocol deviation|1|||
27583299|NCT00558285|80318988|FG002|Overall Study|Protocol deviation|0|||
27583300|NCT00558285|80318989|FG003|Overall Study|Protocol deviation|1|||
27583301|NCT00558285|80318990|FG004|Overall Study|Protocol deviation|0|||
27583302|NCT02799082|80318991|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
27583303|NCT02799082|80318992|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
27583304|NCT02799082|80318991|FG000|Overall Study|Protocol Violation|0|||
27583305|NCT02799082|80318992|FG001|Overall Study|Protocol Violation|1|||
27583306|NCT02480621|80318993|FG000|Randomization|Withdrawal by Subject|1|||
27583307|NCT02480621|80318994|FG001|Randomization|Withdrawal by Subject|0|||
27583308|NCT02480621|80318993|FG000|Randomization|Surgeon did not give intervention|0|||
27583309|NCT02480621|80318994|FG001|Randomization|Surgeon did not give intervention|1|||
27583310|NCT02480621|80318993|FG000|Follow Up|Lost to Follow-up|4|||
27583311|NCT02480621|80318994|FG001|Follow Up|Lost to Follow-up|2|||
27583312|NCT00982020|80318999|FG000|Overall Study|Adverse Event|19|||
27583313|NCT00982020|80319000|FG001|Overall Study|Adverse Event|15|||
27583314|NCT00982020|80318999|FG000|Overall Study|Withdrawal by Subject|11|||
27583315|NCT00982020|80319000|FG001|Overall Study|Withdrawal by Subject|14|||
27583316|NCT00982020|80318999|FG000|Overall Study|Lost to Follow-up|5|||
27583317|NCT00982020|80319000|FG001|Overall Study|Lost to Follow-up|11|||
27583318|NCT00982020|80318999|FG000|Overall Study|Lack of Efficacy|10|||
27583319|NCT00982020|80319000|FG001|Overall Study|Lack of Efficacy|4|||
27583320|NCT00982020|80318999|FG000|Overall Study|Parent/Caregiver Decision|5|||
27583321|NCT00982020|80319000|FG001|Overall Study|Parent/Caregiver Decision|5|||
27583322|NCT00982020|80318999|FG000|Overall Study|Treatment Non-compliance|3|||
27583323|NCT00982020|80319000|FG001|Overall Study|Treatment Non-compliance|6|||
27583324|NCT00982020|80318999|FG000|Overall Study|Physician Decision|2|||
27583325|NCT00982020|80319000|FG001|Overall Study|Physician Decision|5|||
27583326|NCT00982020|80318999|FG000|Overall Study|Entry Criteria Not Met|2|||
27583327|NCT00982020|80319000|FG001|Overall Study|Entry Criteria Not Met|1|||
27583328|NCT00982020|80318999|FG000|Overall Study|Protocol Violation|0|||
27583329|NCT00982020|80319000|FG001|Overall Study|Protocol Violation|2|||
27583330|NCT00982020|80318999|FG000|Overall Study|Clinical Relapse|0|||
27583331|NCT00982020|80319000|FG001|Overall Study|Clinical Relapse|1|||
27583332|NCT01607905|80319003|FG000|Overall Study|Withdrawal by participant|7|||
27583333|NCT01607905|80319004|FG001|Overall Study|Withdrawal by participant|2|||
27583334|NCT01607905|80319005|FG002|Overall Study|Withdrawal by participant|4|||
27583335|NCT01607905|80319006|FG003|Overall Study|Withdrawal by participant|6|||
27583336|NCT01607905|80319007|FG004|Overall Study|Withdrawal by participant|0|||
27583337|NCT01607905|80319008|FG005|Overall Study|Withdrawal by participant|4|||
27583338|NCT01607905|80319009|FG006|Overall Study|Withdrawal by participant|12|||
27583339|NCT01607905|80319003|FG000|Overall Study|Incidence or severity of AEs|5|||
27583340|NCT01607905|80319004|FG001|Overall Study|Incidence or severity of AEs|1|||
27583341|NCT01607905|80319005|FG002|Overall Study|Incidence or severity of AEs|1|||
27583342|NCT01607905|80319006|FG003|Overall Study|Incidence or severity of AEs|3|||
27583343|NCT01607905|80319007|FG004|Overall Study|Incidence or severity of AEs|0|||
27583344|NCT01607905|80319008|FG005|Overall Study|Incidence or severity of AEs|2|||
27583345|NCT01607905|80319009|FG006|Overall Study|Incidence or severity of AEs|8|||
27583346|NCT01607905|80319003|FG000|Overall Study|Disease progression|44|||
27583347|NCT01607905|80319004|FG001|Overall Study|Disease progression|16|||
27583348|NCT01607905|80319005|FG002|Overall Study|Disease progression|15|||
27583349|NCT01607905|80319006|FG003|Overall Study|Disease progression|11|||
27583350|NCT01607905|80319007|FG004|Overall Study|Disease progression|6|||
27583351|NCT01607905|80319008|FG005|Overall Study|Disease progression|7|||
27583352|NCT01607905|80319009|FG006|Overall Study|Disease progression|21|||
27583353|NCT01607905|80319003|FG000|Overall Study|Non-compliance with study procedures|0|||
27583354|NCT01607905|80319004|FG001|Overall Study|Non-compliance with study procedures|0|||
27583355|NCT01607905|80319005|FG002|Overall Study|Non-compliance with study procedures|0|||
27806381|NCT03568500|81120549|FG000|Overall Study|Participant Noncompliance|1|||
27806382|NCT03568500|81120550|FG001|Overall Study|Participant Noncompliance|1|||
27806383|NCT03568500|81120551|FG002|Overall Study|Participant Noncompliance|0|||
27806384|NCT01904383|81123164|FG000|Overall Study|CRF not collected|117|||
27806385|NCT01904383|81123164|FG000|Overall Study|Reason not listed|147|||
27806386|NCT01904383|81123164|FG000|Overall Study|Lost to Follow-up|674|||
27806387|NCT01904383|81123164|FG000|Overall Study|Lack of Efficacy|370|||
27806388|NCT01904383|81123164|FG000|Overall Study|Improvement|141|||
27806389|NCT01904383|81123164|FG000|Overall Study|Adverse Event|271|||
27806390|NCT01904383|81123164|FG000|Overall Study|No patient visit after entry|54|||
27806391|NCT03469271|81123169|FG000|Overall Study|Withdrawal by Subject|2|||
27874010|NCT04211831|81371639|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
28001449|NCT01962441|81834522|FG001|Randomized Period|Lost to Follow-up|4|||
28001450|NCT01962441|81834523|FG002|Randomized Period|Lost to Follow-up|4|||
28001451|NCT01962441|81834521|FG000|Randomized Period|Withdrew Consent|3|||
28001452|NCT01962441|81834522|FG001|Randomized Period|Withdrew Consent|3|||
27583356|NCT01607905|80319006|FG003|Overall Study|Non-compliance with study procedures|0|||
27583357|NCT01607905|80319007|FG004|Overall Study|Non-compliance with study procedures|0|||
28001453|NCT01962441|81834523|FG002|Randomized Period|Withdrew Consent|2|||
28001454|NCT01962441|81834521|FG000|Randomized Period|Adverse Event|1|||
28001455|NCT01962441|81834522|FG001|Randomized Period|Adverse Event|1|||
28001456|NCT01962441|81834523|FG002|Randomized Period|Adverse Event|0|||
28001457|NCT01962441|81834521|FG000|Randomized Period|Death|0|||
28001458|NCT01962441|81834522|FG001|Randomized Period|Death|0|||
28001459|NCT01962441|81834523|FG002|Randomized Period|Death|2|||
28001460|NCT01962441|81834521|FG000|Randomized Period|Protocol Violation|0|||
28001461|NCT01962441|81834522|FG001|Randomized Period|Protocol Violation|1|||
28001462|NCT01962441|81834523|FG002|Randomized Period|Protocol Violation|0|||
28001463|NCT01962441|81834521|FG000|Retreatment Substudy|Lack of Efficacy|1|||
28001464|NCT01962441|81834522|FG001|Retreatment Substudy|Lack of Efficacy|0|||
28001465|NCT01962441|81834523|FG002|Retreatment Substudy|Lack of Efficacy|0|||
28001466|NCT01962441|81834521|FG000|Retreatment Substudy|Lost to Follow-up|1|||
28001467|NCT01962441|81834522|FG001|Retreatment Substudy|Lost to Follow-up|0|||
28001468|NCT01962441|81834523|FG002|Retreatment Substudy|Lost to Follow-up|0|||
28001469|NCT01078441|81834526|FG000|Overall Study|Withdrawal by Subject|1|||
28001470|NCT01236521|81834527|FG000|Overall Study|Withdrawal by Subject|12|||
28001471|NCT01236521|81834528|FG001|Overall Study|Withdrawal by Subject|17|||
28001472|NCT01236521|81834527|FG000|Overall Study|Death|2|||
28001473|NCT01236521|81834528|FG001|Overall Study|Death|1|||
28001474|NCT01236521|81834527|FG000|Overall Study|Lost to Follow-up|9|||
28001475|NCT01236521|81834528|FG001|Overall Study|Lost to Follow-up|7|||
28001476|NCT02679755|81834529|FG000|Overall Study|Death|0|||
28001477|NCT02679755|81834530|FG001|Overall Study|Death|3|||
28001478|NCT02679755|81834529|FG000|Overall Study|Global deterioration of health status|1|||
28001479|NCT02679755|81834530|FG001|Overall Study|Global deterioration of health status|8|||
28001480|NCT02679755|81834529|FG000|Overall Study|Lost to Follow-up|1|||
28001481|NCT02679755|81834530|FG001|Overall Study|Lost to Follow-up|0|||
28001482|NCT02679755|81834529|FG000|Overall Study|Objective progression or relapse|24|||
28001483|NCT02679755|81834530|FG001|Overall Study|Objective progression or relapse|83|||
28001484|NCT02679755|81834529|FG000|Overall Study|Not defined|0|||
28001485|NCT02679755|81834530|FG001|Overall Study|Not defined|2|||
28001486|NCT02679755|81834529|FG000|Overall Study|Withdrawal by participant|6|||
28001487|NCT02679755|81834530|FG001|Overall Study|Withdrawal by participant|3|||
28001488|NCT02679755|81834529|FG000|Overall Study|Adverse Event|1|||
28001489|NCT02679755|81834530|FG001|Overall Study|Adverse Event|4|||
28001490|NCT02679755|81834529|FG000|Overall Study|Adverse events not related to study drug|1|||
28001491|NCT02679755|81834530|FG001|Overall Study|Adverse events not related to study drug|2|||
28001492|NCT02025179|81834531|FG000|Overall Study|Lost to Follow-up|0|||
28001493|NCT02025179|81834532|FG001|Overall Study|Lost to Follow-up|0|||
28001494|NCT02025179|81834533|FG002|Overall Study|Lost to Follow-up|1|||
28001495|NCT00556075|81834536|FG000|Overall Study|Lost to Follow-up|3|||
28001496|NCT00556075|81834537|FG001|Overall Study|Lost to Follow-up|0|||
28001497|NCT00556075|81834538|FG002|Overall Study|Lost to Follow-up|3|||
28001498|NCT00556075|81834536|FG000|Overall Study|Withdrawal by Subject|3|||
27583358|NCT01607905|80319008|FG005|Overall Study|Non-compliance with study procedures|0|||
27583359|NCT01607905|80319009|FG006|Overall Study|Non-compliance with study procedures|1|||
27583360|NCT01607905|80319003|FG000|Overall Study|Death|1|||
27583361|NCT01607905|80319004|FG001|Overall Study|Death|1|||
27583362|NCT01607905|80319005|FG002|Overall Study|Death|1|||
27583363|NCT01607905|80319006|FG003|Overall Study|Death|1|||
27583364|NCT01607905|80319007|FG004|Overall Study|Death|0|||
27583365|NCT01607905|80319008|FG005|Overall Study|Death|0|||
27583366|NCT01607905|80319009|FG006|Overall Study|Death|3|||
27583367|NCT01607905|80319003|FG000|Overall Study|Other treatments become available|1|||
27583368|NCT01607905|80319004|FG001|Overall Study|Other treatments become available|0|||
27583369|NCT01607905|80319005|FG002|Overall Study|Other treatments become available|0|||
28001499|NCT00556075|81834537|FG001|Overall Study|Withdrawal by Subject|3|||
28001500|NCT00556075|81834538|FG002|Overall Study|Withdrawal by Subject|0|||
28001501|NCT00556075|81834536|FG000|Overall Study|Protocol Violation|1|||
27681686|NCT00127205|80671978|FG001|Overall Study|Progression|131|||
27681687|NCT00127205|80671979|FG002|Overall Study|Progression|84|||
27681688|NCT04043143|80671983|FG000|Overall Study|Lost to Follow-up|5|||
27681689|NCT04043143|80671984|FG001|Overall Study|Lost to Follow-up|5|||
27681690|NCT04043143|80671983|FG000|Overall Study|screen failure|1|||
27681691|NCT04043143|80671984|FG001|Overall Study|screen failure|0|||
27681692|NCT01370590|80671985|FG000|Period 1|Adverse Event|8|||
27681693|NCT01370590|80671986|FG001|Period 1|Adverse Event|4|||
27681694|NCT01370590|80671985|FG000|Period 1|Lost to Follow-up|2|||
27681695|NCT01370590|80671986|FG001|Period 1|Lost to Follow-up|2|||
27681696|NCT01370590|80671985|FG000|Period 1|Protocol Violation|2|||
27681697|NCT01370590|80671986|FG001|Period 1|Protocol Violation|2|||
27681698|NCT01370590|80671985|FG000|Period 1|Withdrawal by Subject|4|||
27681699|NCT01370590|80671986|FG001|Period 1|Withdrawal by Subject|2|||
27681700|NCT01370590|80671985|FG000|Period 1|Could not access randomization system|0|||
27681701|NCT01370590|80671986|FG001|Period 1|Could not access randomization system|1|||
27681702|NCT01370590|80671985|FG000|Crossover Washout Period|Adverse Event|1|||
27681703|NCT01370590|80671986|FG001|Crossover Washout Period|Adverse Event|4|||
27681704|NCT01370590|80671985|FG000|Crossover Washout Period|Lost to Follow-up|2|||
27681705|NCT01370590|80671986|FG001|Crossover Washout Period|Lost to Follow-up|0|||
27681706|NCT01370590|80671985|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
27681707|NCT01370590|80671986|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
27681708|NCT01370590|80671985|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
27681709|NCT01370590|80671986|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
27681710|NCT01370590|80671985|FG000|Period 2|Adverse Event|0|||
27681711|NCT01370590|80671986|FG001|Period 2|Adverse Event|1|||
27681712|NCT01370590|80671985|FG000|Period 2|Withdrawal by Subject|1|||
27681713|NCT01370590|80671986|FG001|Period 2|Withdrawal by Subject|1|||
27681714|NCT00798590|80671990|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
27681715|NCT00798590|80671991|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
27681716|NCT04860297|80671992|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
27681717|NCT04860297|80671993|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
27681718|NCT04860297|80671994|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
28001502|NCT00556075|81834537|FG001|Overall Study|Protocol Violation|1|||
28001503|NCT00556075|81834538|FG002|Overall Study|Protocol Violation|3|||
28001504|NCT00556075|81834536|FG000|Overall Study|Not eligible|1|||
28001505|NCT00556075|81834537|FG001|Overall Study|Not eligible|1|||
28001506|NCT00556075|81834538|FG002|Overall Study|Not eligible|2|||
28001507|NCT00556075|81834536|FG000|Overall Study|Adverse Event|1|||
28001508|NCT00556075|81834537|FG001|Overall Study|Adverse Event|2|||
28001509|NCT00556075|81834538|FG002|Overall Study|Adverse Event|0|||
28001510|NCT00556075|81834536|FG000|Overall Study|Personal issues|4|||
27681719|NCT04860297|80671995|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
27681720|NCT04860297|80671996|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
28001511|NCT00556075|81834537|FG001|Overall Study|Personal issues|1|||
28001512|NCT00556075|81834538|FG002|Overall Study|Personal issues|0|||
28001513|NCT00556075|81834536|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
27681721|NCT04860297|80671997|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
27681722|NCT04860297|80671998|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
27681723|NCT04860297|80671999|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
27681724|NCT04860297|80671992|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
27681725|NCT04860297|80671993|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
27681726|NCT04860297|80671994|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
27681727|NCT04860297|80671995|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
27681728|NCT04860297|80671996|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
27681729|NCT04860297|80671997|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
27681730|NCT04860297|80671998|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
27681731|NCT04860297|80671999|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
27681732|NCT04860297|80671992|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
27681733|NCT04860297|80671993|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
28001514|NCT00556075|81834537|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
28001515|NCT00556075|81834538|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
27681734|NCT04860297|80671994|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
27681735|NCT04860297|80671995|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
27681736|NCT04860297|80671996|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
27681737|NCT04860297|80671997|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
27681738|NCT04860297|80671998|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
27681739|NCT04860297|80671999|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
27681740|NCT04860297|80671992|FG000|Part B (Booster Dose)|Other Than Specified|0|||
27681741|NCT04860297|80671993|FG001|Part B (Booster Dose)|Other Than Specified|0|||
27681742|NCT04860297|80671994|FG002|Part B (Booster Dose)|Other Than Specified|0|||
27681743|NCT04860297|80671995|FG003|Part B (Booster Dose)|Other Than Specified|0|||
27681744|NCT04860297|80671996|FG004|Part B (Booster Dose)|Other Than Specified|0|||
27681745|NCT04860297|80671997|FG005|Part B (Booster Dose)|Other Than Specified|1|||
27681746|NCT04860297|80671998|FG006|Part B (Booster Dose)|Other Than Specified|1|||
27681747|NCT04860297|80671999|FG007|Part B (Booster Dose)|Other Than Specified|0|||
27681748|NCT04860297|80671992|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
27681749|NCT04860297|80671993|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
27681750|NCT04860297|80671994|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
27681751|NCT04860297|80671995|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
27681752|NCT04860297|80671996|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
27681753|NCT04860297|80671997|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
27681754|NCT04860297|80671998|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
27681755|NCT04860297|80671999|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
27681756|NCT04860297|80671992|FG000|Part B (Booster Dose)|Death|0|||
28001516|NCT00556998|81834539|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
28001517|NCT00556998|81834539|FG000|Voriconazole Intravenous (IV)|Other|4|||
28001518|NCT00556998|81834539|FG000|Voriconazole Oral|Adverse Event|1|||
28001519|NCT00556998|81834539|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
28001520|NCT03550378|81834540|FG000|Overall Study|Death|0|||
28001521|NCT03550378|81834541|FG001|Overall Study|Death|1|||
28001522|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
28001523|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
28001524|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Death|1|||
28001525|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Death|2|||
28001526|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
28001527|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
28001528|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
28001529|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
28001530|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
28001531|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
27681757|NCT04860297|80671993|FG001|Part B (Booster Dose)|Death|0|||
27681758|NCT04860297|80671994|FG002|Part B (Booster Dose)|Death|0|||
27681759|NCT04860297|80671995|FG003|Part B (Booster Dose)|Death|0|||
27681760|NCT04860297|80671996|FG004|Part B (Booster Dose)|Death|1|||
27806392|NCT03469271|81123170|FG001|Overall Study|Withdrawal by Subject|0|||
27806393|NCT03469271|81123171|FG002|Overall Study|Withdrawal by Subject|0|||
27806394|NCT03469271|81123172|FG003|Overall Study|Withdrawal by Subject|1|||
27806395|NCT00566098|81123175|FG000|Collection of MILs|Withdrawal by Subject|1|||
27806396|NCT00566098|81123175|FG000|Collection of MILs|Relapsed|1|||
27806397|NCT00566098|81123175|FG000|Generation of MILs Product|Relapsed|1|||
27806398|NCT00566098|81123175|FG000|Administration of ASCT+MILs|Death|10|||
27806399|NCT00566098|81123175|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
27806400|NCT01121900|81123176|FG000|First Intervention Period|Adverse Event|1|||
27806401|NCT01121900|81123177|FG001|First Intervention Period|Adverse Event|1|||
27806402|NCT01121900|81123176|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27806403|NCT01121900|81123177|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27806404|NCT02370784|81123178|FG000|Overall Study|Patient started prohibited medication|0|||
27806405|NCT02370784|81123179|FG001|Overall Study|Patient started prohibited medication|1|||
28001532|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
28001533|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
27681761|NCT04860297|80671997|FG005|Part B (Booster Dose)|Death|2|||
27681762|NCT04860297|80671998|FG006|Part B (Booster Dose)|Death|1|||
27681763|NCT04860297|80671999|FG007|Part B (Booster Dose)|Death|0|||
27681764|NCT04860297|80671992|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
27681765|NCT04860297|80671993|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
27806406|NCT02624518|81123180|FG000|Overall Study|Physician Decision|1|||
27806407|NCT00905489|81123183|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
27806408|NCT00905489|81123183|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
27806409|NCT00905489|81123183|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
27681766|NCT04860297|80671994|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
27681767|NCT04860297|80671995|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
27681768|NCT04860297|80671996|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
27681769|NCT04860297|80671997|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
27681770|NCT04860297|80671998|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
27681771|NCT04860297|80671999|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
27681772|NCT03816761|80672002|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
27681773|NCT03816761|80672003|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
27681774|NCT03816761|80672004|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
27681775|NCT03816761|80672005|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
27806410|NCT04345471|81123184|FG000|Overall Study|Adverse Event|8|||
27806411|NCT04345471|81123185|FG001|Overall Study|Adverse Event|5|||
27806412|NCT04345471|81123186|FG002|Overall Study|Adverse Event|6|||
27806413|NCT04345471|81123184|FG000|Overall Study|Lack of Efficacy|1|||
27806414|NCT04345471|81123185|FG001|Overall Study|Lack of Efficacy|1|||
27806415|NCT04345471|81123186|FG002|Overall Study|Lack of Efficacy|0|||
27874011|NCT04211831|81371637|FG000|Overall Study|Other|0|||
27874012|NCT04211831|81371638|FG001|Overall Study|Other|1|||
27806416|NCT04345471|81123184|FG000|Overall Study|Protocol Violation|0|||
27806417|NCT04345471|81123185|FG001|Overall Study|Protocol Violation|1|||
27806418|NCT04345471|81123186|FG002|Overall Study|Protocol Violation|2|||
27806419|NCT04345471|81123184|FG000|Overall Study|Withdrawal by Subject|10|||
27806420|NCT04345471|81123185|FG001|Overall Study|Withdrawal by Subject|5|||
27806421|NCT04345471|81123186|FG002|Overall Study|Withdrawal by Subject|10|||
27806422|NCT01677910|81123187|FG000|Double-Blind Treatment Period|Adverse Event|6|||
27806423|NCT01677910|81123188|FG001|Double-Blind Treatment Period|Adverse Event|2|||
27806424|NCT01677910|81123189|FG002|Double-Blind Treatment Period|Adverse Event|3|||
27806425|NCT01677910|81123190|FG003|Double-Blind Treatment Period|Adverse Event|0|||
27806426|NCT01677910|81123187|FG000|Double-Blind Treatment Period|Physician Decision|0|||
27806427|NCT01677910|81123188|FG001|Double-Blind Treatment Period|Physician Decision|0|||
27806428|NCT01677910|81123189|FG002|Double-Blind Treatment Period|Physician Decision|1|||
27806429|NCT01677910|81123190|FG003|Double-Blind Treatment Period|Physician Decision|0|||
27806430|NCT01677910|81123187|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
27806431|NCT01677910|81123188|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
27806432|NCT01677910|81123189|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
27806433|NCT01677910|81123190|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
27806434|NCT01677910|81123187|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
27806435|NCT01677910|81123188|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
27806436|NCT01677910|81123189|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
27874013|NCT04211831|81371639|FG002|Overall Study|Other|0|||
28001534|NCT01794000|81834542|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
28001535|NCT01794000|81834543|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
28001536|NCT01794000|81834542|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
28001537|NCT01794000|81834543|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
28001538|NCT01177007|81834545|FG000|Overall Study|Lost to Follow-up|2|||
28001539|NCT01177007|81834545|FG000|Overall Study|Death|4|||
28001540|NCT01177007|81834545|FG000|Overall Study|Entered hospice care|5|||
28001541|NCT01177007|81834545|FG000|Overall Study|Required additional Y90 treatment|6|||
28001542|NCT01177007|81834545|FG000|Overall Study|Change in treatment modality|21|||
28001543|NCT02631551|81834546|FG000|Overall Study|Adverse Event|1|||
28001544|NCT02631551|81834547|FG001|Overall Study|Adverse Event|2|||
28001545|NCT02631551|81834548|FG002|Overall Study|Adverse Event|4|||
28001546|NCT02631551|81834549|FG003|Overall Study|Adverse Event|0|||
28001547|NCT02631551|81834546|FG000|Overall Study|Lack of Efficacy|0|||
28001548|NCT02631551|81834547|FG001|Overall Study|Lack of Efficacy|0|||
28001549|NCT02631551|81834548|FG002|Overall Study|Lack of Efficacy|1|||
28001550|NCT02631551|81834549|FG003|Overall Study|Lack of Efficacy|0|||
28001551|NCT02631551|81834546|FG000|Overall Study|Lost to Follow-up|1|||
28001552|NCT02631551|81834547|FG001|Overall Study|Lost to Follow-up|2|||
27681776|NCT03816761|80672006|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
27806437|NCT01677910|81123190|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
27806438|NCT01677910|81123187|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
27806439|NCT01677910|81123188|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
27806440|NCT01677910|81123189|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
27874014|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
27874015|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
28001553|NCT02631551|81834548|FG002|Overall Study|Lost to Follow-up|0|||
27806441|NCT01677910|81123190|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
27806442|NCT01677910|81123187|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27806443|NCT01677910|81123188|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27806444|NCT01677910|81123189|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27806445|NCT01677910|81123190|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
27806446|NCT01677910|81123187|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27806447|NCT01677910|81123188|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27806448|NCT01677910|81123189|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27806449|NCT01677910|81123190|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
27806450|NCT01677910|81123187|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
28001554|NCT02631551|81834549|FG003|Overall Study|Lost to Follow-up|3|||
28001555|NCT02631551|81834546|FG000|Overall Study|Withdrawal by Subject|2|||
28001556|NCT02631551|81834547|FG001|Overall Study|Withdrawal by Subject|2|||
28001557|NCT02631551|81834548|FG002|Overall Study|Withdrawal by Subject|0|||
28001558|NCT02631551|81834549|FG003|Overall Study|Withdrawal by Subject|5|||
28001559|NCT02631551|81834546|FG000|Overall Study|Protocol deviation|3|||
28001560|NCT02631551|81834547|FG001|Overall Study|Protocol deviation|6|||
28001561|NCT02631551|81834548|FG002|Overall Study|Protocol deviation|3|||
28001562|NCT02631551|81834549|FG003|Overall Study|Protocol deviation|0|||
28001563|NCT02631551|81834546|FG000|Overall Study|Non-compliance with study procedures|0|||
27681777|NCT03816761|80672007|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
27681778|NCT03816761|80672002|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
27681779|NCT03816761|80672003|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
27681780|NCT03816761|80672004|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
27681781|NCT03816761|80672005|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
28001564|NCT02631551|81834547|FG001|Overall Study|Non-compliance with study procedures|0|||
28001565|NCT02631551|81834548|FG002|Overall Study|Non-compliance with study procedures|1|||
28001566|NCT02631551|81834549|FG003|Overall Study|Non-compliance with study procedures|1|||
28001567|NCT02631551|81834546|FG000|Overall Study|Non-compliance with study drug|1|||
28001568|NCT02631551|81834547|FG001|Overall Study|Non-compliance with study drug|0|||
28001569|NCT02631551|81834548|FG002|Overall Study|Non-compliance with study drug|0|||
28001570|NCT02631551|81834549|FG003|Overall Study|Non-compliance with study drug|0|||
28001571|NCT02631551|81834546|FG000|Overall Study|Other, specific reasons not collected|5|||
28001572|NCT02631551|81834547|FG001|Overall Study|Other, specific reasons not collected|7|||
28001573|NCT02631551|81834548|FG002|Overall Study|Other, specific reasons not collected|2|||
28001574|NCT02631551|81834549|FG003|Overall Study|Other, specific reasons not collected|2|||
27583370|NCT01607905|80319006|FG003|Overall Study|Other treatments become available|0|||
27583371|NCT01607905|80319007|FG004|Overall Study|Other treatments become available|0|||
27583372|NCT01607905|80319008|FG005|Overall Study|Other treatments become available|0|||
27583373|NCT01607905|80319009|FG006|Overall Study|Other treatments become available|1|||
27583374|NCT01607905|80319003|FG000|Overall Study|Investigator discretion|0|||
27806451|NCT01677910|81123188|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27806452|NCT01677910|81123189|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27806453|NCT01677910|81123190|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
28001575|NCT02562716|81834554|FG000|Overall Study|Adverse Event|7|||
28001576|NCT02562716|81834555|FG001|Overall Study|Adverse Event|14|||
28001577|NCT02562716|81834554|FG000|Overall Study|Withdrawal unrelated to AE|7|||
27583375|NCT01607905|80319004|FG001|Overall Study|Investigator discretion|0|||
27583376|NCT01607905|80319005|FG002|Overall Study|Investigator discretion|0|||
27583377|NCT01607905|80319006|FG003|Overall Study|Investigator discretion|0|||
27583378|NCT01607905|80319007|FG004|Overall Study|Investigator discretion|0|||
27583379|NCT01607905|80319008|FG005|Overall Study|Investigator discretion|1|||
27681782|NCT03816761|80672006|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
27681783|NCT03816761|80672007|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
27681784|NCT00515671|80672008|FG000|Overall Study|Lost to Follow-up|13|||
27681785|NCT00515671|80672009|FG001|Overall Study|Lost to Follow-up|10|||
27583380|NCT01607905|80319009|FG006|Overall Study|Investigator discretion|0|||
27583381|NCT01607905|80319003|FG000|Overall Study|Other|1|||
27583382|NCT01607905|80319004|FG001|Overall Study|Other|0|||
27583383|NCT01607905|80319005|FG002|Overall Study|Other|0|||
27583384|NCT01607905|80319006|FG003|Overall Study|Other|0|||
27583385|NCT01607905|80319007|FG004|Overall Study|Other|0|||
27681786|NCT00515671|80672008|FG000|Overall Study|Withdrawal by Subject|3|||
27681787|NCT00515671|80672009|FG001|Overall Study|Withdrawal by Subject|5|||
27681788|NCT00515671|80672008|FG000|Overall Study|incarcerated|1|||
27681789|NCT00515671|80672009|FG001|Overall Study|incarcerated|2|||
27681790|NCT00320528|80672010|FG000|Study Period II|Adverse Event|3|||
27681791|NCT00320528|80672011|FG001|Study Period II|Adverse Event|4|||
28001578|NCT02562716|81834555|FG001|Overall Study|Withdrawal unrelated to AE|1|||
28001579|NCT02562716|81834554|FG000|Overall Study|Progression|8|||
27583386|NCT01607905|80319008|FG005|Overall Study|Other|0|||
27583387|NCT01607905|80319009|FG006|Overall Study|Other|1|||
27583388|NCT01607905|80319003|FG000|Overall Study|Randomized but not treated|1|||
27583389|NCT01607905|80319004|FG001|Overall Study|Randomized but not treated|0|||
27583390|NCT01607905|80319005|FG002|Overall Study|Randomized but not treated|0|||
27583391|NCT01607905|80319006|FG003|Overall Study|Randomized but not treated|0|||
27583392|NCT01607905|80319007|FG004|Overall Study|Randomized but not treated|1|||
27583393|NCT01607905|80319008|FG005|Overall Study|Randomized but not treated|1|||
27583394|NCT01607905|80319009|FG006|Overall Study|Randomized but not treated|0|||
27583395|NCT02120924|80319012|FG000|Overall Study|Lack of Efficacy|1|||
27583396|NCT02120924|80319013|FG001|Overall Study|Lack of Efficacy|2|||
27583397|NCT02120924|80319014|FG002|Overall Study|Lack of Efficacy|3|||
27583398|NCT02120924|80319012|FG000|Overall Study|Adverse Event|0|||
27583399|NCT02120924|80319013|FG001|Overall Study|Adverse Event|1|||
27583400|NCT02120924|80319014|FG002|Overall Study|Adverse Event|3|||
27583401|NCT02120924|80319012|FG000|Overall Study|Withdrawal by Subject|16|||
27583402|NCT02120924|80319013|FG001|Overall Study|Withdrawal by Subject|20|||
27583403|NCT02120924|80319014|FG002|Overall Study|Withdrawal by Subject|8|||
27583404|NCT02120924|80319012|FG000|Overall Study|Lost to Follow-up|14|||
27583405|NCT02120924|80319013|FG001|Overall Study|Lost to Follow-up|14|||
27583406|NCT02120924|80319014|FG002|Overall Study|Lost to Follow-up|11|||
27583407|NCT02120924|80319012|FG000|Overall Study|Pregnancy|2|||
27583408|NCT02120924|80319013|FG001|Overall Study|Pregnancy|0|||
27583409|NCT02120924|80319014|FG002|Overall Study|Pregnancy|0|||
27583410|NCT02120924|80319012|FG000|Overall Study|Protocol Violation|3|||
27583411|NCT02120924|80319013|FG001|Overall Study|Protocol Violation|7|||
27583412|NCT02120924|80319014|FG002|Overall Study|Protocol Violation|2|||
27583413|NCT02120924|80319012|FG000|Overall Study|Physician Decision|0|||
27583414|NCT02120924|80319013|FG001|Overall Study|Physician Decision|1|||
27583415|NCT02120924|80319014|FG002|Overall Study|Physician Decision|1|||
27583416|NCT02120924|80319012|FG000|Overall Study|Death|1|||
27583417|NCT02120924|80319013|FG001|Overall Study|Death|0|||
27583418|NCT02120924|80319014|FG002|Overall Study|Death|0|||
27583419|NCT02120924|80319012|FG000|Overall Study|Compliance with IP|5|||
27583420|NCT02120924|80319013|FG001|Overall Study|Compliance with IP|1|||
27583421|NCT02120924|80319014|FG002|Overall Study|Compliance with IP|1|||
27583422|NCT01921348|80319015|FG000|Overall Study|Withdrawal by Subject|1|||
27583423|NCT01921348|80319016|FG001|Overall Study|Withdrawal by Subject|0|||
27583424|NCT01921348|80319015|FG000|Overall Study|Lost to Follow-up|0|||
27583425|NCT01921348|80319016|FG001|Overall Study|Lost to Follow-up|2|||
27583426|NCT01218646|80319017|FG000|Overall Study|Adverse Event|0|||
27583427|NCT01218646|80319018|FG001|Overall Study|Adverse Event|0|||
27583428|NCT01218646|80319019|FG002|Overall Study|Adverse Event|1|||
27583429|NCT01218646|80319020|FG003|Overall Study|Adverse Event|0|||
27583430|NCT01218646|80319017|FG000|Overall Study|Lost to Follow-up|1|||
27583431|NCT01218646|80319018|FG001|Overall Study|Lost to Follow-up|0|||
27583432|NCT01218646|80319019|FG002|Overall Study|Lost to Follow-up|0|||
27583433|NCT01218646|80319020|FG003|Overall Study|Lost to Follow-up|0|||
27583434|NCT01218646|80319017|FG000|Overall Study|Protocol Violation|0|||
27583435|NCT01218646|80319018|FG001|Overall Study|Protocol Violation|0|||
27583436|NCT01218646|80319019|FG002|Overall Study|Protocol Violation|1|||
27583437|NCT01218646|80319020|FG003|Overall Study|Protocol Violation|1|||
27583438|NCT03891524|80319028|FG000|Overall Study|Death|0|||
27583439|NCT03891524|80319029|FG001|Overall Study|Death|0|||
27583440|NCT03891524|80319030|FG002|Overall Study|Death|0|||
27583441|NCT03891524|80319031|FG003|Overall Study|Death|0|||
27583442|NCT03891524|80319032|FG004|Overall Study|Death|0|||
27583443|NCT03891524|80319033|FG005|Overall Study|Death|0|||
27583444|NCT03891524|80319034|FG006|Overall Study|Death|0|||
27583445|NCT03891524|80319035|FG007|Overall Study|Death|1|||
27583446|NCT03891524|80319028|FG000|Overall Study|Withdrawal by Subject|0|||
27583447|NCT03891524|80319029|FG001|Overall Study|Withdrawal by Subject|1|||
27583448|NCT03891524|80319030|FG002|Overall Study|Withdrawal by Subject|2|||
27583449|NCT03891524|80319031|FG003|Overall Study|Withdrawal by Subject|1|||
27583450|NCT03891524|80319032|FG004|Overall Study|Withdrawal by Subject|2|||
27583451|NCT03891524|80319033|FG005|Overall Study|Withdrawal by Subject|2|||
27583452|NCT03891524|80319034|FG006|Overall Study|Withdrawal by Subject|2|||
27583453|NCT03891524|80319035|FG007|Overall Study|Withdrawal by Subject|1|||
27583454|NCT01722331|80319036|FG000|Part 1|Adverse Event|5|||
27583455|NCT01722331|80319037|FG001|Part 1|Adverse Event|0|||
27583456|NCT01722331|80319038|FG002|Part 1|Adverse Event|0|||
28001580|NCT02562716|81834555|FG001|Overall Study|Progression|10|||
27583457|NCT01722331|80319039|FG003|Part 1|Adverse Event|0|||
27583458|NCT01722331|80319040|FG004|Part 1|Adverse Event|0|||
27583459|NCT01722331|80319041|FG005|Part 1|Adverse Event|0|||
27583460|NCT01722331|80319042|FG006|Part 1|Adverse Event|0|||
27583461|NCT01722331|80319036|FG000|Part 1|Lack of Efficacy|0|||
27583462|NCT01722331|80319037|FG001|Part 1|Lack of Efficacy|0|||
27583463|NCT01722331|80319038|FG002|Part 1|Lack of Efficacy|1|||
27583464|NCT01722331|80319039|FG003|Part 1|Lack of Efficacy|0|||
27583465|NCT01722331|80319040|FG004|Part 1|Lack of Efficacy|2|||
27583466|NCT01722331|80319041|FG005|Part 1|Lack of Efficacy|0|||
27583467|NCT01722331|80319042|FG006|Part 1|Lack of Efficacy|0|||
27583468|NCT01722331|80319036|FG000|Part 1|Lost to Follow-up|1|||
27583469|NCT01722331|80319037|FG001|Part 1|Lost to Follow-up|0|||
27583470|NCT01722331|80319038|FG002|Part 1|Lost to Follow-up|2|||
27583471|NCT01722331|80319039|FG003|Part 1|Lost to Follow-up|0|||
27583472|NCT01722331|80319040|FG004|Part 1|Lost to Follow-up|1|||
27583473|NCT01722331|80319041|FG005|Part 1|Lost to Follow-up|0|||
27583474|NCT01722331|80319042|FG006|Part 1|Lost to Follow-up|0|||
27583475|NCT01722331|80319036|FG000|Part 1|Physician Decision|0|||
27583476|NCT01722331|80319037|FG001|Part 1|Physician Decision|0|||
27583477|NCT01722331|80319038|FG002|Part 1|Physician Decision|3|||
27583478|NCT01722331|80319039|FG003|Part 1|Physician Decision|0|||
27583479|NCT01722331|80319040|FG004|Part 1|Physician Decision|1|||
27583480|NCT01722331|80319041|FG005|Part 1|Physician Decision|0|||
27583481|NCT01722331|80319042|FG006|Part 1|Physician Decision|0|||
27583482|NCT01722331|80319036|FG000|Part 1|Pregnancy|1|||
27583483|NCT01722331|80319037|FG001|Part 1|Pregnancy|0|||
27583484|NCT01722331|80319038|FG002|Part 1|Pregnancy|0|||
27583485|NCT01722331|80319039|FG003|Part 1|Pregnancy|0|||
27583486|NCT01722331|80319040|FG004|Part 1|Pregnancy|0|||
27583487|NCT01722331|80319041|FG005|Part 1|Pregnancy|0|||
27583488|NCT01722331|80319042|FG006|Part 1|Pregnancy|0|||
27583489|NCT01722331|80319036|FG000|Part 1|Progressive Disease|0|||
27583490|NCT01722331|80319037|FG001|Part 1|Progressive Disease|0|||
27583491|NCT01722331|80319038|FG002|Part 1|Progressive Disease|0|||
27583492|NCT01722331|80319039|FG003|Part 1|Progressive Disease|0|||
27583493|NCT01722331|80319040|FG004|Part 1|Progressive Disease|1|||
27681792|NCT00320528|80672012|FG002|Study Period II|Adverse Event|8|||
27583494|NCT01722331|80319041|FG005|Part 1|Progressive Disease|0|||
27583495|NCT01722331|80319042|FG006|Part 1|Progressive Disease|0|||
27681793|NCT00320528|80672010|FG000|Study Period II|Parent/Caregiver Decision|8|||
27583496|NCT01722331|80319036|FG000|Part 1|Protocol Violation|1|||
27583497|NCT01722331|80319037|FG001|Part 1|Protocol Violation|0|||
27583498|NCT01722331|80319038|FG002|Part 1|Protocol Violation|0|||
27583499|NCT01722331|80319039|FG003|Part 1|Protocol Violation|0|||
27583500|NCT01722331|80319040|FG004|Part 1|Protocol Violation|1|||
27583501|NCT01722331|80319041|FG005|Part 1|Protocol Violation|0|||
27583502|NCT01722331|80319042|FG006|Part 1|Protocol Violation|0|||
27681794|NCT00320528|80672011|FG001|Study Period II|Parent/Caregiver Decision|3|||
27583503|NCT01722331|80319036|FG000|Part 1|Withdrawal by Subject|2|||
27583504|NCT01722331|80319037|FG001|Part 1|Withdrawal by Subject|0|||
27583505|NCT01722331|80319038|FG002|Part 1|Withdrawal by Subject|3|||
27583506|NCT01722331|80319039|FG003|Part 1|Withdrawal by Subject|0|||
27681795|NCT00320528|80672012|FG002|Study Period II|Parent/Caregiver Decision|11|||
27681796|NCT00320528|80672010|FG000|Study Period II|Withdrawal by Subject|0|||
27681797|NCT00320528|80672011|FG001|Study Period II|Withdrawal by Subject|1|||
27583507|NCT01722331|80319040|FG004|Part 1|Withdrawal by Subject|3|||
27583508|NCT01722331|80319041|FG005|Part 1|Withdrawal by Subject|0|||
27583509|NCT01722331|80319042|FG006|Part 1|Withdrawal by Subject|0|||
27583510|NCT01722331|80319036|FG000|Part 2|Adverse Event|3|||
27583511|NCT01722331|80319037|FG001|Part 2|Adverse Event|0|||
27583512|NCT01722331|80319038|FG002|Part 2|Adverse Event|0|||
27583513|NCT01722331|80319039|FG003|Part 2|Adverse Event|0|||
27583514|NCT01722331|80319040|FG004|Part 2|Adverse Event|0|||
27583515|NCT01722331|80319041|FG005|Part 2|Adverse Event|1|||
27583516|NCT01722331|80319042|FG006|Part 2|Adverse Event|0|||
27583517|NCT01722331|80319036|FG000|Part 2|Lack of Efficacy|3|||
27583518|NCT01722331|80319037|FG001|Part 2|Lack of Efficacy|0|||
27583519|NCT01722331|80319038|FG002|Part 2|Lack of Efficacy|11|||
27583520|NCT01722331|80319039|FG003|Part 2|Lack of Efficacy|0|||
27583521|NCT01722331|80319040|FG004|Part 2|Lack of Efficacy|0|||
27583522|NCT01722331|80319041|FG005|Part 2|Lack of Efficacy|3|||
27583523|NCT01722331|80319042|FG006|Part 2|Lack of Efficacy|3|||
27583524|NCT01722331|80319036|FG000|Part 2|Lost to Follow-up|0|||
27583525|NCT01722331|80319037|FG001|Part 2|Lost to Follow-up|0|||
27583526|NCT01722331|80319038|FG002|Part 2|Lost to Follow-up|3|||
27583527|NCT01722331|80319039|FG003|Part 2|Lost to Follow-up|0|||
27583528|NCT01722331|80319040|FG004|Part 2|Lost to Follow-up|0|||
27583529|NCT01722331|80319041|FG005|Part 2|Lost to Follow-up|1|||
27583530|NCT01722331|80319042|FG006|Part 2|Lost to Follow-up|1|||
27583531|NCT01722331|80319036|FG000|Part 2|Non-Compliance with Study Drug|1|||
27583532|NCT01722331|80319037|FG001|Part 2|Non-Compliance with Study Drug|0|||
27583533|NCT01722331|80319038|FG002|Part 2|Non-Compliance with Study Drug|1|||
27583534|NCT01722331|80319039|FG003|Part 2|Non-Compliance with Study Drug|0|||
27583535|NCT01722331|80319040|FG004|Part 2|Non-Compliance with Study Drug|0|||
27583536|NCT01722331|80319041|FG005|Part 2|Non-Compliance with Study Drug|0|||
27583537|NCT01722331|80319042|FG006|Part 2|Non-Compliance with Study Drug|0|||
27583538|NCT01722331|80319036|FG000|Part 2|Physician Decision|0|||
27583539|NCT01722331|80319037|FG001|Part 2|Physician Decision|0|||
27583540|NCT01722331|80319038|FG002|Part 2|Physician Decision|2|||
27583541|NCT01722331|80319039|FG003|Part 2|Physician Decision|0|||
27583542|NCT01722331|80319040|FG004|Part 2|Physician Decision|0|||
27583543|NCT01722331|80319041|FG005|Part 2|Physician Decision|0|||
27583544|NCT01722331|80319042|FG006|Part 2|Physician Decision|0|||
27681798|NCT00320528|80672012|FG002|Study Period II|Withdrawal by Subject|1|||
27681799|NCT00320528|80672010|FG000|Study Period II|Entry Criteria Exclusion|0|||
27681800|NCT00320528|80672011|FG001|Study Period II|Entry Criteria Exclusion|2|||
27681801|NCT00320528|80672012|FG002|Study Period II|Entry Criteria Exclusion|2|||
27681802|NCT00320528|80672010|FG000|Study Period III|Adverse Event|1|||
27583545|NCT01722331|80319036|FG000|Part 2|Pregnancy|0|||
27583546|NCT01722331|80319037|FG001|Part 2|Pregnancy|0|||
27583547|NCT01722331|80319038|FG002|Part 2|Pregnancy|0|||
27583548|NCT01722331|80319039|FG003|Part 2|Pregnancy|0|||
27583549|NCT01722331|80319040|FG004|Part 2|Pregnancy|0|||
27583550|NCT01722331|80319041|FG005|Part 2|Pregnancy|1|||
27583551|NCT01722331|80319042|FG006|Part 2|Pregnancy|0|||
27583552|NCT01722331|80319036|FG000|Part 2|Progressive Disease|0|||
27583553|NCT01722331|80319037|FG001|Part 2|Progressive Disease|0|||
27583554|NCT01722331|80319038|FG002|Part 2|Progressive Disease|1|||
27583555|NCT01722331|80319039|FG003|Part 2|Progressive Disease|0|||
28001581|NCT02562716|81834554|FG000|Overall Study|Death|2|||
27583556|NCT01722331|80319040|FG004|Part 2|Progressive Disease|0|||
27583557|NCT01722331|80319041|FG005|Part 2|Progressive Disease|0|||
27583558|NCT01722331|80319042|FG006|Part 2|Progressive Disease|0|||
27583559|NCT01722331|80319036|FG000|Part 2|Protocol Violation|1|||
27681803|NCT00320528|80672011|FG001|Study Period III|Adverse Event|0|||
27681804|NCT00320528|80672012|FG002|Study Period III|Adverse Event|0|||
27681805|NCT00320528|80672010|FG000|Study Period III|Lost to Follow-up|1|||
27583560|NCT01722331|80319037|FG001|Part 2|Protocol Violation|0|||
27583561|NCT01722331|80319038|FG002|Part 2|Protocol Violation|0|||
27583562|NCT01722331|80319039|FG003|Part 2|Protocol Violation|0|||
27583563|NCT01722331|80319040|FG004|Part 2|Protocol Violation|0|||
27583564|NCT01722331|80319041|FG005|Part 2|Protocol Violation|0|||
27583565|NCT01722331|80319042|FG006|Part 2|Protocol Violation|0|||
27681806|NCT00320528|80672011|FG001|Study Period III|Lost to Follow-up|0|||
27583566|NCT01722331|80319036|FG000|Part 2|Withdrawal by Subject|5|||
27583567|NCT01722331|80319037|FG001|Part 2|Withdrawal by Subject|0|||
27583568|NCT01722331|80319038|FG002|Part 2|Withdrawal by Subject|3|||
27583569|NCT01722331|80319039|FG003|Part 2|Withdrawal by Subject|0|||
27583570|NCT01722331|80319040|FG004|Part 2|Withdrawal by Subject|0|||
27583571|NCT01722331|80319041|FG005|Part 2|Withdrawal by Subject|2|||
27583572|NCT01722331|80319042|FG006|Part 2|Withdrawal by Subject|2|||
27583573|NCT01722331|80319036|FG000|Part 2|Other Protocol Specified Criteria|6|||
27583574|NCT01722331|80319037|FG001|Part 2|Other Protocol Specified Criteria|0|||
27583575|NCT01722331|80319038|FG002|Part 2|Other Protocol Specified Criteria|10|||
27583576|NCT01722331|80319039|FG003|Part 2|Other Protocol Specified Criteria|0|||
27583577|NCT01722331|80319040|FG004|Part 2|Other Protocol Specified Criteria|0|||
27583578|NCT01722331|80319041|FG005|Part 2|Other Protocol Specified Criteria|2|||
27681807|NCT00320528|80672012|FG002|Study Period III|Lost to Follow-up|0|||
27583579|NCT01722331|80319042|FG006|Part 2|Other Protocol Specified Criteria|1|||
27583580|NCT01722331|80319036|FG000|Part 3|Adverse Event|2|||
27681808|NCT00320528|80672010|FG000|Study Period III|Withdrawal by Subject|1|||
27681809|NCT00320528|80672011|FG001|Study Period III|Withdrawal by Subject|1|||
27681810|NCT00320528|80672012|FG002|Study Period III|Withdrawal by Subject|2|||
27681811|NCT00320528|80672010|FG000|Study Period III|Lack of Efficacy|2|||
27583581|NCT01722331|80319037|FG001|Part 3|Adverse Event|2|||
27583582|NCT01722331|80319038|FG002|Part 3|Adverse Event|0|||
27583583|NCT01722331|80319039|FG003|Part 3|Adverse Event|1|||
27583584|NCT01722331|80319040|FG004|Part 3|Adverse Event|0|||
27583585|NCT01722331|80319041|FG005|Part 3|Adverse Event|0|||
27583586|NCT01722331|80319042|FG006|Part 3|Adverse Event|0|||
27583587|NCT01722331|80319036|FG000|Part 3|Death|1|||
27583588|NCT01722331|80319037|FG001|Part 3|Death|0|||
27583589|NCT01722331|80319038|FG002|Part 3|Death|0|||
27583590|NCT01722331|80319039|FG003|Part 3|Death|0|||
27583591|NCT01722331|80319040|FG004|Part 3|Death|0|||
27583592|NCT01722331|80319041|FG005|Part 3|Death|0|||
27583593|NCT01722331|80319042|FG006|Part 3|Death|0|||
27583594|NCT01722331|80319036|FG000|Part 3|Lack of Efficacy|1|||
27583595|NCT01722331|80319037|FG001|Part 3|Lack of Efficacy|0|||
27583596|NCT01722331|80319038|FG002|Part 3|Lack of Efficacy|0|||
27583597|NCT01722331|80319039|FG003|Part 3|Lack of Efficacy|0|||
27583598|NCT01722331|80319040|FG004|Part 3|Lack of Efficacy|0|||
27583599|NCT01722331|80319041|FG005|Part 3|Lack of Efficacy|0|||
27583600|NCT01722331|80319042|FG006|Part 3|Lack of Efficacy|0|||
27583601|NCT01722331|80319036|FG000|Part 3|Lost to Follow-up|3|||
27583602|NCT01722331|80319037|FG001|Part 3|Lost to Follow-up|4|||
27583603|NCT01722331|80319038|FG002|Part 3|Lost to Follow-up|0|||
27583604|NCT01722331|80319039|FG003|Part 3|Lost to Follow-up|0|||
27583605|NCT01722331|80319040|FG004|Part 3|Lost to Follow-up|0|||
27583606|NCT01722331|80319041|FG005|Part 3|Lost to Follow-up|1|||
27681812|NCT00320528|80672011|FG001|Study Period III|Lack of Efficacy|0|||
27681813|NCT00320528|80672012|FG002|Study Period III|Lack of Efficacy|0|||
27681814|NCT00320528|80672010|FG000|Study Period III|Parent/Caregiver Decision|14|||
27681815|NCT00320528|80672011|FG001|Study Period III|Parent/Caregiver Decision|3|||
27583607|NCT01722331|80319042|FG006|Part 3|Lost to Follow-up|0|||
27583608|NCT01722331|80319036|FG000|Part 3|Non-Compliance with Study Drug|0|||
27583609|NCT01722331|80319037|FG001|Part 3|Non-Compliance with Study Drug|1|||
27583610|NCT01722331|80319038|FG002|Part 3|Non-Compliance with Study Drug|0|||
27681816|NCT00320528|80672012|FG002|Study Period III|Parent/Caregiver Decision|11|||
27681817|NCT00320528|80672010|FG000|Study Period III|Protocol Violation|0|||
27681818|NCT00320528|80672011|FG001|Study Period III|Protocol Violation|1|||
27681819|NCT00320528|80672012|FG002|Study Period III|Protocol Violation|0|||
27681820|NCT00320528|80672010|FG000|Study Period III|Physician Decision|0|||
27681821|NCT00320528|80672011|FG001|Study Period III|Physician Decision|1|||
27681822|NCT00320528|80672012|FG002|Study Period III|Physician Decision|2|||
27681823|NCT00320528|80672010|FG000|Study Period III|Sponsor Decision|0|||
27681824|NCT00320528|80672011|FG001|Study Period III|Sponsor Decision|0|||
27681825|NCT00320528|80672012|FG002|Study Period III|Sponsor Decision|1|||
27681826|NCT00320528|80672010|FG000|Study Period III|Atomoxetine Commercially Available|68|||
27681827|NCT00320528|80672011|FG001|Study Period III|Atomoxetine Commercially Available|25|||
27681828|NCT00320528|80672012|FG002|Study Period III|Atomoxetine Commercially Available|90|||
27681829|NCT00468143|80672013|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
27681830|NCT00468143|80672014|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
27681831|NCT00468143|80672013|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
27681832|NCT00468143|80672014|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
27681833|NCT02591953|80672015|FG000|Overall Study|Lost to Follow-up|6|||
27806454|NCT01677910|81123187|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
27681834|NCT02591953|80672016|FG001|Overall Study|Lost to Follow-up|6|||
27681835|NCT02535091|80672017|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
27806455|NCT01677910|81123188|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
28001582|NCT02562716|81834555|FG001|Overall Study|Death|1|||
27583611|NCT01722331|80319039|FG003|Part 3|Non-Compliance with Study Drug|0|||
27583612|NCT01722331|80319040|FG004|Part 3|Non-Compliance with Study Drug|0|||
27583613|NCT01722331|80319041|FG005|Part 3|Non-Compliance with Study Drug|0|||
27583614|NCT01722331|80319042|FG006|Part 3|Non-Compliance with Study Drug|0|||
27583615|NCT01722331|80319036|FG000|Part 3|Physician Decision|1|||
27583616|NCT01722331|80319037|FG001|Part 3|Physician Decision|1|||
27583617|NCT01722331|80319038|FG002|Part 3|Physician Decision|0|||
27583618|NCT01722331|80319039|FG003|Part 3|Physician Decision|0|||
27583619|NCT01722331|80319040|FG004|Part 3|Physician Decision|0|||
27583620|NCT01722331|80319041|FG005|Part 3|Physician Decision|0|||
27583621|NCT01722331|80319042|FG006|Part 3|Physician Decision|1|||
27583622|NCT01722331|80319036|FG000|Part 3|Protocol Violation|2|||
27583623|NCT01722331|80319037|FG001|Part 3|Protocol Violation|1|||
27583624|NCT01722331|80319038|FG002|Part 3|Protocol Violation|0|||
27583625|NCT01722331|80319039|FG003|Part 3|Protocol Violation|0|||
27583626|NCT01722331|80319040|FG004|Part 3|Protocol Violation|0|||
27583627|NCT01722331|80319041|FG005|Part 3|Protocol Violation|0|||
27583628|NCT01722331|80319042|FG006|Part 3|Protocol Violation|0|||
27583629|NCT01722331|80319036|FG000|Part 3|Withdrawal by Subject|4|||
27583630|NCT01722331|80319037|FG001|Part 3|Withdrawal by Subject|7|||
27583631|NCT01722331|80319038|FG002|Part 3|Withdrawal by Subject|0|||
27583632|NCT01722331|80319039|FG003|Part 3|Withdrawal by Subject|0|||
27583633|NCT01722331|80319040|FG004|Part 3|Withdrawal by Subject|0|||
27583634|NCT01722331|80319041|FG005|Part 3|Withdrawal by Subject|2|||
27583635|NCT01722331|80319042|FG006|Part 3|Withdrawal by Subject|1|||
27583636|NCT01722331|80319036|FG000|Part 3|Other Protocol Specified Criteria|1|||
27583637|NCT01722331|80319037|FG001|Part 3|Other Protocol Specified Criteria|1|||
27583638|NCT01722331|80319038|FG002|Part 3|Other Protocol Specified Criteria|0|||
27583639|NCT01722331|80319039|FG003|Part 3|Other Protocol Specified Criteria|0|||
27583640|NCT01722331|80319040|FG004|Part 3|Other Protocol Specified Criteria|0|||
27583641|NCT01722331|80319041|FG005|Part 3|Other Protocol Specified Criteria|0|||
27583642|NCT01722331|80319042|FG006|Part 3|Other Protocol Specified Criteria|0|||
27583643|NCT02162810|80319043|FG000|Overall Study|Protocol Violation|1|||
27583644|NCT02162810|80319044|FG001|Overall Study|Protocol Violation|0|||
27583645|NCT02162810|80319043|FG000|Overall Study|patients did not report compliance|4|||
27583646|NCT02162810|80319044|FG001|Overall Study|patients did not report compliance|1|||
27583647|NCT00439777|80319045|FG000|Treatment Period|Death|29|||
27583648|NCT00439777|80319046|FG001|Treatment Period|Death|21|||
27583649|NCT00439777|80319045|FG000|Treatment Period|Study terminated by sponsor|125|||
27583650|NCT00439777|80319046|FG001|Treatment Period|Study terminated by sponsor|132|||
27583651|NCT00439777|80319045|FG000|Treatment Period|Site closed by investigator|0|||
27583652|NCT00439777|80319046|FG001|Treatment Period|Site closed by investigator|1|||
27583653|NCT00439777|80319045|FG000|Treatment Period|Did not take study treatment|7|||
27583654|NCT00439777|80319046|FG001|Treatment Period|Did not take study treatment|8|||
27583655|NCT00439777|80319045|FG000|Treatment Period|Adverse Event|111|||
27583656|NCT00439777|80319046|FG001|Treatment Period|Adverse Event|92|||
27583657|NCT00439777|80319045|FG000|Treatment Period|Protocol Violation|23|||
27583658|NCT00439777|80319046|FG001|Treatment Period|Protocol Violation|30|||
27583659|NCT00439777|80319045|FG000|Treatment Period|Withdrawal by Subject|66|||
27583660|NCT00439777|80319046|FG001|Treatment Period|Withdrawal by Subject|118|||
27583661|NCT00439777|80319045|FG000|Treatment Period|Lack of Efficacy|1|||
28001583|NCT02562716|81834554|FG000|Overall Study|Not protocol specified|4|||
27583662|NCT00439777|80319046|FG001|Treatment Period|Lack of Efficacy|4|||
27583663|NCT00439777|80319045|FG000|Treatment Period|Lost to Follow-up|8|||
27583664|NCT00439777|80319046|FG001|Treatment Period|Lost to Follow-up|10|||
27583665|NCT00439777|80319045|FG000|Treatment Period|Protocol driven decision point|1|||
27583666|NCT00439777|80319046|FG001|Treatment Period|Protocol driven decision point|3|||
27583667|NCT00439777|80319045|FG000|Treatment Period|Physician Decision|7|||
27583668|NCT00439777|80319046|FG001|Treatment Period|Physician Decision|18|||
27583669|NCT00439777|80319045|FG000|Treatment Period|Clinical endpoint reached|26|||
27583670|NCT00439777|80319046|FG001|Treatment Period|Clinical endpoint reached|13|||
27583671|NCT00439777|80319045|FG000|Treatment Period|Technical problems|3|||
27583672|NCT00439777|80319046|FG001|Treatment Period|Technical problems|1|||
27583673|NCT00439777|80319045|FG000|Treatment Period|Participant convenience|12|||
27583674|NCT00439777|80319046|FG001|Treatment Period|Participant convenience|8|||
27583675|NCT00439777|80319045|FG000|Observational Period|Protocol Violation|0|||
27583676|NCT00439777|80319046|FG001|Observational Period|Protocol Violation|2|||
27583677|NCT00439777|80319045|FG000|Observational Period|Withdrawal by Subject|9|||
27583678|NCT00439777|80319046|FG001|Observational Period|Withdrawal by Subject|5|||
27583679|NCT00439777|80319045|FG000|Observational Period|Lost to Follow-up|1|||
27583680|NCT00439777|80319046|FG001|Observational Period|Lost to Follow-up|11|||
27583681|NCT00439777|80319045|FG000|Observational Period|Death|27|||
27583682|NCT00439777|80319046|FG001|Observational Period|Death|20|||
27583683|NCT00439777|80319045|FG000|Observational Period|Study terminated by sponsor|3|||
27583684|NCT00439777|80319046|FG001|Observational Period|Study terminated by sponsor|1|||
27583685|NCT00439777|80319045|FG000|Observational Period|Protocol driven decision point|0|||
27583686|NCT00439777|80319046|FG001|Observational Period|Protocol driven decision point|1|||
27583687|NCT00439777|80319045|FG000|Observational Period|Lack of Efficacy|1|||
27583688|NCT00439777|80319046|FG001|Observational Period|Lack of Efficacy|0|||
27583689|NCT00439777|80319045|FG000|Observational Period|Technical problems|0|||
27681836|NCT02535091|80672018|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
27700989|NCT01241552|80741290|FG001|Overall Study|Progressive Disease|0|||
27583690|NCT00439777|80319046|FG001|Observational Period|Technical problems|1|||
27583691|NCT01557946|80319047|FG000|Overall Study|Adverse Event|3|||
27583692|NCT01557946|80319048|FG001|Overall Study|Adverse Event|0|||
27583693|NCT01640301|80319049|FG000|Overall Study|Death|0|||
27583694|NCT01640301|80319050|FG001|Overall Study|Death|8|||
27583695|NCT01337245|80319051|FG000|Overall Study|Lost to Follow-up|1|||
27583696|NCT02806986|80319052|FG000|Treatment Stage 1|Adverse Event|1|||
27583697|NCT02806986|80319052|FG000|Treatment Stage 2|Adverse Event|3|||
27583698|NCT02806986|80319052|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
27583699|NCT01785524|80319055|FG000|Overall Study|Withdrawal by Subject|2|||
27583700|NCT01785524|80319056|FG001|Overall Study|Withdrawal by Subject|2|||
27583701|NCT02371369|80319057|FG000|Part 1|Physician Decision|0|||
27583702|NCT02371369|80319058|FG001|Part 1|Physician Decision|3|||
27583703|NCT02371369|80319057|FG000|Part 1|Adverse Event|8|||
27583704|NCT02371369|80319058|FG001|Part 1|Adverse Event|0|||
27583705|NCT02371369|80319057|FG000|Part 1|Withdrawal by Subject|1|||
27583706|NCT02371369|80319058|FG001|Part 1|Withdrawal by Subject|6|||
27583707|NCT02371369|80319057|FG000|Part 1|Disease progression|0|||
27583708|NCT02371369|80319058|FG001|Part 1|Disease progression|1|||
27583709|NCT02371369|80319057|FG000|Part 1|Protocol Violation|0|||
27583710|NCT02371369|80319058|FG001|Part 1|Protocol Violation|1|||
27583711|NCT02371369|80319057|FG000|Part 2|Adverse Event|6|||
27583712|NCT02371369|80319058|FG001|Part 2|Adverse Event|5|||
27583713|NCT02371369|80319057|FG000|Part 2|Withdrawal by Subject|16|||
27583714|NCT02371369|80319058|FG001|Part 2|Withdrawal by Subject|6|||
27583715|NCT02371369|80319057|FG000|Part 2|Investigator decision|1|||
27583716|NCT02371369|80319058|FG001|Part 2|Investigator decision|2|||
27583717|NCT02371369|80319057|FG000|Part 2|Death|0|||
27583718|NCT02371369|80319058|FG001|Part 2|Death|1|||
27583719|NCT02371369|80319057|FG000|Part 2|Disease progression|1|||
27583720|NCT02371369|80319058|FG001|Part 2|Disease progression|0|||
27583721|NCT02371369|80319057|FG000|Part 2|Subject Noncompliance|1|||
27583722|NCT02371369|80319058|FG001|Part 2|Subject Noncompliance|0|||
27583723|NCT02371369|80319057|FG000|Part 2|Lost to Follow-up|1|||
27583724|NCT02371369|80319058|FG001|Part 2|Lost to Follow-up|1|||
27583725|NCT02371369|80319057|FG000|Part 2|Subject transitioned to commercial supply|6|||
27583726|NCT02371369|80319058|FG001|Part 2|Subject transitioned to commercial supply|4|||
27583727|NCT02371369|80319057|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
27583728|NCT02371369|80319058|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
27583729|NCT02371369|80319057|FG000|Part 2|Surgical resection of tumor|1|||
27583730|NCT02371369|80319058|FG001|Part 2|Surgical resection of tumor|1|||
27583731|NCT02371369|80319057|FG000|Part 2|Other|0|||
27583732|NCT02371369|80319058|FG001|Part 2|Other|1|||
27583733|NCT02823145|80319059|FG000|Enrollment|Other|1|||
27583734|NCT02823145|80319060|FG001|Enrollment|Other|0|||
27583735|NCT02823145|80319059|FG000|Treatment|Adverse Event|0|||
27583736|NCT02823145|80319060|FG001|Treatment|Adverse Event|11|||
27583737|NCT02823145|80319059|FG000|Treatment|Death|0|||
27583738|NCT02823145|80319060|FG001|Treatment|Death|3|||
27583739|NCT02823145|80319059|FG000|Treatment|Family Decision|0|||
27583740|NCT02823145|80319060|FG001|Treatment|Family Decision|1|||
27583741|NCT02823145|80319059|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
27583742|NCT02823145|80319060|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
27583743|NCT02823145|80319059|FG000|Treatment|Lack of Efficacy|0|||
27583744|NCT02823145|80319060|FG001|Treatment|Lack of Efficacy|48|||
27583745|NCT02823145|80319059|FG000|Treatment|Non-Compliance With E-Diary|0|||
27583746|NCT02823145|80319060|FG001|Treatment|Non-Compliance With E-Diary|1|||
27583747|NCT02823145|80319059|FG000|Treatment|Physician Decision|0|||
27583748|NCT02823145|80319060|FG001|Treatment|Physician Decision|2|||
27583749|NCT02823145|80319059|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
27583750|NCT02823145|80319060|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
27583751|NCT02823145|80319059|FG000|Treatment|Subject needed to take prohibited medication|0|||
27583752|NCT02823145|80319060|FG001|Treatment|Subject needed to take prohibited medication|1|||
27583753|NCT02823145|80319059|FG000|Treatment|Subject transferred to direct access programme|0|||
27583754|NCT02823145|80319060|FG001|Treatment|Subject transferred to direct access programme|1|||
27583755|NCT02823145|80319059|FG000|Treatment|Switching to commercially available drug|0|||
27583756|NCT02823145|80319060|FG001|Treatment|Switching to commercially available drug|11|||
27583757|NCT02823145|80319059|FG000|Treatment|Transitioned to commercial supply of medication|0|||
27583758|NCT02823145|80319060|FG001|Treatment|Transitioned to commercial supply of medication|1|||
27583759|NCT02823145|80319059|FG000|Treatment|Withdrawal By Caregiver|0|||
27583760|NCT02823145|80319060|FG001|Treatment|Withdrawal By Caregiver|1|||
27583761|NCT02823145|80319059|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
27583762|NCT02823145|80319060|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
27583763|NCT02823145|80319059|FG000|Treatment|Withdrawal by Subject|0|||
27583764|NCT02823145|80319060|FG001|Treatment|Withdrawal by Subject|16|||
27583765|NCT02823145|80319059|FG000|Treatment|Reason unknown|0|||
27583766|NCT02823145|80319060|FG001|Treatment|Reason unknown|1|||
27583767|NCT01602315|80319061|FG000|Overall Study|Protocol Violation|0|||
27583768|NCT01602315|80319062|FG001|Overall Study|Protocol Violation|0|||
27583769|NCT01602315|80319063|FG002|Overall Study|Protocol Violation|0|||
27583770|NCT01602315|80319064|FG003|Overall Study|Protocol Violation|0|||
27583771|NCT01602315|80319065|FG004|Overall Study|Protocol Violation|0|||
27583772|NCT01602315|80319066|FG005|Overall Study|Protocol Violation|1|||
27583773|NCT01602315|80319067|FG006|Overall Study|Protocol Violation|0|||
27583774|NCT01602315|80319061|FG000|Overall Study|Physician Decision|2|||
27583775|NCT01602315|80319062|FG001|Overall Study|Physician Decision|0|||
27583776|NCT01602315|80319063|FG002|Overall Study|Physician Decision|0|||
27583777|NCT01602315|80319064|FG003|Overall Study|Physician Decision|0|||
27583778|NCT01602315|80319065|FG004|Overall Study|Physician Decision|2|||
27583779|NCT01602315|80319066|FG005|Overall Study|Physician Decision|1|||
27583780|NCT01602315|80319067|FG006|Overall Study|Physician Decision|1|||
27583781|NCT01602315|80319061|FG000|Overall Study|Disease progression|6|||
27583782|NCT01602315|80319062|FG001|Overall Study|Disease progression|3|||
27583783|NCT01602315|80319063|FG002|Overall Study|Disease progression|10|||
27583784|NCT01602315|80319064|FG003|Overall Study|Disease progression|1|||
27583785|NCT01602315|80319065|FG004|Overall Study|Disease progression|41|||
27583786|NCT01602315|80319066|FG005|Overall Study|Disease progression|12|||
27583787|NCT01602315|80319067|FG006|Overall Study|Disease progression|15|||
27583788|NCT01602315|80319061|FG000|Overall Study|Death|1|||
27583789|NCT01602315|80319062|FG001|Overall Study|Death|1|||
27583790|NCT01602315|80319063|FG002|Overall Study|Death|1|||
27583791|NCT01602315|80319064|FG003|Overall Study|Death|1|||
27583792|NCT01602315|80319065|FG004|Overall Study|Death|7|||
27583793|NCT01602315|80319066|FG005|Overall Study|Death|2|||
27583794|NCT01602315|80319067|FG006|Overall Study|Death|2|||
27583795|NCT01602315|80319061|FG000|Overall Study|Withdrawal by Subject|2|||
27583796|NCT01602315|80319062|FG001|Overall Study|Withdrawal by Subject|0|||
27583797|NCT01602315|80319063|FG002|Overall Study|Withdrawal by Subject|2|||
27583798|NCT01602315|80319064|FG003|Overall Study|Withdrawal by Subject|0|||
27583799|NCT01602315|80319065|FG004|Overall Study|Withdrawal by Subject|6|||
27583800|NCT01602315|80319066|FG005|Overall Study|Withdrawal by Subject|0|||
27583801|NCT01602315|80319067|FG006|Overall Study|Withdrawal by Subject|1|||
27583802|NCT01602315|80319061|FG000|Overall Study|Adverse Event|5|||
27583803|NCT01602315|80319062|FG001|Overall Study|Adverse Event|1|||
27583804|NCT01602315|80319063|FG002|Overall Study|Adverse Event|5|||
27583805|NCT01602315|80319064|FG003|Overall Study|Adverse Event|4|||
27583806|NCT01602315|80319065|FG004|Overall Study|Adverse Event|15|||
27583807|NCT01602315|80319066|FG005|Overall Study|Adverse Event|3|||
27583808|NCT01602315|80319067|FG006|Overall Study|Adverse Event|9|||
27583809|NCT01602315|80319061|FG000|Overall Study|Subject/guardian decision|0|||
27583810|NCT01602315|80319062|FG001|Overall Study|Subject/guardian decision|0|||
27583811|NCT01602315|80319063|FG002|Overall Study|Subject/guardian decision|0|||
27583812|NCT01602315|80319064|FG003|Overall Study|Subject/guardian decision|0|||
27583813|NCT01602315|80319065|FG004|Overall Study|Subject/guardian decision|0|||
27583814|NCT01602315|80319066|FG005|Overall Study|Subject/guardian decision|0|||
27583815|NCT01602315|80319067|FG006|Overall Study|Subject/guardian decision|1|||
27583816|NCT01602315|80319061|FG000|Overall Study|Cross-over patients to combo treatment|0|||
27583817|NCT01602315|80319062|FG001|Overall Study|Cross-over patients to combo treatment|0|||
27806456|NCT01677910|81123189|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
27806457|NCT01677910|81123190|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
27806458|NCT01677910|81123187|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
27806459|NCT01677910|81123188|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
27806460|NCT01677910|81123189|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
27806461|NCT01677910|81123190|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
27806462|NCT00787566|81123197|FG000|Overall Study|AE related to chemotherapy|0|||
27806463|NCT00787566|81123198|FG001|Overall Study|AE related to chemotherapy|1|||
27806464|NCT00787566|81123199|FG002|Overall Study|AE related to chemotherapy|0|||
27806465|NCT01991977|81123204|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
28001584|NCT02562716|81834555|FG001|Overall Study|Not protocol specified|2|||
27583818|NCT01602315|80319063|FG002|Overall Study|Cross-over patients to combo treatment|0|||
27583819|NCT01602315|80319064|FG003|Overall Study|Cross-over patients to combo treatment|0|||
27583820|NCT01602315|80319065|FG004|Overall Study|Cross-over patients to combo treatment|0|||
27583821|NCT01602315|80319066|FG005|Overall Study|Cross-over patients to combo treatment|16|||
28001585|NCT02252146|81838106|FG000|Overall Study|Lack of Efficacy|4|||
27583822|NCT01602315|80319067|FG006|Overall Study|Cross-over patients to combo treatment|0|||
27583823|NCT00384085|80319068|FG000|Overall Study|Adverse Event|5|||
27583824|NCT00384085|80319069|FG001|Overall Study|Adverse Event|5|||
27583825|NCT00384085|80319070|FG002|Overall Study|Adverse Event|4|||
27583826|NCT00384085|80319068|FG000|Overall Study|Lack of Efficacy|0|||
27583827|NCT00384085|80319069|FG001|Overall Study|Lack of Efficacy|3|||
27583828|NCT00384085|80319070|FG002|Overall Study|Lack of Efficacy|2|||
27583829|NCT00384085|80319068|FG000|Overall Study|No longer Requires Study Treatment|1|||
27583830|NCT00384085|80319069|FG001|Overall Study|No longer Requires Study Treatment|0|||
28001586|NCT02252146|81838106|FG000|Overall Study|Entered hospice care|1|||
28001587|NCT02252146|81838106|FG000|Overall Study|Inability to travel to study site|1|||
27806466|NCT01991977|81123204|FG000|Overall Study|Withdrew after start of treatment|5|||
27806467|NCT03558997|81123205|FG000|Overall Study|Adverse Event|0|||
27806468|NCT03558997|81123206|FG001|Overall Study|Adverse Event|2|||
27806469|NCT03558997|81123207|FG002|Overall Study|Adverse Event|5|||
27806470|NCT03558997|81123208|FG003|Overall Study|Adverse Event|1|||
27806471|NCT03558997|81123205|FG000|Overall Study|Physician Decision|0|||
27806472|NCT03558997|81123206|FG001|Overall Study|Physician Decision|0|||
27806473|NCT03558997|81123207|FG002|Overall Study|Physician Decision|1|||
27806474|NCT03558997|81123208|FG003|Overall Study|Physician Decision|0|||
27806475|NCT03558997|81123205|FG000|Overall Study|Withdrawal by Subject|1|||
27806476|NCT03558997|81123206|FG001|Overall Study|Withdrawal by Subject|0|||
27700990|NCT01241552|80741291|FG002|Overall Study|Progressive Disease|1|||
27806477|NCT03558997|81123207|FG002|Overall Study|Withdrawal by Subject|1|||
27806478|NCT03558997|81123208|FG003|Overall Study|Withdrawal by Subject|1|||
27583831|NCT00384085|80319070|FG002|Overall Study|No longer Requires Study Treatment|1|||
27583832|NCT00384085|80319068|FG000|Overall Study|Protocol Violation|2|||
27583833|NCT00384085|80319069|FG001|Overall Study|Protocol Violation|2|||
27583834|NCT00384085|80319070|FG002|Overall Study|Protocol Violation|2|||
27583835|NCT00384085|80319068|FG000|Overall Study|Lost to Follow-up|9|||
27583836|NCT00384085|80319069|FG001|Overall Study|Lost to Follow-up|9|||
27583837|NCT00384085|80319070|FG002|Overall Study|Lost to Follow-up|10|||
27583838|NCT00384085|80319068|FG000|Overall Study|Progressive Disease|0|||
27583839|NCT00384085|80319069|FG001|Overall Study|Progressive Disease|1|||
27583840|NCT00384085|80319070|FG002|Overall Study|Progressive Disease|0|||
27583841|NCT00384085|80319068|FG000|Overall Study|Withdrawal by Subject|14|||
27583842|NCT00384085|80319069|FG001|Overall Study|Withdrawal by Subject|19|||
27583843|NCT00384085|80319070|FG002|Overall Study|Withdrawal by Subject|29|||
27583844|NCT00384085|80319068|FG000|Overall Study|Patient non-compliant|4|||
27583845|NCT00384085|80319069|FG001|Overall Study|Patient non-compliant|4|||
27583846|NCT00384085|80319070|FG002|Overall Study|Patient non-compliant|5|||
27583847|NCT00384085|80319068|FG000|Overall Study|Physician Decision|1|||
27583848|NCT00384085|80319069|FG001|Overall Study|Physician Decision|0|||
27583849|NCT00384085|80319070|FG002|Overall Study|Physician Decision|0|||
27583850|NCT00384085|80319068|FG000|Overall Study|Loss of site personnel|1|||
27583851|NCT00384085|80319069|FG001|Overall Study|Loss of site personnel|0|||
27583852|NCT00384085|80319070|FG002|Overall Study|Loss of site personnel|1|||
27583853|NCT00384085|80319068|FG000|Overall Study|Sponsor decision|1|||
27583854|NCT00384085|80319069|FG001|Overall Study|Sponsor decision|2|||
27583855|NCT00384085|80319070|FG002|Overall Study|Sponsor decision|1|||
27583856|NCT00384085|80319068|FG000|Overall Study|Patient moved|1|||
27583857|NCT00384085|80319069|FG001|Overall Study|Patient moved|0|||
27583858|NCT00384085|80319070|FG002|Overall Study|Patient moved|1|||
27583859|NCT00384085|80319068|FG000|Overall Study|Patient required surgery|0|||
27583860|NCT00384085|80319069|FG001|Overall Study|Patient required surgery|1|||
28001588|NCT04033367|81838113|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
28001589|NCT04033367|81838114|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
27583861|NCT00384085|80319070|FG002|Overall Study|Patient required surgery|0|||
28001590|NCT04033367|81838113|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
28001591|NCT04033367|81838114|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
28001592|NCT04033367|81838113|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
28001593|NCT04033367|81838114|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
28001594|NCT04033367|81838113|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
28001595|NCT04033367|81838114|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
28001596|NCT00601835|81838115|FG000|Overall Study|Withdrawal by Subject|9|||
28001597|NCT00601835|81838116|FG001|Overall Study|Withdrawal by Subject|6|||
28001598|NCT00601835|81838115|FG000|Overall Study|Physician Decision|1|||
28001599|NCT00601835|81838116|FG001|Overall Study|Physician Decision|0|||
28001600|NCT00601835|81838115|FG000|Overall Study|Lost to Follow-up|37|||
28001601|NCT00601835|81838116|FG001|Overall Study|Lost to Follow-up|5|||
28001602|NCT00601835|81838115|FG000|Overall Study|Adverse Event|1|||
28001603|NCT00601835|81838116|FG001|Overall Study|Adverse Event|1|||
28001604|NCT00601835|81838115|FG000|Overall Study|Relocate|12|||
28001605|NCT00601835|81838116|FG001|Overall Study|Relocate|2|||
28001606|NCT03016312|81838117|FG000|Overall Study|discontinued before the treatment started|0|||
28001607|NCT03016312|81838118|FG001|Overall Study|discontinued before the treatment started|1|||
28001608|NCT03016312|81838117|FG000|Overall Study|Withdrawal by Subject|37|||
28001609|NCT03016312|81838118|FG001|Overall Study|Withdrawal by Subject|44|||
28001610|NCT03016312|81838117|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
28001611|NCT03016312|81838118|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
28001612|NCT03016312|81838117|FG000|Overall Study|Physician Decision|1|||
28001613|NCT03016312|81838118|FG001|Overall Study|Physician Decision|3|||
28001614|NCT03016312|81838117|FG000|Overall Study|Lost to Follow-up|12|||
28001615|NCT03016312|81838118|FG001|Overall Study|Lost to Follow-up|12|||
28001616|NCT03016312|81838117|FG000|Overall Study|Death|210|||
27583862|NCT00047463|80319071|FG000|Overall Study|Withdrawal by Subject|0|||
27583863|NCT00047463|80319072|FG001|Overall Study|Withdrawal by Subject|3|||
27583864|NCT00844194|80319075|FG000|Overall Study|Adverse Event|17|||
27583865|NCT00844194|80319076|FG001|Overall Study|Adverse Event|5|||
27583866|NCT00844194|80319075|FG000|Overall Study|Protocol Violation|1|||
27583867|NCT00844194|80319076|FG001|Overall Study|Protocol Violation|1|||
27583868|NCT00844194|80319075|FG000|Overall Study|Lost to Follow-up|1|||
27583869|NCT00844194|80319076|FG001|Overall Study|Lost to Follow-up|1|||
28001617|NCT03016312|81838118|FG001|Overall Study|Death|184|||
27700991|NCT01241552|80741292|FG003|Overall Study|Progressive Disease|2|||
28001618|NCT03016312|81838117|FG000|Overall Study|loss to contact|1|||
28001619|NCT03016312|81838118|FG001|Overall Study|loss to contact|0|||
28001620|NCT03016312|81838117|FG000|Overall Study|started a new cancer therapy|1|||
28001621|NCT03016312|81838118|FG001|Overall Study|started a new cancer therapy|0|||
27681837|NCT02535091|80672019|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
27681838|NCT02535091|80672017|FG000|Overall Study|Withdrawal by Subject|14|||
27874016|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
27874017|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874018|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
27681839|NCT02535091|80672018|FG001|Overall Study|Withdrawal by Subject|5|||
27681840|NCT02535091|80672019|FG002|Overall Study|Withdrawal by Subject|121|||
27681841|NCT02535091|80672017|FG000|Overall Study|Adverse Event|9|||
27681842|NCT02535091|80672018|FG001|Overall Study|Adverse Event|4|||
27874019|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
27874020|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874021|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874022|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874023|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874024|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874025|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874026|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874027|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874028|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
27874029|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
28001622|NCT01664910|81838120|FG000|Overall Study|Adverse Event|0|||
28001623|NCT01664910|81838121|FG001|Overall Study|Adverse Event|0|||
28001624|NCT01664910|81838122|FG002|Overall Study|Adverse Event|1|||
28001625|NCT01618669|81838126|FG000|Overall Study|Lost to Follow-up|1|||
27681843|NCT02535091|80672019|FG002|Overall Study|Adverse Event|170|||
27681844|NCT02535091|80672017|FG000|Overall Study|Other|4|||
27681845|NCT02535091|80672018|FG001|Overall Study|Other|3|||
27681846|NCT02535091|80672019|FG002|Overall Study|Other|81|||
27681847|NCT02535091|80672017|FG000|Overall Study|Lost to Follow-up|0|||
27681848|NCT02535091|80672018|FG001|Overall Study|Lost to Follow-up|1|||
27681849|NCT02535091|80672019|FG002|Overall Study|Lost to Follow-up|19|||
27681850|NCT02535091|80672017|FG000|Overall Study|Protocol Violation|0|||
27681851|NCT02535091|80672018|FG001|Overall Study|Protocol Violation|1|||
27681852|NCT02535091|80672019|FG002|Overall Study|Protocol Violation|11|||
28001626|NCT01618669|81838127|FG001|Overall Study|Lost to Follow-up|1|||
28001627|NCT01618669|81838126|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
28001628|NCT01618669|81838127|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
28001629|NCT01618669|81838126|FG000|Overall Study|Adverse Event|16|||
28001630|NCT01618669|81838127|FG001|Overall Study|Adverse Event|7|||
28001631|NCT01618669|81838126|FG000|Overall Study|Protocol Violation|5|||
28001632|NCT01618669|81838127|FG001|Overall Study|Protocol Violation|3|||
28001633|NCT01618669|81838126|FG000|Overall Study|Withdrawal by Subject|9|||
28001634|NCT01618669|81838127|FG001|Overall Study|Withdrawal by Subject|9|||
28001635|NCT01618669|81838126|FG000|Overall Study|Miscellaneous Reason|0|||
28001636|NCT01618669|81838127|FG001|Overall Study|Miscellaneous Reason|1|||
28001637|NCT01927497|81838128|FG000|Overall Study|Death|0|||
28001638|NCT01927497|81838129|FG001|Overall Study|Death|1|||
28001639|NCT01927497|81838128|FG000|Overall Study|Protocol Violation|2|||
28001640|NCT01927497|81838129|FG001|Overall Study|Protocol Violation|0|||
28001641|NCT01574274|81838130|FG000|Overall Study|Ineligible|0|||
28001642|NCT01574274|81838131|FG001|Overall Study|Ineligible|1|||
28001643|NCT01574274|81838130|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
28001644|NCT01574274|81838131|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
28001645|NCT01574274|81838130|FG000|Overall Study|Ph+ B-ALL|3|||
28001646|NCT01574274|81838131|FG001|Overall Study|Ph+ B-ALL|4|||
28001647|NCT01574274|81838130|FG000|Overall Study|Induction Death|2|||
28001648|NCT01574274|81838131|FG001|Overall Study|Induction Death|0|||
28001649|NCT01574274|81838130|FG000|Overall Study|Induction Failure|4|||
28001650|NCT01574274|81838131|FG001|Overall Study|Induction Failure|1|||
28001651|NCT01574274|81838130|FG000|Overall Study|Adverse Event|16|||
28001652|NCT01574274|81838131|FG001|Overall Study|Adverse Event|13|||
28001653|NCT01574274|81838130|FG000|Overall Study|Remission Death|1|||
28001654|NCT01574274|81838131|FG001|Overall Study|Remission Death|0|||
28001655|NCT01574274|81838130|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
28001656|NCT01574274|81838131|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
28001657|NCT01574274|81838130|FG000|Overall Study|Other, unknown|3|||
28001658|NCT01574274|81838131|FG001|Overall Study|Other, unknown|2|||
28001659|NCT04332107|81838132|FG000|Day 3|Lost to Follow-up|23|||
27681853|NCT02535091|80672017|FG000|Overall Study|Pregnancy|0|||
27681854|NCT02535091|80672018|FG001|Overall Study|Pregnancy|0|||
27681855|NCT02535091|80672019|FG002|Overall Study|Pregnancy|7|||
28001660|NCT04332107|81838133|FG001|Day 3|Lost to Follow-up|14|||
28001661|NCT04332107|81838132|FG000|Day 3|Missing outcome data|3|||
27681856|NCT01075958|80672020|FG000|Overall Study|Blood sample could not be obtained|44|||
28001662|NCT04332107|81838133|FG001|Day 3|Missing outcome data|6|||
28001663|NCT04332107|81838132|FG000|Day 14|Lost to Follow-up|13|||
27681857|NCT02175641|80672023|FG000|Overall Study|Death|3|||
27681858|NCT02175641|80672024|FG001|Overall Study|Death|4|||
27681859|NCT02175641|80672023|FG000|Overall Study|Lost to Follow-up|4|||
27681860|NCT02175641|80672024|FG001|Overall Study|Lost to Follow-up|4|||
27681861|NCT02175641|80672023|FG000|Overall Study|Withdrawal by Subject|7|||
28001664|NCT04332107|81838133|FG001|Day 14|Lost to Follow-up|4|||
28001665|NCT04332107|81838132|FG000|Day 14|Missing outcome data|4|||
28001666|NCT04332107|81838133|FG001|Day 14|Missing outcome data|4|||
27583870|NCT00844194|80319075|FG000|Overall Study|Withdrawal by Subject|2|||
27681862|NCT02175641|80672024|FG001|Overall Study|Withdrawal by Subject|4|||
27681863|NCT02175641|80672023|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
27681864|NCT02175641|80672024|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
27681865|NCT02175641|80672023|FG000|Overall Study|Developed Contraindicated Condition|8|||
27681866|NCT02175641|80672024|FG001|Overall Study|Developed Contraindicated Condition|0|||
27681867|NCT01280357|80672025|FG000|Overall Study|Excluded no internal monitoring|14|||
27681868|NCT01280357|80672025|FG000|Overall Study|IInsufficient data/No data supplied|12|||
27681869|NCT02703259|80672026|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
27681870|NCT02703259|80672027|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
27681871|NCT02703259|80672026|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
27681872|NCT02703259|80672027|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
27681873|NCT02703259|80672026|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
27681874|NCT02703259|80672027|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
27681875|NCT03538938|80672028|FG000|Overall Study|Death|0|||
27681876|NCT03538938|80672029|FG001|Overall Study|Death|0|||
27681877|NCT03538938|80672030|FG002|Overall Study|Death|2|||
27681878|NCT03538938|80672031|FG003|Overall Study|Death|0|||
27681879|NCT03538938|80672032|FG004|Overall Study|Death|0|||
27681880|NCT03538938|80672033|FG005|Overall Study|Death|1|||
27681881|NCT03538938|80672034|FG006|Overall Study|Death|0|||
27681882|NCT03538938|80672035|FG007|Overall Study|Death|1|||
28001667|NCT04332107|81838132|FG000|Day 21|Lost to Follow-up|10|||
28001668|NCT04332107|81838133|FG001|Day 21|Lost to Follow-up|2|||
27583871|NCT00844194|80319076|FG001|Overall Study|Withdrawal by Subject|1|||
27583872|NCT00844194|80319075|FG000|Overall Study|Lack of Efficacy|3|||
27583873|NCT00844194|80319076|FG001|Overall Study|Lack of Efficacy|0|||
27583874|NCT00844194|80319075|FG000|Overall Study|Other reason (not specified)|1|||
27583875|NCT00844194|80319076|FG001|Overall Study|Other reason (not specified)|0|||
27583876|NCT03095417|80319077|FG000|Overall Study|missed|1|||
27583877|NCT03095417|80319078|FG001|Overall Study|missed|2|||
27583878|NCT03095417|80319079|FG002|Overall Study|missed|0|||
27583879|NCT03095417|80319080|FG003|Overall Study|missed|1|||
27583880|NCT03095417|80319077|FG000|Overall Study|Lost to Follow-up|2|||
27583881|NCT03095417|80319078|FG001|Overall Study|Lost to Follow-up|2|||
27583882|NCT03095417|80319079|FG002|Overall Study|Lost to Follow-up|1|||
27583883|NCT03095417|80319080|FG003|Overall Study|Lost to Follow-up|0|||
27583884|NCT03095417|80319077|FG000|Overall Study|refusal|0|||
27583885|NCT03095417|80319078|FG001|Overall Study|refusal|1|||
27583886|NCT03095417|80319079|FG002|Overall Study|refusal|0|||
27583887|NCT03095417|80319080|FG003|Overall Study|refusal|1|||
27583888|NCT03095417|80319077|FG000|Overall Study|Withdrawal by Subject|8|||
27583889|NCT03095417|80319078|FG001|Overall Study|Withdrawal by Subject|2|||
27583890|NCT03095417|80319079|FG002|Overall Study|Withdrawal by Subject|5|||
27583891|NCT03095417|80319080|FG003|Overall Study|Withdrawal by Subject|4|||
27583892|NCT03095417|80319077|FG000|Overall Study|Physician Decision|1|||
27583893|NCT03095417|80319078|FG001|Overall Study|Physician Decision|2|||
27583894|NCT03095417|80319079|FG002|Overall Study|Physician Decision|2|||
27583895|NCT03095417|80319080|FG003|Overall Study|Physician Decision|2|||
27583896|NCT03095417|80319077|FG000|Overall Study|Death|1|||
27583897|NCT03095417|80319078|FG001|Overall Study|Death|2|||
27583898|NCT03095417|80319079|FG002|Overall Study|Death|1|||
27583899|NCT03095417|80319080|FG003|Overall Study|Death|3|||
27583900|NCT02731131|80319081|FG000|Overall Study|Psychiatric Disorder|0|||
27583901|NCT02731131|80319082|FG001|Overall Study|Psychiatric Disorder|1|||
27583902|NCT02731131|80319081|FG000|Overall Study|Refused Therapy|0|||
27583903|NCT02731131|80319082|FG001|Overall Study|Refused Therapy|1|||
27583904|NCT03029208|80319086|FG000|Overall Study|Withdrawal by Subject|2|||
27583905|NCT03029208|80319087|FG001|Overall Study|Withdrawal by Subject|3|||
27583906|NCT03029208|80319086|FG000|Overall Study|Lost to Follow-up|0|||
27583907|NCT03029208|80319087|FG001|Overall Study|Lost to Follow-up|1|||
27583908|NCT02606136|80319090|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
27583909|NCT02606136|80319090|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
27583910|NCT02606136|80319090|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
27583911|NCT02606136|80319090|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
27583912|NCT01343056|80319091|FG000|Overall Study|Lost to Follow-up|7|||
27583913|NCT01343056|80319092|FG001|Overall Study|Lost to Follow-up|5|||
27583914|NCT01343056|80319093|FG002|Overall Study|Lost to Follow-up|3|||
27681883|NCT03538938|80672036|FG008|Overall Study|Death|1|||
27681884|NCT03538938|80672037|FG009|Overall Study|Death|1|||
27681885|NCT03538938|80672038|FG010|Overall Study|Death|0|||
27681886|NCT03538938|80672039|FG011|Overall Study|Death|0|||
27681887|NCT03538938|80672040|FG012|Overall Study|Death|1|||
27681888|NCT03538938|80672041|FG013|Overall Study|Death|1|||
27681889|NCT03538938|80672042|FG014|Overall Study|Death|0|||
27681890|NCT03538938|80672043|FG015|Overall Study|Death|1|||
27681891|NCT03538938|80672028|FG000|Overall Study|Withdrawal by Subject|4|||
27681892|NCT03538938|80672029|FG001|Overall Study|Withdrawal by Subject|6|||
27681893|NCT03538938|80672030|FG002|Overall Study|Withdrawal by Subject|5|||
27681894|NCT03538938|80672031|FG003|Overall Study|Withdrawal by Subject|3|||
27681895|NCT03538938|80672032|FG004|Overall Study|Withdrawal by Subject|0|||
27681896|NCT03538938|80672033|FG005|Overall Study|Withdrawal by Subject|0|||
27681897|NCT03538938|80672034|FG006|Overall Study|Withdrawal by Subject|3|||
27681898|NCT03538938|80672035|FG007|Overall Study|Withdrawal by Subject|1|||
27681899|NCT03538938|80672036|FG008|Overall Study|Withdrawal by Subject|5|||
27681900|NCT03538938|80672037|FG009|Overall Study|Withdrawal by Subject|1|||
27681901|NCT03538938|80672038|FG010|Overall Study|Withdrawal by Subject|2|||
27681902|NCT03538938|80672039|FG011|Overall Study|Withdrawal by Subject|1|||
27681903|NCT03538938|80672040|FG012|Overall Study|Withdrawal by Subject|3|||
27681904|NCT03538938|80672041|FG013|Overall Study|Withdrawal by Subject|0|||
27681905|NCT03538938|80672042|FG014|Overall Study|Withdrawal by Subject|2|||
27681906|NCT03538938|80672043|FG015|Overall Study|Withdrawal by Subject|4|||
27681907|NCT03538938|80672028|FG000|Overall Study|Incarcerated|0|||
27681908|NCT03538938|80672029|FG001|Overall Study|Incarcerated|0|||
27681909|NCT03538938|80672030|FG002|Overall Study|Incarcerated|0|||
27681910|NCT03538938|80672031|FG003|Overall Study|Incarcerated|0|||
27681911|NCT03538938|80672032|FG004|Overall Study|Incarcerated|0|||
27681912|NCT03538938|80672033|FG005|Overall Study|Incarcerated|0|||
27681913|NCT03538938|80672034|FG006|Overall Study|Incarcerated|0|||
27681914|NCT03538938|80672035|FG007|Overall Study|Incarcerated|0|||
27681915|NCT03538938|80672036|FG008|Overall Study|Incarcerated|0|||
27681916|NCT03538938|80672037|FG009|Overall Study|Incarcerated|0|||
27681917|NCT03538938|80672038|FG010|Overall Study|Incarcerated|0|||
27681918|NCT03538938|80672039|FG011|Overall Study|Incarcerated|1|||
27681919|NCT03538938|80672040|FG012|Overall Study|Incarcerated|0|||
27681920|NCT03538938|80672041|FG013|Overall Study|Incarcerated|0|||
27681921|NCT03538938|80672042|FG014|Overall Study|Incarcerated|0|||
27681922|NCT03538938|80672043|FG015|Overall Study|Incarcerated|0|||
27681923|NCT00953771|80672044|FG000|Overall Study|Death|1|||
27681924|NCT00953771|80672045|FG001|Overall Study|Death|0|||
27681925|NCT03683823|80672052|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
27681926|NCT03683823|80672053|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
27681927|NCT03683823|80672052|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
27681928|NCT03683823|80672053|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
27681929|NCT03683823|80672052|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
27681930|NCT03683823|80672053|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
27681931|NCT00700778|80672054|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
27681932|NCT00859222|80672055|FG000|Overall Study|Adverse Event|2|||
27681933|NCT00859222|80672056|FG001|Overall Study|Adverse Event|3|||
27681934|NCT00859222|80672057|FG002|Overall Study|Adverse Event|6|||
27681935|NCT00859222|80672058|FG003|Overall Study|Adverse Event|24|||
27681936|NCT00859222|80672059|FG004|Overall Study|Adverse Event|15|||
27806479|NCT03558997|81123205|FG000|Overall Study|Lost to Follow-up|0|||
27806480|NCT03558997|81123206|FG001|Overall Study|Lost to Follow-up|0|||
27806481|NCT03558997|81123207|FG002|Overall Study|Lost to Follow-up|1|||
27806482|NCT03558997|81123208|FG003|Overall Study|Lost to Follow-up|0|||
27806483|NCT02499354|81123209|FG000|Overall Study|Withdrawal by Subject|1|||
27806484|NCT02499354|81123210|FG001|Overall Study|Withdrawal by Subject|0|||
27806485|NCT00297479|81123214|FG000|Overall Study|Lost to Follow-up|37|||
27806486|NCT00297479|81123215|FG001|Overall Study|Lost to Follow-up|54|||
27806487|NCT00297479|81123216|FG002|Overall Study|Lost to Follow-up|51|||
27806488|NCT01034137|81123217|FG000|Overall Study|Adverse Event|9|||
27583915|NCT01343056|80319094|FG003|Overall Study|Lost to Follow-up|9|||
27806489|NCT01034137|81123218|FG001|Overall Study|Adverse Event|10|||
27806490|NCT01034137|81123219|FG002|Overall Study|Adverse Event|8|||
27583916|NCT00659646|80319095|FG000|Overall Study|Protocol Violation|12|||
27583917|NCT00659646|80319096|FG001|Overall Study|Protocol Violation|8|||
27583918|NCT00659646|80319095|FG000|Overall Study|Adverse Event|1|||
27583919|NCT00659646|80319096|FG001|Overall Study|Adverse Event|0|||
27583920|NCT00659646|80319095|FG000|Overall Study|Lost to Follow-up|1|||
27583921|NCT00659646|80319096|FG001|Overall Study|Lost to Follow-up|0|||
27583922|NCT00659646|80319095|FG000|Overall Study|protocol noncompliance after randomized|1|||
27583923|NCT00659646|80319096|FG001|Overall Study|protocol noncompliance after randomized|0|||
27583924|NCT01913041|80319097|FG000|Overall Study|Protocol Violation|35|||
27583925|NCT01913041|80319097|FG000|Overall Study|Withdrawal by Subject|3|||
27583926|NCT01913041|80319097|FG000|Overall Study|Physician Decision|1|||
27681937|NCT00859222|80672055|FG000|Overall Study|DLT|1|||
27681938|NCT00859222|80672056|FG001|Overall Study|DLT|0|||
27681939|NCT00859222|80672057|FG002|Overall Study|DLT|0|||
27681940|NCT00859222|80672058|FG003|Overall Study|DLT|0|||
27681941|NCT00859222|80672059|FG004|Overall Study|DLT|0|||
27681942|NCT02136134|80672060|FG000|Overall Study|Death|170|||
27806491|NCT01034137|81123217|FG000|Overall Study|Withdrawal by Subject|4|||
27681943|NCT02136134|80672061|FG001|Overall Study|Death|148|||
27681944|NCT02136134|80672060|FG000|Overall Study|Withdrawal by Subject|19|||
27681945|NCT02136134|80672061|FG001|Overall Study|Withdrawal by Subject|10|||
27681946|NCT02136134|80672060|FG000|Overall Study|Lost to Follow-up|3|||
27681947|NCT02136134|80672061|FG001|Overall Study|Lost to Follow-up|3|||
27681948|NCT02136134|80672060|FG000|Overall Study|Uspecified|55|||
27681949|NCT02136134|80672061|FG001|Overall Study|Uspecified|90|||
27681950|NCT01162863|80672062|FG000|Overall Study|Lack of Efficacy|1|||
27681951|NCT01162863|80672063|FG001|Overall Study|Lack of Efficacy|0|||
27681952|NCT01162863|80672064|FG002|Overall Study|Lack of Efficacy|0|||
27681953|NCT01162863|80672062|FG000|Overall Study|Adverse Event|0|||
27681954|NCT01162863|80672063|FG001|Overall Study|Adverse Event|1|||
27681955|NCT01162863|80672064|FG002|Overall Study|Adverse Event|0|||
27681956|NCT00283244|80672067|FG000|Overall Study|Adverse Event|0|||
27681957|NCT00283244|80672068|FG001|Overall Study|Adverse Event|8|||
27681958|NCT00283244|80672069|FG002|Overall Study|Adverse Event|11|||
27681959|NCT00283244|80672067|FG000|Overall Study|Death|4|||
27681960|NCT00283244|80672068|FG001|Overall Study|Death|3|||
27681961|NCT00283244|80672069|FG002|Overall Study|Death|2|||
27681962|NCT00283244|80672067|FG000|Overall Study|Lack of Efficacy|8|||
27681963|NCT00283244|80672068|FG001|Overall Study|Lack of Efficacy|32|||
27681964|NCT00283244|80672069|FG002|Overall Study|Lack of Efficacy|26|||
27681965|NCT00283244|80672067|FG000|Overall Study|Withdrawal by Subject|1|||
27681966|NCT00283244|80672068|FG001|Overall Study|Withdrawal by Subject|2|||
27681967|NCT00283244|80672069|FG002|Overall Study|Withdrawal by Subject|2|||
27681968|NCT00283244|80672067|FG000|Overall Study|Physician Decision|0|||
27681969|NCT00283244|80672068|FG001|Overall Study|Physician Decision|0|||
27681970|NCT00283244|80672069|FG002|Overall Study|Physician Decision|1|||
27681971|NCT00283244|80672067|FG000|Overall Study|Medical illness (other complicating dz)|4|||
27681972|NCT00283244|80672068|FG001|Overall Study|Medical illness (other complicating dz)|3|||
27681973|NCT00283244|80672069|FG002|Overall Study|Medical illness (other complicating dz)|6|||
27681974|NCT00283244|80672067|FG000|Overall Study|Clinical deterioration|1|||
27681975|NCT00283244|80672068|FG001|Overall Study|Clinical deterioration|3|||
27681976|NCT00283244|80672069|FG002|Overall Study|Clinical deterioration|3|||
27681977|NCT03868787|80672072|FG000|Overall Study|Withdrawal by Subject|2|||
27681978|NCT03868787|80672073|FG001|Overall Study|Withdrawal by Subject|1|||
27681979|NCT02248818|80672078|FG000|Screening|Protocol Violation|0|||
27681980|NCT02248818|80672079|FG001|Screening|Protocol Violation|0|||
27681981|NCT02248818|80672080|FG002|Screening|Protocol Violation|0|||
27681982|NCT02248818|80672081|FG003|Screening|Protocol Violation|0|||
27681983|NCT02248818|80672082|FG004|Screening|Protocol Violation|0|||
28001669|NCT00496015|81838138|FG000|Overall Study|Other|1|||
27681984|NCT02248818|80672083|FG005|Screening|Protocol Violation|0|||
27681985|NCT02248818|80672084|FG006|Screening|Protocol Violation|0|||
27806492|NCT01034137|81123218|FG001|Overall Study|Withdrawal by Subject|3|||
27806493|NCT01034137|81123219|FG002|Overall Study|Withdrawal by Subject|3|||
27806494|NCT01034137|81123217|FG000|Overall Study|Lack of Efficacy|9|||
27806495|NCT01034137|81123218|FG001|Overall Study|Lack of Efficacy|4|||
27806496|NCT01034137|81123219|FG002|Overall Study|Lack of Efficacy|13|||
27806497|NCT01034137|81123217|FG000|Overall Study|Protocol Violation|2|||
28001670|NCT00496015|81838139|FG001|Overall Study|Other|0|||
27583927|NCT01462344|80319102|FG000|Overall Study|Withdrawal by Subject|245|||
27681986|NCT02248818|80672085|FG007|Screening|Protocol Violation|0|||
27681987|NCT02248818|80672086|FG008|Screening|Protocol Violation|7|||
27681988|NCT02248818|80672078|FG000|Screening|Study fully enrolled|0|||
27806498|NCT01034137|81123218|FG001|Overall Study|Protocol Violation|2|||
27806499|NCT01034137|81123219|FG002|Overall Study|Protocol Violation|1|||
27806500|NCT01034137|81123217|FG000|Overall Study|Refused treatment or did not cooperate|2|||
27583928|NCT01462344|80319103|FG001|Overall Study|Withdrawal by Subject|226|||
27583929|NCT01462344|80319102|FG000|Overall Study|Adverse Event|24|||
27681989|NCT02248818|80672079|FG001|Screening|Study fully enrolled|0|||
27681990|NCT02248818|80672080|FG002|Screening|Study fully enrolled|0|||
27681991|NCT02248818|80672081|FG003|Screening|Study fully enrolled|0|||
27681992|NCT02248818|80672082|FG004|Screening|Study fully enrolled|0|||
27681993|NCT02248818|80672083|FG005|Screening|Study fully enrolled|0|||
27681994|NCT02248818|80672084|FG006|Screening|Study fully enrolled|0|||
27681995|NCT02248818|80672085|FG007|Screening|Study fully enrolled|0|||
27681996|NCT02248818|80672086|FG008|Screening|Study fully enrolled|14|||
27681997|NCT02248818|80672078|FG000|Screening|Physician Decision|0|||
27681998|NCT02248818|80672079|FG001|Screening|Physician Decision|0|||
27681999|NCT02248818|80672080|FG002|Screening|Physician Decision|0|||
27682000|NCT02248818|80672081|FG003|Screening|Physician Decision|0|||
27682001|NCT02248818|80672082|FG004|Screening|Physician Decision|0|||
28001671|NCT00496015|81838140|FG002|Overall Study|Other|0|||
27682002|NCT02248818|80672083|FG005|Screening|Physician Decision|0|||
27682003|NCT02248818|80672084|FG006|Screening|Physician Decision|0|||
27682004|NCT02248818|80672085|FG007|Screening|Physician Decision|0|||
27682005|NCT02248818|80672086|FG008|Screening|Physician Decision|73|||
27682006|NCT02248818|80672078|FG000|Screening|Withdrawal by Subject|0|||
27682007|NCT02248818|80672079|FG001|Screening|Withdrawal by Subject|0|||
27682008|NCT02248818|80672080|FG002|Screening|Withdrawal by Subject|0|||
27682009|NCT02248818|80672081|FG003|Screening|Withdrawal by Subject|0|||
27682010|NCT02248818|80672082|FG004|Screening|Withdrawal by Subject|0|||
27682011|NCT02248818|80672083|FG005|Screening|Withdrawal by Subject|0|||
27682012|NCT02248818|80672084|FG006|Screening|Withdrawal by Subject|0|||
27682013|NCT02248818|80672085|FG007|Screening|Withdrawal by Subject|0|||
27682014|NCT02248818|80672086|FG008|Screening|Withdrawal by Subject|6|||
27682015|NCT02248818|80672078|FG000|Screening|Lost to Follow-up|0|||
27682016|NCT02248818|80672079|FG001|Screening|Lost to Follow-up|0|||
27682017|NCT02248818|80672080|FG002|Screening|Lost to Follow-up|0|||
27682018|NCT02248818|80672081|FG003|Screening|Lost to Follow-up|0|||
27682019|NCT02248818|80672082|FG004|Screening|Lost to Follow-up|0|||
27682020|NCT02248818|80672083|FG005|Screening|Lost to Follow-up|0|||
27682021|NCT02248818|80672084|FG006|Screening|Lost to Follow-up|0|||
27682022|NCT02248818|80672085|FG007|Screening|Lost to Follow-up|0|||
27682023|NCT02248818|80672086|FG008|Screening|Lost to Follow-up|7|||
27682024|NCT02248818|80672078|FG000|Randomised Study|Administrative - randomization error|0|||
27682025|NCT02248818|80672079|FG001|Randomised Study|Administrative - randomization error|0|||
27682026|NCT02248818|80672080|FG002|Randomised Study|Administrative - randomization error|0|||
27682027|NCT02248818|80672081|FG003|Randomised Study|Administrative - randomization error|0|||
27682028|NCT02248818|80672082|FG004|Randomised Study|Administrative - randomization error|0|||
27682029|NCT02248818|80672083|FG005|Randomised Study|Administrative - randomization error|8|||
27682030|NCT02248818|80672084|FG006|Randomised Study|Administrative - randomization error|0|||
27682031|NCT02248818|80672085|FG007|Randomised Study|Administrative - randomization error|0|||
27682032|NCT02248818|80672086|FG008|Randomised Study|Administrative - randomization error|0|||
27682033|NCT03014479|80672087|FG000|Overall Study|Adverse Event|0|||
27682034|NCT03014479|80672088|FG001|Overall Study|Adverse Event|1|||
27682035|NCT03014479|80672087|FG000|Overall Study|Voluntary Withdrawal|0|||
27682036|NCT03014479|80672088|FG001|Overall Study|Voluntary Withdrawal|2|||
27682037|NCT03014479|80672087|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
27682038|NCT03014479|80672088|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
27682039|NCT02235311|80672089|FG000|Overall Study|Lost to Follow-up|0|||
27682040|NCT02235311|80672090|FG001|Overall Study|Lost to Follow-up|1|||
27806501|NCT01034137|81123218|FG001|Overall Study|Refused treatment or did not cooperate|0|||
27806502|NCT01034137|81123219|FG002|Overall Study|Refused treatment or did not cooperate|1|||
27806503|NCT01034137|81123217|FG000|Overall Study|Administrative or other|2|||
27806504|NCT01034137|81123218|FG001|Overall Study|Administrative or other|3|||
27806505|NCT01034137|81123219|FG002|Overall Study|Administrative or other|4|||
27806506|NCT01489956|81123220|FG000|Overall Study|Lost to Follow-up|1|||
27806507|NCT01489956|81123221|FG001|Overall Study|Lost to Follow-up|0|||
27806508|NCT01489956|81123222|FG002|Overall Study|Lost to Follow-up|0|||
27806509|NCT01489956|81123220|FG000|Overall Study|Withdrawal by Subject|0|||
27806510|NCT01489956|81123221|FG001|Overall Study|Withdrawal by Subject|0|||
27806511|NCT01489956|81123222|FG002|Overall Study|Withdrawal by Subject|1|||
28001672|NCT00496015|81838141|FG003|Overall Study|Other|1|||
28001673|NCT00496015|81838142|FG004|Overall Study|Other|0|||
28001674|NCT01859923|81838143|FG000|Overall Study|Adverse Event|0|||
28001675|NCT01859923|81838144|FG001|Overall Study|Adverse Event|0|||
28001676|NCT01859923|81838145|FG002|Overall Study|Adverse Event|1|||
28001677|NCT01859923|81838146|FG003|Overall Study|Adverse Event|1|||
28001678|NCT00844844|81838152|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
28001679|NCT00844844|81838152|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
28001680|NCT00844844|81838152|FG000|Extension Treatment Period|Adverse Event|2|||
28001681|NCT00844844|81838152|FG000|Post Treatment Period|Withdrawal by Subject|1|||
28001682|NCT03883581|81838155|FG000|Overall Study|Withdrawal by Subject|4|||
27583930|NCT01462344|80319103|FG001|Overall Study|Adverse Event|23|||
28001683|NCT00330759|81838159|FG000|Overall Study|Death|316|||
28001684|NCT00330759|81838160|FG001|Overall Study|Death|310|||
27583931|NCT01462344|80319102|FG000|Overall Study|Asthma Exacerbation|34|||
27806512|NCT01623830|81123223|FG000|Overall Study|Withdrawal by Subject|6|||
28001685|NCT00330759|81838159|FG000|Overall Study|Disease progression|104|||
28001686|NCT00330759|81838160|FG001|Overall Study|Disease progression|126|||
27682041|NCT02235311|80672089|FG000|Overall Study|Protocol Violation|0|||
27682042|NCT02235311|80672090|FG001|Overall Study|Protocol Violation|1|||
27682043|NCT03106753|80672091|FG000|Overall Study|Withdrawal by Subject|0|||
27682044|NCT03106753|80672092|FG001|Overall Study|Withdrawal by Subject|1|||
27682045|NCT02842151|80672095|FG000|Overall Study|Adverse Event|1|||
27682046|NCT02842151|80672095|FG000|Overall Study|Subject moved too far away|1|||
28001687|NCT00330759|81838159|FG000|Overall Study|Withdrawal by Subject|143|||
28001688|NCT00330759|81838160|FG001|Overall Study|Withdrawal by Subject|124|||
27682047|NCT01228318|80672096|FG000|Overall Study|Clinic no show to receive intervention|1|||
27682048|NCT01228318|80672097|FG001|Overall Study|Clinic no show to receive intervention|0|||
27682049|NCT01228318|80672096|FG000|Overall Study|Unable to contact|2|||
27682050|NCT01228318|80672097|FG001|Overall Study|Unable to contact|5|||
27682051|NCT01228318|80672096|FG000|Overall Study|Moved|0|||
27682052|NCT01228318|80672097|FG001|Overall Study|Moved|2|||
27682053|NCT01228318|80672096|FG000|Overall Study|Incarcerated|1|||
28001689|NCT00330759|81838159|FG000|Overall Study|Adverse Event|48|||
28001690|NCT00330759|81838160|FG001|Overall Study|Adverse Event|36|||
28001691|NCT00330759|81838159|FG000|Overall Study|Participant request|31|||
28001692|NCT00330759|81838160|FG001|Overall Study|Participant request|22|||
28001693|NCT00330759|81838159|FG000|Overall Study|Lost to Follow-up|16|||
28001694|NCT00330759|81838160|FG001|Overall Study|Lost to Follow-up|22|||
28001695|NCT00330759|81838159|FG000|Overall Study|Noncompliance|15|||
28001696|NCT00330759|81838160|FG001|Overall Study|Noncompliance|17|||
28001697|NCT00330759|81838159|FG000|Overall Study|Physician Decision|1|||
28001698|NCT00330759|81838160|FG001|Overall Study|Physician Decision|2|||
28001699|NCT00330759|81838159|FG000|Overall Study|Protocol deviation|0|||
28001700|NCT00330759|81838160|FG001|Overall Study|Protocol deviation|2|||
28001701|NCT00330759|81838159|FG000|Overall Study|Ineligibility determined|2|||
27583932|NCT01462344|80319103|FG001|Overall Study|Asthma Exacerbation|35|||
27583933|NCT01462344|80319102|FG000|Overall Study|Lack of Efficacy|5|||
27583934|NCT01462344|80319103|FG001|Overall Study|Lack of Efficacy|6|||
27583935|NCT01462344|80319102|FG000|Overall Study|Protocol Violation|68|||
27583936|NCT01462344|80319103|FG001|Overall Study|Protocol Violation|53|||
27583937|NCT01462344|80319102|FG000|Overall Study|Lost to Follow-up|7|||
27583938|NCT01462344|80319103|FG001|Overall Study|Lost to Follow-up|7|||
27583939|NCT01525082|80319110|FG000|Overall Study|Death|1|||
27583940|NCT02819726|80319111|FG000|Part A (All Participants)|Lost to Follow-up|0|||
27583941|NCT02819726|80319112|FG001|Part A (All Participants)|Lost to Follow-up|1|||
27583942|NCT02819726|80319113|FG002|Part A (All Participants)|Lost to Follow-up|0|||
27583943|NCT02819726|80319114|FG003|Part A (All Participants)|Lost to Follow-up|0|||
27583944|NCT02819726|80319111|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
27583945|NCT02819726|80319112|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
27583946|NCT02819726|80319113|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
27583947|NCT02819726|80319114|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
27583948|NCT02819726|80319111|FG000|Part A (All Participants)|Protocol non-compliance|3|||
27583949|NCT02819726|80319112|FG001|Part A (All Participants)|Protocol non-compliance|4|||
27583950|NCT02819726|80319113|FG002|Part A (All Participants)|Protocol non-compliance|5|||
27583951|NCT02819726|80319114|FG003|Part A (All Participants)|Protocol non-compliance|0|||
27583952|NCT02819726|80319111|FG000|Part B (All Participants)|Lost to Follow-up|1|||
27583953|NCT02819726|80319112|FG001|Part B (All Participants)|Lost to Follow-up|1|||
27583954|NCT02819726|80319113|FG002|Part B (All Participants)|Lost to Follow-up|2|||
27583955|NCT02819726|80319114|FG003|Part B (All Participants)|Lost to Follow-up|2|||
27583956|NCT02819726|80319111|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
27583957|NCT02819726|80319112|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
27583958|NCT02819726|80319113|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
27583959|NCT02819726|80319114|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
27583960|NCT02819726|80319111|FG000|Part B (All Participants)|Protocol non-compliance|0|||
27583961|NCT02819726|80319112|FG001|Part B (All Participants)|Protocol non-compliance|0|||
27583962|NCT02819726|80319113|FG002|Part B (All Participants)|Protocol non-compliance|1|||
27583963|NCT02819726|80319114|FG003|Part B (All Participants)|Protocol non-compliance|0|||
27583964|NCT00009737|80319115|FG000|Overall Study|Adverse Event|112|||
27583965|NCT00009737|80319116|FG001|Overall Study|Adverse Event|75|||
27583966|NCT00009737|80319115|FG000|Overall Study|Death|4|||
27583967|NCT00009737|80319116|FG001|Overall Study|Death|6|||
27583968|NCT00009737|80319115|FG000|Overall Study|Lack of Efficacy|17|||
27583969|NCT00009737|80319116|FG001|Overall Study|Lack of Efficacy|15|||
27583970|NCT00009737|80319115|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
27583971|NCT00009737|80319116|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
27583972|NCT00009737|80319115|FG000|Overall Study|Other Protocol Violation|1|||
27583973|NCT00009737|80319116|FG001|Overall Study|Other Protocol Violation|0|||
27583974|NCT00009737|80319115|FG000|Overall Study|Refused Treatment|15|||
27583975|NCT00009737|80319116|FG001|Overall Study|Refused Treatment|16|||
27583976|NCT00009737|80319115|FG000|Overall Study|Lost to Follow-up|1|||
27583977|NCT00009737|80319116|FG001|Overall Study|Lost to Follow-up|1|||
27583978|NCT00009737|80319115|FG000|Overall Study|Administrative/Other Reasons|7|||
27583979|NCT00009737|80319116|FG001|Overall Study|Administrative/Other Reasons|1|||
27583980|NCT01047683|80319125|FG000|Overall Study|Adverse Event|3|||
27583981|NCT01047683|80319126|FG001|Overall Study|Adverse Event|1|||
27583982|NCT01047683|80319127|FG002|Overall Study|Adverse Event|0|||
27583983|NCT01047683|80319125|FG000|Overall Study|Withdrew Consent|1|||
27583984|NCT01047683|80319126|FG001|Overall Study|Withdrew Consent|4|||
27583985|NCT01047683|80319127|FG002|Overall Study|Withdrew Consent|2|||
27682054|NCT01228318|80672097|FG001|Overall Study|Incarcerated|0|||
27682055|NCT01374568|80672102|FG000|Overall Study|Lab unable to analyze BTM|0|||
27682056|NCT01374568|80672103|FG001|Overall Study|Lab unable to analyze BTM|2|||
27682057|NCT01020877|80672105|FG000|Second Intervention|Withdrawal by Subject|1|||
27682058|NCT01020877|80672106|FG001|Second Intervention|Withdrawal by Subject|0|||
27682059|NCT00818779|80672107|FG000|Overall Study|Protocol Violation|1|||
27682060|NCT00818779|80672108|FG001|Overall Study|Protocol Violation|0|||
27682061|NCT00818779|80672107|FG000|Overall Study|Lost to Follow-up|1|||
27682062|NCT00818779|80672108|FG001|Overall Study|Lost to Follow-up|0|||
27682063|NCT00818779|80672107|FG000|Overall Study|Adverse Event|4|||
27682064|NCT00818779|80672108|FG001|Overall Study|Adverse Event|1|||
27682065|NCT01088984|80672109|FG000|Phase 1|Death|2|||
27682066|NCT01088984|80672110|FG001|Phase 1|Death|1|||
27682067|NCT01088984|80672109|FG000|Phase 1|Disease Progression|2|||
27682068|NCT01088984|80672110|FG001|Phase 1|Disease Progression|4|||
27682069|NCT01088984|80672109|FG000|Phase 1|Other|1|||
27682070|NCT01088984|80672110|FG001|Phase 1|Other|1|||
27682071|NCT01088984|80672109|FG000|Phase 2|Death|0|||
27682072|NCT01088984|80672110|FG001|Phase 2|Death|5|||
27682073|NCT01088984|80672109|FG000|Phase 2|Withdrawal by Subject|0|||
27682074|NCT01088984|80672110|FG001|Phase 2|Withdrawal by Subject|1|||
27682075|NCT01088984|80672109|FG000|Phase 2|DIsease Progression|0|||
27682076|NCT01088984|80672110|FG001|Phase 2|DIsease Progression|25|||
27682077|NCT01088984|80672109|FG000|Phase 2|Other|0|||
27682078|NCT01088984|80672110|FG001|Phase 2|Other|1|||
27682079|NCT03026075|80672111|FG000|Overall Study|Physician Decision|1|||
27682080|NCT02770612|80672112|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
27682081|NCT01940939|80672113|FG000|Overall Study|Withdrawal by Subject|2|||
27682082|NCT01940939|80672114|FG001|Overall Study|Withdrawal by Subject|8|||
27682083|NCT02546921|80672115|FG000|Overall Study|Adverse Event|0|||
27682084|NCT02546921|80672116|FG001|Overall Study|Adverse Event|5|||
27682085|NCT02546921|80672117|FG002|Overall Study|Adverse Event|2|||
27682086|NCT02546921|80672118|FG003|Overall Study|Adverse Event|0|||
27682087|NCT02546921|80672119|FG004|Overall Study|Adverse Event|0|||
27682088|NCT02546921|80672120|FG005|Overall Study|Adverse Event|0|||
27682089|NCT02546921|80672121|FG006|Overall Study|Adverse Event|0|||
27682090|NCT02546921|80672115|FG000|Overall Study|Evidence of Disease Progression|1|||
27682091|NCT02546921|80672116|FG001|Overall Study|Evidence of Disease Progression|0|||
27682092|NCT02546921|80672117|FG002|Overall Study|Evidence of Disease Progression|0|||
27682093|NCT02546921|80672118|FG003|Overall Study|Evidence of Disease Progression|0|||
27682094|NCT02546921|80672119|FG004|Overall Study|Evidence of Disease Progression|1|||
27682095|NCT02546921|80672120|FG005|Overall Study|Evidence of Disease Progression|0|||
27682096|NCT02546921|80672121|FG006|Overall Study|Evidence of Disease Progression|0|||
27682097|NCT02546921|80672115|FG000|Overall Study|Patient Choice|0|||
28001702|NCT00330759|81838160|FG001|Overall Study|Ineligibility determined|1|||
27583986|NCT01047683|80319125|FG000|Overall Study|Lost to Follow-up|0|||
27583987|NCT01047683|80319126|FG001|Overall Study|Lost to Follow-up|1|||
27583988|NCT01047683|80319127|FG002|Overall Study|Lost to Follow-up|0|||
27583989|NCT01047683|80319125|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
27583990|NCT01047683|80319126|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
27583991|NCT01047683|80319127|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
27583992|NCT03738150|80319131|FG000|Base Study|Withdrawal by Subject|1|||
27583993|NCT03738150|80319131|FG000|Extension Study|Withdrawal by Subject|1|||
27583994|NCT03936244|80319136|FG000|Overall Study|Lost to Follow-up|5|||
27583995|NCT03936244|80319137|FG001|Overall Study|Lost to Follow-up|1|||
27583996|NCT03936244|80319136|FG000|Overall Study|Physician Decision|7|||
27583997|NCT03936244|80319137|FG001|Overall Study|Physician Decision|3|||
27583998|NCT01591681|80319138|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
27583999|NCT01591681|80319138|FG000|Overall Study|Failed to use system during run-in|1|||
27584000|NCT02086591|80319139|FG000|Overall Study|Adverse Event|1|||
27584001|NCT02086591|80319139|FG000|Overall Study|Withdrawal by Subject|1|||
27584002|NCT02086591|80319139|FG000|Overall Study|protocol terminated|3|||
27584003|NCT03634579|80319140|FG000|Overall Study|study termination|9|||
27584004|NCT05077267|80319141|FG000|Treatment Period|Lost to Follow-up|0|||
27584005|NCT05077267|80319142|FG001|Treatment Period|Lost to Follow-up|1|||
27584006|NCT05077267|80319143|FG002|Treatment Period|Lost to Follow-up|0|||
27584007|NCT05077267|80319141|FG000|Treatment Period|Withdrawal by Subject|0|||
27584008|NCT05077267|80319142|FG001|Treatment Period|Withdrawal by Subject|1|||
27584009|NCT05077267|80319143|FG002|Treatment Period|Withdrawal by Subject|0|||
27584010|NCT05077267|80319141|FG000|Follow-up Period|Lost to Follow-up|0|||
27584011|NCT05077267|80319142|FG001|Follow-up Period|Lost to Follow-up|5|||
27584012|NCT05077267|80319143|FG002|Follow-up Period|Lost to Follow-up|7|||
27584013|NCT05077267|80319141|FG000|Follow-up Period|Withdrawal by Subject|0|||
27584014|NCT05077267|80319142|FG001|Follow-up Period|Withdrawal by Subject|2|||
27584015|NCT05077267|80319143|FG002|Follow-up Period|Withdrawal by Subject|5|||
27584016|NCT05077267|80319141|FG000|Follow-up Period|Study terminated by sponsor|0|||
27584017|NCT05077267|80319142|FG001|Follow-up Period|Study terminated by sponsor|27|||
27682098|NCT02546921|80672116|FG001|Overall Study|Patient Choice|1|||
27682099|NCT02546921|80672117|FG002|Overall Study|Patient Choice|0|||
27682100|NCT02546921|80672118|FG003|Overall Study|Patient Choice|0|||
27682101|NCT02546921|80672119|FG004|Overall Study|Patient Choice|0|||
27682102|NCT02546921|80672120|FG005|Overall Study|Patient Choice|1|||
27682103|NCT02546921|80672121|FG006|Overall Study|Patient Choice|0|||
27682104|NCT02755818|80672124|FG000|Overall Study|Withdrawal by Subject|0|||
27682105|NCT02755818|80672125|FG001|Overall Study|Withdrawal by Subject|0|||
27682106|NCT02755818|80672126|FG002|Overall Study|Withdrawal by Subject|0|||
27682107|NCT02755818|80672127|FG003|Overall Study|Withdrawal by Subject|2|||
27682108|NCT02755818|80672124|FG000|Overall Study|withdrawal by PI|0|||
27682109|NCT02755818|80672125|FG001|Overall Study|withdrawal by PI|0|||
27682110|NCT02755818|80672126|FG002|Overall Study|withdrawal by PI|1|||
27682111|NCT02755818|80672127|FG003|Overall Study|withdrawal by PI|1|||
27584018|NCT05077267|80319143|FG002|Follow-up Period|Study terminated by sponsor|23|||
27584019|NCT05077267|80319141|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
27584020|NCT05077267|80319142|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
27584021|NCT05077267|80319143|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
27584022|NCT05077267|80319141|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
27682112|NCT03921723|80672128|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
27682113|NCT03921723|80672128|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
27682114|NCT01743989|80672130|FG000|Treatment Phase|Unstable MR4.0|0|||
27682115|NCT01743989|80672131|FG001|Treatment Phase|Unstable MR4.0|6|||
27682116|NCT01743989|80672132|FG002|Treatment Phase|Unstable MR4.0|263|||
27682117|NCT01743989|80672130|FG000|Treatment Phase|Adverse Event|0|||
27682118|NCT01743989|80672131|FG001|Treatment Phase|Adverse Event|4|||
27682119|NCT01743989|80672132|FG002|Treatment Phase|Adverse Event|67|||
27682120|NCT01743989|80672130|FG000|Treatment Phase|Withdrawal by Subject|1|||
27682121|NCT01743989|80672131|FG001|Treatment Phase|Withdrawal by Subject|3|||
27682122|NCT01743989|80672132|FG002|Treatment Phase|Withdrawal by Subject|28|||
27682123|NCT01743989|80672130|FG000|Treatment Phase|Death|0|||
27682124|NCT01743989|80672131|FG001|Treatment Phase|Death|1|||
27682125|NCT01743989|80672132|FG002|Treatment Phase|Death|3|||
27682126|NCT01743989|80672130|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
27682127|NCT01743989|80672131|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
27682128|NCT01743989|80672132|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
27682129|NCT01743989|80672130|FG000|Treatment Phase|Protocol deviation|0|||
27806513|NCT01623830|81123224|FG001|Overall Study|Withdrawal by Subject|7|||
27806514|NCT01623830|81123223|FG000|Overall Study|Exclusion from Study|1|||
27806515|NCT01623830|81123224|FG001|Overall Study|Exclusion from Study|2|||
27806516|NCT02328547|81123225|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
27806517|NCT02328547|81123226|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
27806518|NCT02328547|81123225|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
27806519|NCT02328547|81123226|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
27806520|NCT02280421|81123227|FG000|Washout (2 Weeks)|Adverse Event|0|||
27806521|NCT02280421|81123228|FG001|Washout (2 Weeks)|Adverse Event|1|||
27806522|NCT02280421|81123227|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
27806523|NCT02280421|81123228|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
27806524|NCT04908722|81123229|FG000|Overall Study|Protocol deviation|1|||
27806525|NCT04908722|81123230|FG001|Overall Study|Protocol deviation|0|||
27806526|NCT04908722|81123231|FG002|Overall Study|Protocol deviation|0|||
27806527|NCT04908722|81123232|FG003|Overall Study|Protocol deviation|0|||
27806528|NCT04908722|81123233|FG004|Overall Study|Protocol deviation|0|||
27806529|NCT04908722|81123234|FG005|Overall Study|Protocol deviation|1|||
27806530|NCT04908722|81123229|FG000|Overall Study|Lost to Follow-up|33|||
27806531|NCT04908722|81123230|FG001|Overall Study|Lost to Follow-up|33|||
27806532|NCT04908722|81123231|FG002|Overall Study|Lost to Follow-up|36|||
27806533|NCT04908722|81123232|FG003|Overall Study|Lost to Follow-up|30|||
27806534|NCT04908722|81123233|FG004|Overall Study|Lost to Follow-up|32|||
27806535|NCT04908722|81123234|FG005|Overall Study|Lost to Follow-up|34|||
27806536|NCT04908722|81123229|FG000|Overall Study|Physician Decision|1|||
27874030|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
28001703|NCT00330759|81838159|FG000|Overall Study|Other|36|||
27682130|NCT01743989|80672131|FG001|Treatment Phase|Protocol deviation|0|||
27682131|NCT01743989|80672132|FG002|Treatment Phase|Protocol deviation|3|||
27682132|NCT01743989|80672130|FG000|Treatment Phase|Pregnancy|0|||
27682133|NCT01743989|80672131|FG001|Treatment Phase|Pregnancy|0|||
27806537|NCT04908722|81123230|FG001|Overall Study|Physician Decision|1|||
27806538|NCT04908722|81123231|FG002|Overall Study|Physician Decision|1|||
27806539|NCT04908722|81123232|FG003|Overall Study|Physician Decision|2|||
27806540|NCT04908722|81123233|FG004|Overall Study|Physician Decision|0|||
27584023|NCT05077267|80319142|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
27682134|NCT01743989|80672132|FG002|Treatment Phase|Pregnancy|2|||
27806541|NCT04908722|81123234|FG005|Overall Study|Physician Decision|0|||
27682135|NCT01743989|80672130|FG000|Treatment Phase|Lost to Follow-up|0|||
27682136|NCT01743989|80672131|FG001|Treatment Phase|Lost to Follow-up|0|||
27682137|NCT01743989|80672132|FG002|Treatment Phase|Lost to Follow-up|2|||
27682138|NCT01743989|80672130|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
27682139|NCT01743989|80672131|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
27682140|NCT01743989|80672132|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
27682141|NCT01743989|80672130|FG000|Treatment Phase|Administrative problems|0|||
27682142|NCT01743989|80672131|FG001|Treatment Phase|Administrative problems|0|||
27682143|NCT01743989|80672132|FG002|Treatment Phase|Administrative problems|1|||
27682144|NCT01743989|80672130|FG000|Treatment Phase|New cancer (CML) therapy|0|||
27682145|NCT01743989|80672131|FG001|Treatment Phase|New cancer (CML) therapy|1|||
27682146|NCT01743989|80672132|FG002|Treatment Phase|New cancer (CML) therapy|0|||
27682147|NCT01743989|80672130|FG000|Treatment Phase|Physician Decision|0|||
27682148|NCT01743989|80672131|FG001|Treatment Phase|Physician Decision|0|||
27682149|NCT01743989|80672132|FG002|Treatment Phase|Physician Decision|3|||
27682150|NCT01743989|80672130|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
27682151|NCT01743989|80672131|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
27682152|NCT01743989|80672132|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
27682153|NCT01743989|80672130|FG000|Treatment Phase|Not randomized by mistake|0|||
27682154|NCT01743989|80672131|FG001|Treatment Phase|Not randomized by mistake|0|||
27682155|NCT01743989|80672132|FG002|Treatment Phase|Not randomized by mistake|1|||
27682156|NCT01743989|80672130|FG000|Treatment Phase|Included by mistake|0|||
27806542|NCT04908722|81123229|FG000|Overall Study|Death|1|||
27806543|NCT04908722|81123230|FG001|Overall Study|Death|0|||
27806544|NCT04908722|81123231|FG002|Overall Study|Death|0|||
27806545|NCT04908722|81123232|FG003|Overall Study|Death|0|||
27806546|NCT04908722|81123233|FG004|Overall Study|Death|0|||
27874031|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
27874032|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27806547|NCT04908722|81123234|FG005|Overall Study|Death|1|||
27806548|NCT04908722|81123229|FG000|Overall Study|Withdrawal by Subject|12|||
27806549|NCT04908722|81123230|FG001|Overall Study|Withdrawal by Subject|8|||
27806550|NCT04908722|81123231|FG002|Overall Study|Withdrawal by Subject|7|||
27806551|NCT04908722|81123232|FG003|Overall Study|Withdrawal by Subject|6|||
27806552|NCT04908722|81123233|FG004|Overall Study|Withdrawal by Subject|12|||
27806553|NCT04908722|81123234|FG005|Overall Study|Withdrawal by Subject|14|||
27806554|NCT04908722|81123229|FG000|Overall Study|Other|3|||
27806555|NCT04908722|81123230|FG001|Overall Study|Other|1|||
27806556|NCT04908722|81123231|FG002|Overall Study|Other|3|||
27806557|NCT04908722|81123232|FG003|Overall Study|Other|2|||
27806558|NCT04908722|81123233|FG004|Overall Study|Other|4|||
27806559|NCT04908722|81123234|FG005|Overall Study|Other|1|||
27806560|NCT04908722|81123229|FG000|Overall Study|Initiated prohibited medication|0|||
27806561|NCT04908722|81123230|FG001|Overall Study|Initiated prohibited medication|0|||
27806562|NCT04908722|81123231|FG002|Overall Study|Initiated prohibited medication|0|||
27806563|NCT04908722|81123232|FG003|Overall Study|Initiated prohibited medication|1|||
27806564|NCT04908722|81123233|FG004|Overall Study|Initiated prohibited medication|0|||
27806565|NCT04908722|81123234|FG005|Overall Study|Initiated prohibited medication|1|||
27806566|NCT04908722|81123229|FG000|Overall Study|Randomized but not vaccinated|3|||
27806567|NCT04908722|81123230|FG001|Overall Study|Randomized but not vaccinated|1|||
27806568|NCT04908722|81123231|FG002|Overall Study|Randomized but not vaccinated|2|||
27806569|NCT04908722|81123232|FG003|Overall Study|Randomized but not vaccinated|2|||
27806570|NCT04908722|81123233|FG004|Overall Study|Randomized but not vaccinated|3|||
27806571|NCT04908722|81123234|FG005|Overall Study|Randomized but not vaccinated|4|||
27806572|NCT01306253|81123238|FG000|Overall Study|Lost to Follow-up|1|||
27806573|NCT01306253|81123239|FG001|Overall Study|Lost to Follow-up|1|||
27806574|NCT04274192|81123241|FG000|Overall Study|Protocol Violation|1|||
27806575|NCT04274192|81123242|FG001|Overall Study|Protocol Violation|0|||
27806576|NCT02451670|81123243|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
27874033|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
27874034|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
27874035|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
27682157|NCT01743989|80672131|FG001|Treatment Phase|Included by mistake|0|||
27682158|NCT01743989|80672132|FG002|Treatment Phase|Included by mistake|1|||
27806577|NCT02451670|81123244|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
27806578|NCT02791659|81123245|FG000|Overall Study|Protocol Violation|0|||
27806579|NCT02791659|81123246|FG001|Overall Study|Protocol Violation|1|||
27806580|NCT01967888|81123247|FG000|Overall Study|Lost to Follow-up|6|||
27806581|NCT01967888|81123248|FG001|Overall Study|Lost to Follow-up|4|||
27806582|NCT01967888|81123247|FG000|Overall Study|Withdrawal by Subject|1|||
27806583|NCT01967888|81123248|FG001|Overall Study|Withdrawal by Subject|1|||
27806584|NCT01967888|81123247|FG000|Overall Study|Did Not Have Transplant|1|||
27806585|NCT01967888|81123248|FG001|Overall Study|Did Not Have Transplant|0|||
27806586|NCT01967888|81123247|FG000|Overall Study|Research visit not done, data recorded|1|||
27806587|NCT01967888|81123248|FG001|Overall Study|Research visit not done, data recorded|0|||
27682159|NCT01743989|80672130|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
27682160|NCT01743989|80672131|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
27584024|NCT05077267|80319143|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
27584025|NCT01931839|80319144|FG000|Overall Study|Death|0|||
27584026|NCT01931839|80319145|FG001|Overall Study|Death|1|||
27584027|NCT01931839|80319146|FG002|Overall Study|Death|2|||
27584028|NCT01931839|80319147|FG003|Overall Study|Death|0|||
27682161|NCT01743989|80672132|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
27682162|NCT01743989|80672130|FG000|TFR Phase|Adverse Event|0|||
27806588|NCT01967888|81123247|FG000|Overall Study|Subject excluded after randomization|1|||
27806589|NCT01967888|81123248|FG001|Overall Study|Subject excluded after randomization|0|||
27806590|NCT01967888|81123247|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
27806591|NCT01967888|81123248|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
27806592|NCT01967888|81123247|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
27806593|NCT01967888|81123248|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
27806594|NCT00911859|81123249|FG000|Treatment Period|Adverse Event|3|||
27806595|NCT00911859|81123250|FG001|Treatment Period|Adverse Event|3|||
27806596|NCT00911859|81123251|FG002|Treatment Period|Adverse Event|7|||
27806597|NCT00911859|81123249|FG000|Treatment Period|Death|1|||
27806598|NCT00911859|81123250|FG001|Treatment Period|Death|3|||
27806599|NCT00911859|81123251|FG002|Treatment Period|Death|5|||
27682163|NCT01743989|80672131|FG001|TFR Phase|Adverse Event|1|||
27682164|NCT01743989|80672132|FG002|TFR Phase|Adverse Event|0|||
27584029|NCT01931839|80319148|FG004|Overall Study|Death|0|||
27682165|NCT01743989|80672130|FG000|TFR Phase|Lost to Follow-up|0|||
28001704|NCT00330759|81838160|FG001|Overall Study|Other|44|||
28001705|NCT00088530|81838161|FG000|Overall Study|Progressive/Relapsed Disease|28|||
28001706|NCT00088530|81838162|FG001|Overall Study|Progressive/Relapsed Disease|39|||
28001707|NCT00088530|81838161|FG000|Overall Study|Adverse Event|15|||
28001708|NCT00088530|81838162|FG001|Overall Study|Adverse Event|9|||
27584030|NCT01931839|80319149|FG005|Overall Study|Death|0|||
27584031|NCT01931839|80319150|FG006|Overall Study|Death|0|||
27584032|NCT01931839|80319144|FG000|Overall Study|Physician Decision|1|||
27584033|NCT01931839|80319145|FG001|Overall Study|Physician Decision|0|||
27584034|NCT01931839|80319146|FG002|Overall Study|Physician Decision|1|||
28001709|NCT00088530|81838161|FG000|Overall Study|Withdrawal by Subject|2|||
28001710|NCT00088530|81838162|FG001|Overall Study|Withdrawal by Subject|5|||
28001711|NCT00088530|81838161|FG000|Overall Study|Lost to Follow-up|2|||
28001712|NCT00088530|81838162|FG001|Overall Study|Lost to Follow-up|0|||
28001713|NCT00088530|81838161|FG000|Overall Study|Physician Decision|2|||
28001714|NCT00088530|81838162|FG001|Overall Study|Physician Decision|0|||
28001715|NCT00088530|81838161|FG000|Overall Study|Sponsor decision|0|||
28001716|NCT00088530|81838162|FG001|Overall Study|Sponsor decision|1|||
28001717|NCT00088530|81838161|FG000|Overall Study|Patient never treated|1|||
28001718|NCT00088530|81838162|FG001|Overall Study|Patient never treated|0|||
28001719|NCT00587158|81838163|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
28001720|NCT00587158|81838164|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
28001721|NCT00587158|81838163|FG000|Overall Study|Physician Decision|0|||
28001722|NCT00587158|81838164|FG001|Overall Study|Physician Decision|1|||
28001723|NCT00587158|81838163|FG000|Overall Study|Lost to Follow-up|1|||
28001724|NCT00587158|81838164|FG001|Overall Study|Lost to Follow-up|2|||
28001725|NCT00587158|81838163|FG000|Overall Study|Death|0|||
28001726|NCT00587158|81838164|FG001|Overall Study|Death|1|||
28001727|NCT00587158|81838163|FG000|Overall Study|Subject did not want to take study med|0|||
28001728|NCT00587158|81838164|FG001|Overall Study|Subject did not want to take study med|1|||
28001729|NCT02407223|81838165|FG000|Overall Study|Adverse Event|1|||
28001730|NCT02407223|81838166|FG001|Overall Study|Adverse Event|0|||
28001731|NCT02407223|81838167|FG002|Overall Study|Adverse Event|1|||
28001732|NCT02407223|81838165|FG000|Overall Study|Lack of Efficacy|6|||
28001733|NCT02407223|81838166|FG001|Overall Study|Lack of Efficacy|6|||
28001734|NCT02407223|81838167|FG002|Overall Study|Lack of Efficacy|4|||
28001735|NCT02407223|81838165|FG000|Overall Study|Lost to Follow-up|1|||
28001736|NCT02407223|81838166|FG001|Overall Study|Lost to Follow-up|0|||
28001737|NCT02407223|81838167|FG002|Overall Study|Lost to Follow-up|2|||
28001738|NCT02407223|81838165|FG000|Overall Study|Withdrawal by Subject|2|||
28001739|NCT02407223|81838166|FG001|Overall Study|Withdrawal by Subject|4|||
28001740|NCT02407223|81838167|FG002|Overall Study|Withdrawal by Subject|4|||
28001741|NCT02407223|81838165|FG000|Overall Study|Study Terminated by Sponsor|77|||
28001742|NCT02407223|81838166|FG001|Overall Study|Study Terminated by Sponsor|80|||
28001743|NCT02407223|81838167|FG002|Overall Study|Study Terminated by Sponsor|86|||
28001744|NCT02407223|81838165|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
28001745|NCT02407223|81838166|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
28001746|NCT02407223|81838167|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
28001747|NCT02407223|81838165|FG000|Overall Study|Other|29|||
28001748|NCT02407223|81838166|FG001|Overall Study|Other|27|||
28001749|NCT02407223|81838167|FG002|Overall Study|Other|25|||
28001750|NCT04612725|81838168|FG000|Overall Study|Adverse Event|1|||
28001751|NCT04612725|81838169|FG001|Overall Study|Adverse Event|3|||
28001752|NCT04612725|81838170|FG002|Overall Study|Adverse Event|1|||
28001753|NCT04612725|81838171|FG003|Overall Study|Adverse Event|0|||
28001754|NCT04612725|81838172|FG004|Overall Study|Adverse Event|1|||
28001755|NCT04612725|81838168|FG000|Overall Study|Lost to Follow-up|0|||
28001756|NCT04612725|81838169|FG001|Overall Study|Lost to Follow-up|1|||
28001757|NCT04612725|81838170|FG002|Overall Study|Lost to Follow-up|0|||
28001758|NCT04612725|81838171|FG003|Overall Study|Lost to Follow-up|0|||
28001759|NCT04612725|81838172|FG004|Overall Study|Lost to Follow-up|0|||
28001760|NCT04612725|81838168|FG000|Overall Study|Physician Decision|2|||
28001761|NCT04612725|81838169|FG001|Overall Study|Physician Decision|0|||
28001762|NCT04612725|81838170|FG002|Overall Study|Physician Decision|0|||
27584035|NCT01931839|80319147|FG003|Overall Study|Physician Decision|0|||
27584036|NCT01931839|80319148|FG004|Overall Study|Physician Decision|0|||
27682166|NCT01743989|80672131|FG001|TFR Phase|Lost to Follow-up|2|||
28001763|NCT04612725|81838171|FG003|Overall Study|Physician Decision|0|||
28001764|NCT04612725|81838172|FG004|Overall Study|Physician Decision|0|||
27584037|NCT01931839|80319149|FG005|Overall Study|Physician Decision|0|||
27584038|NCT01931839|80319150|FG006|Overall Study|Physician Decision|1|||
27584039|NCT01931839|80319144|FG000|Overall Study|Withdrawal of consent|0|||
27584040|NCT01931839|80319145|FG001|Overall Study|Withdrawal of consent|0|||
28001765|NCT04612725|81838168|FG000|Overall Study|Study terminated by sponsor|3|||
28001766|NCT04612725|81838169|FG001|Overall Study|Study terminated by sponsor|1|||
28001767|NCT04612725|81838170|FG002|Overall Study|Study terminated by sponsor|2|||
28001768|NCT04612725|81838171|FG003|Overall Study|Study terminated by sponsor|4|||
27874036|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
27874037|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874038|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874039|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874040|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874041|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874042|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874043|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874044|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874045|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27806600|NCT00911859|81123249|FG000|Treatment Period|Lack of Efficacy|1|||
27806601|NCT00911859|81123250|FG001|Treatment Period|Lack of Efficacy|7|||
27806602|NCT00911859|81123251|FG002|Treatment Period|Lack of Efficacy|5|||
27806603|NCT00911859|81123249|FG000|Treatment Period|Physician Decision|3|||
27806604|NCT00911859|81123250|FG001|Treatment Period|Physician Decision|3|||
27806605|NCT00911859|81123251|FG002|Treatment Period|Physician Decision|3|||
27806606|NCT00911859|81123249|FG000|Treatment Period|Withdrawal by Subject|0|||
27806607|NCT00911859|81123250|FG001|Treatment Period|Withdrawal by Subject|4|||
27806608|NCT00911859|81123251|FG002|Treatment Period|Withdrawal by Subject|5|||
27806609|NCT00911859|81123249|FG000|Treatment Period|Did not receive study treatment|0|||
27806610|NCT00911859|81123250|FG001|Treatment Period|Did not receive study treatment|1|||
27806611|NCT00911859|81123251|FG002|Treatment Period|Did not receive study treatment|0|||
28001769|NCT04612725|81838172|FG004|Overall Study|Study terminated by sponsor|5|||
27806612|NCT00911859|81123249|FG000|Maintainance Period|Lack of Efficacy|0|||
27806613|NCT00911859|81123250|FG001|Maintainance Period|Lack of Efficacy|0|||
27806614|NCT00911859|81123251|FG002|Maintainance Period|Lack of Efficacy|9|||
27806615|NCT00911859|81123249|FG000|Maintainance Period|Physician Decision|0|||
27806616|NCT00911859|81123250|FG001|Maintainance Period|Physician Decision|0|||
27806617|NCT00911859|81123251|FG002|Maintainance Period|Physician Decision|9|||
27806618|NCT00911859|81123249|FG000|Maintainance Period|Withdrawal by Subject|0|||
27806619|NCT00911859|81123250|FG001|Maintainance Period|Withdrawal by Subject|0|||
27806620|NCT00911859|81123251|FG002|Maintainance Period|Withdrawal by Subject|3|||
27806621|NCT00911859|81123249|FG000|Follow-up Period|Death|5|||
27806622|NCT00911859|81123250|FG001|Follow-up Period|Death|8|||
27806623|NCT00911859|81123251|FG002|Follow-up Period|Death|10|||
27806624|NCT00911859|81123249|FG000|Follow-up Period|Lost to Follow-up|1|||
27806625|NCT00911859|81123250|FG001|Follow-up Period|Lost to Follow-up|1|||
28001770|NCT04612725|81838168|FG000|Overall Study|Withdrawal by Subject|8|||
28001771|NCT04612725|81838169|FG001|Overall Study|Withdrawal by Subject|3|||
28001772|NCT04612725|81838170|FG002|Overall Study|Withdrawal by Subject|5|||
28001773|NCT04612725|81838171|FG003|Overall Study|Withdrawal by Subject|1|||
28001774|NCT04612725|81838172|FG004|Overall Study|Withdrawal by Subject|9|||
28001775|NCT04612725|81838168|FG000|Overall Study|Other|0|||
28001776|NCT04612725|81838169|FG001|Overall Study|Other|0|||
28001777|NCT04612725|81838170|FG002|Overall Study|Other|0|||
28001778|NCT04612725|81838171|FG003|Overall Study|Other|0|||
28001779|NCT04612725|81838172|FG004|Overall Study|Other|1|||
28001780|NCT04864639|81838173|FG000|Overall Study|Death|1|||
28001781|NCT04864639|81838173|FG000|Overall Study|Lost to Follow-up|1|||
28001782|NCT00100789|81838181|FG000|Overall Study|Adverse Event|10|||
28001783|NCT00100789|81838181|FG000|Overall Study|Withdrawal by Subject|1|||
28001784|NCT00100789|81838181|FG000|Overall Study|Progression/relapse|42|||
28001785|NCT00100789|81838181|FG000|Overall Study|Death|2|||
28001786|NCT00100789|81838181|FG000|Overall Study|Not protocol specified|5|||
28001787|NCT00100789|81838181|FG000|Overall Study|Ineligible|3|||
28001788|NCT00100789|81838181|FG000|Overall Study|Never received treatment|1|||
28001789|NCT02210000|81838184|FG000|Overall Study|Study Terminated|11|||
28001790|NCT02210000|81838185|FG001|Overall Study|Study Terminated|12|||
28001791|NCT02210000|81838184|FG000|Overall Study|Withdrawal by Subject|7|||
27682167|NCT01743989|80672132|FG002|TFR Phase|Lost to Follow-up|0|||
27806626|NCT00911859|81123251|FG002|Follow-up Period|Lost to Follow-up|0|||
27806627|NCT00911859|81123249|FG000|Follow-up Period|Withdrawal by Subject|0|||
27806628|NCT00911859|81123250|FG001|Follow-up Period|Withdrawal by Subject|4|||
27806629|NCT00911859|81123251|FG002|Follow-up Period|Withdrawal by Subject|4|||
27806630|NCT00911859|81123249|FG000|Follow-up Period|Study terminated by sponsor|5|||
27874046|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874047|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
27874048|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
27806631|NCT00911859|81123250|FG001|Follow-up Period|Study terminated by sponsor|33|||
27806632|NCT00911859|81123251|FG002|Follow-up Period|Study terminated by sponsor|27|||
27806633|NCT02024698|81123252|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
27874049|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
28001792|NCT02210000|81838185|FG001|Overall Study|Withdrawal by Subject|1|||
28001793|NCT02210000|81838184|FG000|Overall Study|Adverse Event|1|||
28001794|NCT02210000|81838185|FG001|Overall Study|Adverse Event|5|||
27584041|NCT01931839|80319146|FG002|Overall Study|Withdrawal of consent|0|||
27584042|NCT01931839|80319147|FG003|Overall Study|Withdrawal of consent|0|||
27584043|NCT01931839|80319148|FG004|Overall Study|Withdrawal of consent|1|||
27682168|NCT01743989|80672130|FG000|TFR Phase|Physician Decision|0|||
27682169|NCT01743989|80672131|FG001|TFR Phase|Physician Decision|1|||
27806634|NCT02024698|81123253|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
27806635|NCT01841359|81123266|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
27806636|NCT01841359|81123266|FG000|Overall Study|Concommitant medical issues|2|||
27806637|NCT01841359|81123266|FG000|Overall Study|Adverse Event|3|||
27806638|NCT01841359|81123266|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
27806639|NCT00399490|81123267|FG000|Overall Study|Adverse Event|19|||
27806640|NCT00399490|81123267|FG000|Overall Study|Lack of Efficacy|31|||
27806641|NCT00399490|81123267|FG000|Overall Study|Lost to Follow-up|5|||
27806642|NCT00399490|81123267|FG000|Overall Study|Withdrawal by Subject|18|||
27806643|NCT00399490|81123267|FG000|Overall Study|Other|25|||
27806644|NCT01663714|81123273|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
27806645|NCT01663714|81123273|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
27806646|NCT01663714|81123273|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
27806647|NCT01663714|81123273|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
27806648|NCT01663714|81123273|FG000|Long-Term Follow-Up|Death|4|||
27806649|NCT01663714|81123273|FG000|Long-Term Follow-Up|Non-compliance|1|||
27806650|NCT01252238|81123274|FG000|Overall Study|Sponsor terminated study|4|||
27806651|NCT01252238|81123275|FG001|Overall Study|Sponsor terminated study|4|||
27806652|NCT01252238|81123276|FG002|Overall Study|Sponsor terminated study|4|||
27806653|NCT00065065|81123277|FG000|Overall Study|Adverse Event|3|||
27806654|NCT00065065|81123278|FG001|Overall Study|Adverse Event|2|||
27806655|NCT00065065|81123277|FG000|Overall Study|Withdrawal by Subject|1|||
27806656|NCT00065065|81123278|FG001|Overall Study|Withdrawal by Subject|5|||
27806657|NCT00065065|81123277|FG000|Overall Study|Lack of Efficacy|4|||
27806658|NCT00065065|81123278|FG001|Overall Study|Lack of Efficacy|11|||
27806659|NCT00065065|81123277|FG000|Overall Study|Other|2|||
27806660|NCT00065065|81123278|FG001|Overall Study|Other|2|||
28001795|NCT02210000|81838184|FG000|Overall Study|Lost to Follow-up|0|||
28001796|NCT02210000|81838185|FG001|Overall Study|Lost to Follow-up|2|||
28001797|NCT02210000|81838184|FG000|Overall Study|Physician Decision|0|||
28001798|NCT02210000|81838185|FG001|Overall Study|Physician Decision|1|||
28001799|NCT02336607|81838188|FG000|Overall Study|Physician Decision|1|||
28001800|NCT02336607|81838189|FG001|Overall Study|Physician Decision|4|||
28001801|NCT02336607|81838190|FG002|Overall Study|Physician Decision|3|||
28001802|NCT02336607|81838191|FG003|Overall Study|Physician Decision|15|||
28001803|NCT02336607|81838188|FG000|Overall Study|Lack of Efficacy|1|||
28001804|NCT02336607|81838189|FG001|Overall Study|Lack of Efficacy|0|||
28001805|NCT02336607|81838190|FG002|Overall Study|Lack of Efficacy|0|||
28001806|NCT02336607|81838191|FG003|Overall Study|Lack of Efficacy|2|||
28001807|NCT02336607|81838188|FG000|Overall Study|Lost to Follow-up|2|||
28001808|NCT02336607|81838189|FG001|Overall Study|Lost to Follow-up|1|||
28001809|NCT02336607|81838190|FG002|Overall Study|Lost to Follow-up|0|||
28001810|NCT02336607|81838191|FG003|Overall Study|Lost to Follow-up|21|||
28001811|NCT02336607|81838188|FG000|Overall Study|Protocol Violation|0|||
28001812|NCT02336607|81838189|FG001|Overall Study|Protocol Violation|1|||
28001813|NCT02336607|81838190|FG002|Overall Study|Protocol Violation|1|||
28001814|NCT02336607|81838191|FG003|Overall Study|Protocol Violation|3|||
28001815|NCT02336607|81838188|FG000|Overall Study|Adverse Event|0|||
28001816|NCT02336607|81838189|FG001|Overall Study|Adverse Event|2|||
28001817|NCT02336607|81838190|FG002|Overall Study|Adverse Event|2|||
28001818|NCT02336607|81838191|FG003|Overall Study|Adverse Event|26|||
28001819|NCT02336607|81838188|FG000|Overall Study|Withdrawal by Subject|0|||
28001820|NCT02336607|81838189|FG001|Overall Study|Withdrawal by Subject|2|||
28001821|NCT02336607|81838190|FG002|Overall Study|Withdrawal by Subject|0|||
28001822|NCT02336607|81838191|FG003|Overall Study|Withdrawal by Subject|20|||
28001823|NCT01759420|81838195|FG000|Overall Study|Screen failure|5|||
27682170|NCT01743989|80672132|FG002|TFR Phase|Physician Decision|0|||
28001824|NCT01759420|81838195|FG000|Overall Study|Inaccurate EKG machine readings|1|||
28001825|NCT04737278|81838198|FG000|Overall Study|Lost to Follow-up|1|||
28001826|NCT04737278|81838199|FG001|Overall Study|Lost to Follow-up|1|||
28001827|NCT04737278|81838198|FG000|Overall Study|Withdrawal by Subject|1|||
27806661|NCT03862625|81123279|FG000|Overall Study|Lost to Follow-up|0|||
27806662|NCT03862625|81123280|FG001|Overall Study|Lost to Follow-up|1|||
27806663|NCT01298596|81123281|FG000|Overall Study|Withdrawal by Subject|1|||
27806664|NCT01298596|81123282|FG001|Overall Study|Withdrawal by Subject|1|||
27806665|NCT01298596|81123281|FG000|Overall Study|Death|5|||
27806666|NCT01298596|81123282|FG001|Overall Study|Death|3|||
28001828|NCT04737278|81838199|FG001|Overall Study|Withdrawal by Subject|0|||
28001829|NCT04737278|81838198|FG000|Overall Study|Protocol Violation|1|||
27682171|NCT01743989|80672130|FG000|TFR Phase|Logistical problems|0|||
28001830|NCT04737278|81838199|FG001|Overall Study|Protocol Violation|1|||
28001831|NCT04737278|81838198|FG000|Overall Study|failure to complete questionnaire|1|||
27682172|NCT01743989|80672131|FG001|TFR Phase|Logistical problems|2|||
27584044|NCT01931839|80319149|FG005|Overall Study|Withdrawal of consent|0|||
27874050|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
27584045|NCT01931839|80319150|FG006|Overall Study|Withdrawal of consent|0|||
27584046|NCT01931839|80319144|FG000|Overall Study|Adverse Event|9|||
27584047|NCT01931839|80319145|FG001|Overall Study|Adverse Event|4|||
27682173|NCT01743989|80672132|FG002|TFR Phase|Logistical problems|0|||
27682174|NCT01743989|80672130|FG000|TFR Phase|Protocol deviation|0|||
27806667|NCT01298596|81123281|FG000|Overall Study|Lost to Follow-up|6|||
27806668|NCT01298596|81123282|FG001|Overall Study|Lost to Follow-up|14|||
27806669|NCT01298596|81123281|FG000|Overall Study|Referred for further management|16|||
27806670|NCT01298596|81123282|FG001|Overall Study|Referred for further management|15|||
27806671|NCT03237611|81123293|FG000|Overall Study|Withdrawal by Subject|1|||
27806672|NCT03237611|81123293|FG000|Overall Study|Ineligible|1|||
27806673|NCT02544633|81123294|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
27806674|NCT02544633|81123295|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
27806675|NCT02544633|81123296|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
27806676|NCT02544633|81123297|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
27806677|NCT02544633|81123294|FG000|Treatment Period|Adverse Event|7|||
27874051|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
27874052|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
27584048|NCT01931839|80319146|FG002|Overall Study|Adverse Event|1|||
27584049|NCT01931839|80319147|FG003|Overall Study|Adverse Event|3|||
27584050|NCT01931839|80319148|FG004|Overall Study|Adverse Event|0|||
27584051|NCT01931839|80319149|FG005|Overall Study|Adverse Event|0|||
27584052|NCT01931839|80319150|FG006|Overall Study|Adverse Event|1|||
27584053|NCT01931839|80319144|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
27584054|NCT01931839|80319145|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
27584055|NCT01931839|80319146|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
27584056|NCT01931839|80319147|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
27584057|NCT01931839|80319148|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
27584058|NCT01931839|80319149|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
27584059|NCT01931839|80319150|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
27584060|NCT01931839|80319144|FG000|Overall Study|Other non-compliance|15|||
27584061|NCT01931839|80319145|FG001|Overall Study|Other non-compliance|9|||
27584062|NCT01931839|80319146|FG002|Overall Study|Other non-compliance|12|||
27584063|NCT01931839|80319147|FG003|Overall Study|Other non-compliance|3|||
27584064|NCT01931839|80319148|FG004|Overall Study|Other non-compliance|0|||
27584065|NCT01931839|80319149|FG005|Overall Study|Other non-compliance|3|||
27584066|NCT01931839|80319150|FG006|Overall Study|Other non-compliance|0|||
27584067|NCT01931839|80319144|FG000|Overall Study|Lost to Follow-up|1|||
27584068|NCT01931839|80319145|FG001|Overall Study|Lost to Follow-up|2|||
27584069|NCT01931839|80319146|FG002|Overall Study|Lost to Follow-up|4|||
27584070|NCT01931839|80319147|FG003|Overall Study|Lost to Follow-up|5|||
27584071|NCT01931839|80319148|FG004|Overall Study|Lost to Follow-up|0|||
27584072|NCT01931839|80319149|FG005|Overall Study|Lost to Follow-up|0|||
27584073|NCT01931839|80319150|FG006|Overall Study|Lost to Follow-up|0|||
27584074|NCT01931839|80319144|FG000|Overall Study|Other|4|||
27584075|NCT01931839|80319145|FG001|Overall Study|Other|2|||
27584076|NCT01931839|80319146|FG002|Overall Study|Other|6|||
27584077|NCT01931839|80319147|FG003|Overall Study|Other|0|||
27584078|NCT01931839|80319148|FG004|Overall Study|Other|0|||
27584079|NCT01931839|80319149|FG005|Overall Study|Other|0|||
27584080|NCT01931839|80319150|FG006|Overall Study|Other|0|||
27584081|NCT00352534|80319151|FG000|Initial Staging|Ineligible|8|||
27584082|NCT00352534|80319152|FG001|Initial Staging|Ineligible|9|||
27584083|NCT00352534|80319153|FG002|Initial Staging|Ineligible|0|||
27584084|NCT00352534|80319154|FG003|Initial Staging|Ineligible|0|||
27584085|NCT00352534|80319155|FG004|Initial Staging|Ineligible|0|||
27584086|NCT00352534|80319156|FG005|Initial Staging|Ineligible|0|||
27584087|NCT00352534|80319157|FG006|Initial Staging|Ineligible|0|||
27682175|NCT01743989|80672131|FG001|TFR Phase|Protocol deviation|1|||
27806678|NCT02544633|81123295|FG001|Treatment Period|Adverse Event|4|||
27806679|NCT02544633|81123296|FG002|Treatment Period|Adverse Event|0|||
27806680|NCT02544633|81123297|FG003|Treatment Period|Adverse Event|5|||
27874053|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
27584088|NCT00352534|80319151|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
27584089|NCT00352534|80319152|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
27584090|NCT00352534|80319153|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
27584091|NCT00352534|80319154|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
27584092|NCT00352534|80319155|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
27806681|NCT02544633|81123294|FG000|Treatment Period|Lack of Efficacy|17|||
27584093|NCT00352534|80319156|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
27584094|NCT00352534|80319157|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
27584095|NCT00352534|80319151|FG000|Final Risk Group Assignment|Physician Decision|0|||
27584096|NCT00352534|80319152|FG001|Final Risk Group Assignment|Physician Decision|0|||
27584097|NCT00352534|80319153|FG002|Final Risk Group Assignment|Physician Decision|0|||
27584098|NCT00352534|80319154|FG003|Final Risk Group Assignment|Physician Decision|0|||
27584099|NCT00352534|80319155|FG004|Final Risk Group Assignment|Physician Decision|0|||
27584100|NCT00352534|80319156|FG005|Final Risk Group Assignment|Physician Decision|8|||
27584101|NCT00352534|80319157|FG006|Final Risk Group Assignment|Physician Decision|0|||
27584102|NCT00352534|80319151|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
27584103|NCT00352534|80319152|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
27584104|NCT00352534|80319153|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
27584105|NCT00352534|80319154|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
27584106|NCT00352534|80319155|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
27584107|NCT00352534|80319156|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
27584108|NCT00352534|80319157|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
27584109|NCT00352534|80319151|FG000|Final Risk Group Assignment|Ineligible|0|||
27584110|NCT00352534|80319152|FG001|Final Risk Group Assignment|Ineligible|0|||
27584111|NCT00352534|80319153|FG002|Final Risk Group Assignment|Ineligible|3|||
28001832|NCT04737278|81838199|FG001|Overall Study|failure to complete questionnaire|1|||
28001833|NCT00880620|81838200|FG000|Overall Study|Adverse Event|4|||
27584112|NCT00352534|80319154|FG003|Final Risk Group Assignment|Ineligible|1|||
27584113|NCT00352534|80319155|FG004|Final Risk Group Assignment|Ineligible|0|||
27584114|NCT00352534|80319156|FG005|Final Risk Group Assignment|Ineligible|13|||
27584115|NCT00352534|80319157|FG006|Final Risk Group Assignment|Ineligible|0|||
27584116|NCT00352534|80319151|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
27584117|NCT00352534|80319152|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
27584118|NCT00352534|80319153|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
27682176|NCT01743989|80672132|FG002|TFR Phase|Protocol deviation|0|||
27682177|NCT01743989|80672130|FG000|TFR Phase|Withdrawal by Subject|0|||
27682178|NCT01743989|80672131|FG001|TFR Phase|Withdrawal by Subject|2|||
27682179|NCT01743989|80672132|FG002|TFR Phase|Withdrawal by Subject|0|||
27584119|NCT00352534|80319154|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
27584120|NCT00352534|80319155|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
27584121|NCT00352534|80319156|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
27584122|NCT00352534|80319157|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
27584123|NCT00352534|80319151|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27584124|NCT00352534|80319152|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27584125|NCT00352534|80319153|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27584126|NCT00352534|80319154|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27584127|NCT00352534|80319155|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27584128|NCT00352534|80319156|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
27584129|NCT00352534|80319157|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
27584130|NCT00352534|80319151|FG000|Final Risk Group Assignment|Death|0|||
27584131|NCT00352534|80319152|FG001|Final Risk Group Assignment|Death|0|||
27584132|NCT00352534|80319153|FG002|Final Risk Group Assignment|Death|0|||
27584133|NCT00352534|80319154|FG003|Final Risk Group Assignment|Death|0|||
28001834|NCT00880620|81838201|FG001|Overall Study|Adverse Event|5|||
28001835|NCT00880620|81838202|FG002|Overall Study|Adverse Event|15|||
28001836|NCT00880620|81838203|FG003|Overall Study|Adverse Event|15|||
28001837|NCT00880620|81838200|FG000|Overall Study|Death|0|||
28001838|NCT00880620|81838201|FG001|Overall Study|Death|0|||
28001839|NCT00880620|81838202|FG002|Overall Study|Death|1|||
28001840|NCT00880620|81838203|FG003|Overall Study|Death|0|||
27584134|NCT00352534|80319155|FG004|Final Risk Group Assignment|Death|0|||
27584135|NCT00352534|80319156|FG005|Final Risk Group Assignment|Death|2|||
27584136|NCT00352534|80319157|FG006|Final Risk Group Assignment|Death|0|||
27584137|NCT03855189|80319158|FG000|Overall Study|Adverse Event|5|||
27584138|NCT03855189|80319159|FG001|Overall Study|Adverse Event|2|||
27584139|NCT03855189|80319160|FG002|Overall Study|Adverse Event|4|||
27584140|NCT03855189|80319158|FG000|Overall Study|Treatment Failure|1|||
27584141|NCT03855189|80319159|FG001|Overall Study|Treatment Failure|1|||
27584142|NCT03855189|80319160|FG002|Overall Study|Treatment Failure|2|||
27584143|NCT03855189|80319158|FG000|Overall Study|Noncompliance with Protocol|0|||
27584144|NCT03855189|80319159|FG001|Overall Study|Noncompliance with Protocol|1|||
28001841|NCT00880620|81838200|FG000|Overall Study|Lack of Efficacy|12|||
28001842|NCT00880620|81838201|FG001|Overall Study|Lack of Efficacy|4|||
28001843|NCT00880620|81838202|FG002|Overall Study|Lack of Efficacy|0|||
27584145|NCT03855189|80319160|FG002|Overall Study|Noncompliance with Protocol|0|||
27584146|NCT03855189|80319158|FG000|Overall Study|Did Not Return|4|||
27584147|NCT03855189|80319159|FG001|Overall Study|Did Not Return|3|||
27584148|NCT03855189|80319160|FG002|Overall Study|Did Not Return|0|||
27584149|NCT00499889|80319168|FG000|Overall Study|Infection prior to treatment|1|||
27584150|NCT02564198|80319173|FG000|Overall Study|Withdrawal by Subject|2|||
27584151|NCT02564198|80319174|FG001|Overall Study|Withdrawal by Subject|4|||
27682180|NCT01743989|80672130|FG000|Re-treatment Phase|Adverse Event|8|||
28001844|NCT00880620|81838203|FG003|Overall Study|Lack of Efficacy|1|||
28001845|NCT00880620|81838200|FG000|Overall Study|Lost to Follow-up|0|||
27806682|NCT02544633|81123295|FG001|Treatment Period|Lack of Efficacy|11|||
27806683|NCT02544633|81123296|FG002|Treatment Period|Lack of Efficacy|5|||
27806684|NCT02544633|81123297|FG003|Treatment Period|Lack of Efficacy|5|||
28001846|NCT00880620|81838201|FG001|Overall Study|Lost to Follow-up|1|||
28001847|NCT00880620|81838202|FG002|Overall Study|Lost to Follow-up|1|||
27806685|NCT02544633|81123294|FG000|Treatment Period|Global Deterioration of Health|3|||
27806686|NCT02544633|81123295|FG001|Treatment Period|Global Deterioration of Health|3|||
27806687|NCT02544633|81123296|FG002|Treatment Period|Global Deterioration of Health|0|||
27806688|NCT02544633|81123297|FG003|Treatment Period|Global Deterioration of Health|1|||
27806689|NCT02544633|81123294|FG000|Treatment Period|Withdrawal by Subject|1|||
27806690|NCT02544633|81123295|FG001|Treatment Period|Withdrawal by Subject|0|||
27806691|NCT02544633|81123296|FG002|Treatment Period|Withdrawal by Subject|0|||
27806692|NCT02544633|81123297|FG003|Treatment Period|Withdrawal by Subject|0|||
27806693|NCT02544633|81123294|FG000|Treatment Period|Lost to Follow-up|0|||
27806694|NCT02544633|81123295|FG001|Treatment Period|Lost to Follow-up|1|||
27806695|NCT02544633|81123296|FG002|Treatment Period|Lost to Follow-up|0|||
27806696|NCT02544633|81123297|FG003|Treatment Period|Lost to Follow-up|0|||
27806697|NCT02544633|81123294|FG000|Treatment Period|Death|0|||
27806698|NCT02544633|81123295|FG001|Treatment Period|Death|0|||
27806699|NCT02544633|81123296|FG002|Treatment Period|Death|1|||
27806700|NCT02544633|81123297|FG003|Treatment Period|Death|0|||
27806701|NCT02544633|81123294|FG000|Treatment Period|Non-compliance|0|||
27806702|NCT02544633|81123295|FG001|Treatment Period|Non-compliance|0|||
27806703|NCT02544633|81123296|FG002|Treatment Period|Non-compliance|1|||
27806704|NCT02544633|81123297|FG003|Treatment Period|Non-compliance|0|||
27806705|NCT02544633|81123294|FG000|Treatment Period|Clinical Disease Progression|0|||
27806706|NCT02544633|81123295|FG001|Treatment Period|Clinical Disease Progression|0|||
28001848|NCT00880620|81838203|FG003|Overall Study|Lost to Follow-up|0|||
28001849|NCT00880620|81838200|FG000|Overall Study|Protocol Violation|0|||
28001850|NCT00880620|81838201|FG001|Overall Study|Protocol Violation|1|||
28001851|NCT00880620|81838202|FG002|Overall Study|Protocol Violation|0|||
28001852|NCT00880620|81838203|FG003|Overall Study|Protocol Violation|2|||
28001853|NCT00880620|81838200|FG000|Overall Study|Withdrawal by Subject|4|||
28001854|NCT00880620|81838201|FG001|Overall Study|Withdrawal by Subject|3|||
28001855|NCT00880620|81838202|FG002|Overall Study|Withdrawal by Subject|1|||
28001856|NCT00880620|81838203|FG003|Overall Study|Withdrawal by Subject|3|||
28001857|NCT00880620|81838200|FG000|Overall Study|Noncompliance|0|||
28001858|NCT00880620|81838201|FG001|Overall Study|Noncompliance|0|||
28001859|NCT00880620|81838202|FG002|Overall Study|Noncompliance|1|||
28001860|NCT00880620|81838203|FG003|Overall Study|Noncompliance|1|||
28001861|NCT00880620|81838200|FG000|Overall Study|Other|1|||
28001862|NCT00880620|81838201|FG001|Overall Study|Other|1|||
28001863|NCT00880620|81838202|FG002|Overall Study|Other|2|||
28001864|NCT00880620|81838203|FG003|Overall Study|Other|2|||
28001865|NCT04023526|81838204|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
28001866|NCT04023526|81838205|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
28001867|NCT04023526|81838204|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
28001868|NCT04023526|81838205|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
27584152|NCT02564198|80319175|FG002|Overall Study|Withdrawal by Subject|0|||
27806707|NCT02544633|81123296|FG002|Treatment Period|Clinical Disease Progression|0|||
27806708|NCT02544633|81123297|FG003|Treatment Period|Clinical Disease Progression|1|||
27806709|NCT02544633|81123294|FG000|Survival Follow-up Period|Death|12|||
27806710|NCT02544633|81123295|FG001|Survival Follow-up Period|Death|14|||
27806711|NCT02544633|81123296|FG002|Survival Follow-up Period|Death|3|||
27874054|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27806712|NCT02544633|81123297|FG003|Survival Follow-up Period|Death|9|||
28001869|NCT00539994|81838208|FG000|Overall Study|Lost to Follow-up|2|||
28001870|NCT00539994|81838209|FG001|Overall Study|Lost to Follow-up|1|||
28001871|NCT00539994|81838210|FG002|Overall Study|Lost to Follow-up|0|||
27806713|NCT02544633|81123294|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
27806714|NCT02544633|81123295|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
28001872|NCT00539994|81838208|FG000|Overall Study|Withdrawal by Subject|1|||
28001873|NCT00539994|81838209|FG001|Overall Study|Withdrawal by Subject|0|||
27806715|NCT02544633|81123296|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
27806716|NCT02544633|81123297|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
27806717|NCT02544633|81123294|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
27806718|NCT02544633|81123295|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
27806719|NCT02544633|81123296|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
27806720|NCT02544633|81123297|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
27806721|NCT02544633|81123294|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
27806722|NCT02544633|81123295|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
27806723|NCT02544633|81123296|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
27806724|NCT02544633|81123297|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
27806725|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
27806726|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
27806727|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
27806728|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
27806729|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
27806730|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
27806731|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
27806732|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
27806733|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
27806734|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
27806735|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
27806736|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
27806737|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
27806738|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
27806739|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
27806740|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
27806741|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
28001874|NCT00539994|81838210|FG002|Overall Study|Withdrawal by Subject|1|||
28001875|NCT00539994|81838208|FG000|Overall Study|Physician Decision|0|||
28001876|NCT00539994|81838209|FG001|Overall Study|Physician Decision|0|||
28001877|NCT00539994|81838210|FG002|Overall Study|Physician Decision|1|||
28001878|NCT01121146|81838211|FG000|Overall Study|Death|17|||
28001879|NCT01121146|81838212|FG001|Overall Study|Death|15|||
28001880|NCT01121146|81838211|FG000|Overall Study|Adverse Event|2|||
28001881|NCT01121146|81838212|FG001|Overall Study|Adverse Event|11|||
28001882|NCT01121146|81838211|FG000|Overall Study|Lost to Follow-up|7|||
28001883|NCT01121146|81838212|FG001|Overall Study|Lost to Follow-up|16|||
28001884|NCT04024891|81838220|FG000|Overall Study|Pregnancy|0|||
28001885|NCT04024891|81838221|FG001|Overall Study|Pregnancy|1|||
28001886|NCT03347123|81838222|FG000|Overall Study|Death|1|||
28001887|NCT03347123|81838223|FG001|Overall Study|Death|2|||
28001888|NCT03347123|81838224|FG002|Overall Study|Death|0|||
28001889|NCT03347123|81838225|FG003|Overall Study|Death|0|||
28001890|NCT03347123|81838226|FG004|Overall Study|Death|0|||
28001891|NCT03347123|81838227|FG005|Overall Study|Death|0|||
28001892|NCT03347123|81838228|FG006|Overall Study|Death|0|||
28001893|NCT03347123|81838222|FG000|Overall Study|Withdrawal by Subject|1|||
28001894|NCT03347123|81838223|FG001|Overall Study|Withdrawal by Subject|0|||
28001895|NCT03347123|81838224|FG002|Overall Study|Withdrawal by Subject|0|||
28001896|NCT03347123|81838225|FG003|Overall Study|Withdrawal by Subject|0|||
28001897|NCT03347123|81838226|FG004|Overall Study|Withdrawal by Subject|0|||
28001898|NCT03347123|81838227|FG005|Overall Study|Withdrawal by Subject|0|||
28001899|NCT03347123|81838228|FG006|Overall Study|Withdrawal by Subject|0|||
28001900|NCT03347123|81838222|FG000|Overall Study|Reason not Specified|3|||
28001901|NCT03347123|81838223|FG001|Overall Study|Reason not Specified|4|||
28001902|NCT03347123|81838224|FG002|Overall Study|Reason not Specified|0|||
28001903|NCT03347123|81838225|FG003|Overall Study|Reason not Specified|0|||
28001904|NCT03347123|81838226|FG004|Overall Study|Reason not Specified|0|||
28001905|NCT03347123|81838227|FG005|Overall Study|Reason not Specified|0|||
28001906|NCT03347123|81838228|FG006|Overall Study|Reason not Specified|0|||
28001907|NCT01096316|81838229|FG000|Overall Study|Lost to Follow-up|15|||
28001908|NCT01096316|81838230|FG001|Overall Study|Lost to Follow-up|9|||
27806742|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
27806743|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
28001909|NCT03137992|81838231|FG000|Washout Period 1|Adverse Event|1|||
28001910|NCT03137992|81838232|FG001|Washout Period 1|Adverse Event|1|||
28001911|NCT03137992|81838233|FG002|Washout Period 1|Adverse Event|0|||
28001912|NCT03137992|81838234|FG003|Washout Period 1|Adverse Event|0|||
28001913|NCT03137992|81838235|FG004|Washout Period 1|Adverse Event|0|||
28001914|NCT03137992|81838236|FG005|Washout Period 1|Adverse Event|1|||
28001915|NCT03137992|81838231|FG000|Washout Period 1|Withdrawal by Subject|0|||
28001916|NCT03137992|81838232|FG001|Washout Period 1|Withdrawal by Subject|1|||
28001917|NCT03137992|81838233|FG002|Washout Period 1|Withdrawal by Subject|1|||
28001918|NCT03137992|81838234|FG003|Washout Period 1|Withdrawal by Subject|0|||
27584153|NCT02564198|80319173|FG000|Overall Study|Adverse Event|0|||
27584154|NCT02564198|80319174|FG001|Overall Study|Adverse Event|1|||
27584155|NCT02564198|80319175|FG002|Overall Study|Adverse Event|0|||
27584156|NCT00723801|80319176|FG000|Overall Study|Lost to Follow-up|1|||
27584157|NCT00723801|80319177|FG001|Overall Study|Lost to Follow-up|2|||
27584158|NCT00723801|80319176|FG000|Overall Study|Protocol Violation|2|||
27584159|NCT00723801|80319177|FG001|Overall Study|Protocol Violation|1|||
27584160|NCT02899728|80319178|FG000|Overall Study|Withdrawal by Subject|1|||
27584161|NCT02899728|80319179|FG001|Overall Study|Withdrawal by Subject|1|||
27584162|NCT03156023|80319180|FG000|Overall Study|Withdrawal by Subject|1|||
27584163|NCT03156023|80319181|FG001|Overall Study|Withdrawal by Subject|0|||
28001919|NCT03137992|81838235|FG004|Washout Period 1|Withdrawal by Subject|0|||
27584164|NCT03156023|80319182|FG002|Overall Study|Withdrawal by Subject|2|||
27584165|NCT03156023|80319183|FG003|Overall Study|Withdrawal by Subject|1|||
27584166|NCT03156023|80319184|FG004|Overall Study|Withdrawal by Subject|1|||
27584167|NCT03156023|80319180|FG000|Overall Study|Lost to Follow-up|0|||
27584168|NCT03156023|80319181|FG001|Overall Study|Lost to Follow-up|0|||
27584169|NCT03156023|80319182|FG002|Overall Study|Lost to Follow-up|0|||
27584170|NCT03156023|80319183|FG003|Overall Study|Lost to Follow-up|0|||
27584171|NCT03156023|80319184|FG004|Overall Study|Lost to Follow-up|1|||
27682181|NCT01743989|80672131|FG001|Re-treatment Phase|Adverse Event|4|||
27806744|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
27806745|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
27806746|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
27806747|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
27806748|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
27806749|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
28001920|NCT03137992|81838236|FG005|Washout Period 1|Withdrawal by Subject|0|||
28001921|NCT03137992|81838231|FG000|Washout Period 1|Principal Investigator Discretion|0|||
28001922|NCT03137992|81838232|FG001|Washout Period 1|Principal Investigator Discretion|1|||
28001923|NCT03137992|81838233|FG002|Washout Period 1|Principal Investigator Discretion|0|||
27806750|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
27806751|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
27806752|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
27806753|NCT01872689|81123298|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
27806754|NCT01872689|81123299|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
27806755|NCT01872689|81123300|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
27806756|NCT01872689|81123301|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
27806757|NCT01872689|81123298|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
27806758|NCT01872689|81123299|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
27806759|NCT01872689|81123300|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
27806760|NCT01872689|81123301|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
27806761|NCT01872689|81123298|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
27806762|NCT01872689|81123299|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
27806763|NCT01872689|81123300|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
27806764|NCT01872689|81123301|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
27806765|NCT01872689|81123298|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
27874055|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
28001924|NCT03137992|81838234|FG003|Washout Period 1|Principal Investigator Discretion|0|||
28001925|NCT03137992|81838235|FG004|Washout Period 1|Principal Investigator Discretion|0|||
28001926|NCT03137992|81838236|FG005|Washout Period 1|Principal Investigator Discretion|0|||
28001927|NCT03137992|81838231|FG000|Washout Period 1|COPD Exacerbation|1|||
28001928|NCT03137992|81838232|FG001|Washout Period 1|COPD Exacerbation|1|||
28001929|NCT03137992|81838233|FG002|Washout Period 1|COPD Exacerbation|1|||
28001930|NCT03137992|81838234|FG003|Washout Period 1|COPD Exacerbation|0|||
28001931|NCT03137992|81838235|FG004|Washout Period 1|COPD Exacerbation|1|||
28001932|NCT03137992|81838236|FG005|Washout Period 1|COPD Exacerbation|1|||
28001933|NCT03137992|81838231|FG000|Washout Period 1|Subject Noncompliance|1|||
28001934|NCT03137992|81838232|FG001|Washout Period 1|Subject Noncompliance|0|||
28001935|NCT03137992|81838233|FG002|Washout Period 1|Subject Noncompliance|0|||
28001936|NCT03137992|81838234|FG003|Washout Period 1|Subject Noncompliance|0|||
27584172|NCT00724971|80319185|FG000|Overall Study|Adverse Event|5|||
27584173|NCT00724971|80319185|FG000|Overall Study|Withdrawal by Subject|1|||
27874056|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27584174|NCT02096835|80319188|FG000|Overall Study|Withdrawal by Subject|1|||
27682182|NCT01743989|80672132|FG002|Re-treatment Phase|Adverse Event|0|||
27806766|NCT01872689|81123299|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
28001937|NCT03137992|81838235|FG004|Washout Period 1|Subject Noncompliance|1|||
28001938|NCT03137992|81838236|FG005|Washout Period 1|Subject Noncompliance|0|||
28001939|NCT03137992|81838231|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
28001940|NCT03137992|81838232|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
28001941|NCT03137992|81838233|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
28001942|NCT03137992|81838234|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
28001943|NCT03137992|81838235|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
28001944|NCT03137992|81838236|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
28001945|NCT03137992|81838231|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
28001946|NCT03137992|81838232|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
28001947|NCT03137992|81838233|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
28001948|NCT03137992|81838234|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
28001949|NCT03137992|81838235|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
28001950|NCT03137992|81838236|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
28001951|NCT03137992|81838231|FG000|Period 2 (Visit 3)|Adverse Event|0|||
28001952|NCT03137992|81838232|FG001|Period 2 (Visit 3)|Adverse Event|1|||
28001953|NCT03137992|81838233|FG002|Period 2 (Visit 3)|Adverse Event|0|||
28001954|NCT03137992|81838234|FG003|Period 2 (Visit 3)|Adverse Event|0|||
28001955|NCT03137992|81838235|FG004|Period 2 (Visit 3)|Adverse Event|0|||
28001956|NCT03137992|81838236|FG005|Period 2 (Visit 3)|Adverse Event|0|||
28001957|NCT03137992|81838231|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
28001958|NCT03137992|81838232|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
28001959|NCT03137992|81838233|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
28001960|NCT03137992|81838234|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
28001961|NCT03137992|81838235|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
28001962|NCT03137992|81838236|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
28001963|NCT03137992|81838231|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28001964|NCT03137992|81838232|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
28001965|NCT03137992|81838233|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28001966|NCT03137992|81838234|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28001967|NCT03137992|81838235|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
28001968|NCT03137992|81838236|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
28001969|NCT03137992|81838231|FG000|Washout Period 2|COPD Exacerbation|1|||
28001970|NCT03137992|81838232|FG001|Washout Period 2|COPD Exacerbation|1|||
28001971|NCT03137992|81838233|FG002|Washout Period 2|COPD Exacerbation|0|||
28001972|NCT03137992|81838234|FG003|Washout Period 2|COPD Exacerbation|0|||
28001973|NCT03137992|81838235|FG004|Washout Period 2|COPD Exacerbation|1|||
28001974|NCT03137992|81838236|FG005|Washout Period 2|COPD Exacerbation|0|||
28001975|NCT03137992|81838231|FG000|Washout Period 2|Subject Non-compliance|0|||
28001976|NCT03137992|81838232|FG001|Washout Period 2|Subject Non-compliance|1|||
28001977|NCT03137992|81838233|FG002|Washout Period 2|Subject Non-compliance|0|||
28001978|NCT03137992|81838234|FG003|Washout Period 2|Subject Non-compliance|0|||
28001979|NCT03137992|81838235|FG004|Washout Period 2|Subject Non-compliance|0|||
28001980|NCT03137992|81838236|FG005|Washout Period 2|Subject Non-compliance|0|||
28001981|NCT03137992|81838231|FG000|Washout Period 2|Adverse Event|0|||
28001982|NCT03137992|81838232|FG001|Washout Period 2|Adverse Event|0|||
28001983|NCT03137992|81838233|FG002|Washout Period 2|Adverse Event|0|||
28001984|NCT03137992|81838234|FG003|Washout Period 2|Adverse Event|1|||
28001985|NCT03137992|81838235|FG004|Washout Period 2|Adverse Event|1|||
28001986|NCT03137992|81838236|FG005|Washout Period 2|Adverse Event|0|||
28001987|NCT03137992|81838231|FG000|Washout Period 2|Withdrawal by Subject|1|||
28001988|NCT03137992|81838232|FG001|Washout Period 2|Withdrawal by Subject|0|||
28001989|NCT03137992|81838233|FG002|Washout Period 2|Withdrawal by Subject|0|||
28001990|NCT03137992|81838234|FG003|Washout Period 2|Withdrawal by Subject|0|||
28001991|NCT03137992|81838235|FG004|Washout Period 2|Withdrawal by Subject|1|||
28001992|NCT03137992|81838236|FG005|Washout Period 2|Withdrawal by Subject|0|||
28001993|NCT03137992|81838231|FG000|Washout Period 2|Sponsor Decision|0|||
27682183|NCT01743989|80672130|FG000|Re-treatment Phase|Death|1|||
28001994|NCT03137992|81838232|FG001|Washout Period 2|Sponsor Decision|0|||
28001995|NCT03137992|81838233|FG002|Washout Period 2|Sponsor Decision|0|||
28001996|NCT03137992|81838234|FG003|Washout Period 2|Sponsor Decision|0|||
28001997|NCT03137992|81838235|FG004|Washout Period 2|Sponsor Decision|0|||
28001998|NCT03137992|81838236|FG005|Washout Period 2|Sponsor Decision|1|||
27806767|NCT01872689|81123300|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
28001999|NCT03137992|81838231|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
28002000|NCT03137992|81838232|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
28002001|NCT03137992|81838233|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
28002002|NCT03137992|81838234|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
28002003|NCT03137992|81838235|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
28002004|NCT03137992|81838236|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
28002005|NCT03137992|81838231|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
28002006|NCT03137992|81838232|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
28002007|NCT03137992|81838233|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
28002008|NCT03137992|81838234|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
28002009|NCT03137992|81838235|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
28002010|NCT03137992|81838236|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
28002011|NCT03137992|81838231|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
28002012|NCT03137992|81838232|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28002013|NCT03137992|81838233|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
28002014|NCT03137992|81838234|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28002015|NCT03137992|81838235|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28002016|NCT03137992|81838236|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
28002017|NCT03137992|81838231|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28002018|NCT03137992|81838232|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28002019|NCT03137992|81838233|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28002020|NCT03137992|81838234|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
28002021|NCT03137992|81838235|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28002022|NCT03137992|81838236|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
28002023|NCT03137992|81838231|FG000|Part 2 (Open-label Extension)|Per study team|1|||
28002024|NCT03137992|81838232|FG001|Part 2 (Open-label Extension)|Per study team|0|||
28002025|NCT03137992|81838233|FG002|Part 2 (Open-label Extension)|Per study team|0|||
28002026|NCT03137992|81838234|FG003|Part 2 (Open-label Extension)|Per study team|0|||
28002027|NCT03137992|81838235|FG004|Part 2 (Open-label Extension)|Per study team|0|||
28002028|NCT03137992|81838236|FG005|Part 2 (Open-label Extension)|Per study team|0|||
28002029|NCT03137992|81838231|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28002030|NCT03137992|81838232|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28002031|NCT03137992|81838233|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28002032|NCT03137992|81838234|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28002033|NCT03137992|81838235|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
28002034|NCT03137992|81838236|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
28002035|NCT04486235|81838243|FG000|Overall Study|Pregnancy|1|||
28002036|NCT04486235|81838244|FG001|Overall Study|Pregnancy|0|||
28002037|NCT04486235|81838243|FG000|Overall Study|Lost to Follow-up|1|||
28002038|NCT04486235|81838244|FG001|Overall Study|Lost to Follow-up|0|||
28002039|NCT01650558|81838245|FG000|Overall Study|Migration out of study area|61|||
28002040|NCT01650558|81838246|FG001|Overall Study|Migration out of study area|71|||
28002041|NCT01650558|81838247|FG002|Overall Study|Migration out of study area|56|||
28002042|NCT01650558|81838245|FG000|Overall Study|Lost to Follow-up|10|||
28002043|NCT01650558|81838246|FG001|Overall Study|Lost to Follow-up|13|||
28002044|NCT01650558|81838247|FG002|Overall Study|Lost to Follow-up|6|||
28002045|NCT01650558|81838245|FG000|Overall Study|Death|10|||
28002046|NCT01650558|81838246|FG001|Overall Study|Death|6|||
28002047|NCT01650558|81838247|FG002|Overall Study|Death|8|||
28002048|NCT01650558|81838245|FG000|Overall Study|Withdrawal by Subject|1|||
28002049|NCT01650558|81838246|FG001|Overall Study|Withdrawal by Subject|1|||
28002050|NCT01650558|81838247|FG002|Overall Study|Withdrawal by Subject|3|||
28002051|NCT01650558|81838245|FG000|Overall Study|Non-compliant participant|1|||
28002052|NCT01650558|81838246|FG001|Overall Study|Non-compliant participant|0|||
28002053|NCT01650558|81838247|FG002|Overall Study|Non-compliant participant|2|||
28002054|NCT01650558|81838245|FG000|Overall Study|Physician Decision|0|||
28002055|NCT01650558|81838246|FG001|Overall Study|Physician Decision|1|||
28002056|NCT01650558|81838247|FG002|Overall Study|Physician Decision|0|||
28002057|NCT03010319|81838248|FG000|Overall Study|Adverse Event|15|||
28002058|NCT03010319|81838249|FG001|Overall Study|Adverse Event|9|||
28002059|NCT03010319|81838248|FG000|Overall Study|Withdrawal by Subject|1|||
28002060|NCT03010319|81838249|FG001|Overall Study|Withdrawal by Subject|6|||
28002061|NCT03010319|81838248|FG000|Overall Study|Physician Decision|2|||
28002062|NCT03010319|81838249|FG001|Overall Study|Physician Decision|4|||
28002063|NCT03010319|81838248|FG000|Overall Study|Sponsor requested withdrawal|2|||
28002064|NCT03010319|81838249|FG001|Overall Study|Sponsor requested withdrawal|2|||
28002065|NCT03010319|81838248|FG000|Overall Study|Death|1|||
28002066|NCT03010319|81838249|FG001|Overall Study|Death|0|||
28002067|NCT03010319|81838248|FG000|Overall Study|Lost to Follow-up|0|||
28002068|NCT03010319|81838249|FG001|Overall Study|Lost to Follow-up|1|||
28002069|NCT03010319|81838248|FG000|Overall Study|Other Reason|5|||
27682184|NCT01743989|80672131|FG001|Re-treatment Phase|Death|1|||
28002070|NCT03010319|81838249|FG001|Overall Study|Other Reason|7|||
28002071|NCT00531284|81838250|FG000|Overall Study|Progressive Disease|1|||
28002072|NCT00531284|81838251|FG001|Overall Study|Progressive Disease|3|||
28002073|NCT00531284|81838252|FG002|Overall Study|Progressive Disease|5|||
28002074|NCT00531284|81838253|FG003|Overall Study|Progressive Disease|42|||
28002075|NCT00531284|81838254|FG004|Overall Study|Progressive Disease|4|||
28002076|NCT00531284|81838255|FG005|Overall Study|Progressive Disease|4|||
28002077|NCT00531284|81838256|FG006|Overall Study|Progressive Disease|3|||
28002078|NCT00531284|81838257|FG007|Overall Study|Progressive Disease|8|||
28002079|NCT00531284|81838258|FG008|Overall Study|Progressive Disease|6|||
28002080|NCT00531284|81838259|FG009|Overall Study|Progressive Disease|3|||
28002081|NCT00531284|81838260|FG010|Overall Study|Progressive Disease|3|||
28002082|NCT00531284|81838261|FG011|Overall Study|Progressive Disease|14|||
28002083|NCT00531284|81838262|FG012|Overall Study|Progressive Disease|2|||
28002084|NCT00531284|81838263|FG013|Overall Study|Progressive Disease|1|||
28002085|NCT00531284|81838264|FG014|Overall Study|Progressive Disease|2|||
28002086|NCT00531284|81838265|FG015|Overall Study|Progressive Disease|11|||
28002087|NCT00531284|81838266|FG016|Overall Study|Progressive Disease|5|||
28002088|NCT00531284|81838250|FG000|Overall Study|Adverse Event|0|||
28002089|NCT00531284|81838251|FG001|Overall Study|Adverse Event|1|||
28002090|NCT00531284|81838252|FG002|Overall Study|Adverse Event|1|||
28002091|NCT00531284|81838253|FG003|Overall Study|Adverse Event|7|||
28002092|NCT00531284|81838254|FG004|Overall Study|Adverse Event|0|||
28002093|NCT00531284|81838255|FG005|Overall Study|Adverse Event|2|||
28002094|NCT00531284|81838256|FG006|Overall Study|Adverse Event|3|||
28002095|NCT00531284|81838257|FG007|Overall Study|Adverse Event|2|||
28002096|NCT00531284|81838258|FG008|Overall Study|Adverse Event|3|||
28002097|NCT00531284|81838259|FG009|Overall Study|Adverse Event|0|||
28002098|NCT00531284|81838260|FG010|Overall Study|Adverse Event|0|||
28002099|NCT00531284|81838261|FG011|Overall Study|Adverse Event|5|||
28002100|NCT00531284|81838262|FG012|Overall Study|Adverse Event|0|||
28002101|NCT00531284|81838263|FG013|Overall Study|Adverse Event|1|||
27682185|NCT01743989|80672132|FG002|Re-treatment Phase|Death|0|||
27682186|NCT01743989|80672130|FG000|Re-treatment Phase|Administrative problems|1|||
27682187|NCT01743989|80672131|FG001|Re-treatment Phase|Administrative problems|1|||
27682188|NCT01743989|80672132|FG002|Re-treatment Phase|Administrative problems|0|||
27682189|NCT01743989|80672130|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
27682190|NCT01743989|80672131|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
27682191|NCT01743989|80672132|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
27682192|NCT01743989|80672130|FG000|Re-treatment Phase|Unstable MR|1|||
27682193|NCT01743989|80672131|FG001|Re-treatment Phase|Unstable MR|0|||
27682194|NCT01743989|80672132|FG002|Re-treatment Phase|Unstable MR|0|||
27682195|NCT01743989|80672130|FG000|Re-treatment Phase|Physician Decision|0|||
27682196|NCT01743989|80672131|FG001|Re-treatment Phase|Physician Decision|1|||
28002102|NCT00531284|81838264|FG014|Overall Study|Adverse Event|1|||
28002103|NCT00531284|81838265|FG015|Overall Study|Adverse Event|0|||
28002104|NCT00531284|81838266|FG016|Overall Study|Adverse Event|2|||
28002105|NCT00531284|81838250|FG000|Overall Study|Withdrawal by Subject|1|||
28002106|NCT00531284|81838251|FG001|Overall Study|Withdrawal by Subject|0|||
28002107|NCT00531284|81838252|FG002|Overall Study|Withdrawal by Subject|0|||
28002108|NCT00531284|81838253|FG003|Overall Study|Withdrawal by Subject|4|||
28002109|NCT00531284|81838254|FG004|Overall Study|Withdrawal by Subject|0|||
28002110|NCT00531284|81838255|FG005|Overall Study|Withdrawal by Subject|0|||
28002111|NCT00531284|81838256|FG006|Overall Study|Withdrawal by Subject|0|||
28002112|NCT00531284|81838257|FG007|Overall Study|Withdrawal by Subject|0|||
28002113|NCT00531284|81838258|FG008|Overall Study|Withdrawal by Subject|0|||
28002114|NCT00531284|81838259|FG009|Overall Study|Withdrawal by Subject|0|||
28002115|NCT00531284|81838260|FG010|Overall Study|Withdrawal by Subject|0|||
28002116|NCT00531284|81838261|FG011|Overall Study|Withdrawal by Subject|3|||
28002117|NCT00531284|81838262|FG012|Overall Study|Withdrawal by Subject|0|||
28002118|NCT00531284|81838263|FG013|Overall Study|Withdrawal by Subject|1|||
28002119|NCT00531284|81838264|FG014|Overall Study|Withdrawal by Subject|0|||
28002120|NCT00531284|81838265|FG015|Overall Study|Withdrawal by Subject|1|||
28002121|NCT00531284|81838266|FG016|Overall Study|Withdrawal by Subject|1|||
28002122|NCT00531284|81838250|FG000|Overall Study|Other|1|||
28002123|NCT00531284|81838251|FG001|Overall Study|Other|0|||
28002124|NCT00531284|81838252|FG002|Overall Study|Other|0|||
28002125|NCT00531284|81838253|FG003|Overall Study|Other|10|||
28002126|NCT00531284|81838254|FG004|Overall Study|Other|2|||
28002127|NCT00531284|81838255|FG005|Overall Study|Other|1|||
28002128|NCT00531284|81838256|FG006|Overall Study|Other|0|||
28002129|NCT00531284|81838257|FG007|Overall Study|Other|0|||
28002130|NCT00531284|81838258|FG008|Overall Study|Other|2|||
28002131|NCT00531284|81838259|FG009|Overall Study|Other|1|||
28002132|NCT00531284|81838260|FG010|Overall Study|Other|0|||
28002133|NCT00531284|81838261|FG011|Overall Study|Other|2|||
28002134|NCT00531284|81838262|FG012|Overall Study|Other|0|||
28002135|NCT00531284|81838263|FG013|Overall Study|Other|0|||
28002136|NCT00531284|81838264|FG014|Overall Study|Other|1|||
28002137|NCT00531284|81838265|FG015|Overall Study|Other|0|||
28002138|NCT00531284|81838266|FG016|Overall Study|Other|0|||
28002139|NCT02675907|81838269|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
28002140|NCT02675907|81838270|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
28002141|NCT02675907|81838269|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
28002142|NCT02675907|81838270|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
28002143|NCT02675907|81838269|FG000|Study Overall|Lack of Efficacy|1|||
28002144|NCT02675907|81838270|FG001|Study Overall|Lack of Efficacy|0|||
28002145|NCT02675907|81838269|FG000|Study Overall|Withdrawal by Subject|2|||
28002146|NCT02675907|81838270|FG001|Study Overall|Withdrawal by Subject|2|||
28002147|NCT02675907|81838269|FG000|Study Overall|Lost to Follow-up|0|||
28002148|NCT02675907|81838270|FG001|Study Overall|Lost to Follow-up|2|||
28002149|NCT00922623|81838280|FG000|Overall Study|Other|4|||
28002150|NCT00922623|81838280|FG000|Overall Study|Lost to Follow-up|1|||
28002151|NCT04590014|81838285|FG000|Overall Study|Withdrawal by Subject|1|||
28002152|NCT04590014|81838286|FG001|Overall Study|Withdrawal by Subject|0|||
28002153|NCT01485094|81838291|FG000|Overall Study|Adverse Event|1|||
28002154|NCT01485094|81838292|FG001|Overall Study|Adverse Event|1|||
28002155|NCT01485094|81838293|FG002|Overall Study|Adverse Event|1|||
28002156|NCT01485094|81838291|FG000|Overall Study|Lost to Follow-up|1|||
28002157|NCT01485094|81838292|FG001|Overall Study|Lost to Follow-up|0|||
28002158|NCT01485094|81838293|FG002|Overall Study|Lost to Follow-up|0|||
28002159|NCT01485094|81838291|FG000|Overall Study|Withdrawal by Subject|1|||
28002160|NCT01485094|81838292|FG001|Overall Study|Withdrawal by Subject|1|||
28002161|NCT01485094|81838293|FG002|Overall Study|Withdrawal by Subject|0|||
28002162|NCT02090426|81838295|FG000|Overall Study|Lost to Follow-up|12|||
28002163|NCT02090426|81838296|FG001|Overall Study|Lost to Follow-up|6|||
28002164|NCT01092728|81838301|FG000|Overall Study|Withdrawal by Subject|2|||
28002165|NCT01092728|81838302|FG001|Overall Study|Withdrawal by Subject|0|||
28002166|NCT01092728|81838301|FG000|Overall Study|Adverse Event|0|||
28002167|NCT01092728|81838302|FG001|Overall Study|Adverse Event|1|||
28002168|NCT01092728|81838301|FG000|Overall Study|Disease Progression|1|||
28002169|NCT01092728|81838302|FG001|Overall Study|Disease Progression|13|||
28002170|NCT01092728|81838301|FG000|Overall Study|Prohibited Concomitant Medications|1|||
28002171|NCT01092728|81838302|FG001|Overall Study|Prohibited Concomitant Medications|0|||
28002172|NCT00961181|81838305|FG000|Overall Study|Death|2|||
28002173|NCT00961181|81838305|FG000|Overall Study|Withdrawal by Subject|2|||
28002174|NCT00961181|81838305|FG000|Overall Study|Lost to Follow-up|1|||
28002175|NCT03071263|81838327|FG000|Overall Study|Adverse Event|1|||
28002176|NCT03071263|81838328|FG001|Overall Study|Adverse Event|3|||
28002177|NCT03071263|81838327|FG000|Overall Study|Withdrawal by Subject|1|||
28002178|NCT03071263|81838328|FG001|Overall Study|Withdrawal by Subject|3|||
28002179|NCT03071263|81838327|FG000|Overall Study|Physician Decision|1|||
28002180|NCT03071263|81838328|FG001|Overall Study|Physician Decision|0|||
28002181|NCT03071263|81838327|FG000|Overall Study|Participant moved to another city|0|||
28002182|NCT03071263|81838328|FG001|Overall Study|Participant moved to another city|1|||
28002183|NCT00743249|81838333|FG000|Overall Study|Adverse Event|0|||
28002184|NCT00743249|81838334|FG001|Overall Study|Adverse Event|4|||
28002185|NCT00743249|81838333|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
28002186|NCT00743249|81838334|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
28002187|NCT00743249|81838333|FG000|Overall Study|Unsuccessful insertion of stent|2|||
28002188|NCT00743249|81838334|FG001|Overall Study|Unsuccessful insertion of stent|1|||
28002189|NCT02714569|81838337|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
28002190|NCT02714569|81838338|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
28002191|NCT02714569|81838339|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
28002192|NCT02714569|81838340|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
28002193|NCT02714569|81838341|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
28002194|NCT02714569|81838342|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
28002195|NCT02714569|81838343|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
28002196|NCT02714569|81838344|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
28002197|NCT02714569|81838345|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
28002198|NCT02714569|81838346|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
28002199|NCT02714569|81838347|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
28002200|NCT02714569|81838337|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002201|NCT02714569|81838338|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002202|NCT02714569|81838339|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002203|NCT02714569|81838340|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
28002204|NCT02714569|81838341|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002205|NCT02714569|81838342|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002206|NCT02714569|81838343|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002207|NCT02714569|81838344|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002208|NCT02714569|81838345|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002209|NCT02714569|81838346|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002210|NCT02714569|81838347|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
28002211|NCT02714569|81838337|FG000|Part A Third Intervention|Adverse Event|0|||
28002212|NCT02714569|81838338|FG001|Part A Third Intervention|Adverse Event|0|||
28002213|NCT02714569|81838339|FG002|Part A Third Intervention|Adverse Event|1|||
28002214|NCT02714569|81838340|FG003|Part A Third Intervention|Adverse Event|0|||
28002215|NCT02714569|81838341|FG004|Part A Third Intervention|Adverse Event|0|||
27806768|NCT01872689|81123301|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
27806769|NCT01872689|81123298|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
27806770|NCT01872689|81123299|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
27806771|NCT01872689|81123300|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
27806772|NCT01872689|81123301|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
27682197|NCT01743989|80672132|FG002|Re-treatment Phase|Physician Decision|0|||
27682198|NCT01743989|80672130|FG000|Re-treatment Phase|Lost to Follow-up|0|||
27682199|NCT01743989|80672131|FG001|Re-treatment Phase|Lost to Follow-up|1|||
27682200|NCT01743989|80672132|FG002|Re-treatment Phase|Lost to Follow-up|0|||
27682201|NCT03596762|80672134|FG000|Overall Study|Protocol Violation|0|||
27682202|NCT03596762|80672135|FG001|Overall Study|Protocol Violation|0|||
27682203|NCT03596762|80672136|FG002|Overall Study|Protocol Violation|0|||
27682204|NCT03596762|80672137|FG003|Overall Study|Protocol Violation|0|||
27682205|NCT03596762|80672138|FG004|Overall Study|Protocol Violation|1|||
27682206|NCT03596762|80672134|FG000|Overall Study|Adverse Event|2|||
27682207|NCT03596762|80672135|FG001|Overall Study|Adverse Event|0|||
27682208|NCT03596762|80672136|FG002|Overall Study|Adverse Event|1|||
27682209|NCT03596762|80672137|FG003|Overall Study|Adverse Event|0|||
27682210|NCT03596762|80672138|FG004|Overall Study|Adverse Event|5|||
27682211|NCT03596762|80672134|FG000|Overall Study|Withdrawal by Subject|2|||
27682212|NCT03596762|80672135|FG001|Overall Study|Withdrawal by Subject|1|||
27682213|NCT03596762|80672136|FG002|Overall Study|Withdrawal by Subject|0|||
27682214|NCT03596762|80672137|FG003|Overall Study|Withdrawal by Subject|1|||
27682215|NCT03596762|80672138|FG004|Overall Study|Withdrawal by Subject|1|||
27682216|NCT00415051|80672139|FG000|Overall Study|Protocol Violation|1|||
27682217|NCT01305239|80672140|FG000|Overall Study|Adverse Event|22|||
27682218|NCT01305239|80672140|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
27682219|NCT01427725|80672141|FG000|Overall Study|Lost to Follow-up|17|||
27682220|NCT01427725|80672141|FG000|Overall Study|Protocol Violation|1|||
27682221|NCT01427725|80672141|FG000|Overall Study|Drug not administered|1|||
27682222|NCT01427725|80672141|FG000|Overall Study|Failure to visit|7|||
27682223|NCT01427725|80672141|FG000|Overall Study|Adverse Event|46|||
27682224|NCT01427725|80672141|FG000|Overall Study|Failure to visit after administration|40|||
27806773|NCT01872689|81123298|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
27682225|NCT01427725|80672141|FG000|Overall Study|Patient's rejection|27|||
27682226|NCT01427725|80672141|FG000|Overall Study|Transfer to a different hospital|17|||
27682227|NCT01427725|80672141|FG000|Overall Study|Lack of Efficacy|8|||
27682228|NCT01427725|80672141|FG000|Overall Study|Death|7|||
27682229|NCT01427725|80672141|FG000|Overall Study|Symptom improvement|6|||
28002216|NCT02714569|81838342|FG005|Part A Third Intervention|Adverse Event|0|||
27682230|NCT01427725|80672141|FG000|Overall Study|AE and Patient's rejection|5|||
27682231|NCT01427725|80672141|FG000|Overall Study|Physician Decision|5|||
27700992|NCT01241552|80741289|FG000|Overall Study|Protocol Violation|0|||
27584175|NCT02096835|80319189|FG001|Overall Study|Withdrawal by Subject|0|||
27584176|NCT02096835|80319190|FG002|Overall Study|Withdrawal by Subject|0|||
27584177|NCT02096835|80319188|FG000|Overall Study|converted to open procedures|1|||
27584178|NCT02096835|80319189|FG001|Overall Study|converted to open procedures|0|||
27584179|NCT02096835|80319190|FG002|Overall Study|converted to open procedures|0|||
27584180|NCT02096835|80319188|FG000|Overall Study|Lost to Follow-up|1|||
27584181|NCT02096835|80319189|FG001|Overall Study|Lost to Follow-up|0|||
27584182|NCT02096835|80319190|FG002|Overall Study|Lost to Follow-up|1|||
27584183|NCT02401672|80319191|FG000|Overall Study|Withdrawal by Subject|1|||
27584184|NCT02401672|80319192|FG001|Overall Study|Withdrawal by Subject|3|||
27584185|NCT01898195|80319199|FG000|Smoking Abstinence|Did not have good measurements|35|||
27584186|NCT01898195|80319200|FG001|Smoking Abstinence|Did not have good measurements|38|||
27584187|NCT01898195|80319201|FG002|Smoking Abstinence|Did not have good measurements|36|||
27584188|NCT00975975|80319202|FG000|Overall Study|Death|6|||
27584189|NCT03811912|80319207|FG000|Overall Study|Withdrew Consent|4|||
27584190|NCT03811912|80319208|FG001|Overall Study|Withdrew Consent|2|||
27584191|NCT00856856|80319209|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
27584192|NCT00856856|80319209|FG000|4-year Clinical Follow-up|Missed visit|1|||
27584193|NCT04572633|80319213|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
27584194|NCT02207829|80319214|FG000|Overall Study|Adverse Event|10|||
27584195|NCT02207829|80319215|FG001|Overall Study|Adverse Event|9|||
27584196|NCT02207829|80319214|FG000|Overall Study|Lack of Efficacy|7|||
27584197|NCT02207829|80319215|FG001|Overall Study|Lack of Efficacy|5|||
27584198|NCT02207829|80319214|FG000|Overall Study|Lost to Follow-up|2|||
27584199|NCT02207829|80319215|FG001|Overall Study|Lost to Follow-up|2|||
27584200|NCT02207829|80319214|FG000|Overall Study|Protocol deviation|5|||
27584201|NCT02207829|80319215|FG001|Overall Study|Protocol deviation|4|||
28002217|NCT02714569|81838343|FG006|Part A Third Intervention|Adverse Event|0|||
28002218|NCT02714569|81838344|FG007|Part A Third Intervention|Adverse Event|0|||
28002219|NCT02714569|81838345|FG008|Part A Third Intervention|Adverse Event|0|||
28002220|NCT02714569|81838346|FG009|Part A Third Intervention|Adverse Event|0|||
28002221|NCT02714569|81838347|FG010|Part A Third Intervention|Adverse Event|0|||
28002222|NCT02714569|81838337|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
28002223|NCT02714569|81838338|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002224|NCT02714569|81838339|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002225|NCT02714569|81838340|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002226|NCT02714569|81838341|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002227|NCT02714569|81838342|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
28002228|NCT02714569|81838343|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002229|NCT02714569|81838344|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002230|NCT02714569|81838345|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002231|NCT02714569|81838346|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002232|NCT02714569|81838347|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
28002233|NCT02714569|81838337|FG000|Part B (Overall)|Lost to Follow-up|0|||
28002234|NCT02714569|81838338|FG001|Part B (Overall)|Lost to Follow-up|0|||
28002235|NCT02714569|81838339|FG002|Part B (Overall)|Lost to Follow-up|0|||
28002236|NCT02714569|81838340|FG003|Part B (Overall)|Lost to Follow-up|0|||
28002237|NCT02714569|81838341|FG004|Part B (Overall)|Lost to Follow-up|0|||
28002238|NCT02714569|81838342|FG005|Part B (Overall)|Lost to Follow-up|0|||
28002239|NCT02714569|81838343|FG006|Part B (Overall)|Lost to Follow-up|1|||
28002240|NCT02714569|81838344|FG007|Part B (Overall)|Lost to Follow-up|0|||
28002241|NCT02714569|81838345|FG008|Part B (Overall)|Lost to Follow-up|0|||
28002242|NCT02714569|81838346|FG009|Part B (Overall)|Lost to Follow-up|0|||
28002243|NCT02714569|81838347|FG010|Part B (Overall)|Lost to Follow-up|0|||
28002244|NCT02714569|81838337|FG000|Part B (Overall)|Withdrawal by Subject|0|||
28002245|NCT02714569|81838338|FG001|Part B (Overall)|Withdrawal by Subject|0|||
28002246|NCT02714569|81838339|FG002|Part B (Overall)|Withdrawal by Subject|0|||
28002247|NCT02714569|81838340|FG003|Part B (Overall)|Withdrawal by Subject|0|||
28002248|NCT02714569|81838341|FG004|Part B (Overall)|Withdrawal by Subject|0|||
28002249|NCT02714569|81838342|FG005|Part B (Overall)|Withdrawal by Subject|0|||
28002250|NCT02714569|81838343|FG006|Part B (Overall)|Withdrawal by Subject|0|||
28002251|NCT02714569|81838344|FG007|Part B (Overall)|Withdrawal by Subject|1|||
28002252|NCT02714569|81838345|FG008|Part B (Overall)|Withdrawal by Subject|0|||
28002253|NCT02714569|81838346|FG009|Part B (Overall)|Withdrawal by Subject|1|||
28002254|NCT02714569|81838347|FG010|Part B (Overall)|Withdrawal by Subject|0|||
27584202|NCT02207829|80319214|FG000|Overall Study|Withdrew consent|18|||
27806774|NCT01872689|81123299|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
27584203|NCT02207829|80319215|FG001|Overall Study|Withdrew consent|14|||
27584204|NCT02066298|80319216|FG000|Overall Study|Lost to Follow-up|3|||
27584205|NCT02066298|80319217|FG001|Overall Study|Lost to Follow-up|2|||
27806775|NCT01872689|81123300|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
27682232|NCT01427725|80672141|FG000|Overall Study|Exacerbation of underlying disease|5|||
27682233|NCT01427725|80672141|FG000|Overall Study|Oral feeding difficulty|5|||
27682234|NCT01427725|80672141|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
27682235|NCT01427725|80672141|FG000|Overall Study|Forgetting prescription|1|||
27682236|NCT01427725|80672141|FG000|Overall Study|Other|2|||
27682237|NCT01499303|80672142|FG000|Overall Study|Ongoing|2|||
27682238|NCT01499303|80672143|FG001|Overall Study|Ongoing|1|||
27682239|NCT01499303|80672142|FG000|Overall Study|Withdrawal by Subject|0|||
27682240|NCT01499303|80672143|FG001|Overall Study|Withdrawal by Subject|1|||
27682241|NCT01499303|80672142|FG000|Overall Study|Adverse Event|1|||
27682242|NCT01499303|80672143|FG001|Overall Study|Adverse Event|4|||
27682243|NCT01499303|80672142|FG000|Overall Study|Other|0|||
27682244|NCT01499303|80672143|FG001|Overall Study|Other|1|||
27682245|NCT04276415|80672144|FG000|Overall Study|Adverse Event|0|||
27682246|NCT04276415|80672145|FG001|Overall Study|Adverse Event|0|||
27682247|NCT04276415|80672146|FG002|Overall Study|Adverse Event|0|||
27682248|NCT04276415|80672147|FG003|Overall Study|Adverse Event|3|||
27682249|NCT04276415|80672148|FG004|Overall Study|Adverse Event|0|||
27682250|NCT04276415|80672149|FG005|Overall Study|Adverse Event|0|||
27682251|NCT04276415|80672144|FG000|Overall Study|Clinical progression|1|||
27682252|NCT04276415|80672145|FG001|Overall Study|Clinical progression|1|||
27682253|NCT04276415|80672146|FG002|Overall Study|Clinical progression|0|||
27682254|NCT04276415|80672147|FG003|Overall Study|Clinical progression|0|||
27682255|NCT04276415|80672148|FG004|Overall Study|Clinical progression|1|||
27682256|NCT04276415|80672149|FG005|Overall Study|Clinical progression|0|||
27682257|NCT04276415|80672144|FG000|Overall Study|Other|0|||
27682258|NCT04276415|80672145|FG001|Overall Study|Other|0|||
27682259|NCT04276415|80672146|FG002|Overall Study|Other|0|||
27682260|NCT04276415|80672147|FG003|Overall Study|Other|1|||
27682261|NCT04276415|80672148|FG004|Overall Study|Other|0|||
27682262|NCT04276415|80672149|FG005|Overall Study|Other|0|||
27682263|NCT04276415|80672144|FG000|Overall Study|Physician Decision|0|||
27682264|NCT04276415|80672145|FG001|Overall Study|Physician Decision|0|||
27682265|NCT04276415|80672146|FG002|Overall Study|Physician Decision|1|||
27682266|NCT04276415|80672147|FG003|Overall Study|Physician Decision|3|||
27682267|NCT04276415|80672148|FG004|Overall Study|Physician Decision|2|||
27682268|NCT04276415|80672149|FG005|Overall Study|Physician Decision|0|||
27682269|NCT04276415|80672144|FG000|Overall Study|Progressive disease|3|||
27682270|NCT04276415|80672145|FG001|Overall Study|Progressive disease|3|||
27682271|NCT04276415|80672146|FG002|Overall Study|Progressive disease|4|||
27682272|NCT04276415|80672147|FG003|Overall Study|Progressive disease|5|||
27682273|NCT04276415|80672148|FG004|Overall Study|Progressive disease|1|||
27682274|NCT04276415|80672149|FG005|Overall Study|Progressive disease|2|||
27682275|NCT04276415|80672144|FG000|Overall Study|Withdrawal by patient|0|||
27682276|NCT04276415|80672145|FG001|Overall Study|Withdrawal by patient|0|||
27682277|NCT04276415|80672146|FG002|Overall Study|Withdrawal by patient|0|||
27682278|NCT04276415|80672147|FG003|Overall Study|Withdrawal by patient|1|||
27682279|NCT04276415|80672148|FG004|Overall Study|Withdrawal by patient|2|||
27682280|NCT04276415|80672149|FG005|Overall Study|Withdrawal by patient|0|||
27682281|NCT02643472|80672152|FG000|Overall Study|Death|2|||
27682282|NCT02643472|80672153|FG001|Overall Study|Death|5|||
27682283|NCT02643472|80672152|FG000|Overall Study|Withdrawal by Subject|3|||
27682284|NCT02643472|80672153|FG001|Overall Study|Withdrawal by Subject|2|||
27682285|NCT02643472|80672152|FG000|Overall Study|Protocol Violation|0|||
27682286|NCT02643472|80672153|FG001|Overall Study|Protocol Violation|1|||
27682287|NCT02643472|80672152|FG000|Overall Study|Lost to Follow-up|22|||
27682288|NCT02643472|80672153|FG001|Overall Study|Lost to Follow-up|26|||
27682289|NCT01598662|80672154|FG000|Overall Study|Lost to Follow-up|10|||
27682290|NCT01598662|80672155|FG001|Overall Study|Lost to Follow-up|17|||
27682291|NCT01598662|80672154|FG000|Overall Study|Physician Decision|1|||
27682292|NCT01598662|80672155|FG001|Overall Study|Physician Decision|2|||
27682293|NCT01598662|80672154|FG000|Overall Study|IUD expelled before month 6|0|||
27682294|NCT01598662|80672155|FG001|Overall Study|IUD expelled before month 6|2|||
27682295|NCT00403767|80672156|FG000|Overall Study|Adverse Event|993|||
27682296|NCT00403767|80672157|FG001|Overall Study|Adverse Event|919|||
27682297|NCT00403767|80672156|FG000|Overall Study|Non-compliant with study medication|134|||
27682298|NCT00403767|80672157|FG001|Overall Study|Non-compliant with study medication|164|||
27682299|NCT00403767|80672156|FG000|Overall Study|Consent withdrawn|671|||
27682300|NCT00403767|80672157|FG001|Overall Study|Consent withdrawn|673|||
27682301|NCT00403767|80672156|FG000|Overall Study|Investigator dec./not protocol-related|191|||
27682302|NCT00403767|80672157|FG001|Overall Study|Investigator dec./not protocol-related|178|||
27682303|NCT00403767|80672156|FG000|Overall Study|Lost to Follow-up|6|||
27682304|NCT00403767|80672157|FG001|Overall Study|Lost to Follow-up|8|||
27682305|NCT00403767|80672156|FG000|Overall Study|Protocol Violation|142|||
27682306|NCT00403767|80672157|FG001|Overall Study|Protocol Violation|124|||
27682307|NCT00403767|80672156|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
27682308|NCT00403767|80672157|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
27682309|NCT00403767|80672156|FG000|Overall Study|Study terminated by sponsor|82|||
27682310|NCT00403767|80672157|FG001|Overall Study|Study terminated by sponsor|69|||
27682311|NCT00403767|80672156|FG000|Overall Study|Missing/incomplete data|1|||
27682312|NCT00403767|80672157|FG001|Overall Study|Missing/incomplete data|1|||
27682313|NCT00357110|80672158|FG000|Overall Study|Early study termination|5|||
27682314|NCT00357110|80672159|FG001|Overall Study|Early study termination|5|||
27682315|NCT03377699|80672162|FG000|Overall Study|Withdrawal by Subject|2|||
27682316|NCT03377699|80672163|FG001|Overall Study|Withdrawal by Subject|9|||
27682317|NCT03377699|80672162|FG000|Overall Study|Lost to Follow-up|1|||
27682318|NCT03377699|80672163|FG001|Overall Study|Lost to Follow-up|1|||
27682319|NCT03377699|80672162|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
27682320|NCT03377699|80672163|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
27682321|NCT03377699|80672162|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
28002255|NCT02714569|81838337|FG000|Part B (Overall)|Adverse Event|0|||
28002256|NCT02714569|81838338|FG001|Part B (Overall)|Adverse Event|0|||
28002257|NCT02714569|81838339|FG002|Part B (Overall)|Adverse Event|0|||
28002258|NCT02714569|81838340|FG003|Part B (Overall)|Adverse Event|0|||
28002259|NCT02714569|81838341|FG004|Part B (Overall)|Adverse Event|0|||
28002260|NCT02714569|81838342|FG005|Part B (Overall)|Adverse Event|0|||
27682322|NCT03377699|80672163|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
27682323|NCT03377699|80672162|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
27682324|NCT03377699|80672163|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
27682325|NCT03377699|80672162|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
27682326|NCT03377699|80672163|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
27682327|NCT03046121|80672164|FG000|Overall Study|Death|32|||
27682328|NCT03046121|80672165|FG001|Overall Study|Death|60|||
27682329|NCT03046121|80672164|FG000|Overall Study|Withdrawal by Subject|14|||
27682330|NCT03046121|80672165|FG001|Overall Study|Withdrawal by Subject|12|||
27682331|NCT02971761|80672170|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
27682332|NCT01641159|80672175|FG000|Overall Study|Lost to Follow-up|2|||
27682333|NCT01641159|80672176|FG001|Overall Study|Lost to Follow-up|1|||
27682334|NCT01641159|80672175|FG000|Overall Study|Withdrawal by Subject|0|||
27682335|NCT01641159|80672176|FG001|Overall Study|Withdrawal by Subject|1|||
27682336|NCT00974259|80672177|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
27682337|NCT00974259|80672178|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
27682338|NCT00299494|80672184|FG000|Overall Study|Withdrawal by Subject|0|||
27682339|NCT00299494|80672185|FG001|Overall Study|Withdrawal by Subject|0|||
27682340|NCT00299494|80672186|FG002|Overall Study|Withdrawal by Subject|0|||
27682341|NCT00299494|80672187|FG003|Overall Study|Withdrawal by Subject|3|||
27682342|NCT00299494|80672188|FG004|Overall Study|Withdrawal by Subject|1|||
27682343|NCT00299494|80672189|FG005|Overall Study|Withdrawal by Subject|4|||
27682344|NCT00299494|80672184|FG000|Overall Study|Physician Decision|0|||
27682345|NCT00299494|80672185|FG001|Overall Study|Physician Decision|0|||
27682346|NCT00299494|80672186|FG002|Overall Study|Physician Decision|0|||
27682347|NCT00299494|80672187|FG003|Overall Study|Physician Decision|0|||
27682348|NCT00299494|80672188|FG004|Overall Study|Physician Decision|1|||
27682349|NCT00299494|80672189|FG005|Overall Study|Physician Decision|0|||
27682350|NCT00299494|80672184|FG000|Overall Study|Death|3|||
27682351|NCT00299494|80672185|FG001|Overall Study|Death|1|||
27682352|NCT00299494|80672186|FG002|Overall Study|Death|4|||
27682353|NCT00299494|80672187|FG003|Overall Study|Death|6|||
27682354|NCT00299494|80672188|FG004|Overall Study|Death|18|||
27682355|NCT00299494|80672189|FG005|Overall Study|Death|19|||
27682356|NCT00299494|80672184|FG000|Overall Study|Lost to Follow-up|0|||
27682357|NCT00299494|80672185|FG001|Overall Study|Lost to Follow-up|0|||
27682358|NCT00299494|80672186|FG002|Overall Study|Lost to Follow-up|0|||
27682359|NCT00299494|80672187|FG003|Overall Study|Lost to Follow-up|0|||
27682360|NCT00299494|80672188|FG004|Overall Study|Lost to Follow-up|3|||
27682361|NCT00299494|80672189|FG005|Overall Study|Lost to Follow-up|1|||
27682362|NCT00299494|80672184|FG000|Overall Study|Other - Unspecified|0|||
27682363|NCT00299494|80672185|FG001|Overall Study|Other - Unspecified|0|||
27682364|NCT00299494|80672186|FG002|Overall Study|Other - Unspecified|0|||
27682365|NCT00299494|80672187|FG003|Overall Study|Other - Unspecified|0|||
27682366|NCT00299494|80672188|FG004|Overall Study|Other - Unspecified|3|||
27682367|NCT00299494|80672189|FG005|Overall Study|Other - Unspecified|1|||
27682368|NCT00299494|80672184|FG000|Overall Study|Other - site closure|0|||
27682369|NCT00299494|80672185|FG001|Overall Study|Other - site closure|0|||
27682370|NCT00299494|80672186|FG002|Overall Study|Other - site closure|0|||
28002261|NCT02714569|81838343|FG006|Part B (Overall)|Adverse Event|0|||
28002262|NCT02714569|81838344|FG007|Part B (Overall)|Adverse Event|0|||
27682371|NCT00299494|80672187|FG003|Overall Study|Other - site closure|1|||
27682372|NCT00299494|80672188|FG004|Overall Study|Other - site closure|1|||
27682373|NCT00299494|80672189|FG005|Overall Study|Other - site closure|1|||
27682374|NCT02224703|80672190|FG000|Overall Study|Adverse Event|0|||
27682375|NCT02224703|80672191|FG001|Overall Study|Adverse Event|5|||
28002263|NCT02714569|81838345|FG008|Part B (Overall)|Adverse Event|0|||
28002264|NCT02714569|81838346|FG009|Part B (Overall)|Adverse Event|1|||
27682376|NCT02224703|80672192|FG002|Overall Study|Adverse Event|0|||
27682377|NCT02224703|80672190|FG000|Overall Study|Withdrawn by investigator|1|||
27682378|NCT02224703|80672191|FG001|Overall Study|Withdrawn by investigator|0|||
27682379|NCT02224703|80672192|FG002|Overall Study|Withdrawn by investigator|0|||
27682380|NCT02224703|80672190|FG000|Overall Study|Advised by medical monitor|1|||
27682381|NCT02224703|80672191|FG001|Overall Study|Advised by medical monitor|0|||
27682382|NCT02224703|80672192|FG002|Overall Study|Advised by medical monitor|0|||
27682383|NCT02224703|80672190|FG000|Overall Study|Withdrawn by parent/guardian|0|||
27682384|NCT02224703|80672191|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27682385|NCT02224703|80672192|FG002|Overall Study|Withdrawn by parent/guardian|0|||
27682386|NCT02224703|80672190|FG000|Overall Study|Lack of Efficacy|1|||
27682387|NCT02224703|80672191|FG001|Overall Study|Lack of Efficacy|0|||
27682388|NCT02224703|80672192|FG002|Overall Study|Lack of Efficacy|0|||
27682389|NCT02672852|80672193|FG000|Part A1|Disease Worsening|1|||
27682390|NCT02672852|80672194|FG001|Part A1|Disease Worsening|0|||
27682391|NCT02672852|80672195|FG002|Part A1|Disease Worsening|0|||
27682392|NCT02672852|80672196|FG003|Part A1|Disease Worsening|0|||
27682393|NCT02672852|80672197|FG004|Part A1|Disease Worsening|0|||
27682394|NCT02672852|80672198|FG005|Part A1|Disease Worsening|0|||
27682395|NCT02672852|80672199|FG006|Part A1|Disease Worsening|0|||
27682396|NCT02672852|80672193|FG000|Part A1|Adverse Event|0|||
27682397|NCT02672852|80672194|FG001|Part A1|Adverse Event|1|||
27682398|NCT02672852|80672195|FG002|Part A1|Adverse Event|0|||
27682399|NCT02672852|80672196|FG003|Part A1|Adverse Event|0|||
27682400|NCT02672852|80672197|FG004|Part A1|Adverse Event|0|||
28002265|NCT02714569|81838347|FG010|Part B (Overall)|Adverse Event|0|||
28002266|NCT01960140|81838348|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
27682401|NCT02672852|80672198|FG005|Part A1|Adverse Event|0|||
27682402|NCT02672852|80672199|FG006|Part A1|Adverse Event|0|||
27682403|NCT02672852|80672193|FG000|Part A1|Lost to Follow-up|1|||
27682404|NCT02672852|80672194|FG001|Part A1|Lost to Follow-up|2|||
27682405|NCT02672852|80672195|FG002|Part A1|Lost to Follow-up|0|||
27682406|NCT02672852|80672196|FG003|Part A1|Lost to Follow-up|0|||
27682407|NCT02672852|80672197|FG004|Part A1|Lost to Follow-up|0|||
27682408|NCT02672852|80672198|FG005|Part A1|Lost to Follow-up|0|||
28002267|NCT00296816|81838349|FG000|Overall Study|Disease Progression|37|||
28002268|NCT00296816|81838349|FG000|Overall Study|Adverse Event|18|||
28002269|NCT00296816|81838349|FG000|Overall Study|Investigator/Participant request|5|||
28002270|NCT00296816|81838349|FG000|Overall Study|Non-compliance|1|||
28002271|NCT00296816|81838349|FG000|Overall Study|Missing for end of treatment|4|||
28002272|NCT00296816|81838349|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
28002273|NCT00296816|81838349|FG000|Overall Study|Poor performance status|1|||
28002274|NCT00296816|81838349|FG000|Overall Study|Relocation to Florida|1|||
28002275|NCT00296816|81838349|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
28002276|NCT00296816|81838349|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
28002277|NCT00296816|81838349|FG000|Overall Study|Neuropathy/patient preference|1|||
28002278|NCT00296816|81838349|FG000|Overall Study|Proteinuria|1|||
28002279|NCT00296816|81838349|FG000|Overall Study|ineligibility due to radiation treatment|1|||
28002280|NCT00360412|81838350|FG000|Overall Study|Adverse Event|37|||
28002281|NCT00360412|81838351|FG001|Overall Study|Adverse Event|65|||
28002282|NCT00360412|81838350|FG000|Overall Study|Protocol Violation|2|||
28002283|NCT00360412|81838351|FG001|Overall Study|Protocol Violation|5|||
28002284|NCT00360412|81838350|FG000|Overall Study|Patient withdrew consent|27|||
28002285|NCT00360412|81838351|FG001|Overall Study|Patient withdrew consent|52|||
28002286|NCT00360412|81838350|FG000|Overall Study|Lack of therapeutic efficacy|46|||
28002287|NCT00360412|81838351|FG001|Overall Study|Lack of therapeutic efficacy|61|||
28002288|NCT00360412|81838350|FG000|Overall Study|Physician Decision|2|||
28002289|NCT00360412|81838351|FG001|Overall Study|Physician Decision|4|||
28002290|NCT00360412|81838350|FG000|Overall Study|Other|5|||
28002291|NCT00360412|81838351|FG001|Overall Study|Other|6|||
27682409|NCT02672852|80672199|FG006|Part A1|Lost to Follow-up|0|||
27682410|NCT02672852|80672193|FG000|Part A1|Withdrawal by Subject|1|||
27682411|NCT02672852|80672194|FG001|Part A1|Withdrawal by Subject|1|||
27682412|NCT02672852|80672195|FG002|Part A1|Withdrawal by Subject|0|||
27682413|NCT02672852|80672196|FG003|Part A1|Withdrawal by Subject|0|||
27682414|NCT02672852|80672197|FG004|Part A1|Withdrawal by Subject|0|||
27682415|NCT02672852|80672198|FG005|Part A1|Withdrawal by Subject|0|||
27682416|NCT02672852|80672199|FG006|Part A1|Withdrawal by Subject|0|||
27682417|NCT02672852|80672193|FG000|Part A2|Disease worsening|0|||
27682418|NCT02672852|80672194|FG001|Part A2|Disease worsening|0|||
27682419|NCT02672852|80672195|FG002|Part A2|Disease worsening|1|||
27682420|NCT02672852|80672196|FG003|Part A2|Disease worsening|0|||
27682421|NCT02672852|80672197|FG004|Part A2|Disease worsening|0|||
27682422|NCT02672852|80672198|FG005|Part A2|Disease worsening|0|||
27682423|NCT02672852|80672199|FG006|Part A2|Disease worsening|0|||
27682424|NCT02672852|80672193|FG000|Part A2|Adverse Event|0|||
28002292|NCT00360412|81838350|FG000|Overall Study|Study termination by Sponsor|214|||
28002293|NCT00360412|81838351|FG001|Overall Study|Study termination by Sponsor|469|||
28002294|NCT01100320|81838352|FG000|Period 1|Withdrawal by Subject|2|||
28002295|NCT01100320|81838353|FG001|Period 1|Withdrawal by Subject|4|||
28002296|NCT01100320|81838352|FG000|Period 1|Positive Drug Screen|1|||
28002297|NCT01100320|81838353|FG001|Period 1|Positive Drug Screen|1|||
28002298|NCT01100320|81838352|FG000|Period 1|Adverse Event|2|||
28002299|NCT01100320|81838353|FG001|Period 1|Adverse Event|2|||
28002300|NCT01100320|81838352|FG000|Period 2|Withdrawal by Subject|1|||
28002301|NCT01100320|81838353|FG001|Period 2|Withdrawal by Subject|1|||
28002302|NCT00419393|81838354|FG000|Overall Study|Adverse Event|5|||
28002303|NCT00419393|81838354|FG000|Overall Study|Protocol Violation|5|||
28002304|NCT00419393|81838354|FG000|Overall Study|Withdrawal by Subject|7|||
28002305|NCT00419393|81838354|FG000|Overall Study|Other: Sponsor request|3|||
28002306|NCT00419393|81838354|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
28002307|NCT00419393|81838354|FG000|Overall Study|Other: Site closure|1|||
28002308|NCT00419393|81838354|FG000|Overall Study|Other: Other health problems|1|||
28002309|NCT00419393|81838354|FG000|Overall Study|Other: Investigator decision|1|||
28002310|NCT00681629|81838355|FG000|Overall Study|Study termination|4|||
28002311|NCT00681629|81838356|FG001|Overall Study|Study termination|2|||
28002312|NCT00681629|81838355|FG000|Overall Study|Adverse Event|1|||
28002313|NCT00681629|81838356|FG001|Overall Study|Adverse Event|0|||
28002314|NCT01332994|81838375|FG000|Overall Study|Adverse Event|34|||
28002315|NCT01332994|81838375|FG000|Overall Study|Death|1|||
28002316|NCT01332994|81838375|FG000|Overall Study|Lack of Efficacy|1|||
28002317|NCT01332994|81838375|FG000|Overall Study|Lost to Follow-up|4|||
28002318|NCT01332994|81838375|FG000|Overall Study|Protocol Violation|6|||
27682425|NCT02672852|80672194|FG001|Part A2|Adverse Event|0|||
27682426|NCT02672852|80672195|FG002|Part A2|Adverse Event|3|||
27682427|NCT02672852|80672196|FG003|Part A2|Adverse Event|0|||
27682428|NCT02672852|80672197|FG004|Part A2|Adverse Event|0|||
27682429|NCT02672852|80672198|FG005|Part A2|Adverse Event|0|||
27682430|NCT02672852|80672199|FG006|Part A2|Adverse Event|0|||
27682431|NCT02672852|80672193|FG000|Part A2|Lost to Follow-up|0|||
27682432|NCT02672852|80672194|FG001|Part A2|Lost to Follow-up|0|||
28002319|NCT01332994|81838375|FG000|Overall Study|Withdrawal by Subject|15|||
27682433|NCT02672852|80672195|FG002|Part A2|Lost to Follow-up|2|||
27682434|NCT02672852|80672196|FG003|Part A2|Lost to Follow-up|0|||
27682435|NCT02672852|80672197|FG004|Part A2|Lost to Follow-up|0|||
27682436|NCT02672852|80672198|FG005|Part A2|Lost to Follow-up|0|||
27682437|NCT02672852|80672199|FG006|Part A2|Lost to Follow-up|0|||
27682438|NCT02672852|80672193|FG000|Part A2|Withdrawal by Subject|0|||
27682439|NCT02672852|80672194|FG001|Part A2|Withdrawal by Subject|0|||
27682440|NCT02672852|80672195|FG002|Part A2|Withdrawal by Subject|1|||
27682441|NCT02672852|80672196|FG003|Part A2|Withdrawal by Subject|0|||
27682442|NCT02672852|80672197|FG004|Part A2|Withdrawal by Subject|0|||
27682443|NCT02672852|80672198|FG005|Part A2|Withdrawal by Subject|0|||
27682444|NCT02672852|80672199|FG006|Part A2|Withdrawal by Subject|0|||
27682445|NCT02672852|80672193|FG000|Part A2|Other|0|||
27806776|NCT01872689|81123301|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
28002320|NCT01332994|81838375|FG000|Overall Study|Administrative Problem|2|||
28002321|NCT01332994|81838375|FG000|Overall Study|Other|8|||
28002322|NCT00404651|81838376|FG000|Overall Study|Serious Adverse Event|0|||
28002323|NCT00404651|81838377|FG001|Overall Study|Serious Adverse Event|0|||
28002324|NCT00404651|81838378|FG002|Overall Study|Serious Adverse Event|2|||
28002325|NCT00404651|81838379|FG003|Overall Study|Serious Adverse Event|0|||
28002326|NCT00404651|81838376|FG000|Overall Study|Protocol Violation|10|||
28002327|NCT00404651|81838377|FG001|Overall Study|Protocol Violation|5|||
27682446|NCT02672852|80672194|FG001|Part A2|Other|0|||
27682447|NCT02672852|80672195|FG002|Part A2|Other|3|||
27682448|NCT02672852|80672196|FG003|Part A2|Other|0|||
27682449|NCT02672852|80672197|FG004|Part A2|Other|0|||
27682450|NCT02672852|80672198|FG005|Part A2|Other|0|||
27682451|NCT02672852|80672199|FG006|Part A2|Other|0|||
27682452|NCT02672852|80672193|FG000|Part A2|Not entered in Part B|0|||
27682453|NCT02672852|80672194|FG001|Part A2|Not entered in Part B|0|||
27682454|NCT02672852|80672195|FG002|Part A2|Not entered in Part B|0|||
27682455|NCT02672852|80672196|FG003|Part A2|Not entered in Part B|4|||
27682456|NCT02672852|80672197|FG004|Part A2|Not entered in Part B|0|||
27682457|NCT02672852|80672198|FG005|Part A2|Not entered in Part B|0|||
27682458|NCT02672852|80672199|FG006|Part A2|Not entered in Part B|0|||
28002328|NCT00404651|81838378|FG002|Overall Study|Protocol Violation|14|||
27682459|NCT02672852|80672193|FG000|Part B|Disease worsening|0|||
27682460|NCT02672852|80672194|FG001|Part B|Disease worsening|0|||
27682461|NCT02672852|80672195|FG002|Part B|Disease worsening|0|||
27682462|NCT02672852|80672196|FG003|Part B|Disease worsening|0|||
27682463|NCT02672852|80672197|FG004|Part B|Disease worsening|1|||
28002329|NCT00404651|81838379|FG003|Overall Study|Protocol Violation|5|||
28002330|NCT00404651|81838376|FG000|Overall Study|Lost to Follow-up|15|||
28002331|NCT00404651|81838377|FG001|Overall Study|Lost to Follow-up|11|||
28002332|NCT00404651|81838378|FG002|Overall Study|Lost to Follow-up|13|||
28002333|NCT00404651|81838379|FG003|Overall Study|Lost to Follow-up|10|||
28002334|NCT00404651|81838376|FG000|Overall Study|Withdrawal by Subject|14|||
28002335|NCT00404651|81838377|FG001|Overall Study|Withdrawal by Subject|12|||
28002336|NCT00404651|81838378|FG002|Overall Study|Withdrawal by Subject|16|||
28002337|NCT00404651|81838379|FG003|Overall Study|Withdrawal by Subject|6|||
28002338|NCT01300728|81838391|FG000|Overall Study|Withdrawal by Subject|1|||
28002339|NCT01300728|81838392|FG001|Overall Study|Withdrawal by Subject|1|||
28002340|NCT01300728|81838391|FG000|Overall Study|Physician Decision|1|||
28002341|NCT01300728|81838392|FG001|Overall Study|Physician Decision|0|||
28002342|NCT02469623|81838393|FG000|Overall Study|Not consented for long-term follow-up|4|||
28002343|NCT02469623|81838393|FG000|Overall Study|Lost to Follow-up|4|||
28002344|NCT02469623|81838393|FG000|Overall Study|Withdrawal by Subject|2|||
28002345|NCT02469623|81838393|FG000|Overall Study|Death|3|||
28002346|NCT01894607|81838396|FG000|Overall Study|Ineligible|1|||
28002347|NCT03546621|81838397|FG000|Overall Study|Withdrawal by Subject|0|||
28002348|NCT03546621|81838398|FG001|Overall Study|Withdrawal by Subject|1|||
28002349|NCT03546621|81838399|FG002|Overall Study|Withdrawal by Subject|2|||
28002350|NCT03546621|81838400|FG003|Overall Study|Withdrawal by Subject|1|||
28002351|NCT03546621|81838397|FG000|Overall Study|Lost to Follow-up|0|||
28002352|NCT03546621|81838398|FG001|Overall Study|Lost to Follow-up|1|||
28002353|NCT03546621|81838399|FG002|Overall Study|Lost to Follow-up|0|||
28002354|NCT03546621|81838400|FG003|Overall Study|Lost to Follow-up|0|||
28002355|NCT03546621|81838397|FG000|Overall Study|Adverse Event|0|||
28002356|NCT03546621|81838398|FG001|Overall Study|Adverse Event|1|||
28002357|NCT03546621|81838399|FG002|Overall Study|Adverse Event|0|||
28002358|NCT03546621|81838400|FG003|Overall Study|Adverse Event|1|||
28002359|NCT03546621|81838397|FG000|Overall Study|Progressive disease|0|||
28002360|NCT03546621|81838398|FG001|Overall Study|Progressive disease|0|||
28002361|NCT03546621|81838399|FG002|Overall Study|Progressive disease|0|||
28002362|NCT03546621|81838400|FG003|Overall Study|Progressive disease|1|||
27584206|NCT02066298|80319218|FG002|Overall Study|Lost to Follow-up|3|||
27584207|NCT02066298|80319219|FG003|Overall Study|Lost to Follow-up|2|||
27682464|NCT02672852|80672198|FG005|Part B|Disease worsening|0|||
27682465|NCT02672852|80672199|FG006|Part B|Disease worsening|1|||
27682466|NCT02672852|80672193|FG000|Part B|Worsening pre-existing condition|0|||
27682467|NCT02672852|80672194|FG001|Part B|Worsening pre-existing condition|0|||
27682468|NCT02672852|80672195|FG002|Part B|Worsening pre-existing condition|0|||
27682469|NCT02672852|80672196|FG003|Part B|Worsening pre-existing condition|0|||
27682470|NCT02672852|80672197|FG004|Part B|Worsening pre-existing condition|0|||
27682471|NCT02672852|80672198|FG005|Part B|Worsening pre-existing condition|1|||
27682472|NCT02672852|80672199|FG006|Part B|Worsening pre-existing condition|0|||
27682473|NCT02672852|80672193|FG000|Part B|Other adverse event|0|||
27682474|NCT02672852|80672194|FG001|Part B|Other adverse event|0|||
27682475|NCT02672852|80672195|FG002|Part B|Other adverse event|0|||
27682476|NCT02672852|80672196|FG003|Part B|Other adverse event|0|||
27682477|NCT02672852|80672197|FG004|Part B|Other adverse event|3|||
27682478|NCT02672852|80672198|FG005|Part B|Other adverse event|5|||
27682479|NCT02672852|80672199|FG006|Part B|Other adverse event|1|||
27682480|NCT02672852|80672193|FG000|Part B|Lost to Follow-up|0|||
27682481|NCT02672852|80672194|FG001|Part B|Lost to Follow-up|0|||
27682482|NCT02672852|80672195|FG002|Part B|Lost to Follow-up|0|||
27682483|NCT02672852|80672196|FG003|Part B|Lost to Follow-up|0|||
27682484|NCT02672852|80672197|FG004|Part B|Lost to Follow-up|3|||
27682485|NCT02672852|80672198|FG005|Part B|Lost to Follow-up|4|||
27682486|NCT02672852|80672199|FG006|Part B|Lost to Follow-up|1|||
27682487|NCT02672852|80672193|FG000|Part B|Withdrawal by Subject|0|||
27682488|NCT02672852|80672194|FG001|Part B|Withdrawal by Subject|0|||
27682489|NCT02672852|80672195|FG002|Part B|Withdrawal by Subject|0|||
27682490|NCT02672852|80672196|FG003|Part B|Withdrawal by Subject|0|||
27682491|NCT02672852|80672197|FG004|Part B|Withdrawal by Subject|5|||
27682492|NCT02672852|80672198|FG005|Part B|Withdrawal by Subject|0|||
27682493|NCT02672852|80672199|FG006|Part B|Withdrawal by Subject|7|||
27682494|NCT02672852|80672193|FG000|Part B|Other|0|||
27806777|NCT01872689|81123298|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
27806778|NCT01872689|81123299|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
28002363|NCT01338818|81838404|FG000|Overall Study|Adverse Event|8|||
27682495|NCT02672852|80672194|FG001|Part B|Other|0|||
27682496|NCT02672852|80672195|FG002|Part B|Other|0|||
27682497|NCT02672852|80672196|FG003|Part B|Other|0|||
27682498|NCT02672852|80672197|FG004|Part B|Other|4|||
27682499|NCT02672852|80672198|FG005|Part B|Other|1|||
27682500|NCT02672852|80672199|FG006|Part B|Other|2|||
27682501|NCT00461981|80672209|FG000|Overall Study|Lost to Follow-up|9|||
27806779|NCT01872689|81123300|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
28002364|NCT01338818|81838404|FG000|Overall Study|Lack of Efficacy|5|||
28002365|NCT01338818|81838404|FG000|Overall Study|no longer require study drug|1|||
28002366|NCT01338818|81838404|FG000|Overall Study|Withdrawal by Subject|11|||
28002367|NCT01338818|81838404|FG000|Overall Study|Lost to Follow-up|4|||
28002368|NCT01338818|81838404|FG000|Overall Study|Administrative problems|3|||
28002369|NCT01338818|81838404|FG000|Overall Study|Protocol Deviation|4|||
28002370|NCT02807623|81838408|FG000|Overall Study|Lost to Follow-up|23|||
28002371|NCT02807623|81838409|FG001|Overall Study|Lost to Follow-up|18|||
28002372|NCT02807623|81838410|FG002|Overall Study|Lost to Follow-up|22|||
27682502|NCT00461981|80672210|FG001|Overall Study|Lost to Follow-up|6|||
27682503|NCT00461981|80672209|FG000|Overall Study|Withdrawal by Subject|2|||
27682504|NCT00461981|80672210|FG001|Overall Study|Withdrawal by Subject|3|||
27682505|NCT01281839|80672211|FG000|Overall Study|Lost to Follow-up|6|||
27682506|NCT01281839|80672212|FG001|Overall Study|Lost to Follow-up|3|||
27682507|NCT01281839|80672211|FG000|Overall Study|Withdrawal by Subject|4|||
27682508|NCT01281839|80672212|FG001|Overall Study|Withdrawal by Subject|10|||
27682509|NCT01281839|80672211|FG000|Overall Study|Reason not specified|0|||
27682510|NCT01281839|80672212|FG001|Overall Study|Reason not specified|1|||
27682511|NCT00324116|80672213|FG000|Overall Study|Adverse Event|5|||
27682512|NCT00324116|80672213|FG000|Overall Study|Lack of Efficacy|17|||
27682513|NCT00324116|80672213|FG000|Overall Study|Withdrawal by Subject|5|||
27682514|NCT00324116|80672213|FG000|Overall Study|Other|5|||
27682515|NCT04445987|80672214|FG000|Overall Study|Adverse Event|0|||
27682516|NCT04445987|80672215|FG001|Overall Study|Adverse Event|0|||
27682517|NCT04445987|80672216|FG002|Overall Study|Adverse Event|1|||
27682518|NCT04445987|80672217|FG003|Overall Study|Adverse Event|0|||
27682519|NCT04445987|80672218|FG004|Overall Study|Adverse Event|4|||
27682520|NCT04445987|80672219|FG005|Overall Study|Adverse Event|0|||
27682521|NCT04445987|80672214|FG000|Overall Study|Lost to Follow-up|4|||
27682522|NCT04445987|80672215|FG001|Overall Study|Lost to Follow-up|3|||
27682523|NCT04445987|80672216|FG002|Overall Study|Lost to Follow-up|1|||
27682524|NCT04445987|80672217|FG003|Overall Study|Lost to Follow-up|1|||
27682525|NCT04445987|80672218|FG004|Overall Study|Lost to Follow-up|29|||
27682526|NCT04445987|80672219|FG005|Overall Study|Lost to Follow-up|0|||
27682527|NCT04445987|80672214|FG000|Overall Study|Physician Decision|0|||
27682528|NCT04445987|80672215|FG001|Overall Study|Physician Decision|0|||
27682529|NCT04445987|80672216|FG002|Overall Study|Physician Decision|0|||
27682530|NCT04445987|80672217|FG003|Overall Study|Physician Decision|0|||
27682531|NCT04445987|80672218|FG004|Overall Study|Physician Decision|1|||
27682532|NCT04445987|80672219|FG005|Overall Study|Physician Decision|0|||
27682533|NCT04445987|80672214|FG000|Overall Study|Protocol Violation|1|||
27682534|NCT04445987|80672215|FG001|Overall Study|Protocol Violation|0|||
27682535|NCT04445987|80672216|FG002|Overall Study|Protocol Violation|0|||
27682536|NCT04445987|80672217|FG003|Overall Study|Protocol Violation|0|||
27682537|NCT04445987|80672218|FG004|Overall Study|Protocol Violation|2|||
27682538|NCT04445987|80672219|FG005|Overall Study|Protocol Violation|0|||
27682539|NCT04445987|80672214|FG000|Overall Study|Withdrawal by Subject|4|||
27682540|NCT04445987|80672215|FG001|Overall Study|Withdrawal by Subject|0|||
27682541|NCT04445987|80672216|FG002|Overall Study|Withdrawal by Subject|1|||
27682542|NCT04445987|80672217|FG003|Overall Study|Withdrawal by Subject|0|||
27682543|NCT04445987|80672218|FG004|Overall Study|Withdrawal by Subject|18|||
27682544|NCT04445987|80672219|FG005|Overall Study|Withdrawal by Subject|1|||
27682545|NCT04445987|80672214|FG000|Overall Study|Other reason|0|||
27682546|NCT04445987|80672215|FG001|Overall Study|Other reason|0|||
27682547|NCT04445987|80672216|FG002|Overall Study|Other reason|1|||
27682548|NCT04445987|80672217|FG003|Overall Study|Other reason|0|||
27682549|NCT04445987|80672218|FG004|Overall Study|Other reason|2|||
27682550|NCT04445987|80672219|FG005|Overall Study|Other reason|0|||
27682551|NCT01125046|80672223|FG000|First 6 Months of Treatment|Death|1|||
27682552|NCT01125046|80672223|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
27682553|NCT01125046|80672223|FG000|First 6 Months of Treatment|Non-compliance|1|||
27682554|NCT01125046|80672223|FG000|First 6 Months of Treatment|Surgery|1|||
27682555|NCT01125046|80672223|FG000|First 6 Months of Treatment|Progressive Disease|7|||
27682556|NCT01125046|80672223|FG000|First 6 Months of Treatment|Adverse Event|2|||
27682557|NCT01125046|80672223|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
27682558|NCT01125046|80672223|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
27682559|NCT01125046|80672223|FG000|Follow-up/Data Cut Off Point|Death|29|||
27682560|NCT01125046|80672223|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
27682561|NCT04145700|80672224|FG000|Overall Study|Withdrawal by Subject|8|||
27682562|NCT04145700|80672225|FG001|Overall Study|Withdrawal by Subject|3|||
27682563|NCT00780559|80672226|FG000|Overall Study|Lost to Follow-up|2|||
27682564|NCT00780559|80672227|FG001|Overall Study|Lost to Follow-up|7|||
27682565|NCT00780559|80672226|FG000|Overall Study|Death|1|||
27682566|NCT00780559|80672227|FG001|Overall Study|Death|0|||
27682567|NCT00568178|80672228|FG000|Double Blind Base Study|Adverse Event|0|||
27682568|NCT00568178|80672229|FG001|Double Blind Base Study|Adverse Event|2|||
27682569|NCT00568178|80672230|FG002|Double Blind Base Study|Adverse Event|1|||
27682570|NCT00568178|80672231|FG003|Double Blind Base Study|Adverse Event|2|||
27682571|NCT00568178|80672232|FG004|Double Blind Base Study|Adverse Event|0|||
27682572|NCT00568178|80672233|FG005|Double Blind Base Study|Adverse Event|0|||
27682573|NCT00568178|80672228|FG000|Double Blind Base Study|Lost to Follow-up|1|||
27682574|NCT00568178|80672229|FG001|Double Blind Base Study|Lost to Follow-up|0|||
27682575|NCT00568178|80672230|FG002|Double Blind Base Study|Lost to Follow-up|0|||
27682576|NCT00568178|80672231|FG003|Double Blind Base Study|Lost to Follow-up|1|||
27682577|NCT00568178|80672232|FG004|Double Blind Base Study|Lost to Follow-up|0|||
27682578|NCT00568178|80672233|FG005|Double Blind Base Study|Lost to Follow-up|0|||
27682579|NCT00568178|80672228|FG000|Double Blind Base Study|Physician Decision|1|||
27682580|NCT00568178|80672229|FG001|Double Blind Base Study|Physician Decision|1|||
27682581|NCT00568178|80672230|FG002|Double Blind Base Study|Physician Decision|0|||
27682582|NCT00568178|80672231|FG003|Double Blind Base Study|Physician Decision|1|||
27682583|NCT00568178|80672232|FG004|Double Blind Base Study|Physician Decision|0|||
27682584|NCT00568178|80672233|FG005|Double Blind Base Study|Physician Decision|0|||
27682585|NCT00568178|80672228|FG000|Double Blind Base Study|Protocol Violation|3|||
27682586|NCT00568178|80672229|FG001|Double Blind Base Study|Protocol Violation|2|||
27682587|NCT00568178|80672230|FG002|Double Blind Base Study|Protocol Violation|0|||
27682588|NCT00568178|80672231|FG003|Double Blind Base Study|Protocol Violation|0|||
27682589|NCT00568178|80672232|FG004|Double Blind Base Study|Protocol Violation|0|||
27682590|NCT00568178|80672233|FG005|Double Blind Base Study|Protocol Violation|0|||
27682591|NCT00568178|80672228|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
27682592|NCT00568178|80672229|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
27682593|NCT00568178|80672230|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
27682594|NCT00568178|80672231|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
27682595|NCT00568178|80672232|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
27682596|NCT00568178|80672233|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
27682597|NCT00568178|80672228|FG000|Double Blind Base Study|Progressive Disease|0|||
27682598|NCT00568178|80672229|FG001|Double Blind Base Study|Progressive Disease|0|||
27682599|NCT00568178|80672230|FG002|Double Blind Base Study|Progressive Disease|0|||
27682600|NCT00568178|80672231|FG003|Double Blind Base Study|Progressive Disease|1|||
27682601|NCT00568178|80672232|FG004|Double Blind Base Study|Progressive Disease|0|||
27682602|NCT00568178|80672233|FG005|Double Blind Base Study|Progressive Disease|0|||
27682603|NCT00568178|80672228|FG000|Open Label Extension|Adverse Event|0|||
27682604|NCT00568178|80672229|FG001|Open Label Extension|Adverse Event|0|||
27682605|NCT00568178|80672230|FG002|Open Label Extension|Adverse Event|0|||
27682606|NCT00568178|80672231|FG003|Open Label Extension|Adverse Event|0|||
27682607|NCT00568178|80672232|FG004|Open Label Extension|Adverse Event|11|||
27682608|NCT00568178|80672233|FG005|Open Label Extension|Adverse Event|8|||
27682609|NCT00568178|80672228|FG000|Open Label Extension|Protocol Violation|0|||
27682610|NCT00568178|80672229|FG001|Open Label Extension|Protocol Violation|0|||
27682611|NCT00568178|80672230|FG002|Open Label Extension|Protocol Violation|0|||
27682612|NCT00568178|80672231|FG003|Open Label Extension|Protocol Violation|0|||
27682613|NCT00568178|80672232|FG004|Open Label Extension|Protocol Violation|1|||
27682614|NCT00568178|80672233|FG005|Open Label Extension|Protocol Violation|0|||
27682615|NCT00568178|80672228|FG000|Open Label Extension|Lost to Follow-up|0|||
27682616|NCT00568178|80672229|FG001|Open Label Extension|Lost to Follow-up|0|||
27682617|NCT00568178|80672230|FG002|Open Label Extension|Lost to Follow-up|0|||
27682618|NCT00568178|80672231|FG003|Open Label Extension|Lost to Follow-up|0|||
27682619|NCT00568178|80672232|FG004|Open Label Extension|Lost to Follow-up|6|||
27682620|NCT00568178|80672233|FG005|Open Label Extension|Lost to Follow-up|11|||
27682621|NCT00568178|80672228|FG000|Open Label Extension|Physician Decision|0|||
27682622|NCT00568178|80672229|FG001|Open Label Extension|Physician Decision|0|||
27682623|NCT00568178|80672230|FG002|Open Label Extension|Physician Decision|0|||
27682624|NCT00568178|80672231|FG003|Open Label Extension|Physician Decision|0|||
27682625|NCT00568178|80672232|FG004|Open Label Extension|Physician Decision|9|||
27682626|NCT00568178|80672233|FG005|Open Label Extension|Physician Decision|8|||
27682627|NCT00568178|80672228|FG000|Open Label Extension|Pregnancy|0|||
27682628|NCT00568178|80672229|FG001|Open Label Extension|Pregnancy|0|||
27682629|NCT00568178|80672230|FG002|Open Label Extension|Pregnancy|0|||
27682630|NCT00568178|80672231|FG003|Open Label Extension|Pregnancy|0|||
27682631|NCT00568178|80672232|FG004|Open Label Extension|Pregnancy|0|||
27682632|NCT00568178|80672233|FG005|Open Label Extension|Pregnancy|1|||
27682633|NCT00568178|80672228|FG000|Open Label Extension|Progressive Disease|0|||
27682634|NCT00568178|80672229|FG001|Open Label Extension|Progressive Disease|0|||
27682635|NCT00568178|80672230|FG002|Open Label Extension|Progressive Disease|0|||
27682636|NCT00568178|80672231|FG003|Open Label Extension|Progressive Disease|0|||
27682637|NCT00568178|80672232|FG004|Open Label Extension|Progressive Disease|3|||
27682638|NCT00568178|80672233|FG005|Open Label Extension|Progressive Disease|1|||
27682639|NCT00568178|80672228|FG000|Open Label Extension|Termination of Trial|0|||
27682640|NCT00568178|80672229|FG001|Open Label Extension|Termination of Trial|0|||
27682641|NCT00568178|80672230|FG002|Open Label Extension|Termination of Trial|0|||
27682642|NCT00568178|80672231|FG003|Open Label Extension|Termination of Trial|0|||
27682643|NCT00568178|80672232|FG004|Open Label Extension|Termination of Trial|45|||
27682644|NCT00568178|80672233|FG005|Open Label Extension|Termination of Trial|47|||
27682645|NCT00568178|80672228|FG000|Open Label Extension|Withdrawal by Subject|0|||
27682646|NCT00568178|80672229|FG001|Open Label Extension|Withdrawal by Subject|0|||
27682647|NCT00568178|80672230|FG002|Open Label Extension|Withdrawal by Subject|0|||
27682648|NCT00568178|80672231|FG003|Open Label Extension|Withdrawal by Subject|0|||
27682649|NCT00568178|80672232|FG004|Open Label Extension|Withdrawal by Subject|4|||
27682650|NCT00568178|80672233|FG005|Open Label Extension|Withdrawal by Subject|4|||
27874057|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27682651|NCT01468181|80672239|FG000|Overall Study|Adverse Event|8|||
28002373|NCT02807623|81838408|FG000|Overall Study|Drug intolerance|0|||
27682652|NCT01468181|80672240|FG001|Overall Study|Adverse Event|1|||
27682653|NCT01468181|80672241|FG002|Overall Study|Adverse Event|6|||
27682654|NCT01468181|80672242|FG003|Overall Study|Adverse Event|2|||
27682655|NCT01468181|80672243|FG004|Overall Study|Adverse Event|2|||
27682656|NCT01468181|80672239|FG000|Overall Study|Protocol Violation|2|||
27682657|NCT01468181|80672240|FG001|Overall Study|Protocol Violation|0|||
27682658|NCT01468181|80672241|FG002|Overall Study|Protocol Violation|1|||
27682659|NCT01468181|80672242|FG003|Overall Study|Protocol Violation|0|||
27682660|NCT01468181|80672243|FG004|Overall Study|Protocol Violation|1|||
27682661|NCT01468181|80672239|FG000|Overall Study|Physician Decision|0|||
27682662|NCT01468181|80672240|FG001|Overall Study|Physician Decision|0|||
27682663|NCT01468181|80672241|FG002|Overall Study|Physician Decision|0|||
27682664|NCT01468181|80672242|FG003|Overall Study|Physician Decision|1|||
27682665|NCT01468181|80672243|FG004|Overall Study|Physician Decision|1|||
27682666|NCT01468181|80672239|FG000|Overall Study|Lost to Follow-up|0|||
27682667|NCT01468181|80672240|FG001|Overall Study|Lost to Follow-up|0|||
27682668|NCT01468181|80672241|FG002|Overall Study|Lost to Follow-up|1|||
27682669|NCT01468181|80672242|FG003|Overall Study|Lost to Follow-up|0|||
27682670|NCT01468181|80672243|FG004|Overall Study|Lost to Follow-up|1|||
27682671|NCT01468181|80672239|FG000|Overall Study|Withdrawal by Subject|0|||
27682672|NCT01468181|80672240|FG001|Overall Study|Withdrawal by Subject|1|||
27682673|NCT01468181|80672241|FG002|Overall Study|Withdrawal by Subject|0|||
27682674|NCT01468181|80672242|FG003|Overall Study|Withdrawal by Subject|0|||
27682675|NCT01468181|80672243|FG004|Overall Study|Withdrawal by Subject|0|||
27682676|NCT00902746|80672244|FG000|Overall Study|Protocol Violation|7|||
27682677|NCT00902746|80672244|FG000|Overall Study|Withdrawal by Subject|16|||
27682678|NCT00902746|80672244|FG000|Overall Study|Adverse Event|8|||
27682679|NCT00902746|80672244|FG000|Overall Study|Lost to Follow-up|3|||
27682680|NCT00902746|80672244|FG000|Overall Study|Physician Decision|2|||
27682681|NCT01519089|80672245|FG000|Overall Study|Adverse Event|4|||
27682682|NCT01519089|80672246|FG001|Overall Study|Adverse Event|4|||
27682683|NCT01519089|80672245|FG000|Overall Study|Lack of Efficacy|0|||
27682684|NCT01519089|80672246|FG001|Overall Study|Lack of Efficacy|2|||
27682685|NCT01519089|80672245|FG000|Overall Study|Lost to Follow-up|1|||
27682686|NCT01519089|80672246|FG001|Overall Study|Lost to Follow-up|0|||
27682687|NCT01519089|80672245|FG000|Overall Study|Withdrawal by Subject|0|||
27682688|NCT01519089|80672246|FG001|Overall Study|Withdrawal by Subject|2|||
27682689|NCT01519089|80672245|FG000|Overall Study|Other|2|||
27682690|NCT01519089|80672246|FG001|Overall Study|Other|6|||
27682691|NCT01519089|80672245|FG000|Overall Study|Not received study drug|0|||
27682692|NCT01519089|80672246|FG001|Overall Study|Not received study drug|1|||
27682693|NCT01531673|80675721|FG000|Overall Study|Non-Compliance|0|||
28002374|NCT02807623|81838409|FG001|Overall Study|Drug intolerance|1|||
28002375|NCT02807623|81838410|FG002|Overall Study|Drug intolerance|0|||
28002376|NCT02807623|81838408|FG000|Overall Study|incomplete blood draw|0|||
28002377|NCT02807623|81838409|FG001|Overall Study|incomplete blood draw|2|||
28002378|NCT02807623|81838410|FG002|Overall Study|incomplete blood draw|1|||
28002379|NCT02960217|81838412|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
28002380|NCT02960217|81838413|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
27682694|NCT01531673|80675722|FG001|Overall Study|Non-Compliance|0|||
27682695|NCT01531673|80675723|FG002|Overall Study|Non-Compliance|0|||
27682696|NCT01531673|80675724|FG003|Overall Study|Non-Compliance|0|||
27682697|NCT01531673|80675725|FG004|Overall Study|Non-Compliance|0|||
27682698|NCT01531673|80675726|FG005|Overall Study|Non-Compliance|1|||
27682699|NCT01531673|80675727|FG006|Overall Study|Non-Compliance|0|||
27682700|NCT01531673|80675728|FG007|Overall Study|Non-Compliance|0|||
27682701|NCT01531673|80675729|FG008|Overall Study|Non-Compliance|0|||
27682702|NCT01531673|80675730|FG009|Overall Study|Non-Compliance|0|||
27682703|NCT01531673|80675731|FG010|Overall Study|Non-Compliance|0|||
27682704|NCT01531673|80675732|FG011|Overall Study|Non-Compliance|0|||
27682705|NCT01531673|80675733|FG012|Overall Study|Non-Compliance|0|||
28002381|NCT02960217|81838412|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
28002382|NCT02960217|81838413|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
28002383|NCT02960217|81838412|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
28002384|NCT02960217|81838413|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
27682706|NCT01531673|80675721|FG000|Overall Study|Adverse Event|0|||
27682707|NCT01531673|80675722|FG001|Overall Study|Adverse Event|1|||
27682708|NCT01531673|80675723|FG002|Overall Study|Adverse Event|0|||
27682709|NCT01531673|80675724|FG003|Overall Study|Adverse Event|0|||
27682710|NCT01531673|80675725|FG004|Overall Study|Adverse Event|0|||
27682711|NCT01531673|80675726|FG005|Overall Study|Adverse Event|0|||
27682712|NCT01531673|80675727|FG006|Overall Study|Adverse Event|0|||
27682713|NCT01531673|80675728|FG007|Overall Study|Adverse Event|0|||
27682714|NCT01531673|80675729|FG008|Overall Study|Adverse Event|0|||
27682715|NCT01531673|80675730|FG009|Overall Study|Adverse Event|0|||
27682716|NCT01531673|80675731|FG010|Overall Study|Adverse Event|0|||
27682717|NCT01531673|80675732|FG011|Overall Study|Adverse Event|0|||
27682718|NCT01531673|80675733|FG012|Overall Study|Adverse Event|0|||
27682719|NCT01531673|80675721|FG000|Overall Study|Lost to Follow-up|0|||
27682720|NCT01531673|80675722|FG001|Overall Study|Lost to Follow-up|0|||
27682721|NCT01531673|80675723|FG002|Overall Study|Lost to Follow-up|0|||
27682722|NCT01531673|80675724|FG003|Overall Study|Lost to Follow-up|0|||
27682723|NCT01531673|80675725|FG004|Overall Study|Lost to Follow-up|1|||
27682724|NCT01531673|80675726|FG005|Overall Study|Lost to Follow-up|0|||
27682725|NCT01531673|80675727|FG006|Overall Study|Lost to Follow-up|0|||
27682726|NCT01531673|80675728|FG007|Overall Study|Lost to Follow-up|0|||
27682727|NCT01531673|80675729|FG008|Overall Study|Lost to Follow-up|0|||
27682728|NCT01531673|80675730|FG009|Overall Study|Lost to Follow-up|0|||
27682729|NCT01531673|80675731|FG010|Overall Study|Lost to Follow-up|0|||
27682730|NCT01531673|80675732|FG011|Overall Study|Lost to Follow-up|0|||
27682731|NCT01531673|80675733|FG012|Overall Study|Lost to Follow-up|0|||
27682732|NCT01531673|80675721|FG000|Overall Study|Other|0|||
27682733|NCT01531673|80675722|FG001|Overall Study|Other|0|||
27682734|NCT01531673|80675723|FG002|Overall Study|Other|0|||
27682735|NCT01531673|80675724|FG003|Overall Study|Other|1|||
27682736|NCT01531673|80675725|FG004|Overall Study|Other|0|||
27682737|NCT01531673|80675726|FG005|Overall Study|Other|0|||
27682738|NCT01531673|80675727|FG006|Overall Study|Other|0|||
27682739|NCT01531673|80675728|FG007|Overall Study|Other|0|||
27682740|NCT01531673|80675729|FG008|Overall Study|Other|0|||
27682741|NCT01531673|80675730|FG009|Overall Study|Other|1|||
27682742|NCT01531673|80675731|FG010|Overall Study|Other|0|||
27682743|NCT01531673|80675732|FG011|Overall Study|Other|0|||
27682744|NCT01531673|80675733|FG012|Overall Study|Other|0|||
27682745|NCT02180243|80675734|FG000|Overall Study|Withdrawal by Subject|12|||
27682746|NCT02180243|80675735|FG001|Overall Study|Withdrawal by Subject|12|||
27682747|NCT02180243|80675734|FG000|Overall Study|Lost to Follow-up|12|||
27682748|NCT02180243|80675735|FG001|Overall Study|Lost to Follow-up|2|||
27682749|NCT01669577|80675738|FG000|Overall Study|Death|22|||
27682750|NCT01669577|80675738|FG000|Overall Study|Lost to Follow-up|78|||
27682751|NCT01669577|80675738|FG000|Overall Study|Physician Decision|34|||
27682752|NCT03339245|80675739|FG000|Overall Study|Adverse Event|1|||
27682753|NCT03339245|80675740|FG001|Overall Study|Adverse Event|1|||
27682754|NCT03339245|80675739|FG000|Overall Study|Withdrawal by Subject|1|||
27682755|NCT03339245|80675740|FG001|Overall Study|Withdrawal by Subject|0|||
27682756|NCT01373151|80675743|FG000|Period 1|Lack of Efficacy|3|||
27682757|NCT01373151|80675744|FG001|Period 1|Lack of Efficacy|0|||
27682758|NCT01373151|80675745|FG002|Period 1|Lack of Efficacy|0|||
27682759|NCT01373151|80675746|FG003|Period 1|Lack of Efficacy|0|||
27682760|NCT01373151|80675747|FG004|Period 1|Lack of Efficacy|1|||
27584208|NCT02066298|80319220|FG004|Overall Study|Lost to Follow-up|3|||
27682761|NCT01373151|80675748|FG005|Period 1|Lack of Efficacy|0|||
27682762|NCT01373151|80675749|FG006|Period 1|Lack of Efficacy|0|||
27682763|NCT01373151|80675743|FG000|Period 1|Adverse Event|0|||
27682764|NCT01373151|80675744|FG001|Period 1|Adverse Event|0|||
27682765|NCT01373151|80675745|FG002|Period 1|Adverse Event|1|||
27682766|NCT01373151|80675746|FG003|Period 1|Adverse Event|0|||
27682767|NCT01373151|80675747|FG004|Period 1|Adverse Event|4|||
27682768|NCT01373151|80675748|FG005|Period 1|Adverse Event|3|||
27682769|NCT01373151|80675749|FG006|Period 1|Adverse Event|0|||
27682770|NCT01373151|80675743|FG000|Period 1|Withdrawal by Subject|2|||
27682771|NCT01373151|80675744|FG001|Period 1|Withdrawal by Subject|0|||
27682772|NCT01373151|80675745|FG002|Period 1|Withdrawal by Subject|3|||
27682773|NCT01373151|80675746|FG003|Period 1|Withdrawal by Subject|1|||
27682774|NCT01373151|80675747|FG004|Period 1|Withdrawal by Subject|0|||
27682775|NCT01373151|80675748|FG005|Period 1|Withdrawal by Subject|1|||
27682776|NCT01373151|80675749|FG006|Period 1|Withdrawal by Subject|0|||
27682777|NCT01373151|80675743|FG000|Period 2|Lack of Efficacy|9|||
27682778|NCT01373151|80675744|FG001|Period 2|Lack of Efficacy|0|||
27682779|NCT01373151|80675745|FG002|Period 2|Lack of Efficacy|0|||
27682780|NCT01373151|80675746|FG003|Period 2|Lack of Efficacy|1|||
27682781|NCT01373151|80675747|FG004|Period 2|Lack of Efficacy|2|||
27682782|NCT01373151|80675748|FG005|Period 2|Lack of Efficacy|0|||
27682783|NCT01373151|80675749|FG006|Period 2|Lack of Efficacy|3|||
27682784|NCT01373151|80675743|FG000|Period 2|Adverse Event|0|||
27682785|NCT01373151|80675744|FG001|Period 2|Adverse Event|0|||
27682786|NCT01373151|80675745|FG002|Period 2|Adverse Event|3|||
27682787|NCT01373151|80675746|FG003|Period 2|Adverse Event|3|||
27682788|NCT01373151|80675747|FG004|Period 2|Adverse Event|0|||
27682789|NCT01373151|80675748|FG005|Period 2|Adverse Event|0|||
27682790|NCT01373151|80675749|FG006|Period 2|Adverse Event|1|||
27682791|NCT01373151|80675743|FG000|Period 2|subject request to discontinue|0|||
27682792|NCT01373151|80675744|FG001|Period 2|subject request to discontinue|1|||
27682793|NCT01373151|80675745|FG002|Period 2|subject request to discontinue|0|||
27682794|NCT01373151|80675746|FG003|Period 2|subject request to discontinue|0|||
27682795|NCT01373151|80675747|FG004|Period 2|subject request to discontinue|0|||
27682796|NCT01373151|80675748|FG005|Period 2|subject request to discontinue|0|||
27682797|NCT01373151|80675749|FG006|Period 2|subject request to discontinue|0|||
27806780|NCT01872689|81123301|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
27682798|NCT01373151|80675743|FG000|Period 2|Withdrawal by Subject|0|||
27682799|NCT01373151|80675744|FG001|Period 2|Withdrawal by Subject|0|||
27682800|NCT01373151|80675745|FG002|Period 2|Withdrawal by Subject|0|||
27682801|NCT01373151|80675746|FG003|Period 2|Withdrawal by Subject|1|||
27682802|NCT01373151|80675747|FG004|Period 2|Withdrawal by Subject|0|||
27682803|NCT01373151|80675748|FG005|Period 2|Withdrawal by Subject|0|||
27682804|NCT01373151|80675749|FG006|Period 2|Withdrawal by Subject|0|||
27682805|NCT01373151|80675743|FG000|Period 2|Other|0|||
27682806|NCT01373151|80675744|FG001|Period 2|Other|0|||
27682807|NCT01373151|80675745|FG002|Period 2|Other|1|||
27682808|NCT01373151|80675746|FG003|Period 2|Other|0|||
27682809|NCT01373151|80675747|FG004|Period 2|Other|0|||
27682810|NCT01373151|80675748|FG005|Period 2|Other|0|||
27682811|NCT01373151|80675749|FG006|Period 2|Other|1|||
27682812|NCT01806623|80675750|FG000|Overall Study|Withdrawal by Subject|1|||
27682813|NCT01806623|80675750|FG000|Overall Study|Adverse Event|1|||
27682814|NCT01806623|80675750|FG000|Overall Study|Did not meet the inclusion criteria|56|||
27682815|NCT02389452|80675751|FG000|Overall Study|Lost to Follow-up|13|||
27682816|NCT02389452|80675751|FG000|Overall Study|Adverse Event|1|||
27682817|NCT02389452|80675751|FG000|Overall Study|Withdrawal by Subject|5|||
27682818|NCT02389452|80675751|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
27806781|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
27806782|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
27806783|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
27806784|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
27806785|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
27806786|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
27806787|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
27806788|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
27806789|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
27584209|NCT02066298|80319221|FG005|Overall Study|Lost to Follow-up|4|||
27584210|NCT02066298|80319216|FG000|Overall Study|Withdrawal by Subject|6|||
27584211|NCT02066298|80319217|FG001|Overall Study|Withdrawal by Subject|6|||
27584212|NCT02066298|80319218|FG002|Overall Study|Withdrawal by Subject|6|||
27584213|NCT02066298|80319219|FG003|Overall Study|Withdrawal by Subject|4|||
27584214|NCT02066298|80319220|FG004|Overall Study|Withdrawal by Subject|5|||
27584215|NCT02066298|80319221|FG005|Overall Study|Withdrawal by Subject|8|||
27584216|NCT02066298|80319216|FG000|Overall Study|Physician Decision|0|||
27584217|NCT02066298|80319217|FG001|Overall Study|Physician Decision|0|||
27584218|NCT02066298|80319218|FG002|Overall Study|Physician Decision|1|||
27584219|NCT02066298|80319219|FG003|Overall Study|Physician Decision|0|||
27584220|NCT02066298|80319220|FG004|Overall Study|Physician Decision|1|||
27584221|NCT02066298|80319221|FG005|Overall Study|Physician Decision|0|||
27584222|NCT02348216|80319225|FG000|Overall Study|Death|5|||
27584223|NCT02348216|80319226|FG001|Overall Study|Death|53|||
27584224|NCT02348216|80319227|FG002|Overall Study|Death|11|||
27584225|NCT02348216|80319228|FG003|Overall Study|Death|20|||
27584226|NCT02348216|80319229|FG004|Overall Study|Death|16|||
27584227|NCT02348216|80319230|FG005|Overall Study|Death|32|||
27584228|NCT02348216|80319231|FG006|Overall Study|Death|17|||
27584229|NCT02348216|80319225|FG000|Overall Study|Full consent withdrawal|0|||
27584230|NCT02348216|80319226|FG001|Overall Study|Full consent withdrawal|0|||
27682819|NCT00925353|80675757|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
27682820|NCT03214640|80675759|FG000|Overall Study|Protocol Violation|1|||
27682821|NCT03214640|80675760|FG001|Overall Study|Protocol Violation|2|||
27682822|NCT03214640|80675761|FG002|Overall Study|Protocol Violation|1|||
27682823|NCT03214640|80675762|FG003|Overall Study|Protocol Violation|4|||
27682824|NCT00474526|80675763|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
27682825|NCT00474526|80675764|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
27682826|NCT00474526|80675765|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
27682827|NCT00474526|80675766|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
27682828|NCT00474526|80675767|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
27682829|NCT00474526|80675768|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
27682830|NCT00474526|80675769|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
27682831|NCT00474526|80675770|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
27682832|NCT00474526|80675771|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
27682833|NCT00474526|80675772|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
27682834|NCT00474526|80675773|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
28002385|NCT02960217|81838412|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
28002386|NCT02960217|81838413|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
27584231|NCT02348216|80319227|FG002|Overall Study|Full consent withdrawal|0|||
27682835|NCT00474526|80675774|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
27584232|NCT02348216|80319228|FG003|Overall Study|Full consent withdrawal|1|||
27584233|NCT02348216|80319229|FG004|Overall Study|Full consent withdrawal|3|||
27584234|NCT02348216|80319230|FG005|Overall Study|Full consent withdrawal|0|||
27584235|NCT02348216|80319231|FG006|Overall Study|Full consent withdrawal|3|||
27584236|NCT02348216|80319225|FG000|Overall Study|Lost to Follow-up|0|||
27584237|NCT02348216|80319226|FG001|Overall Study|Lost to Follow-up|5|||
27584238|NCT02348216|80319227|FG002|Overall Study|Lost to Follow-up|2|||
27584239|NCT02348216|80319228|FG003|Overall Study|Lost to Follow-up|0|||
27584240|NCT02348216|80319229|FG004|Overall Study|Lost to Follow-up|1|||
27584241|NCT02348216|80319230|FG005|Overall Study|Lost to Follow-up|1|||
28002387|NCT02960217|81838412|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
28002388|NCT02960217|81838413|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
28002389|NCT02960217|81838412|FG000|Open-Label Extension Phase|Adverse Event|1|||
28002390|NCT02960217|81838413|FG001|Open-Label Extension Phase|Adverse Event|0|||
28002391|NCT02960217|81838412|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
28002392|NCT02960217|81838413|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
28002393|NCT02960217|81838412|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
28002394|NCT02960217|81838413|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
28002395|NCT02960217|81838412|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
28002396|NCT02960217|81838413|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
28002397|NCT00117637|81838419|FG000|First Intervention (Period 1)|Adverse Event|11|||
28002398|NCT00117637|81838420|FG001|First Intervention (Period 1)|Adverse Event|16|||
28002399|NCT00117637|81838419|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
28002400|NCT00117637|81838420|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
28002401|NCT00117637|81838419|FG000|First Intervention (Period 1)|Protocol Violation|1|||
28002402|NCT00117637|81838420|FG001|First Intervention (Period 1)|Protocol Violation|0|||
28002403|NCT00117637|81838419|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
28002404|NCT00117637|81838420|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
28002405|NCT00117637|81838419|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
28002406|NCT00117637|81838420|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
28002407|NCT00117637|81838419|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
28002408|NCT00117637|81838420|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
28002409|NCT00117637|81838419|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
28002410|NCT00117637|81838420|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
28002411|NCT00117637|81838419|FG000|First Intervention (Period 1)|reason not reported|0|||
28002412|NCT00117637|81838420|FG001|First Intervention (Period 1)|reason not reported|1|||
28002413|NCT00117637|81838419|FG000|Second Intervention (Period 2)|Adverse Event|0|||
28002414|NCT00117637|81838420|FG001|Second Intervention (Period 2)|Adverse Event|9|||
28002415|NCT00117637|81838419|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
28002416|NCT00117637|81838420|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
28002417|NCT00117637|81838419|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
28002418|NCT00117637|81838420|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
28002419|NCT00117637|81838419|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
28002420|NCT00117637|81838420|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
28002421|NCT00117637|81838419|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
28002422|NCT00117637|81838420|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
28002423|NCT00117637|81838419|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
28002424|NCT00117637|81838420|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
28002425|NCT00117637|81838419|FG000|Second Intervention (Period 2)|reason not reported|1|||
28002426|NCT00117637|81838420|FG001|Second Intervention (Period 2)|reason not reported|0|||
27584242|NCT02348216|80319231|FG006|Overall Study|Lost to Follow-up|1|||
28002427|NCT01392547|81838425|FG000|Overall Study|Adverse Event|2|||
27682836|NCT00474526|80675775|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
28002428|NCT01392547|81838425|FG000|Overall Study|Non-compliance|2|||
28002429|NCT01392547|81838425|FG000|Overall Study|Withdrawal criteria|3|||
28002430|NCT01392547|81838425|FG000|Overall Study|Unclassified|1|||
27682837|NCT00474526|80675776|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
27682838|NCT00474526|80675777|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
27682839|NCT00474526|80675778|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
27682840|NCT00474526|80675779|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
27682841|NCT00474526|80675763|FG000|Overall Study|Adverse Event|2|||
27682842|NCT00474526|80675764|FG001|Overall Study|Adverse Event|0|||
27682843|NCT00474526|80675765|FG002|Overall Study|Adverse Event|2|||
27682844|NCT00474526|80675766|FG003|Overall Study|Adverse Event|4|||
27682845|NCT00474526|80675767|FG004|Overall Study|Adverse Event|2|||
27682846|NCT00474526|80675768|FG005|Overall Study|Adverse Event|1|||
27682847|NCT00474526|80675769|FG006|Overall Study|Adverse Event|1|||
27682848|NCT00474526|80675770|FG007|Overall Study|Adverse Event|0|||
27682849|NCT00474526|80675771|FG008|Overall Study|Adverse Event|0|||
27682850|NCT00474526|80675772|FG009|Overall Study|Adverse Event|0|||
27682851|NCT00474526|80675773|FG010|Overall Study|Adverse Event|0|||
27682852|NCT00474526|80675774|FG011|Overall Study|Adverse Event|0|||
27682853|NCT00474526|80675775|FG012|Overall Study|Adverse Event|0|||
27682854|NCT00474526|80675776|FG013|Overall Study|Adverse Event|0|||
27682855|NCT00474526|80675777|FG014|Overall Study|Adverse Event|1|||
27682856|NCT00474526|80675778|FG015|Overall Study|Adverse Event|1|||
27682857|NCT00474526|80675779|FG016|Overall Study|Adverse Event|0|||
27682858|NCT00474526|80675763|FG000|Overall Study|Death|0|||
28002431|NCT03431441|81838426|FG000|Overall Study|Withdrawal by Subject|2|||
28002432|NCT03431441|81838426|FG000|Overall Study|Adverse Event|2|||
28002433|NCT03431441|81838426|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
28002434|NCT03480152|81838427|FG000|Phase I|Signed consent. Died before treatment.|1|||
28002435|NCT03480152|81838428|FG001|Phase I|Signed consent. Died before treatment.|0|||
28002436|NCT03480152|81838429|FG002|Phase I|Signed consent. Died before treatment.|0|||
28002437|NCT00667888|81838430|FG000|Overall Study|Death|1|||
28002438|NCT00667888|81838431|FG001|Overall Study|Death|1|||
28002439|NCT00667888|81838430|FG000|Overall Study|Withdrawal by Subject|6|||
28002440|NCT00667888|81838431|FG001|Overall Study|Withdrawal by Subject|3|||
28002441|NCT00667888|81838430|FG000|Overall Study|Proceed with other treatment|3|||
28002442|NCT00667888|81838431|FG001|Overall Study|Proceed with other treatment|3|||
28002443|NCT00667888|81838430|FG000|Overall Study|Ineligible after SIM|0|||
28002444|NCT00667888|81838431|FG001|Overall Study|Ineligible after SIM|2|||
28002445|NCT03901144|81838434|FG000|Overall Study|Lost to Follow-up|1|||
28002446|NCT03901144|81838435|FG001|Overall Study|Lost to Follow-up|1|||
28002447|NCT03901144|81838436|FG002|Overall Study|Lost to Follow-up|1|||
28002448|NCT03901144|81838437|FG003|Overall Study|Lost to Follow-up|1|||
28002449|NCT00960063|81838438|FG000|Overall Study|Adverse Event|1|||
28002450|NCT00960063|81838439|FG001|Overall Study|Adverse Event|0|||
28002451|NCT00960063|81838440|FG002|Overall Study|Adverse Event|0|||
28002452|NCT00960063|81838438|FG000|Overall Study|Progression of Disease|0|||
28002453|NCT00960063|81838439|FG001|Overall Study|Progression of Disease|0|||
28002454|NCT00960063|81838440|FG002|Overall Study|Progression of Disease|3|||
28002455|NCT00614380|81838441|FG000|Overall Study|Adverse Event|14|||
28002456|NCT00614380|81838442|FG001|Overall Study|Adverse Event|4|||
27682859|NCT00474526|80675764|FG001|Overall Study|Death|0|||
27682860|NCT00474526|80675765|FG002|Overall Study|Death|0|||
27682861|NCT00474526|80675766|FG003|Overall Study|Death|0|||
27682862|NCT00474526|80675767|FG004|Overall Study|Death|0|||
27682863|NCT00474526|80675768|FG005|Overall Study|Death|0|||
27682864|NCT00474526|80675769|FG006|Overall Study|Death|0|||
27682865|NCT00474526|80675770|FG007|Overall Study|Death|0|||
27682866|NCT00474526|80675771|FG008|Overall Study|Death|0|||
28002457|NCT00614380|81838443|FG002|Overall Study|Adverse Event|0|||
28002458|NCT00614380|81838444|FG003|Overall Study|Adverse Event|0|||
28002459|NCT00614380|81838441|FG000|Overall Study|Lost to Follow-up|6|||
28002460|NCT00614380|81838442|FG001|Overall Study|Lost to Follow-up|1|||
28002461|NCT00614380|81838443|FG002|Overall Study|Lost to Follow-up|0|||
28002462|NCT00614380|81838444|FG003|Overall Study|Lost to Follow-up|0|||
28002463|NCT00614380|81838441|FG000|Overall Study|Non compliant with the protocol|12|||
28002464|NCT00614380|81838442|FG001|Overall Study|Non compliant with the protocol|2|||
28002465|NCT00614380|81838443|FG002|Overall Study|Non compliant with the protocol|1|||
28002466|NCT00614380|81838444|FG003|Overall Study|Non compliant with the protocol|2|||
28002467|NCT00614380|81838441|FG000|Overall Study|Consent withdrawn|3|||
28002468|NCT00614380|81838442|FG001|Overall Study|Consent withdrawn|1|||
28002469|NCT00614380|81838443|FG002|Overall Study|Consent withdrawn|0|||
27584243|NCT02348216|80319225|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
27584244|NCT02348216|80319226|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
27584245|NCT02348216|80319227|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
27584246|NCT02348216|80319228|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
27584247|NCT02348216|80319229|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
27584248|NCT02348216|80319230|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
27682867|NCT00474526|80675772|FG009|Overall Study|Death|0|||
27682868|NCT00474526|80675773|FG010|Overall Study|Death|0|||
27806790|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
27806791|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
27806792|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
27806793|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
27806794|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
28002470|NCT00614380|81838444|FG003|Overall Study|Consent withdrawn|0|||
28002471|NCT00999544|81838445|FG000|Overall Study|Withdrawal by Subject|1|||
28002472|NCT00506350|81838446|FG000|Overall Study|Serious Adverse Event|1|||
28002473|NCT00506350|81838447|FG001|Overall Study|Serious Adverse Event|0|||
28002474|NCT00506350|81838448|FG002|Overall Study|Serious Adverse Event|0|||
28002475|NCT00506350|81838449|FG003|Overall Study|Serious Adverse Event|0|||
28002476|NCT00506350|81838450|FG004|Overall Study|Serious Adverse Event|0|||
28002477|NCT00506350|81838451|FG005|Overall Study|Serious Adverse Event|0|||
28002478|NCT00506350|81838452|FG006|Overall Study|Serious Adverse Event|0|||
28002479|NCT00506350|81838453|FG007|Overall Study|Serious Adverse Event|0|||
28002480|NCT00506350|81838454|FG008|Overall Study|Serious Adverse Event|0|||
28002481|NCT00506350|81838446|FG000|Overall Study|Adverse Event|0|||
28002482|NCT00506350|81838447|FG001|Overall Study|Adverse Event|0|||
28002483|NCT00506350|81838448|FG002|Overall Study|Adverse Event|0|||
28002484|NCT00506350|81838449|FG003|Overall Study|Adverse Event|0|||
28002485|NCT00506350|81838450|FG004|Overall Study|Adverse Event|0|||
28002486|NCT00506350|81838451|FG005|Overall Study|Adverse Event|0|||
28002487|NCT00506350|81838452|FG006|Overall Study|Adverse Event|0|||
28002488|NCT00506350|81838453|FG007|Overall Study|Adverse Event|1|||
28002489|NCT00506350|81838454|FG008|Overall Study|Adverse Event|1|||
28002490|NCT00506350|81838446|FG000|Overall Study|Protocol Violation|0|||
28002491|NCT00506350|81838447|FG001|Overall Study|Protocol Violation|0|||
28002492|NCT00506350|81838448|FG002|Overall Study|Protocol Violation|1|||
28002493|NCT00506350|81838449|FG003|Overall Study|Protocol Violation|0|||
28002494|NCT00506350|81838450|FG004|Overall Study|Protocol Violation|0|||
28002495|NCT00506350|81838451|FG005|Overall Study|Protocol Violation|0|||
28002496|NCT00506350|81838452|FG006|Overall Study|Protocol Violation|1|||
28002497|NCT00506350|81838453|FG007|Overall Study|Protocol Violation|0|||
28002498|NCT00506350|81838454|FG008|Overall Study|Protocol Violation|0|||
28002499|NCT00506350|81838446|FG000|Overall Study|Withdrawal by Subject|0|||
28002500|NCT00506350|81838447|FG001|Overall Study|Withdrawal by Subject|1|||
28002501|NCT00506350|81838448|FG002|Overall Study|Withdrawal by Subject|1|||
28002502|NCT00506350|81838449|FG003|Overall Study|Withdrawal by Subject|1|||
28002503|NCT00506350|81838450|FG004|Overall Study|Withdrawal by Subject|4|||
28002504|NCT00506350|81838451|FG005|Overall Study|Withdrawal by Subject|1|||
28002505|NCT00506350|81838452|FG006|Overall Study|Withdrawal by Subject|1|||
28002506|NCT00506350|81838453|FG007|Overall Study|Withdrawal by Subject|2|||
28002507|NCT00506350|81838454|FG008|Overall Study|Withdrawal by Subject|0|||
28002508|NCT00506350|81838446|FG000|Overall Study|Lost to Follow-up|1|||
28002509|NCT00506350|81838447|FG001|Overall Study|Lost to Follow-up|1|||
28002510|NCT00506350|81838448|FG002|Overall Study|Lost to Follow-up|1|||
28002511|NCT00506350|81838449|FG003|Overall Study|Lost to Follow-up|1|||
28002512|NCT00506350|81838450|FG004|Overall Study|Lost to Follow-up|2|||
27682869|NCT00474526|80675774|FG011|Overall Study|Death|0|||
27682870|NCT00474526|80675775|FG012|Overall Study|Death|0|||
27682871|NCT00474526|80675776|FG013|Overall Study|Death|3|||
28002513|NCT00506350|81838451|FG005|Overall Study|Lost to Follow-up|1|||
28002514|NCT00506350|81838452|FG006|Overall Study|Lost to Follow-up|0|||
28002515|NCT00506350|81838453|FG007|Overall Study|Lost to Follow-up|0|||
28002516|NCT00506350|81838454|FG008|Overall Study|Lost to Follow-up|2|||
28002517|NCT00506350|81838446|FG000|Overall Study|Medical Reason|0|||
28002518|NCT00506350|81838447|FG001|Overall Study|Medical Reason|0|||
28002519|NCT00506350|81838448|FG002|Overall Study|Medical Reason|0|||
28002520|NCT00506350|81838449|FG003|Overall Study|Medical Reason|0|||
28002521|NCT00506350|81838450|FG004|Overall Study|Medical Reason|1|||
28002522|NCT00506350|81838451|FG005|Overall Study|Medical Reason|0|||
28002523|NCT00506350|81838452|FG006|Overall Study|Medical Reason|0|||
27806795|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
27806796|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
27806797|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
27806798|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
27806799|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
27806800|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
27806801|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
27806802|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
27806803|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
27806804|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
27806805|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
27806806|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
27806807|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
27806808|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
27806809|NCT00528879|81123302|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
27806810|NCT00528879|81123303|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
27806811|NCT00528879|81123304|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
27806812|NCT00528879|81123305|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
27806813|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
27806814|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
27806815|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
27806816|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
27806817|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
27806818|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
27806819|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
27806820|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
27806821|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
27806822|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
27806823|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
27806824|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
27874058|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27874059|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27874060|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27874061|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27874062|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27874063|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
27874064|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
28002524|NCT00506350|81838453|FG007|Overall Study|Medical Reason|0|||
28002525|NCT00506350|81838454|FG008|Overall Study|Medical Reason|0|||
28002526|NCT00506350|81838446|FG000|Overall Study|Other|1|||
28002527|NCT00506350|81838447|FG001|Overall Study|Other|1|||
28002528|NCT00506350|81838448|FG002|Overall Study|Other|3|||
28002529|NCT00506350|81838449|FG003|Overall Study|Other|0|||
28002530|NCT00506350|81838450|FG004|Overall Study|Other|3|||
28002531|NCT00506350|81838451|FG005|Overall Study|Other|0|||
28002532|NCT00506350|81838452|FG006|Overall Study|Other|0|||
28002533|NCT00506350|81838453|FG007|Overall Study|Other|2|||
28002534|NCT00506350|81838454|FG008|Overall Study|Other|2|||
28002535|NCT01814527|81838457|FG000|Overall Study|RTP greater than 30 days|6|||
28002536|NCT01814527|81838458|FG001|Overall Study|RTP greater than 30 days|1|||
28002537|NCT00527735|81838460|FG000|Overall Study|Disease progression|47|||
28002538|NCT00527735|81838461|FG001|Overall Study|Disease progression|61|||
28002539|NCT00527735|81838462|FG002|Overall Study|Disease progression|53|||
28002540|NCT00527735|81838460|FG000|Overall Study|Death|23|||
28002541|NCT00527735|81838461|FG001|Overall Study|Death|13|||
28002542|NCT00527735|81838462|FG002|Overall Study|Death|15|||
28002543|NCT00527735|81838460|FG000|Overall Study|Completed treatment in treatment phase|14|||
28002544|NCT00527735|81838461|FG001|Overall Study|Completed treatment in treatment phase|13|||
28002545|NCT00527735|81838462|FG002|Overall Study|Completed treatment in treatment phase|18|||
28002546|NCT00527735|81838460|FG000|Overall Study|Adverse Event|10|||
28002547|NCT00527735|81838461|FG001|Overall Study|Adverse Event|6|||
27682872|NCT00474526|80675777|FG014|Overall Study|Death|0|||
27682873|NCT00474526|80675778|FG015|Overall Study|Death|0|||
28002548|NCT00527735|81838462|FG002|Overall Study|Adverse Event|7|||
27682874|NCT00474526|80675779|FG016|Overall Study|Death|0|||
27682875|NCT00474526|80675763|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
28002549|NCT00527735|81838460|FG000|Overall Study|Not identified|5|||
28002550|NCT00527735|81838461|FG001|Overall Study|Not identified|5|||
28002551|NCT00527735|81838462|FG002|Overall Study|Not identified|5|||
28002552|NCT00527735|81838460|FG000|Overall Study|Withdrawal by Subject|5|||
28002553|NCT00527735|81838461|FG001|Overall Study|Withdrawal by Subject|4|||
28002554|NCT00527735|81838462|FG002|Overall Study|Withdrawal by Subject|3|||
27874065|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874066|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
27874067|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
27874068|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874069|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
27874070|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
27874071|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874072|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874073|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874074|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874075|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874076|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27806825|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
27806826|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
27806827|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
27806828|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
27806829|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
27806830|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
27806831|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
27806832|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
27806833|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
27806834|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
27806835|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
27806836|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
27806837|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
27806838|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
27806839|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
27806840|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
27806841|NCT00528879|81123302|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
27806842|NCT00528879|81123303|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
27806843|NCT00528879|81123304|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
27806844|NCT00528879|81123305|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
27806845|NCT01102777|81123306|FG000|Overall Study|Death|2|||
27806846|NCT01102777|81123307|FG001|Overall Study|Death|6|||
27806847|NCT01102777|81123306|FG000|Overall Study|Lost to Follow-up|7|||
27806848|NCT01102777|81123307|FG001|Overall Study|Lost to Follow-up|10|||
27806849|NCT00580983|81123308|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
27806850|NCT03208933|81123309|FG000|Overall Study|Death|3|||
27806851|NCT03208933|81123309|FG000|Overall Study|Withdrawal by Subject|3|||
27806852|NCT03208933|81123309|FG000|Overall Study|Adverse Event|1|||
27806853|NCT03208933|81123309|FG000|Overall Study|Lost to Follow-up|2|||
27806854|NCT03208933|81123309|FG000|Overall Study|Physician Decision|3|||
27806855|NCT03208933|81123309|FG000|Overall Study|Protocol Violation|1|||
27806856|NCT01625845|81123310|FG000|Overall Study|Adverse Event|1|||
27806857|NCT01625845|81123311|FG001|Overall Study|Adverse Event|2|||
27806858|NCT01625845|81123310|FG000|Overall Study|Lost to Follow-up|2|||
27806859|NCT01625845|81123311|FG001|Overall Study|Lost to Follow-up|1|||
27806860|NCT01625845|81123310|FG000|Overall Study|Withdrawal by Subject|2|||
27806861|NCT01625845|81123311|FG001|Overall Study|Withdrawal by Subject|0|||
27806862|NCT04535583|81123312|FG000|Overall Study|Lost to Follow-up|1|||
27806863|NCT04535583|81123312|FG000|Overall Study|Physician Decision|1|||
27806864|NCT04535583|81123312|FG000|Overall Study|Withdrawal by Subject|1|||
27806865|NCT01086215|81123314|FG000|Overall Study|Death|14|||
27806866|NCT01086215|81123315|FG001|Overall Study|Death|8|||
27806867|NCT01086215|81123316|FG002|Overall Study|Death|8|||
27874077|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874078|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27806868|NCT01086215|81123317|FG003|Overall Study|Death|1|||
27806869|NCT01086215|81123314|FG000|Overall Study|Lost to Follow-up|22|||
27806870|NCT01086215|81123315|FG001|Overall Study|Lost to Follow-up|39|||
27806871|NCT01086215|81123316|FG002|Overall Study|Lost to Follow-up|18|||
27874079|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27874080|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27806872|NCT01086215|81123317|FG003|Overall Study|Lost to Follow-up|2|||
27806873|NCT01377233|81123318|FG000|Open-label|Adverse Event|1|||
27806874|NCT01377233|81123319|FG001|Open-label|Adverse Event|0|||
27806875|NCT01377233|81123320|FG002|Open-label|Adverse Event|0|||
27806876|NCT01377233|81123321|FG003|Open-label|Adverse Event|0|||
27874081|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
27806877|NCT01377233|81123322|FG004|Open-label|Adverse Event|0|||
27806878|NCT01377233|81123318|FG000|Open-label|Withdrawal by Subject|3|||
27806879|NCT01377233|81123319|FG001|Open-label|Withdrawal by Subject|0|||
27874082|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874083|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27806880|NCT01377233|81123320|FG002|Open-label|Withdrawal by Subject|0|||
27806881|NCT01377233|81123321|FG003|Open-label|Withdrawal by Subject|0|||
28002555|NCT00527735|81838460|FG000|Overall Study|No longer met study criteria|2|||
28002556|NCT00527735|81838461|FG001|Overall Study|No longer met study criteria|2|||
28002557|NCT00527735|81838462|FG002|Overall Study|No longer met study criteria|1|||
27874084|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
27806882|NCT01377233|81123322|FG004|Open-label|Withdrawal by Subject|0|||
27806883|NCT01377233|81123318|FG000|Double-blind|Adverse Event|0|||
27806884|NCT01377233|81123319|FG001|Double-blind|Adverse Event|1|||
27806885|NCT01377233|81123320|FG002|Double-blind|Adverse Event|2|||
27806886|NCT01377233|81123321|FG003|Double-blind|Adverse Event|2|||
27806887|NCT01377233|81123322|FG004|Double-blind|Adverse Event|0|||
27806888|NCT01377233|81123318|FG000|Double-blind|Protocol Violation|0|||
27806889|NCT01377233|81123319|FG001|Double-blind|Protocol Violation|0|||
27806890|NCT01377233|81123320|FG002|Double-blind|Protocol Violation|0|||
27806891|NCT01377233|81123321|FG003|Double-blind|Protocol Violation|0|||
27806892|NCT01377233|81123322|FG004|Double-blind|Protocol Violation|1|||
27806893|NCT01377233|81123318|FG000|Double-blind|Withdrawal by Subject|0|||
27806894|NCT01377233|81123319|FG001|Double-blind|Withdrawal by Subject|0|||
27806895|NCT01377233|81123320|FG002|Double-blind|Withdrawal by Subject|0|||
27806896|NCT01377233|81123321|FG003|Double-blind|Withdrawal by Subject|1|||
27806897|NCT01377233|81123322|FG004|Double-blind|Withdrawal by Subject|0|||
27806898|NCT01377233|81123318|FG000|Double-blind|Administrative or other|0|||
27874085|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
27874086|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874087|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874088|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874089|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874090|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874091|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874092|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874093|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
28002558|NCT00527735|81838460|FG000|Overall Study|Lost to Follow-up|0|||
28002559|NCT00527735|81838461|FG001|Overall Study|Lost to Follow-up|0|||
28002560|NCT00527735|81838462|FG002|Overall Study|Lost to Follow-up|3|||
28002561|NCT00527735|81838460|FG000|Overall Study|Poor compliance or noncompliance|0|||
28002562|NCT00527735|81838461|FG001|Overall Study|Poor compliance or noncompliance|1|||
28002563|NCT00527735|81838462|FG002|Overall Study|Poor compliance or noncompliance|1|||
28002564|NCT00527735|81838460|FG000|Overall Study|Completed treatment during maintenance|2|||
28002565|NCT00527735|81838461|FG001|Overall Study|Completed treatment during maintenance|2|||
28002566|NCT00527735|81838462|FG002|Overall Study|Completed treatment during maintenance|1|||
28002567|NCT01020786|81838463|FG000|Induction Period|Entry Criteria Not Met|2|||
28002568|NCT01020786|81838463|FG000|Induction Period|Adverse Event|10|||
28002569|NCT01020786|81838463|FG000|Induction Period|Progressive Disease|31|||
28002570|NCT01020786|81838463|FG000|Induction Period|Investigator Decision|3|||
28002571|NCT01020786|81838463|FG000|Induction Period|Withdrawal by Subject|3|||
28002572|NCT01020786|81838463|FG000|Maintenance Period|Adverse Event|8|||
28002573|NCT01020786|81838463|FG000|Maintenance Period|Progressive Disease|43|||
28002574|NCT01020786|81838463|FG000|Maintenance Period|Withdrawal by Subject|8|||
28002575|NCT01020786|81838463|FG000|Maintenance Period|Sponsor Decision|1|||
28002576|NCT01602224|81842217|FG000|Overall Study|Adverse Event|0|||
28002577|NCT01602224|81842218|FG001|Overall Study|Adverse Event|1|||
28002578|NCT01602224|81842219|FG002|Overall Study|Adverse Event|0|||
28002579|NCT01602224|81842217|FG000|Overall Study|Investigator Decison|1|||
28002580|NCT01602224|81842218|FG001|Overall Study|Investigator Decison|0|||
28002581|NCT01602224|81842219|FG002|Overall Study|Investigator Decison|0|||
28002582|NCT01602224|81842217|FG000|Overall Study|Lost to Follow-up|0|||
28002583|NCT01602224|81842218|FG001|Overall Study|Lost to Follow-up|0|||
27806899|NCT01377233|81123319|FG001|Double-blind|Administrative or other|0|||
27806900|NCT01377233|81123320|FG002|Double-blind|Administrative or other|0|||
27806901|NCT01377233|81123321|FG003|Double-blind|Administrative or other|1|||
28002584|NCT01602224|81842219|FG002|Overall Study|Lost to Follow-up|1|||
27806902|NCT01377233|81123322|FG004|Double-blind|Administrative or other|1|||
27806903|NCT03840811|81123323|FG000|Overall Study|Lost to Follow-up|0|||
27806904|NCT03840811|81123324|FG001|Overall Study|Lost to Follow-up|0|||
27806905|NCT03840811|81123325|FG002|Overall Study|Lost to Follow-up|1|||
27806906|NCT02109133|81123330|FG000|Overall Study|Lost to Follow-up|1|||
27806907|NCT02109133|81123331|FG001|Overall Study|Lost to Follow-up|0|||
27874094|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
28002585|NCT01602224|81842217|FG000|Overall Study|Protocol Violation|0|||
28002586|NCT01602224|81842218|FG001|Overall Study|Protocol Violation|1|||
28002587|NCT01602224|81842219|FG002|Overall Study|Protocol Violation|0|||
27806908|NCT00660790|81123332|FG000|Baseline to 3 Months|Death|1|||
27806909|NCT00660790|81123332|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
27806910|NCT00660790|81123332|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
27806911|NCT00626925|81123333|FG000|Overall Study|Lost to Follow-up|1|||
27806912|NCT00626925|81123334|FG001|Overall Study|Lost to Follow-up|2|||
27806913|NCT00626925|81123333|FG000|Overall Study|relapse|1|||
27806914|NCT00626925|81123334|FG001|Overall Study|relapse|0|||
27806915|NCT00626925|81123333|FG000|Overall Study|Adverse effect|6|||
27806916|NCT00626925|81123334|FG001|Overall Study|Adverse effect|2|||
27806917|NCT00626925|81123333|FG000|Overall Study|Lack of Efficacy|1|||
27806918|NCT00626925|81123334|FG001|Overall Study|Lack of Efficacy|4|||
27806919|NCT00626925|81123333|FG000|Overall Study|Time constraints|3|||
27806920|NCT00626925|81123334|FG001|Overall Study|Time constraints|1|||
27806921|NCT01862328|81123344|FG000|Overall Study|Progressive Disease|3|||
27806922|NCT01862328|81123345|FG001|Overall Study|Progressive Disease|11|||
27806923|NCT01862328|81123346|FG002|Overall Study|Progressive Disease|5|||
27806924|NCT01862328|81123347|FG003|Overall Study|Progressive Disease|6|||
27806925|NCT01862328|81123348|FG004|Overall Study|Progressive Disease|7|||
27806926|NCT01862328|81123349|FG005|Overall Study|Progressive Disease|4|||
27806927|NCT01862328|81123350|FG006|Overall Study|Progressive Disease|3|||
27806928|NCT01862328|81123344|FG000|Overall Study|Adverse Event|0|||
27806929|NCT01862328|81123345|FG001|Overall Study|Adverse Event|4|||
27806930|NCT01862328|81123346|FG002|Overall Study|Adverse Event|0|||
27806931|NCT01862328|81123347|FG003|Overall Study|Adverse Event|1|||
27806932|NCT01862328|81123348|FG004|Overall Study|Adverse Event|0|||
27806933|NCT01862328|81123349|FG005|Overall Study|Adverse Event|2|||
27806934|NCT01862328|81123350|FG006|Overall Study|Adverse Event|4|||
27806935|NCT01862328|81123344|FG000|Overall Study|Other|0|||
27806936|NCT01862328|81123345|FG001|Overall Study|Other|2|||
27806937|NCT01862328|81123346|FG002|Overall Study|Other|1|||
27874095|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874096|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874097|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874098|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
27874099|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874100|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874101|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874102|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874103|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
27874104|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874105|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874106|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874107|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874108|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874109|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874110|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874111|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874112|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874113|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874114|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874115|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
27874116|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874117|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
27806938|NCT01862328|81123347|FG003|Overall Study|Other|0|||
27806939|NCT01862328|81123348|FG004|Overall Study|Other|4|||
27806940|NCT01862328|81123349|FG005|Overall Study|Other|0|||
27806941|NCT01862328|81123350|FG006|Overall Study|Other|1|||
27806942|NCT01862328|81123344|FG000|Overall Study|Withdrawal by Subject|1|||
27806943|NCT01862328|81123345|FG001|Overall Study|Withdrawal by Subject|1|||
27806944|NCT01862328|81123346|FG002|Overall Study|Withdrawal by Subject|0|||
27806945|NCT01862328|81123347|FG003|Overall Study|Withdrawal by Subject|0|||
27874118|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27806946|NCT01862328|81123348|FG004|Overall Study|Withdrawal by Subject|1|||
27806947|NCT01862328|81123349|FG005|Overall Study|Withdrawal by Subject|1|||
27594398|NCT00955357|80356063|FG000|Titration Phase|Withdrawal by Subject|3|||
27682876|NCT00474526|80675764|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
27682877|NCT00474526|80675765|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27806948|NCT01862328|81123350|FG006|Overall Study|Withdrawal by Subject|1|||
27806949|NCT01862328|81123344|FG000|Overall Study|Symptomatic Deterioration|0|||
27806950|NCT01862328|81123345|FG001|Overall Study|Symptomatic Deterioration|0|||
27806951|NCT01862328|81123346|FG002|Overall Study|Symptomatic Deterioration|0|||
27806952|NCT01862328|81123347|FG003|Overall Study|Symptomatic Deterioration|0|||
27806953|NCT01862328|81123348|FG004|Overall Study|Symptomatic Deterioration|0|||
27806954|NCT01862328|81123349|FG005|Overall Study|Symptomatic Deterioration|0|||
27806955|NCT01862328|81123350|FG006|Overall Study|Symptomatic Deterioration|1|||
27806956|NCT01025193|81123351|FG000|Overall Study|Protocol Violation|1|||
27806957|NCT01025193|81123351|FG000|Overall Study|Adverse Event|3|||
27806958|NCT00544557|81123354|FG000|Overall Study|Adverse Event|140|||
27806959|NCT00544557|81123354|FG000|Overall Study|Lack of Efficacy|196|||
27874119|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874120|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
28002588|NCT01602224|81842217|FG000|Overall Study|Sponsor Decision|2|||
28002589|NCT01602224|81842218|FG001|Overall Study|Sponsor Decision|3|||
28002590|NCT01602224|81842219|FG002|Overall Study|Sponsor Decision|2|||
28002591|NCT01602224|81842217|FG000|Overall Study|Withdrawal by Subject|5|||
28002592|NCT01602224|81842218|FG001|Overall Study|Withdrawal by Subject|3|||
28002593|NCT01602224|81842219|FG002|Overall Study|Withdrawal by Subject|3|||
28002594|NCT01290523|81842228|FG000|Overall Study|Death|3|||
28002595|NCT02422498|81842229|FG000|Overall Study|Inevaluable|4|||
28002596|NCT02451917|81842232|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
28002597|NCT02451917|81842233|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
28002598|NCT02451917|81842232|FG000|First Intervention (24 Weeks)|Death|0|||
28002599|NCT02451917|81842233|FG001|First Intervention (24 Weeks)|Death|1|||
28002600|NCT02451917|81842232|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
28002601|NCT02451917|81842233|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
28002602|NCT00948064|81842236|FG000|Phase I|No treatment received|1|||
28002603|NCT00948064|81842237|FG001|Phase I|No treatment received|0|||
28002604|NCT00948064|81842238|FG002|Phase I|No treatment received|0|||
28002605|NCT00948064|81842236|FG000|Phase II|Physician Decision|0|||
28002606|NCT00948064|81842237|FG001|Phase II|Physician Decision|0|||
28002607|NCT00948064|81842238|FG002|Phase II|Physician Decision|1|||
28002608|NCT00948064|81842236|FG000|Phase II|Withdrawal by Subject|0|||
28002609|NCT00948064|81842237|FG001|Phase II|Withdrawal by Subject|1|||
28002610|NCT00948064|81842238|FG002|Phase II|Withdrawal by Subject|0|||
28002611|NCT00965081|81842239|FG000|Overall Study|Adverse Event|14|||
28002612|NCT00965081|81842240|FG001|Overall Study|Adverse Event|9|||
28002613|NCT00965081|81842239|FG000|Overall Study|Lack of Efficacy|2|||
28002614|NCT00965081|81842240|FG001|Overall Study|Lack of Efficacy|5|||
28002615|NCT00965081|81842239|FG000|Overall Study|Lost to Follow-up|4|||
28002616|NCT00965081|81842240|FG001|Overall Study|Lost to Follow-up|5|||
28002617|NCT00965081|81842239|FG000|Overall Study|Physician Decision|2|||
28002618|NCT00965081|81842240|FG001|Overall Study|Physician Decision|0|||
28002619|NCT00965081|81842239|FG000|Overall Study|Protocol Violation|2|||
28002620|NCT00965081|81842240|FG001|Overall Study|Protocol Violation|5|||
28002621|NCT00965081|81842239|FG000|Overall Study|Sponsor Decision|1|||
28002622|NCT00965081|81842240|FG001|Overall Study|Sponsor Decision|0|||
28002623|NCT00965081|81842239|FG000|Overall Study|Withdrawal by Subject|4|||
28002624|NCT00965081|81842240|FG001|Overall Study|Withdrawal by Subject|7|||
28002625|NCT00965081|81842239|FG000|Overall Study|Switched to Rescue Arm|5|||
28002626|NCT00965081|81842240|FG001|Overall Study|Switched to Rescue Arm|12|||
28002627|NCT02123134|81842241|FG000|Overall Study|Withdrawal of consent|3|||
28002628|NCT02123134|81842242|FG001|Overall Study|Withdrawal of consent|2|||
28002629|NCT02123134|81842241|FG000|Overall Study|Administrative decision|0|||
28002630|NCT02123134|81842242|FG001|Overall Study|Administrative decision|1|||
28002631|NCT01410890|81842243|FG000|Overall Study|Withdrawal by Subject|0|||
28002632|NCT01410890|81842244|FG001|Overall Study|Withdrawal by Subject|1|||
28002633|NCT02201524|81842245|FG000|Overall Study|Adverse Event|0|||
28002634|NCT02201524|81842246|FG001|Overall Study|Adverse Event|2|||
28002635|NCT02201524|81842247|FG002|Overall Study|Adverse Event|1|||
28002636|NCT02201524|81842248|FG003|Overall Study|Adverse Event|0|||
28002637|NCT02201524|81842245|FG000|Overall Study|Insufficient clinical response|1|||
28002638|NCT02201524|81842246|FG001|Overall Study|Insufficient clinical response|0|||
28002639|NCT02201524|81842247|FG002|Overall Study|Insufficient clinical response|0|||
28002640|NCT02201524|81842248|FG003|Overall Study|Insufficient clinical response|0|||
28002641|NCT02201524|81842245|FG000|Overall Study|Lost to Follow-up|0|||
27806960|NCT00544557|81123354|FG000|Overall Study|Other|98|||
28002642|NCT02201524|81842246|FG001|Overall Study|Lost to Follow-up|0|||
28002643|NCT02201524|81842247|FG002|Overall Study|Lost to Follow-up|2|||
27584249|NCT02348216|80319231|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
27806961|NCT04071366|81123355|FG000|Part 1: Open-label (29 Days)|Death|4|||
28002644|NCT02201524|81842248|FG003|Overall Study|Lost to Follow-up|0|||
28002645|NCT02201524|81842245|FG000|Overall Study|No longer meets eligibility criteria|0|||
28002646|NCT02201524|81842246|FG001|Overall Study|No longer meets eligibility criteria|0|||
28002647|NCT02201524|81842247|FG002|Overall Study|No longer meets eligibility criteria|0|||
28002648|NCT02201524|81842248|FG003|Overall Study|No longer meets eligibility criteria|2|||
28002649|NCT02201524|81842245|FG000|Overall Study|Protocol Violation|0|||
28002650|NCT02201524|81842246|FG001|Overall Study|Protocol Violation|0|||
28002651|NCT02201524|81842247|FG002|Overall Study|Protocol Violation|0|||
28002652|NCT02201524|81842248|FG003|Overall Study|Protocol Violation|1|||
28002653|NCT02201524|81842245|FG000|Overall Study|Withdrawal by Subject|0|||
27806962|NCT04071366|81123356|FG001|Part 1: Open-label (29 Days)|Death|2|||
27806963|NCT04071366|81123357|FG002|Part 1: Open-label (29 Days)|Death|8|||
27584250|NCT02348216|80319225|FG000|Overall Study|Reason not specified|2|||
27682878|NCT00474526|80675766|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
27806964|NCT04071366|81123358|FG003|Part 1: Open-label (29 Days)|Death|0|||
27806965|NCT04071366|81123359|FG004|Part 1: Open-label (29 Days)|Death|0|||
27806966|NCT04071366|81123355|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
27806967|NCT04071366|81123356|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
28002654|NCT02201524|81842246|FG001|Overall Study|Withdrawal by Subject|0|||
28002655|NCT02201524|81842247|FG002|Overall Study|Withdrawal by Subject|1|||
28002656|NCT02201524|81842248|FG003|Overall Study|Withdrawal by Subject|1|||
28002657|NCT02201524|81842245|FG000|Overall Study|Other|1|||
28002658|NCT02201524|81842246|FG001|Overall Study|Other|1|||
27584251|NCT02348216|80319226|FG001|Overall Study|Reason not specified|19|||
27682879|NCT00474526|80675767|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
27682880|NCT00474526|80675768|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27806968|NCT04071366|81123357|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
27806969|NCT04071366|81123358|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
27806970|NCT04071366|81123359|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
27806971|NCT04071366|81123355|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
27806972|NCT04071366|81123356|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
27806973|NCT04071366|81123357|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
27806974|NCT04071366|81123358|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
27806975|NCT04071366|81123359|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
27806976|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Death|0|||
27806977|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Death|0|||
27806978|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Death|0|||
28002659|NCT02201524|81842247|FG002|Overall Study|Other|0|||
28002660|NCT02201524|81842248|FG003|Overall Study|Other|0|||
27682881|NCT00474526|80675769|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
28002661|NCT00248495|81842254|FG000|Overall Study|Withdrawal by Subject|1|||
28002662|NCT03642873|81842255|FG000|Third Intervention (1 Day)|Screen failure|0|||
28002663|NCT03642873|81842256|FG001|Third Intervention (1 Day)|Screen failure|0|||
28002664|NCT03642873|81842257|FG002|Third Intervention (1 Day)|Screen failure|0|||
28002665|NCT03642873|81842258|FG003|Third Intervention (1 Day)|Screen failure|0|||
28002666|NCT03642873|81842259|FG004|Third Intervention (1 Day)|Screen failure|1|||
28002667|NCT03642873|81842260|FG005|Third Intervention (1 Day)|Screen failure|0|||
28002668|NCT00659061|81842261|FG000|Overall Study|Migration due to political unrest|21|||
28002669|NCT00659061|81842262|FG001|Overall Study|Migration due to political unrest|15|||
28002670|NCT01421017|81842263|FG000|Overall Study|Withdrawal by Subject|2|||
28002671|NCT01421017|81842264|FG001|Overall Study|Withdrawal by Subject|0|||
28002672|NCT01421017|81842265|FG002|Overall Study|Withdrawal by Subject|0|||
28002673|NCT01421017|81842263|FG000|Overall Study|POD|0|||
28002674|NCT01421017|81842264|FG001|Overall Study|POD|6|||
28002675|NCT01421017|81842265|FG002|Overall Study|POD|3|||
28002676|NCT02193776|81842266|FG000|Overall Study|Consent withdrawn|1|||
28002677|NCT02193776|81842267|FG001|Overall Study|Consent withdrawn|0|||
28002678|NCT02193776|81842268|FG002|Overall Study|Consent withdrawn|0|||
28002679|NCT02193776|81842269|FG003|Overall Study|Consent withdrawn|0|||
28002680|NCT02193776|81842266|FG000|Overall Study|Failure to comply with protocol|0|||
28002681|NCT02193776|81842267|FG001|Overall Study|Failure to comply with protocol|1|||
28002682|NCT02193776|81842268|FG002|Overall Study|Failure to comply with protocol|0|||
28002683|NCT02193776|81842269|FG003|Overall Study|Failure to comply with protocol|0|||
27806979|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Death|2|||
27874121|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874122|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874123|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874124|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874125|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874126|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874127|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874128|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874129|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27874130|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
28002684|NCT02193776|81842266|FG000|Overall Study|Investigator/Sponsor decision|1|||
28002685|NCT02193776|81842267|FG001|Overall Study|Investigator/Sponsor decision|1|||
27806980|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Death|2|||
27806981|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
27806982|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
27806983|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
27806984|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
27806985|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
27806986|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
27806987|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
28002686|NCT02193776|81842268|FG002|Overall Study|Investigator/Sponsor decision|0|||
27806988|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
28002687|NCT02193776|81842269|FG003|Overall Study|Investigator/Sponsor decision|0|||
28002688|NCT02193776|81842266|FG000|Overall Study|Death|1|||
28002689|NCT02193776|81842267|FG001|Overall Study|Death|0|||
28002690|NCT02193776|81842268|FG002|Overall Study|Death|0|||
28002691|NCT02193776|81842269|FG003|Overall Study|Death|0|||
28002692|NCT02193776|81842266|FG000|Overall Study|Adverse event/Specific toxicity|5|||
28002693|NCT02193776|81842267|FG001|Overall Study|Adverse event/Specific toxicity|5|||
28002694|NCT02193776|81842268|FG002|Overall Study|Adverse event/Specific toxicity|2|||
28002695|NCT02193776|81842269|FG003|Overall Study|Adverse event/Specific toxicity|2|||
28002696|NCT00416624|81842270|FG000|Overall Study|Withdrawal by Subject|1|||
28002697|NCT00416624|81842271|FG001|Overall Study|Withdrawal by Subject|6|||
28002698|NCT00416624|81842272|FG002|Overall Study|Withdrawal by Subject|4|||
28002699|NCT00416624|81842273|FG003|Overall Study|Withdrawal by Subject|9|||
28002700|NCT00416624|81842270|FG000|Overall Study|Death|4|||
28002701|NCT00416624|81842271|FG001|Overall Study|Death|7|||
28002702|NCT00416624|81842272|FG002|Overall Study|Death|7|||
28002703|NCT00416624|81842273|FG003|Overall Study|Death|1|||
28002704|NCT00416624|81842270|FG000|Overall Study|Adverse Event|8|||
28002705|NCT00416624|81842271|FG001|Overall Study|Adverse Event|3|||
28002706|NCT00416624|81842272|FG002|Overall Study|Adverse Event|2|||
28002707|NCT00416624|81842273|FG003|Overall Study|Adverse Event|2|||
28002708|NCT00416624|81842270|FG000|Overall Study|Other|8|||
28002709|NCT00416624|81842271|FG001|Overall Study|Other|11|||
28002710|NCT00416624|81842272|FG002|Overall Study|Other|5|||
28002711|NCT00416624|81842273|FG003|Overall Study|Other|5|||
27584252|NCT02348216|80319227|FG002|Overall Study|Reason not specified|11|||
27584253|NCT02348216|80319228|FG003|Overall Study|Reason not specified|17|||
27584254|NCT02348216|80319229|FG004|Overall Study|Reason not specified|21|||
27584255|NCT02348216|80319230|FG005|Overall Study|Reason not specified|17|||
27584256|NCT02348216|80319231|FG006|Overall Study|Reason not specified|19|||
27584257|NCT01762761|80319232|FG000|Overall Study|Adverse Event|15|||
27584258|NCT01762761|80319233|FG001|Overall Study|Adverse Event|17|||
27584259|NCT01762761|80319232|FG000|Overall Study|Lack of Efficacy|9|||
27584260|NCT01762761|80319233|FG001|Overall Study|Lack of Efficacy|25|||
27584261|NCT01762761|80319232|FG000|Overall Study|Protocol Violation|1|||
27584262|NCT01762761|80319233|FG001|Overall Study|Protocol Violation|1|||
27584263|NCT01762761|80319232|FG000|Overall Study|Study closed/terminated|0|||
27584264|NCT01762761|80319233|FG001|Overall Study|Study closed/terminated|2|||
27584265|NCT01762761|80319232|FG000|Overall Study|Lost to Follow-up|3|||
27584266|NCT01762761|80319233|FG001|Overall Study|Lost to Follow-up|6|||
27584267|NCT01762761|80319232|FG000|Overall Study|Physician Decision|4|||
27584268|NCT01762761|80319233|FG001|Overall Study|Physician Decision|6|||
27584269|NCT01762761|80319232|FG000|Overall Study|Withdrawal by Subject|7|||
27584270|NCT01762761|80319233|FG001|Overall Study|Withdrawal by Subject|8|||
27584271|NCT03295201|80319234|FG000|Overall Study|Lost to Follow-up|1|||
27584272|NCT03295201|80319235|FG001|Overall Study|Lost to Follow-up|1|||
27806989|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
27806990|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
27806991|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
27806992|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
27806993|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
27806994|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
27806995|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
27806996|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
27806997|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
27806998|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
27806999|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
27807000|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
27807001|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
27807002|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
27807003|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
27807004|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
27807005|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
27807006|NCT04071366|81123355|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
28002712|NCT00416624|81842270|FG000|Overall Study|Cancel|1|||
28002713|NCT00416624|81842271|FG001|Overall Study|Cancel|0|||
28002714|NCT00416624|81842272|FG002|Overall Study|Cancel|0|||
28002715|NCT00416624|81842273|FG003|Overall Study|Cancel|0|||
27584273|NCT03295201|80319234|FG000|Overall Study|Hospital admission|0|||
27584274|NCT03295201|80319235|FG001|Overall Study|Hospital admission|1|||
27584275|NCT01748994|80319236|FG000|Overall Study|Lost to Follow-up|8|||
27584276|NCT01748994|80319237|FG001|Overall Study|Lost to Follow-up|6|||
27584277|NCT00023673|80319238|FG000|Overall Study|Ineligible / no protocol treatment|0|||
27584278|NCT00023673|80319239|FG001|Overall Study|Ineligible / no protocol treatment|0|||
28002716|NCT00615017|81842277|FG000|Overall Study|Adverse Event|0|||
28002717|NCT00615017|81842278|FG001|Overall Study|Adverse Event|1|||
27584279|NCT00023673|80319240|FG002|Overall Study|Ineligible / no protocol treatment|0|||
27584280|NCT00023673|80319241|FG003|Overall Study|Ineligible / no protocol treatment|1|||
27682882|NCT00474526|80675770|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682883|NCT00474526|80675771|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682884|NCT00474526|80675772|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682885|NCT00474526|80675773|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682886|NCT00474526|80675774|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682887|NCT00474526|80675775|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682888|NCT00474526|80675776|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
27682889|NCT00474526|80675777|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
27682890|NCT00474526|80675778|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682891|NCT00474526|80675779|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
27682892|NCT00474526|80675763|FG000|Overall Study|Lost to Follow-up|8|||
27682893|NCT00474526|80675764|FG001|Overall Study|Lost to Follow-up|6|||
27682894|NCT00474526|80675765|FG002|Overall Study|Lost to Follow-up|13|||
27682895|NCT00474526|80675766|FG003|Overall Study|Lost to Follow-up|29|||
27682896|NCT00474526|80675767|FG004|Overall Study|Lost to Follow-up|11|||
27682897|NCT00474526|80675768|FG005|Overall Study|Lost to Follow-up|5|||
27682898|NCT00474526|80675769|FG006|Overall Study|Lost to Follow-up|8|||
27682899|NCT00474526|80675770|FG007|Overall Study|Lost to Follow-up|1|||
27682900|NCT00474526|80675771|FG008|Overall Study|Lost to Follow-up|0|||
27682901|NCT00474526|80675772|FG009|Overall Study|Lost to Follow-up|6|||
27682902|NCT00474526|80675773|FG010|Overall Study|Lost to Follow-up|2|||
27682903|NCT00474526|80675774|FG011|Overall Study|Lost to Follow-up|4|||
27682904|NCT00474526|80675775|FG012|Overall Study|Lost to Follow-up|6|||
27682905|NCT00474526|80675776|FG013|Overall Study|Lost to Follow-up|74|||
27682906|NCT00474526|80675777|FG014|Overall Study|Lost to Follow-up|29|||
27682907|NCT00474526|80675778|FG015|Overall Study|Lost to Follow-up|4|||
27682908|NCT00474526|80675779|FG016|Overall Study|Lost to Follow-up|5|||
27682909|NCT00474526|80675763|FG000|Overall Study|Protocol Violation|2|||
27682910|NCT00474526|80675764|FG001|Overall Study|Protocol Violation|6|||
27682911|NCT00474526|80675765|FG002|Overall Study|Protocol Violation|4|||
27682912|NCT00474526|80675766|FG003|Overall Study|Protocol Violation|12|||
27682913|NCT00474526|80675767|FG004|Overall Study|Protocol Violation|3|||
27682914|NCT00474526|80675768|FG005|Overall Study|Protocol Violation|1|||
27682915|NCT00474526|80675769|FG006|Overall Study|Protocol Violation|3|||
27682916|NCT00474526|80675770|FG007|Overall Study|Protocol Violation|0|||
27682917|NCT00474526|80675771|FG008|Overall Study|Protocol Violation|0|||
27682918|NCT00474526|80675772|FG009|Overall Study|Protocol Violation|4|||
27682919|NCT00474526|80675773|FG010|Overall Study|Protocol Violation|2|||
27682920|NCT00474526|80675774|FG011|Overall Study|Protocol Violation|2|||
27682921|NCT00474526|80675775|FG012|Overall Study|Protocol Violation|4|||
27682922|NCT00474526|80675776|FG013|Overall Study|Protocol Violation|19|||
27682923|NCT00474526|80675777|FG014|Overall Study|Protocol Violation|9|||
27682924|NCT00474526|80675778|FG015|Overall Study|Protocol Violation|6|||
27682925|NCT00474526|80675779|FG016|Overall Study|Protocol Violation|2|||
27682926|NCT00474526|80675763|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
27682927|NCT00474526|80675764|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
27682928|NCT00474526|80675765|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
27682929|NCT00474526|80675766|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
27682930|NCT00474526|80675767|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
27682931|NCT00474526|80675768|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
27682932|NCT00474526|80675769|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
27682933|NCT00474526|80675770|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
27682934|NCT00474526|80675771|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
27682935|NCT00474526|80675772|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
27682936|NCT00474526|80675773|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
27682937|NCT00474526|80675774|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
27682938|NCT00474526|80675775|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
27682939|NCT00474526|80675776|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
27682940|NCT00474526|80675777|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
27682941|NCT00474526|80675778|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
27682942|NCT00474526|80675779|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
27682943|NCT00474526|80675763|FG000|Overall Study|Withdrawal by Subject|9|||
27682944|NCT00474526|80675764|FG001|Overall Study|Withdrawal by Subject|24|||
27682945|NCT00474526|80675765|FG002|Overall Study|Withdrawal by Subject|21|||
27682946|NCT00474526|80675766|FG003|Overall Study|Withdrawal by Subject|52|||
27874131|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27682947|NCT00474526|80675767|FG004|Overall Study|Withdrawal by Subject|38|||
27682948|NCT00474526|80675768|FG005|Overall Study|Withdrawal by Subject|6|||
27682949|NCT00474526|80675769|FG006|Overall Study|Withdrawal by Subject|12|||
27682950|NCT00474526|80675770|FG007|Overall Study|Withdrawal by Subject|4|||
27682951|NCT00474526|80675771|FG008|Overall Study|Withdrawal by Subject|4|||
27682952|NCT00474526|80675772|FG009|Overall Study|Withdrawal by Subject|13|||
27682953|NCT00474526|80675773|FG010|Overall Study|Withdrawal by Subject|5|||
27682954|NCT00474526|80675774|FG011|Overall Study|Withdrawal by Subject|4|||
27682955|NCT00474526|80675775|FG012|Overall Study|Withdrawal by Subject|4|||
27682956|NCT00474526|80675776|FG013|Overall Study|Withdrawal by Subject|37|||
27682957|NCT00474526|80675777|FG014|Overall Study|Withdrawal by Subject|22|||
27682958|NCT00474526|80675778|FG015|Overall Study|Withdrawal by Subject|1|||
27682959|NCT00474526|80675779|FG016|Overall Study|Withdrawal by Subject|1|||
27682960|NCT01142115|80675782|FG000|First Intervention|Lack of Efficacy|1|||
27682961|NCT01142115|80675783|FG001|First Intervention|Lack of Efficacy|1|||
27682962|NCT01142115|80675782|FG000|First Intervention|Adverse Event|1|||
27682963|NCT01142115|80675783|FG001|First Intervention|Adverse Event|0|||
27682964|NCT02731690|80675784|FG000|Overall Study|Adverse Event|1|||
27682965|NCT02731690|80675784|FG000|Overall Study|Withdrawal by Subject|3|||
27682966|NCT02731690|80675784|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
27682967|NCT00095056|80675789|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
27682968|NCT00095056|80675790|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
27682969|NCT00095056|80675789|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
27682970|NCT00095056|80675790|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
27807007|NCT04071366|81123356|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
27807008|NCT04071366|81123357|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
27682971|NCT00095056|80675789|FG000|Phase A (Weeks 0-12)|Death|1|||
27682972|NCT00095056|80675790|FG001|Phase A (Weeks 0-12)|Death|0|||
27682973|NCT00095056|80675789|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
27682974|NCT00095056|80675790|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
27682975|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
27682976|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
27682977|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
27682978|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
27682979|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
27682980|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
27682981|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
27682982|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
27682983|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Death|3|||
27682984|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Death|1|||
27682985|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
27682986|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
27682987|NCT00095056|80675789|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
27682988|NCT00095056|80675790|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
27682989|NCT02311673|80675791|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
27682990|NCT02311673|80675792|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
27682991|NCT02311673|80675793|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
27682992|NCT02311673|80675794|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
27682993|NCT01253135|80675808|FG000|Original Protocol|Protocol Amendment|15|||
27682994|NCT01253135|80675808|FG000|Amended Protocol|Non-compliance|1|||
27682995|NCT03651622|80675809|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
27682996|NCT03651622|80675810|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
27682997|NCT03651622|80675811|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
27682998|NCT03651622|80675809|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
27682999|NCT03651622|80675810|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
27683000|NCT03651622|80675811|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
27683001|NCT03651622|80675809|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
27683002|NCT03651622|80675810|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
27683003|NCT03651622|80675811|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
27683004|NCT03651622|80675809|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
27683005|NCT03651622|80675810|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
27683006|NCT03651622|80675811|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
27683007|NCT03651622|80675809|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
27683008|NCT03651622|80675810|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
27807009|NCT04071366|81123358|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
27807010|NCT04071366|81123359|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
27807011|NCT02513459|81123360|FG000|Overall Study|Adverse Event|7|||
27807012|NCT02513459|81123360|FG000|Overall Study|Withdrew consent|5|||
27807013|NCT02513459|81123360|FG000|Overall Study|Loss of efficacy|2|||
27807014|NCT02513459|81123360|FG000|Overall Study|Pregnancy|2|||
27807015|NCT02513459|81123360|FG000|Overall Study|Subject decision|2|||
27807016|NCT02513459|81123360|FG000|Overall Study|Lack of response|1|||
27807017|NCT02513459|81123360|FG000|Overall Study|Reproductive plans|1|||
27807018|NCT02513459|81123360|FG000|Overall Study|Surgery planned-- not done|1|||
27683009|NCT03651622|80675811|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
27874132|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
27683010|NCT01528345|80675812|FG000|Overall Study|Adverse Event|10|||
27807019|NCT00490061|81123367|FG000|Overall Study|Physician Decision|1|||
27807020|NCT02521948|81123368|FG000|Overall Study|Adverse Event|2|||
27874133|NCT00758524|81371640|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27683011|NCT01528345|80675813|FG001|Overall Study|Adverse Event|1|||
27683012|NCT01528345|80675812|FG000|Overall Study|Death|1|||
27683013|NCT01528345|80675813|FG001|Overall Study|Death|1|||
27683014|NCT01528345|80675812|FG000|Overall Study|Non-compliance with study treatment|1|||
27683015|NCT01528345|80675813|FG001|Overall Study|Non-compliance with study treatment|0|||
27683016|NCT01528345|80675812|FG000|Overall Study|Progressive Disease|26|||
27683017|NCT01528345|80675813|FG001|Overall Study|Progressive Disease|40|||
27683018|NCT01528345|80675812|FG000|Overall Study|Study Terminated by Sponsor|4|||
27683019|NCT01528345|80675813|FG001|Overall Study|Study Terminated by Sponsor|8|||
27683020|NCT01528345|80675812|FG000|Overall Study|Subject/Guardian Decision|5|||
27683021|NCT01528345|80675813|FG001|Overall Study|Subject/Guardian Decision|0|||
27683022|NCT00710021|80675818|FG000|Overall Study|Lost to Follow-up|1|||
27683023|NCT00710021|80675819|FG001|Overall Study|Lost to Follow-up|0|||
27683024|NCT00710021|80675820|FG002|Overall Study|Lost to Follow-up|0|||
27683025|NCT00710021|80675818|FG000|Overall Study|Subject's Decision|0|||
27683026|NCT00710021|80675819|FG001|Overall Study|Subject's Decision|1|||
27683027|NCT00710021|80675820|FG002|Overall Study|Subject's Decision|0|||
27683028|NCT00710021|80675818|FG000|Overall Study|Subject misrandomized|0|||
27683029|NCT00710021|80675819|FG001|Overall Study|Subject misrandomized|1|||
27683030|NCT00710021|80675820|FG002|Overall Study|Subject misrandomized|1|||
27683031|NCT00710021|80675818|FG000|Overall Study|Physician Decision|0|||
27683032|NCT00710021|80675819|FG001|Overall Study|Physician Decision|1|||
27683033|NCT00710021|80675820|FG002|Overall Study|Physician Decision|0|||
27683034|NCT03274687|80675821|FG000|Overall Study|Protocol Violation|1|||
27683035|NCT03274687|80675822|FG001|Overall Study|Protocol Violation|1|||
27683036|NCT03181789|80675823|FG000|Overall Study|Withdrawal by Subject|0|||
27683037|NCT03181789|80675824|FG001|Overall Study|Withdrawal by Subject|1|||
27683038|NCT03181789|80675825|FG002|Overall Study|Withdrawal by Subject|1|||
27683039|NCT03181789|80675826|FG003|Overall Study|Withdrawal by Subject|0|||
27683040|NCT03181789|80675823|FG000|Overall Study|Lost to Follow-up|7|||
27683041|NCT03181789|80675824|FG001|Overall Study|Lost to Follow-up|1|||
27683042|NCT03181789|80675825|FG002|Overall Study|Lost to Follow-up|0|||
27683043|NCT03181789|80675826|FG003|Overall Study|Lost to Follow-up|0|||
27683044|NCT03181789|80675823|FG000|Overall Study|Participant unable to adhere to visit|0|||
27683045|NCT03181789|80675824|FG001|Overall Study|Participant unable to adhere to visit|1|||
27683046|NCT03181789|80675825|FG002|Overall Study|Participant unable to adhere to visit|0|||
27683047|NCT03181789|80675826|FG003|Overall Study|Participant unable to adhere to visit|0|||
27683048|NCT02636725|80675827|FG000|Overall Study|Adverse Event|1|||
27683049|NCT03139604|80675830|FG000|Overall Study|Other|7|||
27683050|NCT03139604|80675831|FG001|Overall Study|Other|3|||
27683051|NCT03139604|80675830|FG000|Overall Study|Withdrawal by Subject|16|||
27683052|NCT03139604|80675831|FG001|Overall Study|Withdrawal by Subject|17|||
27683053|NCT03139604|80675830|FG000|Overall Study|Physician Decision|1|||
27683054|NCT03139604|80675831|FG001|Overall Study|Physician Decision|2|||
27683055|NCT03139604|80675830|FG000|Overall Study|Lost to Follow-up|3|||
27683056|NCT03139604|80675831|FG001|Overall Study|Lost to Follow-up|1|||
27683057|NCT03139604|80675830|FG000|Overall Study|Death|65|||
27683058|NCT03139604|80675831|FG001|Overall Study|Death|67|||
27683059|NCT03139604|80675830|FG000|Overall Study|Study Terminated by Sponsor|122|||
27683060|NCT03139604|80675831|FG001|Overall Study|Study Terminated by Sponsor|127|||
27683061|NCT03139604|80675830|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
27683062|NCT03139604|80675831|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
27683063|NCT01022112|80675832|FG000|Overall Study|Adverse Event|1|||
27683064|NCT01022112|80675833|FG001|Overall Study|Adverse Event|2|||
27683065|NCT01022112|80675834|FG002|Overall Study|Adverse Event|0|||
28002718|NCT00615017|81842279|FG002|Overall Study|Adverse Event|2|||
28002719|NCT00615017|81842280|FG003|Overall Study|Adverse Event|0|||
28002720|NCT00615017|81842281|FG004|Overall Study|Adverse Event|0|||
28002721|NCT00615017|81842282|FG005|Overall Study|Adverse Event|1|||
28002722|NCT00615017|81842277|FG000|Overall Study|Death|0|||
28002723|NCT00615017|81842278|FG001|Overall Study|Death|0|||
28002724|NCT00615017|81842279|FG002|Overall Study|Death|2|||
28002725|NCT00615017|81842280|FG003|Overall Study|Death|0|||
28002726|NCT00615017|81842281|FG004|Overall Study|Death|1|||
28002727|NCT00615017|81842282|FG005|Overall Study|Death|1|||
28002728|NCT00615017|81842277|FG000|Overall Study|Sepsis resolved|0|||
28002729|NCT00615017|81842278|FG001|Overall Study|Sepsis resolved|0|||
28002730|NCT00615017|81842279|FG002|Overall Study|Sepsis resolved|1|||
28002731|NCT00615017|81842280|FG003|Overall Study|Sepsis resolved|0|||
28002732|NCT00615017|81842281|FG004|Overall Study|Sepsis resolved|0|||
27683066|NCT01022112|80675835|FG003|Overall Study|Adverse Event|1|||
27683067|NCT01022112|80675836|FG004|Overall Study|Adverse Event|0|||
27683068|NCT01022112|80675832|FG000|Overall Study|Lack of Efficacy|1|||
27683069|NCT01022112|80675833|FG001|Overall Study|Lack of Efficacy|0|||
27683070|NCT01022112|80675834|FG002|Overall Study|Lack of Efficacy|0|||
27683071|NCT01022112|80675835|FG003|Overall Study|Lack of Efficacy|0|||
27683072|NCT01022112|80675836|FG004|Overall Study|Lack of Efficacy|1|||
27683073|NCT01022112|80675832|FG000|Overall Study|Physician Decision|0|||
27683074|NCT01022112|80675833|FG001|Overall Study|Physician Decision|0|||
27683075|NCT01022112|80675834|FG002|Overall Study|Physician Decision|1|||
27683076|NCT01022112|80675835|FG003|Overall Study|Physician Decision|0|||
28002733|NCT00615017|81842282|FG005|Overall Study|Sepsis resolved|0|||
28002734|NCT00615017|81842277|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
28002735|NCT00615017|81842278|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
28002736|NCT00615017|81842279|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
28002737|NCT00615017|81842280|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
28002738|NCT00615017|81842281|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
28002739|NCT00615017|81842282|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
28002740|NCT00615017|81842277|FG000|Overall Study|Physician discontinued drug|0|||
28002741|NCT00615017|81842278|FG001|Overall Study|Physician discontinued drug|0|||
28002742|NCT00615017|81842279|FG002|Overall Study|Physician discontinued drug|0|||
28002743|NCT00615017|81842280|FG003|Overall Study|Physician discontinued drug|0|||
28002744|NCT00615017|81842281|FG004|Overall Study|Physician discontinued drug|0|||
28002745|NCT00615017|81842282|FG005|Overall Study|Physician discontinued drug|1|||
28002746|NCT03206216|81842283|FG000|Overall Study|Withdrawal by Subject|0|||
28002747|NCT03206216|81842284|FG001|Overall Study|Withdrawal by Subject|1|||
28002748|NCT02719171|81842286|FG000|Overall Study|Adverse Event|1|||
28002749|NCT02719171|81842287|FG001|Overall Study|Adverse Event|2|||
28002750|NCT02719171|81842288|FG002|Overall Study|Adverse Event|0|||
28002751|NCT02719171|81842289|FG003|Overall Study|Adverse Event|0|||
28002752|NCT02719171|81842290|FG004|Overall Study|Adverse Event|2|||
28002753|NCT02719171|81842286|FG000|Overall Study|Lost to Follow-up|0|||
28002754|NCT02719171|81842287|FG001|Overall Study|Lost to Follow-up|0|||
28002755|NCT02719171|81842288|FG002|Overall Study|Lost to Follow-up|1|||
28002756|NCT02719171|81842289|FG003|Overall Study|Lost to Follow-up|0|||
28002757|NCT02719171|81842290|FG004|Overall Study|Lost to Follow-up|0|||
28002758|NCT02719171|81842286|FG000|Overall Study|Subject Withdrawal|0|||
28002759|NCT02719171|81842287|FG001|Overall Study|Subject Withdrawal|2|||
27683077|NCT01022112|80675836|FG004|Overall Study|Physician Decision|1|||
27683078|NCT01022112|80675832|FG000|Overall Study|Withdrawal by Subject|0|||
27683079|NCT01022112|80675833|FG001|Overall Study|Withdrawal by Subject|1|||
27683080|NCT01022112|80675834|FG002|Overall Study|Withdrawal by Subject|2|||
27683081|NCT01022112|80675835|FG003|Overall Study|Withdrawal by Subject|2|||
27683082|NCT01022112|80675836|FG004|Overall Study|Withdrawal by Subject|1|||
27683083|NCT01022112|80675832|FG000|Overall Study|Fasting plasma glucose level increased|1|||
27683084|NCT01022112|80675833|FG001|Overall Study|Fasting plasma glucose level increased|0|||
27683085|NCT01022112|80675834|FG002|Overall Study|Fasting plasma glucose level increased|0|||
28002760|NCT02719171|81842288|FG002|Overall Study|Subject Withdrawal|2|||
28002761|NCT02719171|81842289|FG003|Overall Study|Subject Withdrawal|1|||
27683086|NCT01022112|80675835|FG003|Overall Study|Fasting plasma glucose level increased|0|||
27683087|NCT01022112|80675836|FG004|Overall Study|Fasting plasma glucose level increased|7|||
27683088|NCT02898077|80675837|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
27683089|NCT02898077|80675838|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
27683090|NCT02898077|80675837|FG000|Overall Study|Lost to Follow-up|4|||
27683091|NCT02898077|80675838|FG001|Overall Study|Lost to Follow-up|3|||
27683092|NCT02898077|80675837|FG000|Overall Study|Physician Decision|0|||
27683093|NCT02898077|80675838|FG001|Overall Study|Physician Decision|2|||
27683094|NCT02898077|80675837|FG000|Overall Study|Sponsor Decision|32|||
27683095|NCT02898077|80675838|FG001|Overall Study|Sponsor Decision|13|||
27683096|NCT02898077|80675837|FG000|Overall Study|Withdrawal by Subject|6|||
27683097|NCT02898077|80675838|FG001|Overall Study|Withdrawal by Subject|3|||
27683098|NCT02898077|80675837|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
27683099|NCT02898077|80675838|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
28002762|NCT02719171|81842290|FG004|Overall Study|Subject Withdrawal|0|||
28002763|NCT02719171|81842286|FG000|Overall Study|Other|0|||
28002764|NCT02719171|81842287|FG001|Overall Study|Other|0|||
28002765|NCT02719171|81842288|FG002|Overall Study|Other|0|||
27683100|NCT02898077|80675837|FG000|Overall Study|Ended extension period|3|||
27683101|NCT02898077|80675838|FG001|Overall Study|Ended extension period|0|||
27683102|NCT01014208|80675839|FG000|Overall Study|Lost to Follow-up|2|||
27683103|NCT01014208|80675840|FG001|Overall Study|Lost to Follow-up|5|||
27683104|NCT01014208|80675839|FG000|Overall Study|Participant Withdrew Consent|12|||
27683105|NCT01014208|80675840|FG001|Overall Study|Participant Withdrew Consent|12|||
27683106|NCT01014208|80675839|FG000|Overall Study|Did Not Receive Study Drug|2|||
27683107|NCT01014208|80675840|FG001|Overall Study|Did Not Receive Study Drug|0|||
27683108|NCT01014208|80675839|FG000|Overall Study|Study Closed/terminated|78|||
27807021|NCT02521948|81123368|FG000|Overall Study|Death|4|||
27807022|NCT02521948|81123368|FG000|Overall Study|Lost to Follow-up|1|||
27807023|NCT02521948|81123368|FG000|Overall Study|Did not attend one or both follow-ups|6|||
27807024|NCT04409002|81123378|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
27807025|NCT02666430|81123379|FG000|Period 1|Lost to Follow-up|1|||
28002766|NCT02719171|81842289|FG003|Overall Study|Other|1|||
28002767|NCT02719171|81842290|FG004|Overall Study|Other|0|||
27683109|NCT01014208|80675840|FG001|Overall Study|Study Closed/terminated|83|||
27683110|NCT02383940|80675841|FG000|Overall Study|Adverse Event|1|||
28002768|NCT01788566|81842291|FG000|Overall Study|Death|4|||
28002769|NCT01788566|81842291|FG000|Overall Study|Adverse Event|1|||
27683111|NCT02383940|80675842|FG001|Overall Study|Adverse Event|0|||
27683112|NCT02383940|80675841|FG000|Overall Study|Lost to Follow-up|2|||
27683113|NCT02383940|80675842|FG001|Overall Study|Lost to Follow-up|2|||
27683114|NCT02383940|80675841|FG000|Overall Study|Physician Decision|2|||
27683115|NCT02383940|80675842|FG001|Overall Study|Physician Decision|0|||
27683116|NCT02383940|80675841|FG000|Overall Study|Withdrawal by Subject|1|||
27683117|NCT02383940|80675842|FG001|Overall Study|Withdrawal by Subject|1|||
27683118|NCT02383940|80675841|FG000|Overall Study|Randomized but not treated|2|||
27683119|NCT02383940|80675842|FG001|Overall Study|Randomized but not treated|0|||
27683120|NCT02383940|80675841|FG000|Overall Study|Other than specified above|1|||
27683121|NCT02383940|80675842|FG001|Overall Study|Other than specified above|0|||
27683122|NCT04155047|80675843|FG000|Overall Study|Adverse Event|1|||
27683123|NCT04155047|80675844|FG001|Overall Study|Adverse Event|0|||
27683124|NCT04155047|80675843|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
27683125|NCT04155047|80675844|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
27683126|NCT00126503|80675845|FG000|Overall Study|disease progression|23|||
27683127|NCT00126503|80675846|FG001|Overall Study|disease progression|14|||
27683128|NCT00126503|80675845|FG000|Overall Study|Withdrawal by Subject|0|||
27683129|NCT00126503|80675846|FG001|Overall Study|Withdrawal by Subject|1|||
27683130|NCT00126503|80675845|FG000|Overall Study|alternative therapy|1|||
27683131|NCT00126503|80675846|FG001|Overall Study|alternative therapy|1|||
27683132|NCT00126503|80675845|FG000|Overall Study|other complicating disease|4|||
27683133|NCT00126503|80675846|FG001|Overall Study|other complicating disease|1|||
27683134|NCT00126503|80675845|FG000|Overall Study|Death|3|||
27683135|NCT00126503|80675846|FG001|Overall Study|Death|0|||
27683136|NCT00126503|80675845|FG000|Overall Study|Adverse Event|13|||
27683137|NCT00126503|80675846|FG001|Overall Study|Adverse Event|3|||
27683138|NCT00126503|80675845|FG000|Overall Study|non-compliant|1|||
27683139|NCT00126503|80675846|FG001|Overall Study|non-compliant|0|||
27683140|NCT00126503|80675845|FG000|Overall Study|Physician Decision|2|||
27683141|NCT00126503|80675846|FG001|Overall Study|Physician Decision|1|||
27683142|NCT01593787|80675847|FG000|Overall Study|Adverse Event|1|||
27683143|NCT01593787|80675848|FG001|Overall Study|Adverse Event|0|||
27683144|NCT01593787|80675849|FG002|Overall Study|Adverse Event|0|||
27683145|NCT05032872|80675850|FG000|Overall Study|Adverse Event|1|||
27683146|NCT05032872|80675851|FG001|Overall Study|Adverse Event|0|||
27683147|NCT05032872|80675850|FG000|Overall Study|Lost to Follow-up|2|||
27683148|NCT05032872|80675851|FG001|Overall Study|Lost to Follow-up|4|||
27683149|NCT05032872|80675850|FG000|Overall Study|Withdrawal by Subject|4|||
27683150|NCT05032872|80675851|FG001|Overall Study|Withdrawal by Subject|3|||
27683151|NCT01964924|80675853|FG000|Trametinib Monotherapy|Progression|19|||
27683152|NCT01964924|80675854|FG001|Trametinib Monotherapy|Progression|0|||
27683153|NCT01327495|80675865|FG000|Overall Study|Adverse Event|2|||
27683154|NCT01327495|80675866|FG001|Overall Study|Adverse Event|1|||
27683155|NCT01327495|80675867|FG002|Overall Study|Adverse Event|1|||
27683156|NCT01327495|80675868|FG003|Overall Study|Adverse Event|0|||
27683157|NCT01327495|80675869|FG004|Overall Study|Adverse Event|0|||
27683158|NCT01327495|80675870|FG005|Overall Study|Adverse Event|2|||
27683159|NCT01327495|80675865|FG000|Overall Study|Withdrawal by Subject|0|||
27683160|NCT01327495|80675866|FG001|Overall Study|Withdrawal by Subject|1|||
27683161|NCT01327495|80675867|FG002|Overall Study|Withdrawal by Subject|1|||
27683162|NCT01327495|80675868|FG003|Overall Study|Withdrawal by Subject|0|||
27683163|NCT01327495|80675869|FG004|Overall Study|Withdrawal by Subject|1|||
27683164|NCT01327495|80675870|FG005|Overall Study|Withdrawal by Subject|0|||
27683165|NCT01327495|80675865|FG000|Overall Study|Physician Decision|0|||
27683166|NCT01327495|80675866|FG001|Overall Study|Physician Decision|0|||
27683167|NCT01327495|80675867|FG002|Overall Study|Physician Decision|0|||
27683168|NCT01327495|80675868|FG003|Overall Study|Physician Decision|0|||
27683169|NCT01327495|80675869|FG004|Overall Study|Physician Decision|2|||
27683170|NCT01327495|80675870|FG005|Overall Study|Physician Decision|0|||
27683171|NCT01011153|80675872|FG000|Overall Study|Less than 78 cases completed|8|||
27683172|NCT01011153|80675873|FG001|Overall Study|Less than 78 cases completed|11|||
27683173|NCT01011153|80675874|FG002|Overall Study|Less than 78 cases completed|9|||
27683174|NCT01202903|80675875|FG000|Overall Study|Administrative Probelms|1|||
27807026|NCT02666430|81123380|FG001|Period 1|Lost to Follow-up|0|||
27683175|NCT01202903|80675876|FG001|Overall Study|Administrative Probelms|4|||
27683176|NCT01202903|80675875|FG000|Overall Study|Protocol Violation|0|||
27683177|NCT01202903|80675876|FG001|Overall Study|Protocol Violation|1|||
27683178|NCT01202903|80675875|FG000|Overall Study|Death|1|||
27683179|NCT01202903|80675876|FG001|Overall Study|Death|0|||
27683180|NCT01202903|80675875|FG000|Overall Study|Lost to Follow-up|1|||
27683181|NCT01202903|80675876|FG001|Overall Study|Lost to Follow-up|1|||
27683182|NCT01202903|80675875|FG000|Overall Study|Lack of Efficacy|1|||
27683183|NCT01202903|80675876|FG001|Overall Study|Lack of Efficacy|3|||
27683184|NCT01202903|80675875|FG000|Overall Study|Adverse Event|3|||
27683185|NCT01202903|80675876|FG001|Overall Study|Adverse Event|3|||
27683186|NCT01202903|80675875|FG000|Overall Study|Withdrawal by Subject|4|||
27807027|NCT02666430|81123379|FG000|Period 1|Adverse Event|0|||
27683187|NCT01202903|80675876|FG001|Overall Study|Withdrawal by Subject|4|||
27683188|NCT00772330|80675879|FG000|Overall Study|Lost to Follow-up|3|||
27683189|NCT04927884|80675880|FG000|Overall Study|Progressive Disease|2|||
27683190|NCT03896152|80675881|FG000|Overall Study|Patient/guardian decision|1|||
27683191|NCT03896152|80675882|FG001|Overall Study|Patient/guardian decision|1|||
27683192|NCT03896152|80675881|FG000|Overall Study|Adverse Event|0|||
27683193|NCT03896152|80675882|FG001|Overall Study|Adverse Event|1|||
27683194|NCT03896152|80675881|FG000|Overall Study|Physician Decision|1|||
27683195|NCT03896152|80675882|FG001|Overall Study|Physician Decision|0|||
27683196|NCT03896152|80675881|FG000|Overall Study|Technical problems|1|||
27683197|NCT03896152|80675882|FG001|Overall Study|Technical problems|0|||
27683198|NCT00037830|80675883|FG000|Overall Study|Adverse Event|2|||
27683199|NCT00037830|80675884|FG001|Overall Study|Adverse Event|0|||
27683200|NCT00037830|80675885|FG002|Overall Study|Adverse Event|0|||
27683201|NCT00037830|80675883|FG000|Overall Study|Withdrawal by Subject|4|||
27683202|NCT00037830|80675884|FG001|Overall Study|Withdrawal by Subject|5|||
27683203|NCT00037830|80675885|FG002|Overall Study|Withdrawal by Subject|1|||
27683204|NCT00037830|80675883|FG000|Overall Study|Protocol Violation|2|||
27683205|NCT00037830|80675884|FG001|Overall Study|Protocol Violation|2|||
27683206|NCT00037830|80675885|FG002|Overall Study|Protocol Violation|0|||
27683207|NCT00037830|80675883|FG000|Overall Study|Unrelated Medical Problem|2|||
27683208|NCT00037830|80675884|FG001|Overall Study|Unrelated Medical Problem|0|||
27683209|NCT00037830|80675885|FG002|Overall Study|Unrelated Medical Problem|0|||
27683210|NCT03449901|80675886|FG000|Overall Study|Progression|57|||
27683211|NCT03449901|80675887|FG001|Overall Study|Progression|12|||
27683212|NCT03449901|80675886|FG000|Overall Study|Adverse Event|3|||
27683213|NCT03449901|80675887|FG001|Overall Study|Adverse Event|0|||
27683214|NCT03449901|80675886|FG000|Overall Study|Death|6|||
27683215|NCT03449901|80675887|FG001|Overall Study|Death|2|||
27683216|NCT03449901|80675886|FG000|Overall Study|Withdrawal by Subject|12|||
27683217|NCT03449901|80675887|FG001|Overall Study|Withdrawal by Subject|1|||
27683218|NCT03449901|80675886|FG000|Overall Study|Physician Decision|1|||
27683219|NCT03449901|80675887|FG001|Overall Study|Physician Decision|0|||
27683220|NCT03449901|80675886|FG000|Overall Study|Patient elected for surgical intervention|1|||
27683221|NCT03449901|80675887|FG001|Overall Study|Patient elected for surgical intervention|0|||
27683222|NCT03449901|80675886|FG000|Overall Study|Patient off for other complicating disease|1|||
27683223|NCT03449901|80675887|FG001|Overall Study|Patient off for other complicating disease|0|||
27683224|NCT04664400|80675893|FG000|Overall Study|Withdrawal by Subject|2|||
27683225|NCT04514510|80675894|FG000|Overall Study|Lost to Follow-up|0|||
27683226|NCT04514510|80675895|FG001|Overall Study|Lost to Follow-up|1|||
27683227|NCT04514510|80675894|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
27683228|NCT04514510|80675895|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
27683229|NCT02285153|80675900|FG000|Overall Study|Adverse Event|1|||
27683230|NCT02285153|80675901|FG001|Overall Study|Adverse Event|0|||
27683231|NCT02766777|80675902|FG000|Overall Study|Adverse Event|12|||
27683232|NCT02766777|80675902|FG000|Overall Study|Lost to Follow-up|16|||
27683233|NCT02766777|80675902|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27683234|NCT02766777|80675902|FG000|Overall Study|Protocol Violation|1|||
27683235|NCT02766777|80675902|FG000|Overall Study|Withdrawal by Subject|4|||
27874134|NCT00758524|81371641|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
27874135|NCT00758524|81371642|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874136|NCT00758524|81371643|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
28002770|NCT01788566|81842291|FG000|Overall Study|Clinical Progressive Disease|3|||
28002771|NCT01176032|81842294|FG000|Overall Study|Adverse Event|1|||
28002772|NCT01176032|81842295|FG001|Overall Study|Adverse Event|0|||
27683236|NCT00436852|80675903|FG000|Overall Study|Death|23|||
27683237|NCT00436852|80675904|FG001|Overall Study|Death|34|||
27807028|NCT02666430|81123380|FG001|Period 1|Adverse Event|1|||
27807029|NCT02666430|81123379|FG000|Period 2|Withdrawal by Subject|1|||
27807030|NCT02666430|81123380|FG001|Period 2|Withdrawal by Subject|4|||
27807031|NCT02666430|81123379|FG000|Period 3|Lost to Follow-up|1|||
27807032|NCT02666430|81123380|FG001|Period 3|Lost to Follow-up|0|||
27807033|NCT00686920|81123381|FG000|Overall Study|Death|45|||
27807034|NCT00686920|81123382|FG001|Overall Study|Death|14|||
27807035|NCT00686920|81123381|FG000|Overall Study|Liver Transplant|23|||
27807036|NCT00686920|81123382|FG001|Overall Study|Liver Transplant|8|||
27807037|NCT00686920|81123381|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
27807038|NCT00686920|81123382|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
27683238|NCT00436852|80675903|FG000|Overall Study|Lack of Efficacy|9|||
27683239|NCT00436852|80675904|FG001|Overall Study|Lack of Efficacy|7|||
27683240|NCT00436852|80675903|FG000|Overall Study|Withdrawal by Subject|2|||
27683241|NCT00436852|80675904|FG001|Overall Study|Withdrawal by Subject|4|||
27683242|NCT00436852|80675903|FG000|Overall Study|Ineligible|1|||
27683243|NCT00436852|80675904|FG001|Overall Study|Ineligible|0|||
27683244|NCT00699153|80675907|FG000|Overall Study|Lost to Follow-up|1|||
27683245|NCT00699153|80675908|FG001|Overall Study|Lost to Follow-up|0|||
27807039|NCT00686920|81123381|FG000|Overall Study|Withdrawal by Subject|23|||
28002773|NCT01176032|81842294|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27683246|NCT00699153|80675907|FG000|Overall Study|Adverse Event|0|||
27683247|NCT00699153|80675908|FG001|Overall Study|Adverse Event|2|||
27683248|NCT00699153|80675907|FG000|Overall Study|Protocol Violation|1|||
27683249|NCT00699153|80675908|FG001|Overall Study|Protocol Violation|0|||
27683250|NCT00699153|80675907|FG000|Overall Study|Travel Problem|1|||
27683251|NCT00699153|80675908|FG001|Overall Study|Travel Problem|0|||
27683252|NCT01638429|80675909|FG000|Overall Study|Withdrawal by Subject|1|||
27683253|NCT03980808|80675910|FG000|Overall Study|Lost to Follow-up|2|||
27683254|NCT03980808|80675911|FG001|Overall Study|Lost to Follow-up|2|||
27683255|NCT00742326|80675912|FG000|Overall Study|Physician Decision|0|||
27683256|NCT00742326|80675913|FG001|Overall Study|Physician Decision|1|||
27683257|NCT03682302|80675914|FG000|Overall Study|Lost to Follow-up|1|||
27683258|NCT03682302|80675915|FG001|Overall Study|Lost to Follow-up|2|||
27683259|NCT03682302|80675916|FG002|Overall Study|Lost to Follow-up|0|||
27683260|NCT03682302|80675917|FG003|Overall Study|Lost to Follow-up|1|||
27683261|NCT03682302|80675914|FG000|Overall Study|Study drug was not administered|0|||
27683262|NCT03682302|80675915|FG001|Overall Study|Study drug was not administered|0|||
27683263|NCT03682302|80675916|FG002|Overall Study|Study drug was not administered|1|||
27683264|NCT03682302|80675917|FG003|Overall Study|Study drug was not administered|1|||
27683265|NCT00663702|80675918|FG000|Overall Study|Adverse Event|8|||
27683266|NCT00663702|80675919|FG001|Overall Study|Adverse Event|4|||
27683267|NCT00663702|80675918|FG000|Overall Study|Withdrawal by Subject|3|||
27683268|NCT00663702|80675919|FG001|Overall Study|Withdrawal by Subject|1|||
27683269|NCT00663702|80675918|FG000|Overall Study|Pregnancy|0|||
27683270|NCT00663702|80675919|FG001|Overall Study|Pregnancy|1|||
27683271|NCT00663702|80675918|FG000|Overall Study|Lost to Follow-up|3|||
27683272|NCT00663702|80675919|FG001|Overall Study|Lost to Follow-up|0|||
27683273|NCT00663702|80675918|FG000|Overall Study|Death|1|||
27683274|NCT00663702|80675919|FG001|Overall Study|Death|1|||
27683275|NCT00663702|80675918|FG000|Overall Study|Lack of Efficacy|3|||
27683276|NCT00663702|80675919|FG001|Overall Study|Lack of Efficacy|3|||
27683277|NCT00022659|80675920|FG000|Overall Study|Ineligible: wrong primary|1|||
27683278|NCT00022659|80675920|FG000|Overall Study|Never treated|1|||
27683279|NCT02559895|80675925|FG000|Overall Study|Adverse Event|3|||
27683280|NCT02559895|80675926|FG001|Overall Study|Adverse Event|3|||
27683281|NCT02559895|80675927|FG002|Overall Study|Adverse Event|2|||
27683282|NCT02559895|80675928|FG003|Overall Study|Adverse Event|1|||
27683283|NCT02559895|80675925|FG000|Overall Study|Lack of Efficacy|2|||
27683284|NCT02559895|80675926|FG001|Overall Study|Lack of Efficacy|3|||
27683285|NCT02559895|80675927|FG002|Overall Study|Lack of Efficacy|2|||
27683286|NCT02559895|80675928|FG003|Overall Study|Lack of Efficacy|8|||
27683287|NCT02559895|80675925|FG000|Overall Study|Lost to Follow-up|22|||
27683288|NCT02559895|80675926|FG001|Overall Study|Lost to Follow-up|16|||
27683289|NCT02559895|80675927|FG002|Overall Study|Lost to Follow-up|12|||
27683290|NCT02559895|80675928|FG003|Overall Study|Lost to Follow-up|17|||
27683291|NCT02559895|80675925|FG000|Overall Study|Physician Decision|1|||
27683292|NCT02559895|80675926|FG001|Overall Study|Physician Decision|1|||
27683293|NCT02559895|80675927|FG002|Overall Study|Physician Decision|3|||
27683294|NCT02559895|80675928|FG003|Overall Study|Physician Decision|0|||
27683295|NCT02559895|80675925|FG000|Overall Study|Withdrawal by Subject|16|||
27683296|NCT02559895|80675926|FG001|Overall Study|Withdrawal by Subject|9|||
27683297|NCT02559895|80675927|FG002|Overall Study|Withdrawal by Subject|20|||
27683298|NCT02559895|80675928|FG003|Overall Study|Withdrawal by Subject|9|||
27683299|NCT02559895|80675925|FG000|Overall Study|Study Burden|10|||
27683300|NCT02559895|80675926|FG001|Overall Study|Study Burden|16|||
27683301|NCT02559895|80675927|FG002|Overall Study|Study Burden|12|||
28002774|NCT01176032|81842295|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
28002775|NCT01176032|81842294|FG000|Overall Study|Protocol Violation|1|||
28002776|NCT01176032|81842295|FG001|Overall Study|Protocol Violation|0|||
28002777|NCT01176032|81842294|FG000|Overall Study|Informed consent withdrawn|3|||
28002778|NCT01176032|81842295|FG001|Overall Study|Informed consent withdrawn|0|||
28002779|NCT01176032|81842294|FG000|Overall Study|Other|1|||
28002780|NCT01176032|81842295|FG001|Overall Study|Other|0|||
28002781|NCT01903460|81842296|FG000|Overall Study|Adverse Event|0|||
28002782|NCT01903460|81842297|FG001|Overall Study|Adverse Event|0|||
28002783|NCT01903460|81842298|FG002|Overall Study|Adverse Event|0|||
28002784|NCT01903460|81842299|FG003|Overall Study|Adverse Event|1|||
27683302|NCT02559895|80675928|FG003|Overall Study|Study Burden|22|||
28002785|NCT01428258|81842302|FG000|Intervention 1|Withdrawal by Subject|2|||
28002786|NCT01428258|81842303|FG001|Intervention 1|Withdrawal by Subject|0|||
27683303|NCT02559895|80675925|FG000|Overall Study|Other|1|||
27683304|NCT02559895|80675926|FG001|Overall Study|Other|5|||
27683305|NCT02559895|80675927|FG002|Overall Study|Other|3|||
27683306|NCT02559895|80675928|FG003|Overall Study|Other|3|||
27683307|NCT02304705|80675931|FG000|Overall Study|Withdrawal by Subject|2|||
27683308|NCT02304705|80675932|FG001|Overall Study|Withdrawal by Subject|0|||
27683309|NCT02304705|80675931|FG000|Overall Study|Physician Decision|2|||
27683310|NCT02304705|80675932|FG001|Overall Study|Physician Decision|4|||
27683311|NCT02304705|80675931|FG000|Overall Study|Death|0|||
28002787|NCT01469221|81842304|FG000|Double Blind Phase|Protocol Violation|1|||
28002788|NCT01469221|81842305|FG001|Double Blind Phase|Protocol Violation|0|||
28002789|NCT01469221|81842306|FG002|Double Blind Phase|Protocol Violation|0|||
28002790|NCT01469221|81842304|FG000|Double Blind Phase|Physician Decision|1|||
28002791|NCT01469221|81842305|FG001|Double Blind Phase|Physician Decision|1|||
28002792|NCT01469221|81842306|FG002|Double Blind Phase|Physician Decision|0|||
28002793|NCT01469221|81842304|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
28002794|NCT01469221|81842305|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
28002795|NCT01469221|81842306|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
28002796|NCT03309878|81842307|FG000|Overall Study|Adverse Event|1|||
28002797|NCT03309878|81842308|FG001|Overall Study|Adverse Event|0|||
27683312|NCT02304705|80675932|FG001|Overall Study|Death|1|||
27683313|NCT02304705|80675931|FG000|Overall Study|Lost to Follow-up|0|||
27683314|NCT02304705|80675932|FG001|Overall Study|Lost to Follow-up|2|||
27683315|NCT00867308|80675933|FG000|Overall Study|Death|1|||
27683316|NCT00867308|80675934|FG001|Overall Study|Death|0|||
27683317|NCT00867308|80675933|FG000|Overall Study|Adverse Event|1|||
27683318|NCT00867308|80675934|FG001|Overall Study|Adverse Event|4|||
27683319|NCT00867308|80675933|FG000|Overall Study|Lack of Efficacy|6|||
27683320|NCT00867308|80675934|FG001|Overall Study|Lack of Efficacy|12|||
27683321|NCT00867308|80675933|FG000|Overall Study|Withdrawal by Subject|1|||
27683322|NCT00867308|80675934|FG001|Overall Study|Withdrawal by Subject|2|||
27683323|NCT02476175|80675935|FG000|Overall Study|Adverse Event|2|||
27683324|NCT00929110|80675938|FG000|Overall Study|Adverse Event|40|||
27683325|NCT00929110|80675939|FG001|Overall Study|Adverse Event|29|||
27683326|NCT00929110|80675940|FG002|Overall Study|Adverse Event|18|||
27683327|NCT00929110|80675938|FG000|Overall Study|Subject withdrew consent|40|||
27683328|NCT00929110|80675939|FG001|Overall Study|Subject withdrew consent|23|||
27683329|NCT00929110|80675940|FG002|Overall Study|Subject withdrew consent|26|||
27683330|NCT00929110|80675938|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
27683331|NCT00929110|80675939|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
27683332|NCT00929110|80675940|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
27683333|NCT00929110|80675938|FG000|Overall Study|Lost to Follow-up|7|||
27683334|NCT00929110|80675939|FG001|Overall Study|Lost to Follow-up|7|||
27683335|NCT00929110|80675940|FG002|Overall Study|Lost to Follow-up|3|||
27683336|NCT00929110|80675938|FG000|Overall Study|Protocol deviation|5|||
27683337|NCT00929110|80675939|FG001|Overall Study|Protocol deviation|2|||
27683338|NCT00929110|80675940|FG002|Overall Study|Protocol deviation|4|||
27683339|NCT00929110|80675938|FG000|Overall Study|Administrative problems|4|||
27807040|NCT00686920|81123382|FG001|Overall Study|Withdrawal by Subject|5|||
27807041|NCT00686920|81123381|FG000|Overall Study|Protocol Violation|2|||
27807042|NCT00686920|81123382|FG001|Overall Study|Protocol Violation|1|||
27807043|NCT00686920|81123381|FG000|Overall Study|Adverse Event|10|||
27807044|NCT00686920|81123382|FG001|Overall Study|Adverse Event|2|||
28002798|NCT03309878|81842309|FG002|Overall Study|Adverse Event|0|||
28002799|NCT03309878|81842310|FG003|Overall Study|Adverse Event|0|||
28002800|NCT03309878|81842307|FG000|Overall Study|Did not maintain eligibility|2|||
28002801|NCT03309878|81842308|FG001|Overall Study|Did not maintain eligibility|1|||
28002802|NCT03309878|81842309|FG002|Overall Study|Did not maintain eligibility|0|||
28002803|NCT03309878|81842310|FG003|Overall Study|Did not maintain eligibility|0|||
28002804|NCT03309878|81842307|FG000|Overall Study|Withdrawal by Subject|0|||
28002805|NCT03309878|81842308|FG001|Overall Study|Withdrawal by Subject|1|||
28002806|NCT03309878|81842309|FG002|Overall Study|Withdrawal by Subject|0|||
28002807|NCT03309878|81842310|FG003|Overall Study|Withdrawal by Subject|0|||
28002808|NCT01724866|81842311|FG000|Overall Study|Adverse Event|0|||
28002809|NCT01724866|81842312|FG001|Overall Study|Adverse Event|0|||
28002810|NCT01724866|81842313|FG002|Overall Study|Adverse Event|1|||
28002811|NCT01724866|81842314|FG003|Overall Study|Adverse Event|1|||
28002812|NCT01724866|81842311|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
27807045|NCT00686920|81123381|FG000|Overall Study|Personal Reason|0|||
27807046|NCT00686920|81123382|FG001|Overall Study|Personal Reason|1|||
28002813|NCT01724866|81842312|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
28002814|NCT01724866|81842313|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
28002815|NCT01724866|81842314|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
28002816|NCT01724866|81842311|FG000|Overall Study|Investigator's Discretion|0|||
27683340|NCT00929110|80675939|FG001|Overall Study|Administrative problems|1|||
27683341|NCT00929110|80675940|FG002|Overall Study|Administrative problems|2|||
27683342|NCT00929110|80675938|FG000|Overall Study|Death|2|||
27683343|NCT00929110|80675939|FG001|Overall Study|Death|2|||
28002817|NCT01724866|81842312|FG001|Overall Study|Investigator's Discretion|1|||
28002818|NCT01724866|81842313|FG002|Overall Study|Investigator's Discretion|1|||
27683344|NCT00929110|80675940|FG002|Overall Study|Death|2|||
27683345|NCT00929110|80675938|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27683346|NCT00929110|80675939|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27807047|NCT00686920|81123381|FG000|Overall Study|Lost to Follow-up|15|||
27807048|NCT00686920|81123382|FG001|Overall Study|Lost to Follow-up|3|||
27807049|NCT00686920|81123381|FG000|Overall Study|Moved to Another State|1|||
27807050|NCT00686920|81123382|FG001|Overall Study|Moved to Another State|0|||
27807051|NCT00686920|81123381|FG000|Overall Study|Transferred to Nursing Home|1|||
27807052|NCT00686920|81123382|FG001|Overall Study|Transferred to Nursing Home|0|||
27807053|NCT00686920|81123381|FG000|Overall Study|Noncompliance|9|||
27807054|NCT00686920|81123382|FG001|Overall Study|Noncompliance|0|||
27807055|NCT00686920|81123381|FG000|Overall Study|Principal Investigator Decision|2|||
27807056|NCT00686920|81123382|FG001|Overall Study|Principal Investigator Decision|0|||
27807057|NCT03705351|81123383|FG000|Overall Study|Study termination|3|||
27807058|NCT03705351|81123383|FG000|Overall Study|Death|1|||
27874137|NCT00758524|81371644|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874138|NCT00758524|81371645|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874139|NCT00758524|81371646|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874140|NCT00758524|81371647|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874141|NCT00758524|81371648|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874142|NCT00758524|81371649|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874143|NCT00758524|81371650|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874144|NCT00758524|81371651|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874145|NCT00758524|81371652|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874146|NCT00758524|81371653|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874147|NCT00758524|81371654|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874148|NCT00758524|81371655|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874149|NCT00758524|81371656|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
27874150|NCT00758524|81371640|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874151|NCT00758524|81371641|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874152|NCT00758524|81371642|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874153|NCT00758524|81371643|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874154|NCT00758524|81371644|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874155|NCT00758524|81371645|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874156|NCT00758524|81371646|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874157|NCT00758524|81371647|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874158|NCT00758524|81371648|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
27874159|NCT00758524|81371649|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874160|NCT00758524|81371650|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874161|NCT00758524|81371651|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874162|NCT00758524|81371652|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874163|NCT00758524|81371653|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874164|NCT00758524|81371654|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874165|NCT00758524|81371655|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874166|NCT00758524|81371656|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
27874167|NCT00758524|81371640|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874168|NCT00758524|81371641|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874169|NCT00758524|81371642|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874170|NCT00758524|81371643|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874171|NCT00758524|81371644|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874172|NCT00758524|81371645|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874173|NCT00758524|81371646|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
27874174|NCT00758524|81371647|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874175|NCT00758524|81371648|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874176|NCT00758524|81371649|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874177|NCT00758524|81371650|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874178|NCT00758524|81371651|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874179|NCT00758524|81371652|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874180|NCT00758524|81371653|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874181|NCT00758524|81371654|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874182|NCT00758524|81371655|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874183|NCT00758524|81371656|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
27874184|NCT05048329|81371657|FG000|Overall Study|Withdrawal by Subject|1|||
27874185|NCT05048329|81371657|FG000|Overall Study|Screenfail|1|||
27874186|NCT01153815|81371663|FG000|Overall Study|Adverse Event|3|||
28002819|NCT01724866|81842314|FG003|Overall Study|Investigator's Discretion|0|||
27683347|NCT00929110|80675940|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27807059|NCT03705351|81123383|FG000|Overall Study|Lack of Efficacy|2|||
27807060|NCT03705351|81123383|FG000|Overall Study|Withdrawal by Subject|1|||
27807061|NCT00254397|81123386|FG000|Overall Study|Disease Progression|4|||
27874187|NCT01153815|81371664|FG001|Overall Study|Adverse Event|1|||
27874188|NCT01153815|81371663|FG000|Overall Study|Withdrawal by Subject|6|||
27874189|NCT01153815|81371664|FG001|Overall Study|Withdrawal by Subject|4|||
27874190|NCT01942993|81371673|FG000|Overall Study|Lost to Follow-up|1|||
27874191|NCT01942993|81371673|FG000|Overall Study|Physician Decision|1|||
28002820|NCT01724866|81842311|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
28002821|NCT01724866|81842312|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
27683348|NCT00929110|80675938|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27683349|NCT00929110|80675939|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27683350|NCT00929110|80675940|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27683351|NCT00929110|80675938|FG000|Overall Study|Patient inability to use the device|0|||
27683352|NCT00929110|80675939|FG001|Overall Study|Patient inability to use the device|1|||
27683353|NCT00929110|80675940|FG002|Overall Study|Patient inability to use the device|0|||
27683354|NCT00490724|80675941|FG000|Period I|Physician Decision|0|||
27683355|NCT00490724|80675942|FG001|Period I|Physician Decision|0|||
28002822|NCT01724866|81842313|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
27807062|NCT00254397|81123387|FG001|Overall Study|Disease Progression|1|||
27807063|NCT00254397|81123388|FG002|Overall Study|Disease Progression|16|||
27807064|NCT00254397|81123389|FG003|Overall Study|Disease Progression|23|||
27807065|NCT00254397|81123386|FG000|Overall Study|Non-Compliant|0|||
27807066|NCT00254397|81123387|FG001|Overall Study|Non-Compliant|0|||
27807067|NCT00254397|81123388|FG002|Overall Study|Non-Compliant|0|||
27807068|NCT00254397|81123389|FG003|Overall Study|Non-Compliant|1|||
27874192|NCT01894919|81371674|FG000|Overall Study|Withdrawal by Subject|1|||
27874193|NCT01894919|81371675|FG001|Overall Study|Withdrawal by Subject|0|||
28002823|NCT01724866|81842314|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
28002824|NCT01724866|81842311|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
28002825|NCT01724866|81842312|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
28002826|NCT01724866|81842313|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
28002827|NCT01724866|81842314|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
28002828|NCT00079040|81842315|FG000|Overall Study|Withdrew before treatment|1|||
28002829|NCT00079040|81842315|FG000|Overall Study|Ineligible|1|||
28002830|NCT02269124|81842316|FG000|Overall Study|Lost to Follow-up|1|||
28002831|NCT02269124|81842317|FG001|Overall Study|Lost to Follow-up|0|||
28002832|NCT02269124|81842316|FG000|Overall Study|Withdrawal by Subject|0|||
28002833|NCT02269124|81842317|FG001|Overall Study|Withdrawal by Subject|2|||
28002834|NCT02542865|81842320|FG000|Overall Study|Identified as screen failure|1|||
28002835|NCT02542865|81842321|FG001|Overall Study|Identified as screen failure|0|||
28002836|NCT02542865|81842320|FG000|Overall Study|Withdrawal by Subject|16|||
28002837|NCT02542865|81842321|FG001|Overall Study|Withdrawal by Subject|0|||
28002838|NCT00721396|81842323|FG000|Overall Study|Adverse Event|4|||
28002839|NCT00721396|81842324|FG001|Overall Study|Adverse Event|7|||
28002840|NCT00721396|81842325|FG002|Overall Study|Adverse Event|2|||
28002841|NCT00721396|81842326|FG003|Overall Study|Adverse Event|0|||
28002842|NCT00721396|81842323|FG000|Overall Study|Withdrawal by Subject|12|||
28002843|NCT00721396|81842324|FG001|Overall Study|Withdrawal by Subject|15|||
28002844|NCT00721396|81842325|FG002|Overall Study|Withdrawal by Subject|3|||
28002845|NCT00721396|81842326|FG003|Overall Study|Withdrawal by Subject|7|||
28002846|NCT00721396|81842323|FG000|Overall Study|Lost to Follow-up|7|||
27683356|NCT00490724|80675943|FG002|Period I|Physician Decision|1|||
27683357|NCT00490724|80675941|FG000|Period II|Treatment Discontinuation|3|||
27683358|NCT00490724|80675942|FG001|Period II|Treatment Discontinuation|1|||
27683359|NCT00490724|80675943|FG002|Period II|Treatment Discontinuation|3|||
27874194|NCT01894919|81371676|FG002|Overall Study|Withdrawal by Subject|0|||
27874195|NCT01894919|81371677|FG003|Overall Study|Withdrawal by Subject|0|||
27807069|NCT00254397|81123386|FG000|Overall Study|Adverse Event|2|||
28002847|NCT00721396|81842324|FG001|Overall Study|Lost to Follow-up|9|||
27807070|NCT00254397|81123387|FG001|Overall Study|Adverse Event|0|||
27807071|NCT00254397|81123388|FG002|Overall Study|Adverse Event|3|||
27874196|NCT01894919|81371678|FG004|Overall Study|Withdrawal by Subject|1|||
27874197|NCT01894919|81371679|FG005|Overall Study|Withdrawal by Subject|0|||
28002848|NCT00721396|81842325|FG002|Overall Study|Lost to Follow-up|3|||
28002849|NCT00721396|81842326|FG003|Overall Study|Lost to Follow-up|3|||
27807072|NCT00254397|81123389|FG003|Overall Study|Adverse Event|1|||
28002850|NCT00721396|81842323|FG000|Overall Study|Protocol Violation|4|||
28002851|NCT00721396|81842324|FG001|Overall Study|Protocol Violation|3|||
28002852|NCT00721396|81842325|FG002|Overall Study|Protocol Violation|1|||
28002853|NCT00721396|81842326|FG003|Overall Study|Protocol Violation|0|||
28002854|NCT00721396|81842323|FG000|Overall Study|Inappropriate enrollment|0|||
28002855|NCT00721396|81842324|FG001|Overall Study|Inappropriate enrollment|2|||
28002856|NCT00721396|81842325|FG002|Overall Study|Inappropriate enrollment|0|||
28002857|NCT00721396|81842326|FG003|Overall Study|Inappropriate enrollment|0|||
28002858|NCT00721396|81842323|FG000|Overall Study|Administrative reason|3|||
28002859|NCT00721396|81842324|FG001|Overall Study|Administrative reason|0|||
28002860|NCT00721396|81842325|FG002|Overall Study|Administrative reason|1|||
28002861|NCT00721396|81842326|FG003|Overall Study|Administrative reason|0|||
28002862|NCT03798717|81842339|FG000|Overall Study|Failed Screening|0|||
27683360|NCT00626197|80675944|FG000|Overall Study|Did not cooperate|2|||
27683361|NCT00626197|80675945|FG001|Overall Study|Did not cooperate|6|||
27683362|NCT00626197|80675946|FG002|Overall Study|Did not cooperate|1|||
27683363|NCT00626197|80675944|FG000|Overall Study|Failure to return|6|||
27807073|NCT01388647|81123390|FG000|Overall Study|Adverse Event|1|||
27807074|NCT01388647|81123391|FG001|Overall Study|Adverse Event|2|||
27807075|NCT00289458|81123392|FG000|Overall Study|Death|1|||
27807076|NCT00289458|81123393|FG001|Overall Study|Death|0|||
27807077|NCT00289458|81123394|FG002|Overall Study|Death|0|||
27807078|NCT00289458|81123392|FG000|Overall Study|Physician Decision|3|||
27807079|NCT00289458|81123393|FG001|Overall Study|Physician Decision|4|||
27807080|NCT00289458|81123394|FG002|Overall Study|Physician Decision|2|||
27807081|NCT00289458|81123392|FG000|Overall Study|Withdrawal by Subject|2|||
27807082|NCT00289458|81123393|FG001|Overall Study|Withdrawal by Subject|2|||
27807083|NCT00289458|81123394|FG002|Overall Study|Withdrawal by Subject|4|||
27807084|NCT02598193|81123397|FG000|Overall Study|Adverse Event|13|||
27807085|NCT02598193|81123397|FG000|Overall Study|Withdrawal by Subject|1|||
27807086|NCT02598193|81123397|FG000|Overall Study|Listed in active lung transplant list|1|||
27807087|NCT02598193|81123397|FG000|Overall Study|Does not want to take Nintedanib|1|||
27807088|NCT03111147|81123399|FG000|Overall Study|Lost to Follow-up|2|||
27807089|NCT03111147|81123400|FG001|Overall Study|Lost to Follow-up|5|||
27807090|NCT03111147|81123399|FG000|Overall Study|Withdrawal by Subject|4|||
27807091|NCT03111147|81123400|FG001|Overall Study|Withdrawal by Subject|3|||
27807092|NCT03111147|81123399|FG000|Overall Study|Protocol Violation|2|||
27807093|NCT03111147|81123400|FG001|Overall Study|Protocol Violation|1|||
27807094|NCT03111147|81123399|FG000|Overall Study|Death|1|||
27807095|NCT03111147|81123400|FG001|Overall Study|Death|1|||
27807096|NCT01965535|81123415|FG000|Overall Study|Lack of Efficacy|2|||
27807097|NCT01965535|81123416|FG001|Overall Study|Lack of Efficacy|1|||
27807098|NCT00326885|81123417|FG000|Overall Study|Adverse Event|1|||
27807099|NCT00326885|81123417|FG000|Overall Study|Withdrawal by Subject|3|||
27807100|NCT00326885|81123417|FG000|Overall Study|Physician Decision|1|||
27807101|NCT00326885|81123417|FG000|Overall Study|Hospice withdrew consent|2|||
27807102|NCT01859390|81123419|FG000|Overall Study|Insufficient Sputum Collected|1|||
27807103|NCT01859390|81123420|FG001|Overall Study|Insufficient Sputum Collected|3|||
27807104|NCT01859390|81123419|FG000|Overall Study|Sample Missing Collection Date|0|||
27807105|NCT01859390|81123420|FG001|Overall Study|Sample Missing Collection Date|1|||
27807106|NCT01859390|81123419|FG000|Overall Study|Tube Cracked|0|||
27807107|NCT01859390|81123420|FG001|Overall Study|Tube Cracked|2|||
27807108|NCT01859390|81123419|FG000|Overall Study|Shipment Error|0|||
27807109|NCT01859390|81123420|FG001|Overall Study|Shipment Error|1|||
27874198|NCT01894919|81371680|FG006|Overall Study|Withdrawal by Subject|0|||
27874199|NCT01894919|81371681|FG007|Overall Study|Withdrawal by Subject|0|||
27874200|NCT01894919|81371682|FG008|Overall Study|Withdrawal by Subject|0|||
28002863|NCT03798717|81842340|FG001|Overall Study|Failed Screening|0|||
27683364|NCT00626197|80675945|FG001|Overall Study|Failure to return|5|||
27683365|NCT00626197|80675946|FG002|Overall Study|Failure to return|6|||
27683366|NCT00626197|80675944|FG000|Overall Study|Adverse event, serious fatal|3|||
28002864|NCT03798717|81842341|FG002|Overall Study|Failed Screening|0|||
27683367|NCT00626197|80675945|FG001|Overall Study|Adverse event, serious fatal|6|||
27807110|NCT04335110|81123421|FG000|Overall Study|Withdrawal by Subject|1|||
27807111|NCT04335110|81123422|FG001|Overall Study|Withdrawal by Subject|1|||
27807112|NCT04335110|81123421|FG000|Overall Study|Death|0|||
27807113|NCT04335110|81123422|FG001|Overall Study|Death|1|||
27807114|NCT01783496|81123425|FG000|Overall Study|Lost to Follow-up|0|||
27807115|NCT01783496|81123426|FG001|Overall Study|Lost to Follow-up|0|||
27807116|NCT01783496|81123427|FG002|Overall Study|Lost to Follow-up|0|||
27874201|NCT01894919|81371683|FG009|Overall Study|Withdrawal by Subject|1|||
27807117|NCT01783496|81123428|FG003|Overall Study|Lost to Follow-up|2|||
27807118|NCT01783496|81123429|FG004|Overall Study|Lost to Follow-up|0|||
27807119|NCT01783496|81123430|FG005|Overall Study|Lost to Follow-up|1|||
27807120|NCT01783496|81123425|FG000|Overall Study|Withdrawal by Subject|1|||
27807121|NCT01783496|81123426|FG001|Overall Study|Withdrawal by Subject|0|||
28002865|NCT03798717|81842342|FG003|Overall Study|Failed Screening|0|||
28002866|NCT03798717|81842343|FG004|Overall Study|Failed Screening|0|||
27807122|NCT01783496|81123427|FG002|Overall Study|Withdrawal by Subject|0|||
27807123|NCT01783496|81123428|FG003|Overall Study|Withdrawal by Subject|0|||
27807124|NCT01783496|81123429|FG004|Overall Study|Withdrawal by Subject|0|||
27807125|NCT01783496|81123430|FG005|Overall Study|Withdrawal by Subject|0|||
27807126|NCT01512979|81123431|FG000|Overall Study|Adverse Event|2|||
27807127|NCT01512979|81123432|FG001|Overall Study|Adverse Event|2|||
27807128|NCT01512979|81123431|FG000|Overall Study|Protocol Violation|1|||
27807129|NCT01512979|81123432|FG001|Overall Study|Protocol Violation|4|||
27807130|NCT01512979|81123431|FG000|Overall Study|Lost to Follow-up|2|||
27807131|NCT01512979|81123432|FG001|Overall Study|Lost to Follow-up|5|||
27807132|NCT01512979|81123431|FG000|Overall Study|Withdrawal by Subject|1|||
27807133|NCT01512979|81123432|FG001|Overall Study|Withdrawal by Subject|2|||
27807134|NCT01512979|81123431|FG000|Overall Study|Reason other than stated above|13|||
27807135|NCT01512979|81123432|FG001|Overall Study|Reason other than stated above|9|||
27807136|NCT03763331|81123434|FG000|Overall Study|Lost to Follow-up|1|||
27807137|NCT03763331|81123435|FG001|Overall Study|Lost to Follow-up|0|||
27807138|NCT03763331|81123434|FG000|Overall Study|Withdrawal by Subject|1|||
27807139|NCT03763331|81123435|FG001|Overall Study|Withdrawal by Subject|0|||
27807140|NCT03763331|81123434|FG000|Overall Study|Non-compliance|0|||
27807141|NCT03763331|81123435|FG001|Overall Study|Non-compliance|3|||
27807142|NCT03016078|81123438|FG000|Overall Study|Protocol Violation|1|||
27807143|NCT03016078|81123438|FG000|Overall Study|Protocol Violation|1|||
27807144|NCT02360397|81123439|FG000|Overall Study|Incomplete screening|3|||
27807145|NCT02360397|81123439|FG000|Overall Study|Adverse Event|1|||
27807146|NCT00707174|81123440|FG000|Overall Study|Adverse Event|1|||
27807147|NCT00707174|81123441|FG001|Overall Study|Adverse Event|6|||
27807148|NCT00707174|81123440|FG000|Overall Study|Withdrawal by Subject|4|||
27807149|NCT00707174|81123441|FG001|Overall Study|Withdrawal by Subject|1|||
27807150|NCT01312779|81123442|FG000|Overall Study|Withdrawal by Subject|2|||
27807151|NCT01312779|81123442|FG000|Overall Study|Death|3|||
27807152|NCT01312779|81123442|FG000|Overall Study|Not Implanted with Device|27|||
27807153|NCT01814137|81123443|FG000|Overall Study|Adverse Event|0|||
27807154|NCT01814137|81123444|FG001|Overall Study|Adverse Event|1|||
27807155|NCT01814137|81123443|FG000|Overall Study|Withdrawal by Subject|2|||
27807156|NCT01814137|81123444|FG001|Overall Study|Withdrawal by Subject|2|||
27807157|NCT01814137|81123443|FG000|Overall Study|Physician Decision|1|||
27807158|NCT01814137|81123444|FG001|Overall Study|Physician Decision|1|||
27807159|NCT01814137|81123443|FG000|Overall Study|Unclassified|2|||
27807160|NCT01814137|81123444|FG001|Overall Study|Unclassified|1|||
27807161|NCT01965652|81123445|FG000|Overall Study|Adverse Event|40|||
27807162|NCT01965652|81123446|FG001|Overall Study|Adverse Event|37|||
28002867|NCT03798717|81842344|FG005|Overall Study|Failed Screening|1|||
28002868|NCT03798717|81842339|FG000|Overall Study|Physician Decision|1|||
28002869|NCT03798717|81842340|FG001|Overall Study|Physician Decision|0|||
28002870|NCT03798717|81842341|FG002|Overall Study|Physician Decision|1|||
27807163|NCT01965652|81123445|FG000|Overall Study|Withdrawal by Subject|62|||
27807164|NCT01965652|81123446|FG001|Overall Study|Withdrawal by Subject|69|||
27807165|NCT01965652|81123445|FG000|Overall Study|Lost to Follow-up|53|||
27874202|NCT01894919|81371684|FG010|Overall Study|Withdrawal by Subject|1|||
27584281|NCT00023673|80319238|FG000|Overall Study|Patient withdrew consent|0|||
27584282|NCT00023673|80319239|FG001|Overall Study|Patient withdrew consent|0|||
27874203|NCT01894919|81371685|FG011|Overall Study|Withdrawal by Subject|0|||
28002871|NCT03798717|81842342|FG003|Overall Study|Physician Decision|0|||
28002872|NCT03798717|81842343|FG004|Overall Study|Physician Decision|0|||
28002873|NCT03798717|81842344|FG005|Overall Study|Physician Decision|0|||
28002874|NCT03798717|81842339|FG000|Overall Study|Withdrawal by Subject|0|||
28002875|NCT03798717|81842340|FG001|Overall Study|Withdrawal by Subject|0|||
28002876|NCT03798717|81842341|FG002|Overall Study|Withdrawal by Subject|0|||
28002877|NCT03798717|81842342|FG003|Overall Study|Withdrawal by Subject|1|||
28002878|NCT03798717|81842343|FG004|Overall Study|Withdrawal by Subject|0|||
28002879|NCT03798717|81842344|FG005|Overall Study|Withdrawal by Subject|0|||
28002880|NCT03798717|81842339|FG000|Overall Study|Lost to Follow-up|1|||
28002881|NCT03798717|81842340|FG001|Overall Study|Lost to Follow-up|0|||
28002882|NCT03798717|81842341|FG002|Overall Study|Lost to Follow-up|0|||
28002883|NCT03798717|81842342|FG003|Overall Study|Lost to Follow-up|1|||
28002884|NCT03798717|81842343|FG004|Overall Study|Lost to Follow-up|0|||
28002885|NCT03798717|81842344|FG005|Overall Study|Lost to Follow-up|0|||
28002886|NCT03798717|81842339|FG000|Overall Study|Adverse Event|0|||
27584283|NCT00023673|80319240|FG002|Overall Study|Patient withdrew consent|0|||
27807166|NCT01965652|81123446|FG001|Overall Study|Lost to Follow-up|40|||
27807167|NCT01965652|81123445|FG000|Overall Study|Protocol Violation|34|||
27807168|NCT01965652|81123446|FG001|Overall Study|Protocol Violation|38|||
27807169|NCT01965652|81123445|FG000|Overall Study|Death|3|||
27584284|NCT00023673|80319241|FG003|Overall Study|Patient withdrew consent|1|||
27807170|NCT01965652|81123446|FG001|Overall Study|Death|4|||
27807171|NCT01965652|81123445|FG000|Overall Study|Other - Miscellaneous|18|||
27807172|NCT01965652|81123446|FG001|Overall Study|Other - Miscellaneous|21|||
28002887|NCT03798717|81842340|FG001|Overall Study|Adverse Event|1|||
28002888|NCT03798717|81842341|FG002|Overall Study|Adverse Event|0|||
27807173|NCT01965652|81123445|FG000|Overall Study|Pregnancy|0|||
27807174|NCT01965652|81123446|FG001|Overall Study|Pregnancy|1|||
27807175|NCT02094937|81123447|FG000|8 Weeks in Period 1|Adverse Event|9|||
27807176|NCT02094937|81123448|FG001|8 Weeks in Period 1|Adverse Event|0|||
27807177|NCT02094937|81123449|FG002|8 Weeks in Period 1|Adverse Event|0|||
27807178|NCT02094937|81123450|FG003|8 Weeks in Period 1|Adverse Event|0|||
27807179|NCT02094937|81123447|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
27807180|NCT02094937|81123448|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
27807181|NCT02094937|81123449|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
27807182|NCT02094937|81123450|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
27807183|NCT02094937|81123447|FG000|8 Weeks in Period 1|Protocol Violation|2|||
27807184|NCT02094937|81123448|FG001|8 Weeks in Period 1|Protocol Violation|0|||
27807185|NCT02094937|81123449|FG002|8 Weeks in Period 1|Protocol Violation|0|||
27807186|NCT02094937|81123450|FG003|8 Weeks in Period 1|Protocol Violation|0|||
27807187|NCT02094937|81123447|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
27807188|NCT02094937|81123448|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
27807189|NCT02094937|81123449|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
27807190|NCT02094937|81123450|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
27807191|NCT02094937|81123447|FG000|8 Weeks in Period 1|Physician Decision|1|||
27807192|NCT02094937|81123448|FG001|8 Weeks in Period 1|Physician Decision|0|||
27807193|NCT02094937|81123449|FG002|8 Weeks in Period 1|Physician Decision|0|||
27807194|NCT02094937|81123450|FG003|8 Weeks in Period 1|Physician Decision|0|||
27807195|NCT02094937|81123447|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
27807196|NCT02094937|81123448|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
27807197|NCT02094937|81123449|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
27807198|NCT02094937|81123450|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
27807199|NCT02094937|81123447|FG000|12 Weeks in Period 2|Adverse Event|0|||
27807200|NCT02094937|81123448|FG001|12 Weeks in Period 2|Adverse Event|2|||
27807201|NCT02094937|81123449|FG002|12 Weeks in Period 2|Adverse Event|4|||
27807202|NCT02094937|81123450|FG003|12 Weeks in Period 2|Adverse Event|1|||
27807203|NCT02094937|81123447|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
27807204|NCT02094937|81123448|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
27807205|NCT02094937|81123449|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
27807206|NCT02094937|81123450|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
27807207|NCT02094937|81123447|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
27807208|NCT02094937|81123448|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
27807209|NCT02094937|81123449|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
27807210|NCT02094937|81123450|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
27807211|NCT02094937|81123447|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
27807212|NCT02094937|81123448|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
27807213|NCT02094937|81123449|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
27807214|NCT02094937|81123450|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
27807215|NCT02094937|81123447|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
27807216|NCT02094937|81123448|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
27807217|NCT02094937|81123449|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
27807218|NCT02094937|81123450|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
27807219|NCT05017493|81123454|FG000|Overall Study|Withdrawal by Subject|26|||
27807220|NCT05017493|81123455|FG001|Overall Study|Withdrawal by Subject|0|||
27807221|NCT05017493|81123454|FG000|Overall Study|Physician Decision|15|||
27807222|NCT05017493|81123455|FG001|Overall Study|Physician Decision|0|||
27807223|NCT05017493|81123454|FG000|Overall Study|Protocol Violation|81|||
27807224|NCT05017493|81123455|FG001|Overall Study|Protocol Violation|0|||
27807225|NCT01907737|81123456|FG000|Overall Study|Withdrawal by Subject|1|||
27807226|NCT02965820|81127040|FG000|Period 2, Second 30 Days|Adverse Event|1|||
27807227|NCT02965820|81127041|FG001|Period 2, Second 30 Days|Adverse Event|1|||
27807228|NCT02151461|81127047|FG000|Overall Study|Adverse Event|5|||
27807229|NCT02151461|81127048|FG001|Overall Study|Adverse Event|1|||
27807230|NCT02151461|81127049|FG002|Overall Study|Adverse Event|0|||
27807231|NCT02151461|81127050|FG003|Overall Study|Adverse Event|2|||
27807232|NCT02151461|81127047|FG000|Overall Study|Lost to Follow-up|0|||
27807233|NCT02151461|81127048|FG001|Overall Study|Lost to Follow-up|0|||
27807234|NCT02151461|81127049|FG002|Overall Study|Lost to Follow-up|1|||
27807235|NCT02151461|81127050|FG003|Overall Study|Lost to Follow-up|1|||
28002889|NCT03798717|81842342|FG003|Overall Study|Adverse Event|0|||
28002890|NCT03798717|81842343|FG004|Overall Study|Adverse Event|0|||
27807236|NCT02151461|81127047|FG000|Overall Study|Withdrawal by Subject|1|||
27807237|NCT02151461|81127048|FG001|Overall Study|Withdrawal by Subject|0|||
27807238|NCT02151461|81127049|FG002|Overall Study|Withdrawal by Subject|1|||
27807239|NCT02151461|81127050|FG003|Overall Study|Withdrawal by Subject|1|||
27807240|NCT02151461|81127047|FG000|Overall Study|Treatment discontinuation|0|||
27807241|NCT02151461|81127048|FG001|Overall Study|Treatment discontinuation|0|||
27807242|NCT02151461|81127049|FG002|Overall Study|Treatment discontinuation|1|||
27807243|NCT02151461|81127050|FG003|Overall Study|Treatment discontinuation|0|||
27807244|NCT01169649|81127051|FG000|Overall Study|Patient Not Treated|3|||
28002891|NCT03798717|81842344|FG005|Overall Study|Adverse Event|0|||
27807245|NCT00576199|81127052|FG000|Overall Study|Adverse Event|12|||
27807246|NCT00576199|81127052|FG000|Overall Study|Insufficient Therapeutic Response|14|||
27807247|NCT00576199|81127052|FG000|Overall Study|Refused Treatment|2|||
27807248|NCT00576199|81127052|FG000|Overall Study|Reason Unspecified|2|||
27807249|NCT01580020|81127057|FG000|Overall Study|Lack of Efficacy|0|||
27807250|NCT01580020|81127058|FG001|Overall Study|Lack of Efficacy|5|||
27807251|NCT01580020|81127059|FG002|Overall Study|Lack of Efficacy|0|||
27807252|NCT01580020|81127060|FG003|Overall Study|Lack of Efficacy|1|||
27807253|NCT01580020|81127057|FG000|Overall Study|Withdrawal by Subject|0|||
27807254|NCT01580020|81127058|FG001|Overall Study|Withdrawal by Subject|1|||
27807255|NCT01580020|81127059|FG002|Overall Study|Withdrawal by Subject|1|||
27807256|NCT01580020|81127060|FG003|Overall Study|Withdrawal by Subject|0|||
27807257|NCT01580020|81127057|FG000|Overall Study|Adverse Event|1|||
27807258|NCT01580020|81127058|FG001|Overall Study|Adverse Event|1|||
27807259|NCT01580020|81127059|FG002|Overall Study|Adverse Event|1|||
27807260|NCT01580020|81127060|FG003|Overall Study|Adverse Event|1|||
27807261|NCT01580020|81127057|FG000|Overall Study|Administrative Problems|0|||
27807262|NCT01580020|81127058|FG001|Overall Study|Administrative Problems|0|||
27807263|NCT01580020|81127059|FG002|Overall Study|Administrative Problems|1|||
27807264|NCT01580020|81127060|FG003|Overall Study|Administrative Problems|0|||
27807265|NCT01580020|81127057|FG000|Overall Study|Lost to Follow-up|0|||
27807266|NCT01580020|81127058|FG001|Overall Study|Lost to Follow-up|0|||
27807267|NCT01580020|81127059|FG002|Overall Study|Lost to Follow-up|1|||
27807268|NCT01580020|81127060|FG003|Overall Study|Lost to Follow-up|0|||
27807269|NCT00876733|81127061|FG000|Overall Study|Adverse Event|34|||
27807270|NCT00876733|81127062|FG001|Overall Study|Adverse Event|20|||
27807271|NCT00876733|81127063|FG002|Overall Study|Adverse Event|10|||
27807272|NCT00876733|81127064|FG003|Overall Study|Adverse Event|3|||
27807273|NCT00876733|81127061|FG000|Overall Study|Lack of Efficacy|17|||
27807274|NCT00876733|81127062|FG001|Overall Study|Lack of Efficacy|9|||
27807275|NCT00876733|81127063|FG002|Overall Study|Lack of Efficacy|10|||
27807276|NCT00876733|81127064|FG003|Overall Study|Lack of Efficacy|1|||
27807277|NCT00876733|81127061|FG000|Overall Study|Lost to Follow-up|26|||
27807278|NCT00876733|81127062|FG001|Overall Study|Lost to Follow-up|10|||
27807279|NCT00876733|81127063|FG002|Overall Study|Lost to Follow-up|3|||
27807280|NCT00876733|81127064|FG003|Overall Study|Lost to Follow-up|2|||
27807281|NCT00876733|81127061|FG000|Overall Study|Data not available|14|||
27807282|NCT00876733|81127062|FG001|Overall Study|Data not available|3|||
27807283|NCT00876733|81127063|FG002|Overall Study|Data not available|7|||
27807284|NCT00876733|81127064|FG003|Overall Study|Data not available|1|||
27807285|NCT03990389|81127069|FG000|Overall Study|Lost to Follow-up|3|||
27807286|NCT03990389|81127070|FG001|Overall Study|Lost to Follow-up|0|||
27807287|NCT00481247|81127071|FG000|Overall Study|Death|0|||
27807288|NCT00481247|81127072|FG001|Overall Study|Death|1|||
27807289|NCT00481247|81127071|FG000|Overall Study|Disease progression|18|||
27807290|NCT00481247|81127072|FG001|Overall Study|Disease progression|22|||
27807291|NCT00481247|81127071|FG000|Overall Study|Intolerance|42|||
27807292|NCT00481247|81127072|FG001|Overall Study|Intolerance|17|||
27807293|NCT00481247|81127071|FG000|Overall Study|Treatment failure|10|||
27807294|NCT00481247|81127072|FG001|Overall Study|Treatment failure|14|||
27807295|NCT00481247|81127071|FG000|Overall Study|AE unrelated to study drug|13|||
27807296|NCT00481247|81127072|FG001|Overall Study|AE unrelated to study drug|4|||
27807297|NCT00481247|81127071|FG000|Overall Study|Withdrawal by Subject|8|||
27807298|NCT00481247|81127072|FG001|Overall Study|Withdrawal by Subject|13|||
27807299|NCT00481247|81127071|FG000|Overall Study|Pregnancy|2|||
27807300|NCT00481247|81127072|FG001|Overall Study|Pregnancy|1|||
28002892|NCT03798717|81842339|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28002893|NCT03798717|81842340|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28002894|NCT03798717|81842341|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28002895|NCT03798717|81842342|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28002896|NCT03798717|81842343|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
28002897|NCT03798717|81842344|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
28002898|NCT00551759|81842345|FG000|Overall Study|Adverse Event|7|||
28002899|NCT00551759|81842345|FG000|Overall Study|Death|5|||
28002900|NCT00551759|81842345|FG000|Overall Study|Ineligible|1|||
28002901|NCT00857285|81842346|FG000|Overall Study|Adverse Event|4|||
28002902|NCT00857285|81842347|FG001|Overall Study|Adverse Event|2|||
27807301|NCT00481247|81127071|FG000|Overall Study|Lost to Follow-up|1|||
27807302|NCT00481247|81127072|FG001|Overall Study|Lost to Follow-up|2|||
27807303|NCT00481247|81127071|FG000|Overall Study|Poor compliance/noncompliance|1|||
27807304|NCT00481247|81127072|FG001|Overall Study|Poor compliance/noncompliance|7|||
27807305|NCT00481247|81127071|FG000|Overall Study|Administrative reason by sponsor|157|||
27807306|NCT00481247|81127072|FG001|Overall Study|Administrative reason by sponsor|162|||
28002903|NCT00857285|81842346|FG000|Overall Study|Lack of Efficacy|0|||
27807307|NCT00481247|81127071|FG000|Overall Study|Varied|6|||
27807308|NCT00481247|81127072|FG001|Overall Study|Varied|15|||
27807309|NCT00481247|81127071|FG000|Overall Study|Did not receive treatment|1|||
27807310|NCT00481247|81127072|FG001|Overall Study|Did not receive treatment|2|||
27807311|NCT00673790|81127079|FG000|Overall Study|Adverse Event|23|||
28002904|NCT00857285|81842347|FG001|Overall Study|Lack of Efficacy|2|||
28002905|NCT00857285|81842346|FG000|Overall Study|Protocol Violation|3|||
28002906|NCT00857285|81842347|FG001|Overall Study|Protocol Violation|1|||
28002907|NCT00857285|81842346|FG000|Overall Study|Withdrawal by Subject|4|||
28002908|NCT00857285|81842347|FG001|Overall Study|Withdrawal by Subject|0|||
28002909|NCT00857285|81842346|FG000|Overall Study|Randomization criteria not met|1|||
28002910|NCT00857285|81842347|FG001|Overall Study|Randomization criteria not met|1|||
28002911|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
28002912|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
28002913|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
27683368|NCT00626197|80675946|FG002|Overall Study|Adverse event, serious fatal|6|||
27807312|NCT00673790|81127080|FG001|Overall Study|Adverse Event|14|||
27807313|NCT00673790|81127081|FG002|Overall Study|Adverse Event|2|||
27807314|NCT00673790|81127079|FG000|Overall Study|Lack of Efficacy|2|||
27807315|NCT00673790|81127080|FG001|Overall Study|Lack of Efficacy|2|||
27807316|NCT00673790|81127081|FG002|Overall Study|Lack of Efficacy|2|||
27807317|NCT00673790|81127079|FG000|Overall Study|Protocol Violation|6|||
27807318|NCT00673790|81127080|FG001|Overall Study|Protocol Violation|9|||
27807319|NCT00673790|81127081|FG002|Overall Study|Protocol Violation|1|||
27807320|NCT00673790|81127079|FG000|Overall Study|Withdrawal by Subject|7|||
27807321|NCT00673790|81127080|FG001|Overall Study|Withdrawal by Subject|4|||
27807322|NCT00673790|81127081|FG002|Overall Study|Withdrawal by Subject|1|||
27807323|NCT00673790|81127079|FG000|Overall Study|Lost to Follow-up|6|||
27807324|NCT00673790|81127080|FG001|Overall Study|Lost to Follow-up|6|||
27807325|NCT00673790|81127081|FG002|Overall Study|Lost to Follow-up|5|||
27807326|NCT00673790|81127079|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
27807327|NCT00673790|81127080|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
27807328|NCT00673790|81127081|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
27807329|NCT00673790|81127079|FG000|Overall Study|Poor compliance|1|||
27807330|NCT00673790|81127080|FG001|Overall Study|Poor compliance|0|||
27807331|NCT00673790|81127081|FG002|Overall Study|Poor compliance|0|||
27807332|NCT00673790|81127079|FG000|Overall Study|Participated in two Nebivolol studies|0|||
27807333|NCT00673790|81127080|FG001|Overall Study|Participated in two Nebivolol studies|0|||
27807334|NCT00673790|81127081|FG002|Overall Study|Participated in two Nebivolol studies|1|||
27807335|NCT00673790|81127079|FG000|Overall Study|Unconfirmed pregnancy|0|||
27807336|NCT00673790|81127080|FG001|Overall Study|Unconfirmed pregnancy|1|||
27807337|NCT00673790|81127081|FG002|Overall Study|Unconfirmed pregnancy|0|||
27807338|NCT00673790|81127079|FG000|Overall Study|Randomization criteria not met|0|||
27807339|NCT00673790|81127080|FG001|Overall Study|Randomization criteria not met|1|||
27807340|NCT00673790|81127081|FG002|Overall Study|Randomization criteria not met|0|||
27807341|NCT01446913|81127083|FG000|Overall Study|Significant illness|1|||
27807342|NCT01446913|81127084|FG001|Overall Study|Significant illness|1|||
27807343|NCT01446913|81127085|FG002|Overall Study|Significant illness|1|||
27807344|NCT01446913|81127083|FG000|Overall Study|Withdrawal by Subject|5|||
27807345|NCT01446913|81127084|FG001|Overall Study|Withdrawal by Subject|3|||
27807346|NCT01446913|81127085|FG002|Overall Study|Withdrawal by Subject|5|||
27807347|NCT01446913|81127083|FG000|Overall Study|Physician Decision|0|||
27807348|NCT01446913|81127084|FG001|Overall Study|Physician Decision|0|||
27807349|NCT01446913|81127085|FG002|Overall Study|Physician Decision|2|||
27807350|NCT01446913|81127083|FG000|Overall Study|Lost to Follow-up|3|||
27807351|NCT01446913|81127084|FG001|Overall Study|Lost to Follow-up|5|||
27807352|NCT01446913|81127085|FG002|Overall Study|Lost to Follow-up|3|||
27807353|NCT00450216|81127089|FG000|Overall Study|Adverse Event|38|||
27807354|NCT00450216|81127090|FG001|Overall Study|Adverse Event|23|||
27807355|NCT00450216|81127089|FG000|Overall Study|Withdrawal by Subject|48|||
27807356|NCT00450216|81127090|FG001|Overall Study|Withdrawal by Subject|26|||
27807357|NCT00450216|81127089|FG000|Overall Study|Lost to Follow-up|16|||
27807358|NCT00450216|81127090|FG001|Overall Study|Lost to Follow-up|9|||
27807359|NCT00450216|81127089|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
27807360|NCT00450216|81127090|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
27807361|NCT00450216|81127089|FG000|Overall Study|misc|21|||
27807362|NCT00450216|81127090|FG001|Overall Study|misc|20|||
27683369|NCT00626197|80675944|FG000|Overall Study|Adverse Event|1|||
27683370|NCT00626197|80675945|FG001|Overall Study|Adverse Event|1|||
27807363|NCT03433001|81127091|FG000|Overall Study|Lack of Efficacy|109|||
27807364|NCT03433001|81127091|FG000|Overall Study|Adverse Event|69|||
27807365|NCT03433001|81127091|FG000|Overall Study|Withdrawal by Subject|10|||
27807366|NCT03433001|81127091|FG000|Overall Study|Death|12|||
27807367|NCT03433001|81127091|FG000|Overall Study|Lost to Follow-up|4|||
27807368|NCT03433001|81127091|FG000|Overall Study|Other|25|||
27807369|NCT02400905|81127100|FG000|Overall Study|Death|24|||
27807370|NCT02400905|81127100|FG000|Overall Study|Lost to Follow-up|18|||
27807371|NCT02400905|81127100|FG000|Overall Study|Withdrawal by Subject|16|||
27807372|NCT02400905|81127100|FG000|Overall Study|Physician Decision|4|||
27807373|NCT02400905|81127100|FG000|Overall Study|Other|1|||
27874204|NCT01894919|81371686|FG012|Overall Study|Withdrawal by Subject|0|||
27874205|NCT01894919|81371674|FG000|Overall Study|Adverse Event|0|||
27874206|NCT01894919|81371675|FG001|Overall Study|Adverse Event|0|||
27874207|NCT01894919|81371676|FG002|Overall Study|Adverse Event|0|||
28002914|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
28002915|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
28002916|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
28002917|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
28002918|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
28002919|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
28002920|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
28002921|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
28002922|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
28002923|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
28002924|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
28002925|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
28002926|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
28002927|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
28002928|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
28002929|NCT03605667|81842348|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
28002930|NCT03605667|81842349|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
28002931|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
28002932|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
28002933|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Other|6|||
28002934|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Other|8|||
28002935|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
28002936|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
28002937|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
28002938|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
28002939|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
28002940|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
28002941|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
28002942|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
28002943|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
28002944|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
28002945|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
28002946|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
28002947|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Death|0|||
28002948|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Death|2|||
28002949|NCT03605667|81842348|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
28002950|NCT03605667|81842349|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
28002951|NCT01050634|81842350|FG000|Overall Study|Enrolled, but Not Treated|56|||
28002952|NCT01050634|81842350|FG000|Overall Study|Death|2|||
28002953|NCT01050634|81842350|FG000|Overall Study|Adverse Event|42|||
28002954|NCT01050634|81842350|FG000|Overall Study|Lost to Follow-up|2|||
28002955|NCT01050634|81842350|FG000|Overall Study|Other|21|||
28002956|NCT01050634|81842350|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
28002957|NCT01232868|81842351|FG000|Overall Study|Lost to Follow-up|2|||
28002958|NCT01232868|81842352|FG001|Overall Study|Lost to Follow-up|4|||
28002959|NCT00757237|81842353|FG000|Overall Study|Lost to Follow-up|0|||
28002960|NCT00757237|81842354|FG001|Overall Study|Lost to Follow-up|1|||
28002961|NCT00757237|81842353|FG000|Overall Study|Protocol Violation|0|||
28002962|NCT00757237|81842354|FG001|Overall Study|Protocol Violation|2|||
28002963|NCT00757237|81842353|FG000|Overall Study|Physician Decision|2|||
28002964|NCT00757237|81842354|FG001|Overall Study|Physician Decision|3|||
28002965|NCT00757237|81842353|FG000|Overall Study|Withdrawal by Subject|8|||
28002966|NCT00757237|81842354|FG001|Overall Study|Withdrawal by Subject|12|||
28002967|NCT00757237|81842353|FG000|Overall Study|Safety or Tolerability|3|||
28002968|NCT00757237|81842354|FG001|Overall Study|Safety or Tolerability|5|||
28002969|NCT00757237|81842353|FG000|Overall Study|Other|0|||
28002970|NCT00757237|81842354|FG001|Overall Study|Other|2|||
28002971|NCT01046565|81842359|FG000|Overall Study|Adverse Event|2|||
28002972|NCT01046565|81842359|FG000|Overall Study|Withdrawal by Subject|7|||
28002973|NCT00362648|81842360|FG000|Overall Study|Adverse Event|12|||
27807374|NCT03124381|81127101|FG000|Overall Study|Lost to Follow-up|1|||
27807375|NCT03124381|81127102|FG001|Overall Study|Lost to Follow-up|1|||
27807376|NCT03124381|81127101|FG000|Overall Study|Withdrawal by Subject|6|||
27807377|NCT03124381|81127102|FG001|Overall Study|Withdrawal by Subject|3|||
27807378|NCT03124381|81127101|FG000|Overall Study|Protocol Violation|0|||
27807379|NCT03124381|81127102|FG001|Overall Study|Protocol Violation|1|||
27807380|NCT03124381|81127101|FG000|Overall Study|Adverse Event|1|||
27807381|NCT03124381|81127102|FG001|Overall Study|Adverse Event|1|||
27807382|NCT03124381|81127101|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
27807383|NCT03124381|81127102|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
27807384|NCT02102490|81127106|FG000|Overall Study|Death|6|||
27807385|NCT02102490|81127106|FG000|Overall Study|Lost to Follow-up|1|||
27807386|NCT00706706|81127107|FG000|Overall Study|Death|53|||
27807387|NCT00706706|81127107|FG000|Overall Study|Lost to Follow-up|7|||
27807388|NCT00706706|81127107|FG000|Overall Study|Study endpoint had reached|45|||
27807389|NCT04132232|81127110|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
27807390|NCT04132232|81127111|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
27807391|NCT04132232|81127110|FG000|Overall Study|Lost to Follow-up|6|||
27807392|NCT04132232|81127111|FG001|Overall Study|Lost to Follow-up|7|||
27807393|NCT00618774|81127112|FG000|Overall Study|Adverse Event|5|||
27807394|NCT00618774|81127113|FG001|Overall Study|Adverse Event|3|||
27807395|NCT00618774|81127112|FG000|Overall Study|Withdrawal by Subject|1|||
27807396|NCT00618774|81127113|FG001|Overall Study|Withdrawal by Subject|0|||
27807397|NCT01299038|81127114|FG000|Overall Study|Withdrawal by Subject|1|||
27807398|NCT01299038|81127115|FG001|Overall Study|Withdrawal by Subject|0|||
28002974|NCT00362648|81842361|FG001|Overall Study|Adverse Event|21|||
28002975|NCT00362648|81842362|FG002|Overall Study|Adverse Event|1|||
28002976|NCT00362648|81842363|FG003|Overall Study|Adverse Event|0|||
28002977|NCT00362648|81842360|FG000|Overall Study|Lost to Follow-up|62|||
28002978|NCT00362648|81842361|FG001|Overall Study|Lost to Follow-up|69|||
28002979|NCT00362648|81842362|FG002|Overall Study|Lost to Follow-up|4|||
28002980|NCT00362648|81842363|FG003|Overall Study|Lost to Follow-up|3|||
28002981|NCT00362648|81842360|FG000|Overall Study|Protocol Violation|4|||
28002982|NCT00362648|81842361|FG001|Overall Study|Protocol Violation|2|||
28002983|NCT00362648|81842362|FG002|Overall Study|Protocol Violation|2|||
28002984|NCT00362648|81842363|FG003|Overall Study|Protocol Violation|2|||
28002985|NCT00362648|81842360|FG000|Overall Study|Withdrawal by Subject|48|||
28002986|NCT00362648|81842361|FG001|Overall Study|Withdrawal by Subject|42|||
28002987|NCT00362648|81842362|FG002|Overall Study|Withdrawal by Subject|2|||
28002988|NCT00362648|81842363|FG003|Overall Study|Withdrawal by Subject|6|||
28002989|NCT00953667|81842366|FG000|Overall Study|Lost to Follow-up|11|||
28002990|NCT00953667|81842366|FG000|Overall Study|Physician Decision|35|||
28002991|NCT00953667|81842366|FG000|Overall Study|Withdrawal by Subject|63|||
28002992|NCT00953667|81842366|FG000|Overall Study|Adverse Event|10|||
28002993|NCT00953667|81842366|FG000|Overall Study|poor venous access,unable to draw blood|4|||
28002994|NCT01791244|81842368|FG000|Overall Study|Adverse Event|5|||
28002995|NCT01791244|81842369|FG001|Overall Study|Adverse Event|7|||
28002996|NCT01791244|81842368|FG000|Overall Study|Insufficient clinical response|10|||
28002997|NCT01791244|81842369|FG001|Overall Study|Insufficient clinical response|10|||
28002998|NCT01791244|81842368|FG000|Overall Study|Laboratory Abnormality|0|||
28002999|NCT01791244|81842369|FG001|Overall Study|Laboratory Abnormality|1|||
28003000|NCT02159066|81842370|FG000|Part I|Adverse Event|7|||
28003001|NCT02159066|81842371|FG001|Part I|Adverse Event|5|||
28003002|NCT02159066|81842372|FG002|Part I|Adverse Event|0|||
28003003|NCT02159066|81842373|FG003|Part I|Adverse Event|0|||
28003004|NCT02159066|81842374|FG004|Part I|Adverse Event|0|||
28003005|NCT02159066|81842375|FG005|Part I|Adverse Event|0|||
28003006|NCT02159066|81842370|FG000|Part I|Death|11|||
28003007|NCT02159066|81842371|FG001|Part I|Death|9|||
28003008|NCT02159066|81842372|FG002|Part I|Death|0|||
28003009|NCT02159066|81842373|FG003|Part I|Death|0|||
28003010|NCT02159066|81842374|FG004|Part I|Death|0|||
28003011|NCT02159066|81842375|FG005|Part I|Death|0|||
28003012|NCT02159066|81842370|FG000|Part I|Progressive Disease|37|||
27807399|NCT02295774|81127117|FG000|Overall Study|Physician Decision|1|||
27807400|NCT02295774|81127117|FG000|Overall Study|Withdrawal by Subject|2|||
27807401|NCT00863057|81127118|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
28003013|NCT02159066|81842371|FG001|Part I|Progressive Disease|46|||
28003014|NCT02159066|81842372|FG002|Part I|Progressive Disease|0|||
28003015|NCT02159066|81842373|FG003|Part I|Progressive Disease|0|||
28003016|NCT02159066|81842374|FG004|Part I|Progressive Disease|0|||
28003017|NCT02159066|81842375|FG005|Part I|Progressive Disease|0|||
28003018|NCT02159066|81842370|FG000|Part I|New Therapy for Study Indication|5|||
28003019|NCT02159066|81842371|FG001|Part I|New Therapy for Study Indication|4|||
27807402|NCT00863057|81127119|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
28003020|NCT02159066|81842372|FG002|Part I|New Therapy for Study Indication|0|||
28003021|NCT02159066|81842373|FG003|Part I|New Therapy for Study Indication|0|||
28003022|NCT02159066|81842374|FG004|Part I|New Therapy for Study Indication|0|||
28003023|NCT02159066|81842375|FG005|Part I|New Therapy for Study Indication|0|||
28003024|NCT02159066|81842370|FG000|Part I|Termination of participants from the study|3|||
28003025|NCT02159066|81842371|FG001|Part I|Termination of participants from the study|3|||
28003026|NCT02159066|81842372|FG002|Part I|Termination of participants from the study|0|||
28003027|NCT02159066|81842373|FG003|Part I|Termination of participants from the study|0|||
28003028|NCT02159066|81842374|FG004|Part I|Termination of participants from the study|0|||
28003029|NCT02159066|81842375|FG005|Part I|Termination of participants from the study|0|||
28003030|NCT02159066|81842370|FG000|Part I|Physician Decision|2|||
28003031|NCT02159066|81842371|FG001|Part I|Physician Decision|9|||
28003032|NCT02159066|81842372|FG002|Part I|Physician Decision|0|||
28003033|NCT02159066|81842373|FG003|Part I|Physician Decision|0|||
28003034|NCT02159066|81842374|FG004|Part I|Physician Decision|0|||
28003035|NCT02159066|81842375|FG005|Part I|Physician Decision|0|||
28003036|NCT02159066|81842370|FG000|Part I|Participant/Guardian Decision|9|||
28003037|NCT02159066|81842371|FG001|Part I|Participant/Guardian Decision|3|||
28003038|NCT02159066|81842372|FG002|Part I|Participant/Guardian Decision|0|||
28003039|NCT02159066|81842373|FG003|Part I|Participant/Guardian Decision|0|||
28003040|NCT02159066|81842374|FG004|Part I|Participant/Guardian Decision|0|||
28003041|NCT02159066|81842375|FG005|Part I|Participant/Guardian Decision|0|||
28003042|NCT02159066|81842370|FG000|Part I|Missing Data|1|||
28003043|NCT02159066|81842371|FG001|Part I|Missing Data|0|||
28003044|NCT02159066|81842372|FG002|Part I|Missing Data|0|||
28003045|NCT02159066|81842373|FG003|Part I|Missing Data|0|||
28003046|NCT02159066|81842374|FG004|Part I|Missing Data|0|||
28003047|NCT02159066|81842375|FG005|Part I|Missing Data|0|||
28003048|NCT02159066|81842370|FG000|Part II|Adverse Event|0|||
28003049|NCT02159066|81842371|FG001|Part II|Adverse Event|0|||
28003050|NCT02159066|81842372|FG002|Part II|Adverse Event|1|||
28003051|NCT02159066|81842373|FG003|Part II|Adverse Event|0|||
28003052|NCT02159066|81842374|FG004|Part II|Adverse Event|1|||
28003053|NCT02159066|81842375|FG005|Part II|Adverse Event|1|||
28003054|NCT02159066|81842370|FG000|Part II|Death|0|||
28003055|NCT02159066|81842371|FG001|Part II|Death|0|||
28003056|NCT02159066|81842372|FG002|Part II|Death|1|||
27584285|NCT03165045|80319242|FG000|Visit 1|No registration after visit 1|9|||
27807403|NCT00863057|81127120|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
27807404|NCT00863057|81127121|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
27807405|NCT00863057|81127118|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
27807406|NCT00863057|81127119|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
27807407|NCT00863057|81127120|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
27807408|NCT00863057|81127121|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
27807409|NCT00863057|81127118|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
27807410|NCT00863057|81127119|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
27807411|NCT00863057|81127120|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
27807412|NCT00863057|81127121|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
27807413|NCT00863057|81127118|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
27807414|NCT00863057|81127119|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
27807415|NCT00863057|81127120|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
27807416|NCT00863057|81127121|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
27807417|NCT01590433|81127126|FG000|Overall Study|Lost to Follow-up|20|||
27807418|NCT01590433|81127127|FG001|Overall Study|Lost to Follow-up|8|||
27807419|NCT01590433|81127126|FG000|Overall Study|Withdrawal by Subject|21|||
27807420|NCT01590433|81127127|FG001|Overall Study|Withdrawal by Subject|11|||
27807421|NCT01590433|81127126|FG000|Overall Study|Adverse Event|11|||
27807422|NCT01590433|81127127|FG001|Overall Study|Adverse Event|3|||
27807423|NCT02557672|81127130|FG000|Overall Study|Withdrawal by Subject|4|||
27807424|NCT02557672|81127131|FG001|Overall Study|Withdrawal by Subject|2|||
27807425|NCT01759537|81127132|FG000|Overall Study|Death|1|||
27807426|NCT01759537|81127133|FG001|Overall Study|Death|1|||
27807427|NCT01759537|81127132|FG000|Overall Study|Pregnancy|1|||
27807428|NCT01759537|81127133|FG001|Overall Study|Pregnancy|1|||
27807429|NCT01759537|81127132|FG000|Overall Study|Lost to Follow-up|9|||
27807430|NCT01759537|81127133|FG001|Overall Study|Lost to Follow-up|9|||
28003057|NCT02159066|81842373|FG003|Part II|Death|0|||
28003058|NCT02159066|81842374|FG004|Part II|Death|2|||
27584286|NCT03165045|80319242|FG000|Visit 1|No treatment documented|10|||
27807431|NCT01759537|81127132|FG000|Overall Study|Accident involving jaw fracture|1|||
27807432|NCT01759537|81127133|FG001|Overall Study|Accident involving jaw fracture|1|||
28003059|NCT02159066|81842375|FG005|Part II|Death|1|||
28003060|NCT02159066|81842370|FG000|Part II|Progressive Disease|0|||
27584287|NCT03165045|80319242|FG000|Visit 1|No visit 1|10|||
27807433|NCT01759537|81127132|FG000|Overall Study|Subcrestal implant too coronal|1|||
28003061|NCT02159066|81842371|FG001|Part II|Progressive Disease|0|||
28003062|NCT02159066|81842372|FG002|Part II|Progressive Disease|35|||
28003063|NCT02159066|81842373|FG003|Part II|Progressive Disease|1|||
28003064|NCT02159066|81842374|FG004|Part II|Progressive Disease|7|||
28003065|NCT02159066|81842375|FG005|Part II|Progressive Disease|4|||
28003066|NCT02159066|81842370|FG000|Part II|New Therapy for Study Indication|0|||
27807434|NCT01759537|81127133|FG001|Overall Study|Subcrestal implant too coronal|1|||
27807435|NCT00936975|81127134|FG000|Overall Study|Withdrawal by Subject|1|||
27807436|NCT00936975|81127134|FG000|Overall Study|Disease progression|3|||
27807437|NCT00936975|81127134|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
27807438|NCT01851590|81127137|FG000|Overall Study|Withdrawal by Subject|0|||
27807439|NCT01851590|81127138|FG001|Overall Study|Withdrawal by Subject|0|||
27807440|NCT01851590|81127139|FG002|Overall Study|Withdrawal by Subject|1|||
27807441|NCT01851590|81127137|FG000|Overall Study|Adverse Event|0|||
27807442|NCT01851590|81127138|FG001|Overall Study|Adverse Event|0|||
27807443|NCT01851590|81127139|FG002|Overall Study|Adverse Event|2|||
27807444|NCT01851590|81127137|FG000|Overall Study|Lack of Efficacy|0|||
27807445|NCT01851590|81127138|FG001|Overall Study|Lack of Efficacy|1|||
27807446|NCT01851590|81127139|FG002|Overall Study|Lack of Efficacy|0|||
27807447|NCT01084005|81127140|FG000|Overall Study|Adverse Event|1|||
27807448|NCT01084005|81127141|FG001|Overall Study|Adverse Event|8|||
27807449|NCT01084005|81127140|FG000|Overall Study|Protocol Violation|3|||
27807450|NCT01084005|81127141|FG001|Overall Study|Protocol Violation|7|||
27807451|NCT01084005|81127140|FG000|Overall Study|Withdrawal by Subject|1|||
27807452|NCT01084005|81127141|FG001|Overall Study|Withdrawal by Subject|1|||
27807453|NCT03063632|81127146|FG000|Overall Study|Death|4|||
27807454|NCT03063632|81127147|FG001|Overall Study|Death|6|||
27807455|NCT03063632|81127146|FG000|Overall Study|Lost to Follow-up|0|||
27807456|NCT03063632|81127147|FG001|Overall Study|Lost to Follow-up|1|||
27807457|NCT03063632|81127146|FG000|Overall Study|Withdrawal by Subject|0|||
27807458|NCT03063632|81127147|FG001|Overall Study|Withdrawal by Subject|2|||
27807459|NCT03063632|81127146|FG000|Overall Study|Physician Decision|2|||
27807460|NCT03063632|81127147|FG001|Overall Study|Physician Decision|0|||
27807461|NCT03063632|81127146|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
27807462|NCT03063632|81127147|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
27807463|NCT01698320|81127148|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
27807464|NCT01698320|81127149|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
27807465|NCT01698320|81127150|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
27807466|NCT01698320|81127148|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
27807467|NCT01698320|81127149|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
27807468|NCT01698320|81127150|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
27807469|NCT01698320|81127148|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
27807470|NCT01698320|81127149|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
27807471|NCT01698320|81127150|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
27807472|NCT01698320|81127148|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
27807473|NCT01698320|81127149|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
27807474|NCT01698320|81127150|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
28003067|NCT02159066|81842371|FG001|Part II|New Therapy for Study Indication|0|||
28003068|NCT02159066|81842372|FG002|Part II|New Therapy for Study Indication|0|||
28003069|NCT02159066|81842373|FG003|Part II|New Therapy for Study Indication|0|||
28003070|NCT02159066|81842374|FG004|Part II|New Therapy for Study Indication|1|||
28003071|NCT02159066|81842375|FG005|Part II|New Therapy for Study Indication|0|||
28003072|NCT02159066|81842370|FG000|Part II|Physician Decision|0|||
28003073|NCT02159066|81842371|FG001|Part II|Physician Decision|0|||
28003074|NCT02159066|81842372|FG002|Part II|Physician Decision|1|||
28003075|NCT02159066|81842373|FG003|Part II|Physician Decision|0|||
28003076|NCT02159066|81842374|FG004|Part II|Physician Decision|0|||
28003077|NCT02159066|81842375|FG005|Part II|Physician Decision|0|||
28003078|NCT02159066|81842370|FG000|Part II|Participant/Guardian Decision|0|||
28003079|NCT02159066|81842371|FG001|Part II|Participant/Guardian Decision|0|||
28003080|NCT02159066|81842372|FG002|Part II|Participant/Guardian Decision|0|||
28003081|NCT02159066|81842373|FG003|Part II|Participant/Guardian Decision|0|||
28003082|NCT02159066|81842374|FG004|Part II|Participant/Guardian Decision|2|||
28003083|NCT02159066|81842375|FG005|Part II|Participant/Guardian Decision|0|||
28003084|NCT03836625|81842383|FG000|Overall Study|Lost to Follow-up|9|||
28003085|NCT03836625|81842384|FG001|Overall Study|Lost to Follow-up|9|||
28003086|NCT03836625|81842383|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
28003087|NCT03836625|81842384|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
28003088|NCT03836625|81842383|FG000|Overall Study|Death|0|||
28003089|NCT03836625|81842384|FG001|Overall Study|Death|1|||
28003090|NCT03836625|81842383|FG000|Overall Study|Refused follow-up|0|||
28003091|NCT03836625|81842384|FG001|Overall Study|Refused follow-up|1|||
27807475|NCT01698320|81127148|FG000|12-Week Double-Blind Period|Adverse Event|0|||
27807476|NCT01698320|81127149|FG001|12-Week Double-Blind Period|Adverse Event|1|||
28003092|NCT04664153|81842387|FG000|Overall Study|Lack of Efficacy|0|||
28003093|NCT04664153|81842388|FG001|Overall Study|Lack of Efficacy|0|||
28003094|NCT04664153|81842389|FG002|Overall Study|Lack of Efficacy|1|||
27807477|NCT01698320|81127150|FG002|12-Week Double-Blind Period|Adverse Event|1|||
27807478|NCT01698320|81127148|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
27807479|NCT01698320|81127149|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
28003095|NCT04664153|81842390|FG003|Overall Study|Lack of Efficacy|0|||
28003096|NCT04664153|81842387|FG000|Overall Study|Physician Decision|0|||
28003097|NCT04664153|81842388|FG001|Overall Study|Physician Decision|0|||
28003098|NCT04664153|81842389|FG002|Overall Study|Physician Decision|1|||
28003099|NCT04664153|81842390|FG003|Overall Study|Physician Decision|0|||
28003100|NCT04664153|81842387|FG000|Overall Study|Withdrawal by Subject|3|||
28003101|NCT04664153|81842388|FG001|Overall Study|Withdrawal by Subject|2|||
28003102|NCT04664153|81842389|FG002|Overall Study|Withdrawal by Subject|1|||
28003103|NCT04664153|81842390|FG003|Overall Study|Withdrawal by Subject|2|||
28003104|NCT04664153|81842387|FG000|Overall Study|Other|0|||
28003105|NCT04664153|81842388|FG001|Overall Study|Other|1|||
28003106|NCT04664153|81842389|FG002|Overall Study|Other|0|||
28003107|NCT04664153|81842390|FG003|Overall Study|Other|0|||
28003108|NCT04664153|81842387|FG000|Overall Study|Adverse Event|4|||
28003109|NCT04664153|81842388|FG001|Overall Study|Adverse Event|0|||
28003110|NCT04664153|81842389|FG002|Overall Study|Adverse Event|1|||
28003111|NCT04664153|81842390|FG003|Overall Study|Adverse Event|0|||
28003112|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
28003113|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
28003114|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
28003115|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
28003116|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
28003117|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
28003118|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
28003119|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
28003120|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
28003121|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
28003122|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
28003123|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
28003124|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
28003125|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
28003126|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
28003127|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
28003128|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
28003129|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
28003130|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
28003131|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
28003132|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
28003133|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
28003134|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
28003135|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
28003136|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
28003137|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
28003138|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
28003139|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
28003140|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
28003141|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
28003142|NCT01173601|81842391|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
28003143|NCT01173601|81842392|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
28003144|NCT01173601|81842393|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
28003145|NCT01173601|81842394|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
28003146|NCT01173601|81842395|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
28003147|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
28003148|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
28003149|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
28003150|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
28003151|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
28003152|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
28003153|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
28003154|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
28003155|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
28003156|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
28003157|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
28003158|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
28003159|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
28003160|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
28003161|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
28003162|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
28003163|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
28003164|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
28003165|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
28003166|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
28003167|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
28003168|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
28003169|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
28003170|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
28003171|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
28003172|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
28003173|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
28003174|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
28003175|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
27874208|NCT01894919|81371677|FG003|Overall Study|Adverse Event|0|||
27874209|NCT01894919|81371678|FG004|Overall Study|Adverse Event|0|||
27874210|NCT01894919|81371679|FG005|Overall Study|Adverse Event|0|||
27874211|NCT01894919|81371680|FG006|Overall Study|Adverse Event|0|||
27874212|NCT01894919|81371681|FG007|Overall Study|Adverse Event|0|||
27874213|NCT01894919|81371682|FG008|Overall Study|Adverse Event|0|||
27874214|NCT01894919|81371683|FG009|Overall Study|Adverse Event|0|||
27874215|NCT01894919|81371684|FG010|Overall Study|Adverse Event|1|||
27874216|NCT01894919|81371685|FG011|Overall Study|Adverse Event|0|||
27874217|NCT01894919|81371686|FG012|Overall Study|Adverse Event|0|||
27874218|NCT01894919|81371674|FG000|Overall Study|Other-Unspecified|1|||
27874219|NCT01894919|81371675|FG001|Overall Study|Other-Unspecified|0|||
27874220|NCT01894919|81371676|FG002|Overall Study|Other-Unspecified|0|||
27874221|NCT01894919|81371677|FG003|Overall Study|Other-Unspecified|0|||
27874222|NCT01894919|81371678|FG004|Overall Study|Other-Unspecified|0|||
27874223|NCT01894919|81371679|FG005|Overall Study|Other-Unspecified|0|||
27874224|NCT01894919|81371680|FG006|Overall Study|Other-Unspecified|0|||
27874225|NCT01894919|81371681|FG007|Overall Study|Other-Unspecified|0|||
27874226|NCT01894919|81371682|FG008|Overall Study|Other-Unspecified|0|||
27874227|NCT01894919|81371683|FG009|Overall Study|Other-Unspecified|0|||
27874228|NCT01894919|81371684|FG010|Overall Study|Other-Unspecified|0|||
27874229|NCT01894919|81371685|FG011|Overall Study|Other-Unspecified|0|||
27874230|NCT01894919|81371686|FG012|Overall Study|Other-Unspecified|0|||
27874231|NCT01894919|81371674|FG000|Overall Study|Lost to Follow-up|0|||
27874232|NCT01894919|81371675|FG001|Overall Study|Lost to Follow-up|0|||
27874233|NCT01894919|81371676|FG002|Overall Study|Lost to Follow-up|0|||
27874234|NCT01894919|81371677|FG003|Overall Study|Lost to Follow-up|0|||
27874235|NCT01894919|81371678|FG004|Overall Study|Lost to Follow-up|2|||
27874236|NCT01894919|81371679|FG005|Overall Study|Lost to Follow-up|0|||
27874237|NCT01894919|81371680|FG006|Overall Study|Lost to Follow-up|0|||
27874238|NCT01894919|81371681|FG007|Overall Study|Lost to Follow-up|0|||
27874239|NCT01894919|81371682|FG008|Overall Study|Lost to Follow-up|0|||
27874240|NCT01894919|81371683|FG009|Overall Study|Lost to Follow-up|0|||
27874241|NCT01894919|81371684|FG010|Overall Study|Lost to Follow-up|0|||
27874242|NCT01894919|81371685|FG011|Overall Study|Lost to Follow-up|0|||
27874243|NCT01894919|81371686|FG012|Overall Study|Lost to Follow-up|0|||
27874244|NCT02077140|81371691|FG000|Overall Study|Lost to Follow-up|4|||
27874245|NCT02077140|81371692|FG001|Overall Study|Lost to Follow-up|1|||
27874246|NCT02077140|81371693|FG002|Overall Study|Lost to Follow-up|2|||
27874247|NCT02077140|81371694|FG003|Overall Study|Lost to Follow-up|2|||
27874248|NCT02077140|81371695|FG004|Overall Study|Lost to Follow-up|3|||
27874249|NCT02077140|81371691|FG000|Overall Study|Withdrawal by Subject|0|||
27874250|NCT02077140|81371692|FG001|Overall Study|Withdrawal by Subject|1|||
27874251|NCT02077140|81371693|FG002|Overall Study|Withdrawal by Subject|0|||
27874252|NCT02077140|81371694|FG003|Overall Study|Withdrawal by Subject|2|||
27874253|NCT02077140|81371695|FG004|Overall Study|Withdrawal by Subject|2|||
27874254|NCT02182843|81371696|FG000|Overall Study|Withdrawal by Subject|7|||
27874255|NCT02182843|81371696|FG000|Overall Study|Lost to Follow-up|2|||
27874256|NCT02182843|81371696|FG000|Overall Study|Adverse Event|1|||
27874257|NCT01578239|81371699|FG000|Treatment Period|Progressive Disease|19|||
27874258|NCT01578239|81371700|FG001|Treatment Period|Progressive Disease|64|||
27874259|NCT01578239|81371699|FG000|Treatment Period|Physician Decision|17|||
27874260|NCT01578239|81371700|FG001|Treatment Period|Physician Decision|17|||
27874261|NCT01578239|81371699|FG000|Treatment Period|Adverse Event|13|||
27874262|NCT01578239|81371700|FG001|Treatment Period|Adverse Event|10|||
27874263|NCT01578239|81371699|FG000|Treatment Period|Non-compliance|2|||
27874264|NCT01578239|81371700|FG001|Treatment Period|Non-compliance|0|||
27874265|NCT01578239|81371699|FG000|Treatment Period|Withdrawal by Subject|10|||
27874266|NCT01578239|81371700|FG001|Treatment Period|Withdrawal by Subject|9|||
27874267|NCT01578239|81371699|FG000|Treatment Period|Other|6|||
27874268|NCT01578239|81371700|FG001|Treatment Period|Other|1|||
27874269|NCT01578239|81371699|FG000|Long-term Follow-Up Period|Death|69|||
27874270|NCT01578239|81371700|FG001|Long-term Follow-Up Period|Death|64|||
27874271|NCT01578239|81371699|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
27874272|NCT01578239|81371700|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
28003176|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
28003177|NCT01173601|81842391|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
28003178|NCT01173601|81842392|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
28003179|NCT01173601|81842393|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
28003180|NCT01173601|81842394|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
28003181|NCT01173601|81842395|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
28003182|NCT00101686|81842397|FG000|Overall Study|Progressive Disease|37|||
28003183|NCT00101686|81842398|FG001|Overall Study|Progressive Disease|28|||
28003184|NCT00101686|81842399|FG002|Overall Study|Progressive Disease|37|||
28003185|NCT00101686|81842400|FG003|Overall Study|Progressive Disease|38|||
28003186|NCT00101686|81842401|FG004|Overall Study|Progressive Disease|28|||
28003187|NCT00101686|81842402|FG005|Overall Study|Progressive Disease|25|||
28003188|NCT00101686|81842403|FG006|Overall Study|Progressive Disease|5|||
28003189|NCT00101686|81842404|FG007|Overall Study|Progressive Disease|7|||
28003190|NCT00101686|81842405|FG008|Overall Study|Progressive Disease|10|||
28003191|NCT00101686|81842406|FG009|Overall Study|Progressive Disease|8|||
28003192|NCT00101686|81842397|FG000|Overall Study|initiation other anti-cancer treatment|4|||
28003193|NCT00101686|81842398|FG001|Overall Study|initiation other anti-cancer treatment|3|||
28003194|NCT00101686|81842399|FG002|Overall Study|initiation other anti-cancer treatment|4|||
28003195|NCT00101686|81842400|FG003|Overall Study|initiation other anti-cancer treatment|3|||
28003196|NCT00101686|81842401|FG004|Overall Study|initiation other anti-cancer treatment|1|||
28003197|NCT00101686|81842402|FG005|Overall Study|initiation other anti-cancer treatment|1|||
28003198|NCT00101686|81842403|FG006|Overall Study|initiation other anti-cancer treatment|2|||
28003199|NCT00101686|81842404|FG007|Overall Study|initiation other anti-cancer treatment|2|||
28003200|NCT00101686|81842405|FG008|Overall Study|initiation other anti-cancer treatment|3|||
28003201|NCT00101686|81842406|FG009|Overall Study|initiation other anti-cancer treatment|3|||
28003202|NCT00101686|81842397|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
28003203|NCT00101686|81842398|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
28003204|NCT00101686|81842399|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
28003205|NCT00101686|81842400|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
28003206|NCT00101686|81842401|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
28003207|NCT00101686|81842402|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
28003208|NCT00101686|81842403|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
28003209|NCT00101686|81842404|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
28003210|NCT00101686|81842405|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
28003211|NCT00101686|81842406|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
28003212|NCT00101686|81842397|FG000|Overall Study|unacceptable toxicity|3|||
28003213|NCT00101686|81842398|FG001|Overall Study|unacceptable toxicity|9|||
28003214|NCT00101686|81842399|FG002|Overall Study|unacceptable toxicity|10|||
28003215|NCT00101686|81842400|FG003|Overall Study|unacceptable toxicity|6|||
28003216|NCT00101686|81842401|FG004|Overall Study|unacceptable toxicity|16|||
28003217|NCT00101686|81842402|FG005|Overall Study|unacceptable toxicity|10|||
28003218|NCT00101686|81842403|FG006|Overall Study|unacceptable toxicity|4|||
28003219|NCT00101686|81842404|FG007|Overall Study|unacceptable toxicity|2|||
28003220|NCT00101686|81842405|FG008|Overall Study|unacceptable toxicity|1|||
28003221|NCT00101686|81842406|FG009|Overall Study|unacceptable toxicity|4|||
28003222|NCT00101686|81842397|FG000|Overall Study|Randomized but did not receive treament|1|||
28003223|NCT00101686|81842398|FG001|Overall Study|Randomized but did not receive treament|6|||
28003224|NCT00101686|81842399|FG002|Overall Study|Randomized but did not receive treament|2|||
28003225|NCT00101686|81842400|FG003|Overall Study|Randomized but did not receive treament|2|||
28003226|NCT00101686|81842401|FG004|Overall Study|Randomized but did not receive treament|2|||
28003227|NCT00101686|81842402|FG005|Overall Study|Randomized but did not receive treament|2|||
28003228|NCT00101686|81842403|FG006|Overall Study|Randomized but did not receive treament|0|||
28003229|NCT00101686|81842404|FG007|Overall Study|Randomized but did not receive treament|1|||
28003230|NCT00101686|81842405|FG008|Overall Study|Randomized but did not receive treament|0|||
28003231|NCT00101686|81842406|FG009|Overall Study|Randomized but did not receive treament|1|||
28003232|NCT00101686|81842397|FG000|Overall Study|intercurrent non-cancer related illness|0|||
28003233|NCT00101686|81842398|FG001|Overall Study|intercurrent non-cancer related illness|0|||
28003234|NCT00101686|81842399|FG002|Overall Study|intercurrent non-cancer related illness|2|||
28003235|NCT00101686|81842400|FG003|Overall Study|intercurrent non-cancer related illness|0|||
28003236|NCT00101686|81842401|FG004|Overall Study|intercurrent non-cancer related illness|1|||
28003237|NCT00101686|81842402|FG005|Overall Study|intercurrent non-cancer related illness|3|||
28003238|NCT00101686|81842403|FG006|Overall Study|intercurrent non-cancer related illness|1|||
28003239|NCT00101686|81842404|FG007|Overall Study|intercurrent non-cancer related illness|0|||
28003240|NCT00101686|81842405|FG008|Overall Study|intercurrent non-cancer related illness|1|||
28003241|NCT00101686|81842406|FG009|Overall Study|intercurrent non-cancer related illness|1|||
28003242|NCT00101686|81842397|FG000|Overall Study|Physician Decision|10|||
28003243|NCT00101686|81842398|FG001|Overall Study|Physician Decision|13|||
28003244|NCT00101686|81842399|FG002|Overall Study|Physician Decision|6|||
27683371|NCT00626197|80675946|FG002|Overall Study|Adverse Event|2|||
27683372|NCT00626197|80675944|FG000|Overall Study|Withdrawal by Subject|17|||
27683373|NCT00626197|80675945|FG001|Overall Study|Withdrawal by Subject|17|||
27683374|NCT00626197|80675946|FG002|Overall Study|Withdrawal by Subject|7|||
27683375|NCT00626197|80675944|FG000|Overall Study|Administrative reasons|15|||
27584288|NCT03165045|80319242|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
27584289|NCT03165045|80319242|FG000|Visit 2|No available total CCQ score at all|29|||
27584290|NCT03165045|80319242|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
27584291|NCT01046110|80319243|FG000|Overall Study|Adverse Event|9|||
27683376|NCT00626197|80675945|FG001|Overall Study|Administrative reasons|19|||
27683377|NCT00626197|80675946|FG002|Overall Study|Administrative reasons|55|||
27683378|NCT00635427|80675947|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27683379|NCT00635427|80675948|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27683380|NCT00635427|80675949|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
27683381|NCT00635427|80675950|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27683382|NCT00635427|80675951|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
27683383|NCT00635427|80675947|FG000|Overall Study|Death|0|||
27584292|NCT01046110|80319244|FG001|Overall Study|Adverse Event|2|||
27584293|NCT01046110|80319243|FG000|Overall Study|Lack of Efficacy|0|||
27584294|NCT01046110|80319244|FG001|Overall Study|Lack of Efficacy|1|||
27584295|NCT01046110|80319243|FG000|Overall Study|Protocol Violation|7|||
27584296|NCT01046110|80319244|FG001|Overall Study|Protocol Violation|12|||
27584297|NCT01046110|80319243|FG000|Overall Study|Withdrawal Criteria|3|||
27584298|NCT01046110|80319244|FG001|Overall Study|Withdrawal Criteria|5|||
27584299|NCT01046110|80319243|FG000|Overall Study|Unclassified|36|||
27584300|NCT01046110|80319244|FG001|Overall Study|Unclassified|35|||
27584301|NCT01490060|80319245|FG000|Cycle 1|Change of Treatment|0|||
27584302|NCT01490060|80319246|FG001|Cycle 1|Change of Treatment|1|||
27584303|NCT01490060|80319247|FG002|Cycle 1|Change of Treatment|1|||
27584304|NCT01490060|80319248|FG003|Cycle 1|Change of Treatment|1|||
27584305|NCT01490060|80319245|FG000|Cycle 1|Insurance Denied|0|||
27584306|NCT01490060|80319246|FG001|Cycle 1|Insurance Denied|0|||
27584307|NCT01490060|80319247|FG002|Cycle 1|Insurance Denied|2|||
27584308|NCT01490060|80319248|FG003|Cycle 1|Insurance Denied|0|||
27584309|NCT01490060|80319245|FG000|Cycle 1|Withdrawal by Subject|0|||
27584310|NCT01490060|80319246|FG001|Cycle 1|Withdrawal by Subject|0|||
27584311|NCT01490060|80319247|FG002|Cycle 1|Withdrawal by Subject|0|||
27584312|NCT01490060|80319248|FG003|Cycle 1|Withdrawal by Subject|1|||
27584313|NCT01490060|80319245|FG000|Cycle 1|Treatment at Another Facility|0|||
27584314|NCT01490060|80319246|FG001|Cycle 1|Treatment at Another Facility|0|||
27584315|NCT01490060|80319247|FG002|Cycle 1|Treatment at Another Facility|0|||
27584316|NCT01490060|80319248|FG003|Cycle 1|Treatment at Another Facility|1|||
27584317|NCT01490060|80319245|FG000|Cycle 2|Change of Treatment|1|||
27584318|NCT01490060|80319246|FG001|Cycle 2|Change of Treatment|1|||
27584319|NCT01490060|80319247|FG002|Cycle 2|Change of Treatment|0|||
27683384|NCT00635427|80675948|FG001|Overall Study|Death|0|||
27584320|NCT01490060|80319248|FG003|Cycle 2|Change of Treatment|0|||
27584321|NCT01490060|80319245|FG000|Cycle 2|Non-Compliance|0|||
27584322|NCT01490060|80319246|FG001|Cycle 2|Non-Compliance|0|||
27584323|NCT01490060|80319247|FG002|Cycle 2|Non-Compliance|1|||
27584324|NCT01490060|80319248|FG003|Cycle 2|Non-Compliance|0|||
27584325|NCT01490060|80319245|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
27584326|NCT01490060|80319246|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
27584327|NCT01490060|80319247|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
27584328|NCT01490060|80319248|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
27683385|NCT00635427|80675949|FG002|Overall Study|Death|0|||
27683386|NCT00635427|80675950|FG003|Overall Study|Death|1|||
27683387|NCT00635427|80675951|FG004|Overall Study|Death|0|||
27683388|NCT00635427|80675947|FG000|Overall Study|Termination Of Study By Sponsor|12|||
27683389|NCT00635427|80675948|FG001|Overall Study|Termination Of Study By Sponsor|6|||
27683390|NCT00635427|80675949|FG002|Overall Study|Termination Of Study By Sponsor|10|||
27683391|NCT00635427|80675950|FG003|Overall Study|Termination Of Study By Sponsor|6|||
27683392|NCT00635427|80675951|FG004|Overall Study|Termination Of Study By Sponsor|6|||
27683393|NCT00635427|80675947|FG000|Overall Study|Withdrawal Of Consent|0|||
27683394|NCT00635427|80675948|FG001|Overall Study|Withdrawal Of Consent|0|||
28003245|NCT00101686|81842400|FG003|Overall Study|Physician Decision|7|||
28003246|NCT00101686|81842401|FG004|Overall Study|Physician Decision|8|||
28003247|NCT00101686|81842402|FG005|Overall Study|Physician Decision|9|||
28003248|NCT00101686|81842403|FG006|Overall Study|Physician Decision|5|||
28003249|NCT00101686|81842404|FG007|Overall Study|Physician Decision|5|||
28003250|NCT00101686|81842405|FG008|Overall Study|Physician Decision|1|||
27683395|NCT00635427|80675949|FG002|Overall Study|Withdrawal Of Consent|0|||
27683396|NCT00635427|80675950|FG003|Overall Study|Withdrawal Of Consent|2|||
27683397|NCT00635427|80675951|FG004|Overall Study|Withdrawal Of Consent|2|||
27683398|NCT01205152|80675952|FG000|Overall Study|Death|1|||
27683399|NCT01253018|80675953|FG000|Overall Study|Lost to Follow-up|1|||
27683400|NCT01253018|80675954|FG001|Overall Study|Lost to Follow-up|1|||
27683401|NCT01253018|80675953|FG000|Overall Study|Robot Repair Issues|2|||
27683402|NCT01253018|80675954|FG001|Overall Study|Robot Repair Issues|0|||
27683403|NCT01253018|80675953|FG000|Overall Study|Withdrawal by Subject|1|||
27683404|NCT01253018|80675954|FG001|Overall Study|Withdrawal by Subject|1|||
27683405|NCT04608773|80675955|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
27683406|NCT04608773|80675956|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
27683407|NCT04608773|80675955|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
27683408|NCT04608773|80675956|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
27683409|NCT04608773|80675955|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
27683410|NCT04608773|80675956|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
27683411|NCT04608773|80675955|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
27683412|NCT04608773|80675956|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
27683413|NCT04608773|80675955|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
27683414|NCT04608773|80675956|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
27683415|NCT01036438|80675957|FG000|Overall Study|Adverse Event|7|||
27683416|NCT01036438|80675958|FG001|Overall Study|Adverse Event|8|||
28003251|NCT00101686|81842406|FG009|Overall Study|Physician Decision|1|||
28003252|NCT00101686|81842397|FG000|Overall Study|Other|1|||
28003253|NCT00101686|81842398|FG001|Overall Study|Other|4|||
28003254|NCT00101686|81842399|FG002|Overall Study|Other|1|||
28003255|NCT00101686|81842400|FG003|Overall Study|Other|6|||
28003256|NCT00101686|81842401|FG004|Overall Study|Other|2|||
28003257|NCT00101686|81842402|FG005|Overall Study|Other|12|||
28003258|NCT00101686|81842403|FG006|Overall Study|Other|1|||
27584329|NCT01389973|80319251|FG000|Overall Study|Lost to Follow-up|1|||
27584330|NCT01389973|80319251|FG000|Overall Study|Trial Stopped by Sponsor|9|||
28003259|NCT00101686|81842404|FG007|Overall Study|Other|5|||
28003260|NCT00101686|81842405|FG008|Overall Study|Other|3|||
28003261|NCT00101686|81842406|FG009|Overall Study|Other|3|||
28003262|NCT00101686|81842397|FG000|Overall Study|Withdrawal by Subject|9|||
28003263|NCT00101686|81842398|FG001|Overall Study|Withdrawal by Subject|8|||
28003264|NCT00101686|81842399|FG002|Overall Study|Withdrawal by Subject|6|||
28003265|NCT00101686|81842400|FG003|Overall Study|Withdrawal by Subject|8|||
28003266|NCT00101686|81842401|FG004|Overall Study|Withdrawal by Subject|8|||
28003267|NCT00101686|81842402|FG005|Overall Study|Withdrawal by Subject|7|||
27584331|NCT01389973|80319251|FG000|Overall Study|Other|10|||
27584332|NCT03669081|80319253|FG000|Overall Study|Data could not be validated|1|||
27584333|NCT03669081|80319254|FG001|Overall Study|Data could not be validated|1|||
27584334|NCT03143829|80319255|FG000|Overall Study|Withdrawal by Subject|2|||
27584335|NCT03143829|80319256|FG001|Overall Study|Withdrawal by Subject|5|||
27584336|NCT03143829|80319255|FG000|Overall Study|Lost to Follow-up|0|||
27584337|NCT03143829|80319256|FG001|Overall Study|Lost to Follow-up|2|||
27584338|NCT03143829|80319255|FG000|Overall Study|Death|1|||
27584339|NCT03143829|80319256|FG001|Overall Study|Death|1|||
27584340|NCT03143829|80319255|FG000|Overall Study|changed treatment, no longer eligible|2|||
27584341|NCT03143829|80319256|FG001|Overall Study|changed treatment, no longer eligible|2|||
27584342|NCT03299049|80319257|FG000|Overall Study|On-going|486|||
27584343|NCT03299049|80319258|FG001|Overall Study|On-going|481|||
27584344|NCT03299049|80319257|FG000|Overall Study|Withdrawal by Subject|6|||
27584345|NCT03299049|80319258|FG001|Overall Study|Withdrawal by Subject|21|||
27584346|NCT03299049|80319257|FG000|Overall Study|Physician Decision|5|||
27584347|NCT03299049|80319258|FG001|Overall Study|Physician Decision|1|||
27584348|NCT03299049|80319257|FG000|Overall Study|Lost to Follow-up|2|||
27584349|NCT03299049|80319258|FG001|Overall Study|Lost to Follow-up|0|||
27584350|NCT03299049|80319257|FG000|Overall Study|Pregnancy|1|||
27584351|NCT03299049|80319258|FG001|Overall Study|Pregnancy|3|||
27683417|NCT01036438|80675957|FG000|Overall Study|Death|0|||
27683418|NCT01036438|80675958|FG001|Overall Study|Death|1|||
27683419|NCT01036438|80675957|FG000|Overall Study|No effect of study treatment|3|||
27683420|NCT01036438|80675958|FG001|Overall Study|No effect of study treatment|1|||
27683421|NCT00727311|80675963|FG000|Overall Study|Did not receive drug|316|||
27683422|NCT00727311|80675963|FG000|Overall Study|Missing end of therapy data|205|||
27683423|NCT00727311|80675963|FG000|Overall Study|Adverse Event|58|||
27683424|NCT00727311|80675963|FG000|Overall Study|Lack of Efficacy|242|||
27683425|NCT00727311|80675963|FG000|Overall Study|Lost to Follow-up|73|||
27683426|NCT00727311|80675963|FG000|Overall Study|Withdrawal by Subject|77|||
27683427|NCT00727311|80675963|FG000|Overall Study|Other|97|||
27683428|NCT00727311|80675963|FG000|Overall Study|Multiple reasons|39|||
27683429|NCT02706405|80675966|FG000|Overall Study|Death|3|||
27683430|NCT02706405|80675967|FG001|Overall Study|Death|2|||
27683431|NCT02706405|80675968|FG002|Overall Study|Death|0|||
27683432|NCT02706405|80675969|FG003|Overall Study|Death|1|||
27683433|NCT02706405|80675970|FG004|Overall Study|Death|0|||
27683434|NCT02706405|80675971|FG005|Overall Study|Death|0|||
27683435|NCT02706405|80675972|FG006|Overall Study|Death|3|||
27683436|NCT02706405|80675973|FG007|Overall Study|Death|4|||
27683437|NCT02706405|80675966|FG000|Overall Study|Disease progression|0|||
27683438|NCT02706405|80675967|FG001|Overall Study|Disease progression|0|||
27683439|NCT02706405|80675968|FG002|Overall Study|Disease progression|0|||
27683440|NCT02706405|80675969|FG003|Overall Study|Disease progression|0|||
27683441|NCT02706405|80675970|FG004|Overall Study|Disease progression|0|||
27683442|NCT02706405|80675971|FG005|Overall Study|Disease progression|0|||
27683443|NCT02706405|80675972|FG006|Overall Study|Disease progression|0|||
27683444|NCT02706405|80675973|FG007|Overall Study|Disease progression|1|||
27683445|NCT02706405|80675966|FG000|Overall Study|Pt moved to new therapy|0|||
27683446|NCT02706405|80675967|FG001|Overall Study|Pt moved to new therapy|0|||
27683447|NCT02706405|80675968|FG002|Overall Study|Pt moved to new therapy|0|||
27683448|NCT02706405|80675969|FG003|Overall Study|Pt moved to new therapy|0|||
27683449|NCT02706405|80675970|FG004|Overall Study|Pt moved to new therapy|0|||
27683450|NCT02706405|80675971|FG005|Overall Study|Pt moved to new therapy|1|||
27683451|NCT02706405|80675972|FG006|Overall Study|Pt moved to new therapy|0|||
27683452|NCT02706405|80675973|FG007|Overall Study|Pt moved to new therapy|1|||
27683453|NCT02706405|80675966|FG000|Overall Study|Physician Decision|1|||
27683454|NCT02706405|80675967|FG001|Overall Study|Physician Decision|0|||
27683455|NCT02706405|80675968|FG002|Overall Study|Physician Decision|0|||
27683456|NCT02706405|80675969|FG003|Overall Study|Physician Decision|0|||
27683457|NCT02706405|80675970|FG004|Overall Study|Physician Decision|0|||
27683458|NCT02706405|80675971|FG005|Overall Study|Physician Decision|0|||
28003268|NCT00101686|81842403|FG006|Overall Study|Withdrawal by Subject|7|||
28003269|NCT00101686|81842404|FG007|Overall Study|Withdrawal by Subject|7|||
28003270|NCT00101686|81842405|FG008|Overall Study|Withdrawal by Subject|8|||
28003271|NCT00101686|81842406|FG009|Overall Study|Withdrawal by Subject|9|||
28003272|NCT00423657|81842407|FG000|Overall Study|Withdrew consent|10|||
28003273|NCT00423657|81842408|FG001|Overall Study|Withdrew consent|8|||
28003274|NCT00423657|81842407|FG000|Overall Study|Non-compliance|0|||
28003275|NCT00423657|81842408|FG001|Overall Study|Non-compliance|1|||
28003276|NCT00423657|81842407|FG000|Overall Study|Other|15|||
28003277|NCT00423657|81842408|FG001|Overall Study|Other|16|||
28003278|NCT00423657|81842407|FG000|Overall Study|Request of sponsor/investigator|1|||
28003279|NCT00423657|81842408|FG001|Overall Study|Request of sponsor/investigator|0|||
28003280|NCT00859547|81842409|FG000|Overall Study|Lost to Follow-up|1|||
28003281|NCT00859547|81842409|FG000|Overall Study|Parent withdrew consent|1|||
28003282|NCT00990106|81842413|FG000|Overall Study|"too busy to continue"|1|||
28003283|NCT00990106|81842414|FG001|Overall Study|"too busy to continue"|2|||
28003284|NCT00990106|81842413|FG000|Overall Study|Lost to Follow-up|1|||
28003285|NCT00990106|81842414|FG001|Overall Study|Lost to Follow-up|3|||
28003286|NCT00990106|81842413|FG000|Overall Study|Withdrawal by Subject|2|||
28003287|NCT00990106|81842414|FG001|Overall Study|Withdrawal by Subject|1|||
28003288|NCT00990106|81842413|FG000|Overall Study|opted for open label prazosin|1|||
28003289|NCT00990106|81842414|FG001|Overall Study|opted for open label prazosin|1|||
28003290|NCT00990106|81842413|FG000|Overall Study|relocation/deployment|4|||
28003291|NCT00990106|81842414|FG001|Overall Study|relocation/deployment|1|||
28003292|NCT00990106|81842413|FG000|Overall Study|started exclusionary medication|0|||
28003293|NCT00990106|81842414|FG001|Overall Study|started exclusionary medication|1|||
27683459|NCT02706405|80675972|FG006|Overall Study|Physician Decision|0|||
27683460|NCT02706405|80675973|FG007|Overall Study|Physician Decision|0|||
27683461|NCT00862719|80675977|FG000|Overall Study|Disease Progression|5|||
28003294|NCT00990106|81842413|FG000|Overall Study|planned major surgery|0|||
28003295|NCT00990106|81842414|FG001|Overall Study|planned major surgery|1|||
28003296|NCT00990106|81842413|FG000|Overall Study|scheduling conflicts|0|||
27683462|NCT00862719|80675978|FG001|Overall Study|Disease Progression|0|||
27683463|NCT00862719|80675979|FG002|Overall Study|Disease Progression|1|||
27683464|NCT00862719|80675980|FG003|Overall Study|Disease Progression|0|||
27683465|NCT00862719|80675977|FG000|Overall Study|Death|5|||
27683466|NCT00862719|80675978|FG001|Overall Study|Death|6|||
27584352|NCT03299049|80319257|FG000|Overall Study|Protocol Violation|1|||
27584353|NCT03299049|80319258|FG001|Overall Study|Protocol Violation|1|||
27584354|NCT03299049|80319257|FG000|Overall Study|Lack of Efficacy|9|||
27584355|NCT03299049|80319258|FG001|Overall Study|Lack of Efficacy|3|||
27584356|NCT03299049|80319257|FG000|Overall Study|Adverse Event|12|||
27584357|NCT03299049|80319258|FG001|Overall Study|Adverse Event|13|||
27584358|NCT01059617|80319259|FG000|Overall Study|Other|7|||
27584359|NCT01059617|80319260|FG001|Overall Study|Other|1|||
27584360|NCT01059617|80319261|FG002|Overall Study|Other|8|||
27584361|NCT01059617|80319262|FG003|Overall Study|Other|6|||
27584362|NCT02641080|80319263|FG000|Overall Study|Physician Decision|2|||
27584363|NCT02641080|80319264|FG001|Overall Study|Physician Decision|0|||
27584364|NCT02641080|80319263|FG000|Overall Study|Withdrawal by Subject|0|||
27584365|NCT02641080|80319264|FG001|Overall Study|Withdrawal by Subject|1|||
27584366|NCT02641080|80319263|FG000|Overall Study|Rehab Center denied use of pumps|0|||
27584367|NCT02641080|80319264|FG001|Overall Study|Rehab Center denied use of pumps|3|||
27584368|NCT02641080|80319263|FG000|Overall Study|Lost to Follow-up|0|||
27584369|NCT02641080|80319264|FG001|Overall Study|Lost to Follow-up|3|||
27584370|NCT01296568|80321844|FG000|Continued Access Phase|Lost to Follow-up|1|||
27807480|NCT01698320|81127150|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
27807481|NCT01698320|81127148|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
27807482|NCT01698320|81127149|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
27807483|NCT01698320|81127150|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
27807484|NCT01698320|81127148|FG000|12-Week Double-Blind Period|Pregnancy|0|||
28003297|NCT00990106|81842414|FG001|Overall Study|scheduling conflicts|2|||
28003298|NCT00467740|81842420|FG000|Overall Study|Adverse Event|0|||
28003299|NCT00467740|81842421|FG001|Overall Study|Adverse Event|0|||
28003300|NCT00467740|81842422|FG002|Overall Study|Adverse Event|1|||
28003301|NCT00467740|81842423|FG003|Overall Study|Adverse Event|0|||
28003302|NCT00467740|81842424|FG004|Overall Study|Adverse Event|0|||
28003303|NCT00467740|81842420|FG000|Overall Study|Protocol Violation|0|||
28003304|NCT00467740|81842421|FG001|Overall Study|Protocol Violation|0|||
28003305|NCT00467740|81842422|FG002|Overall Study|Protocol Violation|1|||
28003306|NCT00467740|81842423|FG003|Overall Study|Protocol Violation|0|||
28003307|NCT00467740|81842424|FG004|Overall Study|Protocol Violation|0|||
28003308|NCT00467740|81842420|FG000|Overall Study|Lost to Follow-up|0|||
28003309|NCT00467740|81842421|FG001|Overall Study|Lost to Follow-up|1|||
28003310|NCT00467740|81842422|FG002|Overall Study|Lost to Follow-up|0|||
27584371|NCT01296568|80321844|FG000|Continued Access Phase|Withdrawal by Subject|1|||
27584372|NCT01296568|80321844|FG000|Continued Access Phase|Disease Progression|1|||
27584373|NCT00709722|80321845|FG000|Overall Study|Adverse Event|1|||
27584374|NCT00003498|80321850|FG000|Overall Study|Not evaluable.|4|||
27807485|NCT01698320|81127149|FG001|12-Week Double-Blind Period|Pregnancy|1|||
28003311|NCT00467740|81842423|FG003|Overall Study|Lost to Follow-up|0|||
28003312|NCT00467740|81842424|FG004|Overall Study|Lost to Follow-up|0|||
28003313|NCT00467740|81842420|FG000|Overall Study|Withdrawal by Subject|1|||
27807486|NCT01698320|81127150|FG002|12-Week Double-Blind Period|Pregnancy|1|||
27874273|NCT01578239|81371699|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
27874274|NCT01578239|81371700|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
28003314|NCT00467740|81842421|FG001|Overall Study|Withdrawal by Subject|1|||
28003315|NCT00467740|81842422|FG002|Overall Study|Withdrawal by Subject|0|||
28003316|NCT00467740|81842423|FG003|Overall Study|Withdrawal by Subject|1|||
28003317|NCT00467740|81842424|FG004|Overall Study|Withdrawal by Subject|0|||
28003318|NCT00467740|81842420|FG000|Overall Study|Lack of Efficacy|0|||
28003319|NCT00467740|81842421|FG001|Overall Study|Lack of Efficacy|1|||
27584375|NCT02696850|80321854|FG000|Overall Study|Withdrawal by Subject|3|||
27584376|NCT02696850|80321855|FG001|Overall Study|Withdrawal by Subject|3|||
27584377|NCT02696850|80321854|FG000|Overall Study|Lost to Follow-up|8|||
27584378|NCT02696850|80321855|FG001|Overall Study|Lost to Follow-up|5|||
27683467|NCT00862719|80675979|FG002|Overall Study|Death|1|||
27807487|NCT01698320|81127148|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
28003320|NCT00467740|81842422|FG002|Overall Study|Lack of Efficacy|0|||
28003321|NCT00467740|81842423|FG003|Overall Study|Lack of Efficacy|0|||
27584379|NCT03870763|80321856|FG000|Overall Study|Study terminated by sponsor|0|||
27584380|NCT03870763|80321857|FG001|Overall Study|Study terminated by sponsor|2|||
27584381|NCT03870763|80321858|FG002|Overall Study|Study terminated by sponsor|0|||
28003322|NCT00467740|81842424|FG004|Overall Study|Lack of Efficacy|0|||
28003323|NCT02485691|81842428|FG000|Overall Study|Adverse Event|25|||
28003324|NCT02485691|81842429|FG001|Overall Study|Adverse Event|11|||
28003325|NCT02485691|81842428|FG000|Overall Study|Poor compliance to protocol|0|||
27683468|NCT00862719|80675980|FG003|Overall Study|Death|1|||
27683469|NCT00862719|80675977|FG000|Overall Study|Engraftment failure|0|||
27683470|NCT00862719|80675978|FG001|Overall Study|Engraftment failure|0|||
27683471|NCT00862719|80675979|FG002|Overall Study|Engraftment failure|1|||
27683472|NCT00862719|80675980|FG003|Overall Study|Engraftment failure|0|||
27683473|NCT00862719|80675977|FG000|Overall Study|Veno-Occlusive Disease|0|||
27683474|NCT00862719|80675978|FG001|Overall Study|Veno-Occlusive Disease|0|||
27683475|NCT00862719|80675979|FG002|Overall Study|Veno-Occlusive Disease|1|||
27683476|NCT00862719|80675980|FG003|Overall Study|Veno-Occlusive Disease|0|||
27683477|NCT02060370|80675981|FG000|Overall Study|Physician Decision|1|||
27683478|NCT00468559|80675984|FG000|Open-label Treatment Phase|Adverse Event|5|||
27683479|NCT00468559|80675985|FG001|Open-label Treatment Phase|Adverse Event|0|||
27683480|NCT00468559|80675986|FG002|Open-label Treatment Phase|Adverse Event|0|||
27683481|NCT00468559|80675984|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
27683482|NCT00468559|80675985|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
27683483|NCT00468559|80675986|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
27683484|NCT00468559|80675984|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
27683485|NCT00468559|80675985|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
27683486|NCT00468559|80675986|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
27683487|NCT00468559|80675984|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
27683488|NCT00468559|80675985|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
27683489|NCT00468559|80675986|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
27683490|NCT00468559|80675984|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
27683491|NCT00468559|80675985|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
27683492|NCT00468559|80675986|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
27683493|NCT01484431|80675987|FG000|Period 1: High Dose|Physician Decision|0|||
27683494|NCT01484431|80675988|FG001|Period 1: High Dose|Physician Decision|1|||
27683495|NCT01484431|80675989|FG002|Period 1: High Dose|Physician Decision|0|||
28003326|NCT02485691|81842429|FG001|Overall Study|Poor compliance to protocol|1|||
28003327|NCT02485691|81842428|FG000|Overall Study|Disease progression|57|||
28003328|NCT02485691|81842429|FG001|Overall Study|Disease progression|92|||
28003329|NCT02485691|81842428|FG000|Overall Study|Investigator's decision|23|||
28003330|NCT02485691|81842429|FG001|Overall Study|Investigator's decision|5|||
28003331|NCT02485691|81842428|FG000|Overall Study|Participant's request|13|||
28003332|NCT02485691|81842429|FG001|Overall Study|Participant's request|6|||
28003333|NCT02485691|81842428|FG000|Overall Study|Other reason|8|||
28003334|NCT02485691|81842429|FG001|Overall Study|Other reason|9|||
28003335|NCT02485691|81842428|FG000|Overall Study|Randomized and not treated|3|||
28003336|NCT02485691|81842429|FG001|Overall Study|Randomized and not treated|2|||
28003337|NCT01300234|81842430|FG000|Overall Study|Adverse Event|1|||
28003338|NCT01300234|81842431|FG001|Overall Study|Adverse Event|1|||
28003339|NCT01300234|81842430|FG000|Overall Study|Protocol Violation|2|||
28003340|NCT01300234|81842431|FG001|Overall Study|Protocol Violation|3|||
28003341|NCT01300234|81842430|FG000|Overall Study|Withdrawal by Subject|5|||
28003342|NCT01300234|81842431|FG001|Overall Study|Withdrawal by Subject|9|||
28003343|NCT01300234|81842430|FG000|Overall Study|Lost to Follow-up|14|||
28003344|NCT01300234|81842431|FG001|Overall Study|Lost to Follow-up|12|||
28003345|NCT01300234|81842430|FG000|Overall Study|Pregnancy|2|||
28003346|NCT01300234|81842431|FG001|Overall Study|Pregnancy|1|||
28003347|NCT01300234|81842430|FG000|Overall Study|Participant reached stopping critera|2|||
28003348|NCT01300234|81842431|FG001|Overall Study|Participant reached stopping critera|0|||
28003349|NCT01300234|81842430|FG000|Overall Study|Participant stopped medication|1|||
28003350|NCT01300234|81842431|FG001|Overall Study|Participant stopped medication|1|||
28003351|NCT01300234|81842430|FG000|Overall Study|Participant refused return to hospital|1|||
28003352|NCT01300234|81842431|FG001|Overall Study|Participant refused return to hospital|0|||
28003353|NCT00113841|81842432|FG000|Overall Study|Disease progression|0|||
28003354|NCT00113841|81842433|FG001|Overall Study|Disease progression|2|||
28003355|NCT00113841|81842432|FG000|Overall Study|Non-compliant|1|||
28003356|NCT00113841|81842433|FG001|Overall Study|Non-compliant|0|||
28003357|NCT01329263|81842439|FG000|Overall Study|Lost to Follow-up|4|||
28003358|NCT01329263|81842440|FG001|Overall Study|Lost to Follow-up|21|||
28003359|NCT01329263|81842439|FG000|Overall Study|Withdrawal by Subject|1|||
27683496|NCT01484431|80675987|FG000|Period 2|Death|0|||
28003360|NCT01329263|81842440|FG001|Overall Study|Withdrawal by Subject|2|||
28003361|NCT00985673|81842441|FG000|Overall Study|Lost to Follow-up|6|||
28003362|NCT00985673|81842442|FG001|Overall Study|Lost to Follow-up|7|||
28003363|NCT00985673|81842443|FG002|Overall Study|Lost to Follow-up|6|||
28003364|NCT00985673|81842444|FG003|Overall Study|Lost to Follow-up|10|||
28003365|NCT00985673|81842445|FG004|Overall Study|Lost to Follow-up|5|||
28003366|NCT00985673|81842446|FG005|Overall Study|Lost to Follow-up|3|||
27683497|NCT01484431|80675988|FG001|Period 2|Death|1|||
28003367|NCT00985673|81842441|FG000|Overall Study|Withdrawal by Subject|0|||
28003368|NCT00985673|81842442|FG001|Overall Study|Withdrawal by Subject|4|||
28003369|NCT00985673|81842443|FG002|Overall Study|Withdrawal by Subject|5|||
28003370|NCT00985673|81842444|FG003|Overall Study|Withdrawal by Subject|2|||
28003371|NCT00985673|81842445|FG004|Overall Study|Withdrawal by Subject|2|||
28003372|NCT00985673|81842446|FG005|Overall Study|Withdrawal by Subject|3|||
28003373|NCT00985673|81842441|FG000|Overall Study|Other|1|||
28003374|NCT00985673|81842442|FG001|Overall Study|Other|0|||
28003375|NCT00985673|81842443|FG002|Overall Study|Other|1|||
28003376|NCT00985673|81842444|FG003|Overall Study|Other|0|||
28003377|NCT00985673|81842445|FG004|Overall Study|Other|1|||
28003378|NCT00985673|81842446|FG005|Overall Study|Other|0|||
28003379|NCT02721875|81842447|FG000|Overall Study|Progressive disease/relapse|1|||
28003380|NCT02721875|81842448|FG001|Overall Study|Progressive disease/relapse|0|||
28003381|NCT02888106|81842450|FG000|Overall Study|Withdrawal by Subject|1|||
28003382|NCT02888106|81842451|FG001|Overall Study|Withdrawal by Subject|2|||
28003383|NCT02888106|81842452|FG002|Overall Study|Withdrawal by Subject|0|||
28003384|NCT02888106|81842453|FG003|Overall Study|Withdrawal by Subject|1|||
28003385|NCT02888106|81842454|FG004|Overall Study|Withdrawal by Subject|0|||
28003386|NCT02888106|81842455|FG005|Overall Study|Withdrawal by Subject|0|||
28003387|NCT02888106|81842450|FG000|Overall Study|Lost to Follow-up|1|||
28003388|NCT02888106|81842451|FG001|Overall Study|Lost to Follow-up|0|||
28003389|NCT02888106|81842452|FG002|Overall Study|Lost to Follow-up|0|||
28003390|NCT02888106|81842453|FG003|Overall Study|Lost to Follow-up|1|||
28003391|NCT02888106|81842454|FG004|Overall Study|Lost to Follow-up|0|||
28003392|NCT02888106|81842455|FG005|Overall Study|Lost to Follow-up|1|||
28003393|NCT02888106|81842450|FG000|Overall Study|Adverse Event|2|||
28003394|NCT02888106|81842451|FG001|Overall Study|Adverse Event|0|||
28003395|NCT02888106|81842452|FG002|Overall Study|Adverse Event|0|||
27683498|NCT01484431|80675989|FG002|Period 2|Death|1|||
27683499|NCT01484431|80675987|FG000|Period 2|Physician Decision|0|||
27683500|NCT01484431|80675988|FG001|Period 2|Physician Decision|0|||
27683501|NCT01484431|80675989|FG002|Period 2|Physician Decision|1|||
27683502|NCT01484431|80675987|FG000|Period 2|Non-Compliance with Study Drug|1|||
27807488|NCT01698320|81127149|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
27807489|NCT01698320|81127150|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
27807490|NCT01698320|81127148|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
27807491|NCT01698320|81127149|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
28003396|NCT02888106|81842453|FG003|Overall Study|Adverse Event|0|||
28003397|NCT02888106|81842454|FG004|Overall Study|Adverse Event|0|||
27807492|NCT01698320|81127150|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
27807493|NCT01698320|81127148|FG000|40-Week Open-Label Period|Adverse Event|0|||
27807494|NCT01698320|81127149|FG001|40-Week Open-Label Period|Adverse Event|3|||
27807495|NCT01698320|81127150|FG002|40-Week Open-Label Period|Adverse Event|2|||
27807496|NCT01698320|81127148|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
27807497|NCT01698320|81127149|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
27807498|NCT01698320|81127150|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
27807499|NCT01698320|81127148|FG000|40-Week Open-Label Period|Pregnancy|0|||
27807500|NCT01698320|81127149|FG001|40-Week Open-Label Period|Pregnancy|2|||
27807501|NCT01698320|81127150|FG002|40-Week Open-Label Period|Pregnancy|1|||
27807502|NCT01698320|81127148|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
27807503|NCT01698320|81127149|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
27807504|NCT01698320|81127150|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
27874275|NCT01578239|81371699|FG000|Long-term Follow-Up Period|Other|2|||
28003398|NCT02888106|81842455|FG005|Overall Study|Adverse Event|0|||
28003399|NCT02888106|81842450|FG000|Overall Study|Withdrawal of consent|0|||
28003400|NCT02888106|81842451|FG001|Overall Study|Withdrawal of consent|0|||
28003401|NCT02888106|81842452|FG002|Overall Study|Withdrawal of consent|0|||
28003402|NCT02888106|81842453|FG003|Overall Study|Withdrawal of consent|0|||
28003403|NCT02888106|81842454|FG004|Overall Study|Withdrawal of consent|1|||
28003404|NCT02888106|81842455|FG005|Overall Study|Withdrawal of consent|0|||
28003405|NCT02888106|81842450|FG000|Overall Study|Pregnancy|1|||
28003406|NCT02888106|81842451|FG001|Overall Study|Pregnancy|0|||
28003407|NCT02888106|81842452|FG002|Overall Study|Pregnancy|0|||
28003408|NCT02888106|81842453|FG003|Overall Study|Pregnancy|0|||
28003409|NCT02888106|81842454|FG004|Overall Study|Pregnancy|0|||
28003410|NCT02888106|81842455|FG005|Overall Study|Pregnancy|0|||
28003411|NCT00550953|81842456|FG000|Overall Study|Adverse Event|4|||
28003412|NCT00550953|81842457|FG001|Overall Study|Adverse Event|3|||
27584382|NCT03870763|80321856|FG000|Overall Study|Withdrawal by Subject|0|||
27584383|NCT03870763|80321857|FG001|Overall Study|Withdrawal by Subject|1|||
27584384|NCT03870763|80321858|FG002|Overall Study|Withdrawal by Subject|0|||
27807505|NCT01698320|81127148|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
28003413|NCT00550953|81842456|FG000|Overall Study|Not able to visit the site|2|||
28003414|NCT00550953|81842457|FG001|Overall Study|Not able to visit the site|3|||
28003415|NCT04537793|81842458|FG000|Part B (24 Weeks)|Adverse Event|0|||
28003416|NCT04537793|81842459|FG001|Part B (24 Weeks)|Adverse Event|1|||
28003417|NCT01255423|81842460|FG000|Overall Study|Abnormal Laboratory value|3|||
27807506|NCT01698320|81127149|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
27807507|NCT01698320|81127150|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
27807508|NCT00003782|81127151|FG000|Overall Study|No follow up data|30|||
27807509|NCT00003782|81127152|FG001|Overall Study|No follow up data|31|||
27807510|NCT00003782|81127153|FG002|Overall Study|No follow up data|26|||
27807511|NCT02742181|81127154|FG000|Overall Study|Physician Decision|1|||
27807512|NCT02742181|81127155|FG001|Overall Study|Physician Decision|0|||
28003418|NCT01255423|81842461|FG001|Overall Study|Abnormal Laboratory value|2|||
28003419|NCT01255423|81842460|FG000|Overall Study|Use of prohibited medications|0|||
27584385|NCT03870763|80321856|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
27584386|NCT03870763|80321857|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
27584387|NCT03870763|80321858|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
27683503|NCT01484431|80675988|FG001|Period 2|Non-Compliance with Study Drug|0|||
27807513|NCT03751020|81127157|FG000|Overall Study|Withdrawal by Subject|2|||
27807514|NCT03751020|81127158|FG001|Overall Study|Withdrawal by Subject|0|||
27807515|NCT03751020|81127159|FG002|Overall Study|Withdrawal by Subject|0|||
27807516|NCT03751020|81127157|FG000|Overall Study|Lost to Follow-up|7|||
27807517|NCT03751020|81127158|FG001|Overall Study|Lost to Follow-up|4|||
27807518|NCT03751020|81127159|FG002|Overall Study|Lost to Follow-up|10|||
27807519|NCT02622074|81127162|FG000|Overall Study|Death|4|||
27807520|NCT02622074|81127163|FG001|Overall Study|Death|0|||
27807521|NCT02622074|81127164|FG002|Overall Study|Death|0|||
28003420|NCT01255423|81842461|FG001|Overall Study|Use of prohibited medications|1|||
28003421|NCT03473236|81842462|FG000|Overall Study|Withdrawal by Subject|0|||
28003422|NCT03473236|81842463|FG001|Overall Study|Withdrawal by Subject|0|||
28003423|NCT03473236|81842464|FG002|Overall Study|Withdrawal by Subject|0|||
28003424|NCT03473236|81842465|FG003|Overall Study|Withdrawal by Subject|0|||
28003425|NCT03473236|81842466|FG004|Overall Study|Withdrawal by Subject|0|||
28003426|NCT03473236|81842467|FG005|Overall Study|Withdrawal by Subject|1|||
28003427|NCT03473236|81842468|FG006|Overall Study|Withdrawal by Subject|0|||
28003428|NCT03473236|81842469|FG007|Overall Study|Withdrawal by Subject|0|||
28003429|NCT03473236|81842470|FG008|Overall Study|Withdrawal by Subject|1|||
28003430|NCT03473236|81842471|FG009|Overall Study|Withdrawal by Subject|0|||
28003431|NCT00474955|81842480|FG000|Overall Study|Adverse Event|2|||
28003432|NCT00474955|81842480|FG000|Overall Study|Drug unavailability|1|||
28003433|NCT00474955|81842480|FG000|Overall Study|Personal reasons|5|||
28003434|NCT03353675|81842481|FG000|Overall Study|Adverse Event|4|||
28003435|NCT03050801|81842482|FG000|Experiment 1|Lost to Follow-up|0|||
28003436|NCT03050801|81842483|FG001|Experiment 1|Lost to Follow-up|1|||
27807522|NCT02622074|81127165|FG003|Overall Study|Death|1|||
27807523|NCT02622074|81127166|FG004|Overall Study|Death|1|||
27807524|NCT02622074|81127167|FG005|Overall Study|Death|0|||
27807525|NCT02622074|81127162|FG000|Overall Study|Withdrawal by Subject|0|||
28003437|NCT03050801|81842484|FG002|Experiment 1|Lost to Follow-up|0|||
28003438|NCT03050801|81842485|FG003|Experiment 1|Lost to Follow-up|0|||
28003439|NCT03050801|81842486|FG004|Experiment 1|Lost to Follow-up|0|||
28003440|NCT03050801|81842487|FG005|Experiment 1|Lost to Follow-up|0|||
28003441|NCT03050801|81842482|FG000|Experiment 1|Physician Decision|0|||
28003442|NCT03050801|81842483|FG001|Experiment 1|Physician Decision|3|||
28003443|NCT03050801|81842484|FG002|Experiment 1|Physician Decision|0|||
28003444|NCT03050801|81842485|FG003|Experiment 1|Physician Decision|0|||
28003445|NCT03050801|81842486|FG004|Experiment 1|Physician Decision|0|||
28003446|NCT03050801|81842487|FG005|Experiment 1|Physician Decision|0|||
28003447|NCT03050801|81842482|FG000|Experiment 1|Change of experimental design|0|||
28003448|NCT03050801|81842483|FG001|Experiment 1|Change of experimental design|3|||
28003449|NCT03050801|81842484|FG002|Experiment 1|Change of experimental design|0|||
28003450|NCT03050801|81842485|FG003|Experiment 1|Change of experimental design|0|||
28003451|NCT03050801|81842486|FG004|Experiment 1|Change of experimental design|0|||
28003452|NCT03050801|81842487|FG005|Experiment 1|Change of experimental design|0|||
28003453|NCT03050801|81842482|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
28003454|NCT03050801|81842483|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
27683504|NCT01484431|80675989|FG002|Period 2|Non-Compliance with Study Drug|0|||
27683505|NCT02217475|80675990|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
27683506|NCT02217475|80675991|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
27683507|NCT02217475|80675992|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
27683508|NCT02217475|80675990|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
27683509|NCT02217475|80675991|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
27683510|NCT02217475|80675992|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
27683511|NCT02217475|80675990|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
27683512|NCT02217475|80675991|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
27683513|NCT02217475|80675992|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
27683514|NCT02217475|80675990|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
27683515|NCT02217475|80675991|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
27683516|NCT02217475|80675992|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
27807526|NCT02622074|81127163|FG001|Overall Study|Withdrawal by Subject|1|||
27807527|NCT02622074|81127164|FG002|Overall Study|Withdrawal by Subject|0|||
27807528|NCT02622074|81127165|FG003|Overall Study|Withdrawal by Subject|0|||
27807529|NCT02622074|81127166|FG004|Overall Study|Withdrawal by Subject|0|||
27807530|NCT02622074|81127167|FG005|Overall Study|Withdrawal by Subject|0|||
27807531|NCT01017029|81127168|FG000|Overall Study|Lost to Follow-up|1|||
27807532|NCT01017029|81127169|FG001|Overall Study|Lost to Follow-up|0|||
27807533|NCT01017029|81127168|FG000|Overall Study|Administrative problem|0|||
27807534|NCT01017029|81127169|FG001|Overall Study|Administrative problem|1|||
27807535|NCT01017029|81127168|FG000|Overall Study|Death|3|||
27807536|NCT01017029|81127169|FG001|Overall Study|Death|1|||
27874276|NCT01578239|81371700|FG001|Long-term Follow-Up Period|Other|2|||
27874277|NCT01827111|81371701|FG000|Overall Study|Disease Progression|1|||
27807537|NCT00415532|81127170|FG000|Treatment Period|Adverse Event|2|||
28003455|NCT03050801|81842484|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
28003456|NCT03050801|81842485|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
28003457|NCT03050801|81842486|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
27683517|NCT02217475|80675990|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
27683518|NCT02217475|80675991|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
27683519|NCT02217475|80675992|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
27683520|NCT02217475|80675990|FG000|Discontinued After Period 1|Adverse Event|1|||
28003458|NCT03050801|81842487|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
27683521|NCT02217475|80675991|FG001|Discontinued After Period 1|Adverse Event|2|||
27807538|NCT00415532|81127171|FG001|Treatment Period|Adverse Event|3|||
27807539|NCT00415532|81127170|FG000|Treatment Period|Death|2|||
27807540|NCT00415532|81127171|FG001|Treatment Period|Death|1|||
27807541|NCT00415532|81127170|FG000|Treatment Period|Lost to Follow-up|1|||
27807542|NCT00415532|81127171|FG001|Treatment Period|Lost to Follow-up|1|||
27807543|NCT00415532|81127170|FG000|Treatment Period|Protocol Violation|1|||
27807544|NCT00415532|81127171|FG001|Treatment Period|Protocol Violation|0|||
27807545|NCT00415532|81127170|FG000|Treatment Period|Withdrawal by Subject|6|||
27807546|NCT00415532|81127171|FG001|Treatment Period|Withdrawal by Subject|6|||
27807547|NCT00415532|81127170|FG000|Treatment Period|Other|2|||
27807548|NCT00415532|81127171|FG001|Treatment Period|Other|2|||
27807549|NCT00415532|81127170|FG000|Treatment Period|Ineligibility determined|1|||
27807550|NCT00415532|81127171|FG001|Treatment Period|Ineligibility determined|1|||
27807551|NCT00415532|81127170|FG000|Treatment Period|Noncompliance|1|||
27807552|NCT00415532|81127171|FG001|Treatment Period|Noncompliance|1|||
27807553|NCT00415532|81127170|FG000|Treatment Period|Requirement for alternative therapy|1|||
27807554|NCT00415532|81127171|FG001|Treatment Period|Requirement for alternative therapy|0|||
27807555|NCT00415532|81127170|FG000|Safety Follow Up Period|Adverse Event|1|||
27807556|NCT00415532|81127171|FG001|Safety Follow Up Period|Adverse Event|3|||
28003459|NCT03050801|81842482|FG000|Experiment 2|Lost to Follow-up|0|||
27807557|NCT00415532|81127170|FG000|Safety Follow Up Period|Death|3|||
28003460|NCT03050801|81842483|FG001|Experiment 2|Lost to Follow-up|0|||
28003461|NCT03050801|81842484|FG002|Experiment 2|Lost to Follow-up|0|||
28003462|NCT03050801|81842485|FG003|Experiment 2|Lost to Follow-up|1|||
28003463|NCT03050801|81842486|FG004|Experiment 2|Lost to Follow-up|1|||
28003464|NCT03050801|81842487|FG005|Experiment 2|Lost to Follow-up|0|||
28003465|NCT03050801|81842482|FG000|Experiment 2|Physician Decision|0|||
28003466|NCT03050801|81842483|FG001|Experiment 2|Physician Decision|0|||
28003467|NCT03050801|81842484|FG002|Experiment 2|Physician Decision|0|||
28003468|NCT03050801|81842485|FG003|Experiment 2|Physician Decision|0|||
28003469|NCT03050801|81842486|FG004|Experiment 2|Physician Decision|1|||
28003470|NCT03050801|81842487|FG005|Experiment 2|Physician Decision|0|||
28003471|NCT03050801|81842482|FG000|Experiment 2|Pregnancy|0|||
28003472|NCT03050801|81842483|FG001|Experiment 2|Pregnancy|0|||
27683522|NCT02217475|80675992|FG002|Discontinued After Period 1|Adverse Event|0|||
27683523|NCT02217475|80675990|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
27683524|NCT02217475|80675991|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
27807558|NCT00415532|81127171|FG001|Safety Follow Up Period|Death|0|||
27807559|NCT00415532|81127170|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
27807560|NCT00415532|81127171|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
28003473|NCT03050801|81842484|FG002|Experiment 2|Pregnancy|0|||
28003474|NCT03050801|81842485|FG003|Experiment 2|Pregnancy|0|||
28003475|NCT03050801|81842486|FG004|Experiment 2|Pregnancy|1|||
28003476|NCT03050801|81842487|FG005|Experiment 2|Pregnancy|0|||
28003477|NCT03050801|81842482|FG000|Experiment 2|Withdrawal by Subject|0|||
28003478|NCT03050801|81842483|FG001|Experiment 2|Withdrawal by Subject|0|||
28003479|NCT03050801|81842484|FG002|Experiment 2|Withdrawal by Subject|0|||
28003480|NCT03050801|81842485|FG003|Experiment 2|Withdrawal by Subject|1|||
28003481|NCT03050801|81842486|FG004|Experiment 2|Withdrawal by Subject|0|||
28003482|NCT03050801|81842487|FG005|Experiment 2|Withdrawal by Subject|0|||
28003483|NCT03050801|81842482|FG000|Experiment 2|Poor data quality|0|||
28003484|NCT03050801|81842483|FG001|Experiment 2|Poor data quality|0|||
27683525|NCT02217475|80675992|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
27683526|NCT02217475|80675990|FG000|Discontinued After Period 1|Physician Decision|0|||
27683527|NCT02217475|80675991|FG001|Discontinued After Period 1|Physician Decision|0|||
27683528|NCT02217475|80675992|FG002|Discontinued After Period 1|Physician Decision|1|||
27683529|NCT02217475|80675990|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
27683530|NCT02217475|80675991|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
27807561|NCT00415532|81127170|FG000|Safety Follow Up Period|Other|1|||
27807562|NCT00415532|81127171|FG001|Safety Follow Up Period|Other|4|||
27807563|NCT00415532|81127170|FG000|Safety Follow Up Period|Ineligibility determined|1|||
28003485|NCT03050801|81842484|FG002|Experiment 2|Poor data quality|0|||
27807564|NCT00415532|81127171|FG001|Safety Follow Up Period|Ineligibility determined|1|||
27584388|NCT02194621|80321861|FG000|Overall Study|6 withdrew prior to randomization|2|||
27584389|NCT02194621|80321862|FG001|Overall Study|6 withdrew prior to randomization|2|||
27584390|NCT02194621|80321863|FG002|Overall Study|6 withdrew prior to randomization|2|||
27807565|NCT00415532|81127170|FG000|Safety Follow Up Period|Noncompliance|1|||
27584391|NCT02194621|80321861|FG000|Overall Study|Withdrawal by Subject|4|||
27683531|NCT02217475|80675992|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
27807566|NCT00415532|81127171|FG001|Safety Follow Up Period|Noncompliance|0|||
27807567|NCT00415532|81127170|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
27807568|NCT00415532|81127171|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
27807569|NCT01084603|81127172|FG000|Baseline|Withdrawal by Subject|2|||
28003486|NCT03050801|81842485|FG003|Experiment 2|Poor data quality|4|||
28003487|NCT03050801|81842486|FG004|Experiment 2|Poor data quality|1|||
27807570|NCT01084603|81127172|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
27807571|NCT01084603|81127172|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
27807572|NCT01084603|81127172|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
27807573|NCT01084603|81127172|FG000|Washout Period 4|Adverse Event|1|||
27807574|NCT01427803|81127175|FG000|Overall Study|Lost to Follow-up|32|||
27807575|NCT01427803|81127176|FG001|Overall Study|Lost to Follow-up|26|||
27807576|NCT01427803|81127175|FG000|Overall Study|Withdrawal by Subject|20|||
27874278|NCT01777282|81371702|FG000|Overall Study|Persistent Hyperglycemia|0|||
27874279|NCT01777282|81371703|FG001|Overall Study|Persistent Hyperglycemia|0|||
28003488|NCT03050801|81842487|FG005|Experiment 2|Poor data quality|0|||
27584392|NCT02194621|80321862|FG001|Overall Study|Withdrawal by Subject|4|||
27683532|NCT02217475|80675990|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
27683533|NCT02217475|80675991|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
28003489|NCT03050801|81842482|FG000|Experiment 2|Discomfort during stimulation|0|||
28003490|NCT03050801|81842483|FG001|Experiment 2|Discomfort during stimulation|0|||
28003491|NCT03050801|81842484|FG002|Experiment 2|Discomfort during stimulation|0|||
28003492|NCT03050801|81842485|FG003|Experiment 2|Discomfort during stimulation|0|||
27584393|NCT02194621|80321863|FG002|Overall Study|Withdrawal by Subject|7|||
27584394|NCT02417246|80321864|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
27584395|NCT02417246|80321865|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
28003493|NCT03050801|81842486|FG004|Experiment 2|Discomfort during stimulation|0|||
28003494|NCT03050801|81842487|FG005|Experiment 2|Discomfort during stimulation|2|||
28003495|NCT00866177|81842488|FG000|Overall Study|Withdrawal by Subject|1|||
28003496|NCT00866177|81842488|FG000|Overall Study|Not Treated|151|||
28003497|NCT00539981|81842489|FG000|Overall Study|Adverse events (AE)|3|||
28003498|NCT00539981|81842490|FG001|Overall Study|Adverse events (AE)|3|||
27584396|NCT02417246|80321864|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
27584397|NCT02417246|80321865|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
27584398|NCT02417246|80321864|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
27584399|NCT02417246|80321865|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
27584400|NCT02417246|80321864|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
27584401|NCT02417246|80321865|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
27584402|NCT00214136|80321869|FG000|Overall Study|Death|5|||
27584403|NCT02121847|80321873|FG000|Overall Study|Administrative Reasons|1|||
27584404|NCT02121847|80321873|FG000|Overall Study|Adverse Event|2|||
27584405|NCT02553330|80321879|FG000|Overall Study|Study Terminated by Sponsor|2|||
28003499|NCT00539981|81842489|FG000|Overall Study|Lost to Follow-up|260|||
28003500|NCT00539981|81842490|FG001|Overall Study|Lost to Follow-up|251|||
28003501|NCT00539981|81842489|FG000|Overall Study|Withdrew consent|22|||
27584406|NCT02553330|80321880|FG001|Overall Study|Study Terminated by Sponsor|13|||
27584407|NCT02553330|80321881|FG002|Overall Study|Study Terminated by Sponsor|12|||
27584408|NCT02553330|80321879|FG000|Overall Study|Withdrawal by Subject|3|||
27584409|NCT02553330|80321880|FG001|Overall Study|Withdrawal by Subject|19|||
27584410|NCT02553330|80321881|FG002|Overall Study|Withdrawal by Subject|21|||
27584411|NCT02553330|80321879|FG000|Overall Study|Other|0|||
27584412|NCT02553330|80321880|FG001|Overall Study|Other|1|||
27584413|NCT02553330|80321881|FG002|Overall Study|Other|0|||
27584414|NCT02553330|80321879|FG000|Overall Study|Non compliance to study treatment|0|||
27584415|NCT02553330|80321880|FG001|Overall Study|Non compliance to study treatment|1|||
27584416|NCT02553330|80321881|FG002|Overall Study|Non compliance to study treatment|0|||
27584417|NCT02553330|80321879|FG000|Overall Study|Adverse Event|0|||
27584418|NCT02553330|80321880|FG001|Overall Study|Adverse Event|1|||
27584419|NCT02553330|80321881|FG002|Overall Study|Adverse Event|0|||
27584420|NCT02553330|80321879|FG000|Overall Study|Lost to Follow-up|0|||
27584421|NCT02553330|80321880|FG001|Overall Study|Lost to Follow-up|4|||
27584422|NCT02553330|80321881|FG002|Overall Study|Lost to Follow-up|4|||
27584423|NCT04558346|80321882|FG000|Overall Study|Withdrawal by Subject|2|||
27584424|NCT04558346|80321883|FG001|Overall Study|Withdrawal by Subject|0|||
27584425|NCT04558346|80321882|FG000|Overall Study|Lost to Follow-up|0|||
27584426|NCT04558346|80321883|FG001|Overall Study|Lost to Follow-up|1|||
27584427|NCT04558346|80321882|FG000|Overall Study|Adverse Event|0|||
27584428|NCT04558346|80321883|FG001|Overall Study|Adverse Event|1|||
27584429|NCT00364858|80321884|FG000|Overall Study|Adverse Event|1|||
27584430|NCT00364858|80321885|FG001|Overall Study|Adverse Event|5|||
27584431|NCT00364858|80321884|FG000|Overall Study|Withdrawal by Subject|1|||
27584432|NCT00364858|80321885|FG001|Overall Study|Withdrawal by Subject|1|||
27584433|NCT00364858|80321884|FG000|Overall Study|Pregnancy|1|||
27584434|NCT00364858|80321885|FG001|Overall Study|Pregnancy|1|||
27584435|NCT00364858|80321884|FG000|Overall Study|Clinical failure|2|||
27584436|NCT00364858|80321885|FG001|Overall Study|Clinical failure|13|||
28003502|NCT00539981|81842490|FG001|Overall Study|Withdrew consent|14|||
28003503|NCT00539981|81842489|FG000|Overall Study|Death|1|||
28003504|NCT00539981|81842490|FG001|Overall Study|Death|1|||
27584437|NCT00364858|80321884|FG000|Overall Study|Discontinuation at baseline|1|||
27584438|NCT00364858|80321885|FG001|Overall Study|Discontinuation at baseline|0|||
27584439|NCT00364858|80321884|FG000|Overall Study|Non-compliant|1|||
27584440|NCT00364858|80321885|FG001|Overall Study|Non-compliant|0|||
27584441|NCT00364858|80321884|FG000|Overall Study|Return to Q2 regimen|0|||
27584442|NCT00364858|80321885|FG001|Overall Study|Return to Q2 regimen|1|||
28003505|NCT00539981|81842489|FG000|Overall Study|Other reason-unspecified|9|||
28003506|NCT00539981|81842490|FG001|Overall Study|Other reason-unspecified|13|||
28003507|NCT02859246|81842492|FG000|Overall Study|Screen fails|3|||
27584443|NCT00364858|80321884|FG000|Overall Study|Clinical baseline issue|0|||
27584444|NCT00364858|80321885|FG001|Overall Study|Clinical baseline issue|1|||
27683534|NCT02217475|80675992|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
27683535|NCT02217475|80675990|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
27683536|NCT02217475|80675991|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
27683537|NCT02217475|80675992|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
27683538|NCT02217475|80675990|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
27683539|NCT02217475|80675991|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
27683540|NCT02217475|80675992|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
27683541|NCT02217475|80675990|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
27683542|NCT02217475|80675991|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
27683543|NCT02217475|80675992|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
27683544|NCT01977677|80675993|FG000|Overall Study|Unrelated Adverse Event|0|||
27683545|NCT01977677|80675994|FG001|Overall Study|Unrelated Adverse Event|0|||
27683546|NCT01977677|80675995|FG002|Overall Study|Unrelated Adverse Event|1|||
27683547|NCT01879553|80675996|FG000|Overall Study|Withdrawal by Subject|1|||
27683548|NCT01879553|80675997|FG001|Overall Study|Withdrawal by Subject|0|||
27683549|NCT02334423|80675998|FG000|Overall Study|Protocol Violation|10|||
27683550|NCT02334423|80675999|FG001|Overall Study|Protocol Violation|3|||
27683551|NCT01518153|80676000|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
27807577|NCT01427803|81127176|FG001|Overall Study|Withdrawal by Subject|0|||
27807578|NCT01427803|81127175|FG000|Overall Study|Unable to complete full treatment period|6|||
27807579|NCT01427803|81127176|FG001|Overall Study|Unable to complete full treatment period|0|||
27807580|NCT01427803|81127175|FG000|Overall Study|Protocol Violation|1|||
27807581|NCT01427803|81127176|FG001|Overall Study|Protocol Violation|0|||
27807582|NCT01427803|81127175|FG000|Overall Study|Physician Decision|3|||
27807583|NCT01427803|81127176|FG001|Overall Study|Physician Decision|0|||
27807584|NCT01427803|81127175|FG000|Overall Study|did not take product|1|||
27807585|NCT01427803|81127176|FG001|Overall Study|did not take product|0|||
27807586|NCT03137082|81127177|FG000|Overall Study|Withdrawal by Subject|1|||
27807587|NCT03137082|81127178|FG001|Overall Study|Withdrawal by Subject|1|||
27807588|NCT03137082|81127177|FG000|Overall Study|Lost to Follow-up|1|||
27807589|NCT03137082|81127178|FG001|Overall Study|Lost to Follow-up|0|||
27807590|NCT02762565|81127181|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
27807591|NCT01326702|81127182|FG000|Overall Study|Other|1|||
27807592|NCT01326702|81127183|FG001|Overall Study|Other|0|||
27807593|NCT01326702|81127184|FG002|Overall Study|Other|0|||
27807594|NCT01326702|81127185|FG003|Overall Study|Other|0|||
27807595|NCT01326702|81127186|FG004|Overall Study|Other|0|||
27807596|NCT01326702|81127187|FG005|Overall Study|Other|1|||
27807597|NCT01326702|81127188|FG006|Overall Study|Other|0|||
27807598|NCT01326702|81127182|FG000|Overall Study|progressive disease|1|||
27807599|NCT01326702|81127183|FG001|Overall Study|progressive disease|1|||
27807600|NCT01326702|81127184|FG002|Overall Study|progressive disease|3|||
27807601|NCT01326702|81127185|FG003|Overall Study|progressive disease|1|||
27807602|NCT01326702|81127186|FG004|Overall Study|progressive disease|3|||
27807603|NCT01326702|81127187|FG005|Overall Study|progressive disease|2|||
27807604|NCT01326702|81127188|FG006|Overall Study|progressive disease|3|||
27807605|NCT01326702|81127182|FG000|Overall Study|Death|0|||
27807606|NCT01326702|81127183|FG001|Overall Study|Death|1|||
27807607|NCT01326702|81127184|FG002|Overall Study|Death|0|||
27807608|NCT01326702|81127185|FG003|Overall Study|Death|0|||
27807609|NCT01326702|81127186|FG004|Overall Study|Death|0|||
27807610|NCT01326702|81127187|FG005|Overall Study|Death|0|||
27807611|NCT01326702|81127188|FG006|Overall Study|Death|0|||
27807612|NCT01326702|81127182|FG000|Overall Study|Adverse Event|0|||
27807613|NCT01326702|81127183|FG001|Overall Study|Adverse Event|0|||
27807614|NCT01326702|81127184|FG002|Overall Study|Adverse Event|1|||
27807615|NCT01326702|81127185|FG003|Overall Study|Adverse Event|1|||
27807616|NCT01326702|81127186|FG004|Overall Study|Adverse Event|0|||
27807617|NCT01326702|81127187|FG005|Overall Study|Adverse Event|3|||
27807618|NCT01326702|81127188|FG006|Overall Study|Adverse Event|1|||
27807619|NCT01326702|81127182|FG000|Overall Study|Withdrawal by Subject|0|||
27807620|NCT01326702|81127183|FG001|Overall Study|Withdrawal by Subject|0|||
27807621|NCT01326702|81127184|FG002|Overall Study|Withdrawal by Subject|1|||
27683552|NCT01518153|80676001|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
27683553|NCT01518153|80676002|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
27683554|NCT01518153|80676000|FG000|Stem Cell Transplant|Death|2|||
27807622|NCT01326702|81127185|FG003|Overall Study|Withdrawal by Subject|0|||
27807623|NCT01326702|81127186|FG004|Overall Study|Withdrawal by Subject|1|||
27807624|NCT01326702|81127187|FG005|Overall Study|Withdrawal by Subject|1|||
27807625|NCT01326702|81127188|FG006|Overall Study|Withdrawal by Subject|3|||
27807626|NCT01326702|81127182|FG000|Overall Study|Not Treated|0|||
27807627|NCT01326702|81127183|FG001|Overall Study|Not Treated|0|||
27807628|NCT01326702|81127184|FG002|Overall Study|Not Treated|0|||
27807629|NCT01326702|81127185|FG003|Overall Study|Not Treated|1|||
27807630|NCT01326702|81127186|FG004|Overall Study|Not Treated|0|||
27807631|NCT01326702|81127187|FG005|Overall Study|Not Treated|1|||
27807632|NCT01326702|81127188|FG006|Overall Study|Not Treated|0|||
27807633|NCT00475852|81127189|FG000|Overall Study|Death|444|||
27683555|NCT01518153|80676001|FG001|Stem Cell Transplant|Death|0|||
27683556|NCT01518153|80676002|FG002|Stem Cell Transplant|Death|0|||
27683557|NCT01518153|80676000|FG000|Stem Cell Transplant|Secondary graft failure|1|||
27683558|NCT01518153|80676001|FG001|Stem Cell Transplant|Secondary graft failure|0|||
27683559|NCT01518153|80676002|FG002|Stem Cell Transplant|Secondary graft failure|0|||
27683560|NCT01518153|80676000|FG000|Stem Cell Transplant|Adverse Event|1|||
27683561|NCT01518153|80676001|FG001|Stem Cell Transplant|Adverse Event|0|||
27683562|NCT01518153|80676002|FG002|Stem Cell Transplant|Adverse Event|0|||
27683563|NCT01518153|80676000|FG000|Donor Lymphocyte Infusion|Death|0|||
27683564|NCT01518153|80676001|FG001|Donor Lymphocyte Infusion|Death|2|||
27683565|NCT01518153|80676002|FG002|Donor Lymphocyte Infusion|Death|1|||
27683566|NCT03592745|80676003|FG000|Overall Study|Adverse Event|0|||
27683567|NCT03592745|80676004|FG001|Overall Study|Adverse Event|2|||
27683568|NCT03592745|80676003|FG000|Overall Study|Lost to Follow-up|2|||
28003508|NCT02859246|81842492|FG000|Overall Study|Adverse Event|1|||
28003509|NCT02859246|81842492|FG000|Overall Study|Withdrawal by Subject|1|||
28003510|NCT04426318|81842494|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
28003511|NCT04426318|81842495|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
28003512|NCT00660192|81842496|FG000|Overall Study|Lost to Follow-up|2|||
28003513|NCT00660192|81842497|FG001|Overall Study|Lost to Follow-up|3|||
28003514|NCT05470387|81842498|FG000|Overall Study|Protocol Violation|0|||
28003515|NCT05470387|81842499|FG001|Overall Study|Protocol Violation|3|||
28003516|NCT02748863|81842501|FG000|Treatment Period 1|Adverse Event|0|||
28003517|NCT02748863|81842502|FG001|Treatment Period 1|Adverse Event|1|||
28003518|NCT02748863|81842503|FG002|Treatment Period 1|Adverse Event|0|||
28003519|NCT02748863|81842504|FG003|Treatment Period 1|Adverse Event|0|||
28003520|NCT02748863|81842505|FG004|Treatment Period 1|Adverse Event|0|||
28003521|NCT02748863|81842501|FG000|Treatment Period 1|Lack of Efficacy|0|||
28003522|NCT02748863|81842502|FG001|Treatment Period 1|Lack of Efficacy|0|||
28003523|NCT02748863|81842503|FG002|Treatment Period 1|Lack of Efficacy|1|||
28003524|NCT02748863|81842504|FG003|Treatment Period 1|Lack of Efficacy|0|||
28003525|NCT02748863|81842505|FG004|Treatment Period 1|Lack of Efficacy|0|||
28003526|NCT02748863|81842501|FG000|Treatment Period 1|Withdrawal by Subject|0|||
28003527|NCT02748863|81842502|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27683569|NCT03592745|80676004|FG001|Overall Study|Lost to Follow-up|0|||
27683570|NCT03592745|80676003|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
27683571|NCT03592745|80676004|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
27683572|NCT02113124|80676005|FG000|Overall Study|Unable to retrieve blood sample|1|||
27683573|NCT02113124|80676006|FG001|Overall Study|Unable to retrieve blood sample|1|||
27683574|NCT04400487|80676009|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
27683575|NCT04400487|80676009|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
27683576|NCT04400487|80676009|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
27683577|NCT02550938|80676011|FG000|Overall Study|Lost to Follow-up|8|||
27683578|NCT02550938|80676012|FG001|Overall Study|Lost to Follow-up|7|||
27683579|NCT02550938|80676013|FG002|Overall Study|Lost to Follow-up|12|||
27683580|NCT02550938|80676014|FG003|Overall Study|Lost to Follow-up|11|||
27683581|NCT00400725|80676015|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
27683582|NCT00400725|80676016|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
27683583|NCT00400725|80676017|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
27683584|NCT00400725|80676015|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
27683585|NCT00400725|80676016|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
27683586|NCT00400725|80676017|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
27683587|NCT00400725|80676015|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
27683588|NCT00400725|80676016|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
27683589|NCT00400725|80676017|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
27683590|NCT00400725|80676015|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
27683591|NCT00400725|80676016|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
27683592|NCT00400725|80676017|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
27683593|NCT00400725|80676015|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
27683594|NCT00400725|80676016|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
27683595|NCT00400725|80676017|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
27683596|NCT00400725|80676015|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
27807634|NCT00475852|81127190|FG001|Overall Study|Death|456|||
28003528|NCT02748863|81842503|FG002|Treatment Period 1|Withdrawal by Subject|1|||
28003529|NCT02748863|81842504|FG003|Treatment Period 1|Withdrawal by Subject|0|||
28003530|NCT02748863|81842505|FG004|Treatment Period 1|Withdrawal by Subject|0|||
28003531|NCT02748863|81842501|FG000|Treatment Period 2|Lost to Follow-up|2|||
28003532|NCT02748863|81842502|FG001|Treatment Period 2|Lost to Follow-up|0|||
27683597|NCT00400725|80676016|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
27683598|NCT00400725|80676017|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
27683599|NCT00400725|80676015|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
27683600|NCT00400725|80676016|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
27584445|NCT02219932|80321886|FG000|Overall Study|Other|5|||
27584446|NCT02219932|80321887|FG001|Overall Study|Other|11|||
27584447|NCT02219932|80321886|FG000|Overall Study|Death|1|||
27584448|NCT02219932|80321887|FG001|Overall Study|Death|1|||
27584449|NCT02219932|80321886|FG000|Overall Study|Investigator Decision|0|||
27584450|NCT02219932|80321887|FG001|Overall Study|Investigator Decision|1|||
27584451|NCT02219932|80321886|FG000|Overall Study|Consent Withdrawn|11|||
27584452|NCT02219932|80321887|FG001|Overall Study|Consent Withdrawn|7|||
27584453|NCT02219932|80321886|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
27584454|NCT02219932|80321887|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
27584455|NCT02219932|80321886|FG000|Overall Study|Protocol Violation|10|||
27584456|NCT02219932|80321887|FG001|Overall Study|Protocol Violation|6|||
27584457|NCT02219932|80321886|FG000|Overall Study|Pregnancy|1|||
27584458|NCT02219932|80321887|FG001|Overall Study|Pregnancy|0|||
27584459|NCT02219932|80321886|FG000|Overall Study|Lost to Follow-up|4|||
27584460|NCT02219932|80321887|FG001|Overall Study|Lost to Follow-up|2|||
27584461|NCT02219932|80321886|FG000|Overall Study|Adverse Event|23|||
27584462|NCT02219932|80321887|FG001|Overall Study|Adverse Event|21|||
27584463|NCT02239510|80321888|FG000|Overall Study|Lost to Follow-up|2|||
27584464|NCT02239510|80321889|FG001|Overall Study|Lost to Follow-up|1|||
27584465|NCT01782131|80321890|FG000|Overall Study|Death|93|||
27584466|NCT01782131|80321891|FG001|Overall Study|Death|96|||
27584467|NCT01782131|80321890|FG000|Overall Study|Lost to Follow-up|1|||
27584468|NCT01782131|80321891|FG001|Overall Study|Lost to Follow-up|3|||
27584469|NCT01782131|80321890|FG000|Overall Study|Withdrawal by Subject|10|||
27584470|NCT01782131|80321891|FG001|Overall Study|Withdrawal by Subject|10|||
27584471|NCT01782131|80321890|FG000|Overall Study|Randomized but not treated|5|||
27584472|NCT01782131|80321891|FG001|Overall Study|Randomized but not treated|5|||
27584473|NCT01782131|80321890|FG000|Overall Study|Reason not provided|0|||
27584474|NCT01782131|80321891|FG001|Overall Study|Reason not provided|1|||
27584475|NCT02138214|80321892|FG000|Overall Study|Withdrawal by Subject|0|||
27584476|NCT02138214|80321893|FG001|Overall Study|Withdrawal by Subject|1|||
27584477|NCT02138214|80321894|FG002|Overall Study|Withdrawal by Subject|0|||
27584478|NCT02138214|80321892|FG000|Overall Study|Lost to Follow-up|0|||
27584479|NCT02138214|80321893|FG001|Overall Study|Lost to Follow-up|2|||
27584480|NCT02138214|80321894|FG002|Overall Study|Lost to Follow-up|4|||
27584481|NCT02138214|80321892|FG000|Overall Study|Screen Failure|0|||
27584482|NCT02138214|80321893|FG001|Overall Study|Screen Failure|1|||
27683601|NCT00400725|80676017|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
27683602|NCT00400725|80676015|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
27683603|NCT00400725|80676016|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
27683604|NCT00400725|80676017|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
27683605|NCT00400725|80676015|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
27683606|NCT00400725|80676016|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
27683607|NCT00400725|80676017|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
27683608|NCT00743431|80676029|FG000|Overall Study|Toxicity|6|||
27683609|NCT00743431|80676029|FG000|Overall Study|Tumor progression|56|||
27683610|NCT00743431|80676029|FG000|Overall Study|Withdrawal by Subject|13|||
27683611|NCT00743431|80676029|FG000|Overall Study|Death|9|||
27683612|NCT00743431|80676029|FG000|Overall Study|Reason for discontinuation not specified|29|||
27683613|NCT00743431|80676029|FG000|Overall Study|No documentation available|13|||
27683614|NCT00789360|80676030|FG000|Overall Study|Protocol Violation|3|||
27683615|NCT00789360|80676031|FG001|Overall Study|Protocol Violation|1|||
27683616|NCT02544451|80679168|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
27683617|NCT02544451|80679169|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
27683618|NCT02544451|80679170|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
27683619|NCT02544451|80679171|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
27683620|NCT02544451|80679168|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
27683621|NCT02544451|80679169|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
27683622|NCT02544451|80679170|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
27683623|NCT02544451|80679171|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
27683624|NCT02544451|80679168|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
27683625|NCT02544451|80679169|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
27683626|NCT02544451|80679170|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
27683627|NCT02544451|80679171|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
27683628|NCT02544451|80679168|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
27683629|NCT02544451|80679169|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
27683630|NCT02544451|80679170|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
27683631|NCT02544451|80679171|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
27683632|NCT02544451|80679168|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
27683633|NCT02544451|80679169|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
27683634|NCT02544451|80679170|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
27683635|NCT02544451|80679171|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
27683636|NCT02544451|80679168|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
27683637|NCT02544451|80679169|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
27683638|NCT02544451|80679170|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
27683639|NCT02544451|80679171|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
27683640|NCT03541200|80679172|FG000|Overall Study|Adverse Event|19|||
27683641|NCT03541200|80679172|FG000|Overall Study|Death|1|||
27683642|NCT03541200|80679172|FG000|Overall Study|Lost to Follow-up|10|||
27683643|NCT03541200|80679172|FG000|Overall Study|Physician Decision|1|||
27683644|NCT03541200|80679172|FG000|Overall Study|Protocol Violation|51|||
27683645|NCT03541200|80679172|FG000|Overall Study|Withdrawal by Subject|23|||
27683646|NCT03541200|80679172|FG000|Overall Study|other|8|||
27683647|NCT01008410|80679173|FG000|Overall Study|Adverse Event|13|||
27683648|NCT01008410|80679174|FG001|Overall Study|Adverse Event|7|||
27683649|NCT01008410|80679173|FG000|Overall Study|Withdrawal by Subject|6|||
27683650|NCT01008410|80679174|FG001|Overall Study|Withdrawal by Subject|2|||
27683651|NCT01008410|80679173|FG000|Overall Study|Lost to Follow-up|1|||
27683652|NCT01008410|80679174|FG001|Overall Study|Lost to Follow-up|0|||
27683653|NCT01008410|80679173|FG000|Overall Study|Noncompliance|1|||
27683654|NCT01008410|80679174|FG001|Overall Study|Noncompliance|0|||
27683655|NCT01008410|80679173|FG000|Overall Study|Low Cortisol|2|||
27683656|NCT01008410|80679174|FG001|Overall Study|Low Cortisol|0|||
27683657|NCT01008410|80679173|FG000|Overall Study|Lack of Efficacy|2|||
27683658|NCT01008410|80679174|FG001|Overall Study|Lack of Efficacy|6|||
27683659|NCT01008410|80679173|FG000|Overall Study|Met Exclusion Criterion|0|||
27683660|NCT01008410|80679174|FG001|Overall Study|Met Exclusion Criterion|1|||
27683661|NCT00506441|80679183|FG000|Period 1; Open-label Period|Adverse Event|21|||
27683662|NCT00506441|80679184|FG001|Period 1; Open-label Period|Adverse Event|0|||
27683663|NCT00506441|80679183|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
27683664|NCT00506441|80679184|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
27683665|NCT00506441|80679183|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
27683666|NCT00506441|80679184|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
27683667|NCT00506441|80679183|FG000|Period 1; Open-label Period|Physician Decision|5|||
27683668|NCT00506441|80679184|FG001|Period 1; Open-label Period|Physician Decision|0|||
27683669|NCT00506441|80679183|FG000|Period 1; Open-label Period|Protocol Violation|9|||
27683670|NCT00506441|80679184|FG001|Period 1; Open-label Period|Protocol Violation|0|||
27683671|NCT00506441|80679183|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
27683672|NCT00506441|80679184|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
27683673|NCT00506441|80679183|FG000|Period 1; Open-label Period|Other Reasons|13|||
28003533|NCT02748863|81842503|FG002|Treatment Period 2|Lost to Follow-up|0|||
28003534|NCT02748863|81842504|FG003|Treatment Period 2|Lost to Follow-up|0|||
28003535|NCT02748863|81842505|FG004|Treatment Period 2|Lost to Follow-up|0|||
28003536|NCT02748863|81842501|FG000|Treatment Period 2|Adverse Event|3|||
28003537|NCT02748863|81842502|FG001|Treatment Period 2|Adverse Event|2|||
27584483|NCT02138214|80321894|FG002|Overall Study|Screen Failure|0|||
27584484|NCT03867734|80321895|FG000|Overall Study|Lost to Follow-up|2|||
28003538|NCT02748863|81842503|FG002|Treatment Period 2|Adverse Event|0|||
28003539|NCT02748863|81842504|FG003|Treatment Period 2|Adverse Event|2|||
28003540|NCT02748863|81842505|FG004|Treatment Period 2|Adverse Event|0|||
28003541|NCT02748863|81842501|FG000|Treatment Period 2|Lack of Efficacy|0|||
28003542|NCT02748863|81842502|FG001|Treatment Period 2|Lack of Efficacy|1|||
28003543|NCT02748863|81842503|FG002|Treatment Period 2|Lack of Efficacy|0|||
28003544|NCT02748863|81842504|FG003|Treatment Period 2|Lack of Efficacy|0|||
27584485|NCT01682837|80321898|FG000|Baseline|Withdrawal by Subject|5|||
27584486|NCT00835406|80321899|FG000|Period: First Intervention|Adverse Event|0|||
27584487|NCT00835406|80321900|FG001|Period: First Intervention|Adverse Event|1|||
27584488|NCT00835406|80321899|FG000|Period: First Intervention|Withdrawal by Subject|2|||
27584489|NCT00835406|80321900|FG001|Period: First Intervention|Withdrawal by Subject|0|||
27584490|NCT00835406|80321899|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
27584491|NCT00835406|80321900|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
27584492|NCT03912259|80321901|FG000|Overall Study|Adverse Event (AE)|2|||
27584493|NCT03912259|80321902|FG001|Overall Study|Adverse Event (AE)|4|||
27584494|NCT03912259|80321901|FG000|Overall Study|Lack of Efficacy|4|||
27584495|NCT03912259|80321902|FG001|Overall Study|Lack of Efficacy|1|||
27584496|NCT03912259|80321901|FG000|Overall Study|Withdrawal by Subject|11|||
27584497|NCT03912259|80321902|FG001|Overall Study|Withdrawal by Subject|1|||
27584498|NCT04287920|80321903|FG000|Overall Study|Lost to Follow-up|1|||
27683674|NCT00506441|80679184|FG001|Period 1; Open-label Period|Other Reasons|0|||
27683675|NCT00506441|80679183|FG000|Period 2; Double-blind Period|Adverse Event|0|||
27683676|NCT00506441|80679184|FG001|Period 2; Double-blind Period|Adverse Event|1|||
28003545|NCT02748863|81842505|FG004|Treatment Period 2|Lack of Efficacy|0|||
28003546|NCT02748863|81842501|FG000|Treatment Period 2|Pregnancy|0|||
28003547|NCT02748863|81842502|FG001|Treatment Period 2|Pregnancy|0|||
28003548|NCT02748863|81842503|FG002|Treatment Period 2|Pregnancy|0|||
28003549|NCT02748863|81842504|FG003|Treatment Period 2|Pregnancy|0|||
28003550|NCT02748863|81842505|FG004|Treatment Period 2|Pregnancy|1|||
28003551|NCT01132807|81842506|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
28003552|NCT01132807|81842507|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
28003553|NCT01132807|81842508|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
28003554|NCT01132807|81842506|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
28003555|NCT01132807|81842507|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
27584499|NCT04287920|80321904|FG001|Overall Study|Lost to Follow-up|1|||
27584500|NCT04287920|80321903|FG000|Overall Study|Withdrawal by Subject|0|||
27584501|NCT04287920|80321904|FG001|Overall Study|Withdrawal by Subject|3|||
27683677|NCT00506441|80679183|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
27683678|NCT00506441|80679184|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
27683679|NCT00506441|80679183|FG000|Period 2; Double-blind Period|Physician Decision|1|||
27584502|NCT02663817|80321905|FG000|Overall Study|Screen failure|2|||
27584503|NCT00898677|80321906|FG000|Overall Study|Adverse Event|0|||
27584504|NCT00898677|80321907|FG001|Overall Study|Adverse Event|0|||
27584505|NCT00898677|80321908|FG002|Overall Study|Adverse Event|1|||
28003556|NCT01132807|81842508|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
28003557|NCT00657540|81842509|FG000|Overall Study|Lost to Follow-up|1|||
28003558|NCT00657540|81842510|FG001|Overall Study|Lost to Follow-up|4|||
28003559|NCT03951077|81842511|FG000|Overall Study|Adverse Event|1|||
28003560|NCT03951077|81842512|FG001|Overall Study|Adverse Event|0|||
28003561|NCT03951077|81842513|FG002|Overall Study|Adverse Event|0|||
27683680|NCT00506441|80679184|FG001|Period 2; Double-blind Period|Physician Decision|1|||
27683681|NCT00506441|80679183|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
27683682|NCT00506441|80679184|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
27683683|NCT00506441|80679183|FG000|Period 2; Double-blind Period|Other Reason|1|||
27683684|NCT00506441|80679184|FG001|Period 2; Double-blind Period|Other Reason|1|||
27683685|NCT01656200|80679185|FG000|Overall Study|Withdrawal by Subject|1|||
27683686|NCT00979576|80679189|FG000|Combination Treatment Phase|Progressive disease|3|||
27683687|NCT00979576|80679190|FG001|Combination Treatment Phase|Progressive disease|1|||
27683688|NCT00979576|80679191|FG002|Combination Treatment Phase|Progressive disease|5|||
28003562|NCT03951077|81842514|FG003|Overall Study|Adverse Event|0|||
28003563|NCT03951077|81842515|FG004|Overall Study|Adverse Event|0|||
28003564|NCT03951077|81842516|FG005|Overall Study|Adverse Event|0|||
28003565|NCT03951077|81842511|FG000|Overall Study|Withdrawal by Subject|3|||
28003566|NCT03951077|81842512|FG001|Overall Study|Withdrawal by Subject|3|||
28003567|NCT03951077|81842513|FG002|Overall Study|Withdrawal by Subject|0|||
28003568|NCT03951077|81842514|FG003|Overall Study|Withdrawal by Subject|3|||
28003569|NCT03951077|81842515|FG004|Overall Study|Withdrawal by Subject|3|||
28003570|NCT03951077|81842516|FG005|Overall Study|Withdrawal by Subject|2|||
27683689|NCT00979576|80679189|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
27683690|NCT00979576|80679190|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
27683691|NCT00979576|80679191|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
27683692|NCT00979576|80679189|FG000|Combination Treatment Phase|Adverse Event|0|||
27683693|NCT00979576|80679190|FG001|Combination Treatment Phase|Adverse Event|2|||
27683694|NCT00979576|80679191|FG002|Combination Treatment Phase|Adverse Event|2|||
27683695|NCT00979576|80679189|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
27683696|NCT00979576|80679190|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
27683697|NCT00979576|80679191|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
27683698|NCT02601300|80679192|FG000|Induction Phase|Lack of Efficacy|2|||
27683699|NCT02601300|80679192|FG000|Induction Phase|Protocol Violation|1|||
27683700|NCT02601300|80679192|FG000|Extension Phase|Withdrawal by Subject|3|||
27683701|NCT02601300|80679192|FG000|Extension Phase|Adverse Event|4|||
27683702|NCT02601300|80679192|FG000|Extension Phase|Lack of Efficacy|10|||
27683703|NCT01552603|80679193|FG000|Overall Study|Physician Decision|1|||
27683704|NCT01283152|80679194|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
27683705|NCT01283152|80679195|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
27683706|NCT01283152|80679194|FG000|Overall Study|Refused HESA|1|||
27683707|NCT01283152|80679195|FG001|Overall Study|Refused HESA|0|||
27683708|NCT00350103|80679196|FG000|Overall Study|Adverse Event|12|||
27683709|NCT00350103|80679197|FG001|Overall Study|Adverse Event|29|||
27683710|NCT00350103|80679198|FG002|Overall Study|Adverse Event|17|||
27683711|NCT00350103|80679196|FG000|Overall Study|Lack of Efficacy|5|||
27683712|NCT00350103|80679197|FG001|Overall Study|Lack of Efficacy|1|||
27683713|NCT00350103|80679198|FG002|Overall Study|Lack of Efficacy|3|||
27683714|NCT00350103|80679196|FG000|Overall Study|Withdrawal by Subject|6|||
27683715|NCT00350103|80679197|FG001|Overall Study|Withdrawal by Subject|6|||
27683716|NCT00350103|80679198|FG002|Overall Study|Withdrawal by Subject|8|||
27683717|NCT00350103|80679196|FG000|Overall Study|Protocol Violation|0|||
27683718|NCT00350103|80679197|FG001|Overall Study|Protocol Violation|0|||
27683719|NCT00350103|80679198|FG002|Overall Study|Protocol Violation|1|||
27683720|NCT00350103|80679196|FG000|Overall Study|Unsatisfactory Compliance|2|||
27683721|NCT00350103|80679197|FG001|Overall Study|Unsatisfactory Compliance|2|||
27683722|NCT00350103|80679198|FG002|Overall Study|Unsatisfactory Compliance|1|||
27683723|NCT00350103|80679196|FG000|Overall Study|Investigator´s decision|1|||
27683724|NCT00350103|80679197|FG001|Overall Study|Investigator´s decision|1|||
27683725|NCT00350103|80679198|FG002|Overall Study|Investigator´s decision|0|||
27683726|NCT00350103|80679196|FG000|Overall Study|Exclusion criteria met|0|||
27683727|NCT00350103|80679197|FG001|Overall Study|Exclusion criteria met|0|||
27683728|NCT00350103|80679198|FG002|Overall Study|Exclusion criteria met|1|||
27683729|NCT00350103|80679196|FG000|Overall Study|Patient relocated|0|||
27683730|NCT00350103|80679197|FG001|Overall Study|Patient relocated|0|||
27683731|NCT00350103|80679198|FG002|Overall Study|Patient relocated|1|||
27683732|NCT00350103|80679196|FG000|Overall Study|Need for prohibited medication|1|||
27683733|NCT00350103|80679197|FG001|Overall Study|Need for prohibited medication|0|||
27683734|NCT00350103|80679198|FG002|Overall Study|Need for prohibited medication|0|||
27683735|NCT00350103|80679196|FG000|Overall Study|Personal reasons|0|||
27683736|NCT00350103|80679197|FG001|Overall Study|Personal reasons|0|||
28003571|NCT03951077|81842511|FG000|Overall Study|Lost to Follow-up|1|||
28003572|NCT03951077|81842512|FG001|Overall Study|Lost to Follow-up|1|||
28003573|NCT03951077|81842513|FG002|Overall Study|Lost to Follow-up|2|||
27807635|NCT00475852|81127189|FG000|Overall Study|Withdrawal by Subject|19|||
28003574|NCT03951077|81842514|FG003|Overall Study|Lost to Follow-up|3|||
27683737|NCT00350103|80679198|FG002|Overall Study|Personal reasons|1|||
27683738|NCT00350103|80679196|FG000|Overall Study|Patient stopped feeling pain|1|||
28003575|NCT03951077|81842515|FG004|Overall Study|Lost to Follow-up|2|||
28003576|NCT03951077|81842516|FG005|Overall Study|Lost to Follow-up|3|||
27683739|NCT00350103|80679197|FG001|Overall Study|Patient stopped feeling pain|0|||
27683740|NCT00350103|80679198|FG002|Overall Study|Patient stopped feeling pain|0|||
27683741|NCT00350103|80679196|FG000|Overall Study|PR greater than 250ms|0|||
27683742|NCT00350103|80679197|FG001|Overall Study|PR greater than 250ms|0|||
28003577|NCT03951077|81842511|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
28003578|NCT03951077|81842512|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
28003579|NCT03951077|81842513|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
28003580|NCT03951077|81842514|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
28003581|NCT03951077|81842515|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
28003582|NCT03951077|81842516|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
28003583|NCT03951077|81842511|FG000|Overall Study|Other, Not Specified|12|||
28003584|NCT03951077|81842512|FG001|Overall Study|Other, Not Specified|10|||
28003585|NCT03951077|81842513|FG002|Overall Study|Other, Not Specified|10|||
28003586|NCT03951077|81842514|FG003|Overall Study|Other, Not Specified|5|||
28003587|NCT03951077|81842515|FG004|Overall Study|Other, Not Specified|9|||
28003588|NCT03951077|81842516|FG005|Overall Study|Other, Not Specified|6|||
27807636|NCT00475852|81127190|FG001|Overall Study|Withdrawal by Subject|24|||
28003589|NCT03951077|81842511|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
27683743|NCT00350103|80679198|FG002|Overall Study|PR greater than 250ms|1|||
27683744|NCT00350103|80679196|FG000|Overall Study|Wrong calculation of QT interval|0|||
27683745|NCT00350103|80679197|FG001|Overall Study|Wrong calculation of QT interval|0|||
27683746|NCT00350103|80679198|FG002|Overall Study|Wrong calculation of QT interval|1|||
27683747|NCT00350103|80679196|FG000|Overall Study|Sponsor mistake|1|||
27683748|NCT00350103|80679197|FG001|Overall Study|Sponsor mistake|0|||
27683749|NCT00350103|80679198|FG002|Overall Study|Sponsor mistake|0|||
27683750|NCT00350103|80679196|FG000|Overall Study|Randomization mistake|0|||
27683751|NCT00350103|80679197|FG001|Overall Study|Randomization mistake|1|||
27683752|NCT00350103|80679198|FG002|Overall Study|Randomization mistake|1|||
27683753|NCT00350103|80679196|FG000|Overall Study|Sponsor´s decision|0|||
27683754|NCT00350103|80679197|FG001|Overall Study|Sponsor´s decision|1|||
27683755|NCT00350103|80679198|FG002|Overall Study|Sponsor´s decision|0|||
27683756|NCT00350103|80679196|FG000|Overall Study|Lost, Reason unknown|1|||
27683757|NCT00350103|80679197|FG001|Overall Study|Lost, Reason unknown|1|||
27683758|NCT00350103|80679198|FG002|Overall Study|Lost, Reason unknown|0|||
27683759|NCT00503139|80679199|FG000|Overall Study|Case Report Forms were not collected|4|||
27683760|NCT00503139|80679199|FG000|Overall Study|Protocol Violation|4|||
27683761|NCT00958841|80679200|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27683762|NCT00958841|80679200|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27683763|NCT00958841|80679200|FG000|Overall Study|Administrative problems|1|||
27683764|NCT00958841|80679200|FG000|Overall Study|Adverse Event|8|||
27683765|NCT00958841|80679200|FG000|Overall Study|New cancer therapy|5|||
27683766|NCT00958841|80679200|FG000|Overall Study|Withdrawal by Subject|1|||
27683767|NCT00958841|80679200|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
27683768|NCT00958841|80679200|FG000|Overall Study|Completed M6/did not enter extension|27|||
27683769|NCT00958841|80679200|FG000|Overall Study|Discontinued prior to M*|28|||
27683770|NCT01195948|80679201|FG000|Overall Study|Lost to Follow-up|0|||
27683771|NCT01195948|80679202|FG001|Overall Study|Lost to Follow-up|1|||
27807637|NCT00475852|81127189|FG000|Overall Study|Lost to Follow-up|54|||
27683772|NCT01195948|80679203|FG002|Overall Study|Lost to Follow-up|2|||
27683773|NCT03435692|80679204|FG000|Overall Study|Lack of Efficacy|2|||
27683774|NCT03435692|80679205|FG001|Overall Study|Lack of Efficacy|2|||
27683775|NCT03435692|80679206|FG002|Overall Study|Lack of Efficacy|0|||
27683776|NCT02075476|80679207|FG000|Overall Study|Death|2|||
27683777|NCT02075476|80679208|FG001|Overall Study|Death|2|||
27683778|NCT02075476|80679207|FG000|Overall Study|Lost to Follow-up|1|||
27683779|NCT02075476|80679208|FG001|Overall Study|Lost to Follow-up|3|||
27807638|NCT00475852|81127190|FG001|Overall Study|Lost to Follow-up|68|||
27807639|NCT00697112|81127192|FG000|Overall Study|Adverse Event|8|||
28003590|NCT03951077|81842512|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
28003591|NCT03951077|81842513|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
27683780|NCT00659880|80679212|FG000|Overall Study|Lost to Follow-up|5|||
27683781|NCT01853475|80679213|FG000|Overall Study|Withdrawal by Subject|0|||
27683782|NCT01853475|80679214|FG001|Overall Study|Withdrawal by Subject|1|||
27683783|NCT01853475|80679215|FG002|Overall Study|Withdrawal by Subject|0|||
27683784|NCT04546217|80679225|FG000|Overall Study|Withdrawal by Subject|2|||
27683785|NCT04546217|80679226|FG001|Overall Study|Withdrawal by Subject|0|||
27807640|NCT00697112|81127192|FG000|Overall Study|Lost to Follow-up|1|||
27807641|NCT00697112|81127192|FG000|Overall Study|Did not meet inclusion criteria|1|||
27807642|NCT02123459|81127193|FG000|Washout Period (1 Day)|Adverse Event|1|||
27807643|NCT02123459|81127194|FG001|Washout Period (1 Day)|Adverse Event|0|||
27807644|NCT01806597|81127195|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
28003592|NCT03951077|81842514|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
28003593|NCT03951077|81842515|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
27683786|NCT04546217|80679225|FG000|Overall Study|Uncontrolled hypertension|1|||
27683787|NCT04546217|80679226|FG001|Overall Study|Uncontrolled hypertension|0|||
28003594|NCT03951077|81842516|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
28003595|NCT03007966|81842517|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
28003596|NCT03007966|81842518|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
28003597|NCT00399516|81842521|FG000|Overall Study|Lost to Follow-up|2|||
28003598|NCT01141712|81842527|FG000|Overall Study|Disease progression|3|||
28003599|NCT02922725|81842528|FG000|Overall Study|Withdrawal by Subject|1|||
28003600|NCT02922725|81842529|FG001|Overall Study|Withdrawal by Subject|0|||
28003601|NCT02922725|81842530|FG002|Overall Study|Withdrawal by Subject|0|||
27683788|NCT00545753|80679229|FG000|Overall Study|Withdrawal by Subject|0|||
27683789|NCT00545753|80679230|FG001|Overall Study|Withdrawal by Subject|1|||
27683790|NCT00545753|80679231|FG002|Overall Study|Withdrawal by Subject|10|||
27807645|NCT01806597|81127196|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
27683791|NCT00545753|80679229|FG000|Overall Study|Lost to Follow-up|13|||
27807646|NCT01806597|81127197|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
27807647|NCT01806597|81127198|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
27807648|NCT01806597|81127199|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
27807649|NCT01806597|81127200|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
27807650|NCT01806597|81127195|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
27807651|NCT01806597|81127196|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27807652|NCT01806597|81127197|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27807653|NCT01806597|81127198|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27807654|NCT01806597|81127199|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
27807655|NCT01806597|81127200|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
27807656|NCT01806597|81127195|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27807657|NCT01806597|81127196|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
27807658|NCT01806597|81127197|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27807659|NCT01806597|81127198|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27807660|NCT01806597|81127199|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27807661|NCT01806597|81127200|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
27807662|NCT01806597|81127195|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
27807663|NCT01806597|81127196|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
27807664|NCT01806597|81127197|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
27807665|NCT01806597|81127198|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
27807666|NCT01806597|81127199|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
27807667|NCT01806597|81127200|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
27807668|NCT01806597|81127195|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27807669|NCT01806597|81127196|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
27807670|NCT01806597|81127197|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27807671|NCT01806597|81127198|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27807672|NCT01806597|81127199|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27807673|NCT01806597|81127200|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
27807674|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
27807675|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
27807676|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
27807677|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
28003602|NCT01216202|81842535|FG000|Overall Study|Withdrawal by Subject|8|||
28003603|NCT01216202|81842536|FG001|Overall Study|Withdrawal by Subject|0|||
28003604|NCT01216202|81842535|FG000|Overall Study|Death|0|||
28003605|NCT01216202|81842536|FG001|Overall Study|Death|2|||
28003606|NCT01216202|81842535|FG000|Overall Study|Lost to Follow-up|14|||
28003607|NCT01216202|81842536|FG001|Overall Study|Lost to Follow-up|0|||
28003608|NCT00730158|81842539|FG000|Overall Study|Withdrawal by Subject|1|||
28003609|NCT00730158|81842540|FG001|Overall Study|Withdrawal by Subject|1|||
28003610|NCT01631435|81842545|FG000|Overall Study|Adverse Event|2|||
28003611|NCT01631435|81842545|FG000|Overall Study|Withdrawal by Subject|2|||
28003612|NCT01631435|81842545|FG000|Overall Study|incomplete study procedure|5|||
28003613|NCT02753946|81846206|FG000|Overall Study|Adverse Event|7|||
27807678|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
27807679|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
28003614|NCT02753946|81846207|FG001|Overall Study|Adverse Event|6|||
28003615|NCT02753946|81846206|FG000|Overall Study|Withdrawal by Subject|6|||
28003616|NCT02753946|81846207|FG001|Overall Study|Withdrawal by Subject|1|||
27683792|NCT00545753|80679230|FG001|Overall Study|Lost to Follow-up|3|||
27683793|NCT00545753|80679231|FG002|Overall Study|Lost to Follow-up|12|||
27683794|NCT00545753|80679229|FG000|Overall Study|Protocol Violation|3|||
27683795|NCT00545753|80679230|FG001|Overall Study|Protocol Violation|1|||
27683796|NCT00545753|80679231|FG002|Overall Study|Protocol Violation|4|||
27683797|NCT03965351|80679232|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
27683798|NCT03965351|80679233|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
27683799|NCT03965351|80679232|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
27683800|NCT03965351|80679233|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
27683801|NCT03231800|80679234|FG000|Overall Study|Lost to Follow-up|0|||
27683802|NCT03231800|80679235|FG001|Overall Study|Lost to Follow-up|2|||
27683803|NCT03231800|80679234|FG000|Overall Study|Protocol Violation|1|||
27683804|NCT03231800|80679235|FG001|Overall Study|Protocol Violation|1|||
27683805|NCT03231800|80679234|FG000|Overall Study|reason not provided|2|||
27683806|NCT03231800|80679235|FG001|Overall Study|reason not provided|0|||
27683807|NCT02580305|80679236|FG000|Overall Study|Adverse Event|15|||
27683808|NCT02580305|80679237|FG001|Overall Study|Adverse Event|19|||
27683809|NCT02580305|80679238|FG002|Overall Study|Adverse Event|10|||
27683810|NCT02580305|80679236|FG000|Overall Study|Lack of Efficacy|5|||
27683811|NCT02580305|80679237|FG001|Overall Study|Lack of Efficacy|0|||
27683812|NCT02580305|80679238|FG002|Overall Study|Lack of Efficacy|2|||
27683813|NCT02580305|80679236|FG000|Overall Study|Protocol Violation|4|||
27683814|NCT02580305|80679237|FG001|Overall Study|Protocol Violation|9|||
27683815|NCT02580305|80679238|FG002|Overall Study|Protocol Violation|6|||
27683816|NCT02580305|80679236|FG000|Overall Study|Lost to Follow-up|4|||
27683817|NCT02580305|80679237|FG001|Overall Study|Lost to Follow-up|4|||
27683818|NCT02580305|80679238|FG002|Overall Study|Lost to Follow-up|2|||
27683819|NCT02580305|80679236|FG000|Overall Study|Withdrawal by Subject|11|||
27683820|NCT02580305|80679237|FG001|Overall Study|Withdrawal by Subject|9|||
27683821|NCT02580305|80679238|FG002|Overall Study|Withdrawal by Subject|7|||
27683822|NCT02580305|80679236|FG000|Overall Study|Randomized in error and never treated|4|||
27683823|NCT02580305|80679237|FG001|Overall Study|Randomized in error and never treated|8|||
28003617|NCT02753946|81846206|FG000|Overall Study|Lack of Efficacy|1|||
28003618|NCT02753946|81846207|FG001|Overall Study|Lack of Efficacy|0|||
28003619|NCT02753946|81846206|FG000|Overall Study|Physician Decision|0|||
28003620|NCT02753946|81846207|FG001|Overall Study|Physician Decision|2|||
28003621|NCT01535040|81846208|FG000|Overall Study|Physician Decision|0|||
28003622|NCT01535040|81846209|FG001|Overall Study|Physician Decision|1|||
28003623|NCT01535040|81846208|FG000|Overall Study|Withdrawal by Subject|13|||
28003624|NCT01535040|81846209|FG001|Overall Study|Withdrawal by Subject|10|||
28003625|NCT01535040|81846208|FG000|Overall Study|Never Started|9|||
28003626|NCT01535040|81846209|FG001|Overall Study|Never Started|4|||
28003627|NCT01535040|81846208|FG000|Overall Study|Toxicity|7|||
28003628|NCT01535040|81846209|FG001|Overall Study|Toxicity|5|||
28003629|NCT01535040|81846208|FG000|Overall Study|Multiple Reasons|1|||
28003630|NCT01535040|81846209|FG001|Overall Study|Multiple Reasons|1|||
28003631|NCT00321789|81846210|FG000|Overall Study|Lost to Follow-up|4|||
28003632|NCT00321789|81846211|FG001|Overall Study|Lost to Follow-up|7|||
28003633|NCT00321789|81846210|FG000|Overall Study|Withdrawal by Subject|6|||
28003634|NCT00321789|81846211|FG001|Overall Study|Withdrawal by Subject|6|||
28003635|NCT00321789|81846210|FG000|Overall Study|Protocol Violation|5|||
28003636|NCT00321789|81846211|FG001|Overall Study|Protocol Violation|3|||
28003637|NCT00982735|81846212|FG000|Overall Study|Lost to Follow-up|6|||
28003638|NCT00982735|81846212|FG000|Overall Study|Patient ineligible for trial|224|||
28003639|NCT02138890|81846214|FG000|Overall Study|Adverse Event|1|||
27584506|NCT00898677|80321909|FG003|Overall Study|Adverse Event|0|||
27683824|NCT02580305|80679238|FG002|Overall Study|Randomized in error and never treated|5|||
27683825|NCT00436605|80679239|FG000|Overall Study|Protocol Violation|3|||
27683826|NCT05327816|80679242|FG000|Overall Study|Lost to Follow-up|1|||
27683827|NCT05327816|80679243|FG001|Overall Study|Lost to Follow-up|0|||
27683828|NCT05327816|80679244|FG002|Overall Study|Lost to Follow-up|0|||
27683829|NCT05327816|80679245|FG003|Overall Study|Lost to Follow-up|0|||
27683830|NCT05327816|80679246|FG004|Overall Study|Lost to Follow-up|0|||
27683831|NCT05327816|80679247|FG005|Overall Study|Lost to Follow-up|0|||
28003640|NCT02138890|81846215|FG001|Overall Study|Adverse Event|0|||
28003641|NCT02903160|81846216|FG000|Overall Study|Adverse Event|2|||
28003642|NCT02903160|81846216|FG000|Overall Study|Death|1|||
27683832|NCT05327816|80679248|FG006|Overall Study|Lost to Follow-up|0|||
28003643|NCT02903160|81846216|FG000|Overall Study|Lost to Follow-up|2|||
28003644|NCT02903160|81846216|FG000|Overall Study|Withdrawal by Subject|1|||
27683833|NCT05327816|80679249|FG007|Overall Study|Lost to Follow-up|0|||
27683834|NCT05327816|80679250|FG008|Overall Study|Lost to Follow-up|0|||
27683835|NCT05327816|80679251|FG009|Overall Study|Lost to Follow-up|1|||
27683836|NCT05327816|80679252|FG010|Overall Study|Lost to Follow-up|0|||
27683837|NCT05327816|80679242|FG000|Overall Study|Withdrawal by Subject|0|||
27683838|NCT05327816|80679243|FG001|Overall Study|Withdrawal by Subject|0|||
27683839|NCT05327816|80679244|FG002|Overall Study|Withdrawal by Subject|0|||
27683840|NCT05327816|80679245|FG003|Overall Study|Withdrawal by Subject|0|||
27807680|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
27807681|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
27874280|NCT01777282|81371704|FG002|Overall Study|Persistent Hyperglycemia|1|||
27874281|NCT01777282|81371705|FG003|Overall Study|Persistent Hyperglycemia|0|||
27874282|NCT01777282|81371706|FG004|Overall Study|Persistent Hyperglycemia|0|||
27584507|NCT00898677|80321906|FG000|Overall Study|Lost to Follow-up|0|||
27584508|NCT00898677|80321907|FG001|Overall Study|Lost to Follow-up|0|||
27584509|NCT00898677|80321908|FG002|Overall Study|Lost to Follow-up|2|||
27584510|NCT00898677|80321909|FG003|Overall Study|Lost to Follow-up|0|||
27874283|NCT01777282|81371702|FG000|Overall Study|New Antidiabetic Medication|0|||
27874284|NCT01777282|81371703|FG001|Overall Study|New Antidiabetic Medication|0|||
27584511|NCT00898677|80321906|FG000|Overall Study|Protocol Violation|1|||
27584512|NCT00898677|80321907|FG001|Overall Study|Protocol Violation|1|||
27584513|NCT00898677|80321908|FG002|Overall Study|Protocol Violation|2|||
27584514|NCT00898677|80321909|FG003|Overall Study|Protocol Violation|0|||
27584515|NCT00898677|80321906|FG000|Overall Study|Withdrawal by Subject|0|||
27584516|NCT00898677|80321907|FG001|Overall Study|Withdrawal by Subject|0|||
27584517|NCT00898677|80321908|FG002|Overall Study|Withdrawal by Subject|0|||
27584518|NCT00898677|80321909|FG003|Overall Study|Withdrawal by Subject|1|||
27584519|NCT00898677|80321906|FG000|Overall Study|Not Treated: Adverse Event|0|||
27584520|NCT00898677|80321907|FG001|Overall Study|Not Treated: Adverse Event|2|||
27584521|NCT00898677|80321908|FG002|Overall Study|Not Treated: Adverse Event|1|||
27807682|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
27807683|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
27874285|NCT01777282|81371704|FG002|Overall Study|New Antidiabetic Medication|1|||
28003645|NCT02903160|81846216|FG000|Overall Study|Medical Insurance Barriers|1|||
28003646|NCT00687401|81846217|FG000|Overall Study|Protocol Violation|7|||
28003647|NCT00687401|81846217|FG000|Overall Study|Adverse Event|6|||
28003648|NCT00687401|81846217|FG000|Overall Study|Lack of Efficacy|6|||
28003649|NCT00687401|81846217|FG000|Overall Study|Withdrawal by Subject|4|||
27807684|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
27807685|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
27807686|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
28003650|NCT00687401|81846217|FG000|Overall Study|Did not return for visit|3|||
28003651|NCT00687401|81846217|FG000|Overall Study|For reasons different from those above|4|||
28003652|NCT03310723|81846218|FG000|Overall Study|Withdrawal by Subject|0|||
28003653|NCT03310723|81846219|FG001|Overall Study|Withdrawal by Subject|1|||
28003654|NCT03310723|81846218|FG000|Overall Study|Protocol Violation|0|||
28003655|NCT03310723|81846219|FG001|Overall Study|Protocol Violation|2|||
28003656|NCT01329978|81846220|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
28003657|NCT01329978|81846221|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
28003658|NCT01329978|81846222|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
28003659|NCT01329978|81846223|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
28003660|NCT01329978|81846224|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
28003661|NCT01329978|81846220|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
28003662|NCT01329978|81846221|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
28003663|NCT01329978|81846222|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
28003664|NCT01329978|81846223|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
28003665|NCT01329978|81846224|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
28003666|NCT01329978|81846220|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
28003667|NCT01329978|81846221|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
27683841|NCT05327816|80679246|FG004|Overall Study|Withdrawal by Subject|1|||
27683842|NCT05327816|80679247|FG005|Overall Study|Withdrawal by Subject|1|||
27683843|NCT05327816|80679248|FG006|Overall Study|Withdrawal by Subject|0|||
27874286|NCT01777282|81371705|FG003|Overall Study|New Antidiabetic Medication|0|||
27874287|NCT01777282|81371706|FG004|Overall Study|New Antidiabetic Medication|0|||
27874288|NCT01777282|81371702|FG000|Overall Study|Adverse Event|4|||
27874289|NCT01777282|81371703|FG001|Overall Study|Adverse Event|4|||
28003668|NCT01329978|81846222|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
28003669|NCT01329978|81846223|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
27584522|NCT00898677|80321909|FG003|Overall Study|Not Treated: Adverse Event|0|||
27584523|NCT00898677|80321906|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
27584524|NCT00898677|80321907|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
27584525|NCT00898677|80321908|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
27683844|NCT05327816|80679249|FG007|Overall Study|Withdrawal by Subject|0|||
27584526|NCT00898677|80321909|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
27584527|NCT00898677|80321906|FG000|Overall Study|Not Treated: Pregnancy|0|||
27584528|NCT00898677|80321907|FG001|Overall Study|Not Treated: Pregnancy|0|||
27807687|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27807688|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27584529|NCT00898677|80321908|FG002|Overall Study|Not Treated: Pregnancy|1|||
27584530|NCT00898677|80321909|FG003|Overall Study|Not Treated: Pregnancy|0|||
27584531|NCT00898677|80321906|FG000|Overall Study|Not Treated: Protocol Violation|2|||
27807689|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27807690|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27807691|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
27807692|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
28003670|NCT01329978|81846224|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
28003671|NCT01329978|81846220|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28003672|NCT01329978|81846221|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
28003673|NCT01329978|81846222|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28003674|NCT01329978|81846223|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28003675|NCT01329978|81846224|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
28003676|NCT01329978|81846220|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28003677|NCT01329978|81846221|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
28003678|NCT01329978|81846222|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28003679|NCT01329978|81846223|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28003680|NCT01329978|81846224|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
28003681|NCT01329978|81846220|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
28003682|NCT01329978|81846221|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
28003683|NCT01329978|81846222|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
28003684|NCT01329978|81846223|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
28003685|NCT01329978|81846224|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
28003686|NCT01329978|81846220|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28003687|NCT01329978|81846221|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28003688|NCT01329978|81846222|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28003689|NCT01329978|81846223|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
28003690|NCT01329978|81846224|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
28003691|NCT01033240|81846225|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
28003692|NCT01033240|81846226|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
28003693|NCT01033240|81846227|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
28003694|NCT01033240|81846225|FG000|Overall Study|Death|2|||
28003695|NCT01033240|81846226|FG001|Overall Study|Death|0|||
28003696|NCT01033240|81846227|FG002|Overall Study|Death|0|||
28003697|NCT01033240|81846225|FG000|Overall Study|Withdrew Consent|2|||
28003698|NCT01033240|81846226|FG001|Overall Study|Withdrew Consent|9|||
28003699|NCT01033240|81846227|FG002|Overall Study|Withdrew Consent|2|||
28003700|NCT01033240|81846225|FG000|Overall Study|Disease Progression|35|||
28003701|NCT01033240|81846226|FG001|Overall Study|Disease Progression|32|||
28003702|NCT01033240|81846227|FG002|Overall Study|Disease Progression|41|||
28003703|NCT01033240|81846225|FG000|Overall Study|Investigator Discretion|0|||
28003704|NCT01033240|81846226|FG001|Overall Study|Investigator Discretion|0|||
28003705|NCT01033240|81846227|FG002|Overall Study|Investigator Discretion|2|||
28003706|NCT01033240|81846225|FG000|Overall Study|Other|0|||
28003707|NCT01033240|81846226|FG001|Overall Study|Other|1|||
28003708|NCT01033240|81846227|FG002|Overall Study|Other|2|||
28003709|NCT01277744|81846228|FG000|Overall Study|Physician Decision|2|||
28003710|NCT02868554|81846229|FG000|Overall Study|Lost to Follow-up|3|||
28003711|NCT02868554|81846230|FG001|Overall Study|Lost to Follow-up|0|||
28003712|NCT02868554|81846231|FG002|Overall Study|Lost to Follow-up|1|||
28003713|NCT02349633|81846239|FG000|Overall Study|Death|0|||
28003714|NCT02349633|81846240|FG001|Overall Study|Death|1|||
28003715|NCT02349633|81846241|FG002|Overall Study|Death|0|||
28003716|NCT02349633|81846242|FG003|Overall Study|Death|0|||
28003717|NCT02349633|81846243|FG004|Overall Study|Death|0|||
28003718|NCT02349633|81846244|FG005|Overall Study|Death|1|||
28003719|NCT02349633|81846245|FG006|Overall Study|Death|1|||
28003720|NCT02349633|81846246|FG007|Overall Study|Death|1|||
27807693|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
27874290|NCT01777282|81371704|FG002|Overall Study|Adverse Event|2|||
28003721|NCT02349633|81846247|FG008|Overall Study|Death|0|||
28003722|NCT02349633|81846248|FG009|Overall Study|Death|1|||
28003723|NCT02349633|81846249|FG010|Overall Study|Death|0|||
28003724|NCT02349633|81846250|FG011|Overall Study|Death|0|||
28003725|NCT02349633|81846251|FG012|Overall Study|Death|0|||
27584532|NCT00898677|80321907|FG001|Overall Study|Not Treated: Protocol Violation|0|||
27584533|NCT00898677|80321908|FG002|Overall Study|Not Treated: Protocol Violation|2|||
28003726|NCT02349633|81846252|FG013|Overall Study|Death|0|||
28003727|NCT02349633|81846239|FG000|Overall Study|Withdrawal by Subject|0|||
28003728|NCT02349633|81846240|FG001|Overall Study|Withdrawal by Subject|0|||
28003729|NCT02349633|81846241|FG002|Overall Study|Withdrawal by Subject|0|||
28003730|NCT02349633|81846242|FG003|Overall Study|Withdrawal by Subject|1|||
28003731|NCT02349633|81846243|FG004|Overall Study|Withdrawal by Subject|0|||
27807694|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27807695|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27807696|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27807697|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
27807698|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
27807699|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
28003732|NCT02349633|81846244|FG005|Overall Study|Withdrawal by Subject|0|||
28003733|NCT02349633|81846245|FG006|Overall Study|Withdrawal by Subject|0|||
28003734|NCT02349633|81846246|FG007|Overall Study|Withdrawal by Subject|2|||
28003735|NCT02349633|81846247|FG008|Overall Study|Withdrawal by Subject|2|||
28003736|NCT02349633|81846248|FG009|Overall Study|Withdrawal by Subject|1|||
28003737|NCT02349633|81846249|FG010|Overall Study|Withdrawal by Subject|0|||
28003738|NCT02349633|81846250|FG011|Overall Study|Withdrawal by Subject|0|||
28003739|NCT02349633|81846251|FG012|Overall Study|Withdrawal by Subject|0|||
28003740|NCT02349633|81846252|FG013|Overall Study|Withdrawal by Subject|0|||
28003741|NCT02349633|81846239|FG000|Overall Study|Withdrawal of informed consent|0|||
28003742|NCT02349633|81846240|FG001|Overall Study|Withdrawal of informed consent|0|||
28003743|NCT02349633|81846241|FG002|Overall Study|Withdrawal of informed consent|0|||
28003744|NCT02349633|81846242|FG003|Overall Study|Withdrawal of informed consent|1|||
28003745|NCT02349633|81846243|FG004|Overall Study|Withdrawal of informed consent|1|||
28003746|NCT02349633|81846244|FG005|Overall Study|Withdrawal of informed consent|0|||
28003747|NCT02349633|81846245|FG006|Overall Study|Withdrawal of informed consent|0|||
28003748|NCT02349633|81846246|FG007|Overall Study|Withdrawal of informed consent|3|||
28003749|NCT02349633|81846247|FG008|Overall Study|Withdrawal of informed consent|0|||
28003750|NCT02349633|81846248|FG009|Overall Study|Withdrawal of informed consent|0|||
28003751|NCT02349633|81846249|FG010|Overall Study|Withdrawal of informed consent|0|||
28003752|NCT02349633|81846250|FG011|Overall Study|Withdrawal of informed consent|0|||
28003753|NCT02349633|81846251|FG012|Overall Study|Withdrawal of informed consent|0|||
28003754|NCT02349633|81846252|FG013|Overall Study|Withdrawal of informed consent|0|||
28003755|NCT02349633|81846239|FG000|Overall Study|Transition to compassionate use|0|||
28003756|NCT02349633|81846240|FG001|Overall Study|Transition to compassionate use|0|||
28003757|NCT02349633|81846241|FG002|Overall Study|Transition to compassionate use|0|||
28003758|NCT02349633|81846242|FG003|Overall Study|Transition to compassionate use|0|||
28003759|NCT02349633|81846243|FG004|Overall Study|Transition to compassionate use|1|||
28003760|NCT02349633|81846244|FG005|Overall Study|Transition to compassionate use|0|||
28003761|NCT02349633|81846245|FG006|Overall Study|Transition to compassionate use|0|||
28003762|NCT02349633|81846246|FG007|Overall Study|Transition to compassionate use|3|||
28003763|NCT02349633|81846247|FG008|Overall Study|Transition to compassionate use|0|||
28003764|NCT02349633|81846248|FG009|Overall Study|Transition to compassionate use|1|||
28003765|NCT02349633|81846249|FG010|Overall Study|Transition to compassionate use|0|||
27584534|NCT00898677|80321909|FG003|Overall Study|Not Treated: Protocol Violation|0|||
27584535|NCT00898677|80321906|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
27584536|NCT00898677|80321907|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
27584537|NCT00898677|80321908|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
27584538|NCT00898677|80321909|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
27584539|NCT00898677|80321906|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
27584540|NCT00898677|80321907|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
27584541|NCT00898677|80321908|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
27584542|NCT00898677|80321909|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
27584543|NCT00898677|80321906|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
27584544|NCT00898677|80321907|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
27584545|NCT00898677|80321908|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
27584546|NCT00898677|80321909|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
27584547|NCT00898677|80321906|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
27584548|NCT00898677|80321907|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
27807700|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
28003766|NCT02349633|81846250|FG011|Overall Study|Transition to compassionate use|0|||
28003767|NCT02349633|81846251|FG012|Overall Study|Transition to compassionate use|0|||
27584549|NCT00898677|80321908|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
27584550|NCT00898677|80321909|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
27584551|NCT00898677|80321906|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
27584552|NCT00898677|80321907|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
27584553|NCT00898677|80321908|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
27584554|NCT00898677|80321909|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
27584555|NCT00898677|80321906|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
27584556|NCT00898677|80321907|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
27584557|NCT00898677|80321908|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
27584558|NCT00898677|80321909|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
27584559|NCT00898677|80321906|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
27584560|NCT00898677|80321907|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
27584561|NCT00898677|80321908|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
27584562|NCT00898677|80321909|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
27584563|NCT03965052|80321922|FG000|Overall Study|Protocol Violation|1|||
27584564|NCT03965052|80321923|FG001|Overall Study|Protocol Violation|0|||
27584565|NCT01337089|80321929|FG000|Overall Study|Adverse Event|237|||
27584566|NCT01337089|80321929|FG000|Overall Study|Withdrawal by Subject|129|||
27584567|NCT01337089|80321929|FG000|Overall Study|Withdrawal by Investigator|33|||
27584568|NCT01337089|80321929|FG000|Overall Study|Met Withdrawal Criteria|3|||
27584569|NCT01337089|80321929|FG000|Overall Study|Lost to Follow-up|2|||
27584570|NCT03359096|80321933|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
27584571|NCT03359096|80321934|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
27584572|NCT03359096|80321933|FG000|First Intervention (4 Weeks)|Death|1|||
27584573|NCT03359096|80321934|FG001|First Intervention (4 Weeks)|Death|0|||
27584574|NCT03359096|80321933|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
27584575|NCT03359096|80321934|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
27584576|NCT00003457|80321936|FG000|Overall Study|Not evaluable|9|||
27584577|NCT04755595|80321937|FG000|Overall Study|Lost to Follow-up|1|||
27584578|NCT03346759|80321941|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
27584579|NCT03346759|80321942|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
27584580|NCT03346759|80321941|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
27584581|NCT03346759|80321942|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
27584582|NCT03346759|80321941|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
27584583|NCT03346759|80321942|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
27584584|NCT02886572|80321943|FG000|Overall Study|Death|8|||
27584585|NCT01265953|80321944|FG000|Overall Study|Non compliance|5|||
27584586|NCT01265953|80321945|FG001|Overall Study|Non compliance|3|||
27584587|NCT02546544|80321958|FG000|Overall Study|Disease Progression|14|||
27584588|NCT02546544|80321958|FG000|Overall Study|Adverse Event|1|||
27584589|NCT02546544|80321958|FG000|Overall Study|Withdrawal by Subject|1|||
27584590|NCT00701051|80321959|FG000|Screening|Failed Screening|40|||
27584591|NCT00701051|80321960|FG001|Screening|Failed Screening|0|||
27584592|NCT00701051|80321961|FG002|Screening|Failed Screening|0|||
27584593|NCT00701051|80321959|FG000|Screening|Time conflicts|19|||
27584594|NCT00701051|80321960|FG001|Screening|Time conflicts|0|||
27584595|NCT00701051|80321961|FG002|Screening|Time conflicts|0|||
27584596|NCT00701051|80321959|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
27584597|NCT00701051|80321960|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
27584598|NCT00701051|80321961|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
27584599|NCT00099983|80321962|FG000|Overall Study|Lost to Follow-up|2|||
27584600|NCT00099983|80321963|FG001|Overall Study|Lost to Follow-up|3|||
27584601|NCT00099983|80321962|FG000|Overall Study|Missing Source Documents|14|||
27584602|NCT00099983|80321963|FG001|Overall Study|Missing Source Documents|15|||
27584603|NCT00099983|80321962|FG000|Overall Study|Withdrawal by Subject|3|||
27584604|NCT00099983|80321963|FG001|Overall Study|Withdrawal by Subject|2|||
27584605|NCT00099983|80321962|FG000|Overall Study|Adverse Event|1|||
27584606|NCT00099983|80321963|FG001|Overall Study|Adverse Event|1|||
27584607|NCT00099983|80321962|FG000|Overall Study|Lack of Efficacy|0|||
27584608|NCT00099983|80321963|FG001|Overall Study|Lack of Efficacy|1|||
27584609|NCT00099983|80321962|FG000|Overall Study|Unable to return for appointments|1|||
27584610|NCT00099983|80321963|FG001|Overall Study|Unable to return for appointments|1|||
27584611|NCT00099983|80321962|FG000|Overall Study|Moved|1|||
27584612|NCT00099983|80321963|FG001|Overall Study|Moved|0|||
27584613|NCT00099983|80321962|FG000|Overall Study|Other psychiatric problem|1|||
27584614|NCT00099983|80321963|FG001|Overall Study|Other psychiatric problem|0|||
27683845|NCT05327816|80679250|FG008|Overall Study|Withdrawal by Subject|0|||
27683846|NCT05327816|80679251|FG009|Overall Study|Withdrawal by Subject|0|||
27683847|NCT05327816|80679252|FG010|Overall Study|Withdrawal by Subject|0|||
27683848|NCT05327816|80679242|FG000|Overall Study|Study Terminated by Sponsor|11|||
27683849|NCT05327816|80679243|FG001|Overall Study|Study Terminated by Sponsor|12|||
27683850|NCT05327816|80679244|FG002|Overall Study|Study Terminated by Sponsor|12|||
27807701|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27683851|NCT05327816|80679245|FG003|Overall Study|Study Terminated by Sponsor|12|||
27683852|NCT05327816|80679246|FG004|Overall Study|Study Terminated by Sponsor|11|||
27683853|NCT05327816|80679247|FG005|Overall Study|Study Terminated by Sponsor|11|||
27683854|NCT05327816|80679248|FG006|Overall Study|Study Terminated by Sponsor|11|||
27683855|NCT05327816|80679249|FG007|Overall Study|Study Terminated by Sponsor|11|||
27683856|NCT05327816|80679250|FG008|Overall Study|Study Terminated by Sponsor|11|||
27683857|NCT05327816|80679251|FG009|Overall Study|Study Terminated by Sponsor|11|||
27683858|NCT05327816|80679252|FG010|Overall Study|Study Terminated by Sponsor|12|||
27683859|NCT05327816|80679242|FG000|Overall Study|Randomized but not treated|0|||
27683860|NCT05327816|80679243|FG001|Overall Study|Randomized but not treated|0|||
27683861|NCT05327816|80679244|FG002|Overall Study|Randomized but not treated|0|||
27683862|NCT05327816|80679245|FG003|Overall Study|Randomized but not treated|0|||
27683863|NCT05327816|80679246|FG004|Overall Study|Randomized but not treated|0|||
27683864|NCT05327816|80679247|FG005|Overall Study|Randomized but not treated|0|||
27683865|NCT05327816|80679248|FG006|Overall Study|Randomized but not treated|1|||
27683866|NCT05327816|80679249|FG007|Overall Study|Randomized but not treated|1|||
27683867|NCT05327816|80679250|FG008|Overall Study|Randomized but not treated|1|||
27683868|NCT05327816|80679251|FG009|Overall Study|Randomized but not treated|0|||
27683869|NCT05327816|80679252|FG010|Overall Study|Randomized but not treated|0|||
27683870|NCT01901419|80679253|FG000|Overall Study|Protocol Violation|2|||
27683871|NCT01901419|80679254|FG001|Overall Study|Protocol Violation|6|||
27683872|NCT01901419|80679253|FG000|Overall Study|unavailable researchers|6|||
27683873|NCT01901419|80679254|FG001|Overall Study|unavailable researchers|3|||
27683874|NCT03554629|80679255|FG000|Overall Study|Inadequate data|6|||
27683875|NCT02735577|80679256|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
27683876|NCT02735577|80679256|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
27683877|NCT00588692|80679258|FG000|Overall Study|Withdrawal by Subject|4|||
27683878|NCT00588692|80679259|FG001|Overall Study|Withdrawal by Subject|2|||
27683879|NCT00588692|80679258|FG000|Overall Study|Hip Surgery|0|||
27683880|NCT00588692|80679259|FG001|Overall Study|Hip Surgery|1|||
27683881|NCT00588692|80679258|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
27683882|NCT00588692|80679259|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
27683883|NCT00588692|80679258|FG000|Overall Study|Cancer|1|||
27683884|NCT00588692|80679259|FG001|Overall Study|Cancer|0|||
27683885|NCT00588692|80679258|FG000|Overall Study|Death|1|||
27683886|NCT00588692|80679259|FG001|Overall Study|Death|0|||
27683887|NCT00992225|80679260|FG000|Overall Study|Entry Criteria Not Met|8|||
27683888|NCT00992225|80679260|FG000|Overall Study|Adverse Event|2|||
27683889|NCT02207569|80679265|FG000|1-Month|Death|6|||
27683890|NCT02207569|80679265|FG000|1-Month|Withdrawal by Subject|2|||
27683891|NCT02207569|80679265|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
27683892|NCT02207569|80679265|FG000|6-Month|Death|8|||
27683893|NCT02207569|80679265|FG000|6-Month|Withdrawal by Subject|2|||
27683894|NCT02207569|80679265|FG000|12-Month|Death|14|||
27683895|NCT02207569|80679265|FG000|12-Month|Withdrawal by Subject|2|||
27683896|NCT02207569|80679265|FG000|24-Month|Death|23|||
27683897|NCT02207569|80679265|FG000|24-Month|Withdrawal by Subject|3|||
27683898|NCT02207569|80679265|FG000|36-Month|Death|23|||
27683899|NCT02207569|80679265|FG000|36-Month|Withdrawal by Subject|4|||
27683900|NCT02207569|80679265|FG000|48-Month|Death|25|||
27683901|NCT02207569|80679265|FG000|48-Month|Withdrawal by Subject|2|||
27683902|NCT02207569|80679265|FG000|48-Month|Lost to Follow-up|4|||
27683903|NCT02207569|80679265|FG000|60-Month|Death|1|||
27683904|NCT02207569|80679265|FG000|60-Month|Lost to Follow-up|1|||
27683905|NCT02207569|80679265|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
27683906|NCT02207569|80679265|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
27683907|NCT04738292|80679267|FG000|Overall Study|Death|1|||
27683908|NCT02738853|80679268|FG000|Enrollment|Inclusion/Exclusion not met|21|||
27807702|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27807703|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
27683909|NCT02738853|80679268|FG000|Enrollment|Withdrawal by Subject|3|||
27683910|NCT02738853|80679268|FG000|Enrollment|Subject treated with commercially available device|6|||
27683911|NCT02738853|80679268|FG000|Enrollment|Study Enrollment Closed|3|||
27683912|NCT02738853|80679268|FG000|Procedure|Death|1|||
27683913|NCT02738853|80679268|FG000|1 Month|Death|2|||
27683914|NCT02738853|80679268|FG000|6 Month|Death|4|||
27683915|NCT02738853|80679268|FG000|6 Month|Withdrawal by Subject|2|||
27683916|NCT02738853|80679268|FG000|1 Year|Death|6|||
27683917|NCT02738853|80679268|FG000|1 Year|Withdrawal by Subject|1|||
27683918|NCT02738853|80679268|FG000|2 Year|Death|2|||
27683919|NCT02738853|80679268|FG000|2 Year|Lost to Follow-up|1|||
27683920|NCT02738853|80679268|FG000|3 Year|Death|2|||
27683921|NCT02738853|80679268|FG000|3 Year|Withdrawal by Subject|1|||
27683922|NCT02738853|80679268|FG000|4 Year|Death|9|||
27683923|NCT02738853|80679268|FG000|5 Year|Lost to Follow-up|4|||
27683924|NCT03245151|80679279|FG000|Overall Study|Withdrawal by Subject|2|||
27683925|NCT03245151|80679280|FG001|Overall Study|Withdrawal by Subject|0|||
27683926|NCT03245151|80679281|FG002|Overall Study|Withdrawal by Subject|0|||
27683927|NCT03245151|80679282|FG003|Overall Study|Withdrawal by Subject|2|||
27683928|NCT03245151|80679283|FG004|Overall Study|Withdrawal by Subject|1|||
27683929|NCT03245151|80679279|FG000|Overall Study|Death|3|||
27683930|NCT03245151|80679280|FG001|Overall Study|Death|14|||
27683931|NCT03245151|80679281|FG002|Overall Study|Death|9|||
27683932|NCT03245151|80679282|FG003|Overall Study|Death|16|||
27683933|NCT03245151|80679283|FG004|Overall Study|Death|7|||
27683934|NCT03245151|80679279|FG000|Overall Study|Sponsor's decision|0|||
27683935|NCT03245151|80679280|FG001|Overall Study|Sponsor's decision|1|||
27683936|NCT03245151|80679281|FG002|Overall Study|Sponsor's decision|0|||
27683937|NCT03245151|80679282|FG003|Overall Study|Sponsor's decision|0|||
27683938|NCT03245151|80679283|FG004|Overall Study|Sponsor's decision|0|||
27683939|NCT00939822|80679284|FG000|Overall Study|Lost to Follow-up|1|||
27683940|NCT00939822|80679285|FG001|Overall Study|Lost to Follow-up|0|||
27683941|NCT00939822|80679284|FG000|Overall Study|withdrew from study due to busy schedule|1|||
27683942|NCT00939822|80679285|FG001|Overall Study|withdrew from study due to busy schedule|1|||
27683943|NCT00939822|80679284|FG000|Overall Study|Mental health issues|0|||
27683944|NCT00939822|80679285|FG001|Overall Study|Mental health issues|2|||
27683945|NCT00316602|80679293|FG000|Overall Study|Withdrawal by Subject|3|||
27683946|NCT00316602|80679294|FG001|Overall Study|Withdrawal by Subject|2|||
27683947|NCT00316602|80679293|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
27683948|NCT00316602|80679294|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
27683949|NCT00316602|80679293|FG000|Overall Study|Adverse Event|1|||
27683950|NCT00316602|80679294|FG001|Overall Study|Adverse Event|0|||
27683951|NCT00316602|80679293|FG000|Overall Study|Other|3|||
27683952|NCT00316602|80679294|FG001|Overall Study|Other|6|||
27683953|NCT00128102|80679295|FG000|Overall Study|Site Discontinued|3|||
27683954|NCT00128102|80679296|FG001|Overall Study|Site Discontinued|6|||
27683955|NCT00128102|80679295|FG000|Overall Study|Other|0|||
27683956|NCT00128102|80679296|FG001|Overall Study|Other|1|||
27683957|NCT00128102|80679295|FG000|Overall Study|Progressive Disease|255|||
27683958|NCT00128102|80679296|FG001|Overall Study|Progressive Disease|285|||
27683959|NCT00128102|80679295|FG000|Overall Study|Adverse Event|34|||
27683960|NCT00128102|80679296|FG001|Overall Study|Adverse Event|11|||
27683961|NCT00128102|80679295|FG000|Overall Study|Death|12|||
27683962|NCT00128102|80679296|FG001|Overall Study|Death|13|||
27683963|NCT00128102|80679295|FG000|Overall Study|Physician Decision|3|||
27683964|NCT00128102|80679296|FG001|Overall Study|Physician Decision|3|||
27683965|NCT00128102|80679295|FG000|Overall Study|Withdrawal by Subject|19|||
27683966|NCT00128102|80679296|FG001|Overall Study|Withdrawal by Subject|11|||
27683967|NCT00128102|80679295|FG000|Overall Study|Protocol Violation|2|||
27683968|NCT00128102|80679296|FG001|Overall Study|Protocol Violation|2|||
27683969|NCT01994837|80679297|FG000|Overall Study|Progressive disease per protocol|23|||
27683970|NCT01994837|80679297|FG000|Overall Study|Adv event related to progressive disease|3|||
27683971|NCT01994837|80679297|FG000|Overall Study|Fatal progressive disease|2|||
27683972|NCT01994837|80679297|FG000|Overall Study|Adverse event not related to progression|1|||
27683973|NCT01994837|80679297|FG000|Overall Study|Chose palliative care|1|||
27683974|NCT01994837|80679297|FG000|Overall Study|Proceeded to transplant|1|||
27683975|NCT01994837|80679297|FG000|Overall Study|Removed from study due to no response|1|||
27807704|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27807705|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
27807706|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27874291|NCT01777282|81371705|FG003|Overall Study|Adverse Event|1|||
27683976|NCT01056718|80679302|FG000|Overall Study|Withdrawal by Subject|2|||
27683977|NCT01056718|80679302|FG000|Overall Study|Ischemia on baseline stress test|1|||
27683978|NCT03845140|80679305|FG000|Overall Study|Participant travelled outside study area|0|||
27683979|NCT03845140|80679306|FG001|Overall Study|Participant travelled outside study area|1|||
27683980|NCT03845140|80679307|FG002|Overall Study|Participant travelled outside study area|0|||
27683981|NCT03845140|80679308|FG003|Overall Study|Participant travelled outside study area|0|||
27683982|NCT03845140|80679309|FG004|Overall Study|Participant travelled outside study area|0|||
27683983|NCT03845140|80679310|FG005|Overall Study|Participant travelled outside study area|0|||
27683984|NCT00858364|80679314|FG000|Overall Study|Administrative Decision|3|||
27683985|NCT00858364|80679315|FG001|Overall Study|Administrative Decision|2|||
27683986|NCT00858364|80679314|FG000|Overall Study|Adverse Event|5|||
27683987|NCT00858364|80679315|FG001|Overall Study|Adverse Event|2|||
28003768|NCT02349633|81846252|FG013|Overall Study|Transition to compassionate use|0|||
28003769|NCT02349633|81846239|FG000|Overall Study|Early termination of survival follow-up|0|||
28003770|NCT02349633|81846240|FG001|Overall Study|Early termination of survival follow-up|0|||
28003771|NCT02349633|81846241|FG002|Overall Study|Early termination of survival follow-up|0|||
28003772|NCT02349633|81846242|FG003|Overall Study|Early termination of survival follow-up|0|||
28003773|NCT02349633|81846243|FG004|Overall Study|Early termination of survival follow-up|0|||
28003774|NCT02349633|81846244|FG005|Overall Study|Early termination of survival follow-up|0|||
28003775|NCT02349633|81846245|FG006|Overall Study|Early termination of survival follow-up|0|||
28003776|NCT02349633|81846246|FG007|Overall Study|Early termination of survival follow-up|4|||
28003777|NCT02349633|81846247|FG008|Overall Study|Early termination of survival follow-up|0|||
28003778|NCT02349633|81846248|FG009|Overall Study|Early termination of survival follow-up|0|||
28003779|NCT02349633|81846249|FG010|Overall Study|Early termination of survival follow-up|0|||
28003780|NCT02349633|81846250|FG011|Overall Study|Early termination of survival follow-up|0|||
28003781|NCT02349633|81846251|FG012|Overall Study|Early termination of survival follow-up|0|||
28003782|NCT02349633|81846252|FG013|Overall Study|Early termination of survival follow-up|0|||
28003783|NCT02349633|81846239|FG000|Overall Study|Termination by sponsor|0|||
28003784|NCT02349633|81846240|FG001|Overall Study|Termination by sponsor|0|||
28003785|NCT02349633|81846241|FG002|Overall Study|Termination by sponsor|0|||
28003786|NCT02349633|81846242|FG003|Overall Study|Termination by sponsor|0|||
28003787|NCT02349633|81846243|FG004|Overall Study|Termination by sponsor|0|||
28003788|NCT02349633|81846244|FG005|Overall Study|Termination by sponsor|0|||
28003789|NCT02349633|81846245|FG006|Overall Study|Termination by sponsor|0|||
28003790|NCT02349633|81846246|FG007|Overall Study|Termination by sponsor|1|||
27807707|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
27807708|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27807709|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
27807710|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
27807711|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
27807712|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
27807713|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
27807714|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
27807715|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
28003791|NCT02349633|81846247|FG008|Overall Study|Termination by sponsor|0|||
28003792|NCT02349633|81846248|FG009|Overall Study|Termination by sponsor|2|||
28003793|NCT02349633|81846249|FG010|Overall Study|Termination by sponsor|0|||
28003794|NCT02349633|81846250|FG011|Overall Study|Termination by sponsor|0|||
28003795|NCT02349633|81846251|FG012|Overall Study|Termination by sponsor|0|||
28003796|NCT02349633|81846252|FG013|Overall Study|Termination by sponsor|0|||
28003797|NCT02349633|81846239|FG000|Overall Study|Other|0|||
28003798|NCT02349633|81846240|FG001|Overall Study|Other|0|||
28003799|NCT02349633|81846241|FG002|Overall Study|Other|0|||
28003800|NCT02349633|81846242|FG003|Overall Study|Other|0|||
28003801|NCT02349633|81846243|FG004|Overall Study|Other|0|||
28003802|NCT02349633|81846244|FG005|Overall Study|Other|0|||
28003803|NCT02349633|81846245|FG006|Overall Study|Other|0|||
28003804|NCT02349633|81846246|FG007|Overall Study|Other|2|||
28003805|NCT02349633|81846247|FG008|Overall Study|Other|0|||
27683988|NCT00858364|80679314|FG000|Overall Study|Withdrawal by Subject|44|||
27700993|NCT01241552|80741290|FG001|Overall Study|Protocol Violation|2|||
27807716|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
27807717|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
27807718|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
27807719|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
27807720|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
27807721|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
27807722|NCT01806597|81127195|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
27807723|NCT01806597|81127196|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27807724|NCT01806597|81127197|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27807725|NCT01806597|81127198|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27807726|NCT01806597|81127199|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
28003806|NCT02349633|81846248|FG009|Overall Study|Other|0|||
28003807|NCT02349633|81846249|FG010|Overall Study|Other|0|||
28003808|NCT02349633|81846250|FG011|Overall Study|Other|0|||
28003809|NCT02349633|81846251|FG012|Overall Study|Other|0|||
28003810|NCT02349633|81846252|FG013|Overall Study|Other|0|||
28003811|NCT00475670|81846253|FG000|Overall Study|Death|0|||
28003812|NCT00475670|81846254|FG001|Overall Study|Death|1|||
27584615|NCT00099983|80321962|FG000|Overall Study|Incarcerated|0|||
27584616|NCT00099983|80321963|FG001|Overall Study|Incarcerated|1|||
27584617|NCT00099983|80321962|FG000|Overall Study|Intolerant of burden of visits|0|||
27807727|NCT01806597|81127200|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
27807728|NCT01806597|81127195|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27807729|NCT01806597|81127196|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27807730|NCT01806597|81127197|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27807731|NCT01806597|81127198|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27807732|NCT01806597|81127199|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
27807733|NCT01806597|81127200|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
27807734|NCT01806597|81127195|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27807735|NCT01806597|81127196|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27807736|NCT01806597|81127197|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27807737|NCT01806597|81127198|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27807738|NCT01806597|81127199|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
27807739|NCT01806597|81127200|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
27807740|NCT01806597|81127195|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27807741|NCT01806597|81127196|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27807742|NCT01806597|81127197|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27807743|NCT01806597|81127198|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27807744|NCT01806597|81127199|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
27807745|NCT01806597|81127200|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
27807746|NCT01806597|81127195|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27807747|NCT01806597|81127196|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27807748|NCT01806597|81127197|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27807749|NCT01806597|81127198|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27807750|NCT01806597|81127199|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
27807751|NCT01806597|81127200|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
27807752|NCT01806597|81127195|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27807753|NCT01806597|81127196|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27807754|NCT01806597|81127197|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27807755|NCT01806597|81127198|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27807756|NCT01806597|81127199|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
27874292|NCT01777282|81371706|FG004|Overall Study|Adverse Event|3|||
28003813|NCT00475670|81846253|FG000|Overall Study|Lack of Efficacy|3|||
28003814|NCT00475670|81846254|FG001|Overall Study|Lack of Efficacy|34|||
28003815|NCT00475670|81846253|FG000|Overall Study|Refused treatment|0|||
28003816|NCT00475670|81846254|FG001|Overall Study|Refused treatment|2|||
28003817|NCT00475670|81846253|FG000|Overall Study|Failure to Return|0|||
28003818|NCT00475670|81846254|FG001|Overall Study|Failure to Return|1|||
28003819|NCT00475670|81846253|FG000|Overall Study|Other|0|||
28003820|NCT00475670|81846254|FG001|Overall Study|Other|3|||
28003821|NCT03582215|81846255|FG000|Overall Study|Adverse Event|1|||
28003822|NCT03582215|81846256|FG001|Overall Study|Adverse Event|0|||
27683989|NCT00858364|80679315|FG001|Overall Study|Withdrawal by Subject|118|||
27683990|NCT00858364|80679314|FG000|Overall Study|Ineligibility Determined|1|||
27683991|NCT00858364|80679315|FG001|Overall Study|Ineligibility Determined|10|||
27683992|NCT00858364|80679314|FG000|Overall Study|Lost to Follow-up|24|||
27683993|NCT00858364|80679315|FG001|Overall Study|Lost to Follow-up|54|||
27683994|NCT00858364|80679314|FG000|Overall Study|Noncompliance|3|||
27683995|NCT00858364|80679315|FG001|Overall Study|Noncompliance|4|||
27683996|NCT00858364|80679314|FG000|Overall Study|Protocol Deviation|0|||
27683997|NCT00858364|80679315|FG001|Overall Study|Protocol Deviation|2|||
27683998|NCT00858364|80679314|FG000|Overall Study|Other|9|||
27683999|NCT00858364|80679315|FG001|Overall Study|Other|17|||
27684000|NCT00858364|80679314|FG000|Overall Study|Missing|1|||
27684001|NCT00858364|80679315|FG001|Overall Study|Missing|1|||
27684002|NCT00858364|80679314|FG000|Overall Study|Still on-study|114|||
27684003|NCT00858364|80679315|FG001|Overall Study|Still on-study|247|||
27684004|NCT03525392|80679316|FG000|Overall Study|Adverse Event|1|||
27684005|NCT03525392|80679317|FG001|Overall Study|Adverse Event|0|||
27684006|NCT03525392|80679318|FG002|Overall Study|Adverse Event|2|||
27684007|NCT03525392|80679319|FG003|Overall Study|Adverse Event|0|||
27684008|NCT03525392|80679320|FG004|Overall Study|Adverse Event|0|||
27684009|NCT03525392|80679316|FG000|Overall Study|Progressive disease|0|||
27684010|NCT03525392|80679317|FG001|Overall Study|Progressive disease|1|||
27684011|NCT03525392|80679318|FG002|Overall Study|Progressive disease|1|||
27684012|NCT03525392|80679319|FG003|Overall Study|Progressive disease|3|||
27684013|NCT03525392|80679320|FG004|Overall Study|Progressive disease|1|||
27684014|NCT00490490|80679321|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
27684015|NCT00490490|80679321|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
27684016|NCT00316017|80679322|FG000|Overall Study|Protocol Violation|11|||
27684017|NCT00316017|80679323|FG001|Overall Study|Protocol Violation|13|||
27684018|NCT00316017|80679324|FG002|Overall Study|Protocol Violation|19|||
27684019|NCT01803282|80679329|FG000|Overall Study|Progressive Disease|4|||
27684020|NCT01803282|80679330|FG001|Overall Study|Progressive Disease|3|||
27684021|NCT01803282|80679331|FG002|Overall Study|Progressive Disease|6|||
27684022|NCT01803282|80679332|FG003|Overall Study|Progressive Disease|22|||
27684023|NCT01803282|80679333|FG004|Overall Study|Progressive Disease|5|||
27684024|NCT01803282|80679334|FG005|Overall Study|Progressive Disease|8|||
27807757|NCT01806597|81127200|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
27807758|NCT02970669|81127201|FG000|Double-blind Period|Adverse Event|4|||
27807759|NCT02970669|81127202|FG001|Double-blind Period|Adverse Event|0|||
27807760|NCT02970669|81127201|FG000|Double-blind Period|Death|1|||
27807761|NCT02970669|81127202|FG001|Double-blind Period|Death|0|||
27807762|NCT02970669|81127201|FG000|Double-blind Period|Study terminated by sponsor|1|||
27807763|NCT02970669|81127202|FG001|Double-blind Period|Study terminated by sponsor|2|||
27807764|NCT02970669|81127201|FG000|Double-blind Period|Physician Decision|0|||
27684025|NCT01803282|80679335|FG006|Overall Study|Progressive Disease|23|||
27684026|NCT01803282|80679336|FG007|Overall Study|Progressive Disease|24|||
27684027|NCT01803282|80679337|FG008|Overall Study|Progressive Disease|3|||
27684028|NCT01803282|80679338|FG009|Overall Study|Progressive Disease|29|||
27684029|NCT01803282|80679339|FG010|Overall Study|Progressive Disease|6|||
27684030|NCT01803282|80679340|FG011|Overall Study|Progressive Disease|11|||
27684031|NCT01803282|80679329|FG000|Overall Study|Death|0|||
27684032|NCT01803282|80679330|FG001|Overall Study|Death|0|||
27684033|NCT01803282|80679331|FG002|Overall Study|Death|0|||
27684034|NCT01803282|80679332|FG003|Overall Study|Death|0|||
27684035|NCT01803282|80679333|FG004|Overall Study|Death|2|||
27684036|NCT01803282|80679334|FG005|Overall Study|Death|1|||
27684037|NCT01803282|80679335|FG006|Overall Study|Death|1|||
27684038|NCT01803282|80679336|FG007|Overall Study|Death|5|||
27684039|NCT01803282|80679337|FG008|Overall Study|Death|1|||
27684040|NCT01803282|80679338|FG009|Overall Study|Death|1|||
27684041|NCT01803282|80679339|FG010|Overall Study|Death|0|||
27684042|NCT01803282|80679340|FG011|Overall Study|Death|0|||
27684043|NCT01803282|80679329|FG000|Overall Study|Withdrew Consent|0|||
27807765|NCT02970669|81127202|FG001|Double-blind Period|Physician Decision|2|||
27684044|NCT01803282|80679330|FG001|Overall Study|Withdrew Consent|0|||
27684045|NCT01803282|80679331|FG002|Overall Study|Withdrew Consent|0|||
27684046|NCT01803282|80679332|FG003|Overall Study|Withdrew Consent|6|||
27684047|NCT01803282|80679333|FG004|Overall Study|Withdrew Consent|1|||
27684048|NCT01803282|80679334|FG005|Overall Study|Withdrew Consent|0|||
27684049|NCT01803282|80679335|FG006|Overall Study|Withdrew Consent|8|||
27684050|NCT01803282|80679336|FG007|Overall Study|Withdrew Consent|3|||
27807766|NCT02970669|81127201|FG000|Double-blind Period|Withdrawal by Subject|2|||
27807767|NCT02970669|81127202|FG001|Double-blind Period|Withdrawal by Subject|2|||
27684051|NCT01803282|80679337|FG008|Overall Study|Withdrew Consent|1|||
27684052|NCT01803282|80679338|FG009|Overall Study|Withdrew Consent|5|||
27684053|NCT01803282|80679339|FG010|Overall Study|Withdrew Consent|0|||
27684054|NCT01803282|80679340|FG011|Overall Study|Withdrew Consent|1|||
27684055|NCT01803282|80679329|FG000|Overall Study|Investigator's Discretion|0|||
27684056|NCT01803282|80679330|FG001|Overall Study|Investigator's Discretion|0|||
27684057|NCT01803282|80679331|FG002|Overall Study|Investigator's Discretion|0|||
27684058|NCT01803282|80679332|FG003|Overall Study|Investigator's Discretion|7|||
27684059|NCT01803282|80679333|FG004|Overall Study|Investigator's Discretion|2|||
27684060|NCT01803282|80679334|FG005|Overall Study|Investigator's Discretion|1|||
27684061|NCT01803282|80679335|FG006|Overall Study|Investigator's Discretion|7|||
27684062|NCT01803282|80679336|FG007|Overall Study|Investigator's Discretion|10|||
27684063|NCT01803282|80679337|FG008|Overall Study|Investigator's Discretion|6|||
27684064|NCT01803282|80679338|FG009|Overall Study|Investigator's Discretion|7|||
27684065|NCT01803282|80679339|FG010|Overall Study|Investigator's Discretion|1|||
27684066|NCT01803282|80679340|FG011|Overall Study|Investigator's Discretion|0|||
27684067|NCT01803282|80679329|FG000|Overall Study|Adverse Event|0|||
27684068|NCT01803282|80679330|FG001|Overall Study|Adverse Event|0|||
27684069|NCT01803282|80679331|FG002|Overall Study|Adverse Event|0|||
27684070|NCT01803282|80679332|FG003|Overall Study|Adverse Event|0|||
27684071|NCT01803282|80679333|FG004|Overall Study|Adverse Event|0|||
27684072|NCT01803282|80679334|FG005|Overall Study|Adverse Event|0|||
27684073|NCT01803282|80679335|FG006|Overall Study|Adverse Event|1|||
27684074|NCT01803282|80679336|FG007|Overall Study|Adverse Event|2|||
27684075|NCT01803282|80679337|FG008|Overall Study|Adverse Event|0|||
27684076|NCT01803282|80679338|FG009|Overall Study|Adverse Event|1|||
27684077|NCT01803282|80679339|FG010|Overall Study|Adverse Event|0|||
27684078|NCT01803282|80679340|FG011|Overall Study|Adverse Event|3|||
27684079|NCT01803282|80679329|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27684080|NCT01803282|80679330|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27684081|NCT01803282|80679331|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27684082|NCT01803282|80679332|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27684083|NCT01803282|80679333|FG004|Overall Study|Non-Compliance with Study Drug|0|||
27684084|NCT01803282|80679334|FG005|Overall Study|Non-Compliance with Study Drug|0|||
27684085|NCT01803282|80679335|FG006|Overall Study|Non-Compliance with Study Drug|0|||
27684086|NCT01803282|80679336|FG007|Overall Study|Non-Compliance with Study Drug|0|||
27684087|NCT01803282|80679337|FG008|Overall Study|Non-Compliance with Study Drug|0|||
27684088|NCT01803282|80679338|FG009|Overall Study|Non-Compliance with Study Drug|0|||
27684089|NCT01803282|80679339|FG010|Overall Study|Non-Compliance with Study Drug|0|||
27684090|NCT01803282|80679340|FG011|Overall Study|Non-Compliance with Study Drug|0|||
27684091|NCT01803282|80679329|FG000|Overall Study|Unknown Reason|0|||
27684092|NCT01803282|80679330|FG001|Overall Study|Unknown Reason|0|||
27684093|NCT01803282|80679331|FG002|Overall Study|Unknown Reason|0|||
27684094|NCT01803282|80679332|FG003|Overall Study|Unknown Reason|0|||
27684095|NCT01803282|80679333|FG004|Overall Study|Unknown Reason|0|||
27684096|NCT01803282|80679334|FG005|Overall Study|Unknown Reason|0|||
27684097|NCT01803282|80679335|FG006|Overall Study|Unknown Reason|0|||
27684098|NCT01803282|80679336|FG007|Overall Study|Unknown Reason|1|||
27684099|NCT01803282|80679337|FG008|Overall Study|Unknown Reason|0|||
27684100|NCT01803282|80679338|FG009|Overall Study|Unknown Reason|0|||
27684101|NCT01803282|80679339|FG010|Overall Study|Unknown Reason|0|||
27684102|NCT01803282|80679340|FG011|Overall Study|Unknown Reason|0|||
27684103|NCT01803282|80679329|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
27684104|NCT01803282|80679330|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
27684105|NCT01803282|80679331|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
27684106|NCT01803282|80679332|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
27684107|NCT01803282|80679333|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
27684108|NCT01803282|80679334|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
27684109|NCT01803282|80679335|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
27684110|NCT01803282|80679336|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
27684111|NCT01803282|80679337|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
27684112|NCT01803282|80679338|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
27684113|NCT01803282|80679339|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
27684114|NCT01803282|80679340|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
27684115|NCT01803282|80679329|FG000|Overall Study|Enrolled but Never Treated|0|||
27684116|NCT01803282|80679330|FG001|Overall Study|Enrolled but Never Treated|0|||
27684117|NCT01803282|80679331|FG002|Overall Study|Enrolled but Never Treated|0|||
27684118|NCT01803282|80679332|FG003|Overall Study|Enrolled but Never Treated|0|||
27684119|NCT01803282|80679333|FG004|Overall Study|Enrolled but Never Treated|1|||
27684120|NCT01803282|80679334|FG005|Overall Study|Enrolled but Never Treated|0|||
27684121|NCT01803282|80679335|FG006|Overall Study|Enrolled but Never Treated|1|||
27807768|NCT02970669|81127201|FG000|Open-label Period|Withdrawal by Subject|2|||
27807769|NCT02970669|81127202|FG001|Open-label Period|Withdrawal by Subject|2|||
27684122|NCT01803282|80679336|FG007|Overall Study|Enrolled but Never Treated|1|||
27684123|NCT01803282|80679337|FG008|Overall Study|Enrolled but Never Treated|0|||
27684124|NCT01803282|80679338|FG009|Overall Study|Enrolled but Never Treated|1|||
27684125|NCT01803282|80679339|FG010|Overall Study|Enrolled but Never Treated|0|||
27684126|NCT01803282|80679340|FG011|Overall Study|Enrolled but Never Treated|0|||
27684127|NCT03775434|80679342|FG000|Overall Study|Adverse Event|2|||
27684128|NCT03775434|80679342|FG000|Overall Study|Withdrawal by Subject|1|||
27684129|NCT00652327|80679343|FG000|Overall Study|Adverse Event|0|||
27684130|NCT00652327|80679344|FG001|Overall Study|Adverse Event|2|||
27684131|NCT00652327|80679343|FG000|Overall Study|Lost to Follow-up|0|||
27684132|NCT00652327|80679344|FG001|Overall Study|Lost to Follow-up|3|||
27684133|NCT01888900|80679348|FG000|Overall Study|failed treatment|0|||
27684134|NCT01888900|80679349|FG001|Overall Study|failed treatment|2|||
27584618|NCT00099983|80321963|FG001|Overall Study|Intolerant of burden of visits|1|||
27584619|NCT00099983|80321962|FG000|Overall Study|Other issue|1|||
27584620|NCT00099983|80321963|FG001|Overall Study|Other issue|0|||
27584621|NCT00661492|80321966|FG000|Overall Study|Adverse Event|16|||
27584622|NCT00661492|80321967|FG001|Overall Study|Adverse Event|13|||
27584623|NCT00661492|80321966|FG000|Overall Study|Disease Progression|44|||
27584624|NCT00661492|80321967|FG001|Overall Study|Disease Progression|14|||
27584625|NCT00661492|80321966|FG000|Overall Study|Patient Request|6|||
27584626|NCT00661492|80321967|FG001|Overall Study|Patient Request|1|||
27584627|NCT00661492|80321966|FG000|Overall Study|Investigator Request|1|||
27584628|NCT00661492|80321967|FG001|Overall Study|Investigator Request|0|||
27584629|NCT00661492|80321966|FG000|Overall Study|Lost to Follow-up|0|||
27584630|NCT00661492|80321967|FG001|Overall Study|Lost to Follow-up|1|||
27584631|NCT00661492|80321966|FG000|Overall Study|Other|1|||
27584632|NCT00661492|80321967|FG001|Overall Study|Other|0|||
27584633|NCT01992536|80321968|FG000|Overall Study|Administrative Reason|0|||
27584634|NCT01992536|80321969|FG001|Overall Study|Administrative Reason|0|||
27584635|NCT01992536|80321970|FG002|Overall Study|Administrative Reason|0|||
27584636|NCT01992536|80321971|FG003|Overall Study|Administrative Reason|0|||
27584637|NCT01992536|80321972|FG004|Overall Study|Administrative Reason|0|||
27584638|NCT01992536|80321973|FG005|Overall Study|Administrative Reason|0|||
27584639|NCT01992536|80321974|FG006|Overall Study|Administrative Reason|7|||
27584640|NCT01992536|80321975|FG007|Overall Study|Administrative Reason|0|||
27584641|NCT01992536|80321976|FG008|Overall Study|Administrative Reason|0|||
27584642|NCT01992536|80321977|FG009|Overall Study|Administrative Reason|0|||
27584643|NCT01992536|80321968|FG000|Overall Study|Lost to Follow-up|4|||
27584644|NCT01992536|80321969|FG001|Overall Study|Lost to Follow-up|2|||
27584645|NCT01992536|80321970|FG002|Overall Study|Lost to Follow-up|1|||
27584646|NCT01992536|80321971|FG003|Overall Study|Lost to Follow-up|0|||
27584647|NCT01992536|80321972|FG004|Overall Study|Lost to Follow-up|0|||
27584648|NCT01992536|80321973|FG005|Overall Study|Lost to Follow-up|1|||
27584649|NCT01992536|80321974|FG006|Overall Study|Lost to Follow-up|0|||
27584650|NCT01992536|80321975|FG007|Overall Study|Lost to Follow-up|0|||
27584651|NCT01992536|80321976|FG008|Overall Study|Lost to Follow-up|1|||
27584652|NCT01992536|80321977|FG009|Overall Study|Lost to Follow-up|1|||
27584653|NCT01992536|80321968|FG000|Overall Study|Withdrawal by Subject|0|||
27584654|NCT01992536|80321969|FG001|Overall Study|Withdrawal by Subject|1|||
27584655|NCT01992536|80321970|FG002|Overall Study|Withdrawal by Subject|0|||
27584656|NCT01992536|80321971|FG003|Overall Study|Withdrawal by Subject|2|||
27584657|NCT01992536|80321972|FG004|Overall Study|Withdrawal by Subject|0|||
27584658|NCT01992536|80321973|FG005|Overall Study|Withdrawal by Subject|0|||
27584659|NCT01992536|80321974|FG006|Overall Study|Withdrawal by Subject|0|||
27584660|NCT01992536|80321975|FG007|Overall Study|Withdrawal by Subject|0|||
27584661|NCT01992536|80321976|FG008|Overall Study|Withdrawal by Subject|0|||
27584662|NCT01992536|80321977|FG009|Overall Study|Withdrawal by Subject|0|||
27584663|NCT02056301|80321978|FG000|Overall Study|Protocol Violation|1|||
27584664|NCT02056301|80321979|FG001|Overall Study|Protocol Violation|2|||
27584665|NCT02056301|80321978|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
27584666|NCT02056301|80321979|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
27584667|NCT02056301|80321978|FG000|Overall Study|Withdrawal by Subject|0|||
27584668|NCT02056301|80321979|FG001|Overall Study|Withdrawal by Subject|1|||
27584669|NCT02056301|80321978|FG000|Overall Study|Issues with epidural|0|||
27584670|NCT02056301|80321979|FG001|Overall Study|Issues with epidural|3|||
27584671|NCT03647501|80321981|FG000|Overall Study|Lost to Follow-up|1|||
27584672|NCT03647501|80321982|FG001|Overall Study|Lost to Follow-up|1|||
27584673|NCT03647501|80321981|FG000|Overall Study|Withdrawal by Subject|0|||
27584674|NCT03647501|80321982|FG001|Overall Study|Withdrawal by Subject|1|||
27584675|NCT00803634|80321991|FG000|Overall Study|Withdrew Consent|1|||
27584676|NCT00803634|80321992|FG001|Overall Study|Withdrew Consent|0|||
27584677|NCT00803634|80321991|FG000|Overall Study|Lost to Follow-up|2|||
27584678|NCT00803634|80321992|FG001|Overall Study|Lost to Follow-up|3|||
27584679|NCT00803634|80321991|FG000|Overall Study|Death|3|||
27584680|NCT00803634|80321992|FG001|Overall Study|Death|2|||
27584681|NCT00710424|80321997|FG000|Overall Study|Adverse Event|30|||
27684135|NCT01859988|80679352|FG000|Overall Study|Withdrawal by Subject|6|||
27684136|NCT01859988|80679353|FG001|Overall Study|Withdrawal by Subject|3|||
27584682|NCT00710424|80321998|FG001|Overall Study|Adverse Event|12|||
27684137|NCT01859988|80679354|FG002|Overall Study|Withdrawal by Subject|4|||
27584683|NCT00710424|80321997|FG000|Overall Study|Lack of Efficacy|4|||
27584684|NCT00710424|80321998|FG001|Overall Study|Lack of Efficacy|5|||
27584685|NCT00710424|80321997|FG000|Overall Study|Withdrawal by Subject|5|||
27584686|NCT00710424|80321998|FG001|Overall Study|Withdrawal by Subject|3|||
27584687|NCT00710424|80321997|FG000|Overall Study|Lost to Follow-up|0|||
28003823|NCT03582215|81846257|FG002|Overall Study|Adverse Event|0|||
28003824|NCT03582215|81846258|FG003|Overall Study|Adverse Event|0|||
28003825|NCT03582215|81846259|FG004|Overall Study|Adverse Event|0|||
28003826|NCT03582215|81846260|FG005|Overall Study|Adverse Event|0|||
28003827|NCT03582215|81846261|FG006|Overall Study|Adverse Event|2|||
28003828|NCT03582215|81846262|FG007|Overall Study|Adverse Event|2|||
28003829|NCT02898454|81846266|FG000|Overall Study|Adverse Event|4|||
28003830|NCT02898454|81846267|FG001|Overall Study|Adverse Event|1|||
28003831|NCT02898454|81846268|FG002|Overall Study|Adverse Event|2|||
28003832|NCT02898454|81846266|FG000|Overall Study|Protocol Violation|1|||
28003833|NCT02898454|81846267|FG001|Overall Study|Protocol Violation|0|||
28003834|NCT02898454|81846268|FG002|Overall Study|Protocol Violation|1|||
28003835|NCT02898454|81846266|FG000|Overall Study|Lack of Efficacy|4|||
28003836|NCT02898454|81846267|FG001|Overall Study|Lack of Efficacy|1|||
28003837|NCT02898454|81846268|FG002|Overall Study|Lack of Efficacy|0|||
28003838|NCT02898454|81846266|FG000|Overall Study|Withdrawal by Subject|6|||
28003839|NCT02898454|81846267|FG001|Overall Study|Withdrawal by Subject|3|||
28003840|NCT02898454|81846268|FG002|Overall Study|Withdrawal by Subject|3|||
28003841|NCT02898454|81846266|FG000|Overall Study|Lost to Follow-up|1|||
28003842|NCT02898454|81846267|FG001|Overall Study|Lost to Follow-up|0|||
28003843|NCT02898454|81846268|FG002|Overall Study|Lost to Follow-up|0|||
28003844|NCT02898454|81846266|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
28003845|NCT02898454|81846267|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
28003846|NCT02898454|81846268|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
28003847|NCT02738801|81846269|FG000|Overall Study|Adverse Event|1|||
28003848|NCT02738801|81846270|FG001|Overall Study|Adverse Event|1|||
28003849|NCT02738801|81846269|FG000|Overall Study|Withdrawal by Subject|0|||
28003850|NCT02738801|81846270|FG001|Overall Study|Withdrawal by Subject|1|||
28003851|NCT03084796|81846271|FG000|Overall Study|Adverse Event|4|||
28003852|NCT03084796|81846272|FG001|Overall Study|Adverse Event|5|||
28003853|NCT03084796|81846273|FG002|Overall Study|Adverse Event|6|||
28003854|NCT03084796|81846274|FG003|Overall Study|Adverse Event|2|||
28003855|NCT03084796|81846275|FG004|Overall Study|Adverse Event|3|||
28003856|NCT03084796|81846276|FG005|Overall Study|Adverse Event|5|||
28003857|NCT03084796|81846271|FG000|Overall Study|Withdrawal by Subject|3|||
28003858|NCT03084796|81846272|FG001|Overall Study|Withdrawal by Subject|5|||
27807770|NCT02970669|81127201|FG000|Open-label Period|Adverse Event|1|||
28003859|NCT03084796|81846273|FG002|Overall Study|Withdrawal by Subject|2|||
28003860|NCT03084796|81846274|FG003|Overall Study|Withdrawal by Subject|1|||
28003861|NCT03084796|81846275|FG004|Overall Study|Withdrawal by Subject|3|||
28003862|NCT03084796|81846276|FG005|Overall Study|Withdrawal by Subject|0|||
28003863|NCT03084796|81846271|FG000|Overall Study|Protocol Violation|0|||
28003864|NCT03084796|81846272|FG001|Overall Study|Protocol Violation|0|||
27807771|NCT02970669|81127202|FG001|Open-label Period|Adverse Event|0|||
27807772|NCT02970669|81127201|FG000|Open-label Period|Physician Decision|1|||
27807773|NCT02970669|81127202|FG001|Open-label Period|Physician Decision|0|||
27807774|NCT01337050|81127214|FG000|Overall Study|Death|0|||
27807775|NCT01337050|81127215|FG001|Overall Study|Death|0|||
27807776|NCT01337050|81127216|FG002|Overall Study|Death|4|||
27807777|NCT01337050|81127214|FG000|Overall Study|Other|4|||
27807778|NCT01337050|81127215|FG001|Overall Study|Other|6|||
27807779|NCT01337050|81127216|FG002|Overall Study|Other|8|||
27807780|NCT01337050|81127214|FG000|Overall Study|Participants refused further follow-up|0|||
27807781|NCT01337050|81127215|FG001|Overall Study|Participants refused further follow-up|7|||
27807782|NCT01337050|81127216|FG002|Overall Study|Participants refused further follow-up|7|||
28003865|NCT03084796|81846273|FG002|Overall Study|Protocol Violation|1|||
28003866|NCT03084796|81846274|FG003|Overall Study|Protocol Violation|0|||
28003867|NCT03084796|81846275|FG004|Overall Study|Protocol Violation|1|||
28003868|NCT03084796|81846276|FG005|Overall Study|Protocol Violation|1|||
28003869|NCT03084796|81846271|FG000|Overall Study|Lack of Efficacy|0|||
28003870|NCT03084796|81846272|FG001|Overall Study|Lack of Efficacy|0|||
27807783|NCT00593333|81127223|FG000|Overall Study|Lost to Follow-up|10|||
27807784|NCT00593333|81127224|FG001|Overall Study|Lost to Follow-up|11|||
27807785|NCT05476679|81127225|FG000|Overall Study|Withdrawal by Subject|0|||
27807786|NCT05476679|81127226|FG001|Overall Study|Withdrawal by Subject|0|||
28003871|NCT03084796|81846273|FG002|Overall Study|Lack of Efficacy|1|||
28003872|NCT03084796|81846274|FG003|Overall Study|Lack of Efficacy|0|||
28003873|NCT03084796|81846275|FG004|Overall Study|Lack of Efficacy|1|||
28003874|NCT03084796|81846276|FG005|Overall Study|Lack of Efficacy|0|||
27807787|NCT05476679|81127227|FG002|Overall Study|Withdrawal by Subject|0|||
27807788|NCT05476679|81127228|FG003|Overall Study|Withdrawal by Subject|1|||
27807789|NCT05476679|81127229|FG004|Overall Study|Withdrawal by Subject|0|||
28003875|NCT03084796|81846271|FG000|Overall Study|Lost to Follow-up|0|||
28003876|NCT03084796|81846272|FG001|Overall Study|Lost to Follow-up|0|||
28003877|NCT03084796|81846273|FG002|Overall Study|Lost to Follow-up|1|||
28003878|NCT03084796|81846274|FG003|Overall Study|Lost to Follow-up|1|||
28003879|NCT03084796|81846275|FG004|Overall Study|Lost to Follow-up|3|||
28003880|NCT03084796|81846276|FG005|Overall Study|Lost to Follow-up|1|||
27684138|NCT01859988|80679355|FG003|Overall Study|Withdrawal by Subject|3|||
27684139|NCT01859988|80679356|FG004|Overall Study|Withdrawal by Subject|2|||
27684140|NCT01859988|80679357|FG005|Overall Study|Withdrawal by Subject|2|||
27684141|NCT01859988|80679352|FG000|Overall Study|Lack of Efficacy|1|||
27807790|NCT05476679|81127225|FG000|Overall Study|Lost to Follow-up|0|||
27807791|NCT05476679|81127226|FG001|Overall Study|Lost to Follow-up|0|||
27807792|NCT05476679|81127227|FG002|Overall Study|Lost to Follow-up|0|||
27807793|NCT05476679|81127228|FG003|Overall Study|Lost to Follow-up|1|||
27807794|NCT05476679|81127229|FG004|Overall Study|Lost to Follow-up|0|||
27807795|NCT03280537|81127230|FG000|Overall Study|Withdrawal by Subject|2|||
27807796|NCT03280537|81127231|FG001|Overall Study|Withdrawal by Subject|4|||
27807797|NCT02629133|81127232|FG000|Overall Study|Lost to Follow-up|3|||
28003881|NCT03084796|81846271|FG000|Overall Study|Randomization error|0|||
28003882|NCT03084796|81846272|FG001|Overall Study|Randomization error|0|||
28003883|NCT03084796|81846273|FG002|Overall Study|Randomization error|1|||
28003884|NCT03084796|81846274|FG003|Overall Study|Randomization error|0|||
28003885|NCT03084796|81846275|FG004|Overall Study|Randomization error|0|||
28003886|NCT03084796|81846276|FG005|Overall Study|Randomization error|0|||
28003887|NCT03449758|81846280|FG000|Overall Study|Major protocol deviation|1|||
28003888|NCT03449758|81846280|FG000|Overall Study|Treatment inefficacy|5|||
28003889|NCT03449758|81846280|FG000|Overall Study|Adverse Event|9|||
28003890|NCT03449758|81846280|FG000|Overall Study|Consent withdrawal|1|||
27807798|NCT02629133|81127233|FG001|Overall Study|Lost to Follow-up|1|||
27807799|NCT02629133|81127232|FG000|Overall Study|Withdrawal by Subject|1|||
27807800|NCT02629133|81127233|FG001|Overall Study|Withdrawal by Subject|1|||
27807801|NCT00633152|81127238|FG000|Overall Study|Adverse Event|1|||
27807802|NCT00633152|81127239|FG001|Overall Study|Adverse Event|0|||
27807803|NCT00633152|81127238|FG000|Overall Study|Randomized, did not receive study drug|5|||
27807804|NCT00633152|81127239|FG001|Overall Study|Randomized, did not receive study drug|2|||
27807805|NCT00633152|81127238|FG000|Overall Study|Withdrawal by Subject|1|||
27807806|NCT00633152|81127239|FG001|Overall Study|Withdrawal by Subject|1|||
27807807|NCT00633152|81127238|FG000|Overall Study|Lost to Follow-up|4|||
27807808|NCT00633152|81127239|FG001|Overall Study|Lost to Follow-up|1|||
27807809|NCT00633152|81127238|FG000|Overall Study|Miscellaneous Other|3|||
27807810|NCT00633152|81127239|FG001|Overall Study|Miscellaneous Other|2|||
27807811|NCT00526890|81127240|FG000|Overall Study|Adverse Event|2|||
27807812|NCT01507896|81127241|FG000|Overall Study|Withdrawal by Subject|1|||
27807813|NCT01507896|81127241|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
27807814|NCT03555890|81127242|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27807815|NCT03555890|81127243|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27807816|NCT03555890|81127244|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27807817|NCT03555890|81127245|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
27807818|NCT02904200|81127246|FG000|Overall Study|Withdrawal by Subject|1|||
27807819|NCT02904200|81127247|FG001|Overall Study|Withdrawal by Subject|0|||
27807820|NCT02082262|81127248|FG000|Overall Study|Withdrawal by Subject|3|||
28003891|NCT03449758|81846280|FG000|Overall Study|Other unspecified reason|3|||
28003892|NCT03149055|81846281|FG000|Overall Study|Not treated|4|||
28003893|NCT02653326|81846288|FG000|Overall Study|Lost to Follow-up|10|||
28003894|NCT02653326|81846289|FG001|Overall Study|Lost to Follow-up|7|||
28003895|NCT04292535|81846290|FG000|Overall Study|Withdrawal by Subject|0|||
28003896|NCT04292535|81846291|FG001|Overall Study|Withdrawal by Subject|0|||
28003897|NCT04292535|81846292|FG002|Overall Study|Withdrawal by Subject|0|||
28003898|NCT04292535|81846293|FG003|Overall Study|Withdrawal by Subject|0|||
28003899|NCT04292535|81846294|FG004|Overall Study|Withdrawal by Subject|0|||
28003900|NCT04292535|81846295|FG005|Overall Study|Withdrawal by Subject|0|||
28003901|NCT04292535|81846296|FG006|Overall Study|Withdrawal by Subject|0|||
28003902|NCT04292535|81846297|FG007|Overall Study|Withdrawal by Subject|1|||
28003903|NCT04292535|81846298|FG008|Overall Study|Withdrawal by Subject|0|||
28003904|NCT04292535|81846299|FG009|Overall Study|Withdrawal by Subject|0|||
28003905|NCT04292535|81846300|FG010|Overall Study|Withdrawal by Subject|0|||
28003906|NCT04292535|81846301|FG011|Overall Study|Withdrawal by Subject|0|||
27807821|NCT02082262|81127248|FG000|Overall Study|Adverse Event|48|||
27807822|NCT02424565|81127254|FG000|Period 1 (D0)|Protocol Violation|0|||
27807823|NCT02424565|81127255|FG001|Period 1 (D0)|Protocol Violation|1|||
27807824|NCT00693784|81127256|FG000|Overall Study|Lost to Follow-up|2|||
28003907|NCT04292535|81846302|FG012|Overall Study|Withdrawal by Subject|0|||
28003908|NCT04292535|81846303|FG013|Overall Study|Withdrawal by Subject|0|||
28003909|NCT04292535|81846290|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
27584688|NCT00710424|80321998|FG001|Overall Study|Lost to Follow-up|1|||
27584689|NCT00710424|80321997|FG000|Overall Study|Refused medication, no side effects|1|||
28003910|NCT04292535|81846291|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
27807825|NCT00693784|81127256|FG000|Overall Study|Withdrawal by Subject|2|||
27807826|NCT01186978|81127257|FG000|Overall Study|Withdrawal by Subject|1|||
27807827|NCT00408876|81127258|FG000|Overall Study|Adverse Event|9|||
27807828|NCT00408876|81127259|FG001|Overall Study|Adverse Event|17|||
27807829|NCT00408876|81127260|FG002|Overall Study|Adverse Event|27|||
27807830|NCT00408876|81127261|FG003|Overall Study|Adverse Event|10|||
27807831|NCT00408876|81127258|FG000|Overall Study|Withdrawal by Subject|3|||
27807832|NCT00408876|81127259|FG001|Overall Study|Withdrawal by Subject|6|||
27807833|NCT00408876|81127260|FG002|Overall Study|Withdrawal by Subject|6|||
27807834|NCT00408876|81127261|FG003|Overall Study|Withdrawal by Subject|14|||
27807835|NCT00408876|81127258|FG000|Overall Study|Lack of Efficacy|2|||
27807836|NCT00408876|81127259|FG001|Overall Study|Lack of Efficacy|4|||
27807837|NCT00408876|81127260|FG002|Overall Study|Lack of Efficacy|5|||
27807838|NCT00408876|81127261|FG003|Overall Study|Lack of Efficacy|6|||
27807839|NCT00408876|81127258|FG000|Overall Study|Lost to Follow-up|1|||
27807840|NCT00408876|81127259|FG001|Overall Study|Lost to Follow-up|6|||
27807841|NCT00408876|81127260|FG002|Overall Study|Lost to Follow-up|5|||
27807842|NCT00408876|81127261|FG003|Overall Study|Lost to Follow-up|2|||
27807843|NCT00408876|81127258|FG000|Overall Study|Protocol Violation|0|||
27807844|NCT00408876|81127259|FG001|Overall Study|Protocol Violation|3|||
27807845|NCT00408876|81127260|FG002|Overall Study|Protocol Violation|4|||
27807846|NCT00408876|81127261|FG003|Overall Study|Protocol Violation|3|||
27807847|NCT00408876|81127258|FG000|Overall Study|Physician Decision|1|||
27807848|NCT00408876|81127259|FG001|Overall Study|Physician Decision|0|||
27807849|NCT00408876|81127260|FG002|Overall Study|Physician Decision|3|||
27807850|NCT00408876|81127261|FG003|Overall Study|Physician Decision|0|||
27807851|NCT02436135|81127262|FG000|Overall Study|Progressive Disease|3|||
27807852|NCT02436135|81127263|FG001|Overall Study|Progressive Disease|1|||
27807853|NCT02436135|81127262|FG000|Overall Study|Investigator Discretion|1|||
27807854|NCT02436135|81127263|FG001|Overall Study|Investigator Discretion|2|||
27807855|NCT02436135|81127262|FG000|Overall Study|Adverse Event|1|||
27807856|NCT02436135|81127263|FG001|Overall Study|Adverse Event|0|||
27807857|NCT02436135|81127262|FG000|Overall Study|Withdrawal by Participant|1|||
27807858|NCT02436135|81127263|FG001|Overall Study|Withdrawal by Participant|0|||
28003911|NCT04292535|81846292|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003912|NCT04292535|81846293|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003913|NCT04292535|81846294|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003914|NCT04292535|81846295|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003915|NCT04292535|81846296|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003916|NCT04292535|81846297|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
28003917|NCT04292535|81846298|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003918|NCT04292535|81846299|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003919|NCT04292535|81846300|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003920|NCT04292535|81846301|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
28003921|NCT04292535|81846302|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
28003922|NCT04292535|81846303|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
28003923|NCT04292535|81846290|FG000|Overall Study|Report of Dizziness|0|||
28003924|NCT04292535|81846291|FG001|Overall Study|Report of Dizziness|0|||
28003925|NCT04292535|81846292|FG002|Overall Study|Report of Dizziness|0|||
28003926|NCT04292535|81846293|FG003|Overall Study|Report of Dizziness|0|||
28003927|NCT04292535|81846294|FG004|Overall Study|Report of Dizziness|0|||
28003928|NCT04292535|81846295|FG005|Overall Study|Report of Dizziness|0|||
28003929|NCT04292535|81846296|FG006|Overall Study|Report of Dizziness|0|||
28003930|NCT04292535|81846297|FG007|Overall Study|Report of Dizziness|0|||
28003931|NCT04292535|81846298|FG008|Overall Study|Report of Dizziness|0|||
28003932|NCT04292535|81846299|FG009|Overall Study|Report of Dizziness|0|||
28003933|NCT04292535|81846300|FG010|Overall Study|Report of Dizziness|0|||
28003934|NCT04292535|81846301|FG011|Overall Study|Report of Dizziness|0|||
28003935|NCT04292535|81846302|FG012|Overall Study|Report of Dizziness|0|||
28003936|NCT04292535|81846303|FG013|Overall Study|Report of Dizziness|1|||
28003937|NCT04292535|81846290|FG000|Overall Study|Equipment Failure|0|||
28003938|NCT04292535|81846291|FG001|Overall Study|Equipment Failure|0|||
28003939|NCT04292535|81846292|FG002|Overall Study|Equipment Failure|0|||
28003940|NCT04292535|81846293|FG003|Overall Study|Equipment Failure|0|||
28003941|NCT04292535|81846294|FG004|Overall Study|Equipment Failure|0|||
28003942|NCT04292535|81846295|FG005|Overall Study|Equipment Failure|0|||
28003943|NCT04292535|81846296|FG006|Overall Study|Equipment Failure|0|||
27807859|NCT02436135|81127262|FG000|Overall Study|Study Terminated By Sponsor|0|||
27807860|NCT02436135|81127263|FG001|Overall Study|Study Terminated By Sponsor|1|||
27807861|NCT00003102|81127264|FG000|Overall Study|Physician Decision|1|||
27807862|NCT00003102|81127265|FG001|Overall Study|Physician Decision|1|||
27807863|NCT00003102|81127266|FG002|Overall Study|Physician Decision|0|||
27807864|NCT00003102|81127264|FG000|Overall Study|Progressive Disease|0|||
27807865|NCT00003102|81127265|FG001|Overall Study|Progressive Disease|1|||
27807866|NCT00003102|81127266|FG002|Overall Study|Progressive Disease|0|||
27807867|NCT00003102|81127264|FG000|Overall Study|Adverse Event|0|||
27807868|NCT00003102|81127265|FG001|Overall Study|Adverse Event|1|||
27807869|NCT00003102|81127266|FG002|Overall Study|Adverse Event|1|||
27807870|NCT00003102|81127264|FG000|Overall Study|Death|0|||
27807871|NCT00003102|81127265|FG001|Overall Study|Death|0|||
27807872|NCT00003102|81127266|FG002|Overall Study|Death|1|||
27807873|NCT01381900|81127280|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
27807874|NCT01381900|81127281|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
27807875|NCT01381900|81127282|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
27807876|NCT01381900|81127280|FG000|Overall Study|Adverse Event|4|||
27807877|NCT01381900|81127281|FG001|Overall Study|Adverse Event|6|||
27807878|NCT01381900|81127282|FG002|Overall Study|Adverse Event|7|||
27807879|NCT01381900|81127280|FG000|Overall Study|Noncompliance with study drug|0|||
27807880|NCT01381900|81127281|FG001|Overall Study|Noncompliance with study drug|0|||
27807881|NCT01381900|81127282|FG002|Overall Study|Noncompliance with study drug|1|||
27807882|NCT01381900|81127280|FG000|Overall Study|Physician Decision|0|||
27807883|NCT01381900|81127281|FG001|Overall Study|Physician Decision|1|||
27807884|NCT01381900|81127282|FG002|Overall Study|Physician Decision|1|||
27807885|NCT01381900|81127280|FG000|Overall Study|Protocol Violation|0|||
27807886|NCT01381900|81127281|FG001|Overall Study|Protocol Violation|1|||
27807887|NCT01381900|81127282|FG002|Overall Study|Protocol Violation|1|||
27807888|NCT01381900|81127280|FG000|Overall Study|Withdrawal by Subject|0|||
27807889|NCT01381900|81127281|FG001|Overall Study|Withdrawal by Subject|0|||
27807890|NCT01381900|81127282|FG002|Overall Study|Withdrawal by Subject|1|||
27807891|NCT01381900|81127280|FG000|Overall Study|Early withdraw|3|||
27807892|NCT01381900|81127281|FG001|Overall Study|Early withdraw|1|||
27807893|NCT01381900|81127282|FG002|Overall Study|Early withdraw|1|||
27807894|NCT02049359|81127283|FG000|Overall Study|Lost to Follow-up|26|||
27807895|NCT02049359|81127284|FG001|Overall Study|Lost to Follow-up|19|||
27807896|NCT03493698|81127285|FG000|Treatment Period C|Adverse Event|1|||
27807897|NCT03493698|81127285|FG000|Treatment Period C|Withdrawal by Subject|1|||
27807898|NCT01023269|81127288|FG000|Overall Study|early termination of the study|2|||
27807899|NCT01023269|81127289|FG001|Overall Study|early termination of the study|0|||
27807900|NCT02308111|81127290|FG000|Overall Study|Adverse Event|31|||
27807901|NCT02308111|81127291|FG001|Overall Study|Adverse Event|19|||
27807902|NCT02308111|81127290|FG000|Overall Study|Death|9|||
27807903|NCT02308111|81127291|FG001|Overall Study|Death|6|||
28003944|NCT04292535|81846297|FG007|Overall Study|Equipment Failure|0|||
28003945|NCT04292535|81846298|FG008|Overall Study|Equipment Failure|0|||
28003946|NCT04292535|81846299|FG009|Overall Study|Equipment Failure|0|||
28003947|NCT04292535|81846300|FG010|Overall Study|Equipment Failure|0|||
28003948|NCT04292535|81846301|FG011|Overall Study|Equipment Failure|1|||
28003949|NCT04292535|81846302|FG012|Overall Study|Equipment Failure|0|||
28003950|NCT04292535|81846303|FG013|Overall Study|Equipment Failure|0|||
28003951|NCT02738008|81846305|FG000|Overall Study|Study Terminated by Sponsor|1|||
28003952|NCT02738008|81846306|FG001|Overall Study|Study Terminated by Sponsor|5|||
28003953|NCT02738008|81846307|FG002|Overall Study|Study Terminated by Sponsor|3|||
28003954|NCT02738008|81846305|FG000|Overall Study|Adverse Event|0|||
28003955|NCT02738008|81846306|FG001|Overall Study|Adverse Event|1|||
28003956|NCT02738008|81846307|FG002|Overall Study|Adverse Event|2|||
28003957|NCT02872116|81846308|FG000|Pre-Treatment|Disease Progression|0|||
28003958|NCT02872116|81846309|FG001|Pre-Treatment|Disease Progression|1|||
28003959|NCT02872116|81846310|FG002|Pre-Treatment|Disease Progression|0|||
28003960|NCT02872116|81846308|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
28003961|NCT02872116|81846309|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
28003962|NCT02872116|81846310|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
28003963|NCT02872116|81846308|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
28003964|NCT02872116|81846309|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
28003965|NCT02872116|81846310|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
28003966|NCT02872116|81846308|FG000|Pre-Treatment|Participant withdrew consent|2|||
28003967|NCT02872116|81846309|FG001|Pre-Treatment|Participant withdrew consent|20|||
28003968|NCT02872116|81846310|FG002|Pre-Treatment|Participant withdrew consent|3|||
28003969|NCT02872116|81846308|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
28003970|NCT02872116|81846309|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
28003971|NCT02872116|81846310|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
27807904|NCT02308111|81127290|FG000|Overall Study|Lost to Follow-up|2|||
28003972|NCT02872116|81846308|FG000|Pre-Treatment|Other reasons|1|||
28003973|NCT02872116|81846309|FG001|Pre-Treatment|Other reasons|2|||
28003974|NCT02872116|81846310|FG002|Pre-Treatment|Other reasons|2|||
28003975|NCT02872116|81846308|FG000|Treatment|Death|122|||
28003976|NCT02872116|81846309|FG001|Treatment|Death|94|||
27807905|NCT02308111|81127291|FG001|Overall Study|Lost to Follow-up|7|||
27807906|NCT02308111|81127290|FG000|Overall Study|Physician Decision|6|||
27807907|NCT02308111|81127291|FG001|Overall Study|Physician Decision|17|||
27807908|NCT02308111|81127290|FG000|Overall Study|Protocol Violation|0|||
27807909|NCT02308111|81127291|FG001|Overall Study|Protocol Violation|1|||
27807910|NCT02308111|81127290|FG000|Overall Study|Withdrawal by Subject|28|||
27807911|NCT02308111|81127291|FG001|Overall Study|Withdrawal by Subject|38|||
28003977|NCT02872116|81846310|FG002|Treatment|Death|68|||
27807912|NCT02308111|81127290|FG000|Overall Study|Study Terminated by Sponsor|72|||
27807913|NCT02308111|81127291|FG001|Overall Study|Study Terminated by Sponsor|61|||
27807914|NCT02308111|81127290|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
27807915|NCT02308111|81127291|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
27807916|NCT02308111|81127290|FG000|Overall Study|Site Closure|3|||
27807917|NCT02308111|81127291|FG001|Overall Study|Site Closure|3|||
27807918|NCT02308111|81127290|FG000|Overall Study|Non-compliance with Study Drug|3|||
27807919|NCT02308111|81127291|FG001|Overall Study|Non-compliance with Study Drug|1|||
27807920|NCT02308111|81127290|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
27807921|NCT02308111|81127291|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
28003978|NCT02872116|81846308|FG000|Treatment|Lost to Follow-up|5|||
28003979|NCT02872116|81846309|FG001|Treatment|Lost to Follow-up|7|||
28003980|NCT02872116|81846310|FG002|Treatment|Lost to Follow-up|3|||
28003981|NCT02872116|81846308|FG000|Treatment|Participant withdrew consent|20|||
27807922|NCT02308111|81127290|FG000|Overall Study|Liver Transplant|3|||
27807923|NCT02308111|81127291|FG001|Overall Study|Liver Transplant|3|||
28003982|NCT02872116|81846309|FG001|Treatment|Participant withdrew consent|40|||
28003983|NCT02872116|81846310|FG002|Treatment|Participant withdrew consent|8|||
28003984|NCT02872116|81846308|FG000|Treatment|Other reasons|12|||
28003985|NCT02872116|81846309|FG001|Treatment|Other reasons|12|||
28003986|NCT02872116|81846310|FG002|Treatment|Other reasons|5|||
28003987|NCT01643668|81846313|FG000|Overall Study|Death|1|||
28003988|NCT01917747|81846314|FG000|Overall Study|Withdrawal by Subject|1|||
28003989|NCT01917747|81846315|FG001|Overall Study|Withdrawal by Subject|2|||
28003990|NCT01917747|81846314|FG000|Overall Study|Lost to Follow-up|18|||
28003991|NCT01917747|81846315|FG001|Overall Study|Lost to Follow-up|9|||
28003992|NCT02519439|81846318|FG000|Overall Study|Study Termination|19|||
28003993|NCT02519439|81846318|FG000|Overall Study|Withdrawal by Subject|1|||
28003994|NCT02519439|81846318|FG000|Overall Study|Adverse Event|1|||
28003995|NCT00333775|81846321|FG000|Overall Study|Death|144|||
28003996|NCT00333775|81846322|FG001|Overall Study|Death|149|||
28003997|NCT00333775|81846323|FG002|Overall Study|Death|143|||
28003998|NCT00333775|81846321|FG000|Overall Study|In Follow-up When Study Stopped|87|||
28003999|NCT00333775|81846322|FG001|Overall Study|In Follow-up When Study Stopped|92|||
28004000|NCT00333775|81846323|FG002|Overall Study|In Follow-up When Study Stopped|96|||
28004001|NCT00333775|81846321|FG000|Overall Study|Lost to Follow-up|10|||
28004002|NCT00333775|81846322|FG001|Overall Study|Lost to Follow-up|7|||
28004003|NCT00333775|81846323|FG002|Overall Study|Lost to Follow-up|8|||
28004004|NCT00528957|81846324|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
28004005|NCT00528957|81846325|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
28004006|NCT00528957|81846324|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
28004007|NCT00528957|81846325|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
28004008|NCT00528957|81846324|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
28004009|NCT00528957|81846325|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
28004010|NCT00528957|81846324|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
28004011|NCT00528957|81846325|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
28004012|NCT00528957|81846324|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
28004013|NCT00528957|81846325|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
28004014|NCT00528957|81846324|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
28004015|NCT00528957|81846325|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
28004016|NCT00528957|81846324|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
28004017|NCT00528957|81846325|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
28004018|NCT00528957|81846324|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
28004019|NCT00528957|81846325|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
28004020|NCT00528957|81846324|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
28004021|NCT00528957|81846325|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
28004022|NCT00528957|81846324|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
27807924|NCT02308111|81127290|FG000|Overall Study|Liver Transplant Waitlist|2|||
27807925|NCT02308111|81127291|FG001|Overall Study|Liver Transplant Waitlist|2|||
27807926|NCT02308111|81127290|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
27807927|NCT02308111|81127291|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
27807928|NCT00752856|81127292|FG000|Overall Study|randomized but did not do viral kinetics|0|||
27807929|NCT00752856|81127293|FG001|Overall Study|randomized but did not do viral kinetics|1|||
27807930|NCT03372369|81127308|FG000|Qualification Period|Withdrawal by Subject|16|||
28004023|NCT00528957|81846325|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
28004024|NCT00528957|81846324|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
28004025|NCT00528957|81846325|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
28004026|NCT00528957|81846324|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
28004027|NCT00528957|81846325|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
27584690|NCT00710424|80321998|FG001|Overall Study|Refused medication, no side effects|0|||
27807931|NCT03372369|81127309|FG001|Qualification Period|Withdrawal by Subject|13|||
27807932|NCT03372369|81127308|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
27807933|NCT03372369|81127309|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
27807934|NCT03372369|81127308|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
27807935|NCT03372369|81127309|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
27807936|NCT00303316|81127315|FG000|Overall Study|Protocol Violation|1|||
27807937|NCT00303316|81127316|FG001|Overall Study|Protocol Violation|0|||
28004028|NCT00528957|81846324|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
28004029|NCT00528957|81846325|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
28004030|NCT00528957|81846324|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
28004031|NCT00528957|81846325|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
28004032|NCT00528957|81846324|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
28004033|NCT00528957|81846325|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
28004034|NCT00528957|81846324|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
27807938|NCT00303316|81127315|FG000|Overall Study|Lost to Follow-up|0|||
28004035|NCT00528957|81846325|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
28004036|NCT01620060|81846326|FG000|Overall Study|Adverse Event|9|||
28004037|NCT01620060|81846326|FG000|Overall Study|Protocol Violation|1|||
28004038|NCT01620060|81846326|FG000|Overall Study|Withdrawal by Subject|1|||
28004039|NCT01620060|81846326|FG000|Overall Study|Did not comply with Study Produre|1|||
28004040|NCT01620060|81846326|FG000|Overall Study|Family emergency|1|||
28004041|NCT01620060|81846326|FG000|Overall Study|Per Sponsor Decision|2|||
28004042|NCT04999839|81846327|FG000|Overall Study|Adverse Event|1|||
28004043|NCT04999839|81846328|FG001|Overall Study|Adverse Event|1|||
28004044|NCT04999839|81846329|FG002|Overall Study|Adverse Event|1|||
28004045|NCT04999839|81846330|FG003|Overall Study|Adverse Event|1|||
28004046|NCT04999839|81846331|FG004|Overall Study|Adverse Event|1|||
28004047|NCT04999839|81846327|FG000|Overall Study|Lost to Follow-up|2|||
28004048|NCT04999839|81846328|FG001|Overall Study|Lost to Follow-up|0|||
28004049|NCT04999839|81846329|FG002|Overall Study|Lost to Follow-up|2|||
28004050|NCT04999839|81846330|FG003|Overall Study|Lost to Follow-up|4|||
28004051|NCT04999839|81846331|FG004|Overall Study|Lost to Follow-up|1|||
28004052|NCT04999839|81846327|FG000|Overall Study|Withdrawal by Subject|6|||
28004053|NCT04999839|81846328|FG001|Overall Study|Withdrawal by Subject|5|||
28004054|NCT04999839|81846329|FG002|Overall Study|Withdrawal by Subject|3|||
28004055|NCT04999839|81846330|FG003|Overall Study|Withdrawal by Subject|2|||
28004056|NCT04999839|81846331|FG004|Overall Study|Withdrawal by Subject|2|||
28004057|NCT04999839|81846327|FG000|Overall Study|Lack of Efficacy|0|||
28004058|NCT04999839|81846328|FG001|Overall Study|Lack of Efficacy|1|||
28004059|NCT04999839|81846329|FG002|Overall Study|Lack of Efficacy|0|||
28004060|NCT04999839|81846330|FG003|Overall Study|Lack of Efficacy|0|||
28004061|NCT04999839|81846331|FG004|Overall Study|Lack of Efficacy|0|||
28004062|NCT04999839|81846327|FG000|Overall Study|Physician Decision|0|||
28004063|NCT04999839|81846328|FG001|Overall Study|Physician Decision|0|||
28004064|NCT04999839|81846329|FG002|Overall Study|Physician Decision|0|||
28004065|NCT04999839|81846330|FG003|Overall Study|Physician Decision|0|||
28004066|NCT04999839|81846331|FG004|Overall Study|Physician Decision|1|||
28004067|NCT04999839|81846327|FG000|Overall Study|Sponsor request|0|||
28004068|NCT04999839|81846328|FG001|Overall Study|Sponsor request|1|||
28004069|NCT04999839|81846329|FG002|Overall Study|Sponsor request|0|||
28004070|NCT04999839|81846330|FG003|Overall Study|Sponsor request|0|||
28004071|NCT04999839|81846331|FG004|Overall Study|Sponsor request|0|||
28004072|NCT04999839|81846327|FG000|Overall Study|Other|0|||
28004073|NCT04999839|81846328|FG001|Overall Study|Other|0|||
28004074|NCT04999839|81846329|FG002|Overall Study|Other|1|||
28004075|NCT04999839|81846330|FG003|Overall Study|Other|0|||
28004076|NCT04999839|81846331|FG004|Overall Study|Other|0|||
28004077|NCT00227721|81846332|FG000|Overall Study|On study, but never treated.|1|||
28004078|NCT00981149|81846333|FG000|Overall Study|Lost to Follow-up|1|||
28004079|NCT00981149|81846334|FG001|Overall Study|Lost to Follow-up|2|||
28004080|NCT00981149|81846333|FG000|Overall Study|Withdrawal by Subject|1|||
28004081|NCT00981149|81846334|FG001|Overall Study|Withdrawal by Subject|1|||
28004082|NCT00849940|81846335|FG000|Overall Study|Physician Decision|4|||
27584691|NCT00710424|80321997|FG000|Overall Study|Non-compliance with stable analgesia|1|||
28004083|NCT00308139|81846343|FG000|Overall Study|Adverse Event|20|||
28004084|NCT00308139|81846344|FG001|Overall Study|Adverse Event|14|||
27584692|NCT00710424|80321998|FG001|Overall Study|Non-compliance with stable analgesia|0|||
27807939|NCT00303316|81127316|FG001|Overall Study|Lost to Follow-up|1|||
28004085|NCT00308139|81846343|FG000|Overall Study|Lost to Follow-up|13|||
28004086|NCT00308139|81846344|FG001|Overall Study|Lost to Follow-up|8|||
28004087|NCT00308139|81846343|FG000|Overall Study|Protocol Violation|3|||
28004088|NCT00308139|81846344|FG001|Overall Study|Protocol Violation|2|||
28004089|NCT00308139|81846343|FG000|Overall Study|Withdrawal of Consent|40|||
28004090|NCT00308139|81846344|FG001|Overall Study|Withdrawal of Consent|42|||
28004091|NCT00308139|81846343|FG000|Overall Study|Investigator Decision|11|||
27684142|NCT01859988|80679353|FG001|Overall Study|Lack of Efficacy|1|||
28004092|NCT00308139|81846344|FG001|Overall Study|Investigator Decision|10|||
28004093|NCT00308139|81846343|FG000|Overall Study|Loss of Glucose Control|5|||
28004094|NCT00308139|81846344|FG001|Overall Study|Loss of Glucose Control|7|||
27807940|NCT00303316|81127315|FG000|Overall Study|Withdrawal by Subject|1|||
27807941|NCT00303316|81127316|FG001|Overall Study|Withdrawal by Subject|2|||
27807942|NCT01859702|81127318|FG000|Overall Study|Protocol deviation|3|||
27807943|NCT01859702|81127318|FG000|Overall Study|Adverse Event|2|||
27807944|NCT01015612|81127319|FG000|Overall Study|Death|113|||
27807945|NCT01015612|81127319|FG000|Overall Study|Withdrawal by Subject|40|||
27807946|NCT03031899|81127342|FG000|Overall Study|Protocol Violation|1|||
27807947|NCT03031899|81127342|FG000|Overall Study|lesion disappeared after stopping habit|1|||
27807948|NCT01078623|81127343|FG000|Treatment Period 1|Adverse Event|1|||
27807949|NCT01078623|81127344|FG001|Treatment Period 1|Adverse Event|1|||
27807950|NCT01078623|81127345|FG002|Treatment Period 1|Adverse Event|1|||
27807951|NCT01078623|81127346|FG003|Treatment Period 1|Adverse Event|0|||
27807952|NCT01078623|81127347|FG004|Treatment Period 1|Adverse Event|0|||
27807953|NCT01078623|81127348|FG005|Treatment Period 1|Adverse Event|0|||
27807954|NCT01078623|81127349|FG006|Treatment Period 1|Adverse Event|1|||
27807955|NCT01078623|81127350|FG007|Treatment Period 1|Adverse Event|0|||
27807956|NCT01078623|81127351|FG008|Treatment Period 1|Adverse Event|1|||
27807957|NCT01078623|81127352|FG009|Treatment Period 1|Adverse Event|1|||
27807958|NCT01078623|81127353|FG010|Treatment Period 1|Adverse Event|0|||
27807959|NCT01078623|81127354|FG011|Treatment Period 1|Adverse Event|0|||
27807960|NCT01078623|81127355|FG012|Treatment Period 1|Adverse Event|0|||
27807961|NCT01078623|81127356|FG013|Treatment Period 1|Adverse Event|0|||
27807962|NCT01078623|81127357|FG014|Treatment Period 1|Adverse Event|0|||
27807963|NCT01078623|81127358|FG015|Treatment Period 1|Adverse Event|0|||
27807964|NCT01078623|81127359|FG016|Treatment Period 1|Adverse Event|0|||
27807965|NCT01078623|81127360|FG017|Treatment Period 1|Adverse Event|0|||
27807966|NCT01078623|81127361|FG018|Treatment Period 1|Adverse Event|0|||
27807967|NCT01078623|81127362|FG019|Treatment Period 1|Adverse Event|0|||
27807968|NCT01078623|81127343|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27807969|NCT01078623|81127344|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27807970|NCT01078623|81127345|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27807971|NCT01078623|81127346|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27807972|NCT01078623|81127347|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27807973|NCT01078623|81127348|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27807974|NCT01078623|81127349|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27807975|NCT01078623|81127350|FG007|Treatment Period 1|Withdrawal by Subject|1|||
27807976|NCT01078623|81127351|FG008|Treatment Period 1|Withdrawal by Subject|0|||
28004095|NCT00308139|81846343|FG000|Overall Study|Administrative|1|||
28004096|NCT00308139|81846344|FG001|Overall Study|Administrative|4|||
28004097|NCT00308139|81846343|FG000|Overall Study|Other|1|||
28004098|NCT00308139|81846344|FG001|Overall Study|Other|0|||
28004099|NCT01350999|81846346|FG000|Overall Study|Adverse Event|4|||
28004100|NCT01350999|81846347|FG001|Overall Study|Adverse Event|9|||
28004101|NCT01350999|81846348|FG002|Overall Study|Adverse Event|10|||
28004102|NCT01350999|81846346|FG000|Overall Study|Voluntary withdrawal|3|||
28004103|NCT01350999|81846347|FG001|Overall Study|Voluntary withdrawal|4|||
28004104|NCT01350999|81846348|FG002|Overall Study|Voluntary withdrawal|6|||
28004105|NCT01350999|81846346|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
28004106|NCT01350999|81846347|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
28004107|NCT01350999|81846348|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
28004108|NCT01339689|81846349|FG000|Overall Study|Adverse Event|1|||
28004109|NCT01339689|81846350|FG001|Overall Study|Adverse Event|2|||
28004110|NCT01339689|81846349|FG000|Overall Study|Lost to Follow-up|9|||
28004111|NCT01339689|81846350|FG001|Overall Study|Lost to Follow-up|3|||
28004112|NCT01339689|81846349|FG000|Overall Study|Withdrawal by Subject|3|||
28004113|NCT01339689|81846350|FG001|Overall Study|Withdrawal by Subject|0|||
28004114|NCT01339689|81846349|FG000|Overall Study|Noncompliance|1|||
28004115|NCT01339689|81846350|FG001|Overall Study|Noncompliance|0|||
28004116|NCT01339689|81846349|FG000|Overall Study|Relocated out of area|0|||
28004117|NCT01339689|81846350|FG001|Overall Study|Relocated out of area|1|||
28004118|NCT01339689|81846349|FG000|Overall Study|Other|2|||
27684143|NCT01859988|80679354|FG002|Overall Study|Lack of Efficacy|5|||
27807977|NCT01078623|81127352|FG009|Treatment Period 1|Withdrawal by Subject|0|||
27807978|NCT01078623|81127353|FG010|Treatment Period 1|Withdrawal by Subject|1|||
28004119|NCT01339689|81846350|FG001|Overall Study|Other|2|||
27807979|NCT01078623|81127354|FG011|Treatment Period 1|Withdrawal by Subject|0|||
27807980|NCT01078623|81127355|FG012|Treatment Period 1|Withdrawal by Subject|0|||
27807981|NCT01078623|81127356|FG013|Treatment Period 1|Withdrawal by Subject|0|||
27807982|NCT01078623|81127357|FG014|Treatment Period 1|Withdrawal by Subject|0|||
27807983|NCT01078623|81127358|FG015|Treatment Period 1|Withdrawal by Subject|0|||
28004120|NCT01339689|81846349|FG000|Overall Study|multiple reasons|1|||
28004121|NCT01339689|81846350|FG001|Overall Study|multiple reasons|1|||
28004122|NCT00702702|81846353|FG000|Overall Study|Study prematurely terminated|56|||
28004123|NCT00668148|81846354|FG000|Overall Study|Adverse Event|5|||
27807984|NCT01078623|81127359|FG016|Treatment Period 1|Withdrawal by Subject|0|||
27807985|NCT01078623|81127360|FG017|Treatment Period 1|Withdrawal by Subject|0|||
27807986|NCT01078623|81127361|FG018|Treatment Period 1|Withdrawal by Subject|0|||
27807987|NCT01078623|81127362|FG019|Treatment Period 1|Withdrawal by Subject|0|||
27807988|NCT01078623|81127343|FG000|Treatment Period 1|Protocol Violation|0|||
27807989|NCT01078623|81127344|FG001|Treatment Period 1|Protocol Violation|0|||
28004124|NCT00668148|81846354|FG000|Overall Study|Subject Non-compliance|1|||
28004125|NCT00668148|81846354|FG000|Overall Study|Progressive Disease Before Treatment|2|||
27807990|NCT01078623|81127345|FG002|Treatment Period 1|Protocol Violation|0|||
27807991|NCT01078623|81127346|FG003|Treatment Period 1|Protocol Violation|0|||
27807992|NCT01078623|81127347|FG004|Treatment Period 1|Protocol Violation|0|||
27807993|NCT01078623|81127348|FG005|Treatment Period 1|Protocol Violation|1|||
27807994|NCT01078623|81127349|FG006|Treatment Period 1|Protocol Violation|0|||
27807995|NCT01078623|81127350|FG007|Treatment Period 1|Protocol Violation|0|||
27807996|NCT01078623|81127351|FG008|Treatment Period 1|Protocol Violation|0|||
27807997|NCT01078623|81127352|FG009|Treatment Period 1|Protocol Violation|0|||
27807998|NCT01078623|81127353|FG010|Treatment Period 1|Protocol Violation|0|||
27807999|NCT01078623|81127354|FG011|Treatment Period 1|Protocol Violation|0|||
27808000|NCT01078623|81127355|FG012|Treatment Period 1|Protocol Violation|0|||
28004126|NCT00668148|81846354|FG000|Overall Study|Withdrawal of Consent|2|||
28004127|NCT00647296|81846355|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
28004128|NCT00647296|81846356|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
28004129|NCT00647296|81846357|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
28004130|NCT00647296|81846358|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
28004131|NCT00647296|81846355|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
28004132|NCT00647296|81846356|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
28004133|NCT00647296|81846357|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
28004134|NCT00647296|81846358|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
28004135|NCT00647296|81846355|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
28004136|NCT00647296|81846356|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
28004137|NCT00647296|81846357|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
28004138|NCT00647296|81846358|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
28004139|NCT00647296|81846355|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
28004140|NCT00647296|81846356|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
28004141|NCT00647296|81846357|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
28004142|NCT00647296|81846358|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
28004143|NCT00647296|81846355|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
28004144|NCT00647296|81846356|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
28004145|NCT00647296|81846357|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
28004146|NCT00647296|81846358|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
28004147|NCT00647296|81846355|FG000|Part 2: 4-week Placebo Washout|Death|3|||
28004148|NCT00647296|81846356|FG001|Part 2: 4-week Placebo Washout|Death|0|||
28004149|NCT00647296|81846357|FG002|Part 2: 4-week Placebo Washout|Death|0|||
28004150|NCT00647296|81846358|FG003|Part 2: 4-week Placebo Washout|Death|0|||
28004151|NCT00647296|81846355|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
28004152|NCT00647296|81846356|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
28004153|NCT00647296|81846357|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
28004154|NCT00647296|81846358|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
28004155|NCT00647296|81846355|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
28004156|NCT00647296|81846356|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
28004157|NCT00647296|81846357|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
28004158|NCT00647296|81846358|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
27808001|NCT01078623|81127356|FG013|Treatment Period 1|Protocol Violation|0|||
27808002|NCT01078623|81127357|FG014|Treatment Period 1|Protocol Violation|0|||
27808003|NCT01078623|81127358|FG015|Treatment Period 1|Protocol Violation|0|||
27808004|NCT01078623|81127359|FG016|Treatment Period 1|Protocol Violation|0|||
27808005|NCT01078623|81127360|FG017|Treatment Period 1|Protocol Violation|0|||
27808006|NCT01078623|81127361|FG018|Treatment Period 1|Protocol Violation|0|||
27808007|NCT01078623|81127362|FG019|Treatment Period 1|Protocol Violation|0|||
27808008|NCT01078623|81127343|FG000|Treatment Period 2|Adverse Event|0|||
27808009|NCT01078623|81127344|FG001|Treatment Period 2|Adverse Event|0|||
27808010|NCT01078623|81127345|FG002|Treatment Period 2|Adverse Event|0|||
27808011|NCT01078623|81127346|FG003|Treatment Period 2|Adverse Event|0|||
27808012|NCT01078623|81127347|FG004|Treatment Period 2|Adverse Event|0|||
27808013|NCT01078623|81127348|FG005|Treatment Period 2|Adverse Event|0|||
27808014|NCT01078623|81127349|FG006|Treatment Period 2|Adverse Event|1|||
27808015|NCT01078623|81127350|FG007|Treatment Period 2|Adverse Event|0|||
27808016|NCT01078623|81127351|FG008|Treatment Period 2|Adverse Event|0|||
27808017|NCT01078623|81127352|FG009|Treatment Period 2|Adverse Event|0|||
28004159|NCT00647296|81846355|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
28004160|NCT00647296|81846356|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
27684144|NCT01859988|80679355|FG003|Overall Study|Lack of Efficacy|0|||
27684145|NCT01859988|80679356|FG004|Overall Study|Lack of Efficacy|7|||
27684146|NCT01859988|80679357|FG005|Overall Study|Lack of Efficacy|9|||
27684147|NCT01859988|80679352|FG000|Overall Study|Physician Decision|1|||
27684148|NCT01859988|80679353|FG001|Overall Study|Physician Decision|3|||
27684149|NCT01859988|80679354|FG002|Overall Study|Physician Decision|1|||
27684150|NCT01859988|80679355|FG003|Overall Study|Physician Decision|3|||
27684151|NCT01859988|80679356|FG004|Overall Study|Physician Decision|4|||
27684152|NCT01859988|80679357|FG005|Overall Study|Physician Decision|1|||
27684153|NCT01859988|80679352|FG000|Overall Study|Adverse Event|2|||
27684154|NCT01859988|80679353|FG001|Overall Study|Adverse Event|1|||
27684155|NCT01859988|80679354|FG002|Overall Study|Adverse Event|3|||
27684156|NCT01859988|80679355|FG003|Overall Study|Adverse Event|1|||
27684157|NCT01859988|80679356|FG004|Overall Study|Adverse Event|2|||
27684158|NCT01859988|80679357|FG005|Overall Study|Adverse Event|2|||
27684159|NCT01859988|80679352|FG000|Overall Study|Lost to Follow-up|1|||
27684160|NCT01859988|80679353|FG001|Overall Study|Lost to Follow-up|2|||
27684161|NCT01859988|80679354|FG002|Overall Study|Lost to Follow-up|3|||
27684162|NCT01859988|80679355|FG003|Overall Study|Lost to Follow-up|0|||
27684163|NCT01859988|80679356|FG004|Overall Study|Lost to Follow-up|3|||
27684164|NCT01859988|80679357|FG005|Overall Study|Lost to Follow-up|2|||
27684165|NCT01859988|80679352|FG000|Overall Study|Protocol Violation|0|||
27684166|NCT01859988|80679353|FG001|Overall Study|Protocol Violation|0|||
27684167|NCT01859988|80679354|FG002|Overall Study|Protocol Violation|1|||
27684168|NCT01859988|80679355|FG003|Overall Study|Protocol Violation|0|||
27684169|NCT01859988|80679356|FG004|Overall Study|Protocol Violation|0|||
27684170|NCT01859988|80679357|FG005|Overall Study|Protocol Violation|0|||
27684171|NCT01859988|80679352|FG000|Overall Study|Other than specified above|0|||
27684172|NCT01859988|80679353|FG001|Overall Study|Other than specified above|2|||
27684173|NCT01859988|80679354|FG002|Overall Study|Other than specified above|11|||
27684174|NCT01859988|80679355|FG003|Overall Study|Other than specified above|3|||
27684175|NCT01859988|80679356|FG004|Overall Study|Other than specified above|5|||
27684176|NCT01859988|80679357|FG005|Overall Study|Other than specified above|3|||
27684177|NCT02643303|80679358|FG000|Overall Study|Progressive Disease|4|||
27684178|NCT02643303|80679359|FG001|Overall Study|Progressive Disease|4|||
27684179|NCT02643303|80679360|FG002|Overall Study|Progressive Disease|1|||
27684180|NCT02643303|80679361|FG003|Overall Study|Progressive Disease|12|||
27684181|NCT02643303|80679362|FG004|Overall Study|Progressive Disease|6|||
27684182|NCT02643303|80679363|FG005|Overall Study|Progressive Disease|4|||
27684183|NCT02643303|80679364|FG006|Overall Study|Progressive Disease|8|||
27684184|NCT02643303|80679365|FG007|Overall Study|Progressive Disease|2|||
27684185|NCT02643303|80679366|FG008|Overall Study|Progressive Disease|6|||
27684186|NCT02643303|80679358|FG000|Overall Study|Adverse Event|0|||
27684187|NCT02643303|80679359|FG001|Overall Study|Adverse Event|1|||
27684188|NCT02643303|80679360|FG002|Overall Study|Adverse Event|0|||
27684189|NCT02643303|80679361|FG003|Overall Study|Adverse Event|0|||
27684190|NCT02643303|80679362|FG004|Overall Study|Adverse Event|1|||
27684191|NCT02643303|80679363|FG005|Overall Study|Adverse Event|0|||
27684192|NCT02643303|80679364|FG006|Overall Study|Adverse Event|0|||
27684193|NCT02643303|80679365|FG007|Overall Study|Adverse Event|0|||
27684194|NCT02643303|80679366|FG008|Overall Study|Adverse Event|0|||
27684195|NCT02643303|80679358|FG000|Overall Study|Withdrawal by Subject|0|||
27684196|NCT02643303|80679359|FG001|Overall Study|Withdrawal by Subject|0|||
27684197|NCT02643303|80679360|FG002|Overall Study|Withdrawal by Subject|0|||
27684198|NCT02643303|80679361|FG003|Overall Study|Withdrawal by Subject|1|||
27684199|NCT02643303|80679362|FG004|Overall Study|Withdrawal by Subject|0|||
27684200|NCT02643303|80679363|FG005|Overall Study|Withdrawal by Subject|0|||
27684201|NCT02643303|80679364|FG006|Overall Study|Withdrawal by Subject|1|||
27684202|NCT02643303|80679365|FG007|Overall Study|Withdrawal by Subject|1|||
27684203|NCT02643303|80679366|FG008|Overall Study|Withdrawal by Subject|1|||
27684204|NCT03507777|80679367|FG000|Overall Study|Lost to Follow-up|5|||
27684205|NCT03507777|80679368|FG001|Overall Study|Lost to Follow-up|7|||
27874293|NCT01777282|81371702|FG000|Overall Study|Withdrawal by Subject|4|||
27874294|NCT01777282|81371703|FG001|Overall Study|Withdrawal by Subject|0|||
27684206|NCT03507777|80679367|FG000|Overall Study|Withdrawal by Subject|6|||
27684207|NCT03507777|80679368|FG001|Overall Study|Withdrawal by Subject|11|||
27684208|NCT03507777|80679367|FG000|Overall Study|Death|30|||
27684209|NCT03507777|80679368|FG001|Overall Study|Death|44|||
27684210|NCT03507777|80679367|FG000|Overall Study|Other Reasons|3|||
27684211|NCT03507777|80679368|FG001|Overall Study|Other Reasons|8|||
27684212|NCT02019667|80679369|FG000|First Intervention (6 Months)|Adverse Event|0|||
27684213|NCT02019667|80679370|FG001|First Intervention (6 Months)|Adverse Event|1|||
27684214|NCT02019667|80679369|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
27684215|NCT02019667|80679370|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
27684216|NCT02019667|80679369|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
27684217|NCT02019667|80679370|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
27684218|NCT03828747|80679371|FG000|Double-Blind Treatment Period|Adverse Event|6|||
27684219|NCT03828747|80679372|FG001|Double-Blind Treatment Period|Adverse Event|6|||
28004161|NCT00647296|81846357|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
28004162|NCT00647296|81846358|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
28004163|NCT00647296|81846355|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
28004164|NCT00647296|81846356|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
28004165|NCT00647296|81846357|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
28004166|NCT00647296|81846358|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
28004167|NCT00647296|81846355|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
28004168|NCT00647296|81846356|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
28004169|NCT00647296|81846357|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
28004170|NCT00647296|81846358|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
28004171|NCT01005251|81846359|FG000|Overall Study|Withdrawal by Subject|2|||
28004172|NCT01005251|81846360|FG001|Overall Study|Withdrawal by Subject|5|||
28004173|NCT01005251|81846361|FG002|Overall Study|Withdrawal by Subject|3|||
28004174|NCT01005251|81846362|FG003|Overall Study|Withdrawal by Subject|4|||
28004175|NCT01005251|81846363|FG004|Overall Study|Withdrawal by Subject|9|||
28004176|NCT01005251|81846359|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
28004177|NCT01005251|81846360|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27808018|NCT01078623|81127353|FG010|Treatment Period 2|Adverse Event|0|||
27808019|NCT01078623|81127354|FG011|Treatment Period 2|Adverse Event|0|||
27808020|NCT01078623|81127355|FG012|Treatment Period 2|Adverse Event|0|||
28004178|NCT01005251|81846361|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
28004179|NCT01005251|81846362|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
28004180|NCT01005251|81846363|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
28004181|NCT01005251|81846359|FG000|Overall Study|Adverse Event|2|||
28004182|NCT01005251|81846360|FG001|Overall Study|Adverse Event|6|||
28004183|NCT01005251|81846361|FG002|Overall Study|Adverse Event|8|||
28004184|NCT01005251|81846362|FG003|Overall Study|Adverse Event|5|||
28004185|NCT01005251|81846363|FG004|Overall Study|Adverse Event|4|||
28004186|NCT01005251|81846359|FG000|Overall Study|Protocol Violation|1|||
28004187|NCT01005251|81846360|FG001|Overall Study|Protocol Violation|0|||
28004188|NCT01005251|81846361|FG002|Overall Study|Protocol Violation|0|||
27684220|NCT03828747|80679371|FG000|Double-Blind Treatment Period|Death|1|||
27684221|NCT03828747|80679372|FG001|Double-Blind Treatment Period|Death|1|||
27684222|NCT03828747|80679371|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27684223|NCT03828747|80679372|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
27684224|NCT03828747|80679371|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
27684225|NCT03828747|80679372|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
27684226|NCT03828747|80679371|FG000|Double-Blind Treatment Period|Physician Decision|1|||
27684227|NCT03828747|80679372|FG001|Double-Blind Treatment Period|Physician Decision|4|||
27684228|NCT03828747|80679371|FG000|Double-Blind Treatment Period|Various reasons|5|||
27684229|NCT03828747|80679372|FG001|Double-Blind Treatment Period|Various reasons|3|||
27684230|NCT03828747|80679371|FG000|Open-Label Extension|Adverse Event|9|||
27684231|NCT03828747|80679372|FG001|Open-Label Extension|Adverse Event|7|||
27684232|NCT03828747|80679371|FG000|Open-Label Extension|Death|0|||
27684233|NCT03828747|80679372|FG001|Open-Label Extension|Death|2|||
27684234|NCT03828747|80679371|FG000|Open-Label Extension|Lost to Follow-up|4|||
27684235|NCT03828747|80679372|FG001|Open-Label Extension|Lost to Follow-up|0|||
27684236|NCT03828747|80679371|FG000|Open-Label Extension|Withdrawal by Subject|31|||
27684237|NCT03828747|80679372|FG001|Open-Label Extension|Withdrawal by Subject|30|||
27684238|NCT03828747|80679371|FG000|Open-Label Extension|Various reasons|4|||
27684239|NCT03828747|80679372|FG001|Open-Label Extension|Various reasons|4|||
27684240|NCT03828747|80679371|FG000|Open-Label Extension|Physician Decision|6|||
27684241|NCT03828747|80679372|FG001|Open-Label Extension|Physician Decision|2|||
27808021|NCT01078623|81127356|FG013|Treatment Period 2|Adverse Event|0|||
27808022|NCT01078623|81127357|FG014|Treatment Period 2|Adverse Event|0|||
27808023|NCT01078623|81127358|FG015|Treatment Period 2|Adverse Event|0|||
27808024|NCT01078623|81127359|FG016|Treatment Period 2|Adverse Event|0|||
27808025|NCT01078623|81127360|FG017|Treatment Period 2|Adverse Event|0|||
27874295|NCT01777282|81371704|FG002|Overall Study|Withdrawal by Subject|0|||
27874296|NCT01777282|81371705|FG003|Overall Study|Withdrawal by Subject|1|||
28004189|NCT01005251|81846362|FG003|Overall Study|Protocol Violation|0|||
28004190|NCT01005251|81846363|FG004|Overall Study|Protocol Violation|2|||
28004191|NCT01005251|81846359|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
28004192|NCT01005251|81846360|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
27684242|NCT03241927|80679373|FG000|Overall Study|study terminated|1|||
27684243|NCT03241927|80679374|FG001|Overall Study|study terminated|0|||
27684244|NCT01305200|80679375|FG000|Overall Study|Physician Decision|4|||
27684245|NCT01305200|80679376|FG001|Overall Study|Physician Decision|6|||
27684246|NCT01305200|80679377|FG002|Overall Study|Physician Decision|1|||
27808026|NCT01078623|81127361|FG018|Treatment Period 2|Adverse Event|1|||
27808027|NCT01078623|81127362|FG019|Treatment Period 2|Adverse Event|0|||
27808028|NCT01078623|81127343|FG000|Treatment Period 2|Withdrawal by Subject|0|||
28004193|NCT01005251|81846361|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
27684247|NCT01305200|80679375|FG000|Overall Study|Withdrawal by Subject|24|||
27684248|NCT01305200|80679376|FG001|Overall Study|Withdrawal by Subject|21|||
27684249|NCT01305200|80679377|FG002|Overall Study|Withdrawal by Subject|1|||
27684250|NCT01305200|80679375|FG000|Overall Study|Ineligible|1|||
27684251|NCT01305200|80679376|FG001|Overall Study|Ineligible|2|||
27808029|NCT01078623|81127344|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27808030|NCT01078623|81127345|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27808031|NCT01078623|81127346|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27808032|NCT01078623|81127347|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27684252|NCT01305200|80679377|FG002|Overall Study|Ineligible|1|||
27684253|NCT01305200|80679375|FG000|Overall Study|Death|0|||
27684254|NCT01305200|80679376|FG001|Overall Study|Death|2|||
27684255|NCT01305200|80679377|FG002|Overall Study|Death|0|||
27684256|NCT01493427|80679380|FG000|Overall Study|Adverse Event|10|||
27684257|NCT01493427|80679380|FG000|Overall Study|Personal Reasons|4|||
27684258|NCT01493427|80679380|FG000|Overall Study|Lost to Follow-up|2|||
27684259|NCT01493427|80679380|FG000|Overall Study|Inability to Follow Instructions|2|||
27684260|NCT01493427|80679380|FG000|Overall Study|Other|2|||
27684261|NCT01081665|80679382|FG000|Overall Study|Death|41|||
27684262|NCT01081665|80679382|FG000|Overall Study|Lost to Follow-up|18|||
27684263|NCT01081665|80679382|FG000|Overall Study|Withdrawal by Subject|17|||
27684264|NCT01081665|80679382|FG000|Overall Study|Change of dialysis unit|10|||
27684265|NCT01081665|80679382|FG000|Overall Study|Regulation of iPTH|5|||
27684266|NCT01081665|80679382|FG000|Overall Study|Change in renal replacement therapy|2|||
27684267|NCT01081665|80679382|FG000|Overall Study|Adverse Event|1|||
27684268|NCT01081665|80679382|FG000|Overall Study|Lack of Efficacy|1|||
27684269|NCT02112708|80679383|FG000|Baseline|Physician Decision|16|||
27684270|NCT02112708|80679384|FG001|Baseline|Physician Decision|11|||
27808033|NCT01078623|81127348|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27808034|NCT01078623|81127349|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27808035|NCT01078623|81127350|FG007|Treatment Period 2|Withdrawal by Subject|0|||
27808036|NCT01078623|81127351|FG008|Treatment Period 2|Withdrawal by Subject|0|||
27808037|NCT01078623|81127352|FG009|Treatment Period 2|Withdrawal by Subject|0|||
27808038|NCT01078623|81127353|FG010|Treatment Period 2|Withdrawal by Subject|0|||
28004194|NCT01005251|81846362|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
28004195|NCT01005251|81846363|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
28004196|NCT01005251|81846359|FG000|Overall Study|Lost to Follow-up|1|||
28004197|NCT01005251|81846360|FG001|Overall Study|Lost to Follow-up|4|||
28004198|NCT01005251|81846361|FG002|Overall Study|Lost to Follow-up|2|||
28004199|NCT01005251|81846362|FG003|Overall Study|Lost to Follow-up|0|||
28004200|NCT01005251|81846363|FG004|Overall Study|Lost to Follow-up|0|||
28004201|NCT01005251|81846359|FG000|Overall Study|Physician Decision|0|||
27808039|NCT01078623|81127354|FG011|Treatment Period 2|Withdrawal by Subject|0|||
27808040|NCT01078623|81127355|FG012|Treatment Period 2|Withdrawal by Subject|0|||
27808041|NCT01078623|81127356|FG013|Treatment Period 2|Withdrawal by Subject|0|||
27808042|NCT01078623|81127357|FG014|Treatment Period 2|Withdrawal by Subject|0|||
27808043|NCT01078623|81127358|FG015|Treatment Period 2|Withdrawal by Subject|0|||
28004202|NCT01005251|81846360|FG001|Overall Study|Physician Decision|0|||
28004203|NCT01005251|81846361|FG002|Overall Study|Physician Decision|0|||
28004204|NCT01005251|81846362|FG003|Overall Study|Physician Decision|0|||
27808044|NCT01078623|81127359|FG016|Treatment Period 2|Withdrawal by Subject|0|||
27808045|NCT01078623|81127360|FG017|Treatment Period 2|Withdrawal by Subject|0|||
27808046|NCT01078623|81127361|FG018|Treatment Period 2|Withdrawal by Subject|0|||
27808047|NCT01078623|81127362|FG019|Treatment Period 2|Withdrawal by Subject|0|||
28004205|NCT01005251|81846363|FG004|Overall Study|Physician Decision|2|||
27684271|NCT02112708|80679383|FG000|Baseline|Lost to Follow-up|12|||
27684272|NCT02112708|80679384|FG001|Baseline|Lost to Follow-up|0|||
27684273|NCT02112708|80679383|FG000|4 Month|Death|0|||
27684274|NCT02112708|80679384|FG001|4 Month|Death|1|||
27684275|NCT02112708|80679383|FG000|4 Month|Withdrawal by Subject|12|||
27684276|NCT02112708|80679384|FG001|4 Month|Withdrawal by Subject|0|||
27684277|NCT01631227|80679385|FG000|Overall Study|withdrawn consent|27|||
27684278|NCT01631227|80679386|FG001|Overall Study|withdrawn consent|21|||
27684279|NCT01631227|80679385|FG000|Overall Study|Adverse Event|1|||
27684280|NCT01631227|80679386|FG001|Overall Study|Adverse Event|0|||
27684281|NCT01631227|80679385|FG000|Overall Study|administrative|2|||
27684282|NCT01631227|80679386|FG001|Overall Study|administrative|1|||
27684283|NCT00266227|80679387|FG000|Initial Treatment|Adverse Event|0|||
27684284|NCT00266227|80679388|FG001|Initial Treatment|Adverse Event|0|||
27684285|NCT00266227|80679389|FG002|Initial Treatment|Adverse Event|13|||
27808048|NCT01078623|81127343|FG000|Treatment Period 3|Adverse Event|0|||
27808049|NCT01078623|81127344|FG001|Treatment Period 3|Adverse Event|0|||
27808050|NCT01078623|81127345|FG002|Treatment Period 3|Adverse Event|0|||
27808051|NCT01078623|81127346|FG003|Treatment Period 3|Adverse Event|0|||
28004206|NCT01005251|81846359|FG000|Overall Study|Patient moved|1|||
28004207|NCT01005251|81846360|FG001|Overall Study|Patient moved|0|||
27684286|NCT00266227|80679387|FG000|Initial Treatment|Lost to Follow-up|0|||
27684287|NCT00266227|80679388|FG001|Initial Treatment|Lost to Follow-up|0|||
27684288|NCT00266227|80679389|FG002|Initial Treatment|Lost to Follow-up|6|||
27684289|NCT00266227|80679387|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
27684290|NCT00266227|80679388|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
27684291|NCT00266227|80679389|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
27684292|NCT00266227|80679387|FG000|Initial Treatment|Physician decision to withdraw|0|||
27684293|NCT00266227|80679388|FG001|Initial Treatment|Physician decision to withdraw|0|||
27684294|NCT00266227|80679389|FG002|Initial Treatment|Physician decision to withdraw|12|||
27684295|NCT00266227|80679387|FG000|Initial Treatment|Pregnancy|0|||
27684296|NCT00266227|80679388|FG001|Initial Treatment|Pregnancy|0|||
27684297|NCT00266227|80679389|FG002|Initial Treatment|Pregnancy|1|||
27684298|NCT00266227|80679387|FG000|Retreatment: Up to Week 48|Death|1|||
27684299|NCT00266227|80679388|FG001|Retreatment: Up to Week 48|Death|0|||
28004208|NCT01005251|81846361|FG002|Overall Study|Patient moved|0|||
28004209|NCT01005251|81846362|FG003|Overall Study|Patient moved|0|||
28004210|NCT01005251|81846363|FG004|Overall Study|Patient moved|0|||
28004211|NCT01005251|81846359|FG000|Overall Study|Wrong drug dispensed|0|||
28004212|NCT01005251|81846360|FG001|Overall Study|Wrong drug dispensed|1|||
28004213|NCT01005251|81846361|FG002|Overall Study|Wrong drug dispensed|0|||
28004214|NCT01005251|81846362|FG003|Overall Study|Wrong drug dispensed|0|||
28004215|NCT01005251|81846363|FG004|Overall Study|Wrong drug dispensed|0|||
28004216|NCT01005251|81846359|FG000|Overall Study|Randomized in error|0|||
27684300|NCT00266227|80679389|FG002|Retreatment: Up to Week 48|Death|0|||
27684301|NCT00266227|80679387|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
27684302|NCT00266227|80679388|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
27684303|NCT00266227|80679389|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
27684304|NCT00266227|80679387|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
27684305|NCT00266227|80679388|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
27684306|NCT00266227|80679389|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
27684307|NCT00266227|80679387|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
27684308|NCT00266227|80679388|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
27874297|NCT01777282|81371706|FG004|Overall Study|Withdrawal by Subject|2|||
27874298|NCT01777282|81371702|FG000|Overall Study|Protocol Violation|2|||
27874299|NCT01777282|81371703|FG001|Overall Study|Protocol Violation|0|||
27874300|NCT01777282|81371704|FG002|Overall Study|Protocol Violation|1|||
27874301|NCT01777282|81371705|FG003|Overall Study|Protocol Violation|0|||
27684309|NCT00266227|80679389|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
27684310|NCT00266227|80679387|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
27684311|NCT00266227|80679388|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
27684312|NCT00266227|80679389|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
27684313|NCT00266227|80679387|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
27684314|NCT00266227|80679388|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
27684315|NCT00266227|80679389|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
27684316|NCT00266227|80679387|FG000|Retreatment: Week 48 to Week 72|Death|1|||
27684317|NCT00266227|80679388|FG001|Retreatment: Week 48 to Week 72|Death|1|||
27684318|NCT00266227|80679389|FG002|Retreatment: Week 48 to Week 72|Death|0|||
27684319|NCT00266227|80679387|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
27684320|NCT00266227|80679388|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
28004217|NCT01005251|81846360|FG001|Overall Study|Randomized in error|0|||
28004218|NCT01005251|81846361|FG002|Overall Study|Randomized in error|1|||
28004219|NCT01005251|81846362|FG003|Overall Study|Randomized in error|1|||
27684321|NCT00266227|80679389|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
27684322|NCT00266227|80679387|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
27684323|NCT00266227|80679388|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
27684324|NCT00266227|80679389|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
27684325|NCT00266227|80679387|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
27684326|NCT00266227|80679388|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
27684327|NCT00266227|80679389|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
27684328|NCT00266227|80679387|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
27684329|NCT00266227|80679388|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
27684330|NCT00266227|80679389|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
27684331|NCT00564889|80679393|FG000|Overall Study|Death|7|||
27684332|NCT00564889|80679393|FG000|Overall Study|Adverse Event|12|||
27684333|NCT00564889|80679393|FG000|Overall Study|Alternative treatment|3|||
27684334|NCT00564889|80679393|FG000|Overall Study|Disease progression|3|||
27684335|NCT00564889|80679393|FG000|Overall Study|Other, not specified|4|||
27684336|NCT01758900|80679394|FG000|Overall Study|difficulty for further intubation|7|||
27684337|NCT01758900|80679395|FG001|Overall Study|difficulty for further intubation|8|||
27684338|NCT03291288|80679396|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
27684339|NCT03291288|80679397|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
27684340|NCT03291288|80679396|FG000|Drug-drug Interaction Phase|Disease progression|1|||
27874302|NCT01777282|81371706|FG004|Overall Study|Protocol Violation|2|||
28004220|NCT01005251|81846363|FG004|Overall Study|Randomized in error|0|||
27684341|NCT03291288|80679397|FG001|Drug-drug Interaction Phase|Disease progression|0|||
27684342|NCT03291288|80679396|FG000|Drug-drug Interaction Phase|Other|3|||
27684343|NCT03291288|80679397|FG001|Drug-drug Interaction Phase|Other|0|||
27684344|NCT03291288|80679396|FG000|Pexidartinib Only|Ongoing|0|||
27684345|NCT03291288|80679397|FG001|Pexidartinib Only|Ongoing|2|||
27684346|NCT04476251|80679398|FG000|Overall Study|Not treated|1|||
27684347|NCT00616902|80679399|FG000|Overall Study|Termination of study|6|||
27684348|NCT00616902|80679400|FG001|Overall Study|Termination of study|6|||
27684349|NCT00528931|80679401|FG000|Overall Study|Lost to Follow-up|1|||
27684350|NCT04958642|80679408|FG000|Overall Study|Transferred to OLEX program|3|||
27684351|NCT04958642|80679409|FG001|Overall Study|Transferred to OLEX program|0|||
27684352|NCT04958642|80679410|FG002|Overall Study|Transferred to OLEX program|5|||
27684353|NCT04958642|80679408|FG000|Overall Study|Death|0|||
27684354|NCT04958642|80679409|FG001|Overall Study|Death|0|||
27684355|NCT04958642|80679410|FG002|Overall Study|Death|1|||
27684356|NCT04958642|80679408|FG000|Overall Study|Withdrawal by Subject|4|||
27684357|NCT04958642|80679409|FG001|Overall Study|Withdrawal by Subject|9|||
27684358|NCT04958642|80679410|FG002|Overall Study|Withdrawal by Subject|13|||
27684359|NCT04958642|80679408|FG000|Overall Study|Investigator's Decision|0|||
27684360|NCT04958642|80679409|FG001|Overall Study|Investigator's Decision|0|||
27684361|NCT04958642|80679410|FG002|Overall Study|Investigator's Decision|1|||
27684362|NCT04958642|80679408|FG000|Overall Study|Adverse Event|1|||
27684363|NCT04958642|80679409|FG001|Overall Study|Adverse Event|0|||
27684364|NCT04958642|80679410|FG002|Overall Study|Adverse Event|1|||
27684365|NCT04958642|80679408|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
27684366|NCT04958642|80679409|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
27684367|NCT04958642|80679410|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
27684368|NCT04958642|80679408|FG000|Overall Study|Lost to Follow-up|1|||
27684369|NCT04958642|80679409|FG001|Overall Study|Lost to Follow-up|0|||
27684370|NCT04958642|80679410|FG002|Overall Study|Lost to Follow-up|0|||
27684371|NCT04958642|80679408|FG000|Overall Study|Transferred to EAP following study termination|0|||
27684372|NCT04958642|80679409|FG001|Overall Study|Transferred to EAP following study termination|0|||
27684373|NCT04958642|80679410|FG002|Overall Study|Transferred to EAP following study termination|1|||
27684374|NCT04958642|80679408|FG000|Overall Study|Transferred to Expanded Access Program|1|||
27684375|NCT04958642|80679409|FG001|Overall Study|Transferred to Expanded Access Program|0|||
27684376|NCT04958642|80679410|FG002|Overall Study|Transferred to Expanded Access Program|0|||
27684377|NCT02081417|80679414|FG000|Overall Study|Lost to Follow-up|26|||
27684378|NCT02081417|80679415|FG001|Overall Study|Lost to Follow-up|23|||
27684379|NCT02081417|80679414|FG000|Overall Study|Moved Away|1|||
27684380|NCT02081417|80679415|FG001|Overall Study|Moved Away|2|||
27684381|NCT02081417|80679414|FG000|Overall Study|Incarcerated|2|||
27684382|NCT02081417|80679415|FG001|Overall Study|Incarcerated|2|||
27684383|NCT02081417|80679414|FG000|Overall Study|Death|4|||
27684384|NCT02081417|80679415|FG001|Overall Study|Death|3|||
27684385|NCT02081417|80679414|FG000|Overall Study|Withdrawal by Subject|4|||
27684386|NCT02081417|80679415|FG001|Overall Study|Withdrawal by Subject|0|||
27684387|NCT02081417|80679414|FG000|Overall Study|Admitted to Residential Treatment|2|||
27684388|NCT02081417|80679415|FG001|Overall Study|Admitted to Residential Treatment|0|||
27684389|NCT02081417|80679414|FG000|Overall Study|Did not start treatment|17|||
27684390|NCT02081417|80679415|FG001|Overall Study|Did not start treatment|21|||
27684391|NCT01283516|80679419|FG000|Overall Study|Adverse Event|0|||
27684392|NCT01283516|80679420|FG001|Overall Study|Adverse Event|0|||
27684393|NCT01283516|80679421|FG002|Overall Study|Adverse Event|0|||
27684394|NCT01283516|80679422|FG003|Overall Study|Adverse Event|0|||
27684395|NCT01283516|80679423|FG004|Overall Study|Adverse Event|0|||
27684396|NCT01283516|80679424|FG005|Overall Study|Adverse Event|0|||
27684397|NCT01283516|80679425|FG006|Overall Study|Adverse Event|2|||
27808052|NCT01078623|81127347|FG004|Treatment Period 3|Adverse Event|1|||
27808053|NCT01078623|81127348|FG005|Treatment Period 3|Adverse Event|0|||
27808054|NCT01078623|81127349|FG006|Treatment Period 3|Adverse Event|0|||
27684398|NCT01283516|80679426|FG007|Overall Study|Adverse Event|0|||
27684399|NCT01283516|80679427|FG008|Overall Study|Adverse Event|28|||
27808055|NCT01078623|81127350|FG007|Treatment Period 3|Adverse Event|0|||
27684400|NCT01283516|80679419|FG000|Overall Study|Death|0|||
27684401|NCT01283516|80679420|FG001|Overall Study|Death|0|||
27684402|NCT01283516|80679421|FG002|Overall Study|Death|0|||
27684403|NCT01283516|80679422|FG003|Overall Study|Death|0|||
27808056|NCT01078623|81127351|FG008|Treatment Period 3|Adverse Event|0|||
27684404|NCT01283516|80679423|FG004|Overall Study|Death|0|||
27684405|NCT01283516|80679424|FG005|Overall Study|Death|1|||
27684406|NCT01283516|80679425|FG006|Overall Study|Death|0|||
27684407|NCT01283516|80679426|FG007|Overall Study|Death|1|||
27808057|NCT01078623|81127352|FG009|Treatment Period 3|Adverse Event|0|||
27684408|NCT01283516|80679427|FG008|Overall Study|Death|12|||
27684409|NCT01283516|80679419|FG000|Overall Study|Disease Progression|2|||
27684410|NCT01283516|80679420|FG001|Overall Study|Disease Progression|2|||
27808058|NCT01078623|81127353|FG010|Treatment Period 3|Adverse Event|0|||
27684411|NCT01283516|80679421|FG002|Overall Study|Disease Progression|3|||
28004221|NCT01005251|81846359|FG000|Overall Study|Lack of Efficacy|0|||
28004222|NCT01005251|81846360|FG001|Overall Study|Lack of Efficacy|0|||
28004223|NCT01005251|81846361|FG002|Overall Study|Lack of Efficacy|1|||
28004224|NCT01005251|81846362|FG003|Overall Study|Lack of Efficacy|1|||
28004225|NCT01005251|81846363|FG004|Overall Study|Lack of Efficacy|0|||
28004226|NCT00141102|81846364|FG000|Overall Study|Adverse Event|233|||
28004227|NCT00141102|81846365|FG001|Overall Study|Adverse Event|305|||
28004228|NCT00141102|81846364|FG000|Overall Study|Laboratory Abnormality|9|||
28004229|NCT00141102|81846365|FG001|Overall Study|Laboratory Abnormality|33|||
27684412|NCT01283516|80679422|FG003|Overall Study|Disease Progression|3|||
27684413|NCT01283516|80679423|FG004|Overall Study|Disease Progression|13|||
27684414|NCT01283516|80679424|FG005|Overall Study|Disease Progression|8|||
27684415|NCT01283516|80679425|FG006|Overall Study|Disease Progression|6|||
27684416|NCT01283516|80679426|FG007|Overall Study|Disease Progression|3|||
27684417|NCT01283516|80679427|FG008|Overall Study|Disease Progression|139|||
27684418|NCT01283516|80679419|FG000|Overall Study|Withdrawal by Subject|0|||
27684419|NCT01283516|80679420|FG001|Overall Study|Withdrawal by Subject|0|||
27684420|NCT01283516|80679421|FG002|Overall Study|Withdrawal by Subject|0|||
27684421|NCT01283516|80679422|FG003|Overall Study|Withdrawal by Subject|0|||
27684422|NCT01283516|80679423|FG004|Overall Study|Withdrawal by Subject|1|||
27684423|NCT01283516|80679424|FG005|Overall Study|Withdrawal by Subject|0|||
27684424|NCT01283516|80679425|FG006|Overall Study|Withdrawal by Subject|1|||
27684425|NCT01283516|80679426|FG007|Overall Study|Withdrawal by Subject|0|||
27684426|NCT01283516|80679427|FG008|Overall Study|Withdrawal by Subject|36|||
27684427|NCT01283516|80679419|FG000|Overall Study|Administrative problems|0|||
27684428|NCT01283516|80679420|FG001|Overall Study|Administrative problems|0|||
27684429|NCT01283516|80679421|FG002|Overall Study|Administrative problems|0|||
27684430|NCT01283516|80679422|FG003|Overall Study|Administrative problems|0|||
27684431|NCT01283516|80679423|FG004|Overall Study|Administrative problems|0|||
27684432|NCT01283516|80679424|FG005|Overall Study|Administrative problems|1|||
27684433|NCT01283516|80679425|FG006|Overall Study|Administrative problems|1|||
27684434|NCT01283516|80679426|FG007|Overall Study|Administrative problems|1|||
28004230|NCT00141102|81846364|FG000|Overall Study|Lack of Efficacy|21|||
28004231|NCT00141102|81846365|FG001|Overall Study|Lack of Efficacy|26|||
28004232|NCT00141102|81846364|FG000|Overall Study|Lost to Follow-up|29|||
28004233|NCT00141102|81846365|FG001|Overall Study|Lost to Follow-up|32|||
28004234|NCT00141102|81846364|FG000|Overall Study|Other|87|||
28004235|NCT00141102|81846365|FG001|Overall Study|Other|76|||
28004236|NCT00141102|81846364|FG000|Overall Study|Withdrawal by Subject|112|||
28004237|NCT00141102|81846365|FG001|Overall Study|Withdrawal by Subject|142|||
28004238|NCT00141102|81846364|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
28004239|NCT00141102|81846365|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
28004240|NCT00141102|81846364|FG000|Overall Study|Death|2|||
28004241|NCT00141102|81846365|FG001|Overall Study|Death|2|||
28004242|NCT02994108|81846371|FG000|Intervention Messages|Withdrawal by Subject|2|||
28004243|NCT02994108|81846372|FG001|Intervention Messages|Withdrawal by Subject|0|||
28004244|NCT02994108|81846371|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
27684435|NCT01283516|80679427|FG008|Overall Study|Administrative problems|39|||
27684436|NCT01283516|80679419|FG000|Overall Study|Lost to Follow-up|0|||
27684437|NCT01283516|80679420|FG001|Overall Study|Lost to Follow-up|0|||
27684438|NCT01283516|80679421|FG002|Overall Study|Lost to Follow-up|0|||
27684439|NCT01283516|80679422|FG003|Overall Study|Lost to Follow-up|0|||
27684440|NCT01283516|80679423|FG004|Overall Study|Lost to Follow-up|0|||
27684441|NCT01283516|80679424|FG005|Overall Study|Lost to Follow-up|0|||
27684442|NCT01283516|80679425|FG006|Overall Study|Lost to Follow-up|0|||
27684443|NCT01283516|80679426|FG007|Overall Study|Lost to Follow-up|0|||
27684444|NCT01283516|80679427|FG008|Overall Study|Lost to Follow-up|1|||
27684445|NCT03330405|80679435|FG000|Overall Study|Other|1|||
27684446|NCT03330405|80679436|FG001|Overall Study|Other|3|||
27684447|NCT03330405|80679437|FG002|Overall Study|Other|1|||
27684448|NCT03330405|80679438|FG003|Overall Study|Other|0|||
27684449|NCT03330405|80679439|FG004|Overall Study|Other|2|||
27684450|NCT03330405|80679440|FG005|Overall Study|Other|0|||
27684451|NCT03330405|80679441|FG006|Overall Study|Other|1|||
27684452|NCT03330405|80679442|FG007|Overall Study|Other|0|||
27684453|NCT03330405|80679443|FG008|Overall Study|Other|0|||
27684454|NCT03330405|80679444|FG009|Overall Study|Other|0|||
27684455|NCT03330405|80679445|FG010|Overall Study|Other|0|||
27684456|NCT03330405|80679435|FG000|Overall Study|Progressive disease|8|||
27684457|NCT03330405|80679436|FG001|Overall Study|Progressive disease|27|||
28004245|NCT02994108|81846372|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
27684458|NCT03330405|80679437|FG002|Overall Study|Progressive disease|4|||
27684459|NCT03330405|80679438|FG003|Overall Study|Progressive disease|18|||
27684460|NCT03330405|80679439|FG004|Overall Study|Progressive disease|16|||
27684461|NCT03330405|80679440|FG005|Overall Study|Progressive disease|14|||
27684462|NCT03330405|80679441|FG006|Overall Study|Progressive disease|7|||
27684463|NCT03330405|80679442|FG007|Overall Study|Progressive disease|29|||
28004246|NCT02994108|81846371|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
28004247|NCT02994108|81846372|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
27684464|NCT03330405|80679443|FG008|Overall Study|Progressive disease|9|||
27684465|NCT03330405|80679444|FG009|Overall Study|Progressive disease|11|||
27684466|NCT03330405|80679445|FG010|Overall Study|Progressive disease|5|||
27684467|NCT03330405|80679435|FG000|Overall Study|Withdrawal by Subject|1|||
27684468|NCT03330405|80679436|FG001|Overall Study|Withdrawal by Subject|4|||
27684469|NCT03330405|80679437|FG002|Overall Study|Withdrawal by Subject|0|||
27684470|NCT03330405|80679438|FG003|Overall Study|Withdrawal by Subject|1|||
27684471|NCT03330405|80679439|FG004|Overall Study|Withdrawal by Subject|1|||
27684472|NCT03330405|80679440|FG005|Overall Study|Withdrawal by Subject|1|||
27684473|NCT03330405|80679441|FG006|Overall Study|Withdrawal by Subject|0|||
27684474|NCT03330405|80679442|FG007|Overall Study|Withdrawal by Subject|2|||
27684475|NCT03330405|80679443|FG008|Overall Study|Withdrawal by Subject|2|||
27684476|NCT03330405|80679444|FG009|Overall Study|Withdrawal by Subject|1|||
27684477|NCT03330405|80679445|FG010|Overall Study|Withdrawal by Subject|1|||
27684478|NCT03330405|80679435|FG000|Overall Study|Global deterioration of health status|2|||
27684479|NCT03330405|80679436|FG001|Overall Study|Global deterioration of health status|3|||
27684480|NCT03330405|80679437|FG002|Overall Study|Global deterioration of health status|0|||
28004248|NCT02994108|81846371|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
28004249|NCT02994108|81846372|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
27684481|NCT03330405|80679438|FG003|Overall Study|Global deterioration of health status|2|||
27684482|NCT03330405|80679439|FG004|Overall Study|Global deterioration of health status|3|||
27684483|NCT03330405|80679440|FG005|Overall Study|Global deterioration of health status|3|||
27684484|NCT03330405|80679441|FG006|Overall Study|Global deterioration of health status|0|||
27684485|NCT03330405|80679442|FG007|Overall Study|Global deterioration of health status|2|||
27684486|NCT03330405|80679443|FG008|Overall Study|Global deterioration of health status|8|||
27684487|NCT03330405|80679444|FG009|Overall Study|Global deterioration of health status|4|||
27684488|NCT03330405|80679445|FG010|Overall Study|Global deterioration of health status|1|||
27684489|NCT03330405|80679435|FG000|Overall Study|Adverse Event|0|||
27684490|NCT03330405|80679436|FG001|Overall Study|Adverse Event|1|||
27684491|NCT03330405|80679437|FG002|Overall Study|Adverse Event|0|||
27684492|NCT03330405|80679438|FG003|Overall Study|Adverse Event|1|||
27684493|NCT03330405|80679439|FG004|Overall Study|Adverse Event|1|||
27684494|NCT03330405|80679440|FG005|Overall Study|Adverse Event|1|||
27684495|NCT03330405|80679441|FG006|Overall Study|Adverse Event|3|||
27684496|NCT03330405|80679442|FG007|Overall Study|Adverse Event|4|||
27684497|NCT03330405|80679443|FG008|Overall Study|Adverse Event|2|||
27684498|NCT03330405|80679444|FG009|Overall Study|Adverse Event|2|||
27684499|NCT03330405|80679445|FG010|Overall Study|Adverse Event|2|||
28004250|NCT01600885|81846378|FG000|First Period|Adverse Event|1|||
28004251|NCT01600885|81846379|FG001|First Period|Adverse Event|1|||
28004252|NCT01600885|81846378|FG000|First Period|moved out of area|1|||
28004253|NCT01600885|81846379|FG001|First Period|moved out of area|0|||
28004254|NCT00057863|81846384|FG000|Overall Study|Death|1|||
28004255|NCT00057863|81846384|FG000|Overall Study|Withdrawal by Subject|2|||
28004256|NCT01945021|81846389|FG000|Overall Study|Adverse Event|1|||
28004257|NCT01945021|81846389|FG000|Overall Study|Withdrawal of consent|12|||
28004258|NCT01945021|81846389|FG000|Overall Study|Lost to Follow-up|5|||
28004259|NCT01945021|81846389|FG000|Overall Study|Death|65|||
28004260|NCT02559622|81846393|FG000|Overall Study|Progressive disease|0|||
28004261|NCT02559622|81846394|FG001|Overall Study|Progressive disease|1|||
28004262|NCT02559622|81846395|FG002|Overall Study|Progressive disease|0|||
28004263|NCT02559622|81846396|FG003|Overall Study|Progressive disease|0|||
28004264|NCT02559622|81846393|FG000|Overall Study|Adverse Event|0|||
28004265|NCT02559622|81846394|FG001|Overall Study|Adverse Event|2|||
27584693|NCT00710424|80321997|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
28004266|NCT02559622|81846395|FG002|Overall Study|Adverse Event|2|||
28004267|NCT02559622|81846396|FG003|Overall Study|Adverse Event|2|||
28004268|NCT02559622|81846393|FG000|Overall Study|Patient/guardian decision|1|||
28004269|NCT02559622|81846394|FG001|Overall Study|Patient/guardian decision|2|||
27808059|NCT01078623|81127354|FG011|Treatment Period 3|Adverse Event|0|||
27584694|NCT00710424|80321998|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
27584695|NCT00710424|80321997|FG000|Overall Study|Subject thought medication changed|1|||
27584696|NCT00710424|80321998|FG001|Overall Study|Subject thought medication changed|0|||
27684500|NCT03330405|80679435|FG000|Overall Study|Death|0|||
27684501|NCT03330405|80679436|FG001|Overall Study|Death|4|||
27684502|NCT03330405|80679437|FG002|Overall Study|Death|0|||
27684503|NCT03330405|80679438|FG003|Overall Study|Death|0|||
27808060|NCT01078623|81127355|FG012|Treatment Period 3|Adverse Event|0|||
28004270|NCT02559622|81846395|FG002|Overall Study|Patient/guardian decision|0|||
27684504|NCT03330405|80679439|FG004|Overall Study|Death|0|||
27684505|NCT03330405|80679440|FG005|Overall Study|Death|1|||
27684506|NCT03330405|80679441|FG006|Overall Study|Death|0|||
28004271|NCT02559622|81846396|FG003|Overall Study|Patient/guardian decision|1|||
28004272|NCT01731912|81846400|FG000|Overall Study|noncompliance|2|||
28004273|NCT01884077|81846401|FG000|Overall Study|screen fail|0|||
28004274|NCT01884077|81846402|FG001|Overall Study|screen fail|2|||
28004275|NCT01884077|81846401|FG000|Overall Study|canceled surgery|2|||
27584697|NCT00710424|80321997|FG000|Overall Study|Ceased treatment due to travel|1|||
27584698|NCT00710424|80321998|FG001|Overall Study|Ceased treatment due to travel|0|||
27808061|NCT01078623|81127356|FG013|Treatment Period 3|Adverse Event|1|||
27808062|NCT01078623|81127357|FG014|Treatment Period 3|Adverse Event|0|||
27808063|NCT01078623|81127358|FG015|Treatment Period 3|Adverse Event|0|||
27584699|NCT00710424|80321997|FG000|Overall Study|Subject preferred paracetamol|0|||
27584700|NCT00710424|80321998|FG001|Overall Study|Subject preferred paracetamol|1|||
27584701|NCT00710424|80321997|FG000|Overall Study|Felt good so stopped treatment|0|||
27584702|NCT00710424|80321998|FG001|Overall Study|Felt good so stopped treatment|1|||
27584703|NCT04598152|80321999|FG000|Overall Study|Lost to Follow-up|0|||
27584704|NCT04598152|80322000|FG001|Overall Study|Lost to Follow-up|1|||
27584705|NCT03349710|80322002|FG000|Treatment Period|Death|0|||
27584706|NCT03349710|80322003|FG001|Treatment Period|Death|0|||
27584707|NCT03349710|80322004|FG002|Treatment Period|Death|1|||
27584708|NCT03349710|80322005|FG003|Treatment Period|Death|0|||
27584709|NCT03349710|80322002|FG000|Treatment Period|Disease Progression|0|||
27584710|NCT03349710|80322003|FG001|Treatment Period|Disease Progression|2|||
27584711|NCT03349710|80322004|FG002|Treatment Period|Disease Progression|0|||
27584712|NCT03349710|80322005|FG003|Treatment Period|Disease Progression|1|||
27584713|NCT03349710|80322002|FG000|Treatment Period|Study Drug Toxicity|1|||
27584714|NCT03349710|80322003|FG001|Treatment Period|Study Drug Toxicity|0|||
27584715|NCT03349710|80322004|FG002|Treatment Period|Study Drug Toxicity|1|||
27584716|NCT03349710|80322005|FG003|Treatment Period|Study Drug Toxicity|1|||
27584717|NCT03349710|80322002|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
27584718|NCT03349710|80322003|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
27584719|NCT03349710|80322004|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
27584720|NCT03349710|80322005|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
27584721|NCT03349710|80322002|FG000|Treatment Period|admin reason by sponsor|0|||
27584722|NCT03349710|80322003|FG001|Treatment Period|admin reason by sponsor|7|||
27584723|NCT03349710|80322004|FG002|Treatment Period|admin reason by sponsor|0|||
27584724|NCT03349710|80322005|FG003|Treatment Period|admin reason by sponsor|19|||
27584725|NCT03349710|80322002|FG000|Treatment Period|Other Reason|2|||
27584726|NCT03349710|80322003|FG001|Treatment Period|Other Reason|0|||
27584727|NCT03349710|80322004|FG002|Treatment Period|Other Reason|2|||
27584728|NCT03349710|80322005|FG003|Treatment Period|Other Reason|1|||
27584729|NCT03349710|80322002|FG000|Treatment Period|completed|6|||
27584730|NCT03349710|80322003|FG001|Treatment Period|completed|0|||
27584731|NCT03349710|80322004|FG002|Treatment Period|completed|18|||
27584732|NCT03349710|80322005|FG003|Treatment Period|completed|1|||
27584733|NCT03349710|80322002|FG000|Treatment Period|participant request to discontinue|0|||
27584734|NCT03349710|80322003|FG001|Treatment Period|participant request to discontinue|0|||
27584735|NCT03349710|80322004|FG002|Treatment Period|participant request to discontinue|4|||
27584736|NCT03349710|80322005|FG003|Treatment Period|participant request to discontinue|0|||
27584737|NCT03349710|80322002|FG000|Treatment Period|participant withdrew consent|1|||
27584738|NCT03349710|80322003|FG001|Treatment Period|participant withdrew consent|0|||
27584739|NCT03349710|80322004|FG002|Treatment Period|participant withdrew consent|0|||
27584740|NCT03349710|80322005|FG003|Treatment Period|participant withdrew consent|0|||
27584741|NCT01312909|80322007|FG000|Overall Study|Randomized but not treated|1|||
27584742|NCT01312909|80322008|FG001|Overall Study|Randomized but not treated|3|||
27584743|NCT01312909|80322009|FG002|Overall Study|Randomized but not treated|1|||
27584744|NCT01312909|80322007|FG000|Overall Study|Adverse Event|1|||
27584745|NCT01312909|80322008|FG001|Overall Study|Adverse Event|0|||
27584746|NCT01312909|80322009|FG002|Overall Study|Adverse Event|3|||
27808064|NCT01078623|81127359|FG016|Treatment Period 3|Adverse Event|0|||
27808065|NCT01078623|81127360|FG017|Treatment Period 3|Adverse Event|0|||
27808066|NCT01078623|81127361|FG018|Treatment Period 3|Adverse Event|0|||
27808067|NCT01078623|81127362|FG019|Treatment Period 3|Adverse Event|0|||
27808068|NCT01078623|81127343|FG000|Treatment Period 4|Adverse Event|0|||
27808069|NCT01078623|81127344|FG001|Treatment Period 4|Adverse Event|0|||
27808070|NCT01078623|81127345|FG002|Treatment Period 4|Adverse Event|1|||
27808071|NCT01078623|81127346|FG003|Treatment Period 4|Adverse Event|0|||
27584747|NCT01312909|80322007|FG000|Overall Study|Protocol Violation|2|||
27584748|NCT01312909|80322008|FG001|Overall Study|Protocol Violation|0|||
27584749|NCT01312909|80322009|FG002|Overall Study|Protocol Violation|2|||
27584750|NCT01312909|80322007|FG000|Overall Study|Other|9|||
27584751|NCT01312909|80322008|FG001|Overall Study|Other|6|||
27584752|NCT01312909|80322009|FG002|Overall Study|Other|11|||
27808072|NCT01078623|81127347|FG004|Treatment Period 4|Adverse Event|0|||
27808073|NCT01078623|81127348|FG005|Treatment Period 4|Adverse Event|0|||
27808074|NCT01078623|81127349|FG006|Treatment Period 4|Adverse Event|0|||
27808075|NCT01078623|81127350|FG007|Treatment Period 4|Adverse Event|0|||
27584753|NCT01312909|80322007|FG000|Overall Study|Withdrawal by Subject|8|||
27684507|NCT03330405|80679442|FG007|Overall Study|Death|2|||
27684508|NCT03330405|80679443|FG008|Overall Study|Death|0|||
27808076|NCT01078623|81127351|FG008|Treatment Period 4|Adverse Event|0|||
27808077|NCT01078623|81127352|FG009|Treatment Period 4|Adverse Event|0|||
27808078|NCT01078623|81127353|FG010|Treatment Period 4|Adverse Event|0|||
27684509|NCT03330405|80679444|FG009|Overall Study|Death|0|||
27684510|NCT03330405|80679445|FG010|Overall Study|Death|0|||
27684511|NCT03330405|80679435|FG000|Overall Study|Physician Decision|0|||
27684512|NCT03330405|80679436|FG001|Overall Study|Physician Decision|0|||
28004276|NCT01884077|81846402|FG001|Overall Study|canceled surgery|0|||
28004277|NCT01884077|81846401|FG000|Overall Study|Lost to Follow-up|0|||
28004278|NCT01884077|81846402|FG001|Overall Study|Lost to Follow-up|4|||
28004279|NCT01884077|81846401|FG000|Overall Study|study closed|6|||
28004280|NCT01884077|81846402|FG001|Overall Study|study closed|4|||
28004281|NCT04233801|81846403|FG000|Overall Study|Other than listed|0|||
28004282|NCT04233801|81846404|FG001|Overall Study|Other than listed|0|||
28004283|NCT04233801|81846405|FG002|Overall Study|Other than listed|1|||
28004284|NCT04233801|81846403|FG000|Overall Study|Withdrawal by Subject|0|||
28004285|NCT04233801|81846404|FG001|Overall Study|Withdrawal by Subject|2|||
28004286|NCT04233801|81846405|FG002|Overall Study|Withdrawal by Subject|3|||
28004287|NCT00449696|81846407|FG000|Overall Study|Other Treatment Required|6|||
28004288|NCT00449696|81846408|FG001|Overall Study|Other Treatment Required|1|||
28004289|NCT00449696|81846407|FG000|Overall Study|Withdrawal by Subject|5|||
28004290|NCT00449696|81846408|FG001|Overall Study|Withdrawal by Subject|5|||
28004291|NCT00449696|81846407|FG000|Overall Study|Lost to Follow-up|2|||
28004292|NCT00449696|81846408|FG001|Overall Study|Lost to Follow-up|3|||
28004293|NCT00449696|81846407|FG000|Overall Study|Others|7|||
28004294|NCT00449696|81846408|FG001|Overall Study|Others|0|||
28004295|NCT04258423|81846409|FG000|Overall Study|Study Closure|2|||
28004296|NCT04258423|81846410|FG001|Overall Study|Study Closure|2|||
28004297|NCT02813889|81846411|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
28004298|NCT02813889|81846412|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
27808079|NCT01078623|81127354|FG011|Treatment Period 4|Adverse Event|0|||
27808080|NCT01078623|81127355|FG012|Treatment Period 4|Adverse Event|0|||
27808081|NCT01078623|81127356|FG013|Treatment Period 4|Adverse Event|0|||
27808082|NCT01078623|81127357|FG014|Treatment Period 4|Adverse Event|0|||
27808083|NCT01078623|81127358|FG015|Treatment Period 4|Adverse Event|0|||
27808084|NCT01078623|81127359|FG016|Treatment Period 4|Adverse Event|0|||
27808085|NCT01078623|81127360|FG017|Treatment Period 4|Adverse Event|0|||
27808086|NCT01078623|81127361|FG018|Treatment Period 4|Adverse Event|0|||
27808087|NCT01078623|81127362|FG019|Treatment Period 4|Adverse Event|0|||
27808088|NCT01078623|81127343|FG000|Treatment Period 4|Withdrawal by Subject|0|||
27874303|NCT01777282|81371702|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
27874304|NCT01777282|81371703|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
28004299|NCT01451723|81846413|FG000|Overall Study|study halted|6|||
27684513|NCT03330405|80679437|FG002|Overall Study|Physician Decision|0|||
27808089|NCT01078623|81127344|FG001|Treatment Period 4|Withdrawal by Subject|0|||
27808090|NCT01078623|81127345|FG002|Treatment Period 4|Withdrawal by Subject|0|||
27684514|NCT03330405|80679438|FG003|Overall Study|Physician Decision|0|||
27684515|NCT03330405|80679439|FG004|Overall Study|Physician Decision|0|||
27684516|NCT03330405|80679440|FG005|Overall Study|Physician Decision|0|||
27684517|NCT03330405|80679441|FG006|Overall Study|Physician Decision|0|||
27684518|NCT03330405|80679442|FG007|Overall Study|Physician Decision|1|||
27684519|NCT03330405|80679443|FG008|Overall Study|Physician Decision|0|||
27684520|NCT03330405|80679444|FG009|Overall Study|Physician Decision|0|||
27684521|NCT03330405|80679445|FG010|Overall Study|Physician Decision|0|||
28004300|NCT01451723|81846414|FG001|Overall Study|study halted|5|||
27684522|NCT01789567|80679446|FG000|Overall Study|Death|6|||
27684523|NCT01302080|80679447|FG000|Overall Study|Withdrew Consent|92|||
27684524|NCT01302080|80679448|FG001|Overall Study|Withdrew Consent|39|||
27684525|NCT01302080|80679447|FG000|Overall Study|Patient/Family Moved|28|||
27684526|NCT01302080|80679448|FG001|Overall Study|Patient/Family Moved|3|||
27684527|NCT01302080|80679447|FG000|Overall Study|Lost to Follow-up|192|||
27684528|NCT01302080|80679448|FG001|Overall Study|Lost to Follow-up|93|||
27684529|NCT01302080|80679447|FG000|Overall Study|Death|1|||
27684530|NCT01302080|80679448|FG001|Overall Study|Death|0|||
27684531|NCT01302080|80679447|FG000|Overall Study|Other|52|||
27684532|NCT01302080|80679448|FG001|Overall Study|Other|8|||
27684533|NCT01302080|80679447|FG000|Overall Study|Reason Missing For Discontinuation|1|||
27684534|NCT01302080|80679448|FG001|Overall Study|Reason Missing For Discontinuation|0|||
27684535|NCT01012414|80679451|FG000|Overall Study|Withdrawal by Subject|2|||
27684536|NCT01012414|80679451|FG000|Overall Study|Lost to Follow-up|1|||
27684537|NCT01012414|80679451|FG000|Overall Study|Trial was stopped before completed|7|||
28004301|NCT03557970|81846416|FG000|Overall Study|Study closure|1|||
28004302|NCT03557970|81846417|FG001|Overall Study|Study closure|0|||
27684538|NCT03333876|80679452|FG000|Screening Period|Screen Failure|4|||
27684539|NCT03333876|80679452|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
27684540|NCT03333876|80679452|FG000|Mandibular Advancement|Adverse Event|2|||
27684541|NCT03333876|80679452|FG000|Mandibular Advancement|Product Damage|2|||
27808091|NCT01078623|81127346|FG003|Treatment Period 4|Withdrawal by Subject|0|||
27808092|NCT01078623|81127347|FG004|Treatment Period 4|Withdrawal by Subject|0|||
27808093|NCT01078623|81127348|FG005|Treatment Period 4|Withdrawal by Subject|0|||
28004303|NCT03557970|81846416|FG000|Overall Study|Physician Decision|0|||
28004304|NCT03557970|81846417|FG001|Overall Study|Physician Decision|1|||
28004305|NCT03557970|81846416|FG000|Overall Study|Death|0|||
28004306|NCT03557970|81846417|FG001|Overall Study|Death|1|||
28004307|NCT00689390|81846418|FG000|Overall Study|Adverse Event|19|||
28004308|NCT00689390|81846419|FG001|Overall Study|Adverse Event|0|||
28004309|NCT00689390|81846418|FG000|Overall Study|Lost to Follow-up|179|||
28004310|NCT00689390|81846419|FG001|Overall Study|Lost to Follow-up|7|||
28004311|NCT00689390|81846418|FG000|Overall Study|Withdrawal by Subject|117|||
28004312|NCT00689390|81846419|FG001|Overall Study|Withdrawal by Subject|3|||
28004313|NCT00689390|81846418|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
28004314|NCT00689390|81846419|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
28004315|NCT00689390|81846418|FG000|Overall Study|Non-Compliance With Protocol|21|||
28004316|NCT00689390|81846419|FG001|Overall Study|Non-Compliance With Protocol|0|||
28004317|NCT00689390|81846418|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
28004318|NCT00689390|81846419|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
28004319|NCT00689390|81846418|FG000|Overall Study|Administrative|37|||
28004320|NCT00689390|81846419|FG001|Overall Study|Administrative|0|||
28004321|NCT01576341|81846420|FG000|Overall Study|Withdrawal by Subject|24|||
28004322|NCT01576341|81846420|FG000|Overall Study|Adverse Event|10|||
28004323|NCT01576341|81846420|FG000|Overall Study|Death|21|||
28004324|NCT01576341|81846420|FG000|Overall Study|Physician Decision|2|||
28004325|NCT01576341|81846420|FG000|Overall Study|Lost to Follow-up|2|||
28004326|NCT01576341|81846420|FG000|Overall Study|Kidney transplantation|10|||
28004327|NCT01576341|81846420|FG000|Overall Study|Protocol Violation|12|||
28004328|NCT01576341|81846420|FG000|Overall Study|Other|12|||
28004329|NCT01476722|81846423|FG000|Overall Study|Adverse Event|1|||
28004330|NCT01517750|81846424|FG000|Overall Study|Lost to Follow-up|1|||
28004331|NCT01517750|81846425|FG001|Overall Study|Lost to Follow-up|2|||
28004332|NCT01517750|81846426|FG002|Overall Study|Lost to Follow-up|4|||
28004333|NCT01517750|81846427|FG003|Overall Study|Lost to Follow-up|1|||
28004334|NCT00644358|81846430|FG000|Overall Study|Adverse Event|124|||
28004335|NCT00644358|81846430|FG000|Overall Study|Lost to Follow-up|105|||
28004336|NCT00644358|81846430|FG000|Overall Study|Consent Withdrawal|64|||
28004337|NCT00644358|81846430|FG000|Overall Study|Lack of Effectiveness|39|||
28004338|NCT00644358|81846430|FG000|Overall Study|Protocol Violation|5|||
28004339|NCT00644358|81846430|FG000|Overall Study|Noncompliance|14|||
28004340|NCT00644358|81846430|FG000|Overall Study|Other Unspecified|11|||
28004341|NCT01488045|81846431|FG000|Overall Study|Withdrawal by Subject|6|||
28004342|NCT01488045|81846432|FG001|Overall Study|Withdrawal by Subject|11|||
28004343|NCT01488045|81846431|FG000|Overall Study|Failure to present for colonoscopy|3|||
28004344|NCT01488045|81846432|FG001|Overall Study|Failure to present for colonoscopy|6|||
28004345|NCT01488045|81846431|FG000|Overall Study|Failure to report exclusion criteria|0|||
28004346|NCT01488045|81846432|FG001|Overall Study|Failure to report exclusion criteria|1|||
28004347|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
28004348|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
28004349|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
28004350|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
28004351|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
28004352|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
28004353|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
28004354|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
28004355|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
28004356|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
28004357|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
28004358|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
28004359|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
28004360|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
28004361|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
28004362|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
28004363|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
28004364|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
28004365|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
28004366|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
28004367|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
28004368|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
28004369|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
28004370|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
28004371|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
27808094|NCT01078623|81127349|FG006|Treatment Period 4|Withdrawal by Subject|0|||
27808095|NCT01078623|81127350|FG007|Treatment Period 4|Withdrawal by Subject|0|||
27684542|NCT01163292|80679453|FG000|Overall Study|Lack of Efficacy|9|||
27684543|NCT01163292|80679454|FG001|Overall Study|Lack of Efficacy|0|||
27684544|NCT01163292|80679453|FG000|Overall Study|Adverse Event|6|||
27684545|NCT01163292|80679454|FG001|Overall Study|Adverse Event|0|||
27684546|NCT01163292|80679453|FG000|Overall Study|Initiation of biological therapy|0|||
27684547|NCT01163292|80679454|FG001|Overall Study|Initiation of biological therapy|15|||
27684548|NCT01163292|80679453|FG000|Overall Study|Sufficient response to adalimumab|8|||
27684549|NCT01163292|80679454|FG001|Overall Study|Sufficient response to adalimumab|0|||
27684550|NCT01163292|80679453|FG000|Overall Study|Refusal to receive adalimumab|7|||
27684551|NCT01163292|80679454|FG001|Overall Study|Refusal to receive adalimumab|0|||
27684552|NCT01163292|80679453|FG000|Overall Study|Economic reasons|6|||
27684553|NCT01163292|80679454|FG001|Overall Study|Economic reasons|0|||
27684554|NCT01163292|80679453|FG000|Overall Study|No further visits|5|||
27684555|NCT01163292|80679454|FG001|Overall Study|No further visits|7|||
27684556|NCT00488475|80679455|FG000|Overall Study|Other|1754|||
27684557|NCT02787044|80679459|FG000|Overall Study|Lost to Follow-up|15|||
27684558|NCT02787044|80679460|FG001|Overall Study|Lost to Follow-up|19|||
27684559|NCT01517295|80679462|FG000|Overall Study|Physician Decision|1|||
27684560|NCT01517295|80679463|FG001|Overall Study|Physician Decision|0|||
27684561|NCT01050790|80683503|FG000|Overall Study|Adverse Event|1|||
27684562|NCT02964325|80683504|FG000|Overall Study|Lost to Follow-up|3|||
27684563|NCT02964325|80683505|FG001|Overall Study|Lost to Follow-up|3|||
27684564|NCT02964325|80683504|FG000|Overall Study|Physician Decision|5|||
27684565|NCT02964325|80683505|FG001|Overall Study|Physician Decision|4|||
27808096|NCT01078623|81127351|FG008|Treatment Period 4|Withdrawal by Subject|0|||
27808097|NCT01078623|81127352|FG009|Treatment Period 4|Withdrawal by Subject|0|||
27808098|NCT01078623|81127353|FG010|Treatment Period 4|Withdrawal by Subject|0|||
27808099|NCT01078623|81127354|FG011|Treatment Period 4|Withdrawal by Subject|0|||
27808100|NCT01078623|81127355|FG012|Treatment Period 4|Withdrawal by Subject|0|||
27808101|NCT01078623|81127356|FG013|Treatment Period 4|Withdrawal by Subject|0|||
27808102|NCT01078623|81127357|FG014|Treatment Period 4|Withdrawal by Subject|0|||
28004372|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
28004373|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
28004374|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
28004375|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
27808103|NCT01078623|81127358|FG015|Treatment Period 4|Withdrawal by Subject|1|||
27808104|NCT01078623|81127359|FG016|Treatment Period 4|Withdrawal by Subject|0|||
27808105|NCT01078623|81127360|FG017|Treatment Period 4|Withdrawal by Subject|0|||
27808106|NCT01078623|81127361|FG018|Treatment Period 4|Withdrawal by Subject|0|||
27808107|NCT01078623|81127362|FG019|Treatment Period 4|Withdrawal by Subject|0|||
28004376|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
28004377|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
28004378|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
28004379|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
28004380|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
28004381|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
28004382|NCT02831764|81846433|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
28004383|NCT02831764|81846434|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
28004384|NCT02831764|81846435|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
28004385|NCT02831764|81846436|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
28004386|NCT02831764|81846437|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
28004387|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
28004388|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
27808108|NCT03770000|81127363|FG000|Overall Study|Premature discontinuation due to PD|0|||
27808109|NCT03770000|81127364|FG001|Overall Study|Premature discontinuation due to PD|0|||
27808110|NCT03770000|81127365|FG002|Overall Study|Premature discontinuation due to PD|1|||
27808111|NCT03770000|81127366|FG003|Overall Study|Premature discontinuation due to PD|3|||
27584754|NCT01312909|80322008|FG001|Overall Study|Withdrawal by Subject|10|||
27584755|NCT01312909|80322009|FG002|Overall Study|Withdrawal by Subject|7|||
27584756|NCT01312909|80322007|FG000|Overall Study|Lost to Follow-up|21|||
27684566|NCT02964325|80683504|FG000|Overall Study|Death|1|||
27684567|NCT02964325|80683505|FG001|Overall Study|Death|3|||
27684568|NCT02964325|80683504|FG000|Overall Study|Withdrawal by Subject|2|||
27684569|NCT02964325|80683505|FG001|Overall Study|Withdrawal by Subject|1|||
27808112|NCT03770000|81127367|FG004|Overall Study|Premature discontinuation due to PD|2|||
27808113|NCT03627195|81127368|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
27808114|NCT03627195|81127369|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
27808115|NCT03627195|81127370|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
27808116|NCT03627195|81127371|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
27808117|NCT03627195|81127372|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
27808118|NCT03627195|81127373|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
27808119|NCT02175966|81127374|FG000|Follow-up Period|Lack of Efficacy|10|||
27808120|NCT02175966|81127375|FG001|Follow-up Period|Lack of Efficacy|6|||
28004389|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
28004390|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
28004391|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
28004392|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
28004393|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
28004394|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
28004395|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
28004396|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
28004397|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
28004398|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
28004399|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
28004400|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
28004401|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
28004402|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
28004403|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
28004404|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
28004405|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
28004406|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
28004407|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
28004408|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
28004409|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
28004410|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
28004411|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
28004412|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
28004413|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
28004414|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
28004415|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
28004416|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
27808121|NCT02006147|81127377|FG000|Overall Study|Protocol Violation|1|||
27808122|NCT02006147|81127378|FG001|Overall Study|Protocol Violation|1|||
27808123|NCT02006147|81127379|FG002|Overall Study|Protocol Violation|0|||
27808124|NCT02006147|81127380|FG003|Overall Study|Protocol Violation|0|||
27808125|NCT02006147|81127377|FG000|Overall Study|Withdrawal by Subject|0|||
27808126|NCT02006147|81127378|FG001|Overall Study|Withdrawal by Subject|1|||
27808127|NCT02006147|81127379|FG002|Overall Study|Withdrawal by Subject|0|||
27808128|NCT02006147|81127380|FG003|Overall Study|Withdrawal by Subject|0|||
27808129|NCT02006147|81127377|FG000|Overall Study|Withdrawal by Sponsor|1|||
27808130|NCT02006147|81127378|FG001|Overall Study|Withdrawal by Sponsor|0|||
27808131|NCT02006147|81127379|FG002|Overall Study|Withdrawal by Sponsor|0|||
27808132|NCT02006147|81127380|FG003|Overall Study|Withdrawal by Sponsor|0|||
27808133|NCT00395083|81127384|FG000|Overall Study|Withdrawal by Subject|6|||
27808134|NCT00395083|81127385|FG001|Overall Study|Withdrawal by Subject|5|||
27808135|NCT00395083|81127384|FG000|Overall Study|Developed another disease|4|||
27808136|NCT00395083|81127385|FG001|Overall Study|Developed another disease|3|||
27808137|NCT00832078|81127389|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
27808138|NCT00832078|81127390|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
27808139|NCT00832078|81127389|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
27808140|NCT00832078|81127390|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
27808141|NCT00775983|81127391|FG000|Overall Study|Protocol Violation|1|||
27808142|NCT00775983|81127392|FG001|Overall Study|Protocol Violation|2|||
27808143|NCT01875445|81127393|FG000|Overall Study|Lost to Follow-up|5|||
27808144|NCT01875445|81127394|FG001|Overall Study|Lost to Follow-up|0|||
27808145|NCT01875445|81127393|FG000|Overall Study|Withdrawal by Subject|2|||
27808146|NCT01875445|81127394|FG001|Overall Study|Withdrawal by Subject|0|||
27808147|NCT02472977|81127395|FG000|Overall Study|Disease progression|4|||
27808148|NCT02472977|81127396|FG001|Overall Study|Disease progression|25|||
27808149|NCT02472977|81127397|FG002|Overall Study|Disease progression|6|||
27808150|NCT02472977|81127395|FG000|Overall Study|Withdrawal by Subject|0|||
27808151|NCT02472977|81127396|FG001|Overall Study|Withdrawal by Subject|1|||
28004417|NCT02831764|81846433|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
27808152|NCT02472977|81127397|FG002|Overall Study|Withdrawal by Subject|0|||
27808153|NCT02472977|81127395|FG000|Overall Study|Study drug toxicity|2|||
27808154|NCT02472977|81127396|FG001|Overall Study|Study drug toxicity|0|||
27808155|NCT02472977|81127397|FG002|Overall Study|Study drug toxicity|2|||
27808156|NCT02472977|81127395|FG000|Overall Study|Subject request to discontinue treatment|0|||
27808157|NCT02472977|81127396|FG001|Overall Study|Subject request to discontinue treatment|1|||
27808158|NCT02472977|81127397|FG002|Overall Study|Subject request to discontinue treatment|0|||
27833149|NCT04281472|81219493|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
27808159|NCT02415959|81130556|FG000|Overall Study|Adverse Event|0|||
27808160|NCT02415959|81130557|FG001|Overall Study|Adverse Event|1|||
27808161|NCT02415959|81130558|FG002|Overall Study|Adverse Event|0|||
27808162|NCT02415959|81130559|FG003|Overall Study|Adverse Event|0|||
27808163|NCT02415959|81130560|FG004|Overall Study|Adverse Event|0|||
27808164|NCT02415959|81130556|FG000|Overall Study|Protocol Violation|0|||
27808165|NCT02415959|81130557|FG001|Overall Study|Protocol Violation|0|||
27808166|NCT02415959|81130558|FG002|Overall Study|Protocol Violation|0|||
27808167|NCT02415959|81130559|FG003|Overall Study|Protocol Violation|1|||
27808168|NCT02415959|81130560|FG004|Overall Study|Protocol Violation|0|||
27808169|NCT01113710|81130561|FG000|Overall Study|Adverse Event|64|||
27808170|NCT01113710|81130561|FG000|Overall Study|Lack of Efficacy|41|||
27808171|NCT01113710|81130561|FG000|Overall Study|No Information Available|40|||
27808172|NCT01113710|81130561|FG000|Overall Study|Withdrawal by Subject|28|||
27808173|NCT01113710|81130561|FG000|Overall Study|Lost to Follow-up|20|||
27808174|NCT01113710|81130561|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
27808175|NCT01113710|81130561|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
27808176|NCT01113710|81130561|FG000|Overall Study|Lack of Patient's Compliance|8|||
27808177|NCT01113710|81130561|FG000|Overall Study|Other|7|||
27808178|NCT01113710|81130561|FG000|Overall Study|Adverse Event/Other|5|||
27808179|NCT01113710|81130561|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
27808180|NCT01113710|81130561|FG000|Overall Study|Lack of Efficacy/Other|4|||
27808181|NCT01113710|81130561|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
27808182|NCT01113710|81130561|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
27808183|NCT01113710|81130561|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
27808184|NCT01113710|81130561|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
27808185|NCT01113710|81130561|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
27808186|NCT01113710|81130561|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
27808187|NCT01113710|81130561|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
27808188|NCT01113710|81130561|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
27808189|NCT01113710|81130561|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
27808190|NCT01113710|81130561|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
27808191|NCT01113710|81130561|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
27808192|NCT01113710|81130561|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
27808193|NCT01113710|81130561|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
27808194|NCT01588106|81130562|FG000|Overall Study|Withdrawal by Subject|5|||
27808195|NCT01588106|81130563|FG001|Overall Study|Withdrawal by Subject|4|||
27808196|NCT00472446|81130564|FG000|Overall Study|Protocol Violation|0|||
27808197|NCT00472446|81130565|FG001|Overall Study|Protocol Violation|0|||
27808198|NCT00472446|81130566|FG002|Overall Study|Protocol Violation|0|||
27808199|NCT00472446|81130567|FG003|Overall Study|Protocol Violation|1|||
27808200|NCT00472446|81130564|FG000|Overall Study|Reintervention|0|||
27808201|NCT00472446|81130565|FG001|Overall Study|Reintervention|0|||
27808202|NCT00472446|81130566|FG002|Overall Study|Reintervention|1|||
27808203|NCT00472446|81130567|FG003|Overall Study|Reintervention|1|||
27808204|NCT00472446|81130564|FG000|Overall Study|Questionnaires not returned|5|||
27808205|NCT00472446|81130565|FG001|Overall Study|Questionnaires not returned|6|||
27808206|NCT00472446|81130566|FG002|Overall Study|Questionnaires not returned|6|||
27808207|NCT00472446|81130567|FG003|Overall Study|Questionnaires not returned|4|||
27808208|NCT02139306|81130568|FG000|Overall Study|Withdrawal by Subject|4|||
27808209|NCT02139306|81130569|FG001|Overall Study|Withdrawal by Subject|6|||
27808210|NCT02139306|81130568|FG000|Overall Study|Adverse Event|3|||
27808211|NCT02139306|81130569|FG001|Overall Study|Adverse Event|4|||
27808212|NCT02139306|81130568|FG000|Overall Study|Physician Decision|0|||
27808213|NCT02139306|81130569|FG001|Overall Study|Physician Decision|1|||
27808214|NCT02139306|81130568|FG000|Overall Study|Other Unspecified|2|||
27808215|NCT02139306|81130569|FG001|Overall Study|Other Unspecified|3|||
28004418|NCT02831764|81846434|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
28004419|NCT02831764|81846435|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
28004420|NCT02831764|81846436|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
28004421|NCT02831764|81846437|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
28004422|NCT02831764|81846433|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
28004423|NCT02831764|81846434|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
28004424|NCT02831764|81846435|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
27808216|NCT02139306|81130568|FG000|Overall Study|Protocol Violation|4|||
27808217|NCT02139306|81130569|FG001|Overall Study|Protocol Violation|0|||
27808218|NCT00614055|81130570|FG000|Overall Study|Adverse Event|1|||
27808219|NCT00614055|81130571|FG001|Overall Study|Adverse Event|0|||
27808220|NCT00614055|81130572|FG002|Overall Study|Adverse Event|0|||
27808221|NCT00614055|81130570|FG000|Overall Study|Protocol Violation|2|||
27808222|NCT00614055|81130571|FG001|Overall Study|Protocol Violation|2|||
27808223|NCT00614055|81130572|FG002|Overall Study|Protocol Violation|1|||
27684570|NCT02964325|80683504|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
27808224|NCT00614055|81130570|FG000|Overall Study|Lack of Efficacy|0|||
27808225|NCT00614055|81130571|FG001|Overall Study|Lack of Efficacy|0|||
27808226|NCT00614055|81130572|FG002|Overall Study|Lack of Efficacy|2|||
27808227|NCT00614055|81130570|FG000|Overall Study|Unclassified|1|||
28004425|NCT02831764|81846436|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
27808228|NCT00614055|81130571|FG001|Overall Study|Unclassified|4|||
27808229|NCT00614055|81130572|FG002|Overall Study|Unclassified|2|||
27808230|NCT03567057|81130573|FG000|Overall Study|Adverse Event|56|||
27808231|NCT03567057|81130574|FG001|Overall Study|Adverse Event|53|||
28004426|NCT02831764|81846437|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
28004427|NCT02831764|81846433|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
28004428|NCT02831764|81846434|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
28004429|NCT02831764|81846435|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
28004430|NCT02831764|81846436|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
28004431|NCT02831764|81846437|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
28004432|NCT02831764|81846433|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
28004433|NCT02831764|81846434|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
28004434|NCT02831764|81846435|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
28004435|NCT02831764|81846436|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
28004436|NCT02831764|81846437|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
28004437|NCT02831764|81846433|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
28004438|NCT02831764|81846434|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
28004439|NCT02831764|81846435|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
28004440|NCT02831764|81846436|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
28004441|NCT02831764|81846437|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
28004442|NCT02796677|81846438|FG000|Overall Study|Adverse Event|11|||
28004443|NCT02796677|81846439|FG001|Overall Study|Adverse Event|22|||
28004444|NCT02796677|81846440|FG002|Overall Study|Adverse Event|14|||
28004445|NCT02796677|81846441|FG003|Overall Study|Adverse Event|14|||
28004446|NCT02796677|81846438|FG000|Overall Study|Protocol Violation|7|||
28004447|NCT02796677|81846439|FG001|Overall Study|Protocol Violation|5|||
28004448|NCT02796677|81846440|FG002|Overall Study|Protocol Violation|4|||
28004449|NCT02796677|81846441|FG003|Overall Study|Protocol Violation|8|||
28004450|NCT02796677|81846438|FG000|Overall Study|Lost to Follow-up|1|||
28004451|NCT02796677|81846439|FG001|Overall Study|Lost to Follow-up|5|||
28004452|NCT02796677|81846440|FG002|Overall Study|Lost to Follow-up|2|||
28004453|NCT02796677|81846441|FG003|Overall Study|Lost to Follow-up|2|||
28004454|NCT02796677|81846438|FG000|Overall Study|Lack of Efficacy|7|||
28004455|NCT02796677|81846439|FG001|Overall Study|Lack of Efficacy|9|||
28004456|NCT02796677|81846440|FG002|Overall Study|Lack of Efficacy|14|||
28004457|NCT02796677|81846441|FG003|Overall Study|Lack of Efficacy|20|||
28004458|NCT02796677|81846438|FG000|Overall Study|Withdrawal by Subject|4|||
28004459|NCT02796677|81846439|FG001|Overall Study|Withdrawal by Subject|14|||
28004460|NCT02796677|81846440|FG002|Overall Study|Withdrawal by Subject|6|||
28004461|NCT02796677|81846441|FG003|Overall Study|Withdrawal by Subject|7|||
28004462|NCT02796677|81846438|FG000|Overall Study|Progressive disease|6|||
27684571|NCT02964325|80683505|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
27808232|NCT03567057|81130575|FG002|Overall Study|Adverse Event|28|||
27808233|NCT03567057|81130573|FG000|Overall Study|Withdrawal by Subject|22|||
28004463|NCT02796677|81846439|FG001|Overall Study|Progressive disease|15|||
28004464|NCT02796677|81846440|FG002|Overall Study|Progressive disease|13|||
28004465|NCT02796677|81846441|FG003|Overall Study|Progressive disease|18|||
28004466|NCT02796677|81846438|FG000|Overall Study|Reason not mentioned|2|||
28004467|NCT02796677|81846439|FG001|Overall Study|Reason not mentioned|3|||
28004468|NCT02796677|81846440|FG002|Overall Study|Reason not mentioned|0|||
28004469|NCT02796677|81846441|FG003|Overall Study|Reason not mentioned|5|||
28004470|NCT02366195|81846444|FG000|Overall Study|Protocol-specified criteria|3|||
28004471|NCT02366195|81846444|FG000|Overall Study|Withdrawal by Subject|9|||
28004472|NCT02366195|81846444|FG000|Overall Study|Lost to Follow-up|1|||
28004473|NCT02366195|81846444|FG000|Overall Study|Death|41|||
28004474|NCT02587221|81846447|FG000|Overall Study|Adverse Event|3|||
28004475|NCT02587221|81846448|FG001|Overall Study|Adverse Event|3|||
28004476|NCT02587221|81846447|FG000|Overall Study|Death|33|||
28004477|NCT02587221|81846448|FG001|Overall Study|Death|34|||
27808234|NCT03567057|81130574|FG001|Overall Study|Withdrawal by Subject|24|||
28004478|NCT02587221|81846447|FG000|Overall Study|Withdrawal by Subject|66|||
28004479|NCT02587221|81846448|FG001|Overall Study|Withdrawal by Subject|61|||
28004480|NCT02587221|81846447|FG000|Overall Study|Lost to Follow-up|21|||
28004481|NCT02587221|81846448|FG001|Overall Study|Lost to Follow-up|19|||
28004482|NCT02587221|81846447|FG000|Overall Study|Protocol Violation|6|||
27808235|NCT03567057|81130575|FG002|Overall Study|Withdrawal by Subject|13|||
27808236|NCT03567057|81130573|FG000|Overall Study|Lost to Follow-up|3|||
27808237|NCT03567057|81130574|FG001|Overall Study|Lost to Follow-up|5|||
27808238|NCT03567057|81130575|FG002|Overall Study|Lost to Follow-up|2|||
27808239|NCT03567057|81130573|FG000|Overall Study|COVID-19 pandemic|4|||
27808240|NCT03567057|81130574|FG001|Overall Study|COVID-19 pandemic|3|||
27808241|NCT03567057|81130575|FG002|Overall Study|COVID-19 pandemic|0|||
27808242|NCT03567057|81130573|FG000|Overall Study|Non-compliance with study drug|4|||
27808243|NCT03567057|81130574|FG001|Overall Study|Non-compliance with study drug|2|||
27808244|NCT03567057|81130575|FG002|Overall Study|Non-compliance with study drug|0|||
27808245|NCT03567057|81130573|FG000|Overall Study|Lack of Efficacy|3|||
27808246|NCT03567057|81130574|FG001|Overall Study|Lack of Efficacy|0|||
27808247|NCT03567057|81130575|FG002|Overall Study|Lack of Efficacy|1|||
27808248|NCT03567057|81130573|FG000|Overall Study|Death|1|||
27808249|NCT03567057|81130574|FG001|Overall Study|Death|0|||
27808250|NCT03567057|81130575|FG002|Overall Study|Death|0|||
27808251|NCT03567057|81130573|FG000|Overall Study|Physician Decision|1|||
27808252|NCT03567057|81130574|FG001|Overall Study|Physician Decision|0|||
27808253|NCT03567057|81130575|FG002|Overall Study|Physician Decision|0|||
27808254|NCT03567057|81130573|FG000|Overall Study|Unstable medical condition|1|||
27808255|NCT03567057|81130574|FG001|Overall Study|Unstable medical condition|0|||
27808256|NCT03567057|81130575|FG002|Overall Study|Unstable medical condition|0|||
27808257|NCT03567057|81130573|FG000|Overall Study|Medical history event|0|||
27808258|NCT03567057|81130574|FG001|Overall Study|Medical history event|0|||
27808259|NCT03567057|81130575|FG002|Overall Study|Medical history event|1|||
27808260|NCT03567057|81130573|FG000|Overall Study|Other|0|||
27808261|NCT03567057|81130574|FG001|Overall Study|Other|0|||
27808262|NCT03567057|81130575|FG002|Overall Study|Other|1|||
27808263|NCT02260492|81130576|FG000|Overall Study|Adverse Event|6|||
27808264|NCT02260492|81130577|FG001|Overall Study|Adverse Event|1|||
27808265|NCT02260492|81130578|FG002|Overall Study|Adverse Event|2|||
27808266|NCT02260492|81130576|FG000|Overall Study|Death|0|||
27808267|NCT02260492|81130577|FG001|Overall Study|Death|1|||
27808268|NCT02260492|81130578|FG002|Overall Study|Death|0|||
27808269|NCT02260492|81130576|FG000|Overall Study|Lost to Follow-up|12|||
27808270|NCT02260492|81130577|FG001|Overall Study|Lost to Follow-up|9|||
27808271|NCT02260492|81130578|FG002|Overall Study|Lost to Follow-up|0|||
27808272|NCT02260492|81130576|FG000|Overall Study|Physician Decision|2|||
27808273|NCT02260492|81130577|FG001|Overall Study|Physician Decision|0|||
27808274|NCT02260492|81130578|FG002|Overall Study|Physician Decision|1|||
27808275|NCT02260492|81130576|FG000|Overall Study|Withdrawal by Subject|3|||
28004483|NCT02587221|81846448|FG001|Overall Study|Protocol Violation|5|||
28004484|NCT02587221|81846447|FG000|Overall Study|Other Reason or Unspecified|2|||
28004485|NCT02587221|81846448|FG001|Overall Study|Other Reason or Unspecified|1|||
28004486|NCT03811340|81846449|FG000|Overall Study|subjects did not complete the survey.|90|||
28004487|NCT00216671|81846450|FG000|Overall Study|Adverse Event|4|||
28004488|NCT00216671|81846451|FG001|Overall Study|Adverse Event|9|||
28004489|NCT00216671|81846450|FG000|Overall Study|Pregnancy|0|||
28004490|NCT00216671|81846451|FG001|Overall Study|Pregnancy|1|||
28004491|NCT00216671|81846450|FG000|Overall Study|Withdrawal by Subject|4|||
28004492|NCT00216671|81846451|FG001|Overall Study|Withdrawal by Subject|2|||
28004493|NCT00216671|81846450|FG000|Overall Study|Refused Injections|3|||
27874305|NCT01777282|81371704|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
27874306|NCT01777282|81371705|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
27874307|NCT01777282|81371706|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
27874308|NCT01753570|81371711|FG000|Overall Study|Adverse Event|1|||
27874309|NCT01753570|81371712|FG001|Overall Study|Adverse Event|0|||
27874310|NCT01753570|81371713|FG002|Overall Study|Adverse Event|1|||
27874311|NCT01753570|81371711|FG000|Overall Study|Physician Decision|0|||
27874312|NCT01753570|81371712|FG001|Overall Study|Physician Decision|1|||
27874313|NCT01753570|81371713|FG002|Overall Study|Physician Decision|0|||
27874314|NCT01753570|81371711|FG000|Overall Study|Withdrawal by Subject|1|||
27874315|NCT01753570|81371712|FG001|Overall Study|Withdrawal by Subject|4|||
27874316|NCT01753570|81371713|FG002|Overall Study|Withdrawal by Subject|0|||
27874317|NCT04123405|81371720|FG000|Overall Study|Adverse Event|1|||
27874318|NCT04123405|81371721|FG001|Overall Study|Adverse Event|2|||
27874319|NCT04123405|81371722|FG002|Overall Study|Adverse Event|3|||
27874320|NCT04123405|81371723|FG003|Overall Study|Adverse Event|3|||
27874321|NCT04123405|81371720|FG000|Overall Study|Exclusion criteria met|1|||
27874322|NCT04123405|81371721|FG001|Overall Study|Exclusion criteria met|2|||
27874323|NCT04123405|81371722|FG002|Overall Study|Exclusion criteria met|0|||
27874324|NCT04123405|81371723|FG003|Overall Study|Exclusion criteria met|2|||
27874325|NCT04123405|81371720|FG000|Overall Study|Withdrawal by Subject|1|||
27874326|NCT04123405|81371721|FG001|Overall Study|Withdrawal by Subject|3|||
27874327|NCT04123405|81371722|FG002|Overall Study|Withdrawal by Subject|0|||
27874328|NCT04123405|81371723|FG003|Overall Study|Withdrawal by Subject|2|||
27874329|NCT04123405|81371720|FG000|Overall Study|Contact to subject lost|0|||
27808276|NCT02260492|81130577|FG001|Overall Study|Withdrawal by Subject|2|||
27808277|NCT02260492|81130578|FG002|Overall Study|Withdrawal by Subject|2|||
27808278|NCT02444533|81130579|FG000|Overall Study|Not able to complete forms|0|||
27808279|NCT02444533|81130580|FG001|Overall Study|Not able to complete forms|2|||
27808280|NCT02444533|81130579|FG000|Overall Study|Only gave post-procedure complications|2|||
27808281|NCT02444533|81130580|FG001|Overall Study|Only gave post-procedure complications|2|||
27874330|NCT04123405|81371721|FG001|Overall Study|Contact to subject lost|0|||
27874331|NCT04123405|81371722|FG002|Overall Study|Contact to subject lost|0|||
28004494|NCT00216671|81846451|FG001|Overall Study|Refused Injections|13|||
28004495|NCT00216671|81846450|FG000|Overall Study|No Need to Continue Medication|1|||
28004496|NCT00216671|81846451|FG001|Overall Study|No Need to Continue Medication|1|||
28004497|NCT00216671|81846450|FG000|Overall Study|Insufficient Response|9|||
28004498|NCT00216671|81846451|FG001|Overall Study|Insufficient Response|4|||
28004499|NCT00216671|81846450|FG000|Overall Study|Lost to Follow-up|3|||
28004500|NCT00216671|81846451|FG001|Overall Study|Lost to Follow-up|5|||
28004501|NCT00216671|81846450|FG000|Overall Study|Non compliant|2|||
28004502|NCT00216671|81846451|FG001|Overall Study|Non compliant|2|||
28004503|NCT00216671|81846450|FG000|Overall Study|Ineligible|0|||
28004504|NCT00216671|81846451|FG001|Overall Study|Ineligible|2|||
28004505|NCT00216671|81846450|FG000|Overall Study|Physician Decision|1|||
28004506|NCT00216671|81846451|FG001|Overall Study|Physician Decision|1|||
27808282|NCT02611752|81130583|FG000|Overall Study|Adverse Event|0|||
27874332|NCT04123405|81371723|FG003|Overall Study|Contact to subject lost|1|||
27874333|NCT04123405|81371720|FG000|Overall Study|screening failure|1|||
27874334|NCT04123405|81371721|FG001|Overall Study|screening failure|0|||
28004507|NCT00216671|81846450|FG000|Overall Study|Protocol Violation|3|||
28004508|NCT00216671|81846451|FG001|Overall Study|Protocol Violation|5|||
28004509|NCT00216671|81846450|FG000|Overall Study|Relapse|1|||
28004510|NCT00216671|81846451|FG001|Overall Study|Relapse|0|||
28004511|NCT00216671|81846450|FG000|Overall Study|Investigator Illness|0|||
28004512|NCT00216671|81846451|FG001|Overall Study|Investigator Illness|1|||
28004513|NCT00216671|81846450|FG000|Overall Study|Patient Moved|0|||
28004514|NCT00216671|81846451|FG001|Overall Study|Patient Moved|1|||
28004515|NCT00216671|81846450|FG000|Overall Study|Ineligible, no efficacy data|2|||
27808283|NCT02611752|81130584|FG001|Overall Study|Adverse Event|1|||
27808284|NCT01626885|81130588|FG000|Overall Study|Adverse Event|8|||
27808285|NCT01626885|81130588|FG000|Overall Study|Withdrawal by Subject|4|||
27808286|NCT02110706|81130589|FG000|Overall Study|Adverse Event|2|||
27808287|NCT02110706|81130590|FG001|Overall Study|Adverse Event|3|||
27808288|NCT02110706|81130589|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
27874335|NCT04123405|81371722|FG002|Overall Study|screening failure|0|||
27874336|NCT04123405|81371723|FG003|Overall Study|screening failure|0|||
27874337|NCT02287922|81371726|FG000|Overall Study|Adverse Event|1|||
27874338|NCT02287922|81371727|FG001|Overall Study|Adverse Event|1|||
27874339|NCT02287922|81371728|FG002|Overall Study|Adverse Event|3|||
27874340|NCT02287922|81371729|FG003|Overall Study|Adverse Event|4|||
27874341|NCT02287922|81371726|FG000|Overall Study|Withdrawal by Subject|1|||
27874342|NCT02287922|81371727|FG001|Overall Study|Withdrawal by Subject|1|||
27808289|NCT02110706|81130590|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
27874343|NCT02287922|81371728|FG002|Overall Study|Withdrawal by Subject|1|||
28004516|NCT00216671|81846451|FG001|Overall Study|Ineligible, no efficacy data|2|||
27584757|NCT01312909|80322008|FG001|Overall Study|Lost to Follow-up|17|||
27584758|NCT01312909|80322009|FG002|Overall Study|Lost to Follow-up|20|||
27584759|NCT01312909|80322007|FG000|Overall Study|Insufficient clinical response|0|||
27584760|NCT01312909|80322008|FG001|Overall Study|Insufficient clinical response|0|||
27584761|NCT01312909|80322009|FG002|Overall Study|Insufficient clinical response|1|||
27584762|NCT01312909|80322007|FG000|Overall Study|Entrance criteria not met|0|||
27584763|NCT01312909|80322008|FG001|Overall Study|Entrance criteria not met|0|||
27584764|NCT01312909|80322009|FG002|Overall Study|Entrance criteria not met|2|||
27584765|NCT01925183|80322010|FG000|Overall Study|Adverse Event|1|||
27584766|NCT01925183|80322011|FG001|Overall Study|Adverse Event|0|||
27584767|NCT02866682|80322016|FG000|Overall Study|Death|0|||
27584768|NCT02866682|80322017|FG001|Overall Study|Death|1|||
27584769|NCT02866682|80322016|FG000|Overall Study|Lost to Follow-up|0|||
27584770|NCT02866682|80322017|FG001|Overall Study|Lost to Follow-up|4|||
27584771|NCT02866682|80322016|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
27808290|NCT01294592|81130591|FG000|Overall Study|Adverse Event|28|||
27808291|NCT01294592|81130592|FG001|Overall Study|Adverse Event|13|||
27808292|NCT01294592|81130591|FG000|Overall Study|Lack of Efficacy|7|||
27808293|NCT01294592|81130592|FG001|Overall Study|Lack of Efficacy|5|||
27808294|NCT01294592|81130591|FG000|Overall Study|Protocol Violation|1|||
27808295|NCT01294592|81130592|FG001|Overall Study|Protocol Violation|7|||
27808296|NCT01294592|81130591|FG000|Overall Study|Lost to Follow-up|7|||
27808297|NCT01294592|81130592|FG001|Overall Study|Lost to Follow-up|9|||
27808298|NCT01294592|81130591|FG000|Overall Study|Physician Decision|6|||
27808299|NCT01294592|81130592|FG001|Overall Study|Physician Decision|11|||
27808300|NCT01294592|81130591|FG000|Overall Study|Withdrawal by Subject|28|||
27808301|NCT01294592|81130592|FG001|Overall Study|Withdrawal by Subject|28|||
27808302|NCT00310856|81130593|FG000|Overall Study|Withdrawal by Subject|2|||
27808303|NCT00310856|81130594|FG001|Overall Study|Withdrawal by Subject|2|||
27808304|NCT00310856|81130595|FG002|Overall Study|Withdrawal by Subject|2|||
27808305|NCT00310856|81130593|FG000|Overall Study|Lost to Follow-up|1|||
27808306|NCT00310856|81130594|FG001|Overall Study|Lost to Follow-up|2|||
27808307|NCT00310856|81130595|FG002|Overall Study|Lost to Follow-up|6|||
27808308|NCT00310856|81130593|FG000|Overall Study|Inappropriate enrollment|1|||
27808309|NCT00310856|81130594|FG001|Overall Study|Inappropriate enrollment|1|||
27808310|NCT00310856|81130595|FG002|Overall Study|Inappropriate enrollment|0|||
27808311|NCT00310856|81130593|FG000|Overall Study|Unable to classify|1|||
27808312|NCT00310856|81130594|FG001|Overall Study|Unable to classify|0|||
27808313|NCT00310856|81130595|FG002|Overall Study|Unable to classify|0|||
27808314|NCT03349333|81130596|FG000|Overall Study|Progression of Disease|36|||
27808315|NCT03349333|81130596|FG000|Overall Study|Adverse Event|11|||
28004517|NCT00216671|81846450|FG000|Overall Study|Insufficient Response Adverse Event|2|||
28004518|NCT00216671|81846451|FG001|Overall Study|Insufficient Response Adverse Event|1|||
28004519|NCT02285855|81846454|FG000|Overall Study|Withdrawal by Subject|2|||
28004520|NCT02285855|81846455|FG001|Overall Study|Withdrawal by Subject|1|||
28004521|NCT02552966|81846456|FG000|Overall Study|Lost to Follow-up|2|||
28004522|NCT02552966|81846456|FG000|Overall Study|Withdrawal by Subject|3|||
27808316|NCT03349333|81130596|FG000|Overall Study|Other|6|||
27808317|NCT03349333|81130596|FG000|Overall Study|Withdrawal by Subject|5|||
27808318|NCT03349333|81130596|FG000|Overall Study|Conditions interfere with participation|2|||
27808319|NCT03349333|81130596|FG000|Overall Study|Physician Decision|2|||
28004523|NCT02525471|81846457|FG000|Overall Study|Screen Failure|6|||
28004524|NCT02525471|81846457|FG000|Overall Study|Withdrawal by Subject|4|||
28004525|NCT02525471|81846457|FG000|Overall Study|Death|1|||
28004526|NCT03261336|81846458|FG000|Overall Study|Adverse Event|1|||
28004527|NCT02914639|81846459|FG000|Overall Study|Withdrawal by Subject|0|||
27584772|NCT02866682|80322017|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
27584773|NCT02866682|80322016|FG000|Overall Study|Other|0|||
27584774|NCT02866682|80322017|FG001|Overall Study|Other|1|||
27808320|NCT03349333|81130596|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
27808321|NCT03349333|81130596|FG000|Overall Study|Patients in treatment less than 24 month|8|||
28004528|NCT02914639|81846460|FG001|Overall Study|Withdrawal by Subject|2|||
28004529|NCT02051764|81846461|FG000|Overall Study|Study terminated by sponsor|0|||
28004530|NCT02051764|81846462|FG001|Overall Study|Study terminated by sponsor|7|||
28004531|NCT02314052|81846466|FG000|Cycle One|Adverse Event|0|||
28004532|NCT02314052|81846467|FG001|Cycle One|Adverse Event|0|||
28004533|NCT02314052|81846468|FG002|Cycle One|Adverse Event|0|||
27584775|NCT00432380|80322020|FG000|Overall Study|Migrated/moved from study area|3|||
27808322|NCT01452529|81130597|FG000|Run-in Period|Adverse Event|96|||
27584776|NCT00432380|80322021|FG001|Overall Study|Migrated/moved from study area|4|||
27808323|NCT01452529|81130598|FG001|Run-in Period|Adverse Event|0|||
27808324|NCT01452529|81130599|FG002|Run-in Period|Adverse Event|0|||
27808325|NCT01452529|81130597|FG000|Run-in Period|Withdrawal by Subject|49|||
27808326|NCT01452529|81130598|FG001|Run-in Period|Withdrawal by Subject|0|||
28004534|NCT02314052|81846469|FG003|Cycle One|Adverse Event|1|||
28004535|NCT02314052|81846470|FG004|Cycle One|Adverse Event|0|||
28004536|NCT02314052|81846471|FG005|Cycle One|Adverse Event|0|||
27874344|NCT02287922|81371729|FG003|Overall Study|Withdrawal by Subject|2|||
27874345|NCT02287922|81371726|FG000|Overall Study|Lost to Follow-up|0|||
27874346|NCT02287922|81371727|FG001|Overall Study|Lost to Follow-up|0|||
27874347|NCT02287922|81371728|FG002|Overall Study|Lost to Follow-up|1|||
27874348|NCT02287922|81371729|FG003|Overall Study|Lost to Follow-up|0|||
27874349|NCT02287922|81371726|FG000|Overall Study|Sponsor's decision|0|||
27874350|NCT02287922|81371727|FG001|Overall Study|Sponsor's decision|0|||
27874351|NCT02287922|81371728|FG002|Overall Study|Sponsor's decision|0|||
27874352|NCT02287922|81371729|FG003|Overall Study|Sponsor's decision|1|||
27874353|NCT02287922|81371726|FG000|Overall Study|Other|1|||
27874354|NCT02287922|81371727|FG001|Overall Study|Other|0|||
27874355|NCT02287922|81371728|FG002|Overall Study|Other|2|||
27874356|NCT02287922|81371729|FG003|Overall Study|Other|0|||
27874357|NCT03896022|81371735|FG000|Overall Study|Withdrawal by Subject|1|||
27874358|NCT03896022|81371736|FG001|Overall Study|Withdrawal by Subject|0|||
27874359|NCT03896022|81371737|FG002|Overall Study|Withdrawal by Subject|0|||
27874360|NCT03896022|81371735|FG000|Overall Study|Did not have procedure|3|||
27874361|NCT03896022|81371736|FG001|Overall Study|Did not have procedure|0|||
27874362|NCT03896022|81371737|FG002|Overall Study|Did not have procedure|0|||
27874363|NCT00979654|81371738|FG000|Overall Study|Lost to Follow-up|1|||
27874364|NCT00979654|81371738|FG000|Overall Study|Withdrawal by Subject|22|||
27874365|NCT00979654|81371738|FG000|Overall Study|Death|1|||
27874366|NCT00979654|81371738|FG000|Overall Study|Lack of Efficacy|6|||
27874367|NCT00979654|81371738|FG000|Overall Study|Adverse Event|1|||
27874368|NCT00979654|81371738|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
27874369|NCT00979654|81371738|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
27874370|NCT00979654|81371738|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
27808327|NCT01452529|81130599|FG002|Run-in Period|Withdrawal by Subject|0|||
27874371|NCT00979654|81371738|FG000|Overall Study|Serious Adverse Event|1|||
27874372|NCT00979654|81371738|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
27808328|NCT01452529|81130597|FG000|Run-in Period|Lost to Follow-up|19|||
27808329|NCT01452529|81130598|FG001|Run-in Period|Lost to Follow-up|0|||
27808330|NCT01452529|81130599|FG002|Run-in Period|Lost to Follow-up|0|||
27808331|NCT01452529|81130597|FG000|Run-in Period|Lack of Efficacy|46|||
27808332|NCT01452529|81130598|FG001|Run-in Period|Lack of Efficacy|0|||
27808333|NCT01452529|81130599|FG002|Run-in Period|Lack of Efficacy|0|||
27808334|NCT01452529|81130597|FG000|Run-in Period|Confirmed or suspected diversion|23|||
27808335|NCT01452529|81130598|FG001|Run-in Period|Confirmed or suspected diversion|0|||
27808336|NCT01452529|81130599|FG002|Run-in Period|Confirmed or suspected diversion|0|||
27808337|NCT01452529|81130597|FG000|Run-in Period|Administrative|21|||
27808338|NCT01452529|81130598|FG001|Run-in Period|Administrative|0|||
27808339|NCT01452529|81130599|FG002|Run-in Period|Administrative|0|||
27808340|NCT01452529|81130597|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
27808341|NCT01452529|81130598|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
27808342|NCT01452529|81130599|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
27808343|NCT01452529|81130597|FG000|Double-blind (DB) Period|Adverse Event|0|||
27808344|NCT01452529|81130598|FG001|Double-blind (DB) Period|Adverse Event|18|||
27808345|NCT01452529|81130599|FG002|Double-blind (DB) Period|Adverse Event|11|||
27808346|NCT01452529|81130597|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
27808347|NCT01452529|81130598|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
27808348|NCT01452529|81130599|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
27808349|NCT01452529|81130597|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
27808350|NCT01452529|81130598|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
27808351|NCT01452529|81130599|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
27808352|NCT01452529|81130597|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
27808353|NCT01452529|81130598|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
27808354|NCT01452529|81130599|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
27808355|NCT01452529|81130597|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
27874373|NCT02291237|81371739|FG000|Overall Study|Study Terminated by Sponsor|72|||
27584777|NCT00432380|80322022|FG002|Overall Study|Migrated/moved from study area|1|||
27584778|NCT00432380|80322020|FG000|Overall Study|Adverse Event|1|||
27808356|NCT01452529|81130598|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
27874374|NCT02291237|81371740|FG001|Overall Study|Study Terminated by Sponsor|67|||
27874375|NCT02291237|81371739|FG000|Overall Study|Adverse Event|1|||
27584779|NCT00432380|80322021|FG001|Overall Study|Adverse Event|0|||
27808357|NCT01452529|81130599|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
27808358|NCT01452529|81130597|FG000|Double-blind (DB) Period|Administrative|0|||
27874376|NCT02291237|81371740|FG001|Overall Study|Adverse Event|3|||
27874377|NCT02291237|81371739|FG000|Overall Study|Investigator's Discretion|0|||
27874378|NCT02291237|81371740|FG001|Overall Study|Investigator's Discretion|3|||
27874379|NCT02291237|81371739|FG000|Overall Study|Withdrew Consent|11|||
27874380|NCT02291237|81371740|FG001|Overall Study|Withdrew Consent|11|||
27874381|NCT02291237|81371739|FG000|Overall Study|Lost to Follow-up|0|||
27874382|NCT02291237|81371740|FG001|Overall Study|Lost to Follow-up|2|||
27874383|NCT02291237|81371739|FG000|Overall Study|Subject Required Prohibited Medication|2|||
28004537|NCT02735239|81846472|FG000|Overall Study|Adverse Event|0|||
28004538|NCT02735239|81846473|FG001|Overall Study|Adverse Event|0|||
28004539|NCT02735239|81846474|FG002|Overall Study|Adverse Event|4|||
28004540|NCT02735239|81846475|FG003|Overall Study|Adverse Event|0|||
28004541|NCT02735239|81846476|FG004|Overall Study|Adverse Event|0|||
28004542|NCT02735239|81846477|FG005|Overall Study|Adverse Event|0|||
28004543|NCT02735239|81846472|FG000|Overall Study|Death|1|||
28004544|NCT02735239|81846473|FG001|Overall Study|Death|1|||
28004545|NCT02735239|81846474|FG002|Overall Study|Death|0|||
28004546|NCT02735239|81846475|FG003|Overall Study|Death|0|||
28004547|NCT02735239|81846476|FG004|Overall Study|Death|0|||
28004548|NCT02735239|81846477|FG005|Overall Study|Death|0|||
28004549|NCT02735239|81846472|FG000|Overall Study|Physician Decision|0|||
28004550|NCT02735239|81846473|FG001|Overall Study|Physician Decision|0|||
28004551|NCT02735239|81846474|FG002|Overall Study|Physician Decision|1|||
28004552|NCT02735239|81846475|FG003|Overall Study|Physician Decision|0|||
28004553|NCT02735239|81846476|FG004|Overall Study|Physician Decision|0|||
28004554|NCT02735239|81846477|FG005|Overall Study|Physician Decision|0|||
28004555|NCT02735239|81846472|FG000|Overall Study|Progressive disease|3|||
28004556|NCT02735239|81846473|FG001|Overall Study|Progressive disease|1|||
28004557|NCT02735239|81846474|FG002|Overall Study|Progressive disease|3|||
28004558|NCT02735239|81846475|FG003|Overall Study|Progressive disease|0|||
28004559|NCT02735239|81846476|FG004|Overall Study|Progressive disease|0|||
28004560|NCT02735239|81846477|FG005|Overall Study|Progressive disease|2|||
28004561|NCT02735239|81846472|FG000|Overall Study|Withdrawal by Subject|0|||
28004562|NCT02735239|81846473|FG001|Overall Study|Withdrawal by Subject|1|||
28004563|NCT02735239|81846474|FG002|Overall Study|Withdrawal by Subject|0|||
28004564|NCT02735239|81846475|FG003|Overall Study|Withdrawal by Subject|0|||
28004565|NCT02735239|81846476|FG004|Overall Study|Withdrawal by Subject|0|||
28004566|NCT02735239|81846477|FG005|Overall Study|Withdrawal by Subject|0|||
28004567|NCT01506271|81846478|FG000|Overall Study|Progressive disease|0|||
28004568|NCT01506271|81846479|FG001|Overall Study|Progressive disease|1|||
28004569|NCT01506271|81846480|FG002|Overall Study|Progressive disease|0|||
28004570|NCT01506271|81846478|FG000|Overall Study|Protocol Violation|3|||
28004571|NCT01506271|81846479|FG001|Overall Study|Protocol Violation|1|||
28004572|NCT01506271|81846480|FG002|Overall Study|Protocol Violation|0|||
28004573|NCT01506271|81846478|FG000|Overall Study|Death|0|||
28004574|NCT01506271|81846479|FG001|Overall Study|Death|1|||
28004575|NCT01506271|81846480|FG002|Overall Study|Death|0|||
28004576|NCT01506271|81846478|FG000|Overall Study|Adverse Event|0|||
28004577|NCT01506271|81846479|FG001|Overall Study|Adverse Event|2|||
28004578|NCT01506271|81846480|FG002|Overall Study|Adverse Event|0|||
28004579|NCT01506271|81846478|FG000|Overall Study|Insufficient supply of study drug|1|||
28004580|NCT01506271|81846479|FG001|Overall Study|Insufficient supply of study drug|0|||
28004581|NCT01506271|81846480|FG002|Overall Study|Insufficient supply of study drug|0|||
28004582|NCT01506271|81846478|FG000|Overall Study|Withdrawal by Subject|0|||
28004583|NCT01506271|81846479|FG001|Overall Study|Withdrawal by Subject|1|||
28004584|NCT01506271|81846480|FG002|Overall Study|Withdrawal by Subject|1|||
28004585|NCT01506271|81846478|FG000|Overall Study|Lost to Follow-up|0|||
28004586|NCT01506271|81846479|FG001|Overall Study|Lost to Follow-up|1|||
27584780|NCT00432380|80322022|FG002|Overall Study|Adverse Event|0|||
27584781|NCT00572572|80322026|FG000|Overall Study|Withdrawal by Subject|3|||
27808359|NCT01452529|81130598|FG001|Double-blind (DB) Period|Administrative|11|||
27808360|NCT01452529|81130599|FG002|Double-blind (DB) Period|Administrative|7|||
27808361|NCT02040428|81130600|FG000|Overall Study|Death|4|||
27808362|NCT02040428|81130601|FG001|Overall Study|Death|3|||
27808363|NCT02040428|81130600|FG000|Overall Study|Withdrawal by Subject|1|||
27808364|NCT02040428|81130601|FG001|Overall Study|Withdrawal by Subject|1|||
27808365|NCT02268045|81130602|FG000|Overall Study|Death|4|||
27808366|NCT02268045|81130603|FG001|Overall Study|Death|4|||
27808367|NCT02268045|81130602|FG000|Overall Study|Disease Progression|2|||
27874384|NCT02291237|81371740|FG001|Overall Study|Subject Required Prohibited Medication|0|||
27874385|NCT00586703|81371741|FG000|Overall Study|Death|12|||
27808368|NCT02268045|81130603|FG001|Overall Study|Disease Progression|1|||
27808369|NCT02268045|81130602|FG000|Overall Study|Adverse Event|7|||
27874386|NCT00470470|81371742|FG000|Overall Study|Adverse Event|2|||
28004587|NCT01506271|81846480|FG002|Overall Study|Lost to Follow-up|2|||
28004588|NCT00468299|81846485|FG000|Overall Study|Withdrawal by Subject|0|||
28004589|NCT00468299|81846486|FG001|Overall Study|Withdrawal by Subject|1|||
28004590|NCT03367858|81846487|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
28004591|NCT03367858|81846488|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
28004592|NCT03367858|81846487|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
28004593|NCT03367858|81846488|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
28004594|NCT03367858|81846487|FG000|3 Month Follow Up|Lost to Follow-up|8|||
28004595|NCT03367858|81846488|FG001|3 Month Follow Up|Lost to Follow-up|3|||
28004596|NCT03367858|81846487|FG000|3 Month Follow Up|Moved out of study area|2|||
28004597|NCT03367858|81846488|FG001|3 Month Follow Up|Moved out of study area|6|||
28004598|NCT03367858|81846487|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
27808370|NCT02268045|81130603|FG001|Overall Study|Adverse Event|7|||
27808371|NCT02268045|81130602|FG000|Overall Study|Withdrawal by Subject|2|||
27808372|NCT02268045|81130603|FG001|Overall Study|Withdrawal by Subject|6|||
27808373|NCT02268045|81130602|FG000|Overall Study|Physician Decision|0|||
27808374|NCT02268045|81130603|FG001|Overall Study|Physician Decision|1|||
27808375|NCT02268045|81130602|FG000|Overall Study|Protocol Violation|1|||
27808376|NCT02268045|81130603|FG001|Overall Study|Protocol Violation|1|||
27808377|NCT02140164|81130604|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
27808378|NCT01223196|81130605|FG000|Overall Study|Lost to Follow-up|2|||
27808379|NCT01223196|81130606|FG001|Overall Study|Lost to Follow-up|0|||
27808380|NCT01223196|81130605|FG000|Overall Study|Physician Decision|1|||
27808381|NCT01223196|81130606|FG001|Overall Study|Physician Decision|0|||
27808382|NCT01223196|81130605|FG000|Overall Study|Withdrawal by Subject|1|||
27808383|NCT01223196|81130606|FG001|Overall Study|Withdrawal by Subject|0|||
27808384|NCT03549130|81130609|FG000|Overall Study|Adverse Event|0|||
27808385|NCT03549130|81130610|FG001|Overall Study|Adverse Event|1|||
27808386|NCT03549130|81130609|FG000|Overall Study|Lost to Follow-up|0|||
27808387|NCT03549130|81130610|FG001|Overall Study|Lost to Follow-up|1|||
27808388|NCT00410410|81130615|FG000|Induction Period (IP)|Death|1|||
27808389|NCT00410410|81130616|FG001|Induction Period (IP)|Death|0|||
27808390|NCT00410410|81130617|FG002|Induction Period (IP)|Death|0|||
27808391|NCT00410410|81130618|FG003|Induction Period (IP)|Death|0|||
27808392|NCT00410410|81130619|FG004|Induction Period (IP)|Death|0|||
27808393|NCT00410410|81130620|FG005|Induction Period (IP)|Death|0|||
27808394|NCT00410410|81130621|FG006|Induction Period (IP)|Death|0|||
27808395|NCT00410410|81130622|FG007|Induction Period (IP)|Death|0|||
27808396|NCT00410410|81130623|FG008|Induction Period (IP)|Death|0|||
27808397|NCT00410410|81130615|FG000|Induction Period (IP)|Adverse Event|3|||
27808398|NCT00410410|81130616|FG001|Induction Period (IP)|Adverse Event|4|||
27808399|NCT00410410|81130617|FG002|Induction Period (IP)|Adverse Event|2|||
27808400|NCT00410410|81130618|FG003|Induction Period (IP)|Adverse Event|4|||
27808401|NCT00410410|81130619|FG004|Induction Period (IP)|Adverse Event|1|||
27808402|NCT00410410|81130620|FG005|Induction Period (IP)|Adverse Event|0|||
27808403|NCT00410410|81130621|FG006|Induction Period (IP)|Adverse Event|0|||
27808404|NCT00410410|81130622|FG007|Induction Period (IP)|Adverse Event|0|||
27808405|NCT00410410|81130623|FG008|Induction Period (IP)|Adverse Event|0|||
27808406|NCT00410410|81130615|FG000|Induction Period (IP)|Lack of Efficacy|26|||
27808407|NCT00410410|81130616|FG001|Induction Period (IP)|Lack of Efficacy|24|||
27808408|NCT00410410|81130617|FG002|Induction Period (IP)|Lack of Efficacy|8|||
27808409|NCT00410410|81130618|FG003|Induction Period (IP)|Lack of Efficacy|8|||
27808410|NCT00410410|81130619|FG004|Induction Period (IP)|Lack of Efficacy|7|||
27808411|NCT00410410|81130620|FG005|Induction Period (IP)|Lack of Efficacy|7|||
27808412|NCT00410410|81130621|FG006|Induction Period (IP)|Lack of Efficacy|0|||
27808413|NCT00410410|81130622|FG007|Induction Period (IP)|Lack of Efficacy|0|||
27808414|NCT00410410|81130623|FG008|Induction Period (IP)|Lack of Efficacy|0|||
27584782|NCT00572572|80322027|FG001|Overall Study|Withdrawal by Subject|6|||
27584783|NCT01617629|80322028|FG000|Overall Study|Death|2|||
27584784|NCT01617629|80322028|FG000|Overall Study|Investigator's Clinical Judgement|1|||
27584785|NCT01617629|80322028|FG000|Overall Study|Reason Not Specified|1|||
27584786|NCT01617629|80322028|FG000|Overall Study|Participant Withdrew Consent|2|||
27584787|NCT04443218|80322029|FG000|Overall Study|Exited study for other reasons|9|||
27584788|NCT04443218|80322029|FG000|Overall Study|Withdrawal by Subject|1|||
27584789|NCT04443218|80322029|FG000|Overall Study|Lost to Follow-up|4|||
27584790|NCT04443218|80322029|FG000|Overall Study|Death|19|||
27584791|NCT00932893|80322032|FG000|Overall Study|Death|115|||
27584792|NCT00932893|80322033|FG001|Overall Study|Death|24|||
27584793|NCT00932893|80322032|FG000|Overall Study|Lost to Follow-up|8|||
27584794|NCT00932893|80322033|FG001|Overall Study|Lost to Follow-up|0|||
27584795|NCT00932893|80322032|FG000|Overall Study|Withdrawal by Subject|5|||
27584796|NCT00932893|80322033|FG001|Overall Study|Withdrawal by Subject|2|||
27584797|NCT00932893|80322032|FG000|Overall Study|Other|5|||
27808415|NCT00410410|81130615|FG000|Induction Period (IP)|Lost to Follow-up|2|||
27808416|NCT00410410|81130616|FG001|Induction Period (IP)|Lost to Follow-up|2|||
27808417|NCT00410410|81130617|FG002|Induction Period (IP)|Lost to Follow-up|2|||
27808418|NCT00410410|81130618|FG003|Induction Period (IP)|Lost to Follow-up|3|||
27808419|NCT00410410|81130619|FG004|Induction Period (IP)|Lost to Follow-up|0|||
27808420|NCT00410410|81130620|FG005|Induction Period (IP)|Lost to Follow-up|1|||
27808421|NCT00410410|81130621|FG006|Induction Period (IP)|Lost to Follow-up|0|||
27808422|NCT00410410|81130622|FG007|Induction Period (IP)|Lost to Follow-up|0|||
28004599|NCT03367858|81846488|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
27584798|NCT00932893|80322033|FG001|Overall Study|Other|144|||
27584799|NCT00129987|80322034|FG000|1st Educational Session|Withdrawal by Subject|141|||
27584800|NCT00129987|80322035|FG001|1st Educational Session|Withdrawal by Subject|109|||
27808423|NCT00410410|81130623|FG008|Induction Period (IP)|Lost to Follow-up|0|||
27808424|NCT00410410|81130615|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
28004600|NCT03367858|81846487|FG000|3 Month Follow Up|MRI contraindication|2|||
27808425|NCT00410410|81130616|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
27874387|NCT00470470|81371742|FG000|Overall Study|Death|2|||
27874388|NCT00470470|81371742|FG000|Overall Study|Not treated|1|||
27874389|NCT00485264|81371750|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
27874390|NCT00485264|81371751|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
27874391|NCT00485264|81371752|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
27808426|NCT00410410|81130617|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
27808427|NCT00410410|81130618|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
27808428|NCT00410410|81130619|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
27808429|NCT00410410|81130620|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
27808430|NCT00410410|81130621|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
27808431|NCT00410410|81130622|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
27808432|NCT00410410|81130623|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
27808433|NCT00410410|81130615|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808434|NCT00410410|81130616|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808435|NCT00410410|81130617|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
27808436|NCT00410410|81130618|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808437|NCT00410410|81130619|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808438|NCT00410410|81130620|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808439|NCT00410410|81130621|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808440|NCT00410410|81130622|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808441|NCT00410410|81130623|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
27808442|NCT00410410|81130615|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808443|NCT00410410|81130616|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808444|NCT00410410|81130617|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808445|NCT00410410|81130618|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808446|NCT00410410|81130619|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
27874392|NCT00485264|81371753|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
27874393|NCT00485264|81371754|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
27874394|NCT00485264|81371755|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
27874395|NCT00485264|81371750|FG000|Overall Study|Death|1|||
27874396|NCT00485264|81371751|FG001|Overall Study|Death|0|||
27874397|NCT00485264|81371752|FG002|Overall Study|Death|0|||
27874398|NCT00485264|81371753|FG003|Overall Study|Death|0|||
27874399|NCT00485264|81371754|FG004|Overall Study|Death|1|||
27874400|NCT00485264|81371755|FG005|Overall Study|Death|0|||
27874401|NCT00485264|81371750|FG000|Overall Study|Adverse Event|1|||
27874402|NCT00485264|81371751|FG001|Overall Study|Adverse Event|0|||
27874403|NCT00485264|81371752|FG002|Overall Study|Adverse Event|2|||
27874404|NCT00485264|81371753|FG003|Overall Study|Adverse Event|3|||
27874405|NCT00485264|81371754|FG004|Overall Study|Adverse Event|1|||
28004601|NCT03367858|81846488|FG001|3 Month Follow Up|MRI contraindication|1|||
28004602|NCT03367858|81846487|FG000|3 Month Follow Up|Incarcerated|0|||
28004603|NCT03367858|81846488|FG001|3 Month Follow Up|Incarcerated|1|||
28004604|NCT03367858|81846487|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
28004605|NCT03367858|81846488|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
28004606|NCT03367858|81846487|FG000|6 Month Follow Up|Lost to Follow-up|5|||
28004607|NCT03367858|81846488|FG001|6 Month Follow Up|Lost to Follow-up|2|||
27684572|NCT01253304|80683506|FG000|Overall Study|Adverse Event|0|||
27684573|NCT01253304|80683507|FG001|Overall Study|Adverse Event|0|||
27684574|NCT01253304|80683508|FG002|Overall Study|Adverse Event|0|||
27684575|NCT01253304|80683509|FG003|Overall Study|Adverse Event|1|||
27808447|NCT00410410|81130620|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
27874406|NCT00485264|81371755|FG005|Overall Study|Adverse Event|3|||
27874407|NCT00485264|81371750|FG000|Overall Study|Pregnancy|4|||
28004608|NCT03367858|81846487|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
28004609|NCT03367858|81846488|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
27684576|NCT01877239|80683510|FG000|Overall Study|Adverse Event|4|||
27684577|NCT01877239|80683510|FG000|Overall Study|Disease Remission|1|||
27684578|NCT01877239|80683510|FG000|Overall Study|Withdrawal by Subject|4|||
27684579|NCT01877239|80683510|FG000|Overall Study|Other|2|||
27808448|NCT00410410|81130621|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808449|NCT00410410|81130622|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808450|NCT00410410|81130623|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
27808451|NCT00410410|81130615|FG000|Induction Period (IP)|Other|0|||
27808452|NCT00410410|81130616|FG001|Induction Period (IP)|Other|0|||
27874408|NCT00485264|81371751|FG001|Overall Study|Pregnancy|0|||
27874409|NCT00485264|81371752|FG002|Overall Study|Pregnancy|0|||
27874410|NCT00485264|81371753|FG003|Overall Study|Pregnancy|0|||
27874411|NCT00485264|81371754|FG004|Overall Study|Pregnancy|0|||
27874412|NCT00485264|81371755|FG005|Overall Study|Pregnancy|0|||
27874413|NCT00485264|81371750|FG000|Overall Study|Disallowed Medication|0|||
27874414|NCT00485264|81371751|FG001|Overall Study|Disallowed Medication|0|||
27874415|NCT00485264|81371752|FG002|Overall Study|Disallowed Medication|0|||
28004610|NCT03367858|81846487|FG000|12 Month Follow Up|Lost to Follow-up|3|||
27584801|NCT00129987|80322034|FG000|1 Year|Withdrawal by Subject|32|||
27584802|NCT00129987|80322035|FG001|1 Year|Withdrawal by Subject|21|||
27584803|NCT01774903|80322036|FG000|Overall Study|Adverse Event|7|||
27584804|NCT01774903|80322036|FG000|Overall Study|Withdrawal by Subject|2|||
27584805|NCT01774903|80322036|FG000|Overall Study|Lack of Efficacy|1|||
27584806|NCT01774903|80322036|FG000|Overall Study|Ineligible to continue the trial|1|||
27584807|NCT00924950|80322037|FG000|Overall Study|Lost to Follow-up|2|||
27584808|NCT02473614|80322040|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
27584809|NCT02473614|80322041|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
27584810|NCT00127608|80322042|FG000|Overall Study|VZV DNA negative|1|||
27584811|NCT02667912|80322043|FG000|Overall Study|Death|3|||
27584812|NCT02667912|80322044|FG001|Overall Study|Death|1|||
27584813|NCT02667912|80322043|FG000|Overall Study|Withdrawal by Subject|1|||
27584814|NCT02667912|80322044|FG001|Overall Study|Withdrawal by Subject|2|||
27584815|NCT02667912|80322043|FG000|Overall Study|Withdrawal by Subject|1|||
27584816|NCT02667912|80322044|FG001|Overall Study|Withdrawal by Subject|0|||
27584817|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
27584818|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
27584819|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
27584820|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
27584821|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
27584822|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
27584823|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
27584824|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
27584825|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
27584826|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
27584827|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
27584828|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
27584829|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
27584830|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
27584831|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
27584832|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
27584833|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
27584834|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
27584835|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
27584836|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
28004611|NCT03367858|81846488|FG001|12 Month Follow Up|Lost to Follow-up|3|||
28004612|NCT03367858|81846487|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
28004613|NCT03367858|81846488|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
28004614|NCT00768989|81849652|FG000|Prior to Week 24|Withdrawal by Subject|1|||
28004615|NCT00768989|81849653|FG001|Prior to Week 24|Withdrawal by Subject|0|||
28004616|NCT00768989|81849652|FG000|Prior to Week 24|Adverse Event|3|||
28004617|NCT00768989|81849653|FG001|Prior to Week 24|Adverse Event|0|||
28004618|NCT00768989|81849652|FG000|Prior to Week 24|Lost to Follow-up|0|||
28004619|NCT00768989|81849653|FG001|Prior to Week 24|Lost to Follow-up|1|||
27584837|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
27584838|NCT02161718|80322045|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
27584839|NCT02161718|80322046|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
27584840|NCT02161718|80322047|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
27584841|NCT02161718|80322045|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
27584842|NCT02161718|80322046|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
27584843|NCT02161718|80322047|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
27584844|NCT02161718|80322045|FG000|Post- Randomization Period|Lost to Follow-up|0|||
27584845|NCT02161718|80322046|FG001|Post- Randomization Period|Lost to Follow-up|9|||
27584846|NCT02161718|80322047|FG002|Post- Randomization Period|Lost to Follow-up|15|||
27808453|NCT00410410|81130617|FG002|Induction Period (IP)|Other|1|||
27808454|NCT00410410|81130618|FG003|Induction Period (IP)|Other|0|||
27808455|NCT00410410|81130619|FG004|Induction Period (IP)|Other|0|||
27808456|NCT00410410|81130620|FG005|Induction Period (IP)|Other|0|||
27808457|NCT00410410|81130621|FG006|Induction Period (IP)|Other|0|||
27808458|NCT00410410|81130622|FG007|Induction Period (IP)|Other|0|||
27808459|NCT00410410|81130623|FG008|Induction Period (IP)|Other|0|||
27808460|NCT00410410|81130615|FG000|Maintenance Period (MP)|Death|0|||
27808461|NCT00410410|81130616|FG001|Maintenance Period (MP)|Death|0|||
27808462|NCT00410410|81130617|FG002|Maintenance Period (MP)|Death|0|||
27808463|NCT00410410|81130618|FG003|Maintenance Period (MP)|Death|0|||
28004620|NCT00768989|81849652|FG000|Prior to Week 24|Protocol Violation|0|||
28004621|NCT00768989|81849653|FG001|Prior to Week 24|Protocol Violation|2|||
27584847|NCT02161718|80322045|FG000|Post- Randomization Period|Adverse Event|0|||
27584848|NCT02161718|80322046|FG001|Post- Randomization Period|Adverse Event|9|||
28004622|NCT00768989|81849652|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
28004623|NCT00768989|81849653|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
27684580|NCT01877239|80683510|FG000|Overall Study|Lack of Efficacy|4|||
27684581|NCT01877239|80683510|FG000|Overall Study|Data not available|35|||
27684582|NCT01012817|80683511|FG000|Overall Study|Withdrawal by Subject|0|||
27808464|NCT00410410|81130619|FG004|Maintenance Period (MP)|Death|0|||
27808465|NCT00410410|81130620|FG005|Maintenance Period (MP)|Death|0|||
27808466|NCT00410410|81130621|FG006|Maintenance Period (MP)|Death|1|||
27808467|NCT00410410|81130622|FG007|Maintenance Period (MP)|Death|0|||
27808468|NCT00410410|81130623|FG008|Maintenance Period (MP)|Death|0|||
27808469|NCT00410410|81130615|FG000|Maintenance Period (MP)|Adverse Event|0|||
27808470|NCT00410410|81130616|FG001|Maintenance Period (MP)|Adverse Event|0|||
27808471|NCT00410410|81130617|FG002|Maintenance Period (MP)|Adverse Event|0|||
27808472|NCT00410410|81130618|FG003|Maintenance Period (MP)|Adverse Event|0|||
27808473|NCT00410410|81130619|FG004|Maintenance Period (MP)|Adverse Event|0|||
27808474|NCT00410410|81130620|FG005|Maintenance Period (MP)|Adverse Event|0|||
27808475|NCT00410410|81130621|FG006|Maintenance Period (MP)|Adverse Event|1|||
27808476|NCT00410410|81130622|FG007|Maintenance Period (MP)|Adverse Event|3|||
27808477|NCT00410410|81130623|FG008|Maintenance Period (MP)|Adverse Event|0|||
27808478|NCT00410410|81130615|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
27808479|NCT00410410|81130616|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
27808480|NCT00410410|81130617|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
27808481|NCT00410410|81130618|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
27808482|NCT00410410|81130619|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
27808483|NCT00410410|81130620|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
27808484|NCT00410410|81130621|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
27808485|NCT00410410|81130622|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
27808486|NCT00410410|81130623|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
27808487|NCT00410410|81130615|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
27808488|NCT00410410|81130616|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
27808489|NCT00410410|81130617|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
27874416|NCT00485264|81371753|FG003|Overall Study|Disallowed Medication|0|||
28004624|NCT00768989|81849652|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
28004625|NCT00768989|81849653|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
28004626|NCT00768989|81849652|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
28004627|NCT00768989|81849653|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
28004628|NCT00768989|81849652|FG000|On or After Week 36|Lack of Efficacy|1|||
28004629|NCT00768989|81849653|FG001|On or After Week 36|Lack of Efficacy|0|||
28004630|NCT00768989|81849652|FG000|On or After Week 36|Adverse Event|0|||
28004631|NCT00768989|81849653|FG001|On or After Week 36|Adverse Event|1|||
28004632|NCT00768989|81849652|FG000|On or After Week 36|Lost to Follow-up|1|||
28004633|NCT00768989|81849653|FG001|On or After Week 36|Lost to Follow-up|0|||
28004634|NCT00768989|81849652|FG000|On or After Week 36|Poor Compliance|1|||
28004635|NCT00768989|81849653|FG001|On or After Week 36|Poor Compliance|0|||
28004636|NCT00768989|81849652|FG000|On or After Week 36|Protocol Violation|1|||
28004637|NCT00768989|81849653|FG001|On or After Week 36|Protocol Violation|0|||
28004638|NCT00768989|81849652|FG000|On or After Week 36|Did not attend termination visit|2|||
28004639|NCT00768989|81849653|FG001|On or After Week 36|Did not attend termination visit|0|||
28004640|NCT00768989|81849652|FG000|On or After Week 36|Sponsor Termination|45|||
28004641|NCT00768989|81849653|FG001|On or After Week 36|Sponsor Termination|26|||
28004642|NCT01389882|81849654|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
28004643|NCT01389882|81849655|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
28004644|NCT01389882|81849654|FG000|Overall Study|Withdrawal by Subject|0|||
28004645|NCT01389882|81849655|FG001|Overall Study|Withdrawal by Subject|1|||
28004646|NCT00561652|81849656|FG000|Overall Study|Withdrawal by Subject|0|||
28004647|NCT00561652|81849657|FG001|Overall Study|Withdrawal by Subject|1|||
28004648|NCT00614575|81849660|FG000|Overall Study|Adverse Event|106|||
28004649|NCT00614575|81849660|FG000|Overall Study|Lost to Follow-up|55|||
28004650|NCT00614575|81849660|FG000|Overall Study|Lack of Efficacy|14|||
28004651|NCT00614575|81849660|FG000|Overall Study|Withdrawal by Subject|6|||
28004652|NCT00614575|81849660|FG000|Overall Study|Death|3|||
28004653|NCT00614575|81849660|FG000|Overall Study|Physician Decision|2|||
27684583|NCT01012817|80683512|FG001|Overall Study|Withdrawal by Subject|0|||
27684584|NCT01012817|80683513|FG002|Overall Study|Withdrawal by Subject|0|||
27808490|NCT00410410|81130618|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
27808491|NCT00410410|81130619|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
27874417|NCT00485264|81371754|FG004|Overall Study|Disallowed Medication|0|||
27808492|NCT00410410|81130620|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
28004654|NCT00614575|81849660|FG000|Overall Study|No data were collected.|18|||
28004655|NCT00614575|81849660|FG000|Overall Study|Irregularly enrolled patients|23|||
28004656|NCT00614575|81849660|FG000|Overall Study|No treatment|1|||
28004657|NCT01069484|81849661|FG000|Overall Study|Death-in-near-family|1|||
28004658|NCT01069484|81849662|FG001|Overall Study|Death-in-near-family|0|||
28004659|NCT01069484|81849661|FG000|Overall Study|No specific reason|8|||
28004660|NCT01069484|81849662|FG001|Overall Study|No specific reason|2|||
28004661|NCT01069484|81849661|FG000|Overall Study|Illness mother or child|3|||
28004662|NCT01069484|81849662|FG001|Overall Study|Illness mother or child|1|||
28004663|NCT01420861|81849663|FG000|Overall Study|Adverse Event|2|||
28004664|NCT01420861|81849663|FG000|Overall Study|Study terminated by Sponsor|7|||
28004665|NCT01420861|81849663|FG000|Overall Study|Screen failure|7|||
28004666|NCT01420861|81849663|FG000|Overall Study|Randomized not Treated|2|||
28004667|NCT00855959|81849664|FG000|Overall Study|Adverse Event|2|||
28004668|NCT00855959|81849664|FG000|Overall Study|Lost to Follow-up|2|||
28004669|NCT00855959|81849664|FG000|Overall Study|Withdrawal by Subject|3|||
28004670|NCT00855959|81849664|FG000|Overall Study|Pregnancy|1|||
28004671|NCT00855959|81849664|FG000|Overall Study|Incorrect enrolment|1|||
28004672|NCT01706458|81849665|FG000|Overall Study|Physician Decision|3|||
28004673|NCT01706458|81849666|FG001|Overall Study|Physician Decision|4|||
28004674|NCT01790594|81849671|FG000|Overall Study|Death|1|||
28004675|NCT01790594|81849672|FG001|Overall Study|Death|0|||
28004676|NCT01790594|81849673|FG002|Overall Study|Death|0|||
28004677|NCT01790594|81849671|FG000|Overall Study|Physician Decision|2|||
28004678|NCT01790594|81849672|FG001|Overall Study|Physician Decision|1|||
28004679|NCT01790594|81849673|FG002|Overall Study|Physician Decision|0|||
28004680|NCT01790594|81849671|FG000|Overall Study|Withdrawal by Subject|2|||
28004681|NCT01790594|81849672|FG001|Overall Study|Withdrawal by Subject|0|||
28004682|NCT01790594|81849673|FG002|Overall Study|Withdrawal by Subject|0|||
28004683|NCT01790594|81849671|FG000|Overall Study|Transplant was not done|0|||
28004684|NCT01790594|81849672|FG001|Overall Study|Transplant was not done|0|||
28004685|NCT01790594|81849673|FG002|Overall Study|Transplant was not done|3|||
28004686|NCT01790594|81849671|FG000|Overall Study|Terminated prior to week 76|0|||
28004687|NCT01790594|81849672|FG001|Overall Study|Terminated prior to week 76|2|||
27684585|NCT01012817|80683514|FG003|Overall Study|Withdrawal by Subject|1|||
27684586|NCT01012817|80683515|FG004|Overall Study|Withdrawal by Subject|0|||
27684587|NCT01012817|80683516|FG005|Overall Study|Withdrawal by Subject|0|||
28004688|NCT01790594|81849673|FG002|Overall Study|Terminated prior to week 76|0|||
28004689|NCT02178995|81849674|FG000|Double Blind|Adverse Event|0|||
28004690|NCT02178995|81849675|FG001|Double Blind|Adverse Event|0|||
28004691|NCT02178995|81849676|FG002|Double Blind|Adverse Event|0|||
28004692|NCT02178995|81849677|FG003|Double Blind|Adverse Event|0|||
28004693|NCT02178995|81849678|FG004|Double Blind|Adverse Event|0|||
28004694|NCT02178995|81849679|FG005|Double Blind|Adverse Event|1|||
28004695|NCT02178995|81849680|FG006|Double Blind|Adverse Event|0|||
28004696|NCT02178995|81849681|FG007|Double Blind|Adverse Event|1|||
28004697|NCT02178995|81849682|FG008|Double Blind|Adverse Event|1|||
28004698|NCT02178995|81849674|FG000|Double Blind|Lost to Follow-up|0|||
28004699|NCT02178995|81849675|FG001|Double Blind|Lost to Follow-up|1|||
27808493|NCT00410410|81130621|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
27808494|NCT00410410|81130622|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
27808495|NCT00410410|81130623|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
27808496|NCT00410410|81130615|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808497|NCT00410410|81130616|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808498|NCT00410410|81130617|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808499|NCT00410410|81130618|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808500|NCT00410410|81130619|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808501|NCT00410410|81130620|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808502|NCT00410410|81130621|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
27808503|NCT00410410|81130622|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
27808504|NCT00410410|81130623|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
27808505|NCT00410410|81130615|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
27808506|NCT00410410|81130616|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
28004700|NCT02178995|81849676|FG002|Double Blind|Lost to Follow-up|0|||
28004701|NCT02178995|81849677|FG003|Double Blind|Lost to Follow-up|0|||
28004702|NCT02178995|81849678|FG004|Double Blind|Lost to Follow-up|0|||
28004703|NCT02178995|81849679|FG005|Double Blind|Lost to Follow-up|0|||
28004704|NCT02178995|81849680|FG006|Double Blind|Lost to Follow-up|0|||
28004705|NCT02178995|81849681|FG007|Double Blind|Lost to Follow-up|1|||
27684588|NCT01012817|80683517|FG006|Overall Study|Withdrawal by Subject|0|||
28004706|NCT02178995|81849682|FG008|Double Blind|Lost to Follow-up|0|||
28004707|NCT02178995|81849674|FG000|Open Label|Adverse Event|2|||
28004708|NCT02178995|81849675|FG001|Open Label|Adverse Event|0|||
28004709|NCT02178995|81849676|FG002|Open Label|Adverse Event|0|||
28004710|NCT02178995|81849677|FG003|Open Label|Adverse Event|0|||
27684589|NCT01012817|80683518|FG007|Overall Study|Withdrawal by Subject|1|||
27684590|NCT01012817|80683519|FG008|Overall Study|Withdrawal by Subject|0|||
27684591|NCT01012817|80683520|FG009|Overall Study|Withdrawal by Subject|0|||
28004711|NCT02178995|81849678|FG004|Open Label|Adverse Event|0|||
28004712|NCT02178995|81849679|FG005|Open Label|Adverse Event|0|||
28004713|NCT02178995|81849680|FG006|Open Label|Adverse Event|0|||
27584849|NCT02161718|80322047|FG002|Post- Randomization Period|Adverse Event|10|||
27584850|NCT02161718|80322045|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
27584851|NCT02161718|80322046|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
27584852|NCT02161718|80322047|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
27584853|NCT02161718|80322045|FG000|Post- Randomization Period|Physician Decision|0|||
27584854|NCT02161718|80322046|FG001|Post- Randomization Period|Physician Decision|2|||
27584855|NCT02161718|80322047|FG002|Post- Randomization Period|Physician Decision|4|||
27584856|NCT02161718|80322045|FG000|Post- Randomization Period|Protocol Violation|0|||
27584857|NCT02161718|80322046|FG001|Post- Randomization Period|Protocol Violation|2|||
27584858|NCT02161718|80322047|FG002|Post- Randomization Period|Protocol Violation|3|||
27584859|NCT02161718|80322045|FG000|Post- Randomization Period|Lack of Efficacy|0|||
27584860|NCT02161718|80322046|FG001|Post- Randomization Period|Lack of Efficacy|0|||
27584861|NCT02161718|80322047|FG002|Post- Randomization Period|Lack of Efficacy|1|||
27584862|NCT02161718|80322045|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
27584863|NCT02161718|80322046|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
27584864|NCT02161718|80322047|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
27584865|NCT02161718|80322045|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
27584866|NCT02161718|80322046|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
27584867|NCT02161718|80322047|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
27584868|NCT02161718|80322045|FG000|Post- Randomization Period|Relocation|0|||
27584869|NCT02161718|80322046|FG001|Post- Randomization Period|Relocation|3|||
27584870|NCT02161718|80322047|FG002|Post- Randomization Period|Relocation|0|||
27584871|NCT00363766|80322048|FG000|Overall Study|Progressive Disease|15|||
27584872|NCT00363766|80322049|FG001|Overall Study|Progressive Disease|9|||
27584873|NCT00363766|80322048|FG000|Overall Study|Adverse Event|10|||
27584874|NCT00363766|80322049|FG001|Overall Study|Adverse Event|2|||
27584875|NCT00363766|80322048|FG000|Overall Study|Disease Related Death|1|||
27584876|NCT00363766|80322049|FG001|Overall Study|Disease Related Death|3|||
27584877|NCT00363766|80322048|FG000|Overall Study|Not Disease Related Death|3|||
27584878|NCT00363766|80322049|FG001|Overall Study|Not Disease Related Death|4|||
27584879|NCT00363766|80322048|FG000|Overall Study|Withdrawal by Subject|2|||
27584880|NCT00363766|80322049|FG001|Overall Study|Withdrawal by Subject|0|||
27584881|NCT00363766|80322048|FG000|Overall Study|Physician Decision|1|||
27584882|NCT00363766|80322049|FG001|Overall Study|Physician Decision|2|||
27584883|NCT01024387|80322050|FG000|Overall Study|Radiographic Progression|29|||
27584884|NCT01024387|80322050|FG000|Overall Study|Symptomatic Progression|10|||
27584885|NCT01024387|80322050|FG000|Overall Study|Physician Decision|5|||
27584886|NCT01024387|80322050|FG000|Overall Study|Withdrawal by Subject|5|||
27584887|NCT01024387|80322050|FG000|Overall Study|Death|2|||
27584888|NCT01024387|80322050|FG000|Overall Study|Prolonged Treatment Delay|1|||
27584889|NCT01024387|80322050|FG000|Overall Study|Adverse Event|3|||
27584890|NCT01024387|80322050|FG000|Overall Study|Other|5|||
27584891|NCT02032901|80322051|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
27584892|NCT02032901|80322052|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
27584893|NCT02032901|80322051|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
27584894|NCT02032901|80322052|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
27584895|NCT00345397|80322055|FG000|Overall Study|Death|1|||
27584896|NCT03136068|80322061|FG000|Overall Study|Lost to Follow-up|1|||
27584897|NCT03136068|80322062|FG001|Overall Study|Lost to Follow-up|1|||
27584898|NCT03136068|80322061|FG000|Overall Study|Protocol Violation|1|||
27584899|NCT03136068|80322062|FG001|Overall Study|Protocol Violation|0|||
27584900|NCT01193556|80322063|FG000|Overall Study|Study termination|26|||
27874418|NCT00485264|81371755|FG005|Overall Study|Disallowed Medication|1|||
27584901|NCT01193556|80322064|FG001|Overall Study|Study termination|25|||
27584902|NCT00922428|80322067|FG000|Overall Study|retrospective/extremely implausible data|2|||
27584903|NCT00922428|80322067|FG000|Overall Study|no medication use or questionable use|13|||
27584904|NCT03738865|80322068|FG000|Overall Study|Withdrawal by Subject|3|||
27684592|NCT01012817|80683521|FG010|Overall Study|Withdrawal by Subject|1|||
28004714|NCT02178995|81849681|FG007|Open Label|Adverse Event|0|||
27584905|NCT03738865|80322069|FG001|Overall Study|Withdrawal by Subject|3|||
27584906|NCT03738865|80322068|FG000|Overall Study|Adverse Event|2|||
27584907|NCT03738865|80322069|FG001|Overall Study|Adverse Event|0|||
27584908|NCT03738865|80322068|FG000|Overall Study|Physician Decision|0|||
27584909|NCT03738865|80322069|FG001|Overall Study|Physician Decision|1|||
27584910|NCT01303627|80322070|FG000|Overall Study|the failure while performing URS|0|||
28004715|NCT02178995|81849682|FG008|Open Label|Adverse Event|0|||
28004716|NCT00499486|81849688|FG000|Overall Study|Withdrawal by Subject|16|||
27684593|NCT01012817|80683522|FG011|Overall Study|Withdrawal by Subject|1|||
28004717|NCT01217944|81849689|FG000|Overall Study|Protocol Violation|1|||
28004718|NCT01217944|81849690|FG001|Overall Study|Protocol Violation|1|||
28004719|NCT01217944|81849691|FG002|Overall Study|Protocol Violation|0|||
28004720|NCT01217944|81849689|FG000|Overall Study|Lost to Follow-up|3|||
28004721|NCT01217944|81849690|FG001|Overall Study|Lost to Follow-up|1|||
28004722|NCT01217944|81849691|FG002|Overall Study|Lost to Follow-up|0|||
28004723|NCT01217944|81849689|FG000|Overall Study|Withdrawal by Subject|1|||
28004724|NCT01217944|81849690|FG001|Overall Study|Withdrawal by Subject|2|||
28004725|NCT01217944|81849691|FG002|Overall Study|Withdrawal by Subject|0|||
28004726|NCT01217944|81849689|FG000|Overall Study|Lack of Efficacy|1|||
28004727|NCT01217944|81849690|FG001|Overall Study|Lack of Efficacy|0|||
28004728|NCT01217944|81849691|FG002|Overall Study|Lack of Efficacy|0|||
28004729|NCT01582061|81849693|FG000|Overall Study|Lack of Efficacy|3|||
28004730|NCT01582061|81849694|FG001|Overall Study|Lack of Efficacy|23|||
28004731|NCT01582061|81849693|FG000|Overall Study|Adverse Event|12|||
28004732|NCT01582061|81849694|FG001|Overall Study|Adverse Event|8|||
28004733|NCT01582061|81849693|FG000|Overall Study|Withdrawal by Subject|10|||
27808507|NCT00410410|81130617|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
27808508|NCT00410410|81130618|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
27808509|NCT00410410|81130619|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
27808510|NCT00410410|81130620|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
27808511|NCT00410410|81130621|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
27808512|NCT00410410|81130622|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
27808513|NCT00410410|81130623|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
27808514|NCT00410410|81130615|FG000|Open-Label Period (OL)|Death|0|||
27808515|NCT00410410|81130616|FG001|Open-Label Period (OL)|Death|0|||
27808516|NCT00410410|81130617|FG002|Open-Label Period (OL)|Death|0|||
27808517|NCT00410410|81130618|FG003|Open-Label Period (OL)|Death|0|||
27808518|NCT00410410|81130619|FG004|Open-Label Period (OL)|Death|0|||
27808519|NCT00410410|81130620|FG005|Open-Label Period (OL)|Death|0|||
27808520|NCT00410410|81130621|FG006|Open-Label Period (OL)|Death|0|||
27808521|NCT00410410|81130622|FG007|Open-Label Period (OL)|Death|0|||
27808522|NCT00410410|81130623|FG008|Open-Label Period (OL)|Death|1|||
28004734|NCT01582061|81849694|FG001|Overall Study|Withdrawal by Subject|4|||
28004735|NCT01582061|81849693|FG000|Overall Study|Abnormal laboratory value(s)|1|||
28004736|NCT01582061|81849694|FG001|Overall Study|Abnormal laboratory value(s)|0|||
28004737|NCT01582061|81849693|FG000|Overall Study|Death|0|||
28004738|NCT01582061|81849694|FG001|Overall Study|Death|1|||
28004739|NCT01582061|81849693|FG000|Overall Study|condition no longer requires study drug|1|||
28004740|NCT01582061|81849694|FG001|Overall Study|condition no longer requires study drug|0|||
28004741|NCT01582061|81849693|FG000|Overall Study|Lost to Follow-up|1|||
28004742|NCT01582061|81849694|FG001|Overall Study|Lost to Follow-up|0|||
28004743|NCT01045460|81849696|FG000|Overall Study|Physician Decision|3|||
28004744|NCT01045460|81849697|FG001|Overall Study|Physician Decision|2|||
28004745|NCT01045460|81849696|FG000|Overall Study|Lost to Follow-up|0|||
27808523|NCT00410410|81130615|FG000|Open-Label Period (OL)|Adverse Event|0|||
27808524|NCT00410410|81130616|FG001|Open-Label Period (OL)|Adverse Event|0|||
27808525|NCT00410410|81130617|FG002|Open-Label Period (OL)|Adverse Event|0|||
27808526|NCT00410410|81130618|FG003|Open-Label Period (OL)|Adverse Event|0|||
27808527|NCT00410410|81130619|FG004|Open-Label Period (OL)|Adverse Event|0|||
28004746|NCT01045460|81849697|FG001|Overall Study|Lost to Follow-up|1|||
28004747|NCT01045460|81849696|FG000|Overall Study|Lack of Efficacy|3|||
28004748|NCT01045460|81849697|FG001|Overall Study|Lack of Efficacy|0|||
28004749|NCT03186209|81849701|FG000|Overall Study|Withdrawal by Subject|11|||
28004750|NCT03186209|81849702|FG001|Overall Study|Withdrawal by Subject|22|||
28004751|NCT03186209|81849701|FG000|Overall Study|Pregnancy|1|||
28004752|NCT03186209|81849702|FG001|Overall Study|Pregnancy|0|||
28004753|NCT03186209|81849701|FG000|Overall Study|Adverse Event|4|||
28004754|NCT03186209|81849702|FG001|Overall Study|Adverse Event|0|||
28004755|NCT03186209|81849701|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
28004756|NCT03186209|81849702|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
28004757|NCT03186209|81849701|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
28004758|NCT03186209|81849702|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
27808528|NCT00410410|81130620|FG005|Open-Label Period (OL)|Adverse Event|0|||
27808529|NCT00410410|81130621|FG006|Open-Label Period (OL)|Adverse Event|0|||
27808530|NCT00410410|81130622|FG007|Open-Label Period (OL)|Adverse Event|0|||
28004759|NCT03186209|81849701|FG000|Overall Study|Fail to meet randomization criteria|0|||
28004760|NCT03186209|81849702|FG001|Overall Study|Fail to meet randomization criteria|1|||
27684594|NCT01012817|80683523|FG012|Overall Study|Withdrawal by Subject|0|||
27808531|NCT00410410|81130623|FG008|Open-Label Period (OL)|Adverse Event|10|||
27808532|NCT00410410|81130615|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
28004761|NCT03186209|81849701|FG000|Overall Study|Lost to Follow-up|0|||
28004762|NCT03186209|81849702|FG001|Overall Study|Lost to Follow-up|1|||
28004763|NCT01419769|81849705|FG000|Overall Study|Did not receive the AXIOS stent|3|||
27808533|NCT00410410|81130616|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
28004764|NCT01419769|81849705|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
27684595|NCT01012817|80683524|FG013|Overall Study|Withdrawal by Subject|1|||
27684596|NCT01012817|80683511|FG000|Overall Study|Adverse Event|0|||
27808534|NCT00410410|81130617|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
27808535|NCT00410410|81130618|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
27808536|NCT00410410|81130619|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
27808537|NCT00410410|81130620|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
27808538|NCT00410410|81130621|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
27808539|NCT00410410|81130622|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
27808540|NCT00410410|81130623|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
27808541|NCT00410410|81130615|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
27808542|NCT00410410|81130616|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
27808543|NCT00410410|81130617|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
28004765|NCT00265564|81849706|FG000|Overall Study|Lost to Follow-up|5|||
28004766|NCT00265564|81849707|FG001|Overall Study|Lost to Follow-up|7|||
28004767|NCT00265564|81849706|FG000|Overall Study|met exclusion criteria|5|||
28004768|NCT00265564|81849707|FG001|Overall Study|met exclusion criteria|2|||
28004769|NCT03634085|81849710|FG000|Overall Study|Adverse Event|1|||
28004770|NCT03634085|81849711|FG001|Overall Study|Adverse Event|0|||
28004771|NCT03634085|81849710|FG000|Overall Study|Withdrawal by Subject|0|||
28004772|NCT03634085|81849711|FG001|Overall Study|Withdrawal by Subject|2|||
28004773|NCT02539797|81849712|FG000|Overall Study|Lost to Follow-up|0|||
28004774|NCT02539797|81849713|FG001|Overall Study|Lost to Follow-up|1|||
28004775|NCT02539797|81849714|FG002|Overall Study|Lost to Follow-up|0|||
28004776|NCT01018030|81849718|FG000|Overall Study|Adverse Event|10|||
28004777|NCT01018030|81849719|FG001|Overall Study|Adverse Event|5|||
28004778|NCT01018030|81849720|FG002|Overall Study|Adverse Event|5|||
28004779|NCT01018030|81849718|FG000|Overall Study|Withdrawal by Subject|2|||
28004780|NCT01018030|81849719|FG001|Overall Study|Withdrawal by Subject|2|||
28004781|NCT01018030|81849720|FG002|Overall Study|Withdrawal by Subject|4|||
28004782|NCT01018030|81849718|FG000|Overall Study|Lost to Follow-up|2|||
28004783|NCT01018030|81849719|FG001|Overall Study|Lost to Follow-up|0|||
28004784|NCT01018030|81849720|FG002|Overall Study|Lost to Follow-up|3|||
28004785|NCT01018030|81849718|FG000|Overall Study|Protocol Violation|2|||
28004786|NCT01018030|81849719|FG001|Overall Study|Protocol Violation|1|||
28004787|NCT01018030|81849720|FG002|Overall Study|Protocol Violation|0|||
28004788|NCT01018030|81849718|FG000|Overall Study|Physician Decision|1|||
28004789|NCT01018030|81849719|FG001|Overall Study|Physician Decision|0|||
28004790|NCT01018030|81849720|FG002|Overall Study|Physician Decision|1|||
28004791|NCT01018030|81849718|FG000|Overall Study|Lack of Efficacy|1|||
28004792|NCT01018030|81849719|FG001|Overall Study|Lack of Efficacy|0|||
28004793|NCT01018030|81849720|FG002|Overall Study|Lack of Efficacy|0|||
28004794|NCT01018030|81849718|FG000|Overall Study|Did Not Receive Study Drug|1|||
28004795|NCT01018030|81849719|FG001|Overall Study|Did Not Receive Study Drug|3|||
28004796|NCT01018030|81849720|FG002|Overall Study|Did Not Receive Study Drug|0|||
28004797|NCT00322881|81849732|FG000|Overall Study|Death|2|||
28004798|NCT00322881|81849732|FG000|Overall Study|Adverse Event|1|||
28004799|NCT00322881|81849732|FG000|Overall Study|Disease Progression|2|||
28004800|NCT00791388|81849736|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
28004801|NCT00791388|81849737|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
28004802|NCT00791388|81849738|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
28004803|NCT00791388|81849739|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
28004804|NCT00791388|81849740|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
28004805|NCT00791388|81849736|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
28004806|NCT00791388|81849737|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
28004807|NCT00791388|81849738|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
28004808|NCT00791388|81849739|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
28004809|NCT00791388|81849740|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
28004810|NCT00791388|81849736|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
28004811|NCT00791388|81849737|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
28004812|NCT00791388|81849738|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
28004813|NCT00791388|81849739|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
28004814|NCT00791388|81849740|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
28004815|NCT00657046|81849744|FG000|Overall Study|Adverse Event|1|||
28004816|NCT00657046|81849745|FG001|Overall Study|Adverse Event|1|||
28004817|NCT00657046|81849746|FG002|Overall Study|Adverse Event|0|||
27684597|NCT01012817|80683512|FG001|Overall Study|Adverse Event|0|||
27684598|NCT01012817|80683513|FG002|Overall Study|Adverse Event|0|||
27684599|NCT01012817|80683514|FG003|Overall Study|Adverse Event|0|||
27684600|NCT01012817|80683515|FG004|Overall Study|Adverse Event|0|||
27684601|NCT01012817|80683516|FG005|Overall Study|Adverse Event|1|||
27684602|NCT01012817|80683517|FG006|Overall Study|Adverse Event|0|||
27684603|NCT01012817|80683518|FG007|Overall Study|Adverse Event|0|||
27684604|NCT01012817|80683519|FG008|Overall Study|Adverse Event|0|||
27684605|NCT01012817|80683520|FG009|Overall Study|Adverse Event|0|||
27684606|NCT01012817|80683521|FG010|Overall Study|Adverse Event|1|||
27684607|NCT01012817|80683522|FG011|Overall Study|Adverse Event|0|||
27684608|NCT01012817|80683523|FG012|Overall Study|Adverse Event|0|||
27684609|NCT01012817|80683524|FG013|Overall Study|Adverse Event|1|||
27684610|NCT04488770|80683525|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27808544|NCT00410410|81130618|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
27808545|NCT00410410|81130619|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
27808546|NCT00410410|81130620|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
27808547|NCT00410410|81130621|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
28004818|NCT00657046|81849744|FG000|Overall Study|Protocol Violation|2|||
28004819|NCT00657046|81849745|FG001|Overall Study|Protocol Violation|2|||
28004820|NCT00657046|81849746|FG002|Overall Study|Protocol Violation|0|||
28004821|NCT00657046|81849744|FG000|Overall Study|Withdrawal by Subject|1|||
27808548|NCT00410410|81130622|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
28004822|NCT00657046|81849745|FG001|Overall Study|Withdrawal by Subject|0|||
28004823|NCT00657046|81849746|FG002|Overall Study|Withdrawal by Subject|0|||
28004824|NCT00657046|81849744|FG000|Overall Study|Death|0|||
28004825|NCT00657046|81849745|FG001|Overall Study|Death|0|||
28004826|NCT00657046|81849746|FG002|Overall Study|Death|1|||
28004827|NCT00657046|81849744|FG000|Overall Study|Surgery|0|||
28004828|NCT00657046|81849745|FG001|Overall Study|Surgery|0|||
28004829|NCT00657046|81849746|FG002|Overall Study|Surgery|1|||
28004830|NCT03935126|81849751|FG000|Overall Study|Study termination by sponsor|3|||
28004831|NCT03623243|81849752|FG000|Overall Study|Adverse Event|15|||
28004832|NCT03623243|81849752|FG000|Overall Study|Guardian Decision|1|||
28004833|NCT03623243|81849752|FG000|Overall Study|New Therapy for Study Indication|1|||
28004834|NCT03623243|81849752|FG000|Overall Study|Protocol Deviation|3|||
28004835|NCT03623243|81849752|FG000|Overall Study|Physician Decision|4|||
28004836|NCT03623243|81849752|FG000|Overall Study|Patient Decision|15|||
28004837|NCT02978417|81849753|FG000|Overall Study|Lost to Follow-up|2|||
28004838|NCT02978417|81849754|FG001|Overall Study|Lost to Follow-up|2|||
27808549|NCT00410410|81130623|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
27808550|NCT00410410|81130615|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808551|NCT00410410|81130616|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808552|NCT00410410|81130617|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808553|NCT00410410|81130618|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808554|NCT00410410|81130619|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808555|NCT00410410|81130620|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808556|NCT00410410|81130621|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808557|NCT00410410|81130622|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
27808558|NCT00410410|81130623|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
27808559|NCT00410410|81130615|FG000|Open-Label Period (OL)|Pregnancy|0|||
27808560|NCT00410410|81130616|FG001|Open-Label Period (OL)|Pregnancy|0|||
27808561|NCT00410410|81130617|FG002|Open-Label Period (OL)|Pregnancy|0|||
27808562|NCT00410410|81130618|FG003|Open-Label Period (OL)|Pregnancy|0|||
27808563|NCT00410410|81130619|FG004|Open-Label Period (OL)|Pregnancy|0|||
27808564|NCT00410410|81130620|FG005|Open-Label Period (OL)|Pregnancy|0|||
27808565|NCT00410410|81130621|FG006|Open-Label Period (OL)|Pregnancy|0|||
27808566|NCT00410410|81130622|FG007|Open-Label Period (OL)|Pregnancy|0|||
27808567|NCT00410410|81130623|FG008|Open-Label Period (OL)|Pregnancy|1|||
27808568|NCT00410410|81130615|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808569|NCT00410410|81130616|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808570|NCT00410410|81130617|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808571|NCT00410410|81130618|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808572|NCT00410410|81130619|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808573|NCT00410410|81130620|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808574|NCT00410410|81130621|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808575|NCT00410410|81130622|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
27808576|NCT00410410|81130623|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
27808577|NCT00410410|81130615|FG000|Open-Label Period (OL)|Other|0|||
27808578|NCT00410410|81130616|FG001|Open-Label Period (OL)|Other|0|||
27808579|NCT00410410|81130617|FG002|Open-Label Period (OL)|Other|0|||
27808580|NCT00410410|81130618|FG003|Open-Label Period (OL)|Other|0|||
27808581|NCT00410410|81130619|FG004|Open-Label Period (OL)|Other|0|||
27808582|NCT00410410|81130620|FG005|Open-Label Period (OL)|Other|0|||
27808583|NCT00410410|81130621|FG006|Open-Label Period (OL)|Other|0|||
27808584|NCT00410410|81130622|FG007|Open-Label Period (OL)|Other|0|||
27808585|NCT00410410|81130623|FG008|Open-Label Period (OL)|Other|7|||
27808586|NCT04317781|81130624|FG000|Overall Study|Adverse Event|1|||
27874419|NCT00485264|81371750|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
27874420|NCT00485264|81371751|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
28004839|NCT02920892|81849756|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
27808587|NCT04317781|81130624|FG000|Overall Study|Disease relapse|1|||
27808588|NCT04317781|81130624|FG000|Overall Study|Withdrawal by Subject|1|||
27874421|NCT00485264|81371752|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
28004840|NCT02920892|81849757|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
28004841|NCT02920892|81849758|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
27808589|NCT03273387|81130625|FG000|Overall Study|Death|2|||
27808590|NCT03273387|81130626|FG001|Overall Study|Death|2|||
27874422|NCT00485264|81371753|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
27684611|NCT04488770|80683526|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684612|NCT04488770|80683527|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684613|NCT04488770|80683528|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
27684614|NCT04488770|80683529|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684615|NCT04488770|80683530|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
28004842|NCT02920892|81849756|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
28004843|NCT02920892|81849757|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
27808591|NCT03273387|81130625|FG000|Overall Study|Withdrawal by Subject|1|||
27808592|NCT03273387|81130626|FG001|Overall Study|Withdrawal by Subject|1|||
27684616|NCT04488770|80683531|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684617|NCT04488770|80683532|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684618|NCT04488770|80683533|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684619|NCT04488770|80683534|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684620|NCT04488770|80683535|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684621|NCT04488770|80683536|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684622|NCT04488770|80683537|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
27684623|NCT04488770|80683525|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
27684624|NCT04488770|80683526|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27808593|NCT00671879|81130629|FG000|Overall Study|Withdrawal by Subject|0|||
27808594|NCT00671879|81130630|FG001|Overall Study|Withdrawal by Subject|4|||
27808595|NCT00671879|81130631|FG002|Overall Study|Withdrawal by Subject|6|||
27808596|NCT00207714|81130633|FG000|Overall Study|Adverse Event|6|||
27684625|NCT04488770|80683527|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684626|NCT04488770|80683528|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684627|NCT04488770|80683529|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684628|NCT04488770|80683530|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684629|NCT04488770|80683531|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684630|NCT04488770|80683532|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684631|NCT04488770|80683533|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684632|NCT04488770|80683534|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684633|NCT04488770|80683535|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684634|NCT04488770|80683536|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27684635|NCT04488770|80683537|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
27808597|NCT00207714|81130634|FG001|Overall Study|Adverse Event|2|||
27808598|NCT00207714|81130635|FG002|Overall Study|Adverse Event|4|||
27808599|NCT00207714|81130636|FG003|Overall Study|Adverse Event|3|||
27808600|NCT00207714|81130637|FG004|Overall Study|Adverse Event|1|||
27808601|NCT00207714|81130633|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27808602|NCT00207714|81130634|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27808603|NCT00207714|81130635|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27808604|NCT00207714|81130636|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
27808605|NCT00207714|81130637|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
27808606|NCT00207714|81130633|FG000|Overall Study|Other|3|||
27808607|NCT00207714|81130634|FG001|Overall Study|Other|2|||
27808608|NCT00207714|81130635|FG002|Overall Study|Other|5|||
27808609|NCT00207714|81130636|FG003|Overall Study|Other|1|||
28004844|NCT02920892|81849758|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
28004845|NCT02920892|81849756|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
28004846|NCT02920892|81849757|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
28004847|NCT02920892|81849758|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
28004848|NCT02920892|81849756|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
28004849|NCT02920892|81849757|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
28004850|NCT02920892|81849758|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
28004851|NCT02920892|81849756|FG000|Placebo-Controlled Period|Physician Decision|0|||
27684636|NCT04488770|80683525|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684637|NCT04488770|80683526|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684638|NCT04488770|80683527|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684639|NCT04488770|80683528|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684640|NCT04488770|80683529|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684641|NCT04488770|80683530|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
27684642|NCT04488770|80683531|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
27684643|NCT04488770|80683532|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684644|NCT04488770|80683533|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684645|NCT04488770|80683534|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27700994|NCT01241552|80741291|FG002|Overall Study|Protocol Violation|6|||
27808610|NCT00207714|81130637|FG004|Overall Study|Other|0|||
27808611|NCT01159769|81130641|FG000|Overall Study|Adverse Event|1|||
27808612|NCT04378010|81130642|FG000|Overall Study|Adverse Event|8|||
27808613|NCT04378010|81130643|FG001|Overall Study|Adverse Event|14|||
28004852|NCT02920892|81849757|FG001|Placebo-Controlled Period|Physician Decision|0|||
27684646|NCT04488770|80683535|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684647|NCT04488770|80683536|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684648|NCT04488770|80683537|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27684649|NCT04488770|80683525|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27874423|NCT00485264|81371754|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
27874424|NCT00485264|81371755|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
27684650|NCT04488770|80683526|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684651|NCT04488770|80683527|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684652|NCT04488770|80683528|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
28004853|NCT02920892|81849758|FG002|Placebo-Controlled Period|Physician Decision|1|||
28004854|NCT02920892|81849756|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
28004855|NCT02920892|81849757|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
28004856|NCT02920892|81849758|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
28004857|NCT02920892|81849756|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
28004858|NCT02920892|81849757|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
28004859|NCT02920892|81849758|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
28004860|NCT02920892|81849756|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
28004861|NCT02920892|81849757|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
28004862|NCT02920892|81849758|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
28004863|NCT02520726|81849768|FG000|Overall Study|Lost to Follow-up|3|||
28004864|NCT02520726|81849769|FG001|Overall Study|Lost to Follow-up|2|||
28004865|NCT01188772|81849781|FG000|Overall Study|Randomized but Not Treated|0|||
28004866|NCT01188772|81849782|FG001|Overall Study|Randomized but Not Treated|1|||
28004867|NCT01188772|81849783|FG002|Overall Study|Randomized but Not Treated|0|||
28004868|NCT01188772|81849784|FG003|Overall Study|Randomized but Not Treated|0|||
28004869|NCT01188772|81849781|FG000|Overall Study|Adverse Event|0|||
28004870|NCT01188772|81849782|FG001|Overall Study|Adverse Event|1|||
28004871|NCT01188772|81849783|FG002|Overall Study|Adverse Event|2|||
28004872|NCT01188772|81849784|FG003|Overall Study|Adverse Event|0|||
27584911|NCT01303627|80322071|FG001|Overall Study|the failure while performing URS|1|||
27584912|NCT01539291|80322072|FG000|Study GS-US-312-0116|Adverse Event|9|||
27584913|NCT01539291|80322073|FG001|Study GS-US-312-0116|Adverse Event|0|||
27584914|NCT01539291|80322074|FG002|Study GS-US-312-0116|Adverse Event|0|||
27584915|NCT01539291|80322075|FG003|Study GS-US-312-0116|Adverse Event|0|||
27584916|NCT01539291|80322072|FG000|Study GS-US-312-0116|Physician Decision|1|||
27584917|NCT01539291|80322073|FG001|Study GS-US-312-0116|Physician Decision|0|||
27584918|NCT01539291|80322074|FG002|Study GS-US-312-0116|Physician Decision|0|||
27584919|NCT01539291|80322075|FG003|Study GS-US-312-0116|Physician Decision|0|||
27584920|NCT01539291|80322072|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
27684653|NCT04488770|80683529|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
27684654|NCT04488770|80683530|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684655|NCT04488770|80683531|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27874425|NCT00485264|81371750|FG000|Overall Study|Lack of Efficacy|0|||
27874426|NCT00485264|81371751|FG001|Overall Study|Lack of Efficacy|1|||
27874427|NCT00485264|81371752|FG002|Overall Study|Lack of Efficacy|0|||
27874428|NCT00485264|81371753|FG003|Overall Study|Lack of Efficacy|0|||
27874429|NCT00485264|81371754|FG004|Overall Study|Lack of Efficacy|0|||
27874430|NCT00485264|81371755|FG005|Overall Study|Lack of Efficacy|0|||
27874431|NCT00485264|81371750|FG000|Overall Study|Guardian Consent Withdrawn|1|||
27874432|NCT00485264|81371751|FG001|Overall Study|Guardian Consent Withdrawn|0|||
27584921|NCT01539291|80322073|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
27874433|NCT00485264|81371752|FG002|Overall Study|Guardian Consent Withdrawn|0|||
27874434|NCT00485264|81371753|FG003|Overall Study|Guardian Consent Withdrawn|0|||
27874435|NCT00485264|81371754|FG004|Overall Study|Guardian Consent Withdrawn|1|||
27874436|NCT00485264|81371755|FG005|Overall Study|Guardian Consent Withdrawn|0|||
27874437|NCT00485264|81371750|FG000|Overall Study|Physician Decision|0|||
27874438|NCT00485264|81371751|FG001|Overall Study|Physician Decision|2|||
27874439|NCT00485264|81371752|FG002|Overall Study|Physician Decision|0|||
27874440|NCT00485264|81371753|FG003|Overall Study|Physician Decision|0|||
28004873|NCT01188772|81849781|FG000|Overall Study|Lost to Follow-up|4|||
27584922|NCT01539291|80322074|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
27584923|NCT01539291|80322075|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
27584924|NCT01539291|80322072|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
27584925|NCT01539291|80322073|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
27584926|NCT01539291|80322074|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
27584927|NCT01539291|80322075|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
27584928|NCT01539291|80322072|FG000|Study GS-US-312-0116|Other|1|||
27584929|NCT01539291|80322073|FG001|Study GS-US-312-0116|Other|0|||
27584930|NCT01539291|80322074|FG002|Study GS-US-312-0116|Other|0|||
28004874|NCT01188772|81849782|FG001|Overall Study|Lost to Follow-up|1|||
28004875|NCT01188772|81849783|FG002|Overall Study|Lost to Follow-up|1|||
28004876|NCT01188772|81849784|FG003|Overall Study|Lost to Follow-up|1|||
28004877|NCT01188772|81849781|FG000|Overall Study|Non-responder|0|||
27684656|NCT04488770|80683532|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684657|NCT04488770|80683533|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684658|NCT04488770|80683534|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684659|NCT04488770|80683535|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684660|NCT04488770|80683536|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684661|NCT04488770|80683537|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
27684662|NCT00836745|80683538|FG000|Overall Study|Death|2|||
27684663|NCT00836745|80683538|FG000|Overall Study|Lost to Follow-up|10|||
27684664|NCT00836745|80683538|FG000|Overall Study|Adverse Event|3|||
27684665|NCT00836745|80683538|FG000|Overall Study|Objective progression or relapse|4|||
27684666|NCT00836745|80683538|FG000|Overall Study|Other|2|||
27684667|NCT01307579|80683539|FG000|Overall Study|Death|3|||
27684668|NCT01307579|80683540|FG001|Overall Study|Death|6|||
27684669|NCT01307579|80683539|FG000|Overall Study|Physician Decision|26|||
27684670|NCT01307579|80683540|FG001|Overall Study|Physician Decision|29|||
27684671|NCT01307579|80683539|FG000|Overall Study|Withdrawal by Subject|7|||
27684672|NCT01307579|80683540|FG001|Overall Study|Withdrawal by Subject|3|||
27684673|NCT01307579|80683539|FG000|Overall Study|Institutional diagnosis of IFD|21|||
27684674|NCT01307579|80683540|FG001|Overall Study|Institutional diagnosis of IFD|36|||
27684675|NCT01307579|80683539|FG000|Overall Study|Begin conditioning for HSCT|42|||
27684676|NCT01307579|80683540|FG001|Overall Study|Begin conditioning for HSCT|44|||
27684677|NCT01307579|80683539|FG000|Overall Study|Refractory or relapsed AML|38|||
27684678|NCT01307579|80683540|FG001|Overall Study|Refractory or relapsed AML|23|||
27684679|NCT01307579|80683539|FG000|Overall Study|Ineligible|3|||
27684680|NCT01307579|80683540|FG001|Overall Study|Ineligible|4|||
27684681|NCT00589121|80683541|FG000|Overall Study|Protocol Violation|2|||
27684682|NCT00589121|80683542|FG001|Overall Study|Protocol Violation|6|||
27684683|NCT00589121|80683541|FG000|Overall Study|No protocol treatment received|0|||
27684684|NCT00589121|80683542|FG001|Overall Study|No protocol treatment received|1|||
27684685|NCT03223662|80683543|FG000|Overall Study|Physician Decision|1|||
27684686|NCT03223662|80683543|FG000|Overall Study|Study closure|1|||
27684687|NCT01262027|80683544|FG000|Overall Study|Adverse Event|1|||
27684688|NCT01262027|80683544|FG000|Overall Study|Withdrawal by Subject|3|||
27684689|NCT01262027|80683544|FG000|Overall Study|Protocol Violation|1|||
27684690|NCT03014011|80683545|FG000|First Intervention|Withdrawal by Subject|1|||
27684691|NCT03014011|80683546|FG001|First Intervention|Withdrawal by Subject|0|||
27684692|NCT03014011|80683545|FG000|Washout|Withdrawal by Subject|1|||
27684693|NCT03014011|80683546|FG001|Washout|Withdrawal by Subject|0|||
27684694|NCT04032613|80683550|FG000|Overall Study|Did not complete post-program assessment|5|||
27684695|NCT04032613|80683551|FG001|Overall Study|Did not complete post-program assessment|2|||
27684696|NCT01125514|80683554|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
27684697|NCT01125514|80683554|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
27684698|NCT01125514|80683554|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
27684699|NCT01125514|80683554|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
27684700|NCT01125514|80683554|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
27684701|NCT01125514|80683554|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
27684702|NCT04510090|80683555|FG000|FE-HS|Withdrawal by Subject|0|||
27684703|NCT04510090|80683556|FG001|FE-HS|Withdrawal by Subject|0|||
27684704|NCT04510090|80683557|FG002|FE-HS|Withdrawal by Subject|0|||
27684705|NCT04510090|80683558|FG003|FE-HS|Withdrawal by Subject|0|||
27684706|NCT04510090|80683559|FG004|FE-HS|Withdrawal by Subject|1|||
27684707|NCT04510090|80683560|FG005|FE-HS|Withdrawal by Subject|0|||
27684708|NCT04510090|80683561|FG006|FE-HS|Withdrawal by Subject|0|||
27684709|NCT04510090|80683562|FG007|FE-HS|Withdrawal by Subject|0|||
27684710|NCT01215188|80683563|FG000|Overall Study|Lost to Follow-up|22|||
27684711|NCT01215188|80683564|FG001|Overall Study|Lost to Follow-up|22|||
27684712|NCT01215188|80683565|FG002|Overall Study|Lost to Follow-up|16|||
27684713|NCT01215188|80683563|FG000|Overall Study|Adverse Event|1|||
27684714|NCT01215188|80683564|FG001|Overall Study|Adverse Event|1|||
27684715|NCT01215188|80683565|FG002|Overall Study|Adverse Event|3|||
27684716|NCT01215188|80683563|FG000|Overall Study|Physician Decision|2|||
27684717|NCT01215188|80683564|FG001|Overall Study|Physician Decision|1|||
27684718|NCT01215188|80683565|FG002|Overall Study|Physician Decision|0|||
27684719|NCT01215188|80683563|FG000|Overall Study|Lack of Efficacy|0|||
27684720|NCT01215188|80683564|FG001|Overall Study|Lack of Efficacy|0|||
27684721|NCT01215188|80683565|FG002|Overall Study|Lack of Efficacy|1|||
27684722|NCT01215188|80683563|FG000|Overall Study|Protocol Violation|1|||
27684723|NCT01215188|80683564|FG001|Overall Study|Protocol Violation|1|||
27684724|NCT01215188|80683565|FG002|Overall Study|Protocol Violation|1|||
27684725|NCT01215188|80683563|FG000|Overall Study|Withdrawal by Subject|32|||
27684726|NCT01215188|80683564|FG001|Overall Study|Withdrawal by Subject|34|||
27684727|NCT01215188|80683565|FG002|Overall Study|Withdrawal by Subject|31|||
27684728|NCT01258595|80683566|FG000|Overall Study|Lost to Follow-up|1|||
27684729|NCT01258595|80683567|FG001|Overall Study|Lost to Follow-up|0|||
27684730|NCT01258595|80683566|FG000|Overall Study|Withdrawal by Subject|0|||
27684731|NCT01258595|80683567|FG001|Overall Study|Withdrawal by Subject|1|||
27684732|NCT00414908|80683575|FG000|Overall Study|Protocol Violation|1|||
27684733|NCT00414908|80683576|FG001|Overall Study|Protocol Violation|1|||
27684734|NCT01353859|80683580|FG000|Overall Study|Adverse Event|3|||
27684735|NCT01353859|80683580|FG000|Overall Study|Lack of Efficacy|1|||
27684736|NCT02399254|80683582|FG000|Overall Study|Physician Decision|2|||
27684737|NCT04101318|80683583|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
27684738|NCT04101318|80683584|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
27684739|NCT04101318|80683583|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
27684740|NCT04101318|80683584|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
27684741|NCT04101318|80683583|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
27684742|NCT04101318|80683584|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
27684743|NCT02930226|80683586|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
27684744|NCT02930226|80683587|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
27684745|NCT02930226|80683588|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
27684746|NCT02930226|80683589|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
27684747|NCT02930226|80683590|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
27684748|NCT02930226|80683591|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
27684749|NCT01871805|80683592|FG000|Phase I|Death|7|||
27684750|NCT01871805|80683593|FG001|Phase I|Death|4|||
27684751|NCT01871805|80683594|FG002|Phase I|Death|6|||
27684752|NCT01871805|80683595|FG003|Phase I|Death|2|||
27684753|NCT01871805|80683596|FG004|Phase I|Death|9|||
27684754|NCT01871805|80683597|FG005|Phase I|Death|0|||
27684755|NCT01871805|80683592|FG000|Phase I|Alive in Survival Follow-up|0|||
27684756|NCT01871805|80683593|FG001|Phase I|Alive in Survival Follow-up|2|||
27684757|NCT01871805|80683594|FG002|Phase I|Alive in Survival Follow-up|4|||
27684758|NCT01871805|80683595|FG003|Phase I|Alive in Survival Follow-up|5|||
27684759|NCT01871805|80683596|FG004|Phase I|Alive in Survival Follow-up|4|||
27684760|NCT01871805|80683597|FG005|Phase I|Alive in Survival Follow-up|0|||
27684761|NCT01871805|80683592|FG000|Phase I|Lost to Follow-up|0|||
27684762|NCT01871805|80683593|FG001|Phase I|Lost to Follow-up|1|||
27684763|NCT01871805|80683594|FG002|Phase I|Lost to Follow-up|3|||
27684764|NCT01871805|80683595|FG003|Phase I|Lost to Follow-up|0|||
27684765|NCT01871805|80683596|FG004|Phase I|Lost to Follow-up|0|||
27684766|NCT01871805|80683597|FG005|Phase I|Lost to Follow-up|0|||
27684767|NCT01871805|80683592|FG000|Phase II|Death|0|||
27684768|NCT01871805|80683593|FG001|Phase II|Death|0|||
27684769|NCT01871805|80683594|FG002|Phase II|Death|0|||
27684770|NCT01871805|80683595|FG003|Phase II|Death|0|||
27684771|NCT01871805|80683596|FG004|Phase II|Death|0|||
27684772|NCT01871805|80683597|FG005|Phase II|Death|45|||
27684773|NCT01871805|80683592|FG000|Phase II|Alive in Survival Follow-up|0|||
27684774|NCT01871805|80683593|FG001|Phase II|Alive in Survival Follow-up|0|||
27684775|NCT01871805|80683594|FG002|Phase II|Alive in Survival Follow-up|0|||
27684776|NCT01871805|80683595|FG003|Phase II|Alive in Survival Follow-up|0|||
27684777|NCT01871805|80683596|FG004|Phase II|Alive in Survival Follow-up|0|||
27684778|NCT01871805|80683597|FG005|Phase II|Alive in Survival Follow-up|29|||
27684779|NCT01871805|80683592|FG000|Phase II|Lost to Follow-up|0|||
27684780|NCT01871805|80683593|FG001|Phase II|Lost to Follow-up|0|||
27684781|NCT01871805|80683594|FG002|Phase II|Lost to Follow-up|0|||
27684782|NCT01871805|80683595|FG003|Phase II|Lost to Follow-up|0|||
27684783|NCT01871805|80683596|FG004|Phase II|Lost to Follow-up|0|||
27684784|NCT01871805|80683597|FG005|Phase II|Lost to Follow-up|13|||
27684785|NCT01076647|80683598|FG000|Overall Study|Adverse Event|4|||
27684786|NCT01076647|80683599|FG001|Overall Study|Adverse Event|1|||
27684787|NCT01076647|80683598|FG000|Overall Study|Lack of Efficacy|0|||
27684788|NCT01076647|80683599|FG001|Overall Study|Lack of Efficacy|1|||
27684789|NCT01076647|80683598|FG000|Overall Study|Protocol Violation|7|||
27874441|NCT00485264|81371754|FG004|Overall Study|Physician Decision|0|||
27584931|NCT01539291|80322075|FG003|Study GS-US-312-0116|Other|0|||
27584932|NCT01539291|80322072|FG000|Study GS-US-312-0117|Adverse Event|22|||
27584933|NCT01539291|80322073|FG001|Study GS-US-312-0117|Adverse Event|1|||
27584934|NCT01539291|80322074|FG002|Study GS-US-312-0117|Adverse Event|9|||
27584935|NCT01539291|80322075|FG003|Study GS-US-312-0117|Adverse Event|12|||
27584936|NCT01539291|80322072|FG000|Study GS-US-312-0117|Physician Decision|9|||
27584937|NCT01539291|80322073|FG001|Study GS-US-312-0117|Physician Decision|0|||
27584938|NCT01539291|80322074|FG002|Study GS-US-312-0117|Physician Decision|6|||
27584939|NCT01539291|80322075|FG003|Study GS-US-312-0117|Physician Decision|4|||
27584940|NCT01539291|80322072|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
27584941|NCT01539291|80322073|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
27584942|NCT01539291|80322074|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
27584943|NCT01539291|80322075|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
27584944|NCT01539291|80322072|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
27584945|NCT01539291|80322073|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
27584946|NCT01539291|80322074|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
27584947|NCT01539291|80322075|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
27584948|NCT01539291|80322072|FG000|Study GS-US-312-0117|Other|2|||
27874442|NCT00485264|81371755|FG005|Overall Study|Physician Decision|0|||
27874443|NCT00485264|81371750|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
27874444|NCT00485264|81371751|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
27874445|NCT00485264|81371752|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
27874446|NCT00485264|81371753|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
27874447|NCT00485264|81371754|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
27874448|NCT00485264|81371755|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
27874449|NCT00485264|81371750|FG000|Overall Study|Not Able to Attend Clinic|5|||
27874450|NCT00485264|81371751|FG001|Overall Study|Not Able to Attend Clinic|0|||
27874451|NCT00485264|81371752|FG002|Overall Study|Not Able to Attend Clinic|0|||
27874452|NCT00485264|81371753|FG003|Overall Study|Not Able to Attend Clinic|1|||
27874453|NCT00485264|81371754|FG004|Overall Study|Not Able to Attend Clinic|1|||
27874454|NCT00485264|81371755|FG005|Overall Study|Not Able to Attend Clinic|2|||
27874455|NCT00485264|81371750|FG000|Overall Study|Non-Compliant|17|||
27874456|NCT00485264|81371751|FG001|Overall Study|Non-Compliant|2|||
27874457|NCT00485264|81371752|FG002|Overall Study|Non-Compliant|1|||
27874458|NCT00485264|81371753|FG003|Overall Study|Non-Compliant|0|||
27874459|NCT00485264|81371754|FG004|Overall Study|Non-Compliant|1|||
27874460|NCT00485264|81371755|FG005|Overall Study|Non-Compliant|0|||
27874461|NCT00485264|81371750|FG000|Overall Study|Lost to Follow-up|2|||
28004878|NCT01188772|81849782|FG001|Overall Study|Non-responder|0|||
28004879|NCT01188772|81849783|FG002|Overall Study|Non-responder|3|||
28004880|NCT01188772|81849784|FG003|Overall Study|Non-responder|0|||
28004881|NCT01188772|81849781|FG000|Overall Study|Physician Decision|0|||
28004882|NCT01188772|81849782|FG001|Overall Study|Physician Decision|0|||
28004883|NCT01188772|81849783|FG002|Overall Study|Physician Decision|1|||
28004884|NCT01188772|81849784|FG003|Overall Study|Physician Decision|0|||
28004885|NCT01188772|81849781|FG000|Overall Study|Terminated by Sponsor|0|||
28004886|NCT01188772|81849782|FG001|Overall Study|Terminated by Sponsor|0|||
28004887|NCT01188772|81849783|FG002|Overall Study|Terminated by Sponsor|1|||
28004888|NCT01188772|81849784|FG003|Overall Study|Terminated by Sponsor|0|||
28004889|NCT01188772|81849781|FG000|Overall Study|Treatment Failure|0|||
27584949|NCT01539291|80322073|FG001|Study GS-US-312-0117|Other|1|||
27584950|NCT01539291|80322074|FG002|Study GS-US-312-0117|Other|1|||
27584951|NCT01539291|80322075|FG003|Study GS-US-312-0117|Other|1|||
27584952|NCT02617589|80322078|FG000|Randomization|Request to Discontinue Study Treatment|1|||
27584953|NCT02617589|80322079|FG001|Randomization|Request to Discontinue Study Treatment|3|||
27584954|NCT02617589|80322078|FG000|Randomization|Participant Withdrew Consent|1|||
27584955|NCT02617589|80322079|FG001|Randomization|Participant Withdrew Consent|2|||
27584956|NCT02617589|80322078|FG000|Treatment|Other Reasons|3|||
27584957|NCT02617589|80322079|FG001|Treatment|Other Reasons|3|||
27584958|NCT02617589|80322078|FG000|Treatment|Poor/Non Compliance|1|||
27584959|NCT02617589|80322079|FG001|Treatment|Poor/Non Compliance|1|||
27584960|NCT02617589|80322078|FG000|Treatment|Maximum Clinical Benefit|0|||
27584961|NCT02617589|80322079|FG001|Treatment|Maximum Clinical Benefit|2|||
27584962|NCT02617589|80322078|FG000|Treatment|Participant Withdrew Consent|2|||
27584963|NCT02617589|80322079|FG001|Treatment|Participant Withdrew Consent|6|||
27584964|NCT02617589|80322078|FG000|Treatment|Participant Request to Discontinue|12|||
27584965|NCT02617589|80322079|FG001|Treatment|Participant Request to Discontinue|21|||
27584966|NCT02617589|80322078|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
27584967|NCT02617589|80322079|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
27584968|NCT02617589|80322078|FG000|Treatment|Death|1|||
27584969|NCT02617589|80322079|FG001|Treatment|Death|1|||
27584970|NCT02617589|80322078|FG000|Treatment|Study Drug Toxicity|27|||
27584971|NCT02617589|80322079|FG001|Treatment|Study Drug Toxicity|20|||
27584972|NCT02617589|80322078|FG000|Treatment|Disease Progression|216|||
27584973|NCT02617589|80322079|FG001|Treatment|Disease Progression|136|||
27584974|NCT03701555|80322080|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
27584975|NCT03701555|80322081|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
27584976|NCT03701555|80322082|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
27584977|NCT03701555|80322083|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
27584978|NCT03701555|80322084|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
28004890|NCT01188772|81849782|FG001|Overall Study|Treatment Failure|0|||
28004891|NCT01188772|81849783|FG002|Overall Study|Treatment Failure|1|||
28004892|NCT01188772|81849784|FG003|Overall Study|Treatment Failure|0|||
27584979|NCT03701555|80322085|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
27874462|NCT00485264|81371751|FG001|Overall Study|Lost to Follow-up|1|||
27584980|NCT03701555|80322086|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
27584981|NCT03701555|80322087|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
27584982|NCT03701555|80322088|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
27584983|NCT03701555|80322089|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
27584984|NCT03701555|80322090|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
27874463|NCT00485264|81371752|FG002|Overall Study|Lost to Follow-up|1|||
27874464|NCT00485264|81371753|FG003|Overall Study|Lost to Follow-up|0|||
27874465|NCT00485264|81371754|FG004|Overall Study|Lost to Follow-up|0|||
28004893|NCT01188772|81849781|FG000|Overall Study|Virologic Failure|1|||
28004894|NCT01188772|81849782|FG001|Overall Study|Virologic Failure|0|||
28004895|NCT01188772|81849783|FG002|Overall Study|Virologic Failure|0|||
28004896|NCT01188772|81849784|FG003|Overall Study|Virologic Failure|0|||
28004897|NCT01188772|81849781|FG000|Overall Study|Withdrawal by Subject|0|||
28004898|NCT01188772|81849782|FG001|Overall Study|Withdrawal by Subject|0|||
28004899|NCT01188772|81849783|FG002|Overall Study|Withdrawal by Subject|2|||
28004900|NCT01188772|81849784|FG003|Overall Study|Withdrawal by Subject|0|||
28004901|NCT01519323|81849785|FG000|Overall Study|Death|3|||
28004902|NCT01519323|81849786|FG001|Overall Study|Death|2|||
28004903|NCT01519323|81849785|FG000|Overall Study|Study terminated by sponsor|0|||
28004904|NCT01519323|81849786|FG001|Overall Study|Study terminated by sponsor|1|||
28004905|NCT03790111|81849789|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
28004906|NCT05135871|81849800|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
28004907|NCT05135871|81849801|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
28004908|NCT05135871|81849802|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
28004909|NCT05135871|81849803|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
28004910|NCT04842747|81849804|FG000|Overall Study|Withdrawal by Subject|6|||
28004911|NCT04842747|81849805|FG001|Overall Study|Withdrawal by Subject|2|||
28004912|NCT04842747|81849804|FG000|Overall Study|Lost to Follow-up|1|||
28004913|NCT04842747|81849805|FG001|Overall Study|Lost to Follow-up|2|||
28004914|NCT04842747|81849804|FG000|Overall Study|Physician Decision|1|||
28004915|NCT04842747|81849805|FG001|Overall Study|Physician Decision|0|||
28004916|NCT04842747|81849804|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
28004917|NCT04842747|81849805|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
28004918|NCT01308736|81849808|FG000|Overall Study|Did not attend a single session|6|||
28004919|NCT01308736|81849809|FG001|Overall Study|Did not attend a single session|5|||
28004920|NCT01921205|81849811|FG000|Overall Study|Adverse Event|12|||
28004921|NCT01921205|81849812|FG001|Overall Study|Adverse Event|7|||
28004922|NCT01921205|81849811|FG000|Overall Study|Lack of Efficacy|1|||
28004923|NCT01921205|81849812|FG001|Overall Study|Lack of Efficacy|0|||
28004924|NCT01921205|81849811|FG000|Overall Study|Protocol Violation|1|||
28004925|NCT01921205|81849812|FG001|Overall Study|Protocol Violation|3|||
28004926|NCT01921205|81849811|FG000|Overall Study|Lost to Follow-up|1|||
28004927|NCT01921205|81849812|FG001|Overall Study|Lost to Follow-up|1|||
28004928|NCT01921205|81849811|FG000|Overall Study|Withdrawal by Subject|6|||
28004929|NCT01921205|81849812|FG001|Overall Study|Withdrawal by Subject|5|||
28004930|NCT01921205|81849811|FG000|Overall Study|Use Of Prohibited Medication|0|||
28004931|NCT01921205|81849812|FG001|Overall Study|Use Of Prohibited Medication|1|||
28004932|NCT01921205|81849811|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
28004933|NCT01921205|81849812|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
28004934|NCT01921205|81849811|FG000|Overall Study|Non Compliance Of The Parent|0|||
28004935|NCT01921205|81849812|FG001|Overall Study|Non Compliance Of The Parent|1|||
28004936|NCT01921205|81849811|FG000|Overall Study|Non Compliance Of Child|0|||
27584985|NCT03701555|80322091|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
27584986|NCT03701555|80322092|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
27584987|NCT03701555|80322093|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
27584988|NCT03701555|80322094|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
27584989|NCT03701555|80322095|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
27584990|NCT03701555|80322096|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
27584991|NCT03701555|80322097|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
27584992|NCT03701555|80322098|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
27584993|NCT03701555|80322099|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
27808614|NCT04378010|81130644|FG002|Overall Study|Adverse Event|4|||
27584994|NCT03701555|80322100|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
27584995|NCT03701555|80322101|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
27584996|NCT03701555|80322102|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
27584997|NCT03701555|80322103|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
27584998|NCT03701555|80322104|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
27808615|NCT04378010|81130642|FG000|Overall Study|Withdrawal by Subject|0|||
27808616|NCT04378010|81130643|FG001|Overall Study|Withdrawal by Subject|2|||
28004937|NCT01921205|81849812|FG001|Overall Study|Non Compliance Of Child|1|||
28004938|NCT00445549|81849823|FG000|Overall Study|progressive disease|12|||
27808617|NCT04378010|81130644|FG002|Overall Study|Withdrawal by Subject|1|||
27684790|NCT01076647|80683599|FG001|Overall Study|Protocol Violation|9|||
27684791|NCT01076647|80683598|FG000|Overall Study|Withdrawal criteria|2|||
27684792|NCT01076647|80683599|FG001|Overall Study|Withdrawal criteria|2|||
27684793|NCT01076647|80683598|FG000|Overall Study|Unclassified|12|||
27684794|NCT01076647|80683599|FG001|Overall Study|Unclassified|12|||
27684795|NCT03466073|80683606|FG000|Overall Study|Death|1|||
27684796|NCT03466073|80683607|FG001|Overall Study|Death|0|||
27684797|NCT03466073|80683608|FG002|Overall Study|Death|0|||
28004939|NCT03212326|81849824|FG000|Overall Study|Physician Decision|4|||
28004940|NCT00453154|81849825|FG000|Double BIind Maintenance|Adverse Event|0|||
27684798|NCT03466073|80683609|FG003|Overall Study|Death|0|||
27684799|NCT03466073|80683610|FG004|Overall Study|Death|0|||
27684800|NCT03466073|80683611|FG005|Overall Study|Death|1|||
27684801|NCT01451827|80683612|FG000|Overall Study|Adverse Event|2|||
27684802|NCT01451827|80683613|FG001|Overall Study|Adverse Event|0|||
28004941|NCT00453154|81849826|FG001|Double BIind Maintenance|Adverse Event|0|||
27684803|NCT01451827|80683614|FG002|Overall Study|Adverse Event|1|||
27684804|NCT01451827|80683615|FG003|Overall Study|Adverse Event|1|||
27684805|NCT01451827|80683612|FG000|Overall Study|Protocol deviation|1|||
27584999|NCT03701555|80322105|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
27585000|NCT03701555|80322106|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
27684806|NCT01451827|80683613|FG001|Overall Study|Protocol deviation|0|||
27684807|NCT01451827|80683614|FG002|Overall Study|Protocol deviation|0|||
27684808|NCT01451827|80683615|FG003|Overall Study|Protocol deviation|0|||
27684809|NCT01451827|80683612|FG000|Overall Study|Lost to Follow-up|0|||
27684810|NCT01451827|80683613|FG001|Overall Study|Lost to Follow-up|3|||
27684811|NCT01451827|80683614|FG002|Overall Study|Lost to Follow-up|0|||
27684812|NCT01451827|80683615|FG003|Overall Study|Lost to Follow-up|2|||
27684813|NCT01451827|80683612|FG000|Overall Study|Participant met withdrawal criteria|0|||
28004942|NCT00453154|81849827|FG002|Double BIind Maintenance|Adverse Event|3|||
28004943|NCT00453154|81849828|FG003|Double BIind Maintenance|Adverse Event|12|||
28004944|NCT00453154|81849825|FG000|Double BIind Maintenance|Death|0|||
28004945|NCT00453154|81849826|FG001|Double BIind Maintenance|Death|0|||
28004946|NCT00453154|81849827|FG002|Double BIind Maintenance|Death|2|||
28004947|NCT00453154|81849828|FG003|Double BIind Maintenance|Death|1|||
28004948|NCT00453154|81849825|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
28004949|NCT00453154|81849826|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
28004950|NCT00453154|81849827|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
28004951|NCT00453154|81849828|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
27585001|NCT03701555|80322107|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
27684814|NCT01451827|80683613|FG001|Overall Study|Participant met withdrawal criteria|2|||
27684815|NCT01451827|80683614|FG002|Overall Study|Participant met withdrawal criteria|0|||
27684816|NCT01451827|80683615|FG003|Overall Study|Participant met withdrawal criteria|0|||
27684817|NCT01451827|80683612|FG000|Overall Study|Withdrawal by Subject|0|||
28004952|NCT00453154|81849825|FG000|Double BIind Maintenance|Progression|0|||
28004953|NCT00453154|81849826|FG001|Double BIind Maintenance|Progression|0|||
27585002|NCT03701555|80322108|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
27585003|NCT03701555|80322109|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
27585004|NCT03701555|80322110|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
27585005|NCT03701555|80322111|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
27585006|NCT03701555|80322112|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
27585007|NCT03701555|80322113|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
27585008|NCT03701555|80322114|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
27585009|NCT03701555|80322115|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
27585010|NCT03701555|80322080|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
27585011|NCT03701555|80322081|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
27585012|NCT03701555|80322082|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
27585013|NCT03701555|80322083|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
27585014|NCT03701555|80322084|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
27585015|NCT03701555|80322085|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
27585016|NCT03701555|80322086|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
27585017|NCT03701555|80322087|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
27585018|NCT03701555|80322088|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
27585019|NCT03701555|80322089|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
28004954|NCT00453154|81849827|FG002|Double BIind Maintenance|Progression|29|||
28004955|NCT00453154|81849828|FG003|Double BIind Maintenance|Progression|26|||
28004956|NCT00453154|81849825|FG000|Double BIind Maintenance|Medical Issues|0|||
28004957|NCT00453154|81849826|FG001|Double BIind Maintenance|Medical Issues|0|||
28004958|NCT00453154|81849827|FG002|Double BIind Maintenance|Medical Issues|3|||
28004959|NCT00453154|81849828|FG003|Double BIind Maintenance|Medical Issues|1|||
28004960|NCT00453154|81849825|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
28004961|NCT00453154|81849826|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
28004962|NCT00453154|81849827|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
28004963|NCT00453154|81849828|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
28004964|NCT03305666|81849829|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
28004965|NCT03305666|81849830|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
28004966|NCT00683878|81849831|FG000|Overall Study|Lack of Efficacy|3|||
28004967|NCT00683878|81849832|FG001|Overall Study|Lack of Efficacy|0|||
28004968|NCT00683878|81849833|FG002|Overall Study|Lack of Efficacy|1|||
28004969|NCT00683878|81849831|FG000|Overall Study|Adverse Event|4|||
28004970|NCT00683878|81849832|FG001|Overall Study|Adverse Event|3|||
28004971|NCT00683878|81849833|FG002|Overall Study|Adverse Event|3|||
28004972|NCT00683878|81849831|FG000|Overall Study|Withdrawal by Subject|9|||
28004973|NCT00683878|81849832|FG001|Overall Study|Withdrawal by Subject|8|||
28004974|NCT00683878|81849833|FG002|Overall Study|Withdrawal by Subject|6|||
28004975|NCT00683878|81849831|FG000|Overall Study|Death|0|||
28004976|NCT00683878|81849832|FG001|Overall Study|Death|1|||
28004977|NCT00683878|81849833|FG002|Overall Study|Death|0|||
28004978|NCT00683878|81849831|FG000|Overall Study|Lost to Follow-up|4|||
28004979|NCT00683878|81849832|FG001|Overall Study|Lost to Follow-up|2|||
28004980|NCT00683878|81849833|FG002|Overall Study|Lost to Follow-up|4|||
28004981|NCT00683878|81849831|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
28004982|NCT00683878|81849832|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
28004983|NCT00683878|81849833|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
28004984|NCT01129622|81849838|FG000|Overall Study|Withdrawal by Subject|2|||
28004985|NCT00591006|81849839|FG000|Overall Study|Withdrawal by Subject|0|||
28004986|NCT00591006|81849840|FG001|Overall Study|Withdrawal by Subject|0|||
28004987|NCT00591006|81849841|FG002|Overall Study|Withdrawal by Subject|0|||
28004988|NCT00591006|81849842|FG003|Overall Study|Withdrawal by Subject|0|||
28004989|NCT00591006|81849843|FG004|Overall Study|Withdrawal by Subject|0|||
28004990|NCT00591006|81849844|FG005|Overall Study|Withdrawal by Subject|0|||
28004991|NCT00591006|81849845|FG006|Overall Study|Withdrawal by Subject|0|||
28004992|NCT00591006|81849846|FG007|Overall Study|Withdrawal by Subject|0|||
28004993|NCT00591006|81849847|FG008|Overall Study|Withdrawal by Subject|0|||
28004994|NCT00591006|81849848|FG009|Overall Study|Withdrawal by Subject|0|||
28004995|NCT00591006|81849849|FG010|Overall Study|Withdrawal by Subject|0|||
28004996|NCT00591006|81849850|FG011|Overall Study|Withdrawal by Subject|0|||
28004997|NCT00591006|81849851|FG012|Overall Study|Withdrawal by Subject|0|||
28004998|NCT00591006|81849852|FG013|Overall Study|Withdrawal by Subject|0|||
28004999|NCT00591006|81849853|FG014|Overall Study|Withdrawal by Subject|0|||
28005000|NCT00591006|81849854|FG015|Overall Study|Withdrawal by Subject|1|||
28005001|NCT00591006|81849855|FG016|Overall Study|Withdrawal by Subject|0|||
28005002|NCT00591006|81849856|FG017|Overall Study|Withdrawal by Subject|0|||
28005003|NCT00591006|81849857|FG018|Overall Study|Withdrawal by Subject|0|||
28005004|NCT00591006|81849858|FG019|Overall Study|Withdrawal by Subject|0|||
28005005|NCT00591006|81849859|FG020|Overall Study|Withdrawal by Subject|0|||
28005006|NCT00591006|81849860|FG021|Overall Study|Withdrawal by Subject|0|||
28005007|NCT00591006|81849861|FG022|Overall Study|Withdrawal by Subject|0|||
28005008|NCT00591006|81849862|FG023|Overall Study|Withdrawal by Subject|1|||
28005009|NCT00591006|81849839|FG000|Overall Study|Adverse Event|0|||
28005010|NCT00591006|81849840|FG001|Overall Study|Adverse Event|0|||
28005011|NCT00591006|81849841|FG002|Overall Study|Adverse Event|0|||
28005012|NCT00591006|81849842|FG003|Overall Study|Adverse Event|0|||
28005013|NCT00591006|81849843|FG004|Overall Study|Adverse Event|0|||
28005014|NCT00591006|81849844|FG005|Overall Study|Adverse Event|0|||
28005015|NCT00591006|81849845|FG006|Overall Study|Adverse Event|0|||
28005016|NCT00591006|81849846|FG007|Overall Study|Adverse Event|0|||
28005017|NCT00591006|81849847|FG008|Overall Study|Adverse Event|0|||
28005018|NCT00591006|81849848|FG009|Overall Study|Adverse Event|0|||
28005019|NCT00591006|81849849|FG010|Overall Study|Adverse Event|0|||
28005020|NCT00591006|81849850|FG011|Overall Study|Adverse Event|0|||
28005021|NCT00591006|81849851|FG012|Overall Study|Adverse Event|0|||
28005022|NCT00591006|81849852|FG013|Overall Study|Adverse Event|0|||
27684818|NCT01451827|80683613|FG001|Overall Study|Withdrawal by Subject|0|||
28005023|NCT00591006|81849853|FG014|Overall Study|Adverse Event|0|||
27684819|NCT01451827|80683614|FG002|Overall Study|Withdrawal by Subject|1|||
28005024|NCT00591006|81849854|FG015|Overall Study|Adverse Event|0|||
28005025|NCT00591006|81849855|FG016|Overall Study|Adverse Event|0|||
28005026|NCT00591006|81849856|FG017|Overall Study|Adverse Event|0|||
28005027|NCT00591006|81849857|FG018|Overall Study|Adverse Event|0|||
28005028|NCT00591006|81849858|FG019|Overall Study|Adverse Event|0|||
28005029|NCT00591006|81849859|FG020|Overall Study|Adverse Event|0|||
28005030|NCT00591006|81849860|FG021|Overall Study|Adverse Event|0|||
28005031|NCT00591006|81849861|FG022|Overall Study|Adverse Event|1|||
28005032|NCT00591006|81849862|FG023|Overall Study|Adverse Event|0|||
28005033|NCT01342913|81849865|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
28005034|NCT01342913|81849866|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
28005035|NCT01342913|81849867|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
28005036|NCT01342913|81849865|FG000|2-week Run-in Period|Physician Decision|6|||
28005037|NCT01342913|81849866|FG001|2-week Run-in Period|Physician Decision|0|||
28005038|NCT01342913|81849867|FG002|2-week Run-in Period|Physician Decision|0|||
28005039|NCT01342913|81849865|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
28005040|NCT01342913|81849866|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
28005041|NCT01342913|81849867|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
28005042|NCT01342913|81849865|FG000|2-week Run-in Period|Adverse Event|2|||
28005043|NCT01342913|81849866|FG001|2-week Run-in Period|Adverse Event|0|||
28005044|NCT01342913|81849867|FG002|2-week Run-in Period|Adverse Event|0|||
28005045|NCT01342913|81849865|FG000|2-week Run-in Period|Protocol Violation|5|||
28005046|NCT01342913|81849866|FG001|2-week Run-in Period|Protocol Violation|0|||
28005047|NCT01342913|81849867|FG002|2-week Run-in Period|Protocol Violation|0|||
28005048|NCT01342913|81849865|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
28005049|NCT01342913|81849866|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
28005050|NCT01342913|81849867|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
28005051|NCT01342913|81849865|FG000|Double-Blind Treatment Period|Adverse Event|0|||
28005052|NCT01342913|81849866|FG001|Double-Blind Treatment Period|Adverse Event|3|||
28005053|NCT01342913|81849867|FG002|Double-Blind Treatment Period|Adverse Event|6|||
28005054|NCT01342913|81849865|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
28005055|NCT01342913|81849866|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
28005056|NCT01342913|81849867|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
28005057|NCT01342913|81849865|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
28005058|NCT01342913|81849866|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
28005059|NCT01342913|81849867|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
28005060|NCT01342913|81849865|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27874466|NCT00485264|81371755|FG005|Overall Study|Lost to Follow-up|1|||
27874467|NCT00485264|81371750|FG000|Overall Study|Other Reason|3|||
27874468|NCT00485264|81371751|FG001|Overall Study|Other Reason|0|||
27874469|NCT00485264|81371752|FG002|Overall Study|Other Reason|0|||
27874470|NCT00485264|81371753|FG003|Overall Study|Other Reason|0|||
27874471|NCT00485264|81371754|FG004|Overall Study|Other Reason|0|||
27874472|NCT00485264|81371755|FG005|Overall Study|Other Reason|0|||
27874473|NCT01103180|81371762|FG000|Overall Study|Withdrawal by Subject|8|||
27874474|NCT01103180|81371763|FG001|Overall Study|Withdrawal by Subject|13|||
27874475|NCT01103180|81371762|FG000|Overall Study|Lost to Follow-up|13|||
27874476|NCT01103180|81371763|FG001|Overall Study|Lost to Follow-up|7|||
27874477|NCT01103180|81371762|FG000|Overall Study|Physician Decision|1|||
27874478|NCT01103180|81371763|FG001|Overall Study|Physician Decision|0|||
27874479|NCT01103180|81371762|FG000|Overall Study|Protocol Violation|0|||
27874480|NCT01103180|81371763|FG001|Overall Study|Protocol Violation|1|||
27874481|NCT02604407|81371764|FG000|Overall Study|Adverse Event|0|||
27874482|NCT02604407|81371765|FG001|Overall Study|Adverse Event|7|||
27874483|NCT02604407|81371766|FG002|Overall Study|Adverse Event|5|||
27874484|NCT02604407|81371764|FG000|Overall Study|Protocol Violation|2|||
27874485|NCT02604407|81371765|FG001|Overall Study|Protocol Violation|0|||
27874486|NCT02604407|81371766|FG002|Overall Study|Protocol Violation|0|||
27874487|NCT02604407|81371764|FG000|Overall Study|Withdrawal by Subject|3|||
27874488|NCT02604407|81371765|FG001|Overall Study|Withdrawal by Subject|3|||
27874489|NCT02604407|81371766|FG002|Overall Study|Withdrawal by Subject|5|||
27874490|NCT02604407|81371764|FG000|Overall Study|Lost to Follow-up|2|||
27874491|NCT02604407|81371765|FG001|Overall Study|Lost to Follow-up|1|||
27874492|NCT02604407|81371766|FG002|Overall Study|Lost to Follow-up|2|||
28005061|NCT01342913|81849866|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
27874493|NCT02604407|81371764|FG000|Overall Study|Lack of Efficacy|1|||
27874494|NCT02604407|81371765|FG001|Overall Study|Lack of Efficacy|0|||
28005062|NCT01342913|81849867|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
28005063|NCT01342913|81849865|FG000|Double-Blind Treatment Period|Physician Decision|0|||
28005064|NCT01342913|81849866|FG001|Double-Blind Treatment Period|Physician Decision|2|||
28005065|NCT01342913|81849867|FG002|Double-Blind Treatment Period|Physician Decision|0|||
28005066|NCT01342913|81849865|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27874495|NCT02604407|81371766|FG002|Overall Study|Lack of Efficacy|0|||
27874496|NCT02604407|81371764|FG000|Overall Study|Other|3|||
28005067|NCT01342913|81849866|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
28005068|NCT01342913|81849867|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
28005069|NCT01808196|81849870|FG000|Overall Study|Lost to Follow-up|1|||
28005070|NCT00883779|81849873|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
27874497|NCT02604407|81371765|FG001|Overall Study|Other|1|||
27874498|NCT02604407|81371766|FG002|Overall Study|Other|4|||
27874499|NCT01709500|81371767|FG000|Overall Study|Randomized but not treated|0|||
27874500|NCT01709500|81371768|FG001|Overall Study|Randomized but not treated|1|||
27874501|NCT01709500|81371767|FG000|Overall Study|Adverse Event|5|||
27874502|NCT01709500|81371768|FG001|Overall Study|Adverse Event|1|||
27874503|NCT01709500|81371767|FG000|Overall Study|Poor compliance to protocol|2|||
27874504|NCT01709500|81371768|FG001|Overall Study|Poor compliance to protocol|1|||
27874505|NCT01709500|81371767|FG000|Overall Study|Other|3|||
27874506|NCT01709500|81371768|FG001|Overall Study|Other|1|||
27874507|NCT01709500|81371767|FG000|Overall Study|Related to IMP administration|1|||
27874508|NCT01709500|81371768|FG001|Overall Study|Related to IMP administration|0|||
27874509|NCT01709500|81371767|FG000|Overall Study|Treatment ongoing|156|||
27874510|NCT01709500|81371768|FG001|Overall Study|Treatment ongoing|78|||
27874511|NCT01000155|81371769|FG000|Overall Study|Withdrawal by Subject|1|||
27874512|NCT01000155|81371769|FG000|Overall Study|Adverse Event|1|||
27874513|NCT00858273|81371774|FG000|Overall Study|Protocol Violation|3|||
27874514|NCT00858273|81371775|FG001|Overall Study|Protocol Violation|5|||
27874515|NCT00570063|81371776|FG000|Overall Study|Adverse Event|4|||
27874516|NCT00570063|81371777|FG001|Overall Study|Adverse Event|1|||
27874517|NCT00570063|81371776|FG000|Overall Study|Lack of Efficacy|0|||
27874518|NCT00570063|81371777|FG001|Overall Study|Lack of Efficacy|1|||
27874519|NCT00570063|81371776|FG000|Overall Study|Withdrawal by Subject|4|||
27874520|NCT00570063|81371777|FG001|Overall Study|Withdrawal by Subject|3|||
27874521|NCT00570063|81371776|FG000|Overall Study|Sponsor's Decision|7|||
27874522|NCT00570063|81371777|FG001|Overall Study|Sponsor's Decision|3|||
27874523|NCT01269918|81371778|FG000|Overall Study|Did not receive study drug|0|||
27874524|NCT01269918|81371779|FG001|Overall Study|Did not receive study drug|3|||
27874525|NCT01482312|81371780|FG000|Period 1, 90 Minutes of Wear|Other|1|||
27874526|NCT01482312|81371781|FG001|Period 1, 90 Minutes of Wear|Other|0|||
28005071|NCT00883779|81849874|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
28005072|NCT00883779|81849873|FG000|Primary Study Treatment Phase|Disease progression|75|||
28005073|NCT00883779|81849874|FG001|Primary Study Treatment Phase|Disease progression|59|||
28005074|NCT00883779|81849873|FG000|Primary Study Treatment Phase|Adverse Event|16|||
28005075|NCT00883779|81849874|FG001|Primary Study Treatment Phase|Adverse Event|16|||
28005076|NCT00883779|81849873|FG000|Primary Study Treatment Phase|Death|2|||
28005077|NCT00883779|81849874|FG001|Primary Study Treatment Phase|Death|3|||
28005078|NCT00883779|81849873|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
28005079|NCT00883779|81849874|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
28005080|NCT00883779|81849873|FG000|Primary Study Treatment Phase|Other|3|||
28005081|NCT00883779|81849874|FG001|Primary Study Treatment Phase|Other|0|||
28005082|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Adverse Event|2|||
28005083|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Adverse Event|3|||
28005084|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Death|1|||
28005085|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Death|3|||
28005086|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
28005087|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
28005088|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
28005089|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
28005090|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Disease progression|103|||
28005091|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Disease progression|122|||
28005092|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Other|3|||
28005093|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Other|0|||
28005094|NCT00883779|81849873|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
28005095|NCT00883779|81849874|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
27684820|NCT01451827|80683615|FG003|Overall Study|Withdrawal by Subject|1|||
27684821|NCT01323972|80683625|FG000|Overall Study|Withdrawal by Subject|1|||
27874527|NCT01482312|81371782|FG002|Period 1, 90 Minutes of Wear|Other|0|||
27874528|NCT01482312|81371780|FG000|Period 2, 90 Minutes of Wear|Other|1|||
27874529|NCT01482312|81371781|FG001|Period 2, 90 Minutes of Wear|Other|0|||
28005096|NCT00883779|81849873|FG000|Off-study Phase|Death|185|||
28005097|NCT00883779|81849874|FG001|Off-study Phase|Death|174|||
28005098|NCT00883779|81849873|FG000|Off-study Phase|Refused treatment|1|||
28005099|NCT00883779|81849874|FG001|Off-study Phase|Refused treatment|1|||
28005100|NCT00883779|81849873|FG000|Off-study Phase|Failure to return|5|||
28005101|NCT00883779|81849874|FG001|Off-study Phase|Failure to return|6|||
28005102|NCT00883779|81849873|FG000|Off-study Phase|Other|18|||
28005103|NCT00883779|81849874|FG001|Off-study Phase|Other|21|||
27874530|NCT01482312|81371782|FG002|Period 2, 90 Minutes of Wear|Other|0|||
27874531|NCT02548156|81371785|FG000|Washout Period 1|Lost to Follow-up|0|||
27874532|NCT02548156|81371786|FG001|Washout Period 1|Lost to Follow-up|0|||
27874533|NCT02548156|81371787|FG002|Washout Period 1|Lost to Follow-up|0|||
28005104|NCT03287791|81849877|FG000|Overall Study|Insufficient Therapeutic Response|0|||
28005105|NCT03287791|81849878|FG001|Overall Study|Insufficient Therapeutic Response|0|||
28005106|NCT03287791|81849879|FG002|Overall Study|Insufficient Therapeutic Response|1|||
28005107|NCT03287791|81849877|FG000|Overall Study|Adverse Event|0|||
28005108|NCT03287791|81849878|FG001|Overall Study|Adverse Event|4|||
28005109|NCT03287791|81849879|FG002|Overall Study|Adverse Event|3|||
28005110|NCT03287791|81849877|FG000|Overall Study|Withdrawal by Subject|12|||
28005111|NCT03287791|81849878|FG001|Overall Study|Withdrawal by Subject|12|||
28005112|NCT03287791|81849879|FG002|Overall Study|Withdrawal by Subject|17|||
28005113|NCT03287791|81849877|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
28005114|NCT03287791|81849878|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
28005115|NCT03287791|81849879|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
28005116|NCT03287791|81849877|FG000|Overall Study|Lost to Follow-up|8|||
28005117|NCT03287791|81849878|FG001|Overall Study|Lost to Follow-up|14|||
28005118|NCT03287791|81849879|FG002|Overall Study|Lost to Follow-up|11|||
28005119|NCT03287791|81849877|FG000|Overall Study|Protocol Violation|7|||
28005120|NCT03287791|81849878|FG001|Overall Study|Protocol Violation|2|||
28005121|NCT03287791|81849879|FG002|Overall Study|Protocol Violation|1|||
28005122|NCT03287791|81849877|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
28005123|NCT03287791|81849878|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
28005124|NCT03287791|81849879|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
28005125|NCT03287791|81849877|FG000|Overall Study|Too much time between 2 visits|0|||
28005126|NCT03287791|81849878|FG001|Overall Study|Too much time between 2 visits|1|||
28005127|NCT03287791|81849879|FG002|Overall Study|Too much time between 2 visits|0|||
28005128|NCT03287791|81849877|FG000|Overall Study|Non-compliance|0|||
28005129|NCT03287791|81849878|FG001|Overall Study|Non-compliance|1|||
28005130|NCT03287791|81849879|FG002|Overall Study|Non-compliance|0|||
28005131|NCT03287791|81849877|FG000|Overall Study|Did not meet inclusion criteria|1|||
28005132|NCT03287791|81849878|FG001|Overall Study|Did not meet inclusion criteria|0|||
28005133|NCT03287791|81849879|FG002|Overall Study|Did not meet inclusion criteria|0|||
27684822|NCT01323972|80683626|FG001|Overall Study|Withdrawal by Subject|0|||
27684823|NCT01323972|80683627|FG002|Overall Study|Withdrawal by Subject|1|||
27684824|NCT01323972|80683628|FG003|Overall Study|Withdrawal by Subject|0|||
27684825|NCT01323972|80683625|FG000|Overall Study|Migrated/moved from study area|1|||
27808618|NCT04378010|81130642|FG000|Overall Study|Protocol Violation|2|||
27808619|NCT04378010|81130643|FG001|Overall Study|Protocol Violation|1|||
27808620|NCT04378010|81130644|FG002|Overall Study|Protocol Violation|4|||
27808621|NCT04378010|81130642|FG000|Overall Study|Study terminated by Sponsor|22|||
27808622|NCT04378010|81130643|FG001|Overall Study|Study terminated by Sponsor|16|||
27808623|NCT04378010|81130644|FG002|Overall Study|Study terminated by Sponsor|22|||
27808624|NCT04378010|81130642|FG000|Overall Study|Subject inability to complete study visit|0|||
27808625|NCT04378010|81130643|FG001|Overall Study|Subject inability to complete study visit|0|||
27808626|NCT04378010|81130644|FG002|Overall Study|Subject inability to complete study visit|1|||
27808627|NCT04378010|81130642|FG000|Overall Study|Subject never dosed|0|||
27808628|NCT04378010|81130643|FG001|Overall Study|Subject never dosed|1|||
27808629|NCT04378010|81130644|FG002|Overall Study|Subject never dosed|0|||
27808630|NCT00685919|81130645|FG000|Overall Study|Withdrawal by Subject|0|||
27808631|NCT00685919|81130646|FG001|Overall Study|Withdrawal by Subject|0|||
27808632|NCT00685919|81130647|FG002|Overall Study|Withdrawal by Subject|1|||
27808633|NCT00685919|81130648|FG003|Overall Study|Withdrawal by Subject|0|||
27808634|NCT00685919|81130645|FG000|Overall Study|Physician Decision|1|||
27808635|NCT00685919|81130646|FG001|Overall Study|Physician Decision|0|||
27808636|NCT00685919|81130647|FG002|Overall Study|Physician Decision|0|||
27808637|NCT00685919|81130648|FG003|Overall Study|Physician Decision|0|||
27808638|NCT04014959|81130649|FG000|Baseline MRI and Assessments|Physician Decision|2|||
28005134|NCT02174731|81849884|FG000|Overall Study|Participant decision|67|||
28005135|NCT02174731|81849885|FG001|Overall Study|Participant decision|64|||
28005136|NCT02174731|81849884|FG000|Overall Study|Incorrect enrolment before randomization|0|||
28005137|NCT02174731|81849885|FG001|Overall Study|Incorrect enrolment before randomization|1|||
28005138|NCT02174731|81849884|FG000|Overall Study|Missing|2|||
28005139|NCT02174731|81849885|FG001|Overall Study|Missing|0|||
28005140|NCT00447226|81849886|FG000|12-Week Open-label Phase|Adverse Event|0|||
28005141|NCT00447226|81849887|FG001|12-Week Open-label Phase|Adverse Event|3|||
28005142|NCT00447226|81849886|FG000|12-Week Open-label Phase|Protocol Violation|0|||
27585020|NCT03701555|80322090|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
28005143|NCT00447226|81849887|FG001|12-Week Open-label Phase|Protocol Violation|1|||
28005144|NCT00447226|81849886|FG000|12-Week Open-label Phase|Disease Progression|0|||
28005145|NCT00447226|81849887|FG001|12-Week Open-label Phase|Disease Progression|20|||
28005146|NCT00447226|81849886|FG000|12-Week Open-label Phase|Physician Decision|0|||
28005147|NCT00447226|81849887|FG001|12-Week Open-label Phase|Physician Decision|1|||
28005148|NCT00447226|81849886|FG000|Double-blind Phase|Disease Progression|4|||
28005149|NCT00447226|81849887|FG001|Double-blind Phase|Disease Progression|3|||
27585021|NCT03701555|80322091|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
27585022|NCT03701555|80322092|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
27585023|NCT03701555|80322093|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
27585024|NCT03701555|80322094|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
27585025|NCT03701555|80322095|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
27585026|NCT03701555|80322096|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
27585027|NCT03701555|80322097|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
27585028|NCT03701555|80322098|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
27585029|NCT03701555|80322099|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
27585030|NCT03701555|80322100|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
27585031|NCT03701555|80322101|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
27585032|NCT03701555|80322102|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
27585033|NCT03701555|80322103|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
27585034|NCT03701555|80322104|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
27585035|NCT03701555|80322105|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
27585036|NCT03701555|80322106|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
27585037|NCT03701555|80322107|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
27585038|NCT03701555|80322108|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
27585039|NCT03701555|80322109|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
27585040|NCT03701555|80322110|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
27585041|NCT03701555|80322111|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
27808639|NCT04014959|81130649|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
28005150|NCT01089504|81849888|FG000|Overall Study|Lost to Follow-up|1|||
28005151|NCT01089504|81849889|FG001|Overall Study|Lost to Follow-up|1|||
28005152|NCT01089504|81849888|FG000|Overall Study|Withdrawal by Subject|2|||
28005153|NCT01089504|81849889|FG001|Overall Study|Withdrawal by Subject|0|||
28005154|NCT03337308|81849890|FG000|Overall Study|Adverse Event|2|||
28005155|NCT03337308|81849891|FG001|Overall Study|Adverse Event|3|||
28005156|NCT03337308|81849892|FG002|Overall Study|Adverse Event|3|||
28005157|NCT03337308|81849893|FG003|Overall Study|Adverse Event|1|||
28005158|NCT03337308|81849890|FG000|Overall Study|Lost to Follow-up|1|||
28005159|NCT03337308|81849891|FG001|Overall Study|Lost to Follow-up|2|||
28005160|NCT03337308|81849892|FG002|Overall Study|Lost to Follow-up|0|||
27808640|NCT04014959|81130649|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
27808641|NCT04049552|81130650|FG000|Overall Study|Lost to Follow-up|1|||
27808642|NCT00130520|81130651|FG000|Overall Study|Adverse Event|11|||
27808643|NCT00130520|81130651|FG000|Overall Study|Death|1|||
27808644|NCT00130520|81130651|FG000|Overall Study|Physician Decision|1|||
27808645|NCT00130520|81130651|FG000|Overall Study|Withdrawal by Subject|1|||
27808646|NCT00130520|81130651|FG000|Overall Study|Disease Progression|23|||
27808647|NCT00130520|81130651|FG000|Overall Study|Protocol non-compliance|1|||
27808648|NCT00130520|81130651|FG000|Overall Study|Did not meet re-treatment criteria|1|||
27808649|NCT02533999|81130656|FG000|Overall Study|Lost to Follow-up|3|||
27808650|NCT02533999|81130657|FG001|Overall Study|Lost to Follow-up|5|||
27808651|NCT02533999|81130656|FG000|Overall Study|Protocol Violation|3|||
27808652|NCT02533999|81130657|FG001|Overall Study|Protocol Violation|0|||
27808653|NCT02533999|81130656|FG000|Overall Study|Adverse Event|0|||
27808654|NCT02533999|81130657|FG001|Overall Study|Adverse Event|1|||
27808655|NCT02533999|81130656|FG000|Overall Study|Randomized but intervention not received|0|||
27808656|NCT02533999|81130657|FG001|Overall Study|Randomized but intervention not received|1|||
27808657|NCT00006721|81130658|FG000|Overall Study|Adverse Event|0|||
27808658|NCT00006721|81130659|FG001|Overall Study|Adverse Event|4|||
27808659|NCT00006721|81130660|FG002|Overall Study|Adverse Event|4|||
27808660|NCT00006721|81130658|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
27808661|NCT00006721|81130659|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
27808662|NCT00006721|81130660|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
28005161|NCT03337308|81849893|FG003|Overall Study|Lost to Follow-up|0|||
28005162|NCT03337308|81849890|FG000|Overall Study|Withdrawal by Subject|2|||
27585042|NCT03701555|80322112|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
27585043|NCT03701555|80322113|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
27585044|NCT03701555|80322114|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
27585045|NCT03701555|80322115|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
27585046|NCT03701555|80322080|FG000|Part 2 (Day 1)|Other|0|||
27585047|NCT03701555|80322081|FG001|Part 2 (Day 1)|Other|0|||
27700995|NCT01241552|80741292|FG003|Overall Study|Protocol Violation|1|||
28005163|NCT03337308|81849891|FG001|Overall Study|Withdrawal by Subject|1|||
28005164|NCT03337308|81849892|FG002|Overall Study|Withdrawal by Subject|2|||
28005165|NCT03337308|81849893|FG003|Overall Study|Withdrawal by Subject|1|||
27874534|NCT02548156|81371788|FG003|Washout Period 1|Lost to Follow-up|0|||
27874535|NCT02548156|81371789|FG004|Washout Period 1|Lost to Follow-up|1|||
27874536|NCT02548156|81371790|FG005|Washout Period 1|Lost to Follow-up|0|||
27874537|NCT01254643|81371798|FG000|Overall Study|Withdrawal by Subject|1|||
27874538|NCT00459355|81371799|FG000|Overall Study|Subject no longer met inc criteria|20|||
27874539|NCT00459355|81371800|FG001|Overall Study|Subject no longer met inc criteria|18|||
27874540|NCT00118157|81371801|FG000|Overall Study|Adverse Event|2|||
27874541|NCT00118157|81371801|FG000|Overall Study|Death|8|||
27874542|NCT00118157|81371801|FG000|Overall Study|Withdrawal by Subject|2|||
27874543|NCT00666328|81371807|FG000|Overall Study|Death|2|||
27808663|NCT00006721|81130658|FG000|Overall Study|Progression/Relapse|0|||
27874544|NCT00666328|81371807|FG000|Overall Study|Lost to Follow-up|2|||
27874545|NCT00666328|81371807|FG000|Overall Study|No longer met eligibility criteria|1|||
27874546|NCT00473590|81371813|FG000|Overall Study|Adverse Event|3|||
27874547|NCT00473590|81371814|FG001|Overall Study|Adverse Event|3|||
27874548|NCT00473590|81371813|FG000|Overall Study|Death|4|||
27874549|NCT00473590|81371814|FG001|Overall Study|Death|2|||
27874550|NCT00473590|81371813|FG000|Overall Study|Progression not resulting in death|24|||
27874551|NCT00473590|81371814|FG001|Overall Study|Progression not resulting in death|20|||
27874552|NCT00473590|81371813|FG000|Overall Study|Non-protocol-specified therapy|7|||
27808664|NCT00006721|81130659|FG001|Overall Study|Progression/Relapse|1|||
27808665|NCT00006721|81130660|FG002|Overall Study|Progression/Relapse|2|||
27808666|NCT00006721|81130658|FG000|Overall Study|Death|0|||
27808667|NCT00006721|81130659|FG001|Overall Study|Death|1|||
27808668|NCT00006721|81130660|FG002|Overall Study|Death|2|||
27808669|NCT00006721|81130658|FG000|Overall Study|Other - Not Protocol Specified|0|||
27808670|NCT00006721|81130659|FG001|Overall Study|Other - Not Protocol Specified|7|||
27874553|NCT00473590|81371814|FG001|Overall Study|Non-protocol-specified therapy|5|||
27874554|NCT00473590|81371813|FG000|Overall Study|Physician Decision|2|||
27874555|NCT00473590|81371814|FG001|Overall Study|Physician Decision|4|||
27874556|NCT00473590|81371813|FG000|Overall Study|Withdrawal by Subject|5|||
27874557|NCT00473590|81371814|FG001|Overall Study|Withdrawal by Subject|3|||
27874558|NCT00473590|81371813|FG000|Overall Study|Other|0|||
27874559|NCT00473590|81371814|FG001|Overall Study|Other|1|||
27874560|NCT02633293|81371815|FG000|Overall Study|Death|56|||
27874561|NCT02633293|81371815|FG000|Overall Study|Progressive Disease|12|||
27874562|NCT02633293|81371815|FG000|Overall Study|Adverse Event|29|||
27874563|NCT02633293|81371815|FG000|Overall Study|Withdrawal by Subject|41|||
27874564|NCT02633293|81371815|FG000|Overall Study|Protocol Violation|1|||
27874565|NCT02633293|81371815|FG000|Overall Study|Lost to Follow-up|1|||
27874566|NCT02633293|81371815|FG000|Overall Study|Study Terminated by Sponsor|24|||
27874567|NCT02633293|81371815|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
27874568|NCT02633293|81371815|FG000|Overall Study|Lung Transplant|5|||
27874569|NCT02633293|81371815|FG000|Overall Study|Lack of Efficacy|2|||
27874570|NCT02633293|81371815|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
27874571|NCT03597295|81371818|FG000|Overall Study|Death|70|||
27874572|NCT03597295|81371818|FG000|Overall Study|Lost to Follow-up|7|||
27874573|NCT02105987|81371826|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
27874574|NCT02105987|81371827|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27874575|NCT02105987|81371828|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27874576|NCT02105987|81371829|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27874577|NCT02105987|81371830|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27874578|NCT02105987|81371831|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
27874579|NCT02105987|81371826|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
27874580|NCT02105987|81371827|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
27874581|NCT02105987|81371828|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
28005166|NCT03337308|81849890|FG000|Overall Study|Protocol Violation|0|||
28005167|NCT03337308|81849891|FG001|Overall Study|Protocol Violation|1|||
28005168|NCT03337308|81849892|FG002|Overall Study|Protocol Violation|0|||
28005169|NCT03337308|81849893|FG003|Overall Study|Protocol Violation|0|||
28005170|NCT02656017|81849894|FG000|Overall Study|Study burden|3|||
28005171|NCT02656017|81849895|FG001|Overall Study|Study burden|3|||
27874582|NCT02105987|81371829|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27874583|NCT02105987|81371830|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27874584|NCT02105987|81371831|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
27874585|NCT02105987|81371826|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
27874586|NCT02105987|81371827|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
27874587|NCT02105987|81371828|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874588|NCT02105987|81371829|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874589|NCT02105987|81371830|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874590|NCT02105987|81371831|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
28005172|NCT02656017|81849894|FG000|Overall Study|Adverse Event|2|||
28005173|NCT02656017|81849895|FG001|Overall Study|Adverse Event|1|||
27808671|NCT00006721|81130660|FG002|Overall Study|Other - Not Protocol Specified|7|||
27808672|NCT00006721|81130658|FG000|Overall Study|Ineligible|2|||
27808673|NCT00006721|81130659|FG001|Overall Study|Ineligible|12|||
27585048|NCT03701555|80322082|FG002|Part 2 (Day 1)|Other|0|||
27585049|NCT03701555|80322083|FG003|Part 2 (Day 1)|Other|0|||
27585050|NCT03701555|80322084|FG004|Part 2 (Day 1)|Other|0|||
27585051|NCT03701555|80322085|FG005|Part 2 (Day 1)|Other|0|||
27585052|NCT03701555|80322086|FG006|Part 2 (Day 1)|Other|0|||
27585053|NCT03701555|80322087|FG007|Part 2 (Day 1)|Other|0|||
27585054|NCT03701555|80322088|FG008|Part 2 (Day 1)|Other|0|||
27585055|NCT03701555|80322089|FG009|Part 2 (Day 1)|Other|0|||
27585056|NCT03701555|80322090|FG010|Part 2 (Day 1)|Other|3|||
27585057|NCT03701555|80322091|FG011|Part 2 (Day 1)|Other|1|||
27585058|NCT03701555|80322092|FG012|Part 2 (Day 1)|Other|0|||
27585059|NCT03701555|80322093|FG013|Part 2 (Day 1)|Other|1|||
27585060|NCT03701555|80322094|FG014|Part 2 (Day 1)|Other|0|||
27585061|NCT03701555|80322095|FG015|Part 2 (Day 1)|Other|2|||
27585062|NCT03701555|80322096|FG016|Part 2 (Day 1)|Other|2|||
27585063|NCT03701555|80322097|FG017|Part 2 (Day 1)|Other|0|||
27585064|NCT03701555|80322098|FG018|Part 2 (Day 1)|Other|0|||
27585065|NCT03701555|80322099|FG019|Part 2 (Day 1)|Other|0|||
27585066|NCT03701555|80322100|FG020|Part 2 (Day 1)|Other|0|||
27585067|NCT03701555|80322101|FG021|Part 2 (Day 1)|Other|0|||
27874591|NCT02105987|81371826|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
27874592|NCT02105987|81371827|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
27874593|NCT02105987|81371828|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874594|NCT02105987|81371829|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874595|NCT02105987|81371830|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874596|NCT02105987|81371831|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874597|NCT02105987|81371826|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
27874598|NCT02105987|81371827|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
27874599|NCT02105987|81371828|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27874600|NCT02105987|81371829|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27874601|NCT02105987|81371830|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27874602|NCT02105987|81371831|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
27874603|NCT02105987|81371826|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27874604|NCT02105987|81371827|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
27874605|NCT02105987|81371828|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27874606|NCT02105987|81371829|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27874607|NCT02105987|81371830|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27874608|NCT02105987|81371831|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
27874609|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27874610|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27874611|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
27874612|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
27874613|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27874614|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
27874615|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
27874616|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
27874617|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
27874618|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
27874619|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
27874620|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
28005174|NCT02656017|81849894|FG000|Overall Study|Unable/unwilling to take study medication|2|||
28005175|NCT02656017|81849895|FG001|Overall Study|Unable/unwilling to take study medication|1|||
28005176|NCT02656017|81849894|FG000|Overall Study|Began Tolvaptan|1|||
28005177|NCT02656017|81849895|FG001|Overall Study|Began Tolvaptan|1|||
28005178|NCT02656017|81849894|FG000|Overall Study|Withdrawal by Subject|1|||
28005179|NCT02656017|81849895|FG001|Overall Study|Withdrawal by Subject|0|||
28005180|NCT00528112|81849896|FG000|Treatment up to 3 Years|Adverse Event|313|||
28005181|NCT00528112|81849897|FG001|Treatment up to 3 Years|Adverse Event|278|||
28005182|NCT00528112|81849896|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
28005183|NCT00528112|81849897|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
28005184|NCT00528112|81849896|FG000|Treatment up to 3 Years|Protocol Violation|16|||
27585068|NCT03701555|80322102|FG022|Part 2 (Day 1)|Other|0|||
27585069|NCT03701555|80322103|FG023|Part 2 (Day 1)|Other|0|||
27874621|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874622|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874623|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
28005185|NCT00528112|81849897|FG001|Treatment up to 3 Years|Protocol Violation|16|||
28005186|NCT00528112|81849896|FG000|Treatment up to 3 Years|Death|0|||
28005187|NCT00528112|81849897|FG001|Treatment up to 3 Years|Death|1|||
27585070|NCT03701555|80322104|FG024|Part 2 (Day 1)|Other|0|||
27585071|NCT03701555|80322105|FG025|Part 2 (Day 1)|Other|0|||
27585072|NCT03701555|80322106|FG026|Part 2 (Day 1)|Other|0|||
27585073|NCT03701555|80322107|FG027|Part 2 (Day 1)|Other|0|||
27585074|NCT03701555|80322108|FG028|Part 2 (Day 1)|Other|0|||
27585075|NCT03701555|80322109|FG029|Part 2 (Day 1)|Other|0|||
27585076|NCT03701555|80322110|FG030|Part 2 (Day 1)|Other|0|||
27585077|NCT03701555|80322111|FG031|Part 2 (Day 1)|Other|0|||
27585078|NCT03701555|80322112|FG032|Part 2 (Day 1)|Other|0|||
27585079|NCT03701555|80322113|FG033|Part 2 (Day 1)|Other|0|||
27585080|NCT03701555|80322114|FG034|Part 2 (Day 1)|Other|0|||
27585081|NCT03701555|80322115|FG035|Part 2 (Day 1)|Other|0|||
27585082|NCT03701555|80322080|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
27585083|NCT03701555|80322081|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
27585084|NCT03701555|80322082|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
27585085|NCT03701555|80322083|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
27585086|NCT03701555|80322084|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
27585087|NCT03701555|80322085|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
27585088|NCT03701555|80322086|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
27585089|NCT03701555|80322087|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
27585090|NCT03701555|80322088|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
27585091|NCT03701555|80322089|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
27585092|NCT03701555|80322090|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
27585093|NCT03701555|80322091|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
27585094|NCT03701555|80322092|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
27585095|NCT03701555|80322093|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
27585096|NCT03701555|80322094|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
27585097|NCT03701555|80322095|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
27585098|NCT03701555|80322096|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
27585099|NCT03701555|80322097|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
27585100|NCT03701555|80322098|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
27585101|NCT03701555|80322099|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
27585102|NCT03701555|80322100|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
27585103|NCT03701555|80322101|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
27585104|NCT03701555|80322102|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
27585105|NCT03701555|80322103|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
27585106|NCT03701555|80322104|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
27585107|NCT03701555|80322105|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
27585108|NCT03701555|80322106|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
27585109|NCT03701555|80322107|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
27585110|NCT03701555|80322108|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
27585111|NCT03701555|80322109|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
27585112|NCT03701555|80322110|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
27585113|NCT03701555|80322111|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
27585114|NCT03701555|80322112|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
27585115|NCT03701555|80322113|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
27585116|NCT03701555|80322114|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
27585117|NCT03701555|80322115|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
27585118|NCT03701555|80322080|FG000|Part 3 (Day 1)|Subject Decision|0|||
27585119|NCT03701555|80322081|FG001|Part 3 (Day 1)|Subject Decision|0|||
27585120|NCT03701555|80322082|FG002|Part 3 (Day 1)|Subject Decision|0|||
27585121|NCT03701555|80322083|FG003|Part 3 (Day 1)|Subject Decision|0|||
27585122|NCT03701555|80322084|FG004|Part 3 (Day 1)|Subject Decision|0|||
27585123|NCT03701555|80322085|FG005|Part 3 (Day 1)|Subject Decision|0|||
27585124|NCT03701555|80322086|FG006|Part 3 (Day 1)|Subject Decision|0|||
27585125|NCT03701555|80322087|FG007|Part 3 (Day 1)|Subject Decision|0|||
27585126|NCT03701555|80322088|FG008|Part 3 (Day 1)|Subject Decision|0|||
27585127|NCT03701555|80322089|FG009|Part 3 (Day 1)|Subject Decision|0|||
27585128|NCT03701555|80322090|FG010|Part 3 (Day 1)|Subject Decision|0|||
27585129|NCT03701555|80322091|FG011|Part 3 (Day 1)|Subject Decision|0|||
27585130|NCT03701555|80322092|FG012|Part 3 (Day 1)|Subject Decision|0|||
27585131|NCT03701555|80322093|FG013|Part 3 (Day 1)|Subject Decision|0|||
27585132|NCT03701555|80322094|FG014|Part 3 (Day 1)|Subject Decision|0|||
27585133|NCT03701555|80322095|FG015|Part 3 (Day 1)|Subject Decision|0|||
27585134|NCT03701555|80322096|FG016|Part 3 (Day 1)|Subject Decision|0|||
27585135|NCT03701555|80322097|FG017|Part 3 (Day 1)|Subject Decision|0|||
27585136|NCT03701555|80322098|FG018|Part 3 (Day 1)|Subject Decision|0|||
27585137|NCT03701555|80322099|FG019|Part 3 (Day 1)|Subject Decision|0|||
27585138|NCT03701555|80322100|FG020|Part 3 (Day 1)|Subject Decision|0|||
27585139|NCT03701555|80322101|FG021|Part 3 (Day 1)|Subject Decision|0|||
27585140|NCT03701555|80322102|FG022|Part 3 (Day 1)|Subject Decision|0|||
27585141|NCT03701555|80322103|FG023|Part 3 (Day 1)|Subject Decision|0|||
27684826|NCT01323972|80683626|FG001|Overall Study|Migrated/moved from study area|2|||
27808674|NCT00006721|81130660|FG002|Overall Study|Ineligible|10|||
27585142|NCT03701555|80322104|FG024|Part 3 (Day 1)|Subject Decision|0|||
27585143|NCT03701555|80322105|FG025|Part 3 (Day 1)|Subject Decision|0|||
27585144|NCT03701555|80322106|FG026|Part 3 (Day 1)|Subject Decision|1|||
27585145|NCT03701555|80322107|FG027|Part 3 (Day 1)|Subject Decision|0|||
27585146|NCT03701555|80322108|FG028|Part 3 (Day 1)|Subject Decision|0|||
27585147|NCT03701555|80322109|FG029|Part 3 (Day 1)|Subject Decision|0|||
27684827|NCT01323972|80683627|FG002|Overall Study|Migrated/moved from study area|0|||
27585148|NCT03701555|80322110|FG030|Part 3 (Day 1)|Subject Decision|0|||
27585149|NCT03701555|80322111|FG031|Part 3 (Day 1)|Subject Decision|2|||
27585150|NCT03701555|80322112|FG032|Part 3 (Day 1)|Subject Decision|1|||
27585151|NCT03701555|80322113|FG033|Part 3 (Day 1)|Subject Decision|1|||
27585152|NCT03701555|80322114|FG034|Part 3 (Day 1)|Subject Decision|0|||
27585153|NCT03701555|80322115|FG035|Part 3 (Day 1)|Subject Decision|0|||
27585154|NCT03701555|80322080|FG000|Part 3 (Day 1)|Other|0|||
27585155|NCT03701555|80322081|FG001|Part 3 (Day 1)|Other|0|||
27585156|NCT03701555|80322082|FG002|Part 3 (Day 1)|Other|0|||
27585157|NCT03701555|80322083|FG003|Part 3 (Day 1)|Other|0|||
27585158|NCT03701555|80322084|FG004|Part 3 (Day 1)|Other|0|||
27585159|NCT03701555|80322085|FG005|Part 3 (Day 1)|Other|0|||
27585160|NCT03701555|80322086|FG006|Part 3 (Day 1)|Other|0|||
27585161|NCT03701555|80322087|FG007|Part 3 (Day 1)|Other|0|||
27585162|NCT03701555|80322088|FG008|Part 3 (Day 1)|Other|0|||
27585163|NCT03701555|80322089|FG009|Part 3 (Day 1)|Other|0|||
27585164|NCT03701555|80322090|FG010|Part 3 (Day 1)|Other|0|||
27585165|NCT03701555|80322091|FG011|Part 3 (Day 1)|Other|0|||
27585166|NCT03701555|80322092|FG012|Part 3 (Day 1)|Other|0|||
27585167|NCT03701555|80322093|FG013|Part 3 (Day 1)|Other|0|||
27585168|NCT03701555|80322094|FG014|Part 3 (Day 1)|Other|0|||
27585169|NCT03701555|80322095|FG015|Part 3 (Day 1)|Other|0|||
27585170|NCT03701555|80322096|FG016|Part 3 (Day 1)|Other|0|||
27585171|NCT03701555|80322097|FG017|Part 3 (Day 1)|Other|0|||
27585172|NCT03701555|80322098|FG018|Part 3 (Day 1)|Other|0|||
27585173|NCT03701555|80322099|FG019|Part 3 (Day 1)|Other|0|||
27585174|NCT03701555|80322100|FG020|Part 3 (Day 1)|Other|0|||
27585175|NCT03701555|80322101|FG021|Part 3 (Day 1)|Other|0|||
27585176|NCT03701555|80322102|FG022|Part 3 (Day 1)|Other|0|||
27585177|NCT03701555|80322103|FG023|Part 3 (Day 1)|Other|0|||
27585178|NCT03701555|80322104|FG024|Part 3 (Day 1)|Other|1|||
27585179|NCT03701555|80322105|FG025|Part 3 (Day 1)|Other|1|||
27585180|NCT03701555|80322106|FG026|Part 3 (Day 1)|Other|0|||
27585181|NCT03701555|80322107|FG027|Part 3 (Day 1)|Other|0|||
27585182|NCT03701555|80322108|FG028|Part 3 (Day 1)|Other|0|||
27585183|NCT03701555|80322109|FG029|Part 3 (Day 1)|Other|1|||
27585184|NCT03701555|80322110|FG030|Part 3 (Day 1)|Other|1|||
27585185|NCT03701555|80322111|FG031|Part 3 (Day 1)|Other|0|||
27585186|NCT03701555|80322112|FG032|Part 3 (Day 1)|Other|1|||
27585187|NCT03701555|80322113|FG033|Part 3 (Day 1)|Other|1|||
27585188|NCT03701555|80322114|FG034|Part 3 (Day 1)|Other|0|||
27585189|NCT03701555|80322115|FG035|Part 3 (Day 1)|Other|0|||
27585190|NCT03783923|80322116|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
27585191|NCT03783923|80322117|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
27585192|NCT03783923|80322116|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
27585193|NCT03783923|80322117|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
27585194|NCT03783923|80322116|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
27585195|NCT03783923|80322117|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
28005188|NCT00528112|81849896|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
28005189|NCT00528112|81849897|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
28005190|NCT00528112|81849896|FG000|Treatment up to 3 Years|Pregnancy|9|||
28005191|NCT00528112|81849897|FG001|Treatment up to 3 Years|Pregnancy|10|||
28005192|NCT00528112|81849896|FG000|Treatment up to 3 Years|Other reasons|186|||
28005193|NCT00528112|81849897|FG001|Treatment up to 3 Years|Other reasons|186|||
28005194|NCT00528112|81849896|FG000|Extension Phase|Withdrawal by Subject|0|||
28005195|NCT00528112|81849897|FG001|Extension Phase|Withdrawal by Subject|3|||
28005196|NCT00528112|81849896|FG000|Extension Phase|Other reasons|0|||
28005197|NCT00528112|81849897|FG001|Extension Phase|Other reasons|100|||
28005198|NCT00528112|81849896|FG000|Extension Phase|Pregnancy|0|||
28005199|NCT00528112|81849897|FG001|Extension Phase|Pregnancy|3|||
28005200|NCT00528112|81849896|FG000|Extension Phase|Lost to Follow-up|0|||
28005201|NCT00528112|81849897|FG001|Extension Phase|Lost to Follow-up|12|||
28005202|NCT00528112|81849896|FG000|Extension Phase|Death|0|||
28005203|NCT00528112|81849897|FG001|Extension Phase|Death|1|||
28005204|NCT00528112|81849896|FG000|Extension Phase|Adverse Event|0|||
27585196|NCT03783923|80322116|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
27585197|NCT03783923|80322117|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
27585198|NCT03783923|80322116|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
27585199|NCT03783923|80322117|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
27585200|NCT00504829|80324411|FG000|Overall Study|Protocol Violation|6|||
27585201|NCT00504829|80324412|FG001|Overall Study|Protocol Violation|4|||
27585202|NCT00504829|80324413|FG002|Overall Study|Protocol Violation|10|||
27585203|NCT00680407|80324417|FG000|Overall Study|Lost to Follow-up|3|||
28005205|NCT00528112|81849897|FG001|Extension Phase|Adverse Event|36|||
28005206|NCT00528112|81849896|FG000|Extension Phase|Protocol Violation|0|||
28005207|NCT00528112|81849897|FG001|Extension Phase|Protocol Violation|2|||
27585204|NCT00680407|80324418|FG001|Overall Study|Lost to Follow-up|3|||
27585205|NCT00680407|80324419|FG002|Overall Study|Lost to Follow-up|1|||
27585206|NCT00680407|80324417|FG000|Overall Study|Withdrawal by Subject|5|||
27585207|NCT00680407|80324418|FG001|Overall Study|Withdrawal by Subject|2|||
27585208|NCT00680407|80324419|FG002|Overall Study|Withdrawal by Subject|2|||
27585209|NCT01181921|80324421|FG000|Overall Study|Lost to Follow-up|1|||
28005208|NCT04002960|81849898|FG000|Overall Study|Withdrawn prior to Completion|2|||
28005209|NCT03057496|81849899|FG000|Overall Study|Withdrawal by Subject|8|||
28005210|NCT03057496|81849899|FG000|Overall Study|Lost to Follow-up|5|||
28005211|NCT03057496|81849899|FG000|Overall Study|Did not use device during home trial|3|||
28005212|NCT03057496|81849899|FG000|Overall Study|Device failure|2|||
28005213|NCT05196828|81849909|FG000|Overall Study|Withdrawal by Subject|2|||
28005214|NCT05196828|81849910|FG001|Overall Study|Withdrawal by Subject|0|||
28005215|NCT05196828|81849909|FG000|Overall Study|Lost to Follow-up|0|||
28005216|NCT05196828|81849910|FG001|Overall Study|Lost to Follow-up|4|||
28005217|NCT05196828|81849909|FG000|Overall Study|Adverse Event|1|||
28005218|NCT05196828|81849910|FG001|Overall Study|Adverse Event|0|||
28005219|NCT02322281|81849911|FG000|Overall Study|Progressive Disease|42|||
28005220|NCT02322281|81849912|FG001|Overall Study|Progressive Disease|14|||
28005221|NCT02322281|81849913|FG002|Overall Study|Progressive Disease|49|||
28005222|NCT02322281|81849911|FG000|Overall Study|Adverse Event|3|||
28005223|NCT02322281|81849912|FG001|Overall Study|Adverse Event|4|||
28005224|NCT02322281|81849913|FG002|Overall Study|Adverse Event|6|||
28005225|NCT02322281|81849911|FG000|Overall Study|Death|3|||
27585210|NCT02863991|80324422|FG000|Overall Study|Death|0|||
27585211|NCT02863991|80324423|FG001|Overall Study|Death|3|||
27585212|NCT02863991|80324422|FG000|Overall Study|Lack of Efficacy|0|||
27585213|NCT02863991|80324423|FG001|Overall Study|Lack of Efficacy|1|||
27585214|NCT02863991|80324422|FG000|Overall Study|Study Terminated|2|||
27585215|NCT02863991|80324423|FG001|Overall Study|Study Terminated|8|||
27585216|NCT01226745|80324424|FG000|Overall Study|Did not complete schedule of assessments|8|||
27585217|NCT01226745|80324425|FG001|Overall Study|Did not complete schedule of assessments|3|||
27585218|NCT01226745|80324426|FG002|Overall Study|Did not complete schedule of assessments|6|||
27585219|NCT01226745|80324427|FG003|Overall Study|Did not complete schedule of assessments|0|||
27585220|NCT01226745|80324428|FG004|Overall Study|Did not complete schedule of assessments|0|||
27585221|NCT01226745|80324429|FG005|Overall Study|Did not complete schedule of assessments|1|||
27585222|NCT01226745|80324424|FG000|Overall Study|Lost to Follow-up|2|||
27585223|NCT01226745|80324425|FG001|Overall Study|Lost to Follow-up|6|||
27585224|NCT01226745|80324426|FG002|Overall Study|Lost to Follow-up|6|||
27585225|NCT01226745|80324427|FG003|Overall Study|Lost to Follow-up|1|||
27585226|NCT01226745|80324428|FG004|Overall Study|Lost to Follow-up|1|||
27808675|NCT00006721|81130658|FG000|Overall Study|Eligible but no Treatment Received|1|||
27808676|NCT00006721|81130659|FG001|Overall Study|Eligible but no Treatment Received|0|||
27808677|NCT00006721|81130660|FG002|Overall Study|Eligible but no Treatment Received|0|||
27808678|NCT03652961|81130669|FG000|Overall Study|Lost to Follow-up|3|||
27808679|NCT03652961|81130669|FG000|Overall Study|Screen Failure|1|||
27808680|NCT00881959|81130670|FG000|Overall Study|Lost to Follow-up|2|||
27808681|NCT00881959|81130671|FG001|Overall Study|Lost to Follow-up|4|||
27808682|NCT00814658|81130672|FG000|Overall Study|Lost to Follow-up|0|||
27808683|NCT00814658|81130673|FG001|Overall Study|Lost to Follow-up|1|||
28005226|NCT02322281|81849912|FG001|Overall Study|Death|3|||
28005227|NCT02322281|81849913|FG002|Overall Study|Death|3|||
28005228|NCT02322281|81849911|FG000|Overall Study|Withdrawal by Subject|1|||
28005229|NCT02322281|81849912|FG001|Overall Study|Withdrawal by Subject|1|||
28005230|NCT02322281|81849913|FG002|Overall Study|Withdrawal by Subject|6|||
28005231|NCT02322281|81849911|FG000|Overall Study|Physician Decision|2|||
28005232|NCT02322281|81849912|FG001|Overall Study|Physician Decision|0|||
28005233|NCT02322281|81849913|FG002|Overall Study|Physician Decision|5|||
28005234|NCT02322281|81849911|FG000|Overall Study|Study Terminated by Sponsor|2|||
28005235|NCT02322281|81849912|FG001|Overall Study|Study Terminated by Sponsor|0|||
28005236|NCT02322281|81849913|FG002|Overall Study|Study Terminated by Sponsor|0|||
28005237|NCT02322281|81849911|FG000|Overall Study|Missing|0|||
28005238|NCT02322281|81849912|FG001|Overall Study|Missing|0|||
28005239|NCT02322281|81849913|FG002|Overall Study|Missing|1|||
28005240|NCT02322281|81849911|FG000|Overall Study|Miscellaneous|0|||
28005241|NCT02322281|81849912|FG001|Overall Study|Miscellaneous|0|||
28005242|NCT02322281|81849913|FG002|Overall Study|Miscellaneous|4|||
28005243|NCT00525512|81849916|FG000|Double-Blind Phase|Adverse Event|48|||
27808684|NCT00814658|81130672|FG000|Overall Study|Physician Decision|1|||
27808685|NCT00814658|81130673|FG001|Overall Study|Physician Decision|0|||
27808686|NCT00814658|81130672|FG000|Overall Study|Adverse Event|3|||
28005244|NCT00525512|81849917|FG001|Double-Blind Phase|Adverse Event|28|||
28005245|NCT00525512|81849918|FG002|Double-Blind Phase|Adverse Event|0|||
27585227|NCT01226745|80324429|FG005|Overall Study|Lost to Follow-up|2|||
27585228|NCT01226745|80324424|FG000|Overall Study|Death|1|||
27808687|NCT00814658|81130673|FG001|Overall Study|Adverse Event|3|||
27808688|NCT02884206|81130674|FG000|Valsartan Run-in Period|Death|1|||
27808689|NCT02884206|81130675|FG001|Valsartan Run-in Period|Death|0|||
28005246|NCT00525512|81849919|FG003|Double-Blind Phase|Adverse Event|0|||
28005247|NCT00525512|81849916|FG000|Double-Blind Phase|Protocol Violation|3|||
28005248|NCT00525512|81849917|FG001|Double-Blind Phase|Protocol Violation|1|||
28005249|NCT00525512|81849918|FG002|Double-Blind Phase|Protocol Violation|0|||
28005250|NCT00525512|81849919|FG003|Double-Blind Phase|Protocol Violation|0|||
28005251|NCT00525512|81849916|FG000|Double-Blind Phase|Lost to Follow-up|3|||
27808690|NCT02884206|81130676|FG002|Valsartan Run-in Period|Death|0|||
27808691|NCT02884206|81130674|FG000|Valsartan Run-in Period|Adverse Event|31|||
27808692|NCT02884206|81130675|FG001|Valsartan Run-in Period|Adverse Event|0|||
27808693|NCT02884206|81130676|FG002|Valsartan Run-in Period|Adverse Event|0|||
27808694|NCT02884206|81130674|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
27808695|NCT02884206|81130675|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
27808696|NCT02884206|81130676|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
27808697|NCT02884206|81130674|FG000|Valsartan Run-in Period|Protocol deviation|4|||
27808698|NCT02884206|81130675|FG001|Valsartan Run-in Period|Protocol deviation|0|||
27874624|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
27874625|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874626|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
27874627|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874628|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874629|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
27874630|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
27874631|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874632|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
27874633|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27874634|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27874635|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
28005252|NCT00525512|81849917|FG001|Double-Blind Phase|Lost to Follow-up|7|||
28005253|NCT00525512|81849918|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27874636|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27874637|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27874638|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
27874639|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27874640|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27874641|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27874642|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
27874643|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27874644|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
27874645|NCT02105987|81371826|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27874646|NCT02105987|81371827|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27874647|NCT02105987|81371828|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
27874648|NCT02105987|81371829|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27874649|NCT02105987|81371830|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27874650|NCT02105987|81371831|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
27874651|NCT02105987|81371826|FG000|Continuation Phase|Protocol Violation|0|||
27874652|NCT02105987|81371827|FG001|Continuation Phase|Protocol Violation|0|||
27874653|NCT02105987|81371828|FG002|Continuation Phase|Protocol Violation|0|||
27874654|NCT02105987|81371829|FG003|Continuation Phase|Protocol Violation|0|||
27874655|NCT02105987|81371830|FG004|Continuation Phase|Protocol Violation|1|||
27874656|NCT02105987|81371831|FG005|Continuation Phase|Protocol Violation|0|||
28005254|NCT00525512|81849919|FG003|Double-Blind Phase|Lost to Follow-up|0|||
28005255|NCT00525512|81849916|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
28005256|NCT00525512|81849917|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
28005257|NCT00525512|81849918|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
28005258|NCT00525512|81849919|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
28005259|NCT00525512|81849916|FG000|Double-Blind Phase|Lack of Efficacy|13|||
28005260|NCT00525512|81849917|FG001|Double-Blind Phase|Lack of Efficacy|5|||
28005261|NCT00525512|81849918|FG002|Double-Blind Phase|Lack of Efficacy|0|||
28005262|NCT00525512|81849919|FG003|Double-Blind Phase|Lack of Efficacy|0|||
28005263|NCT00525512|81849916|FG000|Double-Blind Phase|Other reason (not specified)|12|||
28005264|NCT00525512|81849917|FG001|Double-Blind Phase|Other reason (not specified)|13|||
28005265|NCT00525512|81849918|FG002|Double-Blind Phase|Other reason (not specified)|0|||
28005266|NCT00525512|81849919|FG003|Double-Blind Phase|Other reason (not specified)|0|||
28005267|NCT00525512|81849916|FG000|Open-Label Phase|Adverse Event|0|||
28005268|NCT00525512|81849917|FG001|Open-Label Phase|Adverse Event|0|||
28005269|NCT00525512|81849918|FG002|Open-Label Phase|Adverse Event|1|||
28005270|NCT00525512|81849919|FG003|Open-Label Phase|Adverse Event|0|||
28005271|NCT00525512|81849916|FG000|Open-Label Phase|Lost to Follow-up|0|||
28005272|NCT00525512|81849917|FG001|Open-Label Phase|Lost to Follow-up|0|||
27585229|NCT01226745|80324425|FG001|Overall Study|Death|0|||
27874657|NCT00071110|81371832|FG000|Overall Study|Protocol Violation|0|||
28005273|NCT00525512|81849918|FG002|Open-Label Phase|Lost to Follow-up|1|||
28005274|NCT00525512|81849919|FG003|Open-Label Phase|Lost to Follow-up|0|||
27585230|NCT01226745|80324426|FG002|Overall Study|Death|0|||
27808699|NCT02884206|81130676|FG002|Valsartan Run-in Period|Protocol deviation|0|||
28005275|NCT00525512|81849916|FG000|Open-Label Phase|Other reason (not specified)|0|||
27585231|NCT01226745|80324427|FG003|Overall Study|Death|0|||
27808700|NCT02884206|81130674|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
27808701|NCT02884206|81130675|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
27808702|NCT02884206|81130676|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
27808703|NCT02884206|81130674|FG000|Valsartan Run-in Period|Physician Decision|1|||
27808704|NCT02884206|81130675|FG001|Valsartan Run-in Period|Physician Decision|0|||
27808705|NCT02884206|81130676|FG002|Valsartan Run-in Period|Physician Decision|0|||
28005276|NCT00525512|81849917|FG001|Open-Label Phase|Other reason (not specified)|0|||
28005277|NCT00525512|81849918|FG002|Open-Label Phase|Other reason (not specified)|4|||
28005278|NCT00525512|81849919|FG003|Open-Label Phase|Other reason (not specified)|5|||
28005279|NCT03271151|81849922|FG000|Overall Study|Lost to Follow-up|1|||
28005280|NCT03271151|81849923|FG001|Overall Study|Lost to Follow-up|3|||
28005281|NCT03271151|81849922|FG000|Overall Study|Withdrawal by Subject|1|||
28005282|NCT03271151|81849923|FG001|Overall Study|Withdrawal by Subject|0|||
28005283|NCT02240485|81849927|FG000|3 Months Post-admission|Lost to Follow-up|1|||
28005284|NCT02240485|81849928|FG001|3 Months Post-admission|Lost to Follow-up|5|||
28005285|NCT02240485|81849927|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
28005286|NCT02240485|81849928|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
28005287|NCT02240485|81849927|FG000|9 Months Post-admission|Lost to Follow-up|3|||
28005288|NCT02240485|81849928|FG001|9 Months Post-admission|Lost to Follow-up|1|||
28005289|NCT02240485|81849927|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
28005290|NCT02240485|81849928|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
28005291|NCT02240485|81849927|FG000|18 Months Post-admission|Lost to Follow-up|1|||
28005292|NCT02240485|81849928|FG001|18 Months Post-admission|Lost to Follow-up|1|||
28005293|NCT02240485|81849927|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
28005294|NCT02240485|81849928|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
28005295|NCT00960375|81849930|FG000|Overall Study|Lost to Follow-up|20|||
28005296|NCT00960375|81849931|FG001|Overall Study|Lost to Follow-up|22|||
28005297|NCT01702844|81849934|FG000|Overall Study|Adverse Event|9|||
28005298|NCT01702844|81849934|FG000|Overall Study|Death|1|||
28005299|NCT01702844|81849934|FG000|Overall Study|Withdrawal by Subject|3|||
28005300|NCT01702844|81849934|FG000|Overall Study|Physician Decision|6|||
28005301|NCT01172535|81849941|FG000|Overall Study|Death|3|||
28005302|NCT01172535|81849941|FG000|Overall Study|Withdrawal by Subject|2|||
28005303|NCT01172535|81849941|FG000|Overall Study|Lost to Follow-up|1|||
28005304|NCT01172535|81849941|FG000|Overall Study|Ineligible at study entry|1|||
28005305|NCT01172535|81849941|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
28005306|NCT03740048|81849948|FG000|Overall Study|Withdrawal by Subject|1|||
28005307|NCT03740048|81849949|FG001|Overall Study|Withdrawal by Subject|1|||
28005308|NCT03740048|81849948|FG000|Overall Study|Death|1|||
28005309|NCT03740048|81849949|FG001|Overall Study|Death|6|||
28005310|NCT03740048|81849948|FG000|Overall Study|Switched to thrice-weekly HD|2|||
28005311|NCT03740048|81849949|FG001|Overall Study|Switched to thrice-weekly HD|0|||
28005312|NCT03740048|81849948|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
28005313|NCT03740048|81849949|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
28005314|NCT03740048|81849948|FG000|Overall Study|Lost to Follow-up|0|||
28005315|NCT03740048|81849949|FG001|Overall Study|Lost to Follow-up|1|||
28005316|NCT03740048|81849948|FG000|Overall Study|Non-compliance with HD|0|||
28005317|NCT03740048|81849949|FG001|Overall Study|Non-compliance with HD|1|||
28005318|NCT00317473|81849950|FG000|Overall Study|Withdrawal by Subject|2|||
28005319|NCT00317473|81849951|FG001|Overall Study|Withdrawal by Subject|1|||
28005320|NCT00317473|81849952|FG002|Overall Study|Withdrawal by Subject|2|||
28005321|NCT00317473|81849953|FG003|Overall Study|Withdrawal by Subject|1|||
28005322|NCT00317473|81849954|FG004|Overall Study|Withdrawal by Subject|3|||
28005323|NCT00317473|81849955|FG005|Overall Study|Withdrawal by Subject|1|||
28005324|NCT00317473|81849950|FG000|Overall Study|Relocation|1|||
28005325|NCT00317473|81849951|FG001|Overall Study|Relocation|0|||
28005326|NCT00317473|81849952|FG002|Overall Study|Relocation|1|||
28005327|NCT00317473|81849953|FG003|Overall Study|Relocation|1|||
28005328|NCT00317473|81849954|FG004|Overall Study|Relocation|5|||
28005329|NCT00317473|81849955|FG005|Overall Study|Relocation|2|||
27808706|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Adverse Event|38|||
27808707|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Adverse Event|0|||
27808708|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Adverse Event|0|||
28005330|NCT00317473|81849950|FG000|Overall Study|Death|1|||
28005331|NCT00317473|81849951|FG001|Overall Study|Death|0|||
28005332|NCT00317473|81849952|FG002|Overall Study|Death|0|||
28005333|NCT00317473|81849953|FG003|Overall Study|Death|0|||
28005334|NCT00317473|81849954|FG004|Overall Study|Death|0|||
28005335|NCT00317473|81849955|FG005|Overall Study|Death|0|||
28005336|NCT00317473|81849950|FG000|Overall Study|Other|0|||
28005337|NCT00317473|81849951|FG001|Overall Study|Other|2|||
28005338|NCT00317473|81849952|FG002|Overall Study|Other|0|||
28005339|NCT00317473|81849953|FG003|Overall Study|Other|0|||
27808709|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Death|2|||
28005340|NCT00317473|81849954|FG004|Overall Study|Other|0|||
28005341|NCT00317473|81849955|FG005|Overall Study|Other|0|||
28005342|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
27808710|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Death|0|||
27808711|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Death|0|||
27585232|NCT01226745|80324428|FG004|Overall Study|Death|0|||
27684828|NCT01323972|80683628|FG003|Overall Study|Migrated/moved from study area|0|||
27808712|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
27808713|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
27808714|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
27808715|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
27808716|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
27808717|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
27808718|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
27808719|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
27808720|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
27808721|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Physician Decision|1|||
27808722|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Physician Decision|0|||
27808723|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Physician Decision|0|||
27808724|NCT02884206|81130674|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
27808725|NCT02884206|81130675|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
27808726|NCT02884206|81130676|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
27808727|NCT02884206|81130674|FG000|Double-Blind Period|Death|0|||
27808728|NCT02884206|81130675|FG001|Double-Blind Period|Death|28|||
27808729|NCT02884206|81130676|FG002|Double-Blind Period|Death|39|||
27808730|NCT02884206|81130674|FG000|Double-Blind Period|Patient/guardian decision|0|||
27808731|NCT02884206|81130675|FG001|Double-Blind Period|Patient/guardian decision|10|||
27808732|NCT02884206|81130676|FG002|Double-Blind Period|Patient/guardian decision|13|||
27808733|NCT02884206|81130674|FG000|Double-Blind Period|Lost to Follow-up|0|||
27808734|NCT02884206|81130675|FG001|Double-Blind Period|Lost to Follow-up|4|||
27808735|NCT02884206|81130676|FG002|Double-Blind Period|Lost to Follow-up|4|||
27808736|NCT02884206|81130674|FG000|Double-Blind Period|Physician Decision|0|||
27808737|NCT02884206|81130675|FG001|Double-Blind Period|Physician Decision|2|||
27808738|NCT02884206|81130676|FG002|Double-Blind Period|Physician Decision|0|||
27808739|NCT02884206|81130674|FG000|Double-Blind Period|Adverse Event|0|||
27808740|NCT02884206|81130675|FG001|Double-Blind Period|Adverse Event|0|||
27808741|NCT02884206|81130676|FG002|Double-Blind Period|Adverse Event|3|||
27808742|NCT02884206|81130674|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
27808743|NCT02884206|81130675|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
27808744|NCT02884206|81130676|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
27808745|NCT00638157|81130678|FG000|Overall Study|Adverse Event|0|||
27808746|NCT00638157|81130679|FG001|Overall Study|Adverse Event|1|||
27808747|NCT00638157|81130678|FG000|Overall Study|Clinical (symptomatic) failure|1|||
27808748|NCT00638157|81130679|FG001|Overall Study|Clinical (symptomatic) failure|1|||
27808749|NCT00638157|81130678|FG000|Overall Study|Microbiological failure|1|||
27808750|NCT00638157|81130679|FG001|Overall Study|Microbiological failure|0|||
27808751|NCT00638157|81130678|FG000|Overall Study|Lost to Follow-up|1|||
27808752|NCT00638157|81130679|FG001|Overall Study|Lost to Follow-up|0|||
27808753|NCT00638157|81130678|FG000|Overall Study|Physician Decision|1|||
27808754|NCT00638157|81130679|FG001|Overall Study|Physician Decision|0|||
27808755|NCT00638157|81130678|FG000|Overall Study|Other|1|||
27808756|NCT00638157|81130679|FG001|Overall Study|Other|2|||
27808757|NCT00638157|81130678|FG000|Overall Study|Randomized, not treated|2|||
27808758|NCT00638157|81130679|FG001|Overall Study|Randomized, not treated|0|||
27808759|NCT00827827|81130680|FG000|Overall Study|Lost to Follow-up|3|||
27808760|NCT00827827|81130681|FG001|Overall Study|Lost to Follow-up|0|||
27808761|NCT00827827|81130680|FG000|Overall Study|Fall at home- hospitalization|1|||
27808762|NCT00827827|81130681|FG001|Overall Study|Fall at home- hospitalization|0|||
27808763|NCT00827827|81130680|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
27808764|NCT00827827|81130681|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
27808765|NCT00827827|81130680|FG000|Overall Study|Gout|1|||
27808766|NCT00827827|81130681|FG001|Overall Study|Gout|0|||
27808767|NCT00827827|81130680|FG000|Overall Study|Transportation issues|1|||
27808768|NCT00827827|81130681|FG001|Overall Study|Transportation issues|0|||
27808769|NCT00827827|81130680|FG000|Overall Study|Burned with water at home|1|||
27808770|NCT00827827|81130681|FG001|Overall Study|Burned with water at home|0|||
27808771|NCT03196791|81130685|FG000|Overall Study|Protocol Violation|7|||
27808772|NCT03196791|81130686|FG001|Overall Study|Protocol Violation|3|||
27808773|NCT03196791|81130685|FG000|Overall Study|Withdrawal by Subject|3|||
27808774|NCT03196791|81130686|FG001|Overall Study|Withdrawal by Subject|2|||
27808775|NCT03740698|81130689|FG000|Overall Study|Physician Decision|0|||
27808776|NCT03740698|81130690|FG001|Overall Study|Physician Decision|1|||
27808777|NCT03740698|81130691|FG002|Overall Study|Physician Decision|1|||
27874658|NCT00071110|81371833|FG001|Overall Study|Protocol Violation|4|||
27684829|NCT01323972|80683625|FG000|Overall Study|Lost to Follow-up|0|||
27874659|NCT02137252|81371836|FG000|Overall Study|trial terminated early|2|||
27808778|NCT01162499|81130692|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
27808779|NCT01162499|81130693|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
27874660|NCT02137252|81371837|FG001|Overall Study|trial terminated early|1|||
28005343|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28005344|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28005345|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005346|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005347|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005348|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
27808780|NCT01907087|81130697|FG000|Overall Study|Withdrawal by Subject|1|||
27808781|NCT01193517|81130700|FG000|Overall Study|Early Progression|1|||
27808782|NCT01193517|81130701|FG001|Overall Study|Early Progression|0|||
27808783|NCT01193517|81130702|FG002|Overall Study|Early Progression|0|||
27808784|NCT03355742|81130707|FG000|Overall Study|Lost to Follow-up|4|||
27808785|NCT03355742|81130707|FG000|Overall Study|Withdrawal by Subject|29|||
27808786|NCT03355742|81130707|FG000|Overall Study|Physician Decision|6|||
27808787|NCT03355742|81130707|FG000|Overall Study|Death|55|||
27808788|NCT03355742|81130707|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
27808789|NCT01313728|81130710|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
27808790|NCT01254045|81130711|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
27808791|NCT01254045|81130712|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27808792|NCT01254045|81130713|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27808793|NCT01254045|81130714|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27808794|NCT01254045|81130715|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27808795|NCT01254045|81130716|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
27808796|NCT04147715|81130717|FG000|Overall Study|Adverse Event|0|||
27808797|NCT04147715|81130718|FG001|Overall Study|Adverse Event|0|||
27808798|NCT04147715|81130719|FG002|Overall Study|Adverse Event|0|||
27808799|NCT04147715|81130720|FG003|Overall Study|Adverse Event|0|||
27808800|NCT04147715|81130721|FG004|Overall Study|Adverse Event|0|||
27808801|NCT04147715|81130722|FG005|Overall Study|Adverse Event|0|||
28005349|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005350|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005351|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005352|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005353|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005354|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
28005355|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005356|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
28005357|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005358|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28005359|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005360|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005361|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
28005362|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28005363|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
28005364|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
28005365|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005366|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28005367|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005368|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005369|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
28005370|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
28005371|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
28005372|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
28005373|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
28005374|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
28005375|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
28005376|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
28005377|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
28005378|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
28005379|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
28005380|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
27808802|NCT04147715|81130723|FG006|Overall Study|Adverse Event|0|||
27808803|NCT04147715|81130724|FG007|Overall Study|Adverse Event|2|||
27808804|NCT04147715|81130725|FG008|Overall Study|Adverse Event|1|||
27808805|NCT04147715|81130726|FG009|Overall Study|Adverse Event|0|||
27808806|NCT04147715|81130727|FG010|Overall Study|Adverse Event|0|||
27808807|NCT04147715|81130728|FG011|Overall Study|Adverse Event|0|||
27808808|NCT00571922|81130730|FG000|Overall Study|Completion unknown|36|||
28005381|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
28005382|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
28005383|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
28005384|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
27585233|NCT01226745|80324429|FG005|Overall Study|Death|1|||
27808809|NCT00571922|81130731|FG001|Overall Study|Completion unknown|36|||
27808810|NCT01785875|81130732|FG000|Overall Study|Withdrawal by Subject|41|||
27808811|NCT01785875|81130733|FG001|Overall Study|Withdrawal by Subject|34|||
27808812|NCT01785875|81130734|FG002|Overall Study|Withdrawal by Subject|36|||
27808813|NCT01785875|81130732|FG000|Overall Study|Lost to Follow-up|19|||
27808814|NCT01785875|81130733|FG001|Overall Study|Lost to Follow-up|22|||
27808815|NCT01785875|81130734|FG002|Overall Study|Lost to Follow-up|6|||
27808816|NCT01785875|81130732|FG000|Overall Study|Death|27|||
27808817|NCT01785875|81130733|FG001|Overall Study|Death|16|||
27808818|NCT01785875|81130734|FG002|Overall Study|Death|7|||
27808819|NCT01785875|81130732|FG000|Overall Study|Sponsor Decision|0|||
27808820|NCT01785875|81130733|FG001|Overall Study|Sponsor Decision|2|||
27808821|NCT01785875|81130734|FG002|Overall Study|Sponsor Decision|0|||
27585234|NCT01226745|80324424|FG000|Overall Study|Other|6|||
27585235|NCT01226745|80324425|FG001|Overall Study|Other|7|||
27585236|NCT01226745|80324426|FG002|Overall Study|Other|8|||
27808822|NCT01785875|81130732|FG000|Overall Study|Protocol Specified Criteria|207|||
27808823|NCT01785875|81130733|FG001|Overall Study|Protocol Specified Criteria|214|||
27808824|NCT01785875|81130734|FG002|Overall Study|Protocol Specified Criteria|55|||
27808825|NCT01785875|81130732|FG000|Overall Study|Missing|0|||
27808826|NCT01785875|81130733|FG001|Overall Study|Missing|1|||
27808827|NCT01785875|81130734|FG002|Overall Study|Missing|3|||
27808828|NCT02257632|81130735|FG000|Overall Study|Withdrawal by Subject|0|||
27808829|NCT02257632|81130736|FG001|Overall Study|Withdrawal by Subject|1|||
27808830|NCT02257632|81130735|FG000|Overall Study|Adverse Event|1|||
27808831|NCT02257632|81130736|FG001|Overall Study|Adverse Event|2|||
27808832|NCT01664052|81130739|FG000|Phase 1|No device placement|6|||
27808833|NCT01664052|81130740|FG001|Phase 1|No device placement|0|||
27808834|NCT01664052|81130739|FG000|Phase 1|No HSG 1 hr post placement|1|||
27808835|NCT01664052|81130740|FG001|Phase 1|No HSG 1 hr post placement|0|||
27808836|NCT01664052|81130739|FG000|Phase 2|No device placement|0|||
27808837|NCT01664052|81130740|FG001|Phase 2|No device placement|4|||
27808838|NCT03118739|81130743|FG000|Overall Study|Physician Decision|0|||
27808839|NCT03118739|81130744|FG001|Overall Study|Physician Decision|1|||
27808840|NCT03118739|81130743|FG000|Overall Study|Withdrawal by Subject|5|||
27808841|NCT03118739|81130744|FG001|Overall Study|Withdrawal by Subject|3|||
27808842|NCT03118739|81130743|FG000|Overall Study|Lost to Follow-up|2|||
27808843|NCT03118739|81130744|FG001|Overall Study|Lost to Follow-up|0|||
27808844|NCT00463866|81130745|FG000|Overall Study|Adverse Event|70|||
27808845|NCT00463866|81130746|FG001|Overall Study|Adverse Event|93|||
27808846|NCT00463866|81130745|FG000|Overall Study|Withdrawal by Subject|81|||
27808847|NCT00463866|81130746|FG001|Overall Study|Withdrawal by Subject|79|||
27808848|NCT00463866|81130745|FG000|Overall Study|Lost to Follow-up|46|||
27808849|NCT00463866|81130746|FG001|Overall Study|Lost to Follow-up|55|||
27808850|NCT00463866|81130745|FG000|Overall Study|Incorrect Enrolment|64|||
27808851|NCT00463866|81130746|FG001|Overall Study|Incorrect Enrolment|66|||
27808852|NCT00463866|81130745|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
27808853|NCT00463866|81130746|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
27808854|NCT00463866|81130745|FG000|Overall Study|Safety Reason|1|||
27808855|NCT00463866|81130746|FG001|Overall Study|Safety Reason|3|||
27808856|NCT00463866|81130745|FG000|Overall Study|Mis-Randomization of subject|0|||
27808857|NCT00463866|81130746|FG001|Overall Study|Mis-Randomization of subject|1|||
27585237|NCT01226745|80324427|FG003|Overall Study|Other|4|||
27585238|NCT01226745|80324428|FG004|Overall Study|Other|3|||
27808858|NCT00463866|81130745|FG000|Overall Study|Other|22|||
27808859|NCT00463866|81130746|FG001|Overall Study|Other|22|||
27808860|NCT00979628|81130747|FG000|Overall Study|received regimen < 24 hours|7|||
27808861|NCT00979628|81130748|FG001|Overall Study|received regimen < 24 hours|6|||
27808862|NCT00979628|81130749|FG002|Overall Study|received regimen < 24 hours|5|||
27808863|NCT00979628|81130747|FG000|Overall Study|received steroids|1|||
27808864|NCT00979628|81130748|FG001|Overall Study|received steroids|1|||
27808865|NCT00979628|81130749|FG002|Overall Study|received steroids|0|||
27585239|NCT01226745|80324429|FG005|Overall Study|Other|1|||
27808866|NCT00979628|81130747|FG000|Overall Study|transferred to ICU|1|||
27808867|NCT00979628|81130748|FG001|Overall Study|transferred to ICU|2|||
27808868|NCT00979628|81130749|FG002|Overall Study|transferred to ICU|1|||
27808869|NCT02468557|81130750|FG000|Overall Study|Adverse Event|1|||
27808870|NCT02468557|81130750|FG000|Overall Study|Death|1|||
27808871|NCT02468557|81130750|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
27808872|NCT02468557|81130750|FG000|Overall Study|All Enrolled but Never Dosed|4|||
27808873|NCT00417027|81130751|FG000|Overall Study|Protocol Violation|0|||
27808874|NCT00417027|81130752|FG001|Overall Study|Protocol Violation|5|||
27808875|NCT00417027|81130753|FG002|Overall Study|Protocol Violation|5|||
27808876|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
27808877|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
27808878|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
27808879|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
27808880|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
27808881|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
27808882|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
27808883|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
27808884|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
27808885|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
27808886|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
27808887|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
27808888|NCT01227668|81130758|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
27808889|NCT01227668|81130759|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
27808890|NCT01227668|81130758|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
27808891|NCT01227668|81130759|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
27808892|NCT01227668|81130758|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
27808893|NCT01227668|81130759|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
27808894|NCT01227668|81130758|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
27808895|NCT01227668|81130759|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
27808896|NCT01227668|81130758|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
27808897|NCT01227668|81130759|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
27808898|NCT01227668|81130758|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
27808899|NCT01227668|81130759|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
27808900|NCT01789281|81130760|FG000|Overall Study|Disease progression|15|||
27808901|NCT01789281|81130761|FG001|Overall Study|Disease progression|4|||
27808902|NCT01789281|81130760|FG000|Overall Study|Adverse Event|5|||
27808903|NCT01789281|81130761|FG001|Overall Study|Adverse Event|5|||
27808904|NCT01789281|81130760|FG000|Overall Study|Withdrawal by Subject|1|||
27808905|NCT01789281|81130761|FG001|Overall Study|Withdrawal by Subject|0|||
27808906|NCT01789281|81130760|FG000|Overall Study|Lost to Follow-up|1|||
27808907|NCT01789281|81130761|FG001|Overall Study|Lost to Follow-up|0|||
27808908|NCT01789281|81130760|FG000|Overall Study|Administrative problems|0|||
27808909|NCT01789281|81130761|FG001|Overall Study|Administrative problems|1|||
27808910|NCT01830920|81130762|FG000|Overall Study|Adverse Event|1|||
27808911|NCT01830920|81130763|FG001|Overall Study|Adverse Event|0|||
27808912|NCT01830920|81130764|FG002|Overall Study|Adverse Event|1|||
27808913|NCT01830920|81130765|FG003|Overall Study|Adverse Event|0|||
27808914|NCT01830920|81130766|FG004|Overall Study|Adverse Event|0|||
27808915|NCT01830920|81130762|FG000|Overall Study|Withdrawal by Subject|2|||
27808916|NCT01830920|81130763|FG001|Overall Study|Withdrawal by Subject|2|||
27808917|NCT01830920|81130764|FG002|Overall Study|Withdrawal by Subject|1|||
27808918|NCT01830920|81130765|FG003|Overall Study|Withdrawal by Subject|7|||
28005385|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
28005386|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
28005387|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
28005388|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005389|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005390|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
28005391|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005392|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005393|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005394|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005395|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005396|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005397|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
28005398|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005399|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005400|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005401|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
28005402|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005403|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
27808919|NCT01830920|81130766|FG004|Overall Study|Withdrawal by Subject|1|||
27808920|NCT01830920|81130762|FG000|Overall Study|Death|3|||
27808921|NCT01830920|81130763|FG001|Overall Study|Death|3|||
27808922|NCT01830920|81130764|FG002|Overall Study|Death|5|||
27808923|NCT01830920|81130765|FG003|Overall Study|Death|4|||
27808924|NCT01830920|81130766|FG004|Overall Study|Death|4|||
27808925|NCT01830920|81130762|FG000|Overall Study|Other|15|||
27808926|NCT01830920|81130763|FG001|Overall Study|Other|1|||
27808927|NCT01830920|81130764|FG002|Overall Study|Other|1|||
27808928|NCT01830920|81130765|FG003|Overall Study|Other|5|||
27808929|NCT01830920|81130766|FG004|Overall Study|Other|3|||
27808930|NCT01154153|81130768|FG000|Overall Study|Poor compliance to protocol|2|||
27808931|NCT01154153|81130769|FG001|Overall Study|Poor compliance to protocol|0|||
27808932|NCT01154153|81130768|FG000|Overall Study|Unable to use labs|2|||
27808933|NCT01154153|81130769|FG001|Overall Study|Unable to use labs|3|||
27808934|NCT01154153|81130768|FG000|Overall Study|Withdrew consent|1|||
27808935|NCT01154153|81130769|FG001|Overall Study|Withdrew consent|0|||
27808936|NCT02711956|81130770|FG000|Overall Study|Adverse Event|0|||
27808937|NCT02711956|81130771|FG001|Overall Study|Adverse Event|0|||
27585240|NCT00512135|80324430|FG000|Overall Study|Not Treated|5|||
27585241|NCT00512135|80324430|FG000|Overall Study|Lack of Efficacy|2|||
27585242|NCT00512135|80324430|FG000|Overall Study|Adverse Event|6|||
27585243|NCT00512135|80324430|FG000|Overall Study|Withdrawal by Subject|22|||
27585244|NCT00512135|80324430|FG000|Overall Study|Lost to Follow-up|27|||
27585245|NCT00512135|80324430|FG000|Overall Study|Other|22|||
27585246|NCT01808313|80324431|FG000|Overall Study|Adverse Event|5|||
27585247|NCT01808313|80324431|FG000|Overall Study|Protocol Violation|2|||
27585248|NCT01808313|80324431|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27585249|NCT01808313|80324431|FG000|Overall Study|Lost to Follow-up|1|||
27585250|NCT01808313|80324431|FG000|Overall Study|Physician Decision|1|||
27585251|NCT03264989|80324432|FG000|Overall Study|Lost to Follow-up|1|||
27585252|NCT03264989|80324433|FG001|Overall Study|Lost to Follow-up|0|||
27585253|NCT03264989|80324432|FG000|Overall Study|New Therapy for study Indication|1|||
27585254|NCT03264989|80324433|FG001|Overall Study|New Therapy for study Indication|0|||
27585255|NCT03264989|80324432|FG000|Overall Study|Protocol Violation|0|||
27585256|NCT03264989|80324433|FG001|Overall Study|Protocol Violation|1|||
27585257|NCT03264989|80324432|FG000|Overall Study|Patient decision|13|||
27585258|NCT03264989|80324433|FG001|Overall Study|Patient decision|0|||
27585259|NCT03264989|80324432|FG000|Overall Study|Physician Decision|6|||
27585260|NCT03264989|80324433|FG001|Overall Study|Physician Decision|4|||
27585261|NCT03264989|80324432|FG000|Overall Study|Adverse Event|2|||
27585262|NCT03264989|80324433|FG001|Overall Study|Adverse Event|1|||
27585263|NCT03264989|80324432|FG000|Overall Study|Death|1|||
27585264|NCT03264989|80324433|FG001|Overall Study|Death|1|||
27585265|NCT03264989|80324432|FG000|Overall Study|Pregnancy|2|||
27585266|NCT03264989|80324433|FG001|Overall Study|Pregnancy|0|||
27585267|NCT03264989|80324432|FG000|Overall Study|End of Study|19|||
27585268|NCT03264989|80324433|FG001|Overall Study|End of Study|5|||
27585269|NCT01165281|80324436|FG000|Overall Study|Adverse Event|12|||
27585270|NCT01165281|80324437|FG001|Overall Study|Adverse Event|14|||
27585271|NCT01165281|80324436|FG000|Overall Study|Death|3|||
27585272|NCT01165281|80324437|FG001|Overall Study|Death|4|||
27585273|NCT01165281|80324436|FG000|Overall Study|Lack of Efficacy|4|||
27585274|NCT01165281|80324437|FG001|Overall Study|Lack of Efficacy|1|||
27585275|NCT01165281|80324436|FG000|Overall Study|Lost to Follow-up|0|||
27585276|NCT01165281|80324437|FG001|Overall Study|Lost to Follow-up|1|||
27585277|NCT01165281|80324436|FG000|Overall Study|Physician Decision|8|||
27585278|NCT01165281|80324437|FG001|Overall Study|Physician Decision|1|||
27585279|NCT01165281|80324436|FG000|Overall Study|Protocol Violation|6|||
27585280|NCT01165281|80324437|FG001|Overall Study|Protocol Violation|5|||
27585281|NCT01165281|80324436|FG000|Overall Study|Withdrawal by Subject|8|||
27585282|NCT01165281|80324437|FG001|Overall Study|Withdrawal by Subject|7|||
27585283|NCT01165281|80324436|FG000|Overall Study|Noncompliance with Study Drug|1|||
27585284|NCT01165281|80324437|FG001|Overall Study|Noncompliance with Study Drug|4|||
27585285|NCT01165281|80324436|FG000|Overall Study|Progressive Disease|10|||
27585286|NCT01165281|80324437|FG001|Overall Study|Progressive Disease|14|||
27585287|NCT01165281|80324436|FG000|Overall Study|Other|6|||
27808938|NCT02711956|81130772|FG002|Overall Study|Adverse Event|0|||
27585288|NCT01165281|80324437|FG001|Overall Study|Other|0|||
27585289|NCT03579459|80324438|FG000|Overall Study|Adverse Event|7|||
27585290|NCT03579459|80324439|FG001|Overall Study|Adverse Event|6|||
27585291|NCT03579459|80324440|FG002|Overall Study|Adverse Event|2|||
27808939|NCT02711956|81130773|FG003|Overall Study|Adverse Event|1|||
27808940|NCT02711956|81130774|FG004|Overall Study|Adverse Event|2|||
27585292|NCT03579459|80324441|FG003|Overall Study|Adverse Event|6|||
27585293|NCT03579459|80324438|FG000|Overall Study|Death|1|||
27585294|NCT03579459|80324439|FG001|Overall Study|Death|0|||
27585295|NCT03579459|80324440|FG002|Overall Study|Death|1|||
27585296|NCT03579459|80324441|FG003|Overall Study|Death|2|||
27585297|NCT03579459|80324438|FG000|Overall Study|Lost to Follow-up|6|||
27808941|NCT02711956|81130775|FG005|Overall Study|Adverse Event|0|||
27808942|NCT02711956|81130776|FG006|Overall Study|Adverse Event|0|||
27808943|NCT02711956|81130777|FG007|Overall Study|Adverse Event|1|||
27808944|NCT02711956|81130778|FG008|Overall Study|Adverse Event|1|||
27808945|NCT02711956|81130779|FG009|Overall Study|Adverse Event|1|||
27808946|NCT02711956|81130780|FG010|Overall Study|Adverse Event|1|||
27808947|NCT02711956|81130781|FG011|Overall Study|Adverse Event|0|||
27808948|NCT02711956|81130782|FG012|Overall Study|Adverse Event|0|||
27808949|NCT02711956|81130783|FG013|Overall Study|Adverse Event|0|||
27808950|NCT02711956|81130784|FG014|Overall Study|Adverse Event|2|||
27808951|NCT02711956|81130770|FG000|Overall Study|Physician Decision|0|||
27808952|NCT02711956|81130771|FG001|Overall Study|Physician Decision|0|||
28005404|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005405|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005406|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28005407|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28005408|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005409|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28005410|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005411|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28005412|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005413|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28005414|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005415|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
28005416|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
28005417|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005418|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005419|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005420|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
28005421|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005422|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005423|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005424|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005425|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005426|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005427|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
28005428|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005429|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005430|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005431|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
28005432|NCT01147666|81849956|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005433|NCT01147666|81849957|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005434|NCT01147666|81849958|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005435|NCT01147666|81849959|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005436|NCT01147666|81849960|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005437|NCT01147666|81849961|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005438|NCT01147666|81849962|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005439|NCT01147666|81849963|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005440|NCT01147666|81849964|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005441|NCT01147666|81849965|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005442|NCT01147666|81849966|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005443|NCT01147666|81849967|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
28005444|NCT01147666|81849968|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
28005445|NCT01147666|81849969|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
28005446|NCT01147666|81849970|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
28005447|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
28005448|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
28005449|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
28005450|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
28005451|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
28005452|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
28005453|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
28005454|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
28005455|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
27808953|NCT02711956|81130772|FG002|Overall Study|Physician Decision|0|||
27808954|NCT02711956|81130773|FG003|Overall Study|Physician Decision|2|||
28005456|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
27808955|NCT02711956|81130774|FG004|Overall Study|Physician Decision|0|||
27808956|NCT02711956|81130775|FG005|Overall Study|Physician Decision|0|||
28005457|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
28005458|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
28005459|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
27585298|NCT03579459|80324439|FG001|Overall Study|Lost to Follow-up|2|||
27585299|NCT03579459|80324440|FG002|Overall Study|Lost to Follow-up|4|||
27585300|NCT03579459|80324441|FG003|Overall Study|Lost to Follow-up|1|||
27585301|NCT03579459|80324438|FG000|Overall Study|Physician Decision|0|||
27585302|NCT03579459|80324439|FG001|Overall Study|Physician Decision|1|||
27585303|NCT03579459|80324440|FG002|Overall Study|Physician Decision|0|||
27585304|NCT03579459|80324441|FG003|Overall Study|Physician Decision|1|||
27585305|NCT03579459|80324438|FG000|Overall Study|Protocol Violation|1|||
27808957|NCT02711956|81130776|FG006|Overall Study|Physician Decision|0|||
27808958|NCT02711956|81130777|FG007|Overall Study|Physician Decision|0|||
27808959|NCT02711956|81130778|FG008|Overall Study|Physician Decision|0|||
27808960|NCT02711956|81130779|FG009|Overall Study|Physician Decision|0|||
27808961|NCT02711956|81130780|FG010|Overall Study|Physician Decision|0|||
27808962|NCT02711956|81130781|FG011|Overall Study|Physician Decision|0|||
27808963|NCT02711956|81130782|FG012|Overall Study|Physician Decision|0|||
27808964|NCT02711956|81130783|FG013|Overall Study|Physician Decision|0|||
28005460|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
28005461|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
27808965|NCT02711956|81130784|FG014|Overall Study|Physician Decision|0|||
27808966|NCT02711956|81130770|FG000|Overall Study|Withdrawal by Subject|0|||
27808967|NCT02711956|81130771|FG001|Overall Study|Withdrawal by Subject|0|||
28005462|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005463|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005464|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005465|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005466|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
28005467|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
28005468|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
28005469|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
28005470|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005471|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
28005472|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005473|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005474|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
28005475|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
28005476|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
28005477|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005478|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005479|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005480|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
28005481|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005482|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005483|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005484|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005485|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005486|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005487|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005488|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005489|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
27585306|NCT03579459|80324439|FG001|Overall Study|Protocol Violation|2|||
27585307|NCT03579459|80324440|FG002|Overall Study|Protocol Violation|3|||
27585308|NCT03579459|80324441|FG003|Overall Study|Protocol Violation|5|||
27684830|NCT01323972|80683626|FG001|Overall Study|Lost to Follow-up|1|||
27808968|NCT02711956|81130772|FG002|Overall Study|Withdrawal by Subject|0|||
27808969|NCT02711956|81130773|FG003|Overall Study|Withdrawal by Subject|0|||
27808970|NCT02711956|81130774|FG004|Overall Study|Withdrawal by Subject|0|||
27808971|NCT02711956|81130775|FG005|Overall Study|Withdrawal by Subject|0|||
27808972|NCT02711956|81130776|FG006|Overall Study|Withdrawal by Subject|1|||
27808973|NCT02711956|81130777|FG007|Overall Study|Withdrawal by Subject|0|||
27808974|NCT02711956|81130778|FG008|Overall Study|Withdrawal by Subject|0|||
27808975|NCT02711956|81130779|FG009|Overall Study|Withdrawal by Subject|0|||
27808976|NCT02711956|81130780|FG010|Overall Study|Withdrawal by Subject|0|||
27808977|NCT02711956|81130781|FG011|Overall Study|Withdrawal by Subject|1|||
27808978|NCT02711956|81130782|FG012|Overall Study|Withdrawal by Subject|6|||
27808979|NCT02711956|81130783|FG013|Overall Study|Withdrawal by Subject|0|||
27808980|NCT02711956|81130784|FG014|Overall Study|Withdrawal by Subject|1|||
27808981|NCT02711956|81130770|FG000|Overall Study|Clinical progression|1|||
27808982|NCT02711956|81130771|FG001|Overall Study|Clinical progression|0|||
27808983|NCT02711956|81130772|FG002|Overall Study|Clinical progression|0|||
27808984|NCT02711956|81130773|FG003|Overall Study|Clinical progression|0|||
27808985|NCT02711956|81130774|FG004|Overall Study|Clinical progression|0|||
27808986|NCT02711956|81130775|FG005|Overall Study|Clinical progression|0|||
27808987|NCT02711956|81130776|FG006|Overall Study|Clinical progression|1|||
28005490|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005491|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
28005492|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005493|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005494|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005495|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005496|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28005497|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28005498|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005499|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28005500|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005501|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28005502|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005503|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005504|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005505|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
28005506|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
28005507|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005508|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005509|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
27808988|NCT02711956|81130777|FG007|Overall Study|Clinical progression|0|||
27808989|NCT02711956|81130778|FG008|Overall Study|Clinical progression|1|||
27808990|NCT02711956|81130779|FG009|Overall Study|Clinical progression|0|||
28005510|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
28005511|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005512|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
27808991|NCT02711956|81130780|FG010|Overall Study|Clinical progression|0|||
27808992|NCT02711956|81130781|FG011|Overall Study|Clinical progression|2|||
27808993|NCT02711956|81130782|FG012|Overall Study|Clinical progression|4|||
28005513|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005514|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
27808994|NCT02711956|81130783|FG013|Overall Study|Clinical progression|1|||
27585309|NCT03579459|80324438|FG000|Overall Study|Withdrawal by Subject|12|||
27585310|NCT03579459|80324439|FG001|Overall Study|Withdrawal by Subject|8|||
27585311|NCT03579459|80324440|FG002|Overall Study|Withdrawal by Subject|11|||
27585312|NCT03579459|80324441|FG003|Overall Study|Withdrawal by Subject|8|||
27585313|NCT03579459|80324438|FG000|Overall Study|Medication error without associated adverse event|2|||
27585314|NCT03579459|80324439|FG001|Overall Study|Medication error without associated adverse event|1|||
27585315|NCT03579459|80324440|FG002|Overall Study|Medication error without associated adverse event|1|||
27585316|NCT03579459|80324441|FG003|Overall Study|Medication error without associated adverse event|0|||
27585317|NCT03579459|80324438|FG000|Overall Study|Other|0|||
27585318|NCT03579459|80324439|FG001|Overall Study|Other|1|||
27585319|NCT03579459|80324440|FG002|Overall Study|Other|1|||
27585320|NCT03579459|80324441|FG003|Overall Study|Other|0|||
27585321|NCT03579459|80324438|FG000|Overall Study|Randomized not vaccinated|0|||
27585322|NCT03579459|80324439|FG001|Overall Study|Randomized not vaccinated|2|||
27585323|NCT03579459|80324440|FG002|Overall Study|Randomized not vaccinated|0|||
27585324|NCT03579459|80324441|FG003|Overall Study|Randomized not vaccinated|1|||
27585325|NCT03832946|80324442|FG000|Overall Study|Adverse Event|3|||
27585326|NCT03832946|80324443|FG001|Overall Study|Adverse Event|1|||
27585327|NCT03832946|80324442|FG000|Overall Study|Lost to Follow-up|1|||
27585328|NCT03832946|80324443|FG001|Overall Study|Lost to Follow-up|0|||
27585329|NCT03832946|80324442|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
27585330|NCT03832946|80324443|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
27585331|NCT03832946|80324442|FG000|Overall Study|Lack of Efficacy|1|||
27585332|NCT03832946|80324443|FG001|Overall Study|Lack of Efficacy|0|||
27585333|NCT03832946|80324442|FG000|Overall Study|Withdrawal by Subject|12|||
27585334|NCT03832946|80324443|FG001|Overall Study|Withdrawal by Subject|9|||
27585335|NCT04862143|80324448|FG000|Overall Study|Adverse Event|1|||
27585336|NCT04862143|80324448|FG000|Overall Study|Study terminated by sponsor|1|||
27585337|NCT00581945|80324449|FG000|Overall Study|Adverse Event|4|||
27585338|NCT00581945|80324450|FG001|Overall Study|Adverse Event|4|||
27585339|NCT00581945|80324449|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27585340|NCT00581945|80324450|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27585341|NCT00581945|80324449|FG000|Overall Study|Withdrawal by Subject|2|||
27585342|NCT00581945|80324450|FG001|Overall Study|Withdrawal by Subject|6|||
27585343|NCT00581945|80324449|FG000|Overall Study|Death|1|||
27585344|NCT00581945|80324450|FG001|Overall Study|Death|0|||
27585345|NCT01660763|80324451|FG000|Overall Study|Lack of Efficacy|45|||
27585346|NCT01660763|80324452|FG001|Overall Study|Lack of Efficacy|50|||
27585347|NCT01660763|80324451|FG000|Overall Study|Adverse Event|22|||
27585348|NCT01660763|80324452|FG001|Overall Study|Adverse Event|7|||
27585349|NCT01660763|80324451|FG000|Overall Study|Protocol Violation|1|||
28005515|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005516|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005517|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
28005518|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005519|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005520|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005521|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
28005522|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005523|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
27585350|NCT01660763|80324452|FG001|Overall Study|Protocol Violation|0|||
28005524|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005525|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
27585351|NCT01660763|80324451|FG000|Overall Study|Withdrawal by Subject|4|||
27585352|NCT01660763|80324452|FG001|Overall Study|Withdrawal by Subject|0|||
27585353|NCT01660763|80324451|FG000|Overall Study|Patient ready for early discharge|28|||
27585354|NCT01660763|80324452|FG001|Overall Study|Patient ready for early discharge|4|||
27585355|NCT01175668|80324455|FG000|Overall Study|Withdrawal by Subject|2|||
27585356|NCT01175668|80324456|FG001|Overall Study|Withdrawal by Subject|0|||
27585357|NCT02055352|80324460|FG000|Overall Study|Adverse Event|0|||
27585358|NCT02055352|80324461|FG001|Overall Study|Adverse Event|1|||
27585359|NCT02055352|80324460|FG000|Overall Study|Non-eligible|0|||
28005526|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005527|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005528|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005529|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
27585360|NCT02055352|80324461|FG001|Overall Study|Non-eligible|1|||
28005530|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005531|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005532|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005533|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005534|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
28005535|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005536|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
28005537|NCT01147666|81849956|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005538|NCT01147666|81849957|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005539|NCT01147666|81849958|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005540|NCT01147666|81849959|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005541|NCT01147666|81849960|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005542|NCT01147666|81849961|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005543|NCT01147666|81849962|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005544|NCT01147666|81849963|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005545|NCT01147666|81849964|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005546|NCT01147666|81849965|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005547|NCT01147666|81849966|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005548|NCT01147666|81849967|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005549|NCT01147666|81849968|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
27874661|NCT00991887|81371838|FG000|Overall Study|Lost to Follow-up|2|||
28005550|NCT01147666|81849969|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
28005551|NCT01147666|81849970|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
28005552|NCT00499681|81849975|FG000|Overall Study|toxicity|0|||
28005553|NCT00499681|81849976|FG001|Overall Study|toxicity|1|||
28005554|NCT00499681|81849975|FG000|Overall Study|disease progression|0|||
28005555|NCT00499681|81849976|FG001|Overall Study|disease progression|1|||
28005556|NCT03905096|81849984|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
28005557|NCT03905096|81849985|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
28005558|NCT00189540|81849986|FG000|Overall Study|Withdrawal by Subject|3|||
28005559|NCT00189540|81849987|FG001|Overall Study|Withdrawal by Subject|0|||
28005560|NCT00189540|81849986|FG000|Overall Study|Death|4|||
28005561|NCT00189540|81849987|FG001|Overall Study|Death|1|||
28005562|NCT00918385|81849988|FG000|Monotherapy|Adverse Event|1|||
28005563|NCT00918385|81849989|FG001|Monotherapy|Adverse Event|6|||
28005564|NCT00918385|81849988|FG000|Monotherapy|Complicating illness|1|||
28005565|NCT00918385|81849989|FG001|Monotherapy|Complicating illness|0|||
28005566|NCT00918385|81849988|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
28005567|NCT00918385|81849989|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
28005568|NCT00918385|81849988|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
27808995|NCT02711956|81130784|FG014|Overall Study|Clinical progression|1|||
27808996|NCT02711956|81130770|FG000|Overall Study|Radiographic progression|1|||
28005569|NCT00918385|81849989|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
28005570|NCT00918385|81849988|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
28005571|NCT00918385|81849989|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
28005572|NCT00918385|81849988|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
28005573|NCT00918385|81849989|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
28005574|NCT00979901|81849991|FG000|Overall Study|Adverse Event|1|||
28005575|NCT00979901|81849992|FG001|Overall Study|Adverse Event|3|||
28005576|NCT00979901|81849993|FG002|Overall Study|Adverse Event|9|||
28005577|NCT00979901|81849994|FG003|Overall Study|Adverse Event|2|||
28005578|NCT00979901|81849991|FG000|Overall Study|Lack of Efficacy|8|||
28005579|NCT00979901|81849992|FG001|Overall Study|Lack of Efficacy|4|||
28005580|NCT00979901|81849993|FG002|Overall Study|Lack of Efficacy|9|||
28005581|NCT00979901|81849994|FG003|Overall Study|Lack of Efficacy|0|||
28005582|NCT00979901|81849991|FG000|Overall Study|Lost to Follow-up|1|||
28005583|NCT00979901|81849992|FG001|Overall Study|Lost to Follow-up|1|||
28005584|NCT00979901|81849993|FG002|Overall Study|Lost to Follow-up|2|||
28005585|NCT00979901|81849994|FG003|Overall Study|Lost to Follow-up|0|||
28005586|NCT00979901|81849991|FG000|Overall Study|Protocol Violation|2|||
28005587|NCT00979901|81849992|FG001|Overall Study|Protocol Violation|2|||
28005588|NCT00979901|81849993|FG002|Overall Study|Protocol Violation|7|||
28005589|NCT00979901|81849994|FG003|Overall Study|Protocol Violation|1|||
28005590|NCT00979901|81849991|FG000|Overall Study|Withdrawal by Subject|2|||
28005591|NCT00979901|81849992|FG001|Overall Study|Withdrawal by Subject|1|||
28005592|NCT00979901|81849993|FG002|Overall Study|Withdrawal by Subject|1|||
28005593|NCT00979901|81849994|FG003|Overall Study|Withdrawal by Subject|1|||
28005594|NCT00979901|81849991|FG000|Overall Study|Noncompliance|1|||
28005595|NCT00979901|81849992|FG001|Overall Study|Noncompliance|0|||
28005596|NCT00979901|81849993|FG002|Overall Study|Noncompliance|0|||
28005597|NCT00979901|81849994|FG003|Overall Study|Noncompliance|0|||
28005598|NCT00979901|81849991|FG000|Overall Study|out-of-state|1|||
28005599|NCT00979901|81849992|FG001|Overall Study|out-of-state|0|||
28005600|NCT00979901|81849993|FG002|Overall Study|out-of-state|0|||
28005601|NCT00979901|81849994|FG003|Overall Study|out-of-state|0|||
28005602|NCT00979901|81849991|FG000|Overall Study|vacation|1|||
28005603|NCT00979901|81849992|FG001|Overall Study|vacation|0|||
28005604|NCT00979901|81849993|FG002|Overall Study|vacation|0|||
28005605|NCT00979901|81849994|FG003|Overall Study|vacation|0|||
28005606|NCT00979901|81849991|FG000|Overall Study|elevated lab values pre-randomization|1|||
27808997|NCT02711956|81130771|FG001|Overall Study|Radiographic progression|1|||
27808998|NCT02711956|81130772|FG002|Overall Study|Radiographic progression|2|||
27808999|NCT02711956|81130773|FG003|Overall Study|Radiographic progression|0|||
27809000|NCT02711956|81130774|FG004|Overall Study|Radiographic progression|1|||
27809001|NCT02711956|81130775|FG005|Overall Study|Radiographic progression|0|||
27809002|NCT02711956|81130776|FG006|Overall Study|Radiographic progression|0|||
27809003|NCT02711956|81130777|FG007|Overall Study|Radiographic progression|0|||
27809004|NCT02711956|81130778|FG008|Overall Study|Radiographic progression|2|||
27874662|NCT00991887|81371839|FG001|Overall Study|Lost to Follow-up|1|||
28005607|NCT00979901|81849992|FG001|Overall Study|elevated lab values pre-randomization|0|||
28005608|NCT00979901|81849993|FG002|Overall Study|elevated lab values pre-randomization|0|||
28005609|NCT00979901|81849994|FG003|Overall Study|elevated lab values pre-randomization|0|||
28005610|NCT00979901|81849991|FG000|Overall Study|Discontinued in Error|0|||
28005611|NCT00979901|81849992|FG001|Overall Study|Discontinued in Error|1|||
28005612|NCT00979901|81849993|FG002|Overall Study|Discontinued in Error|0|||
28005613|NCT00979901|81849994|FG003|Overall Study|Discontinued in Error|0|||
28005614|NCT00979901|81849991|FG000|Overall Study|Left Country|0|||
27874663|NCT00564850|81371840|FG000|Overall Study|Protocol Violation|2|||
28005615|NCT00979901|81849992|FG001|Overall Study|Left Country|0|||
27585361|NCT02055352|80324460|FG000|Overall Study|Poor compliance|1|||
27809005|NCT02711956|81130779|FG009|Overall Study|Radiographic progression|1|||
28005616|NCT00979901|81849993|FG002|Overall Study|Left Country|1|||
28005617|NCT00979901|81849994|FG003|Overall Study|Left Country|0|||
28005618|NCT00979901|81849991|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
27809006|NCT02711956|81130780|FG010|Overall Study|Radiographic progression|0|||
27809007|NCT02711956|81130781|FG011|Overall Study|Radiographic progression|5|||
27809008|NCT02711956|81130782|FG012|Overall Study|Radiographic progression|3|||
27809009|NCT02711956|81130783|FG013|Overall Study|Radiographic progression|0|||
27809010|NCT02711956|81130784|FG014|Overall Study|Radiographic progression|1|||
27809011|NCT02711956|81130770|FG000|Overall Study|PSA progression with clinical progression|0|||
27809012|NCT02711956|81130771|FG001|Overall Study|PSA progression with clinical progression|0|||
27809013|NCT02711956|81130772|FG002|Overall Study|PSA progression with clinical progression|0|||
27809014|NCT02711956|81130773|FG003|Overall Study|PSA progression with clinical progression|0|||
27809015|NCT02711956|81130774|FG004|Overall Study|PSA progression with clinical progression|1|||
27809016|NCT02711956|81130775|FG005|Overall Study|PSA progression with clinical progression|0|||
27809017|NCT02711956|81130776|FG006|Overall Study|PSA progression with clinical progression|0|||
27809018|NCT02711956|81130777|FG007|Overall Study|PSA progression with clinical progression|0|||
27809019|NCT02711956|81130778|FG008|Overall Study|PSA progression with clinical progression|0|||
28005619|NCT00979901|81849992|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
28005620|NCT00979901|81849993|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
28005621|NCT00979901|81849994|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
28005622|NCT02782676|81853509|FG000|Overall Study|Lost to Follow-up|0|||
28005623|NCT02782676|81853510|FG001|Overall Study|Lost to Follow-up|1|||
28005624|NCT03253679|81853511|FG000|Overall Study|Screen Failure|1|||
28005625|NCT01393158|81853512|FG000|Overall Study|Adverse Event|1|||
28005626|NCT01393158|81853513|FG001|Overall Study|Adverse Event|0|||
28005627|NCT02421172|81853514|FG000|Period 1|Adverse Event|1|||
28005628|NCT02421172|81853515|FG001|Period 1|Adverse Event|0|||
28005629|NCT02421172|81853516|FG002|Period 1|Adverse Event|0|||
28005630|NCT02421172|81853517|FG003|Period 1|Adverse Event|0|||
28005631|NCT02421172|81853518|FG004|Period 1|Adverse Event|0|||
28005632|NCT02421172|81853514|FG000|Period 1|Lost to Follow-up|3|||
28005633|NCT02421172|81853515|FG001|Period 1|Lost to Follow-up|1|||
28005634|NCT02421172|81853516|FG002|Period 1|Lost to Follow-up|0|||
28005635|NCT02421172|81853517|FG003|Period 1|Lost to Follow-up|0|||
28005636|NCT02421172|81853518|FG004|Period 1|Lost to Follow-up|0|||
28005637|NCT02421172|81853514|FG000|Period 1|Patient/guardian decision|0|||
28005638|NCT02421172|81853515|FG001|Period 1|Patient/guardian decision|1|||
28005639|NCT02421172|81853516|FG002|Period 1|Patient/guardian decision|0|||
28005640|NCT02421172|81853517|FG003|Period 1|Patient/guardian decision|0|||
28005641|NCT02421172|81853518|FG004|Period 1|Patient/guardian decision|0|||
28005642|NCT02421172|81853514|FG000|Period 2|Adverse Event|0|||
28005643|NCT02421172|81853515|FG001|Period 2|Adverse Event|0|||
28005644|NCT02421172|81853516|FG002|Period 2|Adverse Event|4|||
28005645|NCT02421172|81853517|FG003|Period 2|Adverse Event|0|||
28005646|NCT02421172|81853518|FG004|Period 2|Adverse Event|0|||
28005647|NCT02421172|81853514|FG000|Period 2|Lost to Follow-up|0|||
28005648|NCT02421172|81853515|FG001|Period 2|Lost to Follow-up|0|||
28005649|NCT02421172|81853516|FG002|Period 2|Lost to Follow-up|0|||
28005650|NCT02421172|81853517|FG003|Period 2|Lost to Follow-up|1|||
28005651|NCT02421172|81853518|FG004|Period 2|Lost to Follow-up|0|||
28005652|NCT02421172|81853514|FG000|Period 2|Patient/guardian decision|0|||
28005653|NCT02421172|81853515|FG001|Period 2|Patient/guardian decision|0|||
28005654|NCT02421172|81853516|FG002|Period 2|Patient/guardian decision|3|||
28005655|NCT02421172|81853517|FG003|Period 2|Patient/guardian decision|2|||
28005656|NCT02421172|81853518|FG004|Period 2|Patient/guardian decision|1|||
28005657|NCT02544321|81853523|FG000|Overall Study|Withdrawal by Subject|1|||
28005658|NCT02544321|81853524|FG001|Overall Study|Withdrawal by Subject|2|||
28005659|NCT02544321|81853523|FG000|Overall Study|Adverse Event|1|||
28005660|NCT02544321|81853524|FG001|Overall Study|Adverse Event|1|||
28005661|NCT02544321|81853523|FG000|Overall Study|Protocol Violation|0|||
28005662|NCT02544321|81853524|FG001|Overall Study|Protocol Violation|1|||
28005663|NCT01777308|81853528|FG000|Overall Study|Withdrawal by Subject|5|||
27585362|NCT02055352|80324461|FG001|Overall Study|Poor compliance|1|||
27809020|NCT02711956|81130779|FG009|Overall Study|PSA progression with clinical progression|0|||
27809021|NCT02711956|81130780|FG010|Overall Study|PSA progression with clinical progression|0|||
28005664|NCT01777308|81853529|FG001|Overall Study|Withdrawal by Subject|1|||
28005665|NCT01777308|81853528|FG000|Overall Study|Migrated/moved from study area|1|||
28005666|NCT01777308|81853529|FG001|Overall Study|Migrated/moved from study area|0|||
28005667|NCT01777308|81853528|FG000|Overall Study|Lost to Follow-up|7|||
28005668|NCT01777308|81853529|FG001|Overall Study|Lost to Follow-up|2|||
28005669|NCT01777308|81853528|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
28005670|NCT01777308|81853529|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
28005671|NCT05362487|81853530|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
28005672|NCT02234843|81853532|FG000|Overall Study|Death|1|||
27585363|NCT02055352|80324460|FG000|Overall Study|Death|1|||
28005673|NCT02234843|81853533|FG001|Overall Study|Death|0|||
27809022|NCT02711956|81130781|FG011|Overall Study|PSA progression with clinical progression|0|||
28005674|NCT02234843|81853534|FG002|Overall Study|Death|0|||
28005675|NCT02234843|81853535|FG003|Overall Study|Death|0|||
28005676|NCT02234843|81853536|FG004|Overall Study|Death|0|||
28005677|NCT02234843|81853537|FG005|Overall Study|Death|0|||
28005678|NCT02234843|81853538|FG006|Overall Study|Death|0|||
28005679|NCT02234843|81853539|FG007|Overall Study|Death|0|||
28005680|NCT02234843|81853540|FG008|Overall Study|Death|0|||
28005681|NCT02234843|81853541|FG009|Overall Study|Death|0|||
28005682|NCT02234843|81853532|FG000|Overall Study|Protocol Violation|1|||
28005683|NCT02234843|81853533|FG001|Overall Study|Protocol Violation|0|||
28005684|NCT02234843|81853534|FG002|Overall Study|Protocol Violation|1|||
28005685|NCT02234843|81853535|FG003|Overall Study|Protocol Violation|0|||
28005686|NCT02234843|81853536|FG004|Overall Study|Protocol Violation|0|||
28005687|NCT02234843|81853537|FG005|Overall Study|Protocol Violation|0|||
28005688|NCT02234843|81853538|FG006|Overall Study|Protocol Violation|0|||
28005689|NCT02234843|81853539|FG007|Overall Study|Protocol Violation|0|||
28005690|NCT02234843|81853540|FG008|Overall Study|Protocol Violation|0|||
28005691|NCT02234843|81853541|FG009|Overall Study|Protocol Violation|0|||
28005692|NCT02234843|81853532|FG000|Overall Study|Efficacy outcome reached|2|||
28005693|NCT02234843|81853533|FG001|Overall Study|Efficacy outcome reached|0|||
28005694|NCT02234843|81853534|FG002|Overall Study|Efficacy outcome reached|0|||
28005695|NCT02234843|81853535|FG003|Overall Study|Efficacy outcome reached|0|||
28005696|NCT02234843|81853536|FG004|Overall Study|Efficacy outcome reached|0|||
27684831|NCT01323972|80683627|FG002|Overall Study|Lost to Follow-up|1|||
27684832|NCT01323972|80683628|FG003|Overall Study|Lost to Follow-up|1|||
27684833|NCT02712905|80683629|FG000|Monotherapy|Death|2|||
27684834|NCT02712905|80683630|FG001|Monotherapy|Death|5|||
27684835|NCT02712905|80683631|FG002|Monotherapy|Death|0|||
27684836|NCT02712905|80683632|FG003|Monotherapy|Death|3|||
27684837|NCT02712905|80683633|FG004|Monotherapy|Death|15|||
27684838|NCT02712905|80683634|FG005|Monotherapy|Death|1|||
27684839|NCT02712905|80683635|FG006|Monotherapy|Death|3|||
27684840|NCT02712905|80683636|FG007|Monotherapy|Death|3|||
27684841|NCT02712905|80683637|FG008|Monotherapy|Death|0|||
27684842|NCT02712905|80683638|FG009|Monotherapy|Death|27|||
27684843|NCT02712905|80683639|FG010|Monotherapy|Death|2|||
27684844|NCT02712905|80683640|FG011|Monotherapy|Death|5|||
27684845|NCT02712905|80683641|FG012|Monotherapy|Death|0|||
27684846|NCT02712905|80683642|FG013|Monotherapy|Death|0|||
27684847|NCT02712905|80683643|FG014|Monotherapy|Death|0|||
27684848|NCT02712905|80683644|FG015|Monotherapy|Death|0|||
28005697|NCT02234843|81853537|FG005|Overall Study|Efficacy outcome reached|2|||
28005698|NCT02234843|81853538|FG006|Overall Study|Efficacy outcome reached|0|||
28005699|NCT02234843|81853539|FG007|Overall Study|Efficacy outcome reached|0|||
27684849|NCT02712905|80683645|FG016|Monotherapy|Death|0|||
27684850|NCT02712905|80683646|FG017|Monotherapy|Death|0|||
27684851|NCT02712905|80683629|FG000|Monotherapy|Lost to Follow-up|0|||
27684852|NCT02712905|80683630|FG001|Monotherapy|Lost to Follow-up|1|||
27809023|NCT02711956|81130782|FG012|Overall Study|PSA progression with clinical progression|1|||
27809024|NCT02711956|81130783|FG013|Overall Study|PSA progression with clinical progression|1|||
27809025|NCT02711956|81130784|FG014|Overall Study|PSA progression with clinical progression|0|||
27809026|NCT02711956|81130770|FG000|Overall Study|PSA progression with radiographic progression|0|||
27809027|NCT02711956|81130771|FG001|Overall Study|PSA progression with radiographic progression|1|||
27809028|NCT02711956|81130772|FG002|Overall Study|PSA progression with radiographic progression|0|||
27809029|NCT02711956|81130773|FG003|Overall Study|PSA progression with radiographic progression|0|||
27809030|NCT02711956|81130774|FG004|Overall Study|PSA progression with radiographic progression|0|||
27809031|NCT02711956|81130775|FG005|Overall Study|PSA progression with radiographic progression|2|||
27809032|NCT02711956|81130776|FG006|Overall Study|PSA progression with radiographic progression|2|||
27809033|NCT02711956|81130777|FG007|Overall Study|PSA progression with radiographic progression|1|||
27809034|NCT02711956|81130778|FG008|Overall Study|PSA progression with radiographic progression|0|||
27809035|NCT02711956|81130779|FG009|Overall Study|PSA progression with radiographic progression|1|||
27809036|NCT02711956|81130780|FG010|Overall Study|PSA progression with radiographic progression|0|||
27809037|NCT02711956|81130781|FG011|Overall Study|PSA progression with radiographic progression|1|||
27809038|NCT02711956|81130782|FG012|Overall Study|PSA progression with radiographic progression|2|||
27809039|NCT02711956|81130783|FG013|Overall Study|PSA progression with radiographic progression|3|||
28005700|NCT02234843|81853540|FG008|Overall Study|Efficacy outcome reached|0|||
28005701|NCT02234843|81853541|FG009|Overall Study|Efficacy outcome reached|0|||
27684853|NCT02712905|80683631|FG002|Monotherapy|Lost to Follow-up|0|||
27684854|NCT02712905|80683632|FG003|Monotherapy|Lost to Follow-up|1|||
27684855|NCT02712905|80683633|FG004|Monotherapy|Lost to Follow-up|0|||
27684856|NCT02712905|80683634|FG005|Monotherapy|Lost to Follow-up|0|||
27684857|NCT02712905|80683635|FG006|Monotherapy|Lost to Follow-up|0|||
27684858|NCT02712905|80683636|FG007|Monotherapy|Lost to Follow-up|0|||
27684859|NCT02712905|80683637|FG008|Monotherapy|Lost to Follow-up|0|||
27684860|NCT02712905|80683638|FG009|Monotherapy|Lost to Follow-up|2|||
27684861|NCT02712905|80683639|FG010|Monotherapy|Lost to Follow-up|0|||
27684862|NCT02712905|80683640|FG011|Monotherapy|Lost to Follow-up|0|||
28005702|NCT02234843|81853532|FG000|Overall Study|Patient convenience|2|||
27809040|NCT02711956|81130784|FG014|Overall Study|PSA progression with radiographic progression|3|||
27809041|NCT02143947|81130785|FG000|Overall Study|Lost to Follow-up|4|||
27809042|NCT02143947|81130786|FG001|Overall Study|Lost to Follow-up|2|||
27809043|NCT02058628|81130787|FG000|Overall Study|Adverse Event|1|||
27809044|NCT02058628|81130788|FG001|Overall Study|Adverse Event|0|||
27809045|NCT02058628|81130787|FG000|Overall Study|Withdrawal by Subject|2|||
27809046|NCT02058628|81130788|FG001|Overall Study|Withdrawal by Subject|2|||
27809047|NCT02058628|81130787|FG000|Overall Study|Lost to Follow-up|2|||
27809048|NCT02058628|81130788|FG001|Overall Study|Lost to Follow-up|4|||
27809049|NCT02058628|81130787|FG000|Overall Study|Not in time schedule|0|||
27809050|NCT02058628|81130788|FG001|Overall Study|Not in time schedule|1|||
27809051|NCT02058628|81130787|FG000|Overall Study|The visit date was not in timeline|0|||
27809052|NCT02058628|81130788|FG001|Overall Study|The visit date was not in timeline|1|||
27809053|NCT02058628|81130787|FG000|Overall Study|A lot of time for study for participant|1|||
27809054|NCT02058628|81130788|FG001|Overall Study|A lot of time for study for participant|0|||
27809055|NCT02058628|81130787|FG000|Overall Study|Non compliance|1|||
27809056|NCT02058628|81130788|FG001|Overall Study|Non compliance|0|||
27809057|NCT00264810|81130789|FG000|Baseline|Withdrawal by Subject|10|||
27874664|NCT02550561|81371841|FG000|Overall Study|Lost to Follow-up|5|||
27874665|NCT02550561|81371841|FG000|Overall Study|Withdrawal by Subject|1|||
27874666|NCT05064397|81371842|FG000|Overall Study|Adverse Event|4|||
27874667|NCT05064397|81371842|FG000|Overall Study|Lack of Efficacy|12|||
27874668|NCT05064397|81371842|FG000|Overall Study|Withdrawal by Subject|3|||
27874669|NCT05064397|81371842|FG000|Overall Study|Lost to Follow-up|1|||
27874670|NCT05064397|81371842|FG000|Overall Study|Other reasons|3|||
28005703|NCT02234843|81853533|FG001|Overall Study|Patient convenience|0|||
28005704|NCT02234843|81853534|FG002|Overall Study|Patient convenience|0|||
28005705|NCT02234843|81853535|FG003|Overall Study|Patient convenience|0|||
28005706|NCT02234843|81853536|FG004|Overall Study|Patient convenience|0|||
28005707|NCT02234843|81853537|FG005|Overall Study|Patient convenience|1|||
28005708|NCT02234843|81853538|FG006|Overall Study|Patient convenience|0|||
28005709|NCT02234843|81853539|FG007|Overall Study|Patient convenience|0|||
28005710|NCT02234843|81853540|FG008|Overall Study|Patient convenience|0|||
28005711|NCT02234843|81853541|FG009|Overall Study|Patient convenience|0|||
28005712|NCT02234843|81853532|FG000|Overall Study|Withdrawal by Subject|5|||
28005713|NCT02234843|81853533|FG001|Overall Study|Withdrawal by Subject|1|||
28005714|NCT02234843|81853534|FG002|Overall Study|Withdrawal by Subject|1|||
28005715|NCT02234843|81853535|FG003|Overall Study|Withdrawal by Subject|0|||
28005716|NCT02234843|81853536|FG004|Overall Study|Withdrawal by Subject|0|||
28005717|NCT02234843|81853537|FG005|Overall Study|Withdrawal by Subject|7|||
28005718|NCT02234843|81853538|FG006|Overall Study|Withdrawal by Subject|0|||
28005719|NCT02234843|81853539|FG007|Overall Study|Withdrawal by Subject|0|||
28005720|NCT02234843|81853540|FG008|Overall Study|Withdrawal by Subject|0|||
28005721|NCT02234843|81853541|FG009|Overall Study|Withdrawal by Subject|0|||
28005722|NCT02234843|81853532|FG000|Overall Study|Recovery|1|||
28005723|NCT02234843|81853533|FG001|Overall Study|Recovery|0|||
28005724|NCT02234843|81853534|FG002|Overall Study|Recovery|0|||
28005725|NCT02234843|81853535|FG003|Overall Study|Recovery|0|||
28005726|NCT02234843|81853536|FG004|Overall Study|Recovery|0|||
28005727|NCT02234843|81853537|FG005|Overall Study|Recovery|0|||
28005728|NCT02234843|81853538|FG006|Overall Study|Recovery|0|||
28005729|NCT02234843|81853539|FG007|Overall Study|Recovery|0|||
28005730|NCT02234843|81853540|FG008|Overall Study|Recovery|0|||
28005731|NCT02234843|81853541|FG009|Overall Study|Recovery|0|||
27585364|NCT02055352|80324461|FG001|Overall Study|Death|2|||
27809058|NCT00264810|81130790|FG001|Baseline|Withdrawal by Subject|10|||
27809059|NCT00264810|81130789|FG000|Baseline|Physician Decision|7|||
27809060|NCT00264810|81130790|FG001|Baseline|Physician Decision|8|||
27809061|NCT00264810|81130789|FG000|Baseline|Subject Compliance Failure|3|||
27809062|NCT00264810|81130790|FG001|Baseline|Subject Compliance Failure|3|||
27809063|NCT00264810|81130789|FG000|Baseline|Insufficient Seizure Frequency|2|||
27874671|NCT01791894|81371843|FG000|Overall Study|Adverse Event|1|||
27874672|NCT03866577|81375240|FG000|Overall Study|Protocol Violation|0|||
27874673|NCT03866577|81375241|FG001|Overall Study|Protocol Violation|0|||
28005732|NCT02234843|81853532|FG000|Overall Study|Other|0|||
28005733|NCT02234843|81853533|FG001|Overall Study|Other|2|||
28005734|NCT02234843|81853534|FG002|Overall Study|Other|0|||
27809064|NCT00264810|81130790|FG001|Baseline|Insufficient Seizure Frequency|2|||
27809065|NCT00264810|81130789|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
27809066|NCT00264810|81130790|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
27809067|NCT00264810|81130789|FG000|Baseline|Other|0|||
27809068|NCT00264810|81130790|FG001|Baseline|Other|1|||
27809069|NCT00264810|81130789|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
27874674|NCT03866577|81375242|FG002|Overall Study|Protocol Violation|0|||
28005735|NCT02234843|81853535|FG003|Overall Study|Other|1|||
28005736|NCT02234843|81853536|FG004|Overall Study|Other|0|||
28005737|NCT02234843|81853537|FG005|Overall Study|Other|1|||
28005738|NCT02234843|81853538|FG006|Overall Study|Other|0|||
28005739|NCT02234843|81853539|FG007|Overall Study|Other|1|||
28005740|NCT02234843|81853540|FG008|Overall Study|Other|0|||
27684863|NCT02712905|80683641|FG012|Monotherapy|Lost to Follow-up|0|||
28005741|NCT02234843|81853541|FG009|Overall Study|Other|0|||
28005742|NCT02234843|81853532|FG000|Overall Study|Physician Decision|4|||
28005743|NCT02234843|81853533|FG001|Overall Study|Physician Decision|1|||
28005744|NCT02234843|81853534|FG002|Overall Study|Physician Decision|0|||
27684864|NCT02712905|80683642|FG013|Monotherapy|Lost to Follow-up|0|||
27684865|NCT02712905|80683643|FG014|Monotherapy|Lost to Follow-up|0|||
27684866|NCT02712905|80683644|FG015|Monotherapy|Lost to Follow-up|0|||
27684867|NCT02712905|80683645|FG016|Monotherapy|Lost to Follow-up|0|||
27684868|NCT02712905|80683646|FG017|Monotherapy|Lost to Follow-up|0|||
27684869|NCT02712905|80683629|FG000|Monotherapy|Physician Decision|1|||
27684870|NCT02712905|80683630|FG001|Monotherapy|Physician Decision|0|||
27684871|NCT02712905|80683631|FG002|Monotherapy|Physician Decision|0|||
27684872|NCT02712905|80683632|FG003|Monotherapy|Physician Decision|1|||
27684873|NCT02712905|80683633|FG004|Monotherapy|Physician Decision|0|||
27684874|NCT02712905|80683634|FG005|Monotherapy|Physician Decision|0|||
27684875|NCT02712905|80683635|FG006|Monotherapy|Physician Decision|0|||
27684876|NCT02712905|80683636|FG007|Monotherapy|Physician Decision|0|||
27684877|NCT02712905|80683637|FG008|Monotherapy|Physician Decision|0|||
27684878|NCT02712905|80683638|FG009|Monotherapy|Physician Decision|1|||
27684879|NCT02712905|80683639|FG010|Monotherapy|Physician Decision|0|||
27684880|NCT02712905|80683640|FG011|Monotherapy|Physician Decision|0|||
27684881|NCT02712905|80683641|FG012|Monotherapy|Physician Decision|0|||
27684882|NCT02712905|80683642|FG013|Monotherapy|Physician Decision|0|||
27684883|NCT02712905|80683643|FG014|Monotherapy|Physician Decision|0|||
27684884|NCT02712905|80683644|FG015|Monotherapy|Physician Decision|0|||
27684885|NCT02712905|80683645|FG016|Monotherapy|Physician Decision|0|||
28005745|NCT02234843|81853535|FG003|Overall Study|Physician Decision|1|||
28005746|NCT02234843|81853536|FG004|Overall Study|Physician Decision|0|||
28005747|NCT02234843|81853537|FG005|Overall Study|Physician Decision|0|||
28005748|NCT02234843|81853538|FG006|Overall Study|Physician Decision|0|||
27684886|NCT02712905|80683646|FG017|Monotherapy|Physician Decision|0|||
27684887|NCT02712905|80683629|FG000|Monotherapy|Study Terminated by Sponsor|0|||
27684888|NCT02712905|80683630|FG001|Monotherapy|Study Terminated by Sponsor|0|||
27684889|NCT02712905|80683631|FG002|Monotherapy|Study Terminated by Sponsor|0|||
27809070|NCT00264810|81130790|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
27809071|NCT00264810|81130789|FG000|Stimulation Optimization Period|Death|0|||
27809072|NCT00264810|81130790|FG001|Stimulation Optimization Period|Death|1|||
27809073|NCT00264810|81130789|FG000|Blinded Evaluation Period|Explant due to infection|1|||
27809074|NCT00264810|81130790|FG001|Blinded Evaluation Period|Explant due to infection|1|||
27809075|NCT00264810|81130789|FG000|Open Label Evaluation Period|Explant due to infection|1|||
27809076|NCT00264810|81130790|FG001|Open Label Evaluation Period|Explant due to infection|1|||
28005749|NCT02234843|81853539|FG007|Overall Study|Physician Decision|1|||
28005750|NCT02234843|81853540|FG008|Overall Study|Physician Decision|0|||
27809077|NCT00264810|81130789|FG000|Open Label Evaluation Period|Death|3|||
27809078|NCT00264810|81130790|FG001|Open Label Evaluation Period|Death|2|||
27809079|NCT00264810|81130789|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
27809080|NCT00264810|81130790|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
27809081|NCT02789111|81130798|FG000|Overall Study|Withdrawal by Subject|1|||
27809082|NCT02789111|81130799|FG001|Overall Study|Withdrawal by Subject|4|||
27809083|NCT01889862|81130800|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
28005751|NCT02234843|81853541|FG009|Overall Study|Physician Decision|0|||
28005752|NCT02234843|81853532|FG000|Overall Study|Adverse Event|5|||
28005753|NCT02234843|81853533|FG001|Overall Study|Adverse Event|1|||
28005754|NCT02234843|81853534|FG002|Overall Study|Adverse Event|1|||
28005755|NCT02234843|81853535|FG003|Overall Study|Adverse Event|3|||
28005756|NCT02234843|81853536|FG004|Overall Study|Adverse Event|2|||
28005757|NCT02234843|81853537|FG005|Overall Study|Adverse Event|1|||
28005758|NCT02234843|81853538|FG006|Overall Study|Adverse Event|0|||
28005759|NCT02234843|81853539|FG007|Overall Study|Adverse Event|0|||
28005760|NCT02234843|81853540|FG008|Overall Study|Adverse Event|1|||
27684890|NCT02712905|80683632|FG003|Monotherapy|Study Terminated by Sponsor|0|||
27684891|NCT02712905|80683633|FG004|Monotherapy|Study Terminated by Sponsor|1|||
27684892|NCT02712905|80683634|FG005|Monotherapy|Study Terminated by Sponsor|0|||
27684893|NCT02712905|80683635|FG006|Monotherapy|Study Terminated by Sponsor|0|||
27684894|NCT02712905|80683636|FG007|Monotherapy|Study Terminated by Sponsor|0|||
27684895|NCT02712905|80683637|FG008|Monotherapy|Study Terminated by Sponsor|0|||
27684896|NCT02712905|80683638|FG009|Monotherapy|Study Terminated by Sponsor|2|||
27684897|NCT02712905|80683639|FG010|Monotherapy|Study Terminated by Sponsor|0|||
27684898|NCT02712905|80683640|FG011|Monotherapy|Study Terminated by Sponsor|0|||
27809084|NCT01889862|81130801|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27809085|NCT01889862|81130802|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
28005761|NCT02234843|81853541|FG009|Overall Study|Adverse Event|0|||
28005762|NCT02234843|81853532|FG000|Overall Study|Non-compliance with study drug|1|||
28005763|NCT02234843|81853533|FG001|Overall Study|Non-compliance with study drug|0|||
28005764|NCT02234843|81853534|FG002|Overall Study|Non-compliance with study drug|0|||
28005765|NCT02234843|81853535|FG003|Overall Study|Non-compliance with study drug|0|||
27809086|NCT01889862|81130803|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27809087|NCT01889862|81130804|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
27809088|NCT01889862|81130800|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
27809089|NCT01889862|81130801|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27809090|NCT01889862|81130802|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27809091|NCT01889862|81130803|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
28005766|NCT02234843|81853536|FG004|Overall Study|Non-compliance with study drug|0|||
28005767|NCT02234843|81853537|FG005|Overall Study|Non-compliance with study drug|1|||
27585365|NCT02055352|80324460|FG000|Overall Study|Patient decision|1|||
27585366|NCT02055352|80324461|FG001|Overall Study|Patient decision|1|||
27585367|NCT02055352|80324460|FG000|Overall Study|Use of prohibited treatment|0|||
28005768|NCT02234843|81853538|FG006|Overall Study|Non-compliance with study drug|1|||
28005769|NCT02234843|81853539|FG007|Overall Study|Non-compliance with study drug|0|||
28005770|NCT02234843|81853540|FG008|Overall Study|Non-compliance with study drug|0|||
28005771|NCT02234843|81853541|FG009|Overall Study|Non-compliance with study drug|0|||
28005772|NCT02234843|81853532|FG000|Overall Study|Lost to Follow-up|0|||
28005773|NCT02234843|81853533|FG001|Overall Study|Lost to Follow-up|1|||
28005774|NCT02234843|81853534|FG002|Overall Study|Lost to Follow-up|0|||
28005775|NCT02234843|81853535|FG003|Overall Study|Lost to Follow-up|0|||
28005776|NCT02234843|81853536|FG004|Overall Study|Lost to Follow-up|0|||
28005777|NCT02234843|81853537|FG005|Overall Study|Lost to Follow-up|0|||
27585368|NCT02055352|80324461|FG001|Overall Study|Use of prohibited treatment|3|||
27585369|NCT02055352|80324460|FG000|Overall Study|AE, study drug would be detrimental|1|||
27585370|NCT02055352|80324461|FG001|Overall Study|AE, study drug would be detrimental|3|||
27585371|NCT02055352|80324460|FG000|Overall Study|Withdrawal of informed consent|1|||
27585372|NCT02055352|80324461|FG001|Overall Study|Withdrawal of informed consent|0|||
27585373|NCT02055352|80324460|FG000|Overall Study|Reason unknown|1|||
27585374|NCT02055352|80324461|FG001|Overall Study|Reason unknown|5|||
27585375|NCT01043874|80324462|FG000|Overall Study|Adverse Event|3|||
27585376|NCT01043874|80324462|FG000|Overall Study|Withdrawal by Subject|1|||
27585377|NCT01043874|80324462|FG000|Overall Study|Lack of Efficacy|1|||
27585378|NCT01043874|80324462|FG000|Overall Study|Administrative Problems|1|||
27585379|NCT01054729|80324463|FG000|Overall Study|Randomized but Not Treated|0|||
27585380|NCT01054729|80324464|FG001|Overall Study|Randomized but Not Treated|1|||
27585381|NCT01054729|80324465|FG002|Overall Study|Randomized but Not Treated|0|||
27585382|NCT01054729|80324466|FG003|Overall Study|Randomized but Not Treated|0|||
27585383|NCT01054729|80324463|FG000|Overall Study|Adverse Event|1|||
27809092|NCT01889862|81130804|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
27585384|NCT01054729|80324464|FG001|Overall Study|Adverse Event|1|||
27585385|NCT01054729|80324465|FG002|Overall Study|Adverse Event|2|||
27585386|NCT01054729|80324466|FG003|Overall Study|Adverse Event|1|||
27585387|NCT01054729|80324463|FG000|Overall Study|Withdrawal by Subject|1|||
27809093|NCT01889862|81130800|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
27809094|NCT01889862|81130801|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
28005778|NCT02234843|81853538|FG006|Overall Study|Lost to Follow-up|1|||
28005779|NCT02234843|81853539|FG007|Overall Study|Lost to Follow-up|0|||
27585388|NCT01054729|80324464|FG001|Overall Study|Withdrawal by Subject|0|||
27585389|NCT01054729|80324465|FG002|Overall Study|Withdrawal by Subject|1|||
27585390|NCT01054729|80324466|FG003|Overall Study|Withdrawal by Subject|0|||
27585391|NCT01054729|80324463|FG000|Overall Study|Lost to Follow-up|0|||
27585392|NCT01054729|80324464|FG001|Overall Study|Lost to Follow-up|1|||
27585393|NCT01054729|80324465|FG002|Overall Study|Lost to Follow-up|0|||
27585394|NCT01054729|80324466|FG003|Overall Study|Lost to Follow-up|0|||
27585395|NCT01054729|80324463|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
27585396|NCT01054729|80324464|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
27585397|NCT01054729|80324465|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
27585398|NCT01054729|80324466|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
27585399|NCT01054729|80324463|FG000|Overall Study|Non-responder|1|||
27585400|NCT01054729|80324464|FG001|Overall Study|Non-responder|0|||
27585401|NCT01054729|80324465|FG002|Overall Study|Non-responder|1|||
27585402|NCT01054729|80324466|FG003|Overall Study|Non-responder|1|||
27585403|NCT01054729|80324463|FG000|Overall Study|PEG/RBV Non-responder|1|||
27585404|NCT01054729|80324464|FG001|Overall Study|PEG/RBV Non-responder|0|||
27585405|NCT01054729|80324465|FG002|Overall Study|PEG/RBV Non-responder|1|||
27585406|NCT01054729|80324466|FG003|Overall Study|PEG/RBV Non-responder|0|||
27585407|NCT01054729|80324463|FG000|Overall Study|Personal/Obligations|0|||
27585408|NCT01054729|80324464|FG001|Overall Study|Personal/Obligations|1|||
27585409|NCT01054729|80324465|FG002|Overall Study|Personal/Obligations|0|||
27585410|NCT01054729|80324466|FG003|Overall Study|Personal/Obligations|0|||
27585411|NCT01054729|80324463|FG000|Overall Study|Subject moved|0|||
27585412|NCT01054729|80324464|FG001|Overall Study|Subject moved|0|||
27585413|NCT01054729|80324465|FG002|Overall Study|Subject moved|1|||
27585414|NCT01054729|80324466|FG003|Overall Study|Subject moved|0|||
27585415|NCT01054729|80324463|FG000|Overall Study|Lack of Efficacy|0|||
27585416|NCT01054729|80324464|FG001|Overall Study|Lack of Efficacy|0|||
27585417|NCT01054729|80324465|FG002|Overall Study|Lack of Efficacy|0|||
27585418|NCT01054729|80324466|FG003|Overall Study|Lack of Efficacy|1|||
27585419|NCT03329092|80324469|FG000|Overall Study|Other|2|||
27585420|NCT03329092|80324470|FG001|Overall Study|Other|2|||
27585421|NCT03329092|80324469|FG000|Overall Study|Withdrawal by Subject|16|||
27585422|NCT03329092|80324470|FG001|Overall Study|Withdrawal by Subject|3|||
27585423|NCT03329092|80324469|FG000|Overall Study|Physician Decision|1|||
27585424|NCT03329092|80324470|FG001|Overall Study|Physician Decision|0|||
27585425|NCT03329092|80324469|FG000|Overall Study|Death|17|||
27585426|NCT03329092|80324470|FG001|Overall Study|Death|11|||
27585427|NCT03329092|80324469|FG000|Overall Study|Adverse Event|3|||
27585428|NCT03329092|80324470|FG001|Overall Study|Adverse Event|1|||
27585429|NCT03329092|80324469|FG000|Overall Study|Lost to Follow-up|1|||
27585430|NCT03329092|80324470|FG001|Overall Study|Lost to Follow-up|1|||
27585431|NCT02536508|80324471|FG000|Overall Study|Withdrawal by Subject|18|||
27585432|NCT02536508|80324472|FG001|Overall Study|Withdrawal by Subject|13|||
27585433|NCT02536508|80324473|FG002|Overall Study|Withdrawal by Subject|7|||
27585434|NCT02536508|80324471|FG000|Overall Study|Adverse Event|14|||
27585435|NCT02536508|80324472|FG001|Overall Study|Adverse Event|13|||
27585436|NCT02536508|80324473|FG002|Overall Study|Adverse Event|6|||
27585437|NCT02536508|80324471|FG000|Overall Study|Lost to Follow-up|12|||
27585438|NCT02536508|80324472|FG001|Overall Study|Lost to Follow-up|4|||
27585439|NCT02536508|80324473|FG002|Overall Study|Lost to Follow-up|0|||
27585440|NCT02536508|80324471|FG000|Overall Study|Lack of Efficacy|3|||
27585441|NCT02536508|80324472|FG001|Overall Study|Lack of Efficacy|5|||
27585442|NCT02536508|80324473|FG002|Overall Study|Lack of Efficacy|4|||
27585443|NCT02536508|80324471|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
27585444|NCT02536508|80324472|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
27585445|NCT02536508|80324473|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
27585446|NCT02536508|80324471|FG000|Overall Study|Physician Decision|0|||
27585447|NCT02536508|80324472|FG001|Overall Study|Physician Decision|4|||
27585448|NCT02536508|80324473|FG002|Overall Study|Physician Decision|2|||
27585449|NCT02536508|80324471|FG000|Overall Study|Major Protocol Deviation|2|||
28005780|NCT02234843|81853540|FG008|Overall Study|Lost to Follow-up|0|||
28005781|NCT02234843|81853541|FG009|Overall Study|Lost to Follow-up|0|||
27585450|NCT02536508|80324472|FG001|Overall Study|Major Protocol Deviation|2|||
27585451|NCT02536508|80324473|FG002|Overall Study|Major Protocol Deviation|2|||
27585452|NCT02536508|80324471|FG000|Overall Study|Administrative Reasons|0|||
27585453|NCT02536508|80324472|FG001|Overall Study|Administrative Reasons|1|||
27585454|NCT02536508|80324473|FG002|Overall Study|Administrative Reasons|0|||
27585455|NCT03086447|80324479|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27585456|NCT03086447|80324480|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
27585457|NCT03086447|80324479|FG000|Overall Study|Lost Lens|2|||
27585458|NCT03086447|80324480|FG001|Overall Study|Lost Lens|5|||
27585459|NCT03086447|80324479|FG000|Overall Study|Product quality complaint|0|||
27585460|NCT03086447|80324480|FG001|Overall Study|Product quality complaint|1|||
27585461|NCT03086447|80324479|FG000|Overall Study|Lens Damage|1|||
27585462|NCT03086447|80324480|FG001|Overall Study|Lens Damage|6|||
27585463|NCT03086447|80324479|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
27585464|NCT03086447|80324480|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27585465|NCT03086447|80324479|FG000|Overall Study|Test Article No Longer Available|1|||
27585466|NCT03086447|80324480|FG001|Overall Study|Test Article No Longer Available|0|||
28005782|NCT00472108|81853542|FG000|Overall Study|Lost to Follow-up|0|||
28005783|NCT00472108|81853543|FG001|Overall Study|Lost to Follow-up|1|||
28005784|NCT03041038|81853544|FG000|Overall Study|Withdrawal by Subject|4|||
28005785|NCT03041038|81853545|FG001|Overall Study|Withdrawal by Subject|0|||
28005786|NCT03041038|81853544|FG000|Overall Study|Lost to Follow-up|1|||
28005787|NCT03041038|81853545|FG001|Overall Study|Lost to Follow-up|1|||
28005788|NCT03041038|81853544|FG000|Overall Study|Protocol Violation|1|||
28005789|NCT03041038|81853545|FG001|Overall Study|Protocol Violation|1|||
28005790|NCT00097500|81853547|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
28005791|NCT00097500|81853548|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
28005792|NCT00097500|81853547|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
28005793|NCT00097500|81853548|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
28005794|NCT00097500|81853547|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
28005795|NCT00097500|81853548|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
27585467|NCT03086447|80324479|FG000|Overall Study|Protocol Violation|2|||
27585468|NCT03086447|80324480|FG001|Overall Study|Protocol Violation|4|||
27585469|NCT03086447|80324479|FG000|Overall Study|Lost to Follow-up|0|||
27585470|NCT03086447|80324480|FG001|Overall Study|Lost to Follow-up|1|||
27585471|NCT03086447|80324479|FG000|Overall Study|Adverse Event|3|||
27809095|NCT01889862|81130802|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27809096|NCT01889862|81130803|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27809097|NCT01889862|81130804|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
27809098|NCT01889862|81130800|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
28005796|NCT00097500|81853547|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
28005797|NCT00097500|81853548|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
28005798|NCT00097500|81853547|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
28005799|NCT00097500|81853548|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
28005800|NCT00097500|81853547|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
28005801|NCT00097500|81853548|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
28005802|NCT00097500|81853547|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
28005803|NCT00097500|81853548|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
28005804|NCT02513563|81853549|FG000|Overall Study|Death|4|||
28005805|NCT02513563|81853549|FG000|Overall Study|Withdrawal by Subject|4|||
28005806|NCT02513563|81853549|FG000|Overall Study|Physician Decision|1|||
28005807|NCT01091675|81853550|FG000|Overall Study|Adverse Event|7|||
28005808|NCT01091675|81853550|FG000|Overall Study|Lack of Efficacy|27|||
28005809|NCT01285401|81853551|FG000|Overall Study|Prematurely withdrawn from the study|17|||
28005810|NCT01285401|81853552|FG001|Overall Study|Prematurely withdrawn from the study|29|||
28005811|NCT04349072|81853553|FG000|Randomization Period|Found ineligible post enrollment|0|||
28005812|NCT04349072|81853554|FG001|Randomization Period|Found ineligible post enrollment|1|||
28005813|NCT04349072|81853553|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
28005814|NCT04349072|81853554|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
28005815|NCT04349072|81853553|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
28005816|NCT04349072|81853554|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
28005817|NCT04349072|81853553|FG000|Treatment Period|Physician Decision|0|||
28005818|NCT04349072|81853554|FG001|Treatment Period|Physician Decision|1|||
28005819|NCT04349072|81853553|FG000|Treatment Period|Protocol Violation|0|||
28005820|NCT04349072|81853554|FG001|Treatment Period|Protocol Violation|1|||
28005821|NCT04349072|81853553|FG000|Treatment Period|Withdrawal by Subject|1|||
27809099|NCT01889862|81130801|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27809100|NCT01889862|81130802|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27809101|NCT01889862|81130803|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
27809102|NCT01889862|81130804|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
28005822|NCT04349072|81853554|FG001|Treatment Period|Withdrawal by Subject|1|||
28005823|NCT04516746|81853555|FG000|Overall Study|Randomized but not Treated|51|||
28005824|NCT04516746|81853556|FG001|Overall Study|Randomized but not Treated|19|||
28005825|NCT04516746|81853555|FG000|Overall Study|Adverse Event|0|||
27809103|NCT01889862|81130800|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
27809104|NCT01889862|81130801|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
28005826|NCT04516746|81853556|FG001|Overall Study|Adverse Event|1|||
27809105|NCT01889862|81130802|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
27585472|NCT03086447|80324480|FG001|Overall Study|Adverse Event|0|||
27809106|NCT01889862|81130803|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
27809107|NCT01889862|81130804|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
28005827|NCT04516746|81853555|FG000|Overall Study|Death|62|||
28005828|NCT04516746|81853556|FG001|Overall Study|Death|32|||
28005829|NCT04516746|81853555|FG000|Overall Study|Lost to Follow-up|3431|||
28005830|NCT04516746|81853556|FG001|Overall Study|Lost to Follow-up|1831|||
27585473|NCT03086447|80324479|FG000|Overall Study|Lens Discomfort|2|||
27585474|NCT03086447|80324480|FG001|Overall Study|Lens Discomfort|1|||
28005831|NCT04516746|81853555|FG000|Overall Study|Withdrawal by Subject|1946|||
28005832|NCT04516746|81853556|FG001|Overall Study|Withdrawal by Subject|1696|||
28005833|NCT04516746|81853555|FG000|Overall Study|Physician Decision|10|||
28005834|NCT04516746|81853556|FG001|Overall Study|Physician Decision|8|||
28005835|NCT04516746|81853555|FG000|Overall Study|Other|35|||
28005836|NCT04516746|81853556|FG001|Overall Study|Other|16|||
28005837|NCT03812380|81853557|FG000|Overall Study|Protocol Violation|3|||
28005838|NCT03812380|81853558|FG001|Overall Study|Protocol Violation|3|||
28005839|NCT03812380|81853557|FG000|Overall Study|Withdrawal by Subject|5|||
28005840|NCT03812380|81853558|FG001|Overall Study|Withdrawal by Subject|4|||
28005841|NCT03812380|81853557|FG000|Overall Study|Early termination of study|14|||
28005842|NCT03812380|81853558|FG001|Overall Study|Early termination of study|14|||
27684899|NCT02712905|80683641|FG012|Monotherapy|Study Terminated by Sponsor|0|||
27684900|NCT02712905|80683642|FG013|Monotherapy|Study Terminated by Sponsor|0|||
27809108|NCT01889862|81130800|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27809109|NCT01889862|81130801|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27684901|NCT02712905|80683643|FG014|Monotherapy|Study Terminated by Sponsor|0|||
27684902|NCT02712905|80683644|FG015|Monotherapy|Study Terminated by Sponsor|0|||
27684903|NCT02712905|80683645|FG016|Monotherapy|Study Terminated by Sponsor|0|||
27684904|NCT02712905|80683646|FG017|Monotherapy|Study Terminated by Sponsor|0|||
28005843|NCT01405768|81853563|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
28005844|NCT01405768|81853564|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
28005845|NCT00740220|81853565|FG000|Overall Study|screen failures (non-COPD patients)|9|||
28005846|NCT01539759|81853568|FG000|Overall Study|Lost to Follow-up|6|||
28005847|NCT01539759|81853569|FG001|Overall Study|Lost to Follow-up|8|||
28005848|NCT01009060|81853570|FG000|Overall Study|Adverse Event|1|||
28005849|NCT01009060|81853571|FG001|Overall Study|Adverse Event|2|||
28005850|NCT01009060|81853570|FG000|Overall Study|Protocol Violation|0|||
28005851|NCT01009060|81853571|FG001|Overall Study|Protocol Violation|1|||
28005852|NCT01009060|81853570|FG000|Overall Study|Lost to Follow-up|1|||
28005853|NCT01009060|81853571|FG001|Overall Study|Lost to Follow-up|0|||
28005854|NCT01009060|81853570|FG000|Overall Study|Physician Decision|1|||
27684905|NCT02712905|80683629|FG000|Monotherapy|Withdrawal by Subject|0|||
27684906|NCT02712905|80683630|FG001|Monotherapy|Withdrawal by Subject|0|||
27684907|NCT02712905|80683631|FG002|Monotherapy|Withdrawal by Subject|1|||
27684908|NCT02712905|80683632|FG003|Monotherapy|Withdrawal by Subject|0|||
27684909|NCT02712905|80683633|FG004|Monotherapy|Withdrawal by Subject|2|||
27684910|NCT02712905|80683634|FG005|Monotherapy|Withdrawal by Subject|0|||
27684911|NCT02712905|80683635|FG006|Monotherapy|Withdrawal by Subject|0|||
27684912|NCT02712905|80683636|FG007|Monotherapy|Withdrawal by Subject|0|||
27684913|NCT02712905|80683637|FG008|Monotherapy|Withdrawal by Subject|0|||
27684914|NCT02712905|80683638|FG009|Monotherapy|Withdrawal by Subject|4|||
27684915|NCT02712905|80683639|FG010|Monotherapy|Withdrawal by Subject|1|||
27684916|NCT02712905|80683640|FG011|Monotherapy|Withdrawal by Subject|2|||
27684917|NCT02712905|80683641|FG012|Monotherapy|Withdrawal by Subject|0|||
27684918|NCT02712905|80683642|FG013|Monotherapy|Withdrawal by Subject|0|||
27809110|NCT01889862|81130802|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27809111|NCT01889862|81130803|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
27809112|NCT01889862|81130804|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
27809113|NCT01889862|81130800|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
28005855|NCT01009060|81853571|FG001|Overall Study|Physician Decision|1|||
28005856|NCT01009060|81853570|FG000|Overall Study|Withdrawal by Subject|1|||
28005857|NCT01009060|81853571|FG001|Overall Study|Withdrawal by Subject|1|||
28005858|NCT03341299|81853574|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
28005859|NCT03341299|81853575|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
28005860|NCT03341299|81853576|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
28005861|NCT03341299|81853577|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
28005862|NCT00377520|81853578|FG000|Overall Study|Ineligible (Prior radiation)|1|||
28005863|NCT04583280|81853588|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
28005864|NCT04583280|81853589|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
28005865|NCT04481243|81853590|FG000|Overall Study|Withdrawal by Subject|4|||
27684919|NCT02712905|80683643|FG014|Monotherapy|Withdrawal by Subject|0|||
28005866|NCT00894803|81853593|FG000|Overall Study|Death|20|||
27684920|NCT02712905|80683644|FG015|Monotherapy|Withdrawal by Subject|0|||
27684921|NCT02712905|80683645|FG016|Monotherapy|Withdrawal by Subject|0|||
27684922|NCT02712905|80683646|FG017|Monotherapy|Withdrawal by Subject|0|||
27684923|NCT02712905|80683629|FG000|Monotherapy|Started New Cancer Drug|0|||
28005867|NCT00894803|81853594|FG001|Overall Study|Death|4|||
28005868|NCT00894803|81853593|FG000|Overall Study|Lost to Follow-up|0|||
28005869|NCT00894803|81853594|FG001|Overall Study|Lost to Follow-up|1|||
28005870|NCT02021565|81853595|FG000|Baseline Through Intervention|Death|0|||
28005871|NCT02021565|81853596|FG001|Baseline Through Intervention|Death|1|||
28005872|NCT02021565|81853595|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
28005873|NCT02021565|81853596|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
28005874|NCT02021565|81853595|FG000|Baseline Through Intervention|Protocol Violation|0|||
28005875|NCT02021565|81853596|FG001|Baseline Through Intervention|Protocol Violation|7|||
28005876|NCT02021565|81853595|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
28005877|NCT02021565|81853596|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
28005878|NCT02021565|81853595|FG000|3-month Follow-up|Death|3|||
28005879|NCT02021565|81853596|FG001|3-month Follow-up|Death|0|||
28005880|NCT02021565|81853595|FG000|3-month Follow-up|Withdrawal by Subject|4|||
28005881|NCT02021565|81853596|FG001|3-month Follow-up|Withdrawal by Subject|0|||
28005882|NCT02021565|81853595|FG000|3-month Follow-up|Protocol Violation|3|||
28005883|NCT02021565|81853596|FG001|3-month Follow-up|Protocol Violation|2|||
28005884|NCT00774046|81853599|FG000|Screening|Not eligible|56|||
28005885|NCT00774046|81853599|FG000|Enrollment|Desired other therapy/refused|28|||
28005886|NCT00774046|81853599|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
28005887|NCT01611792|81853600|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
28005888|NCT01611792|81853601|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
28005889|NCT01611792|81853600|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
28005890|NCT01611792|81853601|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
28005891|NCT01453049|81853605|FG000|Overall Study|Protocol Violation|2|||
28005892|NCT01453049|81853606|FG001|Overall Study|Protocol Violation|5|||
28005893|NCT01453049|81853605|FG000|Overall Study|Lost to Follow-up|2|||
28005894|NCT01453049|81853606|FG001|Overall Study|Lost to Follow-up|1|||
28005895|NCT01453049|81853605|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
28005896|NCT01453049|81853606|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
28005897|NCT01453049|81853605|FG000|Overall Study|Withdrawal by Subject|1|||
28005898|NCT01453049|81853606|FG001|Overall Study|Withdrawal by Subject|0|||
28005899|NCT01453049|81853605|FG000|Overall Study|Randomized in Error|1|||
28005900|NCT01453049|81853606|FG001|Overall Study|Randomized in Error|0|||
28005901|NCT02927301|81853607|FG000|Overall Study|Death|39|||
28005902|NCT02927301|81853607|FG000|Overall Study|Lost to Follow-up|8|||
28005903|NCT02927301|81853607|FG000|Overall Study|Physician Decision|2|||
27684924|NCT02712905|80683630|FG001|Monotherapy|Started New Cancer Drug|0|||
27684925|NCT02712905|80683631|FG002|Monotherapy|Started New Cancer Drug|0|||
27684926|NCT02712905|80683632|FG003|Monotherapy|Started New Cancer Drug|0|||
27684927|NCT02712905|80683633|FG004|Monotherapy|Started New Cancer Drug|0|||
27684928|NCT02712905|80683634|FG005|Monotherapy|Started New Cancer Drug|1|||
27684929|NCT02712905|80683635|FG006|Monotherapy|Started New Cancer Drug|0|||
27684930|NCT02712905|80683636|FG007|Monotherapy|Started New Cancer Drug|0|||
27684931|NCT02712905|80683637|FG008|Monotherapy|Started New Cancer Drug|0|||
27684932|NCT02712905|80683638|FG009|Monotherapy|Started New Cancer Drug|0|||
27684933|NCT02712905|80683639|FG010|Monotherapy|Started New Cancer Drug|0|||
27684934|NCT02712905|80683640|FG011|Monotherapy|Started New Cancer Drug|0|||
27684935|NCT02712905|80683641|FG012|Monotherapy|Started New Cancer Drug|0|||
27684936|NCT02712905|80683642|FG013|Monotherapy|Started New Cancer Drug|0|||
28005904|NCT02927301|81853607|FG000|Overall Study|Withdrawal by Subject|12|||
28005905|NCT02927301|81853607|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
27684937|NCT02712905|80683643|FG014|Monotherapy|Started New Cancer Drug|0|||
27684938|NCT02712905|80683644|FG015|Monotherapy|Started New Cancer Drug|0|||
28005906|NCT02412306|81853608|FG000|Overall Study|Lost to Follow-up|0|||
27684939|NCT02712905|80683645|FG016|Monotherapy|Started New Cancer Drug|0|||
27684940|NCT02712905|80683646|FG017|Monotherapy|Started New Cancer Drug|0|||
27684941|NCT02712905|80683629|FG000|Monotherapy|Adverse Event|0|||
27684942|NCT02712905|80683630|FG001|Monotherapy|Adverse Event|0|||
27684943|NCT02712905|80683631|FG002|Monotherapy|Adverse Event|0|||
27684944|NCT02712905|80683632|FG003|Monotherapy|Adverse Event|0|||
27684945|NCT02712905|80683633|FG004|Monotherapy|Adverse Event|0|||
27684946|NCT02712905|80683634|FG005|Monotherapy|Adverse Event|0|||
27684947|NCT02712905|80683635|FG006|Monotherapy|Adverse Event|0|||
27684948|NCT02712905|80683636|FG007|Monotherapy|Adverse Event|0|||
27684949|NCT02712905|80683637|FG008|Monotherapy|Adverse Event|1|||
27684950|NCT02712905|80683638|FG009|Monotherapy|Adverse Event|0|||
27809114|NCT01889862|81130801|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
27809115|NCT01889862|81130802|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
27809116|NCT01889862|81130803|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
28005907|NCT02412306|81853609|FG001|Overall Study|Lost to Follow-up|1|||
27809117|NCT01889862|81130804|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
28005908|NCT02412306|81853610|FG002|Overall Study|Lost to Follow-up|0|||
27684951|NCT02712905|80683639|FG010|Monotherapy|Adverse Event|0|||
27809118|NCT01889862|81130800|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
28005909|NCT02412306|81853611|FG003|Overall Study|Lost to Follow-up|0|||
28005910|NCT02412306|81853612|FG004|Overall Study|Lost to Follow-up|0|||
28005911|NCT02412306|81853608|FG000|Overall Study|Withdrawal by Subject|0|||
27684952|NCT02712905|80683640|FG011|Monotherapy|Adverse Event|0|||
27684953|NCT02712905|80683641|FG012|Monotherapy|Adverse Event|0|||
27684954|NCT02712905|80683642|FG013|Monotherapy|Adverse Event|0|||
27684955|NCT02712905|80683643|FG014|Monotherapy|Adverse Event|0|||
27684956|NCT02712905|80683644|FG015|Monotherapy|Adverse Event|0|||
27684957|NCT02712905|80683645|FG016|Monotherapy|Adverse Event|0|||
27684958|NCT02712905|80683646|FG017|Monotherapy|Adverse Event|0|||
27684959|NCT02712905|80683629|FG000|Combination Therapy|Death|0|||
27684960|NCT02712905|80683630|FG001|Combination Therapy|Death|0|||
27684961|NCT02712905|80683631|FG002|Combination Therapy|Death|0|||
27684962|NCT02712905|80683632|FG003|Combination Therapy|Death|0|||
27684963|NCT02712905|80683633|FG004|Combination Therapy|Death|0|||
27684964|NCT02712905|80683634|FG005|Combination Therapy|Death|0|||
27684965|NCT02712905|80683635|FG006|Combination Therapy|Death|0|||
27684966|NCT02712905|80683636|FG007|Combination Therapy|Death|0|||
27684967|NCT02712905|80683637|FG008|Combination Therapy|Death|0|||
27684968|NCT02712905|80683638|FG009|Combination Therapy|Death|0|||
27684969|NCT02712905|80683639|FG010|Combination Therapy|Death|0|||
27684970|NCT02712905|80683640|FG011|Combination Therapy|Death|0|||
27684971|NCT02712905|80683641|FG012|Combination Therapy|Death|5|||
27684972|NCT02712905|80683642|FG013|Combination Therapy|Death|6|||
27809119|NCT01889862|81130801|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27809120|NCT01889862|81130802|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27809121|NCT01889862|81130803|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
27809122|NCT01889862|81130804|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
27809123|NCT01889862|81130800|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27585475|NCT01753193|80324483|FG000|Overall Study|Withdrawal by Subject|23|||
27809124|NCT01889862|81130801|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27809125|NCT01889862|81130802|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27809126|NCT01889862|81130803|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
27809127|NCT01889862|81130804|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
27809128|NCT01889862|81130800|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27809129|NCT01889862|81130801|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27809130|NCT01889862|81130802|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27809131|NCT01889862|81130803|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
27809132|NCT01889862|81130804|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
27874675|NCT03866577|81375243|FG003|Overall Study|Protocol Violation|0|||
27585476|NCT01753193|80324483|FG000|Overall Study|Lost to Follow-up|6|||
27585477|NCT01753193|80324483|FG000|Overall Study|Death|1|||
27684973|NCT02712905|80683643|FG014|Combination Therapy|Death|1|||
27684974|NCT02712905|80683644|FG015|Combination Therapy|Death|3|||
27684975|NCT02712905|80683645|FG016|Combination Therapy|Death|1|||
27684976|NCT02712905|80683646|FG017|Combination Therapy|Death|3|||
27684977|NCT02712905|80683629|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
27684978|NCT02712905|80683630|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
27684979|NCT02712905|80683631|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
27809133|NCT01717456|81130805|FG000|End of Treatment|Physician Decision|0|||
27809134|NCT01717456|81130806|FG001|End of Treatment|Physician Decision|1|||
27809135|NCT01717456|81130805|FG000|End of Treatment|Lost to Follow-up|0|||
27809136|NCT01717456|81130806|FG001|End of Treatment|Lost to Follow-up|1|||
27585478|NCT01753193|80324483|FG000|Overall Study|Other|16|||
27585479|NCT00759109|80324484|FG000|Overall Study|Adverse Event|17|||
27585480|NCT00759109|80324485|FG001|Overall Study|Adverse Event|12|||
27585481|NCT00759109|80324484|FG000|Overall Study|Inability to comply|1|||
27585482|NCT00759109|80324485|FG001|Overall Study|Inability to comply|1|||
27585483|NCT00759109|80324484|FG000|Overall Study|Withdrawal by Subject|9|||
27585484|NCT00759109|80324485|FG001|Overall Study|Withdrawal by Subject|5|||
27585485|NCT00759109|80324484|FG000|Overall Study|Death|4|||
27585486|NCT00759109|80324485|FG001|Overall Study|Death|3|||
27585487|NCT00759109|80324484|FG000|Overall Study|Lost to Follow-up|4|||
27585488|NCT00759109|80324485|FG001|Overall Study|Lost to Follow-up|6|||
27585489|NCT00759109|80324484|FG000|Overall Study|Started new therapy|2|||
27585490|NCT00759109|80324485|FG001|Overall Study|Started new therapy|6|||
27585491|NCT00759109|80324484|FG000|Overall Study|HCV RNA negative|1|||
27585492|NCT00759109|80324485|FG001|Overall Study|HCV RNA negative|0|||
27585493|NCT00759109|80324484|FG000|Overall Study|Participant moved to a different city|0|||
27585494|NCT00759109|80324485|FG001|Overall Study|Participant moved to a different city|1|||
27585495|NCT00759109|80324484|FG000|Overall Study|Participant had a liver transplant|0|||
27809137|NCT01717456|81130805|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
27809138|NCT01717456|81130806|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
27585496|NCT00759109|80324485|FG001|Overall Study|Participant had a liver transplant|1|||
27585497|NCT00759109|80324484|FG000|Overall Study|Lost during study|1|||
27585498|NCT00759109|80324485|FG001|Overall Study|Lost during study|0|||
27585499|NCT01045447|80324490|FG000|Overall Study|Adverse Event|0|||
27585500|NCT01045447|80324491|FG001|Overall Study|Adverse Event|1|||
27585501|NCT01045447|80324490|FG000|Overall Study|Lack of Efficacy|3|||
27585502|NCT01045447|80324491|FG001|Overall Study|Lack of Efficacy|1|||
27585503|NCT01045447|80324490|FG000|Overall Study|Protocol Violation|6|||
27585504|NCT01045447|80324491|FG001|Overall Study|Protocol Violation|3|||
27585505|NCT01045447|80324490|FG000|Overall Study|Withdrawal Criteria|10|||
27585506|NCT01045447|80324491|FG001|Overall Study|Withdrawal Criteria|10|||
27585507|NCT01045447|80324490|FG000|Overall Study|Unclassified|17|||
27585508|NCT01045447|80324491|FG001|Overall Study|Unclassified|13|||
27585509|NCT02331134|80324492|FG000|Overall Study|Withdrawal by Subject|1|||
27585510|NCT00389324|80324493|FG000|Run-In Phase|Adverse Event|1|||
27585511|NCT00389324|80324493|FG000|Run-In Phase|Lost to Follow-up|1|||
27585512|NCT00389324|80324493|FG000|Run-In Phase|Withdrawal by Subject|1|||
27585513|NCT00389324|80324493|FG000|Subcutaneous Phase|Adverse Event|2|||
27585514|NCT00389324|80324493|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
27585515|NCT00389324|80324493|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
27585516|NCT00389324|80324493|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
27585517|NCT02691455|80324498|FG000|Overall Study|Withdrawal by Subject|1|||
27585518|NCT02691455|80324499|FG001|Overall Study|Withdrawal by Subject|2|||
27585519|NCT02691455|80324498|FG000|Overall Study|Lost to Follow-up|15|||
27585520|NCT02691455|80324499|FG001|Overall Study|Lost to Follow-up|15|||
27585521|NCT00618514|80324500|FG000|Overall Study|Lost to Follow-up|11|||
27585522|NCT00618514|80324501|FG001|Overall Study|Lost to Follow-up|12|||
27585523|NCT00618514|80324502|FG002|Overall Study|Lost to Follow-up|4|||
27809139|NCT01952574|81130807|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
27809140|NCT01952574|81130808|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
27809141|NCT01952574|81130809|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
27809142|NCT01952574|81130810|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
27809143|NCT01952574|81130811|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27809144|NCT01952574|81130812|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27809145|NCT01952574|81130813|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27874676|NCT03866577|81375244|FG004|Overall Study|Protocol Violation|0|||
28005912|NCT02412306|81853609|FG001|Overall Study|Withdrawal by Subject|0|||
28005913|NCT02412306|81853610|FG002|Overall Study|Withdrawal by Subject|1|||
27585524|NCT03328897|80324503|FG000|Randomized-treatment Epoch|Adverse Event|4|||
27585525|NCT03328897|80324504|FG001|Randomized-treatment Epoch|Adverse Event|1|||
27585526|NCT03328897|80324505|FG002|Randomized-treatment Epoch|Adverse Event|1|||
27585527|NCT03328897|80324503|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
27585528|NCT03328897|80324504|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
27585529|NCT03328897|80324505|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
27585530|NCT03328897|80324503|FG000|Randomized-treatment Epoch|Pregnancy|3|||
27585531|NCT03328897|80324504|FG001|Randomized-treatment Epoch|Pregnancy|0|||
27585532|NCT03328897|80324505|FG002|Randomized-treatment Epoch|Pregnancy|0|||
27585533|NCT03328897|80324503|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
27585534|NCT03328897|80324504|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
27585535|NCT03328897|80324505|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
27585536|NCT03328897|80324503|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
27585537|NCT03328897|80324504|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
27585538|NCT03328897|80324505|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
27585539|NCT03328897|80324503|FG000|Follow-up Epoch|Adverse Event|4|||
27585540|NCT03328897|80324504|FG001|Follow-up Epoch|Adverse Event|0|||
27585541|NCT03328897|80324505|FG002|Follow-up Epoch|Adverse Event|1|||
27874677|NCT03866577|81375245|FG005|Overall Study|Protocol Violation|0|||
27874678|NCT03866577|81375246|FG006|Overall Study|Protocol Violation|0|||
27874679|NCT03866577|81375247|FG007|Overall Study|Protocol Violation|0|||
27874680|NCT03866577|81375248|FG008|Overall Study|Protocol Violation|0|||
27874681|NCT03866577|81375249|FG009|Overall Study|Protocol Violation|0|||
27874682|NCT03866577|81375250|FG010|Overall Study|Protocol Violation|0|||
27874683|NCT03866577|81375251|FG011|Overall Study|Protocol Violation|1|||
27874684|NCT03866577|81375252|FG012|Overall Study|Protocol Violation|0|||
27874685|NCT03866577|81375240|FG000|Overall Study|Withdrawal by Subject|0|||
27874686|NCT03866577|81375241|FG001|Overall Study|Withdrawal by Subject|0|||
27874687|NCT03866577|81375242|FG002|Overall Study|Withdrawal by Subject|0|||
27874688|NCT03866577|81375243|FG003|Overall Study|Withdrawal by Subject|0|||
27874689|NCT03866577|81375244|FG004|Overall Study|Withdrawal by Subject|0|||
27874690|NCT03866577|81375245|FG005|Overall Study|Withdrawal by Subject|0|||
27874691|NCT03866577|81375246|FG006|Overall Study|Withdrawal by Subject|0|||
27874692|NCT03866577|81375247|FG007|Overall Study|Withdrawal by Subject|0|||
27874693|NCT03866577|81375248|FG008|Overall Study|Withdrawal by Subject|1|||
27874694|NCT03866577|81375249|FG009|Overall Study|Withdrawal by Subject|1|||
27874695|NCT03866577|81375250|FG010|Overall Study|Withdrawal by Subject|0|||
27874696|NCT03866577|81375251|FG011|Overall Study|Withdrawal by Subject|0|||
27874697|NCT03866577|81375252|FG012|Overall Study|Withdrawal by Subject|0|||
27874698|NCT03866577|81375240|FG000|Overall Study|Not qualified for IVIg infusion|0|||
27874699|NCT03866577|81375241|FG001|Overall Study|Not qualified for IVIg infusion|0|||
27874700|NCT03866577|81375242|FG002|Overall Study|Not qualified for IVIg infusion|0|||
27874701|NCT03866577|81375243|FG003|Overall Study|Not qualified for IVIg infusion|0|||
27874702|NCT03866577|81375244|FG004|Overall Study|Not qualified for IVIg infusion|0|||
27874703|NCT03866577|81375245|FG005|Overall Study|Not qualified for IVIg infusion|0|||
27874704|NCT03866577|81375246|FG006|Overall Study|Not qualified for IVIg infusion|0|||
27874705|NCT03866577|81375247|FG007|Overall Study|Not qualified for IVIg infusion|0|||
27874706|NCT03866577|81375248|FG008|Overall Study|Not qualified for IVIg infusion|0|||
27874707|NCT03866577|81375249|FG009|Overall Study|Not qualified for IVIg infusion|1|||
27874708|NCT03866577|81375250|FG010|Overall Study|Not qualified for IVIg infusion|0|||
27874709|NCT03866577|81375251|FG011|Overall Study|Not qualified for IVIg infusion|0|||
27874710|NCT03866577|81375252|FG012|Overall Study|Not qualified for IVIg infusion|0|||
27874711|NCT01922037|81375255|FG000|Overall Study|Withdrawal by Subject|2|||
27874712|NCT01922037|81375256|FG001|Overall Study|Withdrawal by Subject|44|||
27874713|NCT01922037|81375255|FG000|Overall Study|Adverse Event|1|||
27874714|NCT01922037|81375256|FG001|Overall Study|Adverse Event|7|||
27874715|NCT01922037|81375255|FG000|Overall Study|Death|0|||
27874716|NCT01922037|81375256|FG001|Overall Study|Death|5|||
27874717|NCT01922037|81375255|FG000|Overall Study|Pregnancy|0|||
28005914|NCT02412306|81853611|FG003|Overall Study|Withdrawal by Subject|0|||
28005915|NCT02412306|81853612|FG004|Overall Study|Withdrawal by Subject|0|||
27684980|NCT02712905|80683632|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
27684981|NCT02712905|80683633|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
27684982|NCT02712905|80683634|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
27684983|NCT02712905|80683635|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
27585542|NCT03328897|80324503|FG000|Follow-up Epoch|Lack of Efficacy|1|||
27585543|NCT03328897|80324504|FG001|Follow-up Epoch|Lack of Efficacy|1|||
27585544|NCT03328897|80324505|FG002|Follow-up Epoch|Lack of Efficacy|1|||
28005916|NCT02412306|81853608|FG000|Overall Study|Death|5|||
28005917|NCT02412306|81853609|FG001|Overall Study|Death|7|||
28005918|NCT02412306|81853610|FG002|Overall Study|Death|15|||
28005919|NCT02412306|81853611|FG003|Overall Study|Death|0|||
28005920|NCT02412306|81853612|FG004|Overall Study|Death|2|||
27585545|NCT03328897|80324503|FG000|Follow-up Epoch|Lost to Follow-up|0|||
27874718|NCT01922037|81375256|FG001|Overall Study|Pregnancy|2|||
27874719|NCT01922037|81375255|FG000|Overall Study|Participant non-compliance|4|||
27585546|NCT03328897|80324504|FG001|Follow-up Epoch|Lost to Follow-up|1|||
27874720|NCT01922037|81375256|FG001|Overall Study|Participant non-compliance|46|||
27874721|NCT01922037|81375255|FG000|Overall Study|Investigator/Sponsor decision|1|||
28005921|NCT00083889|81853620|FG000|Overall Study|Adverse Event|76|||
27874722|NCT01922037|81375256|FG001|Overall Study|Investigator/Sponsor decision|4|||
27874723|NCT01922037|81375255|FG000|Overall Study|Other unspecified|2|||
27874724|NCT01922037|81375256|FG001|Overall Study|Other unspecified|66|||
27874725|NCT00897715|81375261|FG000|Overall Study|Lost to Follow-up|0|||
28005922|NCT00083889|81853621|FG001|Overall Study|Adverse Event|86|||
27684984|NCT02712905|80683636|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
27585547|NCT03328897|80324505|FG002|Follow-up Epoch|Lost to Follow-up|0|||
28005923|NCT00083889|81853620|FG000|Overall Study|Protocol Violation|2|||
27585548|NCT03328897|80324503|FG000|Follow-up Epoch|Pregnancy|1|||
27585549|NCT03328897|80324504|FG001|Follow-up Epoch|Pregnancy|0|||
27585550|NCT03328897|80324505|FG002|Follow-up Epoch|Pregnancy|0|||
27809146|NCT01952574|81130807|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
27809147|NCT01952574|81130808|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
27809148|NCT01952574|81130809|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
27809149|NCT01952574|81130810|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
27809150|NCT01952574|81130811|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
27809151|NCT01952574|81130812|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
27809152|NCT01952574|81130813|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
27809153|NCT01952574|81130807|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
27809154|NCT01952574|81130808|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
27809155|NCT01952574|81130809|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
27809156|NCT01952574|81130810|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
27809157|NCT01952574|81130811|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
27809158|NCT01952574|81130812|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
27809159|NCT01952574|81130813|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
27809160|NCT01952574|81130807|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
27809161|NCT01952574|81130808|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
27809162|NCT01952574|81130809|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
27809163|NCT01952574|81130810|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
27809164|NCT01952574|81130811|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
27809165|NCT01952574|81130812|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
27874726|NCT00897715|81375262|FG001|Overall Study|Lost to Follow-up|1|||
27874727|NCT00897715|81375261|FG000|Overall Study|Physician Decision|1|||
27874728|NCT00897715|81375262|FG001|Overall Study|Physician Decision|0|||
27874729|NCT00897715|81375261|FG000|Overall Study|increased risk of infection|1|||
27874730|NCT00897715|81375262|FG001|Overall Study|increased risk of infection|0|||
27874731|NCT01692626|81375263|FG000|Overall Study|Death|0|||
27874732|NCT01692626|81375264|FG001|Overall Study|Death|1|||
27874733|NCT01692626|81375263|FG000|Overall Study|Adverse Event|2|||
27874734|NCT01692626|81375264|FG001|Overall Study|Adverse Event|3|||
27874735|NCT01692626|81375263|FG000|Overall Study|Protocol Violation|1|||
27874736|NCT01692626|81375264|FG001|Overall Study|Protocol Violation|2|||
27874737|NCT01692626|81375263|FG000|Overall Study|Withdrawal by Subject|1|||
27874738|NCT01692626|81375264|FG001|Overall Study|Withdrawal by Subject|0|||
27874739|NCT00837148|81375265|FG000|Overall Study|Adverse Event|1|||
27874740|NCT00837148|81375265|FG000|Overall Study|Death|1|||
27874741|NCT01052480|81375266|FG000|Overall Study|Lost to Follow-up|3|||
27874742|NCT01052480|81375267|FG001|Overall Study|Lost to Follow-up|3|||
27874743|NCT01052480|81375266|FG000|Overall Study|Protocol Violation|1|||
27874744|NCT01052480|81375267|FG001|Overall Study|Protocol Violation|0|||
28005924|NCT00083889|81853621|FG001|Overall Study|Protocol Violation|2|||
27809166|NCT01952574|81130813|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
27809167|NCT01952574|81130807|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
27809168|NCT01952574|81130808|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
27809169|NCT01952574|81130809|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
27809170|NCT01952574|81130810|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
27809171|NCT01952574|81130811|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
28005925|NCT00083889|81853620|FG000|Overall Study|Withdrawal by Subject|22|||
27809172|NCT01952574|81130812|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
27809173|NCT01952574|81130813|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
27809174|NCT01952574|81130807|FG000|Open-label Treatment Phase|Missing|0|||
27809175|NCT01952574|81130808|FG001|Open-label Treatment Phase|Missing|0|||
27809176|NCT01952574|81130809|FG002|Open-label Treatment Phase|Missing|0|||
27809177|NCT01952574|81130810|FG003|Open-label Treatment Phase|Missing|0|||
27809178|NCT01952574|81130811|FG004|Open-label Treatment Phase|Missing|4|||
27809179|NCT01952574|81130812|FG005|Open-label Treatment Phase|Missing|0|||
28005926|NCT00083889|81853621|FG001|Overall Study|Withdrawal by Subject|24|||
27684985|NCT02712905|80683637|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
27684986|NCT02712905|80683638|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
27684987|NCT02712905|80683639|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
27684988|NCT02712905|80683640|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
27684989|NCT02712905|80683641|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
27809180|NCT01952574|81130813|FG006|Open-label Treatment Phase|Missing|0|||
27809181|NCT01952574|81130807|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
27809182|NCT01952574|81130808|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
27809183|NCT01952574|81130809|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
27874745|NCT01052480|81375266|FG000|Overall Study|Withdrawal by Subject|3|||
27809184|NCT01952574|81130810|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
27874746|NCT01052480|81375267|FG001|Overall Study|Withdrawal by Subject|7|||
27874747|NCT01052480|81375266|FG000|Overall Study|Physician Decision|0|||
27809185|NCT01952574|81130811|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
27874748|NCT01052480|81375267|FG001|Overall Study|Physician Decision|2|||
27874749|NCT01052480|81375266|FG000|Overall Study|Death|1|||
27874750|NCT01052480|81375267|FG001|Overall Study|Death|5|||
27809186|NCT01952574|81130812|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
27809187|NCT01952574|81130813|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
27809188|NCT01952574|81130807|FG000|Open-label Treatment Phase|Death|0|||
27809189|NCT01952574|81130808|FG001|Open-label Treatment Phase|Death|0|||
27809190|NCT01952574|81130809|FG002|Open-label Treatment Phase|Death|0|||
27809191|NCT01952574|81130810|FG003|Open-label Treatment Phase|Death|0|||
27809192|NCT01952574|81130811|FG004|Open-label Treatment Phase|Death|1|||
27809193|NCT01952574|81130812|FG005|Open-label Treatment Phase|Death|0|||
27809194|NCT01952574|81130813|FG006|Open-label Treatment Phase|Death|0|||
27809195|NCT01952574|81130807|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
27809196|NCT01952574|81130808|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
27809197|NCT01952574|81130809|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
27809198|NCT01952574|81130810|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
27809199|NCT01952574|81130811|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
27809200|NCT01952574|81130812|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
27809201|NCT01952574|81130813|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
27809202|NCT01952574|81130807|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
27809203|NCT01952574|81130808|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
27809204|NCT01952574|81130809|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
27809205|NCT01952574|81130810|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
27809206|NCT01952574|81130811|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
27809207|NCT01952574|81130812|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
27809208|NCT01952574|81130813|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
27585551|NCT03328897|80324503|FG000|Follow-up Epoch|Patient/guardian decision|2|||
27809209|NCT02019979|81130814|FG000|Overall Study|study terminated|14|||
27809210|NCT00814320|81130815|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
27809211|NCT00814320|81130816|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
27809212|NCT00814320|81130815|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
27809213|NCT00814320|81130816|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
27809214|NCT00814320|81130815|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
27809215|NCT00814320|81130816|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
27809216|NCT00814320|81130815|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
27874751|NCT00359424|81375268|FG000|Overall Study|Death|99|||
27874752|NCT00359424|81375269|FG001|Overall Study|Death|58|||
27874753|NCT00359424|81375268|FG000|Overall Study|Lost to Follow-up|19|||
27874754|NCT00359424|81375269|FG001|Overall Study|Lost to Follow-up|7|||
27874755|NCT00359424|81375268|FG000|Overall Study|Withdrawal by Subject|10|||
27874756|NCT00359424|81375269|FG001|Overall Study|Withdrawal by Subject|2|||
27874757|NCT00359424|81375268|FG000|Overall Study|follow up not conducted|2|||
27874758|NCT00359424|81375269|FG001|Overall Study|follow up not conducted|0|||
27874759|NCT00662649|81375270|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
27874760|NCT00662649|81375271|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
27874761|NCT00662649|81375272|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
27874762|NCT00662649|81375273|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
27585552|NCT03328897|80324504|FG001|Follow-up Epoch|Patient/guardian decision|1|||
27585553|NCT03328897|80324505|FG002|Follow-up Epoch|Patient/guardian decision|0|||
27585554|NCT01233817|80324506|FG000|Overall Study|Lost to Follow-up|1|||
27585555|NCT01233817|80324506|FG000|Overall Study|Withdrawal by Subject|2|||
27874763|NCT00662649|81375274|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
27874764|NCT00662649|81375270|FG000|Core Study (24 Months)|Adverse Event|22|||
27874765|NCT00662649|81375271|FG001|Core Study (24 Months)|Adverse Event|13|||
27874766|NCT00662649|81375272|FG002|Core Study (24 Months)|Adverse Event|18|||
27874767|NCT00662649|81375273|FG003|Core Study (24 Months)|Adverse Event|0|||
27874768|NCT00662649|81375274|FG004|Core Study (24 Months)|Adverse Event|0|||
27874769|NCT00662649|81375270|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
27874770|NCT00662649|81375271|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
27874771|NCT00662649|81375272|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
27874772|NCT00662649|81375273|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
27874773|NCT00662649|81375274|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
27874774|NCT00662649|81375270|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
27874775|NCT00662649|81375271|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
28005927|NCT00083889|81853620|FG000|Overall Study|Lack of Efficacy|240|||
27585556|NCT02343458|80324510|FG000|Overall Study|Adverse Event|15|||
27809217|NCT00814320|81130816|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
27809218|NCT00814320|81130815|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
27874776|NCT00662649|81375272|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
27874777|NCT00662649|81375273|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
27874778|NCT00662649|81375274|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
27874779|NCT00662649|81375270|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
27874780|NCT00662649|81375271|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
27684990|NCT02712905|80683642|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
27585557|NCT02343458|80324511|FG001|Overall Study|Adverse Event|14|||
27585558|NCT02343458|80324512|FG002|Overall Study|Adverse Event|15|||
27585559|NCT02343458|80324513|FG003|Overall Study|Adverse Event|3|||
27585560|NCT02343458|80324510|FG000|Overall Study|Lack of Efficacy|3|||
27585561|NCT02343458|80324511|FG001|Overall Study|Lack of Efficacy|8|||
27585562|NCT02343458|80324512|FG002|Overall Study|Lack of Efficacy|4|||
27585563|NCT02343458|80324513|FG003|Overall Study|Lack of Efficacy|8|||
27585564|NCT02343458|80324510|FG000|Overall Study|Withdrawal by Subject|18|||
27585565|NCT02343458|80324511|FG001|Overall Study|Withdrawal by Subject|17|||
27585566|NCT02343458|80324512|FG002|Overall Study|Withdrawal by Subject|23|||
27585567|NCT02343458|80324513|FG003|Overall Study|Withdrawal by Subject|14|||
27585568|NCT02343458|80324510|FG000|Overall Study|Physician Decision|1|||
27585569|NCT02343458|80324511|FG001|Overall Study|Physician Decision|4|||
27585570|NCT02343458|80324512|FG002|Overall Study|Physician Decision|2|||
27585571|NCT02343458|80324513|FG003|Overall Study|Physician Decision|2|||
27585572|NCT02343458|80324510|FG000|Overall Study|Lost to Follow-up|5|||
27585573|NCT02343458|80324511|FG001|Overall Study|Lost to Follow-up|5|||
27585574|NCT02343458|80324512|FG002|Overall Study|Lost to Follow-up|3|||
27585575|NCT02343458|80324513|FG003|Overall Study|Lost to Follow-up|1|||
27585576|NCT02343458|80324510|FG000|Overall Study|Protocol Violation|2|||
27585577|NCT02343458|80324511|FG001|Overall Study|Protocol Violation|5|||
27585578|NCT02343458|80324512|FG002|Overall Study|Protocol Violation|2|||
27585579|NCT02343458|80324513|FG003|Overall Study|Protocol Violation|2|||
27585580|NCT02343458|80324510|FG000|Overall Study|Protocol Specified Criteria|17|||
27585581|NCT02343458|80324511|FG001|Overall Study|Protocol Specified Criteria|13|||
27585582|NCT02343458|80324512|FG002|Overall Study|Protocol Specified Criteria|14|||
27585583|NCT02343458|80324513|FG003|Overall Study|Protocol Specified Criteria|8|||
27585584|NCT00856583|80324514|FG000|Overall Study|Lack of Efficacy|389|||
27585585|NCT00856583|80324515|FG001|Overall Study|Lack of Efficacy|377|||
27585586|NCT00856583|80324514|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
27585587|NCT00856583|80324515|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
27585588|NCT00856583|80324514|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
27585589|NCT00856583|80324515|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
27585590|NCT00856583|80324514|FG000|Overall Study|Non-compliance|305|||
27585591|NCT00856583|80324515|FG001|Overall Study|Non-compliance|262|||
27585592|NCT00856583|80324514|FG000|Overall Study|Withdrawal by Subject|1092|||
27585593|NCT00856583|80324515|FG001|Overall Study|Withdrawal by Subject|919|||
27585594|NCT00856583|80324514|FG000|Overall Study|Physician Decision|59|||
27585595|NCT00856583|80324515|FG001|Overall Study|Physician Decision|82|||
27585596|NCT00856583|80324514|FG000|Overall Study|Pregnancy|14|||
27585597|NCT00856583|80324515|FG001|Overall Study|Pregnancy|5|||
27585598|NCT00856583|80324514|FG000|Overall Study|Other|92|||
27585599|NCT00856583|80324515|FG001|Overall Study|Other|104|||
27585600|NCT00856583|80324514|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
27585601|NCT00856583|80324515|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
27684991|NCT02712905|80683643|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
27809219|NCT00814320|81130816|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
27809220|NCT00814320|81130815|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
27809221|NCT00814320|81130816|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
27809222|NCT00814320|81130815|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
27809223|NCT00814320|81130816|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
27809224|NCT00814320|81130815|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
27809225|NCT00814320|81130816|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
27809226|NCT00814320|81130815|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
27809227|NCT00814320|81130816|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
27809228|NCT00814320|81130815|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
27809229|NCT00814320|81130816|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
27809230|NCT00767325|81130817|FG000|Overall Study|Lack of Efficacy|2|||
27809231|NCT00767325|81130817|FG000|Overall Study|Adverse Event|7|||
27809232|NCT00767325|81130817|FG000|Overall Study|Lost to Follow-up|3|||
27809233|NCT00767325|81130817|FG000|Overall Study|No longer met study criteria|2|||
27809234|NCT00767325|81130817|FG000|Overall Study|Missed visit due to family reasons|1|||
27809235|NCT01073020|81130818|FG000|Overall Study|Withdrawal by Subject|6|||
27809236|NCT01073020|81130819|FG001|Overall Study|Withdrawal by Subject|4|||
27809237|NCT01073020|81130820|FG002|Overall Study|Withdrawal by Subject|1|||
27809238|NCT01073020|81130821|FG003|Overall Study|Withdrawal by Subject|2|||
27809239|NCT01073020|81130818|FG000|Overall Study|Physician Decision|1|||
27585602|NCT04102501|80324516|FG000|Overall Study|Withdrawal by Subject|7|||
27585603|NCT04102501|80324517|FG001|Overall Study|Withdrawal by Subject|9|||
27585604|NCT04102501|80324516|FG000|Overall Study|Adverse Event|1|||
27585605|NCT04102501|80324517|FG001|Overall Study|Adverse Event|3|||
27585606|NCT01793792|80324531|FG000|Overall Study|Death|5|||
27585607|NCT01793792|80324531|FG000|Overall Study|Lost to Follow-up|5|||
27585608|NCT01793792|80324531|FG000|Overall Study|Withdrawal by Subject|1|||
27585609|NCT01793792|80324531|FG000|Overall Study|Device Not Implanted|1|||
27585610|NCT00714168|80324532|FG000|Overall Study|Pregnancy|5|||
27585611|NCT00714168|80324533|FG001|Overall Study|Pregnancy|4|||
27585612|NCT00714168|80324532|FG000|Overall Study|Lost to Follow-up|32|||
27585613|NCT00714168|80324533|FG001|Overall Study|Lost to Follow-up|50|||
27585614|NCT00714168|80324532|FG000|Overall Study|Relocation|4|||
27585615|NCT00714168|80324533|FG001|Overall Study|Relocation|3|||
27585616|NCT00714168|80324532|FG000|Overall Study|Non-study medical condition|3|||
27585617|NCT00714168|80324533|FG001|Overall Study|Non-study medical condition|2|||
27585618|NCT01046643|80324534|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
27585619|NCT01046643|80324535|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
27585620|NCT01046643|80324536|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
27585621|NCT01046643|80324537|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
27585622|NCT00736996|80324540|FG000|Overall Study|Lost to Follow-up|1|||
27585623|NCT00736996|80324541|FG001|Overall Study|Lost to Follow-up|9|||
27585624|NCT00736996|80324542|FG002|Overall Study|Lost to Follow-up|2|||
27585625|NCT01259713|80324543|FG000|Overall Study|Adverse Event|54|||
27585626|NCT01259713|80324544|FG001|Overall Study|Adverse Event|23|||
27585627|NCT01259713|80324543|FG000|Overall Study|Death Not Related to IFI|8|||
27585628|NCT01259713|80324544|FG001|Overall Study|Death Not Related to IFI|1|||
27585629|NCT01259713|80324543|FG000|Overall Study|Investigators Discretion|14|||
27585630|NCT01259713|80324544|FG001|Overall Study|Investigators Discretion|6|||
27585631|NCT01259713|80324543|FG000|Overall Study|Lack of Efficacy|2|||
27585632|NCT01259713|80324544|FG001|Overall Study|Lack of Efficacy|0|||
27585633|NCT01259713|80324543|FG000|Overall Study|Protocol Violation|5|||
27585634|NCT01259713|80324544|FG001|Overall Study|Protocol Violation|4|||
27585635|NCT01259713|80324543|FG000|Overall Study|Subject Withdrew Consent|12|||
27585636|NCT01259713|80324544|FG001|Overall Study|Subject Withdrew Consent|7|||
27585637|NCT01870843|80324545|FG000|Overall Study|Adverse Event|10|||
27585638|NCT01870843|80324545|FG000|Overall Study|Lost to Follow-up|24|||
27585639|NCT01870843|80324545|FG000|Overall Study|Death|1|||
27585640|NCT01870843|80324545|FG000|Overall Study|Withdrawal by Subject|18|||
27585641|NCT01344460|80324546|FG000|Overall Study|Withdrawal by Subject|1|||
27585642|NCT01344460|80324546|FG000|Overall Study|Lost to Follow-up|2|||
27585643|NCT01205685|80324547|FG000|Overall Study|Disease Progression|10|||
27585644|NCT01205685|80324547|FG000|Overall Study|Withdrawal by Subject|1|||
27585645|NCT02223390|80324548|FG000|Overall Study|Lost to Follow-up|9|||
27585646|NCT02223390|80324549|FG001|Overall Study|Lost to Follow-up|4|||
27585647|NCT02103439|80324550|FG000|Overall Study|Adverse Event|0|||
27585648|NCT02103439|80324551|FG001|Overall Study|Adverse Event|2|||
27585649|NCT02103439|80324550|FG000|Overall Study|Withdrawal by Subject|3|||
27585650|NCT02103439|80324551|FG001|Overall Study|Withdrawal by Subject|1|||
27585651|NCT00462384|80324555|FG000|Overall Study|Adverse Event|2|||
27585652|NCT00462384|80324555|FG000|Overall Study|Death|2|||
27585653|NCT00462384|80324555|FG000|Overall Study|Withdrawal by Subject|1|||
27585654|NCT00462384|80324555|FG000|Overall Study|Other|4|||
27585655|NCT02317575|80324556|FG000|Period 1|Difficulty with venous cannulation|0|||
27585656|NCT02317575|80324557|FG001|Period 1|Difficulty with venous cannulation|1|||
27585657|NCT02317575|80324558|FG002|Period 1|Difficulty with venous cannulation|0|||
27585658|NCT02317575|80324559|FG003|Period 1|Difficulty with venous cannulation|0|||
27585659|NCT02317575|80324560|FG004|Period 1|Difficulty with venous cannulation|0|||
27585660|NCT02317575|80324556|FG000|Period 1|Withdrawal by Subject|1|||
27585661|NCT02317575|80324557|FG001|Period 1|Withdrawal by Subject|0|||
27585662|NCT02317575|80324558|FG002|Period 1|Withdrawal by Subject|0|||
27585663|NCT02317575|80324559|FG003|Period 1|Withdrawal by Subject|0|||
27585664|NCT02317575|80324560|FG004|Period 1|Withdrawal by Subject|0|||
27585665|NCT01197950|80324565|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
27585666|NCT01197950|80324566|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
27585667|NCT01197950|80324567|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
27585668|NCT04266028|80324575|FG000|Overall Study|Adverse Event|0|||
27585669|NCT04266028|80324576|FG001|Overall Study|Adverse Event|0|||
27585670|NCT04266028|80324577|FG002|Overall Study|Adverse Event|1|||
27585671|NCT04266028|80324578|FG003|Overall Study|Adverse Event|0|||
27585672|NCT04266028|80324579|FG004|Overall Study|Adverse Event|1|||
27585673|NCT04266028|80324580|FG005|Overall Study|Adverse Event|0|||
27585674|NCT04266028|80324581|FG006|Overall Study|Adverse Event|2|||
27585675|NCT04266028|80324582|FG007|Overall Study|Adverse Event|0|||
27585676|NCT04266028|80324575|FG000|Overall Study|temporary halt of the study|0|||
27585677|NCT04266028|80324576|FG001|Overall Study|temporary halt of the study|0|||
27585678|NCT04266028|80324577|FG002|Overall Study|temporary halt of the study|0|||
27585679|NCT04266028|80324578|FG003|Overall Study|temporary halt of the study|0|||
27585680|NCT04266028|80324579|FG004|Overall Study|temporary halt of the study|0|||
27585681|NCT04266028|80324580|FG005|Overall Study|temporary halt of the study|0|||
27585682|NCT04266028|80324581|FG006|Overall Study|temporary halt of the study|2|||
27585683|NCT04266028|80324582|FG007|Overall Study|temporary halt of the study|1|||
27585684|NCT04266028|80324575|FG000|Overall Study|Onset of birch pollen season|0|||
27585685|NCT04266028|80324576|FG001|Overall Study|Onset of birch pollen season|0|||
27585686|NCT04266028|80324577|FG002|Overall Study|Onset of birch pollen season|0|||
27585687|NCT04266028|80324578|FG003|Overall Study|Onset of birch pollen season|0|||
27585688|NCT04266028|80324579|FG004|Overall Study|Onset of birch pollen season|1|||
27585689|NCT04266028|80324580|FG005|Overall Study|Onset of birch pollen season|0|||
27585690|NCT04266028|80324581|FG006|Overall Study|Onset of birch pollen season|0|||
27585691|NCT04266028|80324582|FG007|Overall Study|Onset of birch pollen season|0|||
27585692|NCT01831089|80324588|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
27585693|NCT01831089|80324589|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
27585694|NCT01831089|80324590|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
27585695|NCT01831089|80324591|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
27585696|NCT01831089|80324592|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
27585697|NCT01831089|80324593|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
27585698|NCT01831089|80324588|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
27585699|NCT01831089|80324589|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
27585700|NCT01831089|80324590|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
27585701|NCT01831089|80324591|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
27585702|NCT01831089|80324592|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
27585703|NCT01831089|80324593|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
27585704|NCT01831089|80324588|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27585705|NCT01831089|80324589|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
27585706|NCT01831089|80324590|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27585707|NCT01831089|80324591|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27585708|NCT01831089|80324592|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27585709|NCT01831089|80324593|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
27585710|NCT01831089|80324588|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
27585711|NCT01831089|80324589|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
27585712|NCT01831089|80324590|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
27585713|NCT01831089|80324591|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
27585714|NCT01831089|80324592|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
27585715|NCT01831089|80324593|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
27585716|NCT01831089|80324588|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27585717|NCT01831089|80324589|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27809240|NCT01073020|81130819|FG001|Overall Study|Physician Decision|0|||
27874781|NCT00662649|81375272|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
27874782|NCT00662649|81375273|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
27874783|NCT00662649|81375274|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
27874784|NCT00662649|81375270|FG000|Core Study (24 Months)|Protocol Violation|5|||
27874785|NCT00662649|81375271|FG001|Core Study (24 Months)|Protocol Violation|5|||
27874786|NCT00662649|81375272|FG002|Core Study (24 Months)|Protocol Violation|4|||
27874787|NCT00662649|81375273|FG003|Core Study (24 Months)|Protocol Violation|0|||
27874788|NCT00662649|81375274|FG004|Core Study (24 Months)|Protocol Violation|0|||
27874789|NCT00662649|81375270|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
27585718|NCT01831089|80324590|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
27809241|NCT01073020|81130820|FG002|Overall Study|Physician Decision|2|||
27809242|NCT01073020|81130821|FG003|Overall Study|Physician Decision|0|||
27809243|NCT01073020|81130818|FG000|Overall Study|Death|0|||
27809244|NCT01073020|81130819|FG001|Overall Study|Death|1|||
27809245|NCT01073020|81130820|FG002|Overall Study|Death|0|||
27809246|NCT01073020|81130821|FG003|Overall Study|Death|0|||
27809247|NCT02614703|81130822|FG000|Overall Study|Withdrawal by Subject|7|||
27809248|NCT02614703|81130823|FG001|Overall Study|Withdrawal by Subject|1|||
27809249|NCT03035227|81130824|FG000|Overall Study|study stopped due to PI leaving institut|1|||
27809250|NCT03035227|81130825|FG001|Overall Study|study stopped due to PI leaving institut|1|||
27809251|NCT01165242|81130832|FG000|Overall Study|Unreachable Subjects|1|||
27874790|NCT00662649|81375271|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
27585719|NCT01831089|80324591|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27585720|NCT01831089|80324592|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27585721|NCT01831089|80324593|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
27585722|NCT01831089|80324588|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
27585723|NCT01831089|80324589|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
27585724|NCT01831089|80324590|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
27585725|NCT01831089|80324591|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
27585726|NCT01831089|80324592|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
27585727|NCT01831089|80324593|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
27585728|NCT01831089|80324588|FG000|Cohort III: Dose Level 3|Global end of study|0|||
27585729|NCT01831089|80324589|FG001|Cohort III: Dose Level 3|Global end of study|0|||
27874791|NCT00662649|81375272|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
27874792|NCT00662649|81375273|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
27585730|NCT01831089|80324590|FG002|Cohort III: Dose Level 3|Global end of study|1|||
27809252|NCT01165242|81130833|FG001|Overall Study|Unreachable Subjects|0|||
27809253|NCT01165242|81130834|FG002|Overall Study|Unreachable Subjects|0|||
27874793|NCT00662649|81375274|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
27874794|NCT00662649|81375270|FG000|Core Study (24 Months)|Death|1|||
27585731|NCT01831089|80324591|FG003|Cohort III: Dose Level 3|Global end of study|0|||
27585732|NCT01831089|80324592|FG004|Cohort III: Dose Level 3|Global end of study|0|||
27585733|NCT01831089|80324593|FG005|Cohort III: Dose Level 3|Global end of study|0|||
27585734|NCT01831089|80324588|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
27585735|NCT01831089|80324589|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
27585736|NCT01831089|80324590|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
27585737|NCT01831089|80324591|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
28005928|NCT00083889|81853621|FG001|Overall Study|Lack of Efficacy|219|||
28005929|NCT00083889|81853620|FG000|Overall Study|Decision of sponsor|32|||
27809254|NCT01165242|81130832|FG000|Overall Study|Incarcerated Subjects|0|||
27809255|NCT01165242|81130833|FG001|Overall Study|Incarcerated Subjects|1|||
27809256|NCT01165242|81130834|FG002|Overall Study|Incarcerated Subjects|0|||
27809257|NCT01165242|81130832|FG000|Overall Study|Visit 2 Declined by Subject|0|||
27809258|NCT01165242|81130833|FG001|Overall Study|Visit 2 Declined by Subject|0|||
27809259|NCT01165242|81130834|FG002|Overall Study|Visit 2 Declined by Subject|1|||
27809260|NCT01165242|81130832|FG000|Overall Study|Withdrawal by Subject|0|||
27809261|NCT01165242|81130833|FG001|Overall Study|Withdrawal by Subject|2|||
27809262|NCT01165242|81130834|FG002|Overall Study|Withdrawal by Subject|2|||
27809263|NCT01165242|81130832|FG000|Overall Study|Extended Holiday|0|||
27809264|NCT01165242|81130833|FG001|Overall Study|Extended Holiday|0|||
27809265|NCT01165242|81130834|FG002|Overall Study|Extended Holiday|1|||
27809266|NCT01165242|81130832|FG000|Overall Study|Lost to Follow-up|9|||
27809267|NCT01165242|81130833|FG001|Overall Study|Lost to Follow-up|7|||
27809268|NCT01165242|81130834|FG002|Overall Study|Lost to Follow-up|10|||
27809269|NCT00906347|81130845|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
27809270|NCT00906347|81130846|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
27809271|NCT00906347|81130845|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
27809272|NCT00906347|81130846|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
27809273|NCT00906347|81130845|FG000|Received Study Drug|Refused study drug|1|||
27809274|NCT00906347|81130846|FG001|Received Study Drug|Refused study drug|0|||
27809275|NCT00906347|81130845|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
27809276|NCT00906347|81130846|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
27809277|NCT01814761|81130847|FG000|Overall Study|Other Reasons|1|||
27809278|NCT01814761|81130848|FG001|Overall Study|Other Reasons|10|||
27809279|NCT01814761|81130847|FG000|Overall Study|Ocular Adverse Event|6|||
27809280|NCT01814761|81130848|FG001|Overall Study|Ocular Adverse Event|15|||
27809281|NCT01814761|81130847|FG000|Overall Study|Lost to Follow-up|1|||
27809282|NCT01814761|81130848|FG001|Overall Study|Lost to Follow-up|5|||
27809283|NCT02266706|81130849|FG000|Overall Study|Withdrawal by Subject|0|||
27809284|NCT02266706|81130850|FG001|Overall Study|Withdrawal by Subject|1|||
27809285|NCT02266706|81130851|FG002|Overall Study|Withdrawal by Subject|1|||
27809286|NCT02266706|81130852|FG003|Overall Study|Withdrawal by Subject|0|||
27809287|NCT02266706|81130853|FG004|Overall Study|Withdrawal by Subject|0|||
27809288|NCT02266706|81130854|FG005|Overall Study|Withdrawal by Subject|1|||
27809289|NCT02266706|81130855|FG006|Overall Study|Withdrawal by Subject|0|||
27809290|NCT02266706|81130856|FG007|Overall Study|Withdrawal by Subject|0|||
27809291|NCT02266706|81130857|FG008|Overall Study|Withdrawal by Subject|0|||
27809292|NCT02266706|81130849|FG000|Overall Study|Screen failure|0|||
27809293|NCT02266706|81130850|FG001|Overall Study|Screen failure|0|||
27809294|NCT02266706|81130851|FG002|Overall Study|Screen failure|0|||
27809295|NCT02266706|81130852|FG003|Overall Study|Screen failure|0|||
27809296|NCT02266706|81130853|FG004|Overall Study|Screen failure|0|||
27809297|NCT02266706|81130854|FG005|Overall Study|Screen failure|1|||
27809298|NCT02266706|81130855|FG006|Overall Study|Screen failure|1|||
27809299|NCT02266706|81130856|FG007|Overall Study|Screen failure|0|||
28005930|NCT00083889|81853621|FG001|Overall Study|Decision of sponsor|4|||
28005931|NCT00083889|81853620|FG000|Overall Study|Randomized: did not take study drug|0|||
27585738|NCT01831089|80324592|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
27809300|NCT02266706|81130857|FG008|Overall Study|Screen failure|0|||
27809301|NCT02266706|81130849|FG000|Overall Study|Enrollment in another study|0|||
27809302|NCT02266706|81130850|FG001|Overall Study|Enrollment in another study|0|||
27809303|NCT02266706|81130851|FG002|Overall Study|Enrollment in another study|0|||
27809304|NCT02266706|81130852|FG003|Overall Study|Enrollment in another study|1|||
27809305|NCT02266706|81130853|FG004|Overall Study|Enrollment in another study|0|||
27809306|NCT02266706|81130854|FG005|Overall Study|Enrollment in another study|0|||
27809307|NCT02266706|81130855|FG006|Overall Study|Enrollment in another study|0|||
28005932|NCT00083889|81853621|FG001|Overall Study|Randomized: did not take study drug|15|||
28005933|NCT00083889|81853620|FG000|Overall Study|Completed on marketed sunitinub|3|||
28005934|NCT00083889|81853621|FG001|Overall Study|Completed on marketed sunitinub|0|||
27809308|NCT02266706|81130856|FG007|Overall Study|Enrollment in another study|0|||
27809309|NCT02266706|81130857|FG008|Overall Study|Enrollment in another study|0|||
27809310|NCT01314703|81130858|FG000|Overall Study|screen failure and closed enrollment|8|||
27809311|NCT03487796|81130859|FG000|Overall Study|Lost to Follow-up|18|||
28005935|NCT00083889|81853620|FG000|Overall Study|Crossover to SU011248|0|||
28005936|NCT00083889|81853621|FG001|Overall Study|Crossover to SU011248|25|||
27809312|NCT03487796|81130860|FG001|Overall Study|Lost to Follow-up|6|||
27809313|NCT02764489|81130861|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
27809314|NCT02764489|81130862|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
27809315|NCT02764489|81130861|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
27809316|NCT02764489|81130862|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
27809317|NCT02764489|81130861|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
27809318|NCT02764489|81130862|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
27809319|NCT02764489|81130861|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
27874795|NCT00662649|81375271|FG001|Core Study (24 Months)|Death|0|||
27874796|NCT00662649|81375272|FG002|Core Study (24 Months)|Death|2|||
27874797|NCT00662649|81375273|FG003|Core Study (24 Months)|Death|0|||
27874798|NCT00662649|81375274|FG004|Core Study (24 Months)|Death|0|||
27874799|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
27874800|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
27874801|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
27874802|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
27874803|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
27874804|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
27874805|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
27874806|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
27874807|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
27874808|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
27874809|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
27874810|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
27874811|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
27874812|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
27874813|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
28005937|NCT02313766|81853622|FG000|Overall Study|surgery cancelled|1|||
28005938|NCT02313766|81853623|FG001|Overall Study|surgery cancelled|0|||
28005939|NCT02313766|81853624|FG002|Overall Study|surgery cancelled|0|||
28005940|NCT02313766|81853622|FG000|Overall Study|Lost to Follow-up|0|||
28005941|NCT02313766|81853623|FG001|Overall Study|Lost to Follow-up|2|||
28005942|NCT02313766|81853624|FG002|Overall Study|Lost to Follow-up|0|||
28005943|NCT02313766|81853622|FG000|Overall Study|Adverse Event|0|||
28005944|NCT02313766|81853623|FG001|Overall Study|Adverse Event|1|||
28005945|NCT02313766|81853624|FG002|Overall Study|Adverse Event|0|||
28005946|NCT00346216|81853626|FG000|Overall Study|Other|181|||
28005947|NCT00346216|81853627|FG001|Overall Study|Other|231|||
28005948|NCT00346216|81853628|FG002|Overall Study|Other|205|||
28005949|NCT00346216|81853626|FG000|Overall Study|No longer willing to participate|600|||
27809320|NCT02764489|81130862|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
27809321|NCT01847313|81130863|FG000|Overall Study|Death|0|||
28005950|NCT00346216|81853627|FG001|Overall Study|No longer willing to participate|606|||
28005951|NCT00346216|81853628|FG002|Overall Study|No longer willing to participate|585|||
28005952|NCT00346216|81853626|FG000|Overall Study|Withdrawal by Subject|661|||
28005953|NCT00346216|81853627|FG001|Overall Study|Withdrawal by Subject|692|||
28005954|NCT00346216|81853628|FG002|Overall Study|Withdrawal by Subject|651|||
28005955|NCT00346216|81853626|FG000|Overall Study|Lost to Follow-up|611|||
27874814|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
27874815|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
27874816|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
27874817|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
27874818|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
27874819|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
27874820|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
27874821|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
27809322|NCT01847313|81130864|FG001|Overall Study|Death|1|||
27809323|NCT01847313|81130863|FG000|Overall Study|Withdrawal by Subject|0|||
27809324|NCT01847313|81130864|FG001|Overall Study|Withdrawal by Subject|1|||
27809325|NCT03008460|81133864|FG000|Overall Study|Protocol deviation|0|||
27809326|NCT03008460|81133865|FG001|Overall Study|Protocol deviation|2|||
27809327|NCT03008460|81133864|FG000|Overall Study|Study drug not dispensed|0|||
27809328|NCT03008460|81133865|FG001|Overall Study|Study drug not dispensed|1|||
27809329|NCT03008460|81133864|FG000|Overall Study|Adverse Event|0|||
27809330|NCT03008460|81133865|FG001|Overall Study|Adverse Event|1|||
27809331|NCT03008460|81133864|FG000|Overall Study|Withdrawal by Subject|5|||
27809332|NCT03008460|81133865|FG001|Overall Study|Withdrawal by Subject|6|||
27809333|NCT03008460|81133864|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
27809334|NCT03008460|81133865|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
27809335|NCT03008460|81133864|FG000|Overall Study|End of study visit outside permitted time window|0|||
27809336|NCT03008460|81133865|FG001|Overall Study|End of study visit outside permitted time window|1|||
27809337|NCT03008460|81133864|FG000|Overall Study|Lost to Follow-up|1|||
27809338|NCT03008460|81133865|FG001|Overall Study|Lost to Follow-up|3|||
27809339|NCT04228302|81133870|FG000|Overall Study|Adverse Event|0|||
27809340|NCT04228302|81133871|FG001|Overall Study|Adverse Event|0|||
27809341|NCT04228302|81133872|FG002|Overall Study|Adverse Event|0|||
27809342|NCT04228302|81133873|FG003|Overall Study|Adverse Event|0|||
27809343|NCT04228302|81133874|FG004|Overall Study|Adverse Event|1|||
27809344|NCT04228302|81133875|FG005|Overall Study|Adverse Event|0|||
27809345|NCT01070966|81133879|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
27809346|NCT01070966|81133879|FG000|Participants for Safety Evaluation|Off-label use|9|||
27809347|NCT01070966|81133879|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
27809348|NCT01070966|81133879|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
27809349|NCT01070966|81133879|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
27809350|NCT01070966|81133879|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
27809351|NCT01070966|81133879|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
27874822|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
27874823|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
28005956|NCT00346216|81853627|FG001|Overall Study|Lost to Follow-up|588|||
28005957|NCT00346216|81853628|FG002|Overall Study|Lost to Follow-up|542|||
28005958|NCT00346216|81853626|FG000|Overall Study|Physician Decision|80|||
28005959|NCT00346216|81853627|FG001|Overall Study|Physician Decision|76|||
28005960|NCT00346216|81853628|FG002|Overall Study|Physician Decision|59|||
28005961|NCT00346216|81853626|FG000|Overall Study|Does not meet entrance criteria|13|||
28005962|NCT00346216|81853627|FG001|Overall Study|Does not meet entrance criteria|10|||
28005963|NCT00346216|81853628|FG002|Overall Study|Does not meet entrance criteria|8|||
28005964|NCT00346216|81853626|FG000|Overall Study|Death|189|||
28005965|NCT00346216|81853627|FG001|Overall Study|Death|192|||
28005966|NCT00346216|81853628|FG002|Overall Study|Death|228|||
28005967|NCT00346216|81853626|FG000|Overall Study|Study terminated by sponsor|11|||
28005968|NCT00346216|81853627|FG001|Overall Study|Study terminated by sponsor|4|||
28005969|NCT00346216|81853628|FG002|Overall Study|Study terminated by sponsor|8|||
27585739|NCT01831089|80324593|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
27809352|NCT01070966|81133879|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
27874824|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
27874825|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
27874826|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
28005970|NCT00346216|81853626|FG000|Overall Study|Missing Subject Summary Status|62|||
28005971|NCT00346216|81853627|FG001|Overall Study|Missing Subject Summary Status|61|||
27585740|NCT01831089|80324588|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
27684992|NCT02712905|80683644|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
28005972|NCT00346216|81853628|FG002|Overall Study|Missing Subject Summary Status|62|||
28005973|NCT03253393|81853629|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
28005974|NCT03253393|81853630|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
27874827|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
27874828|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
27874829|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
27874830|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
27874831|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
27874832|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
27874833|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
27874834|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
27874835|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
27874836|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
27874837|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
27874838|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
27874839|NCT00662649|81375270|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
27809353|NCT00252187|81133880|FG000|Overall Study|Adverse Event|3|||
27809354|NCT00252187|81133881|FG001|Overall Study|Adverse Event|1|||
27809355|NCT00252187|81133880|FG000|Overall Study|Withdrawal by Subject|1|||
27809356|NCT00252187|81133881|FG001|Overall Study|Withdrawal by Subject|0|||
27874840|NCT00662649|81375271|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
27874841|NCT00662649|81375272|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
27874842|NCT00662649|81375273|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
27874843|NCT00662649|81375274|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
27874844|NCT01199939|81375279|FG000|Overall Study|Adverse Event|4|||
27874845|NCT01199939|81375279|FG000|Overall Study|Protocol Violation|3|||
27874846|NCT01199939|81375279|FG000|Overall Study|Lost to Follow-up|2|||
28005975|NCT03253393|81853631|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
28005976|NCT00510835|81853632|FG000|Overall Study|Withdrawal by Subject|6|||
28005977|NCT00510835|81853633|FG001|Overall Study|Withdrawal by Subject|2|||
28005978|NCT00510835|81853634|FG002|Overall Study|Withdrawal by Subject|2|||
28005979|NCT03655132|81853635|FG000|Overall Study|Lost to Follow-up|2|||
28005980|NCT03655132|81853636|FG001|Overall Study|Lost to Follow-up|1|||
28005981|NCT03655132|81853635|FG000|Overall Study|Withdrawal by Subject|0|||
28005982|NCT03655132|81853636|FG001|Overall Study|Withdrawal by Subject|1|||
28005983|NCT03655132|81853635|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
28005984|NCT03655132|81853636|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
28005985|NCT04388111|81853641|FG000|Overall Study|Lost to Follow-up|5|||
28005986|NCT04388111|81853642|FG001|Overall Study|Lost to Follow-up|3|||
28005987|NCT04388111|81853641|FG000|Overall Study|Adverse Event|1|||
27809357|NCT04820842|81133891|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
27809358|NCT04820842|81133892|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
27809359|NCT04820842|81133893|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
27809360|NCT04820842|81133894|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
27809361|NCT04820842|81133895|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
27809362|NCT04820842|81133896|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
27809363|NCT04820842|81133897|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
27809364|NCT04820842|81133891|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
27809365|NCT04820842|81133892|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
27809366|NCT04820842|81133893|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
27809367|NCT04820842|81133894|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809368|NCT04820842|81133895|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809369|NCT04820842|81133896|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809370|NCT04820842|81133897|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809371|NCT04820842|81133891|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27809372|NCT04820842|81133892|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
27809373|NCT04820842|81133893|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27809374|NCT04820842|81133894|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27874847|NCT01199939|81375279|FG000|Overall Study|Reached a virologic endpoint|4|||
27874848|NCT02342678|81375280|FG000|Overall Study|Lost to Follow-up|0|||
27874849|NCT02342678|81375281|FG001|Overall Study|Lost to Follow-up|1|||
28005988|NCT04388111|81853642|FG001|Overall Study|Adverse Event|1|||
28005989|NCT04388111|81853641|FG000|Overall Study|Protocol Violation|2|||
28005990|NCT04388111|81853642|FG001|Overall Study|Protocol Violation|4|||
28005991|NCT04388111|81853641|FG000|Overall Study|Withdrawal by Subject|1|||
28005992|NCT04388111|81853642|FG001|Overall Study|Withdrawal by Subject|0|||
28005993|NCT03001557|81853643|FG000|Core Phase|Randomized but not treated|0|||
28005994|NCT03001557|81853644|FG001|Core Phase|Randomized but not treated|0|||
28005995|NCT03001557|81853645|FG002|Core Phase|Randomized but not treated|1|||
28005996|NCT03001557|81853646|FG003|Core Phase|Randomized but not treated|0|||
28005997|NCT03001557|81853647|FG004|Core Phase|Randomized but not treated|0|||
28005998|NCT03001557|81853648|FG005|Core Phase|Randomized but not treated|0|||
28005999|NCT03001557|81853649|FG006|Core Phase|Randomized but not treated|0|||
28006000|NCT03001557|81853650|FG007|Core Phase|Randomized but not treated|0|||
28006001|NCT03001557|81853643|FG000|Extension Phase|Adverse Event|0|||
28006002|NCT03001557|81853644|FG001|Extension Phase|Adverse Event|0|||
28006003|NCT03001557|81853645|FG002|Extension Phase|Adverse Event|0|||
28006004|NCT03001557|81853646|FG003|Extension Phase|Adverse Event|0|||
28006005|NCT03001557|81853647|FG004|Extension Phase|Adverse Event|0|||
28006006|NCT03001557|81853648|FG005|Extension Phase|Adverse Event|2|||
28006007|NCT03001557|81853649|FG006|Extension Phase|Adverse Event|0|||
28006008|NCT03001557|81853650|FG007|Extension Phase|Adverse Event|0|||
28006009|NCT03001557|81853643|FG000|Extension Phase|Withdrawal by Subject|0|||
28006010|NCT03001557|81853644|FG001|Extension Phase|Withdrawal by Subject|0|||
28006011|NCT03001557|81853645|FG002|Extension Phase|Withdrawal by Subject|0|||
28006012|NCT03001557|81853646|FG003|Extension Phase|Withdrawal by Subject|0|||
28006013|NCT03001557|81853647|FG004|Extension Phase|Withdrawal by Subject|0|||
28006014|NCT03001557|81853648|FG005|Extension Phase|Withdrawal by Subject|1|||
28006015|NCT03001557|81853649|FG006|Extension Phase|Withdrawal by Subject|5|||
28006016|NCT03001557|81853650|FG007|Extension Phase|Withdrawal by Subject|2|||
28006017|NCT03001557|81853643|FG000|Extension Phase|Lost to Follow-up|0|||
28006018|NCT03001557|81853644|FG001|Extension Phase|Lost to Follow-up|0|||
28006019|NCT03001557|81853645|FG002|Extension Phase|Lost to Follow-up|0|||
28006020|NCT03001557|81853646|FG003|Extension Phase|Lost to Follow-up|0|||
28006021|NCT03001557|81853647|FG004|Extension Phase|Lost to Follow-up|0|||
28006022|NCT03001557|81853648|FG005|Extension Phase|Lost to Follow-up|0|||
28006023|NCT03001557|81853649|FG006|Extension Phase|Lost to Follow-up|2|||
28006024|NCT03001557|81853650|FG007|Extension Phase|Lost to Follow-up|1|||
28006025|NCT03001557|81853643|FG000|Extension Phase|Administrative Reason|0|||
28006026|NCT03001557|81853644|FG001|Extension Phase|Administrative Reason|0|||
28006027|NCT03001557|81853645|FG002|Extension Phase|Administrative Reason|0|||
28006028|NCT03001557|81853646|FG003|Extension Phase|Administrative Reason|0|||
28006029|NCT03001557|81853647|FG004|Extension Phase|Administrative Reason|0|||
28006030|NCT03001557|81853648|FG005|Extension Phase|Administrative Reason|1|||
28006031|NCT03001557|81853649|FG006|Extension Phase|Administrative Reason|3|||
28006032|NCT03001557|81853650|FG007|Extension Phase|Administrative Reason|3|||
28006033|NCT03001557|81853643|FG000|Extension Phase|Loss of caregiver|0|||
27585741|NCT01831089|80324589|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
27585742|NCT01831089|80324590|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
27585743|NCT01831089|80324591|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
27585744|NCT01831089|80324592|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
27585745|NCT01831089|80324593|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
27585746|NCT01831089|80324588|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27874850|NCT02342678|81375280|FG000|Overall Study|Too busy to complete study|0|||
27874851|NCT02342678|81375281|FG001|Overall Study|Too busy to complete study|2|||
27874852|NCT02342678|81375280|FG000|Overall Study|Family illness/emergency|0|||
27874853|NCT02342678|81375281|FG001|Overall Study|Family illness/emergency|1|||
27874854|NCT02342678|81375280|FG000|Overall Study|Illness/medical reason|1|||
27874855|NCT02342678|81375281|FG001|Overall Study|Illness/medical reason|1|||
27874856|NCT02640482|81375285|FG000|Overall Study|Lost to Follow-up|3|||
27874857|NCT02640482|81375286|FG001|Overall Study|Lost to Follow-up|0|||
27874858|NCT02969044|81375291|FG000|Overall Study|Withdrawal by Subject|2|||
27874859|NCT02969044|81375292|FG001|Overall Study|Withdrawal by Subject|6|||
28006034|NCT03001557|81853644|FG001|Extension Phase|Loss of caregiver|0|||
28006035|NCT03001557|81853645|FG002|Extension Phase|Loss of caregiver|0|||
27874860|NCT02969044|81375291|FG000|Overall Study|Adverse Event|3|||
28006036|NCT03001557|81853646|FG003|Extension Phase|Loss of caregiver|0|||
28006037|NCT03001557|81853647|FG004|Extension Phase|Loss of caregiver|0|||
28006038|NCT03001557|81853648|FG005|Extension Phase|Loss of caregiver|0|||
28006039|NCT03001557|81853649|FG006|Extension Phase|Loss of caregiver|1|||
28006040|NCT03001557|81853650|FG007|Extension Phase|Loss of caregiver|0|||
27874861|NCT02969044|81375292|FG001|Overall Study|Adverse Event|0|||
28006041|NCT03001557|81853643|FG000|Extension Phase|Others|0|||
28006042|NCT03001557|81853644|FG001|Extension Phase|Others|0|||
28006043|NCT03001557|81853645|FG002|Extension Phase|Others|0|||
28006044|NCT03001557|81853646|FG003|Extension Phase|Others|0|||
28006045|NCT03001557|81853647|FG004|Extension Phase|Others|0|||
28006046|NCT03001557|81853648|FG005|Extension Phase|Others|1|||
28006047|NCT03001557|81853649|FG006|Extension Phase|Others|3|||
28006048|NCT03001557|81853650|FG007|Extension Phase|Others|0|||
28006049|NCT00703014|81853657|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
28006050|NCT00703014|81853658|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
28006051|NCT00703014|81853659|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
27809375|NCT04820842|81133895|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27809376|NCT04820842|81133896|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27809377|NCT04820842|81133897|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27809378|NCT04820842|81133891|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809379|NCT04820842|81133892|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809380|NCT04820842|81133893|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809381|NCT04820842|81133894|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
27809382|NCT04820842|81133895|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809383|NCT04820842|81133896|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
27809384|NCT04820842|81133897|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
27809385|NCT01214603|81133898|FG000|Overall Study|Adverse Event|0|||
27809386|NCT01214603|81133899|FG001|Overall Study|Adverse Event|0|||
27809387|NCT01214603|81133900|FG002|Overall Study|Adverse Event|1|||
27809388|NCT01214603|81133898|FG000|Overall Study|Death|1|||
28006052|NCT00703014|81853660|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
28006053|NCT00703014|81853657|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
28006054|NCT00703014|81853658|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
28006055|NCT00703014|81853659|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
27809389|NCT01214603|81133899|FG001|Overall Study|Death|0|||
27809390|NCT01214603|81133900|FG002|Overall Study|Death|0|||
27809391|NCT01214603|81133898|FG000|Overall Study|Progressive Disease|4|||
27809392|NCT01214603|81133899|FG001|Overall Study|Progressive Disease|1|||
27809393|NCT01214603|81133900|FG002|Overall Study|Progressive Disease|3|||
27809394|NCT01706198|81133901|FG000|Overall Study|Adverse Event|12|||
27809395|NCT01706198|81133902|FG001|Overall Study|Adverse Event|15|||
27809396|NCT01706198|81133901|FG000|Overall Study|Protocol Violation|7|||
27809397|NCT01706198|81133902|FG001|Overall Study|Protocol Violation|5|||
27809398|NCT01706198|81133901|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
27809399|NCT01706198|81133902|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
27809400|NCT01706198|81133901|FG000|Overall Study|Lost to Follow-up|97|||
27809401|NCT01706198|81133902|FG001|Overall Study|Lost to Follow-up|93|||
27809402|NCT01706198|81133901|FG000|Overall Study|Physician Decision|23|||
27809403|NCT01706198|81133902|FG001|Overall Study|Physician Decision|37|||
27809404|NCT01706198|81133901|FG000|Overall Study|Withdrawal by Subject|23|||
27809405|NCT01706198|81133902|FG001|Overall Study|Withdrawal by Subject|31|||
27809406|NCT02752776|81133903|FG000|Overall Study|Adverse Event|15|||
27809407|NCT02752776|81133904|FG001|Overall Study|Adverse Event|23|||
27809408|NCT02752776|81133905|FG002|Overall Study|Adverse Event|11|||
27809409|NCT02752776|81133903|FG000|Overall Study|Lack of Efficacy|2|||
27809410|NCT02752776|81133904|FG001|Overall Study|Lack of Efficacy|6|||
27809411|NCT02752776|81133905|FG002|Overall Study|Lack of Efficacy|14|||
27809412|NCT02752776|81133903|FG000|Overall Study|Lost to Follow-up|11|||
27809413|NCT02752776|81133904|FG001|Overall Study|Lost to Follow-up|12|||
27809414|NCT02752776|81133905|FG002|Overall Study|Lost to Follow-up|4|||
27809415|NCT02752776|81133903|FG000|Overall Study|Non-compliance with study treatment|0|||
27809416|NCT02752776|81133904|FG001|Overall Study|Non-compliance with study treatment|0|||
27809417|NCT02752776|81133905|FG002|Overall Study|Non-compliance with study treatment|1|||
27809418|NCT02752776|81133903|FG000|Overall Study|Physician Decision|2|||
27809419|NCT02752776|81133904|FG001|Overall Study|Physician Decision|6|||
27809420|NCT02752776|81133905|FG002|Overall Study|Physician Decision|2|||
27809421|NCT02752776|81133903|FG000|Overall Study|Pregnancy|1|||
27809422|NCT02752776|81133904|FG001|Overall Study|Pregnancy|6|||
28006056|NCT00703014|81853660|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
27585747|NCT01831089|80324589|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27809423|NCT02752776|81133905|FG002|Overall Study|Pregnancy|3|||
27809424|NCT02752776|81133903|FG000|Overall Study|Protocol Violation|10|||
27809425|NCT02752776|81133904|FG001|Overall Study|Protocol Violation|13|||
27809426|NCT02752776|81133905|FG002|Overall Study|Protocol Violation|6|||
27809427|NCT02752776|81133903|FG000|Overall Study|Subject/guardian decision|8|||
27809428|NCT02752776|81133904|FG001|Overall Study|Subject/guardian decision|6|||
27809429|NCT02752776|81133905|FG002|Overall Study|Subject/guardian decision|4|||
27809430|NCT02752776|81133903|FG000|Overall Study|Death|0|||
27809431|NCT02752776|81133904|FG001|Overall Study|Death|0|||
28006057|NCT00625131|81853666|FG000|Overall Study|Lost to Follow-up|3|||
27585748|NCT01831089|80324590|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27585749|NCT01831089|80324591|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27585750|NCT01831089|80324592|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
27585751|NCT01831089|80324593|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
27585752|NCT01831089|80324588|FG000|Cohort V: Dose Level 5|Death|0|||
27585753|NCT01831089|80324589|FG001|Cohort V: Dose Level 5|Death|0|||
27585754|NCT01831089|80324590|FG002|Cohort V: Dose Level 5|Death|0|||
27585755|NCT01831089|80324591|FG003|Cohort V: Dose Level 5|Death|0|||
27585756|NCT01831089|80324592|FG004|Cohort V: Dose Level 5|Death|1|||
27585757|NCT01831089|80324593|FG005|Cohort V: Dose Level 5|Death|0|||
27585758|NCT01831089|80324588|FG000|Cohort V: Dose Level 5|Global end of study|0|||
27585759|NCT01831089|80324589|FG001|Cohort V: Dose Level 5|Global end of study|0|||
28006058|NCT00625131|81853667|FG001|Overall Study|Lost to Follow-up|2|||
27809432|NCT02752776|81133905|FG002|Overall Study|Death|1|||
27809433|NCT02752776|81133903|FG000|Overall Study|Withdrawal by Subject|3|||
27809434|NCT02752776|81133904|FG001|Overall Study|Withdrawal by Subject|4|||
27809435|NCT02752776|81133905|FG002|Overall Study|Withdrawal by Subject|2|||
27809436|NCT02853929|81133906|FG000|Overall Study|Lost to Follow-up|3|||
27809437|NCT02853929|81133907|FG001|Overall Study|Lost to Follow-up|0|||
27809438|NCT02853929|81133906|FG000|Overall Study|Withdrawal by Subject|1|||
27809439|NCT02853929|81133907|FG001|Overall Study|Withdrawal by Subject|0|||
27809440|NCT02853929|81133906|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
27809441|NCT02853929|81133907|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
27809442|NCT04828161|81133908|FG000|Overall Study|Withdrawal by Subject|0|||
27809443|NCT04828161|81133909|FG001|Overall Study|Withdrawal by Subject|3|||
27809444|NCT04828161|81133910|FG002|Overall Study|Withdrawal by Subject|3|||
27809445|NCT04828161|81133911|FG003|Overall Study|Withdrawal by Subject|4|||
27809446|NCT04828161|81133908|FG000|Overall Study|Lost to Follow-up|1|||
27809447|NCT04828161|81133909|FG001|Overall Study|Lost to Follow-up|4|||
27809448|NCT04828161|81133910|FG002|Overall Study|Lost to Follow-up|2|||
27809449|NCT04828161|81133911|FG003|Overall Study|Lost to Follow-up|2|||
27809450|NCT04828161|81133908|FG000|Overall Study|Other|2|||
27809451|NCT04828161|81133909|FG001|Overall Study|Other|0|||
27809452|NCT04828161|81133910|FG002|Overall Study|Other|2|||
27809453|NCT04828161|81133911|FG003|Overall Study|Other|0|||
27809454|NCT04828161|81133908|FG000|Overall Study|Death|0|||
27809455|NCT04828161|81133909|FG001|Overall Study|Death|0|||
27809456|NCT04828161|81133910|FG002|Overall Study|Death|0|||
27809457|NCT04828161|81133911|FG003|Overall Study|Death|2|||
27809458|NCT01238822|81133912|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
27809459|NCT01688037|81133914|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
27809460|NCT01688037|81133915|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
27809461|NCT01688037|81133916|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
27809462|NCT01688037|81133914|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
27809463|NCT01688037|81133915|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
27809464|NCT01688037|81133916|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
27809465|NCT01688037|81133914|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
27809466|NCT01688037|81133915|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
27809467|NCT01688037|81133916|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
27809468|NCT01688037|81133914|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
27809469|NCT01688037|81133915|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
27809470|NCT01688037|81133916|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
27809471|NCT01688037|81133914|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
27809472|NCT01688037|81133915|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
27809473|NCT01688037|81133916|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
27809474|NCT01688037|81133914|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
27809475|NCT01688037|81133915|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
28006059|NCT00625131|81853668|FG002|Overall Study|Lost to Follow-up|0|||
28006060|NCT00625131|81853666|FG000|Overall Study|Withdrawal by Subject|1|||
28006061|NCT00625131|81853667|FG001|Overall Study|Withdrawal by Subject|0|||
28006062|NCT00625131|81853668|FG002|Overall Study|Withdrawal by Subject|5|||
27585760|NCT01831089|80324590|FG002|Cohort V: Dose Level 5|Global end of study|0|||
27809476|NCT01688037|81133916|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
27809477|NCT01688037|81133914|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
27809478|NCT01688037|81133915|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
28006063|NCT04050553|81853671|FG000|Period 1|Physician Decision|2|||
28006064|NCT04050553|81853672|FG001|Period 1|Physician Decision|2|||
28006065|NCT04050553|81853671|FG000|Period 1|Adverse Event|1|||
27585761|NCT01831089|80324591|FG003|Cohort V: Dose Level 5|Global end of study|0|||
27585762|NCT01831089|80324592|FG004|Cohort V: Dose Level 5|Global end of study|2|||
27809479|NCT01688037|81133916|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
28006066|NCT04050553|81853672|FG001|Period 1|Adverse Event|1|||
28006067|NCT04050553|81853671|FG000|Period 1|Withdrawal by Subject|0|||
28006068|NCT04050553|81853672|FG001|Period 1|Withdrawal by Subject|1|||
28006069|NCT04050553|81853671|FG000|Wash-out|Adverse Event|0|||
28006070|NCT04050553|81853672|FG001|Wash-out|Adverse Event|1|||
28006071|NCT04050553|81853671|FG000|Wash-out|Withdrawal by Subject|0|||
28006072|NCT04050553|81853672|FG001|Wash-out|Withdrawal by Subject|1|||
28006073|NCT02343263|81853673|FG000|Overall Study|Physician Decision|5|||
28006074|NCT02343263|81853674|FG001|Overall Study|Physician Decision|3|||
28006075|NCT02343263|81853675|FG002|Overall Study|Physician Decision|1|||
28006076|NCT02219464|81853679|FG000|Overall Study|Withdrawal by Subject|1|||
27809480|NCT01688037|81133914|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
27809481|NCT01688037|81133915|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
27809482|NCT01688037|81133916|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
27809483|NCT01688037|81133914|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
27809484|NCT01688037|81133915|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
27809485|NCT01688037|81133916|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
27809486|NCT01688037|81133914|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
27809487|NCT01688037|81133915|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
27809488|NCT01688037|81133916|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
27809489|NCT00613574|81133918|FG000|Overall Study|Adverse Event|3|||
27809490|NCT00613574|81133918|FG000|Overall Study|Lost to Follow-up|2|||
27809491|NCT00613574|81133918|FG000|Overall Study|Other|1|||
27809492|NCT02668783|81133919|FG000|Overall Study|Pregnancy|0|||
27809493|NCT02668783|81133920|FG001|Overall Study|Pregnancy|1|||
27809494|NCT02668783|81133919|FG000|Overall Study|Protocol Violation|2|||
27809495|NCT02668783|81133920|FG001|Overall Study|Protocol Violation|1|||
27809496|NCT02668783|81133919|FG000|Overall Study|Study terminated by sponsor|9|||
27809497|NCT02668783|81133920|FG001|Overall Study|Study terminated by sponsor|10|||
27809498|NCT02668783|81133919|FG000|Overall Study|Subject moved|1|||
27809499|NCT02668783|81133920|FG001|Overall Study|Subject moved|0|||
27809500|NCT02668783|81133919|FG000|Overall Study|Withdrawal by Subject|1|||
27809501|NCT02668783|81133920|FG001|Overall Study|Withdrawal by Subject|0|||
27809502|NCT02087046|81133921|FG000|Overall Study|Adverse Event|4|||
27809503|NCT02087046|81133921|FG000|Overall Study|Death|1|||
27809504|NCT02087046|81133921|FG000|Overall Study|Lost to Follow-up|3|||
27809505|NCT02087046|81133921|FG000|Overall Study|Withdrawal by Subject|2|||
27809506|NCT02087046|81133921|FG000|Overall Study|Physician Decision|1|||
27809507|NCT03507439|81133922|FG000|Overall Study|Other|2|||
27809508|NCT03507439|81133923|FG001|Overall Study|Other|1|||
27809509|NCT03507439|81133922|FG000|Overall Study|Withdrawal by Subject|1|||
27809510|NCT03507439|81133923|FG001|Overall Study|Withdrawal by Subject|0|||
27809511|NCT03507439|81133922|FG000|Overall Study|Death|1|||
28006077|NCT02219464|81853680|FG001|Overall Study|Withdrawal by Subject|0|||
28006078|NCT02219464|81853679|FG000|Overall Study|case cancelled|1|||
28006079|NCT02219464|81853680|FG001|Overall Study|case cancelled|0|||
28006080|NCT02219464|81853679|FG000|Overall Study|catheter malfunction|1|||
28006081|NCT02219464|81853680|FG001|Overall Study|catheter malfunction|0|||
28006082|NCT00713609|81853687|FG000|Overall Study|Adverse Event|2|||
28006083|NCT00713609|81853688|FG001|Overall Study|Adverse Event|0|||
28006084|NCT00713609|81853689|FG002|Overall Study|Adverse Event|2|||
28006085|NCT00713609|81853690|FG003|Overall Study|Adverse Event|2|||
28006086|NCT00713609|81853691|FG004|Overall Study|Adverse Event|3|||
28006087|NCT00713609|81853692|FG005|Overall Study|Adverse Event|1|||
28006088|NCT00713609|81853687|FG000|Overall Study|Lost to Follow-up|5|||
28006089|NCT00713609|81853688|FG001|Overall Study|Lost to Follow-up|7|||
27684993|NCT02712905|80683645|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
27809512|NCT03507439|81133923|FG001|Overall Study|Death|1|||
27809513|NCT01798485|81133924|FG000|Overall Study|Adverse Event|32|||
27809514|NCT01798485|81133925|FG001|Overall Study|Adverse Event|40|||
28006090|NCT00713609|81853689|FG002|Overall Study|Lost to Follow-up|5|||
28006091|NCT00713609|81853690|FG003|Overall Study|Lost to Follow-up|5|||
28006092|NCT00713609|81853691|FG004|Overall Study|Lost to Follow-up|7|||
28006093|NCT00713609|81853692|FG005|Overall Study|Lost to Follow-up|0|||
28006094|NCT00713609|81853687|FG000|Overall Study|Lack of Efficacy|1|||
28006095|NCT00713609|81853688|FG001|Overall Study|Lack of Efficacy|3|||
28006096|NCT00713609|81853689|FG002|Overall Study|Lack of Efficacy|0|||
28006097|NCT00713609|81853690|FG003|Overall Study|Lack of Efficacy|0|||
28006098|NCT00713609|81853691|FG004|Overall Study|Lack of Efficacy|1|||
28006099|NCT00713609|81853692|FG005|Overall Study|Lack of Efficacy|0|||
27684994|NCT02712905|80683646|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
27809515|NCT01798485|81133924|FG000|Overall Study|Withdrawal by Subject|27|||
27809516|NCT01798485|81133925|FG001|Overall Study|Withdrawal by Subject|31|||
27809517|NCT01798485|81133924|FG000|Overall Study|Lost to Follow-up|0|||
27809518|NCT01798485|81133925|FG001|Overall Study|Lost to Follow-up|3|||
27809519|NCT01798485|81133924|FG000|Overall Study|Physician Decision|14|||
27809520|NCT01798485|81133925|FG001|Overall Study|Physician Decision|10|||
27809521|NCT01798485|81133924|FG000|Overall Study|Objective Disease Progression|152|||
27809522|NCT01798485|81133925|FG001|Overall Study|Objective Disease Progression|106|||
28006100|NCT00713609|81853687|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
28006101|NCT00713609|81853688|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
27809523|NCT01798485|81133924|FG000|Overall Study|Death|25|||
27809524|NCT01798485|81133925|FG001|Overall Study|Death|22|||
27809525|NCT01798485|81133924|FG000|Overall Study|Sponsor Decision|61|||
27809526|NCT01798485|81133925|FG001|Overall Study|Sponsor Decision|54|||
27809527|NCT01798485|81133924|FG000|Overall Study|Clinical Progression|35|||
27809528|NCT01798485|81133925|FG001|Overall Study|Clinical Progression|24|||
27809529|NCT01007916|81133930|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
27809530|NCT01007916|81133931|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
27809531|NCT01007916|81133930|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
27809532|NCT01007916|81133931|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
27809533|NCT00753714|81133932|FG000|Overall Study|Lack of Efficacy|21|||
27809534|NCT00753714|81133933|FG001|Overall Study|Lack of Efficacy|34|||
27809535|NCT00753714|81133932|FG000|Overall Study|Adverse Event|26|||
27809536|NCT00753714|81133933|FG001|Overall Study|Adverse Event|18|||
28006102|NCT00713609|81853689|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
28006103|NCT00713609|81853690|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
28006104|NCT00713609|81853691|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
28006105|NCT00713609|81853692|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
28006106|NCT00713609|81853687|FG000|Overall Study|Withdrawal by Subject|6|||
28006107|NCT00713609|81853688|FG001|Overall Study|Withdrawal by Subject|1|||
28006108|NCT00713609|81853689|FG002|Overall Study|Withdrawal by Subject|5|||
28006109|NCT00713609|81853690|FG003|Overall Study|Withdrawal by Subject|1|||
28006110|NCT00713609|81853691|FG004|Overall Study|Withdrawal by Subject|5|||
28006111|NCT00713609|81853692|FG005|Overall Study|Withdrawal by Subject|7|||
28006112|NCT00713609|81853687|FG000|Overall Study|Protocol Violation|6|||
28006113|NCT00713609|81853688|FG001|Overall Study|Protocol Violation|3|||
28006114|NCT00713609|81853689|FG002|Overall Study|Protocol Violation|1|||
28006115|NCT00713609|81853690|FG003|Overall Study|Protocol Violation|1|||
28006116|NCT00713609|81853691|FG004|Overall Study|Protocol Violation|2|||
28006117|NCT00713609|81853692|FG005|Overall Study|Protocol Violation|0|||
28006118|NCT03309020|81853695|FG000|Overall Study|Death|1|||
28006119|NCT03309020|81853696|FG001|Overall Study|Death|0|||
28006120|NCT03309020|81853695|FG000|Overall Study|Did not undergo surgery|2|||
28006121|NCT03309020|81853696|FG001|Overall Study|Did not undergo surgery|1|||
28006122|NCT05482308|81853697|FG000|Overall Study|Withdrawal by Subject|1|||
28006123|NCT05482308|81853698|FG001|Overall Study|Withdrawal by Subject|0|||
27809537|NCT00753714|81133932|FG000|Overall Study|Protocol Violation|1|||
27809538|NCT00753714|81133933|FG001|Overall Study|Protocol Violation|0|||
27809539|NCT00753714|81133932|FG000|Overall Study|Lost to Follow-up|0|||
27809540|NCT00753714|81133933|FG001|Overall Study|Lost to Follow-up|1|||
28006124|NCT05482308|81853697|FG000|Overall Study|No longer meets eligibility criteria|0|||
28006125|NCT05482308|81853698|FG001|Overall Study|No longer meets eligibility criteria|1|||
28006126|NCT00918281|81853699|FG000|Overall Study|Physician Decision|29|||
28006127|NCT00001959|81853707|FG000|Overall Study|newly diagnosed colon cancer|1|||
28006128|NCT00001959|81853707|FG000|Overall Study|disabling sedation|1|||
28006129|NCT00001959|81853707|FG000|Overall Study|non-compliance|1|||
28006130|NCT04423718|81853708|FG000|Overall Study|Adverse Event|6|||
28006131|NCT04423718|81853709|FG001|Overall Study|Adverse Event|2|||
27809541|NCT00753714|81133932|FG000|Overall Study|Withdrawal by Subject|2|||
27809542|NCT00753714|81133933|FG001|Overall Study|Withdrawal by Subject|1|||
27809543|NCT00753714|81133932|FG000|Overall Study|Death|3|||
27809544|NCT00753714|81133933|FG001|Overall Study|Death|3|||
27809545|NCT00753714|81133932|FG000|Overall Study|Other|7|||
27809546|NCT00753714|81133933|FG001|Overall Study|Other|5|||
27809547|NCT03404206|81133934|FG000|Overall Study|Withdrawal by Subject|1|||
27809548|NCT03404206|81133935|FG001|Overall Study|Withdrawal by Subject|1|||
27809549|NCT03404206|81133936|FG002|Overall Study|Withdrawal by Subject|0|||
27809550|NCT03404206|81133934|FG000|Overall Study|Lost to Follow-up|3|||
27809551|NCT03404206|81133935|FG001|Overall Study|Lost to Follow-up|1|||
27809552|NCT03404206|81133936|FG002|Overall Study|Lost to Follow-up|0|||
27809553|NCT01078090|81133937|FG000|Overall Study|Lost to Follow-up|2363|||
27809554|NCT01078090|81133937|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
27809555|NCT01078090|81133937|FG000|Overall Study|Lack of Efficacy|1193|||
27874862|NCT02942017|81375293|FG000|Overall Study|Adverse Event|0|||
27809556|NCT01078090|81133937|FG000|Overall Study|ADR and lack of efficacy|61|||
28006132|NCT04423718|81853710|FG002|Overall Study|Adverse Event|5|||
28006133|NCT04423718|81853708|FG000|Overall Study|Physician Decision|1|||
28006134|NCT04423718|81853709|FG001|Overall Study|Physician Decision|4|||
28006135|NCT04423718|81853710|FG002|Overall Study|Physician Decision|1|||
28006136|NCT04423718|81853708|FG000|Overall Study|Protocol Violation|0|||
28006137|NCT04423718|81853709|FG001|Overall Study|Protocol Violation|1|||
27585763|NCT01831089|80324593|FG005|Cohort V: Dose Level 5|Global end of study|0|||
27809557|NCT01078090|81133937|FG000|Overall Study|Other|523|||
27809558|NCT01564758|81133938|FG000|Overall Study|Death|8|||
28006138|NCT04423718|81853710|FG002|Overall Study|Protocol Violation|1|||
27809559|NCT01564758|81133938|FG000|Overall Study|Adverse Event|3|||
28006139|NCT04423718|81853708|FG000|Overall Study|Lost to Follow-up|1|||
27809560|NCT01564758|81133938|FG000|Overall Study|Other|3|||
27809561|NCT01141283|81133940|FG000|Overall Study|Adverse Event|56|||
27809562|NCT01141283|81133940|FG000|Overall Study|Lost to Follow-up|4|||
27809563|NCT01141283|81133940|FG000|Overall Study|Withdrawal by Subject|14|||
27809564|NCT01141283|81133940|FG000|Overall Study|Administrative|4|||
27809565|NCT01141283|81133940|FG000|Overall Study|Lack of Efficacy|10|||
27809566|NCT01211769|81133941|FG000|Overall Study|Lost to Follow-up|7|||
27809567|NCT01211769|81133942|FG001|Overall Study|Lost to Follow-up|9|||
27809568|NCT01211769|81133943|FG002|Overall Study|Lost to Follow-up|5|||
27809569|NCT01211769|81133944|FG003|Overall Study|Lost to Follow-up|9|||
27809570|NCT01211769|81133941|FG000|Overall Study|Physician Decision|2|||
27809571|NCT01211769|81133942|FG001|Overall Study|Physician Decision|0|||
27809572|NCT01211769|81133943|FG002|Overall Study|Physician Decision|2|||
27809573|NCT01211769|81133944|FG003|Overall Study|Physician Decision|1|||
27809574|NCT01211769|81133941|FG000|Overall Study|Adverse Event|0|||
27809575|NCT01211769|81133942|FG001|Overall Study|Adverse Event|1|||
27809576|NCT01211769|81133943|FG002|Overall Study|Adverse Event|1|||
27809577|NCT01211769|81133944|FG003|Overall Study|Adverse Event|1|||
27809578|NCT02207621|81133945|FG000|Overall Study|Adverse Event|71|||
27809579|NCT02207621|81133946|FG001|Overall Study|Adverse Event|15|||
27809580|NCT02207621|81133947|FG002|Overall Study|Adverse Event|132|||
27809581|NCT02207621|81133945|FG000|Overall Study|Withdrawal by Subject|9|||
27809582|NCT02207621|81133946|FG001|Overall Study|Withdrawal by Subject|9|||
27809583|NCT02207621|81133947|FG002|Overall Study|Withdrawal by Subject|13|||
27809584|NCT02207621|81133945|FG000|Overall Study|Non-Compliant|3|||
28006140|NCT04423718|81853709|FG001|Overall Study|Lost to Follow-up|1|||
27684995|NCT02712905|80683629|FG000|Combination Therapy|Withdrawal by Subject|0|||
28006141|NCT04423718|81853710|FG002|Overall Study|Lost to Follow-up|2|||
28006142|NCT04423718|81853708|FG000|Overall Study|Lack of Efficacy|2|||
28006143|NCT04423718|81853709|FG001|Overall Study|Lack of Efficacy|0|||
28006144|NCT04423718|81853710|FG002|Overall Study|Lack of Efficacy|0|||
28006145|NCT04423718|81853708|FG000|Overall Study|Withdrawal by Subject|6|||
28006146|NCT04423718|81853709|FG001|Overall Study|Withdrawal by Subject|8|||
28006147|NCT04423718|81853710|FG002|Overall Study|Withdrawal by Subject|14|||
28006148|NCT04423718|81853708|FG000|Overall Study|Death|5|||
28006149|NCT04423718|81853709|FG001|Overall Study|Death|3|||
28006150|NCT04423718|81853710|FG002|Overall Study|Death|2|||
28006151|NCT04423718|81853708|FG000|Overall Study|COVID-19 pandemic|2|||
28006152|NCT04423718|81853709|FG001|Overall Study|COVID-19 pandemic|2|||
28006153|NCT04423718|81853710|FG002|Overall Study|COVID-19 pandemic|2|||
28006154|NCT04423718|81853708|FG000|Overall Study|Other|6|||
28006155|NCT04423718|81853709|FG001|Overall Study|Other|2|||
28006156|NCT04423718|81853710|FG002|Overall Study|Other|2|||
28006157|NCT04423718|81853708|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
28006158|NCT04423718|81853709|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
28006159|NCT04423718|81853710|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
27684996|NCT02712905|80683630|FG001|Combination Therapy|Withdrawal by Subject|0|||
27684997|NCT02712905|80683631|FG002|Combination Therapy|Withdrawal by Subject|0|||
27684998|NCT02712905|80683632|FG003|Combination Therapy|Withdrawal by Subject|0|||
27684999|NCT02712905|80683633|FG004|Combination Therapy|Withdrawal by Subject|0|||
27685000|NCT02712905|80683634|FG005|Combination Therapy|Withdrawal by Subject|0|||
27685001|NCT02712905|80683635|FG006|Combination Therapy|Withdrawal by Subject|0|||
27685002|NCT02712905|80683636|FG007|Combination Therapy|Withdrawal by Subject|0|||
27685003|NCT02712905|80683637|FG008|Combination Therapy|Withdrawal by Subject|0|||
27685004|NCT02712905|80683638|FG009|Combination Therapy|Withdrawal by Subject|0|||
27809585|NCT02207621|81133946|FG001|Overall Study|Non-Compliant|3|||
27809586|NCT02207621|81133947|FG002|Overall Study|Non-Compliant|1|||
27809587|NCT02207621|81133945|FG000|Overall Study|Lost to Follow-up|1|||
27809588|NCT02207621|81133946|FG001|Overall Study|Lost to Follow-up|0|||
27685005|NCT02712905|80683639|FG010|Combination Therapy|Withdrawal by Subject|0|||
27809589|NCT02207621|81133947|FG002|Overall Study|Lost to Follow-up|3|||
27809590|NCT02207621|81133945|FG000|Overall Study|Lack of Efficacy|10|||
27809591|NCT02207621|81133946|FG001|Overall Study|Lack of Efficacy|2|||
28006160|NCT00388349|81853711|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
28006161|NCT00388349|81853712|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
28006162|NCT00436332|81853713|FG000|Overall Study|Adverse Event|9|||
28006163|NCT00436332|81853713|FG000|Overall Study|Withdrawal by Subject|2|||
28006164|NCT00436332|81853713|FG000|Overall Study|Progression|59|||
28006165|NCT00436332|81853713|FG000|Overall Study|Death|2|||
27685006|NCT02712905|80683640|FG011|Combination Therapy|Withdrawal by Subject|0|||
27685007|NCT02712905|80683641|FG012|Combination Therapy|Withdrawal by Subject|0|||
27685008|NCT02712905|80683642|FG013|Combination Therapy|Withdrawal by Subject|0|||
27685009|NCT02712905|80683643|FG014|Combination Therapy|Withdrawal by Subject|0|||
27685010|NCT02712905|80683644|FG015|Combination Therapy|Withdrawal by Subject|1|||
27874863|NCT02942017|81375294|FG001|Overall Study|Adverse Event|1|||
27874864|NCT02942017|81375293|FG000|Overall Study|Withdrawal by Subject|0|||
27874865|NCT02942017|81375294|FG001|Overall Study|Withdrawal by Subject|1|||
27874866|NCT02942017|81375293|FG000|Overall Study|Lost to Follow-up|1|||
27874867|NCT02942017|81375294|FG001|Overall Study|Lost to Follow-up|1|||
27874868|NCT02942017|81375293|FG000|Overall Study|Randomized but not dosed|1|||
27874869|NCT02942017|81375294|FG001|Overall Study|Randomized but not dosed|3|||
27874870|NCT00654095|81375295|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
27874871|NCT00654095|81375295|FG000|Overall Study|Elevated triglyceride level (2)|1|||
27874872|NCT00654095|81375295|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
27874873|NCT00654095|81375295|FG000|Overall Study|Adverse Event|11|||
27874874|NCT00654095|81375295|FG000|Overall Study|Withdrawal by Subject|5|||
27874875|NCT00654095|81375295|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
27874876|NCT00654095|81375295|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
27874877|NCT00654095|81375295|FG000|Overall Study|Did not meet inclusion criteria|1|||
27874878|NCT00811733|81375296|FG000|Overall Study|Investigator Discretion|10|||
27874879|NCT00811733|81375297|FG001|Overall Study|Investigator Discretion|8|||
27874880|NCT00811733|81375296|FG000|Overall Study|Withdrawal by Subject|1|||
27874881|NCT00811733|81375297|FG001|Overall Study|Withdrawal by Subject|2|||
28006166|NCT00436332|81853713|FG000|Overall Study|Not Protocol Specified|6|||
28006167|NCT00436332|81853713|FG000|Overall Study|Ineligible|2|||
28006168|NCT00436332|81853713|FG000|Overall Study|Never Received Treatment|3|||
28006169|NCT00651924|81853714|FG000|Overall Study|Withdrawal by PI|0|||
28006170|NCT00651924|81853715|FG001|Overall Study|Withdrawal by PI|2|||
28006171|NCT00651924|81853714|FG000|Overall Study|Withdrawal by Subject|0|||
28006172|NCT00651924|81853715|FG001|Overall Study|Withdrawal by Subject|5|||
28006173|NCT00001832|81853717|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
28006174|NCT00001832|81853718|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
28006175|NCT00001832|81853719|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
28006176|NCT00001832|81853720|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
28006177|NCT00001832|81853721|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
27685011|NCT02712905|80683645|FG016|Combination Therapy|Withdrawal by Subject|0|||
27685012|NCT02712905|80683646|FG017|Combination Therapy|Withdrawal by Subject|2|||
27685013|NCT02712905|80683629|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685014|NCT02712905|80683630|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27809592|NCT02207621|81133947|FG002|Overall Study|Lack of Efficacy|4|||
27809593|NCT02207621|81133945|FG000|Overall Study|Disallowed Concurrent Medication|2|||
27809594|NCT02207621|81133946|FG001|Overall Study|Disallowed Concurrent Medication|5|||
27809595|NCT02207621|81133947|FG002|Overall Study|Disallowed Concurrent Medication|2|||
27809596|NCT02207621|81133945|FG000|Overall Study|Physician Decision|1|||
27809597|NCT02207621|81133946|FG001|Overall Study|Physician Decision|2|||
27809598|NCT02207621|81133947|FG002|Overall Study|Physician Decision|2|||
27809599|NCT02207621|81133945|FG000|Overall Study|Protocol Violation|4|||
27809600|NCT02207621|81133946|FG001|Overall Study|Protocol Violation|10|||
27809601|NCT02207621|81133947|FG002|Overall Study|Protocol Violation|6|||
27809602|NCT02207621|81133945|FG000|Overall Study|Death|2|||
27809603|NCT02207621|81133946|FG001|Overall Study|Death|0|||
27809604|NCT02207621|81133947|FG002|Overall Study|Death|0|||
27809605|NCT02207621|81133945|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
27809606|NCT02207621|81133946|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
27809607|NCT02207621|81133947|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
27809608|NCT00910858|81133948|FG000|Pharmacokinetic Phase|Adverse Event|1|||
27809609|NCT00910858|81133949|FG001|Pharmacokinetic Phase|Adverse Event|0|||
27809610|NCT00910858|81133950|FG002|Pharmacokinetic Phase|Adverse Event|0|||
27809611|NCT00910858|81133948|FG000|Monotherapy Phase|Adverse Event|3|||
27809612|NCT00910858|81133949|FG001|Monotherapy Phase|Adverse Event|2|||
27809613|NCT00910858|81133950|FG002|Monotherapy Phase|Adverse Event|0|||
27809614|NCT00910858|81133948|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
27809615|NCT00910858|81133949|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
27809616|NCT00910858|81133950|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
27809617|NCT00910858|81133948|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
27809618|NCT00910858|81133949|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
27809619|NCT00910858|81133950|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
27809620|NCT00910858|81133948|FG000|Monotherapy Phase|Protocol Violation|1|||
27874882|NCT02568189|81375298|FG000|Overall Study|Protocol Violation|0|||
27874883|NCT02568189|81375299|FG001|Overall Study|Protocol Violation|0|||
27874884|NCT02568189|81375300|FG002|Overall Study|Protocol Violation|19|||
27874885|NCT02568189|81375301|FG003|Overall Study|Protocol Violation|18|||
28006178|NCT00001832|81853722|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
28006179|NCT00001832|81853723|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
27874886|NCT04173507|81375307|FG000|Overall Study|On Treatment|3|||
27874887|NCT04173507|81375307|FG000|Overall Study|Adverse Event|3|||
27874888|NCT04173507|81375307|FG000|Overall Study|Progression/Relapse|34|||
27874889|NCT04173507|81375307|FG000|Overall Study|Death|2|||
27874890|NCT02347813|81375308|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
27685015|NCT02712905|80683631|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685016|NCT02712905|80683632|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685017|NCT02712905|80683633|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685018|NCT02712905|80683634|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685019|NCT02712905|80683635|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685020|NCT02712905|80683636|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685021|NCT02712905|80683637|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685022|NCT02712905|80683638|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685023|NCT02712905|80683639|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685024|NCT02712905|80683640|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685025|NCT02712905|80683641|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685026|NCT02712905|80683642|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27700996|NCT01241552|80741289|FG000|Overall Study|Withdrawal by Subject|7|||
27874891|NCT02347813|81375309|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
27874892|NCT02347813|81375308|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
27874893|NCT02347813|81375309|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
27809621|NCT00910858|81133949|FG001|Monotherapy Phase|Protocol Violation|0|||
27809622|NCT00910858|81133950|FG002|Monotherapy Phase|Protocol Violation|0|||
27809623|NCT00910858|81133948|FG000|Monotherapy Phase|Other|3|||
27809624|NCT00910858|81133949|FG001|Monotherapy Phase|Other|4|||
27809625|NCT00910858|81133950|FG002|Monotherapy Phase|Other|2|||
27809626|NCT00910858|81133948|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
27809627|NCT00910858|81133949|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
27809628|NCT00910858|81133950|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
27809629|NCT00910858|81133948|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
27809630|NCT00910858|81133949|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
27809631|NCT00910858|81133950|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
27809632|NCT00910858|81133948|FG000|Combined Treatment Phase|Protocol Violation|1|||
27809633|NCT00910858|81133949|FG001|Combined Treatment Phase|Protocol Violation|0|||
27809634|NCT00910858|81133950|FG002|Combined Treatment Phase|Protocol Violation|0|||
27809635|NCT00910858|81133948|FG000|Combined Treatment Phase|Other|0|||
27809636|NCT00910858|81133949|FG001|Combined Treatment Phase|Other|2|||
27809637|NCT00910858|81133950|FG002|Combined Treatment Phase|Other|1|||
27809638|NCT00467818|81133951|FG000|Overall Study|Adverse Event|1|||
27809639|NCT00467818|81133952|FG001|Overall Study|Adverse Event|0|||
27809640|NCT00467818|81133951|FG000|Overall Study|Lost to Follow-up|2|||
27809641|NCT00467818|81133952|FG001|Overall Study|Lost to Follow-up|2|||
27809642|NCT02497391|81133954|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
27809643|NCT02497391|81133955|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
27809644|NCT02497391|81133956|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
27809645|NCT02497391|81133957|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
27809646|NCT02497391|81133958|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
27809647|NCT02497391|81133959|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
27809648|NCT02497391|81133954|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
27809649|NCT02497391|81133955|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
27809650|NCT02497391|81133956|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
27809651|NCT02497391|81133957|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
27809652|NCT02497391|81133958|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
27809653|NCT02497391|81133959|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
27809654|NCT02497391|81133954|FG000|Period 3 (14 Days)|Adverse Event|0|||
27809655|NCT02497391|81133955|FG001|Period 3 (14 Days)|Adverse Event|1|||
27809656|NCT02497391|81133956|FG002|Period 3 (14 Days)|Adverse Event|0|||
27809657|NCT02497391|81133957|FG003|Period 3 (14 Days)|Adverse Event|0|||
27809658|NCT02497391|81133958|FG004|Period 3 (14 Days)|Adverse Event|0|||
27809659|NCT02497391|81133959|FG005|Period 3 (14 Days)|Adverse Event|0|||
27809660|NCT02497391|81133954|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
27809661|NCT02497391|81133955|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
27809662|NCT02497391|81133956|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
27809663|NCT02497391|81133957|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
27809664|NCT02497391|81133958|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
27809665|NCT02497391|81133959|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
27809666|NCT02497391|81133954|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
27809667|NCT02497391|81133955|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
27809668|NCT02497391|81133956|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
27809669|NCT02497391|81133957|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
27809670|NCT02497391|81133958|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
27809671|NCT02497391|81133959|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
27809672|NCT03072459|81133965|FG000|Overall Study|Device revised/removed|1|||
27809673|NCT03072459|81133965|FG000|Overall Study|Subject not able to return|1|||
27809674|NCT04079842|81133966|FG000|Overall Study|Request of subject|2|||
27809675|NCT04079842|81133966|FG000|Overall Study|Unable to draw Arterial samples|1|||
27809676|NCT01620489|81133975|FG000|Overall Study|Adverse Event|17|||
27809677|NCT01620489|81133976|FG001|Overall Study|Adverse Event|4|||
27809678|NCT01620489|81133975|FG000|Overall Study|Protocol Violation|0|||
27809679|NCT01620489|81133976|FG001|Overall Study|Protocol Violation|3|||
27809680|NCT01620489|81133975|FG000|Overall Study|Withdrawal Criteria|17|||
27809681|NCT01620489|81133976|FG001|Overall Study|Withdrawal Criteria|25|||
27809682|NCT01620489|81133975|FG000|Overall Study|Unclassified|1|||
27809683|NCT01620489|81133976|FG001|Overall Study|Unclassified|2|||
27809684|NCT02035137|81133977|FG000|Overall Study|Physician Decision|0|||
28006180|NCT00001832|81853724|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
28006181|NCT00001832|81853725|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
28006182|NCT00001832|81853726|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
28006183|NCT00001832|81853727|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
28006184|NCT00001832|81853728|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
28006185|NCT00001832|81853729|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
28006186|NCT00001832|81853730|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
27685027|NCT02712905|80683643|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685028|NCT02712905|80683644|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
27685029|NCT02712905|80683645|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685030|NCT02712905|80683646|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
27685031|NCT04677179|80683647|FG000|Induction Treatment Period|Adverse Event|1|||
27685032|NCT04677179|80683648|FG001|Induction Treatment Period|Adverse Event|0|||
27685033|NCT04677179|80683649|FG002|Induction Treatment Period|Adverse Event|0|||
27685034|NCT04677179|80683650|FG003|Induction Treatment Period|Adverse Event|0|||
27685035|NCT04677179|80683651|FG004|Induction Treatment Period|Adverse Event|0|||
27685036|NCT04677179|80683652|FG005|Induction Treatment Period|Adverse Event|0|||
27685037|NCT04677179|80683653|FG006|Induction Treatment Period|Adverse Event|0|||
27809685|NCT02035137|81133978|FG001|Overall Study|Physician Decision|0|||
27809686|NCT02035137|81133979|FG002|Overall Study|Physician Decision|1|||
27809687|NCT02035137|81133977|FG000|Overall Study|Withdrawal by Subject|0|||
27809688|NCT02035137|81133978|FG001|Overall Study|Withdrawal by Subject|1|||
27809689|NCT02035137|81133979|FG002|Overall Study|Withdrawal by Subject|2|||
27809690|NCT02035137|81133977|FG000|Overall Study|Ineligible|0|||
27809691|NCT02035137|81133978|FG001|Overall Study|Ineligible|1|||
27809692|NCT02035137|81133979|FG002|Overall Study|Ineligible|2|||
27809693|NCT02035137|81133977|FG000|Overall Study|Disease progression prior to treatment start|2|||
27809694|NCT02035137|81133978|FG001|Overall Study|Disease progression prior to treatment start|0|||
28006187|NCT00001832|81853731|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
28006188|NCT00001832|81853717|FG000|Treatment Period|Death during treatment|0|||
28006189|NCT00001832|81853718|FG001|Treatment Period|Death during treatment|0|||
28006190|NCT00001832|81853719|FG002|Treatment Period|Death during treatment|0|||
28006191|NCT00001832|81853720|FG003|Treatment Period|Death during treatment|0|||
28006192|NCT00001832|81853721|FG004|Treatment Period|Death during treatment|0|||
28006193|NCT00001832|81853722|FG005|Treatment Period|Death during treatment|1|||
28006194|NCT00001832|81853723|FG006|Treatment Period|Death during treatment|0|||
28006195|NCT00001832|81853724|FG007|Treatment Period|Death during treatment|0|||
28006196|NCT00001832|81853725|FG008|Treatment Period|Death during treatment|0|||
28006197|NCT00001832|81853726|FG009|Treatment Period|Death during treatment|0|||
28006198|NCT00001832|81853727|FG010|Treatment Period|Death during treatment|0|||
28006199|NCT00001832|81853728|FG011|Treatment Period|Death during treatment|0|||
28006200|NCT00001832|81853729|FG012|Treatment Period|Death during treatment|0|||
28006201|NCT00001832|81853730|FG013|Treatment Period|Death during treatment|0|||
28006202|NCT00001832|81853731|FG014|Treatment Period|Death during treatment|0|||
28006203|NCT00001832|81853717|FG000|Treatment Period|Not treated|0|||
28006204|NCT00001832|81853718|FG001|Treatment Period|Not treated|0|||
28006205|NCT00001832|81853719|FG002|Treatment Period|Not treated|0|||
28006206|NCT00001832|81853720|FG003|Treatment Period|Not treated|0|||
28006207|NCT00001832|81853721|FG004|Treatment Period|Not treated|0|||
28006208|NCT00001832|81853722|FG005|Treatment Period|Not treated|0|||
28006209|NCT00001832|81853723|FG006|Treatment Period|Not treated|0|||
28006210|NCT00001832|81853724|FG007|Treatment Period|Not treated|1|||
28006211|NCT00001832|81853725|FG008|Treatment Period|Not treated|0|||
28006212|NCT00001832|81853726|FG009|Treatment Period|Not treated|0|||
28006213|NCT00001832|81853727|FG010|Treatment Period|Not treated|0|||
28006214|NCT00001832|81853728|FG011|Treatment Period|Not treated|0|||
28006215|NCT00001832|81853729|FG012|Treatment Period|Not treated|0|||
28006216|NCT00001832|81853730|FG013|Treatment Period|Not treated|0|||
28006217|NCT00001832|81853731|FG014|Treatment Period|Not treated|0|||
28006218|NCT02636699|81853732|FG000|Overall Study|Adverse Event|4|||
28006219|NCT02636699|81853733|FG001|Overall Study|Adverse Event|0|||
28006220|NCT02636699|81853732|FG000|Overall Study|Lost to Follow-up|3|||
28006221|NCT02636699|81853733|FG001|Overall Study|Lost to Follow-up|3|||
28006222|NCT02636699|81853732|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
27809695|NCT02035137|81133979|FG002|Overall Study|Disease progression prior to treatment start|0|||
27874894|NCT00360282|81375310|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
27874895|NCT00360282|81375311|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
27585764|NCT01831089|80324588|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27809696|NCT00891293|81133983|FG000|Overall Study|Adverse Event|2|||
27809697|NCT00891293|81133983|FG000|Overall Study|Protocol Violation|2|||
27809698|NCT00891293|81133983|FG000|Overall Study|Laboratory abnormality|4|||
27809699|NCT00891293|81133983|FG000|Overall Study|Lost to Follow-up|7|||
27809700|NCT00891293|81133983|FG000|Overall Study|Subject withdrew consent|7|||
27585765|NCT01831089|80324589|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27585766|NCT01831089|80324590|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27585767|NCT01831089|80324591|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27585768|NCT01831089|80324592|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
27585769|NCT01831089|80324593|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
27585770|NCT01831089|80324588|FG000|Cohort B: Arm B|Progressive disease|0|||
27585771|NCT01831089|80324589|FG001|Cohort B: Arm B|Progressive disease|0|||
27585772|NCT01831089|80324590|FG002|Cohort B: Arm B|Progressive disease|0|||
27585773|NCT01831089|80324591|FG003|Cohort B: Arm B|Progressive disease|0|||
27585774|NCT01831089|80324592|FG004|Cohort B: Arm B|Progressive disease|0|||
27809701|NCT00891293|81133983|FG000|Overall Study|Sponsor termination|62|||
27809702|NCT02891200|81133984|FG000|Overall Study|Lost to Follow-up|31|||
27809703|NCT02891200|81133985|FG001|Overall Study|Lost to Follow-up|36|||
27585775|NCT01831089|80324593|FG005|Cohort B: Arm B|Progressive disease|8|||
27585776|NCT01831089|80324588|FG000|Cohort B: Arm B|Physician Decision|0|||
27585777|NCT01831089|80324589|FG001|Cohort B: Arm B|Physician Decision|0|||
27585778|NCT01831089|80324590|FG002|Cohort B: Arm B|Physician Decision|0|||
27585779|NCT01831089|80324591|FG003|Cohort B: Arm B|Physician Decision|0|||
27585780|NCT01831089|80324592|FG004|Cohort B: Arm B|Physician Decision|0|||
27585781|NCT01831089|80324593|FG005|Cohort B: Arm B|Physician Decision|2|||
27585782|NCT01831089|80324588|FG000|Cohort B: Arm B|Never treated|0|||
27585783|NCT01831089|80324589|FG001|Cohort B: Arm B|Never treated|0|||
27585784|NCT01831089|80324590|FG002|Cohort B: Arm B|Never treated|0|||
27585785|NCT01831089|80324591|FG003|Cohort B: Arm B|Never treated|0|||
27585786|NCT01831089|80324592|FG004|Cohort B: Arm B|Never treated|0|||
27585787|NCT01831089|80324593|FG005|Cohort B: Arm B|Never treated|2|||
27585788|NCT01831089|80324588|FG000|Cohort B: Arm B|Adverse Event|0|||
27585789|NCT01831089|80324589|FG001|Cohort B: Arm B|Adverse Event|0|||
27585790|NCT01831089|80324590|FG002|Cohort B: Arm B|Adverse Event|0|||
27585791|NCT01831089|80324591|FG003|Cohort B: Arm B|Adverse Event|0|||
27585792|NCT01831089|80324592|FG004|Cohort B: Arm B|Adverse Event|0|||
27585793|NCT01831089|80324593|FG005|Cohort B: Arm B|Adverse Event|1|||
27585794|NCT01831089|80324588|FG000|Cohort B: Arm B|Global end of study|0|||
27585795|NCT01831089|80324589|FG001|Cohort B: Arm B|Global end of study|0|||
27585796|NCT01831089|80324590|FG002|Cohort B: Arm B|Global end of study|0|||
27585797|NCT01831089|80324591|FG003|Cohort B: Arm B|Global end of study|0|||
27585798|NCT01831089|80324592|FG004|Cohort B: Arm B|Global end of study|0|||
27585799|NCT01831089|80324593|FG005|Cohort B: Arm B|Global end of study|1|||
27585800|NCT02613481|80324594|FG000|Overall Study|Lost to Follow-up|7|||
27585801|NCT02613481|80324594|FG000|Overall Study|Withdrawal by Subject|2|||
27585802|NCT02627677|80324601|FG000|Overall Study|Adverse event (not progressive disease)|1|||
27585803|NCT02627677|80324602|FG001|Overall Study|Adverse event (not progressive disease)|4|||
27585804|NCT02627677|80324603|FG002|Overall Study|Adverse event (not progressive disease)|1|||
27585805|NCT02627677|80324601|FG000|Overall Study|Progressive disease|1|||
27585806|NCT02627677|80324602|FG001|Overall Study|Progressive disease|3|||
27585807|NCT02627677|80324603|FG002|Overall Study|Progressive disease|0|||
27809704|NCT02891200|81133984|FG000|Overall Study|Death|10|||
27809705|NCT02891200|81133985|FG001|Overall Study|Death|9|||
27809706|NCT02891200|81133984|FG000|Overall Study|Withdrawal by Subject|1|||
27809707|NCT02891200|81133985|FG001|Overall Study|Withdrawal by Subject|4|||
27809708|NCT01873859|81133986|FG000|Overall Study|Withdrawal by Subject|0|||
27809709|NCT01873859|81133987|FG001|Overall Study|Withdrawal by Subject|4|||
27809710|NCT04104646|81133988|FG000|Overall Study|Withdrawal by Subject|1|||
27809711|NCT04104646|81133989|FG001|Overall Study|Withdrawal by Subject|1|||
27809712|NCT04104646|81133988|FG000|Overall Study|Lost to Follow-up|1|||
27585808|NCT02627677|80324601|FG000|Overall Study|Lack of Efficacy|1|||
27585809|NCT02627677|80324602|FG001|Overall Study|Lack of Efficacy|2|||
27685038|NCT04677179|80683654|FG007|Induction Treatment Period|Adverse Event|0|||
27585810|NCT02627677|80324603|FG002|Overall Study|Lack of Efficacy|0|||
27585811|NCT02627677|80324601|FG000|Overall Study|Lost to Follow-up|0|||
27585812|NCT02627677|80324602|FG001|Overall Study|Lost to Follow-up|0|||
27585813|NCT02627677|80324603|FG002|Overall Study|Lost to Follow-up|1|||
27809713|NCT04104646|81133989|FG001|Overall Study|Lost to Follow-up|0|||
27809714|NCT04104646|81133988|FG000|Overall Study|Physician Decision|2|||
27809715|NCT04104646|81133989|FG001|Overall Study|Physician Decision|0|||
27585814|NCT02627677|80324601|FG000|Overall Study|Pregnancy|0|||
27585815|NCT02627677|80324602|FG001|Overall Study|Pregnancy|1|||
27585816|NCT02627677|80324603|FG002|Overall Study|Pregnancy|0|||
27809716|NCT01736553|81133990|FG000|Overall Study|Death|12|||
27809717|NCT01736553|81133991|FG001|Overall Study|Death|0|||
27809718|NCT01736553|81133990|FG000|Overall Study|Withdrawal by Subject|5|||
27809719|NCT01736553|81133991|FG001|Overall Study|Withdrawal by Subject|2|||
27809720|NCT01736553|81133990|FG000|Overall Study|Lost to Follow-up|2|||
27809721|NCT01736553|81133991|FG001|Overall Study|Lost to Follow-up|2|||
27809722|NCT01772368|81134004|FG000|Overall Study|Adverse Event|1|||
27809723|NCT01772368|81134004|FG000|Overall Study|Withdrawal by Subject|3|||
27809724|NCT01772368|81134004|FG000|Overall Study|Protocol Violation|2|||
27809725|NCT01772368|81134004|FG000|Overall Study|Other|1|||
27809726|NCT00772577|81134005|FG000|Overall Study|Adverse Event|6|||
27809727|NCT00772577|81134006|FG001|Overall Study|Adverse Event|3|||
27809728|NCT00772577|81134005|FG000|Overall Study|Abnormal laboratory values|0|||
27809729|NCT00772577|81134006|FG001|Overall Study|Abnormal laboratory values|1|||
27809730|NCT00772577|81134005|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27809731|NCT00772577|81134006|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27809732|NCT00772577|81134005|FG000|Overall Study|Patient withdrew consent|8|||
27809733|NCT00772577|81134006|FG001|Overall Study|Patient withdrew consent|5|||
27809734|NCT00772577|81134005|FG000|Overall Study|Lost to Follow-up|4|||
27809735|NCT00772577|81134006|FG001|Overall Study|Lost to Follow-up|3|||
27809736|NCT00772577|81134005|FG000|Overall Study|Administrative problems|2|||
27809737|NCT00772577|81134006|FG001|Overall Study|Administrative problems|1|||
27809738|NCT00772577|81134005|FG000|Overall Study|Protocol Deviation|3|||
27809739|NCT00772577|81134006|FG001|Overall Study|Protocol Deviation|2|||
27809740|NCT01783483|81134008|FG000|Overall Study|Death|3|||
27809741|NCT01783483|81134009|FG001|Overall Study|Death|3|||
27809742|NCT01783483|81134008|FG000|Overall Study|Lost to Follow-up|14|||
27809743|NCT01783483|81134009|FG001|Overall Study|Lost to Follow-up|10|||
27809744|NCT01783483|81134008|FG000|Overall Study|Withdrawal by Subject|2|||
27809745|NCT01783483|81134009|FG001|Overall Study|Withdrawal by Subject|1|||
27809746|NCT01783483|81134008|FG000|Overall Study|Physician Decision|1|||
27809747|NCT01783483|81134009|FG001|Overall Study|Physician Decision|1|||
27809748|NCT00106028|81134010|FG000|Overall Study|Adverse Event|3|||
27809749|NCT00106028|81134011|FG001|Overall Study|Adverse Event|2|||
27809750|NCT00106028|81134010|FG000|Overall Study|Protocol Violation|1|||
27809751|NCT00106028|81134011|FG001|Overall Study|Protocol Violation|1|||
27809752|NCT00106028|81134010|FG000|Overall Study|Withdrawal by Subject|2|||
27809753|NCT00106028|81134011|FG001|Overall Study|Withdrawal by Subject|8|||
27809754|NCT00106028|81134010|FG000|Overall Study|Lost to Follow-up|0|||
27809755|NCT00106028|81134011|FG001|Overall Study|Lost to Follow-up|1|||
27809756|NCT01405950|81134012|FG000|Overall Study|Withdrawal by Subject|1|||
27809757|NCT01405950|81134013|FG001|Overall Study|Withdrawal by Subject|0|||
27809758|NCT01405950|81134014|FG002|Overall Study|Withdrawal by Subject|0|||
27809759|NCT01405950|81134015|FG003|Overall Study|Withdrawal by Subject|0|||
27809760|NCT02100956|81134016|FG000|At Least One Week Between Injections|Adverse Event|0|||
27809761|NCT02100956|81134017|FG001|At Least One Week Between Injections|Adverse Event|1|||
27809762|NCT01618305|81134018|FG000|Overall Study|Death|0|||
27809763|NCT01618305|81134019|FG001|Overall Study|Death|1|||
27809764|NCT01618305|81134018|FG000|Overall Study|Lost to Follow-up|11|||
27809765|NCT01618305|81134019|FG001|Overall Study|Lost to Follow-up|7|||
27809766|NCT01618305|81134018|FG000|Overall Study|Protocol Violation|1|||
27809767|NCT01618305|81134019|FG001|Overall Study|Protocol Violation|0|||
27809768|NCT01618305|81134018|FG000|Overall Study|Withdrawal by Subject|3|||
27809769|NCT01618305|81134019|FG001|Overall Study|Withdrawal by Subject|2|||
27809770|NCT01724359|81134020|FG000|Overall Study|Adverse Event|10|||
27809771|NCT01724359|81134020|FG000|Overall Study|Death|1|||
27809772|NCT01724359|81134020|FG000|Overall Study|Other|20|||
27809773|NCT02041494|81134021|FG000|Overall Study|Death|1|||
27809774|NCT02041494|81134022|FG001|Overall Study|Death|3|||
27809775|NCT02041494|81134021|FG000|Overall Study|Lost to Follow-up|2|||
27809776|NCT02041494|81134022|FG001|Overall Study|Lost to Follow-up|6|||
28006223|NCT02636699|81853733|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
28006224|NCT02636699|81853732|FG000|Overall Study|Physician Decision|0|||
28006225|NCT02636699|81853733|FG001|Overall Study|Physician Decision|1|||
28006226|NCT02636699|81853732|FG000|Overall Study|Withdrawal by Subject|13|||
28006227|NCT02636699|81853733|FG001|Overall Study|Withdrawal by Subject|6|||
28006228|NCT02636699|81853732|FG000|Overall Study|Other|3|||
28006229|NCT02636699|81853733|FG001|Overall Study|Other|1|||
28006230|NCT01358877|81853734|FG000|Overall Study|Death|80|||
28006231|NCT01358877|81853735|FG001|Overall Study|Death|89|||
28006232|NCT01358877|81853734|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
28006233|NCT01358877|81853735|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
27809777|NCT02041494|81134021|FG000|Overall Study|study terminated|16|||
27809778|NCT02041494|81134022|FG001|Overall Study|study terminated|11|||
27874896|NCT00360282|81375312|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
28006234|NCT01358877|81853734|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
28006235|NCT01358877|81853735|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
27809779|NCT01809314|81134023|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
27809780|NCT01809314|81134023|FG000|Overall Study|Adverse Event|6|||
27809781|NCT01809314|81134023|FG000|Overall Study|Insufficient Therapeutic Response|14|||
27585817|NCT02627677|80324601|FG000|Overall Study|Study Terminated by Sponsor|5|||
27585818|NCT02627677|80324602|FG001|Overall Study|Study Terminated by Sponsor|10|||
27585819|NCT02627677|80324603|FG002|Overall Study|Study Terminated by Sponsor|6|||
27585820|NCT02627677|80324601|FG000|Overall Study|Physician Decision|0|||
27585821|NCT02627677|80324602|FG001|Overall Study|Physician Decision|0|||
27585822|NCT02627677|80324603|FG002|Overall Study|Physician Decision|2|||
27585823|NCT02627677|80324601|FG000|Overall Study|Withdrawal by Subject|2|||
27585824|NCT02627677|80324602|FG001|Overall Study|Withdrawal by Subject|1|||
27585825|NCT02627677|80324603|FG002|Overall Study|Withdrawal by Subject|1|||
27585826|NCT02627677|80324601|FG000|Overall Study|Reason not Specified|0|||
27585827|NCT02627677|80324602|FG001|Overall Study|Reason not Specified|0|||
27585828|NCT02627677|80324603|FG002|Overall Study|Reason not Specified|1|||
27585829|NCT02627677|80324601|FG000|Overall Study|Randomized but not Treated|1|||
27585830|NCT02627677|80324602|FG001|Overall Study|Randomized but not Treated|0|||
27585831|NCT02627677|80324603|FG002|Overall Study|Randomized but not Treated|0|||
27585832|NCT01863680|80324604|FG000|Overall Study|Adverse Event|17|||
27585833|NCT01863680|80324604|FG000|Overall Study|Risk of OHSS|17|||
27585834|NCT01863680|80324604|FG000|Overall Study|Spontaneous pregnancy|2|||
27585835|NCT01863680|80324604|FG000|Overall Study|Withdrawal by Subject|1|||
27585836|NCT01863680|80324604|FG000|Overall Study|Did not undergo IVF/ET|14|||
27585837|NCT01863680|80324604|FG000|Overall Study|Other|6|||
27585838|NCT03067441|80324606|FG000|Overall Study|Withdrawal by Subject|16|||
27585839|NCT03067441|80324607|FG001|Overall Study|Withdrawal by Subject|34|||
27585840|NCT03067441|80324606|FG000|Overall Study|Lost to Follow-up|7|||
27585841|NCT03067441|80324607|FG001|Overall Study|Lost to Follow-up|5|||
27585842|NCT03067441|80324606|FG000|Overall Study|Adverse Event|7|||
27809782|NCT01809314|81134023|FG000|Overall Study|Lost to Follow-up|724|||
27809783|NCT00306384|81134030|FG000|Overall Study|Adverse Event|103|||
27809784|NCT00306384|81134031|FG001|Overall Study|Adverse Event|87|||
27809785|NCT00306384|81134032|FG002|Overall Study|Adverse Event|40|||
27809786|NCT00306384|81134030|FG000|Overall Study|Major protocol deviation|43|||
27809787|NCT00306384|81134031|FG001|Overall Study|Major protocol deviation|51|||
27809788|NCT00306384|81134032|FG002|Overall Study|Major protocol deviation|18|||
27809789|NCT00306384|81134030|FG000|Overall Study|Lost to Follow-up|57|||
27809790|NCT00306384|81134031|FG001|Overall Study|Lost to Follow-up|41|||
27809791|NCT00306384|81134032|FG002|Overall Study|Lost to Follow-up|35|||
27874897|NCT00360282|81375313|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
27585843|NCT03067441|80324607|FG001|Overall Study|Adverse Event|14|||
27809792|NCT00306384|81134030|FG000|Overall Study|Voluntary withdrawal|199|||
27809793|NCT00306384|81134031|FG001|Overall Study|Voluntary withdrawal|187|||
27809794|NCT00306384|81134032|FG002|Overall Study|Voluntary withdrawal|91|||
27809795|NCT00306384|81134030|FG000|Overall Study|Study termination|1|||
27809796|NCT00306384|81134031|FG001|Overall Study|Study termination|0|||
27809797|NCT00306384|81134032|FG002|Overall Study|Study termination|1|||
27809798|NCT00306384|81134030|FG000|Overall Study|Pregnancy|3|||
27809799|NCT00306384|81134031|FG001|Overall Study|Pregnancy|1|||
27809800|NCT00306384|81134032|FG002|Overall Study|Pregnancy|1|||
27809801|NCT00306384|81134030|FG000|Overall Study|Lack of Efficacy|26|||
27809802|NCT00306384|81134031|FG001|Overall Study|Lack of Efficacy|40|||
27809803|NCT00306384|81134032|FG002|Overall Study|Lack of Efficacy|38|||
27809804|NCT00306384|81134030|FG000|Overall Study|Investigator discretion|28|||
27809805|NCT00306384|81134031|FG001|Overall Study|Investigator discretion|31|||
27809806|NCT00306384|81134032|FG002|Overall Study|Investigator discretion|21|||
27809807|NCT00306384|81134030|FG000|Overall Study|Other|80|||
27809808|NCT00306384|81134031|FG001|Overall Study|Other|70|||
27809809|NCT00306384|81134032|FG002|Overall Study|Other|32|||
27809810|NCT00306384|81134030|FG000|Overall Study|Site closure|2|||
27809811|NCT00306384|81134031|FG001|Overall Study|Site closure|0|||
27874898|NCT00360282|81375310|FG000|Second Intervention|Adverse Event|0|||
27585844|NCT03067441|80324606|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
27585845|NCT03067441|80324607|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
27585846|NCT03067441|80324606|FG000|Overall Study|Physician Decision|1|||
27585847|NCT03067441|80324607|FG001|Overall Study|Physician Decision|3|||
27585848|NCT03067441|80324606|FG000|Overall Study|Other|1|||
27585849|NCT03067441|80324607|FG001|Overall Study|Other|1|||
27685039|NCT04677179|80683655|FG008|Induction Treatment Period|Adverse Event|0|||
27685040|NCT04677179|80683656|FG009|Induction Treatment Period|Adverse Event|0|||
27874899|NCT00360282|81375311|FG001|Second Intervention|Adverse Event|1|||
27585850|NCT03794089|80324608|FG000|Overall Study|Lost to Follow-up|4|||
27585851|NCT03794089|80324609|FG001|Overall Study|Lost to Follow-up|1|||
27585852|NCT03794089|80324608|FG000|Overall Study|Withdrawal by Subject|2|||
27585853|NCT03794089|80324609|FG001|Overall Study|Withdrawal by Subject|0|||
27585854|NCT01308580|80324610|FG000|Overall Study|Lost to Follow-up|12|||
27585855|NCT01308580|80324611|FG001|Overall Study|Lost to Follow-up|7|||
27585856|NCT01767116|80324615|FG000|Overall Study|Lost to Follow-up|2|||
27809812|NCT00306384|81134032|FG002|Overall Study|Site closure|0|||
27809813|NCT01214330|81134033|FG000|Overall Study|Withdrawal by Subject|2|||
27809814|NCT01214330|81134033|FG000|Overall Study|Withdrawal by Subject|2|||
27874900|NCT00360282|81375312|FG002|Second Intervention|Adverse Event|0|||
27809815|NCT03387059|81134042|FG000|Overall Study|Study termination|5|||
28006236|NCT01358877|81853734|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
28006237|NCT01358877|81853735|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
28006238|NCT01358877|81853734|FG000|Overall Study|Other|142|||
28006239|NCT01358877|81853735|FG001|Overall Study|Other|129|||
28006240|NCT03115359|81853736|FG000|Overall Study|Withdrawal by Subject|29|||
28006241|NCT03115359|81853737|FG001|Overall Study|Withdrawal by Subject|39|||
28006242|NCT03115359|81853736|FG000|Overall Study|Scheduling conflict|25|||
28006243|NCT03115359|81853737|FG001|Overall Study|Scheduling conflict|23|||
28006244|NCT03115359|81853736|FG000|Overall Study|Personal reasons including health|12|||
28006245|NCT03115359|81853737|FG001|Overall Study|Personal reasons including health|9|||
28006246|NCT03115359|81853736|FG000|Overall Study|Transportation barriers|3|||
28006247|NCT03115359|81853737|FG001|Overall Study|Transportation barriers|0|||
28006248|NCT03115359|81853736|FG000|Overall Study|No longer interested|5|||
28006249|NCT03115359|81853737|FG001|Overall Study|No longer interested|4|||
28006250|NCT03115359|81853736|FG000|Overall Study|No reason provided|45|||
28006251|NCT03115359|81853737|FG001|Overall Study|No reason provided|47|||
28006252|NCT04890652|81853741|FG000|Overall Study|Withdrawal by Subject|2|||
28006253|NCT03253796|81853742|FG000|Period 1: Run-In|Adverse Event|4|||
27585857|NCT01767116|80324616|FG001|Overall Study|Lost to Follow-up|2|||
28006254|NCT03253796|81853743|FG001|Period 1: Run-In|Adverse Event|0|||
28006255|NCT03253796|81853744|FG002|Period 1: Run-In|Adverse Event|0|||
28006256|NCT03253796|81853745|FG003|Period 1: Run-In|Adverse Event|0|||
28006257|NCT03253796|81853746|FG004|Period 1: Run-In|Adverse Event|0|||
28006258|NCT03253796|81853742|FG000|Period 1: Run-In|Lack of Efficacy|1|||
28006259|NCT03253796|81853743|FG001|Period 1: Run-In|Lack of Efficacy|0|||
28006260|NCT03253796|81853744|FG002|Period 1: Run-In|Lack of Efficacy|0|||
28006261|NCT03253796|81853745|FG003|Period 1: Run-In|Lack of Efficacy|0|||
28006262|NCT03253796|81853746|FG004|Period 1: Run-In|Lack of Efficacy|0|||
28006263|NCT03253796|81853742|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
28006264|NCT03253796|81853743|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
28006265|NCT03253796|81853744|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
28006266|NCT03253796|81853745|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
28006267|NCT03253796|81853746|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
28006268|NCT03253796|81853742|FG000|Period 1: Run-In|Protocol Violation|5|||
28006269|NCT03253796|81853743|FG001|Period 1: Run-In|Protocol Violation|0|||
27585858|NCT02039505|80324617|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
27809816|NCT03387059|81134043|FG001|Overall Study|Study termination|4|||
27809817|NCT00423800|81134044|FG000|Overall Study|Protocol Violation|0|||
27809818|NCT00423800|81134045|FG001|Overall Study|Protocol Violation|1|||
27809819|NCT01868009|81134046|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
27809820|NCT01868009|81134047|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
27809821|NCT01868009|81134046|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
27809822|NCT01868009|81134047|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
27809823|NCT01868009|81134046|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
27809824|NCT01868009|81134047|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
27809825|NCT02585258|81134053|FG000|Overall Study|Adverse Event|28|||
27809826|NCT02585258|81134054|FG001|Overall Study|Adverse Event|29|||
27809827|NCT02585258|81134053|FG000|Overall Study|Death|3|||
27809828|NCT02585258|81134054|FG001|Overall Study|Death|2|||
27809829|NCT02585258|81134053|FG000|Overall Study|Lack of Efficacy|7|||
27809830|NCT02585258|81134054|FG001|Overall Study|Lack of Efficacy|9|||
27809831|NCT02585258|81134053|FG000|Overall Study|includes covid-related access problems|42|||
27809832|NCT02585258|81134054|FG001|Overall Study|includes covid-related access problems|46|||
27809833|NCT02585258|81134053|FG000|Overall Study|Lost to Follow-up|5|||
27809834|NCT02585258|81134054|FG001|Overall Study|Lost to Follow-up|2|||
27809835|NCT01133392|81134055|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
27809836|NCT01133392|81134056|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
27809837|NCT01133392|81134055|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
27809838|NCT01133392|81134056|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
27809839|NCT00441584|81134057|FG000|Overall Study|Lack of Efficacy|79|||
27809840|NCT00441584|81134057|FG000|Overall Study|Withdrawal by Subject|8|||
27809841|NCT00441584|81134057|FG000|Overall Study|Adverse Event|6|||
28006270|NCT03253796|81853744|FG002|Period 1: Run-In|Protocol Violation|0|||
28006271|NCT03253796|81853745|FG003|Period 1: Run-In|Protocol Violation|0|||
28006272|NCT03253796|81853746|FG004|Period 1: Run-In|Protocol Violation|0|||
28006273|NCT03253796|81853742|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
28006274|NCT03253796|81853743|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
27585859|NCT02039505|80324618|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
27585860|NCT02039505|80324619|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
27809842|NCT00441584|81134057|FG000|Overall Study|Protocol Violation|5|||
27809843|NCT00441584|81134057|FG000|Overall Study|Lost to Follow-up|4|||
27809844|NCT00441584|81134057|FG000|Overall Study|Failure to meet eligibility criteria|3|||
27809845|NCT00909727|81134058|FG000|Overall Study|Adverse Event|1|||
28006275|NCT03253796|81853744|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
28006276|NCT03253796|81853745|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
28006277|NCT03253796|81853746|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
28006278|NCT03253796|81853742|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28006279|NCT03253796|81853743|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28006280|NCT03253796|81853744|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
28006281|NCT03253796|81853745|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28006282|NCT03253796|81853746|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
28006283|NCT03253796|81853742|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
28006284|NCT03253796|81853743|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
28006285|NCT03253796|81853744|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
28006286|NCT03253796|81853745|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
28006287|NCT03253796|81853746|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
28006288|NCT03253796|81853742|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
28006289|NCT03253796|81853743|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
28006290|NCT03253796|81853744|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
28006291|NCT03253796|81853745|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
28006292|NCT03253796|81853746|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
28006293|NCT03253796|81853742|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28006294|NCT03253796|81853743|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28006295|NCT03253796|81853744|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
28006296|NCT03253796|81853745|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28006297|NCT03253796|81853746|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
28006298|NCT03253796|81853742|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
28006299|NCT03253796|81853743|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
28006300|NCT03253796|81853744|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
28006301|NCT03253796|81853745|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
28006302|NCT03253796|81853746|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
28006303|NCT03253796|81853742|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28006304|NCT03253796|81853743|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28006305|NCT03253796|81853744|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
28006306|NCT03253796|81853745|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
27585861|NCT02039505|80324620|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27585862|NCT02039505|80324621|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27585863|NCT02039505|80324622|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27585864|NCT02039505|80324623|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
27585865|NCT02039505|80324617|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
27809846|NCT00909727|81134059|FG001|Overall Study|Adverse Event|0|||
27809847|NCT00909727|81134058|FG000|Overall Study|Wrong Genotype|1|||
27809848|NCT00909727|81134059|FG001|Overall Study|Wrong Genotype|0|||
27809849|NCT00909727|81134058|FG000|Overall Study|Withdrawal of Consent|1|||
27809850|NCT00909727|81134059|FG001|Overall Study|Withdrawal of Consent|0|||
27809851|NCT00909727|81134058|FG000|Overall Study|Prohibited Medication|1|||
27809852|NCT00909727|81134059|FG001|Overall Study|Prohibited Medication|0|||
27809853|NCT02482805|81134061|FG000|Overall Study|Lost to Follow-up|4|||
27809854|NCT02482805|81134062|FG001|Overall Study|Lost to Follow-up|4|||
27809855|NCT02482805|81134063|FG002|Overall Study|Lost to Follow-up|0|||
27809856|NCT02780700|81134064|FG000|Overall Study|Progressive disease|1|||
27809857|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
27809858|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
27809859|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
27809860|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
27809861|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
27809862|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
27809863|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
27809864|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
27809865|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
27809866|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
27809867|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
27809868|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
27809869|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
27809870|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
27809871|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
27809872|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
27874901|NCT00360282|81375313|FG003|Second Intervention|Adverse Event|0|||
27809873|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
27809874|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
27809875|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
27809876|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
27809877|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
27809878|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
27809879|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
27809880|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
27809881|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
27809882|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
27809883|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
27809884|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
27809885|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
27809886|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
27809887|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
27809888|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
27809889|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
27809890|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
27809891|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
27809892|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
27809893|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
27809894|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
27809895|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
27809896|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
27809897|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
27809898|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
27809899|NCT00606684|81134065|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
27809900|NCT00606684|81134066|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
27809901|NCT00606684|81134067|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
27809902|NCT00606684|81134068|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
27809903|NCT00606684|81134069|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
27809904|NCT00606684|81134070|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
27809905|NCT00606684|81134071|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
27809906|NCT00606684|81134065|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27809907|NCT00606684|81134066|FG001|Double-Blind Treatment Period|Adverse Event|3|||
27809908|NCT00606684|81134067|FG002|Double-Blind Treatment Period|Adverse Event|2|||
27809909|NCT00606684|81134068|FG003|Double-Blind Treatment Period|Adverse Event|4|||
27809910|NCT00606684|81134069|FG004|Double-Blind Treatment Period|Adverse Event|2|||
27809911|NCT00606684|81134070|FG005|Double-Blind Treatment Period|Adverse Event|0|||
27809912|NCT00606684|81134071|FG006|Double-Blind Treatment Period|Adverse Event|1|||
27809913|NCT00606684|81134065|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
27874902|NCT00273182|81375316|FG000|Overall Study|Death|450|||
27874903|NCT00273182|81375316|FG000|Overall Study|Lost to Follow-up|88|||
27874904|NCT00273182|81375316|FG000|Overall Study|Withdrawal by Subject|257|||
27874905|NCT00273182|81375316|FG000|Overall Study|Device/System Explant|154|||
27874906|NCT00273182|81375316|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
27874907|NCT02727478|81375319|FG000|Overall Study|Withdrawal by Subject|8|||
27874908|NCT02727478|81375320|FG001|Overall Study|Withdrawal by Subject|10|||
28006307|NCT03253796|81853746|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
28006308|NCT03095651|81853747|FG000|Overall Study|Lost to Follow-up|1|||
28006309|NCT03095651|81853748|FG001|Overall Study|Lost to Follow-up|1|||
28006310|NCT03095651|81853749|FG002|Overall Study|Lost to Follow-up|0|||
28006311|NCT03095651|81853750|FG003|Overall Study|Lost to Follow-up|1|||
28006312|NCT03095651|81853751|FG004|Overall Study|Lost to Follow-up|0|||
28006313|NCT03095651|81853752|FG005|Overall Study|Lost to Follow-up|0|||
28006314|NCT03095651|81853753|FG006|Overall Study|Lost to Follow-up|0|||
28006315|NCT03095651|81853754|FG007|Overall Study|Lost to Follow-up|0|||
28006316|NCT03095651|81853747|FG000|Overall Study|Withdrawal by Subject|0|||
28006317|NCT03095651|81853748|FG001|Overall Study|Withdrawal by Subject|0|||
28006318|NCT03095651|81853749|FG002|Overall Study|Withdrawal by Subject|0|||
28006319|NCT03095651|81853750|FG003|Overall Study|Withdrawal by Subject|0|||
28006320|NCT03095651|81853751|FG004|Overall Study|Withdrawal by Subject|0|||
28006321|NCT03095651|81853752|FG005|Overall Study|Withdrawal by Subject|1|||
27585866|NCT02039505|80324618|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
27585867|NCT02039505|80324619|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
27585868|NCT02039505|80324620|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27585869|NCT02039505|80324621|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27585870|NCT02039505|80324622|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27809914|NCT00606684|81134066|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
27809915|NCT00606684|81134067|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
27809916|NCT00606684|81134068|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
27809917|NCT00606684|81134069|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
27809918|NCT00606684|81134070|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
27809919|NCT00606684|81134071|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
27809920|NCT00606684|81134065|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27809921|NCT00606684|81134066|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
27809922|NCT00606684|81134067|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
27585871|NCT02039505|80324623|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
27585872|NCT02039505|80324617|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
27585873|NCT02039505|80324618|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27585874|NCT02039505|80324619|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27585875|NCT02039505|80324620|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27809923|NCT00606684|81134068|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
27809924|NCT00606684|81134069|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
27809925|NCT00606684|81134070|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
27809926|NCT00606684|81134071|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
27809927|NCT00606684|81134065|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
27809928|NCT00606684|81134066|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
27809929|NCT00606684|81134067|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
27809930|NCT00606684|81134068|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
27809931|NCT00606684|81134069|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
27809932|NCT00606684|81134070|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
27809933|NCT00606684|81134071|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
27809934|NCT00606684|81134065|FG000|Double-Blind Treatment Period|Physician Decision|0|||
27809935|NCT00606684|81134066|FG001|Double-Blind Treatment Period|Physician Decision|5|||
27809936|NCT00606684|81134067|FG002|Double-Blind Treatment Period|Physician Decision|1|||
27585876|NCT02039505|80324621|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27585877|NCT02039505|80324622|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27809937|NCT00606684|81134068|FG003|Double-Blind Treatment Period|Physician Decision|0|||
27809938|NCT00606684|81134069|FG004|Double-Blind Treatment Period|Physician Decision|3|||
27809939|NCT00606684|81134070|FG005|Double-Blind Treatment Period|Physician Decision|1|||
27809940|NCT00606684|81134071|FG006|Double-Blind Treatment Period|Physician Decision|2|||
27809941|NCT00606684|81134065|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27809942|NCT00606684|81134066|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27809943|NCT00606684|81134067|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27809944|NCT00606684|81134068|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27809945|NCT00606684|81134069|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27809946|NCT00606684|81134070|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27809947|NCT00606684|81134071|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27809948|NCT01001169|81134072|FG000|Overall Study|Withdrawal by Subject|2|||
27809949|NCT01001169|81134073|FG001|Overall Study|Withdrawal by Subject|1|||
27809950|NCT00634179|81134074|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
27809951|NCT00321711|81134075|FG000|Part A|Adverse Event|3|||
27809952|NCT00321711|81134076|FG001|Part A|Adverse Event|3|||
27809953|NCT00321711|81134077|FG002|Part A|Adverse Event|2|||
27809954|NCT00321711|81134078|FG003|Part A|Adverse Event|0|||
27809955|NCT00321711|81134079|FG004|Part A|Adverse Event|0|||
27809956|NCT00321711|81134075|FG000|Part A|Withdrawal by Subject|1|||
27809957|NCT00321711|81134076|FG001|Part A|Withdrawal by Subject|1|||
27809958|NCT00321711|81134077|FG002|Part A|Withdrawal by Subject|1|||
27809959|NCT00321711|81134078|FG003|Part A|Withdrawal by Subject|0|||
27809960|NCT00321711|81134079|FG004|Part A|Withdrawal by Subject|0|||
27809961|NCT00321711|81134075|FG000|Part A|Disease progression|0|||
27809962|NCT00321711|81134076|FG001|Part A|Disease progression|1|||
27809963|NCT00321711|81134077|FG002|Part A|Disease progression|0|||
27809964|NCT00321711|81134078|FG003|Part A|Disease progression|0|||
27809965|NCT00321711|81134079|FG004|Part A|Disease progression|0|||
27809966|NCT00321711|81134075|FG000|Part A|Requirement for alternative therapy|0|||
27874909|NCT04688671|81375322|FG000|Overall Study|Adverse Event|3|||
27874910|NCT04688671|81375323|FG001|Overall Study|Adverse Event|1|||
27809967|NCT00321711|81134076|FG001|Part A|Requirement for alternative therapy|2|||
27809968|NCT00321711|81134077|FG002|Part A|Requirement for alternative therapy|1|||
27809969|NCT00321711|81134078|FG003|Part A|Requirement for alternative therapy|0|||
27809970|NCT00321711|81134079|FG004|Part A|Requirement for alternative therapy|0|||
27809971|NCT00321711|81134075|FG000|Part A|Physician Decision|0|||
27585878|NCT02039505|80324623|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
27585879|NCT02039505|80324617|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27585880|NCT02039505|80324618|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27585881|NCT02039505|80324619|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27585882|NCT02039505|80324620|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
27585883|NCT02039505|80324621|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
27585884|NCT02039505|80324622|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
27585885|NCT02039505|80324623|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
27585886|NCT02039505|80324617|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27585887|NCT02039505|80324618|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27585888|NCT02039505|80324619|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27585889|NCT02039505|80324620|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
27585890|NCT02039505|80324621|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
27585891|NCT02039505|80324622|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
27585892|NCT02039505|80324623|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
27585893|NCT02039505|80324617|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27585894|NCT02039505|80324618|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27585895|NCT02039505|80324619|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27585896|NCT02039505|80324620|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
27585897|NCT02039505|80324621|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
27585898|NCT02039505|80324622|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
27585899|NCT02039505|80324623|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
27585900|NCT02039505|80324617|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27585901|NCT02039505|80324618|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27585902|NCT02039505|80324619|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27585903|NCT02039505|80324620|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
27585904|NCT02039505|80324621|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27585905|NCT02039505|80324622|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27585906|NCT02039505|80324623|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
27585907|NCT02039505|80324617|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27585908|NCT02039505|80324618|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27585909|NCT02039505|80324619|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27585910|NCT02039505|80324620|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27585911|NCT02039505|80324621|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27585912|NCT02039505|80324622|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
27585913|NCT02039505|80324623|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
27585914|NCT02039505|80324617|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27585915|NCT02039505|80324618|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27585916|NCT02039505|80324619|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27585917|NCT02039505|80324620|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27585918|NCT02039505|80324621|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27585919|NCT02039505|80324622|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
27585920|NCT02039505|80324623|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
27585921|NCT02039505|80324617|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27585922|NCT02039505|80324618|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27585923|NCT02039505|80324619|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27585924|NCT02039505|80324620|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27585925|NCT02039505|80324621|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27585926|NCT02039505|80324622|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
27585927|NCT02039505|80324623|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
28006322|NCT03095651|81853753|FG006|Overall Study|Withdrawal by Subject|0|||
28006323|NCT03095651|81853754|FG007|Overall Study|Withdrawal by Subject|0|||
28006324|NCT03617172|81853755|FG000|Overall Study|Lost to Follow-up|1|||
28006325|NCT03617172|81853756|FG001|Overall Study|Lost to Follow-up|0|||
28006326|NCT01075243|81853757|FG000|Overall Study|Lost to Follow-up|5|||
28006327|NCT01075243|81853758|FG001|Overall Study|Lost to Follow-up|2|||
28006328|NCT01075243|81853759|FG002|Overall Study|Lost to Follow-up|0|||
28006329|NCT01075243|81853757|FG000|Overall Study|Withdrawal by Subject|1|||
28006330|NCT01075243|81853758|FG001|Overall Study|Withdrawal by Subject|1|||
28006331|NCT01075243|81853759|FG002|Overall Study|Withdrawal by Subject|0|||
28006332|NCT02648204|81853762|FG000|Overall Study|Withdrawal by Subject|12|||
28006333|NCT02648204|81853763|FG001|Overall Study|Withdrawal by Subject|8|||
28006334|NCT02648204|81853764|FG002|Overall Study|Withdrawal by Subject|2|||
28006335|NCT02648204|81853765|FG003|Overall Study|Withdrawal by Subject|6|||
28006336|NCT02648204|81853762|FG000|Overall Study|Lost to Follow-up|5|||
28006337|NCT02648204|81853763|FG001|Overall Study|Lost to Follow-up|8|||
28006338|NCT02648204|81853764|FG002|Overall Study|Lost to Follow-up|4|||
28006339|NCT02648204|81853765|FG003|Overall Study|Lost to Follow-up|6|||
28006340|NCT02648204|81853762|FG000|Overall Study|Missing follow-up information|4|||
28006341|NCT02648204|81853763|FG001|Overall Study|Missing follow-up information|4|||
28006342|NCT02648204|81853764|FG002|Overall Study|Missing follow-up information|4|||
28006343|NCT02648204|81853765|FG003|Overall Study|Missing follow-up information|2|||
28006344|NCT02648204|81853762|FG000|Overall Study|Death|1|||
28006345|NCT02648204|81853763|FG001|Overall Study|Death|1|||
28006346|NCT02648204|81853764|FG002|Overall Study|Death|2|||
28006347|NCT02648204|81853765|FG003|Overall Study|Death|2|||
28006348|NCT02648204|81853762|FG000|Overall Study|Adverse Event|0|||
28006349|NCT02648204|81853763|FG001|Overall Study|Adverse Event|0|||
28006350|NCT02648204|81853764|FG002|Overall Study|Adverse Event|1|||
28006351|NCT02648204|81853765|FG003|Overall Study|Adverse Event|0|||
28006352|NCT00928486|81853766|FG000|Overall Study|Adverse Event|2|||
28006353|NCT00928486|81853766|FG000|Overall Study|Disease Progression|7|||
28006354|NCT00928486|81853766|FG000|Overall Study|Withdrawal by Subject|1|||
27809972|NCT00321711|81134076|FG001|Part A|Physician Decision|1|||
27809973|NCT00321711|81134077|FG002|Part A|Physician Decision|3|||
27809974|NCT00321711|81134078|FG003|Part A|Physician Decision|0|||
27809975|NCT00321711|81134079|FG004|Part A|Physician Decision|0|||
27809976|NCT00321711|81134075|FG000|Part A|Other|1|||
27809977|NCT00321711|81134076|FG001|Part A|Other|2|||
27809978|NCT00321711|81134077|FG002|Part A|Other|3|||
27809979|NCT00321711|81134078|FG003|Part A|Other|0|||
27809980|NCT00321711|81134079|FG004|Part A|Other|0|||
27809981|NCT00321711|81134075|FG000|Part A|Protocol deviation|0|||
27809982|NCT00321711|81134076|FG001|Part A|Protocol deviation|0|||
27809983|NCT00321711|81134077|FG002|Part A|Protocol deviation|1|||
27809984|NCT00321711|81134078|FG003|Part A|Protocol deviation|0|||
27809985|NCT00321711|81134079|FG004|Part A|Protocol deviation|0|||
27809986|NCT00321711|81134075|FG000|Part B|Noncompliance|0|||
27809987|NCT00321711|81134076|FG001|Part B|Noncompliance|0|||
27809988|NCT00321711|81134077|FG002|Part B|Noncompliance|0|||
27809989|NCT00321711|81134078|FG003|Part B|Noncompliance|0|||
27809990|NCT00321711|81134079|FG004|Part B|Noncompliance|1|||
27809991|NCT00321711|81134075|FG000|Part B|Adverse Event|0|||
27809992|NCT00321711|81134076|FG001|Part B|Adverse Event|0|||
27809993|NCT00321711|81134077|FG002|Part B|Adverse Event|0|||
27809994|NCT00321711|81134078|FG003|Part B|Adverse Event|2|||
27809995|NCT00321711|81134079|FG004|Part B|Adverse Event|1|||
27809996|NCT00321711|81134075|FG000|Part B|Disease progression|0|||
27809997|NCT00321711|81134076|FG001|Part B|Disease progression|0|||
27809998|NCT00321711|81134077|FG002|Part B|Disease progression|0|||
27809999|NCT00321711|81134078|FG003|Part B|Disease progression|1|||
27810000|NCT00321711|81134079|FG004|Part B|Disease progression|0|||
27810001|NCT00321711|81134075|FG000|Part B|Physician Decision|0|||
27810002|NCT00321711|81134076|FG001|Part B|Physician Decision|0|||
27810003|NCT00321711|81134077|FG002|Part B|Physician Decision|0|||
27810004|NCT00321711|81134078|FG003|Part B|Physician Decision|1|||
27810005|NCT00321711|81134079|FG004|Part B|Physician Decision|2|||
28006355|NCT01746368|81853767|FG000|Overall Study|Lost to Follow-up|2|||
28006356|NCT01746368|81853768|FG001|Overall Study|Lost to Follow-up|0|||
28006357|NCT01746368|81853767|FG000|Overall Study|Withdrawal by Subject|0|||
28006358|NCT01746368|81853768|FG001|Overall Study|Withdrawal by Subject|1|||
27810006|NCT00321711|81134075|FG000|Part B|Death|0|||
27810007|NCT00321711|81134076|FG001|Part B|Death|0|||
27810008|NCT00321711|81134077|FG002|Part B|Death|0|||
27810009|NCT00321711|81134078|FG003|Part B|Death|2|||
28006359|NCT03760029|81853771|FG000|Overall Study|Death|1|||
27810010|NCT00321711|81134079|FG004|Part B|Death|1|||
27810011|NCT02843074|81134080|FG000|Overall Study|Withdrawal by Subject|5|||
27810012|NCT02843074|81134080|FG000|Overall Study|Progressive disease|1|||
27810013|NCT02843074|81134080|FG000|Overall Study|Physician Decision|1|||
27810014|NCT02843074|81134080|FG000|Overall Study|Lost to Follow-up|1|||
28006360|NCT03760029|81853772|FG001|Overall Study|Death|0|||
28006361|NCT03760029|81853773|FG002|Overall Study|Death|0|||
28006362|NCT03760029|81853771|FG000|Overall Study|Lost to Follow-up|0|||
27810015|NCT02843074|81134080|FG000|Overall Study|Death|9|||
27810016|NCT00583596|81134081|FG000|Overall Study|Lost to Follow-up|110|||
27810017|NCT00583596|81134081|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
27810018|NCT00583596|81134081|FG000|Overall Study|Death|2|||
27810019|NCT00583596|81134081|FG000|Overall Study|Withdrawal by Subject|6|||
27810020|NCT00583596|81134081|FG000|Overall Study|Lost to Follow-up|94|||
27810021|NCT00583596|81134081|FG000|Overall Study|Data not complete|1|||
27810022|NCT00583596|81134081|FG000|Overall Study|Not consented|15|||
27810023|NCT00583596|81134081|FG000|Overall Study|Outside f-up window|26|||
27810024|NCT02168270|81134082|FG000|Overall Study|Lack of Efficacy|4|||
27810025|NCT00788957|81134083|FG000|Part 1|Death|8|||
27810026|NCT00788957|81134084|FG001|Part 1|Death|0|||
27810027|NCT00788957|81134085|FG002|Part 1|Death|0|||
28006363|NCT03760029|81853772|FG001|Overall Study|Lost to Follow-up|2|||
28006364|NCT03760029|81853773|FG002|Overall Study|Lost to Follow-up|1|||
28006365|NCT03760029|81853771|FG000|Overall Study|Withdrawal by Subject|1|||
28006366|NCT03760029|81853772|FG001|Overall Study|Withdrawal by Subject|4|||
28006367|NCT03760029|81853773|FG002|Overall Study|Withdrawal by Subject|1|||
28006368|NCT03760029|81853771|FG000|Overall Study|Withdrawal by parent/guardian|4|||
28006369|NCT03760029|81853772|FG001|Overall Study|Withdrawal by parent/guardian|4|||
28006370|NCT03760029|81853773|FG002|Overall Study|Withdrawal by parent/guardian|1|||
28006371|NCT03760029|81853771|FG000|Overall Study|Other|2|||
28006372|NCT03760029|81853772|FG001|Overall Study|Other|1|||
27810028|NCT00788957|81134086|FG003|Part 1|Death|0|||
27810029|NCT00788957|81134087|FG004|Part 1|Death|0|||
27810030|NCT00788957|81134088|FG005|Part 1|Death|0|||
27810031|NCT00788957|81134083|FG000|Part 1|Lost to Follow-up|1|||
27810032|NCT00788957|81134084|FG001|Part 1|Lost to Follow-up|0|||
28006373|NCT03760029|81853773|FG002|Overall Study|Other|0|||
28006374|NCT03224130|81853774|FG000|Overall Study|consent issue|0|||
28006375|NCT03224130|81853775|FG001|Overall Study|consent issue|1|||
28006376|NCT00642356|81853776|FG000|Overall Study|Adverse Event|1|||
28006377|NCT00642356|81853777|FG001|Overall Study|Adverse Event|0|||
28006378|NCT00642356|81853776|FG000|Overall Study|Protocol Violation|0|||
28006379|NCT00642356|81853777|FG001|Overall Study|Protocol Violation|3|||
28006380|NCT00642356|81853776|FG000|Overall Study|Lack of Efficacy|1|||
28006381|NCT00642356|81853777|FG001|Overall Study|Lack of Efficacy|0|||
27810033|NCT00788957|81134085|FG002|Part 1|Lost to Follow-up|0|||
27810034|NCT00788957|81134086|FG003|Part 1|Lost to Follow-up|0|||
27810035|NCT00788957|81134087|FG004|Part 1|Lost to Follow-up|0|||
27810036|NCT00788957|81134088|FG005|Part 1|Lost to Follow-up|0|||
27810037|NCT00788957|81134083|FG000|Part 2|Withdrawal by Subject|0|||
27810038|NCT00788957|81134084|FG001|Part 2|Withdrawal by Subject|9|||
27810039|NCT00788957|81134085|FG002|Part 2|Withdrawal by Subject|5|||
27810040|NCT00788957|81134086|FG003|Part 2|Withdrawal by Subject|3|||
28006382|NCT01710345|81853780|FG000|Overall Study|Adverse Event|0|||
28006383|NCT01710345|81853781|FG001|Overall Study|Adverse Event|2|||
28006384|NCT01710345|81853782|FG002|Overall Study|Adverse Event|0|||
28006385|NCT01710345|81853780|FG000|Overall Study|Lack of Efficacy|2|||
28006386|NCT01710345|81853781|FG001|Overall Study|Lack of Efficacy|3|||
27810041|NCT00788957|81134087|FG004|Part 2|Withdrawal by Subject|0|||
27810042|NCT00788957|81134088|FG005|Part 2|Withdrawal by Subject|0|||
27810043|NCT00788957|81134083|FG000|Part 2|Death|0|||
27810044|NCT00788957|81134084|FG001|Part 2|Death|32|||
28006387|NCT01710345|81853782|FG002|Overall Study|Lack of Efficacy|1|||
28006388|NCT01710345|81853780|FG000|Overall Study|Drug Dosing Error|1|||
27810045|NCT00788957|81134085|FG002|Part 2|Death|35|||
27810046|NCT00788957|81134086|FG003|Part 2|Death|37|||
27810047|NCT00788957|81134087|FG004|Part 2|Death|0|||
27810048|NCT00788957|81134088|FG005|Part 2|Death|0|||
28006389|NCT01710345|81853781|FG001|Overall Study|Drug Dosing Error|0|||
27685041|NCT04677179|80683647|FG000|Induction Treatment Period|Physician Decision|1|||
27685042|NCT04677179|80683648|FG001|Induction Treatment Period|Physician Decision|0|||
27685043|NCT04677179|80683649|FG002|Induction Treatment Period|Physician Decision|1|||
27685044|NCT04677179|80683650|FG003|Induction Treatment Period|Physician Decision|0|||
27685045|NCT04677179|80683651|FG004|Induction Treatment Period|Physician Decision|0|||
27685046|NCT04677179|80683652|FG005|Induction Treatment Period|Physician Decision|0|||
27685047|NCT04677179|80683653|FG006|Induction Treatment Period|Physician Decision|0|||
27685048|NCT04677179|80683654|FG007|Induction Treatment Period|Physician Decision|0|||
27685049|NCT04677179|80683655|FG008|Induction Treatment Period|Physician Decision|0|||
27685050|NCT04677179|80683656|FG009|Induction Treatment Period|Physician Decision|0|||
27685051|NCT04677179|80683647|FG000|Induction Treatment Period|Protocol Violation|0|||
27685052|NCT04677179|80683648|FG001|Induction Treatment Period|Protocol Violation|1|||
27685053|NCT04677179|80683649|FG002|Induction Treatment Period|Protocol Violation|0|||
27810049|NCT00788957|81134083|FG000|Part 2|Lost to Follow-up|0|||
27810050|NCT00788957|81134084|FG001|Part 2|Lost to Follow-up|0|||
27810051|NCT00788957|81134085|FG002|Part 2|Lost to Follow-up|3|||
27810052|NCT00788957|81134086|FG003|Part 2|Lost to Follow-up|0|||
27810053|NCT00788957|81134087|FG004|Part 2|Lost to Follow-up|0|||
27810054|NCT00788957|81134088|FG005|Part 2|Lost to Follow-up|0|||
27810055|NCT00788957|81134083|FG000|Part 2|On-study at time of data cut-off|0|||
28006390|NCT01710345|81853782|FG002|Overall Study|Drug Dosing Error|0|||
28006391|NCT04439136|81853783|FG000|Overall Study|Ineligible|1|||
28006392|NCT04439136|81853783|FG000|Overall Study|Never Started Treatment|2|||
28006393|NCT04439136|81853783|FG000|Overall Study|Adverse Event|4|||
28006394|NCT04439136|81853783|FG000|Overall Study|Death|3|||
28006395|NCT04439136|81853783|FG000|Overall Study|Disease Progression|27|||
28006396|NCT04439136|81853783|FG000|Overall Study|Alternative Therapy|1|||
28006397|NCT04439136|81853783|FG000|Overall Study|Increased Tumor Burden|1|||
28006398|NCT04439136|81853783|FG000|Overall Study|Symptomatic Detrioration|1|||
28006399|NCT00671658|81853785|FG000|Overall Study|Physician Decision|5|||
28006400|NCT01231984|81853786|FG000|Study Period 1|Withdrawal by Subject|0|||
28006401|NCT01231984|81853787|FG001|Study Period 1|Withdrawal by Subject|0|||
28006402|NCT01231984|81853788|FG002|Study Period 1|Withdrawal by Subject|0|||
28006403|NCT01231984|81853789|FG003|Study Period 1|Withdrawal by Subject|1|||
28006404|NCT01231984|81853786|FG000|Study Period 1|Lost to Follow-up|1|||
28006405|NCT01231984|81853787|FG001|Study Period 1|Lost to Follow-up|1|||
28006406|NCT01231984|81853788|FG002|Study Period 1|Lost to Follow-up|1|||
28006407|NCT01231984|81853789|FG003|Study Period 1|Lost to Follow-up|0|||
28006408|NCT01231984|81853786|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
28006409|NCT01231984|81853787|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
28006410|NCT01231984|81853788|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
28006411|NCT01231984|81853789|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
28006412|NCT01231984|81853786|FG000|Study Period 1|Screen Failure|0|||
28006413|NCT01231984|81853787|FG001|Study Period 1|Screen Failure|0|||
28006414|NCT01231984|81853788|FG002|Study Period 1|Screen Failure|0|||
28006415|NCT01231984|81853789|FG003|Study Period 1|Screen Failure|1|||
27685054|NCT04677179|80683650|FG003|Induction Treatment Period|Protocol Violation|0|||
27685055|NCT04677179|80683651|FG004|Induction Treatment Period|Protocol Violation|0|||
27685056|NCT04677179|80683652|FG005|Induction Treatment Period|Protocol Violation|0|||
27685057|NCT04677179|80683653|FG006|Induction Treatment Period|Protocol Violation|0|||
27685058|NCT04677179|80683654|FG007|Induction Treatment Period|Protocol Violation|0|||
27685059|NCT04677179|80683655|FG008|Induction Treatment Period|Protocol Violation|0|||
27685060|NCT04677179|80683656|FG009|Induction Treatment Period|Protocol Violation|0|||
27685061|NCT04677179|80683647|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
27685062|NCT04677179|80683648|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
27810056|NCT00788957|81134084|FG001|Part 2|On-study at time of data cut-off|1|||
27810057|NCT00788957|81134085|FG002|Part 2|On-study at time of data cut-off|1|||
27810058|NCT00788957|81134086|FG003|Part 2|On-study at time of data cut-off|1|||
27810059|NCT00788957|81134087|FG004|Part 2|On-study at time of data cut-off|0|||
27810060|NCT00788957|81134088|FG005|Part 2|On-study at time of data cut-off|0|||
27810061|NCT00788957|81134083|FG000|Part 3|Withdrawal by Subject|0|||
27810062|NCT00788957|81134084|FG001|Part 3|Withdrawal by Subject|0|||
27810063|NCT00788957|81134085|FG002|Part 3|Withdrawal by Subject|0|||
27810064|NCT00788957|81134086|FG003|Part 3|Withdrawal by Subject|0|||
28006416|NCT01231984|81853786|FG000|Study Period 1|Non-compliance with study requirements|5|||
28006417|NCT01231984|81853787|FG001|Study Period 1|Non-compliance with study requirements|0|||
27810065|NCT00788957|81134087|FG004|Part 3|Withdrawal by Subject|0|||
28006418|NCT01231984|81853788|FG002|Study Period 1|Non-compliance with study requirements|2|||
28006419|NCT01231984|81853789|FG003|Study Period 1|Non-compliance with study requirements|1|||
27810066|NCT00788957|81134088|FG005|Part 3|Withdrawal by Subject|2|||
27810067|NCT00788957|81134083|FG000|Part 3|Death|0|||
28006420|NCT01231984|81853786|FG000|Study Period 1|Protocol Violation|3|||
28006421|NCT01231984|81853787|FG001|Study Period 1|Protocol Violation|4|||
27810068|NCT00788957|81134084|FG001|Part 3|Death|0|||
27810069|NCT00788957|81134085|FG002|Part 3|Death|0|||
27685063|NCT04677179|80683649|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
27685064|NCT04677179|80683650|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
27685065|NCT04677179|80683651|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
27685066|NCT04677179|80683652|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
28006422|NCT01231984|81853788|FG002|Study Period 1|Protocol Violation|2|||
28006423|NCT01231984|81853789|FG003|Study Period 1|Protocol Violation|3|||
28006424|NCT01231984|81853786|FG000|Study Period 1|Adverse Event|1|||
28006425|NCT01231984|81853787|FG001|Study Period 1|Adverse Event|0|||
28006426|NCT01231984|81853788|FG002|Study Period 1|Adverse Event|0|||
28006427|NCT01231984|81853789|FG003|Study Period 1|Adverse Event|0|||
28006428|NCT01231984|81853786|FG000|Study Period 1|Other|0|||
28006429|NCT01231984|81853787|FG001|Study Period 1|Other|0|||
27685067|NCT04677179|80683653|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
27685068|NCT04677179|80683654|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
27685069|NCT04677179|80683655|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
27685070|NCT04677179|80683656|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
27685071|NCT04677179|80683647|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
27685072|NCT04677179|80683648|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
27685073|NCT04677179|80683649|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
27685074|NCT04677179|80683650|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
28006430|NCT01231984|81853788|FG002|Study Period 1|Other|0|||
28006431|NCT01231984|81853789|FG003|Study Period 1|Other|1|||
28006432|NCT01231984|81853786|FG000|Study Period 2|Withdrawal by Subject|1|||
28006433|NCT01231984|81853787|FG001|Study Period 2|Withdrawal by Subject|1|||
28006434|NCT01231984|81853788|FG002|Study Period 2|Withdrawal by Subject|0|||
28006435|NCT01231984|81853789|FG003|Study Period 2|Withdrawal by Subject|0|||
28006436|NCT01231984|81853786|FG000|Study Period 2|Lost to Follow-up|1|||
28006437|NCT01231984|81853787|FG001|Study Period 2|Lost to Follow-up|0|||
28006438|NCT01231984|81853788|FG002|Study Period 2|Lost to Follow-up|0|||
28006439|NCT01231984|81853789|FG003|Study Period 2|Lost to Follow-up|3|||
28006440|NCT01231984|81853786|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
28006441|NCT01231984|81853787|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
28006442|NCT01231984|81853788|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
28006443|NCT01231984|81853789|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
28006444|NCT00771914|81853790|FG000|Overall Study|Physician Decision|0|||
28006445|NCT00771914|81853791|FG001|Overall Study|Physician Decision|0|||
28006446|NCT00771914|81853792|FG002|Overall Study|Physician Decision|0|||
28006447|NCT00771914|81853793|FG003|Overall Study|Physician Decision|1|||
27685075|NCT04677179|80683651|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
27685076|NCT04677179|80683652|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
27685077|NCT04677179|80683653|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
27685078|NCT04677179|80683654|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
27685079|NCT04677179|80683655|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
27685080|NCT04677179|80683656|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
27685081|NCT04677179|80683647|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
27685082|NCT04677179|80683648|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
27685083|NCT04677179|80683649|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
27685084|NCT04677179|80683650|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
27685085|NCT04677179|80683651|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
27685086|NCT04677179|80683652|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
27685087|NCT04677179|80683653|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
27685088|NCT04677179|80683654|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
27685089|NCT04677179|80683655|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
27685090|NCT04677179|80683656|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
27685091|NCT04677179|80683647|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685092|NCT04677179|80683648|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685093|NCT04677179|80683649|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685094|NCT04677179|80683650|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
27685095|NCT04677179|80683651|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685096|NCT04677179|80683652|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685097|NCT04677179|80683653|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685098|NCT04677179|80683654|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685099|NCT04677179|80683655|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
27810070|NCT00788957|81134086|FG003|Part 3|Death|0|||
28006448|NCT00771914|81853790|FG000|Overall Study|Lost to Follow-up|0|||
27685100|NCT04677179|80683656|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
27685101|NCT04677179|80683647|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
28006449|NCT00771914|81853791|FG001|Overall Study|Lost to Follow-up|0|||
28006450|NCT00771914|81853792|FG002|Overall Study|Lost to Follow-up|0|||
28006451|NCT00771914|81853793|FG003|Overall Study|Lost to Follow-up|1|||
28006452|NCT00468169|81853796|FG000|Overall Study|Withdrawal by Subject|1|||
28006453|NCT00468169|81853797|FG001|Overall Study|Withdrawal by Subject|0|||
28006454|NCT01352117|81853802|FG000|Overall Study|Death|15|||
27685102|NCT04677179|80683648|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
27685103|NCT04677179|80683649|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
27685104|NCT04677179|80683650|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
27685105|NCT04677179|80683651|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
27685106|NCT04677179|80683652|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
27685107|NCT04677179|80683653|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
27685108|NCT04677179|80683654|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
27685109|NCT04677179|80683655|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
27685110|NCT04677179|80683656|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
27685111|NCT04677179|80683647|FG000|Extension Treatment Period|Lack of Efficacy|0|||
27685112|NCT04677179|80683648|FG001|Extension Treatment Period|Lack of Efficacy|0|||
27685113|NCT04677179|80683649|FG002|Extension Treatment Period|Lack of Efficacy|0|||
27685114|NCT04677179|80683650|FG003|Extension Treatment Period|Lack of Efficacy|0|||
27685115|NCT04677179|80683651|FG004|Extension Treatment Period|Lack of Efficacy|0|||
27685116|NCT04677179|80683652|FG005|Extension Treatment Period|Lack of Efficacy|0|||
27685117|NCT04677179|80683653|FG006|Extension Treatment Period|Lack of Efficacy|6|||
27685118|NCT04677179|80683654|FG007|Extension Treatment Period|Lack of Efficacy|0|||
27685119|NCT04677179|80683655|FG008|Extension Treatment Period|Lack of Efficacy|0|||
27685120|NCT04677179|80683656|FG009|Extension Treatment Period|Lack of Efficacy|0|||
27685121|NCT04677179|80683647|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
27685122|NCT04677179|80683648|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27685123|NCT04677179|80683649|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
27685124|NCT04677179|80683650|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
27685125|NCT04677179|80683651|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
27685126|NCT04677179|80683652|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
27685127|NCT04677179|80683653|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
27685128|NCT04677179|80683654|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
27685129|NCT04677179|80683655|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
27685130|NCT04677179|80683656|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
27685131|NCT04677179|80683647|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
27685132|NCT04677179|80683648|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
27685133|NCT04677179|80683649|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
27685134|NCT04677179|80683650|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
27685135|NCT04677179|80683651|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
27685136|NCT04677179|80683652|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
27685137|NCT04677179|80683653|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
27685138|NCT04677179|80683654|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
27685139|NCT04677179|80683655|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
27685140|NCT04677179|80683656|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
27685141|NCT04677179|80683647|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
27685142|NCT04677179|80683648|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
27685143|NCT04677179|80683649|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
27810071|NCT00788957|81134087|FG004|Part 3|Death|8|||
27810072|NCT00788957|81134088|FG005|Part 3|Death|8|||
27810073|NCT00788957|81134083|FG000|Part 3|On-study at time of data cut-off|0|||
27810074|NCT00788957|81134084|FG001|Part 3|On-study at time of data cut-off|0|||
28006455|NCT01352117|81853803|FG001|Overall Study|Death|16|||
28006456|NCT01352117|81853802|FG000|Overall Study|Withdrawal by Subject|1|||
28006457|NCT01352117|81853803|FG001|Overall Study|Withdrawal by Subject|0|||
28006458|NCT01352117|81853802|FG000|Overall Study|Lost to Follow-up|2|||
27810075|NCT00788957|81134085|FG002|Part 3|On-study at time of data cut-off|0|||
27810076|NCT00788957|81134086|FG003|Part 3|On-study at time of data cut-off|0|||
27810077|NCT00788957|81134087|FG004|Part 3|On-study at time of data cut-off|1|||
27810078|NCT00788957|81134088|FG005|Part 3|On-study at time of data cut-off|0|||
27810079|NCT01138150|81134089|FG000|Overall Study|blood unable to be processed|0|||
27810080|NCT01138150|81134090|FG001|Overall Study|blood unable to be processed|1|||
27810081|NCT01138150|81134089|FG000|Overall Study|Physician Decision|1|||
27810082|NCT01138150|81134090|FG001|Overall Study|Physician Decision|0|||
27810083|NCT00720122|81134091|FG000|Overall Study|Lost to Follow-up|1|||
27810084|NCT00720122|81134091|FG000|Overall Study|Physician Decision|1|||
27810085|NCT00720122|81134091|FG000|Overall Study|Withdrawal by Subject|7|||
27810086|NCT01042977|81134099|FG000|Overall Study|Adverse Event|4|||
27810087|NCT01042977|81134100|FG001|Overall Study|Adverse Event|12|||
27810088|NCT01042977|81134099|FG000|Overall Study|Death|2|||
27810089|NCT01042977|81134100|FG001|Overall Study|Death|1|||
27810090|NCT01042977|81134099|FG000|Overall Study|Withdrawal by Subject|8|||
27810091|NCT01042977|81134100|FG001|Overall Study|Withdrawal by Subject|16|||
27810092|NCT01042977|81134099|FG000|Overall Study|Lost to Follow-up|0|||
27810093|NCT01042977|81134100|FG001|Overall Study|Lost to Follow-up|2|||
28006459|NCT01352117|81853803|FG001|Overall Study|Lost to Follow-up|7|||
28006460|NCT01352117|81853802|FG000|Overall Study|Non-adherent to study requirements|1|||
27685144|NCT04677179|80683650|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
27685145|NCT04677179|80683651|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
27685146|NCT04677179|80683652|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
27685147|NCT04677179|80683653|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
27685148|NCT04677179|80683654|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
27685149|NCT04677179|80683655|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
27685150|NCT04677179|80683656|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
27874911|NCT04688671|81375322|FG000|Overall Study|Withdrawal by Subject|3|||
27874912|NCT04688671|81375323|FG001|Overall Study|Withdrawal by Subject|1|||
27874913|NCT04688671|81375322|FG000|Overall Study|Lack of Efficacy|1|||
27874914|NCT04688671|81375323|FG001|Overall Study|Lack of Efficacy|1|||
27874915|NCT04688671|81375322|FG000|Overall Study|Protocol Violation|1|||
27874916|NCT04688671|81375323|FG001|Overall Study|Protocol Violation|0|||
27874917|NCT04688671|81375322|FG000|Overall Study|Lost to Follow-up|0|||
27874918|NCT04688671|81375323|FG001|Overall Study|Lost to Follow-up|1|||
27874919|NCT03539302|81375324|FG000|Overall Study|Spontaneous cardio version|0|||
27874920|NCT03539302|81375325|FG001|Overall Study|Spontaneous cardio version|0|||
27874921|NCT03539302|81375326|FG002|Overall Study|Spontaneous cardio version|0|||
27874922|NCT03539302|81375327|FG003|Overall Study|Spontaneous cardio version|0|||
27874923|NCT03539302|81375328|FG004|Overall Study|Spontaneous cardio version|0|||
27874924|NCT03539302|81375329|FG005|Overall Study|Spontaneous cardio version|1|||
27874925|NCT03539302|81375330|FG006|Overall Study|Spontaneous cardio version|1|||
27874926|NCT02105467|81375331|FG000|Period 1|Lost to Follow-up|1|||
27874927|NCT02105467|81375332|FG001|Period 1|Lost to Follow-up|0|||
27874928|NCT02105467|81375331|FG000|Period 1|Death|1|||
27874929|NCT02105467|81375332|FG001|Period 1|Death|0|||
27874930|NCT02105467|81375331|FG000|Period 2|Lost to Follow-up|1|||
27874931|NCT02105467|81375332|FG001|Period 2|Lost to Follow-up|0|||
27874932|NCT02105467|81375331|FG000|Period 2|Death|1|||
27685151|NCT04677179|80683647|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685152|NCT04677179|80683648|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685153|NCT04677179|80683649|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685154|NCT04677179|80683650|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685155|NCT04677179|80683651|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685156|NCT04677179|80683652|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685157|NCT04677179|80683653|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27685158|NCT04677179|80683654|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
27685159|NCT04677179|80683655|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
27685160|NCT04677179|80683656|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
27874933|NCT02105467|81375332|FG001|Period 2|Death|0|||
27874934|NCT02105467|81375331|FG000|Period 2|Withdrawal by Subject|0|||
27874935|NCT02105467|81375332|FG001|Period 2|Withdrawal by Subject|2|||
27685161|NCT04677179|80683647|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27685162|NCT04677179|80683648|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27685163|NCT04677179|80683649|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27810094|NCT01042977|81134099|FG000|Overall Study|Poor/non-compliance|3|||
27810095|NCT01042977|81134100|FG001|Overall Study|Poor/non-compliance|4|||
27810096|NCT01042977|81134099|FG000|Overall Study|Subject no longer meets study criteria|15|||
27810097|NCT01042977|81134100|FG001|Overall Study|Subject no longer meets study criteria|13|||
27810098|NCT01042977|81134099|FG000|Overall Study|Incorrect enrollment|6|||
27810099|NCT01042977|81134100|FG001|Overall Study|Incorrect enrollment|4|||
27810100|NCT01042977|81134099|FG000|Overall Study|Safety|0|||
27810101|NCT01042977|81134100|FG001|Overall Study|Safety|2|||
27810102|NCT01042977|81134099|FG000|Overall Study|Administrative reason by sponsor|0|||
27810103|NCT01042977|81134100|FG001|Overall Study|Administrative reason by sponsor|1|||
27810104|NCT01042977|81134099|FG000|Overall Study|Various|3|||
27810105|NCT01042977|81134100|FG001|Overall Study|Various|0|||
27874936|NCT02105467|81375331|FG000|Period 3|Lost to Follow-up|0|||
27874937|NCT02105467|81375332|FG001|Period 3|Lost to Follow-up|1|||
27810106|NCT00681863|81134105|FG000|Overall Study|Adverse Event|1|||
27810107|NCT00681863|81134105|FG000|Overall Study|Lost to Follow-up|2|||
27810108|NCT00681863|81134105|FG000|Overall Study|Lack of Efficacy|2|||
27810109|NCT00681863|81134105|FG000|Overall Study|Other|18|||
27874938|NCT03877068|81375333|FG000|Overall Study|Physician Decision|9|||
27874939|NCT03877068|81375334|FG001|Overall Study|Physician Decision|3|||
27874940|NCT02088177|81375339|FG000|Overall Study|Lost to Follow-up|3|||
28006461|NCT01352117|81853803|FG001|Overall Study|Non-adherent to study requirements|1|||
27810110|NCT01199601|81134106|FG000|Overall Study|Lost to Follow-up|47|||
27810111|NCT01199601|81134107|FG001|Overall Study|Lost to Follow-up|66|||
27874941|NCT01422213|81375340|FG000|Overall Study|Adverse Event|8|||
27874942|NCT01422213|81375341|FG001|Overall Study|Adverse Event|7|||
27874943|NCT01422213|81375342|FG002|Overall Study|Adverse Event|11|||
28006462|NCT01352117|81853802|FG000|Overall Study|Did not initiate study treatment|1|||
28006463|NCT01352117|81853803|FG001|Overall Study|Did not initiate study treatment|0|||
28006464|NCT01352117|81853802|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
28006465|NCT01352117|81853803|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
28006466|NCT00387881|81853807|FG000|Overall Study|Lost to Follow-up|23|||
27685164|NCT04677179|80683650|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27685165|NCT04677179|80683651|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27685166|NCT04677179|80683652|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27685167|NCT04677179|80683653|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27810112|NCT01199601|81134106|FG000|Overall Study|Withdrawal by Subject|15|||
27810113|NCT01199601|81134107|FG001|Overall Study|Withdrawal by Subject|3|||
27810114|NCT01199601|81134106|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
27810115|NCT01199601|81134107|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
27810116|NCT02753400|81134108|FG000|Overall Study|Adverse Event|3|||
27810117|NCT02753400|81134109|FG001|Overall Study|Adverse Event|0|||
27810118|NCT02753400|81134108|FG000|Overall Study|Withdrawal by Subject|2|||
27810119|NCT02753400|81134109|FG001|Overall Study|Withdrawal by Subject|1|||
27810120|NCT01958281|81134110|FG000|Overall Study|Lack of Efficacy|5|||
27810121|NCT01958281|81134111|FG001|Overall Study|Lack of Efficacy|2|||
27810122|NCT01958281|81134112|FG002|Overall Study|Lack of Efficacy|0|||
27810123|NCT01958281|81134110|FG000|Overall Study|Adverse Event|0|||
27810124|NCT01958281|81134111|FG001|Overall Study|Adverse Event|2|||
27810125|NCT01958281|81134112|FG002|Overall Study|Adverse Event|0|||
27810126|NCT01958281|81134110|FG000|Overall Study|Withdrew Consent|1|||
27810127|NCT01958281|81134111|FG001|Overall Study|Withdrew Consent|0|||
27810128|NCT01958281|81134112|FG002|Overall Study|Withdrew Consent|0|||
27810129|NCT01464827|81134113|FG000|Overall Study|Adverse Event|0|||
28006467|NCT00387881|81853808|FG001|Overall Study|Lost to Follow-up|23|||
28006468|NCT00387881|81853807|FG000|Overall Study|Protocol Violation|2|||
28006469|NCT00387881|81853808|FG001|Overall Study|Protocol Violation|12|||
28006470|NCT00387881|81853807|FG000|Overall Study|Withdrawal by Subject|15|||
28006471|NCT00387881|81853808|FG001|Overall Study|Withdrawal by Subject|18|||
28006472|NCT00387881|81853807|FG000|Overall Study|Sponsor terminated Study|0|||
28006473|NCT00387881|81853808|FG001|Overall Study|Sponsor terminated Study|1|||
28006474|NCT00387881|81853807|FG000|Overall Study|Not eligible|6|||
27685168|NCT04677179|80683654|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
27685169|NCT04677179|80683655|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27685170|NCT04677179|80683656|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27810130|NCT01464827|81134114|FG001|Overall Study|Adverse Event|0|||
27810131|NCT01464827|81134115|FG002|Overall Study|Adverse Event|0|||
27810132|NCT01464827|81134116|FG003|Overall Study|Adverse Event|0|||
27810133|NCT01464827|81134117|FG004|Overall Study|Adverse Event|0|||
27810134|NCT01464827|81134118|FG005|Overall Study|Adverse Event|0|||
27810135|NCT01464827|81134119|FG006|Overall Study|Adverse Event|0|||
27810136|NCT01464827|81134120|FG007|Overall Study|Adverse Event|0|||
27810137|NCT01464827|81134121|FG008|Overall Study|Adverse Event|0|||
27810138|NCT01464827|81134122|FG009|Overall Study|Adverse Event|0|||
27810139|NCT01464827|81134123|FG010|Overall Study|Adverse Event|0|||
27810140|NCT01464827|81134124|FG011|Overall Study|Adverse Event|0|||
27810141|NCT01464827|81134125|FG012|Overall Study|Adverse Event|1|||
27810142|NCT01464827|81134126|FG013|Overall Study|Adverse Event|0|||
27810143|NCT01464827|81134113|FG000|Overall Study|Withdrawal by Subject|1|||
27810144|NCT01464827|81134114|FG001|Overall Study|Withdrawal by Subject|0|||
27810145|NCT01464827|81134115|FG002|Overall Study|Withdrawal by Subject|0|||
27810146|NCT01464827|81134116|FG003|Overall Study|Withdrawal by Subject|0|||
27810147|NCT01464827|81134117|FG004|Overall Study|Withdrawal by Subject|1|||
27810148|NCT01464827|81134118|FG005|Overall Study|Withdrawal by Subject|0|||
27810149|NCT01464827|81134119|FG006|Overall Study|Withdrawal by Subject|0|||
27810150|NCT01464827|81134120|FG007|Overall Study|Withdrawal by Subject|1|||
27810151|NCT01464827|81134121|FG008|Overall Study|Withdrawal by Subject|0|||
27874944|NCT01422213|81375340|FG000|Overall Study|Lack of Efficacy|10|||
28006475|NCT00387881|81853808|FG001|Overall Study|Not eligible|7|||
27685171|NCT04677179|80683647|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685172|NCT04677179|80683648|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685173|NCT04677179|80683649|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685174|NCT04677179|80683650|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685175|NCT04677179|80683651|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685176|NCT04677179|80683652|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685177|NCT04677179|80683653|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685178|NCT04677179|80683654|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
27874945|NCT01422213|81375341|FG001|Overall Study|Lack of Efficacy|2|||
27874946|NCT01422213|81375342|FG002|Overall Study|Lack of Efficacy|2|||
27810152|NCT01464827|81134122|FG009|Overall Study|Withdrawal by Subject|0|||
27810153|NCT01464827|81134123|FG010|Overall Study|Withdrawal by Subject|0|||
27874947|NCT01422213|81375340|FG000|Overall Study|Non-compliance with study drug|0|||
27874948|NCT01422213|81375341|FG001|Overall Study|Non-compliance with study drug|1|||
27874949|NCT01422213|81375342|FG002|Overall Study|Non-compliance with study drug|0|||
27874950|NCT01422213|81375340|FG000|Overall Study|Protocol Violation|0|||
27874951|NCT01422213|81375341|FG001|Overall Study|Protocol Violation|2|||
27874952|NCT01422213|81375342|FG002|Overall Study|Protocol Violation|4|||
27874953|NCT01422213|81375340|FG000|Overall Study|Withdrawal of Consent|7|||
27874954|NCT01422213|81375341|FG001|Overall Study|Withdrawal of Consent|3|||
27874955|NCT01422213|81375342|FG002|Overall Study|Withdrawal of Consent|5|||
27874956|NCT01422213|81375340|FG000|Overall Study|Lost to Follow-up|3|||
27874957|NCT01422213|81375341|FG001|Overall Study|Lost to Follow-up|3|||
27874958|NCT01422213|81375342|FG002|Overall Study|Lost to Follow-up|5|||
27874959|NCT01422213|81375340|FG000|Overall Study|Administrative or Other Reason(s)|5|||
27810154|NCT01464827|81134124|FG011|Overall Study|Withdrawal by Subject|0|||
27810155|NCT01464827|81134125|FG012|Overall Study|Withdrawal by Subject|0|||
27810156|NCT01464827|81134126|FG013|Overall Study|Withdrawal by Subject|0|||
27810157|NCT01464827|81134113|FG000|Overall Study|Lost to Follow-up|0|||
27810158|NCT01464827|81134114|FG001|Overall Study|Lost to Follow-up|2|||
27810159|NCT01464827|81134115|FG002|Overall Study|Lost to Follow-up|0|||
27810160|NCT01464827|81134116|FG003|Overall Study|Lost to Follow-up|2|||
27810161|NCT01464827|81134117|FG004|Overall Study|Lost to Follow-up|3|||
27810162|NCT01464827|81134118|FG005|Overall Study|Lost to Follow-up|1|||
27810163|NCT01464827|81134119|FG006|Overall Study|Lost to Follow-up|2|||
27810164|NCT01464827|81134120|FG007|Overall Study|Lost to Follow-up|2|||
27810165|NCT01464827|81134121|FG008|Overall Study|Lost to Follow-up|0|||
27810166|NCT01464827|81134122|FG009|Overall Study|Lost to Follow-up|0|||
27810167|NCT01464827|81134123|FG010|Overall Study|Lost to Follow-up|0|||
27810168|NCT01464827|81134124|FG011|Overall Study|Lost to Follow-up|1|||
27810169|NCT01464827|81134125|FG012|Overall Study|Lost to Follow-up|0|||
27810170|NCT01464827|81134126|FG013|Overall Study|Lost to Follow-up|1|||
27810171|NCT01464827|81134113|FG000|Overall Study|Other|2|||
27810172|NCT01464827|81134114|FG001|Overall Study|Other|3|||
27810173|NCT01464827|81134115|FG002|Overall Study|Other|0|||
27810174|NCT01464827|81134116|FG003|Overall Study|Other|2|||
27810175|NCT01464827|81134117|FG004|Overall Study|Other|3|||
27810176|NCT01464827|81134118|FG005|Overall Study|Other|0|||
27810177|NCT01464827|81134119|FG006|Overall Study|Other|1|||
27810178|NCT01464827|81134120|FG007|Overall Study|Other|0|||
27810179|NCT01464827|81134121|FG008|Overall Study|Other|3|||
27810180|NCT01464827|81134122|FG009|Overall Study|Other|1|||
27810181|NCT01464827|81134123|FG010|Overall Study|Other|2|||
27810182|NCT01464827|81134124|FG011|Overall Study|Other|0|||
27810183|NCT01464827|81134125|FG012|Overall Study|Other|1|||
27810184|NCT01464827|81134126|FG013|Overall Study|Other|0|||
27810185|NCT01464827|81134113|FG000|Overall Study|Not Treated|0|||
27810186|NCT01464827|81134114|FG001|Overall Study|Not Treated|2|||
27810187|NCT01464827|81134115|FG002|Overall Study|Not Treated|0|||
27810188|NCT01464827|81134116|FG003|Overall Study|Not Treated|0|||
27810189|NCT01464827|81134117|FG004|Overall Study|Not Treated|1|||
27810190|NCT01464827|81134118|FG005|Overall Study|Not Treated|0|||
27810191|NCT01464827|81134119|FG006|Overall Study|Not Treated|1|||
27810192|NCT01464827|81134120|FG007|Overall Study|Not Treated|0|||
27810193|NCT01464827|81134121|FG008|Overall Study|Not Treated|0|||
27810194|NCT01464827|81134122|FG009|Overall Study|Not Treated|2|||
27810195|NCT01464827|81134123|FG010|Overall Study|Not Treated|0|||
27810196|NCT01464827|81134124|FG011|Overall Study|Not Treated|1|||
27874960|NCT01422213|81375341|FG001|Overall Study|Administrative or Other Reason(s)|4|||
27874961|NCT01422213|81375342|FG002|Overall Study|Administrative or Other Reason(s)|2|||
27685179|NCT04677179|80683655|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
27810197|NCT01464827|81134125|FG012|Overall Study|Not Treated|0|||
27810198|NCT01464827|81134126|FG013|Overall Study|Not Treated|2|||
27810199|NCT03896490|81134127|FG000|Overall Study|Withdrawal by Subject|1|||
27810200|NCT03896490|81134128|FG001|Overall Study|Withdrawal by Subject|1|||
27810201|NCT00947427|81134129|FG000|Overall Study|Withdrawal by Subject|1|||
27810202|NCT00947427|81134130|FG001|Overall Study|Withdrawal by Subject|3|||
27810203|NCT00947427|81134129|FG000|Overall Study|Protocol Violation|0|||
27810204|NCT00947427|81134130|FG001|Overall Study|Protocol Violation|1|||
27810205|NCT02087059|81134138|FG000|Overall Study|Disease Progression|1|||
27810206|NCT02087059|81134138|FG000|Overall Study|Adverse Event|5|||
27810207|NCT02087059|81134138|FG000|Overall Study|Lost to Follow-up|1|||
27810208|NCT00947856|81134139|FG000|Treatment Period|Progressive Disease|33|||
27810209|NCT00947856|81134140|FG001|Treatment Period|Progressive Disease|12|||
27810210|NCT00947856|81134139|FG000|Treatment Period|Adverse Event|15|||
27810211|NCT00947856|81134140|FG001|Treatment Period|Adverse Event|9|||
27810212|NCT00947856|81134139|FG000|Treatment Period|Physician Decision|14|||
27810213|NCT00947856|81134140|FG001|Treatment Period|Physician Decision|6|||
27810214|NCT00947856|81134139|FG000|Treatment Period|Study Stopped by Sponsor|4|||
27810215|NCT00947856|81134140|FG001|Treatment Period|Study Stopped by Sponsor|4|||
27810216|NCT00947856|81134139|FG000|Treatment Period|Withdrawal by Subject|12|||
27810217|NCT00947856|81134140|FG001|Treatment Period|Withdrawal by Subject|1|||
27810218|NCT00947856|81134139|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
27810219|NCT00947856|81134140|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
27810220|NCT00947856|81134139|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
27810221|NCT00947856|81134140|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
28006476|NCT00387881|81853807|FG000|Overall Study|No opportunity to treat headache|32|||
28006477|NCT00387881|81853808|FG001|Overall Study|No opportunity to treat headache|34|||
28006478|NCT00387881|81853807|FG000|Overall Study|Not otherwise specified|11|||
28006479|NCT00387881|81853808|FG001|Overall Study|Not otherwise specified|7|||
28006480|NCT00997035|81853809|FG000|3-week Followup Visit|Lost to Follow-up|9|||
28006481|NCT00997035|81853810|FG001|3-week Followup Visit|Lost to Follow-up|6|||
28006482|NCT00997035|81853809|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
28006483|NCT00997035|81853810|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
28006484|NCT00383552|81853815|FG000|Overall Study|Adverse Event|7|||
28006485|NCT00383552|81853816|FG001|Overall Study|Adverse Event|6|||
28006486|NCT00383552|81853817|FG002|Overall Study|Adverse Event|9|||
28006487|NCT00383552|81853818|FG003|Overall Study|Adverse Event|6|||
28006488|NCT00383552|81853815|FG000|Overall Study|Lack of Efficacy|4|||
28006489|NCT00383552|81853816|FG001|Overall Study|Lack of Efficacy|13|||
28006490|NCT00383552|81853817|FG002|Overall Study|Lack of Efficacy|29|||
28006491|NCT00383552|81853818|FG003|Overall Study|Lack of Efficacy|42|||
28006492|NCT00383552|81853815|FG000|Overall Study|Lost to Follow-up|0|||
28006493|NCT00383552|81853816|FG001|Overall Study|Lost to Follow-up|1|||
28006494|NCT00383552|81853817|FG002|Overall Study|Lost to Follow-up|5|||
28006495|NCT00383552|81853818|FG003|Overall Study|Lost to Follow-up|1|||
28006496|NCT00383552|81853815|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
28006497|NCT00383552|81853816|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
28006498|NCT00383552|81853817|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
28006499|NCT00383552|81853818|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
28006500|NCT00383552|81853815|FG000|Overall Study|Did not wish to continue (related)|1|||
28006501|NCT00383552|81853816|FG001|Overall Study|Did not wish to continue (related)|0|||
28006502|NCT00383552|81853817|FG002|Overall Study|Did not wish to continue (related)|2|||
28006503|NCT00383552|81853818|FG003|Overall Study|Did not wish to continue (related)|3|||
28006504|NCT00383552|81853815|FG000|Overall Study|Noncompliance with the protocol|11|||
28006505|NCT00383552|81853816|FG001|Overall Study|Noncompliance with the protocol|6|||
28006506|NCT00383552|81853817|FG002|Overall Study|Noncompliance with the protocol|8|||
28006507|NCT00383552|81853818|FG003|Overall Study|Noncompliance with the protocol|10|||
28006508|NCT00383552|81853815|FG000|Overall Study|Did not meet protocol eligibility|8|||
28006509|NCT00383552|81853816|FG001|Overall Study|Did not meet protocol eligibility|6|||
28006510|NCT00383552|81853817|FG002|Overall Study|Did not meet protocol eligibility|2|||
27810222|NCT00947856|81134139|FG000|Follow-up Period|Lost to Follow-up|7|||
27810223|NCT00947856|81134140|FG001|Follow-up Period|Lost to Follow-up|0|||
27810224|NCT00947856|81134139|FG000|Follow-up Period|Patient unavailable for site visits|1|||
27810225|NCT00947856|81134140|FG001|Follow-up Period|Patient unavailable for site visits|0|||
27874962|NCT04314037|81375343|FG000|Treatment Period 2|Adverse Event|1|||
27874963|NCT04314037|81375344|FG001|Treatment Period 2|Adverse Event|0|||
28006511|NCT00383552|81853818|FG003|Overall Study|Did not meet protocol eligibility|3|||
28006512|NCT00383552|81853815|FG000|Overall Study|Administrative|1|||
28006513|NCT00383552|81853816|FG001|Overall Study|Administrative|0|||
27810226|NCT00947856|81134139|FG000|Follow-up Period|Withdrawal by Subject|1|||
28006514|NCT00383552|81853817|FG002|Overall Study|Administrative|1|||
28006515|NCT00383552|81853818|FG003|Overall Study|Administrative|1|||
28006516|NCT00152503|81853822|FG000|Overall Study|Adverse Event|4|||
28006517|NCT00517296|81856555|FG000|Overall Study|Withdrawal by Subject|1|||
28006518|NCT00517296|81856556|FG001|Overall Study|Withdrawal by Subject|0|||
28006519|NCT01381016|81856557|FG000|Overall Study|Lost to Follow-up|1|||
28006520|NCT01381016|81856558|FG001|Overall Study|Lost to Follow-up|1|||
28006521|NCT01381016|81856557|FG000|Overall Study|Screen Failure|2|||
28006522|NCT01381016|81856558|FG001|Overall Study|Screen Failure|2|||
28006523|NCT01381016|81856557|FG000|Overall Study|Withdrawal by Subject|0|||
28006524|NCT01381016|81856558|FG001|Overall Study|Withdrawal by Subject|1|||
28006525|NCT01381016|81856557|FG000|Overall Study|Physician Decision|0|||
28006526|NCT01381016|81856558|FG001|Overall Study|Physician Decision|2|||
28006527|NCT01349959|81856559|FG000|Overall Study|Adverse Event|7|||
28006528|NCT03489863|81856560|FG000|Overall Study|Withdrawal by Subject|0|||
28006529|NCT03489863|81856561|FG001|Overall Study|Withdrawal by Subject|1|||
27810227|NCT00947856|81134140|FG001|Follow-up Period|Withdrawal by Subject|0|||
27810228|NCT02742090|81134145|FG000|Overall Study|Adverse Event|10|||
27810229|NCT02742090|81134145|FG000|Overall Study|Death|3|||
27585928|NCT02039505|80324617|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27585929|NCT02039505|80324618|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27585930|NCT02039505|80324619|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27585931|NCT02039505|80324620|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27585932|NCT02039505|80324621|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27585933|NCT02039505|80324622|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
27585934|NCT02039505|80324623|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
27585935|NCT00253864|80324625|FG000|Overall Study|Lost to Follow-up|5|||
27585936|NCT00253864|80324626|FG001|Overall Study|Lost to Follow-up|8|||
27585937|NCT01568047|80324630|FG000|Overall Study|Ineligibility|1|||
27585938|NCT01568047|80324631|FG001|Overall Study|Ineligibility|0|||
27585939|NCT01568047|80324632|FG002|Overall Study|Ineligibility|0|||
27585940|NCT01568047|80324633|FG003|Overall Study|Ineligibility|0|||
27585941|NCT01568047|80324630|FG000|Overall Study|Withdrawal by Subject|0|||
27585942|NCT01568047|80324631|FG001|Overall Study|Withdrawal by Subject|1|||
27585943|NCT01568047|80324632|FG002|Overall Study|Withdrawal by Subject|0|||
27585944|NCT01568047|80324633|FG003|Overall Study|Withdrawal by Subject|0|||
27585945|NCT01568047|80324630|FG000|Overall Study|Adverse Event|0|||
27585946|NCT01568047|80324631|FG001|Overall Study|Adverse Event|0|||
27585947|NCT01568047|80324632|FG002|Overall Study|Adverse Event|1|||
27585948|NCT01568047|80324633|FG003|Overall Study|Adverse Event|1|||
27585949|NCT04258020|80324640|FG000|Overall Study|Withdrawal by Subject|1|||
27585950|NCT04258020|80324641|FG001|Overall Study|Withdrawal by Subject|0|||
27585951|NCT00613951|80324642|FG000|Overall Study|Adverse Event|1|||
27585952|NCT00613951|80324643|FG001|Overall Study|Adverse Event|0|||
27685180|NCT04677179|80683656|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27685181|NCT04677179|80683647|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685182|NCT04677179|80683648|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685183|NCT04677179|80683649|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685184|NCT04677179|80683650|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685185|NCT04677179|80683651|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685186|NCT04677179|80683652|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685187|NCT04677179|80683653|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
27685188|NCT04677179|80683654|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
27685189|NCT04677179|80683655|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
27685190|NCT04677179|80683656|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
27810230|NCT02742090|81134145|FG000|Overall Study|Disease Progression|25|||
27810231|NCT02742090|81134145|FG000|Overall Study|Investigator's Decision|1|||
27810232|NCT02742090|81134145|FG000|Overall Study|Lost to Follow-up|1|||
27810233|NCT02742090|81134145|FG000|Overall Study|Non-compliance with Study|1|||
27810234|NCT02742090|81134145|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
27810235|NCT02742090|81134145|FG000|Overall Study|Withdrawal by Subject|4|||
27810236|NCT02742090|81134145|FG000|Overall Study|Reason Not Specified|1|||
27810237|NCT02480010|81134146|FG000|Overall Study|Adverse Event|3|||
27585953|NCT00613951|80324644|FG002|Overall Study|Adverse Event|1|||
27585954|NCT00613951|80324642|FG000|Overall Study|Lack of Efficacy|0|||
27585955|NCT00613951|80324643|FG001|Overall Study|Lack of Efficacy|1|||
27810238|NCT02480010|81134147|FG001|Overall Study|Adverse Event|1|||
27585956|NCT00613951|80324644|FG002|Overall Study|Lack of Efficacy|1|||
28006530|NCT02694744|81856564|FG000|Overall Study|Adverse Event|2|||
28006531|NCT02694744|81856565|FG001|Overall Study|Adverse Event|1|||
28006532|NCT02694744|81856564|FG000|Overall Study|Withdrawal by Subject|2|||
27585957|NCT00613951|80324642|FG000|Overall Study|Protocol Violation|1|||
27585958|NCT00613951|80324643|FG001|Overall Study|Protocol Violation|1|||
27585959|NCT00613951|80324644|FG002|Overall Study|Protocol Violation|1|||
27585960|NCT00613951|80324642|FG000|Overall Study|Unclassified|5|||
27585961|NCT00613951|80324643|FG001|Overall Study|Unclassified|3|||
27585962|NCT00613951|80324644|FG002|Overall Study|Unclassified|2|||
27585963|NCT03943095|80328157|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
27585964|NCT03943095|80328158|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
27585965|NCT03943095|80328157|FG000|Overall Study|Withdrawal by Subject|1|||
27585966|NCT03943095|80328158|FG001|Overall Study|Withdrawal by Subject|0|||
27585967|NCT02075593|80328159|FG000|Overall Study|Withdrawal by Subject|1|||
27585968|NCT00254982|80328160|FG000|Overall Study|Other|2|||
27585969|NCT00254982|80328161|FG001|Overall Study|Other|1|||
27585970|NCT00254982|80328160|FG000|Overall Study|Lack of Efficacy|5|||
27585971|NCT00254982|80328161|FG001|Overall Study|Lack of Efficacy|3|||
27585972|NCT00254982|80328160|FG000|Overall Study|Lost to Follow-up|5|||
27585973|NCT00254982|80328161|FG001|Overall Study|Lost to Follow-up|3|||
27585974|NCT00254982|80328160|FG000|Overall Study|Adverse Event|18|||
27585975|NCT00254982|80328161|FG001|Overall Study|Adverse Event|16|||
27585976|NCT00254982|80328160|FG000|Overall Study|Withdrawal by Subject|1|||
27685191|NCT01796548|80683657|FG000|Overall Study|Lost to Follow-up|1|||
27685192|NCT01796548|80683657|FG000|Overall Study|Other|2|||
27810239|NCT02480010|81134146|FG000|Overall Study|Death|1|||
27810240|NCT02480010|81134147|FG001|Overall Study|Death|0|||
27810241|NCT02480010|81134146|FG000|Overall Study|Insufficient therapeutic response|31|||
27685193|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
27685194|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
27685195|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
27685196|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
27810242|NCT02480010|81134147|FG001|Overall Study|Insufficient therapeutic response|29|||
27810243|NCT02480010|81134146|FG000|Overall Study|Refused Treatment|0|||
27810244|NCT02480010|81134147|FG001|Overall Study|Refused Treatment|3|||
27874964|NCT04314037|81375343|FG000|Treatment Period 3|Protocol Violation|1|||
27810245|NCT00319449|81134148|FG000|Overall Study|Subject did not wish to continue|1|||
27810246|NCT00319449|81134149|FG001|Overall Study|Subject did not wish to continue|0|||
27810247|NCT00319449|81134148|FG000|Overall Study|Noncompliance with the protocol|1|||
27810248|NCT00319449|81134149|FG001|Overall Study|Noncompliance with the protocol|0|||
27810249|NCT03384745|81134151|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
27810250|NCT03384745|81134152|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
27810251|NCT03384745|81134153|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
27810252|NCT03384745|81134154|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
27810253|NCT03384745|81134155|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
27810254|NCT03384745|81134156|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
27810255|NCT03384745|81134151|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
27810256|NCT03384745|81134152|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
27810257|NCT03384745|81134153|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
27874965|NCT04314037|81375344|FG001|Treatment Period 3|Protocol Violation|0|||
27874966|NCT04314037|81375343|FG000|Treatment Period 3|Adverse Event|0|||
27874967|NCT04314037|81375344|FG001|Treatment Period 3|Adverse Event|1|||
27874968|NCT03642262|81375351|FG000|Period 1|Withdrawal by Subject|1|||
27874969|NCT03642262|81375352|FG001|Period 1|Withdrawal by Subject|1|||
27874970|NCT03642262|81375351|FG000|Period 1|Adverse Event|0|||
27874971|NCT03642262|81375352|FG001|Period 1|Adverse Event|1|||
27874972|NCT02653625|81375353|FG000|Overall Study|Adverse Event|1|||
27874973|NCT02653625|81375353|FG000|Overall Study|Non-compliance with Study Drug|1|||
27874974|NCT02653625|81375353|FG000|Overall Study|Protocol Violation|1|||
27874975|NCT02653625|81375353|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
27874976|NCT04537078|81375354|FG000|Overall Study|Protocol Violation|3|||
27874977|NCT04537078|81375355|FG001|Overall Study|Protocol Violation|2|||
27874978|NCT04537078|81375354|FG000|Overall Study|Lost to Follow-up|1|||
27874979|NCT04537078|81375355|FG001|Overall Study|Lost to Follow-up|0|||
27874980|NCT04537078|81375354|FG000|Overall Study|Withdrawal by Subject|0|||
27874981|NCT04537078|81375355|FG001|Overall Study|Withdrawal by Subject|1|||
27874982|NCT02090725|81375356|FG000|Overall Study|Withdrawal by Subject|1|||
27874983|NCT02090725|81375356|FG000|Overall Study|participants moved from area|3|||
27874984|NCT04011722|81375359|FG000|30 Days|Death|5|||
27874985|NCT04011722|81375360|FG001|30 Days|Death|1|||
27874986|NCT04011722|81375359|FG000|1 Year|Death|13|||
27874987|NCT04011722|81375360|FG001|1 Year|Death|5|||
27874988|NCT04011722|81375359|FG000|1 Year|Withdrawal by Subject|8|||
27874989|NCT04011722|81375360|FG001|1 Year|Withdrawal by Subject|2|||
27874990|NCT04011722|81375359|FG000|1 Year|Missed Visit|6|||
27585977|NCT00254982|80328161|FG001|Overall Study|Withdrawal by Subject|1|||
27585978|NCT00254982|80328160|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
27585979|NCT00254982|80328161|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
27585980|NCT00254982|80328160|FG000|Overall Study|Protocol deviation|1|||
27585981|NCT00254982|80328161|FG001|Overall Study|Protocol deviation|1|||
27585982|NCT00254982|80328160|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
27585983|NCT00254982|80328161|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
27585984|NCT00254982|80328160|FG000|Overall Study|Malignancy|0|||
27585985|NCT00254982|80328161|FG001|Overall Study|Malignancy|2|||
27585986|NCT00254982|80328160|FG000|Overall Study|Opportunistic infection|1|||
27585987|NCT00254982|80328161|FG001|Overall Study|Opportunistic infection|0|||
27585988|NCT00254982|80328160|FG000|Overall Study|Abnormal liver function tests|2|||
27585989|NCT00254982|80328161|FG001|Overall Study|Abnormal liver function tests|1|||
27585990|NCT01934218|80328165|FG000|Double-blind Phase|Adverse Event|8|||
27585991|NCT01934218|80328166|FG001|Double-blind Phase|Adverse Event|8|||
27585992|NCT01934218|80328165|FG000|Double-blind Phase|Lack of Efficacy|6|||
27585993|NCT01934218|80328166|FG001|Double-blind Phase|Lack of Efficacy|7|||
27585994|NCT01934218|80328165|FG000|Double-blind Phase|Lost to Follow-up|7|||
27585995|NCT01934218|80328166|FG001|Double-blind Phase|Lost to Follow-up|14|||
27585996|NCT01934218|80328165|FG000|Double-blind Phase|Physician Decision|1|||
27585997|NCT01934218|80328166|FG001|Double-blind Phase|Physician Decision|2|||
27585998|NCT01934218|80328165|FG000|Double-blind Phase|Protocol Violation|4|||
27585999|NCT01934218|80328166|FG001|Double-blind Phase|Protocol Violation|0|||
27586000|NCT01934218|80328165|FG000|Double-blind Phase|Withdrawal by Subject|16|||
27586001|NCT01934218|80328166|FG001|Double-blind Phase|Withdrawal by Subject|13|||
27586002|NCT01934218|80328165|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
27586003|NCT01934218|80328166|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
27586004|NCT01934218|80328165|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
27586005|NCT01934218|80328166|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
27586006|NCT01934218|80328165|FG000|Open-Label Phase|Adverse Event|2|||
27586007|NCT01934218|80328166|FG001|Open-Label Phase|Adverse Event|4|||
27586008|NCT01934218|80328165|FG000|Open-Label Phase|Lack of Efficacy|1|||
27586009|NCT01934218|80328166|FG001|Open-Label Phase|Lack of Efficacy|4|||
27586010|NCT01934218|80328165|FG000|Open-Label Phase|Lost to Follow-up|4|||
27586011|NCT01934218|80328166|FG001|Open-Label Phase|Lost to Follow-up|2|||
27586012|NCT01934218|80328165|FG000|Open-Label Phase|Physician Decision|1|||
27586013|NCT01934218|80328166|FG001|Open-Label Phase|Physician Decision|0|||
27586014|NCT01934218|80328165|FG000|Open-Label Phase|Protocol Violation|1|||
27586015|NCT01934218|80328166|FG001|Open-Label Phase|Protocol Violation|0|||
27586016|NCT01934218|80328165|FG000|Open-Label Phase|Withdrawal by Subject|13|||
27586017|NCT01934218|80328166|FG001|Open-Label Phase|Withdrawal by Subject|11|||
27586018|NCT01934218|80328165|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
27586019|NCT01934218|80328166|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
27586020|NCT01934218|80328165|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
27586021|NCT01934218|80328166|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
27586022|NCT03985423|80328170|FG000|Overall Study|Adverse Event|1|||
27586023|NCT03985423|80328170|FG000|Overall Study|Death|2|||
27586024|NCT03985423|80328170|FG000|Overall Study|Physician Decision|1|||
27586025|NCT03985423|80328170|FG000|Overall Study|Withdrawal by Subject|2|||
27586026|NCT03985423|80328170|FG000|Overall Study|Lack of insurance and citizenship|1|||
27685197|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
27810258|NCT03384745|81134154|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
27810259|NCT03384745|81134155|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
27810260|NCT03384745|81134156|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
27810261|NCT03384745|81134151|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
27810262|NCT03384745|81134152|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
27810263|NCT03384745|81134153|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
27810264|NCT03384745|81134154|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
27810265|NCT03384745|81134155|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
27810266|NCT03384745|81134156|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
27810267|NCT03384745|81134151|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
27810268|NCT03384745|81134152|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
27874991|NCT04011722|81375360|FG001|1 Year|Missed Visit|1|||
27874992|NCT04011722|81375359|FG000|1 Year|Pending Visit|0|||
27874993|NCT04011722|81375360|FG001|1 Year|Pending Visit|11|||
27874994|NCT04011722|81375359|FG000|1 Year|Not Yet Due|0|||
27685198|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
27685199|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
27685200|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
27586027|NCT01605617|80328171|FG000|First Intervention|Adverse Event|0|||
27586028|NCT01605617|80328172|FG001|First Intervention|Adverse Event|1|||
27586029|NCT01605617|80328171|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
27586030|NCT01605617|80328172|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
27586031|NCT02707055|80328173|FG000|Phase 1|Withdrawal by Subject|1|||
27586032|NCT02707055|80328174|FG001|Phase 1|Withdrawal by Subject|2|||
27586033|NCT02707055|80328173|FG000|Phase 1|Physician Decision|0|||
27586034|NCT02707055|80328174|FG001|Phase 1|Physician Decision|1|||
27586035|NCT02707055|80328173|FG000|Phase 2|Adverse Event|1|||
27586036|NCT02707055|80328174|FG001|Phase 2|Adverse Event|2|||
27586037|NCT04782323|80328175|FG000|Overall Study|Death|1|||
27586038|NCT04782323|80328176|FG001|Overall Study|Death|0|||
27586039|NCT04782323|80328177|FG002|Overall Study|Death|0|||
27586040|NCT04782323|80328178|FG003|Overall Study|Death|0|||
27586041|NCT04782323|80328179|FG004|Overall Study|Death|1|||
27586042|NCT04782323|80328180|FG005|Overall Study|Death|1|||
27586043|NCT04782323|80328181|FG006|Overall Study|Death|1|||
27586044|NCT04782323|80328182|FG007|Overall Study|Death|0|||
27586045|NCT04782323|80328175|FG000|Overall Study|Withdrawal by Subject|0|||
27586046|NCT04782323|80328176|FG001|Overall Study|Withdrawal by Subject|0|||
27586047|NCT04782323|80328177|FG002|Overall Study|Withdrawal by Subject|1|||
27586048|NCT04782323|80328178|FG003|Overall Study|Withdrawal by Subject|0|||
27586049|NCT04782323|80328179|FG004|Overall Study|Withdrawal by Subject|0|||
27586050|NCT04782323|80328180|FG005|Overall Study|Withdrawal by Subject|1|||
27586051|NCT04782323|80328181|FG006|Overall Study|Withdrawal by Subject|0|||
27586052|NCT04782323|80328182|FG007|Overall Study|Withdrawal by Subject|1|||
27586053|NCT04782323|80328175|FG000|Overall Study|Lost to Follow-up|0|||
27586054|NCT04782323|80328176|FG001|Overall Study|Lost to Follow-up|1|||
27586055|NCT04782323|80328177|FG002|Overall Study|Lost to Follow-up|1|||
27586056|NCT04782323|80328178|FG003|Overall Study|Lost to Follow-up|0|||
27586057|NCT04782323|80328179|FG004|Overall Study|Lost to Follow-up|0|||
27586058|NCT04782323|80328180|FG005|Overall Study|Lost to Follow-up|1|||
27586059|NCT04782323|80328181|FG006|Overall Study|Lost to Follow-up|1|||
27586060|NCT04782323|80328182|FG007|Overall Study|Lost to Follow-up|2|||
27586061|NCT04782323|80328175|FG000|Overall Study|randomization in error|1|||
27586062|NCT04782323|80328176|FG001|Overall Study|randomization in error|0|||
27586063|NCT04782323|80328177|FG002|Overall Study|randomization in error|0|||
27586064|NCT04782323|80328178|FG003|Overall Study|randomization in error|0|||
27586065|NCT04782323|80328179|FG004|Overall Study|randomization in error|0|||
27586066|NCT04782323|80328180|FG005|Overall Study|randomization in error|0|||
28006533|NCT02694744|81856565|FG001|Overall Study|Withdrawal by Subject|1|||
28006534|NCT02694744|81856564|FG000|Overall Study|Physician Decision|1|||
28006535|NCT02694744|81856565|FG001|Overall Study|Physician Decision|2|||
28006536|NCT02694744|81856564|FG000|Overall Study|Lost to Follow-up|1|||
28006537|NCT02694744|81856565|FG001|Overall Study|Lost to Follow-up|0|||
28006538|NCT02694744|81856564|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
28006539|NCT02694744|81856565|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
28006540|NCT04416204|81856566|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
28006541|NCT04416204|81856567|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
28006542|NCT04416204|81856568|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
28006543|NCT04416204|81856569|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
28006544|NCT04906499|81856570|FG000|Overall Study|Lack of time|1|||
28006545|NCT00770653|81856571|FG000|Overall Study|Adverse Event|13|||
28006546|NCT00770653|81856572|FG001|Overall Study|Adverse Event|5|||
28006547|NCT00770653|81856571|FG000|Overall Study|Protocol Violation|8|||
28006548|NCT00770653|81856572|FG001|Overall Study|Protocol Violation|6|||
28006549|NCT00770653|81856571|FG000|Overall Study|Withdrawal by Subject|4|||
28006550|NCT00770653|81856572|FG001|Overall Study|Withdrawal by Subject|7|||
28006551|NCT00770653|81856571|FG000|Overall Study|Lack of Compliance|1|||
27586067|NCT04782323|80328181|FG006|Overall Study|randomization in error|0|||
27586068|NCT04782323|80328182|FG007|Overall Study|randomization in error|0|||
27586069|NCT00970502|80328185|FG000|Overall Study|Withdrawal by Subject|1|||
27586070|NCT01136291|80328186|FG000|Overall Study|Lost to Follow-up|1|||
27586071|NCT01136291|80328187|FG001|Overall Study|Lost to Follow-up|1|||
27586072|NCT00435370|80328190|FG000|Overall Study|Adverse Event|8|||
27586073|NCT00435370|80328191|FG001|Overall Study|Adverse Event|8|||
27586074|NCT00435370|80328190|FG000|Overall Study|Withdrawal by Subject|10|||
27586075|NCT00435370|80328191|FG001|Overall Study|Withdrawal by Subject|10|||
28006552|NCT00770653|81856572|FG001|Overall Study|Lack of Compliance|4|||
27586076|NCT00435370|80328190|FG000|Overall Study|Antipsychotic medication changed|4|||
27586077|NCT00435370|80328191|FG001|Overall Study|Antipsychotic medication changed|2|||
27586078|NCT04773587|80328192|FG000|Overall Study|Lost to Follow-up|11|||
27586079|NCT04773587|80328193|FG001|Overall Study|Lost to Follow-up|3|||
27586080|NCT04773587|80328192|FG000|Overall Study|Adverse Event|6|||
27586081|NCT04773587|80328193|FG001|Overall Study|Adverse Event|3|||
27586082|NCT04773587|80328192|FG000|Overall Study|Lack of Efficacy|5|||
27586083|NCT04773587|80328193|FG001|Overall Study|Lack of Efficacy|2|||
27586084|NCT04773587|80328192|FG000|Overall Study|Withdrawal by Subject|4|||
27586085|NCT04773587|80328193|FG001|Overall Study|Withdrawal by Subject|5|||
27586086|NCT04773587|80328192|FG000|Overall Study|Noncompliance|1|||
27586087|NCT04773587|80328193|FG001|Overall Study|Noncompliance|0|||
27586088|NCT04773587|80328192|FG000|Overall Study|Protocol Violation|1|||
28006553|NCT00770653|81856571|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
28006554|NCT00770653|81856572|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
28006555|NCT00770653|81856571|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
28006556|NCT00770653|81856572|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
27586089|NCT04773587|80328193|FG001|Overall Study|Protocol Violation|0|||
27586090|NCT04773587|80328192|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
27586091|NCT04773587|80328193|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
27586092|NCT00993447|80328195|FG000|Overall Study|Withdrawal by Subject|23|||
27586093|NCT00993447|80328196|FG001|Overall Study|Withdrawal by Subject|8|||
27586094|NCT00993447|80328195|FG000|Overall Study|Protocol Violation|12|||
27586095|NCT00993447|80328196|FG001|Overall Study|Protocol Violation|8|||
27586096|NCT00993447|80328195|FG000|Overall Study|Lost to Follow-up|1|||
27586097|NCT00993447|80328196|FG001|Overall Study|Lost to Follow-up|3|||
27586098|NCT00993447|80328195|FG000|Overall Study|Adverse Event|1|||
27586099|NCT00993447|80328196|FG001|Overall Study|Adverse Event|0|||
27586100|NCT02159482|80328197|FG000|Overall Study|Withdrawal by Subject|2|||
27586101|NCT02159482|80328197|FG000|Overall Study|Physician Decision|3|||
27586102|NCT01198600|80328198|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
27586103|NCT01198600|80328199|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
27586104|NCT01198600|80328200|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
27586105|NCT01198600|80328201|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
27586106|NCT01198600|80328198|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
27586107|NCT01198600|80328199|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
27586108|NCT01198600|80328200|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
27586109|NCT01198600|80328201|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
27586110|NCT01198600|80328198|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
27586111|NCT01198600|80328199|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
27586112|NCT01198600|80328200|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
27586113|NCT01198600|80328201|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
27586114|NCT01198600|80328198|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
27586115|NCT01198600|80328199|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
27586116|NCT01198600|80328200|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
27586117|NCT01198600|80328201|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
27586118|NCT01198600|80328198|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
27586119|NCT01198600|80328199|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
27586120|NCT01198600|80328200|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
27586121|NCT01198600|80328201|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
27874995|NCT04011722|81375360|FG001|1 Year|Not Yet Due|9|||
27874996|NCT04011722|81375359|FG000|2 Year|Death|16|||
27874997|NCT04011722|81375360|FG001|2 Year|Death|1|||
27874998|NCT04011722|81375359|FG000|2 Year|Withdrawal by Subject|10|||
27874999|NCT04011722|81375360|FG001|2 Year|Withdrawal by Subject|1|||
27875000|NCT04011722|81375359|FG000|2 Year|Missed Visit|9|||
27875001|NCT04011722|81375360|FG001|2 Year|Missed Visit|0|||
27875002|NCT04011722|81375359|FG000|2 Year|Visit Pending|1|||
27875003|NCT04011722|81375360|FG001|2 Year|Visit Pending|3|||
27875004|NCT04011722|81375359|FG000|2 Year|Not Yet Due|43|||
27875005|NCT04011722|81375360|FG001|2 Year|Not Yet Due|54|||
27875006|NCT04011722|81375359|FG000|3 Year|Death|10|||
27875007|NCT04011722|81375360|FG001|3 Year|Death|0|||
27875008|NCT04011722|81375359|FG000|3 Year|Withdrawal by Subject|2|||
27875009|NCT04011722|81375360|FG001|3 Year|Withdrawal by Subject|0|||
27875010|NCT04011722|81375359|FG000|3 Year|Missed Visit|2|||
27875011|NCT04011722|81375360|FG001|3 Year|Missed Visit|0|||
27875012|NCT04011722|81375359|FG000|3 Year|Pending Visit|34|||
28006557|NCT00770653|81856571|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
27586122|NCT01198600|80328198|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
27586123|NCT01198600|80328199|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
27586124|NCT01198600|80328200|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
27586125|NCT01198600|80328201|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
27586126|NCT01198600|80328198|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
27586127|NCT01198600|80328199|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
27810269|NCT03384745|81134153|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
27810270|NCT03384745|81134154|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
27810271|NCT03384745|81134155|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
27810272|NCT03384745|81134156|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
27810273|NCT03384745|81134151|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
27810274|NCT03384745|81134152|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
27810275|NCT03384745|81134153|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
27810276|NCT03384745|81134154|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
27810277|NCT03384745|81134155|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
27810278|NCT03384745|81134156|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
27875013|NCT04011722|81375360|FG001|3 Year|Pending Visit|0|||
27875014|NCT04011722|81375359|FG000|3 Year|Not Yet Due|99|||
27875015|NCT04011722|81375360|FG001|3 Year|Not Yet Due|0|||
27875016|NCT01433471|81375363|FG000|Overall Study|Withdrawal by Subject|0|||
27586128|NCT01198600|80328200|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
27586129|NCT01198600|80328201|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
27586130|NCT01404312|80328205|FG000|Overall Study|Death|21|||
27586131|NCT01404312|80328206|FG001|Overall Study|Death|27|||
27586132|NCT01404312|80328205|FG000|Overall Study|Withdrawal by Subject|15|||
27586133|NCT01404312|80328206|FG001|Overall Study|Withdrawal by Subject|18|||
27810279|NCT03384745|81134151|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
28006558|NCT00770653|81856572|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
28006559|NCT00770653|81856571|FG000|Overall Study|Lost to Follow-up|1|||
28006560|NCT00770653|81856572|FG001|Overall Study|Lost to Follow-up|2|||
28006561|NCT00770653|81856571|FG000|Overall Study|Physician Decision|1|||
28006562|NCT00770653|81856572|FG001|Overall Study|Physician Decision|0|||
28006563|NCT00112736|81856573|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
28006564|NCT00112736|81856574|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
28006565|NCT01667900|81856577|FG000|Part B|Death|0|||
28006566|NCT01667900|81856578|FG001|Part B|Death|0|||
28006567|NCT01667900|81856579|FG002|Part B|Death|0|||
28006568|NCT01667900|81856580|FG003|Part B|Death|0|||
28006569|NCT01667900|81856581|FG004|Part B|Death|0|||
28006570|NCT01667900|81856582|FG005|Part B|Death|0|||
28006571|NCT01667900|81856583|FG006|Part B|Death|0|||
28006572|NCT01667900|81856584|FG007|Part B|Death|0|||
28006573|NCT01667900|81856585|FG008|Part B|Death|0|||
28006574|NCT01667900|81856586|FG009|Part B|Death|0|||
28006575|NCT01667900|81856587|FG010|Part B|Death|0|||
28006576|NCT01667900|81856588|FG011|Part B|Death|0|||
28006577|NCT01667900|81856589|FG012|Part B|Death|0|||
28006578|NCT01667900|81856590|FG013|Part B|Death|0|||
28006579|NCT01667900|81856591|FG014|Part B|Death|0|||
28006580|NCT01667900|81856592|FG015|Part B|Death|0|||
28006581|NCT01667900|81856593|FG016|Part B|Death|1|||
28006582|NCT01667900|81856594|FG017|Part B|Death|0|||
28006583|NCT01667900|81856595|FG018|Part B|Death|0|||
28006584|NCT01667900|81856596|FG019|Part B|Death|0|||
28006585|NCT03525444|81856598|FG000|Overall Study|Adverse Event|0|||
28006586|NCT03525444|81856599|FG001|Overall Study|Adverse Event|1|||
28006587|NCT03525444|81856598|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
28006588|NCT03525444|81856599|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
28006589|NCT03525444|81856598|FG000|Overall Study|Other|0|||
28006590|NCT03525444|81856599|FG001|Overall Study|Other|1|||
28006591|NCT00231777|81856600|FG000|Overall Study|Lost to Follow-up|3|||
28006592|NCT00231777|81856601|FG001|Overall Study|Lost to Follow-up|0|||
28006593|NCT00231777|81856600|FG000|Overall Study|Other|3|||
28006594|NCT00231777|81856601|FG001|Overall Study|Other|2|||
28006595|NCT01052493|81856602|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
28006596|NCT01052493|81856603|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
28006597|NCT01052493|81856604|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
28006598|NCT00168844|81856605|FG000|Overall Study|Adverse Event|31|||
28006599|NCT00168844|81856606|FG001|Overall Study|Adverse Event|32|||
28006600|NCT00168844|81856607|FG002|Overall Study|Adverse Event|48|||
28006601|NCT00168844|81856605|FG000|Overall Study|Lost to Follow-up|4|||
28006602|NCT00168844|81856606|FG001|Overall Study|Lost to Follow-up|5|||
27810280|NCT03384745|81134152|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
27810281|NCT03384745|81134153|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
27810282|NCT03384745|81134154|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
27810283|NCT03384745|81134155|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
27810284|NCT03384745|81134156|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
27810285|NCT03384745|81134151|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
27810286|NCT03384745|81134152|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
27810287|NCT03384745|81134153|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
27810288|NCT03384745|81134154|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
27810289|NCT03384745|81134155|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
27810290|NCT03384745|81134156|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
27810291|NCT03384745|81134151|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
28006603|NCT00168844|81856607|FG002|Overall Study|Lost to Follow-up|11|||
28006604|NCT00168844|81856605|FG000|Overall Study|Withdrawal by Subject|12|||
28006605|NCT00168844|81856606|FG001|Overall Study|Withdrawal by Subject|9|||
28006606|NCT00168844|81856607|FG002|Overall Study|Withdrawal by Subject|19|||
28006607|NCT00168844|81856605|FG000|Overall Study|Protocol Violation|2|||
28006608|NCT00168844|81856606|FG001|Overall Study|Protocol Violation|2|||
28006609|NCT00168844|81856607|FG002|Overall Study|Protocol Violation|4|||
27586134|NCT01404312|80328205|FG000|Overall Study|Participant Unable to get to clinic|93|||
27586135|NCT01404312|80328206|FG001|Overall Study|Participant Unable to get to clinic|103|||
28006610|NCT00168844|81856605|FG000|Overall Study|Other|6|||
28006611|NCT00168844|81856606|FG001|Overall Study|Other|7|||
28006612|NCT00168844|81856607|FG002|Overall Study|Other|9|||
28006613|NCT01323582|81856608|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
28006614|NCT01323582|81856609|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
28006615|NCT01323582|81856608|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
27810292|NCT03384745|81134152|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
27810293|NCT03384745|81134153|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
27810294|NCT03384745|81134154|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
27810295|NCT03384745|81134155|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
27810296|NCT03384745|81134156|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
27810297|NCT03384745|81134151|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
27810298|NCT03384745|81134152|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
27810299|NCT03384745|81134153|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
27875017|NCT01433471|81375364|FG001|Overall Study|Withdrawal by Subject|1|||
27875018|NCT02389829|81375372|FG000|Overall Study|Lost to Follow-up|0|||
27875019|NCT02389829|81375373|FG001|Overall Study|Lost to Follow-up|1|||
27875020|NCT01169350|81375374|FG000|Overall Study|Physician Decision|3|||
27875021|NCT01169350|81375374|FG000|Overall Study|Lost to Follow-up|2|||
27875022|NCT02301169|81375375|FG000|Overall Study|Adverse Event|1|||
27875023|NCT02301169|81375376|FG001|Overall Study|Adverse Event|0|||
27875024|NCT02070965|81375377|FG000|Overall Study|Lost to Follow-up|0|||
27875025|NCT02070965|81375378|FG001|Overall Study|Lost to Follow-up|1|||
27875026|NCT02070965|81375379|FG002|Overall Study|Lost to Follow-up|0|||
27875027|NCT02070965|81375377|FG000|Overall Study|Withdrawal by Subject|1|||
27875028|NCT02070965|81375378|FG001|Overall Study|Withdrawal by Subject|1|||
27875029|NCT02070965|81375379|FG002|Overall Study|Withdrawal by Subject|1|||
27875030|NCT02070965|81375377|FG000|Overall Study|Subject moved|1|||
27875031|NCT02070965|81375378|FG001|Overall Study|Subject moved|0|||
27875032|NCT02070965|81375379|FG002|Overall Study|Subject moved|0|||
27875033|NCT00942357|81375380|FG000|Overall Study|Ineligible|37|||
27875034|NCT00942357|81375381|FG001|Overall Study|Ineligible|40|||
27875035|NCT01202175|81375382|FG000|Overall Study|Lost to Follow-up|2|||
27875036|NCT01202175|81375382|FG000|Overall Study|Withdrawal by Subject|1|||
27875037|NCT01202175|81375382|FG000|Overall Study|Adverse Event|2|||
27875038|NCT00661193|81375387|FG000|Overall Study|Adverse Event|2|||
27875039|NCT00661193|81375388|FG001|Overall Study|Adverse Event|1|||
27875040|NCT00661193|81375387|FG000|Overall Study|Withdrawal by Subject|3|||
27875041|NCT00661193|81375388|FG001|Overall Study|Withdrawal by Subject|1|||
27875042|NCT00661193|81375387|FG000|Overall Study|Progression|27|||
27875043|NCT00661193|81375388|FG001|Overall Study|Progression|24|||
27875044|NCT00661193|81375387|FG000|Overall Study|Not protocol specified|1|||
27875045|NCT00661193|81375388|FG001|Overall Study|Not protocol specified|0|||
27875046|NCT00725920|81375389|FG000|Overall Study|Lack of Efficacy|3|||
27875047|NCT00725920|81375390|FG001|Overall Study|Lack of Efficacy|6|||
27875048|NCT02623725|81375393|FG000|Overall Study|Non compliance with protocol|9|||
27810300|NCT03384745|81134154|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
27810301|NCT03384745|81134155|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
27810302|NCT03384745|81134156|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
27875049|NCT02623725|81375394|FG001|Overall Study|Non compliance with protocol|3|||
27875050|NCT02623725|81375393|FG000|Overall Study|Serious adverse event|0|||
27875051|NCT02623725|81375394|FG001|Overall Study|Serious adverse event|2|||
27875052|NCT02623725|81375393|FG000|Overall Study|Withdrawal by Subject|7|||
27875053|NCT02623725|81375394|FG001|Overall Study|Withdrawal by Subject|1|||
27810303|NCT03384745|81134151|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
27810304|NCT03384745|81134152|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
27810305|NCT03384745|81134153|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
27810306|NCT03384745|81134154|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
27810307|NCT03384745|81134155|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
27810308|NCT03384745|81134156|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
27810309|NCT03384745|81134151|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
27810310|NCT03384745|81134152|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
27810311|NCT03384745|81134153|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
27810312|NCT03384745|81134154|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
27810313|NCT03384745|81134155|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
27810314|NCT03384745|81134156|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
27810315|NCT00712010|81134157|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
27810316|NCT01620983|81134158|FG000|Overall Study|Lost to Follow-up|8|||
27810317|NCT01620983|81134159|FG001|Overall Study|Lost to Follow-up|4|||
27875054|NCT03408639|81375395|FG000|Overall Study|Death|5|||
27875055|NCT03408639|81375396|FG001|Overall Study|Death|5|||
27875056|NCT03408639|81375395|FG000|Overall Study|Lost to Follow-up|1|||
27875057|NCT03408639|81375396|FG001|Overall Study|Lost to Follow-up|4|||
27810318|NCT01620983|81134160|FG002|Overall Study|Lost to Follow-up|9|||
27810319|NCT01620983|81134158|FG000|Overall Study|Withdrawal by Subject|6|||
27875058|NCT03408639|81375395|FG000|Overall Study|Withdrawal by Subject|2|||
27875059|NCT03408639|81375396|FG001|Overall Study|Withdrawal by Subject|7|||
27875060|NCT03408639|81375395|FG000|Overall Study|Physician Decision|3|||
27875061|NCT03408639|81375396|FG001|Overall Study|Physician Decision|6|||
27875062|NCT02656303|81375399|FG000|Overall Study|Adverse Event|3|||
27875063|NCT02656303|81375400|FG001|Overall Study|Adverse Event|2|||
27875064|NCT02656303|81375401|FG002|Overall Study|Adverse Event|0|||
27875065|NCT02656303|81375399|FG000|Overall Study|Death|12|||
28006616|NCT01323582|81856609|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
28006617|NCT01323582|81856608|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
28006618|NCT01323582|81856609|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
28006619|NCT00762359|81856610|FG000|Overall Study|Adverse Event|20|||
28006620|NCT00762359|81856611|FG001|Overall Study|Adverse Event|23|||
28006621|NCT00762359|81856610|FG000|Overall Study|Protocol Violation|21|||
28006622|NCT00762359|81856611|FG001|Overall Study|Protocol Violation|13|||
28006623|NCT00762359|81856610|FG000|Overall Study|Withdrawal by Subject|13|||
28006624|NCT00762359|81856611|FG001|Overall Study|Withdrawal by Subject|10|||
28006625|NCT00762359|81856610|FG000|Overall Study|Lack of Efficacy|0|||
28006626|NCT00762359|81856611|FG001|Overall Study|Lack of Efficacy|4|||
28006627|NCT00762359|81856610|FG000|Overall Study|Institution closed|2|||
28006628|NCT00762359|81856611|FG001|Overall Study|Institution closed|3|||
28006629|NCT00762359|81856610|FG000|Overall Study|Physician Decision|2|||
28006630|NCT00762359|81856611|FG001|Overall Study|Physician Decision|3|||
28006631|NCT00762359|81856610|FG000|Overall Study|Removal|0|||
28006632|NCT00762359|81856611|FG001|Overall Study|Removal|1|||
28006633|NCT00762359|81856610|FG000|Overall Study|Withdrew consent|1|||
28006634|NCT00762359|81856611|FG001|Overall Study|Withdrew consent|0|||
28006635|NCT01751061|81856612|FG000|Overall Study|Death|1|||
28006636|NCT01751061|81856613|FG001|Overall Study|Death|0|||
28006637|NCT01751061|81856612|FG000|Overall Study|patient death|5|||
28006638|NCT01751061|81856613|FG001|Overall Study|patient death|0|||
28006639|NCT01751061|81856612|FG000|Overall Study|Lost to Follow-up|40|||
28006640|NCT01751061|81856613|FG001|Overall Study|Lost to Follow-up|25|||
28006641|NCT01751061|81856612|FG000|Overall Study|patient regained decisional capacity|4|||
28006642|NCT01751061|81856613|FG001|Overall Study|patient regained decisional capacity|8|||
28006643|NCT01751061|81856612|FG000|Overall Study|Withdrawal by Subject|4|||
28006644|NCT01751061|81856613|FG001|Overall Study|Withdrawal by Subject|1|||
28006645|NCT01751061|81856612|FG000|Overall Study|Physician Decision|2|||
28006646|NCT01751061|81856613|FG001|Overall Study|Physician Decision|0|||
28006647|NCT00062439|81856614|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
28006648|NCT00062439|81856614|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
28006649|NCT00062439|81856614|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
28006650|NCT00062439|81856614|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
28006651|NCT00062439|81856614|FG000|Post Chemoradiation Assessment|Death|1|||
28006652|NCT00062439|81856614|FG000|Post Chemoradiation Assessment|Disease progression|2|||
28006653|NCT00062439|81856614|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
28006654|NCT00062439|81856614|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
28006655|NCT00062439|81856614|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
28006656|NCT00062439|81856614|FG000|Surgery|Physician Decision|4|||
28006657|NCT00062439|81856614|FG000|Surgery|Death|1|||
28006658|NCT00062439|81856614|FG000|Surgery|Adverse Event|2|||
28006659|NCT00062439|81856614|FG000|Consolidation Chemotherapy|Adverse Event|2|||
28006660|NCT04247347|81856617|FG000|Overall Study|Withdrawal by Subject|2|||
28006661|NCT04247347|81856618|FG001|Overall Study|Withdrawal by Subject|3|||
28006662|NCT04247347|81856619|FG002|Overall Study|Withdrawal by Subject|3|||
28006663|NCT04247347|81856617|FG000|Overall Study|Lost to Follow-up|1|||
28006664|NCT04247347|81856618|FG001|Overall Study|Lost to Follow-up|1|||
28006665|NCT04247347|81856619|FG002|Overall Study|Lost to Follow-up|1|||
28006666|NCT02163902|81856626|FG000|Overall Study|Subject's Request|3|||
28006667|NCT02163902|81856627|FG001|Overall Study|Subject's Request|4|||
28006668|NCT02163902|81856626|FG000|Overall Study|Lost to Follow-up|6|||
28006669|NCT02163902|81856627|FG001|Overall Study|Lost to Follow-up|7|||
28006670|NCT02163902|81856626|FG000|Overall Study|Administrative Decision|2|||
28006671|NCT02163902|81856627|FG001|Overall Study|Administrative Decision|2|||
28006672|NCT03452540|81856632|FG000|Overall Study|Adverse Event|1|||
28006673|NCT03452540|81856632|FG000|Overall Study|Withdrawal by Subject|1|||
28006674|NCT03452540|81856632|FG000|Overall Study|Other SAE and AE|2|||
28006675|NCT00383786|81856633|FG000|Overall Study|Protocol Violation|2|||
28006676|NCT00383786|81856634|FG001|Overall Study|Protocol Violation|6|||
28006677|NCT00383786|81856633|FG000|Overall Study|Withdrawal by Subject|2|||
28006678|NCT00383786|81856634|FG001|Overall Study|Withdrawal by Subject|5|||
28006679|NCT00383786|81856633|FG000|Overall Study|Physician Decision|0|||
27586136|NCT01404312|80328205|FG000|Overall Study|Lost to Follow-up|115|||
28006680|NCT00383786|81856634|FG001|Overall Study|Physician Decision|1|||
27586137|NCT01404312|80328206|FG001|Overall Study|Lost to Follow-up|111|||
27875066|NCT02656303|81375400|FG001|Overall Study|Death|4|||
28006681|NCT01924845|81856635|FG000|Overall Study|Adverse Event|3|||
28006682|NCT01924845|81856635|FG000|Overall Study|Withdrawal by Subject|2|||
28006683|NCT01924845|81856635|FG000|Overall Study|Protocol Violation|1|||
28006684|NCT01690052|81856637|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
28006685|NCT01690052|81856638|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
28006686|NCT01755234|81856648|FG000|Overall Study|Lost to Follow-up|11|||
27586138|NCT01404312|80328205|FG000|Overall Study|Site closed|22|||
28006687|NCT01755234|81856649|FG001|Overall Study|Lost to Follow-up|6|||
28006688|NCT01755234|81856648|FG000|Overall Study|Change in surgical case|2|||
28006689|NCT01755234|81856649|FG001|Overall Study|Change in surgical case|1|||
28006690|NCT01755234|81856648|FG000|Overall Study|case cancelled|1|||
28006691|NCT01755234|81856649|FG001|Overall Study|case cancelled|0|||
28006692|NCT01755234|81856648|FG000|Overall Study|Withdrawal by Subject|0|||
28006693|NCT01755234|81856649|FG001|Overall Study|Withdrawal by Subject|1|||
28006694|NCT01755234|81856648|FG000|Overall Study|unblinded|1|||
28006695|NCT01755234|81856649|FG001|Overall Study|unblinded|0|||
28006696|NCT00772538|81856650|FG000|Overall Study|Adverse Event|6|||
28006697|NCT00772538|81856651|FG001|Overall Study|Adverse Event|6|||
28006698|NCT00772538|81856650|FG000|Overall Study|Protocol Violation|3|||
28006699|NCT00772538|81856651|FG001|Overall Study|Protocol Violation|3|||
28006700|NCT00772538|81856650|FG000|Overall Study|Lost to Follow-up|1|||
28006701|NCT00772538|81856651|FG001|Overall Study|Lost to Follow-up|1|||
28006702|NCT00772538|81856650|FG000|Overall Study|Withdrawal by Subject|3|||
28006703|NCT00772538|81856651|FG001|Overall Study|Withdrawal by Subject|8|||
28006704|NCT00772538|81856650|FG000|Overall Study|Lack of Efficacy|0|||
28006705|NCT00772538|81856651|FG001|Overall Study|Lack of Efficacy|1|||
28006706|NCT00772538|81856650|FG000|Overall Study|Other|7|||
28006707|NCT00772538|81856651|FG001|Overall Study|Other|7|||
28006708|NCT01844765|81856654|FG000|Overall Study|Adverse Event|6|||
28006709|NCT01844765|81856655|FG001|Overall Study|Adverse Event|8|||
28006710|NCT01844765|81856654|FG000|Overall Study|Withdrawal by Subject|2|||
28006711|NCT01844765|81856655|FG001|Overall Study|Withdrawal by Subject|3|||
28006712|NCT01844765|81856654|FG000|Overall Study|Disease progression|1|||
28006713|NCT01844765|81856655|FG001|Overall Study|Disease progression|0|||
28006714|NCT01844765|81856654|FG000|Overall Study|Administrative problems|3|||
28006715|NCT01844765|81856655|FG001|Overall Study|Administrative problems|4|||
28006716|NCT01844765|81856654|FG000|Overall Study|Protocol deviation|2|||
28006717|NCT01844765|81856655|FG001|Overall Study|Protocol deviation|0|||
28006718|NCT01844765|81856654|FG000|Overall Study|Untreated|1|||
28006719|NCT01844765|81856655|FG001|Overall Study|Untreated|0|||
28006720|NCT01446159|81856656|FG000|Overall Study|Withdrawal by Subject|1|||
28006721|NCT01446159|81856657|FG001|Overall Study|Withdrawal by Subject|0|||
28006722|NCT01446159|81856658|FG002|Overall Study|Withdrawal by Subject|14|||
28006723|NCT01446159|81856659|FG003|Overall Study|Withdrawal by Subject|11|||
28006724|NCT01446159|81856656|FG000|Overall Study|Lost to Follow-up|0|||
28006725|NCT01446159|81856657|FG001|Overall Study|Lost to Follow-up|0|||
28006726|NCT01446159|81856658|FG002|Overall Study|Lost to Follow-up|1|||
28006727|NCT01446159|81856659|FG003|Overall Study|Lost to Follow-up|2|||
28006728|NCT01446159|81856656|FG000|Overall Study|Death|2|||
28006729|NCT01446159|81856657|FG001|Overall Study|Death|3|||
28006730|NCT01446159|81856658|FG002|Overall Study|Death|43|||
28006731|NCT01446159|81856659|FG003|Overall Study|Death|36|||
28006732|NCT01446159|81856656|FG000|Overall Study|Other|0|||
28006733|NCT01446159|81856657|FG001|Overall Study|Other|0|||
28006734|NCT01446159|81856658|FG002|Overall Study|Other|13|||
28006735|NCT01446159|81856659|FG003|Overall Study|Other|13|||
27810320|NCT01620983|81134159|FG001|Overall Study|Withdrawal by Subject|8|||
28006736|NCT03379818|81856660|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
28006737|NCT03379818|81856661|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
28006738|NCT03379818|81856660|FG000|Overall Study|Withdrawal by Subject|2|||
28006739|NCT03379818|81856661|FG001|Overall Study|Withdrawal by Subject|3|||
28006740|NCT03379818|81856660|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
28006741|NCT03379818|81856661|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
28006742|NCT04349891|81856664|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
28006743|NCT04349891|81856665|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
28006744|NCT04349891|81856664|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
28006745|NCT04349891|81856665|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
28006746|NCT04349891|81856664|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
28006747|NCT04349891|81856665|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
28006748|NCT04349891|81856664|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
28006749|NCT04349891|81856665|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
27810321|NCT01620983|81134160|FG002|Overall Study|Withdrawal by Subject|1|||
27810322|NCT01620983|81134158|FG000|Overall Study|Death|2|||
28006750|NCT02973100|81856668|FG000|Overall Study|Adverse Event|1|||
28006751|NCT02973100|81856669|FG001|Overall Study|Adverse Event|2|||
28006752|NCT02973100|81856670|FG002|Overall Study|Adverse Event|1|||
28006753|NCT02973100|81856671|FG003|Overall Study|Adverse Event|2|||
28006754|NCT02973100|81856668|FG000|Overall Study|Lost to Follow-up|3|||
28006755|NCT02973100|81856669|FG001|Overall Study|Lost to Follow-up|1|||
28006756|NCT02973100|81856670|FG002|Overall Study|Lost to Follow-up|1|||
28006757|NCT02973100|81856671|FG003|Overall Study|Lost to Follow-up|0|||
27810323|NCT01620983|81134159|FG001|Overall Study|Death|0|||
27810324|NCT01620983|81134160|FG002|Overall Study|Death|0|||
28006758|NCT02973100|81856668|FG000|Overall Study|Withdrawal by Subject|3|||
28006759|NCT02973100|81856669|FG001|Overall Study|Withdrawal by Subject|5|||
27810325|NCT01620983|81134158|FG000|Overall Study|Physician Decision|3|||
27810326|NCT01620983|81134159|FG001|Overall Study|Physician Decision|10|||
27810327|NCT01620983|81134160|FG002|Overall Study|Physician Decision|5|||
27810328|NCT01606137|81134161|FG000|Overall Study|Adverse Event|85|||
27810329|NCT01606137|81134161|FG000|Overall Study|Withdrawal by Subject|74|||
27810330|NCT01606137|81134161|FG000|Overall Study|Lack of Efficacy|56|||
27810331|NCT01606137|81134161|FG000|Overall Study|Lost to Follow-up|15|||
27810332|NCT01606137|81134161|FG000|Overall Study|Protocol Violation|1|||
27810333|NCT01606137|81134161|FG000|Overall Study|Patient non-compliance|9|||
27810334|NCT01606137|81134161|FG000|Overall Study|Death|1|||
27810335|NCT01606137|81134161|FG000|Overall Study|Decreased/no pain|4|||
27810336|NCT01606137|81134161|FG000|Overall Study|Issues with driving|4|||
27810337|NCT01606137|81134161|FG000|Overall Study|multiple sclerosis less stable|1|||
27810338|NCT01606137|81134161|FG000|Overall Study|Increased bilirubin|1|||
27810339|NCT01606137|81134161|FG000|Overall Study|Spray causes nausea|1|||
27810340|NCT01606137|81134161|FG000|Overall Study|Not enough improvement|4|||
27810341|NCT01606137|81134161|FG000|Overall Study|Wanted to try another treatment|1|||
27810342|NCT01606137|81134161|FG000|Overall Study|Patient leaving country|1|||
27810343|NCT01606137|81134161|FG000|Overall Study|Personal reasons|1|||
27810344|NCT01606137|81134161|FG000|Overall Study|Unable to tolerate study med. taste|1|||
27810345|NCT01606137|81134161|FG000|Overall Study|Patient moving|1|||
27810346|NCT01606137|81134161|FG000|Overall Study|Unable to collect consistent data|1|||
27810347|NCT01488578|81134167|FG000|Overall Study|Protocol Violation|1836|||
27810348|NCT02473510|81134173|FG000|Overall Study|Lost to Follow-up|1|||
27810349|NCT02473510|81134174|FG001|Overall Study|Lost to Follow-up|2|||
27810350|NCT01886300|81137310|FG000|Overall Study|Trial terminated by sponsor|16|||
27810351|NCT04896385|81137317|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
27810352|NCT04896385|81137318|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
27810353|NCT04896385|81137319|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
27810354|NCT04896385|81137320|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
27875067|NCT02656303|81375401|FG002|Overall Study|Death|1|||
27875068|NCT02656303|81375399|FG000|Overall Study|Lack of Efficacy|1|||
27875069|NCT02656303|81375400|FG001|Overall Study|Lack of Efficacy|0|||
27875070|NCT02656303|81375401|FG002|Overall Study|Lack of Efficacy|0|||
27875071|NCT02656303|81375399|FG000|Overall Study|Non-Compliance with Study|1|||
27875072|NCT02656303|81375400|FG001|Overall Study|Non-Compliance with Study|1|||
27875073|NCT02656303|81375401|FG002|Overall Study|Non-Compliance with Study|0|||
27875074|NCT02656303|81375399|FG000|Overall Study|Investigator Decision|2|||
27875075|NCT02656303|81375400|FG001|Overall Study|Investigator Decision|1|||
27875076|NCT02656303|81375401|FG002|Overall Study|Investigator Decision|0|||
27875077|NCT02656303|81375399|FG000|Overall Study|Progressive Disease|25|||
27875078|NCT02656303|81375400|FG001|Overall Study|Progressive Disease|14|||
27875079|NCT02656303|81375401|FG002|Overall Study|Progressive Disease|10|||
27875080|NCT02656303|81375399|FG000|Overall Study|Study Terminated by Sponsor|20|||
27875081|NCT02656303|81375400|FG001|Overall Study|Study Terminated by Sponsor|7|||
27875082|NCT02656303|81375401|FG002|Overall Study|Study Terminated by Sponsor|5|||
27875083|NCT02656303|81375399|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
27875084|NCT02656303|81375400|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
27875085|NCT02656303|81375401|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
27875086|NCT02656303|81375399|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
27875087|NCT02656303|81375400|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
27875088|NCT02656303|81375401|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
27875089|NCT02656303|81375399|FG000|Overall Study|Reason not Specified|1|||
27875090|NCT02656303|81375400|FG001|Overall Study|Reason not Specified|1|||
27875091|NCT02656303|81375401|FG002|Overall Study|Reason not Specified|2|||
27875092|NCT01515423|81375403|FG000|Open Label Phase|Adverse Event|57|||
27875093|NCT01515423|81375404|FG001|Open Label Phase|Adverse Event|0|||
28006760|NCT02973100|81856670|FG002|Overall Study|Withdrawal by Subject|1|||
28006761|NCT02973100|81856671|FG003|Overall Study|Withdrawal by Subject|4|||
27875094|NCT01515423|81375405|FG002|Open Label Phase|Adverse Event|0|||
27875095|NCT01515423|81375403|FG000|Open Label Phase|Death|2|||
27875096|NCT01515423|81375404|FG001|Open Label Phase|Death|0|||
27875097|NCT01515423|81375405|FG002|Open Label Phase|Death|0|||
28006762|NCT02973100|81856668|FG000|Overall Study|Notification of change in address|0|||
27810355|NCT04896385|81137317|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
27810356|NCT04896385|81137318|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
27810357|NCT04896385|81137319|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
27810358|NCT04896385|81137320|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
27810359|NCT04896385|81137317|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
27810360|NCT04896385|81137318|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
27875098|NCT01515423|81375403|FG000|Open Label Phase|Lack of Efficacy|117|||
27875099|NCT01515423|81375404|FG001|Open Label Phase|Lack of Efficacy|0|||
27875100|NCT01515423|81375405|FG002|Open Label Phase|Lack of Efficacy|0|||
27875101|NCT01515423|81375403|FG000|Open Label Phase|Lost to Follow-up|21|||
27875102|NCT01515423|81375404|FG001|Open Label Phase|Lost to Follow-up|0|||
28006763|NCT02973100|81856669|FG001|Overall Study|Notification of change in address|0|||
28006764|NCT02973100|81856670|FG002|Overall Study|Notification of change in address|0|||
28006765|NCT02973100|81856671|FG003|Overall Study|Notification of change in address|1|||
28006766|NCT02973100|81856668|FG000|Overall Study|Failed to attend Safety followup period|0|||
28006767|NCT02973100|81856669|FG001|Overall Study|Failed to attend Safety followup period|0|||
28006768|NCT02973100|81856670|FG002|Overall Study|Failed to attend Safety followup period|1|||
28006769|NCT02973100|81856671|FG003|Overall Study|Failed to attend Safety followup period|0|||
28006770|NCT00837434|81856676|FG000|Overall Study|Physician Decision|3|||
28006771|NCT00837434|81856677|FG001|Overall Study|Physician Decision|0|||
28006772|NCT00837434|81856676|FG000|Overall Study|Lost to Follow-up|1|||
28006773|NCT00837434|81856677|FG001|Overall Study|Lost to Follow-up|1|||
28006774|NCT00837434|81856676|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
28006775|NCT00837434|81856677|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
28006776|NCT00837434|81856676|FG000|Overall Study|Noncompliant|2|||
28006777|NCT00837434|81856677|FG001|Overall Study|Noncompliant|0|||
28006778|NCT00837434|81856676|FG000|Overall Study|Baseline assessments not done in time|1|||
28006779|NCT00837434|81856677|FG001|Overall Study|Baseline assessments not done in time|0|||
27586139|NCT01404312|80328206|FG001|Overall Study|Site closed|21|||
27586140|NCT01404312|80328205|FG000|Overall Study|Participant not willing to adhere to req|31|||
27586141|NCT01404312|80328206|FG001|Overall Study|Participant not willing to adhere to req|29|||
27586142|NCT01404312|80328205|FG000|Overall Study|Severe debilitation, unable to continue|1|||
27586143|NCT01404312|80328206|FG001|Overall Study|Severe debilitation, unable to continue|2|||
27586144|NCT02013765|80328211|FG000|Overall Study|Trial was terminated by sponsor|1|||
27586145|NCT02648698|80328214|FG000|Overall Study|Protocol Violation|1|||
27586146|NCT02648698|80328215|FG001|Overall Study|Protocol Violation|5|||
27586147|NCT04642638|80328216|FG000|Overall Study|Withdrawal by Subject|23|||
27586148|NCT04642638|80328217|FG001|Overall Study|Withdrawal by Subject|29|||
27586149|NCT04642638|80328218|FG002|Overall Study|Withdrawal by Subject|9|||
27586150|NCT04642638|80328219|FG003|Overall Study|Withdrawal by Subject|7|||
27586151|NCT04642638|80328220|FG004|Overall Study|Withdrawal by Subject|61|||
27586152|NCT04642638|80328221|FG005|Overall Study|Withdrawal by Subject|27|||
27586153|NCT04642638|80328216|FG000|Overall Study|Lost to Follow-up|17|||
27586154|NCT04642638|80328217|FG001|Overall Study|Lost to Follow-up|18|||
27586155|NCT04642638|80328218|FG002|Overall Study|Lost to Follow-up|5|||
27586156|NCT04642638|80328219|FG003|Overall Study|Lost to Follow-up|5|||
27586157|NCT04642638|80328220|FG004|Overall Study|Lost to Follow-up|6|||
27586158|NCT04642638|80328221|FG005|Overall Study|Lost to Follow-up|3|||
27586159|NCT04642638|80328216|FG000|Overall Study|Adverse Event|0|||
27586160|NCT04642638|80328217|FG001|Overall Study|Adverse Event|0|||
27586161|NCT04642638|80328218|FG002|Overall Study|Adverse Event|1|||
27586162|NCT04642638|80328219|FG003|Overall Study|Adverse Event|0|||
27586163|NCT04642638|80328220|FG004|Overall Study|Adverse Event|10|||
27586164|NCT04642638|80328221|FG005|Overall Study|Adverse Event|3|||
27586165|NCT04642638|80328216|FG000|Overall Study|Reason Not Specified|1|||
27586166|NCT04642638|80328217|FG001|Overall Study|Reason Not Specified|4|||
27586167|NCT04642638|80328218|FG002|Overall Study|Reason Not Specified|0|||
27586168|NCT04642638|80328219|FG003|Overall Study|Reason Not Specified|0|||
27586169|NCT04642638|80328220|FG004|Overall Study|Reason Not Specified|38|||
27586170|NCT04642638|80328221|FG005|Overall Study|Reason Not Specified|16|||
27586171|NCT04642638|80328216|FG000|Overall Study|Physician Decision|0|||
27586172|NCT04642638|80328217|FG001|Overall Study|Physician Decision|0|||
27586173|NCT04642638|80328218|FG002|Overall Study|Physician Decision|0|||
27586174|NCT04642638|80328219|FG003|Overall Study|Physician Decision|0|||
27586175|NCT04642638|80328220|FG004|Overall Study|Physician Decision|2|||
27586176|NCT04642638|80328221|FG005|Overall Study|Physician Decision|1|||
27586177|NCT04642638|80328216|FG000|Overall Study|Protocol Deviation|0|||
27586178|NCT04642638|80328217|FG001|Overall Study|Protocol Deviation|0|||
27586179|NCT04642638|80328218|FG002|Overall Study|Protocol Deviation|0|||
27685201|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
27685202|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
27586180|NCT04642638|80328219|FG003|Overall Study|Protocol Deviation|0|||
27586181|NCT04642638|80328220|FG004|Overall Study|Protocol Deviation|1|||
27586182|NCT04642638|80328221|FG005|Overall Study|Protocol Deviation|3|||
27586183|NCT04642638|80328216|FG000|Overall Study|Study Terminated|0|||
27586184|NCT04642638|80328217|FG001|Overall Study|Study Terminated|0|||
27586185|NCT04642638|80328218|FG002|Overall Study|Study Terminated|0|||
27586186|NCT04642638|80328219|FG003|Overall Study|Study Terminated|0|||
27586187|NCT04642638|80328220|FG004|Overall Study|Study Terminated|484|||
27586188|NCT04642638|80328221|FG005|Overall Study|Study Terminated|250|||
27586189|NCT04642638|80328216|FG000|Overall Study|Pregnancy|0|||
27586190|NCT04642638|80328217|FG001|Overall Study|Pregnancy|0|||
27586191|NCT04642638|80328218|FG002|Overall Study|Pregnancy|0|||
28006780|NCT00837434|81856676|FG000|Overall Study|Unable to obtain study drug|1|||
27586192|NCT04642638|80328219|FG003|Overall Study|Pregnancy|0|||
27586193|NCT04642638|80328220|FG004|Overall Study|Pregnancy|1|||
27586194|NCT04642638|80328221|FG005|Overall Study|Pregnancy|0|||
27586195|NCT01306162|80328222|FG000|Period 1|Adverse Event|0|||
27875103|NCT01515423|81375405|FG002|Open Label Phase|Lost to Follow-up|0|||
27875104|NCT01515423|81375403|FG000|Open Label Phase|Withdrawal by Subject|118|||
27875105|NCT01515423|81375404|FG001|Open Label Phase|Withdrawal by Subject|0|||
27875106|NCT01515423|81375405|FG002|Open Label Phase|Withdrawal by Subject|0|||
27875107|NCT01515423|81375403|FG000|Open Label Phase|excluded from DB Phase|70|||
27875108|NCT01515423|81375404|FG001|Open Label Phase|excluded from DB Phase|0|||
27875109|NCT01515423|81375405|FG002|Open Label Phase|excluded from DB Phase|0|||
27875110|NCT01515423|81375403|FG000|Open Label Phase|Other|28|||
27810361|NCT04896385|81137319|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
27810362|NCT04896385|81137320|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
27810363|NCT04896385|81137317|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
27810364|NCT04896385|81137318|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
27810365|NCT04896385|81137319|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
27810366|NCT04896385|81137320|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
27586196|NCT01306162|80328223|FG001|Period 1|Adverse Event|0|||
27586197|NCT01306162|80328224|FG002|Period 1|Adverse Event|0|||
27586198|NCT01306162|80328225|FG003|Period 1|Adverse Event|1|||
27586199|NCT01306162|80328222|FG000|Washout 1|Non-compliance to protocol|0|||
27810367|NCT04896385|81137317|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
27810368|NCT04896385|81137318|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
27810369|NCT04896385|81137319|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
27810370|NCT04896385|81137320|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
27810371|NCT04896385|81137317|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
27810372|NCT04896385|81137318|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
27810373|NCT04896385|81137319|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
27810374|NCT04896385|81137320|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
27810375|NCT00982410|81137321|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
27810376|NCT00982410|81137322|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
27810377|NCT00982410|81137321|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
27810378|NCT00982410|81137322|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
27810379|NCT00982410|81137321|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
27810380|NCT00982410|81137322|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
27810381|NCT00982410|81137321|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
27810382|NCT00982410|81137322|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
27810383|NCT00982410|81137321|FG000|6-month Follow-up Assessment|participant no transportation|1|||
27810384|NCT00982410|81137322|FG001|6-month Follow-up Assessment|participant no transportation|0|||
27810385|NCT00982410|81137321|FG000|6-month Follow-up Assessment|incarceration|0|||
27810386|NCT00982410|81137322|FG001|6-month Follow-up Assessment|incarceration|2|||
27810387|NCT00982410|81137321|FG000|6-month Follow-up Assessment|patent surgery|0|||
27810388|NCT00982410|81137322|FG001|6-month Follow-up Assessment|patent surgery|1|||
27810389|NCT00982410|81137321|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
27810390|NCT00982410|81137322|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
27810391|NCT00982410|81137321|FG000|12-month Follow-up Assessment|Death|0|||
27810392|NCT00982410|81137322|FG001|12-month Follow-up Assessment|Death|2|||
27810393|NCT00982410|81137321|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
27810394|NCT00982410|81137322|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
27810395|NCT00982410|81137321|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
27810396|NCT00982410|81137322|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
27810397|NCT00982410|81137321|FG000|12-month Follow-up Assessment|incarceration|2|||
27810398|NCT00982410|81137322|FG001|12-month Follow-up Assessment|incarceration|1|||
27810399|NCT00982410|81137321|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
27810400|NCT00982410|81137322|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
27810401|NCT01280981|81137323|FG000|Overall Study|Withdrawal by Subject|11|||
27810402|NCT01280981|81137323|FG000|Overall Study|Protocol Violation|2|||
27810403|NCT01280981|81137323|FG000|Overall Study|Lack of Efficacy|13|||
27810404|NCT01280981|81137323|FG000|Overall Study|Lost to Follow-up|3|||
27810405|NCT01280981|81137323|FG000|Overall Study|Adverse Event|6|||
27875111|NCT01515423|81375404|FG001|Open Label Phase|Other|0|||
27875112|NCT01515423|81375405|FG002|Open Label Phase|Other|0|||
27875113|NCT01515423|81375403|FG000|DOUBLE BLIND|Adverse Event|0|||
27875114|NCT01515423|81375404|FG001|DOUBLE BLIND|Adverse Event|15|||
27875115|NCT01515423|81375405|FG002|DOUBLE BLIND|Adverse Event|13|||
27810406|NCT01280981|81137323|FG000|Overall Study|Irregular or discontinued menses|3|||
27810407|NCT01280981|81137323|FG000|Overall Study|Failed to return|45|||
27810408|NCT01280981|81137323|FG000|Overall Study|Non-compliance with protocol|3|||
27810409|NCT01280981|81137323|FG000|Overall Study|Withdrawal of consent|3|||
27810410|NCT01280981|81137323|FG000|Overall Study|Elective surgery|2|||
27810411|NCT01280981|81137323|FG000|Overall Study|Study site closure|1|||
27810412|NCT02004847|81137327|FG000|Overall Study|Protocol Violation|1|||
27875116|NCT01515423|81375403|FG000|DOUBLE BLIND|Death|0|||
27875117|NCT01515423|81375404|FG001|DOUBLE BLIND|Death|1|||
27586200|NCT01306162|80328223|FG001|Washout 1|Non-compliance to protocol|1|||
27810413|NCT02004847|81137328|FG001|Overall Study|Protocol Violation|1|||
28006781|NCT00837434|81856677|FG001|Overall Study|Unable to obtain study drug|0|||
28006782|NCT02173769|81856678|FG000|Overall Study|Protocol Violation|4|||
28006783|NCT04924062|81856679|FG000|Overall Study|Death|49|||
28006784|NCT04924062|81856680|FG001|Overall Study|Death|63|||
28006785|NCT04924062|81856679|FG000|Overall Study|Participant On-going|26|||
28006786|NCT04924062|81856680|FG001|Overall Study|Participant On-going|20|||
28006787|NCT03724942|81856700|FG000|Overall Study|Adverse Event|20|||
28006788|NCT03724942|81856701|FG001|Overall Study|Adverse Event|14|||
28006789|NCT03724942|81856700|FG000|Overall Study|Lack of Efficacy|0|||
28006790|NCT03724942|81856701|FG001|Overall Study|Lack of Efficacy|1|||
28006791|NCT03724942|81856700|FG000|Overall Study|Physician Decision|5|||
28006792|NCT03724942|81856701|FG001|Overall Study|Physician Decision|2|||
28006793|NCT03724942|81856700|FG000|Overall Study|Protocol Violation|1|||
28006794|NCT03724942|81856701|FG001|Overall Study|Protocol Violation|0|||
28006795|NCT03724942|81856700|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
28006796|NCT03724942|81856701|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
28006797|NCT03724942|81856700|FG000|Overall Study|Withdrawal by Legal Representative|3|||
28006798|NCT03724942|81856701|FG001|Overall Study|Withdrawal by Legal Representative|0|||
28006799|NCT06308822|81856702|FG000|Overall Study|Mutation Status Not Confirmed|17|||
28006800|NCT06308822|81856702|FG000|Overall Study|Adverse Event|1|||
28006801|NCT06308822|81856702|FG000|Overall Study|Death|5|||
28006802|NCT06308822|81856702|FG000|Overall Study|Disease progression|8|||
28006803|NCT06308822|81856702|FG000|Overall Study|Withdrawal by Subject|1|||
28006804|NCT06308822|81856702|FG000|Overall Study|Physician Decision|3|||
28006805|NCT02087423|81856703|FG000|Overall Study|Withdrawal by Subject|20|||
28006806|NCT02087423|81856704|FG001|Overall Study|Withdrawal by Subject|20|||
28006807|NCT02087423|81856705|FG002|Overall Study|Withdrawal by Subject|3|||
28006808|NCT02087423|81856703|FG000|Overall Study|Death|68|||
28006809|NCT02087423|81856704|FG001|Overall Study|Death|207|||
28006810|NCT02087423|81856705|FG002|Overall Study|Death|40|||
28006811|NCT02087423|81856703|FG000|Overall Study|Lost to Follow-up|0|||
28006812|NCT02087423|81856704|FG001|Overall Study|Lost to Follow-up|2|||
28006813|NCT02087423|81856705|FG002|Overall Study|Lost to Follow-up|0|||
28006814|NCT02087423|81856703|FG000|Overall Study|Terminated from study at final DCO|23|||
28006815|NCT02087423|81856704|FG001|Overall Study|Terminated from study at final DCO|36|||
27586201|NCT01306162|80328224|FG002|Washout 1|Non-compliance to protocol|0|||
27586202|NCT01306162|80328225|FG003|Washout 1|Non-compliance to protocol|0|||
27586203|NCT01073618|80328226|FG000|Overall Study|Death|208|||
27586204|NCT01073618|80328226|FG000|Overall Study|Adverse Event|19|||
27586205|NCT01073618|80328226|FG000|Overall Study|Other|80|||
27586206|NCT02043782|80328227|FG000|Period 1|Adverse Event|0|||
27586207|NCT02043782|80328228|FG001|Period 1|Adverse Event|0|||
27586208|NCT02043782|80328229|FG002|Period 1|Adverse Event|1|||
27586209|NCT02043782|80328230|FG003|Period 1|Adverse Event|0|||
27586210|NCT02043782|80328231|FG004|Period 1|Adverse Event|0|||
27586211|NCT02043782|80328232|FG005|Period 1|Adverse Event|0|||
27586212|NCT00353704|80328233|FG000|Overall Study|Protocol Violation|3|||
27586213|NCT00353704|80328234|FG001|Overall Study|Protocol Violation|1|||
27586214|NCT01329029|80328235|FG000|Overall Study|Withdrawal by Subject|117|||
27810414|NCT00385541|81137329|FG000|Overall Study|severe pain, clinician requested unblind|0|||
27810415|NCT00385541|81137330|FG001|Overall Study|severe pain, clinician requested unblind|1|||
27810416|NCT03538756|81137335|FG000|Long-Term Follow-up|Adverse Event|0|||
27810417|NCT03538756|81137336|FG001|Long-Term Follow-up|Adverse Event|0|||
27810418|NCT03538756|81137337|FG002|Long-Term Follow-up|Adverse Event|6|||
28006816|NCT02087423|81856705|FG002|Overall Study|Terminated from study at final DCO|25|||
28006817|NCT04124939|81856709|FG000|Overall Study|Lost to Follow-up|1|||
28006818|NCT04124939|81856710|FG001|Overall Study|Lost to Follow-up|3|||
28006819|NCT03600909|81856713|FG000|Overall Study|Not treated|0|||
28006820|NCT03600909|81856714|FG001|Overall Study|Not treated|3|||
28006821|NCT03600909|81856715|FG002|Overall Study|Not treated|0|||
27586215|NCT01329029|80328236|FG001|Overall Study|Withdrawal by Subject|87|||
27586216|NCT01329029|80328235|FG000|Overall Study|Adverse Event|82|||
27586217|NCT01329029|80328236|FG001|Overall Study|Adverse Event|29|||
27586218|NCT01329029|80328235|FG000|Overall Study|Death|16|||
27586219|NCT01329029|80328236|FG001|Overall Study|Death|19|||
27586220|NCT01329029|80328235|FG000|Overall Study|Other|14|||
28006822|NCT00481832|81856716|FG000|Enrollment|Physician Decision|8|||
28006823|NCT00481832|81856716|FG000|Enrollment|Unable to collect enough stem cells|2|||
28006824|NCT00481832|81856716|FG000|Inter-transplant Period|Adverse Event|4|||
28006825|NCT00481832|81856716|FG000|Inter-transplant Period|Death|3|||
28006826|NCT00481832|81856716|FG000|Inter-transplant Period|Physician Decision|4|||
28006827|NCT00481832|81856716|FG000|Inter-transplant Period|Disease relapse|11|||
28006828|NCT00481832|81856716|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
28006829|NCT00474812|81856717|FG000|Overall Study|Withdrawal by Subject|5|||
28006830|NCT00474812|81856717|FG000|Overall Study|No Initiation of treatment|2|||
28006831|NCT00617734|81856718|FG000|Overall Study|Withdrew Consent|2|||
28006832|NCT00617734|81856719|FG001|Overall Study|Withdrew Consent|0|||
27685203|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Adverse Event|0|||
27685204|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Adverse Event|0|||
27875118|NCT01515423|81375405|FG002|DOUBLE BLIND|Death|2|||
27875119|NCT01515423|81375403|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
27875120|NCT01515423|81375404|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
27875121|NCT01515423|81375405|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
27875122|NCT01515423|81375403|FG000|DOUBLE BLIND|Pregnancy|0|||
27875123|NCT01515423|81375404|FG001|DOUBLE BLIND|Pregnancy|2|||
27875124|NCT01515423|81375405|FG002|DOUBLE BLIND|Pregnancy|0|||
27875125|NCT01515423|81375403|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
27875126|NCT01515423|81375404|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
27875127|NCT01515423|81375405|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
27875128|NCT01515423|81375403|FG000|DOUBLE BLIND|Other|0|||
27875129|NCT01515423|81375404|FG001|DOUBLE BLIND|Other|6|||
27875130|NCT01515423|81375405|FG002|DOUBLE BLIND|Other|12|||
27875131|NCT01515423|81375403|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
27875132|NCT01515423|81375404|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
27875133|NCT01515423|81375405|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
27875134|NCT01139775|81375406|FG000|Overall Study|Adverse Event|0|||
27875135|NCT01139775|81375407|FG001|Overall Study|Adverse Event|6|||
27875136|NCT01139775|81375408|FG002|Overall Study|Adverse Event|2|||
27875137|NCT01139775|81375406|FG000|Overall Study|Protocol Violation|0|||
28006833|NCT00617734|81856718|FG000|Overall Study|Adverse Event|4|||
28006834|NCT00617734|81856719|FG001|Overall Study|Adverse Event|1|||
28006835|NCT00617734|81856718|FG000|Overall Study|Protocol Violation|1|||
28006836|NCT00617734|81856719|FG001|Overall Study|Protocol Violation|0|||
28006837|NCT00617734|81856718|FG000|Overall Study|Found Ineligible After Randomization|1|||
28006838|NCT00617734|81856719|FG001|Overall Study|Found Ineligible After Randomization|4|||
28006839|NCT00617734|81856718|FG000|Overall Study|Lost to Follow-up|0|||
28006840|NCT00617734|81856719|FG001|Overall Study|Lost to Follow-up|1|||
27810419|NCT03538756|81137335|FG000|Long-Term Follow-up|Death|0|||
27810420|NCT03538756|81137336|FG001|Long-Term Follow-up|Death|0|||
27810421|NCT03538756|81137337|FG002|Long-Term Follow-up|Death|1|||
27810422|NCT03538756|81137335|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
27810423|NCT03538756|81137336|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
27810424|NCT03538756|81137337|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
27810425|NCT03538756|81137335|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
27810426|NCT03538756|81137336|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
27810427|NCT03538756|81137337|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
27810428|NCT03538756|81137335|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
27810429|NCT03538756|81137336|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
27810430|NCT03538756|81137337|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
27810431|NCT01346410|81137338|FG000|Overall Study|Death|1|||
27810432|NCT01953783|81137339|FG000|Overall Study|Progressive disease|2|||
27810433|NCT02232074|81137340|FG000|Overall Study|Withdrawal by Subject|5|||
27810434|NCT02232074|81137341|FG001|Overall Study|Withdrawal by Subject|3|||
27810435|NCT02232074|81137340|FG000|Overall Study|No legal concerns at baseline|36|||
27810436|NCT02232074|81137341|FG001|Overall Study|No legal concerns at baseline|41|||
27810437|NCT02232074|81137340|FG000|Overall Study|deemed ineligible|0|||
27810438|NCT02232074|81137341|FG001|Overall Study|deemed ineligible|1|||
27810439|NCT00278200|81137342|FG000|Overall Study|Death|1|||
27810440|NCT00278200|81137343|FG001|Overall Study|Death|3|||
27810441|NCT00278200|81137342|FG000|Overall Study|Physician Decision|0|||
27810442|NCT00278200|81137343|FG001|Overall Study|Physician Decision|1|||
27810443|NCT00384033|81137344|FG000|Overall Study|Adverse Event|10|||
27810444|NCT00384033|81137345|FG001|Overall Study|Adverse Event|8|||
27810445|NCT00384033|81137346|FG002|Overall Study|Adverse Event|11|||
27810446|NCT00384033|81137347|FG003|Overall Study|Adverse Event|20|||
27810447|NCT00384033|81137344|FG000|Overall Study|Failed to return|1|||
27810448|NCT00384033|81137345|FG001|Overall Study|Failed to return|3|||
27810449|NCT00384033|81137346|FG002|Overall Study|Failed to return|2|||
27810450|NCT00384033|81137347|FG003|Overall Study|Failed to return|2|||
27810451|NCT00384033|81137344|FG000|Overall Study|Physician Decision|1|||
27810452|NCT00384033|81137345|FG001|Overall Study|Physician Decision|0|||
27810453|NCT00384033|81137346|FG002|Overall Study|Physician Decision|0|||
27810454|NCT00384033|81137347|FG003|Overall Study|Physician Decision|0|||
27810455|NCT00384033|81137344|FG000|Overall Study|Lost to Follow-up|6|||
27810456|NCT00384033|81137345|FG001|Overall Study|Lost to Follow-up|12|||
27810457|NCT00384033|81137346|FG002|Overall Study|Lost to Follow-up|7|||
27810458|NCT00384033|81137347|FG003|Overall Study|Lost to Follow-up|7|||
27810459|NCT00384033|81137344|FG000|Overall Study|Other|2|||
27810460|NCT00384033|81137345|FG001|Overall Study|Other|0|||
27875138|NCT01139775|81375407|FG001|Overall Study|Protocol Violation|5|||
27875139|NCT01139775|81375408|FG002|Overall Study|Protocol Violation|0|||
27875140|NCT01139775|81375406|FG000|Overall Study|Withdrawal by Subject|1|||
27875141|NCT01139775|81375407|FG001|Overall Study|Withdrawal by Subject|0|||
27875142|NCT01139775|81375408|FG002|Overall Study|Withdrawal by Subject|2|||
28006841|NCT03532542|81856720|FG000|Overall Study|Death|1|||
28006842|NCT03532542|81856721|FG001|Overall Study|Death|0|||
27586221|NCT01329029|80328236|FG001|Overall Study|Other|20|||
27586222|NCT01329029|80328235|FG000|Overall Study|COPD Exacerbation|11|||
27586223|NCT01329029|80328236|FG001|Overall Study|COPD Exacerbation|18|||
27586224|NCT01329029|80328235|FG000|Overall Study|Physician Decision|16|||
27586225|NCT01329029|80328236|FG001|Overall Study|Physician Decision|13|||
27586226|NCT01329029|80328235|FG000|Overall Study|Lost to Follow-up|8|||
27586227|NCT01329029|80328236|FG001|Overall Study|Lost to Follow-up|5|||
27586228|NCT01329029|80328235|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
27586229|NCT01329029|80328236|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
27586230|NCT01286779|80328237|FG000|Overall Study|Withdrawal by Subject|9|||
27586231|NCT01286779|80328237|FG000|Overall Study|Protocol Violation|5|||
27586232|NCT01286779|80328237|FG000|Overall Study|Physician Decision|2|||
27586233|NCT01286779|80328237|FG000|Overall Study|Participant had scheduled surgery|1|||
27586234|NCT01286779|80328237|FG000|Overall Study|Participant moved to another country|1|||
27586235|NCT01286779|80328237|FG000|Overall Study|Discontinued by sponsor|1|||
27586236|NCT02802345|80328240|FG000|Overall Study|Not Treated|0|||
27810461|NCT00384033|81137346|FG002|Overall Study|Other|0|||
27810462|NCT00384033|81137347|FG003|Overall Study|Other|0|||
28006843|NCT03532542|81856720|FG000|Overall Study|Study Terminated by Sponsor|41|||
28006844|NCT03532542|81856721|FG001|Overall Study|Study Terminated by Sponsor|65|||
28006845|NCT03532542|81856720|FG000|Overall Study|Withdrawal by Subject|6|||
28006846|NCT03532542|81856721|FG001|Overall Study|Withdrawal by Subject|5|||
28006847|NCT03597347|81856723|FG000|Overall Study|Withdrawal by Subject|1|||
28006848|NCT03597347|81856724|FG001|Overall Study|Withdrawal by Subject|1|||
28006849|NCT03597347|81856725|FG002|Overall Study|Withdrawal by Subject|0|||
27810463|NCT00384033|81137344|FG000|Overall Study|Protocol Violation|5|||
27810464|NCT00384033|81137345|FG001|Overall Study|Protocol Violation|0|||
27810465|NCT00384033|81137346|FG002|Overall Study|Protocol Violation|5|||
27810466|NCT00384033|81137347|FG003|Overall Study|Protocol Violation|6|||
27810467|NCT00384033|81137344|FG000|Overall Study|Withdrawal by Subject|6|||
27810468|NCT00384033|81137345|FG001|Overall Study|Withdrawal by Subject|2|||
27810469|NCT00384033|81137346|FG002|Overall Study|Withdrawal by Subject|5|||
27875143|NCT01139775|81375406|FG000|Overall Study|Physician Decision|0|||
28006850|NCT03597347|81856723|FG000|Overall Study|Withdrawal due to Covid-19|3|||
28006851|NCT03597347|81856724|FG001|Overall Study|Withdrawal due to Covid-19|0|||
28006852|NCT03597347|81856725|FG002|Overall Study|Withdrawal due to Covid-19|0|||
28006853|NCT03597347|81856723|FG000|Overall Study|Sponsor decision to terminate study|3|||
28006854|NCT03597347|81856724|FG001|Overall Study|Sponsor decision to terminate study|2|||
28006855|NCT03597347|81856725|FG002|Overall Study|Sponsor decision to terminate study|4|||
28006856|NCT04551989|81856728|FG000|Overall Study|Adverse Event|4|||
28006857|NCT04551989|81856728|FG000|Overall Study|Protocol Violation|3|||
28006858|NCT04551989|81856728|FG000|Overall Study|Lost to Follow-up|1|||
28006859|NCT04551989|81856728|FG000|Overall Study|Physician Decision|3|||
28006860|NCT01908426|81856731|FG000|Overall Study|Adverse Event|98|||
28006861|NCT01908426|81856732|FG001|Overall Study|Adverse Event|11|||
28006862|NCT01908426|81856731|FG000|Overall Study|Clinical Deterioration|72|||
28006863|NCT01908426|81856732|FG001|Overall Study|Clinical Deterioration|38|||
28006864|NCT01908426|81856731|FG000|Overall Study|Lack of Efficacy|3|||
28006865|NCT01908426|81856732|FG001|Overall Study|Lack of Efficacy|0|||
28006866|NCT01908426|81856731|FG000|Overall Study|Lost to Follow-up|0|||
28006867|NCT01908426|81856732|FG001|Overall Study|Lost to Follow-up|1|||
28006868|NCT01908426|81856731|FG000|Overall Study|Physician Decision|3|||
28006869|NCT01908426|81856732|FG001|Overall Study|Physician Decision|3|||
28006870|NCT01908426|81856731|FG000|Overall Study|Withdrawal by Subject|11|||
28006871|NCT01908426|81856732|FG001|Overall Study|Withdrawal by Subject|6|||
28006872|NCT01908426|81856731|FG000|Overall Study|Progressive Disease|206|||
27586237|NCT02802345|80328241|FG001|Overall Study|Not Treated|1|||
27586238|NCT02802345|80328240|FG000|Overall Study|Adverse Event|28|||
27586239|NCT02802345|80328241|FG001|Overall Study|Adverse Event|20|||
27586240|NCT02802345|80328240|FG000|Overall Study|Withdrawal by Subject|3|||
27586241|NCT02802345|80328241|FG001|Overall Study|Withdrawal by Subject|3|||
27586242|NCT02802345|80328240|FG000|Overall Study|Protocol Violation|0|||
27586243|NCT02802345|80328241|FG001|Overall Study|Protocol Violation|1|||
27810470|NCT00384033|81137347|FG003|Overall Study|Withdrawal by Subject|2|||
27810471|NCT00384033|81137344|FG000|Overall Study|Lack of Efficacy|7|||
27810472|NCT00384033|81137345|FG001|Overall Study|Lack of Efficacy|3|||
28006873|NCT01908426|81856732|FG001|Overall Study|Progressive Disease|152|||
28006874|NCT01908426|81856731|FG000|Overall Study|Protocol Violation|1|||
28006875|NCT01908426|81856732|FG001|Overall Study|Protocol Violation|0|||
28006876|NCT01908426|81856731|FG000|Overall Study|No Study Treatment Given|3|||
28006877|NCT01908426|81856732|FG001|Overall Study|No Study Treatment Given|0|||
28006878|NCT00107653|81856733|FG000|Overall Study|Adverse Event|24|||
28006879|NCT00107653|81856734|FG001|Overall Study|Adverse Event|43|||
28006880|NCT00107653|81856733|FG000|Overall Study|Insufficient Therapeutic Response|25|||
27810473|NCT00384033|81137346|FG002|Overall Study|Lack of Efficacy|3|||
28006881|NCT00107653|81856734|FG001|Overall Study|Insufficient Therapeutic Response|11|||
28006882|NCT00107653|81856733|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
28006883|NCT00107653|81856734|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
28006884|NCT00107653|81856733|FG000|Overall Study|Protocol Violation|1|||
28006885|NCT00107653|81856734|FG001|Overall Study|Protocol Violation|0|||
28006886|NCT00107653|81856733|FG000|Overall Study|Withdrawal by Subject|12|||
28006887|NCT00107653|81856734|FG001|Overall Study|Withdrawal by Subject|13|||
28006888|NCT00107653|81856733|FG000|Overall Study|Lost to Follow-up|13|||
28006889|NCT00107653|81856734|FG001|Overall Study|Lost to Follow-up|5|||
28006890|NCT00107653|81856733|FG000|Overall Study|Administrative Reasons|3|||
28006891|NCT00107653|81856734|FG001|Overall Study|Administrative Reasons|3|||
28006892|NCT02399215|81856748|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
28006893|NCT02399215|81856748|FG000|Overall Study|Withdrawal by Subject|1|||
28006894|NCT00771758|81856749|FG000|Overall Study|Adverse Event|2|||
28006895|NCT00771758|81856750|FG001|Overall Study|Adverse Event|8|||
28006896|NCT00771758|81856751|FG002|Overall Study|Adverse Event|1|||
28006897|NCT00771758|81856749|FG000|Overall Study|Lack of Efficacy|0|||
28006898|NCT00771758|81856750|FG001|Overall Study|Lack of Efficacy|2|||
28006899|NCT00771758|81856751|FG002|Overall Study|Lack of Efficacy|1|||
28006900|NCT00771758|81856749|FG000|Overall Study|Lost to Follow-up|1|||
28006901|NCT00771758|81856750|FG001|Overall Study|Lost to Follow-up|0|||
28006902|NCT00771758|81856751|FG002|Overall Study|Lost to Follow-up|0|||
28006903|NCT00771758|81856749|FG000|Overall Study|Protocol Violation|1|||
28006904|NCT00771758|81856750|FG001|Overall Study|Protocol Violation|0|||
28006905|NCT00771758|81856751|FG002|Overall Study|Protocol Violation|0|||
28006906|NCT00771758|81856749|FG000|Overall Study|Withdrawal by Subject|1|||
28006907|NCT00771758|81856750|FG001|Overall Study|Withdrawal by Subject|0|||
28006908|NCT00771758|81856751|FG002|Overall Study|Withdrawal by Subject|0|||
28006909|NCT00771758|81856749|FG000|Overall Study|Other|3|||
28006910|NCT00771758|81856750|FG001|Overall Study|Other|2|||
28006911|NCT00771758|81856751|FG002|Overall Study|Other|0|||
28006912|NCT03259230|81856754|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
28006913|NCT03259230|81856755|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
28006914|NCT03416868|81856756|FG000|Overall Study|Withdrawal by Subject|2|||
28006915|NCT03416868|81856756|FG000|Overall Study|Lost to Follow-up|1|||
28006916|NCT00473434|81856757|FG000|Overall Study|Physician Decision|3|||
28006917|NCT00473434|81856757|FG000|Overall Study|Withdrawal by Subject|9|||
28006918|NCT00473434|81856757|FG000|Overall Study|Compliance|3|||
28006919|NCT00473434|81856757|FG000|Overall Study|Lack of Efficacy|3|||
28006920|NCT00473434|81856757|FG000|Overall Study|Adverse Event|3|||
28006921|NCT00473434|81856757|FG000|Overall Study|Patient was selling medication to others|1|||
28006922|NCT00473434|81856757|FG000|Overall Study|Safety evaluation|1|||
28006923|NCT00473434|81856757|FG000|Overall Study|Reason not specified|6|||
28006924|NCT00473434|81856757|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
28006925|NCT00473434|81856757|FG000|Overall Study|Switching to trial medication|1|||
28006926|NCT00473434|81856757|FG000|Overall Study|No longer required|1|||
28006927|NCT01097668|81856760|FG000|Overall Study|Withdrawal by Subject|1|||
28006928|NCT01097668|81856761|FG001|Overall Study|Withdrawal by Subject|2|||
28006929|NCT01097668|81856760|FG000|Overall Study|Lost to Follow-up|1|||
28006930|NCT01097668|81856761|FG001|Overall Study|Lost to Follow-up|0|||
28006931|NCT00141453|81856762|FG000|Overall Study|Protocol Violation|6|||
28006932|NCT00141453|81856763|FG001|Overall Study|Protocol Violation|5|||
28006933|NCT02384551|81856764|FG000|Overall Study|Lost to Follow-up|13|||
28006934|NCT02384551|81856765|FG001|Overall Study|Lost to Follow-up|14|||
28006935|NCT02384551|81856766|FG002|Overall Study|Lost to Follow-up|14|||
28006936|NCT02384551|81856767|FG003|Overall Study|Lost to Follow-up|14|||
28006937|NCT03040999|81856768|FG000|Overall Study|Lost to Follow-up|1|||
28006938|NCT03040999|81856769|FG001|Overall Study|Lost to Follow-up|0|||
28006939|NCT03040999|81856768|FG000|Overall Study|Withdrawal by Subject|7|||
28006940|NCT03040999|81856769|FG001|Overall Study|Withdrawal by Subject|12|||
28006941|NCT03040999|81856768|FG000|Overall Study|Death|128|||
28006942|NCT03040999|81856769|FG001|Overall Study|Death|138|||
28006943|NCT03040999|81856768|FG000|Overall Study|Participants Ongoing in Trial|266|||
28006944|NCT03040999|81856769|FG001|Overall Study|Participants Ongoing in Trial|252|||
28006945|NCT03922581|81856773|FG000|Overall Study|Lost to Follow-up|20|||
28006946|NCT03922581|81856774|FG001|Overall Study|Lost to Follow-up|9|||
28006947|NCT03922581|81856773|FG000|Overall Study|Physician Decision|1|||
28006948|NCT03922581|81856774|FG001|Overall Study|Physician Decision|1|||
28006949|NCT03922581|81856773|FG000|Overall Study|Withdrawal by Subject|1|||
28006950|NCT03922581|81856774|FG001|Overall Study|Withdrawal by Subject|0|||
28006951|NCT01126749|81856775|FG000|Phase 1b|Other|0|||
28006952|NCT01126749|81856776|FG001|Phase 1b|Other|1|||
28006953|NCT01126749|81856777|FG002|Phase 1b|Other|0|||
28006954|NCT01126749|81856778|FG003|Phase 1b|Other|0|||
28006955|NCT01126749|81856775|FG000|Phase 1b|Withdrawal by Subject|0|||
28006956|NCT01126749|81856776|FG001|Phase 1b|Withdrawal by Subject|1|||
28006957|NCT01126749|81856777|FG002|Phase 1b|Withdrawal by Subject|0|||
28006958|NCT01126749|81856778|FG003|Phase 1b|Withdrawal by Subject|0|||
28006959|NCT01126749|81856775|FG000|Phase 1b|Death|3|||
27810474|NCT00384033|81137347|FG003|Overall Study|Lack of Efficacy|1|||
27810475|NCT00384033|81137344|FG000|Overall Study|Randomized but not treated|3|||
27810476|NCT00384033|81137345|FG001|Overall Study|Randomized but not treated|7|||
27875144|NCT01139775|81375407|FG001|Overall Study|Physician Decision|2|||
27875145|NCT01139775|81375408|FG002|Overall Study|Physician Decision|2|||
27875146|NCT00733005|81375409|FG000|Overall Study|Adverse Event|0|||
27875147|NCT00733005|81375410|FG001|Overall Study|Adverse Event|1|||
27875148|NCT00733005|81375409|FG000|Overall Study|Treatment Failure|0|||
27875149|NCT00733005|81375410|FG001|Overall Study|Treatment Failure|1|||
27875150|NCT00733005|81375409|FG000|Overall Study|Withdrawal by Subject|0|||
27875151|NCT00733005|81375410|FG001|Overall Study|Withdrawal by Subject|1|||
27875152|NCT00733005|81375409|FG000|Overall Study|Protocol Violation|2|||
27875153|NCT00733005|81375410|FG001|Overall Study|Protocol Violation|0|||
27875154|NCT03627546|81375415|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
27875155|NCT03627546|81375416|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
27875156|NCT03627546|81375417|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
27875157|NCT03627546|81375415|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
27875158|NCT03627546|81375416|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
27875159|NCT03627546|81375417|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
27875160|NCT02440464|81375418|FG000|Overall Study|Withdrawal by Subject|3|||
27875161|NCT02440464|81375419|FG001|Overall Study|Withdrawal by Subject|2|||
27875162|NCT01778855|81375420|FG000|Overall Study|Death|0|||
27875163|NCT01778855|81375421|FG001|Overall Study|Death|1|||
27875164|NCT01217112|81375424|FG000|Overall Study|Adverse Event|0|||
28006960|NCT01126749|81856776|FG001|Phase 1b|Death|4|||
28006961|NCT01126749|81856777|FG002|Phase 1b|Death|0|||
28006962|NCT01126749|81856778|FG003|Phase 1b|Death|0|||
28006963|NCT01126749|81856775|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
28006964|NCT01126749|81856776|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
28006965|NCT01126749|81856777|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
28006966|NCT01126749|81856778|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
27586244|NCT02802345|80328240|FG000|Overall Study|Other than listed|1|||
27586245|NCT02802345|80328241|FG001|Overall Study|Other than listed|5|||
27586246|NCT04408469|80328243|FG000|Overall Study|Lost to Follow-up|6|||
27586247|NCT04408469|80328244|FG001|Overall Study|Lost to Follow-up|9|||
27586248|NCT04408469|80328243|FG000|Overall Study|Withdrawal by Subject|6|||
27586249|NCT04408469|80328244|FG001|Overall Study|Withdrawal by Subject|1|||
27586250|NCT04408469|80328243|FG000|Overall Study|Dismissal due to ineligibility|0|||
27586251|NCT04408469|80328244|FG001|Overall Study|Dismissal due to ineligibility|1|||
27586252|NCT02660944|80328246|FG000|Overall Study|Adverse Event|3|||
27810477|NCT00384033|81137346|FG002|Overall Study|Randomized but not treated|10|||
27810478|NCT00384033|81137347|FG003|Overall Study|Randomized but not treated|2|||
27586253|NCT02660944|80328247|FG001|Overall Study|Adverse Event|4|||
27810479|NCT03377556|81137348|FG000|Overall Study|Adverse Event|5|||
27810480|NCT03377556|81137348|FG000|Overall Study|Refusal unrelated to adverse events|1|||
27810481|NCT03377556|81137348|FG000|Overall Study|Progression/relapse|38|||
27810482|NCT03377556|81137348|FG000|Overall Study|Death|3|||
27810483|NCT01497938|81137349|FG000|Overall Study|Adverse Event|0|||
27810484|NCT01497938|81137350|FG001|Overall Study|Adverse Event|1|||
27810485|NCT01497938|81137349|FG000|Overall Study|Physician Decision|0|||
27810486|NCT01497938|81137350|FG001|Overall Study|Physician Decision|1|||
27810487|NCT01497938|81137349|FG000|Overall Study|Withdrawal by Subject|4|||
27810488|NCT01497938|81137350|FG001|Overall Study|Withdrawal by Subject|0|||
27810489|NCT01497938|81137349|FG000|Overall Study|Device Violation|1|||
27810490|NCT01497938|81137350|FG001|Overall Study|Device Violation|0|||
27810491|NCT00608205|81137352|FG000|Overall Study|Adverse Event|3|||
28006967|NCT01126749|81856775|FG000|Phase 2|Study Termination by Sponsor|0|||
28006968|NCT01126749|81856776|FG001|Phase 2|Study Termination by Sponsor|0|||
28006969|NCT01126749|81856777|FG002|Phase 2|Study Termination by Sponsor|12|||
28006970|NCT01126749|81856778|FG003|Phase 2|Study Termination by Sponsor|6|||
28006971|NCT01126749|81856775|FG000|Phase 2|Other|0|||
28006972|NCT01126749|81856776|FG001|Phase 2|Other|0|||
27586254|NCT02660944|80328246|FG000|Overall Study|Physician Decision|3|||
27586255|NCT02660944|80328247|FG001|Overall Study|Physician Decision|1|||
27586256|NCT02660944|80328246|FG000|Overall Study|Withdrawal by Subject|5|||
27810492|NCT00608205|81137353|FG001|Overall Study|Adverse Event|2|||
27586257|NCT02660944|80328247|FG001|Overall Study|Withdrawal by Subject|3|||
27810493|NCT00608205|81137352|FG000|Overall Study|Patient non-compliant|0|||
27810494|NCT00608205|81137353|FG001|Overall Study|Patient non-compliant|1|||
27810495|NCT02688400|81137355|FG000|Overall Study|Protocol Violation|2|||
27810496|NCT02688400|81137356|FG001|Overall Study|Protocol Violation|5|||
27810497|NCT02688400|81137355|FG000|Overall Study|Lack of Efficacy|7|||
27875165|NCT01217112|81375425|FG001|Overall Study|Adverse Event|2|||
27875166|NCT01217112|81375426|FG002|Overall Study|Adverse Event|0|||
27875167|NCT01217112|81375427|FG003|Overall Study|Adverse Event|2|||
27875168|NCT01217112|81375428|FG004|Overall Study|Adverse Event|0|||
27875169|NCT01217112|81375424|FG000|Overall Study|Withdrawal by Subject|0|||
27810498|NCT02688400|81137356|FG001|Overall Study|Lack of Efficacy|7|||
27810499|NCT02688400|81137355|FG000|Overall Study|Adverse Event|21|||
27810500|NCT02688400|81137356|FG001|Overall Study|Adverse Event|12|||
27810501|NCT02688400|81137355|FG000|Overall Study|Withdrawal by Subject|15|||
27810502|NCT02688400|81137356|FG001|Overall Study|Withdrawal by Subject|13|||
27810503|NCT02688400|81137355|FG000|Overall Study|No study medication intake|1|||
27810504|NCT02688400|81137356|FG001|Overall Study|No study medication intake|4|||
27810505|NCT02688400|81137355|FG000|Overall Study|Lost to Follow-up|0|||
27810506|NCT02688400|81137356|FG001|Overall Study|Lost to Follow-up|3|||
27810507|NCT02739984|81137364|FG000|Overall Study|Sponsor Decision|1|||
27810508|NCT02739984|81137365|FG001|Overall Study|Sponsor Decision|0|||
27810509|NCT02739984|81137364|FG000|Overall Study|Withdrawal by Subject|1|||
27810510|NCT02739984|81137365|FG001|Overall Study|Withdrawal by Subject|1|||
27810511|NCT02739984|81137364|FG000|Overall Study|Death|0|||
27810512|NCT02739984|81137365|FG001|Overall Study|Death|1|||
27810513|NCT02739984|81137364|FG000|Overall Study|Lost to Follow-up|3|||
27810514|NCT02739984|81137365|FG001|Overall Study|Lost to Follow-up|0|||
27810515|NCT00891774|81137373|FG000|Overall Study|Lost to Follow-up|5|||
27810516|NCT00891774|81137373|FG000|Overall Study|Illness (Self/Mother)|3|||
27810517|NCT00891774|81137373|FG000|Overall Study|Withdrawal by Subject|2|||
27810518|NCT00891774|81137373|FG000|Overall Study|Protocol Violation|4|||
27810519|NCT05085964|81137374|FG000|Overall Study|Premature termination of study|21|||
27810520|NCT05085964|81137375|FG001|Overall Study|Premature termination of study|0|||
27810521|NCT03731182|81137380|FG000|Overall Study|Lost to Follow-up|2|||
27810522|NCT03731182|81137381|FG001|Overall Study|Lost to Follow-up|0|||
27810523|NCT03731182|81137380|FG000|Overall Study|Physician Decision|1|||
27810524|NCT03731182|81137381|FG001|Overall Study|Physician Decision|0|||
27810525|NCT03731182|81137380|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
27810526|NCT03731182|81137381|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
27810527|NCT00759148|81137385|FG000|Overall Study|Adverse Event|1|||
27810528|NCT00759148|81137386|FG001|Overall Study|Adverse Event|6|||
27810529|NCT00759148|81137385|FG000|Overall Study|Withdrawal by Subject|3|||
27810530|NCT00759148|81137386|FG001|Overall Study|Withdrawal by Subject|7|||
27810531|NCT00759148|81137385|FG000|Overall Study|Lost to Follow-up|3|||
27810532|NCT00759148|81137386|FG001|Overall Study|Lost to Follow-up|9|||
27810533|NCT00759148|81137385|FG000|Overall Study|Treatment Failure|6|||
27810534|NCT00759148|81137386|FG001|Overall Study|Treatment Failure|10|||
27810535|NCT00759148|81137385|FG000|Overall Study|Reason not given|1|||
27810536|NCT00759148|81137386|FG001|Overall Study|Reason not given|0|||
27810537|NCT01725113|81137390|FG000|Overall Study|Kidney Transplant|1|||
27810538|NCT01725113|81137391|FG001|Overall Study|Kidney Transplant|1|||
27810539|NCT01725113|81137390|FG000|Overall Study|Withdrawal by Subject|0|||
27810540|NCT01725113|81137391|FG001|Overall Study|Withdrawal by Subject|1|||
27810541|NCT01960816|81137392|FG000|Overall Study|Lost to Follow-up|1|||
27810542|NCT01625377|81137393|FG000|Overall Study|Death|1|||
27810543|NCT01625377|81137394|FG001|Overall Study|Death|1|||
27810544|NCT01625377|81137393|FG000|Overall Study|Administrative Problem|1|||
27810545|NCT01625377|81137394|FG001|Overall Study|Administrative Problem|1|||
27810546|NCT01625377|81137393|FG000|Overall Study|Protocol Violation|0|||
27810547|NCT01625377|81137394|FG001|Overall Study|Protocol Violation|3|||
27810548|NCT01625377|81137393|FG000|Overall Study|Adverse Event|3|||
27810549|NCT01625377|81137394|FG001|Overall Study|Adverse Event|16|||
27810550|NCT01625377|81137393|FG000|Overall Study|Graft loss|1|||
27810551|NCT01625377|81137394|FG001|Overall Study|Graft loss|0|||
27810552|NCT01625377|81137393|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27810553|NCT01625377|81137394|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27810554|NCT01625377|81137393|FG000|Overall Study|Abnormal laboratory values|1|||
27875170|NCT01217112|81375425|FG001|Overall Study|Withdrawal by Subject|0|||
28006973|NCT01126749|81856777|FG002|Phase 2|Other|4|||
28006974|NCT01126749|81856778|FG003|Phase 2|Other|2|||
28006975|NCT01126749|81856775|FG000|Phase 2|Withdrawal by Subject|0|||
28006976|NCT01126749|81856776|FG001|Phase 2|Withdrawal by Subject|0|||
28006977|NCT01126749|81856777|FG002|Phase 2|Withdrawal by Subject|0|||
28006978|NCT01126749|81856778|FG003|Phase 2|Withdrawal by Subject|2|||
28006979|NCT01126749|81856775|FG000|Phase 2|Lost to Follow-up|0|||
27810555|NCT01625377|81137394|FG001|Overall Study|Abnormal laboratory values|0|||
27810556|NCT04081337|81137395|FG000|Overall Study|Adverse Event|0|||
27810557|NCT04081337|81137396|FG001|Overall Study|Adverse Event|1|||
28006980|NCT01126749|81856776|FG001|Phase 2|Lost to Follow-up|0|||
27810558|NCT04081337|81137395|FG000|Overall Study|Withdrawal by Subject|2|||
27810559|NCT04081337|81137396|FG001|Overall Study|Withdrawal by Subject|0|||
27810560|NCT04081337|81137395|FG000|Overall Study|Physician Decision|1|||
27810561|NCT04081337|81137396|FG001|Overall Study|Physician Decision|2|||
27810562|NCT04081337|81137395|FG000|Overall Study|Lost to Follow-up|1|||
27810563|NCT04081337|81137396|FG001|Overall Study|Lost to Follow-up|0|||
27810564|NCT02570165|81137397|FG000|Overall Study|Adverse Event|1|||
27810565|NCT02570165|81137398|FG001|Overall Study|Adverse Event|0|||
27810566|NCT02570165|81137399|FG002|Overall Study|Adverse Event|2|||
27810567|NCT02570165|81137400|FG003|Overall Study|Adverse Event|0|||
28006981|NCT01126749|81856777|FG002|Phase 2|Lost to Follow-up|0|||
27810568|NCT02570165|81137401|FG004|Overall Study|Adverse Event|0|||
27810569|NCT02570165|81137402|FG005|Overall Study|Adverse Event|0|||
27810570|NCT02570165|81137403|FG006|Overall Study|Adverse Event|0|||
27810571|NCT02570165|81137397|FG000|Overall Study|Lack of Efficacy|0|||
27810572|NCT02570165|81137398|FG001|Overall Study|Lack of Efficacy|1|||
27810573|NCT02570165|81137399|FG002|Overall Study|Lack of Efficacy|0|||
27586258|NCT02660944|80328246|FG000|Overall Study|Lost to Follow-up|4|||
27586259|NCT02660944|80328247|FG001|Overall Study|Lost to Follow-up|1|||
27586260|NCT02660944|80328246|FG000|Overall Study|Subject schedule|0|||
27586261|NCT02660944|80328247|FG001|Overall Study|Subject schedule|1|||
27586262|NCT02660944|80328246|FG000|Overall Study|Exclusion criteria met|2|||
27586263|NCT02660944|80328247|FG001|Overall Study|Exclusion criteria met|0|||
27586264|NCT00583557|80328248|FG000|Overall Study|Withdrawal by Subject|18|||
27586265|NCT00583557|80328248|FG000|Overall Study|Adverse Event|9|||
27810574|NCT02570165|81137400|FG003|Overall Study|Lack of Efficacy|0|||
27810575|NCT02570165|81137401|FG004|Overall Study|Lack of Efficacy|4|||
27810576|NCT02570165|81137402|FG005|Overall Study|Lack of Efficacy|0|||
27810577|NCT02570165|81137403|FG006|Overall Study|Lack of Efficacy|0|||
27810578|NCT02570165|81137397|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
28006982|NCT01126749|81856778|FG003|Phase 2|Lost to Follow-up|1|||
28006983|NCT01126749|81856775|FG000|Phase 2|Death|0|||
27586266|NCT00583557|80328248|FG000|Overall Study|Lack of Efficacy|31|||
27586267|NCT00583557|80328248|FG000|Overall Study|Lack of Compliance|5|||
27586268|NCT00583557|80328248|FG000|Overall Study|Other|5|||
27586269|NCT00583557|80328248|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
27586270|NCT01910519|80328249|FG000|Overall Study|Withdrawal by Subject|2|||
28006984|NCT01126749|81856776|FG001|Phase 2|Death|0|||
28006985|NCT01126749|81856777|FG002|Phase 2|Death|22|||
28006986|NCT01126749|81856778|FG003|Phase 2|Death|22|||
28006987|NCT01126749|81856775|FG000|Phase 2|Adverse Event|0|||
27586271|NCT01910519|80328250|FG001|Overall Study|Withdrawal by Subject|0|||
27586272|NCT01910519|80328249|FG000|Overall Study|Adverse Event|2|||
27586273|NCT01910519|80328250|FG001|Overall Study|Adverse Event|0|||
28006988|NCT01126749|81856776|FG001|Phase 2|Adverse Event|0|||
28006989|NCT01126749|81856777|FG002|Phase 2|Adverse Event|0|||
28006990|NCT01126749|81856778|FG003|Phase 2|Adverse Event|1|||
28006991|NCT03040141|81856779|FG000|Overall Study|Death|1|||
28006992|NCT03040141|81856780|FG001|Overall Study|Death|2|||
28006993|NCT03040141|81856781|FG002|Overall Study|Death|3|||
28006994|NCT03040141|81856779|FG000|Overall Study|Withdrawal by Subject|3|||
28006995|NCT03040141|81856780|FG001|Overall Study|Withdrawal by Subject|1|||
28006996|NCT03040141|81856781|FG002|Overall Study|Withdrawal by Subject|1|||
28006997|NCT03040141|81856779|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
28006998|NCT03040141|81856780|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
28006999|NCT03040141|81856781|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
28007000|NCT03040141|81856779|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
28007001|NCT03040141|81856780|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
28007002|NCT03040141|81856781|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
28007003|NCT00739401|81856782|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
28007004|NCT00739401|81856782|FG000|Overall Study|Death|3|||
28007005|NCT00739401|81856782|FG000|Overall Study|Withdrawal by Subject|4|||
28007006|NCT03796728|81856783|FG000|Overall Study|Lost to Follow-up|8|||
28007007|NCT03796728|81856783|FG000|Overall Study|Reason not Specified|16|||
28007008|NCT00758771|81856784|FG000|Overall Study|Withdrawal by Subject|1|||
28007009|NCT00758771|81856785|FG001|Overall Study|Withdrawal by Subject|1|||
28007010|NCT00758771|81856784|FG000|Overall Study|Did not meet eligibility criteria|2|||
27685205|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Adverse Event|3|||
27685206|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Adverse Event|2|||
27685207|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Adverse Event|13|||
27685208|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
27685209|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
27685210|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
28007011|NCT00758771|81856785|FG001|Overall Study|Did not meet eligibility criteria|4|||
28007012|NCT00360230|81856786|FG000|Overall Study|Withdrawal by Subject|1|||
27586274|NCT05245864|80328252|FG000|Overall Study|Withdrawal by Subject|1|||
27685211|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
27810579|NCT02570165|81137398|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
27586275|NCT05245864|80328253|FG001|Overall Study|Withdrawal by Subject|1|||
27810580|NCT02570165|81137399|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
27810581|NCT02570165|81137400|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
27586276|NCT02528214|80328256|FG000|Overall Study|Protocol Violation|0|||
27586277|NCT02528214|80328257|FG001|Overall Study|Protocol Violation|1|||
27586278|NCT02528214|80328256|FG000|Overall Study|Adverse Event|0|||
27810582|NCT02570165|81137401|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
27586279|NCT02528214|80328257|FG001|Overall Study|Adverse Event|1|||
27586280|NCT02528214|80328256|FG000|Overall Study|Other than specified above|0|||
27586281|NCT02528214|80328257|FG001|Overall Study|Other than specified above|1|||
27586282|NCT02345512|80328258|FG000|Overall Study|Adverse Event|1|||
27586283|NCT02345512|80328258|FG000|Overall Study|Withdrawal by Subject|1|||
27586284|NCT01773226|80328259|FG000|Overall Study|Withdrawal by Subject|1|||
27586285|NCT02286089|80328262|FG000|Overall Study|Ongoing in Study|1|||
27586286|NCT02286089|80328263|FG001|Overall Study|Ongoing in Study|1|||
28007013|NCT00360230|81856787|FG001|Overall Study|Withdrawal by Subject|1|||
28007014|NCT00360230|81856788|FG002|Overall Study|Withdrawal by Subject|0|||
27586287|NCT02286089|80328264|FG002|Overall Study|Ongoing in Study|4|||
28007015|NCT00360230|81856789|FG003|Overall Study|Withdrawal by Subject|1|||
27685212|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
27685213|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Patient's wish|0|||
28007016|NCT00360230|81856790|FG004|Overall Study|Withdrawal by Subject|1|||
28007017|NCT00360230|81856791|FG005|Overall Study|Withdrawal by Subject|1|||
28007018|NCT00360230|81856792|FG006|Overall Study|Withdrawal by Subject|0|||
28007019|NCT00360230|81856786|FG000|Overall Study|Migrated|4|||
28007020|NCT00360230|81856787|FG001|Overall Study|Migrated|1|||
28007021|NCT00360230|81856788|FG002|Overall Study|Migrated|3|||
28007022|NCT00360230|81856789|FG003|Overall Study|Migrated|1|||
28007023|NCT00360230|81856790|FG004|Overall Study|Migrated|4|||
28007024|NCT00360230|81856791|FG005|Overall Study|Migrated|1|||
28007025|NCT00360230|81856792|FG006|Overall Study|Migrated|1|||
28007026|NCT00360230|81856786|FG000|Overall Study|Other|1|||
28007027|NCT00360230|81856787|FG001|Overall Study|Other|0|||
28007028|NCT00360230|81856788|FG002|Overall Study|Other|0|||
28007029|NCT00360230|81856789|FG003|Overall Study|Other|0|||
28007030|NCT00360230|81856790|FG004|Overall Study|Other|0|||
28007031|NCT00360230|81856791|FG005|Overall Study|Other|0|||
28007032|NCT00360230|81856792|FG006|Overall Study|Other|0|||
28007033|NCT00360230|81856786|FG000|Overall Study|Protocol Violation|0|||
28007034|NCT00360230|81856787|FG001|Overall Study|Protocol Violation|0|||
28007035|NCT00360230|81856788|FG002|Overall Study|Protocol Violation|0|||
28007036|NCT00360230|81856789|FG003|Overall Study|Protocol Violation|0|||
28007037|NCT00360230|81856790|FG004|Overall Study|Protocol Violation|0|||
28007038|NCT00360230|81856791|FG005|Overall Study|Protocol Violation|1|||
27685214|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Patient's wish|0|||
27685215|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Patient's wish|19|||
28007039|NCT00360230|81856792|FG006|Overall Study|Protocol Violation|0|||
28007040|NCT00360230|81856786|FG000|Overall Study|Death|0|||
28007041|NCT00360230|81856787|FG001|Overall Study|Death|1|||
28007042|NCT00360230|81856788|FG002|Overall Study|Death|0|||
27685216|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Patient's wish|9|||
27875171|NCT01217112|81375426|FG002|Overall Study|Withdrawal by Subject|1|||
28007043|NCT00360230|81856789|FG003|Overall Study|Death|0|||
28007044|NCT00360230|81856790|FG004|Overall Study|Death|0|||
28007045|NCT00360230|81856791|FG005|Overall Study|Death|1|||
28007046|NCT00360230|81856792|FG006|Overall Study|Death|1|||
28007047|NCT01478971|81856793|FG000|Standard of Care Period|Adverse Event|1|||
28007048|NCT01478971|81856793|FG000|Standard of Care Period|Withdrawal by Subject|3|||
27586288|NCT02286089|80328265|FG003|Overall Study|Ongoing in Study|10|||
27586289|NCT02286089|80328262|FG000|Overall Study|Withdrawal by Subject|0|||
28007049|NCT01478971|81856793|FG000|Standard of Care Period|Death|8|||
28007050|NCT01478971|81856793|FG000|Standard of Care Period|Lost to Follow-up|9|||
28007051|NCT01478971|81856793|FG000|Standard of Care Period|Other|4|||
28007052|NCT01478971|81856793|FG000|Peginesatide Treatment Period|Adverse Event|1|||
28007053|NCT01478971|81856793|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
28007054|NCT01478971|81856793|FG000|Peginesatide Treatment Period|Death|4|||
28007055|NCT01478971|81856793|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
27810583|NCT02570165|81137402|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
27586290|NCT02286089|80328263|FG001|Overall Study|Withdrawal by Subject|0|||
27586291|NCT02286089|80328264|FG002|Overall Study|Withdrawal by Subject|2|||
27875172|NCT01217112|81375427|FG003|Overall Study|Withdrawal by Subject|0|||
27875173|NCT01217112|81375428|FG004|Overall Study|Withdrawal by Subject|0|||
27875174|NCT01217112|81375424|FG000|Overall Study|Physician Decision|0|||
27875175|NCT01217112|81375425|FG001|Overall Study|Physician Decision|0|||
27875176|NCT01217112|81375426|FG002|Overall Study|Physician Decision|0|||
27875177|NCT01217112|81375427|FG003|Overall Study|Physician Decision|0|||
27875178|NCT01217112|81375428|FG004|Overall Study|Physician Decision|1|||
27875179|NCT03850483|81375429|FG000|Treatment for Stage 1|Adverse Event|1|||
27875180|NCT03850483|81375430|FG001|Treatment for Stage 1|Adverse Event|1|||
27875181|NCT03850483|81375431|FG002|Treatment for Stage 1|Adverse Event|3|||
28007056|NCT01478971|81856793|FG000|Peginesatide Treatment Period|Other|4|||
28007057|NCT02723773|81856796|FG000|Overall Study|Adverse Event|934|||
28007058|NCT02723773|81856797|FG001|Overall Study|Adverse Event|3|||
27810584|NCT02570165|81137403|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
27810585|NCT02570165|81137397|FG000|Overall Study|Lost to Follow-up|0|||
27810586|NCT02570165|81137398|FG001|Overall Study|Lost to Follow-up|0|||
27810587|NCT02570165|81137399|FG002|Overall Study|Lost to Follow-up|1|||
27810588|NCT02570165|81137400|FG003|Overall Study|Lost to Follow-up|1|||
27810589|NCT02570165|81137401|FG004|Overall Study|Lost to Follow-up|0|||
27810590|NCT02570165|81137402|FG005|Overall Study|Lost to Follow-up|0|||
27810591|NCT02570165|81137403|FG006|Overall Study|Lost to Follow-up|0|||
27810592|NCT02570165|81137397|FG000|Overall Study|Physician Decision|0|||
27810593|NCT02570165|81137398|FG001|Overall Study|Physician Decision|1|||
27810594|NCT02570165|81137399|FG002|Overall Study|Physician Decision|0|||
27810595|NCT02570165|81137400|FG003|Overall Study|Physician Decision|0|||
27810596|NCT02570165|81137401|FG004|Overall Study|Physician Decision|0|||
27810597|NCT02570165|81137402|FG005|Overall Study|Physician Decision|0|||
27810598|NCT02570165|81137403|FG006|Overall Study|Physician Decision|0|||
27810599|NCT02570165|81137397|FG000|Overall Study|Withdrawal by Subject|0|||
27810600|NCT02570165|81137398|FG001|Overall Study|Withdrawal by Subject|0|||
27810601|NCT02570165|81137399|FG002|Overall Study|Withdrawal by Subject|0|||
27810602|NCT02570165|81137400|FG003|Overall Study|Withdrawal by Subject|2|||
27875182|NCT03850483|81375432|FG003|Treatment for Stage 1|Adverse Event|0|||
27875183|NCT03850483|81375433|FG004|Treatment for Stage 1|Adverse Event|2|||
27875184|NCT03850483|81375434|FG005|Treatment for Stage 1|Adverse Event|0|||
27875185|NCT03850483|81375435|FG006|Treatment for Stage 1|Adverse Event|2|||
27875186|NCT03850483|81375436|FG007|Treatment for Stage 1|Adverse Event|2|||
27875187|NCT03850483|81375437|FG008|Treatment for Stage 1|Adverse Event|0|||
27875188|NCT03850483|81375438|FG009|Treatment for Stage 1|Adverse Event|0|||
27875189|NCT03850483|81375429|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
27875190|NCT03850483|81375430|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
27875191|NCT03850483|81375431|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
27875192|NCT03850483|81375432|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
27875193|NCT03850483|81375433|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
27875194|NCT03850483|81375434|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
27875195|NCT03850483|81375435|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
27875196|NCT03850483|81375436|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
27875197|NCT03850483|81375437|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
27875198|NCT03850483|81375438|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
27875199|NCT03850483|81375429|FG000|Treatment for Stage 1|Protocol Violation|1|||
27875200|NCT03850483|81375430|FG001|Treatment for Stage 1|Protocol Violation|0|||
27875201|NCT03850483|81375431|FG002|Treatment for Stage 1|Protocol Violation|0|||
27875202|NCT03850483|81375432|FG003|Treatment for Stage 1|Protocol Violation|0|||
27875203|NCT03850483|81375433|FG004|Treatment for Stage 1|Protocol Violation|0|||
27875204|NCT03850483|81375434|FG005|Treatment for Stage 1|Protocol Violation|0|||
27875205|NCT03850483|81375435|FG006|Treatment for Stage 1|Protocol Violation|1|||
27875206|NCT03850483|81375436|FG007|Treatment for Stage 1|Protocol Violation|0|||
27875207|NCT03850483|81375437|FG008|Treatment for Stage 1|Protocol Violation|0|||
27875208|NCT03850483|81375438|FG009|Treatment for Stage 1|Protocol Violation|0|||
27875209|NCT03850483|81375429|FG000|Treatment for Stage 1|Physician Decision|0|||
27875210|NCT03850483|81375430|FG001|Treatment for Stage 1|Physician Decision|0|||
27875211|NCT03850483|81375431|FG002|Treatment for Stage 1|Physician Decision|0|||
27875212|NCT03850483|81375432|FG003|Treatment for Stage 1|Physician Decision|0|||
27586292|NCT02286089|80328265|FG003|Overall Study|Withdrawal by Subject|2|||
27810603|NCT02570165|81137401|FG004|Overall Study|Withdrawal by Subject|1|||
27810604|NCT02570165|81137402|FG005|Overall Study|Withdrawal by Subject|0|||
27810605|NCT02570165|81137403|FG006|Overall Study|Withdrawal by Subject|0|||
27875213|NCT03850483|81375433|FG004|Treatment for Stage 1|Physician Decision|0|||
28007059|NCT02723773|81856798|FG002|Overall Study|Adverse Event|1|||
27810606|NCT02570165|81137397|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
27810607|NCT02570165|81137398|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
27810608|NCT02570165|81137399|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
27875214|NCT03850483|81375434|FG005|Treatment for Stage 1|Physician Decision|1|||
27875215|NCT03850483|81375435|FG006|Treatment for Stage 1|Physician Decision|0|||
27875216|NCT03850483|81375436|FG007|Treatment for Stage 1|Physician Decision|0|||
27875217|NCT03850483|81375437|FG008|Treatment for Stage 1|Physician Decision|0|||
27875218|NCT03850483|81375438|FG009|Treatment for Stage 1|Physician Decision|0|||
27875219|NCT03850483|81375429|FG000|Treatment for Stage 1|Other|0|||
27875220|NCT03850483|81375430|FG001|Treatment for Stage 1|Other|0|||
27875221|NCT03850483|81375431|FG002|Treatment for Stage 1|Other|0|||
27875222|NCT03850483|81375432|FG003|Treatment for Stage 1|Other|0|||
27875223|NCT03850483|81375433|FG004|Treatment for Stage 1|Other|2|||
27810609|NCT02570165|81137400|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
27810610|NCT02570165|81137401|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
27810611|NCT02570165|81137402|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
27810612|NCT02570165|81137403|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
27810613|NCT02570165|81137397|FG000|Overall Study|Withdrawal Request by GSK|0|||
27810614|NCT02570165|81137398|FG001|Overall Study|Withdrawal Request by GSK|0|||
27810615|NCT02570165|81137399|FG002|Overall Study|Withdrawal Request by GSK|2|||
27810616|NCT02570165|81137400|FG003|Overall Study|Withdrawal Request by GSK|0|||
27810617|NCT02570165|81137401|FG004|Overall Study|Withdrawal Request by GSK|0|||
27810618|NCT02570165|81137402|FG005|Overall Study|Withdrawal Request by GSK|0|||
27810619|NCT02570165|81137403|FG006|Overall Study|Withdrawal Request by GSK|0|||
27810620|NCT01738581|81137404|FG000|Overall Study|Lost to Follow-up|1|||
27810621|NCT01738581|81137405|FG001|Overall Study|Lost to Follow-up|0|||
27810622|NCT01405820|81137406|FG000|Randomized Treatment Period|Adverse Event|3|||
27810623|NCT01405820|81137407|FG001|Randomized Treatment Period|Adverse Event|3|||
27810624|NCT01405820|81137408|FG002|Randomized Treatment Period|Adverse Event|3|||
27810625|NCT01405820|81137409|FG003|Randomized Treatment Period|Adverse Event|0|||
27810626|NCT01405820|81137410|FG004|Randomized Treatment Period|Adverse Event|2|||
27810627|NCT01405820|81137411|FG005|Randomized Treatment Period|Adverse Event|1|||
27810628|NCT01405820|81137406|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
27875224|NCT03850483|81375434|FG005|Treatment for Stage 1|Other|1|||
27875225|NCT03850483|81375435|FG006|Treatment for Stage 1|Other|0|||
27875226|NCT03850483|81375436|FG007|Treatment for Stage 1|Other|0|||
27875227|NCT03850483|81375437|FG008|Treatment for Stage 1|Other|0|||
27875228|NCT03850483|81375438|FG009|Treatment for Stage 1|Other|0|||
27685217|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Patient's wish|20|||
27685218|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
27685219|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
27685220|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
27810629|NCT01405820|81137407|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
27875229|NCT03850483|81375429|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27685221|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
27810630|NCT01405820|81137408|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
27810631|NCT01405820|81137409|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
27810632|NCT01405820|81137410|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
27875230|NCT03850483|81375430|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
28007060|NCT02723773|81856799|FG003|Overall Study|Adverse Event|9|||
27586293|NCT01610700|80328271|FG000|Overall Study|Adverse Event|3|||
28007061|NCT02723773|81856796|FG000|Overall Study|Protocol Violation|1|||
28007062|NCT02723773|81856797|FG001|Overall Study|Protocol Violation|0|||
28007063|NCT02723773|81856798|FG002|Overall Study|Protocol Violation|0|||
28007064|NCT02723773|81856799|FG003|Overall Study|Protocol Violation|0|||
28007065|NCT02723773|81856796|FG000|Overall Study|Withdrawal by Subject|360|||
28007066|NCT02723773|81856797|FG001|Overall Study|Withdrawal by Subject|5|||
28007067|NCT02723773|81856798|FG002|Overall Study|Withdrawal by Subject|6|||
28007068|NCT02723773|81856799|FG003|Overall Study|Withdrawal by Subject|10|||
28007069|NCT02723773|81856796|FG000|Overall Study|Migrated/moved from study area|37|||
28007070|NCT02723773|81856797|FG001|Overall Study|Migrated/moved from study area|0|||
28007071|NCT02723773|81856798|FG002|Overall Study|Migrated/moved from study area|0|||
27586294|NCT01610700|80328272|FG001|Overall Study|Adverse Event|1|||
27586295|NCT01610700|80328271|FG000|Overall Study|Withdrawal by Subject|0|||
27586296|NCT01610700|80328272|FG001|Overall Study|Withdrawal by Subject|1|||
27586297|NCT01610700|80328271|FG000|Overall Study|subject took one dose of street cannabis|0|||
27586298|NCT01610700|80328272|FG001|Overall Study|subject took one dose of street cannabis|1|||
27586299|NCT02114892|80328273|FG000|Overall Study|Lost to Follow-up|1|||
27586300|NCT02114892|80328274|FG001|Overall Study|Lost to Follow-up|2|||
27586301|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
27586302|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
27586303|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
27586304|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
27586305|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
27586306|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
27586307|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
27586308|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
27586309|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
27586310|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
27586311|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
27586312|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
27586313|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
27586314|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
27586315|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
27586316|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
27586317|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
27586318|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
27586319|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
27586320|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
27586321|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
27586322|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
27586323|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
27586324|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
27586325|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
27586326|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
27586327|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
27586328|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
27586329|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
27586330|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
27586331|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
27586332|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
27586333|NCT04818346|80328275|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
27586334|NCT04818346|80328276|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
27586335|NCT04818346|80328277|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
27586336|NCT04818346|80328278|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
27586337|NCT04818346|80328275|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
27586338|NCT04818346|80328276|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
27586339|NCT04818346|80328277|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
27586340|NCT04818346|80328278|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
27586341|NCT04818346|80328275|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
27810633|NCT01405820|81137411|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
28007072|NCT02723773|81856799|FG003|Overall Study|Migrated/moved from study area|1|||
28007073|NCT02723773|81856796|FG000|Overall Study|Lost to Follow-up|198|||
28007074|NCT02723773|81856797|FG001|Overall Study|Lost to Follow-up|0|||
28007075|NCT02723773|81856798|FG002|Overall Study|Lost to Follow-up|0|||
27586342|NCT04818346|80328276|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
27586343|NCT04818346|80328277|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
27586344|NCT04818346|80328278|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
27586345|NCT04818346|80328275|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
27586346|NCT04818346|80328276|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
27586347|NCT04818346|80328277|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
27586348|NCT04818346|80328278|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
27586349|NCT04818346|80328275|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
27586350|NCT04818346|80328276|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
27586351|NCT04818346|80328277|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
27586352|NCT04818346|80328278|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
27586353|NCT04818346|80328275|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
27586354|NCT04818346|80328276|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
27586355|NCT04818346|80328277|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
27586356|NCT04818346|80328278|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
27586357|NCT04818346|80328275|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
27586358|NCT04818346|80328276|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
27586359|NCT04818346|80328277|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
27586360|NCT04818346|80328278|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
27586361|NCT00659269|80328282|FG000|Overall Study|Physician Decision|1|||
27586362|NCT00659269|80328283|FG001|Overall Study|Physician Decision|1|||
27586363|NCT00655980|80328284|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
27586364|NCT00655980|80328285|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
27586365|NCT00655980|80328286|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
27586366|NCT03277313|80328287|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
27586367|NCT03277313|80328288|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
27685222|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
27685223|NCT00444275|80683658|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
27685224|NCT00444275|80683659|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
27685225|NCT00444275|80683660|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
27685226|NCT00444275|80683661|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
27685227|NCT00444275|80683662|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
27685228|NCT00886795|80683663|FG000|Overall Study|Lack of Efficacy|1|||
27685229|NCT01302067|80683664|FG000|Overall Study|Death|0|||
27685230|NCT01302067|80683665|FG001|Overall Study|Death|0|||
27685231|NCT01302067|80683666|FG002|Overall Study|Death|1|||
27685232|NCT01302067|80683664|FG000|Overall Study|Physician Decision|9|||
27685233|NCT01302067|80683665|FG001|Overall Study|Physician Decision|5|||
27685234|NCT01302067|80683666|FG002|Overall Study|Physician Decision|14|||
27685235|NCT01302067|80683664|FG000|Overall Study|Lack of Efficacy|8|||
27685236|NCT01302067|80683665|FG001|Overall Study|Lack of Efficacy|4|||
27685237|NCT01302067|80683666|FG002|Overall Study|Lack of Efficacy|2|||
27685238|NCT01302067|80683664|FG000|Overall Study|Lost to Follow-up|9|||
27685239|NCT01302067|80683665|FG001|Overall Study|Lost to Follow-up|4|||
27685240|NCT01302067|80683666|FG002|Overall Study|Lost to Follow-up|15|||
27685241|NCT01302067|80683664|FG000|Overall Study|Withdrawal by Subject|13|||
27685242|NCT01302067|80683665|FG001|Overall Study|Withdrawal by Subject|6|||
27685243|NCT01302067|80683666|FG002|Overall Study|Withdrawal by Subject|10|||
27685244|NCT01302067|80683664|FG000|Overall Study|Other|1|||
27685245|NCT01302067|80683665|FG001|Overall Study|Other|1|||
27685246|NCT01302067|80683666|FG002|Overall Study|Other|3|||
27685247|NCT01302067|80683664|FG000|Overall Study|Protocol Violation|11|||
27685248|NCT01302067|80683665|FG001|Overall Study|Protocol Violation|0|||
27685249|NCT01302067|80683666|FG002|Overall Study|Protocol Violation|8|||
27685250|NCT01302067|80683664|FG000|Overall Study|Adverse Event|27|||
27685251|NCT01302067|80683665|FG001|Overall Study|Adverse Event|14|||
27685252|NCT01302067|80683666|FG002|Overall Study|Adverse Event|45|||
27685253|NCT03208036|80683669|FG000|Baseline Assessment|Withdrawal by Subject|1|||
27685254|NCT03208036|80683670|FG001|Baseline Assessment|Withdrawal by Subject|1|||
27685255|NCT03208036|80683669|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
28007076|NCT02723773|81856799|FG003|Overall Study|Lost to Follow-up|0|||
28007077|NCT02723773|81856796|FG000|Overall Study|Other|189|||
28007078|NCT02723773|81856797|FG001|Overall Study|Other|1|||
27586368|NCT03277313|80328287|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
27685256|NCT03208036|80683670|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
27685257|NCT03208036|80683669|FG000|Intervention|Withdrawal by Subject|3|||
27685258|NCT03208036|80683670|FG001|Intervention|Withdrawal by Subject|2|||
27685259|NCT03208036|80683669|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
27685260|NCT03208036|80683670|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
28007079|NCT02723773|81856798|FG002|Overall Study|Other|2|||
27875231|NCT03850483|81375431|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
28007080|NCT02723773|81856799|FG003|Overall Study|Other|2|||
27685261|NCT01655693|80683687|FG000|Overall Study|Progression of Disease|92|||
27685262|NCT01655693|80683688|FG001|Overall Study|Progression of Disease|76|||
27685263|NCT01655693|80683689|FG002|Overall Study|Progression of Disease|58|||
27685264|NCT01655693|80683687|FG000|Overall Study|Death|8|||
27685265|NCT01655693|80683688|FG001|Overall Study|Death|9|||
27685266|NCT01655693|80683689|FG002|Overall Study|Death|12|||
27685267|NCT01655693|80683687|FG000|Overall Study|Serious Adverse Event|3|||
27685268|NCT01655693|80683688|FG001|Overall Study|Serious Adverse Event|15|||
27685269|NCT01655693|80683689|FG002|Overall Study|Serious Adverse Event|11|||
27685270|NCT01655693|80683687|FG000|Overall Study|Withdrawal by Subject|3|||
28007081|NCT03466658|81856801|FG000|Overall Study|Withdrawal by Subject|3|||
28007082|NCT02336282|81856802|FG000|Overall Study|Unrelated illness|1|||
28007083|NCT02336282|81856802|FG000|Overall Study|Uncomfortable with technology|1|||
28007084|NCT02336282|81856802|FG000|Overall Study|Lost to Follow-up|1|||
28007085|NCT02336282|81856802|FG000|Overall Study|Not enough time to complete sessions|2|||
28007086|NCT02426580|81856803|FG000|Overall Study|Death|2|||
28007087|NCT02426580|81856804|FG001|Overall Study|Death|2|||
28007088|NCT02426580|81856803|FG000|Overall Study|Lost to Follow-up|0|||
28007089|NCT02426580|81856804|FG001|Overall Study|Lost to Follow-up|9|||
28007090|NCT02426580|81856803|FG000|Overall Study|transfer to hemodialysis|5|||
28007091|NCT02426580|81856804|FG001|Overall Study|transfer to hemodialysis|5|||
28007092|NCT02426580|81856803|FG000|Overall Study|Kidney transplant|3|||
28007093|NCT02426580|81856804|FG001|Overall Study|Kidney transplant|0|||
28007094|NCT02426580|81856803|FG000|Overall Study|Allergic to egg white|1|||
28007095|NCT02426580|81856804|FG001|Overall Study|Allergic to egg white|0|||
28007096|NCT03585660|81856805|FG000|Overall Study|operator error|1|||
28007097|NCT03585660|81856805|FG000|Overall Study|technical error|2|||
28007098|NCT03585660|81856805|FG000|Overall Study|hip prosthesis|2|||
28007099|NCT03585660|81856805|FG000|Overall Study|did not undergo biopsy|8|||
28007100|NCT03585660|81856805|FG000|Overall Study|scanner problem|2|||
28007101|NCT03919773|81856808|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
28007102|NCT03919773|81856809|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
28007103|NCT03919773|81856808|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
28007104|NCT03919773|81856809|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
28007105|NCT00644423|81859489|FG000|Overall Study|Lost to Follow-up|1|||
28007106|NCT00644423|81859490|FG001|Overall Study|Lost to Follow-up|1|||
28007107|NCT00686777|81859491|FG000|Overall Study|Adverse Event|2|||
28007108|NCT00686777|81859491|FG000|Overall Study|Pregnancy|1|||
28007109|NCT00686777|81859491|FG000|Overall Study|Withdrawal by Subject|2|||
28007110|NCT00686777|81859491|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
28007111|NCT00686777|81859491|FG000|Overall Study|No Visit|1|||
28007112|NCT00435409|81859492|FG000|Overall Study|Protocol Violation|1|||
28007113|NCT00435409|81859493|FG001|Overall Study|Protocol Violation|2|||
28007114|NCT00435409|81859494|FG002|Overall Study|Protocol Violation|0|||
28007115|NCT00435409|81859492|FG000|Overall Study|Lost to Follow-up|1|||
28007116|NCT00435409|81859493|FG001|Overall Study|Lost to Follow-up|2|||
28007117|NCT00435409|81859494|FG002|Overall Study|Lost to Follow-up|0|||
28007118|NCT00435409|81859492|FG000|Overall Study|Death|8|||
28007119|NCT00435409|81859493|FG001|Overall Study|Death|6|||
28007120|NCT00435409|81859494|FG002|Overall Study|Death|6|||
28007121|NCT00435409|81859492|FG000|Overall Study|Objective progression or relapse|158|||
28007122|NCT00435409|81859493|FG001|Overall Study|Objective progression or relapse|93|||
28007123|NCT00435409|81859494|FG002|Overall Study|Objective progression or relapse|58|||
28007124|NCT00435409|81859492|FG000|Overall Study|Global deterioration of health status|0|||
28007125|NCT00435409|81859493|FG001|Overall Study|Global deterioration of health status|0|||
28007126|NCT00435409|81859494|FG002|Overall Study|Global deterioration of health status|4|||
28007127|NCT00435409|81859492|FG000|Overall Study|Withdrawal by Subject|8|||
28007128|NCT00435409|81859493|FG001|Overall Study|Withdrawal by Subject|7|||
28007129|NCT00435409|81859494|FG002|Overall Study|Withdrawal by Subject|1|||
28007130|NCT00435409|81859492|FG000|Overall Study|Other|45|||
28007131|NCT00435409|81859493|FG001|Overall Study|Other|30|||
28007132|NCT00435409|81859494|FG002|Overall Study|Other|1|||
28007133|NCT00435409|81859492|FG000|Overall Study|Adverse Event|0|||
27685271|NCT01655693|80683688|FG001|Overall Study|Withdrawal by Subject|2|||
28007134|NCT00435409|81859493|FG001|Overall Study|Adverse Event|0|||
28007135|NCT00435409|81859494|FG002|Overall Study|Adverse Event|8|||
28007136|NCT00435409|81859492|FG000|Overall Study|Sponsor decision|0|||
28007137|NCT00435409|81859493|FG001|Overall Study|Sponsor decision|3|||
28007138|NCT00435409|81859494|FG002|Overall Study|Sponsor decision|0|||
28007139|NCT01169103|81859497|FG000|Overall Study|Lost to Follow-up|3|||
28007140|NCT01169103|81859498|FG001|Overall Study|Lost to Follow-up|3|||
28007141|NCT01169103|81859497|FG000|Overall Study|Withdrawal by Subject|3|||
28007142|NCT01169103|81859498|FG001|Overall Study|Withdrawal by Subject|1|||
27685272|NCT01655693|80683689|FG002|Overall Study|Withdrawal by Subject|20|||
27685273|NCT01655693|80683687|FG000|Overall Study|Adverse Event|3|||
28007143|NCT01680341|81859504|FG000|Overall Study|Adverse Event|3|||
27685274|NCT01655693|80683688|FG001|Overall Study|Adverse Event|11|||
27685275|NCT01655693|80683689|FG002|Overall Study|Adverse Event|3|||
27586369|NCT03277313|80328288|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
27586370|NCT03277313|80328287|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
27586371|NCT03277313|80328288|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
27586372|NCT03277313|80328287|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
27586373|NCT03277313|80328288|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
27586374|NCT03277313|80328287|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
27586375|NCT03277313|80328288|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
27586376|NCT00809757|80328291|FG000|Overall Study|Adverse Event|2|||
27586377|NCT00809757|80328292|FG001|Overall Study|Adverse Event|3|||
27586378|NCT00809757|80328293|FG002|Overall Study|Adverse Event|3|||
27586379|NCT00809757|80328291|FG000|Overall Study|Lost to Follow-up|0|||
27586380|NCT00809757|80328292|FG001|Overall Study|Lost to Follow-up|0|||
27586381|NCT00809757|80328293|FG002|Overall Study|Lost to Follow-up|1|||
27586382|NCT00809757|80328291|FG000|Overall Study|Protocol Violation|1|||
27586383|NCT00809757|80328292|FG001|Overall Study|Protocol Violation|1|||
27586384|NCT00809757|80328293|FG002|Overall Study|Protocol Violation|1|||
27586385|NCT00809757|80328291|FG000|Overall Study|Withdrawal by Subject|2|||
27586386|NCT00809757|80328292|FG001|Overall Study|Withdrawal by Subject|1|||
27586387|NCT00809757|80328293|FG002|Overall Study|Withdrawal by Subject|3|||
27586388|NCT00809757|80328291|FG000|Overall Study|Subject Uncooperative|1|||
27586389|NCT00809757|80328292|FG001|Overall Study|Subject Uncooperative|0|||
27586390|NCT00809757|80328293|FG002|Overall Study|Subject Uncooperative|2|||
27586391|NCT00809757|80328291|FG000|Overall Study|Noncompliance with Medication|0|||
27586392|NCT00809757|80328292|FG001|Overall Study|Noncompliance with Medication|0|||
27586393|NCT00809757|80328293|FG002|Overall Study|Noncompliance with Medication|1|||
27586394|NCT05348681|80328297|FG000|Overall Study|Study terminated by Sponsor|8|||
27586395|NCT05348681|80328298|FG001|Overall Study|Study terminated by Sponsor|3|||
27586396|NCT05348681|80328297|FG000|Overall Study|Withdrawal by Subject|1|||
27586397|NCT05348681|80328298|FG001|Overall Study|Withdrawal by Subject|1|||
27586398|NCT05348681|80328297|FG000|Overall Study|Lost to Follow-up|1|||
27586399|NCT05348681|80328298|FG001|Overall Study|Lost to Follow-up|1|||
27586400|NCT05348681|80328297|FG000|Overall Study|Adverse Event|1|||
27586401|NCT05348681|80328298|FG001|Overall Study|Adverse Event|0|||
27586402|NCT05348681|80328297|FG000|Overall Study|Other|2|||
27586403|NCT05348681|80328298|FG001|Overall Study|Other|1|||
27586404|NCT02696317|80328299|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
27586405|NCT02696317|80328300|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
27586406|NCT02696317|80328299|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
27586407|NCT02696317|80328300|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
27586408|NCT01592708|80328301|FG000|Overall Study|Protocol Violation|3|||
27586409|NCT01592708|80328302|FG001|Overall Study|Protocol Violation|0|||
27586410|NCT01365494|80328303|FG000|Overall Study|Adverse Event|1|||
27586411|NCT01365494|80328304|FG001|Overall Study|Adverse Event|0|||
27586412|NCT01365494|80328303|FG000|Overall Study|Withdrawal by Subject|0|||
27586413|NCT01365494|80328304|FG001|Overall Study|Withdrawal by Subject|1|||
27586414|NCT01365494|80328303|FG000|Overall Study|Lost to Follow-up|1|||
27586415|NCT01365494|80328304|FG001|Overall Study|Lost to Follow-up|2|||
27586416|NCT02730819|80328312|FG000|Overall Study|Lost to Follow-up|9|||
27586417|NCT01196975|80328320|FG000|Overall Study|Adverse Event|2|||
27586418|NCT01196975|80328321|FG001|Overall Study|Adverse Event|2|||
27586419|NCT01196975|80328322|FG002|Overall Study|Adverse Event|0|||
27586420|NCT01196975|80328323|FG003|Overall Study|Adverse Event|0|||
27586421|NCT01196975|80328324|FG004|Overall Study|Adverse Event|2|||
27586422|NCT01196975|80328320|FG000|Overall Study|Withdrawal by Subject|2|||
27586423|NCT01196975|80328321|FG001|Overall Study|Withdrawal by Subject|1|||
27586424|NCT01196975|80328322|FG002|Overall Study|Withdrawal by Subject|0|||
27586425|NCT01196975|80328323|FG003|Overall Study|Withdrawal by Subject|1|||
27586426|NCT01196975|80328324|FG004|Overall Study|Withdrawal by Subject|0|||
27586427|NCT01196975|80328320|FG000|Overall Study|Lost to Follow-up|11|||
27586428|NCT01196975|80328321|FG001|Overall Study|Lost to Follow-up|6|||
27586429|NCT01196975|80328322|FG002|Overall Study|Lost to Follow-up|5|||
27586430|NCT01196975|80328323|FG003|Overall Study|Lost to Follow-up|5|||
27810634|NCT01405820|81137406|FG000|Randomized Treatment Period|Other|2|||
27586431|NCT01196975|80328324|FG004|Overall Study|Lost to Follow-up|11|||
27586432|NCT02548962|80328328|FG000|Overall Study|Withdrawal by Subject|1|||
27586433|NCT02548962|80328329|FG001|Overall Study|Withdrawal by Subject|0|||
27586434|NCT00086346|80328336|FG000|Randomization|Did not receive test article|4|||
27586435|NCT00086346|80328337|FG001|Randomization|Did not receive test article|4|||
27586436|NCT00086346|80328336|FG000|Patients Dosed With Test Article|Adverse Event|94|||
27586437|NCT00086346|80328337|FG001|Patients Dosed With Test Article|Adverse Event|11|||
27586438|NCT00086346|80328336|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
27586439|NCT00086346|80328337|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
27586440|NCT00086346|80328336|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
27586441|NCT00086346|80328337|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
27586442|NCT00086346|80328336|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
27586443|NCT00086346|80328337|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
27586444|NCT00086346|80328336|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
27586445|NCT00086346|80328337|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
27586446|NCT00086346|80328336|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
27586447|NCT00086346|80328337|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
27586448|NCT02763384|80328338|FG000|Overall Study|Physician Decision|1|||
27586449|NCT02763384|80328338|FG000|Overall Study|Rapid decline - went on hospice|1|||
27586450|NCT01944046|80328343|FG000|Randomized to DB|Adverse Event|5|||
27586451|NCT01944046|80328344|FG001|Randomized to DB|Adverse Event|2|||
27586452|NCT01944046|80328343|FG000|Randomized to DB|Clinical Worsening|3|||
27586453|NCT01944046|80328344|FG001|Randomized to DB|Clinical Worsening|2|||
27586454|NCT01944046|80328343|FG000|Randomized to DB|Lost to Follow-up|3|||
27586455|NCT01944046|80328344|FG001|Randomized to DB|Lost to Follow-up|3|||
27586456|NCT01944046|80328343|FG000|Randomized to DB|Withdrawal by Subject|2|||
27586457|NCT01944046|80328344|FG001|Randomized to DB|Withdrawal by Subject|4|||
27586458|NCT01944046|80328343|FG000|Randomized to DB|Physician Decision|1|||
27586459|NCT01944046|80328344|FG001|Randomized to DB|Physician Decision|2|||
27586460|NCT01944046|80328343|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
27586461|NCT01944046|80328344|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
27586462|NCT01944046|80328343|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
27586463|NCT01944046|80328344|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
27586464|NCT01944046|80328343|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
27875232|NCT03850483|81375432|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27586465|NCT01944046|80328344|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
27586466|NCT01944046|80328343|FG000|Open Label Eligible and Consented|Adverse Event|6|||
27586467|NCT01944046|80328344|FG001|Open Label Eligible and Consented|Adverse Event|1|||
27586468|NCT01944046|80328343|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
27586469|NCT01944046|80328344|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
27586470|NCT01944046|80328343|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
27586471|NCT01944046|80328344|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
27586472|NCT02646423|80328345|FG000|Overall Study|Adverse Event|5|||
27586473|NCT02646423|80328346|FG001|Overall Study|Adverse Event|7|||
27586474|NCT02646423|80328345|FG000|Overall Study|Ineligible|2|||
27586475|NCT02646423|80328346|FG001|Overall Study|Ineligible|1|||
27586476|NCT03376321|80328347|FG000|Overall Study|Other|5|||
27586477|NCT03376321|80328348|FG001|Overall Study|Other|1|||
27586478|NCT03376321|80328347|FG000|Overall Study|Withdrawal by Subject|8|||
27586479|NCT03376321|80328348|FG001|Overall Study|Withdrawal by Subject|14|||
27586480|NCT03376321|80328347|FG000|Overall Study|Lost to Follow-up|1|||
27586481|NCT03376321|80328348|FG001|Overall Study|Lost to Follow-up|7|||
27586482|NCT03376321|80328347|FG000|Overall Study|Death|4|||
27586483|NCT03376321|80328348|FG001|Overall Study|Death|0|||
27586484|NCT03376321|80328347|FG000|Overall Study|Randomized, not treated|5|||
27586485|NCT03376321|80328348|FG001|Overall Study|Randomized, not treated|3|||
27586486|NCT00407537|80328349|FG000|Overall Study|Death|5|||
27586487|NCT00407537|80328350|FG001|Overall Study|Death|2|||
27586488|NCT00407537|80328349|FG000|Overall Study|Adverse Event|36|||
27586489|NCT00407537|80328350|FG001|Overall Study|Adverse Event|0|||
27586490|NCT00407537|80328349|FG000|Overall Study|Lost to Follow-up|12|||
27586491|NCT00407537|80328350|FG001|Overall Study|Lost to Follow-up|19|||
27586492|NCT00407537|80328349|FG000|Overall Study|Other|6|||
27586493|NCT00407537|80328350|FG001|Overall Study|Other|7|||
27586494|NCT00407537|80328349|FG000|Overall Study|Withdrawal by Subject|34|||
27586495|NCT00407537|80328350|FG001|Overall Study|Withdrawal by Subject|16|||
27586496|NCT00434057|80328354|FG000|Overall Study|Withdrawal by Subject|1|||
27586497|NCT00464542|80328361|FG000|Pre-treatment|Withdrawal by Subject|2|||
27586498|NCT00319098|80328362|FG000|Overall Study|Serious adverse event|3|||
27586499|NCT00319098|80328363|FG001|Overall Study|Serious adverse event|0|||
27586500|NCT00319098|80328362|FG000|Overall Study|Adverse Event|20|||
27586501|NCT00319098|80328363|FG001|Overall Study|Adverse Event|1|||
27586502|NCT00319098|80328362|FG000|Overall Study|Withdrawal by Subject|37|||
27586503|NCT00319098|80328363|FG001|Overall Study|Withdrawal by Subject|8|||
27586504|NCT00319098|80328362|FG000|Overall Study|Migrated/moved from study area|2|||
27586505|NCT00319098|80328363|FG001|Overall Study|Migrated/moved from study area|1|||
27685276|NCT01655693|80683687|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
27586506|NCT00319098|80328362|FG000|Overall Study|Lost to Follow-up|37|||
27586507|NCT00319098|80328363|FG001|Overall Study|Lost to Follow-up|13|||
27685277|NCT01655693|80683688|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
27586508|NCT00319098|80328362|FG000|Overall Study|Others|33|||
27586509|NCT00319098|80328363|FG001|Overall Study|Others|8|||
27586510|NCT00319098|80328362|FG000|Overall Study|Protocol Violation|3|||
27586511|NCT00319098|80328363|FG001|Overall Study|Protocol Violation|1|||
27586512|NCT04757649|80328364|FG000|Overall Study|Withdrawal by Subject|1|||
27586513|NCT04757649|80328364|FG000|Overall Study|Adverse Event|1|||
27586514|NCT01202773|80328366|FG000|Overall Study|Adverse Event|4|||
27685278|NCT01655693|80683689|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
27586515|NCT01202773|80328367|FG001|Overall Study|Adverse Event|5|||
27586516|NCT01202773|80328368|FG002|Overall Study|Adverse Event|5|||
27586517|NCT01202773|80328366|FG000|Overall Study|Lack of Efficacy|5|||
27586518|NCT01202773|80328367|FG001|Overall Study|Lack of Efficacy|4|||
27586519|NCT01202773|80328368|FG002|Overall Study|Lack of Efficacy|9|||
27586520|NCT01202773|80328366|FG000|Overall Study|Entry Criteria Not Met|2|||
27586521|NCT01202773|80328367|FG001|Overall Study|Entry Criteria Not Met|0|||
27586522|NCT01202773|80328368|FG002|Overall Study|Entry Criteria Not Met|1|||
27586523|NCT01202773|80328366|FG000|Overall Study|Lost to Follow-up|1|||
27586524|NCT01202773|80328367|FG001|Overall Study|Lost to Follow-up|2|||
27586525|NCT01202773|80328368|FG002|Overall Study|Lost to Follow-up|2|||
27586526|NCT01202773|80328366|FG000|Overall Study|Withdrawal by Subject|13|||
27586527|NCT01202773|80328367|FG001|Overall Study|Withdrawal by Subject|6|||
27586528|NCT01202773|80328368|FG002|Overall Study|Withdrawal by Subject|5|||
27586529|NCT01202773|80328366|FG000|Overall Study|Physician Decision|2|||
27586530|NCT01202773|80328367|FG001|Overall Study|Physician Decision|0|||
27586531|NCT01202773|80328368|FG002|Overall Study|Physician Decision|0|||
27586532|NCT01202773|80328366|FG000|Overall Study|Protocol Violation|11|||
27586533|NCT01202773|80328367|FG001|Overall Study|Protocol Violation|6|||
27586534|NCT01202773|80328368|FG002|Overall Study|Protocol Violation|10|||
27586535|NCT01202773|80328366|FG000|Overall Study|Sponsor Decision|19|||
27586536|NCT01202773|80328367|FG001|Overall Study|Sponsor Decision|20|||
27586537|NCT01202773|80328368|FG002|Overall Study|Sponsor Decision|23|||
27586538|NCT04001829|80328369|FG000|Overall Study|Never start protocol therapy|5|||
27586539|NCT04001829|80328370|FG001|Overall Study|Never start protocol therapy|5|||
27586540|NCT04001829|80328369|FG000|Overall Study|Adverse Event|11|||
27586541|NCT04001829|80328370|FG001|Overall Study|Adverse Event|7|||
27586542|NCT04001829|80328369|FG000|Overall Study|Alternative therapy|1|||
27586543|NCT04001829|80328370|FG001|Overall Study|Alternative therapy|2|||
27586544|NCT04001829|80328369|FG000|Overall Study|Disease progression/relapse|2|||
27586545|NCT04001829|80328370|FG001|Overall Study|Disease progression/relapse|1|||
27586546|NCT04001829|80328369|FG000|Overall Study|Other complicating disease|1|||
27586547|NCT04001829|80328370|FG001|Overall Study|Other complicating disease|0|||
27586548|NCT04001829|80328369|FG000|Overall Study|Withdrawal by Subject|1|||
27586549|NCT04001829|80328370|FG001|Overall Study|Withdrawal by Subject|4|||
28007144|NCT01680341|81859505|FG001|Overall Study|Adverse Event|2|||
28007145|NCT01680341|81859504|FG000|Overall Study|Unclassified|18|||
28007146|NCT01680341|81859505|FG001|Overall Study|Unclassified|15|||
28007147|NCT02718898|81859506|FG000|Blinded Treatment Period|Adverse Event|5|||
28007148|NCT02718898|81859507|FG001|Blinded Treatment Period|Adverse Event|1|||
28007149|NCT02718898|81859508|FG002|Blinded Treatment Period|Adverse Event|0|||
28007150|NCT02718898|81859509|FG003|Blinded Treatment Period|Adverse Event|0|||
28007151|NCT02718898|81859510|FG004|Blinded Treatment Period|Adverse Event|0|||
28007152|NCT02718898|81859511|FG005|Blinded Treatment Period|Adverse Event|0|||
28007153|NCT02718898|81859512|FG006|Blinded Treatment Period|Adverse Event|0|||
28007154|NCT02718898|81859506|FG000|Blinded Treatment Period|Physician Decision|1|||
28007155|NCT02718898|81859507|FG001|Blinded Treatment Period|Physician Decision|0|||
28007156|NCT02718898|81859508|FG002|Blinded Treatment Period|Physician Decision|0|||
28007157|NCT02718898|81859509|FG003|Blinded Treatment Period|Physician Decision|0|||
28007158|NCT02718898|81859510|FG004|Blinded Treatment Period|Physician Decision|0|||
28007159|NCT02718898|81859511|FG005|Blinded Treatment Period|Physician Decision|0|||
28007160|NCT02718898|81859512|FG006|Blinded Treatment Period|Physician Decision|0|||
28007161|NCT02718898|81859506|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
28007162|NCT02718898|81859507|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
28007163|NCT02718898|81859508|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
28007164|NCT02718898|81859509|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
28007165|NCT02718898|81859510|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
28007166|NCT02718898|81859511|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
28007167|NCT02718898|81859512|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
28007168|NCT02718898|81859506|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
28007169|NCT02718898|81859507|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
28007170|NCT02718898|81859508|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
28007171|NCT02718898|81859509|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
28007172|NCT02718898|81859510|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
28007173|NCT02718898|81859511|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
28007174|NCT02718898|81859512|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
28007175|NCT02718898|81859506|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28007176|NCT02718898|81859507|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
27586550|NCT04001829|80328369|FG000|Overall Study|Ineligible|2|||
28007177|NCT02718898|81859508|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
28007178|NCT02718898|81859509|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
27586551|NCT04001829|80328370|FG001|Overall Study|Ineligible|2|||
27586552|NCT04001829|80328369|FG000|Overall Study|Reason missing due to delinquent data|1|||
27586553|NCT04001829|80328370|FG001|Overall Study|Reason missing due to delinquent data|0|||
27586554|NCT01255358|80328372|FG000|Overall Study|Adverse Event|2|||
28007179|NCT02718898|81859510|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28007180|NCT02718898|81859511|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28007181|NCT02718898|81859512|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
28007182|NCT02718898|81859506|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28007183|NCT02718898|81859507|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28007184|NCT02718898|81859508|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28007185|NCT02718898|81859509|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
27586555|NCT01255358|80328372|FG000|Overall Study|Protocol Violation|2|||
27810635|NCT01405820|81137407|FG001|Randomized Treatment Period|Other|2|||
27586556|NCT04602624|80328373|FG000|Overall Study|Protocol Deviation|1|||
27586557|NCT04602624|80328373|FG000|Overall Study|Withdrawal by Participant|1|||
27586558|NCT02328326|80328374|FG000|Overall Study|Withdrawal by Subject|10|||
27586559|NCT02328326|80328375|FG001|Overall Study|Withdrawal by Subject|3|||
27586560|NCT02328326|80328374|FG000|Overall Study|Death|2|||
27586561|NCT02328326|80328375|FG001|Overall Study|Death|1|||
27586562|NCT02328326|80328374|FG000|Overall Study|Lost to Follow-up|10|||
28007186|NCT02718898|81859510|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28007187|NCT02718898|81859511|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28007188|NCT02718898|81859512|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
28007189|NCT02718898|81859506|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28007190|NCT02718898|81859507|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27586563|NCT02328326|80328375|FG001|Overall Study|Lost to Follow-up|4|||
27586564|NCT03538626|80328376|FG000|Overall Study|Withdrawal by Subject|0|||
27586565|NCT03538626|80328377|FG001|Overall Study|Withdrawal by Subject|1|||
27685279|NCT01655693|80683687|FG000|Overall Study|Non-Compliance|0|||
27685280|NCT01655693|80683688|FG001|Overall Study|Non-Compliance|0|||
27685281|NCT01655693|80683689|FG002|Overall Study|Non-Compliance|7|||
27810636|NCT01405820|81137408|FG002|Randomized Treatment Period|Other|1|||
27810637|NCT01405820|81137409|FG003|Randomized Treatment Period|Other|1|||
27810638|NCT01405820|81137410|FG004|Randomized Treatment Period|Other|0|||
27685282|NCT01655693|80683687|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
27685283|NCT01655693|80683688|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
27685284|NCT01655693|80683689|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
27685285|NCT01655693|80683687|FG000|Overall Study|Protocol Violation|1|||
27685286|NCT01655693|80683688|FG001|Overall Study|Protocol Violation|0|||
27685287|NCT01655693|80683689|FG002|Overall Study|Protocol Violation|3|||
27685288|NCT01655693|80683687|FG000|Overall Study|Lost to Follow-up|1|||
27685289|NCT01655693|80683688|FG001|Overall Study|Lost to Follow-up|0|||
27685290|NCT01655693|80683689|FG002|Overall Study|Lost to Follow-up|1|||
27810639|NCT01405820|81137411|FG005|Randomized Treatment Period|Other|0|||
27810640|NCT01405820|81137406|FG000|Randomized Treatment Period|Physician Decision|0|||
27810641|NCT01405820|81137407|FG001|Randomized Treatment Period|Physician Decision|2|||
27810642|NCT01405820|81137408|FG002|Randomized Treatment Period|Physician Decision|1|||
27810643|NCT01405820|81137409|FG003|Randomized Treatment Period|Physician Decision|0|||
27810644|NCT01405820|81137410|FG004|Randomized Treatment Period|Physician Decision|0|||
27810645|NCT01405820|81137411|FG005|Randomized Treatment Period|Physician Decision|0|||
28007191|NCT02718898|81859508|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
28007192|NCT02718898|81859509|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
28007193|NCT02718898|81859510|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28007194|NCT02718898|81859511|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28007195|NCT02718898|81859512|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
28007196|NCT02718898|81859506|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28007197|NCT02718898|81859507|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28007198|NCT02718898|81859508|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
28007199|NCT02718898|81859509|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
28007200|NCT02718898|81859510|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28007201|NCT02718898|81859511|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28007202|NCT02718898|81859512|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
28007203|NCT02718898|81859506|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
27586566|NCT03538626|80328378|FG002|Overall Study|Withdrawal by Subject|0|||
27586567|NCT03538626|80328379|FG003|Overall Study|Withdrawal by Subject|0|||
27586568|NCT03538626|80328380|FG004|Overall Study|Withdrawal by Subject|0|||
27586569|NCT03538626|80328381|FG005|Overall Study|Withdrawal by Subject|0|||
27685291|NCT01655693|80683687|FG000|Overall Study|Screening Failure|1|||
27685292|NCT01655693|80683688|FG001|Overall Study|Screening Failure|0|||
27685293|NCT01655693|80683689|FG002|Overall Study|Screening Failure|0|||
27586570|NCT03538626|80328382|FG006|Overall Study|Withdrawal by Subject|0|||
27685294|NCT01655693|80683687|FG000|Overall Study|Other|8|||
27685295|NCT01655693|80683688|FG001|Overall Study|Other|6|||
27685296|NCT01655693|80683689|FG002|Overall Study|Other|15|||
27810646|NCT01405820|81137406|FG000|Randomized Treatment Period|Rescue|0|||
27586571|NCT03538626|80328383|FG007|Overall Study|Withdrawal by Subject|0|||
27586572|NCT03538626|80328376|FG000|Overall Study|Lost to Follow-up|0|||
27586573|NCT03538626|80328377|FG001|Overall Study|Lost to Follow-up|0|||
27586574|NCT03538626|80328378|FG002|Overall Study|Lost to Follow-up|0|||
27586575|NCT03538626|80328379|FG003|Overall Study|Lost to Follow-up|0|||
28007204|NCT02718898|81859507|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28007205|NCT02718898|81859508|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28007206|NCT02718898|81859509|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
28007207|NCT02718898|81859510|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28007208|NCT02718898|81859511|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28007209|NCT02718898|81859512|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
28007210|NCT02718898|81859506|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28007211|NCT02718898|81859507|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28007212|NCT02718898|81859508|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28007213|NCT02718898|81859509|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
28007214|NCT02718898|81859510|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28007215|NCT02718898|81859511|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28007216|NCT02718898|81859512|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
28007217|NCT02718898|81859506|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
28007218|NCT02718898|81859507|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
28007219|NCT02718898|81859508|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
28007220|NCT02718898|81859509|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
28007221|NCT02718898|81859510|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
28007222|NCT02718898|81859511|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
27586576|NCT03538626|80328380|FG004|Overall Study|Lost to Follow-up|0|||
27586577|NCT03538626|80328381|FG005|Overall Study|Lost to Follow-up|0|||
27586578|NCT03538626|80328382|FG006|Overall Study|Lost to Follow-up|1|||
27586579|NCT03538626|80328383|FG007|Overall Study|Lost to Follow-up|0|||
27586580|NCT04329104|80328384|FG000|Efficacy Study|Withdrawal by Subject|0|||
27586581|NCT04329104|80328385|FG001|Efficacy Study|Withdrawal by Subject|0|||
27586582|NCT04329104|80328386|FG002|Efficacy Study|Withdrawal by Subject|0|||
27586583|NCT04329104|80328387|FG003|Efficacy Study|Withdrawal by Subject|5|||
27586584|NCT04329104|80328388|FG004|Efficacy Study|Withdrawal by Subject|6|||
27586585|NCT04329104|80328389|FG005|Efficacy Study|Withdrawal by Subject|8|||
27586586|NCT00796718|80328390|FG000|Overall Study|Adverse Event|2|||
27586587|NCT00796718|80328390|FG000|Overall Study|Exclusion Criteria|1|||
27875233|NCT03850483|81375433|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
28007223|NCT02718898|81859512|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
28007224|NCT02718898|81859506|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28007225|NCT02718898|81859507|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28007226|NCT02718898|81859508|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28007227|NCT02718898|81859509|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
28007228|NCT02718898|81859510|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
28007229|NCT02718898|81859511|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
28007230|NCT02718898|81859512|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
28007231|NCT02718898|81859506|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28007232|NCT02718898|81859507|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28007233|NCT02718898|81859508|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28007234|NCT02718898|81859509|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28007235|NCT02718898|81859510|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
28007236|NCT02718898|81859511|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
28007237|NCT02718898|81859512|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
27586588|NCT00796718|80328390|FG000|Overall Study|Lost to Follow-up|5|||
27586589|NCT00796718|80328390|FG000|Overall Study|Withdrawal by Informed Consent|1|||
27586590|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
27586591|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
27586592|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
27586593|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
27685297|NCT01332630|80683690|FG000|Overall Study|Withdrawal by Subject|3|||
27685298|NCT00818168|80683691|FG000|Overall Study|Lack of Efficacy|18|||
27685299|NCT00818168|80683691|FG000|Overall Study|Pregnancy|2|||
27685300|NCT00818168|80683691|FG000|Overall Study|Withdrawal by Subject|16|||
27685301|NCT00818168|80683691|FG000|Overall Study|Lost to Follow-up|7|||
27685302|NCT00818168|80683691|FG000|Overall Study|Adverse Event|19|||
27685303|NCT00818168|80683691|FG000|Overall Study|Reason for Non-completion Not reported|6|||
27685304|NCT00818168|80683691|FG000|Overall Study|Participant Moved|2|||
27685305|NCT01144052|80683699|FG000|Overall Study|Withdrawal by Subject|1|||
27685306|NCT01144052|80683700|FG001|Overall Study|Withdrawal by Subject|1|||
28007238|NCT00784563|81859516|FG000|Years 1 & 2|Withdrawal by Subject|3|||
28007239|NCT00784563|81859517|FG001|Years 1 & 2|Withdrawal by Subject|2|||
28007240|NCT00784563|81859518|FG002|Years 1 & 2|Withdrawal by Subject|0|||
28007241|NCT00784563|81859516|FG000|Years 1 & 2|Adverse Event|0|||
28007242|NCT00784563|81859517|FG001|Years 1 & 2|Adverse Event|3|||
28007243|NCT00784563|81859518|FG002|Years 1 & 2|Adverse Event|0|||
27685307|NCT02141620|80683704|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
27685308|NCT02141620|80683705|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
27685309|NCT01242800|80683706|FG000|Overall Study|Patient refusal|0|||
28007244|NCT00784563|81859516|FG000|Year 3|Withdrawal by Subject|0|||
28007245|NCT00784563|81859517|FG001|Year 3|Withdrawal by Subject|0|||
28007246|NCT00784563|81859518|FG002|Year 3|Withdrawal by Subject|2|||
28007247|NCT00784563|81859516|FG000|Year 3|Adverse Event|0|||
28007248|NCT00784563|81859517|FG001|Year 3|Adverse Event|0|||
28007249|NCT00784563|81859518|FG002|Year 3|Adverse Event|1|||
28007250|NCT01743469|81859521|FG000|Active Treatment Phase|Adverse Event|10|||
28007251|NCT01743469|81859522|FG001|Active Treatment Phase|Adverse Event|5|||
28007252|NCT01743469|81859523|FG002|Active Treatment Phase|Adverse Event|8|||
28007253|NCT01743469|81859524|FG003|Active Treatment Phase|Adverse Event|1|||
28007254|NCT01743469|81859521|FG000|Active Treatment Phase|Disease Progression|40|||
28007255|NCT01743469|81859522|FG001|Active Treatment Phase|Disease Progression|47|||
28007256|NCT01743469|81859523|FG002|Active Treatment Phase|Disease Progression|30|||
28007257|NCT01743469|81859524|FG003|Active Treatment Phase|Disease Progression|20|||
28007258|NCT01743469|81859521|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
28007259|NCT01743469|81859522|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
27586594|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Adverse Event|5|||
28007260|NCT01743469|81859523|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
28007261|NCT01743469|81859524|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
27586595|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Adverse Event|3|||
27586596|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Adverse Event|4|||
27586597|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Adverse Event|10|||
27586598|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
27586599|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
27586600|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
27685310|NCT01242800|80683707|FG001|Overall Study|Patient refusal|10|||
27685311|NCT01242800|80683706|FG000|Overall Study|Physician Decision|0|||
27685312|NCT01242800|80683707|FG001|Overall Study|Physician Decision|1|||
27685313|NCT01242800|80683706|FG000|Overall Study|Disease progression|0|||
27685314|NCT01242800|80683707|FG001|Overall Study|Disease progression|3|||
27685315|NCT01242800|80683706|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
27685316|NCT01242800|80683707|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
27685317|NCT01242800|80683706|FG000|Overall Study|Reasons not reported|0|||
27685318|NCT01242800|80683707|FG001|Overall Study|Reasons not reported|4|||
27810647|NCT01405820|81137407|FG001|Randomized Treatment Period|Rescue|1|||
27810648|NCT01405820|81137408|FG002|Randomized Treatment Period|Rescue|13|||
27810649|NCT01405820|81137409|FG003|Randomized Treatment Period|Rescue|10|||
27810650|NCT01405820|81137410|FG004|Randomized Treatment Period|Rescue|8|||
27810651|NCT01405820|81137411|FG005|Randomized Treatment Period|Rescue|8|||
27810652|NCT01405820|81137406|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
27810653|NCT01405820|81137407|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
27685319|NCT02624791|80683708|FG000|Overall Study|Withdrawal by Subject|2|||
27685320|NCT02624791|80683709|FG001|Overall Study|Withdrawal by Subject|0|||
27685321|NCT02624791|80683710|FG002|Overall Study|Withdrawal by Subject|0|||
27685322|NCT02624791|80683711|FG003|Overall Study|Withdrawal by Subject|0|||
27685323|NCT02624791|80683712|FG004|Overall Study|Withdrawal by Subject|0|||
27685324|NCT02624791|80683713|FG005|Overall Study|Withdrawal by Subject|0|||
27685325|NCT01361594|80683714|FG000|Overall Study|Withdrawal by Subject|1|||
27685326|NCT01361594|80683715|FG001|Overall Study|Withdrawal by Subject|2|||
27685327|NCT00777088|80683716|FG000|Overall Study|PED Treatment not attempted|1|||
27685328|NCT03167359|80683717|FG000|Overall Study|Physician Decision|1|||
27685329|NCT03167359|80683717|FG000|Overall Study|Lost to Follow-up|1|||
27685330|NCT00548262|80683718|FG000|Overall Study|Death|21|||
27685331|NCT00548262|80683718|FG000|Overall Study|Adverse Event|2|||
27685332|NCT00548262|80683718|FG000|Overall Study|Lack of Efficacy|4|||
27685333|NCT00548262|80683718|FG000|Overall Study|Lost to Follow-up|1|||
27685334|NCT00548262|80683718|FG000|Overall Study|Other|3|||
27685335|NCT00548262|80683718|FG000|Overall Study|Withdrawal by Subject|1|||
27685336|NCT01416389|80683719|FG000|Overall Study|Lost to Follow-up|1|||
27685337|NCT01416389|80683720|FG001|Overall Study|Lost to Follow-up|0|||
27685338|NCT01416389|80683719|FG000|Overall Study|Started New Therapy|2|||
27685339|NCT01416389|80683720|FG001|Overall Study|Started New Therapy|0|||
27685340|NCT01099215|80683721|FG000|Overall Study|Withdrawal by Subject|1|||
27685341|NCT01099215|80683722|FG001|Overall Study|Withdrawal by Subject|0|||
27685342|NCT01099215|80683721|FG000|Overall Study|Adverse Event|0|||
27685343|NCT01099215|80683722|FG001|Overall Study|Adverse Event|1|||
27685344|NCT01276379|80683723|FG000|Overall Study|Screening failure|40|||
27685345|NCT01470001|80683724|FG000|Overall Study|Lost to Follow-up|1|||
27685346|NCT01470001|80683725|FG001|Overall Study|Lost to Follow-up|1|||
27685347|NCT01470001|80683724|FG000|Overall Study|Physician Decision|2|||
27586601|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
27685348|NCT01470001|80683725|FG001|Overall Study|Physician Decision|0|||
27685349|NCT01470001|80683724|FG000|Overall Study|Withdrawal by Subject|2|||
27685350|NCT01470001|80683725|FG001|Overall Study|Withdrawal by Subject|1|||
27685351|NCT04552899|80683726|FG000|Overall Study|Adverse Event|4|||
27685352|NCT04552899|80683727|FG001|Overall Study|Adverse Event|3|||
27685353|NCT04552899|80683726|FG000|Overall Study|Death|4|||
27685354|NCT04552899|80683727|FG001|Overall Study|Death|4|||
27685355|NCT04552899|80683726|FG000|Overall Study|Lost to Follow-up|8|||
27685356|NCT04552899|80683727|FG001|Overall Study|Lost to Follow-up|13|||
27685357|NCT04552899|80683726|FG000|Overall Study|Lung Transplant|4|||
27685358|NCT04552899|80683727|FG001|Overall Study|Lung Transplant|3|||
27685359|NCT04552899|80683726|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
27685360|NCT04552899|80683727|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
27685361|NCT04552899|80683726|FG000|Overall Study|Physician Decision|3|||
27685362|NCT04552899|80683727|FG001|Overall Study|Physician Decision|4|||
27685363|NCT04552899|80683726|FG000|Overall Study|Study Terminated By Sponsor|237|||
27685364|NCT04552899|80683727|FG001|Overall Study|Study Terminated By Sponsor|239|||
27685365|NCT04552899|80683726|FG000|Overall Study|Withdrawal by Subject|15|||
27685366|NCT04552899|80683727|FG001|Overall Study|Withdrawal by Subject|17|||
27685367|NCT01769326|80683729|FG000|Overall Study|Lost to Follow-up|1|||
27875234|NCT03850483|81375434|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27875235|NCT03850483|81375435|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27875236|NCT03850483|81375436|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27875237|NCT03850483|81375437|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27875238|NCT03850483|81375438|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
27685368|NCT01769326|80683730|FG001|Overall Study|Lost to Follow-up|2|||
27685369|NCT01769326|80683731|FG002|Overall Study|Lost to Follow-up|0|||
27685370|NCT01769326|80683732|FG003|Overall Study|Lost to Follow-up|0|||
27685371|NCT01769326|80683729|FG000|Overall Study|unrelated injry|1|||
27685372|NCT01769326|80683730|FG001|Overall Study|unrelated injry|1|||
27685373|NCT01769326|80683731|FG002|Overall Study|unrelated injry|0|||
27685374|NCT01769326|80683732|FG003|Overall Study|unrelated injry|0|||
27685375|NCT01769326|80683729|FG000|Overall Study|got a job|0|||
27685376|NCT01769326|80683730|FG001|Overall Study|got a job|1|||
27685377|NCT01769326|80683731|FG002|Overall Study|got a job|0|||
27685378|NCT01769326|80683732|FG003|Overall Study|got a job|0|||
27685379|NCT01769326|80683729|FG000|Overall Study|Got sick and could not complete study|0|||
27685380|NCT01769326|80683730|FG001|Overall Study|Got sick and could not complete study|0|||
27685381|NCT01769326|80683731|FG002|Overall Study|Got sick and could not complete study|1|||
27685382|NCT01769326|80683732|FG003|Overall Study|Got sick and could not complete study|0|||
27685383|NCT03248492|80683735|FG000|Overall Study|Ongoing|23|||
27685384|NCT03248492|80683736|FG001|Overall Study|Ongoing|26|||
27685385|NCT03248492|80683737|FG002|Overall Study|Ongoing|3|||
27685386|NCT03248492|80683738|FG003|Overall Study|Ongoing|85|||
27685387|NCT03248492|80683739|FG004|Overall Study|Ongoing|2|||
27685388|NCT03248492|80683735|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
27685389|NCT03248492|80683736|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
27685390|NCT03248492|80683737|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
27685391|NCT03248492|80683738|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
27685392|NCT03248492|80683739|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
27685393|NCT03248492|80683735|FG000|Overall Study|Adverse Event|6|||
27685394|NCT03248492|80683736|FG001|Overall Study|Adverse Event|6|||
27685395|NCT03248492|80683737|FG002|Overall Study|Adverse Event|8|||
27685396|NCT03248492|80683738|FG003|Overall Study|Adverse Event|8|||
28007262|NCT01743469|81859521|FG000|Active Treatment Phase|Missing|1|||
28007263|NCT01743469|81859522|FG001|Active Treatment Phase|Missing|0|||
28007264|NCT01743469|81859523|FG002|Active Treatment Phase|Missing|0|||
28007265|NCT01743469|81859524|FG003|Active Treatment Phase|Missing|0|||
28007266|NCT01743469|81859521|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
28007267|NCT01743469|81859522|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
28007268|NCT01743469|81859523|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
27586602|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
27875239|NCT03850483|81375429|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875240|NCT03850483|81375430|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875241|NCT03850483|81375431|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875242|NCT03850483|81375432|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875243|NCT03850483|81375433|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875244|NCT03850483|81375434|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
27875245|NCT03850483|81375435|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875246|NCT03850483|81375436|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875247|NCT03850483|81375437|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875248|NCT03850483|81375438|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
27875249|NCT03850483|81375429|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
27586603|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
27875250|NCT03850483|81375430|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
27875251|NCT03850483|81375431|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
28007269|NCT01743469|81859524|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
27685397|NCT03248492|80683739|FG004|Overall Study|Adverse Event|1|||
27685398|NCT03248492|80683735|FG000|Overall Study|Withdrawal by Subject|3|||
27685399|NCT03248492|80683736|FG001|Overall Study|Withdrawal by Subject|3|||
27685400|NCT03248492|80683737|FG002|Overall Study|Withdrawal by Subject|0|||
27685401|NCT03248492|80683738|FG003|Overall Study|Withdrawal by Subject|3|||
27685402|NCT03248492|80683739|FG004|Overall Study|Withdrawal by Subject|1|||
27875252|NCT03850483|81375432|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
27875253|NCT03850483|81375433|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
27875254|NCT03850483|81375434|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
27875255|NCT03850483|81375435|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
27685403|NCT03248492|80683735|FG000|Overall Study|Physician Decision|1|||
27685404|NCT03248492|80683736|FG001|Overall Study|Physician Decision|0|||
27875256|NCT03850483|81375436|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
27875257|NCT03850483|81375437|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
27875258|NCT03850483|81375438|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
27875259|NCT03850483|81375429|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
27875260|NCT03850483|81375430|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
27875261|NCT03850483|81375431|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
27685405|NCT03248492|80683737|FG002|Overall Study|Physician Decision|1|||
27685406|NCT03248492|80683738|FG003|Overall Study|Physician Decision|2|||
27685407|NCT03248492|80683739|FG004|Overall Study|Physician Decision|0|||
27685408|NCT03248492|80683735|FG000|Overall Study|Death|1|||
27685409|NCT03248492|80683736|FG001|Overall Study|Death|0|||
27685410|NCT03248492|80683737|FG002|Overall Study|Death|0|||
27685411|NCT03248492|80683738|FG003|Overall Study|Death|6|||
27685412|NCT03248492|80683739|FG004|Overall Study|Death|0|||
27875262|NCT03850483|81375432|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
27875263|NCT03850483|81375433|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
27875264|NCT03850483|81375434|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
27875265|NCT03850483|81375435|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
27685413|NCT03248492|80683735|FG000|Overall Study|Other|0|||
27685414|NCT03248492|80683736|FG001|Overall Study|Other|1|||
27685415|NCT03248492|80683737|FG002|Overall Study|Other|0|||
27685416|NCT03248492|80683738|FG003|Overall Study|Other|4|||
27685417|NCT03248492|80683739|FG004|Overall Study|Other|0|||
27685418|NCT03056300|80683740|FG000|Overall Study|Surgical reason per study protocol|3|||
27685419|NCT01691768|80683741|FG000|Overall Study|Death|0|||
27685420|NCT01691768|80683742|FG001|Overall Study|Death|2|||
27685421|NCT01691768|80683741|FG000|Overall Study|Lost to Follow-up|4|||
27685422|NCT01691768|80683742|FG001|Overall Study|Lost to Follow-up|3|||
27685423|NCT01691768|80683741|FG000|Overall Study|Withdrawal by Subject|10|||
27685424|NCT01691768|80683742|FG001|Overall Study|Withdrawal by Subject|9|||
27685425|NCT01691768|80683741|FG000|Overall Study|Relocated|0|||
27685426|NCT01691768|80683742|FG001|Overall Study|Relocated|1|||
27685427|NCT01691768|80683741|FG000|Overall Study|Investigator decision|1|||
27685428|NCT01691768|80683742|FG001|Overall Study|Investigator decision|1|||
27685429|NCT00704405|80683743|FG000|Overall Study (NC Population)|Adverse Event|1|||
27685430|NCT00704405|80683744|FG001|Overall Study (NC Population)|Adverse Event|0|||
27685431|NCT00704405|80683745|FG002|Overall Study (NC Population)|Adverse Event|0|||
27685432|NCT00704405|80683746|FG003|Overall Study (NC Population)|Adverse Event|0|||
27685433|NCT00704405|80683747|FG004|Overall Study (NC Population)|Adverse Event|0|||
27685434|NCT00704405|80683743|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
27685435|NCT00704405|80683744|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
27685436|NCT00704405|80683745|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
27685437|NCT00704405|80683746|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
27685438|NCT00704405|80683747|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
27685439|NCT00704405|80683743|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
27685440|NCT00704405|80683744|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
27685441|NCT00704405|80683745|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
27685442|NCT00704405|80683746|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
27685443|NCT00704405|80683747|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
27685444|NCT00704405|80683743|FG000|Overall Study (NC Population)|Other|0|||
27685445|NCT00704405|80683744|FG001|Overall Study (NC Population)|Other|0|||
27685446|NCT00704405|80683745|FG002|Overall Study (NC Population)|Other|0|||
27685447|NCT00704405|80683746|FG003|Overall Study (NC Population)|Other|0|||
27685448|NCT00704405|80683747|FG004|Overall Study (NC Population)|Other|1|||
27875266|NCT03850483|81375436|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
27875267|NCT03850483|81375437|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
27875268|NCT03850483|81375438|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
27875269|NCT03850483|81375429|FG000|Treatment for Stage 1|Death|0|||
27875270|NCT03850483|81375430|FG001|Treatment for Stage 1|Death|0|||
27875271|NCT03850483|81375431|FG002|Treatment for Stage 1|Death|0|||
27875272|NCT03850483|81375432|FG003|Treatment for Stage 1|Death|0|||
27875273|NCT03850483|81375433|FG004|Treatment for Stage 1|Death|0|||
27875274|NCT03850483|81375434|FG005|Treatment for Stage 1|Death|1|||
27875275|NCT03850483|81375435|FG006|Treatment for Stage 1|Death|0|||
27685449|NCT00704405|80683743|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
27875276|NCT03850483|81375436|FG007|Treatment for Stage 1|Death|0|||
27685450|NCT00704405|80683744|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
27685451|NCT00704405|80683745|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
27685452|NCT00704405|80683746|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
27875277|NCT03850483|81375437|FG008|Treatment for Stage 1|Death|0|||
27685453|NCT00704405|80683747|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
27685454|NCT00704405|80683743|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
27685455|NCT00704405|80683744|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
27685456|NCT00704405|80683745|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
27685457|NCT00704405|80683746|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
27685458|NCT00704405|80683747|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
27685459|NCT00439231|80683748|FG000|Overall Study|Lack of Efficacy|28|||
27685460|NCT00132873|80683749|FG000|Overall Study|Adverse Event|3|||
27685461|NCT00132873|80683749|FG000|Overall Study|Lost to Follow-up|1|||
27685462|NCT00132873|80683749|FG000|Overall Study|Lack of Efficacy|1|||
27685463|NCT00132873|80683749|FG000|Overall Study|Withdrawal by Subject|3|||
27685464|NCT00132873|80683749|FG000|Overall Study|Planned Pregnancy|1|||
27685465|NCT00515853|80683750|FG000|Overall Study|Lost to Follow-up|9|||
27685466|NCT00515853|80683751|FG001|Overall Study|Lost to Follow-up|13|||
27685467|NCT00515853|80683750|FG000|Overall Study|Withdrawal by Subject|6|||
27685468|NCT00515853|80683751|FG001|Overall Study|Withdrawal by Subject|4|||
27685469|NCT02124811|80683752|FG000|Overall Study|Early termination|2|||
27685470|NCT02124811|80683753|FG001|Overall Study|Early termination|2|||
27685471|NCT02124811|80683752|FG000|Overall Study|Withdrawal by Subject|1|||
27685472|NCT02124811|80683753|FG001|Overall Study|Withdrawal by Subject|0|||
27685473|NCT00831129|80683754|FG000|Overall Study|Adverse Event|0|||
27875278|NCT03850483|81375438|FG009|Treatment for Stage 1|Death|0|||
27875279|NCT03850483|81375429|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
27875280|NCT03850483|81375430|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
27685474|NCT00831129|80683755|FG001|Overall Study|Adverse Event|1|||
27685475|NCT00831129|80683754|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
27685476|NCT00831129|80683755|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
27685477|NCT03141905|80683756|FG000|Overall Study|Death|3|||
27685478|NCT03141905|80683757|FG001|Overall Study|Death|2|||
27685479|NCT03141905|80683756|FG000|Overall Study|Withdrawal by Subject|1|||
27685480|NCT03141905|80683757|FG001|Overall Study|Withdrawal by Subject|0|||
27685481|NCT03141905|80683756|FG000|Overall Study|Lost to Follow-up|3|||
27685482|NCT03141905|80683757|FG001|Overall Study|Lost to Follow-up|7|||
27685483|NCT03141905|80683756|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
27685484|NCT03141905|80683757|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
27685485|NCT03900416|80683761|FG000|Six Week Follow-up|Lost to Follow-up|1|||
27685486|NCT03900416|80683762|FG001|Six Week Follow-up|Lost to Follow-up|0|||
27875281|NCT03850483|81375431|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
27875282|NCT03850483|81375432|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
27586604|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
27586605|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
27685487|NCT03900416|80683761|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
27685488|NCT03900416|80683762|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
27685489|NCT03900416|80683761|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
27685490|NCT03900416|80683762|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
27685491|NCT03900416|80683761|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
27685492|NCT03900416|80683762|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
27685493|NCT03900416|80683761|FG000|Twelve Week Follow-up|Adverse Event|1|||
27685494|NCT03900416|80683762|FG001|Twelve Week Follow-up|Adverse Event|1|||
27685495|NCT03900416|80683761|FG000|Six Month Follow-up|Lost to Follow-up|4|||
27685496|NCT03900416|80683762|FG001|Six Month Follow-up|Lost to Follow-up|3|||
27685497|NCT03900416|80683761|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
27685498|NCT03900416|80683762|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
27685499|NCT02187159|80683763|FG000|Overall Study|Protocol Violation|4|||
27685500|NCT02187159|80683764|FG001|Overall Study|Protocol Violation|6|||
27685501|NCT02187159|80683765|FG002|Overall Study|Protocol Violation|3|||
27685502|NCT02187159|80683766|FG003|Overall Study|Protocol Violation|4|||
27685503|NCT02187159|80683763|FG000|Overall Study|Lack of Efficacy|10|||
27685504|NCT02187159|80683764|FG001|Overall Study|Lack of Efficacy|5|||
27685505|NCT02187159|80683765|FG002|Overall Study|Lack of Efficacy|4|||
27685506|NCT02187159|80683766|FG003|Overall Study|Lack of Efficacy|7|||
27685507|NCT02187159|80683763|FG000|Overall Study|Adverse Event|28|||
27685508|NCT02187159|80683764|FG001|Overall Study|Adverse Event|33|||
27685509|NCT02187159|80683765|FG002|Overall Study|Adverse Event|42|||
27685510|NCT02187159|80683766|FG003|Overall Study|Adverse Event|50|||
27685511|NCT02187159|80683763|FG000|Overall Study|Withdrawal by Subject|24|||
27685512|NCT02187159|80683764|FG001|Overall Study|Withdrawal by Subject|28|||
27685513|NCT02187159|80683765|FG002|Overall Study|Withdrawal by Subject|25|||
27685514|NCT02187159|80683766|FG003|Overall Study|Withdrawal by Subject|26|||
27685515|NCT02187159|80683763|FG000|Overall Study|Other|3|||
27685516|NCT02187159|80683764|FG001|Overall Study|Other|7|||
27685517|NCT02187159|80683765|FG002|Overall Study|Other|3|||
27685518|NCT02187159|80683766|FG003|Overall Study|Other|9|||
27875283|NCT03850483|81375433|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
28007270|NCT01743469|81859521|FG000|Follow-up Period - Post-Treatment|Death|43|||
27685519|NCT01127763|80683767|FG000|Overall Study|Adverse Event|2|||
27875284|NCT03850483|81375434|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
27875285|NCT03850483|81375435|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
27875286|NCT03850483|81375436|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
27875287|NCT03850483|81375437|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
27875288|NCT03850483|81375438|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
27875289|NCT03850483|81375429|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
27875290|NCT03850483|81375430|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
27875291|NCT03850483|81375431|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
27875292|NCT03850483|81375432|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
27875293|NCT03850483|81375433|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
27875294|NCT03850483|81375434|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
27875295|NCT03850483|81375435|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
27875296|NCT03850483|81375436|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
27875297|NCT03850483|81375437|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
27875298|NCT03850483|81375438|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
27875299|NCT03850483|81375429|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
27586606|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Pregnancy|5|||
27875300|NCT03850483|81375430|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875301|NCT03850483|81375431|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875302|NCT03850483|81375432|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875303|NCT03850483|81375433|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875304|NCT03850483|81375434|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875305|NCT03850483|81375435|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
27875306|NCT03850483|81375436|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
27875307|NCT03850483|81375437|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875308|NCT03850483|81375438|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
27875309|NCT03850483|81375429|FG000|Follow-up for Stage 1|Physician Decision|0|||
27875310|NCT03850483|81375430|FG001|Follow-up for Stage 1|Physician Decision|0|||
27875311|NCT03850483|81375431|FG002|Follow-up for Stage 1|Physician Decision|0|||
27875312|NCT03850483|81375432|FG003|Follow-up for Stage 1|Physician Decision|0|||
27875313|NCT03850483|81375433|FG004|Follow-up for Stage 1|Physician Decision|1|||
27586607|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Pregnancy|0|||
27586608|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Pregnancy|3|||
27586609|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Pregnancy|2|||
27586610|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Non-compliance|1|||
27586611|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Non-compliance|4|||
27586612|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Non-compliance|0|||
27586613|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Non-compliance|3|||
27586614|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Other|0|||
27586615|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Other|3|||
27586616|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Other|3|||
27586617|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Other|1|||
27586618|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
27586619|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
27586620|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
27586621|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
27586622|NCT01760954|80328395|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
27586623|NCT01760954|80328396|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
27586624|NCT01760954|80328397|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
27586625|NCT01760954|80328398|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
27586626|NCT01760954|80328395|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
27586627|NCT01760954|80328396|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
27586628|NCT01760954|80328397|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
27586629|NCT01760954|80328398|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
27586630|NCT01760954|80328395|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
27586631|NCT01760954|80328396|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
27586632|NCT01760954|80328397|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
27586633|NCT01760954|80328398|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
27586634|NCT01760954|80328395|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
27685520|NCT01127763|80683767|FG000|Overall Study|Withdrawal by Subject|1|||
27685521|NCT01127763|80683767|FG000|Overall Study|Physician Decision|2|||
27685522|NCT02153073|80683768|FG000|Overall Study|Case Report Forms Uncollected|230|||
27685523|NCT02153073|80683768|FG000|Overall Study|Protocol Deviation|68|||
27875314|NCT03850483|81375434|FG005|Follow-up for Stage 1|Physician Decision|0|||
28007271|NCT01743469|81859522|FG001|Follow-up Period - Post-Treatment|Death|47|||
27586635|NCT01760954|80328396|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
27586636|NCT01760954|80328397|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
27875315|NCT03850483|81375435|FG006|Follow-up for Stage 1|Physician Decision|1|||
28007272|NCT01743469|81859523|FG002|Follow-up Period - Post-Treatment|Death|22|||
28007273|NCT01743469|81859524|FG003|Follow-up Period - Post-Treatment|Death|16|||
28007274|NCT01743469|81859521|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
28007275|NCT01743469|81859522|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
28007276|NCT01743469|81859523|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
28007277|NCT01743469|81859524|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
28007278|NCT04366349|81859525|FG000|Overall Study|Withdrawal by Subject|1|||
28007279|NCT04366349|81859526|FG001|Overall Study|Withdrawal by Subject|0|||
28007280|NCT04366349|81859527|FG002|Overall Study|Withdrawal by Subject|0|||
28007281|NCT04366349|81859528|FG003|Overall Study|Withdrawal by Subject|0|||
28007282|NCT04366349|81859529|FG004|Overall Study|Withdrawal by Subject|0|||
28007283|NCT04366349|81859530|FG005|Overall Study|Withdrawal by Subject|0|||
28007284|NCT02183675|81859531|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
28007285|NCT02183675|81859532|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
28007286|NCT02183675|81859533|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
28007287|NCT02183675|81859534|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
28007288|NCT02183675|81859535|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
28007289|NCT02183675|81859536|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
28007290|NCT03633396|81859537|FG000|Overall Study|Withdrawal by Subject|4|||
28007291|NCT03633396|81859538|FG001|Overall Study|Withdrawal by Subject|4|||
28007292|NCT03633396|81859537|FG000|Overall Study|Adverse Event|1|||
28007293|NCT03633396|81859538|FG001|Overall Study|Adverse Event|1|||
28007294|NCT03633396|81859537|FG000|Overall Study|Lack of Efficacy|1|||
28007295|NCT03633396|81859538|FG001|Overall Study|Lack of Efficacy|0|||
28007296|NCT03633396|81859537|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
28007297|NCT03633396|81859538|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
28007298|NCT03289208|81859539|FG000|Overall Study|Adverse Event|1|||
28007299|NCT03289208|81859540|FG001|Overall Study|Adverse Event|0|||
28007300|NCT03289208|81859541|FG002|Overall Study|Adverse Event|0|||
28007301|NCT01045967|81859544|FG000|Second Intervention|Protocol Violation|0|||
28007302|NCT01045967|81859545|FG001|Second Intervention|Protocol Violation|1|||
28007303|NCT04235140|81859547|FG000|Overall Study|Adverse Event|2|||
28007304|NCT04235140|81859547|FG000|Overall Study|Lost to Follow-up|1|||
28007305|NCT04235140|81859547|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
28007306|NCT04235140|81859547|FG000|Overall Study|Commercial drug is available for participants|7|||
28007307|NCT00781768|81859548|FG000|Overall Study|Not transplanted.|0|||
28007308|NCT00781768|81859549|FG001|Overall Study|Not transplanted.|2|||
28007309|NCT04869982|81859550|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
28007310|NCT04869982|81859551|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
28007311|NCT04869982|81859550|FG000|Overall Study|Migrated / moved from the study area|1|||
28007312|NCT04869982|81859551|FG001|Overall Study|Migrated / moved from the study area|1|||
28007313|NCT04869982|81859550|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
28007314|NCT04869982|81859551|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
28007315|NCT04869982|81859550|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
28007316|NCT04869982|81859551|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
28007317|NCT04869982|81859550|FG000|Overall Study|Solicited adverse event|2|||
28007318|NCT04869982|81859551|FG001|Overall Study|Solicited adverse event|1|||
28007319|NCT00981656|81859552|FG000|Overall Study|Protocol Violation|1|||
28007320|NCT00981656|81859552|FG000|Overall Study|Did not start protocol treatment|2|||
28007321|NCT05498649|81859553|FG000|Overall Study|Lost to Follow-up|1|||
28007322|NCT04819945|81859554|FG000|Overall Study|Lost to Follow-up|1|||
28007323|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007324|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007325|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007326|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
28007327|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007328|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007329|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007330|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007331|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007332|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
28007333|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
28007334|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
28007335|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
28007336|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
28007337|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
28007338|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
28007339|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
28007340|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
28007341|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
28007342|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
28007343|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
28007344|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
28007345|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
28007346|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
28007347|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
28007348|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
28007349|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
28007350|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
28007351|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
28007352|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
28007353|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
28007354|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
28007355|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
28007356|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
28007357|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
27586637|NCT01760954|80328398|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
27586638|NCT01760954|80328395|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
27586639|NCT01760954|80328396|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
27586640|NCT01760954|80328397|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
27586641|NCT01760954|80328398|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
27586642|NCT01760954|80328395|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
27586643|NCT01760954|80328396|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
27586644|NCT01760954|80328397|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
27586645|NCT01760954|80328398|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
27586646|NCT01760954|80328395|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
27586647|NCT01760954|80328396|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
27586648|NCT01760954|80328397|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
27586649|NCT01760954|80328398|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
27586650|NCT00968669|80328403|FG000|Overall Study|Lost to Follow-up|5|||
27586651|NCT00968669|80328404|FG001|Overall Study|Lost to Follow-up|2|||
27586652|NCT00968669|80328405|FG002|Overall Study|Lost to Follow-up|1|||
27586653|NCT00968669|80328406|FG003|Overall Study|Lost to Follow-up|4|||
27586654|NCT00968669|80328403|FG000|Overall Study|Withdrawal by Subject|9|||
27586655|NCT00968669|80328404|FG001|Overall Study|Withdrawal by Subject|7|||
27586656|NCT00968669|80328405|FG002|Overall Study|Withdrawal by Subject|5|||
27586657|NCT00968669|80328406|FG003|Overall Study|Withdrawal by Subject|3|||
27586658|NCT00968669|80328403|FG000|Overall Study|Pregnancy|0|||
27586659|NCT00968669|80328404|FG001|Overall Study|Pregnancy|0|||
27586660|NCT00968669|80328405|FG002|Overall Study|Pregnancy|2|||
27586661|NCT00968669|80328406|FG003|Overall Study|Pregnancy|0|||
27586662|NCT00968669|80328403|FG000|Overall Study|AE|1|||
27586663|NCT00968669|80328404|FG001|Overall Study|AE|0|||
27586664|NCT00968669|80328405|FG002|Overall Study|AE|0|||
27586665|NCT00968669|80328406|FG003|Overall Study|AE|0|||
27586666|NCT00968669|80328403|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
27586667|NCT00968669|80328404|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
27586668|NCT00968669|80328405|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
27586669|NCT00968669|80328406|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
27586670|NCT00968669|80328403|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
27586671|NCT00968669|80328404|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
27586672|NCT00968669|80328405|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
27586673|NCT00968669|80328406|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
27586674|NCT00968669|80328403|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
27586675|NCT00968669|80328404|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
27586676|NCT00968669|80328405|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
27586677|NCT00968669|80328406|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
27586678|NCT00968669|80328403|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
27586679|NCT00968669|80328404|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
27586680|NCT00968669|80328405|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
27586681|NCT00968669|80328406|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
27586682|NCT00968669|80328403|FG000|Overall Study|EARLY WITHDRAWAL|0|||
27586683|NCT00968669|80328404|FG001|Overall Study|EARLY WITHDRAWAL|1|||
27586684|NCT00968669|80328405|FG002|Overall Study|EARLY WITHDRAWAL|0|||
27586685|NCT00968669|80328406|FG003|Overall Study|EARLY WITHDRAWAL|0|||
27586686|NCT00968669|80328403|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
27586687|NCT00968669|80328404|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
27685524|NCT03292432|80683771|FG000|Overall Study|Lost to Follow-up|11|||
27586688|NCT00968669|80328405|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
27685525|NCT03292432|80683772|FG001|Overall Study|Lost to Follow-up|8|||
27586689|NCT00968669|80328406|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
27586690|NCT00968669|80328403|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
27586691|NCT00968669|80328404|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
27586692|NCT00968669|80328405|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
27586693|NCT00968669|80328406|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
27586694|NCT00968669|80328403|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
27586695|NCT00968669|80328404|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
27586696|NCT00968669|80328405|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
27586697|NCT00968669|80328406|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
27586698|NCT00968669|80328403|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
27586699|NCT00968669|80328404|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
27586700|NCT00968669|80328405|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
27586701|NCT00968669|80328406|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
27586702|NCT00968669|80328403|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
27810654|NCT01405820|81137408|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
27810655|NCT01405820|81137409|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
27586703|NCT00968669|80328404|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
27810656|NCT01405820|81137410|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
27810657|NCT01405820|81137411|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
27810658|NCT01405820|81137406|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
27810659|NCT01405820|81137407|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
27810660|NCT01405820|81137408|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
27810661|NCT01405820|81137409|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
27810662|NCT01405820|81137410|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
27586704|NCT00968669|80328405|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
27586705|NCT00968669|80328406|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
27586706|NCT00968669|80328403|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
27586707|NCT00968669|80328404|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
27586708|NCT00968669|80328405|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
27586709|NCT00968669|80328406|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
27586710|NCT00968669|80328403|FG000|Overall Study|SPONSOR DECISION|0|||
27586711|NCT00968669|80328404|FG001|Overall Study|SPONSOR DECISION|1|||
27586712|NCT00968669|80328405|FG002|Overall Study|SPONSOR DECISION|0|||
27586713|NCT00968669|80328406|FG003|Overall Study|SPONSOR DECISION|0|||
27586714|NCT00968669|80328403|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
27586715|NCT00968669|80328404|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
27586716|NCT00968669|80328405|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
27586717|NCT00968669|80328406|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
27586718|NCT00968669|80328403|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
27586719|NCT00968669|80328404|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
27586720|NCT00968669|80328405|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
27586721|NCT00968669|80328406|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
27586722|NCT00968669|80328403|FG000|Overall Study|SUBJECT INCARCERATED|0|||
27586723|NCT00968669|80328404|FG001|Overall Study|SUBJECT INCARCERATED|1|||
27586724|NCT00968669|80328405|FG002|Overall Study|SUBJECT INCARCERATED|0|||
27586725|NCT00968669|80328406|FG003|Overall Study|SUBJECT INCARCERATED|0|||
27586726|NCT00968669|80328403|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
27586727|NCT00968669|80328404|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
27586728|NCT00968669|80328405|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
27586729|NCT00968669|80328406|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
27586730|NCT00968669|80328403|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
27586731|NCT00968669|80328404|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
27810663|NCT01405820|81137411|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
27810664|NCT01405820|81137406|FG000|Randomized Treatment Period|Death|0|||
28007358|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
28007359|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
28007360|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
28007361|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
28007362|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
28007363|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
28007364|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007365|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
27586732|NCT00968669|80328405|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
27810665|NCT01405820|81137407|FG001|Randomized Treatment Period|Death|0|||
27810666|NCT01405820|81137408|FG002|Randomized Treatment Period|Death|0|||
27586733|NCT00968669|80328406|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
27586734|NCT04000165|80328407|FG000|Overall Study|Physician Decision|1|||
27586735|NCT04000165|80328407|FG000|Overall Study|Withdrawal by Subject|1|||
27586736|NCT02276482|80328408|FG000|Overall Study|Adverse Event|1|||
27685526|NCT03292432|80683771|FG000|Overall Study|Death|2|||
27685527|NCT03292432|80683772|FG001|Overall Study|Death|1|||
27586737|NCT02276482|80328409|FG001|Overall Study|Adverse Event|0|||
27586738|NCT02276482|80328408|FG000|Overall Study|Withdrawal by Subject|1|||
27586739|NCT02276482|80328409|FG001|Overall Study|Withdrawal by Subject|0|||
27586740|NCT02276482|80328408|FG000|Overall Study|Gram-negative infection|1|||
27586741|NCT02276482|80328409|FG001|Overall Study|Gram-negative infection|0|||
27586742|NCT02276482|80328408|FG000|Overall Study|Reason not specified|0|||
27586743|NCT02276482|80328409|FG001|Overall Study|Reason not specified|1|||
27586744|NCT03579563|80328410|FG000|Overall Study|Lost to Follow-up|0|||
27586745|NCT03579563|80328411|FG001|Overall Study|Lost to Follow-up|0|||
27586746|NCT03579563|80328412|FG002|Overall Study|Lost to Follow-up|0|||
27586747|NCT03579563|80328413|FG003|Overall Study|Lost to Follow-up|0|||
27586748|NCT03579563|80328414|FG004|Overall Study|Lost to Follow-up|1|||
27586749|NCT03579563|80328415|FG005|Overall Study|Lost to Follow-up|0|||
27685528|NCT03292432|80683771|FG000|Overall Study|Withdrawal by Subject|1|||
27685529|NCT03292432|80683772|FG001|Overall Study|Withdrawal by Subject|2|||
27685530|NCT03292432|80683771|FG000|Overall Study|Site closed before any data collected|1|||
27685531|NCT03292432|80683772|FG001|Overall Study|Site closed before any data collected|0|||
27685532|NCT00608868|80683774|FG000|Overall Study|Withdrawal by Subject|7|||
27685533|NCT00608868|80683774|FG000|Overall Study|Protocol Violation|3|||
27685534|NCT00608868|80683774|FG000|Overall Study|Lost to Follow-up|2|||
27685535|NCT00608868|80683774|FG000|Overall Study|Adverse Event|1|||
27685536|NCT00608868|80683774|FG000|Overall Study|Physician Decision|2|||
27685537|NCT01395888|80683777|FG000|2-week Run-in Period|Adverse Event|2|||
27875316|NCT03850483|81375436|FG007|Follow-up for Stage 1|Physician Decision|0|||
27875317|NCT03850483|81375437|FG008|Follow-up for Stage 1|Physician Decision|0|||
27875318|NCT03850483|81375438|FG009|Follow-up for Stage 1|Physician Decision|0|||
27875319|NCT03850483|81375429|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
28007366|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007367|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
28007368|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007369|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007370|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007371|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007372|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
28007373|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
28007374|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
28007375|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
28007376|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
27586750|NCT03579563|80328410|FG000|Overall Study|Lack of Efficacy|1|||
27685538|NCT01395888|80683778|FG001|2-week Run-in Period|Adverse Event|0|||
27685539|NCT01395888|80683779|FG002|2-week Run-in Period|Adverse Event|0|||
27685540|NCT01395888|80683777|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
27685541|NCT01395888|80683778|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
27685542|NCT01395888|80683779|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
27685543|NCT01395888|80683777|FG000|2-week Run-in Period|Lost to Follow-up|1|||
27685544|NCT01395888|80683778|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27586751|NCT03579563|80328411|FG001|Overall Study|Lack of Efficacy|1|||
27685545|NCT01395888|80683779|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27685546|NCT01395888|80683777|FG000|2-week Run-in Period|Protocol Violation|2|||
27586752|NCT03579563|80328412|FG002|Overall Study|Lack of Efficacy|4|||
27586753|NCT03579563|80328413|FG003|Overall Study|Lack of Efficacy|1|||
27875320|NCT03850483|81375430|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
27685547|NCT01395888|80683778|FG001|2-week Run-in Period|Protocol Violation|0|||
27685548|NCT01395888|80683779|FG002|2-week Run-in Period|Protocol Violation|0|||
27685549|NCT01395888|80683777|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
27685550|NCT01395888|80683778|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27875321|NCT03850483|81375431|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
27586754|NCT03579563|80328414|FG004|Overall Study|Lack of Efficacy|2|||
27586755|NCT03579563|80328415|FG005|Overall Study|Lack of Efficacy|3|||
27586756|NCT03579563|80328410|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
27586757|NCT03579563|80328411|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
27810667|NCT01405820|81137409|FG003|Randomized Treatment Period|Death|1|||
27810668|NCT01405820|81137410|FG004|Randomized Treatment Period|Death|0|||
27810669|NCT01405820|81137411|FG005|Randomized Treatment Period|Death|0|||
28007377|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
28007378|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
28007379|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
28007380|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
28007381|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
28007382|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
28007383|NCT02365649|81859555|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007384|NCT02365649|81859556|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007385|NCT02365649|81859557|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
28007386|NCT02365649|81859558|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007387|NCT02365649|81859559|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007388|NCT02365649|81859560|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007389|NCT02365649|81859561|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007390|NCT02365649|81859562|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
27810670|NCT01405820|81137406|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27586758|NCT03579563|80328412|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
28007391|NCT02365649|81859563|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
28007392|NCT02365649|81859564|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
27810671|NCT01405820|81137407|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27810672|NCT01405820|81137408|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27810673|NCT01405820|81137409|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
27810674|NCT01405820|81137410|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27810675|NCT01405820|81137411|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
27810676|NCT01405820|81137406|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
27810677|NCT01405820|81137407|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
27810678|NCT01405820|81137408|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
27810679|NCT01405820|81137409|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
27810680|NCT01405820|81137410|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
27810681|NCT01405820|81137411|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
28007393|NCT02365649|81859555|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007394|NCT02365649|81859556|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007395|NCT02365649|81859557|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007396|NCT02365649|81859558|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007397|NCT02365649|81859559|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007398|NCT02365649|81859560|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
27810682|NCT01405820|81137406|FG000|Open-Label Treatment Period|Other|1|||
27810683|NCT01405820|81137407|FG001|Open-Label Treatment Period|Other|1|||
27810684|NCT01405820|81137408|FG002|Open-Label Treatment Period|Other|1|||
27810685|NCT01405820|81137409|FG003|Open-Label Treatment Period|Other|1|||
27810686|NCT01405820|81137410|FG004|Open-Label Treatment Period|Other|1|||
27810687|NCT01405820|81137411|FG005|Open-Label Treatment Period|Other|1|||
27810688|NCT01405820|81137406|FG000|Open-Label Treatment Period|Physician Decision|0|||
27810689|NCT01405820|81137407|FG001|Open-Label Treatment Period|Physician Decision|0|||
27810690|NCT01405820|81137408|FG002|Open-Label Treatment Period|Physician Decision|1|||
27810691|NCT01405820|81137409|FG003|Open-Label Treatment Period|Physician Decision|2|||
27810692|NCT01405820|81137410|FG004|Open-Label Treatment Period|Physician Decision|1|||
27810693|NCT01405820|81137411|FG005|Open-Label Treatment Period|Physician Decision|0|||
27810694|NCT01405820|81137406|FG000|Open-Label Treatment Period|Adverse Event|0|||
27810695|NCT01405820|81137407|FG001|Open-Label Treatment Period|Adverse Event|0|||
27810696|NCT01405820|81137408|FG002|Open-Label Treatment Period|Adverse Event|0|||
27875322|NCT03850483|81375432|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
27810697|NCT01405820|81137409|FG003|Open-Label Treatment Period|Adverse Event|1|||
27810698|NCT01405820|81137410|FG004|Open-Label Treatment Period|Adverse Event|0|||
27810699|NCT01405820|81137411|FG005|Open-Label Treatment Period|Adverse Event|0|||
28007399|NCT02365649|81859561|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
28007400|NCT02365649|81859562|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007401|NCT02365649|81859563|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007402|NCT02365649|81859564|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
28007403|NCT02365649|81859555|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
28007404|NCT02365649|81859556|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
28007405|NCT02365649|81859557|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
28007406|NCT02365649|81859558|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
27685551|NCT01395888|80683779|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27685552|NCT01395888|80683777|FG000|Treatment Period (TP)|Adverse Event|0|||
27685553|NCT01395888|80683778|FG001|Treatment Period (TP)|Adverse Event|7|||
27685554|NCT01395888|80683779|FG002|Treatment Period (TP)|Adverse Event|6|||
27685555|NCT01395888|80683777|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
27685556|NCT01395888|80683778|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
27685557|NCT01395888|80683779|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
27685558|NCT01395888|80683777|FG000|Treatment Period (TP)|Protocol Violation|0|||
27685559|NCT01395888|80683778|FG001|Treatment Period (TP)|Protocol Violation|1|||
27685560|NCT01395888|80683779|FG002|Treatment Period (TP)|Protocol Violation|5|||
27685561|NCT01395888|80683777|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
27685562|NCT01395888|80683778|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
27810700|NCT01090765|81137419|FG000|Overall Study|Patient withdrew consent|0|||
27810701|NCT01090765|81137420|FG001|Overall Study|Patient withdrew consent|0|||
27810702|NCT01090765|81137421|FG002|Overall Study|Patient withdrew consent|0|||
27810703|NCT01090765|81137422|FG003|Overall Study|Patient withdrew consent|0|||
27810704|NCT01090765|81137423|FG004|Overall Study|Patient withdrew consent|1|||
27810705|NCT01090765|81137424|FG005|Overall Study|Patient withdrew consent|1|||
27810706|NCT01090765|81137419|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
27810707|NCT01090765|81137420|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
28007407|NCT02365649|81859559|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
27586759|NCT03579563|80328413|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
27586760|NCT03579563|80328414|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
27810708|NCT01090765|81137421|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
27810709|NCT01090765|81137422|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
28007408|NCT02365649|81859560|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
28007409|NCT02365649|81859561|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
28007410|NCT02365649|81859562|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
28007411|NCT02365649|81859563|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
28007412|NCT02365649|81859564|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
28007413|NCT02365649|81859555|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
28007414|NCT02365649|81859556|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
28007415|NCT02365649|81859557|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
28007416|NCT02365649|81859558|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
28007417|NCT02365649|81859559|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
28007418|NCT02365649|81859560|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
28007419|NCT02365649|81859561|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
28007420|NCT02365649|81859562|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
28007421|NCT02365649|81859563|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
28007422|NCT02365649|81859564|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
28007423|NCT02365649|81859555|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007424|NCT02365649|81859556|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007425|NCT02365649|81859557|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007426|NCT02365649|81859558|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007427|NCT02365649|81859559|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007428|NCT02365649|81859560|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007429|NCT02365649|81859561|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
28007430|NCT02365649|81859562|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
28007431|NCT02365649|81859563|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
27810710|NCT01090765|81137423|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
27810711|NCT01090765|81137424|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
27586761|NCT03579563|80328415|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
27586762|NCT03579563|80328410|FG000|Overall Study|Time/distance concern|0|||
27685563|NCT01395888|80683779|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
27810712|NCT01090765|81137419|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
28007432|NCT02365649|81859564|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
27685564|NCT01395888|80683777|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
28007433|NCT02365649|81859555|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
27810713|NCT01090765|81137420|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
28007434|NCT02365649|81859556|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007435|NCT02365649|81859557|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007436|NCT02365649|81859558|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007437|NCT02365649|81859559|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007438|NCT02365649|81859560|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007439|NCT02365649|81859561|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
28007440|NCT02365649|81859562|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007441|NCT02365649|81859563|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
28007442|NCT02365649|81859564|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
28007443|NCT00301808|81859565|FG000|Overall Study|Adverse Event|5|||
28007444|NCT00301808|81859565|FG000|Overall Study|Death|3|||
28007445|NCT00301808|81859565|FG000|Overall Study|Lack of Efficacy|4|||
28007446|NCT02903914|81859566|FG000|Overall Study|Adverse Event|0|||
28007447|NCT02903914|81859567|FG001|Overall Study|Adverse Event|0|||
28007448|NCT02903914|81859568|FG002|Overall Study|Adverse Event|1|||
28007449|NCT02903914|81859569|FG003|Overall Study|Adverse Event|0|||
28007450|NCT02903914|81859570|FG004|Overall Study|Adverse Event|0|||
27685565|NCT01395888|80683778|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
27685566|NCT01395888|80683779|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
27685567|NCT02045875|80683782|FG000|Overall Study|Lost to Follow-up|3|||
27685568|NCT02045875|80683783|FG001|Overall Study|Lost to Follow-up|0|||
27685569|NCT02045875|80683782|FG000|Overall Study|Withdrawal by Subject|4|||
27685570|NCT02045875|80683783|FG001|Overall Study|Withdrawal by Subject|3|||
27685571|NCT00953745|80683784|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
27685572|NCT00953745|80683785|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
27685573|NCT00953745|80683784|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
27685574|NCT00953745|80683785|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
27685575|NCT00953745|80683784|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
27685576|NCT00953745|80683785|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
27685577|NCT00953745|80683784|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
27685578|NCT00953745|80683785|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
27685579|NCT00953745|80683784|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
27685580|NCT00953745|80683785|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
27685581|NCT00953745|80683784|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
27685582|NCT00953745|80683785|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
27685583|NCT05180500|80683786|FG000|Overall Study|Adverse Event|1|||
27685584|NCT05180500|80683787|FG001|Overall Study|Adverse Event|0|||
27685585|NCT05180500|80683786|FG000|Overall Study|Withdrawal by Subject|2|||
27685586|NCT05180500|80683787|FG001|Overall Study|Withdrawal by Subject|0|||
27685587|NCT00888927|80683788|FG000|Overall Study|Adverse Event|0|||
27685588|NCT00888927|80683789|FG001|Overall Study|Adverse Event|0|||
27685589|NCT00888927|80683790|FG002|Overall Study|Adverse Event|0|||
27810714|NCT01090765|81137421|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
27810715|NCT01090765|81137422|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
27810716|NCT01090765|81137423|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
27810717|NCT01090765|81137424|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
27810718|NCT01567306|81137425|FG000|Overall Study|Protocol Violation|2|||
27810719|NCT01567306|81137426|FG001|Overall Study|Protocol Violation|2|||
27810720|NCT01567306|81137427|FG002|Overall Study|Protocol Violation|0|||
27685590|NCT00888927|80683791|FG003|Overall Study|Adverse Event|1|||
27685591|NCT00888927|80683788|FG000|Overall Study|Withdrawal of consent|0|||
27810721|NCT01567306|81137428|FG003|Overall Study|Protocol Violation|3|||
28007451|NCT02903914|81859571|FG005|Overall Study|Adverse Event|0|||
27685592|NCT00888927|80683789|FG001|Overall Study|Withdrawal of consent|0|||
27685593|NCT00888927|80683790|FG002|Overall Study|Withdrawal of consent|0|||
27685594|NCT00888927|80683791|FG003|Overall Study|Withdrawal of consent|1|||
27685595|NCT00201643|80683793|FG000|Overall Study|Withdrawal by Subject|5|||
27685596|NCT00201643|80683794|FG001|Overall Study|Withdrawal by Subject|4|||
27685597|NCT03122223|80683795|FG000|Overall Study|Withdrawal by Subject|2|||
27685598|NCT03122223|80683796|FG001|Overall Study|Withdrawal by Subject|2|||
27685599|NCT03122223|80683797|FG002|Overall Study|Withdrawal by Subject|1|||
27685600|NCT03122223|80683798|FG003|Overall Study|Withdrawal by Subject|0|||
27685601|NCT03122223|80683795|FG000|Overall Study|Lost to Follow-up|0|||
27685602|NCT03122223|80683796|FG001|Overall Study|Lost to Follow-up|2|||
27685603|NCT03122223|80683797|FG002|Overall Study|Lost to Follow-up|2|||
27685604|NCT03122223|80683798|FG003|Overall Study|Lost to Follow-up|0|||
27685605|NCT03122223|80683795|FG000|Overall Study|Participant unable to adhere|1|||
27685606|NCT03122223|80683796|FG001|Overall Study|Participant unable to adhere|1|||
27685607|NCT03122223|80683797|FG002|Overall Study|Participant unable to adhere|1|||
27685608|NCT03122223|80683798|FG003|Overall Study|Participant unable to adhere|0|||
27685609|NCT02387970|80683799|FG000|Overall Study|Did not complete 1-year follow up|1|||
27685610|NCT02387970|80683800|FG001|Overall Study|Did not complete 1-year follow up|2|||
27685611|NCT03538301|80683801|FG000|Overall Study|Adverse Event|1|||
27685612|NCT03538301|80683802|FG001|Overall Study|Adverse Event|4|||
27685613|NCT03538301|80683803|FG002|Overall Study|Adverse Event|4|||
27685614|NCT03538301|80683801|FG000|Overall Study|Death|1|||
27685615|NCT03538301|80683802|FG001|Overall Study|Death|1|||
27685616|NCT03538301|80683803|FG002|Overall Study|Death|0|||
27685617|NCT03538301|80683801|FG000|Overall Study|Physician Decision|0|||
27685618|NCT03538301|80683802|FG001|Overall Study|Physician Decision|1|||
27685619|NCT03538301|80683803|FG002|Overall Study|Physician Decision|0|||
27685620|NCT03538301|80683801|FG000|Overall Study|Protocol Violation|0|||
27685621|NCT03538301|80683802|FG001|Overall Study|Protocol Violation|0|||
27685622|NCT03538301|80683803|FG002|Overall Study|Protocol Violation|1|||
27685623|NCT03538301|80683801|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
27685624|NCT03538301|80683802|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
27685625|NCT03538301|80683803|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
27685626|NCT04189952|80683806|FG000|Follow-up Period|Death|1|||
27685627|NCT04189952|80683806|FG000|Follow-up Period|Withdrawal by Subject|1|||
27685628|NCT00688870|80683807|FG000|Infant Series|Parent or legal guardian request|4|||
27685629|NCT00688870|80683808|FG001|Infant Series|Parent or legal guardian request|0|||
27685630|NCT02514239|80683809|FG000|Overall Study|Refused to continue trial medication|0|||
27685631|NCT02514239|80683810|FG001|Overall Study|Refused to continue trial medication|0|||
27685632|NCT02514239|80683811|FG002|Overall Study|Refused to continue trial medication|0|||
27685633|NCT02514239|80683812|FG003|Overall Study|Refused to continue trial medication|0|||
27685634|NCT02514239|80683813|FG004|Overall Study|Refused to continue trial medication|0|||
27685635|NCT02514239|80683814|FG005|Overall Study|Refused to continue trial medication|0|||
27685636|NCT02514239|80683815|FG006|Overall Study|Refused to continue trial medication|0|||
27685637|NCT02514239|80683816|FG007|Overall Study|Refused to continue trial medication|0|||
27685638|NCT02514239|80683817|FG008|Overall Study|Refused to continue trial medication|0|||
27685639|NCT02514239|80683818|FG009|Overall Study|Refused to continue trial medication|1|||
27685640|NCT02514239|80683809|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685641|NCT02514239|80683810|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685642|NCT02514239|80683811|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685643|NCT02514239|80683812|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685644|NCT02514239|80683813|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685645|NCT02514239|80683814|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
28007452|NCT02903914|81859572|FG006|Overall Study|Adverse Event|2|||
28007453|NCT02903914|81859573|FG007|Overall Study|Adverse Event|0|||
28007454|NCT02903914|81859566|FG000|Overall Study|Withdrawal by Subject|3|||
28007455|NCT02903914|81859567|FG001|Overall Study|Withdrawal by Subject|1|||
28007456|NCT02903914|81859568|FG002|Overall Study|Withdrawal by Subject|28|||
28007457|NCT02903914|81859569|FG003|Overall Study|Withdrawal by Subject|0|||
28007458|NCT02903914|81859570|FG004|Overall Study|Withdrawal by Subject|1|||
27685646|NCT02514239|80683815|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685647|NCT02514239|80683816|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
27685648|NCT02514239|80683817|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
27685649|NCT02514239|80683818|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
27685650|NCT02514239|80683809|FG000|Overall Study|Not treated|0|||
27685651|NCT02514239|80683810|FG001|Overall Study|Not treated|1|||
27685652|NCT02514239|80683811|FG002|Overall Study|Not treated|0|||
27685653|NCT02514239|80683812|FG003|Overall Study|Not treated|0|||
27685654|NCT02514239|80683813|FG004|Overall Study|Not treated|0|||
27685655|NCT02514239|80683814|FG005|Overall Study|Not treated|0|||
27685656|NCT02514239|80683815|FG006|Overall Study|Not treated|0|||
27685657|NCT02514239|80683816|FG007|Overall Study|Not treated|0|||
28007459|NCT02903914|81859571|FG005|Overall Study|Withdrawal by Subject|2|||
27685658|NCT02514239|80683817|FG008|Overall Study|Not treated|0|||
27685659|NCT02514239|80683818|FG009|Overall Study|Not treated|0|||
27685660|NCT02514239|80683809|FG000|Overall Study|Other Adverse Events|2|||
27685661|NCT02514239|80683810|FG001|Overall Study|Other Adverse Events|0|||
27685662|NCT02514239|80683811|FG002|Overall Study|Other Adverse Events|0|||
27685663|NCT02514239|80683812|FG003|Overall Study|Other Adverse Events|1|||
27685664|NCT02514239|80683813|FG004|Overall Study|Other Adverse Events|0|||
27685665|NCT02514239|80683814|FG005|Overall Study|Other Adverse Events|1|||
27685666|NCT02514239|80683815|FG006|Overall Study|Other Adverse Events|0|||
27685667|NCT02514239|80683816|FG007|Overall Study|Other Adverse Events|1|||
27685668|NCT02514239|80683817|FG008|Overall Study|Other Adverse Events|2|||
27685669|NCT02514239|80683818|FG009|Overall Study|Other Adverse Events|0|||
27685670|NCT02514239|80683809|FG000|Overall Study|Progressive disease|3|||
27685671|NCT02514239|80683810|FG001|Overall Study|Progressive disease|3|||
27685672|NCT02514239|80683811|FG002|Overall Study|Progressive disease|2|||
27685673|NCT02514239|80683812|FG003|Overall Study|Progressive disease|2|||
27685674|NCT02514239|80683813|FG004|Overall Study|Progressive disease|3|||
27685675|NCT02514239|80683814|FG005|Overall Study|Progressive disease|3|||
27685676|NCT02514239|80683815|FG006|Overall Study|Progressive disease|4|||
27685677|NCT02514239|80683816|FG007|Overall Study|Progressive disease|2|||
27685678|NCT02514239|80683817|FG008|Overall Study|Progressive disease|5|||
27685679|NCT02514239|80683818|FG009|Overall Study|Progressive disease|0|||
27685680|NCT02766465|80683828|FG000|Overall Study|Withdrawal by Subject|0|||
27685681|NCT02766465|80683829|FG001|Overall Study|Withdrawal by Subject|10|||
27685682|NCT00943111|80683830|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
27685683|NCT00943111|80683831|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
27685684|NCT00943111|80683832|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
27685685|NCT00943111|80683830|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
27685686|NCT00943111|80683831|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
27685687|NCT00943111|80683832|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
27685688|NCT00943111|80683830|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
27685689|NCT00943111|80683831|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
27685690|NCT00943111|80683832|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
27685691|NCT00943111|80683830|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
27685692|NCT00943111|80683831|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
27685693|NCT00943111|80683832|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
27685694|NCT00943111|80683830|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
27685695|NCT00943111|80683831|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
27685696|NCT00943111|80683832|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
27685697|NCT00943111|80683830|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
27685698|NCT00943111|80683831|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
27685699|NCT00943111|80683832|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
27685700|NCT00943111|80683830|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
27685701|NCT00943111|80683831|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
27685702|NCT00943111|80683832|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
27685703|NCT00943111|80683830|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
27685704|NCT00943111|80683831|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
27685705|NCT00943111|80683832|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
27685706|NCT01757197|80683834|FG000|Overall Study|Death|2|||
27685707|NCT03140280|80683840|FG000|Overall Study|Physician Decision|5|||
27685708|NCT03932812|80683841|FG000|Overall Study|Lost to Follow-up|12|||
27685709|NCT03932812|80683842|FG001|Overall Study|Lost to Follow-up|14|||
27685710|NCT03932812|80683841|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
27685711|NCT03932812|80683842|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
27685712|NCT00379288|80683843|FG000|Overall Study|Adverse Event|5|||
28007460|NCT02903914|81859572|FG006|Overall Study|Withdrawal by Subject|12|||
28007461|NCT02903914|81859573|FG007|Overall Study|Withdrawal by Subject|0|||
28007462|NCT02903914|81859566|FG000|Overall Study|Progressive Disease|1|||
28007463|NCT02903914|81859567|FG001|Overall Study|Progressive Disease|0|||
28007464|NCT02903914|81859568|FG002|Overall Study|Progressive Disease|4|||
28007465|NCT02903914|81859569|FG003|Overall Study|Progressive Disease|0|||
28007466|NCT02903914|81859570|FG004|Overall Study|Progressive Disease|0|||
27685713|NCT00379288|80683844|FG001|Overall Study|Adverse Event|6|||
27685714|NCT00379288|80683845|FG002|Overall Study|Adverse Event|2|||
27685715|NCT00379288|80683846|FG003|Overall Study|Adverse Event|0|||
27685716|NCT00379288|80683843|FG000|Overall Study|Treatment Failure|0|||
27685717|NCT00379288|80683844|FG001|Overall Study|Treatment Failure|1|||
27685718|NCT00379288|80683845|FG002|Overall Study|Treatment Failure|0|||
28007467|NCT02903914|81859571|FG005|Overall Study|Progressive Disease|0|||
27685719|NCT00379288|80683846|FG003|Overall Study|Treatment Failure|1|||
27810722|NCT01567306|81137429|FG004|Overall Study|Protocol Violation|1|||
27810723|NCT01567306|81137430|FG005|Overall Study|Protocol Violation|1|||
28007468|NCT02903914|81859572|FG006|Overall Study|Progressive Disease|2|||
27685720|NCT00379288|80683843|FG000|Overall Study|Lost to Follow-up|3|||
27685721|NCT00379288|80683844|FG001|Overall Study|Lost to Follow-up|3|||
27685722|NCT00379288|80683845|FG002|Overall Study|Lost to Follow-up|2|||
27685723|NCT00379288|80683846|FG003|Overall Study|Lost to Follow-up|0|||
27685724|NCT00379288|80683843|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
27685725|NCT00379288|80683844|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
27685726|NCT00379288|80683845|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
27685727|NCT00379288|80683846|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
27685728|NCT00379288|80683843|FG000|Overall Study|Subject withdrew-related to study drug|1|||
27685729|NCT00379288|80683844|FG001|Overall Study|Subject withdrew-related to study drug|0|||
27685730|NCT00379288|80683845|FG002|Overall Study|Subject withdrew-related to study drug|0|||
27685731|NCT00379288|80683846|FG003|Overall Study|Subject withdrew-related to study drug|1|||
27685732|NCT00379288|80683843|FG000|Overall Study|Noncompliance with protocol|8|||
27685733|NCT00379288|80683844|FG001|Overall Study|Noncompliance with protocol|6|||
27685734|NCT00379288|80683845|FG002|Overall Study|Noncompliance with protocol|2|||
28007469|NCT02903914|81859573|FG007|Overall Study|Progressive Disease|0|||
27685735|NCT00379288|80683846|FG003|Overall Study|Noncompliance with protocol|1|||
27685736|NCT00379288|80683843|FG000|Overall Study|Did not meet protocol eligibility|0|||
27685737|NCT00379288|80683844|FG001|Overall Study|Did not meet protocol eligibility|1|||
27685738|NCT00379288|80683845|FG002|Overall Study|Did not meet protocol eligibility|0|||
27685739|NCT00379288|80683846|FG003|Overall Study|Did not meet protocol eligibility|2|||
27685740|NCT00379288|80683843|FG000|Overall Study|Administrative|2|||
27685741|NCT00379288|80683844|FG001|Overall Study|Administrative|2|||
27685742|NCT00379288|80683845|FG002|Overall Study|Administrative|0|||
27685743|NCT00379288|80683846|FG003|Overall Study|Administrative|1|||
27685744|NCT01879722|80683855|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27685745|NCT01879722|80683856|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27685746|NCT01879722|80683857|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27685747|NCT01879722|80683858|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27810724|NCT01567306|81137425|FG000|Overall Study|Change site living|1|||
27810725|NCT01567306|81137426|FG001|Overall Study|Change site living|0|||
27810726|NCT01567306|81137427|FG002|Overall Study|Change site living|0|||
27810727|NCT01567306|81137428|FG003|Overall Study|Change site living|0|||
27810728|NCT01567306|81137429|FG004|Overall Study|Change site living|0|||
27810729|NCT01567306|81137430|FG005|Overall Study|Change site living|0|||
27810730|NCT01567306|81137425|FG000|Overall Study|Adverse Event|0|||
27810731|NCT01567306|81137426|FG001|Overall Study|Adverse Event|0|||
27810732|NCT01567306|81137427|FG002|Overall Study|Adverse Event|0|||
27810733|NCT01567306|81137428|FG003|Overall Study|Adverse Event|2|||
27810734|NCT01567306|81137429|FG004|Overall Study|Adverse Event|4|||
27810735|NCT01567306|81137430|FG005|Overall Study|Adverse Event|1|||
27810736|NCT01567306|81137425|FG000|Overall Study|Lost to Follow-up|0|||
27810737|NCT01567306|81137426|FG001|Overall Study|Lost to Follow-up|0|||
27810738|NCT01567306|81137427|FG002|Overall Study|Lost to Follow-up|0|||
27810739|NCT01567306|81137428|FG003|Overall Study|Lost to Follow-up|0|||
27810740|NCT01567306|81137429|FG004|Overall Study|Lost to Follow-up|2|||
27810741|NCT01567306|81137430|FG005|Overall Study|Lost to Follow-up|0|||
27810742|NCT01567306|81137425|FG000|Overall Study|Withdrawal by Subject|0|||
27810743|NCT01567306|81137426|FG001|Overall Study|Withdrawal by Subject|0|||
27810744|NCT01567306|81137427|FG002|Overall Study|Withdrawal by Subject|0|||
27810745|NCT01567306|81137428|FG003|Overall Study|Withdrawal by Subject|0|||
27810746|NCT01567306|81137429|FG004|Overall Study|Withdrawal by Subject|0|||
27810747|NCT01567306|81137430|FG005|Overall Study|Withdrawal by Subject|1|||
27810748|NCT00669955|81137431|FG000|Overall Study|Adverse Event|3|||
27810749|NCT00669955|81137432|FG001|Overall Study|Adverse Event|5|||
27810750|NCT00669955|81137431|FG000|Overall Study|Death|0|||
27810751|NCT00669955|81137432|FG001|Overall Study|Death|1|||
27810752|NCT00669955|81137431|FG000|Overall Study|Withdrawal by Subject|2|||
27810753|NCT00669955|81137432|FG001|Overall Study|Withdrawal by Subject|3|||
27810754|NCT00669955|81137431|FG000|Overall Study|Lost to Follow-up|5|||
27810755|NCT00669955|81137432|FG001|Overall Study|Lost to Follow-up|7|||
27810756|NCT00669955|81137431|FG000|Overall Study|Protocol Violation|2|||
28007470|NCT02903914|81859566|FG000|Overall Study|Death|0|||
27685748|NCT01879722|80683859|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
27685749|NCT01879722|80683860|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
27810757|NCT00669955|81137432|FG001|Overall Study|Protocol Violation|7|||
27810758|NCT00669955|81137431|FG000|Overall Study|Investigator Sponsor Judgement|0|||
27810759|NCT00669955|81137432|FG001|Overall Study|Investigator Sponsor Judgement|1|||
27810760|NCT00669955|81137431|FG000|Overall Study|not compliant with study drug/visit|2|||
27810761|NCT00669955|81137432|FG001|Overall Study|not compliant with study drug/visit|3|||
27685750|NCT01879722|80683861|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
27685751|NCT01879722|80683862|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
27810762|NCT02576990|81137433|FG000|Overall Study|Death|29|||
27810763|NCT02576990|81137434|FG001|Overall Study|Death|18|||
27875323|NCT03850483|81375433|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
28007471|NCT02903914|81859567|FG001|Overall Study|Death|0|||
27875324|NCT03850483|81375434|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
27875325|NCT03850483|81375435|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
27875326|NCT03850483|81375436|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
27875327|NCT03850483|81375437|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
27875328|NCT03850483|81375438|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
27875329|NCT03850483|81375429|FG000|Follow-up for Stage 1|Adverse Event|0|||
27875330|NCT03850483|81375430|FG001|Follow-up for Stage 1|Adverse Event|0|||
27875331|NCT03850483|81375431|FG002|Follow-up for Stage 1|Adverse Event|1|||
27875332|NCT03850483|81375432|FG003|Follow-up for Stage 1|Adverse Event|0|||
27875333|NCT03850483|81375433|FG004|Follow-up for Stage 1|Adverse Event|0|||
27875334|NCT03850483|81375434|FG005|Follow-up for Stage 1|Adverse Event|1|||
27875335|NCT03850483|81375435|FG006|Follow-up for Stage 1|Adverse Event|0|||
27875336|NCT03850483|81375436|FG007|Follow-up for Stage 1|Adverse Event|0|||
27875337|NCT03850483|81375437|FG008|Follow-up for Stage 1|Adverse Event|0|||
27875338|NCT03850483|81375438|FG009|Follow-up for Stage 1|Adverse Event|0|||
27875339|NCT03850483|81375429|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27875340|NCT03850483|81375430|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
27875341|NCT03850483|81375431|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27810764|NCT02576990|81137433|FG000|Overall Study|Physician Decision|1|||
27810765|NCT02576990|81137434|FG001|Overall Study|Physician Decision|0|||
27810766|NCT02576990|81137433|FG000|Overall Study|Screen failure|2|||
27810767|NCT02576990|81137434|FG001|Overall Study|Screen failure|0|||
27810768|NCT02576990|81137433|FG000|Overall Study|Sponsor's decision|24|||
27810769|NCT02576990|81137434|FG001|Overall Study|Sponsor's decision|4|||
27810770|NCT02576990|81137433|FG000|Overall Study|Withdrawal by Subject|0|||
27810771|NCT02576990|81137434|FG001|Overall Study|Withdrawal by Subject|2|||
27810772|NCT01766778|81137435|FG000|Overall Study|Adverse Event|4|||
27810773|NCT01766778|81137436|FG001|Overall Study|Adverse Event|4|||
27586763|NCT03579563|80328411|FG001|Overall Study|Time/distance concern|0|||
27586764|NCT03579563|80328412|FG002|Overall Study|Time/distance concern|1|||
27875342|NCT03850483|81375432|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27586765|NCT03579563|80328413|FG003|Overall Study|Time/distance concern|0|||
27586766|NCT03579563|80328414|FG004|Overall Study|Time/distance concern|0|||
27586767|NCT03579563|80328415|FG005|Overall Study|Time/distance concern|1|||
27586768|NCT03579563|80328410|FG000|Overall Study|COVID shutdown|2|||
27586769|NCT03579563|80328411|FG001|Overall Study|COVID shutdown|3|||
27586770|NCT03579563|80328412|FG002|Overall Study|COVID shutdown|4|||
27586771|NCT03579563|80328413|FG003|Overall Study|COVID shutdown|3|||
27586772|NCT03579563|80328414|FG004|Overall Study|COVID shutdown|1|||
27586773|NCT03579563|80328415|FG005|Overall Study|COVID shutdown|2|||
27810774|NCT01766778|81137435|FG000|Overall Study|Withdrawal by Subject|1|||
27810775|NCT01766778|81137436|FG001|Overall Study|Withdrawal by Subject|0|||
27810776|NCT02038634|81137437|FG000|Overall Study|Lost to Follow-up|0|||
27810777|NCT02038634|81137438|FG001|Overall Study|Lost to Follow-up|1|||
27810778|NCT02008721|81137439|FG000|Overall Study|Withdrawal by Subject|5|||
27810779|NCT02008721|81137440|FG001|Overall Study|Withdrawal by Subject|1|||
27810780|NCT02008721|81137439|FG000|Overall Study|Death|4|||
27810781|NCT02008721|81137440|FG001|Overall Study|Death|2|||
27810782|NCT02008721|81137439|FG000|Overall Study|Adverse Event|3|||
27810783|NCT02008721|81137440|FG001|Overall Study|Adverse Event|5|||
27810784|NCT02008721|81137439|FG000|Overall Study|Protocol Violation|3|||
27810785|NCT02008721|81137440|FG001|Overall Study|Protocol Violation|2|||
27810786|NCT01333033|81137441|FG000|Overall Study|Ineligible|0|||
27810787|NCT01333033|81137442|FG001|Overall Study|Ineligible|0|||
27810788|NCT01333033|81137443|FG002|Overall Study|Ineligible|0|||
27810789|NCT01333033|81137444|FG003|Overall Study|Ineligible|0|||
27810790|NCT01333033|81137445|FG004|Overall Study|Ineligible|6|||
27810791|NCT01333033|81137446|FG005|Overall Study|Ineligible|8|||
27810792|NCT01333033|81137441|FG000|Overall Study|Withdrawal by Subject|0|||
27875343|NCT03850483|81375433|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
27875344|NCT03850483|81375434|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
27875345|NCT03850483|81375435|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27810793|NCT01333033|81137442|FG001|Overall Study|Withdrawal by Subject|0|||
27810794|NCT01333033|81137443|FG002|Overall Study|Withdrawal by Subject|0|||
27810795|NCT01333033|81137444|FG003|Overall Study|Withdrawal by Subject|0|||
27810796|NCT01333033|81137445|FG004|Overall Study|Withdrawal by Subject|4|||
27810797|NCT01333033|81137446|FG005|Overall Study|Withdrawal by Subject|2|||
27810798|NCT01333033|81137441|FG000|Overall Study|PET inevaluable|0|||
27586774|NCT03579563|80328410|FG000|Overall Study|Protocol administration error|1|||
27810799|NCT01333033|81137442|FG001|Overall Study|PET inevaluable|0|||
28007472|NCT02903914|81859568|FG002|Overall Study|Death|9|||
27810800|NCT01333033|81137443|FG002|Overall Study|PET inevaluable|0|||
27810801|NCT01333033|81137444|FG003|Overall Study|PET inevaluable|0|||
27810802|NCT01333033|81137445|FG004|Overall Study|PET inevaluable|2|||
27810803|NCT01333033|81137446|FG005|Overall Study|PET inevaluable|4|||
27586775|NCT03579563|80328411|FG001|Overall Study|Protocol administration error|0|||
27586776|NCT03579563|80328412|FG002|Overall Study|Protocol administration error|1|||
27810804|NCT01333033|81137441|FG000|Overall Study|Adverse Event|0|||
27810805|NCT01333033|81137442|FG001|Overall Study|Adverse Event|0|||
27810806|NCT01333033|81137443|FG002|Overall Study|Adverse Event|0|||
27810807|NCT01333033|81137444|FG003|Overall Study|Adverse Event|0|||
27810808|NCT01333033|81137445|FG004|Overall Study|Adverse Event|2|||
27810809|NCT01333033|81137446|FG005|Overall Study|Adverse Event|1|||
27810810|NCT01333033|81137441|FG000|Overall Study|Progression|0|||
27810811|NCT01333033|81137442|FG001|Overall Study|Progression|0|||
27810812|NCT01333033|81137443|FG002|Overall Study|Progression|0|||
27810813|NCT01333033|81137444|FG003|Overall Study|Progression|0|||
27810814|NCT01333033|81137445|FG004|Overall Study|Progression|0|||
27810815|NCT01333033|81137446|FG005|Overall Study|Progression|1|||
27810816|NCT01333033|81137441|FG000|Overall Study|MD Decision|0|||
27810817|NCT01333033|81137442|FG001|Overall Study|MD Decision|0|||
27810818|NCT01333033|81137443|FG002|Overall Study|MD Decision|0|||
27810819|NCT01333033|81137444|FG003|Overall Study|MD Decision|0|||
27810820|NCT01333033|81137445|FG004|Overall Study|MD Decision|0|||
27810821|NCT01333033|81137446|FG005|Overall Study|MD Decision|2|||
27810822|NCT01165684|81137448|FG000|Overall Study|Adverse Event|1|||
27810823|NCT01165684|81137449|FG001|Overall Study|Adverse Event|1|||
27810824|NCT01165684|81137448|FG000|Overall Study|Lack of Efficacy|2|||
27810825|NCT01165684|81137449|FG001|Overall Study|Lack of Efficacy|1|||
27810826|NCT01165684|81137448|FG000|Overall Study|Protocol Violation|7|||
27810827|NCT01165684|81137449|FG001|Overall Study|Protocol Violation|15|||
27810828|NCT01165684|81137448|FG000|Overall Study|Withdrawal Criteria|2|||
27810829|NCT01165684|81137449|FG001|Overall Study|Withdrawal Criteria|13|||
27810830|NCT01165684|81137448|FG000|Overall Study|Unclassified|16|||
27810831|NCT01165684|81137449|FG001|Overall Study|Unclassified|22|||
27810832|NCT03465891|81137455|FG000|Overall Study|Withdrawal by Subject|0|||
27810833|NCT03465891|81137456|FG001|Overall Study|Withdrawal by Subject|1|||
27810834|NCT03465891|81137455|FG000|Overall Study|Disease progression|1|||
27875346|NCT03850483|81375436|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27875347|NCT03850483|81375437|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27875348|NCT03850483|81375438|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
27875349|NCT03850483|81375429|FG000|Follow-up for Stage 1|Other|0|||
27810835|NCT03465891|81137456|FG001|Overall Study|Disease progression|0|||
27810836|NCT02115256|81137471|FG000|Overall Study|Withdrawal by Subject|0|||
27810837|NCT02115256|81137472|FG001|Overall Study|Withdrawal by Subject|1|||
27810838|NCT00429923|81137473|FG000|Overall Study|Adverse Event|0|||
27810839|NCT00429923|81137474|FG001|Overall Study|Adverse Event|2|||
27810840|NCT00429923|81137475|FG002|Overall Study|Adverse Event|3|||
27810841|NCT00429923|81137473|FG000|Overall Study|Lack of Efficacy|4|||
27810842|NCT00429923|81137474|FG001|Overall Study|Lack of Efficacy|1|||
27810843|NCT00429923|81137475|FG002|Overall Study|Lack of Efficacy|33|||
27810844|NCT00429923|81137473|FG000|Overall Study|Lost to Follow-up|0|||
27810845|NCT00429923|81137474|FG001|Overall Study|Lost to Follow-up|0|||
27810846|NCT00429923|81137475|FG002|Overall Study|Lost to Follow-up|2|||
27810847|NCT00429923|81137473|FG000|Overall Study|Withdrew Consent|1|||
27810848|NCT00429923|81137474|FG001|Overall Study|Withdrew Consent|0|||
27810849|NCT00429923|81137475|FG002|Overall Study|Withdrew Consent|1|||
27810850|NCT00429923|81137473|FG000|Overall Study|Early Termination|0|||
27810851|NCT00429923|81137474|FG001|Overall Study|Early Termination|1|||
27810852|NCT00429923|81137475|FG002|Overall Study|Early Termination|0|||
27810853|NCT00673361|81137480|FG000|Overall Study|Screen Failure|2|||
27810854|NCT02231710|81137481|FG000|Overall Study|Physician Decision|1|||
27810855|NCT00988169|81137487|FG000|Overall Study|Withdrawal by Subject|1|||
27810856|NCT02866175|81137488|FG000|Overall Study|Adverse Event|56|||
27810857|NCT02866175|81137489|FG001|Overall Study|Adverse Event|54|||
27810858|NCT02866175|81137488|FG000|Overall Study|Withdrawal by Subject|31|||
27810859|NCT02866175|81137489|FG001|Overall Study|Withdrawal by Subject|52|||
27810860|NCT02866175|81137488|FG000|Overall Study|Death|30|||
27810861|NCT02866175|81137489|FG001|Overall Study|Death|23|||
27810862|NCT02866175|81137488|FG000|Overall Study|Other|7|||
27875350|NCT03850483|81375430|FG001|Follow-up for Stage 1|Other|2|||
27875351|NCT03850483|81375431|FG002|Follow-up for Stage 1|Other|0|||
27875352|NCT03850483|81375432|FG003|Follow-up for Stage 1|Other|2|||
27810863|NCT02866175|81137489|FG001|Overall Study|Other|14|||
27810864|NCT02866175|81137488|FG000|Overall Study|Progressive disease|1|||
27810865|NCT02866175|81137489|FG001|Overall Study|Progressive disease|1|||
27810866|NCT02866175|81137488|FG000|Overall Study|Lost to Follow-up|2|||
27810867|NCT02866175|81137489|FG001|Overall Study|Lost to Follow-up|0|||
27810868|NCT02866175|81137488|FG000|Overall Study|Lack of Efficacy|0|||
27810869|NCT02866175|81137489|FG001|Overall Study|Lack of Efficacy|1|||
27810870|NCT02866175|81137488|FG000|Overall Study|Physician Decision|3|||
27810871|NCT02866175|81137489|FG001|Overall Study|Physician Decision|15|||
27810872|NCT02866175|81137488|FG000|Overall Study|Did not receive treatment|5|||
27810873|NCT02866175|81137489|FG001|Overall Study|Did not receive treatment|15|||
28007473|NCT02903914|81859569|FG003|Overall Study|Death|0|||
27810874|NCT01754259|81137490|FG000|Overall Study|Withdrawal by Subject|2|||
27810875|NCT01754259|81137491|FG001|Overall Study|Withdrawal by Subject|4|||
27875353|NCT03850483|81375433|FG004|Follow-up for Stage 1|Other|0|||
28007474|NCT02903914|81859570|FG004|Overall Study|Death|1|||
28007475|NCT02903914|81859571|FG005|Overall Study|Death|3|||
28007476|NCT02903914|81859572|FG006|Overall Study|Death|24|||
28007477|NCT02903914|81859573|FG007|Overall Study|Death|2|||
28007478|NCT02903914|81859566|FG000|Overall Study|Lost to Follow-up|0|||
28007479|NCT02903914|81859567|FG001|Overall Study|Lost to Follow-up|1|||
28007480|NCT02903914|81859568|FG002|Overall Study|Lost to Follow-up|0|||
28007481|NCT02903914|81859569|FG003|Overall Study|Lost to Follow-up|0|||
28007482|NCT02903914|81859570|FG004|Overall Study|Lost to Follow-up|2|||
28007483|NCT02903914|81859571|FG005|Overall Study|Lost to Follow-up|0|||
28007484|NCT02903914|81859572|FG006|Overall Study|Lost to Follow-up|1|||
28007485|NCT02903914|81859573|FG007|Overall Study|Lost to Follow-up|0|||
28007486|NCT02903914|81859566|FG000|Overall Study|Physician Decision|0|||
28007487|NCT02903914|81859567|FG001|Overall Study|Physician Decision|0|||
28007488|NCT02903914|81859568|FG002|Overall Study|Physician Decision|1|||
28007489|NCT02903914|81859569|FG003|Overall Study|Physician Decision|0|||
28007490|NCT02903914|81859570|FG004|Overall Study|Physician Decision|0|||
28007491|NCT02903914|81859571|FG005|Overall Study|Physician Decision|0|||
28007492|NCT02903914|81859572|FG006|Overall Study|Physician Decision|1|||
28007493|NCT02903914|81859573|FG007|Overall Study|Physician Decision|0|||
28007494|NCT02903914|81859566|FG000|Overall Study|Symptomatic Deterioration|0|||
28007495|NCT02903914|81859567|FG001|Overall Study|Symptomatic Deterioration|0|||
28007496|NCT02903914|81859568|FG002|Overall Study|Symptomatic Deterioration|1|||
28007497|NCT02903914|81859569|FG003|Overall Study|Symptomatic Deterioration|0|||
28007498|NCT02903914|81859570|FG004|Overall Study|Symptomatic Deterioration|0|||
28007499|NCT02903914|81859571|FG005|Overall Study|Symptomatic Deterioration|0|||
28007500|NCT02903914|81859572|FG006|Overall Study|Symptomatic Deterioration|0|||
28007501|NCT02903914|81859573|FG007|Overall Study|Symptomatic Deterioration|0|||
28007502|NCT02903914|81859566|FG000|Overall Study|New Cancer Therapy|2|||
28007503|NCT02903914|81859567|FG001|Overall Study|New Cancer Therapy|2|||
28007504|NCT02903914|81859568|FG002|Overall Study|New Cancer Therapy|21|||
28007505|NCT02903914|81859569|FG003|Overall Study|New Cancer Therapy|4|||
28007506|NCT02903914|81859570|FG004|Overall Study|New Cancer Therapy|3|||
28007507|NCT02903914|81859571|FG005|Overall Study|New Cancer Therapy|6|||
28007508|NCT02903914|81859572|FG006|Overall Study|New Cancer Therapy|56|||
28007509|NCT02903914|81859573|FG007|Overall Study|New Cancer Therapy|3|||
28007510|NCT02903914|81859566|FG000|Overall Study|Didn't Return to Site|1|||
28007511|NCT02903914|81859567|FG001|Overall Study|Didn't Return to Site|0|||
28007512|NCT02903914|81859568|FG002|Overall Study|Didn't Return to Site|1|||
28007513|NCT02903914|81859569|FG003|Overall Study|Didn't Return to Site|1|||
28007514|NCT02903914|81859570|FG004|Overall Study|Didn't Return to Site|0|||
28007515|NCT02903914|81859571|FG005|Overall Study|Didn't Return to Site|0|||
27586777|NCT03579563|80328413|FG003|Overall Study|Protocol administration error|0|||
27586778|NCT03579563|80328414|FG004|Overall Study|Protocol administration error|1|||
27586779|NCT03579563|80328415|FG005|Overall Study|Protocol administration error|5|||
27586780|NCT04313634|80328416|FG000|Overall Study|Adverse Event|2|||
27586781|NCT04313634|80328417|FG001|Overall Study|Adverse Event|2|||
27586782|NCT04313634|80328418|FG002|Overall Study|Adverse Event|0|||
27586783|NCT04313634|80328416|FG000|Overall Study|Withdrawal by Subject|1|||
27586784|NCT04313634|80328417|FG001|Overall Study|Withdrawal by Subject|0|||
27586785|NCT04313634|80328418|FG002|Overall Study|Withdrawal by Subject|1|||
27586786|NCT04313634|80328416|FG000|Overall Study|Protocol Violation|0|||
27586787|NCT04313634|80328417|FG001|Overall Study|Protocol Violation|0|||
27586788|NCT04313634|80328418|FG002|Overall Study|Protocol Violation|1|||
27586789|NCT02462876|80328423|FG000|Overall Study|Death|3|||
27586790|NCT02462876|80328423|FG000|Overall Study|Lost to Follow-up|7|||
27586791|NCT02462876|80328423|FG000|Overall Study|Surgical Bypass|9|||
27586792|NCT02462876|80328423|FG000|Overall Study|Amputation Above the Metatarsals|1|||
27586793|NCT02462876|80328423|FG000|Overall Study|36 months follow-up visit missed|1|||
27586794|NCT02462876|80328423|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
28007516|NCT02903914|81859572|FG006|Overall Study|Didn't Return to Site|2|||
28007517|NCT02903914|81859573|FG007|Overall Study|Didn't Return to Site|0|||
28007518|NCT02903914|81859566|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
28007519|NCT02903914|81859567|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
27586795|NCT02462876|80328423|FG000|Overall Study|Patient did not come back to the vascular department|1|||
27586796|NCT02462876|80328423|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
27586797|NCT02462876|80328423|FG000|Overall Study|Patient refused to come back|1|||
27586798|NCT02462876|80328423|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
28007520|NCT02903914|81859568|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
28007521|NCT02903914|81859569|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
28007522|NCT02903914|81859570|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
28007523|NCT02903914|81859571|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
28007524|NCT02903914|81859572|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
28007525|NCT02903914|81859573|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
28007526|NCT02903914|81859566|FG000|Overall Study|Follow-up Did Not Occur|0|||
27810876|NCT01754259|81137490|FG000|Overall Study|Adverse Event|3|||
27810877|NCT01754259|81137491|FG001|Overall Study|Adverse Event|1|||
27810878|NCT01754259|81137490|FG000|Overall Study|Lost to Follow-up|0|||
27810879|NCT01754259|81137491|FG001|Overall Study|Lost to Follow-up|1|||
27810880|NCT01901055|81137496|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
27810881|NCT01901055|81137497|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
27810882|NCT01901055|81137496|FG000|Randomization But Not Titrated|Physician Decision|0|||
27810883|NCT01901055|81137497|FG001|Randomization But Not Titrated|Physician Decision|1|||
27810884|NCT01901055|81137496|FG000|Started Protocol to Week 6|Physician Decision|2|||
27810885|NCT01901055|81137497|FG001|Started Protocol to Week 6|Physician Decision|1|||
27810886|NCT01901055|81137496|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
27810887|NCT01901055|81137497|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
27810888|NCT01901055|81137496|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
27810889|NCT01901055|81137497|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
27810890|NCT01901055|81137496|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
27810891|NCT01901055|81137497|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
27810892|NCT01901055|81137496|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
27875354|NCT03850483|81375434|FG005|Follow-up for Stage 1|Other|1|||
27875355|NCT03850483|81375435|FG006|Follow-up for Stage 1|Other|0|||
27875356|NCT03850483|81375436|FG007|Follow-up for Stage 1|Other|0|||
27875357|NCT03850483|81375437|FG008|Follow-up for Stage 1|Other|0|||
27875358|NCT03850483|81375438|FG009|Follow-up for Stage 1|Other|0|||
27875359|NCT03850483|81375429|FG000|Treatment for Stage 2|Adverse Event|0|||
27875360|NCT03850483|81375430|FG001|Treatment for Stage 2|Adverse Event|0|||
27875361|NCT03850483|81375431|FG002|Treatment for Stage 2|Adverse Event|0|||
27875362|NCT03850483|81375432|FG003|Treatment for Stage 2|Adverse Event|0|||
27810893|NCT01901055|81137497|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
27810894|NCT01901055|81137496|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
27810895|NCT01901055|81137497|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
27810896|NCT01901055|81137496|FG000|Week 24|Withdrawal by Subject|13|||
27810897|NCT01901055|81137497|FG001|Week 24|Withdrawal by Subject|19|||
27810898|NCT01901055|81137496|FG000|Week 24|Physician Decision|1|||
27586799|NCT02462876|80328423|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
27875363|NCT03850483|81375433|FG004|Treatment for Stage 2|Adverse Event|0|||
27875364|NCT03850483|81375434|FG005|Treatment for Stage 2|Adverse Event|0|||
27875365|NCT03850483|81375435|FG006|Treatment for Stage 2|Adverse Event|0|||
27875366|NCT03850483|81375436|FG007|Treatment for Stage 2|Adverse Event|0|||
27875367|NCT03850483|81375437|FG008|Treatment for Stage 2|Adverse Event|0|||
27875368|NCT03850483|81375438|FG009|Treatment for Stage 2|Adverse Event|1|||
27875369|NCT03850483|81375429|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
27875370|NCT03850483|81375430|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
27875371|NCT03850483|81375431|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
27875372|NCT03850483|81375432|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
27875373|NCT03850483|81375433|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
27875374|NCT03850483|81375434|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
28007527|NCT02903914|81859567|FG001|Overall Study|Follow-up Did Not Occur|1|||
27875375|NCT03850483|81375435|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
27875376|NCT03850483|81375436|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
27875377|NCT03850483|81375437|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
27875378|NCT03850483|81375438|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
28007528|NCT02903914|81859568|FG002|Overall Study|Follow-up Did Not Occur|1|||
28007529|NCT02903914|81859569|FG003|Overall Study|Follow-up Did Not Occur|0|||
28007530|NCT02903914|81859570|FG004|Overall Study|Follow-up Did Not Occur|2|||
28007531|NCT02903914|81859571|FG005|Overall Study|Follow-up Did Not Occur|0|||
28007532|NCT02903914|81859572|FG006|Overall Study|Follow-up Did Not Occur|8|||
28007533|NCT02903914|81859573|FG007|Overall Study|Follow-up Did Not Occur|0|||
28007534|NCT02903914|81859566|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
28007535|NCT02903914|81859567|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
28007536|NCT02903914|81859568|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
28007537|NCT02903914|81859569|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
28007538|NCT02903914|81859570|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
28007539|NCT02903914|81859571|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
28007540|NCT02903914|81859572|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
27586800|NCT00627705|80328426|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
27586801|NCT00627705|80328427|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
27875379|NCT03850483|81375429|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
27875380|NCT03850483|81375430|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
28007541|NCT02903914|81859573|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
27875381|NCT03850483|81375431|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
27875382|NCT03850483|81375432|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
28007542|NCT02903914|81859566|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
28007543|NCT02903914|81859567|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
28007544|NCT02903914|81859568|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
27586802|NCT00627705|80328426|FG000|Overall Study|Adverse Event|1|||
27685752|NCT01879722|80683863|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
27685753|NCT01879722|80683864|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
27875383|NCT03850483|81375433|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
27586803|NCT00627705|80328427|FG001|Overall Study|Adverse Event|0|||
27586804|NCT00627705|80328426|FG000|Overall Study|Withdrawal by Subject|0|||
27586805|NCT00627705|80328427|FG001|Overall Study|Withdrawal by Subject|2|||
27586806|NCT00627705|80328426|FG000|Overall Study|Lost to Follow-up|0|||
27586807|NCT00627705|80328427|FG001|Overall Study|Lost to Follow-up|1|||
27586808|NCT01519206|80328428|FG000|Overall Study|Lost to Follow-up|3|||
27586809|NCT01519206|80328428|FG000|Overall Study|Missed Visit|2|||
27586810|NCT02576574|80328429|FG000|Overall Study|still ongoing|65|||
27586811|NCT02576574|80328430|FG001|Overall Study|still ongoing|66|||
27586812|NCT02576574|80328431|FG002|Overall Study|still ongoing|73|||
27586813|NCT02576574|80328429|FG000|Overall Study|Randomized, not treated|5|||
27586814|NCT02576574|80328430|FG001|Overall Study|Randomized, not treated|4|||
27586815|NCT02576574|80328431|FG002|Overall Study|Randomized, not treated|26|||
27586816|NCT03087591|80328434|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
27586817|NCT03087591|80328434|FG000|Overall Study|Withdrawal by Subject|1|||
27685754|NCT01879722|80683855|FG000|Overall Study|Voluntary Withdrawal|0|||
27685755|NCT01879722|80683856|FG001|Overall Study|Voluntary Withdrawal|0|||
27810899|NCT01901055|81137497|FG001|Week 24|Physician Decision|0|||
27810900|NCT01901055|81137496|FG000|Week 36|Withdrawal by Subject|0|||
27810901|NCT01901055|81137497|FG001|Week 36|Withdrawal by Subject|5|||
27810902|NCT00903383|81137498|FG000|Overall Study|Adverse Event|1|||
27810903|NCT00903383|81137499|FG001|Overall Study|Adverse Event|2|||
27810904|NCT00903383|81137500|FG002|Overall Study|Adverse Event|3|||
27810905|NCT00903383|81137501|FG003|Overall Study|Adverse Event|1|||
27810906|NCT00903383|81137498|FG000|Overall Study|Physician Decision|1|||
27810907|NCT00903383|81137499|FG001|Overall Study|Physician Decision|2|||
27810908|NCT00903383|81137500|FG002|Overall Study|Physician Decision|0|||
27810909|NCT00903383|81137501|FG003|Overall Study|Physician Decision|0|||
27810910|NCT00903383|81137498|FG000|Overall Study|Lost to Follow-up|0|||
27810911|NCT00903383|81137499|FG001|Overall Study|Lost to Follow-up|0|||
27810912|NCT00903383|81137500|FG002|Overall Study|Lost to Follow-up|0|||
27810913|NCT00903383|81137501|FG003|Overall Study|Lost to Follow-up|1|||
27875384|NCT03850483|81375434|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
27875385|NCT03850483|81375435|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
27875386|NCT03850483|81375436|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
27875387|NCT03850483|81375437|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
27875388|NCT03850483|81375438|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
27875389|NCT03850483|81375429|FG000|Treatment for Stage 2|Physician Decision|0|||
27875390|NCT03850483|81375430|FG001|Treatment for Stage 2|Physician Decision|0|||
27875391|NCT03850483|81375431|FG002|Treatment for Stage 2|Physician Decision|0|||
27875392|NCT03850483|81375432|FG003|Treatment for Stage 2|Physician Decision|0|||
27875393|NCT03850483|81375433|FG004|Treatment for Stage 2|Physician Decision|0|||
27875394|NCT03850483|81375434|FG005|Treatment for Stage 2|Physician Decision|0|||
27875395|NCT03850483|81375435|FG006|Treatment for Stage 2|Physician Decision|0|||
27875396|NCT03850483|81375436|FG007|Treatment for Stage 2|Physician Decision|0|||
27875397|NCT03850483|81375437|FG008|Treatment for Stage 2|Physician Decision|0|||
27875398|NCT03850483|81375438|FG009|Treatment for Stage 2|Physician Decision|1|||
27875399|NCT03850483|81375429|FG000|Treatment for Stage 2|Protocol Violation|0|||
27875400|NCT03850483|81375430|FG001|Treatment for Stage 2|Protocol Violation|0|||
27875401|NCT03850483|81375431|FG002|Treatment for Stage 2|Protocol Violation|0|||
27875402|NCT03850483|81375432|FG003|Treatment for Stage 2|Protocol Violation|0|||
27875403|NCT03850483|81375433|FG004|Treatment for Stage 2|Protocol Violation|0|||
27875404|NCT03850483|81375434|FG005|Treatment for Stage 2|Protocol Violation|0|||
27875405|NCT03850483|81375435|FG006|Treatment for Stage 2|Protocol Violation|0|||
27875406|NCT03850483|81375436|FG007|Treatment for Stage 2|Protocol Violation|0|||
27875407|NCT03850483|81375437|FG008|Treatment for Stage 2|Protocol Violation|1|||
27810914|NCT00903383|81137498|FG000|Overall Study|Decision of Sponsor|1|||
27810915|NCT00903383|81137499|FG001|Overall Study|Decision of Sponsor|0|||
27810916|NCT00903383|81137500|FG002|Overall Study|Decision of Sponsor|0|||
27810917|NCT00903383|81137501|FG003|Overall Study|Decision of Sponsor|0|||
27810918|NCT00903383|81137498|FG000|Overall Study|Withdrawal by Subject|4|||
27875408|NCT03850483|81375438|FG009|Treatment for Stage 2|Protocol Violation|0|||
27875409|NCT03850483|81375429|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
27875410|NCT03850483|81375430|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
28007545|NCT02903914|81859569|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
27586818|NCT03564496|80328436|FG000|Overall Study|Withdrawal by Subject|1|||
27810919|NCT00903383|81137499|FG001|Overall Study|Withdrawal by Subject|1|||
27875411|NCT03850483|81375431|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
27875412|NCT03850483|81375432|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
27875413|NCT03850483|81375433|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
27875414|NCT03850483|81375434|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
27875415|NCT03850483|81375435|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
27875416|NCT03850483|81375436|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
27875417|NCT03850483|81375437|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
27875418|NCT03850483|81375438|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
27875419|NCT03850483|81375429|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875420|NCT03850483|81375430|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875421|NCT03850483|81375431|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875422|NCT03850483|81375432|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875423|NCT03850483|81375433|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875424|NCT03850483|81375434|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875425|NCT03850483|81375435|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875426|NCT03850483|81375436|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875427|NCT03850483|81375437|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
27875428|NCT03850483|81375438|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
27875429|NCT03850483|81375429|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
27875430|NCT03850483|81375430|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
27875431|NCT03850483|81375431|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
27875432|NCT03850483|81375432|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
27875433|NCT03850483|81375433|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
27875434|NCT03850483|81375434|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
27875435|NCT03850483|81375435|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
27875436|NCT03850483|81375436|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
27810920|NCT00903383|81137500|FG002|Overall Study|Withdrawal by Subject|0|||
27810921|NCT00903383|81137501|FG003|Overall Study|Withdrawal by Subject|2|||
27810922|NCT00903383|81137498|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
27810923|NCT00903383|81137499|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
27810924|NCT00903383|81137500|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
27810925|NCT00903383|81137501|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
27810926|NCT00903383|81137498|FG000|Overall Study|Patient Decision|0|||
27810927|NCT00903383|81137499|FG001|Overall Study|Patient Decision|0|||
27810928|NCT00903383|81137500|FG002|Overall Study|Patient Decision|0|||
27810929|NCT00903383|81137501|FG003|Overall Study|Patient Decision|1|||
27810930|NCT00969332|81137503|FG000|Overall Study|Physician Decision|8|||
27810931|NCT00969332|81137503|FG000|Overall Study|Withdrawal by Subject|3|||
27810932|NCT01759381|81137504|FG000|Overall Study|Death|1|||
27810933|NCT01759381|81137505|FG001|Overall Study|Death|0|||
27875437|NCT03850483|81375437|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
27875438|NCT03850483|81375438|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
27875439|NCT03850483|81375429|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
27875440|NCT03850483|81375430|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
27875441|NCT03850483|81375431|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
28007546|NCT02903914|81859570|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
27586819|NCT03564496|80328437|FG001|Overall Study|Withdrawal by Subject|1|||
27586820|NCT03564496|80328438|FG002|Overall Study|Withdrawal by Subject|0|||
27586821|NCT03564496|80328436|FG000|Overall Study|Screen failure|0|||
27810934|NCT03551730|81137516|FG000|Overall Study|Adverse Event|1|||
27810935|NCT03551730|81137517|FG001|Overall Study|Adverse Event|0|||
27810936|NCT03551730|81137518|FG002|Overall Study|Adverse Event|0|||
27810937|NCT03551730|81137519|FG003|Overall Study|Adverse Event|0|||
27810938|NCT00444795|81137521|FG000|Overall Study|Not Treated|1|||
27810939|NCT00444795|81137521|FG000|Overall Study|Treated Prior to the Contract Date|2|||
27810940|NCT03828461|81137524|FG000|Overall Study|Lost to Follow-up|1|||
27810941|NCT03828461|81137524|FG000|Overall Study|Withdrawal by Subject|3|||
27810942|NCT00545233|81137525|FG000|Overall Study|Adverse Event|10|||
27810943|NCT00545233|81137526|FG001|Overall Study|Adverse Event|5|||
27810944|NCT00545233|81137525|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
27810945|NCT00545233|81137526|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27810946|NCT00545233|81137525|FG000|Overall Study|Protocol Violation|2|||
27810947|NCT00545233|81137526|FG001|Overall Study|Protocol Violation|0|||
27810948|NCT00545233|81137525|FG000|Overall Study|Refused Treatment|9|||
27810949|NCT00545233|81137526|FG001|Overall Study|Refused Treatment|7|||
27810950|NCT00545233|81137525|FG000|Overall Study|Failure to Return|4|||
27810951|NCT00545233|81137526|FG001|Overall Study|Failure to Return|6|||
27586822|NCT03564496|80328437|FG001|Overall Study|Screen failure|3|||
27810952|NCT00545233|81137525|FG000|Overall Study|Insufficient response|14|||
27810953|NCT00545233|81137526|FG001|Overall Study|Insufficient response|15|||
27810954|NCT00545233|81137525|FG000|Overall Study|Physician Decision|2|||
27810955|NCT00545233|81137526|FG001|Overall Study|Physician Decision|1|||
27810956|NCT00770991|81137530|FG000|Overall Study|Physician Decision|2|||
27810957|NCT00770991|81137531|FG001|Overall Study|Physician Decision|0|||
27810958|NCT00770991|81137530|FG000|Overall Study|Withdrawal by Subject|1|||
27875442|NCT03850483|81375432|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
28007547|NCT02903914|81859571|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
27586823|NCT03564496|80328438|FG002|Overall Study|Screen failure|0|||
27586824|NCT05819749|80328441|FG000|Overall Study|Lost to Follow-up|1|||
27586825|NCT04798781|80328444|FG000|Overall Study|Withdrawal by Subject|1|||
27586826|NCT05799495|80328445|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
27586827|NCT05799495|80328446|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
27586828|NCT05799495|80328447|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
27586829|NCT05799495|80328448|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
28007548|NCT02903914|81859572|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
28007549|NCT02903914|81859573|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
28007550|NCT02903914|81859566|FG000|Overall Study|Clinical Disease Progression|0|||
28007551|NCT02903914|81859567|FG001|Overall Study|Clinical Disease Progression|0|||
28007552|NCT02903914|81859568|FG002|Overall Study|Clinical Disease Progression|2|||
28007553|NCT02903914|81859569|FG003|Overall Study|Clinical Disease Progression|0|||
28007554|NCT02903914|81859570|FG004|Overall Study|Clinical Disease Progression|0|||
28007555|NCT02903914|81859571|FG005|Overall Study|Clinical Disease Progression|0|||
28007556|NCT02903914|81859572|FG006|Overall Study|Clinical Disease Progression|0|||
28007557|NCT02903914|81859573|FG007|Overall Study|Clinical Disease Progression|0|||
28007558|NCT02903914|81859566|FG000|Overall Study|Completed Follow-up Period|0|||
28007559|NCT02903914|81859567|FG001|Overall Study|Completed Follow-up Period|0|||
28007560|NCT02903914|81859568|FG002|Overall Study|Completed Follow-up Period|6|||
28007561|NCT02903914|81859569|FG003|Overall Study|Completed Follow-up Period|2|||
28007562|NCT02903914|81859570|FG004|Overall Study|Completed Follow-up Period|1|||
28007563|NCT02903914|81859571|FG005|Overall Study|Completed Follow-up Period|0|||
28007564|NCT02903914|81859572|FG006|Overall Study|Completed Follow-up Period|9|||
27586830|NCT05799495|80328445|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
27810959|NCT00770991|81137531|FG001|Overall Study|Withdrawal by Subject|0|||
27810960|NCT00770991|81137530|FG000|Overall Study|Adverse Event|1|||
27810961|NCT00770991|81137531|FG001|Overall Study|Adverse Event|5|||
27810962|NCT00770991|81137530|FG000|Overall Study|Pregnancy|1|||
27810963|NCT00770991|81137531|FG001|Overall Study|Pregnancy|0|||
27810964|NCT01347710|81137532|FG000|Overall Study|Withdrawal by Subject|2|||
27810965|NCT01347710|81137532|FG000|Overall Study|Adverse Event|4|||
27810966|NCT01347710|81137532|FG000|Overall Study|Angio or SPECT not completed|18|||
27810967|NCT01347710|81137532|FG000|Overall Study|issue with vitals prior to dosing|1|||
27810968|NCT01347710|81137532|FG000|Overall Study|Lost to Follow-up|1|||
27810969|NCT01347710|81137532|FG000|Overall Study|Physician Decision|2|||
27810970|NCT01347710|81137532|FG000|Overall Study|Other|3|||
27810971|NCT01618266|81137533|FG000|Overall Study|Lost to Follow-up|9|||
27810972|NCT01618266|81137533|FG000|Overall Study|Treatment satisfaction|10|||
27810973|NCT01618266|81137533|FG000|Overall Study|Other reasons|11|||
27810974|NCT01618266|81137533|FG000|Overall Study|Lack of Efficacy|23|||
27810975|NCT01618266|81137533|FG000|Overall Study|Protocol Violation|43|||
27810976|NCT01336894|81137542|FG000|Follow-up|Study terminated prematurely|2|||
27810977|NCT01336894|81137543|FG001|Follow-up|Study terminated prematurely|7|||
27810978|NCT01368276|81137544|FG000|Overall Study|Death|1|||
27810979|NCT01368276|81137545|FG001|Overall Study|Death|10|||
27810980|NCT03922477|81137550|FG000|Overall Study|Death|9|||
27810981|NCT03922477|81137550|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
27810982|NCT03922477|81137550|FG000|Overall Study|Physician Decision|1|||
27810983|NCT03922477|81137550|FG000|Overall Study|Withdrawal by Subject|2|||
27810984|NCT00993616|81137553|FG000|Overall Study|No tumor at entry|1|||
27810985|NCT00993616|81137553|FG000|Overall Study|Never treated|1|||
27810986|NCT02732561|81137554|FG000|Overall Study|Lost to Follow-up|1|||
27810987|NCT02732561|81137555|FG001|Overall Study|Lost to Follow-up|1|||
27810988|NCT02732561|81137554|FG000|Overall Study|Withdrawal by Subject|1|||
27810989|NCT02732561|81137555|FG001|Overall Study|Withdrawal by Subject|0|||
27810990|NCT01896297|81137556|FG000|Overall Study|Died in post treatment phase|1|||
27810991|NCT01829477|81137557|FG000|Overall Study|Study Terminated by Sponsor|15|||
27810992|NCT01829477|81137558|FG001|Overall Study|Study Terminated by Sponsor|15|||
27810993|NCT01829477|81137557|FG000|Overall Study|Withdrawal by Subject|1|||
27810994|NCT01829477|81137558|FG001|Overall Study|Withdrawal by Subject|0|||
27810995|NCT00836927|81137559|FG000|Overall Study|Progressive disease|2|||
27810996|NCT00836927|81137560|FG001|Overall Study|Progressive disease|0|||
27810997|NCT00836927|81137561|FG002|Overall Study|Progressive disease|0|||
28007565|NCT02903914|81859573|FG007|Overall Study|Completed Follow-up Period|1|||
28007566|NCT02903914|81859566|FG000|Overall Study|Taken off Treatment per Protocol|0|||
28007567|NCT02903914|81859567|FG001|Overall Study|Taken off Treatment per Protocol|0|||
27810998|NCT00836927|81137562|FG003|Overall Study|Progressive disease|1|||
27810999|NCT00836927|81137563|FG004|Overall Study|Progressive disease|1|||
27811000|NCT00836927|81137559|FG000|Overall Study|Withdrawal by Subject|1|||
27811001|NCT00836927|81137560|FG001|Overall Study|Withdrawal by Subject|0|||
27811002|NCT00836927|81137561|FG002|Overall Study|Withdrawal by Subject|0|||
27811003|NCT00836927|81137562|FG003|Overall Study|Withdrawal by Subject|0|||
28007568|NCT02903914|81859568|FG002|Overall Study|Taken off Treatment per Protocol|0|||
27875443|NCT03850483|81375433|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
27685756|NCT01879722|80683857|FG002|Overall Study|Voluntary Withdrawal|0|||
27685757|NCT01879722|80683858|FG003|Overall Study|Voluntary Withdrawal|0|||
27685758|NCT01879722|80683859|FG004|Overall Study|Voluntary Withdrawal|0|||
27685759|NCT01879722|80683860|FG005|Overall Study|Voluntary Withdrawal|0|||
27811004|NCT00836927|81137563|FG004|Overall Study|Withdrawal by Subject|0|||
27811005|NCT00798889|81137571|FG000|Overall Study|Adverse Event|53|||
27811006|NCT00798889|81137571|FG000|Overall Study|Protocol Violation|2|||
27811007|NCT00798889|81137571|FG000|Overall Study|Withdrawal by Subject|31|||
27586831|NCT05799495|80328446|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
27875444|NCT03850483|81375434|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
28007569|NCT02903914|81859569|FG003|Overall Study|Taken off Treatment per Protocol|0|||
28007570|NCT02903914|81859570|FG004|Overall Study|Taken off Treatment per Protocol|0|||
28007571|NCT02903914|81859571|FG005|Overall Study|Taken off Treatment per Protocol|1|||
27586832|NCT05799495|80328447|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
27586833|NCT05799495|80328448|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
27586834|NCT05799495|80328445|FG000|Treatment (Up to 5 Days)|Other|0|||
27586835|NCT05799495|80328446|FG001|Treatment (Up to 5 Days)|Other|1|||
27586836|NCT05799495|80328447|FG002|Treatment (Up to 5 Days)|Other|0|||
27586837|NCT05799495|80328448|FG003|Treatment (Up to 5 Days)|Other|0|||
27586838|NCT05799495|80328445|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
27811008|NCT00798889|81137571|FG000|Overall Study|Lost to Follow-up|1|||
27811009|NCT00798889|81137571|FG000|Overall Study|Lack of Efficacy|213|||
27811010|NCT00798889|81137571|FG000|Overall Study|Decision of Sponsor|11|||
27811011|NCT00798889|81137571|FG000|Overall Study|Enrolled, Not treated|3|||
27811012|NCT00146770|81137575|FG000|Overall Study|Adverse Event|2|||
27811013|NCT00146770|81137576|FG001|Overall Study|Adverse Event|0|||
27811014|NCT00146770|81137575|FG000|Overall Study|Pregnancy|1|||
27811015|NCT00146770|81137576|FG001|Overall Study|Pregnancy|0|||
27811016|NCT00146770|81137575|FG000|Overall Study|Withdrawal by Subject|2|||
27811017|NCT00146770|81137576|FG001|Overall Study|Withdrawal by Subject|0|||
27811018|NCT01415921|81137577|FG000|Overall Study|Adverse Event|0|||
27811019|NCT01415921|81137578|FG001|Overall Study|Adverse Event|1|||
27811020|NCT01415921|81137577|FG000|Overall Study|Physician Decision|1|||
27811021|NCT01415921|81137578|FG001|Overall Study|Physician Decision|1|||
27811022|NCT01415921|81137577|FG000|Overall Study|Withdrawal by Subject|0|||
27811023|NCT01415921|81137578|FG001|Overall Study|Withdrawal by Subject|1|||
27811024|NCT01415921|81137577|FG000|Overall Study|Other|2|||
27811025|NCT01415921|81137578|FG001|Overall Study|Other|0|||
27811026|NCT03692676|81137579|FG000|Overall Study|exclude patients with prior use|4424|||
27811027|NCT03692676|81137580|FG001|Overall Study|exclude patients with prior use|24726|||
27811028|NCT03692676|81137581|FG002|Overall Study|exclude patients with prior use|0|||
27811029|NCT03692676|81137582|FG003|Overall Study|exclude patients with prior use|0|||
27811030|NCT03692676|81137579|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
27811031|NCT03692676|81137580|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
27811032|NCT03692676|81137581|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
27811033|NCT03692676|81137582|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
27811034|NCT03692676|81137579|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
27811035|NCT03692676|81137580|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
27811036|NCT03692676|81137581|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
27811037|NCT03692676|81137582|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
27811038|NCT03692676|81137579|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
27811039|NCT03692676|81137580|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
27875445|NCT03850483|81375435|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
27875446|NCT03850483|81375436|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
28007572|NCT02903914|81859572|FG006|Overall Study|Taken off Treatment per Protocol|0|||
28007573|NCT02903914|81859573|FG007|Overall Study|Taken off Treatment per Protocol|0|||
28007574|NCT02903914|81859566|FG000|Overall Study|Refused Further Treatment/Contact|0|||
28007575|NCT02903914|81859567|FG001|Overall Study|Refused Further Treatment/Contact|0|||
28007576|NCT02903914|81859568|FG002|Overall Study|Refused Further Treatment/Contact|0|||
27586839|NCT05799495|80328446|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
27586840|NCT05799495|80328447|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
27685760|NCT01879722|80683861|FG006|Overall Study|Voluntary Withdrawal|0|||
27811040|NCT03692676|81137581|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
27811041|NCT03692676|81137582|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
27811042|NCT03692676|81137579|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
27811043|NCT03692676|81137580|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
27811044|NCT03692676|81137581|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
28007577|NCT02903914|81859569|FG003|Overall Study|Refused Further Treatment/Contact|0|||
27685761|NCT01879722|80683862|FG007|Overall Study|Voluntary Withdrawal|0|||
28007578|NCT02903914|81859570|FG004|Overall Study|Refused Further Treatment/Contact|0|||
27811045|NCT03692676|81137582|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
27811046|NCT03692676|81137579|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
27811047|NCT03692676|81137580|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
27811048|NCT03692676|81137581|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
27811049|NCT03692676|81137582|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
27811050|NCT03692676|81137579|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
27811051|NCT03692676|81137580|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
27811052|NCT03692676|81137581|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
27811053|NCT03692676|81137582|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
27811054|NCT03692676|81137579|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
27811055|NCT03692676|81137580|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
27811056|NCT03692676|81137581|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
27811057|NCT03692676|81137582|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
27811058|NCT03692676|81137579|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
27811059|NCT03692676|81137580|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
27811060|NCT03692676|81137581|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
27811061|NCT03692676|81137582|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
27811062|NCT03692676|81137579|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
27811063|NCT03692676|81137580|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
27811064|NCT03692676|81137581|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
27811065|NCT03692676|81137582|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
27811066|NCT03692676|81137579|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
27811067|NCT03692676|81137580|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
27811068|NCT03692676|81137581|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
27811069|NCT03692676|81137582|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
27811070|NCT03692676|81137579|FG000|Overall Study|Other|0|||
27811071|NCT03692676|81137580|FG001|Overall Study|Other|805|||
27811072|NCT03692676|81137581|FG002|Overall Study|Other|758|||
27811073|NCT03692676|81137582|FG003|Overall Study|Other|277|||
27811074|NCT03692676|81137579|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
27811075|NCT03692676|81137580|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
27811076|NCT03692676|81137581|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
27811077|NCT03692676|81137582|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
27811078|NCT04947579|81137583|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
27811079|NCT04947579|81137584|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
27811080|NCT04947579|81137585|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
27811081|NCT04947579|81137586|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
27811082|NCT04947579|81137587|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
27811083|NCT04947579|81137588|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
27811084|NCT04947579|81137583|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
27811085|NCT04947579|81137584|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
27811086|NCT04947579|81137585|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
27811087|NCT04947579|81137586|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
27811088|NCT04947579|81137587|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
27811089|NCT04947579|81137588|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
27811090|NCT04947579|81137583|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
27811091|NCT04947579|81137584|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
27811092|NCT04947579|81137585|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
27811093|NCT04947579|81137586|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
27811094|NCT04947579|81137587|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
27811095|NCT04947579|81137588|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
27811096|NCT04947579|81137583|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
27811097|NCT04947579|81137584|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
27811098|NCT04947579|81137585|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
27811099|NCT04947579|81137586|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
28007579|NCT02903914|81859571|FG005|Overall Study|Refused Further Treatment/Contact|0|||
28007580|NCT02903914|81859572|FG006|Overall Study|Refused Further Treatment/Contact|1|||
28007581|NCT02903914|81859573|FG007|Overall Study|Refused Further Treatment/Contact|0|||
27811100|NCT04947579|81137587|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
27811101|NCT04947579|81137588|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
27811102|NCT04947579|81137583|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
27811103|NCT04947579|81137584|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
27811104|NCT04947579|81137585|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
27811105|NCT04947579|81137586|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
28007582|NCT02903914|81859566|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007583|NCT02903914|81859567|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007584|NCT02903914|81859568|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007585|NCT02903914|81859569|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007586|NCT02903914|81859570|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007587|NCT02903914|81859571|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007588|NCT02903914|81859572|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
28007589|NCT02903914|81859573|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
28007590|NCT03858049|81859574|FG000|Overall Study|Adverse Event|16|||
28007591|NCT03858049|81859575|FG001|Overall Study|Adverse Event|9|||
28007592|NCT03858049|81859574|FG000|Overall Study|Other|1|||
28007593|NCT03858049|81859575|FG001|Overall Study|Other|1|||
28007594|NCT04011540|81859576|FG000|Overall Study|Lost to Follow-up|9|||
28007595|NCT04011540|81859577|FG001|Overall Study|Lost to Follow-up|6|||
28007596|NCT04663321|81859578|FG000|Overall Study|Study terminated by Sponsor|2|||
28007597|NCT04663321|81859579|FG001|Overall Study|Study terminated by Sponsor|1|||
28007598|NCT04663321|81859580|FG002|Overall Study|Study terminated by Sponsor|2|||
28007599|NCT04663321|81859578|FG000|Overall Study|Withdrawal by Subject|10|||
28007600|NCT04663321|81859579|FG001|Overall Study|Withdrawal by Subject|3|||
28007601|NCT04663321|81859580|FG002|Overall Study|Withdrawal by Subject|2|||
28007602|NCT04663321|81859578|FG000|Overall Study|Not provided|0|||
28007603|NCT04663321|81859579|FG001|Overall Study|Not provided|0|||
28007604|NCT04663321|81859580|FG002|Overall Study|Not provided|1|||
28007605|NCT00231816|81859581|FG000|Overall Study|Adverse Event|1|||
28007606|NCT00231816|81859582|FG001|Overall Study|Adverse Event|0|||
28007607|NCT00231816|81859581|FG000|Overall Study|Lost to Follow-up|8|||
28007608|NCT00231816|81859582|FG001|Overall Study|Lost to Follow-up|5|||
28007609|NCT00231816|81859581|FG000|Overall Study|Protocol Violation|2|||
28007610|NCT00231816|81859582|FG001|Overall Study|Protocol Violation|3|||
28007611|NCT00231816|81859581|FG000|Overall Study|Withdrawal by Subject|3|||
28007612|NCT00231816|81859582|FG001|Overall Study|Withdrawal by Subject|3|||
27586841|NCT05799495|80328448|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
27586842|NCT05799495|80328445|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
28007613|NCT00231816|81859581|FG000|Overall Study|Other|2|||
28007614|NCT00231816|81859582|FG001|Overall Study|Other|1|||
28007615|NCT05789745|81859584|FG000|Overall Study|Withdrawal by Subject|0|||
28007616|NCT05789745|81859585|FG001|Overall Study|Withdrawal by Subject|0|||
28007617|NCT05789745|81859586|FG002|Overall Study|Withdrawal by Subject|0|||
28007618|NCT05789745|81859587|FG003|Overall Study|Withdrawal by Subject|0|||
28007619|NCT05789745|81859588|FG004|Overall Study|Withdrawal by Subject|1|||
28007620|NCT04606134|81859589|FG000|Overall Study|Adverse Event|0|||
28007621|NCT04606134|81859590|FG001|Overall Study|Adverse Event|1|||
28007622|NCT05236270|81859591|FG000|Overall Study|Lost to Follow-up|3|||
27586843|NCT05799495|80328446|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
27586844|NCT05799495|80328447|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
27586845|NCT05799495|80328448|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
27586846|NCT05799495|80328445|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27586847|NCT05799495|80328446|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27811106|NCT04947579|81137587|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
27811107|NCT04947579|81137588|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
27811108|NCT04947579|81137583|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
27811109|NCT04947579|81137584|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
27811110|NCT04947579|81137585|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
27811111|NCT04947579|81137586|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
27811112|NCT04947579|81137587|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
27811113|NCT04947579|81137588|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
27811114|NCT04947579|81137583|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
27811115|NCT04947579|81137584|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
27811116|NCT04947579|81137585|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
28007623|NCT05236270|81859592|FG001|Overall Study|Lost to Follow-up|2|||
28007624|NCT05236270|81859593|FG002|Overall Study|Lost to Follow-up|0|||
28007625|NCT05236270|81859594|FG003|Overall Study|Lost to Follow-up|0|||
28007626|NCT05236270|81859595|FG004|Overall Study|Lost to Follow-up|2|||
28007627|NCT05236270|81859596|FG005|Overall Study|Lost to Follow-up|0|||
28007628|NCT05236270|81859597|FG006|Overall Study|Lost to Follow-up|1|||
28007629|NCT05236270|81859598|FG007|Overall Study|Lost to Follow-up|3|||
28007630|NCT03804528|81859599|FG000|Overall Study|Time Commitment|18|||
28007631|NCT03804528|81859599|FG000|Overall Study|Health Reasons|5|||
28007632|NCT00764699|81859602|FG000|Overall Study|PI left and study terminated|3|||
28007633|NCT05323084|81859603|FG000|Period 2 - Washout|Lost to Follow-up|0|||
28007634|NCT05323084|81859604|FG001|Period 2 - Washout|Lost to Follow-up|1|||
28007635|NCT00280917|81859610|FG000|Overall Study|Adverse Event|1|||
28007636|NCT00280917|81859611|FG001|Overall Study|Adverse Event|1|||
28007637|NCT00280917|81859612|FG002|Overall Study|Adverse Event|4|||
27811117|NCT04947579|81137586|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
27811118|NCT04947579|81137587|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
27811119|NCT04947579|81137588|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
27811120|NCT04947579|81137583|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
27811121|NCT04947579|81137584|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
27811122|NCT04947579|81137585|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
27811123|NCT04947579|81137586|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
27811124|NCT04947579|81137587|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
27811125|NCT04947579|81137588|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
27811126|NCT04947579|81137583|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
27811127|NCT04947579|81137584|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
27811128|NCT04947579|81137585|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
27811129|NCT04947579|81137586|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
27811130|NCT04947579|81137587|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
27811131|NCT04947579|81137588|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
27811132|NCT04947579|81137583|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
27811133|NCT04947579|81137584|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
27811134|NCT04947579|81137585|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
27811135|NCT04947579|81137586|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
27811136|NCT04947579|81137587|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
27811137|NCT04947579|81137588|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
27811138|NCT04947579|81137583|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
27811139|NCT04947579|81137584|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
27811140|NCT04947579|81137585|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
27811141|NCT04947579|81137586|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
27811142|NCT04947579|81137587|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
27811143|NCT04947579|81137588|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
27811144|NCT05266456|81137592|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
27811145|NCT05266456|81137593|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
27811146|NCT05266456|81137594|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
27811147|NCT05266456|81137595|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
27811148|NCT05266456|81137592|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
27811149|NCT05266456|81137593|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
27811150|NCT05266456|81137594|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
27811151|NCT05266456|81137595|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
27811152|NCT05266456|81137592|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
27811153|NCT05266456|81137593|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
27811154|NCT05266456|81137594|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
27811155|NCT05266456|81137595|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
27811156|NCT05266456|81137592|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
27811157|NCT05266456|81137593|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
27811158|NCT05266456|81137594|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
27811159|NCT05266456|81137595|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
27811160|NCT05266456|81137592|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
27811161|NCT05266456|81137593|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
27811162|NCT05266456|81137594|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
27811163|NCT05266456|81137595|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
27811164|NCT00331630|81137596|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
27811165|NCT00331630|81137596|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
27811166|NCT00331630|81137596|FG000|Follow up for 5 Years|Death|5|||
27811167|NCT00331630|81137596|FG000|Follow up for 5 Years|Data collection was stopped|24|||
27811168|NCT01427920|81137599|FG000|Overall Study|Adverse Event|1|||
27811169|NCT01427920|81137600|FG001|Overall Study|Adverse Event|2|||
27811170|NCT01427920|81137599|FG000|Overall Study|Lack of Efficacy|1|||
27811171|NCT01427920|81137600|FG001|Overall Study|Lack of Efficacy|0|||
28007638|NCT00280917|81859613|FG003|Overall Study|Adverse Event|1|||
28007639|NCT00280917|81859610|FG000|Overall Study|Change Therapy|1|||
28007640|NCT00280917|81859611|FG001|Overall Study|Change Therapy|2|||
28007641|NCT00280917|81859612|FG002|Overall Study|Change Therapy|0|||
28007642|NCT00280917|81859613|FG003|Overall Study|Change Therapy|0|||
28007643|NCT00280917|81859610|FG000|Overall Study|Withdrawal by Subject|0|||
27811172|NCT01427920|81137599|FG000|Overall Study|Protocol Violation|1|||
27811173|NCT01427920|81137600|FG001|Overall Study|Protocol Violation|3|||
27811174|NCT01427920|81137599|FG000|Overall Study|Withdrawal Criteria|4|||
27811175|NCT01427920|81137600|FG001|Overall Study|Withdrawal Criteria|4|||
27811176|NCT01427920|81137599|FG000|Overall Study|Unclassified|2|||
27811177|NCT01427920|81137600|FG001|Overall Study|Unclassified|8|||
27811178|NCT02545998|81137609|FG000|Overall Study|Lost to Follow-up|12|||
27811179|NCT02545998|81137610|FG001|Overall Study|Lost to Follow-up|3|||
27811180|NCT02545998|81137609|FG000|Overall Study|Withdrawal by Subject|3|||
27811181|NCT02545998|81137610|FG001|Overall Study|Withdrawal by Subject|2|||
27811182|NCT00760383|81137611|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
27811183|NCT00760383|81137612|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
27811184|NCT03342898|81137615|FG000|Overall Study|Adverse Event|3|||
27811185|NCT03342898|81137616|FG001|Overall Study|Adverse Event|1|||
27811186|NCT03342898|81137617|FG002|Overall Study|Adverse Event|0|||
27811187|NCT03342898|81137615|FG000|Overall Study|Lost to Follow-up|44|||
27811188|NCT03342898|81137616|FG001|Overall Study|Lost to Follow-up|40|||
27811189|NCT03342898|81137617|FG002|Overall Study|Lost to Follow-up|42|||
27811190|NCT03342898|81137615|FG000|Overall Study|Withdrawal of Consent|5|||
27811191|NCT03342898|81137616|FG001|Overall Study|Withdrawal of Consent|9|||
27811192|NCT03342898|81137617|FG002|Overall Study|Withdrawal of Consent|11|||
27811193|NCT03342898|81137615|FG000|Overall Study|Death|0|||
27811194|NCT03342898|81137616|FG001|Overall Study|Death|1|||
27811195|NCT03342898|81137617|FG002|Overall Study|Death|1|||
27811196|NCT03342898|81137615|FG000|Overall Study|Reason not Specified|2|||
27811197|NCT03342898|81137616|FG001|Overall Study|Reason not Specified|2|||
27586848|NCT05799495|80328447|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
27586849|NCT05799495|80328448|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27811198|NCT03342898|81137617|FG002|Overall Study|Reason not Specified|0|||
27811199|NCT03850509|81137620|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
27586850|NCT02896855|80328449|FG000|Overall Study|Death|50|||
27586851|NCT02896855|80328450|FG001|Overall Study|Death|40|||
27586852|NCT02896855|80328449|FG000|Overall Study|Lost to Follow-up|15|||
27586853|NCT02896855|80328450|FG001|Overall Study|Lost to Follow-up|9|||
27586854|NCT02896855|80328449|FG000|Overall Study|Withdrawal by Subject|7|||
27586855|NCT02896855|80328450|FG001|Overall Study|Withdrawal by Subject|4|||
27586856|NCT02308033|80328451|FG000|Overall Study|Normal Gram stain at Baseline|13|||
27586857|NCT02308033|80328452|FG001|Overall Study|Normal Gram stain at Baseline|10|||
27586858|NCT02308033|80328451|FG000|Overall Study|Positive for STD at Baseline|7|||
27586859|NCT02308033|80328452|FG001|Overall Study|Positive for STD at Baseline|4|||
27811200|NCT03850509|81137621|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
27811201|NCT01132118|81137626|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
27811202|NCT01132118|81137627|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
27811203|NCT01132118|81137626|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27811204|NCT01132118|81137627|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
27875447|NCT03850483|81375437|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
27875448|NCT03850483|81375438|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
27586860|NCT02308033|80328451|FG000|Overall Study|Lost to Follow-up|6|||
27586861|NCT02308033|80328452|FG001|Overall Study|Lost to Follow-up|5|||
27586862|NCT03478891|80328453|FG000|Overall Study|Enrolled, but product never administered|0|||
27586863|NCT03478891|80328454|FG001|Overall Study|Enrolled, but product never administered|0|||
27586864|NCT03478891|80328455|FG002|Overall Study|Enrolled, but product never administered|1|||
27586865|NCT03478891|80328453|FG000|Overall Study|Moved from area|0|||
27586866|NCT03478891|80328454|FG001|Overall Study|Moved from area|0|||
27586867|NCT03478891|80328455|FG002|Overall Study|Moved from area|1|||
27586868|NCT03478891|80328453|FG000|Overall Study|Lost to Follow-up|1|||
27586869|NCT03478891|80328454|FG001|Overall Study|Lost to Follow-up|0|||
27586870|NCT03478891|80328455|FG002|Overall Study|Lost to Follow-up|1|||
27586871|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
27586872|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
27586873|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
27586874|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
27811205|NCT01132118|81137626|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
27875449|NCT03850483|81375429|FG000|Follow-up For Stage 2|Other|0|||
27586875|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
27586876|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
27586877|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
27586878|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
27811206|NCT01132118|81137627|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
27811207|NCT00717756|81137628|FG000|Overall Study|Withdrawal by Subject|1|||
27811208|NCT03271528|81137629|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
27811209|NCT03271528|81137630|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
27811210|NCT03271528|81137629|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
27586879|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
27586880|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
27586881|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
27811211|NCT03271528|81137630|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
27811212|NCT03271528|81137629|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
27811213|NCT03271528|81137630|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
27811214|NCT03271528|81137629|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
27811215|NCT03271528|81137630|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
27811216|NCT03271528|81137629|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
27811217|NCT03271528|81137630|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
27811218|NCT03271528|81137629|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
27811219|NCT03271528|81137630|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
27811220|NCT03271528|81137629|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
27811221|NCT03271528|81137630|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
27811222|NCT00928252|81137631|FG000|Overall Study|Physician Decision|3|||
27811223|NCT00549198|81137632|FG000|Overall Study|Adverse Event|28|||
27811224|NCT00549198|81137633|FG001|Overall Study|Adverse Event|26|||
27586882|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
27811225|NCT00549198|81137632|FG000|Overall Study|Insufficient Viral Load Response|4|||
27811226|NCT00549198|81137633|FG001|Overall Study|Insufficient Viral Load Response|2|||
27811227|NCT00549198|81137632|FG000|Overall Study|Protocol-defined Virological Failure|7|||
27811228|NCT00549198|81137633|FG001|Overall Study|Protocol-defined Virological Failure|0|||
27811229|NCT00549198|81137632|FG000|Overall Study|Non-compliance|2|||
27811230|NCT00549198|81137633|FG001|Overall Study|Non-compliance|4|||
27811231|NCT00549198|81137632|FG000|Overall Study|Lost to Follow-up|7|||
27811232|NCT00549198|81137633|FG001|Overall Study|Lost to Follow-up|8|||
27586883|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
27586884|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
27586885|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
27586886|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
27586887|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
27586888|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
27586889|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
27586890|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
27586891|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
27586892|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
27586893|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
27586894|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
27586895|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
27586896|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
27586897|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
27586898|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
27586899|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
27586900|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
27586901|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
27811233|NCT00549198|81137632|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
27811234|NCT00549198|81137633|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
28007644|NCT00280917|81859611|FG001|Overall Study|Withdrawal by Subject|2|||
28007645|NCT00280917|81859612|FG002|Overall Study|Withdrawal by Subject|0|||
28007646|NCT00280917|81859613|FG003|Overall Study|Withdrawal by Subject|1|||
28007647|NCT00280917|81859610|FG000|Overall Study|Noncompliance|0|||
28007648|NCT00280917|81859611|FG001|Overall Study|Noncompliance|1|||
28007649|NCT00280917|81859612|FG002|Overall Study|Noncompliance|2|||
28007650|NCT00280917|81859613|FG003|Overall Study|Noncompliance|0|||
28007651|NCT02177123|81859614|FG000|Overall Study|Lost to Follow-up|6|||
28007652|NCT02177123|81859614|FG000|Overall Study|Withdrawal by Subject|4|||
28007653|NCT02177123|81859614|FG000|Overall Study|Adverse Event|4|||
28007654|NCT02177123|81859614|FG000|Overall Study|Physician Decision|3|||
28007655|NCT02177123|81859614|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
28007656|NCT02177123|81859614|FG000|Overall Study|Excluded for medical reasons|2|||
28007657|NCT02177123|81859614|FG000|Overall Study|Death|1|||
28007658|NCT02177123|81859614|FG000|Overall Study|Other|1|||
27586902|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
27586903|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
27586904|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
27586905|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
27586906|NCT00383435|80328456|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
27586907|NCT00383435|80328457|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
27586908|NCT00383435|80328458|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
27586909|NCT00383435|80328459|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
27586910|NCT00383435|80328460|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
27586911|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
27586912|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
27586913|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
27586914|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
27586915|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
27586916|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
27586917|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
27586918|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
27586919|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
27586920|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
27586921|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
27586922|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
27586923|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
27586924|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
27586925|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
27586926|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
27586927|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
27586928|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
27586929|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
27586930|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
27586931|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
27586932|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
27586933|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
27586934|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
27586935|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
27586936|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
27586937|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
27586938|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
27811235|NCT00549198|81137632|FG000|Overall Study|Protocol Violation|7|||
28007659|NCT02177123|81859614|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
27586939|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
27586940|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
27586941|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
27586942|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
27586943|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
27586944|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
27586945|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
27586946|NCT00383435|80328456|FG000|26-Week Treatment Safety Extension|Administrative|1|||
27586947|NCT00383435|80328457|FG001|26-Week Treatment Safety Extension|Administrative|1|||
27586948|NCT00383435|80328458|FG002|26-Week Treatment Safety Extension|Administrative|0|||
27586949|NCT00383435|80328459|FG003|26-Week Treatment Safety Extension|Administrative|1|||
28007660|NCT01766050|81859615|FG000|Overall Study|Adverse Event|1|||
28007661|NCT01766050|81859615|FG000|Overall Study|Lost to Follow-up|1|||
28007662|NCT01766050|81859615|FG000|Overall Study|Withdrawal by Subject|2|||
28007663|NCT04564846|81859616|FG000|Overall Study|Withdrawal by Subject|2|||
28007664|NCT04564846|81859617|FG001|Overall Study|Withdrawal by Subject|1|||
28007665|NCT04564846|81859616|FG000|Overall Study|Physician Decision|0|||
28007666|NCT04564846|81859617|FG001|Overall Study|Physician Decision|1|||
28007667|NCT04564846|81859616|FG000|Overall Study|Lost to Follow-up|0|||
28007668|NCT04564846|81859617|FG001|Overall Study|Lost to Follow-up|1|||
28007669|NCT04564846|81859616|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
28007670|NCT04564846|81859617|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
28007671|NCT04564846|81859616|FG000|Overall Study|Subject non-compliance|1|||
28007672|NCT04564846|81859617|FG001|Overall Study|Subject non-compliance|0|||
28007673|NCT00627393|81859618|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
28007674|NCT00627393|81859619|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
27586950|NCT00383435|80328460|FG004|26-Week Treatment Safety Extension|Administrative|0|||
27586951|NCT02014116|80328468|FG000|Overall Study|Progressive Disease|3|||
27586952|NCT02014116|80328469|FG001|Overall Study|Progressive Disease|4|||
27586953|NCT02014116|80328470|FG002|Overall Study|Progressive Disease|2|||
27586954|NCT02014116|80328471|FG003|Overall Study|Progressive Disease|6|||
27685762|NCT01879722|80683863|FG008|Overall Study|Voluntary Withdrawal|1|||
27685763|NCT01879722|80683864|FG009|Overall Study|Voluntary Withdrawal|0|||
27586955|NCT02014116|80328472|FG004|Overall Study|Progressive Disease|1|||
27586956|NCT02014116|80328473|FG005|Overall Study|Progressive Disease|13|||
27586957|NCT02014116|80328474|FG006|Overall Study|Progressive Disease|1|||
27586958|NCT02014116|80328475|FG007|Overall Study|Progressive Disease|3|||
27586959|NCT02014116|80328476|FG008|Overall Study|Progressive Disease|7|||
27685764|NCT00658788|80683865|FG000|Overall Study|Adverse Event|11|||
27685765|NCT00658788|80683865|FG000|Overall Study|Withdrawal by Subject|13|||
27811236|NCT00549198|81137633|FG001|Overall Study|Protocol Violation|2|||
27811237|NCT00549198|81137632|FG000|Overall Study|Investigator Decision|4|||
27811238|NCT00549198|81137633|FG001|Overall Study|Investigator Decision|3|||
27811239|NCT00549198|81137632|FG000|Overall Study|Withdrawal by Subject|7|||
27811240|NCT00549198|81137633|FG001|Overall Study|Withdrawal by Subject|7|||
27811241|NCT00549198|81137632|FG000|Overall Study|Disease Progression|1|||
27811242|NCT00549198|81137633|FG001|Overall Study|Disease Progression|0|||
27811243|NCT00549198|81137632|FG000|Overall Study|Participant Moved|2|||
27811244|NCT00549198|81137633|FG001|Overall Study|Participant Moved|0|||
27811245|NCT00549198|81137632|FG000|Overall Study|Participant not able to perform Week 96|1|||
27811246|NCT00549198|81137633|FG001|Overall Study|Participant not able to perform Week 96|0|||
27811247|NCT00549198|81137632|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
27811248|NCT00549198|81137633|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
27811249|NCT00549198|81137632|FG000|Overall Study|Prohibited Medication|1|||
27811250|NCT00549198|81137633|FG001|Overall Study|Prohibited Medication|2|||
27811251|NCT00549198|81137632|FG000|Overall Study|Participant planning pregnancy|1|||
27811252|NCT00549198|81137633|FG001|Overall Study|Participant planning pregnancy|0|||
27811253|NCT00549198|81137632|FG000|Overall Study|Participant overweight, no scan possible|1|||
27685766|NCT00658788|80683865|FG000|Overall Study|Lost to Follow-up|18|||
27811254|NCT00549198|81137633|FG001|Overall Study|Participant overweight, no scan possible|0|||
27811255|NCT00549198|81137632|FG000|Overall Study|No scan facilities|0|||
27811256|NCT00549198|81137633|FG001|Overall Study|No scan facilities|2|||
27811257|NCT00549198|81137632|FG000|Overall Study|Pregnancy|0|||
27811258|NCT00549198|81137633|FG001|Overall Study|Pregnancy|3|||
27811259|NCT00549198|81137632|FG000|Overall Study|Not Exposed to Study Drug|3|||
27811260|NCT00549198|81137633|FG001|Overall Study|Not Exposed to Study Drug|4|||
27811261|NCT01966042|81137634|FG000|Overall Study|Death|2|||
27811262|NCT00329602|81137635|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
27875450|NCT03850483|81375430|FG001|Follow-up For Stage 2|Other|0|||
27875451|NCT03850483|81375431|FG002|Follow-up For Stage 2|Other|0|||
27875452|NCT03850483|81375432|FG003|Follow-up For Stage 2|Other|0|||
27875453|NCT03850483|81375433|FG004|Follow-up For Stage 2|Other|0|||
27875454|NCT03850483|81375434|FG005|Follow-up For Stage 2|Other|0|||
27875455|NCT03850483|81375435|FG006|Follow-up For Stage 2|Other|0|||
28007675|NCT00627393|81859618|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
27875456|NCT03850483|81375436|FG007|Follow-up For Stage 2|Other|0|||
28007676|NCT00627393|81859619|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
28007677|NCT00627393|81859618|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
28007678|NCT00627393|81859619|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
28007679|NCT00627393|81859618|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
28007680|NCT00627393|81859619|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
28007681|NCT02016781|81859620|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
28007682|NCT02016781|81859621|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
28007683|NCT02016781|81859620|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
28007684|NCT02016781|81859621|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
28007685|NCT02016781|81859620|FG000|Final Database Lock|Withdrawal by Subject|2|||
28007686|NCT02016781|81859621|FG001|Final Database Lock|Withdrawal by Subject|1|||
28007687|NCT02016781|81859620|FG000|Final Database Lock|Lost to Follow-up|11|||
28007688|NCT02016781|81859621|FG001|Final Database Lock|Lost to Follow-up|4|||
27586960|NCT02014116|80328468|FG000|Overall Study|Adverse Event|0|||
27685767|NCT00658788|80683865|FG000|Overall Study|Treatment Discontinuation|32|||
27811263|NCT00329602|81137636|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
27875457|NCT03850483|81375437|FG008|Follow-up For Stage 2|Other|0|||
27811264|NCT00329602|81137637|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
27811265|NCT00329602|81137635|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
27811266|NCT00329602|81137636|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
27811267|NCT00329602|81137637|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
27586961|NCT02014116|80328469|FG001|Overall Study|Adverse Event|0|||
27586962|NCT02014116|80328470|FG002|Overall Study|Adverse Event|0|||
27685768|NCT02182947|80683867|FG000|Overall Study|Withdrawal by Subject|7|||
27685769|NCT02182947|80683867|FG000|Overall Study|Lost to Follow-up|3|||
27685770|NCT02182947|80683867|FG000|Overall Study|Failed screening activities|8|||
27685771|NCT01415531|80683868|FG000|Overall Study|Adverse Event|7|||
27685772|NCT01415531|80683869|FG001|Overall Study|Adverse Event|10|||
27685773|NCT01415531|80683868|FG000|Overall Study|Lack of Efficacy|3|||
27685774|NCT01415531|80683869|FG001|Overall Study|Lack of Efficacy|2|||
27685775|NCT01415531|80683868|FG000|Overall Study|Protocol Violation|0|||
27685776|NCT01415531|80683869|FG001|Overall Study|Protocol Violation|1|||
27685777|NCT01415531|80683868|FG000|Overall Study|Withdrawal by Subject|5|||
27685778|NCT01415531|80683869|FG001|Overall Study|Withdrawal by Subject|4|||
27685779|NCT01415531|80683868|FG000|Overall Study|Lost to Follow-up|6|||
27685780|NCT01415531|80683869|FG001|Overall Study|Lost to Follow-up|14|||
27685781|NCT01415531|80683868|FG000|Overall Study|Lack of Compliance|1|||
27685782|NCT01415531|80683869|FG001|Overall Study|Lack of Compliance|4|||
27685783|NCT01415531|80683868|FG000|Overall Study|Other Reasons|3|||
27685784|NCT01415531|80683869|FG001|Overall Study|Other Reasons|2|||
27685785|NCT05593445|80683870|FG000|12-Week DBVC Period|Adverse Event|1|||
27685786|NCT05593445|80683871|FG001|12-Week DBVC Period|Adverse Event|0|||
27685787|NCT05593445|80683872|FG002|12-Week DBVC Period|Adverse Event|0|||
27685788|NCT05593445|80683873|FG003|12-Week DBVC Period|Adverse Event|0|||
27685789|NCT05593445|80683870|FG000|12-Week DBVC Period|Physician Decision|0|||
27685790|NCT05593445|80683871|FG001|12-Week DBVC Period|Physician Decision|1|||
27685791|NCT05593445|80683872|FG002|12-Week DBVC Period|Physician Decision|0|||
27685792|NCT05593445|80683873|FG003|12-Week DBVC Period|Physician Decision|0|||
27685793|NCT05593445|80683870|FG000|12-Week DBVC Period|Protocol Violation|0|||
27685794|NCT05593445|80683871|FG001|12-Week DBVC Period|Protocol Violation|1|||
27685795|NCT05593445|80683872|FG002|12-Week DBVC Period|Protocol Violation|0|||
27685796|NCT05593445|80683873|FG003|12-Week DBVC Period|Protocol Violation|0|||
27685797|NCT05593445|80683870|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
27685798|NCT05593445|80683871|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
27685799|NCT05593445|80683872|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
27685800|NCT05593445|80683873|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
27685801|NCT05593445|80683870|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
27685802|NCT05593445|80683871|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
27685803|NCT05593445|80683872|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
27685804|NCT05593445|80683873|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
27685805|NCT05593445|80683870|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
27685806|NCT05593445|80683871|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
27685807|NCT05593445|80683872|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
27685808|NCT05593445|80683873|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
27685809|NCT05593445|80683870|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
27685810|NCT05593445|80683871|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
27685811|NCT05593445|80683872|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
27685812|NCT05593445|80683873|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
27685813|NCT05593445|80683870|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27685814|NCT05593445|80683871|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27685815|NCT05593445|80683872|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
27685816|NCT05593445|80683873|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27685817|NCT02576587|80683874|FG000|Baseline|Equipment failure|0|||
27875458|NCT03850483|81375438|FG009|Follow-up For Stage 2|Other|1|||
27875459|NCT03194542|81375439|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
27875460|NCT03194542|81375440|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
27875461|NCT03194542|81375441|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
27875462|NCT03194542|81375442|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
27875463|NCT03194542|81375439|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
27875464|NCT03194542|81375440|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
27875465|NCT03194542|81375441|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
27685818|NCT02576587|80683875|FG001|Baseline|Equipment failure|1|||
27685819|NCT02576587|80683874|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
27685820|NCT02576587|80683875|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
27685821|NCT02576587|80683874|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
27875466|NCT03194542|81375442|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
27875467|NCT03194542|81375439|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
27875468|NCT03194542|81375440|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
28007689|NCT02016781|81859620|FG000|Final Database Lock|Missing data|0|||
27685822|NCT02576587|80683875|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
27685823|NCT02576587|80683874|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
27685824|NCT02576587|80683875|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
27685825|NCT02236988|80683888|FG000|Overall Study|Lost to Follow-up|0|||
27875469|NCT03194542|81375441|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
27875470|NCT03194542|81375442|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
27875471|NCT03194542|81375439|FG000|Overall Study|Loss of Response|4|||
27875472|NCT03194542|81375440|FG001|Overall Study|Loss of Response|2|||
27875473|NCT03194542|81375441|FG002|Overall Study|Loss of Response|3|||
27875474|NCT03194542|81375442|FG003|Overall Study|Loss of Response|4|||
27685826|NCT02236988|80683889|FG001|Overall Study|Lost to Follow-up|0|||
27685827|NCT02236988|80683890|FG002|Overall Study|Lost to Follow-up|0|||
27685828|NCT02236988|80683891|FG003|Overall Study|Lost to Follow-up|1|||
27685829|NCT02236988|80683888|FG000|Overall Study|Unable to Comply with Study Visits|0|||
27685830|NCT02236988|80683889|FG001|Overall Study|Unable to Comply with Study Visits|0|||
27685831|NCT02236988|80683890|FG002|Overall Study|Unable to Comply with Study Visits|0|||
27685832|NCT02236988|80683891|FG003|Overall Study|Unable to Comply with Study Visits|2|||
27685833|NCT00998790|80683892|FG000|Overall Study|Withdrawal by Subject|21|||
27685834|NCT04540887|80687496|FG000|Overall Study|Withdrawal by Subject|2|||
27685835|NCT03500159|80687505|FG000|Overall Study|Study Terminated|2|||
27685836|NCT03500159|80687506|FG001|Overall Study|Study Terminated|1|||
27685837|NCT02053792|80687507|FG000|Overall Study|Physician Decision|0|||
27685838|NCT02053792|80687508|FG001|Overall Study|Physician Decision|1|||
27685839|NCT02053792|80687507|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
27685840|NCT02053792|80687508|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
27685841|NCT02053792|80687507|FG000|Overall Study|Lack of Efficacy|1|||
27685842|NCT02053792|80687508|FG001|Overall Study|Lack of Efficacy|0|||
27685843|NCT02053792|80687507|FG000|Overall Study|Adverse Event|1|||
27685844|NCT02053792|80687508|FG001|Overall Study|Adverse Event|0|||
27685845|NCT02053792|80687507|FG000|Overall Study|Withdrawal by Subject|2|||
27685846|NCT02053792|80687508|FG001|Overall Study|Withdrawal by Subject|2|||
27685847|NCT02053792|80687507|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
27685848|NCT02053792|80687508|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
27685849|NCT02053792|80687507|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
27685850|NCT02053792|80687508|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
27685851|NCT00287690|80687510|FG000|Overall Study|Protocol Violation|20|||
27685852|NCT00287690|80687511|FG001|Overall Study|Protocol Violation|26|||
27685853|NCT03053518|80687513|FG000|Overall Study|Withdrawal by Subject|3|||
27685854|NCT03053518|80687513|FG000|Overall Study|Lost to Follow-up|2|||
27685855|NCT03053518|80687513|FG000|Overall Study|Ineligible|5|||
27685856|NCT01151410|80687514|FG000|Overall Study|Withdrawal by Subject|3|||
27685857|NCT01151410|80687515|FG001|Overall Study|Withdrawal by Subject|5|||
27685858|NCT01151410|80687514|FG000|Overall Study|Lost to Follow-up|3|||
28007690|NCT02016781|81859621|FG001|Final Database Lock|Missing data|3|||
28007691|NCT02340026|81859626|FG000|Treatment Phase|Withdrawal by Subject|2|||
28007692|NCT02340026|81859627|FG001|Treatment Phase|Withdrawal by Subject|2|||
28007693|NCT02340026|81859626|FG000|Follow-up Phase|Lost to Follow-up|1|||
28007694|NCT02340026|81859627|FG001|Follow-up Phase|Lost to Follow-up|0|||
28007695|NCT05121766|81859629|FG000|Overall Study|Covid reinfection|3|||
28007696|NCT05121766|81859630|FG001|Overall Study|Covid reinfection|0|||
28007697|NCT05121766|81859629|FG000|Overall Study|Withdrawal by Subject|3|||
27685859|NCT01151410|80687515|FG001|Overall Study|Lost to Follow-up|4|||
27685860|NCT01151410|80687514|FG000|Overall Study|Adverse Event|1|||
27685861|NCT01151410|80687515|FG001|Overall Study|Adverse Event|2|||
27685862|NCT01151410|80687514|FG000|Overall Study|Protocol deviation|2|||
27685863|NCT01151410|80687515|FG001|Overall Study|Protocol deviation|1|||
27685864|NCT01151410|80687514|FG000|Overall Study|Administrative problems|1|||
27685865|NCT01151410|80687515|FG001|Overall Study|Administrative problems|1|||
27685866|NCT01151410|80687514|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27685867|NCT01151410|80687515|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27685868|NCT01151410|80687514|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27685869|NCT01151410|80687515|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27685870|NCT03582943|80687518|FG000|Allocated to Groups|Withdrawal by Subject|1|||
27685871|NCT03582943|80687519|FG001|Allocated to Groups|Withdrawal by Subject|1|||
27685872|NCT03582943|80687518|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
27875475|NCT03194542|81375439|FG000|Overall Study|Physician Decision|0|||
27875476|NCT03194542|81375440|FG001|Overall Study|Physician Decision|1|||
27685873|NCT03582943|80687519|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
27685874|NCT03582943|80687518|FG000|Analyzed|Protocol Violation|4|||
27685875|NCT03582943|80687519|FG001|Analyzed|Protocol Violation|1|||
27875477|NCT03194542|81375441|FG002|Overall Study|Physician Decision|0|||
27875478|NCT03194542|81375442|FG003|Overall Study|Physician Decision|0|||
27875479|NCT03194542|81375439|FG000|Overall Study|Lack of Efficacy|2|||
28007698|NCT05121766|81859630|FG001|Overall Study|Withdrawal by Subject|1|||
27685876|NCT03889704|80687520|FG000|Overall Study|Study terminated due to pandemic|1|||
27875480|NCT03194542|81375440|FG001|Overall Study|Lack of Efficacy|2|||
27875481|NCT03194542|81375441|FG002|Overall Study|Lack of Efficacy|2|||
27685877|NCT01346475|80687521|FG000|First Intervention|Lost to Follow-up|4|||
27685878|NCT01346475|80687522|FG001|First Intervention|Lost to Follow-up|3|||
27685879|NCT04313608|80687523|FG000|Overall Study|Death|12|||
27685880|NCT04313608|80687524|FG001|Overall Study|Death|3|||
27685881|NCT04165031|80687528|FG000|Overall Study|Adverse Event|1|||
27685882|NCT04165031|80687529|FG001|Overall Study|Adverse Event|1|||
27685883|NCT04165031|80687530|FG002|Overall Study|Adverse Event|0|||
27685884|NCT04165031|80687531|FG003|Overall Study|Adverse Event|0|||
27685885|NCT04165031|80687532|FG004|Overall Study|Adverse Event|0|||
27685886|NCT04165031|80687533|FG005|Overall Study|Adverse Event|0|||
27685887|NCT04165031|80687528|FG000|Overall Study|Withdrawal by Subject|0|||
27685888|NCT04165031|80687529|FG001|Overall Study|Withdrawal by Subject|0|||
27685889|NCT04165031|80687530|FG002|Overall Study|Withdrawal by Subject|1|||
27685890|NCT04165031|80687531|FG003|Overall Study|Withdrawal by Subject|0|||
27685891|NCT04165031|80687532|FG004|Overall Study|Withdrawal by Subject|0|||
27685892|NCT04165031|80687533|FG005|Overall Study|Withdrawal by Subject|0|||
27685893|NCT00446043|80687536|FG000|Overall Study|Adverse Event|9|||
27685894|NCT00446043|80687536|FG000|Overall Study|Withdrawal by Subject|70|||
27685895|NCT00446043|80687536|FG000|Overall Study|Protocol Violation|2|||
27685896|NCT00446043|80687536|FG000|Overall Study|Lost to Follow-up|42|||
27685897|NCT00446043|80687536|FG000|Overall Study|Pregnancy|2|||
27685898|NCT01081132|80687538|FG000|Overall Study|Lack of Efficacy|25|||
27685899|NCT01081132|80687539|FG001|Overall Study|Lack of Efficacy|9|||
27685900|NCT01081132|80687538|FG000|Overall Study|Withdrawal by Subject|13|||
27685901|NCT01081132|80687539|FG001|Overall Study|Withdrawal by Subject|16|||
27685902|NCT01081132|80687538|FG000|Overall Study|Lost to Follow-up|4|||
27685903|NCT01081132|80687539|FG001|Overall Study|Lost to Follow-up|11|||
27685904|NCT01081132|80687538|FG000|Overall Study|Adverse Event|3|||
27685905|NCT01081132|80687539|FG001|Overall Study|Adverse Event|9|||
27685906|NCT01081132|80687538|FG000|Overall Study|Non Compliance|4|||
27685907|NCT01081132|80687539|FG001|Overall Study|Non Compliance|2|||
27685908|NCT01081132|80687538|FG000|Overall Study|Lack Of Compliance|0|||
27685909|NCT01081132|80687539|FG001|Overall Study|Lack Of Compliance|1|||
27685910|NCT01081132|80687538|FG000|Overall Study|Missed Visits|1|||
27685911|NCT01081132|80687539|FG001|Overall Study|Missed Visits|1|||
27685912|NCT01081132|80687538|FG000|Overall Study|Stopped Taking Meds|2|||
27685913|NCT01081132|80687539|FG001|Overall Study|Stopped Taking Meds|0|||
27685914|NCT01081132|80687538|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
27685915|NCT01081132|80687539|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
27685916|NCT01081132|80687538|FG000|Overall Study|Declined Taper Phase|0|||
27685917|NCT01081132|80687539|FG001|Overall Study|Declined Taper Phase|1|||
27685918|NCT01081132|80687538|FG000|Overall Study|Protocol Violation|3|||
27685919|NCT01081132|80687539|FG001|Overall Study|Protocol Violation|1|||
27685920|NCT02549196|80687541|FG000|Overall Study|Protocol Violation|0|||
27875482|NCT03194542|81375442|FG003|Overall Study|Lack of Efficacy|6|||
27875483|NCT03194542|81375439|FG000|Overall Study|Withdrawal by Subject|2|||
27875484|NCT03194542|81375440|FG001|Overall Study|Withdrawal by Subject|1|||
27875485|NCT03194542|81375441|FG002|Overall Study|Withdrawal by Subject|5|||
27875486|NCT03194542|81375442|FG003|Overall Study|Withdrawal by Subject|4|||
27875487|NCT03194542|81375439|FG000|Overall Study|Progressive Disease|1|||
27875488|NCT03194542|81375440|FG001|Overall Study|Progressive Disease|0|||
27685921|NCT02549196|80687542|FG001|Overall Study|Protocol Violation|0|||
27685922|NCT02549196|80687543|FG002|Overall Study|Protocol Violation|0|||
27685923|NCT02549196|80687544|FG003|Overall Study|Protocol Violation|1|||
27685924|NCT02549196|80687541|FG000|Overall Study|Withdrawal by Subject|1|||
27685925|NCT02549196|80687542|FG001|Overall Study|Withdrawal by Subject|0|||
27685926|NCT02549196|80687543|FG002|Overall Study|Withdrawal by Subject|1|||
27685927|NCT02549196|80687544|FG003|Overall Study|Withdrawal by Subject|0|||
27685928|NCT03020576|80687545|FG000|Overall Study|Withdrawal by Subject|1|||
27685929|NCT03020576|80687546|FG001|Overall Study|Withdrawal by Subject|2|||
27685930|NCT01639560|80687547|FG000|Overall Study|Withdrawal by Subject|9|||
27685931|NCT01639560|80687548|FG001|Overall Study|Withdrawal by Subject|14|||
27685932|NCT01639560|80687547|FG000|Overall Study|Lack of Efficacy|1|||
27685933|NCT01639560|80687548|FG001|Overall Study|Lack of Efficacy|2|||
27685934|NCT01639560|80687547|FG000|Overall Study|Lost to Follow-up|9|||
27685935|NCT01639560|80687548|FG001|Overall Study|Lost to Follow-up|11|||
27875489|NCT03194542|81375441|FG002|Overall Study|Progressive Disease|1|||
27685936|NCT01639560|80687547|FG000|Overall Study|Adverse Event|0|||
27875490|NCT03194542|81375442|FG003|Overall Study|Progressive Disease|1|||
27875491|NCT03194542|81375439|FG000|Overall Study|Adverse Event|1|||
27875492|NCT03194542|81375440|FG001|Overall Study|Adverse Event|2|||
27685937|NCT01639560|80687548|FG001|Overall Study|Adverse Event|2|||
27685938|NCT03001076|80687558|FG000|Overall Study|Withdrawal by patient|2|||
27685939|NCT03001076|80687559|FG001|Overall Study|Withdrawal by patient|0|||
27685940|NCT03001076|80687558|FG000|Overall Study|Other|1|||
27685941|NCT03001076|80687559|FG001|Overall Study|Other|0|||
27685942|NCT03001076|80687558|FG000|Overall Study|Adverse Event|3|||
27685943|NCT03001076|80687559|FG001|Overall Study|Adverse Event|3|||
27875493|NCT03194542|81375441|FG002|Overall Study|Adverse Event|0|||
27875494|NCT03194542|81375442|FG003|Overall Study|Adverse Event|5|||
27875495|NCT03194542|81375439|FG000|Overall Study|Death|1|||
27875496|NCT03194542|81375440|FG001|Overall Study|Death|2|||
27875497|NCT03194542|81375441|FG002|Overall Study|Death|0|||
27875498|NCT03194542|81375442|FG003|Overall Study|Death|5|||
27685944|NCT03001076|80687558|FG000|Overall Study|Sponsor decision|1|||
27685945|NCT03001076|80687559|FG001|Overall Study|Sponsor decision|0|||
27685946|NCT03001076|80687558|FG000|Overall Study|Lost to Follow-up|0|||
27811268|NCT00329602|81137635|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
27875499|NCT03194542|81375439|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
27875500|NCT03194542|81375440|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
27875501|NCT03194542|81375441|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
27875502|NCT03194542|81375442|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
27875503|NCT01530464|81375447|FG000|Washout (24h)|Withdrawal by Subject|1|||
27875504|NCT01530464|81375448|FG001|Washout (24h)|Withdrawal by Subject|0|||
27811269|NCT00329602|81137636|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
27811270|NCT00329602|81137637|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
27811271|NCT00329602|81137635|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
27811272|NCT00329602|81137636|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
27811273|NCT00329602|81137637|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
27811274|NCT00329602|81137635|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
27811275|NCT00329602|81137636|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
27811276|NCT00329602|81137637|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
27811277|NCT00329602|81137635|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
27811278|NCT00329602|81137636|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
27811279|NCT00329602|81137637|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
27811280|NCT00566709|81137640|FG000|Overall Study|Protocol Violation|5|||
27811281|NCT00566709|81137641|FG001|Overall Study|Protocol Violation|0|||
27811282|NCT00524459|81137642|FG000|Overall Study|Withdrawal by Subject|1|||
27811283|NCT00524459|81137642|FG000|Overall Study|Other|1|||
27811284|NCT03093454|81137643|FG000|Overall Study|Withdrawal by Subject|1|||
27811285|NCT03093454|81137644|FG001|Overall Study|Withdrawal by Subject|1|||
27811286|NCT03093454|81137643|FG000|Overall Study|Scheduling conflict|3|||
27811287|NCT03093454|81137644|FG001|Overall Study|Scheduling conflict|1|||
27811288|NCT03093454|81137643|FG000|Overall Study|Physician Decision|2|||
27811289|NCT03093454|81137644|FG001|Overall Study|Physician Decision|1|||
27811290|NCT02736227|81137646|FG000|Overall Study|Withdrawal by Subject|0|||
27811291|NCT02736227|81137647|FG001|Overall Study|Withdrawal by Subject|0|||
27811292|NCT02736227|81137648|FG002|Overall Study|Withdrawal by Subject|1|||
27811293|NCT02736227|81137646|FG000|Overall Study|Physician Decision|0|||
27811294|NCT02736227|81137647|FG001|Overall Study|Physician Decision|0|||
27811295|NCT02736227|81137648|FG002|Overall Study|Physician Decision|5|||
27811296|NCT02736227|81137646|FG000|Overall Study|Non Compliant|0|||
27811297|NCT02736227|81137647|FG001|Overall Study|Non Compliant|0|||
27811298|NCT02736227|81137648|FG002|Overall Study|Non Compliant|2|||
27811299|NCT02322879|81137651|FG000|First Intervention|Physician Decision|1|||
27811300|NCT02322879|81137652|FG001|First Intervention|Physician Decision|0|||
27811301|NCT02419313|81137653|FG000|First Intervention|Lost to Follow-up|2|||
27811302|NCT02419313|81137654|FG001|First Intervention|Lost to Follow-up|0|||
27811303|NCT02419313|81137653|FG000|Second Intervention|Lost to Follow-up|1|||
27811304|NCT02419313|81137654|FG001|Second Intervention|Lost to Follow-up|0|||
27811305|NCT05751629|81141067|FG000|Overall Study|Withdrawal by Subject|6|||
27811306|NCT05751629|81141067|FG000|Overall Study|Death|25|||
27811307|NCT05751629|81141067|FG000|Overall Study|Study Site Closed|9|||
27811308|NCT05751629|81141067|FG000|Overall Study|Physician Decision|1|||
27811309|NCT01890707|81141068|FG000|Overall Study|Lost to Follow-up|1|||
27811310|NCT01890707|81141069|FG001|Overall Study|Lost to Follow-up|1|||
27811311|NCT00275028|81141070|FG000|Overall Study|Withdrew consent before treatment began|1|||
27811312|NCT00275028|81141070|FG000|Overall Study|Withdrawal by Subject|5|||
27875505|NCT01530464|81375447|FG000|Washout (24h)|Withdrawal by Subject|0|||
27875506|NCT01530464|81375448|FG001|Washout (24h)|Withdrawal by Subject|1|||
27875507|NCT00697463|81375453|FG000|Overall Study|Withdrawal by Subject|1|||
27875508|NCT00287586|81375463|FG000|Overall Study|Withdrew Consent|19|||
27875509|NCT00287586|81375464|FG001|Overall Study|Withdrew Consent|30|||
27875510|NCT00287586|81375463|FG000|Overall Study|Lost to Follow-up|5|||
27811313|NCT00275028|81141070|FG000|Overall Study|Adverse Event|9|||
27875511|NCT00287586|81375464|FG001|Overall Study|Lost to Follow-up|4|||
28007699|NCT05121766|81859629|FG000|Overall Study|Adverse Event|2|||
27685947|NCT03001076|80687559|FG001|Overall Study|Lost to Follow-up|2|||
27811314|NCT00275028|81141070|FG000|Overall Study|Progressive Disease|30|||
27811315|NCT00275028|81141070|FG000|Overall Study|Physician Decision|2|||
27811316|NCT01751412|81141073|FG000|Overall Study|Disease Progression Before Treatment|1|||
27811317|NCT05216978|81141075|FG000|Overall Study|Withdrawal by Subject|3|||
27811318|NCT05216978|81141075|FG000|Overall Study|Lost to Follow-up|5|||
28007700|NCT05121766|81859630|FG001|Overall Study|Adverse Event|4|||
27811319|NCT00859469|81141076|FG000|Overall Study|Adverse Event|2|||
27811320|NCT00859469|81141076|FG000|Overall Study|Lack of Efficacy|9|||
27811321|NCT00859469|81141076|FG000|Overall Study|Withdrawal by Subject|1|||
27811322|NCT00859469|81141076|FG000|Overall Study|Death|16|||
27811323|NCT00598559|81141077|FG000|Overall Study|Adverse Event|11|||
27811324|NCT00598559|81141078|FG001|Overall Study|Adverse Event|7|||
27811325|NCT00598559|81141079|FG002|Overall Study|Adverse Event|0|||
27811326|NCT00598559|81141077|FG000|Overall Study|Withdrawal by Subject|2|||
27811327|NCT00598559|81141078|FG001|Overall Study|Withdrawal by Subject|2|||
27811328|NCT00598559|81141079|FG002|Overall Study|Withdrawal by Subject|0|||
27811329|NCT00598559|81141077|FG000|Overall Study|Protocol Non-compliance|1|||
27811330|NCT00598559|81141078|FG001|Overall Study|Protocol Non-compliance|0|||
28007701|NCT05121766|81859629|FG000|Overall Study|Lost to Follow-up|0|||
28007702|NCT05121766|81859630|FG001|Overall Study|Lost to Follow-up|1|||
27811331|NCT00598559|81141079|FG002|Overall Study|Protocol Non-compliance|0|||
28007703|NCT02529852|81859633|FG000|Overall Study|Withdrawal by Subject|2|||
28007704|NCT00524485|81859634|FG000|Overall Study|Withdrawal by Subject|5|||
27586963|NCT02014116|80328471|FG003|Overall Study|Adverse Event|0|||
27586964|NCT02014116|80328472|FG004|Overall Study|Adverse Event|1|||
27586965|NCT02014116|80328473|FG005|Overall Study|Adverse Event|0|||
27586966|NCT02014116|80328474|FG006|Overall Study|Adverse Event|0|||
27586967|NCT02014116|80328475|FG007|Overall Study|Adverse Event|1|||
27586968|NCT02014116|80328476|FG008|Overall Study|Adverse Event|0|||
27586969|NCT02014116|80328468|FG000|Overall Study|Lost to Follow-up|0|||
27586970|NCT02014116|80328469|FG001|Overall Study|Lost to Follow-up|0|||
27586971|NCT02014116|80328470|FG002|Overall Study|Lost to Follow-up|0|||
27586972|NCT02014116|80328471|FG003|Overall Study|Lost to Follow-up|0|||
27586973|NCT02014116|80328472|FG004|Overall Study|Lost to Follow-up|0|||
27586974|NCT02014116|80328473|FG005|Overall Study|Lost to Follow-up|1|||
27586975|NCT02014116|80328474|FG006|Overall Study|Lost to Follow-up|0|||
27586976|NCT02014116|80328475|FG007|Overall Study|Lost to Follow-up|0|||
27586977|NCT02014116|80328476|FG008|Overall Study|Lost to Follow-up|1|||
27586978|NCT02014116|80328468|FG000|Overall Study|Death|0|||
27586979|NCT02014116|80328469|FG001|Overall Study|Death|0|||
27586980|NCT02014116|80328470|FG002|Overall Study|Death|0|||
27586981|NCT02014116|80328471|FG003|Overall Study|Death|0|||
27586982|NCT02014116|80328472|FG004|Overall Study|Death|0|||
27586983|NCT02014116|80328473|FG005|Overall Study|Death|0|||
27586984|NCT02014116|80328474|FG006|Overall Study|Death|0|||
27586985|NCT02014116|80328475|FG007|Overall Study|Death|1|||
27586986|NCT02014116|80328476|FG008|Overall Study|Death|1|||
27685948|NCT03527550|80687560|FG000|Overall Study|Lost to Follow-up|4|||
27685949|NCT03527550|80687561|FG001|Overall Study|Lost to Follow-up|2|||
27685950|NCT03527550|80687560|FG000|Overall Study|Withdrawal by Subject|4|||
27685951|NCT03527550|80687561|FG001|Overall Study|Withdrawal by Subject|1|||
27685952|NCT03527550|80687560|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
27685953|NCT03527550|80687561|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
27685954|NCT01901432|80687562|FG000|Overall Study|Adverse Event|0|||
27685955|NCT01901432|80687563|FG001|Overall Study|Adverse Event|1|||
27685956|NCT01901432|80687564|FG002|Overall Study|Adverse Event|1|||
27685957|NCT01901432|80687565|FG003|Overall Study|Adverse Event|0|||
27685958|NCT01901432|80687566|FG004|Overall Study|Adverse Event|1|||
27685959|NCT01901432|80687562|FG000|Overall Study|Withdrawal by Subject|0|||
27685960|NCT01901432|80687563|FG001|Overall Study|Withdrawal by Subject|0|||
27685961|NCT01901432|80687564|FG002|Overall Study|Withdrawal by Subject|1|||
27685962|NCT01901432|80687565|FG003|Overall Study|Withdrawal by Subject|0|||
27685963|NCT01901432|80687566|FG004|Overall Study|Withdrawal by Subject|5|||
27685964|NCT01901432|80687562|FG000|Overall Study|Physician Decision|0|||
27685965|NCT01901432|80687563|FG001|Overall Study|Physician Decision|0|||
27685966|NCT01901432|80687564|FG002|Overall Study|Physician Decision|0|||
27685967|NCT01901432|80687565|FG003|Overall Study|Physician Decision|0|||
27685968|NCT01901432|80687566|FG004|Overall Study|Physician Decision|2|||
27586987|NCT02014116|80328468|FG000|Overall Study|Withdrawal by Subject|0|||
27586988|NCT02014116|80328469|FG001|Overall Study|Withdrawal by Subject|0|||
27685969|NCT01901432|80687562|FG000|Overall Study|Patient decision to stop study drug|0|||
27685970|NCT01901432|80687563|FG001|Overall Study|Patient decision to stop study drug|0|||
27685971|NCT01901432|80687564|FG002|Overall Study|Patient decision to stop study drug|0|||
27586989|NCT02014116|80328470|FG002|Overall Study|Withdrawal by Subject|1|||
27586990|NCT02014116|80328471|FG003|Overall Study|Withdrawal by Subject|1|||
27685972|NCT01901432|80687565|FG003|Overall Study|Patient decision to stop study drug|0|||
27685973|NCT01901432|80687566|FG004|Overall Study|Patient decision to stop study drug|1|||
27811332|NCT00598559|81141077|FG000|Overall Study|Early discharge from hospital|9|||
27875512|NCT00287586|81375463|FG000|Overall Study|Death|2|||
27586991|NCT02014116|80328472|FG004|Overall Study|Withdrawal by Subject|0|||
27586992|NCT02014116|80328473|FG005|Overall Study|Withdrawal by Subject|1|||
27586993|NCT02014116|80328474|FG006|Overall Study|Withdrawal by Subject|0|||
27586994|NCT02014116|80328475|FG007|Overall Study|Withdrawal by Subject|0|||
27586995|NCT02014116|80328476|FG008|Overall Study|Withdrawal by Subject|0|||
27586996|NCT02014116|80328468|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
27586997|NCT02014116|80328469|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
27586998|NCT02014116|80328470|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
27586999|NCT02014116|80328471|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
27587000|NCT02014116|80328472|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
27587001|NCT02014116|80328473|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
27587002|NCT02014116|80328474|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
27587003|NCT02014116|80328475|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
27587004|NCT02014116|80328476|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
27587005|NCT02014116|80328468|FG000|Overall Study|Physician Decision|0|||
27587006|NCT02014116|80328469|FG001|Overall Study|Physician Decision|0|||
27587007|NCT02014116|80328470|FG002|Overall Study|Physician Decision|0|||
27587008|NCT02014116|80328471|FG003|Overall Study|Physician Decision|0|||
27587009|NCT02014116|80328472|FG004|Overall Study|Physician Decision|0|||
27587010|NCT02014116|80328473|FG005|Overall Study|Physician Decision|0|||
27587011|NCT02014116|80328474|FG006|Overall Study|Physician Decision|0|||
27587012|NCT02014116|80328475|FG007|Overall Study|Physician Decision|0|||
27587013|NCT02014116|80328476|FG008|Overall Study|Physician Decision|1|||
27587014|NCT02571452|80328477|FG000|Overall Study Treatment|Protocol Violation|0|||
27587015|NCT02571452|80328478|FG001|Overall Study Treatment|Protocol Violation|1|||
27587016|NCT02571452|80328477|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
27587017|NCT02571452|80328478|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
27587018|NCT02571452|80328477|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
27587019|NCT02571452|80328478|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
27587020|NCT03305016|80328481|FG000|Overall Study|Withdrawal by Subject|2|||
27587021|NCT03449030|80328482|FG000|Overall Study|Withdrawal by Subject|0|||
27587022|NCT03449030|80328483|FG001|Overall Study|Withdrawal by Subject|0|||
27587023|NCT03449030|80328484|FG002|Overall Study|Withdrawal by Subject|0|||
27587024|NCT03449030|80328485|FG003|Overall Study|Withdrawal by Subject|1|||
27587025|NCT03449030|80328486|FG004|Overall Study|Withdrawal by Subject|1|||
27587026|NCT03449030|80328487|FG005|Overall Study|Withdrawal by Subject|1|||
27587027|NCT03449030|80328488|FG006|Overall Study|Withdrawal by Subject|1|||
27587028|NCT03449030|80328489|FG007|Overall Study|Withdrawal by Subject|2|||
27587029|NCT03449030|80328490|FG008|Overall Study|Withdrawal by Subject|0|||
27587030|NCT03449030|80328491|FG009|Overall Study|Withdrawal by Subject|0|||
27587031|NCT03449030|80328482|FG000|Overall Study|Symptomatic Deterioration|0|||
27587032|NCT03449030|80328483|FG001|Overall Study|Symptomatic Deterioration|1|||
27587033|NCT03449030|80328484|FG002|Overall Study|Symptomatic Deterioration|0|||
27587034|NCT03449030|80328485|FG003|Overall Study|Symptomatic Deterioration|0|||
27587035|NCT03449030|80328486|FG004|Overall Study|Symptomatic Deterioration|0|||
27587036|NCT03449030|80328487|FG005|Overall Study|Symptomatic Deterioration|1|||
27587037|NCT03449030|80328488|FG006|Overall Study|Symptomatic Deterioration|1|||
27587038|NCT03449030|80328489|FG007|Overall Study|Symptomatic Deterioration|0|||
27587039|NCT03449030|80328490|FG008|Overall Study|Symptomatic Deterioration|2|||
27587040|NCT03449030|80328491|FG009|Overall Study|Symptomatic Deterioration|0|||
27587041|NCT03449030|80328482|FG000|Overall Study|Progressive Disease|1|||
27587042|NCT03449030|80328483|FG001|Overall Study|Progressive Disease|0|||
27587043|NCT03449030|80328484|FG002|Overall Study|Progressive Disease|1|||
27587044|NCT03449030|80328485|FG003|Overall Study|Progressive Disease|4|||
27587045|NCT03449030|80328486|FG004|Overall Study|Progressive Disease|5|||
27587046|NCT03449030|80328487|FG005|Overall Study|Progressive Disease|3|||
28007705|NCT01064440|81859635|FG000|Overall Study|Lost to Follow-up|1|||
28007706|NCT01064440|81859636|FG001|Overall Study|Lost to Follow-up|1|||
28007707|NCT01064440|81859637|FG002|Overall Study|Lost to Follow-up|1|||
28007708|NCT01064440|81859635|FG000|Overall Study|Non-compliance|0|||
28007709|NCT01064440|81859636|FG001|Overall Study|Non-compliance|1|||
28007710|NCT01064440|81859637|FG002|Overall Study|Non-compliance|0|||
28007711|NCT01064440|81859635|FG000|Overall Study|Death|1|||
28007712|NCT01064440|81859636|FG001|Overall Study|Death|0|||
28007713|NCT01064440|81859637|FG002|Overall Study|Death|1|||
28007714|NCT01064440|81859635|FG000|Overall Study|Withdrawal by Subject|0|||
28007715|NCT01064440|81859636|FG001|Overall Study|Withdrawal by Subject|1|||
28007716|NCT01064440|81859637|FG002|Overall Study|Withdrawal by Subject|1|||
28007717|NCT01064440|81859635|FG000|Overall Study|Other: amputation|1|||
28007718|NCT01064440|81859636|FG001|Overall Study|Other: amputation|0|||
27587047|NCT03449030|80328488|FG006|Overall Study|Progressive Disease|0|||
27587048|NCT03449030|80328489|FG007|Overall Study|Progressive Disease|1|||
27587049|NCT03449030|80328490|FG008|Overall Study|Progressive Disease|1|||
27587050|NCT03449030|80328491|FG009|Overall Study|Progressive Disease|1|||
27587051|NCT03449030|80328482|FG000|Overall Study|Adverse Event|0|||
27587052|NCT03449030|80328483|FG001|Overall Study|Adverse Event|0|||
27587053|NCT03449030|80328484|FG002|Overall Study|Adverse Event|0|||
27587054|NCT03449030|80328485|FG003|Overall Study|Adverse Event|0|||
28007719|NCT01064440|81859637|FG002|Overall Study|Other: amputation|0|||
27587055|NCT03449030|80328486|FG004|Overall Study|Adverse Event|0|||
27587056|NCT03449030|80328487|FG005|Overall Study|Adverse Event|2|||
27587057|NCT03449030|80328488|FG006|Overall Study|Adverse Event|0|||
27587058|NCT03449030|80328489|FG007|Overall Study|Adverse Event|0|||
27587059|NCT03449030|80328490|FG008|Overall Study|Adverse Event|0|||
27587060|NCT03449030|80328491|FG009|Overall Study|Adverse Event|0|||
27587061|NCT03449030|80328482|FG000|Overall Study|Death|0|||
27587062|NCT03449030|80328483|FG001|Overall Study|Death|0|||
27587063|NCT03449030|80328484|FG002|Overall Study|Death|0|||
27587064|NCT03449030|80328485|FG003|Overall Study|Death|0|||
27587065|NCT03449030|80328486|FG004|Overall Study|Death|1|||
27587066|NCT03449030|80328487|FG005|Overall Study|Death|0|||
27587067|NCT03449030|80328488|FG006|Overall Study|Death|0|||
27587068|NCT03449030|80328489|FG007|Overall Study|Death|0|||
27587069|NCT03449030|80328490|FG008|Overall Study|Death|0|||
27587070|NCT03449030|80328491|FG009|Overall Study|Death|0|||
27587071|NCT03646513|80331617|FG000|Overall Study|Premature study termination|4|||
27587072|NCT02828111|80331621|FG000|Overall Study|Withdrawal by Subject|0|||
27587073|NCT02828111|80331622|FG001|Overall Study|Withdrawal by Subject|0|||
27587074|NCT02828111|80331623|FG002|Overall Study|Withdrawal by Subject|2|||
27587075|NCT02828111|80331624|FG003|Overall Study|Withdrawal by Subject|0|||
27587076|NCT02828111|80331625|FG004|Overall Study|Withdrawal by Subject|0|||
27587077|NCT02828111|80331621|FG000|Overall Study|Lost to Follow-up|0|||
27587078|NCT02828111|80331622|FG001|Overall Study|Lost to Follow-up|0|||
27587079|NCT02828111|80331623|FG002|Overall Study|Lost to Follow-up|0|||
27587080|NCT02828111|80331624|FG003|Overall Study|Lost to Follow-up|1|||
27587081|NCT02828111|80331625|FG004|Overall Study|Lost to Follow-up|1|||
27587082|NCT00524134|80331630|FG000|Overall Study|Withdrawal by Subject|1|||
27587083|NCT00524134|80331630|FG000|Overall Study|Physician Decision|1|||
27587084|NCT02601313|80331634|FG000|Overall Study|Death|2|||
27587085|NCT02601313|80331635|FG001|Overall Study|Death|16|||
27587086|NCT02601313|80331636|FG002|Overall Study|Death|4|||
27587087|NCT02601313|80331634|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
27587088|NCT02601313|80331635|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
27587089|NCT02601313|80331636|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
27587090|NCT02601313|80331634|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
27587091|NCT02601313|80331635|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
27587092|NCT02601313|80331636|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
27587093|NCT02601313|80331634|FG000|Overall Study|Still on study|0|||
27587094|NCT02601313|80331635|FG001|Overall Study|Still on study|52|||
27587095|NCT02601313|80331636|FG002|Overall Study|Still on study|10|||
27587096|NCT02601313|80331634|FG000|Overall Study|Enrolled, did not initiate AC|4|||
27587097|NCT02601313|80331635|FG001|Overall Study|Enrolled, did not initiate AC|0|||
27587098|NCT02601313|80331636|FG002|Overall Study|Enrolled, did not initiate AC|0|||
27587099|NCT01308749|80331637|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
27587100|NCT01308749|80331638|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
27587101|NCT01308749|80331637|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
27587102|NCT01308749|80331638|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
27587103|NCT01308749|80331637|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
27587104|NCT01308749|80331638|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
27587105|NCT01076400|80331639|FG000|Overall Study|Adverse Event|2|||
27587106|NCT01076400|80331640|FG001|Overall Study|Adverse Event|0|||
27587107|NCT01076400|80331641|FG002|Overall Study|Adverse Event|0|||
27587108|NCT01076400|80331639|FG000|Overall Study|Progressive Disease|5|||
27587109|NCT01076400|80331640|FG001|Overall Study|Progressive Disease|0|||
27587110|NCT01076400|80331641|FG002|Overall Study|Progressive Disease|0|||
27587111|NCT01075074|80331644|FG000|Overall Study|Surgeon changed to open incisional case|1|||
27587112|NCT01075074|80331645|FG001|Overall Study|Surgeon changed to open incisional case|2|||
27587113|NCT01075074|80331646|FG002|Overall Study|Surgeon changed to open incisional case|2|||
27811333|NCT00598559|81141078|FG001|Overall Study|Early discharge from hospital|12|||
27587114|NCT03674177|80331663|FG000|Overall Study|Lost to Follow-up|2|||
27587115|NCT03674177|80331664|FG001|Overall Study|Lost to Follow-up|1|||
27587116|NCT03674177|80331665|FG002|Overall Study|Lost to Follow-up|0|||
27587117|NCT03674177|80331666|FG003|Overall Study|Lost to Follow-up|2|||
27587118|NCT04433767|80331669|FG000|Overall Study|Adverse Event|1|||
27587119|NCT01159691|80331670|FG000|Overall Study|Lost to Follow-up|2|||
27587120|NCT01159691|80331670|FG000|Overall Study|Unknown reasons|1|||
27811334|NCT00598559|81141079|FG002|Overall Study|Early discharge from hospital|3|||
27587121|NCT01159691|80331670|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
27587122|NCT01159691|80331670|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
27587123|NCT01159691|80331670|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
27587124|NCT01159691|80331670|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
27587125|NCT01159691|80331670|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
27587126|NCT01159691|80331670|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
27587127|NCT03321981|80331671|FG000|Overall Study|Progressive Disease (PD)|15|||
27587128|NCT03321981|80331672|FG001|Overall Study|Progressive Disease (PD)|30|||
27587129|NCT03321981|80331673|FG002|Overall Study|Progressive Disease (PD)|47|||
27685974|NCT02233543|80687567|FG000|Period 1|Withdrawal by Subject|1|||
27811335|NCT00598559|81141077|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
27811336|NCT00598559|81141078|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
27811337|NCT00598559|81141079|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
27811338|NCT00192296|81141086|FG000|Overall Study|Withdrawal by Subject|0|||
27811339|NCT00192296|81141087|FG001|Overall Study|Withdrawal by Subject|1|||
27811340|NCT00192296|81141088|FG002|Overall Study|Withdrawal by Subject|0|||
27811341|NCT00192296|81141089|FG003|Overall Study|Withdrawal by Subject|0|||
27811342|NCT01533428|81141090|FG000|Overall Study|Adverse Event|0|||
27811343|NCT01533428|81141091|FG001|Overall Study|Adverse Event|1|||
27811344|NCT01533428|81141090|FG000|Overall Study|Lost to Follow-up|2|||
27811345|NCT01533428|81141091|FG001|Overall Study|Lost to Follow-up|1|||
27811346|NCT01533428|81141090|FG000|Overall Study|Withdrawal by Subject|7|||
27811347|NCT01533428|81141091|FG001|Overall Study|Withdrawal by Subject|6|||
27811348|NCT03650400|81141095|FG000|Overall Study|Study terminated by sponsor|0|||
27811349|NCT03650400|81141096|FG001|Overall Study|Study terminated by sponsor|5|||
27811350|NCT01393990|81141101|FG000|Overall Study|Adverse Event|0|||
27811351|NCT01393990|81141102|FG001|Overall Study|Adverse Event|0|||
27811352|NCT01393990|81141103|FG002|Overall Study|Adverse Event|0|||
27811353|NCT01393990|81141104|FG003|Overall Study|Adverse Event|0|||
27811354|NCT01393990|81141105|FG004|Overall Study|Adverse Event|0|||
27811355|NCT01393990|81141106|FG005|Overall Study|Adverse Event|0|||
27811356|NCT01393990|81141107|FG006|Overall Study|Adverse Event|0|||
27811357|NCT01393990|81141108|FG007|Overall Study|Adverse Event|0|||
27811358|NCT01393990|81141109|FG008|Overall Study|Adverse Event|0|||
27811359|NCT01393990|81141110|FG009|Overall Study|Adverse Event|0|||
27811360|NCT01393990|81141111|FG010|Overall Study|Adverse Event|0|||
27811361|NCT01393990|81141112|FG011|Overall Study|Adverse Event|0|||
27811362|NCT01393990|81141113|FG012|Overall Study|Adverse Event|0|||
27811363|NCT01393990|81141114|FG013|Overall Study|Adverse Event|0|||
27811364|NCT01393990|81141115|FG014|Overall Study|Adverse Event|1|||
27811365|NCT01393990|81141116|FG015|Overall Study|Adverse Event|1|||
27811366|NCT01393990|81141117|FG016|Overall Study|Adverse Event|0|||
27811367|NCT01393990|81141118|FG017|Overall Study|Adverse Event|0|||
27811368|NCT01393990|81141101|FG000|Overall Study|Progressive Disease|1|||
27811369|NCT01393990|81141102|FG001|Overall Study|Progressive Disease|0|||
27811370|NCT01393990|81141103|FG002|Overall Study|Progressive Disease|0|||
27811371|NCT01393990|81141104|FG003|Overall Study|Progressive Disease|1|||
27811372|NCT01393990|81141105|FG004|Overall Study|Progressive Disease|1|||
27811373|NCT01393990|81141106|FG005|Overall Study|Progressive Disease|1|||
27811374|NCT01393990|81141107|FG006|Overall Study|Progressive Disease|1|||
27811375|NCT01393990|81141108|FG007|Overall Study|Progressive Disease|1|||
27811376|NCT01393990|81141109|FG008|Overall Study|Progressive Disease|3|||
27811377|NCT01393990|81141110|FG009|Overall Study|Progressive Disease|1|||
27811378|NCT01393990|81141111|FG010|Overall Study|Progressive Disease|0|||
27811379|NCT01393990|81141112|FG011|Overall Study|Progressive Disease|0|||
27811380|NCT01393990|81141113|FG012|Overall Study|Progressive Disease|0|||
27811381|NCT01393990|81141114|FG013|Overall Study|Progressive Disease|1|||
27811382|NCT01393990|81141115|FG014|Overall Study|Progressive Disease|6|||
27811383|NCT01393990|81141116|FG015|Overall Study|Progressive Disease|1|||
27811384|NCT01393990|81141117|FG016|Overall Study|Progressive Disease|0|||
27811385|NCT01393990|81141118|FG017|Overall Study|Progressive Disease|0|||
27811386|NCT01393990|81141101|FG000|Overall Study|Death|0|||
28007720|NCT03661723|81859638|FG000|Overall Study|Disease Progression|4|||
28007721|NCT03661723|81859639|FG001|Overall Study|Disease Progression|24|||
28007722|NCT03661723|81859640|FG002|Overall Study|Disease Progression|4|||
28007723|NCT03661723|81859641|FG003|Overall Study|Disease Progression|19|||
28007724|NCT03661723|81859638|FG000|Overall Study|Withdrawal by Subject|1|||
28007725|NCT03661723|81859639|FG001|Overall Study|Withdrawal by Subject|0|||
28007726|NCT03661723|81859640|FG002|Overall Study|Withdrawal by Subject|2|||
28007727|NCT03661723|81859641|FG003|Overall Study|Withdrawal by Subject|4|||
28007728|NCT03661723|81859638|FG000|Overall Study|Physician Decision|1|||
28007729|NCT03661723|81859639|FG001|Overall Study|Physician Decision|0|||
28007730|NCT03661723|81859640|FG002|Overall Study|Physician Decision|0|||
28007731|NCT03661723|81859641|FG003|Overall Study|Physician Decision|0|||
27811387|NCT01393990|81141102|FG001|Overall Study|Death|0|||
27811388|NCT01393990|81141103|FG002|Overall Study|Death|0|||
27811389|NCT01393990|81141104|FG003|Overall Study|Death|0|||
28007732|NCT03661723|81859638|FG000|Overall Study|Clinical Deterioration|0|||
27587130|NCT03321981|80331671|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
27811390|NCT01393990|81141105|FG004|Overall Study|Death|1|||
27811391|NCT01393990|81141106|FG005|Overall Study|Death|0|||
27811392|NCT01393990|81141107|FG006|Overall Study|Death|0|||
27811393|NCT01393990|81141108|FG007|Overall Study|Death|0|||
27811394|NCT01393990|81141109|FG008|Overall Study|Death|0|||
27811395|NCT01393990|81141110|FG009|Overall Study|Death|0|||
27811396|NCT01393990|81141111|FG010|Overall Study|Death|0|||
27811397|NCT01393990|81141112|FG011|Overall Study|Death|0|||
27811398|NCT01393990|81141113|FG012|Overall Study|Death|0|||
27811399|NCT01393990|81141114|FG013|Overall Study|Death|1|||
28007733|NCT03661723|81859639|FG001|Overall Study|Clinical Deterioration|0|||
27875513|NCT00287586|81375464|FG001|Overall Study|Death|3|||
27875514|NCT00287586|81375463|FG000|Overall Study|Elevated Hematocrit|3|||
27875515|NCT00287586|81375464|FG001|Overall Study|Elevated Hematocrit|0|||
27875516|NCT00287586|81375463|FG000|Overall Study|Rash|3|||
27875517|NCT00287586|81375464|FG001|Overall Study|Rash|0|||
27875518|NCT00287586|81375463|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
27875519|NCT00287586|81375464|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
27875520|NCT00287586|81375463|FG000|Overall Study|Stroke|2|||
27875521|NCT00287586|81375464|FG001|Overall Study|Stroke|0|||
27875522|NCT00287586|81375463|FG000|Overall Study|Myocardial Infarction|1|||
27875523|NCT00287586|81375464|FG001|Overall Study|Myocardial Infarction|0|||
27875524|NCT00287586|81375463|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
27875525|NCT00287586|81375464|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
27875526|NCT00287586|81375463|FG000|Overall Study|Cognitive Impairment|1|||
27875527|NCT00287586|81375464|FG001|Overall Study|Cognitive Impairment|0|||
27875528|NCT00287586|81375463|FG000|Overall Study|Pancreatic Cancer|1|||
27875529|NCT00287586|81375464|FG001|Overall Study|Pancreatic Cancer|3|||
27875530|NCT00287586|81375463|FG000|Overall Study|Sleep Apnea|1|||
27875531|NCT00287586|81375464|FG001|Overall Study|Sleep Apnea|0|||
27875532|NCT00287586|81375463|FG000|Overall Study|Shoulder Pain|1|||
27875533|NCT00287586|81375464|FG001|Overall Study|Shoulder Pain|0|||
27875534|NCT00287586|81375463|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
27875535|NCT00287586|81375464|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
27875536|NCT00287586|81375463|FG000|Overall Study|Nonadherence|1|||
27875537|NCT00287586|81375464|FG001|Overall Study|Nonadherence|1|||
27875538|NCT00287586|81375463|FG000|Overall Study|Enrolled in Another Study|1|||
27875539|NCT00287586|81375464|FG001|Overall Study|Enrolled in Another Study|0|||
27875540|NCT00287586|81375463|FG000|Overall Study|Major Depression|0|||
27587131|NCT03321981|80331672|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
27587132|NCT03321981|80331673|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
27587133|NCT03321981|80331671|FG000|Overall Study|Adverse Event|0|||
27587134|NCT03321981|80331672|FG001|Overall Study|Adverse Event|0|||
27587135|NCT03321981|80331673|FG002|Overall Study|Adverse Event|2|||
27587136|NCT03321981|80331671|FG000|Overall Study|symptomatic deterioration|0|||
27587137|NCT03321981|80331672|FG001|Overall Study|symptomatic deterioration|1|||
27587138|NCT03321981|80331673|FG002|Overall Study|symptomatic deterioration|1|||
27587139|NCT03321981|80331671|FG000|Overall Study|Lack of compliance|0|||
27587140|NCT03321981|80331672|FG001|Overall Study|Lack of compliance|1|||
27587141|NCT03321981|80331673|FG002|Overall Study|Lack of compliance|0|||
27587142|NCT03321981|80331671|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
27587143|NCT03321981|80331672|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
27685975|NCT02233543|80687568|FG001|Period 1|Withdrawal by Subject|0|||
27875541|NCT00287586|81375464|FG001|Overall Study|Major Depression|2|||
27875542|NCT00287586|81375463|FG000|Overall Study|Lung Cancer|0|||
27875543|NCT00287586|81375464|FG001|Overall Study|Lung Cancer|2|||
27875544|NCT00287586|81375463|FG000|Overall Study|Elevated IPSS Score|0|||
27875545|NCT00287586|81375464|FG001|Overall Study|Elevated IPSS Score|1|||
27875546|NCT00287586|81375463|FG000|Overall Study|Retroperitoneal Cancer|0|||
27875547|NCT00287586|81375464|FG001|Overall Study|Retroperitoneal Cancer|1|||
27875548|NCT00287586|81375463|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
27811400|NCT01393990|81141115|FG014|Overall Study|Death|1|||
27811401|NCT01393990|81141116|FG015|Overall Study|Death|0|||
27811402|NCT01393990|81141117|FG016|Overall Study|Death|0|||
27811403|NCT01393990|81141118|FG017|Overall Study|Death|0|||
27811404|NCT01393990|81141101|FG000|Overall Study|Withdrawal by Subject|0|||
27811405|NCT01393990|81141102|FG001|Overall Study|Withdrawal by Subject|0|||
27811406|NCT01393990|81141103|FG002|Overall Study|Withdrawal by Subject|0|||
27811407|NCT01393990|81141104|FG003|Overall Study|Withdrawal by Subject|0|||
27811408|NCT01393990|81141105|FG004|Overall Study|Withdrawal by Subject|0|||
27811409|NCT01393990|81141106|FG005|Overall Study|Withdrawal by Subject|0|||
27811410|NCT01393990|81141107|FG006|Overall Study|Withdrawal by Subject|0|||
27811411|NCT01393990|81141108|FG007|Overall Study|Withdrawal by Subject|0|||
27811412|NCT01393990|81141109|FG008|Overall Study|Withdrawal by Subject|0|||
27811413|NCT01393990|81141110|FG009|Overall Study|Withdrawal by Subject|0|||
27811414|NCT01393990|81141111|FG010|Overall Study|Withdrawal by Subject|0|||
27811415|NCT01393990|81141112|FG011|Overall Study|Withdrawal by Subject|0|||
27811416|NCT01393990|81141113|FG012|Overall Study|Withdrawal by Subject|0|||
27811417|NCT01393990|81141114|FG013|Overall Study|Withdrawal by Subject|0|||
27811418|NCT01393990|81141115|FG014|Overall Study|Withdrawal by Subject|1|||
27811419|NCT01393990|81141116|FG015|Overall Study|Withdrawal by Subject|1|||
27811420|NCT01393990|81141117|FG016|Overall Study|Withdrawal by Subject|0|||
27811421|NCT01393990|81141118|FG017|Overall Study|Withdrawal by Subject|0|||
27811422|NCT00752791|81141122|FG000|Overall Study|Adverse Event|7|||
27811423|NCT00752791|81141122|FG000|Overall Study|Withdrawal by Subject|1|||
28007734|NCT03661723|81859640|FG002|Overall Study|Clinical Deterioration|0|||
28007735|NCT03661723|81859641|FG003|Overall Study|Clinical Deterioration|1|||
27811424|NCT00752791|81141122|FG000|Overall Study|Physician Decision|1|||
27811425|NCT00752791|81141122|FG000|Overall Study|Death|1|||
27811426|NCT00752791|81141122|FG000|Overall Study|Renal transplant|3|||
27811427|NCT00752791|81141122|FG000|Overall Study|Switched to hemodialysis|2|||
27811428|NCT00752791|81141122|FG000|Overall Study|Protocol deviation|1|||
27811429|NCT03572933|81141132|FG000|Overall Study|Adverse Event|4|||
27811430|NCT03572933|81141133|FG001|Overall Study|Adverse Event|1|||
27811431|NCT03572933|81141132|FG000|Overall Study|Withdrawal by Subject|0|||
27811432|NCT03572933|81141133|FG001|Overall Study|Withdrawal by Subject|1|||
27811433|NCT02607800|81141134|FG000|Overall Study|Lost to Follow-up|7|||
27811434|NCT02607800|81141135|FG001|Overall Study|Lost to Follow-up|10|||
27811435|NCT02607800|81141134|FG000|Overall Study|Withdrew Consent|2|||
27811436|NCT02607800|81141135|FG001|Overall Study|Withdrew Consent|0|||
27811437|NCT02607800|81141134|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
27811438|NCT02607800|81141135|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
27811439|NCT02114931|81141136|FG000|Overall Study|Withdrawal by Subject|15|||
28007736|NCT00074711|81859642|FG000|Overall Study|Withdrawal by Subject|1|||
28007737|NCT00074711|81859643|FG001|Overall Study|Withdrawal by Subject|1|||
28007738|NCT00074711|81859642|FG000|Overall Study|Lost to Follow-up|10|||
28007739|NCT00074711|81859643|FG001|Overall Study|Lost to Follow-up|8|||
28007740|NCT00074711|81859642|FG000|Overall Study|Participant stopped study drug|4|||
28007741|NCT00074711|81859643|FG001|Overall Study|Participant stopped study drug|6|||
28007742|NCT03562195|81859644|FG000|Overall Study|Adverse Event|0|||
28007743|NCT03562195|81859645|FG001|Overall Study|Adverse Event|6|||
28007744|NCT03562195|81859644|FG000|Overall Study|Lack of Efficacy|0|||
27685976|NCT02233543|80687567|FG000|Period 1|Participants required other treatment.|2|||
27811440|NCT02114931|81141137|FG001|Overall Study|Withdrawal by Subject|18|||
27811441|NCT02114931|81141136|FG000|Overall Study|Adverse Event|4|||
27811442|NCT02114931|81141137|FG001|Overall Study|Adverse Event|6|||
27811443|NCT02114931|81141136|FG000|Overall Study|Lost to Follow-up|3|||
27811444|NCT02114931|81141137|FG001|Overall Study|Lost to Follow-up|3|||
27811445|NCT02114931|81141136|FG000|Overall Study|Physician Decision|1|||
27811446|NCT02114931|81141137|FG001|Overall Study|Physician Decision|2|||
27811447|NCT02114931|81141136|FG000|Overall Study|Other|2|||
27811448|NCT02114931|81141137|FG001|Overall Study|Other|1|||
27685977|NCT02233543|80687568|FG001|Period 1|Participants required other treatment.|3|||
27811449|NCT00368537|81141139|FG000|Randomization|No study drug dosed|13|||
27811450|NCT00368537|81141140|FG001|Randomization|No study drug dosed|6|||
27811451|NCT00368537|81141139|FG000|Baseline Participants|Lost to Follow-up|16|||
27811452|NCT00368537|81141140|FG001|Baseline Participants|Lost to Follow-up|17|||
28007745|NCT03562195|81859645|FG001|Overall Study|Lack of Efficacy|5|||
28007746|NCT03562195|81859644|FG000|Overall Study|Protocol Violation|0|||
28007747|NCT03562195|81859645|FG001|Overall Study|Protocol Violation|1|||
27685978|NCT02233543|80687567|FG000|Period 2|Adverse Event|1|||
27811453|NCT00368537|81141139|FG000|Baseline Participants|Withdrawal by Subject|6|||
27811454|NCT00368537|81141140|FG001|Baseline Participants|Withdrawal by Subject|4|||
27811455|NCT00368537|81141139|FG000|Baseline Participants|Death|1|||
27811456|NCT00368537|81141140|FG001|Baseline Participants|Death|2|||
27811457|NCT00368537|81141139|FG000|Baseline Participants|No susceptibility|1|||
27811458|NCT00368537|81141140|FG001|Baseline Participants|No susceptibility|0|||
27811459|NCT00368537|81141139|FG000|Baseline Participants|Patient uncompliant|0|||
27685979|NCT02233543|80687568|FG001|Period 2|Adverse Event|0|||
27685980|NCT02233543|80687567|FG000|Period 2|Participant required other treatment.|0|||
27685981|NCT02233543|80687568|FG001|Period 2|Participant required other treatment.|1|||
27685982|NCT02233543|80687567|FG000|Period 2|COPD exacerbation|1|||
27811460|NCT00368537|81141140|FG001|Baseline Participants|Patient uncompliant|1|||
27811461|NCT02637557|81141141|FG000|Overall Study|Adverse Event|3|||
27811462|NCT02637557|81141142|FG001|Overall Study|Adverse Event|1|||
27811463|NCT02637557|81141143|FG002|Overall Study|Adverse Event|3|||
27811464|NCT02637557|81141144|FG003|Overall Study|Adverse Event|3|||
27811465|NCT02637557|81141141|FG000|Overall Study|Lost to Follow-up|1|||
27811466|NCT02637557|81141142|FG001|Overall Study|Lost to Follow-up|1|||
27811467|NCT02637557|81141143|FG002|Overall Study|Lost to Follow-up|0|||
27811468|NCT02637557|81141144|FG003|Overall Study|Lost to Follow-up|1|||
27811469|NCT02637557|81141141|FG000|Overall Study|Physician Decision|1|||
27811470|NCT02637557|81141142|FG001|Overall Study|Physician Decision|0|||
28007748|NCT03562195|81859644|FG000|Overall Study|Lost to Follow-up|0|||
28007749|NCT03562195|81859645|FG001|Overall Study|Lost to Follow-up|1|||
28007750|NCT03562195|81859644|FG000|Overall Study|Physician Decision|1|||
28007751|NCT03562195|81859645|FG001|Overall Study|Physician Decision|0|||
28007752|NCT03562195|81859644|FG000|Overall Study|Withdrawal by Subject|3|||
28007753|NCT03562195|81859645|FG001|Overall Study|Withdrawal by Subject|0|||
28007754|NCT02246530|81859646|FG000|Overall Study|Lost to Follow-up|4|||
28007755|NCT02246530|81859647|FG001|Overall Study|Lost to Follow-up|0|||
28007756|NCT01436149|81859648|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
28007757|NCT01436149|81859649|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
28007758|NCT01436149|81859650|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
28007759|NCT01436149|81859648|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
28007760|NCT01436149|81859649|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
28007761|NCT01436149|81859650|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
28007762|NCT01436149|81859648|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
28007763|NCT01436149|81859649|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
28007764|NCT01436149|81859650|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
28007765|NCT01436149|81859648|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
28007766|NCT01436149|81859649|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
28007767|NCT01436149|81859650|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
28007768|NCT01436149|81859648|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
28007769|NCT01436149|81859649|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
27685983|NCT02233543|80687568|FG001|Period 2|COPD exacerbation|0|||
27685984|NCT00185965|80687569|FG000|Overall Study|Adverse Event|0|||
27685985|NCT00185965|80687570|FG001|Overall Study|Adverse Event|1|||
27685986|NCT02996474|80687571|FG000|Overall Study|Physician Decision|5|||
27685987|NCT00837694|80687572|FG000|Overall Study|Lost to Follow-up|2|||
27685988|NCT00837694|80687573|FG001|Overall Study|Lost to Follow-up|0|||
27685989|NCT00837694|80687574|FG002|Overall Study|Lost to Follow-up|2|||
27685990|NCT00837694|80687575|FG003|Overall Study|Lost to Follow-up|1|||
27811471|NCT02637557|81141143|FG002|Overall Study|Physician Decision|0|||
27811472|NCT02637557|81141144|FG003|Overall Study|Physician Decision|0|||
27811473|NCT02637557|81141141|FG000|Overall Study|Protocol Violation|2|||
27685991|NCT00837694|80687576|FG004|Overall Study|Lost to Follow-up|1|||
27685992|NCT00837694|80687577|FG005|Overall Study|Lost to Follow-up|1|||
27685993|NCT01712659|80687580|FG000|Dose Escalation|Physician Decision|0|||
27811474|NCT02637557|81141142|FG001|Overall Study|Protocol Violation|0|||
27811475|NCT02637557|81141143|FG002|Overall Study|Protocol Violation|2|||
27811476|NCT02637557|81141144|FG003|Overall Study|Protocol Violation|1|||
27811477|NCT02637557|81141141|FG000|Overall Study|Withdrawal by Subject|1|||
27811478|NCT02637557|81141142|FG001|Overall Study|Withdrawal by Subject|3|||
28007770|NCT01436149|81859650|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
28007771|NCT01436149|81859648|FG000|Antidepressant Lead-in Phase|Other|119|||
28007772|NCT01436149|81859649|FG001|Antidepressant Lead-in Phase|Other|0|||
27685994|NCT01712659|80687581|FG001|Dose Escalation|Physician Decision|1|||
27685995|NCT01712659|80687582|FG002|Dose Escalation|Physician Decision|0|||
27685996|NCT01712659|80687583|FG003|Dose Escalation|Physician Decision|0|||
27685997|NCT01712659|80687584|FG004|Dose Escalation|Physician Decision|0|||
27685998|NCT01712659|80687580|FG000|Dose Escalation|Unable to take study drug|0|||
27685999|NCT01712659|80687581|FG001|Dose Escalation|Unable to take study drug|1|||
27686000|NCT01712659|80687582|FG002|Dose Escalation|Unable to take study drug|0|||
27686001|NCT01712659|80687583|FG003|Dose Escalation|Unable to take study drug|0|||
27686002|NCT01712659|80687584|FG004|Dose Escalation|Unable to take study drug|0|||
27686003|NCT01712659|80687580|FG000|Dose Expansion|Early disease progression|1|||
27686004|NCT01712659|80687581|FG001|Dose Expansion|Early disease progression|0|||
27686005|NCT01712659|80687582|FG002|Dose Expansion|Early disease progression|0|||
27686006|NCT01712659|80687583|FG003|Dose Expansion|Early disease progression|0|||
27686007|NCT01712659|80687584|FG004|Dose Expansion|Early disease progression|0|||
27686008|NCT01712659|80687580|FG000|Dose Expansion|Physician Decision|1|||
27686009|NCT01712659|80687581|FG001|Dose Expansion|Physician Decision|0|||
27686010|NCT01712659|80687582|FG002|Dose Expansion|Physician Decision|0|||
27686011|NCT01712659|80687583|FG003|Dose Expansion|Physician Decision|0|||
27686012|NCT01712659|80687584|FG004|Dose Expansion|Physician Decision|0|||
27686013|NCT02349425|80687585|FG000|Period 1|Adverse Event|1|||
27686014|NCT02349425|80687586|FG001|Period 1|Adverse Event|1|||
27686015|NCT02349425|80687587|FG002|Period 1|Adverse Event|0|||
27686016|NCT02349425|80687588|FG003|Period 1|Adverse Event|0|||
27686017|NCT02349425|80687585|FG000|Period 2|Adverse Event|0|||
27686018|NCT02349425|80687586|FG001|Period 2|Adverse Event|1|||
27686019|NCT02349425|80687587|FG002|Period 2|Adverse Event|1|||
27587144|NCT03321981|80331673|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
27587145|NCT03321981|80331671|FG000|Overall Study|Death|0|||
27587146|NCT03321981|80331672|FG001|Overall Study|Death|1|||
27587147|NCT03321981|80331673|FG002|Overall Study|Death|0|||
27686020|NCT02349425|80687588|FG003|Period 2|Adverse Event|0|||
27686021|NCT04772898|80687589|FG000|Overall Study|Withdrawal by Subject|0|||
27686022|NCT04772898|80687590|FG001|Overall Study|Withdrawal by Subject|1|||
27686023|NCT01239043|80687591|FG000|Overall Study|Protocol Violation|2|||
27686024|NCT01239043|80687592|FG001|Overall Study|Protocol Violation|1|||
27686025|NCT00166712|80687593|FG000|Overall Study|Death|0|||
27686026|NCT00166712|80687594|FG001|Overall Study|Death|1|||
27686027|NCT00166712|80687593|FG000|Overall Study|Adverse Event|1|||
27686028|NCT00166712|80687594|FG001|Overall Study|Adverse Event|0|||
27686029|NCT00166712|80687593|FG000|Overall Study|Withdrawal by Subject|1|||
27686030|NCT00166712|80687594|FG001|Overall Study|Withdrawal by Subject|2|||
27686031|NCT00166712|80687593|FG000|Overall Study|Physician Decision|0|||
27686032|NCT00166712|80687594|FG001|Overall Study|Physician Decision|2|||
28007773|NCT01436149|81859650|FG002|Antidepressant Lead-in Phase|Other|0|||
28007774|NCT01436149|81859648|FG000|Randomized Phase|Adverse Event|9|||
27811479|NCT02637557|81141143|FG002|Overall Study|Withdrawal by Subject|4|||
28007775|NCT01436149|81859649|FG001|Randomized Phase|Adverse Event|10|||
28007776|NCT01436149|81859650|FG002|Randomized Phase|Adverse Event|11|||
28007777|NCT01436149|81859648|FG000|Randomized Phase|Protocol Violation|4|||
28007778|NCT01436149|81859649|FG001|Randomized Phase|Protocol Violation|5|||
28007779|NCT01436149|81859650|FG002|Randomized Phase|Protocol Violation|0|||
27686033|NCT00910039|80687598|FG000|Overall Study|Physician Decision|1|||
27686034|NCT02929329|80687602|FG000|Overall Study|Withdrawal by Subject|24|||
27686035|NCT02929329|80687603|FG001|Overall Study|Withdrawal by Subject|21|||
27686036|NCT02929329|80687602|FG000|Overall Study|Lost to Follow-up|26|||
27686037|NCT02929329|80687603|FG001|Overall Study|Lost to Follow-up|20|||
27686038|NCT02929329|80687602|FG000|Overall Study|Death|1054|||
27686039|NCT02929329|80687603|FG001|Overall Study|Death|1051|||
27686040|NCT00925132|80687606|FG000|Overall Study|Withdrawal by Subject|2|||
27686041|NCT00925132|80687607|FG001|Overall Study|Withdrawal by Subject|0|||
27686042|NCT00925132|80687608|FG002|Overall Study|Withdrawal by Subject|0|||
28007780|NCT01436149|81859648|FG000|Randomized Phase|Withdrawal by Subject|16|||
28007781|NCT01436149|81859649|FG001|Randomized Phase|Withdrawal by Subject|10|||
28007782|NCT01436149|81859650|FG002|Randomized Phase|Withdrawal by Subject|10|||
28007783|NCT01436149|81859648|FG000|Randomized Phase|Lost to Follow-up|34|||
28007784|NCT01436149|81859649|FG001|Randomized Phase|Lost to Follow-up|5|||
28007785|NCT01436149|81859650|FG002|Randomized Phase|Lost to Follow-up|6|||
27587148|NCT03321981|80331671|FG000|Overall Study|Subject withdrawal of investigational product|0|||
27686043|NCT00925132|80687609|FG003|Overall Study|Withdrawal by Subject|0|||
27686044|NCT00925132|80687610|FG004|Overall Study|Withdrawal by Subject|1|||
27686045|NCT00925132|80687606|FG000|Overall Study|Removed due to disease progression|0|||
27686046|NCT00925132|80687607|FG001|Overall Study|Removed due to disease progression|0|||
27686047|NCT00925132|80687608|FG002|Overall Study|Removed due to disease progression|0|||
27811480|NCT02637557|81141144|FG003|Overall Study|Withdrawal by Subject|2|||
27811481|NCT02330081|81141145|FG000|Overall Study|Adverse Event|1|||
28007786|NCT01436149|81859648|FG000|Randomized Phase|Lack of Efficacy|0|||
28007787|NCT01436149|81859649|FG001|Randomized Phase|Lack of Efficacy|0|||
28007788|NCT01436149|81859650|FG002|Randomized Phase|Lack of Efficacy|1|||
27587149|NCT03321981|80331672|FG001|Overall Study|Subject withdrawal of investigational product|1|||
27587150|NCT03321981|80331673|FG002|Overall Study|Subject withdrawal of investigational product|0|||
28007789|NCT01436149|81859648|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
28007790|NCT01436149|81859649|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
27811482|NCT02330081|81141145|FG000|Overall Study|Donation did not meet criteria|1|||
27811483|NCT02330081|81141145|FG000|Overall Study|Protocol Violation|6|||
27811484|NCT04634409|81141146|FG000|Overall Study|Death|0|||
27811485|NCT04634409|81141147|FG001|Overall Study|Death|0|||
27811486|NCT04634409|81141148|FG002|Overall Study|Death|0|||
27811487|NCT04634409|81141149|FG003|Overall Study|Death|0|||
27587151|NCT03321981|80331671|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
27587152|NCT03321981|80331672|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
27587153|NCT03321981|80331673|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
27686048|NCT00925132|80687609|FG003|Overall Study|Removed due to disease progression|0|||
27686049|NCT00925132|80687610|FG004|Overall Study|Removed due to disease progression|4|||
27686050|NCT03534284|80687611|FG000|Overall Study|Death|2|||
27686051|NCT03534284|80687612|FG001|Overall Study|Death|3|||
27811488|NCT04634409|81141150|FG004|Overall Study|Death|0|||
27811489|NCT04634409|81141151|FG005|Overall Study|Death|0|||
27811490|NCT04634409|81141152|FG006|Overall Study|Death|0|||
27811491|NCT04634409|81141153|FG007|Overall Study|Death|0|||
27811492|NCT04634409|81141154|FG008|Overall Study|Death|0|||
27811493|NCT04634409|81141155|FG009|Overall Study|Death|0|||
27811494|NCT04634409|81141156|FG010|Overall Study|Death|1|||
27811495|NCT04634409|81141157|FG011|Overall Study|Death|0|||
27811496|NCT04634409|81141158|FG012|Overall Study|Death|1|||
27811497|NCT04634409|81141159|FG013|Overall Study|Death|0|||
27811498|NCT04634409|81141160|FG014|Overall Study|Death|0|||
27811499|NCT04634409|81141161|FG015|Overall Study|Death|0|||
27811500|NCT04634409|81141162|FG016|Overall Study|Death|0|||
27811501|NCT04634409|81141163|FG017|Overall Study|Death|0|||
27811502|NCT04634409|81141164|FG018|Overall Study|Death|0|||
27811503|NCT04634409|81141165|FG019|Overall Study|Death|0|||
27875549|NCT00287586|81375464|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
27686052|NCT03534284|80687613|FG002|Overall Study|Death|3|||
27686053|NCT03534284|80687611|FG000|Overall Study|Withdrawal by Subject|5|||
27686054|NCT03534284|80687612|FG001|Overall Study|Withdrawal by Subject|0|||
27686055|NCT03534284|80687613|FG002|Overall Study|Withdrawal by Subject|0|||
27686056|NCT05132127|80687614|FG000|Overall Study|Adverse Event|1|||
27686057|NCT00760474|80687615|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
27686058|NCT00760474|80687616|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
27686059|NCT00760474|80687615|FG000|Placebo Washout Period|Other|0|||
27686060|NCT00760474|80687616|FG001|Placebo Washout Period|Other|1|||
27686061|NCT00760474|80687615|FG000|Period 2 (P2)|Lost to Follow-up|1|||
27686062|NCT00760474|80687616|FG001|Period 2 (P2)|Lost to Follow-up|0|||
27686063|NCT00760474|80687615|FG000|Period 2 (P2)|Adverse Event|0|||
27686064|NCT00760474|80687616|FG001|Period 2 (P2)|Adverse Event|1|||
27686065|NCT02665338|80687617|FG000|Overall Study|Withdrawal by Subject|0|||
27686066|NCT02665338|80687618|FG001|Overall Study|Withdrawal by Subject|1|||
27686067|NCT00006011|80687619|FG000|Overall Study|Disease progression|13|||
27686068|NCT00006011|80687620|FG001|Overall Study|Disease progression|6|||
27686069|NCT00006011|80687621|FG002|Overall Study|Disease progression|26|||
27686070|NCT00006011|80687619|FG000|Overall Study|Refused further treatment|15|||
27686071|NCT00006011|80687620|FG001|Overall Study|Refused further treatment|13|||
27686072|NCT00006011|80687621|FG002|Overall Study|Refused further treatment|26|||
27686073|NCT00006011|80687619|FG000|Overall Study|Adverse Event|15|||
27686074|NCT00006011|80687620|FG001|Overall Study|Adverse Event|39|||
27686075|NCT00006011|80687621|FG002|Overall Study|Adverse Event|5|||
27686076|NCT00006011|80687619|FG000|Overall Study|Death|0|||
27686077|NCT00006011|80687620|FG001|Overall Study|Death|1|||
27686078|NCT00006011|80687621|FG002|Overall Study|Death|2|||
27686079|NCT00006011|80687619|FG000|Overall Study|Other|4|||
27875550|NCT00287586|81375463|FG000|Overall Study|Mood Swings and Irritability|0|||
27875551|NCT00287586|81375464|FG001|Overall Study|Mood Swings and Irritability|1|||
27686080|NCT00006011|80687620|FG001|Overall Study|Other|2|||
27875552|NCT00287586|81375463|FG000|Overall Study|Bradycardia|0|||
27686081|NCT00006011|80687621|FG002|Overall Study|Other|5|||
27686082|NCT00006011|80687619|FG000|Overall Study|Ineligible|18|||
27686083|NCT00006011|80687620|FG001|Overall Study|Ineligible|16|||
27811504|NCT04634409|81141166|FG020|Overall Study|Death|0|||
27811505|NCT04634409|81141167|FG021|Overall Study|Death|0|||
27811506|NCT04634409|81141168|FG022|Overall Study|Death|0|||
27811507|NCT04634409|81141169|FG023|Overall Study|Death|0|||
27811508|NCT04634409|81141170|FG024|Overall Study|Death|0|||
27811509|NCT04634409|81141171|FG025|Overall Study|Death|0|||
27811510|NCT04634409|81141172|FG026|Overall Study|Death|0|||
27875553|NCT00287586|81375464|FG001|Overall Study|Bradycardia|1|||
27811511|NCT04634409|81141146|FG000|Overall Study|Adverse Event|0|||
27875554|NCT00287586|81375463|FG000|Overall Study|Itchy Swollen Eyes|0|||
27686084|NCT00006011|80687621|FG002|Overall Study|Ineligible|9|||
27686085|NCT04289051|80687622|FG000|Overall Study|Lost to Follow-up|0|||
27686086|NCT04289051|80687623|FG001|Overall Study|Lost to Follow-up|0|||
27686087|NCT04289051|80687624|FG002|Overall Study|Lost to Follow-up|2|||
27686088|NCT03432260|80687625|FG000|Overall Study|Lost to Follow-up|1|||
27686089|NCT03432260|80687626|FG001|Overall Study|Lost to Follow-up|1|||
27686090|NCT03432260|80687627|FG002|Overall Study|Lost to Follow-up|0|||
27686091|NCT03432260|80687628|FG003|Overall Study|Lost to Follow-up|0|||
27686092|NCT03432260|80687629|FG004|Overall Study|Lost to Follow-up|1|||
27686093|NCT00591851|80687630|FG000|Overall Study|Withdrawal by Subject|3|||
27686094|NCT00591851|80687630|FG000|Overall Study|Adverse Event|2|||
27686095|NCT00591851|80687630|FG000|Overall Study|Progressive Disease|1|||
27686096|NCT04811131|80687631|FG000|Overall Study|Adverse Event|0|||
27686097|NCT04811131|80687632|FG001|Overall Study|Adverse Event|0|||
27686098|NCT04811131|80687633|FG002|Overall Study|Adverse Event|1|||
27686099|NCT04811131|80687634|FG003|Overall Study|Adverse Event|0|||
27686100|NCT04811131|80687631|FG000|Overall Study|Lack of Efficacy|0|||
27686101|NCT04811131|80687632|FG001|Overall Study|Lack of Efficacy|0|||
27686102|NCT04811131|80687633|FG002|Overall Study|Lack of Efficacy|0|||
27686103|NCT04811131|80687634|FG003|Overall Study|Lack of Efficacy|1|||
27686104|NCT04811131|80687631|FG000|Overall Study|Lost to Follow-up|0|||
27686105|NCT04811131|80687632|FG001|Overall Study|Lost to Follow-up|1|||
27686106|NCT04811131|80687633|FG002|Overall Study|Lost to Follow-up|0|||
27686107|NCT04811131|80687634|FG003|Overall Study|Lost to Follow-up|0|||
27686108|NCT04811131|80687631|FG000|Overall Study|Sponsor request|31|||
27686109|NCT04811131|80687632|FG001|Overall Study|Sponsor request|35|||
27686110|NCT04811131|80687633|FG002|Overall Study|Sponsor request|27|||
27686111|NCT04811131|80687634|FG003|Overall Study|Sponsor request|10|||
27686112|NCT04811131|80687631|FG000|Overall Study|Withdrawal by Subject|3|||
27686113|NCT04811131|80687632|FG001|Overall Study|Withdrawal by Subject|1|||
27686114|NCT04811131|80687633|FG002|Overall Study|Withdrawal by Subject|3|||
27686115|NCT04811131|80687634|FG003|Overall Study|Withdrawal by Subject|1|||
27686116|NCT01699503|80687638|FG000|Overall Study|Death|31|||
27686117|NCT01699503|80687639|FG001|Overall Study|Death|40|||
27686118|NCT01699503|80687638|FG000|Overall Study|Withdrawal by Subject|65|||
27686119|NCT01699503|80687639|FG001|Overall Study|Withdrawal by Subject|57|||
27686120|NCT01699503|80687638|FG000|Overall Study|Lost to Follow-up|121|||
27686121|NCT01699503|80687639|FG001|Overall Study|Lost to Follow-up|117|||
27686122|NCT01699503|80687638|FG000|Overall Study|Excluded due to quality|783|||
27686123|NCT01699503|80687639|FG001|Overall Study|Excluded due to quality|791|||
27686124|NCT00738894|80687640|FG000|Overall Study|Lost to Follow-up|23|||
27587154|NCT03321981|80331671|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
27587155|NCT03321981|80331672|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
27587156|NCT03321981|80331673|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
27587157|NCT03021187|80331674|FG000|Overall Study|Death|0|||
27587158|NCT03021187|80331675|FG001|Overall Study|Death|0|||
27587159|NCT03021187|80331676|FG002|Overall Study|Death|3|||
27587160|NCT03021187|80331677|FG003|Overall Study|Death|0|||
27587161|NCT03021187|80331674|FG000|Overall Study|Withdrawal by Subject|0|||
27587162|NCT03021187|80331675|FG001|Overall Study|Withdrawal by Subject|6|||
27587163|NCT03021187|80331676|FG002|Overall Study|Withdrawal by Subject|2|||
27587164|NCT03021187|80331677|FG003|Overall Study|Withdrawal by Subject|5|||
27587165|NCT03021187|80331674|FG000|Overall Study|Lost to Follow-up|10|||
27587166|NCT03021187|80331675|FG001|Overall Study|Lost to Follow-up|3|||
27587167|NCT03021187|80331676|FG002|Overall Study|Lost to Follow-up|1|||
27587168|NCT03021187|80331677|FG003|Overall Study|Lost to Follow-up|4|||
27587169|NCT03131648|80331678|FG000|Initial Treatment Period|Not dosed|2|||
27587170|NCT03131648|80331679|FG001|Initial Treatment Period|Not dosed|2|||
27587171|NCT03131648|80331680|FG002|Initial Treatment Period|Not dosed|0|||
27587172|NCT03131648|80331681|FG003|Initial Treatment Period|Not dosed|0|||
27587173|NCT03131648|80331682|FG004|Initial Treatment Period|Not dosed|0|||
27587174|NCT03131648|80331683|FG005|Initial Treatment Period|Not dosed|0|||
27587175|NCT03131648|80331684|FG006|Initial Treatment Period|Not dosed|0|||
27587176|NCT03131648|80331685|FG007|Initial Treatment Period|Not dosed|0|||
27587177|NCT03131648|80331678|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
27587178|NCT03131648|80331679|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
27587179|NCT03131648|80331680|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27587180|NCT03131648|80331681|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27587181|NCT03131648|80331682|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27587182|NCT03131648|80331683|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27587183|NCT03131648|80331684|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27686125|NCT00738894|80687641|FG001|Overall Study|Lost to Follow-up|13|||
27686126|NCT00738894|80687640|FG000|Overall Study|Withdrawal by Subject|10|||
27686127|NCT00738894|80687641|FG001|Overall Study|Withdrawal by Subject|15|||
27686128|NCT00738894|80687640|FG000|Overall Study|Physician Decision|4|||
27686129|NCT00738894|80687641|FG001|Overall Study|Physician Decision|5|||
27686130|NCT00738894|80687640|FG000|Overall Study|Death|2|||
27686131|NCT00738894|80687641|FG001|Overall Study|Death|0|||
27686132|NCT00653523|80687642|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
27686133|NCT00653523|80687642|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
27686134|NCT00653523|80687642|FG000|Overall Study|Adverse Event|7|||
27811512|NCT04634409|81141147|FG001|Overall Study|Adverse Event|0|||
27811513|NCT04634409|81141148|FG002|Overall Study|Adverse Event|1|||
27811514|NCT04634409|81141149|FG003|Overall Study|Adverse Event|0|||
27811515|NCT04634409|81141150|FG004|Overall Study|Adverse Event|0|||
27686135|NCT00653523|80687642|FG000|Overall Study|Withdrawal by Subject|6|||
27686136|NCT00653523|80687642|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
27686137|NCT00653523|80687642|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
27686138|NCT02495792|80687643|FG000|Overall Study|Lost to Follow-up|5|||
27686139|NCT02495792|80687644|FG001|Overall Study|Lost to Follow-up|9|||
27686140|NCT02495792|80687643|FG000|Overall Study|Protocol Violation|32|||
27686141|NCT02495792|80687644|FG001|Overall Study|Protocol Violation|31|||
27686142|NCT01605916|80687645|FG000|Overall Study|Adverse Event|1|||
27686143|NCT01605916|80687646|FG001|Overall Study|Adverse Event|0|||
27686144|NCT01605916|80687647|FG002|Overall Study|Adverse Event|0|||
27686145|NCT01605916|80687648|FG003|Overall Study|Adverse Event|1|||
27686146|NCT01605916|80687649|FG004|Overall Study|Adverse Event|0|||
27686147|NCT01605916|80687645|FG000|Overall Study|Lack of Efficacy|2|||
27686148|NCT01605916|80687646|FG001|Overall Study|Lack of Efficacy|3|||
27686149|NCT01605916|80687647|FG002|Overall Study|Lack of Efficacy|3|||
27686150|NCT01605916|80687648|FG003|Overall Study|Lack of Efficacy|5|||
27686151|NCT01605916|80687649|FG004|Overall Study|Lack of Efficacy|4|||
27686152|NCT01605916|80687645|FG000|Overall Study|Withdrawal by Subject|1|||
27686153|NCT01605916|80687646|FG001|Overall Study|Withdrawal by Subject|1|||
27686154|NCT01605916|80687647|FG002|Overall Study|Withdrawal by Subject|0|||
27686155|NCT01605916|80687648|FG003|Overall Study|Withdrawal by Subject|0|||
27686156|NCT01605916|80687649|FG004|Overall Study|Withdrawal by Subject|2|||
27686157|NCT05114473|80687654|FG000|Overall Study|Lost to Follow-up|2|||
27686158|NCT05114473|80687655|FG001|Overall Study|Lost to Follow-up|2|||
27686159|NCT05114473|80687656|FG002|Overall Study|Lost to Follow-up|0|||
27686160|NCT03284229|80687659|FG000|Overall Study|Lost to Follow-up|3|||
27686161|NCT02030002|80687660|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
27686162|NCT02030002|80687660|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
27811516|NCT04634409|81141151|FG005|Overall Study|Adverse Event|1|||
27811517|NCT04634409|81141152|FG006|Overall Study|Adverse Event|0|||
27811518|NCT04634409|81141153|FG007|Overall Study|Adverse Event|0|||
27811519|NCT04634409|81141154|FG008|Overall Study|Adverse Event|0|||
27811520|NCT04634409|81141155|FG009|Overall Study|Adverse Event|0|||
27811521|NCT04634409|81141156|FG010|Overall Study|Adverse Event|0|||
27811522|NCT04634409|81141157|FG011|Overall Study|Adverse Event|0|||
27811523|NCT04634409|81141158|FG012|Overall Study|Adverse Event|0|||
27811524|NCT04634409|81141159|FG013|Overall Study|Adverse Event|0|||
27811525|NCT04634409|81141160|FG014|Overall Study|Adverse Event|0|||
27811526|NCT04634409|81141161|FG015|Overall Study|Adverse Event|0|||
27811527|NCT04634409|81141162|FG016|Overall Study|Adverse Event|0|||
27811528|NCT04634409|81141163|FG017|Overall Study|Adverse Event|0|||
27811529|NCT04634409|81141164|FG018|Overall Study|Adverse Event|0|||
27811530|NCT04634409|81141165|FG019|Overall Study|Adverse Event|0|||
27811531|NCT04634409|81141166|FG020|Overall Study|Adverse Event|0|||
27686163|NCT02030002|80687660|FG000|Follow-up|Lost to Follow-up|2|||
27811532|NCT04634409|81141167|FG021|Overall Study|Adverse Event|0|||
27811533|NCT04634409|81141168|FG022|Overall Study|Adverse Event|0|||
27875555|NCT00287586|81375464|FG001|Overall Study|Itchy Swollen Eyes|1|||
27811534|NCT04634409|81141169|FG023|Overall Study|Adverse Event|0|||
27686164|NCT00721149|80687665|FG000|Overall Study|Physician Decision|1|||
27686165|NCT01080716|80687666|FG000|Part 1|Physician Decision|1|||
27686166|NCT01080716|80687667|FG001|Part 1|Physician Decision|0|||
27686167|NCT01080716|80687668|FG002|Part 1|Physician Decision|0|||
27686168|NCT01080716|80687669|FG003|Part 1|Physician Decision|0|||
27811535|NCT04634409|81141170|FG024|Overall Study|Adverse Event|0|||
27811536|NCT04634409|81141171|FG025|Overall Study|Adverse Event|0|||
27686169|NCT01278173|80687670|FG000|Overall Study|Lack of Efficacy|13|||
27686170|NCT01278173|80687670|FG000|Overall Study|Adverse Event|8|||
27686171|NCT01278173|80687670|FG000|Overall Study|Administrative or other reason|4|||
27686172|NCT01278173|80687670|FG000|Overall Study|Protocol Violation|1|||
27686173|NCT01278173|80687670|FG000|Overall Study|Withdrawal by Subject|1|||
27686174|NCT01204710|80687671|FG000|Randomization Treatment|Lost to Follow-up|1|||
27686175|NCT01204710|80687672|FG001|Randomization Treatment|Lost to Follow-up|0|||
27686176|NCT01204710|80687671|FG000|Randomization Treatment|Withdrawal by Subject|6|||
27686177|NCT01204710|80687672|FG001|Randomization Treatment|Withdrawal by Subject|5|||
27686178|NCT01204710|80687671|FG000|Randomization Treatment|Physician Decision|3|||
27686179|NCT01204710|80687672|FG001|Randomization Treatment|Physician Decision|2|||
27686180|NCT01204710|80687671|FG000|Randomization Treatment|Entry criteria not met|0|||
27686181|NCT01204710|80687672|FG001|Randomization Treatment|Entry criteria not met|1|||
27686182|NCT01204710|80687671|FG000|Randomization Treatment|Adverse Event|4|||
27686183|NCT01204710|80687672|FG001|Randomization Treatment|Adverse Event|2|||
27875556|NCT00287586|81375463|FG000|Overall Study|Recurrent Melanoma|0|||
27875557|NCT00287586|81375464|FG001|Overall Study|Recurrent Melanoma|1|||
27875558|NCT01125189|81375465|FG000|Treatment Period|Lack of Efficacy|15|||
27875559|NCT01125189|81375466|FG001|Treatment Period|Lack of Efficacy|18|||
27875560|NCT01125189|81375467|FG002|Treatment Period|Lack of Efficacy|25|||
27875561|NCT01125189|81375465|FG000|Treatment Period|Adverse Event|7|||
27875562|NCT01125189|81375466|FG001|Treatment Period|Adverse Event|8|||
27875563|NCT01125189|81375467|FG002|Treatment Period|Adverse Event|8|||
27875564|NCT01125189|81375465|FG000|Treatment Period|Withdrawal by Subject|3|||
27875565|NCT01125189|81375466|FG001|Treatment Period|Withdrawal by Subject|1|||
27875566|NCT01125189|81375467|FG002|Treatment Period|Withdrawal by Subject|1|||
27875567|NCT01125189|81375465|FG000|Treatment Period|Death|1|||
27875568|NCT01125189|81375466|FG001|Treatment Period|Death|0|||
27875569|NCT01125189|81375467|FG002|Treatment Period|Death|0|||
27875570|NCT01125189|81375465|FG000|Treatment Period|Lost to Follow-up|1|||
27875571|NCT01125189|81375466|FG001|Treatment Period|Lost to Follow-up|2|||
27875572|NCT01125189|81375467|FG002|Treatment Period|Lost to Follow-up|1|||
27875573|NCT01125189|81375465|FG000|Treatment Period|Poor compliance/noncompliance|0|||
27875574|NCT01125189|81375466|FG001|Treatment Period|Poor compliance/noncompliance|1|||
27875575|NCT01125189|81375467|FG002|Treatment Period|Poor compliance/noncompliance|0|||
27875576|NCT01125189|81375465|FG000|Treatment Period|Participants requested to discontinue|1|||
27875577|NCT01125189|81375466|FG001|Treatment Period|Participants requested to discontinue|3|||
27875578|NCT01125189|81375467|FG002|Treatment Period|Participants requested to discontinue|4|||
27875579|NCT01125189|81375465|FG000|Treatment Period|Other reasons|1|||
27875580|NCT01125189|81375466|FG001|Treatment Period|Other reasons|1|||
27875581|NCT01125189|81375467|FG002|Treatment Period|Other reasons|0|||
27875582|NCT01125189|81375465|FG000|Treatment Period|Completed 24 week treatment period only|2|||
27875583|NCT01125189|81375466|FG001|Treatment Period|Completed 24 week treatment period only|1|||
27875584|NCT01125189|81375467|FG002|Treatment Period|Completed 24 week treatment period only|2|||
27875585|NCT01125189|81375465|FG000|Follow up Period|Withdrawal by Subject|3|||
27875586|NCT01125189|81375466|FG001|Follow up Period|Withdrawal by Subject|2|||
27875587|NCT01125189|81375467|FG002|Follow up Period|Withdrawal by Subject|5|||
27875588|NCT01125189|81375465|FG000|Follow up Period|Death|1|||
27875589|NCT01125189|81375466|FG001|Follow up Period|Death|0|||
27875590|NCT01125189|81375467|FG002|Follow up Period|Death|0|||
27875591|NCT01125189|81375465|FG000|Follow up Period|Lost to Follow-up|12|||
27875592|NCT01125189|81375466|FG001|Follow up Period|Lost to Follow-up|9|||
27875593|NCT01125189|81375467|FG002|Follow up Period|Lost to Follow-up|6|||
27875594|NCT01125189|81375465|FG000|Follow up Period|Other reasons|4|||
27875595|NCT01125189|81375466|FG001|Follow up Period|Other reasons|4|||
27875596|NCT01125189|81375467|FG002|Follow up Period|Other reasons|5|||
27686184|NCT01204710|80687671|FG000|Randomization Treatment|Sponsor Decision|0|||
27686185|NCT01204710|80687672|FG001|Randomization Treatment|Sponsor Decision|1|||
27686186|NCT01204710|80687671|FG000|Randomization Treatment|Worsening of General condition|0|||
27686187|NCT01204710|80687672|FG001|Randomization Treatment|Worsening of General condition|1|||
27686188|NCT01204710|80687671|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
27686189|NCT01204710|80687672|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
27875597|NCT03918629|81375468|FG000|Overall Study|Adverse Event|19|||
27875598|NCT03918629|81375469|FG001|Overall Study|Adverse Event|20|||
27875599|NCT03918629|81375468|FG000|Overall Study|Death|14|||
27875600|NCT03918629|81375469|FG001|Overall Study|Death|7|||
27686190|NCT01204710|80687671|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
27686191|NCT01204710|80687672|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
27686192|NCT01204710|80687671|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
27686193|NCT01204710|80687672|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
27686194|NCT01204710|80687671|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
27686195|NCT01204710|80687672|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
27686196|NCT01679405|80687673|FG000|Overall Study|Death|2|||
27686197|NCT01679405|80687674|FG001|Overall Study|Death|5|||
27686198|NCT00770029|80687675|FG000|Overall Study|Lost to Follow-up|2|||
27686199|NCT00770029|80687676|FG001|Overall Study|Lost to Follow-up|0|||
27686200|NCT00770029|80687675|FG000|Overall Study|Withdrawal by Subject|3|||
27686201|NCT00770029|80687676|FG001|Overall Study|Withdrawal by Subject|3|||
27686202|NCT00770029|80687675|FG000|Overall Study|Adverse Event|1|||
27686203|NCT00770029|80687676|FG001|Overall Study|Adverse Event|0|||
27686204|NCT02040259|80687677|FG000|Overall Study|Death|280|||
27686205|NCT02040259|80687677|FG000|Overall Study|Lost to Follow-up|76|||
27686206|NCT02040259|80687677|FG000|Overall Study|Assessment not completed|3|||
27686207|NCT02040259|80687677|FG000|Overall Study|Withdrawal by Subject|4|||
27686208|NCT00864253|80687678|FG000|Overall Study|Adverse Event|56|||
27686209|NCT00864253|80687679|FG001|Overall Study|Adverse Event|11|||
27686210|NCT00864253|80687678|FG000|Overall Study|Unrelated Adverse Event|3|||
27686211|NCT00864253|80687679|FG001|Overall Study|Unrelated Adverse Event|1|||
27686212|NCT00864253|80687678|FG000|Overall Study|Physician Decision|11|||
27686213|NCT00864253|80687679|FG001|Overall Study|Physician Decision|15|||
27686214|NCT00864253|80687678|FG000|Overall Study|Protocol Violation|0|||
27686215|NCT00864253|80687679|FG001|Overall Study|Protocol Violation|2|||
27686216|NCT00864253|80687678|FG000|Overall Study|Lost to Follow-up|1|||
27686217|NCT00864253|80687679|FG001|Overall Study|Lost to Follow-up|1|||
27686218|NCT00864253|80687678|FG000|Overall Study|Withdrawal by Subject|18|||
27686219|NCT00864253|80687679|FG001|Overall Study|Withdrawal by Subject|18|||
27686220|NCT00864253|80687678|FG000|Overall Study|Death|1|||
27686221|NCT00864253|80687679|FG001|Overall Study|Death|0|||
27686222|NCT00864253|80687678|FG000|Overall Study|Ongoing|2|||
27686223|NCT00864253|80687679|FG001|Overall Study|Ongoing|3|||
27686224|NCT00864253|80687678|FG000|Overall Study|Untreated|7|||
27686225|NCT00864253|80687679|FG001|Overall Study|Untreated|7|||
27686226|NCT02008877|80687680|FG000|Overall Study|Inevaluable|0|||
27686227|NCT02008877|80687681|FG001|Overall Study|Inevaluable|1|||
27686228|NCT02008877|80687682|FG002|Overall Study|Inevaluable|0|||
27686229|NCT00872989|80687687|FG000|Overall Study|Adverse Event|7|||
27686230|NCT00872989|80687688|FG001|Overall Study|Adverse Event|15|||
27686231|NCT00872989|80687687|FG000|Overall Study|Withdrawal by Subject|8|||
27686232|NCT00872989|80687688|FG001|Overall Study|Withdrawal by Subject|5|||
27686233|NCT00872989|80687687|FG000|Overall Study|Progression/relapse|47|||
27686234|NCT00872989|80687688|FG001|Overall Study|Progression/relapse|35|||
27686235|NCT00872989|80687687|FG000|Overall Study|Not protocol specified|3|||
27686236|NCT00872989|80687688|FG001|Overall Study|Not protocol specified|8|||
27686237|NCT01342341|80687706|FG000|Overall Study|Lost to Follow-up|4|||
27686238|NCT01342341|80687707|FG001|Overall Study|Lost to Follow-up|4|||
27686239|NCT00116753|80687708|FG000|Overall Study|Adverse Event|16|||
27686240|NCT00116753|80687709|FG001|Overall Study|Adverse Event|10|||
27686241|NCT00116753|80687710|FG002|Overall Study|Adverse Event|7|||
27686242|NCT00116753|80687708|FG000|Overall Study|Withdrawal by Subject|11|||
27686243|NCT00116753|80687709|FG001|Overall Study|Withdrawal by Subject|12|||
27686244|NCT00116753|80687710|FG002|Overall Study|Withdrawal by Subject|8|||
27686245|NCT00116753|80687708|FG000|Overall Study|Lost to Follow-up|0|||
27686246|NCT00116753|80687709|FG001|Overall Study|Lost to Follow-up|2|||
27686247|NCT00116753|80687710|FG002|Overall Study|Lost to Follow-up|1|||
27686248|NCT00116753|80687708|FG000|Overall Study|Protocol Violation|0|||
27686249|NCT00116753|80687709|FG001|Overall Study|Protocol Violation|0|||
27686250|NCT00116753|80687710|FG002|Overall Study|Protocol Violation|1|||
27875601|NCT03918629|81375468|FG000|Overall Study|Lost to Follow-up|36|||
27875602|NCT03918629|81375469|FG001|Overall Study|Lost to Follow-up|28|||
27875603|NCT03918629|81375468|FG000|Overall Study|Physician Decision|1|||
27875604|NCT03918629|81375469|FG001|Overall Study|Physician Decision|0|||
27875605|NCT03918629|81375468|FG000|Overall Study|Protocol Violation|7|||
28007791|NCT01436149|81859650|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
27686251|NCT00116753|80687708|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
27686252|NCT00116753|80687709|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
27686253|NCT00116753|80687710|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
27686254|NCT00116753|80687708|FG000|Overall Study|Disease Progression|3|||
27686255|NCT00116753|80687709|FG001|Overall Study|Disease Progression|4|||
27686256|NCT00116753|80687710|FG002|Overall Study|Disease Progression|3|||
27686257|NCT00116753|80687708|FG000|Overall Study|Abnormal Echocardiogram|0|||
27875606|NCT03918629|81375469|FG001|Overall Study|Protocol Violation|4|||
27686258|NCT00116753|80687709|FG001|Overall Study|Abnormal Echocardiogram|0|||
27686259|NCT00116753|80687710|FG002|Overall Study|Abnormal Echocardiogram|1|||
27686260|NCT00116753|80687708|FG000|Overall Study|Progressive Parkinson's Disease|1|||
27686261|NCT00116753|80687709|FG001|Overall Study|Progressive Parkinson's Disease|0|||
27686262|NCT00116753|80687710|FG002|Overall Study|Progressive Parkinson's Disease|0|||
27686263|NCT00116753|80687708|FG000|Overall Study|Dosing Error|0|||
27686264|NCT00116753|80687709|FG001|Overall Study|Dosing Error|1|||
27686265|NCT00116753|80687710|FG002|Overall Study|Dosing Error|0|||
27686266|NCT00626990|80687716|FG000|Overall Study|Lack of Efficacy|6|||
27686267|NCT00626990|80687717|FG001|Overall Study|Lack of Efficacy|7|||
27686268|NCT00626990|80687718|FG002|Overall Study|Lack of Efficacy|49|||
27686269|NCT00626990|80687719|FG003|Overall Study|Lack of Efficacy|40|||
27686270|NCT00626990|80687716|FG000|Overall Study|Adverse Event|1|||
27686271|NCT00626990|80687717|FG001|Overall Study|Adverse Event|7|||
27686272|NCT00626990|80687718|FG002|Overall Study|Adverse Event|14|||
27686273|NCT00626990|80687719|FG003|Overall Study|Adverse Event|28|||
27686274|NCT00626990|80687716|FG000|Overall Study|Death|0|||
27686275|NCT00626990|80687717|FG001|Overall Study|Death|1|||
27686276|NCT00626990|80687718|FG002|Overall Study|Death|0|||
27686277|NCT00626990|80687719|FG003|Overall Study|Death|0|||
27686278|NCT00626990|80687716|FG000|Overall Study|Withdrawal by Subject|3|||
27686279|NCT00626990|80687717|FG001|Overall Study|Withdrawal by Subject|1|||
27686280|NCT00626990|80687718|FG002|Overall Study|Withdrawal by Subject|5|||
27686281|NCT00626990|80687719|FG003|Overall Study|Withdrawal by Subject|11|||
27686282|NCT00626990|80687716|FG000|Overall Study|Protocol Violation|0|||
27686283|NCT00626990|80687717|FG001|Overall Study|Protocol Violation|1|||
27686284|NCT00626990|80687718|FG002|Overall Study|Protocol Violation|1|||
27686285|NCT00626990|80687719|FG003|Overall Study|Protocol Violation|0|||
27686286|NCT00626990|80687716|FG000|Overall Study|Various different reasons/missing|4|||
27686287|NCT00626990|80687717|FG001|Overall Study|Various different reasons/missing|8|||
27686288|NCT00626990|80687718|FG002|Overall Study|Various different reasons/missing|8|||
27686289|NCT00626990|80687719|FG003|Overall Study|Various different reasons/missing|16|||
27686290|NCT01895101|80687720|FG000|Overall Study|OPCAB procedure|1|||
27686291|NCT01895101|80687721|FG001|Overall Study|OPCAB procedure|1|||
27686292|NCT01895101|80687722|FG002|Overall Study|OPCAB procedure|3|||
27686293|NCT01895101|80687720|FG000|Overall Study|Withdrawal by Subject|0|||
27686294|NCT01895101|80687721|FG001|Overall Study|Withdrawal by Subject|1|||
27686295|NCT01895101|80687722|FG002|Overall Study|Withdrawal by Subject|2|||
27686296|NCT01895101|80687720|FG000|Overall Study|another study, enrolled in other study|0|||
27686297|NCT01895101|80687721|FG001|Overall Study|another study, enrolled in other study|1|||
27686298|NCT01895101|80687722|FG002|Overall Study|another study, enrolled in other study|0|||
27686299|NCT01895101|80687720|FG000|Overall Study|Death|0|||
27686300|NCT01895101|80687721|FG001|Overall Study|Death|1|||
27686301|NCT01895101|80687722|FG002|Overall Study|Death|0|||
27686302|NCT01895101|80687720|FG000|Overall Study|coagulation disorder|0|||
27686303|NCT01895101|80687721|FG001|Overall Study|coagulation disorder|1|||
27686304|NCT01895101|80687722|FG002|Overall Study|coagulation disorder|0|||
27686305|NCT01034163|80687723|FG000|Overall Study|Treatment completed as per protocol|8|||
27686306|NCT01034163|80687724|FG001|Overall Study|Treatment completed as per protocol|7|||
27686307|NCT01034163|80687723|FG000|Overall Study|Withdrawal by Subject|8|||
27686308|NCT01034163|80687724|FG001|Overall Study|Withdrawal by Subject|2|||
27686309|NCT01034163|80687723|FG000|Overall Study|Protocol deviation|1|||
27686310|NCT01034163|80687724|FG001|Overall Study|Protocol deviation|0|||
27686311|NCT01034163|80687723|FG000|Overall Study|Disease progression|3|||
27686312|NCT01034163|80687724|FG001|Overall Study|Disease progression|4|||
27686313|NCT01034163|80687723|FG000|Overall Study|Adverse Event|6|||
27686314|NCT01034163|80687724|FG001|Overall Study|Adverse Event|0|||
27686315|NCT01034163|80687723|FG000|Overall Study|Administrative problems|0|||
27686316|NCT01034163|80687724|FG001|Overall Study|Administrative problems|1|||
27686317|NCT01034163|80687723|FG000|Overall Study|Abnormal laboratory value|1|||
27686318|NCT01034163|80687724|FG001|Overall Study|Abnormal laboratory value|0|||
27686319|NCT01123070|80687725|FG000|Part B Double Blind Period|Protocol Violation|0|||
27686320|NCT01123070|80687726|FG001|Part B Double Blind Period|Protocol Violation|0|||
28007792|NCT01436149|81859648|FG000|Randomized Phase|Other|12|||
28007793|NCT01436149|81859649|FG001|Randomized Phase|Other|5|||
28007794|NCT01436149|81859650|FG002|Randomized Phase|Other|11|||
27686321|NCT01123070|80687727|FG002|Part B Double Blind Period|Protocol Violation|0|||
27686322|NCT01123070|80687728|FG003|Part B Double Blind Period|Protocol Violation|1|||
28007795|NCT03182374|81859654|FG000|Overall Study|Lost to Follow-up|3|||
28007796|NCT03182374|81859655|FG001|Overall Study|Lost to Follow-up|2|||
27587184|NCT03131648|80331685|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
27686323|NCT01123070|80687725|FG000|Part B Double Blind Period|Adverse Event|0|||
27686324|NCT01123070|80687726|FG001|Part B Double Blind Period|Adverse Event|0|||
27686325|NCT01123070|80687727|FG002|Part B Double Blind Period|Adverse Event|2|||
27686326|NCT01123070|80687728|FG003|Part B Double Blind Period|Adverse Event|0|||
28007797|NCT03182374|81859654|FG000|Overall Study|Lack of Efficacy|8|||
27811537|NCT04634409|81141172|FG026|Overall Study|Adverse Event|0|||
27875607|NCT03918629|81375468|FG000|Overall Study|Withdrawal by Subject|47|||
27875608|NCT03918629|81375469|FG001|Overall Study|Withdrawal by Subject|47|||
27875609|NCT03918629|81375468|FG000|Overall Study|Other|7|||
27875610|NCT03918629|81375469|FG001|Overall Study|Other|11|||
27686327|NCT01123070|80687725|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
27686328|NCT01123070|80687726|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
27686329|NCT01123070|80687727|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
27686330|NCT01123070|80687728|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
27811538|NCT04634409|81141146|FG000|Overall Study|Lost to Follow-up|3|||
27811539|NCT04634409|81141147|FG001|Overall Study|Lost to Follow-up|1|||
27811540|NCT04634409|81141148|FG002|Overall Study|Lost to Follow-up|1|||
27811541|NCT04634409|81141149|FG003|Overall Study|Lost to Follow-up|3|||
27811542|NCT04634409|81141150|FG004|Overall Study|Lost to Follow-up|1|||
27811543|NCT04634409|81141151|FG005|Overall Study|Lost to Follow-up|1|||
27811544|NCT04634409|81141152|FG006|Overall Study|Lost to Follow-up|1|||
27811545|NCT04634409|81141153|FG007|Overall Study|Lost to Follow-up|3|||
27811546|NCT04634409|81141154|FG008|Overall Study|Lost to Follow-up|3|||
27811547|NCT04634409|81141155|FG009|Overall Study|Lost to Follow-up|11|||
27811548|NCT04634409|81141156|FG010|Overall Study|Lost to Follow-up|8|||
27811549|NCT04634409|81141157|FG011|Overall Study|Lost to Follow-up|15|||
27811550|NCT04634409|81141158|FG012|Overall Study|Lost to Follow-up|3|||
27811551|NCT04634409|81141159|FG013|Overall Study|Lost to Follow-up|2|||
27811552|NCT04634409|81141160|FG014|Overall Study|Lost to Follow-up|7|||
27811553|NCT04634409|81141161|FG015|Overall Study|Lost to Follow-up|0|||
27811554|NCT04634409|81141162|FG016|Overall Study|Lost to Follow-up|0|||
27811555|NCT04634409|81141163|FG017|Overall Study|Lost to Follow-up|0|||
27811556|NCT04634409|81141164|FG018|Overall Study|Lost to Follow-up|0|||
27811557|NCT04634409|81141165|FG019|Overall Study|Lost to Follow-up|0|||
27811558|NCT04634409|81141166|FG020|Overall Study|Lost to Follow-up|0|||
27811559|NCT04634409|81141167|FG021|Overall Study|Lost to Follow-up|0|||
27811560|NCT04634409|81141168|FG022|Overall Study|Lost to Follow-up|0|||
27811561|NCT04634409|81141169|FG023|Overall Study|Lost to Follow-up|0|||
27811562|NCT04634409|81141170|FG024|Overall Study|Lost to Follow-up|0|||
27811563|NCT04634409|81141171|FG025|Overall Study|Lost to Follow-up|0|||
27811564|NCT04634409|81141172|FG026|Overall Study|Lost to Follow-up|0|||
27811565|NCT04634409|81141146|FG000|Overall Study|Withdrawal by Subject|3|||
27811566|NCT04634409|81141147|FG001|Overall Study|Withdrawal by Subject|1|||
27811567|NCT04634409|81141148|FG002|Overall Study|Withdrawal by Subject|6|||
27811568|NCT04634409|81141149|FG003|Overall Study|Withdrawal by Subject|4|||
27811569|NCT04634409|81141150|FG004|Overall Study|Withdrawal by Subject|2|||
27811570|NCT04634409|81141151|FG005|Overall Study|Withdrawal by Subject|0|||
27811571|NCT04634409|81141152|FG006|Overall Study|Withdrawal by Subject|0|||
27811572|NCT04634409|81141153|FG007|Overall Study|Withdrawal by Subject|2|||
27811573|NCT04634409|81141154|FG008|Overall Study|Withdrawal by Subject|3|||
27811574|NCT04634409|81141155|FG009|Overall Study|Withdrawal by Subject|2|||
27811575|NCT04634409|81141156|FG010|Overall Study|Withdrawal by Subject|3|||
27811576|NCT04634409|81141157|FG011|Overall Study|Withdrawal by Subject|2|||
27811577|NCT04634409|81141158|FG012|Overall Study|Withdrawal by Subject|2|||
27811578|NCT04634409|81141159|FG013|Overall Study|Withdrawal by Subject|1|||
27811579|NCT04634409|81141160|FG014|Overall Study|Withdrawal by Subject|5|||
27811580|NCT04634409|81141161|FG015|Overall Study|Withdrawal by Subject|0|||
27811581|NCT04634409|81141162|FG016|Overall Study|Withdrawal by Subject|0|||
27811582|NCT04634409|81141163|FG017|Overall Study|Withdrawal by Subject|1|||
27811583|NCT04634409|81141164|FG018|Overall Study|Withdrawal by Subject|0|||
27811584|NCT04634409|81141165|FG019|Overall Study|Withdrawal by Subject|0|||
27811585|NCT04634409|81141166|FG020|Overall Study|Withdrawal by Subject|0|||
27811586|NCT04634409|81141167|FG021|Overall Study|Withdrawal by Subject|0|||
27811587|NCT04634409|81141168|FG022|Overall Study|Withdrawal by Subject|0|||
27811588|NCT04634409|81141169|FG023|Overall Study|Withdrawal by Subject|1|||
27811589|NCT04634409|81141170|FG024|Overall Study|Withdrawal by Subject|0|||
27811590|NCT04634409|81141171|FG025|Overall Study|Withdrawal by Subject|0|||
27811591|NCT04634409|81141172|FG026|Overall Study|Withdrawal by Subject|0|||
27811592|NCT04634409|81141146|FG000|Overall Study|Other - As reported by Investigator|1|||
27811593|NCT04634409|81141147|FG001|Overall Study|Other - As reported by Investigator|0|||
27811594|NCT04634409|81141148|FG002|Overall Study|Other - As reported by Investigator|0|||
27811595|NCT04634409|81141149|FG003|Overall Study|Other - As reported by Investigator|0|||
27875611|NCT03918629|81375468|FG000|Overall Study|Randomized but not vaccinated|2|||
27875612|NCT03918629|81375469|FG001|Overall Study|Randomized but not vaccinated|1|||
27875613|NCT01518322|81375470|FG000|Overall Study|FeNO measurement was missing|13|||
27811596|NCT04634409|81141150|FG004|Overall Study|Other - As reported by Investigator|0|||
27587185|NCT03131648|80331678|FG000|Open-label Treatment|Discontinued IMP|0|||
27811597|NCT04634409|81141151|FG005|Overall Study|Other - As reported by Investigator|0|||
27811598|NCT04634409|81141152|FG006|Overall Study|Other - As reported by Investigator|0|||
27875614|NCT03759392|81375471|FG000|Overall Study|Adverse Event|12|||
27686331|NCT03261700|80687729|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
27686332|NCT03261700|80687730|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
27686333|NCT01775475|80687733|FG000|Overall Study|Death|3|||
27686334|NCT01775475|80687734|FG001|Overall Study|Death|3|||
27686335|NCT05007080|80687735|FG000|Overall Study|Lost to Follow-up|0|||
27686336|NCT05007080|80687736|FG001|Overall Study|Lost to Follow-up|1|||
27686337|NCT05007080|80687737|FG002|Overall Study|Lost to Follow-up|0|||
27686338|NCT05007080|80687738|FG003|Overall Study|Lost to Follow-up|1|||
27686339|NCT05007080|80687739|FG004|Overall Study|Lost to Follow-up|1|||
27686340|NCT05007080|80687740|FG005|Overall Study|Lost to Follow-up|1|||
27686341|NCT05007080|80687735|FG000|Overall Study|Death|0|||
27686342|NCT05007080|80687736|FG001|Overall Study|Death|1|||
27686343|NCT05007080|80687737|FG002|Overall Study|Death|0|||
27686344|NCT05007080|80687738|FG003|Overall Study|Death|0|||
27686345|NCT05007080|80687739|FG004|Overall Study|Death|0|||
27686346|NCT05007080|80687740|FG005|Overall Study|Death|0|||
27686347|NCT05007080|80687735|FG000|Overall Study|Withdrawal by Subject|1|||
27686348|NCT05007080|80687736|FG001|Overall Study|Withdrawal by Subject|2|||
27686349|NCT05007080|80687737|FG002|Overall Study|Withdrawal by Subject|0|||
27686350|NCT05007080|80687738|FG003|Overall Study|Withdrawal by Subject|2|||
27686351|NCT05007080|80687739|FG004|Overall Study|Withdrawal by Subject|1|||
27686352|NCT05007080|80687740|FG005|Overall Study|Withdrawal by Subject|1|||
27686353|NCT05007080|80687735|FG000|Overall Study|Other|1|||
27686354|NCT05007080|80687736|FG001|Overall Study|Other|0|||
27686355|NCT05007080|80687737|FG002|Overall Study|Other|1|||
27686356|NCT05007080|80687738|FG003|Overall Study|Other|1|||
27686357|NCT05007080|80687739|FG004|Overall Study|Other|0|||
27686358|NCT05007080|80687740|FG005|Overall Study|Other|2|||
27686359|NCT05007080|80687735|FG000|Overall Study|Randomized not vaccinated|0|||
27686360|NCT05007080|80687736|FG001|Overall Study|Randomized not vaccinated|0|||
27686361|NCT05007080|80687737|FG002|Overall Study|Randomized not vaccinated|0|||
27686362|NCT05007080|80687738|FG003|Overall Study|Randomized not vaccinated|0|||
27686363|NCT05007080|80687739|FG004|Overall Study|Randomized not vaccinated|0|||
27686364|NCT05007080|80687740|FG005|Overall Study|Randomized not vaccinated|1|||
27686365|NCT00540046|80687742|FG000|Overall Study|Lost to Follow-up|33|||
27686366|NCT00540046|80687743|FG001|Overall Study|Lost to Follow-up|23|||
27686367|NCT02217501|80687744|FG000|Overall Study|Death|3|||
27686368|NCT02217501|80687745|FG001|Overall Study|Death|4|||
27686369|NCT02874924|80687746|FG000|Overall Study|Adverse Event|2|||
27686370|NCT02874924|80687747|FG001|Overall Study|Adverse Event|0|||
27686371|NCT02874924|80687748|FG002|Overall Study|Adverse Event|0|||
27686372|NCT02874924|80687746|FG000|Overall Study|Withdrawal by Subject|1|||
27686373|NCT02874924|80687747|FG001|Overall Study|Withdrawal by Subject|0|||
27686374|NCT02874924|80687748|FG002|Overall Study|Withdrawal by Subject|0|||
27686375|NCT04371198|80687749|FG000|Overall Study|inadequate sample|4|||
27686376|NCT00296400|80687750|FG000|Overall Study|Adverse Event|7|||
27686377|NCT00296400|80687751|FG001|Overall Study|Adverse Event|7|||
27686378|NCT00296400|80687752|FG002|Overall Study|Adverse Event|7|||
27686379|NCT00296400|80687750|FG000|Overall Study|Withdrawal by Subject|5|||
27686380|NCT00296400|80687751|FG001|Overall Study|Withdrawal by Subject|6|||
27686381|NCT00296400|80687752|FG002|Overall Study|Withdrawal by Subject|2|||
27686382|NCT00296400|80687750|FG000|Overall Study|Incorrect enrollment|2|||
27686383|NCT00296400|80687751|FG001|Overall Study|Incorrect enrollment|0|||
27686384|NCT00296400|80687752|FG002|Overall Study|Incorrect enrollment|0|||
27686385|NCT00296400|80687750|FG000|Overall Study|Protocol Violation|1|||
27686386|NCT00296400|80687751|FG001|Overall Study|Protocol Violation|1|||
27686387|NCT00296400|80687752|FG002|Overall Study|Protocol Violation|1|||
27686388|NCT00296400|80687750|FG000|Overall Study|Lost to Follow-up|1|||
27686389|NCT00296400|80687751|FG001|Overall Study|Lost to Follow-up|1|||
27686390|NCT00296400|80687752|FG002|Overall Study|Lost to Follow-up|2|||
27811599|NCT04634409|81141153|FG007|Overall Study|Other - As reported by Investigator|6|||
27587186|NCT03131648|80331679|FG001|Open-label Treatment|Discontinued IMP|0|||
27686391|NCT00296400|80687750|FG000|Overall Study|Study specific discontinuation criteria|0|||
27686392|NCT00296400|80687751|FG001|Overall Study|Study specific discontinuation criteria|0|||
27811600|NCT04634409|81141154|FG008|Overall Study|Other - As reported by Investigator|4|||
27686393|NCT00296400|80687752|FG002|Overall Study|Study specific discontinuation criteria|1|||
27686394|NCT00296400|80687750|FG000|Overall Study|Visit 10 was performed earlier|0|||
27686395|NCT00296400|80687751|FG001|Overall Study|Visit 10 was performed earlier|1|||
27686396|NCT00296400|80687752|FG002|Overall Study|Visit 10 was performed earlier|0|||
27811601|NCT04634409|81141155|FG009|Overall Study|Other - As reported by Investigator|0|||
27811602|NCT04634409|81141156|FG010|Overall Study|Other - As reported by Investigator|1|||
27686397|NCT00296400|80687750|FG000|Overall Study|Pregnancy|1|||
27686398|NCT00296400|80687751|FG001|Overall Study|Pregnancy|2|||
27686399|NCT00296400|80687752|FG002|Overall Study|Pregnancy|0|||
27686400|NCT00356408|80687753|FG000|Overall Study|Adverse Event|9|||
27686401|NCT00356408|80687753|FG000|Overall Study|Lack of Efficacy|36|||
27811603|NCT04634409|81141157|FG011|Overall Study|Other - As reported by Investigator|2|||
27686402|NCT00356408|80687753|FG000|Overall Study|Lost to Follow-up|2|||
27811604|NCT04634409|81141158|FG012|Overall Study|Other - As reported by Investigator|2|||
27875615|NCT03759392|81375472|FG001|Overall Study|Adverse Event|4|||
27875616|NCT03759392|81375471|FG000|Overall Study|Death|2|||
27686403|NCT00356408|80687753|FG000|Overall Study|Withdrawal by Subject|6|||
27686404|NCT00356408|80687753|FG000|Overall Study|Other: Principal investigator discretion|3|||
27686405|NCT00356408|80687753|FG000|Overall Study|Other: Sponsor request|1|||
27686406|NCT00356408|80687753|FG000|Overall Study|Other: Azathioprine stopped|1|||
27686407|NCT00356408|80687753|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
27686408|NCT00356408|80687753|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
27686409|NCT02412371|80687754|FG000|Overall Study|Withdrawal by Subject|0|||
27686410|NCT02412371|80687755|FG001|Overall Study|Withdrawal by Subject|2|||
27686411|NCT02412371|80687756|FG002|Overall Study|Withdrawal by Subject|0|||
27686412|NCT02412371|80687757|FG003|Overall Study|Withdrawal by Subject|1|||
27686413|NCT02412371|80687758|FG004|Overall Study|Withdrawal by Subject|1|||
27686414|NCT02412371|80687759|FG005|Overall Study|Withdrawal by Subject|0|||
27811605|NCT04634409|81141159|FG013|Overall Study|Other - As reported by Investigator|1|||
27875617|NCT03759392|81375472|FG001|Overall Study|Death|1|||
27875618|NCT03759392|81375471|FG000|Overall Study|Withdrawal by Subject|2|||
27875619|NCT03759392|81375472|FG001|Overall Study|Withdrawal by Subject|0|||
27875620|NCT03759392|81375471|FG000|Overall Study|Protocol Violation|2|||
27875621|NCT03759392|81375472|FG001|Overall Study|Protocol Violation|0|||
27875622|NCT03759392|81375471|FG000|Overall Study|Physician Decision|0|||
27875623|NCT03759392|81375472|FG001|Overall Study|Physician Decision|1|||
28007798|NCT03182374|81859655|FG001|Overall Study|Lack of Efficacy|14|||
28007799|NCT03182374|81859654|FG000|Overall Study|Withdrawal by Subject|1|||
27587187|NCT03131648|80331680|FG002|Open-label Treatment|Discontinued IMP|0|||
27811606|NCT04634409|81141160|FG014|Overall Study|Other - As reported by Investigator|0|||
27811607|NCT04634409|81141161|FG015|Overall Study|Other - As reported by Investigator|0|||
27811608|NCT04634409|81141162|FG016|Overall Study|Other - As reported by Investigator|0|||
27811609|NCT04634409|81141163|FG017|Overall Study|Other - As reported by Investigator|0|||
27811610|NCT04634409|81141164|FG018|Overall Study|Other - As reported by Investigator|0|||
27587188|NCT03131648|80331681|FG003|Open-label Treatment|Discontinued IMP|0|||
27587189|NCT03131648|80331682|FG004|Open-label Treatment|Discontinued IMP|0|||
27587190|NCT03131648|80331683|FG005|Open-label Treatment|Discontinued IMP|0|||
27587191|NCT03131648|80331684|FG006|Open-label Treatment|Discontinued IMP|112|||
27587192|NCT03131648|80331685|FG007|Open-label Treatment|Discontinued IMP|0|||
27587193|NCT03131648|80331678|FG000|Open-label Treatment|Completed Week 50|0|||
27587194|NCT03131648|80331679|FG001|Open-label Treatment|Completed Week 50|0|||
27587195|NCT03131648|80331680|FG002|Open-label Treatment|Completed Week 50|0|||
27587196|NCT03131648|80331681|FG003|Open-label Treatment|Completed Week 50|0|||
27587197|NCT03131648|80331682|FG004|Open-label Treatment|Completed Week 50|0|||
27587198|NCT03131648|80331683|FG005|Open-label Treatment|Completed Week 50|0|||
27587199|NCT03131648|80331684|FG006|Open-label Treatment|Completed Week 50|6|||
27587200|NCT03131648|80331685|FG007|Open-label Treatment|Completed Week 50|0|||
27587201|NCT03131648|80331678|FG000|Maintenance Treatment Period|Not dosed|0|||
27587202|NCT03131648|80331679|FG001|Maintenance Treatment Period|Not dosed|0|||
27587203|NCT03131648|80331680|FG002|Maintenance Treatment Period|Not dosed|3|||
27587204|NCT03131648|80331681|FG003|Maintenance Treatment Period|Not dosed|2|||
27587205|NCT03131648|80331682|FG004|Maintenance Treatment Period|Not dosed|1|||
27587206|NCT03131648|80331683|FG005|Maintenance Treatment Period|Not dosed|0|||
27587207|NCT03131648|80331684|FG006|Maintenance Treatment Period|Not dosed|0|||
27587208|NCT03131648|80331685|FG007|Maintenance Treatment Period|Not dosed|0|||
27587209|NCT03131648|80331678|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
27587210|NCT03131648|80331679|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
27587211|NCT03131648|80331680|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
27587212|NCT03131648|80331681|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
27587213|NCT03131648|80331682|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
27587214|NCT03131648|80331683|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
27587215|NCT03131648|80331684|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
27587216|NCT03131648|80331685|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
27587217|NCT03131648|80331678|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27587218|NCT03131648|80331679|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27686415|NCT02412371|80687754|FG000|Overall Study|Sponsor Discontinued Study|1|||
27686416|NCT02412371|80687755|FG001|Overall Study|Sponsor Discontinued Study|4|||
27875624|NCT03759392|81375471|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
28007800|NCT03182374|81859655|FG001|Overall Study|Withdrawal by Subject|1|||
27587219|NCT03131648|80331680|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
27587220|NCT03131648|80331681|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
27587221|NCT03131648|80331682|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
27587222|NCT03131648|80331683|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
27587223|NCT03131648|80331684|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27686417|NCT02412371|80687756|FG002|Overall Study|Sponsor Discontinued Study|6|||
27587224|NCT03131648|80331685|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
27587225|NCT03131648|80331678|FG000|Maintenance Treatment Period|Completed Week 50|0|||
27587226|NCT03131648|80331679|FG001|Maintenance Treatment Period|Completed Week 50|0|||
27587227|NCT03131648|80331680|FG002|Maintenance Treatment Period|Completed Week 50|0|||
27587228|NCT03131648|80331681|FG003|Maintenance Treatment Period|Completed Week 50|0|||
27587229|NCT03131648|80331682|FG004|Maintenance Treatment Period|Completed Week 50|1|||
27587230|NCT03131648|80331683|FG005|Maintenance Treatment Period|Completed Week 50|0|||
27587231|NCT03131648|80331684|FG006|Maintenance Treatment Period|Completed Week 50|0|||
27587232|NCT03131648|80331685|FG007|Maintenance Treatment Period|Completed Week 50|0|||
27587233|NCT03131648|80331678|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587234|NCT03131648|80331679|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587235|NCT03131648|80331680|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587236|NCT03131648|80331681|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587237|NCT03131648|80331682|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587238|NCT03131648|80331683|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587239|NCT03131648|80331684|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
27587240|NCT03131648|80331685|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
27587241|NCT00990652|80331686|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
27587242|NCT00990652|80331686|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
27587243|NCT03859323|80331689|FG000|Overall Study|Lost to Follow-up|0|||
27587244|NCT03859323|80331690|FG001|Overall Study|Lost to Follow-up|0|||
27587245|NCT03859323|80331691|FG002|Overall Study|Lost to Follow-up|0|||
27587246|NCT03859323|80331692|FG003|Overall Study|Lost to Follow-up|0|||
27587247|NCT03859323|80331693|FG004|Overall Study|Lost to Follow-up|0|||
27587248|NCT03859323|80331694|FG005|Overall Study|Lost to Follow-up|0|||
27587249|NCT03859323|80331695|FG006|Overall Study|Lost to Follow-up|1|||
27587250|NCT03859323|80331696|FG007|Overall Study|Lost to Follow-up|0|||
27587251|NCT03859323|80331697|FG008|Overall Study|Lost to Follow-up|0|||
27587252|NCT03859323|80331698|FG009|Overall Study|Lost to Follow-up|0|||
27587253|NCT03859323|80331699|FG010|Overall Study|Lost to Follow-up|0|||
27587254|NCT03859323|80331700|FG011|Overall Study|Lost to Follow-up|0|||
27587255|NCT03859323|80331701|FG012|Overall Study|Lost to Follow-up|0|||
27587256|NCT03859323|80331689|FG000|Overall Study|Withdrawal by Subject|0|||
27587257|NCT03859323|80331690|FG001|Overall Study|Withdrawal by Subject|0|||
27587258|NCT03859323|80331691|FG002|Overall Study|Withdrawal by Subject|1|||
27587259|NCT03859323|80331692|FG003|Overall Study|Withdrawal by Subject|0|||
27587260|NCT03859323|80331693|FG004|Overall Study|Withdrawal by Subject|0|||
27587261|NCT03859323|80331694|FG005|Overall Study|Withdrawal by Subject|1|||
27587262|NCT03859323|80331695|FG006|Overall Study|Withdrawal by Subject|0|||
27587263|NCT03859323|80331696|FG007|Overall Study|Withdrawal by Subject|0|||
27587264|NCT03859323|80331697|FG008|Overall Study|Withdrawal by Subject|0|||
27587265|NCT03859323|80331698|FG009|Overall Study|Withdrawal by Subject|1|||
27587266|NCT03859323|80331699|FG010|Overall Study|Withdrawal by Subject|1|||
27587267|NCT03859323|80331700|FG011|Overall Study|Withdrawal by Subject|2|||
27587268|NCT03859323|80331701|FG012|Overall Study|Withdrawal by Subject|1|||
27587269|NCT03859323|80331689|FG000|Overall Study|Pregnancy|0|||
27587270|NCT03859323|80331690|FG001|Overall Study|Pregnancy|0|||
27587271|NCT03859323|80331691|FG002|Overall Study|Pregnancy|0|||
27587272|NCT03859323|80331692|FG003|Overall Study|Pregnancy|0|||
27587273|NCT03859323|80331693|FG004|Overall Study|Pregnancy|0|||
27587274|NCT03859323|80331694|FG005|Overall Study|Pregnancy|0|||
27587275|NCT03859323|80331695|FG006|Overall Study|Pregnancy|0|||
27587276|NCT03859323|80331696|FG007|Overall Study|Pregnancy|0|||
27587277|NCT03859323|80331697|FG008|Overall Study|Pregnancy|0|||
27587278|NCT03859323|80331698|FG009|Overall Study|Pregnancy|1|||
27587279|NCT03859323|80331699|FG010|Overall Study|Pregnancy|0|||
27587280|NCT03859323|80331700|FG011|Overall Study|Pregnancy|0|||
27587281|NCT03859323|80331701|FG012|Overall Study|Pregnancy|0|||
27587282|NCT00586105|80331707|FG000|Overall Study|Adverse Event|4|||
27587283|NCT00586105|80331707|FG000|Overall Study|Death|2|||
27587284|NCT00586105|80331707|FG000|Overall Study|Protocol Violation|1|||
27587285|NCT00586105|80331707|FG000|Overall Study|Withdrawal by Subject|3|||
28007801|NCT03182374|81859654|FG000|Overall Study|exit for non-compliance|1|||
28007802|NCT03182374|81859655|FG001|Overall Study|exit for non-compliance|1|||
27587286|NCT00586105|80331707|FG000|Overall Study|Disease progression|19|||
27587287|NCT00586105|80331707|FG000|Overall Study|Switched to commercial drug|9|||
27587288|NCT00586105|80331707|FG000|Overall Study|Reason not reported|1|||
27587289|NCT00562159|80331710|FG000|Overall Study|Adverse Event|11|||
27587290|NCT00562159|80331711|FG001|Overall Study|Adverse Event|8|||
27587291|NCT00562159|80331710|FG000|Overall Study|Lost to Follow-up|5|||
27587292|NCT00562159|80331711|FG001|Overall Study|Lost to Follow-up|4|||
27587293|NCT00562159|80331710|FG000|Overall Study|Withdrawal by Subject|9|||
27587294|NCT00562159|80331711|FG001|Overall Study|Withdrawal by Subject|8|||
27686418|NCT02412371|80687757|FG003|Overall Study|Sponsor Discontinued Study|4|||
28007803|NCT03182374|81859654|FG000|Overall Study|one subject was randomized but not treated|1|||
27587295|NCT00562159|80331710|FG000|Overall Study|Protocol Violation|12|||
27587296|NCT00562159|80331711|FG001|Overall Study|Protocol Violation|12|||
27587297|NCT00562159|80331710|FG000|Overall Study|Did not meet protocol eligibility|1|||
27587298|NCT00562159|80331711|FG001|Overall Study|Did not meet protocol eligibility|1|||
27587299|NCT01153633|80331715|FG000|Overall Study|Protocol Violation|1|||
27587300|NCT01153633|80331716|FG001|Overall Study|Protocol Violation|1|||
27811611|NCT04634409|81141165|FG019|Overall Study|Other - As reported by Investigator|0|||
27587301|NCT01153633|80331715|FG000|Overall Study|Therapeutic failure|3|||
27811612|NCT04634409|81141166|FG020|Overall Study|Other - As reported by Investigator|0|||
27811613|NCT04634409|81141167|FG021|Overall Study|Other - As reported by Investigator|0|||
27811614|NCT04634409|81141168|FG022|Overall Study|Other - As reported by Investigator|0|||
27811615|NCT04634409|81141169|FG023|Overall Study|Other - As reported by Investigator|0|||
28007804|NCT03182374|81859655|FG001|Overall Study|one subject was randomized but not treated|0|||
28007805|NCT03182374|81859654|FG000|Overall Study|Other reasons|0|||
28007806|NCT03182374|81859655|FG001|Overall Study|Other reasons|3|||
28007807|NCT01451606|81859662|FG000|Overall Study|Withdrawal by Subject|4|||
28007808|NCT01451606|81859663|FG001|Overall Study|Withdrawal by Subject|3|||
28007809|NCT03547518|81859668|FG000|Overall Study|Lost to Follow-up|2|||
28007810|NCT03547518|81859669|FG001|Overall Study|Lost to Follow-up|0|||
28007811|NCT05473026|81859670|FG000|Overall Study|Lost to Follow-up|5|||
28007812|NCT05473026|81859671|FG001|Overall Study|Lost to Follow-up|2|||
28007813|NCT00865345|81859673|FG000|Overall Study|Withdrawal by Subject|2|||
28007814|NCT00667628|81859679|FG000|Overall Study|Lost to Follow-up|1|||
28007815|NCT00667628|81859680|FG001|Overall Study|Lost to Follow-up|0|||
28007816|NCT00667628|81859679|FG000|Overall Study|Death|6|||
28007817|NCT00667628|81859680|FG001|Overall Study|Death|6|||
28007818|NCT00667628|81859679|FG000|Overall Study|Investigator Considers in Best Interest|1|||
28007819|NCT00667628|81859680|FG001|Overall Study|Investigator Considers in Best Interest|0|||
28007820|NCT00667628|81859679|FG000|Overall Study|Sponsor Terminated Study|17|||
28007821|NCT00667628|81859680|FG001|Overall Study|Sponsor Terminated Study|21|||
28007822|NCT03744312|81859684|FG000|Overall Study|Withdrawal by Subject|0|||
28007823|NCT03744312|81859685|FG001|Overall Study|Withdrawal by Subject|1|||
28007824|NCT03744312|81859684|FG000|Overall Study|Screen fail|0|||
28007825|NCT03744312|81859685|FG001|Overall Study|Screen fail|1|||
28007826|NCT01415882|81859691|FG000|Overall Study|Ineligible|1|||
28007827|NCT01415882|81859692|FG001|Overall Study|Ineligible|0|||
28007828|NCT01415882|81859693|FG002|Overall Study|Ineligible|0|||
28007829|NCT01415882|81859694|FG003|Overall Study|Ineligible|3|||
28007830|NCT01415882|81859695|FG004|Overall Study|Ineligible|0|||
28007831|NCT01415882|81859691|FG000|Overall Study|Withdrawal by Subject|0|||
28007832|NCT01415882|81859692|FG001|Overall Study|Withdrawal by Subject|1|||
28007833|NCT01415882|81859693|FG002|Overall Study|Withdrawal by Subject|0|||
28007834|NCT01415882|81859694|FG003|Overall Study|Withdrawal by Subject|1|||
28007835|NCT01415882|81859695|FG004|Overall Study|Withdrawal by Subject|0|||
28007836|NCT04529083|81859696|FG000|Overall Study|Withdrawal by Subject|3|||
28007837|NCT04949191|81859698|FG000|Overall Study|Non-compliance with Study Drug|1|||
28007838|NCT04949191|81859699|FG001|Overall Study|Non-compliance with Study Drug|0|||
28007839|NCT04949191|81859700|FG002|Overall Study|Non-compliance with Study Drug|0|||
28007840|NCT04949191|81859701|FG003|Overall Study|Non-compliance with Study Drug|0|||
28007841|NCT04949191|81859698|FG000|Overall Study|Progressive Disease|0|||
28007842|NCT04949191|81859699|FG001|Overall Study|Progressive Disease|1|||
28007843|NCT04949191|81859700|FG002|Overall Study|Progressive Disease|0|||
28007844|NCT04949191|81859701|FG003|Overall Study|Progressive Disease|0|||
28007845|NCT04949191|81859698|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
28007846|NCT04949191|81859699|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
28007847|NCT04949191|81859700|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
28007848|NCT04949191|81859701|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
28007849|NCT04949191|81859698|FG000|Overall Study|Sponsor Terminated Study|0|||
28007850|NCT04949191|81859699|FG001|Overall Study|Sponsor Terminated Study|0|||
28007851|NCT04949191|81859700|FG002|Overall Study|Sponsor Terminated Study|1|||
28007852|NCT04949191|81859701|FG003|Overall Study|Sponsor Terminated Study|1|||
28007853|NCT03770260|81859702|FG000|Overall Study|Disease progression|0|||
28007854|NCT03770260|81859703|FG001|Overall Study|Disease progression|1|||
28007855|NCT03770260|81859704|FG002|Overall Study|Disease progression|0|||
28007856|NCT03770260|81859705|FG003|Overall Study|Disease progression|0|||
28007857|NCT02475681|81859706|FG000|Overall Study|Death|16|||
28007858|NCT02475681|81859707|FG001|Overall Study|Death|6|||
28007859|NCT02475681|81859708|FG002|Overall Study|Death|9|||
28007860|NCT02475681|81859706|FG000|Overall Study|Physician Decision|0|||
28007861|NCT02475681|81859707|FG001|Overall Study|Physician Decision|3|||
28007862|NCT02475681|81859708|FG002|Overall Study|Physician Decision|1|||
28007863|NCT02475681|81859706|FG000|Overall Study|Withdrawal by Subject|12|||
28007864|NCT02475681|81859707|FG001|Overall Study|Withdrawal by Subject|6|||
28007865|NCT02475681|81859708|FG002|Overall Study|Withdrawal by Subject|9|||
28007866|NCT02475681|81859706|FG000|Overall Study|Lost to Follow-up|2|||
28007867|NCT02475681|81859707|FG001|Overall Study|Lost to Follow-up|1|||
27811616|NCT04634409|81141170|FG024|Overall Study|Other - As reported by Investigator|0|||
27811617|NCT04634409|81141171|FG025|Overall Study|Other - As reported by Investigator|0|||
27811618|NCT04634409|81141172|FG026|Overall Study|Other - As reported by Investigator|0|||
27811619|NCT00419926|81141173|FG000|Overall Study|Withdrawal by Subject|7|||
28007868|NCT02475681|81859708|FG002|Overall Study|Lost to Follow-up|3|||
28007869|NCT02475681|81859706|FG000|Overall Study|Ongoing in Study|0|||
28007870|NCT02475681|81859707|FG001|Overall Study|Ongoing in Study|163|||
28007871|NCT02475681|81859708|FG002|Overall Study|Ongoing in Study|157|||
28007872|NCT02475681|81859706|FG000|Overall Study|Reasons other than above listed|2|||
28007873|NCT02475681|81859707|FG001|Overall Study|Reasons other than above listed|0|||
28007874|NCT02475681|81859708|FG002|Overall Study|Reasons other than above listed|0|||
28007875|NCT04196686|81859710|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
28007876|NCT04196686|81859711|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
27875625|NCT03759392|81375472|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
27875626|NCT03759392|81375471|FG000|Overall Study|No longer able to take medicines|1|||
27875627|NCT03759392|81375472|FG001|Overall Study|No longer able to take medicines|0|||
27875628|NCT03759392|81375471|FG000|Overall Study|Stopped taking study drug|1|||
27875629|NCT03759392|81375472|FG001|Overall Study|Stopped taking study drug|0|||
27875630|NCT00745901|81375474|FG000|Overall Study|Adverse Event|3|||
27875631|NCT00745901|81375475|FG001|Overall Study|Adverse Event|4|||
27875632|NCT00745901|81375474|FG000|Overall Study|Protocol Violation|0|||
27875633|NCT00745901|81375475|FG001|Overall Study|Protocol Violation|1|||
27875634|NCT00745901|81375474|FG000|Overall Study|Withdrawal by Subject|1|||
27875635|NCT00745901|81375475|FG001|Overall Study|Withdrawal by Subject|0|||
27875636|NCT00745901|81375474|FG000|Overall Study|Lost to Follow-up|7|||
27875637|NCT00745901|81375475|FG001|Overall Study|Lost to Follow-up|4|||
27875638|NCT00745901|81375474|FG000|Overall Study|Pregnancy|2|||
28007877|NCT04672239|81859715|FG000|Week 2 Survey|Failed survey check items|1|||
28007878|NCT04672239|81859716|FG001|Week 2 Survey|Failed survey check items|2|||
28007879|NCT04672239|81859717|FG002|Week 2 Survey|Failed survey check items|3|||
28007880|NCT04672239|81859715|FG000|Week 2 Survey|Partially completed survey|7|||
28007881|NCT04672239|81859716|FG001|Week 2 Survey|Partially completed survey|1|||
28007882|NCT04672239|81859717|FG002|Week 2 Survey|Partially completed survey|4|||
28007883|NCT04672239|81859715|FG000|Week 2 Survey|Withdrawal by Subject|0|||
28007884|NCT04672239|81859716|FG001|Week 2 Survey|Withdrawal by Subject|1|||
28007885|NCT04672239|81859717|FG002|Week 2 Survey|Withdrawal by Subject|0|||
28007886|NCT04672239|81859715|FG000|Week 2 Survey|Lost to Follow-up|3|||
28007887|NCT04672239|81859716|FG001|Week 2 Survey|Lost to Follow-up|2|||
28007888|NCT04672239|81859717|FG002|Week 2 Survey|Lost to Follow-up|5|||
28007889|NCT04672239|81859715|FG000|Week 6 Survey|Failed survey check items|2|||
28007890|NCT04672239|81859716|FG001|Week 6 Survey|Failed survey check items|2|||
28007891|NCT04672239|81859717|FG002|Week 6 Survey|Failed survey check items|2|||
28007892|NCT04672239|81859715|FG000|Week 6 Survey|Partially completed survey|3|||
28007893|NCT04672239|81859716|FG001|Week 6 Survey|Partially completed survey|3|||
28007894|NCT04672239|81859717|FG002|Week 6 Survey|Partially completed survey|2|||
28007895|NCT04672239|81859715|FG000|Week 6 Survey|Withdrawal by Subject|1|||
28007896|NCT04672239|81859716|FG001|Week 6 Survey|Withdrawal by Subject|1|||
28007897|NCT04672239|81859717|FG002|Week 6 Survey|Withdrawal by Subject|1|||
28007898|NCT04672239|81859715|FG000|Week 6 Survey|Withdrawn by PI|0|||
28007899|NCT04672239|81859716|FG001|Week 6 Survey|Withdrawn by PI|1|||
28007900|NCT04672239|81859717|FG002|Week 6 Survey|Withdrawn by PI|0|||
28007901|NCT04672239|81859715|FG000|Week 6 Survey|Lost to Follow-up|12|||
28007902|NCT04672239|81859716|FG001|Week 6 Survey|Lost to Follow-up|2|||
28007903|NCT04672239|81859717|FG002|Week 6 Survey|Lost to Follow-up|5|||
28007904|NCT04672239|81859715|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
28007905|NCT04672239|81859716|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
28007906|NCT04672239|81859717|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
28007907|NCT04672239|81859715|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
28007908|NCT04672239|81859716|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
28007909|NCT04672239|81859717|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
28007910|NCT04672239|81859715|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
28007911|NCT04672239|81859716|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
28007912|NCT04672239|81859717|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
28007913|NCT04672239|81859715|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
28007914|NCT04672239|81859716|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
28007915|NCT04672239|81859717|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
28007916|NCT04672239|81859715|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
28007917|NCT04672239|81859716|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
28007918|NCT04672239|81859717|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
28007919|NCT04672239|81859715|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
28007920|NCT04672239|81859716|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
28007921|NCT04672239|81859717|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
28007922|NCT04672239|81859715|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
28007923|NCT04672239|81859716|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
28007924|NCT04672239|81859717|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
28007925|NCT02101775|81859719|FG000|Overall Study|Adverse Event|4|||
27875639|NCT00745901|81375475|FG001|Overall Study|Pregnancy|4|||
27875640|NCT00745901|81375474|FG000|Overall Study|Lack of compliance|2|||
27875641|NCT00745901|81375475|FG001|Overall Study|Lack of compliance|2|||
28007926|NCT02101775|81859720|FG001|Overall Study|Adverse Event|0|||
28007927|NCT02101775|81859721|FG002|Overall Study|Adverse Event|0|||
28007928|NCT02101775|81859719|FG000|Overall Study|Admission to Hospital|0|||
28007929|NCT02101775|81859720|FG001|Overall Study|Admission to Hospital|1|||
28007930|NCT02101775|81859721|FG002|Overall Study|Admission to Hospital|0|||
28007931|NCT03737123|81859722|FG000|Study Treatment|Adverse Event|2|||
28007932|NCT03737123|81859723|FG001|Study Treatment|Adverse Event|0|||
28007933|NCT03737123|81859722|FG000|Study Treatment|Disease Progression|2|||
27875642|NCT00745901|81375474|FG000|Overall Study|Patient's next menses did not start with|1|||
27875643|NCT00745901|81375475|FG001|Overall Study|Patient's next menses did not start with|0|||
27875644|NCT00745901|81375474|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
27875645|NCT00745901|81375475|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
27875646|NCT00745901|81375474|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
27875647|NCT00745901|81375475|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
27875648|NCT00745901|81375474|FG000|Overall Study|Patient didn't take any study medication|7|||
27875649|NCT00745901|81375475|FG001|Overall Study|Patient didn't take any study medication|3|||
27875650|NCT01532934|81375476|FG000|Overall Study|Lost to Follow-up|11|||
27875651|NCT01532934|81375477|FG001|Overall Study|Lost to Follow-up|11|||
27875652|NCT01532934|81375476|FG000|Overall Study|In controlled environment|3|||
27875653|NCT01532934|81375477|FG001|Overall Study|In controlled environment|2|||
27875654|NCT03367819|81375478|FG000|Overall Study|Adverse Event|4|||
27875655|NCT03367819|81375479|FG001|Overall Study|Adverse Event|4|||
27875656|NCT03367819|81375478|FG000|Overall Study|Progressive Disease|15|||
27875657|NCT03367819|81375479|FG001|Overall Study|Progressive Disease|13|||
27875658|NCT03367819|81375478|FG000|Overall Study|Withdrawal by Subject|1|||
27875659|NCT03367819|81375479|FG001|Overall Study|Withdrawal by Subject|0|||
27875660|NCT03367819|81375478|FG000|Overall Study|Other|4|||
27875661|NCT03367819|81375479|FG001|Overall Study|Other|2|||
27875662|NCT03859427|81375480|FG000|Overall Study|Withdrawal by Subject|4|||
27875663|NCT03859427|81375481|FG001|Overall Study|Withdrawal by Subject|7|||
27875664|NCT03859427|81375480|FG000|Overall Study|Decision by sponsor|0|||
27875665|NCT03859427|81375481|FG001|Overall Study|Decision by sponsor|3|||
27875666|NCT03859427|81375480|FG000|Overall Study|Lost to Follow-up|3|||
27875667|NCT03859427|81375481|FG001|Overall Study|Lost to Follow-up|2|||
27875668|NCT03859427|81375480|FG000|Overall Study|Death|22|||
27875669|NCT03859427|81375481|FG001|Overall Study|Death|25|||
27875670|NCT01882985|81375482|FG000|Overall Study|Lost to Follow-up|1|||
27875671|NCT01882985|81375482|FG000|Overall Study|Withdrawal by Subject|1|||
27875672|NCT00699816|81375483|FG000|Overall Study|Protocol Violation|1|||
27875673|NCT00699816|81375484|FG001|Overall Study|Protocol Violation|3|||
27875674|NCT02058069|81375489|FG000|Overall Study|Exclusion due to implant size|5|||
27875675|NCT02058069|81375489|FG000|Overall Study|Withdrawal by Subject|6|||
27875676|NCT01836471|81375490|FG000|Overall Study|Pregnancy|1|||
27875677|NCT01836471|81375491|FG001|Overall Study|Pregnancy|0|||
27875678|NCT01836471|81375492|FG002|Overall Study|Pregnancy|0|||
27875679|NCT01836471|81375493|FG003|Overall Study|Pregnancy|0|||
27875680|NCT01836471|81375494|FG004|Overall Study|Pregnancy|0|||
27875681|NCT01836471|81375490|FG000|Overall Study|Withdrawal by Subject|3|||
27875682|NCT01836471|81375491|FG001|Overall Study|Withdrawal by Subject|4|||
27875683|NCT01836471|81375492|FG002|Overall Study|Withdrawal by Subject|1|||
27875684|NCT01836471|81375493|FG003|Overall Study|Withdrawal by Subject|0|||
27875685|NCT01836471|81375494|FG004|Overall Study|Withdrawal by Subject|2|||
27875686|NCT01836471|81375490|FG000|Overall Study|Physician Decision|0|||
27875687|NCT01836471|81375491|FG001|Overall Study|Physician Decision|1|||
27875688|NCT01836471|81375492|FG002|Overall Study|Physician Decision|0|||
27875689|NCT01836471|81375493|FG003|Overall Study|Physician Decision|0|||
27875690|NCT01836471|81375494|FG004|Overall Study|Physician Decision|0|||
27875691|NCT01836471|81375490|FG000|Overall Study|Lost to Follow-up|0|||
27875692|NCT01836471|81375491|FG001|Overall Study|Lost to Follow-up|0|||
27875693|NCT01836471|81375492|FG002|Overall Study|Lost to Follow-up|0|||
27875694|NCT01836471|81375493|FG003|Overall Study|Lost to Follow-up|1|||
27875695|NCT01836471|81375494|FG004|Overall Study|Lost to Follow-up|1|||
27875696|NCT01836471|81375490|FG000|Overall Study|Adverse Event|6|||
27875697|NCT01836471|81375491|FG001|Overall Study|Adverse Event|3|||
27875698|NCT01836471|81375492|FG002|Overall Study|Adverse Event|1|||
27875699|NCT01836471|81375493|FG003|Overall Study|Adverse Event|1|||
27875700|NCT01836471|81375494|FG004|Overall Study|Adverse Event|2|||
27875701|NCT01836471|81375490|FG000|Overall Study|Non compliance with tx|1|||
27875702|NCT01836471|81375491|FG001|Overall Study|Non compliance with tx|1|||
27875703|NCT01836471|81375492|FG002|Overall Study|Non compliance with tx|0|||
27875704|NCT01836471|81375493|FG003|Overall Study|Non compliance with tx|0|||
27875705|NCT01836471|81375494|FG004|Overall Study|Non compliance with tx|0|||
27875706|NCT01965860|81375495|FG000|Overall Study|Pregnancy|1|||
27875707|NCT01965860|81375496|FG001|Overall Study|Pregnancy|0|||
27875708|NCT01965860|81375497|FG002|Overall Study|Pregnancy|1|||
27875709|NCT01965860|81375495|FG000|Overall Study|Logistics|1|||
27875710|NCT01965860|81375496|FG001|Overall Study|Logistics|0|||
27875711|NCT01965860|81375497|FG002|Overall Study|Logistics|0|||
27875712|NCT01779440|81375500|FG000|Overall Study|Withdrawal by Subject|3|||
27875713|NCT01779440|81375501|FG001|Overall Study|Withdrawal by Subject|5|||
27875714|NCT02837731|81375508|FG000|Allocation|Admitted to General Floor|3|||
27875715|NCT02837731|81375509|FG001|Allocation|Admitted to General Floor|4|||
27875716|NCT02837731|81375508|FG000|Allocation|Immediate surgery/withdrew|2|||
27875717|NCT02837731|81375509|FG001|Allocation|Immediate surgery/withdrew|0|||
27875718|NCT02837731|81375508|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
27875719|NCT02837731|81375509|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
27875720|NCT02837731|81375508|FG000|Allocation|Withdrawal by Subject|2|||
27875721|NCT02837731|81375509|FG001|Allocation|Withdrawal by Subject|0|||
27875722|NCT02837731|81375508|FG000|Allocation|Device not available|1|||
27875723|NCT02837731|81375509|FG001|Allocation|Device not available|0|||
27875724|NCT02837731|81375508|FG000|Allocation|Protocol not implemented|7|||
28007934|NCT03737123|81859723|FG001|Study Treatment|Disease Progression|0|||
28007935|NCT03737123|81859722|FG000|Study Treatment|Withdrawal by Subject|2|||
28007936|NCT03737123|81859723|FG001|Study Treatment|Withdrawal by Subject|0|||
28007937|NCT03737123|81859722|FG000|Follow up|Death|1|||
28007938|NCT03737123|81859723|FG001|Follow up|Death|0|||
28007939|NCT03737123|81859722|FG000|Follow up|Withdrawal by Subject|1|||
28007940|NCT03737123|81859723|FG001|Follow up|Withdrawal by Subject|0|||
28007941|NCT03737123|81859722|FG000|Follow up|Termination of study|4|||
28007942|NCT03737123|81859723|FG001|Follow up|Termination of study|0|||
28007943|NCT00976274|81859730|FG000|Overall Study|Lost to Follow-up|5|||
28007944|NCT00976274|81859731|FG001|Overall Study|Lost to Follow-up|5|||
28007945|NCT00976274|81859730|FG000|Overall Study|Withdrawal by Subject|1|||
28007946|NCT00976274|81859731|FG001|Overall Study|Withdrawal by Subject|1|||
28007947|NCT00976274|81859730|FG000|Overall Study|Physician Decision|1|||
28007948|NCT00976274|81859731|FG001|Overall Study|Physician Decision|2|||
28007949|NCT02891174|81859733|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
28007950|NCT02891174|81859734|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
27811620|NCT00419926|81141174|FG001|Overall Study|Withdrawal by Subject|3|||
27811621|NCT00419926|81141173|FG000|Overall Study|Administrative Problem|4|||
27811622|NCT00419926|81141174|FG001|Overall Study|Administrative Problem|4|||
27811623|NCT00419926|81141173|FG000|Overall Study|Lost to Follow-up|1|||
27811624|NCT00419926|81141174|FG001|Overall Study|Lost to Follow-up|2|||
27811625|NCT00419926|81141173|FG000|Overall Study|Death|2|||
27811626|NCT00419926|81141174|FG001|Overall Study|Death|1|||
27811627|NCT00686036|81141175|FG000|Overall Study|Adverse Event|3|||
27811628|NCT00686036|81141176|FG001|Overall Study|Adverse Event|0|||
27811629|NCT00686036|81141175|FG000|Overall Study|Withdrawal by Subject|3|||
27811630|NCT00686036|81141176|FG001|Overall Study|Withdrawal by Subject|1|||
27811631|NCT00686036|81141175|FG000|Overall Study|Study terminated by AstraZeneca|2|||
27811632|NCT00686036|81141176|FG001|Overall Study|Study terminated by AstraZeneca|1|||
27811633|NCT00686036|81141175|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
27811634|NCT00686036|81141176|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
27811635|NCT00686036|81141175|FG000|Overall Study|Other reasons not identified|0|||
27811636|NCT00686036|81141176|FG001|Overall Study|Other reasons not identified|4|||
27811637|NCT00447603|81141177|FG000|Screening|Withdrawal by Subject|1|||
27811638|NCT00447603|81141178|FG001|Screening|Withdrawal by Subject|0|||
27811639|NCT00447603|81141179|FG002|Screening|Withdrawal by Subject|0|||
27811640|NCT00447603|81141177|FG000|Screening|Protocol Violation|1|||
27811641|NCT00447603|81141178|FG001|Screening|Protocol Violation|0|||
27811642|NCT00447603|81141179|FG002|Screening|Protocol Violation|0|||
27811643|NCT00447603|81141177|FG000|Screening|Screen Failure|4|||
27811644|NCT00447603|81141178|FG001|Screening|Screen Failure|0|||
28007951|NCT02891174|81859733|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
28007952|NCT02891174|81859734|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
27811645|NCT00447603|81141179|FG002|Screening|Screen Failure|0|||
27875725|NCT02837731|81375509|FG001|Allocation|Protocol not implemented|0|||
27811646|NCT00447603|81141177|FG000|Screening|Study Terminated by Sponsor|15|||
27811647|NCT00447603|81141178|FG001|Screening|Study Terminated by Sponsor|0|||
27811648|NCT00447603|81141179|FG002|Screening|Study Terminated by Sponsor|0|||
27811649|NCT00447603|81141177|FG000|Filter Period|Adverse Event|0|||
27811650|NCT00447603|81141178|FG001|Filter Period|Adverse Event|0|||
27811651|NCT00447603|81141179|FG002|Filter Period|Adverse Event|1|||
27811652|NCT00447603|81141177|FG000|Filter Period|Screen Failure|0|||
27811653|NCT00447603|81141178|FG001|Filter Period|Screen Failure|3|||
27811654|NCT00447603|81141179|FG002|Filter Period|Screen Failure|4|||
27811655|NCT00447603|81141177|FG000|Filter Period|Study terminated by Sponsor|0|||
27811656|NCT00447603|81141178|FG001|Filter Period|Study terminated by Sponsor|1|||
27811657|NCT00447603|81141179|FG002|Filter Period|Study terminated by Sponsor|10|||
27811658|NCT02669264|81141180|FG000|Overall Study|Death|5|||
27811659|NCT02669264|81141181|FG001|Overall Study|Death|5|||
27811660|NCT02669264|81141182|FG002|Overall Study|Death|3|||
27811661|NCT02669264|81141183|FG003|Overall Study|Death|3|||
27811662|NCT02669264|81141184|FG004|Overall Study|Death|3|||
27811663|NCT02669264|81141185|FG005|Overall Study|Death|6|||
27811664|NCT02669264|81141186|FG006|Overall Study|Death|3|||
27811665|NCT02669264|81141180|FG000|Overall Study|Withdrawal by Subject|0|||
27811666|NCT02669264|81141181|FG001|Overall Study|Withdrawal by Subject|1|||
27811667|NCT02669264|81141182|FG002|Overall Study|Withdrawal by Subject|0|||
27811668|NCT02669264|81141183|FG003|Overall Study|Withdrawal by Subject|0|||
27811669|NCT02669264|81141184|FG004|Overall Study|Withdrawal by Subject|1|||
27811670|NCT02669264|81141185|FG005|Overall Study|Withdrawal by Subject|0|||
27811671|NCT02669264|81141186|FG006|Overall Study|Withdrawal by Subject|0|||
27811672|NCT02669264|81141180|FG000|Overall Study|Lost to Follow-up|0|||
27811673|NCT02669264|81141181|FG001|Overall Study|Lost to Follow-up|0|||
27811674|NCT02669264|81141182|FG002|Overall Study|Lost to Follow-up|0|||
27811675|NCT02669264|81141183|FG003|Overall Study|Lost to Follow-up|0|||
27811676|NCT02669264|81141184|FG004|Overall Study|Lost to Follow-up|1|||
27811677|NCT02669264|81141185|FG005|Overall Study|Lost to Follow-up|0|||
27811678|NCT02669264|81141186|FG006|Overall Study|Lost to Follow-up|0|||
27811679|NCT02669264|81141180|FG000|Overall Study|Miscellaneous|0|||
27811680|NCT02669264|81141181|FG001|Overall Study|Miscellaneous|0|||
27811681|NCT02669264|81141182|FG002|Overall Study|Miscellaneous|0|||
27811682|NCT02669264|81141183|FG003|Overall Study|Miscellaneous|0|||
27811683|NCT02669264|81141184|FG004|Overall Study|Miscellaneous|0|||
27811684|NCT02669264|81141185|FG005|Overall Study|Miscellaneous|0|||
27811685|NCT02669264|81141186|FG006|Overall Study|Miscellaneous|2|||
27811686|NCT01992107|81141187|FG000|Overall Study|Administrative reasons|2|||
27811687|NCT01992107|81141188|FG001|Overall Study|Administrative reasons|0|||
27811688|NCT01992107|81141189|FG002|Overall Study|Administrative reasons|0|||
27811689|NCT01992107|81141187|FG000|Overall Study|Adverse Event|0|||
27811690|NCT01992107|81141188|FG001|Overall Study|Adverse Event|1|||
27811691|NCT01992107|81141189|FG002|Overall Study|Adverse Event|0|||
27811692|NCT01992107|81141187|FG000|Overall Study|Lost to Follow-up|46|||
27811693|NCT01992107|81141188|FG001|Overall Study|Lost to Follow-up|22|||
27811694|NCT01992107|81141189|FG002|Overall Study|Lost to Follow-up|26|||
27811695|NCT01992107|81141187|FG000|Overall Study|noncompliance and were unavailable|7|||
27811696|NCT01992107|81141188|FG001|Overall Study|noncompliance and were unavailable|3|||
27811697|NCT01992107|81141189|FG002|Overall Study|noncompliance and were unavailable|2|||
27811698|NCT01992107|81141187|FG000|Overall Study|Withdrawal by Subject|13|||
27811699|NCT01992107|81141188|FG001|Overall Study|Withdrawal by Subject|7|||
27587302|NCT01153633|80331716|FG001|Overall Study|Therapeutic failure|3|||
27811700|NCT01992107|81141189|FG002|Overall Study|Withdrawal by Subject|8|||
27811701|NCT00278512|81141202|FG000|Overall Study|Death|1|||
27811702|NCT00278512|81141203|FG001|Overall Study|Death|0|||
27811703|NCT00458302|81141207|FG000|Overall Study|Adverse Event|4|||
27811704|NCT00458302|81141208|FG001|Overall Study|Adverse Event|14|||
27811705|NCT00458302|81141207|FG000|Overall Study|Pregnancy|2|||
27811706|NCT00458302|81141208|FG001|Overall Study|Pregnancy|1|||
27811707|NCT00458302|81141207|FG000|Overall Study|Protocol Violation|0|||
27811708|NCT00458302|81141208|FG001|Overall Study|Protocol Violation|2|||
27811709|NCT00458302|81141207|FG000|Overall Study|Withdrawal by Subject|6|||
27811710|NCT00458302|81141208|FG001|Overall Study|Withdrawal by Subject|4|||
27811711|NCT00458302|81141207|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
27811712|NCT00458302|81141208|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
27811713|NCT00458302|81141207|FG000|Overall Study|Study Termination By Sponsor|1|||
27811714|NCT00458302|81141208|FG001|Overall Study|Study Termination By Sponsor|0|||
27811715|NCT00458302|81141207|FG000|Overall Study|Lost to Follow-up|2|||
27811716|NCT00458302|81141208|FG001|Overall Study|Lost to Follow-up|0|||
27811717|NCT00458302|81141207|FG000|Overall Study|Other|4|||
27811718|NCT00458302|81141208|FG001|Overall Study|Other|2|||
27811719|NCT00601484|81141209|FG000|Overall Study|Adverse Event|0|||
27811720|NCT00601484|81141210|FG001|Overall Study|Adverse Event|1|||
27811721|NCT00601484|81141209|FG000|Overall Study|Lost to Follow-up|4|||
27811722|NCT00601484|81141210|FG001|Overall Study|Lost to Follow-up|3|||
27811723|NCT00601484|81141209|FG000|Overall Study|Lack of Efficacy|0|||
27811724|NCT00601484|81141210|FG001|Overall Study|Lack of Efficacy|2|||
28007953|NCT02891174|81859733|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
28007954|NCT02891174|81859734|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
28007955|NCT02891174|81859733|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
28007956|NCT02891174|81859734|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
28007957|NCT02891174|81859733|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
28007958|NCT02891174|81859734|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
28007959|NCT02891174|81859733|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
27587303|NCT01310036|80331717|FG000|Overall Study|Administrative/other|10|||
27587304|NCT01310036|80331717|FG000|Overall Study|Withdrew Consent|11|||
27587305|NCT01310036|80331717|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
27587306|NCT01310036|80331717|FG000|Overall Study|Progression of Disease|164|||
27587307|NCT01310036|80331717|FG000|Overall Study|Death|1|||
27587308|NCT01310036|80331717|FG000|Overall Study|Adverse event or intercurrent illness|12|||
27587309|NCT03667053|80331720|FG000|Overall Study|Withdrawal by Subject|1|||
27587310|NCT03667053|80331721|FG001|Overall Study|Withdrawal by Subject|0|||
27587311|NCT03667053|80331722|FG002|Overall Study|Withdrawal by Subject|0|||
27587312|NCT01672801|80331723|FG000|Overall Study|Screen Failure|0|||
27587313|NCT01672801|80331724|FG001|Overall Study|Screen Failure|1|||
27587314|NCT02363738|80331725|FG000|Overall Study|Adverse Event|5|||
27587315|NCT02363738|80331726|FG001|Overall Study|Adverse Event|2|||
27587316|NCT02363738|80331725|FG000|Overall Study|Lack of Efficacy|1|||
27587317|NCT02363738|80331726|FG001|Overall Study|Lack of Efficacy|2|||
27587318|NCT02363738|80331725|FG000|Overall Study|Lost to Follow-up|2|||
27587319|NCT02363738|80331726|FG001|Overall Study|Lost to Follow-up|1|||
27811725|NCT00601484|81141209|FG000|Overall Study|Withdrawal by Subject|1|||
27811726|NCT00601484|81141210|FG001|Overall Study|Withdrawal by Subject|1|||
27811727|NCT00601484|81141209|FG000|Overall Study|Randomized, but not treated|0|||
27811728|NCT00601484|81141210|FG001|Overall Study|Randomized, but not treated|1|||
27811729|NCT04527471|81141232|FG000|Overall Study|Adverse Event|1|||
27811730|NCT04527471|81141233|FG001|Overall Study|Adverse Event|0|||
27811731|NCT04527471|81141232|FG000|Overall Study|Lost to Follow-up|1|||
27875726|NCT02837731|81375508|FG000|Allocation|Moribund/Do not resuscitate|2|||
27587320|NCT03034577|80331732|FG000|Overall Study|Withdrawal by Subject|6|||
27587321|NCT03034577|80331733|FG001|Overall Study|Withdrawal by Subject|9|||
27587322|NCT03034577|80331732|FG000|Overall Study|Lost to Follow-up|25|||
27587323|NCT03034577|80331733|FG001|Overall Study|Lost to Follow-up|26|||
27587324|NCT03778294|80331739|FG000|Overall Study|Death|1|||
27587325|NCT03778294|80331739|FG000|Overall Study|Issues with insurance|1|||
27587326|NCT03778294|80331739|FG000|Overall Study|disease progression before treatment|2|||
27811732|NCT04527471|81141233|FG001|Overall Study|Lost to Follow-up|0|||
27811733|NCT02708277|81141234|FG000|Overall Study|Lost to Follow-up|7|||
27811734|NCT02708277|81141235|FG001|Overall Study|Lost to Follow-up|4|||
27811735|NCT01842958|81141236|FG000|Overall Study|Lost to Follow-up|1|||
27811736|NCT01842958|81141237|FG001|Overall Study|Lost to Follow-up|1|||
27875727|NCT02837731|81375509|FG001|Allocation|Moribund/Do not resuscitate|0|||
27587327|NCT02044510|80331740|FG000|Overall Study|Adverse Event|1|||
27587328|NCT02044510|80331741|FG001|Overall Study|Adverse Event|2|||
27875728|NCT02837731|81375508|FG000|Allocation|Did not meet sepsis criteria|1|||
27686419|NCT02412371|80687758|FG004|Overall Study|Sponsor Discontinued Study|5|||
27686420|NCT02412371|80687759|FG005|Overall Study|Sponsor Discontinued Study|0|||
27686421|NCT02412371|80687754|FG000|Overall Study|Death|4|||
27686422|NCT02412371|80687755|FG001|Overall Study|Death|2|||
27686423|NCT02412371|80687756|FG002|Overall Study|Death|1|||
27686424|NCT02412371|80687757|FG003|Overall Study|Death|3|||
27686425|NCT02412371|80687758|FG004|Overall Study|Death|5|||
27686426|NCT02412371|80687759|FG005|Overall Study|Death|2|||
27686427|NCT02412371|80687754|FG000|Overall Study|Other|2|||
27686428|NCT02412371|80687755|FG001|Overall Study|Other|1|||
27686429|NCT02412371|80687756|FG002|Overall Study|Other|0|||
27686430|NCT02412371|80687757|FG003|Overall Study|Other|0|||
27686431|NCT02412371|80687758|FG004|Overall Study|Other|1|||
27686432|NCT02412371|80687759|FG005|Overall Study|Other|3|||
27686433|NCT00384189|80687760|FG000|Overall Study|Reason Not Specified|50|||
27686434|NCT00384189|80687761|FG001|Overall Study|Reason Not Specified|57|||
27686435|NCT00384189|80687762|FG002|Overall Study|Reason Not Specified|58|||
27686436|NCT00384189|80687763|FG003|Overall Study|Reason Not Specified|40|||
27686437|NCT03590366|80687764|FG000|Overall Study|Adverse Event|0|||
27686438|NCT03590366|80687765|FG001|Overall Study|Adverse Event|3|||
27686439|NCT03590366|80687764|FG000|Overall Study|Lost to Follow-up|3|||
27686440|NCT03590366|80687765|FG001|Overall Study|Lost to Follow-up|3|||
27686441|NCT03590366|80687764|FG000|Overall Study|Withdrawal by Subject|0|||
27686442|NCT03590366|80687765|FG001|Overall Study|Withdrawal by Subject|2|||
27686443|NCT01097707|80687767|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27686444|NCT01097707|80687768|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27686445|NCT01097707|80687769|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27686446|NCT01097707|80687770|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27686447|NCT01097707|80687771|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27686448|NCT01097707|80687767|FG000|Overall Study|Adverse Event|4|||
27686449|NCT01097707|80687768|FG001|Overall Study|Adverse Event|2|||
27686450|NCT01097707|80687769|FG002|Overall Study|Adverse Event|3|||
27686451|NCT01097707|80687770|FG003|Overall Study|Adverse Event|1|||
27686452|NCT01097707|80687771|FG004|Overall Study|Adverse Event|3|||
27686453|NCT01097707|80687767|FG000|Overall Study|Entry Criteria Not Met|2|||
27686454|NCT01097707|80687768|FG001|Overall Study|Entry Criteria Not Met|1|||
27686455|NCT01097707|80687769|FG002|Overall Study|Entry Criteria Not Met|1|||
27686456|NCT01097707|80687770|FG003|Overall Study|Entry Criteria Not Met|0|||
27686457|NCT01097707|80687771|FG004|Overall Study|Entry Criteria Not Met|1|||
27686458|NCT01097707|80687767|FG000|Overall Study|Lack of Efficacy|1|||
27686459|NCT01097707|80687768|FG001|Overall Study|Lack of Efficacy|0|||
27686460|NCT01097707|80687769|FG002|Overall Study|Lack of Efficacy|0|||
27686461|NCT01097707|80687770|FG003|Overall Study|Lack of Efficacy|1|||
27686462|NCT01097707|80687771|FG004|Overall Study|Lack of Efficacy|0|||
27686463|NCT01097707|80687767|FG000|Overall Study|Lost to Follow-up|1|||
27686464|NCT01097707|80687768|FG001|Overall Study|Lost to Follow-up|1|||
27686465|NCT01097707|80687769|FG002|Overall Study|Lost to Follow-up|2|||
27686466|NCT01097707|80687770|FG003|Overall Study|Lost to Follow-up|0|||
27686467|NCT01097707|80687771|FG004|Overall Study|Lost to Follow-up|3|||
27811737|NCT00434161|81141241|FG000|Overall Study|Adverse Event|5|||
27811738|NCT00434161|81141242|FG001|Overall Study|Adverse Event|1|||
27811739|NCT00434161|81141243|FG002|Overall Study|Adverse Event|4|||
27811740|NCT00434161|81141241|FG000|Overall Study|Lost to Follow-up|0|||
27811741|NCT00434161|81141242|FG001|Overall Study|Lost to Follow-up|1|||
27811742|NCT00434161|81141243|FG002|Overall Study|Lost to Follow-up|0|||
27811743|NCT00434161|81141241|FG000|Overall Study|Death|1|||
27811744|NCT00434161|81141242|FG001|Overall Study|Death|0|||
27811745|NCT00434161|81141243|FG002|Overall Study|Death|1|||
27811746|NCT00434161|81141241|FG000|Overall Study|Non-Compliance|1|||
27811747|NCT00434161|81141242|FG001|Overall Study|Non-Compliance|1|||
28007960|NCT02891174|81859734|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
28007961|NCT02891174|81859733|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
28007962|NCT02891174|81859734|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
27811748|NCT00434161|81141243|FG002|Overall Study|Non-Compliance|0|||
27811749|NCT00434161|81141241|FG000|Overall Study|Withdrawal by Subject|2|||
27811750|NCT00434161|81141242|FG001|Overall Study|Withdrawal by Subject|0|||
27811751|NCT00434161|81141243|FG002|Overall Study|Withdrawal by Subject|3|||
28007963|NCT03291067|81859735|FG000|Overall Study|Adverse Event|0|||
27686468|NCT01097707|80687767|FG000|Overall Study|Protocol Violation|2|||
27686469|NCT01097707|80687768|FG001|Overall Study|Protocol Violation|2|||
27686470|NCT01097707|80687769|FG002|Overall Study|Protocol Violation|3|||
27686471|NCT01097707|80687770|FG003|Overall Study|Protocol Violation|2|||
27686472|NCT01097707|80687771|FG004|Overall Study|Protocol Violation|2|||
27686473|NCT01097707|80687767|FG000|Overall Study|Sponsor Decision|31|||
27686474|NCT01097707|80687768|FG001|Overall Study|Sponsor Decision|31|||
27686475|NCT01097707|80687769|FG002|Overall Study|Sponsor Decision|34|||
27686476|NCT01097707|80687770|FG003|Overall Study|Sponsor Decision|35|||
27686477|NCT01097707|80687771|FG004|Overall Study|Sponsor Decision|36|||
27811752|NCT00434161|81141241|FG000|Overall Study|Logistical error study assessments|1|||
27686478|NCT01097707|80687767|FG000|Overall Study|Withdrawal by Subject|3|||
27686479|NCT01097707|80687768|FG001|Overall Study|Withdrawal by Subject|6|||
27686480|NCT01097707|80687769|FG002|Overall Study|Withdrawal by Subject|1|||
27686481|NCT01097707|80687770|FG003|Overall Study|Withdrawal by Subject|4|||
27686482|NCT01097707|80687771|FG004|Overall Study|Withdrawal by Subject|3|||
27686483|NCT01097707|80687767|FG000|Overall Study|Reason unknown|0|||
27686484|NCT01097707|80687768|FG001|Overall Study|Reason unknown|0|||
27686485|NCT01097707|80687769|FG002|Overall Study|Reason unknown|0|||
27686486|NCT01097707|80687770|FG003|Overall Study|Reason unknown|0|||
27686487|NCT01097707|80687771|FG004|Overall Study|Reason unknown|1|||
27686488|NCT04606771|80687772|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
27686489|NCT04606771|80687773|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
27686490|NCT04606771|80687772|FG000|Overall Study|Death|5|||
27686491|NCT04606771|80687773|FG001|Overall Study|Death|6|||
27686492|NCT04606771|80687772|FG000|Overall Study|Wrong randomisation|0|||
27686493|NCT04606771|80687773|FG001|Overall Study|Wrong randomisation|1|||
27686494|NCT01142232|80687777|FG000|Overall Study|Adverse Event|1|||
27686495|NCT01142232|80687778|FG001|Overall Study|Adverse Event|2|||
27686496|NCT01142232|80687779|FG002|Overall Study|Adverse Event|1|||
27686497|NCT01142232|80687780|FG003|Overall Study|Adverse Event|0|||
27686498|NCT01142232|80687781|FG004|Overall Study|Adverse Event|4|||
27686499|NCT01142232|80687777|FG000|Overall Study|Death|0|||
27686500|NCT01142232|80687778|FG001|Overall Study|Death|0|||
27686501|NCT01142232|80687779|FG002|Overall Study|Death|0|||
27686502|NCT01142232|80687780|FG003|Overall Study|Death|0|||
27686503|NCT01142232|80687781|FG004|Overall Study|Death|1|||
27686504|NCT01142232|80687777|FG000|Overall Study|Disease Progression|2|||
27686505|NCT01142232|80687778|FG001|Overall Study|Disease Progression|0|||
27686506|NCT01142232|80687779|FG002|Overall Study|Disease Progression|1|||
27686507|NCT01142232|80687780|FG003|Overall Study|Disease Progression|2|||
27686508|NCT01142232|80687781|FG004|Overall Study|Disease Progression|12|||
27686509|NCT01142232|80687777|FG000|Overall Study|Withdrawal by Subject|0|||
27686510|NCT01142232|80687778|FG001|Overall Study|Withdrawal by Subject|0|||
27686511|NCT01142232|80687779|FG002|Overall Study|Withdrawal by Subject|0|||
27686512|NCT01142232|80687780|FG003|Overall Study|Withdrawal by Subject|1|||
27686513|NCT01142232|80687781|FG004|Overall Study|Withdrawal by Subject|3|||
27686514|NCT01142232|80687777|FG000|Overall Study|Physician Decision|0|||
27686515|NCT01142232|80687778|FG001|Overall Study|Physician Decision|1|||
27686516|NCT01142232|80687779|FG002|Overall Study|Physician Decision|0|||
27686517|NCT01142232|80687780|FG003|Overall Study|Physician Decision|2|||
27686518|NCT01142232|80687781|FG004|Overall Study|Physician Decision|10|||
27811753|NCT00434161|81141242|FG001|Overall Study|Logistical error study assessments|0|||
27811754|NCT00434161|81141243|FG002|Overall Study|Logistical error study assessments|3|||
27811755|NCT03504852|81141244|FG000|Overall Study|Withdrawal of informed consent|2|||
27811756|NCT03504852|81141245|FG001|Overall Study|Withdrawal of informed consent|1|||
27811757|NCT03504852|81141246|FG002|Overall Study|Withdrawal of informed consent|0|||
27811758|NCT03504852|81141244|FG000|Overall Study|Withdrawal by Subject|5|||
27811759|NCT03504852|81141245|FG001|Overall Study|Withdrawal by Subject|5|||
27811760|NCT03504852|81141246|FG002|Overall Study|Withdrawal by Subject|1|||
27811761|NCT03504852|81141244|FG000|Overall Study|Lost to Follow-up|4|||
27811762|NCT03504852|81141245|FG001|Overall Study|Lost to Follow-up|1|||
27811763|NCT03504852|81141246|FG002|Overall Study|Lost to Follow-up|0|||
27811764|NCT03504852|81141244|FG000|Overall Study|New therapy for study indication|1|||
27811765|NCT03504852|81141245|FG001|Overall Study|New therapy for study indication|0|||
27811766|NCT03504852|81141246|FG002|Overall Study|New therapy for study indication|0|||
27811767|NCT03504852|81141244|FG000|Overall Study|Lack of Efficacy|1|||
27811768|NCT03504852|81141245|FG001|Overall Study|Lack of Efficacy|2|||
27811769|NCT03504852|81141246|FG002|Overall Study|Lack of Efficacy|0|||
27811770|NCT03504852|81141244|FG000|Overall Study|Death|0|||
27811771|NCT03504852|81141245|FG001|Overall Study|Death|1|||
27811772|NCT03504852|81141246|FG002|Overall Study|Death|0|||
27811773|NCT03504852|81141244|FG000|Overall Study|Adverse Event|4|||
27811774|NCT03504852|81141245|FG001|Overall Study|Adverse Event|8|||
27811775|NCT03504852|81141246|FG002|Overall Study|Adverse Event|2|||
27811776|NCT02043366|81141249|FG000|Overall Study|Lost to Follow-up|2|||
27811777|NCT02043366|81141250|FG001|Overall Study|Lost to Follow-up|2|||
27811778|NCT02043366|81141251|FG002|Overall Study|Lost to Follow-up|2|||
27875729|NCT02837731|81375509|FG001|Allocation|Did not meet sepsis criteria|2|||
27686519|NCT01142232|80687777|FG000|Overall Study|Alternative Therapy|0|||
27686520|NCT01142232|80687778|FG001|Overall Study|Alternative Therapy|1|||
27686521|NCT01142232|80687779|FG002|Overall Study|Alternative Therapy|1|||
27686522|NCT01142232|80687780|FG003|Overall Study|Alternative Therapy|0|||
27686523|NCT01142232|80687781|FG004|Overall Study|Alternative Therapy|1|||
27686524|NCT01142232|80687777|FG000|Overall Study|Off Trt for other complicating disease|0|||
27686525|NCT01142232|80687778|FG001|Overall Study|Off Trt for other complicating disease|0|||
27686526|NCT01142232|80687779|FG002|Overall Study|Off Trt for other complicating disease|0|||
27686527|NCT01142232|80687780|FG003|Overall Study|Off Trt for other complicating disease|0|||
27686528|NCT01142232|80687781|FG004|Overall Study|Off Trt for other complicating disease|1|||
27686529|NCT01142232|80687777|FG000|Overall Study|Noncompliance|0|||
27686530|NCT01142232|80687778|FG001|Overall Study|Noncompliance|0|||
27686531|NCT01142232|80687779|FG002|Overall Study|Noncompliance|0|||
27686532|NCT01142232|80687780|FG003|Overall Study|Noncompliance|0|||
27686533|NCT01142232|80687781|FG004|Overall Study|Noncompliance|2|||
27686534|NCT03207451|80687782|FG000|Overall Study|scheduling conflict|1|||
27686535|NCT03207451|80687783|FG001|Overall Study|scheduling conflict|0|||
27686536|NCT03207451|80687784|FG002|Overall Study|scheduling conflict|2|||
27686537|NCT03207451|80687785|FG003|Overall Study|scheduling conflict|2|||
27686538|NCT03207451|80687782|FG000|Overall Study|Adverse Event|0|||
27686539|NCT03207451|80687783|FG001|Overall Study|Adverse Event|0|||
27587329|NCT04265755|80331742|FG000|Overall Study|Withdrawal by Subject|39|||
27587330|NCT04265755|80331742|FG000|Overall Study|Decision by sponsor|2|||
27587331|NCT04265755|80331742|FG000|Overall Study|Lost to Follow-up|11|||
27587332|NCT04265755|80331742|FG000|Overall Study|Death|1|||
27686540|NCT03207451|80687784|FG002|Overall Study|Adverse Event|0|||
27686541|NCT03207451|80687785|FG003|Overall Study|Adverse Event|1|||
27686542|NCT04833127|80687792|FG000|Overall Study|Lost to Follow-up|1|||
27686543|NCT04833127|80687793|FG001|Overall Study|Lost to Follow-up|1|||
27811779|NCT02043366|81141252|FG003|Overall Study|Lost to Follow-up|2|||
27811780|NCT02043366|81141253|FG004|Overall Study|Lost to Follow-up|2|||
27811781|NCT02043366|81141254|FG005|Overall Study|Lost to Follow-up|2|||
27811782|NCT02784106|81141255|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
27811783|NCT02784106|81141256|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
27811784|NCT02784106|81141257|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27686544|NCT01732822|80687794|FG000|Overall Study|Withdrawal by Subject|123|||
27686545|NCT01732822|80687795|FG001|Overall Study|Withdrawal by Subject|113|||
27686546|NCT00297427|80687796|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
27686547|NCT00297427|80687797|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
27686548|NCT00297427|80687796|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
27686549|NCT00297427|80687797|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
27686550|NCT00297427|80687796|FG000|Phase 1: Initial Intervention|Death|0|||
27686551|NCT00297427|80687797|FG001|Phase 1: Initial Intervention|Death|1|||
27686552|NCT00297427|80687796|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
27686553|NCT00297427|80687797|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
27686554|NCT00297427|80687796|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
27686555|NCT00297427|80687797|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
27686556|NCT00297427|80687796|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
27686557|NCT00297427|80687797|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
27686558|NCT00297427|80687796|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
27686559|NCT00297427|80687797|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
27686560|NCT00297427|80687796|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
27686561|NCT00297427|80687797|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
27686562|NCT02314780|80687801|FG000|Overall Study|organizational reasons|0|||
27811785|NCT02784106|81141258|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27811786|NCT02784106|81141255|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
28007964|NCT03291067|81859736|FG001|Overall Study|Adverse Event|2|||
28007965|NCT03291067|81859737|FG002|Overall Study|Adverse Event|17|||
28007966|NCT03291067|81859738|FG003|Overall Study|Adverse Event|3|||
28007967|NCT03291067|81859735|FG000|Overall Study|Lost to Follow-up|2|||
28007968|NCT03291067|81859736|FG001|Overall Study|Lost to Follow-up|1|||
27587333|NCT02843568|80331743|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
27587334|NCT02843568|80331744|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
27587335|NCT02843568|80331743|FG000|Overall Study|Death|3|||
27587336|NCT02843568|80331744|FG001|Overall Study|Death|3|||
27587337|NCT02843568|80331743|FG000|Overall Study|Withdrawal by Subject|1|||
27587338|NCT02843568|80331744|FG001|Overall Study|Withdrawal by Subject|1|||
27587339|NCT02843568|80331743|FG000|Overall Study|Lost to Follow-up|2|||
27587340|NCT02843568|80331744|FG001|Overall Study|Lost to Follow-up|0|||
27587341|NCT00511004|80331746|FG000|Overall Study|Lost to Follow-up|0|||
27587342|NCT00511004|80331747|FG001|Overall Study|Lost to Follow-up|0|||
27587343|NCT00511004|80331748|FG002|Overall Study|Lost to Follow-up|4|||
27587344|NCT00817089|80331749|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
27587345|NCT00817089|80331750|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
27587346|NCT00817089|80331751|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
27587347|NCT00817089|80331752|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
27587348|NCT00817089|80331749|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
27686563|NCT02314780|80687802|FG001|Overall Study|organizational reasons|2|||
27686564|NCT02314780|80687803|FG002|Overall Study|organizational reasons|0|||
27686565|NCT02314780|80687801|FG000|Overall Study|Adverse Event|0|||
27686566|NCT02314780|80687802|FG001|Overall Study|Adverse Event|1|||
27686567|NCT02314780|80687803|FG002|Overall Study|Adverse Event|0|||
27686568|NCT01942590|80687806|FG000|Overall Study|Withdrawal by Subject|0|||
27686569|NCT01942590|80687807|FG001|Overall Study|Withdrawal by Subject|1|||
27686570|NCT01942590|80687806|FG000|Overall Study|Adverse Event|1|||
27686571|NCT01942590|80687807|FG001|Overall Study|Adverse Event|0|||
27686572|NCT02781090|80687810|FG000|3-Month Follow-Up|Missed Visit|20|||
27686573|NCT02781090|80687811|FG001|3-Month Follow-Up|Missed Visit|20|||
27686574|NCT02781090|80687810|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
27686575|NCT02781090|80687811|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
27686576|NCT02781090|80687810|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
27686577|NCT02781090|80687811|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
27686578|NCT02781090|80687810|FG000|3-Month Follow-Up|Death|1|||
27686579|NCT02781090|80687811|FG001|3-Month Follow-Up|Death|0|||
27686580|NCT02781090|80687810|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
27686581|NCT02781090|80687811|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
27686582|NCT02781090|80687810|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
27686583|NCT02781090|80687811|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
27686584|NCT02781090|80687810|FG000|6-Month Follow-Up|Death|0|||
27686585|NCT02781090|80687811|FG001|6-Month Follow-Up|Death|1|||
27686586|NCT04737187|80687813|FG000|Overall Study|Switched to marketed drug|32|||
27811787|NCT02784106|81141256|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
27811788|NCT02784106|81141257|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27811789|NCT02784106|81141258|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27811790|NCT02784106|81141255|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
27811791|NCT02784106|81141256|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
27811792|NCT02784106|81141257|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
27811793|NCT02784106|81141258|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
27811794|NCT02784106|81141255|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
27811795|NCT02784106|81141256|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27811796|NCT02784106|81141257|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27811797|NCT02784106|81141258|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27811798|NCT02784106|81141255|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
27811799|NCT02784106|81141256|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
27811800|NCT02784106|81141257|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
27811801|NCT02784106|81141258|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
27811802|NCT02784106|81141255|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
27811803|NCT02784106|81141256|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
27811804|NCT02784106|81141257|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
27811805|NCT02784106|81141258|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
27811806|NCT02180061|81141259|FG000|Overall Study|Adverse Event|4|||
27811807|NCT02180061|81141260|FG001|Overall Study|Adverse Event|2|||
27811808|NCT02180061|81141259|FG000|Overall Study|Clinical Progression|5|||
27811809|NCT02180061|81141260|FG001|Overall Study|Clinical Progression|1|||
27811810|NCT02180061|81141259|FG000|Overall Study|Progressive Disease|15|||
27811811|NCT02180061|81141260|FG001|Overall Study|Progressive Disease|5|||
27811812|NCT02180061|81141259|FG000|Overall Study|Physician Decision|1|||
27811813|NCT02180061|81141260|FG001|Overall Study|Physician Decision|0|||
27811814|NCT01752920|81141265|FG000|Overall Study|Adverse Event|1|||
27811815|NCT01752920|81141266|FG001|Overall Study|Adverse Event|0|||
27811816|NCT01752920|81141267|FG002|Overall Study|Adverse Event|5|||
27811817|NCT01752920|81141268|FG003|Overall Study|Adverse Event|10|||
27811818|NCT01752920|81141265|FG000|Overall Study|Clinical Disease Progression|6|||
27811819|NCT01752920|81141266|FG001|Overall Study|Clinical Disease Progression|4|||
27811820|NCT01752920|81141267|FG002|Overall Study|Clinical Disease Progression|1|||
27811821|NCT01752920|81141268|FG003|Overall Study|Clinical Disease Progression|13|||
27811822|NCT01752920|81141265|FG000|Overall Study|Physician Decision|1|||
27811823|NCT01752920|81141266|FG001|Overall Study|Physician Decision|0|||
27811824|NCT01752920|81141267|FG002|Overall Study|Physician Decision|0|||
27811825|NCT01752920|81141268|FG003|Overall Study|Physician Decision|3|||
27811826|NCT01752920|81141265|FG000|Overall Study|Radiographic Disease Progression|20|||
27811827|NCT01752920|81141266|FG001|Overall Study|Radiographic Disease Progression|7|||
27587349|NCT00817089|80331750|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
27686587|NCT04737187|80687814|FG001|Overall Study|Switched to marketed drug|4|||
27686588|NCT04737187|80687813|FG000|Overall Study|Radiological Progressive Disease|145|||
27686589|NCT04737187|80687814|FG001|Overall Study|Radiological Progressive Disease|146|||
27686590|NCT04737187|80687813|FG000|Overall Study|Clinical Progressive Disease|20|||
27587350|NCT00817089|80331751|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
27686591|NCT04737187|80687814|FG001|Overall Study|Clinical Progressive Disease|20|||
27686592|NCT04737187|80687813|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
27811828|NCT01752920|81141267|FG002|Overall Study|Radiographic Disease Progression|12|||
27811829|NCT01752920|81141268|FG003|Overall Study|Radiographic Disease Progression|29|||
27811830|NCT01752920|81141265|FG000|Overall Study|Study Terminated by Sponsor|0|||
27811831|NCT01752920|81141266|FG001|Overall Study|Study Terminated by Sponsor|0|||
27811832|NCT01752920|81141267|FG002|Overall Study|Study Terminated by Sponsor|0|||
27811833|NCT01752920|81141268|FG003|Overall Study|Study Terminated by Sponsor|1|||
27811834|NCT01752920|81141265|FG000|Overall Study|Withdrawal by Subject|0|||
27811835|NCT01752920|81141266|FG001|Overall Study|Withdrawal by Subject|1|||
27811836|NCT01752920|81141267|FG002|Overall Study|Withdrawal by Subject|0|||
27811837|NCT01752920|81141268|FG003|Overall Study|Withdrawal by Subject|1|||
27811838|NCT01752920|81141265|FG000|Overall Study|Lack of clinical benefit|1|||
27811839|NCT01752920|81141266|FG001|Overall Study|Lack of clinical benefit|1|||
27811840|NCT01752920|81141267|FG002|Overall Study|Lack of clinical benefit|1|||
27811841|NCT01752920|81141268|FG003|Overall Study|Lack of clinical benefit|1|||
27811842|NCT00290745|81141269|FG000|Overall Study|Withdrawal by Subject|4|||
27811843|NCT00290745|81141269|FG000|Overall Study|Physician Decision|2|||
27811844|NCT00290745|81141269|FG000|Overall Study|Surgery after 3 months for progression|3|||
27811845|NCT00290745|81141269|FG000|Overall Study|Baseline MRI not available|3|||
27811846|NCT01703741|81141270|FG000|Overall Study|Withdrawal by Subject|6|||
27811847|NCT01703741|81141270|FG000|Overall Study|Adverse Event|2|||
27811848|NCT01703741|81141270|FG000|Overall Study|Physician Decision|2|||
27811849|NCT01703741|81141270|FG000|Overall Study|Protocol Violation|1|||
27811850|NCT01703741|81141270|FG000|Overall Study|Lost to Follow-up|3|||
27811851|NCT01703741|81141270|FG000|Overall Study|Subject did not want to continue|2|||
27811852|NCT01703741|81141270|FG000|Overall Study|Subject cannot comply with study visits|1|||
27686593|NCT04737187|80687814|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
27811853|NCT01703741|81141270|FG000|Overall Study|Subject started testosterone injections|1|||
27811854|NCT03982433|81141271|FG000|Overall Study|Lost to Follow-up|1|||
27811855|NCT00623623|81141272|FG000|Overall Study|Previous enrolment into this study|1|||
27811856|NCT00623623|81141273|FG001|Overall Study|Previous enrolment into this study|1|||
27811857|NCT02919475|81141276|FG000|Overall Study|Adverse Event|3|||
27811858|NCT02919475|81141277|FG001|Overall Study|Adverse Event|3|||
27811859|NCT02919475|81141278|FG002|Overall Study|Adverse Event|3|||
27811860|NCT02919475|81141279|FG003|Overall Study|Adverse Event|9|||
27811861|NCT02919475|81141280|FG004|Overall Study|Adverse Event|2|||
27811862|NCT02919475|81141276|FG000|Overall Study|Death|0|||
27811863|NCT02919475|81141277|FG001|Overall Study|Death|1|||
27811864|NCT02919475|81141278|FG002|Overall Study|Death|0|||
27811865|NCT02919475|81141279|FG003|Overall Study|Death|0|||
27811866|NCT02919475|81141280|FG004|Overall Study|Death|0|||
27811867|NCT02919475|81141276|FG000|Overall Study|Lost to Follow-up|0|||
27811868|NCT02919475|81141277|FG001|Overall Study|Lost to Follow-up|0|||
27811869|NCT02919475|81141278|FG002|Overall Study|Lost to Follow-up|0|||
27811870|NCT02919475|81141279|FG003|Overall Study|Lost to Follow-up|1|||
27811871|NCT02919475|81141280|FG004|Overall Study|Lost to Follow-up|0|||
27811872|NCT02919475|81141276|FG000|Overall Study|Withdrawal by Subject|2|||
27811873|NCT02919475|81141277|FG001|Overall Study|Withdrawal by Subject|3|||
27811874|NCT02919475|81141278|FG002|Overall Study|Withdrawal by Subject|1|||
27811875|NCT02919475|81141279|FG003|Overall Study|Withdrawal by Subject|2|||
27811876|NCT02919475|81141280|FG004|Overall Study|Withdrawal by Subject|2|||
27811877|NCT02919475|81141276|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27811878|NCT02919475|81141277|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27811879|NCT02919475|81141278|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27811880|NCT02919475|81141279|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27811881|NCT02919475|81141280|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27811882|NCT02637076|81141281|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
27811883|NCT02637076|81141282|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
27587351|NCT00817089|80331752|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
27587352|NCT00724282|80331755|FG000|Overall Study|Withdrawal by Subject|3|||
27811884|NCT02637076|81141281|FG000|Overall Study|Withdrawal by Subject|0|||
27811885|NCT02637076|81141282|FG001|Overall Study|Withdrawal by Subject|4|||
27811886|NCT02826603|81141283|FG000|Overall Study|Adverse Event|17|||
27811887|NCT02826603|81141284|FG001|Overall Study|Adverse Event|9|||
27811888|NCT02826603|81141283|FG000|Overall Study|Lack of Efficacy|4|||
27811889|NCT02826603|81141284|FG001|Overall Study|Lack of Efficacy|9|||
27811890|NCT02826603|81141283|FG000|Overall Study|Lost to Follow-up|13|||
27811891|NCT02826603|81141284|FG001|Overall Study|Lost to Follow-up|12|||
27811892|NCT02826603|81141283|FG000|Overall Study|Noncompliance with treatment|0|||
27811893|NCT02826603|81141284|FG001|Overall Study|Noncompliance with treatment|2|||
27587353|NCT00724282|80331755|FG000|Overall Study|Physician Decision|1|||
27587354|NCT02265237|80331757|FG000|As Treated (Overall Study)|Adverse Event|1|||
27587355|NCT02265237|80331758|FG001|As Treated (Overall Study)|Adverse Event|1|||
27587356|NCT02265237|80331759|FG002|As Treated (Overall Study)|Adverse Event|0|||
27587357|NCT02265237|80331760|FG003|As Treated (Overall Study)|Adverse Event|0|||
27811894|NCT02826603|81141283|FG000|Overall Study|Physician Decision|1|||
27811895|NCT02826603|81141284|FG001|Overall Study|Physician Decision|7|||
27811896|NCT02826603|81141283|FG000|Overall Study|Pregnancy|1|||
27811897|NCT02826603|81141284|FG001|Overall Study|Pregnancy|2|||
27811898|NCT02826603|81141283|FG000|Overall Study|Protocol Violation|3|||
27811899|NCT02826603|81141284|FG001|Overall Study|Protocol Violation|3|||
27811900|NCT02826603|81141283|FG000|Overall Study|Withdrawal by Subject|20|||
27811901|NCT02826603|81141284|FG001|Overall Study|Withdrawal by Subject|19|||
27811902|NCT02826603|81141283|FG000|Overall Study|Death|2|||
27811903|NCT02826603|81141284|FG001|Overall Study|Death|0|||
27811904|NCT02826603|81141283|FG000|Overall Study|New therapy for study indication|0|||
27811905|NCT02826603|81141284|FG001|Overall Study|New therapy for study indication|1|||
27811906|NCT00679783|81141285|FG000|Overall Study|Adverse Event|0|||
27811907|NCT00679783|81141286|FG001|Overall Study|Adverse Event|0|||
27811908|NCT00679783|81141287|FG002|Overall Study|Adverse Event|0|||
27811909|NCT00679783|81141288|FG003|Overall Study|Adverse Event|3|||
27811910|NCT00679783|81141289|FG004|Overall Study|Adverse Event|0|||
27811911|NCT00679783|81141290|FG005|Overall Study|Adverse Event|0|||
27811912|NCT00679783|81141291|FG006|Overall Study|Adverse Event|1|||
27811913|NCT00679783|81141285|FG000|Overall Study|Lack of Efficacy|0|||
27811914|NCT00679783|81141286|FG001|Overall Study|Lack of Efficacy|1|||
27811915|NCT00679783|81141287|FG002|Overall Study|Lack of Efficacy|0|||
27811916|NCT00679783|81141288|FG003|Overall Study|Lack of Efficacy|2|||
27811917|NCT00679783|81141289|FG004|Overall Study|Lack of Efficacy|0|||
27811918|NCT00679783|81141290|FG005|Overall Study|Lack of Efficacy|0|||
27811919|NCT00679783|81141291|FG006|Overall Study|Lack of Efficacy|0|||
27811920|NCT00679783|81141285|FG000|Overall Study|Withdrawal by Subject|0|||
27811921|NCT00679783|81141286|FG001|Overall Study|Withdrawal by Subject|0|||
27811922|NCT00679783|81141287|FG002|Overall Study|Withdrawal by Subject|1|||
27811923|NCT00679783|81141288|FG003|Overall Study|Withdrawal by Subject|1|||
27587358|NCT02265237|80331757|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
27587359|NCT02265237|80331758|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
27587360|NCT02265237|80331759|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
27686594|NCT04737187|80687813|FG000|Overall Study|Adverse Event|16|||
27686595|NCT04737187|80687814|FG001|Overall Study|Adverse Event|16|||
27811924|NCT00679783|81141289|FG004|Overall Study|Withdrawal by Subject|0|||
27811925|NCT00679783|81141290|FG005|Overall Study|Withdrawal by Subject|0|||
27811926|NCT00679783|81141291|FG006|Overall Study|Withdrawal by Subject|0|||
27811927|NCT00679783|81141285|FG000|Overall Study|Not Captured|0|||
27811928|NCT00679783|81141286|FG001|Overall Study|Not Captured|0|||
27811929|NCT00679783|81141287|FG002|Overall Study|Not Captured|0|||
27811930|NCT00679783|81141288|FG003|Overall Study|Not Captured|5|||
27811931|NCT00679783|81141289|FG004|Overall Study|Not Captured|0|||
27811932|NCT00679783|81141290|FG005|Overall Study|Not Captured|0|||
27811933|NCT00679783|81141291|FG006|Overall Study|Not Captured|0|||
27811934|NCT00679783|81141285|FG000|Overall Study|Ongoing at data cut-off|2|||
27811935|NCT00679783|81141286|FG001|Overall Study|Ongoing at data cut-off|2|||
27811936|NCT00679783|81141287|FG002|Overall Study|Ongoing at data cut-off|0|||
27811937|NCT00679783|81141288|FG003|Overall Study|Ongoing at data cut-off|9|||
27811938|NCT00679783|81141289|FG004|Overall Study|Ongoing at data cut-off|1|||
27811939|NCT00679783|81141290|FG005|Overall Study|Ongoing at data cut-off|0|||
27811940|NCT00679783|81141291|FG006|Overall Study|Ongoing at data cut-off|0|||
27811941|NCT02577354|81141293|FG000|Overall Study|Lack of Efficacy|4|||
27811942|NCT02577354|81141294|FG001|Overall Study|Lack of Efficacy|4|||
27811943|NCT02577354|81141293|FG000|Overall Study|Lost to Follow-up|3|||
27811944|NCT02577354|81141294|FG001|Overall Study|Lost to Follow-up|1|||
27811945|NCT02577354|81141293|FG000|Overall Study|Missed Visit|4|||
27811946|NCT02577354|81141294|FG001|Overall Study|Missed Visit|3|||
27811947|NCT02577354|81141293|FG000|Overall Study|Adverse Event|4|||
27811948|NCT02577354|81141294|FG001|Overall Study|Adverse Event|5|||
27811949|NCT01059071|81141295|FG000|Overall Study|Lack of Efficacy|1|||
27811950|NCT01059071|81141296|FG001|Overall Study|Lack of Efficacy|4|||
27811951|NCT01059071|81141297|FG002|Overall Study|Lack of Efficacy|2|||
27811952|NCT01059071|81141298|FG003|Overall Study|Lack of Efficacy|3|||
27811953|NCT01059071|81141295|FG000|Overall Study|Withdrawal by Subject|1|||
27811954|NCT01059071|81141296|FG001|Overall Study|Withdrawal by Subject|0|||
27811955|NCT01059071|81141297|FG002|Overall Study|Withdrawal by Subject|0|||
27811956|NCT01059071|81141298|FG003|Overall Study|Withdrawal by Subject|2|||
27811957|NCT01059071|81141295|FG000|Overall Study|Physician Decision|0|||
27811958|NCT01059071|81141296|FG001|Overall Study|Physician Decision|0|||
27811959|NCT01059071|81141297|FG002|Overall Study|Physician Decision|0|||
27811960|NCT01059071|81141298|FG003|Overall Study|Physician Decision|1|||
27811961|NCT01748890|81141301|FG000|Overall Study|Insufficient recruitment for analysis|4|||
27811962|NCT01047345|81141302|FG000|Base Study|Adverse Event|3|||
27686596|NCT04737187|80687813|FG000|Overall Study|Physician Decision|2|||
27686597|NCT04737187|80687814|FG001|Overall Study|Physician Decision|0|||
27686598|NCT04737187|80687813|FG000|Overall Study|Withdrawal by Subject|5|||
27686599|NCT04737187|80687814|FG001|Overall Study|Withdrawal by Subject|8|||
27686600|NCT00924027|80687815|FG000|Overall Study|Lost to Further Follow-Up|4|||
27686601|NCT00924027|80687816|FG001|Overall Study|Lost to Further Follow-Up|0|||
27686602|NCT00924027|80687817|FG002|Overall Study|Lost to Further Follow-Up|0|||
27686603|NCT00924027|80687818|FG003|Overall Study|Lost to Further Follow-Up|0|||
27686604|NCT00924027|80687815|FG000|Overall Study|Physician Decision|1|||
27686605|NCT00924027|80687816|FG001|Overall Study|Physician Decision|0|||
27686606|NCT00924027|80687817|FG002|Overall Study|Physician Decision|0|||
27686607|NCT00924027|80687818|FG003|Overall Study|Physician Decision|1|||
27686608|NCT00924027|80687815|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
27686609|NCT00924027|80687816|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
27686610|NCT00924027|80687817|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
27686611|NCT00924027|80687818|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
27686612|NCT00924027|80687815|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
27686613|NCT00924027|80687816|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
27686614|NCT00924027|80687817|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
27686615|NCT00924027|80687818|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
27686616|NCT00924027|80687815|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
27686617|NCT00924027|80687816|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
27686618|NCT00924027|80687817|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
27686619|NCT00924027|80687818|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
27686620|NCT01204398|80687825|FG000|Overall Study|Adverse Event|1|||
27686621|NCT03981861|80687826|FG000|Overall Study|Withdrawal by Subject|3|||
27686622|NCT03446781|80687827|FG000|Overall Study|Lost to Follow-up|11|||
27686623|NCT03446781|80687828|FG001|Overall Study|Lost to Follow-up|5|||
27686624|NCT03446781|80687827|FG000|Overall Study|Withdrawal by Subject|9|||
27686625|NCT03446781|80687828|FG001|Overall Study|Withdrawal by Subject|7|||
27686626|NCT03446781|80687827|FG000|Overall Study|Adverse Event|8|||
27686627|NCT03446781|80687828|FG001|Overall Study|Adverse Event|2|||
27686628|NCT03446781|80687827|FG000|Overall Study|Protocol Violation|0|||
27686629|NCT03446781|80687828|FG001|Overall Study|Protocol Violation|3|||
27686630|NCT03339583|80687829|FG000|First Intervention (14 Days)|Adverse Event|1|||
27686631|NCT03339583|80687830|FG001|First Intervention (14 Days)|Adverse Event|0|||
27686632|NCT03339583|80687829|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
27686633|NCT03339583|80687830|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
27686634|NCT03339583|80687829|FG000|Second Intervention (14 Days)|Adverse Event|0|||
27686635|NCT03339583|80687830|FG001|Second Intervention (14 Days)|Adverse Event|1|||
27686636|NCT03339583|80687829|FG000|Follow-up (14 Days)|Physician Decision|6|||
27686637|NCT03339583|80687830|FG001|Follow-up (14 Days)|Physician Decision|3|||
27686638|NCT00620282|80690384|FG000|Overall Study|Adverse Event|0|||
27686639|NCT00620282|80690385|FG001|Overall Study|Adverse Event|1|||
27686640|NCT00620282|80690386|FG002|Overall Study|Adverse Event|0|||
27686641|NCT00620282|80690384|FG000|Overall Study|Arterial line unable to be placed|0|||
27686642|NCT00620282|80690385|FG001|Overall Study|Arterial line unable to be placed|0|||
27686643|NCT00620282|80690386|FG002|Overall Study|Arterial line unable to be placed|1|||
27686644|NCT00620282|80690384|FG000|Overall Study|Withdrawal by Subject|0|||
27686645|NCT00620282|80690385|FG001|Overall Study|Withdrawal by Subject|1|||
27686646|NCT00620282|80690386|FG002|Overall Study|Withdrawal by Subject|0|||
27686647|NCT00532493|80690387|FG000|Overall Study|Death|1|||
27686648|NCT00532493|80690388|FG001|Overall Study|Death|1|||
27686649|NCT00532493|80690387|FG000|Overall Study|Lost to Follow-up|10|||
27811963|NCT01047345|81141303|FG001|Base Study|Adverse Event|0|||
27811964|NCT01047345|81141304|FG002|Base Study|Adverse Event|0|||
27811965|NCT01047345|81141302|FG000|Base Study|Lost to Follow-up|4|||
27811966|NCT01047345|81141303|FG001|Base Study|Lost to Follow-up|1|||
27587361|NCT02265237|80331760|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
27587362|NCT02265237|80331757|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
27587363|NCT02265237|80331758|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
27587364|NCT02265237|80331759|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
27587365|NCT02265237|80331760|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
27686650|NCT00532493|80690388|FG001|Overall Study|Lost to Follow-up|7|||
27686651|NCT00532493|80690387|FG000|Overall Study|Withdrawal by Subject|7|||
27686652|NCT00532493|80690388|FG001|Overall Study|Withdrawal by Subject|9|||
27686653|NCT00532493|80690387|FG000|Overall Study|Physician Decision|1|||
27686654|NCT00532493|80690388|FG001|Overall Study|Physician Decision|6|||
27686655|NCT00532493|80690387|FG000|Overall Study|Adverse Event|6|||
27686656|NCT00532493|80690388|FG001|Overall Study|Adverse Event|5|||
27587366|NCT02265237|80331757|FG000|As Treated (Overall Study)|Other|2|||
27587367|NCT02265237|80331758|FG001|As Treated (Overall Study)|Other|0|||
27587368|NCT02265237|80331759|FG002|As Treated (Overall Study)|Other|3|||
27587369|NCT02265237|80331760|FG003|As Treated (Overall Study)|Other|1|||
27587370|NCT01221597|80331764|FG000|Overall Study|Adverse Event|4|||
27587371|NCT01221597|80331765|FG001|Overall Study|Adverse Event|1|||
27587372|NCT01221597|80331764|FG000|Overall Study|Withdrawal by Subject|20|||
27587373|NCT01221597|80331765|FG001|Overall Study|Withdrawal by Subject|6|||
27811967|NCT01047345|81141304|FG002|Base Study|Lost to Follow-up|0|||
27811968|NCT01047345|81141302|FG000|Base Study|Protocol Violation|3|||
27811969|NCT01047345|81141303|FG001|Base Study|Protocol Violation|1|||
27811970|NCT01047345|81141304|FG002|Base Study|Protocol Violation|0|||
27811971|NCT01047345|81141302|FG000|Base Study|Withdrawal by Subject|12|||
27811972|NCT01047345|81141303|FG001|Base Study|Withdrawal by Subject|4|||
27811973|NCT01047345|81141304|FG002|Base Study|Withdrawal by Subject|0|||
27811974|NCT01047345|81141302|FG000|Extension|Withdrawal by Subject|0|||
27811975|NCT01047345|81141303|FG001|Extension|Withdrawal by Subject|0|||
27811976|NCT01047345|81141304|FG002|Extension|Withdrawal by Subject|1|||
27811977|NCT01047345|81141302|FG000|Extension|Lost to Follow-up|0|||
27811978|NCT01047345|81141303|FG001|Extension|Lost to Follow-up|0|||
27811979|NCT01047345|81141304|FG002|Extension|Lost to Follow-up|5|||
27811980|NCT02795104|81141312|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
27811981|NCT02795104|81141313|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
27811982|NCT02795104|81141314|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
27811983|NCT02795104|81141312|FG000|Overall Study|Withdrawal by Subject|0|||
27811984|NCT02795104|81141313|FG001|Overall Study|Withdrawal by Subject|2|||
27811985|NCT02795104|81141314|FG002|Overall Study|Withdrawal by Subject|0|||
27811986|NCT02795104|81141312|FG000|Overall Study|Lost to Follow-up|0|||
27811987|NCT02795104|81141313|FG001|Overall Study|Lost to Follow-up|0|||
27811988|NCT02795104|81141314|FG002|Overall Study|Lost to Follow-up|1|||
27811989|NCT03443869|81141319|FG000|Overall Study|Death|3|||
27811990|NCT03443869|81141320|FG001|Overall Study|Death|3|||
27811991|NCT03443869|81141319|FG000|Overall Study|Withdrawal by Subject|34|||
27811992|NCT03443869|81141320|FG001|Overall Study|Withdrawal by Subject|22|||
27811993|NCT03443869|81141319|FG000|Overall Study|Lost to Follow-up|1|||
27811994|NCT03443869|81141320|FG001|Overall Study|Lost to Follow-up|2|||
27811995|NCT03443869|81141319|FG000|Overall Study|Physician Decision|3|||
28007969|NCT03291067|81859737|FG002|Overall Study|Lost to Follow-up|0|||
28007970|NCT03291067|81859738|FG003|Overall Study|Lost to Follow-up|1|||
28007971|NCT03291067|81859735|FG000|Overall Study|Physician Decision|0|||
28007972|NCT03291067|81859736|FG001|Overall Study|Physician Decision|0|||
28007973|NCT03291067|81859737|FG002|Overall Study|Physician Decision|1|||
27587374|NCT01221597|80331764|FG000|Overall Study|Lost to Follow-up|6|||
28007974|NCT03291067|81859738|FG003|Overall Study|Physician Decision|0|||
27587375|NCT01221597|80331765|FG001|Overall Study|Lost to Follow-up|5|||
27587376|NCT01221597|80331764|FG000|Overall Study|Protocol Violation|1|||
27811996|NCT03443869|81141320|FG001|Overall Study|Physician Decision|3|||
27811997|NCT03443869|81141319|FG000|Overall Study|Other|4|||
27811998|NCT03443869|81141320|FG001|Overall Study|Other|4|||
27811999|NCT03305055|81141321|FG000|Overall Study|Withdrawal by Subject|0|||
27812000|NCT03305055|81141322|FG001|Overall Study|Withdrawal by Subject|1|||
27812001|NCT03305055|81141321|FG000|Overall Study|Adverse Event|1|||
27812002|NCT03305055|81141322|FG001|Overall Study|Adverse Event|1|||
27812003|NCT01628120|81141323|FG000|Overall Study|Withdrawal by Subject|7|||
27812004|NCT01628120|81141323|FG000|Overall Study|Adverse Event|12|||
27812005|NCT01628120|81141323|FG000|Overall Study|Lost to Follow-up|1|||
27812006|NCT01628120|81141323|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
27812007|NCT01628120|81141323|FG000|Overall Study|Non-compliant with Study Procedures|1|||
27812008|NCT01628120|81141323|FG000|Overall Study|Not Treated|3|||
27812009|NCT01628120|81141323|FG000|Overall Study|Sponsor Decision|5|||
27812010|NCT01628120|81141323|FG000|Overall Study|Switched Dialysis Method|2|||
27812011|NCT01628120|81141323|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
27587377|NCT01221597|80331765|FG001|Overall Study|Protocol Violation|0|||
27812012|NCT01628120|81141323|FG000|Overall Study|Moved or Relocated|5|||
27812013|NCT01628120|81141323|FG000|Overall Study|Kidney Transplant|2|||
27812014|NCT01628120|81141323|FG000|Overall Study|Use of Standard of Care|1|||
27812015|NCT03522948|81141327|FG000|Overall Study|Lost to Follow-up|1|||
27812016|NCT01298323|81141328|FG000|Overall Study|Adverse Event|2|||
27812017|NCT01298323|81141329|FG001|Overall Study|Adverse Event|4|||
27812018|NCT01298323|81141328|FG000|Overall Study|Death|11|||
27812019|NCT01298323|81141329|FG001|Overall Study|Death|16|||
27812020|NCT01298323|81141328|FG000|Overall Study|Lost to Follow-up|1|||
27812021|NCT01298323|81141329|FG001|Overall Study|Lost to Follow-up|0|||
27812022|NCT01298323|81141328|FG000|Overall Study|Withdrawal by Subject|6|||
27812023|NCT01298323|81141329|FG001|Overall Study|Withdrawal by Subject|3|||
27812024|NCT01298323|81141328|FG000|Overall Study|Protocol Violation|1|||
28007975|NCT03291067|81859735|FG000|Overall Study|Protocol Violation|5|||
27587378|NCT01221597|80331764|FG000|Overall Study|Other|3|||
27587379|NCT01221597|80331765|FG001|Overall Study|Other|4|||
28007976|NCT03291067|81859736|FG001|Overall Study|Protocol Violation|3|||
27812025|NCT01298323|81141329|FG001|Overall Study|Protocol Violation|0|||
27812026|NCT01298323|81141328|FG000|Overall Study|Other|10|||
27812027|NCT01298323|81141329|FG001|Overall Study|Other|9|||
27812028|NCT01298323|81141328|FG000|Overall Study|Ongoing|55|||
27812029|NCT01298323|81141329|FG001|Overall Study|Ongoing|55|||
27812030|NCT01298323|81141328|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27587380|NCT01221597|80331764|FG000|Overall Study|Death|2|||
27587381|NCT01221597|80331765|FG001|Overall Study|Death|0|||
28007977|NCT03291067|81859737|FG002|Overall Study|Protocol Violation|4|||
28007978|NCT03291067|81859738|FG003|Overall Study|Protocol Violation|2|||
28007979|NCT03291067|81859735|FG000|Overall Study|Withdrawal by Subject|3|||
28007980|NCT03291067|81859736|FG001|Overall Study|Withdrawal by Subject|4|||
28007981|NCT03291067|81859737|FG002|Overall Study|Withdrawal by Subject|7|||
28007982|NCT03291067|81859738|FG003|Overall Study|Withdrawal by Subject|5|||
28007983|NCT03291067|81859735|FG000|Overall Study|Other|0|||
28007984|NCT03291067|81859736|FG001|Overall Study|Other|4|||
28007985|NCT03291067|81859737|FG002|Overall Study|Other|4|||
28007986|NCT03291067|81859738|FG003|Overall Study|Other|6|||
28007987|NCT04750824|81859744|FG000|Overall Study|Toxicity/intolerability|3|||
28007988|NCT04750824|81859745|FG001|Overall Study|Toxicity/intolerability|1|||
28007989|NCT04750824|81859744|FG000|Overall Study|Death|1|||
28007990|NCT04750824|81859745|FG001|Overall Study|Death|3|||
28007991|NCT04750824|81859744|FG000|Overall Study|Scheduled duration of therapy complete|1|||
28007992|NCT04750824|81859745|FG001|Overall Study|Scheduled duration of therapy complete|9|||
28007993|NCT04750824|81859744|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
28007994|NCT04750824|81859745|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
28007995|NCT02140047|81859746|FG000|Overall Study|Withdrawal by parent/guardian|1|||
28007996|NCT02140047|81859747|FG001|Overall Study|Withdrawal by parent/guardian|1|||
28007997|NCT02140047|81859748|FG002|Overall Study|Withdrawal by parent/guardian|0|||
28007998|NCT00984256|81859755|FG000|Overall Study|Withdrawal by Subject|0|||
28007999|NCT00984256|81859756|FG001|Overall Study|Withdrawal by Subject|1|||
28008000|NCT05280717|81859757|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
28008001|NCT05280717|81859758|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
28008002|NCT05280717|81859759|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
28008003|NCT05280717|81859760|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
28008004|NCT05280717|81859761|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
28008005|NCT05280717|81859762|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
28008006|NCT05280717|81859763|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
28008007|NCT05280717|81859757|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
27812031|NCT01298323|81141329|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27812032|NCT01565083|81141330|FG000|Overall Study|Withdrawal by Subject|6|||
27812033|NCT01565083|81141331|FG001|Overall Study|Withdrawal by Subject|4|||
27812034|NCT01565083|81141330|FG000|Overall Study|Lost to Follow-up|2|||
27812035|NCT01565083|81141331|FG001|Overall Study|Lost to Follow-up|7|||
27812036|NCT01565083|81141330|FG000|Overall Study|Death|22|||
27812037|NCT01565083|81141331|FG001|Overall Study|Death|23|||
27812038|NCT01565083|81141330|FG000|Overall Study|Other|3|||
27812039|NCT01565083|81141331|FG001|Overall Study|Other|5|||
27812040|NCT03206203|81141338|FG000|Treatment|Death|38|||
27812041|NCT03206203|81141339|FG001|Treatment|Death|26|||
28008008|NCT05280717|81859758|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
28008009|NCT05280717|81859759|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
28008010|NCT05280717|81859760|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
27587382|NCT02415400|80331766|FG000|Overall Study|Adverse Event|0|||
27812042|NCT03206203|81141340|FG002|Treatment|Death|0|||
27812043|NCT03206203|81141338|FG000|Treatment|Withdrawal by Subject|1|||
27812044|NCT03206203|81141339|FG001|Treatment|Withdrawal by Subject|0|||
27812045|NCT03206203|81141340|FG002|Treatment|Withdrawal by Subject|0|||
27812046|NCT03206203|81141338|FG000|Treatment|Lost to Follow-up|4|||
27812047|NCT03206203|81141339|FG001|Treatment|Lost to Follow-up|0|||
27812048|NCT03206203|81141340|FG002|Treatment|Lost to Follow-up|0|||
27812049|NCT03206203|81141338|FG000|Treatment|N/A in Follow-Up|8|||
27812050|NCT03206203|81141339|FG001|Treatment|N/A in Follow-Up|1|||
28008011|NCT05280717|81859761|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
28008012|NCT05280717|81859762|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
28008013|NCT05280717|81859763|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
28008014|NCT05280717|81859757|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
28008015|NCT05280717|81859758|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
28008016|NCT05280717|81859759|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
28008017|NCT05280717|81859760|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
28008018|NCT05280717|81859761|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
28008019|NCT05280717|81859762|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
28008020|NCT05280717|81859763|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
28008021|NCT05280717|81859757|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
28008022|NCT05280717|81859758|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
28008023|NCT05280717|81859759|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
28008024|NCT05280717|81859760|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
28008025|NCT05280717|81859761|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
28008026|NCT05280717|81859762|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
27812051|NCT03206203|81141340|FG002|Treatment|N/A in Follow-Up|0|||
27812052|NCT03206203|81141338|FG000|Treatment|Disease progression|0|||
27812053|NCT03206203|81141339|FG001|Treatment|Disease progression|1|||
27812054|NCT03206203|81141340|FG002|Treatment|Disease progression|0|||
27812055|NCT03206203|81141338|FG000|Treatment|Refused follow-up|0|||
27812056|NCT03206203|81141339|FG001|Treatment|Refused follow-up|1|||
27812057|NCT03206203|81141340|FG002|Treatment|Refused follow-up|0|||
27812058|NCT03206203|81141338|FG000|Treatment|Cross over to Arm 1|0|||
27812059|NCT03206203|81141339|FG001|Treatment|Cross over to Arm 1|19|||
27812060|NCT03206203|81141340|FG002|Treatment|Cross over to Arm 1|0|||
27812061|NCT03206203|81141338|FG000|Optional Cross-Over|Death|0|||
27812062|NCT03206203|81141339|FG001|Optional Cross-Over|Death|0|||
27812063|NCT03206203|81141340|FG002|Optional Cross-Over|Death|14|||
27812064|NCT03206203|81141338|FG000|Optional Cross-Over|Refused follow-up|0|||
27812065|NCT03206203|81141339|FG001|Optional Cross-Over|Refused follow-up|0|||
27812066|NCT03206203|81141340|FG002|Optional Cross-Over|Refused follow-up|2|||
27812067|NCT00672620|81141341|FG000|Overall Study|Adverse Event|7|||
27812068|NCT00672620|81141342|FG001|Overall Study|Adverse Event|7|||
27812069|NCT00672620|81141343|FG002|Overall Study|Adverse Event|12|||
27812070|NCT00672620|81141344|FG003|Overall Study|Adverse Event|17|||
27812071|NCT00672620|81141341|FG000|Overall Study|Lack of Efficacy|1|||
27812072|NCT00672620|81141342|FG001|Overall Study|Lack of Efficacy|2|||
27812073|NCT00672620|81141343|FG002|Overall Study|Lack of Efficacy|2|||
27812074|NCT00672620|81141344|FG003|Overall Study|Lack of Efficacy|0|||
27812075|NCT00672620|81141341|FG000|Overall Study|Noncompliance with Study Drug|3|||
27812076|NCT00672620|81141342|FG001|Overall Study|Noncompliance with Study Drug|4|||
27812077|NCT00672620|81141343|FG002|Overall Study|Noncompliance with Study Drug|0|||
27812078|NCT00672620|81141344|FG003|Overall Study|Noncompliance with Study Drug|2|||
27812079|NCT00672620|81141341|FG000|Overall Study|Protocol Deviations|5|||
27812080|NCT00672620|81141342|FG001|Overall Study|Protocol Deviations|7|||
27812081|NCT00672620|81141343|FG002|Overall Study|Protocol Deviations|2|||
27812082|NCT00672620|81141344|FG003|Overall Study|Protocol Deviations|5|||
27812083|NCT00672620|81141341|FG000|Overall Study|Withdrawal of Consent|6|||
27812084|NCT00672620|81141342|FG001|Overall Study|Withdrawal of Consent|12|||
27812085|NCT00672620|81141343|FG002|Overall Study|Withdrawal of Consent|5|||
27812086|NCT00672620|81141344|FG003|Overall Study|Withdrawal of Consent|6|||
27812087|NCT00672620|81141341|FG000|Overall Study|Lost to Follow-up|8|||
27812088|NCT00672620|81141342|FG001|Overall Study|Lost to Follow-up|19|||
27812089|NCT00672620|81141343|FG002|Overall Study|Lost to Follow-up|8|||
27812090|NCT00672620|81141344|FG003|Overall Study|Lost to Follow-up|11|||
27812091|NCT00672620|81141341|FG000|Overall Study|Reason not Specified|3|||
27812092|NCT00672620|81141342|FG001|Overall Study|Reason not Specified|3|||
27875730|NCT02837731|81375508|FG000|Allocation|Known aortic abnormalities|0|||
27812093|NCT00672620|81141343|FG002|Overall Study|Reason not Specified|2|||
27812094|NCT00672620|81141344|FG003|Overall Study|Reason not Specified|1|||
27812095|NCT01894984|81141346|FG000|Overall Study|Other|314|||
27812096|NCT01894984|81141347|FG001|Overall Study|Other|175|||
27812097|NCT02961920|81141356|FG000|Overall Study|did not achive stydy protocol schedule|1|||
27812098|NCT02961920|81141357|FG001|Overall Study|did not achive stydy protocol schedule|1|||
27812099|NCT01595009|81141363|FG000|Core|Patients completed per protocol|85|||
27812100|NCT01595009|81141364|FG001|Core|Patients completed per protocol|44|||
28008027|NCT05280717|81859763|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
28008028|NCT05280717|81859757|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
28008029|NCT05280717|81859758|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
28008030|NCT05280717|81859759|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
28008031|NCT05280717|81859760|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
28008032|NCT05280717|81859761|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
28008033|NCT05280717|81859762|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
28008034|NCT05280717|81859763|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
28008035|NCT05280717|81859757|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
28008036|NCT05280717|81859758|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
28008037|NCT05280717|81859759|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
28008038|NCT05280717|81859760|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
28008039|NCT05280717|81859761|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
28008040|NCT05280717|81859762|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
28008041|NCT05280717|81859763|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
27812101|NCT01595009|81141365|FG002|Core|Patients completed per protocol|0|||
27812102|NCT01595009|81141366|FG003|Core|Patients completed per protocol|0|||
27812103|NCT01595009|81141363|FG000|Core|Adverse Event|19|||
27812104|NCT01595009|81141364|FG001|Core|Adverse Event|23|||
27812105|NCT01595009|81141365|FG002|Core|Adverse Event|0|||
27812106|NCT01595009|81141366|FG003|Core|Adverse Event|0|||
27812107|NCT01595009|81141363|FG000|Core|Disease progression|14|||
27812108|NCT01595009|81141364|FG001|Core|Disease progression|26|||
27812109|NCT01595009|81141365|FG002|Core|Disease progression|0|||
27812110|NCT01595009|81141366|FG003|Core|Disease progression|0|||
27812111|NCT01595009|81141363|FG000|Core|Withdrawal by Subject|4|||
27812112|NCT01595009|81141364|FG001|Core|Withdrawal by Subject|17|||
27812113|NCT01595009|81141365|FG002|Core|Withdrawal by Subject|0|||
27812114|NCT01595009|81141366|FG003|Core|Withdrawal by Subject|0|||
27812115|NCT01595009|81141363|FG000|Core|Death|3|||
27812116|NCT01595009|81141364|FG001|Core|Death|6|||
27812117|NCT01595009|81141365|FG002|Core|Death|0|||
27812118|NCT01595009|81141366|FG003|Core|Death|0|||
27812119|NCT01595009|81141363|FG000|Core|Lost to Follow-up|1|||
27812120|NCT01595009|81141364|FG001|Core|Lost to Follow-up|2|||
28008042|NCT04607668|81861980|FG000|Overall Study|Death|49|||
27875731|NCT02837731|81375509|FG001|Allocation|Known aortic abnormalities|1|||
27875732|NCT01252095|81375510|FG000|Overall Study|Disease progression|1|||
27875733|NCT01252095|81375511|FG001|Overall Study|Disease progression|0|||
27875734|NCT00495391|81375512|FG000|Overall Study|Lack of Efficacy|34|||
27875735|NCT00495391|81375513|FG001|Overall Study|Lack of Efficacy|18|||
28008043|NCT04607668|81861981|FG001|Overall Study|Death|26|||
28008044|NCT04607668|81861980|FG000|Overall Study|Lost to Follow-up|3|||
28008045|NCT04607668|81861981|FG001|Overall Study|Lost to Follow-up|4|||
27686657|NCT00532493|80690387|FG000|Overall Study|Protocol Deviation|1|||
27686658|NCT00532493|80690388|FG001|Overall Study|Protocol Deviation|0|||
27686659|NCT00532493|80690387|FG000|Overall Study|Subject Moved Away|3|||
27686660|NCT00532493|80690388|FG001|Overall Study|Subject Moved Away|1|||
27686661|NCT00532493|80690387|FG000|Overall Study|Contraindicative Medication|1|||
27686662|NCT00532493|80690388|FG001|Overall Study|Contraindicative Medication|0|||
27686663|NCT03309813|80690389|FG000|Main Randomized Study|Withdrawal by Subject|1|||
27686664|NCT03309813|80690390|FG001|Main Randomized Study|Withdrawal by Subject|0|||
27686665|NCT02150343|80690391|FG000|Overall Study|Adverse Event|2|||
27686666|NCT02150343|80690392|FG001|Overall Study|Adverse Event|0|||
27686667|NCT02150343|80690393|FG002|Overall Study|Adverse Event|1|||
28008046|NCT04607668|81861980|FG000|Overall Study|Study terminated by Sponsor|92|||
28008047|NCT04607668|81861981|FG001|Overall Study|Study terminated by Sponsor|114|||
27686668|NCT02150343|80690394|FG003|Overall Study|Adverse Event|1|||
27686669|NCT02150343|80690391|FG000|Overall Study|Withdrawal by Subject|13|||
27686670|NCT02150343|80690392|FG001|Overall Study|Withdrawal by Subject|10|||
27686671|NCT02150343|80690393|FG002|Overall Study|Withdrawal by Subject|9|||
27686672|NCT02150343|80690394|FG003|Overall Study|Withdrawal by Subject|4|||
27686673|NCT02150343|80690391|FG000|Overall Study|Lost to Follow-up|4|||
27686674|NCT02150343|80690392|FG001|Overall Study|Lost to Follow-up|4|||
27686675|NCT02150343|80690393|FG002|Overall Study|Lost to Follow-up|2|||
27686676|NCT02150343|80690394|FG003|Overall Study|Lost to Follow-up|3|||
27686677|NCT02150343|80690391|FG000|Overall Study|Other|2|||
27686678|NCT02150343|80690392|FG001|Overall Study|Other|6|||
27686679|NCT02150343|80690393|FG002|Overall Study|Other|0|||
27686680|NCT02150343|80690394|FG003|Overall Study|Other|2|||
27686681|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
27686682|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27686683|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27686684|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27686685|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27686686|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
27686687|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
27686688|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27686689|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27686690|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27812121|NCT01595009|81141365|FG002|Core|Lost to Follow-up|0|||
27812122|NCT01595009|81141366|FG003|Core|Lost to Follow-up|0|||
27812123|NCT01595009|81141363|FG000|Core|Protocol deviation|0|||
27812124|NCT01595009|81141364|FG001|Core|Protocol deviation|1|||
27812125|NCT01595009|81141365|FG002|Core|Protocol deviation|0|||
27875736|NCT00495391|81375512|FG000|Overall Study|Withdrawal by Subject|2|||
27875737|NCT00495391|81375513|FG001|Overall Study|Withdrawal by Subject|3|||
27875738|NCT05266053|81375514|FG000|Overall Study|Withdrawal by Subject|8|||
28008048|NCT04607668|81861980|FG000|Overall Study|Withdrawal by Subject|12|||
28008049|NCT04607668|81861981|FG001|Overall Study|Withdrawal by Subject|11|||
28008050|NCT04607668|81861980|FG000|Overall Study|Other, unspecified|8|||
28008051|NCT04607668|81861981|FG001|Overall Study|Other, unspecified|7|||
27587383|NCT02415400|80331767|FG001|Overall Study|Adverse Event|1|||
27587384|NCT02415400|80331768|FG002|Overall Study|Adverse Event|1|||
27587385|NCT02415400|80331769|FG003|Overall Study|Adverse Event|2|||
27587386|NCT02415400|80331766|FG000|Overall Study|Participant request to stop therapy|4|||
27587387|NCT02415400|80331767|FG001|Overall Study|Participant request to stop therapy|3|||
27587388|NCT02415400|80331768|FG002|Overall Study|Participant request to stop therapy|8|||
27587389|NCT02415400|80331769|FG003|Overall Study|Participant request to stop therapy|6|||
27587390|NCT02415400|80331766|FG000|Overall Study|Participant withdrew consent|14|||
27587391|NCT02415400|80331767|FG001|Overall Study|Participant withdrew consent|12|||
27587392|NCT02415400|80331768|FG002|Overall Study|Participant withdrew consent|30|||
27587393|NCT02415400|80331769|FG003|Overall Study|Participant withdrew consent|21|||
27587394|NCT02415400|80331766|FG000|Overall Study|Death|39|||
27587395|NCT02415400|80331767|FG001|Overall Study|Death|41|||
27587396|NCT02415400|80331768|FG002|Overall Study|Death|35|||
27686691|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27686692|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
27686693|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
27686694|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27686695|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27686696|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27686697|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27686698|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
27686699|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
27812126|NCT01595009|81141366|FG003|Core|Protocol deviation|0|||
27812127|NCT01595009|81141363|FG000|Core|Administrative problems|0|||
27812128|NCT01595009|81141364|FG001|Core|Administrative problems|1|||
27812129|NCT01595009|81141365|FG002|Core|Administrative problems|0|||
27812130|NCT01595009|81141366|FG003|Core|Administrative problems|0|||
27812131|NCT01595009|81141363|FG000|Extension|Administrative problems|0|||
27812132|NCT01595009|81141364|FG001|Extension|Administrative problems|0|||
27812133|NCT01595009|81141365|FG002|Extension|Administrative problems|0|||
27812134|NCT01595009|81141366|FG003|Extension|Administrative problems|1|||
27812135|NCT01595009|81141363|FG000|Extension|Patients completed per protocol|0|||
27812136|NCT01595009|81141364|FG001|Extension|Patients completed per protocol|0|||
27812137|NCT01595009|81141365|FG002|Extension|Patients completed per protocol|0|||
27812138|NCT01595009|81141366|FG003|Extension|Patients completed per protocol|2|||
27812139|NCT01595009|81141363|FG000|Extension|Disease progression|0|||
27812140|NCT01595009|81141364|FG001|Extension|Disease progression|0|||
27812141|NCT01595009|81141365|FG002|Extension|Disease progression|4|||
27812142|NCT01595009|81141366|FG003|Extension|Disease progression|7|||
27812143|NCT01595009|81141363|FG000|Extension|Adverse Event|0|||
28008052|NCT03192176|81861982|FG000|Overall Study|Adverse Event|1|||
28008053|NCT03192176|81861983|FG001|Overall Study|Adverse Event|0|||
28008054|NCT03192176|81861984|FG002|Overall Study|Adverse Event|4|||
28008055|NCT03192176|81861985|FG003|Overall Study|Adverse Event|5|||
27812144|NCT01595009|81141364|FG001|Extension|Adverse Event|0|||
27812145|NCT01595009|81141365|FG002|Extension|Adverse Event|0|||
27812146|NCT01595009|81141366|FG003|Extension|Adverse Event|1|||
27812147|NCT02737306|81141367|FG000|Overall Study|Adverse Event|3|||
27812148|NCT02737306|81141368|FG001|Overall Study|Adverse Event|0|||
27812149|NCT02737306|81141367|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
27812150|NCT02737306|81141368|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
27812151|NCT00112489|81141375|FG000|Overall Study|Refused further treatment|8|||
27812152|NCT00112489|81141375|FG000|Overall Study|Adverse Event|12|||
27812153|NCT00112489|81141375|FG000|Overall Study|Death|2|||
27812154|NCT00112489|81141375|FG000|Overall Study|Other, Not Specified|9|||
28008056|NCT03192176|81861986|FG004|Overall Study|Adverse Event|3|||
27686700|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27686701|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27686702|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27686703|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27686704|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
27686705|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
27686706|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27686707|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27686708|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27686709|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27686710|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
27686711|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
27686712|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27686713|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27686714|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27686715|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27812155|NCT00112489|81141375|FG000|Overall Study|Patient never treated|2|||
27812156|NCT00112489|81141375|FG000|Overall Study|Ineligible|7|||
28008057|NCT03192176|81861987|FG005|Overall Study|Adverse Event|2|||
28008058|NCT03192176|81861988|FG006|Overall Study|Adverse Event|3|||
28008059|NCT03192176|81861989|FG007|Overall Study|Adverse Event|3|||
28008060|NCT03192176|81861982|FG000|Overall Study|Lost to Follow-up|0|||
27812157|NCT02322047|81141376|FG000|Overall Study|Physician Decision|1|||
27812158|NCT02322047|81141377|FG001|Overall Study|Physician Decision|0|||
27812159|NCT02322047|81141378|FG002|Overall Study|Physician Decision|0|||
27812160|NCT02322047|81141379|FG003|Overall Study|Physician Decision|0|||
27812161|NCT02322047|81141376|FG000|Overall Study|Withdrawal by Subject|1|||
27812162|NCT02322047|81141377|FG001|Overall Study|Withdrawal by Subject|0|||
27812163|NCT02322047|81141378|FG002|Overall Study|Withdrawal by Subject|0|||
28008061|NCT03192176|81861983|FG001|Overall Study|Lost to Follow-up|0|||
27686716|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
27686717|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
27686718|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27686719|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27686720|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27686721|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27686722|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
27686723|NCT01160289|80690395|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
27686724|NCT01160289|80690396|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27686725|NCT01160289|80690397|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27686726|NCT01160289|80690398|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27686727|NCT01160289|80690399|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27686728|NCT01160289|80690400|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
27686729|NCT01160289|80690395|FG000|Post-Randomization Period|Adverse Event|0|||
27812164|NCT02322047|81141379|FG003|Overall Study|Withdrawal by Subject|1|||
28008062|NCT03192176|81861984|FG002|Overall Study|Lost to Follow-up|1|||
28008063|NCT03192176|81861985|FG003|Overall Study|Lost to Follow-up|2|||
28008064|NCT03192176|81861986|FG004|Overall Study|Lost to Follow-up|3|||
28008065|NCT03192176|81861987|FG005|Overall Study|Lost to Follow-up|1|||
28008066|NCT03192176|81861988|FG006|Overall Study|Lost to Follow-up|1|||
28008067|NCT03192176|81861989|FG007|Overall Study|Lost to Follow-up|1|||
27686730|NCT01160289|80690396|FG001|Post-Randomization Period|Adverse Event|4|||
27686731|NCT01160289|80690397|FG002|Post-Randomization Period|Adverse Event|4|||
27812165|NCT02322047|81141376|FG000|Overall Study|Adverse Event|0|||
27812166|NCT02322047|81141377|FG001|Overall Study|Adverse Event|1|||
27812167|NCT02322047|81141378|FG002|Overall Study|Adverse Event|0|||
27812168|NCT02322047|81141379|FG003|Overall Study|Adverse Event|0|||
27812169|NCT02322047|81141376|FG000|Overall Study|Lost to Follow-up|0|||
27812170|NCT02322047|81141377|FG001|Overall Study|Lost to Follow-up|0|||
27812171|NCT02322047|81141378|FG002|Overall Study|Lost to Follow-up|1|||
27812172|NCT02322047|81141379|FG003|Overall Study|Lost to Follow-up|1|||
27812173|NCT01165996|81141380|FG000|Overall Study|Death|1|||
27812174|NCT01165996|81141380|FG000|Overall Study|Physician Decision|1|||
27812175|NCT05188521|81141381|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
27812176|NCT05188521|81141382|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
27686732|NCT01160289|80690398|FG003|Post-Randomization Period|Adverse Event|2|||
27686733|NCT01160289|80690399|FG004|Post-Randomization Period|Adverse Event|0|||
27686734|NCT01160289|80690400|FG005|Post-Randomization Period|Adverse Event|0|||
27686735|NCT01160289|80690395|FG000|Post-Randomization Period|Death|0|||
27686736|NCT01160289|80690396|FG001|Post-Randomization Period|Death|0|||
27686737|NCT01160289|80690397|FG002|Post-Randomization Period|Death|0|||
27686738|NCT01160289|80690398|FG003|Post-Randomization Period|Death|1|||
27686739|NCT01160289|80690399|FG004|Post-Randomization Period|Death|0|||
27812177|NCT04633837|81141383|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
27812178|NCT04633837|81141384|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
27812179|NCT03687125|81141385|FG000|Overall Study|Progressive Disease|2|||
27812180|NCT03687125|81141386|FG001|Overall Study|Progressive Disease|1|||
27812181|NCT03687125|81141385|FG000|Overall Study|Protocol Violation|1|||
27812182|NCT03687125|81141386|FG001|Overall Study|Protocol Violation|0|||
27812183|NCT00467584|81141387|FG000|Overall Study|Withdrawal by Subject|4|||
27812184|NCT00467584|81141388|FG001|Overall Study|Withdrawal by Subject|5|||
27686740|NCT01160289|80690400|FG005|Post-Randomization Period|Death|0|||
27686741|NCT01160289|80690395|FG000|Post-Randomization Period|Lack of Efficacy|0|||
27686742|NCT01160289|80690396|FG001|Post-Randomization Period|Lack of Efficacy|1|||
27686743|NCT01160289|80690397|FG002|Post-Randomization Period|Lack of Efficacy|0|||
27686744|NCT01160289|80690398|FG003|Post-Randomization Period|Lack of Efficacy|3|||
27812185|NCT00467584|81141389|FG002|Overall Study|Withdrawal by Subject|1|||
27812186|NCT01612000|81141392|FG000|Overall Study|Lost to Follow-up|6|||
27812187|NCT01612000|81141393|FG001|Overall Study|Lost to Follow-up|4|||
27812188|NCT01612000|81141394|FG002|Overall Study|Lost to Follow-up|4|||
27812189|NCT01612000|81141395|FG003|Overall Study|Lost to Follow-up|8|||
27812190|NCT01612000|81141392|FG000|Overall Study|Physician Decision|0|||
27812191|NCT01612000|81141393|FG001|Overall Study|Physician Decision|0|||
27812192|NCT01612000|81141394|FG002|Overall Study|Physician Decision|1|||
27812193|NCT01612000|81141395|FG003|Overall Study|Physician Decision|0|||
27875739|NCT05266053|81375515|FG001|Overall Study|Withdrawal by Subject|4|||
27875740|NCT00720213|81375516|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
28008068|NCT03192176|81861982|FG000|Overall Study|Physician Decision|1|||
27812194|NCT01612000|81141392|FG000|Overall Study|Withdrawal by Subject|3|||
27812195|NCT01612000|81141393|FG001|Overall Study|Withdrawal by Subject|1|||
28008069|NCT03192176|81861983|FG001|Overall Study|Physician Decision|0|||
27812196|NCT01612000|81141394|FG002|Overall Study|Withdrawal by Subject|2|||
27812197|NCT01612000|81141395|FG003|Overall Study|Withdrawal by Subject|2|||
27812198|NCT00745251|81141396|FG000|Overall Study|Adverse Event|1|||
27812199|NCT00745251|81141397|FG001|Overall Study|Adverse Event|2|||
27812200|NCT00745251|81141396|FG000|Overall Study|Withdrawal by Subject|1|||
27812201|NCT00745251|81141397|FG001|Overall Study|Withdrawal by Subject|1|||
27812202|NCT00553540|81141398|FG000|Overall Study|discharged after first visit|2|||
27812203|NCT00553540|81141399|FG001|Overall Study|discharged after first visit|5|||
27812204|NCT01808209|81141400|FG000|Overall Study|Lost to Follow-up|0|||
27812205|NCT01808209|81141401|FG001|Overall Study|Lost to Follow-up|1|||
27812206|NCT00929708|81141403|FG000|Overall Study|Protocol Violation|2|||
27812207|NCT00929708|81141404|FG001|Overall Study|Protocol Violation|1|||
27812208|NCT00929708|81141405|FG002|Overall Study|Protocol Violation|1|||
27812209|NCT00929708|81141406|FG003|Overall Study|Protocol Violation|1|||
27812210|NCT00929708|81141407|FG004|Overall Study|Protocol Violation|1|||
27812211|NCT00929708|81141403|FG000|Overall Study|Withdrawal by Subject|2|||
27812212|NCT00929708|81141404|FG001|Overall Study|Withdrawal by Subject|0|||
27812213|NCT00929708|81141405|FG002|Overall Study|Withdrawal by Subject|0|||
27812214|NCT00929708|81141406|FG003|Overall Study|Withdrawal by Subject|2|||
27812215|NCT00929708|81141407|FG004|Overall Study|Withdrawal by Subject|1|||
27812216|NCT00929708|81141403|FG000|Overall Study|Adverse Event|0|||
27812217|NCT00929708|81141404|FG001|Overall Study|Adverse Event|0|||
27812218|NCT00929708|81141405|FG002|Overall Study|Adverse Event|0|||
27812219|NCT00929708|81141406|FG003|Overall Study|Adverse Event|0|||
27812220|NCT00929708|81141407|FG004|Overall Study|Adverse Event|3|||
27812221|NCT00929708|81141403|FG000|Overall Study|Physician Decision|0|||
27812222|NCT00929708|81141404|FG001|Overall Study|Physician Decision|2|||
27812223|NCT00929708|81141405|FG002|Overall Study|Physician Decision|2|||
27812224|NCT00929708|81141406|FG003|Overall Study|Physician Decision|2|||
27812225|NCT00929708|81141407|FG004|Overall Study|Physician Decision|1|||
27812226|NCT00929708|81141403|FG000|Overall Study|Lost to Follow-up|0|||
27812227|NCT00929708|81141404|FG001|Overall Study|Lost to Follow-up|0|||
27812228|NCT00929708|81141405|FG002|Overall Study|Lost to Follow-up|0|||
27812229|NCT00929708|81141406|FG003|Overall Study|Lost to Follow-up|1|||
27812230|NCT00929708|81141407|FG004|Overall Study|Lost to Follow-up|0|||
27812231|NCT00783796|81141409|FG000|Overall Study|Did not receive any stent|4|||
27812232|NCT00783796|81141409|FG000|Overall Study|Received non-XIENCE V stent|1|||
27812233|NCT00783796|81141409|FG000|Overall Study|Received commercial XIENCE V stent|1|||
27812234|NCT03131999|81141410|FG000|Overall Study|Withdrawal by Subject|0|||
27812235|NCT03131999|81141411|FG001|Overall Study|Withdrawal by Subject|1|||
27812236|NCT04467697|81141412|FG000|Overall Study|Adverse Event|2|||
27812237|NCT04467697|81141412|FG000|Overall Study|Lost to Follow-up|6|||
27812238|NCT04467697|81141412|FG000|Overall Study|Withdrawal by Subject|9|||
27812239|NCT04467697|81141412|FG000|Overall Study|Protocol Violation|3|||
27812240|NCT02688608|81141413|FG000|Overall Study|Lost to Follow-up|1|||
27812241|NCT03347695|81141418|FG000|Overall Study|Death|0|||
27812242|NCT03347695|81141419|FG001|Overall Study|Death|4|||
27812243|NCT03347695|81141418|FG000|Overall Study|Lost to Follow-up|0|||
27812244|NCT03347695|81141419|FG001|Overall Study|Lost to Follow-up|1|||
27812245|NCT03141177|81141420|FG000|Overall Study|Death|62|||
27812246|NCT03141177|81141421|FG001|Overall Study|Death|13|||
27812247|NCT03141177|81141422|FG002|Overall Study|Death|84|||
27812248|NCT03141177|81141420|FG000|Overall Study|Participant withdrew consent|9|||
27686745|NCT01160289|80690399|FG004|Post-Randomization Period|Lack of Efficacy|0|||
27686746|NCT01160289|80690400|FG005|Post-Randomization Period|Lack of Efficacy|0|||
27686747|NCT01160289|80690395|FG000|Post-Randomization Period|Lost to Follow-up|0|||
27686748|NCT01160289|80690396|FG001|Post-Randomization Period|Lost to Follow-up|3|||
27686749|NCT01160289|80690397|FG002|Post-Randomization Period|Lost to Follow-up|2|||
27686750|NCT01160289|80690398|FG003|Post-Randomization Period|Lost to Follow-up|5|||
27686751|NCT01160289|80690399|FG004|Post-Randomization Period|Lost to Follow-up|3|||
27686752|NCT01160289|80690400|FG005|Post-Randomization Period|Lost to Follow-up|4|||
27686753|NCT01160289|80690395|FG000|Post-Randomization Period|Physician Decision|0|||
27686754|NCT01160289|80690396|FG001|Post-Randomization Period|Physician Decision|0|||
27812249|NCT03141177|81141421|FG001|Overall Study|Participant withdrew consent|2|||
27812250|NCT03141177|81141422|FG002|Overall Study|Participant withdrew consent|13|||
27812251|NCT03141177|81141420|FG000|Overall Study|Not reported|1|||
27812252|NCT03141177|81141421|FG001|Overall Study|Not reported|0|||
27812253|NCT03141177|81141422|FG002|Overall Study|Not reported|1|||
27812254|NCT03141177|81141420|FG000|Overall Study|Lost to Follow-up|2|||
27812255|NCT03141177|81141421|FG001|Overall Study|Lost to Follow-up|1|||
27812256|NCT03141177|81141422|FG002|Overall Study|Lost to Follow-up|1|||
27812257|NCT03141177|81141420|FG000|Overall Study|Other reasons|4|||
27812258|NCT03141177|81141421|FG001|Overall Study|Other reasons|0|||
27812259|NCT03141177|81141422|FG002|Overall Study|Other reasons|11|||
27812260|NCT03141177|81141420|FG000|Overall Study|Participants did not start treatment period|3|||
27812261|NCT03141177|81141421|FG001|Overall Study|Participants did not start treatment period|0|||
27812262|NCT03141177|81141422|FG002|Overall Study|Participants did not start treatment period|8|||
27812263|NCT01855126|81141423|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
27812264|NCT01855126|81141424|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
27812265|NCT01855126|81141423|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
27812266|NCT01855126|81141424|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
27812267|NCT00696709|81141425|FG000|Overall Study|Withdrawal by Subject|1|||
27812268|NCT00696709|81141426|FG001|Overall Study|Withdrawal by Subject|2|||
27812269|NCT00696709|81141427|FG002|Overall Study|Withdrawal by Subject|1|||
27812270|NCT00696709|81141428|FG003|Overall Study|Withdrawal by Subject|4|||
27812271|NCT00696709|81141429|FG004|Overall Study|Withdrawal by Subject|3|||
27812272|NCT00696709|81141425|FG000|Overall Study|Protocol Violation|1|||
27812273|NCT00696709|81141426|FG001|Overall Study|Protocol Violation|0|||
27812274|NCT00696709|81141427|FG002|Overall Study|Protocol Violation|0|||
27812275|NCT00696709|81141428|FG003|Overall Study|Protocol Violation|0|||
27812276|NCT00696709|81141429|FG004|Overall Study|Protocol Violation|0|||
27812277|NCT00696709|81141425|FG000|Overall Study|Lost to Follow-up|1|||
27812278|NCT00696709|81141426|FG001|Overall Study|Lost to Follow-up|1|||
27812279|NCT00696709|81141427|FG002|Overall Study|Lost to Follow-up|0|||
28008070|NCT03192176|81861984|FG002|Overall Study|Physician Decision|0|||
28008071|NCT03192176|81861985|FG003|Overall Study|Physician Decision|0|||
28008072|NCT03192176|81861986|FG004|Overall Study|Physician Decision|0|||
28008073|NCT03192176|81861987|FG005|Overall Study|Physician Decision|2|||
28008074|NCT03192176|81861988|FG006|Overall Study|Physician Decision|1|||
27686755|NCT01160289|80690397|FG002|Post-Randomization Period|Physician Decision|1|||
27686756|NCT01160289|80690398|FG003|Post-Randomization Period|Physician Decision|0|||
27686757|NCT01160289|80690399|FG004|Post-Randomization Period|Physician Decision|0|||
27686758|NCT01160289|80690400|FG005|Post-Randomization Period|Physician Decision|0|||
27686759|NCT01160289|80690395|FG000|Post-Randomization Period|Protocol Violation|0|||
27686760|NCT01160289|80690396|FG001|Post-Randomization Period|Protocol Violation|4|||
27686761|NCT01160289|80690397|FG002|Post-Randomization Period|Protocol Violation|2|||
27686762|NCT01160289|80690398|FG003|Post-Randomization Period|Protocol Violation|0|||
27686763|NCT01160289|80690399|FG004|Post-Randomization Period|Protocol Violation|1|||
27812280|NCT00696709|81141428|FG003|Overall Study|Lost to Follow-up|0|||
27812281|NCT00696709|81141429|FG004|Overall Study|Lost to Follow-up|0|||
27812282|NCT00696709|81141425|FG000|Overall Study|Adverse Event|0|||
27812283|NCT00696709|81141426|FG001|Overall Study|Adverse Event|0|||
27812284|NCT00696709|81141427|FG002|Overall Study|Adverse Event|0|||
27812285|NCT00696709|81141428|FG003|Overall Study|Adverse Event|1|||
27812286|NCT00696709|81141429|FG004|Overall Study|Adverse Event|0|||
27812287|NCT01787825|81143573|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
27812288|NCT01787825|81143574|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
27812289|NCT01787825|81143573|FG000|Overall Study|Data Not Analyzable|5|||
27812290|NCT01787825|81143574|FG001|Overall Study|Data Not Analyzable|1|||
27812291|NCT05431153|81143575|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27812292|NCT05431153|81143576|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27812293|NCT05431153|81143577|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27812294|NCT05431153|81143578|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27812295|NCT05431153|81143579|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
27812296|NCT05431153|81143580|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27812297|NCT02015793|81143589|FG000|Overall Study|Adverse Event|3|||
27812298|NCT02015793|81143590|FG001|Overall Study|Adverse Event|3|||
27812299|NCT02015793|81143589|FG000|Overall Study|Withdrawal by Subject|1|||
27812300|NCT02015793|81143590|FG001|Overall Study|Withdrawal by Subject|1|||
27812301|NCT02236130|81143593|FG000|Overall Study|Lost to Follow-up|7|||
27812302|NCT02236130|81143594|FG001|Overall Study|Lost to Follow-up|12|||
27812303|NCT02710071|81143598|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
27812304|NCT02710071|81143599|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
27812305|NCT02710071|81143598|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
27812306|NCT02710071|81143599|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
27812307|NCT02153736|81143602|FG000|Overall Study|Lost to Follow-up|1|||
27812308|NCT02153736|81143603|FG001|Overall Study|Lost to Follow-up|0|||
27812309|NCT02153736|81143602|FG000|Overall Study|Medical status change made ineligible|1|||
27812310|NCT02153736|81143603|FG001|Overall Study|Medical status change made ineligible|0|||
27812311|NCT02153736|81143602|FG000|Overall Study|Death|0|||
27812312|NCT02153736|81143603|FG001|Overall Study|Death|1|||
27812313|NCT02153736|81143602|FG000|Overall Study|Withdrawal by Subject|0|||
27875741|NCT00720213|81375517|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
28008075|NCT03192176|81861989|FG007|Overall Study|Physician Decision|0|||
28008076|NCT03192176|81861982|FG000|Overall Study|Protocol Deviation|1|||
27812314|NCT02153736|81143603|FG001|Overall Study|Withdrawal by Subject|1|||
27812315|NCT01104662|81143606|FG000|Overall Study|Adverse Event|2|||
27812316|NCT01104662|81143607|FG001|Overall Study|Adverse Event|2|||
27812317|NCT01104662|81143608|FG002|Overall Study|Adverse Event|0|||
27812318|NCT01104662|81143609|FG003|Overall Study|Adverse Event|1|||
27812319|NCT01104662|81143610|FG004|Overall Study|Adverse Event|1|||
27812320|NCT01104662|81143611|FG005|Overall Study|Adverse Event|1|||
27812321|NCT01104662|81143612|FG006|Overall Study|Adverse Event|0|||
28008077|NCT03192176|81861983|FG001|Overall Study|Protocol Deviation|1|||
27686764|NCT01160289|80690400|FG005|Post-Randomization Period|Protocol Violation|3|||
27812322|NCT01104662|81143613|FG007|Overall Study|Adverse Event|0|||
27812323|NCT01104662|81143606|FG000|Overall Study|Clinical Failure|1|||
27812324|NCT01104662|81143607|FG001|Overall Study|Clinical Failure|0|||
27812325|NCT01104662|81143608|FG002|Overall Study|Clinical Failure|0|||
27812326|NCT01104662|81143609|FG003|Overall Study|Clinical Failure|0|||
27812327|NCT01104662|81143610|FG004|Overall Study|Clinical Failure|0|||
27812328|NCT01104662|81143611|FG005|Overall Study|Clinical Failure|1|||
27686765|NCT01160289|80690395|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
27812329|NCT01104662|81143612|FG006|Overall Study|Clinical Failure|0|||
27812330|NCT01104662|81143613|FG007|Overall Study|Clinical Failure|0|||
27812331|NCT01104662|81143606|FG000|Overall Study|Participant left investigator's care|1|||
27812332|NCT01104662|81143607|FG001|Overall Study|Participant left investigator's care|1|||
27812333|NCT01104662|81143608|FG002|Overall Study|Participant left investigator's care|0|||
27812334|NCT01104662|81143609|FG003|Overall Study|Participant left investigator's care|0|||
27812335|NCT01104662|81143610|FG004|Overall Study|Participant left investigator's care|0|||
27812336|NCT01104662|81143611|FG005|Overall Study|Participant left investigator's care|0|||
27812337|NCT01104662|81143612|FG006|Overall Study|Participant left investigator's care|0|||
27812338|NCT01104662|81143613|FG007|Overall Study|Participant left investigator's care|0|||
27812339|NCT01104662|81143606|FG000|Overall Study|Reason not specified|3|||
27812340|NCT01104662|81143607|FG001|Overall Study|Reason not specified|3|||
27812341|NCT01104662|81143608|FG002|Overall Study|Reason not specified|0|||
27686766|NCT01160289|80690396|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
27686767|NCT01160289|80690397|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
27686768|NCT01160289|80690398|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
27686769|NCT01160289|80690399|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
27686770|NCT01160289|80690400|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
27686771|NCT01160289|80690395|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
27686772|NCT01160289|80690396|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
27686773|NCT01160289|80690397|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
27686774|NCT01160289|80690398|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
27686775|NCT01160289|80690399|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
27686776|NCT01160289|80690400|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
27686777|NCT01160289|80690395|FG000|Post-Randomization Period|Sponsor Decision|0|||
27686778|NCT01160289|80690396|FG001|Post-Randomization Period|Sponsor Decision|1|||
27686779|NCT01160289|80690397|FG002|Post-Randomization Period|Sponsor Decision|0|||
27686780|NCT01160289|80690398|FG003|Post-Randomization Period|Sponsor Decision|0|||
27686781|NCT01160289|80690399|FG004|Post-Randomization Period|Sponsor Decision|0|||
27686782|NCT01160289|80690400|FG005|Post-Randomization Period|Sponsor Decision|0|||
27686783|NCT00923260|80690401|FG000|Overall Study|Lost to Follow-up|1|||
27686784|NCT00923260|80690402|FG001|Overall Study|Lost to Follow-up|1|||
27686785|NCT04138576|80690404|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
27686786|NCT05398237|80690405|FG000|Overall Study|Withdrawal by Subject|1|||
27686787|NCT01394978|80690406|FG000|Overall Study|Withdrawal by Subject|2|||
27686788|NCT01394978|80690407|FG001|Overall Study|Withdrawal by Subject|4|||
27686789|NCT01394978|80690406|FG000|Overall Study|Lost to Follow-up|13|||
27686790|NCT01394978|80690407|FG001|Overall Study|Lost to Follow-up|20|||
27686791|NCT01394978|80690406|FG000|Overall Study|Death|6|||
27686792|NCT01394978|80690407|FG001|Overall Study|Death|7|||
27686793|NCT00215137|80690409|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
27686794|NCT00215137|80690410|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
27686795|NCT00215137|80690411|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
27686796|NCT00215137|80690409|FG000|Randomization Period|Lost to Follow-up|0|||
27686797|NCT00215137|80690410|FG001|Randomization Period|Lost to Follow-up|1|||
27686798|NCT00215137|80690411|FG002|Randomization Period|Lost to Follow-up|0|||
27686799|NCT00215137|80690409|FG000|Randomization Period|Withdrawal by Subject|0|||
27686800|NCT00215137|80690410|FG001|Randomization Period|Withdrawal by Subject|1|||
27686801|NCT00215137|80690411|FG002|Randomization Period|Withdrawal by Subject|0|||
27686802|NCT00621777|80690414|FG000|Open Phase|Adverse Event|20|||
27686803|NCT00621777|80690415|FG001|Open Phase|Adverse Event|0|||
27812342|NCT01104662|81143609|FG003|Overall Study|Reason not specified|0|||
27686804|NCT00621777|80690414|FG000|Open Phase|Did not abstain during open phase|56|||
27686805|NCT00621777|80690415|FG001|Open Phase|Did not abstain during open phase|0|||
27812343|NCT01104662|81143610|FG004|Overall Study|Reason not specified|0|||
28008078|NCT03192176|81861984|FG002|Overall Study|Protocol Deviation|0|||
27686806|NCT00621777|80690414|FG000|Open Phase|Withdrawal by Subject|17|||
27686807|NCT00621777|80690415|FG001|Open Phase|Withdrawal by Subject|0|||
27686808|NCT00621777|80690414|FG000|Open Phase|administrative|13|||
27686809|NCT00621777|80690415|FG001|Open Phase|administrative|0|||
27812344|NCT01104662|81143611|FG005|Overall Study|Reason not specified|1|||
27812345|NCT01104662|81143612|FG006|Overall Study|Reason not specified|0|||
27812346|NCT01104662|81143613|FG007|Overall Study|Reason not specified|0|||
27812347|NCT01104662|81143606|FG000|Overall Study|Randomized but not treated|3|||
27812348|NCT01104662|81143607|FG001|Overall Study|Randomized but not treated|4|||
27812349|NCT01104662|81143608|FG002|Overall Study|Randomized but not treated|1|||
27812350|NCT01104662|81143609|FG003|Overall Study|Randomized but not treated|0|||
27686810|NCT00621777|80690414|FG000|Open Phase|Lost to Follow-up|10|||
27686811|NCT00621777|80690415|FG001|Open Phase|Lost to Follow-up|0|||
27686812|NCT00621777|80690414|FG000|Randomized Phase|Adverse Event|3|||
27686813|NCT00621777|80690415|FG001|Randomized Phase|Adverse Event|3|||
27686814|NCT00621777|80690414|FG000|Randomized Phase|Lost to Follow-up|3|||
27686815|NCT00621777|80690415|FG001|Randomized Phase|Lost to Follow-up|3|||
27686816|NCT00621777|80690414|FG000|Randomized Phase|Withdrawal by Subject|1|||
27686817|NCT00621777|80690415|FG001|Randomized Phase|Withdrawal by Subject|9|||
27686818|NCT00621777|80690414|FG000|Randomized Phase|administrative|0|||
27686819|NCT00621777|80690415|FG001|Randomized Phase|administrative|3|||
27686820|NCT00621777|80690414|FG000|Randomized Phase|Death|0|||
27686821|NCT00621777|80690415|FG001|Randomized Phase|Death|1|||
27686822|NCT03705832|80690416|FG000|Overall Study|Physician Decision|0|||
27686823|NCT03705832|80690417|FG001|Overall Study|Physician Decision|1|||
27686824|NCT03705832|80690416|FG000|Overall Study|Withdrawal by Subject|1|||
27812351|NCT01104662|81143610|FG004|Overall Study|Randomized but not treated|0|||
27812352|NCT01104662|81143611|FG005|Overall Study|Randomized but not treated|1|||
27812353|NCT01104662|81143612|FG006|Overall Study|Randomized but not treated|0|||
27812354|NCT01104662|81143613|FG007|Overall Study|Randomized but not treated|0|||
27812355|NCT01339910|81143616|FG000|Overall Study|Withdrawal by Subject|1|||
27812356|NCT01339910|81143617|FG001|Overall Study|Withdrawal by Subject|0|||
27812357|NCT01339910|81143616|FG000|Overall Study|Physician Decision|1|||
27812358|NCT01339910|81143617|FG001|Overall Study|Physician Decision|0|||
27812359|NCT01339910|81143616|FG000|Overall Study|Disease relapse|1|||
27812360|NCT01339910|81143617|FG001|Overall Study|Disease relapse|4|||
27812361|NCT03907280|81143620|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
27812362|NCT03907280|81143621|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
27812363|NCT03907280|81143622|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
27812364|NCT00901628|81143626|FG000|Overall Study|disconnection of catheter|4|||
27812365|NCT00901628|81143627|FG001|Overall Study|disconnection of catheter|8|||
27812366|NCT00901628|81143626|FG000|Overall Study|disconnection of drain|0|||
27812367|NCT00901628|81143627|FG001|Overall Study|disconnection of drain|1|||
27812368|NCT00901628|81143626|FG000|Overall Study|peroneal nerve palsy|0|||
27812369|NCT00901628|81143627|FG001|Overall Study|peroneal nerve palsy|1|||
27812370|NCT01709383|81143628|FG000|Overall Study|Lost to Follow-up|1|||
27812371|NCT01709383|81143629|FG001|Overall Study|Lost to Follow-up|0|||
27812372|NCT00210626|81143632|FG000|Overall Study|Adverse Event|1|||
27812373|NCT00210626|81143633|FG001|Overall Study|Adverse Event|2|||
27812374|NCT00210626|81143632|FG000|Overall Study|Protocol Violation|1|||
27812375|NCT00210626|81143633|FG001|Overall Study|Protocol Violation|5|||
27812376|NCT00210626|81143632|FG000|Overall Study|Lost to Follow-up|11|||
27812377|NCT00210626|81143633|FG001|Overall Study|Lost to Follow-up|11|||
27812378|NCT00210626|81143632|FG000|Overall Study|Death|1|||
27812379|NCT00210626|81143633|FG001|Overall Study|Death|0|||
27812380|NCT00210626|81143632|FG000|Overall Study|Withdrawal by Subject|29|||
27812381|NCT00210626|81143633|FG001|Overall Study|Withdrawal by Subject|20|||
27812382|NCT00210626|81143632|FG000|Overall Study|Physician Decision|0|||
27812383|NCT00210626|81143633|FG001|Overall Study|Physician Decision|2|||
27812384|NCT00210626|81143632|FG000|Overall Study|Sponser Request|1|||
27812385|NCT00210626|81143633|FG001|Overall Study|Sponser Request|0|||
27875742|NCT00720213|81375518|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
28008079|NCT03192176|81861985|FG003|Overall Study|Protocol Deviation|0|||
28008080|NCT03192176|81861986|FG004|Overall Study|Protocol Deviation|2|||
28008081|NCT03192176|81861987|FG005|Overall Study|Protocol Deviation|0|||
28008082|NCT03192176|81861988|FG006|Overall Study|Protocol Deviation|0|||
28008083|NCT03192176|81861989|FG007|Overall Study|Protocol Deviation|0|||
28008084|NCT03192176|81861982|FG000|Overall Study|Withdrawal by Subject|3|||
28008085|NCT03192176|81861983|FG001|Overall Study|Withdrawal by Subject|4|||
28008086|NCT03192176|81861984|FG002|Overall Study|Withdrawal by Subject|0|||
28008087|NCT03192176|81861985|FG003|Overall Study|Withdrawal by Subject|4|||
27686825|NCT03705832|80690417|FG001|Overall Study|Withdrawal by Subject|0|||
27686826|NCT01290029|80690420|FG000|Overall Study|Other|2|||
27686827|NCT00688103|80690421|FG000|Overall Study|Adverse Event|4|||
27686828|NCT00688103|80690422|FG001|Overall Study|Adverse Event|1|||
27686829|NCT00688103|80690421|FG000|Overall Study|Lack of Efficacy|11|||
27686830|NCT00688103|80690422|FG001|Overall Study|Lack of Efficacy|1|||
27686831|NCT00688103|80690421|FG000|Overall Study|Withdrawal by Subject|4|||
27686832|NCT00688103|80690422|FG001|Overall Study|Withdrawal by Subject|2|||
27812386|NCT00210626|81143632|FG000|Overall Study|Other|4|||
27812387|NCT00210626|81143633|FG001|Overall Study|Other|5|||
27812388|NCT02456909|81143634|FG000|Overall Study|Did not receive allocated intervention|24|||
27812389|NCT02456909|81143635|FG001|Overall Study|Did not receive allocated intervention|26|||
27812390|NCT02456909|81143634|FG000|Overall Study|Did not complete the primary outcome|0|||
28008088|NCT03192176|81861986|FG004|Overall Study|Withdrawal by Subject|3|||
28008089|NCT03192176|81861987|FG005|Overall Study|Withdrawal by Subject|4|||
27812391|NCT02456909|81143635|FG001|Overall Study|Did not complete the primary outcome|1|||
27812392|NCT00322556|81143636|FG000|Overall Study|Adverse Event|1|||
27812393|NCT00322556|81143636|FG000|Overall Study|Withdrawal by Subject|1|||
27812394|NCT00322556|81143636|FG000|Overall Study|Lost to Follow-up|3|||
27812395|NCT00322556|81143636|FG000|Overall Study|Other Reason|7|||
28008090|NCT03192176|81861988|FG006|Overall Study|Withdrawal by Subject|4|||
28008091|NCT03192176|81861989|FG007|Overall Study|Withdrawal by Subject|2|||
28008092|NCT03192176|81861982|FG000|Overall Study|Miscellaneous|1|||
28008093|NCT03192176|81861983|FG001|Overall Study|Miscellaneous|0|||
28008094|NCT03192176|81861984|FG002|Overall Study|Miscellaneous|1|||
28008095|NCT03192176|81861985|FG003|Overall Study|Miscellaneous|1|||
28008096|NCT03192176|81861986|FG004|Overall Study|Miscellaneous|1|||
28008097|NCT03192176|81861987|FG005|Overall Study|Miscellaneous|2|||
28008098|NCT03192176|81861988|FG006|Overall Study|Miscellaneous|0|||
28008099|NCT03192176|81861989|FG007|Overall Study|Miscellaneous|1|||
28008100|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
28008101|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
28008102|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
28008103|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
28008104|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
28008105|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
28008106|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
28008107|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
28008108|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
28008109|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
28008110|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
28008111|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
28008112|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
28008113|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
28008114|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
27686833|NCT00688103|80690421|FG000|Overall Study|complex reasons|11|||
27686834|NCT00688103|80690422|FG001|Overall Study|complex reasons|9|||
27686835|NCT04410523|80690423|FG000|Overall Study|Study terminated by sponsor|1|||
27686836|NCT04410523|80690424|FG001|Overall Study|Study terminated by sponsor|3|||
27686837|NCT04410523|80690425|FG002|Overall Study|Study terminated by sponsor|2|||
27686838|NCT04410523|80690426|FG003|Overall Study|Study terminated by sponsor|6|||
27686839|NCT04410523|80690427|FG004|Overall Study|Study terminated by sponsor|3|||
27686840|NCT04410523|80690428|FG005|Overall Study|Study terminated by sponsor|4|||
27686841|NCT04410523|80690423|FG000|Overall Study|Adverse Event|1|||
27686842|NCT04410523|80690424|FG001|Overall Study|Adverse Event|0|||
27686843|NCT04410523|80690425|FG002|Overall Study|Adverse Event|0|||
27686844|NCT04410523|80690426|FG003|Overall Study|Adverse Event|0|||
27686845|NCT04410523|80690427|FG004|Overall Study|Adverse Event|0|||
27686846|NCT04410523|80690428|FG005|Overall Study|Adverse Event|2|||
27686847|NCT04410523|80690423|FG000|Overall Study|Lost to Follow-up|0|||
27686848|NCT04410523|80690424|FG001|Overall Study|Lost to Follow-up|1|||
27686849|NCT04410523|80690425|FG002|Overall Study|Lost to Follow-up|0|||
27686850|NCT04410523|80690426|FG003|Overall Study|Lost to Follow-up|0|||
27686851|NCT04410523|80690427|FG004|Overall Study|Lost to Follow-up|0|||
27686852|NCT04410523|80690428|FG005|Overall Study|Lost to Follow-up|0|||
27686853|NCT04410523|80690423|FG000|Overall Study|Physician Decision|0|||
27686854|NCT04410523|80690424|FG001|Overall Study|Physician Decision|1|||
27686855|NCT04410523|80690425|FG002|Overall Study|Physician Decision|0|||
27686856|NCT04410523|80690426|FG003|Overall Study|Physician Decision|0|||
27686857|NCT04410523|80690427|FG004|Overall Study|Physician Decision|0|||
27686858|NCT04410523|80690428|FG005|Overall Study|Physician Decision|0|||
27812396|NCT02006706|81143637|FG000|Overall Study|Lost to Follow-up|1|||
27812397|NCT01498484|81143638|FG000|Overall Study|Death|6|||
27812398|NCT01498484|81143639|FG001|Overall Study|Death|3|||
27812399|NCT01498484|81143640|FG002|Overall Study|Death|1|||
27812400|NCT01498484|81143641|FG003|Overall Study|Death|1|||
28008115|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
27686859|NCT04410523|80690423|FG000|Overall Study|Pregnancy|0|||
27686860|NCT04410523|80690424|FG001|Overall Study|Pregnancy|0|||
27686861|NCT04410523|80690425|FG002|Overall Study|Pregnancy|0|||
27686862|NCT04410523|80690426|FG003|Overall Study|Pregnancy|0|||
27686863|NCT04410523|80690427|FG004|Overall Study|Pregnancy|0|||
27686864|NCT04410523|80690428|FG005|Overall Study|Pregnancy|1|||
27686865|NCT04410523|80690423|FG000|Overall Study|Protocol deviation|0|||
27812401|NCT01498484|81143642|FG004|Overall Study|Death|0|||
27812402|NCT01498484|81143643|FG005|Overall Study|Death|0|||
27812403|NCT01498484|81143644|FG006|Overall Study|Death|10|||
27812404|NCT01498484|81143645|FG007|Overall Study|Death|1|||
27812405|NCT01498484|81143646|FG008|Overall Study|Death|0|||
27812406|NCT01498484|81143638|FG000|Overall Study|Physician Decision|3|||
27812407|NCT01498484|81143639|FG001|Overall Study|Physician Decision|2|||
27812408|NCT01498484|81143640|FG002|Overall Study|Physician Decision|1|||
27812409|NCT01498484|81143641|FG003|Overall Study|Physician Decision|1|||
27686866|NCT04410523|80690424|FG001|Overall Study|Protocol deviation|0|||
27686867|NCT04410523|80690425|FG002|Overall Study|Protocol deviation|0|||
27686868|NCT04410523|80690426|FG003|Overall Study|Protocol deviation|0|||
27686869|NCT04410523|80690427|FG004|Overall Study|Protocol deviation|0|||
27686870|NCT04410523|80690428|FG005|Overall Study|Protocol deviation|2|||
27686871|NCT04410523|80690423|FG000|Overall Study|Subject decision|2|||
27812410|NCT01498484|81143642|FG004|Overall Study|Physician Decision|0|||
27812411|NCT01498484|81143643|FG005|Overall Study|Physician Decision|0|||
27812412|NCT01498484|81143644|FG006|Overall Study|Physician Decision|8|||
27812413|NCT01498484|81143645|FG007|Overall Study|Physician Decision|13|||
27812414|NCT01498484|81143646|FG008|Overall Study|Physician Decision|1|||
27812415|NCT01498484|81143638|FG000|Overall Study|Adverse Event|0|||
27812416|NCT01498484|81143639|FG001|Overall Study|Adverse Event|0|||
27812417|NCT01498484|81143640|FG002|Overall Study|Adverse Event|0|||
27812418|NCT01498484|81143641|FG003|Overall Study|Adverse Event|0|||
27812419|NCT01498484|81143642|FG004|Overall Study|Adverse Event|0|||
27812420|NCT01498484|81143643|FG005|Overall Study|Adverse Event|1|||
27812421|NCT01498484|81143644|FG006|Overall Study|Adverse Event|0|||
27812422|NCT01498484|81143645|FG007|Overall Study|Adverse Event|0|||
27812423|NCT01498484|81143646|FG008|Overall Study|Adverse Event|0|||
27812424|NCT01498484|81143638|FG000|Overall Study|Withdrawal by Subject|0|||
27686872|NCT04410523|80690424|FG001|Overall Study|Subject decision|0|||
27686873|NCT04410523|80690425|FG002|Overall Study|Subject decision|0|||
27686874|NCT04410523|80690426|FG003|Overall Study|Subject decision|1|||
27686875|NCT04410523|80690427|FG004|Overall Study|Subject decision|0|||
27686876|NCT04410523|80690428|FG005|Overall Study|Subject decision|1|||
27812425|NCT01498484|81143639|FG001|Overall Study|Withdrawal by Subject|0|||
27812426|NCT01498484|81143640|FG002|Overall Study|Withdrawal by Subject|0|||
27812427|NCT01498484|81143641|FG003|Overall Study|Withdrawal by Subject|1|||
27812428|NCT01498484|81143642|FG004|Overall Study|Withdrawal by Subject|0|||
27812429|NCT01498484|81143643|FG005|Overall Study|Withdrawal by Subject|0|||
27812430|NCT01498484|81143644|FG006|Overall Study|Withdrawal by Subject|1|||
27812431|NCT01498484|81143645|FG007|Overall Study|Withdrawal by Subject|0|||
28008116|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
28008117|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
27686877|NCT00657020|80690429|FG000|PERIOD 1|Adverse Event|0|||
27686878|NCT00657020|80690430|FG001|PERIOD 1|Adverse Event|1|||
27686879|NCT01076153|80690431|FG000|Overall Study|Symptoms improved/resolved|10|||
27686880|NCT01076153|80690431|FG000|Overall Study|Adverse Event|1|||
27686881|NCT00993668|80690434|FG000|Single-Blind Period|Adverse Event|1|||
27686882|NCT00993668|80690435|FG001|Single-Blind Period|Adverse Event|1|||
27686883|NCT00993668|80690434|FG000|Single-Blind Period|Lack of Efficacy|0|||
27686884|NCT00993668|80690435|FG001|Single-Blind Period|Lack of Efficacy|1|||
27686885|NCT00993668|80690434|FG000|Single-Blind Period|Lost to Follow-up|3|||
27686886|NCT00993668|80690435|FG001|Single-Blind Period|Lost to Follow-up|1|||
27686887|NCT00993668|80690434|FG000|Open-Label Period|Adverse Event|9|||
27686888|NCT00993668|80690435|FG001|Open-Label Period|Adverse Event|8|||
27686889|NCT00993668|80690434|FG000|Open-Label Period|Lack of Efficacy|4|||
27686890|NCT00993668|80690435|FG001|Open-Label Period|Lack of Efficacy|3|||
27686891|NCT00993668|80690434|FG000|Open-Label Period|Withdrawal by Subject|4|||
27686892|NCT00993668|80690435|FG001|Open-Label Period|Withdrawal by Subject|3|||
27686893|NCT00993668|80690434|FG000|Open-Label Period|Lost to Follow-up|6|||
27812432|NCT01498484|81143646|FG008|Overall Study|Withdrawal by Subject|0|||
27812433|NCT01498484|81143638|FG000|Overall Study|Other|5|||
27812434|NCT01498484|81143639|FG001|Overall Study|Other|2|||
28008118|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
28008119|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
27686894|NCT00993668|80690435|FG001|Open-Label Period|Lost to Follow-up|1|||
27686895|NCT05020327|80690443|FG000|Overall Study|Physician Decision|3|||
27686896|NCT05020327|80690444|FG001|Overall Study|Physician Decision|0|||
27812435|NCT01498484|81143640|FG002|Overall Study|Other|0|||
27812436|NCT01498484|81143641|FG003|Overall Study|Other|0|||
27686897|NCT05020327|80690445|FG002|Overall Study|Physician Decision|0|||
27686898|NCT05020327|80690443|FG000|Overall Study|Withdrawal by Subject|1|||
27686899|NCT05020327|80690444|FG001|Overall Study|Withdrawal by Subject|1|||
27686900|NCT05020327|80690445|FG002|Overall Study|Withdrawal by Subject|0|||
27812437|NCT01498484|81143642|FG004|Overall Study|Other|1|||
27686901|NCT05020327|80690443|FG000|Overall Study|personal/cultural, ineligible|12|||
27686902|NCT05020327|80690444|FG001|Overall Study|personal/cultural, ineligible|0|||
27812438|NCT01498484|81143643|FG005|Overall Study|Other|0|||
27812439|NCT01498484|81143644|FG006|Overall Study|Other|3|||
27686903|NCT05020327|80690445|FG002|Overall Study|personal/cultural, ineligible|0|||
27686904|NCT01004848|80690446|FG000|Overall Study|Lost to Follow-up|55|||
27686905|NCT01004848|80690447|FG001|Overall Study|Lost to Follow-up|45|||
27686906|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
27686907|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
27686908|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
27686909|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
27686910|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
27686911|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
27686912|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
27686913|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
27686914|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
27686915|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
27812440|NCT01498484|81143645|FG007|Overall Study|Other|0|||
27812441|NCT01498484|81143646|FG008|Overall Study|Other|1|||
27812442|NCT02034799|81143647|FG000|Overall Study|Withdrawal by Subject|0|||
27812443|NCT02034799|81143648|FG001|Overall Study|Withdrawal by Subject|2|||
27812444|NCT02034799|81143647|FG000|Overall Study|Lost to Follow-up|0|||
27812445|NCT02034799|81143648|FG001|Overall Study|Lost to Follow-up|1|||
27812446|NCT02034799|81143647|FG000|Overall Study|Death|2|||
27812447|NCT02034799|81143648|FG001|Overall Study|Death|1|||
27686916|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
27686917|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
27686918|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
27686919|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
27812448|NCT01691859|81143649|FG000|Overall Study|Adverse Event|19|||
27812449|NCT01691859|81143649|FG000|Overall Study|Lack of Efficacy|11|||
27812450|NCT01691859|81143649|FG000|Overall Study|Protocol Violation|4|||
27812451|NCT01691859|81143649|FG000|Overall Study|Product commercially available|221|||
27812452|NCT01691859|81143649|FG000|Overall Study|Study closed/terminated|50|||
27812453|NCT01691859|81143649|FG000|Overall Study|Lost to Follow-up|5|||
27812454|NCT01691859|81143649|FG000|Overall Study|Physician Decision|6|||
27812455|NCT01691859|81143649|FG000|Overall Study|Withdrawal by Subject|31|||
27812456|NCT00661505|81143650|FG000|Overall Study|Adverse Event|3|||
27812457|NCT00661505|81143650|FG000|Overall Study|Protocol Violation|14|||
27812458|NCT00661505|81143650|FG000|Overall Study|Withdrawal by Subject|8|||
27812459|NCT00661505|81143650|FG000|Overall Study|Lost to Follow-up|3|||
27812460|NCT00661505|81143650|FG000|Overall Study|Other|2|||
27812461|NCT03495869|81143651|FG000|Overall Study|Lost to Follow-up|4|||
27812462|NCT03495869|81143652|FG001|Overall Study|Lost to Follow-up|17|||
27812463|NCT03495869|81143653|FG002|Overall Study|Lost to Follow-up|8|||
27812464|NCT03495869|81143654|FG003|Overall Study|Lost to Follow-up|14|||
27812465|NCT03495869|81143651|FG000|Overall Study|Withdrawal by Subject|0|||
27812466|NCT03495869|81143652|FG001|Overall Study|Withdrawal by Subject|3|||
27812467|NCT03495869|81143653|FG002|Overall Study|Withdrawal by Subject|0|||
27812468|NCT03495869|81143654|FG003|Overall Study|Withdrawal by Subject|3|||
27812469|NCT03495869|81143651|FG000|Overall Study|Dropped from study|0|||
27812470|NCT03495869|81143652|FG001|Overall Study|Dropped from study|7|||
27812471|NCT03495869|81143653|FG002|Overall Study|Dropped from study|2|||
27812472|NCT03495869|81143654|FG003|Overall Study|Dropped from study|4|||
27812473|NCT02750761|81143655|FG000|Overall Study|Lost to Follow-up|0|||
27812474|NCT02750761|81143656|FG001|Overall Study|Lost to Follow-up|0|||
27812475|NCT02750761|81143657|FG002|Overall Study|Lost to Follow-up|1|||
27812476|NCT02750761|81143658|FG003|Overall Study|Lost to Follow-up|0|||
27812477|NCT02750761|81143659|FG004|Overall Study|Lost to Follow-up|0|||
27812478|NCT02750761|81143660|FG005|Overall Study|Lost to Follow-up|0|||
27812479|NCT00319956|81143661|FG000|Overall Study|Death|20|||
27812480|NCT00319956|81143662|FG001|Overall Study|Death|24|||
27812481|NCT00376220|81143663|FG000|Overall Study|Lost to Follow-up|7|||
27812482|NCT00376220|81143664|FG001|Overall Study|Lost to Follow-up|10|||
27812483|NCT00376220|81143663|FG000|Overall Study|Withdrawal by Subject|3|||
27812484|NCT00376220|81143664|FG001|Overall Study|Withdrawal by Subject|2|||
27812485|NCT02178709|81143665|FG000|Overall Study|Adverse Event|5|||
27812486|NCT02178709|81143665|FG000|Overall Study|Death|2|||
27686920|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
27686921|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
27686922|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
27686923|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
27686924|NCT03412747|80690448|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
27686925|NCT03412747|80690449|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
27686926|NCT03412747|80690450|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
27812487|NCT02178709|81143665|FG000|Overall Study|Withdrawal by Subject|2|||
27587397|NCT02415400|80331769|FG003|Overall Study|Death|42|||
27812488|NCT02178709|81143665|FG000|Overall Study|Physician Decision|2|||
27812489|NCT02178709|81143665|FG000|Overall Study|Disease Progression|5|||
27812490|NCT01003886|81143666|FG000|Overall Study|Lack of Efficacy|5|||
27812491|NCT01003886|81143666|FG000|Overall Study|Lost to Follow-up|169|||
27812492|NCT01003886|81143666|FG000|Overall Study|Withdrawal by Subject|39|||
27812493|NCT01003886|81143666|FG000|Overall Study|Other|14|||
27812494|NCT01003886|81143666|FG000|Overall Study|Adverse Event|3|||
27812495|NCT00124020|81143669|FG000|Overall Study|Death|67|||
27812496|NCT00124020|81143670|FG001|Overall Study|Death|71|||
27812497|NCT00124020|81143669|FG000|Overall Study|Withdrawal by Subject|13|||
27812498|NCT00124020|81143670|FG001|Overall Study|Withdrawal by Subject|11|||
27812499|NCT00124020|81143669|FG000|Overall Study|Lost to Follow-up|5|||
27812500|NCT00124020|81143670|FG001|Overall Study|Lost to Follow-up|8|||
27812501|NCT00124020|81143669|FG000|Overall Study|Other|1|||
27812502|NCT00124020|81143670|FG001|Overall Study|Other|1|||
27812503|NCT00124020|81143669|FG000|Overall Study|Transfer to another hospital|2|||
27686927|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
27686928|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
27686929|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
27686930|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
27686931|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
27812504|NCT00124020|81143670|FG001|Overall Study|Transfer to another hospital|0|||
27812505|NCT01844583|81143674|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
27812506|NCT01844583|81143675|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
27812507|NCT00113490|81143676|FG000|Overall Study|Withdrawal by Subject|1|||
27812508|NCT00113490|81143677|FG001|Overall Study|Withdrawal by Subject|3|||
27812509|NCT00113490|81143676|FG000|Overall Study|Lost to Follow-up|1|||
27812510|NCT00113490|81143677|FG001|Overall Study|Lost to Follow-up|0|||
27812511|NCT01118728|81143678|FG000|Overall Study|Adverse Event|17|||
27812512|NCT01118728|81143678|FG000|Overall Study|Lack of Efficacy|27|||
27812513|NCT01118728|81143678|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
27812514|NCT01118728|81143678|FG000|Overall Study|Withdrawal by Subject|3|||
27812515|NCT01118728|81143678|FG000|Overall Study|Lost to Follow-up|4|||
27812516|NCT00622908|81143679|FG000|Overall Study|Protocol Violation|1|||
27812517|NCT00622908|81143680|FG001|Overall Study|Protocol Violation|0|||
27812518|NCT00622908|81143679|FG000|Overall Study|Adverse Event|0|||
27812519|NCT00622908|81143680|FG001|Overall Study|Adverse Event|1|||
27812520|NCT00622908|81143679|FG000|Overall Study|Lack of Efficacy|1|||
27812521|NCT00622908|81143680|FG001|Overall Study|Lack of Efficacy|7|||
27686932|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
27686933|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
27686934|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
27686935|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
27812522|NCT00622908|81143679|FG000|Overall Study|Lost to Follow-up|1|||
27812523|NCT00622908|81143680|FG001|Overall Study|Lost to Follow-up|0|||
27812524|NCT00622908|81143679|FG000|Overall Study|Refusal|0|||
27812525|NCT00622908|81143680|FG001|Overall Study|Refusal|1|||
27812526|NCT00622908|81143679|FG000|Overall Study|Termination by study sponser|0|||
27812527|NCT00622908|81143680|FG001|Overall Study|Termination by study sponser|1|||
27812528|NCT00704418|81143681|FG000|Overall Study|Withdrawal by Subject|2|||
28008120|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
27686936|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
27686937|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
28008121|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
28008122|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27686938|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
27686939|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
27686940|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
27686941|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
27686942|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
27686943|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
27686944|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
27686945|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
27686946|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
27686947|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
27587398|NCT02415400|80331766|FG000|Overall Study|Lost to Follow-up|3|||
27686948|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
27686949|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
27812529|NCT00704418|81143682|FG001|Overall Study|Withdrawal by Subject|0|||
27812530|NCT00704418|81143681|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
27812531|NCT00704418|81143682|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
27812532|NCT01797120|81143684|FG000|Overall Study|Disesae progression|37|||
27812533|NCT01797120|81143685|FG001|Overall Study|Disesae progression|49|||
27812534|NCT01797120|81143684|FG000|Overall Study|Adverse Event|13|||
27812535|NCT01797120|81143685|FG001|Overall Study|Adverse Event|5|||
27812536|NCT01797120|81143684|FG000|Overall Study|Withdrawal by Subject|6|||
27686950|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
27686951|NCT03412747|80690448|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
27686952|NCT03412747|80690449|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
27686953|NCT03412747|80690450|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
27686954|NCT00766363|80690451|FG000|Overall Study|Withdrawal by Subject|1|||
27686955|NCT00766363|80690452|FG001|Overall Study|Withdrawal by Subject|0|||
27686956|NCT00766363|80690453|FG002|Overall Study|Withdrawal by Subject|0|||
27686957|NCT00766363|80690454|FG003|Overall Study|Withdrawal by Subject|0|||
27686958|NCT00766363|80690451|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
27686959|NCT00766363|80690452|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
27686960|NCT00766363|80690453|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
27686961|NCT00766363|80690454|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
27686962|NCT01427751|80690457|FG000|Overall Study|Adverse Event|18|||
27686963|NCT01427751|80690458|FG001|Overall Study|Adverse Event|2|||
27686964|NCT01427751|80690457|FG000|Overall Study|No further treatment benefit expected|5|||
27686965|NCT01427751|80690458|FG001|Overall Study|No further treatment benefit expected|1|||
27686966|NCT01427751|80690457|FG000|Overall Study|Lost to Follow-up|3|||
27686967|NCT01427751|80690458|FG001|Overall Study|Lost to Follow-up|1|||
27686968|NCT01427751|80690457|FG000|Overall Study|Withdrawal of consent|2|||
27686969|NCT01427751|80690458|FG001|Overall Study|Withdrawal of consent|2|||
27686970|NCT01427751|80690457|FG000|Overall Study|Protocol Violation|6|||
27686971|NCT01427751|80690458|FG001|Overall Study|Protocol Violation|4|||
27812537|NCT01797120|81143685|FG001|Overall Study|Withdrawal by Subject|6|||
27812538|NCT01797120|81143684|FG000|Overall Study|Symptomatic progression|2|||
27812539|NCT01797120|81143685|FG001|Overall Study|Symptomatic progression|1|||
27812540|NCT01797120|81143684|FG000|Overall Study|Non-compliance|1|||
27812541|NCT01797120|81143685|FG001|Overall Study|Non-compliance|0|||
27812542|NCT01797120|81143684|FG000|Overall Study|Physician Decision|3|||
27812543|NCT01797120|81143685|FG001|Overall Study|Physician Decision|0|||
27812544|NCT01797120|81143684|FG000|Overall Study|still on treatment|2|||
27812545|NCT01797120|81143685|FG001|Overall Study|still on treatment|4|||
27812546|NCT01797120|81143684|FG000|Overall Study|never start protocol therapy|2|||
27812547|NCT01797120|81143685|FG001|Overall Study|never start protocol therapy|0|||
27812548|NCT02097121|81143691|FG000|Overall Study|Other, not specified|4|||
27812549|NCT02097121|81143692|FG001|Overall Study|Other, not specified|2|||
27812550|NCT02097121|81143693|FG002|Overall Study|Other, not specified|3|||
27812551|NCT02097121|81143691|FG000|Overall Study|Lack of Efficacy|2|||
27812552|NCT02097121|81143692|FG001|Overall Study|Lack of Efficacy|1|||
27812553|NCT02097121|81143693|FG002|Overall Study|Lack of Efficacy|3|||
27812554|NCT02097121|81143691|FG000|Overall Study|Withdrawal by Subject|0|||
27812555|NCT02097121|81143692|FG001|Overall Study|Withdrawal by Subject|1|||
27812556|NCT02097121|81143693|FG002|Overall Study|Withdrawal by Subject|2|||
27812557|NCT02097121|81143691|FG000|Overall Study|Adverse Event|0|||
28008123|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
28008124|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
28008125|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
28008126|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
28008127|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
28008128|NCT04026113|81861994|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
28008129|NCT04026113|81861995|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
28008130|NCT04026113|81861996|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
28008131|NCT04026113|81861997|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
28008132|NCT04026113|81861994|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
28008133|NCT04026113|81861995|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
28008134|NCT04026113|81861996|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
28008135|NCT04026113|81861997|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
28008136|NCT03035032|81862000|FG000|Overall Study|Adverse Event|2|||
28008137|NCT03035032|81862000|FG000|Overall Study|Death|9|||
28008138|NCT03035032|81862000|FG000|Overall Study|Lost to Follow-up|1|||
28008139|NCT03035032|81862000|FG000|Overall Study|Progressive Disease|22|||
27686972|NCT01427751|80690457|FG000|Overall Study|Death|2|||
27686973|NCT01427751|80690458|FG001|Overall Study|Death|0|||
27686974|NCT01427751|80690457|FG000|Overall Study|Other miscellaneous reasons|6|||
27686975|NCT01427751|80690458|FG001|Overall Study|Other miscellaneous reasons|4|||
27686976|NCT00345293|80690459|FG000|Overall Study|Unable to access line for sample|1|||
27812558|NCT02097121|81143692|FG001|Overall Study|Adverse Event|1|||
28008140|NCT03035032|81862000|FG000|Overall Study|Protocol Violation|2|||
28008141|NCT03035032|81862000|FG000|Overall Study|Withdrawal by Subject|2|||
28008142|NCT03035032|81862000|FG000|Overall Study|Physician Decision|5|||
27812559|NCT02097121|81143693|FG002|Overall Study|Adverse Event|0|||
27812560|NCT02097121|81143691|FG000|Overall Study|Lost to Follow-up|1|||
27812561|NCT02097121|81143692|FG001|Overall Study|Lost to Follow-up|1|||
28008143|NCT02218372|81862001|FG000|Overall Study|Adverse Event|1|||
27686977|NCT00345293|80690460|FG001|Overall Study|Unable to access line for sample|0|||
27686978|NCT00345293|80690459|FG000|Overall Study|Withdrawal by Subject|1|||
27686979|NCT00345293|80690460|FG001|Overall Study|Withdrawal by Subject|0|||
27686980|NCT00307684|80690461|FG000|Open Label Phase|Lack of Efficacy|0|||
27686981|NCT00307684|80690462|FG001|Open Label Phase|Lack of Efficacy|0|||
27686982|NCT00307684|80690463|FG002|Open Label Phase|Lack of Efficacy|3|||
27587399|NCT02415400|80331767|FG001|Overall Study|Lost to Follow-up|3|||
27587400|NCT02415400|80331768|FG002|Overall Study|Lost to Follow-up|2|||
27587401|NCT02415400|80331769|FG003|Overall Study|Lost to Follow-up|5|||
27587402|NCT02415400|80331766|FG000|Overall Study|Poor/Non-Compliance|0|||
27686983|NCT00307684|80690461|FG000|Open Label Phase|Adverse Event|0|||
27686984|NCT00307684|80690462|FG001|Open Label Phase|Adverse Event|0|||
27686985|NCT00307684|80690463|FG002|Open Label Phase|Adverse Event|16|||
27686986|NCT00307684|80690461|FG000|Open Label Phase|Withdrawal by Subject|0|||
27587403|NCT02415400|80331767|FG001|Overall Study|Poor/Non-Compliance|1|||
27587404|NCT02415400|80331768|FG002|Overall Study|Poor/Non-Compliance|3|||
27587405|NCT02415400|80331769|FG003|Overall Study|Poor/Non-Compliance|4|||
27587406|NCT02415400|80331766|FG000|Overall Study|Participant no longer meets criteria|2|||
27587407|NCT02415400|80331767|FG001|Overall Study|Participant no longer meets criteria|0|||
27587408|NCT02415400|80331768|FG002|Overall Study|Participant no longer meets criteria|0|||
27587409|NCT02415400|80331769|FG003|Overall Study|Participant no longer meets criteria|1|||
27587410|NCT02415400|80331766|FG000|Overall Study|Participant doesn't answer phone|1|||
27587411|NCT02415400|80331767|FG001|Overall Study|Participant doesn't answer phone|0|||
27587412|NCT02415400|80331768|FG002|Overall Study|Participant doesn't answer phone|0|||
27587413|NCT02415400|80331769|FG003|Overall Study|Participant doesn't answer phone|0|||
27587414|NCT02415400|80331766|FG000|Overall Study|Participant wanted home visits|1|||
27587415|NCT02415400|80331767|FG001|Overall Study|Participant wanted home visits|0|||
27587416|NCT02415400|80331768|FG002|Overall Study|Participant wanted home visits|0|||
27587417|NCT02415400|80331769|FG003|Overall Study|Participant wanted home visits|0|||
27587418|NCT02415400|80331766|FG000|Overall Study|Randomized in error|2|||
27686987|NCT00307684|80690462|FG001|Open Label Phase|Withdrawal by Subject|0|||
27686988|NCT00307684|80690463|FG002|Open Label Phase|Withdrawal by Subject|15|||
27686989|NCT00307684|80690461|FG000|Open Label Phase|Lost to Follow-up|0|||
27875743|NCT00982657|81375522|FG000|Overall Study|Death|1|||
27875744|NCT00982657|81375523|FG001|Overall Study|Death|0|||
27875745|NCT00982657|81375524|FG002|Overall Study|Death|1|||
27875746|NCT00982657|81375525|FG003|Overall Study|Death|1|||
27875747|NCT00982657|81375522|FG000|Overall Study|Withdrawal by Subject|0|||
27875748|NCT00982657|81375523|FG001|Overall Study|Withdrawal by Subject|0|||
27875749|NCT00982657|81375524|FG002|Overall Study|Withdrawal by Subject|1|||
27875750|NCT00982657|81375525|FG003|Overall Study|Withdrawal by Subject|3|||
27875751|NCT00982657|81375522|FG000|Overall Study|Other|0|||
27875752|NCT00982657|81375523|FG001|Overall Study|Other|0|||
27875753|NCT00982657|81375524|FG002|Overall Study|Other|0|||
27875754|NCT00982657|81375525|FG003|Overall Study|Other|4|||
27875755|NCT00982657|81375522|FG000|Overall Study|On going at date of cut-off|0|||
27875756|NCT00982657|81375523|FG001|Overall Study|On going at date of cut-off|0|||
27875757|NCT00982657|81375524|FG002|Overall Study|On going at date of cut-off|0|||
27875758|NCT00982657|81375525|FG003|Overall Study|On going at date of cut-off|1|||
27875759|NCT01207687|81375529|FG000|Overall Study|Adverse Event|1|||
27875760|NCT01207687|81375529|FG000|Overall Study|Withdrawal by Subject|1|||
27875761|NCT03564119|81375535|FG000|Overall Study|Adverse Event|4|||
28008144|NCT02218372|81862002|FG001|Overall Study|Adverse Event|1|||
28008145|NCT02218372|81862001|FG000|Overall Study|Miscellaneous|2|||
28008146|NCT02218372|81862002|FG001|Overall Study|Miscellaneous|1|||
28008147|NCT02218372|81862001|FG000|Overall Study|Randomized but did not receive treatment|2|||
28008148|NCT02218372|81862002|FG001|Overall Study|Randomized but did not receive treatment|3|||
28008149|NCT02218372|81862001|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
28008150|NCT02218372|81862002|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
28008151|NCT03959423|81862003|FG000|Overall Study|Withdrawal by Subject|2|||
28008152|NCT03959423|81862004|FG001|Overall Study|Withdrawal by Subject|3|||
28008153|NCT03959423|81862003|FG000|Overall Study|Physician Decision|0|||
28008154|NCT03959423|81862004|FG001|Overall Study|Physician Decision|1|||
28008155|NCT03959423|81862003|FG000|Overall Study|Lost to Follow-up|1|||
28008156|NCT03959423|81862004|FG001|Overall Study|Lost to Follow-up|0|||
28008157|NCT03959423|81862003|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
28008158|NCT03959423|81862004|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27587419|NCT02415400|80331767|FG001|Overall Study|Randomized in error|0|||
27587420|NCT02415400|80331768|FG002|Overall Study|Randomized in error|0|||
28008159|NCT04201431|81862005|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
27587421|NCT02415400|80331769|FG003|Overall Study|Randomized in error|0|||
27686990|NCT00307684|80690462|FG001|Open Label Phase|Lost to Follow-up|0|||
27686991|NCT00307684|80690463|FG002|Open Label Phase|Lost to Follow-up|11|||
27875762|NCT03564119|81375536|FG001|Overall Study|Adverse Event|0|||
27875763|NCT03564119|81375535|FG000|Overall Study|Lost to Follow-up|1|||
27875764|NCT03564119|81375536|FG001|Overall Study|Lost to Follow-up|4|||
27875765|NCT03564119|81375535|FG000|Overall Study|Protocol Violation|1|||
27587422|NCT02415400|80331766|FG000|Overall Study|No study drug on site|0|||
27587423|NCT02415400|80331767|FG001|Overall Study|No study drug on site|1|||
27812562|NCT02097121|81143693|FG002|Overall Study|Lost to Follow-up|2|||
27812563|NCT00368277|81143696|FG000|Overall Study|Adverse Event|33|||
27812564|NCT00368277|81143697|FG001|Overall Study|Adverse Event|49|||
27812565|NCT00368277|81143696|FG000|Overall Study|Death|2|||
27812566|NCT00368277|81143697|FG001|Overall Study|Death|1|||
27812567|NCT00368277|81143696|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
27812568|NCT00368277|81143697|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
27812569|NCT00368277|81143696|FG000|Overall Study|Protocol deviation|7|||
27812570|NCT00368277|81143697|FG001|Overall Study|Protocol deviation|0|||
27812571|NCT00368277|81143696|FG000|Overall Study|Patient withdrew consent|32|||
27812572|NCT00368277|81143697|FG001|Overall Study|Patient withdrew consent|28|||
27812573|NCT00368277|81143696|FG000|Overall Study|Lost to Follow-up|8|||
28008160|NCT04201431|81862006|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
28008161|NCT04201431|81862007|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
28008162|NCT04571944|81862008|FG000|Overall Study|Death|1|||
28008163|NCT04571944|81862009|FG001|Overall Study|Death|0|||
28008164|NCT04571944|81862008|FG000|Overall Study|Withdrawal by Subject|3|||
28008165|NCT04571944|81862009|FG001|Overall Study|Withdrawal by Subject|0|||
28008166|NCT04571944|81862008|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
28008167|NCT04571944|81862009|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
28008168|NCT04575155|81862019|FG000|2 Month|Withdrawal by Subject|1|||
27812574|NCT00368277|81143697|FG001|Overall Study|Lost to Follow-up|6|||
27812575|NCT00829413|81143698|FG000|Overall Study|No study drug admimnistered|13|||
27812576|NCT00829413|81143698|FG000|Overall Study|Training Patients|67|||
27812577|NCT00829413|81143698|FG000|Overall Study|No truth standard procedure available|9|||
27812578|NCT00829413|81143698|FG000|Overall Study|Technically inadequate truth standard|2|||
27812579|NCT00829413|81143698|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
27812580|NCT03734237|81143699|FG000|Overall Study|Lost to Follow-up|1|||
27812581|NCT03734237|81143700|FG001|Overall Study|Lost to Follow-up|3|||
27812582|NCT03734237|81143701|FG002|Overall Study|Lost to Follow-up|0|||
27812583|NCT03734237|81143699|FG000|Overall Study|Withdrawal by Subject|7|||
27812584|NCT03734237|81143700|FG001|Overall Study|Withdrawal by Subject|9|||
27812585|NCT03734237|81143701|FG002|Overall Study|Withdrawal by Subject|10|||
27812586|NCT01411995|81143705|FG000|Overall Study|Failed IUD insertion|0|||
27812587|NCT01411995|81143706|FG001|Overall Study|Failed IUD insertion|1|||
27812588|NCT00294723|81143708|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
27812589|NCT00294723|81143709|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
27812590|NCT00294723|81143710|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
27812591|NCT00294723|81143708|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
27812592|NCT00294723|81143709|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
27812593|NCT00294723|81143710|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
27812594|NCT00294723|81143708|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
27812595|NCT00294723|81143709|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
27812596|NCT00294723|81143710|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
27812597|NCT00294723|81143708|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
27812598|NCT00294723|81143709|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
27812599|NCT00294723|81143710|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
27812600|NCT00294723|81143708|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
27812601|NCT00294723|81143709|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
27812602|NCT00294723|81143710|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
27812603|NCT00294723|81143708|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
27812604|NCT00294723|81143709|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
27812605|NCT00294723|81143710|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
27812606|NCT00294723|81143708|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
27812607|NCT00294723|81143709|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
27812608|NCT00294723|81143710|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
27812609|NCT00294723|81143708|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
27812610|NCT00294723|81143709|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
27812611|NCT00294723|81143710|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
27875766|NCT03564119|81375536|FG001|Overall Study|Protocol Violation|0|||
28008169|NCT04575155|81862020|FG001|2 Month|Withdrawal by Subject|1|||
27812612|NCT00294723|81143708|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
27812613|NCT00294723|81143709|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
27812614|NCT00294723|81143710|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
27812615|NCT00294723|81143708|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
27812616|NCT00294723|81143709|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
27812617|NCT00294723|81143710|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
27812618|NCT00294723|81143708|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
27875767|NCT03564119|81375535|FG000|Overall Study|Withdrawal by Subject|9|||
28008170|NCT04575155|81862019|FG000|2 Month|Lost to Follow-up|5|||
28008171|NCT04575155|81862020|FG001|2 Month|Lost to Follow-up|3|||
27587424|NCT02415400|80331768|FG002|Overall Study|No study drug on site|0|||
27587425|NCT02415400|80331769|FG003|Overall Study|No study drug on site|0|||
27587426|NCT02415400|80331766|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
27587427|NCT02415400|80331767|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
27587428|NCT02415400|80331768|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
27587429|NCT02415400|80331769|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
27587430|NCT02415400|80331766|FG000|Overall Study|Coagulation values cannot be set|0|||
27587431|NCT02415400|80331767|FG001|Overall Study|Coagulation values cannot be set|0|||
27587432|NCT02415400|80331768|FG002|Overall Study|Coagulation values cannot be set|1|||
27587433|NCT02415400|80331769|FG003|Overall Study|Coagulation values cannot be set|0|||
27587434|NCT02415400|80331766|FG000|Overall Study|State regulations prevent participation|0|||
27587435|NCT02415400|80331767|FG001|Overall Study|State regulations prevent participation|0|||
27875768|NCT03564119|81375536|FG001|Overall Study|Withdrawal by Subject|4|||
27875769|NCT03564119|81375535|FG000|Overall Study|Other Than Specified|0|||
27875770|NCT03564119|81375536|FG001|Overall Study|Other Than Specified|1|||
27875771|NCT04871776|81375537|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
27875772|NCT04871776|81375538|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
27875773|NCT04871776|81375539|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
28008172|NCT04575155|81862019|FG000|2 Month|Ineligible|1|||
28008173|NCT04575155|81862020|FG001|2 Month|Ineligible|0|||
27587436|NCT02415400|80331768|FG002|Overall Study|State regulations prevent participation|1|||
27587437|NCT02415400|80331769|FG003|Overall Study|State regulations prevent participation|0|||
27587438|NCT02415400|80331766|FG000|Overall Study|Poor treatment monitoring|0|||
27587439|NCT02415400|80331767|FG001|Overall Study|Poor treatment monitoring|0|||
27587440|NCT02415400|80331768|FG002|Overall Study|Poor treatment monitoring|1|||
27587441|NCT02415400|80331769|FG003|Overall Study|Poor treatment monitoring|0|||
27587442|NCT02415400|80331766|FG000|Overall Study|Participant in jail|0|||
27587443|NCT02415400|80331767|FG001|Overall Study|Participant in jail|0|||
27587444|NCT02415400|80331768|FG002|Overall Study|Participant in jail|1|||
27587445|NCT02415400|80331769|FG003|Overall Study|Participant in jail|0|||
27587446|NCT02415400|80331766|FG000|Overall Study|Investigator decision|0|||
27686992|NCT00307684|80690461|FG000|Open Label Phase|non compliance|0|||
27686993|NCT00307684|80690462|FG001|Open Label Phase|non compliance|0|||
27686994|NCT00307684|80690463|FG002|Open Label Phase|non compliance|5|||
28008174|NCT03915717|81862021|FG000|Overall Study|EchoMark Not Implanted|6|||
28008175|NCT03267277|81862022|FG000|Overall Study|Withdrawal by Subject|1|||
28008176|NCT04079296|81862023|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
28008177|NCT04079296|81862024|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
27686995|NCT00307684|80690461|FG000|Open Label Phase|other|0|||
28008178|NCT04079296|81862025|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
27587447|NCT02415400|80331767|FG001|Overall Study|Investigator decision|0|||
27587448|NCT02415400|80331768|FG002|Overall Study|Investigator decision|1|||
27587449|NCT02415400|80331769|FG003|Overall Study|Investigator decision|1|||
27587450|NCT02415400|80331766|FG000|Overall Study|Site closure; participant won't transfer|0|||
27587451|NCT02415400|80331767|FG001|Overall Study|Site closure; participant won't transfer|0|||
27587452|NCT02415400|80331768|FG002|Overall Study|Site closure; participant won't transfer|0|||
28008179|NCT04079296|81862026|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
28008180|NCT04079296|81862027|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
28008181|NCT04079296|81862023|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
28008182|NCT04079296|81862024|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
28008183|NCT04079296|81862025|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
28008184|NCT04079296|81862026|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
28008185|NCT04079296|81862027|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
28008186|NCT04079296|81862023|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
28008187|NCT04079296|81862024|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
28008188|NCT04079296|81862025|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
28008189|NCT04079296|81862026|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
28008190|NCT04079296|81862027|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
28008191|NCT04079296|81862023|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
28008192|NCT04079296|81862024|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
28008193|NCT04079296|81862025|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
28008194|NCT04079296|81862026|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
28008195|NCT04079296|81862027|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
28008196|NCT04079296|81862023|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
28008197|NCT04079296|81862024|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
28008198|NCT04079296|81862025|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
28008199|NCT04079296|81862026|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
28008200|NCT04079296|81862027|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
28008201|NCT04079296|81862023|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
28008202|NCT04079296|81862024|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
28008203|NCT04079296|81862025|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
28008204|NCT04079296|81862026|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
28008205|NCT04079296|81862027|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
28008206|NCT04079296|81862023|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
28008207|NCT04079296|81862024|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
28008208|NCT04079296|81862025|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
28008209|NCT04079296|81862026|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
28008210|NCT04079296|81862027|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
28008211|NCT04079296|81862023|FG000|Dose Expansion Phase (168 Days)|Death|0|||
28008212|NCT04079296|81862024|FG001|Dose Expansion Phase (168 Days)|Death|0|||
28008213|NCT04079296|81862025|FG002|Dose Expansion Phase (168 Days)|Death|0|||
28008214|NCT04079296|81862026|FG003|Dose Expansion Phase (168 Days)|Death|1|||
28008215|NCT04079296|81862027|FG004|Dose Expansion Phase (168 Days)|Death|0|||
28008216|NCT03768414|81862028|FG000|Overall Study|Adverse Event or side effects|72|||
28008217|NCT03768414|81862029|FG001|Overall Study|Adverse Event or side effects|28|||
28008218|NCT03768414|81862028|FG000|Overall Study|Refusal unrelated to adverse event|33|||
28008219|NCT03768414|81862029|FG001|Overall Study|Refusal unrelated to adverse event|33|||
28008220|NCT03768414|81862028|FG000|Overall Study|Progression/relapse|132|||
28008221|NCT03768414|81862029|FG001|Overall Study|Progression/relapse|60|||
28008222|NCT03768414|81862028|FG000|Overall Study|Death|9|||
28008223|NCT03768414|81862029|FG001|Overall Study|Death|6|||
28008224|NCT03768414|81862028|FG000|Overall Study|Other - not protocol specified|45|||
28008225|NCT03768414|81862029|FG001|Overall Study|Other - not protocol specified|18|||
28008226|NCT03768414|81862028|FG000|Overall Study|Reason under review|3|||
28008227|NCT03768414|81862029|FG001|Overall Study|Reason under review|2|||
28008228|NCT04484961|81862033|FG000|Overall Study|Lost to Follow-up|9|||
28008229|NCT04484961|81862034|FG001|Overall Study|Lost to Follow-up|9|||
28008230|NCT03318549|81862037|FG000|Overall Study|Withdrawal by Subject|5|||
28008231|NCT03318549|81862038|FG001|Overall Study|Withdrawal by Subject|19|||
28008232|NCT03318549|81862039|FG002|Overall Study|Withdrawal by Subject|2|||
28008233|NCT03318549|81862040|FG003|Overall Study|Withdrawal by Subject|0|||
28008234|NCT03318549|81862041|FG004|Overall Study|Withdrawal by Subject|0|||
28008235|NCT03318549|81862042|FG005|Overall Study|Withdrawal by Subject|0|||
28008236|NCT03318549|81862043|FG006|Overall Study|Withdrawal by Subject|0|||
28008237|NCT03318549|81862037|FG000|Overall Study|Physician Decision|0|||
28008238|NCT03318549|81862038|FG001|Overall Study|Physician Decision|4|||
28008239|NCT03318549|81862039|FG002|Overall Study|Physician Decision|1|||
28008240|NCT03318549|81862040|FG003|Overall Study|Physician Decision|0|||
28008241|NCT03318549|81862041|FG004|Overall Study|Physician Decision|0|||
28008242|NCT03318549|81862042|FG005|Overall Study|Physician Decision|0|||
28008243|NCT03318549|81862043|FG006|Overall Study|Physician Decision|0|||
28008244|NCT03318549|81862037|FG000|Overall Study|Lost to Follow-up|0|||
28008245|NCT03318549|81862038|FG001|Overall Study|Lost to Follow-up|3|||
28008246|NCT03318549|81862039|FG002|Overall Study|Lost to Follow-up|3|||
28008247|NCT03318549|81862040|FG003|Overall Study|Lost to Follow-up|0|||
28008248|NCT03318549|81862041|FG004|Overall Study|Lost to Follow-up|0|||
28008249|NCT03318549|81862042|FG005|Overall Study|Lost to Follow-up|0|||
28008250|NCT03318549|81862043|FG006|Overall Study|Lost to Follow-up|0|||
28008251|NCT02521285|81862044|FG000|Overall Study|Lost to Follow-up|1|||
27587453|NCT02415400|80331769|FG003|Overall Study|Site closure; participant won't transfer|1|||
27587454|NCT00673049|80331770|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
27587455|NCT00673049|80331771|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
27587456|NCT00673049|80331772|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
27587457|NCT00673049|80331773|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
27587458|NCT00673049|80331770|FG000|Before Progression on Erlotinib|Death|235|||
27587459|NCT00673049|80331771|FG001|Before Progression on Erlotinib|Death|167|||
27587460|NCT00673049|80331772|FG002|Before Progression on Erlotinib|Death|1|||
27587461|NCT00673049|80331773|FG003|Before Progression on Erlotinib|Death|0|||
27587462|NCT00673049|80331770|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
27587463|NCT00673049|80331771|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
27587464|NCT00673049|80331772|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
27587465|NCT00673049|80331773|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
27587466|NCT00673049|80331770|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
27587467|NCT00673049|80331771|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
27587468|NCT00673049|80331772|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
27587469|NCT00673049|80331773|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
27587470|NCT00673049|80331770|FG000|Before Progression on Erlotinib|Other|1|||
27587471|NCT00673049|80331771|FG001|Before Progression on Erlotinib|Other|2|||
27587472|NCT00673049|80331772|FG002|Before Progression on Erlotinib|Other|0|||
27587473|NCT00673049|80331773|FG003|Before Progression on Erlotinib|Other|0|||
27587474|NCT00673049|80331770|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
27587475|NCT00673049|80331771|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
27587476|NCT00673049|80331772|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
27587477|NCT00673049|80331773|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
27587478|NCT00673049|80331770|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
27587479|NCT00673049|80331771|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
27587480|NCT00673049|80331772|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
27587481|NCT00673049|80331773|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
27587482|NCT00673049|80331770|FG000|After Progression on Erlotinib|Death|0|||
27587483|NCT00673049|80331771|FG001|After Progression on Erlotinib|Death|0|||
27587484|NCT00673049|80331772|FG002|After Progression on Erlotinib|Death|0|||
27587485|NCT00673049|80331773|FG003|After Progression on Erlotinib|Death|71|||
27587486|NCT00673049|80331770|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
27587487|NCT00673049|80331771|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
27587488|NCT00673049|80331772|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
27587489|NCT00673049|80331773|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
27587490|NCT00673049|80331770|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
27587491|NCT00673049|80331771|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
27587492|NCT00673049|80331772|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
27587493|NCT00673049|80331773|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
27587494|NCT00673049|80331770|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
27587495|NCT00673049|80331771|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
27587496|NCT00673049|80331772|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
27587497|NCT00673049|80331773|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
27587498|NCT01985126|80331774|FG000|Overall Study|Death|15|||
27587499|NCT01985126|80331775|FG001|Overall Study|Death|69|||
27587500|NCT01985126|80331774|FG000|Overall Study|Lost to Follow-up|0|||
27587501|NCT01985126|80331775|FG001|Overall Study|Lost to Follow-up|8|||
27587502|NCT01985126|80331774|FG000|Overall Study|Study Terminated By Sponsor|1|||
27587503|NCT01985126|80331775|FG001|Overall Study|Study Terminated By Sponsor|22|||
27587504|NCT01985126|80331774|FG000|Overall Study|Withdrawal by Subject|2|||
27587505|NCT01985126|80331775|FG001|Overall Study|Withdrawal by Subject|7|||
27587506|NCT03836053|80331776|FG000|Overall Study|Protocol-specified criteria|0|||
27587507|NCT03836053|80331777|FG001|Overall Study|Protocol-specified criteria|2|||
27587508|NCT03836053|80331778|FG002|Overall Study|Protocol-specified criteria|1|||
27587509|NCT03836053|80331776|FG000|Overall Study|Death|1|||
27587510|NCT03836053|80331777|FG001|Overall Study|Death|6|||
27587511|NCT03836053|80331778|FG002|Overall Study|Death|4|||
27587512|NCT03836053|80331776|FG000|Overall Study|Withdrawal of consent from study|0|||
27587513|NCT03836053|80331777|FG001|Overall Study|Withdrawal of consent from study|0|||
27812619|NCT00294723|81143709|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
27587514|NCT03836053|80331778|FG002|Overall Study|Withdrawal of consent from study|1|||
27587515|NCT03836053|80331776|FG000|Overall Study|Decision by sponsor|0|||
27587516|NCT03836053|80331777|FG001|Overall Study|Decision by sponsor|2|||
28008252|NCT02521285|81862045|FG001|Overall Study|Lost to Follow-up|1|||
27587517|NCT03836053|80331778|FG002|Overall Study|Decision by sponsor|4|||
27587518|NCT02624804|80331780|FG000|Overall Study|Screen Failure|5|||
27587519|NCT03152552|80331784|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
27587520|NCT03152552|80331785|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
27587521|NCT03152552|80331786|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
27587522|NCT03152552|80331787|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
27587523|NCT03152552|80331788|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
27587524|NCT03152552|80331784|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
27587525|NCT03152552|80331785|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
27587526|NCT03152552|80331786|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
27587527|NCT03152552|80331787|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
27587528|NCT03152552|80331788|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
27587529|NCT03152552|80331784|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
27587530|NCT03152552|80331785|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
27587531|NCT03152552|80331786|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
27587532|NCT03152552|80331787|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
27587533|NCT03152552|80331788|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
27587534|NCT03152552|80331784|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27587535|NCT03152552|80331785|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27587536|NCT03152552|80331786|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27587537|NCT03152552|80331787|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27587538|NCT03152552|80331788|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27587539|NCT03152552|80331784|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
27587540|NCT03152552|80331785|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
27587541|NCT03152552|80331786|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
27587542|NCT03152552|80331787|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
27587543|NCT03152552|80331788|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
27587544|NCT03152552|80331784|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
28008253|NCT02521285|81862044|FG000|Overall Study|Withdrawal by Subject|1|||
28008254|NCT02521285|81862045|FG001|Overall Study|Withdrawal by Subject|1|||
28008255|NCT02521285|81862044|FG000|Overall Study|Adverse Event|0|||
28008256|NCT02521285|81862045|FG001|Overall Study|Adverse Event|1|||
28008257|NCT03043313|81862046|FG000|Overall Study|Withdrawal by Subject|5|||
28008258|NCT03043313|81862047|FG001|Overall Study|Withdrawal by Subject|1|||
28008259|NCT03043313|81862048|FG002|Overall Study|Withdrawal by Subject|1|||
28008260|NCT03043313|81862046|FG000|Overall Study|Lost to Follow-up|1|||
28008261|NCT03043313|81862047|FG001|Overall Study|Lost to Follow-up|1|||
28008262|NCT03043313|81862048|FG002|Overall Study|Lost to Follow-up|0|||
28008263|NCT03043313|81862046|FG000|Overall Study|Death|28|||
28008264|NCT03043313|81862047|FG001|Overall Study|Death|26|||
28008265|NCT03043313|81862048|FG002|Overall Study|Death|17|||
28008266|NCT03043313|81862046|FG000|Overall Study|Participation terminated by sponsor|11|||
28008267|NCT03043313|81862047|FG001|Overall Study|Participation terminated by sponsor|13|||
28008268|NCT03043313|81862048|FG002|Overall Study|Participation terminated by sponsor|13|||
28008269|NCT00980954|81862049|FG000|Overall Study|Protocol Violation|9|||
28008270|NCT00980954|81862050|FG001|Overall Study|Protocol Violation|15|||
28008271|NCT03534804|81862052|FG000|Overall Study|Withdrawal by Subject|1|||
28008272|NCT03009058|81862057|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
28008273|NCT05194124|81862058|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008274|NCT05194124|81862059|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008275|NCT05194124|81862060|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008276|NCT05194124|81862061|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
28008277|NCT05194124|81862062|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008278|NCT05194124|81862063|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
28008279|NCT05194124|81862064|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008280|NCT05194124|81862065|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008281|NCT05194124|81862066|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008282|NCT05194124|81862067|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
28008283|NCT05194124|81862058|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008284|NCT05194124|81862059|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008285|NCT05194124|81862060|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008286|NCT05194124|81862061|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008287|NCT05194124|81862062|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
27587545|NCT03152552|80331785|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
27587546|NCT03152552|80331786|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
27587547|NCT03152552|80331787|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
27587548|NCT03152552|80331788|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
27587549|NCT03152552|80331784|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
28008288|NCT05194124|81862063|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008289|NCT05194124|81862064|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
27587550|NCT03152552|80331785|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
27686996|NCT00307684|80690462|FG001|Open Label Phase|other|0|||
27587551|NCT03152552|80331786|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
27587552|NCT03152552|80331787|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
27587553|NCT03152552|80331788|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
27587554|NCT00823719|80331791|FG000|Overall Study|Adverse Event|1|||
27587555|NCT00823719|80331792|FG001|Overall Study|Adverse Event|2|||
27587556|NCT00823719|80331791|FG000|Overall Study|Physician Decision|1|||
27587557|NCT00823719|80331792|FG001|Overall Study|Physician Decision|4|||
27587558|NCT00823719|80331791|FG000|Overall Study|Withdrawal by Subject|0|||
27587559|NCT00823719|80331792|FG001|Overall Study|Withdrawal by Subject|1|||
27587560|NCT00823719|80331791|FG000|Overall Study|Disease Progression|4|||
27587561|NCT00823719|80331792|FG001|Overall Study|Disease Progression|4|||
27587562|NCT02979535|80331793|FG000|Overall Study|Non compliance with the protocol|78|||
27587563|NCT02979535|80331794|FG001|Overall Study|Non compliance with the protocol|82|||
27587564|NCT02979535|80331793|FG000|Overall Study|Consent withdrawn by participant|11|||
27587565|NCT02979535|80331794|FG001|Overall Study|Consent withdrawn by participant|18|||
27587566|NCT02979535|80331793|FG000|Overall Study|Lost to Follow-up|6|||
27587567|NCT02979535|80331794|FG001|Overall Study|Lost to Follow-up|1|||
27587568|NCT00506493|80331795|FG000|Overall Study|Death|6|||
27587569|NCT00506493|80331795|FG000|Overall Study|Withdrawal by Subject|5|||
27587570|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
27587571|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
27587572|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
27587573|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
27587574|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
27587575|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
27587576|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
27587577|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
27587578|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
27587579|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
27587580|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
27686997|NCT00307684|80690463|FG002|Open Label Phase|other|6|||
27686998|NCT00307684|80690461|FG000|Double Blind Phase|Lack of Efficacy|2|||
27686999|NCT00307684|80690462|FG001|Double Blind Phase|Lack of Efficacy|5|||
27687000|NCT00307684|80690463|FG002|Double Blind Phase|Lack of Efficacy|0|||
27687001|NCT03727438|80690470|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
28008290|NCT05194124|81862065|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008291|NCT05194124|81862066|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
28008292|NCT05194124|81862067|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
28008293|NCT05064735|81862068|FG000|Overall Study|Withdrawal by Subject|7|||
28008294|NCT05064735|81862069|FG001|Overall Study|Withdrawal by Subject|8|||
28008295|NCT05064735|81862068|FG000|Overall Study|Lost to Follow-up|7|||
28008296|NCT05064735|81862069|FG001|Overall Study|Lost to Follow-up|2|||
28008297|NCT05064735|81862068|FG000|Overall Study|Physician Decision|2|||
28008298|NCT05064735|81862069|FG001|Overall Study|Physician Decision|1|||
28008299|NCT05064735|81862068|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
28008300|NCT05064735|81862069|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
28008301|NCT05064735|81862068|FG000|Overall Study|Site Closure|7|||
28008302|NCT05064735|81862069|FG001|Overall Study|Site Closure|2|||
28008303|NCT03839940|81862070|FG000|Overall Study|Withdrawal by Subject|3|||
28008304|NCT03839940|81862071|FG001|Overall Study|Withdrawal by Subject|0|||
28008305|NCT03839940|81862070|FG000|Overall Study|Protocol Violation|0|||
28008306|NCT03839940|81862071|FG001|Overall Study|Protocol Violation|1|||
28008307|NCT03839940|81862070|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
28008308|NCT03839940|81862071|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
28008309|NCT03474588|81862072|FG000|Overall Study|Withdrawal by Subject|4|||
28008310|NCT03474588|81862073|FG001|Overall Study|Withdrawal by Subject|3|||
28008311|NCT03474588|81862072|FG000|Overall Study|Death|0|||
28008312|NCT03474588|81862073|FG001|Overall Study|Death|1|||
28008313|NCT05138653|81862078|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
28008314|NCT05138653|81862079|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
27587581|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
27587582|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
27587583|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
27587584|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
27587585|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
27587586|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
27587587|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
27587588|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
27587589|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
28008315|NCT05138653|81862080|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008316|NCT05138653|81862081|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008317|NCT05138653|81862082|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
27812620|NCT00294723|81143710|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
28008318|NCT05138653|81862083|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008319|NCT05138653|81862084|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008320|NCT05138653|81862085|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008321|NCT05138653|81862086|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008322|NCT05138653|81862087|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008323|NCT05138653|81862088|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008324|NCT05138653|81862089|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008325|NCT05138653|81862090|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
27587590|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
27587591|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
27812621|NCT00294723|81143708|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
27812622|NCT00294723|81143709|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
27812623|NCT00294723|81143710|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
27812624|NCT00927810|81143714|FG000|Overall Study|Withdrawal by Subject|0|||
27812625|NCT00927810|81143715|FG001|Overall Study|Withdrawal by Subject|3|||
27812626|NCT00927810|81143716|FG002|Overall Study|Withdrawal by Subject|0|||
27812627|NCT00927810|81143717|FG003|Overall Study|Withdrawal by Subject|1|||
27812628|NCT00927810|81143714|FG000|Overall Study|Lost to Follow-up|0|||
27812629|NCT00927810|81143715|FG001|Overall Study|Lost to Follow-up|2|||
27812630|NCT00927810|81143716|FG002|Overall Study|Lost to Follow-up|1|||
27812631|NCT00927810|81143717|FG003|Overall Study|Lost to Follow-up|1|||
27812632|NCT00927810|81143714|FG000|Overall Study|Death|0|||
27812633|NCT00927810|81143715|FG001|Overall Study|Death|2|||
27812634|NCT00927810|81143716|FG002|Overall Study|Death|0|||
27812635|NCT00927810|81143717|FG003|Overall Study|Death|0|||
27812636|NCT00927810|81143714|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27812637|NCT00927810|81143715|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27812638|NCT00927810|81143716|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27812639|NCT00927810|81143717|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27812640|NCT00522457|81143718|FG000|Overall Study|Due to disease progression|16|||
27812641|NCT00522457|81143718|FG000|Overall Study|Adverse Event|2|||
27812642|NCT00952484|81143719|FG000|Overall Study|Withdrawal by Subject|0|||
27812643|NCT00952484|81143720|FG001|Overall Study|Withdrawal by Subject|1|||
27812644|NCT00952484|81143721|FG002|Overall Study|Withdrawal by Subject|0|||
27812645|NCT00265759|81143723|FG000|Overall Study|Withdrawal by Subject|0|||
27812646|NCT00265759|81143724|FG001|Overall Study|Withdrawal by Subject|1|||
27812647|NCT00265759|81143725|FG002|Overall Study|Withdrawal by Subject|2|||
27812648|NCT00265759|81143726|FG003|Overall Study|Withdrawal by Subject|2|||
27812649|NCT00265759|81143723|FG000|Overall Study|Cancel|0|||
27812650|NCT00265759|81143724|FG001|Overall Study|Cancel|0|||
27812651|NCT00265759|81143725|FG002|Overall Study|Cancel|0|||
27812652|NCT00265759|81143726|FG003|Overall Study|Cancel|3|||
27812653|NCT00265759|81143723|FG000|Overall Study|Ineligible|0|||
27812654|NCT00265759|81143724|FG001|Overall Study|Ineligible|0|||
27812655|NCT00265759|81143725|FG002|Overall Study|Ineligible|0|||
27812656|NCT00265759|81143726|FG003|Overall Study|Ineligible|1|||
27812657|NCT00265759|81143723|FG000|Overall Study|Bilateral disease|0|||
27812658|NCT00265759|81143724|FG001|Overall Study|Bilateral disease|0|||
27812659|NCT00265759|81143725|FG002|Overall Study|Bilateral disease|0|||
27812660|NCT00265759|81143726|FG003|Overall Study|Bilateral disease|2|||
27812661|NCT00265759|81143723|FG000|Overall Study|Discontinued due to intolerability|0|||
27812662|NCT00265759|81143724|FG001|Overall Study|Discontinued due to intolerability|0|||
27812663|NCT00265759|81143725|FG002|Overall Study|Discontinued due to intolerability|0|||
27812664|NCT00265759|81143726|FG003|Overall Study|Discontinued due to intolerability|1|||
27812665|NCT03083483|81143728|FG000|Overall Study|Adverse Event|1|||
27812666|NCT03083483|81143729|FG001|Overall Study|Adverse Event|1|||
27812667|NCT03083483|81143730|FG002|Overall Study|Adverse Event|1|||
27812668|NCT03083483|81143728|FG000|Overall Study|Lost to Follow-up|2|||
27812669|NCT03083483|81143729|FG001|Overall Study|Lost to Follow-up|1|||
27875774|NCT04871776|81375537|FG000|Overall Study|Did not meet eligibility criteria|1|||
27875775|NCT04871776|81375538|FG001|Overall Study|Did not meet eligibility criteria|1|||
27687002|NCT03727438|80690471|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
27812670|NCT03083483|81143730|FG002|Overall Study|Lost to Follow-up|1|||
27812671|NCT03083483|81143728|FG000|Overall Study|technological issues|1|||
27812672|NCT03083483|81143729|FG001|Overall Study|technological issues|0|||
27812673|NCT03083483|81143730|FG002|Overall Study|technological issues|1|||
27875776|NCT04871776|81375539|FG002|Overall Study|Did not meet eligibility criteria|1|||
27875777|NCT00380874|81375542|FG000|Overall Study|Adverse Event|7|||
27875778|NCT00380874|81375543|FG001|Overall Study|Adverse Event|7|||
28008326|NCT05138653|81862091|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
27812674|NCT02518685|81143731|FG000|Overall Study|Adverse Event|29|||
27812675|NCT02518685|81143732|FG001|Overall Study|Adverse Event|1|||
27812676|NCT02518685|81143731|FG000|Overall Study|Withdrawal by Subject|10|||
27875779|NCT00380874|81375542|FG000|Overall Study|Death|1|||
28008327|NCT05138653|81862092|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008328|NCT05138653|81862093|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
28008329|NCT05138653|81862078|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008330|NCT05138653|81862079|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
28008331|NCT05138653|81862080|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008332|NCT05138653|81862081|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008333|NCT05138653|81862082|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008334|NCT05138653|81862083|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008335|NCT05138653|81862084|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008336|NCT05138653|81862085|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008337|NCT05138653|81862086|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
28008338|NCT05138653|81862087|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008339|NCT05138653|81862088|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008340|NCT05138653|81862089|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008341|NCT05138653|81862090|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008342|NCT05138653|81862091|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008343|NCT05138653|81862092|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008344|NCT05138653|81862093|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
28008345|NCT05138653|81862078|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008346|NCT05138653|81862079|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
28008347|NCT05138653|81862080|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008348|NCT05138653|81862081|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008349|NCT05138653|81862082|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
28008350|NCT05138653|81862083|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008351|NCT05138653|81862084|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008352|NCT05138653|81862085|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008353|NCT05138653|81862086|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008354|NCT05138653|81862087|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008355|NCT05138653|81862088|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008356|NCT05138653|81862089|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008357|NCT05138653|81862090|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008358|NCT05138653|81862091|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008359|NCT05138653|81862092|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008360|NCT05138653|81862093|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
28008361|NCT05138653|81862078|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008362|NCT05138653|81862079|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008363|NCT05138653|81862080|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008364|NCT05138653|81862081|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008365|NCT05138653|81862082|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008366|NCT05138653|81862083|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008367|NCT05138653|81862084|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
28008368|NCT05138653|81862085|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008369|NCT05138653|81862086|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008370|NCT05138653|81862087|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008371|NCT05138653|81862088|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008372|NCT05138653|81862089|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008373|NCT05138653|81862090|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008374|NCT05138653|81862091|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008375|NCT05138653|81862092|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008376|NCT05138653|81862093|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
28008377|NCT05138653|81862078|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008378|NCT05138653|81862079|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008379|NCT05138653|81862080|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008380|NCT05138653|81862081|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008381|NCT05138653|81862082|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008382|NCT05138653|81862083|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008383|NCT05138653|81862084|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008384|NCT05138653|81862085|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008385|NCT05138653|81862086|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
27812677|NCT02518685|81143732|FG001|Overall Study|Withdrawal by Subject|3|||
27812678|NCT02518685|81143731|FG000|Overall Study|relocation, study fatigue|7|||
27812679|NCT02518685|81143732|FG001|Overall Study|relocation, study fatigue|2|||
27812680|NCT02518685|81143731|FG000|Overall Study|Pregnancy|1|||
27812681|NCT02518685|81143732|FG001|Overall Study|Pregnancy|0|||
27812682|NCT02518685|81143731|FG000|Overall Study|Physician Decision|1|||
28008386|NCT05138653|81862087|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008387|NCT05138653|81862088|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
28008388|NCT05138653|81862089|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008389|NCT05138653|81862090|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
28008390|NCT05138653|81862091|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008391|NCT05138653|81862092|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
28008392|NCT05138653|81862093|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
28008393|NCT05138653|81862078|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008394|NCT05138653|81862079|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008395|NCT05138653|81862080|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008396|NCT05138653|81862081|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008397|NCT05138653|81862082|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008398|NCT05138653|81862083|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008399|NCT05138653|81862084|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008400|NCT05138653|81862085|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008401|NCT05138653|81862086|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008402|NCT05138653|81862087|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008403|NCT05138653|81862088|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008404|NCT05138653|81862089|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008405|NCT05138653|81862090|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008406|NCT05138653|81862091|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008407|NCT05138653|81862092|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
28008408|NCT05138653|81862093|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
28008409|NCT05138653|81862078|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008410|NCT05138653|81862079|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008411|NCT05138653|81862080|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008412|NCT05138653|81862081|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008413|NCT05138653|81862082|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008414|NCT05138653|81862083|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008415|NCT05138653|81862084|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008416|NCT05138653|81862085|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008417|NCT05138653|81862086|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008418|NCT05138653|81862087|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008419|NCT05138653|81862088|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008420|NCT05138653|81862089|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008421|NCT05138653|81862090|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008422|NCT05138653|81862091|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
28008423|NCT05138653|81862092|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
28008424|NCT05138653|81862093|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
27812683|NCT02518685|81143732|FG001|Overall Study|Physician Decision|0|||
27812684|NCT02518685|81143731|FG000|Overall Study|Lost to Follow-up|1|||
27812685|NCT02518685|81143732|FG001|Overall Study|Lost to Follow-up|4|||
27812686|NCT01048333|81143733|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
28008425|NCT04607005|81862094|FG000|Overall Study|Adverse Event|0|||
28008426|NCT04607005|81862095|FG001|Overall Study|Adverse Event|1|||
28008427|NCT04607005|81862094|FG000|Overall Study|Lack of Efficacy|1|||
28008428|NCT04607005|81862095|FG001|Overall Study|Lack of Efficacy|6|||
28008429|NCT04607005|81862094|FG000|Overall Study|Withdrawal by Subject|4|||
28008430|NCT04607005|81862095|FG001|Overall Study|Withdrawal by Subject|9|||
28008431|NCT04607005|81862094|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
28008432|NCT04607005|81862095|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
28008433|NCT03389477|81862096|FG000|Step 1|Withdrawal by Subject|1|||
28008434|NCT03389477|81862097|FG001|Step 1|Withdrawal by Subject|0|||
28008435|NCT03389477|81862096|FG000|Step 2|Withdrawal by Subject|1|||
27812687|NCT01048333|81143734|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
27812688|NCT01048333|81143735|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27812689|NCT01048333|81143736|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27812690|NCT01048333|81143737|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27812691|NCT01048333|81143738|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
27812692|NCT01579474|81143739|FG000|Overall Study|Adverse Event|1|||
27812693|NCT01579474|81143740|FG001|Overall Study|Adverse Event|13|||
27812694|NCT01579474|81143741|FG002|Overall Study|Adverse Event|2|||
28008436|NCT03389477|81862097|FG001|Step 2|Withdrawal by Subject|2|||
28008437|NCT03389477|81862096|FG000|Step 2|Disease progression|1|||
28008438|NCT03389477|81862097|FG001|Step 2|Disease progression|0|||
28008439|NCT03389477|81862096|FG000|Step 2|Death|0|||
28008440|NCT03389477|81862097|FG001|Step 2|Death|1|||
28008441|NCT03389477|81862096|FG000|Step 2|Poor performance status and nutrition|0|||
28008442|NCT03389477|81862097|FG001|Step 2|Poor performance status and nutrition|1|||
28008443|NCT03389477|81862096|FG000|Step 3|Withdrawal after 3 cycles|0|||
28008444|NCT03389477|81862097|FG001|Step 3|Withdrawal after 3 cycles|1|||
28008445|NCT03389477|81862096|FG000|Step 3|Still receiving active treatment|4|||
28008446|NCT03389477|81862097|FG001|Step 3|Still receiving active treatment|0|||
28008447|NCT03389477|81862096|FG000|Step 3|Progressive disease after 2 cycles|1|||
28008448|NCT03389477|81862097|FG001|Step 3|Progressive disease after 2 cycles|0|||
28008449|NCT03589859|81862106|FG000|Overall Study|Withdrawal by Subject|0|||
28008450|NCT03589859|81862107|FG001|Overall Study|Withdrawal by Subject|6|||
28008451|NCT02852655|81862108|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
28008452|NCT02852655|81862109|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
28008453|NCT02852655|81862110|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
28008454|NCT02852655|81862108|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
28008455|NCT02852655|81862109|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
28008456|NCT02852655|81862110|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
28008457|NCT02852655|81862108|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
28008458|NCT02852655|81862109|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
28008459|NCT02852655|81862110|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
28008460|NCT02852655|81862108|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
28008461|NCT02852655|81862109|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
28008462|NCT02852655|81862110|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
28008463|NCT02852655|81862108|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
28008464|NCT02852655|81862109|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
28008465|NCT02852655|81862110|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
28008466|NCT02852655|81862108|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
28008467|NCT02852655|81862109|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
28008468|NCT02852655|81862110|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
28008469|NCT02852655|81862108|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
28008470|NCT02852655|81862109|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
28008471|NCT02852655|81862110|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
28008472|NCT02852655|81862108|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
28008473|NCT02852655|81862109|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
28008474|NCT02852655|81862110|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
28008475|NCT02852655|81862108|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
28008476|NCT02852655|81862109|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
28008477|NCT02852655|81862110|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
28008478|NCT04825574|81862114|FG000|Overall Study|Commercial treatment became available|1|||
28008479|NCT04825574|81862114|FG000|Overall Study|Disease progression|1|||
28008480|NCT02702492|81862121|FG000|Overall Study|Disease progression|3|||
28008481|NCT02702492|81862122|FG001|Overall Study|Disease progression|3|||
28008482|NCT02702492|81862123|FG002|Overall Study|Disease progression|2|||
28008483|NCT02702492|81862124|FG003|Overall Study|Disease progression|4|||
27587592|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
27587593|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
27587594|NCT01715805|80331796|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
27587595|NCT01715805|80331797|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
27587596|NCT01715805|80331798|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
27587597|NCT01715805|80331799|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
27587598|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
27587599|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
27587600|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
27587601|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
27587602|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
27587603|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
27587604|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
27587605|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
27812695|NCT01579474|81143742|FG003|Overall Study|Adverse Event|0|||
28008484|NCT02702492|81862125|FG004|Overall Study|Disease progression|4|||
27587606|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
27812696|NCT01579474|81143743|FG004|Overall Study|Adverse Event|0|||
28008485|NCT02702492|81862126|FG005|Overall Study|Disease progression|1|||
28008486|NCT02702492|81862127|FG006|Overall Study|Disease progression|2|||
28008487|NCT02702492|81862128|FG007|Overall Study|Disease progression|8|||
28008488|NCT02702492|81862129|FG008|Overall Study|Disease progression|5|||
28008489|NCT02702492|81862130|FG009|Overall Study|Disease progression|1|||
28008490|NCT02702492|81862131|FG010|Overall Study|Disease progression|0|||
28008491|NCT02702492|81862132|FG011|Overall Study|Disease progression|3|||
28008492|NCT02702492|81862133|FG012|Overall Study|Disease progression|2|||
28008493|NCT02702492|81862121|FG000|Overall Study|Clinical progression|0|||
27687003|NCT03727438|80690470|FG000|Intervention Period|Excluded (health)|1|||
27687004|NCT03727438|80690471|FG001|Intervention Period|Excluded (health)|0|||
27687005|NCT03727438|80690470|FG000|Intervention Period|Withdrawal by Subject|3|||
27687006|NCT03727438|80690471|FG001|Intervention Period|Withdrawal by Subject|1|||
27687007|NCT03727438|80690470|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
27687008|NCT03727438|80690471|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
27687009|NCT03727438|80690470|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
27687010|NCT03727438|80690471|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
27687011|NCT03727438|80690470|FG000|8 Week Assessment|Withdrawal by Subject|6|||
27687012|NCT03727438|80690471|FG001|8 Week Assessment|Withdrawal by Subject|1|||
27687013|NCT03727438|80690470|FG000|6 mo Assessment|did not complete assessment|10|||
27687014|NCT03727438|80690471|FG001|6 mo Assessment|did not complete assessment|11|||
27687015|NCT01182194|80690472|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
27687016|NCT01182194|80690473|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
27687017|NCT03316300|80690484|FG000|Overall Study|Withdrawal by Subject|3|||
27687018|NCT03316300|80690485|FG001|Overall Study|Withdrawal by Subject|2|||
27687019|NCT03316300|80690484|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
27687020|NCT03316300|80690485|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
27687021|NCT03316300|80690484|FG000|Overall Study|Adverse Event|1|||
27687022|NCT03316300|80690485|FG001|Overall Study|Adverse Event|0|||
27687023|NCT03316300|80690484|FG000|Overall Study|COVID-19|0|||
27687024|NCT03316300|80690485|FG001|Overall Study|COVID-19|1|||
27687025|NCT01281969|80690486|FG000|Overall Study|not randomized didn't meet criteria|0|||
27687026|NCT01281969|80690487|FG001|Overall Study|not randomized didn't meet criteria|0|||
27687027|NCT01281969|80690488|FG002|Overall Study|not randomized didn't meet criteria|7|||
27687028|NCT01281969|80690486|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
27687029|NCT01281969|80690487|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
27687030|NCT01281969|80690488|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
27687031|NCT01281969|80690486|FG000|Overall Study|not randomized, child consent not given|0|||
27687032|NCT01281969|80690487|FG001|Overall Study|not randomized, child consent not given|0|||
27687033|NCT01281969|80690488|FG002|Overall Study|not randomized, child consent not given|2|||
27687034|NCT00572039|80690492|FG000|Overall Study|Withdrawal by Subject|9|||
27687035|NCT00572039|80690493|FG001|Overall Study|Withdrawal by Subject|6|||
27687036|NCT00572039|80690492|FG000|Overall Study|Death|2|||
27687037|NCT00572039|80690493|FG001|Overall Study|Death|3|||
27687038|NCT00572039|80690492|FG000|Overall Study|Ill|5|||
27812697|NCT01579474|81143744|FG005|Overall Study|Adverse Event|1|||
27812698|NCT01579474|81143739|FG000|Overall Study|Lack of Efficacy|1|||
27812699|NCT01579474|81143740|FG001|Overall Study|Lack of Efficacy|0|||
27812700|NCT01579474|81143741|FG002|Overall Study|Lack of Efficacy|0|||
27812701|NCT01579474|81143742|FG003|Overall Study|Lack of Efficacy|0|||
27812702|NCT01579474|81143743|FG004|Overall Study|Lack of Efficacy|1|||
27812703|NCT01579474|81143744|FG005|Overall Study|Lack of Efficacy|0|||
28008494|NCT02702492|81862122|FG001|Overall Study|Clinical progression|0|||
27687039|NCT00572039|80690493|FG001|Overall Study|Ill|1|||
27687040|NCT00577577|80690494|FG000|Overall Study|Adverse Event|3|||
27687041|NCT00577577|80690495|FG001|Overall Study|Adverse Event|2|||
27687042|NCT00577577|80690494|FG000|Overall Study|Lost to Follow-up|1|||
27687043|NCT00577577|80690495|FG001|Overall Study|Lost to Follow-up|0|||
27687044|NCT00577577|80690494|FG000|Overall Study|Protocol Violation|0|||
27687045|NCT00577577|80690495|FG001|Overall Study|Protocol Violation|3|||
27812704|NCT01579474|81143739|FG000|Overall Study|Withdrawal by Subject|1|||
27812705|NCT01579474|81143740|FG001|Overall Study|Withdrawal by Subject|0|||
28008495|NCT02702492|81862123|FG002|Overall Study|Clinical progression|2|||
27687046|NCT00577577|80690494|FG000|Overall Study|Transportation|1|||
27687047|NCT00577577|80690495|FG001|Overall Study|Transportation|0|||
27687048|NCT00774930|80690496|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
27687049|NCT00774930|80690497|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
27687050|NCT00774930|80690496|FG000|DB Phase|Adverse Event|1|||
27687051|NCT00774930|80690497|FG001|DB Phase|Adverse Event|2|||
27687052|NCT00774930|80690496|FG000|DB Phase|Subject Decision|1|||
27687053|NCT00774930|80690497|FG001|DB Phase|Subject Decision|5|||
27687054|NCT00774930|80690496|FG000|DB Phase|Sponsor Decision|0|||
27687055|NCT00774930|80690497|FG001|DB Phase|Sponsor Decision|1|||
27687056|NCT00774930|80690496|FG000|DB Phase|Disease Progression|1|||
27687057|NCT00774930|80690497|FG001|DB Phase|Disease Progression|1|||
27687058|NCT00774930|80690496|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
27687059|NCT00774930|80690497|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
27687060|NCT00774930|80690496|FG000|IOL Phase|Adverse Event|1|||
27687061|NCT00774930|80690497|FG001|IOL Phase|Adverse Event|1|||
27687062|NCT00774930|80690496|FG000|IOL Phase|Subject Decision|4|||
27687063|NCT00774930|80690497|FG001|IOL Phase|Subject Decision|3|||
27687064|NCT00774930|80690496|FG000|IOL Phase|Physician Decision|3|||
27687065|NCT00774930|80690497|FG001|IOL Phase|Physician Decision|2|||
27687066|NCT00774930|80690496|FG000|IOL Phase|Sponsor Decision|1|||
27687067|NCT00774930|80690497|FG001|IOL Phase|Sponsor Decision|0|||
27687068|NCT00774930|80690496|FG000|IOL Phase|Disease Progression|2|||
27687069|NCT00774930|80690497|FG001|IOL Phase|Disease Progression|1|||
27687070|NCT00774930|80690496|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
27687071|NCT00774930|80690497|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
27687072|NCT00774930|80690496|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
27687073|NCT00774930|80690497|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
27687074|NCT00774930|80690496|FG000|IOL Phase|Other|1|||
27687075|NCT00774930|80690497|FG001|IOL Phase|Other|0|||
27875780|NCT00380874|81375543|FG001|Overall Study|Death|0|||
27587607|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
27587608|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
27587609|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
27587610|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
27587611|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
27587612|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
27587613|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
27587614|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
27587615|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
27587616|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
27587617|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
27587618|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
27587619|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
27587620|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
27587621|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
27587622|NCT01715805|80331796|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
27587623|NCT01715805|80331797|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
27587624|NCT01715805|80331798|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
27587625|NCT01715805|80331799|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
27587626|NCT02519504|80331804|FG000|Overall Study|Protocol Violation|6|||
27587627|NCT02519504|80331805|FG001|Overall Study|Protocol Violation|5|||
27587628|NCT02519504|80331804|FG000|Overall Study|Ineligible for direct testing|12|||
27587629|NCT02519504|80331805|FG001|Overall Study|Ineligible for direct testing|12|||
27587630|NCT02519504|80331804|FG000|Overall Study|Did not participate in direct testing|95|||
27587631|NCT02519504|80331805|FG001|Overall Study|Did not participate in direct testing|86|||
27587632|NCT02525133|80331809|FG000|Overall Study|Adverse Event|0|||
27587633|NCT02525133|80331810|FG001|Overall Study|Adverse Event|1|||
27587634|NCT02525133|80331809|FG000|Overall Study|Death|0|||
27587635|NCT02525133|80331810|FG001|Overall Study|Death|1|||
27587636|NCT02525133|80331809|FG000|Overall Study|did not meet randomization criteria|1|||
27587637|NCT02525133|80331810|FG001|Overall Study|did not meet randomization criteria|0|||
27587638|NCT02525133|80331809|FG000|Overall Study|Lost to Follow-up|5|||
27587639|NCT02525133|80331810|FG001|Overall Study|Lost to Follow-up|1|||
27587640|NCT02525133|80331809|FG000|Overall Study|randomized not enrolled|3|||
27587641|NCT02525133|80331810|FG001|Overall Study|randomized not enrolled|0|||
27587642|NCT02525133|80331809|FG000|Overall Study|Withdrawal by Subject|1|||
27587643|NCT02525133|80331810|FG001|Overall Study|Withdrawal by Subject|0|||
27587644|NCT03314987|80331811|FG000|Overall Study|Lost to Follow-up|13|||
27587645|NCT03314987|80331812|FG001|Overall Study|Lost to Follow-up|13|||
27587646|NCT00744653|80331813|FG000|Overall Study|antineoplastic treatment|11|||
27587647|NCT00744653|80331813|FG000|Overall Study|Death|1|||
27812706|NCT01579474|81143741|FG002|Overall Study|Withdrawal by Subject|0|||
27812707|NCT01579474|81143742|FG003|Overall Study|Withdrawal by Subject|0|||
27687076|NCT00774930|80690496|FG000|IOL Phase|Brain radiation|0|||
27687077|NCT00774930|80690497|FG001|IOL Phase|Brain radiation|1|||
27687078|NCT00774930|80690496|FG000|LTOLE Phase|Adverse Event|7|||
27687079|NCT00774930|80690497|FG001|LTOLE Phase|Adverse Event|3|||
27687080|NCT00774930|80690496|FG000|LTOLE Phase|Subject decision|0|||
27687081|NCT00774930|80690497|FG001|LTOLE Phase|Subject decision|5|||
27687082|NCT00774930|80690496|FG000|LTOLE Phase|Physician Decision|4|||
27687083|NCT00774930|80690497|FG001|LTOLE Phase|Physician Decision|1|||
27687084|NCT00774930|80690496|FG000|LTOLE Phase|Sponsor decision|2|||
27687085|NCT00774930|80690497|FG001|LTOLE Phase|Sponsor decision|1|||
27687086|NCT00774930|80690496|FG000|LTOLE Phase|Disease Progression|2|||
27687087|NCT00774930|80690497|FG001|LTOLE Phase|Disease Progression|5|||
27687088|NCT00774930|80690496|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
27687089|NCT00774930|80690497|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
27687090|NCT00774930|80690496|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
27687091|NCT00774930|80690497|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
27687092|NCT01445301|80690498|FG000|Overall Study|Adverse Event|15|||
27687093|NCT01445301|80690499|FG001|Overall Study|Adverse Event|25|||
27687094|NCT01445301|80690500|FG002|Overall Study|Adverse Event|4|||
27687095|NCT01445301|80690498|FG000|Overall Study|Lack of Efficacy|0|||
27687096|NCT01445301|80690499|FG001|Overall Study|Lack of Efficacy|1|||
27687097|NCT01445301|80690500|FG002|Overall Study|Lack of Efficacy|0|||
27687098|NCT01445301|80690498|FG000|Overall Study|Protocol Violation|1|||
27687099|NCT01445301|80690499|FG001|Overall Study|Protocol Violation|0|||
27875781|NCT00380874|81375542|FG000|Overall Study|Withdrawal by Subject|2|||
27875782|NCT00380874|81375543|FG001|Overall Study|Withdrawal by Subject|1|||
27875783|NCT00380874|81375542|FG000|Overall Study|Not related to study drug|3|||
28008496|NCT02702492|81862124|FG003|Overall Study|Clinical progression|1|||
27687100|NCT01445301|80690500|FG002|Overall Study|Protocol Violation|0|||
27812708|NCT01579474|81143743|FG004|Overall Study|Withdrawal by Subject|0|||
27812709|NCT01579474|81143744|FG005|Overall Study|Withdrawal by Subject|0|||
28008497|NCT02702492|81862125|FG004|Overall Study|Clinical progression|0|||
28008498|NCT02702492|81862126|FG005|Overall Study|Clinical progression|2|||
28008499|NCT02702492|81862127|FG006|Overall Study|Clinical progression|1|||
28008500|NCT02702492|81862128|FG007|Overall Study|Clinical progression|4|||
28008501|NCT02702492|81862129|FG008|Overall Study|Clinical progression|0|||
28008502|NCT02702492|81862130|FG009|Overall Study|Clinical progression|0|||
27812710|NCT04534283|81143745|FG000|Overall Study|Physician Decision|2|||
27812711|NCT04534283|81143745|FG000|Overall Study|Withdrawal by Subject|1|||
27812712|NCT04534283|81143745|FG000|Overall Study|Disease Progression|12|||
27812713|NCT04534283|81143745|FG000|Overall Study|Adverse Event|1|||
27812714|NCT01399723|81143746|FG000|Overall Study|Lost to Follow-up|0|||
27812715|NCT01399723|81143747|FG001|Overall Study|Lost to Follow-up|1|||
27812716|NCT01133821|81143748|FG000|Overall Study|Lost to Follow-up|8|||
28008503|NCT02702492|81862131|FG010|Overall Study|Clinical progression|1|||
28008504|NCT02702492|81862132|FG011|Overall Study|Clinical progression|2|||
28008505|NCT02702492|81862133|FG012|Overall Study|Clinical progression|0|||
28008506|NCT02702492|81862121|FG000|Overall Study|Adverse Event|0|||
27687101|NCT01445301|80690498|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
27687102|NCT01445301|80690499|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
27687103|NCT01445301|80690500|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
27812717|NCT01133821|81143749|FG001|Overall Study|Lost to Follow-up|11|||
27812718|NCT01133821|81143748|FG000|Overall Study|Withdrawal by Subject|8|||
27812719|NCT01133821|81143749|FG001|Overall Study|Withdrawal by Subject|3|||
27812720|NCT01133821|81143748|FG000|Overall Study|preferred other treatment|1|||
27812721|NCT01133821|81143749|FG001|Overall Study|preferred other treatment|1|||
27812722|NCT01133821|81143748|FG000|Overall Study|Protocol Violation|0|||
27875784|NCT00380874|81375543|FG001|Overall Study|Not related to study drug|2|||
27687104|NCT01445301|80690498|FG000|Overall Study|Physician Decision|0|||
28008507|NCT02702492|81862122|FG001|Overall Study|Adverse Event|0|||
28008508|NCT02702492|81862123|FG002|Overall Study|Adverse Event|1|||
28008509|NCT02702492|81862124|FG003|Overall Study|Adverse Event|2|||
27687105|NCT01445301|80690499|FG001|Overall Study|Physician Decision|2|||
27812723|NCT01133821|81143749|FG001|Overall Study|Protocol Violation|1|||
27812724|NCT01133821|81143748|FG000|Overall Study|Refused participation|1|||
27812725|NCT01133821|81143749|FG001|Overall Study|Refused participation|3|||
27687106|NCT01445301|80690500|FG002|Overall Study|Physician Decision|0|||
27687107|NCT01445301|80690498|FG000|Overall Study|Withdrawal by Subject|5|||
27812726|NCT00582036|81143750|FG000|Overall Study|Withdrawal by Subject|0|||
27812727|NCT00582036|81143751|FG001|Overall Study|Withdrawal by Subject|1|||
27812728|NCT02507375|81143753|FG000|Overall Study|Progressive Disease|4|||
28008510|NCT02702492|81862125|FG004|Overall Study|Adverse Event|1|||
28008511|NCT02702492|81862126|FG005|Overall Study|Adverse Event|0|||
28008512|NCT02702492|81862127|FG006|Overall Study|Adverse Event|1|||
27687108|NCT01445301|80690499|FG001|Overall Study|Withdrawal by Subject|6|||
27687109|NCT01445301|80690500|FG002|Overall Study|Withdrawal by Subject|4|||
27687110|NCT00998335|80690501|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
27687111|NCT00998335|80690502|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
27687112|NCT01867333|80690503|FG000|Overall Study|Withdrawal by Subject|1|||
27687113|NCT01867333|80690504|FG001|Overall Study|Withdrawal by Subject|0|||
27687114|NCT01867333|80690503|FG000|Overall Study|Adverse Event|1|||
27687115|NCT01867333|80690504|FG001|Overall Study|Adverse Event|0|||
27687116|NCT01867333|80690503|FG000|Overall Study|Participant choice|1|||
27687117|NCT01867333|80690504|FG001|Overall Study|Participant choice|2|||
27687118|NCT01867333|80690503|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
27687119|NCT01867333|80690504|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
27687120|NCT01867333|80690503|FG000|Overall Study|Death|0|||
27687121|NCT01867333|80690504|FG001|Overall Study|Death|1|||
27687122|NCT01867333|80690503|FG000|Overall Study|Physician Decision|3|||
27687123|NCT01867333|80690504|FG001|Overall Study|Physician Decision|2|||
27687124|NCT01867333|80690503|FG000|Overall Study|Switched to alternative treatment|1|||
27687125|NCT01867333|80690504|FG001|Overall Study|Switched to alternative treatment|0|||
27687126|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
27687127|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27687128|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27687129|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27687130|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
27687131|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
27687132|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
28008513|NCT02702492|81862128|FG007|Overall Study|Adverse Event|0|||
27687133|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27687134|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27687135|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
27687136|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
27687137|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27687138|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27687139|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27687140|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
27687141|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
27687142|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27687143|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27687144|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27687145|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
27687146|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
27687147|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27687148|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27687149|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
27687150|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
28008514|NCT02702492|81862129|FG008|Overall Study|Adverse Event|2|||
28008515|NCT02702492|81862130|FG009|Overall Study|Adverse Event|0|||
28008516|NCT02702492|81862131|FG010|Overall Study|Adverse Event|0|||
28008517|NCT02702492|81862132|FG011|Overall Study|Adverse Event|0|||
28008518|NCT02702492|81862133|FG012|Overall Study|Adverse Event|1|||
28008519|NCT02702492|81862121|FG000|Overall Study|Other|0|||
28008520|NCT02702492|81862122|FG001|Overall Study|Other|0|||
28008521|NCT02702492|81862123|FG002|Overall Study|Other|0|||
28008522|NCT02702492|81862124|FG003|Overall Study|Other|0|||
28008523|NCT02702492|81862125|FG004|Overall Study|Other|0|||
28008524|NCT02702492|81862126|FG005|Overall Study|Other|0|||
27687151|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
27687152|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27687153|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27687154|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27875785|NCT01686373|81375545|FG000|Overall Study|Lost to Follow-up|3|||
28008525|NCT02702492|81862127|FG006|Overall Study|Other|0|||
28008526|NCT02702492|81862128|FG007|Overall Study|Other|0|||
28008527|NCT02702492|81862129|FG008|Overall Study|Other|0|||
28008528|NCT02702492|81862130|FG009|Overall Study|Other|0|||
27687155|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
27687156|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
28008529|NCT02702492|81862131|FG010|Overall Study|Other|0|||
28008530|NCT02702492|81862132|FG011|Overall Study|Other|0|||
28008531|NCT02702492|81862133|FG012|Overall Study|Other|1|||
27687157|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27687158|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27687159|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27687160|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
27687161|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
27687162|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27687163|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27687164|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27687165|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
27687166|NCT00700427|80690507|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
27687167|NCT00700427|80690508|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27687168|NCT00700427|80690509|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27687169|NCT00700427|80690510|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27687170|NCT00700427|80690511|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
27687171|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27687172|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
27687173|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27687174|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27687175|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
27687176|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27687177|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
27687178|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27687179|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27687180|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
27687181|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27687182|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
27687183|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27687184|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27687185|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
27687186|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27687187|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
27687188|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27687189|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27687190|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
27687191|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27687192|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
27687193|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27687194|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27687195|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
27687196|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27687197|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
27687198|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27687199|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27687200|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
27687201|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27687202|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
27687203|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27687204|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27687205|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
27687206|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27812729|NCT02507375|81143754|FG001|Overall Study|Progressive Disease|5|||
27812730|NCT02507375|81143753|FG000|Overall Study|Death|0|||
27687207|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
27687208|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27687209|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27687210|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
27687211|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27687212|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
27687213|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27687214|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27687215|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
27812731|NCT02507375|81143754|FG001|Overall Study|Death|1|||
27687216|NCT00700427|80690507|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27812732|NCT02507375|81143753|FG000|Overall Study|Refused treatment|0|||
28008532|NCT05652010|81862138|FG000|First Intervention|Withdrawal by Subject|0|||
27687217|NCT00700427|80690508|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
27687218|NCT00700427|80690509|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27687219|NCT00700427|80690510|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27687220|NCT00700427|80690511|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
27687221|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
27687222|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
27687223|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
27687224|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
27687225|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
27687226|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
27687227|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
27687228|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
27687229|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
27687230|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
27687231|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
27687232|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
27687233|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
27687234|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
27687235|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
27687236|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
27687237|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
27687238|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
27812733|NCT02507375|81143754|FG001|Overall Study|Refused treatment|1|||
27812734|NCT02507375|81143753|FG000|Overall Study|Adverse Event|0|||
27812735|NCT02507375|81143754|FG001|Overall Study|Adverse Event|1|||
27812736|NCT02346201|81143755|FG000|Overall Study|Adverse Event|3|||
27812737|NCT02346201|81143756|FG001|Overall Study|Adverse Event|2|||
27812738|NCT02346201|81143755|FG000|Overall Study|Lost to Follow-up|1|||
28008533|NCT05652010|81862139|FG001|First Intervention|Withdrawal by Subject|1|||
27812739|NCT02346201|81143756|FG001|Overall Study|Lost to Follow-up|0|||
27812740|NCT02346201|81143755|FG000|Overall Study|Withdrawal by Subject|6|||
27812741|NCT02346201|81143756|FG001|Overall Study|Withdrawal by Subject|3|||
27812742|NCT02346201|81143755|FG000|Overall Study|Unavailable for future follow-up|0|||
27812743|NCT02346201|81143756|FG001|Overall Study|Unavailable for future follow-up|1|||
27812744|NCT02346201|81143755|FG000|Overall Study|Physician Decision|0|||
27812745|NCT02346201|81143756|FG001|Overall Study|Physician Decision|1|||
27812746|NCT02346201|81143755|FG000|Overall Study|Missed final visit|0|||
27812747|NCT02346201|81143756|FG001|Overall Study|Missed final visit|2|||
27812748|NCT00295854|81143757|FG000|Overall Study|Adverse Event|7|||
27812749|NCT00295854|81143758|FG001|Overall Study|Adverse Event|7|||
27812750|NCT00295854|81143759|FG002|Overall Study|Adverse Event|6|||
27812751|NCT00295854|81143757|FG000|Overall Study|Protocol Violation|1|||
27812752|NCT00295854|81143758|FG001|Overall Study|Protocol Violation|1|||
27812753|NCT00295854|81143759|FG002|Overall Study|Protocol Violation|1|||
27812754|NCT00295854|81143757|FG000|Overall Study|Lost to Follow-up|2|||
27812755|NCT00295854|81143758|FG001|Overall Study|Lost to Follow-up|0|||
27812756|NCT00295854|81143759|FG002|Overall Study|Lost to Follow-up|1|||
27812757|NCT00295854|81143757|FG000|Overall Study|Withdrawal by Subject|3|||
27812758|NCT00295854|81143758|FG001|Overall Study|Withdrawal by Subject|7|||
27812759|NCT00295854|81143759|FG002|Overall Study|Withdrawal by Subject|4|||
27812760|NCT00295854|81143757|FG000|Overall Study|did not continue to meet criteria|1|||
27812761|NCT00295854|81143758|FG001|Overall Study|did not continue to meet criteria|1|||
27812762|NCT00295854|81143759|FG002|Overall Study|did not continue to meet criteria|2|||
27812763|NCT00295854|81143757|FG000|Overall Study|required a prohibited medication|1|||
27812764|NCT00295854|81143758|FG001|Overall Study|required a prohibited medication|0|||
27812765|NCT00295854|81143759|FG002|Overall Study|required a prohibited medication|0|||
27812766|NCT00295854|81143757|FG000|Overall Study|Other|3|||
27812767|NCT00295854|81143758|FG001|Overall Study|Other|5|||
27812768|NCT00295854|81143759|FG002|Overall Study|Other|1|||
27812769|NCT00922779|81143760|FG000|Overall Study|Adverse Event|67|||
28008534|NCT05652010|81862138|FG000|Second Intervention|Withdrawal by Subject|1|||
27812770|NCT00922779|81143760|FG000|Overall Study|Pregnancy|7|||
27875786|NCT01686373|81375546|FG001|Overall Study|Lost to Follow-up|0|||
28008535|NCT05652010|81862139|FG001|Second Intervention|Withdrawal by Subject|0|||
27812771|NCT00922779|81143760|FG000|Overall Study|Withdrawal by Subject|308|||
27812772|NCT00922779|81143760|FG000|Overall Study|Lost to Follow-up|44|||
27812773|NCT00922779|81143760|FG000|Overall Study|Other|27|||
27812774|NCT00922779|81143760|FG000|Overall Study|Missing|1874|||
27812775|NCT02524379|81143761|FG000|Overall Study|Death|1|||
28008536|NCT05472090|81862147|FG000|Overall Study|Adverse Event|2|||
27812776|NCT02497781|81143762|FG000|Overall Study|Withdrawal by Subject|2|||
27812777|NCT02497781|81143763|FG001|Overall Study|Withdrawal by Subject|0|||
28008537|NCT05472090|81862148|FG001|Overall Study|Adverse Event|3|||
27812778|NCT02497781|81143762|FG000|Overall Study|Lack of Efficacy|0|||
27812779|NCT02497781|81143763|FG001|Overall Study|Lack of Efficacy|1|||
27812780|NCT02497781|81143762|FG000|Overall Study|Randomised but not treated|1|||
27812781|NCT02497781|81143763|FG001|Overall Study|Randomised but not treated|1|||
27812782|NCT02497781|81143762|FG000|Overall Study|Lost to Follow-up|1|||
27812783|NCT02497781|81143763|FG001|Overall Study|Lost to Follow-up|1|||
27812784|NCT01821625|81143764|FG000|Overall Study|Withdrawal by Subject|2|||
27812785|NCT01821625|81143764|FG000|Overall Study|Lack of Efficacy|2|||
27812786|NCT01821625|81143764|FG000|Overall Study|Adverse Event|1|||
27812787|NCT01821625|81143764|FG000|Overall Study|Medical contraindication|1|||
27812788|NCT02292238|81143765|FG000|Overall Study|Protocol Violation|1|||
27812789|NCT02292238|81143766|FG001|Overall Study|Protocol Violation|2|||
27812790|NCT02292238|81143765|FG000|Overall Study|Withdrawal by Subject|2|||
27812791|NCT02292238|81143766|FG001|Overall Study|Withdrawal by Subject|1|||
27812792|NCT02292238|81143765|FG000|Overall Study|Lost to Follow-up|1|||
27812793|NCT02292238|81143766|FG001|Overall Study|Lost to Follow-up|0|||
27812794|NCT02292238|81143765|FG000|Overall Study|Physician Decision|0|||
27812795|NCT02292238|81143766|FG001|Overall Study|Physician Decision|1|||
27812796|NCT02352337|81143767|FG000|Overall Study|Patients never treated|4|||
27812797|NCT02352337|81143768|FG001|Overall Study|Patients never treated|1|||
27812798|NCT02352337|81143769|FG002|Overall Study|Patients never treated|2|||
27812799|NCT02729896|81143770|FG000|Overall Study|Death|0|||
27812800|NCT02729896|81143771|FG001|Overall Study|Death|2|||
27812801|NCT02729896|81143772|FG002|Overall Study|Death|13|||
27812802|NCT02729896|81143770|FG000|Overall Study|Lost to Follow-up|0|||
27812803|NCT02729896|81143771|FG001|Overall Study|Lost to Follow-up|2|||
27812804|NCT02729896|81143772|FG002|Overall Study|Lost to Follow-up|3|||
27812805|NCT02729896|81143770|FG000|Overall Study|Other|0|||
27812806|NCT02729896|81143771|FG001|Overall Study|Other|2|||
27812807|NCT02729896|81143772|FG002|Overall Study|Other|0|||
27812808|NCT02729896|81143770|FG000|Overall Study|Physician Decision|1|||
27812809|NCT02729896|81143771|FG001|Overall Study|Physician Decision|2|||
27812810|NCT02729896|81143772|FG002|Overall Study|Physician Decision|3|||
27812811|NCT02729896|81143770|FG000|Overall Study|Progressive Disease|0|||
27812812|NCT02729896|81143771|FG001|Overall Study|Progressive Disease|1|||
27812813|NCT02729896|81143772|FG002|Overall Study|Progressive Disease|0|||
27587648|NCT00744653|80331813|FG000|Overall Study|Lost to Follow-up|1|||
27587649|NCT00744653|80331813|FG000|Overall Study|Physician Decision|3|||
27587650|NCT00355082|80331816|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
27587651|NCT00355082|80331817|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
27587652|NCT00355082|80331818|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
27587653|NCT00355082|80331816|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
27587654|NCT00355082|80331817|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
27587655|NCT00355082|80331818|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
27587656|NCT00355082|80331816|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
27587657|NCT00355082|80331817|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
27587658|NCT00355082|80331818|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
27587659|NCT00355082|80331816|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
27587660|NCT00355082|80331817|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
27587661|NCT00355082|80331818|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
27587662|NCT00355082|80331816|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
27587663|NCT00355082|80331817|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
27587664|NCT00355082|80331818|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
27587665|NCT00355082|80331816|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
27587666|NCT00355082|80331817|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
27587667|NCT00355082|80331818|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
27587668|NCT00355082|80331816|FG000|Continuation Phase|Adverse Event|2|||
27812814|NCT02729896|81143770|FG000|Overall Study|Withdrawal by Subject|1|||
27812815|NCT02729896|81143771|FG001|Overall Study|Withdrawal by Subject|0|||
27812816|NCT02729896|81143772|FG002|Overall Study|Withdrawal by Subject|3|||
27812817|NCT01767597|81143779|FG000|Overall Study|Incomplete intervention|3|||
27812818|NCT01767597|81143780|FG001|Overall Study|Incomplete intervention|1|||
27875787|NCT01686373|81375545|FG000|Overall Study|Withdrawal by Subject|0|||
27812819|NCT01767597|81143779|FG000|Overall Study|Withdrawal by Subject|1|||
27812820|NCT01767597|81143780|FG001|Overall Study|Withdrawal by Subject|0|||
27587669|NCT00355082|80331817|FG001|Continuation Phase|Adverse Event|0|||
27587670|NCT00355082|80331818|FG002|Continuation Phase|Adverse Event|1|||
27812821|NCT01508936|81143781|FG000|Overall Study|Adverse Event|11|||
27812822|NCT01508936|81143782|FG001|Overall Study|Adverse Event|32|||
27812823|NCT01508936|81143781|FG000|Overall Study|Lack of Efficacy|0|||
27812824|NCT01508936|81143782|FG001|Overall Study|Lack of Efficacy|1|||
27812825|NCT01508936|81143781|FG000|Overall Study|Withdrawal by Subject|4|||
27812826|NCT01508936|81143782|FG001|Overall Study|Withdrawal by Subject|18|||
27812827|NCT01508936|81143781|FG000|Overall Study|Protocol Violation|2|||
27812828|NCT01508936|81143782|FG001|Overall Study|Protocol Violation|3|||
27587671|NCT00355082|80331816|FG000|Continuation Phase|Lost to Follow-up|2|||
27587672|NCT00355082|80331817|FG001|Continuation Phase|Lost to Follow-up|0|||
27587673|NCT00355082|80331818|FG002|Continuation Phase|Lost to Follow-up|1|||
27587674|NCT00355082|80331816|FG000|Continuation Phase|Protocol Violation|1|||
27587675|NCT00355082|80331817|FG001|Continuation Phase|Protocol Violation|0|||
27587676|NCT00355082|80331818|FG002|Continuation Phase|Protocol Violation|1|||
27587677|NCT00355082|80331816|FG000|Continuation Phase|Withdrawal by Subject|4|||
27587678|NCT00355082|80331817|FG001|Continuation Phase|Withdrawal by Subject|0|||
27587679|NCT00355082|80331818|FG002|Continuation Phase|Withdrawal by Subject|0|||
27587680|NCT00355082|80331816|FG000|Continuation Phase|Lack of Efficacy|5|||
27587681|NCT00355082|80331817|FG001|Continuation Phase|Lack of Efficacy|0|||
27587682|NCT00355082|80331818|FG002|Continuation Phase|Lack of Efficacy|0|||
27587683|NCT00355082|80331816|FG000|Continuation Phase|Site Closed by Sponsor|8|||
27587684|NCT00355082|80331817|FG001|Continuation Phase|Site Closed by Sponsor|0|||
27587685|NCT00355082|80331818|FG002|Continuation Phase|Site Closed by Sponsor|0|||
27587686|NCT00355082|80331816|FG000|Continuation Phase|Scheduling Error|1|||
27587687|NCT00355082|80331817|FG001|Continuation Phase|Scheduling Error|0|||
27587688|NCT00355082|80331818|FG002|Continuation Phase|Scheduling Error|0|||
27587689|NCT00355082|80331816|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
27587690|NCT00355082|80331817|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
27587691|NCT00355082|80331818|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
27587692|NCT03832010|80331821|FG000|Overall Study|Withdrawal by Subject|2|||
27587693|NCT03832010|80331822|FG001|Overall Study|Withdrawal by Subject|1|||
27587694|NCT03832010|80331823|FG002|Overall Study|Withdrawal by Subject|0|||
27587695|NCT03832010|80331821|FG000|Overall Study|Lost to Follow-up|2|||
27587696|NCT03832010|80331822|FG001|Overall Study|Lost to Follow-up|1|||
27587697|NCT03832010|80331823|FG002|Overall Study|Lost to Follow-up|1|||
27587698|NCT00784043|80331824|FG000|Overall Study|Withdrawal by Subject|8|||
27587699|NCT00784043|80331825|FG001|Overall Study|Withdrawal by Subject|5|||
27587700|NCT00784043|80331824|FG000|Overall Study|Protocol Terminated|23|||
27587701|NCT00784043|80331825|FG001|Overall Study|Protocol Terminated|1|||
27587702|NCT03043664|80331826|FG000|Overall Study|Lost to Follow-up|1|||
27587703|NCT02493361|80331829|FG000|Overall Study|Withdrawal by Subject|3|||
27587704|NCT04095858|80331831|FG000|Overall Study|Death|1|||
27587705|NCT04095858|80331832|FG001|Overall Study|Death|0|||
27587706|NCT04095858|80331831|FG000|Overall Study|Study terminated by Sponsor|2|||
27587707|NCT04095858|80331832|FG001|Overall Study|Study terminated by Sponsor|4|||
27587708|NCT02647658|80331833|FG000|Overall Study|Consent refusal|15|||
27587709|NCT02647658|80331834|FG001|Overall Study|Consent refusal|24|||
27587710|NCT00360308|80331835|FG000|Overall Study|Adverse Event|15|||
27587711|NCT00360308|80331836|FG001|Overall Study|Adverse Event|14|||
27587712|NCT00360308|80331837|FG002|Overall Study|Adverse Event|25|||
27587713|NCT00360308|80331835|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
27587714|NCT00360308|80331836|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
27587715|NCT00360308|80331837|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
27587716|NCT00360308|80331835|FG000|Overall Study|Protocol Violation|2|||
27587717|NCT00360308|80331836|FG001|Overall Study|Protocol Violation|1|||
27587718|NCT00360308|80331837|FG002|Overall Study|Protocol Violation|2|||
27587719|NCT00360308|80331835|FG000|Overall Study|Withdrawal by Subject|11|||
27587720|NCT00360308|80331836|FG001|Overall Study|Withdrawal by Subject|7|||
27587721|NCT00360308|80331837|FG002|Overall Study|Withdrawal by Subject|14|||
27587722|NCT00360308|80331835|FG000|Overall Study|Lack of Efficacy|3|||
27587723|NCT00360308|80331836|FG001|Overall Study|Lack of Efficacy|0|||
27587724|NCT00360308|80331837|FG002|Overall Study|Lack of Efficacy|2|||
27587725|NCT00360308|80331835|FG000|Overall Study|Other|2|||
27587726|NCT00360308|80331836|FG001|Overall Study|Other|1|||
27587727|NCT00360308|80331837|FG002|Overall Study|Other|1|||
27587728|NCT00360308|80331835|FG000|Overall Study|Study termination by sponsor|43|||
27587729|NCT00360308|80331836|FG001|Overall Study|Study termination by sponsor|55|||
27587730|NCT00360308|80331837|FG002|Overall Study|Study termination by sponsor|44|||
27587731|NCT00408993|80331838|FG000|Overall Study|Adverse Event|15|||
27587732|NCT00408993|80331839|FG001|Overall Study|Adverse Event|4|||
27587733|NCT00408993|80331838|FG000|Overall Study|Protocol Violation|1|||
27587734|NCT00408993|80331839|FG001|Overall Study|Protocol Violation|6|||
27587735|NCT00408993|80331838|FG000|Overall Study|Lack of Efficacy|1|||
27587736|NCT00408993|80331839|FG001|Overall Study|Lack of Efficacy|4|||
27587737|NCT00408993|80331838|FG000|Overall Study|Withdrawal by Subject|2|||
27587738|NCT00408993|80331839|FG001|Overall Study|Withdrawal by Subject|3|||
27587739|NCT01174342|80331845|FG000|Overall Study|Conversion to cesarean section|4|||
27587740|NCT00237744|80331846|FG000|Overall Study|Withdrawal by Subject|3|||
27587741|NCT00237744|80331847|FG001|Overall Study|Withdrawal by Subject|1|||
27587742|NCT00237744|80331848|FG002|Overall Study|Withdrawal by Subject|0|||
27587743|NCT01178853|80331849|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
27587744|NCT01178853|80331850|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
27587745|NCT01178853|80331849|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
27587746|NCT01178853|80331850|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
27587747|NCT01178853|80331849|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
27587748|NCT01178853|80331850|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
27587749|NCT01178853|80331849|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
27587750|NCT01178853|80331850|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
27587751|NCT01178853|80331849|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
27587752|NCT01178853|80331850|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
27587753|NCT00874029|80331856|FG000|Overall Study|Withdrawal by Subject|10|||
27587754|NCT00874029|80331856|FG000|Overall Study|Pregnancy|4|||
27587755|NCT00874029|80331856|FG000|Overall Study|Physician Decision|1|||
27587756|NCT00874029|80331856|FG000|Overall Study|Adverse Event|1|||
27587757|NCT00874029|80331856|FG000|Overall Study|Lost to Follow-up|5|||
27587758|NCT03387852|80331857|FG000|Overall Study|Adverse event (AE)|3|||
27587759|NCT03387852|80331858|FG001|Overall Study|Adverse event (AE)|0|||
27587760|NCT03387852|80331859|FG002|Overall Study|Adverse event (AE)|2|||
27587761|NCT03387852|80331860|FG003|Overall Study|Adverse event (AE)|0|||
27587762|NCT03387852|80331857|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
27587763|NCT03387852|80331858|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
27587764|NCT03387852|80331859|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
27812829|NCT01508936|81143781|FG000|Overall Study|Lost to Follow-up|2|||
27812830|NCT01508936|81143782|FG001|Overall Study|Lost to Follow-up|9|||
27812831|NCT01508936|81143781|FG000|Overall Study|Other|0|||
27812832|NCT01508936|81143782|FG001|Overall Study|Other|5|||
27875788|NCT01686373|81375546|FG001|Overall Study|Withdrawal by Subject|1|||
27875789|NCT01686373|81375545|FG000|Overall Study|Adverse Event|0|||
27875790|NCT01686373|81375546|FG001|Overall Study|Adverse Event|1|||
27875791|NCT00987337|81379590|FG000|Overall Study|Adverse Event|10|||
27875792|NCT00987337|81379591|FG001|Overall Study|Adverse Event|9|||
27875793|NCT00987337|81379592|FG002|Overall Study|Adverse Event|8|||
27875794|NCT00987337|81379590|FG000|Overall Study|Insufficient Virologic Response|10|||
27875795|NCT00987337|81379591|FG001|Overall Study|Insufficient Virologic Response|7|||
27875796|NCT00987337|81379592|FG002|Overall Study|Insufficient Virologic Response|12|||
27875797|NCT00987337|81379590|FG000|Overall Study|Virologic Breakthrough|2|||
27875798|NCT00987337|81379591|FG001|Overall Study|Virologic Breakthrough|2|||
27875799|NCT00987337|81379592|FG002|Overall Study|Virologic Breakthrough|8|||
27875800|NCT00987337|81379590|FG000|Overall Study|Lost to Follow-up|10|||
28008538|NCT05472090|81862147|FG000|Overall Study|Lack of Efficacy|1|||
28008539|NCT05472090|81862148|FG001|Overall Study|Lack of Efficacy|0|||
28008540|NCT05472090|81862147|FG000|Overall Study|Physician Decision|1|||
28008541|NCT05472090|81862148|FG001|Overall Study|Physician Decision|0|||
28008542|NCT05472090|81862147|FG000|Overall Study|Withdrawal by Subject|2|||
28008543|NCT05472090|81862148|FG001|Overall Study|Withdrawal by Subject|0|||
28008544|NCT05472090|81862147|FG000|Overall Study|Lost to Follow-up|0|||
28008545|NCT05472090|81862148|FG001|Overall Study|Lost to Follow-up|3|||
28008546|NCT04801420|81862149|FG000|Overall Study|Other|1|||
28008547|NCT04801420|81862150|FG001|Overall Study|Other|2|||
28008548|NCT04801420|81862151|FG002|Overall Study|Other|1|||
28008549|NCT04801420|81862149|FG000|Overall Study|Lost to Follow-up|7|||
28008550|NCT04801420|81862150|FG001|Overall Study|Lost to Follow-up|9|||
28008551|NCT04801420|81862151|FG002|Overall Study|Lost to Follow-up|10|||
28008552|NCT04801420|81862149|FG000|Overall Study|Moved from study area|0|||
28008553|NCT04801420|81862150|FG001|Overall Study|Moved from study area|1|||
28008554|NCT04801420|81862151|FG002|Overall Study|Moved from study area|1|||
28008555|NCT04801420|81862149|FG000|Overall Study|Withdrawal by Subject|5|||
28008556|NCT04801420|81862150|FG001|Overall Study|Withdrawal by Subject|1|||
28008557|NCT04801420|81862151|FG002|Overall Study|Withdrawal by Subject|4|||
27812833|NCT01508936|81143781|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
27812834|NCT01508936|81143782|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
27812835|NCT02224456|81143785|FG000|Overall Study|Lack of Efficacy|1|||
27812836|NCT02224456|81143785|FG000|Overall Study|Lost to Follow-up|15|||
27812837|NCT02224456|81143785|FG000|Overall Study|Withdrawal by Subject|9|||
27875801|NCT00987337|81379591|FG001|Overall Study|Lost to Follow-up|6|||
27875802|NCT00987337|81379592|FG002|Overall Study|Lost to Follow-up|2|||
27587765|NCT03387852|80331860|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
27587766|NCT03387852|80331857|FG000|Overall Study|Withdrawal by participant|1|||
27587767|NCT03387852|80331858|FG001|Overall Study|Withdrawal by participant|1|||
27587768|NCT03387852|80331859|FG002|Overall Study|Withdrawal by participant|3|||
28008558|NCT04801420|81862149|FG000|Overall Study|Individual stopping criteria reached|0|||
27812838|NCT02224456|81143785|FG000|Overall Study|Physician Decision|3|||
27812839|NCT02224456|81143785|FG000|Overall Study|Death|2|||
28008559|NCT04801420|81862150|FG001|Overall Study|Individual stopping criteria reached|1|||
28008560|NCT04801420|81862151|FG002|Overall Study|Individual stopping criteria reached|0|||
27587769|NCT03387852|80331860|FG003|Overall Study|Withdrawal by participant|2|||
27875803|NCT00987337|81379590|FG000|Overall Study|Withdrawal by Subject|6|||
27875804|NCT00987337|81379591|FG001|Overall Study|Withdrawal by Subject|9|||
28008561|NCT04801420|81862149|FG000|Overall Study|Ongoing in the study|195|||
28008562|NCT04801420|81862150|FG001|Overall Study|Ongoing in the study|195|||
28008563|NCT04801420|81862151|FG002|Overall Study|Ongoing in the study|192|||
27812840|NCT02224456|81143785|FG000|Overall Study|Pregnancy|4|||
27812841|NCT02224456|81143785|FG000|Overall Study|Protocol Violation|1|||
27812842|NCT02224456|81143785|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
27812843|NCT01054599|81143786|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
27812844|NCT01054599|81143787|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
27812845|NCT01054599|81143786|FG000|Overall Study|Protocol Violation|1|||
27812846|NCT01054599|81143787|FG001|Overall Study|Protocol Violation|0|||
27812847|NCT01054599|81143786|FG000|Overall Study|Spells/seizure-like episodes|1|||
27812848|NCT01054599|81143787|FG001|Overall Study|Spells/seizure-like episodes|1|||
27587770|NCT03387852|80331857|FG000|Overall Study|Other- Unspecified|1|||
27812849|NCT01054599|81143786|FG000|Overall Study|Timing/scheduling difficulties|1|||
27875805|NCT00987337|81379592|FG002|Overall Study|Withdrawal by Subject|9|||
27875806|NCT00987337|81379590|FG000|Overall Study|Other|0|||
27875807|NCT00987337|81379591|FG001|Overall Study|Other|2|||
27875808|NCT00987337|81379592|FG002|Overall Study|Other|5|||
27875809|NCT00987337|81379590|FG000|Overall Study|Protocol Violation|1|||
27875810|NCT00987337|81379591|FG001|Overall Study|Protocol Violation|0|||
27875811|NCT00987337|81379592|FG002|Overall Study|Protocol Violation|2|||
27875812|NCT00987337|81379590|FG000|Overall Study|Participant Relapsed|18|||
27875813|NCT00987337|81379591|FG001|Overall Study|Participant Relapsed|20|||
27875814|NCT00987337|81379592|FG002|Overall Study|Participant Relapsed|5|||
27875815|NCT00594165|81379593|FG000|Overall Study|Major protocol violation|1|||
27875816|NCT00594165|81379593|FG000|Overall Study|Lack of Efficacy|12|||
27875817|NCT00594165|81379593|FG000|Overall Study|Adverse Event|52|||
27875818|NCT00594165|81379593|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
27687239|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
27687240|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
27687241|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
27687242|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
27687243|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
27687244|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
27687245|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
27687246|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27687247|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27687248|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27687249|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
27687250|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
27687251|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27687252|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27687253|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27687254|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
27687255|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
27687256|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
27687257|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
27687258|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
27687259|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
27687260|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
27687261|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27687262|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27687263|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
27687264|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27687265|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
27687266|NCT00700427|80690507|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
27687267|NCT00700427|80690508|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
27687268|NCT00700427|80690509|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
27687269|NCT00700427|80690510|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
27687270|NCT00700427|80690511|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
27687271|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27687272|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27687273|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27687274|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
27687275|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
27687276|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
27687277|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
27687278|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
27687279|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
27687280|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
27687281|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27687282|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27687283|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27687284|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
27687285|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
27687286|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27687287|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27687288|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27687289|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
27687290|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
27687291|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27687292|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27687293|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27687294|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
27687295|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
27687296|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27687297|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27687298|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27687299|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
27687300|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
27687301|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27587771|NCT03387852|80331858|FG001|Overall Study|Other- Unspecified|1|||
27587772|NCT03387852|80331859|FG002|Overall Study|Other- Unspecified|2|||
27587773|NCT03387852|80331860|FG003|Overall Study|Other- Unspecified|1|||
27587774|NCT03387852|80331857|FG000|Overall Study|Poor compliance to protocol|0|||
27587775|NCT03387852|80331858|FG001|Overall Study|Poor compliance to protocol|0|||
27587776|NCT03387852|80331859|FG002|Overall Study|Poor compliance to protocol|0|||
27587777|NCT03387852|80331860|FG003|Overall Study|Poor compliance to protocol|1|||
27587778|NCT03387852|80331857|FG000|Overall Study|Randomized and not treated|0|||
27587779|NCT03387852|80331858|FG001|Overall Study|Randomized and not treated|0|||
27587780|NCT03387852|80331859|FG002|Overall Study|Randomized and not treated|0|||
27587781|NCT03387852|80331860|FG003|Overall Study|Randomized and not treated|1|||
27587782|NCT00380068|80331861|FG000|Overall Study|Adverse Event|40|||
27587783|NCT00380068|80331861|FG000|Overall Study|Withdrawal by Subject|10|||
27587784|NCT00380068|80331861|FG000|Overall Study|Not compliant|6|||
27587785|NCT00380068|80331861|FG000|Overall Study|Lost to Follow-up|1|||
27587786|NCT00380068|80331861|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
27587787|NCT00380068|80331861|FG000|Overall Study|Lung transplant|3|||
27587788|NCT00380068|80331861|FG000|Overall Study|Physician Decision|2|||
27587789|NCT00380068|80331861|FG000|Overall Study|Partipant moved away|1|||
27587790|NCT00380068|80331861|FG000|Overall Study|Lack of Efficacy|5|||
27587791|NCT03690869|80331869|FG000|Overall Study|Adverse Event|0|||
27587792|NCT03690869|80331870|FG001|Overall Study|Adverse Event|0|||
27587793|NCT03690869|80331871|FG002|Overall Study|Adverse Event|0|||
27587794|NCT03690869|80331872|FG003|Overall Study|Adverse Event|1|||
27587795|NCT03690869|80331873|FG004|Overall Study|Adverse Event|0|||
27587796|NCT03690869|80331874|FG005|Overall Study|Adverse Event|0|||
27587797|NCT03690869|80331875|FG006|Overall Study|Adverse Event|0|||
27587798|NCT03690869|80331876|FG007|Overall Study|Adverse Event|1|||
27587799|NCT03690869|80331877|FG008|Overall Study|Adverse Event|0|||
27587800|NCT03690869|80331878|FG009|Overall Study|Adverse Event|1|||
27587801|NCT03690869|80331869|FG000|Overall Study|Death|1|||
27587802|NCT03690869|80331870|FG001|Overall Study|Death|1|||
27587803|NCT03690869|80331871|FG002|Overall Study|Death|1|||
27587804|NCT03690869|80331872|FG003|Overall Study|Death|4|||
27587805|NCT03690869|80331873|FG004|Overall Study|Death|2|||
27587806|NCT03690869|80331874|FG005|Overall Study|Death|5|||
27587807|NCT03690869|80331875|FG006|Overall Study|Death|3|||
27587808|NCT03690869|80331876|FG007|Overall Study|Death|2|||
27587809|NCT03690869|80331877|FG008|Overall Study|Death|0|||
27587810|NCT03690869|80331878|FG009|Overall Study|Death|3|||
27587811|NCT03690869|80331869|FG000|Overall Study|Lost to Follow-up|0|||
27587812|NCT03690869|80331870|FG001|Overall Study|Lost to Follow-up|0|||
27587813|NCT03690869|80331871|FG002|Overall Study|Lost to Follow-up|1|||
27587814|NCT03690869|80331872|FG003|Overall Study|Lost to Follow-up|0|||
27587815|NCT03690869|80331873|FG004|Overall Study|Lost to Follow-up|0|||
27587816|NCT03690869|80331874|FG005|Overall Study|Lost to Follow-up|0|||
27587817|NCT03690869|80331875|FG006|Overall Study|Lost to Follow-up|0|||
27587818|NCT03690869|80331876|FG007|Overall Study|Lost to Follow-up|0|||
27587819|NCT03690869|80331877|FG008|Overall Study|Lost to Follow-up|0|||
27587820|NCT03690869|80331878|FG009|Overall Study|Lost to Follow-up|0|||
27587821|NCT03690869|80331869|FG000|Overall Study|Other Treatment|1|||
27587822|NCT03690869|80331870|FG001|Overall Study|Other Treatment|1|||
27587823|NCT03690869|80331871|FG002|Overall Study|Other Treatment|1|||
27587824|NCT03690869|80331872|FG003|Overall Study|Other Treatment|2|||
27587825|NCT03690869|80331873|FG004|Overall Study|Other Treatment|3|||
27587826|NCT03690869|80331874|FG005|Overall Study|Other Treatment|1|||
27587827|NCT03690869|80331875|FG006|Overall Study|Other Treatment|2|||
27587828|NCT03690869|80331876|FG007|Overall Study|Other Treatment|7|||
27587829|NCT03690869|80331877|FG008|Overall Study|Other Treatment|0|||
27812850|NCT01054599|81143787|FG001|Overall Study|Timing/scheduling difficulties|1|||
27812851|NCT01054599|81143786|FG000|Overall Study|Visual impairment, WTAR <80|0|||
27812852|NCT01054599|81143787|FG001|Overall Study|Visual impairment, WTAR <80|1|||
27587830|NCT03690869|80331878|FG009|Overall Study|Other Treatment|3|||
27812853|NCT01054599|81143786|FG000|Overall Study|Lost to Follow-up|0|||
27812854|NCT01054599|81143787|FG001|Overall Study|Lost to Follow-up|2|||
27812855|NCT01054599|81143786|FG000|Overall Study|Adverse Event|0|||
27812856|NCT01054599|81143787|FG001|Overall Study|Adverse Event|1|||
27587831|NCT03690869|80331869|FG000|Overall Study|Physician Decision|0|||
27587832|NCT03690869|80331870|FG001|Overall Study|Physician Decision|1|||
27812857|NCT01054599|81143786|FG000|Overall Study|Withdrawal by Subject|0|||
27587833|NCT03690869|80331871|FG002|Overall Study|Physician Decision|0|||
27587834|NCT03690869|80331872|FG003|Overall Study|Physician Decision|0|||
27587835|NCT03690869|80331873|FG004|Overall Study|Physician Decision|0|||
27587836|NCT03690869|80331874|FG005|Overall Study|Physician Decision|0|||
27587837|NCT03690869|80331875|FG006|Overall Study|Physician Decision|0|||
27587838|NCT03690869|80331876|FG007|Overall Study|Physician Decision|0|||
27587839|NCT03690869|80331877|FG008|Overall Study|Physician Decision|0|||
27587840|NCT03690869|80331878|FG009|Overall Study|Physician Decision|0|||
27587841|NCT03690869|80331869|FG000|Overall Study|Progressive Disease|1|||
27587842|NCT03690869|80331870|FG001|Overall Study|Progressive Disease|2|||
27587843|NCT03690869|80331871|FG002|Overall Study|Progressive Disease|0|||
27687302|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27687303|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27687304|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
27687305|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
27687306|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27687307|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27687308|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27687309|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
27687310|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
27687311|NCT00700427|80690507|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27687312|NCT00700427|80690508|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27687313|NCT00700427|80690509|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27687314|NCT00700427|80690510|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
27687315|NCT00700427|80690511|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
27687316|NCT00928018|80690519|FG000|Overall Study|Withdrawal by Subject|1|||
27687317|NCT00928018|80690520|FG001|Overall Study|Withdrawal by Subject|0|||
27687318|NCT00844532|80690529|FG000|Overall Study|Death|16|||
27687319|NCT00844532|80690529|FG000|Overall Study|Withdrawal by Subject|16|||
27687320|NCT00844532|80690529|FG000|Overall Study|Lost to Follow-up|7|||
27687321|NCT00735475|80690530|FG000|Overall Study|Adverse Event|0|||
27687322|NCT00735475|80690531|FG001|Overall Study|Adverse Event|1|||
27687323|NCT00735475|80690530|FG000|Overall Study|Death|1|||
27687324|NCT00735475|80690531|FG001|Overall Study|Death|1|||
27687325|NCT00735475|80690530|FG000|Overall Study|Lost to Follow-up|3|||
27687326|NCT00735475|80690531|FG001|Overall Study|Lost to Follow-up|3|||
27687327|NCT00735475|80690530|FG000|Overall Study|Physician Decision|0|||
27687328|NCT00735475|80690531|FG001|Overall Study|Physician Decision|1|||
27687329|NCT00735475|80690530|FG000|Overall Study|Withdrawal by Subject|4|||
27687330|NCT00735475|80690531|FG001|Overall Study|Withdrawal by Subject|5|||
27687331|NCT02432196|80690535|FG000|Overall Study|Exit - did not receive study device|1|||
27687332|NCT02432196|80690535|FG000|Overall Study|Death|2|||
27687333|NCT02432196|80690535|FG000|Overall Study|Reoperation|3|||
27687334|NCT00603304|80690536|FG000|Overall Study|Lost to Follow-up|5|||
27687335|NCT00603304|80690537|FG001|Overall Study|Lost to Follow-up|7|||
27687336|NCT00603304|80690536|FG000|Overall Study|Withdrawal by Subject|8|||
27687337|NCT00603304|80690537|FG001|Overall Study|Withdrawal by Subject|5|||
27687338|NCT00603304|80690536|FG000|Overall Study|Protocol Violation|1|||
27687339|NCT00603304|80690537|FG001|Overall Study|Protocol Violation|0|||
27687340|NCT00603304|80690536|FG000|Overall Study|Adverse Event|4|||
27687341|NCT00603304|80690537|FG001|Overall Study|Adverse Event|2|||
27687342|NCT00603304|80690536|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
27687343|NCT00603304|80690537|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
27687344|NCT00603304|80690536|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
27687345|NCT00603304|80690537|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
27687346|NCT00603304|80690536|FG000|Overall Study|Exclusionary Medication|2|||
27687347|NCT00603304|80690537|FG001|Overall Study|Exclusionary Medication|3|||
27687348|NCT00603304|80690536|FG000|Overall Study|Non-Compliant|0|||
27687349|NCT00603304|80690537|FG001|Overall Study|Non-Compliant|1|||
27687350|NCT00603304|80690536|FG000|Overall Study|Moved Away|0|||
27687351|NCT00603304|80690537|FG001|Overall Study|Moved Away|2|||
27687352|NCT00603304|80690536|FG000|Overall Study|Other|2|||
27687353|NCT00603304|80690537|FG001|Overall Study|Other|0|||
27687354|NCT00603304|80690536|FG000|Overall Study|Patient Decision|2|||
27812858|NCT01054599|81143787|FG001|Overall Study|Withdrawal by Subject|1|||
27812859|NCT00698685|81143788|FG000|Overall Study|Sister withdrew as donor|1|||
27812860|NCT00698685|81143788|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
27687355|NCT00603304|80690537|FG001|Overall Study|Patient Decision|0|||
27687356|NCT05086276|80690547|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
27687357|NCT05086276|80690548|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
27687358|NCT04343872|80690549|FG000|Overall Study|Lost to Follow-up|6|||
27687359|NCT04343872|80690550|FG001|Overall Study|Lost to Follow-up|3|||
27687360|NCT04602221|80690551|FG000|Overall Study|Discontinuation of trial treatment|0|||
27687361|NCT04602221|80690552|FG001|Overall Study|Discontinuation of trial treatment|0|||
27687362|NCT04602221|80690553|FG002|Overall Study|Discontinuation of trial treatment|1|||
27812861|NCT01937364|81143789|FG000|Overall Study|Adverse Event|2|||
27812862|NCT01937364|81143790|FG001|Overall Study|Adverse Event|1|||
27812863|NCT01077713|81143791|FG000|Overall Study|Withdrawal by Subject|1|||
27812864|NCT01077713|81143792|FG001|Overall Study|Withdrawal by Subject|2|||
27812865|NCT01077713|81143791|FG000|Overall Study|Progressive Disease (PD)|0|||
27812866|NCT01077713|81143792|FG001|Overall Study|Progressive Disease (PD)|1|||
27812867|NCT01077713|81143791|FG000|Overall Study|Death|28|||
27812868|NCT01077713|81143792|FG001|Overall Study|Death|29|||
27812869|NCT01077713|81143791|FG000|Overall Study|Lost to Follow-up|1|||
27812870|NCT01077713|81143792|FG001|Overall Study|Lost to Follow-up|1|||
27812871|NCT01077713|81143791|FG000|Overall Study|Adverse Event|2|||
27812872|NCT01077713|81143792|FG001|Overall Study|Adverse Event|1|||
27812873|NCT01077713|81143791|FG000|Overall Study|Other|4|||
27812874|NCT01077713|81143792|FG001|Overall Study|Other|2|||
27812875|NCT01793610|81143793|FG000|Overall Study|Withdrawal by Subject|1|||
27812876|NCT01793610|81143794|FG001|Overall Study|Withdrawal by Subject|0|||
27812877|NCT01793610|81143795|FG002|Overall Study|Withdrawal by Subject|1|||
27812878|NCT02492958|81143796|FG000|Overall Study|Withdrawal by Subject|0|||
27812879|NCT02492958|81143797|FG001|Overall Study|Withdrawal by Subject|0|||
27875819|NCT00594165|81379593|FG000|Overall Study|Subject withdrew consent|27|||
27875820|NCT00594165|81379593|FG000|Overall Study|Study ended per sponsor|102|||
27875821|NCT00594165|81379593|FG000|Overall Study|Lost to Follow-up|4|||
27875822|NCT00594165|81379593|FG000|Overall Study|Other: PI discretion|5|||
27875823|NCT00594165|81379593|FG000|Overall Study|Other: Subject moving|3|||
27875824|NCT00594165|81379593|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
27875825|NCT00594165|81379593|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
27875826|NCT00594165|81379593|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
27875827|NCT00594165|81379593|FG000|Overall Study|Other: Site terminated participation|2|||
27875828|NCT01958437|81379594|FG000|Overall Study|Incidental MRI findings|0|||
27875829|NCT01958437|81379595|FG001|Overall Study|Incidental MRI findings|0|||
27875830|NCT01958437|81379596|FG002|Overall Study|Incidental MRI findings|1|||
27875831|NCT01958437|81379597|FG003|Overall Study|Incidental MRI findings|1|||
27875832|NCT03518008|81379598|FG000|Period 2, Second Week of Wear|Family emergency|0|||
27812880|NCT02492958|81143798|FG002|Overall Study|Withdrawal by Subject|1|||
27812881|NCT02492958|81143799|FG003|Overall Study|Withdrawal by Subject|0|||
27587844|NCT03690869|80331872|FG003|Overall Study|Progressive Disease|1|||
27587845|NCT03690869|80331873|FG004|Overall Study|Progressive Disease|0|||
27587846|NCT03690869|80331874|FG005|Overall Study|Progressive Disease|0|||
27587847|NCT03690869|80331875|FG006|Overall Study|Progressive Disease|0|||
27587848|NCT03690869|80331876|FG007|Overall Study|Progressive Disease|0|||
27587849|NCT03690869|80331877|FG008|Overall Study|Progressive Disease|1|||
27587850|NCT03690869|80331878|FG009|Overall Study|Progressive Disease|1|||
27587851|NCT03690869|80331869|FG000|Overall Study|Subject Decision|0|||
27587852|NCT03690869|80331870|FG001|Overall Study|Subject Decision|0|||
27587853|NCT03690869|80331871|FG002|Overall Study|Subject Decision|0|||
27587854|NCT03690869|80331872|FG003|Overall Study|Subject Decision|1|||
27587855|NCT03690869|80331873|FG004|Overall Study|Subject Decision|0|||
27587856|NCT03690869|80331874|FG005|Overall Study|Subject Decision|0|||
27587857|NCT03690869|80331875|FG006|Overall Study|Subject Decision|0|||
27587858|NCT03690869|80331876|FG007|Overall Study|Subject Decision|1|||
27587859|NCT03690869|80331877|FG008|Overall Study|Subject Decision|0|||
27587860|NCT03690869|80331878|FG009|Overall Study|Subject Decision|0|||
27587861|NCT00377819|80331882|FG000|Overall Study|Adverse Event|2|||
27587862|NCT00377819|80331883|FG001|Overall Study|Adverse Event|3|||
27587863|NCT00377819|80331882|FG000|Overall Study|Withdrawal by Subject|10|||
27587864|NCT00377819|80331883|FG001|Overall Study|Withdrawal by Subject|4|||
27587865|NCT00377819|80331882|FG000|Overall Study|Death|0|||
27587866|NCT00377819|80331883|FG001|Overall Study|Death|1|||
27587867|NCT00377819|80331882|FG000|Overall Study|Lost to Follow-up|0|||
27587868|NCT00377819|80331883|FG001|Overall Study|Lost to Follow-up|1|||
27587869|NCT00377819|80331882|FG000|Overall Study|Protocol Violation|1|||
27587870|NCT00377819|80331883|FG001|Overall Study|Protocol Violation|1|||
27587871|NCT02053350|80331884|FG000|Overall Study|Withdrawal by Subject|1|||
27587872|NCT02053350|80331884|FG000|Overall Study|Adverse Event|4|||
27587873|NCT01410448|80331885|FG000|Overall Study|No conversion to everolimus|0|||
27587874|NCT01410448|80331886|FG001|Overall Study|No conversion to everolimus|24|||
27812882|NCT02492958|81143796|FG000|Overall Study|Adverse Event|1|||
27812883|NCT02492958|81143797|FG001|Overall Study|Adverse Event|0|||
27587875|NCT01410448|80331885|FG000|Overall Study|Graft loss|4|||
27587876|NCT01410448|80331886|FG001|Overall Study|Graft loss|1|||
27812884|NCT02492958|81143798|FG002|Overall Study|Adverse Event|1|||
27812885|NCT02492958|81143799|FG003|Overall Study|Adverse Event|0|||
27812886|NCT02668302|81143803|FG000|Overall Study|Withdrawal by Subject|1|||
27875833|NCT03518008|81379599|FG001|Period 2, Second Week of Wear|Family emergency|1|||
27587877|NCT01410448|80331885|FG000|Overall Study|Administrative issues|2|||
27587878|NCT01410448|80331886|FG001|Overall Study|Administrative issues|1|||
27875834|NCT00712712|81379602|FG000|Overall Study|Protocol Violation|11|||
27875835|NCT00712712|81379602|FG000|Overall Study|Radiofrequency not done|3|||
27875836|NCT00712712|81379602|FG000|Overall Study|Death|8|||
27875837|NCT00712712|81379602|FG000|Overall Study|Withdrawal by Subject|1|||
27875838|NCT01037218|81379603|FG000|Overall Study|Adverse Event|4|||
27875839|NCT01037218|81379604|FG001|Overall Study|Adverse Event|2|||
27875840|NCT01037218|81379605|FG002|Overall Study|Adverse Event|2|||
27875841|NCT01037218|81379606|FG003|Overall Study|Adverse Event|1|||
27875842|NCT01037218|81379603|FG000|Overall Study|Lack of Efficacy|0|||
27875843|NCT01037218|81379604|FG001|Overall Study|Lack of Efficacy|2|||
27875844|NCT01037218|81379605|FG002|Overall Study|Lack of Efficacy|1|||
27875845|NCT01037218|81379606|FG003|Overall Study|Lack of Efficacy|5|||
27875846|NCT01037218|81379603|FG000|Overall Study|Lost to Follow-up|3|||
27875847|NCT01037218|81379604|FG001|Overall Study|Lost to Follow-up|5|||
27875848|NCT01037218|81379605|FG002|Overall Study|Lost to Follow-up|4|||
27875849|NCT01037218|81379606|FG003|Overall Study|Lost to Follow-up|2|||
27687363|NCT04602221|80690554|FG003|Overall Study|Discontinuation of trial treatment|0|||
27687364|NCT04602221|80690555|FG004|Overall Study|Discontinuation of trial treatment|0|||
27687365|NCT04602221|80690556|FG005|Overall Study|Discontinuation of trial treatment|0|||
27687366|NCT04602221|80690557|FG006|Overall Study|Discontinuation of trial treatment|0|||
27687367|NCT04602221|80690558|FG007|Overall Study|Discontinuation of trial treatment|0|||
27687368|NCT04602221|80690559|FG008|Overall Study|Discontinuation of trial treatment|0|||
27687369|NCT04602221|80690560|FG009|Overall Study|Discontinuation of trial treatment|0|||
27687370|NCT04602221|80690561|FG010|Overall Study|Discontinuation of trial treatment|0|||
27687371|NCT04602221|80690562|FG011|Overall Study|Discontinuation of trial treatment|0|||
27687372|NCT04602221|80690563|FG012|Overall Study|Discontinuation of trial treatment|0|||
27687373|NCT04602221|80690564|FG013|Overall Study|Discontinuation of trial treatment|0|||
27687374|NCT04602221|80690565|FG014|Overall Study|Discontinuation of trial treatment|0|||
27812887|NCT02668302|81143804|FG001|Overall Study|Withdrawal by Subject|0|||
27812888|NCT02649231|81143805|FG000|Overall Study|Adverse Event|0|||
27812889|NCT02649231|81143806|FG001|Overall Study|Adverse Event|0|||
27812890|NCT02649231|81143807|FG002|Overall Study|Adverse Event|0|||
27812891|NCT02649231|81143808|FG003|Overall Study|Adverse Event|1|||
27812892|NCT02649231|81143805|FG000|Overall Study|Lost to Follow-up|2|||
27812893|NCT02649231|81143806|FG001|Overall Study|Lost to Follow-up|1|||
27812894|NCT02649231|81143807|FG002|Overall Study|Lost to Follow-up|1|||
27812895|NCT02649231|81143808|FG003|Overall Study|Lost to Follow-up|0|||
27812896|NCT02649231|81143805|FG000|Overall Study|Withdrawal by Subject|0|||
27875850|NCT01037218|81379603|FG000|Overall Study|Withdrawal by Subject|6|||
27875851|NCT01037218|81379604|FG001|Overall Study|Withdrawal by Subject|7|||
27875852|NCT01037218|81379605|FG002|Overall Study|Withdrawal by Subject|7|||
27875853|NCT01037218|81379606|FG003|Overall Study|Withdrawal by Subject|4|||
27812897|NCT02649231|81143806|FG001|Overall Study|Withdrawal by Subject|1|||
27812898|NCT02649231|81143807|FG002|Overall Study|Withdrawal by Subject|0|||
27875854|NCT01037218|81379603|FG000|Overall Study|Partner Withdrew Consent|0|||
27875855|NCT01037218|81379604|FG001|Overall Study|Partner Withdrew Consent|3|||
27875856|NCT01037218|81379605|FG002|Overall Study|Partner Withdrew Consent|2|||
27875857|NCT01037218|81379606|FG003|Overall Study|Partner Withdrew Consent|1|||
27875858|NCT01037218|81379603|FG000|Overall Study|Protocol Violation|0|||
27875859|NCT01037218|81379604|FG001|Overall Study|Protocol Violation|0|||
27875860|NCT01037218|81379605|FG002|Overall Study|Protocol Violation|2|||
27875861|NCT01037218|81379606|FG003|Overall Study|Protocol Violation|2|||
27875862|NCT01037218|81379603|FG000|Overall Study|Various|3|||
27875863|NCT01037218|81379604|FG001|Overall Study|Various|2|||
27875864|NCT01037218|81379605|FG002|Overall Study|Various|3|||
27875865|NCT01037218|81379606|FG003|Overall Study|Various|1|||
27875866|NCT00725283|81379608|FG000|Overall Study|Missing Code|3|||
27875867|NCT00725283|81379608|FG000|Overall Study|Death|5|||
27875868|NCT00725283|81379608|FG000|Overall Study|Other|6|||
27875869|NCT00725283|81379608|FG000|Overall Study|Withdrawal by Subject|10|||
27875870|NCT02069015|81379609|FG000|Overall Study|Lost to Follow-up|39|||
27875871|NCT02069015|81379610|FG001|Overall Study|Lost to Follow-up|32|||
27875872|NCT02069015|81379609|FG000|Overall Study|Withdrawal by Subject|1|||
27875873|NCT02069015|81379610|FG001|Overall Study|Withdrawal by Subject|1|||
27875874|NCT02394600|81379615|FG000|Overall Study|Adverse Event|3|||
27875875|NCT02394600|81379616|FG001|Overall Study|Adverse Event|0|||
27875876|NCT02394600|81379615|FG000|Overall Study|Lost to Follow-up|0|||
27875877|NCT02394600|81379616|FG001|Overall Study|Lost to Follow-up|1|||
27875878|NCT02394600|81379615|FG000|Overall Study|Withdrawal by Subject|0|||
27875879|NCT02394600|81379616|FG001|Overall Study|Withdrawal by Subject|1|||
27875880|NCT02394600|81379615|FG000|Overall Study|Protocol Violation|1|||
27875881|NCT02394600|81379616|FG001|Overall Study|Protocol Violation|0|||
27875882|NCT03472014|81379617|FG000|Overall Study|Lost to Follow-up|4|||
27875883|NCT00840749|81379618|FG000|Overall Study|Death|1|||
27875884|NCT00840749|81379619|FG001|Overall Study|Death|2|||
27875885|NCT00840749|81379618|FG000|Overall Study|not treated on study arm|11|||
27875886|NCT00840749|81379619|FG001|Overall Study|not treated on study arm|11|||
27875887|NCT00840749|81379618|FG000|Overall Study|study closed|19|||
27875888|NCT00840749|81379619|FG001|Overall Study|study closed|14|||
27875889|NCT02832687|81379620|FG000|Overall Study|Adverse Event|0|||
27875890|NCT02832687|81379621|FG001|Overall Study|Adverse Event|2|||
27875891|NCT03534687|81379622|FG000|Overall Study|Lost to Follow-up|7|||
27875892|NCT03534687|81379623|FG001|Overall Study|Lost to Follow-up|2|||
27875893|NCT01812109|81379626|FG000|Overall Study|research personnel delay|16|||
27875894|NCT01812109|81379626|FG000|Overall Study|NIRS Unattainable|17|||
27875895|NCT03170362|81379627|FG000|Overall Study|Death|2|||
27875896|NCT03170362|81379628|FG001|Overall Study|Death|2|||
27875897|NCT03170362|81379627|FG000|Overall Study|Withdrawal by Subject|23|||
27875898|NCT03170362|81379628|FG001|Overall Study|Withdrawal by Subject|22|||
27875899|NCT03170362|81379627|FG000|Overall Study|Lost to Follow-up|187|||
27875900|NCT03170362|81379628|FG001|Overall Study|Lost to Follow-up|167|||
27875901|NCT00365794|81379629|FG000|Overall Study|Withdrawal by Subject|2|||
27875902|NCT05005507|81379632|FG000|Overall Study|Premature termination of study|1|||
27687375|NCT04602221|80690566|FG015|Overall Study|Discontinuation of trial treatment|0|||
27687376|NCT04602221|80690567|FG016|Overall Study|Discontinuation of trial treatment|0|||
27687377|NCT04602221|80690568|FG017|Overall Study|Discontinuation of trial treatment|0|||
27687378|NCT04602221|80690551|FG000|Overall Study|Other than listed|0|||
27687379|NCT04602221|80690552|FG001|Overall Study|Other than listed|0|||
27687380|NCT04602221|80690553|FG002|Overall Study|Other than listed|0|||
27687381|NCT04602221|80690554|FG003|Overall Study|Other than listed|0|||
27687382|NCT04602221|80690555|FG004|Overall Study|Other than listed|0|||
27687383|NCT04602221|80690556|FG005|Overall Study|Other than listed|0|||
27687384|NCT04602221|80690557|FG006|Overall Study|Other than listed|0|||
27687385|NCT04602221|80690558|FG007|Overall Study|Other than listed|0|||
27687386|NCT04602221|80690559|FG008|Overall Study|Other than listed|0|||
27687387|NCT04602221|80690560|FG009|Overall Study|Other than listed|0|||
27687388|NCT04602221|80690561|FG010|Overall Study|Other than listed|0|||
27687389|NCT04602221|80690562|FG011|Overall Study|Other than listed|0|||
27687390|NCT04602221|80690563|FG012|Overall Study|Other than listed|0|||
27687391|NCT04602221|80690564|FG013|Overall Study|Other than listed|0|||
27687392|NCT04602221|80690565|FG014|Overall Study|Other than listed|0|||
27687393|NCT04602221|80690566|FG015|Overall Study|Other than listed|1|||
27687394|NCT04602221|80690567|FG016|Overall Study|Other than listed|0|||
27687395|NCT04602221|80690568|FG017|Overall Study|Other than listed|1|||
27687396|NCT04602221|80690551|FG000|Overall Study|Withdrawal by Subject|0|||
27687397|NCT04602221|80690552|FG001|Overall Study|Withdrawal by Subject|0|||
27875903|NCT00739882|81379635|FG000|Double-blind Period|Adverse Event|1|||
27687398|NCT04602221|80690553|FG002|Overall Study|Withdrawal by Subject|0|||
27687399|NCT04602221|80690554|FG003|Overall Study|Withdrawal by Subject|0|||
27687400|NCT04602221|80690555|FG004|Overall Study|Withdrawal by Subject|0|||
27687401|NCT04602221|80690556|FG005|Overall Study|Withdrawal by Subject|0|||
27687402|NCT04602221|80690557|FG006|Overall Study|Withdrawal by Subject|0|||
27875904|NCT00739882|81379636|FG001|Double-blind Period|Adverse Event|2|||
27875905|NCT00739882|81379635|FG000|Double-blind Period|Protocol Violation|1|||
27875906|NCT00739882|81379636|FG001|Double-blind Period|Protocol Violation|0|||
27875907|NCT00739882|81379635|FG000|Double-blind Period|Lack of Efficacy|1|||
27875908|NCT00739882|81379636|FG001|Double-blind Period|Lack of Efficacy|1|||
27875909|NCT00739882|81379635|FG000|Double-blind Period|Other|16|||
27875910|NCT00739882|81379636|FG001|Double-blind Period|Other|8|||
27875911|NCT00739882|81379635|FG000|Open-label Period|Adverse Event|1|||
27875912|NCT00739882|81379636|FG001|Open-label Period|Adverse Event|0|||
27875913|NCT00739882|81379635|FG000|Open-label Period|Other|9|||
27875914|NCT00739882|81379636|FG001|Open-label Period|Other|5|||
27812899|NCT02649231|81143808|FG003|Overall Study|Withdrawal by Subject|1|||
27812900|NCT02649231|81143805|FG000|Overall Study|Protocol Violation|2|||
27812901|NCT02649231|81143806|FG001|Overall Study|Protocol Violation|1|||
27812902|NCT02649231|81143807|FG002|Overall Study|Protocol Violation|1|||
27812903|NCT02649231|81143808|FG003|Overall Study|Protocol Violation|0|||
27812904|NCT01215942|81146667|FG000|Treatment Period|Adverse Event|15|||
27812905|NCT01215942|81146668|FG001|Treatment Period|Adverse Event|26|||
27812906|NCT01215942|81146667|FG000|Treatment Period|Death|2|||
27812907|NCT01215942|81146668|FG001|Treatment Period|Death|4|||
27812908|NCT01215942|81146667|FG000|Treatment Period|Lack of Efficacy|23|||
27812909|NCT01215942|81146668|FG001|Treatment Period|Lack of Efficacy|62|||
27812910|NCT01215942|81146667|FG000|Treatment Period|Lost to Follow-up|3|||
27812911|NCT01215942|81146668|FG001|Treatment Period|Lost to Follow-up|4|||
27812912|NCT01215942|81146667|FG000|Treatment Period|Withdrawal by Subject|17|||
27812913|NCT01215942|81146668|FG001|Treatment Period|Withdrawal by Subject|40|||
27812914|NCT01215942|81146667|FG000|Treatment Period|Physician Decision|5|||
27812915|NCT01215942|81146668|FG001|Treatment Period|Physician Decision|5|||
27812916|NCT01215942|81146667|FG000|Treatment Period|Protocol Violation|0|||
27812917|NCT01215942|81146668|FG001|Treatment Period|Protocol Violation|1|||
27812918|NCT01215942|81146667|FG000|Treatment Period|Sponsor Decision|349|||
27812919|NCT01215942|81146668|FG001|Treatment Period|Sponsor Decision|530|||
27812920|NCT01215942|81146667|FG000|Post-Treatment Follow-Up Period|Death|0|||
27812921|NCT01215942|81146668|FG001|Post-Treatment Follow-Up Period|Death|1|||
27812922|NCT01215942|81146667|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
27875915|NCT05377749|81379640|FG000|3 Weeks|Lost to Follow-up|2|||
27875916|NCT05377749|81379641|FG001|3 Weeks|Lost to Follow-up|4|||
27875917|NCT05377749|81379640|FG000|3 Weeks|Withdrawal by Subject|1|||
27875918|NCT05377749|81379641|FG001|3 Weeks|Withdrawal by Subject|1|||
27875919|NCT02462603|81379642|FG000|Overall Study|Investigator Decision|1|||
27875920|NCT02462603|81379642|FG000|Overall Study|Non-Compliance|1|||
27875921|NCT02462603|81379642|FG000|Overall Study|Withdrawal by Subject|2|||
27875922|NCT02157935|81379651|FG000|Overall Study|Withdrawal by Subject|25|||
27812923|NCT01215942|81146668|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
27812924|NCT01215942|81146667|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
27812925|NCT01215942|81146668|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
27812926|NCT01215942|81146667|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
27812927|NCT01215942|81146668|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
27812928|NCT01215942|81146667|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
27875923|NCT02157935|81379652|FG001|Overall Study|Withdrawal by Subject|39|||
27875924|NCT02157935|81379651|FG000|Overall Study|Screen failure|1|||
27812929|NCT01215942|81146668|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
27812930|NCT02672553|81146671|FG000|Overall Study|Death|3|||
27812931|NCT02672553|81146672|FG001|Overall Study|Death|5|||
27812932|NCT02672553|81146671|FG000|Overall Study|Valve Explant|1|||
27812933|NCT02672553|81146672|FG001|Overall Study|Valve Explant|0|||
27812934|NCT02672553|81146671|FG000|Overall Study|Conversion to Commercial Valve|3|||
27812935|NCT02672553|81146672|FG001|Overall Study|Conversion to Commercial Valve|0|||
27812936|NCT02672553|81146671|FG000|Overall Study|Withdrawal by Subject|3|||
27812937|NCT02672553|81146672|FG001|Overall Study|Withdrawal by Subject|3|||
27812938|NCT02672553|81146671|FG000|Overall Study|Intraoperative screen failure|2|||
27812939|NCT02672553|81146672|FG001|Overall Study|Intraoperative screen failure|0|||
27812940|NCT01432171|81146677|FG000|Overall Study|Death|1|||
27812941|NCT01432171|81146678|FG001|Overall Study|Death|2|||
27812942|NCT01432171|81146677|FG000|Overall Study|Lost to Follow-up|6|||
27812943|NCT01432171|81146678|FG001|Overall Study|Lost to Follow-up|5|||
27812944|NCT01432171|81146677|FG000|Overall Study|Withdrawal by Subject|3|||
27812945|NCT01432171|81146678|FG001|Overall Study|Withdrawal by Subject|1|||
27812946|NCT01432171|81146677|FG000|Overall Study|Noncompliance|2|||
27812947|NCT01432171|81146678|FG001|Overall Study|Noncompliance|3|||
27875925|NCT02157935|81379652|FG001|Overall Study|Screen failure|2|||
27875926|NCT02157935|81379651|FG000|Overall Study|Protocol Violation|1|||
27875927|NCT02157935|81379652|FG001|Overall Study|Protocol Violation|0|||
27875928|NCT02157935|81379651|FG000|Overall Study|Progressive disease|0|||
27875929|NCT02157935|81379652|FG001|Overall Study|Progressive disease|2|||
27875930|NCT02157935|81379651|FG000|Overall Study|Other|5|||
27875931|NCT02157935|81379652|FG001|Overall Study|Other|12|||
27875932|NCT02157935|81379651|FG000|Overall Study|Lack of Efficacy|0|||
27875933|NCT02157935|81379652|FG001|Overall Study|Lack of Efficacy|1|||
27875934|NCT02157935|81379651|FG000|Overall Study|Death|4|||
27875935|NCT02157935|81379652|FG001|Overall Study|Death|4|||
27875936|NCT02157935|81379651|FG000|Overall Study|Adverse Event|3|||
27875937|NCT02157935|81379652|FG001|Overall Study|Adverse Event|5|||
27875938|NCT02515331|81379653|FG000|Overall Study|Withdrawal by Subject|0|||
27875939|NCT02515331|81379654|FG001|Overall Study|Withdrawal by Subject|0|||
27875940|NCT02515331|81379655|FG002|Overall Study|Withdrawal by Subject|1|||
27875941|NCT02515331|81379653|FG000|Overall Study|Protocol deviation|0|||
27875942|NCT02515331|81379654|FG001|Overall Study|Protocol deviation|0|||
27875943|NCT02515331|81379655|FG002|Overall Study|Protocol deviation|3|||
27875944|NCT02515331|81379653|FG000|Overall Study|Adverse Event|2|||
27875945|NCT02515331|81379654|FG001|Overall Study|Adverse Event|0|||
27875946|NCT02515331|81379655|FG002|Overall Study|Adverse Event|0|||
27875947|NCT00350207|81379656|FG000|Overall Study|Adverse Event|5|||
27875948|NCT00350207|81379657|FG001|Overall Study|Adverse Event|2|||
27875949|NCT00350207|81379658|FG002|Overall Study|Adverse Event|2|||
27875950|NCT00350207|81379656|FG000|Overall Study|Lack of Efficacy|1|||
27875951|NCT00350207|81379657|FG001|Overall Study|Lack of Efficacy|0|||
27875952|NCT00350207|81379658|FG002|Overall Study|Lack of Efficacy|2|||
27875953|NCT00350207|81379656|FG000|Overall Study|Lost to Follow-up|1|||
27875954|NCT00350207|81379657|FG001|Overall Study|Lost to Follow-up|0|||
27875955|NCT00350207|81379658|FG002|Overall Study|Lost to Follow-up|1|||
27875956|NCT00350207|81379656|FG000|Overall Study|Withdrawal by Subject|0|||
27875957|NCT00350207|81379657|FG001|Overall Study|Withdrawal by Subject|1|||
27875958|NCT00350207|81379658|FG002|Overall Study|Withdrawal by Subject|1|||
27875959|NCT00350207|81379656|FG000|Overall Study|Other|1|||
27875960|NCT00350207|81379657|FG001|Overall Study|Other|3|||
27875961|NCT00350207|81379658|FG002|Overall Study|Other|1|||
27875962|NCT03922321|81379659|FG000|Overall Study|Participant Moved|1|||
27875963|NCT03922321|81379659|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
27875964|NCT01890122|81379692|FG000|Overall Study|Adverse Event|1|||
27875965|NCT01890122|81379693|FG001|Overall Study|Adverse Event|1|||
27875966|NCT01890122|81379694|FG002|Overall Study|Adverse Event|1|||
27812948|NCT01432171|81146677|FG000|Overall Study|Insurance denial trial coverage|1|||
27812949|NCT01432171|81146678|FG001|Overall Study|Insurance denial trial coverage|0|||
27812950|NCT01432171|81146677|FG000|Overall Study|Patient moved to palliative care|1|||
27812951|NCT01432171|81146678|FG001|Overall Study|Patient moved to palliative care|0|||
27875967|NCT01890122|81379695|FG003|Overall Study|Adverse Event|2|||
27875968|NCT01890122|81379692|FG000|Overall Study|Major Protocol Deviation|3|||
27875969|NCT01890122|81379693|FG001|Overall Study|Major Protocol Deviation|1|||
27875970|NCT01890122|81379694|FG002|Overall Study|Major Protocol Deviation|0|||
27812952|NCT03937466|81146679|FG000|Overall Study|not eligbile after the 2-week diary|9|||
27812953|NCT03937466|81146679|FG000|Overall Study|never returned their diary|6|||
27812954|NCT03937466|81146679|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
27875971|NCT01890122|81379695|FG003|Overall Study|Major Protocol Deviation|1|||
27875972|NCT01890122|81379692|FG000|Overall Study|Lost to Follow-up|0|||
27875973|NCT01890122|81379693|FG001|Overall Study|Lost to Follow-up|1|||
27875974|NCT01890122|81379694|FG002|Overall Study|Lost to Follow-up|2|||
27875975|NCT01890122|81379695|FG003|Overall Study|Lost to Follow-up|2|||
27875976|NCT01890122|81379692|FG000|Overall Study|Voluntary Withdrawal|8|||
27875977|NCT01890122|81379693|FG001|Overall Study|Voluntary Withdrawal|8|||
27587879|NCT01410448|80331885|FG000|Overall Study|Lost to Follow-up|1|||
27587880|NCT01410448|80331886|FG001|Overall Study|Lost to Follow-up|0|||
27587881|NCT01410448|80331885|FG000|Overall Study|Withdrawal by Subject|3|||
27587882|NCT01410448|80331886|FG001|Overall Study|Withdrawal by Subject|2|||
27587883|NCT01410448|80331885|FG000|Overall Study|Protocol Violation|0|||
27587884|NCT01410448|80331886|FG001|Overall Study|Protocol Violation|4|||
27587885|NCT01410448|80331885|FG000|Overall Study|Death|2|||
27587886|NCT01410448|80331886|FG001|Overall Study|Death|3|||
27587887|NCT04304833|80331889|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
27587888|NCT04304833|80331890|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
27587889|NCT02621606|80331892|FG000|Overall Study|Withdrawal by Subject|0|||
27587890|NCT02621606|80331893|FG001|Overall Study|Withdrawal by Subject|1|||
27587891|NCT02621606|80331894|FG002|Overall Study|Withdrawal by Subject|0|||
27587892|NCT01730937|80331895|FG000|Overall Study|Protocol Violation|5|||
27587893|NCT01730937|80331896|FG001|Overall Study|Protocol Violation|11|||
27587894|NCT01669122|80331897|FG000|Period I|Lost to Follow-up|1|||
27587895|NCT01669122|80331897|FG000|Washout Period II|Protocol Violation|2|||
27587896|NCT04307186|80331898|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
27587897|NCT04307186|80331898|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
27587898|NCT04307186|80331898|FG000|Washout 3-14 Days|Progressive disease|1|||
27587899|NCT04307186|80331898|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
27587900|NCT04307186|80331898|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
27587901|NCT01248884|80331899|FG000|Overall Study|Withdrawal by Subject|1|||
27587902|NCT01248884|80331900|FG001|Overall Study|Withdrawal by Subject|3|||
27587903|NCT01248884|80331901|FG002|Overall Study|Withdrawal by Subject|1|||
27587904|NCT01248884|80331899|FG000|Overall Study|Adverse Event|1|||
27587905|NCT01248884|80331900|FG001|Overall Study|Adverse Event|0|||
27587906|NCT01248884|80331901|FG002|Overall Study|Adverse Event|0|||
27587907|NCT00936858|80331902|FG000|Overall Study|Death|3|||
27587908|NCT00936858|80331902|FG000|Overall Study|Progression|29|||
27587909|NCT00936858|80331902|FG000|Overall Study|Withdrawal by Subject|5|||
27587910|NCT00936858|80331902|FG000|Overall Study|Adverse Event|1|||
27587911|NCT00936858|80331902|FG000|Overall Study|Physician Decision|7|||
27587912|NCT00936858|80331902|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
27587913|NCT00936858|80331902|FG000|Overall Study|Lost to Follow-up|1|||
27587914|NCT00305058|80331903|FG000|Overall Study|Participant too young|1|||
27587915|NCT00305058|80331904|FG001|Overall Study|Participant too young|0|||
27587916|NCT00305058|80331903|FG000|Overall Study|Missing data collection instrument|3|||
27587917|NCT00305058|80331904|FG001|Overall Study|Missing data collection instrument|2|||
27587918|NCT00305058|80331903|FG000|Overall Study|Missing outcome data|3|||
27587919|NCT00305058|80331904|FG001|Overall Study|Missing outcome data|2|||
27587920|NCT01965834|80331905|FG000|Overall Study|Lack of Efficacy|4|||
27587921|NCT00448539|80331906|FG000|Overall Study|Medication non-compliance|4|||
27587922|NCT00448539|80331907|FG001|Overall Study|Medication non-compliance|1|||
27587923|NCT00448539|80331906|FG000|Overall Study|Protocol Violation|1|||
27587924|NCT00448539|80331907|FG001|Overall Study|Protocol Violation|0|||
27587925|NCT00448539|80331906|FG000|Overall Study|Request of the investigator or sponsor|67|||
27587926|NCT00448539|80331907|FG001|Overall Study|Request of the investigator or sponsor|54|||
27587927|NCT00448539|80331906|FG000|Overall Study|Withdrawal by Subject|20|||
27587928|NCT00448539|80331907|FG001|Overall Study|Withdrawal by Subject|24|||
27587929|NCT00448539|80331906|FG000|Overall Study|Diary non-compliance|1|||
27587930|NCT00448539|80331907|FG001|Overall Study|Diary non-compliance|0|||
27587931|NCT00448539|80331906|FG000|Overall Study|Adverse Event|9|||
27587932|NCT00448539|80331907|FG001|Overall Study|Adverse Event|26|||
27587933|NCT00448539|80331906|FG000|Overall Study|Lack of Efficacy|27|||
27587934|NCT00448539|80331907|FG001|Overall Study|Lack of Efficacy|40|||
27587935|NCT00448539|80331906|FG000|Overall Study|Miscellaneous|2|||
27587936|NCT00448539|80331907|FG001|Overall Study|Miscellaneous|1|||
27587937|NCT00448539|80331906|FG000|Overall Study|Change of meds|2|||
27587938|NCT00448539|80331907|FG001|Overall Study|Change of meds|3|||
27587939|NCT00448539|80331906|FG000|Overall Study|Lost to Follow-up|1|||
27587940|NCT00448539|80331907|FG001|Overall Study|Lost to Follow-up|3|||
27587941|NCT00941603|80331912|FG000|Overall Study|Adverse Event|10|||
27587942|NCT00941603|80331913|FG001|Overall Study|Adverse Event|15|||
27587943|NCT00941603|80331914|FG002|Overall Study|Adverse Event|5|||
27587944|NCT00941603|80331915|FG003|Overall Study|Adverse Event|1|||
27587945|NCT00941603|80331916|FG004|Overall Study|Adverse Event|4|||
27587946|NCT00941603|80331917|FG005|Overall Study|Adverse Event|0|||
27587947|NCT00941603|80331912|FG000|Overall Study|Lost to Follow-up|0|||
27587948|NCT00941603|80331913|FG001|Overall Study|Lost to Follow-up|0|||
27587949|NCT00941603|80331914|FG002|Overall Study|Lost to Follow-up|0|||
27587950|NCT00941603|80331915|FG003|Overall Study|Lost to Follow-up|1|||
27587951|NCT00941603|80331916|FG004|Overall Study|Lost to Follow-up|0|||
27587952|NCT00941603|80331917|FG005|Overall Study|Lost to Follow-up|2|||
27587953|NCT00941603|80331912|FG000|Overall Study|Withdrawal by Subject|0|||
27587954|NCT00941603|80331913|FG001|Overall Study|Withdrawal by Subject|0|||
27587955|NCT00941603|80331914|FG002|Overall Study|Withdrawal by Subject|0|||
27587956|NCT00941603|80331915|FG003|Overall Study|Withdrawal by Subject|2|||
27587957|NCT00941603|80331916|FG004|Overall Study|Withdrawal by Subject|0|||
27587958|NCT00941603|80331917|FG005|Overall Study|Withdrawal by Subject|1|||
27587959|NCT00941603|80331912|FG000|Overall Study|Protocol Violation|0|||
27587960|NCT00941603|80331913|FG001|Overall Study|Protocol Violation|1|||
27687403|NCT04602221|80690558|FG007|Overall Study|Withdrawal by Subject|0|||
27687404|NCT04602221|80690559|FG008|Overall Study|Withdrawal by Subject|0|||
27687405|NCT04602221|80690560|FG009|Overall Study|Withdrawal by Subject|0|||
27687406|NCT04602221|80690561|FG010|Overall Study|Withdrawal by Subject|0|||
27687407|NCT04602221|80690562|FG011|Overall Study|Withdrawal by Subject|0|||
27687408|NCT04602221|80690563|FG012|Overall Study|Withdrawal by Subject|1|||
27687409|NCT04602221|80690564|FG013|Overall Study|Withdrawal by Subject|0|||
27687410|NCT04602221|80690565|FG014|Overall Study|Withdrawal by Subject|0|||
27687411|NCT04602221|80690566|FG015|Overall Study|Withdrawal by Subject|0|||
27687412|NCT04602221|80690567|FG016|Overall Study|Withdrawal by Subject|0|||
27687413|NCT04602221|80690568|FG017|Overall Study|Withdrawal by Subject|0|||
27687414|NCT04602221|80690551|FG000|Overall Study|Lost to Follow-up|0|||
27687415|NCT04602221|80690552|FG001|Overall Study|Lost to Follow-up|0|||
27687416|NCT04602221|80690553|FG002|Overall Study|Lost to Follow-up|0|||
27687417|NCT04602221|80690554|FG003|Overall Study|Lost to Follow-up|0|||
27687418|NCT04602221|80690555|FG004|Overall Study|Lost to Follow-up|0|||
27687419|NCT04602221|80690556|FG005|Overall Study|Lost to Follow-up|1|||
27687420|NCT04602221|80690557|FG006|Overall Study|Lost to Follow-up|0|||
27687421|NCT04602221|80690558|FG007|Overall Study|Lost to Follow-up|0|||
27687422|NCT04602221|80690559|FG008|Overall Study|Lost to Follow-up|0|||
27687423|NCT04602221|80690560|FG009|Overall Study|Lost to Follow-up|0|||
27687424|NCT04602221|80690561|FG010|Overall Study|Lost to Follow-up|0|||
27687425|NCT04602221|80690562|FG011|Overall Study|Lost to Follow-up|0|||
27687426|NCT04602221|80690563|FG012|Overall Study|Lost to Follow-up|0|||
27687427|NCT04602221|80690564|FG013|Overall Study|Lost to Follow-up|0|||
27687428|NCT04602221|80690565|FG014|Overall Study|Lost to Follow-up|0|||
27687429|NCT04602221|80690566|FG015|Overall Study|Lost to Follow-up|0|||
27687430|NCT04602221|80690567|FG016|Overall Study|Lost to Follow-up|0|||
27687431|NCT04602221|80690568|FG017|Overall Study|Lost to Follow-up|0|||
27687432|NCT02914275|80690569|FG000|Overall Study|Lost to Follow-up|84|||
27687433|NCT02914275|80690570|FG001|Overall Study|Lost to Follow-up|29|||
27687434|NCT02914275|80690569|FG000|Overall Study|Withdrawal by Subject|26|||
27687435|NCT02914275|80690570|FG001|Overall Study|Withdrawal by Subject|10|||
27687436|NCT02914275|80690569|FG000|Overall Study|Protocol Violation|1|||
27687437|NCT02914275|80690570|FG001|Overall Study|Protocol Violation|1|||
27687438|NCT02914275|80690569|FG000|Overall Study|Physician Decision|3|||
27687439|NCT02914275|80690570|FG001|Overall Study|Physician Decision|1|||
27687440|NCT02914275|80690569|FG000|Overall Study|Other|4|||
27687441|NCT02914275|80690570|FG001|Overall Study|Other|1|||
27687442|NCT02914275|80690569|FG000|Overall Study|Excluded due to invalid informed consent|3|||
27687443|NCT02914275|80690570|FG001|Overall Study|Excluded due to invalid informed consent|0|||
27687444|NCT02424734|80690573|FG000|Overall Study|Treatment stopped to be discharged home|2|||
27687445|NCT02424734|80690574|FG001|Overall Study|Treatment stopped to be discharged home|2|||
27687446|NCT02424734|80690575|FG002|Overall Study|Treatment stopped to be discharged home|0|||
27812955|NCT03937466|81146679|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
27812956|NCT04120194|81146680|FG000|Overall Study|Lost to Follow-up|11|||
27687447|NCT01021215|80690581|FG000|Overall Study|Lost to Follow-up|3|||
27687448|NCT01021215|80690582|FG001|Overall Study|Lost to Follow-up|0|||
27687449|NCT02751320|80690583|FG000|Overall Study|Adverse Event|2|||
27687450|NCT02751320|80690583|FG000|Overall Study|Withdrawal by Subject|1|||
27687451|NCT01993927|80690584|FG000|Overall Study|Case Report Forms Uncollected|18|||
27687452|NCT01993927|80690584|FG000|Overall Study|Protocol Violation|11|||
27687453|NCT02121301|80690585|FG000|Overall Study|Protocol Violation|1|||
27687454|NCT02121301|80690586|FG001|Overall Study|Protocol Violation|4|||
27687455|NCT02121301|80690587|FG002|Overall Study|Protocol Violation|1|||
27812957|NCT04120194|81146681|FG001|Overall Study|Lost to Follow-up|8|||
27812958|NCT04120194|81146680|FG000|Overall Study|Adverse Event|4|||
27812959|NCT04120194|81146681|FG001|Overall Study|Adverse Event|5|||
27587961|NCT00941603|80331914|FG002|Overall Study|Protocol Violation|0|||
27587962|NCT00941603|80331915|FG003|Overall Study|Protocol Violation|0|||
27687456|NCT02523599|80690588|FG000|Overall Study|Adverse Event|1|||
27687457|NCT02523599|80690589|FG001|Overall Study|Adverse Event|0|||
27687458|NCT02523599|80690588|FG000|Overall Study|Physician Decision|1|||
27687459|NCT02523599|80690589|FG001|Overall Study|Physician Decision|0|||
27687460|NCT02523599|80690588|FG000|Overall Study|Lost to Follow-up|4|||
27687461|NCT02523599|80690589|FG001|Overall Study|Lost to Follow-up|1|||
27687462|NCT02523599|80690588|FG000|Overall Study|Did not return for Day 30 visit|2|||
27687463|NCT02523599|80690589|FG001|Overall Study|Did not return for Day 30 visit|0|||
27875978|NCT01890122|81379694|FG002|Overall Study|Voluntary Withdrawal|2|||
27875979|NCT01890122|81379695|FG003|Overall Study|Voluntary Withdrawal|11|||
27875980|NCT01890122|81379692|FG000|Overall Study|Lack of Efficacy|14|||
27587963|NCT00941603|80331916|FG004|Overall Study|Protocol Violation|0|||
27587964|NCT00941603|80331917|FG005|Overall Study|Protocol Violation|0|||
27587965|NCT00941603|80331912|FG000|Overall Study|Did not meet protocol eligibility|1|||
27587966|NCT00941603|80331913|FG001|Overall Study|Did not meet protocol eligibility|0|||
27587967|NCT00941603|80331914|FG002|Overall Study|Did not meet protocol eligibility|0|||
27587968|NCT00941603|80331915|FG003|Overall Study|Did not meet protocol eligibility|0|||
27587969|NCT00941603|80331916|FG004|Overall Study|Did not meet protocol eligibility|0|||
27587970|NCT00941603|80331917|FG005|Overall Study|Did not meet protocol eligibility|0|||
27587971|NCT02807948|80331925|FG000|Overall Study|Physician Decision|1|||
27587972|NCT02807948|80331926|FG001|Overall Study|Physician Decision|0|||
27587973|NCT02777593|80335463|FG000|Overall Study|Still in study|28|||
27875981|NCT01890122|81379693|FG001|Overall Study|Lack of Efficacy|24|||
27587974|NCT02777593|80335464|FG001|Overall Study|Still in study|71|||
27587975|NCT02777593|80335465|FG002|Overall Study|Still in study|5|||
27875982|NCT01890122|81379694|FG002|Overall Study|Lack of Efficacy|7|||
27587976|NCT02777593|80335466|FG003|Overall Study|Still in study|6|||
27587977|NCT02777593|80335467|FG004|Overall Study|Still in study|6|||
27587978|NCT02777593|80335463|FG000|Overall Study|Death|19|||
27587979|NCT02777593|80335464|FG001|Overall Study|Death|24|||
27587980|NCT02777593|80335465|FG002|Overall Study|Death|0|||
27587981|NCT02777593|80335466|FG003|Overall Study|Death|5|||
27587982|NCT02777593|80335467|FG004|Overall Study|Death|0|||
27587983|NCT02777593|80335463|FG000|Overall Study|Withdrawal by Subject|6|||
27587984|NCT02777593|80335464|FG001|Overall Study|Withdrawal by Subject|3|||
27587985|NCT02777593|80335465|FG002|Overall Study|Withdrawal by Subject|1|||
27587986|NCT02777593|80335466|FG003|Overall Study|Withdrawal by Subject|1|||
27587987|NCT02777593|80335467|FG004|Overall Study|Withdrawal by Subject|0|||
27587988|NCT02777593|80335463|FG000|Overall Study|Lost to Follow-up|4|||
27587989|NCT02777593|80335464|FG001|Overall Study|Lost to Follow-up|12|||
27587990|NCT02777593|80335465|FG002|Overall Study|Lost to Follow-up|4|||
27587991|NCT02777593|80335466|FG003|Overall Study|Lost to Follow-up|0|||
27587992|NCT02777593|80335467|FG004|Overall Study|Lost to Follow-up|0|||
27587993|NCT02777593|80335463|FG000|Overall Study|Physician Decision|2|||
27587994|NCT02777593|80335464|FG001|Overall Study|Physician Decision|2|||
27587995|NCT02777593|80335465|FG002|Overall Study|Physician Decision|0|||
27587996|NCT02777593|80335466|FG003|Overall Study|Physician Decision|0|||
27587997|NCT02777593|80335467|FG004|Overall Study|Physician Decision|0|||
27587998|NCT02777593|80335463|FG000|Overall Study|Discontinued due to Other|3|||
27587999|NCT02777593|80335464|FG001|Overall Study|Discontinued due to Other|0|||
27588000|NCT02777593|80335465|FG002|Overall Study|Discontinued due to Other|0|||
27687464|NCT05559476|80690590|FG000|Overall Study|Adverse Event|2|||
27687465|NCT05559476|80690591|FG001|Overall Study|Adverse Event|0|||
27875983|NCT01890122|81379695|FG003|Overall Study|Lack of Efficacy|41|||
27875984|NCT01890122|81379692|FG000|Overall Study|Reason not Specified|0|||
27875985|NCT01890122|81379693|FG001|Overall Study|Reason not Specified|1|||
27875986|NCT01890122|81379694|FG002|Overall Study|Reason not Specified|1|||
27875987|NCT01890122|81379695|FG003|Overall Study|Reason not Specified|2|||
27875988|NCT01890122|81379692|FG000|Overall Study|Randomized but not Treated|1|||
27875989|NCT01890122|81379693|FG001|Overall Study|Randomized but not Treated|1|||
27875990|NCT01890122|81379694|FG002|Overall Study|Randomized but not Treated|0|||
27588001|NCT02777593|80335466|FG003|Overall Study|Discontinued due to Other|0|||
27875991|NCT01890122|81379695|FG003|Overall Study|Randomized but not Treated|0|||
27875992|NCT03655405|81379696|FG000|Overall Study|Death after initial data collection|4|||
27588002|NCT02777593|80335467|FG004|Overall Study|Discontinued due to Other|0|||
27588003|NCT03434119|80335469|FG000|Overall Study|Randomized but not treated|1|||
27588004|NCT03434119|80335470|FG001|Overall Study|Randomized but not treated|0|||
27588005|NCT03434119|80335469|FG000|Overall Study|Adverse Event|1|||
27588006|NCT03434119|80335470|FG001|Overall Study|Adverse Event|0|||
27687466|NCT05559476|80690590|FG000|Overall Study|Lost to Follow-up|13|||
27687467|NCT05559476|80690591|FG001|Overall Study|Lost to Follow-up|12|||
27687468|NCT05559476|80690590|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
27687469|NCT05559476|80690591|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
27687470|NCT05559476|80690590|FG000|Overall Study|Other|0|||
27687471|NCT05559476|80690591|FG001|Overall Study|Other|2|||
27687472|NCT02516332|80690592|FG000|Overall Study|Withdrawal by Subject|2|||
27687473|NCT02516332|80690593|FG001|Overall Study|Withdrawal by Subject|1|||
27687474|NCT02516332|80690594|FG002|Overall Study|Withdrawal by Subject|2|||
27687475|NCT00151281|80690595|FG000|Overall Study|Not evaluable|3|||
27687476|NCT03218397|80690598|FG000|Overall Study|Prior positive blood culture|8|||
27687477|NCT03218397|80690599|FG001|Overall Study|Prior positive blood culture|13|||
27687478|NCT03218397|80690598|FG000|Overall Study|Comfort care|8|||
27687479|NCT03218397|80690599|FG001|Overall Study|Comfort care|5|||
27687480|NCT03218397|80690598|FG000|Overall Study|Comfort care and positive blood culture|1|||
27687481|NCT03218397|80690599|FG001|Overall Study|Comfort care and positive blood culture|0|||
27687482|NCT03218397|80690598|FG000|Overall Study|Comfort care and mixed culture|0|||
27687483|NCT03218397|80690599|FG001|Overall Study|Comfort care and mixed culture|1|||
27687484|NCT03218397|80690598|FG000|Overall Study|Mixed culture|2|||
27687485|NCT03218397|80690599|FG001|Overall Study|Mixed culture|2|||
27687486|NCT03218397|80690598|FG000|Overall Study|Inaccessible hospital records|2|||
27687487|NCT03218397|80690599|FG001|Overall Study|Inaccessible hospital records|5|||
27687488|NCT03218397|80690598|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
27687489|NCT03218397|80690599|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
27687490|NCT03218397|80690598|FG000|Overall Study|Randomized during laboratory off hours|2|||
27687491|NCT03218397|80690599|FG001|Overall Study|Randomized during laboratory off hours|1|||
27687492|NCT00618618|80690600|FG000|Overall Study|Patient Request|0|||
27687493|NCT00618618|80690601|FG001|Overall Study|Patient Request|0|||
27687494|NCT00618618|80690602|FG002|Overall Study|Patient Request|2|||
27687495|NCT00618618|80690603|FG003|Overall Study|Patient Request|0|||
27687496|NCT00618618|80690600|FG000|Overall Study|Inability to Complete Study Procedures|0|||
27687497|NCT00618618|80690601|FG001|Overall Study|Inability to Complete Study Procedures|1|||
27687498|NCT00618618|80690602|FG002|Overall Study|Inability to Complete Study Procedures|0|||
27687499|NCT00618618|80690603|FG003|Overall Study|Inability to Complete Study Procedures|0|||
27687500|NCT00618618|80690600|FG000|Overall Study|Lost to Follow-up|3|||
27687501|NCT00618618|80690601|FG001|Overall Study|Lost to Follow-up|0|||
27687502|NCT00618618|80690602|FG002|Overall Study|Lost to Follow-up|0|||
27687503|NCT00618618|80690603|FG003|Overall Study|Lost to Follow-up|1|||
27687504|NCT00618618|80690600|FG000|Overall Study|Non-compliance|1|||
27687505|NCT00618618|80690601|FG001|Overall Study|Non-compliance|1|||
27687506|NCT00618618|80690602|FG002|Overall Study|Non-compliance|0|||
27687507|NCT00618618|80690603|FG003|Overall Study|Non-compliance|0|||
27687508|NCT00618618|80690600|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
27687509|NCT00618618|80690601|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
27687510|NCT00618618|80690602|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
27687511|NCT00618618|80690603|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
27687512|NCT00618618|80690600|FG000|Overall Study|Death|0|||
27687513|NCT00618618|80690601|FG001|Overall Study|Death|1|||
27687514|NCT00618618|80690602|FG002|Overall Study|Death|0|||
27687515|NCT00618618|80690603|FG003|Overall Study|Death|0|||
27687516|NCT01621568|80690604|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
27687517|NCT01621568|80690605|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
27875993|NCT03655405|81379697|FG001|Overall Study|Death after initial data collection|2|||
27875994|NCT03655405|81379696|FG000|Overall Study|Died before initial data collection|1|||
27875995|NCT03655405|81379697|FG001|Overall Study|Died before initial data collection|2|||
27687518|NCT01621568|80690604|FG000|Week 5-6 No Treatment|Death|1|||
27875996|NCT03655405|81379696|FG000|Overall Study|Protocol Violation|0|||
27588007|NCT03434119|80335469|FG000|Overall Study|Poor Compliance to Protocol|0|||
27588008|NCT03434119|80335470|FG001|Overall Study|Poor Compliance to Protocol|1|||
27588009|NCT03434119|80335469|FG000|Overall Study|Study Terminated by Sponsor|91|||
27588010|NCT03434119|80335470|FG001|Overall Study|Study Terminated by Sponsor|102|||
27588011|NCT03434119|80335469|FG000|Overall Study|Withdrawal by Subject|7|||
27687519|NCT01621568|80690605|FG001|Week 5-6 No Treatment|Death|0|||
27687520|NCT03189745|80690608|FG000|Overall Study|Conflict in work schedule of participant|1|||
27687521|NCT03189745|80690609|FG001|Overall Study|Conflict in work schedule of participant|1|||
27687522|NCT01238900|80690610|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
27687523|NCT01238900|80690610|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
27687524|NCT03282240|80690611|FG000|Overall Study|Adverse Event|2|||
27875997|NCT03655405|81379697|FG001|Overall Study|Protocol Violation|1|||
27875998|NCT02714218|81379699|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27812960|NCT04120194|81146680|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
27812961|NCT04120194|81146681|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
27812962|NCT04120194|81146680|FG000|Overall Study|Miscellaneous|4|||
27812963|NCT04120194|81146681|FG001|Overall Study|Miscellaneous|5|||
27812964|NCT00125359|81146682|FG000|Overall Study|Death|4|||
27812965|NCT00125359|81146682|FG000|Overall Study|Adverse Event|5|||
27812966|NCT00125359|81146682|FG000|Overall Study|Physician Decision|14|||
27812967|NCT00745095|81146683|FG000|Overall Study|Declined to participate|1|||
27812968|NCT00745095|81146684|FG001|Overall Study|Declined to participate|0|||
27812969|NCT00745095|81146685|FG002|Overall Study|Declined to participate|0|||
27812970|NCT00745095|81146686|FG003|Overall Study|Declined to participate|0|||
27812971|NCT00745095|81146687|FG004|Overall Study|Declined to participate|92|||
27812972|NCT00745095|81146688|FG005|Overall Study|Declined to participate|95|||
27812973|NCT00745095|81146683|FG000|Overall Study|Ineligible due to GFR criteria|0|||
27812974|NCT00745095|81146684|FG001|Overall Study|Ineligible due to GFR criteria|2|||
27812975|NCT00745095|81146685|FG002|Overall Study|Ineligible due to GFR criteria|3|||
27812976|NCT00745095|81146686|FG003|Overall Study|Ineligible due to GFR criteria|3|||
27812977|NCT00745095|81146687|FG004|Overall Study|Ineligible due to GFR criteria|30|||
27812978|NCT00745095|81146688|FG005|Overall Study|Ineligible due to GFR criteria|28|||
27812979|NCT03565211|81146691|FG000|Overall Study|Withdrawal by Subject|2|||
27812980|NCT03565211|81146691|FG000|Overall Study|Lost to Follow-up|1|||
27812981|NCT03565211|81146691|FG000|Overall Study|Adverse Event|44|||
27812982|NCT03565211|81146691|FG000|Overall Study|Personal issues|1|||
27812983|NCT02315898|81146694|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
27812984|NCT02315898|81146695|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
27812985|NCT02315898|81146696|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
27812986|NCT02315898|81146697|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
27812987|NCT02192905|81146699|FG000|Overall Study|Lost to Follow-up|1|||
27812988|NCT02660242|81146701|FG000|Glucose Tabs|Lost to Follow-up|1|||
27812989|NCT02660242|81146701|FG000|Glucagon Injection|Lost to Follow-up|1|||
27812990|NCT01475474|81146702|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
27812991|NCT01475474|81146702|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
27812992|NCT02093689|81146703|FG000|Overall Study|Physician Decision|4|||
27812993|NCT02093689|81146704|FG001|Overall Study|Physician Decision|0|||
27812994|NCT02093689|81146705|FG002|Overall Study|Physician Decision|0|||
27812995|NCT02220907|81146708|FG000|Overall Study|Adverse Event|7|||
27812996|NCT02220907|81146708|FG000|Overall Study|Physician Decision|1|||
27812997|NCT02220907|81146708|FG000|Overall Study|Withdrawal by Subject|2|||
27812998|NCT02220907|81146708|FG000|Overall Study|Conflict with the stopping criteria|1|||
27875999|NCT02714218|81379700|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27876000|NCT02714218|81379701|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27876001|NCT02714218|81379699|FG000|Pre-Treatment Period|Other reasons|0|||
27876002|NCT02714218|81379700|FG001|Pre-Treatment Period|Other reasons|1|||
27876003|NCT02714218|81379701|FG002|Pre-Treatment Period|Other reasons|0|||
27876004|NCT02714218|81379699|FG000|Treatment Period|Disease Progression|55|||
27876005|NCT02714218|81379700|FG001|Treatment Period|Disease Progression|52|||
27876006|NCT02714218|81379701|FG002|Treatment Period|Disease Progression|14|||
27876007|NCT02714218|81379699|FG000|Treatment Period|Study drug toxicity|46|||
27812999|NCT00387712|81146711|FG000|Overall Study|Physician Decision|6|||
27813000|NCT00387712|81146712|FG001|Overall Study|Physician Decision|4|||
27813001|NCT00387712|81146711|FG000|Overall Study|Lost to Follow-up|17|||
27813002|NCT00387712|81146712|FG001|Overall Study|Lost to Follow-up|20|||
27813003|NCT00387712|81146711|FG000|Overall Study|Withdrawal by Subject|6|||
27813004|NCT00387712|81146712|FG001|Overall Study|Withdrawal by Subject|12|||
27813005|NCT01341639|81146721|FG000|Infant Series|Protocol Violation|1|||
27813006|NCT01341639|81146722|FG001|Infant Series|Protocol Violation|0|||
27813007|NCT01341639|81146721|FG000|Infant Series|Not Vaccinated|0|||
27813008|NCT01341639|81146722|FG001|Infant Series|Not Vaccinated|1|||
27813009|NCT01341639|81146721|FG000|Infant Series|Adverse Event|0|||
27876008|NCT02714218|81379700|FG001|Treatment Period|Study drug toxicity|70|||
27876009|NCT02714218|81379701|FG002|Treatment Period|Study drug toxicity|6|||
27813010|NCT01341639|81146722|FG001|Infant Series|Adverse Event|5|||
27813011|NCT01341639|81146721|FG000|Infant Series|Withdrawal by Subject|11|||
27876010|NCT02714218|81379699|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
27876011|NCT02714218|81379700|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
27813012|NCT01341639|81146722|FG001|Infant Series|Withdrawal by Subject|8|||
27813013|NCT01341639|81146721|FG000|Infant Series|Lost to Follow-up|0|||
27813014|NCT01341639|81146722|FG001|Infant Series|Lost to Follow-up|2|||
27813015|NCT01341639|81146721|FG000|Infant Series|Site 0048 Participants|17|||
27813016|NCT01341639|81146722|FG001|Infant Series|Site 0048 Participants|16|||
27813017|NCT01341639|81146721|FG000|Interim Period|Withdrawal by Subject|6|||
27813018|NCT01341639|81146722|FG001|Interim Period|Withdrawal by Subject|7|||
27813019|NCT01341639|81146721|FG000|Interim Period|Lost to Follow-up|2|||
27813020|NCT01341639|81146722|FG001|Interim Period|Lost to Follow-up|0|||
27813021|NCT01341639|81146721|FG000|Interim Period|Physician Decision|0|||
27813022|NCT01341639|81146722|FG001|Interim Period|Physician Decision|1|||
27813023|NCT01341639|81146721|FG000|Interim Period|Protocol Violation|0|||
27813024|NCT01341639|81146722|FG001|Interim Period|Protocol Violation|1|||
27813025|NCT01341639|81146721|FG000|Post-Treatment|Withdrawal by Subject|0|||
27813026|NCT01341639|81146722|FG001|Post-Treatment|Withdrawal by Subject|1|||
27813027|NCT01341639|81146721|FG000|Post-Treatment|Adverse Event|0|||
27813028|NCT01341639|81146722|FG001|Post-Treatment|Adverse Event|2|||
27813029|NCT01298570|81146723|FG000|Overall Study|Disease progression, relapse during acti|64|||
27813030|NCT01298570|81146724|FG001|Overall Study|Disease progression, relapse during acti|40|||
27813031|NCT01298570|81146723|FG000|Overall Study|Adverse Event|20|||
27813032|NCT01298570|81146724|FG001|Overall Study|Adverse Event|2|||
27813033|NCT01298570|81146723|FG000|Overall Study|Withdrawal by Subject|21|||
27813034|NCT01298570|81146724|FG001|Overall Study|Withdrawal by Subject|6|||
27813035|NCT01298570|81146723|FG000|Overall Study|Treatment delay > 4 weeks|4|||
27813036|NCT01298570|81146724|FG001|Overall Study|Treatment delay > 4 weeks|5|||
27813037|NCT01298570|81146723|FG000|Overall Study|Physician Decision|4|||
27813038|NCT01298570|81146724|FG001|Overall Study|Physician Decision|2|||
27813039|NCT01298570|81146723|FG000|Overall Study|Other complicating disease|2|||
27813040|NCT01298570|81146724|FG001|Overall Study|Other complicating disease|1|||
27813041|NCT01298570|81146723|FG000|Overall Study|Surgery|2|||
27813042|NCT01298570|81146724|FG001|Overall Study|Surgery|1|||
27813043|NCT01298570|81146723|FG000|Overall Study|Symptomatic progression/deterioration|3|||
27813044|NCT01298570|81146724|FG001|Overall Study|Symptomatic progression/deterioration|2|||
27813045|NCT01298570|81146723|FG000|Overall Study|Death|0|||
27813046|NCT01298570|81146724|FG001|Overall Study|Death|1|||
27813047|NCT01298570|81146723|FG000|Overall Study|Ineligibility|0|||
27813048|NCT01298570|81146724|FG001|Overall Study|Ineligibility|1|||
27813049|NCT00475020|81146725|FG000|Overall Study|Physician Decision|3|||
27813050|NCT00475020|81146725|FG000|Overall Study|Insurance Denial|1|||
27813051|NCT00475020|81146725|FG000|Overall Study|Donor not able to donate the last minute|1|||
27813052|NCT03519256|81146726|FG000|Overall Study|Disease recurrence|4|||
27813053|NCT03519256|81146727|FG001|Overall Study|Disease recurrence|4|||
27813054|NCT03519256|81146728|FG002|Overall Study|Disease recurrence|5|||
27813055|NCT03519256|81146729|FG003|Overall Study|Disease recurrence|2|||
27813056|NCT03519256|81146726|FG000|Overall Study|Study drug toxicity|0|||
27813057|NCT03519256|81146727|FG001|Overall Study|Study drug toxicity|2|||
27813058|NCT03519256|81146728|FG002|Overall Study|Study drug toxicity|5|||
27813059|NCT03519256|81146729|FG003|Overall Study|Study drug toxicity|2|||
27813060|NCT03519256|81146726|FG000|Overall Study|Adverse event unrelated to study drug|0|||
27813061|NCT03519256|81146727|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27876012|NCT02714218|81379701|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
27876013|NCT02714218|81379699|FG000|Treatment Period|Request to discontinue treatment|1|||
27876014|NCT02714218|81379700|FG001|Treatment Period|Request to discontinue treatment|4|||
27876015|NCT02714218|81379701|FG002|Treatment Period|Request to discontinue treatment|1|||
27876016|NCT02714218|81379699|FG000|Treatment Period|Participant withdrew consent|2|||
27876017|NCT02714218|81379700|FG001|Treatment Period|Participant withdrew consent|2|||
27876018|NCT02714218|81379701|FG002|Treatment Period|Participant withdrew consent|0|||
27876019|NCT02714218|81379699|FG000|Treatment Period|Maximum clinical benefit|4|||
27876020|NCT02714218|81379700|FG001|Treatment Period|Maximum clinical benefit|2|||
27876021|NCT02714218|81379701|FG002|Treatment Period|Maximum clinical benefit|0|||
27876022|NCT02714218|81379699|FG000|Treatment Period|Administrative reason by sponsor|2|||
27876023|NCT02714218|81379700|FG001|Treatment Period|Administrative reason by sponsor|1|||
27876024|NCT02714218|81379701|FG002|Treatment Period|Administrative reason by sponsor|0|||
27876025|NCT02714218|81379699|FG000|Treatment Period|Other reasons|6|||
27876026|NCT02714218|81379700|FG001|Treatment Period|Other reasons|6|||
27876027|NCT02714218|81379701|FG002|Treatment Period|Other reasons|0|||
27876028|NCT02714218|81379699|FG000|Treatment Period|Completed treatment as per protocol|36|||
27876029|NCT02714218|81379700|FG001|Treatment Period|Completed treatment as per protocol|27|||
27876030|NCT02714218|81379701|FG002|Treatment Period|Completed treatment as per protocol|3|||
27876031|NCT02714218|81379699|FG000|Treatment Period|Not reported|9|||
27876032|NCT02714218|81379700|FG001|Treatment Period|Not reported|6|||
27876033|NCT02714218|81379701|FG002|Treatment Period|Not reported|0|||
27876034|NCT00460603|81379702|FG000|Phase 1|Death|1|||
27876035|NCT00460603|81379703|FG001|Phase 1|Death|0|||
27876036|NCT00460603|81379704|FG002|Phase 1|Death|0|||
27876037|NCT00460603|81379705|FG003|Phase 1|Death|2|||
27876038|NCT00460603|81379706|FG004|Phase 1|Death|0|||
27876039|NCT00460603|81379707|FG005|Phase 1|Death|0|||
27876040|NCT00460603|81379708|FG006|Phase 1|Death|0|||
27876041|NCT00460603|81379709|FG007|Phase 1|Death|0|||
27876042|NCT00460603|81379710|FG008|Phase 1|Death|1|||
27876043|NCT00460603|81379711|FG009|Phase 1|Death|0|||
27876044|NCT00460603|81379712|FG010|Phase 1|Death|0|||
27876045|NCT00460603|81379713|FG011|Phase 1|Death|0|||
27876046|NCT00460603|81379702|FG000|Phase 1|Adverse Event|3|||
27876047|NCT00460603|81379703|FG001|Phase 1|Adverse Event|1|||
27876048|NCT00460603|81379704|FG002|Phase 1|Adverse Event|1|||
27876049|NCT00460603|81379705|FG003|Phase 1|Adverse Event|2|||
27876050|NCT00460603|81379706|FG004|Phase 1|Adverse Event|0|||
27876051|NCT00460603|81379707|FG005|Phase 1|Adverse Event|0|||
27876052|NCT00460603|81379708|FG006|Phase 1|Adverse Event|3|||
27876053|NCT00460603|81379709|FG007|Phase 1|Adverse Event|0|||
27876054|NCT00460603|81379710|FG008|Phase 1|Adverse Event|4|||
27876055|NCT00460603|81379711|FG009|Phase 1|Adverse Event|0|||
27876056|NCT00460603|81379712|FG010|Phase 1|Adverse Event|0|||
27876057|NCT00460603|81379713|FG011|Phase 1|Adverse Event|0|||
27876058|NCT00460603|81379702|FG000|Phase 1|Lack of Efficacy|1|||
27876059|NCT00460603|81379703|FG001|Phase 1|Lack of Efficacy|0|||
27876060|NCT00460603|81379704|FG002|Phase 1|Lack of Efficacy|1|||
27876061|NCT00460603|81379705|FG003|Phase 1|Lack of Efficacy|2|||
27876062|NCT00460603|81379706|FG004|Phase 1|Lack of Efficacy|2|||
27876063|NCT00460603|81379707|FG005|Phase 1|Lack of Efficacy|2|||
27876064|NCT00460603|81379708|FG006|Phase 1|Lack of Efficacy|2|||
27876065|NCT00460603|81379709|FG007|Phase 1|Lack of Efficacy|2|||
27876066|NCT00460603|81379710|FG008|Phase 1|Lack of Efficacy|11|||
27876067|NCT00460603|81379711|FG009|Phase 1|Lack of Efficacy|0|||
27876068|NCT00460603|81379712|FG010|Phase 1|Lack of Efficacy|0|||
27876069|NCT00460603|81379713|FG011|Phase 1|Lack of Efficacy|0|||
27876070|NCT00460603|81379702|FG000|Phase 1|Withdrawal by Subject|1|||
27876071|NCT00460603|81379703|FG001|Phase 1|Withdrawal by Subject|2|||
27876072|NCT00460603|81379704|FG002|Phase 1|Withdrawal by Subject|1|||
27876073|NCT00460603|81379705|FG003|Phase 1|Withdrawal by Subject|1|||
27876074|NCT00460603|81379706|FG004|Phase 1|Withdrawal by Subject|3|||
27876075|NCT00460603|81379707|FG005|Phase 1|Withdrawal by Subject|0|||
27876076|NCT00460603|81379708|FG006|Phase 1|Withdrawal by Subject|1|||
27876077|NCT00460603|81379709|FG007|Phase 1|Withdrawal by Subject|0|||
27876078|NCT00460603|81379710|FG008|Phase 1|Withdrawal by Subject|2|||
27876079|NCT00460603|81379711|FG009|Phase 1|Withdrawal by Subject|0|||
27876080|NCT00460603|81379712|FG010|Phase 1|Withdrawal by Subject|0|||
27876081|NCT00460603|81379713|FG011|Phase 1|Withdrawal by Subject|0|||
27876082|NCT00460603|81379702|FG000|Phase 1|Other|0|||
27876083|NCT00460603|81379703|FG001|Phase 1|Other|3|||
27876084|NCT00460603|81379704|FG002|Phase 1|Other|1|||
27876085|NCT00460603|81379705|FG003|Phase 1|Other|1|||
27588012|NCT03434119|80335470|FG001|Overall Study|Withdrawal by Subject|5|||
27588013|NCT03434119|80335469|FG000|Overall Study|Other than specified|7|||
27588014|NCT03434119|80335470|FG001|Overall Study|Other than specified|5|||
27588015|NCT03551938|80335471|FG000|3-Month Follow Up|Lost to Follow-up|39|||
27588016|NCT03551938|80335472|FG001|3-Month Follow Up|Lost to Follow-up|38|||
27588017|NCT03551938|80335471|FG000|6-Month Follow Up|Lost to Follow-up|46|||
27588018|NCT03551938|80335472|FG001|6-Month Follow Up|Lost to Follow-up|42|||
27588019|NCT03551938|80335471|FG000|9-Month Follow Up|Lost to Follow-up|44|||
27588020|NCT03551938|80335472|FG001|9-Month Follow Up|Lost to Follow-up|43|||
27588021|NCT01218438|80335473|FG000|Epoch 1|Physician Decision|2|||
27588022|NCT01218438|80335473|FG000|Epoch 1|Adverse Event|1|||
27588023|NCT01218438|80335473|FG000|Epoch 3|Withdrawal by Subject|3|||
27588024|NCT01218438|80335473|FG000|Epoch 3|Adverse Event|1|||
27588025|NCT01218438|80335473|FG000|Epoch 4|Physician Decision|1|||
27588026|NCT01218438|80335473|FG000|Epoch 4|Withdrawal by Subject|2|||
27588027|NCT04495374|80335474|FG000|Overall Study|Protocol Violation|2|||
27588028|NCT04495374|80335475|FG001|Overall Study|Protocol Violation|1|||
27588029|NCT02416791|80335476|FG000|6 Months|Lost to Follow-up|0|||
27588030|NCT02416791|80335477|FG001|6 Months|Lost to Follow-up|0|||
27588031|NCT02416791|80335478|FG002|6 Months|Lost to Follow-up|1|||
27588032|NCT04348604|80335479|FG000|Week 8|Withdrawal by Subject|1|||
27588033|NCT04348604|80335480|FG001|Week 8|Withdrawal by Subject|1|||
27588034|NCT04348604|80335479|FG000|Week 8|Lost to Follow-up|1|||
27588035|NCT04348604|80335480|FG001|Week 8|Lost to Follow-up|2|||
27588036|NCT04348604|80335479|FG000|Week 8|Suspended|0|||
27813062|NCT03519256|81146728|FG002|Overall Study|Adverse event unrelated to study drug|1|||
27813063|NCT03519256|81146729|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27813064|NCT03519256|81146726|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27813065|NCT03519256|81146727|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27813066|NCT03519256|81146728|FG002|Overall Study|Participant request to discontinue study treatment|0|||
27813067|NCT03519256|81146729|FG003|Overall Study|Participant request to discontinue study treatment|2|||
27813068|NCT03519256|81146726|FG000|Overall Study|Other reasons|0|||
27813069|NCT03519256|81146727|FG001|Overall Study|Other reasons|0|||
27813070|NCT03519256|81146728|FG002|Overall Study|Other reasons|2|||
27813071|NCT03519256|81146729|FG003|Overall Study|Other reasons|0|||
27813072|NCT03519256|81146726|FG000|Overall Study|Disease progression|6|||
27813073|NCT03519256|81146727|FG001|Overall Study|Disease progression|3|||
27813074|NCT03519256|81146728|FG002|Overall Study|Disease progression|2|||
27813075|NCT03519256|81146729|FG003|Overall Study|Disease progression|1|||
27813076|NCT03519256|81146726|FG000|Overall Study|Lost to Follow-up|0|||
27813077|NCT03519256|81146727|FG001|Overall Study|Lost to Follow-up|1|||
27813078|NCT03519256|81146728|FG002|Overall Study|Lost to Follow-up|0|||
27813079|NCT03519256|81146729|FG003|Overall Study|Lost to Follow-up|0|||
27813080|NCT02354586|81146732|FG000|Overall Study|Death|230|||
27813081|NCT02354586|81146732|FG000|Overall Study|Withdrawal by Subject|59|||
27813082|NCT02354586|81146732|FG000|Overall Study|Lost to Follow-up|11|||
27813083|NCT02354586|81146732|FG000|Overall Study|Sponsor decision|51|||
27813084|NCT02354586|81146732|FG000|Overall Study|Site closure|2|||
27813085|NCT02354586|81146732|FG000|Overall Study|Intercurrent illness|1|||
27813086|NCT02354586|81146732|FG000|Overall Study|Protocol Violation|3|||
27813087|NCT02354586|81146732|FG000|Overall Study|Physician Decision|13|||
27813088|NCT02354586|81146732|FG000|Overall Study|Lack of Efficacy|86|||
27813089|NCT02354586|81146732|FG000|Overall Study|Adverse Event|7|||
27813090|NCT02918162|81146735|FG000|Overall Study|Withdrawal by Subject|1|||
27813091|NCT02918162|81146735|FG000|Overall Study|Omental Disease|1|||
27813092|NCT03583333|81146736|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
27813093|NCT03583333|81146737|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
27813094|NCT03583333|81146736|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
27588037|NCT04348604|80335480|FG001|Week 8|Suspended|1|||
27588038|NCT04348604|80335479|FG000|Week 12|Lost to Follow-up|1|||
27588039|NCT04348604|80335480|FG001|Week 12|Lost to Follow-up|2|||
27588040|NCT04348604|80335479|FG000|Week 12|Withdrawal by Subject|1|||
27588041|NCT04348604|80335480|FG001|Week 12|Withdrawal by Subject|0|||
27588042|NCT04348604|80335479|FG000|Week 24|Lost to Follow-up|2|||
27588043|NCT04348604|80335480|FG001|Week 24|Lost to Follow-up|1|||
27588044|NCT02105948|80335481|FG000|Overall Study|Adverse Event|10|||
27813095|NCT03583333|81146737|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
27813096|NCT03583333|81146736|FG000|Overall Study|Withdrawal by Subject|9|||
27876086|NCT00460603|81379706|FG004|Phase 1|Other|1|||
27876087|NCT00460603|81379707|FG005|Phase 1|Other|2|||
27876088|NCT00460603|81379708|FG006|Phase 1|Other|0|||
27588045|NCT02105948|80335482|FG001|Overall Study|Adverse Event|7|||
27588046|NCT02105948|80335483|FG002|Overall Study|Adverse Event|11|||
27588047|NCT02105948|80335484|FG003|Overall Study|Adverse Event|11|||
27588048|NCT02105948|80335481|FG000|Overall Study|Lack of Efficacy|0|||
27588049|NCT02105948|80335482|FG001|Overall Study|Lack of Efficacy|1|||
27588050|NCT02105948|80335483|FG002|Overall Study|Lack of Efficacy|3|||
27588051|NCT02105948|80335484|FG003|Overall Study|Lack of Efficacy|2|||
27588052|NCT02105948|80335481|FG000|Overall Study|Lost to Follow-up|0|||
27588053|NCT02105948|80335482|FG001|Overall Study|Lost to Follow-up|0|||
27588054|NCT02105948|80335483|FG002|Overall Study|Lost to Follow-up|2|||
27588055|NCT02105948|80335484|FG003|Overall Study|Lost to Follow-up|1|||
27588056|NCT02105948|80335481|FG000|Overall Study|Physician Decision|2|||
27588057|NCT02105948|80335482|FG001|Overall Study|Physician Decision|2|||
27588058|NCT02105948|80335483|FG002|Overall Study|Physician Decision|2|||
27588059|NCT02105948|80335484|FG003|Overall Study|Physician Decision|2|||
27588060|NCT02105948|80335481|FG000|Overall Study|Withdrawal by Subject|15|||
27588061|NCT02105948|80335482|FG001|Overall Study|Withdrawal by Subject|10|||
27588062|NCT02105948|80335483|FG002|Overall Study|Withdrawal by Subject|10|||
27588063|NCT02105948|80335484|FG003|Overall Study|Withdrawal by Subject|11|||
27588064|NCT01615029|80335487|FG000|Overall Study|Adverse Event|0|||
27588065|NCT01615029|80335488|FG001|Overall Study|Adverse Event|0|||
27588066|NCT01615029|80335489|FG002|Overall Study|Adverse Event|0|||
27588067|NCT01615029|80335490|FG003|Overall Study|Adverse Event|0|||
27588068|NCT01615029|80335491|FG004|Overall Study|Adverse Event|1|||
27588069|NCT01615029|80335487|FG000|Overall Study|Death|0|||
27588070|NCT01615029|80335488|FG001|Overall Study|Death|0|||
27588071|NCT01615029|80335489|FG002|Overall Study|Death|0|||
27588072|NCT01615029|80335490|FG003|Overall Study|Death|0|||
27588073|NCT01615029|80335491|FG004|Overall Study|Death|1|||
27588074|NCT01615029|80335487|FG000|Overall Study|Lost to Follow-up|0|||
27588075|NCT01615029|80335488|FG001|Overall Study|Lost to Follow-up|0|||
27588076|NCT01615029|80335489|FG002|Overall Study|Lost to Follow-up|0|||
27588077|NCT01615029|80335490|FG003|Overall Study|Lost to Follow-up|0|||
27588078|NCT01615029|80335491|FG004|Overall Study|Lost to Follow-up|1|||
27588079|NCT01615029|80335487|FG000|Overall Study|Progressive disease|2|||
27588080|NCT01615029|80335488|FG001|Overall Study|Progressive disease|1|||
27588081|NCT01615029|80335489|FG002|Overall Study|Progressive disease|1|||
27588082|NCT01615029|80335490|FG003|Overall Study|Progressive disease|1|||
27588083|NCT01615029|80335491|FG004|Overall Study|Progressive disease|5|||
27876089|NCT00460603|81379709|FG007|Phase 1|Other|1|||
27876090|NCT00460603|81379710|FG008|Phase 1|Other|0|||
27876091|NCT00460603|81379711|FG009|Phase 1|Other|0|||
27813097|NCT03583333|81146737|FG001|Overall Study|Withdrawal by Subject|5|||
27813098|NCT03583333|81146736|FG000|Overall Study|Physician Decision|3|||
27813099|NCT03583333|81146737|FG001|Overall Study|Physician Decision|2|||
27813100|NCT03583333|81146736|FG000|Overall Study|Death|12|||
27813101|NCT03583333|81146737|FG001|Overall Study|Death|7|||
27813102|NCT02768298|81146738|FG000|Overall Study|Adverse Event|1|||
27813103|NCT02768298|81146739|FG001|Overall Study|Adverse Event|4|||
27813104|NCT02768298|81146738|FG000|Overall Study|Death|2|||
27876092|NCT00460603|81379712|FG010|Phase 1|Other|0|||
27876093|NCT00460603|81379713|FG011|Phase 1|Other|0|||
27876094|NCT00460603|81379702|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876095|NCT00460603|81379703|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876096|NCT00460603|81379704|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876097|NCT00460603|81379705|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876098|NCT00460603|81379706|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876099|NCT00460603|81379707|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876100|NCT00460603|81379708|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876101|NCT00460603|81379709|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876102|NCT00460603|81379710|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876103|NCT00460603|81379711|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
27876104|NCT00460603|81379712|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27813105|NCT02768298|81146739|FG001|Overall Study|Death|1|||
27813106|NCT02768298|81146738|FG000|Overall Study|Non-compliance with study treatment|0|||
27813107|NCT02768298|81146739|FG001|Overall Study|Non-compliance with study treatment|1|||
27813108|NCT02768298|81146738|FG000|Overall Study|Subject/guardian decision|1|||
27813109|NCT02768298|81146739|FG001|Overall Study|Subject/guardian decision|0|||
27813110|NCT02768298|81146738|FG000|Overall Study|Withdrawal of informed consent|0|||
27813111|NCT02768298|81146739|FG001|Overall Study|Withdrawal of informed consent|1|||
27813112|NCT03267264|81146742|FG000|Overall Study|Withdrawal by Subject|1|||
27813113|NCT03267264|81146743|FG001|Overall Study|Withdrawal by Subject|0|||
27813114|NCT03267264|81146744|FG002|Overall Study|Withdrawal by Subject|2|||
27813115|NCT03267264|81146745|FG003|Overall Study|Withdrawal by Subject|4|||
27813116|NCT00433381|81146746|FG000|Overall Study|Ineligible / no protocol treatment|3|||
27813117|NCT00433381|81146747|FG001|Overall Study|Ineligible / no protocol treatment|3|||
27813118|NCT02130466|81146753|FG000|Overall Study|Death|4|||
27813119|NCT02130466|81146754|FG001|Overall Study|Death|1|||
27813120|NCT02130466|81146755|FG002|Overall Study|Death|1|||
27813121|NCT02130466|81146756|FG003|Overall Study|Death|3|||
27813122|NCT02130466|81146757|FG004|Overall Study|Death|2|||
27813123|NCT02130466|81146758|FG005|Overall Study|Death|30|||
27813124|NCT02130466|81146759|FG006|Overall Study|Death|45|||
27813125|NCT02130466|81146760|FG007|Overall Study|Death|2|||
27813126|NCT02130466|81146761|FG008|Overall Study|Death|3|||
27813127|NCT02130466|81146762|FG009|Overall Study|Death|4|||
27813128|NCT02130466|81146763|FG010|Overall Study|Death|5|||
27813129|NCT02130466|81146764|FG011|Overall Study|Death|3|||
27813130|NCT02130466|81146765|FG012|Overall Study|Death|11|||
27813131|NCT02130466|81146766|FG013|Overall Study|Death|7|||
27813132|NCT02130466|81146753|FG000|Overall Study|Lost to Follow-up|1|||
27813133|NCT02130466|81146754|FG001|Overall Study|Lost to Follow-up|0|||
27813134|NCT02130466|81146755|FG002|Overall Study|Lost to Follow-up|0|||
27813135|NCT02130466|81146756|FG003|Overall Study|Lost to Follow-up|0|||
27813136|NCT02130466|81146757|FG004|Overall Study|Lost to Follow-up|0|||
27813137|NCT02130466|81146758|FG005|Overall Study|Lost to Follow-up|1|||
27813138|NCT02130466|81146759|FG006|Overall Study|Lost to Follow-up|0|||
27813139|NCT02130466|81146760|FG007|Overall Study|Lost to Follow-up|0|||
27813140|NCT02130466|81146761|FG008|Overall Study|Lost to Follow-up|0|||
27876105|NCT00460603|81379713|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
27876106|NCT00460603|81379702|FG000|Phase 2|Adverse Event|0|||
27876107|NCT00460603|81379703|FG001|Phase 2|Adverse Event|0|||
27876108|NCT00460603|81379704|FG002|Phase 2|Adverse Event|0|||
27876109|NCT00460603|81379705|FG003|Phase 2|Adverse Event|0|||
27876110|NCT00460603|81379706|FG004|Phase 2|Adverse Event|0|||
27876111|NCT00460603|81379707|FG005|Phase 2|Adverse Event|0|||
27813141|NCT02130466|81146762|FG009|Overall Study|Lost to Follow-up|0|||
27813142|NCT02130466|81146763|FG010|Overall Study|Lost to Follow-up|0|||
27813143|NCT02130466|81146764|FG011|Overall Study|Lost to Follow-up|0|||
27813144|NCT02130466|81146765|FG012|Overall Study|Lost to Follow-up|1|||
27813145|NCT02130466|81146766|FG013|Overall Study|Lost to Follow-up|0|||
27813146|NCT02130466|81146753|FG000|Overall Study|Physician Decision|0|||
27876112|NCT00460603|81379708|FG006|Phase 2|Adverse Event|0|||
27876113|NCT00460603|81379709|FG007|Phase 2|Adverse Event|0|||
27588084|NCT01615029|80335487|FG000|Overall Study|Physician Decision|0|||
27588085|NCT01615029|80335488|FG001|Overall Study|Physician Decision|0|||
27588086|NCT01615029|80335489|FG002|Overall Study|Physician Decision|0|||
27588087|NCT01615029|80335490|FG003|Overall Study|Physician Decision|0|||
27588088|NCT01615029|80335491|FG004|Overall Study|Physician Decision|1|||
27588089|NCT01615029|80335487|FG000|Overall Study|Ongoing|1|||
27588090|NCT01615029|80335488|FG001|Overall Study|Ongoing|2|||
27588091|NCT01615029|80335489|FG002|Overall Study|Ongoing|3|||
27588092|NCT01615029|80335490|FG003|Overall Study|Ongoing|2|||
27588093|NCT01615029|80335491|FG004|Overall Study|Ongoing|23|||
27588094|NCT03266588|80335492|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
27588095|NCT03266588|80335493|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
27588096|NCT03266588|80335494|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
27588097|NCT03266588|80335492|FG000|Observational Period|Withdrawal by Subject|44|||
27588098|NCT03266588|80335493|FG001|Observational Period|Withdrawal by Subject|22|||
27588099|NCT03266588|80335494|FG002|Observational Period|Withdrawal by Subject|13|||
27588100|NCT03266588|80335492|FG000|Observational Period|Non-compliance|18|||
27588101|NCT03266588|80335493|FG001|Observational Period|Non-compliance|12|||
27588102|NCT03266588|80335494|FG002|Observational Period|Non-compliance|10|||
27588103|NCT03266588|80335492|FG000|Observational Period|Lost to Follow-up|8|||
27588104|NCT03266588|80335493|FG001|Observational Period|Lost to Follow-up|12|||
27588105|NCT03266588|80335494|FG002|Observational Period|Lost to Follow-up|4|||
27588106|NCT03266588|80335492|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
27588107|NCT03266588|80335493|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
27588108|NCT03266588|80335494|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
27588109|NCT03266588|80335492|FG000|Observational Period|Protocol Deviation|1|||
27588110|NCT03266588|80335493|FG001|Observational Period|Protocol Deviation|0|||
27588111|NCT03266588|80335494|FG002|Observational Period|Protocol Deviation|0|||
27588112|NCT03266588|80335492|FG000|Observational Period|Other Reasons|3|||
27588113|NCT03266588|80335493|FG001|Observational Period|Other Reasons|0|||
27588114|NCT03266588|80335494|FG002|Observational Period|Other Reasons|1|||
27588115|NCT03266588|80335492|FG000|Long-term Treatment Period|Adverse Event|33|||
27588116|NCT03266588|80335493|FG001|Long-term Treatment Period|Adverse Event|17|||
27588117|NCT03266588|80335494|FG002|Long-term Treatment Period|Adverse Event|8|||
27588118|NCT03266588|80335492|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
27588119|NCT03266588|80335493|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
27588120|NCT03266588|80335494|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
27588121|NCT03266588|80335492|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
27588122|NCT03266588|80335493|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
27588123|NCT03266588|80335494|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
27588124|NCT03266588|80335492|FG000|Long-term Treatment Period|Non-Compliance|126|||
27588125|NCT03266588|80335493|FG001|Long-term Treatment Period|Non-Compliance|57|||
27588126|NCT03266588|80335494|FG002|Long-term Treatment Period|Non-Compliance|7|||
27588127|NCT03266588|80335492|FG000|Long-term Treatment Period|Pregnancy|11|||
27588128|NCT03266588|80335493|FG001|Long-term Treatment Period|Pregnancy|5|||
27588129|NCT03266588|80335494|FG002|Long-term Treatment Period|Pregnancy|0|||
27588130|NCT03266588|80335492|FG000|Long-term Treatment Period|Protocol Deviation|17|||
27588131|NCT03266588|80335493|FG001|Long-term Treatment Period|Protocol Deviation|10|||
27588132|NCT03266588|80335494|FG002|Long-term Treatment Period|Protocol Deviation|4|||
27588133|NCT03266588|80335492|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
27588134|NCT03266588|80335493|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
27588135|NCT03266588|80335494|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
27588136|NCT03266588|80335492|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
27588137|NCT03266588|80335493|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
27588138|NCT03266588|80335494|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
27588139|NCT03266588|80335492|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
27588140|NCT03266588|80335493|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
27588141|NCT03266588|80335494|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
27588142|NCT03266588|80335492|FG000|Long-term Treatment Period|Other Reasons|5|||
27588143|NCT03266588|80335493|FG001|Long-term Treatment Period|Other Reasons|0|||
27588144|NCT03266588|80335494|FG002|Long-term Treatment Period|Other Reasons|0|||
27588145|NCT03266588|80335492|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
27588146|NCT03266588|80335493|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
27588147|NCT03266588|80335494|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
27588148|NCT02493127|80335495|FG000|Overall Study|Lost to Follow-up|1|||
27588149|NCT02493127|80335496|FG001|Overall Study|Lost to Follow-up|1|||
27588150|NCT00868439|80335497|FG000|Overall Study|Adverse Event|4|||
27588151|NCT00868439|80335498|FG001|Overall Study|Adverse Event|3|||
27588152|NCT00868439|80335497|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
27588153|NCT00868439|80335498|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
27588154|NCT00868439|80335497|FG000|Overall Study|Death|0|||
27588155|NCT00868439|80335498|FG001|Overall Study|Death|1|||
27588156|NCT00868439|80335497|FG000|Overall Study|Protocol Violation|1|||
27588157|NCT00868439|80335498|FG001|Overall Study|Protocol Violation|1|||
27588158|NCT00868439|80335497|FG000|Overall Study|Physician Decision|1|||
27588159|NCT00868439|80335498|FG001|Overall Study|Physician Decision|0|||
27588160|NCT00868439|80335497|FG000|Overall Study|Withdrawal by Subject|0|||
27588161|NCT00868439|80335498|FG001|Overall Study|Withdrawal by Subject|1|||
27588162|NCT02244944|80335506|FG000|Overall Study|Withdrawal by Subject|1|||
27588163|NCT02244944|80335506|FG000|Overall Study|Study Terminated|1|||
27588164|NCT00622167|80335507|FG000|Overall Study|Did not meet angiographic criteria|20|||
27588165|NCT01343368|80335508|FG000|Overall Study|Death|1|||
27588166|NCT01343368|80335509|FG001|Overall Study|Death|0|||
27588167|NCT01343368|80335508|FG000|Overall Study|Lost to Follow-up|1|||
27588168|NCT01343368|80335509|FG001|Overall Study|Lost to Follow-up|0|||
27588169|NCT01412944|80335513|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27588170|NCT01412944|80335514|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27588171|NCT01412944|80335515|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
27588172|NCT01412944|80335516|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27588173|NCT01412944|80335517|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27588174|NCT01412944|80335518|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
27588175|NCT01412944|80335513|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27876114|NCT00460603|81379710|FG008|Phase 2|Adverse Event|0|||
27876115|NCT00460603|81379711|FG009|Phase 2|Adverse Event|12|||
27876116|NCT00460603|81379712|FG010|Phase 2|Adverse Event|9|||
27876117|NCT00460603|81379713|FG011|Phase 2|Adverse Event|10|||
27876118|NCT00460603|81379702|FG000|Phase 2|Death|0|||
27876119|NCT00460603|81379703|FG001|Phase 2|Death|0|||
27876120|NCT00460603|81379704|FG002|Phase 2|Death|0|||
27876121|NCT00460603|81379705|FG003|Phase 2|Death|0|||
27876122|NCT00460603|81379706|FG004|Phase 2|Death|0|||
27876123|NCT00460603|81379707|FG005|Phase 2|Death|0|||
27876124|NCT00460603|81379708|FG006|Phase 2|Death|0|||
27876125|NCT00460603|81379709|FG007|Phase 2|Death|0|||
27876126|NCT00460603|81379710|FG008|Phase 2|Death|0|||
27876127|NCT00460603|81379711|FG009|Phase 2|Death|4|||
27876128|NCT00460603|81379712|FG010|Phase 2|Death|2|||
27876129|NCT00460603|81379713|FG011|Phase 2|Death|2|||
27876130|NCT00460603|81379702|FG000|Phase 2|Protocol Violation|0|||
27876131|NCT00460603|81379703|FG001|Phase 2|Protocol Violation|0|||
27876132|NCT00460603|81379704|FG002|Phase 2|Protocol Violation|0|||
27876133|NCT00460603|81379705|FG003|Phase 2|Protocol Violation|0|||
27876134|NCT00460603|81379706|FG004|Phase 2|Protocol Violation|0|||
27876135|NCT00460603|81379707|FG005|Phase 2|Protocol Violation|0|||
27876136|NCT00460603|81379708|FG006|Phase 2|Protocol Violation|0|||
27876137|NCT00460603|81379709|FG007|Phase 2|Protocol Violation|0|||
27876138|NCT00460603|81379710|FG008|Phase 2|Protocol Violation|0|||
27876139|NCT00460603|81379711|FG009|Phase 2|Protocol Violation|1|||
27876140|NCT00460603|81379712|FG010|Phase 2|Protocol Violation|1|||
27876141|NCT00460603|81379713|FG011|Phase 2|Protocol Violation|0|||
27588176|NCT01412944|80335514|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27588177|NCT01412944|80335515|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27588178|NCT01412944|80335516|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27588179|NCT01412944|80335517|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
27588180|NCT01412944|80335518|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
27588181|NCT01412944|80335513|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27876142|NCT00460603|81379702|FG000|Phase 2|Lost to Follow-up|0|||
27876143|NCT00460603|81379703|FG001|Phase 2|Lost to Follow-up|0|||
27876144|NCT00460603|81379704|FG002|Phase 2|Lost to Follow-up|0|||
27876145|NCT00460603|81379705|FG003|Phase 2|Lost to Follow-up|0|||
27876146|NCT00460603|81379706|FG004|Phase 2|Lost to Follow-up|0|||
27876147|NCT00460603|81379707|FG005|Phase 2|Lost to Follow-up|0|||
27876148|NCT00460603|81379708|FG006|Phase 2|Lost to Follow-up|0|||
27876149|NCT00460603|81379709|FG007|Phase 2|Lost to Follow-up|0|||
27876150|NCT00460603|81379710|FG008|Phase 2|Lost to Follow-up|0|||
27876151|NCT00460603|81379711|FG009|Phase 2|Lost to Follow-up|1|||
27876152|NCT00460603|81379712|FG010|Phase 2|Lost to Follow-up|0|||
27876153|NCT00460603|81379713|FG011|Phase 2|Lost to Follow-up|0|||
27876154|NCT00460603|81379702|FG000|Phase 2|Other|0|||
27876155|NCT00460603|81379703|FG001|Phase 2|Other|0|||
27876156|NCT00460603|81379704|FG002|Phase 2|Other|0|||
27876157|NCT00460603|81379705|FG003|Phase 2|Other|0|||
27876158|NCT00460603|81379706|FG004|Phase 2|Other|0|||
27876159|NCT00460603|81379707|FG005|Phase 2|Other|0|||
27588182|NCT01412944|80335514|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27588183|NCT01412944|80335515|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27588184|NCT01412944|80335516|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27813147|NCT02130466|81146754|FG001|Overall Study|Physician Decision|0|||
27813148|NCT02130466|81146755|FG002|Overall Study|Physician Decision|0|||
27588185|NCT01412944|80335517|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
27588186|NCT01412944|80335518|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
27588187|NCT01412944|80335513|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
27588188|NCT01412944|80335514|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27588189|NCT01412944|80335515|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27588190|NCT01412944|80335516|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27588191|NCT01412944|80335517|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27588192|NCT01412944|80335518|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
27813149|NCT02130466|81146756|FG003|Overall Study|Physician Decision|0|||
27813150|NCT02130466|81146757|FG004|Overall Study|Physician Decision|0|||
27813151|NCT02130466|81146758|FG005|Overall Study|Physician Decision|1|||
27813152|NCT02130466|81146759|FG006|Overall Study|Physician Decision|1|||
27813153|NCT02130466|81146760|FG007|Overall Study|Physician Decision|0|||
27813154|NCT02130466|81146761|FG008|Overall Study|Physician Decision|0|||
27813155|NCT02130466|81146762|FG009|Overall Study|Physician Decision|0|||
27813156|NCT02130466|81146763|FG010|Overall Study|Physician Decision|0|||
27813157|NCT02130466|81146764|FG011|Overall Study|Physician Decision|0|||
27813158|NCT02130466|81146765|FG012|Overall Study|Physician Decision|0|||
27813159|NCT02130466|81146766|FG013|Overall Study|Physician Decision|0|||
27588193|NCT01412944|80335513|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
27588194|NCT01412944|80335514|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
27588195|NCT01412944|80335515|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
27588196|NCT01412944|80335516|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
27588197|NCT01412944|80335517|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
27588198|NCT01412944|80335518|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
27588199|NCT01412944|80335513|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27813160|NCT02130466|81146753|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27813161|NCT02130466|81146754|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
27813162|NCT02130466|81146755|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27813163|NCT02130466|81146756|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
27813164|NCT02130466|81146757|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27588200|NCT01412944|80335514|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
27588201|NCT01412944|80335515|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27813165|NCT02130466|81146758|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
27813166|NCT02130466|81146759|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
27813167|NCT02130466|81146760|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27813168|NCT02130466|81146761|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27813169|NCT02130466|81146762|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27813170|NCT02130466|81146763|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
27813171|NCT02130466|81146764|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27813172|NCT02130466|81146765|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
27813173|NCT02130466|81146766|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
27813174|NCT02130466|81146753|FG000|Overall Study|Withdrawal by Subject|1|||
27813175|NCT02130466|81146754|FG001|Overall Study|Withdrawal by Subject|0|||
27813176|NCT02130466|81146755|FG002|Overall Study|Withdrawal by Subject|0|||
27813177|NCT02130466|81146756|FG003|Overall Study|Withdrawal by Subject|0|||
27813178|NCT02130466|81146757|FG004|Overall Study|Withdrawal by Subject|0|||
27813179|NCT02130466|81146758|FG005|Overall Study|Withdrawal by Subject|1|||
27813180|NCT02130466|81146759|FG006|Overall Study|Withdrawal by Subject|0|||
27813181|NCT02130466|81146760|FG007|Overall Study|Withdrawal by Subject|0|||
27813182|NCT02130466|81146761|FG008|Overall Study|Withdrawal by Subject|1|||
27813183|NCT02130466|81146762|FG009|Overall Study|Withdrawal by Subject|0|||
27876160|NCT00460603|81379708|FG006|Phase 2|Other|0|||
27876161|NCT00460603|81379709|FG007|Phase 2|Other|0|||
27876162|NCT00460603|81379710|FG008|Phase 2|Other|0|||
27588202|NCT01412944|80335516|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27588203|NCT01412944|80335517|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27588204|NCT01412944|80335518|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
27813184|NCT02130466|81146763|FG010|Overall Study|Withdrawal by Subject|0|||
27813185|NCT02130466|81146764|FG011|Overall Study|Withdrawal by Subject|0|||
27813186|NCT02130466|81146765|FG012|Overall Study|Withdrawal by Subject|0|||
27876163|NCT00460603|81379711|FG009|Phase 2|Other|6|||
27876164|NCT00460603|81379712|FG010|Phase 2|Other|16|||
27876165|NCT00460603|81379713|FG011|Phase 2|Other|7|||
27876166|NCT00460603|81379702|FG000|Phase 2|Objective Progression or Relapse|0|||
27876167|NCT00460603|81379703|FG001|Phase 2|Objective Progression or Relapse|0|||
27876168|NCT00460603|81379704|FG002|Phase 2|Objective Progression or Relapse|0|||
27876169|NCT00460603|81379705|FG003|Phase 2|Objective Progression or Relapse|0|||
27876170|NCT00460603|81379706|FG004|Phase 2|Objective Progression or Relapse|0|||
27876171|NCT00460603|81379707|FG005|Phase 2|Objective Progression or Relapse|0|||
27876172|NCT00460603|81379708|FG006|Phase 2|Objective Progression or Relapse|0|||
27876173|NCT00460603|81379709|FG007|Phase 2|Objective Progression or Relapse|0|||
27876174|NCT00460603|81379710|FG008|Phase 2|Objective Progression or Relapse|0|||
27876175|NCT00460603|81379711|FG009|Phase 2|Objective Progression or Relapse|9|||
27876176|NCT00460603|81379712|FG010|Phase 2|Objective Progression or Relapse|10|||
27876177|NCT00460603|81379713|FG011|Phase 2|Objective Progression or Relapse|17|||
27813187|NCT02130466|81146766|FG013|Overall Study|Withdrawal by Subject|0|||
27813188|NCT03402893|81146767|FG000|Overall Study|Withdrawal by Subject|1|||
27813189|NCT01247922|81146772|FG000|Overall Study|Disease progression|4|||
27813190|NCT00619385|81146773|FG000|Overall Study|Adverse Event|0|||
27876178|NCT00460603|81379702|FG000|Phase 2|Global Deterioration of Health Status|0|||
27588205|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588206|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588207|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27588208|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27588209|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27588210|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588211|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Adverse Event|0|||
27588212|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Adverse Event|0|||
27588213|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Adverse Event|0|||
27588214|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Adverse Event|0|||
27588215|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Adverse Event|1|||
27588216|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Adverse Event|0|||
27588217|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
27588218|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
27588219|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
27588220|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
27588221|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
27588222|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
27588223|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588224|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588225|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588226|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588227|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588228|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
27588229|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588230|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588231|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588232|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588233|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
27588234|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588235|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
27588236|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
27588237|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588238|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588239|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588240|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
27588241|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
27588242|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
27876179|NCT00460603|81379703|FG001|Phase 2|Global Deterioration of Health Status|0|||
27876180|NCT00460603|81379704|FG002|Phase 2|Global Deterioration of Health Status|0|||
27876181|NCT00460603|81379705|FG003|Phase 2|Global Deterioration of Health Status|0|||
27876182|NCT00460603|81379706|FG004|Phase 2|Global Deterioration of Health Status|0|||
27876183|NCT00460603|81379707|FG005|Phase 2|Global Deterioration of Health Status|0|||
27876184|NCT00460603|81379708|FG006|Phase 2|Global Deterioration of Health Status|0|||
27876185|NCT00460603|81379709|FG007|Phase 2|Global Deterioration of Health Status|0|||
27876186|NCT00460603|81379710|FG008|Phase 2|Global Deterioration of Health Status|0|||
27876187|NCT00460603|81379711|FG009|Phase 2|Global Deterioration of Health Status|0|||
27876188|NCT00460603|81379712|FG010|Phase 2|Global Deterioration of Health Status|1|||
27876189|NCT00460603|81379713|FG011|Phase 2|Global Deterioration of Health Status|0|||
27876190|NCT00460603|81379702|FG000|Phase 2|Withdrawal by Subject|0|||
27876191|NCT00460603|81379703|FG001|Phase 2|Withdrawal by Subject|0|||
27876192|NCT00460603|81379704|FG002|Phase 2|Withdrawal by Subject|0|||
27876193|NCT00460603|81379705|FG003|Phase 2|Withdrawal by Subject|0|||
27876194|NCT00460603|81379706|FG004|Phase 2|Withdrawal by Subject|0|||
27876195|NCT00460603|81379707|FG005|Phase 2|Withdrawal by Subject|0|||
27876196|NCT00460603|81379708|FG006|Phase 2|Withdrawal by Subject|0|||
27876197|NCT00460603|81379709|FG007|Phase 2|Withdrawal by Subject|0|||
27876198|NCT00460603|81379710|FG008|Phase 2|Withdrawal by Subject|0|||
27876199|NCT00460603|81379711|FG009|Phase 2|Withdrawal by Subject|5|||
27876200|NCT00460603|81379712|FG010|Phase 2|Withdrawal by Subject|4|||
27588243|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
27588244|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
27588245|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
27588246|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
27588247|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588248|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
27876201|NCT00460603|81379713|FG011|Phase 2|Withdrawal by Subject|5|||
27876202|NCT00460603|81379702|FG000|Phase 2|Randomized, but not treated|0|||
27876203|NCT00460603|81379703|FG001|Phase 2|Randomized, but not treated|0|||
27876204|NCT00460603|81379704|FG002|Phase 2|Randomized, but not treated|0|||
27876205|NCT00460603|81379705|FG003|Phase 2|Randomized, but not treated|0|||
27876206|NCT00460603|81379706|FG004|Phase 2|Randomized, but not treated|0|||
27588249|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
27813191|NCT00619385|81146774|FG001|Overall Study|Adverse Event|0|||
27588250|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
27813192|NCT00619385|81146775|FG002|Overall Study|Adverse Event|3|||
27813193|NCT00619385|81146773|FG000|Overall Study|Other|1|||
27813194|NCT00619385|81146774|FG001|Overall Study|Other|2|||
27813195|NCT00619385|81146775|FG002|Overall Study|Other|1|||
27588251|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
27687525|NCT03282240|80690612|FG001|Overall Study|Adverse Event|2|||
27687526|NCT03282240|80690613|FG002|Overall Study|Adverse Event|0|||
27813196|NCT01046253|81146776|FG000|Second Intervention|Adverse Event|0|||
27813197|NCT01046253|81146777|FG001|Second Intervention|Adverse Event|1|||
27813198|NCT01046253|81146776|FG000|Second Intervention|Protocol Violation|0|||
27813199|NCT01046253|81146777|FG001|Second Intervention|Protocol Violation|1|||
27813200|NCT03175120|81146780|FG000|Overall Study|Adverse Event|2|||
27813201|NCT03175120|81146781|FG001|Overall Study|Adverse Event|2|||
27813202|NCT03175120|81146780|FG000|Overall Study|Protocol Violation|5|||
27813203|NCT03175120|81146781|FG001|Overall Study|Protocol Violation|2|||
27813204|NCT03175120|81146780|FG000|Overall Study|Lost to Follow-up|1|||
27813205|NCT03175120|81146781|FG001|Overall Study|Lost to Follow-up|0|||
27813206|NCT03175120|81146780|FG000|Overall Study|Withdrawal by Subject|2|||
27813207|NCT03175120|81146781|FG001|Overall Study|Withdrawal by Subject|5|||
27813208|NCT03175120|81146780|FG000|Overall Study|Other|2|||
27813209|NCT03175120|81146781|FG001|Overall Study|Other|3|||
27813210|NCT00182091|81146782|FG000|Overall Study|Withdrawal by Subject|1|||
27813211|NCT00182091|81146783|FG001|Overall Study|Withdrawal by Subject|0|||
27813212|NCT00182091|81146784|FG002|Overall Study|Withdrawal by Subject|0|||
27813213|NCT00182091|81146785|FG003|Overall Study|Withdrawal by Subject|0|||
27813214|NCT02199509|81146786|FG000|Overall Study|Suicidal Ideation|0|||
27813215|NCT02199509|81146787|FG001|Overall Study|Suicidal Ideation|1|||
27813216|NCT02199509|81146786|FG000|Overall Study|Misunderstood titration schedule|1|||
27813217|NCT02199509|81146787|FG001|Overall Study|Misunderstood titration schedule|0|||
27813218|NCT00729859|81146789|FG000|Overall Study|Adverse Event|0|||
27813219|NCT00729859|81146790|FG001|Overall Study|Adverse Event|1|||
27813220|NCT00729859|81146791|FG002|Overall Study|Adverse Event|0|||
27813221|NCT00729859|81146789|FG000|Overall Study|Withdrawal by Subject|0|||
27813222|NCT00729859|81146790|FG001|Overall Study|Withdrawal by Subject|1|||
27813223|NCT00729859|81146791|FG002|Overall Study|Withdrawal by Subject|0|||
27813224|NCT00708422|81146794|FG000|Overall Study|Adverse Event|3|||
27813225|NCT00708422|81146795|FG001|Overall Study|Adverse Event|1|||
27813226|NCT00708422|81146794|FG000|Overall Study|Withdrawal by Subject|1|||
27813227|NCT00708422|81146795|FG001|Overall Study|Withdrawal by Subject|0|||
27813228|NCT01058421|81146796|FG000|1 Month Outcomes|Death|10|||
27813229|NCT01058421|81146797|FG001|1 Month Outcomes|Death|6|||
27813230|NCT01058421|81146796|FG000|1 Month Outcomes|Lost to Follow-up|8|||
27813231|NCT01058421|81146797|FG001|1 Month Outcomes|Lost to Follow-up|7|||
27813232|NCT01058421|81146796|FG000|1 Month Outcomes|Remained in Hospital|5|||
27813233|NCT01058421|81146797|FG001|1 Month Outcomes|Remained in Hospital|12|||
27813234|NCT01058421|81146796|FG000|1 Month Outcomes|Remained in Other Facility|16|||
27813235|NCT01058421|81146797|FG001|1 Month Outcomes|Remained in Other Facility|17|||
27813236|NCT01058421|81146796|FG000|3 Month Outcomes|Death|3|||
27687527|NCT03282240|80690611|FG000|Overall Study|Lost to Follow-up|3|||
27687528|NCT03282240|80690612|FG001|Overall Study|Lost to Follow-up|0|||
27687529|NCT03282240|80690613|FG002|Overall Study|Lost to Follow-up|0|||
27687530|NCT03282240|80690611|FG000|Overall Study|Protocol Deviation|4|||
27687531|NCT03282240|80690612|FG001|Overall Study|Protocol Deviation|1|||
27687532|NCT03282240|80690613|FG002|Overall Study|Protocol Deviation|2|||
27687533|NCT03282240|80690611|FG000|Overall Study|Withdrawal by Subject|1|||
27687534|NCT03282240|80690612|FG001|Overall Study|Withdrawal by Subject|0|||
27687535|NCT03282240|80690613|FG002|Overall Study|Withdrawal by Subject|1|||
27687536|NCT02738203|80690614|FG000|Overall Study|Failed IUD Insertion|2|||
27687537|NCT02738203|80690615|FG001|Overall Study|Failed IUD Insertion|2|||
27687538|NCT02738203|80690614|FG000|Overall Study|Protocol Violation|0|||
27687539|NCT02738203|80690615|FG001|Overall Study|Protocol Violation|1|||
27687540|NCT01131182|80690618|FG000|Overall Study|Withdrawal by Subject|1|||
27687541|NCT01131182|80690619|FG001|Overall Study|Withdrawal by Subject|1|||
27687542|NCT01131182|80690618|FG000|Overall Study|Lost to Follow-up|14|||
27687543|NCT01131182|80690619|FG001|Overall Study|Lost to Follow-up|15|||
27687544|NCT01131182|80690618|FG000|Overall Study|Other Reason|1|||
27687545|NCT01131182|80690619|FG001|Overall Study|Other Reason|0|||
27687546|NCT01200589|80690620|FG000|Overall Study|Withdrawal by Subject|13|||
27687547|NCT01200589|80690621|FG001|Overall Study|Withdrawal by Subject|11|||
27687548|NCT01200589|80690620|FG000|Overall Study|Physician Decision|2|||
27687549|NCT01200589|80690621|FG001|Overall Study|Physician Decision|2|||
27687550|NCT01200589|80690620|FG000|Overall Study|Lost to Follow-up|5|||
27687551|NCT01200589|80690621|FG001|Overall Study|Lost to Follow-up|4|||
27687552|NCT01200589|80690620|FG000|Overall Study|Study terminated|170|||
27687553|NCT01200589|80690621|FG001|Overall Study|Study terminated|172|||
27813237|NCT01058421|81146797|FG001|3 Month Outcomes|Death|5|||
27813238|NCT01058421|81146796|FG000|3 Month Outcomes|Lost to Follow-up|12|||
27813239|NCT01058421|81146797|FG001|3 Month Outcomes|Lost to Follow-up|11|||
27813240|NCT01058421|81146796|FG000|3 Month Outcomes|Remained in Hospital|0|||
27813241|NCT01058421|81146797|FG001|3 Month Outcomes|Remained in Hospital|2|||
27813242|NCT01058421|81146796|FG000|3 Month Outcomes|Remained in Other Facility|5|||
27687554|NCT01139580|80690622|FG000|Overall Study|Adverse Event|5|||
27687555|NCT01139580|80690623|FG001|Overall Study|Adverse Event|4|||
27687556|NCT01139580|80690622|FG000|Overall Study|Lost to Follow-up|9|||
27687557|NCT01139580|80690623|FG001|Overall Study|Lost to Follow-up|1|||
27687558|NCT01139580|80690622|FG000|Overall Study|Lack of Efficacy|0|||
27813243|NCT01058421|81146797|FG001|3 Month Outcomes|Remained in Other Facility|8|||
27813244|NCT01058421|81146796|FG000|6 Month Outcomes|Death|2|||
27813245|NCT01058421|81146797|FG001|6 Month Outcomes|Death|2|||
27813246|NCT01058421|81146796|FG000|6 Month Outcomes|Lost to Follow-up|16|||
27813247|NCT01058421|81146797|FG001|6 Month Outcomes|Lost to Follow-up|21|||
27813248|NCT01058421|81146796|FG000|6 Month Outcomes|Remained in Other Facility|1|||
27813249|NCT01058421|81146797|FG001|6 Month Outcomes|Remained in Other Facility|3|||
27813250|NCT01974895|81146802|FG000|Overall Study|Protocol Violation|1|||
27813251|NCT01974895|81146803|FG001|Overall Study|Protocol Violation|0|||
27813252|NCT01974895|81146802|FG000|Overall Study|Lost to Follow-up|4|||
27813253|NCT01974895|81146803|FG001|Overall Study|Lost to Follow-up|6|||
27813254|NCT01974895|81146802|FG000|Overall Study|Withdrawal by Subject|0|||
27813255|NCT01974895|81146803|FG001|Overall Study|Withdrawal by Subject|1|||
27813256|NCT01974895|81146802|FG000|Overall Study|Other (Missed Visit)|1|||
27813257|NCT01974895|81146803|FG001|Overall Study|Other (Missed Visit)|0|||
27813258|NCT01974895|81146802|FG000|Overall Study|Other (Reason unknown)|9|||
27813259|NCT01974895|81146803|FG001|Overall Study|Other (Reason unknown)|8|||
27813260|NCT03066999|81146806|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
27813261|NCT03066999|81146807|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
27813262|NCT02985151|81146810|FG000|Original Randomization|Withdrawal by Subject|0|||
27813263|NCT02985151|81146811|FG001|Original Randomization|Withdrawal by Subject|1|||
27813264|NCT01326026|81146812|FG000|Overall Study|Adverse Event|4|||
27813265|NCT01326026|81146813|FG001|Overall Study|Adverse Event|3|||
27813266|NCT01326026|81146812|FG000|Overall Study|Withdrawal Criteria|5|||
27813267|NCT01326026|81146813|FG001|Overall Study|Withdrawal Criteria|7|||
27813268|NCT01326026|81146812|FG000|Overall Study|Other|3|||
27813269|NCT01326026|81146813|FG001|Overall Study|Other|3|||
27813270|NCT00944697|81146816|FG000|Overall Study|Withdrawal by Subject|1|||
27813271|NCT00944697|81146817|FG001|Overall Study|Withdrawal by Subject|1|||
27813272|NCT00944697|81146816|FG000|Overall Study|Adverse Event|0|||
27813273|NCT00944697|81146817|FG001|Overall Study|Adverse Event|3|||
27813274|NCT00944697|81146816|FG000|Overall Study|Administrative|1|||
27813275|NCT00944697|81146817|FG001|Overall Study|Administrative|1|||
27813276|NCT00738673|81146818|FG000|Overall Study|Adverse Event|1|||
27813277|NCT00738673|81146819|FG001|Overall Study|Adverse Event|0|||
27813278|NCT00738673|81146818|FG000|Overall Study|Lack of Efficacy|19|||
27813279|NCT00738673|81146819|FG001|Overall Study|Lack of Efficacy|8|||
27813280|NCT00738673|81146818|FG000|Overall Study|Protocol Violation|1|||
27813281|NCT00738673|81146819|FG001|Overall Study|Protocol Violation|2|||
27813282|NCT00738673|81146818|FG000|Overall Study|Withdrawal by Subject|3|||
27813283|NCT00738673|81146819|FG001|Overall Study|Withdrawal by Subject|1|||
27813284|NCT02486796|81146820|FG000|Overall Study|Withdrawal by Subject|1|||
27813285|NCT02486796|81146821|FG001|Overall Study|Withdrawal by Subject|1|||
27813286|NCT02486796|81146820|FG000|Overall Study|Physician Decision|1|||
27813287|NCT02486796|81146821|FG001|Overall Study|Physician Decision|0|||
27813288|NCT01656889|81146822|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
27813289|NCT01656889|81146823|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
27813290|NCT01656889|81146822|FG000|Treatment Period, 12 Weeks|Death|0|||
27813291|NCT01656889|81146823|FG001|Treatment Period, 12 Weeks|Death|1|||
27813292|NCT01656889|81146822|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
27813293|NCT01656889|81146823|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
27813294|NCT01656889|81146822|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
27813295|NCT01656889|81146823|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
27813296|NCT01656889|81146822|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
27813297|NCT01656889|81146823|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
27813298|NCT01656889|81146822|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
27813299|NCT01656889|81146823|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
27813300|NCT01656889|81146822|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
27813301|NCT01656889|81146823|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
27813302|NCT01656889|81146822|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
27813303|NCT01656889|81146823|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
27813304|NCT01656889|81146822|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
27813305|NCT01656889|81146823|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
27813306|NCT01656889|81146822|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
27813307|NCT01656889|81146823|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
27813308|NCT05487456|81146826|FG000|Overall Study|Withdrawal by Subject|0|||
27813309|NCT05487456|81146827|FG001|Overall Study|Withdrawal by Subject|0|||
27813310|NCT05487456|81146828|FG002|Overall Study|Withdrawal by Subject|1|||
27813311|NCT05487456|81146829|FG003|Overall Study|Withdrawal by Subject|0|||
27813312|NCT04272775|81146832|FG000|Overall Study|Study Terminated by Sponsor|1|||
27813313|NCT04272775|81146833|FG001|Overall Study|Study Terminated by Sponsor|0|||
27813314|NCT04272775|81146832|FG000|Overall Study|Protocol Violation|0|||
27813315|NCT04272775|81146833|FG001|Overall Study|Protocol Violation|1|||
27813316|NCT04272775|81146832|FG000|Overall Study|Symptomatic Deterioration|1|||
27813317|NCT04272775|81146833|FG001|Overall Study|Symptomatic Deterioration|1|||
27813318|NCT04272775|81146832|FG000|Overall Study|Withdrawal by Subject|1|||
27813319|NCT04272775|81146833|FG001|Overall Study|Withdrawal by Subject|2|||
27813320|NCT04272775|81146832|FG000|Overall Study|Adverse Event|1|||
27813321|NCT04272775|81146833|FG001|Overall Study|Adverse Event|2|||
27813322|NCT04272775|81146832|FG000|Overall Study|Progressive Disease|3|||
27813323|NCT04272775|81146833|FG001|Overall Study|Progressive Disease|1|||
27813324|NCT01296932|81146838|FG000|Overall Study|Dose limiting toxicity|0|||
27813325|NCT01296932|81146839|FG001|Overall Study|Dose limiting toxicity|0|||
27813326|NCT01296932|81146840|FG002|Overall Study|Dose limiting toxicity|0|||
27813327|NCT01296932|81146841|FG003|Overall Study|Dose limiting toxicity|0|||
27588252|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
27588253|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588254|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
27588255|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588256|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588257|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588258|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
27588259|NCT01412944|80335513|FG000|Entire: IV + Maintenance|Adverse Event|0|||
27588260|NCT01412944|80335514|FG001|Entire: IV + Maintenance|Adverse Event|1|||
27588261|NCT01412944|80335515|FG002|Entire: IV + Maintenance|Adverse Event|0|||
27588262|NCT01412944|80335516|FG003|Entire: IV + Maintenance|Adverse Event|0|||
27588263|NCT01412944|80335517|FG004|Entire: IV + Maintenance|Adverse Event|0|||
27588264|NCT01412944|80335518|FG005|Entire: IV + Maintenance|Adverse Event|0|||
27588265|NCT03879798|80335519|FG000|Overall Study|Adverse Event|0|||
27813328|NCT01296932|81146842|FG004|Overall Study|Dose limiting toxicity|0|||
27813329|NCT01296932|81146843|FG005|Overall Study|Dose limiting toxicity|0|||
27813330|NCT01296932|81146844|FG006|Overall Study|Dose limiting toxicity|1|||
27813331|NCT01296932|81146845|FG007|Overall Study|Dose limiting toxicity|0|||
27813332|NCT01296932|81146846|FG008|Overall Study|Dose limiting toxicity|1|||
27813333|NCT01296932|81146838|FG000|Overall Study|Progressive disease|2|||
27813334|NCT01296932|81146839|FG001|Overall Study|Progressive disease|0|||
27813335|NCT01296932|81146840|FG002|Overall Study|Progressive disease|1|||
27813336|NCT01296932|81146841|FG003|Overall Study|Progressive disease|1|||
27813337|NCT01296932|81146842|FG004|Overall Study|Progressive disease|2|||
27813338|NCT01296932|81146843|FG005|Overall Study|Progressive disease|3|||
27813339|NCT01296932|81146844|FG006|Overall Study|Progressive disease|1|||
27813340|NCT01296932|81146845|FG007|Overall Study|Progressive disease|0|||
27813341|NCT01296932|81146846|FG008|Overall Study|Progressive disease|0|||
27813342|NCT01296932|81146838|FG000|Overall Study|Withdrawal by Subject|0|||
27813343|NCT01296932|81146839|FG001|Overall Study|Withdrawal by Subject|0|||
27813344|NCT01296932|81146840|FG002|Overall Study|Withdrawal by Subject|1|||
27813345|NCT01296932|81146841|FG003|Overall Study|Withdrawal by Subject|1|||
27813346|NCT01296932|81146842|FG004|Overall Study|Withdrawal by Subject|0|||
27813347|NCT01296932|81146843|FG005|Overall Study|Withdrawal by Subject|0|||
27813348|NCT01296932|81146844|FG006|Overall Study|Withdrawal by Subject|3|||
27813349|NCT01296932|81146845|FG007|Overall Study|Withdrawal by Subject|0|||
27813350|NCT01296932|81146846|FG008|Overall Study|Withdrawal by Subject|0|||
27813351|NCT01296932|81146838|FG000|Overall Study|Adverse Event|1|||
27813352|NCT01296932|81146839|FG001|Overall Study|Adverse Event|1|||
27813353|NCT01296932|81146840|FG002|Overall Study|Adverse Event|1|||
27813354|NCT01296932|81146841|FG003|Overall Study|Adverse Event|2|||
27813355|NCT01296932|81146842|FG004|Overall Study|Adverse Event|1|||
27813356|NCT01296932|81146843|FG005|Overall Study|Adverse Event|0|||
27813357|NCT01296932|81146844|FG006|Overall Study|Adverse Event|0|||
27813358|NCT01296932|81146845|FG007|Overall Study|Adverse Event|0|||
27813359|NCT01296932|81146846|FG008|Overall Study|Adverse Event|1|||
27813360|NCT01296932|81146838|FG000|Overall Study|Investigator decision|0|||
27813361|NCT01296932|81146839|FG001|Overall Study|Investigator decision|1|||
27813362|NCT01296932|81146840|FG002|Overall Study|Investigator decision|0|||
27813363|NCT01296932|81146841|FG003|Overall Study|Investigator decision|1|||
27813364|NCT01296932|81146842|FG004|Overall Study|Investigator decision|0|||
27813365|NCT01296932|81146843|FG005|Overall Study|Investigator decision|0|||
27876207|NCT00460603|81379707|FG005|Phase 2|Randomized, but not treated|0|||
27876208|NCT00460603|81379708|FG006|Phase 2|Randomized, but not treated|0|||
27876209|NCT00460603|81379709|FG007|Phase 2|Randomized, but not treated|0|||
27876210|NCT00460603|81379710|FG008|Phase 2|Randomized, but not treated|0|||
27588266|NCT03879798|80335520|FG001|Overall Study|Adverse Event|0|||
27588267|NCT03879798|80335521|FG002|Overall Study|Adverse Event|0|||
27588268|NCT03879798|80335522|FG003|Overall Study|Adverse Event|0|||
27813366|NCT01296932|81146844|FG006|Overall Study|Investigator decision|1|||
27813367|NCT01296932|81146845|FG007|Overall Study|Investigator decision|0|||
27813368|NCT01296932|81146846|FG008|Overall Study|Investigator decision|1|||
27813369|NCT01296932|81146838|FG000|Overall Study|No clinical benefit anymore|0|||
27813370|NCT01296932|81146839|FG001|Overall Study|No clinical benefit anymore|1|||
27813371|NCT01296932|81146840|FG002|Overall Study|No clinical benefit anymore|0|||
27813372|NCT01296932|81146841|FG003|Overall Study|No clinical benefit anymore|0|||
27813373|NCT01296932|81146842|FG004|Overall Study|No clinical benefit anymore|0|||
27813374|NCT01296932|81146843|FG005|Overall Study|No clinical benefit anymore|0|||
27813375|NCT01296932|81146844|FG006|Overall Study|No clinical benefit anymore|0|||
27813376|NCT01296932|81146845|FG007|Overall Study|No clinical benefit anymore|0|||
27813377|NCT01296932|81146846|FG008|Overall Study|No clinical benefit anymore|0|||
27813378|NCT01296932|81146838|FG000|Overall Study|Physician Decision|0|||
27813379|NCT01296932|81146839|FG001|Overall Study|Physician Decision|0|||
27813380|NCT01296932|81146840|FG002|Overall Study|Physician Decision|1|||
27813381|NCT01296932|81146841|FG003|Overall Study|Physician Decision|0|||
27813382|NCT01296932|81146842|FG004|Overall Study|Physician Decision|0|||
27813383|NCT01296932|81146843|FG005|Overall Study|Physician Decision|0|||
27813384|NCT01296932|81146844|FG006|Overall Study|Physician Decision|0|||
27813385|NCT01296932|81146845|FG007|Overall Study|Physician Decision|0|||
27813386|NCT01296932|81146846|FG008|Overall Study|Physician Decision|0|||
27813387|NCT01296932|81146838|FG000|Overall Study|IV problems, administration not possible|0|||
27813388|NCT01296932|81146839|FG001|Overall Study|IV problems, administration not possible|0|||
27813389|NCT01296932|81146840|FG002|Overall Study|IV problems, administration not possible|1|||
27813390|NCT01296932|81146841|FG003|Overall Study|IV problems, administration not possible|0|||
27813391|NCT01296932|81146842|FG004|Overall Study|IV problems, administration not possible|0|||
27813392|NCT01296932|81146843|FG005|Overall Study|IV problems, administration not possible|0|||
27813393|NCT01296932|81146844|FG006|Overall Study|IV problems, administration not possible|0|||
27813394|NCT01296932|81146845|FG007|Overall Study|IV problems, administration not possible|0|||
27813395|NCT01296932|81146846|FG008|Overall Study|IV problems, administration not possible|0|||
27813396|NCT01296932|81146838|FG000|Overall Study|per protocol|0|||
27813397|NCT01296932|81146839|FG001|Overall Study|per protocol|0|||
27813398|NCT01296932|81146840|FG002|Overall Study|per protocol|1|||
27813399|NCT01296932|81146841|FG003|Overall Study|per protocol|1|||
27813400|NCT01296932|81146842|FG004|Overall Study|per protocol|0|||
27813401|NCT01296932|81146843|FG005|Overall Study|per protocol|0|||
27813402|NCT01296932|81146844|FG006|Overall Study|per protocol|0|||
27813403|NCT01296932|81146845|FG007|Overall Study|per protocol|0|||
27813404|NCT01296932|81146846|FG008|Overall Study|per protocol|0|||
27813405|NCT01296932|81146838|FG000|Overall Study|Low benefit and too many side effects|0|||
27813406|NCT01296932|81146839|FG001|Overall Study|Low benefit and too many side effects|0|||
27876211|NCT00460603|81379711|FG009|Phase 2|Randomized, but not treated|3|||
27876212|NCT00460603|81379712|FG010|Phase 2|Randomized, but not treated|0|||
27687559|NCT01139580|80690623|FG001|Overall Study|Lack of Efficacy|2|||
27687560|NCT01139580|80690622|FG000|Overall Study|Withdrawal by Subject|6|||
27687561|NCT01139580|80690623|FG001|Overall Study|Withdrawal by Subject|9|||
27687562|NCT01139580|80690622|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
27687563|NCT01139580|80690623|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
27687564|NCT01139580|80690622|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
27687565|NCT01139580|80690623|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
27876213|NCT00460603|81379713|FG011|Phase 2|Randomized, but not treated|0|||
27687566|NCT01139580|80690622|FG000|Overall Study|Misrandomized|1|||
27687567|NCT01139580|80690623|FG001|Overall Study|Misrandomized|0|||
27687568|NCT01139580|80690622|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
27687569|NCT01139580|80690623|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
27687570|NCT01139580|80690622|FG000|Overall Study|Participant Randomization in Error|0|||
27687571|NCT01139580|80690623|FG001|Overall Study|Participant Randomization in Error|1|||
27687572|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|Death|1|||
27687573|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|Death|1|||
27687574|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
27687575|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
27687576|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
27687577|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
27687578|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
27687579|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
27687580|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
27687581|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
27687582|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
27687583|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
27687584|NCT00371683|80690624|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
27687585|NCT00371683|80690625|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
27813407|NCT01296932|81146840|FG002|Overall Study|Low benefit and too many side effects|0|||
27813408|NCT01296932|81146841|FG003|Overall Study|Low benefit and too many side effects|0|||
27813409|NCT01296932|81146842|FG004|Overall Study|Low benefit and too many side effects|0|||
27813410|NCT01296932|81146843|FG005|Overall Study|Low benefit and too many side effects|0|||
27813411|NCT01296932|81146844|FG006|Overall Study|Low benefit and too many side effects|0|||
27813412|NCT01296932|81146845|FG007|Overall Study|Low benefit and too many side effects|1|||
27813413|NCT01296932|81146846|FG008|Overall Study|Low benefit and too many side effects|0|||
27876214|NCT03313180|81379718|FG000|Overall Study|Adverse Event|120|||
27687586|NCT00371683|80690624|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
27687587|NCT00371683|80690625|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
27687588|NCT00371683|80690624|FG000|Follow-Up Period - Randomized Patients|Death|0|||
27687589|NCT00371683|80690625|FG001|Follow-Up Period - Randomized Patients|Death|2|||
27687590|NCT00371683|80690624|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
27687591|NCT00371683|80690625|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
27687592|NCT00371683|80690624|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
27687593|NCT00371683|80690625|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
27687594|NCT00847808|80690626|FG000|Overall Study|Adverse Event|7|||
27687595|NCT00847808|80690626|FG000|Overall Study|Protocol Violation|1|||
27687596|NCT00847808|80690626|FG000|Overall Study|Lost to Follow-up|1|||
27687597|NCT00847808|80690626|FG000|Overall Study|Withdrawal by Subject|4|||
27687598|NCT00847808|80690626|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
27687599|NCT00847808|80690626|FG000|Overall Study|Participant Took Excluded Medication|1|||
27687600|NCT00141219|80690629|FG000|Overall Study|Protocol violations|5|||
27687601|NCT00141219|80690630|FG001|Overall Study|Protocol violations|4|||
27687602|NCT00141219|80690629|FG000|Overall Study|Adverse Event|8|||
27687603|NCT00141219|80690630|FG001|Overall Study|Adverse Event|6|||
27687604|NCT00141219|80690629|FG000|Overall Study|Lack of Efficacy|5|||
27687605|NCT00141219|80690630|FG001|Overall Study|Lack of Efficacy|4|||
27687606|NCT00141219|80690629|FG000|Overall Study|Withdrawal by Subject|6|||
27687607|NCT00141219|80690630|FG001|Overall Study|Withdrawal by Subject|2|||
27687608|NCT01737827|80690631|FG000|Overall Study|Adverse Event|3|||
27687609|NCT01737827|80690632|FG001|Overall Study|Adverse Event|6|||
27588269|NCT03879798|80335523|FG004|Overall Study|Adverse Event|0|||
27588270|NCT03879798|80335524|FG005|Overall Study|Adverse Event|1|||
27687610|NCT01737827|80690633|FG002|Overall Study|Adverse Event|0|||
27687611|NCT01737827|80690631|FG000|Overall Study|Lost to Follow-up|0|||
27687612|NCT01737827|80690632|FG001|Overall Study|Lost to Follow-up|1|||
27687613|NCT01737827|80690633|FG002|Overall Study|Lost to Follow-up|0|||
27687614|NCT01737827|80690631|FG000|Overall Study|Physician Decision|0|||
27687615|NCT01737827|80690632|FG001|Overall Study|Physician Decision|2|||
27687616|NCT01737827|80690633|FG002|Overall Study|Physician Decision|0|||
27687617|NCT01737827|80690631|FG000|Overall Study|Progressive Disease|5|||
27687618|NCT01737827|80690632|FG001|Overall Study|Progressive Disease|16|||
27687619|NCT01737827|80690633|FG002|Overall Study|Progressive Disease|2|||
27687620|NCT01737827|80690631|FG000|Overall Study|Study Terminated by Sponsor|0|||
27687621|NCT01737827|80690632|FG001|Overall Study|Study Terminated by Sponsor|1|||
27687622|NCT01737827|80690633|FG002|Overall Study|Study Terminated by Sponsor|0|||
27687623|NCT01737827|80690631|FG000|Overall Study|Subject/Guardian Decision|0|||
27687624|NCT01737827|80690632|FG001|Overall Study|Subject/Guardian Decision|2|||
27687625|NCT01737827|80690633|FG002|Overall Study|Subject/Guardian Decision|0|||
27687626|NCT00196976|80694084|FG000|Primary Study|Migrated from study area|0|||
27687627|NCT00196976|80694085|FG001|Primary Study|Migrated from study area|0|||
27687628|NCT00196976|80694086|FG002|Primary Study|Migrated from study area|0|||
27687629|NCT00196976|80694087|FG003|Primary Study|Migrated from study area|0|||
27687630|NCT00196976|80694088|FG004|Primary Study|Migrated from study area|0|||
27588271|NCT03879798|80335519|FG000|Overall Study|Lack of Efficacy|0|||
27588272|NCT03879798|80335520|FG001|Overall Study|Lack of Efficacy|0|||
27588273|NCT03879798|80335521|FG002|Overall Study|Lack of Efficacy|0|||
27588274|NCT03879798|80335522|FG003|Overall Study|Lack of Efficacy|0|||
27588275|NCT03879798|80335523|FG004|Overall Study|Lack of Efficacy|0|||
27588276|NCT03879798|80335524|FG005|Overall Study|Lack of Efficacy|1|||
27588277|NCT03879798|80335519|FG000|Overall Study|Withdrawal by Subject|0|||
27588278|NCT03879798|80335520|FG001|Overall Study|Withdrawal by Subject|0|||
27588279|NCT03879798|80335521|FG002|Overall Study|Withdrawal by Subject|0|||
27588280|NCT03879798|80335522|FG003|Overall Study|Withdrawal by Subject|0|||
27588281|NCT03879798|80335523|FG004|Overall Study|Withdrawal by Subject|0|||
27588282|NCT03879798|80335524|FG005|Overall Study|Withdrawal by Subject|1|||
27588283|NCT03694548|80335527|FG000|Part A Survey|Protocol Violation|3|||
27588284|NCT03694548|80335528|FG001|Part A Survey|Protocol Violation|3|||
27588285|NCT03694548|80335529|FG002|Part A Survey|Protocol Violation|0|||
27588286|NCT03694548|80335527|FG000|Part B Yoga Program|Protocol Violation|0|||
27588287|NCT03694548|80335528|FG001|Part B Yoga Program|Protocol Violation|0|||
27588288|NCT03694548|80335529|FG002|Part B Yoga Program|Protocol Violation|3|||
27687631|NCT00196976|80694089|FG005|Primary Study|Migrated from study area|0|||
27687632|NCT00196976|80694090|FG006|Primary Study|Migrated from study area|0|||
27687633|NCT00196976|80694091|FG007|Primary Study|Migrated from study area|1|||
27687634|NCT00196976|80694092|FG008|Primary Study|Migrated from study area|0|||
27687635|NCT00196976|80694093|FG009|Primary Study|Migrated from study area|0|||
27687636|NCT00196976|80694094|FG010|Primary Study|Migrated from study area|0|||
27687637|NCT00196976|80694095|FG011|Primary Study|Migrated from study area|0|||
27687638|NCT00196976|80694096|FG012|Primary Study|Migrated from study area|0|||
27687639|NCT00196976|80694097|FG013|Primary Study|Migrated from study area|0|||
27687640|NCT00196976|80694084|FG000|Primary Study|Protocol Violation|0|||
27687641|NCT00196976|80694085|FG001|Primary Study|Protocol Violation|1|||
27687642|NCT00196976|80694086|FG002|Primary Study|Protocol Violation|1|||
27687643|NCT00196976|80694087|FG003|Primary Study|Protocol Violation|0|||
27687644|NCT00196976|80694088|FG004|Primary Study|Protocol Violation|0|||
27687645|NCT00196976|80694089|FG005|Primary Study|Protocol Violation|0|||
27687646|NCT00196976|80694090|FG006|Primary Study|Protocol Violation|0|||
27687647|NCT00196976|80694091|FG007|Primary Study|Protocol Violation|0|||
27687648|NCT00196976|80694092|FG008|Primary Study|Protocol Violation|0|||
27687649|NCT00196976|80694093|FG009|Primary Study|Protocol Violation|0|||
27687650|NCT00196976|80694094|FG010|Primary Study|Protocol Violation|0|||
27687651|NCT00196976|80694095|FG011|Primary Study|Protocol Violation|0|||
27687652|NCT00196976|80694096|FG012|Primary Study|Protocol Violation|0|||
27687653|NCT00196976|80694097|FG013|Primary Study|Protocol Violation|0|||
27687654|NCT00196976|80694084|FG000|Primary Study|Withdrawal by Subject|1|||
27687655|NCT00196976|80694085|FG001|Primary Study|Withdrawal by Subject|0|||
27687656|NCT00196976|80694086|FG002|Primary Study|Withdrawal by Subject|1|||
27687657|NCT00196976|80694087|FG003|Primary Study|Withdrawal by Subject|1|||
27687658|NCT00196976|80694088|FG004|Primary Study|Withdrawal by Subject|2|||
27687659|NCT00196976|80694089|FG005|Primary Study|Withdrawal by Subject|1|||
27588289|NCT03694548|80335527|FG000|Part B Yoga Program|Did not attend intervention|0|||
27687660|NCT00196976|80694090|FG006|Primary Study|Withdrawal by Subject|0|||
27687661|NCT00196976|80694091|FG007|Primary Study|Withdrawal by Subject|0|||
27687662|NCT00196976|80694092|FG008|Primary Study|Withdrawal by Subject|0|||
27687663|NCT00196976|80694093|FG009|Primary Study|Withdrawal by Subject|1|||
27687664|NCT00196976|80694094|FG010|Primary Study|Withdrawal by Subject|0|||
27687665|NCT00196976|80694095|FG011|Primary Study|Withdrawal by Subject|0|||
27687666|NCT00196976|80694096|FG012|Primary Study|Withdrawal by Subject|0|||
27687667|NCT00196976|80694097|FG013|Primary Study|Withdrawal by Subject|0|||
27687668|NCT00196976|80694084|FG000|Primary Study|Lost to Follow-up|0|||
27687669|NCT00196976|80694085|FG001|Primary Study|Lost to Follow-up|0|||
27687670|NCT00196976|80694086|FG002|Primary Study|Lost to Follow-up|0|||
27687671|NCT00196976|80694087|FG003|Primary Study|Lost to Follow-up|0|||
27687672|NCT00196976|80694088|FG004|Primary Study|Lost to Follow-up|1|||
27687673|NCT00196976|80694089|FG005|Primary Study|Lost to Follow-up|1|||
27687674|NCT00196976|80694090|FG006|Primary Study|Lost to Follow-up|0|||
27687675|NCT00196976|80694091|FG007|Primary Study|Lost to Follow-up|2|||
27687676|NCT00196976|80694092|FG008|Primary Study|Lost to Follow-up|0|||
27687677|NCT00196976|80694093|FG009|Primary Study|Lost to Follow-up|0|||
27687678|NCT00196976|80694094|FG010|Primary Study|Lost to Follow-up|0|||
27687679|NCT00196976|80694095|FG011|Primary Study|Lost to Follow-up|0|||
27687680|NCT00196976|80694096|FG012|Primary Study|Lost to Follow-up|0|||
27687681|NCT00196976|80694097|FG013|Primary Study|Lost to Follow-up|0|||
27687682|NCT00196976|80694084|FG000|Primary Study|Other|0|||
27687683|NCT00196976|80694085|FG001|Primary Study|Other|0|||
27687684|NCT00196976|80694086|FG002|Primary Study|Other|2|||
27813414|NCT01296932|81146838|FG000|Overall Study|No adequate treatment response|0|||
27813415|NCT01296932|81146839|FG001|Overall Study|No adequate treatment response|0|||
27813416|NCT01296932|81146840|FG002|Overall Study|No adequate treatment response|0|||
27588290|NCT03694548|80335528|FG001|Part B Yoga Program|Did not attend intervention|0|||
27588291|NCT03694548|80335529|FG002|Part B Yoga Program|Did not attend intervention|8|||
27588292|NCT04401579|80335530|FG000|Overall Study|Death|23|||
27588293|NCT04401579|80335531|FG001|Overall Study|Death|36|||
27588294|NCT04401579|80335530|FG000|Overall Study|Lost to Follow-up|40|||
27588295|NCT04401579|80335531|FG001|Overall Study|Lost to Follow-up|41|||
27588296|NCT04401579|80335530|FG000|Overall Study|Withdrawal by Subject|8|||
27588297|NCT04401579|80335531|FG001|Overall Study|Withdrawal by Subject|16|||
27588298|NCT04401579|80335530|FG000|Overall Study|Physician Decision|1|||
27588299|NCT04401579|80335531|FG001|Overall Study|Physician Decision|2|||
27588300|NCT04401579|80335530|FG000|Overall Study|Became ineligible after enrollment|1|||
27588301|NCT04401579|80335531|FG001|Overall Study|Became ineligible after enrollment|1|||
27588302|NCT04401579|80335530|FG000|Overall Study|Enrolled but treatment not administered|7|||
27588303|NCT04401579|80335531|FG001|Overall Study|Enrolled but treatment not administered|9|||
27588304|NCT04401579|80335530|FG000|Overall Study|Adverse Event|2|||
27588305|NCT04401579|80335531|FG001|Overall Study|Adverse Event|1|||
27588306|NCT04401579|80335530|FG000|Overall Study|Scheduling error|1|||
27588307|NCT04401579|80335531|FG001|Overall Study|Scheduling error|2|||
27687685|NCT00196976|80694087|FG003|Primary Study|Other|0|||
27687686|NCT00196976|80694088|FG004|Primary Study|Other|0|||
27687687|NCT00196976|80694089|FG005|Primary Study|Other|0|||
27687688|NCT00196976|80694090|FG006|Primary Study|Other|0|||
27687689|NCT00196976|80694091|FG007|Primary Study|Other|0|||
27687690|NCT00196976|80694092|FG008|Primary Study|Other|0|||
27687691|NCT00196976|80694093|FG009|Primary Study|Other|0|||
27588308|NCT04401579|80335530|FG000|Overall Study|Transferred to another hospital|1|||
27687692|NCT00196976|80694094|FG010|Primary Study|Other|0|||
27687693|NCT00196976|80694095|FG011|Primary Study|Other|0|||
27687694|NCT00196976|80694096|FG012|Primary Study|Other|0|||
27687695|NCT00196976|80694097|FG013|Primary Study|Other|0|||
27687696|NCT00196976|80694084|FG000|Booster Study|Withdrawal by Subject|0|||
27687697|NCT00196976|80694085|FG001|Booster Study|Withdrawal by Subject|0|||
27687698|NCT00196976|80694086|FG002|Booster Study|Withdrawal by Subject|0|||
27687699|NCT00196976|80694087|FG003|Booster Study|Withdrawal by Subject|0|||
27588309|NCT04401579|80335531|FG001|Overall Study|Transferred to another hospital|2|||
27588310|NCT04757753|80335532|FG000|Overall Study|Lost to Follow-up|7|||
27588311|NCT04757753|80335533|FG001|Overall Study|Lost to Follow-up|7|||
27588312|NCT04757753|80335532|FG000|Overall Study|Withdrawal by Subject|0|||
27588313|NCT04757753|80335533|FG001|Overall Study|Withdrawal by Subject|3|||
27588314|NCT04757753|80335532|FG000|Overall Study|Endodontic treatment failure|1|||
27588315|NCT04757753|80335533|FG001|Overall Study|Endodontic treatment failure|2|||
27588316|NCT04757753|80335532|FG000|Overall Study|Tooth fracture/extraction|3|||
27687700|NCT00196976|80694088|FG004|Booster Study|Withdrawal by Subject|0|||
27687701|NCT00196976|80694089|FG005|Booster Study|Withdrawal by Subject|0|||
27687702|NCT00196976|80694090|FG006|Booster Study|Withdrawal by Subject|0|||
27687703|NCT00196976|80694091|FG007|Booster Study|Withdrawal by Subject|0|||
27687704|NCT00196976|80694092|FG008|Booster Study|Withdrawal by Subject|0|||
27687705|NCT00196976|80694093|FG009|Booster Study|Withdrawal by Subject|0|||
27687706|NCT00196976|80694094|FG010|Booster Study|Withdrawal by Subject|1|||
27687707|NCT00196976|80694095|FG011|Booster Study|Withdrawal by Subject|0|||
27687708|NCT00196976|80694096|FG012|Booster Study|Withdrawal by Subject|0|||
27687709|NCT00196976|80694097|FG013|Booster Study|Withdrawal by Subject|0|||
27687710|NCT00196976|80694084|FG000|Booster Study|Lost to Follow-up|0|||
27687711|NCT00196976|80694085|FG001|Booster Study|Lost to Follow-up|0|||
27813417|NCT01296932|81146841|FG003|Overall Study|No adequate treatment response|0|||
27813418|NCT01296932|81146842|FG004|Overall Study|No adequate treatment response|0|||
27813419|NCT01296932|81146843|FG005|Overall Study|No adequate treatment response|0|||
27813420|NCT01296932|81146844|FG006|Overall Study|No adequate treatment response|0|||
27813421|NCT01296932|81146845|FG007|Overall Study|No adequate treatment response|1|||
27813422|NCT01296932|81146846|FG008|Overall Study|No adequate treatment response|0|||
27813423|NCT01296932|81146838|FG000|Overall Study|Dosage already reduced, AE still present|0|||
27813424|NCT01296932|81146839|FG001|Overall Study|Dosage already reduced, AE still present|0|||
27813425|NCT01296932|81146840|FG002|Overall Study|Dosage already reduced, AE still present|0|||
27813426|NCT01296932|81146841|FG003|Overall Study|Dosage already reduced, AE still present|0|||
27813427|NCT01296932|81146842|FG004|Overall Study|Dosage already reduced, AE still present|0|||
27813428|NCT01296932|81146843|FG005|Overall Study|Dosage already reduced, AE still present|0|||
27813429|NCT01296932|81146844|FG006|Overall Study|Dosage already reduced, AE still present|0|||
27813430|NCT01296932|81146845|FG007|Overall Study|Dosage already reduced, AE still present|0|||
27813431|NCT01296932|81146846|FG008|Overall Study|Dosage already reduced, AE still present|1|||
27813432|NCT00135707|81146847|FG000|Overall Study|Lost to Follow-up|94|||
27813433|NCT00135707|81146848|FG001|Overall Study|Lost to Follow-up|89|||
27813434|NCT00135707|81146847|FG000|Overall Study|Withdrawal by Subject|0|||
27813435|NCT00135707|81146848|FG001|Overall Study|Withdrawal by Subject|1|||
27813436|NCT00135707|81146847|FG000|Overall Study|Institutional review board request|1|||
27813437|NCT00135707|81146848|FG001|Overall Study|Institutional review board request|0|||
27813438|NCT00743197|81146850|FG000|Overall Study|Study terminated due to departure of PI.|1|||
27813439|NCT00743197|81146851|FG001|Overall Study|Study terminated due to departure of PI.|2|||
27813440|NCT04543136|81146852|FG000|Overall Study|Withdrawal by Subject|0|||
27813441|NCT04543136|81146853|FG001|Overall Study|Withdrawal by Subject|1|||
27813442|NCT04543136|81146854|FG002|Overall Study|Withdrawal by Subject|0|||
27813443|NCT04543136|81146855|FG003|Overall Study|Withdrawal by Subject|1|||
27813444|NCT04543136|81146856|FG004|Overall Study|Withdrawal by Subject|0|||
27813445|NCT04543136|81146857|FG005|Overall Study|Withdrawal by Subject|0|||
27813446|NCT01466686|81146867|FG000|Overall Study|Withdrawal by Subject|1|||
27813447|NCT03322462|81146869|FG000|Overall Study|Technical difficulties|2|||
27813448|NCT03322462|81146869|FG000|Overall Study|Other|1|||
27813449|NCT00586521|81146872|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
27813450|NCT02427607|81146873|FG000|Overall Study|Withdrawal by Subject|1|||
27813451|NCT01400113|81146876|FG000|Overall Study|Withdrawal by Subject|1|||
27813452|NCT01400113|81146877|FG001|Overall Study|Withdrawal by Subject|1|||
27813453|NCT00601354|81146880|FG000|Overall Study|Lost to Follow-up|4|||
27813454|NCT00601354|81146881|FG001|Overall Study|Lost to Follow-up|5|||
27876215|NCT03313180|81379718|FG000|Overall Study|Lost to Follow-up|3|||
27588317|NCT04757753|80335533|FG001|Overall Study|Tooth fracture/extraction|0|||
27588318|NCT01131312|80335536|FG000|Overall Study|Lost to Follow-up|425|||
27813455|NCT02806232|81146887|FG000|Overall Study|Lost to Follow-up|1|||
27813456|NCT02806232|81146888|FG001|Overall Study|Lost to Follow-up|2|||
27813457|NCT02806232|81146889|FG002|Overall Study|Lost to Follow-up|1|||
27813458|NCT02806232|81146890|FG003|Overall Study|Lost to Follow-up|0|||
27813459|NCT02806232|81146891|FG004|Overall Study|Lost to Follow-up|0|||
27813460|NCT02806232|81146892|FG005|Overall Study|Lost to Follow-up|1|||
27813461|NCT02806232|81146893|FG006|Overall Study|Lost to Follow-up|0|||
27876216|NCT03313180|81379718|FG000|Overall Study|Withdrawal by Subject|39|||
27876217|NCT03313180|81379718|FG000|Overall Study|Other than listed above|15|||
27876218|NCT03313180|81379718|FG000|Overall Study|Covid-19 related|2|||
27876219|NCT01068860|81379727|FG000|Overall Study|Withdrawal by Subject|0|||
27876220|NCT01068860|81379728|FG001|Overall Study|Withdrawal by Subject|0|||
27876221|NCT01068860|81379729|FG002|Overall Study|Withdrawal by Subject|0|||
27876222|NCT01068860|81379730|FG003|Overall Study|Withdrawal by Subject|0|||
27876223|NCT01068860|81379731|FG004|Overall Study|Withdrawal by Subject|0|||
27876224|NCT01068860|81379732|FG005|Overall Study|Withdrawal by Subject|2|||
27876225|NCT01068860|81379733|FG006|Overall Study|Withdrawal by Subject|0|||
27876226|NCT01068860|81379734|FG007|Overall Study|Withdrawal by Subject|0|||
27588319|NCT01131312|80335537|FG001|Overall Study|Lost to Follow-up|229|||
27588320|NCT01131312|80335538|FG002|Overall Study|Lost to Follow-up|351|||
27588321|NCT00467870|80335539|FG000|Overall Study|Adverse Event|13|||
27588322|NCT00467870|80335540|FG001|Overall Study|Adverse Event|9|||
27588323|NCT00467870|80335541|FG002|Overall Study|Adverse Event|1|||
27588324|NCT00467870|80335542|FG003|Overall Study|Adverse Event|15|||
27588325|NCT00467870|80335543|FG004|Overall Study|Adverse Event|15|||
27588326|NCT00467870|80335544|FG005|Overall Study|Adverse Event|1|||
27588327|NCT00467870|80335539|FG000|Overall Study|Protocol Violation|2|||
27687712|NCT00196976|80694086|FG002|Booster Study|Lost to Follow-up|0|||
27687713|NCT00196976|80694087|FG003|Booster Study|Lost to Follow-up|0|||
27813462|NCT02806232|81146894|FG007|Overall Study|Lost to Follow-up|0|||
27813463|NCT02806232|81146895|FG008|Overall Study|Lost to Follow-up|0|||
27813464|NCT02806232|81146887|FG000|Overall Study|Withdrawal by Subject|0|||
27813465|NCT02806232|81146888|FG001|Overall Study|Withdrawal by Subject|2|||
27813466|NCT02806232|81146889|FG002|Overall Study|Withdrawal by Subject|0|||
27813467|NCT02806232|81146890|FG003|Overall Study|Withdrawal by Subject|0|||
27813468|NCT02806232|81146891|FG004|Overall Study|Withdrawal by Subject|2|||
27813469|NCT02806232|81146892|FG005|Overall Study|Withdrawal by Subject|1|||
27813470|NCT02806232|81146893|FG006|Overall Study|Withdrawal by Subject|0|||
27813471|NCT02806232|81146894|FG007|Overall Study|Withdrawal by Subject|0|||
27813472|NCT02806232|81146895|FG008|Overall Study|Withdrawal by Subject|0|||
27813473|NCT04480463|81146900|FG000|Overall Study|Death|0|||
27813474|NCT04480463|81146901|FG001|Overall Study|Death|1|||
27813475|NCT04480463|81146900|FG000|Overall Study|Adverse Event|6|||
27813476|NCT04480463|81146901|FG001|Overall Study|Adverse Event|8|||
27813477|NCT04480463|81146900|FG000|Overall Study|Lost to Follow-up|3|||
27813478|NCT04480463|81146901|FG001|Overall Study|Lost to Follow-up|2|||
27813479|NCT04480463|81146900|FG000|Overall Study|Physician Decision|2|||
27813480|NCT04480463|81146901|FG001|Overall Study|Physician Decision|5|||
27813481|NCT04480463|81146900|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
27813482|NCT04480463|81146901|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
27813483|NCT04480463|81146900|FG000|Overall Study|Protocol Violation|2|||
27813484|NCT04480463|81146901|FG001|Overall Study|Protocol Violation|1|||
27813485|NCT04480463|81146900|FG000|Overall Study|Withdrawal by Subject|6|||
27813486|NCT04480463|81146901|FG001|Overall Study|Withdrawal by Subject|7|||
27813487|NCT04480463|81146900|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
27813488|NCT04480463|81146901|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
27813489|NCT04480463|81146900|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
27813490|NCT04480463|81146901|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
27813491|NCT04480463|81146900|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
27813492|NCT04480463|81146901|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
27813493|NCT04480463|81146900|FG000|Overall Study|Other|6|||
27813494|NCT04480463|81146901|FG001|Overall Study|Other|4|||
27813495|NCT01506323|81146902|FG000|Overall Study|Lost to Follow-up|5|||
27813496|NCT01506323|81146903|FG001|Overall Study|Lost to Follow-up|4|||
27813497|NCT01506323|81146902|FG000|Overall Study|Withdrawal by Subject|4|||
27876227|NCT01068860|81379735|FG008|Overall Study|Withdrawal by Subject|0|||
27876228|NCT01068860|81379736|FG009|Overall Study|Withdrawal by Subject|3|||
27876229|NCT01068860|81379727|FG000|Overall Study|Administrative problems; misrandomized|0|||
27588328|NCT00467870|80335540|FG001|Overall Study|Protocol Violation|1|||
27813498|NCT01506323|81146903|FG001|Overall Study|Withdrawal by Subject|4|||
27813499|NCT01506323|81146902|FG000|Overall Study|Lack of Efficacy|1|||
27813500|NCT01506323|81146903|FG001|Overall Study|Lack of Efficacy|3|||
27813501|NCT01506323|81146902|FG000|Overall Study|Moved out of area|5|||
27813502|NCT01506323|81146903|FG001|Overall Study|Moved out of area|2|||
27813503|NCT01506323|81146902|FG000|Overall Study|Schedule or Transportation conflict|8|||
27876230|NCT01068860|81379728|FG001|Overall Study|Administrative problems; misrandomized|0|||
27876231|NCT01068860|81379729|FG002|Overall Study|Administrative problems; misrandomized|0|||
27876232|NCT01068860|81379730|FG003|Overall Study|Administrative problems; misrandomized|1|||
27876233|NCT01068860|81379731|FG004|Overall Study|Administrative problems; misrandomized|0|||
27876234|NCT01068860|81379732|FG005|Overall Study|Administrative problems; misrandomized|0|||
27876235|NCT01068860|81379733|FG006|Overall Study|Administrative problems; misrandomized|0|||
27876236|NCT01068860|81379734|FG007|Overall Study|Administrative problems; misrandomized|0|||
27876237|NCT01068860|81379735|FG008|Overall Study|Administrative problems; misrandomized|0|||
27876238|NCT01068860|81379736|FG009|Overall Study|Administrative problems; misrandomized|1|||
27876239|NCT01068860|81379727|FG000|Overall Study|Lost to Follow-up|0|||
27876240|NCT01068860|81379728|FG001|Overall Study|Lost to Follow-up|1|||
27588329|NCT00467870|80335541|FG002|Overall Study|Protocol Violation|1|||
27588330|NCT00467870|80335542|FG003|Overall Study|Protocol Violation|2|||
27588331|NCT00467870|80335543|FG004|Overall Study|Protocol Violation|0|||
27588332|NCT00467870|80335544|FG005|Overall Study|Protocol Violation|0|||
27588333|NCT00467870|80335539|FG000|Overall Study|Withdrawal by Subject|14|||
27588334|NCT00467870|80335540|FG001|Overall Study|Withdrawal by Subject|21|||
27588335|NCT00467870|80335541|FG002|Overall Study|Withdrawal by Subject|0|||
27588336|NCT00467870|80335542|FG003|Overall Study|Withdrawal by Subject|9|||
27588337|NCT00467870|80335543|FG004|Overall Study|Withdrawal by Subject|10|||
27588338|NCT00467870|80335544|FG005|Overall Study|Withdrawal by Subject|1|||
27588339|NCT00467870|80335539|FG000|Overall Study|Lost to Follow-up|5|||
27588340|NCT00467870|80335540|FG001|Overall Study|Lost to Follow-up|3|||
27588341|NCT00467870|80335541|FG002|Overall Study|Lost to Follow-up|1|||
27588342|NCT00467870|80335542|FG003|Overall Study|Lost to Follow-up|1|||
27588343|NCT00467870|80335543|FG004|Overall Study|Lost to Follow-up|3|||
27588344|NCT00467870|80335544|FG005|Overall Study|Lost to Follow-up|0|||
27588345|NCT00467870|80335539|FG000|Overall Study|Subject Non-compliance|3|||
27588346|NCT00467870|80335540|FG001|Overall Study|Subject Non-compliance|4|||
27588347|NCT00467870|80335541|FG002|Overall Study|Subject Non-compliance|0|||
27588348|NCT00467870|80335542|FG003|Overall Study|Subject Non-compliance|1|||
27588349|NCT00467870|80335543|FG004|Overall Study|Subject Non-compliance|5|||
27588350|NCT00467870|80335544|FG005|Overall Study|Subject Non-compliance|0|||
27588351|NCT00467870|80335539|FG000|Overall Study|Other/Unknown|8|||
27588352|NCT00467870|80335540|FG001|Overall Study|Other/Unknown|5|||
27876241|NCT01068860|81379729|FG002|Overall Study|Lost to Follow-up|0|||
27876242|NCT01068860|81379730|FG003|Overall Study|Lost to Follow-up|0|||
27876243|NCT01068860|81379731|FG004|Overall Study|Lost to Follow-up|0|||
27876244|NCT01068860|81379732|FG005|Overall Study|Lost to Follow-up|0|||
27876245|NCT01068860|81379733|FG006|Overall Study|Lost to Follow-up|0|||
27876246|NCT01068860|81379734|FG007|Overall Study|Lost to Follow-up|0|||
27876247|NCT01068860|81379735|FG008|Overall Study|Lost to Follow-up|0|||
27876248|NCT01068860|81379736|FG009|Overall Study|Lost to Follow-up|0|||
27876249|NCT03214224|81379737|FG000|Overall Study|Protocol Violation|1|||
27876250|NCT03214224|81379737|FG000|Overall Study|Withdrawal by Subject|2|||
27876251|NCT03214224|81379737|FG000|Overall Study|Practice controls or therapists|6|||
27876252|NCT04054765|81379740|FG000|Baseline|Withdrawal by Subject|5|||
27876253|NCT04054765|81379741|FG001|Baseline|Withdrawal by Subject|3|||
27876254|NCT04054765|81379740|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
27876255|NCT04054765|81379741|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
27876256|NCT04054765|81379740|FG000|3-month Follow up|Withdrawal by Subject|0|||
27876257|NCT04054765|81379741|FG001|3-month Follow up|Withdrawal by Subject|3|||
27876258|NCT04054765|81379740|FG000|6-month Follow up|Lost to Follow-up|32|||
27876259|NCT04054765|81379741|FG001|6-month Follow up|Lost to Follow-up|32|||
27876260|NCT02568072|81379742|FG000|Overall Study|Unavailable for appointment|23|||
27876261|NCT02568072|81379742|FG000|Overall Study|Unable to contact|3|||
27588353|NCT00467870|80335541|FG002|Overall Study|Other/Unknown|1|||
27588354|NCT00467870|80335542|FG003|Overall Study|Other/Unknown|5|||
27588355|NCT00467870|80335543|FG004|Overall Study|Other/Unknown|4|||
27588356|NCT00467870|80335544|FG005|Overall Study|Other/Unknown|0|||
27588357|NCT02365467|80335545|FG000|Overall Study|Death|3|||
27876262|NCT02568072|81379742|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
27876263|NCT02568072|81379742|FG000|Overall Study|Withdrawal by Subject|1|||
27876264|NCT02568072|81379742|FG000|Overall Study|Sustained injury, marathon not run|24|||
27588358|NCT05554237|80335551|FG000|Part 2 (7 Days)|Adverse Event|0|||
27876265|NCT04421131|81379745|FG000|Overall Study|Lost to Follow-up|1|||
27588359|NCT05554237|80335552|FG001|Part 2 (7 Days)|Adverse Event|0|||
27588360|NCT05554237|80335553|FG002|Part 2 (7 Days)|Adverse Event|0|||
27813504|NCT01506323|81146903|FG001|Overall Study|Schedule or Transportation conflict|0|||
27813505|NCT01506323|81146902|FG000|Overall Study|Started another treatment|1|||
27813506|NCT01506323|81146903|FG001|Overall Study|Started another treatment|0|||
27813507|NCT00108732|81146904|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
27813508|NCT00108732|81146904|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
27813509|NCT00108732|81146904|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
27813510|NCT00108732|81146904|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
27813511|NCT00108732|81146904|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
27813512|NCT00108732|81146904|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
27813513|NCT00108732|81146904|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
27813514|NCT01185288|81146905|FG000|Overall Study|Adverse Event|7|||
27813515|NCT01185288|81146906|FG001|Overall Study|Adverse Event|6|||
27813516|NCT01185288|81146905|FG000|Overall Study|Withdrawal by Subject|6|||
27813517|NCT01185288|81146906|FG001|Overall Study|Withdrawal by Subject|4|||
27813518|NCT01185288|81146905|FG000|Overall Study|Lost to Follow-up|2|||
27813519|NCT01185288|81146906|FG001|Overall Study|Lost to Follow-up|5|||
27813520|NCT01185288|81146905|FG000|Overall Study|Lack of Efficacy|2|||
27813521|NCT01185288|81146906|FG001|Overall Study|Lack of Efficacy|0|||
27813522|NCT01185288|81146905|FG000|Overall Study|Investigator discretion|1|||
27813523|NCT01185288|81146906|FG001|Overall Study|Investigator discretion|0|||
27813524|NCT01185288|81146905|FG000|Overall Study|Did not meet inclusion criteria|1|||
27813525|NCT01185288|81146906|FG001|Overall Study|Did not meet inclusion criteria|0|||
27813526|NCT01185288|81146905|FG000|Overall Study|Noncompliance|0|||
27813527|NCT01185288|81146906|FG001|Overall Study|Noncompliance|1|||
27813528|NCT00555009|81146911|FG000|Overall Study|Withdrawal by Subject|0|||
27813529|NCT00555009|81146912|FG001|Overall Study|Withdrawal by Subject|1|||
27813530|NCT00555009|81146911|FG000|Overall Study|Terminated by Sponsor|2|||
27813531|NCT00555009|81146912|FG001|Overall Study|Terminated by Sponsor|5|||
27813532|NCT04583579|81146916|FG000|Overall Study|Lost to Follow-up|4|||
27813533|NCT00266409|81146917|FG000|Overall Study|Lack of Efficacy|2|||
27813534|NCT00266409|81146918|FG001|Overall Study|Lack of Efficacy|6|||
27813535|NCT00266409|81146919|FG002|Overall Study|Lack of Efficacy|1|||
27813536|NCT00266409|81146920|FG003|Overall Study|Lack of Efficacy|2|||
27813537|NCT00266409|81146917|FG000|Overall Study|Adverse Event|7|||
27813538|NCT00266409|81146918|FG001|Overall Study|Adverse Event|2|||
27813539|NCT00266409|81146919|FG002|Overall Study|Adverse Event|1|||
27813540|NCT00266409|81146920|FG003|Overall Study|Adverse Event|1|||
27813541|NCT00266409|81146917|FG000|Overall Study|Lost to Follow-up|18|||
27813542|NCT00266409|81146918|FG001|Overall Study|Lost to Follow-up|21|||
27813543|NCT00266409|81146919|FG002|Overall Study|Lost to Follow-up|6|||
27813544|NCT00266409|81146920|FG003|Overall Study|Lost to Follow-up|8|||
27813545|NCT00266409|81146917|FG000|Overall Study|Withdrawal by Subject|6|||
27813546|NCT00266409|81146918|FG001|Overall Study|Withdrawal by Subject|10|||
27813547|NCT00266409|81146919|FG002|Overall Study|Withdrawal by Subject|3|||
27813548|NCT00266409|81146920|FG003|Overall Study|Withdrawal by Subject|9|||
27813549|NCT00266409|81146917|FG000|Overall Study|Protocol Violation|5|||
27813550|NCT00266409|81146918|FG001|Overall Study|Protocol Violation|3|||
27813551|NCT00266409|81146919|FG002|Overall Study|Protocol Violation|4|||
27813552|NCT00266409|81146920|FG003|Overall Study|Protocol Violation|2|||
27813553|NCT00266409|81146917|FG000|Overall Study|Other|7|||
27813554|NCT00266409|81146918|FG001|Overall Study|Other|4|||
27813555|NCT00266409|81146919|FG002|Overall Study|Other|2|||
27813556|NCT00266409|81146920|FG003|Overall Study|Other|0|||
27813557|NCT00970281|81146921|FG000|Overall Study|Lack of Efficacy|1|||
27813558|NCT00970281|81146922|FG001|Overall Study|Lack of Efficacy|14|||
27813559|NCT00970281|81146921|FG000|Overall Study|Withdrawal by Subject|0|||
27813560|NCT00970281|81146922|FG001|Overall Study|Withdrawal by Subject|1|||
27813561|NCT00970281|81146921|FG000|Overall Study|Physician Decision|1|||
27813562|NCT00970281|81146922|FG001|Overall Study|Physician Decision|1|||
27813563|NCT01691248|81146923|FG000|Overall Study|Protocol Violation|43|||
27813564|NCT01691248|81146924|FG001|Overall Study|Protocol Violation|27|||
27813565|NCT01691248|81146923|FG000|Overall Study|Adverse Event|24|||
27813566|NCT01691248|81146924|FG001|Overall Study|Adverse Event|22|||
27813567|NCT01691248|81146923|FG000|Overall Study|Withdrawal by Subject|20|||
27813568|NCT01691248|81146924|FG001|Overall Study|Withdrawal by Subject|18|||
27813569|NCT01691248|81146923|FG000|Overall Study|Confirmed CDAD|14|||
27813570|NCT01691248|81146924|FG001|Overall Study|Confirmed CDAD|31|||
27813571|NCT01691248|81146923|FG000|Overall Study|Lost to Follow-up|2|||
27813572|NCT01691248|81146924|FG001|Overall Study|Lost to Follow-up|5|||
27813573|NCT01691248|81146923|FG000|Overall Study|Reason not provided|4|||
27813574|NCT01691248|81146924|FG001|Overall Study|Reason not provided|4|||
27813575|NCT01691248|81146923|FG000|Overall Study|Not Treated|4|||
27813576|NCT01691248|81146924|FG001|Overall Study|Not Treated|7|||
27813577|NCT02750306|81146925|FG000|Overall Study|Withdrawal by Subject|5|||
27813578|NCT02750306|81146926|FG001|Overall Study|Withdrawal by Subject|2|||
27813579|NCT02750306|81146925|FG000|Overall Study|Protocol Violation|1|||
27813580|NCT02750306|81146926|FG001|Overall Study|Protocol Violation|0|||
27813581|NCT01631864|81146927|FG000|Overall Study|Withdrawal by Subject|0|||
27813582|NCT01631864|81146928|FG001|Overall Study|Withdrawal by Subject|1|||
27813583|NCT01631864|81146927|FG000|Overall Study|Adverse Event|2|||
27813584|NCT01631864|81146928|FG001|Overall Study|Adverse Event|3|||
27813585|NCT02623829|81146929|FG000|Overall Study|Lost to Follow-up|1|||
27813586|NCT02623829|81146930|FG001|Overall Study|Lost to Follow-up|1|||
27813587|NCT01364870|81146931|FG000|Overall Study|Withdrawal by Subject|13|||
27813588|NCT01364870|81146932|FG001|Overall Study|Withdrawal by Subject|24|||
27813589|NCT01364870|81146933|FG002|Overall Study|Withdrawal by Subject|10|||
27813590|NCT01364870|81146931|FG000|Overall Study|Adverse Event|8|||
27813591|NCT01364870|81146932|FG001|Overall Study|Adverse Event|6|||
27813592|NCT01364870|81146933|FG002|Overall Study|Adverse Event|4|||
27813593|NCT01364870|81146931|FG000|Overall Study|Protocol Violation|1|||
27813594|NCT01364870|81146932|FG001|Overall Study|Protocol Violation|0|||
27813595|NCT01364870|81146933|FG002|Overall Study|Protocol Violation|0|||
27813596|NCT03529955|81146934|FG000|Overall Study|Adverse Event|1|||
27813597|NCT03529955|81146934|FG000|Overall Study|Lack of Efficacy|1|||
27813598|NCT00662129|81146939|FG000|Overall Study|Protocol Violation|1|||
27813599|NCT00662129|81146939|FG000|Overall Study|Cancel prior to beginning treatment|1|||
27813600|NCT00662129|81146939|FG000|Overall Study|Ineligible|1|||
27813601|NCT00635778|81146944|FG000|Overall Study|Adverse Event|1|||
27813602|NCT00635778|81146945|FG001|Overall Study|Adverse Event|0|||
27813603|NCT00635778|81146946|FG002|Overall Study|Adverse Event|0|||
27813604|NCT00635778|81146947|FG003|Overall Study|Adverse Event|3|||
27813605|NCT00635778|81146948|FG004|Overall Study|Adverse Event|3|||
27813606|NCT00635778|81146949|FG005|Overall Study|Adverse Event|6|||
27813607|NCT00635778|81146950|FG006|Overall Study|Adverse Event|1|||
27813608|NCT00635778|81146944|FG000|Overall Study|Withdrawal by Subject|0|||
27813609|NCT00635778|81146945|FG001|Overall Study|Withdrawal by Subject|0|||
27813610|NCT00635778|81146946|FG002|Overall Study|Withdrawal by Subject|0|||
27813611|NCT00635778|81146947|FG003|Overall Study|Withdrawal by Subject|1|||
27813612|NCT00635778|81146948|FG004|Overall Study|Withdrawal by Subject|0|||
27813613|NCT00635778|81146949|FG005|Overall Study|Withdrawal by Subject|1|||
27813614|NCT00635778|81146950|FG006|Overall Study|Withdrawal by Subject|1|||
27813615|NCT00635778|81146944|FG000|Overall Study|Progressive disease|0|||
27813616|NCT00635778|81146945|FG001|Overall Study|Progressive disease|3|||
27813617|NCT00635778|81146946|FG002|Overall Study|Progressive disease|3|||
27813618|NCT00635778|81146947|FG003|Overall Study|Progressive disease|4|||
27813619|NCT00635778|81146948|FG004|Overall Study|Progressive disease|5|||
27813620|NCT00635778|81146949|FG005|Overall Study|Progressive disease|14|||
27813621|NCT00635778|81146950|FG006|Overall Study|Progressive disease|4|||
27813622|NCT00996736|81146951|FG000|Overall Study|Death|1|||
27813623|NCT00996736|81146952|FG001|Overall Study|Death|1|||
27813624|NCT00996736|81146951|FG000|Overall Study|Lost to Follow-up|15|||
27813625|NCT00996736|81146952|FG001|Overall Study|Lost to Follow-up|14|||
27813626|NCT00996736|81146951|FG000|Overall Study|Visit not within 3-month window|5|||
27813627|NCT00996736|81146952|FG001|Overall Study|Visit not within 3-month window|3|||
27813628|NCT00582309|81146964|FG000|Overall Study|Protocol Violation|0|||
27813629|NCT00582309|81146965|FG001|Overall Study|Protocol Violation|0|||
27813630|NCT00582309|81146966|FG002|Overall Study|Protocol Violation|2|||
27813631|NCT03211156|81146967|FG000|Overall Study|Withdrawal by Subject|0|||
27813632|NCT03211156|81146968|FG001|Overall Study|Withdrawal by Subject|2|||
27813633|NCT03211156|81146967|FG000|Overall Study|Lost to Follow-up|1|||
27813634|NCT03211156|81146968|FG001|Overall Study|Lost to Follow-up|1|||
27813635|NCT03211156|81146967|FG000|Overall Study|Adverse Event|1|||
27876266|NCT04421131|81379745|FG000|Overall Study|Protocol Violation|2|||
27876267|NCT04421131|81379745|FG000|Overall Study|App crashed|5|||
27876268|NCT04021914|81379746|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
27876269|NCT04341363|81379747|FG000|Overall Study|Adverse Event|1|||
27876270|NCT04341363|81379747|FG000|Overall Study|Withdrawal by Subject|1|||
27876271|NCT01808066|81379748|FG000|Overall Study|Withdrawal by Subject|15|||
27876272|NCT02810457|81379753|FG000|Overall Study|Randomised but no treatment received|2|||
27876273|NCT02810457|81379754|FG001|Overall Study|Randomised but no treatment received|1|||
27876274|NCT02810457|81379753|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
27876275|NCT02810457|81379754|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
27876276|NCT02810457|81379753|FG000|Overall Study|Adverse Event|37|||
27876277|NCT02810457|81379754|FG001|Overall Study|Adverse Event|43|||
27876278|NCT02810457|81379753|FG000|Overall Study|Patient decision|31|||
27876279|NCT02810457|81379754|FG001|Overall Study|Patient decision|35|||
27876280|NCT02810457|81379753|FG000|Overall Study|Patient lost to follow-up|2|||
27876281|NCT02810457|81379754|FG001|Overall Study|Patient lost to follow-up|2|||
27876282|NCT02810457|81379753|FG000|Overall Study|Death|39|||
27588361|NCT05554237|80335554|FG003|Part 2 (7 Days)|Adverse Event|0|||
27588362|NCT05554237|80335555|FG004|Part 2 (7 Days)|Adverse Event|2|||
27588363|NCT05554237|80335556|FG005|Part 2 (7 Days)|Adverse Event|0|||
27588364|NCT05554237|80335557|FG006|Part 2 (7 Days)|Adverse Event|0|||
27588365|NCT05554237|80335558|FG007|Part 2 (7 Days)|Adverse Event|0|||
27588366|NCT05554237|80335559|FG008|Part 2 (7 Days)|Adverse Event|0|||
27588367|NCT05554237|80335560|FG009|Part 2 (7 Days)|Adverse Event|1|||
27876283|NCT02810457|81379754|FG001|Overall Study|Death|28|||
27876284|NCT02810457|81379753|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
27876285|NCT02810457|81379754|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
27588368|NCT05554237|80335561|FG010|Part 2 (7 Days)|Adverse Event|0|||
27588369|NCT05554237|80335562|FG011|Part 2 (7 Days)|Adverse Event|0|||
27876286|NCT02810457|81379753|FG000|Overall Study|Clinical progression|15|||
27588370|NCT05554237|80335563|FG012|Part 2 (7 Days)|Adverse Event|1|||
27876287|NCT02810457|81379754|FG001|Overall Study|Clinical progression|16|||
27876288|NCT02810457|81379753|FG000|Overall Study|Investigator decision|3|||
27687714|NCT00196976|80694088|FG004|Booster Study|Lost to Follow-up|0|||
27687715|NCT00196976|80694089|FG005|Booster Study|Lost to Follow-up|0|||
27687716|NCT00196976|80694090|FG006|Booster Study|Lost to Follow-up|0|||
27687717|NCT00196976|80694091|FG007|Booster Study|Lost to Follow-up|0|||
27687718|NCT00196976|80694092|FG008|Booster Study|Lost to Follow-up|0|||
27687719|NCT00196976|80694093|FG009|Booster Study|Lost to Follow-up|0|||
27813636|NCT03211156|81146968|FG001|Overall Study|Adverse Event|0|||
27813637|NCT01107535|81146969|FG000|Overall Study|Death|5|||
27813638|NCT02410252|81146972|FG000|Overall Study|Withdrawal by Subject|4|||
27813639|NCT02410252|81146972|FG000|Overall Study|Physician Decision|2|||
27813640|NCT04588259|81150128|FG000|Run-in Period|Run-in failure|0|||
27813641|NCT04588259|81150129|FG001|Run-in Period|Run-in failure|23|||
27813642|NCT04588259|81150128|FG000|Run-in Period|Withdrawn before randomisation|0|||
27813643|NCT04588259|81150129|FG001|Run-in Period|Withdrawn before randomisation|8|||
27687720|NCT00196976|80694094|FG010|Booster Study|Lost to Follow-up|1|||
27687721|NCT00196976|80694095|FG011|Booster Study|Lost to Follow-up|2|||
27687722|NCT00196976|80694096|FG012|Booster Study|Lost to Follow-up|0|||
27687723|NCT00196976|80694097|FG013|Booster Study|Lost to Follow-up|0|||
27687724|NCT02581631|80694098|FG000|Overall Study|Disease progression|29|||
27687725|NCT02581631|80694099|FG001|Overall Study|Disease progression|19|||
27687726|NCT02581631|80694100|FG002|Overall Study|Disease progression|13|||
27687727|NCT02581631|80694101|FG003|Overall Study|Disease progression|5|||
27687728|NCT02581631|80694102|FG004|Overall Study|Disease progression|8|||
27687729|NCT02581631|80694098|FG000|Overall Study|Study drug toxicity|4|||
27687730|NCT02581631|80694099|FG001|Overall Study|Study drug toxicity|6|||
27687731|NCT02581631|80694100|FG002|Overall Study|Study drug toxicity|7|||
27687732|NCT02581631|80694101|FG003|Overall Study|Study drug toxicity|0|||
27687733|NCT02581631|80694102|FG004|Overall Study|Study drug toxicity|3|||
27687734|NCT02581631|80694098|FG000|Overall Study|AE unrelated to study drug|3|||
27687735|NCT02581631|80694099|FG001|Overall Study|AE unrelated to study drug|1|||
27687736|NCT02581631|80694100|FG002|Overall Study|AE unrelated to study drug|1|||
27687737|NCT02581631|80694101|FG003|Overall Study|AE unrelated to study drug|0|||
27687738|NCT02581631|80694102|FG004|Overall Study|AE unrelated to study drug|2|||
27687739|NCT02581631|80694098|FG000|Overall Study|Request to discontinue|1|||
27687740|NCT02581631|80694099|FG001|Overall Study|Request to discontinue|0|||
27687741|NCT02581631|80694100|FG002|Overall Study|Request to discontinue|3|||
27687742|NCT02581631|80694101|FG003|Overall Study|Request to discontinue|0|||
27687743|NCT02581631|80694102|FG004|Overall Study|Request to discontinue|1|||
27687744|NCT02581631|80694098|FG000|Overall Study|participant withdrew consent|3|||
27687745|NCT02581631|80694099|FG001|Overall Study|participant withdrew consent|0|||
27687746|NCT02581631|80694100|FG002|Overall Study|participant withdrew consent|1|||
27687747|NCT02581631|80694101|FG003|Overall Study|participant withdrew consent|0|||
27687748|NCT02581631|80694102|FG004|Overall Study|participant withdrew consent|0|||
27687749|NCT02581631|80694098|FG000|Overall Study|Maximum clinical benefit|1|||
27687750|NCT02581631|80694099|FG001|Overall Study|Maximum clinical benefit|7|||
27687751|NCT02581631|80694100|FG002|Overall Study|Maximum clinical benefit|1|||
27687752|NCT02581631|80694101|FG003|Overall Study|Maximum clinical benefit|3|||
27687753|NCT02581631|80694102|FG004|Overall Study|Maximum clinical benefit|13|||
27687754|NCT02581631|80694098|FG000|Overall Study|Other Reasons|1|||
27687755|NCT02581631|80694099|FG001|Overall Study|Other Reasons|0|||
27687756|NCT02581631|80694100|FG002|Overall Study|Other Reasons|2|||
27687757|NCT02581631|80694101|FG003|Overall Study|Other Reasons|2|||
27813644|NCT04588259|81150128|FG000|Treatment Period|Withdrawal by Subject|6|||
27813645|NCT04588259|81150129|FG001|Treatment Period|Withdrawal by Subject|6|||
27687758|NCT02581631|80694102|FG004|Overall Study|Other Reasons|3|||
27687759|NCT02581631|80694098|FG000|Overall Study|Poor/Non-Compliance|0|||
27813646|NCT01066052|81150130|FG000|Overall Study|Enrolled But Not Treated|3|||
27687760|NCT02581631|80694099|FG001|Overall Study|Poor/Non-Compliance|0|||
27687761|NCT02581631|80694100|FG002|Overall Study|Poor/Non-Compliance|1|||
27687762|NCT02581631|80694101|FG003|Overall Study|Poor/Non-Compliance|0|||
27687763|NCT02581631|80694102|FG004|Overall Study|Poor/Non-Compliance|0|||
27687764|NCT02245737|80694105|FG000|Overall Study|Adverse Event|23|||
27813647|NCT01066052|81150131|FG001|Overall Study|Enrolled But Not Treated|0|||
27813648|NCT03870997|81150132|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
27813649|NCT03870997|81150133|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
27813650|NCT03870997|81150134|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
27813651|NCT03870997|81150135|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
27813652|NCT03870997|81150136|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
27813653|NCT03870997|81150137|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
27813654|NCT02448771|81150139|FG000|Overall Study|Disease Progression|30|||
27813655|NCT02448771|81150139|FG000|Overall Study|Unacceptable Toxicity|1|||
27813656|NCT02448771|81150139|FG000|Overall Study|Physician Decision|3|||
27813657|NCT02448771|81150139|FG000|Overall Study|Started new therapy|2|||
27813658|NCT01644890|81150140|FG000|Overall Study|Adverse Event|7|||
27813659|NCT01644890|81150141|FG001|Overall Study|Adverse Event|20|||
27813660|NCT01644890|81150140|FG000|Overall Study|Death|1|||
27813661|NCT01644890|81150141|FG001|Overall Study|Death|3|||
27813662|NCT01644890|81150140|FG000|Overall Study|Physician Decision|3|||
27813663|NCT01644890|81150141|FG001|Overall Study|Physician Decision|9|||
27813664|NCT01644890|81150140|FG000|Overall Study|Protocol Violation|6|||
27813665|NCT01644890|81150141|FG001|Overall Study|Protocol Violation|7|||
27813666|NCT01644890|81150140|FG000|Overall Study|Withdrawal by Subject|19|||
27813667|NCT01644890|81150141|FG001|Overall Study|Withdrawal by Subject|27|||
27813668|NCT01644890|81150140|FG000|Overall Study|Progression Disease|160|||
27813669|NCT01644890|81150141|FG001|Overall Study|Progression Disease|131|||
27588371|NCT05554237|80335564|FG013|Part 2 (7 Days)|Adverse Event|0|||
27588372|NCT00455195|80335565|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
27687765|NCT02245737|80694106|FG001|Overall Study|Adverse Event|26|||
27687766|NCT02245737|80694107|FG002|Overall Study|Adverse Event|33|||
27876289|NCT02810457|81379754|FG001|Overall Study|Investigator decision|2|||
27588373|NCT00455195|80335566|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
27588374|NCT00455195|80335565|FG000|Double-blind Study AGLU02704|Death|1|||
27588375|NCT00455195|80335566|FG001|Double-blind Study AGLU02704|Death|0|||
27588376|NCT00455195|80335565|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
27588377|NCT00455195|80335566|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
27588378|NCT00455195|80335565|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
27588379|NCT00455195|80335566|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
27588380|NCT02091726|80335569|FG000|Overall Study|Lost to Follow-up|6|||
27588381|NCT01159938|80335570|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27588382|NCT01159938|80335571|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27588383|NCT01159938|80335572|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
27588384|NCT01159938|80335573|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27588385|NCT01159938|80335574|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
27588386|NCT00833989|80335575|FG000|Overall Study|Physician Decision|0|||
27588387|NCT00833989|80335576|FG001|Overall Study|Physician Decision|0|||
27588388|NCT00833989|80335577|FG002|Overall Study|Physician Decision|0|||
27588389|NCT00833989|80335578|FG003|Overall Study|Physician Decision|1|||
27588390|NCT00833989|80335575|FG000|Overall Study|Withdrawal by Subject|3|||
27588391|NCT00833989|80335576|FG001|Overall Study|Withdrawal by Subject|0|||
27588392|NCT00833989|80335577|FG002|Overall Study|Withdrawal by Subject|1|||
27588393|NCT00833989|80335578|FG003|Overall Study|Withdrawal by Subject|1|||
27588394|NCT02007577|80335579|FG000|Overall Study|Adverse Event|1|||
27588395|NCT02007577|80335580|FG001|Overall Study|Adverse Event|0|||
27588396|NCT02007577|80335579|FG000|Overall Study|Withdrawal by Subject|0|||
27588397|NCT02007577|80335580|FG001|Overall Study|Withdrawal by Subject|1|||
27588398|NCT02543346|80335586|FG000|Second Priming Visit|Withdrawal by Subject|0|||
27588399|NCT02543346|80335587|FG001|Second Priming Visit|Withdrawal by Subject|2|||
27588400|NCT02543346|80335588|FG002|Second Priming Visit|Withdrawal by Subject|2|||
27588401|NCT02543346|80335589|FG003|Second Priming Visit|Withdrawal by Subject|2|||
27588402|NCT02543346|80335586|FG000|Second Priming Visit|Adverse Event|1|||
27588403|NCT02543346|80335587|FG001|Second Priming Visit|Adverse Event|0|||
27588404|NCT02543346|80335588|FG002|Second Priming Visit|Adverse Event|0|||
27588405|NCT02543346|80335589|FG003|Second Priming Visit|Adverse Event|0|||
27588406|NCT01496976|80335590|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
27588407|NCT04743908|80335593|FG000|Overall Study|Death|1|||
27588408|NCT04743908|80335594|FG001|Overall Study|Death|0|||
27588409|NCT04743908|80335593|FG000|Overall Study|Lost to Follow-up|181|||
27588410|NCT04743908|80335594|FG001|Overall Study|Lost to Follow-up|180|||
27588411|NCT04743908|80335593|FG000|Overall Study|Withdrawal by Subject|1|||
27588412|NCT04743908|80335594|FG001|Overall Study|Withdrawal by Subject|2|||
27588413|NCT04154787|80335595|FG000|Overall Study|Adverse Event|0|||
27588414|NCT04154787|80335596|FG001|Overall Study|Adverse Event|1|||
27588415|NCT04154787|80335597|FG002|Overall Study|Adverse Event|0|||
27588416|NCT04154787|80335595|FG000|Overall Study|Patient Requires Other Treatment|0|||
27588417|NCT04154787|80335596|FG001|Overall Study|Patient Requires Other Treatment|1|||
27588418|NCT04154787|80335597|FG002|Overall Study|Patient Requires Other Treatment|0|||
27588419|NCT04154787|80335595|FG000|Overall Study|Study Terminated By Sponsor|0|||
27588420|NCT04154787|80335596|FG001|Overall Study|Study Terminated By Sponsor|6|||
27588421|NCT04154787|80335597|FG002|Overall Study|Study Terminated By Sponsor|1|||
27588422|NCT04154787|80335595|FG000|Overall Study|Subject Decision|0|||
27588423|NCT04154787|80335596|FG001|Overall Study|Subject Decision|1|||
27687767|NCT02245737|80694105|FG000|Overall Study|Condition Worsened|9|||
27588424|NCT04154787|80335597|FG002|Overall Study|Subject Decision|0|||
27588425|NCT04154787|80335595|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
27588426|NCT04154787|80335596|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
27588427|NCT04154787|80335597|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
27588428|NCT02508311|80335598|FG000|Overall Study|Withdrawal by Subject|1|||
27588429|NCT02508311|80335599|FG001|Overall Study|Withdrawal by Subject|0|||
27588430|NCT02079805|80335600|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27588431|NCT02079805|80335601|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27588432|NCT02079805|80335600|FG000|Overall Study|Voluntary Withdrawal|0|||
27588433|NCT02079805|80335601|FG001|Overall Study|Voluntary Withdrawal|1|||
27588434|NCT01343082|80335602|FG000|The run-in Period|Not meeting criteria|3|||
27588435|NCT01343082|80335603|FG001|The run-in Period|Not meeting criteria|4|||
27588436|NCT01343082|80335604|FG002|The run-in Period|Not meeting criteria|5|||
27588437|NCT01343082|80335602|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
27588438|NCT01343082|80335603|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
27588439|NCT01343082|80335604|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
27588440|NCT01343082|80335602|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
27588441|NCT01343082|80335603|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
27588442|NCT01343082|80335604|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
27588443|NCT01343082|80335602|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
27588444|NCT01343082|80335603|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
27588445|NCT01343082|80335604|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
27588446|NCT01343082|80335602|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
27588447|NCT01343082|80335603|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
27588448|NCT01343082|80335604|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
27588449|NCT02132611|80335609|FG000|Overall Study|Death|2|||
27588450|NCT01808690|80335612|FG000|Overall Study|Withdrawal by Subject|1|||
27588451|NCT01808690|80335613|FG001|Overall Study|Withdrawal by Subject|2|||
27588452|NCT01682460|80335616|FG000|Overall Study|Withdrawal by Subject|2|||
27588453|NCT01682460|80335616|FG000|Overall Study|Did not meet inclusion criteria|2|||
27588454|NCT00599326|80335617|FG000|Overall Study|Lost to Follow-up|1|||
27588455|NCT00599326|80335617|FG000|Overall Study|Noncompliant|1|||
27588456|NCT03321019|80335623|FG000|Overall Study|Withdrawal by Subject|0|||
27588457|NCT03321019|80335624|FG001|Overall Study|Withdrawal by Subject|6|||
27588458|NCT03321019|80335623|FG000|Overall Study|Lost to Follow-up|0|||
27588459|NCT03321019|80335624|FG001|Overall Study|Lost to Follow-up|22|||
27588460|NCT02504294|80335625|FG000|Overall Study|Adverse Event|15|||
27588461|NCT02504294|80335626|FG001|Overall Study|Adverse Event|12|||
27588462|NCT02504294|80335625|FG000|Overall Study|Withdrawal by Subject|7|||
27588463|NCT02504294|80335626|FG001|Overall Study|Withdrawal by Subject|1|||
27588464|NCT02504294|80335625|FG000|Overall Study|Protocol Violation|27|||
27588465|NCT02504294|80335626|FG001|Overall Study|Protocol Violation|26|||
27588466|NCT02504294|80335625|FG000|Overall Study|Physician Decision|1|||
27588467|NCT02504294|80335626|FG001|Overall Study|Physician Decision|2|||
27588468|NCT02504294|80335625|FG000|Overall Study|Lost to Follow-up|6|||
27588469|NCT02504294|80335626|FG001|Overall Study|Lost to Follow-up|7|||
27588470|NCT02169674|80335628|FG000|Overall Study|Withdrawal by Subject|2|||
27588471|NCT02169674|80335629|FG001|Overall Study|Withdrawal by Subject|1|||
27588472|NCT02169674|80335628|FG000|Overall Study|Seroprotected|30|||
27588473|NCT02169674|80335629|FG001|Overall Study|Seroprotected|76|||
27588474|NCT02169674|80335628|FG000|Overall Study|Lost to Follow-up|0|||
27588475|NCT02169674|80335629|FG001|Overall Study|Lost to Follow-up|1|||
27588476|NCT00563784|80335631|FG000|Overall Study|Withdrawal by Subject|2|||
27588477|NCT00563784|80335631|FG000|Overall Study|Screen Failures|20|||
27588478|NCT04389840|80335632|FG000|Overall Study|Adverse Event|0|||
27588479|NCT04389840|80335633|FG001|Overall Study|Adverse Event|0|||
27588480|NCT04389840|80335634|FG002|Overall Study|Adverse Event|0|||
27588481|NCT04389840|80335635|FG003|Overall Study|Adverse Event|1|||
27588482|NCT04389840|80335636|FG004|Overall Study|Adverse Event|0|||
27588483|NCT04389840|80335637|FG005|Overall Study|Adverse Event|0|||
27687768|NCT02245737|80694106|FG001|Overall Study|Condition Worsened|10|||
27687769|NCT02245737|80694107|FG002|Overall Study|Condition Worsened|9|||
27588484|NCT04389840|80335632|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
27588485|NCT04389840|80335633|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
27588486|NCT04389840|80335634|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
27588487|NCT04389840|80335635|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
27588488|NCT04389840|80335636|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
27588489|NCT04389840|80335637|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
27588490|NCT04389840|80335632|FG000|Overall Study|Death|0|||
27588491|NCT04389840|80335633|FG001|Overall Study|Death|1|||
27588492|NCT04389840|80335634|FG002|Overall Study|Death|0|||
27588493|NCT04389840|80335635|FG003|Overall Study|Death|0|||
27588494|NCT04389840|80335636|FG004|Overall Study|Death|0|||
27588495|NCT04389840|80335637|FG005|Overall Study|Death|0|||
27588496|NCT03972488|80335638|FG000|Overall Study|Progressive disease|42|||
27588497|NCT03972488|80335639|FG001|Overall Study|Progressive disease|44|||
27588498|NCT03972488|80335638|FG000|Overall Study|Physician Decision|13|||
27588499|NCT03972488|80335639|FG001|Overall Study|Physician Decision|7|||
27588500|NCT03972488|80335638|FG000|Overall Study|Adverse Event|8|||
27588501|NCT03972488|80335639|FG001|Overall Study|Adverse Event|1|||
27588502|NCT03972488|80335638|FG000|Overall Study|Death|4|||
27588503|NCT03972488|80335639|FG001|Overall Study|Death|4|||
27588504|NCT03972488|80335638|FG000|Overall Study|Withdrawal by Subject|3|||
27588505|NCT03972488|80335639|FG001|Overall Study|Withdrawal by Subject|4|||
27588506|NCT03972488|80335638|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
27588507|NCT03972488|80335639|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
27588508|NCT04820673|80335640|FG000|Overall Study|Adverse Event|6|||
27588509|NCT04820673|80335640|FG000|Overall Study|Due to Lack of Effectiveness|1|||
27588510|NCT04820673|80335640|FG000|Overall Study|Pregnancy|1|||
27588511|NCT04820673|80335640|FG000|Overall Study|Voluntary Withdrawal|20|||
27588512|NCT04820673|80335640|FG000|Overall Study|Lost to Follow-up|10|||
27588513|NCT01660906|80335641|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
27588514|NCT02370602|80335649|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27588515|NCT02370602|80335650|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27588516|NCT02370602|80335651|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27588517|NCT02370602|80335652|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
27588518|NCT02370602|80335653|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27588519|NCT02370602|80335654|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
27588520|NCT00782340|80335658|FG000|Open Label Titration|Adverse Event|12|||
27687770|NCT02245737|80694105|FG000|Overall Study|Death|2|||
27588521|NCT00782340|80335659|FG001|Open Label Titration|Adverse Event|0|||
27588522|NCT00782340|80335660|FG002|Open Label Titration|Adverse Event|0|||
27588523|NCT00782340|80335658|FG000|Open Label Titration|Treatment failure|50|||
27588524|NCT00782340|80335659|FG001|Open Label Titration|Treatment failure|0|||
27588525|NCT00782340|80335660|FG002|Open Label Titration|Treatment failure|0|||
27588526|NCT00782340|80335658|FG000|Open Label Titration|Protocol Violation|5|||
27588527|NCT00782340|80335659|FG001|Open Label Titration|Protocol Violation|0|||
27588528|NCT00782340|80335660|FG002|Open Label Titration|Protocol Violation|0|||
27588529|NCT00782340|80335658|FG000|Open Label Titration|Withdrawal by Subject|5|||
27588530|NCT00782340|80335659|FG001|Open Label Titration|Withdrawal by Subject|0|||
27588531|NCT00782340|80335660|FG002|Open Label Titration|Withdrawal by Subject|0|||
27588532|NCT00782340|80335658|FG000|Open Label Titration|Enrollment capped|16|||
27588533|NCT00782340|80335659|FG001|Open Label Titration|Enrollment capped|0|||
27588534|NCT00782340|80335660|FG002|Open Label Titration|Enrollment capped|0|||
27687771|NCT02245737|80694106|FG001|Overall Study|Death|4|||
27687772|NCT02245737|80694107|FG002|Overall Study|Death|4|||
27687773|NCT02245737|80694105|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
27687774|NCT02245737|80694106|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
27687775|NCT02245737|80694107|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
27687776|NCT02245737|80694105|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
27687777|NCT02245737|80694106|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
27687778|NCT02245737|80694107|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
27687779|NCT02245737|80694105|FG000|Overall Study|Lost to Follow-up|2|||
27687780|NCT02245737|80694106|FG001|Overall Study|Lost to Follow-up|5|||
27687781|NCT02245737|80694107|FG002|Overall Study|Lost to Follow-up|4|||
27687782|NCT02245737|80694105|FG000|Overall Study|Other-determined by Investigator|9|||
27687783|NCT02245737|80694106|FG001|Overall Study|Other-determined by Investigator|10|||
27687784|NCT02245737|80694107|FG002|Overall Study|Other-determined by Investigator|10|||
27687785|NCT02245737|80694105|FG000|Overall Study|Physician Decision|6|||
27687786|NCT02245737|80694106|FG001|Overall Study|Physician Decision|3|||
27687787|NCT02245737|80694107|FG002|Overall Study|Physician Decision|6|||
27687788|NCT02245737|80694105|FG000|Overall Study|Protocol Violation|3|||
27687789|NCT02245737|80694106|FG001|Overall Study|Protocol Violation|2|||
27687790|NCT02245737|80694107|FG002|Overall Study|Protocol Violation|3|||
27687791|NCT02245737|80694105|FG000|Overall Study|Withdrawal by Subject|40|||
27687792|NCT02245737|80694106|FG001|Overall Study|Withdrawal by Subject|41|||
27687793|NCT02245737|80694107|FG002|Overall Study|Withdrawal by Subject|44|||
27687794|NCT02245737|80694105|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
27687795|NCT02245737|80694106|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
27687796|NCT02245737|80694107|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
27687797|NCT02245737|80694105|FG000|Overall Study|Sponsor Decision|445|||
27687798|NCT02245737|80694106|FG001|Overall Study|Sponsor Decision|430|||
27687799|NCT02245737|80694107|FG002|Overall Study|Sponsor Decision|432|||
27687800|NCT00730275|80694111|FG000|Overall Study|Withdrawal by Subject|0|||
27687801|NCT00730275|80694112|FG001|Overall Study|Withdrawal by Subject|0|||
27687802|NCT00730275|80694113|FG002|Overall Study|Withdrawal by Subject|0|||
27687803|NCT00730275|80694114|FG003|Overall Study|Withdrawal by Subject|1|||
27687804|NCT01049217|80694115|FG000|Overall Study|Adverse Event|2|||
27687805|NCT01049217|80694116|FG001|Overall Study|Adverse Event|1|||
27687806|NCT01049217|80694115|FG000|Overall Study|Lack of Efficacy|1|||
27687807|NCT01049217|80694116|FG001|Overall Study|Lack of Efficacy|1|||
27687808|NCT01049217|80694115|FG000|Overall Study|Lost to Follow-up|3|||
27687809|NCT01049217|80694116|FG001|Overall Study|Lost to Follow-up|8|||
27687810|NCT01049217|80694115|FG000|Overall Study|Withdrawal by Subject|4|||
27687811|NCT01049217|80694116|FG001|Overall Study|Withdrawal by Subject|3|||
27687812|NCT01049217|80694115|FG000|Overall Study|Protocol Violation|1|||
27687813|NCT01049217|80694116|FG001|Overall Study|Protocol Violation|3|||
27687814|NCT01049217|80694115|FG000|Overall Study|Pregnancy|1|||
27687815|NCT01049217|80694116|FG001|Overall Study|Pregnancy|0|||
27687816|NCT01049217|80694115|FG000|Overall Study|Study Terminated by Sponsor|43|||
27687817|NCT01049217|80694116|FG001|Overall Study|Study Terminated by Sponsor|43|||
27687818|NCT01049217|80694115|FG000|Overall Study|Other|1|||
27588535|NCT00782340|80335658|FG000|Open Label Titration|Did not meet responder criteria|2|||
27588536|NCT00782340|80335659|FG001|Open Label Titration|Did not meet responder criteria|0|||
27588537|NCT00782340|80335660|FG002|Open Label Titration|Did not meet responder criteria|0|||
27687819|NCT01049217|80694116|FG001|Overall Study|Other|2|||
27687820|NCT01049217|80694115|FG000|Overall Study|Randomized but not Treated|0|||
27687821|NCT01049217|80694116|FG001|Overall Study|Randomized but not Treated|2|||
27687822|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
27813670|NCT01644890|81150140|FG000|Overall Study|Clinical Progression|6|||
27813671|NCT01644890|81150141|FG001|Overall Study|Clinical Progression|6|||
27813672|NCT01644890|81150140|FG000|Overall Study|> 28 days since last dose of study drug|6|||
27813673|NCT01644890|81150141|FG001|Overall Study|> 28 days since last dose of study drug|3|||
27813674|NCT01644890|81150140|FG000|Overall Study|Other|8|||
27813675|NCT01644890|81150141|FG001|Overall Study|Other|9|||
27813676|NCT04956666|81150142|FG000|Overall Study|Adverse Event|18|||
27813677|NCT04956666|81150142|FG000|Overall Study|Physician Decision|5|||
27813678|NCT01290263|81150143|FG000|Overall Study|Adverse Event|0|||
27813679|NCT01290263|81150144|FG001|Overall Study|Adverse Event|0|||
27813680|NCT01290263|81150145|FG002|Overall Study|Adverse Event|0|||
27813681|NCT01290263|81150146|FG003|Overall Study|Adverse Event|1|||
27813682|NCT01290263|81150147|FG004|Overall Study|Adverse Event|1|||
27813683|NCT01290263|81150143|FG000|Overall Study|Lack of Efficacy|8|||
27813684|NCT01290263|81150144|FG001|Overall Study|Lack of Efficacy|2|||
27588538|NCT00782340|80335658|FG000|Open Label Titration|Lost to Follow-up|5|||
27588539|NCT00782340|80335659|FG001|Open Label Titration|Lost to Follow-up|0|||
27588540|NCT00782340|80335660|FG002|Open Label Titration|Lost to Follow-up|0|||
27588541|NCT00782340|80335658|FG000|Open Label Titration|Randomized in error|6|||
27588542|NCT00782340|80335659|FG001|Open Label Titration|Randomized in error|0|||
27588543|NCT00782340|80335660|FG002|Open Label Titration|Randomized in error|0|||
27588544|NCT02460991|80335664|FG000|Overall Study|Withdrawal by Subject|0|||
27588545|NCT02460991|80335665|FG001|Overall Study|Withdrawal by Subject|2|||
27588546|NCT02566031|80335666|FG000|Overall Study|Patient/guardian decision|14|||
27588547|NCT02566031|80335667|FG001|Overall Study|Patient/guardian decision|7|||
27588548|NCT02566031|80335666|FG000|Overall Study|Protocol deviation|2|||
27588549|NCT02566031|80335667|FG001|Overall Study|Protocol deviation|3|||
27588550|NCT02566031|80335666|FG000|Overall Study|Adverse Event|3|||
27588551|NCT02566031|80335667|FG001|Overall Study|Adverse Event|1|||
27588552|NCT02566031|80335666|FG000|Overall Study|Lost to Follow-up|1|||
27813685|NCT01290263|81150145|FG002|Overall Study|Lack of Efficacy|7|||
27813686|NCT01290263|81150146|FG003|Overall Study|Lack of Efficacy|24|||
27813687|NCT01290263|81150147|FG004|Overall Study|Lack of Efficacy|33|||
27813688|NCT01290263|81150143|FG000|Overall Study|Withdrawal by Subject|3|||
27813689|NCT01290263|81150144|FG001|Overall Study|Withdrawal by Subject|1|||
27813690|NCT01290263|81150145|FG002|Overall Study|Withdrawal by Subject|0|||
27813691|NCT01290263|81150146|FG003|Overall Study|Withdrawal by Subject|1|||
27813692|NCT01290263|81150147|FG004|Overall Study|Withdrawal by Subject|2|||
27813693|NCT01290263|81150143|FG000|Overall Study|Participant Non-Compliance|0|||
27813694|NCT01290263|81150144|FG001|Overall Study|Participant Non-Compliance|0|||
27813695|NCT01290263|81150145|FG002|Overall Study|Participant Non-Compliance|0|||
27813696|NCT01290263|81150146|FG003|Overall Study|Participant Non-Compliance|1|||
27813697|NCT01290263|81150147|FG004|Overall Study|Participant Non-Compliance|1|||
27813698|NCT01996033|81150148|FG000|Overall Study|Death|1|||
27813699|NCT01996033|81150148|FG000|Overall Study|Physician Decision|1|||
27813700|NCT01996033|81150148|FG000|Overall Study|Withdrawal by Subject|4|||
27813701|NCT01996033|81150148|FG000|Overall Study|Lost to Follow-up|3|||
27813702|NCT01835145|81150149|FG000|Overall Study|Ineligible prior to treatment|1|||
27813703|NCT01835145|81150150|FG001|Overall Study|Ineligible prior to treatment|0|||
27813704|NCT00721409|81150155|FG000|Overall Study|Global deterioration of health status|2|||
27813705|NCT00721409|81150156|FG001|Overall Study|Global deterioration of health status|6|||
27813706|NCT00721409|81150157|FG002|Overall Study|Global deterioration of health status|3|||
27813707|NCT00721409|81150155|FG000|Overall Study|Death|0|||
27813708|NCT00721409|81150156|FG001|Overall Study|Death|1|||
27813709|NCT00721409|81150157|FG002|Overall Study|Death|0|||
27588553|NCT02566031|80335667|FG001|Overall Study|Lost to Follow-up|1|||
27588554|NCT02459574|80335668|FG000|Overall Study|Withdrawal by Subject|6|||
27813710|NCT00721409|81150155|FG000|Overall Study|Randomized not Treated|0|||
27813711|NCT00721409|81150156|FG001|Overall Study|Randomized not Treated|1|||
27813712|NCT00721409|81150157|FG002|Overall Study|Randomized not Treated|4|||
27813713|NCT00721409|81150155|FG000|Overall Study|Reason not specified|1|||
27813714|NCT00721409|81150156|FG001|Overall Study|Reason not specified|0|||
27588555|NCT02459574|80335669|FG001|Overall Study|Withdrawal by Subject|6|||
27813715|NCT00721409|81150157|FG002|Overall Study|Reason not specified|2|||
27813716|NCT00721409|81150155|FG000|Overall Study|Adverse Event|0|||
27813717|NCT00721409|81150156|FG001|Overall Study|Adverse Event|13|||
27813718|NCT00721409|81150157|FG002|Overall Study|Adverse Event|2|||
27813719|NCT00721409|81150155|FG000|Overall Study|Lost to Follow-up|0|||
27813720|NCT00721409|81150156|FG001|Overall Study|Lost to Follow-up|0|||
27588556|NCT02459574|80335670|FG002|Overall Study|Withdrawal by Subject|2|||
27588557|NCT02459574|80335668|FG000|Overall Study|Lost to Follow-up|1|||
27588558|NCT02459574|80335669|FG001|Overall Study|Lost to Follow-up|1|||
27813721|NCT00721409|81150157|FG002|Overall Study|Lost to Follow-up|1|||
27813722|NCT00721409|81150155|FG000|Overall Study|Withdrawal by Subject|1|||
27813723|NCT00721409|81150156|FG001|Overall Study|Withdrawal by Subject|6|||
27813724|NCT00721409|81150157|FG002|Overall Study|Withdrawal by Subject|5|||
27813725|NCT00721409|81150155|FG000|Overall Study|Objective progression or relapse|8|||
27687823|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
27687824|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
27687825|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
27687826|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
27687827|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
27687828|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
27687829|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
27687830|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
27687831|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
27687832|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
27687833|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
27687834|NCT04493502|80694117|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
27687835|NCT04493502|80694118|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
27687836|NCT04493502|80694117|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
27687837|NCT04493502|80694118|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
27687838|NCT04493502|80694117|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
27687839|NCT04493502|80694118|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
27687840|NCT04493502|80694117|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
27687841|NCT04493502|80694118|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
27687842|NCT04493502|80694117|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
27687843|NCT04493502|80694118|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
27687844|NCT04493502|80694117|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
27687845|NCT04493502|80694118|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
27687846|NCT04493502|80694117|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
27687847|NCT04493502|80694118|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
27687848|NCT04971681|80694119|FG000|Followup|Lost to Follow-up|1|||
27687849|NCT04971681|80694120|FG001|Followup|Lost to Follow-up|0|||
27687850|NCT01014143|80694121|FG000|Second Intervention|Lost to Follow-up|2|||
27687851|NCT01014143|80694122|FG001|Second Intervention|Lost to Follow-up|0|||
27687852|NCT01014143|80694123|FG002|Second Intervention|Lost to Follow-up|0|||
27687853|NCT03035201|80694126|FG000|Overall Study|Death|9|||
27687854|NCT03035201|80694127|FG001|Overall Study|Death|12|||
27687855|NCT03035201|80694128|FG002|Overall Study|Death|9|||
27687856|NCT03035201|80694129|FG003|Overall Study|Death|10|||
27687857|NCT03035201|80694126|FG000|Overall Study|Withdrawal by Subject|51|||
27687858|NCT03035201|80694127|FG001|Overall Study|Withdrawal by Subject|49|||
27687859|NCT03035201|80694128|FG002|Overall Study|Withdrawal by Subject|37|||
27687860|NCT03035201|80694129|FG003|Overall Study|Withdrawal by Subject|46|||
27687861|NCT03035201|80694126|FG000|Overall Study|Lost to Follow-up|67|||
27687862|NCT03035201|80694127|FG001|Overall Study|Lost to Follow-up|51|||
27687863|NCT03035201|80694128|FG002|Overall Study|Lost to Follow-up|64|||
27687864|NCT03035201|80694129|FG003|Overall Study|Lost to Follow-up|69|||
27687865|NCT02663518|80694130|FG000|Part 1: Phase 1a Escalation|Death|0|||
27687866|NCT02663518|80694131|FG001|Part 1: Phase 1a Escalation|Death|0|||
27687867|NCT02663518|80694132|FG002|Part 1: Phase 1a Escalation|Death|1|||
27687868|NCT02663518|80694133|FG003|Part 1: Phase 1a Escalation|Death|0|||
27687869|NCT02663518|80694134|FG004|Part 1: Phase 1a Escalation|Death|0|||
27687870|NCT02663518|80694135|FG005|Part 1: Phase 1a Escalation|Death|0|||
27687871|NCT02663518|80694136|FG006|Part 1: Phase 1a Escalation|Death|0|||
27687872|NCT02663518|80694137|FG007|Part 1: Phase 1a Escalation|Death|0|||
27687873|NCT02663518|80694138|FG008|Part 1: Phase 1a Escalation|Death|0|||
27687874|NCT02663518|80694139|FG009|Part 1: Phase 1a Escalation|Death|0|||
27876290|NCT02810457|81379753|FG000|Overall Study|Patient ineligibility|3|||
27876291|NCT02810457|81379754|FG001|Overall Study|Patient ineligibility|0|||
27876292|NCT02810457|81379753|FG000|Overall Study|Miscalculated PD|1|||
27876293|NCT02810457|81379754|FG001|Overall Study|Miscalculated PD|0|||
27876294|NCT02810457|81379753|FG000|Overall Study|Physician Decision|0|||
27876295|NCT02810457|81379754|FG001|Overall Study|Physician Decision|1|||
27876296|NCT00678210|81379755|FG000|Overall Study|Adverse Event|1|||
27876297|NCT00678210|81379756|FG001|Overall Study|Adverse Event|2|||
27876298|NCT00678210|81379757|FG002|Overall Study|Adverse Event|3|||
27876299|NCT00678210|81379758|FG003|Overall Study|Adverse Event|3|||
27876300|NCT00678210|81379755|FG000|Overall Study|Lack of Efficacy|2|||
27876301|NCT00678210|81379756|FG001|Overall Study|Lack of Efficacy|3|||
27876302|NCT00678210|81379757|FG002|Overall Study|Lack of Efficacy|1|||
27876303|NCT00678210|81379758|FG003|Overall Study|Lack of Efficacy|9|||
27876304|NCT00678210|81379755|FG000|Overall Study|Lost to Follow-up|4|||
27876305|NCT00678210|81379756|FG001|Overall Study|Lost to Follow-up|2|||
27876306|NCT00678210|81379757|FG002|Overall Study|Lost to Follow-up|0|||
27876307|NCT00678210|81379758|FG003|Overall Study|Lost to Follow-up|1|||
27876308|NCT00678210|81379755|FG000|Overall Study|Withdrawal by Subject|3|||
27876309|NCT00678210|81379756|FG001|Overall Study|Withdrawal by Subject|4|||
27876310|NCT00678210|81379757|FG002|Overall Study|Withdrawal by Subject|1|||
27876311|NCT00678210|81379758|FG003|Overall Study|Withdrawal by Subject|7|||
27876312|NCT00678210|81379755|FG000|Overall Study|Other|1|||
27876313|NCT00678210|81379756|FG001|Overall Study|Other|0|||
27876314|NCT00678210|81379757|FG002|Overall Study|Other|1|||
27876315|NCT00678210|81379758|FG003|Overall Study|Other|0|||
27876316|NCT00413699|81379766|FG000|Initial Period|Death|25|||
27687875|NCT02663518|80694140|FG010|Part 1: Phase 1a Escalation|Death|0|||
27876317|NCT00413699|81379767|FG001|Initial Period|Death|30|||
27876318|NCT00413699|81379768|FG002|Initial Period|Death|0|||
27876319|NCT00413699|81379766|FG000|Initial Period|Lack of Efficacy|59|||
27876320|NCT00413699|81379767|FG001|Initial Period|Lack of Efficacy|115|||
27876321|NCT00413699|81379768|FG002|Initial Period|Lack of Efficacy|0|||
27876322|NCT00413699|81379766|FG000|Initial Period|Lost to Follow-up|31|||
27876323|NCT00413699|81379767|FG001|Initial Period|Lost to Follow-up|101|||
27876324|NCT00413699|81379768|FG002|Initial Period|Lost to Follow-up|0|||
27876325|NCT00413699|81379766|FG000|Initial Period|Protocol Violation|38|||
27687876|NCT02663518|80694141|FG011|Part 1: Phase 1a Escalation|Death|0|||
27876326|NCT00413699|81379767|FG001|Initial Period|Protocol Violation|89|||
27876327|NCT00413699|81379768|FG002|Initial Period|Protocol Violation|0|||
27876328|NCT00413699|81379766|FG000|Initial Period|Pregnancy|10|||
27876329|NCT00413699|81379767|FG001|Initial Period|Pregnancy|8|||
27876330|NCT00413699|81379768|FG002|Initial Period|Pregnancy|0|||
27876331|NCT00413699|81379766|FG000|Initial Period|Did not meet entrance criteria|2|||
27876332|NCT00413699|81379767|FG001|Initial Period|Did not meet entrance criteria|2|||
27876333|NCT00413699|81379768|FG002|Initial Period|Did not meet entrance criteria|0|||
27876334|NCT00413699|81379766|FG000|Initial Period|Medication error without adverse event|0|||
27876335|NCT00413699|81379767|FG001|Initial Period|Medication error without adverse event|1|||
27876336|NCT00413699|81379768|FG002|Initial Period|Medication error without adverse event|0|||
27876337|NCT00413699|81379766|FG000|Initial Period|Study terminated by Sponsor|0|||
27876338|NCT00413699|81379767|FG001|Initial Period|Study terminated by Sponsor|1|||
27876339|NCT00413699|81379768|FG002|Initial Period|Study terminated by Sponsor|0|||
27876340|NCT00413699|81379766|FG000|Initial Period|Other|67|||
27876341|NCT00413699|81379767|FG001|Initial Period|Other|211|||
27876342|NCT00413699|81379768|FG002|Initial Period|Other|0|||
27876343|NCT00413699|81379766|FG000|Initial Period|Adverse event related to study drug|178|||
27876344|NCT00413699|81379767|FG001|Initial Period|Adverse event related to study drug|527|||
27876345|NCT00413699|81379768|FG002|Initial Period|Adverse event related to study drug|0|||
27876346|NCT00413699|81379766|FG000|Initial Period|Adverse event not related to study drug|113|||
27876347|NCT00413699|81379767|FG001|Initial Period|Adverse event not related to study drug|248|||
27876348|NCT00413699|81379768|FG002|Initial Period|Adverse event not related to study drug|0|||
27876349|NCT00413699|81379766|FG000|Initial Period|Missing end of study page|0|||
27876350|NCT00413699|81379767|FG001|Initial Period|Missing end of study page|4|||
27876351|NCT00413699|81379768|FG002|Initial Period|Missing end of study page|0|||
27876352|NCT00413699|81379766|FG000|Initial Period|No longer willing to participate|116|||
27876353|NCT00413699|81379767|FG001|Initial Period|No longer willing to participate|368|||
27876354|NCT00413699|81379768|FG002|Initial Period|No longer willing to participate|0|||
27876355|NCT00413699|81379766|FG000|Extension Period|No Longer Willing to Participate|0|||
27876356|NCT00413699|81379767|FG001|Extension Period|No Longer Willing to Participate|0|||
27876357|NCT00413699|81379768|FG002|Extension Period|No Longer Willing to Participate|2|||
27876358|NCT00413699|81379766|FG000|Extension Period|Protocol Violation|0|||
27876359|NCT00413699|81379767|FG001|Extension Period|Protocol Violation|0|||
27876360|NCT00413699|81379768|FG002|Extension Period|Protocol Violation|1|||
27876361|NCT00413699|81379766|FG000|Extension Period|Adverse Event|0|||
27876362|NCT00413699|81379767|FG001|Extension Period|Adverse Event|0|||
27876363|NCT00413699|81379768|FG002|Extension Period|Adverse Event|2|||
27876364|NCT03711188|81379769|FG000|Overall Study|Disease progression|11|||
27876365|NCT03711188|81379769|FG000|Overall Study|Adverse Event|1|||
27876366|NCT01486446|81379773|FG000|Overall Study|Adverse Event|1|||
27876367|NCT01486446|81379774|FG001|Overall Study|Adverse Event|0|||
27876368|NCT02747108|81379775|FG000|Overall Study|Death|2|||
27876369|NCT02747108|81379776|FG001|Overall Study|Death|2|||
27876370|NCT02747108|81379775|FG000|Overall Study|Withdrawal by Subject|1|||
27876371|NCT02747108|81379776|FG001|Overall Study|Withdrawal by Subject|0|||
27876372|NCT02747108|81379775|FG000|Overall Study|Protocol Violation|2|||
27876373|NCT02747108|81379776|FG001|Overall Study|Protocol Violation|0|||
27876374|NCT01796392|81379780|FG000|Overall Study|Withdrawal by Subject|2|||
27876375|NCT01796392|81379781|FG001|Overall Study|Withdrawal by Subject|0|||
27876376|NCT01796392|81379780|FG000|Overall Study|Death|5|||
27876377|NCT01796392|81379781|FG001|Overall Study|Death|1|||
27876378|NCT01796392|81379780|FG000|Overall Study|Excluded for medical reasons|1|||
27876379|NCT01796392|81379781|FG001|Overall Study|Excluded for medical reasons|2|||
27876380|NCT01796392|81379780|FG000|Overall Study|Lost to Follow-up|1|||
27876381|NCT01796392|81379781|FG001|Overall Study|Lost to Follow-up|0|||
27876382|NCT01321879|81379782|FG000|Overall Study|Lack of Efficacy|5|||
27876383|NCT01321879|81379782|FG000|Overall Study|Adverse Event|5|||
27876384|NCT01321879|81379782|FG000|Overall Study|Death|3|||
27876385|NCT01321879|81379782|FG000|Overall Study|Withdrawal by Subject|1|||
27876386|NCT02166333|81379783|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
27876387|NCT02166333|81379784|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
27876388|NCT02166333|81379785|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
27876389|NCT02166333|81379786|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
27876390|NCT02166333|81379787|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
27876391|NCT02166333|81379788|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
27876392|NCT02166333|81379783|FG000|Stage 1|Death|4|||
27687877|NCT02663518|80694142|FG012|Part 1: Phase 1a Escalation|Death|0|||
27687878|NCT02663518|80694143|FG013|Part 1: Phase 1a Escalation|Death|0|||
27876393|NCT02166333|81379784|FG001|Stage 1|Death|0|||
27876394|NCT02166333|81379785|FG002|Stage 1|Death|2|||
27588559|NCT02459574|80335670|FG002|Overall Study|Lost to Follow-up|0|||
27687879|NCT02663518|80694130|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687880|NCT02663518|80694131|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687881|NCT02663518|80694132|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
27876395|NCT02166333|81379786|FG003|Stage 1|Death|0|||
27876396|NCT02166333|81379787|FG004|Stage 1|Death|3|||
27876397|NCT02166333|81379788|FG005|Stage 1|Death|2|||
27876398|NCT02166333|81379783|FG000|Stage 1|Lost to Follow-up|12|||
27876399|NCT02166333|81379784|FG001|Stage 1|Lost to Follow-up|0|||
27876400|NCT02166333|81379785|FG002|Stage 1|Lost to Follow-up|6|||
27876401|NCT02166333|81379786|FG003|Stage 1|Lost to Follow-up|0|||
27876402|NCT02166333|81379787|FG004|Stage 1|Lost to Follow-up|3|||
27876403|NCT02166333|81379788|FG005|Stage 1|Lost to Follow-up|3|||
27876404|NCT02166333|81379783|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
27876405|NCT02166333|81379784|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
27876406|NCT02166333|81379785|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
27876407|NCT02166333|81379786|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
27876408|NCT02166333|81379787|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
27876409|NCT02166333|81379788|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
27876410|NCT02166333|81379783|FG000|Stage 2|Death|4|||
27876411|NCT02166333|81379784|FG001|Stage 2|Death|2|||
27588560|NCT02459574|80335668|FG000|Overall Study|Death|0|||
27588561|NCT02459574|80335669|FG001|Overall Study|Death|1|||
27588562|NCT02459574|80335670|FG002|Overall Study|Death|0|||
27588563|NCT01659021|80335675|FG000|Main Study|Adverse Event|2|||
27588564|NCT01659021|80335676|FG001|Main Study|Adverse Event|3|||
27588565|NCT01659021|80335675|FG000|Main Study|Lost to Follow-up|1|||
27588566|NCT01659021|80335676|FG001|Main Study|Lost to Follow-up|0|||
27876412|NCT02166333|81379785|FG002|Stage 2|Death|1|||
27588567|NCT01659021|80335675|FG000|Main Study|Unknown Reasons|2|||
27588568|NCT01659021|80335676|FG001|Main Study|Unknown Reasons|1|||
27876413|NCT02166333|81379786|FG003|Stage 2|Death|0|||
27876414|NCT02166333|81379787|FG004|Stage 2|Death|0|||
27876415|NCT02166333|81379788|FG005|Stage 2|Death|1|||
27876416|NCT02166333|81379783|FG000|Stage 2|Lost to Follow-up|23|||
27876417|NCT02166333|81379784|FG001|Stage 2|Lost to Follow-up|4|||
27876418|NCT02166333|81379785|FG002|Stage 2|Lost to Follow-up|11|||
27876419|NCT02166333|81379786|FG003|Stage 2|Lost to Follow-up|9|||
27876420|NCT02166333|81379787|FG004|Stage 2|Lost to Follow-up|3|||
27876421|NCT02166333|81379788|FG005|Stage 2|Lost to Follow-up|6|||
27876422|NCT00707239|81379789|FG000|Overall Study|Adverse Event|5|||
27588569|NCT01659021|80335675|FG000|Main Study|Physician Decision|34|||
27876423|NCT00707239|81379790|FG001|Overall Study|Adverse Event|3|||
27876424|NCT00707239|81379791|FG002|Overall Study|Adverse Event|2|||
27876425|NCT00707239|81379789|FG000|Overall Study|Death|3|||
27588570|NCT01659021|80335676|FG001|Main Study|Physician Decision|16|||
27588571|NCT01659021|80335675|FG000|Main Study|Withdrawal by Subject|19|||
27588572|NCT01659021|80335676|FG001|Main Study|Withdrawal by Subject|16|||
27588573|NCT01659021|80335675|FG000|Main Study|Study Terminated by Sponsor|16|||
27588574|NCT01659021|80335676|FG001|Main Study|Study Terminated by Sponsor|1|||
27588575|NCT01659021|80335675|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
27588576|NCT01659021|80335676|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
27588577|NCT01659021|80335675|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
27588578|NCT01659021|80335676|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
27588579|NCT03058679|80335677|FG000|Baseline to Week 6|Lost to Follow-up|3|||
27588580|NCT03058679|80335678|FG001|Baseline to Week 6|Lost to Follow-up|2|||
27588581|NCT03058679|80335677|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
27588582|NCT03058679|80335678|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
27588583|NCT03058679|80335677|FG000|Baseline to Week 6|Adverse Event|6|||
27588584|NCT03058679|80335678|FG001|Baseline to Week 6|Adverse Event|6|||
27588585|NCT03058679|80335677|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
27588586|NCT03058679|80335678|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
27588587|NCT03058679|80335677|FG000|Baseline to Week 6|Difficulty following the diet|0|||
27588588|NCT03058679|80335678|FG001|Baseline to Week 6|Difficulty following the diet|2|||
27588589|NCT03058679|80335677|FG000|Baseline to Week 6|Physician Decision|1|||
27588590|NCT03058679|80335678|FG001|Baseline to Week 6|Physician Decision|0|||
27687882|NCT02663518|80694133|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687883|NCT02663518|80694134|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27813726|NCT00721409|81150156|FG001|Overall Study|Objective progression or relapse|55|||
27813727|NCT00721409|81150157|FG002|Overall Study|Objective progression or relapse|62|||
27813728|NCT03036579|81150158|FG000|2 Years|Lost to Follow-up|1|||
27813729|NCT03036579|81150159|FG001|2 Years|Lost to Follow-up|0|||
27813730|NCT03036579|81150158|FG000|3 Years|Lost to Follow-up|0|||
27813731|NCT03036579|81150159|FG001|3 Years|Lost to Follow-up|1|||
27813732|NCT00299156|81150163|FG000|Period 2 (Randomized)|Screen Failure|0|||
27813733|NCT00299156|81150164|FG001|Period 2 (Randomized)|Screen Failure|1|||
27813734|NCT00299156|81150165|FG002|Period 2 (Randomized)|Screen Failure|0|||
27813735|NCT01478620|81150170|FG000|Overall Study|Lost to Follow-up|6|||
27813736|NCT01799590|81150174|FG000|Overall Study|Adverse Event|13|||
27813737|NCT01799590|81150175|FG001|Overall Study|Adverse Event|7|||
27813738|NCT01799590|81150176|FG002|Overall Study|Adverse Event|5|||
27813739|NCT01799590|81150174|FG000|Overall Study|Pregnancy|2|||
27813740|NCT01799590|81150175|FG001|Overall Study|Pregnancy|0|||
27813741|NCT01799590|81150176|FG002|Overall Study|Pregnancy|0|||
27813742|NCT01799590|81150174|FG000|Overall Study|Lack of Efficacy|3|||
27813743|NCT01799590|81150175|FG001|Overall Study|Lack of Efficacy|1|||
27813744|NCT01799590|81150176|FG002|Overall Study|Lack of Efficacy|3|||
27813745|NCT01799590|81150174|FG000|Overall Study|Participants convenience|4|||
27813746|NCT01799590|81150175|FG001|Overall Study|Participants convenience|4|||
27813747|NCT01799590|81150176|FG002|Overall Study|Participants convenience|2|||
27588591|NCT03058679|80335677|FG000|Week 6 to Week 12|Change in medication|5|||
27588592|NCT03058679|80335678|FG001|Week 6 to Week 12|Change in medication|7|||
27687884|NCT02663518|80694135|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687885|NCT02663518|80694136|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27813748|NCT01799590|81150174|FG000|Overall Study|Aggravation of complications|0|||
27813749|NCT01799590|81150175|FG001|Overall Study|Aggravation of complications|1|||
27813750|NCT01799590|81150176|FG002|Overall Study|Aggravation of complications|1|||
27813751|NCT01799590|81150174|FG000|Overall Study|Using drugs with restricted days of use|0|||
27813752|NCT01799590|81150175|FG001|Overall Study|Using drugs with restricted days of use|3|||
27813753|NCT01799590|81150176|FG002|Overall Study|Using drugs with restricted days of use|2|||
27813754|NCT01799590|81150174|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
27813755|NCT01799590|81150175|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
27813756|NCT01799590|81150176|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
27813757|NCT01799590|81150174|FG000|Overall Study|Other|3|||
27588593|NCT03058679|80335677|FG000|Week 6 to Week 12|Adverse Event|4|||
27588594|NCT03058679|80335678|FG001|Week 6 to Week 12|Adverse Event|3|||
27588595|NCT03058679|80335677|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
27588596|NCT03058679|80335678|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
27588597|NCT03058679|80335677|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
27588598|NCT03058679|80335678|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
27588599|NCT02270450|80335679|FG000|Overall Study|Refusal unrelated to adverse event|3|||
27588600|NCT02270450|80335680|FG001|Overall Study|Refusal unrelated to adverse event|1|||
27588601|NCT02270450|80335681|FG002|Overall Study|Refusal unrelated to adverse event|5|||
27588602|NCT02270450|80335682|FG003|Overall Study|Refusal unrelated to adverse event|14|||
27588603|NCT02270450|80335679|FG000|Overall Study|Progression/relapse|1|||
27588604|NCT02270450|80335680|FG001|Overall Study|Progression/relapse|2|||
27588605|NCT02270450|80335681|FG002|Overall Study|Progression/relapse|4|||
27588606|NCT02270450|80335682|FG003|Overall Study|Progression/relapse|9|||
27588607|NCT02270450|80335679|FG000|Overall Study|Death|19|||
27588608|NCT02270450|80335680|FG001|Overall Study|Death|19|||
27588609|NCT02270450|80335681|FG002|Overall Study|Death|31|||
27588610|NCT02270450|80335682|FG003|Overall Study|Death|59|||
27588611|NCT00936390|80335694|FG000|Overall Study|Protocol Violation|21|||
27588612|NCT00936390|80335695|FG001|Overall Study|Protocol Violation|25|||
27588613|NCT01435577|80335696|FG000|Overall Study|Adverse Event|10|||
27588614|NCT01435577|80335697|FG001|Overall Study|Adverse Event|0|||
27588615|NCT01435577|80335696|FG000|Overall Study|Lack of Efficacy|7|||
27588616|NCT01435577|80335697|FG001|Overall Study|Lack of Efficacy|51|||
27588617|NCT01435577|80335696|FG000|Overall Study|Alternative treatment started|0|||
27588618|NCT01435577|80335697|FG001|Overall Study|Alternative treatment started|1|||
27588619|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Adverse Event|5|||
27588620|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Adverse Event|8|||
27588621|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Adverse Event|4|||
27588622|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Adverse Event|8|||
27588623|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
27588624|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
27588625|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
27588626|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
27588627|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
27588628|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
27687886|NCT02663518|80694137|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687887|NCT02663518|80694138|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27588629|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
27588630|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
27588631|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Physician Decision|1|||
27588632|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Physician Decision|0|||
27588633|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Physician Decision|0|||
27687888|NCT02663518|80694139|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687889|NCT02663518|80694140|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27588634|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Physician Decision|0|||
27588635|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
27588636|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
27588637|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
27588638|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
27588639|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Pregnancy|0|||
27588640|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Pregnancy|1|||
27588641|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Pregnancy|0|||
27588642|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Pregnancy|0|||
27588643|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
27588644|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
27588645|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
27588646|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
27588647|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Death|0|||
27588648|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Death|1|||
27588649|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Death|0|||
27588650|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Death|0|||
27588651|NCT00071487|80335699|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
27588652|NCT00071487|80335700|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
27588653|NCT00071487|80335701|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
27588654|NCT00071487|80335702|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
27588655|NCT00071487|80335699|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
27588656|NCT00071487|80335700|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
27588657|NCT00071487|80335701|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
27588658|NCT00071487|80335702|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
27588659|NCT00071487|80335699|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27588660|NCT00071487|80335700|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27588661|NCT00071487|80335701|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
27588662|NCT00071487|80335702|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
27588663|NCT00071487|80335699|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27588664|NCT00071487|80335700|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27588665|NCT00071487|80335701|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
27588666|NCT00071487|80335702|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
27588667|NCT00071487|80335699|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
27588668|NCT00071487|80335700|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
27588669|NCT00071487|80335701|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
27588670|NCT00071487|80335702|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
27588671|NCT00071487|80335699|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
27588672|NCT00071487|80335700|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
27588673|NCT00071487|80335701|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
27588674|NCT00071487|80335702|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
27588675|NCT00071487|80335699|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
27588676|NCT00071487|80335700|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
27588677|NCT00071487|80335701|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
27588678|NCT00071487|80335702|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
27588679|NCT02005471|80335703|FG000|Main Study|Adverse Event|0|||
27588680|NCT02005471|80335704|FG001|Main Study|Adverse Event|1|||
27588681|NCT02005471|80335705|FG002|Main Study|Adverse Event|0|||
27588682|NCT02005471|80335706|FG003|Main Study|Adverse Event|0|||
27588683|NCT02005471|80335703|FG000|Main Study|Death|83|||
27588684|NCT02005471|80335704|FG001|Main Study|Death|52|||
27588685|NCT02005471|80335705|FG002|Main Study|Death|0|||
27588686|NCT02005471|80335706|FG003|Main Study|Death|0|||
27588687|NCT02005471|80335703|FG000|Main Study|Lost to Follow-up|4|||
27588688|NCT02005471|80335704|FG001|Main Study|Lost to Follow-up|5|||
27588689|NCT02005471|80335705|FG002|Main Study|Lost to Follow-up|0|||
27588690|NCT02005471|80335706|FG003|Main Study|Lost to Follow-up|0|||
27687890|NCT02663518|80694141|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687891|NCT02663518|80694142|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687892|NCT02663518|80694143|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
27687893|NCT02663518|80694130|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
27588691|NCT02005471|80335703|FG000|Main Study|Physician Decision|3|||
27588692|NCT02005471|80335704|FG001|Main Study|Physician Decision|1|||
27588693|NCT02005471|80335705|FG002|Main Study|Physician Decision|0|||
27588694|NCT02005471|80335706|FG003|Main Study|Physician Decision|0|||
27588695|NCT02005471|80335703|FG000|Main Study|Withdrawal by Subject|26|||
27588696|NCT02005471|80335704|FG001|Main Study|Withdrawal by Subject|11|||
27588697|NCT02005471|80335705|FG002|Main Study|Withdrawal by Subject|0|||
27588698|NCT02005471|80335706|FG003|Main Study|Withdrawal by Subject|0|||
27588699|NCT02005471|80335703|FG000|Main Study|Reason not Specified|0|||
27588700|NCT02005471|80335704|FG001|Main Study|Reason not Specified|6|||
27687894|NCT02663518|80694131|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
27687895|NCT02663518|80694132|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
27588701|NCT02005471|80335705|FG002|Main Study|Reason not Specified|0|||
27588702|NCT02005471|80335706|FG003|Main Study|Reason not Specified|0|||
27588703|NCT02005471|80335703|FG000|Main Study|Randomized but not Dosed|8|||
27588704|NCT02005471|80335704|FG001|Main Study|Randomized but not Dosed|0|||
27588705|NCT02005471|80335705|FG002|Main Study|Randomized but not Dosed|0|||
27588706|NCT02005471|80335706|FG003|Main Study|Randomized but not Dosed|0|||
27588707|NCT02005471|80335703|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
27588708|NCT02005471|80335704|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
27588709|NCT02005471|80335705|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
27588710|NCT02005471|80335706|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
27588711|NCT02005471|80335703|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
27588712|NCT02005471|80335704|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
27588713|NCT02005471|80335705|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
27588714|NCT02005471|80335706|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
27588715|NCT02005471|80335703|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
27588716|NCT02005471|80335704|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
27588717|NCT02005471|80335705|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
27588718|NCT02005471|80335706|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
27588719|NCT03550313|80335707|FG000|Overall Study|Adverse Event|0|||
27588720|NCT03550313|80335708|FG001|Overall Study|Adverse Event|1|||
27588721|NCT03550313|80335709|FG002|Overall Study|Adverse Event|0|||
27687896|NCT02663518|80694133|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
27687897|NCT02663518|80694134|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27813758|NCT01799590|81150175|FG001|Overall Study|Other|0|||
27813759|NCT01799590|81150176|FG002|Overall Study|Other|1|||
27588722|NCT03550313|80335707|FG000|Overall Study|Lost to Follow-up|5|||
27813760|NCT04161144|81150179|FG000|Overall Study|Withdrawal by Subject|0|||
27813761|NCT04161144|81150180|FG001|Overall Study|Withdrawal by Subject|1|||
27813762|NCT04161144|81150179|FG000|Overall Study|Protocol Violation|1|||
27813763|NCT04161144|81150180|FG001|Overall Study|Protocol Violation|0|||
27813764|NCT00658320|81150183|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
27813765|NCT00658320|81150184|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
27588723|NCT03550313|80335708|FG001|Overall Study|Lost to Follow-up|7|||
27588724|NCT03550313|80335709|FG002|Overall Study|Lost to Follow-up|12|||
27687898|NCT02663518|80694135|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27813766|NCT00658320|81150183|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
27813767|NCT00658320|81150184|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
27876426|NCT00707239|81379790|FG001|Overall Study|Death|1|||
27876427|NCT00707239|81379791|FG002|Overall Study|Death|3|||
27813768|NCT00658320|81150183|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
27876428|NCT00707239|81379789|FG000|Overall Study|Physician Decision|1|||
27588725|NCT03550313|80335707|FG000|Overall Study|Study terminated by sponsor|44|||
27588726|NCT03550313|80335708|FG001|Overall Study|Study terminated by sponsor|37|||
27588727|NCT03550313|80335709|FG002|Overall Study|Study terminated by sponsor|48|||
27588728|NCT03550313|80335707|FG000|Overall Study|No longer met eligibility criteria|3|||
27588729|NCT03550313|80335708|FG001|Overall Study|No longer met eligibility criteria|5|||
27588730|NCT03550313|80335709|FG002|Overall Study|No longer met eligibility criteria|6|||
27588731|NCT03550313|80335707|FG000|Overall Study|Withdrawal by parent/guardian|20|||
27588732|NCT03550313|80335708|FG001|Overall Study|Withdrawal by parent/guardian|18|||
27588733|NCT03550313|80335709|FG002|Overall Study|Withdrawal by parent/guardian|26|||
27588734|NCT03550313|80335707|FG000|Overall Study|Other|4|||
27588735|NCT03550313|80335708|FG001|Overall Study|Other|2|||
27588736|NCT03550313|80335709|FG002|Overall Study|Other|2|||
27588737|NCT03550313|80335707|FG000|Overall Study|Randomized but not vaccinated|3|||
27588738|NCT03550313|80335708|FG001|Overall Study|Randomized but not vaccinated|23|||
27588739|NCT03550313|80335709|FG002|Overall Study|Randomized but not vaccinated|2|||
27588740|NCT03550313|80335707|FG000|Overall Study|Sites terminated due to quality issues|18|||
27588741|NCT03550313|80335708|FG001|Overall Study|Sites terminated due to quality issues|17|||
27588742|NCT03550313|80335709|FG002|Overall Study|Sites terminated due to quality issues|18|||
27687899|NCT02663518|80694136|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687900|NCT02663518|80694137|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687901|NCT02663518|80694138|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687902|NCT02663518|80694139|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687903|NCT02663518|80694140|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687904|NCT02663518|80694141|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687905|NCT02663518|80694142|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27687906|NCT02663518|80694143|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
27588743|NCT00490646|80335710|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
27588744|NCT00490646|80335711|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
27588745|NCT00490646|80335710|FG000|Overall Study|Never Treated (had an adverse event)|1|||
27687907|NCT02663518|80694130|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
27687908|NCT02663518|80694131|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687909|NCT02663518|80694132|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
27687910|NCT02663518|80694133|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
27687911|NCT02663518|80694134|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27876429|NCT00707239|81379790|FG001|Overall Study|Physician Decision|1|||
27687912|NCT02663518|80694135|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687913|NCT02663518|80694136|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687914|NCT02663518|80694137|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687915|NCT02663518|80694138|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687916|NCT02663518|80694139|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687917|NCT02663518|80694140|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687918|NCT02663518|80694141|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687919|NCT02663518|80694142|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687920|NCT02663518|80694143|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
27687921|NCT02663518|80694130|FG000|Part 1: Phase 1a Escalation|Other|0|||
27687922|NCT02663518|80694131|FG001|Part 1: Phase 1a Escalation|Other|0|||
27687923|NCT02663518|80694132|FG002|Part 1: Phase 1a Escalation|Other|2|||
27687924|NCT02663518|80694133|FG003|Part 1: Phase 1a Escalation|Other|0|||
27687925|NCT02663518|80694134|FG004|Part 1: Phase 1a Escalation|Other|0|||
27687926|NCT02663518|80694135|FG005|Part 1: Phase 1a Escalation|Other|0|||
27687927|NCT02663518|80694136|FG006|Part 1: Phase 1a Escalation|Other|0|||
27687928|NCT02663518|80694137|FG007|Part 1: Phase 1a Escalation|Other|0|||
27687929|NCT02663518|80694138|FG008|Part 1: Phase 1a Escalation|Other|0|||
27687930|NCT02663518|80694139|FG009|Part 1: Phase 1a Escalation|Other|0|||
27687931|NCT02663518|80694140|FG010|Part 1: Phase 1a Escalation|Other|0|||
27687932|NCT02663518|80694141|FG011|Part 1: Phase 1a Escalation|Other|0|||
27687933|NCT02663518|80694142|FG012|Part 1: Phase 1a Escalation|Other|0|||
27687934|NCT02663518|80694143|FG013|Part 1: Phase 1a Escalation|Other|0|||
27687935|NCT02663518|80694130|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687936|NCT02663518|80694131|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687937|NCT02663518|80694132|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687938|NCT02663518|80694133|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687939|NCT02663518|80694134|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
27687940|NCT02663518|80694135|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687941|NCT02663518|80694136|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
27687942|NCT02663518|80694137|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
27687943|NCT02663518|80694138|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687944|NCT02663518|80694139|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687945|NCT02663518|80694140|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687946|NCT02663518|80694141|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687947|NCT02663518|80694142|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687948|NCT02663518|80694143|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
27687949|NCT02663518|80694130|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687950|NCT02663518|80694131|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27813769|NCT00658320|81150184|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
27813770|NCT00658320|81150183|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
27687951|NCT02663518|80694132|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687952|NCT02663518|80694133|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687953|NCT02663518|80694134|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
27687954|NCT02663518|80694135|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687955|NCT02663518|80694136|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
27687956|NCT02663518|80694137|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
27687957|NCT02663518|80694138|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687958|NCT02663518|80694139|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687959|NCT02663518|80694140|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687960|NCT02663518|80694141|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687961|NCT02663518|80694142|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687962|NCT02663518|80694143|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
27687963|NCT02663518|80694130|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687964|NCT02663518|80694131|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687965|NCT02663518|80694132|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687966|NCT02663518|80694133|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687967|NCT02663518|80694134|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
27687968|NCT02663518|80694135|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687969|NCT02663518|80694136|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687970|NCT02663518|80694137|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687971|NCT02663518|80694138|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27813771|NCT00658320|81150184|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
27813772|NCT02162758|81150191|FG000|Overall Study|Study termination|0|||
27813773|NCT02162758|81150192|FG001|Overall Study|Study termination|1|||
27813774|NCT02070744|81150197|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27813775|NCT02070744|81150198|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27813776|NCT02070744|81150199|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27687972|NCT02663518|80694139|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27813777|NCT02070744|81150200|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
27687973|NCT02663518|80694140|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687974|NCT02663518|80694141|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687975|NCT02663518|80694142|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687976|NCT02663518|80694143|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
27687977|NCT02663518|80694130|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687978|NCT02663518|80694131|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687979|NCT02663518|80694132|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687980|NCT02663518|80694133|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687981|NCT02663518|80694134|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
27687982|NCT02663518|80694135|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
27687983|NCT02663518|80694136|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
27687984|NCT02663518|80694137|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
27687985|NCT02663518|80694138|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687986|NCT02663518|80694139|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687987|NCT02663518|80694140|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687988|NCT02663518|80694141|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687989|NCT02663518|80694142|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687990|NCT02663518|80694143|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
27687991|NCT02663518|80694130|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
27687992|NCT02663518|80694131|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
27687993|NCT02663518|80694132|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
27687994|NCT02663518|80694133|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
27813778|NCT02070744|81150201|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
27813779|NCT02070744|81150197|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27813780|NCT02070744|81150198|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27813781|NCT02070744|81150199|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27588746|NCT00490646|80335711|FG001|Overall Study|Never Treated (had an adverse event)|0|||
27813782|NCT02070744|81150200|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
27813783|NCT02070744|81150201|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
27813784|NCT02070744|81150197|FG000|OLE Phase (48 Weeks)|Other|0|||
27813785|NCT02070744|81150198|FG001|OLE Phase (48 Weeks)|Other|0|||
27813786|NCT02070744|81150199|FG002|OLE Phase (48 Weeks)|Other|0|||
27813787|NCT02070744|81150200|FG003|OLE Phase (48 Weeks)|Other|0|||
27813788|NCT02070744|81150201|FG004|OLE Phase (48 Weeks)|Other|1|||
27813789|NCT01387282|81150202|FG000|Overall Study|Death|47|||
27813790|NCT01387282|81150203|FG001|Overall Study|Death|16|||
27813791|NCT01387282|81150202|FG000|Overall Study|Other|5|||
27813792|NCT01387282|81150203|FG001|Overall Study|Other|1|||
27813793|NCT01387282|81150202|FG000|Overall Study|Unrelated AE|6|||
27813794|NCT01387282|81150203|FG001|Overall Study|Unrelated AE|4|||
27813795|NCT01387282|81150202|FG000|Overall Study|Withdrawal by patient|33|||
27813796|NCT01387282|81150203|FG001|Overall Study|Withdrawal by patient|23|||
27813797|NCT01387282|81150202|FG000|Overall Study|Study drug-related AE|2|||
27813798|NCT01387282|81150203|FG001|Overall Study|Study drug-related AE|2|||
27813799|NCT01387282|81150202|FG000|Overall Study|Lost to Follow-up|4|||
27813800|NCT01387282|81150203|FG001|Overall Study|Lost to Follow-up|1|||
27813801|NCT01621490|81150204|FG000|Overall Study|Subject no longer meets study criteria|0|||
27813802|NCT01621490|81150205|FG001|Overall Study|Subject no longer meets study criteria|0|||
27813803|NCT01621490|81150206|FG002|Overall Study|Subject no longer meets study criteria|0|||
27813804|NCT01621490|81150207|FG003|Overall Study|Subject no longer meets study criteria|0|||
27813805|NCT01621490|81150208|FG004|Overall Study|Subject no longer meets study criteria|1|||
27813806|NCT01621490|81150209|FG005|Overall Study|Subject no longer meets study criteria|0|||
27813807|NCT01621490|81150210|FG006|Overall Study|Subject no longer meets study criteria|0|||
27813808|NCT01621490|81150211|FG007|Overall Study|Subject no longer meets study criteria|0|||
27813809|NCT01621490|81150212|FG008|Overall Study|Subject no longer meets study criteria|0|||
27813810|NCT01621490|81150213|FG009|Overall Study|Subject no longer meets study criteria|0|||
27813811|NCT01621490|81150214|FG010|Overall Study|Subject no longer meets study criteria|0|||
27813812|NCT01621490|81150204|FG000|Overall Study|Maximum clinical benefit|3|||
27813813|NCT01621490|81150205|FG001|Overall Study|Maximum clinical benefit|2|||
27813814|NCT01621490|81150206|FG002|Overall Study|Maximum clinical benefit|0|||
27687995|NCT02663518|80694134|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
27687996|NCT02663518|80694135|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
27813815|NCT01621490|81150207|FG003|Overall Study|Maximum clinical benefit|0|||
27813816|NCT01621490|81150208|FG004|Overall Study|Maximum clinical benefit|0|||
27876430|NCT00707239|81379791|FG002|Overall Study|Physician Decision|2|||
27687997|NCT02663518|80694136|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
27876431|NCT00707239|81379789|FG000|Overall Study|Protocol Violation|0|||
27876432|NCT00707239|81379790|FG001|Overall Study|Protocol Violation|0|||
27876433|NCT00707239|81379791|FG002|Overall Study|Protocol Violation|1|||
27876434|NCT00707239|81379789|FG000|Overall Study|Lack of Efficacy|1|||
27876435|NCT00707239|81379790|FG001|Overall Study|Lack of Efficacy|2|||
27876436|NCT00707239|81379791|FG002|Overall Study|Lack of Efficacy|0|||
27876437|NCT00707239|81379789|FG000|Overall Study|Randomized, but not treated|1|||
27876438|NCT00707239|81379790|FG001|Overall Study|Randomized, but not treated|1|||
27876439|NCT00707239|81379791|FG002|Overall Study|Randomized, but not treated|1|||
27876440|NCT00707239|81379789|FG000|Overall Study|Other|8|||
27876441|NCT00707239|81379790|FG001|Overall Study|Other|3|||
27876442|NCT00707239|81379791|FG002|Overall Study|Other|5|||
27876443|NCT05244122|81379792|FG000|Overall Study|Withdrawal by Subject|318|||
27876444|NCT00886015|81379793|FG000|Overall Study|Death|0|||
27588747|NCT00490646|80335710|FG000|Overall Study|Never Treated (withdrew consent)|0|||
27876445|NCT00886015|81379794|FG001|Overall Study|Death|2|||
27876446|NCT02505217|81379795|FG000|Overall Study|Withdrawal by Subject|1|||
27876447|NCT02505217|81379796|FG001|Overall Study|Withdrawal by Subject|2|||
27813817|NCT01621490|81150209|FG005|Overall Study|Maximum clinical benefit|0|||
27813818|NCT01621490|81150210|FG006|Overall Study|Maximum clinical benefit|1|||
27813819|NCT01621490|81150211|FG007|Overall Study|Maximum clinical benefit|2|||
27813820|NCT01621490|81150212|FG008|Overall Study|Maximum clinical benefit|2|||
27813821|NCT01621490|81150213|FG009|Overall Study|Maximum clinical benefit|0|||
27813822|NCT01621490|81150214|FG010|Overall Study|Maximum clinical benefit|0|||
27813823|NCT01621490|81150204|FG000|Overall Study|Withdrawal by Subject|1|||
27813824|NCT01621490|81150205|FG001|Overall Study|Withdrawal by Subject|0|||
27813825|NCT01621490|81150206|FG002|Overall Study|Withdrawal by Subject|0|||
27813826|NCT01621490|81150207|FG003|Overall Study|Withdrawal by Subject|0|||
27813827|NCT01621490|81150208|FG004|Overall Study|Withdrawal by Subject|0|||
27813828|NCT01621490|81150209|FG005|Overall Study|Withdrawal by Subject|1|||
27813829|NCT01621490|81150210|FG006|Overall Study|Withdrawal by Subject|0|||
27813830|NCT01621490|81150211|FG007|Overall Study|Withdrawal by Subject|0|||
27813831|NCT01621490|81150212|FG008|Overall Study|Withdrawal by Subject|0|||
27813832|NCT01621490|81150213|FG009|Overall Study|Withdrawal by Subject|0|||
27813833|NCT01621490|81150214|FG010|Overall Study|Withdrawal by Subject|0|||
27813834|NCT01621490|81150204|FG000|Overall Study|Subject request to discontinue study|1|||
27813835|NCT01621490|81150205|FG001|Overall Study|Subject request to discontinue study|3|||
27813836|NCT01621490|81150206|FG002|Overall Study|Subject request to discontinue study|1|||
27813837|NCT01621490|81150207|FG003|Overall Study|Subject request to discontinue study|1|||
27813838|NCT01621490|81150208|FG004|Overall Study|Subject request to discontinue study|0|||
27813839|NCT01621490|81150209|FG005|Overall Study|Subject request to discontinue study|2|||
27813840|NCT01621490|81150210|FG006|Overall Study|Subject request to discontinue study|1|||
27813841|NCT01621490|81150211|FG007|Overall Study|Subject request to discontinue study|0|||
27813842|NCT01621490|81150212|FG008|Overall Study|Subject request to discontinue study|1|||
27813843|NCT01621490|81150213|FG009|Overall Study|Subject request to discontinue study|0|||
27813844|NCT01621490|81150214|FG010|Overall Study|Subject request to discontinue study|0|||
27813845|NCT01621490|81150204|FG000|Overall Study|Adverse event unrelated to study drug|1|||
27813846|NCT01621490|81150205|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27813847|NCT01621490|81150206|FG002|Overall Study|Adverse event unrelated to study drug|0|||
27813848|NCT01621490|81150207|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27876448|NCT01402570|81379797|FG000|Overall Study|Adverse Event|1|||
27876449|NCT03361306|81379800|FG000|Overall Study|Death|5|||
27876450|NCT03361306|81379800|FG000|Overall Study|Still On Study (on study treatment)|3|||
27876451|NCT03361306|81379800|FG000|Overall Study|Still On Study (in follow up)|7|||
27876452|NCT00884117|81379805|FG000|Overall Study|Adverse Event|2|||
27876453|NCT00884117|81379805|FG000|Overall Study|Withdrawal by Subject|89|||
27876454|NCT00884117|81379805|FG000|Overall Study|Death|3|||
27876455|NCT00884117|81379805|FG000|Overall Study|Lost to Follow-up|143|||
27876456|NCT00884117|81379805|FG000|Overall Study|Other|12|||
27876457|NCT00460811|81379806|FG000|Overall Study|Adverse Event|4|||
27876458|NCT00460811|81379807|FG001|Overall Study|Adverse Event|6|||
27876459|NCT00460811|81379808|FG002|Overall Study|Adverse Event|3|||
27876460|NCT00460811|81379809|FG003|Overall Study|Adverse Event|10|||
27876461|NCT00460811|81379810|FG004|Overall Study|Adverse Event|2|||
27876462|NCT00460811|81379806|FG000|Overall Study|Noncompliance|1|||
27876463|NCT00460811|81379807|FG001|Overall Study|Noncompliance|0|||
27876464|NCT00460811|81379808|FG002|Overall Study|Noncompliance|0|||
27876465|NCT00460811|81379809|FG003|Overall Study|Noncompliance|2|||
27876466|NCT00460811|81379810|FG004|Overall Study|Noncompliance|1|||
27876467|NCT00460811|81379806|FG000|Overall Study|Withdrawal by Subject|7|||
27876468|NCT00460811|81379807|FG001|Overall Study|Withdrawal by Subject|7|||
27876469|NCT00460811|81379808|FG002|Overall Study|Withdrawal by Subject|6|||
27876470|NCT00460811|81379809|FG003|Overall Study|Withdrawal by Subject|3|||
27876471|NCT00460811|81379810|FG004|Overall Study|Withdrawal by Subject|11|||
27876472|NCT00460811|81379806|FG000|Overall Study|Physician Decision|1|||
27876473|NCT00460811|81379807|FG001|Overall Study|Physician Decision|0|||
27876474|NCT00460811|81379808|FG002|Overall Study|Physician Decision|0|||
27876475|NCT00460811|81379809|FG003|Overall Study|Physician Decision|0|||
27876476|NCT00460811|81379810|FG004|Overall Study|Physician Decision|0|||
27876477|NCT00460811|81379806|FG000|Overall Study|Lost to Follow-up|3|||
27876478|NCT00460811|81379807|FG001|Overall Study|Lost to Follow-up|2|||
27876479|NCT00460811|81379808|FG002|Overall Study|Lost to Follow-up|5|||
27876480|NCT00460811|81379809|FG003|Overall Study|Lost to Follow-up|3|||
27876481|NCT00460811|81379810|FG004|Overall Study|Lost to Follow-up|6|||
27876482|NCT00391768|81379811|FG000|Overall Study|Withdrawal by Subject|0|||
27876483|NCT00391768|81379812|FG001|Overall Study|Withdrawal by Subject|0|||
27876484|NCT00391768|81379813|FG002|Overall Study|Withdrawal by Subject|1|||
27876485|NCT00391768|81379814|FG003|Overall Study|Withdrawal by Subject|0|||
27876486|NCT00391768|81379815|FG004|Overall Study|Withdrawal by Subject|0|||
27876487|NCT00391768|81379816|FG005|Overall Study|Withdrawal by Subject|1|||
27876488|NCT00391768|81379817|FG006|Overall Study|Withdrawal by Subject|1|||
27876489|NCT00391768|81379811|FG000|Overall Study|Lost to Follow-up|0|||
27876490|NCT00391768|81379812|FG001|Overall Study|Lost to Follow-up|0|||
27876491|NCT00391768|81379813|FG002|Overall Study|Lost to Follow-up|0|||
27876492|NCT00391768|81379814|FG003|Overall Study|Lost to Follow-up|1|||
27876493|NCT00391768|81379815|FG004|Overall Study|Lost to Follow-up|2|||
27876494|NCT00391768|81379816|FG005|Overall Study|Lost to Follow-up|2|||
27876495|NCT00391768|81379817|FG006|Overall Study|Lost to Follow-up|3|||
27876496|NCT01801865|81379818|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
27876497|NCT01801865|81379818|FG000|Overall Study|Physician Decision|7|||
27876498|NCT03762265|81379819|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
27876499|NCT03762265|81379820|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
27876500|NCT03762265|81379819|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
27876501|NCT03762265|81379820|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
27876502|NCT03762265|81379819|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
27876503|NCT03762265|81379820|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
27876504|NCT03762265|81379819|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
27876505|NCT03762265|81379820|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
27876506|NCT03762265|81379819|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
27876507|NCT03762265|81379820|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
27876508|NCT03762265|81379819|FG000|BT Period: Weeks 1 to 37|Other|0|||
27876509|NCT03762265|81379820|FG001|BT Period: Weeks 1 to 37|Other|1|||
27876510|NCT03762265|81379819|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
27876511|NCT03762265|81379820|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
27876512|NCT03762265|81379819|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
27876513|NCT03762265|81379820|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
27876514|NCT03762265|81379819|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
27876515|NCT03762265|81379820|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
27876516|NCT03762265|81379819|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
27876517|NCT03762265|81379820|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
27876518|NCT03762265|81379819|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
27876519|NCT03762265|81379820|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
27876520|NCT03762265|81379819|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
27876521|NCT03762265|81379820|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
27876522|NCT03762265|81379819|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
27876523|NCT03762265|81379820|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
27876524|NCT03762265|81379819|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
27876525|NCT03762265|81379820|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
27876526|NCT03762265|81379819|FG000|LTE Period: Weeks 61 to 109|Other|1|||
27876527|NCT03762265|81379820|FG001|LTE Period: Weeks 61 to 109|Other|0|||
27876528|NCT00954941|81379821|FG000|Overall Study|Received treatment at home|1|||
27876529|NCT00954941|81379822|FG001|Overall Study|Received treatment at home|0|||
27876530|NCT00954941|81379821|FG000|Overall Study|Withdrawal by Subject|1|||
27876531|NCT00954941|81379822|FG001|Overall Study|Withdrawal by Subject|0|||
27876532|NCT00954941|81379821|FG000|Overall Study|Insurance Denial|2|||
27588748|NCT00490646|80335711|FG001|Overall Study|Never Treated (withdrew consent)|1|||
27588749|NCT04831736|80335712|FG000|Overall Study|Withdrawal by Subject|0|||
27588750|NCT04831736|80335713|FG001|Overall Study|Withdrawal by Subject|1|||
27588751|NCT00110617|80335714|FG000|Overall Study|Adverse Event|2|||
27588752|NCT00110617|80335715|FG001|Overall Study|Adverse Event|4|||
27588753|NCT00110617|80335714|FG000|Overall Study|Abnormal Laboratory Value|4|||
27588754|NCT00110617|80335715|FG001|Overall Study|Abnormal Laboratory Value|2|||
27588755|NCT00110617|80335714|FG000|Overall Study|Lack of Efficacy|1|||
27588756|NCT00110617|80335715|FG001|Overall Study|Lack of Efficacy|0|||
27588757|NCT00110617|80335714|FG000|Overall Study|Patient no longer requires study drug|1|||
27588758|NCT00110617|80335715|FG001|Overall Study|Patient no longer requires study drug|0|||
27588759|NCT00110617|80335714|FG000|Overall Study|Protocol Violation|5|||
27588760|NCT00110617|80335715|FG001|Overall Study|Protocol Violation|0|||
27588761|NCT00110617|80335714|FG000|Overall Study|Withdrawal by Subject|10|||
27588762|NCT00110617|80335715|FG001|Overall Study|Withdrawal by Subject|4|||
27588763|NCT00110617|80335714|FG000|Overall Study|Lost to Follow-up|9|||
27588764|NCT00110617|80335715|FG001|Overall Study|Lost to Follow-up|1|||
27588765|NCT00110617|80335714|FG000|Overall Study|Administrative problems|6|||
27588766|NCT00110617|80335715|FG001|Overall Study|Administrative problems|5|||
27588767|NCT00110617|80335714|FG000|Overall Study|Death|1|||
27588768|NCT00110617|80335715|FG001|Overall Study|Death|1|||
27588769|NCT00110617|80335714|FG000|Overall Study|Did not receive study drug|0|||
27588770|NCT00110617|80335715|FG001|Overall Study|Did not receive study drug|12|||
27588771|NCT00566228|80335719|FG000|Overall Study|Withdrawal by Subject|1|||
27588772|NCT00566228|80335720|FG001|Overall Study|Withdrawal by Subject|0|||
27588773|NCT00566228|80335719|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
27588774|NCT00566228|80335720|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
27588775|NCT00566228|80335719|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
27588776|NCT00566228|80335720|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
27588777|NCT00566228|80335719|FG000|Overall Study|progressed before infusion could occur|0|||
27588778|NCT00566228|80335720|FG001|Overall Study|progressed before infusion could occur|1|||
27588779|NCT05073133|80335723|FG000|Overall Study|Death|2|||
27588780|NCT01314118|80335726|FG000|Overall Study|Adverse Event|9|||
27588781|NCT01314118|80335726|FG000|Overall Study|Progressive disease|27|||
27588782|NCT01314118|80335726|FG000|Overall Study|Physician Decision|11|||
27588783|NCT01314118|80335726|FG000|Overall Study|Death|4|||
27588784|NCT01314118|80335726|FG000|Overall Study|Protocol Violation|5|||
27588785|NCT01314118|80335726|FG000|Overall Study|Withdrawal by Subject|11|||
27588786|NCT01314118|80335726|FG000|Overall Study|Other|2|||
27588787|NCT01314118|80335726|FG000|Overall Study|Ongoing|62|||
27588788|NCT01127178|80335727|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
27588789|NCT01127178|80335728|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
27588790|NCT01127178|80335727|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
27588791|NCT01127178|80335728|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
27588792|NCT01127178|80335727|FG000|Dose Escalation: Treatment Phase|Other|2|||
27588793|NCT01127178|80335728|FG001|Dose Escalation: Treatment Phase|Other|0|||
27588794|NCT01127178|80335727|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
27588795|NCT01127178|80335728|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
27588796|NCT01127178|80335727|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
27687998|NCT02663518|80694137|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
27687999|NCT02663518|80694138|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
27813849|NCT01621490|81150208|FG004|Overall Study|Adverse event unrelated to study drug|0|||
27813850|NCT01621490|81150209|FG005|Overall Study|Adverse event unrelated to study drug|0|||
27813851|NCT01621490|81150210|FG006|Overall Study|Adverse event unrelated to study drug|0|||
27813852|NCT01621490|81150211|FG007|Overall Study|Adverse event unrelated to study drug|2|||
27813853|NCT01621490|81150212|FG008|Overall Study|Adverse event unrelated to study drug|0|||
27813854|NCT01621490|81150213|FG009|Overall Study|Adverse event unrelated to study drug|0|||
27588797|NCT01127178|80335728|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
27588798|NCT01127178|80335727|FG000|Dose Escalation: Extension Phase|Other|1|||
27813855|NCT01621490|81150214|FG010|Overall Study|Adverse event unrelated to study drug|0|||
27813856|NCT01621490|81150204|FG000|Overall Study|Disease progression|27|||
27588799|NCT01127178|80335728|FG001|Dose Escalation: Extension Phase|Other|0|||
27588800|NCT02864082|80335729|FG000|Overall Study|Adverse Event|1|||
27588801|NCT02864082|80335730|FG001|Overall Study|Adverse Event|1|||
27588802|NCT02864082|80335729|FG000|Overall Study|Lost to Follow-up|0|||
27588803|NCT02864082|80335730|FG001|Overall Study|Lost to Follow-up|1|||
27588804|NCT02864082|80335729|FG000|Overall Study|Withdrawal by Subject|2|||
27588805|NCT02864082|80335730|FG001|Overall Study|Withdrawal by Subject|2|||
27588806|NCT03447769|80335731|FG000|Overall Study|Progressive disease|138|||
27588807|NCT03447769|80335732|FG001|Overall Study|Progressive disease|148|||
27588808|NCT03447769|80335731|FG000|Overall Study|Study terminated by Sponsor|60|||
27588809|NCT03447769|80335732|FG001|Overall Study|Study terminated by Sponsor|44|||
27588810|NCT03447769|80335731|FG000|Overall Study|Adverse Event|34|||
27588811|NCT03447769|80335732|FG001|Overall Study|Adverse Event|31|||
27588812|NCT03447769|80335731|FG000|Overall Study|Patient decision|27|||
27588813|NCT03447769|80335732|FG001|Overall Study|Patient decision|27|||
27588814|NCT03447769|80335731|FG000|Overall Study|Protocol deviation|4|||
27588815|NCT03447769|80335732|FG001|Overall Study|Protocol deviation|6|||
27588816|NCT03447769|80335731|FG000|Overall Study|Death|2|||
27876533|NCT00954941|81379822|FG001|Overall Study|Insurance Denial|2|||
27876534|NCT00954941|81379821|FG000|Overall Study|Physician Decision|2|||
27876535|NCT00954941|81379822|FG001|Overall Study|Physician Decision|2|||
27876536|NCT00954941|81379821|FG000|Overall Study|Ineligible|2|||
27876537|NCT00954941|81379822|FG001|Overall Study|Ineligible|2|||
27876538|NCT00954941|81379821|FG000|Overall Study|Adverse Event|0|||
27876539|NCT00954941|81379822|FG001|Overall Study|Adverse Event|1|||
27876540|NCT02741076|81379830|FG000|Overall Study|Adverse Event|0|||
27876541|NCT02741076|81379831|FG001|Overall Study|Adverse Event|1|||
27876542|NCT02741076|81379832|FG002|Overall Study|Adverse Event|1|||
27876543|NCT02741076|81379833|FG003|Overall Study|Adverse Event|0|||
27876544|NCT02741076|81379830|FG000|Overall Study|Lack of Efficacy|1|||
27876545|NCT02741076|81379831|FG001|Overall Study|Lack of Efficacy|0|||
27876546|NCT02741076|81379832|FG002|Overall Study|Lack of Efficacy|0|||
27876547|NCT02741076|81379833|FG003|Overall Study|Lack of Efficacy|0|||
27588817|NCT03447769|80335732|FG001|Overall Study|Death|7|||
27588818|NCT03447769|80335731|FG000|Overall Study|Technical problems|1|||
27876548|NCT02741076|81379830|FG000|Overall Study|Withdrawal by Subject|0|||
27876549|NCT02741076|81379831|FG001|Overall Study|Withdrawal by Subject|1|||
27876550|NCT02741076|81379832|FG002|Overall Study|Withdrawal by Subject|0|||
27876551|NCT02741076|81379833|FG003|Overall Study|Withdrawal by Subject|0|||
27876552|NCT02741076|81379830|FG000|Overall Study|Sponsor Request|2|||
27876553|NCT02741076|81379831|FG001|Overall Study|Sponsor Request|3|||
27876554|NCT02741076|81379832|FG002|Overall Study|Sponsor Request|0|||
27876555|NCT02741076|81379833|FG003|Overall Study|Sponsor Request|1|||
27876556|NCT02741076|81379830|FG000|Overall Study|No additional information available|0|||
27876557|NCT02741076|81379831|FG001|Overall Study|No additional information available|0|||
27876558|NCT02741076|81379832|FG002|Overall Study|No additional information available|1|||
27876559|NCT02741076|81379833|FG003|Overall Study|No additional information available|1|||
27876560|NCT01954056|81379835|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
27876561|NCT01954056|81379836|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
27876562|NCT00513240|81379841|FG000|Overall Study|Did not have intended surgery|3|||
27876563|NCT00513240|81379842|FG001|Overall Study|Did not have intended surgery|0|||
27876564|NCT00513240|81379841|FG000|Overall Study|Death|3|||
27876565|NCT00513240|81379842|FG001|Overall Study|Death|3|||
27876566|NCT00513240|81379841|FG000|Overall Study|Withdrawal by Subject|7|||
27876567|NCT00513240|81379842|FG001|Overall Study|Withdrawal by Subject|4|||
27876568|NCT01205776|81379843|FG000|Overall Study|Lost to Follow-up|53|||
27876569|NCT01205776|81379844|FG001|Overall Study|Lost to Follow-up|61|||
27588819|NCT03447769|80335732|FG001|Overall Study|Technical problems|0|||
27588820|NCT03447769|80335731|FG000|Overall Study|Lost to Follow-up|0|||
27876570|NCT01205776|81379843|FG000|Overall Study|Withdrawal by Subject|11|||
27876571|NCT01205776|81379844|FG001|Overall Study|Withdrawal by Subject|34|||
27876572|NCT04358081|81379845|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
27876573|NCT04358081|81379846|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
27876574|NCT04358081|81379847|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
27876575|NCT04358081|81379845|FG000|Treatment Phase of Study|Adverse Event|1|||
27876576|NCT04358081|81379846|FG001|Treatment Phase of Study|Adverse Event|0|||
27876577|NCT04358081|81379847|FG002|Treatment Phase of Study|Adverse Event|1|||
27876578|NCT04358081|81379845|FG000|Treatment Phase of Study|Physician Decision|2|||
27876579|NCT04358081|81379846|FG001|Treatment Phase of Study|Physician Decision|0|||
27876580|NCT04358081|81379847|FG002|Treatment Phase of Study|Physician Decision|1|||
27876581|NCT04358081|81379845|FG000|Treatment Phase of Study|Protocol Violation|1|||
27876582|NCT04358081|81379846|FG001|Treatment Phase of Study|Protocol Violation|0|||
27588821|NCT03447769|80335732|FG001|Overall Study|Lost to Follow-up|1|||
27588822|NCT03447769|80335731|FG000|Overall Study|Physician Decision|13|||
27588823|NCT03447769|80335732|FG001|Overall Study|Physician Decision|5|||
27588824|NCT00144339|80335734|FG000|Overall Study|Adverse Event|746|||
27876583|NCT04358081|81379847|FG002|Treatment Phase of Study|Protocol Violation|0|||
27876584|NCT04358081|81379845|FG000|Study Completion Phase|Death|0|||
27876585|NCT04358081|81379846|FG001|Study Completion Phase|Death|0|||
27876586|NCT04358081|81379847|FG002|Study Completion Phase|Death|1|||
27876587|NCT04358081|81379845|FG000|Study Completion Phase|Lost to Follow-up|1|||
27876588|NCT04358081|81379846|FG001|Study Completion Phase|Lost to Follow-up|0|||
27876589|NCT04358081|81379847|FG002|Study Completion Phase|Lost to Follow-up|1|||
27876590|NCT00114140|81379854|FG000|Overall Study|Protocol Violation|7|||
27876591|NCT01283464|81379858|FG000|Overall Study|Lost to Follow-up|0|||
27876592|NCT01283464|81379859|FG001|Overall Study|Lost to Follow-up|1|||
27876593|NCT01283464|81379858|FG000|Overall Study|Withdrawal by Subject|1|||
27876594|NCT01283464|81379859|FG001|Overall Study|Withdrawal by Subject|0|||
27876595|NCT01283464|81379858|FG000|Overall Study|Physician Decision|1|||
27876596|NCT01283464|81379859|FG001|Overall Study|Physician Decision|0|||
27876597|NCT00740636|81379860|FG000|Overall Study|Adverse Event|0|||
27876598|NCT00740636|81379861|FG001|Overall Study|Adverse Event|2|||
27876599|NCT00740636|81379860|FG000|Overall Study|Patient Ineligible|0|||
27876600|NCT00740636|81379861|FG001|Overall Study|Patient Ineligible|1|||
27876601|NCT00740636|81379860|FG000|Overall Study|Patient Not Treated|0|||
27876602|NCT00740636|81379861|FG001|Overall Study|Patient Not Treated|1|||
27588825|NCT00144339|80335735|FG001|Overall Study|Adverse Event|627|||
27588826|NCT00144339|80335734|FG000|Overall Study|Protocol Violation|75|||
27588827|NCT00144339|80335735|FG001|Overall Study|Protocol Violation|48|||
27588828|NCT00144339|80335734|FG000|Overall Study|Withdrawal by Subject|403|||
27588829|NCT00144339|80335735|FG001|Overall Study|Withdrawal by Subject|300|||
27588830|NCT00144339|80335734|FG000|Overall Study|Lost to Follow-up|76|||
27588831|NCT00144339|80335735|FG001|Overall Study|Lost to Follow-up|64|||
27588832|NCT00144339|80335734|FG000|Overall Study|Other|58|||
27588833|NCT00144339|80335735|FG001|Overall Study|Other|60|||
27588834|NCT03521635|80335736|FG000|Overall Study|Adverse Event|1|||
27813857|NCT01621490|81150205|FG001|Overall Study|Disease progression|28|||
27876603|NCT00740636|81379860|FG000|Overall Study|Progressive Disease|1|||
27876604|NCT00740636|81379861|FG001|Overall Study|Progressive Disease|0|||
27876605|NCT00740636|81379860|FG000|Overall Study|Death|1|||
27876606|NCT00740636|81379861|FG001|Overall Study|Death|0|||
27876607|NCT01464593|81379862|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
27876608|NCT01134939|81379863|FG000|Overall Study|Adverse Event|9|||
27876609|NCT01134939|81379864|FG001|Overall Study|Adverse Event|3|||
27876610|NCT01134939|81379865|FG002|Overall Study|Adverse Event|4|||
27876611|NCT01134939|81379866|FG003|Overall Study|Adverse Event|5|||
27876612|NCT01134939|81379867|FG004|Overall Study|Adverse Event|5|||
27876613|NCT01134939|81379868|FG005|Overall Study|Adverse Event|5|||
27876614|NCT01134939|81379869|FG006|Overall Study|Adverse Event|1|||
27876615|NCT01134939|81379870|FG007|Overall Study|Adverse Event|0|||
27876616|NCT01134939|81379863|FG000|Overall Study|Lack of Efficacy|2|||
27876617|NCT01134939|81379864|FG001|Overall Study|Lack of Efficacy|5|||
27876618|NCT01134939|81379865|FG002|Overall Study|Lack of Efficacy|1|||
27876619|NCT01134939|81379866|FG003|Overall Study|Lack of Efficacy|0|||
27876620|NCT01134939|81379867|FG004|Overall Study|Lack of Efficacy|3|||
27876621|NCT01134939|81379868|FG005|Overall Study|Lack of Efficacy|0|||
27876622|NCT01134939|81379869|FG006|Overall Study|Lack of Efficacy|1|||
27813858|NCT01621490|81150206|FG002|Overall Study|Disease progression|1|||
27813859|NCT01621490|81150207|FG003|Overall Study|Disease progression|5|||
27813860|NCT01621490|81150208|FG004|Overall Study|Disease progression|3|||
27813861|NCT01621490|81150209|FG005|Overall Study|Disease progression|8|||
27813862|NCT01621490|81150210|FG006|Overall Study|Disease progression|7|||
27813863|NCT01621490|81150211|FG007|Overall Study|Disease progression|1|||
27813864|NCT01621490|81150212|FG008|Overall Study|Disease progression|4|||
27813865|NCT01621490|81150213|FG009|Overall Study|Disease progression|1|||
27876623|NCT01134939|81379870|FG007|Overall Study|Lack of Efficacy|0|||
27876624|NCT01134939|81379863|FG000|Overall Study|Lost to Follow-up|2|||
27876625|NCT01134939|81379864|FG001|Overall Study|Lost to Follow-up|3|||
27876626|NCT01134939|81379865|FG002|Overall Study|Lost to Follow-up|0|||
27876627|NCT01134939|81379866|FG003|Overall Study|Lost to Follow-up|1|||
27876628|NCT01134939|81379867|FG004|Overall Study|Lost to Follow-up|2|||
27876629|NCT01134939|81379868|FG005|Overall Study|Lost to Follow-up|1|||
27876630|NCT01134939|81379869|FG006|Overall Study|Lost to Follow-up|0|||
27876631|NCT01134939|81379870|FG007|Overall Study|Lost to Follow-up|0|||
27876632|NCT01134939|81379863|FG000|Overall Study|Death|0|||
27876633|NCT01134939|81379864|FG001|Overall Study|Death|1|||
27588835|NCT03521635|80335737|FG001|Overall Study|Adverse Event|1|||
27588836|NCT03521635|80335736|FG000|Overall Study|Refused to complete study visit|1|||
27588837|NCT03521635|80335737|FG001|Overall Study|Refused to complete study visit|0|||
27813866|NCT01621490|81150214|FG010|Overall Study|Disease progression|1|||
27813867|NCT01621490|81150204|FG000|Overall Study|Study drug toxicity|1|||
27876634|NCT01134939|81379865|FG002|Overall Study|Death|0|||
27876635|NCT01134939|81379866|FG003|Overall Study|Death|0|||
27876636|NCT01134939|81379867|FG004|Overall Study|Death|0|||
27876637|NCT01134939|81379868|FG005|Overall Study|Death|0|||
27876638|NCT01134939|81379869|FG006|Overall Study|Death|0|||
27588838|NCT03521635|80335736|FG000|Overall Study|Refused to continue trial medication|2|||
27588839|NCT03521635|80335737|FG001|Overall Study|Refused to continue trial medication|2|||
27588840|NCT03521635|80335736|FG000|Overall Study|Lost to Follow-up|0|||
27876639|NCT01134939|81379870|FG007|Overall Study|Death|0|||
27876640|NCT01134939|81379863|FG000|Overall Study|Termination page not available|4|||
27588841|NCT03521635|80335737|FG001|Overall Study|Lost to Follow-up|1|||
27588842|NCT03521635|80335736|FG000|Overall Study|Meet exclusion criteria|0|||
27588843|NCT03521635|80335737|FG001|Overall Study|Meet exclusion criteria|1|||
27588844|NCT03521635|80335736|FG000|Overall Study|Patient not taken study medicine|0|||
27588845|NCT03521635|80335737|FG001|Overall Study|Patient not taken study medicine|1|||
27588846|NCT00121238|80335739|FG000|Overall Study|disease progression before intervention|1|||
27588847|NCT00121238|80335739|FG000|Overall Study|Protocol Violation|2|||
27588848|NCT02246998|80335740|FG000|Overall Study|Adverse Event|0|||
27588849|NCT02246998|80335741|FG001|Overall Study|Adverse Event|1|||
27588850|NCT02246998|80335742|FG002|Overall Study|Adverse Event|1|||
27813868|NCT01621490|81150205|FG001|Overall Study|Study drug toxicity|4|||
27813869|NCT01621490|81150206|FG002|Overall Study|Study drug toxicity|5|||
27876641|NCT01134939|81379864|FG001|Overall Study|Termination page not available|6|||
27876642|NCT01134939|81379865|FG002|Overall Study|Termination page not available|5|||
27876643|NCT01134939|81379866|FG003|Overall Study|Termination page not available|8|||
27876644|NCT01134939|81379867|FG004|Overall Study|Termination page not available|0|||
27876645|NCT01134939|81379868|FG005|Overall Study|Termination page not available|3|||
27876646|NCT01134939|81379869|FG006|Overall Study|Termination page not available|7|||
27876647|NCT01134939|81379870|FG007|Overall Study|Termination page not available|0|||
27876648|NCT00813150|81379871|FG000|Treatment Period|Adverse Event|16|||
27876649|NCT00813150|81379872|FG001|Treatment Period|Adverse Event|15|||
27876650|NCT00813150|81379871|FG000|Treatment Period|Death|2|||
27876651|NCT00813150|81379872|FG001|Treatment Period|Death|0|||
27876652|NCT00813150|81379871|FG000|Treatment Period|Progressive disease|1|||
27876653|NCT00813150|81379872|FG001|Treatment Period|Progressive disease|0|||
27876654|NCT00813150|81379871|FG000|Treatment Period|Complete response|0|||
27876655|NCT00813150|81379872|FG001|Treatment Period|Complete response|1|||
27588851|NCT02246998|80335743|FG003|Overall Study|Adverse Event|0|||
27588852|NCT02246998|80335740|FG000|Overall Study|Lost to Follow-up|1|||
27813870|NCT01621490|81150207|FG003|Overall Study|Study drug toxicity|3|||
27813871|NCT01621490|81150208|FG004|Overall Study|Study drug toxicity|1|||
27813872|NCT01621490|81150209|FG005|Overall Study|Study drug toxicity|10|||
27813873|NCT01621490|81150210|FG006|Overall Study|Study drug toxicity|1|||
27813874|NCT01621490|81150211|FG007|Overall Study|Study drug toxicity|4|||
27813875|NCT01621490|81150212|FG008|Overall Study|Study drug toxicity|1|||
27876656|NCT00813150|81379871|FG000|Treatment Period|Stable disease|1|||
27876657|NCT00813150|81379872|FG001|Treatment Period|Stable disease|2|||
27876658|NCT00813150|81379871|FG000|Treatment Period|Protocol Violation|3|||
27876659|NCT00813150|81379872|FG001|Treatment Period|Protocol Violation|4|||
27876660|NCT00813150|81379871|FG000|Treatment Period|Withdrawal by Subject|5|||
27876661|NCT00813150|81379872|FG001|Treatment Period|Withdrawal by Subject|3|||
27876662|NCT00813150|81379871|FG000|Treatment Period|Non compliance|0|||
27876663|NCT00813150|81379872|FG001|Treatment Period|Non compliance|1|||
27876664|NCT00813150|81379871|FG000|Treatment Period|Reason not specified|3|||
27588853|NCT02246998|80335741|FG001|Overall Study|Lost to Follow-up|0|||
27813876|NCT01621490|81150213|FG009|Overall Study|Study drug toxicity|0|||
27813877|NCT01621490|81150214|FG010|Overall Study|Study drug toxicity|0|||
27588854|NCT02246998|80335742|FG002|Overall Study|Lost to Follow-up|0|||
27588855|NCT02246998|80335743|FG003|Overall Study|Lost to Follow-up|1|||
27588856|NCT02246998|80335740|FG000|Overall Study|Randomized but Never Dosed|1|||
27588857|NCT02246998|80335741|FG001|Overall Study|Randomized but Never Dosed|2|||
27588858|NCT02246998|80335742|FG002|Overall Study|Randomized but Never Dosed|2|||
27588859|NCT02246998|80335743|FG003|Overall Study|Randomized but Never Dosed|1|||
27588860|NCT02911948|80335747|FG000|Overall Study|Protocol Violation|0|||
27588861|NCT02911948|80335748|FG001|Overall Study|Protocol Violation|1|||
27588862|NCT02911948|80335747|FG000|Overall Study|Withdrawal by Subject|0|||
27588863|NCT02911948|80335748|FG001|Overall Study|Withdrawal by Subject|2|||
27588864|NCT02911948|80335747|FG000|Overall Study|Lack of Efficacy|0|||
27588865|NCT02911948|80335748|FG001|Overall Study|Lack of Efficacy|1|||
27588866|NCT02911948|80335747|FG000|Overall Study|Unclassified|0|||
27588867|NCT02911948|80335748|FG001|Overall Study|Unclassified|3|||
27588868|NCT00659334|80335749|FG000|Overall Study|Screen Failure|8|||
27588869|NCT00659334|80335750|FG001|Overall Study|Screen Failure|5|||
27588870|NCT00659334|80335751|FG002|Overall Study|Screen Failure|0|||
27588871|NCT00659334|80335752|FG003|Overall Study|Screen Failure|0|||
27588872|NCT00659334|80335753|FG004|Overall Study|Screen Failure|0|||
27588873|NCT00659334|80335754|FG005|Overall Study|Screen Failure|0|||
27588874|NCT00659334|80335755|FG006|Overall Study|Screen Failure|1|||
27588875|NCT03624504|80335756|FG000|Overall Study|Unsuccessful Implant|1|||
27588876|NCT02367911|80335757|FG000|Overall Study|Withdrawal by Subject|3|||
27588877|NCT02367911|80335758|FG001|Overall Study|Withdrawal by Subject|2|||
27588878|NCT02367911|80335757|FG000|Overall Study|Lost to Follow-up|2|||
27588879|NCT02367911|80335758|FG001|Overall Study|Lost to Follow-up|2|||
27588880|NCT02511431|80335761|FG000|Treatment|Lost to Follow-up|0|||
27588881|NCT02511431|80335762|FG001|Treatment|Lost to Follow-up|0|||
27588882|NCT02511431|80335763|FG002|Treatment|Lost to Follow-up|1|||
27588883|NCT02511431|80335764|FG003|Treatment|Lost to Follow-up|0|||
27588884|NCT02511431|80335765|FG004|Treatment|Lost to Follow-up|0|||
27588885|NCT02511431|80335766|FG005|Treatment|Lost to Follow-up|1|||
27588886|NCT02827877|80335767|FG000|Overall Study|Withdrawal by Subject|1|||
27588887|NCT03336619|80340225|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
27588888|NCT03336619|80340226|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
27588889|NCT03336619|80340225|FG000|Overall Study|Withdrawal by Subject|17|||
27588890|NCT03336619|80340226|FG001|Overall Study|Withdrawal by Subject|16|||
27588891|NCT03336619|80340225|FG000|Overall Study|Adverse Event|2|||
27588892|NCT03336619|80340226|FG001|Overall Study|Adverse Event|5|||
27588893|NCT03336619|80340225|FG000|Overall Study|Physician Decision|3|||
27588894|NCT03336619|80340226|FG001|Overall Study|Physician Decision|0|||
27588895|NCT03923959|80340227|FG000|Overall Study|Death|16|||
27588896|NCT03923959|80340228|FG001|Overall Study|Death|12|||
27588897|NCT03923959|80340227|FG000|Overall Study|Lost to Follow-up|56|||
27588898|NCT03923959|80340228|FG001|Overall Study|Lost to Follow-up|56|||
27588899|NCT03923959|80340227|FG000|Overall Study|Withdrawal by Subject|1|||
27588900|NCT03923959|80340228|FG001|Overall Study|Withdrawal by Subject|1|||
27588901|NCT03923959|80340227|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
27813878|NCT01621490|81150204|FG000|Overall Study|Death|0|||
27813879|NCT01621490|81150205|FG001|Overall Study|Death|0|||
27813880|NCT01621490|81150206|FG002|Overall Study|Death|0|||
27813881|NCT01621490|81150207|FG003|Overall Study|Death|0|||
27813882|NCT01621490|81150208|FG004|Overall Study|Death|0|||
27813883|NCT01621490|81150209|FG005|Overall Study|Death|0|||
27813884|NCT01621490|81150210|FG006|Overall Study|Death|0|||
27813885|NCT01621490|81150211|FG007|Overall Study|Death|0|||
27813886|NCT01621490|81150212|FG008|Overall Study|Death|1|||
27588902|NCT03923959|80340228|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
27588903|NCT01627249|80340232|FG000|Overall Study|Death|3|||
27588904|NCT01627249|80340233|FG001|Overall Study|Death|5|||
27588905|NCT01627249|80340234|FG002|Overall Study|Death|3|||
27588906|NCT01627249|80340232|FG000|Overall Study|Withdrawal by Subject|12|||
27588907|NCT01627249|80340233|FG001|Overall Study|Withdrawal by Subject|6|||
27813887|NCT01621490|81150213|FG009|Overall Study|Death|0|||
27813888|NCT01621490|81150214|FG010|Overall Study|Death|0|||
27688000|NCT02663518|80694139|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
27688001|NCT02663518|80694140|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
27688002|NCT02663518|80694141|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
27688003|NCT02663518|80694142|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
27688004|NCT02663518|80694143|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
27688005|NCT02663518|80694130|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688006|NCT02663518|80694131|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688007|NCT02663518|80694132|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688008|NCT02663518|80694133|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688009|NCT02663518|80694134|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688010|NCT02663518|80694135|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688011|NCT02663518|80694136|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
27688012|NCT02663518|80694137|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688013|NCT02663518|80694138|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688014|NCT02663518|80694139|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688015|NCT02663518|80694140|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688016|NCT02663518|80694141|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688017|NCT02663518|80694142|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688018|NCT02663518|80694143|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
27688019|NCT02663518|80694130|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
27688020|NCT02663518|80694131|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
27688021|NCT02663518|80694132|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
27688022|NCT02663518|80694133|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
27688023|NCT02663518|80694134|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
27688024|NCT02663518|80694135|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
27813889|NCT01621490|81150204|FG000|Overall Study|Other reasons|7|||
27813890|NCT01621490|81150205|FG001|Overall Study|Other reasons|6|||
27813891|NCT01621490|81150206|FG002|Overall Study|Other reasons|4|||
27813892|NCT01621490|81150207|FG003|Overall Study|Other reasons|1|||
27813893|NCT01621490|81150208|FG004|Overall Study|Other reasons|1|||
27813894|NCT01621490|81150209|FG005|Overall Study|Other reasons|3|||
27813895|NCT01621490|81150210|FG006|Overall Study|Other reasons|1|||
27813896|NCT01621490|81150211|FG007|Overall Study|Other reasons|1|||
27813897|NCT01621490|81150212|FG008|Overall Study|Other reasons|1|||
27813898|NCT01621490|81150213|FG009|Overall Study|Other reasons|0|||
27813899|NCT01621490|81150214|FG010|Overall Study|Other reasons|0|||
27813900|NCT02974114|81150220|FG000|Overall Study|Other (Not specified)|0|||
27813901|NCT02974114|81150221|FG001|Overall Study|Other (Not specified)|1|||
27813902|NCT02974114|81150222|FG002|Overall Study|Other (Not specified)|2|||
27813903|NCT02563522|81150227|FG000|Overall Study|Adverse Event|2|||
27813904|NCT02563522|81150228|FG001|Overall Study|Adverse Event|3|||
27813905|NCT02563522|81150227|FG000|Overall Study|Lost to Follow-up|1|||
27813906|NCT02563522|81150228|FG001|Overall Study|Lost to Follow-up|0|||
27876665|NCT00813150|81379872|FG001|Treatment Period|Reason not specified|4|||
27876666|NCT00813150|81379871|FG000|Treatment Period|Data not available|1|||
27876667|NCT00813150|81379872|FG001|Treatment Period|Data not available|2|||
27688025|NCT02663518|80694136|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
27688026|NCT02663518|80694137|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
27876668|NCT00813150|81379871|FG000|Long Term Follow-up|Death|0|||
27688027|NCT02663518|80694138|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
27688028|NCT02663518|80694139|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
27688029|NCT02663518|80694140|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
27813907|NCT02563522|81150227|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
27813908|NCT02563522|81150228|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
27813909|NCT00282256|81150232|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
27876669|NCT00813150|81379872|FG001|Long Term Follow-up|Death|4|||
27876670|NCT00813150|81379871|FG000|Long Term Follow-up|Other|0|||
27876671|NCT00813150|81379872|FG001|Long Term Follow-up|Other|3|||
27876672|NCT00813150|81379871|FG000|Long Term Follow-up|Lost to Follow-up|2|||
27876673|NCT00813150|81379872|FG001|Long Term Follow-up|Lost to Follow-up|0|||
27876674|NCT00813150|81379871|FG000|Long Term Follow-up|Progression/Relapse|22|||
27876675|NCT00813150|81379872|FG001|Long Term Follow-up|Progression/Relapse|24|||
27688030|NCT02663518|80694141|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
27813910|NCT00282256|81150232|FG000|Extension Treatment Period|Adverse Event|2|||
27813911|NCT03038113|81150235|FG000|Overall Study|Withdrawal by Subject|0|||
27813912|NCT03038113|81150236|FG001|Overall Study|Withdrawal by Subject|0|||
27813913|NCT03038113|81150237|FG002|Overall Study|Withdrawal by Subject|1|||
27876676|NCT02286713|81379878|FG000|One Week Follow-Up|Death|1|||
27876677|NCT02286713|81379879|FG001|One Week Follow-Up|Death|0|||
27876678|NCT02286713|81379878|FG000|One Week Follow-Up|Lost to Follow-up|17|||
27688031|NCT02663518|80694142|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
27688032|NCT02663518|80694143|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
27688033|NCT02663518|80694130|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688034|NCT02663518|80694131|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688035|NCT02663518|80694132|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688036|NCT02663518|80694133|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688037|NCT02663518|80694134|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688038|NCT02663518|80694135|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688039|NCT02663518|80694136|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688040|NCT02663518|80694137|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688041|NCT02663518|80694138|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688042|NCT02663518|80694139|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688043|NCT02663518|80694140|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688044|NCT02663518|80694141|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688045|NCT02663518|80694142|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
27688046|NCT02663518|80694143|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
27688047|NCT02663518|80694130|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688048|NCT02663518|80694131|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688049|NCT02663518|80694132|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688050|NCT02663518|80694133|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688051|NCT02663518|80694134|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688052|NCT02663518|80694135|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688053|NCT02663518|80694136|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688054|NCT02663518|80694137|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688055|NCT02663518|80694138|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688056|NCT02663518|80694139|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688057|NCT02663518|80694140|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27688058|NCT02663518|80694141|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
27688059|NCT02663518|80694142|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27813914|NCT03038113|81150238|FG003|Overall Study|Withdrawal by Subject|0|||
27813915|NCT03038113|81150239|FG004|Overall Study|Withdrawal by Subject|0|||
27813916|NCT03038113|81150240|FG005|Overall Study|Withdrawal by Subject|0|||
27813917|NCT03038113|81150241|FG006|Overall Study|Withdrawal by Subject|0|||
27813918|NCT03038113|81150242|FG007|Overall Study|Withdrawal by Subject|0|||
27813919|NCT03038113|81150243|FG008|Overall Study|Withdrawal by Subject|0|||
27813920|NCT03038113|81150244|FG009|Overall Study|Withdrawal by Subject|0|||
27813921|NCT03038113|81150245|FG010|Overall Study|Withdrawal by Subject|0|||
27813922|NCT03038113|81150246|FG011|Overall Study|Withdrawal by Subject|0|||
27813923|NCT03038113|81150247|FG012|Overall Study|Withdrawal by Subject|0|||
27813924|NCT03038113|81150248|FG013|Overall Study|Withdrawal by Subject|1|||
27813925|NCT03038113|81150235|FG000|Overall Study|Lost to Follow-up|0|||
27813926|NCT03038113|81150236|FG001|Overall Study|Lost to Follow-up|0|||
27813927|NCT03038113|81150237|FG002|Overall Study|Lost to Follow-up|0|||
27813928|NCT03038113|81150238|FG003|Overall Study|Lost to Follow-up|0|||
27813929|NCT03038113|81150239|FG004|Overall Study|Lost to Follow-up|0|||
27813930|NCT03038113|81150240|FG005|Overall Study|Lost to Follow-up|0|||
27813931|NCT03038113|81150241|FG006|Overall Study|Lost to Follow-up|1|||
27813932|NCT03038113|81150242|FG007|Overall Study|Lost to Follow-up|0|||
27813933|NCT03038113|81150243|FG008|Overall Study|Lost to Follow-up|0|||
27813934|NCT03038113|81150244|FG009|Overall Study|Lost to Follow-up|0|||
27813935|NCT03038113|81150245|FG010|Overall Study|Lost to Follow-up|0|||
27813936|NCT03038113|81150246|FG011|Overall Study|Lost to Follow-up|0|||
27813937|NCT03038113|81150247|FG012|Overall Study|Lost to Follow-up|0|||
27876679|NCT02286713|81379879|FG001|One Week Follow-Up|Lost to Follow-up|21|||
27588908|NCT01627249|80340234|FG002|Overall Study|Withdrawal by Subject|9|||
27588909|NCT01627249|80340232|FG000|Overall Study|Missed Visit|1|||
27588910|NCT01627249|80340233|FG001|Overall Study|Missed Visit|1|||
27588911|NCT01627249|80340234|FG002|Overall Study|Missed Visit|0|||
27588912|NCT02937545|80340235|FG000|Overall Study|Withdrawal by Subject|1|||
27588913|NCT02937545|80340236|FG001|Overall Study|Withdrawal by Subject|2|||
27588914|NCT02937545|80340237|FG002|Overall Study|Withdrawal by Subject|6|||
27588915|NCT02937545|80340238|FG003|Overall Study|Withdrawal by Subject|7|||
27588916|NCT02937545|80340235|FG000|Overall Study|Lost to Follow-up|1|||
27588917|NCT02937545|80340236|FG001|Overall Study|Lost to Follow-up|0|||
27588918|NCT02937545|80340237|FG002|Overall Study|Lost to Follow-up|0|||
27588919|NCT02937545|80340238|FG003|Overall Study|Lost to Follow-up|0|||
27588920|NCT01565707|80340239|FG000|Overall Study|Adverse Event|1|||
27588921|NCT01565707|80340240|FG001|Overall Study|Adverse Event|6|||
27588922|NCT01565707|80340241|FG002|Overall Study|Adverse Event|2|||
27588923|NCT01565707|80340242|FG003|Overall Study|Adverse Event|1|||
27588924|NCT01565707|80340239|FG000|Overall Study|Lost to Follow-up|1|||
27588925|NCT01565707|80340240|FG001|Overall Study|Lost to Follow-up|0|||
27813938|NCT03038113|81150248|FG013|Overall Study|Lost to Follow-up|0|||
27813939|NCT03882047|81150249|FG000|Overall Study|Adverse Event|0|||
27813940|NCT03882047|81150250|FG001|Overall Study|Adverse Event|2|||
27813941|NCT03882047|81150251|FG002|Overall Study|Adverse Event|2|||
27813942|NCT03882047|81150249|FG000|Overall Study|Treatment Failure|3|||
27813943|NCT03882047|81150250|FG001|Overall Study|Treatment Failure|3|||
27813944|NCT03882047|81150251|FG002|Overall Study|Treatment Failure|12|||
27813945|NCT03882047|81150249|FG000|Overall Study|Lost to Follow-up|0|||
27813946|NCT03882047|81150250|FG001|Overall Study|Lost to Follow-up|1|||
27813947|NCT03882047|81150251|FG002|Overall Study|Lost to Follow-up|0|||
27813948|NCT03882047|81150249|FG000|Overall Study|Did Not Wish to Continue|1|||
27813949|NCT03882047|81150250|FG001|Overall Study|Did Not Wish to Continue|4|||
27813950|NCT03882047|81150251|FG002|Overall Study|Did Not Wish to Continue|1|||
27813951|NCT03882047|81150249|FG000|Overall Study|Noncompliance With Protocol|2|||
27813952|NCT03882047|81150250|FG001|Overall Study|Noncompliance With Protocol|0|||
27813953|NCT03882047|81150251|FG002|Overall Study|Noncompliance With Protocol|0|||
27813954|NCT03882047|81150249|FG000|Overall Study|Did Not Meet Eligibility|0|||
27813955|NCT03882047|81150250|FG001|Overall Study|Did Not Meet Eligibility|0|||
27813956|NCT03882047|81150251|FG002|Overall Study|Did Not Meet Eligibility|1|||
27813957|NCT01170364|81150252|FG000|Overall Study|Protocol Violation|4|||
27876680|NCT02286713|81379878|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
27876681|NCT02286713|81379879|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
27876682|NCT02286713|81379878|FG000|Three Month Follow-Up|Death|1|||
27876683|NCT02286713|81379879|FG001|Three Month Follow-Up|Death|1|||
27876684|NCT02286713|81379878|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
27876685|NCT02286713|81379879|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
27588926|NCT01565707|80340241|FG002|Overall Study|Lost to Follow-up|0|||
27588927|NCT01565707|80340242|FG003|Overall Study|Lost to Follow-up|0|||
27588928|NCT01565707|80340239|FG000|Overall Study|Protocol Violation|1|||
27588929|NCT01565707|80340240|FG001|Overall Study|Protocol Violation|0|||
27588930|NCT01565707|80340241|FG002|Overall Study|Protocol Violation|0|||
27813958|NCT01170364|81150253|FG001|Overall Study|Protocol Violation|1|||
27813959|NCT01361126|81150254|FG000|Overall Study|Sponsor decision|0|||
27588931|NCT01565707|80340242|FG003|Overall Study|Protocol Violation|1|||
27588932|NCT01565707|80340239|FG000|Overall Study|Withdrawal by Subject|3|||
27588933|NCT01565707|80340240|FG001|Overall Study|Withdrawal by Subject|1|||
27588934|NCT01565707|80340241|FG002|Overall Study|Withdrawal by Subject|1|||
27588935|NCT01565707|80340242|FG003|Overall Study|Withdrawal by Subject|1|||
27588936|NCT01565707|80340239|FG000|Overall Study|Randomized but not evaluable|2|||
27588937|NCT01565707|80340240|FG001|Overall Study|Randomized but not evaluable|0|||
27588938|NCT01565707|80340241|FG002|Overall Study|Randomized but not evaluable|0|||
27588939|NCT01565707|80340242|FG003|Overall Study|Randomized but not evaluable|0|||
27588940|NCT01565707|80340239|FG000|Overall Study|Miscellaneous|1|||
27588941|NCT01565707|80340240|FG001|Overall Study|Miscellaneous|1|||
27588942|NCT01565707|80340241|FG002|Overall Study|Miscellaneous|0|||
27588943|NCT01565707|80340242|FG003|Overall Study|Miscellaneous|2|||
27588944|NCT01664078|80340243|FG000|Overall Study|Death|9|||
27588945|NCT01664078|80340243|FG000|Overall Study|Withdrawal by Subject|4|||
27588946|NCT01664078|80340243|FG000|Overall Study|Lost to Follow-up|2|||
27588947|NCT01664078|80340243|FG000|Overall Study|missed 5 year visit|1|||
27588948|NCT01664078|80340243|FG000|Overall Study|Other|53|||
27588949|NCT03776136|80340244|FG000|Overall Study|Death|85|||
27588950|NCT03776136|80340244|FG000|Overall Study|Withdrawal by Subject|3|||
27588951|NCT03776136|80340244|FG000|Overall Study|Sponsor Decision|15|||
27588952|NCT01953926|80340248|FG000|Overall Study|Withdrawal by Subject|23|||
27588953|NCT01953926|80340249|FG001|Overall Study|Withdrawal by Subject|3|||
27588954|NCT01953926|80340250|FG002|Overall Study|Withdrawal by Subject|3|||
27813960|NCT01361126|81150255|FG001|Overall Study|Sponsor decision|2|||
27876686|NCT02286713|81379878|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
27588955|NCT01953926|80340251|FG003|Overall Study|Withdrawal by Subject|5|||
27588956|NCT01953926|80340252|FG004|Overall Study|Withdrawal by Subject|6|||
27588957|NCT01953926|80340253|FG005|Overall Study|Withdrawal by Subject|0|||
27588958|NCT01953926|80340254|FG006|Overall Study|Withdrawal by Subject|1|||
27588959|NCT01953926|80340248|FG000|Overall Study|Physician Decision|1|||
27588960|NCT01953926|80340249|FG001|Overall Study|Physician Decision|0|||
27813961|NCT04128007|81150260|FG000|Overall Study|Withdrawal by Subject|9|||
27813962|NCT04128007|81150261|FG001|Overall Study|Withdrawal by Subject|6|||
27876687|NCT02286713|81379879|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
27876688|NCT02286713|81379878|FG000|Six Month Follow-Up|Death|2|||
27588961|NCT01953926|80340250|FG002|Overall Study|Physician Decision|0|||
27588962|NCT01953926|80340251|FG003|Overall Study|Physician Decision|0|||
27813963|NCT04128007|81150260|FG000|Overall Study|Protocol Violation|1|||
27813964|NCT04128007|81150261|FG001|Overall Study|Protocol Violation|0|||
27813965|NCT04128007|81150260|FG000|Overall Study|Lost to Follow-up|8|||
27813966|NCT04128007|81150261|FG001|Overall Study|Lost to Follow-up|7|||
27813967|NCT04128007|81150260|FG000|Overall Study|Adverse Event|5|||
27588963|NCT01953926|80340252|FG004|Overall Study|Physician Decision|2|||
27588964|NCT01953926|80340253|FG005|Overall Study|Physician Decision|0|||
27588965|NCT01953926|80340254|FG006|Overall Study|Physician Decision|0|||
27588966|NCT01953926|80340248|FG000|Overall Study|Lost to Follow-up|18|||
27588967|NCT01953926|80340249|FG001|Overall Study|Lost to Follow-up|3|||
27588968|NCT01953926|80340250|FG002|Overall Study|Lost to Follow-up|0|||
27588969|NCT01953926|80340251|FG003|Overall Study|Lost to Follow-up|5|||
27588970|NCT01953926|80340252|FG004|Overall Study|Lost to Follow-up|3|||
27588971|NCT01953926|80340253|FG005|Overall Study|Lost to Follow-up|0|||
27588972|NCT01953926|80340254|FG006|Overall Study|Lost to Follow-up|0|||
27588973|NCT01953926|80340248|FG000|Overall Study|Protocol Violation|1|||
27588974|NCT01953926|80340249|FG001|Overall Study|Protocol Violation|0|||
27588975|NCT01953926|80340250|FG002|Overall Study|Protocol Violation|0|||
27588976|NCT01953926|80340251|FG003|Overall Study|Protocol Violation|0|||
27588977|NCT01953926|80340252|FG004|Overall Study|Protocol Violation|0|||
27588978|NCT01953926|80340253|FG005|Overall Study|Protocol Violation|0|||
27588979|NCT01953926|80340254|FG006|Overall Study|Protocol Violation|0|||
27588980|NCT01953926|80340248|FG000|Overall Study|Other, Disease progression|2|||
27588981|NCT01953926|80340249|FG001|Overall Study|Other, Disease progression|1|||
27588982|NCT01953926|80340250|FG002|Overall Study|Other, Disease progression|0|||
27588983|NCT01953926|80340251|FG003|Overall Study|Other, Disease progression|0|||
27588984|NCT01953926|80340252|FG004|Overall Study|Other, Disease progression|1|||
27688060|NCT02663518|80694143|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
27813968|NCT04128007|81150261|FG001|Overall Study|Adverse Event|2|||
27813969|NCT04128007|81150260|FG000|Overall Study|Not reported|0|||
27813970|NCT04128007|81150261|FG001|Overall Study|Not reported|2|||
27876689|NCT02286713|81379879|FG001|Six Month Follow-Up|Death|0|||
27876690|NCT02286713|81379878|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
27876691|NCT02286713|81379879|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
27876692|NCT05271175|81379880|FG000|One Week Follow up|Lost to Follow-up|10|||
27876693|NCT05271175|81379881|FG001|One Week Follow up|Lost to Follow-up|7|||
27588985|NCT01953926|80340253|FG005|Overall Study|Other, Disease progression|0|||
27588986|NCT01953926|80340254|FG006|Overall Study|Other, Disease progression|0|||
27588987|NCT01953926|80340248|FG000|Overall Study|Discontinuation of study by sponsor|41|||
27588988|NCT01953926|80340249|FG001|Overall Study|Discontinuation of study by sponsor|7|||
27813971|NCT02888171|81150263|FG000|Overall Study|Lost to Follow-up|2|||
27813972|NCT02888171|81150264|FG001|Overall Study|Lost to Follow-up|1|||
27813973|NCT02888171|81150263|FG000|Overall Study|Withdrawal by Subject|3|||
27813974|NCT02888171|81150264|FG001|Overall Study|Withdrawal by Subject|2|||
27813975|NCT02888171|81150263|FG000|Overall Study|Adverse Event|0|||
27813976|NCT02888171|81150264|FG001|Overall Study|Adverse Event|1|||
27813977|NCT00536575|81150267|FG000|Overall Study|Withdrawal by Subject|1|||
27813978|NCT00536575|81150267|FG000|Overall Study|Death|1|||
27813979|NCT00449072|81150268|FG000|Overall Study|Adverse Event|3|||
27813980|NCT00449072|81150269|FG001|Overall Study|Adverse Event|1|||
27813981|NCT00449072|81150268|FG000|Overall Study|Protocol Violation|14|||
27813982|NCT00449072|81150269|FG001|Overall Study|Protocol Violation|12|||
27813983|NCT00449072|81150268|FG000|Overall Study|Lost to Follow-up|5|||
27813984|NCT00449072|81150269|FG001|Overall Study|Lost to Follow-up|7|||
27813985|NCT00449072|81150268|FG000|Overall Study|Withdrawal by Subject|11|||
27813986|NCT00449072|81150269|FG001|Overall Study|Withdrawal by Subject|8|||
27813987|NCT00449072|81150268|FG000|Overall Study|Lack of Efficacy|1|||
27813988|NCT00449072|81150269|FG001|Overall Study|Lack of Efficacy|1|||
27813989|NCT00449072|81150268|FG000|Overall Study|Physician Decision|1|||
27813990|NCT00449072|81150269|FG001|Overall Study|Physician Decision|0|||
27813991|NCT00449072|81150268|FG000|Overall Study|Not treated|0|||
27876694|NCT05271175|81379882|FG002|One Week Follow up|Lost to Follow-up|5|||
27876695|NCT05271175|81379880|FG000|One Month Follow up|Lost to Follow-up|12|||
27588989|NCT01953926|80340250|FG002|Overall Study|Discontinuation of study by sponsor|5|||
27588990|NCT01953926|80340251|FG003|Overall Study|Discontinuation of study by sponsor|12|||
27813992|NCT00449072|81150269|FG001|Overall Study|Not treated|1|||
27813993|NCT00449072|81150268|FG000|Overall Study|Excluded medication|0|||
27813994|NCT00449072|81150269|FG001|Overall Study|Excluded medication|2|||
27813995|NCT00449072|81150268|FG000|Overall Study|Non-compliance|2|||
27813996|NCT00449072|81150269|FG001|Overall Study|Non-compliance|5|||
27588991|NCT01953926|80340252|FG004|Overall Study|Discontinuation of study by sponsor|46|||
27588992|NCT01953926|80340253|FG005|Overall Study|Discontinuation of study by sponsor|5|||
27588993|NCT01953926|80340254|FG006|Overall Study|Discontinuation of study by sponsor|6|||
27588994|NCT01953926|80340248|FG000|Overall Study|Not Treated|1|||
27588995|NCT01953926|80340249|FG001|Overall Study|Not Treated|0|||
27588996|NCT01953926|80340250|FG002|Overall Study|Not Treated|1|||
27588997|NCT01953926|80340251|FG003|Overall Study|Not Treated|0|||
27588998|NCT01953926|80340252|FG004|Overall Study|Not Treated|0|||
27588999|NCT01953926|80340253|FG005|Overall Study|Not Treated|0|||
27589000|NCT01953926|80340254|FG006|Overall Study|Not Treated|0|||
27589001|NCT02096900|80340255|FG000|Overall Study|Did not receive medication|3|||
27589002|NCT02096900|80340256|FG001|Overall Study|Did not receive medication|1|||
27589003|NCT02096900|80340255|FG000|Overall Study|Surgery cancelled- medication received|1|||
27589004|NCT02096900|80340256|FG001|Overall Study|Surgery cancelled- medication received|1|||
27589005|NCT00715429|80340257|FG000|Overall Study|Did not complete the study diary|0|||
27589006|NCT00715429|80340258|FG001|Overall Study|Did not complete the study diary|1|||
27589007|NCT00360529|80340259|FG000|Overall Study|Adverse Event|10|||
27589008|NCT00360529|80340260|FG001|Overall Study|Adverse Event|23|||
27589009|NCT00360529|80340261|FG002|Overall Study|Adverse Event|33|||
27589010|NCT00360529|80340259|FG000|Overall Study|Protocol Violation|3|||
27589011|NCT00360529|80340260|FG001|Overall Study|Protocol Violation|3|||
27589012|NCT00360529|80340261|FG002|Overall Study|Protocol Violation|11|||
27813997|NCT00449072|81150268|FG000|Overall Study|Sponsor decision|1|||
27813998|NCT00449072|81150269|FG001|Overall Study|Sponsor decision|3|||
27813999|NCT00449072|81150268|FG000|Overall Study|Relocation|3|||
27814000|NCT00449072|81150269|FG001|Overall Study|Relocation|2|||
27814001|NCT01531205|81150270|FG000|Overall Study|Did not proceed to surgery|1|||
27814002|NCT02658084|81150271|FG000|Overall Study|Withdrawal by Subject|1|||
27814003|NCT02658084|81150272|FG001|Overall Study|Withdrawal by Subject|0|||
27814004|NCT02658084|81150271|FG000|Overall Study|Study Termination|1|||
27814005|NCT02658084|81150272|FG001|Overall Study|Study Termination|0|||
27814006|NCT03276975|81150273|FG000|Overall Study|Withdrawal by Subject|1|||
27814007|NCT03276975|81150274|FG001|Overall Study|Withdrawal by Subject|0|||
27814008|NCT03341273|81150280|FG000|Overall Study|Lost to Follow-up|7|||
27814009|NCT03341273|81150281|FG001|Overall Study|Lost to Follow-up|7|||
27876696|NCT05271175|81379881|FG001|One Month Follow up|Lost to Follow-up|7|||
27876697|NCT05271175|81379882|FG002|One Month Follow up|Lost to Follow-up|9|||
27876698|NCT05271175|81379880|FG000|Six Months Follow up|Lost to Follow-up|8|||
27876699|NCT05271175|81379881|FG001|Six Months Follow up|Lost to Follow-up|2|||
27876700|NCT05271175|81379882|FG002|Six Months Follow up|Lost to Follow-up|2|||
27876701|NCT02712320|81379885|FG000|Overall Study|Lost to Follow-up|1|||
27876702|NCT02712320|81379885|FG000|Overall Study|Withdrawal by Subject|1|||
27876703|NCT02712320|81379885|FG000|Overall Study|Transferred to another facility|1|||
27876704|NCT02712320|81379885|FG000|Overall Study|Treating with the prohibited medications|2|||
27589013|NCT00360529|80340259|FG000|Overall Study|Lost to Follow-up|14|||
27589014|NCT00360529|80340260|FG001|Overall Study|Lost to Follow-up|10|||
27589015|NCT00360529|80340261|FG002|Overall Study|Lost to Follow-up|13|||
27589016|NCT00360529|80340259|FG000|Overall Study|Withdrawal by Subject|22|||
27589017|NCT00360529|80340260|FG001|Overall Study|Withdrawal by Subject|14|||
27589018|NCT00360529|80340261|FG002|Overall Study|Withdrawal by Subject|18|||
27589019|NCT00360529|80340259|FG000|Overall Study|Lack of Efficacy|8|||
27589020|NCT00360529|80340260|FG001|Overall Study|Lack of Efficacy|6|||
27589021|NCT00360529|80340261|FG002|Overall Study|Lack of Efficacy|5|||
27589022|NCT00360529|80340259|FG000|Overall Study|Reason discontinued not explained above|4|||
27589023|NCT00360529|80340260|FG001|Overall Study|Reason discontinued not explained above|9|||
27589024|NCT00360529|80340261|FG002|Overall Study|Reason discontinued not explained above|11|||
27688061|NCT02663518|80694130|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27876705|NCT02630251|81379886|FG000|Overall Study|Physician Decision|0|||
27876706|NCT02630251|81379887|FG001|Overall Study|Physician Decision|0|||
27876707|NCT02630251|81379888|FG002|Overall Study|Physician Decision|1|||
27876708|NCT02630251|81379889|FG003|Overall Study|Physician Decision|0|||
27589025|NCT02671435|80340264|FG000|Overall Study|Death|1|||
27589026|NCT02671435|80340265|FG001|Overall Study|Death|3|||
27814010|NCT03341273|81150280|FG000|Overall Study|Withdrawal by Subject|4|||
27814011|NCT03341273|81150281|FG001|Overall Study|Withdrawal by Subject|2|||
27814012|NCT03341273|81150280|FG000|Overall Study|Physician Decision|1|||
27814013|NCT03341273|81150281|FG001|Overall Study|Physician Decision|0|||
27814014|NCT03341273|81150280|FG000|Overall Study|Protocol Violation|0|||
27814015|NCT03341273|81150281|FG001|Overall Study|Protocol Violation|1|||
27814016|NCT03341273|81150280|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
27814017|NCT03341273|81150281|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
27814018|NCT03341273|81150280|FG000|Overall Study|Became ineligible after enrollment|1|||
27814019|NCT03341273|81150281|FG001|Overall Study|Became ineligible after enrollment|0|||
27814020|NCT03341273|81150280|FG000|Overall Study|Not Eligible at Enrollment|0|||
27876709|NCT02946463|81379891|FG000|Primary Evaluation Period|Physician Decision|0|||
27876710|NCT02946463|81379892|FG001|Primary Evaluation Period|Physician Decision|1|||
27876711|NCT02946463|81379893|FG002|Primary Evaluation Period|Physician Decision|0|||
27876712|NCT02946463|81379894|FG003|Primary Evaluation Period|Physician Decision|0|||
27876713|NCT02946463|81379891|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
27876714|NCT02946463|81379892|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
27876715|NCT02946463|81379893|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
27876716|NCT02946463|81379894|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
27876717|NCT02946463|81379891|FG000|Extension Period|Death|4|||
27876718|NCT02946463|81379892|FG001|Extension Period|Death|4|||
27876719|NCT02946463|81379893|FG002|Extension Period|Death|0|||
27876720|NCT02946463|81379894|FG003|Extension Period|Death|0|||
27876721|NCT02946463|81379891|FG000|Extension Period|Withdrawal by Subject|4|||
27876722|NCT02946463|81379892|FG001|Extension Period|Withdrawal by Subject|3|||
27876723|NCT02946463|81379893|FG002|Extension Period|Withdrawal by Subject|0|||
27876724|NCT02946463|81379894|FG003|Extension Period|Withdrawal by Subject|0|||
27876725|NCT02946463|81379891|FG000|Extension Period|Other than specified|2|||
27876726|NCT02946463|81379892|FG001|Extension Period|Other than specified|3|||
27876727|NCT02946463|81379893|FG002|Extension Period|Other than specified|2|||
27876728|NCT02946463|81379894|FG003|Extension Period|Other than specified|0|||
27876729|NCT02946463|81379891|FG000|Extension Period|Physician Decision|1|||
27876730|NCT02946463|81379892|FG001|Extension Period|Physician Decision|4|||
27876731|NCT02946463|81379893|FG002|Extension Period|Physician Decision|0|||
27814021|NCT03341273|81150281|FG001|Overall Study|Not Eligible at Enrollment|1|||
27814022|NCT03341273|81150280|FG000|Overall Study|Participant incarcerated|1|||
27814023|NCT03341273|81150281|FG001|Overall Study|Participant incarcerated|0|||
27814024|NCT00268346|81150284|FG000|Overall Study|Adverse Event|0|||
27814025|NCT00268346|81150285|FG001|Overall Study|Adverse Event|1|||
27876732|NCT02946463|81379894|FG003|Extension Period|Physician Decision|0|||
27814026|NCT00268346|81150284|FG000|Overall Study|Death|0|||
27688062|NCT02663518|80694131|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688063|NCT02663518|80694132|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688064|NCT02663518|80694133|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688065|NCT02663518|80694134|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688066|NCT02663518|80694135|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688067|NCT02663518|80694136|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688068|NCT02663518|80694137|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688069|NCT02663518|80694138|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688070|NCT02663518|80694139|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
27688071|NCT02663518|80694140|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
27688072|NCT02663518|80694141|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
27688073|NCT02663518|80694142|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
27688074|NCT02663518|80694143|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
27688075|NCT02663518|80694130|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
27688076|NCT02663518|80694131|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
27688077|NCT02663518|80694132|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
27688078|NCT02663518|80694133|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
27688079|NCT02663518|80694134|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
27688080|NCT02663518|80694135|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
27688081|NCT02663518|80694136|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
27688082|NCT02663518|80694137|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
27688083|NCT02663518|80694138|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
27688084|NCT02663518|80694139|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
27688085|NCT02663518|80694140|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
27688086|NCT02663518|80694141|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
27688087|NCT02663518|80694142|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
27688088|NCT02663518|80694143|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
27688089|NCT02663518|80694130|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688090|NCT02663518|80694131|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27876733|NCT02946463|81379891|FG000|Extension Period|Pregnancy|3|||
27688091|NCT02663518|80694132|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27814027|NCT00268346|81150285|FG001|Overall Study|Death|1|||
27814028|NCT00268346|81150284|FG000|Overall Study|Withdrawal by Subject|0|||
27814029|NCT00268346|81150285|FG001|Overall Study|Withdrawal by Subject|1|||
27814030|NCT03381248|81150289|FG000|0-6 Months|Withdrawal by Subject|4|||
27814031|NCT03381248|81150290|FG001|0-6 Months|Withdrawal by Subject|1|||
27814032|NCT03381248|81150289|FG000|0-6 Months|Lost to Follow-up|3|||
27814033|NCT03381248|81150290|FG001|0-6 Months|Lost to Follow-up|2|||
27814034|NCT03381248|81150289|FG000|0-6 Months|Lack of Efficacy|1|||
27814035|NCT03381248|81150290|FG001|0-6 Months|Lack of Efficacy|0|||
27814036|NCT03381248|81150289|FG000|0-6 Months|Adverse Event|1|||
27814037|NCT03381248|81150290|FG001|0-6 Months|Adverse Event|0|||
27814038|NCT03381248|81150289|FG000|0-6 Months|Protocol Violation|2|||
27814039|NCT03381248|81150290|FG001|0-6 Months|Protocol Violation|1|||
27814040|NCT03381248|81150289|FG000|0-6 Months|Physician Decision|1|||
27814041|NCT03381248|81150290|FG001|0-6 Months|Physician Decision|0|||
27814042|NCT03381248|81150289|FG000|0-6 Months|Planning another procedure|1|||
27814043|NCT03381248|81150290|FG001|0-6 Months|Planning another procedure|2|||
27814044|NCT03381248|81150289|FG000|6-12 Months|Withdrawal by Subject|1|||
27814045|NCT03381248|81150290|FG001|6-12 Months|Withdrawal by Subject|3|||
27814046|NCT03381248|81150289|FG000|6-12 Months|Lost to Follow-up|0|||
27589027|NCT02671435|80340266|FG002|Overall Study|Death|0|||
27589028|NCT02671435|80340267|FG003|Overall Study|Death|16|||
27589029|NCT02671435|80340268|FG004|Overall Study|Death|14|||
27589030|NCT02671435|80340269|FG005|Overall Study|Death|29|||
27589031|NCT02671435|80340270|FG006|Overall Study|Death|34|||
27589032|NCT02671435|80340271|FG007|Overall Study|Death|28|||
27589033|NCT02671435|80340272|FG008|Overall Study|Death|19|||
27589034|NCT02671435|80340273|FG009|Overall Study|Death|10|||
27589035|NCT02671435|80340274|FG010|Overall Study|Death|8|||
27589036|NCT02671435|80340275|FG011|Overall Study|Death|29|||
27589037|NCT02671435|80340276|FG012|Overall Study|Death|29|||
27814047|NCT03381248|81150290|FG001|6-12 Months|Lost to Follow-up|2|||
27814048|NCT03381248|81150289|FG000|6-12 Months|Protocol Violation|3|||
27814049|NCT03381248|81150290|FG001|6-12 Months|Protocol Violation|2|||
27814050|NCT03381248|81150289|FG000|6-12 Months|Planning another procedure|6|||
27876734|NCT02946463|81379892|FG001|Extension Period|Pregnancy|1|||
27589038|NCT02671435|80340277|FG013|Overall Study|Death|29|||
27589039|NCT02671435|80340278|FG014|Overall Study|Death|27|||
27589040|NCT02671435|80340264|FG000|Overall Study|Lost to Follow-up|0|||
27589041|NCT02671435|80340265|FG001|Overall Study|Lost to Follow-up|0|||
27589042|NCT02671435|80340266|FG002|Overall Study|Lost to Follow-up|1|||
27814051|NCT03381248|81150290|FG001|6-12 Months|Planning another procedure|2|||
27814052|NCT03381248|81150289|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
27814053|NCT03381248|81150290|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
27814054|NCT03381248|81150289|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
27589043|NCT02671435|80340267|FG003|Overall Study|Lost to Follow-up|0|||
27688092|NCT02663518|80694133|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688093|NCT02663518|80694134|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688094|NCT02663518|80694135|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688095|NCT02663518|80694136|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688096|NCT02663518|80694137|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688097|NCT02663518|80694138|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688098|NCT02663518|80694139|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688099|NCT02663518|80694140|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688100|NCT02663518|80694141|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688101|NCT02663518|80694142|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
27688102|NCT02663518|80694143|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
27688103|NCT01535560|80694144|FG000|Overall Study|Adverse Event|12|||
27814055|NCT03381248|81150290|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
27814056|NCT03381248|81150289|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
27814057|NCT03381248|81150290|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
27814058|NCT00989261|81150291|FG000|Overall Study|Still in follow up|12|||
27814059|NCT00989261|81150292|FG001|Overall Study|Still in follow up|21|||
27814060|NCT00989261|81150291|FG000|Overall Study|Withdrawal by Subject|0|||
27814061|NCT00989261|81150292|FG001|Overall Study|Withdrawal by Subject|1|||
27814062|NCT00989261|81150291|FG000|Overall Study|Lost to Follow-up|3|||
27814063|NCT00989261|81150292|FG001|Overall Study|Lost to Follow-up|0|||
27814064|NCT00635154|81150293|FG000|Overall Study|Alternative Treatment|8|||
27814065|NCT00635154|81150293|FG000|Overall Study|Other|4|||
27814066|NCT00635154|81150293|FG000|Overall Study|Still on treatment|21|||
27814067|NCT02158936|81150297|FG000|Overall Study|Study closed/ terminated|57|||
27814068|NCT02158936|81150298|FG001|Overall Study|Study closed/ terminated|77|||
27814069|NCT02158936|81150297|FG000|Overall Study|Azacitidine tx discontinued|53|||
27814070|NCT02158936|81150298|FG001|Overall Study|Azacitidine tx discontinued|46|||
27814071|NCT02158936|81150297|FG000|Overall Study|Adverse Event|39|||
27814072|NCT02158936|81150298|FG001|Overall Study|Adverse Event|24|||
27814073|NCT02158936|81150297|FG000|Overall Study|Withdrawal by Subject|15|||
27589044|NCT02671435|80340268|FG004|Overall Study|Lost to Follow-up|1|||
27589045|NCT02671435|80340269|FG005|Overall Study|Lost to Follow-up|1|||
27589046|NCT02671435|80340270|FG006|Overall Study|Lost to Follow-up|2|||
27589047|NCT02671435|80340271|FG007|Overall Study|Lost to Follow-up|2|||
27589048|NCT02671435|80340272|FG008|Overall Study|Lost to Follow-up|0|||
27589049|NCT02671435|80340273|FG009|Overall Study|Lost to Follow-up|2|||
27589050|NCT02671435|80340274|FG010|Overall Study|Lost to Follow-up|0|||
27589051|NCT02671435|80340275|FG011|Overall Study|Lost to Follow-up|3|||
27589052|NCT02671435|80340276|FG012|Overall Study|Lost to Follow-up|3|||
27589053|NCT02671435|80340277|FG013|Overall Study|Lost to Follow-up|2|||
27589054|NCT02671435|80340278|FG014|Overall Study|Lost to Follow-up|0|||
27589055|NCT02671435|80340264|FG000|Overall Study|Withdrawal by Subject|2|||
27589056|NCT02671435|80340265|FG001|Overall Study|Withdrawal by Subject|0|||
27589057|NCT02671435|80340266|FG002|Overall Study|Withdrawal by Subject|2|||
27589058|NCT02671435|80340267|FG003|Overall Study|Withdrawal by Subject|2|||
27589059|NCT02671435|80340268|FG004|Overall Study|Withdrawal by Subject|2|||
27589060|NCT02671435|80340269|FG005|Overall Study|Withdrawal by Subject|7|||
27589061|NCT02671435|80340270|FG006|Overall Study|Withdrawal by Subject|2|||
27589062|NCT02671435|80340271|FG007|Overall Study|Withdrawal by Subject|7|||
27589063|NCT02671435|80340272|FG008|Overall Study|Withdrawal by Subject|1|||
27589064|NCT02671435|80340273|FG009|Overall Study|Withdrawal by Subject|1|||
27589065|NCT02671435|80340274|FG010|Overall Study|Withdrawal by Subject|2|||
27589066|NCT02671435|80340275|FG011|Overall Study|Withdrawal by Subject|4|||
27589067|NCT02671435|80340276|FG012|Overall Study|Withdrawal by Subject|4|||
27589068|NCT02671435|80340277|FG013|Overall Study|Withdrawal by Subject|4|||
27589069|NCT02671435|80340278|FG014|Overall Study|Withdrawal by Subject|2|||
27589070|NCT02671435|80340264|FG000|Overall Study|Un-specified|0|||
27589071|NCT02671435|80340265|FG001|Overall Study|Un-specified|0|||
27589072|NCT02671435|80340266|FG002|Overall Study|Un-specified|0|||
27589073|NCT02671435|80340267|FG003|Overall Study|Un-specified|0|||
27589074|NCT02671435|80340268|FG004|Overall Study|Un-specified|1|||
27589075|NCT02671435|80340269|FG005|Overall Study|Un-specified|3|||
27589076|NCT02671435|80340270|FG006|Overall Study|Un-specified|2|||
27589077|NCT02671435|80340271|FG007|Overall Study|Un-specified|3|||
27589078|NCT02671435|80340272|FG008|Overall Study|Un-specified|0|||
27589079|NCT02671435|80340273|FG009|Overall Study|Un-specified|5|||
27589080|NCT02671435|80340274|FG010|Overall Study|Un-specified|8|||
27589081|NCT02671435|80340275|FG011|Overall Study|Un-specified|4|||
27589082|NCT02671435|80340276|FG012|Overall Study|Un-specified|5|||
27589083|NCT02671435|80340277|FG013|Overall Study|Un-specified|9|||
27589084|NCT02671435|80340278|FG014|Overall Study|Un-specified|8|||
27688104|NCT01535560|80694145|FG001|Overall Study|Adverse Event|7|||
27688105|NCT01535560|80694144|FG000|Overall Study|Lost to Follow-up|1|||
27688106|NCT01535560|80694145|FG001|Overall Study|Lost to Follow-up|3|||
27688107|NCT01535560|80694144|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
27688108|NCT01535560|80694145|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
27688109|NCT01535560|80694144|FG000|Overall Study|Treatment Failure|21|||
27688110|NCT01535560|80694145|FG001|Overall Study|Treatment Failure|83|||
27688111|NCT01535560|80694144|FG000|Overall Study|Other|0|||
27688112|NCT01535560|80694145|FG001|Overall Study|Other|1|||
27688113|NCT01535560|80694144|FG000|Overall Study|Randomized in Error|0|||
27688114|NCT01535560|80694145|FG001|Overall Study|Randomized in Error|1|||
27688115|NCT03702231|80694148|FG000|Overall Study|Withdrawal by Subject|1|||
27688116|NCT03702231|80694149|FG001|Overall Study|Withdrawal by Subject|0|||
27688117|NCT03702231|80694150|FG002|Overall Study|Withdrawal by Subject|0|||
27688118|NCT03702231|80694148|FG000|Overall Study|Protocol Violation|0|||
27688119|NCT03702231|80694149|FG001|Overall Study|Protocol Violation|0|||
27688120|NCT03702231|80694150|FG002|Overall Study|Protocol Violation|1|||
27688121|NCT03702231|80694148|FG000|Overall Study|Change in CLL Treatment|0|||
27688122|NCT03702231|80694149|FG001|Overall Study|Change in CLL Treatment|0|||
27688123|NCT03702231|80694150|FG002|Overall Study|Change in CLL Treatment|1|||
27688124|NCT03702231|80694148|FG000|Overall Study|COVID Pandemic|1|||
27688125|NCT03702231|80694149|FG001|Overall Study|COVID Pandemic|4|||
27589085|NCT04837482|80340279|FG000|Period 2|Withdrawal by Subject|0|||
27589086|NCT04837482|80340280|FG001|Period 2|Withdrawal by Subject|1|||
27688126|NCT03702231|80694150|FG002|Overall Study|COVID Pandemic|1|||
27688127|NCT03702231|80694148|FG000|Overall Study|Non-compliance|0|||
27688128|NCT03702231|80694149|FG001|Overall Study|Non-compliance|0|||
27688129|NCT03702231|80694150|FG002|Overall Study|Non-compliance|1|||
27688130|NCT05330312|80694151|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
27688131|NCT05330312|80694152|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
27688132|NCT05330312|80694153|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
27688133|NCT05330312|80694151|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
27688134|NCT05330312|80694152|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
27688135|NCT05330312|80694153|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
27688136|NCT05330312|80694151|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
27688137|NCT05330312|80694152|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
27688138|NCT05330312|80694153|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
27589087|NCT00896168|80340281|FG000|Overall Study|Adverse Event|4|||
27589088|NCT00896168|80340282|FG001|Overall Study|Adverse Event|7|||
27589089|NCT00896168|80340281|FG000|Overall Study|Treatment failure|8|||
27688139|NCT05330312|80694151|FG000|Pivotal Investigation - Part 2|Death|1|||
27688140|NCT05330312|80694152|FG001|Pivotal Investigation - Part 2|Death|4|||
27589090|NCT00896168|80340282|FG001|Overall Study|Treatment failure|10|||
27589091|NCT00896168|80340281|FG000|Overall Study|Lost to Follow-up|1|||
27688141|NCT05330312|80694153|FG002|Pivotal Investigation - Part 2|Death|0|||
27688142|NCT02075073|80694157|FG000|Overall Study|Withdrawal by Subject|0|||
27688143|NCT02075073|80694158|FG001|Overall Study|Withdrawal by Subject|1|||
27688144|NCT02075073|80694159|FG002|Overall Study|Withdrawal by Subject|0|||
27688145|NCT01171807|80694160|FG000|Overall Study|Treatment failure|2|||
27688146|NCT01171807|80694161|FG001|Overall Study|Treatment failure|4|||
27688147|NCT01171807|80694160|FG000|Overall Study|Non compliance|1|||
27688148|NCT01171807|80694161|FG001|Overall Study|Non compliance|0|||
27688149|NCT01171807|80694160|FG000|Overall Study|Lost to Follow-up|3|||
27688150|NCT01171807|80694161|FG001|Overall Study|Lost to Follow-up|0|||
27688151|NCT01815138|80694164|FG000|Overall Study|Withdrawal by Subject|0|||
27688152|NCT01815138|80694165|FG001|Overall Study|Withdrawal by Subject|1|||
27688153|NCT01815138|80694164|FG000|Overall Study|Physician Decision|8|||
27688154|NCT01815138|80694165|FG001|Overall Study|Physician Decision|5|||
27688155|NCT02004353|80694171|FG000|Overall Study|Voluntary participation|1334|||
27688156|NCT00752557|80694173|FG000|Overall Study|Withdrawal by Subject|4|||
27688157|NCT00752557|80694174|FG001|Overall Study|Withdrawal by Subject|3|||
27688158|NCT00752557|80694175|FG002|Overall Study|Withdrawal by Subject|3|||
27688159|NCT00752557|80694173|FG000|Overall Study|Unspecified resaons|0|||
27688160|NCT00752557|80694174|FG001|Overall Study|Unspecified resaons|2|||
27688161|NCT00752557|80694175|FG002|Overall Study|Unspecified resaons|2|||
27688162|NCT00752557|80694173|FG000|Overall Study|Lost to Follow-up|1|||
27688163|NCT00752557|80694174|FG001|Overall Study|Lost to Follow-up|0|||
27688164|NCT00752557|80694175|FG002|Overall Study|Lost to Follow-up|1|||
27688165|NCT01880528|80694176|FG000|Overall Study|Other|1|||
27688166|NCT01880528|80694177|FG001|Overall Study|Other|1|||
27688167|NCT01967147|80694182|FG000|Overall Study|Adverse Event|5|||
27688168|NCT01967147|80694183|FG001|Overall Study|Adverse Event|2|||
27688169|NCT01967147|80694182|FG000|Overall Study|Lack of Efficacy|1|||
27688170|NCT01967147|80694183|FG001|Overall Study|Lack of Efficacy|4|||
27688171|NCT01967147|80694182|FG000|Overall Study|Lost to Follow-up|1|||
27688172|NCT01967147|80694183|FG001|Overall Study|Lost to Follow-up|2|||
27688173|NCT01967147|80694182|FG000|Overall Study|Withdrawal by Subject|2|||
27688174|NCT01967147|80694183|FG001|Overall Study|Withdrawal by Subject|4|||
27688175|NCT01967147|80694182|FG000|Overall Study|Non-compliance with Study Drug|0|||
27688176|NCT01967147|80694183|FG001|Overall Study|Non-compliance with Study Drug|3|||
27688177|NCT01967147|80694182|FG000|Overall Study|Other|4|||
27688178|NCT01967147|80694183|FG001|Overall Study|Other|5|||
27688179|NCT05062759|80694184|FG000|Overall Study|Death|0|||
27688180|NCT05062759|80694185|FG001|Overall Study|Death|1|||
27688181|NCT05062759|80694184|FG000|Overall Study|Lost to Follow-up|1|||
27688182|NCT05062759|80694185|FG001|Overall Study|Lost to Follow-up|0|||
27688183|NCT02297139|80694188|FG000|Overall Study|Disease progression|0|||
27688184|NCT02297139|80694189|FG001|Overall Study|Disease progression|1|||
27688185|NCT02297139|80694188|FG000|Overall Study|Study drug toxicity|0|||
27688186|NCT02297139|80694189|FG001|Overall Study|Study drug toxicity|4|||
27688187|NCT02297139|80694188|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27688188|NCT02297139|80694189|FG001|Overall Study|Participant request to discontinue study treatment|1|||
27688189|NCT02297139|80694188|FG000|Overall Study|Maximum clinical benefit|1|||
27814074|NCT02158936|81150298|FG001|Overall Study|Withdrawal by Subject|16|||
27814075|NCT02158936|81150297|FG000|Overall Study|Physician Decision|15|||
27814076|NCT02158936|81150298|FG001|Overall Study|Physician Decision|13|||
27814077|NCT02158936|81150297|FG000|Overall Study|Lost to Follow-up|0|||
27814078|NCT02158936|81150298|FG001|Overall Study|Lost to Follow-up|1|||
27814079|NCT01202747|81150299|FG000|Overall Study|Withdrawal by Subject|1|||
27814080|NCT00625807|81150300|FG000|Overall Study|schedule conflict|2|||
27814081|NCT00625807|81150301|FG001|Overall Study|schedule conflict|8|||
27814082|NCT02224391|81150302|FG000|Overall Study|Lost to Follow-up|26|||
27814083|NCT02224391|81150303|FG001|Overall Study|Lost to Follow-up|19|||
27814084|NCT02224391|81150302|FG000|Overall Study|Withdrawal by Subject|6|||
27814085|NCT02224391|81150303|FG001|Overall Study|Withdrawal by Subject|5|||
27814086|NCT01937390|81150306|FG000|Overall Study|Death|2|||
27688190|NCT02297139|80694189|FG001|Overall Study|Maximum clinical benefit|0|||
27688191|NCT02297139|80694188|FG000|Overall Study|Administrative reason by sponsor|0|||
27688192|NCT02297139|80694189|FG001|Overall Study|Administrative reason by sponsor|2|||
27688193|NCT02297139|80694188|FG000|Overall Study|Other reasons|0|||
27688194|NCT02297139|80694189|FG001|Overall Study|Other reasons|8|||
27688195|NCT02224690|80694190|FG000|Overall Study|Adverse Event|8|||
27688196|NCT02224690|80694191|FG001|Overall Study|Adverse Event|1|||
27688197|NCT02224690|80694190|FG000|Overall Study|Met Withdrawal Criteria|4|||
27688198|NCT02224690|80694191|FG001|Overall Study|Met Withdrawal Criteria|0|||
27688199|NCT02224690|80694190|FG000|Overall Study|Use of G-tube|1|||
27814087|NCT01937390|81150306|FG000|Overall Study|Lost to Follow-up|7|||
27814088|NCT01937390|81150306|FG000|Overall Study|Withdrawal by Subject|5|||
27688200|NCT02224690|80694191|FG001|Overall Study|Use of G-tube|0|||
27814089|NCT01937390|81150306|FG000|Overall Study|Fail to return|21|||
27814090|NCT02153398|81150307|FG000|Overall Study|Withdrawal by Subject|1|||
27814091|NCT02153398|81150308|FG001|Overall Study|Withdrawal by Subject|0|||
27814092|NCT02153398|81150309|FG002|Overall Study|Withdrawal by Subject|0|||
27814093|NCT02153398|81150310|FG003|Overall Study|Withdrawal by Subject|0|||
27814094|NCT02153398|81150311|FG004|Overall Study|Withdrawal by Subject|0|||
27814095|NCT02153398|81150307|FG000|Overall Study|Adverse Event|0|||
27814096|NCT02153398|81150308|FG001|Overall Study|Adverse Event|0|||
27814097|NCT02153398|81150309|FG002|Overall Study|Adverse Event|1|||
27814098|NCT02153398|81150310|FG003|Overall Study|Adverse Event|1|||
27814099|NCT02153398|81150311|FG004|Overall Study|Adverse Event|0|||
27814100|NCT01659567|81150316|FG000|Overall Study|Lack of Efficacy|22|||
27814101|NCT01659567|81150316|FG000|Overall Study|Switched to Pegferon|6|||
27814102|NCT01659567|81150316|FG000|Overall Study|Adverse Event|12|||
27814103|NCT01659567|81150316|FG000|Overall Study|Good result at early stage of treatment|5|||
27814104|NCT01659567|81150316|FG000|Overall Study|Withdrawal by Subject|64|||
27814105|NCT01659567|81150316|FG000|Overall Study|Progression of the main disease|1|||
27814106|NCT01659567|81150316|FG000|Overall Study|Other|13|||
27814107|NCT00585351|81150317|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
27814108|NCT00585351|81150318|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
27814109|NCT00585351|81150319|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
27814110|NCT00585351|81150320|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
27814111|NCT00585351|81150321|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
27814112|NCT00585351|81150322|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
27814113|NCT00585351|81150323|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
27814114|NCT00585351|81150324|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
27814115|NCT00585351|81150317|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
27814116|NCT00585351|81150318|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
27814117|NCT00585351|81150319|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
27814118|NCT00585351|81150320|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
27814119|NCT00585351|81150321|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
27814120|NCT00585351|81150322|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
27814121|NCT00585351|81150323|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
27814122|NCT00585351|81150324|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
27814123|NCT00585351|81150317|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
27814124|NCT00585351|81150318|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
27814125|NCT00585351|81150319|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
27814126|NCT00585351|81150320|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
27814127|NCT00585351|81150321|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
27814128|NCT00585351|81150322|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
27814129|NCT00585351|81150323|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
27814130|NCT00585351|81150324|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
27814131|NCT00585351|81150317|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
27814132|NCT00585351|81150318|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
27814133|NCT00585351|81150319|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27814134|NCT00585351|81150320|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27814135|NCT00585351|81150321|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27814136|NCT00585351|81150322|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27814137|NCT00585351|81150323|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27814138|NCT00585351|81150324|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
27814139|NCT00585351|81150317|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
27814140|NCT00585351|81150318|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
27814141|NCT00585351|81150319|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
27876735|NCT02946463|81379893|FG002|Extension Period|Pregnancy|0|||
27876736|NCT02946463|81379894|FG003|Extension Period|Pregnancy|0|||
27589092|NCT00896168|80340282|FG001|Overall Study|Lost to Follow-up|1|||
27688201|NCT02224690|80694190|FG000|Overall Study|Did not meet eligibility criteria|1|||
27589093|NCT00896168|80340281|FG000|Overall Study|Other|1|||
27589094|NCT00896168|80340282|FG001|Overall Study|Other|1|||
27589095|NCT03725982|80340287|FG000|First Intervention|Withdrawal by Subject|0|||
27589096|NCT03725982|80340288|FG001|First Intervention|Withdrawal by Subject|1|||
27876737|NCT02946463|81379891|FG000|Extension Period|Adverse Event|1|||
27876738|NCT02946463|81379892|FG001|Extension Period|Adverse Event|2|||
27876739|NCT02946463|81379893|FG002|Extension Period|Adverse Event|0|||
27876740|NCT02946463|81379894|FG003|Extension Period|Adverse Event|0|||
27876741|NCT02946463|81379891|FG000|Extension Period|Lost to Follow-up|1|||
27876742|NCT02946463|81379892|FG001|Extension Period|Lost to Follow-up|0|||
27876743|NCT02946463|81379893|FG002|Extension Period|Lost to Follow-up|0|||
27876744|NCT02946463|81379894|FG003|Extension Period|Lost to Follow-up|0|||
27876745|NCT02220764|81379895|FG000|Overall Study|Lost to Follow-up|3|||
27876746|NCT02220764|81379896|FG001|Overall Study|Lost to Follow-up|1|||
27876747|NCT02220764|81379895|FG000|Overall Study|Death|1|||
27876748|NCT02220764|81379896|FG001|Overall Study|Death|0|||
27876749|NCT01205269|81379901|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27876750|NCT01205269|81379902|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27876751|NCT01205269|81379903|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27876752|NCT01205269|81379904|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
27876753|NCT01205269|81379905|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27876754|NCT01205269|81379906|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
27876755|NCT03631706|81379907|FG000|Overall Study|Randomized, not treated|1|||
27876756|NCT03631706|81379908|FG001|Overall Study|Randomized, not treated|0|||
27876757|NCT03631706|81379907|FG000|Overall Study|Treatment ongoing|26|||
27876758|NCT03631706|81379908|FG001|Overall Study|Treatment ongoing|57|||
27876759|NCT03631706|81379907|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
27876760|NCT03631706|81379908|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
27876761|NCT03640312|81379909|FG000|Overall Study|Lost to Follow-up|3|||
27876762|NCT03640312|81379910|FG001|Overall Study|Lost to Follow-up|6|||
27876763|NCT01982682|81379911|FG000|Overall Study|Physician Decision|1|||
27876764|NCT02273388|81379912|FG000|Overall Study|Adverse Event|0|||
27876765|NCT02273388|81379913|FG001|Overall Study|Adverse Event|0|||
27876766|NCT02273388|81379914|FG002|Overall Study|Adverse Event|0|||
27876767|NCT02273388|81379915|FG003|Overall Study|Adverse Event|0|||
27876768|NCT02273388|81379916|FG004|Overall Study|Adverse Event|0|||
27589097|NCT03725982|80340287|FG000|First Intervention|Physician Decision|1|||
27589098|NCT03725982|80340288|FG001|First Intervention|Physician Decision|1|||
27589099|NCT02534909|80340290|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
27589100|NCT00839072|80340291|FG000|First Intervention Period|Withdrawal by Subject|1|||
27589101|NCT00839072|80340292|FG001|First Intervention Period|Withdrawal by Subject|0|||
27589102|NCT00839072|80340291|FG000|First Intervention Period|Adverse Event|1|||
27589103|NCT00839072|80340292|FG001|First Intervention Period|Adverse Event|1|||
27589104|NCT00839072|80340291|FG000|Second Intervention Period|Withdrawal by Subject|1|||
27589105|NCT00839072|80340292|FG001|Second Intervention Period|Withdrawal by Subject|0|||
27589106|NCT01910129|80340300|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
27589107|NCT01910129|80340301|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
27589108|NCT01910129|80340302|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
27589109|NCT01910129|80340300|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
27589110|NCT01910129|80340301|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
27589111|NCT01910129|80340302|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
27589112|NCT01666002|80340303|FG000|Overall Study|Lost to Follow-up|5|||
27589113|NCT01666002|80340304|FG001|Overall Study|Lost to Follow-up|0|||
27589114|NCT02273141|80340305|FG000|Overall Study|Adverse Event|0|||
27589115|NCT02273141|80340306|FG001|Overall Study|Adverse Event|1|||
27589116|NCT02273141|80340305|FG000|Overall Study|Lost to Follow-up|1|||
27589117|NCT02273141|80340306|FG001|Overall Study|Lost to Follow-up|3|||
27688202|NCT02224690|80694191|FG001|Overall Study|Did not meet eligibility criteria|0|||
27876769|NCT02273388|81379917|FG005|Overall Study|Adverse Event|0|||
27589118|NCT02273141|80340305|FG000|Overall Study|Withdrawal by Subject|10|||
27589119|NCT02273141|80340306|FG001|Overall Study|Withdrawal by Subject|15|||
27589120|NCT02273141|80340305|FG000|Overall Study|Various|6|||
27688203|NCT01153321|80694196|FG000|Overall Study|Development of study withdrawal criteria|0|||
27688204|NCT01153321|80694197|FG001|Overall Study|Development of study withdrawal criteria|1|||
27876770|NCT02273388|81379918|FG006|Overall Study|Adverse Event|1|||
27876771|NCT02273388|81379919|FG007|Overall Study|Adverse Event|2|||
27876772|NCT02273388|81379920|FG008|Overall Study|Adverse Event|0|||
27589121|NCT02273141|80340306|FG001|Overall Study|Various|6|||
27589122|NCT02291614|80340310|FG000|Overall Study|Lost to Follow-up|0|||
27589123|NCT02291614|80340311|FG001|Overall Study|Lost to Follow-up|0|||
27589124|NCT02291614|80340312|FG002|Overall Study|Lost to Follow-up|0|||
27589125|NCT02291614|80340313|FG003|Overall Study|Lost to Follow-up|0|||
27589126|NCT02291614|80340314|FG004|Overall Study|Lost to Follow-up|0|||
27589127|NCT02291614|80340315|FG005|Overall Study|Lost to Follow-up|0|||
27589128|NCT02291614|80340316|FG006|Overall Study|Lost to Follow-up|0|||
27589129|NCT02291614|80340317|FG007|Overall Study|Lost to Follow-up|1|||
27589130|NCT02291614|80340318|FG008|Overall Study|Lost to Follow-up|0|||
27589131|NCT02291614|80340319|FG009|Overall Study|Lost to Follow-up|0|||
27589132|NCT02291614|80340320|FG010|Overall Study|Lost to Follow-up|0|||
27589133|NCT02291614|80340310|FG000|Overall Study|Withdrawal by Subject|0|||
27589134|NCT02291614|80340311|FG001|Overall Study|Withdrawal by Subject|1|||
27589135|NCT02291614|80340312|FG002|Overall Study|Withdrawal by Subject|0|||
27589136|NCT02291614|80340313|FG003|Overall Study|Withdrawal by Subject|0|||
27589137|NCT02291614|80340314|FG004|Overall Study|Withdrawal by Subject|0|||
27589138|NCT02291614|80340315|FG005|Overall Study|Withdrawal by Subject|0|||
27589139|NCT02291614|80340316|FG006|Overall Study|Withdrawal by Subject|0|||
27589140|NCT02291614|80340317|FG007|Overall Study|Withdrawal by Subject|0|||
27589141|NCT02291614|80340318|FG008|Overall Study|Withdrawal by Subject|0|||
27589142|NCT02291614|80340319|FG009|Overall Study|Withdrawal by Subject|2|||
27589143|NCT02291614|80340320|FG010|Overall Study|Withdrawal by Subject|2|||
27589144|NCT02291614|80340310|FG000|Overall Study|Decision by sponsor|0|||
27589145|NCT02291614|80340311|FG001|Overall Study|Decision by sponsor|0|||
27589146|NCT02291614|80340312|FG002|Overall Study|Decision by sponsor|0|||
27589147|NCT02291614|80340313|FG003|Overall Study|Decision by sponsor|1|||
27589148|NCT02291614|80340314|FG004|Overall Study|Decision by sponsor|0|||
27589149|NCT02291614|80340315|FG005|Overall Study|Decision by sponsor|0|||
27876773|NCT02273388|81379921|FG009|Overall Study|Adverse Event|0|||
27876774|NCT02273388|81379922|FG010|Overall Study|Adverse Event|0|||
27876775|NCT02273388|81379923|FG011|Overall Study|Adverse Event|0|||
27876776|NCT02273388|81379912|FG000|Overall Study|Adverse Event study disease worse|4|||
27876777|NCT02273388|81379913|FG001|Overall Study|Adverse Event study disease worse|3|||
27876778|NCT02273388|81379914|FG002|Overall Study|Adverse Event study disease worse|3|||
27876779|NCT02273388|81379915|FG003|Overall Study|Adverse Event study disease worse|2|||
27876780|NCT02273388|81379916|FG004|Overall Study|Adverse Event study disease worse|4|||
27876781|NCT02273388|81379917|FG005|Overall Study|Adverse Event study disease worse|3|||
27876782|NCT02273388|81379918|FG006|Overall Study|Adverse Event study disease worse|14|||
27876783|NCT02273388|81379919|FG007|Overall Study|Adverse Event study disease worse|6|||
27876784|NCT02273388|81379920|FG008|Overall Study|Adverse Event study disease worse|6|||
27876785|NCT02273388|81379921|FG009|Overall Study|Adverse Event study disease worse|5|||
27589150|NCT02291614|80340316|FG006|Overall Study|Decision by sponsor|0|||
27814142|NCT00585351|81150320|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
27814143|NCT00585351|81150321|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
27814144|NCT00585351|81150322|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
27814145|NCT00585351|81150323|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
27814146|NCT00585351|81150324|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
27814147|NCT00585351|81150317|FG000|Enrollment Period (Intervention)|Death|0|||
27814148|NCT00585351|81150318|FG001|Enrollment Period (Intervention)|Death|0|||
27814149|NCT00585351|81150319|FG002|Enrollment Period (Intervention)|Death|0|||
27814150|NCT00585351|81150320|FG003|Enrollment Period (Intervention)|Death|0|||
27814151|NCT00585351|81150321|FG004|Enrollment Period (Intervention)|Death|1|||
27814152|NCT00585351|81150322|FG005|Enrollment Period (Intervention)|Death|0|||
27814153|NCT00585351|81150323|FG006|Enrollment Period (Intervention)|Death|1|||
27814154|NCT00585351|81150324|FG007|Enrollment Period (Intervention)|Death|0|||
27814155|NCT00585351|81150317|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
27814156|NCT00585351|81150318|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
27814157|NCT00585351|81150319|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
27814158|NCT00585351|81150320|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
27876786|NCT02273388|81379922|FG010|Overall Study|Adverse Event study disease worse|10|||
27876787|NCT02273388|81379923|FG011|Overall Study|Adverse Event study disease worse|1|||
27876788|NCT02273388|81379912|FG000|Overall Study|Sponsor decision|0|||
27876789|NCT02273388|81379913|FG001|Overall Study|Sponsor decision|0|||
27876790|NCT02273388|81379914|FG002|Overall Study|Sponsor decision|0|||
27589151|NCT02291614|80340317|FG007|Overall Study|Decision by sponsor|0|||
27589152|NCT02291614|80340318|FG008|Overall Study|Decision by sponsor|0|||
27589153|NCT02291614|80340319|FG009|Overall Study|Decision by sponsor|0|||
27589154|NCT02291614|80340320|FG010|Overall Study|Decision by sponsor|0|||
27589155|NCT02291614|80340310|FG000|Overall Study|Death|0|||
27589156|NCT02291614|80340311|FG001|Overall Study|Death|0|||
27589157|NCT02291614|80340312|FG002|Overall Study|Death|1|||
27876791|NCT02273388|81379915|FG003|Overall Study|Sponsor decision|0|||
27876792|NCT02273388|81379916|FG004|Overall Study|Sponsor decision|0|||
27876793|NCT02273388|81379917|FG005|Overall Study|Sponsor decision|0|||
27876794|NCT02273388|81379918|FG006|Overall Study|Sponsor decision|0|||
27876795|NCT02273388|81379919|FG007|Overall Study|Sponsor decision|0|||
27876796|NCT02273388|81379920|FG008|Overall Study|Sponsor decision|0|||
27876797|NCT02273388|81379921|FG009|Overall Study|Sponsor decision|0|||
27876798|NCT02273388|81379922|FG010|Overall Study|Sponsor decision|0|||
27876799|NCT02273388|81379923|FG011|Overall Study|Sponsor decision|1|||
27876800|NCT00395629|81379926|FG000|Core Study|Adverse Event|0|||
27876801|NCT00395629|81379927|FG001|Core Study|Adverse Event|3|||
27876802|NCT00395629|81379928|FG002|Core Study|Adverse Event|4|||
27876803|NCT00395629|81379926|FG000|Core Study|Abnormal laboratory value(s)|0|||
27876804|NCT00395629|81379927|FG001|Core Study|Abnormal laboratory value(s)|0|||
27876805|NCT00395629|81379928|FG002|Core Study|Abnormal laboratory value(s)|1|||
27876806|NCT00395629|81379926|FG000|Core Study|Protocol Violation|1|||
27876807|NCT00395629|81379927|FG001|Core Study|Protocol Violation|0|||
27876808|NCT00395629|81379928|FG002|Core Study|Protocol Violation|0|||
27876809|NCT00395629|81379926|FG000|Core Study|Withdrawal by Subject|0|||
27876810|NCT00395629|81379927|FG001|Core Study|Withdrawal by Subject|1|||
27876811|NCT00395629|81379928|FG002|Core Study|Withdrawal by Subject|1|||
27876812|NCT00395629|81379926|FG000|Core Study|Lost to Follow-up|0|||
27876813|NCT00395629|81379927|FG001|Core Study|Lost to Follow-up|0|||
27876814|NCT00395629|81379928|FG002|Core Study|Lost to Follow-up|1|||
27876815|NCT00395629|81379926|FG000|Extension Study|Adverse Event|0|||
27876816|NCT00395629|81379927|FG001|Extension Study|Adverse Event|0|||
27814159|NCT00585351|81150321|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
27814160|NCT00585351|81150322|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
27814161|NCT00585351|81150323|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
27814162|NCT00585351|81150324|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
27814163|NCT01606306|81150325|FG000|Overall Study|Lack of Efficacy|2|||
27814164|NCT01606306|81150326|FG001|Overall Study|Lack of Efficacy|1|||
27814165|NCT01606306|81150327|FG002|Overall Study|Lack of Efficacy|4|||
27814166|NCT01606306|81150328|FG003|Overall Study|Lack of Efficacy|4|||
27814167|NCT01606306|81150329|FG004|Overall Study|Lack of Efficacy|1|||
27814168|NCT01606306|81150330|FG005|Overall Study|Lack of Efficacy|2|||
27814169|NCT01606306|81150325|FG000|Overall Study|Adverse Event|1|||
27814170|NCT01606306|81150326|FG001|Overall Study|Adverse Event|0|||
27814171|NCT01606306|81150327|FG002|Overall Study|Adverse Event|1|||
27814172|NCT01606306|81150328|FG003|Overall Study|Adverse Event|1|||
27814173|NCT01606306|81150329|FG004|Overall Study|Adverse Event|2|||
27814174|NCT01606306|81150330|FG005|Overall Study|Adverse Event|0|||
27814175|NCT01606306|81150325|FG000|Overall Study|Lost to Follow-up|7|||
27814176|NCT01606306|81150326|FG001|Overall Study|Lost to Follow-up|4|||
27814177|NCT01606306|81150327|FG002|Overall Study|Lost to Follow-up|5|||
27814178|NCT01606306|81150328|FG003|Overall Study|Lost to Follow-up|4|||
27814179|NCT01606306|81150329|FG004|Overall Study|Lost to Follow-up|3|||
27814180|NCT01606306|81150330|FG005|Overall Study|Lost to Follow-up|5|||
27814181|NCT01606306|81150325|FG000|Overall Study|Withdrawal by Subject|4|||
27814182|NCT01606306|81150326|FG001|Overall Study|Withdrawal by Subject|3|||
27814183|NCT01606306|81150327|FG002|Overall Study|Withdrawal by Subject|4|||
27814184|NCT01606306|81150328|FG003|Overall Study|Withdrawal by Subject|4|||
27814185|NCT01606306|81150329|FG004|Overall Study|Withdrawal by Subject|5|||
27814186|NCT01606306|81150330|FG005|Overall Study|Withdrawal by Subject|4|||
27814187|NCT01606306|81150325|FG000|Overall Study|Physician Decision|1|||
27814188|NCT01606306|81150326|FG001|Overall Study|Physician Decision|2|||
27814189|NCT01606306|81150327|FG002|Overall Study|Physician Decision|0|||
27814190|NCT01606306|81150328|FG003|Overall Study|Physician Decision|0|||
27814191|NCT01606306|81150329|FG004|Overall Study|Physician Decision|0|||
27814192|NCT01606306|81150330|FG005|Overall Study|Physician Decision|0|||
27814193|NCT02022007|81150331|FG000|Overall Study|Withdrawal by Subject|1|||
27814194|NCT02022007|81150332|FG001|Overall Study|Withdrawal by Subject|1|||
27814195|NCT02022007|81150333|FG002|Overall Study|Withdrawal by Subject|1|||
27814196|NCT02022007|81150331|FG000|Overall Study|Noncompliant|0|||
27814197|NCT02022007|81150332|FG001|Overall Study|Noncompliant|0|||
27814198|NCT02022007|81150333|FG002|Overall Study|Noncompliant|1|||
27814199|NCT00720798|81150338|FG000|Overall Study|Adverse Event|304|||
27814200|NCT00720798|81150338|FG000|Overall Study|Death|39|||
27814201|NCT00720798|81150338|FG000|Overall Study|Insufficient Therapeutic Response|129|||
27814202|NCT00720798|81150338|FG000|Overall Study|Protocol Violation|4|||
27814203|NCT00720798|81150338|FG000|Overall Study|Refused Treatment|151|||
27814204|NCT00720798|81150338|FG000|Overall Study|Failure to Return|46|||
27814205|NCT00720798|81150338|FG000|Overall Study|Reason not Specified|83|||
27814206|NCT01309919|81150339|FG000|Overall Study|Did not receive a postpartum IUD|17|||
27814207|NCT01309919|81150340|FG001|Overall Study|Did not receive a postpartum IUD|48|||
27876817|NCT00395629|81379928|FG002|Extension Study|Adverse Event|2|||
27876818|NCT00395629|81379926|FG000|Extension Study|Administrative problems|0|||
27814208|NCT01927757|81150342|FG000|Overall Study|Withdrawal by Subject|14|||
27814209|NCT01927757|81150342|FG000|Overall Study|Lost to Follow-up|2|||
27814210|NCT01927757|81150342|FG000|Overall Study|Decision by Sponsor|2|||
27876819|NCT00395629|81379927|FG001|Extension Study|Administrative problems|0|||
27876820|NCT00395629|81379928|FG002|Extension Study|Administrative problems|1|||
27876821|NCT03307252|81379929|FG000|Part 2, Period 1|Treatment not received|0|||
27876822|NCT03307252|81379930|FG001|Part 2, Period 1|Treatment not received|0|||
27876823|NCT03307252|81379931|FG002|Part 2, Period 1|Treatment not received|0|||
27876824|NCT03307252|81379932|FG003|Part 2, Period 1|Treatment not received|0|||
27814211|NCT01927757|81150342|FG000|Overall Study|Other|1|||
27814212|NCT01927757|81150342|FG000|Overall Study|Ethical Reasons|4|||
27814213|NCT00886483|81150343|FG000|Overall Study|Lost to Follow-up|0|||
27814214|NCT00886483|81150344|FG001|Overall Study|Lost to Follow-up|1|||
27814215|NCT00886483|81150343|FG000|Overall Study|Pursue medications|1|||
27814216|NCT00886483|81150344|FG001|Overall Study|Pursue medications|2|||
27814217|NCT00886483|81150343|FG000|Overall Study|Distance to center, poor grades|1|||
27814218|NCT00886483|81150344|FG001|Overall Study|Distance to center, poor grades|0|||
27814219|NCT00358826|81150346|FG000|Core Study|Adverse Event|1|||
27814220|NCT00358826|81150347|FG001|Core Study|Adverse Event|3|||
27814221|NCT00358826|81150348|FG002|Core Study|Adverse Event|1|||
27814222|NCT00358826|81150349|FG003|Core Study|Adverse Event|1|||
27814223|NCT00358826|81150350|FG004|Core Study|Adverse Event|0|||
27814224|NCT00358826|81150351|FG005|Core Study|Adverse Event|0|||
27814225|NCT00358826|81150352|FG006|Core Study|Adverse Event|0|||
27814226|NCT00358826|81150353|FG007|Core Study|Adverse Event|0|||
27814227|NCT00358826|81150346|FG000|Core Study|Withdrawal by Subject|2|||
27814228|NCT00358826|81150347|FG001|Core Study|Withdrawal by Subject|2|||
27814229|NCT00358826|81150348|FG002|Core Study|Withdrawal by Subject|0|||
27814230|NCT00358826|81150349|FG003|Core Study|Withdrawal by Subject|0|||
27814231|NCT00358826|81150350|FG004|Core Study|Withdrawal by Subject|0|||
27814232|NCT00358826|81150351|FG005|Core Study|Withdrawal by Subject|0|||
27814233|NCT00358826|81150352|FG006|Core Study|Withdrawal by Subject|0|||
27814234|NCT00358826|81150353|FG007|Core Study|Withdrawal by Subject|0|||
27814235|NCT00358826|81150346|FG000|Core Study|Lost to Follow-up|0|||
27814236|NCT00358826|81150347|FG001|Core Study|Lost to Follow-up|0|||
27814237|NCT00358826|81150348|FG002|Core Study|Lost to Follow-up|0|||
27814238|NCT00358826|81150349|FG003|Core Study|Lost to Follow-up|1|||
27814239|NCT00358826|81150350|FG004|Core Study|Lost to Follow-up|0|||
27814240|NCT00358826|81150351|FG005|Core Study|Lost to Follow-up|0|||
27814241|NCT00358826|81150352|FG006|Core Study|Lost to Follow-up|0|||
27814242|NCT00358826|81150353|FG007|Core Study|Lost to Follow-up|0|||
27814243|NCT00358826|81150346|FG000|Core Study|Physician Decision|0|||
27814244|NCT00358826|81150347|FG001|Core Study|Physician Decision|0|||
27814245|NCT00358826|81150348|FG002|Core Study|Physician Decision|1|||
27814246|NCT00358826|81150349|FG003|Core Study|Physician Decision|0|||
27814247|NCT00358826|81150350|FG004|Core Study|Physician Decision|0|||
27814248|NCT00358826|81150351|FG005|Core Study|Physician Decision|0|||
27814249|NCT00358826|81150352|FG006|Core Study|Physician Decision|0|||
27814250|NCT00358826|81150353|FG007|Core Study|Physician Decision|0|||
27814251|NCT00358826|81150346|FG000|MDCT Substudy|Adverse Event|0|||
27814252|NCT00358826|81150347|FG001|MDCT Substudy|Adverse Event|0|||
27814253|NCT00358826|81150348|FG002|MDCT Substudy|Adverse Event|0|||
27814254|NCT00358826|81150349|FG003|MDCT Substudy|Adverse Event|0|||
27814255|NCT00358826|81150350|FG004|MDCT Substudy|Adverse Event|1|||
27814256|NCT00358826|81150351|FG005|MDCT Substudy|Adverse Event|0|||
27814257|NCT00358826|81150352|FG006|MDCT Substudy|Adverse Event|0|||
27814258|NCT00358826|81150353|FG007|MDCT Substudy|Adverse Event|0|||
27814259|NCT00358826|81150346|FG000|MDCT Substudy|Lost to Follow-up|0|||
27814260|NCT00358826|81150347|FG001|MDCT Substudy|Lost to Follow-up|0|||
27814261|NCT00358826|81150348|FG002|MDCT Substudy|Lost to Follow-up|0|||
27814262|NCT00358826|81150349|FG003|MDCT Substudy|Lost to Follow-up|0|||
27814263|NCT00358826|81150350|FG004|MDCT Substudy|Lost to Follow-up|0|||
27876825|NCT03307252|81379933|FG004|Part 2, Period 1|Treatment not received|0|||
27876826|NCT03307252|81379934|FG005|Part 2, Period 1|Treatment not received|1|||
27589158|NCT02291614|80340313|FG003|Overall Study|Death|0|||
27814264|NCT00358826|81150351|FG005|MDCT Substudy|Lost to Follow-up|1|||
27814265|NCT00358826|81150352|FG006|MDCT Substudy|Lost to Follow-up|0|||
27814266|NCT00358826|81150353|FG007|MDCT Substudy|Lost to Follow-up|0|||
27814267|NCT00358826|81150346|FG000|MDCT Substudy|Withdrawal by Subject|0|||
27814268|NCT00358826|81150347|FG001|MDCT Substudy|Withdrawal by Subject|0|||
27814269|NCT00358826|81150348|FG002|MDCT Substudy|Withdrawal by Subject|0|||
27814270|NCT00358826|81150349|FG003|MDCT Substudy|Withdrawal by Subject|0|||
27814271|NCT00358826|81150350|FG004|MDCT Substudy|Withdrawal by Subject|0|||
27814272|NCT00358826|81150351|FG005|MDCT Substudy|Withdrawal by Subject|1|||
27814273|NCT00358826|81150352|FG006|MDCT Substudy|Withdrawal by Subject|0|||
27814274|NCT00358826|81150353|FG007|MDCT Substudy|Withdrawal by Subject|0|||
27814275|NCT02277769|81150359|FG000|Overall Study|Protocol Violation|3|||
27814276|NCT02277769|81150360|FG001|Overall Study|Protocol Violation|3|||
27814277|NCT02277769|81150361|FG002|Overall Study|Protocol Violation|5|||
27814278|NCT02277769|81150359|FG000|Overall Study|Lack of Efficacy|17|||
27814279|NCT02277769|81150360|FG001|Overall Study|Lack of Efficacy|0|||
27814280|NCT02277769|81150361|FG002|Overall Study|Lack of Efficacy|4|||
27814281|NCT02277769|81150359|FG000|Overall Study|Adverse Event|14|||
27814282|NCT02277769|81150360|FG001|Overall Study|Adverse Event|2|||
27814283|NCT02277769|81150361|FG002|Overall Study|Adverse Event|4|||
27814284|NCT02277769|81150359|FG000|Overall Study|Other than specified above|12|||
27814285|NCT02277769|81150360|FG001|Overall Study|Other than specified above|8|||
27814286|NCT02277769|81150361|FG002|Overall Study|Other than specified above|5|||
27814287|NCT00992407|81150362|FG000|Overall Study|Protocol Violation|2|||
27814288|NCT00992407|81150363|FG001|Overall Study|Protocol Violation|1|||
27814289|NCT00992407|81150362|FG000|Overall Study|Lost to Follow-up|3|||
27814290|NCT00992407|81150363|FG001|Overall Study|Lost to Follow-up|3|||
27814291|NCT00992407|81150362|FG000|Overall Study|Adverse Event|3|||
27814292|NCT00992407|81150363|FG001|Overall Study|Adverse Event|2|||
27814293|NCT00992407|81150362|FG000|Overall Study|protocol Violation & Adverse events|2|||
27814294|NCT00992407|81150363|FG001|Overall Study|protocol Violation & Adverse events|4|||
27814295|NCT00992407|81150362|FG000|Overall Study|Other|2|||
27814296|NCT00992407|81150363|FG001|Overall Study|Other|0|||
27814297|NCT00992407|81150362|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
27814298|NCT00992407|81150363|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
27589159|NCT02291614|80340314|FG004|Overall Study|Death|1|||
27589160|NCT02291614|80340315|FG005|Overall Study|Death|1|||
27589161|NCT02291614|80340316|FG006|Overall Study|Death|1|||
27589162|NCT02291614|80340317|FG007|Overall Study|Death|0|||
27589163|NCT02291614|80340318|FG008|Overall Study|Death|0|||
27589164|NCT02291614|80340319|FG009|Overall Study|Death|0|||
27589165|NCT02291614|80340320|FG010|Overall Study|Death|0|||
27589166|NCT01154166|80340321|FG000|Overall Study|Adverse Event|14|||
27589167|NCT01154166|80340322|FG001|Overall Study|Adverse Event|9|||
27688205|NCT01153321|80694196|FG000|Overall Study|Withdrawal by Subject|0|||
27688206|NCT01153321|80694197|FG001|Overall Study|Withdrawal by Subject|1|||
27876827|NCT03307252|81379935|FG006|Part 2, Period 1|Treatment not received|0|||
27876828|NCT03307252|81379936|FG007|Part 2, Period 1|Treatment not received|0|||
27876829|NCT03307252|81379937|FG008|Part 2, Period 1|Treatment not received|0|||
27876830|NCT03307252|81379938|FG009|Part 2, Period 1|Treatment not received|0|||
27876831|NCT03307252|81379939|FG010|Part 2, Period 1|Treatment not received|0|||
27876832|NCT03307252|81379929|FG000|Part 2, Period 3|Other than listed|0|||
27876833|NCT03307252|81379930|FG001|Part 2, Period 3|Other than listed|0|||
27876834|NCT03307252|81379931|FG002|Part 2, Period 3|Other than listed|0|||
27876835|NCT03307252|81379932|FG003|Part 2, Period 3|Other than listed|0|||
27876836|NCT03307252|81379933|FG004|Part 2, Period 3|Other than listed|1|||
27876837|NCT03307252|81379934|FG005|Part 2, Period 3|Other than listed|0|||
27876838|NCT03307252|81379935|FG006|Part 2, Period 3|Other than listed|0|||
27876839|NCT03307252|81379936|FG007|Part 2, Period 3|Other than listed|0|||
27876840|NCT03307252|81379937|FG008|Part 2, Period 3|Other than listed|0|||
27876841|NCT03307252|81379938|FG009|Part 2, Period 3|Other than listed|0|||
27876842|NCT03307252|81379939|FG010|Part 2, Period 3|Other than listed|0|||
27876843|NCT03307252|81379929|FG000|Part 2, Period 4|Other than listed|0|||
27876844|NCT03307252|81379930|FG001|Part 2, Period 4|Other than listed|0|||
27876845|NCT03307252|81379931|FG002|Part 2, Period 4|Other than listed|0|||
27876846|NCT03307252|81379932|FG003|Part 2, Period 4|Other than listed|0|||
27876847|NCT03307252|81379933|FG004|Part 2, Period 4|Other than listed|0|||
27876848|NCT03307252|81379934|FG005|Part 2, Period 4|Other than listed|0|||
27876849|NCT03307252|81379935|FG006|Part 2, Period 4|Other than listed|1|||
27876850|NCT03307252|81379936|FG007|Part 2, Period 4|Other than listed|0|||
27876851|NCT03307252|81379937|FG008|Part 2, Period 4|Other than listed|0|||
27876852|NCT03307252|81379938|FG009|Part 2, Period 4|Other than listed|0|||
27876853|NCT03307252|81379939|FG010|Part 2, Period 4|Other than listed|0|||
27876854|NCT03307252|81379929|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876855|NCT03307252|81379930|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876856|NCT03307252|81379931|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876857|NCT03307252|81379932|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876858|NCT03307252|81379933|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876859|NCT03307252|81379934|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876860|NCT03307252|81379935|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876861|NCT03307252|81379936|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876862|NCT03307252|81379937|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876863|NCT03307252|81379938|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
27876864|NCT03307252|81379939|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
27876865|NCT03164551|81379940|FG000|Overall Study|Imaging discontinued prior completion|8|||
27876866|NCT03164551|81379941|FG001|Overall Study|Imaging discontinued prior completion|0|||
27876867|NCT03164551|81379940|FG000|Overall Study|Participant was non-compliant|1|||
27876868|NCT03164551|81379941|FG001|Overall Study|Participant was non-compliant|0|||
27589168|NCT01154166|80340321|FG000|Overall Study|Lost to Follow-up|1|||
27876869|NCT03164551|81379940|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
27876870|NCT03164551|81379941|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
27876871|NCT03164551|81379940|FG000|Overall Study|Other|8|||
27876872|NCT03164551|81379941|FG001|Overall Study|Other|2|||
27876873|NCT03517540|81379942|FG000|Overall Study|Protocol Violation|2|||
27876874|NCT03517540|81379943|FG001|Overall Study|Protocol Violation|0|||
27876875|NCT03517540|81379944|FG002|Overall Study|Protocol Violation|0|||
27589169|NCT01154166|80340322|FG001|Overall Study|Lost to Follow-up|1|||
27589170|NCT01154166|80340321|FG000|Overall Study|Protocol Violation|4|||
27589171|NCT01154166|80340322|FG001|Overall Study|Protocol Violation|1|||
27589172|NCT01154166|80340321|FG000|Overall Study|Withdrawal by Subject|10|||
27589173|NCT01154166|80340322|FG001|Overall Study|Withdrawal by Subject|1|||
27589174|NCT01154166|80340321|FG000|Overall Study|Lack of Efficacy|3|||
27589175|NCT01154166|80340322|FG001|Overall Study|Lack of Efficacy|0|||
27589176|NCT01154166|80340321|FG000|Overall Study|Disease Progression|1|||
27589177|NCT01154166|80340322|FG001|Overall Study|Disease Progression|0|||
27876876|NCT03517540|81379945|FG003|Overall Study|Protocol Violation|1|||
27876877|NCT03517540|81379942|FG000|Overall Study|Adverse Event|9|||
27876878|NCT03517540|81379943|FG001|Overall Study|Adverse Event|3|||
27876879|NCT03517540|81379944|FG002|Overall Study|Adverse Event|8|||
27876880|NCT03517540|81379945|FG003|Overall Study|Adverse Event|1|||
27876881|NCT03517540|81379942|FG000|Overall Study|Withdrawal by Subject|3|||
27876882|NCT03517540|81379943|FG001|Overall Study|Withdrawal by Subject|4|||
27876883|NCT03517540|81379944|FG002|Overall Study|Withdrawal by Subject|1|||
27876884|NCT03517540|81379945|FG003|Overall Study|Withdrawal by Subject|3|||
27876885|NCT00449865|81383069|FG000|Overall Study|Withdrawal by Subject|110|||
27876886|NCT00449865|81383070|FG001|Overall Study|Withdrawal by Subject|110|||
27876887|NCT00449865|81383069|FG000|Overall Study|Lost to Follow-up|36|||
27876888|NCT00449865|81383070|FG001|Overall Study|Lost to Follow-up|37|||
27876889|NCT00449865|81383069|FG000|Overall Study|Physician Decision|13|||
27589178|NCT01154166|80340321|FG000|Overall Study|Poor Compliance|1|||
27589179|NCT01154166|80340322|FG001|Overall Study|Poor Compliance|0|||
27589180|NCT04955639|80340323|FG000|Overall Study|Withdrawal by Subject|2|||
27589181|NCT04955639|80340324|FG001|Overall Study|Withdrawal by Subject|2|||
27876890|NCT00449865|81383070|FG001|Overall Study|Physician Decision|12|||
27876891|NCT00449865|81383069|FG000|Overall Study|Death|31|||
27876892|NCT00449865|81383070|FG001|Overall Study|Death|40|||
27876893|NCT00449865|81383069|FG000|Overall Study|Protocol Violation|8|||
27814299|NCT00992407|81150362|FG000|Overall Study|Study medication not administered|17|||
27814300|NCT00992407|81150363|FG001|Overall Study|Study medication not administered|13|||
27814301|NCT03283709|81150364|FG000|Overall Study|trial terminated|0|||
27814302|NCT03283709|81150365|FG001|Overall Study|trial terminated|1|||
27814303|NCT02187042|81150367|FG000|Overall Study|Death|1|||
27814304|NCT02187042|81150368|FG001|Overall Study|Death|1|||
27688207|NCT01153321|80694196|FG000|Overall Study|Adverse Event|1|||
27688208|NCT01153321|80694197|FG001|Overall Study|Adverse Event|1|||
27688209|NCT01590082|80694200|FG000|Overall Study|Withdrawal by Subject|1|||
27688210|NCT01590082|80694201|FG001|Overall Study|Withdrawal by Subject|0|||
27688211|NCT01590082|80694200|FG000|Overall Study|Ineligible|1|||
27688212|NCT01590082|80694201|FG001|Overall Study|Ineligible|0|||
27589182|NCT04955639|80340323|FG000|Overall Study|Week 26 survey not completed|2|||
27589183|NCT04955639|80340324|FG001|Overall Study|Week 26 survey not completed|2|||
27589184|NCT00295750|80340325|FG000|Overall Study|Adverse Event|19|||
27589185|NCT00295750|80340326|FG001|Overall Study|Adverse Event|15|||
27589186|NCT00295750|80340327|FG002|Overall Study|Adverse Event|12|||
27589187|NCT00295750|80340325|FG000|Overall Study|Lack of Efficacy|1|||
27589188|NCT00295750|80340326|FG001|Overall Study|Lack of Efficacy|1|||
27589189|NCT00295750|80340327|FG002|Overall Study|Lack of Efficacy|0|||
27589190|NCT00295750|80340325|FG000|Overall Study|Lost to Follow-up|1|||
27589191|NCT00295750|80340326|FG001|Overall Study|Lost to Follow-up|4|||
27589192|NCT00295750|80340327|FG002|Overall Study|Lost to Follow-up|1|||
27589193|NCT00295750|80340325|FG000|Overall Study|Taking prohibited therapy|2|||
27589194|NCT00295750|80340326|FG001|Overall Study|Taking prohibited therapy|3|||
27688213|NCT01536015|80694202|FG000|Overall Study|Adverse Event|1|||
27688214|NCT01536015|80694203|FG001|Overall Study|Adverse Event|4|||
27688215|NCT01536015|80694202|FG000|Overall Study|Lost to Follow-up|0|||
27688216|NCT01536015|80694203|FG001|Overall Study|Lost to Follow-up|1|||
27688217|NCT01536015|80694202|FG000|Overall Study|Inclusion Criterion not met|2|||
27688218|NCT01536015|80694203|FG001|Overall Study|Inclusion Criterion not met|0|||
27688219|NCT01536015|80694202|FG000|Overall Study|Study closure|5|||
27688220|NCT01536015|80694203|FG001|Overall Study|Study closure|5|||
27589195|NCT00295750|80340327|FG002|Overall Study|Taking prohibited therapy|2|||
27589196|NCT00295750|80340325|FG000|Overall Study|Administrative errors|2|||
27589197|NCT00295750|80340326|FG001|Overall Study|Administrative errors|4|||
27589198|NCT00295750|80340327|FG002|Overall Study|Administrative errors|5|||
27589199|NCT00295750|80340325|FG000|Overall Study|Trial drug errors|1|||
27688221|NCT02442336|80694204|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
27688222|NCT02442336|80694204|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
27688223|NCT02442336|80694204|FG000|Overall Study|Lost to Follow-up|11|||
27688224|NCT01946438|80694208|FG000|Overall Study|Adverse Event|0|||
27688225|NCT01946438|80694209|FG001|Overall Study|Adverse Event|0|||
27688226|NCT01946438|80694210|FG002|Overall Study|Adverse Event|0|||
27688227|NCT01946438|80694211|FG003|Overall Study|Adverse Event|1|||
27688228|NCT01946438|80694208|FG000|Overall Study|Serious Adverse event|1|||
27688229|NCT01946438|80694209|FG001|Overall Study|Serious Adverse event|0|||
27688230|NCT01946438|80694210|FG002|Overall Study|Serious Adverse event|0|||
27589200|NCT00295750|80340326|FG001|Overall Study|Trial drug errors|1|||
27589201|NCT00295750|80340327|FG002|Overall Study|Trial drug errors|0|||
27688231|NCT01946438|80694211|FG003|Overall Study|Serious Adverse event|0|||
27688232|NCT01946438|80694208|FG000|Overall Study|Protocol Violation|0|||
27688233|NCT01946438|80694209|FG001|Overall Study|Protocol Violation|0|||
27688234|NCT01946438|80694210|FG002|Overall Study|Protocol Violation|1|||
27688235|NCT01946438|80694211|FG003|Overall Study|Protocol Violation|0|||
27688236|NCT01946438|80694208|FG000|Overall Study|Withdrawal by Subject|1|||
27688237|NCT01946438|80694209|FG001|Overall Study|Withdrawal by Subject|0|||
27688238|NCT01946438|80694210|FG002|Overall Study|Withdrawal by Subject|0|||
27688239|NCT01946438|80694211|FG003|Overall Study|Withdrawal by Subject|0|||
27688240|NCT05087979|80694212|FG000|Overall Study|Converted to general anesthesia|1|||
27688241|NCT05087979|80694213|FG001|Overall Study|Converted to general anesthesia|0|||
27814305|NCT02187042|81150367|FG000|Overall Study|Toxicity|6|||
27876894|NCT00449865|81383070|FG001|Overall Study|Protocol Violation|7|||
27589202|NCT00295750|80340325|FG000|Overall Study|Disease progression|2|||
27589203|NCT00295750|80340326|FG001|Overall Study|Disease progression|1|||
27589204|NCT00295750|80340327|FG002|Overall Study|Disease progression|0|||
27589205|NCT00295750|80340325|FG000|Overall Study|Personal reasons|0|||
27589206|NCT00295750|80340326|FG001|Overall Study|Personal reasons|1|||
27589207|NCT00295750|80340327|FG002|Overall Study|Personal reasons|0|||
27589208|NCT00295750|80340325|FG000|Overall Study|Randomized but never received trial drug|4|||
27589209|NCT00295750|80340326|FG001|Overall Study|Randomized but never received trial drug|3|||
27589210|NCT00295750|80340327|FG002|Overall Study|Randomized but never received trial drug|3|||
27589211|NCT00295750|80340325|FG000|Overall Study|Withdrawal by Subject|9|||
27688242|NCT00994682|80694218|FG000|Double Bilnd|Withdrawal by Subject|5|||
27814306|NCT02187042|81150368|FG001|Overall Study|Toxicity|5|||
27876895|NCT00449865|81383069|FG000|Overall Study|Study was stopped|324|||
27589212|NCT00295750|80340326|FG001|Overall Study|Withdrawal by Subject|4|||
27814307|NCT02187042|81150367|FG000|Overall Study|Participant choice|1|||
27814308|NCT02187042|81150368|FG001|Overall Study|Participant choice|0|||
27814309|NCT02187042|81150367|FG000|Overall Study|Doctor choice|1|||
27814310|NCT02187042|81150368|FG001|Overall Study|Doctor choice|0|||
27814311|NCT02187042|81150367|FG000|Overall Study|Progressive disease|4|||
27814312|NCT02187042|81150368|FG001|Overall Study|Progressive disease|8|||
27814313|NCT03775681|81150369|FG000|Overall Study|Physician Decision|3|||
27814314|NCT02514174|81150370|FG000|Overall Study|Patient refused to continue medication|1|||
27876896|NCT00449865|81383070|FG001|Overall Study|Study was stopped|328|||
27876897|NCT03192488|81383073|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
27876898|NCT03192488|81383074|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
27589213|NCT00295750|80340327|FG002|Overall Study|Withdrawal by Subject|7|||
27589214|NCT00295750|80340325|FG000|Overall Study|Protocol Violation|2|||
27688243|NCT00994682|80694219|FG001|Double Bilnd|Withdrawal by Subject|6|||
27688244|NCT00994682|80694218|FG000|Double Bilnd|Lost to Follow-up|3|||
27814315|NCT02514174|81150370|FG000|Overall Study|Adverse Event|2|||
27589215|NCT00295750|80340326|FG001|Overall Study|Protocol Violation|4|||
27589216|NCT00295750|80340327|FG002|Overall Study|Protocol Violation|2|||
27589217|NCT04053764|80340330|FG000|Overall Study|Withdrawal by Subject|6|||
27589218|NCT04053764|80340331|FG001|Overall Study|Withdrawal by Subject|2|||
27589219|NCT04053764|80340330|FG000|Overall Study|Physician Decision|2|||
27589220|NCT04053764|80340331|FG001|Overall Study|Physician Decision|1|||
27589221|NCT04053764|80340330|FG000|Overall Study|Adverse Event|1|||
27589222|NCT04053764|80340331|FG001|Overall Study|Adverse Event|0|||
27589223|NCT04053764|80340330|FG000|Overall Study|Pregnancy|1|||
27589224|NCT04053764|80340331|FG001|Overall Study|Pregnancy|0|||
27589225|NCT02891187|80340332|FG000|Overall Study|Lost to Follow-up|1|||
27589226|NCT02891187|80340333|FG001|Overall Study|Lost to Follow-up|2|||
27589227|NCT04667117|80340334|FG000|Investigational Period|Lost to Follow-up|0|||
27589228|NCT04667117|80340335|FG001|Investigational Period|Lost to Follow-up|0|||
27589229|NCT04667117|80340336|FG002|Investigational Period|Lost to Follow-up|1|||
27589230|NCT04667117|80340334|FG000|Investigational Period|Protocol Deviation|0|||
27589231|NCT04667117|80340335|FG001|Investigational Period|Protocol Deviation|1|||
27589232|NCT04667117|80340336|FG002|Investigational Period|Protocol Deviation|0|||
27589233|NCT04667117|80340334|FG000|Extension Period|Lost to Follow-up|1|||
27589234|NCT04667117|80340335|FG001|Extension Period|Lost to Follow-up|0|||
27589235|NCT04667117|80340336|FG002|Extension Period|Lost to Follow-up|0|||
27589236|NCT00727272|80340337|FG000|Washout Period A|Adverse Event|0|||
27589237|NCT00727272|80340338|FG001|Washout Period A|Adverse Event|0|||
27589238|NCT00727272|80340339|FG002|Washout Period A|Adverse Event|1|||
27589239|NCT00727272|80340337|FG000|Washout Period B|Withdrawal by Subject|0|||
27589240|NCT00727272|80340338|FG001|Washout Period B|Withdrawal by Subject|0|||
27589241|NCT00727272|80340339|FG002|Washout Period B|Withdrawal by Subject|1|||
27589242|NCT00321919|80340343|FG000|Overall Study|Adverse Event|17|||
27589243|NCT00321919|80340344|FG001|Overall Study|Adverse Event|10|||
27589244|NCT00321919|80340343|FG000|Overall Study|Death|21|||
27589245|NCT00321919|80340344|FG001|Overall Study|Death|17|||
27589246|NCT00321919|80340343|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27589247|NCT00321919|80340344|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27589248|NCT00321919|80340343|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27589249|NCT00321919|80340344|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27814316|NCT02514174|81150370|FG000|Overall Study|Study closed by sponsor|9|||
27814317|NCT02514174|81150370|FG000|Overall Study|Progressive disease|11|||
27814318|NCT02514174|81150370|FG000|Overall Study|Treatment change|1|||
27814319|NCT02514174|81150370|FG000|Overall Study|Treated off study with Afatinib.|1|||
27814320|NCT00561730|81150377|FG000|Overall Study|Adverse Event|2|||
27814321|NCT00561730|81150377|FG000|Overall Study|Handling of the drug|1|||
27814322|NCT00561730|81150377|FG000|Overall Study|Lost to Follow-up|5|||
27814323|NCT00561730|81150377|FG000|Overall Study|Not specified reasons|1|||
27814324|NCT01153984|81150378|FG000|Overall Study|Withdrawal by Subject|1|||
27814325|NCT01153984|81150378|FG000|Overall Study|Adverse Event|1|||
27814326|NCT05200858|81150380|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
27814327|NCT05200858|81150381|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
27814328|NCT05200858|81150382|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
27814329|NCT05200858|81150383|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
27814330|NCT01469546|81150384|FG000|Received 5 mg Dose|Adverse Event|13|||
27814331|NCT01469546|81150384|FG000|Received 5 mg Dose|Death|2|||
27814332|NCT01469546|81150384|FG000|Received 5 mg Dose|Protocol Violation|2|||
27814333|NCT01469546|81150384|FG000|Received 5 mg Dose|Progressive Disease|3|||
27814334|NCT01469546|81150384|FG000|Received 5 mg Dose|Physician Decision|3|||
27814335|NCT02568384|81150389|FG000|Overall Study|Mobile devices incompatible with App|2|||
27814336|NCT01759290|81150390|FG000|Overall Study|Subjects withdrawn consent|5|||
27814337|NCT01759290|81150390|FG000|Overall Study|Physician Decision|2|||
27814338|NCT01759290|81150390|FG000|Overall Study|Death|17|||
27814339|NCT01759290|81150390|FG000|Overall Study|Lost to Follow-up|53|||
27814340|NCT01759290|81150390|FG000|Overall Study|Unknown reason|4|||
27814341|NCT01006707|81150391|FG000|Study Session 1|Lost to Follow-up|2|||
27876899|NCT03192488|81383075|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
27876900|NCT03192488|81383076|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
27589250|NCT00321919|80340343|FG000|Overall Study|Refused Treatment|23|||
27589251|NCT00321919|80340344|FG001|Overall Study|Refused Treatment|14|||
27589252|NCT00321919|80340343|FG000|Overall Study|Other Protocol Violation|2|||
27589253|NCT00321919|80340344|FG001|Overall Study|Other Protocol Violation|3|||
27589254|NCT00321919|80340343|FG000|Overall Study|Failure to Return|3|||
27688245|NCT00994682|80694219|FG001|Double Bilnd|Lost to Follow-up|3|||
27589255|NCT00321919|80340344|FG001|Overall Study|Failure to Return|1|||
27589256|NCT00321919|80340343|FG000|Overall Study|Other withdrawal reason|7|||
27814342|NCT01006707|81150392|FG001|Study Session 1|Lost to Follow-up|0|||
27814343|NCT01006707|81150393|FG002|Study Session 1|Lost to Follow-up|0|||
27814344|NCT01006707|81150391|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
27589257|NCT00321919|80340344|FG001|Overall Study|Other withdrawal reason|6|||
27589258|NCT00116805|80340345|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
27814345|NCT01006707|81150392|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
27814346|NCT01006707|81150393|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
27814347|NCT00617461|81150396|FG000|First Treatment Intervention Period|Adverse Event|2|||
27814348|NCT00617461|81150397|FG001|First Treatment Intervention Period|Adverse Event|0|||
27814349|NCT00617461|81150396|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
27814350|NCT00617461|81150397|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
27814351|NCT00617461|81150396|FG000|First Treatment Intervention Period|Protocol Violation|2|||
27814352|NCT00617461|81150397|FG001|First Treatment Intervention Period|Protocol Violation|1|||
27814353|NCT00617461|81150396|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
27814354|NCT00617461|81150397|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
27814355|NCT00617461|81150396|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
27814356|NCT00617461|81150397|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
27814357|NCT00617461|81150396|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
27814358|NCT00617461|81150397|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
27814359|NCT00617461|81150396|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
27814360|NCT00617461|81150397|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
27814361|NCT00617461|81150396|FG000|Second Treatment Intervention Period|Adverse Event|0|||
27814362|NCT00617461|81150397|FG001|Second Treatment Intervention Period|Adverse Event|1|||
27814363|NCT00617461|81150396|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
27814364|NCT00617461|81150397|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
27814365|NCT00617461|81150396|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
27814366|NCT00617461|81150397|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
27814367|NCT00617461|81150396|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
27814368|NCT00617461|81150397|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
27814369|NCT00506753|81150399|FG000|Overall Study|Lost to Follow-up|21|||
27814370|NCT00506753|81150400|FG001|Overall Study|Lost to Follow-up|15|||
27814371|NCT04582266|81150401|FG000|Overall Study|Lost to Follow-up|7|||
27814372|NCT04582266|81150402|FG001|Overall Study|Lost to Follow-up|5|||
27814373|NCT04582266|81150401|FG000|Overall Study|Withdrawal by Subject|1|||
27814374|NCT04582266|81150402|FG001|Overall Study|Withdrawal by Subject|0|||
27814375|NCT04582266|81150401|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
27814376|NCT04582266|81150402|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
27814377|NCT02324465|81150407|FG000|Overall Study|device failure|0|||
27814378|NCT02324465|81150408|FG001|Overall Study|device failure|1|||
27814379|NCT01789320|81150414|FG000|Overall Study|Re-enrolled into study|1|||
27814380|NCT01789320|81150414|FG000|Overall Study|Lost to Follow-up|1|||
27814381|NCT02247479|81150415|FG000|Overall Study|Adverse Event|8|||
27814382|NCT02247479|81150416|FG001|Overall Study|Adverse Event|9|||
27814383|NCT02247479|81150417|FG002|Overall Study|Adverse Event|8|||
27814384|NCT02247479|81150415|FG000|Overall Study|Death|5|||
27814385|NCT02247479|81150416|FG001|Overall Study|Death|4|||
27814386|NCT02247479|81150417|FG002|Overall Study|Death|6|||
27814387|NCT02247479|81150415|FG000|Overall Study|Lost to Follow-up|3|||
27814388|NCT02247479|81150416|FG001|Overall Study|Lost to Follow-up|3|||
27814389|NCT02247479|81150417|FG002|Overall Study|Lost to Follow-up|1|||
27814390|NCT02247479|81150415|FG000|Overall Study|Non-compliance|0|||
27814391|NCT02247479|81150416|FG001|Overall Study|Non-compliance|0|||
27814392|NCT02247479|81150417|FG002|Overall Study|Non-compliance|1|||
27814393|NCT02247479|81150415|FG000|Overall Study|Withdrawal by Subject|25|||
27814394|NCT02247479|81150416|FG001|Overall Study|Withdrawal by Subject|29|||
27814395|NCT02247479|81150417|FG002|Overall Study|Withdrawal by Subject|24|||
27814396|NCT02247479|81150415|FG000|Overall Study|Study Terminated by Sponsor|98|||
27814397|NCT02247479|81150416|FG001|Overall Study|Study Terminated by Sponsor|88|||
27814398|NCT02247479|81150417|FG002|Overall Study|Study Terminated by Sponsor|94|||
27814399|NCT02247479|81150415|FG000|Overall Study|Physician Decision|1|||
27814400|NCT02247479|81150416|FG001|Overall Study|Physician Decision|0|||
27814401|NCT02247479|81150417|FG002|Overall Study|Physician Decision|2|||
27814402|NCT02247479|81150415|FG000|Overall Study|Unspecified Reason|2|||
27814403|NCT02247479|81150416|FG001|Overall Study|Unspecified Reason|5|||
27814404|NCT02247479|81150417|FG002|Overall Study|Unspecified Reason|2|||
27814405|NCT00365352|81150418|FG000|Overall Study|Adverse Event|6|||
27814406|NCT00365352|81150419|FG001|Overall Study|Adverse Event|7|||
27814407|NCT00365352|81150420|FG002|Overall Study|Adverse Event|8|||
27814408|NCT00365352|81150418|FG000|Overall Study|Participant Withdrew Consent|8|||
27814409|NCT00365352|81150419|FG001|Overall Study|Participant Withdrew Consent|3|||
27814410|NCT00365352|81150420|FG002|Overall Study|Participant Withdrew Consent|4|||
27814411|NCT00365352|81150418|FG000|Overall Study|Lack of Efficacy|3|||
27814412|NCT00365352|81150419|FG001|Overall Study|Lack of Efficacy|0|||
27814413|NCT00365352|81150420|FG002|Overall Study|Lack of Efficacy|0|||
27814414|NCT00365352|81150418|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
27814415|NCT00365352|81150419|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
27814416|NCT00365352|81150420|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
27814417|NCT00365352|81150418|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
27876901|NCT03192488|81383077|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
27876902|NCT03192488|81383078|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
27876903|NCT03192488|81383073|FG000|Third Intervention (d1)|Adverse Event|0|||
27876904|NCT03192488|81383074|FG001|Third Intervention (d1)|Adverse Event|0|||
27876905|NCT03192488|81383075|FG002|Third Intervention (d1)|Adverse Event|0|||
27876906|NCT03192488|81383076|FG003|Third Intervention (d1)|Adverse Event|0|||
27876907|NCT03192488|81383077|FG004|Third Intervention (d1)|Adverse Event|1|||
27876908|NCT03192488|81383078|FG005|Third Intervention (d1)|Adverse Event|0|||
27876909|NCT03711786|81383079|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
27876910|NCT03711786|81383080|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
27876911|NCT03711786|81383079|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
27876912|NCT03711786|81383080|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
27876913|NCT03711786|81383079|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
27876914|NCT03711786|81383080|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
27876915|NCT03711786|81383079|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
27876916|NCT03711786|81383080|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
27814418|NCT00365352|81150419|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
27814419|NCT00365352|81150420|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
27814420|NCT00365352|81150418|FG000|Overall Study|Lost to Follow-up|1|||
27814421|NCT00365352|81150419|FG001|Overall Study|Lost to Follow-up|1|||
27814422|NCT00365352|81150420|FG002|Overall Study|Lost to Follow-up|0|||
27814423|NCT00365352|81150418|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
27814424|NCT00365352|81150419|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
27814425|NCT00365352|81150420|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
27814426|NCT03387098|81150421|FG000|Overall Study|progressive disease|1|||
27814427|NCT03387098|81150421|FG000|Overall Study|Withdrawal by Subject|2|||
27814428|NCT03387098|81150421|FG000|Overall Study|study terminated by sponsor|1|||
27876917|NCT03711786|81383079|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
27876918|NCT03711786|81383080|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
27876919|NCT03711786|81383079|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
27876920|NCT03711786|81383080|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
27876921|NCT01956773|81383081|FG000|Overall Study|Lost to Follow-up|628|||
27814429|NCT03222141|81154286|FG000|Overall Study|Death|15|||
27814430|NCT03222141|81154286|FG000|Overall Study|Lost to Follow-up|3|||
27814431|NCT01939197|81154291|FG000|Overall Study|Withdrawal by Subject|1|||
27814432|NCT01939197|81154292|FG001|Overall Study|Withdrawal by Subject|0|||
27814433|NCT01939197|81154293|FG002|Overall Study|Withdrawal by Subject|0|||
27814434|NCT01939197|81154294|FG003|Overall Study|Withdrawal by Subject|0|||
27814435|NCT01939197|81154295|FG004|Overall Study|Withdrawal by Subject|1|||
27876922|NCT01956773|81383082|FG001|Overall Study|Lost to Follow-up|1|||
27814436|NCT01939197|81154296|FG005|Overall Study|Withdrawal by Subject|0|||
27814437|NCT01939197|81154297|FG006|Overall Study|Withdrawal by Subject|0|||
27876923|NCT03181633|81383087|FG000|Overall Study|Withdrawal by Subject|1|||
27876924|NCT03181633|81383087|FG000|Overall Study|Missing follow-up visit|1|||
27876925|NCT01277601|81383088|FG000|Overall Study|Adverse Event|5|||
27876926|NCT01277601|81383089|FG001|Overall Study|Adverse Event|3|||
27876927|NCT01277601|81383090|FG002|Overall Study|Adverse Event|0|||
27876928|NCT01277601|81383091|FG003|Overall Study|Adverse Event|7|||
27589259|NCT00116805|80340346|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
27589260|NCT00116805|80340345|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
27589261|NCT00116805|80340346|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
27589262|NCT00116805|80340345|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
27589263|NCT00116805|80340346|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
27589264|NCT00116805|80340345|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
27589265|NCT00116805|80340346|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
27589266|NCT00116805|80340345|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
27589267|NCT00116805|80340346|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
27589268|NCT00116805|80340345|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
27589269|NCT00116805|80340346|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
27589270|NCT00116805|80340345|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
27589271|NCT00116805|80340346|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
27589272|NCT00116805|80340345|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
27589273|NCT00116805|80340346|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
27589274|NCT00116805|80340345|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
27688246|NCT00994682|80694218|FG000|Double Bilnd|Adverse Event|1|||
27814438|NCT01939197|81154291|FG000|Overall Study|Lost to Follow-up|0|||
27814439|NCT01939197|81154292|FG001|Overall Study|Lost to Follow-up|1|||
27814440|NCT01939197|81154293|FG002|Overall Study|Lost to Follow-up|0|||
27814441|NCT01939197|81154294|FG003|Overall Study|Lost to Follow-up|1|||
27814442|NCT01939197|81154295|FG004|Overall Study|Lost to Follow-up|3|||
27589275|NCT00116805|80340346|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
27688247|NCT00994682|80694219|FG001|Double Bilnd|Adverse Event|0|||
27688248|NCT00994682|80694218|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
27814443|NCT01939197|81154296|FG005|Overall Study|Lost to Follow-up|1|||
27814444|NCT01939197|81154297|FG006|Overall Study|Lost to Follow-up|2|||
27814445|NCT00249821|81154298|FG000|Overall Study|Technical problem|0|||
27814446|NCT00249821|81154299|FG001|Overall Study|Technical problem|1|||
27814447|NCT03361423|81154300|FG000|Overall Study|Withdrawal by Subject|4|||
27814448|NCT03361423|81154301|FG001|Overall Study|Withdrawal by Subject|3|||
27814449|NCT03361423|81154300|FG000|Overall Study|Did not treat|19|||
27814450|NCT03361423|81154301|FG001|Overall Study|Did not treat|18|||
27814451|NCT03361423|81154300|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
27814452|NCT03361423|81154301|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
27814453|NCT03361423|81154300|FG000|Overall Study|Missing data|4|||
27814454|NCT03361423|81154301|FG001|Overall Study|Missing data|1|||
27814455|NCT00337077|81154302|FG000|Overall Study|Progressive disease|25|||
27814456|NCT00337077|81154303|FG001|Overall Study|Progressive disease|37|||
27814457|NCT00337077|81154304|FG002|Overall Study|Progressive disease|19|||
27814458|NCT00337077|81154302|FG000|Overall Study|Adverse Event|7|||
27814459|NCT00337077|81154303|FG001|Overall Study|Adverse Event|7|||
27814460|NCT00337077|81154304|FG002|Overall Study|Adverse Event|1|||
27814461|NCT00337077|81154302|FG000|Overall Study|Death|0|||
27814462|NCT00337077|81154303|FG001|Overall Study|Death|1|||
27814463|NCT00337077|81154304|FG002|Overall Study|Death|0|||
27814464|NCT00337077|81154302|FG000|Overall Study|Withdrawal by Subject|7|||
27814465|NCT00337077|81154303|FG001|Overall Study|Withdrawal by Subject|2|||
27814466|NCT00337077|81154304|FG002|Overall Study|Withdrawal by Subject|2|||
27814467|NCT00337077|81154302|FG000|Overall Study|Alternative therapy|1|||
27814468|NCT00337077|81154303|FG001|Overall Study|Alternative therapy|0|||
27814469|NCT00337077|81154304|FG002|Overall Study|Alternative therapy|0|||
27814470|NCT00337077|81154302|FG000|Overall Study|Physician Decision|1|||
27814471|NCT00337077|81154303|FG001|Overall Study|Physician Decision|4|||
27814472|NCT00337077|81154304|FG002|Overall Study|Physician Decision|2|||
27589276|NCT00116805|80340345|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
27814473|NCT00337077|81154302|FG000|Overall Study|Never started treatment|1|||
27814474|NCT00337077|81154303|FG001|Overall Study|Never started treatment|1|||
27814475|NCT00337077|81154304|FG002|Overall Study|Never started treatment|0|||
27814476|NCT00337077|81154302|FG000|Overall Study|Ineligible|1|||
27814477|NCT00337077|81154303|FG001|Overall Study|Ineligible|1|||
27814478|NCT00337077|81154304|FG002|Overall Study|Ineligible|1|||
27814479|NCT01884025|81154305|FG000|Overall Study|Lost to Follow-up|3|||
27814480|NCT01884025|81154306|FG001|Overall Study|Lost to Follow-up|4|||
27814481|NCT00368966|81154307|FG000|Infant Series|Withdrawal by Subject|11|||
27814482|NCT00368966|81154308|FG001|Infant Series|Withdrawal by Subject|6|||
27814483|NCT00368966|81154307|FG000|Infant Series|Protocol Violation|2|||
27814484|NCT00368966|81154308|FG001|Infant Series|Protocol Violation|1|||
27814485|NCT00368966|81154307|FG000|Infant Series|Lost to Follow-up|2|||
27814486|NCT00368966|81154308|FG001|Infant Series|Lost to Follow-up|0|||
27814487|NCT00368966|81154307|FG000|Infant Series|Randomization error|0|||
27814488|NCT00368966|81154308|FG001|Infant Series|Randomization error|1|||
27814489|NCT00368966|81154307|FG000|Infant Series|Failed to meet eligibility criteria|0|||
27814490|NCT00368966|81154308|FG001|Infant Series|Failed to meet eligibility criteria|1|||
27814491|NCT00368966|81154307|FG000|Infant Series|Adverse Event|0|||
27814492|NCT00368966|81154308|FG001|Infant Series|Adverse Event|1|||
27814493|NCT00368966|81154307|FG000|Infant Series|Failed to return|1|||
27814494|NCT00368966|81154308|FG001|Infant Series|Failed to return|0|||
27814495|NCT00368966|81154307|FG000|After Infant|Failed to return|3|||
27814496|NCT00368966|81154308|FG001|After Infant|Failed to return|1|||
27814497|NCT00368966|81154307|FG000|After Infant|Adverse Event|1|||
27814498|NCT00368966|81154308|FG001|After Infant|Adverse Event|2|||
27814499|NCT00368966|81154307|FG000|After Infant|Withdrawal by Subject|1|||
27814500|NCT00368966|81154308|FG001|After Infant|Withdrawal by Subject|1|||
27814501|NCT00368966|81154307|FG000|After Infant|Death|1|||
27814502|NCT00368966|81154308|FG001|After Infant|Death|0|||
27814503|NCT00368966|81154307|FG000|After Infant|Lost to Follow-up|0|||
27814504|NCT00368966|81154308|FG001|After Infant|Lost to Follow-up|1|||
27814505|NCT00368966|81154307|FG000|Toddler Dose|Withdrawal by Subject|1|||
27814506|NCT00368966|81154308|FG001|Toddler Dose|Withdrawal by Subject|1|||
27814507|NCT00368966|81154307|FG000|Toddler Dose|Lost to Follow-up|0|||
27814508|NCT00368966|81154308|FG001|Toddler Dose|Lost to Follow-up|2|||
27814509|NCT03144687|81154309|FG000|Overall Study|Death|0|||
27814510|NCT03144687|81154310|FG001|Overall Study|Death|2|||
27814511|NCT03144687|81154309|FG000|Overall Study|Lost to Follow-up|0|||
27814512|NCT03144687|81154310|FG001|Overall Study|Lost to Follow-up|1|||
27814513|NCT03144687|81154309|FG000|Overall Study|Physician Decision|0|||
27814514|NCT03144687|81154310|FG001|Overall Study|Physician Decision|1|||
27814515|NCT03144687|81154309|FG000|Overall Study|Withdrawal by Subject|1|||
27814516|NCT03144687|81154310|FG001|Overall Study|Withdrawal by Subject|3|||
27814517|NCT03144687|81154309|FG000|Overall Study|Not Reported|2|||
27814518|NCT03144687|81154310|FG001|Overall Study|Not Reported|0|||
27814519|NCT01922349|81154311|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
27814520|NCT01922349|81154312|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
27814521|NCT01922349|81154313|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
27814522|NCT01922349|81154314|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
27814523|NCT02275364|81154318|FG000|Period 1|Withdrawal by Subject|1|||
27814524|NCT02275364|81154319|FG001|Period 1|Withdrawal by Subject|0|||
27814525|NCT02275364|81154318|FG000|Period 1|Other reason|1|||
27814526|NCT02275364|81154319|FG001|Period 1|Other reason|0|||
27814527|NCT00634907|81154320|FG000|Overall Study|Withdrawal by Subject|3|||
27814528|NCT00634907|81154321|FG001|Overall Study|Withdrawal by Subject|0|||
27814529|NCT00634907|81154320|FG000|Overall Study|Physician Decision|3|||
27814530|NCT00634907|81154321|FG001|Overall Study|Physician Decision|9|||
27814531|NCT00634907|81154320|FG000|Overall Study|Withdrawal by Subject|11|||
27814532|NCT00634907|81154321|FG001|Overall Study|Withdrawal by Subject|8|||
27814533|NCT01626859|81154322|FG000|Overall Study|Adverse Event|1|||
27814534|NCT01626859|81154323|FG001|Overall Study|Adverse Event|3|||
27814535|NCT01626859|81154324|FG002|Overall Study|Adverse Event|2|||
27688249|NCT00994682|80694219|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
27688250|NCT00994682|80694218|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
27688251|NCT00994682|80694219|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
27688252|NCT00994682|80694218|FG000|Pioglitazone Open Label|Physician Decision|6|||
27688253|NCT00994682|80694219|FG001|Pioglitazone Open Label|Physician Decision|1|||
27814536|NCT01626859|81154322|FG000|Overall Study|Physician Decision|0|||
27814537|NCT01626859|81154323|FG001|Overall Study|Physician Decision|1|||
27814538|NCT01626859|81154324|FG002|Overall Study|Physician Decision|0|||
27814539|NCT01626859|81154322|FG000|Overall Study|Withdrawal by Subject|1|||
27814540|NCT01626859|81154323|FG001|Overall Study|Withdrawal by Subject|4|||
27814541|NCT01626859|81154324|FG002|Overall Study|Withdrawal by Subject|2|||
27814542|NCT04000009|81154325|FG000|Overall Study|Adverse Event|13|||
27814543|NCT04000009|81154325|FG000|Overall Study|Lack of Efficacy|7|||
27814544|NCT04000009|81154325|FG000|Overall Study|Lost to Follow-up|8|||
27814545|NCT04000009|81154325|FG000|Overall Study|Noncompliance with study drug|4|||
27814546|NCT04000009|81154325|FG000|Overall Study|Physician Decision|1|||
27814547|NCT04000009|81154325|FG000|Overall Study|Use of prohibited medication|3|||
27688254|NCT03694275|80694220|FG000|Overall Study|Adverse Event|0|||
27814548|NCT04000009|81154325|FG000|Overall Study|Pregnancy|1|||
27688255|NCT03694275|80694221|FG001|Overall Study|Adverse Event|1|||
27814549|NCT04000009|81154325|FG000|Overall Study|Withdrawal by Subject|22|||
27814550|NCT04000009|81154325|FG000|Overall Study|Study terminated by sponsor|98|||
27589277|NCT00116805|80340346|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
27589278|NCT00116805|80340345|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
27589279|NCT00116805|80340346|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
27589280|NCT00116805|80340345|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
27589281|NCT00116805|80340346|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
27688256|NCT03694275|80694220|FG000|Overall Study|Reason not Specified|0|||
27688257|NCT03694275|80694221|FG001|Overall Study|Reason not Specified|1|||
27688258|NCT00903006|80694222|FG000|Overall Study|Withdrawal by Subject|2|||
27688259|NCT00903006|80694223|FG001|Overall Study|Withdrawal by Subject|0|||
27688260|NCT00903006|80694224|FG002|Overall Study|Withdrawal by Subject|0|||
27688261|NCT00903006|80694225|FG003|Overall Study|Withdrawal by Subject|0|||
27688262|NCT00903006|80694222|FG000|Overall Study|Progressive Disease|0|||
27688263|NCT00903006|80694223|FG001|Overall Study|Progressive Disease|3|||
27688264|NCT00903006|80694224|FG002|Overall Study|Progressive Disease|1|||
27688265|NCT00903006|80694225|FG003|Overall Study|Progressive Disease|0|||
27814551|NCT04000009|81154325|FG000|Overall Study|Not further specified|8|||
27814552|NCT02339909|81154326|FG000|Overall Study|Became ineligible after randomisation|89|||
27814553|NCT02339909|81154327|FG001|Overall Study|Became ineligible after randomisation|63|||
27814554|NCT02339909|81154328|FG002|Overall Study|Became ineligible after randomisation|71|||
27814555|NCT01338636|81154331|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
27814556|NCT02540356|81154332|FG000|Overall Study|Terminated due to disease progression|1|||
27814557|NCT02540356|81154333|FG001|Overall Study|Terminated due to disease progression|0|||
27814558|NCT01941095|81154340|FG000|Overall Study|Insufficient therapeutic response|13|||
27814559|NCT01941095|81154340|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
27814560|NCT01941095|81154340|FG000|Overall Study|Adverse Event|11|||
27814561|NCT01941095|81154340|FG000|Overall Study|Physician Decision|3|||
27814562|NCT01941095|81154340|FG000|Overall Study|Withdrawal by Subject|17|||
27814563|NCT01941095|81154340|FG000|Overall Study|Lost to Follow-up|10|||
27814564|NCT02518113|81154341|FG000|Overall Study|Adverse Event|1|||
27814565|NCT02518113|81154342|FG001|Overall Study|Adverse Event|0|||
27814566|NCT02518113|81154343|FG002|Overall Study|Adverse Event|1|||
27814567|NCT02518113|81154344|FG003|Overall Study|Adverse Event|0|||
27814568|NCT02518113|81154341|FG000|Overall Study|Death|1|||
27814569|NCT02518113|81154342|FG001|Overall Study|Death|2|||
27814570|NCT02518113|81154343|FG002|Overall Study|Death|0|||
27814571|NCT02518113|81154344|FG003|Overall Study|Death|0|||
27814572|NCT02518113|81154341|FG000|Overall Study|Physician Decision|0|||
27814573|NCT02518113|81154342|FG001|Overall Study|Physician Decision|1|||
27814574|NCT02518113|81154343|FG002|Overall Study|Physician Decision|0|||
27814575|NCT02518113|81154344|FG003|Overall Study|Physician Decision|0|||
27814576|NCT02518113|81154341|FG000|Overall Study|Progressive Disease|1|||
27814577|NCT02518113|81154342|FG001|Overall Study|Progressive Disease|2|||
27814578|NCT02518113|81154343|FG002|Overall Study|Progressive Disease|3|||
27814579|NCT02518113|81154344|FG003|Overall Study|Progressive Disease|0|||
27814580|NCT00319111|81154354|FG000|Overall Study|Adverse Event|20|||
27814581|NCT00319111|81154354|FG000|Overall Study|Withdrawal of consent|11|||
27876929|NCT01277601|81383088|FG000|Overall Study|Withdrawal by Subject|18|||
27814582|NCT00319111|81154354|FG000|Overall Study|Death|9|||
27814583|NCT00319111|81154354|FG000|Overall Study|Lack of clinical improvement|4|||
27814584|NCT00319111|81154354|FG000|Overall Study|Administrative|2|||
27814585|NCT00319111|81154354|FG000|Overall Study|Treatment failure|1|||
27814586|NCT02576509|81154355|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
27814587|NCT02576509|81154356|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
27814588|NCT02576509|81154355|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
27688266|NCT01820585|80694226|FG000|Overall Study|Adverse Event|9|||
27814589|NCT02576509|81154356|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
27814590|NCT02576509|81154355|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
27876930|NCT01277601|81383089|FG001|Overall Study|Withdrawal by Subject|21|||
27688267|NCT01820585|80694227|FG001|Overall Study|Adverse Event|13|||
27688268|NCT01820585|80694228|FG002|Overall Study|Adverse Event|23|||
27688269|NCT01820585|80694229|FG003|Overall Study|Adverse Event|34|||
27688270|NCT01820585|80694226|FG000|Overall Study|Lack of Efficacy|9|||
27688271|NCT01820585|80694227|FG001|Overall Study|Lack of Efficacy|7|||
27688272|NCT01820585|80694228|FG002|Overall Study|Lack of Efficacy|5|||
27688273|NCT01820585|80694229|FG003|Overall Study|Lack of Efficacy|1|||
27688274|NCT01820585|80694226|FG000|Overall Study|Withdrawal by Subject|3|||
27688275|NCT01820585|80694227|FG001|Overall Study|Withdrawal by Subject|7|||
27688276|NCT01820585|80694228|FG002|Overall Study|Withdrawal by Subject|3|||
27688277|NCT01820585|80694229|FG003|Overall Study|Withdrawal by Subject|8|||
27688278|NCT01820585|80694226|FG000|Overall Study|Lost to Follow-up|3|||
27688279|NCT01820585|80694227|FG001|Overall Study|Lost to Follow-up|3|||
27688280|NCT01820585|80694228|FG002|Overall Study|Lost to Follow-up|0|||
27688281|NCT01820585|80694229|FG003|Overall Study|Lost to Follow-up|3|||
27688282|NCT01820585|80694226|FG000|Overall Study|Protocol Violation|3|||
27688283|NCT01820585|80694227|FG001|Overall Study|Protocol Violation|1|||
27688284|NCT01820585|80694228|FG002|Overall Study|Protocol Violation|1|||
27688285|NCT01820585|80694229|FG003|Overall Study|Protocol Violation|1|||
27688286|NCT01820585|80694226|FG000|Overall Study|Subject non-compliance|0|||
27688287|NCT01820585|80694227|FG001|Overall Study|Subject non-compliance|0|||
27688288|NCT01820585|80694228|FG002|Overall Study|Subject non-compliance|1|||
27688289|NCT01820585|80694229|FG003|Overall Study|Subject non-compliance|2|||
27688290|NCT01820585|80694226|FG000|Overall Study|at sponsor request|0|||
27688291|NCT01820585|80694227|FG001|Overall Study|at sponsor request|0|||
27688292|NCT01820585|80694228|FG002|Overall Study|at sponsor request|1|||
27688293|NCT01820585|80694229|FG003|Overall Study|at sponsor request|0|||
27688294|NCT01820585|80694226|FG000|Overall Study|Pregnancy|0|||
27688295|NCT01820585|80694227|FG001|Overall Study|Pregnancy|1|||
27688296|NCT01820585|80694228|FG002|Overall Study|Pregnancy|0|||
27688297|NCT01820585|80694229|FG003|Overall Study|Pregnancy|0|||
27688298|NCT00910689|80694235|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
27688299|NCT00910689|80694236|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
27688300|NCT00910689|80694237|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
27688301|NCT00910689|80694238|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
27688302|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
27688303|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
27688304|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
27688305|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
27688306|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
27688307|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
27688308|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
27688309|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
27688310|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
27688311|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
27688312|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
27688313|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
27688314|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
27688315|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
27688316|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
27688317|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
27688318|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
27688319|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
27688320|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
27688321|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
27688322|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
27688323|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
27688324|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
27688325|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
27688326|NCT00910689|80694235|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
27688327|NCT00910689|80694236|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
27688328|NCT00910689|80694237|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
27688329|NCT00910689|80694238|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
27688330|NCT00910689|80694235|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
27688331|NCT00910689|80694236|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
27688332|NCT00910689|80694237|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
27688333|NCT00910689|80694238|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
27688334|NCT00910689|80694235|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
27688335|NCT00910689|80694236|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
27814591|NCT02576509|81154356|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
27688336|NCT00910689|80694237|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
27688337|NCT00910689|80694238|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
27688338|NCT00910689|80694235|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
27688339|NCT00910689|80694236|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
27688340|NCT00910689|80694237|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
27688341|NCT00910689|80694238|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
27688342|NCT00910689|80694235|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
27688343|NCT00910689|80694236|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
27688344|NCT00910689|80694237|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
27688345|NCT00910689|80694238|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
27688346|NCT00910689|80694235|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
27688347|NCT00910689|80694236|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
27688348|NCT00910689|80694237|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
27688349|NCT00910689|80694238|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
27688350|NCT00910689|80694235|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
27688351|NCT00910689|80694236|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
27688352|NCT00910689|80694237|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
27688353|NCT00910689|80694238|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
27688354|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
27688355|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
27688356|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
27688357|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
27688358|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
27688359|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
27688360|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
27688361|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
27688362|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
27688363|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
27688364|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
27688365|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
27688366|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
27688367|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
27688368|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
27688369|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
27688370|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
27688371|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
27688372|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
27688373|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
27688374|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
27688375|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
27688376|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
27688377|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
27688378|NCT00910689|80694235|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
27688379|NCT00910689|80694236|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
27688380|NCT00910689|80694237|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
27688381|NCT00910689|80694238|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
27688382|NCT01850446|80694239|FG000|Overall Study|Lack of Efficacy|1|||
27688383|NCT01850446|80694240|FG001|Overall Study|Lack of Efficacy|0|||
27688384|NCT01850446|80694239|FG000|Overall Study|Withdrawal by Subject|4|||
27688385|NCT01850446|80694240|FG001|Overall Study|Withdrawal by Subject|0|||
27688386|NCT01850446|80694239|FG000|Overall Study|Protocol Violation|0|||
27688387|NCT01850446|80694240|FG001|Overall Study|Protocol Violation|2|||
27688388|NCT01901341|80694241|FG000|Overall Study|Adverse Event|4|||
27688389|NCT01901341|80694242|FG001|Overall Study|Adverse Event|2|||
27688390|NCT01901341|80694241|FG000|Overall Study|Lack of Efficacy|0|||
27688391|NCT01901341|80694242|FG001|Overall Study|Lack of Efficacy|2|||
27688392|NCT01901341|80694241|FG000|Overall Study|Lost to Follow-up|0|||
27688393|NCT01901341|80694242|FG001|Overall Study|Lost to Follow-up|1|||
27688394|NCT01901341|80694241|FG000|Overall Study|Protocol Violation|2|||
27688395|NCT01901341|80694242|FG001|Overall Study|Protocol Violation|0|||
27688396|NCT01901341|80694241|FG000|Overall Study|Study Terminated by Sponsor|13|||
27688397|NCT01901341|80694242|FG001|Overall Study|Study Terminated by Sponsor|15|||
27688398|NCT01901341|80694241|FG000|Overall Study|Withdrawal by Subject|1|||
27814592|NCT02576509|81154355|FG000|Treatment Period|Disease progression|245|||
27814593|NCT02576509|81154356|FG001|Treatment Period|Disease progression|240|||
27814594|NCT02576509|81154355|FG000|Treatment Period|Study drug toxicity|32|||
27814595|NCT02576509|81154356|FG001|Treatment Period|Study drug toxicity|41|||
27814596|NCT02576509|81154355|FG000|Treatment Period|Death|1|||
27688399|NCT01901341|80694242|FG001|Overall Study|Withdrawal by Subject|1|||
27688400|NCT02101385|80694245|FG000|Study Treatment|Disease Progression|9|||
27688401|NCT02101385|80694246|FG001|Study Treatment|Disease Progression|3|||
27688402|NCT02101385|80694245|FG000|Study Treatment|Alternative therapy|0|||
27688403|NCT02101385|80694246|FG001|Study Treatment|Alternative therapy|1|||
27814597|NCT02576509|81154356|FG001|Treatment Period|Death|1|||
27688404|NCT02101385|80694245|FG000|Study Treatment|No treatment, per protocol criteria|0|||
27688405|NCT02101385|80694246|FG001|Study Treatment|No treatment, per protocol criteria|4|||
27688406|NCT02101385|80694245|FG000|Study Treatment|Patient Non compliance|0|||
27688407|NCT02101385|80694246|FG001|Study Treatment|Patient Non compliance|2|||
27688408|NCT02101385|80694245|FG000|Study Treatment|Withdrawal by Subject|5|||
27688409|NCT02101385|80694246|FG001|Study Treatment|Withdrawal by Subject|2|||
27688410|NCT02101385|80694245|FG000|Study Treatment|screen failure|1|||
27688411|NCT02101385|80694246|FG001|Study Treatment|screen failure|0|||
27688412|NCT02101385|80694245|FG000|Study Treatment|AE/Side Effects/Complications|8|||
27688413|NCT02101385|80694246|FG001|Study Treatment|AE/Side Effects/Complications|0|||
27688414|NCT02101385|80694245|FG000|Study Treatment|Lost to Follow-up|1|||
27688415|NCT02101385|80694246|FG001|Study Treatment|Lost to Follow-up|0|||
27688416|NCT02101385|80694245|FG000|Study Treatment|Disease Progression before treatment|1|||
27688417|NCT02101385|80694246|FG001|Study Treatment|Disease Progression before treatment|0|||
27688418|NCT02101385|80694245|FG000|Study Treatment|Death|1|||
27688419|NCT02101385|80694246|FG001|Study Treatment|Death|0|||
27688420|NCT02101385|80694245|FG000|Follow up|Lost to Follow-up|4|||
27688421|NCT02101385|80694246|FG001|Follow up|Lost to Follow-up|9|||
27688422|NCT02101385|80694245|FG000|Follow up|Refused to follow up|5|||
27688423|NCT02101385|80694246|FG001|Follow up|Refused to follow up|4|||
27688424|NCT02101385|80694245|FG000|Follow up|Death|21|||
27688425|NCT02101385|80694246|FG001|Follow up|Death|39|||
27688426|NCT02101385|80694245|FG000|Follow up|study completed|33|||
27688427|NCT02101385|80694246|FG001|Follow up|study completed|52|||
27688428|NCT02101385|80694245|FG000|Follow up|screen failure|2|||
27688429|NCT02101385|80694246|FG001|Follow up|screen failure|0|||
27688430|NCT02101385|80694245|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
27688431|NCT02101385|80694246|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
27700997|NCT01241552|80741290|FG001|Overall Study|Withdrawal by Subject|15|||
27876931|NCT01277601|81383090|FG002|Overall Study|Withdrawal by Subject|8|||
27876932|NCT01277601|81383091|FG003|Overall Study|Withdrawal by Subject|17|||
27876933|NCT01277601|81383088|FG000|Overall Study|Lost to Follow-up|7|||
27876934|NCT01277601|81383089|FG001|Overall Study|Lost to Follow-up|9|||
27876935|NCT01277601|81383090|FG002|Overall Study|Lost to Follow-up|4|||
27876936|NCT01277601|81383091|FG003|Overall Study|Lost to Follow-up|2|||
27876937|NCT01277601|81383088|FG000|Overall Study|Physician Decision|3|||
27876938|NCT01277601|81383089|FG001|Overall Study|Physician Decision|5|||
27876939|NCT01277601|81383090|FG002|Overall Study|Physician Decision|1|||
27876940|NCT01277601|81383091|FG003|Overall Study|Physician Decision|6|||
27876941|NCT01277601|81383088|FG000|Overall Study|Pregnancy|2|||
27876942|NCT01277601|81383089|FG001|Overall Study|Pregnancy|2|||
27876943|NCT01277601|81383090|FG002|Overall Study|Pregnancy|4|||
27876944|NCT01277601|81383091|FG003|Overall Study|Pregnancy|1|||
27876945|NCT01277601|81383088|FG000|Overall Study|Noncompliance with Study Drug|1|||
27876946|NCT01277601|81383089|FG001|Overall Study|Noncompliance with Study Drug|3|||
27876947|NCT01277601|81383090|FG002|Overall Study|Noncompliance with Study Drug|2|||
27876948|NCT01277601|81383091|FG003|Overall Study|Noncompliance with Study Drug|0|||
27876949|NCT01277601|81383088|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
27876950|NCT01277601|81383089|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
27876951|NCT01277601|81383090|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
27876952|NCT01277601|81383091|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
27876953|NCT01277601|81383088|FG000|Overall Study|Protocol Violation|0|||
27876954|NCT01277601|81383089|FG001|Overall Study|Protocol Violation|2|||
27876955|NCT01277601|81383090|FG002|Overall Study|Protocol Violation|5|||
27876956|NCT01277601|81383091|FG003|Overall Study|Protocol Violation|0|||
27876957|NCT01277601|81383088|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
27876958|NCT01277601|81383089|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
27876959|NCT01277601|81383090|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
27876960|NCT01277601|81383091|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
27876961|NCT04846569|81383094|FG000|Overall Study|Withdrawal by Subject|3|||
27876962|NCT04846569|81383095|FG001|Overall Study|Withdrawal by Subject|1|||
27876963|NCT00063934|81383096|FG000|Overall Study|Ineligible|1|||
27876964|NCT01113892|81383100|FG000|Overall Study|Lost to Follow-up|2|||
27876965|NCT01113892|81383101|FG001|Overall Study|Lost to Follow-up|2|||
27589282|NCT00116805|80340345|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
27876966|NCT01113892|81383100|FG000|Overall Study|Withdrawal by Subject|1|||
27876967|NCT01113892|81383101|FG001|Overall Study|Withdrawal by Subject|1|||
27876968|NCT01113892|81383100|FG000|Overall Study|Death|2|||
27589283|NCT00116805|80340346|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
27589284|NCT00116805|80340345|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
27589285|NCT00116805|80340346|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
27814598|NCT02576509|81154355|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
27814599|NCT02576509|81154356|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
27814600|NCT02576509|81154355|FG000|Treatment Period|Participant request to stop treatment|8|||
27814601|NCT02576509|81154356|FG001|Treatment Period|Participant request to stop treatment|17|||
27814602|NCT02576509|81154355|FG000|Treatment Period|Participant withdrew consent|2|||
27814603|NCT02576509|81154356|FG001|Treatment Period|Participant withdrew consent|7|||
27814604|NCT02576509|81154355|FG000|Treatment Period|Lost to Follow-up|0|||
27814605|NCT02576509|81154356|FG001|Treatment Period|Lost to Follow-up|1|||
27814606|NCT02576509|81154355|FG000|Treatment Period|Maximum clinical benefit|1|||
27814607|NCT02576509|81154356|FG001|Treatment Period|Maximum clinical benefit|0|||
27814608|NCT02576509|81154355|FG000|Treatment Period|Poor/non-compliance|0|||
27589286|NCT00116805|80340345|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
27589287|NCT00116805|80340346|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
27589288|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
27589289|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
27589290|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
27814609|NCT02576509|81154356|FG001|Treatment Period|Poor/non-compliance|1|||
27814610|NCT02576509|81154355|FG000|Treatment Period|Participant no longer meets criteria|1|||
27589291|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
27589292|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
27589293|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
27876969|NCT01113892|81383101|FG001|Overall Study|Death|4|||
27700998|NCT01241552|80741291|FG002|Overall Study|Withdrawal by Subject|14|||
27876970|NCT01113892|81383100|FG000|Overall Study|Graft no longer evaluable|9|||
27876971|NCT01113892|81383101|FG001|Overall Study|Graft no longer evaluable|9|||
27876972|NCT02502149|81383102|FG000|Intermediate|Discontinued prematurely|1|||
27876973|NCT02502149|81383103|FG001|Intermediate|Discontinued prematurely|0|||
27876974|NCT02502149|81383104|FG002|Intermediate|Discontinued prematurely|0|||
27876975|NCT02502149|81383105|FG003|Intermediate|Discontinued prematurely|0|||
27876976|NCT02502149|81383106|FG004|Intermediate|Discontinued prematurely|0|||
27876977|NCT00105079|81383110|FG000|Overall Study|Adverse Event|5|||
27876978|NCT00105079|81383111|FG001|Overall Study|Adverse Event|12|||
27876979|NCT00105079|81383110|FG000|Overall Study|Death|3|||
27876980|NCT00105079|81383111|FG001|Overall Study|Death|1|||
27876981|NCT00105079|81383110|FG000|Overall Study|Lost to Follow-up|12|||
27876982|NCT00105079|81383111|FG001|Overall Study|Lost to Follow-up|12|||
27876983|NCT00105079|81383110|FG000|Overall Study|Lack of Efficacy|9|||
27876984|NCT00105079|81383111|FG001|Overall Study|Lack of Efficacy|3|||
27876985|NCT00105079|81383110|FG000|Overall Study|Refused treatment|6|||
27876986|NCT00105079|81383111|FG001|Overall Study|Refused treatment|4|||
27876987|NCT00105079|81383110|FG000|Overall Study|Violation of selection criteria at entry|0|||
27876988|NCT00105079|81383111|FG001|Overall Study|Violation of selection criteria at entry|2|||
27876989|NCT00105079|81383110|FG000|Overall Study|Protocol Violation|1|||
27876990|NCT00105079|81383111|FG001|Overall Study|Protocol Violation|0|||
27876991|NCT00105079|81383110|FG000|Overall Study|Other|3|||
27876992|NCT00105079|81383111|FG001|Overall Study|Other|1|||
27876993|NCT03885661|81383118|FG000|Overall Study|Withdrawal by Subject|0|||
27876994|NCT03885661|81383119|FG001|Overall Study|Withdrawal by Subject|1|||
27876995|NCT03885661|81383118|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
27876996|NCT03885661|81383119|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
27876997|NCT03150719|81383120|FG000|Overall Study|Adverse Event|0|||
27876998|NCT03150719|81383121|FG001|Overall Study|Adverse Event|1|||
27876999|NCT03150719|81383120|FG000|Overall Study|Death|0|||
27877000|NCT03150719|81383121|FG001|Overall Study|Death|1|||
27877001|NCT03150719|81383120|FG000|Overall Study|Other|1|||
27877002|NCT03150719|81383121|FG001|Overall Study|Other|0|||
27877003|NCT00396656|81383122|FG000|First Treatment Period|Withdrawal by Subject|0|||
27877004|NCT00396656|81383123|FG001|First Treatment Period|Withdrawal by Subject|2|||
27877005|NCT00396656|81383122|FG000|Second Treatment Period|Adverse Event|0|||
27877006|NCT00396656|81383123|FG001|Second Treatment Period|Adverse Event|1|||
27877007|NCT04152837|81383124|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
27877008|NCT04152837|81383124|FG000|Maintenance Period|Adverse Event|1|||
27877009|NCT04152837|81383124|FG000|Maintenance Period|Withdrawal by Subject|1|||
27877010|NCT04152837|81383124|FG000|Maintenance Period|Sponsor Termination of Study|2|||
27877011|NCT01787292|81383125|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
27877012|NCT01787292|81383126|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
27877013|NCT01787292|81383125|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
27877014|NCT01787292|81383126|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
27877015|NCT03660930|81383127|FG000|Overall Study|Adverse Event|0|||
27877016|NCT03660930|81383128|FG001|Overall Study|Adverse Event|0|||
27877017|NCT03660930|81383129|FG002|Overall Study|Adverse Event|0|||
27877018|NCT03660930|81383130|FG003|Overall Study|Adverse Event|2|||
27814611|NCT02576509|81154356|FG001|Treatment Period|Participant no longer meets criteria|0|||
27814612|NCT02576509|81154355|FG000|Treatment Period|Other reason|2|||
27814613|NCT02576509|81154356|FG001|Treatment Period|Other reason|7|||
27814614|NCT02576509|81154355|FG000|Follow-up Period|Death|41|||
27814615|NCT02576509|81154356|FG001|Follow-up Period|Death|35|||
27814616|NCT02576509|81154355|FG000|Follow-up Period|Participant withdrew consent|7|||
27814617|NCT02576509|81154356|FG001|Follow-up Period|Participant withdrew consent|14|||
27814618|NCT02576509|81154355|FG000|Follow-up Period|Lost to Follow-up|0|||
27814619|NCT02576509|81154356|FG001|Follow-up Period|Lost to Follow-up|1|||
27814620|NCT02576509|81154355|FG000|Follow-up Period|Other reason|1|||
27814621|NCT02576509|81154356|FG001|Follow-up Period|Other reason|2|||
27814622|NCT04604184|81154361|FG000|Overall Study|Adverse Event|5|||
27814623|NCT04604184|81154362|FG001|Overall Study|Adverse Event|5|||
27814624|NCT04604184|81154361|FG000|Overall Study|Death|2|||
27814625|NCT04604184|81154362|FG001|Overall Study|Death|1|||
27814626|NCT04604184|81154361|FG000|Overall Study|Withdrawal by Subject|1|||
27814627|NCT04604184|81154362|FG001|Overall Study|Withdrawal by Subject|3|||
27814628|NCT04604184|81154361|FG000|Overall Study|Not treated|2|||
27814629|NCT04604184|81154362|FG001|Overall Study|Not treated|2|||
27814630|NCT04604184|81154361|FG000|Overall Study|Due to sponsor decision|9|||
27814631|NCT04604184|81154362|FG001|Overall Study|Due to sponsor decision|7|||
27814632|NCT04604184|81154361|FG000|Overall Study|Physician Decision|0|||
27814633|NCT04604184|81154362|FG001|Overall Study|Physician Decision|1|||
27814634|NCT04604184|81154361|FG000|Overall Study|Transfer to healthcare|1|||
27814635|NCT04604184|81154362|FG001|Overall Study|Transfer to healthcare|0|||
27814636|NCT02564263|81154363|FG000|Overall Study|Adverse Event|31|||
27814637|NCT02564263|81154364|FG001|Overall Study|Adverse Event|29|||
27814638|NCT02564263|81154363|FG000|Overall Study|Death|270|||
27814639|NCT02564263|81154364|FG001|Overall Study|Death|262|||
27814640|NCT02564263|81154363|FG000|Overall Study|Withdrawal by Subject|4|||
27814641|NCT02564263|81154364|FG001|Overall Study|Withdrawal by Subject|19|||
27814642|NCT02564263|81154363|FG000|Overall Study|Sponsor's decision|9|||
27814643|NCT02564263|81154364|FG001|Overall Study|Sponsor's decision|4|||
27814644|NCT00718159|81154365|FG000|Overall Study|Progressive Disease|3|||
27589294|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
27814645|NCT00718159|81154366|FG001|Overall Study|Progressive Disease|3|||
27814646|NCT00718159|81154367|FG002|Overall Study|Progressive Disease|2|||
27814647|NCT00718159|81154368|FG003|Overall Study|Progressive Disease|0|||
27814648|NCT00718159|81154369|FG004|Overall Study|Progressive Disease|6|||
27814649|NCT00718159|81154370|FG005|Overall Study|Progressive Disease|0|||
27814650|NCT00718159|81154371|FG006|Overall Study|Progressive Disease|0|||
27814651|NCT00718159|81154365|FG000|Overall Study|Death due to Adverse Event|0|||
27814652|NCT00718159|81154366|FG001|Overall Study|Death due to Adverse Event|0|||
27814653|NCT00718159|81154367|FG002|Overall Study|Death due to Adverse Event|0|||
27877019|NCT03660930|81383131|FG004|Overall Study|Adverse Event|0|||
27877020|NCT03660930|81383132|FG005|Overall Study|Adverse Event|1|||
27877021|NCT03660930|81383133|FG006|Overall Study|Adverse Event|0|||
27814654|NCT00718159|81154368|FG003|Overall Study|Death due to Adverse Event|2|||
27814655|NCT00718159|81154369|FG004|Overall Study|Death due to Adverse Event|2|||
27814656|NCT00718159|81154370|FG005|Overall Study|Death due to Adverse Event|0|||
27814657|NCT00718159|81154371|FG006|Overall Study|Death due to Adverse Event|0|||
27814658|NCT00718159|81154365|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
27814659|NCT00718159|81154366|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
27814660|NCT00718159|81154367|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
27814661|NCT00718159|81154368|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
27814662|NCT00718159|81154369|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
27814663|NCT00718159|81154370|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
27814664|NCT00718159|81154371|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
27814665|NCT00718159|81154365|FG000|Overall Study|Investigator Decision|0|||
27814666|NCT00718159|81154366|FG001|Overall Study|Investigator Decision|0|||
27814667|NCT00718159|81154367|FG002|Overall Study|Investigator Decision|0|||
27814668|NCT00718159|81154368|FG003|Overall Study|Investigator Decision|0|||
27814669|NCT00718159|81154369|FG004|Overall Study|Investigator Decision|0|||
27814670|NCT00718159|81154370|FG005|Overall Study|Investigator Decision|1|||
27814671|NCT00718159|81154371|FG006|Overall Study|Investigator Decision|1|||
27814672|NCT00865709|81154374|FG000|Treatment|Adverse Event|9|||
27814673|NCT00865709|81154375|FG001|Treatment|Adverse Event|6|||
27814674|NCT00865709|81154374|FG000|Treatment|Withdrawal by Subject|10|||
27814675|NCT00865709|81154375|FG001|Treatment|Withdrawal by Subject|7|||
27814676|NCT00865709|81154374|FG000|Treatment|Physician Decision|3|||
27814677|NCT00865709|81154375|FG001|Treatment|Physician Decision|2|||
27814678|NCT00865709|81154374|FG000|Treatment|Surgery|8|||
27814679|NCT00865709|81154375|FG001|Treatment|Surgery|3|||
27814680|NCT02785913|81154376|FG000|Overall Study|Adverse Event|5|||
27814681|NCT02785913|81154376|FG000|Overall Study|Death|2|||
27814682|NCT02785913|81154376|FG000|Overall Study|Progression|18|||
27814683|NCT02785913|81154376|FG000|Overall Study|Not protocol specified|1|||
27814684|NCT04099888|81154377|FG000|Overall Study|Study terminated by sponsor|9|||
27814685|NCT04099888|81154378|FG001|Overall Study|Study terminated by sponsor|11|||
27814686|NCT04099888|81154377|FG000|Overall Study|Lost to Follow-up|1|||
27814687|NCT04099888|81154378|FG001|Overall Study|Lost to Follow-up|1|||
27814688|NCT04099888|81154377|FG000|Overall Study|Withdrawal by Subject|5|||
27814689|NCT04099888|81154378|FG001|Overall Study|Withdrawal by Subject|6|||
27814690|NCT04099888|81154377|FG000|Overall Study|Death|5|||
27814691|NCT04099888|81154378|FG001|Overall Study|Death|2|||
27814692|NCT04099888|81154377|FG000|Overall Study|Other|1|||
27814693|NCT04099888|81154378|FG001|Overall Study|Other|0|||
27814694|NCT01315249|81154385|FG000|Overall Study|Adverse Event|22|||
27814695|NCT01315249|81154386|FG001|Overall Study|Adverse Event|26|||
27814696|NCT01315249|81154385|FG000|Overall Study|Withdrawal by Subject|11|||
27814697|NCT01315249|81154386|FG001|Overall Study|Withdrawal by Subject|10|||
27814698|NCT01315249|81154385|FG000|Overall Study|Protocol Violation|8|||
27814699|NCT01315249|81154386|FG001|Overall Study|Protocol Violation|5|||
27814700|NCT01315249|81154385|FG000|Overall Study|Abnormal test results|1|||
27814701|NCT01315249|81154386|FG001|Overall Study|Abnormal test results|2|||
27814702|NCT01315249|81154385|FG000|Overall Study|Administrative problems|1|||
27814703|NCT01315249|81154386|FG001|Overall Study|Administrative problems|0|||
27814704|NCT01315249|81154385|FG000|Overall Study|inability to use device|1|||
27814705|NCT01315249|81154386|FG001|Overall Study|inability to use device|0|||
27814706|NCT01315249|81154385|FG000|Overall Study|Lack of Efficacy|0|||
27814707|NCT01315249|81154386|FG001|Overall Study|Lack of Efficacy|1|||
27814708|NCT01315249|81154385|FG000|Overall Study|Lost to Follow-up|0|||
27814709|NCT01315249|81154386|FG001|Overall Study|Lost to Follow-up|2|||
27814710|NCT01315249|81154385|FG000|Overall Study|Death|0|||
27814711|NCT01315249|81154386|FG001|Overall Study|Death|1|||
27814712|NCT02396381|81154387|FG000|Overall Study|Adverse Event|3|||
27814713|NCT02396381|81154388|FG001|Overall Study|Adverse Event|2|||
27814714|NCT02396381|81154387|FG000|Overall Study|Withdrawal by Subject|33|||
27814715|NCT02396381|81154388|FG001|Overall Study|Withdrawal by Subject|24|||
27814716|NCT02396381|81154387|FG000|Overall Study|Lost to Follow-up|49|||
27814717|NCT02396381|81154388|FG001|Overall Study|Lost to Follow-up|31|||
27814718|NCT02396381|81154387|FG000|Overall Study|Protocol Violation|1|||
27814719|NCT02396381|81154388|FG001|Overall Study|Protocol Violation|0|||
27814720|NCT02396381|81154387|FG000|Overall Study|Site terminated by sponsor|7|||
27814721|NCT02396381|81154388|FG001|Overall Study|Site terminated by sponsor|8|||
27814722|NCT02396381|81154387|FG000|Overall Study|Physician Decision|5|||
27814723|NCT02396381|81154388|FG001|Overall Study|Physician Decision|5|||
27814724|NCT02396381|81154387|FG000|Overall Study|Pregnancy|2|||
27814725|NCT02396381|81154388|FG001|Overall Study|Pregnancy|0|||
27814726|NCT02396381|81154387|FG000|Overall Study|Non-compliance with study procedures|1|||
27814727|NCT02396381|81154388|FG001|Overall Study|Non-compliance with study procedures|0|||
27814728|NCT02396381|81154387|FG000|Overall Study|Moved out of town/state|1|||
27814729|NCT02396381|81154388|FG001|Overall Study|Moved out of town/state|3|||
27814730|NCT02396381|81154387|FG000|Overall Study|Could not complete visit|1|||
27814731|NCT02396381|81154388|FG001|Overall Study|Could not complete visit|0|||
27877022|NCT03660930|81383134|FG007|Overall Study|Adverse Event|0|||
27877023|NCT03660930|81383127|FG000|Overall Study|Withdrawal by Subject|0|||
27877024|NCT03660930|81383128|FG001|Overall Study|Withdrawal by Subject|0|||
27877025|NCT03660930|81383129|FG002|Overall Study|Withdrawal by Subject|0|||
27877026|NCT03660930|81383130|FG003|Overall Study|Withdrawal by Subject|0|||
27877027|NCT03660930|81383131|FG004|Overall Study|Withdrawal by Subject|0|||
27877028|NCT03660930|81383132|FG005|Overall Study|Withdrawal by Subject|1|||
27877029|NCT03660930|81383133|FG006|Overall Study|Withdrawal by Subject|0|||
27877030|NCT03660930|81383134|FG007|Overall Study|Withdrawal by Subject|0|||
27877031|NCT03660930|81383127|FG000|Overall Study|On Treatment|0|||
27877032|NCT03660930|81383128|FG001|Overall Study|On Treatment|0|||
27877033|NCT03660930|81383129|FG002|Overall Study|On Treatment|0|||
27877034|NCT03660930|81383130|FG003|Overall Study|On Treatment|0|||
27877035|NCT03660930|81383131|FG004|Overall Study|On Treatment|0|||
27877036|NCT03660930|81383132|FG005|Overall Study|On Treatment|0|||
27877037|NCT03660930|81383133|FG006|Overall Study|On Treatment|0|||
27877038|NCT03660930|81383134|FG007|Overall Study|On Treatment|1|||
27877039|NCT03660930|81383127|FG000|Overall Study|In Follow-up|0|||
27877040|NCT03660930|81383128|FG001|Overall Study|In Follow-up|0|||
27877041|NCT03660930|81383129|FG002|Overall Study|In Follow-up|0|||
27877042|NCT03660930|81383130|FG003|Overall Study|In Follow-up|0|||
27877043|NCT03660930|81383131|FG004|Overall Study|In Follow-up|0|||
27877044|NCT03660930|81383132|FG005|Overall Study|In Follow-up|0|||
27814732|NCT02396381|81154387|FG000|Overall Study|Possible conflict of interest|1|||
27814733|NCT02396381|81154388|FG001|Overall Study|Possible conflict of interest|0|||
27814734|NCT02396381|81154387|FG000|Overall Study|Randomization/Screening Error|3|||
27877045|NCT03660930|81383133|FG006|Overall Study|In Follow-up|1|||
27877046|NCT03660930|81383134|FG007|Overall Study|In Follow-up|2|||
27877047|NCT03743051|81383137|FG000|Overall Study|Adverse Event|5|||
27877048|NCT03743051|81383138|FG001|Overall Study|Adverse Event|9|||
27877049|NCT03743051|81383137|FG000|Overall Study|Death|27|||
27877050|NCT03743051|81383138|FG001|Overall Study|Death|26|||
27877051|NCT03743051|81383137|FG000|Overall Study|Lost to Follow-up|4|||
27877052|NCT03743051|81383138|FG001|Overall Study|Lost to Follow-up|8|||
27877053|NCT03743051|81383137|FG000|Overall Study|Withdrawal by Subject|32|||
27877054|NCT03743051|81383138|FG001|Overall Study|Withdrawal by Subject|19|||
27877055|NCT03743051|81383137|FG000|Overall Study|Physician Decision|10|||
27877056|NCT03743051|81383138|FG001|Overall Study|Physician Decision|15|||
27877057|NCT03743051|81383137|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
27877058|NCT03743051|81383138|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
27877059|NCT04390113|81383139|FG000|Overall Study|Not Treated|0|||
27877060|NCT04390113|81383140|FG001|Overall Study|Not Treated|1|||
27877061|NCT04390113|81383139|FG000|Overall Study|Adverse Event|1|||
27877062|NCT04390113|81383140|FG001|Overall Study|Adverse Event|0|||
27877063|NCT04390113|81383139|FG000|Overall Study|Death|2|||
27877064|NCT04390113|81383140|FG001|Overall Study|Death|1|||
27877065|NCT04390113|81383139|FG000|Overall Study|Physician Decision|1|||
27877066|NCT04390113|81383140|FG001|Overall Study|Physician Decision|3|||
27877067|NCT04390113|81383139|FG000|Overall Study|Study Terminated by Sponsor|5|||
27877068|NCT04390113|81383140|FG001|Overall Study|Study Terminated by Sponsor|3|||
27877069|NCT04390113|81383139|FG000|Overall Study|Withdrawal by Subject|10|||
27877070|NCT04390113|81383140|FG001|Overall Study|Withdrawal by Subject|5|||
27877071|NCT04390113|81383139|FG000|Overall Study|Other|1|||
27877072|NCT04390113|81383140|FG001|Overall Study|Other|0|||
27877073|NCT04390113|81383139|FG000|Overall Study|Missing|0|||
27877074|NCT04390113|81383140|FG001|Overall Study|Missing|1|||
27877075|NCT03620708|81383141|FG000|Overall Study|Lost to Follow-up|1|||
27877076|NCT03620708|81383142|FG001|Overall Study|Lost to Follow-up|1|||
27877077|NCT03620708|81383143|FG002|Overall Study|Lost to Follow-up|2|||
27877078|NCT03620708|81383141|FG000|Overall Study|Withdrawal by Subject|0|||
27877079|NCT03620708|81383142|FG001|Overall Study|Withdrawal by Subject|0|||
27814735|NCT02396381|81154388|FG001|Overall Study|Randomization/Screening Error|1|||
27814736|NCT02343120|81154389|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
27814737|NCT02343120|81154390|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
27814738|NCT02343120|81154391|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
27814739|NCT02343120|81154392|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
27814740|NCT02343120|81154393|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
27814741|NCT02343120|81154389|FG000|Part 1: Dose Escalation|Death|1|||
27814742|NCT02343120|81154390|FG001|Part 1: Dose Escalation|Death|2|||
27814743|NCT02343120|81154391|FG002|Part 1: Dose Escalation|Death|2|||
27814744|NCT02343120|81154392|FG003|Part 1: Dose Escalation|Death|2|||
27814745|NCT02343120|81154393|FG004|Part 1: Dose Escalation|Death|1|||
27814746|NCT02343120|81154389|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
27814747|NCT02343120|81154390|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
27814748|NCT02343120|81154391|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
27814749|NCT02343120|81154392|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
27814750|NCT02343120|81154393|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
27814751|NCT02343120|81154389|FG000|Part 2: Expansion|Sponsor decision|0|||
27814752|NCT02343120|81154390|FG001|Part 2: Expansion|Sponsor decision|0|||
27814753|NCT02343120|81154391|FG002|Part 2: Expansion|Sponsor decision|0|||
27814754|NCT02343120|81154392|FG003|Part 2: Expansion|Sponsor decision|165|||
27814755|NCT02343120|81154393|FG004|Part 2: Expansion|Sponsor decision|67|||
27814756|NCT02343120|81154389|FG000|Part 2: Expansion|Death|0|||
27814757|NCT02343120|81154390|FG001|Part 2: Expansion|Death|0|||
27814758|NCT02343120|81154391|FG002|Part 2: Expansion|Death|0|||
27814759|NCT02343120|81154392|FG003|Part 2: Expansion|Death|74|||
27814760|NCT02343120|81154393|FG004|Part 2: Expansion|Death|17|||
27814761|NCT02343120|81154389|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
27814762|NCT02343120|81154390|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
27814763|NCT02343120|81154391|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
27814764|NCT02343120|81154392|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
27814765|NCT02343120|81154393|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
27814766|NCT02343120|81154389|FG000|Part 2: Expansion|Lost to Follow-up|0|||
27814767|NCT02343120|81154390|FG001|Part 2: Expansion|Lost to Follow-up|0|||
27814768|NCT02343120|81154391|FG002|Part 2: Expansion|Lost to Follow-up|0|||
27814769|NCT02343120|81154392|FG003|Part 2: Expansion|Lost to Follow-up|5|||
27877080|NCT03620708|81383143|FG002|Overall Study|Withdrawal by Subject|1|||
27877081|NCT01234350|81383145|FG000|Overall Study|Adverse Event|277|||
27877082|NCT01234350|81383146|FG001|Overall Study|Adverse Event|92|||
27877083|NCT01234350|81383145|FG000|Overall Study|Withdrawal by Subject|61|||
27877084|NCT01234350|81383146|FG001|Overall Study|Withdrawal by Subject|36|||
27877085|NCT01234350|81383145|FG000|Overall Study|Lost to Follow-up|115|||
27877086|NCT01234350|81383146|FG001|Overall Study|Lost to Follow-up|47|||
27877087|NCT01234350|81383145|FG000|Overall Study|Covers a diverse set of reasons|234|||
27877088|NCT01234350|81383146|FG001|Overall Study|Covers a diverse set of reasons|92|||
27877089|NCT02512302|81383153|FG000|Period 1|Adverse Event|0|||
27877090|NCT02512302|81383154|FG001|Period 1|Adverse Event|1|||
27877091|NCT02512302|81383155|FG002|Period 1|Adverse Event|0|||
27877092|NCT02512302|81383156|FG003|Period 1|Adverse Event|0|||
27877093|NCT02512302|81383157|FG004|Period 1|Adverse Event|0|||
27877094|NCT02512302|81383158|FG005|Period 1|Adverse Event|0|||
27877095|NCT02512302|81383159|FG006|Period 1|Adverse Event|0|||
27877096|NCT02512302|81383160|FG007|Period 1|Adverse Event|0|||
27814770|NCT02343120|81154393|FG004|Part 2: Expansion|Lost to Follow-up|2|||
27814771|NCT02343120|81154389|FG000|Part 2: Expansion|Other|0|||
27814772|NCT02343120|81154390|FG001|Part 2: Expansion|Other|0|||
27814773|NCT02343120|81154391|FG002|Part 2: Expansion|Other|0|||
27814774|NCT02343120|81154392|FG003|Part 2: Expansion|Other|1|||
27877097|NCT02512302|81383161|FG008|Period 1|Adverse Event|0|||
27877098|NCT02512302|81383162|FG009|Period 1|Adverse Event|0|||
27877099|NCT02512302|81383153|FG000|Period 2|Adverse Event|0|||
27877100|NCT02512302|81383154|FG001|Period 2|Adverse Event|0|||
27877101|NCT02512302|81383155|FG002|Period 2|Adverse Event|0|||
27877102|NCT02512302|81383156|FG003|Period 2|Adverse Event|0|||
27877103|NCT02512302|81383157|FG004|Period 2|Adverse Event|0|||
27877104|NCT02512302|81383158|FG005|Period 2|Adverse Event|0|||
27877105|NCT02512302|81383159|FG006|Period 2|Adverse Event|0|||
27877106|NCT02512302|81383160|FG007|Period 2|Adverse Event|0|||
27877107|NCT02512302|81383161|FG008|Period 2|Adverse Event|0|||
27877108|NCT02512302|81383162|FG009|Period 2|Adverse Event|1|||
27877109|NCT02512302|81383153|FG000|Period 3|Lost to Follow-up|0|||
27877110|NCT02512302|81383154|FG001|Period 3|Lost to Follow-up|0|||
27877111|NCT02512302|81383155|FG002|Period 3|Lost to Follow-up|1|||
27877112|NCT02512302|81383156|FG003|Period 3|Lost to Follow-up|0|||
27877113|NCT02512302|81383157|FG004|Period 3|Lost to Follow-up|0|||
27877114|NCT02512302|81383158|FG005|Period 3|Lost to Follow-up|0|||
27877115|NCT02512302|81383159|FG006|Period 3|Lost to Follow-up|0|||
27877116|NCT02512302|81383160|FG007|Period 3|Lost to Follow-up|0|||
27877117|NCT02512302|81383161|FG008|Period 3|Lost to Follow-up|0|||
27877118|NCT02512302|81383162|FG009|Period 3|Lost to Follow-up|0|||
27877119|NCT02512302|81383153|FG000|Period 4|Adverse Event|0|||
27877120|NCT02512302|81383154|FG001|Period 4|Adverse Event|0|||
27877121|NCT02512302|81383155|FG002|Period 4|Adverse Event|0|||
27877122|NCT02512302|81383156|FG003|Period 4|Adverse Event|0|||
27877123|NCT02512302|81383157|FG004|Period 4|Adverse Event|0|||
27877124|NCT02512302|81383158|FG005|Period 4|Adverse Event|0|||
27877125|NCT02512302|81383159|FG006|Period 4|Adverse Event|1|||
27877126|NCT02512302|81383160|FG007|Period 4|Adverse Event|0|||
27877127|NCT02512302|81383161|FG008|Period 4|Adverse Event|0|||
27877128|NCT02512302|81383162|FG009|Period 4|Adverse Event|0|||
27877129|NCT00014495|81383163|FG000|Overall Study|Death|0|||
27877130|NCT00014495|81383164|FG001|Overall Study|Death|0|||
27877131|NCT00014495|81383165|FG002|Overall Study|Death|1|||
27877132|NCT00014495|81383166|FG003|Overall Study|Death|0|||
27877133|NCT00014495|81383163|FG000|Overall Study|Clinical deterioration|0|||
27877134|NCT00014495|81383164|FG001|Overall Study|Clinical deterioration|0|||
27877135|NCT00014495|81383165|FG002|Overall Study|Clinical deterioration|0|||
27877136|NCT00014495|81383166|FG003|Overall Study|Clinical deterioration|1|||
27877137|NCT02996968|81383171|FG000|Overall Study|Withdrawal by Subject|1|||
27877138|NCT02996968|81383172|FG001|Overall Study|Withdrawal by Subject|0|||
27877139|NCT04030299|81383180|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
27877140|NCT04030299|81383180|FG000|Overall Study|Withdrawal by Subject|3|||
27877141|NCT01408303|81383183|FG000|Overall Study|Adverse Event|3|||
27877142|NCT01408303|81383184|FG001|Overall Study|Adverse Event|7|||
27877143|NCT01408303|81383185|FG002|Overall Study|Adverse Event|2|||
27877144|NCT01408303|81383183|FG000|Overall Study|Lost to Follow-up|0|||
27877145|NCT01408303|81383184|FG001|Overall Study|Lost to Follow-up|1|||
27877146|NCT01408303|81383185|FG002|Overall Study|Lost to Follow-up|2|||
27877147|NCT01408303|81383183|FG000|Overall Study|Withdrawal by Subject|2|||
27877148|NCT01408303|81383184|FG001|Overall Study|Withdrawal by Subject|3|||
27877149|NCT01408303|81383185|FG002|Overall Study|Withdrawal by Subject|1|||
27877150|NCT01408303|81383183|FG000|Overall Study|Protocol Violation|0|||
27877151|NCT01408303|81383184|FG001|Overall Study|Protocol Violation|1|||
27877152|NCT01408303|81383185|FG002|Overall Study|Protocol Violation|0|||
27877153|NCT01408303|81383183|FG000|Overall Study|Noncompliance|1|||
27877154|NCT01408303|81383184|FG001|Overall Study|Noncompliance|0|||
27877155|NCT01408303|81383185|FG002|Overall Study|Noncompliance|1|||
27877156|NCT02418182|81383188|FG000|Overall Study|Unable to re-consent|18|||
27877157|NCT02418182|81383189|FG001|Overall Study|Unable to re-consent|15|||
27877158|NCT02418182|81383188|FG000|Overall Study|Lost to Follow-up|0|||
27877159|NCT02418182|81383189|FG001|Overall Study|Lost to Follow-up|2|||
27814775|NCT02343120|81154393|FG004|Part 2: Expansion|Other|5|||
27814776|NCT02343120|81154389|FG000|Part 2: Expansion|Adverse Event|0|||
27814777|NCT02343120|81154390|FG001|Part 2: Expansion|Adverse Event|0|||
27814778|NCT02343120|81154391|FG002|Part 2: Expansion|Adverse Event|0|||
27814779|NCT02343120|81154392|FG003|Part 2: Expansion|Adverse Event|1|||
27814780|NCT02343120|81154393|FG004|Part 2: Expansion|Adverse Event|1|||
27814781|NCT02001558|81154394|FG000|Overall Study|Lost to Follow-up|8|||
27814782|NCT02001558|81154395|FG001|Overall Study|Lost to Follow-up|14|||
27814783|NCT01265784|81154396|FG000|Overall Study|Lost to Follow-up|5|||
27814784|NCT01265784|81154397|FG001|Overall Study|Lost to Follow-up|3|||
27814785|NCT01265784|81154398|FG002|Overall Study|Lost to Follow-up|2|||
27814786|NCT01265784|81154396|FG000|Overall Study|Withdrawal by Subject|0|||
27814787|NCT01265784|81154397|FG001|Overall Study|Withdrawal by Subject|5|||
27814788|NCT01265784|81154398|FG002|Overall Study|Withdrawal by Subject|0|||
27814789|NCT01265784|81154396|FG000|Overall Study|Physician Decision|1|||
27877160|NCT02288325|81383192|FG000|Run-in Period|Adverse Event|48|||
27877161|NCT02288325|81383193|FG001|Run-in Period|Adverse Event|0|||
27877162|NCT02288325|81383194|FG002|Run-in Period|Adverse Event|0|||
27877163|NCT02288325|81383192|FG000|Run-in Period|Lack of Efficacy|16|||
27877164|NCT02288325|81383193|FG001|Run-in Period|Lack of Efficacy|0|||
27877165|NCT02288325|81383194|FG002|Run-in Period|Lack of Efficacy|0|||
27877166|NCT02288325|81383192|FG000|Run-in Period|Withdrawal of Consent|28|||
27877167|NCT02288325|81383193|FG001|Run-in Period|Withdrawal of Consent|0|||
27877168|NCT02288325|81383194|FG002|Run-in Period|Withdrawal of Consent|0|||
27877169|NCT02288325|81383192|FG000|Run-in Period|Lost to Follow-up|25|||
27877170|NCT02288325|81383193|FG001|Run-in Period|Lost to Follow-up|0|||
27877171|NCT02288325|81383194|FG002|Run-in Period|Lost to Follow-up|0|||
27877172|NCT02288325|81383192|FG000|Run-in Period|Protocol Violation|17|||
27814790|NCT01265784|81154397|FG001|Overall Study|Physician Decision|0|||
27814791|NCT01265784|81154398|FG002|Overall Study|Physician Decision|1|||
27814792|NCT01265784|81154396|FG000|Overall Study|Adverse Event|1|||
27814793|NCT01265784|81154397|FG001|Overall Study|Adverse Event|0|||
27814794|NCT01265784|81154398|FG002|Overall Study|Adverse Event|0|||
27814795|NCT01265784|81154396|FG000|Overall Study|Death|3|||
27814796|NCT01265784|81154397|FG001|Overall Study|Death|0|||
27814797|NCT01265784|81154398|FG002|Overall Study|Death|0|||
27814798|NCT01265784|81154396|FG000|Overall Study|Protocol Violation|2|||
27814799|NCT01265784|81154397|FG001|Overall Study|Protocol Violation|0|||
27814800|NCT01265784|81154398|FG002|Overall Study|Protocol Violation|0|||
27814801|NCT01265784|81154396|FG000|Overall Study|Incorrectly Randomized|0|||
27814802|NCT01265784|81154397|FG001|Overall Study|Incorrectly Randomized|0|||
27814803|NCT01265784|81154398|FG002|Overall Study|Incorrectly Randomized|1|||
27814804|NCT01521559|81154399|FG000|Overall Study|Adverse Event|0|||
27814805|NCT01521559|81154400|FG001|Overall Study|Adverse Event|4|||
27814806|NCT01521559|81154399|FG000|Overall Study|Death|1|||
27814807|NCT01521559|81154400|FG001|Overall Study|Death|0|||
27814808|NCT01521559|81154399|FG000|Overall Study|Withdrawal by Subject|9|||
27814809|NCT01521559|81154400|FG001|Overall Study|Withdrawal by Subject|11|||
27814810|NCT01521559|81154399|FG000|Overall Study|Lost to Follow-up|3|||
27877173|NCT02288325|81383193|FG001|Run-in Period|Protocol Violation|0|||
27877174|NCT02288325|81383194|FG002|Run-in Period|Protocol Violation|0|||
27814811|NCT01521559|81154400|FG001|Overall Study|Lost to Follow-up|1|||
27814812|NCT01521559|81154399|FG000|Overall Study|Protocol Violation|1|||
27877175|NCT02288325|81383192|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
27877176|NCT02288325|81383193|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
27814813|NCT01521559|81154400|FG001|Overall Study|Protocol Violation|0|||
27814814|NCT01521559|81154399|FG000|Overall Study|Other|1|||
27814815|NCT01521559|81154400|FG001|Overall Study|Other|2|||
27814816|NCT01267266|81154401|FG000|Enrollment Phase|Withdrawal by Subject|2|||
27814817|NCT01267266|81154402|FG001|Enrollment Phase|Withdrawal by Subject|0|||
27877177|NCT02288325|81383194|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
27814818|NCT01267266|81154401|FG000|Lead-in Phase|Lack of Efficacy|20|||
27814819|NCT01267266|81154402|FG001|Lead-in Phase|Lack of Efficacy|0|||
27814820|NCT01267266|81154401|FG000|Lead-in Phase|Adverse Event|2|||
27814821|NCT01267266|81154402|FG001|Lead-in Phase|Adverse Event|0|||
27814822|NCT01267266|81154401|FG000|Lead-in Phase|Withdrawal by Subject|1|||
27814823|NCT01267266|81154402|FG001|Lead-in Phase|Withdrawal by Subject|0|||
27814824|NCT01400425|81154408|FG000|Overall Study|Withdrawal by Subject|10|||
27814825|NCT01029353|81154409|FG000|Overall Study|Lost to Follow-up|4|||
27814826|NCT01029353|81154410|FG001|Overall Study|Lost to Follow-up|5|||
27814827|NCT01029353|81154411|FG002|Overall Study|Lost to Follow-up|5|||
27814828|NCT01029353|81154412|FG003|Overall Study|Lost to Follow-up|4|||
27814829|NCT01029353|81154409|FG000|Overall Study|Consent Withdrawn|2|||
27814830|NCT01029353|81154410|FG001|Overall Study|Consent Withdrawn|0|||
27814831|NCT01029353|81154411|FG002|Overall Study|Consent Withdrawn|0|||
27814832|NCT01029353|81154412|FG003|Overall Study|Consent Withdrawn|0|||
27877178|NCT02288325|81383192|FG000|Run-in Period|Reason not Specified|8|||
27877179|NCT02288325|81383193|FG001|Run-in Period|Reason not Specified|0|||
27877180|NCT02288325|81383194|FG002|Run-in Period|Reason not Specified|0|||
27877181|NCT02288325|81383192|FG000|Stabilization Period|Adverse Event|13|||
27877182|NCT02288325|81383193|FG001|Stabilization Period|Adverse Event|0|||
27877183|NCT02288325|81383194|FG002|Stabilization Period|Adverse Event|0|||
27877184|NCT02288325|81383192|FG000|Stabilization Period|Lack of Efficacy|22|||
27877185|NCT02288325|81383193|FG001|Stabilization Period|Lack of Efficacy|0|||
27877186|NCT02288325|81383194|FG002|Stabilization Period|Lack of Efficacy|0|||
27877187|NCT02288325|81383192|FG000|Stabilization Period|Withdrawal of Consent|23|||
27877188|NCT02288325|81383193|FG001|Stabilization Period|Withdrawal of Consent|0|||
27877189|NCT02288325|81383194|FG002|Stabilization Period|Withdrawal of Consent|0|||
27877190|NCT02288325|81383192|FG000|Stabilization Period|Lost to Follow-up|12|||
27877191|NCT02288325|81383193|FG001|Stabilization Period|Lost to Follow-up|0|||
27877192|NCT02288325|81383194|FG002|Stabilization Period|Lost to Follow-up|0|||
27877193|NCT02288325|81383192|FG000|Stabilization Period|Protocol Violation|8|||
27877194|NCT02288325|81383193|FG001|Stabilization Period|Protocol Violation|0|||
27877195|NCT02288325|81383194|FG002|Stabilization Period|Protocol Violation|0|||
27877196|NCT02288325|81383192|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
27877197|NCT02288325|81383193|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
27877198|NCT02288325|81383194|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
27877199|NCT02288325|81383192|FG000|Stabilization Period|Reason not Specified|15|||
27877200|NCT02288325|81383193|FG001|Stabilization Period|Reason not Specified|0|||
27877201|NCT02288325|81383194|FG002|Stabilization Period|Reason not Specified|0|||
27877202|NCT02288325|81383192|FG000|Double-blind Treatment Period|Adverse Event|0|||
27700999|NCT01241552|80741292|FG003|Overall Study|Withdrawal by Subject|15|||
27814833|NCT01029353|81154409|FG000|Overall Study|Primary Outcome Indeterminate|1|||
27877203|NCT02288325|81383193|FG001|Double-blind Treatment Period|Adverse Event|2|||
27877204|NCT02288325|81383194|FG002|Double-blind Treatment Period|Adverse Event|5|||
27877205|NCT02288325|81383192|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
27814834|NCT01029353|81154410|FG001|Overall Study|Primary Outcome Indeterminate|3|||
27814835|NCT01029353|81154411|FG002|Overall Study|Primary Outcome Indeterminate|2|||
27814836|NCT01029353|81154412|FG003|Overall Study|Primary Outcome Indeterminate|0|||
27814837|NCT00424489|81154422|FG000|Overall Study|Death|3|||
27814838|NCT00198029|81154423|FG000|Overall Study|Withdrawal by Subject|4|||
27814839|NCT02040766|81154426|FG000|Overall Study|Adverse Event|1|||
27814840|NCT02040766|81154427|FG001|Overall Study|Adverse Event|1|||
27814841|NCT02040766|81154428|FG002|Overall Study|Adverse Event|1|||
27814842|NCT02040766|81154429|FG003|Overall Study|Adverse Event|0|||
27814843|NCT02040766|81154430|FG004|Overall Study|Adverse Event|2|||
27589295|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
27589296|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
27701000|NCT01241552|80741289|FG000|Overall Study|Physician Decision|2|||
27814844|NCT02040766|81154426|FG000|Overall Study|Withdrawal by Subject|4|||
27814845|NCT02040766|81154427|FG001|Overall Study|Withdrawal by Subject|3|||
27688432|NCT02101385|80694245|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
27688433|NCT02101385|80694246|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
27688434|NCT02101385|80694245|FG000|Follow up|Withdrawal by Subject|2|||
27688435|NCT02101385|80694246|FG001|Follow up|Withdrawal by Subject|2|||
27688436|NCT02101385|80694245|FG000|Follow up|PI requested closure of site|0|||
27688437|NCT02101385|80694246|FG001|Follow up|PI requested closure of site|5|||
27688438|NCT00734097|80694247|FG000|Screening|Protocol Violation|12|||
27688439|NCT00734097|80694247|FG000|Screening|Withdrawal by Subject|5|||
27688440|NCT00734097|80694247|FG000|Screening|Lost to Follow-up|2|||
27688441|NCT00734097|80694247|FG000|Screening|Unconfirmed pregnancy|1|||
27688442|NCT00734097|80694247|FG000|Open Label|Lost to Follow-up|7|||
27688443|NCT00734097|80694247|FG000|Open Label|Withdrawal by Subject|5|||
27688444|NCT00734097|80694247|FG000|Open Label|Protocol Violation|4|||
27688445|NCT00948766|80694248|FG000|Core Study|Adverse Event|73|||
27688446|NCT00948766|80694249|FG001|Core Study|Adverse Event|51|||
27688447|NCT00948766|80694248|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
27688448|NCT00948766|80694249|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
27688449|NCT00948766|80694248|FG000|Core Study|Patient Withdrew Consent|27|||
27688450|NCT00948766|80694249|FG001|Core Study|Patient Withdrew Consent|46|||
27688451|NCT00948766|80694248|FG000|Core Study|Lost to Follow-up|3|||
27688452|NCT00948766|80694249|FG001|Core Study|Lost to Follow-up|2|||
27688453|NCT00948766|80694248|FG000|Core Study|Administrative Problems|2|||
27701001|NCT01241552|80741290|FG001|Overall Study|Physician Decision|4|||
27814846|NCT02040766|81154428|FG002|Overall Study|Withdrawal by Subject|2|||
27814847|NCT02040766|81154429|FG003|Overall Study|Withdrawal by Subject|3|||
27814848|NCT02040766|81154430|FG004|Overall Study|Withdrawal by Subject|2|||
27814849|NCT02040766|81154426|FG000|Overall Study|Non-compliance|0|||
27814850|NCT02040766|81154427|FG001|Overall Study|Non-compliance|1|||
27814851|NCT02040766|81154428|FG002|Overall Study|Non-compliance|0|||
27814852|NCT02040766|81154429|FG003|Overall Study|Non-compliance|0|||
27814853|NCT02040766|81154430|FG004|Overall Study|Non-compliance|0|||
27814854|NCT02040766|81154426|FG000|Overall Study|Protocol Violation|2|||
27814855|NCT02040766|81154427|FG001|Overall Study|Protocol Violation|1|||
27814856|NCT02040766|81154428|FG002|Overall Study|Protocol Violation|2|||
27814857|NCT02040766|81154429|FG003|Overall Study|Protocol Violation|3|||
27814858|NCT02040766|81154430|FG004|Overall Study|Protocol Violation|0|||
27814859|NCT02040766|81154426|FG000|Overall Study|Lost to Follow-up|4|||
27814860|NCT02040766|81154427|FG001|Overall Study|Lost to Follow-up|1|||
27814861|NCT02040766|81154428|FG002|Overall Study|Lost to Follow-up|3|||
27814862|NCT02040766|81154429|FG003|Overall Study|Lost to Follow-up|1|||
27814863|NCT02040766|81154430|FG004|Overall Study|Lost to Follow-up|4|||
27814864|NCT02040766|81154426|FG000|Overall Study|Not reported|1|||
27814865|NCT02040766|81154427|FG001|Overall Study|Not reported|0|||
27814866|NCT02040766|81154428|FG002|Overall Study|Not reported|0|||
27814867|NCT02040766|81154429|FG003|Overall Study|Not reported|0|||
27814868|NCT02040766|81154430|FG004|Overall Study|Not reported|0|||
27814869|NCT02040766|81154426|FG000|Overall Study|Lack of Efficacy|6|||
27877206|NCT02288325|81383193|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
27877207|NCT02288325|81383194|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
27877208|NCT02288325|81383192|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27814870|NCT02040766|81154427|FG001|Overall Study|Lack of Efficacy|3|||
27814871|NCT02040766|81154428|FG002|Overall Study|Lack of Efficacy|4|||
27814872|NCT02040766|81154429|FG003|Overall Study|Lack of Efficacy|6|||
27814873|NCT02040766|81154430|FG004|Overall Study|Lack of Efficacy|5|||
27814874|NCT00193609|81154439|FG000|Overall Study|Lack of Efficacy|2|||
27814875|NCT00193609|81154439|FG000|Overall Study|Adverse Event|2|||
27877209|NCT02288325|81383193|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
27877210|NCT02288325|81383194|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
27877211|NCT02288325|81383192|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27877212|NCT02288325|81383193|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27877213|NCT02288325|81383194|FG002|Double-blind Treatment Period|Protocol Violation|2|||
27877214|NCT02288325|81383192|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
27877215|NCT02288325|81383193|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
27877216|NCT02288325|81383194|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
27877217|NCT02288325|81383192|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
27877218|NCT02288325|81383193|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
27877219|NCT02288325|81383194|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
27877220|NCT00315458|81383195|FG000|Overall Study|Administrative|0|||
27877221|NCT00315458|81383196|FG001|Overall Study|Administrative|3|||
27877222|NCT00315458|81383197|FG002|Overall Study|Administrative|8|||
27877223|NCT00315458|81383198|FG003|Overall Study|Administrative|21|||
27877224|NCT00315458|81383195|FG000|Overall Study|Adverse Event|2|||
27877225|NCT00315458|81383196|FG001|Overall Study|Adverse Event|4|||
27877226|NCT00315458|81383197|FG002|Overall Study|Adverse Event|23|||
27877227|NCT00315458|81383198|FG003|Overall Study|Adverse Event|3|||
27877228|NCT00315458|81383195|FG000|Overall Study|Lost to Follow-up|1|||
27877229|NCT00315458|81383196|FG001|Overall Study|Lost to Follow-up|2|||
27877230|NCT00315458|81383197|FG002|Overall Study|Lost to Follow-up|0|||
27877231|NCT00315458|81383198|FG003|Overall Study|Lost to Follow-up|2|||
27877232|NCT00315458|81383195|FG000|Overall Study|Withdrawal by Subject|0|||
27877233|NCT00315458|81383196|FG001|Overall Study|Withdrawal by Subject|3|||
27877234|NCT00315458|81383197|FG002|Overall Study|Withdrawal by Subject|0|||
27877235|NCT00315458|81383198|FG003|Overall Study|Withdrawal by Subject|2|||
27589297|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
27814876|NCT01893138|81154440|FG000|Double-Blind Period|Withdrawal by Subject|1|||
27814877|NCT01893138|81154441|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27814878|NCT01893138|81154440|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
27814879|NCT01893138|81154441|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
27877236|NCT00315458|81383195|FG000|Overall Study|Lack of Efficacy|0|||
27877237|NCT00315458|81383196|FG001|Overall Study|Lack of Efficacy|0|||
27877238|NCT00315458|81383197|FG002|Overall Study|Lack of Efficacy|20|||
27877239|NCT00315458|81383198|FG003|Overall Study|Lack of Efficacy|1|||
27814880|NCT01893138|81154440|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
27814881|NCT01893138|81154441|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
27814882|NCT01893138|81154440|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
27877240|NCT00315458|81383195|FG000|Overall Study|Did not qualify|0|||
27877241|NCT00315458|81383196|FG001|Overall Study|Did not qualify|0|||
27589298|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
27589299|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
27589300|NCT00116805|80340345|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
27877242|NCT00315458|81383197|FG002|Overall Study|Did not qualify|1|||
27877243|NCT00315458|81383198|FG003|Overall Study|Did not qualify|0|||
27877244|NCT00828568|81383199|FG000|Randomized|Withdrawal by Subject|1|||
27877245|NCT00828568|81383200|FG001|Randomized|Withdrawal by Subject|0|||
27877246|NCT00828568|81383201|FG002|Randomized|Withdrawal by Subject|2|||
27877247|NCT00828568|81383199|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
27877248|NCT00828568|81383200|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
27877249|NCT00828568|81383201|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
27877250|NCT00828568|81383199|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
27877251|NCT00828568|81383200|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
27877252|NCT00828568|81383201|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
27877253|NCT00828568|81383199|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
27877254|NCT00828568|81383200|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
27877255|NCT00828568|81383201|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
27877256|NCT00828568|81383199|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
27877257|NCT00828568|81383200|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
27877258|NCT00828568|81383201|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
27877259|NCT00733421|81383205|FG000|Overall Study|Withdrawal by Subject|1|||
27877260|NCT00733421|81383206|FG001|Overall Study|Withdrawal by Subject|1|||
27877261|NCT03751098|81383207|FG000|Overall Study|Withdrawal by Subject|0|||
27877262|NCT03751098|81383208|FG001|Overall Study|Withdrawal by Subject|1|||
27877263|NCT03335475|81383219|FG000|Overall Study|Did not wear accelerometer|4|||
27877264|NCT03335475|81383220|FG001|Overall Study|Did not wear accelerometer|0|||
27877265|NCT03335475|81383219|FG000|Overall Study|Withdrawal by Subject|0|||
27877266|NCT03335475|81383220|FG001|Overall Study|Withdrawal by Subject|1|||
27877267|NCT00793871|81383224|FG000|Overall Study|Death|50|||
27877268|NCT00793871|81383224|FG000|Overall Study|Lost to Follow-up|3|||
27877269|NCT00793871|81383224|FG000|Overall Study|Study terminated by the Sponsor|7|||
27877270|NCT00529087|81383225|FG000|Overall Study|Adverse Event|10|||
27877271|NCT00529087|81383226|FG001|Overall Study|Adverse Event|13|||
27877272|NCT00529087|81383227|FG002|Overall Study|Adverse Event|4|||
27589301|NCT00116805|80340346|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
27688454|NCT00948766|80694249|FG001|Core Study|Administrative Problems|2|||
27814883|NCT01893138|81154441|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
27814884|NCT01893138|81154440|FG000|Open Label - Unblinded Period|Adverse Event|1|||
27814885|NCT01893138|81154441|FG001|Open Label - Unblinded Period|Adverse Event|0|||
27814886|NCT00502775|81154445|FG000|Overall Study|Adverse Event|1|||
27814887|NCT00502775|81154446|FG001|Overall Study|Adverse Event|2|||
27814888|NCT00502775|81154447|FG002|Overall Study|Adverse Event|1|||
27814889|NCT00502775|81154445|FG000|Overall Study|Protocol Violation|1|||
27814890|NCT00502775|81154446|FG001|Overall Study|Protocol Violation|5|||
27814891|NCT00502775|81154447|FG002|Overall Study|Protocol Violation|2|||
27814892|NCT00502775|81154445|FG000|Overall Study|Withdrawal by Subject|1|||
27814893|NCT00502775|81154446|FG001|Overall Study|Withdrawal by Subject|1|||
27814894|NCT00502775|81154447|FG002|Overall Study|Withdrawal by Subject|2|||
27688455|NCT00948766|80694248|FG000|Core Study|Death|1|||
27814895|NCT00502775|81154445|FG000|Overall Study|Sponsor Terminated Study|1|||
27877273|NCT00529087|81383225|FG000|Overall Study|Lost to Follow-up|6|||
27877274|NCT00529087|81383226|FG001|Overall Study|Lost to Follow-up|4|||
27877275|NCT00529087|81383227|FG002|Overall Study|Lost to Follow-up|1|||
27877276|NCT00529087|81383225|FG000|Overall Study|Protocol Violation|8|||
27877277|NCT00529087|81383226|FG001|Overall Study|Protocol Violation|7|||
27877278|NCT00529087|81383227|FG002|Overall Study|Protocol Violation|6|||
27877279|NCT00529087|81383225|FG000|Overall Study|Withdrawal by Subject|3|||
27877280|NCT00529087|81383226|FG001|Overall Study|Withdrawal by Subject|3|||
27877281|NCT00529087|81383227|FG002|Overall Study|Withdrawal by Subject|3|||
27877282|NCT00529087|81383225|FG000|Overall Study|Protocol deviation|1|||
27877283|NCT00529087|81383226|FG001|Overall Study|Protocol deviation|1|||
27877284|NCT00529087|81383227|FG002|Overall Study|Protocol deviation|2|||
27877285|NCT00536939|81383240|FG000|Overall Study|Withdrawal by Subject|1|||
27877286|NCT00536939|81383241|FG001|Overall Study|Withdrawal by Subject|0|||
27877287|NCT00536939|81383240|FG000|Overall Study|Other Complicating Disease|1|||
27877288|NCT00536939|81383241|FG001|Overall Study|Other Complicating Disease|0|||
27877289|NCT01991743|81383247|FG000|Overall Study|external cephalic version not performed|0|||
27877290|NCT01991743|81383248|FG001|Overall Study|external cephalic version not performed|0|||
27877291|NCT01991743|81383249|FG002|Overall Study|external cephalic version not performed|1|||
27877292|NCT01991743|81383250|FG003|Overall Study|external cephalic version not performed|0|||
27877293|NCT00696423|81383251|FG000|Overall Study|Lost to Follow-up|0|||
27877294|NCT00696423|81383252|FG001|Overall Study|Lost to Follow-up|5|||
27877295|NCT01415518|81383257|FG000|Overall Study|Withdrawal by Subject|2|||
27877296|NCT01415518|81383258|FG001|Overall Study|Withdrawal by Subject|12|||
27877297|NCT01415518|81383257|FG000|Overall Study|Protocol Violation|6|||
27877298|NCT01415518|81383258|FG001|Overall Study|Protocol Violation|8|||
27814896|NCT00502775|81154446|FG001|Overall Study|Sponsor Terminated Study|0|||
27814897|NCT00502775|81154447|FG002|Overall Study|Sponsor Terminated Study|1|||
27814898|NCT00502775|81154445|FG000|Overall Study|Non-compliance with eDiary|4|||
27814899|NCT00502775|81154446|FG001|Overall Study|Non-compliance with eDiary|1|||
27814900|NCT00502775|81154447|FG002|Overall Study|Non-compliance with eDiary|1|||
27589302|NCT00116805|80340345|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
27589303|NCT00116805|80340346|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
27589304|NCT00116805|80340345|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
27589305|NCT00116805|80340346|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
27589306|NCT00116805|80340345|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
27589307|NCT00116805|80340346|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
27594399|NCT00955357|80356064|FG001|Titration Phase|Withdrawal by Subject|5|||
27814901|NCT00502775|81154445|FG000|Overall Study|Subject unable to swallow capsule|1|||
27814902|NCT00502775|81154446|FG001|Overall Study|Subject unable to swallow capsule|0|||
27814903|NCT00502775|81154447|FG002|Overall Study|Subject unable to swallow capsule|1|||
27814904|NCT00502775|81154445|FG000|Overall Study|Logpad compliance <80%|1|||
27814905|NCT00502775|81154446|FG001|Overall Study|Logpad compliance <80%|0|||
27814906|NCT00502775|81154447|FG002|Overall Study|Logpad compliance <80%|0|||
27814907|NCT00502775|81154445|FG000|Overall Study|Randomized in error|0|||
27814908|NCT00502775|81154446|FG001|Overall Study|Randomized in error|1|||
27814909|NCT00502775|81154447|FG002|Overall Study|Randomized in error|1|||
27877299|NCT01415518|81383257|FG000|Overall Study|Lost to Follow-up|3|||
27877300|NCT01415518|81383258|FG001|Overall Study|Lost to Follow-up|5|||
27877301|NCT01415518|81383257|FG000|Overall Study|Adverse Event|3|||
27877302|NCT01415518|81383258|FG001|Overall Study|Adverse Event|4|||
27814910|NCT00502775|81154445|FG000|Overall Study|Non-compliance|0|||
27814911|NCT00502775|81154446|FG001|Overall Study|Non-compliance|2|||
27814912|NCT00502775|81154447|FG002|Overall Study|Non-compliance|2|||
27877303|NCT01415518|81383257|FG000|Overall Study|Death|1|||
27877304|NCT01415518|81383258|FG001|Overall Study|Death|1|||
27877305|NCT01415518|81383257|FG000|Overall Study|Condition under Investigation Worsened|1|||
27589308|NCT00116805|80340345|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
27589309|NCT00116805|80340346|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
27589310|NCT00116805|80340345|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
27589311|NCT00116805|80340346|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
27589312|NCT00116805|80340345|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
27589313|NCT00116805|80340346|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
27589314|NCT00116805|80340345|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
27589315|NCT00116805|80340346|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
27589316|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
27589317|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
27589318|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
27589319|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
27589320|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
27589321|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
27589322|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
27877306|NCT01415518|81383258|FG001|Overall Study|Condition under Investigation Worsened|1|||
27877307|NCT02570308|81383259|FG000|Overall Study|Death|1|||
27877308|NCT02570308|81383260|FG001|Overall Study|Death|5|||
27877309|NCT02570308|81383261|FG002|Overall Study|Death|4|||
27589323|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
27589324|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
27589325|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
27589326|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
27589327|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
27589328|NCT00116805|80340345|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
27589329|NCT00116805|80340346|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
27589330|NCT00116805|80340345|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
27589331|NCT00116805|80340346|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
27589332|NCT00116805|80340345|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
27589333|NCT00116805|80340346|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
27589334|NCT00116805|80340345|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
27814913|NCT00502775|81154445|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
27814914|NCT00502775|81154446|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
27814915|NCT00502775|81154447|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
27814916|NCT00502775|81154445|FG000|Overall Study|Declining pollen counts|0|||
27814917|NCT00502775|81154446|FG001|Overall Study|Declining pollen counts|1|||
27814918|NCT00502775|81154447|FG002|Overall Study|Declining pollen counts|1|||
27814919|NCT00502775|81154445|FG000|Overall Study|Subject in jail|0|||
27814920|NCT00502775|81154446|FG001|Overall Study|Subject in jail|1|||
27814921|NCT00502775|81154447|FG002|Overall Study|Subject in jail|0|||
27814922|NCT00502775|81154445|FG000|Overall Study|Subject took disallowed drug|0|||
27814923|NCT00502775|81154446|FG001|Overall Study|Subject took disallowed drug|0|||
27814924|NCT00502775|81154447|FG002|Overall Study|Subject took disallowed drug|1|||
27814925|NCT02204371|81154448|FG000|Overall Study|Adverse Event|1|||
27814926|NCT04529109|81154454|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
27814927|NCT04529109|81154455|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
27877310|NCT02570308|81383262|FG003|Overall Study|Death|4|||
27877311|NCT02570308|81383263|FG004|Overall Study|Death|69|||
27589335|NCT00116805|80340346|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
27589336|NCT00116805|80340345|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
27589337|NCT00116805|80340346|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
27589338|NCT00116805|80340345|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
27589339|NCT00116805|80340346|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
27589340|NCT00116805|80340345|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
27589341|NCT00116805|80340346|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
27589342|NCT00116805|80340345|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
27589343|NCT00116805|80340346|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
27589344|NCT00116805|80340345|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
27589345|NCT00116805|80340346|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
27589346|NCT00116805|80340345|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
27589347|NCT00116805|80340346|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
27589348|NCT00843167|80340347|FG000|Treatment Period|Adverse Event|1|||
27814928|NCT03532009|81154461|FG000|Overall Study|Other|1|||
27814929|NCT03532009|81154462|FG001|Overall Study|Other|1|||
27814930|NCT03532009|81154461|FG000|Overall Study|Death|1|||
27814931|NCT03532009|81154462|FG001|Overall Study|Death|1|||
27814932|NCT03532009|81154461|FG000|Overall Study|Withdrawal by Patient|0|||
27814933|NCT03532009|81154462|FG001|Overall Study|Withdrawal by Patient|2|||
27814934|NCT03992196|81154463|FG000|Enrollment|lost to follow-up prior dosing|1|||
27814935|NCT03992196|81154464|FG001|Enrollment|lost to follow-up prior dosing|0|||
27814936|NCT03992196|81154465|FG002|Enrollment|lost to follow-up prior dosing|0|||
27814937|NCT03992196|81154463|FG000|Treatment|Protocol Violation|0|||
27814938|NCT03992196|81154464|FG001|Treatment|Protocol Violation|0|||
27814939|NCT03992196|81154465|FG002|Treatment|Protocol Violation|1|||
27814940|NCT03992196|81154463|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
27814941|NCT03992196|81154464|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
27814942|NCT03992196|81154465|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
27589349|NCT00843167|80340348|FG001|Treatment Period|Adverse Event|5|||
27589350|NCT00843167|80340347|FG000|Treatment Period|Withdrawal by Subject|2|||
27589351|NCT00843167|80340348|FG001|Treatment Period|Withdrawal by Subject|3|||
27589352|NCT03759873|80340349|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
27589353|NCT03759873|80340350|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
27589354|NCT03759873|80340351|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
27589355|NCT03759873|80340352|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
27589356|NCT03759873|80340349|FG000|Overall Study|Moved outside eligible area|0|||
27589357|NCT03759873|80340350|FG001|Overall Study|Moved outside eligible area|2|||
27589358|NCT03759873|80340351|FG002|Overall Study|Moved outside eligible area|0|||
27589359|NCT03759873|80340352|FG003|Overall Study|Moved outside eligible area|0|||
27589360|NCT03759873|80340349|FG000|Overall Study|Withdrawal by Subject|0|||
27589361|NCT03759873|80340350|FG001|Overall Study|Withdrawal by Subject|0|||
27589362|NCT03759873|80340351|FG002|Overall Study|Withdrawal by Subject|1|||
27589363|NCT03759873|80340352|FG003|Overall Study|Withdrawal by Subject|0|||
27589364|NCT03998618|80340353|FG000|Overall Study|Death|7|||
27589365|NCT03998618|80340354|FG001|Overall Study|Death|11|||
27589366|NCT03998618|80340353|FG000|Overall Study|hospice enrollment|3|||
27589367|NCT03998618|80340354|FG001|Overall Study|hospice enrollment|3|||
27589368|NCT03998618|80340353|FG000|Overall Study|Not feeling well/health problems|3|||
27589369|NCT03998618|80340354|FG001|Overall Study|Not feeling well/health problems|5|||
27589370|NCT03998618|80340353|FG000|Overall Study|Lost to Follow-up|6|||
27589371|NCT03998618|80340354|FG001|Overall Study|Lost to Follow-up|6|||
27589372|NCT03998618|80340353|FG000|Overall Study|Withdrawal by Subject|0|||
27589373|NCT03998618|80340354|FG001|Overall Study|Withdrawal by Subject|4|||
27589374|NCT02010060|80340355|FG000|Overall Study|Lost to Follow-up|1|||
27589375|NCT02010060|80340356|FG001|Overall Study|Lost to Follow-up|2|||
27589376|NCT02010060|80340357|FG002|Overall Study|Lost to Follow-up|2|||
27589377|NCT02010060|80340355|FG000|Overall Study|Injury|0|||
27589378|NCT02010060|80340356|FG001|Overall Study|Injury|1|||
27589379|NCT02010060|80340357|FG002|Overall Study|Injury|0|||
27589380|NCT01693120|80340358|FG000|Enrollment|Lost to Follow-up|1|||
27589381|NCT01693120|80340358|FG000|Enrollment|Withdrawal by Subject|10|||
27589382|NCT01693120|80340358|FG000|Enrollment|Protocol Violation|46|||
27589383|NCT01693120|80340358|FG000|Enrollment|Physician Decision|3|||
27589384|NCT01693120|80340358|FG000|Enrollment|Adverse Event|1|||
27589385|NCT01693120|80340358|FG000|Enrollment|Study closed|8|||
27589386|NCT01693120|80340358|FG000|Enrollment|Other|1|||
27589387|NCT01693120|80340358|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
27589388|NCT01693120|80340358|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
27589389|NCT01693120|80340358|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
27589390|NCT01693120|80340358|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
27589391|NCT01693120|80340358|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
27589392|NCT04139317|80340359|FG000|Overall Study|Adverse Event|10|||
27589393|NCT04139317|80340360|FG001|Overall Study|Adverse Event|2|||
27589394|NCT04139317|80340359|FG000|Overall Study|Death|6|||
27589395|NCT04139317|80340360|FG001|Overall Study|Death|4|||
27589396|NCT04139317|80340359|FG000|Overall Study|Lost to Follow-up|1|||
27589397|NCT04139317|80340360|FG001|Overall Study|Lost to Follow-up|0|||
27688456|NCT00948766|80694249|FG001|Core Study|Death|1|||
27688457|NCT00948766|80694248|FG000|Core Study|Protocol Deviation|8|||
27814943|NCT03992196|81154463|FG000|Treatment|Withdrawal due to non-compliance|0|||
27589398|NCT04139317|80340359|FG000|Overall Study|Physician Decision|3|||
27589399|NCT04139317|80340360|FG001|Overall Study|Physician Decision|1|||
27589400|NCT04139317|80340359|FG000|Overall Study|Progressive Disease|19|||
27589401|NCT04139317|80340360|FG001|Overall Study|Progressive Disease|9|||
27589402|NCT04139317|80340359|FG000|Overall Study|Subject Decision|2|||
27589403|NCT04139317|80340360|FG001|Overall Study|Subject Decision|2|||
27688458|NCT00948766|80694249|FG001|Core Study|Protocol Deviation|10|||
27877312|NCT02570308|81383259|FG000|Overall Study|Lost to Follow-up|0|||
27589404|NCT01750268|80340362|FG000|Overall Study|Lost to Follow-up|0|||
27589405|NCT01750268|80340363|FG001|Overall Study|Lost to Follow-up|2|||
27589406|NCT01750268|80340362|FG000|Overall Study|Physician Decision|0|||
27589407|NCT01750268|80340363|FG001|Overall Study|Physician Decision|3|||
27589408|NCT01750268|80340362|FG000|Overall Study|Withdrawal by Subject|2|||
27589409|NCT01750268|80340363|FG001|Overall Study|Withdrawal by Subject|0|||
27589410|NCT04066114|80340367|FG000|Overall Study|Adverse Event|1|||
27589411|NCT04066114|80340368|FG001|Overall Study|Adverse Event|0|||
27589412|NCT04066114|80340369|FG002|Overall Study|Adverse Event|0|||
27589413|NCT04066114|80340367|FG000|Overall Study|Withdrawal by Subject|1|||
27877313|NCT02570308|81383260|FG001|Overall Study|Lost to Follow-up|0|||
27877314|NCT02570308|81383261|FG002|Overall Study|Lost to Follow-up|0|||
27877315|NCT02570308|81383262|FG003|Overall Study|Lost to Follow-up|0|||
27877316|NCT02570308|81383263|FG004|Overall Study|Lost to Follow-up|2|||
27877317|NCT02570308|81383259|FG000|Overall Study|Withdrawal by Subject|0|||
27877318|NCT02570308|81383260|FG001|Overall Study|Withdrawal by Subject|0|||
27877319|NCT02570308|81383261|FG002|Overall Study|Withdrawal by Subject|0|||
27877320|NCT02570308|81383262|FG003|Overall Study|Withdrawal by Subject|0|||
27589414|NCT04066114|80340368|FG001|Overall Study|Withdrawal by Subject|0|||
27589415|NCT04066114|80340369|FG002|Overall Study|Withdrawal by Subject|0|||
27589416|NCT04066114|80340367|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
27589417|NCT04066114|80340368|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
27589418|NCT04066114|80340369|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
27589419|NCT04323436|80340372|FG000|Overall Study|Adverse Event|7|||
27589420|NCT04323436|80340373|FG001|Overall Study|Adverse Event|0|||
27589421|NCT04323436|80340374|FG002|Overall Study|Adverse Event|0|||
27589422|NCT04323436|80340372|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
27589423|NCT04323436|80340373|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
27589424|NCT04323436|80340374|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
27589425|NCT04323436|80340372|FG000|Overall Study|Death|1|||
27589426|NCT04323436|80340373|FG001|Overall Study|Death|0|||
27589427|NCT04323436|80340374|FG002|Overall Study|Death|0|||
27589428|NCT04323436|80340372|FG000|Overall Study|Physician Decision|2|||
27589429|NCT04323436|80340373|FG001|Overall Study|Physician Decision|0|||
27589430|NCT04323436|80340374|FG002|Overall Study|Physician Decision|0|||
27589431|NCT04323436|80340372|FG000|Overall Study|Progressive disease|10|||
27589432|NCT04323436|80340373|FG001|Overall Study|Progressive disease|0|||
27589433|NCT04323436|80340374|FG002|Overall Study|Progressive disease|0|||
27589434|NCT04323436|80340372|FG000|Overall Study|Subject decision|3|||
27688459|NCT00948766|80694248|FG000|Extension Study|Adverse Event|43|||
27814944|NCT03992196|81154464|FG001|Treatment|Withdrawal due to non-compliance|0|||
27814945|NCT03992196|81154465|FG002|Treatment|Withdrawal due to non-compliance|1|||
27814946|NCT03992196|81154463|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
27814947|NCT03992196|81154464|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
27814948|NCT03992196|81154465|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
27814949|NCT03992196|81154463|FG000|Treatment|Withdrawal by parent/guardian|0|||
27814950|NCT03992196|81154464|FG001|Treatment|Withdrawal by parent/guardian|0|||
27814951|NCT03992196|81154465|FG002|Treatment|Withdrawal by parent/guardian|2|||
27814952|NCT00442936|81154468|FG000|Overall Study|Protocol Violation|1|||
27814953|NCT00442936|81154469|FG001|Overall Study|Protocol Violation|0|||
27814954|NCT00442936|81154470|FG002|Overall Study|Protocol Violation|1|||
27814955|NCT00442936|81154471|FG003|Overall Study|Protocol Violation|1|||
27814956|NCT02374918|81154472|FG000|Overall Study|Protocol Violation|2|||
27814957|NCT02374918|81154473|FG001|Overall Study|Protocol Violation|0|||
27814958|NCT02374918|81154474|FG002|Overall Study|Protocol Violation|2|||
27814959|NCT02374918|81154475|FG003|Overall Study|Protocol Violation|1|||
27814960|NCT02374918|81154472|FG000|Overall Study|Withdrawal by Subject|1|||
27814961|NCT02374918|81154473|FG001|Overall Study|Withdrawal by Subject|1|||
27814962|NCT02374918|81154474|FG002|Overall Study|Withdrawal by Subject|1|||
27814963|NCT02374918|81154475|FG003|Overall Study|Withdrawal by Subject|0|||
27814964|NCT02374918|81154472|FG000|Overall Study|Lack of Efficacy|0|||
27877321|NCT02570308|81383263|FG004|Overall Study|Withdrawal by Subject|1|||
27877322|NCT02570308|81383259|FG000|Overall Study|Other|0|||
27877323|NCT02570308|81383260|FG001|Overall Study|Other|0|||
27877324|NCT02570308|81383261|FG002|Overall Study|Other|0|||
27877325|NCT02570308|81383262|FG003|Overall Study|Other|0|||
27877326|NCT02570308|81383263|FG004|Overall Study|Other|2|||
27877327|NCT05393037|81383268|FG000|Overall Study|Death|1|||
27589435|NCT04323436|80340373|FG001|Overall Study|Subject decision|0|||
27589436|NCT04323436|80340374|FG002|Overall Study|Subject decision|0|||
27589437|NCT04179032|80340378|FG000|Part B (Up to Week 52)|Adverse Event|1|||
27589438|NCT04179032|80340378|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
27589439|NCT04179032|80340378|FG000|Access Extension Phase|Ongoing|11|||
27589440|NCT00288587|80340379|FG000|Overall Study|Death|4|||
27589441|NCT00288587|80340380|FG001|Overall Study|Death|4|||
27814965|NCT02374918|81154473|FG001|Overall Study|Lack of Efficacy|0|||
27877328|NCT05393037|81383269|FG001|Overall Study|Death|0|||
27589442|NCT00288587|80340379|FG000|Overall Study|Transplant|0|||
27814966|NCT02374918|81154474|FG002|Overall Study|Lack of Efficacy|1|||
27814967|NCT02374918|81154475|FG003|Overall Study|Lack of Efficacy|1|||
27814968|NCT01485536|81154476|FG000|Overall Study|Withdrawal by Subject|3|||
27814969|NCT01485536|81154476|FG000|Overall Study|Adverse Event|1|||
27814970|NCT02016300|81154477|FG000|Overall Study|Lost to Follow-up|0|||
27814971|NCT02016300|81154478|FG001|Overall Study|Lost to Follow-up|3|||
27814972|NCT01193608|81154481|FG000|Overall Study|Other|0|||
27814973|NCT01193608|81154482|FG001|Overall Study|Other|1|||
27814974|NCT01193608|81154483|FG002|Overall Study|Other|0|||
27814975|NCT01193608|81154484|FG003|Overall Study|Other|0|||
27814976|NCT01193608|81154485|FG004|Overall Study|Other|0|||
27814977|NCT01193608|81154486|FG005|Overall Study|Other|0|||
27814978|NCT01193608|81154481|FG000|Overall Study|Withdrawal by Subject|0|||
27688460|NCT00948766|80694249|FG001|Extension Study|Adverse Event|0|||
27589443|NCT00288587|80340380|FG001|Overall Study|Transplant|3|||
27589444|NCT00288587|80340379|FG000|Overall Study|Adverse Event|0|||
27589445|NCT00288587|80340380|FG001|Overall Study|Adverse Event|1|||
27589446|NCT00288587|80340379|FG000|Overall Study|Physician Decision|0|||
27589447|NCT00288587|80340380|FG001|Overall Study|Physician Decision|2|||
27589448|NCT00288587|80340379|FG000|Overall Study|Severe Aortic Stenosis|1|||
27589449|NCT00288587|80340380|FG001|Overall Study|Severe Aortic Stenosis|0|||
27589450|NCT02576067|80340384|FG000|Overall Study|Death|0|||
27589451|NCT02576067|80340385|FG001|Overall Study|Death|1|||
27589452|NCT02576067|80340384|FG000|Overall Study|Lack of Efficacy|1|||
27589453|NCT02576067|80340385|FG001|Overall Study|Lack of Efficacy|0|||
27589454|NCT02576067|80340384|FG000|Overall Study|Lost to Follow-up|11|||
27589455|NCT02576067|80340385|FG001|Overall Study|Lost to Follow-up|0|||
27589456|NCT02576067|80340384|FG000|Overall Study|Withdrawal by Subject|11|||
27589457|NCT02576067|80340385|FG001|Overall Study|Withdrawal by Subject|2|||
27589458|NCT02576067|80340384|FG000|Overall Study|study closure of main CIRT trial)|0|||
27589459|NCT02576067|80340385|FG001|Overall Study|study closure of main CIRT trial)|8|||
27589460|NCT02576067|80340384|FG000|Overall Study|not randomized, failed run-in|7|||
27589461|NCT02576067|80340385|FG001|Overall Study|not randomized, failed run-in|0|||
27589462|NCT02576067|80340384|FG000|Overall Study|screen failure/ re-enrolled|0|||
27688461|NCT00948766|80694248|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
27688462|NCT00948766|80694249|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
27688463|NCT00948766|80694248|FG000|Extension Study|Study Drug No Longer Required|1|||
27688464|NCT00948766|80694249|FG001|Extension Study|Study Drug No Longer Required|0|||
27688465|NCT00948766|80694248|FG000|Extension Study|Patient Withdrew Consent|32|||
27688466|NCT00948766|80694249|FG001|Extension Study|Patient Withdrew Consent|0|||
27688467|NCT00948766|80694248|FG000|Extension Study|Lost to Follow-up|8|||
27688468|NCT00948766|80694249|FG001|Extension Study|Lost to Follow-up|0|||
27688469|NCT00948766|80694248|FG000|Extension Study|Administrative Problems|1|||
27688470|NCT00948766|80694249|FG001|Extension Study|Administrative Problems|0|||
27688471|NCT00948766|80694248|FG000|Extension Study|Death|4|||
27688472|NCT00948766|80694249|FG001|Extension Study|Death|0|||
27688473|NCT01293487|80694250|FG000|Overall Study|Lost to Follow-up|0|||
27688474|NCT01293487|80694251|FG001|Overall Study|Lost to Follow-up|0|||
27688475|NCT01293487|80694252|FG002|Overall Study|Lost to Follow-up|0|||
27688476|NCT01293487|80694253|FG003|Overall Study|Lost to Follow-up|1|||
27688477|NCT01293487|80694254|FG004|Overall Study|Lost to Follow-up|0|||
27688478|NCT01293487|80694255|FG005|Overall Study|Lost to Follow-up|0|||
27688479|NCT01293487|80694256|FG006|Overall Study|Lost to Follow-up|0|||
27589463|NCT02576067|80340385|FG001|Overall Study|screen failure/ re-enrolled|25|||
27688480|NCT01293487|80694257|FG007|Overall Study|Lost to Follow-up|0|||
27688481|NCT01293487|80694250|FG000|Overall Study|Withdrawal by Subject|0|||
27688482|NCT01293487|80694251|FG001|Overall Study|Withdrawal by Subject|0|||
27688483|NCT01293487|80694252|FG002|Overall Study|Withdrawal by Subject|0|||
27688484|NCT01293487|80694253|FG003|Overall Study|Withdrawal by Subject|0|||
27688485|NCT01293487|80694254|FG004|Overall Study|Withdrawal by Subject|0|||
27589464|NCT02576067|80340384|FG000|Overall Study|Physician Decision|4|||
27589465|NCT02576067|80340385|FG001|Overall Study|Physician Decision|0|||
27688486|NCT01293487|80694255|FG005|Overall Study|Withdrawal by Subject|0|||
27688487|NCT01293487|80694256|FG006|Overall Study|Withdrawal by Subject|0|||
27688488|NCT01293487|80694257|FG007|Overall Study|Withdrawal by Subject|2|||
27688489|NCT03075410|80694258|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
27688490|NCT03075410|80694259|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688491|NCT03075410|80694260|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
27688492|NCT03075410|80694261|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688493|NCT03075410|80694262|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688494|NCT03075410|80694263|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688495|NCT03075410|80694264|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688496|NCT03075410|80694265|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688497|NCT03075410|80694266|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
27688498|NCT03075410|80694258|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
27688499|NCT03075410|80694259|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688500|NCT03075410|80694260|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688501|NCT03075410|80694261|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688502|NCT03075410|80694262|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688503|NCT03075410|80694263|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688504|NCT03075410|80694264|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688505|NCT03075410|80694265|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688506|NCT03075410|80694266|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
27688507|NCT00979134|80694267|FG000|Overall Study|Disease progression|18|||
27688508|NCT00979134|80694268|FG001|Overall Study|Disease progression|2|||
27688509|NCT00979134|80694269|FG002|Overall Study|Disease progression|5|||
27688510|NCT00979134|80694267|FG000|Overall Study|Adverse Event|0|||
27688511|NCT00979134|80694268|FG001|Overall Study|Adverse Event|0|||
27688512|NCT00979134|80694269|FG002|Overall Study|Adverse Event|2|||
27688513|NCT00979134|80694267|FG000|Overall Study|Withdrawal by Subject|1|||
27688514|NCT00979134|80694268|FG001|Overall Study|Withdrawal by Subject|1|||
27688515|NCT00979134|80694269|FG002|Overall Study|Withdrawal by Subject|2|||
27688516|NCT00979134|80694267|FG000|Overall Study|Lost to Follow-up|2|||
27688517|NCT00979134|80694268|FG001|Overall Study|Lost to Follow-up|2|||
27688518|NCT00979134|80694269|FG002|Overall Study|Lost to Follow-up|0|||
27688519|NCT00979134|80694267|FG000|Overall Study|Death|4|||
27688520|NCT00979134|80694268|FG001|Overall Study|Death|0|||
27688521|NCT00979134|80694269|FG002|Overall Study|Death|26|||
27688522|NCT00979134|80694267|FG000|Overall Study|Other|8|||
27688523|NCT00979134|80694268|FG001|Overall Study|Other|1|||
27688524|NCT00979134|80694269|FG002|Overall Study|Other|5|||
27688525|NCT04797650|80694270|FG000|Overall Study|Reason Not Specified|5|||
27688526|NCT04797650|80694271|FG001|Overall Study|Reason Not Specified|12|||
27688527|NCT04797650|80694272|FG002|Overall Study|Reason Not Specified|5|||
27688528|NCT04797650|80694270|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
27688529|NCT04797650|80694271|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
27814979|NCT01193608|81154482|FG001|Overall Study|Withdrawal by Subject|1|||
27688530|NCT04797650|80694272|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
27688531|NCT04797650|80694270|FG000|Overall Study|Lack of Efficacy|1|||
27688532|NCT04797650|80694271|FG001|Overall Study|Lack of Efficacy|0|||
27688533|NCT04797650|80694272|FG002|Overall Study|Lack of Efficacy|1|||
27814980|NCT01193608|81154483|FG002|Overall Study|Withdrawal by Subject|2|||
27688534|NCT04797650|80694270|FG000|Overall Study|Non-compliance with Study Drug|0|||
27688535|NCT04797650|80694271|FG001|Overall Study|Non-compliance with Study Drug|0|||
27688536|NCT04797650|80694272|FG002|Overall Study|Non-compliance with Study Drug|2|||
27688537|NCT04797650|80694270|FG000|Overall Study|Lost to Follow-up|4|||
27688538|NCT04797650|80694271|FG001|Overall Study|Lost to Follow-up|6|||
27688539|NCT04797650|80694272|FG002|Overall Study|Lost to Follow-up|1|||
27688540|NCT01910181|80694274|FG000|Overall Study|Death|37|||
27688541|NCT01910181|80694274|FG000|Overall Study|Lost to Follow-up|3|||
27814981|NCT01193608|81154484|FG003|Overall Study|Withdrawal by Subject|3|||
27688542|NCT01910181|80694274|FG000|Overall Study|Study Terminated by Sponsor|6|||
27688543|NCT03482466|80694279|FG000|Overall Study|Protocol Violation|2|||
27688544|NCT01959334|80694280|FG000|Second Dose|Adverse Event|1|||
27688545|NCT01959334|80694281|FG001|Second Dose|Adverse Event|0|||
27688546|NCT01959334|80694280|FG000|Third Dose|Adverse Event|0|||
27688547|NCT01959334|80694281|FG001|Third Dose|Adverse Event|1|||
27688548|NCT00232544|80694284|FG000|Overall Study|Lost to Follow-up|20|||
27688549|NCT00232544|80694285|FG001|Overall Study|Lost to Follow-up|15|||
27688550|NCT00470366|80694286|FG000|Overall Study|Adverse Event|3|||
27688551|NCT00470366|80694286|FG000|Overall Study|Poor compliance|1|||
27688552|NCT00935818|80694287|FG000|Overall Study|Withdrawal by Subject|45|||
27688553|NCT00935818|80694288|FG001|Overall Study|Withdrawal by Subject|50|||
27688554|NCT00935818|80694287|FG000|Overall Study|Lost to Follow-up|40|||
27688555|NCT00935818|80694288|FG001|Overall Study|Lost to Follow-up|42|||
27688556|NCT00935818|80694287|FG000|Overall Study|Adverse Event|6|||
27688557|NCT00935818|80694288|FG001|Overall Study|Adverse Event|7|||
27589466|NCT01292603|80340387|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27589467|NCT01292603|80340388|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27589468|NCT01292603|80340389|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27589469|NCT01292603|80340390|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
27589470|NCT01292603|80340391|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27589471|NCT01292603|80340392|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
27589472|NCT01292603|80340387|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
27589473|NCT01292603|80340388|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
27589474|NCT01292603|80340389|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
27589475|NCT01292603|80340390|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
27589476|NCT01292603|80340391|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
27589477|NCT01292603|80340392|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
27589478|NCT01292603|80340387|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27589479|NCT01292603|80340388|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27589480|NCT01292603|80340389|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27589481|NCT01292603|80340390|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
27589482|NCT01292603|80340391|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27589483|NCT01292603|80340392|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
27589484|NCT01292603|80340387|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27589485|NCT01292603|80340388|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27589486|NCT01292603|80340389|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27589487|NCT01292603|80340390|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
27589488|NCT01292603|80340391|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27589489|NCT01292603|80340392|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
27589490|NCT01292603|80340387|FG000|Part 1: Regular Follow-Up Period|Death|3|||
27589491|NCT01292603|80340388|FG001|Part 1: Regular Follow-Up Period|Death|1|||
27589492|NCT01292603|80340389|FG002|Part 1: Regular Follow-Up Period|Death|3|||
27589493|NCT01292603|80340390|FG003|Part 1: Regular Follow-Up Period|Death|1|||
27814982|NCT01193608|81154485|FG004|Overall Study|Withdrawal by Subject|3|||
27589494|NCT01292603|80340391|FG004|Part 1: Regular Follow-Up Period|Death|0|||
27589495|NCT01292603|80340392|FG005|Part 1: Regular Follow-Up Period|Death|0|||
27688558|NCT00935818|80694287|FG000|Overall Study|Physician Decision|0|||
27688559|NCT00935818|80694288|FG001|Overall Study|Physician Decision|1|||
27814983|NCT01193608|81154486|FG005|Overall Study|Withdrawal by Subject|0|||
27589496|NCT01292603|80340387|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
27688560|NCT01153958|80694289|FG000|Overall Study|Study Terminated|36|||
27814984|NCT01193608|81154481|FG000|Overall Study|Lost to Follow-up|0|||
27688561|NCT01153958|80694290|FG001|Overall Study|Study Terminated|32|||
27688562|NCT01156792|80694291|FG000|Overall Study|Adverse Event|1|||
27688563|NCT01156792|80694291|FG000|Overall Study|Lack of Efficacy|36|||
27688564|NCT01156792|80694291|FG000|Overall Study|Protocol Violation|6|||
27688565|NCT01156792|80694291|FG000|Overall Study|Lost to Follow-up|3|||
27688566|NCT01156792|80694291|FG000|Overall Study|Physician Decision|3|||
27688567|NCT01156792|80694291|FG000|Overall Study|Withdrawal by Subject|9|||
27688568|NCT01156792|80694291|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
27688569|NCT01775124|80694292|FG000|Core Period|Disease Progression|0|||
27688570|NCT01775124|80694293|FG001|Core Period|Disease Progression|1|||
27688571|NCT01775124|80694292|FG000|Core Period|Physician Decision|1|||
27688572|NCT01775124|80694293|FG001|Core Period|Physician Decision|1|||
27688573|NCT01775124|80694292|FG000|Core Period|Death|0|||
27688574|NCT01775124|80694293|FG001|Core Period|Death|1|||
27688575|NCT01775124|80694292|FG000|Core Period|Administrative problems|1|||
27688576|NCT01775124|80694293|FG001|Core Period|Administrative problems|0|||
27688577|NCT01775124|80694292|FG000|Core Period|Withdrawal by Subject|4|||
27688578|NCT01775124|80694293|FG001|Core Period|Withdrawal by Subject|2|||
27688579|NCT01775124|80694292|FG000|Core Period|Adverse Event|5|||
27688580|NCT01775124|80694293|FG001|Core Period|Adverse Event|5|||
27589497|NCT01292603|80340388|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
27589498|NCT01292603|80340389|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
27589499|NCT01292603|80340390|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
27589500|NCT01292603|80340391|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
27589501|NCT01292603|80340392|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
27589502|NCT01292603|80340387|FG000|Part 2: Dose Confirmation Period|Death|0|||
27688581|NCT01775124|80694292|FG000|Extension Period|Adverse Event|3|||
27688582|NCT01775124|80694293|FG001|Extension Period|Adverse Event|2|||
27688583|NCT01775124|80694292|FG000|Extension Period|Physician Decision|0|||
27688584|NCT01775124|80694293|FG001|Extension Period|Physician Decision|2|||
27688585|NCT01775124|80694292|FG000|Extension Period|Administrative problems|0|||
27688586|NCT01775124|80694293|FG001|Extension Period|Administrative problems|1|||
27688587|NCT01775124|80694292|FG000|Extension Period|Lost to Follow-up|0|||
27688588|NCT01775124|80694293|FG001|Extension Period|Lost to Follow-up|1|||
27688589|NCT01775124|80694292|FG000|Extension Period|Withdrawal by Subject|9|||
27688590|NCT01775124|80694293|FG001|Extension Period|Withdrawal by Subject|12|||
27688591|NCT00291642|80694298|FG000|Overall Study|Adverse Event|1|||
27688592|NCT00291642|80694299|FG001|Overall Study|Adverse Event|0|||
27688593|NCT00291642|80694300|FG002|Overall Study|Adverse Event|1|||
27688594|NCT00291642|80694301|FG003|Overall Study|Adverse Event|0|||
27688595|NCT00291642|80694302|FG004|Overall Study|Adverse Event|1|||
27688596|NCT00291642|80694298|FG000|Overall Study|Patient missed visit|0|||
27688597|NCT00291642|80694299|FG001|Overall Study|Patient missed visit|0|||
27688598|NCT00291642|80694300|FG002|Overall Study|Patient missed visit|1|||
27688599|NCT00291642|80694301|FG003|Overall Study|Patient missed visit|0|||
27688600|NCT00291642|80694302|FG004|Overall Study|Patient missed visit|0|||
27688601|NCT00291642|80694298|FG000|Overall Study|Intake of prohibited medication|1|||
27688602|NCT00291642|80694299|FG001|Overall Study|Intake of prohibited medication|0|||
27688603|NCT00291642|80694300|FG002|Overall Study|Intake of prohibited medication|0|||
27688604|NCT00291642|80694301|FG003|Overall Study|Intake of prohibited medication|0|||
27688605|NCT00291642|80694302|FG004|Overall Study|Intake of prohibited medication|0|||
27877329|NCT05393037|81383268|FG000|Overall Study|Lost to Follow-up|1|||
27589503|NCT01292603|80340388|FG001|Part 2: Dose Confirmation Period|Death|0|||
27589504|NCT01292603|80340389|FG002|Part 2: Dose Confirmation Period|Death|0|||
27589505|NCT01292603|80340390|FG003|Part 2: Dose Confirmation Period|Death|0|||
27589506|NCT01292603|80340391|FG004|Part 2: Dose Confirmation Period|Death|1|||
27688606|NCT03319849|80694303|FG000|Overall Study|Adverse Event|1|||
27688607|NCT03319849|80694304|FG001|Overall Study|Adverse Event|0|||
27688608|NCT03319849|80694303|FG000|Overall Study|Physician Decision|0|||
27688609|NCT03319849|80694304|FG001|Overall Study|Physician Decision|1|||
27688610|NCT03319849|80694303|FG000|Overall Study|Withdrawal by Subject|0|||
27688611|NCT03319849|80694304|FG001|Overall Study|Withdrawal by Subject|1|||
27688612|NCT03319849|80694303|FG000|Overall Study|COVID-19|0|||
27688613|NCT03319849|80694304|FG001|Overall Study|COVID-19|1|||
27688614|NCT03319849|80694303|FG000|Overall Study|Other|1|||
27688615|NCT03319849|80694304|FG001|Overall Study|Other|2|||
27688616|NCT03319849|80694303|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
27688617|NCT03319849|80694304|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
27688618|NCT03319849|80694303|FG000|Overall Study|Lost to Follow-up|0|||
27688619|NCT03319849|80694304|FG001|Overall Study|Lost to Follow-up|2|||
27688620|NCT03459443|80694305|FG000|Overall Study|Lack of Efficacy|3|||
27688621|NCT03459443|80694305|FG000|Overall Study|Adverse Event|1|||
27688622|NCT03459443|80694305|FG000|Overall Study|Sponsor's decision to close the study|18|||
27688623|NCT00194987|80694306|FG000|Overall Study|Withdrawal by Subject|0|||
27688624|NCT00194987|80694307|FG001|Overall Study|Withdrawal by Subject|3|||
27688625|NCT02414932|80694308|FG000|Overall Study|Withdrawal by Subject|2|||
27688626|NCT02414932|80694309|FG001|Overall Study|Withdrawal by Subject|3|||
27688627|NCT02414932|80694308|FG000|Overall Study|Adverse Event|1|||
27688628|NCT02414932|80694309|FG001|Overall Study|Adverse Event|0|||
27688629|NCT02317432|80694311|FG000|Overall Study|Death|4|||
27688630|NCT02317432|80694312|FG001|Overall Study|Death|1|||
27688631|NCT02317432|80694311|FG000|Overall Study|Lost to Follow-up|0|||
27688632|NCT02317432|80694312|FG001|Overall Study|Lost to Follow-up|5|||
27688633|NCT02317432|80694311|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
27688634|NCT02317432|80694312|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
27688635|NCT04279392|80694313|FG000|Overall Study|Physician Decision|1|||
27688636|NCT04279392|80694314|FG001|Overall Study|Physician Decision|0|||
27688637|NCT02656329|80694317|FG000|Overall Study|Lost to Follow-up|2|||
27688638|NCT02656329|80694318|FG001|Overall Study|Lost to Follow-up|3|||
27688639|NCT02656329|80694317|FG000|Overall Study|Withdrawal by Subject|7|||
27688640|NCT02656329|80694318|FG001|Overall Study|Withdrawal by Subject|6|||
27688641|NCT02656329|80694317|FG000|Overall Study|Study termination by Sponsor|150|||
27688642|NCT02656329|80694318|FG001|Overall Study|Study termination by Sponsor|142|||
27688643|NCT02656329|80694317|FG000|Overall Study|Other than specified above|5|||
27688644|NCT02656329|80694318|FG001|Overall Study|Other than specified above|6|||
27688645|NCT01177800|80694319|FG000|Overall Study|Adverse Event|9|||
27688646|NCT01177800|80694320|FG001|Overall Study|Adverse Event|3|||
27688647|NCT01177800|80694319|FG000|Overall Study|Protocol Violation|0|||
27688648|NCT01177800|80694320|FG001|Overall Study|Protocol Violation|1|||
27688649|NCT01177800|80694319|FG000|Overall Study|Physician Decision|1|||
27688650|NCT01177800|80694320|FG001|Overall Study|Physician Decision|0|||
27688651|NCT01177800|80694319|FG000|Overall Study|Withdrawal of informed consent|0|||
27688652|NCT01177800|80694320|FG001|Overall Study|Withdrawal of informed consent|1|||
27688653|NCT00467285|80694321|FG000|Overall Study|Lost to Follow-up|4|||
27688654|NCT00467285|80694322|FG001|Overall Study|Lost to Follow-up|4|||
27688655|NCT01920854|80694323|FG000|Overall Study|Withdrawal by Subject|1|||
27688656|NCT01920854|80694324|FG001|Overall Study|Withdrawal by Subject|0|||
27688657|NCT01920854|80694325|FG002|Overall Study|Withdrawal by Subject|0|||
27688658|NCT01920854|80694326|FG003|Overall Study|Withdrawal by Subject|0|||
27688659|NCT01920854|80694327|FG004|Overall Study|Withdrawal by Subject|1|||
27688660|NCT01920854|80694328|FG005|Overall Study|Withdrawal by Subject|0|||
27688661|NCT01920854|80694329|FG006|Overall Study|Withdrawal by Subject|1|||
27688662|NCT02884908|80694330|FG000|Overall Study|Lost to Follow-up|13|||
27688663|NCT02884908|80694331|FG001|Overall Study|Lost to Follow-up|18|||
27688664|NCT02545933|80694334|FG000|Overall Study|Adverse Event|3|||
27688665|NCT02545933|80694335|FG001|Overall Study|Adverse Event|0|||
27688666|NCT02545933|80694336|FG002|Overall Study|Adverse Event|0|||
27688667|NCT02545933|80694334|FG000|Overall Study|Withdrawal by Subject|2|||
27688668|NCT02545933|80694335|FG001|Overall Study|Withdrawal by Subject|3|||
27688669|NCT02545933|80694336|FG002|Overall Study|Withdrawal by Subject|3|||
27688670|NCT02545933|80694334|FG000|Overall Study|Protocol Violation|1|||
27688671|NCT02545933|80694335|FG001|Overall Study|Protocol Violation|0|||
27688672|NCT02545933|80694336|FG002|Overall Study|Protocol Violation|1|||
27688673|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
27688674|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
27688675|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
27688676|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
27688677|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
27688678|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
27688679|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
27688680|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
27688681|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
27688682|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
27688683|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
27688684|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
27688685|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
27688686|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
27688687|NCT00600886|80694337|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
27688688|NCT00600886|80694338|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
27688689|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
27688690|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
27688691|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
27688692|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
27688693|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
27688694|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
27688695|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
27688696|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
27688697|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
27688698|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
27688699|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
27877330|NCT05393037|81383269|FG001|Overall Study|Lost to Follow-up|1|||
27877331|NCT05393037|81383268|FG000|Overall Study|Withdrawal by Subject|2|||
27877332|NCT05393037|81383269|FG001|Overall Study|Withdrawal by Subject|4|||
27877333|NCT05393037|81383268|FG000|Overall Study|Ongoing|152|||
27877334|NCT05393037|81383269|FG001|Overall Study|Ongoing|0|||
27589507|NCT01292603|80340392|FG005|Part 2: Dose Confirmation Period|Death|0|||
27589508|NCT01292603|80340387|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
27589509|NCT01292603|80340388|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
27589510|NCT01292603|80340389|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
27589511|NCT01292603|80340390|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
27877335|NCT04620746|81383270|FG000|Overall Study|Adverse Event|2|||
27877336|NCT04620746|81383271|FG001|Overall Study|Adverse Event|0|||
27877337|NCT04620746|81383270|FG000|Overall Study|Uniterpretable skin test|1|||
27877338|NCT04620746|81383271|FG001|Overall Study|Uniterpretable skin test|0|||
27877339|NCT04620746|81383270|FG000|Overall Study|Withdrawal by Subject|0|||
27877340|NCT04620746|81383271|FG001|Overall Study|Withdrawal by Subject|1|||
27877341|NCT00778817|81383274|FG000|Overall Study|Adverse Event|2|||
27589512|NCT01292603|80340391|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
27589513|NCT01292603|80340392|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
27589514|NCT01292603|80340387|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27589515|NCT01292603|80340388|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27589516|NCT01292603|80340389|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27589517|NCT01292603|80340390|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
27589518|NCT01292603|80340391|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
27589519|NCT01292603|80340392|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
27589520|NCT01292603|80340387|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
27589521|NCT01292603|80340388|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
27589522|NCT01292603|80340389|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
27589523|NCT01292603|80340390|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
27877342|NCT00778817|81383274|FG000|Overall Study|Withdrawal by Subject|2|||
27877343|NCT02075203|81383276|FG000|Overall Study|Withdrawal by Subject|1|||
27589524|NCT01292603|80340391|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
27589525|NCT01292603|80340392|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
27589526|NCT01292603|80340387|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27589527|NCT01292603|80340388|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27589528|NCT01292603|80340389|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27589529|NCT01292603|80340390|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
27589530|NCT01292603|80340391|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
27589531|NCT01292603|80340392|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
27589532|NCT01292603|80340387|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27589533|NCT01292603|80340388|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27589534|NCT01292603|80340389|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27589535|NCT01292603|80340390|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27589536|NCT01292603|80340391|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
27589537|NCT01292603|80340392|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
27589538|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Death|0|||
27589539|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Death|0|||
27589540|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Death|0|||
27589541|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Death|0|||
27589542|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Death|6|||
27589543|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Death|3|||
27589544|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
27589545|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
27589546|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
27589547|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
27589548|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
27589549|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
27589550|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
27589551|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
27877344|NCT02075203|81383277|FG001|Overall Study|Withdrawal by Subject|0|||
27877345|NCT02075203|81383278|FG002|Overall Study|Withdrawal by Subject|1|||
27877346|NCT02075203|81383276|FG000|Overall Study|Adverse Event|1|||
27877347|NCT02075203|81383277|FG001|Overall Study|Adverse Event|0|||
27877348|NCT02075203|81383278|FG002|Overall Study|Adverse Event|0|||
27877349|NCT02075203|81383276|FG000|Overall Study|participant refused to use contraception|1|||
27877350|NCT02075203|81383277|FG001|Overall Study|participant refused to use contraception|0|||
27589552|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
27589553|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
27589554|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
27589555|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
27589556|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27589557|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27589558|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27688700|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
27877351|NCT02075203|81383278|FG002|Overall Study|participant refused to use contraception|0|||
27877352|NCT02044302|81383279|FG000|Overall Study|study terminated|2|||
27877353|NCT02044302|81383280|FG001|Overall Study|study terminated|0|||
27877354|NCT00915018|81383285|FG000|Overall Study|Death|75|||
27688701|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Death|1|||
27688702|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Death|1|||
27688703|NCT00600886|80694337|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
27688704|NCT00600886|80694338|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
27688705|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
27688706|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
27688707|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
27589559|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27589560|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
27589561|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
27589562|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
27589563|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
27589564|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
27589565|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
27589566|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
27589567|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
27589568|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
27589569|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
27589570|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
27589571|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
27589572|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
27589573|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
27589574|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27589575|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27589576|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27589577|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
27589578|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
27589579|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
27589580|NCT01292603|80340387|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
27589581|NCT01292603|80340388|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
27589582|NCT01292603|80340389|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
27688708|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
27688709|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
27814985|NCT01193608|81154482|FG001|Overall Study|Lost to Follow-up|0|||
27814986|NCT01193608|81154483|FG002|Overall Study|Lost to Follow-up|0|||
27814987|NCT01193608|81154484|FG003|Overall Study|Lost to Follow-up|0|||
27877355|NCT00915018|81383286|FG001|Overall Study|Death|70|||
27877356|NCT00915018|81383285|FG000|Overall Study|Lost to Follow-up|10|||
27877357|NCT00915018|81383286|FG001|Overall Study|Lost to Follow-up|5|||
27877358|NCT00915018|81383285|FG000|Overall Study|Withdrawal by Subject|38|||
27877359|NCT00915018|81383286|FG001|Overall Study|Withdrawal by Subject|27|||
27877360|NCT00915018|81383285|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
27814988|NCT01193608|81154485|FG004|Overall Study|Lost to Follow-up|1|||
27814989|NCT01193608|81154486|FG005|Overall Study|Lost to Follow-up|2|||
27814990|NCT01193608|81154481|FG000|Overall Study|Adverse Event|0|||
27814991|NCT01193608|81154482|FG001|Overall Study|Adverse Event|0|||
27814992|NCT01193608|81154483|FG002|Overall Study|Adverse Event|0|||
27814993|NCT01193608|81154484|FG003|Overall Study|Adverse Event|0|||
27814994|NCT01193608|81154485|FG004|Overall Study|Adverse Event|1|||
27814995|NCT01193608|81154486|FG005|Overall Study|Adverse Event|0|||
27877361|NCT00915018|81383286|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
27877362|NCT02314026|81383287|FG000|Overall Study|Protocol Violation|28|||
27877363|NCT01591096|81383288|FG000|Overall Study|Adverse Event|1|||
27877364|NCT01167140|81383289|FG000|Overall Study|Withdrawal by Subject|1|||
27877365|NCT00488644|81383290|FG000|Overall Study|Not Eligible|1|||
27877366|NCT00488644|81383290|FG000|Overall Study|Not Evaluable|1|||
27688710|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
27877367|NCT01431716|81383295|FG000|Overall Study|Withdrawal of consent|1|||
27877368|NCT01870973|81383298|FG000|Overall Study|Lost to Follow-up|10|||
27589583|NCT01292603|80340390|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
27589584|NCT01292603|80340391|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
27589585|NCT01292603|80340392|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
27589586|NCT01292603|80340387|FG000|Overall Survival Status|Death|3|||
27589587|NCT01292603|80340388|FG001|Overall Survival Status|Death|1|||
27814996|NCT03341507|81154487|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
27814997|NCT01769378|81154488|FG000|Overall Study|Adverse Event|10|||
27814998|NCT01769378|81154489|FG001|Overall Study|Adverse Event|0|||
27877369|NCT01870973|81383299|FG001|Overall Study|Lost to Follow-up|3|||
27877370|NCT01730053|81383305|FG000|Overall Study|Participant moved|0|||
27877371|NCT01730053|81383306|FG001|Overall Study|Participant moved|0|||
27877372|NCT01730053|81383307|FG002|Overall Study|Participant moved|1|||
27877373|NCT01730053|81383308|FG003|Overall Study|Participant moved|0|||
27877374|NCT01730053|81383309|FG004|Overall Study|Participant moved|0|||
27877375|NCT01730053|81383310|FG005|Overall Study|Participant moved|0|||
27877376|NCT01730053|81383305|FG000|Overall Study|Physician Decision|0|||
27877377|NCT01730053|81383306|FG001|Overall Study|Physician Decision|0|||
27877378|NCT01730053|81383307|FG002|Overall Study|Physician Decision|0|||
27877379|NCT01730053|81383308|FG003|Overall Study|Physician Decision|1|||
27877380|NCT01730053|81383309|FG004|Overall Study|Physician Decision|0|||
27877381|NCT01730053|81383310|FG005|Overall Study|Physician Decision|0|||
27877382|NCT01730053|81383305|FG000|Overall Study|Adverse Event|2|||
27877383|NCT01730053|81383306|FG001|Overall Study|Adverse Event|6|||
27877384|NCT01730053|81383307|FG002|Overall Study|Adverse Event|3|||
27877385|NCT01730053|81383308|FG003|Overall Study|Adverse Event|3|||
27877386|NCT01730053|81383309|FG004|Overall Study|Adverse Event|2|||
27877387|NCT01730053|81383310|FG005|Overall Study|Adverse Event|2|||
27877388|NCT01730053|81383305|FG000|Overall Study|Poor compliance to protocol|1|||
27877389|NCT01730053|81383306|FG001|Overall Study|Poor compliance to protocol|2|||
27877390|NCT01730053|81383307|FG002|Overall Study|Poor compliance to protocol|2|||
27877391|NCT01730053|81383308|FG003|Overall Study|Poor compliance to protocol|0|||
27877392|NCT01730053|81383309|FG004|Overall Study|Poor compliance to protocol|0|||
27877393|NCT01730053|81383310|FG005|Overall Study|Poor compliance to protocol|2|||
27877394|NCT01730053|81383305|FG000|Overall Study|Other than specified|2|||
27877395|NCT01730053|81383306|FG001|Overall Study|Other than specified|6|||
27877396|NCT01730053|81383307|FG002|Overall Study|Other than specified|5|||
27877397|NCT01730053|81383308|FG003|Overall Study|Other than specified|4|||
27877398|NCT01730053|81383309|FG004|Overall Study|Other than specified|7|||
27877399|NCT01730053|81383310|FG005|Overall Study|Other than specified|9|||
27877400|NCT03989102|81383313|FG000|Year 1|Withdrawal by Subject|6|||
27877401|NCT03989102|81383314|FG001|Year 1|Withdrawal by Subject|2|||
27877402|NCT03989102|81383315|FG002|Year 1|Withdrawal by Subject|7|||
27877403|NCT03989102|81383313|FG000|Year 1|Lost to Follow-up|5|||
27877404|NCT03989102|81383314|FG001|Year 1|Lost to Follow-up|2|||
27877405|NCT03989102|81383315|FG002|Year 1|Lost to Follow-up|5|||
27877406|NCT03989102|81383313|FG000|Year 1|Subject met withdrawal criteria|1|||
27877407|NCT03989102|81383314|FG001|Year 1|Subject met withdrawal criteria|0|||
27877408|NCT03989102|81383315|FG002|Year 1|Subject met withdrawal criteria|1|||
27877409|NCT03989102|81383313|FG000|Year 2|Lost to Follow-up|7|||
27877410|NCT03989102|81383314|FG001|Year 2|Lost to Follow-up|3|||
27877411|NCT03989102|81383315|FG002|Year 2|Lost to Follow-up|4|||
27877412|NCT03989102|81383313|FG000|Year 2|Withdrawal by Subject|3|||
27877413|NCT03989102|81383314|FG001|Year 2|Withdrawal by Subject|1|||
27877414|NCT03989102|81383315|FG002|Year 2|Withdrawal by Subject|2|||
27877415|NCT03989102|81383313|FG000|Year 2|Subject non-compliant|3|||
27877416|NCT03989102|81383314|FG001|Year 2|Subject non-compliant|2|||
27877417|NCT03989102|81383315|FG002|Year 2|Subject non-compliant|0|||
27877418|NCT03989102|81383313|FG000|Year 2|Travel|1|||
27877419|NCT03989102|81383314|FG001|Year 2|Travel|0|||
27877420|NCT03989102|81383315|FG002|Year 2|Travel|1|||
27877421|NCT03989102|81383313|FG000|Year 2|P16 missing|4|||
27877422|NCT03989102|81383314|FG001|Year 2|P16 missing|2|||
27877423|NCT03989102|81383315|FG002|Year 2|P16 missing|1|||
27877424|NCT03989102|81383313|FG000|Year 2|P11 missing|1|||
27877425|NCT03989102|81383314|FG001|Year 2|P11 missing|3|||
27877426|NCT03989102|81383315|FG002|Year 2|P11 missing|7|||
27877427|NCT03989102|81383313|FG000|Year 2|Definitive displacement outside the study site|0|||
27877428|NCT03989102|81383314|FG001|Year 2|Definitive displacement outside the study site|1|||
27877429|NCT03989102|81383315|FG002|Year 2|Definitive displacement outside the study site|0|||
27877430|NCT03989102|81383313|FG000|Year 2|Subject missed last study visit|0|||
27877431|NCT03989102|81383314|FG001|Year 2|Subject missed last study visit|1|||
27877432|NCT03989102|81383315|FG002|Year 2|Subject missed last study visit|0|||
27877433|NCT03989102|81383313|FG000|Year 2|Death|0|||
27877434|NCT03989102|81383314|FG001|Year 2|Death|1|||
27877435|NCT03989102|81383315|FG002|Year 2|Death|0|||
27877436|NCT03989102|81383313|FG000|Year 2|Subject not reachable|0|||
27877437|NCT03989102|81383314|FG001|Year 2|Subject not reachable|0|||
27877438|NCT03989102|81383315|FG002|Year 2|Subject not reachable|1|||
27589588|NCT01292603|80340389|FG002|Overall Survival Status|Death|3|||
27589589|NCT01292603|80340390|FG003|Overall Survival Status|Death|1|||
27589590|NCT01292603|80340391|FG004|Overall Survival Status|Death|16|||
27589591|NCT01292603|80340392|FG005|Overall Survival Status|Death|10|||
27589592|NCT02363946|80340393|FG000|Overall Study|Lost to Follow-up|0|||
27589593|NCT02363946|80340394|FG001|Overall Study|Lost to Follow-up|0|||
27589594|NCT02363946|80340395|FG002|Overall Study|Lost to Follow-up|0|||
27589595|NCT02363946|80340396|FG003|Overall Study|Lost to Follow-up|0|||
27589596|NCT02363946|80340397|FG004|Overall Study|Lost to Follow-up|0|||
27589597|NCT02363946|80340398|FG005|Overall Study|Lost to Follow-up|0|||
27589598|NCT02363946|80340399|FG006|Overall Study|Lost to Follow-up|0|||
27589599|NCT02363946|80340400|FG007|Overall Study|Lost to Follow-up|1|||
27589600|NCT02363946|80340401|FG008|Overall Study|Lost to Follow-up|0|||
27814999|NCT01769378|81154488|FG000|Overall Study|Entry criteria not met|1|||
27815000|NCT01769378|81154489|FG001|Overall Study|Entry criteria not met|0|||
27815001|NCT01769378|81154488|FG000|Overall Study|Protocol Violation|1|||
27815002|NCT01769378|81154489|FG001|Overall Study|Protocol Violation|1|||
27815003|NCT01769378|81154488|FG000|Overall Study|Withdrawal by Subject|10|||
27815004|NCT01769378|81154489|FG001|Overall Study|Withdrawal by Subject|3|||
27815005|NCT01769378|81154488|FG000|Overall Study|Sponsor Decision|1|||
27815006|NCT01769378|81154489|FG001|Overall Study|Sponsor Decision|0|||
27815007|NCT01769378|81154488|FG000|Overall Study|Lost to Follow-up|2|||
27815008|NCT01769378|81154489|FG001|Overall Study|Lost to Follow-up|0|||
27815009|NCT00602030|81154490|FG000|Lead-in Phase|Disease Progression|2|||
27815010|NCT00602030|81154491|FG001|Lead-in Phase|Disease Progression|3|||
27815011|NCT00602030|81154492|FG002|Lead-in Phase|Disease Progression|0|||
27815012|NCT00602030|81154493|FG003|Lead-in Phase|Disease Progression|0|||
27815013|NCT00602030|81154494|FG004|Lead-in Phase|Disease Progression|0|||
27815014|NCT00602030|81154490|FG000|Lead-in Phase|Adverse Event|0|||
27815015|NCT00602030|81154491|FG001|Lead-in Phase|Adverse Event|2|||
27815016|NCT00602030|81154492|FG002|Lead-in Phase|Adverse Event|0|||
27815017|NCT00602030|81154493|FG003|Lead-in Phase|Adverse Event|0|||
27815018|NCT00602030|81154494|FG004|Lead-in Phase|Adverse Event|0|||
27815019|NCT00602030|81154490|FG000|Double-blind Phase|Disease progression|0|||
27815020|NCT00602030|81154491|FG001|Double-blind Phase|Disease progression|0|||
27815021|NCT00602030|81154492|FG002|Double-blind Phase|Disease progression|33|||
27815022|NCT00602030|81154493|FG003|Double-blind Phase|Disease progression|30|||
27815023|NCT00602030|81154494|FG004|Double-blind Phase|Disease progression|0|||
27815024|NCT00602030|81154490|FG000|Double-blind Phase|Adverse Event|0|||
27815025|NCT00602030|81154491|FG001|Double-blind Phase|Adverse Event|0|||
27815026|NCT00602030|81154492|FG002|Double-blind Phase|Adverse Event|9|||
27815027|NCT00602030|81154493|FG003|Double-blind Phase|Adverse Event|18|||
27815028|NCT00602030|81154494|FG004|Double-blind Phase|Adverse Event|0|||
27815029|NCT00602030|81154490|FG000|Double-blind Phase|Consent withdrawal|0|||
27815030|NCT00602030|81154491|FG001|Double-blind Phase|Consent withdrawal|0|||
27815031|NCT00602030|81154492|FG002|Double-blind Phase|Consent withdrawal|4|||
27815032|NCT00602030|81154493|FG003|Double-blind Phase|Consent withdrawal|3|||
27815033|NCT00602030|81154494|FG004|Double-blind Phase|Consent withdrawal|0|||
27815034|NCT00602030|81154490|FG000|Double-blind Phase|Death|0|||
27815035|NCT00602030|81154491|FG001|Double-blind Phase|Death|0|||
27589601|NCT02363946|80340402|FG009|Overall Study|Lost to Follow-up|0|||
27589602|NCT02363946|80340403|FG010|Overall Study|Lost to Follow-up|0|||
27815036|NCT00602030|81154492|FG002|Double-blind Phase|Death|3|||
27815037|NCT00602030|81154493|FG003|Double-blind Phase|Death|3|||
27815038|NCT00602030|81154494|FG004|Double-blind Phase|Death|0|||
27815039|NCT00602030|81154490|FG000|Double-blind Phase|Administrative decision|0|||
27815040|NCT00602030|81154491|FG001|Double-blind Phase|Administrative decision|0|||
27815041|NCT00602030|81154492|FG002|Double-blind Phase|Administrative decision|0|||
27815042|NCT00602030|81154493|FG003|Double-blind Phase|Administrative decision|2|||
27815043|NCT00602030|81154494|FG004|Double-blind Phase|Administrative decision|0|||
27815044|NCT00602030|81154490|FG000|Double-blind Phase|Ineligibility|0|||
27815045|NCT00602030|81154491|FG001|Double-blind Phase|Ineligibility|0|||
27815046|NCT00602030|81154492|FG002|Double-blind Phase|Ineligibility|0|||
27877439|NCT03989102|81383313|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
27877440|NCT03989102|81383314|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
27877441|NCT03989102|81383315|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
27877442|NCT03989102|81383313|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
27877443|NCT03989102|81383314|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
27877444|NCT03989102|81383315|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
27877445|NCT03989102|81383313|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
27877446|NCT03989102|81383314|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
27877447|NCT03989102|81383315|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
27877448|NCT03989102|81383313|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
27877449|NCT03989102|81383314|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
27877450|NCT03989102|81383315|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
27877451|NCT03989102|81383313|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
27877452|NCT03989102|81383314|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
27877453|NCT03989102|81383315|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
27877454|NCT03989102|81383313|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
27877455|NCT03989102|81383314|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
27589603|NCT02363946|80340404|FG011|Overall Study|Lost to Follow-up|0|||
27589604|NCT02363946|80340405|FG012|Overall Study|Lost to Follow-up|0|||
27589605|NCT03422003|80340406|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
27589606|NCT03422003|80340407|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
27877456|NCT03989102|81383315|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
27877457|NCT01290068|81383318|FG000|Overall Study|Adverse Event|1|||
27877458|NCT01290068|81383319|FG001|Overall Study|Adverse Event|3|||
27589607|NCT03422003|80340406|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
27877459|NCT01290068|81383318|FG000|Overall Study|Lost to Follow-up|3|||
27877460|NCT01290068|81383319|FG001|Overall Study|Lost to Follow-up|0|||
27877461|NCT01290068|81383318|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
27877462|NCT01290068|81383319|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
27877463|NCT01290068|81383318|FG000|Overall Study|Other|3|||
27877464|NCT01290068|81383319|FG001|Overall Study|Other|1|||
27877465|NCT01303172|81383320|FG000|Overall Study|Physician Decision|9|||
27877466|NCT01303172|81383321|FG001|Overall Study|Physician Decision|6|||
27877467|NCT01303172|81383320|FG000|Overall Study|Adverse Event|5|||
27877468|NCT01303172|81383321|FG001|Overall Study|Adverse Event|2|||
27877469|NCT01303172|81383320|FG000|Overall Study|Withdrawal by Subject|4|||
27877470|NCT01303172|81383321|FG001|Overall Study|Withdrawal by Subject|2|||
27877471|NCT01303172|81383320|FG000|Overall Study|Death|20|||
27877472|NCT01303172|81383321|FG001|Overall Study|Death|7|||
27877473|NCT01303172|81383320|FG000|Overall Study|Lack of Efficacy|25|||
27877474|NCT01303172|81383321|FG001|Overall Study|Lack of Efficacy|17|||
27877475|NCT01293695|81383324|FG000|Overall Study|Withdrawal by Subject|7|||
27877476|NCT01293695|81383325|FG001|Overall Study|Withdrawal by Subject|1|||
27877477|NCT01293695|81383324|FG000|Overall Study|Lost to Follow-up|8|||
27877478|NCT01293695|81383325|FG001|Overall Study|Lost to Follow-up|6|||
27589608|NCT03422003|80340407|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
27589609|NCT01775904|80340409|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
27589610|NCT01775904|80340409|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
27589611|NCT00688636|80340410|FG000|Overall Study|Adverse Event|2|||
27589612|NCT00688636|80340411|FG001|Overall Study|Adverse Event|1|||
27589613|NCT01369342|80340412|FG000|Overall Study|Withdrawal by Subject|7|||
27589614|NCT01369342|80340413|FG001|Overall Study|Withdrawal by Subject|7|||
27589615|NCT01369342|80340414|FG002|Overall Study|Withdrawal by Subject|2|||
27589616|NCT01369342|80340412|FG000|Overall Study|Lost to Follow-up|5|||
27589617|NCT01369342|80340413|FG001|Overall Study|Lost to Follow-up|2|||
27589618|NCT01369342|80340414|FG002|Overall Study|Lost to Follow-up|1|||
27589619|NCT01369342|80340412|FG000|Overall Study|Not Treated|1|||
27589620|NCT01369342|80340413|FG001|Overall Study|Not Treated|0|||
27877479|NCT00314327|81383326|FG000|Overall Study|Withdrawal by Subject|1|||
27877480|NCT02025725|81383327|FG000|Overall Study|Adverse Event|5|||
27877481|NCT02025725|81383328|FG001|Overall Study|Adverse Event|0|||
27877482|NCT02025725|81383327|FG000|Overall Study|Lost to Follow-up|2|||
27877483|NCT02025725|81383328|FG001|Overall Study|Lost to Follow-up|0|||
27877484|NCT02025725|81383327|FG000|Overall Study|Protocol Violation|1|||
27877485|NCT02025725|81383328|FG001|Overall Study|Protocol Violation|1|||
27877486|NCT02025725|81383327|FG000|Overall Study|Withdrawal by Subject|3|||
27877487|NCT02025725|81383328|FG001|Overall Study|Withdrawal by Subject|2|||
27877488|NCT02025725|81383327|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
27877489|NCT02025725|81383328|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
27877490|NCT00615550|81383333|FG000|Overall Study|Lost to Follow-up|6|||
27589621|NCT01369342|80340414|FG002|Overall Study|Not Treated|0|||
27589622|NCT03150056|80340417|FG000|Overall Study|Withdrawal by Subject|0|||
27589623|NCT03150056|80340418|FG001|Overall Study|Withdrawal by Subject|0|||
27877491|NCT00615550|81383334|FG001|Overall Study|Lost to Follow-up|1|||
27589624|NCT03150056|80340419|FG002|Overall Study|Withdrawal by Subject|0|||
27589625|NCT03150056|80340420|FG003|Overall Study|Withdrawal by Subject|0|||
27589626|NCT03150056|80340421|FG004|Overall Study|Withdrawal by Subject|0|||
27589627|NCT03150056|80340422|FG005|Overall Study|Withdrawal by Subject|2|||
27589628|NCT03150056|80340417|FG000|Overall Study|Study terminated by Sponsor|1|||
27589629|NCT03150056|80340418|FG001|Overall Study|Study terminated by Sponsor|3|||
27589630|NCT03150056|80340419|FG002|Overall Study|Study terminated by Sponsor|1|||
27589631|NCT03150056|80340420|FG003|Overall Study|Study terminated by Sponsor|1|||
27589632|NCT03150056|80340421|FG004|Overall Study|Study terminated by Sponsor|5|||
27589633|NCT03150056|80340422|FG005|Overall Study|Study terminated by Sponsor|6|||
27589634|NCT03150056|80340417|FG000|Overall Study|Death|9|||
27589635|NCT03150056|80340418|FG001|Overall Study|Death|2|||
27589636|NCT03150056|80340419|FG002|Overall Study|Death|2|||
27589637|NCT03150056|80340420|FG003|Overall Study|Death|7|||
27589638|NCT03150056|80340421|FG004|Overall Study|Death|8|||
27589639|NCT03150056|80340422|FG005|Overall Study|Death|10|||
27589640|NCT04302350|80340423|FG000|Overall Study|Physician Decision|1|||
27589641|NCT04302350|80340424|FG001|Overall Study|Physician Decision|1|||
27589642|NCT04302350|80340425|FG002|Overall Study|Physician Decision|2|||
27589643|NCT04302350|80340423|FG000|Overall Study|Lack of Efficacy|1|||
27589644|NCT04302350|80340424|FG001|Overall Study|Lack of Efficacy|1|||
27589645|NCT04302350|80340425|FG002|Overall Study|Lack of Efficacy|4|||
27589646|NCT04302350|80340423|FG000|Overall Study|Adverse Event|0|||
27589647|NCT04302350|80340424|FG001|Overall Study|Adverse Event|1|||
27589648|NCT04302350|80340425|FG002|Overall Study|Adverse Event|2|||
27589649|NCT03389802|80340426|FG000|Overall Study|Lack of Efficacy|3|||
27589650|NCT03389802|80340427|FG001|Overall Study|Lack of Efficacy|3|||
27589651|NCT03389802|80340428|FG002|Overall Study|Lack of Efficacy|13|||
27589652|NCT03389802|80340429|FG003|Overall Study|Lack of Efficacy|6|||
27701002|NCT01241552|80741291|FG002|Overall Study|Physician Decision|2|||
27589653|NCT03389802|80340430|FG004|Overall Study|Lack of Efficacy|1|||
27589654|NCT03389802|80340426|FG000|Overall Study|Adverse Event|0|||
27589655|NCT03389802|80340427|FG001|Overall Study|Adverse Event|0|||
27589656|NCT03389802|80340428|FG002|Overall Study|Adverse Event|1|||
27589657|NCT03389802|80340429|FG003|Overall Study|Adverse Event|0|||
27589658|NCT03389802|80340430|FG004|Overall Study|Adverse Event|4|||
27589659|NCT03389802|80340426|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
27589660|NCT03389802|80340427|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
27589661|NCT03389802|80340428|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
27815047|NCT00602030|81154493|FG003|Double-blind Phase|Ineligibility|1|||
27589662|NCT03389802|80340429|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
27589663|NCT03389802|80340430|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
27594400|NCT00955357|80356063|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
27815048|NCT00602030|81154494|FG004|Double-blind Phase|Ineligibility|0|||
27815049|NCT00602030|81154490|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
27815050|NCT00602030|81154491|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
27815051|NCT00602030|81154492|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
27815052|NCT00602030|81154493|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
27815053|NCT00602030|81154494|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
27815054|NCT00602030|81154490|FG000|Double-blind Phase|Reason not specified|0|||
27815055|NCT00602030|81154491|FG001|Double-blind Phase|Reason not specified|0|||
27815056|NCT00602030|81154492|FG002|Double-blind Phase|Reason not specified|4|||
27815057|NCT00602030|81154493|FG003|Double-blind Phase|Reason not specified|2|||
27815058|NCT00602030|81154494|FG004|Double-blind Phase|Reason not specified|0|||
27815059|NCT00602030|81154490|FG000|Crossover Phase|Disease Progression|0|||
27815060|NCT00602030|81154491|FG001|Crossover Phase|Disease Progression|0|||
27701003|NCT01241552|80741292|FG003|Overall Study|Physician Decision|3|||
27815061|NCT00602030|81154492|FG002|Crossover Phase|Disease Progression|0|||
27815062|NCT00602030|81154493|FG003|Crossover Phase|Disease Progression|0|||
27815063|NCT00602030|81154494|FG004|Crossover Phase|Disease Progression|11|||
27688711|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
27688712|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
27688713|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
27688714|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
27688715|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
27688716|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
27589664|NCT01434602|80340431|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
27589665|NCT01434602|80340432|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
27589666|NCT01434602|80340433|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
27589667|NCT01434602|80340434|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
27594401|NCT00955357|80356064|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
27589668|NCT01434602|80340435|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
27589669|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
27589670|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
27589671|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
27589672|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
27589673|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
27589674|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
27589675|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
27589676|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
27589677|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
27594402|NCT00955357|80356063|FG000|Titration Phase|Study medication not tolerated|0|||
27589678|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
27589679|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
27589680|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
27589681|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
27589682|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
27589683|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
27589684|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
27589685|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
27589686|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
27589687|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
27589688|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
27589689|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
27589690|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
27589691|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
27589692|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
27589693|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
27589694|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
27589695|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
27589696|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
27589697|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
27589698|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
27589699|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
27589700|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
27589701|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
27589702|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
27589703|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
27589704|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
27589705|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
27589706|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
27589707|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
27589708|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
27589709|NCT01434602|80340431|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
27589710|NCT01434602|80340432|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
27815064|NCT00602030|81154490|FG000|Crossover Phase|Adverse Event|0|||
27589711|NCT01434602|80340433|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
27589712|NCT01434602|80340434|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
27589713|NCT01434602|80340435|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
27688717|NCT00600886|80694337|FG000|Extension - After Crossover (CAS)|Death|1|||
27688718|NCT00600886|80694338|FG001|Extension - After Crossover (CAS)|Death|0|||
27688719|NCT02781844|80694342|FG000|Treatment Period 1|Adverse Event|0|||
27688720|NCT02781844|80694343|FG001|Treatment Period 1|Adverse Event|0|||
27688721|NCT02781844|80694344|FG002|Treatment Period 1|Adverse Event|0|||
27688722|NCT02781844|80694345|FG003|Treatment Period 1|Adverse Event|0|||
27688723|NCT02781844|80694346|FG004|Treatment Period 1|Adverse Event|0|||
27688724|NCT02781844|80694347|FG005|Treatment Period 1|Adverse Event|1|||
27688725|NCT02781844|80694348|FG006|Treatment Period 1|Adverse Event|0|||
27688726|NCT02781844|80694349|FG007|Treatment Period 1|Adverse Event|0|||
27688727|NCT02595073|80694350|FG000|Overall Study|Progressive Disease|0|||
27688728|NCT02595073|80694351|FG001|Overall Study|Progressive Disease|1|||
27688729|NCT02595073|80694350|FG000|Overall Study|Protocol Violation|2|||
27815065|NCT00602030|81154491|FG001|Crossover Phase|Adverse Event|0|||
27688730|NCT02595073|80694351|FG001|Overall Study|Protocol Violation|0|||
27688731|NCT00423943|80694352|FG000|Overall Study|Withdrawal by Subject|3|||
27688732|NCT00423943|80694353|FG001|Overall Study|Withdrawal by Subject|1|||
27688733|NCT02704754|80694356|FG000|Overall Study|Lost to Follow-up|1|||
27688734|NCT02704754|80694357|FG001|Overall Study|Lost to Follow-up|1|||
27688735|NCT02704754|80694356|FG000|Overall Study|Lack of Efficacy|1|||
27688736|NCT02704754|80694357|FG001|Overall Study|Lack of Efficacy|0|||
27688737|NCT02704754|80694356|FG000|Overall Study|Withdrawal by Subject|1|||
27688738|NCT02704754|80694357|FG001|Overall Study|Withdrawal by Subject|0|||
27688739|NCT01474434|80694358|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
27688740|NCT01474434|80694359|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
27688741|NCT01474434|80694360|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
27688742|NCT01474434|80694361|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
27688743|NCT01474434|80694358|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
27688744|NCT01474434|80694359|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
27688745|NCT01474434|80694360|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
27688746|NCT01474434|80694361|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
27688747|NCT01474434|80694358|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
27688748|NCT01474434|80694359|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
27688749|NCT01474434|80694360|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
27688750|NCT01474434|80694361|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
27688751|NCT02724969|80694362|FG000|Overall Study|Lost to Follow-up|12|||
27688752|NCT02724969|80694363|FG001|Overall Study|Lost to Follow-up|6|||
27688753|NCT02724969|80694362|FG000|Overall Study|Withdrawal by Subject|3|||
27688754|NCT02724969|80694363|FG001|Overall Study|Withdrawal by Subject|3|||
27688755|NCT02724969|80694362|FG000|Overall Study|Infant demise|0|||
27589714|NCT04717596|80340436|FG000|Overall Study|Withdrawal by Subject|4|||
27688756|NCT02724969|80694363|FG001|Overall Study|Infant demise|2|||
27688757|NCT00381615|80694367|FG000|Overall Study|Withdrawal by Subject|1|||
27877492|NCT01611883|81383335|FG000|Overall Study|Adverse Event|1|||
27877493|NCT01611883|81383336|FG001|Overall Study|Adverse Event|1|||
27877494|NCT00958828|81383337|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
27877495|NCT00958828|81383338|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
27877496|NCT00958828|81383337|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
27877497|NCT00958828|81383338|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
27877498|NCT00985504|81383343|FG000|Acute Treatment Period|Adverse Event|3|||
27877499|NCT00985504|81383344|FG001|Acute Treatment Period|Adverse Event|4|||
27877500|NCT00985504|81383343|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
27877501|NCT00985504|81383344|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
27877502|NCT00985504|81383343|FG000|Acute Treatment Period|Protocol Violation|2|||
27877503|NCT00985504|81383344|FG001|Acute Treatment Period|Protocol Violation|0|||
27877504|NCT00985504|81383343|FG000|Acute Treatment Period|Sponsor Decision|0|||
27877505|NCT00985504|81383344|FG001|Acute Treatment Period|Sponsor Decision|1|||
27877506|NCT00985504|81383343|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
27877507|NCT00985504|81383344|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
27877508|NCT00985504|81383343|FG000|Optimization Period|Adverse Event|7|||
27877509|NCT00985504|81383344|FG001|Optimization Period|Adverse Event|9|||
27877510|NCT00985504|81383343|FG000|Optimization Period|Death|0|||
27688758|NCT00381615|80694368|FG001|Overall Study|Withdrawal by Subject|3|||
27877511|NCT00985504|81383344|FG001|Optimization Period|Death|1|||
27877512|NCT00985504|81383343|FG000|Optimization Period|Lack of Efficacy|5|||
27688759|NCT00381615|80694369|FG002|Overall Study|Withdrawal by Subject|0|||
27688760|NCT00381615|80694370|FG003|Overall Study|Withdrawal by Subject|1|||
27688761|NCT00381615|80694367|FG000|Overall Study|Lost to Follow-up|3|||
27688762|NCT00381615|80694368|FG001|Overall Study|Lost to Follow-up|2|||
27815066|NCT00602030|81154492|FG002|Crossover Phase|Adverse Event|0|||
27815067|NCT00602030|81154493|FG003|Crossover Phase|Adverse Event|0|||
27815068|NCT00602030|81154494|FG004|Crossover Phase|Adverse Event|3|||
27815069|NCT00602030|81154490|FG000|Crossover Phase|Consent withdrawal|0|||
27815070|NCT00602030|81154491|FG001|Crossover Phase|Consent withdrawal|0|||
27815071|NCT00602030|81154492|FG002|Crossover Phase|Consent withdrawal|0|||
27815072|NCT00602030|81154493|FG003|Crossover Phase|Consent withdrawal|0|||
27688763|NCT00381615|80694369|FG002|Overall Study|Lost to Follow-up|0|||
27815073|NCT00602030|81154494|FG004|Crossover Phase|Consent withdrawal|2|||
27688764|NCT00381615|80694370|FG003|Overall Study|Lost to Follow-up|1|||
27877513|NCT00985504|81383344|FG001|Optimization Period|Lack of Efficacy|3|||
27877514|NCT00985504|81383343|FG000|Optimization Period|Lost to Follow-up|0|||
27877515|NCT00985504|81383344|FG001|Optimization Period|Lost to Follow-up|1|||
27877516|NCT00985504|81383343|FG000|Optimization Period|Physician Decision|1|||
27877517|NCT00985504|81383344|FG001|Optimization Period|Physician Decision|0|||
27877518|NCT00985504|81383343|FG000|Optimization Period|Protocol Violation|3|||
27877519|NCT00985504|81383344|FG001|Optimization Period|Protocol Violation|1|||
27877520|NCT00985504|81383343|FG000|Optimization Period|Withdrawal by Subject|10|||
27589715|NCT01432366|80340437|FG000|Overall Study|Non-Responder|7|||
27589716|NCT01432366|80340437|FG000|Overall Study|Adverse Event|8|||
27877521|NCT00985504|81383344|FG001|Optimization Period|Withdrawal by Subject|8|||
27877522|NCT00722137|81383358|FG000|Overall Study|Overt Disease Progression|5|||
27877523|NCT00722137|81383359|FG001|Overall Study|Overt Disease Progression|4|||
27877524|NCT00722137|81383358|FG000|Overall Study|Adverse Event|17|||
27589717|NCT01432366|80340437|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
27877525|NCT00722137|81383359|FG001|Overall Study|Adverse Event|21|||
27877526|NCT00722137|81383358|FG000|Overall Study|Death|12|||
27877527|NCT00722137|81383359|FG001|Overall Study|Death|7|||
27589718|NCT01432366|80340437|FG000|Overall Study|Pregnancy|1|||
27688765|NCT00381615|80694367|FG000|Overall Study|Protocol Violation|0|||
27688766|NCT00381615|80694368|FG001|Overall Study|Protocol Violation|0|||
27688767|NCT00381615|80694369|FG002|Overall Study|Protocol Violation|1|||
27688768|NCT00381615|80694370|FG003|Overall Study|Protocol Violation|0|||
27688769|NCT00484289|80694373|FG000|Long Term Phase|Adverse Event|1|||
27688770|NCT00484289|80694374|FG001|Long Term Phase|Adverse Event|17|||
27688771|NCT00484289|80694375|FG002|Long Term Phase|Adverse Event|5|||
27688772|NCT00484289|80694373|FG000|Long Term Phase|Withdrawal by Subject|0|||
27815074|NCT02579096|81154495|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
27815075|NCT02579096|81154496|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
27815076|NCT02579096|81154495|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
27815077|NCT02579096|81154496|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
27815078|NCT02579096|81154495|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
27688773|NCT00484289|80694374|FG001|Long Term Phase|Withdrawal by Subject|7|||
27688774|NCT00484289|80694375|FG002|Long Term Phase|Withdrawal by Subject|6|||
27688775|NCT00484289|80694373|FG000|Long Term Phase|Inadequate response|2|||
27877528|NCT00722137|81383358|FG000|Overall Study|Withdrawal by Subject|6|||
27877529|NCT00722137|81383359|FG001|Overall Study|Withdrawal by Subject|9|||
27877530|NCT00722137|81383358|FG000|Overall Study|Other Reason Unknown|3|||
27877531|NCT00722137|81383359|FG001|Overall Study|Other Reason Unknown|4|||
27877532|NCT00722137|81383358|FG000|Overall Study|Randomized But Not Treated|2|||
27877533|NCT00722137|81383359|FG001|Overall Study|Randomized But Not Treated|3|||
27877534|NCT02554682|81383360|FG000|Overall Study|Lost to Follow-up|11|||
27877535|NCT02554682|81383361|FG001|Overall Study|Lost to Follow-up|9|||
27877536|NCT02554682|81383362|FG002|Overall Study|Lost to Follow-up|4|||
27877537|NCT02554682|81383363|FG003|Overall Study|Lost to Follow-up|3|||
27877538|NCT02554682|81383364|FG004|Overall Study|Lost to Follow-up|2|||
27877539|NCT02554682|81383365|FG005|Overall Study|Lost to Follow-up|1|||
27877540|NCT02554682|81383366|FG006|Overall Study|Lost to Follow-up|6|||
27877541|NCT02554682|81383367|FG007|Overall Study|Lost to Follow-up|6|||
27877542|NCT02554682|81383368|FG008|Overall Study|Lost to Follow-up|2|||
27877543|NCT02554682|81383369|FG009|Overall Study|Lost to Follow-up|2|||
27877544|NCT02554682|81383360|FG000|Overall Study|Withdrawal by Subject|2|||
27877545|NCT02554682|81383361|FG001|Overall Study|Withdrawal by Subject|1|||
27877546|NCT02554682|81383362|FG002|Overall Study|Withdrawal by Subject|0|||
27877547|NCT02554682|81383363|FG003|Overall Study|Withdrawal by Subject|0|||
27877548|NCT02554682|81383364|FG004|Overall Study|Withdrawal by Subject|0|||
27877549|NCT02554682|81383365|FG005|Overall Study|Withdrawal by Subject|0|||
27877550|NCT02554682|81383366|FG006|Overall Study|Withdrawal by Subject|0|||
27877551|NCT02554682|81383367|FG007|Overall Study|Withdrawal by Subject|0|||
27877552|NCT02554682|81383368|FG008|Overall Study|Withdrawal by Subject|0|||
27877553|NCT02554682|81383369|FG009|Overall Study|Withdrawal by Subject|0|||
27877554|NCT02554682|81383360|FG000|Overall Study|Physician Decision|2|||
27877555|NCT02554682|81383361|FG001|Overall Study|Physician Decision|2|||
27877556|NCT02554682|81383362|FG002|Overall Study|Physician Decision|0|||
27877557|NCT02554682|81383363|FG003|Overall Study|Physician Decision|0|||
27877558|NCT02554682|81383364|FG004|Overall Study|Physician Decision|0|||
27877559|NCT02554682|81383365|FG005|Overall Study|Physician Decision|0|||
27877560|NCT02554682|81383366|FG006|Overall Study|Physician Decision|0|||
27877561|NCT02554682|81383367|FG007|Overall Study|Physician Decision|0|||
27877562|NCT02554682|81383368|FG008|Overall Study|Physician Decision|0|||
27877563|NCT02554682|81383369|FG009|Overall Study|Physician Decision|0|||
27877564|NCT03817125|81383372|FG000|Overall Study|Adverse Event|1|||
27877565|NCT03817125|81383373|FG001|Overall Study|Adverse Event|0|||
27877566|NCT03817125|81383372|FG000|Overall Study|Physician Decision|0|||
27877567|NCT03817125|81383373|FG001|Overall Study|Physician Decision|1|||
27877568|NCT03817125|81383372|FG000|Overall Study|Lack of Efficacy|1|||
27877569|NCT03817125|81383373|FG001|Overall Study|Lack of Efficacy|5|||
27877570|NCT03802825|81383374|FG000|Overall Study|Lost to follow-up for intervention|12|||
27877571|NCT03802825|81383375|FG001|Overall Study|Lost to follow-up for intervention|3|||
27877572|NCT03802825|81383374|FG000|Overall Study|Received only 1 component of intervention|0|||
27877573|NCT03802825|81383375|FG001|Overall Study|Received only 1 component of intervention|13|||
27877574|NCT01567462|81383376|FG000|Overall Study|Withdrawal by Subject|4|||
27877575|NCT01567462|81383377|FG001|Overall Study|Withdrawal by Subject|7|||
27877576|NCT02801617|81383378|FG000|Overall Study|Protocol Violation|2|||
27877577|NCT02801617|81383379|FG001|Overall Study|Protocol Violation|6|||
27877578|NCT02548143|81383380|FG000|Overall Study|Adverse Event|1|||
27877579|NCT02548143|81383381|FG001|Overall Study|Adverse Event|0|||
27877580|NCT02548143|81383380|FG000|Overall Study|Withdrawal by Subject|0|||
27877581|NCT02548143|81383381|FG001|Overall Study|Withdrawal by Subject|1|||
27877582|NCT00669669|81383382|FG000|Overall Study|To late to start treatment|1|||
27877583|NCT02222922|81383388|FG000|Overall Study|Death|0|||
27877584|NCT02222922|81383389|FG001|Overall Study|Death|0|||
27877585|NCT02222922|81383390|FG002|Overall Study|Death|0|||
27877586|NCT02222922|81383391|FG003|Overall Study|Death|0|||
27877587|NCT02222922|81383392|FG004|Overall Study|Death|13|||
27877588|NCT02222922|81383393|FG005|Overall Study|Death|0|||
27877589|NCT02222922|81383394|FG006|Overall Study|Death|0|||
27877590|NCT02222922|81383395|FG007|Overall Study|Death|0|||
27877591|NCT02222922|81383396|FG008|Overall Study|Death|2|||
27877592|NCT02222922|81383388|FG000|Overall Study|Lost to Follow-up|0|||
27877593|NCT02222922|81383389|FG001|Overall Study|Lost to Follow-up|0|||
27877594|NCT02222922|81383390|FG002|Overall Study|Lost to Follow-up|1|||
27877595|NCT02222922|81383391|FG003|Overall Study|Lost to Follow-up|0|||
27877596|NCT02222922|81383392|FG004|Overall Study|Lost to Follow-up|9|||
27877597|NCT02222922|81383393|FG005|Overall Study|Lost to Follow-up|1|||
27877598|NCT02222922|81383394|FG006|Overall Study|Lost to Follow-up|0|||
27877599|NCT02222922|81383395|FG007|Overall Study|Lost to Follow-up|0|||
27877600|NCT02222922|81383396|FG008|Overall Study|Lost to Follow-up|0|||
27877601|NCT02222922|81383388|FG000|Overall Study|Other|0|||
27877602|NCT02222922|81383389|FG001|Overall Study|Other|0|||
27877603|NCT02222922|81383390|FG002|Overall Study|Other|0|||
27877604|NCT02222922|81383391|FG003|Overall Study|Other|2|||
27877605|NCT02222922|81383392|FG004|Overall Study|Other|10|||
27877606|NCT02222922|81383393|FG005|Overall Study|Other|2|||
27877607|NCT02222922|81383394|FG006|Overall Study|Other|2|||
27877608|NCT02222922|81383395|FG007|Overall Study|Other|4|||
27877609|NCT02222922|81383396|FG008|Overall Study|Other|1|||
27877610|NCT02222922|81383388|FG000|Overall Study|Participant refused further follow-up|1|||
27877611|NCT02222922|81383389|FG001|Overall Study|Participant refused further follow-up|0|||
27877612|NCT02222922|81383390|FG002|Overall Study|Participant refused further follow-up|0|||
27877613|NCT02222922|81383391|FG003|Overall Study|Participant refused further follow-up|1|||
27877614|NCT02222922|81383392|FG004|Overall Study|Participant refused further follow-up|6|||
27877615|NCT02222922|81383393|FG005|Overall Study|Participant refused further follow-up|0|||
27877616|NCT02222922|81383394|FG006|Overall Study|Participant refused further follow-up|0|||
27877617|NCT02222922|81383395|FG007|Overall Study|Participant refused further follow-up|0|||
27877618|NCT02222922|81383396|FG008|Overall Study|Participant refused further follow-up|3|||
27877619|NCT04909853|81383397|FG000|Part 1|Assigned but not treated|0|||
27877620|NCT04909853|81383398|FG001|Part 1|Assigned but not treated|0|||
27877621|NCT04909853|81383399|FG002|Part 1|Assigned but not treated|1|||
27688776|NCT00484289|80694374|FG001|Long Term Phase|Inadequate response|7|||
27877622|NCT04909853|81383400|FG003|Part 1|Assigned but not treated|0|||
27877623|NCT04909853|81383397|FG000|Part 2|Adverse Event|0|||
27877624|NCT04909853|81383398|FG001|Part 2|Adverse Event|0|||
27877625|NCT04909853|81383399|FG002|Part 2|Adverse Event|0|||
27877626|NCT04909853|81383400|FG003|Part 2|Adverse Event|1|||
27877627|NCT02750618|81383401|FG000|Overall Study|Withdrawal by Subject|1|||
27877628|NCT01960257|81383402|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
27877629|NCT01960257|81383403|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
27877630|NCT01960257|81383404|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
27877631|NCT01960257|81383402|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
27877632|NCT01960257|81383403|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
27877633|NCT01960257|81383404|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
27877634|NCT01960257|81383402|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
27877635|NCT01960257|81383403|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
27877636|NCT01960257|81383404|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
27877637|NCT03379727|81387045|FG000|Overall Study|Lack of Efficacy|73|||
27877638|NCT03379727|81387045|FG000|Overall Study|Adverse Event|32|||
27877639|NCT03379727|81387045|FG000|Overall Study|Death|18|||
27877640|NCT03379727|81387045|FG000|Overall Study|Patient/guardian decision|17|||
27877641|NCT03379727|81387045|FG000|Overall Study|Physician Decision|104|||
27877642|NCT03379727|81387045|FG000|Overall Study|Protocol Violation|4|||
27877643|NCT03379727|81387045|FG000|Overall Study|Lost to Follow-up|1|||
27877644|NCT03428152|81387046|FG000|Overall Study|Physician Decision|4|||
27589719|NCT01432366|80340437|FG000|Overall Study|Lost to Follow-up|13|||
27589720|NCT01432366|80340437|FG000|Overall Study|Lack of Efficacy|1|||
27877645|NCT03428152|81387047|FG001|Overall Study|Physician Decision|2|||
27877646|NCT03428152|81387046|FG000|Overall Study|Protocol Violation|3|||
27877647|NCT03428152|81387047|FG001|Overall Study|Protocol Violation|5|||
27877648|NCT03428152|81387046|FG000|Overall Study|Lack of Efficacy|0|||
27877649|NCT03428152|81387047|FG001|Overall Study|Lack of Efficacy|4|||
27877650|NCT04855760|81387048|FG000|Overall Study|Adverse Event|21|||
27877651|NCT04855760|81387048|FG000|Overall Study|Withdrawal by Subject|116|||
27877652|NCT04855760|81387048|FG000|Overall Study|Lack of Efficacy|21|||
27877653|NCT04855760|81387048|FG000|Overall Study|Lost to Follow-up|49|||
27877654|NCT04855760|81387048|FG000|Overall Study|Protocol Violation|2|||
27877655|NCT04855760|81387048|FG000|Overall Study|Physician Decision|5|||
27877656|NCT04855760|81387048|FG000|Overall Study|Pregnancy|1|||
27877657|NCT04855760|81387048|FG000|Overall Study|Non-Compliance with Study Drug|11|||
27877658|NCT04855760|81387048|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
27877659|NCT04855760|81387048|FG000|Overall Study|Study Completed by Sponsor|202|||
27877660|NCT04855760|81387048|FG000|Overall Study|Other|13|||
27877661|NCT02877004|81387049|FG000|Overall Study|Pregnancy|0|||
27877662|NCT02877004|81387050|FG001|Overall Study|Pregnancy|0|||
27877663|NCT02877004|81387051|FG002|Overall Study|Pregnancy|1|||
27877664|NCT02099110|81387052|FG000|Overall Study|Protocol Violation|2|||
27877665|NCT02099110|81387053|FG001|Overall Study|Protocol Violation|1|||
27877666|NCT02099110|81387054|FG002|Overall Study|Protocol Violation|0|||
27877667|NCT02099110|81387055|FG003|Overall Study|Protocol Violation|3|||
27877668|NCT02099110|81387056|FG004|Overall Study|Protocol Violation|1|||
27877669|NCT02099110|81387052|FG000|Overall Study|Participant moved|1|||
27877670|NCT02099110|81387053|FG001|Overall Study|Participant moved|1|||
27877671|NCT02099110|81387054|FG002|Overall Study|Participant moved|1|||
27877672|NCT02099110|81387055|FG003|Overall Study|Participant moved|0|||
27877673|NCT02099110|81387056|FG004|Overall Study|Participant moved|2|||
27877674|NCT02099110|81387052|FG000|Overall Study|Withdrawal by Subject|7|||
27877675|NCT02099110|81387053|FG001|Overall Study|Withdrawal by Subject|11|||
27877676|NCT02099110|81387054|FG002|Overall Study|Withdrawal by Subject|13|||
27877677|NCT02099110|81387055|FG003|Overall Study|Withdrawal by Subject|9|||
27877678|NCT02099110|81387056|FG004|Overall Study|Withdrawal by Subject|13|||
27877679|NCT02099110|81387052|FG000|Overall Study|Adverse Event|3|||
27877680|NCT02099110|81387053|FG001|Overall Study|Adverse Event|5|||
27589721|NCT01432366|80340437|FG000|Overall Study|Site Closed|20|||
27589722|NCT01432366|80340437|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
27589723|NCT01432366|80340437|FG000|Overall Study|Other|14|||
27589724|NCT04786444|80340442|FG000|Overall Study|Withdrawal by Subject|4|||
27589725|NCT04786444|80340443|FG001|Overall Study|Withdrawal by Subject|7|||
27589726|NCT04786444|80340444|FG002|Overall Study|Withdrawal by Subject|2|||
27688777|NCT00484289|80694375|FG002|Long Term Phase|Inadequate response|4|||
27877681|NCT02099110|81387054|FG002|Overall Study|Adverse Event|2|||
27877682|NCT02099110|81387055|FG003|Overall Study|Adverse Event|3|||
27688778|NCT00484289|80694373|FG000|Long Term Phase|Other Reason|0|||
27877683|NCT02099110|81387056|FG004|Overall Study|Adverse Event|2|||
27877684|NCT02099110|81387052|FG000|Overall Study|Lost to Follow-up|6|||
27877685|NCT02099110|81387053|FG001|Overall Study|Lost to Follow-up|12|||
27877686|NCT02099110|81387054|FG002|Overall Study|Lost to Follow-up|11|||
27877687|NCT02099110|81387055|FG003|Overall Study|Lost to Follow-up|5|||
27589727|NCT04786444|80340442|FG000|Overall Study|Lost to Follow-up|11|||
27589728|NCT04786444|80340443|FG001|Overall Study|Lost to Follow-up|9|||
27877688|NCT02099110|81387056|FG004|Overall Study|Lost to Follow-up|6|||
27877689|NCT02099110|81387052|FG000|Overall Study|Death|0|||
27815079|NCT02579096|81154496|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
27815080|NCT02579096|81154495|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
27815081|NCT02579096|81154496|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
27815082|NCT02579096|81154495|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
27877690|NCT02099110|81387053|FG001|Overall Study|Death|1|||
27877691|NCT02099110|81387054|FG002|Overall Study|Death|0|||
27877692|NCT02099110|81387055|FG003|Overall Study|Death|0|||
27877693|NCT02099110|81387056|FG004|Overall Study|Death|0|||
27877694|NCT02099110|81387052|FG000|Overall Study|Screen failure|0|||
27877695|NCT02099110|81387053|FG001|Overall Study|Screen failure|0|||
27877696|NCT02099110|81387054|FG002|Overall Study|Screen failure|0|||
27877697|NCT02099110|81387055|FG003|Overall Study|Screen failure|0|||
27877698|NCT02099110|81387056|FG004|Overall Study|Screen failure|1|||
27877699|NCT02099110|81387052|FG000|Overall Study|Non-compliance with study drug|2|||
27815083|NCT02579096|81154496|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
27815084|NCT02579096|81154495|FG000|Phase 2, Weeks 25 - 48|Death|2|||
27815085|NCT02579096|81154496|FG001|Phase 2, Weeks 25 - 48|Death|4|||
27815086|NCT02579096|81154495|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
27815087|NCT02579096|81154496|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
27815088|NCT02579096|81154495|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
27815089|NCT02579096|81154496|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
27815090|NCT02579096|81154495|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
27815091|NCT02579096|81154496|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
27815092|NCT02579096|81154495|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
27815093|NCT02579096|81154496|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
27815094|NCT02579096|81154495|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
27815095|NCT02579096|81154496|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
27815096|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Death|3|||
27815097|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Death|2|||
27815098|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
27815099|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
27815100|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
27815101|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
27815102|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
27815103|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
27815104|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
27877700|NCT02099110|81387053|FG001|Overall Study|Non-compliance with study drug|0|||
27877701|NCT02099110|81387054|FG002|Overall Study|Non-compliance with study drug|0|||
27877702|NCT02099110|81387055|FG003|Overall Study|Non-compliance with study drug|0|||
27815105|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
27877703|NCT02099110|81387056|FG004|Overall Study|Non-compliance with study drug|1|||
27877704|NCT02099110|81387052|FG000|Overall Study|Physician Decision|3|||
27877705|NCT02099110|81387053|FG001|Overall Study|Physician Decision|0|||
27815106|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
27815107|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
27815108|NCT02579096|81154495|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
27815109|NCT02579096|81154496|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
27815110|NCT00819247|81154497|FG000|Overall Study|Adverse Event|0|||
27815111|NCT00819247|81154498|FG001|Overall Study|Adverse Event|5|||
27815112|NCT00819247|81154499|FG002|Overall Study|Adverse Event|3|||
27815113|NCT00819247|81154497|FG000|Overall Study|Insufficient testosterone response|5|||
27815114|NCT00819247|81154498|FG001|Overall Study|Insufficient testosterone response|8|||
27815115|NCT00819247|81154499|FG002|Overall Study|Insufficient testosterone response|10|||
27589729|NCT04786444|80340444|FG002|Overall Study|Lost to Follow-up|10|||
27815116|NCT00819247|81154497|FG000|Overall Study|Withdrawal by Subject|1|||
27815117|NCT00819247|81154498|FG001|Overall Study|Withdrawal by Subject|0|||
27815118|NCT00819247|81154499|FG002|Overall Study|Withdrawal by Subject|0|||
27815119|NCT00819247|81154497|FG000|Overall Study|Protocol Violation|1|||
27589730|NCT04786444|80340442|FG000|Overall Study|Subject would like to become pregnant|0|||
27815120|NCT00819247|81154498|FG001|Overall Study|Protocol Violation|0|||
27815121|NCT00819247|81154499|FG002|Overall Study|Protocol Violation|1|||
27815122|NCT00819247|81154497|FG000|Overall Study|Mistakenly withdrawn|0|||
27815123|NCT00819247|81154498|FG001|Overall Study|Mistakenly withdrawn|1|||
27815124|NCT00819247|81154499|FG002|Overall Study|Mistakenly withdrawn|0|||
27815125|NCT00819247|81154497|FG000|Overall Study|Bad prostate-specific antigen response|3|||
27815126|NCT00819247|81154498|FG001|Overall Study|Bad prostate-specific antigen response|2|||
27815127|NCT00819247|81154499|FG002|Overall Study|Bad prostate-specific antigen response|0|||
27815128|NCT00819247|81154497|FG000|Overall Study|Other|1|||
27815129|NCT00819247|81154498|FG001|Overall Study|Other|0|||
27815130|NCT00819247|81154499|FG002|Overall Study|Other|0|||
27815131|NCT00491504|81154500|FG000|Overall Study|Adverse Event|0|||
27815132|NCT00491504|81154501|FG001|Overall Study|Adverse Event|1|||
27815133|NCT00491504|81154502|FG002|Overall Study|Adverse Event|0|||
27815134|NCT00491504|81154503|FG003|Overall Study|Adverse Event|0|||
27815135|NCT00491504|81154500|FG000|Overall Study|Withdrawal by Subject|0|||
27815136|NCT00491504|81154501|FG001|Overall Study|Withdrawal by Subject|0|||
27815137|NCT00491504|81154502|FG002|Overall Study|Withdrawal by Subject|1|||
27815138|NCT00491504|81154503|FG003|Overall Study|Withdrawal by Subject|2|||
27815139|NCT00491504|81154500|FG000|Overall Study|Protocol Violation|0|||
27815140|NCT00491504|81154501|FG001|Overall Study|Protocol Violation|0|||
27815141|NCT00491504|81154502|FG002|Overall Study|Protocol Violation|3|||
27815142|NCT00491504|81154503|FG003|Overall Study|Protocol Violation|2|||
27815143|NCT01977092|81154505|FG000|Overall Study|Death|3|||
27815144|NCT01977092|81154506|FG001|Overall Study|Death|4|||
27815145|NCT01977092|81154505|FG000|Overall Study|Lost to Follow-up|23|||
27815146|NCT01977092|81154506|FG001|Overall Study|Lost to Follow-up|14|||
27815147|NCT01977092|81154505|FG000|Overall Study|Withdrawal by Subject|2|||
27815148|NCT01977092|81154506|FG001|Overall Study|Withdrawal by Subject|1|||
27815149|NCT01977092|81154505|FG000|Overall Study|In prison|3|||
27815150|NCT01977092|81154506|FG001|Overall Study|In prison|11|||
27815151|NCT00462982|81154507|FG000|Overall Study|Adverse Event|1|||
27815152|NCT00462982|81154507|FG000|Overall Study|Patient Not Treated|2|||
27815153|NCT02848599|81154508|FG000|Overall Study|Protocol Violation|7|||
27589731|NCT04786444|80340443|FG001|Overall Study|Subject would like to become pregnant|1|||
27688779|NCT00484289|80694374|FG001|Long Term Phase|Other Reason|5|||
27815154|NCT02848599|81154509|FG001|Overall Study|Protocol Violation|9|||
27815155|NCT02603952|81154517|FG000|Overall Study|Withdrawal by Subject|1|||
27815156|NCT02603952|81154518|FG001|Overall Study|Withdrawal by Subject|0|||
27815157|NCT02603952|81154519|FG002|Overall Study|Withdrawal by Subject|0|||
27815158|NCT02603952|81154520|FG003|Overall Study|Withdrawal by Subject|0|||
27815159|NCT02603952|81154517|FG000|Overall Study|Received oseltamivir by error|0|||
27815160|NCT02603952|81154518|FG001|Overall Study|Received oseltamivir by error|0|||
27815161|NCT02603952|81154519|FG002|Overall Study|Received oseltamivir by error|0|||
27815162|NCT02603952|81154520|FG003|Overall Study|Received oseltamivir by error|1|||
27815163|NCT02483975|81154523|FG000|Overall Study|Adverse Event|0|||
27815164|NCT02483975|81154524|FG001|Overall Study|Adverse Event|1|||
27815165|NCT02483975|81154523|FG000|Overall Study|Lost to Follow-up|0|||
27815166|NCT02483975|81154524|FG001|Overall Study|Lost to Follow-up|1|||
27815167|NCT02483975|81154523|FG000|Overall Study|Physician Decision|2|||
27815168|NCT02483975|81154524|FG001|Overall Study|Physician Decision|0|||
27815169|NCT00203307|81154525|FG000|First Intervention|Adverse Event|2|||
27815170|NCT00203307|81154526|FG001|First Intervention|Adverse Event|0|||
27815171|NCT02801877|81154527|FG000|Overall Study|Lost to Follow-up|1|||
27815172|NCT02801877|81154528|FG001|Overall Study|Lost to Follow-up|1|||
27815173|NCT02801877|81154529|FG002|Overall Study|Lost to Follow-up|2|||
27815174|NCT02801877|81154530|FG003|Overall Study|Lost to Follow-up|0|||
27815175|NCT02801877|81154527|FG000|Overall Study|Never Started Treatment|2|||
27815176|NCT02801877|81154528|FG001|Overall Study|Never Started Treatment|0|||
27877706|NCT02099110|81387054|FG002|Overall Study|Physician Decision|1|||
27815177|NCT02801877|81154529|FG002|Overall Study|Never Started Treatment|4|||
27815178|NCT02801877|81154530|FG003|Overall Study|Never Started Treatment|0|||
27815179|NCT01620177|81154534|FG000|Overall Study|Failure at Screening Visit|43|||
27815180|NCT01620177|81154534|FG000|Overall Study|Withdrawal by Subject|26|||
27815181|NCT01620177|81154534|FG000|Overall Study|Lost to Follow-up|7|||
27815182|NCT01620177|81154534|FG000|Overall Study|Physician Decision|2|||
27815183|NCT01620177|81154534|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
27815184|NCT03655106|81154535|FG000|Overall Study|Withdrawal by Subject|3|||
27815185|NCT03655106|81154536|FG001|Overall Study|Withdrawal by Subject|2|||
27815186|NCT03655106|81154535|FG000|Overall Study|Lost to Follow-up|2|||
27815187|NCT03655106|81154536|FG001|Overall Study|Lost to Follow-up|1|||
27815188|NCT03655106|81154535|FG000|Overall Study|Duplicate Enrollment|1|||
27815189|NCT03655106|81154536|FG001|Overall Study|Duplicate Enrollment|1|||
27815190|NCT03655106|81154535|FG000|Overall Study|Protocol Violation|3|||
27815191|NCT03655106|81154536|FG001|Overall Study|Protocol Violation|0|||
27815192|NCT01909466|81154537|FG000|Overall Study|Lost to Follow-up|5|||
27815193|NCT01909466|81154538|FG001|Overall Study|Lost to Follow-up|7|||
27815194|NCT01909466|81154537|FG000|Overall Study|Adverse Event|3|||
27815195|NCT01909466|81154538|FG001|Overall Study|Adverse Event|4|||
27815196|NCT01909466|81154537|FG000|Overall Study|Met Withdrawal Criteria|0|||
27815197|NCT01909466|81154538|FG001|Overall Study|Met Withdrawal Criteria|3|||
27815198|NCT01909466|81154537|FG000|Overall Study|Physician Decision|2|||
27815199|NCT01909466|81154538|FG001|Overall Study|Physician Decision|0|||
27815200|NCT01909466|81154537|FG000|Overall Study|Withdrawal by Subject|11|||
27815201|NCT01909466|81154538|FG001|Overall Study|Withdrawal by Subject|9|||
27815202|NCT01909466|81154537|FG000|Overall Study|Lack of Efficacy|1|||
27815203|NCT01909466|81154538|FG001|Overall Study|Lack of Efficacy|0|||
27815204|NCT02428699|81154541|FG000|Washout Period 1|Screen Failure|1|||
27815205|NCT02428699|81154542|FG001|Washout Period 1|Screen Failure|2|||
27815206|NCT01654380|81154544|FG000|Part B, Period 1|Physician Decision|0|||
27815207|NCT01654380|81154545|FG001|Part B, Period 1|Physician Decision|0|||
27815208|NCT01654380|81154546|FG002|Part B, Period 1|Physician Decision|1|||
27815209|NCT01654380|81154547|FG003|Part B, Period 1|Physician Decision|0|||
27815210|NCT01929109|81154548|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
27815211|NCT01929109|81154549|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
27815212|NCT01929109|81154550|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
27815213|NCT01929109|81154551|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
27877707|NCT02099110|81387055|FG003|Overall Study|Physician Decision|2|||
27877708|NCT02099110|81387056|FG004|Overall Study|Physician Decision|1|||
27877709|NCT04762160|81387057|FG000|Overall Study|Study terminated early due to business reasons|5|||
27815214|NCT01929109|81154552|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
27815215|NCT00806156|81154553|FG000|Overall Study|Death|35|||
27815216|NCT00806156|81154554|FG001|Overall Study|Death|95|||
27815217|NCT00806156|81154553|FG000|Overall Study|Did not meet eligibility criteria|1|||
27815218|NCT00806156|81154554|FG001|Overall Study|Did not meet eligibility criteria|0|||
27815219|NCT00806156|81154553|FG000|Overall Study|Study terminated by Sponsor|2|||
27877710|NCT00739661|81387060|FG000|Overall Study|Adverse Event|2|||
27877711|NCT00739661|81387061|FG001|Overall Study|Adverse Event|0|||
27815220|NCT00806156|81154554|FG001|Overall Study|Study terminated by Sponsor|40|||
27815221|NCT00806156|81154553|FG000|Overall Study|Consent withdrawn by subject|1|||
27815222|NCT00806156|81154554|FG001|Overall Study|Consent withdrawn by subject|3|||
27589732|NCT04786444|80340444|FG002|Overall Study|Subject would like to become pregnant|0|||
27589733|NCT01556438|80340445|FG000|Overall Study|Adverse Event|4|||
27589734|NCT01556438|80340446|FG001|Overall Study|Adverse Event|2|||
27688780|NCT00484289|80694375|FG002|Long Term Phase|Other Reason|1|||
27815223|NCT00806156|81154553|FG000|Overall Study|Lost to Follow-up|0|||
27815224|NCT00806156|81154554|FG001|Overall Study|Lost to Follow-up|1|||
27815225|NCT01025037|81154555|FG000|Overall Study|Adverse Event|3|||
27815226|NCT01025037|81154555|FG000|Overall Study|Lost to Follow-up|7|||
27815227|NCT01025037|81154555|FG000|Overall Study|Withdrawal by Subject|1|||
27815228|NCT01569152|81154556|FG000|Phase IIa, Period 1|Early Escape|5|||
27815229|NCT01569152|81154557|FG001|Phase IIa, Period 1|Early Escape|22|||
27815230|NCT01569152|81154558|FG002|Phase IIa, Period 1|Early Escape|0|||
27815231|NCT01569152|81154556|FG000|Phase IIa, Period 1|Adverse Event|4|||
27815232|NCT01569152|81154557|FG001|Phase IIa, Period 1|Adverse Event|0|||
27815233|NCT01569152|81154558|FG002|Phase IIa, Period 1|Adverse Event|0|||
27815234|NCT01569152|81154556|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
27815235|NCT01569152|81154557|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
27815236|NCT01569152|81154558|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
27815237|NCT01569152|81154556|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
27815238|NCT01569152|81154557|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
27815239|NCT01569152|81154558|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
27815240|NCT01569152|81154556|FG000|Phase IIa, Period 1|Protocol Violation|0|||
27815241|NCT01569152|81154557|FG001|Phase IIa, Period 1|Protocol Violation|1|||
27815242|NCT01569152|81154558|FG002|Phase IIa, Period 1|Protocol Violation|0|||
27815243|NCT01569152|81154556|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
27815244|NCT01569152|81154557|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
27815245|NCT01569152|81154558|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
27815246|NCT01569152|81154556|FG000|Safety Extension, Period 3|Adverse Event|0|||
27589735|NCT01556438|80340445|FG000|Overall Study|Sponsor Decision|0|||
27815247|NCT01569152|81154557|FG001|Safety Extension, Period 3|Adverse Event|0|||
27815248|NCT01569152|81154558|FG002|Safety Extension, Period 3|Adverse Event|4|||
27815249|NCT01569152|81154556|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
27589736|NCT01556438|80340446|FG001|Overall Study|Sponsor Decision|2|||
27589737|NCT01556438|80340445|FG000|Overall Study|Progressive Disease|0|||
27589738|NCT01556438|80340446|FG001|Overall Study|Progressive Disease|6|||
27589739|NCT01556438|80340445|FG000|Overall Study|Death|0|||
27589740|NCT01556438|80340446|FG001|Overall Study|Death|1|||
27589741|NCT05553808|80340447|FG000|Overall Study|Death|25|||
27589742|NCT05553808|80340448|FG001|Overall Study|Death|62|||
27589743|NCT05553808|80340447|FG000|Overall Study|Site Closed|6|||
27589744|NCT05553808|80340448|FG001|Overall Study|Site Closed|6|||
27589745|NCT05553808|80340447|FG000|Overall Study|Lost to Follow-up|1|||
27589746|NCT05553808|80340448|FG001|Overall Study|Lost to Follow-up|0|||
27589747|NCT05553808|80340447|FG000|Overall Study|Withdrawal by Subject|3|||
27815250|NCT01569152|81154557|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
27589748|NCT05553808|80340448|FG001|Overall Study|Withdrawal by Subject|2|||
27688781|NCT00484289|80694373|FG000|Post Marketing Phase|Adverse Event|0|||
27688782|NCT00484289|80694374|FG001|Post Marketing Phase|Adverse Event|1|||
27688783|NCT00484289|80694375|FG002|Post Marketing Phase|Adverse Event|0|||
27688784|NCT01028027|80694376|FG000|Overall Study|Lost to Follow-up|4|||
27688785|NCT01028027|80694377|FG001|Overall Study|Lost to Follow-up|1|||
27688786|NCT01028027|80694376|FG000|Overall Study|Withdrawal by Subject|5|||
27688787|NCT01028027|80694377|FG001|Overall Study|Withdrawal by Subject|3|||
27688788|NCT01028027|80694376|FG000|Overall Study|Adverse Event|4|||
27688789|NCT01028027|80694377|FG001|Overall Study|Adverse Event|7|||
27688790|NCT01028027|80694376|FG000|Overall Study|Protocol Violation|3|||
27815251|NCT01569152|81154558|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
27815252|NCT01569152|81154556|FG000|Safety Extension, Period 3|Physician Decision|0|||
27815253|NCT01569152|81154557|FG001|Safety Extension, Period 3|Physician Decision|0|||
27815254|NCT01569152|81154558|FG002|Safety Extension, Period 3|Physician Decision|2|||
27815255|NCT01569152|81154556|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
27815256|NCT01569152|81154557|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
27815257|NCT01569152|81154558|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
27688791|NCT01028027|80694377|FG001|Overall Study|Protocol Violation|1|||
27688792|NCT01028027|80694376|FG000|Overall Study|Lack of Efficacy|0|||
27688793|NCT01028027|80694377|FG001|Overall Study|Lack of Efficacy|1|||
27688794|NCT00833261|80694379|FG000|Overall Study|Withdrawal by Subject|4|||
27688795|NCT02047903|80694380|FG000|Overall Study|Adverse Event|14|||
27688796|NCT02047903|80694380|FG000|Overall Study|Serious adverse event|10|||
27688797|NCT02047903|80694380|FG000|Overall Study|Withdrawal by Subject|16|||
27688798|NCT02047903|80694380|FG000|Overall Study|Lost to Follow-up|4|||
27688799|NCT02047903|80694380|FG000|Overall Study|Reason not listed|6|||
27688800|NCT02047903|80694380|FG000|Overall Study|Not Treated|9|||
27688801|NCT03256851|80694385|FG000|Overall Study|Withdrawal by Subject|1|||
27688802|NCT03256851|80694386|FG001|Overall Study|Withdrawal by Subject|0|||
27688803|NCT00545051|80698814|FG000|Overall Study|Adverse Event|7|||
27688804|NCT00545051|80698815|FG001|Overall Study|Adverse Event|3|||
27688805|NCT00545051|80698814|FG000|Overall Study|Death|1|||
27688806|NCT00545051|80698815|FG001|Overall Study|Death|0|||
27688807|NCT00545051|80698814|FG000|Overall Study|Violation of inclusion/exclusion|0|||
27688808|NCT00545051|80698815|FG001|Overall Study|Violation of inclusion/exclusion|2|||
27688809|NCT00545051|80698814|FG000|Overall Study|Protocol Violation|1|||
27688810|NCT00545051|80698815|FG001|Overall Study|Protocol Violation|0|||
27688811|NCT00545051|80698814|FG000|Overall Study|Withdrawal by Subject|0|||
27688812|NCT00545051|80698815|FG001|Overall Study|Withdrawal by Subject|1|||
27688813|NCT00545051|80698814|FG000|Overall Study|Administrative reasons|0|||
27688814|NCT00545051|80698815|FG001|Overall Study|Administrative reasons|1|||
27688815|NCT03656510|80698818|FG000|Overall Study|Lost to Follow-up|1|||
27688816|NCT03656510|80698819|FG001|Overall Study|Lost to Follow-up|0|||
27688817|NCT03656510|80698820|FG002|Overall Study|Lost to Follow-up|0|||
27688818|NCT03656510|80698821|FG003|Overall Study|Lost to Follow-up|0|||
27688819|NCT03656510|80698822|FG004|Overall Study|Lost to Follow-up|0|||
27688820|NCT03656510|80698823|FG005|Overall Study|Lost to Follow-up|0|||
27688821|NCT03656510|80698818|FG000|Overall Study|Withdrawal by Subject|1|||
27815258|NCT02896361|81154559|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
27877712|NCT00739661|81387060|FG000|Overall Study|Physician decision to withdraw patient|1|||
27877713|NCT00739661|81387061|FG001|Overall Study|Physician decision to withdraw patient|0|||
27688822|NCT03656510|80698819|FG001|Overall Study|Withdrawal by Subject|1|||
27688823|NCT03656510|80698820|FG002|Overall Study|Withdrawal by Subject|0|||
27688824|NCT03656510|80698821|FG003|Overall Study|Withdrawal by Subject|1|||
27688825|NCT03656510|80698822|FG004|Overall Study|Withdrawal by Subject|0|||
27688826|NCT03656510|80698823|FG005|Overall Study|Withdrawal by Subject|0|||
27688827|NCT00895154|80698824|FG000|Overall Study|Lost to Follow-up|1|||
27688828|NCT00895154|80698825|FG001|Overall Study|Lost to Follow-up|1|||
27688829|NCT00895154|80698824|FG000|Overall Study|Withdrawal by Subject|0|||
27688830|NCT00895154|80698825|FG001|Overall Study|Withdrawal by Subject|1|||
27688831|NCT02003573|80698829|FG000|Overall Study|Progressive disease|2|||
27688832|NCT02003573|80698830|FG001|Overall Study|Progressive disease|0|||
27688833|NCT02003573|80698831|FG002|Overall Study|Progressive disease|1|||
27688834|NCT02003573|80698829|FG000|Overall Study|Other Adverse event|0|||
27688835|NCT02003573|80698830|FG001|Overall Study|Other Adverse event|1|||
27688836|NCT02003573|80698831|FG002|Overall Study|Other Adverse event|1|||
27688837|NCT02003573|80698829|FG000|Overall Study|Refuse to take trial medication|0|||
27815259|NCT02896361|81154560|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
27877714|NCT00739661|81387060|FG000|Overall Study|Patient decision to withdraw|9|||
27815260|NCT02896361|81154561|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
27815261|NCT02896361|81154559|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
27815262|NCT02896361|81154560|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
27815263|NCT02896361|81154561|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
27815264|NCT02041702|81154562|FG000|Overall Study|Lost to Follow-up|1|||
27815265|NCT02041702|81154563|FG001|Overall Study|Lost to Follow-up|6|||
27815266|NCT02041702|81154562|FG000|Overall Study|Death|4|||
27815267|NCT02041702|81154563|FG001|Overall Study|Death|0|||
27815268|NCT02041702|81154562|FG000|Overall Study|Withdrawal by Subject|4|||
27815269|NCT02041702|81154563|FG001|Overall Study|Withdrawal by Subject|3|||
27815270|NCT02041702|81154562|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
27815271|NCT02041702|81154563|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
27815272|NCT02041702|81154562|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
27815273|NCT02041702|81154563|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
27815274|NCT01829464|81154571|FG000|Overall Study|Adverse Event|1|||
27815275|NCT01829464|81154572|FG001|Overall Study|Adverse Event|0|||
27815276|NCT01829464|81154573|FG002|Overall Study|Adverse Event|0|||
27815277|NCT01829464|81154571|FG000|Overall Study|Lost to Follow-up|0|||
27815278|NCT01829464|81154572|FG001|Overall Study|Lost to Follow-up|0|||
27815279|NCT01829464|81154573|FG002|Overall Study|Lost to Follow-up|1|||
27877715|NCT00739661|81387061|FG001|Overall Study|Patient decision to withdraw|4|||
27877716|NCT00739661|81387060|FG000|Overall Study|Disease progression, radiographic|33|||
27877717|NCT00739661|81387061|FG001|Overall Study|Disease progression, radiographic|37|||
27877718|NCT00739661|81387060|FG000|Overall Study|Reason for discontinuation not available|1|||
27877719|NCT00739661|81387061|FG001|Overall Study|Reason for discontinuation not available|1|||
27877720|NCT01286467|81387062|FG000|Overall Study|Death|1|||
27877721|NCT01286467|81387063|FG001|Overall Study|Death|1|||
27815280|NCT01829464|81154571|FG000|Overall Study|Withdrawal by Subject|2|||
27877722|NCT01286467|81387064|FG002|Overall Study|Death|1|||
27877723|NCT01286467|81387065|FG003|Overall Study|Death|0|||
27815281|NCT01829464|81154572|FG001|Overall Study|Withdrawal by Subject|0|||
27877724|NCT01286467|81387062|FG000|Overall Study|Lost to Follow-up|0|||
27815282|NCT01829464|81154573|FG002|Overall Study|Withdrawal by Subject|0|||
27815283|NCT01829464|81154571|FG000|Overall Study|Study terminated by sponsor|25|||
27815284|NCT01829464|81154572|FG001|Overall Study|Study terminated by sponsor|28|||
27815285|NCT01829464|81154573|FG002|Overall Study|Study terminated by sponsor|25|||
27815286|NCT01829464|81154571|FG000|Overall Study|Lack of Efficacy|0|||
27688838|NCT02003573|80698830|FG001|Overall Study|Refuse to take trial medication|1|||
27688839|NCT02003573|80698831|FG002|Overall Study|Refuse to take trial medication|1|||
27688840|NCT02003573|80698829|FG000|Overall Study|Other than specified|1|||
27688841|NCT02003573|80698830|FG001|Overall Study|Other than specified|2|||
27688842|NCT02003573|80698831|FG002|Overall Study|Other than specified|3|||
27688843|NCT01052103|80698832|FG000|Overall Study|Adverse Event|10|||
27688844|NCT01052103|80698833|FG001|Overall Study|Adverse Event|6|||
27688845|NCT01052103|80698832|FG000|Overall Study|Entry Criteria Not Met|3|||
27688846|NCT01052103|80698833|FG001|Overall Study|Entry Criteria Not Met|1|||
27688847|NCT01052103|80698832|FG000|Overall Study|Lost to Follow-up|3|||
27688848|NCT01052103|80698833|FG001|Overall Study|Lost to Follow-up|5|||
27688849|NCT01052103|80698832|FG000|Overall Study|Protocol Violation|10|||
27688850|NCT01052103|80698833|FG001|Overall Study|Protocol Violation|4|||
27688851|NCT01052103|80698832|FG000|Overall Study|Scheduling conflict|2|||
27688852|NCT01052103|80698833|FG001|Overall Study|Scheduling conflict|1|||
27688853|NCT01052103|80698832|FG000|Overall Study|Sponsor Decision|2|||
27688854|NCT01052103|80698833|FG001|Overall Study|Sponsor Decision|0|||
27688855|NCT01052103|80698832|FG000|Overall Study|Withdrawal by Subject|3|||
27815287|NCT01829464|81154572|FG001|Overall Study|Lack of Efficacy|1|||
27815288|NCT01829464|81154573|FG002|Overall Study|Lack of Efficacy|0|||
27815289|NCT04094870|81154577|FG000|Overall Study|Lost to Follow-up|1|||
27815290|NCT04094870|81154578|FG001|Overall Study|Lost to Follow-up|1|||
27815291|NCT00497796|81154581|FG000|Overall Study|Adverse event (not related)|9|||
27815292|NCT00497796|81154582|FG001|Overall Study|Adverse event (not related)|9|||
27815293|NCT00497796|81154581|FG000|Overall Study|Adverse event (related)|5|||
27877725|NCT01286467|81387063|FG001|Overall Study|Lost to Follow-up|0|||
27688856|NCT01052103|80698833|FG001|Overall Study|Withdrawal by Subject|6|||
27688857|NCT01052103|80698832|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27688858|NCT01052103|80698833|FG001|Overall Study|Perceived Lack of Efficacy|0|||
27688859|NCT02947087|80698836|FG000|Overall Study|Withdrawal by Subject|3|||
27877726|NCT01286467|81387064|FG002|Overall Study|Lost to Follow-up|0|||
27688860|NCT02947087|80698837|FG001|Overall Study|Withdrawal by Subject|2|||
27688861|NCT01127893|80698838|FG000|Overall Study|Study Termination by the Sponsor|1|||
27688862|NCT02585232|80698839|FG000|Overall Study|Lost to Follow-up|8|||
27688863|NCT02585232|80698840|FG001|Overall Study|Lost to Follow-up|8|||
27815294|NCT00497796|81154582|FG001|Overall Study|Adverse event (related)|4|||
27877727|NCT01286467|81387065|FG003|Overall Study|Lost to Follow-up|1|||
27877728|NCT01286467|81387062|FG000|Overall Study|Withdrawal by Subject|0|||
27815295|NCT00497796|81154581|FG000|Overall Study|CMV infection or disease treatment|30|||
27815296|NCT00497796|81154582|FG001|Overall Study|CMV infection or disease treatment|4|||
27815297|NCT00497796|81154581|FG000|Overall Study|Consent withdrawn|10|||
27815298|NCT00497796|81154582|FG001|Overall Study|Consent withdrawn|3|||
27815299|NCT00497796|81154581|FG000|Overall Study|Investigator/sponsor discretion|31|||
27815300|NCT00497796|81154582|FG001|Overall Study|Investigator/sponsor discretion|34|||
27815301|NCT00497796|81154581|FG000|Overall Study|Lost to Follow-up|0|||
27815302|NCT00497796|81154582|FG001|Overall Study|Lost to Follow-up|1|||
27815303|NCT00497796|81154581|FG000|Overall Study|Not applicable (randomized not treated)|0|||
27815304|NCT00497796|81154582|FG001|Overall Study|Not applicable (randomized not treated)|4|||
27815305|NCT00531206|81154585|FG000|Overall Study|Adverse Event related|5|||
27815306|NCT00531206|81154585|FG000|Overall Study|Lack of Efficacy|2|||
27815307|NCT00531206|81154585|FG000|Overall Study|Lost to Follow-up|5|||
27815308|NCT00531206|81154585|FG000|Overall Study|including non-related adverse events|8|||
27815309|NCT00275002|81154586|FG000|Overall Study|Death|1|||
27815310|NCT00275002|81154587|FG001|Overall Study|Death|0|||
27815311|NCT00275002|81154586|FG000|Overall Study|Disease progression|21|||
27815312|NCT00275002|81154587|FG001|Overall Study|Disease progression|15|||
27815313|NCT00275002|81154586|FG000|Overall Study|Adverse Event|0|||
27815314|NCT00275002|81154587|FG001|Overall Study|Adverse Event|1|||
27815315|NCT03335371|81154588|FG000|Overall Study|Lost to Follow-up|0|||
27815316|NCT03335371|81154589|FG001|Overall Study|Lost to Follow-up|0|||
27815317|NCT03335371|81154590|FG002|Overall Study|Lost to Follow-up|0|||
27815318|NCT03335371|81154591|FG003|Overall Study|Lost to Follow-up|0|||
27815319|NCT03335371|81154592|FG004|Overall Study|Lost to Follow-up|1|||
27815320|NCT03335371|81154588|FG000|Overall Study|Withdrawal by Subject|0|||
27815321|NCT03335371|81154589|FG001|Overall Study|Withdrawal by Subject|0|||
27815322|NCT03335371|81154590|FG002|Overall Study|Withdrawal by Subject|0|||
27815323|NCT03335371|81154591|FG003|Overall Study|Withdrawal by Subject|0|||
27815324|NCT03335371|81154592|FG004|Overall Study|Withdrawal by Subject|1|||
27815325|NCT03335371|81154588|FG000|Overall Study|Randomization Error|0|||
27815326|NCT03335371|81154589|FG001|Overall Study|Randomization Error|0|||
27815327|NCT03335371|81154590|FG002|Overall Study|Randomization Error|1|||
27815328|NCT03335371|81154591|FG003|Overall Study|Randomization Error|0|||
27815329|NCT03335371|81154592|FG004|Overall Study|Randomization Error|0|||
27815330|NCT03039023|81154594|FG000|Overall Study|Withdrawal by Subject|1|||
27815331|NCT03039023|81154595|FG001|Overall Study|Withdrawal by Subject|0|||
27815332|NCT03039023|81154596|FG002|Overall Study|Withdrawal by Subject|1|||
27815333|NCT03039023|81154597|FG003|Overall Study|Withdrawal by Subject|1|||
27815334|NCT03039023|81154598|FG004|Overall Study|Withdrawal by Subject|0|||
27815335|NCT03039023|81154594|FG000|Overall Study|Physician Decision|0|||
27815336|NCT03039023|81154595|FG001|Overall Study|Physician Decision|0|||
27815337|NCT03039023|81154596|FG002|Overall Study|Physician Decision|0|||
27815338|NCT03039023|81154597|FG003|Overall Study|Physician Decision|1|||
27815339|NCT03039023|81154598|FG004|Overall Study|Physician Decision|0|||
27815340|NCT03294538|81154599|FG000|Overall Study|Adverse Event|0|||
27815341|NCT03294538|81154600|FG001|Overall Study|Adverse Event|1|||
27815342|NCT03294538|81154601|FG002|Overall Study|Adverse Event|1|||
27815343|NCT03294538|81154599|FG000|Overall Study|Lost to Follow-up|1|||
27815344|NCT03294538|81154600|FG001|Overall Study|Lost to Follow-up|0|||
27815345|NCT03294538|81154601|FG002|Overall Study|Lost to Follow-up|0|||
27815346|NCT03294538|81154599|FG000|Overall Study|Outside of Visit Window|4|||
27815347|NCT03294538|81154600|FG001|Overall Study|Outside of Visit Window|4|||
27815348|NCT03294538|81154601|FG002|Overall Study|Outside of Visit Window|1|||
27815349|NCT02359890|81154602|FG000|Overall Study|Not meeting eligibility|4|||
27815350|NCT02359890|81154602|FG000|Overall Study|Never treated with study catheter|6|||
27815351|NCT01946165|81154603|FG000|Overall Study|Physician Decision|2|||
27815352|NCT01946165|81154604|FG001|Overall Study|Physician Decision|0|||
27815353|NCT01946165|81154603|FG000|Overall Study|Withdrawal by Subject|0|||
27688864|NCT02585232|80698839|FG000|Overall Study|Withdrawal by Subject|4|||
27688865|NCT02585232|80698840|FG001|Overall Study|Withdrawal by Subject|8|||
27688866|NCT02128542|80698843|FG000|Overall Study|Lost to Follow-up|3|||
27688867|NCT02128542|80698844|FG001|Overall Study|Lost to Follow-up|0|||
27688868|NCT02128542|80698843|FG000|Overall Study|Withdrew Consent|1|||
27688869|NCT02128542|80698844|FG001|Overall Study|Withdrew Consent|0|||
27688870|NCT01877837|80698845|FG000|Overall Study|Lost to Follow-up|1|||
27688871|NCT01877837|80698845|FG000|Overall Study|Ineligible|4|||
27688872|NCT02476279|80698849|FG000|Overall Study|Lost to Follow-up|1|||
27688873|NCT02476279|80698850|FG001|Overall Study|Lost to Follow-up|1|||
27688874|NCT01014533|80698851|FG000|Overall Study|Protocol Violation|3|||
27688875|NCT01014533|80698852|FG001|Overall Study|Protocol Violation|2|||
27688876|NCT01014533|80698851|FG000|Overall Study|Withdrawal by Subject|2|||
27815354|NCT01946165|81154604|FG001|Overall Study|Withdrawal by Subject|2|||
27815355|NCT01673009|81154611|FG000|Overall Study|Physician Decision|5|||
27815356|NCT01673009|81154611|FG000|Overall Study|Withdrawal by Subject|8|||
27815357|NCT00782509|81154615|FG000|Overall Study|Adverse Event|20|||
27815358|NCT00782509|81154616|FG001|Overall Study|Adverse Event|10|||
27815359|NCT00782509|81154617|FG002|Overall Study|Adverse Event|20|||
27815360|NCT00782509|81154615|FG000|Overall Study|Lost to Follow-up|1|||
27815361|NCT00782509|81154616|FG001|Overall Study|Lost to Follow-up|2|||
27815362|NCT00782509|81154617|FG002|Overall Study|Lost to Follow-up|3|||
27815363|NCT00782509|81154615|FG000|Overall Study|Withdrawal by Subject|3|||
27815364|NCT00782509|81154616|FG001|Overall Study|Withdrawal by Subject|5|||
27815365|NCT00782509|81154617|FG002|Overall Study|Withdrawal by Subject|8|||
27815366|NCT00782509|81154615|FG000|Overall Study|Non compliance with protocol|2|||
27815367|NCT00782509|81154616|FG001|Overall Study|Non compliance with protocol|0|||
27815368|NCT00782509|81154617|FG002|Overall Study|Non compliance with protocol|0|||
27815369|NCT00782509|81154615|FG000|Overall Study|Other reasons not stated above|5|||
27815370|NCT00782509|81154616|FG001|Overall Study|Other reasons not stated above|2|||
27815371|NCT00782509|81154617|FG002|Overall Study|Other reasons not stated above|3|||
27815372|NCT00782509|81154615|FG000|Overall Study|Lack of Efficacy|10|||
27815373|NCT00782509|81154616|FG001|Overall Study|Lack of Efficacy|5|||
27815374|NCT00782509|81154617|FG002|Overall Study|Lack of Efficacy|2|||
27815375|NCT00860028|81154618|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
27815376|NCT00860028|81154619|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
27815377|NCT05034731|81154620|FG000|Overall Study|Screen fail|1|||
27877729|NCT01286467|81387063|FG001|Overall Study|Withdrawal by Subject|0|||
27877730|NCT01286467|81387064|FG002|Overall Study|Withdrawal by Subject|1|||
27589749|NCT04479618|80340458|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
27589750|NCT04479618|80340459|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
27589751|NCT04479618|80340460|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
27589752|NCT04479618|80340458|FG000|Overall Study|Lack of Efficacy|1|||
27589753|NCT04479618|80340459|FG001|Overall Study|Lack of Efficacy|0|||
27589754|NCT04479618|80340460|FG002|Overall Study|Lack of Efficacy|0|||
27589755|NCT04479618|80340458|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
27589756|NCT04479618|80340459|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
27877731|NCT01286467|81387065|FG003|Overall Study|Withdrawal by Subject|0|||
27877732|NCT01286467|81387062|FG000|Overall Study|Physician Decision|0|||
27877733|NCT01286467|81387063|FG001|Overall Study|Physician Decision|0|||
27877734|NCT01286467|81387064|FG002|Overall Study|Physician Decision|0|||
27589757|NCT04479618|80340460|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
27688877|NCT01014533|80698852|FG001|Overall Study|Withdrawal by Subject|0|||
27688878|NCT01014533|80698851|FG000|Overall Study|unable to come to appointment|0|||
27688879|NCT01014533|80698852|FG001|Overall Study|unable to come to appointment|3|||
27688880|NCT00434213|80698854|FG000|Overall Study|Adverse Event|12|||
27688881|NCT00434213|80698854|FG000|Overall Study|Lack of Efficacy|9|||
27815378|NCT05034731|81154621|FG001|Overall Study|Screen fail|1|||
27815379|NCT02994056|81154622|FG000|Overall Study|Death|8|||
27815380|NCT02994056|81154622|FG000|Overall Study|Withdrew Consent|1|||
27815381|NCT01325207|81154623|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27815382|NCT01325207|81154624|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27815383|NCT01325207|81154625|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27688882|NCT00434213|80698854|FG000|Overall Study|Lost to Follow-up|14|||
27688883|NCT00434213|80698854|FG000|Overall Study|Withdrawal by Subject|7|||
27688884|NCT00434213|80698854|FG000|Overall Study|Protocol Violation|3|||
27815384|NCT01325207|81154626|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27815385|NCT01325207|81154627|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
27815386|NCT01325207|81154628|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
27815387|NCT01325207|81154623|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
27589758|NCT04479618|80340458|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
27589759|NCT04479618|80340459|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
27589760|NCT04479618|80340460|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
27589761|NCT04479618|80340458|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
27589762|NCT04479618|80340459|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
27589763|NCT04479618|80340460|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
27589764|NCT04479618|80340458|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
27589765|NCT04479618|80340459|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
27589766|NCT04479618|80340460|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
27589767|NCT03712917|80340465|FG000|Overall Study|Pregnancy|0|||
27589768|NCT03712917|80340466|FG001|Overall Study|Pregnancy|0|||
27589769|NCT03712917|80340467|FG002|Overall Study|Pregnancy|1|||
27589770|NCT03712917|80340465|FG000|Overall Study|Adverse Event|0|||
27589771|NCT03712917|80340466|FG001|Overall Study|Adverse Event|4|||
27589772|NCT03712917|80340467|FG002|Overall Study|Adverse Event|3|||
27589773|NCT03712917|80340465|FG000|Overall Study|Lost to Follow-up|9|||
27589774|NCT03712917|80340466|FG001|Overall Study|Lost to Follow-up|4|||
27589775|NCT03712917|80340467|FG002|Overall Study|Lost to Follow-up|5|||
27589776|NCT00096135|80340468|FG000|Overall Study|Physician Decision|20|||
27589777|NCT00096135|80340469|FG001|Overall Study|Physician Decision|4|||
27589778|NCT00096135|80340468|FG000|Overall Study|Refusal of further protocol therapy|4|||
27589779|NCT00096135|80340469|FG001|Overall Study|Refusal of further protocol therapy|1|||
27589780|NCT00096135|80340468|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
27589781|NCT00096135|80340469|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
27589782|NCT00096135|80340468|FG000|Overall Study|Other, specify|15|||
27589783|NCT00096135|80340469|FG001|Overall Study|Other, specify|3|||
27589784|NCT00096135|80340468|FG000|Overall Study|Ineligible|2|||
27589785|NCT00096135|80340469|FG001|Overall Study|Ineligible|0|||
27688885|NCT00434213|80698854|FG000|Overall Study|Unable to comply with study visit window|2|||
27688886|NCT00434213|80698854|FG000|Overall Study|Application site reaction|1|||
27688887|NCT00434213|80698854|FG000|Overall Study|Non-compliant to study schedule|1|||
27688888|NCT04988867|80698855|FG000|Overall Study|Study terminated by Sponsor|12|||
27815388|NCT01325207|81154624|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
27815389|NCT01325207|81154625|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
27815390|NCT01325207|81154626|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
27688889|NCT04988867|80698855|FG000|Overall Study|Adverse Event|2|||
27688890|NCT04988867|80698855|FG000|Overall Study|Study drug noncompliance|1|||
27688891|NCT03940703|80698856|FG000|Overall Study|Still under treatment|31|||
27688892|NCT03940703|80698857|FG001|Overall Study|Still under treatment|0|||
27688893|NCT01146782|80698872|FG000|Screening Cohort|Screen Failure|187|||
27688894|NCT01146782|80698872|FG000|Screening Cohort|Lost to Follow-up|4|||
27688895|NCT01146782|80698872|FG000|Screening Cohort|Physician Decision|1|||
27688896|NCT01146782|80698872|FG000|Screening Cohort|Withdrawal by Subject|29|||
27589786|NCT03743038|80340470|FG000|Overall Study|Physician Decision|1|||
27688897|NCT01146782|80698872|FG000|Safety Cohort|Screen Failure|61|||
27688898|NCT01146782|80698872|FG000|Safety Cohort|Withdrawal by Subject|4|||
27688899|NCT01146782|80698872|FG000|Safety Cohort|Control AHI <5|4|||
27688900|NCT01146782|80698872|FG000|Safety Cohort|TST <4 hrs|14|||
27688901|NCT01146782|80698872|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
27688902|NCT01146782|80698872|FG000|Primary Endpoint Cohort|Physician Decision|1|||
27688903|NCT04447846|80698873|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
27688904|NCT00412061|80698876|FG000|Double Blind Phase|Disease Progression|101|||
27688905|NCT00412061|80698877|FG001|Double Blind Phase|Disease Progression|154|||
27688906|NCT00412061|80698876|FG000|Double Blind Phase|Adverse Event|61|||
27688907|NCT00412061|80698877|FG001|Double Blind Phase|Adverse Event|16|||
27688908|NCT00412061|80698876|FG000|Double Blind Phase|Final Primary Analysis|26|||
27688909|NCT00412061|80698877|FG001|Double Blind Phase|Final Primary Analysis|14|||
27688910|NCT00412061|80698876|FG000|Double Blind Phase|Withdrawal by Subject|18|||
27688911|NCT00412061|80698877|FG001|Double Blind Phase|Withdrawal by Subject|20|||
27688912|NCT00412061|80698876|FG000|Double Blind Phase|Death|6|||
27688913|NCT00412061|80698877|FG001|Double Blind Phase|Death|3|||
27688914|NCT00412061|80698876|FG000|Double Blind Phase|Protocol Violation|3|||
27688915|NCT00412061|80698877|FG001|Double Blind Phase|Protocol Violation|4|||
27688916|NCT00412061|80698876|FG000|Double Blind Phase|New Cander Therapy|1|||
27688917|NCT00412061|80698877|FG001|Double Blind Phase|New Cander Therapy|1|||
27688918|NCT00412061|80698876|FG000|Double Blind Phase|Lost to Follow-up|0|||
27688919|NCT00412061|80698877|FG001|Double Blind Phase|Lost to Follow-up|1|||
27688920|NCT00412061|80698876|FG000|Open Label Phase|Disease Progression|0|||
27688921|NCT00412061|80698877|FG001|Open Label Phase|Disease Progression|86|||
27688922|NCT00412061|80698876|FG000|Open Label Phase|Adverse Event|0|||
27688923|NCT00412061|80698877|FG001|Open Label Phase|Adverse Event|46|||
27688924|NCT00412061|80698876|FG000|Open Label Phase|Withdrawal by Subject|0|||
27688925|NCT00412061|80698877|FG001|Open Label Phase|Withdrawal by Subject|15|||
27688926|NCT00412061|80698876|FG000|Open Label Phase|Administrative Problems|0|||
27688927|NCT00412061|80698877|FG001|Open Label Phase|Administrative Problems|13|||
27688928|NCT00412061|80698876|FG000|Open Label Phase|Death|0|||
27688929|NCT00412061|80698877|FG001|Open Label Phase|Death|7|||
27688930|NCT00412061|80698876|FG000|Open Label Phase|Lost to Follow-up|0|||
27688931|NCT00412061|80698877|FG001|Open Label Phase|Lost to Follow-up|2|||
27688932|NCT00412061|80698876|FG000|Open Label Phase|New Cancer Therapy|0|||
27688933|NCT00412061|80698877|FG001|Open Label Phase|New Cancer Therapy|1|||
27688934|NCT01675479|80698878|FG000|Overall Study|Lost to Follow-up|11|||
27688935|NCT00370682|80698879|FG000|Overall Study|Moved from area|0|||
27688936|NCT00370682|80698880|FG001|Overall Study|Moved from area|2|||
27688937|NCT00370682|80698881|FG002|Overall Study|Moved from area|0|||
27688938|NCT00370682|80698879|FG000|Overall Study|Lost to Follow-up|0|||
27688939|NCT00370682|80698880|FG001|Overall Study|Lost to Follow-up|1|||
27688940|NCT00370682|80698881|FG002|Overall Study|Lost to Follow-up|1|||
27688941|NCT03573583|80698882|FG000|Overall Study|Lost to Follow-up|1|||
27688942|NCT03573583|80698883|FG001|Overall Study|Lost to Follow-up|0|||
27688943|NCT03573583|80698882|FG000|Overall Study|Withdrawal by Subject|1|||
27688944|NCT03573583|80698883|FG001|Overall Study|Withdrawal by Subject|1|||
27688945|NCT00189488|80698884|FG000|Overall Study|Ineligibility determined|1|||
27688946|NCT00189488|80698885|FG001|Overall Study|Ineligibility determined|0|||
27688947|NCT00189488|80698884|FG000|Overall Study|Protocol deviation|2|||
27688948|NCT00189488|80698885|FG001|Overall Study|Protocol deviation|1|||
27688949|NCT00189488|80698884|FG000|Overall Study|Adverse Event|2|||
27688950|NCT00189488|80698885|FG001|Overall Study|Adverse Event|1|||
27688951|NCT00189488|80698884|FG000|Overall Study|Withdrawal by Subject|2|||
27688952|NCT00189488|80698885|FG001|Overall Study|Withdrawal by Subject|6|||
27688953|NCT00189488|80698884|FG000|Overall Study|Disease progression|2|||
27688954|NCT00189488|80698885|FG001|Overall Study|Disease progression|4|||
27688955|NCT00189488|80698884|FG000|Overall Study|Administrative Decision|0|||
27688956|NCT00189488|80698885|FG001|Overall Study|Administrative Decision|2|||
27688957|NCT00189488|80698884|FG000|Overall Study|Death|5|||
27688958|NCT00189488|80698885|FG001|Overall Study|Death|8|||
27688959|NCT00189488|80698884|FG000|Overall Study|Other|1|||
27688960|NCT00189488|80698885|FG001|Overall Study|Other|0|||
27688961|NCT04725240|80698886|FG000|Overall Study|Adverse Event|2|||
27688962|NCT01656733|80698887|FG000|Overall Study|No permission to collect birth outcomes|0|||
27688963|NCT01656733|80698888|FG001|Overall Study|No permission to collect birth outcomes|1|||
27688964|NCT01656733|80698887|FG000|Overall Study|Delivery at another hospital|0|||
27688965|NCT01656733|80698888|FG001|Overall Study|Delivery at another hospital|2|||
27688966|NCT01656733|80698887|FG000|Overall Study|Spontaneous abortion|0|||
27688967|NCT01656733|80698888|FG001|Overall Study|Spontaneous abortion|1|||
27688968|NCT01983254|80698891|FG000|Overall Study|Death|6|||
27688969|NCT01983254|80698892|FG001|Overall Study|Death|6|||
27688970|NCT01983254|80698891|FG000|Overall Study|Lost to Follow-up|17|||
27688971|NCT01983254|80698892|FG001|Overall Study|Lost to Follow-up|16|||
27688972|NCT01983254|80698891|FG000|Overall Study|too ill|11|||
27688973|NCT01983254|80698892|FG001|Overall Study|too ill|8|||
27688974|NCT00306670|80698893|FG000|Overall Study|patients recruited; Genentech, the st|0|||
27688975|NCT00306670|80698894|FG001|Overall Study|patients recruited; Genentech, the st|2|||
27688976|NCT01119105|80698895|FG000|Overall Study|Withdrawal by Subject|1|||
27688977|NCT01119105|80698896|FG001|Overall Study|Withdrawal by Subject|1|||
27688978|NCT01119105|80698897|FG002|Overall Study|Withdrawal by Subject|1|||
27688979|NCT01119105|80698895|FG000|Overall Study|Lost to Follow-up|0|||
27688980|NCT01119105|80698896|FG001|Overall Study|Lost to Follow-up|2|||
27688981|NCT01119105|80698897|FG002|Overall Study|Lost to Follow-up|5|||
27688982|NCT01119105|80698895|FG000|Overall Study|Adverse Event|1|||
27688983|NCT01119105|80698896|FG001|Overall Study|Adverse Event|0|||
27688984|NCT01119105|80698897|FG002|Overall Study|Adverse Event|1|||
27688985|NCT01119105|80698895|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
27688986|NCT01119105|80698896|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
27688987|NCT01119105|80698897|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
27688988|NCT01119105|80698895|FG000|Overall Study|Other|1|||
27688989|NCT01119105|80698896|FG001|Overall Study|Other|1|||
27688990|NCT01119105|80698897|FG002|Overall Study|Other|0|||
27688991|NCT03581825|80698899|FG000|Period 1|Lens Discomfort|1|||
27688992|NCT03581825|80698900|FG001|Period 1|Lens Discomfort|0|||
27688993|NCT03581825|80698899|FG000|Period 2|Unsatisfactory Vision to Test|0|||
27688994|NCT03581825|80698900|FG001|Period 2|Unsatisfactory Vision to Test|1|||
27688995|NCT00712673|80698901|FG000|Overall Study|Adverse Event|3|||
27688996|NCT00712673|80698902|FG001|Overall Study|Adverse Event|3|||
27688997|NCT00712673|80698903|FG002|Overall Study|Adverse Event|21|||
27688998|NCT00712673|80698904|FG003|Overall Study|Adverse Event|26|||
27688999|NCT00712673|80698901|FG000|Overall Study|Lack of Efficacy|2|||
27689000|NCT00712673|80698902|FG001|Overall Study|Lack of Efficacy|8|||
27689001|NCT00712673|80698903|FG002|Overall Study|Lack of Efficacy|8|||
27689002|NCT00712673|80698904|FG003|Overall Study|Lack of Efficacy|6|||
27689003|NCT00712673|80698901|FG000|Overall Study|Poor Compliance to Protocol|3|||
27689004|NCT00712673|80698902|FG001|Overall Study|Poor Compliance to Protocol|3|||
27689005|NCT00712673|80698903|FG002|Overall Study|Poor Compliance to Protocol|4|||
27689006|NCT00712673|80698904|FG003|Overall Study|Poor Compliance to Protocol|16|||
27877735|NCT01286467|81387065|FG003|Overall Study|Physician Decision|1|||
27877736|NCT01286467|81387062|FG000|Overall Study|Disease progression|3|||
27877737|NCT01286467|81387063|FG001|Overall Study|Disease progression|2|||
27689007|NCT00712673|80698901|FG000|Overall Study|Lost to Follow-up|1|||
27689008|NCT00712673|80698902|FG001|Overall Study|Lost to Follow-up|0|||
27877738|NCT01286467|81387064|FG002|Overall Study|Disease progression|2|||
27877739|NCT01286467|81387065|FG003|Overall Study|Disease progression|3|||
27877740|NCT01286467|81387062|FG000|Overall Study|Adverse Event|0|||
27877741|NCT01286467|81387063|FG001|Overall Study|Adverse Event|1|||
27877742|NCT01286467|81387064|FG002|Overall Study|Adverse Event|2|||
27877743|NCT01286467|81387065|FG003|Overall Study|Adverse Event|3|||
27877744|NCT01286467|81387062|FG000|Overall Study|Study drug stop longer than 14 days|0|||
27877745|NCT01286467|81387063|FG001|Overall Study|Study drug stop longer than 14 days|0|||
27877746|NCT01286467|81387064|FG002|Overall Study|Study drug stop longer than 14 days|1|||
27877747|NCT01286467|81387065|FG003|Overall Study|Study drug stop longer than 14 days|0|||
27689009|NCT00712673|80698903|FG002|Overall Study|Lost to Follow-up|2|||
27689010|NCT00712673|80698904|FG003|Overall Study|Lost to Follow-up|0|||
27689011|NCT00712673|80698901|FG000|Overall Study|Withdrawal by Subject|6|||
27689012|NCT00712673|80698902|FG001|Overall Study|Withdrawal by Subject|7|||
27877748|NCT01420068|81387066|FG000|Overall Study|Administrative problems|1|||
27877749|NCT01420068|81387067|FG001|Overall Study|Administrative problems|3|||
27689013|NCT00712673|80698903|FG002|Overall Study|Withdrawal by Subject|15|||
27689014|NCT00712673|80698904|FG003|Overall Study|Withdrawal by Subject|20|||
27689015|NCT00712673|80698901|FG000|Overall Study|Familial and Personal Reasons|5|||
27689016|NCT00712673|80698902|FG001|Overall Study|Familial and Personal Reasons|0|||
27689017|NCT00712673|80698903|FG002|Overall Study|Familial and Personal Reasons|5|||
27689018|NCT00712673|80698904|FG003|Overall Study|Familial and Personal Reasons|2|||
27689019|NCT00712673|80698901|FG000|Overall Study|Investigator's Decision|1|||
27689020|NCT00712673|80698902|FG001|Overall Study|Investigator's Decision|0|||
27877750|NCT01420068|81387066|FG000|Overall Study|Withdrawal by Subject|1|||
27877751|NCT01420068|81387067|FG001|Overall Study|Withdrawal by Subject|2|||
27877752|NCT01198470|81387074|FG000|Overall Study|Adverse Event|2|||
27689021|NCT00712673|80698903|FG002|Overall Study|Investigator's Decision|0|||
27689022|NCT00712673|80698904|FG003|Overall Study|Investigator's Decision|0|||
27689023|NCT00712673|80698901|FG000|Overall Study|Protocol Violation|0|||
27689024|NCT00712673|80698902|FG001|Overall Study|Protocol Violation|0|||
27689025|NCT00712673|80698903|FG002|Overall Study|Protocol Violation|2|||
27689026|NCT00712673|80698904|FG003|Overall Study|Protocol Violation|0|||
27689027|NCT01263665|80698905|FG000|Overall Study|Withdrew Consent|1|||
27689028|NCT01263665|80698905|FG000|Overall Study|Lost to Follow-up|3|||
27689029|NCT01263665|80698905|FG000|Overall Study|Death|2|||
27689030|NCT01263665|80698905|FG000|Overall Study|Amputation above the ankle|1|||
27689031|NCT01263665|80698905|FG000|Overall Study|Surgical Bypass|2|||
27689032|NCT03756129|80698906|FG000|Overall Study|Adverse Event|1|||
27689033|NCT03756129|80698907|FG001|Overall Study|Adverse Event|1|||
27689034|NCT03756129|80698908|FG002|Overall Study|Adverse Event|0|||
27689035|NCT03756129|80698909|FG003|Overall Study|Adverse Event|2|||
27689036|NCT03756129|80698910|FG004|Overall Study|Adverse Event|0|||
27689037|NCT03756129|80698911|FG005|Overall Study|Adverse Event|0|||
27689038|NCT03756129|80698906|FG000|Overall Study|Withdrawal by Subject|2|||
27877753|NCT04570670|81387075|FG000|Overall Study|Withdrawal by Subject|1|||
27877754|NCT04570670|81387076|FG001|Overall Study|Withdrawal by Subject|0|||
27877755|NCT02013817|81387079|FG000|Overall Study|Adverse Event|12|||
27877756|NCT02013817|81387079|FG000|Overall Study|Withdrawal by Subject|4|||
27877757|NCT02013817|81387079|FG000|Overall Study|Death|2|||
27877758|NCT02013817|81387079|FG000|Overall Study|Other|9|||
27589787|NCT02252211|80340472|FG000|Overall Study|Adverse Event|0|||
27689039|NCT03756129|80698907|FG001|Overall Study|Withdrawal by Subject|1|||
27689040|NCT03756129|80698908|FG002|Overall Study|Withdrawal by Subject|3|||
27689041|NCT03756129|80698909|FG003|Overall Study|Withdrawal by Subject|1|||
27689042|NCT03756129|80698910|FG004|Overall Study|Withdrawal by Subject|1|||
27689043|NCT03756129|80698911|FG005|Overall Study|Withdrawal by Subject|3|||
27815391|NCT01325207|81154627|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
27815392|NCT01325207|81154628|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
27815393|NCT01325207|81154623|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27815394|NCT01325207|81154624|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27815395|NCT01325207|81154625|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27815396|NCT01325207|81154626|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
27815397|NCT01325207|81154627|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
27815398|NCT01325207|81154628|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
27815399|NCT01325207|81154623|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27815400|NCT01325207|81154624|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
27815401|NCT01325207|81154625|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27815402|NCT01325207|81154626|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27877759|NCT01537042|81387083|FG000|Overall Study|Adverse Event|0|||
27877760|NCT01537042|81387084|FG001|Overall Study|Adverse Event|2|||
27689044|NCT03756129|80698906|FG000|Overall Study|Lost to Follow-up|0|||
27689045|NCT03756129|80698907|FG001|Overall Study|Lost to Follow-up|0|||
27589788|NCT02252211|80340473|FG001|Overall Study|Adverse Event|1|||
27589789|NCT02252211|80340474|FG002|Overall Study|Adverse Event|0|||
27589790|NCT02252211|80340472|FG000|Overall Study|Progressive disease|3|||
27589791|NCT02252211|80340473|FG001|Overall Study|Progressive disease|2|||
27589792|NCT02252211|80340474|FG002|Overall Study|Progressive disease|0|||
27589793|NCT02252211|80340472|FG000|Overall Study|Withdrawal by Subject|1|||
27589794|NCT02252211|80340473|FG001|Overall Study|Withdrawal by Subject|0|||
27589795|NCT02252211|80340474|FG002|Overall Study|Withdrawal by Subject|0|||
27589796|NCT02252211|80340472|FG000|Overall Study|Serious Adverse Event During Screening|1|||
27589797|NCT02252211|80340473|FG001|Overall Study|Serious Adverse Event During Screening|0|||
27589798|NCT02252211|80340474|FG002|Overall Study|Serious Adverse Event During Screening|1|||
27589799|NCT02682264|80340475|FG000|Overall Study|Withdrawal by Subject|56|||
27589800|NCT02682264|80340476|FG001|Overall Study|Withdrawal by Subject|45|||
27589801|NCT02682264|80340475|FG000|Overall Study|Lost to Follow-up|49|||
27589802|NCT02682264|80340476|FG001|Overall Study|Lost to Follow-up|41|||
27589803|NCT02682264|80340475|FG000|Overall Study|Lack of Efficacy|14|||
27589804|NCT02682264|80340476|FG001|Overall Study|Lack of Efficacy|16|||
27589805|NCT02682264|80340475|FG000|Overall Study|Withdrawal by Parent|6|||
27589806|NCT02682264|80340476|FG001|Overall Study|Withdrawal by Parent|7|||
27589807|NCT02682264|80340475|FG000|Overall Study|Adverse Event|9|||
27589808|NCT02682264|80340476|FG001|Overall Study|Adverse Event|0|||
27589809|NCT02682264|80340475|FG000|Overall Study|Noncompliance with study drug|1|||
27589810|NCT02682264|80340476|FG001|Overall Study|Noncompliance with study drug|4|||
27589811|NCT02682264|80340475|FG000|Overall Study|Pregnancy|1|||
27589812|NCT02682264|80340476|FG001|Overall Study|Pregnancy|2|||
27589813|NCT02682264|80340475|FG000|Overall Study|Recovery|1|||
27589814|NCT02682264|80340476|FG001|Overall Study|Recovery|2|||
27589815|NCT02682264|80340475|FG000|Overall Study|Progressive Disease|1|||
27589816|NCT02682264|80340476|FG001|Overall Study|Progressive Disease|0|||
27589817|NCT02682264|80340475|FG000|Overall Study|Technical Problems|0|||
27689046|NCT03756129|80698908|FG002|Overall Study|Lost to Follow-up|0|||
27689047|NCT03756129|80698909|FG003|Overall Study|Lost to Follow-up|0|||
27689048|NCT03756129|80698910|FG004|Overall Study|Lost to Follow-up|0|||
27689049|NCT03756129|80698911|FG005|Overall Study|Lost to Follow-up|1|||
27689050|NCT03756129|80698906|FG000|Overall Study|Physician Decision|0|||
27689051|NCT03756129|80698907|FG001|Overall Study|Physician Decision|0|||
27689052|NCT03756129|80698908|FG002|Overall Study|Physician Decision|0|||
27689053|NCT03756129|80698909|FG003|Overall Study|Physician Decision|0|||
27689054|NCT03756129|80698910|FG004|Overall Study|Physician Decision|0|||
27689055|NCT03756129|80698911|FG005|Overall Study|Physician Decision|1|||
27689056|NCT00581555|80698912|FG000|Overall Study|Adverse Event|4|||
27689057|NCT00581555|80698913|FG001|Overall Study|Adverse Event|3|||
27689058|NCT00581555|80698912|FG000|Overall Study|Physician Decision|3|||
27815403|NCT01325207|81154627|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27815404|NCT01325207|81154628|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
27589818|NCT02682264|80340476|FG001|Overall Study|Technical Problems|1|||
27589819|NCT02682264|80340475|FG000|Overall Study|Moved abroad and unable to continue|0|||
27589820|NCT02682264|80340476|FG001|Overall Study|Moved abroad and unable to continue|3|||
27589821|NCT02682264|80340475|FG000|Overall Study|Stopped test article application|0|||
27689059|NCT00581555|80698913|FG001|Overall Study|Physician Decision|2|||
27589822|NCT02682264|80340476|FG001|Overall Study|Stopped test article application|1|||
27689060|NCT00581555|80698912|FG000|Overall Study|Withdrawal by Subject|18|||
27689061|NCT00581555|80698913|FG001|Overall Study|Withdrawal by Subject|9|||
27689062|NCT00581555|80698912|FG000|Overall Study|Lost to Follow-up|2|||
27689063|NCT00581555|80698913|FG001|Overall Study|Lost to Follow-up|2|||
27689064|NCT00581555|80698912|FG000|Overall Study|Other reasons|16|||
27589823|NCT03713593|80340481|FG000|Overall Study|Participants Ongoing|140|||
27589824|NCT03713593|80340482|FG001|Overall Study|Participants Ongoing|114|||
27589825|NCT03713593|80340481|FG000|Overall Study|Withdrawal by Subject|3|||
27589826|NCT03713593|80340482|FG001|Overall Study|Withdrawal by Subject|6|||
27589827|NCT03713593|80340481|FG000|Overall Study|Death|252|||
27589828|NCT03713593|80340482|FG001|Overall Study|Death|279|||
27589829|NCT02352948|80340484|FG000|Overall Study|Death|47|||
27689065|NCT00581555|80698913|FG001|Overall Study|Other reasons|4|||
27689066|NCT00468104|80698914|FG000|First Intervention|Protocol Violation|2|||
27689067|NCT00468104|80698915|FG001|First Intervention|Protocol Violation|1|||
27689068|NCT00468104|80698914|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
27689069|NCT00468104|80698915|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
27689070|NCT00468104|80698914|FG000|First Intervention|died within 3 weeks|1|||
27689071|NCT00468104|80698915|FG001|First Intervention|died within 3 weeks|0|||
27689072|NCT00468104|80698914|FG000|First Intervention|malposition/blocked chest tube tube|2|||
27589830|NCT02352948|80340485|FG001|Overall Study|Death|48|||
27589831|NCT02352948|80340486|FG002|Overall Study|Death|114|||
27589832|NCT02352948|80340487|FG003|Overall Study|Death|74|||
27589833|NCT02352948|80340488|FG004|Overall Study|Death|77|||
27589834|NCT02352948|80340489|FG005|Overall Study|Death|44|||
27589835|NCT02352948|80340484|FG000|Overall Study|Lost to Follow-up|1|||
27589836|NCT02352948|80340485|FG001|Overall Study|Lost to Follow-up|0|||
27689073|NCT00468104|80698915|FG001|First Intervention|malposition/blocked chest tube tube|0|||
27689074|NCT00468104|80698914|FG000|First Intervention|large lung mass with minimal effusion|1|||
27689075|NCT00468104|80698915|FG001|First Intervention|large lung mass with minimal effusion|0|||
27689076|NCT00468104|80698914|FG000|First Intervention|associated prolonged pneumothorax|1|||
27589837|NCT02352948|80340486|FG002|Overall Study|Lost to Follow-up|2|||
27589838|NCT02352948|80340487|FG003|Overall Study|Lost to Follow-up|1|||
27877761|NCT01537042|81387083|FG000|Overall Study|Lack of Efficacy|0|||
27877762|NCT01537042|81387084|FG001|Overall Study|Lack of Efficacy|1|||
27877763|NCT01537042|81387083|FG000|Overall Study|Protocol Violation|0|||
27877764|NCT01537042|81387084|FG001|Overall Study|Protocol Violation|1|||
27877765|NCT01537042|81387083|FG000|Overall Study|Other|0|||
27877766|NCT01537042|81387084|FG001|Overall Study|Other|1|||
27877767|NCT01422889|81387085|FG000|Overall Study|No Data Entered for Study Stent|9|||
27877768|NCT03096314|81387086|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
27877769|NCT03096314|81387087|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
27877770|NCT05370040|81387092|FG000|Overall Study|Lost to Follow-up|0|||
27877771|NCT05370040|81387093|FG001|Overall Study|Lost to Follow-up|0|||
27877772|NCT05370040|81387094|FG002|Overall Study|Lost to Follow-up|1|||
27877773|NCT05370040|81387095|FG003|Overall Study|Lost to Follow-up|0|||
27877774|NCT05370040|81387096|FG004|Overall Study|Lost to Follow-up|1|||
27877775|NCT05370040|81387097|FG005|Overall Study|Lost to Follow-up|0|||
27877776|NCT03743415|81387098|FG000|Overall Study|Death|5|||
27877777|NCT03743415|81387099|FG001|Overall Study|Death|3|||
27877778|NCT03743415|81387100|FG002|Overall Study|Death|1|||
27877779|NCT03743415|81387101|FG003|Overall Study|Death|4|||
27877780|NCT03743415|81387102|FG004|Overall Study|Death|0|||
27877781|NCT03743415|81387103|FG005|Overall Study|Death|0|||
27877782|NCT03743415|81387104|FG006|Overall Study|Death|0|||
27877783|NCT03743415|81387105|FG007|Overall Study|Death|0|||
27877784|NCT03743415|81387106|FG008|Overall Study|Death|1|||
27877785|NCT03743415|81387107|FG009|Overall Study|Death|0|||
27877786|NCT03743415|81387098|FG000|Overall Study|Withdrawal by Subject|1|||
27877787|NCT03743415|81387099|FG001|Overall Study|Withdrawal by Subject|0|||
27877788|NCT03743415|81387100|FG002|Overall Study|Withdrawal by Subject|4|||
27877789|NCT03743415|81387101|FG003|Overall Study|Withdrawal by Subject|5|||
27877790|NCT03743415|81387102|FG004|Overall Study|Withdrawal by Subject|5|||
27877791|NCT03743415|81387103|FG005|Overall Study|Withdrawal by Subject|2|||
27877792|NCT03743415|81387104|FG006|Overall Study|Withdrawal by Subject|2|||
27877793|NCT03743415|81387105|FG007|Overall Study|Withdrawal by Subject|5|||
27877794|NCT03743415|81387106|FG008|Overall Study|Withdrawal by Subject|9|||
27877795|NCT03743415|81387107|FG009|Overall Study|Withdrawal by Subject|10|||
27877796|NCT03743415|81387098|FG000|Overall Study|Lost to Follow-up|2|||
27877797|NCT03743415|81387099|FG001|Overall Study|Lost to Follow-up|0|||
27877798|NCT03743415|81387100|FG002|Overall Study|Lost to Follow-up|2|||
27877799|NCT03743415|81387101|FG003|Overall Study|Lost to Follow-up|1|||
27877800|NCT03743415|81387102|FG004|Overall Study|Lost to Follow-up|1|||
27877801|NCT03743415|81387103|FG005|Overall Study|Lost to Follow-up|0|||
27877802|NCT03743415|81387104|FG006|Overall Study|Lost to Follow-up|1|||
27877803|NCT03743415|81387105|FG007|Overall Study|Lost to Follow-up|4|||
27877804|NCT03743415|81387106|FG008|Overall Study|Lost to Follow-up|13|||
27589839|NCT02352948|80340488|FG004|Overall Study|Lost to Follow-up|2|||
27589840|NCT02352948|80340489|FG005|Overall Study|Lost to Follow-up|1|||
27589841|NCT02352948|80340484|FG000|Overall Study|Withdrawal by Subject|1|||
27589842|NCT02352948|80340485|FG001|Overall Study|Withdrawal by Subject|10|||
27589843|NCT02352948|80340486|FG002|Overall Study|Withdrawal by Subject|11|||
27589844|NCT02352948|80340487|FG003|Overall Study|Withdrawal by Subject|23|||
27689077|NCT00468104|80698915|FG001|First Intervention|associated prolonged pneumothorax|0|||
27689078|NCT00468104|80698914|FG000|First Intervention|trapped lung|1|||
27689079|NCT00468104|80698915|FG001|First Intervention|trapped lung|0|||
27689080|NCT00468104|80698914|FG000|Second Intervention|Withdrawal by Subject|5|||
27689081|NCT00468104|80698915|FG001|Second Intervention|Withdrawal by Subject|2|||
27689082|NCT00468104|80698914|FG000|Second Intervention|discarded for malposition of chest tube|0|||
27689083|NCT00468104|80698915|FG001|Second Intervention|discarded for malposition of chest tube|2|||
27689084|NCT02859324|80698919|FG000|Overall Study|Death|4|||
27689085|NCT02859324|80698920|FG001|Overall Study|Death|6|||
27689086|NCT02859324|80698921|FG002|Overall Study|Death|5|||
27689087|NCT02859324|80698919|FG000|Overall Study|Other reasons|3|||
27689088|NCT02859324|80698920|FG001|Overall Study|Other reasons|3|||
27689089|NCT02859324|80698921|FG002|Overall Study|Other reasons|0|||
27689090|NCT00658684|80698922|FG000|Overall Study|Adverse Event|10|||
27689091|NCT00658684|80698923|FG001|Overall Study|Adverse Event|8|||
27689092|NCT00658684|80698924|FG002|Overall Study|Adverse Event|2|||
27689093|NCT00658684|80698925|FG003|Overall Study|Adverse Event|0|||
27689094|NCT00658684|80698922|FG000|Overall Study|Withdrawal by Subject|6|||
27689095|NCT00658684|80698923|FG001|Overall Study|Withdrawal by Subject|4|||
27689096|NCT00658684|80698924|FG002|Overall Study|Withdrawal by Subject|1|||
27689097|NCT00658684|80698925|FG003|Overall Study|Withdrawal by Subject|1|||
27589845|NCT02352948|80340488|FG004|Overall Study|Withdrawal by Subject|9|||
27589846|NCT02352948|80340489|FG005|Overall Study|Withdrawal by Subject|4|||
27589847|NCT02352948|80340484|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27689098|NCT00658684|80698922|FG000|Overall Study|Lack of Efficacy|1|||
27689099|NCT00658684|80698923|FG001|Overall Study|Lack of Efficacy|1|||
27689100|NCT00658684|80698924|FG002|Overall Study|Lack of Efficacy|0|||
27689101|NCT00658684|80698925|FG003|Overall Study|Lack of Efficacy|0|||
27689102|NCT00658684|80698922|FG000|Overall Study|Protocol Violation|1|||
27689103|NCT00658684|80698923|FG001|Overall Study|Protocol Violation|1|||
27689104|NCT00658684|80698924|FG002|Overall Study|Protocol Violation|0|||
27689105|NCT00658684|80698925|FG003|Overall Study|Protocol Violation|0|||
27689106|NCT00658684|80698922|FG000|Overall Study|Pregnancy|1|||
27689107|NCT00658684|80698923|FG001|Overall Study|Pregnancy|1|||
27589848|NCT02352948|80340485|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27589849|NCT02352948|80340486|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27689108|NCT00658684|80698924|FG002|Overall Study|Pregnancy|0|||
27689109|NCT00658684|80698925|FG003|Overall Study|Pregnancy|0|||
27689110|NCT01077271|80698926|FG000|Overall Study|Parental desire|8|||
27689111|NCT01077271|80698926|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
27689112|NCT01077271|80698926|FG000|Overall Study|Noncompliance|2|||
27689113|NCT01077271|80698926|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
27689114|NCT01077271|80698926|FG000|Overall Study|Changed doctors|2|||
27815405|NCT01325207|81154623|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27815406|NCT01325207|81154624|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27815407|NCT01325207|81154625|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27815408|NCT01325207|81154626|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27815409|NCT01325207|81154627|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
27815410|NCT01325207|81154628|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
27815411|NCT01325207|81154623|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27815412|NCT01325207|81154624|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27815413|NCT01325207|81154625|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27815414|NCT01325207|81154626|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27815415|NCT01325207|81154627|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
27815416|NCT01325207|81154628|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
27815417|NCT01325207|81154623|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27815418|NCT01325207|81154624|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27815419|NCT01325207|81154625|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27815420|NCT01325207|81154626|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27815421|NCT01325207|81154627|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
27815422|NCT01325207|81154628|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
27815423|NCT02978326|81154629|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
27815424|NCT02978326|81154630|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
27815425|NCT02978326|81154631|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
27815426|NCT02978326|81154629|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
27815427|NCT02978326|81154630|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
27815428|NCT02978326|81154631|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
27815429|NCT02978326|81154629|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
27815430|NCT02978326|81154630|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
27815431|NCT02978326|81154631|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
27815432|NCT02978326|81154629|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
27815433|NCT02978326|81154630|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
27815434|NCT02978326|81154631|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
27815435|NCT02385526|81154632|FG000|Overall Study|Withdrawal by Subject|0|||
27815436|NCT02385526|81154633|FG001|Overall Study|Withdrawal by Subject|2|||
27815437|NCT02385526|81154634|FG002|Overall Study|Withdrawal by Subject|0|||
27815438|NCT02385526|81154632|FG000|Overall Study|Lost to Follow-up|0|||
27815439|NCT02385526|81154633|FG001|Overall Study|Lost to Follow-up|1|||
27815440|NCT02385526|81154634|FG002|Overall Study|Lost to Follow-up|0|||
27815441|NCT02385526|81154632|FG000|Overall Study|Physician Decision|1|||
27815442|NCT02385526|81154633|FG001|Overall Study|Physician Decision|0|||
27815443|NCT02385526|81154634|FG002|Overall Study|Physician Decision|0|||
27815444|NCT02385526|81154632|FG000|Overall Study|Protocol Violation|1|||
27815445|NCT02385526|81154633|FG001|Overall Study|Protocol Violation|0|||
27815446|NCT02385526|81154634|FG002|Overall Study|Protocol Violation|0|||
27815447|NCT00812253|81154638|FG000|Overall Study|Withdrawal by Subject|3|||
27815448|NCT00812253|81154639|FG001|Overall Study|Withdrawal by Subject|2|||
27815449|NCT00812253|81154638|FG000|Overall Study|Protocol Violation|1|||
27815450|NCT00812253|81154639|FG001|Overall Study|Protocol Violation|1|||
27815451|NCT00812253|81154638|FG000|Overall Study|Lost to Follow-up|2|||
27815452|NCT00812253|81154639|FG001|Overall Study|Lost to Follow-up|0|||
27815453|NCT01180244|81158558|FG000|Overall Study|Lack of Efficacy|0|||
27815454|NCT01180244|81158559|FG001|Overall Study|Lack of Efficacy|7|||
27815455|NCT01180244|81158558|FG000|Overall Study|Physician Decision|3|||
27815456|NCT01180244|81158559|FG001|Overall Study|Physician Decision|0|||
27815457|NCT01180244|81158558|FG000|Overall Study|Adverse Event|1|||
27815458|NCT01180244|81158559|FG001|Overall Study|Adverse Event|0|||
27815459|NCT01180244|81158558|FG000|Overall Study|Withdrawal by Subject|0|||
27689115|NCT01077271|80698926|FG000|Overall Study|Parents thought too many injections|2|||
27689116|NCT01077271|80698926|FG000|Overall Study|End of RSV season nearly reached|1|||
27689117|NCT01077271|80698926|FG000|Overall Study|Mother unconvinced of the necessity|1|||
27689118|NCT02641496|80698927|FG000|Overall Study|Lost to Follow-up|13|||
27689119|NCT02641496|80698928|FG001|Overall Study|Lost to Follow-up|12|||
27815460|NCT01180244|81158559|FG001|Overall Study|Withdrawal by Subject|1|||
27815461|NCT01180244|81158558|FG000|Overall Study|Protocol Violation|1|||
27877805|NCT03743415|81387107|FG009|Overall Study|Lost to Follow-up|13|||
27877806|NCT01346696|81387108|FG000|Overall Study|Death|1|||
27877807|NCT02445248|81387109|FG000|Overall Study|Death|45|||
27877808|NCT02445248|81387110|FG001|Overall Study|Death|12|||
27877809|NCT02445248|81387109|FG000|Overall Study|Progressive disease|13|||
27877810|NCT02445248|81387110|FG001|Overall Study|Progressive disease|1|||
27877811|NCT02445248|81387109|FG000|Overall Study|Subject decision|8|||
27877812|NCT02445248|81387110|FG001|Overall Study|Subject decision|0|||
27877813|NCT02445248|81387109|FG000|Overall Study|Physician Decision|5|||
27877814|NCT02445248|81387110|FG001|Overall Study|Physician Decision|0|||
27877815|NCT02445248|81387109|FG000|Overall Study|Adverse Event|1|||
27877816|NCT02445248|81387110|FG001|Overall Study|Adverse Event|0|||
27877817|NCT02445248|81387109|FG000|Overall Study|Lost to Follow-up|1|||
27877818|NCT02445248|81387110|FG001|Overall Study|Lost to Follow-up|0|||
27877819|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
27877820|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
27877821|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
27877822|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
27877823|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
27877824|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
27877825|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
27877826|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
27877827|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
27877828|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
27877829|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
27877830|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
27877831|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27877832|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27877833|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
27877834|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
27877835|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
27877836|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
27877837|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
27877838|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
27877839|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
27877840|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
27877841|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
27877842|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
27877843|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
27877844|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
27877845|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
27877846|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
27877847|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
27877848|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
27877849|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
27877850|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
27877851|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
27877852|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
27877853|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
27877854|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
27877855|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
27877856|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
27877857|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
27877858|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
27877859|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
27877860|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
27877861|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
27877862|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
27877863|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
27877864|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
27877865|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
27877866|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
27877867|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
27877868|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
27877869|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
27877870|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
27589850|NCT02352948|80340487|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27877871|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Site closed|0|||
27877872|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Site closed|0|||
27689120|NCT02641496|80698927|FG000|Overall Study|Withdrawal by Subject|1|||
27689121|NCT02641496|80698928|FG001|Overall Study|Withdrawal by Subject|0|||
27689122|NCT00700258|80698929|FG000|Overall Study|Premature discontinuation of documentation|136|||
27689123|NCT00700258|80698929|FG000|Overall Study|Type of study end not documented|1|||
27689124|NCT00700258|80698929|FG000|Overall Study|Lost to Follow-up|81|||
27689125|NCT00700258|80698929|FG000|Overall Study|Premature discontinuation of therapy|1013|||
27815462|NCT01180244|81158559|FG001|Overall Study|Protocol Violation|0|||
27815463|NCT01180244|81158558|FG000|Overall Study|Lost to Follow-up|1|||
27689126|NCT05718466|80698930|FG000|Overall Study|Withdrawal by Subject|1|||
27689127|NCT05718466|80698931|FG001|Overall Study|Withdrawal by Subject|2|||
27689128|NCT05718466|80698930|FG000|Overall Study|Death|0|||
27815464|NCT01180244|81158559|FG001|Overall Study|Lost to Follow-up|0|||
27815465|NCT02132247|81158562|FG000|Overall Study|Protocol Violation|1|||
27815466|NCT02132247|81158563|FG001|Overall Study|Protocol Violation|0|||
27815467|NCT01004172|81158565|FG000|Overall Study|Progressive Disease in CNS Only|16|||
27815468|NCT01004172|81158565|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
27815469|NCT01004172|81158565|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
27815470|NCT01004172|81158565|FG000|Overall Study|Adverse Event|1|||
27815471|NCT01004172|81158565|FG000|Overall Study|Physician Decision|1|||
27815472|NCT01004172|81158565|FG000|Overall Study|Symptomatic Deterioration|2|||
27815473|NCT02841709|81158568|FG000|5th Intervention|Adverse Event|2|||
27815474|NCT02841709|81158569|FG001|5th Intervention|Adverse Event|0|||
27815475|NCT02841709|81158570|FG002|5th Intervention|Adverse Event|0|||
27815476|NCT02841709|81158571|FG003|5th Intervention|Adverse Event|0|||
27815477|NCT02841709|81158572|FG004|5th Intervention|Adverse Event|2|||
27815478|NCT04117607|81158573|FG000|Overall Study|Early Termination|0|||
27815479|NCT04117607|81158574|FG001|Overall Study|Early Termination|1|||
27815480|NCT04117607|81158575|FG002|Overall Study|Early Termination|0|||
27815481|NCT04117607|81158576|FG003|Overall Study|Early Termination|0|||
27815482|NCT04117607|81158577|FG004|Overall Study|Early Termination|0|||
27815483|NCT04117607|81158578|FG005|Overall Study|Early Termination|0|||
27815484|NCT04117607|81158579|FG006|Overall Study|Early Termination|1|||
27815485|NCT04117607|81158580|FG007|Overall Study|Early Termination|0|||
27689129|NCT05718466|80698931|FG001|Overall Study|Death|1|||
27877873|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Site closed|1|||
27877874|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Site closed|0|||
27877875|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
27877876|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
27877877|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
27877878|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
27877879|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
27877880|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
27877881|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
27877882|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
27877883|NCT00838903|81387114|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
27877884|NCT00838903|81387115|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
27877885|NCT00838903|81387116|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
27877886|NCT00838903|81387117|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
27589851|NCT02352948|80340488|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
27589852|NCT02352948|80340489|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
27589853|NCT02352948|80340484|FG000|Overall Study|Other|0|||
27589854|NCT02352948|80340485|FG001|Overall Study|Other|0|||
27589855|NCT02352948|80340486|FG002|Overall Study|Other|2|||
27589856|NCT02352948|80340487|FG003|Overall Study|Other|0|||
27589857|NCT02352948|80340488|FG004|Overall Study|Other|0|||
27589858|NCT02352948|80340489|FG005|Overall Study|Other|0|||
27589859|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
27589860|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
27589861|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
27589862|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
27589863|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
27589864|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
27589865|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
27589866|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
27589867|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
27589868|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
27589869|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
27589870|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
27589871|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
27589872|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
27589873|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
27589874|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
27589875|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
27589876|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
27589877|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
27589878|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
27589879|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
27689130|NCT00558259|80698932|FG000|Overall Study|Adverse Event|50|||
27689131|NCT00558259|80698933|FG001|Overall Study|Adverse Event|81|||
27689132|NCT00558259|80698932|FG000|Overall Study|Protocol Violation|9|||
27689133|NCT00558259|80698933|FG001|Overall Study|Protocol Violation|5|||
27689134|NCT00558259|80698932|FG000|Overall Study|Withdrawal by Subject|12|||
27689135|NCT00558259|80698933|FG001|Overall Study|Withdrawal by Subject|13|||
27689136|NCT00069108|80698938|FG000|Overall Study|Withdrawal by Subject|5|||
27689137|NCT00069108|80698939|FG001|Overall Study|Withdrawal by Subject|9|||
27689138|NCT00069108|80698938|FG000|Overall Study|Adverse Event|64|||
27689139|NCT00069108|80698939|FG001|Overall Study|Adverse Event|42|||
27689140|NCT00069108|80698938|FG000|Overall Study|Death|6|||
27689141|NCT00069108|80698939|FG001|Overall Study|Death|6|||
27689142|NCT00069108|80698938|FG000|Overall Study|Administration|15|||
27689143|NCT00069108|80698939|FG001|Overall Study|Administration|4|||
27877887|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
27877888|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
27877889|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
27877890|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
27589880|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
27589881|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
27589882|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
27689144|NCT00069108|80698938|FG000|Overall Study|Insufficient therapy|117|||
27689145|NCT00069108|80698939|FG001|Overall Study|Insufficient therapy|144|||
27689146|NCT00069108|80698938|FG000|Overall Study|Violation criteria|1|||
27589883|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589884|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589885|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589886|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589887|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589888|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589889|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589890|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589891|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589892|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589893|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589894|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589895|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27689147|NCT00069108|80698939|FG001|Overall Study|Violation criteria|4|||
27689148|NCT00069108|80698938|FG000|Overall Study|Refused treatment|5|||
27689149|NCT00069108|80698939|FG001|Overall Study|Refused treatment|10|||
27689150|NCT03965689|80698940|FG000|Overall Study|Too sick to get study intervention|2|||
27689151|NCT00574873|80698941|FG000|Overall Study|Withdrawal by Subject|18|||
27689152|NCT00574873|80698942|FG001|Overall Study|Withdrawal by Subject|19|||
27689153|NCT00574873|80698941|FG000|Overall Study|Investigator request|18|||
27815486|NCT04117607|81158581|FG008|Overall Study|Early Termination|0|||
27815487|NCT04117607|81158582|FG009|Overall Study|Early Termination|0|||
27815488|NCT04117607|81158583|FG010|Overall Study|Early Termination|0|||
27815489|NCT04117607|81158584|FG011|Overall Study|Early Termination|0|||
27815490|NCT04117607|81158585|FG012|Overall Study|Early Termination|0|||
27815491|NCT04117607|81158586|FG013|Overall Study|Early Termination|0|||
27877891|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
27877892|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
27877893|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
27877894|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
27877895|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
27877896|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
27589896|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27815492|NCT02201251|81158587|FG000|Overall Study|Adverse Event|1|||
27815493|NCT02201251|81158588|FG001|Overall Study|Adverse Event|1|||
27589897|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27589898|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
27689154|NCT00574873|80698942|FG001|Overall Study|Investigator request|8|||
27815494|NCT02201251|81158587|FG000|Overall Study|Protocol Violation|1|||
27689155|NCT00574873|80698941|FG000|Overall Study|Death|15|||
27689156|NCT00574873|80698942|FG001|Overall Study|Death|14|||
27689157|NCT00574873|80698941|FG000|Overall Study|Lost to Follow-up|14|||
27689158|NCT00574873|80698942|FG001|Overall Study|Lost to Follow-up|5|||
27689159|NCT00574873|80698941|FG000|Overall Study|Other|40|||
27689160|NCT00574873|80698942|FG001|Overall Study|Other|4|||
27689161|NCT00574873|80698941|FG000|Overall Study|Discontinuation of study by sponsor|5|||
27689162|NCT00574873|80698942|FG001|Overall Study|Discontinuation of study by sponsor|199|||
27689163|NCT00574873|80698941|FG000|Overall Study|Blank, site closed per local regulations|2|||
27689164|NCT00574873|80698942|FG001|Overall Study|Blank, site closed per local regulations|2|||
27689165|NCT00574873|80698941|FG000|Overall Study|Extension Study|126|||
27689166|NCT00574873|80698942|FG001|Overall Study|Extension Study|0|||
27815495|NCT02201251|81158588|FG001|Overall Study|Protocol Violation|0|||
27815496|NCT02201251|81158587|FG000|Overall Study|Noncompliance with Study Drug|0|||
27815497|NCT02201251|81158588|FG001|Overall Study|Noncompliance with Study Drug|1|||
27815498|NCT02201251|81158587|FG000|Overall Study|Withdrawal by Subject|2|||
27815499|NCT02201251|81158588|FG001|Overall Study|Withdrawal by Subject|1|||
27815500|NCT04471935|81158590|FG000|Overall Study|Withdrawal by Subject|1|||
27815501|NCT04471935|81158590|FG000|Overall Study|Deemed ineligible to participate|1|||
27815502|NCT00421174|81158594|FG000|Overall Study|Withdrawal by Subject|0|||
27877897|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
27689167|NCT01981473|80698945|FG000|Overall Study|Incorrect diagnosis of RA|0|||
27689168|NCT01981473|80698946|FG001|Overall Study|Incorrect diagnosis of RA|0|||
27689169|NCT01981473|80698947|FG002|Overall Study|Incorrect diagnosis of RA|1|||
27689170|NCT01981473|80698945|FG000|Overall Study|Received treatment for < 6 months|0|||
27689171|NCT01981473|80698946|FG001|Overall Study|Received treatment for < 6 months|0|||
27689172|NCT01981473|80698947|FG002|Overall Study|Received treatment for < 6 months|1|||
27689173|NCT01981473|80698945|FG000|Overall Study|Received treatment for >24 months|2|||
27689174|NCT01981473|80698946|FG001|Overall Study|Received treatment for >24 months|0|||
27689175|NCT01981473|80698947|FG002|Overall Study|Received treatment for >24 months|6|||
27689176|NCT00744757|80698949|FG000|Overall Study|Objective disease progression|7|||
27689177|NCT00744757|80698949|FG000|Overall Study|Physician Decision|5|||
27689178|NCT00744757|80698949|FG000|Overall Study|Withdrawal by Subject|1|||
27877898|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
27877899|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
27877900|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
27877901|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
27877902|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
27877903|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
27815503|NCT00421174|81158595|FG001|Overall Study|Withdrawal by Subject|1|||
27815504|NCT00421174|81158594|FG000|Overall Study|Ineligible due to infection|2|||
27877904|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
27877905|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
27877906|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
27877907|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
27877908|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
27877909|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
27877910|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
27877911|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
27877912|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
27877913|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
27877914|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
27877915|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
27689179|NCT00744757|80698949|FG000|Overall Study|Death|6|||
27689180|NCT00744757|80698949|FG000|Overall Study|Adverse Event|2|||
27689181|NCT04075994|80698950|FG000|Overall Study|Withdrawal by Subject|8|||
27689182|NCT04075994|80698951|FG001|Overall Study|Withdrawal by Subject|9|||
27877916|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
27877917|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
27877918|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
27877919|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
27877920|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
27877921|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
27877922|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
27815505|NCT00421174|81158595|FG001|Overall Study|Ineligible due to infection|0|||
27877923|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
27877924|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
27877925|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
27877926|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
27877927|NCT00838903|81387114|FG000|Follow-up Period (8 Weeks)|Missing|1|||
27877928|NCT00838903|81387115|FG001|Follow-up Period (8 Weeks)|Missing|2|||
27877929|NCT00838903|81387116|FG002|Follow-up Period (8 Weeks)|Missing|1|||
27877930|NCT00838903|81387117|FG003|Follow-up Period (8 Weeks)|Missing|1|||
27877931|NCT00848718|81387118|FG000|Overall Study|Adverse Event|2|||
27877932|NCT00848718|81387119|FG001|Overall Study|Adverse Event|2|||
27877933|NCT00848718|81387120|FG002|Overall Study|Adverse Event|1|||
27877934|NCT00848718|81387121|FG003|Overall Study|Adverse Event|1|||
27877935|NCT00848718|81387122|FG004|Overall Study|Adverse Event|1|||
27815506|NCT01755858|81158596|FG000|Overall Study|Adverse Event|1|||
27815507|NCT01755858|81158597|FG001|Overall Study|Adverse Event|1|||
27815508|NCT02154529|81158600|FG000|Overall Study|Death|1|||
27815509|NCT02154529|81158601|FG001|Overall Study|Death|1|||
27877936|NCT00848718|81387123|FG005|Overall Study|Adverse Event|0|||
27877937|NCT00848718|81387124|FG006|Overall Study|Adverse Event|0|||
27589899|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589900|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589901|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
27589902|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
27589903|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
27589904|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27815510|NCT02154529|81158602|FG002|Overall Study|Death|5|||
27815511|NCT02154529|81158603|FG003|Overall Study|Death|1|||
27815512|NCT02154529|81158600|FG000|Overall Study|Termination of study by sponsor|2|||
27815513|NCT02154529|81158601|FG001|Overall Study|Termination of study by sponsor|2|||
27815514|NCT02154529|81158602|FG002|Overall Study|Termination of study by sponsor|3|||
27815515|NCT02154529|81158603|FG003|Overall Study|Termination of study by sponsor|1|||
27815516|NCT02154529|81158600|FG000|Overall Study|Lost to Follow-up|1|||
27815517|NCT02154529|81158601|FG001|Overall Study|Lost to Follow-up|0|||
27815518|NCT02154529|81158602|FG002|Overall Study|Lost to Follow-up|0|||
27815519|NCT02154529|81158603|FG003|Overall Study|Lost to Follow-up|0|||
27815520|NCT01166568|81158604|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
27815521|NCT01166568|81158605|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
27877938|NCT00848718|81387125|FG007|Overall Study|Adverse Event|1|||
27589905|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27815522|NCT01166568|81158606|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
27815523|NCT01166568|81158604|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
27689183|NCT04075994|80698950|FG000|Overall Study|Adverse Event|2|||
27689184|NCT04075994|80698951|FG001|Overall Study|Adverse Event|2|||
27689185|NCT04075994|80698950|FG000|Overall Study|Investigator withdrew|3|||
27689186|NCT04075994|80698951|FG001|Overall Study|Investigator withdrew|1|||
27589906|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589907|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589908|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27689187|NCT01034176|80698952|FG000|Overall Study|Physician Decision|2|||
27689188|NCT01034176|80698953|FG001|Overall Study|Physician Decision|0|||
27689189|NCT01034176|80698952|FG000|Overall Study|Withdrawal by Subject|0|||
27689190|NCT01034176|80698953|FG001|Overall Study|Withdrawal by Subject|1|||
27689191|NCT01034176|80698952|FG000|Overall Study|Lost to Follow-up|0|||
27689192|NCT01034176|80698953|FG001|Overall Study|Lost to Follow-up|1|||
27689193|NCT03212989|80698954|FG000|Overall Study|Physician Decision|8|||
27689194|NCT02924064|80698955|FG000|Overall Study|Adverse Event|2|||
27689195|NCT02924064|80698956|FG001|Overall Study|Adverse Event|2|||
27689196|NCT02924064|80698955|FG000|Overall Study|Lost to Follow-up|0|||
27689197|NCT02924064|80698956|FG001|Overall Study|Lost to Follow-up|2|||
27689198|NCT02924064|80698955|FG000|Overall Study|Physician Decision|0|||
27689199|NCT02924064|80698956|FG001|Overall Study|Physician Decision|2|||
27815524|NCT01166568|81158605|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
27815525|NCT01166568|81158606|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
27815526|NCT01166568|81158604|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
27815527|NCT01166568|81158605|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
27589909|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27689200|NCT02924064|80698955|FG000|Overall Study|Protocol Violation|1|||
27689201|NCT02924064|80698956|FG001|Overall Study|Protocol Violation|3|||
27689202|NCT02924064|80698955|FG000|Overall Study|Withdrawal by Subject|4|||
27689203|NCT02924064|80698956|FG001|Overall Study|Withdrawal by Subject|5|||
27689204|NCT02924064|80698955|FG000|Overall Study|Other|17|||
27689205|NCT02924064|80698956|FG001|Overall Study|Other|29|||
27689206|NCT03606668|80698957|FG000|Overall Study|Screen Failure|1|||
27689207|NCT03606668|80698957|FG000|Overall Study|Lost to Follow-up|1|||
27689208|NCT00190749|80698958|FG000|Overall Study|Lost to Follow-up|8|||
27689209|NCT00190749|80698959|FG001|Overall Study|Lost to Follow-up|11|||
27689210|NCT00190749|80698958|FG000|Overall Study|Withdrawal by Subject|10|||
27689211|NCT00190749|80698959|FG001|Overall Study|Withdrawal by Subject|6|||
27689212|NCT00190749|80698958|FG000|Overall Study|Protocol Violation|5|||
27689213|NCT00190749|80698959|FG001|Overall Study|Protocol Violation|4|||
27689214|NCT00190749|80698958|FG000|Overall Study|Adverse Event|0|||
27689215|NCT00190749|80698959|FG001|Overall Study|Adverse Event|5|||
27689216|NCT00190749|80698958|FG000|Overall Study|Lack of Efficacy|2|||
27689217|NCT00190749|80698959|FG001|Overall Study|Lack of Efficacy|3|||
27689218|NCT00190749|80698958|FG000|Overall Study|Reason Not Specified|0|||
27689219|NCT00190749|80698959|FG001|Overall Study|Reason Not Specified|2|||
27689220|NCT00190749|80698958|FG000|Overall Study|Sponsor Decision|1|||
27689221|NCT00190749|80698959|FG001|Overall Study|Sponsor Decision|0|||
27689222|NCT00911937|80698960|FG000|Overall Study|Death|1|||
27689223|NCT00911937|80698961|FG001|Overall Study|Death|0|||
27689224|NCT00911937|80698960|FG000|Overall Study|Lost to Follow-up|8|||
27689225|NCT00911937|80698961|FG001|Overall Study|Lost to Follow-up|5|||
27689226|NCT00911937|80698960|FG000|Overall Study|Withdrawal by Subject|10|||
27689227|NCT00911937|80698961|FG001|Overall Study|Withdrawal by Subject|7|||
27689228|NCT00911937|80698960|FG000|Overall Study|Withdrawn due to pregnancy|1|||
27815528|NCT01166568|81158606|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
27815529|NCT01611090|81158607|FG000|Randomized Period|Lost to Follow-up|8|||
27815530|NCT01611090|81158608|FG001|Randomized Period|Lost to Follow-up|3|||
27689229|NCT00911937|80698961|FG001|Overall Study|Withdrawn due to pregnancy|0|||
27689230|NCT00911937|80698960|FG000|Overall Study|Adverse Event|11|||
27689231|NCT00911937|80698961|FG001|Overall Study|Adverse Event|25|||
27689232|NCT00911937|80698960|FG000|Overall Study|Lack of Efficacy|11|||
27689233|NCT00911937|80698961|FG001|Overall Study|Lack of Efficacy|6|||
27689234|NCT00911937|80698960|FG000|Overall Study|Did not meet inclusion criteria|9|||
27689235|NCT00911937|80698961|FG001|Overall Study|Did not meet inclusion criteria|11|||
27689236|NCT00911937|80698960|FG000|Overall Study|Protocol Violation|14|||
27689237|NCT00911937|80698961|FG001|Overall Study|Protocol Violation|23|||
27689238|NCT00911937|80698960|FG000|Overall Study|Randomized but not treated|13|||
27689239|NCT00911937|80698961|FG001|Overall Study|Randomized but not treated|13|||
27689240|NCT00911937|80698960|FG000|Overall Study|Other|9|||
27689241|NCT00911937|80698961|FG001|Overall Study|Other|5|||
27689242|NCT00440999|80698962|FG000|Overall Study|Adverse Event|0|||
27689243|NCT00440999|80698963|FG001|Overall Study|Adverse Event|2|||
27689244|NCT00440999|80698962|FG000|Overall Study|Lack of Efficacy|6|||
27689245|NCT00440999|80698963|FG001|Overall Study|Lack of Efficacy|7|||
27689246|NCT00440999|80698962|FG000|Overall Study|Lost to Follow-up|19|||
27689247|NCT00440999|80698963|FG001|Overall Study|Lost to Follow-up|12|||
27689248|NCT00440999|80698962|FG000|Overall Study|Protocol Violation|1|||
27689249|NCT00440999|80698963|FG001|Overall Study|Protocol Violation|0|||
27689250|NCT00440999|80698962|FG000|Overall Study|Withdrawal by Subject|2|||
27689251|NCT00440999|80698963|FG001|Overall Study|Withdrawal by Subject|5|||
27689252|NCT00440999|80698962|FG000|Overall Study|Subjets missed the visit|1|||
27689253|NCT00440999|80698963|FG001|Overall Study|Subjets missed the visit|0|||
27689254|NCT00440999|80698962|FG000|Overall Study|Mixed infection at entry|1|||
27689255|NCT00440999|80698963|FG001|Overall Study|Mixed infection at entry|0|||
27689256|NCT00440999|80698962|FG000|Overall Study|P. falciparum malaria|5|||
27689257|NCT00440999|80698963|FG001|Overall Study|P. falciparum malaria|14|||
27689258|NCT00440999|80698962|FG000|Overall Study|Subj left hosp without inform staff|0|||
27689259|NCT00440999|80698963|FG001|Overall Study|Subj left hosp without inform staff|1|||
27689260|NCT01489891|80698964|FG000|Overall Study|Endoscopy failure|1|||
27877939|NCT00848718|81387126|FG008|Overall Study|Adverse Event|1|||
27877940|NCT00848718|81387127|FG009|Overall Study|Adverse Event|0|||
27877941|NCT00848718|81387128|FG010|Overall Study|Adverse Event|0|||
27815531|NCT01611090|81158609|FG002|Randomized Period|Lost to Follow-up|0|||
27815532|NCT01611090|81158607|FG000|Randomized Period|Withdrawal by Subject|22|||
27815533|NCT01611090|81158608|FG001|Randomized Period|Withdrawal by Subject|26|||
27815534|NCT01611090|81158609|FG002|Randomized Period|Withdrawal by Subject|0|||
27815535|NCT01611090|81158607|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
27689261|NCT01489891|80698965|FG001|Overall Study|Endoscopy failure|0|||
27689262|NCT02146326|80698970|FG000|Overall Study|Lost to Follow-up|3|||
27689263|NCT02146326|80698971|FG001|Overall Study|Lost to Follow-up|3|||
27689264|NCT02146326|80698972|FG002|Overall Study|Lost to Follow-up|11|||
27689265|NCT02146326|80698973|FG003|Overall Study|Lost to Follow-up|19|||
27689266|NCT02146326|80698970|FG000|Overall Study|Withdrawal by Subject|2|||
27689267|NCT02146326|80698971|FG001|Overall Study|Withdrawal by Subject|1|||
27689268|NCT02146326|80698972|FG002|Overall Study|Withdrawal by Subject|15|||
27689269|NCT02146326|80698973|FG003|Overall Study|Withdrawal by Subject|11|||
27689270|NCT02146326|80698970|FG000|Overall Study|Separated from mental health center|23|||
27689271|NCT02146326|80698971|FG001|Overall Study|Separated from mental health center|33|||
27689272|NCT02146326|80698972|FG002|Overall Study|Separated from mental health center|0|||
27689273|NCT02146326|80698973|FG003|Overall Study|Separated from mental health center|0|||
27689274|NCT02146326|80698970|FG000|Overall Study|Incarcerated|0|||
27689275|NCT02146326|80698971|FG001|Overall Study|Incarcerated|0|||
27689276|NCT02146326|80698972|FG002|Overall Study|Incarcerated|3|||
27689277|NCT02146326|80698973|FG003|Overall Study|Incarcerated|8|||
27815536|NCT01611090|81158608|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
27815537|NCT01611090|81158609|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
27815538|NCT01611090|81158607|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
27815539|NCT01611090|81158608|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
27815540|NCT01611090|81158609|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
27815541|NCT01766921|81158616|FG000|Overall Study|Administrative Reason|5|||
27815542|NCT01766921|81158617|FG001|Overall Study|Administrative Reason|5|||
27815543|NCT01766921|81158616|FG000|Overall Study|Death|1|||
27815544|NCT01766921|81158617|FG001|Overall Study|Death|1|||
27689278|NCT02146326|80698970|FG000|Overall Study|Death|0|||
27689279|NCT02146326|80698971|FG001|Overall Study|Death|0|||
27689280|NCT02146326|80698972|FG002|Overall Study|Death|4|||
27689281|NCT02146326|80698973|FG003|Overall Study|Death|4|||
27689282|NCT02146326|80698970|FG000|Overall Study|Unable to complete interview|0|||
27689283|NCT02146326|80698971|FG001|Overall Study|Unable to complete interview|0|||
27689284|NCT02146326|80698972|FG002|Overall Study|Unable to complete interview|10|||
27689285|NCT02146326|80698973|FG003|Overall Study|Unable to complete interview|6|||
27689286|NCT01145898|80698974|FG000|3-year Treatment|medication change by treating physician|3|||
27701004|NCT01241552|80741289|FG000|Overall Study|Lost to Follow-up|2|||
27815545|NCT01766921|81158616|FG000|Overall Study|Lost to Follow-up|1|||
27815546|NCT01766921|81158617|FG001|Overall Study|Lost to Follow-up|3|||
27815547|NCT01766921|81158616|FG000|Overall Study|Unclassified|2|||
27815548|NCT01766921|81158617|FG001|Overall Study|Unclassified|2|||
27815549|NCT01766921|81158616|FG000|Overall Study|Protocol Violation|1|||
27815550|NCT01766921|81158617|FG001|Overall Study|Protocol Violation|1|||
27815551|NCT01766921|81158616|FG000|Overall Study|Withdrawal by Subject|14|||
27815552|NCT01766921|81158617|FG001|Overall Study|Withdrawal by Subject|5|||
27815553|NCT00576901|81158618|FG000|Overall Study|Withdrawal by Subject|1|||
27815554|NCT00576901|81158618|FG000|Overall Study|Disease course|1|||
27815555|NCT00576901|81158618|FG000|Overall Study|Protocol Violation|1|||
27815556|NCT00623103|81158619|FG000|Overall Study|Adverse Event|70|||
27815557|NCT00623103|81158620|FG001|Overall Study|Adverse Event|60|||
27815558|NCT00623103|81158619|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27815559|NCT00623103|81158620|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
27815560|NCT00623103|81158619|FG000|Overall Study|Withdrawal by Subject|18|||
27815561|NCT00623103|81158620|FG001|Overall Study|Withdrawal by Subject|24|||
27815562|NCT00623103|81158619|FG000|Overall Study|Lost to Follow-up|4|||
27815563|NCT00623103|81158620|FG001|Overall Study|Lost to Follow-up|1|||
27815564|NCT00623103|81158619|FG000|Overall Study|Administrative problems|2|||
27815565|NCT00623103|81158620|FG001|Overall Study|Administrative problems|4|||
27815566|NCT00623103|81158619|FG000|Overall Study|Death|11|||
27815567|NCT00623103|81158620|FG001|Overall Study|Death|11|||
27815568|NCT00623103|81158619|FG000|Overall Study|Protocol deviation|2|||
27815569|NCT00623103|81158620|FG001|Overall Study|Protocol deviation|1|||
27815570|NCT00472290|81158623|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
27815571|NCT00472290|81158623|FG000|Overall Study|Protocol Specified Criteria|7|||
27815572|NCT00472290|81158623|FG000|Overall Study|Administrative Decision|37|||
27815573|NCT00472290|81158623|FG000|Overall Study|Death|3|||
27815574|NCT00472290|81158623|FG000|Overall Study|Lost to Follow-up|1|||
27815575|NCT00472290|81158623|FG000|Overall Study|Lack of Efficacy|1|||
27815576|NCT00472290|81158623|FG000|Overall Study|Disease Progression|4|||
27815577|NCT00472290|81158623|FG000|Overall Study|Withdrawal by Subject|5|||
27815578|NCT00472290|81158623|FG000|Overall Study|Adverse Event|6|||
27815579|NCT00472290|81158623|FG000|Overall Study|Requirement for alternative therapy|7|||
27815580|NCT02305758|81158624|FG000|Overall Study|Death|27|||
27815581|NCT02305758|81158625|FG001|Overall Study|Death|27|||
27815582|NCT02305758|81158624|FG000|Overall Study|Withdrew consent|9|||
27815583|NCT02305758|81158625|FG001|Overall Study|Withdrew consent|2|||
27815584|NCT02305758|81158624|FG000|Overall Study|Lost to Follow-up|6|||
27815585|NCT02305758|81158625|FG001|Overall Study|Lost to Follow-up|1|||
27815586|NCT02305758|81158624|FG000|Overall Study|Study Terminated by Sponsor|21|||
27815587|NCT02305758|81158625|FG001|Overall Study|Study Terminated by Sponsor|34|||
27815588|NCT02305758|81158624|FG000|Overall Study|Other, not specified|2|||
27815589|NCT02305758|81158625|FG001|Overall Study|Other, not specified|1|||
27815590|NCT02309099|81158627|FG000|Overall Study|Adverse Event|2|||
27815591|NCT02309099|81158628|FG001|Overall Study|Adverse Event|0|||
27815592|NCT01816477|81158629|FG000|Overall Study|Withdrawal by Subject|13|||
27815593|NCT01816477|81158630|FG001|Overall Study|Withdrawal by Subject|1|||
27815594|NCT01816477|81158629|FG000|Overall Study|Unable to tolerate catheter placement|3|||
27815595|NCT01816477|81158630|FG001|Overall Study|Unable to tolerate catheter placement|0|||
27815596|NCT02003183|81158632|FG000|Overall Study|Lost to Follow-up|0|||
27815597|NCT02003183|81158633|FG001|Overall Study|Lost to Follow-up|2|||
27815598|NCT03500484|81158634|FG000|Overall Study|Adverse Event|2|||
27815599|NCT03500484|81158635|FG001|Overall Study|Adverse Event|0|||
27815600|NCT03500484|81158634|FG000|Overall Study|Physician Decision|1|||
27815601|NCT03500484|81158635|FG001|Overall Study|Physician Decision|0|||
27815602|NCT03500484|81158634|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
27815603|NCT03500484|81158635|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
27815604|NCT01278862|81158636|FG000|Overall Study|Lost to Follow-up|1|||
27815605|NCT01278862|81158637|FG001|Overall Study|Lost to Follow-up|1|||
27815606|NCT00322491|81158638|FG000|Overall Study|Adverse Event|1|||
27815607|NCT00322491|81158639|FG001|Overall Study|Adverse Event|0|||
27815608|NCT00322491|81158638|FG000|Overall Study|Death|1|||
27689287|NCT01145898|80698975|FG001|3-year Treatment|medication change by treating physician|16|||
27689288|NCT00598273|80698976|FG000|Overall Study|Adverse Event|4|||
27689289|NCT00598273|80698977|FG001|Overall Study|Adverse Event|5|||
27689290|NCT00598273|80698978|FG002|Overall Study|Adverse Event|2|||
27689291|NCT00598273|80698976|FG000|Overall Study|Death|6|||
27689292|NCT00598273|80698977|FG001|Overall Study|Death|12|||
27689293|NCT00598273|80698978|FG002|Overall Study|Death|8|||
27689294|NCT00598273|80698976|FG000|Overall Study|Lost to Follow-up|8|||
27689295|NCT00598273|80698977|FG001|Overall Study|Lost to Follow-up|3|||
27689296|NCT00598273|80698978|FG002|Overall Study|Lost to Follow-up|5|||
27689297|NCT00598273|80698976|FG000|Overall Study|Physician Decision|0|||
27689298|NCT00598273|80698977|FG001|Overall Study|Physician Decision|0|||
27689299|NCT00598273|80698978|FG002|Overall Study|Physician Decision|1|||
27689300|NCT00598273|80698976|FG000|Overall Study|Withdrawal by Subject|12|||
27689301|NCT00598273|80698977|FG001|Overall Study|Withdrawal by Subject|10|||
27689302|NCT00598273|80698978|FG002|Overall Study|Withdrawal by Subject|10|||
27689303|NCT00598273|80698976|FG000|Overall Study|Noncompliance|3|||
27689304|NCT00598273|80698977|FG001|Overall Study|Noncompliance|2|||
27689305|NCT00598273|80698978|FG002|Overall Study|Noncompliance|3|||
27689306|NCT00598273|80698976|FG000|Overall Study|Relocation|0|||
27689307|NCT00598273|80698977|FG001|Overall Study|Relocation|2|||
27689308|NCT00598273|80698978|FG002|Overall Study|Relocation|4|||
27689309|NCT00598273|80698976|FG000|Overall Study|Renal transplant|1|||
27689310|NCT00598273|80698977|FG001|Overall Study|Renal transplant|0|||
27689311|NCT00598273|80698978|FG002|Overall Study|Renal transplant|1|||
27689312|NCT00598273|80698976|FG000|Overall Study|Site elected to close|1|||
27689313|NCT00598273|80698977|FG001|Overall Study|Site elected to close|0|||
27689314|NCT00598273|80698978|FG002|Overall Study|Site elected to close|0|||
27689315|NCT00598273|80698976|FG000|Overall Study|Started dialysis|6|||
27689316|NCT00598273|80698977|FG001|Overall Study|Started dialysis|4|||
27689317|NCT00598273|80698978|FG002|Overall Study|Started dialysis|5|||
27689318|NCT01723254|80698980|FG000|Overall Study|Conflict with work schedule|0|||
27689319|NCT01723254|80698981|FG001|Overall Study|Conflict with work schedule|0|||
27689320|NCT01723254|80698982|FG002|Overall Study|Conflict with work schedule|0|||
27689321|NCT01723254|80698983|FG003|Overall Study|Conflict with work schedule|0|||
27689322|NCT01723254|80698984|FG004|Overall Study|Conflict with work schedule|0|||
27689323|NCT01723254|80698985|FG005|Overall Study|Conflict with work schedule|0|||
27689324|NCT01723254|80698986|FG006|Overall Study|Conflict with work schedule|0|||
27689325|NCT01723254|80698987|FG007|Overall Study|Conflict with work schedule|1|||
27689326|NCT01723254|80698980|FG000|Overall Study|Personal issues|0|||
27689327|NCT01723254|80698981|FG001|Overall Study|Personal issues|0|||
27689328|NCT01723254|80698982|FG002|Overall Study|Personal issues|0|||
27689329|NCT01723254|80698983|FG003|Overall Study|Personal issues|0|||
27689330|NCT01723254|80698984|FG004|Overall Study|Personal issues|0|||
27815609|NCT00322491|81158639|FG001|Overall Study|Death|2|||
27815610|NCT02532764|81158641|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815611|NCT02532764|81158642|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815612|NCT02532764|81158643|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815613|NCT02532764|81158644|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815614|NCT02532764|81158645|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815615|NCT02532764|81158646|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815616|NCT02532764|81158647|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
27815617|NCT02532764|81158648|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
27815618|NCT02532764|81158649|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
27815619|NCT02532764|81158650|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
27815620|NCT01802879|81158652|FG000|Overall Study|Administrative problems|2|||
27815621|NCT01802879|81158652|FG000|Overall Study|Disease progression|6|||
27815622|NCT00922974|81158660|FG000|Phase II Component|Protocol Violation|2|||
27815623|NCT00922974|81158661|FG001|Phase II Component|Protocol Violation|0|||
27815624|NCT00922974|81158660|FG000|Phase II Component|Not evaluable for treatment review|5|||
27689331|NCT01723254|80698985|FG005|Overall Study|Personal issues|1|||
27689332|NCT01723254|80698986|FG006|Overall Study|Personal issues|0|||
27689333|NCT01723254|80698987|FG007|Overall Study|Personal issues|0|||
27689334|NCT01723254|80698980|FG000|Overall Study|No longer have time to participate|0|||
27689335|NCT01723254|80698981|FG001|Overall Study|No longer have time to participate|0|||
27877942|NCT00848718|81387129|FG011|Overall Study|Adverse Event|0|||
27877943|NCT00848718|81387130|FG012|Overall Study|Adverse Event|2|||
27877944|NCT00848718|81387118|FG000|Overall Study|Lack of Efficacy|0|||
27877945|NCT00848718|81387119|FG001|Overall Study|Lack of Efficacy|0|||
27877946|NCT00848718|81387120|FG002|Overall Study|Lack of Efficacy|1|||
27877947|NCT00848718|81387121|FG003|Overall Study|Lack of Efficacy|0|||
27877948|NCT00848718|81387122|FG004|Overall Study|Lack of Efficacy|0|||
27877949|NCT00848718|81387123|FG005|Overall Study|Lack of Efficacy|0|||
27877950|NCT00848718|81387124|FG006|Overall Study|Lack of Efficacy|1|||
27877951|NCT00848718|81387125|FG007|Overall Study|Lack of Efficacy|0|||
27877952|NCT00848718|81387126|FG008|Overall Study|Lack of Efficacy|0|||
27877953|NCT00848718|81387127|FG009|Overall Study|Lack of Efficacy|0|||
27877954|NCT00848718|81387128|FG010|Overall Study|Lack of Efficacy|0|||
27877955|NCT00848718|81387129|FG011|Overall Study|Lack of Efficacy|0|||
27877956|NCT00848718|81387130|FG012|Overall Study|Lack of Efficacy|0|||
27877957|NCT00848718|81387118|FG000|Overall Study|Physician Decision|0|||
27877958|NCT00848718|81387119|FG001|Overall Study|Physician Decision|1|||
27877959|NCT00848718|81387120|FG002|Overall Study|Physician Decision|0|||
27877960|NCT00848718|81387121|FG003|Overall Study|Physician Decision|0|||
27877961|NCT00848718|81387122|FG004|Overall Study|Physician Decision|1|||
27877962|NCT00848718|81387123|FG005|Overall Study|Physician Decision|1|||
27877963|NCT00848718|81387124|FG006|Overall Study|Physician Decision|0|||
27877964|NCT00848718|81387125|FG007|Overall Study|Physician Decision|0|||
27877965|NCT00848718|81387126|FG008|Overall Study|Physician Decision|1|||
27877966|NCT00848718|81387127|FG009|Overall Study|Physician Decision|2|||
27877967|NCT00848718|81387128|FG010|Overall Study|Physician Decision|0|||
27877968|NCT00848718|81387129|FG011|Overall Study|Physician Decision|0|||
27877969|NCT00848718|81387130|FG012|Overall Study|Physician Decision|1|||
27877970|NCT00848718|81387118|FG000|Overall Study|Progressive disease before treatment|1|||
27877971|NCT00848718|81387119|FG001|Overall Study|Progressive disease before treatment|5|||
27877972|NCT00848718|81387120|FG002|Overall Study|Progressive disease before treatment|1|||
27877973|NCT00848718|81387121|FG003|Overall Study|Progressive disease before treatment|3|||
27877974|NCT00848718|81387122|FG004|Overall Study|Progressive disease before treatment|4|||
27877975|NCT00848718|81387123|FG005|Overall Study|Progressive disease before treatment|4|||
27877976|NCT00848718|81387124|FG006|Overall Study|Progressive disease before treatment|2|||
27877977|NCT00848718|81387125|FG007|Overall Study|Progressive disease before treatment|1|||
27877978|NCT00848718|81387126|FG008|Overall Study|Progressive disease before treatment|2|||
27877979|NCT00848718|81387127|FG009|Overall Study|Progressive disease before treatment|7|||
27877980|NCT00848718|81387128|FG010|Overall Study|Progressive disease before treatment|3|||
27877981|NCT00848718|81387129|FG011|Overall Study|Progressive disease before treatment|6|||
27877982|NCT00848718|81387130|FG012|Overall Study|Progressive disease before treatment|2|||
27877983|NCT00848718|81387118|FG000|Overall Study|Protocol Violation|0|||
27877984|NCT00848718|81387119|FG001|Overall Study|Protocol Violation|1|||
27877985|NCT00848718|81387120|FG002|Overall Study|Protocol Violation|0|||
27877986|NCT00848718|81387121|FG003|Overall Study|Protocol Violation|0|||
27877987|NCT00848718|81387122|FG004|Overall Study|Protocol Violation|0|||
27877988|NCT00848718|81387123|FG005|Overall Study|Protocol Violation|0|||
27877989|NCT00848718|81387124|FG006|Overall Study|Protocol Violation|0|||
27877990|NCT00848718|81387125|FG007|Overall Study|Protocol Violation|1|||
27877991|NCT00848718|81387126|FG008|Overall Study|Protocol Violation|0|||
27877992|NCT00848718|81387127|FG009|Overall Study|Protocol Violation|0|||
27877993|NCT00848718|81387128|FG010|Overall Study|Protocol Violation|0|||
27877994|NCT00848718|81387129|FG011|Overall Study|Protocol Violation|0|||
27877995|NCT00848718|81387130|FG012|Overall Study|Protocol Violation|1|||
27877996|NCT00848718|81387118|FG000|Overall Study|Withdrawal by Subject|1|||
27877997|NCT00848718|81387119|FG001|Overall Study|Withdrawal by Subject|0|||
27877998|NCT00848718|81387120|FG002|Overall Study|Withdrawal by Subject|0|||
27877999|NCT00848718|81387121|FG003|Overall Study|Withdrawal by Subject|1|||
27878000|NCT00848718|81387122|FG004|Overall Study|Withdrawal by Subject|0|||
27878001|NCT00848718|81387123|FG005|Overall Study|Withdrawal by Subject|0|||
27878002|NCT00848718|81387124|FG006|Overall Study|Withdrawal by Subject|0|||
27878003|NCT00848718|81387125|FG007|Overall Study|Withdrawal by Subject|0|||
27878004|NCT00848718|81387126|FG008|Overall Study|Withdrawal by Subject|0|||
27878005|NCT00848718|81387127|FG009|Overall Study|Withdrawal by Subject|0|||
27878006|NCT00848718|81387128|FG010|Overall Study|Withdrawal by Subject|1|||
27878007|NCT00848718|81387129|FG011|Overall Study|Withdrawal by Subject|0|||
27878008|NCT00848718|81387130|FG012|Overall Study|Withdrawal by Subject|0|||
27878009|NCT00848718|81387118|FG000|Overall Study|Progressive disease during treatment|3|||
27878010|NCT00848718|81387119|FG001|Overall Study|Progressive disease during treatment|0|||
27878011|NCT00848718|81387120|FG002|Overall Study|Progressive disease during treatment|3|||
27878012|NCT00848718|81387121|FG003|Overall Study|Progressive disease during treatment|0|||
27878013|NCT00848718|81387122|FG004|Overall Study|Progressive disease during treatment|0|||
27878014|NCT00848718|81387123|FG005|Overall Study|Progressive disease during treatment|0|||
27878015|NCT00848718|81387124|FG006|Overall Study|Progressive disease during treatment|0|||
27878016|NCT00848718|81387125|FG007|Overall Study|Progressive disease during treatment|2|||
27878017|NCT00848718|81387126|FG008|Overall Study|Progressive disease during treatment|0|||
27878018|NCT00848718|81387127|FG009|Overall Study|Progressive disease during treatment|0|||
27878019|NCT00848718|81387128|FG010|Overall Study|Progressive disease during treatment|0|||
27878020|NCT00848718|81387129|FG011|Overall Study|Progressive disease during treatment|0|||
27878021|NCT00848718|81387130|FG012|Overall Study|Progressive disease during treatment|2|||
27878022|NCT02064816|81387131|FG000|Overall Study|Adverse Event|3|||
27878023|NCT02064816|81387132|FG001|Overall Study|Adverse Event|2|||
27878024|NCT02064816|81387131|FG000|Overall Study|Withdrawal by Subject|2|||
27878025|NCT02064816|81387132|FG001|Overall Study|Withdrawal by Subject|1|||
27878026|NCT02064816|81387131|FG000|Overall Study|Lost to Follow-up|2|||
27878027|NCT02064816|81387132|FG001|Overall Study|Lost to Follow-up|1|||
27878028|NCT02064816|81387131|FG000|Overall Study|Therapeutic failure|0|||
27878029|NCT02064816|81387132|FG001|Overall Study|Therapeutic failure|1|||
27878030|NCT02064816|81387131|FG000|Overall Study|Other|1|||
27878031|NCT02064816|81387132|FG001|Overall Study|Other|3|||
27878032|NCT01998919|81387133|FG000|Overall Study|Death|2|||
27878033|NCT01998919|81387134|FG001|Overall Study|Death|2|||
27878034|NCT01998919|81387133|FG000|Overall Study|Adverse Event|0|||
27878035|NCT01998919|81387134|FG001|Overall Study|Adverse Event|5|||
27878036|NCT01998919|81387133|FG000|Overall Study|Disease progression|31|||
27878037|NCT01998919|81387134|FG001|Overall Study|Disease progression|22|||
27878038|NCT01998919|81387133|FG000|Overall Study|Withdrawal by Subject|2|||
27878039|NCT01998919|81387134|FG001|Overall Study|Withdrawal by Subject|4|||
27878040|NCT01998919|81387133|FG000|Overall Study|Lost to Follow-up|2|||
27878041|NCT01998919|81387134|FG001|Overall Study|Lost to Follow-up|0|||
27878042|NCT01998919|81387133|FG000|Overall Study|Other|5|||
27878043|NCT01998919|81387134|FG001|Overall Study|Other|2|||
27878044|NCT00455403|81387135|FG000|Overall Study|Lost to Follow-up|2|||
27701005|NCT01241552|80741290|FG001|Overall Study|Lost to Follow-up|11|||
27878045|NCT00455403|81387136|FG001|Overall Study|Lost to Follow-up|1|||
27878046|NCT00455403|81387135|FG000|Overall Study|Withdrawal by Subject|1|||
27878047|NCT00455403|81387136|FG001|Overall Study|Withdrawal by Subject|3|||
27878048|NCT00455403|81387135|FG000|Overall Study|Protocol Violation|0|||
27878049|NCT00455403|81387136|FG001|Overall Study|Protocol Violation|2|||
27589910|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589911|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27815625|NCT00922974|81158661|FG001|Phase II Component|Not evaluable for treatment review|0|||
27815626|NCT00922974|81158660|FG000|Phase III Component|Protocol Violation|8|||
27815627|NCT00922974|81158661|FG001|Phase III Component|Protocol Violation|6|||
27815628|NCT03997448|81158662|FG000|Study Treatment|Disease Progression|1|||
27815629|NCT03997448|81158662|FG000|Study Treatment|Symptomatic Deterioration|1|||
27815630|NCT03997448|81158662|FG000|Follow up|Death|2|||
27815631|NCT03997448|81158662|FG000|Follow up|study terminated|1|||
27815632|NCT02674334|81158666|FG000|Overall Study|Lost to Follow-up|5|||
27815633|NCT02674334|81158667|FG001|Overall Study|Lost to Follow-up|3|||
27815634|NCT02674334|81158666|FG000|Overall Study|participant difficulty breathing|1|||
27815635|NCT02674334|81158667|FG001|Overall Study|participant difficulty breathing|0|||
27815636|NCT02674334|81158666|FG000|Overall Study|NIRS not recording|1|||
27815637|NCT02674334|81158667|FG001|Overall Study|NIRS not recording|0|||
27815638|NCT00287118|81158675|FG000|Overall Study|Adverse Event|30|||
27815639|NCT00287118|81158675|FG000|Overall Study|Death|1|||
27815640|NCT00287118|81158675|FG000|Overall Study|Lack of Efficacy|11|||
27815641|NCT00287118|81158675|FG000|Overall Study|Lost to Follow-up|1|||
27815642|NCT00287118|81158675|FG000|Overall Study|Protocol Violation|2|||
27815643|NCT00287118|81158675|FG000|Overall Study|Other|7|||
27815644|NCT00084084|81158676|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
27815645|NCT00084084|81158676|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
27815646|NCT01249664|81158677|FG000|Overall Study|Withdrawal by Subject|5|||
27815647|NCT01249664|81158678|FG001|Overall Study|Withdrawal by Subject|0|||
27815648|NCT01249664|81158677|FG000|Overall Study|Adverse Event|1|||
27815649|NCT01249664|81158678|FG001|Overall Study|Adverse Event|0|||
27815650|NCT02927847|81158679|FG000|Overall Study|Lost to Follow-up|1|||
27815651|NCT02927847|81158680|FG001|Overall Study|Lost to Follow-up|0|||
27815652|NCT02927847|81158679|FG000|Overall Study|Withdrawal by Subject|4|||
27815653|NCT02927847|81158680|FG001|Overall Study|Withdrawal by Subject|2|||
27815654|NCT02927847|81158679|FG000|Overall Study|PI withdrawn due to missed visits|1|||
27815655|NCT02927847|81158680|FG001|Overall Study|PI withdrawn due to missed visits|1|||
27815656|NCT02398188|81158681|FG000|Overall Study|Adverse Event|2|||
27815657|NCT02398188|81158682|FG001|Overall Study|Adverse Event|3|||
27815658|NCT02398188|81158681|FG000|Overall Study|Lost to Follow-up|5|||
27589912|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27815659|NCT02398188|81158682|FG001|Overall Study|Lost to Follow-up|0|||
27815660|NCT02398188|81158681|FG000|Overall Study|Non-compliance|4|||
27815661|NCT02398188|81158682|FG001|Overall Study|Non-compliance|4|||
27815662|NCT02398188|81158681|FG000|Overall Study|Protocol Violation|6|||
27815663|NCT02398188|81158682|FG001|Overall Study|Protocol Violation|10|||
27815664|NCT02398188|81158681|FG000|Overall Study|Sponsor Decision|2|||
27815665|NCT02398188|81158682|FG001|Overall Study|Sponsor Decision|1|||
27589913|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27878050|NCT02712554|81387142|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
27878051|NCT02712554|81387143|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
27878052|NCT02712554|81387142|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
27878053|NCT02712554|81387143|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
27878054|NCT02712554|81387142|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
27589914|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27689336|NCT01723254|80698982|FG002|Overall Study|No longer have time to participate|0|||
27589915|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589916|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589917|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27589918|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
27689337|NCT01723254|80698983|FG003|Overall Study|No longer have time to participate|1|||
27689338|NCT01723254|80698984|FG004|Overall Study|No longer have time to participate|0|||
27589919|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
27589920|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
27589921|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
27589922|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
27589923|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
27689339|NCT01723254|80698985|FG005|Overall Study|No longer have time to participate|0|||
27689340|NCT01723254|80698986|FG006|Overall Study|No longer have time to participate|0|||
27689341|NCT01723254|80698987|FG007|Overall Study|No longer have time to participate|0|||
27878055|NCT02712554|81387143|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
27689342|NCT01723254|80698980|FG000|Overall Study|Move/Left to another country/city|0|||
27689343|NCT01723254|80698981|FG001|Overall Study|Move/Left to another country/city|0|||
27689344|NCT01723254|80698982|FG002|Overall Study|Move/Left to another country/city|2|||
27689345|NCT01723254|80698983|FG003|Overall Study|Move/Left to another country/city|1|||
27689346|NCT01723254|80698984|FG004|Overall Study|Move/Left to another country/city|1|||
27689347|NCT01723254|80698985|FG005|Overall Study|Move/Left to another country/city|0|||
27689348|NCT01723254|80698986|FG006|Overall Study|Move/Left to another country/city|0|||
27689349|NCT01723254|80698987|FG007|Overall Study|Move/Left to another country/city|0|||
27689350|NCT01723254|80698980|FG000|Overall Study|Protocol Violation|0|||
27689351|NCT01723254|80698981|FG001|Overall Study|Protocol Violation|1|||
27689352|NCT01723254|80698982|FG002|Overall Study|Protocol Violation|0|||
27689353|NCT01723254|80698983|FG003|Overall Study|Protocol Violation|0|||
27689354|NCT01723254|80698984|FG004|Overall Study|Protocol Violation|0|||
27689355|NCT01723254|80698985|FG005|Overall Study|Protocol Violation|0|||
27689356|NCT01723254|80698986|FG006|Overall Study|Protocol Violation|0|||
27689357|NCT01723254|80698987|FG007|Overall Study|Protocol Violation|0|||
27689358|NCT01723254|80698980|FG000|Overall Study|Withdrawal by Subject|1|||
27689359|NCT01723254|80698981|FG001|Overall Study|Withdrawal by Subject|2|||
27689360|NCT01723254|80698982|FG002|Overall Study|Withdrawal by Subject|1|||
27689361|NCT01723254|80698983|FG003|Overall Study|Withdrawal by Subject|0|||
27689362|NCT01723254|80698984|FG004|Overall Study|Withdrawal by Subject|1|||
27689363|NCT01723254|80698985|FG005|Overall Study|Withdrawal by Subject|1|||
27689364|NCT01723254|80698986|FG006|Overall Study|Withdrawal by Subject|1|||
27689365|NCT01723254|80698987|FG007|Overall Study|Withdrawal by Subject|2|||
27689366|NCT03836716|80698990|FG000|Overall Study|Adverse Event|3|||
27689367|NCT03836716|80698990|FG000|Overall Study|Death|22|||
27689368|NCT03836716|80698990|FG000|Overall Study|Withdrawal by Subject|8|||
27689369|NCT03836716|80698990|FG000|Overall Study|Study terminated by sponsor|87|||
27689370|NCT01886378|80698991|FG000|Overall Study|Adverse Event|1|||
27689371|NCT01886378|80698991|FG000|Overall Study|Withdrawal by Subject|4|||
27689372|NCT00522873|80698996|FG000|Overall Study|Adverse Event|41|||
27689373|NCT00522873|80698997|FG001|Overall Study|Adverse Event|26|||
27689374|NCT00522873|80698996|FG000|Overall Study|Withdrawal by Subject|20|||
27689375|NCT00522873|80698997|FG001|Overall Study|Withdrawal by Subject|9|||
27689376|NCT00522873|80698996|FG000|Overall Study|Protocol Violation|14|||
27689377|NCT00522873|80698997|FG001|Overall Study|Protocol Violation|4|||
27689378|NCT00522873|80698996|FG000|Overall Study|Lost to Follow-up|11|||
27689379|NCT00522873|80698997|FG001|Overall Study|Lost to Follow-up|3|||
27689380|NCT00522873|80698996|FG000|Overall Study|Personal Reasons|8|||
27689381|NCT00522873|80698997|FG001|Overall Study|Personal Reasons|1|||
27689382|NCT00522873|80698996|FG000|Overall Study|Medication Errors|1|||
27689383|NCT00522873|80698997|FG001|Overall Study|Medication Errors|1|||
27878056|NCT02712554|81387142|FG000|Part B: Qualification Phase|Adverse Event|0|||
27878057|NCT02712554|81387143|FG001|Part B: Qualification Phase|Adverse Event|1|||
27878058|NCT02712554|81387142|FG000|Part B: Treatment Phase|Adverse Event|0|||
27878059|NCT02712554|81387143|FG001|Part B: Treatment Phase|Adverse Event|1|||
27878060|NCT02712554|81387142|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
27589924|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
27589925|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
27689384|NCT00522873|80698996|FG000|Overall Study|Never Received Medication|1|||
27689385|NCT00522873|80698997|FG001|Overall Study|Never Received Medication|0|||
27689386|NCT01257425|80699001|FG000|Overall Study|Lack of Efficacy|3|||
27689387|NCT01257425|80699002|FG001|Overall Study|Lack of Efficacy|3|||
27689388|NCT01257425|80699001|FG000|Overall Study|Adverse Event|1|||
27689389|NCT01257425|80699002|FG001|Overall Study|Adverse Event|1|||
27689390|NCT01257425|80699001|FG000|Overall Study|Protocol Violation|1|||
27689391|NCT01257425|80699002|FG001|Overall Study|Protocol Violation|1|||
27878061|NCT02712554|81387143|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
27878062|NCT02712554|81387142|FG000|Part B: Treatment Phase|Other|0|||
27878063|NCT02712554|81387143|FG001|Part B: Treatment Phase|Other|1|||
27878064|NCT00191477|81387145|FG000|Overall Study|Tumor Recurrence|49|||
27878065|NCT00191477|81387146|FG001|Overall Study|Tumor Recurrence|48|||
27878066|NCT00191477|81387145|FG000|Overall Study|Death, Study Disease|1|||
27878067|NCT00191477|81387146|FG001|Overall Study|Death, Study Disease|1|||
27878068|NCT00191477|81387145|FG000|Overall Study|Death, Other Cause|3|||
27878069|NCT00191477|81387146|FG001|Overall Study|Death, Other Cause|6|||
27878070|NCT00191477|81387145|FG000|Overall Study|Lost to Follow-up|23|||
27878071|NCT00191477|81387146|FG001|Overall Study|Lost to Follow-up|21|||
27878072|NCT00191477|81387145|FG000|Overall Study|Protocol Violation|1|||
27878073|NCT00191477|81387146|FG001|Overall Study|Protocol Violation|1|||
27878074|NCT00191477|81387145|FG000|Overall Study|Treatment Change|2|||
27878075|NCT00191477|81387146|FG001|Overall Study|Treatment Change|0|||
27878076|NCT00191477|81387145|FG000|Overall Study|Withdrawal by Subject|2|||
27878077|NCT00191477|81387146|FG001|Overall Study|Withdrawal by Subject|0|||
27878078|NCT00191477|81387145|FG000|Overall Study|Other|2|||
27878079|NCT00191477|81387146|FG001|Overall Study|Other|0|||
27878080|NCT00191477|81387145|FG000|Overall Study|Not Eligible|41|||
27878081|NCT00191477|81387146|FG001|Overall Study|Not Eligible|38|||
27878082|NCT00191477|81387145|FG000|Overall Study|Pathological Specimen Lost|1|||
27878083|NCT00191477|81387146|FG001|Overall Study|Pathological Specimen Lost|0|||
27878084|NCT00191477|81387145|FG000|Overall Study|Discontinued Prior to Instillation|13|||
27878085|NCT00191477|81387146|FG001|Overall Study|Discontinued Prior to Instillation|14|||
27878086|NCT00764660|81387147|FG000|Overall Study|Adverse Event|6|||
27878087|NCT00764660|81387148|FG001|Overall Study|Adverse Event|3|||
27878088|NCT00764660|81387147|FG000|Overall Study|Lost to Follow-up|3|||
27878089|NCT00764660|81387148|FG001|Overall Study|Lost to Follow-up|4|||
27878090|NCT00764660|81387147|FG000|Overall Study|Withdrawal by Subject|7|||
27878091|NCT00764660|81387148|FG001|Overall Study|Withdrawal by Subject|3|||
27878092|NCT00764660|81387147|FG000|Overall Study|Noncompliance With Protocol|5|||
27878093|NCT00764660|81387148|FG001|Overall Study|Noncompliance With Protocol|1|||
27878094|NCT00764660|81387147|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
27878095|NCT00764660|81387148|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
27878096|NCT02965573|81387149|FG000|Overall Study|Lack of Efficacy|1|||
27878097|NCT02965573|81387150|FG001|Overall Study|Lack of Efficacy|0|||
27878098|NCT01960413|81387151|FG000|Overall Study|Withdrawal by Subject|1|||
27878099|NCT01960413|81387152|FG001|Overall Study|Withdrawal by Subject|1|||
27878100|NCT01960413|81387151|FG000|Overall Study|Physician Decision|1|||
27689392|NCT01257425|80699001|FG000|Overall Study|Withdrawal by Subject|0|||
27689393|NCT01257425|80699002|FG001|Overall Study|Withdrawal by Subject|1|||
27689394|NCT01257425|80699001|FG000|Overall Study|Death|1|||
27878101|NCT01960413|81387152|FG001|Overall Study|Physician Decision|0|||
27878102|NCT01960413|81387151|FG000|Overall Study|Lost to Follow-up|2|||
27878103|NCT01960413|81387152|FG001|Overall Study|Lost to Follow-up|0|||
27878104|NCT03817853|81387153|FG000|Induction Phase|Adverse Event|5|||
27878105|NCT03817853|81387154|FG001|Induction Phase|Adverse Event|0|||
27878106|NCT03817853|81387155|FG002|Induction Phase|Adverse Event|0|||
27878107|NCT03817853|81387153|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
27886631|NCT01938430|81418142|FG006|Overall Study|Randomized but Not Treated|0|||
27815666|NCT02398188|81158681|FG000|Overall Study|Pregnancy|1|||
27815667|NCT02398188|81158682|FG001|Overall Study|Pregnancy|0|||
27815668|NCT02398188|81158681|FG000|Overall Study|Withdrawal by Subject|7|||
27815669|NCT02398188|81158682|FG001|Overall Study|Withdrawal by Subject|16|||
27815670|NCT00948675|81158683|FG000|Overall Study|Lost to Follow-up|1|||
27815671|NCT00948675|81158684|FG001|Overall Study|Lost to Follow-up|0|||
27815672|NCT00958256|81158688|FG000|Overall Study|Adverse Event|3|||
27815673|NCT01367275|81158689|FG000|Overall Study|Ineligible|1|||
27815674|NCT01367275|81158689|FG000|Overall Study|Disease Progression|2|||
27815675|NCT02655237|81158694|FG000|Overall Study|Adverse Event|10|||
27815676|NCT02655237|81158695|FG001|Overall Study|Adverse Event|7|||
27815677|NCT02655237|81158694|FG000|Overall Study|Protocol Deviation|2|||
27815678|NCT02655237|81158695|FG001|Overall Study|Protocol Deviation|0|||
27815679|NCT02655237|81158694|FG000|Overall Study|Withdrawal by Participant|1|||
27815680|NCT02655237|81158695|FG001|Overall Study|Withdrawal by Participant|2|||
27815681|NCT02655237|81158694|FG000|Overall Study|Lack of Efficacy|0|||
27815682|NCT02655237|81158695|FG001|Overall Study|Lack of Efficacy|1|||
27815683|NCT02655237|81158694|FG000|Overall Study|Recovery Leading to Surgery|2|||
27815684|NCT02655237|81158695|FG001|Overall Study|Recovery Leading to Surgery|1|||
27815685|NCT02655237|81158694|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
27815686|NCT02655237|81158695|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
27689395|NCT01257425|80699002|FG001|Overall Study|Death|0|||
27689396|NCT00996476|80699010|FG000|Overall Study|Withdrawal by Subject|1|||
27689397|NCT00996476|80699011|FG001|Overall Study|Withdrawal by Subject|2|||
27689398|NCT00996476|80699012|FG002|Overall Study|Withdrawal by Subject|1|||
27689399|NCT00996476|80699013|FG003|Overall Study|Withdrawal by Subject|0|||
27689400|NCT00996476|80699014|FG004|Overall Study|Withdrawal by Subject|1|||
27815687|NCT02655237|81158694|FG000|Overall Study|Randomized but Not Treated|1|||
27689401|NCT00996476|80699010|FG000|Overall Study|Adverse Event|0|||
27815688|NCT02655237|81158695|FG001|Overall Study|Randomized but Not Treated|0|||
27815689|NCT04471207|81158696|FG000|Overall Study|Lost to Follow-up|4|||
27689402|NCT00996476|80699011|FG001|Overall Study|Adverse Event|1|||
27589926|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
27815690|NCT04471207|81158697|FG001|Overall Study|Lost to Follow-up|1|||
27815691|NCT04471207|81158696|FG000|Overall Study|Medication Contraindication|0|||
27815692|NCT04471207|81158697|FG001|Overall Study|Medication Contraindication|1|||
27689403|NCT00996476|80699012|FG002|Overall Study|Adverse Event|0|||
27689404|NCT00996476|80699013|FG003|Overall Study|Adverse Event|0|||
27689405|NCT00996476|80699014|FG004|Overall Study|Adverse Event|1|||
27689406|NCT00081497|80699015|FG000|Overall Study|Adverse Event|2|||
27815693|NCT04471207|81158696|FG000|Overall Study|Loss of Interest|2|||
27815694|NCT04471207|81158697|FG001|Overall Study|Loss of Interest|1|||
27815695|NCT04471207|81158696|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
27815696|NCT04471207|81158697|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
27815697|NCT04471207|81158696|FG000|Overall Study|Scheduling Conflicts|3|||
27689407|NCT00081497|80699016|FG001|Overall Study|Adverse Event|0|||
27689408|NCT00081497|80699015|FG000|Overall Study|Death|0|||
27689409|NCT00081497|80699016|FG001|Overall Study|Death|1|||
27689410|NCT00081497|80699015|FG000|Overall Study|Withdrawal by Subject|1|||
27689411|NCT00081497|80699016|FG001|Overall Study|Withdrawal by Subject|0|||
27689412|NCT00081497|80699015|FG000|Overall Study|Non-compliance|0|||
27689413|NCT00081497|80699016|FG001|Overall Study|Non-compliance|1|||
27689414|NCT03484273|80699022|FG000|Overall Study|Equipment Malfunction|1|||
27689415|NCT03484273|80699022|FG000|Overall Study|Data excluded from analysis|1|||
27689416|NCT01262677|80699023|FG000|Overall Study|Does not meet entrance criteria|0|||
27689417|NCT01262677|80699024|FG001|Overall Study|Does not meet entrance criteria|2|||
27689418|NCT01262677|80699025|FG002|Overall Study|Does not meet entrance criteria|0|||
27689419|NCT01262677|80699023|FG000|Overall Study|Insufficient clinical response|0|||
27689420|NCT01262677|80699024|FG001|Overall Study|Insufficient clinical response|0|||
27689421|NCT01262677|80699025|FG002|Overall Study|Insufficient clinical response|1|||
27689422|NCT01262677|80699023|FG000|Overall Study|Lost to Follow-up|1|||
27689423|NCT01262677|80699024|FG001|Overall Study|Lost to Follow-up|0|||
27689424|NCT01262677|80699025|FG002|Overall Study|Lost to Follow-up|2|||
27689425|NCT01262677|80699023|FG000|Overall Study|No longer willing to participate|3|||
27689426|NCT01262677|80699024|FG001|Overall Study|No longer willing to participate|3|||
27689427|NCT01262677|80699025|FG002|Overall Study|No longer willing to participate|2|||
27689428|NCT01262677|80699023|FG000|Overall Study|Reason not provided|2|||
27689429|NCT01262677|80699024|FG001|Overall Study|Reason not provided|1|||
27689430|NCT01262677|80699025|FG002|Overall Study|Reason not provided|3|||
27689431|NCT01262677|80699023|FG000|Overall Study|Protocol Violation|0|||
27689432|NCT01262677|80699024|FG001|Overall Study|Protocol Violation|1|||
27689433|NCT01262677|80699025|FG002|Overall Study|Protocol Violation|1|||
27689434|NCT01262677|80699023|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
27689435|NCT01262677|80699024|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
27689436|NCT01262677|80699025|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
27689437|NCT01183260|80699026|FG000|Overall Study|Intraop screen failure|2|||
27689438|NCT01183260|80699027|FG001|Overall Study|Intraop screen failure|0|||
27689439|NCT01183260|80699026|FG000|Overall Study|Withdrawal by Subject|1|||
27689440|NCT01183260|80699027|FG001|Overall Study|Withdrawal by Subject|1|||
27689441|NCT01183260|80699026|FG000|Overall Study|Revised within 30 days|0|||
27689442|NCT01183260|80699027|FG001|Overall Study|Revised within 30 days|1|||
27689443|NCT01183260|80699026|FG000|Overall Study|Death|1|||
27689444|NCT01183260|80699027|FG001|Overall Study|Death|0|||
27689445|NCT01942785|80699031|FG000|Overall Study|Adverse Event|2|||
27689446|NCT01942785|80699031|FG000|Overall Study|Withdrawal by Subject|1|||
27689447|NCT01942785|80699031|FG000|Overall Study|Protocol Violation|1|||
27689448|NCT05326815|80699032|FG000|Overall Study|Withdrawal by Subject|3|||
27689449|NCT05326815|80699032|FG000|Overall Study|Did not complete required labs|6|||
27689450|NCT05326815|80699032|FG000|Overall Study|Screen fail- abnormal labs|5|||
27689451|NCT03254485|80699033|FG000|Overall Study|Adverse Event|3|||
27689452|NCT03254485|80699034|FG001|Overall Study|Adverse Event|0|||
27815698|NCT04471207|81158697|FG001|Overall Study|Scheduling Conflicts|1|||
27815699|NCT04471207|81158696|FG000|Overall Study|Physician Decision|1|||
27689453|NCT03254485|80699035|FG002|Overall Study|Adverse Event|0|||
27689454|NCT03254485|80699036|FG003|Overall Study|Adverse Event|6|||
27689455|NCT03254485|80699033|FG000|Overall Study|Protocol Violation|6|||
27689456|NCT03254485|80699034|FG001|Overall Study|Protocol Violation|0|||
27689457|NCT03254485|80699035|FG002|Overall Study|Protocol Violation|0|||
27689458|NCT03254485|80699036|FG003|Overall Study|Protocol Violation|2|||
27689459|NCT03254485|80699033|FG000|Overall Study|Withdrawal by Subject|1|||
27689460|NCT03254485|80699034|FG001|Overall Study|Withdrawal by Subject|0|||
27689461|NCT03254485|80699035|FG002|Overall Study|Withdrawal by Subject|0|||
27689462|NCT03254485|80699036|FG003|Overall Study|Withdrawal by Subject|4|||
27689463|NCT03254485|80699033|FG000|Overall Study|Death|0|||
27689464|NCT03254485|80699034|FG001|Overall Study|Death|0|||
27689465|NCT03254485|80699035|FG002|Overall Study|Death|0|||
27689466|NCT03254485|80699036|FG003|Overall Study|Death|1|||
27689467|NCT03254485|80699033|FG000|Overall Study|Lost to Follow-up|1|||
27689468|NCT03254485|80699034|FG001|Overall Study|Lost to Follow-up|0|||
27689469|NCT03254485|80699035|FG002|Overall Study|Lost to Follow-up|0|||
27689470|NCT03254485|80699036|FG003|Overall Study|Lost to Follow-up|0|||
27689471|NCT03254485|80699033|FG000|Overall Study|Other|1|||
27689472|NCT03254485|80699034|FG001|Overall Study|Other|0|||
27689473|NCT03254485|80699035|FG002|Overall Study|Other|0|||
27689474|NCT03254485|80699036|FG003|Overall Study|Other|2|||
27689475|NCT04227704|80699037|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
27689476|NCT04227704|80699038|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
27689477|NCT04227704|80699039|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
27689478|NCT04227704|80699037|FG000|Overall Study|due to C/S being cancelled|1|||
27689479|NCT04227704|80699038|FG001|Overall Study|due to C/S being cancelled|0|||
27689480|NCT04227704|80699039|FG002|Overall Study|due to C/S being cancelled|0|||
27689481|NCT00211185|80699040|FG000|Overall Study|Death|2|||
27878108|NCT03817853|81387154|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
27689482|NCT00211185|80699040|FG000|Overall Study|Disease progression|7|||
27689483|NCT00211185|80699040|FG000|Overall Study|Withdrawal by Subject|6|||
27689484|NCT00211185|80699040|FG000|Overall Study|Physician Decision|5|||
27689485|NCT03170349|80699041|FG000|At 30 Days Follow-up|Death|1|||
27689486|NCT03170349|80699041|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
27689487|NCT03170349|80699041|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
27689488|NCT03170349|80699041|FG000|At 6 Months Follow-up|Death|3|||
27689489|NCT03170349|80699041|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
27689490|NCT03170349|80699041|FG000|At 1 Year Follow-up|Death|6|||
27689491|NCT03170349|80699041|FG000|At 2 Year Follow-up|Missed Visit|4|||
27689492|NCT03170349|80699041|FG000|At 2 Year Follow-up|Death|13|||
27689493|NCT03170349|80699041|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
27689494|NCT00252577|80699042|FG000|Overall Study|Lost to Follow-up|20|||
27689495|NCT00819390|80699043|FG000|Overall Study|Lost to Follow-up|1|||
27689496|NCT00819390|80699044|FG001|Overall Study|Lost to Follow-up|1|||
27689497|NCT00819390|80699045|FG002|Overall Study|Lost to Follow-up|0|||
27689498|NCT00819390|80699046|FG003|Overall Study|Lost to Follow-up|0|||
27689499|NCT00819390|80699043|FG000|Overall Study|Withdrawal by Subject|2|||
27689500|NCT00819390|80699044|FG001|Overall Study|Withdrawal by Subject|0|||
27689501|NCT00819390|80699045|FG002|Overall Study|Withdrawal by Subject|0|||
27689502|NCT00819390|80699046|FG003|Overall Study|Withdrawal by Subject|0|||
27689503|NCT00819390|80699043|FG000|Overall Study|Adverse Event|0|||
27689504|NCT00819390|80699044|FG001|Overall Study|Adverse Event|0|||
27689505|NCT00819390|80699045|FG002|Overall Study|Adverse Event|1|||
27689506|NCT00819390|80699046|FG003|Overall Study|Adverse Event|0|||
27689507|NCT05543187|80699048|FG000|Overall Study|Ongoing|3|||
27689508|NCT05543187|80699049|FG001|Overall Study|Ongoing|2|||
27689509|NCT01744392|80699051|FG000|Overall Study|Physician Decision|1|||
27689510|NCT03647488|80699052|FG000|Overall Study|Progressive disease|10|||
27689511|NCT03647488|80699053|FG001|Overall Study|Progressive disease|0|||
27689512|NCT03647488|80699054|FG002|Overall Study|Progressive disease|0|||
27689513|NCT03647488|80699052|FG000|Overall Study|Adverse Event|5|||
27689514|NCT03647488|80699053|FG001|Overall Study|Adverse Event|0|||
27689515|NCT03647488|80699054|FG002|Overall Study|Adverse Event|0|||
27689516|NCT03647488|80699052|FG000|Overall Study|Clinical progression|2|||
27689517|NCT03647488|80699053|FG001|Overall Study|Clinical progression|0|||
27689518|NCT03647488|80699054|FG002|Overall Study|Clinical progression|0|||
27689519|NCT03647488|80699052|FG000|Overall Study|Participant refused to take investigational product|1|||
27689520|NCT03647488|80699053|FG001|Overall Study|Participant refused to take investigational product|0|||
27689521|NCT03647488|80699054|FG002|Overall Study|Participant refused to take investigational product|0|||
27689522|NCT01191268|80699056|FG000|Overall Study|Withdrawal by Subject|19|||
27689523|NCT01191268|80699057|FG001|Overall Study|Withdrawal by Subject|25|||
27689524|NCT01191268|80699058|FG002|Overall Study|Withdrawal by Subject|21|||
27689525|NCT01191268|80699056|FG000|Overall Study|Adverse Event|21|||
27689526|NCT01191268|80699057|FG001|Overall Study|Adverse Event|13|||
27689527|NCT01191268|80699058|FG002|Overall Study|Adverse Event|8|||
27689528|NCT01191268|80699056|FG000|Overall Study|Physician Decision|6|||
27689529|NCT01191268|80699057|FG001|Overall Study|Physician Decision|8|||
27689530|NCT01191268|80699058|FG002|Overall Study|Physician Decision|9|||
27689531|NCT01191268|80699056|FG000|Overall Study|Lost to Follow-up|8|||
27689532|NCT01191268|80699057|FG001|Overall Study|Lost to Follow-up|5|||
27689533|NCT01191268|80699058|FG002|Overall Study|Lost to Follow-up|9|||
27689534|NCT01191268|80699056|FG000|Overall Study|Entry Criteria Not Met|3|||
27689535|NCT01191268|80699057|FG001|Overall Study|Entry Criteria Not Met|1|||
27689536|NCT01191268|80699058|FG002|Overall Study|Entry Criteria Not Met|1|||
27689537|NCT01191268|80699056|FG000|Overall Study|Death|0|||
27689538|NCT01191268|80699057|FG001|Overall Study|Death|1|||
27886632|NCT01938430|81418143|FG007|Overall Study|Randomized but Not Treated|0|||
27689539|NCT01191268|80699058|FG002|Overall Study|Death|3|||
27689540|NCT01191268|80699056|FG000|Overall Study|Protocol Violation|1|||
27689541|NCT01191268|80699057|FG001|Overall Study|Protocol Violation|0|||
27689542|NCT01191268|80699058|FG002|Overall Study|Protocol Violation|1|||
27689543|NCT01191268|80699056|FG000|Overall Study|Sponsor Decision|0|||
27689544|NCT01191268|80699057|FG001|Overall Study|Sponsor Decision|2|||
27689545|NCT01191268|80699058|FG002|Overall Study|Sponsor Decision|0|||
27689546|NCT03426605|80699059|FG000|Overall Study|AML relapse or progression|2|||
27689547|NCT03426605|80699060|FG001|Overall Study|AML relapse or progression|1|||
27689548|NCT03426605|80699061|FG002|Overall Study|AML relapse or progression|2|||
27878109|NCT03817853|81387155|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
27878110|NCT03817853|81387153|FG000|Induction Phase|Physician Decision|2|||
27878111|NCT03817853|81387154|FG001|Induction Phase|Physician Decision|0|||
27878112|NCT03817853|81387155|FG002|Induction Phase|Physician Decision|0|||
27878113|NCT03817853|81387153|FG000|Induction Phase|Progressive Disease|6|||
27878114|NCT03817853|81387154|FG001|Induction Phase|Progressive Disease|0|||
27878115|NCT03817853|81387155|FG002|Induction Phase|Progressive Disease|0|||
27878116|NCT03817853|81387153|FG000|Induction Phase|Withdrawal by Subject|4|||
27878117|NCT03817853|81387154|FG001|Induction Phase|Withdrawal by Subject|0|||
27878118|NCT03817853|81387155|FG002|Induction Phase|Withdrawal by Subject|0|||
27878119|NCT03817853|81387153|FG000|Maintenance Phase|Adverse Event|0|||
27878120|NCT03817853|81387154|FG001|Maintenance Phase|Adverse Event|8|||
27878121|NCT03817853|81387155|FG002|Maintenance Phase|Adverse Event|0|||
27878122|NCT03817853|81387153|FG000|Maintenance Phase|Death|0|||
27878123|NCT03817853|81387154|FG001|Maintenance Phase|Death|5|||
27878124|NCT03817853|81387155|FG002|Maintenance Phase|Death|0|||
27689549|NCT03426605|80699062|FG003|Overall Study|AML relapse or progression|2|||
27689550|NCT03426605|80699059|FG000|Overall Study|Treatment failure|3|||
27689551|NCT03426605|80699060|FG001|Overall Study|Treatment failure|2|||
27689552|NCT03426605|80699061|FG002|Overall Study|Treatment failure|0|||
27689553|NCT03426605|80699062|FG003|Overall Study|Treatment failure|0|||
27815700|NCT04471207|81158697|FG001|Overall Study|Physician Decision|0|||
27878125|NCT03817853|81387153|FG000|Maintenance Phase|Progressive Disease|0|||
27878126|NCT03817853|81387154|FG001|Maintenance Phase|Progressive Disease|7|||
27689554|NCT03426605|80699059|FG000|Overall Study|Adverse Event|1|||
27878127|NCT03817853|81387155|FG002|Maintenance Phase|Progressive Disease|0|||
27878128|NCT03817853|81387153|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27878129|NCT03817853|81387154|FG001|Maintenance Phase|Withdrawal by Subject|2|||
27878130|NCT03817853|81387155|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27878131|NCT03817853|81387153|FG000|Maintenance Phase|Physician Decision|0|||
27815701|NCT04471207|81158696|FG000|Overall Study|Unwilling to Use System|0|||
27815702|NCT04471207|81158697|FG001|Overall Study|Unwilling to Use System|1|||
27815703|NCT00418184|81158702|FG000|Double-blind Phase|Withdrawal by Subject|22|||
27815704|NCT00418184|81158703|FG001|Double-blind Phase|Withdrawal by Subject|9|||
27815705|NCT00418184|81158702|FG000|Double-blind Phase|Adverse Event|2|||
27815706|NCT00418184|81158703|FG001|Double-blind Phase|Adverse Event|1|||
27815707|NCT00418184|81158702|FG000|Double-blind Phase|Poor compliance|3|||
27815708|NCT00418184|81158703|FG001|Double-blind Phase|Poor compliance|1|||
27815709|NCT00878995|81158704|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
27815710|NCT00878995|81158705|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
27815711|NCT01031537|81158707|FG000|Overall Study|medical reasons not related to study|3|||
27815712|NCT01031537|81158707|FG000|Overall Study|Lack of Efficacy|1|||
27815713|NCT01031537|81158707|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
27815714|NCT01031537|81158707|FG000|Overall Study|moved, met exclusion criteria|10|||
27815715|NCT01031537|81158707|FG000|Overall Study|Withdrawal by Subject|5|||
27815716|NCT01031537|81158707|FG000|Overall Study|PI removal, no longer met eligibility|12|||
27815717|NCT04849988|81158715|FG000|Overall Study|Lack of Efficacy|3|||
27815718|NCT04849988|81158716|FG001|Overall Study|Lack of Efficacy|4|||
27815719|NCT04849988|81158717|FG002|Overall Study|Lack of Efficacy|1|||
27815720|NCT04849988|81158718|FG003|Overall Study|Lack of Efficacy|4|||
27815721|NCT04849988|81158715|FG000|Overall Study|Other reasons|1|||
27878132|NCT03817853|81387154|FG001|Maintenance Phase|Physician Decision|1|||
27878133|NCT03817853|81387155|FG002|Maintenance Phase|Physician Decision|0|||
27878134|NCT03817853|81387153|FG000|Maintenance Phase|Various reasons|0|||
27878135|NCT03817853|81387154|FG001|Maintenance Phase|Various reasons|4|||
27878136|NCT03817853|81387155|FG002|Maintenance Phase|Various reasons|0|||
27878137|NCT03817853|81387153|FG000|Maintenance Phase|Protocol Deviation|0|||
27689555|NCT03426605|80699060|FG001|Overall Study|Adverse Event|0|||
27878138|NCT03817853|81387154|FG001|Maintenance Phase|Protocol Deviation|1|||
27878139|NCT03817853|81387155|FG002|Maintenance Phase|Protocol Deviation|0|||
27878140|NCT03817853|81387153|FG000|Follow-up Phase|Adverse Event|0|||
27878141|NCT03817853|81387154|FG001|Follow-up Phase|Adverse Event|0|||
27878142|NCT03817853|81387155|FG002|Follow-up Phase|Adverse Event|2|||
27878143|NCT03817853|81387153|FG000|Follow-up Phase|Death|0|||
27878144|NCT03817853|81387154|FG001|Follow-up Phase|Death|0|||
27878145|NCT03817853|81387155|FG002|Follow-up Phase|Death|1|||
27878146|NCT03817853|81387153|FG000|Follow-up Phase|Progressive Disease|0|||
27878147|NCT03817853|81387154|FG001|Follow-up Phase|Progressive Disease|0|||
27878148|NCT03817853|81387155|FG002|Follow-up Phase|Progressive Disease|3|||
27878149|NCT03817853|81387153|FG000|Follow-up Phase|Withdrawal by Subject|0|||
27878150|NCT03817853|81387154|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27878151|NCT03817853|81387155|FG002|Follow-up Phase|Withdrawal by Subject|1|||
27878152|NCT01164579|81387158|FG000|Overall Study|Lack of Efficacy|0|||
27878153|NCT01164579|81387159|FG001|Overall Study|Lack of Efficacy|0|||
27878154|NCT01164579|81387160|FG002|Overall Study|Lack of Efficacy|6|||
27878155|NCT01164579|81387158|FG000|Overall Study|Lost to Follow-up|1|||
27878156|NCT01164579|81387159|FG001|Overall Study|Lost to Follow-up|1|||
27878157|NCT01164579|81387160|FG002|Overall Study|Lost to Follow-up|0|||
27878158|NCT01164579|81387158|FG000|Overall Study|Withdrawal by Subject|2|||
27878159|NCT01164579|81387159|FG001|Overall Study|Withdrawal by Subject|5|||
27878160|NCT01164579|81387160|FG002|Overall Study|Withdrawal by Subject|3|||
27878161|NCT01164579|81387158|FG000|Overall Study|Protocol Violation|0|||
27878162|NCT01164579|81387159|FG001|Overall Study|Protocol Violation|1|||
27878163|NCT01164579|81387160|FG002|Overall Study|Protocol Violation|2|||
27878164|NCT01164579|81387158|FG000|Overall Study|Adverse Event|4|||
27878165|NCT01164579|81387159|FG001|Overall Study|Adverse Event|2|||
27878166|NCT01164579|81387160|FG002|Overall Study|Adverse Event|5|||
27878167|NCT01164579|81387158|FG000|Overall Study|Reason not specified|1|||
27878168|NCT01164579|81387159|FG001|Overall Study|Reason not specified|0|||
27878169|NCT01164579|81387160|FG002|Overall Study|Reason not specified|0|||
27878170|NCT01641640|81387161|FG000|Overall Study|Enrolled but not treated|1|||
27878171|NCT01641640|81387161|FG000|Overall Study|Efficacy failure|29|||
27878172|NCT01641640|81387161|FG000|Overall Study|Lost to Follow-up|3|||
27878173|NCT01641640|81387161|FG000|Overall Study|Withdrawal by Subject|2|||
27878174|NCT01641640|81387161|FG000|Overall Study|Adverse Event|1|||
27878175|NCT02375971|81387162|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
27878176|NCT02375971|81387163|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
27878177|NCT02375971|81387164|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
27878178|NCT02375971|81387162|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
27878179|NCT02375971|81387163|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
27878180|NCT02375971|81387164|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
27878181|NCT02375971|81387162|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
27878182|NCT02375971|81387163|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
27878183|NCT02375971|81387164|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
27878184|NCT02375971|81387162|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
27878185|NCT02375971|81387163|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
27878186|NCT02375971|81387164|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
27878187|NCT02375971|81387162|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
27878188|NCT02375971|81387163|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
27878189|NCT02375971|81387164|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
27878190|NCT02375971|81387162|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
27878191|NCT02375971|81387163|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
27878192|NCT02375971|81387164|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
27878193|NCT02375971|81387162|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
27815722|NCT04849988|81158716|FG001|Overall Study|Other reasons|2|||
27815723|NCT04849988|81158717|FG002|Overall Study|Other reasons|2|||
27815724|NCT04849988|81158718|FG003|Overall Study|Other reasons|1|||
27815725|NCT01725451|81158720|FG000|Period 1|Withdrawal by Subject|1|||
27815726|NCT01725451|81158721|FG001|Period 1|Withdrawal by Subject|0|||
27815727|NCT01725451|81158722|FG002|Period 1|Withdrawal by Subject|0|||
27815728|NCT01725451|81158723|FG003|Period 1|Withdrawal by Subject|0|||
27815729|NCT01725451|81158720|FG000|Washout From Period 3|Protocol Violation|0|||
27815730|NCT01725451|81158721|FG001|Washout From Period 3|Protocol Violation|0|||
27815731|NCT01725451|81158722|FG002|Washout From Period 3|Protocol Violation|1|||
27815732|NCT01725451|81158723|FG003|Washout From Period 3|Protocol Violation|0|||
27815733|NCT01725451|81158720|FG000|Washout From Period 3|Adverse Event|0|||
27815734|NCT01725451|81158721|FG001|Washout From Period 3|Adverse Event|1|||
27815735|NCT01725451|81158722|FG002|Washout From Period 3|Adverse Event|0|||
27815736|NCT01725451|81158723|FG003|Washout From Period 3|Adverse Event|0|||
27815737|NCT01725451|81158720|FG000|Period 4|Adverse Event|0|||
27815738|NCT01725451|81158721|FG001|Period 4|Adverse Event|0|||
27815739|NCT01725451|81158722|FG002|Period 4|Adverse Event|1|||
27815740|NCT01725451|81158723|FG003|Period 4|Adverse Event|0|||
27815741|NCT00680121|81158728|FG000|Overall Study|Lost to Follow-up|27|||
27815742|NCT00680121|81158729|FG001|Overall Study|Lost to Follow-up|23|||
27815743|NCT03717064|81158732|FG000|Period 2|Adverse Event|1|||
27815744|NCT00797108|81158733|FG000|Overall Study|Adverse Event|1|||
27815745|NCT00797108|81158734|FG001|Overall Study|Adverse Event|0|||
27815746|NCT00797108|81158735|FG002|Overall Study|Adverse Event|3|||
27815747|NCT00797108|81158733|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
27815748|NCT00797108|81158734|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
27815749|NCT00797108|81158735|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
27815750|NCT00797108|81158733|FG000|Overall Study|Global Deterioration of Health Status|0|||
27815751|NCT00797108|81158734|FG001|Overall Study|Global Deterioration of Health Status|1|||
27815752|NCT00797108|81158735|FG002|Overall Study|Global Deterioration of Health Status|0|||
27815753|NCT00797108|81158733|FG000|Overall Study|Lack of Efficacy|1|||
27815754|NCT00797108|81158734|FG001|Overall Study|Lack of Efficacy|0|||
27815755|NCT00797108|81158735|FG002|Overall Study|Lack of Efficacy|1|||
27815756|NCT00797108|81158733|FG000|Overall Study|Other|0|||
27815757|NCT00797108|81158734|FG001|Overall Study|Other|0|||
27815758|NCT00797108|81158735|FG002|Overall Study|Other|2|||
27815759|NCT00797108|81158733|FG000|Overall Study|Randomized but not Treated|2|||
27815760|NCT00797108|81158734|FG001|Overall Study|Randomized but not Treated|0|||
27815761|NCT00797108|81158735|FG002|Overall Study|Randomized but not Treated|0|||
27815762|NCT01254409|81158736|FG000|Overall Study|Adverse Event|0|||
27815763|NCT01254409|81158737|FG001|Overall Study|Adverse Event|1|||
27815764|NCT01254409|81158738|FG002|Overall Study|Adverse Event|0|||
27878194|NCT02375971|81387163|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
27878195|NCT02375971|81387164|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
27878196|NCT02375971|81387162|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
27878197|NCT02375971|81387163|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
27878198|NCT02375971|81387164|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
27878199|NCT04982575|81387165|FG000|Overall Study|Withdrawal by Subject|2|||
27878200|NCT04982575|81387166|FG001|Overall Study|Withdrawal by Subject|0|||
27878201|NCT04982575|81387167|FG002|Overall Study|Withdrawal by Subject|2|||
27878202|NCT04830969|81387168|FG000|Overall Study|Withdrawal by Subject|6|||
27878203|NCT04830969|81387169|FG001|Overall Study|Withdrawal by Subject|2|||
27589927|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
27589928|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
27815765|NCT01254409|81158739|FG003|Overall Study|Adverse Event|0|||
27815766|NCT04015232|81158747|FG000|Overall Study|Withdrawal by Subject|7|||
27815767|NCT04015232|81158748|FG001|Overall Study|Withdrawal by Subject|4|||
27878204|NCT04830969|81387168|FG000|Overall Study|Protocol Violation|3|||
27878205|NCT04830969|81387169|FG001|Overall Study|Protocol Violation|9|||
27815768|NCT04015232|81158747|FG000|Overall Study|Protocol Violation|1|||
27815769|NCT04015232|81158748|FG001|Overall Study|Protocol Violation|0|||
27815770|NCT04015232|81158747|FG000|Overall Study|Medical Grounds|3|||
27815771|NCT04015232|81158748|FG001|Overall Study|Medical Grounds|3|||
27815772|NCT03444038|81158749|FG000|Overall Study|Adverse Event|12|||
27878206|NCT04830969|81387168|FG000|Overall Study|Lost to Follow-up|4|||
27878207|NCT04830969|81387169|FG001|Overall Study|Lost to Follow-up|4|||
27878208|NCT04526288|81387170|FG000|Overall Study|Disease Progression|1|||
27878209|NCT04526288|81387171|FG001|Overall Study|Disease Progression|0|||
27878210|NCT00320710|81387172|FG000|Overall Study|Disease progression|24|||
27878211|NCT00320710|81387173|FG001|Overall Study|Disease progression|19|||
27878212|NCT00320710|81387174|FG002|Overall Study|Disease progression|2|||
27878213|NCT00320710|81387172|FG000|Overall Study|Death|10|||
27878214|NCT00320710|81387173|FG001|Overall Study|Death|7|||
27878215|NCT00320710|81387174|FG002|Overall Study|Death|1|||
27878216|NCT00320710|81387172|FG000|Overall Study|Administrative problems|1|||
27878217|NCT00320710|81387173|FG001|Overall Study|Administrative problems|2|||
27878218|NCT00320710|81387174|FG002|Overall Study|Administrative problems|0|||
27878219|NCT00320710|81387172|FG000|Overall Study|Withdrawal by Subject|20|||
27878220|NCT00320710|81387173|FG001|Overall Study|Withdrawal by Subject|26|||
27878221|NCT00320710|81387174|FG002|Overall Study|Withdrawal by Subject|1|||
27815773|NCT03444038|81158749|FG000|Overall Study|Withdrawal by Subject|7|||
27815774|NCT03444038|81158749|FG000|Overall Study|Lost to Follow-up|1|||
27815775|NCT03444038|81158749|FG000|Overall Study|Physician Decision|2|||
27815776|NCT03444038|81158749|FG000|Overall Study|Lack of Efficacy|7|||
27815777|NCT01179919|81158750|FG000|Overall Study|Protocol Violation|1|||
27815778|NCT01179919|81158750|FG000|Overall Study|Adverse Event|1|||
27815779|NCT03977584|81158751|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
27878222|NCT00320710|81387172|FG000|Overall Study|Protocol Violation|6|||
27878223|NCT00320710|81387173|FG001|Overall Study|Protocol Violation|5|||
27878224|NCT00320710|81387174|FG002|Overall Study|Protocol Violation|0|||
27878225|NCT00320710|81387172|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27878226|NCT00320710|81387173|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27878227|NCT00320710|81387174|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27878228|NCT00320710|81387172|FG000|Overall Study|Abnormal laboratory value(s)|12|||
27878229|NCT00320710|81387173|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27878230|NCT00320710|81387174|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27878231|NCT00320710|81387172|FG000|Overall Study|Adverse Event|18|||
27878232|NCT00320710|81387173|FG001|Overall Study|Adverse Event|14|||
27878233|NCT00320710|81387174|FG002|Overall Study|Adverse Event|1|||
27878234|NCT00320710|81387172|FG000|Overall Study|Lost to Follow-up|1|||
27878235|NCT00320710|81387173|FG001|Overall Study|Lost to Follow-up|0|||
27878236|NCT00320710|81387174|FG002|Overall Study|Lost to Follow-up|0|||
27878237|NCT02059135|81387181|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
27878238|NCT02059135|81387182|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
27878239|NCT02059135|81387181|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
27878240|NCT02059135|81387182|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
27878241|NCT02059135|81387181|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
27878242|NCT02059135|81387182|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
27878243|NCT02059135|81387181|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
27878244|NCT02059135|81387182|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
27878245|NCT02059135|81387181|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
27878246|NCT02059135|81387182|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
27878247|NCT02059135|81387181|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
27878248|NCT02059135|81387182|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
27878249|NCT02059135|81387181|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
27878250|NCT02059135|81387182|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
27878251|NCT02059135|81387181|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
27878252|NCT02059135|81387182|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
27878253|NCT01173523|81387183|FG000|Overall Study|Clinical Progression|1|||
27878254|NCT01173523|81387184|FG001|Overall Study|Clinical Progression|1|||
27878255|NCT01173523|81387183|FG000|Overall Study|Progressive Disease|10|||
27878256|NCT01173523|81387184|FG001|Overall Study|Progressive Disease|8|||
27878257|NCT01173523|81387183|FG000|Overall Study|Other|2|||
27878258|NCT01173523|81387184|FG001|Overall Study|Other|3|||
27878259|NCT00489918|81387185|FG000|Overall Study|Withdrawal by Subject|2|||
27878260|NCT00489918|81387186|FG001|Overall Study|Withdrawal by Subject|1|||
27878261|NCT00489918|81387187|FG002|Overall Study|Withdrawal by Subject|1|||
27878262|NCT00489918|81387188|FG003|Overall Study|Withdrawal by Subject|0|||
27878263|NCT00489918|81387189|FG004|Overall Study|Withdrawal by Subject|1|||
27878264|NCT00489918|81387185|FG000|Overall Study|Adverse Event|0|||
27878265|NCT00489918|81387186|FG001|Overall Study|Adverse Event|1|||
27878266|NCT00489918|81387187|FG002|Overall Study|Adverse Event|1|||
27878267|NCT00489918|81387188|FG003|Overall Study|Adverse Event|0|||
27815780|NCT03977584|81158752|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
27815781|NCT03977584|81158753|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
27815782|NCT04700449|81158754|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
27815783|NCT04700449|81158755|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
27815784|NCT04700449|81158756|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
27815785|NCT04700449|81158757|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
27815786|NCT04700449|81158754|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
27815787|NCT04700449|81158755|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
27815788|NCT04700449|81158756|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
27815789|NCT04700449|81158757|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
27815790|NCT04700449|81158754|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
27815791|NCT04700449|81158755|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
27815792|NCT04700449|81158756|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
27815793|NCT04700449|81158757|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
27815794|NCT04700449|81158754|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
27815795|NCT04700449|81158755|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
27589929|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
27589930|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
27589931|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
27589932|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
27589933|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
27589934|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
27589935|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
27589936|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
27589937|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
27589938|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
27589939|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
27878268|NCT00489918|81387189|FG004|Overall Study|Adverse Event|0|||
27878269|NCT00489918|81387185|FG000|Overall Study|Lost to Follow-up|0|||
27878270|NCT00489918|81387186|FG001|Overall Study|Lost to Follow-up|0|||
27878271|NCT00489918|81387187|FG002|Overall Study|Lost to Follow-up|1|||
27878272|NCT00489918|81387188|FG003|Overall Study|Lost to Follow-up|1|||
27878273|NCT00489918|81387189|FG004|Overall Study|Lost to Follow-up|0|||
27878274|NCT00489918|81387185|FG000|Overall Study|Physician Decision|0|||
27878275|NCT00489918|81387186|FG001|Overall Study|Physician Decision|0|||
27878276|NCT00489918|81387187|FG002|Overall Study|Physician Decision|1|||
27878277|NCT00489918|81387188|FG003|Overall Study|Physician Decision|0|||
27878278|NCT00489918|81387189|FG004|Overall Study|Physician Decision|0|||
27878279|NCT03442751|81387190|FG000|Overall Study|Withdrawal by Subject|3|||
27878280|NCT03442751|81387191|FG001|Overall Study|Withdrawal by Subject|1|||
27878281|NCT03442751|81387190|FG000|Overall Study|Lost to Follow-up|3|||
27878282|NCT03442751|81387191|FG001|Overall Study|Lost to Follow-up|0|||
27878283|NCT02291510|81387193|FG000|Overall Study|Adverse Event|0|||
27878284|NCT02291510|81387194|FG001|Overall Study|Adverse Event|0|||
27878285|NCT02291510|81387195|FG002|Overall Study|Adverse Event|0|||
27878286|NCT02291510|81387196|FG003|Overall Study|Adverse Event|1|||
27878287|NCT04615403|81387197|FG000|Overall Study|Death|1|||
27878288|NCT03652051|81387198|FG000|Stage 1|Adverse Event|0|||
27878289|NCT03652051|81387199|FG001|Stage 1|Adverse Event|5|||
27878290|NCT03652051|81387200|FG002|Stage 1|Adverse Event|7|||
27878291|NCT03652051|81387201|FG003|Stage 1|Adverse Event|1|||
27878292|NCT03652051|81387198|FG000|Stage 1|Withdrawal by Subject|0|||
27878293|NCT03652051|81387199|FG001|Stage 1|Withdrawal by Subject|0|||
27878294|NCT03652051|81387200|FG002|Stage 1|Withdrawal by Subject|1|||
27878295|NCT03652051|81387201|FG003|Stage 1|Withdrawal by Subject|0|||
27878296|NCT03652051|81387198|FG000|Stage 2|Adverse Event|0|||
27878297|NCT03652051|81387199|FG001|Stage 2|Adverse Event|2|||
27878298|NCT03652051|81387200|FG002|Stage 2|Adverse Event|1|||
27878299|NCT03652051|81387201|FG003|Stage 2|Adverse Event|0|||
27878300|NCT03652051|81387198|FG000|Stage 2|Protocol Violation|0|||
27878301|NCT03652051|81387199|FG001|Stage 2|Protocol Violation|1|||
27878302|NCT03652051|81387200|FG002|Stage 2|Protocol Violation|6|||
27878303|NCT03652051|81387201|FG003|Stage 2|Protocol Violation|0|||
27878304|NCT03652051|81387198|FG000|Stage 2|Lost to Follow-up|0|||
27878305|NCT03652051|81387199|FG001|Stage 2|Lost to Follow-up|2|||
27878306|NCT03652051|81387200|FG002|Stage 2|Lost to Follow-up|0|||
27878307|NCT03652051|81387201|FG003|Stage 2|Lost to Follow-up|3|||
27878308|NCT03652051|81387198|FG000|Stage 2|Withdrawal by Subject|0|||
27878309|NCT03652051|81387199|FG001|Stage 2|Withdrawal by Subject|11|||
27878310|NCT03652051|81387200|FG002|Stage 2|Withdrawal by Subject|9|||
27878311|NCT03652051|81387201|FG003|Stage 2|Withdrawal by Subject|3|||
27878312|NCT04509076|81387202|FG000|Overall Study|Withdrawal by Subject|1|||
27878313|NCT04509076|81387203|FG001|Overall Study|Withdrawal by Subject|2|||
27878314|NCT04509076|81387202|FG000|Overall Study|Lost to Follow-up|1|||
27878315|NCT04509076|81387203|FG001|Overall Study|Lost to Follow-up|2|||
27589940|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
27878316|NCT02418949|81387207|FG000|Overall Study|Withdrawal by Subject|1|||
27878317|NCT02418949|81387208|FG001|Overall Study|Withdrawal by Subject|0|||
27878318|NCT02418949|81387209|FG002|Overall Study|Withdrawal by Subject|1|||
27878319|NCT02418949|81387210|FG003|Overall Study|Withdrawal by Subject|1|||
27878320|NCT02418949|81387207|FG000|Overall Study|Lost to Follow-up|1|||
27878321|NCT02418949|81387208|FG001|Overall Study|Lost to Follow-up|0|||
27815796|NCT04700449|81158756|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
27815797|NCT04700449|81158757|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
27815798|NCT04700449|81158754|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
27815799|NCT04700449|81158755|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
27815800|NCT04700449|81158756|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
27815801|NCT04700449|81158757|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
27815802|NCT04700449|81158754|FG000|Stage 1: Double-Blind Period|Other|0|||
27815803|NCT04700449|81158755|FG001|Stage 1: Double-Blind Period|Other|0|||
27878322|NCT02418949|81387209|FG002|Overall Study|Lost to Follow-up|1|||
27878323|NCT02418949|81387210|FG003|Overall Study|Lost to Follow-up|0|||
27878324|NCT02418949|81387207|FG000|Overall Study|Physician Decision|1|||
27878325|NCT02418949|81387208|FG001|Overall Study|Physician Decision|1|||
27815804|NCT04700449|81158756|FG002|Stage 1: Double-Blind Period|Other|1|||
27815805|NCT04700449|81158757|FG003|Stage 1: Double-Blind Period|Other|0|||
27815806|NCT04700449|81158754|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
27815807|NCT04700449|81158755|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
27815808|NCT04700449|81158756|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
27815809|NCT04700449|81158757|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
27815810|NCT04700449|81158754|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
27815811|NCT04700449|81158755|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
27815812|NCT04700449|81158756|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
27878326|NCT02418949|81387209|FG002|Overall Study|Physician Decision|1|||
27689556|NCT03426605|80699061|FG002|Overall Study|Adverse Event|1|||
27689557|NCT03426605|80699062|FG003|Overall Study|Adverse Event|1|||
27689558|NCT03426605|80699059|FG000|Overall Study|Withdrawal by Subject|0|||
27689559|NCT03426605|80699060|FG001|Overall Study|Withdrawal by Subject|0|||
27689560|NCT03426605|80699061|FG002|Overall Study|Withdrawal by Subject|1|||
27815813|NCT04700449|81158757|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
27815814|NCT04700449|81158754|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
27815815|NCT04700449|81158755|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
27815816|NCT04700449|81158756|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
27815817|NCT04700449|81158757|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
27815818|NCT04700449|81158754|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
27815819|NCT04700449|81158755|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
27815820|NCT04700449|81158756|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
27815821|NCT04700449|81158757|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
27815822|NCT04700449|81158754|FG000|Stage 2 Sub-study 1|Other|1|||
27815823|NCT04700449|81158755|FG001|Stage 2 Sub-study 1|Other|2|||
27815824|NCT04700449|81158756|FG002|Stage 2 Sub-study 1|Other|0|||
27815825|NCT04700449|81158757|FG003|Stage 2 Sub-study 1|Other|0|||
27815826|NCT04700449|81158754|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
27815827|NCT04700449|81158755|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
27815828|NCT04700449|81158756|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
27815829|NCT04700449|81158757|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
27689561|NCT03426605|80699062|FG003|Overall Study|Withdrawal by Subject|1|||
27689562|NCT02433340|80699066|FG000|Overall Study|Adverse Event|0|||
27689563|NCT02433340|80699067|FG001|Overall Study|Adverse Event|0|||
27689564|NCT02433340|80699068|FG002|Overall Study|Adverse Event|1|||
27815830|NCT04700449|81158754|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
27589941|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589942|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
27689565|NCT02433340|80699069|FG003|Overall Study|Adverse Event|0|||
27689566|NCT02433340|80699066|FG000|Overall Study|Withdrawal by Subject|1|||
27815831|NCT04700449|81158755|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
27815832|NCT04700449|81158756|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
27815833|NCT04700449|81158757|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
27815834|NCT04700449|81158754|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
27815835|NCT04700449|81158755|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
27815836|NCT04700449|81158756|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
27815837|NCT04700449|81158757|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
27815838|NCT04700449|81158754|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
27815839|NCT04700449|81158755|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
27815840|NCT04700449|81158756|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
27815841|NCT04700449|81158757|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
27815842|NCT04700449|81158754|FG000|Stage 2 Sub-study 2|Other|0|||
27815843|NCT04700449|81158755|FG001|Stage 2 Sub-study 2|Other|0|||
27815844|NCT04700449|81158756|FG002|Stage 2 Sub-study 2|Other|0|||
27815845|NCT04700449|81158757|FG003|Stage 2 Sub-study 2|Other|5|||
27815846|NCT00678392|81158758|FG000|Overall Study|Adverse Event|0|||
27815847|NCT00678392|81158759|FG001|Overall Study|Adverse Event|6|||
27815848|NCT00678392|81158758|FG000|Overall Study|Death|280|||
27815849|NCT00678392|81158759|FG001|Overall Study|Death|269|||
27815850|NCT00678392|81158758|FG000|Overall Study|Lost to Follow-up|15|||
27815851|NCT00678392|81158759|FG001|Overall Study|Lost to Follow-up|13|||
27815852|NCT00678392|81158758|FG000|Overall Study|Objective Progression or Relapse|3|||
27815853|NCT00678392|81158759|FG001|Overall Study|Objective Progression or Relapse|8|||
27815854|NCT00678392|81158758|FG000|Overall Study|Sponsor's Decision|1|||
27815855|NCT00678392|81158759|FG001|Overall Study|Sponsor's Decision|2|||
27815856|NCT00678392|81158758|FG000|Overall Study|Withdrawal by Subject|4|||
27815857|NCT00678392|81158759|FG001|Overall Study|Withdrawal by Subject|4|||
27815858|NCT00678392|81158758|FG000|Overall Study|Randomized But Not Treated|2|||
27815859|NCT00678392|81158759|FG001|Overall Study|Randomized But Not Treated|7|||
27815860|NCT00678392|81158758|FG000|Overall Study|Other|56|||
27878327|NCT02418949|81387210|FG003|Overall Study|Physician Decision|0|||
27689567|NCT02433340|80699067|FG001|Overall Study|Withdrawal by Subject|0|||
27689568|NCT02433340|80699068|FG002|Overall Study|Withdrawal by Subject|1|||
27701006|NCT01241552|80741291|FG002|Overall Study|Lost to Follow-up|15|||
27815861|NCT00678392|81158759|FG001|Overall Study|Other|53|||
27815862|NCT00777829|81158762|FG000|Overall Study|Withdrawal by Subject|0|||
27815863|NCT00777829|81158763|FG001|Overall Study|Withdrawal by Subject|2|||
27815864|NCT02761980|81158764|FG000|Overall Study|Adverse Event|4|||
27815865|NCT02761980|81158765|FG001|Overall Study|Adverse Event|6|||
27815866|NCT02761980|81158766|FG002|Overall Study|Adverse Event|5|||
27815867|NCT02761980|81158767|FG003|Overall Study|Adverse Event|6|||
27815868|NCT02761980|81158764|FG000|Overall Study|Withdrawal by Subject|0|||
27815869|NCT02761980|81158765|FG001|Overall Study|Withdrawal by Subject|1|||
27815870|NCT02761980|81158766|FG002|Overall Study|Withdrawal by Subject|0|||
27815871|NCT02761980|81158767|FG003|Overall Study|Withdrawal by Subject|0|||
27815872|NCT02761980|81158764|FG000|Overall Study|Other|0|||
27689569|NCT02433340|80699069|FG003|Overall Study|Withdrawal by Subject|2|||
27815873|NCT02761980|81158765|FG001|Overall Study|Other|0|||
27815874|NCT02761980|81158766|FG002|Overall Study|Other|1|||
27815875|NCT02761980|81158767|FG003|Overall Study|Other|0|||
27815876|NCT01915732|81158768|FG000|Overall Study|Withdrawal by Subject|18|||
27815877|NCT01915732|81158769|FG001|Overall Study|Withdrawal by Subject|18|||
27815878|NCT01915732|81158768|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
27815879|NCT01915732|81158769|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
27815880|NCT01915732|81158768|FG000|Overall Study|Adverse Event|12|||
27815881|NCT01915732|81158769|FG001|Overall Study|Adverse Event|4|||
27815882|NCT01915732|81158768|FG000|Overall Study|Protocol Violation|5|||
27815883|NCT01915732|81158769|FG001|Overall Study|Protocol Violation|5|||
27815884|NCT01915732|81158768|FG000|Overall Study|Lack of Efficacy|6|||
27815885|NCT01915732|81158769|FG001|Overall Study|Lack of Efficacy|11|||
27815886|NCT01915732|81158768|FG000|Overall Study|Lost to Follow-up|22|||
27815887|NCT01915732|81158769|FG001|Overall Study|Lost to Follow-up|26|||
27815888|NCT01915732|81158768|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
27815889|NCT01915732|81158769|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
27815890|NCT01915732|81158768|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
27815891|NCT01915732|81158769|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
27815892|NCT01915732|81158768|FG000|Overall Study|Drug Release Error|1|||
27815893|NCT01915732|81158769|FG001|Overall Study|Drug Release Error|0|||
27815894|NCT01915732|81158768|FG000|Overall Study|Recovered|1|||
27815895|NCT01915732|81158769|FG001|Overall Study|Recovered|0|||
27815896|NCT01915732|81158768|FG000|Overall Study|Pregnancy|1|||
27815897|NCT01915732|81158769|FG001|Overall Study|Pregnancy|0|||
27815898|NCT01915732|81158768|FG000|Overall Study|Poor Perceived Efficacy|1|||
27815899|NCT01915732|81158769|FG001|Overall Study|Poor Perceived Efficacy|0|||
27815900|NCT01915732|81158768|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
27815901|NCT01915732|81158769|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
27815902|NCT01915732|81158768|FG000|Overall Study|Got Well|0|||
27815903|NCT01915732|81158769|FG001|Overall Study|Got Well|1|||
27815904|NCT01915732|81158768|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
27815905|NCT01915732|81158769|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
27815906|NCT01915732|81158768|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
27815907|NCT01915732|81158769|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
27815908|NCT01915732|81158768|FG000|Overall Study|Job Transfer|0|||
27815909|NCT01915732|81158769|FG001|Overall Study|Job Transfer|1|||
27815910|NCT01915732|81158768|FG000|Overall Study|Improper Facial Procedure|0|||
27815911|NCT01915732|81158769|FG001|Overall Study|Improper Facial Procedure|1|||
27689570|NCT02433340|80699066|FG000|Overall Study|Lost to Follow-up|0|||
27689571|NCT02433340|80699067|FG001|Overall Study|Lost to Follow-up|1|||
27689572|NCT02433340|80699068|FG002|Overall Study|Lost to Follow-up|0|||
27689573|NCT02433340|80699069|FG003|Overall Study|Lost to Follow-up|0|||
27689574|NCT02433340|80699066|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
27815912|NCT01915732|81158768|FG000|Overall Study|Poor Conscious Effect|0|||
27815913|NCT01915732|81158769|FG001|Overall Study|Poor Conscious Effect|1|||
27689575|NCT02433340|80699067|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
27689576|NCT02433340|80699068|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
27689577|NCT02433340|80699069|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
27689578|NCT02433340|80699066|FG000|Overall Study|Other|0|||
27689579|NCT02433340|80699067|FG001|Overall Study|Other|1|||
27878328|NCT00364923|81387217|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
27878329|NCT00364923|81387217|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
27878330|NCT01962103|81387218|FG000|Phase 1|Adverse Event|4|||
27878331|NCT01962103|81387219|FG001|Phase 1|Adverse Event|0|||
27878332|NCT01962103|81387220|FG002|Phase 1|Adverse Event|2|||
27815915|NCT01658943|81158771|FG000|Overall Study|Adverse Event|6|||
27815916|NCT01658943|81158772|FG001|Overall Study|Adverse Event|13|||
27815917|NCT01658943|81158771|FG000|Overall Study|Withdrawal by Subject|9|||
27815918|NCT01658943|81158772|FG001|Overall Study|Withdrawal by Subject|2|||
27815919|NCT01658943|81158771|FG000|Overall Study|Progression/Relapse|39|||
27689580|NCT02433340|80699068|FG002|Overall Study|Other|0|||
27815920|NCT01658943|81158772|FG001|Overall Study|Progression/Relapse|40|||
27815921|NCT01658943|81158771|FG000|Overall Study|Death|4|||
27878333|NCT01962103|81387221|FG003|Phase 1|Adverse Event|1|||
27878334|NCT01962103|81387222|FG004|Phase 1|Adverse Event|2|||
27878335|NCT01962103|81387223|FG005|Phase 1|Adverse Event|2|||
27878336|NCT01962103|81387224|FG006|Phase 1|Adverse Event|0|||
27878337|NCT01962103|81387225|FG007|Phase 1|Adverse Event|0|||
27878338|NCT01962103|81387226|FG008|Phase 1|Adverse Event|0|||
27878339|NCT01962103|81387218|FG000|Phase 1|Progressive Disease|8|||
27878340|NCT01962103|81387219|FG001|Phase 1|Progressive Disease|6|||
27878341|NCT01962103|81387220|FG002|Phase 1|Progressive Disease|8|||
27878342|NCT01962103|81387221|FG003|Phase 1|Progressive Disease|4|||
27878343|NCT01962103|81387222|FG004|Phase 1|Progressive Disease|5|||
27878344|NCT01962103|81387223|FG005|Phase 1|Progressive Disease|4|||
27878345|NCT01962103|81387224|FG006|Phase 1|Progressive Disease|0|||
27878346|NCT01962103|81387225|FG007|Phase 1|Progressive Disease|0|||
27878347|NCT01962103|81387226|FG008|Phase 1|Progressive Disease|0|||
27878348|NCT01962103|81387218|FG000|Phase 1|Withdrawal by Subject|0|||
27878349|NCT01962103|81387219|FG001|Phase 1|Withdrawal by Subject|0|||
27878350|NCT01962103|81387220|FG002|Phase 1|Withdrawal by Subject|0|||
27878351|NCT01962103|81387221|FG003|Phase 1|Withdrawal by Subject|2|||
27878352|NCT01962103|81387222|FG004|Phase 1|Withdrawal by Subject|0|||
27878353|NCT01962103|81387223|FG005|Phase 1|Withdrawal by Subject|0|||
27878354|NCT01962103|81387224|FG006|Phase 1|Withdrawal by Subject|0|||
27878355|NCT01962103|81387225|FG007|Phase 1|Withdrawal by Subject|0|||
27878356|NCT01962103|81387226|FG008|Phase 1|Withdrawal by Subject|0|||
27878357|NCT01962103|81387218|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
27878358|NCT01962103|81387219|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
27878359|NCT01962103|81387220|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
27878360|NCT01962103|81387221|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
27878361|NCT01962103|81387222|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
27878362|NCT01962103|81387223|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
27878363|NCT01962103|81387224|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
27589943|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589944|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589945|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589946|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589947|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589948|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589949|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589950|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
27878364|NCT01962103|81387225|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
27878365|NCT01962103|81387226|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
27878366|NCT01962103|81387218|FG000|Phase 1|Physician Decision|0|||
27878367|NCT01962103|81387219|FG001|Phase 1|Physician Decision|0|||
27878368|NCT01962103|81387220|FG002|Phase 1|Physician Decision|0|||
27878369|NCT01962103|81387221|FG003|Phase 1|Physician Decision|1|||
27878370|NCT01962103|81387222|FG004|Phase 1|Physician Decision|0|||
27878371|NCT01962103|81387223|FG005|Phase 1|Physician Decision|0|||
27878372|NCT01962103|81387224|FG006|Phase 1|Physician Decision|0|||
27878373|NCT01962103|81387225|FG007|Phase 1|Physician Decision|0|||
27878374|NCT01962103|81387226|FG008|Phase 1|Physician Decision|0|||
27878375|NCT01962103|81387218|FG000|Phase 1|Symptomatic Deterioration|3|||
27878376|NCT01962103|81387219|FG001|Phase 1|Symptomatic Deterioration|2|||
27878377|NCT01962103|81387220|FG002|Phase 1|Symptomatic Deterioration|2|||
27878378|NCT01962103|81387221|FG003|Phase 1|Symptomatic Deterioration|2|||
27878379|NCT01962103|81387222|FG004|Phase 1|Symptomatic Deterioration|1|||
27878380|NCT01962103|81387223|FG005|Phase 1|Symptomatic Deterioration|1|||
27589951|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
27878381|NCT01962103|81387224|FG006|Phase 1|Symptomatic Deterioration|0|||
27878382|NCT01962103|81387225|FG007|Phase 1|Symptomatic Deterioration|0|||
27878383|NCT01962103|81387226|FG008|Phase 1|Symptomatic Deterioration|0|||
27878384|NCT01962103|81387218|FG000|Phase 1|Miscellaneous|1|||
27878385|NCT01962103|81387219|FG001|Phase 1|Miscellaneous|0|||
27878386|NCT01962103|81387220|FG002|Phase 1|Miscellaneous|0|||
27878387|NCT01962103|81387221|FG003|Phase 1|Miscellaneous|0|||
27878388|NCT01962103|81387222|FG004|Phase 1|Miscellaneous|0|||
27878389|NCT01962103|81387223|FG005|Phase 1|Miscellaneous|0|||
27878390|NCT01962103|81387224|FG006|Phase 1|Miscellaneous|0|||
27878391|NCT01962103|81387225|FG007|Phase 1|Miscellaneous|0|||
27878392|NCT01962103|81387226|FG008|Phase 1|Miscellaneous|0|||
27878393|NCT01962103|81387218|FG000|Phase 2|Adverse Event|0|||
27589952|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
27878394|NCT01962103|81387219|FG001|Phase 2|Adverse Event|0|||
27878395|NCT01962103|81387220|FG002|Phase 2|Adverse Event|0|||
27878396|NCT01962103|81387221|FG003|Phase 2|Adverse Event|0|||
27878397|NCT01962103|81387222|FG004|Phase 2|Adverse Event|0|||
27878398|NCT01962103|81387223|FG005|Phase 2|Adverse Event|0|||
27878399|NCT01962103|81387224|FG006|Phase 2|Adverse Event|1|||
27878400|NCT01962103|81387225|FG007|Phase 2|Adverse Event|0|||
27878401|NCT01962103|81387226|FG008|Phase 2|Adverse Event|3|||
27878402|NCT01962103|81387218|FG000|Phase 2|Progressive Disease|0|||
27878403|NCT01962103|81387219|FG001|Phase 2|Progressive Disease|0|||
27589953|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589954|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589955|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589956|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589957|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589958|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
27589959|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
27589960|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
27589961|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589962|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
27589963|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
27589964|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27689581|NCT02433340|80699069|FG003|Overall Study|Other|0|||
27815922|NCT01658943|81158772|FG001|Overall Study|Death|2|||
27589965|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27815923|NCT01658943|81158771|FG000|Overall Study|not protocol specified|4|||
27815924|NCT01658943|81158772|FG001|Overall Study|not protocol specified|1|||
27815925|NCT01658943|81158771|FG000|Overall Study|Not eligible|7|||
27815926|NCT01658943|81158772|FG001|Overall Study|Not eligible|9|||
27815927|NCT01658943|81158771|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
27815928|NCT01658943|81158772|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
27815929|NCT03247556|81158773|FG000|Overall Study|Adverse Event|1|||
27815930|NCT03247556|81158774|FG001|Overall Study|Adverse Event|4|||
27815931|NCT03247556|81158775|FG002|Overall Study|Adverse Event|5|||
27815932|NCT03247556|81158773|FG000|Overall Study|Lost to Follow-up|5|||
27815933|NCT03247556|81158774|FG001|Overall Study|Lost to Follow-up|5|||
27815934|NCT03247556|81158775|FG002|Overall Study|Lost to Follow-up|4|||
27815935|NCT03247556|81158773|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
27815936|NCT03247556|81158774|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
27815937|NCT03247556|81158775|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
27815938|NCT03247556|81158773|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
27815939|NCT03247556|81158774|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
27815940|NCT03247556|81158775|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
27815941|NCT03247556|81158773|FG000|Overall Study|Protocol Violation|2|||
27815942|NCT03247556|81158774|FG001|Overall Study|Protocol Violation|0|||
27815943|NCT03247556|81158775|FG002|Overall Study|Protocol Violation|1|||
27589966|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27815944|NCT03247556|81158773|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
27878404|NCT01962103|81387220|FG002|Phase 2|Progressive Disease|0|||
27589967|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589968|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589969|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589970|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589971|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589972|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589973|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589974|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589975|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589976|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589977|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27878405|NCT01962103|81387221|FG003|Phase 2|Progressive Disease|0|||
27878406|NCT01962103|81387222|FG004|Phase 2|Progressive Disease|0|||
27878407|NCT01962103|81387223|FG005|Phase 2|Progressive Disease|0|||
27878408|NCT01962103|81387224|FG006|Phase 2|Progressive Disease|11|||
27878409|NCT01962103|81387225|FG007|Phase 2|Progressive Disease|12|||
27878410|NCT01962103|81387226|FG008|Phase 2|Progressive Disease|11|||
27878411|NCT01962103|81387218|FG000|Phase 2|Symptomatic Deterioration|0|||
27878412|NCT01962103|81387219|FG001|Phase 2|Symptomatic Deterioration|0|||
27878413|NCT01962103|81387220|FG002|Phase 2|Symptomatic Deterioration|0|||
27878414|NCT01962103|81387221|FG003|Phase 2|Symptomatic Deterioration|0|||
27878415|NCT01962103|81387222|FG004|Phase 2|Symptomatic Deterioration|0|||
27878416|NCT01962103|81387223|FG005|Phase 2|Symptomatic Deterioration|0|||
27878417|NCT01962103|81387224|FG006|Phase 2|Symptomatic Deterioration|2|||
27878418|NCT01962103|81387225|FG007|Phase 2|Symptomatic Deterioration|2|||
27878419|NCT01962103|81387226|FG008|Phase 2|Symptomatic Deterioration|0|||
27878420|NCT05000164|81387227|FG000|Overall Study|Adverse Event|1|||
27878421|NCT05000164|81387227|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
27878422|NCT05000164|81387227|FG000|Overall Study|Lens Discomfort|3|||
27878423|NCT05000164|81387227|FG000|Overall Study|Withdrew Consent during Study|2|||
27878424|NCT05000164|81387227|FG000|Overall Study|Subject Withdrawn by PI|2|||
27878425|NCT05000164|81387227|FG000|Overall Study|Other Fractured Test Article|1|||
27878426|NCT01842438|81387228|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
27878427|NCT01842438|81387229|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
27878428|NCT01842438|81387228|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
27878429|NCT01842438|81387229|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
27878430|NCT01842438|81387228|FG000|T2: 6month Follow-up|Death|0|||
27878431|NCT01842438|81387229|FG001|T2: 6month Follow-up|Death|1|||
27878432|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
27878433|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
27878434|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
27689582|NCT02679508|80702447|FG000|Healing Phase|Protocol Violation|1|||
27815945|NCT03247556|81158774|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
27878435|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
27878436|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
27878437|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
27878438|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
27878439|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
27878440|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
27878441|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
27815946|NCT03247556|81158775|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
27815947|NCT03594123|81158776|FG000|Overall Study|Lost to Follow-up|0|||
27878442|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
27878443|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
27815948|NCT03594123|81158777|FG001|Overall Study|Lost to Follow-up|1|||
27815949|NCT03594123|81158776|FG000|Overall Study|Adverse Event|8|||
27815950|NCT03594123|81158777|FG001|Overall Study|Adverse Event|5|||
27815951|NCT03594123|81158776|FG000|Overall Study|Site Terminated by Sponsor|4|||
27815952|NCT03594123|81158777|FG001|Overall Study|Site Terminated by Sponsor|1|||
27815953|NCT03594123|81158776|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
27815954|NCT03594123|81158777|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
27815955|NCT03594123|81158776|FG000|Overall Study|Lack of Efficacy|1|||
27815956|NCT03594123|81158777|FG001|Overall Study|Lack of Efficacy|0|||
27878444|NCT03493854|81387230|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
27878445|NCT03493854|81387231|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
27878446|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
27878447|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
27878448|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
27878449|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
27878450|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
27878451|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
27878452|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
27878453|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
27878454|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
27878455|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
27878456|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
27878457|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
27878458|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
27878459|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
27878460|NCT03493854|81387230|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
27878461|NCT03493854|81387231|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
27878462|NCT03493854|81387230|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
27878463|NCT03493854|81387231|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
27878464|NCT03493854|81387230|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
27878465|NCT03493854|81387231|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
27878466|NCT03493854|81387230|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
27878467|NCT03493854|81387231|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
27878468|NCT01697748|81387232|FG000|Overall Study|ineligible skin incision|1|||
27878469|NCT01697748|81387233|FG001|Overall Study|ineligible skin incision|2|||
27878470|NCT01697748|81387232|FG000|Overall Study|ineligible uterine incision|4|||
27815957|NCT03594123|81158776|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
27878471|NCT01697748|81387233|FG001|Overall Study|ineligible uterine incision|1|||
27878472|NCT01697748|81387232|FG000|Overall Study|Lost to Follow-up|53|||
27878473|NCT01697748|81387233|FG001|Overall Study|Lost to Follow-up|65|||
27878474|NCT01930162|81387236|FG000|Overall Study|Abnormal test procedure result(s)|4|||
27878475|NCT01930162|81387236|FG000|Overall Study|Death|1|||
27815958|NCT03594123|81158777|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
27878476|NCT02268916|81387240|FG000|Overall Study|Lost to Follow-up|1|||
27878477|NCT02268916|81387241|FG001|Overall Study|Lost to Follow-up|1|||
27878478|NCT02268916|81387240|FG000|Overall Study|Withdrawal by Subject|6|||
27878479|NCT02268916|81387241|FG001|Overall Study|Withdrawal by Subject|5|||
27878480|NCT02268916|81387240|FG000|Overall Study|Participant did not have diabetes|1|||
27878481|NCT02268916|81387241|FG001|Overall Study|Participant did not have diabetes|0|||
27878482|NCT02268916|81387240|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
27878483|NCT02268916|81387241|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
27815959|NCT01075763|81158778|FG000|Overall Study|Lost to Follow-up|2|||
27815960|NCT01075763|81158779|FG001|Overall Study|Lost to Follow-up|1|||
27815961|NCT01075763|81158778|FG000|Overall Study|Lack of Efficacy|0|||
27815962|NCT01075763|81158779|FG001|Overall Study|Lack of Efficacy|1|||
27815963|NCT01075763|81158778|FG000|Overall Study|Withdrawal by Subject|2|||
27815964|NCT01075763|81158779|FG001|Overall Study|Withdrawal by Subject|2|||
27878484|NCT00086684|81387242|FG000|Overall Study|Adverse Event|12|||
27878485|NCT00086684|81387243|FG001|Overall Study|Adverse Event|17|||
27878486|NCT00086684|81387244|FG002|Overall Study|Adverse Event|14|||
27878487|NCT00086684|81387242|FG000|Overall Study|Lack of Efficacy|6|||
27878488|NCT00086684|81387243|FG001|Overall Study|Lack of Efficacy|6|||
27878489|NCT00086684|81387244|FG002|Overall Study|Lack of Efficacy|5|||
27878490|NCT00086684|81387242|FG000|Overall Study|Lost to Follow-up|15|||
27878491|NCT00086684|81387243|FG001|Overall Study|Lost to Follow-up|8|||
27878492|NCT00086684|81387244|FG002|Overall Study|Lost to Follow-up|10|||
27878493|NCT00086684|81387242|FG000|Overall Study|Protocol Violation|8|||
27878494|NCT00086684|81387243|FG001|Overall Study|Protocol Violation|3|||
27878495|NCT00086684|81387244|FG002|Overall Study|Protocol Violation|0|||
27878496|NCT00086684|81387242|FG000|Overall Study|Withdrawal by Subject|0|||
27878497|NCT00086684|81387243|FG001|Overall Study|Withdrawal by Subject|4|||
27878498|NCT00086684|81387244|FG002|Overall Study|Withdrawal by Subject|10|||
27878499|NCT00086684|81387242|FG000|Overall Study|NONCOMPLIANCE|5|||
27878500|NCT00086684|81387243|FG001|Overall Study|NONCOMPLIANCE|7|||
27878501|NCT00086684|81387244|FG002|Overall Study|NONCOMPLIANCE|6|||
27878502|NCT00086684|81387242|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27878503|NCT00086684|81387243|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
27878504|NCT00086684|81387244|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27878505|NCT00086684|81387242|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
27878506|NCT00086684|81387243|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
27878507|NCT00086684|81387244|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
27878508|NCT00086684|81387242|FG000|Overall Study|Other|4|||
27878509|NCT00086684|81387243|FG001|Overall Study|Other|2|||
27878510|NCT00086684|81387244|FG002|Overall Study|Other|3|||
27878511|NCT02861807|81387248|FG000|Overall Study|Lost to Follow-up|7|||
27815965|NCT03552757|81158780|FG000|Overall Study|Withdrawal by Subject|10|||
27815966|NCT03552757|81158781|FG001|Overall Study|Withdrawal by Subject|5|||
27815967|NCT03552757|81158782|FG002|Overall Study|Withdrawal by Subject|12|||
27815968|NCT03552757|81158780|FG000|Overall Study|Lost to Follow-up|2|||
27815969|NCT03552757|81158781|FG001|Overall Study|Lost to Follow-up|7|||
27815970|NCT03552757|81158782|FG002|Overall Study|Lost to Follow-up|7|||
27815971|NCT03552757|81158780|FG000|Overall Study|Death|1|||
27815972|NCT03552757|81158781|FG001|Overall Study|Death|1|||
27815973|NCT03552757|81158782|FG002|Overall Study|Death|1|||
27815974|NCT03295721|81158790|FG000|Overall Study|Adverse Event|1|||
27815975|NCT03295721|81158791|FG001|Overall Study|Adverse Event|0|||
27815976|NCT03295721|81158792|FG002|Overall Study|Adverse Event|0|||
27815977|NCT03295721|81158790|FG000|Overall Study|Lost to Follow-up|1|||
27815978|NCT03295721|81158791|FG001|Overall Study|Lost to Follow-up|1|||
27815979|NCT03295721|81158792|FG002|Overall Study|Lost to Follow-up|1|||
27815980|NCT03295721|81158790|FG000|Overall Study|Withdrawal by Subject|1|||
27815981|NCT03295721|81158791|FG001|Overall Study|Withdrawal by Subject|0|||
27878512|NCT02861807|81387249|FG001|Overall Study|Lost to Follow-up|6|||
27878513|NCT02861807|81387248|FG000|Overall Study|Withdrawal by Subject|5|||
27878514|NCT02861807|81387249|FG001|Overall Study|Withdrawal by Subject|8|||
27878515|NCT03187301|81387254|FG000|Titration Period|Adverse Event|0|||
27878516|NCT03187301|81387255|FG001|Titration Period|Adverse Event|0|||
27878517|NCT03187301|81387256|FG002|Titration Period|Adverse Event|0|||
27878518|NCT03187301|81387257|FG003|Titration Period|Adverse Event|0|||
27878519|NCT03187301|81387258|FG004|Titration Period|Adverse Event|0|||
27815982|NCT03295721|81158792|FG002|Overall Study|Withdrawal by Subject|1|||
27815983|NCT03295721|81158790|FG000|Overall Study|Death|0|||
27815984|NCT03295721|81158791|FG001|Overall Study|Death|0|||
27815985|NCT03295721|81158792|FG002|Overall Study|Death|1|||
27815986|NCT02623959|81158794|FG000|Overall Study|Progression|0|||
27815987|NCT02623959|81158795|FG001|Overall Study|Progression|1|||
27878520|NCT03187301|81387259|FG005|Titration Period|Adverse Event|0|||
27878521|NCT03187301|81387260|FG006|Titration Period|Adverse Event|5|||
27878522|NCT03187301|81387254|FG000|Titration Period|Withdrawal by Subject|0|||
27878523|NCT03187301|81387255|FG001|Titration Period|Withdrawal by Subject|0|||
27878524|NCT03187301|81387256|FG002|Titration Period|Withdrawal by Subject|0|||
27878525|NCT03187301|81387257|FG003|Titration Period|Withdrawal by Subject|0|||
27878526|NCT03187301|81387258|FG004|Titration Period|Withdrawal by Subject|0|||
27878527|NCT03187301|81387259|FG005|Titration Period|Withdrawal by Subject|0|||
27878528|NCT03187301|81387260|FG006|Titration Period|Withdrawal by Subject|1|||
27878529|NCT03187301|81387254|FG000|Titration Period|Exclusion Criteria Met|0|||
27878530|NCT03187301|81387255|FG001|Titration Period|Exclusion Criteria Met|0|||
27878531|NCT03187301|81387256|FG002|Titration Period|Exclusion Criteria Met|0|||
27878532|NCT03187301|81387257|FG003|Titration Period|Exclusion Criteria Met|0|||
27878533|NCT03187301|81387258|FG004|Titration Period|Exclusion Criteria Met|0|||
27878534|NCT03187301|81387259|FG005|Titration Period|Exclusion Criteria Met|0|||
27878535|NCT03187301|81387260|FG006|Titration Period|Exclusion Criteria Met|1|||
27878536|NCT03187301|81387254|FG000|Pre-Intervention|Withdrawal by Subject|1|||
27878537|NCT03187301|81387255|FG001|Pre-Intervention|Withdrawal by Subject|0|||
27878538|NCT03187301|81387256|FG002|Pre-Intervention|Withdrawal by Subject|0|||
27878539|NCT03187301|81387257|FG003|Pre-Intervention|Withdrawal by Subject|0|||
27878540|NCT03187301|81387258|FG004|Pre-Intervention|Withdrawal by Subject|0|||
27878541|NCT03187301|81387259|FG005|Pre-Intervention|Withdrawal by Subject|0|||
27878542|NCT03187301|81387260|FG006|Pre-Intervention|Withdrawal by Subject|0|||
27878543|NCT03283566|81387261|FG000|Overall Study|Lost to Follow-up|1|||
27878544|NCT03283566|81387262|FG001|Overall Study|Lost to Follow-up|2|||
27878545|NCT00611923|81387265|FG000|Overall Study|Withdrawal by Subject|2|||
27878546|NCT00611923|81387266|FG001|Overall Study|Withdrawal by Subject|2|||
27878547|NCT00866281|81387267|FG000|Overall Study|Adverse Event|1|||
27878548|NCT00866281|81387268|FG001|Overall Study|Adverse Event|0|||
27878549|NCT00866281|81387267|FG000|Overall Study|Withdrawal by participants|3|||
27878550|NCT00866281|81387268|FG001|Overall Study|Withdrawal by participants|0|||
27878551|NCT00866281|81387267|FG000|Overall Study|Disease progression|3|||
27878552|NCT00866281|81387268|FG001|Overall Study|Disease progression|11|||
27878553|NCT00866281|81387267|FG000|Overall Study|New cancer therapy|0|||
27878554|NCT00866281|81387268|FG001|Overall Study|New cancer therapy|4|||
27878555|NCT02949973|81387269|FG000|Overall Study|Physician Decision|1|||
27878556|NCT01276756|81387270|FG000|Overall Study|Lost to Follow-up|2|||
27878557|NCT01276756|81387271|FG001|Overall Study|Lost to Follow-up|0|||
27878558|NCT01276756|81387270|FG000|Overall Study|Adverse Event|3|||
27878559|NCT01276756|81387271|FG001|Overall Study|Adverse Event|2|||
27878560|NCT01804946|81387272|FG000|Overall Study|Protocol Violation|1|||
27878561|NCT01804946|81387273|FG001|Overall Study|Protocol Violation|0|||
27878562|NCT01804946|81387272|FG000|Overall Study|Adverse Event|0|||
27878563|NCT01804946|81387273|FG001|Overall Study|Adverse Event|1|||
27878564|NCT01804946|81387272|FG000|Overall Study|Insufficient data available|0|||
27878565|NCT01804946|81387273|FG001|Overall Study|Insufficient data available|1|||
27878566|NCT01804946|81387272|FG000|Overall Study|Do not meet inclusion criteria|1|||
27878567|NCT01804946|81387273|FG001|Overall Study|Do not meet inclusion criteria|2|||
27878568|NCT00298272|81387274|FG000|Double-blind Phase|Adverse Event|2|||
27878569|NCT00298272|81387275|FG001|Double-blind Phase|Adverse Event|0|||
27878570|NCT00298272|81387274|FG000|Double-blind Phase|Failure to Return|2|||
27878571|NCT00298272|81387275|FG001|Double-blind Phase|Failure to Return|0|||
27878572|NCT00298272|81387274|FG000|Double-blind Phase|Protocol Violation|2|||
27878573|NCT00298272|81387275|FG001|Double-blind Phase|Protocol Violation|0|||
27878574|NCT00298272|81387274|FG000|Double-blind Phase|Withdrawal by Subject|2|||
27878575|NCT00298272|81387275|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27878576|NCT00298272|81387274|FG000|Open Label Retreatment Phase|Adverse Event|1|||
27878577|NCT00298272|81387275|FG001|Open Label Retreatment Phase|Adverse Event|2|||
27878578|NCT00298272|81387274|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
27878579|NCT00298272|81387275|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
27878580|NCT00298272|81387274|FG000|Open Label Retreatment Phase|Failure to Return|1|||
27878581|NCT00298272|81387275|FG001|Open Label Retreatment Phase|Failure to Return|0|||
27878582|NCT00298272|81387274|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
27815988|NCT00796510|81158796|FG000|Overall Study|Death|1|||
27815989|NCT00796510|81158797|FG001|Overall Study|Death|0|||
27815990|NCT00796510|81158796|FG000|Overall Study|Study Terminated|2|||
27815991|NCT00796510|81158797|FG001|Overall Study|Study Terminated|0|||
27815992|NCT00684671|81158798|FG000|Overall Study|Adverse Event|1|||
27815993|NCT00684671|81158799|FG001|Overall Study|Adverse Event|0|||
27815994|NCT00684671|81158800|FG002|Overall Study|Adverse Event|0|||
27815995|NCT00684671|81158798|FG000|Overall Study|Lost to Follow-up|1|||
27815996|NCT00684671|81158799|FG001|Overall Study|Lost to Follow-up|0|||
27815997|NCT00684671|81158800|FG002|Overall Study|Lost to Follow-up|0|||
27878583|NCT00298272|81387275|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
27878584|NCT00298272|81387274|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
27878585|NCT00298272|81387275|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
27878586|NCT00298272|81387274|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
27815998|NCT00684671|81158798|FG000|Overall Study|Alcoholic dependance|1|||
27815999|NCT00684671|81158799|FG001|Overall Study|Alcoholic dependance|0|||
27816000|NCT00684671|81158800|FG002|Overall Study|Alcoholic dependance|0|||
27816001|NCT01238848|81158801|FG000|Overall Study|Physician Decision|13|||
27878587|NCT00298272|81387275|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
27816002|NCT01238848|81158802|FG001|Overall Study|Physician Decision|5|||
27816003|NCT03702621|81158803|FG000|Overall Study|Physician Decision|6|||
27816004|NCT03702621|81158804|FG001|Overall Study|Physician Decision|6|||
27816005|NCT04591626|81158816|FG000|Overall Study|Adverse Event|4|||
27816006|NCT04591626|81158817|FG001|Overall Study|Adverse Event|0|||
27816007|NCT04591626|81158816|FG000|Overall Study|Withdrawal by Subject|5|||
27816008|NCT04591626|81158817|FG001|Overall Study|Withdrawal by Subject|3|||
27816009|NCT04591626|81158816|FG000|Overall Study|Physician Decision|0|||
27816010|NCT04591626|81158817|FG001|Overall Study|Physician Decision|1|||
27816011|NCT04591626|81158816|FG000|Overall Study|Death|0|||
27816012|NCT04591626|81158817|FG001|Overall Study|Death|1|||
27816013|NCT04591626|81158816|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27816014|NCT04591626|81158817|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27816015|NCT00337571|81158818|FG000|Overall Study|Lack of Efficacy|3|||
27816016|NCT00337571|81158819|FG001|Overall Study|Lack of Efficacy|0|||
27816017|NCT00337571|81158820|FG002|Overall Study|Lack of Efficacy|0|||
27689583|NCT02679508|80702448|FG001|Healing Phase|Protocol Violation|1|||
27816018|NCT00337571|81158821|FG003|Overall Study|Lack of Efficacy|0|||
27816019|NCT00337571|81158818|FG000|Overall Study|Adverse Event|4|||
27816020|NCT00337571|81158819|FG001|Overall Study|Adverse Event|5|||
27689584|NCT02679508|80702447|FG000|Healing Phase|Lost to Follow-up|1|||
27689585|NCT02679508|80702448|FG001|Healing Phase|Lost to Follow-up|0|||
27689586|NCT02679508|80702447|FG000|Maintenance Phase|Adverse Event|12|||
27689587|NCT02679508|80702448|FG001|Maintenance Phase|Adverse Event|2|||
27816021|NCT00337571|81158820|FG002|Overall Study|Adverse Event|8|||
27816022|NCT00337571|81158821|FG003|Overall Study|Adverse Event|4|||
27816023|NCT00337571|81158818|FG000|Overall Study|Withdrawal by Subject|2|||
27816024|NCT00337571|81158819|FG001|Overall Study|Withdrawal by Subject|2|||
27816025|NCT00337571|81158820|FG002|Overall Study|Withdrawal by Subject|1|||
27816026|NCT00337571|81158821|FG003|Overall Study|Withdrawal by Subject|0|||
27816027|NCT00337571|81158818|FG000|Overall Study|Lost to Follow-up|3|||
27816028|NCT00337571|81158819|FG001|Overall Study|Lost to Follow-up|1|||
27816029|NCT00337571|81158820|FG002|Overall Study|Lost to Follow-up|0|||
27816030|NCT00337571|81158821|FG003|Overall Study|Lost to Follow-up|1|||
27816031|NCT00337571|81158818|FG000|Overall Study|Poor/noncompliance|1|||
27816032|NCT00337571|81158819|FG001|Overall Study|Poor/noncompliance|1|||
27816033|NCT00337571|81158820|FG002|Overall Study|Poor/noncompliance|1|||
27816034|NCT00337571|81158821|FG003|Overall Study|Poor/noncompliance|1|||
27816035|NCT00337571|81158818|FG000|Overall Study|No longer met study criteria|1|||
27816036|NCT00337571|81158819|FG001|Overall Study|No longer met study criteria|0|||
27589978|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
27589979|NCT01490632|80340490|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27701007|NCT01241552|80741292|FG003|Overall Study|Lost to Follow-up|16|||
27589980|NCT01490632|80340491|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589981|NCT01490632|80340492|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589982|NCT01490632|80340493|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589983|NCT01490632|80340494|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
27589984|NCT01490632|80340495|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589985|NCT01490632|80340496|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589986|NCT01490632|80340497|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589987|NCT01490632|80340498|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589988|NCT01490632|80340499|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589989|NCT01490632|80340500|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589990|NCT01490632|80340501|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589991|NCT01490632|80340502|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589992|NCT01490632|80340503|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589993|NCT01490632|80340504|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589994|NCT01490632|80340505|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589995|NCT01490632|80340506|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589996|NCT01490632|80340507|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589997|NCT01490632|80340508|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27689588|NCT02679508|80702447|FG000|Maintenance Phase|Lost to Follow-up|0|||
27689589|NCT02679508|80702448|FG001|Maintenance Phase|Lost to Follow-up|1|||
27689590|NCT02679508|80702447|FG000|Maintenance Phase|Withdrawal by Subject|15|||
27689591|NCT02679508|80702448|FG001|Maintenance Phase|Withdrawal by Subject|8|||
27689592|NCT02679508|80702447|FG000|Maintenance Phase|Other|5|||
27689593|NCT02679508|80702448|FG001|Maintenance Phase|Other|4|||
27689594|NCT02988622|80702449|FG000|Overall Study|Lost to Follow-up|17|||
27689595|NCT00192647|80702450|FG000|Overall Study|Death|1|||
27689596|NCT00192647|80702451|FG001|Overall Study|Death|1|||
27689597|NCT00192647|80702450|FG000|Overall Study|Adverse Event|35|||
27689598|NCT00192647|80702451|FG001|Overall Study|Adverse Event|29|||
27689599|NCT00192647|80702450|FG000|Overall Study|Laboratory Test Abnormality|4|||
27689600|NCT00192647|80702451|FG001|Overall Study|Laboratory Test Abnormality|2|||
27689601|NCT00192647|80702450|FG000|Overall Study|Insufficient Therapeutic Response|53|||
27689602|NCT00192647|80702451|FG001|Overall Study|Insufficient Therapeutic Response|83|||
27689603|NCT00192647|80702450|FG000|Overall Study|Entry Criteria Violation|6|||
27689604|NCT00192647|80702451|FG001|Overall Study|Entry Criteria Violation|6|||
27689605|NCT00192647|80702450|FG000|Overall Study|Protocol Violation|3|||
27689606|NCT00192647|80702451|FG001|Overall Study|Protocol Violation|1|||
27689607|NCT00192647|80702450|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
27689608|NCT00192647|80702451|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
27689609|NCT00192647|80702450|FG000|Overall Study|Failure to Return|11|||
27689610|NCT00192647|80702451|FG001|Overall Study|Failure to Return|13|||
27689611|NCT00192647|80702450|FG000|Overall Study|Other/Administrative|5|||
27689612|NCT00192647|80702451|FG001|Overall Study|Other/Administrative|3|||
27689613|NCT02447172|80702460|FG000|Overall Study|Adverse Event|11|||
27689614|NCT02447172|80702461|FG001|Overall Study|Adverse Event|8|||
27689615|NCT02447172|80702462|FG002|Overall Study|Adverse Event|7|||
27689616|NCT02447172|80702460|FG000|Overall Study|Death|3|||
27689617|NCT02447172|80702461|FG001|Overall Study|Death|1|||
27689618|NCT02447172|80702462|FG002|Overall Study|Death|0|||
27689619|NCT02447172|80702460|FG000|Overall Study|Protocol Violation|2|||
27689620|NCT02447172|80702461|FG001|Overall Study|Protocol Violation|1|||
27689621|NCT02447172|80702462|FG002|Overall Study|Protocol Violation|2|||
27689622|NCT02447172|80702460|FG000|Overall Study|Lost to Follow-up|7|||
27689623|NCT02447172|80702461|FG001|Overall Study|Lost to Follow-up|4|||
27689624|NCT02447172|80702462|FG002|Overall Study|Lost to Follow-up|4|||
27689625|NCT02447172|80702460|FG000|Overall Study|Withdrawal by Subject|5|||
27689626|NCT02447172|80702461|FG001|Overall Study|Withdrawal by Subject|1|||
27689627|NCT02447172|80702462|FG002|Overall Study|Withdrawal by Subject|3|||
27689628|NCT02447172|80702460|FG000|Overall Study|protocol specific treatment unrelated|3|||
27689629|NCT02447172|80702461|FG001|Overall Study|protocol specific treatment unrelated|0|||
27689630|NCT02447172|80702462|FG002|Overall Study|protocol specific treatment unrelated|2|||
27689631|NCT02319759|80702463|FG000|Week 0 - 16|Lack of Efficacy|1|||
27689632|NCT02319759|80702464|FG001|Week 0 - 16|Lack of Efficacy|0|||
27689633|NCT02319759|80702465|FG002|Week 0 - 16|Lack of Efficacy|0|||
27689634|NCT02319759|80702466|FG003|Week 0 - 16|Lack of Efficacy|0|||
27689635|NCT02319759|80702467|FG004|Week 0 - 16|Lack of Efficacy|0|||
27689636|NCT02319759|80702463|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
27689637|NCT02319759|80702464|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
27689638|NCT02319759|80702465|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
27689639|NCT02319759|80702466|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
27689640|NCT02319759|80702467|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
27689641|NCT02319759|80702463|FG000|Week 16 - 24|Lack of Efficacy|1|||
27689642|NCT02319759|80702464|FG001|Week 16 - 24|Lack of Efficacy|0|||
27689643|NCT02319759|80702465|FG002|Week 16 - 24|Lack of Efficacy|1|||
27689644|NCT02319759|80702466|FG003|Week 16 - 24|Lack of Efficacy|0|||
27689645|NCT02319759|80702467|FG004|Week 16 - 24|Lack of Efficacy|0|||
27689646|NCT02319759|80702463|FG000|Week 16 - 24|Lost to Follow-up|1|||
27689647|NCT02319759|80702464|FG001|Week 16 - 24|Lost to Follow-up|0|||
27689648|NCT02319759|80702465|FG002|Week 16 - 24|Lost to Follow-up|0|||
27689649|NCT02319759|80702466|FG003|Week 16 - 24|Lost to Follow-up|0|||
27689650|NCT02319759|80702467|FG004|Week 16 - 24|Lost to Follow-up|0|||
27689651|NCT02319759|80702463|FG000|Week 16 - 24|Withdrawal by Subject|0|||
27689652|NCT02319759|80702464|FG001|Week 16 - 24|Withdrawal by Subject|0|||
27689653|NCT02319759|80702465|FG002|Week 16 - 24|Withdrawal by Subject|2|||
27689654|NCT02319759|80702466|FG003|Week 16 - 24|Withdrawal by Subject|0|||
27689655|NCT02319759|80702467|FG004|Week 16 - 24|Withdrawal by Subject|0|||
27689656|NCT02319759|80702463|FG000|Week 24 - 56|Adverse Event|0|||
27689657|NCT02319759|80702464|FG001|Week 24 - 56|Adverse Event|0|||
27689658|NCT02319759|80702465|FG002|Week 24 - 56|Adverse Event|2|||
27689659|NCT02319759|80702466|FG003|Week 24 - 56|Adverse Event|0|||
27689660|NCT02319759|80702467|FG004|Week 24 - 56|Adverse Event|0|||
27689661|NCT02319759|80702463|FG000|Week 24 - 56|Lack of Efficacy|0|||
27689662|NCT02319759|80702464|FG001|Week 24 - 56|Lack of Efficacy|0|||
27689663|NCT02319759|80702465|FG002|Week 24 - 56|Lack of Efficacy|0|||
27689664|NCT02319759|80702466|FG003|Week 24 - 56|Lack of Efficacy|2|||
27689665|NCT02319759|80702467|FG004|Week 24 - 56|Lack of Efficacy|1|||
27689666|NCT02319759|80702463|FG000|Week 24 - 56|Withdrawal by Subject|0|||
27689667|NCT02319759|80702464|FG001|Week 24 - 56|Withdrawal by Subject|1|||
27689668|NCT02319759|80702465|FG002|Week 24 - 56|Withdrawal by Subject|0|||
27689669|NCT02319759|80702466|FG003|Week 24 - 56|Withdrawal by Subject|0|||
27689670|NCT02319759|80702467|FG004|Week 24 - 56|Withdrawal by Subject|0|||
27689671|NCT02319759|80702463|FG000|Week 24 - 56|Lost to Follow-up|0|||
27689672|NCT02319759|80702464|FG001|Week 24 - 56|Lost to Follow-up|0|||
27689673|NCT02319759|80702465|FG002|Week 24 - 56|Lost to Follow-up|0|||
27689674|NCT02319759|80702466|FG003|Week 24 - 56|Lost to Follow-up|0|||
27689675|NCT02319759|80702467|FG004|Week 24 - 56|Lost to Follow-up|1|||
27689676|NCT01970345|80702468|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
27689677|NCT01970345|80702469|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
27689678|NCT01970345|80702468|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
27689679|NCT01970345|80702469|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
27689680|NCT00833833|80702470|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27689681|NCT00833833|80702471|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27689682|NCT00833833|80702472|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
27689683|NCT00833833|80702473|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
27689684|NCT00833833|80702474|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27689685|NCT00833833|80702475|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
27689686|NCT00833833|80702470|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
27816037|NCT00337571|81158820|FG002|Overall Study|No longer met study criteria|0|||
27816038|NCT00337571|81158821|FG003|Overall Study|No longer met study criteria|0|||
27689687|NCT00833833|80702471|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
27689688|NCT00833833|80702472|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
27689689|NCT00833833|80702473|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
27689690|NCT00833833|80702474|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
27689691|NCT00833833|80702475|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
27689692|NCT00833833|80702470|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
27689693|NCT00833833|80702471|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
27689694|NCT00833833|80702472|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
27689695|NCT00833833|80702473|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
27689696|NCT00833833|80702474|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
27689697|NCT00833833|80702475|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
27689698|NCT00833833|80702470|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
27689699|NCT00833833|80702471|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
27589998|NCT01490632|80340509|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
27589999|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590000|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590001|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590002|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590003|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590004|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
27590005|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
27590006|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590007|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590008|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
27689700|NCT00833833|80702472|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
27689701|NCT00833833|80702473|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
27689702|NCT00833833|80702474|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
27689703|NCT00833833|80702475|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
27689704|NCT00833833|80702470|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
27689705|NCT00833833|80702471|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689706|NCT00833833|80702472|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
27689707|NCT00833833|80702473|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689708|NCT00833833|80702474|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689709|NCT00833833|80702475|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689710|NCT00833833|80702470|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
27689711|NCT00833833|80702471|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
27689712|NCT00833833|80702472|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
27689713|NCT00833833|80702473|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
27689714|NCT00833833|80702474|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
27689715|NCT00833833|80702475|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
27689716|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27689717|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27689718|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27689719|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
27689720|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
27689721|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
27689722|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27689723|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27689724|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27689725|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
27689726|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
27689727|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
27689728|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
27689729|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
27689730|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
27689731|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
27689732|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
27689733|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
27689734|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689735|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689736|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689737|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
27689738|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
27689739|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
27689740|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27816039|NCT00337571|81158818|FG000|Overall Study|High Potassium level|0|||
27590009|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
27689741|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27689742|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27689743|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
27689744|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
27689745|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
27689746|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
27689747|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
27689748|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
27689749|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
27689750|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
27689751|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
27689752|NCT00833833|80702470|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27689753|NCT00833833|80702471|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27689754|NCT00833833|80702472|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27689755|NCT00833833|80702473|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27689756|NCT00833833|80702474|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
27689757|NCT00833833|80702475|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
27689758|NCT03567434|80702476|FG000|Overall Study|Lost to Follow-up|1|||
27689759|NCT03567434|80702477|FG001|Overall Study|Lost to Follow-up|3|||
27689760|NCT00477334|80702478|FG000|Overall Study|Discontinued prior to taking study drug|106|||
27689761|NCT00477334|80702479|FG001|Overall Study|Discontinued prior to taking study drug|53|||
27689762|NCT00477334|80702478|FG000|Overall Study|Adverse Event|1|||
27689763|NCT00477334|80702479|FG001|Overall Study|Adverse Event|2|||
27689764|NCT00477334|80702478|FG000|Overall Study|Withdrawal by Subject|2|||
27689765|NCT00477334|80702479|FG001|Overall Study|Withdrawal by Subject|1|||
27689766|NCT00477334|80702478|FG000|Overall Study|Lost to Follow-up|15|||
27689767|NCT00477334|80702479|FG001|Overall Study|Lost to Follow-up|4|||
27689768|NCT00477334|80702478|FG000|Overall Study|Administrative Problems|39|||
27689769|NCT00477334|80702479|FG001|Overall Study|Administrative Problems|15|||
27689770|NCT00477334|80702478|FG000|Overall Study|Protocol Violation|7|||
27689771|NCT00477334|80702479|FG001|Overall Study|Protocol Violation|1|||
27689772|NCT00178126|80702480|FG000|Overall Study|Lost to Follow-up|21|||
27816040|NCT00337571|81158819|FG001|Overall Study|High Potassium level|0|||
27816041|NCT00337571|81158820|FG002|Overall Study|High Potassium level|0|||
27689773|NCT00178126|80702481|FG001|Overall Study|Lost to Follow-up|21|||
27689774|NCT00178126|80702480|FG000|Overall Study|did not receive intervention|4|||
27689775|NCT00178126|80702481|FG001|Overall Study|did not receive intervention|6|||
27689776|NCT02533570|80702482|FG000|Overall Study|Adverse Event|0|||
27689777|NCT02533570|80702483|FG001|Overall Study|Adverse Event|1|||
27689778|NCT02533570|80702484|FG002|Overall Study|Adverse Event|1|||
27689779|NCT01157676|80702491|FG000|Randomization|Death|1|||
27689780|NCT01157676|80702492|FG001|Randomization|Death|1|||
27689781|NCT01157676|80702491|FG000|Randomization|unresectable|2|||
27689782|NCT01157676|80702492|FG001|Randomization|unresectable|3|||
27689783|NCT01157676|80702491|FG000|Randomization|Withdrawal by Subject|17|||
27689784|NCT01157676|80702492|FG001|Randomization|Withdrawal by Subject|13|||
27689785|NCT01157676|80702491|FG000|Randomization|Physician Decision|1|||
27689786|NCT01157676|80702492|FG001|Randomization|Physician Decision|0|||
27689787|NCT01157676|80702491|FG000|Surgery|underwent open cystectomy|0|||
27689788|NCT01157676|80702492|FG001|Surgery|underwent open cystectomy|4|||
27689789|NCT01157676|80702491|FG000|Surgery|converted to open procedure|0|||
27689790|NCT01157676|80702492|FG001|Surgery|converted to open procedure|5|||
27689791|NCT01157676|80702491|FG000|Surgery|underwent robotic cystectomy|1|||
27816042|NCT00337571|81158821|FG003|Overall Study|High Potassium level|1|||
27816043|NCT01379781|81158826|FG000|Overall Study|Lost to Follow-up|11|||
27816044|NCT01379781|81158827|FG001|Overall Study|Lost to Follow-up|8|||
27816045|NCT02192099|81158828|FG000|Overall Study|Adverse Event|1|||
27816046|NCT02192099|81158828|FG000|Overall Study|Lost to Follow-up|2|||
27816047|NCT02192099|81158828|FG000|Overall Study|Physician Decision|1|||
27816048|NCT02192099|81158828|FG000|Overall Study|Pregnancy|1|||
27816049|NCT02192099|81158828|FG000|Overall Study|Protocol Violation|8|||
27689792|NCT01157676|80702492|FG001|Surgery|underwent robotic cystectomy|0|||
27689793|NCT03616977|80702493|FG000|Period 1|Physician Decision|0|||
27689794|NCT03616977|80702494|FG001|Period 1|Physician Decision|1|||
27689795|NCT03616977|80702493|FG000|Period 3|Adverse Event|1|||
27689796|NCT03616977|80702494|FG001|Period 3|Adverse Event|1|||
27816050|NCT02192099|81158828|FG000|Overall Study|Study Terminated by Sponsor|32|||
27816051|NCT02192099|81158828|FG000|Overall Study|Withdrawal by Subject|11|||
27689797|NCT03938545|80702495|FG000|Overall Study|Lost to Follow-up|0|||
27689798|NCT03938545|80702496|FG001|Overall Study|Lost to Follow-up|0|||
27689799|NCT03938545|80702497|FG002|Overall Study|Lost to Follow-up|0|||
27689800|NCT03938545|80702498|FG003|Overall Study|Lost to Follow-up|1|||
27689801|NCT03938545|80702495|FG000|Overall Study|Non-compliance with study drug|0|||
27689802|NCT03938545|80702496|FG001|Overall Study|Non-compliance with study drug|0|||
27689803|NCT03938545|80702497|FG002|Overall Study|Non-compliance with study drug|1|||
27689804|NCT03938545|80702498|FG003|Overall Study|Non-compliance with study drug|0|||
27689805|NCT03938545|80702495|FG000|Overall Study|Pregnancy|1|||
27689806|NCT03938545|80702496|FG001|Overall Study|Pregnancy|0|||
27689807|NCT03938545|80702497|FG002|Overall Study|Pregnancy|0|||
27689808|NCT03938545|80702498|FG003|Overall Study|Pregnancy|0|||
27689809|NCT03938545|80702495|FG000|Overall Study|Study terminated by sponsor|6|||
27689810|NCT03938545|80702496|FG001|Overall Study|Study terminated by sponsor|4|||
27689811|NCT03938545|80702497|FG002|Overall Study|Study terminated by sponsor|2|||
27689812|NCT03938545|80702498|FG003|Overall Study|Study terminated by sponsor|4|||
27689813|NCT03938545|80702495|FG000|Overall Study|Withdrawal by Subject|0|||
27689814|NCT03938545|80702496|FG001|Overall Study|Withdrawal by Subject|1|||
27689815|NCT03938545|80702497|FG002|Overall Study|Withdrawal by Subject|0|||
27689816|NCT03938545|80702498|FG003|Overall Study|Withdrawal by Subject|0|||
27689817|NCT03938545|80702495|FG000|Overall Study|Adverse Event|1|||
27689818|NCT03938545|80702496|FG001|Overall Study|Adverse Event|0|||
27689819|NCT03938545|80702497|FG002|Overall Study|Adverse Event|0|||
27689820|NCT03938545|80702498|FG003|Overall Study|Adverse Event|0|||
27689821|NCT01236365|80702499|FG000|Overall Study|Lost to Follow-up|0|||
27689822|NCT01236365|80702500|FG001|Overall Study|Lost to Follow-up|2|||
27689823|NCT01236365|80702499|FG000|Overall Study|Moved Out of State|1|||
27689824|NCT01236365|80702500|FG001|Overall Study|Moved Out of State|0|||
27689825|NCT01236365|80702499|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
27689826|NCT01236365|80702500|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
27689827|NCT01054170|80702501|FG000|Overall Study|Protocol Violation|1|||
27689828|NCT01054170|80702502|FG001|Overall Study|Protocol Violation|0|||
27689829|NCT01054170|80702501|FG000|Overall Study|Withdrawal by Subject|3|||
27689830|NCT01054170|80702502|FG001|Overall Study|Withdrawal by Subject|2|||
27878588|NCT00298272|81387274|FG000|Safety Follow-up Phase|Failure to Return|1|||
27878589|NCT00298272|81387275|FG001|Safety Follow-up Phase|Failure to Return|1|||
27878590|NCT00298272|81387274|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
27878591|NCT00298272|81387275|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
27878592|NCT00298272|81387274|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
27878593|NCT00298272|81387275|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
27878594|NCT04176250|81387276|FG000|Overall Study|Adverse Event|0|||
27878595|NCT04176250|81387277|FG001|Overall Study|Adverse Event|1|||
27878596|NCT04176250|81387278|FG002|Overall Study|Adverse Event|0|||
27689831|NCT01054170|80702501|FG000|Overall Study|Adverse Event|0|||
27689832|NCT01054170|80702502|FG001|Overall Study|Adverse Event|4|||
27689833|NCT02257567|80702503|FG000|Overall Study|Adverse Event|0|||
27689834|NCT02257567|80702504|FG001|Overall Study|Adverse Event|0|||
27689835|NCT02257567|80702505|FG002|Overall Study|Adverse Event|0|||
27689836|NCT02257567|80702506|FG003|Overall Study|Adverse Event|1|||
27816052|NCT02192099|81158828|FG000|Overall Study|Miscellaneous Reasons|5|||
27816053|NCT00577460|81158829|FG000|Overall Study|Adverse Event|11|||
27816054|NCT00577460|81158830|FG001|Overall Study|Adverse Event|7|||
27816055|NCT00577460|81158831|FG002|Overall Study|Adverse Event|14|||
27816056|NCT00577460|81158829|FG000|Overall Study|Protocol Violation|0|||
27816057|NCT00577460|81158830|FG001|Overall Study|Protocol Violation|1|||
27816058|NCT00577460|81158831|FG002|Overall Study|Protocol Violation|1|||
27816059|NCT00577460|81158829|FG000|Overall Study|Lost to Follow-up|0|||
27878597|NCT04176250|81387279|FG003|Overall Study|Adverse Event|1|||
27878598|NCT04176250|81387280|FG004|Overall Study|Adverse Event|0|||
27878599|NCT04176250|81387281|FG005|Overall Study|Adverse Event|1|||
27689837|NCT02257567|80702507|FG004|Overall Study|Adverse Event|1|||
27689838|NCT02257567|80702508|FG005|Overall Study|Adverse Event|0|||
27689839|NCT02257567|80702509|FG006|Overall Study|Adverse Event|0|||
27689840|NCT02257567|80702510|FG007|Overall Study|Adverse Event|0|||
27689841|NCT02257567|80702511|FG008|Overall Study|Adverse Event|1|||
27689842|NCT02257567|80702512|FG009|Overall Study|Adverse Event|0|||
27689843|NCT02257567|80702513|FG010|Overall Study|Adverse Event|0|||
27689844|NCT02257567|80702503|FG000|Overall Study|Death|2|||
27689845|NCT02257567|80702504|FG001|Overall Study|Death|2|||
27816060|NCT00577460|81158830|FG001|Overall Study|Lost to Follow-up|3|||
27816061|NCT00577460|81158831|FG002|Overall Study|Lost to Follow-up|4|||
27689846|NCT02257567|80702505|FG002|Overall Study|Death|2|||
27689847|NCT02257567|80702506|FG003|Overall Study|Death|4|||
27689848|NCT02257567|80702507|FG004|Overall Study|Death|15|||
27689849|NCT02257567|80702508|FG005|Overall Study|Death|11|||
27689850|NCT02257567|80702509|FG006|Overall Study|Death|26|||
27689851|NCT02257567|80702510|FG007|Overall Study|Death|30|||
27689852|NCT02257567|80702511|FG008|Overall Study|Death|2|||
27689853|NCT02257567|80702512|FG009|Overall Study|Death|18|||
27689854|NCT02257567|80702513|FG010|Overall Study|Death|65|||
27816062|NCT00577460|81158829|FG000|Overall Study|Withdrawal by Subject|5|||
27689855|NCT02257567|80702503|FG000|Overall Study|Lost to Follow-up|0|||
27689856|NCT02257567|80702504|FG001|Overall Study|Lost to Follow-up|0|||
27689857|NCT02257567|80702505|FG002|Overall Study|Lost to Follow-up|0|||
27689858|NCT02257567|80702506|FG003|Overall Study|Lost to Follow-up|0|||
27689859|NCT02257567|80702507|FG004|Overall Study|Lost to Follow-up|2|||
27816063|NCT00577460|81158830|FG001|Overall Study|Withdrawal by Subject|5|||
27816064|NCT00577460|81158831|FG002|Overall Study|Withdrawal by Subject|6|||
27816065|NCT00577460|81158829|FG000|Overall Study|Other|0|||
27816066|NCT00577460|81158830|FG001|Overall Study|Other|3|||
27816067|NCT00577460|81158831|FG002|Overall Study|Other|2|||
27816068|NCT00881621|81158832|FG000|Overall Study|Physician Decision|34|||
27816069|NCT01440283|81158833|FG000|Overall Study|Death|3|||
27816070|NCT01440283|81158833|FG000|Overall Study|Withdrawal by Subject|4|||
27816071|NCT01440283|81158833|FG000|Overall Study|Physician Decision|3|||
27816072|NCT01574248|81158841|FG000|Overall Study|Withdrawal by Subject|2|||
27816073|NCT01574248|81158842|FG001|Overall Study|Withdrawal by Subject|0|||
27816074|NCT01574248|81158841|FG000|Overall Study|Missing primary endpoint data|1|||
27590010|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
27590011|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590012|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590013|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590014|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590015|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590016|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
27816075|NCT01574248|81158842|FG001|Overall Study|Missing primary endpoint data|0|||
27816076|NCT00510510|81158844|FG000|Overall Study|Adverse Event|4|||
27816077|NCT00510510|81158845|FG001|Overall Study|Adverse Event|3|||
27816078|NCT00510510|81158846|FG002|Overall Study|Adverse Event|6|||
27816079|NCT00510510|81158844|FG000|Overall Study|Lack of Efficacy|0|||
27816080|NCT00510510|81158845|FG001|Overall Study|Lack of Efficacy|1|||
27816081|NCT00510510|81158846|FG002|Overall Study|Lack of Efficacy|1|||
27816082|NCT00510510|81158844|FG000|Overall Study|Subjects no longer requires study drug|0|||
27816083|NCT00510510|81158845|FG001|Overall Study|Subjects no longer requires study drug|0|||
27816084|NCT00510510|81158846|FG002|Overall Study|Subjects no longer requires study drug|2|||
27816085|NCT00510510|81158844|FG000|Overall Study|Withdrawal by Subject|1|||
27816086|NCT00510510|81158845|FG001|Overall Study|Withdrawal by Subject|2|||
27816087|NCT00510510|81158846|FG002|Overall Study|Withdrawal by Subject|3|||
27816088|NCT00510510|81158844|FG000|Overall Study|Lost to Follow-up|0|||
27816089|NCT00510510|81158845|FG001|Overall Study|Lost to Follow-up|0|||
27816090|NCT00510510|81158846|FG002|Overall Study|Lost to Follow-up|1|||
27816091|NCT00510510|81158844|FG000|Overall Study|Protocol Violation|0|||
27590017|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
27816092|NCT00510510|81158845|FG001|Overall Study|Protocol Violation|3|||
27816093|NCT00510510|81158846|FG002|Overall Study|Protocol Violation|4|||
27816094|NCT01506947|81158847|FG000|Overall Study|Lost to Follow-up|7|||
27816095|NCT01506947|81158847|FG000|Overall Study|Adverse Event|5|||
27816096|NCT01506947|81158847|FG000|Overall Study|Death|1|||
27590018|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
27590019|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27816097|NCT01506947|81158847|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
27816098|NCT00669864|81158848|FG000|Overall Study|Lost to Follow-up|2|||
27816099|NCT00669864|81158848|FG000|Overall Study|Protocol Violation|2|||
27816100|NCT00669864|81158848|FG000|Overall Study|Withdrawal by Subject|3|||
27816101|NCT00669864|81158848|FG000|Overall Study|Other|2|||
27816102|NCT00408902|81158849|FG000|Overall Study|Lack of Efficacy|7|||
27816103|NCT00408902|81158849|FG000|Overall Study|Adverse Event|3|||
27816104|NCT02928848|81158850|FG000|Arm 2|Withdrawal by Subject|1|||
27816105|NCT02928848|81158851|FG001|Arm 2|Withdrawal by Subject|0|||
27816106|NCT03331042|81158852|FG000|Overall Study|Protocol Violation|1|||
27816107|NCT03331042|81158853|FG001|Overall Study|Protocol Violation|0|||
27816108|NCT03331042|81158854|FG002|Overall Study|Protocol Violation|0|||
27816109|NCT03331042|81158855|FG003|Overall Study|Protocol Violation|0|||
27816110|NCT03331042|81158852|FG000|Overall Study|Physician Decision|0|||
27816111|NCT03331042|81158853|FG001|Overall Study|Physician Decision|0|||
27816112|NCT03331042|81158854|FG002|Overall Study|Physician Decision|1|||
27590020|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590021|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590022|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590023|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590024|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590025|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
27689860|NCT02257567|80702508|FG005|Overall Study|Lost to Follow-up|2|||
27590026|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27689861|NCT02257567|80702509|FG006|Overall Study|Lost to Follow-up|0|||
27689862|NCT02257567|80702510|FG007|Overall Study|Lost to Follow-up|0|||
27689863|NCT02257567|80702511|FG008|Overall Study|Lost to Follow-up|0|||
27689864|NCT02257567|80702512|FG009|Overall Study|Lost to Follow-up|1|||
27816113|NCT03331042|81158855|FG003|Overall Study|Physician Decision|0|||
27590027|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
27816114|NCT03331042|81158852|FG000|Overall Study|Lost to Follow-up|0|||
27816115|NCT03331042|81158853|FG001|Overall Study|Lost to Follow-up|0|||
27689865|NCT02257567|80702513|FG010|Overall Study|Lost to Follow-up|1|||
27701008|NCT03933397|80741293|FG000|Overall Study|No emergency department visit|65|||
27816116|NCT03331042|81158854|FG002|Overall Study|Lost to Follow-up|0|||
27816117|NCT03331042|81158855|FG003|Overall Study|Lost to Follow-up|1|||
27816118|NCT03823300|81158856|FG000|Overall Study|Withdrawal by Subject|16|||
27816119|NCT03823300|81158857|FG001|Overall Study|Withdrawal by Subject|22|||
27816120|NCT03823300|81158856|FG000|Overall Study|Death|10|||
27689866|NCT02257567|80702503|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689867|NCT02257567|80702504|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689868|NCT02257567|80702505|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689869|NCT02257567|80702506|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689870|NCT02257567|80702507|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
27689871|NCT02257567|80702508|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689872|NCT02257567|80702509|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
27701009|NCT03933397|80741294|FG001|Overall Study|No emergency department visit|71|||
27816121|NCT03823300|81158857|FG001|Overall Study|Death|14|||
27816122|NCT03823300|81158856|FG000|Overall Study|Adverse Event|3|||
27816123|NCT03823300|81158857|FG001|Overall Study|Adverse Event|5|||
27816124|NCT03823300|81158856|FG000|Overall Study|Physician Decision|1|||
27816125|NCT03823300|81158857|FG001|Overall Study|Physician Decision|7|||
27816126|NCT03823300|81158856|FG000|Overall Study|Lost to Follow-up|1|||
27816127|NCT03823300|81158857|FG001|Overall Study|Lost to Follow-up|3|||
27816128|NCT03823300|81158856|FG000|Overall Study|Protocol Violation|1|||
27816129|NCT03823300|81158857|FG001|Overall Study|Protocol Violation|1|||
27816130|NCT03823300|81158856|FG000|Overall Study|Lack of Efficacy|1|||
27816131|NCT03823300|81158857|FG001|Overall Study|Lack of Efficacy|1|||
27816132|NCT03823300|81158856|FG000|Overall Study|Not Eligible|0|||
27816133|NCT03823300|81158857|FG001|Overall Study|Not Eligible|1|||
27816134|NCT03823300|81158856|FG000|Overall Study|Other|1|||
27816135|NCT03823300|81158857|FG001|Overall Study|Other|0|||
27816136|NCT02336737|81158858|FG000|Overall Study|Withdrawal by Subject|5|||
27816137|NCT02336737|81158858|FG000|Overall Study|Physician Decision|8|||
27816138|NCT01890915|81158860|FG000|Overall Study|Adverse Event|1|||
27816139|NCT01890915|81158861|FG001|Overall Study|Adverse Event|0|||
27816140|NCT01890915|81158860|FG000|Overall Study|Protocol Violation|2|||
27816141|NCT01890915|81158861|FG001|Overall Study|Protocol Violation|0|||
27816142|NCT01890915|81158860|FG000|Overall Study|Equipment Malfunction|0|||
27816143|NCT01890915|81158861|FG001|Overall Study|Equipment Malfunction|1|||
27816144|NCT03481309|81158862|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
27816145|NCT03481309|81158863|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
27816146|NCT03481309|81158864|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
27816147|NCT03481309|81158865|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
27816148|NCT03481309|81158866|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
27816149|NCT03481309|81158867|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
27816150|NCT01144663|81158868|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
27816151|NCT01144663|81158869|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
27816152|NCT01144663|81158870|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
27816153|NCT01144663|81158871|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
27816154|NCT01144663|81158868|FG000|Primary Vaccination Phase|Adverse Event|1|||
27816155|NCT01144663|81158869|FG001|Primary Vaccination Phase|Adverse Event|0|||
27816156|NCT01144663|81158870|FG002|Primary Vaccination Phase|Adverse Event|0|||
27816157|NCT01144663|81158871|FG003|Primary Vaccination Phase|Adverse Event|1|||
27816158|NCT01144663|81158868|FG000|Primary Vaccination Phase|Protocol Violation|2|||
27816159|NCT01144663|81158869|FG001|Primary Vaccination Phase|Protocol Violation|0|||
27689873|NCT02257567|80702510|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689874|NCT02257567|80702511|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689875|NCT02257567|80702512|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689876|NCT02257567|80702513|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
27689877|NCT02257567|80702503|FG000|Overall Study|Physician Decision|0|||
27689878|NCT02257567|80702504|FG001|Overall Study|Physician Decision|0|||
27689879|NCT02257567|80702505|FG002|Overall Study|Physician Decision|0|||
27689880|NCT02257567|80702506|FG003|Overall Study|Physician Decision|0|||
27689881|NCT02257567|80702507|FG004|Overall Study|Physician Decision|0|||
27689882|NCT02257567|80702508|FG005|Overall Study|Physician Decision|0|||
27689883|NCT02257567|80702509|FG006|Overall Study|Physician Decision|0|||
27689884|NCT02257567|80702510|FG007|Overall Study|Physician Decision|2|||
27689885|NCT02257567|80702511|FG008|Overall Study|Physician Decision|0|||
27689886|NCT02257567|80702512|FG009|Overall Study|Physician Decision|1|||
27689887|NCT02257567|80702513|FG010|Overall Study|Physician Decision|0|||
27689888|NCT02257567|80702503|FG000|Overall Study|Withdrawal by Subject|0|||
27689889|NCT02257567|80702504|FG001|Overall Study|Withdrawal by Subject|0|||
27816160|NCT01144663|81158870|FG002|Primary Vaccination Phase|Protocol Violation|1|||
27689890|NCT02257567|80702505|FG002|Overall Study|Withdrawal by Subject|2|||
27816161|NCT01144663|81158871|FG003|Primary Vaccination Phase|Protocol Violation|0|||
27816162|NCT01144663|81158868|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
27816163|NCT01144663|81158869|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
27816164|NCT01144663|81158870|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
27816165|NCT01144663|81158871|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
27816166|NCT01144663|81158868|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
27816167|NCT01144663|81158869|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
27816168|NCT01144663|81158870|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
27816169|NCT01144663|81158871|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
27816170|NCT01144663|81158868|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
27816171|NCT01144663|81158869|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
27816172|NCT01144663|81158870|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
27816173|NCT01144663|81158871|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
27878600|NCT04176250|81387276|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
27878601|NCT04176250|81387277|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
27689891|NCT02257567|80702506|FG003|Overall Study|Withdrawal by Subject|0|||
27689892|NCT02257567|80702507|FG004|Overall Study|Withdrawal by Subject|0|||
27689893|NCT02257567|80702508|FG005|Overall Study|Withdrawal by Subject|6|||
27816174|NCT01144663|81158868|FG000|Primary Vaccination Phase|Other|0|||
27816175|NCT01144663|81158869|FG001|Primary Vaccination Phase|Other|1|||
27816176|NCT01144663|81158870|FG002|Primary Vaccination Phase|Other|0|||
27689894|NCT02257567|80702509|FG006|Overall Study|Withdrawal by Subject|6|||
27689895|NCT02257567|80702510|FG007|Overall Study|Withdrawal by Subject|6|||
27689896|NCT02257567|80702511|FG008|Overall Study|Withdrawal by Subject|1|||
27689897|NCT02257567|80702512|FG009|Overall Study|Withdrawal by Subject|1|||
27590028|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
27590029|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
27590030|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590031|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590032|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590033|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590034|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590035|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590036|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590037|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590038|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
27590039|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590040|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590041|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590042|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590043|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590044|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590045|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
27689898|NCT02257567|80702513|FG010|Overall Study|Withdrawal by Subject|10|||
27689899|NCT01015560|80702515|FG000|Overall Study|Adverse Event|1|||
27689900|NCT01015560|80702515|FG000|Overall Study|Not protocol specified|1|||
27689901|NCT01015560|80702515|FG000|Overall Study|Withdrawal by Subject|1|||
27689902|NCT01198756|80702516|FG000|Overall Study|Adverse Event|0|||
27689903|NCT01198756|80702517|FG001|Overall Study|Adverse Event|0|||
27689904|NCT01198756|80702518|FG002|Overall Study|Adverse Event|0|||
27689905|NCT01198756|80702519|FG003|Overall Study|Adverse Event|1|||
27689906|NCT01198756|80702516|FG000|Overall Study|Protocol Violation|0|||
27689907|NCT01198756|80702517|FG001|Overall Study|Protocol Violation|0|||
27689908|NCT01198756|80702518|FG002|Overall Study|Protocol Violation|0|||
27689909|NCT01198756|80702519|FG003|Overall Study|Protocol Violation|2|||
27689910|NCT01198756|80702516|FG000|Overall Study|Withdrawal by Subject|9|||
27689911|NCT01198756|80702517|FG001|Overall Study|Withdrawal by Subject|4|||
27689912|NCT01198756|80702518|FG002|Overall Study|Withdrawal by Subject|7|||
27689913|NCT01198756|80702519|FG003|Overall Study|Withdrawal by Subject|5|||
27689914|NCT01198756|80702516|FG000|Overall Study|Lost to Follow-up|29|||
27689915|NCT01198756|80702517|FG001|Overall Study|Lost to Follow-up|36|||
27689916|NCT01198756|80702518|FG002|Overall Study|Lost to Follow-up|23|||
27689917|NCT01198756|80702519|FG003|Overall Study|Lost to Follow-up|18|||
27689918|NCT00195091|80702520|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
27689919|NCT03695237|80702521|FG000|Overall Study|Withdrawal by Subject|1|||
27689920|NCT03695237|80702522|FG001|Overall Study|Withdrawal by Subject|3|||
27689921|NCT03695237|80702521|FG000|Overall Study|Lost to Follow-up|1|||
27689922|NCT03695237|80702522|FG001|Overall Study|Lost to Follow-up|2|||
27689923|NCT03695237|80702521|FG000|Overall Study|Other, Not Specified|8|||
27689924|NCT03695237|80702522|FG001|Overall Study|Other, Not Specified|2|||
27689925|NCT00985153|80702523|FG000|Overall Study|Lost to Follow-up|16|||
27689926|NCT00985153|80702524|FG001|Overall Study|Lost to Follow-up|19|||
27689927|NCT00985153|80702525|FG002|Overall Study|Lost to Follow-up|17|||
27689928|NCT00985153|80702526|FG003|Overall Study|Lost to Follow-up|20|||
27816177|NCT01144663|81158871|FG003|Primary Vaccination Phase|Other|2|||
27816178|NCT01144663|81158868|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
27816179|NCT01144663|81158869|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
27816180|NCT01144663|81158870|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
27590046|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27689929|NCT00985153|80702523|FG000|Overall Study|Protocol Violation|3|||
27689930|NCT00985153|80702524|FG001|Overall Study|Protocol Violation|2|||
27689931|NCT00985153|80702525|FG002|Overall Study|Protocol Violation|4|||
27689932|NCT00985153|80702526|FG003|Overall Study|Protocol Violation|3|||
27689933|NCT00985153|80702523|FG000|Overall Study|Withdrawal by Subject|6|||
27689934|NCT00985153|80702524|FG001|Overall Study|Withdrawal by Subject|11|||
27689935|NCT00985153|80702525|FG002|Overall Study|Withdrawal by Subject|11|||
27689936|NCT00985153|80702526|FG003|Overall Study|Withdrawal by Subject|10|||
27689937|NCT00985153|80702523|FG000|Overall Study|Missed One or More Bleeds|7|||
27689938|NCT00985153|80702524|FG001|Overall Study|Missed One or More Bleeds|7|||
27590047|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590048|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
27590049|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590050|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590051|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590052|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27689939|NCT00985153|80702525|FG002|Overall Study|Missed One or More Bleeds|8|||
27689940|NCT00985153|80702526|FG003|Overall Study|Missed One or More Bleeds|10|||
27689941|NCT00985153|80702523|FG000|Overall Study|Incomplete Safety Follow-up|3|||
27689942|NCT00985153|80702524|FG001|Overall Study|Incomplete Safety Follow-up|5|||
27689943|NCT00985153|80702525|FG002|Overall Study|Incomplete Safety Follow-up|4|||
27689944|NCT00985153|80702526|FG003|Overall Study|Incomplete Safety Follow-up|4|||
27689945|NCT01074216|80702535|FG000|Overall Study|Physician Decision|1|||
27689946|NCT01074216|80702535|FG000|Overall Study|Not Treated|12|||
27689947|NCT02366468|80702536|FG000|Overall Study|Adverse Event|2|||
27689948|NCT02366468|80702537|FG001|Overall Study|Adverse Event|0|||
27689949|NCT02366468|80702536|FG000|Overall Study|Withdrawal by Subject|1|||
27689950|NCT02366468|80702537|FG001|Overall Study|Withdrawal by Subject|5|||
27689951|NCT02366468|80702536|FG000|Overall Study|Lost to Follow-up|2|||
27689952|NCT02366468|80702537|FG001|Overall Study|Lost to Follow-up|0|||
27689953|NCT02366468|80702536|FG000|Overall Study|Death|1|||
27689954|NCT02366468|80702537|FG001|Overall Study|Death|2|||
27689955|NCT02366468|80702536|FG000|Overall Study|Other|0|||
27689956|NCT02366468|80702537|FG001|Overall Study|Other|2|||
27689957|NCT00816400|80702546|FG000|Overall Study|Death|2|||
27689958|NCT00816400|80702547|FG001|Overall Study|Death|3|||
27689959|NCT00816400|80702548|FG002|Overall Study|Death|3|||
27689960|NCT00816400|80702549|FG003|Overall Study|Death|3|||
27689961|NCT00816400|80702550|FG004|Overall Study|Death|2|||
27689962|NCT00816400|80702551|FG005|Overall Study|Death|3|||
27689963|NCT00816400|80702552|FG006|Overall Study|Death|2|||
27689964|NCT00816400|80702553|FG007|Overall Study|Death|5|||
27689965|NCT00816400|80702554|FG008|Overall Study|Death|6|||
27816181|NCT01144663|81158871|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
27816182|NCT01144663|81158868|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
27816183|NCT01144663|81158869|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
27816184|NCT01144663|81158870|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
27816185|NCT01144663|81158871|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
27816186|NCT01144663|81158868|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
27816187|NCT01144663|81158869|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
27816188|NCT01144663|81158870|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
27816189|NCT01144663|81158871|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
27816190|NCT01144663|81158868|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
27816191|NCT01144663|81158869|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
27816192|NCT01144663|81158870|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
27816193|NCT01144663|81158871|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
27816194|NCT01144663|81158868|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
27816195|NCT01144663|81158869|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
27816196|NCT01144663|81158870|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
27816197|NCT01144663|81158871|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
27816198|NCT01144663|81158868|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
27816199|NCT01144663|81158869|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
27816200|NCT01144663|81158870|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
27689966|NCT00816400|80702546|FG000|Overall Study|In hospice care at the end of the study|0|||
27689967|NCT00816400|80702547|FG001|Overall Study|In hospice care at the end of the study|0|||
27816201|NCT01144663|81158871|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
27689968|NCT00816400|80702548|FG002|Overall Study|In hospice care at the end of the study|2|||
27689969|NCT00816400|80702549|FG003|Overall Study|In hospice care at the end of the study|0|||
27689970|NCT00816400|80702550|FG004|Overall Study|In hospice care at the end of the study|0|||
27689971|NCT00816400|80702551|FG005|Overall Study|In hospice care at the end of the study|0|||
27689972|NCT00816400|80702552|FG006|Overall Study|In hospice care at the end of the study|0|||
27689973|NCT00816400|80702553|FG007|Overall Study|In hospice care at the end of the study|0|||
27689974|NCT00816400|80702554|FG008|Overall Study|In hospice care at the end of the study|0|||
27689975|NCT02706899|80702558|FG000|Overall Study|Withdrawal by Subject|1|||
27689976|NCT02706899|80702559|FG001|Overall Study|Withdrawal by Subject|0|||
27689977|NCT02706899|80702558|FG000|Overall Study|Death|8|||
27816202|NCT01694485|81158872|FG000|Overall Study|Withdrawal by Subject|20|||
27816203|NCT01694485|81158873|FG001|Overall Study|Withdrawal by Subject|6|||
27816204|NCT01694485|81158874|FG002|Overall Study|Withdrawal by Subject|7|||
27816205|NCT01694485|81158875|FG003|Overall Study|Withdrawal by Subject|25|||
27816206|NCT01694485|81158876|FG004|Overall Study|Withdrawal by Subject|18|||
27816207|NCT01694485|81158872|FG000|Overall Study|Sponsor Decision|3|||
27816208|NCT01694485|81158873|FG001|Overall Study|Sponsor Decision|0|||
27816209|NCT01694485|81158874|FG002|Overall Study|Sponsor Decision|0|||
27816210|NCT01694485|81158875|FG003|Overall Study|Sponsor Decision|2|||
27816211|NCT01694485|81158876|FG004|Overall Study|Sponsor Decision|0|||
27816212|NCT01694485|81158872|FG000|Overall Study|Lost to Follow-up|9|||
27816213|NCT01694485|81158873|FG001|Overall Study|Lost to Follow-up|1|||
27816214|NCT01694485|81158874|FG002|Overall Study|Lost to Follow-up|6|||
27816215|NCT01694485|81158875|FG003|Overall Study|Lost to Follow-up|10|||
27689978|NCT02706899|80702559|FG001|Overall Study|Death|0|||
27689979|NCT02706899|80702558|FG000|Overall Study|Study Termination by Sponsor|4|||
27816216|NCT01694485|81158876|FG004|Overall Study|Lost to Follow-up|7|||
27816217|NCT01694485|81158872|FG000|Overall Study|Death|1|||
27689980|NCT02706899|80702559|FG001|Overall Study|Study Termination by Sponsor|6|||
27689981|NCT02390245|80702560|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
27689982|NCT02390245|80702561|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
27689983|NCT02390245|80702562|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
27689984|NCT02390245|80702560|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
27689985|NCT02390245|80702561|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
27689986|NCT02390245|80702562|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
27689987|NCT02407990|80702563|FG000|Overall Study|Death|2|||
27689988|NCT02407990|80702564|FG001|Overall Study|Death|22|||
27689989|NCT02407990|80702565|FG002|Overall Study|Death|23|||
27689990|NCT02407990|80702566|FG003|Overall Study|Death|7|||
27689991|NCT02407990|80702567|FG004|Overall Study|Death|17|||
27689992|NCT02407990|80702568|FG005|Overall Study|Death|16|||
27689993|NCT02407990|80702569|FG006|Overall Study|Death|10|||
27689994|NCT02407990|80702570|FG007|Overall Study|Death|248|||
27689995|NCT02407990|80702563|FG000|Overall Study|Lost to Follow-up|0|||
27689996|NCT02407990|80702564|FG001|Overall Study|Lost to Follow-up|1|||
27689997|NCT02407990|80702565|FG002|Overall Study|Lost to Follow-up|0|||
27689998|NCT02407990|80702566|FG003|Overall Study|Lost to Follow-up|0|||
27689999|NCT02407990|80702567|FG004|Overall Study|Lost to Follow-up|0|||
27690000|NCT02407990|80702568|FG005|Overall Study|Lost to Follow-up|0|||
27690001|NCT02407990|80702569|FG006|Overall Study|Lost to Follow-up|0|||
27690002|NCT02407990|80702570|FG007|Overall Study|Lost to Follow-up|17|||
27690003|NCT02407990|80702563|FG000|Overall Study|Progressive Disease|0|||
27690004|NCT02407990|80702564|FG001|Overall Study|Progressive Disease|0|||
27690005|NCT02407990|80702565|FG002|Overall Study|Progressive Disease|0|||
27690006|NCT02407990|80702566|FG003|Overall Study|Progressive Disease|0|||
27690007|NCT02407990|80702567|FG004|Overall Study|Progressive Disease|0|||
27690008|NCT02407990|80702568|FG005|Overall Study|Progressive Disease|0|||
27690009|NCT02407990|80702569|FG006|Overall Study|Progressive Disease|0|||
27690010|NCT02407990|80702570|FG007|Overall Study|Progressive Disease|1|||
27690011|NCT02407990|80702563|FG000|Overall Study|Withdrawal by Subject|0|||
27690012|NCT02407990|80702564|FG001|Overall Study|Withdrawal by Subject|0|||
27690013|NCT02407990|80702565|FG002|Overall Study|Withdrawal by Subject|0|||
27690014|NCT02407990|80702566|FG003|Overall Study|Withdrawal by Subject|0|||
27690015|NCT02407990|80702567|FG004|Overall Study|Withdrawal by Subject|1|||
27690016|NCT02407990|80702568|FG005|Overall Study|Withdrawal by Subject|0|||
27690017|NCT02407990|80702569|FG006|Overall Study|Withdrawal by Subject|0|||
27690018|NCT02407990|80702570|FG007|Overall Study|Withdrawal by Subject|30|||
27690019|NCT02407990|80702563|FG000|Overall Study|Study Terminated by Sponsor|1|||
27690020|NCT02407990|80702564|FG001|Overall Study|Study Terminated by Sponsor|3|||
27690021|NCT02407990|80702565|FG002|Overall Study|Study Terminated by Sponsor|3|||
27690022|NCT02407990|80702566|FG003|Overall Study|Study Terminated by Sponsor|0|||
27690023|NCT02407990|80702567|FG004|Overall Study|Study Terminated by Sponsor|3|||
27690024|NCT02407990|80702568|FG005|Overall Study|Study Terminated by Sponsor|4|||
27690025|NCT02407990|80702569|FG006|Overall Study|Study Terminated by Sponsor|3|||
27690026|NCT02407990|80702570|FG007|Overall Study|Study Terminated by Sponsor|37|||
27690027|NCT02407990|80702563|FG000|Overall Study|Logistics|0|||
27690028|NCT02407990|80702564|FG001|Overall Study|Logistics|0|||
27690029|NCT02407990|80702565|FG002|Overall Study|Logistics|0|||
27690030|NCT02407990|80702566|FG003|Overall Study|Logistics|0|||
27690031|NCT02407990|80702567|FG004|Overall Study|Logistics|0|||
27690032|NCT02407990|80702568|FG005|Overall Study|Logistics|0|||
27690033|NCT02407990|80702569|FG006|Overall Study|Logistics|0|||
27690034|NCT02407990|80702570|FG007|Overall Study|Logistics|1|||
27690035|NCT02407990|80702563|FG000|Overall Study|Rolled into long-term extension study|0|||
27690036|NCT02407990|80702564|FG001|Overall Study|Rolled into long-term extension study|0|||
27690037|NCT02407990|80702565|FG002|Overall Study|Rolled into long-term extension study|0|||
27690038|NCT02407990|80702566|FG003|Overall Study|Rolled into long-term extension study|0|||
27690039|NCT02407990|80702567|FG004|Overall Study|Rolled into long-term extension study|0|||
27690040|NCT02407990|80702568|FG005|Overall Study|Rolled into long-term extension study|0|||
27690041|NCT02407990|80702569|FG006|Overall Study|Rolled into long-term extension study|0|||
27690042|NCT02407990|80702570|FG007|Overall Study|Rolled into long-term extension study|1|||
27690043|NCT03801915|80702572|FG000|Overall Study|Screen failure|0|||
27690044|NCT03801915|80702573|FG001|Overall Study|Screen failure|0|||
27690045|NCT03801915|80702574|FG002|Overall Study|Screen failure|1|||
27690046|NCT03801915|80702572|FG000|Overall Study|Ineligible|1|||
27690047|NCT03801915|80702573|FG001|Overall Study|Ineligible|0|||
27690048|NCT03801915|80702574|FG002|Overall Study|Ineligible|0|||
27690049|NCT03801915|80702572|FG000|Overall Study|Physician Decision|2|||
27690050|NCT03801915|80702573|FG001|Overall Study|Physician Decision|1|||
27690051|NCT03801915|80702574|FG002|Overall Study|Physician Decision|0|||
27690052|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
27690053|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
27690054|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
27690055|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
27690056|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
27878602|NCT04176250|81387278|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
27878603|NCT04176250|81387279|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
27878604|NCT04176250|81387280|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
27878605|NCT04176250|81387281|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
27878606|NCT04176250|81387276|FG000|Overall Study|Withdrawal by Subject|0|||
27878607|NCT04176250|81387277|FG001|Overall Study|Withdrawal by Subject|0|||
27816218|NCT01694485|81158873|FG001|Overall Study|Death|0|||
27878608|NCT04176250|81387278|FG002|Overall Study|Withdrawal by Subject|0|||
27816219|NCT01694485|81158874|FG002|Overall Study|Death|0|||
27816220|NCT01694485|81158875|FG003|Overall Study|Death|1|||
27816221|NCT01694485|81158876|FG004|Overall Study|Death|0|||
27816222|NCT01984242|81158877|FG000|Overall Study|Death|52|||
27816223|NCT01984242|81158878|FG001|Overall Study|Death|50|||
27816224|NCT01984242|81158879|FG002|Overall Study|Death|52|||
27816225|NCT01984242|81158877|FG000|Overall Study|Withdrawal by Subject|5|||
27816226|NCT01984242|81158878|FG001|Overall Study|Withdrawal by Subject|3|||
27816227|NCT01984242|81158879|FG002|Overall Study|Withdrawal by Subject|10|||
27816228|NCT01984242|81158877|FG000|Overall Study|Physician Decision|0|||
27816229|NCT01984242|81158878|FG001|Overall Study|Physician Decision|0|||
27816230|NCT01984242|81158879|FG002|Overall Study|Physician Decision|1|||
27816231|NCT01984242|81158877|FG000|Overall Study|Lost to Follow-up|4|||
27816232|NCT01984242|81158878|FG001|Overall Study|Lost to Follow-up|0|||
27816233|NCT01984242|81158879|FG002|Overall Study|Lost to Follow-up|3|||
27816234|NCT01984242|81158877|FG000|Overall Study|Sponsor Decision|1|||
27878609|NCT04176250|81387279|FG003|Overall Study|Withdrawal by Subject|0|||
27878610|NCT04176250|81387280|FG004|Overall Study|Withdrawal by Subject|0|||
27878611|NCT04176250|81387281|FG005|Overall Study|Withdrawal by Subject|1|||
27878612|NCT04176250|81387276|FG000|Overall Study|Randomized in error|0|||
27878613|NCT04176250|81387277|FG001|Overall Study|Randomized in error|0|||
27816235|NCT01984242|81158878|FG001|Overall Study|Sponsor Decision|0|||
27816236|NCT01984242|81158879|FG002|Overall Study|Sponsor Decision|0|||
27816237|NCT01984242|81158877|FG000|Overall Study|Non-Compliance|1|||
27816238|NCT01984242|81158878|FG001|Overall Study|Non-Compliance|0|||
27816239|NCT01984242|81158879|FG002|Overall Study|Non-Compliance|0|||
27590053|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590054|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590055|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590056|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590057|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590058|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
27590059|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590060|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590061|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590062|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590063|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590064|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590065|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
27590066|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590067|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590068|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590069|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590070|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590071|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590072|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590073|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590074|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590075|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590076|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590077|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590078|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
27590079|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590080|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590081|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590082|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590083|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590084|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
27590085|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590086|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590087|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590088|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590089|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590090|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590091|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590092|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590093|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590094|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590095|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590096|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590097|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590098|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
27590099|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27816240|NCT01984242|81158877|FG000|Overall Study|Study terminated by Sponsor|38|||
27816241|NCT01984242|81158878|FG001|Overall Study|Study terminated by Sponsor|50|||
27816242|NCT01984242|81158879|FG002|Overall Study|Study terminated by Sponsor|34|||
27816243|NCT01984242|81158877|FG000|Overall Study|Disease Progression|0|||
27816244|NCT01984242|81158878|FG001|Overall Study|Disease Progression|0|||
27590100|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590101|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590102|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590103|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590104|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590105|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
27590106|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590107|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
27590108|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590109|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
27590110|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
27590111|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590112|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590113|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590114|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590115|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590116|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590117|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590118|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
27590119|NCT01490632|80340490|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590120|NCT01490632|80340491|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590121|NCT01490632|80340492|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590122|NCT01490632|80340493|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590123|NCT01490632|80340494|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590124|NCT01490632|80340495|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
27590125|NCT01490632|80340496|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
27590126|NCT01490632|80340497|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
27590127|NCT01490632|80340498|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
27590128|NCT01490632|80340499|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
27590129|NCT01490632|80340500|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
27590130|NCT01490632|80340501|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
27590131|NCT01490632|80340502|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590132|NCT01490632|80340503|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590133|NCT01490632|80340504|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27690057|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
27816245|NCT01984242|81158879|FG002|Overall Study|Disease Progression|1|||
27816246|NCT00810368|81158880|FG000|Overall Study|Lost to Follow-up|4|||
27816247|NCT00810368|81158881|FG001|Overall Study|Lost to Follow-up|2|||
27816248|NCT00810368|81158880|FG000|Overall Study|Lack of Efficacy|2|||
27816249|NCT00810368|81158881|FG001|Overall Study|Lack of Efficacy|0|||
27816250|NCT01479439|81158882|FG000|Overall Study|Adverse Event|1|||
27816251|NCT01479439|81158883|FG001|Overall Study|Adverse Event|0|||
27816252|NCT01479439|81158884|FG002|Overall Study|Adverse Event|0|||
27816253|NCT01479439|81158882|FG000|Overall Study|Lost to Follow-up|0|||
27816254|NCT01479439|81158883|FG001|Overall Study|Lost to Follow-up|1|||
27816255|NCT01479439|81158884|FG002|Overall Study|Lost to Follow-up|0|||
27816256|NCT01479439|81158882|FG000|Overall Study|Protocol Violation|0|||
27816257|NCT01479439|81158883|FG001|Overall Study|Protocol Violation|0|||
27816258|NCT01479439|81158884|FG002|Overall Study|Protocol Violation|2|||
27816259|NCT02114697|81158888|FG000|Overall Study|Study terminated|5|||
27816260|NCT02114697|81158889|FG001|Overall Study|Study terminated|4|||
27816261|NCT00661999|81158890|FG000|Overall Study|Adverse Event|11|||
27878614|NCT04176250|81387278|FG002|Overall Study|Randomized in error|0|||
27878615|NCT04176250|81387279|FG003|Overall Study|Randomized in error|0|||
27878616|NCT04176250|81387280|FG004|Overall Study|Randomized in error|1|||
27878617|NCT04176250|81387281|FG005|Overall Study|Randomized in error|0|||
27878618|NCT00595920|81387282|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
27878619|NCT01067105|81387283|FG000|Overall Study|Adverse Event|14|||
27878620|NCT01067105|81387283|FG000|Overall Study|Protocol Violation|48|||
27878621|NCT01067105|81387283|FG000|Overall Study|Withdrawal by Subject|36|||
27878622|NCT01067105|81387283|FG000|Overall Study|Lost to Follow-up|6|||
27878623|NCT01067105|81387283|FG000|Overall Study|Physician Decision|6|||
27878624|NCT01067105|81387283|FG000|Overall Study|Other|31|||
27878625|NCT00162981|81387284|FG000|Overall Study|Adverse Event|2|||
27878626|NCT00162981|81387285|FG001|Overall Study|Adverse Event|5|||
27878627|NCT00162981|81387284|FG000|Overall Study|Withdrawal by Subject|1|||
27878628|NCT00162981|81387285|FG001|Overall Study|Withdrawal by Subject|1|||
27878629|NCT00162981|81387284|FG000|Overall Study|Physician Decision|1|||
27878630|NCT00162981|81387285|FG001|Overall Study|Physician Decision|0|||
27878631|NCT04231825|81387286|FG000|Overall Study|Protocol Violation|3|||
27878632|NCT04231825|81387287|FG001|Overall Study|Protocol Violation|3|||
27878633|NCT04231825|81387286|FG000|Overall Study|Lost to Follow-up|0|||
27878634|NCT04231825|81387287|FG001|Overall Study|Lost to Follow-up|1|||
27878635|NCT02954601|81387292|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
27878636|NCT02954601|81387293|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
27878637|NCT02954601|81387294|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
27878638|NCT02954601|81387295|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
27878639|NCT04335123|81387296|FG000|Overall Study|Withdrawal by Subject|2|||
27878640|NCT04335123|81387297|FG001|Overall Study|Withdrawal by Subject|0|||
27878641|NCT04335123|81387296|FG000|Overall Study|Physician Decision|2|||
27878642|NCT04335123|81387297|FG001|Overall Study|Physician Decision|0|||
27816262|NCT00661999|81158891|FG001|Overall Study|Adverse Event|5|||
27816263|NCT00661999|81158892|FG002|Overall Study|Adverse Event|8|||
27816264|NCT00661999|81158890|FG000|Overall Study|Death|8|||
27816265|NCT00661999|81158891|FG001|Overall Study|Death|6|||
27816266|NCT00661999|81158892|FG002|Overall Study|Death|3|||
27816267|NCT00661999|81158890|FG000|Overall Study|Other Reasons|5|||
27816268|NCT00661999|81158891|FG001|Overall Study|Other Reasons|12|||
27816269|NCT00661999|81158892|FG002|Overall Study|Other Reasons|23|||
27816270|NCT00661999|81158890|FG000|Overall Study|Withdrawal by Subject|30|||
27816271|NCT00661999|81158891|FG001|Overall Study|Withdrawal by Subject|23|||
27816272|NCT00661999|81158892|FG002|Overall Study|Withdrawal by Subject|14|||
27816273|NCT00661999|81158890|FG000|Overall Study|Alternative Treatment|1|||
27816274|NCT00661999|81158891|FG001|Overall Study|Alternative Treatment|0|||
27816275|NCT00661999|81158892|FG002|Overall Study|Alternative Treatment|0|||
27816276|NCT00661999|81158890|FG000|Overall Study|Other Medical Problems|4|||
27816277|NCT00661999|81158891|FG001|Overall Study|Other Medical Problems|4|||
27816278|NCT00661999|81158892|FG002|Overall Study|Other Medical Problems|9|||
27816279|NCT03464136|81162617|FG000|Overall Study|Lost to Follow-up|5|||
27816280|NCT03464136|81162618|FG001|Overall Study|Lost to Follow-up|8|||
27816281|NCT03464136|81162617|FG000|Overall Study|Withdrawal by Subject|16|||
27816282|NCT03464136|81162618|FG001|Overall Study|Withdrawal by Subject|13|||
27816283|NCT03464136|81162617|FG000|Overall Study|Death|1|||
27816284|NCT03464136|81162618|FG001|Overall Study|Death|0|||
27816285|NCT03464136|81162617|FG000|Overall Study|Other|8|||
27816286|NCT03464136|81162618|FG001|Overall Study|Other|4|||
27816287|NCT01575054|81162619|FG000|Overall Study|Other Reasons|5|||
27816288|NCT01575054|81162620|FG001|Overall Study|Other Reasons|3|||
27816289|NCT01575054|81162619|FG000|Overall Study|Protocol Violation|2|||
27878643|NCT05344560|81387298|FG000|Period 1|Subject out of visit window|1|||
27878644|NCT05344560|81387299|FG001|Period 1|Subject out of visit window|1|||
27878645|NCT05344560|81387298|FG000|Period 2|Covid-19 Related|1|||
27816290|NCT01575054|81162620|FG001|Overall Study|Protocol Violation|1|||
27816291|NCT01575054|81162619|FG000|Overall Study|Personal Reasons|10|||
27816292|NCT01575054|81162620|FG001|Overall Study|Personal Reasons|11|||
27816293|NCT01575054|81162619|FG000|Overall Study|Lost to Follow-up|3|||
27816294|NCT01575054|81162620|FG001|Overall Study|Lost to Follow-up|3|||
27816295|NCT01575054|81162619|FG000|Overall Study|Adverse Event|9|||
27816296|NCT01575054|81162620|FG001|Overall Study|Adverse Event|8|||
27590134|NCT01490632|80340505|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590135|NCT01490632|80340506|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590136|NCT01490632|80340507|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590137|NCT01490632|80340508|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27816297|NCT02799602|81162622|FG000|Overall Study|Protocol Violation|1|||
27816298|NCT02799602|81162623|FG001|Overall Study|Protocol Violation|0|||
27816299|NCT02799602|81162622|FG000|Overall Study|Physician Decision|5|||
27816300|NCT02799602|81162623|FG001|Overall Study|Physician Decision|6|||
27816301|NCT02799602|81162622|FG000|Overall Study|Lost to Follow-up|4|||
27816302|NCT02799602|81162623|FG001|Overall Study|Lost to Follow-up|2|||
27816303|NCT02799602|81162622|FG000|Overall Study|Additional primary malignancy|11|||
27816304|NCT02799602|81162623|FG001|Overall Study|Additional primary malignancy|6|||
27816305|NCT02799602|81162622|FG000|Overall Study|Non-compliance with study drug|14|||
27816306|NCT02799602|81162623|FG001|Overall Study|Non-compliance with study drug|12|||
27816307|NCT02799602|81162622|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
27816308|NCT02799602|81162623|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
27816309|NCT02799602|81162622|FG000|Overall Study|Withdrawal by Subject|26|||
27816310|NCT02799602|81162623|FG001|Overall Study|Withdrawal by Subject|40|||
27816311|NCT02799602|81162622|FG000|Overall Study|Progressive disease - clinical progression|131|||
27816312|NCT02799602|81162623|FG001|Overall Study|Progressive disease - clinical progression|276|||
27816313|NCT02799602|81162622|FG000|Overall Study|Progressive disease - radiological progression|90|||
27816314|NCT02799602|81162623|FG001|Overall Study|Progressive disease - radiological progression|133|||
27816315|NCT02799602|81162622|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
27816316|NCT02799602|81162623|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
27816317|NCT02799602|81162622|FG000|Overall Study|Death|9|||
27816318|NCT02799602|81162623|FG001|Overall Study|Death|5|||
27816319|NCT02799602|81162622|FG000|Overall Study|Other|287|||
27816320|NCT02799602|81162623|FG001|Overall Study|Other|118|||
27816321|NCT02799602|81162622|FG000|Overall Study|Study drug never administered|0|||
27816322|NCT02799602|81162623|FG001|Overall Study|Study drug never administered|3|||
27590138|NCT01490632|80340509|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
27590139|NCT01490632|80340490|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590140|NCT01490632|80340491|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590141|NCT01490632|80340492|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590142|NCT01490632|80340493|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590143|NCT01490632|80340494|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590144|NCT01490632|80340495|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590145|NCT01490632|80340496|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590146|NCT01490632|80340497|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590147|NCT01490632|80340498|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590148|NCT01490632|80340499|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590149|NCT01490632|80340500|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590150|NCT01490632|80340501|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590151|NCT01490632|80340502|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590152|NCT01490632|80340503|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590153|NCT01490632|80340504|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
27590154|NCT01490632|80340505|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
27590155|NCT01490632|80340506|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590156|NCT01490632|80340507|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590157|NCT01490632|80340508|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590158|NCT01490632|80340509|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
27590159|NCT01490632|80340490|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590160|NCT01490632|80340491|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590161|NCT01490632|80340492|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590162|NCT01490632|80340493|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590163|NCT01490632|80340494|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590164|NCT01490632|80340495|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590165|NCT01490632|80340496|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590166|NCT01490632|80340497|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590167|NCT01490632|80340498|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590168|NCT01490632|80340499|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590169|NCT01490632|80340500|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590170|NCT01490632|80340501|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590171|NCT01490632|80340502|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590172|NCT01490632|80340503|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
27590173|NCT01490632|80340504|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27816323|NCT00723554|81162627|FG000|Overall Study|Adverse Event|12|||
27816324|NCT00723554|81162627|FG000|Overall Study|Investigator's judgement|5|||
27816325|NCT00723554|81162627|FG000|Overall Study|Inhaled medication other than iloprost|4|||
27816326|NCT00723554|81162627|FG000|Overall Study|Withdrawal of consent|3|||
27816327|NCT00723554|81162627|FG000|Overall Study|Other|3|||
27816328|NCT00723554|81162627|FG000|Overall Study|Lost to Follow-up|1|||
27816329|NCT00723554|81162627|FG000|Overall Study|Non-compliance|1|||
27816330|NCT01617668|81162628|FG000|Overall Study|Adverse Event|7|||
27816331|NCT01617668|81162629|FG001|Overall Study|Adverse Event|0|||
27816332|NCT01617668|81162630|FG002|Overall Study|Adverse Event|12|||
27816333|NCT01617668|81162631|FG003|Overall Study|Adverse Event|5|||
27816334|NCT01617668|81162628|FG000|Overall Study|Physician Decision|1|||
27590174|NCT01490632|80340505|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590175|NCT01490632|80340506|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27878646|NCT05344560|81387299|FG001|Period 2|Covid-19 Related|0|||
27878647|NCT05344560|81387298|FG000|Period 2|Adverse Event|1|||
27590176|NCT01490632|80340507|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590177|NCT01490632|80340508|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590178|NCT01490632|80340509|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
27590179|NCT01490632|80340490|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590180|NCT01490632|80340491|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590181|NCT01490632|80340492|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27816335|NCT01617668|81162629|FG001|Overall Study|Physician Decision|2|||
27816336|NCT01617668|81162630|FG002|Overall Study|Physician Decision|3|||
27816337|NCT01617668|81162631|FG003|Overall Study|Physician Decision|0|||
27816338|NCT01617668|81162628|FG000|Overall Study|Progressive Disease|4|||
27816339|NCT01617668|81162629|FG001|Overall Study|Progressive Disease|4|||
27816340|NCT01617668|81162630|FG002|Overall Study|Progressive Disease|6|||
27816341|NCT01617668|81162631|FG003|Overall Study|Progressive Disease|9|||
27816342|NCT01617668|81162628|FG000|Overall Study|Subject/guardian decision|1|||
27816343|NCT01617668|81162629|FG001|Overall Study|Subject/guardian decision|3|||
27816344|NCT01617668|81162630|FG002|Overall Study|Subject/guardian decision|2|||
27816345|NCT01617668|81162631|FG003|Overall Study|Subject/guardian decision|1|||
27816346|NCT02536378|81162632|FG000|Overall Study|Physician Decision|0|||
27816347|NCT02536378|81162633|FG001|Overall Study|Physician Decision|2|||
27816348|NCT02536378|81162632|FG000|Overall Study|Withdrawal by Subject|0|||
27878648|NCT05344560|81387299|FG001|Period 2|Adverse Event|0|||
27816349|NCT02536378|81162633|FG001|Overall Study|Withdrawal by Subject|1|||
27816350|NCT02536378|81162632|FG000|Overall Study|Death|1|||
27816351|NCT02536378|81162633|FG001|Overall Study|Death|2|||
27816352|NCT02536378|81162632|FG000|Overall Study|Patient refused further follow up|6|||
27816353|NCT02536378|81162633|FG001|Overall Study|Patient refused further follow up|2|||
27816354|NCT01513551|81162636|FG000|Overall Study|Death|0|||
27816355|NCT01513551|81162637|FG001|Overall Study|Death|1|||
27816356|NCT01513551|81162638|FG002|Overall Study|Death|0|||
27878649|NCT05344560|81387298|FG000|Period 2|Subject out of visit window|1|||
27878650|NCT05344560|81387299|FG001|Period 2|Subject out of visit window|1|||
27816357|NCT01513551|81162636|FG000|Overall Study|Lost to Follow-up|3|||
27816358|NCT01513551|81162637|FG001|Overall Study|Lost to Follow-up|5|||
27816359|NCT01513551|81162638|FG002|Overall Study|Lost to Follow-up|2|||
27816360|NCT01513551|81162636|FG000|Overall Study|Withdrawal by Subject|1|||
27816361|NCT01513551|81162637|FG001|Overall Study|Withdrawal by Subject|0|||
27816362|NCT01513551|81162638|FG002|Overall Study|Withdrawal by Subject|2|||
27816363|NCT01513551|81162636|FG000|Overall Study|Randomized but not vaccinated|0|||
27816364|NCT01513551|81162637|FG001|Overall Study|Randomized but not vaccinated|0|||
27816365|NCT01513551|81162638|FG002|Overall Study|Randomized but not vaccinated|1|||
27816366|NCT00760266|81162639|FG000|Overall Study|Adverse Event|13|||
27690058|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
27690059|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
27690060|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
27690061|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
27690062|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
27690063|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
27816367|NCT00760266|81162640|FG001|Overall Study|Adverse Event|7|||
27816368|NCT00760266|81162639|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27816369|NCT00760266|81162640|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27816370|NCT00760266|81162639|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27816371|NCT00760266|81162640|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27816372|NCT00760266|81162639|FG000|Overall Study|Lack of Efficacy|2|||
27816373|NCT00760266|81162640|FG001|Overall Study|Lack of Efficacy|2|||
27816374|NCT00760266|81162639|FG000|Overall Study|Protocol deviation|2|||
27816375|NCT00760266|81162640|FG001|Overall Study|Protocol deviation|4|||
27816376|NCT00760266|81162639|FG000|Overall Study|Patient withdrew consent|3|||
27816377|NCT00760266|81162640|FG001|Overall Study|Patient withdrew consent|3|||
27816378|NCT00760266|81162639|FG000|Overall Study|Lost to Follow-up|2|||
27816379|NCT00760266|81162640|FG001|Overall Study|Lost to Follow-up|1|||
27816380|NCT00760266|81162639|FG000|Overall Study|Administrative Problems|0|||
27816381|NCT00760266|81162640|FG001|Overall Study|Administrative Problems|1|||
27816382|NCT00243932|81162641|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
27816383|NCT00243932|81162642|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
27816384|NCT00243932|81162643|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
27816385|NCT01513148|81162646|FG000|Overall Study|Protocol Violation|2|||
27816386|NCT01513148|81162647|FG001|Overall Study|Protocol Violation|2|||
27816387|NCT01345019|81162651|FG000|Blinded Treatment Phase|Death|147|||
27816388|NCT01345019|81162652|FG001|Blinded Treatment Phase|Death|137|||
27816389|NCT01345019|81162651|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
27690064|NCT02288247|80702577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
27690065|NCT02288247|80702578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
27690066|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
27690067|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
27690068|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
27690069|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
27816390|NCT01345019|81162652|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
27816391|NCT01345019|81162651|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
27816392|NCT01345019|81162652|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
27816393|NCT01345019|81162651|FG000|Blinded Treatment Phase|Disease Progression|12|||
27816394|NCT01345019|81162652|FG001|Blinded Treatment Phase|Disease Progression|10|||
27816395|NCT01345019|81162651|FG000|Blinded Treatment Phase|Adverse Event|6|||
27816396|NCT01345019|81162652|FG001|Blinded Treatment Phase|Adverse Event|13|||
27816397|NCT01345019|81162651|FG000|Blinded Treatment Phase|Administrative Decision|10|||
27878651|NCT05344560|81387298|FG000|Period 3|Subject out of visit window|1|||
27690070|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
27690071|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
27690072|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
27690073|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
27690074|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
27690075|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
27690076|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
27690077|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
27690078|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
27690079|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
27690080|NCT02288247|80702577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
27690081|NCT02288247|80702578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
27690082|NCT00986973|80702579|FG000|Overall Study|Withdrawn by study team|1|||
27690083|NCT02842827|80702580|FG000|Overall Study|Adverse Event|0|||
27690084|NCT02842827|80702581|FG001|Overall Study|Adverse Event|1|||
27690085|NCT02842827|80702582|FG002|Overall Study|Adverse Event|0|||
27690086|NCT02842827|80702583|FG003|Overall Study|Adverse Event|1|||
27690087|NCT02842827|80702584|FG004|Overall Study|Adverse Event|0|||
27690088|NCT02842827|80702585|FG005|Overall Study|Adverse Event|1|||
27690089|NCT02842827|80702586|FG006|Overall Study|Adverse Event|0|||
27690090|NCT02842827|80702587|FG007|Overall Study|Adverse Event|0|||
27690091|NCT02842827|80702580|FG000|Overall Study|Death|1|||
27690092|NCT02842827|80702581|FG001|Overall Study|Death|0|||
27690093|NCT02842827|80702582|FG002|Overall Study|Death|2|||
27690094|NCT02842827|80702583|FG003|Overall Study|Death|3|||
27690095|NCT02842827|80702584|FG004|Overall Study|Death|2|||
27690096|NCT02842827|80702585|FG005|Overall Study|Death|1|||
27690097|NCT02842827|80702586|FG006|Overall Study|Death|0|||
27690098|NCT02842827|80702587|FG007|Overall Study|Death|4|||
27690099|NCT02842827|80702580|FG000|Overall Study|Physician Decision|1|||
27690100|NCT02842827|80702581|FG001|Overall Study|Physician Decision|3|||
27690101|NCT02842827|80702582|FG002|Overall Study|Physician Decision|0|||
27690102|NCT02842827|80702583|FG003|Overall Study|Physician Decision|0|||
27690103|NCT02842827|80702584|FG004|Overall Study|Physician Decision|1|||
27690104|NCT02842827|80702585|FG005|Overall Study|Physician Decision|4|||
27690105|NCT02842827|80702586|FG006|Overall Study|Physician Decision|2|||
27690106|NCT02842827|80702587|FG007|Overall Study|Physician Decision|1|||
27690107|NCT02842827|80702580|FG000|Overall Study|Protocol Defined Disease Progression|0|||
27690108|NCT02842827|80702581|FG001|Overall Study|Protocol Defined Disease Progression|0|||
27690109|NCT02842827|80702582|FG002|Overall Study|Protocol Defined Disease Progression|0|||
27690110|NCT02842827|80702583|FG003|Overall Study|Protocol Defined Disease Progression|0|||
27690111|NCT02842827|80702584|FG004|Overall Study|Protocol Defined Disease Progression|0|||
27690112|NCT02842827|80702585|FG005|Overall Study|Protocol Defined Disease Progression|1|||
27690113|NCT02842827|80702586|FG006|Overall Study|Protocol Defined Disease Progression|0|||
27690114|NCT02842827|80702587|FG007|Overall Study|Protocol Defined Disease Progression|0|||
27690115|NCT02842827|80702580|FG000|Overall Study|Participant Withdrawal of Consent|1|||
27690116|NCT02842827|80702581|FG001|Overall Study|Participant Withdrawal of Consent|2|||
27690117|NCT02842827|80702582|FG002|Overall Study|Participant Withdrawal of Consent|2|||
27690118|NCT02842827|80702583|FG003|Overall Study|Participant Withdrawal of Consent|2|||
27690119|NCT02842827|80702584|FG004|Overall Study|Participant Withdrawal of Consent|2|||
27690120|NCT02842827|80702585|FG005|Overall Study|Participant Withdrawal of Consent|1|||
27690121|NCT02842827|80702586|FG006|Overall Study|Participant Withdrawal of Consent|2|||
27690122|NCT02842827|80702587|FG007|Overall Study|Participant Withdrawal of Consent|1|||
27690123|NCT00903682|80702590|FG000|Overall Study|Adverse Event|6|||
27878652|NCT05344560|81387299|FG001|Period 3|Subject out of visit window|0|||
27690124|NCT00903682|80702591|FG001|Overall Study|Adverse Event|13|||
27690125|NCT00903682|80702590|FG000|Overall Study|Lost to Follow-up|1|||
27690126|NCT00903682|80702591|FG001|Overall Study|Lost to Follow-up|0|||
27690127|NCT00903682|80702590|FG000|Overall Study|Withdrawal by Subject|5|||
27690128|NCT00903682|80702591|FG001|Overall Study|Withdrawal by Subject|0|||
27690129|NCT00903682|80702590|FG000|Overall Study|Pregnancy|0|||
27690130|NCT00903682|80702591|FG001|Overall Study|Pregnancy|1|||
27878653|NCT01082328|81387300|FG000|Overall Study|Adverse Event|1|||
27878654|NCT03270657|81387305|FG000|Overall Study|Withdrawal by Subject|1|||
27690131|NCT00903682|80702590|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
27690132|NCT00903682|80702591|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
27690133|NCT00903682|80702590|FG000|Overall Study|Subject Non-Compliant|1|||
27690134|NCT00903682|80702591|FG001|Overall Study|Subject Non-Compliant|0|||
27690135|NCT00903682|80702590|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
27690136|NCT00903682|80702591|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
27690137|NCT00903682|80702590|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
27690138|NCT00903682|80702591|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
27690139|NCT03207009|80702592|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
27690140|NCT00825825|80702593|FG000|First Medication Period (14 Days)|Adverse Event|1|||
27690141|NCT00825825|80702594|FG001|First Medication Period (14 Days)|Adverse Event|0|||
27690142|NCT00825825|80702595|FG002|First Medication Period (14 Days)|Adverse Event|0|||
27690143|NCT00825825|80702596|FG003|First Medication Period (14 Days)|Adverse Event|0|||
27690144|NCT00825825|80702597|FG004|First Medication Period (14 Days)|Adverse Event|0|||
27690145|NCT00825825|80702598|FG005|First Medication Period (14 Days)|Adverse Event|1|||
27690146|NCT00825825|80702593|FG000|First Medication Period (14 Days)|Physician Decision|2|||
27690147|NCT00825825|80702594|FG001|First Medication Period (14 Days)|Physician Decision|0|||
27690148|NCT00825825|80702595|FG002|First Medication Period (14 Days)|Physician Decision|1|||
27690149|NCT00825825|80702596|FG003|First Medication Period (14 Days)|Physician Decision|0|||
27690150|NCT00825825|80702597|FG004|First Medication Period (14 Days)|Physician Decision|0|||
27690151|NCT00825825|80702598|FG005|First Medication Period (14 Days)|Physician Decision|1|||
27690152|NCT00825825|80702593|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
27690153|NCT00825825|80702594|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
27690154|NCT00825825|80702595|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
27690155|NCT00825825|80702596|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
27690156|NCT00825825|80702597|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
27690157|NCT00825825|80702598|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
27690158|NCT00825825|80702593|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
27690159|NCT00825825|80702594|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
27690160|NCT00825825|80702595|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
27590182|NCT01490632|80340493|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590183|NCT01490632|80340494|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590184|NCT01490632|80340495|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590185|NCT01490632|80340496|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590186|NCT01490632|80340497|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590187|NCT01490632|80340498|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590188|NCT01490632|80340499|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590189|NCT01490632|80340500|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590190|NCT01490632|80340501|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590191|NCT01490632|80340502|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590192|NCT01490632|80340503|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590193|NCT01490632|80340504|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
27590194|NCT01490632|80340505|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
27590195|NCT01490632|80340506|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590196|NCT01490632|80340507|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590197|NCT01490632|80340508|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590198|NCT01490632|80340509|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
27590199|NCT01490632|80340490|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590200|NCT01490632|80340491|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590201|NCT01490632|80340492|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590202|NCT01490632|80340493|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590203|NCT01490632|80340494|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590204|NCT01490632|80340495|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590205|NCT01490632|80340496|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590206|NCT01490632|80340497|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590207|NCT01490632|80340498|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590208|NCT01490632|80340499|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27690161|NCT00825825|80702596|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
27690162|NCT00825825|80702597|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
27690163|NCT00825825|80702598|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
27690164|NCT00825825|80702593|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
27590209|NCT01490632|80340500|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590210|NCT01490632|80340501|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590211|NCT01490632|80340502|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
27590212|NCT01490632|80340503|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
27590213|NCT01490632|80340504|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
27590214|NCT01490632|80340505|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
27590215|NCT01490632|80340506|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590216|NCT01490632|80340507|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590217|NCT01490632|80340508|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590218|NCT01490632|80340509|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
27590219|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
27590220|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
27590221|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
27590222|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
27590223|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
27590224|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
27590225|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
27590226|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
27590227|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
27590228|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
27590229|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
27590230|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
27590231|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
27590232|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
27590233|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
27590234|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
27590235|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
27590236|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
27590237|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
27590238|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
27590239|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Death|0|||
27590240|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Death|0|||
27590241|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Death|0|||
27590242|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Death|0|||
27590243|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Death|0|||
27590244|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Death|0|||
27590245|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Death|0|||
27590246|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Death|0|||
27590247|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Death|0|||
27590248|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Death|0|||
27590249|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Death|0|||
27590250|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Death|0|||
27590251|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Death|0|||
27590252|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Death|0|||
27590253|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Death|0|||
27590254|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Death|0|||
27590255|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Death|0|||
27590256|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Death|0|||
27590257|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Death|1|||
27590258|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Death|0|||
27590259|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590260|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590261|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590262|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590263|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590264|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590265|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590266|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590267|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590268|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27816398|NCT01345019|81162652|FG001|Blinded Treatment Phase|Administrative Decision|8|||
27690165|NCT00825825|80702594|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
27816399|NCT01345019|81162651|FG000|Blinded Treatment Phase|Noncompliance|5|||
27816400|NCT01345019|81162652|FG001|Blinded Treatment Phase|Noncompliance|3|||
27590269|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590270|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590271|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590272|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590273|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590274|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27816401|NCT01345019|81162651|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
27878655|NCT04387435|81387308|FG000|Overall Study|Physician Decision|1|||
27878656|NCT02626026|81387309|FG000|Overall Study|Randomized but Never Treated|0|||
27878657|NCT02626026|81387310|FG001|Overall Study|Randomized but Never Treated|0|||
27878658|NCT02626026|81387311|FG002|Overall Study|Randomized but Never Treated|0|||
27878659|NCT02626026|81387312|FG003|Overall Study|Randomized but Never Treated|0|||
27878660|NCT02626026|81387313|FG004|Overall Study|Randomized but Never Treated|1|||
27878661|NCT02626026|81387314|FG005|Overall Study|Randomized but Never Treated|0|||
27878662|NCT03922308|81387316|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
27878663|NCT03922308|81387317|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
27690166|NCT00825825|80702595|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
27690167|NCT00825825|80702596|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
27690168|NCT00825825|80702597|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
27690169|NCT00825825|80702598|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
27690170|NCT00825825|80702593|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
27690171|NCT00825825|80702594|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
27690172|NCT00825825|80702595|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
27690173|NCT00825825|80702596|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
27690174|NCT00825825|80702597|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
27690175|NCT00825825|80702598|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
27690176|NCT00825825|80702593|FG000|Third Medication Period (14 Days)|poor data quality|0|||
27690177|NCT00825825|80702594|FG001|Third Medication Period (14 Days)|poor data quality|1|||
27690178|NCT00825825|80702595|FG002|Third Medication Period (14 Days)|poor data quality|0|||
27690179|NCT00825825|80702596|FG003|Third Medication Period (14 Days)|poor data quality|0|||
27690180|NCT00825825|80702597|FG004|Third Medication Period (14 Days)|poor data quality|0|||
27690181|NCT00825825|80702598|FG005|Third Medication Period (14 Days)|poor data quality|0|||
27690182|NCT01022268|80702601|FG000|Overall Study|Withdrawal by Subject|1|||
27816402|NCT01345019|81162652|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
27816403|NCT01345019|81162651|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
27816404|NCT01345019|81162652|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
27816405|NCT01345019|81162651|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
27816406|NCT01345019|81162652|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
27816407|NCT01345019|81162651|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
27816408|NCT01345019|81162652|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
27816409|NCT01345019|81162651|FG000|Open Label Treatment Phase|Death|49|||
27816410|NCT01345019|81162652|FG001|Open Label Treatment Phase|Death|48|||
27816411|NCT01345019|81162651|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
27816412|NCT01345019|81162652|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
27816413|NCT01345019|81162651|FG000|Open Label Treatment Phase|Adverse Event|30|||
27816414|NCT01345019|81162652|FG001|Open Label Treatment Phase|Adverse Event|51|||
27690183|NCT01022268|80702602|FG001|Overall Study|Withdrawal by Subject|0|||
27816415|NCT01345019|81162651|FG000|Open Label Treatment Phase|Administrative Decision|30|||
27590275|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
27590276|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
27590277|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
27590278|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
27590279|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590280|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590281|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590282|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590283|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590284|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590285|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27878664|NCT03922308|81387318|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
27878665|NCT03922308|81387316|FG000|Overall Study|Lost to Follow-up|1|||
27878666|NCT03922308|81387317|FG001|Overall Study|Lost to Follow-up|0|||
27878667|NCT03922308|81387318|FG002|Overall Study|Lost to Follow-up|0|||
27878668|NCT03922308|81387316|FG000|Overall Study|Reason not Specified|0|||
27878669|NCT03922308|81387317|FG001|Overall Study|Reason not Specified|2|||
27878670|NCT03922308|81387318|FG002|Overall Study|Reason not Specified|1|||
27878671|NCT05966584|81387319|FG000|Overall Study|Lost to Follow-up|1|||
27878672|NCT01383707|81387320|FG000|Overall Study|Consent withdrawal|6|||
27878673|NCT01383707|81387320|FG000|Overall Study|Death|19|||
27878674|NCT01383707|81387320|FG000|Overall Study|Other|8|||
27878675|NCT01383707|81387320|FG000|Overall Study|Sponsor's decision|2|||
27878676|NCT01383707|81387320|FG000|Overall Study|Adverse Event|14|||
27878677|NCT01383707|81387320|FG000|Overall Study|Progressive disease|23|||
27878678|NCT00734994|81387323|FG000|Overall Study|Withdrawal by Subject|1|||
27878679|NCT01831635|81387324|FG000|Overall Study|Withdrawal by Subject|0|||
27878680|NCT01831635|81387325|FG001|Overall Study|Withdrawal by Subject|2|||
27878681|NCT01831635|81387326|FG002|Overall Study|Withdrawal by Subject|0|||
27878682|NCT01343043|81387327|FG000|Overall Study|Disease progression before treatment|1|||
27878683|NCT01343043|81387328|FG001|Overall Study|Disease progression before treatment|0|||
27878684|NCT01343043|81387329|FG002|Overall Study|Disease progression before treatment|0|||
27878685|NCT01343043|81387330|FG003|Overall Study|Disease progression before treatment|0|||
27878686|NCT01343043|81387327|FG000|Overall Study|Withdrawal by Subject|1|||
27878687|NCT01343043|81387328|FG001|Overall Study|Withdrawal by Subject|0|||
27878688|NCT01343043|81387329|FG002|Overall Study|Withdrawal by Subject|0|||
27878689|NCT01343043|81387330|FG003|Overall Study|Withdrawal by Subject|0|||
27878690|NCT01343043|81387327|FG000|Overall Study|Death|1|||
27590286|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590287|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590288|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590289|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590290|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590291|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590292|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590293|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590294|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590295|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590296|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590297|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
27878691|NCT01343043|81387328|FG001|Overall Study|Death|1|||
27878692|NCT01343043|81387329|FG002|Overall Study|Death|0|||
27878693|NCT01343043|81387330|FG003|Overall Study|Death|1|||
27878694|NCT03926117|81387331|FG000|Overall Study|Unclassified|1|||
27878695|NCT03926117|81387332|FG001|Overall Study|Unclassified|4|||
27878696|NCT03926117|81387333|FG002|Overall Study|Unclassified|1|||
27878697|NCT03926117|81387334|FG003|Overall Study|Unclassified|4|||
27878698|NCT03926117|81387331|FG000|Overall Study|Withdrawal by Subject|3|||
27878699|NCT03926117|81387332|FG001|Overall Study|Withdrawal by Subject|0|||
27878700|NCT03926117|81387333|FG002|Overall Study|Withdrawal by Subject|1|||
27878701|NCT03926117|81387334|FG003|Overall Study|Withdrawal by Subject|1|||
27878702|NCT03926117|81387331|FG000|Overall Study|Lost to Follow-up|0|||
27878703|NCT03926117|81387332|FG001|Overall Study|Lost to Follow-up|2|||
27878704|NCT03926117|81387333|FG002|Overall Study|Lost to Follow-up|1|||
27590298|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
27590299|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
27590300|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
27590301|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
27878705|NCT03926117|81387334|FG003|Overall Study|Lost to Follow-up|0|||
27878706|NCT03926117|81387331|FG000|Overall Study|Adverse Event|1|||
27878707|NCT03926117|81387332|FG001|Overall Study|Adverse Event|2|||
27878708|NCT03926117|81387333|FG002|Overall Study|Adverse Event|3|||
27878709|NCT03926117|81387334|FG003|Overall Study|Adverse Event|1|||
27878710|NCT03926117|81387331|FG000|Overall Study|Randomized but not treated|1|||
27878711|NCT03926117|81387332|FG001|Overall Study|Randomized but not treated|1|||
27690184|NCT01022268|80702601|FG000|Overall Study|Withdrawal by Subject|1|||
27690185|NCT01022268|80702602|FG001|Overall Study|Withdrawal by Subject|0|||
27878712|NCT03926117|81387333|FG002|Overall Study|Randomized but not treated|0|||
27878713|NCT03926117|81387334|FG003|Overall Study|Randomized but not treated|1|||
27878714|NCT02042014|81387339|FG000|Overall Study|Adverse Event|1|||
27878715|NCT02042014|81387339|FG000|Overall Study|Physician Decision|7|||
27878716|NCT00513695|81387343|FG000|Overall Study|Discontinued therapy|2|||
27878717|NCT00513695|81387343|FG000|Overall Study|Progression prior to surgery|3|||
27878718|NCT03570619|81387346|FG000|Overall Study|Adverse Event|2|||
27878719|NCT03570619|81387347|FG001|Overall Study|Adverse Event|0|||
27878720|NCT03570619|81387348|FG002|Overall Study|Adverse Event|1|||
27878721|NCT03570619|81387346|FG000|Overall Study|new diagnosis of new malignancy|1|||
27878722|NCT03570619|81387347|FG001|Overall Study|new diagnosis of new malignancy|0|||
27878723|NCT03570619|81387348|FG002|Overall Study|new diagnosis of new malignancy|0|||
27878724|NCT03570619|81387346|FG000|Overall Study|Physician Decision|1|||
27878725|NCT03570619|81387347|FG001|Overall Study|Physician Decision|1|||
27878726|NCT03570619|81387348|FG002|Overall Study|Physician Decision|0|||
27878727|NCT03570619|81387346|FG000|Overall Study|Withdrawal by Subject|0|||
27816416|NCT01345019|81162652|FG001|Open Label Treatment Phase|Administrative Decision|15|||
27690186|NCT00473265|80702603|FG000|Overall Study|Unrelated adverse event|5|||
27690187|NCT00473265|80702603|FG000|Overall Study|Off treatment early|15|||
27690188|NCT02374671|80702604|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
27690189|NCT02374671|80702605|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
27690190|NCT02374671|80702606|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
27690191|NCT02374671|80702604|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
27690192|NCT02374671|80702605|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
27816417|NCT01345019|81162651|FG000|Open Label Treatment Phase|Disease Progression|17|||
27816418|NCT01345019|81162652|FG001|Open Label Treatment Phase|Disease Progression|18|||
27816419|NCT01345019|81162651|FG000|Open Label Treatment Phase|Noncompliance|5|||
27816420|NCT01345019|81162652|FG001|Open Label Treatment Phase|Noncompliance|4|||
27816421|NCT01345019|81162651|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
27816422|NCT01345019|81162652|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
27816423|NCT01345019|81162651|FG000|Open Label Treatment Phase|Pregnancy|1|||
27816424|NCT01345019|81162652|FG001|Open Label Treatment Phase|Pregnancy|0|||
27816425|NCT01345019|81162651|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
27816426|NCT01345019|81162652|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
27816427|NCT01345019|81162651|FG000|Open Label Treatment Phase|Protocol Violation|0|||
27816428|NCT01345019|81162652|FG001|Open Label Treatment Phase|Protocol Violation|1|||
27816429|NCT01666730|81162653|FG000|Overall Study|Adverse Event|16|||
27816430|NCT01666730|81162653|FG000|Overall Study|Death|2|||
27816431|NCT01666730|81162653|FG000|Overall Study|Physician Decision|5|||
27816432|NCT01666730|81162653|FG000|Overall Study|Withdrawal by Subject|9|||
27816433|NCT01666730|81162653|FG000|Overall Study|Disease progression/relapse|18|||
27816434|NCT02207231|81162654|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
27816435|NCT02207231|81162655|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
27816436|NCT02207231|81162656|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
27816437|NCT02207231|81162657|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
27878728|NCT03570619|81387347|FG001|Overall Study|Withdrawal by Subject|2|||
27878729|NCT03570619|81387348|FG002|Overall Study|Withdrawal by Subject|0|||
27878730|NCT00703157|81387349|FG000|Overall Study|Lost to Follow-up|0|||
27878731|NCT00703157|81387350|FG001|Overall Study|Lost to Follow-up|1|||
27878732|NCT00703157|81387349|FG000|Overall Study|source data permanently lost/ other|4|||
27878733|NCT00703157|81387350|FG001|Overall Study|source data permanently lost/ other|1|||
27878734|NCT01435460|81387361|FG000|Overall Study|Adverse Event|2|||
27878735|NCT01435460|81387362|FG001|Overall Study|Adverse Event|1|||
27878736|NCT01435460|81387361|FG000|Overall Study|Lost to Follow-up|6|||
27878737|NCT01435460|81387362|FG001|Overall Study|Lost to Follow-up|1|||
27878738|NCT01435460|81387361|FG000|Overall Study|Withdrawal by Subject|1|||
27878739|NCT01435460|81387362|FG001|Overall Study|Withdrawal by Subject|3|||
27690193|NCT02374671|80702606|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
27816438|NCT02207231|81162654|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
27816439|NCT02207231|81162655|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
27816440|NCT02207231|81162656|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
27878740|NCT01435460|81387361|FG000|Overall Study|Protocol Violation|0|||
27878741|NCT01435460|81387362|FG001|Overall Study|Protocol Violation|1|||
27690194|NCT02374671|80702604|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
27690195|NCT02374671|80702605|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
27816441|NCT02207231|81162657|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
27878742|NCT01435460|81387361|FG000|Overall Study|Did not meet eligibility criteria|2|||
27878743|NCT01435460|81387362|FG001|Overall Study|Did not meet eligibility criteria|0|||
27878744|NCT03749330|81387363|FG000|Overall Study|Clinicians left work in the CICU|0|||
27878745|NCT03749330|81387364|FG001|Overall Study|Clinicians left work in the CICU|2|||
27878746|NCT03749330|81387365|FG002|Overall Study|Clinicians left work in the CICU|0|||
27816442|NCT02207231|81162654|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
27816443|NCT02207231|81162655|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
27816444|NCT02207231|81162656|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
27816445|NCT02207231|81162657|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
27816446|NCT02207231|81162654|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
27816447|NCT02207231|81162655|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
27816448|NCT02207231|81162656|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
27816449|NCT02207231|81162657|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
27816450|NCT02207231|81162654|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
27816451|NCT02207231|81162655|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
27816452|NCT02207231|81162656|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
27816453|NCT02207231|81162657|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
27816454|NCT02207231|81162654|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
27816455|NCT02207231|81162655|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
27816456|NCT02207231|81162656|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
27816457|NCT02207231|81162657|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
27816458|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
27690196|NCT02374671|80702606|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
27690197|NCT02374671|80702604|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
27690198|NCT02374671|80702605|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
27690199|NCT02374671|80702606|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
27690200|NCT02374671|80702604|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
27690201|NCT02374671|80702605|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
27690202|NCT02374671|80702606|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
27690203|NCT02729753|80702607|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
27690204|NCT02729753|80702608|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
27690205|NCT00605215|80702609|FG000|Overall Study|Death|0|||
27816459|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
27816460|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
27816461|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
27816462|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
27816463|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
27816464|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
27816465|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
27816466|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
27816467|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
27816468|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
27816469|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
27878747|NCT03749330|81387366|FG003|Overall Study|Clinicians left work in the CICU|0|||
27878748|NCT03749330|81387367|FG004|Overall Study|Clinicians left work in the CICU|0|||
27878749|NCT03749330|81387368|FG005|Overall Study|Clinicians left work in the CICU|0|||
27590302|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
27590303|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
27690206|NCT00605215|80702610|FG001|Overall Study|Death|0|||
27816470|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
27816471|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
27816472|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
27816473|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
27816474|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
27816475|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
27816476|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
27816477|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
27816478|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
27816479|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
27816480|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
27816481|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
27816482|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
27816483|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
27816484|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
27816485|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
27816486|NCT02207231|81162654|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
27816487|NCT02207231|81162655|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
27816488|NCT02207231|81162656|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
27878750|NCT00856193|81387369|FG000|Period 2|Abnormal test procedure results|0|||
27690207|NCT00605215|80702611|FG002|Overall Study|Death|1|||
27816489|NCT02207231|81162657|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
27816490|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
27590304|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
27590305|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
27590306|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
27816491|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
27816492|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
27816493|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
27816494|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
27816495|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
27816496|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
27816497|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
27816498|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
27816499|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
27816500|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
27816501|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
27816502|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
27816503|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
27816504|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
27816505|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
27816506|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
27816507|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
27816508|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
27816509|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
27816510|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
27816511|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
27816512|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
27816513|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
27816514|NCT02207231|81162654|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
27816515|NCT02207231|81162655|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
27816516|NCT02207231|81162656|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
27816517|NCT02207231|81162657|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
27816518|NCT00977106|81162658|FG000|Overall Study|Adverse Event|5|||
27816519|NCT00977106|81162659|FG001|Overall Study|Adverse Event|6|||
27816520|NCT00977106|81162658|FG000|Overall Study|Withdrawal by Subject|2|||
27816521|NCT00977106|81162659|FG001|Overall Study|Withdrawal by Subject|2|||
27816522|NCT00977106|81162658|FG000|Overall Study|Lack of Efficacy|2|||
27816523|NCT00977106|81162659|FG001|Overall Study|Lack of Efficacy|2|||
27816524|NCT00977106|81162658|FG000|Overall Study|Protocol Violation|0|||
27816525|NCT00977106|81162659|FG001|Overall Study|Protocol Violation|1|||
27816526|NCT00977106|81162658|FG000|Overall Study|Other|1|||
27816527|NCT00977106|81162659|FG001|Overall Study|Other|0|||
27816528|NCT01256684|81162660|FG000|Overall Study|Adverse Event|1|||
27816529|NCT01256684|81162661|FG001|Overall Study|Adverse Event|4|||
27816530|NCT01256684|81162662|FG002|Overall Study|Adverse Event|2|||
27816531|NCT01256684|81162660|FG000|Overall Study|Withdrawal by Subject|4|||
27816532|NCT01256684|81162661|FG001|Overall Study|Withdrawal by Subject|0|||
27816533|NCT01256684|81162662|FG002|Overall Study|Withdrawal by Subject|2|||
27816534|NCT01256684|81162660|FG000|Overall Study|Physician Decision|0|||
27816535|NCT01256684|81162661|FG001|Overall Study|Physician Decision|1|||
27816536|NCT01256684|81162662|FG002|Overall Study|Physician Decision|0|||
27816537|NCT01256684|81162660|FG000|Overall Study|Lack of Efficacy|0|||
27816538|NCT01256684|81162661|FG001|Overall Study|Lack of Efficacy|1|||
27816539|NCT01256684|81162662|FG002|Overall Study|Lack of Efficacy|1|||
27816540|NCT01256684|81162660|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
27816541|NCT01256684|81162661|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
27816542|NCT01256684|81162662|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
27816543|NCT03019965|81162663|FG000|Overall Study|Withdrawal by Subject|1|||
27816544|NCT03019965|81162664|FG001|Overall Study|Withdrawal by Subject|0|||
27816545|NCT03019965|81162663|FG000|Overall Study|Protocol Violation|1|||
27816546|NCT03019965|81162664|FG001|Overall Study|Protocol Violation|3|||
27878751|NCT00856193|81387370|FG001|Period 2|Abnormal test procedure results|1|||
27590307|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
27590308|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
27590309|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
27816547|NCT03019965|81162663|FG000|Overall Study|viral or fungal infection|3|||
27816548|NCT03019965|81162664|FG001|Overall Study|viral or fungal infection|4|||
27816549|NCT03019965|81162663|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
27878752|NCT00856193|81387369|FG000|Period 2|Lost to Follow-up|0|||
27878753|NCT00856193|81387370|FG001|Period 2|Lost to Follow-up|1|||
27878754|NCT00984542|81387379|FG000|Overall Study|disease progression|19|||
27816550|NCT03019965|81162664|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
27816551|NCT03019965|81162663|FG000|Overall Study|Physician Decision|1|||
27816552|NCT03019965|81162664|FG001|Overall Study|Physician Decision|1|||
27816553|NCT00824265|81162665|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
27816554|NCT00824265|81162666|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
27816555|NCT00824265|81162665|FG000|Treatment Phase|Protocol Violation|1|||
27816556|NCT00824265|81162666|FG001|Treatment Phase|Protocol Violation|0|||
27816557|NCT00824265|81162665|FG000|Treatment Phase|Lost to Follow-up|1|||
27816558|NCT00824265|81162666|FG001|Treatment Phase|Lost to Follow-up|1|||
27816559|NCT00824265|81162665|FG000|Treatment Phase|Physician Decision|6|||
27816560|NCT00824265|81162666|FG001|Treatment Phase|Physician Decision|12|||
27816561|NCT00824265|81162665|FG000|Treatment Phase|Withdrawal by Subject|6|||
27816562|NCT00824265|81162666|FG001|Treatment Phase|Withdrawal by Subject|15|||
27816563|NCT00824265|81162665|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
27816564|NCT00824265|81162666|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
27816565|NCT00824265|81162665|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
27816566|NCT00824265|81162666|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
27590310|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
27590311|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
27590312|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
27816567|NCT03194464|81162667|FG000|Overall Study|data not usable|2|||
27816568|NCT05546411|81162671|FG000|Overall Study|Progressive Disease|1|||
27816569|NCT05546411|81162672|FG001|Overall Study|Progressive Disease|0|||
27816570|NCT05546411|81162671|FG000|Overall Study|Adverse Event|0|||
27878755|NCT00984542|81387379|FG000|Overall Study|toxicity|7|||
27878756|NCT00984542|81387379|FG000|Overall Study|Death|7|||
27878757|NCT00984542|81387379|FG000|Overall Study|complicating disease|3|||
27878758|NCT00984542|81387379|FG000|Overall Study|Withdrawal by Subject|3|||
27878759|NCT00984542|81387379|FG000|Overall Study|clinical deterioration|2|||
27878760|NCT02509507|81387380|FG000|Overall Study|Death|21|||
27878761|NCT02509507|81387381|FG001|Overall Study|Death|3|||
27878762|NCT02509507|81387382|FG002|Overall Study|Death|22|||
27878763|NCT02509507|81387383|FG003|Overall Study|Death|14|||
27878764|NCT02509507|81387384|FG004|Overall Study|Death|8|||
27878765|NCT02509507|81387385|FG005|Overall Study|Death|12|||
27878766|NCT02509507|81387386|FG006|Overall Study|Death|5|||
27878767|NCT02509507|81387387|FG007|Overall Study|Death|4|||
27878768|NCT02509507|81387388|FG008|Overall Study|Death|8|||
27878769|NCT02509507|81387380|FG000|Overall Study|Lost to Follow-up|0|||
27878770|NCT02509507|81387381|FG001|Overall Study|Lost to Follow-up|1|||
27878771|NCT02509507|81387382|FG002|Overall Study|Lost to Follow-up|0|||
27878772|NCT02509507|81387383|FG003|Overall Study|Lost to Follow-up|0|||
27878773|NCT02509507|81387384|FG004|Overall Study|Lost to Follow-up|0|||
27878774|NCT02509507|81387385|FG005|Overall Study|Lost to Follow-up|2|||
27878775|NCT02509507|81387386|FG006|Overall Study|Lost to Follow-up|0|||
27878776|NCT02509507|81387387|FG007|Overall Study|Lost to Follow-up|0|||
27878777|NCT02509507|81387388|FG008|Overall Study|Lost to Follow-up|0|||
27878778|NCT02509507|81387380|FG000|Overall Study|Withdrawal by Subject|2|||
27878779|NCT02509507|81387381|FG001|Overall Study|Withdrawal by Subject|0|||
27878780|NCT02509507|81387382|FG002|Overall Study|Withdrawal by Subject|1|||
27878781|NCT02509507|81387383|FG003|Overall Study|Withdrawal by Subject|4|||
27590313|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
27590314|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
27590315|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
27590316|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
27590317|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
27590318|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
27590319|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
27590320|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
27590321|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
27590322|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
27590323|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
27590324|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
27590325|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
27690208|NCT00605215|80702609|FG000|Overall Study|Adverse Event|19|||
27816571|NCT05546411|81162672|FG001|Overall Study|Adverse Event|1|||
27816572|NCT05546411|81162671|FG000|Overall Study|Metastatic disease|1|||
27816573|NCT05546411|81162672|FG001|Overall Study|Metastatic disease|0|||
27816574|NCT02116803|81162673|FG000|Overall Study|Adverse Event|2|||
27816575|NCT02116803|81162674|FG001|Overall Study|Adverse Event|1|||
27816576|NCT02116803|81162673|FG000|Overall Study|Physician Decision|1|||
27816577|NCT02116803|81162674|FG001|Overall Study|Physician Decision|0|||
27816578|NCT02116803|81162673|FG000|Overall Study|Progressive disease|4|||
27590326|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
27590327|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
27878782|NCT02509507|81387384|FG004|Overall Study|Withdrawal by Subject|1|||
27590328|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
27878783|NCT02509507|81387385|FG005|Overall Study|Withdrawal by Subject|3|||
27590329|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
27816579|NCT02116803|81162674|FG001|Overall Study|Progressive disease|0|||
27816580|NCT02116803|81162673|FG000|Overall Study|Study terminated by sponsor|2|||
27816581|NCT02116803|81162674|FG001|Overall Study|Study terminated by sponsor|1|||
27816582|NCT02116803|81162673|FG000|Overall Study|Death|1|||
27816583|NCT02116803|81162674|FG001|Overall Study|Death|0|||
27690209|NCT00605215|80702610|FG001|Overall Study|Adverse Event|21|||
27816584|NCT03679741|81162676|FG000|Period 1|No longer meet eligibility criteria|1|||
27816585|NCT03679741|81162677|FG001|Period 1|No longer meet eligibility criteria|0|||
27816586|NCT03679741|81162676|FG000|Period 1|Lost to Follow-up|0|||
27690210|NCT00605215|80702611|FG002|Overall Study|Adverse Event|26|||
27690211|NCT00605215|80702609|FG000|Overall Study|Refusal to sign the re-consent form|8|||
27690212|NCT00605215|80702610|FG001|Overall Study|Refusal to sign the re-consent form|3|||
27690213|NCT00605215|80702611|FG002|Overall Study|Refusal to sign the re-consent form|3|||
27590330|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
27590331|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
27590332|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
27590333|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
27590334|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
27590335|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
27590336|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
27590337|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
27590338|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
27590339|NCT01490632|80340490|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590340|NCT01490632|80340491|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590341|NCT01490632|80340492|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590342|NCT01490632|80340493|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590343|NCT01490632|80340494|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590344|NCT01490632|80340495|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590345|NCT01490632|80340496|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590346|NCT01490632|80340497|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590347|NCT01490632|80340498|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590348|NCT01490632|80340499|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590349|NCT01490632|80340500|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590350|NCT01490632|80340501|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590351|NCT01490632|80340502|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590352|NCT01490632|80340503|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27690214|NCT00605215|80702609|FG000|Overall Study|Withdrawal by Subject|39|||
27690215|NCT00605215|80702610|FG001|Overall Study|Withdrawal by Subject|37|||
27690216|NCT00605215|80702611|FG002|Overall Study|Withdrawal by Subject|27|||
27690217|NCT00605215|80702609|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
27690218|NCT00605215|80702610|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
27590353|NCT01490632|80340504|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590354|NCT01490632|80340505|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27590355|NCT01490632|80340506|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
27690219|NCT00605215|80702611|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
27690220|NCT00605215|80702609|FG000|Overall Study|Protocol Violation|3|||
27690221|NCT00605215|80702610|FG001|Overall Study|Protocol Violation|4|||
27590356|NCT01490632|80340507|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
27590357|NCT01490632|80340508|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
27590358|NCT01490632|80340509|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
27590359|NCT04419493|80340510|FG000|Wash-out After Period 1|Adverse Event|1|||
27690222|NCT00605215|80702611|FG002|Overall Study|Protocol Violation|1|||
27690223|NCT00605215|80702609|FG000|Overall Study|Pregnancy|8|||
27690224|NCT00605215|80702610|FG001|Overall Study|Pregnancy|5|||
27690225|NCT00605215|80702611|FG002|Overall Study|Pregnancy|4|||
27690226|NCT00605215|80702609|FG000|Overall Study|Lost to Follow-up|8|||
27690227|NCT00605215|80702610|FG001|Overall Study|Lost to Follow-up|5|||
27690228|NCT00605215|80702611|FG002|Overall Study|Lost to Follow-up|2|||
27690229|NCT00605215|80702609|FG000|Overall Study|Other than specified|0|||
27690230|NCT00605215|80702610|FG001|Overall Study|Other than specified|2|||
27690231|NCT00605215|80702611|FG002|Overall Study|Other than specified|1|||
27690232|NCT02673515|80702612|FG000|Overall Study|Lack of motivation|2|||
27690233|NCT02673515|80702613|FG001|Overall Study|Lack of motivation|1|||
27690234|NCT01183234|80702614|FG000|First Intervention|Adverse Event|1|||
27690235|NCT01183234|80702615|FG001|First Intervention|Adverse Event|0|||
27690236|NCT01465347|80702616|FG000|Overall Study|Withdrawal by Subject|1|||
27690237|NCT01465347|80702617|FG001|Overall Study|Withdrawal by Subject|1|||
27690238|NCT01465347|80702616|FG000|Overall Study|Physician Decision|0|||
27690239|NCT01465347|80702617|FG001|Overall Study|Physician Decision|1|||
27690240|NCT01465347|80702616|FG000|Overall Study|Admitted to hospice|0|||
27690241|NCT01465347|80702617|FG001|Overall Study|Admitted to hospice|1|||
27690242|NCT00432666|80702618|FG000|Main Period|Adverse Event|1|||
27690243|NCT00432666|80702619|FG001|Main Period|Adverse Event|1|||
27690244|NCT00432666|80702618|FG000|Main Period|Consent Withdrawn|1|||
27690245|NCT00432666|80702619|FG001|Main Period|Consent Withdrawn|0|||
27690246|NCT00432666|80702618|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
27690247|NCT00432666|80702619|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
27690248|NCT00432666|80702618|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
27690249|NCT00432666|80702619|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
27690250|NCT00432666|80702618|FG000|Open-Label Extension Period|Adverse Event|5|||
27690251|NCT00432666|80702619|FG001|Open-Label Extension Period|Adverse Event|0|||
27690252|NCT00432666|80702618|FG000|Open-Label Extension Period|Consent withdrawn|10|||
27690253|NCT00432666|80702619|FG001|Open-Label Extension Period|Consent withdrawn|0|||
27816587|NCT03679741|81162677|FG001|Period 1|Lost to Follow-up|1|||
27816588|NCT03679741|81162676|FG000|Period 1|Adverse Event|1|||
27816589|NCT03679741|81162677|FG001|Period 1|Adverse Event|1|||
27816590|NCT03679741|81162676|FG000|Period 1|Withdrawal by Subject|0|||
27816591|NCT03679741|81162677|FG001|Period 1|Withdrawal by Subject|1|||
27816592|NCT03679741|81162676|FG000|Period 2|Adverse Event|2|||
27816593|NCT03679741|81162677|FG001|Period 2|Adverse Event|1|||
27816594|NCT03679741|81162676|FG000|Period 2|Withdrawal by Subject|1|||
27816595|NCT03679741|81162677|FG001|Period 2|Withdrawal by Subject|1|||
27816596|NCT01494506|81162678|FG000|Overall Study|Lack of Efficacy|77|||
27816597|NCT01494506|81162679|FG001|Overall Study|Lack of Efficacy|83|||
27816598|NCT01494506|81162680|FG002|Overall Study|Lack of Efficacy|57|||
27816599|NCT01494506|81162678|FG000|Overall Study|Adverse Event|17|||
27816600|NCT01494506|81162679|FG001|Overall Study|Adverse Event|10|||
27816601|NCT01494506|81162680|FG002|Overall Study|Adverse Event|11|||
27816602|NCT01494506|81162678|FG000|Overall Study|Death|9|||
27816603|NCT01494506|81162679|FG001|Overall Study|Death|5|||
27816604|NCT01494506|81162680|FG002|Overall Study|Death|2|||
27816605|NCT01494506|81162678|FG000|Overall Study|Physician Decision|7|||
27816606|NCT01494506|81162679|FG001|Overall Study|Physician Decision|5|||
27816607|NCT01494506|81162680|FG002|Overall Study|Physician Decision|4|||
27816608|NCT01494506|81162678|FG000|Overall Study|Withdrawal by Subject|17|||
27816609|NCT01494506|81162679|FG001|Overall Study|Withdrawal by Subject|20|||
27816610|NCT01494506|81162680|FG002|Overall Study|Withdrawal by Subject|14|||
27816611|NCT01494506|81162678|FG000|Overall Study|Clinical Deterioration|21|||
27816612|NCT01494506|81162679|FG001|Overall Study|Clinical Deterioration|17|||
27690254|NCT00432666|80702618|FG000|Open-Label Extension Period|Physician Decision|3|||
27690255|NCT00432666|80702619|FG001|Open-Label Extension Period|Physician Decision|0|||
27690256|NCT00112047|80702620|FG000|Randomized Phase|Lost to Follow-up|26|||
27690257|NCT00112047|80702621|FG001|Randomized Phase|Lost to Follow-up|33|||
27690258|NCT00112047|80702620|FG000|Randomized Phase|Adverse Event|10|||
27690259|NCT00112047|80702621|FG001|Randomized Phase|Adverse Event|10|||
27690260|NCT00112047|80702620|FG000|Randomized Phase|Withrawal of consent|10|||
27816613|NCT01494506|81162680|FG002|Overall Study|Clinical Deterioration|13|||
27816614|NCT01494506|81162678|FG000|Overall Study|Sponsor Decision|0|||
27690261|NCT00112047|80702621|FG001|Randomized Phase|Withrawal of consent|18|||
27690262|NCT00112047|80702620|FG000|Randomized Phase|Sub-optimal virological response|3|||
27690263|NCT00112047|80702621|FG001|Randomized Phase|Sub-optimal virological response|13|||
27690264|NCT00112047|80702620|FG000|Randomized Phase|Noncompliance|8|||
27816615|NCT01494506|81162679|FG001|Overall Study|Sponsor Decision|0|||
27816616|NCT01494506|81162680|FG002|Overall Study|Sponsor Decision|1|||
27816617|NCT01494506|81162678|FG000|Overall Study|Other|0|||
27816618|NCT01494506|81162679|FG001|Overall Study|Other|3|||
27816619|NCT01494506|81162680|FG002|Overall Study|Other|1|||
27816620|NCT00525590|81162681|FG000|Overall Study|Adverse Event|3|||
27816621|NCT00525590|81162681|FG000|Overall Study|Physician Decision|3|||
27816622|NCT00525590|81162681|FG000|Overall Study|Withdrawal by Subject|16|||
27816623|NCT00525590|81162681|FG000|Overall Study|Lost to Follow-up|1|||
27816624|NCT00525590|81162681|FG000|Overall Study|Death|9|||
27816625|NCT00525590|81162681|FG000|Overall Study|Other|13|||
27816626|NCT00356200|81162682|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
27816627|NCT00356200|81162683|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
27816628|NCT00356200|81162682|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
27816629|NCT00356200|81162683|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
27816630|NCT03209570|81162685|FG000|Overall Study|Death|1|||
27816631|NCT03209570|81162686|FG001|Overall Study|Death|0|||
27816632|NCT03209570|81162685|FG000|Overall Study|Incomplete Data|8|||
27816633|NCT03209570|81162686|FG001|Overall Study|Incomplete Data|10|||
27816634|NCT03209570|81162685|FG000|Overall Study|Protocol Violation|1|||
27816635|NCT03209570|81162686|FG001|Overall Study|Protocol Violation|0|||
27816636|NCT03209570|81162685|FG000|Overall Study|Withdrawal by Subject|0|||
27816637|NCT03209570|81162686|FG001|Overall Study|Withdrawal by Subject|3|||
27816638|NCT00720096|81162687|FG000|Overall Study|Withdrawal by Subject|0|||
27816639|NCT00720096|81162688|FG001|Overall Study|Withdrawal by Subject|2|||
27816640|NCT01196052|81162691|FG000|Overall Study|Adverse Event|9|||
27816641|NCT01196052|81162691|FG000|Overall Study|Lost to Follow-up|1|||
27816642|NCT01196052|81162691|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
27816643|NCT01196052|81162691|FG000|Overall Study|Reason not Specified|5|||
27816644|NCT01196052|81162691|FG000|Overall Study|Withdrawal by Subject|6|||
27816645|NCT03401112|81162694|FG000|Overall Study|Adverse Event|1|||
27816646|NCT03401112|81162695|FG001|Overall Study|Adverse Event|2|||
27816647|NCT03401112|81162696|FG002|Overall Study|Adverse Event|3|||
27816648|NCT03401112|81162697|FG003|Overall Study|Adverse Event|2|||
27816649|NCT03401112|81162698|FG004|Overall Study|Adverse Event|0|||
27816650|NCT03401112|81162694|FG000|Overall Study|Lost to Follow-up|1|||
27816651|NCT03401112|81162695|FG001|Overall Study|Lost to Follow-up|0|||
27816652|NCT03401112|81162696|FG002|Overall Study|Lost to Follow-up|0|||
27816653|NCT03401112|81162697|FG003|Overall Study|Lost to Follow-up|0|||
27816654|NCT03401112|81162698|FG004|Overall Study|Lost to Follow-up|0|||
27816655|NCT03401112|81162694|FG000|Overall Study|Noncompliance|1|||
27816656|NCT03401112|81162695|FG001|Overall Study|Noncompliance|2|||
27816657|NCT03401112|81162696|FG002|Overall Study|Noncompliance|3|||
27816658|NCT03401112|81162697|FG003|Overall Study|Noncompliance|0|||
27816659|NCT03401112|81162698|FG004|Overall Study|Noncompliance|0|||
27816660|NCT03401112|81162694|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
27816661|NCT03401112|81162695|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
27816662|NCT03401112|81162696|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
27816663|NCT03401112|81162697|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
27816664|NCT03401112|81162698|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
27816665|NCT03401112|81162694|FG000|Overall Study|Withdrawal by Subject|0|||
27816666|NCT03401112|81162695|FG001|Overall Study|Withdrawal by Subject|3|||
27816667|NCT03401112|81162696|FG002|Overall Study|Withdrawal by Subject|2|||
27816668|NCT03401112|81162697|FG003|Overall Study|Withdrawal by Subject|1|||
27816669|NCT03401112|81162698|FG004|Overall Study|Withdrawal by Subject|0|||
27816670|NCT03401112|81162694|FG000|Overall Study|Physician Decision|0|||
27816671|NCT03401112|81162695|FG001|Overall Study|Physician Decision|0|||
27816672|NCT03401112|81162696|FG002|Overall Study|Physician Decision|0|||
27816673|NCT03401112|81162697|FG003|Overall Study|Physician Decision|2|||
27690265|NCT00112047|80702621|FG001|Randomized Phase|Noncompliance|4|||
27816674|NCT03401112|81162698|FG004|Overall Study|Physician Decision|0|||
27816675|NCT03401112|81162694|FG000|Overall Study|Study was Terminated by Sponsor|0|||
27590360|NCT04419493|80340511|FG001|Wash-out After Period 1|Adverse Event|2|||
27590361|NCT04419493|80340512|FG002|Wash-out After Period 1|Adverse Event|1|||
27590362|NCT04419493|80340513|FG003|Wash-out After Period 1|Adverse Event|0|||
27590363|NCT01972841|80340514|FG000|Overall Study|Randomized but Never Received Treatment|2|||
27590364|NCT01972841|80340515|FG001|Overall Study|Randomized but Never Received Treatment|5|||
27590365|NCT01972841|80340516|FG002|Overall Study|Randomized but Never Received Treatment|4|||
27590366|NCT01972841|80340517|FG003|Overall Study|Randomized but Never Received Treatment|2|||
27590367|NCT01972841|80340518|FG004|Overall Study|Randomized but Never Received Treatment|6|||
27590368|NCT01972841|80340519|FG005|Overall Study|Randomized but Never Received Treatment|13|||
27590369|NCT01972841|80340514|FG000|Overall Study|Adverse Event|13|||
27590370|NCT01972841|80340515|FG001|Overall Study|Adverse Event|8|||
27590371|NCT01972841|80340516|FG002|Overall Study|Adverse Event|12|||
27590372|NCT01972841|80340517|FG003|Overall Study|Adverse Event|9|||
27590373|NCT01972841|80340518|FG004|Overall Study|Adverse Event|21|||
27590374|NCT01972841|80340519|FG005|Overall Study|Adverse Event|26|||
27590375|NCT01972841|80340514|FG000|Overall Study|Lack of Efficacy|1|||
27590376|NCT01972841|80340515|FG001|Overall Study|Lack of Efficacy|0|||
27590377|NCT01972841|80340516|FG002|Overall Study|Lack of Efficacy|0|||
27590378|NCT01972841|80340517|FG003|Overall Study|Lack of Efficacy|2|||
27590379|NCT01972841|80340518|FG004|Overall Study|Lack of Efficacy|4|||
27590380|NCT01972841|80340519|FG005|Overall Study|Lack of Efficacy|1|||
27816676|NCT03401112|81162695|FG001|Overall Study|Study was Terminated by Sponsor|0|||
27590381|NCT01972841|80340514|FG000|Overall Study|Lost to Follow-up|4|||
27590382|NCT01972841|80340515|FG001|Overall Study|Lost to Follow-up|2|||
27590383|NCT01972841|80340516|FG002|Overall Study|Lost to Follow-up|4|||
27590384|NCT01972841|80340517|FG003|Overall Study|Lost to Follow-up|2|||
27590385|NCT01972841|80340518|FG004|Overall Study|Lost to Follow-up|9|||
27590386|NCT01972841|80340519|FG005|Overall Study|Lost to Follow-up|3|||
27590387|NCT01972841|80340514|FG000|Overall Study|Protocol Violation|2|||
27590388|NCT01972841|80340515|FG001|Overall Study|Protocol Violation|2|||
27590389|NCT01972841|80340516|FG002|Overall Study|Protocol Violation|3|||
27590390|NCT01972841|80340517|FG003|Overall Study|Protocol Violation|5|||
27590391|NCT01972841|80340518|FG004|Overall Study|Protocol Violation|9|||
27590392|NCT01972841|80340519|FG005|Overall Study|Protocol Violation|4|||
27590393|NCT01972841|80340514|FG000|Overall Study|Withdrawal by participants|21|||
27590394|NCT01972841|80340515|FG001|Overall Study|Withdrawal by participants|27|||
27590395|NCT01972841|80340516|FG002|Overall Study|Withdrawal by participants|23|||
27590396|NCT01972841|80340517|FG003|Overall Study|Withdrawal by participants|16|||
27590397|NCT01972841|80340518|FG004|Overall Study|Withdrawal by participants|33|||
27590398|NCT01972841|80340519|FG005|Overall Study|Withdrawal by participants|34|||
27590399|NCT01972841|80340514|FG000|Overall Study|Miscellaneous|0|||
27590400|NCT01972841|80340515|FG001|Overall Study|Miscellaneous|0|||
27590401|NCT01972841|80340516|FG002|Overall Study|Miscellaneous|4|||
27590402|NCT01972841|80340517|FG003|Overall Study|Miscellaneous|1|||
27590403|NCT01972841|80340518|FG004|Overall Study|Miscellaneous|0|||
27590404|NCT01972841|80340519|FG005|Overall Study|Miscellaneous|4|||
27590405|NCT01972841|80340514|FG000|Overall Study|Did not have end of treatment page|0|||
27590406|NCT01972841|80340515|FG001|Overall Study|Did not have end of treatment page|0|||
27816677|NCT03401112|81162696|FG002|Overall Study|Study was Terminated by Sponsor|0|||
27816678|NCT03401112|81162697|FG003|Overall Study|Study was Terminated by Sponsor|1|||
27816679|NCT03401112|81162698|FG004|Overall Study|Study was Terminated by Sponsor|0|||
27816680|NCT03401112|81162694|FG000|Overall Study|Day 1 Assessment not Done|1|||
27816681|NCT03401112|81162695|FG001|Overall Study|Day 1 Assessment not Done|0|||
27816682|NCT03401112|81162696|FG002|Overall Study|Day 1 Assessment not Done|0|||
27816683|NCT03401112|81162697|FG003|Overall Study|Day 1 Assessment not Done|0|||
27816684|NCT03401112|81162698|FG004|Overall Study|Day 1 Assessment not Done|0|||
27816685|NCT03401112|81162694|FG000|Overall Study|Not Dosed|0|||
27816686|NCT03401112|81162695|FG001|Overall Study|Not Dosed|0|||
27816687|NCT03401112|81162696|FG002|Overall Study|Not Dosed|1|||
27816688|NCT03401112|81162697|FG003|Overall Study|Not Dosed|0|||
27816689|NCT03401112|81162698|FG004|Overall Study|Not Dosed|0|||
27816690|NCT03401112|81162694|FG000|Overall Study|Missed Clinical Visit|0|||
27816691|NCT03401112|81162695|FG001|Overall Study|Missed Clinical Visit|0|||
27816692|NCT03401112|81162696|FG002|Overall Study|Missed Clinical Visit|1|||
27816693|NCT03401112|81162697|FG003|Overall Study|Missed Clinical Visit|0|||
27590407|NCT01972841|80340516|FG002|Overall Study|Did not have end of treatment page|0|||
27590408|NCT01972841|80340517|FG003|Overall Study|Did not have end of treatment page|0|||
27590409|NCT01972841|80340518|FG004|Overall Study|Did not have end of treatment page|1|||
27816694|NCT03401112|81162698|FG004|Overall Study|Missed Clinical Visit|0|||
27590410|NCT01972841|80340519|FG005|Overall Study|Did not have end of treatment page|0|||
27590411|NCT01054820|80340520|FG000|Overall Study|Withdrawal by Subject|2|||
27590412|NCT01613248|80340522|FG000|Overall Study|Adverse Event|0|||
27590413|NCT01613248|80340523|FG001|Overall Study|Adverse Event|0|||
27590414|NCT01613248|80340524|FG002|Overall Study|Adverse Event|0|||
27590415|NCT01613248|80340525|FG003|Overall Study|Adverse Event|1|||
27590416|NCT01613248|80340526|FG004|Overall Study|Adverse Event|0|||
27590417|NCT01613248|80340527|FG005|Overall Study|Adverse Event|0|||
27590418|NCT01613248|80340522|FG000|Overall Study|Withdrawal by Subject|3|||
27590419|NCT01613248|80340523|FG001|Overall Study|Withdrawal by Subject|2|||
27590420|NCT01613248|80340524|FG002|Overall Study|Withdrawal by Subject|2|||
27590421|NCT01613248|80340525|FG003|Overall Study|Withdrawal by Subject|5|||
27590422|NCT01613248|80340526|FG004|Overall Study|Withdrawal by Subject|0|||
27590423|NCT01613248|80340527|FG005|Overall Study|Withdrawal by Subject|1|||
27590424|NCT01613248|80340522|FG000|Overall Study|Lost to Follow-up|5|||
27590425|NCT01613248|80340523|FG001|Overall Study|Lost to Follow-up|7|||
27590426|NCT01613248|80340524|FG002|Overall Study|Lost to Follow-up|4|||
27590427|NCT01613248|80340525|FG003|Overall Study|Lost to Follow-up|8|||
27590428|NCT01613248|80340526|FG004|Overall Study|Lost to Follow-up|4|||
27590429|NCT01613248|80340527|FG005|Overall Study|Lost to Follow-up|2|||
27590430|NCT01613248|80340522|FG000|Overall Study|Study Terminated by Sponsor|4|||
27590431|NCT01613248|80340523|FG001|Overall Study|Study Terminated by Sponsor|6|||
27590432|NCT01613248|80340524|FG002|Overall Study|Study Terminated by Sponsor|8|||
27590433|NCT01613248|80340525|FG003|Overall Study|Study Terminated by Sponsor|8|||
27590434|NCT01613248|80340526|FG004|Overall Study|Study Terminated by Sponsor|9|||
27590435|NCT01613248|80340527|FG005|Overall Study|Study Terminated by Sponsor|11|||
27590436|NCT01613248|80340522|FG000|Overall Study|Physician Decision|8|||
27590437|NCT01613248|80340523|FG001|Overall Study|Physician Decision|8|||
27590438|NCT01613248|80340524|FG002|Overall Study|Physician Decision|9|||
27590439|NCT01613248|80340525|FG003|Overall Study|Physician Decision|4|||
27590440|NCT01613248|80340526|FG004|Overall Study|Physician Decision|7|||
27590441|NCT01613248|80340527|FG005|Overall Study|Physician Decision|6|||
27590442|NCT01613248|80340522|FG000|Overall Study|Lack of Qualifying Event|9|||
27590443|NCT01613248|80340523|FG001|Overall Study|Lack of Qualifying Event|11|||
27590444|NCT01613248|80340524|FG002|Overall Study|Lack of Qualifying Event|10|||
27590445|NCT01613248|80340525|FG003|Overall Study|Lack of Qualifying Event|11|||
27590446|NCT01613248|80340526|FG004|Overall Study|Lack of Qualifying Event|15|||
27590447|NCT01613248|80340527|FG005|Overall Study|Lack of Qualifying Event|18|||
27590448|NCT01613248|80340522|FG000|Overall Study|Pregnancy|0|||
27590449|NCT01613248|80340523|FG001|Overall Study|Pregnancy|0|||
27590450|NCT01613248|80340524|FG002|Overall Study|Pregnancy|0|||
27590451|NCT01613248|80340525|FG003|Overall Study|Pregnancy|1|||
27590452|NCT01613248|80340526|FG004|Overall Study|Pregnancy|0|||
27590453|NCT01613248|80340527|FG005|Overall Study|Pregnancy|0|||
27590454|NCT01939028|80340528|FG000|Overall Study|Withdrawal by Subject|5|||
27590455|NCT01939028|80340528|FG000|Overall Study|Physician Decision|7|||
27590456|NCT02535065|80340529|FG000|Overall Study|Death|13|||
27590457|NCT02535065|80340529|FG000|Overall Study|Lost to Follow-up|1|||
27590458|NCT02535065|80340529|FG000|Overall Study|Withdrawal by Subject|6|||
27590459|NCT01302119|80340530|FG000|Overall Study|Withdrawal by Subject|30|||
27590460|NCT01302119|80340531|FG001|Overall Study|Withdrawal by Subject|20|||
27590461|NCT01302119|80340530|FG000|Overall Study|Lost to Follow-up|10|||
27590462|NCT01302119|80340531|FG001|Overall Study|Lost to Follow-up|4|||
27590463|NCT01302119|80340530|FG000|Overall Study|Adverse Event|2|||
27590464|NCT01302119|80340531|FG001|Overall Study|Adverse Event|1|||
27590465|NCT01302119|80340530|FG000|Overall Study|Non-compliance|4|||
27590466|NCT01302119|80340531|FG001|Overall Study|Non-compliance|2|||
27590467|NCT01302119|80340530|FG000|Overall Study|Non-specific|4|||
27590468|NCT01302119|80340531|FG001|Overall Study|Non-specific|1|||
27590469|NCT01328574|80340545|FG000|Overall Study|Refused further treatment|1|||
27590470|NCT00413153|80340551|FG000|Overall Study|Withdrawal by Subject|1|||
27590471|NCT00413153|80340552|FG001|Overall Study|Withdrawal by Subject|1|||
27590472|NCT00413153|80340551|FG000|Overall Study|Adverse Event|1|||
27590473|NCT00413153|80340552|FG001|Overall Study|Adverse Event|0|||
27590474|NCT01914926|80340560|FG000|Overall Study|Adverse Event|1|||
27590475|NCT01914926|80340561|FG001|Overall Study|Adverse Event|0|||
27690266|NCT00112047|80702620|FG000|Randomized Phase|Protocol Violation|2|||
27816695|NCT03401112|81162694|FG000|Overall Study|Missed Doses|0|||
27590476|NCT01914926|80340560|FG000|Overall Study|uncooperative, agitated and removed|0|||
27590477|NCT01914926|80340561|FG001|Overall Study|uncooperative, agitated and removed|1|||
27590478|NCT03117738|80340562|FG000|Overall Study|Withdrawal by Subject|3|||
27590479|NCT03117738|80340563|FG001|Overall Study|Withdrawal by Subject|1|||
27590480|NCT03117738|80340562|FG000|Overall Study|Lost to Follow-up|1|||
27816696|NCT03401112|81162695|FG001|Overall Study|Missed Doses|0|||
27590481|NCT03117738|80340563|FG001|Overall Study|Lost to Follow-up|4|||
27590482|NCT04447404|80340564|FG000|Overall Study|Death|2|||
27590483|NCT04447404|80340565|FG001|Overall Study|Death|0|||
27590484|NCT01949480|80340566|FG000|Overall Study|Physician Decision|5|||
27590485|NCT01949480|80340567|FG001|Overall Study|Physician Decision|8|||
27590486|NCT04899349|80340574|FG000|Overall Study|Study terminated by Sponsor|2|||
27590487|NCT04899349|80340575|FG001|Overall Study|Study terminated by Sponsor|0|||
27590488|NCT02372409|80340577|FG000|Overall Study|Lost to Follow-up|1|||
27590489|NCT02372409|80340578|FG001|Overall Study|Lost to Follow-up|0|||
27590490|NCT02372409|80340577|FG000|Overall Study|Disease progression|1|||
27590491|NCT02372409|80340578|FG001|Overall Study|Disease progression|1|||
27590492|NCT00321854|80340579|FG000|Overall Study|Adverse Event|41|||
27590493|NCT00321854|80340580|FG001|Overall Study|Adverse Event|43|||
27590494|NCT00321854|80340579|FG000|Overall Study|Lack of Efficacy|9|||
27590495|NCT00321854|80340580|FG001|Overall Study|Lack of Efficacy|14|||
27590496|NCT00321854|80340579|FG000|Overall Study|Protocol Violation|6|||
27590497|NCT00321854|80340580|FG001|Overall Study|Protocol Violation|5|||
27590498|NCT00321854|80340579|FG000|Overall Study|Lost to Follow-up|0|||
27590499|NCT00321854|80340580|FG001|Overall Study|Lost to Follow-up|2|||
27590500|NCT00321854|80340579|FG000|Overall Study|Withdrawal by Subject|6|||
27816697|NCT03401112|81162696|FG002|Overall Study|Missed Doses|1|||
27816698|NCT03401112|81162697|FG003|Overall Study|Missed Doses|0|||
27816699|NCT03401112|81162698|FG004|Overall Study|Missed Doses|0|||
27816700|NCT04041570|81162701|FG000|Overall Study|Moved from Area|0|||
27816701|NCT04041570|81162702|FG001|Overall Study|Moved from Area|2|||
27816702|NCT01062256|81162703|FG000|Overall Study|Adverse Event|1|||
27816703|NCT01062256|81162704|FG001|Overall Study|Adverse Event|0|||
27816704|NCT01062256|81162705|FG002|Overall Study|Adverse Event|0|||
27816705|NCT01062256|81162703|FG000|Overall Study|Withdrawal by Subject|1|||
27816706|NCT01062256|81162704|FG001|Overall Study|Withdrawal by Subject|1|||
27816707|NCT01062256|81162705|FG002|Overall Study|Withdrawal by Subject|1|||
27816708|NCT01062256|81162703|FG000|Overall Study|Ineligible|1|||
27816709|NCT01062256|81162704|FG001|Overall Study|Ineligible|4|||
27816710|NCT01062256|81162705|FG002|Overall Study|Ineligible|3|||
27816711|NCT01062256|81162703|FG000|Overall Study|Administrative|0|||
27816712|NCT01062256|81162704|FG001|Overall Study|Administrative|2|||
27816713|NCT01062256|81162705|FG002|Overall Study|Administrative|0|||
27816714|NCT01335477|81162706|FG000|Overall Study|Adverse Event|30|||
27816715|NCT01335477|81162707|FG001|Overall Study|Adverse Event|42|||
27878784|NCT02509507|81387386|FG006|Overall Study|Withdrawal by Subject|4|||
27878785|NCT02509507|81387387|FG007|Overall Study|Withdrawal by Subject|0|||
27878786|NCT02509507|81387388|FG008|Overall Study|Withdrawal by Subject|1|||
27878787|NCT01554527|81387391|FG000|Overall Study|Withdrawal by Subject|1|||
27878788|NCT01554527|81387392|FG001|Overall Study|Withdrawal by Subject|0|||
27878789|NCT01554527|81387393|FG002|Overall Study|Withdrawal by Subject|3|||
27878790|NCT01554527|81387391|FG000|Overall Study|Lost to Follow-up|0|||
27878791|NCT01554527|81387392|FG001|Overall Study|Lost to Follow-up|0|||
27878792|NCT01554527|81387393|FG002|Overall Study|Lost to Follow-up|4|||
27878793|NCT01554527|81387391|FG000|Overall Study|Physician Decision|0|||
27878794|NCT01554527|81387392|FG001|Overall Study|Physician Decision|0|||
27878795|NCT01554527|81387393|FG002|Overall Study|Physician Decision|1|||
27878796|NCT04090060|81387394|FG000|Overall Study|Lost to Follow-up|76|||
27878797|NCT04090060|81387395|FG001|Overall Study|Lost to Follow-up|77|||
27878798|NCT00523848|81387396|FG000|Overall Study|Adverse Event|11|||
27878799|NCT00523848|81387396|FG000|Overall Study|Withdrawal by Subject|2|||
27878800|NCT00523848|81387396|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
27878801|NCT00523848|81387396|FG000|Overall Study|Disease Progression|5|||
27878802|NCT00523848|81387396|FG000|Overall Study|Other, unspecified|4|||
27878803|NCT01321749|81391311|FG000|Overall Study|Lost to Follow-up|4|||
27878804|NCT01321749|81391312|FG001|Overall Study|Lost to Follow-up|11|||
27878805|NCT01321749|81391311|FG000|Overall Study|Protocol Violation|4|||
27878806|NCT01321749|81391312|FG001|Overall Study|Protocol Violation|7|||
27878807|NCT01321749|81391311|FG000|Overall Study|Withdrawal by Subject|5|||
27878808|NCT01321749|81391312|FG001|Overall Study|Withdrawal by Subject|4|||
27878809|NCT05061693|81391313|FG000|Overall Study|Adverse Event|1|||
27878810|NCT05061693|81391314|FG001|Overall Study|Adverse Event|1|||
27878811|NCT05061693|81391315|FG002|Overall Study|Adverse Event|1|||
27878812|NCT05061693|81391316|FG003|Overall Study|Adverse Event|0|||
27878813|NCT05061693|81391313|FG000|Overall Study|Death|0|||
27878814|NCT05061693|81391314|FG001|Overall Study|Death|1|||
27878815|NCT05061693|81391315|FG002|Overall Study|Death|0|||
27878816|NCT05061693|81391316|FG003|Overall Study|Death|0|||
27878817|NCT05061693|81391313|FG000|Overall Study|Lack of Efficacy|1|||
27878818|NCT05061693|81391314|FG001|Overall Study|Lack of Efficacy|0|||
27878819|NCT05061693|81391315|FG002|Overall Study|Lack of Efficacy|0|||
27878820|NCT05061693|81391316|FG003|Overall Study|Lack of Efficacy|0|||
27878821|NCT05061693|81391313|FG000|Overall Study|Lost to Follow-up|0|||
27878822|NCT05061693|81391314|FG001|Overall Study|Lost to Follow-up|0|||
27878823|NCT05061693|81391315|FG002|Overall Study|Lost to Follow-up|1|||
27878824|NCT05061693|81391316|FG003|Overall Study|Lost to Follow-up|0|||
27878825|NCT05061693|81391313|FG000|Overall Study|Protocol Violation|1|||
27878826|NCT05061693|81391314|FG001|Overall Study|Protocol Violation|1|||
27878827|NCT05061693|81391315|FG002|Overall Study|Protocol Violation|1|||
27878828|NCT05061693|81391316|FG003|Overall Study|Protocol Violation|2|||
27878829|NCT05061693|81391313|FG000|Overall Study|Withdrawal by Subject|2|||
27878830|NCT05061693|81391314|FG001|Overall Study|Withdrawal by Subject|4|||
27878831|NCT05061693|81391315|FG002|Overall Study|Withdrawal by Subject|2|||
27878832|NCT05061693|81391316|FG003|Overall Study|Withdrawal by Subject|2|||
27878833|NCT00832455|81391319|FG000|Overall Study|Adverse Event|13|||
27878834|NCT00832455|81391319|FG000|Overall Study|Lost to Follow-up|26|||
27878835|NCT00832455|81391319|FG000|Overall Study|Protocol Violation|4|||
27878836|NCT00832455|81391319|FG000|Overall Study|Withdrawal by Subject|17|||
27878837|NCT00832455|81391319|FG000|Overall Study|Screening Failure|2|||
27878838|NCT00832455|81391319|FG000|Overall Study|Stopped Medication|4|||
27878839|NCT00832455|81391319|FG000|Overall Study|Parent misunderstood study|1|||
27878840|NCT00832455|81391319|FG000|Overall Study|Parent dissatisfied|1|||
27878841|NCT00832455|81391319|FG000|Overall Study|No improvement|3|||
27878842|NCT00832455|81391319|FG000|Overall Study|Patient moved|1|||
27878843|NCT01297517|81391322|FG000|Overall Study|Adverse Event|21|||
27878844|NCT01297517|81391323|FG001|Overall Study|Adverse Event|7|||
27878845|NCT01297517|81391324|FG002|Overall Study|Adverse Event|16|||
27878846|NCT01297517|81391322|FG000|Overall Study|Lost to Follow-up|1|||
27878847|NCT01297517|81391323|FG001|Overall Study|Lost to Follow-up|0|||
27878848|NCT01297517|81391324|FG002|Overall Study|Lost to Follow-up|1|||
27878849|NCT01297517|81391322|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
27878850|NCT01297517|81391323|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
27878851|NCT01297517|81391324|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
27878852|NCT01297517|81391322|FG000|Overall Study|Noncompliance|1|||
27878853|NCT01297517|81391323|FG001|Overall Study|Noncompliance|0|||
27878854|NCT01297517|81391324|FG002|Overall Study|Noncompliance|0|||
27878855|NCT01297517|81391322|FG000|Overall Study|Protocol Violation|1|||
27878856|NCT01297517|81391323|FG001|Overall Study|Protocol Violation|1|||
27878857|NCT01297517|81391324|FG002|Overall Study|Protocol Violation|1|||
27878858|NCT01297517|81391322|FG000|Overall Study|Inadequate Control of IOP|1|||
27878859|NCT01297517|81391323|FG001|Overall Study|Inadequate Control of IOP|1|||
27878860|NCT01297517|81391324|FG002|Overall Study|Inadequate Control of IOP|2|||
27878861|NCT04548193|81391328|FG000|Overall Study|Lost to Follow-up|0|||
27878862|NCT04548193|81391329|FG001|Overall Study|Lost to Follow-up|1|||
27878863|NCT04548193|81391328|FG000|Overall Study|Death|0|||
27878864|NCT04548193|81391329|FG001|Overall Study|Death|1|||
27878865|NCT04548193|81391328|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
27878866|NCT04548193|81391329|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
27878867|NCT04548193|81391328|FG000|Overall Study|Withdrawal by Subject|2|||
27878868|NCT04548193|81391329|FG001|Overall Study|Withdrawal by Subject|2|||
27878869|NCT00586820|81391330|FG000|Overall Study|Unsuccessful PCI|1|||
27878870|NCT00586820|81391331|FG001|Overall Study|Unsuccessful PCI|0|||
27878871|NCT02572570|81391332|FG000|Overall Study|Study Terminated|27|||
27878872|NCT01557504|81391333|FG000|Overall Study|Physician Decision|1|||
27878873|NCT01557504|81391334|FG001|Overall Study|Physician Decision|0|||
27878874|NCT02510664|81391335|FG000|Overall Study|Transferred Care|9|||
27878875|NCT02510664|81391336|FG001|Overall Study|Transferred Care|9|||
27878876|NCT02510664|81391337|FG002|Overall Study|Transferred Care|0|||
27878877|NCT02510664|81391335|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
27878878|NCT02510664|81391336|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
27878879|NCT02510664|81391337|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
27878880|NCT02510664|81391335|FG000|Overall Study|Time Constraints|1|||
27878881|NCT02510664|81391336|FG001|Overall Study|Time Constraints|1|||
27878882|NCT02510664|81391337|FG002|Overall Study|Time Constraints|0|||
27878883|NCT02259010|81391342|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
27878884|NCT02588612|81391343|FG000|Overall Study|Physician Decision|1|||
27878885|NCT02588612|81391343|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
27878886|NCT02588612|81391343|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
27878887|NCT02588612|81391343|FG000|Overall Study|Death prior to T-cell infusion|1|||
27878888|NCT01209949|81391344|FG000|Overall Study|Lost to Follow-up|3|||
27878889|NCT00628212|81391345|FG000|Overall Study|Adverse Event|2|||
27878890|NCT00628212|81391346|FG001|Overall Study|Adverse Event|0|||
27878891|NCT00628212|81391347|FG002|Overall Study|Adverse Event|1|||
27878892|NCT00628212|81391348|FG003|Overall Study|Adverse Event|2|||
27878893|NCT00628212|81391345|FG000|Overall Study|Physician Decision|1|||
27878894|NCT00628212|81391346|FG001|Overall Study|Physician Decision|1|||
27878895|NCT00628212|81391347|FG002|Overall Study|Physician Decision|2|||
27878896|NCT00628212|81391348|FG003|Overall Study|Physician Decision|3|||
27878897|NCT03207815|81391349|FG000|Overall Study|Protocol Violation|3|||
27878898|NCT03207815|81391350|FG001|Overall Study|Protocol Violation|1|||
27878899|NCT03207815|81391349|FG000|Overall Study|Adverse Event|1|||
27878900|NCT03207815|81391350|FG001|Overall Study|Adverse Event|2|||
27878901|NCT03207815|81391349|FG000|Overall Study|Lost to Follow-up|1|||
27816716|NCT01335477|81162706|FG000|Overall Study|Non compliant with protocol|0|||
27816717|NCT01335477|81162707|FG001|Overall Study|Non compliant with protocol|2|||
27816718|NCT01335477|81162706|FG000|Overall Study|Lost to Follow-up|1|||
27816719|NCT01335477|81162707|FG001|Overall Study|Lost to Follow-up|2|||
27816720|NCT01335477|81162706|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
27816721|NCT01335477|81162707|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
27816722|NCT01335477|81162706|FG000|Overall Study|Not treated|1|||
27816723|NCT01335477|81162707|FG001|Overall Study|Not treated|2|||
27816724|NCT01335477|81162706|FG000|Overall Study|Reason other than those stated above|2|||
27816725|NCT01335477|81162707|FG001|Overall Study|Reason other than those stated above|2|||
27816726|NCT01060670|81162708|FG000|Run In|screen failure|0|||
27816727|NCT01060670|81162709|FG001|Run In|screen failure|238|||
27816728|NCT00688064|81162710|FG000|Overall Study|Protocol Violation|0|||
27816729|NCT00688064|81162711|FG001|Overall Study|Protocol Violation|1|||
27816730|NCT00688064|81162710|FG000|Overall Study|Adverse Event|2|||
27816731|NCT00688064|81162711|FG001|Overall Study|Adverse Event|4|||
27816732|NCT00688064|81162710|FG000|Overall Study|Withdrawal by Subject|7|||
27816733|NCT00688064|81162711|FG001|Overall Study|Withdrawal by Subject|7|||
27816734|NCT00688064|81162710|FG000|Overall Study|Lost to Follow-up|10|||
27816735|NCT00688064|81162711|FG001|Overall Study|Lost to Follow-up|10|||
27816736|NCT00688064|81162710|FG000|Overall Study|Lack of Efficacy|0|||
27816737|NCT00688064|81162711|FG001|Overall Study|Lack of Efficacy|1|||
27878902|NCT03207815|81391350|FG001|Overall Study|Lost to Follow-up|2|||
27878903|NCT03207815|81391349|FG000|Overall Study|Investigator's Discretion|1|||
27878904|NCT03207815|81391350|FG001|Overall Study|Investigator's Discretion|1|||
27878905|NCT03207815|81391349|FG000|Overall Study|Lack of Efficacy|0|||
27878906|NCT03207815|81391350|FG001|Overall Study|Lack of Efficacy|1|||
27816738|NCT00688064|81162710|FG000|Overall Study|Pregnancy|1|||
27878907|NCT03207815|81391349|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
27878908|NCT03207815|81391350|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
27590501|NCT00321854|80340580|FG001|Overall Study|Withdrawal by Subject|17|||
27590502|NCT00321854|80340579|FG000|Overall Study|Other|1|||
27590503|NCT00321854|80340580|FG001|Overall Study|Other|1|||
27690267|NCT00112047|80702621|FG001|Randomized Phase|Protocol Violation|0|||
27816739|NCT00688064|81162711|FG001|Overall Study|Pregnancy|0|||
27816740|NCT00688064|81162710|FG000|Overall Study|Any other reasons|1|||
27816741|NCT00688064|81162711|FG001|Overall Study|Any other reasons|3|||
27816742|NCT00444145|81162714|FG000|Overall Study|Withdrawal by Subject|2|||
27816743|NCT00444145|81162714|FG000|Overall Study|Lost to Follow-up|1|||
27816744|NCT00444145|81162714|FG000|Overall Study|non-compliant|11|||
27816745|NCT00444145|81162714|FG000|Overall Study|Screen Failures|5|||
27816746|NCT03184441|81162715|FG000|Overall Study|Withdrawal by Subject|1|||
27816747|NCT02270736|81162716|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27816748|NCT02270736|81162717|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
27816749|NCT02270736|81162718|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27816750|NCT02270736|81162719|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27816751|NCT02270736|81162720|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
27816752|NCT02270736|81162716|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
27816753|NCT02270736|81162717|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
27816754|NCT02270736|81162718|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
27816755|NCT02270736|81162719|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
27816756|NCT02270736|81162720|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
27816757|NCT02270736|81162716|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27816758|NCT02270736|81162717|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
27816759|NCT02270736|81162718|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27816760|NCT02270736|81162719|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27816761|NCT02270736|81162720|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
27816762|NCT02270736|81162716|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27816763|NCT02270736|81162717|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27816764|NCT02270736|81162718|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
27816765|NCT02270736|81162719|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27816766|NCT02270736|81162720|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
27816767|NCT02270736|81162716|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27816768|NCT02270736|81162717|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27816769|NCT02270736|81162718|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27816770|NCT02270736|81162719|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
27816771|NCT02270736|81162720|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
27816772|NCT02270736|81162716|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27816773|NCT02270736|81162717|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27590504|NCT03105362|80340585|FG000|Overall Study|Withdrawal by Subject|1|||
27690268|NCT00112047|80702620|FG000|Randomized Phase|Pregnancy|3|||
27690269|NCT00112047|80702621|FG001|Randomized Phase|Pregnancy|1|||
27690270|NCT00112047|80702620|FG000|Randomized Phase|Death|1|||
27816774|NCT02270736|81162718|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27816775|NCT02270736|81162719|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
27816776|NCT02270736|81162720|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
27816777|NCT02270736|81162716|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27816778|NCT02270736|81162717|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27816779|NCT02270736|81162718|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27816780|NCT02270736|81162719|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
27816781|NCT02270736|81162720|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
27816782|NCT02270736|81162716|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27816783|NCT02270736|81162717|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27816784|NCT02270736|81162718|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27816785|NCT02270736|81162719|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
27816786|NCT02270736|81162720|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
27816787|NCT02270736|81162716|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27816788|NCT02270736|81162717|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27816789|NCT02270736|81162718|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27816790|NCT02270736|81162719|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
27816791|NCT02270736|81162720|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
27816792|NCT01089647|81162723|FG000|Overall Study|Lost to Follow-up|2|||
27816793|NCT01089647|81162724|FG001|Overall Study|Lost to Follow-up|2|||
27816794|NCT01089647|81162723|FG000|Overall Study|Withdrawal by Subject|2|||
27816795|NCT01089647|81162724|FG001|Overall Study|Withdrawal by Subject|1|||
27816796|NCT01089647|81162723|FG000|Overall Study|Adverse Event|0|||
27816797|NCT01089647|81162724|FG001|Overall Study|Adverse Event|1|||
27816798|NCT00870870|81162727|FG000|Overall Study|Withdrawal by Subject|0|||
27590505|NCT03105362|80340585|FG000|Overall Study|Lost to Follow-up|1|||
27816799|NCT00870870|81162728|FG001|Overall Study|Withdrawal by Subject|1|||
27590506|NCT02395120|80340586|FG000|Overall Study|Missed follow-up dental exam|57|||
27590507|NCT02395120|80340587|FG001|Overall Study|Missed follow-up dental exam|62|||
27816800|NCT00870870|81162729|FG002|Overall Study|Withdrawal by Subject|1|||
27590508|NCT02395120|80340588|FG002|Overall Study|Missed follow-up dental exam|6|||
27690271|NCT00112047|80702621|FG001|Randomized Phase|Death|3|||
27690272|NCT00112047|80702620|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
27690273|NCT00112047|80702621|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
27690274|NCT00112047|80702620|FG000|Randomized Phase|Inability to swallow pills|0|||
27690275|NCT00112047|80702621|FG001|Randomized Phase|Inability to swallow pills|1|||
27690276|NCT00112047|80702620|FG000|Randomized Phase|Incarceration|3|||
27690277|NCT00112047|80702621|FG001|Randomized Phase|Incarceration|2|||
27690278|NCT00112047|80702620|FG000|Randomized Phase|Moved out of State|0|||
27690279|NCT00112047|80702621|FG001|Randomized Phase|Moved out of State|1|||
27690280|NCT00112047|80702620|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
27690281|NCT00112047|80702621|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
27690282|NCT00112047|80702620|FG000|Randomized Phase|High Hepatitis B DNA|0|||
27690283|NCT00112047|80702621|FG001|Randomized Phase|High Hepatitis B DNA|1|||
27690284|NCT00112047|80702620|FG000|Atripla Phase|Adverse Event|2|||
27690285|NCT00112047|80702621|FG001|Atripla Phase|Adverse Event|1|||
27690286|NCT00112047|80702620|FG000|Atripla Phase|Lost to Follow-up|5|||
27690287|NCT00112047|80702621|FG001|Atripla Phase|Lost to Follow-up|7|||
27690288|NCT00112047|80702620|FG000|Atripla Phase|Pregnancy|0|||
27690289|NCT00112047|80702621|FG001|Atripla Phase|Pregnancy|1|||
27690290|NCT00112047|80702620|FG000|Atripla Phase|Death|0|||
27690291|NCT00112047|80702621|FG001|Atripla Phase|Death|2|||
27690292|NCT00112047|80702620|FG000|Atripla Phase|Withdrew consent|7|||
27690293|NCT00112047|80702621|FG001|Atripla Phase|Withdrew consent|7|||
27690294|NCT00112047|80702620|FG000|Atripla Phase|Sub-optimal virological response|0|||
27690295|NCT00112047|80702621|FG001|Atripla Phase|Sub-optimal virological response|1|||
27690296|NCT00112047|80702620|FG000|Atripla Phase|Non-compliance|1|||
27690297|NCT00112047|80702621|FG001|Atripla Phase|Non-compliance|0|||
27690298|NCT00112047|80702620|FG000|Atripla Phase|Other|3|||
27690299|NCT00112047|80702621|FG001|Atripla Phase|Other|1|||
27690300|NCT01642251|80702622|FG000|Overall Study|Progressive disease|0|||
27690301|NCT01642251|80702623|FG001|Overall Study|Progressive disease|0|||
27690302|NCT01642251|80702624|FG002|Overall Study|Progressive disease|3|||
27690303|NCT01642251|80702625|FG003|Overall Study|Progressive disease|3|||
27690304|NCT01642251|80702622|FG000|Overall Study|Adverse Event|0|||
27690305|NCT01642251|80702623|FG001|Overall Study|Adverse Event|0|||
27690306|NCT01642251|80702624|FG002|Overall Study|Adverse Event|5|||
27690307|NCT01642251|80702625|FG003|Overall Study|Adverse Event|4|||
27690308|NCT01642251|80702622|FG000|Overall Study|Death|0|||
27690309|NCT01642251|80702623|FG001|Overall Study|Death|0|||
27690310|NCT01642251|80702624|FG002|Overall Study|Death|1|||
27690311|NCT01642251|80702625|FG003|Overall Study|Death|3|||
27690312|NCT01642251|80702622|FG000|Overall Study|Withdrawal by Subject|0|||
27690313|NCT01642251|80702623|FG001|Overall Study|Withdrawal by Subject|0|||
27590509|NCT02395120|80340589|FG003|Overall Study|Missed follow-up dental exam|6|||
27690314|NCT01642251|80702624|FG002|Overall Study|Withdrawal by Subject|1|||
27690315|NCT01642251|80702625|FG003|Overall Study|Withdrawal by Subject|3|||
27690316|NCT01642251|80702622|FG000|Overall Study|Alternative therapy|0|||
27690317|NCT01642251|80702623|FG001|Overall Study|Alternative therapy|0|||
27816801|NCT00870870|81162730|FG003|Overall Study|Withdrawal by Subject|3|||
27590510|NCT02395120|80340590|FG004|Overall Study|Missed follow-up dental exam|51|||
27590511|NCT00838110|80344697|FG000|Overall Study|Death|0|||
27590512|NCT00838110|80344698|FG001|Overall Study|Death|0|||
27590513|NCT00838110|80344699|FG002|Overall Study|Death|1|||
27590514|NCT00838110|80344700|FG003|Overall Study|Death|2|||
27590515|NCT00838110|80344697|FG000|Overall Study|Adverse Event|11|||
27590516|NCT00838110|80344698|FG001|Overall Study|Adverse Event|10|||
27590517|NCT00838110|80344699|FG002|Overall Study|Adverse Event|8|||
27590518|NCT00838110|80344700|FG003|Overall Study|Adverse Event|7|||
27590519|NCT00838110|80344697|FG000|Overall Study|Withdrawal by Subject|5|||
27590520|NCT00838110|80344698|FG001|Overall Study|Withdrawal by Subject|6|||
27590521|NCT00838110|80344699|FG002|Overall Study|Withdrawal by Subject|3|||
27590522|NCT00838110|80344700|FG003|Overall Study|Withdrawal by Subject|4|||
27590523|NCT00838110|80344697|FG000|Overall Study|Other|3|||
27590524|NCT00838110|80344698|FG001|Overall Study|Other|3|||
27590525|NCT00838110|80344699|FG002|Overall Study|Other|3|||
27590526|NCT00838110|80344700|FG003|Overall Study|Other|2|||
27590527|NCT00838110|80344697|FG000|Overall Study|Protocol Violation|0|||
27590528|NCT00838110|80344698|FG001|Overall Study|Protocol Violation|2|||
27590529|NCT00838110|80344699|FG002|Overall Study|Protocol Violation|1|||
27590530|NCT00838110|80344700|FG003|Overall Study|Protocol Violation|1|||
27690318|NCT01642251|80702624|FG002|Overall Study|Alternative therapy|0|||
27690319|NCT01642251|80702625|FG003|Overall Study|Alternative therapy|2|||
27816802|NCT00870870|81162727|FG000|Overall Study|Adverse Event|0|||
27690320|NCT01642251|80702622|FG000|Overall Study|Other complicating disease|0|||
27816803|NCT00870870|81162728|FG001|Overall Study|Adverse Event|0|||
27816804|NCT00870870|81162729|FG002|Overall Study|Adverse Event|2|||
27816805|NCT00870870|81162730|FG003|Overall Study|Adverse Event|2|||
27590531|NCT00838110|80344697|FG000|Overall Study|Lost to Follow-up|3|||
27590532|NCT00838110|80344698|FG001|Overall Study|Lost to Follow-up|0|||
27590533|NCT00838110|80344699|FG002|Overall Study|Lost to Follow-up|0|||
27590534|NCT00838110|80344700|FG003|Overall Study|Lost to Follow-up|0|||
27590535|NCT00838110|80344697|FG000|Overall Study|Did not meet eligibility criteria|0|||
27590536|NCT00838110|80344698|FG001|Overall Study|Did not meet eligibility criteria|0|||
27590537|NCT00838110|80344699|FG002|Overall Study|Did not meet eligibility criteria|1|||
27590538|NCT00838110|80344700|FG003|Overall Study|Did not meet eligibility criteria|2|||
27590539|NCT00838110|80344697|FG000|Overall Study|Randomized but not treated|0|||
27590540|NCT00838110|80344698|FG001|Overall Study|Randomized but not treated|1|||
27590541|NCT00838110|80344699|FG002|Overall Study|Randomized but not treated|0|||
27590542|NCT00838110|80344700|FG003|Overall Study|Randomized but not treated|0|||
27590543|NCT00518115|80344706|FG000|Overall Study|Adverse Event|6|||
27590544|NCT00518115|80344707|FG001|Overall Study|Adverse Event|1|||
27590545|NCT00518115|80344708|FG002|Overall Study|Adverse Event|5|||
27590546|NCT00518115|80344709|FG003|Overall Study|Adverse Event|6|||
27690321|NCT01642251|80702623|FG001|Overall Study|Other complicating disease|0|||
27690322|NCT01642251|80702624|FG002|Overall Study|Other complicating disease|1|||
27690323|NCT01642251|80702625|FG003|Overall Study|Other complicating disease|0|||
27690324|NCT01642251|80702622|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
27690325|NCT01642251|80702623|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
27690326|NCT01642251|80702624|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
27690327|NCT01642251|80702625|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
27690328|NCT00918580|80702626|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
27690329|NCT00918580|80702626|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
27690330|NCT00918580|80702626|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
27690331|NCT00918580|80702626|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
27590547|NCT00518115|80344710|FG004|Overall Study|Adverse Event|5|||
27690332|NCT00918580|80702626|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
27690333|NCT00918580|80702626|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
27690334|NCT00918580|80702626|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
27690335|NCT02891408|80702627|FG000|Overall Study|Lost to Follow-up|0|||
27690336|NCT02891408|80702628|FG001|Overall Study|Lost to Follow-up|0|||
27690337|NCT02891408|80702629|FG002|Overall Study|Lost to Follow-up|1|||
27690338|NCT02891408|80702630|FG003|Overall Study|Lost to Follow-up|0|||
27690339|NCT02891408|80702631|FG004|Overall Study|Lost to Follow-up|0|||
27690340|NCT02891408|80702632|FG005|Overall Study|Lost to Follow-up|0|||
27690341|NCT02891408|80702633|FG006|Overall Study|Lost to Follow-up|0|||
27690342|NCT01659853|80702635|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
27690343|NCT01659853|80702636|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
27690344|NCT01659853|80702635|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
27690345|NCT01659853|80702636|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
27690346|NCT02891837|80702639|FG000|Overall Study|Lost to Follow-up|2|||
27690347|NCT02891837|80702640|FG001|Overall Study|Lost to Follow-up|0|||
27690348|NCT02891837|80702639|FG000|Overall Study|Withdrawal by Subject|1|||
27690349|NCT02891837|80702640|FG001|Overall Study|Withdrawal by Subject|0|||
27690350|NCT03866473|80702644|FG000|Phase 1|Death|1|||
27690351|NCT03866473|80702645|FG001|Phase 1|Death|0|||
27690352|NCT03866473|80702644|FG000|Phase 2|Death|0|||
27690353|NCT03866473|80702645|FG001|Phase 2|Death|2|||
27690354|NCT03866473|80702644|FG000|Phase 2|Dropped|1|||
27690355|NCT03866473|80702645|FG001|Phase 2|Dropped|1|||
27690356|NCT03866473|80702644|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
27690357|NCT03866473|80702645|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
27690358|NCT05323396|80702646|FG000|Overall Study|Lost to Follow-up|1|||
27690359|NCT05323396|80702647|FG001|Overall Study|Lost to Follow-up|31|||
27690360|NCT05323396|80702646|FG000|Overall Study|Pregnancy|1|||
27690361|NCT05323396|80702647|FG001|Overall Study|Pregnancy|0|||
27690362|NCT00461032|80702651|FG000|Overall Study|Adverse Event|5|||
27690363|NCT00461032|80702652|FG001|Overall Study|Adverse Event|6|||
27690364|NCT00461032|80702651|FG000|Overall Study|Lack of Efficacy|5|||
27690365|NCT00461032|80702652|FG001|Overall Study|Lack of Efficacy|1|||
27690366|NCT00461032|80702651|FG000|Overall Study|Lost to Follow-up|7|||
27690367|NCT00461032|80702652|FG001|Overall Study|Lost to Follow-up|12|||
27690368|NCT00461032|80702651|FG000|Overall Study|Protocol Violation|4|||
27690369|NCT00461032|80702652|FG001|Overall Study|Protocol Violation|4|||
27690370|NCT00461032|80702651|FG000|Overall Study|Withdrawal by Subject|7|||
27690371|NCT00461032|80702652|FG001|Overall Study|Withdrawal by Subject|15|||
27690372|NCT00461032|80702651|FG000|Overall Study|Patient Moved or Relocated|2|||
27690373|NCT00461032|80702652|FG001|Overall Study|Patient Moved or Relocated|1|||
27690374|NCT00461032|80702651|FG000|Overall Study|Other|7|||
27690375|NCT00461032|80702652|FG001|Overall Study|Other|5|||
27690376|NCT02533531|80702653|FG000|Overall Study|Device did not turn on|1|||
27690377|NCT01237587|80702654|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
27690378|NCT01237587|80702655|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
27690379|NCT01237587|80702654|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
27690380|NCT01237587|80702655|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
27690381|NCT01237587|80702654|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
27690382|NCT01237587|80702655|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
27690383|NCT01237587|80702654|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
27690384|NCT01237587|80702655|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
27690385|NCT01237587|80702654|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
27690386|NCT01237587|80702655|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
27690387|NCT01237587|80702654|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
27690388|NCT01237587|80702655|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
27690389|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
27690390|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
27690391|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
27690392|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
27690393|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
27690394|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
27690395|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
27690396|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
27690397|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
27690398|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
27690399|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
27690400|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
27690401|NCT01237587|80702654|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
27690402|NCT01237587|80702655|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
27690403|NCT01237587|80702654|FG000|Taper Phase|Adverse Event|0|||
27690404|NCT01237587|80702655|FG001|Taper Phase|Adverse Event|2|||
27690405|NCT01237587|80702654|FG000|Taper Phase|Protocol Violation|2|||
27690406|NCT01237587|80702655|FG001|Taper Phase|Protocol Violation|0|||
27690407|NCT01237587|80702654|FG000|Taper Phase|Lack of Efficacy|2|||
27690408|NCT01237587|80702655|FG001|Taper Phase|Lack of Efficacy|5|||
27690409|NCT01237587|80702654|FG000|Taper Phase|Parent/Guardian Decision|0|||
27690410|NCT01237587|80702655|FG001|Taper Phase|Parent/Guardian Decision|2|||
27690411|NCT01237587|80702654|FG000|Taper Phase|Sponsor Decision|1|||
27690412|NCT01237587|80702655|FG001|Taper Phase|Sponsor Decision|0|||
27690413|NCT01237587|80702654|FG000|Taper Phase|Withdrawal by Subject|0|||
27690414|NCT01237587|80702655|FG001|Taper Phase|Withdrawal by Subject|1|||
27690415|NCT01768637|80702656|FG000|Overall Study|Lost to Follow-up|2|||
27690416|NCT01768637|80702657|FG001|Overall Study|Lost to Follow-up|7|||
27690417|NCT01768637|80702656|FG000|Overall Study|Difficult blood draw|1|||
27690418|NCT01768637|80702657|FG001|Overall Study|Difficult blood draw|0|||
27690419|NCT04275089|80702663|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
27690420|NCT02337751|80702671|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
27690421|NCT02337751|80702672|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
27690422|NCT02337751|80702671|FG000|Overall Study|Voluntary Withdrawal|6|||
27690423|NCT02337751|80702672|FG001|Overall Study|Voluntary Withdrawal|8|||
27690424|NCT02337751|80702671|FG000|Overall Study|Lack of Efficacy|2|||
27690425|NCT02337751|80702672|FG001|Overall Study|Lack of Efficacy|5|||
27690426|NCT02337751|80702671|FG000|Overall Study|Investigator's Judgement|1|||
27690427|NCT02337751|80702672|FG001|Overall Study|Investigator's Judgement|0|||
27690428|NCT01383499|80702673|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
27690429|NCT01383499|80702674|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27690430|NCT01383499|80702675|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27690431|NCT01383499|80702676|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
27690432|NCT01103362|80702677|FG000|Overall Study|study terminated|596|||
27690433|NCT02457559|80702678|FG000|Overall Study|Progressive Disease|1|||
27690434|NCT02457559|80702679|FG001|Overall Study|Progressive Disease|2|||
27590548|NCT00518115|80344711|FG005|Overall Study|Adverse Event|5|||
27590549|NCT00518115|80344712|FG006|Overall Study|Adverse Event|5|||
27590550|NCT00518115|80344713|FG007|Overall Study|Adverse Event|10|||
27590551|NCT00518115|80344714|FG008|Overall Study|Adverse Event|2|||
27690435|NCT02457559|80702680|FG002|Overall Study|Progressive Disease|3|||
27590552|NCT00518115|80344715|FG009|Overall Study|Adverse Event|9|||
27590553|NCT00518115|80344706|FG000|Overall Study|Lost to Follow-up|0|||
27690436|NCT02457559|80702681|FG003|Overall Study|Progressive Disease|0|||
27690437|NCT02457559|80702682|FG004|Overall Study|Progressive Disease|0|||
27690438|NCT02457559|80702683|FG005|Overall Study|Progressive Disease|2|||
27690439|NCT02457559|80702684|FG006|Overall Study|Progressive Disease|1|||
27690440|NCT02457559|80702685|FG007|Overall Study|Progressive Disease|0|||
27690441|NCT02457559|80702686|FG008|Overall Study|Progressive Disease|1|||
27690442|NCT02457559|80702687|FG009|Overall Study|Progressive Disease|1|||
27690443|NCT02457559|80702688|FG010|Overall Study|Progressive Disease|1|||
27690444|NCT02457559|80702678|FG000|Overall Study|Investigator's Discretion|0|||
27690445|NCT02457559|80702679|FG001|Overall Study|Investigator's Discretion|0|||
27690446|NCT02457559|80702680|FG002|Overall Study|Investigator's Discretion|2|||
27690447|NCT02457559|80702681|FG003|Overall Study|Investigator's Discretion|0|||
27690448|NCT02457559|80702682|FG004|Overall Study|Investigator's Discretion|1|||
27690449|NCT02457559|80702683|FG005|Overall Study|Investigator's Discretion|0|||
27690450|NCT02457559|80702684|FG006|Overall Study|Investigator's Discretion|1|||
27690451|NCT02457559|80702685|FG007|Overall Study|Investigator's Discretion|0|||
27690452|NCT02457559|80702686|FG008|Overall Study|Investigator's Discretion|1|||
27690453|NCT02457559|80702687|FG009|Overall Study|Investigator's Discretion|0|||
27590554|NCT00518115|80344707|FG001|Overall Study|Lost to Follow-up|0|||
27690454|NCT02457559|80702688|FG010|Overall Study|Investigator's Discretion|1|||
27690455|NCT02457559|80702678|FG000|Overall Study|Adverse Event|0|||
27690456|NCT02457559|80702679|FG001|Overall Study|Adverse Event|1|||
27690457|NCT02457559|80702680|FG002|Overall Study|Adverse Event|2|||
27690458|NCT02457559|80702681|FG003|Overall Study|Adverse Event|0|||
27690459|NCT02457559|80702682|FG004|Overall Study|Adverse Event|0|||
27690460|NCT02457559|80702683|FG005|Overall Study|Adverse Event|0|||
27690461|NCT02457559|80702684|FG006|Overall Study|Adverse Event|0|||
27690462|NCT02457559|80702685|FG007|Overall Study|Adverse Event|0|||
27690463|NCT02457559|80702686|FG008|Overall Study|Adverse Event|0|||
27690464|NCT02457559|80702687|FG009|Overall Study|Adverse Event|0|||
27690465|NCT02457559|80702688|FG010|Overall Study|Adverse Event|0|||
27690466|NCT02457559|80702678|FG000|Overall Study|Reason not Specified|1|||
27690467|NCT02457559|80702679|FG001|Overall Study|Reason not Specified|0|||
27690468|NCT02457559|80702680|FG002|Overall Study|Reason not Specified|0|||
27690469|NCT02457559|80702681|FG003|Overall Study|Reason not Specified|0|||
27690470|NCT02457559|80702682|FG004|Overall Study|Reason not Specified|0|||
27690471|NCT02457559|80702683|FG005|Overall Study|Reason not Specified|0|||
27690472|NCT02457559|80702684|FG006|Overall Study|Reason not Specified|0|||
27690473|NCT02457559|80702685|FG007|Overall Study|Reason not Specified|0|||
27690474|NCT02457559|80702686|FG008|Overall Study|Reason not Specified|0|||
27690475|NCT02457559|80702687|FG009|Overall Study|Reason not Specified|2|||
27690476|NCT02457559|80702688|FG010|Overall Study|Reason not Specified|0|||
27690477|NCT02457559|80702678|FG000|Overall Study|Death|0|||
27690478|NCT02457559|80702679|FG001|Overall Study|Death|0|||
27690479|NCT02457559|80702680|FG002|Overall Study|Death|0|||
27690480|NCT02457559|80702681|FG003|Overall Study|Death|0|||
27690481|NCT02457559|80702682|FG004|Overall Study|Death|0|||
27690482|NCT02457559|80702683|FG005|Overall Study|Death|0|||
27816806|NCT03103100|81162732|FG000|Overall Study|Adverse Event|1|||
27816807|NCT03103100|81162733|FG001|Overall Study|Adverse Event|0|||
27816808|NCT03103100|81162734|FG002|Overall Study|Adverse Event|0|||
27816809|NCT03103100|81162732|FG000|Overall Study|Physician Decision|1|||
27816810|NCT03103100|81162733|FG001|Overall Study|Physician Decision|0|||
27816811|NCT03103100|81162734|FG002|Overall Study|Physician Decision|2|||
27590555|NCT00518115|80344708|FG002|Overall Study|Lost to Follow-up|2|||
27590556|NCT00518115|80344709|FG003|Overall Study|Lost to Follow-up|3|||
27690483|NCT02457559|80702684|FG006|Overall Study|Death|0|||
27816812|NCT00576381|81162735|FG000|Overall Study|Reoperation|3|||
27816813|NCT00576381|81162735|FG000|Overall Study|Adverse Event|4|||
27816814|NCT02534493|81162744|FG000|Overall Study|Lost to Follow-up|1|||
27816815|NCT02534493|81162744|FG000|Overall Study|Withdrawal by Subject|1|||
27816816|NCT01241461|81162745|FG000|Overall Study|Progressive Disease|3|||
27816817|NCT01241461|81162746|FG001|Overall Study|Progressive Disease|6|||
27816818|NCT03980483|81162747|FG000|Overall Study|Adverse Event|13|||
27816819|NCT03980483|81162748|FG001|Overall Study|Adverse Event|29|||
27816820|NCT03980483|81162749|FG002|Overall Study|Adverse Event|11|||
27816821|NCT03980483|81162750|FG003|Overall Study|Adverse Event|2|||
27816822|NCT03980483|81162751|FG004|Overall Study|Adverse Event|2|||
27816823|NCT03980483|81162752|FG005|Overall Study|Adverse Event|2|||
27816824|NCT03980483|81162747|FG000|Overall Study|Lack of Efficacy|7|||
27816825|NCT03980483|81162748|FG001|Overall Study|Lack of Efficacy|6|||
27690484|NCT02457559|80702685|FG007|Overall Study|Death|0|||
27690485|NCT02457559|80702686|FG008|Overall Study|Death|1|||
27690486|NCT02457559|80702687|FG009|Overall Study|Death|1|||
27816826|NCT03980483|81162749|FG002|Overall Study|Lack of Efficacy|0|||
27690487|NCT02457559|80702688|FG010|Overall Study|Death|0|||
27690488|NCT04002401|80702692|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
27690489|NCT04002401|80702692|FG000|Overall Study|Death|10|||
27816827|NCT03980483|81162750|FG003|Overall Study|Lack of Efficacy|3|||
27816828|NCT03980483|81162751|FG004|Overall Study|Lack of Efficacy|1|||
27816829|NCT03980483|81162752|FG005|Overall Study|Lack of Efficacy|1|||
27816830|NCT03980483|81162747|FG000|Overall Study|Lost to Follow-up|2|||
27816831|NCT03980483|81162748|FG001|Overall Study|Lost to Follow-up|4|||
27690490|NCT04002401|80702692|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
27690491|NCT04002401|80702692|FG000|Overall Study|Enrolled but Never Treated|1|||
27690492|NCT04002401|80702692|FG000|Overall Study|Lost to Follow-up|1|||
27690493|NCT00309959|80702695|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
27690494|NCT01065844|80702705|FG000|Overall Study|Adverse Event|5|||
27690495|NCT01676909|80702710|FG000|Overall Study|Withdrawal by Subject|3|||
27690496|NCT01676909|80702711|FG001|Overall Study|Withdrawal by Subject|5|||
27690497|NCT01676909|80702710|FG000|Overall Study|Lost to Follow-up|15|||
27690498|NCT01676909|80702711|FG001|Overall Study|Lost to Follow-up|9|||
27690499|NCT00446992|80702717|FG000|Overall Study|Adverse Event|11|||
27690500|NCT00446992|80702717|FG000|Overall Study|Lost to Follow-up|5|||
27690501|NCT03265938|80702719|FG000|Overall Study|Withdrawal by Subject|1|||
27690502|NCT03265938|80702719|FG000|Overall Study|Physician Decision|1|||
27690503|NCT03265938|80702719|FG000|Overall Study|friable mass|6|||
27690504|NCT01323634|80702720|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
27690505|NCT01323634|80702721|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
27690506|NCT01323634|80702722|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
27690507|NCT01323634|80702720|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
27690508|NCT01323634|80702721|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
27690509|NCT01323634|80702722|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
27690510|NCT01323634|80702720|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
27690511|NCT01323634|80702721|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27690512|NCT01323634|80702722|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27690513|NCT01323634|80702720|FG000|2-week Run-in Period|Physician Decision|5|||
27690514|NCT01323634|80702721|FG001|2-week Run-in Period|Physician Decision|0|||
27690515|NCT01323634|80702722|FG002|2-week Run-in Period|Physician Decision|0|||
27690516|NCT01323634|80702720|FG000|2-week Run-in Period|Protocol Violation|1|||
27690517|NCT01323634|80702721|FG001|2-week Run-in Period|Protocol Violation|0|||
27690518|NCT01323634|80702722|FG002|2-week Run-in Period|Protocol Violation|0|||
27690519|NCT01323634|80702720|FG000|2-week Run-in Period|Adverse Event|1|||
27690520|NCT01323634|80702721|FG001|2-week Run-in Period|Adverse Event|0|||
27690521|NCT01323634|80702722|FG002|2-week Run-in Period|Adverse Event|0|||
27690522|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27690523|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
27690524|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
27690525|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27690526|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27690527|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
27690528|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27690529|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
27690530|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
27590557|NCT00518115|80344710|FG004|Overall Study|Lost to Follow-up|1|||
27590558|NCT00518115|80344711|FG005|Overall Study|Lost to Follow-up|3|||
27590559|NCT00518115|80344712|FG006|Overall Study|Lost to Follow-up|0|||
27590560|NCT00518115|80344713|FG007|Overall Study|Lost to Follow-up|1|||
27590561|NCT00518115|80344714|FG008|Overall Study|Lost to Follow-up|1|||
27590562|NCT00518115|80344715|FG009|Overall Study|Lost to Follow-up|1|||
27690531|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27690532|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27816832|NCT03980483|81162749|FG002|Overall Study|Lost to Follow-up|2|||
27816833|NCT03980483|81162750|FG003|Overall Study|Lost to Follow-up|1|||
27816834|NCT03980483|81162751|FG004|Overall Study|Lost to Follow-up|2|||
27816835|NCT03980483|81162752|FG005|Overall Study|Lost to Follow-up|0|||
27816836|NCT03980483|81162747|FG000|Overall Study|Protocol Violation|4|||
27816837|NCT03980483|81162748|FG001|Overall Study|Protocol Violation|2|||
27816838|NCT03980483|81162749|FG002|Overall Study|Protocol Violation|1|||
27690533|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27690534|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
27690535|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
27816839|NCT03980483|81162750|FG003|Overall Study|Protocol Violation|1|||
27690536|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
27690537|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27690538|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
27690539|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
27690540|NCT01323634|80702720|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
27690541|NCT01323634|80702721|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
27690542|NCT01323634|80702722|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
27690543|NCT02656823|80702723|FG000|Overall Study|Adverse Event|3|||
27690544|NCT02656823|80702723|FG000|Overall Study|Lost to Follow-up|2|||
27690545|NCT00321373|80702730|FG000|Overall Study|Adverse Event|0|||
27816840|NCT03980483|81162751|FG004|Overall Study|Protocol Violation|0|||
27590563|NCT00518115|80344706|FG000|Overall Study|Protocol Violation|1|||
27590564|NCT00518115|80344707|FG001|Overall Study|Protocol Violation|3|||
27690546|NCT00321373|80702731|FG001|Overall Study|Adverse Event|0|||
27690547|NCT00321373|80702732|FG002|Overall Study|Adverse Event|1|||
27690548|NCT00321373|80702730|FG000|Overall Study|Lost to Follow-up|1|||
27816841|NCT03980483|81162752|FG005|Overall Study|Protocol Violation|0|||
27816842|NCT03980483|81162747|FG000|Overall Study|Physician Decision|14|||
27590565|NCT00518115|80344708|FG002|Overall Study|Protocol Violation|1|||
27590566|NCT00518115|80344709|FG003|Overall Study|Protocol Violation|0|||
27590567|NCT00518115|80344710|FG004|Overall Study|Protocol Violation|0|||
27590568|NCT00518115|80344711|FG005|Overall Study|Protocol Violation|0|||
27590569|NCT00518115|80344712|FG006|Overall Study|Protocol Violation|0|||
27590570|NCT00518115|80344713|FG007|Overall Study|Protocol Violation|0|||
27590571|NCT00518115|80344714|FG008|Overall Study|Protocol Violation|0|||
27590572|NCT00518115|80344715|FG009|Overall Study|Protocol Violation|0|||
27590573|NCT00518115|80344706|FG000|Overall Study|Withdrawal by Subject|1|||
27590574|NCT00518115|80344707|FG001|Overall Study|Withdrawal by Subject|1|||
27590575|NCT00518115|80344708|FG002|Overall Study|Withdrawal by Subject|5|||
27590576|NCT00518115|80344709|FG003|Overall Study|Withdrawal by Subject|0|||
27590577|NCT00518115|80344710|FG004|Overall Study|Withdrawal by Subject|2|||
27590578|NCT00518115|80344711|FG005|Overall Study|Withdrawal by Subject|1|||
27590579|NCT00518115|80344712|FG006|Overall Study|Withdrawal by Subject|0|||
27590580|NCT00518115|80344713|FG007|Overall Study|Withdrawal by Subject|2|||
27590581|NCT00518115|80344714|FG008|Overall Study|Withdrawal by Subject|1|||
27590582|NCT00518115|80344715|FG009|Overall Study|Withdrawal by Subject|3|||
27590583|NCT00518115|80344706|FG000|Overall Study|Lack of Efficacy|1|||
27590584|NCT00518115|80344707|FG001|Overall Study|Lack of Efficacy|0|||
27590585|NCT00518115|80344708|FG002|Overall Study|Lack of Efficacy|1|||
27590586|NCT00518115|80344709|FG003|Overall Study|Lack of Efficacy|1|||
27590587|NCT00518115|80344710|FG004|Overall Study|Lack of Efficacy|0|||
27590588|NCT00518115|80344711|FG005|Overall Study|Lack of Efficacy|0|||
27590589|NCT00518115|80344712|FG006|Overall Study|Lack of Efficacy|0|||
27590590|NCT00518115|80344713|FG007|Overall Study|Lack of Efficacy|1|||
27590591|NCT00518115|80344714|FG008|Overall Study|Lack of Efficacy|0|||
27590592|NCT00518115|80344715|FG009|Overall Study|Lack of Efficacy|0|||
27590593|NCT00518115|80344706|FG000|Overall Study|Non-Compliance|1|||
27590594|NCT00518115|80344707|FG001|Overall Study|Non-Compliance|0|||
27590595|NCT00518115|80344708|FG002|Overall Study|Non-Compliance|1|||
27590596|NCT00518115|80344709|FG003|Overall Study|Non-Compliance|0|||
27590597|NCT00518115|80344710|FG004|Overall Study|Non-Compliance|1|||
27590598|NCT00518115|80344711|FG005|Overall Study|Non-Compliance|1|||
27590599|NCT00518115|80344712|FG006|Overall Study|Non-Compliance|1|||
27590600|NCT00518115|80344713|FG007|Overall Study|Non-Compliance|1|||
27590601|NCT00518115|80344714|FG008|Overall Study|Non-Compliance|0|||
27590602|NCT00518115|80344715|FG009|Overall Study|Non-Compliance|1|||
27590603|NCT00518115|80344706|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
27590604|NCT00518115|80344707|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
27590605|NCT00518115|80344708|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590606|NCT00518115|80344709|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590607|NCT00518115|80344710|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590608|NCT00518115|80344711|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
27590609|NCT00518115|80344712|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590610|NCT00518115|80344713|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590611|NCT00518115|80344714|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590612|NCT00518115|80344715|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
27590613|NCT00518115|80344706|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
27590614|NCT00518115|80344707|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590615|NCT00518115|80344708|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590616|NCT00518115|80344709|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590617|NCT00518115|80344710|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590618|NCT00518115|80344711|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590619|NCT00518115|80344712|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590620|NCT00518115|80344713|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590621|NCT00518115|80344714|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590622|NCT00518115|80344715|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
27590623|NCT00518115|80344706|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590624|NCT00518115|80344707|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590625|NCT00518115|80344708|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
27590626|NCT00518115|80344709|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590627|NCT00518115|80344710|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590628|NCT00518115|80344711|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590629|NCT00518115|80344712|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590630|NCT00518115|80344713|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590631|NCT00518115|80344714|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
27690549|NCT00321373|80702731|FG001|Overall Study|Lost to Follow-up|0|||
27816843|NCT03980483|81162748|FG001|Overall Study|Physician Decision|10|||
27816844|NCT03980483|81162749|FG002|Overall Study|Physician Decision|7|||
27816845|NCT03980483|81162750|FG003|Overall Study|Physician Decision|4|||
27816846|NCT03980483|81162751|FG004|Overall Study|Physician Decision|4|||
27816847|NCT03980483|81162752|FG005|Overall Study|Physician Decision|2|||
27816848|NCT03980483|81162747|FG000|Overall Study|Withdrawal by Subject|38|||
27816849|NCT03980483|81162748|FG001|Overall Study|Withdrawal by Subject|21|||
27816850|NCT03980483|81162749|FG002|Overall Study|Withdrawal by Subject|15|||
27816851|NCT03980483|81162750|FG003|Overall Study|Withdrawal by Subject|5|||
27816852|NCT03980483|81162751|FG004|Overall Study|Withdrawal by Subject|3|||
27816853|NCT03980483|81162752|FG005|Overall Study|Withdrawal by Subject|4|||
27816854|NCT03980483|81162747|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
27816855|NCT03980483|81162748|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
27816856|NCT03980483|81162749|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27816857|NCT03980483|81162750|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
27816858|NCT03980483|81162751|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27816859|NCT03980483|81162752|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27816860|NCT03980483|81162747|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
27816861|NCT03980483|81162748|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
27816862|NCT03980483|81162749|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
27816863|NCT03980483|81162750|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
27816864|NCT03980483|81162751|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
27816865|NCT03980483|81162752|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
27816866|NCT03980483|81162747|FG000|Overall Study|Other|0|||
27816867|NCT03980483|81162748|FG001|Overall Study|Other|1|||
27816868|NCT03980483|81162749|FG002|Overall Study|Other|0|||
27816869|NCT03980483|81162750|FG003|Overall Study|Other|0|||
27816870|NCT03980483|81162751|FG004|Overall Study|Other|0|||
27816871|NCT03980483|81162752|FG005|Overall Study|Other|0|||
27816872|NCT01424722|81162753|FG000|Overall Study|Sponsor terminated investigation|2258|||
27816873|NCT01030965|81162756|FG000|Overall Study|Lack of Efficacy|3|||
27816874|NCT01030965|81162757|FG001|Overall Study|Lack of Efficacy|2|||
27816875|NCT01030965|81162758|FG002|Overall Study|Lack of Efficacy|0|||
27816876|NCT01030965|81162759|FG003|Overall Study|Lack of Efficacy|3|||
27816877|NCT01030965|81162756|FG000|Overall Study|Protocol Violation|1|||
27590632|NCT00518115|80344715|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
27590633|NCT00518115|80344706|FG000|Overall Study|Wrong Monotherapy Administered|0|||
27590634|NCT00518115|80344707|FG001|Overall Study|Wrong Monotherapy Administered|0|||
27590635|NCT00518115|80344708|FG002|Overall Study|Wrong Monotherapy Administered|1|||
27590636|NCT00518115|80344709|FG003|Overall Study|Wrong Monotherapy Administered|0|||
27590637|NCT00518115|80344710|FG004|Overall Study|Wrong Monotherapy Administered|0|||
27816878|NCT01030965|81162757|FG001|Overall Study|Protocol Violation|1|||
27816879|NCT01030965|81162758|FG002|Overall Study|Protocol Violation|1|||
27590638|NCT00518115|80344711|FG005|Overall Study|Wrong Monotherapy Administered|0|||
27690550|NCT00321373|80702732|FG002|Overall Study|Lost to Follow-up|1|||
27690551|NCT00321373|80702730|FG000|Overall Study|Withdrawal by Subject|1|||
27816880|NCT01030965|81162759|FG003|Overall Study|Protocol Violation|1|||
27816881|NCT01030965|81162756|FG000|Overall Study|Adverse Event|0|||
27816882|NCT01030965|81162757|FG001|Overall Study|Adverse Event|1|||
27816883|NCT01030965|81162758|FG002|Overall Study|Adverse Event|2|||
27816884|NCT01030965|81162759|FG003|Overall Study|Adverse Event|1|||
27816885|NCT01030965|81162756|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
27816886|NCT01030965|81162757|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
27816887|NCT01030965|81162758|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
27816888|NCT01030965|81162759|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
27816889|NCT01030965|81162756|FG000|Overall Study|Withdrawal by Subject|0|||
27816890|NCT01030965|81162757|FG001|Overall Study|Withdrawal by Subject|1|||
27878909|NCT03207815|81391349|FG000|Overall Study|Withdrew Consent|1|||
27816891|NCT01030965|81162758|FG002|Overall Study|Withdrawal by Subject|0|||
27816892|NCT01030965|81162759|FG003|Overall Study|Withdrawal by Subject|2|||
27816893|NCT02388763|81162764|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
27816894|NCT02388763|81162765|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
27816895|NCT02388763|81162764|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
27816896|NCT02388763|81162765|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
27816897|NCT03093324|81162766|FG000|Overall Study|Adverse Event|4|||
27816898|NCT03093324|81162767|FG001|Overall Study|Adverse Event|15|||
27816899|NCT03093324|81162766|FG000|Overall Study|Lost to Follow-up|1|||
27816900|NCT03093324|81162767|FG001|Overall Study|Lost to Follow-up|0|||
27816901|NCT03093324|81162766|FG000|Overall Study|Protocol Deviation|2|||
27878910|NCT03207815|81391350|FG001|Overall Study|Withdrew Consent|0|||
27878911|NCT00571727|81391352|FG000|Overall Study|Did not enter in this study|1|||
27590639|NCT00518115|80344712|FG006|Overall Study|Wrong Monotherapy Administered|1|||
27690552|NCT00321373|80702731|FG001|Overall Study|Withdrawal by Subject|0|||
27690553|NCT00321373|80702732|FG002|Overall Study|Withdrawal by Subject|0|||
27690554|NCT00321373|80702730|FG000|Overall Study|Other|0|||
27690555|NCT00321373|80702731|FG001|Overall Study|Other|0|||
27690556|NCT00321373|80702732|FG002|Overall Study|Other|1|||
27690557|NCT01844687|80702735|FG000|Visit 1|Protocol Violation|3|||
27878912|NCT00571727|81391352|FG000|Overall Study|Non-compliance|4|||
27878913|NCT00571727|81391352|FG000|Overall Study|Lost to Follow-up|30|||
27878914|NCT00571727|81391352|FG000|Overall Study|Poor growth|1|||
27878915|NCT00571727|81391352|FG000|Overall Study|Parent/patient decision|2|||
27878916|NCT00571727|81391352|FG000|Overall Study|Participant transferred to commercial drug|14|||
27590640|NCT00518115|80344713|FG007|Overall Study|Wrong Monotherapy Administered|0|||
27590641|NCT00518115|80344714|FG008|Overall Study|Wrong Monotherapy Administered|0|||
27816902|NCT03093324|81162767|FG001|Overall Study|Protocol Deviation|2|||
27816903|NCT03093324|81162766|FG000|Overall Study|Withdrawal by Subject|2|||
27816904|NCT03093324|81162767|FG001|Overall Study|Withdrawal by Subject|2|||
27816905|NCT00454636|81162772|FG000|Overall Study|Adverse Event|10|||
27816906|NCT00454636|81162773|FG001|Overall Study|Adverse Event|6|||
27816907|NCT00454636|81162774|FG002|Overall Study|Adverse Event|9|||
27816908|NCT00454636|81162775|FG003|Overall Study|Adverse Event|15|||
27816909|NCT00454636|81162772|FG000|Overall Study|Disease Progression|11|||
27816910|NCT00454636|81162773|FG001|Overall Study|Disease Progression|12|||
27816911|NCT00454636|81162774|FG002|Overall Study|Disease Progression|4|||
27816912|NCT00454636|81162775|FG003|Overall Study|Disease Progression|11|||
27816913|NCT00454636|81162772|FG000|Overall Study|Protocol Violation|3|||
27816914|NCT00454636|81162773|FG001|Overall Study|Protocol Violation|2|||
27816915|NCT00454636|81162774|FG002|Overall Study|Protocol Violation|3|||
27816916|NCT00454636|81162775|FG003|Overall Study|Protocol Violation|3|||
27816917|NCT00454636|81162772|FG000|Overall Study|Death|6|||
27816918|NCT00454636|81162773|FG001|Overall Study|Death|1|||
27816919|NCT00454636|81162774|FG002|Overall Study|Death|1|||
27816920|NCT00454636|81162775|FG003|Overall Study|Death|1|||
27816921|NCT00454636|81162772|FG000|Overall Study|Patient refusal|1|||
27816922|NCT00454636|81162773|FG001|Overall Study|Patient refusal|1|||
27816923|NCT00454636|81162774|FG002|Overall Study|Patient refusal|3|||
27816924|NCT00454636|81162775|FG003|Overall Study|Patient refusal|2|||
27816925|NCT00454636|81162772|FG000|Overall Study|Lost to Follow-up|0|||
27816926|NCT00454636|81162773|FG001|Overall Study|Lost to Follow-up|1|||
27816927|NCT00454636|81162774|FG002|Overall Study|Lost to Follow-up|0|||
27816928|NCT00454636|81162775|FG003|Overall Study|Lost to Follow-up|0|||
27816929|NCT01867242|81162778|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
27816930|NCT01867242|81162779|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
27816931|NCT01867242|81162780|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
27816932|NCT02636907|81162791|FG000|Autoinjector Assessment Period|Adverse Event|2|||
27816933|NCT02636907|81162791|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
27816934|NCT02636907|81162791|FG000|Extension Phase|Adverse Event|2|||
27816935|NCT02636907|81162791|FG000|Extension Phase|Withdrawal by Subject|4|||
27816936|NCT02636907|81162791|FG000|Extension Phase|Physician Decision|1|||
27816937|NCT02636907|81162791|FG000|Extension Phase|Lost to Follow-up|2|||
27816938|NCT02636907|81162791|FG000|Extension Phase|Lack of Efficacy|1|||
27816939|NCT00918567|81162794|FG000|Overall Study|Lack of Efficacy|3|||
27816940|NCT00918567|81162795|FG001|Overall Study|Lack of Efficacy|1|||
27878917|NCT00571727|81391352|FG000|Overall Study|Unable to provide study drug|6|||
27590642|NCT00518115|80344715|FG009|Overall Study|Wrong Monotherapy Administered|0|||
27816941|NCT00918567|81162794|FG000|Overall Study|Withdrawal by Subject|1|||
27816942|NCT00918567|81162795|FG001|Overall Study|Withdrawal by Subject|1|||
27816943|NCT00918567|81162794|FG000|Overall Study|Adverse Event|1|||
27816944|NCT00918567|81162795|FG001|Overall Study|Adverse Event|0|||
27816945|NCT03738332|81162798|FG000|Overall Study|Withdrawal by Subject|1|||
27816946|NCT00449150|81162801|FG000|Overall Study|Adverse Event|11|||
27816947|NCT00449150|81162802|FG001|Overall Study|Adverse Event|18|||
27816948|NCT00449150|81162803|FG002|Overall Study|Adverse Event|9|||
27816949|NCT00449150|81162801|FG000|Overall Study|Lack of Efficacy|1|||
27878918|NCT00571727|81391352|FG000|Overall Study|On-treatment at end of study|8|||
27816950|NCT00449150|81162802|FG001|Overall Study|Lack of Efficacy|2|||
27816951|NCT00449150|81162803|FG002|Overall Study|Lack of Efficacy|2|||
27816952|NCT00449150|81162801|FG000|Overall Study|Other|16|||
27816953|NCT00449150|81162802|FG001|Overall Study|Other|13|||
27816954|NCT00449150|81162803|FG002|Overall Study|Other|14|||
27816955|NCT00449150|81162801|FG000|Overall Study|Withdrawal by Subject|17|||
27690558|NCT01844687|80702735|FG000|Visit 1|Lost to Follow-up|5|||
27690559|NCT01844687|80702735|FG000|Visit 2|Withdrawal by Subject|1|||
27690560|NCT01844687|80702735|FG000|Visit 2|Protocol Violation|1|||
27690561|NCT01844687|80702735|FG000|Visit 3|Lost to Follow-up|1|||
27690562|NCT01844687|80702735|FG000|Visit 3|Withdrawal by Subject|3|||
27690563|NCT01844687|80702735|FG000|Visit 3|child care problems|1|||
27690564|NCT01844687|80702735|FG000|Visit 4|Pregnancy|1|||
27816956|NCT00449150|81162802|FG001|Overall Study|Withdrawal by Subject|18|||
27816957|NCT00449150|81162803|FG002|Overall Study|Withdrawal by Subject|21|||
27816958|NCT00449150|81162801|FG000|Overall Study|Protocol Violation|1|||
27816959|NCT00449150|81162802|FG001|Overall Study|Protocol Violation|2|||
27816960|NCT00449150|81162803|FG002|Overall Study|Protocol Violation|1|||
27816961|NCT00429364|81162804|FG000|Overall Study|Withdrawal by Subject|11|||
27816962|NCT00429364|81162805|FG001|Overall Study|Withdrawal by Subject|5|||
27816963|NCT00429364|81162804|FG000|Overall Study|Physician Decision|4|||
27816964|NCT00429364|81162805|FG001|Overall Study|Physician Decision|2|||
27816965|NCT00429364|81162804|FG000|Overall Study|Lost to Follow-up|7|||
27816966|NCT00429364|81162805|FG001|Overall Study|Lost to Follow-up|6|||
27816967|NCT00429364|81162804|FG000|Overall Study|Death|0|||
27816968|NCT00429364|81162805|FG001|Overall Study|Death|1|||
27816969|NCT00429364|81162804|FG000|Overall Study|Underwent aortic root surgery|10|||
27816970|NCT00429364|81162805|FG001|Overall Study|Underwent aortic root surgery|18|||
27816971|NCT00429364|81162804|FG000|Overall Study|Pregnancy|0|||
27816972|NCT00429364|81162805|FG001|Overall Study|Pregnancy|1|||
27816973|NCT03213210|81162807|FG000|Overall Study|Lost to Follow-up|2|||
27816974|NCT03213210|81162807|FG000|Overall Study|Study termination|3|||
27816975|NCT00925769|81162808|FG000|Overall Study|Major toxicity|1|||
27816976|NCT00925769|81162809|FG001|Overall Study|Major toxicity|0|||
27816977|NCT00925769|81162810|FG002|Overall Study|Major toxicity|1|||
27816978|NCT00925769|81162811|FG003|Overall Study|Major toxicity|1|||
27878919|NCT01058642|81391354|FG000|Treatment Period 1|Adverse Event|0|||
27878920|NCT01058642|81391355|FG001|Treatment Period 1|Adverse Event|1|||
27878921|NCT01058642|81391356|FG002|Treatment Period 1|Adverse Event|1|||
27878922|NCT01058642|81391357|FG003|Treatment Period 1|Adverse Event|0|||
27878923|NCT01058642|81391354|FG000|Treatment Period 1|Physician Decision|0|||
27816979|NCT00925769|81162812|FG004|Overall Study|Major toxicity|0|||
27816980|NCT00925769|81162813|FG005|Overall Study|Major toxicity|0|||
27878924|NCT01058642|81391355|FG001|Treatment Period 1|Physician Decision|0|||
27690565|NCT01844687|80702735|FG000|Visit 4|Lost to Follow-up|1|||
27690566|NCT01844687|80702735|FG000|Visit 4|Withdrawal by Subject|2|||
27690567|NCT00768079|80702736|FG000|Overall Study|Lost to Follow-up|2|||
27690568|NCT00768079|80702737|FG001|Overall Study|Lost to Follow-up|0|||
27816981|NCT00925769|81162808|FG000|Overall Study|Disease progression|4|||
27878925|NCT01058642|81391356|FG002|Treatment Period 1|Physician Decision|1|||
27690569|NCT00768079|80702738|FG002|Overall Study|Lost to Follow-up|4|||
27690570|NCT00768079|80702736|FG000|Overall Study|Participant incarcerated|0|||
27878926|NCT01058642|81391357|FG003|Treatment Period 1|Physician Decision|0|||
27590643|NCT00518115|80344706|FG000|Overall Study|Violation of Exclusion Criteria|0|||
27590644|NCT00518115|80344707|FG001|Overall Study|Violation of Exclusion Criteria|0|||
27590645|NCT00518115|80344708|FG002|Overall Study|Violation of Exclusion Criteria|0|||
27590646|NCT00518115|80344709|FG003|Overall Study|Violation of Exclusion Criteria|1|||
27590647|NCT00518115|80344710|FG004|Overall Study|Violation of Exclusion Criteria|0|||
27590648|NCT00518115|80344711|FG005|Overall Study|Violation of Exclusion Criteria|0|||
27590649|NCT00518115|80344712|FG006|Overall Study|Violation of Exclusion Criteria|1|||
27590650|NCT00518115|80344713|FG007|Overall Study|Violation of Exclusion Criteria|0|||
27590651|NCT00518115|80344714|FG008|Overall Study|Violation of Exclusion Criteria|0|||
27590652|NCT00518115|80344715|FG009|Overall Study|Violation of Exclusion Criteria|0|||
27590653|NCT00518115|80344706|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
27590654|NCT00518115|80344707|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
27590655|NCT00518115|80344708|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
27590656|NCT00518115|80344709|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
27590657|NCT00518115|80344710|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
27590658|NCT00518115|80344711|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
27590659|NCT00518115|80344712|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
27590660|NCT00518115|80344713|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
27590661|NCT00518115|80344714|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
27590662|NCT00518115|80344715|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
27590663|NCT00518115|80344706|FG000|Overall Study|Withdrew Consent|0|||
27590664|NCT00518115|80344707|FG001|Overall Study|Withdrew Consent|0|||
27590665|NCT00518115|80344708|FG002|Overall Study|Withdrew Consent|0|||
27590666|NCT00518115|80344709|FG003|Overall Study|Withdrew Consent|0|||
27590667|NCT00518115|80344710|FG004|Overall Study|Withdrew Consent|0|||
27590668|NCT00518115|80344711|FG005|Overall Study|Withdrew Consent|1|||
27590669|NCT00518115|80344712|FG006|Overall Study|Withdrew Consent|0|||
27590670|NCT00518115|80344713|FG007|Overall Study|Withdrew Consent|0|||
27590671|NCT00518115|80344714|FG008|Overall Study|Withdrew Consent|0|||
27590672|NCT00518115|80344715|FG009|Overall Study|Withdrew Consent|0|||
27590673|NCT00518115|80344706|FG000|Overall Study|Moved Out of State|0|||
27590674|NCT00518115|80344707|FG001|Overall Study|Moved Out of State|0|||
27590675|NCT00518115|80344708|FG002|Overall Study|Moved Out of State|0|||
27590676|NCT00518115|80344709|FG003|Overall Study|Moved Out of State|0|||
27590677|NCT00518115|80344710|FG004|Overall Study|Moved Out of State|0|||
27590678|NCT00518115|80344711|FG005|Overall Study|Moved Out of State|0|||
27590679|NCT00518115|80344712|FG006|Overall Study|Moved Out of State|0|||
27590680|NCT00518115|80344713|FG007|Overall Study|Moved Out of State|0|||
27590681|NCT00518115|80344714|FG008|Overall Study|Moved Out of State|0|||
27816982|NCT00925769|81162809|FG001|Overall Study|Disease progression|5|||
27816983|NCT00925769|81162810|FG002|Overall Study|Disease progression|3|||
27816984|NCT00925769|81162811|FG003|Overall Study|Disease progression|4|||
27816985|NCT00925769|81162812|FG004|Overall Study|Disease progression|2|||
27816986|NCT00925769|81162813|FG005|Overall Study|Disease progression|3|||
27816987|NCT00925769|81162808|FG000|Overall Study|Death|0|||
27816988|NCT00925769|81162809|FG001|Overall Study|Death|0|||
27816989|NCT00925769|81162810|FG002|Overall Study|Death|1|||
27816990|NCT00925769|81162811|FG003|Overall Study|Death|0|||
27816991|NCT00925769|81162812|FG004|Overall Study|Death|0|||
27816992|NCT00925769|81162813|FG005|Overall Study|Death|0|||
27816993|NCT00925769|81162808|FG000|Overall Study|Physician Decision|1|||
27816994|NCT00925769|81162809|FG001|Overall Study|Physician Decision|0|||
27816995|NCT00925769|81162810|FG002|Overall Study|Physician Decision|0|||
27816996|NCT00925769|81162811|FG003|Overall Study|Physician Decision|0|||
27816997|NCT00925769|81162812|FG004|Overall Study|Physician Decision|0|||
27816998|NCT00925769|81162813|FG005|Overall Study|Physician Decision|0|||
27816999|NCT00925769|81162808|FG000|Overall Study|Missing documentation|0|||
27817000|NCT00925769|81162809|FG001|Overall Study|Missing documentation|1|||
27817001|NCT00925769|81162810|FG002|Overall Study|Missing documentation|0|||
27817002|NCT00925769|81162811|FG003|Overall Study|Missing documentation|0|||
27817003|NCT00925769|81162812|FG004|Overall Study|Missing documentation|0|||
27817004|NCT00925769|81162813|FG005|Overall Study|Missing documentation|0|||
27817005|NCT00925769|81162808|FG000|Overall Study|End of study visit not done|0|||
27817006|NCT00925769|81162809|FG001|Overall Study|End of study visit not done|0|||
27817007|NCT00925769|81162810|FG002|Overall Study|End of study visit not done|1|||
27817008|NCT00925769|81162811|FG003|Overall Study|End of study visit not done|0|||
27817009|NCT00925769|81162812|FG004|Overall Study|End of study visit not done|0|||
27817010|NCT00925769|81162813|FG005|Overall Study|End of study visit not done|0|||
27817011|NCT00925769|81162808|FG000|Overall Study|Participant is unable to swallow drug|0|||
27817012|NCT00925769|81162809|FG001|Overall Study|Participant is unable to swallow drug|0|||
27817013|NCT00925769|81162810|FG002|Overall Study|Participant is unable to swallow drug|0|||
27817014|NCT00925769|81162811|FG003|Overall Study|Participant is unable to swallow drug|1|||
27817015|NCT00925769|81162812|FG004|Overall Study|Participant is unable to swallow drug|0|||
27817016|NCT00925769|81162813|FG005|Overall Study|Participant is unable to swallow drug|0|||
27817017|NCT00925769|81162808|FG000|Overall Study|Adverse Event|0|||
27817018|NCT00925769|81162809|FG001|Overall Study|Adverse Event|0|||
27817019|NCT00925769|81162810|FG002|Overall Study|Adverse Event|0|||
27817020|NCT00925769|81162811|FG003|Overall Study|Adverse Event|0|||
27817021|NCT00925769|81162812|FG004|Overall Study|Adverse Event|1|||
27817022|NCT00925769|81162813|FG005|Overall Study|Adverse Event|0|||
27817023|NCT05346055|81162814|FG000|Overall Study|Withdrawal by Subject|1|||
27817024|NCT05346055|81162814|FG000|Overall Study|Protocol Violation|1|||
27817025|NCT05346055|81162814|FG000|Overall Study|Therapist decision|1|||
27817026|NCT00379340|81162817|FG000|Overall Study|Death|0|||
27817027|NCT00379340|81162818|FG001|Overall Study|Death|0|||
27817028|NCT00379340|81162819|FG002|Overall Study|Death|0|||
27817029|NCT00379340|81162820|FG003|Overall Study|Death|2|||
27817030|NCT00379340|81162821|FG004|Overall Study|Death|0|||
27817031|NCT00379340|81162817|FG000|Overall Study|Lack of Efficacy|6|||
27817032|NCT00379340|81162818|FG001|Overall Study|Lack of Efficacy|1|||
27817033|NCT00379340|81162819|FG002|Overall Study|Lack of Efficacy|0|||
27817034|NCT00379340|81162820|FG003|Overall Study|Lack of Efficacy|4|||
27817035|NCT00379340|81162821|FG004|Overall Study|Lack of Efficacy|3|||
27817036|NCT00379340|81162817|FG000|Overall Study|Physician Decision|6|||
27817037|NCT00379340|81162818|FG001|Overall Study|Physician Decision|2|||
27817038|NCT00379340|81162819|FG002|Overall Study|Physician Decision|1|||
27817039|NCT00379340|81162820|FG003|Overall Study|Physician Decision|2|||
27817040|NCT00379340|81162821|FG004|Overall Study|Physician Decision|3|||
27817041|NCT00379340|81162817|FG000|Overall Study|Withdrawal by Subject|0|||
27817042|NCT00379340|81162818|FG001|Overall Study|Withdrawal by Subject|0|||
27817043|NCT00379340|81162819|FG002|Overall Study|Withdrawal by Subject|0|||
27817044|NCT00379340|81162820|FG003|Overall Study|Withdrawal by Subject|1|||
27817045|NCT00379340|81162821|FG004|Overall Study|Withdrawal by Subject|0|||
27817046|NCT00379340|81162817|FG000|Overall Study|Refusal of further protocol therapy|1|||
27817047|NCT00379340|81162818|FG001|Overall Study|Refusal of further protocol therapy|0|||
27817048|NCT00379340|81162819|FG002|Overall Study|Refusal of further protocol therapy|1|||
27817049|NCT00379340|81162820|FG003|Overall Study|Refusal of further protocol therapy|1|||
27817050|NCT00379340|81162821|FG004|Overall Study|Refusal of further protocol therapy|7|||
27817051|NCT00379340|81162817|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
27817052|NCT00379340|81162818|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
27817053|NCT00379340|81162819|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
27817054|NCT00379340|81162820|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
27817055|NCT00379340|81162821|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
27817056|NCT00379340|81162817|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
27817057|NCT00379340|81162818|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
27817058|NCT00379340|81162819|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
27817059|NCT00379340|81162820|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
27817060|NCT00379340|81162821|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
27817061|NCT01226797|81162822|FG000|Overall Study|Adverse Event|1|||
27817062|NCT01226797|81162823|FG001|Overall Study|Adverse Event|0|||
27817063|NCT01226797|81162822|FG000|Overall Study|No longer willing to participate|1|||
27817064|NCT01226797|81162823|FG001|Overall Study|No longer willing to participate|0|||
27817065|NCT01226797|81162822|FG000|Overall Study|Protocol Violation|0|||
27817066|NCT01226797|81162823|FG001|Overall Study|Protocol Violation|1|||
27817067|NCT00626548|81162824|FG000|Overall Study|Adverse Event|164|||
27817068|NCT00626548|81162825|FG001|Overall Study|Adverse Event|44|||
27817069|NCT00626548|81162824|FG000|Overall Study|Withdrawal by Subject|42|||
27817070|NCT00626548|81162825|FG001|Overall Study|Withdrawal by Subject|46|||
27817071|NCT00626548|81162824|FG000|Overall Study|Protocol Violation|4|||
27817072|NCT00626548|81162825|FG001|Overall Study|Protocol Violation|11|||
27817073|NCT00626548|81162824|FG000|Overall Study|Lost to Follow-up|2|||
27817074|NCT00626548|81162825|FG001|Overall Study|Lost to Follow-up|2|||
27817075|NCT00626548|81162824|FG000|Overall Study|Other termination reason|493|||
27817076|NCT00626548|81162825|FG001|Overall Study|Other termination reason|613|||
27817077|NCT04025879|81162826|FG000|Randomization|Participant withdrew consent|0|||
27817078|NCT04025879|81162827|FG001|Randomization|Participant withdrew consent|1|||
27817079|NCT04025879|81162826|FG000|Randomization|Participant no longer met study criteria|1|||
27817080|NCT04025879|81162827|FG001|Randomization|Participant no longer met study criteria|1|||
27817081|NCT04025879|81162826|FG000|Treatment|Ongoing treatment|10|||
27817082|NCT04025879|81162827|FG001|Treatment|Ongoing treatment|8|||
27817083|NCT04025879|81162826|FG000|Treatment|Disease progression/recurrence|36|||
27817084|NCT04025879|81162827|FG001|Treatment|Disease progression/recurrence|72|||
27817085|NCT04025879|81162826|FG000|Treatment|Study drug toxicity|36|||
27817086|NCT04025879|81162827|FG001|Treatment|Study drug toxicity|13|||
27817087|NCT04025879|81162826|FG000|Treatment|Death|2|||
27817088|NCT04025879|81162827|FG001|Treatment|Death|0|||
27817089|NCT04025879|81162826|FG000|Treatment|Adverse event unrelated to study drug|21|||
27817090|NCT04025879|81162827|FG001|Treatment|Adverse event unrelated to study drug|14|||
27817091|NCT04025879|81162826|FG000|Treatment|Participant request to discontinue study treatment|16|||
27817092|NCT04025879|81162827|FG001|Treatment|Participant request to discontinue study treatment|8|||
27817093|NCT04025879|81162826|FG000|Treatment|Participant withdrew consent|1|||
27817094|NCT04025879|81162827|FG001|Treatment|Participant withdrew consent|3|||
27817095|NCT04025879|81162826|FG000|Treatment|Participant no longer meets study criteria|3|||
27817096|NCT04025879|81162827|FG001|Treatment|Participant no longer meets study criteria|2|||
27817097|NCT04025879|81162826|FG000|Treatment|Lost to Follow-up|1|||
27817098|NCT04025879|81162827|FG001|Treatment|Lost to Follow-up|0|||
27817099|NCT04025879|81162826|FG000|Treatment|Other reasons|15|||
27817100|NCT04025879|81162827|FG001|Treatment|Other reasons|17|||
27817101|NCT04025879|81162826|FG000|Treatment|Administrative reason by sponsor|0|||
27817102|NCT04025879|81162827|FG001|Treatment|Administrative reason by sponsor|1|||
27817103|NCT04025879|81162826|FG000|Treatment|Not reported|2|||
27817104|NCT04025879|81162827|FG001|Treatment|Not reported|0|||
27817105|NCT01411332|81162828|FG000|Enrollment|Protocol Violation|0|||
27817106|NCT01411332|81162829|FG001|Enrollment|Protocol Violation|1|||
27817107|NCT01411332|81162828|FG000|Enrollment|Withdrawal by Subject|0|||
27817108|NCT01411332|81162829|FG001|Enrollment|Withdrawal by Subject|1|||
27817109|NCT01411332|81162828|FG000|Treatment|Lost to Follow-up|1|||
27817110|NCT01411332|81162829|FG001|Treatment|Lost to Follow-up|0|||
27817111|NCT01957488|81162830|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
27817112|NCT01957488|81162831|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
27817113|NCT01957488|81162832|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
27817114|NCT01957488|81162833|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
27817115|NCT01957488|81162834|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
27817116|NCT01957488|81162835|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
27817117|NCT01957488|81162830|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
27817118|NCT01957488|81162831|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
27817119|NCT01957488|81162832|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
27817120|NCT01957488|81162833|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
27817121|NCT01957488|81162834|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
27817122|NCT01957488|81162835|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
27817123|NCT01957488|81162830|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
27817124|NCT01957488|81162831|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
27817125|NCT01957488|81162832|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
27817126|NCT01957488|81162833|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
27817127|NCT01957488|81162834|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
27817128|NCT01957488|81162835|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
27817129|NCT01957488|81162830|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27817130|NCT01957488|81162831|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27817131|NCT01957488|81162832|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27817132|NCT01957488|81162833|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
27817133|NCT01957488|81162834|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
27690571|NCT00768079|80702737|FG001|Overall Study|Participant incarcerated|1|||
27690572|NCT00768079|80702738|FG002|Overall Study|Participant incarcerated|0|||
27690573|NCT03110185|80702739|FG000|Overall Study|Death|0|||
27690574|NCT03110185|80702740|FG001|Overall Study|Death|1|||
27690575|NCT03110185|80702739|FG000|Overall Study|Withdrawal by Subject|2|||
27690576|NCT03110185|80702740|FG001|Overall Study|Withdrawal by Subject|7|||
27690577|NCT03110185|80702739|FG000|Overall Study|Time Constraints|0|||
27817134|NCT01957488|81162835|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
27817135|NCT01957488|81162830|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27817136|NCT01957488|81162831|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27590682|NCT00518115|80344715|FG009|Overall Study|Moved Out of State|1|||
27590683|NCT00374322|80344716|FG000|Overall Study|Lost to Follow-up|92|||
27590684|NCT00374322|80344717|FG001|Overall Study|Lost to Follow-up|90|||
27590685|NCT00374322|80344716|FG000|Overall Study|Protocol Violation|8|||
27590686|NCT00374322|80344717|FG001|Overall Study|Protocol Violation|3|||
27590687|NCT00374322|80344716|FG000|Overall Study|Withdrawal by Subject|235|||
27590688|NCT00374322|80344717|FG001|Overall Study|Withdrawal by Subject|167|||
27590689|NCT00374322|80344716|FG000|Overall Study|Sponsor Terminated Study|866|||
27590690|NCT00374322|80344717|FG001|Overall Study|Sponsor Terminated Study|990|||
27690578|NCT03110185|80702740|FG001|Overall Study|Time Constraints|6|||
27690579|NCT03110185|80702739|FG000|Overall Study|Conflict with care|5|||
27690580|NCT03110185|80702740|FG001|Overall Study|Conflict with care|12|||
27690581|NCT03110185|80702739|FG000|Overall Study|Protocol Violation|1|||
27690582|NCT03110185|80702740|FG001|Overall Study|Protocol Violation|4|||
27690583|NCT03110185|80702739|FG000|Overall Study|MRI Incompatible|2|||
27690584|NCT03110185|80702740|FG001|Overall Study|MRI Incompatible|0|||
27690585|NCT03110185|80702739|FG000|Overall Study|Patient Refusal|0|||
27690586|NCT03110185|80702740|FG001|Overall Study|Patient Refusal|1|||
27690587|NCT02217332|80702741|FG000|Overall Study|Adverse Event|3|||
27690588|NCT02217332|80702741|FG000|Overall Study|Dose interruption >1 month|1|||
27690589|NCT02217332|80702741|FG000|Overall Study|Protocol Violation (eligibility)|1|||
27690590|NCT02217332|80702741|FG000|Overall Study|Withdrawal by Subject|1|||
27690591|NCT02217332|80702741|FG000|Overall Study|Lost to Follow-up|1|||
27690592|NCT00297232|80702751|FG000|Overall Study|Lack of Efficacy|7|||
27690593|NCT00297232|80702751|FG000|Overall Study|Lost to Follow-up|10|||
27690594|NCT00297232|80702751|FG000|Overall Study|Adverse Event|63|||
27690595|NCT00297232|80702751|FG000|Overall Study|Voluntary Withdrawal|120|||
27690596|NCT00297232|80702751|FG000|Overall Study|Subject was Noncompliant|9|||
27690597|NCT00297232|80702751|FG000|Overall Study|Death|9|||
27690598|NCT00297232|80702751|FG000|Overall Study|Anti-natalizumab Positive|8|||
27690599|NCT00297232|80702751|FG000|Overall Study|Switched to Commercial Tysabri|22|||
27690600|NCT00297232|80702751|FG000|Overall Study|Disease Progression|8|||
27690601|NCT00297232|80702751|FG000|Overall Study|Fear of PML|10|||
27690602|NCT00297232|80702751|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
27690603|NCT00297232|80702751|FG000|Overall Study|Miscellaneous|5|||
27690604|NCT00297232|80702751|FG000|Overall Study|Sponsor Decision|34|||
27690605|NCT00297232|80702751|FG000|Overall Study|Subject Relocated|7|||
27690606|NCT00297232|80702751|FG000|Overall Study|Subject Withdrew Consent|37|||
27690607|NCT00297232|80702751|FG000|Overall Study|Persistently Positive Antibodies|11|||
27690608|NCT00297232|80702751|FG000|Overall Study|Investigator Withdrew From Program|19|||
27690609|NCT00297232|80702751|FG000|Overall Study|Did Not Enroll to Week 264|34|||
27690610|NCT00297232|80702751|FG000|Overall Study|Did Not Enroll to Week 480|17|||
27690611|NCT00297232|80702751|FG000|Overall Study|No data available after Week 264|161|||
27690612|NCT00297232|80702751|FG000|Overall Study|Other|1|||
27690613|NCT00591721|80702753|FG000|Overall Study|Withdrawal by Subject|10|||
27690614|NCT00591721|80702754|FG001|Overall Study|Withdrawal by Subject|10|||
27690615|NCT00591721|80702753|FG000|Overall Study|Lost to Follow-up|1|||
27690616|NCT00591721|80702754|FG001|Overall Study|Lost to Follow-up|4|||
27690617|NCT00591721|80702753|FG000|Overall Study|Intervention not received|10|||
27690618|NCT00591721|80702754|FG001|Overall Study|Intervention not received|8|||
27690619|NCT00513604|80702757|FG000|Overall Study|Not treated|2|||
27690620|NCT00513604|80702758|FG001|Overall Study|Not treated|0|||
27690621|NCT00513604|80702759|FG002|Overall Study|Not treated|1|||
27690622|NCT00513604|80702760|FG003|Overall Study|Not treated|0|||
27690623|NCT00513604|80702761|FG004|Overall Study|Not treated|0|||
27690624|NCT00513604|80702757|FG000|Overall Study|Death during treatment|0|||
27690625|NCT00513604|80702758|FG001|Overall Study|Death during treatment|3|||
27690626|NCT00513604|80702759|FG002|Overall Study|Death during treatment|2|||
27690627|NCT00513604|80702760|FG003|Overall Study|Death during treatment|0|||
27690628|NCT00513604|80702761|FG004|Overall Study|Death during treatment|0|||
27690629|NCT01590017|80706003|FG000|Overall Study|Adverse Event|1|||
27690630|NCT01590017|80706003|FG000|Overall Study|Withdrawal by Subject|1|||
27690631|NCT01590017|80706003|FG000|Overall Study|Lack of Efficacy|1|||
27817137|NCT01957488|81162832|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27817138|NCT01957488|81162833|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27817139|NCT01957488|81162834|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
27817140|NCT01957488|81162835|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
27817141|NCT01957488|81162830|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
27817142|NCT01957488|81162831|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
27817143|NCT01957488|81162832|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
27817144|NCT01957488|81162833|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
27817145|NCT01957488|81162834|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
27817146|NCT01957488|81162835|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
27817147|NCT01957488|81162830|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
27817148|NCT01957488|81162831|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
27690632|NCT01590017|80706003|FG000|Overall Study|Physician Decision|1|||
27690633|NCT03241225|80706004|FG000|Overall Study|Lost to Follow-up|2|||
27690634|NCT03241225|80706005|FG001|Overall Study|Lost to Follow-up|1|||
27690635|NCT03241225|80706004|FG000|Overall Study|Protocol Violation|4|||
27590691|NCT00374322|80344716|FG000|Overall Study|Physician Decision|36|||
27590692|NCT00374322|80344717|FG001|Overall Study|Physician Decision|32|||
27590693|NCT00374322|80344716|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
27590694|NCT00374322|80344717|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
27590695|NCT00374322|80344716|FG000|Overall Study|Sponsor Decision|2|||
27590696|NCT00374322|80344717|FG001|Overall Study|Sponsor Decision|3|||
27590697|NCT00374322|80344716|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
27590698|NCT00374322|80344717|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
27590699|NCT00374322|80344716|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
27590700|NCT00374322|80344717|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
27590701|NCT00374322|80344716|FG000|Overall Study|Severe Toxicity|1|||
27590702|NCT00374322|80344717|FG001|Overall Study|Severe Toxicity|0|||
27590703|NCT00374322|80344716|FG000|Overall Study|Site Closed|2|||
27590704|NCT00374322|80344717|FG001|Overall Study|Site Closed|2|||
27590705|NCT00374322|80344716|FG000|Overall Study|Participant Changed Physician|1|||
27590706|NCT00374322|80344717|FG001|Overall Study|Participant Changed Physician|0|||
27590707|NCT00374322|80344716|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
27590708|NCT00374322|80344717|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
27590709|NCT00374322|80344716|FG000|Overall Study|Noncompliance with Study Requirements|0|||
27590710|NCT00374322|80344717|FG001|Overall Study|Noncompliance with Study Requirements|1|||
27590711|NCT00374322|80344716|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
27590712|NCT00374322|80344717|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
27590713|NCT00374322|80344716|FG000|Overall Study|Did Not Receive Study Medication|8|||
27590714|NCT00374322|80344717|FG001|Overall Study|Did Not Receive Study Medication|6|||
27590715|NCT03301051|80344719|FG000|Overall Study|Adverse Event|0|||
27590716|NCT03301051|80344720|FG001|Overall Study|Adverse Event|4|||
27590717|NCT03301051|80344719|FG000|Overall Study|Withdrawal by Subject|59|||
27590718|NCT03301051|80344720|FG001|Overall Study|Withdrawal by Subject|65|||
27590719|NCT03301051|80344719|FG000|Overall Study|Lost to Follow-up|263|||
27590720|NCT03301051|80344720|FG001|Overall Study|Lost to Follow-up|282|||
27590721|NCT03301051|80344719|FG000|Overall Study|Protocol Violation|1|||
27590722|NCT03301051|80344720|FG001|Overall Study|Protocol Violation|3|||
27590723|NCT03301051|80344719|FG000|Overall Study|Physician Decision|1|||
27590724|NCT03301051|80344720|FG001|Overall Study|Physician Decision|3|||
27590725|NCT03301051|80344719|FG000|Overall Study|Death|1|||
27590726|NCT03301051|80344720|FG001|Overall Study|Death|1|||
27590727|NCT03301051|80344719|FG000|Overall Study|Miscellaneous|8|||
27590728|NCT03301051|80344720|FG001|Overall Study|Miscellaneous|4|||
27690636|NCT03241225|80706005|FG001|Overall Study|Protocol Violation|1|||
27690637|NCT03241225|80706004|FG000|Overall Study|Withdrawal by Subject|1|||
27690638|NCT03241225|80706005|FG001|Overall Study|Withdrawal by Subject|0|||
27590729|NCT03301051|80344719|FG000|Overall Study|Randomized, not vaccinated|13|||
27590730|NCT03301051|80344720|FG001|Overall Study|Randomized, not vaccinated|10|||
27690639|NCT01048671|80706006|FG000|Overall Study|Protocol Violation|0|||
27690640|NCT01048671|80706007|FG001|Overall Study|Protocol Violation|1|||
27590731|NCT00492284|80344721|FG000|Overall Study|Adverse Event|0|||
27590732|NCT00492284|80344722|FG001|Overall Study|Adverse Event|1|||
27690641|NCT01048671|80706008|FG002|Overall Study|Protocol Violation|1|||
27690642|NCT03625895|80706009|FG000|Overall Study|Protocol Violation|585|||
27817149|NCT01957488|81162832|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
27817150|NCT01957488|81162833|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
27817151|NCT01957488|81162834|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
27817152|NCT01957488|81162835|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
27817153|NCT01957488|81162830|FG000|Test Period 2 (2 Weeks)|Other|1|||
27817154|NCT01957488|81162831|FG001|Test Period 2 (2 Weeks)|Other|0|||
27817155|NCT01957488|81162832|FG002|Test Period 2 (2 Weeks)|Other|0|||
27817156|NCT01957488|81162833|FG003|Test Period 2 (2 Weeks)|Other|0|||
27817157|NCT01957488|81162834|FG004|Test Period 2 (2 Weeks)|Other|0|||
27817158|NCT01957488|81162835|FG005|Test Period 2 (2 Weeks)|Other|0|||
27817159|NCT01957488|81162830|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27817160|NCT01957488|81162831|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
27817161|NCT01957488|81162832|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27817162|NCT01957488|81162833|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27817163|NCT01957488|81162834|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27817164|NCT01957488|81162835|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
27817165|NCT01957488|81162830|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
27817166|NCT01957488|81162831|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
27817167|NCT01957488|81162832|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
27817168|NCT01957488|81162833|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
27817169|NCT01957488|81162834|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
27690643|NCT01328717|80706010|FG000|Overall Study|Adverse Event|1|||
27817170|NCT01957488|81162835|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
27817171|NCT01957488|81162830|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27690644|NCT00986674|80706011|FG000|Overall Study|Lack of Efficacy|28|||
27590733|NCT00492284|80344723|FG002|Overall Study|Adverse Event|1|||
27590734|NCT00492284|80344724|FG003|Overall Study|Adverse Event|2|||
27590735|NCT00492284|80344721|FG000|Overall Study|Lost to Follow-up|0|||
27590736|NCT00492284|80344722|FG001|Overall Study|Lost to Follow-up|0|||
27590737|NCT00492284|80344723|FG002|Overall Study|Lost to Follow-up|3|||
27590738|NCT00492284|80344724|FG003|Overall Study|Lost to Follow-up|1|||
27590739|NCT00492284|80344721|FG000|Overall Study|Death|0|||
27590740|NCT00492284|80344722|FG001|Overall Study|Death|3|||
27590741|NCT00492284|80344723|FG002|Overall Study|Death|2|||
27590742|NCT00492284|80344724|FG003|Overall Study|Death|5|||
27590743|NCT00492284|80344721|FG000|Overall Study|Withdrawal by Subject|1|||
27590744|NCT00492284|80344722|FG001|Overall Study|Withdrawal by Subject|0|||
27590745|NCT00492284|80344723|FG002|Overall Study|Withdrawal by Subject|0|||
27590746|NCT00492284|80344724|FG003|Overall Study|Withdrawal by Subject|2|||
27590747|NCT02477618|80344725|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
27590748|NCT02477618|80344726|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
27590749|NCT02477618|80344725|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
27590750|NCT02477618|80344726|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
27590751|NCT02477618|80344725|FG000|Overall Study|Adverse Event|1|||
27590752|NCT02477618|80344726|FG001|Overall Study|Adverse Event|1|||
27590753|NCT02477618|80344725|FG000|Overall Study|Transferred Away from Study Site|1|||
27590754|NCT02477618|80344726|FG001|Overall Study|Transferred Away from Study Site|0|||
27590755|NCT02477618|80344725|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
27590756|NCT02477618|80344726|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
27590757|NCT03555396|80344727|FG000|Overall Study|Death|3|||
27590758|NCT03555396|80344728|FG001|Overall Study|Death|1|||
27590759|NCT03555396|80344727|FG000|Overall Study|Lost to Follow-up|0|||
27590760|NCT03555396|80344728|FG001|Overall Study|Lost to Follow-up|2|||
27590761|NCT03826667|80344729|FG000|Overall Study|Protocol deviation|21|||
27590762|NCT01300546|80344735|FG000|Overall Study|Withdrawal by Subject|1|||
27590763|NCT01300546|80344736|FG001|Overall Study|Withdrawal by Subject|0|||
27590764|NCT01300546|80344735|FG000|Overall Study|Lost to Follow-up|0|||
27590765|NCT01300546|80344736|FG001|Overall Study|Lost to Follow-up|2|||
27590766|NCT01300546|80344735|FG000|Overall Study|Lack of Efficacy|0|||
27590767|NCT01300546|80344736|FG001|Overall Study|Lack of Efficacy|3|||
27590768|NCT01300546|80344735|FG000|Overall Study|Adverse Event|0|||
27590769|NCT01300546|80344736|FG001|Overall Study|Adverse Event|1|||
27590770|NCT01458574|80344740|FG000|Overall Study|Adverse Event|5|||
27590771|NCT01458574|80344741|FG001|Overall Study|Adverse Event|9|||
27590772|NCT01458574|80344742|FG002|Overall Study|Adverse Event|7|||
27590773|NCT01458574|80344740|FG000|Overall Study|Lack of Efficacy|70|||
27590774|NCT01458574|80344741|FG001|Overall Study|Lack of Efficacy|53|||
27590775|NCT01458574|80344742|FG002|Overall Study|Lack of Efficacy|132|||
27817172|NCT01957488|81162831|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27817173|NCT01957488|81162832|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27590776|NCT01458574|80344740|FG000|Overall Study|Lost to Follow-up|3|||
27590777|NCT01458574|80344741|FG001|Overall Study|Lost to Follow-up|2|||
27590778|NCT01458574|80344742|FG002|Overall Study|Lost to Follow-up|1|||
27590779|NCT01458574|80344740|FG000|Overall Study|Pregnancy|1|||
27590780|NCT01458574|80344741|FG001|Overall Study|Pregnancy|1|||
27590781|NCT01458574|80344742|FG002|Overall Study|Pregnancy|0|||
27590782|NCT01458574|80344740|FG000|Overall Study|Protocol Violation|0|||
27590783|NCT01458574|80344741|FG001|Overall Study|Protocol Violation|1|||
27590784|NCT01458574|80344742|FG002|Overall Study|Protocol Violation|0|||
27817174|NCT01957488|81162833|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27817175|NCT01957488|81162834|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
27817176|NCT01957488|81162835|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
27817177|NCT01957488|81162830|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
27590785|NCT01458574|80344740|FG000|Overall Study|Withdrawal by Subject|6|||
27590786|NCT01458574|80344741|FG001|Overall Study|Withdrawal by Subject|3|||
27590787|NCT01458574|80344742|FG002|Overall Study|Withdrawal by Subject|5|||
27590788|NCT01458574|80344740|FG000|Overall Study|Other|2|||
27878927|NCT01058642|81391354|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27878928|NCT01058642|81391355|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27878929|NCT01058642|81391356|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27878930|NCT01058642|81391357|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27878931|NCT01058642|81391354|FG000|Treatment Period 1|Lack of Efficacy|0|||
27878932|NCT01058642|81391355|FG001|Treatment Period 1|Lack of Efficacy|0|||
27878933|NCT01058642|81391356|FG002|Treatment Period 1|Lack of Efficacy|0|||
27878934|NCT01058642|81391357|FG003|Treatment Period 1|Lack of Efficacy|1|||
27878935|NCT01058642|81391354|FG000|Treatment Period 1|Protocol Violation|0|||
27590789|NCT01458574|80344741|FG001|Overall Study|Other|1|||
27590790|NCT01458574|80344742|FG002|Overall Study|Other|0|||
27590791|NCT01458574|80344740|FG000|Overall Study|Randomized but not treated|0|||
27878936|NCT01058642|81391355|FG001|Treatment Period 1|Protocol Violation|0|||
27690645|NCT00986674|80706012|FG001|Overall Study|Lack of Efficacy|25|||
27690646|NCT00986674|80706013|FG002|Overall Study|Lack of Efficacy|23|||
27690647|NCT00986674|80706011|FG000|Overall Study|Adverse Event|4|||
27590792|NCT01458574|80344741|FG001|Overall Study|Randomized but not treated|1|||
27590793|NCT01458574|80344742|FG002|Overall Study|Randomized but not treated|0|||
27590794|NCT02015676|80344743|FG000|Overall Study|Adverse Event|2|||
27590795|NCT02015676|80344744|FG001|Overall Study|Adverse Event|18|||
27690648|NCT00986674|80706012|FG001|Overall Study|Adverse Event|8|||
27690649|NCT00986674|80706013|FG002|Overall Study|Adverse Event|9|||
27690650|NCT00986674|80706011|FG000|Overall Study|Death|5|||
27590796|NCT02015676|80344745|FG002|Overall Study|Adverse Event|0|||
27878937|NCT01058642|81391356|FG002|Treatment Period 1|Protocol Violation|0|||
27878938|NCT01058642|81391357|FG003|Treatment Period 1|Protocol Violation|1|||
27878939|NCT01058642|81391354|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
27878940|NCT01058642|81391355|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
27590797|NCT02015676|80344743|FG000|Overall Study|Lack of Efficacy|2|||
27590798|NCT02015676|80344744|FG001|Overall Study|Lack of Efficacy|4|||
27590799|NCT02015676|80344745|FG002|Overall Study|Lack of Efficacy|0|||
27690651|NCT00986674|80706012|FG001|Overall Study|Death|0|||
27690652|NCT00986674|80706013|FG002|Overall Study|Death|4|||
27690653|NCT00986674|80706011|FG000|Overall Study|Withdrawal by Subject|6|||
27590800|NCT02015676|80344743|FG000|Overall Study|Protocol Violation|1|||
27690654|NCT00986674|80706012|FG001|Overall Study|Withdrawal by Subject|2|||
27690655|NCT00986674|80706013|FG002|Overall Study|Withdrawal by Subject|1|||
27690656|NCT00986674|80706011|FG000|Overall Study|alternative therapy|0|||
27878941|NCT01058642|81391356|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
27817178|NCT01957488|81162831|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27817179|NCT01957488|81162832|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27817180|NCT01957488|81162833|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27817181|NCT01957488|81162834|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27817182|NCT01957488|81162835|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
27817183|NCT01957488|81162830|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27817184|NCT01957488|81162831|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
27817185|NCT01957488|81162832|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27817186|NCT01957488|81162833|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27817187|NCT01957488|81162834|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27817188|NCT01957488|81162835|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
27817189|NCT00262600|81162836|FG000|Overall Study|Lost to Follow-up|17|||
27817190|NCT00262600|81162837|FG001|Overall Study|Lost to Follow-up|31|||
27817191|NCT00262600|81162838|FG002|Overall Study|Lost to Follow-up|41|||
27817192|NCT00262600|81162836|FG000|Overall Study|Withdrawal by Subject|128|||
27817193|NCT00262600|81162837|FG001|Overall Study|Withdrawal by Subject|145|||
27817194|NCT00262600|81162838|FG002|Overall Study|Withdrawal by Subject|139|||
27817195|NCT00262600|81162836|FG000|Overall Study|Not Treated|32|||
27817196|NCT00262600|81162837|FG001|Overall Study|Not Treated|17|||
27690657|NCT00986674|80706012|FG001|Overall Study|alternative therapy|0|||
27690658|NCT00986674|80706013|FG002|Overall Study|alternative therapy|1|||
27690659|NCT00986674|80706011|FG000|Overall Study|not start protocol therapy|4|||
27690660|NCT00986674|80706012|FG001|Overall Study|not start protocol therapy|3|||
27690661|NCT00986674|80706013|FG002|Overall Study|not start protocol therapy|1|||
27690662|NCT00986674|80706011|FG000|Overall Study|unknown/not specify|0|||
27690663|NCT00986674|80706012|FG001|Overall Study|unknown/not specify|7|||
27690664|NCT00986674|80706013|FG002|Overall Study|unknown/not specify|9|||
27690665|NCT03343301|80706018|FG000|Overall Study|Withdrawal by Subject|1|||
27690666|NCT03343301|80706019|FG001|Overall Study|Withdrawal by Subject|1|||
27690667|NCT03343301|80706018|FG000|Overall Study|Death|0|||
27690668|NCT03343301|80706019|FG001|Overall Study|Death|2|||
27690669|NCT03343301|80706018|FG000|Overall Study|Other|0|||
27690670|NCT03343301|80706019|FG001|Overall Study|Other|6|||
27690671|NCT03343301|80706018|FG000|Overall Study|Missing|2|||
27690672|NCT03343301|80706019|FG001|Overall Study|Missing|0|||
27690673|NCT01577745|80706020|FG000|Overall Study|Withdrawal by Subject|0|||
27690674|NCT01577745|80706021|FG001|Overall Study|Withdrawal by Subject|1|||
27690675|NCT01577745|80706022|FG002|Overall Study|Withdrawal by Subject|0|||
27690676|NCT01577745|80706023|FG003|Overall Study|Withdrawal by Subject|3|||
27690677|NCT01577745|80706024|FG004|Overall Study|Withdrawal by Subject|2|||
27690678|NCT01577745|80706025|FG005|Overall Study|Withdrawal by Subject|0|||
27690679|NCT01577745|80706020|FG000|Overall Study|Death|3|||
27690680|NCT01577745|80706021|FG001|Overall Study|Death|2|||
27690681|NCT01577745|80706022|FG002|Overall Study|Death|2|||
27690682|NCT01577745|80706023|FG003|Overall Study|Death|1|||
27690683|NCT01577745|80706024|FG004|Overall Study|Death|1|||
27690684|NCT01577745|80706025|FG005|Overall Study|Death|3|||
27690685|NCT01577745|80706020|FG000|Overall Study|Physician Decision|0|||
27690686|NCT01577745|80706021|FG001|Overall Study|Physician Decision|0|||
27690687|NCT01577745|80706022|FG002|Overall Study|Physician Decision|0|||
27690688|NCT01577745|80706023|FG003|Overall Study|Physician Decision|1|||
27690689|NCT01577745|80706024|FG004|Overall Study|Physician Decision|1|||
27690690|NCT01577745|80706025|FG005|Overall Study|Physician Decision|0|||
27690691|NCT01577745|80706020|FG000|Overall Study|Lost to Follow-up|0|||
27690692|NCT01577745|80706021|FG001|Overall Study|Lost to Follow-up|0|||
27690693|NCT01577745|80706022|FG002|Overall Study|Lost to Follow-up|0|||
27690694|NCT01577745|80706023|FG003|Overall Study|Lost to Follow-up|0|||
27690695|NCT01577745|80706024|FG004|Overall Study|Lost to Follow-up|0|||
27690696|NCT01577745|80706025|FG005|Overall Study|Lost to Follow-up|1|||
27690697|NCT01577745|80706020|FG000|Overall Study|Alternative Therapy|0|||
27690698|NCT01577745|80706021|FG001|Overall Study|Alternative Therapy|0|||
27690699|NCT01577745|80706022|FG002|Overall Study|Alternative Therapy|0|||
27690700|NCT01577745|80706023|FG003|Overall Study|Alternative Therapy|1|||
27690701|NCT01577745|80706024|FG004|Overall Study|Alternative Therapy|1|||
27690702|NCT01577745|80706025|FG005|Overall Study|Alternative Therapy|0|||
27878942|NCT01058642|81391357|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
27878943|NCT02454608|81391358|FG000|Double-Blind Period|Lack of Efficacy|0|||
27878944|NCT02454608|81391359|FG001|Double-Blind Period|Lack of Efficacy|2|||
27878945|NCT02454608|81391360|FG002|Double-Blind Period|Lack of Efficacy|0|||
27878946|NCT02454608|81391358|FG000|Open Label Period|Lost to Follow-up|0|||
27878947|NCT02454608|81391359|FG001|Open Label Period|Lost to Follow-up|0|||
27878948|NCT02454608|81391360|FG002|Open Label Period|Lost to Follow-up|11|||
27878949|NCT02454608|81391358|FG000|Open Label Period|Withdrawal by Subject|0|||
27878950|NCT02454608|81391359|FG001|Open Label Period|Withdrawal by Subject|0|||
27878951|NCT02454608|81391360|FG002|Open Label Period|Withdrawal by Subject|8|||
27878952|NCT00658723|81391363|FG000|Overall Study|Lost to Follow-up|0|||
27590801|NCT02015676|80344744|FG001|Overall Study|Protocol Violation|0|||
27590802|NCT02015676|80344745|FG002|Overall Study|Protocol Violation|0|||
27590803|NCT02015676|80344743|FG000|Overall Study|Withdrawal by Subject|1|||
27590804|NCT02015676|80344744|FG001|Overall Study|Withdrawal by Subject|7|||
27690703|NCT03545503|80706026|FG000|Overall Study|Protocol Violation|14|||
27690704|NCT03545503|80706027|FG001|Overall Study|Protocol Violation|16|||
27690705|NCT04822597|80706034|FG000|Overall Study|Withdrawal by Subject|0|||
27690706|NCT04822597|80706035|FG001|Overall Study|Withdrawal by Subject|1|||
27690707|NCT04822597|80706036|FG002|Overall Study|Withdrawal by Subject|1|||
27690708|NCT04822597|80706037|FG003|Overall Study|Withdrawal by Subject|0|||
27690709|NCT04822597|80706034|FG000|Overall Study|Physician Decision|0|||
27690710|NCT04822597|80706035|FG001|Overall Study|Physician Decision|0|||
27690711|NCT04822597|80706036|FG002|Overall Study|Physician Decision|1|||
27690712|NCT04822597|80706037|FG003|Overall Study|Physician Decision|1|||
27690713|NCT04822597|80706034|FG000|Overall Study|Subject withdrawn after enrollment|0|||
27690714|NCT04822597|80706035|FG001|Overall Study|Subject withdrawn after enrollment|1|||
27690715|NCT04822597|80706036|FG002|Overall Study|Subject withdrawn after enrollment|0|||
27878953|NCT00658723|81391364|FG001|Overall Study|Lost to Follow-up|2|||
27878954|NCT00658723|81391365|FG002|Overall Study|Lost to Follow-up|2|||
27878955|NCT00658723|81391363|FG000|Overall Study|Death|2|||
27690716|NCT04822597|80706037|FG003|Overall Study|Subject withdrawn after enrollment|1|||
27690717|NCT04822597|80706034|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
27690718|NCT04822597|80706035|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
27690719|NCT04822597|80706036|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
27690720|NCT04822597|80706037|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
27690721|NCT01585987|80706038|FG000|Randomized|Withdrawal by Subject|0|||
27690722|NCT01585987|80706039|FG001|Randomized|Withdrawal by Subject|4|||
27690723|NCT01585987|80706038|FG000|Randomized|No longer met criteria|0|||
27690724|NCT01585987|80706039|FG001|Randomized|No longer met criteria|2|||
27690725|NCT01585987|80706038|FG000|Treated|Disease Progression|39|||
27690726|NCT01585987|80706039|FG001|Treated|Disease Progression|36|||
27690727|NCT01585987|80706038|FG000|Treated|Study Drug Toxicity|9|||
27690728|NCT01585987|80706039|FG001|Treated|Study Drug Toxicity|5|||
27690729|NCT01585987|80706038|FG000|Treated|Adverse Event|3|||
27690730|NCT01585987|80706039|FG001|Treated|Adverse Event|0|||
27690731|NCT01585987|80706038|FG000|Treated|Withdrawal by Subject|1|||
27690732|NCT01585987|80706039|FG001|Treated|Withdrawal by Subject|2|||
27690733|NCT01585987|80706038|FG000|Treated|Death|1|||
27690734|NCT01585987|80706039|FG001|Treated|Death|0|||
27690735|NCT01585987|80706038|FG000|Treated|Lost to Follow-up|0|||
27690736|NCT01585987|80706039|FG001|Treated|Lost to Follow-up|1|||
27690737|NCT01585987|80706038|FG000|Treated|Maximum Clinical Benefit|0|||
27690738|NCT01585987|80706039|FG001|Treated|Maximum Clinical Benefit|1|||
27690739|NCT01585987|80706038|FG000|Treated|Non-Specified|1|||
27690740|NCT01585987|80706039|FG001|Treated|Non-Specified|2|||
27690741|NCT01585987|80706038|FG000|Treated|Subject Request|0|||
27690742|NCT01585987|80706039|FG001|Treated|Subject Request|1|||
27690743|NCT01585987|80706038|FG000|Treated|Poor/Non-Compliance|0|||
27690744|NCT01585987|80706039|FG001|Treated|Poor/Non-Compliance|1|||
27690745|NCT01047293|80706040|FG000|Overall Study|DLT criteria not fulfilled|1|||
27690746|NCT01047293|80706041|FG001|Overall Study|DLT criteria not fulfilled|1|||
27690747|NCT01047293|80706042|FG002|Overall Study|DLT criteria not fulfilled|0|||
27690748|NCT01047293|80706043|FG003|Overall Study|DLT criteria not fulfilled|0|||
27690749|NCT02383056|80706044|FG000|Overall Study|Adverse Event|1|||
27690750|NCT02383056|80706045|FG001|Overall Study|Adverse Event|0|||
27690751|NCT02383056|80706044|FG000|Overall Study|Lost to Follow-up|0|||
27690752|NCT02383056|80706045|FG001|Overall Study|Lost to Follow-up|2|||
27690753|NCT02029846|80706046|FG000|Overall Study|n=1 each arm|1|||
27690754|NCT02029846|80706047|FG001|Overall Study|n=1 each arm|1|||
27690755|NCT03536143|80706048|FG000|Overall Study|Early termination, Sponsor decision|1|||
27690756|NCT02518490|80706054|FG000|Overall Study|Withdrawal by Subject|1|||
27690757|NCT02518490|80706055|FG001|Overall Study|Withdrawal by Subject|1|||
27690758|NCT03607422|80706061|FG000|Overall Study|Adverse Event|7|||
27690759|NCT03607422|80706062|FG001|Overall Study|Adverse Event|3|||
27690760|NCT03607422|80706063|FG002|Overall Study|Adverse Event|2|||
27690761|NCT03607422|80706064|FG003|Overall Study|Adverse Event|0|||
27690762|NCT03607422|80706065|FG004|Overall Study|Adverse Event|2|||
27690763|NCT03607422|80706066|FG005|Overall Study|Adverse Event|0|||
27690764|NCT03607422|80706061|FG000|Overall Study|Withdrawal by Subject|11|||
27690765|NCT03607422|80706062|FG001|Overall Study|Withdrawal by Subject|3|||
27690766|NCT03607422|80706063|FG002|Overall Study|Withdrawal by Subject|6|||
27690767|NCT03607422|80706064|FG003|Overall Study|Withdrawal by Subject|2|||
27690768|NCT03607422|80706065|FG004|Overall Study|Withdrawal by Subject|0|||
27690769|NCT03607422|80706066|FG005|Overall Study|Withdrawal by Subject|0|||
27690770|NCT03607422|80706061|FG000|Overall Study|Lost to Follow-up|0|||
27690771|NCT03607422|80706062|FG001|Overall Study|Lost to Follow-up|0|||
27690772|NCT03607422|80706063|FG002|Overall Study|Lost to Follow-up|1|||
27690773|NCT03607422|80706064|FG003|Overall Study|Lost to Follow-up|0|||
27690774|NCT03607422|80706065|FG004|Overall Study|Lost to Follow-up|0|||
27690775|NCT03607422|80706066|FG005|Overall Study|Lost to Follow-up|0|||
27690776|NCT03607422|80706061|FG000|Overall Study|Other|12|||
27690777|NCT03607422|80706062|FG001|Overall Study|Other|4|||
27690778|NCT03607422|80706063|FG002|Overall Study|Other|1|||
27690779|NCT03607422|80706064|FG003|Overall Study|Other|2|||
27690780|NCT03607422|80706065|FG004|Overall Study|Other|0|||
27690781|NCT03607422|80706066|FG005|Overall Study|Other|2|||
27690782|NCT03607422|80706061|FG000|Overall Study|Ongoing at Time of Analysis|8|||
27690783|NCT03607422|80706062|FG001|Overall Study|Ongoing at Time of Analysis|0|||
27690784|NCT03607422|80706063|FG002|Overall Study|Ongoing at Time of Analysis|2|||
27690785|NCT03607422|80706064|FG003|Overall Study|Ongoing at Time of Analysis|1|||
27690786|NCT03607422|80706065|FG004|Overall Study|Ongoing at Time of Analysis|1|||
27690787|NCT03607422|80706066|FG005|Overall Study|Ongoing at Time of Analysis|1|||
27690788|NCT03169101|80706067|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
27690789|NCT03169101|80706068|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
27690790|NCT03169101|80706069|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
27690791|NCT03169101|80706070|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
27690792|NCT00156819|80706071|FG000|Overall Study|Lost to Follow-up|1|||
27690793|NCT00156819|80706072|FG001|Overall Study|Lost to Follow-up|1|||
27690794|NCT00156819|80706073|FG002|Overall Study|Lost to Follow-up|3|||
27690795|NCT02413333|80706074|FG000|Period 1|Adverse Event|1|||
27690796|NCT02413333|80706075|FG001|Period 1|Adverse Event|0|||
27690797|NCT02413333|80706074|FG000|Period 1|Reason Not Specified|0|||
27690798|NCT02413333|80706075|FG001|Period 1|Reason Not Specified|1|||
27690799|NCT02413333|80706074|FG000|Period 2|Protocol Deviation|1|||
27690800|NCT02413333|80706075|FG001|Period 2|Protocol Deviation|0|||
27690801|NCT01178385|80706076|FG000|Overall Study|Withdrawal by Subject|2|||
27690802|NCT01178385|80706077|FG001|Overall Study|Withdrawal by Subject|0|||
27690803|NCT01776541|80706081|FG000|Overall Study|Administrative Reason|6|||
27690804|NCT01776541|80706082|FG001|Overall Study|Administrative Reason|2|||
27690805|NCT01776541|80706081|FG000|Overall Study|Death|4|||
27690806|NCT01776541|80706082|FG001|Overall Study|Death|0|||
27690807|NCT01776541|80706081|FG000|Overall Study|Lost to Follow-up|27|||
27690808|NCT01776541|80706082|FG001|Overall Study|Lost to Follow-up|48|||
27690809|NCT01776541|80706081|FG000|Overall Study|Unclassified|5|||
27690810|NCT01776541|80706082|FG001|Overall Study|Unclassified|4|||
27690811|NCT01776541|80706081|FG000|Overall Study|Protocol Violation|2|||
27690812|NCT01776541|80706082|FG001|Overall Study|Protocol Violation|1|||
27690813|NCT01776541|80706081|FG000|Overall Study|Withdrawal by Subject|12|||
27690814|NCT01776541|80706082|FG001|Overall Study|Withdrawal by Subject|20|||
27690815|NCT01236534|80706085|FG000|Overall Study|Adverse Event|3|||
27690816|NCT01236534|80706086|FG001|Overall Study|Adverse Event|0|||
27690817|NCT01323647|80706087|FG000|Overall Study|Migrated/moved from study area|2|||
27690818|NCT01323647|80706088|FG001|Overall Study|Migrated/moved from study area|0|||
27690819|NCT01323647|80706087|FG000|Overall Study|Withdrawal by Subject|5|||
27690820|NCT01323647|80706088|FG001|Overall Study|Withdrawal by Subject|0|||
27690821|NCT01323647|80706087|FG000|Overall Study|Lost to Follow-up|2|||
27690822|NCT01323647|80706088|FG001|Overall Study|Lost to Follow-up|0|||
27690823|NCT03814187|80706089|FG000|Overall Study|Sponsor's Administrative Decision|0|||
27690824|NCT03814187|80706090|FG001|Overall Study|Sponsor's Administrative Decision|0|||
27690825|NCT03814187|80706091|FG002|Overall Study|Sponsor's Administrative Decision|272|||
27690826|NCT03814187|80706089|FG000|Overall Study|Death|80|||
27690827|NCT03814187|80706090|FG001|Overall Study|Death|81|||
27690828|NCT03814187|80706091|FG002|Overall Study|Death|4|||
27690829|NCT03814187|80706089|FG000|Overall Study|Withdrew Consent|77|||
27690830|NCT03814187|80706090|FG001|Overall Study|Withdrew Consent|78|||
27690831|NCT03814187|80706091|FG002|Overall Study|Withdrew Consent|2|||
27690832|NCT03814187|80706089|FG000|Overall Study|Lost to Follow-up|47|||
27690833|NCT03814187|80706090|FG001|Overall Study|Lost to Follow-up|52|||
27690834|NCT03814187|80706091|FG002|Overall Study|Lost to Follow-up|1|||
27690835|NCT03814187|80706089|FG000|Overall Study|Adverse Event|22|||
27690836|NCT03814187|80706090|FG001|Overall Study|Adverse Event|23|||
27690837|NCT03814187|80706091|FG002|Overall Study|Adverse Event|0|||
27690838|NCT03814187|80706089|FG000|Overall Study|Physician Decision|7|||
27690839|NCT03814187|80706090|FG001|Overall Study|Physician Decision|4|||
27690840|NCT03814187|80706091|FG002|Overall Study|Physician Decision|2|||
27690841|NCT03814187|80706089|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
27690842|NCT03814187|80706090|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
27690843|NCT03814187|80706091|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
27690844|NCT03814187|80706089|FG000|Overall Study|Other reasons|34|||
27690845|NCT03814187|80706090|FG001|Overall Study|Other reasons|40|||
27690846|NCT03814187|80706091|FG002|Overall Study|Other reasons|2|||
27690847|NCT02003222|80706094|FG000|Induction|Never started treatment|0|||
27690848|NCT02003222|80706095|FG001|Induction|Never started treatment|0|||
27690849|NCT02003222|80706096|FG002|Induction|Never started treatment|0|||
27690850|NCT02003222|80706097|FG003|Induction|Never started treatment|0|||
27690851|NCT02003222|80706098|FG004|Induction|Never started treatment|8|||
27690852|NCT02003222|80706094|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
27690853|NCT02003222|80706095|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
27690854|NCT02003222|80706096|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
27690855|NCT02003222|80706097|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
27690856|NCT02003222|80706098|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
27690857|NCT02003222|80706094|FG000|Induction|Adverse Event|0|||
27690858|NCT02003222|80706095|FG001|Induction|Adverse Event|0|||
27690859|NCT02003222|80706096|FG002|Induction|Adverse Event|0|||
27690860|NCT02003222|80706097|FG003|Induction|Adverse Event|0|||
27690861|NCT02003222|80706098|FG004|Induction|Adverse Event|13|||
27690862|NCT02003222|80706094|FG000|Induction|Alternative therapy|0|||
27690863|NCT02003222|80706095|FG001|Induction|Alternative therapy|0|||
27690864|NCT02003222|80706096|FG002|Induction|Alternative therapy|0|||
27690865|NCT02003222|80706097|FG003|Induction|Alternative therapy|0|||
27690866|NCT02003222|80706098|FG004|Induction|Alternative therapy|12|||
27690867|NCT02003222|80706094|FG000|Induction|Disease progression|0|||
27690868|NCT02003222|80706095|FG001|Induction|Disease progression|0|||
27690869|NCT02003222|80706096|FG002|Induction|Disease progression|0|||
27690870|NCT02003222|80706097|FG003|Induction|Disease progression|0|||
27690871|NCT02003222|80706098|FG004|Induction|Disease progression|22|||
27690872|NCT02003222|80706094|FG000|Induction|Death|0|||
27690873|NCT02003222|80706095|FG001|Induction|Death|0|||
27690874|NCT02003222|80706096|FG002|Induction|Death|0|||
27690875|NCT02003222|80706097|FG003|Induction|Death|0|||
27690876|NCT02003222|80706098|FG004|Induction|Death|3|||
27690877|NCT02003222|80706094|FG000|Induction|Withdrawal by Subject|0|||
27690878|NCT02003222|80706095|FG001|Induction|Withdrawal by Subject|0|||
27690879|NCT02003222|80706096|FG002|Induction|Withdrawal by Subject|0|||
27690880|NCT02003222|80706097|FG003|Induction|Withdrawal by Subject|0|||
27690881|NCT02003222|80706098|FG004|Induction|Withdrawal by Subject|8|||
27690882|NCT02003222|80706094|FG000|Induction|Other reasons|0|||
27690883|NCT02003222|80706095|FG001|Induction|Other reasons|0|||
27690884|NCT02003222|80706096|FG002|Induction|Other reasons|0|||
27690885|NCT02003222|80706097|FG003|Induction|Other reasons|0|||
27690886|NCT02003222|80706098|FG004|Induction|Other reasons|22|||
27690887|NCT02003222|80706094|FG000|Intensification|Never started treatment|0|||
27690888|NCT02003222|80706095|FG001|Intensification|Never started treatment|0|||
27690889|NCT02003222|80706096|FG002|Intensification|Never started treatment|0|||
27690890|NCT02003222|80706097|FG003|Intensification|Never started treatment|0|||
27690891|NCT02003222|80706098|FG004|Intensification|Never started treatment|2|||
27690892|NCT02003222|80706094|FG000|Intensification|Adverse Event|0|||
27690893|NCT02003222|80706095|FG001|Intensification|Adverse Event|0|||
27690894|NCT02003222|80706096|FG002|Intensification|Adverse Event|0|||
27690895|NCT02003222|80706097|FG003|Intensification|Adverse Event|0|||
27690896|NCT02003222|80706098|FG004|Intensification|Adverse Event|6|||
27690897|NCT02003222|80706094|FG000|Intensification|Alternative therapy|0|||
27690898|NCT02003222|80706095|FG001|Intensification|Alternative therapy|0|||
27690899|NCT02003222|80706096|FG002|Intensification|Alternative therapy|0|||
27690900|NCT02003222|80706097|FG003|Intensification|Alternative therapy|0|||
27690901|NCT02003222|80706098|FG004|Intensification|Alternative therapy|8|||
27690902|NCT02003222|80706094|FG000|Intensification|Disease progression|0|||
27690903|NCT02003222|80706095|FG001|Intensification|Disease progression|0|||
27690904|NCT02003222|80706096|FG002|Intensification|Disease progression|0|||
27690905|NCT02003222|80706097|FG003|Intensification|Disease progression|0|||
27690906|NCT02003222|80706098|FG004|Intensification|Disease progression|18|||
27690907|NCT02003222|80706094|FG000|Intensification|Withdrawal by Subject|0|||
27690908|NCT02003222|80706095|FG001|Intensification|Withdrawal by Subject|0|||
27690909|NCT02003222|80706096|FG002|Intensification|Withdrawal by Subject|0|||
27690910|NCT02003222|80706097|FG003|Intensification|Withdrawal by Subject|0|||
27690911|NCT02003222|80706098|FG004|Intensification|Withdrawal by Subject|5|||
27690912|NCT02003222|80706094|FG000|Intensification|Other reasons|0|||
27690913|NCT02003222|80706095|FG001|Intensification|Other reasons|0|||
27690914|NCT02003222|80706096|FG002|Intensification|Other reasons|0|||
27690915|NCT02003222|80706097|FG003|Intensification|Other reasons|0|||
27690916|NCT02003222|80706098|FG004|Intensification|Other reasons|8|||
27690917|NCT01598311|80706099|FG000|Overall Study|Physician Decision|4|||
27690918|NCT01598311|80706100|FG001|Overall Study|Physician Decision|5|||
27690919|NCT01598311|80706099|FG000|Overall Study|Adverse Event|9|||
27690920|NCT01598311|80706100|FG001|Overall Study|Adverse Event|13|||
27690921|NCT01598311|80706099|FG000|Overall Study|Lost to Follow-up|7|||
27690922|NCT01598311|80706100|FG001|Overall Study|Lost to Follow-up|12|||
27690923|NCT01598311|80706099|FG000|Overall Study|Withdrawal by Subject|9|||
27690924|NCT01598311|80706100|FG001|Overall Study|Withdrawal by Subject|13|||
27690925|NCT01598311|80706099|FG000|Overall Study|No reason provided.|0|||
27817197|NCT00262600|81162838|FG002|Overall Study|Not Treated|24|||
27817198|NCT00262600|81162836|FG000|Overall Study|Other|58|||
27817199|NCT00262600|81162837|FG001|Overall Study|Other|59|||
27817200|NCT00262600|81162838|FG002|Overall Study|Other|62|||
27817201|NCT02146430|81162839|FG000|Overall Study|Protocol Violation|5|||
27817202|NCT02146430|81162840|FG001|Overall Study|Protocol Violation|4|||
27817203|NCT02146430|81162841|FG002|Overall Study|Protocol Violation|8|||
27690926|NCT01598311|80706100|FG001|Overall Study|No reason provided.|5|||
27690927|NCT01598311|80706099|FG000|Overall Study|Randomized but never treated|8|||
27690928|NCT01598311|80706100|FG001|Overall Study|Randomized but never treated|5|||
27690929|NCT01598311|80706099|FG000|Overall Study|Treated but no confirmed CDAD|9|||
27690930|NCT01598311|80706100|FG001|Overall Study|Treated but no confirmed CDAD|8|||
27817204|NCT02146430|81162842|FG003|Overall Study|Protocol Violation|6|||
27590805|NCT02015676|80344745|FG002|Overall Study|Withdrawal by Subject|1|||
27690931|NCT01598311|80706099|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
27690932|NCT01598311|80706100|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
27690933|NCT04684394|80706103|FG000|Overall Study|Death|1|||
27690934|NCT04684394|80706104|FG001|Overall Study|Death|2|||
27690935|NCT04684394|80706103|FG000|Overall Study|Lost to Follow-up|1|||
27690936|NCT04684394|80706104|FG001|Overall Study|Lost to Follow-up|0|||
27817205|NCT02146430|81162839|FG000|Overall Study|Lack of Efficacy|13|||
27817206|NCT02146430|81162840|FG001|Overall Study|Lack of Efficacy|11|||
27817207|NCT02146430|81162841|FG002|Overall Study|Lack of Efficacy|8|||
27817208|NCT02146430|81162842|FG003|Overall Study|Lack of Efficacy|5|||
27817209|NCT02146430|81162839|FG000|Overall Study|Adverse Event|20|||
27817210|NCT02146430|81162840|FG001|Overall Study|Adverse Event|40|||
27817211|NCT02146430|81162841|FG002|Overall Study|Adverse Event|32|||
27817212|NCT02146430|81162842|FG003|Overall Study|Adverse Event|49|||
27817213|NCT02146430|81162839|FG000|Overall Study|Reason missing or not reported|2|||
27817214|NCT02146430|81162840|FG001|Overall Study|Reason missing or not reported|3|||
27817215|NCT02146430|81162841|FG002|Overall Study|Reason missing or not reported|4|||
27817216|NCT02146430|81162842|FG003|Overall Study|Reason missing or not reported|5|||
27817217|NCT02146430|81162839|FG000|Overall Study|Withdrawal by Subject|27|||
27817218|NCT02146430|81162840|FG001|Overall Study|Withdrawal by Subject|29|||
27817219|NCT02146430|81162841|FG002|Overall Study|Withdrawal by Subject|30|||
27817220|NCT02146430|81162842|FG003|Overall Study|Withdrawal by Subject|34|||
27817221|NCT00818883|81162843|FG000|Overall Study|Adverse Event|28|||
27817222|NCT00818883|81162844|FG001|Overall Study|Adverse Event|19|||
27817223|NCT00818883|81162843|FG000|Overall Study|Protocol Violation|2|||
27817224|NCT00818883|81162844|FG001|Overall Study|Protocol Violation|2|||
27817225|NCT00818883|81162843|FG000|Overall Study|Lost to Follow-up|3|||
27817226|NCT00818883|81162844|FG001|Overall Study|Lost to Follow-up|2|||
27690937|NCT04684394|80706103|FG000|Overall Study|Withdrawal by Subject|2|||
27690938|NCT04684394|80706104|FG001|Overall Study|Withdrawal by Subject|0|||
27690939|NCT04684394|80706103|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
27690940|NCT04684394|80706104|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
27690941|NCT00906945|80706105|FG000|Overall Study|Found to be not eligible|0|||
27690942|NCT00906945|80706106|FG001|Overall Study|Found to be not eligible|0|||
27690943|NCT00906945|80706107|FG002|Overall Study|Found to be not eligible|0|||
27690944|NCT00906945|80706108|FG003|Overall Study|Found to be not eligible|1|||
27690945|NCT00906945|80706109|FG004|Overall Study|Found to be not eligible|1|||
27690946|NCT00906945|80706110|FG005|Overall Study|Found to be not eligible|1|||
27690947|NCT00906945|80706105|FG000|Overall Study|Physician Decision|0|||
27690948|NCT00906945|80706106|FG001|Overall Study|Physician Decision|0|||
27690949|NCT00906945|80706107|FG002|Overall Study|Physician Decision|0|||
27690950|NCT00906945|80706108|FG003|Overall Study|Physician Decision|0|||
27690951|NCT00906945|80706109|FG004|Overall Study|Physician Decision|0|||
27690952|NCT00906945|80706110|FG005|Overall Study|Physician Decision|1|||
27690953|NCT01201265|80706111|FG000|Overall Study|Death|14|||
27690954|NCT01201265|80706111|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27690955|NCT01201265|80706111|FG000|Overall Study|Lost to Follow-up|10|||
27690956|NCT01201265|80706111|FG000|Overall Study|Withdrawal by Subject|7|||
27690957|NCT01201265|80706111|FG000|Overall Study|Disease Progression|4|||
27690958|NCT02689518|80706116|FG000|Overall Study|Withdrawal by Subject|3|||
27690959|NCT02980731|80706117|FG000|Overall Study|Death|63|||
27690960|NCT02980731|80706117|FG000|Overall Study|Withdrawal by Subject|6|||
27690961|NCT02980731|80706117|FG000|Overall Study|Lost to Follow-up|5|||
27690962|NCT02980731|80706117|FG000|Overall Study|Study terminated by Sponsor|4|||
27690963|NCT02980731|80706117|FG000|Overall Study|Completed survival follow-up period|65|||
27690964|NCT02980731|80706117|FG000|Overall Study|COVID-19 infection|1|||
27690965|NCT02980731|80706117|FG000|Overall Study|Other, not specified|66|||
27690966|NCT02571049|80706118|FG000|Screening|Did not meet entry criteria|2|||
27690967|NCT02571049|80706119|FG001|Screening|Did not meet entry criteria|2|||
27690968|NCT02571049|80706118|FG000|Randomization|No migraine attack|0|||
27690969|NCT02571049|80706119|FG001|Randomization|No migraine attack|1|||
27690970|NCT02571049|80706118|FG000|Randomization|Adverse Event|0|||
27690971|NCT02571049|80706119|FG001|Randomization|Adverse Event|1|||
27690972|NCT00055601|80706126|FG000|Overall Study|Protocol Violation|1|||
27690973|NCT00055601|80706127|FG001|Overall Study|Protocol Violation|1|||
27690974|NCT00055601|80706126|FG000|Overall Study|No protocol treatment received|1|||
27690975|NCT00055601|80706127|FG001|Overall Study|No protocol treatment received|1|||
27690976|NCT01990560|80706129|FG000|Overall Study|Withdrawal by Subject|1|||
27690977|NCT03737474|80706130|FG000|Overall Study|Adverse Event|18|||
27690978|NCT03737474|80706131|FG001|Overall Study|Adverse Event|48|||
27690979|NCT03737474|80706130|FG000|Overall Study|Lack of Efficacy|1|||
27690980|NCT03737474|80706131|FG001|Overall Study|Lack of Efficacy|3|||
27690981|NCT03737474|80706130|FG000|Overall Study|Protocol Violation|0|||
27690982|NCT03737474|80706131|FG001|Overall Study|Protocol Violation|8|||
27690983|NCT03737474|80706130|FG000|Overall Study|Withdrawal by Subject|5|||
27690984|NCT03737474|80706131|FG001|Overall Study|Withdrawal by Subject|20|||
27690985|NCT03737474|80706130|FG000|Overall Study|Non-compliance With Study Drug|0|||
27690986|NCT03737474|80706131|FG001|Overall Study|Non-compliance With Study Drug|1|||
27690987|NCT03737474|80706130|FG000|Overall Study|Physician Decision|1|||
27817227|NCT00818883|81162843|FG000|Overall Study|Withdrawal by Subject|16|||
27690988|NCT03737474|80706131|FG001|Overall Study|Physician Decision|4|||
27690989|NCT01011387|80706134|FG000|Overall Study|Withdrawal by Subject|3|||
27690990|NCT01011387|80706134|FG000|Overall Study|Adverse Event|2|||
27690991|NCT01011387|80706134|FG000|Overall Study|Protocol Violation|1|||
27817228|NCT00818883|81162844|FG001|Overall Study|Withdrawal by Subject|14|||
27690992|NCT01315353|80706135|FG000|Overall Study|Death|2|||
27690993|NCT01315353|80706136|FG001|Overall Study|Death|1|||
27690994|NCT01315353|80706137|FG002|Overall Study|Death|0|||
27690995|NCT01315353|80706135|FG000|Overall Study|Withdrawal by Subject|2|||
27690996|NCT01315353|80706136|FG001|Overall Study|Withdrawal by Subject|6|||
27690997|NCT01315353|80706137|FG002|Overall Study|Withdrawal by Subject|1|||
27690998|NCT01315353|80706135|FG000|Overall Study|Lost to Follow-up|13|||
27690999|NCT01315353|80706136|FG001|Overall Study|Lost to Follow-up|6|||
27691000|NCT01315353|80706137|FG002|Overall Study|Lost to Follow-up|6|||
27691001|NCT01315353|80706135|FG000|Overall Study|Unwilling to adhere to requirements|5|||
27691002|NCT01315353|80706136|FG001|Overall Study|Unwilling to adhere to requirements|5|||
27691003|NCT01315353|80706137|FG002|Overall Study|Unwilling to adhere to requirements|4|||
27691004|NCT01315353|80706135|FG000|Overall Study|Site closing|7|||
27691005|NCT01315353|80706136|FG001|Overall Study|Site closing|4|||
27691006|NCT01315353|80706137|FG002|Overall Study|Site closing|0|||
27691007|NCT01315353|80706135|FG000|Overall Study|Taken off study by site in error|0|||
27691008|NCT01315353|80706136|FG001|Overall Study|Taken off study by site in error|1|||
27691009|NCT01315353|80706137|FG002|Overall Study|Taken off study by site in error|0|||
27691010|NCT01315353|80706135|FG000|Overall Study|Inadvertent randomization/assignment|0|||
27691011|NCT01315353|80706136|FG001|Overall Study|Inadvertent randomization/assignment|0|||
27691012|NCT01315353|80706137|FG002|Overall Study|Inadvertent randomization/assignment|2|||
27691013|NCT01771107|80706138|FG000|Overall Study|Adverse Event|1|||
27691014|NCT01771107|80706139|FG001|Overall Study|Adverse Event|3|||
27691015|NCT01771107|80706138|FG000|Overall Study|Withdrawal by Subject|0|||
27691016|NCT01771107|80706139|FG001|Overall Study|Withdrawal by Subject|2|||
27691017|NCT01771107|80706138|FG000|Overall Study|Lost to Follow-up|0|||
27691018|NCT01771107|80706139|FG001|Overall Study|Lost to Follow-up|1|||
27691019|NCT01771107|80706138|FG000|Overall Study|participant moved|0|||
27691020|NCT01771107|80706139|FG001|Overall Study|participant moved|1|||
27691021|NCT01771107|80706138|FG000|Overall Study|Other|0|||
27691022|NCT01771107|80706139|FG001|Overall Study|Other|1|||
27691023|NCT01076192|80706144|FG000|Overall Study|Other|197|||
27691024|NCT02831387|80706145|FG000|Overall Study|Withdrawal by Subject|1|||
27691025|NCT02831387|80706146|FG001|Overall Study|Withdrawal by Subject|1|||
27691026|NCT02831387|80706145|FG000|Overall Study|Discontinued due to stock recovery|0|||
27691027|NCT02831387|80706146|FG001|Overall Study|Discontinued due to stock recovery|1|||
27691028|NCT00883051|80706147|FG000|Overall Study|Lost to Follow-up|0|||
27691029|NCT00883051|80706148|FG001|Overall Study|Lost to Follow-up|0|||
27691030|NCT00883051|80706149|FG002|Overall Study|Lost to Follow-up|0|||
27691031|NCT00883051|80706150|FG003|Overall Study|Lost to Follow-up|0|||
27691032|NCT00883051|80706151|FG004|Overall Study|Lost to Follow-up|1|||
27691033|NCT00883051|80706147|FG000|Overall Study|Did not use study medication|24|||
27691034|NCT00883051|80706148|FG001|Overall Study|Did not use study medication|22|||
27691035|NCT00883051|80706149|FG002|Overall Study|Did not use study medication|29|||
27691036|NCT00883051|80706150|FG003|Overall Study|Did not use study medication|29|||
27691037|NCT00883051|80706151|FG004|Overall Study|Did not use study medication|17|||
27691038|NCT00825916|80706154|FG000|Overall Study|Lost to Follow-up|4|||
27691039|NCT00825916|80706155|FG001|Overall Study|Lost to Follow-up|2|||
27691040|NCT00825916|80706156|FG002|Overall Study|Lost to Follow-up|1|||
27691041|NCT01773291|80706157|FG000|Overall Study|Protocol Violation|1|||
27691042|NCT01773291|80706158|FG001|Overall Study|Protocol Violation|0|||
27691043|NCT01773291|80706159|FG002|Overall Study|Protocol Violation|0|||
27691044|NCT01773291|80706157|FG000|Overall Study|Withdrawal by Subject|0|||
27691045|NCT01773291|80706158|FG001|Overall Study|Withdrawal by Subject|0|||
27691046|NCT01773291|80706159|FG002|Overall Study|Withdrawal by Subject|1|||
27691047|NCT01435616|80706162|FG000|Overall Study|Adverse Event|39|||
27691048|NCT01435616|80706163|FG001|Overall Study|Adverse Event|21|||
27691049|NCT01435616|80706162|FG000|Overall Study|Death|7|||
27691050|NCT01435616|80706163|FG001|Overall Study|Death|2|||
27691051|NCT01435616|80706162|FG000|Overall Study|Lost to Follow-up|22|||
27691052|NCT01435616|80706163|FG001|Overall Study|Lost to Follow-up|13|||
27691053|NCT01435616|80706162|FG000|Overall Study|Protocol Violation|16|||
27691054|NCT01435616|80706163|FG001|Overall Study|Protocol Violation|13|||
27691055|NCT01435616|80706162|FG000|Overall Study|Withdrawal by Subject|66|||
27691056|NCT01435616|80706163|FG001|Overall Study|Withdrawal by Subject|24|||
27691057|NCT01435616|80706162|FG000|Overall Study|Physician Decision|20|||
27691058|NCT01435616|80706163|FG001|Overall Study|Physician Decision|7|||
27691059|NCT01435616|80706162|FG000|Overall Study|Sponsor Decision|1|||
27691060|NCT01435616|80706163|FG001|Overall Study|Sponsor Decision|0|||
27691061|NCT01226095|80706167|FG000|Overall Study|Poor compliance|1|||
27691062|NCT01248065|80706170|FG000|Overall Study|Lost to Follow-up|3|||
27691063|NCT01248065|80706171|FG001|Overall Study|Lost to Follow-up|5|||
27691064|NCT01248065|80706170|FG000|Overall Study|Withdrawal by Subject|14|||
27691065|NCT01248065|80706171|FG001|Overall Study|Withdrawal by Subject|11|||
27691066|NCT01248065|80706170|FG000|Overall Study|Adverse Event|3|||
27691067|NCT01248065|80706171|FG001|Overall Study|Adverse Event|0|||
27691068|NCT01248065|80706170|FG000|Overall Study|Third treatment failure event|3|||
27691069|NCT01248065|80706171|FG001|Overall Study|Third treatment failure event|1|||
27691070|NCT01248065|80706170|FG000|Overall Study|Other|3|||
27691071|NCT01248065|80706171|FG001|Overall Study|Other|5|||
27691072|NCT01090427|80706172|FG000|After Controlled Period|Death|0|||
27691073|NCT01090427|80706173|FG001|After Controlled Period|Death|0|||
27691074|NCT01090427|80706174|FG002|After Controlled Period|Death|0|||
27691075|NCT01090427|80706175|FG003|After Controlled Period|Death|0|||
27691076|NCT01090427|80706176|FG004|After Controlled Period|Death|0|||
27691077|NCT01090427|80706177|FG005|After Controlled Period|Death|1|||
27691078|NCT01090427|80706178|FG006|After Controlled Period|Death|0|||
27691079|NCT01090427|80706172|FG000|After Controlled Period|Lack of Efficacy|0|||
27691080|NCT01090427|80706173|FG001|After Controlled Period|Lack of Efficacy|0|||
27691081|NCT01090427|80706174|FG002|After Controlled Period|Lack of Efficacy|0|||
27691082|NCT01090427|80706175|FG003|After Controlled Period|Lack of Efficacy|0|||
27691083|NCT01090427|80706176|FG004|After Controlled Period|Lack of Efficacy|0|||
27691084|NCT01090427|80706177|FG005|After Controlled Period|Lack of Efficacy|3|||
27691085|NCT01090427|80706178|FG006|After Controlled Period|Lack of Efficacy|2|||
27691086|NCT01090427|80706172|FG000|After Controlled Period|Adverse Event|0|||
27691087|NCT01090427|80706173|FG001|After Controlled Period|Adverse Event|0|||
27691088|NCT01090427|80706174|FG002|After Controlled Period|Adverse Event|0|||
27878956|NCT00658723|81391364|FG001|Overall Study|Death|1|||
27878957|NCT00658723|81391365|FG002|Overall Study|Death|4|||
27878958|NCT00658723|81391363|FG000|Overall Study|Scheduling Issue|1|||
27878959|NCT00658723|81391364|FG001|Overall Study|Scheduling Issue|1|||
27878960|NCT00658723|81391365|FG002|Overall Study|Scheduling Issue|0|||
27878961|NCT00658723|81391363|FG000|Overall Study|Withdrawal by Subject|1|||
27878962|NCT00658723|81391364|FG001|Overall Study|Withdrawal by Subject|0|||
27878963|NCT00658723|81391365|FG002|Overall Study|Withdrawal by Subject|1|||
27878964|NCT00921557|81391366|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
27878965|NCT00921557|81391367|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
27878966|NCT00921557|81391368|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
27878967|NCT00921557|81391366|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
27878968|NCT00921557|81391367|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
27878969|NCT00921557|81391368|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
27878970|NCT00921557|81391366|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
27878971|NCT00921557|81391367|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
27878972|NCT00921557|81391368|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
27878973|NCT00921557|81391366|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
27878974|NCT00921557|81391367|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
27878975|NCT00921557|81391368|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
27878976|NCT00921557|81391366|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
27878977|NCT00921557|81391367|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
27878978|NCT00921557|81391368|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
27878979|NCT01532518|81391379|FG000|Overall Study|Withdrawal by Subject|0|||
27878980|NCT01532518|81391380|FG001|Overall Study|Withdrawal by Subject|0|||
27878981|NCT01532518|81391381|FG002|Overall Study|Withdrawal by Subject|1|||
27878982|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
27878983|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
27878984|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
27878985|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
27878986|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
27878987|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
27878988|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
27878989|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
27590806|NCT02015676|80344743|FG000|Overall Study|Administrative reasons|0|||
27691089|NCT01090427|80706175|FG003|After Controlled Period|Adverse Event|2|||
27691090|NCT01090427|80706176|FG004|After Controlled Period|Adverse Event|0|||
27691091|NCT01090427|80706177|FG005|After Controlled Period|Adverse Event|1|||
27691092|NCT01090427|80706178|FG006|After Controlled Period|Adverse Event|0|||
27691093|NCT02962960|80706179|FG000|Overall Study|Withdrawal by Subject|1|||
27691094|NCT02962960|80706180|FG001|Overall Study|Withdrawal by Subject|1|||
27691095|NCT02962960|80706181|FG002|Overall Study|Withdrawal by Subject|0|||
27691096|NCT02962960|80706179|FG000|Overall Study|Adverse Event|1|||
27691097|NCT02962960|80706180|FG001|Overall Study|Adverse Event|1|||
27691098|NCT02962960|80706181|FG002|Overall Study|Adverse Event|0|||
27691099|NCT02962960|80706179|FG000|Overall Study|Protocol Violation|1|||
27590807|NCT02015676|80344744|FG001|Overall Study|Administrative reasons|3|||
27590808|NCT02015676|80344745|FG002|Overall Study|Administrative reasons|1|||
27590809|NCT02015676|80344743|FG000|Overall Study|Death|0|||
27590810|NCT02015676|80344744|FG001|Overall Study|Death|1|||
27590811|NCT02015676|80344745|FG002|Overall Study|Death|0|||
27691100|NCT02962960|80706180|FG001|Overall Study|Protocol Violation|0|||
27590812|NCT02015676|80344743|FG000|Overall Study|Disease progression|3|||
27590813|NCT02015676|80344744|FG001|Overall Study|Disease progression|1|||
27590814|NCT02015676|80344745|FG002|Overall Study|Disease progression|1|||
27590815|NCT02590354|80344746|FG000|Phase 1|Active hepatitis B or C infection|1|||
27590816|NCT02590354|80344746|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
27691101|NCT02962960|80706181|FG002|Overall Study|Protocol Violation|0|||
27691102|NCT01853644|80706182|FG000|Registration and Treatment Start|Did not start treatment|1|||
27817229|NCT00818883|81162843|FG000|Overall Study|Lack of Efficacy|0|||
27817230|NCT00818883|81162844|FG001|Overall Study|Lack of Efficacy|2|||
27817231|NCT00818883|81162843|FG000|Overall Study|Other|2|||
27817232|NCT00818883|81162844|FG001|Overall Study|Other|7|||
27817233|NCT05894577|81162845|FG000|Overall Study|No receipt of study drug|14|||
27817234|NCT05894577|81162846|FG001|Overall Study|No receipt of study drug|13|||
27817235|NCT05894577|81162845|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
27817236|NCT05894577|81162846|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
27817237|NCT05894577|81162845|FG000|Overall Study|Screen Fail|2|||
27817238|NCT05894577|81162846|FG001|Overall Study|Screen Fail|0|||
27817239|NCT05894577|81162845|FG000|Overall Study|Study drug recall|86|||
27817240|NCT05894577|81162846|FG001|Overall Study|Study drug recall|63|||
27817241|NCT03527745|81162850|FG000|Overall Study|Lost to Follow-up|3|||
27817242|NCT03527745|81162851|FG001|Overall Study|Lost to Follow-up|6|||
27590817|NCT02590354|80344746|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
27590818|NCT02590354|80344746|FG000|Phase 1|Subject does not want to participate|20|||
27590819|NCT02590354|80344746|FG000|Phase 1|Lost to Follow-up|1|||
27691103|NCT01853644|80706182|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
27691104|NCT01853644|80706182|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
27691105|NCT01853644|80706182|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
27691106|NCT01853644|80706182|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
27691107|NCT01853644|80706182|FG000|Continued Treatment After First Response|Adverse Event|2|||
27691108|NCT01853644|80706182|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
27691109|NCT01060540|80706183|FG000|Overall Study|Withdrawal by Subject|10|||
27691110|NCT01060540|80706184|FG001|Overall Study|Withdrawal by Subject|20|||
27691111|NCT01060540|80706183|FG000|Overall Study|Lost to Follow-up|52|||
27691112|NCT01060540|80706184|FG001|Overall Study|Lost to Follow-up|43|||
27691113|NCT01060540|80706183|FG000|Overall Study|Death|2|||
27691114|NCT01060540|80706184|FG001|Overall Study|Death|1|||
27691115|NCT01060540|80706183|FG000|Overall Study|Physician Decision|0|||
27691116|NCT01060540|80706184|FG001|Overall Study|Physician Decision|1|||
27691117|NCT00528645|80706187|FG000|Overall Study|Adverse Event|3|||
27691118|NCT00969709|80706192|FG000|Overall Study|Adverse Event|3|||
27691119|NCT00969709|80706193|FG001|Overall Study|Adverse Event|13|||
27691120|NCT00969709|80706194|FG002|Overall Study|Adverse Event|26|||
27691121|NCT00969709|80706195|FG003|Overall Study|Adverse Event|12|||
27691122|NCT00969709|80706192|FG000|Overall Study|Lack of Efficacy|7|||
27691123|NCT00969709|80706193|FG001|Overall Study|Lack of Efficacy|4|||
27691124|NCT00969709|80706194|FG002|Overall Study|Lack of Efficacy|1|||
27691125|NCT00969709|80706195|FG003|Overall Study|Lack of Efficacy|3|||
27691126|NCT00969709|80706192|FG000|Overall Study|Protocol Violation|9|||
27691127|NCT00969709|80706193|FG001|Overall Study|Protocol Violation|5|||
27691128|NCT00969709|80706194|FG002|Overall Study|Protocol Violation|9|||
27691129|NCT00969709|80706195|FG003|Overall Study|Protocol Violation|10|||
27691130|NCT00969709|80706192|FG000|Overall Study|Withdrawal by Subject|9|||
27691131|NCT00969709|80706193|FG001|Overall Study|Withdrawal by Subject|12|||
27691132|NCT00969709|80706194|FG002|Overall Study|Withdrawal by Subject|11|||
27691133|NCT00969709|80706195|FG003|Overall Study|Withdrawal by Subject|23|||
27691134|NCT00969709|80706192|FG000|Overall Study|Lost to Follow-up|10|||
27691135|NCT00969709|80706193|FG001|Overall Study|Lost to Follow-up|14|||
27691136|NCT00969709|80706194|FG002|Overall Study|Lost to Follow-up|8|||
27691137|NCT00969709|80706195|FG003|Overall Study|Lost to Follow-up|15|||
27691138|NCT00969709|80706192|FG000|Overall Study|Other reasons|0|||
27691139|NCT00969709|80706193|FG001|Overall Study|Other reasons|0|||
27691140|NCT00969709|80706194|FG002|Overall Study|Other reasons|3|||
27691141|NCT00969709|80706195|FG003|Overall Study|Other reasons|0|||
27691142|NCT02372136|80706196|FG000|Overall Study|Death|3|||
27691143|NCT02372136|80706197|FG001|Overall Study|Death|1|||
27691144|NCT02502799|80706203|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
27590820|NCT02590354|80344746|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
27691145|NCT02502799|80706204|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
27691146|NCT02502799|80706205|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
27691147|NCT02502799|80706206|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
27590821|NCT05046795|80344747|FG000|Overall Study|Adverse Event|13|||
27691148|NCT02502799|80706203|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
27691149|NCT02502799|80706204|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
27691150|NCT02502799|80706205|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
27691151|NCT02502799|80706206|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
27691152|NCT02502799|80706203|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
27691153|NCT02502799|80706204|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
27691154|NCT02502799|80706205|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
27691155|NCT02502799|80706206|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
27691156|NCT02502799|80706203|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
27691157|NCT02502799|80706204|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
27691158|NCT02502799|80706205|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
27691159|NCT02502799|80706206|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
27691160|NCT02502799|80706203|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
27691161|NCT02502799|80706204|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
27691162|NCT02502799|80706205|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
27691163|NCT02502799|80706206|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
27691164|NCT00324675|80706207|FG000|Overall Study|Adverse Event|1|||
27691165|NCT00324675|80706208|FG001|Overall Study|Adverse Event|0|||
27691166|NCT01248780|80706209|FG000|Overall Study|Lack of Efficacy|2|||
27691167|NCT01248780|80706210|FG001|Overall Study|Lack of Efficacy|0|||
27691168|NCT01248780|80706209|FG000|Overall Study|Lost to Follow-up|0|||
27691169|NCT01248780|80706210|FG001|Overall Study|Lost to Follow-up|1|||
27691170|NCT01248780|80706209|FG000|Overall Study|Death|0|||
27691171|NCT01248780|80706210|FG001|Overall Study|Death|1|||
27691172|NCT01248780|80706209|FG000|Overall Study|Adverse Event|2|||
27691173|NCT01248780|80706210|FG001|Overall Study|Adverse Event|7|||
27691174|NCT01248780|80706209|FG000|Overall Study|Protocol Violation|1|||
27691175|NCT01248780|80706210|FG001|Overall Study|Protocol Violation|1|||
27691176|NCT01248780|80706209|FG000|Overall Study|Withdrawal by Subject|4|||
27691177|NCT01248780|80706210|FG001|Overall Study|Withdrawal by Subject|4|||
27691178|NCT01248780|80706209|FG000|Overall Study|Not treated|0|||
27691179|NCT01248780|80706210|FG001|Overall Study|Not treated|1|||
27691180|NCT00842985|80706211|FG000|Screening|Did not meet entrance requirements|27|||
27691181|NCT00842985|80706211|FG000|First Intervention|Withdrawal by Subject|3|||
27691182|NCT00842985|80706211|FG000|First Intervention|Protocol Violation|3|||
27691183|NCT00842985|80706211|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
27691184|NCT00842985|80706211|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
27691185|NCT01813929|80706212|FG000|Overall Study|Withdrawal by Subject|0|||
27691186|NCT01813929|80706213|FG001|Overall Study|Withdrawal by Subject|1|||
27691187|NCT01009580|80706216|FG000|Overall Study|Adverse Event|4|||
27691188|NCT01009580|80706217|FG001|Overall Study|Adverse Event|4|||
27691189|NCT01009580|80706216|FG000|Overall Study|Lack of Efficacy|0|||
27691190|NCT01009580|80706217|FG001|Overall Study|Lack of Efficacy|1|||
27691191|NCT01009580|80706216|FG000|Overall Study|Protocol Violation|2|||
27691192|NCT01009580|80706217|FG001|Overall Study|Protocol Violation|3|||
27691193|NCT01009580|80706216|FG000|Overall Study|Withdrawal Criteria|4|||
27691194|NCT01009580|80706217|FG001|Overall Study|Withdrawal Criteria|6|||
27691195|NCT01009580|80706216|FG000|Overall Study|Unclassified|17|||
27691196|NCT01009580|80706217|FG001|Overall Study|Unclassified|21|||
27691197|NCT00618982|80706220|FG000|Overall Study|Adverse Event|23|||
27691198|NCT00618982|80706220|FG000|Overall Study|Withdrawal by Subject|1|||
27691199|NCT00618982|80706220|FG000|Overall Study|Protocol Violation|1|||
27691200|NCT00618982|80706220|FG000|Overall Study|ongoing, still treated with study med.|25|||
27691201|NCT00640133|80706229|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
27691202|NCT00640133|80706230|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
27691203|NCT00640133|80706229|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
27817243|NCT03527745|81162852|FG002|Overall Study|Lost to Follow-up|7|||
27817244|NCT03527745|81162853|FG003|Overall Study|Lost to Follow-up|9|||
27691204|NCT00640133|80706230|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
27691205|NCT00640133|80706229|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
27691206|NCT00640133|80706230|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
27691207|NCT00560066|80706231|FG000|Overall Study|Death|2|||
27691208|NCT00560066|80706232|FG001|Overall Study|Death|1|||
27691209|NCT00560066|80706231|FG000|Overall Study|Withdrawal by Subject|0|||
27590822|NCT05046795|80344748|FG001|Overall Study|Adverse Event|15|||
27590823|NCT05046795|80344747|FG000|Overall Study|Withdrawal by Subject|4|||
27590824|NCT05046795|80344748|FG001|Overall Study|Withdrawal by Subject|7|||
27590825|NCT05046795|80344747|FG000|Overall Study|Physician Decision|1|||
27590826|NCT05046795|80344748|FG001|Overall Study|Physician Decision|2|||
27590827|NCT05046795|80344747|FG000|Overall Study|Protocol Violation|1|||
27590828|NCT05046795|80344748|FG001|Overall Study|Protocol Violation|2|||
27878990|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
27878991|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
27878992|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
27878993|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
27878994|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
27878995|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
27878996|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
27878997|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
27878998|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
27878999|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
27879000|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
27879001|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
27879002|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
27879003|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
27879004|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
27879005|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
27879006|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
27879007|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
27879008|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
27879009|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
27879010|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
27879011|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
27879012|NCT03852472|81391382|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
27879013|NCT03852472|81391383|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
27879014|NCT03852472|81391384|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
27879015|NCT03852472|81391385|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
27879016|NCT03852472|81391386|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
27879017|NCT03852472|81391382|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
27879018|NCT03852472|81391383|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
27879019|NCT03852472|81391384|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
27879020|NCT03852472|81391385|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
27879021|NCT03852472|81391386|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
27879022|NCT03852472|81391382|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
27590829|NCT05046795|80344747|FG000|Overall Study|Death|1|||
27590830|NCT05046795|80344748|FG001|Overall Study|Death|0|||
27590831|NCT05046795|80344747|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
27590832|NCT05046795|80344748|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
27590833|NCT00657618|80344749|FG000|Overall Study|Adverse Event|32|||
27590834|NCT00657618|80344749|FG000|Overall Study|Withdrawal by Subject|8|||
27590835|NCT00657618|80344749|FG000|Overall Study|negative for leishmaniasis|2|||
27590836|NCT00657618|80344749|FG000|Overall Study|didn't start due to schedule conflicts|1|||
27590837|NCT02811861|80344761|FG000|Overall Study|Radiological Disease Progression|123|||
27590838|NCT02811861|80344762|FG001|Overall Study|Radiological Disease Progression|97|||
27590839|NCT02811861|80344763|FG002|Overall Study|Radiological Disease Progression|174|||
27879023|NCT03852472|81391383|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
27879024|NCT03852472|81391384|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
27879025|NCT03852472|81391385|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
27590840|NCT02811861|80344761|FG000|Overall Study|Clinical Disease Progression|20|||
27590841|NCT02811861|80344762|FG001|Overall Study|Clinical Disease Progression|19|||
27590842|NCT02811861|80344763|FG002|Overall Study|Clinical Disease Progression|22|||
27590843|NCT02811861|80344761|FG000|Overall Study|Adverse Event|63|||
27590844|NCT02811861|80344762|FG001|Overall Study|Adverse Event|60|||
27879026|NCT03852472|81391386|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
27879027|NCT03852472|81391382|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
27691210|NCT00560066|80706232|FG001|Overall Study|Withdrawal by Subject|3|||
27691211|NCT00560066|80706231|FG000|Overall Study|Lost to Follow-up|4|||
27691212|NCT00560066|80706232|FG001|Overall Study|Lost to Follow-up|10|||
27691213|NCT00560066|80706231|FG000|Overall Study|Protocol Violation|0|||
27691214|NCT00560066|80706232|FG001|Overall Study|Protocol Violation|1|||
27691215|NCT00560066|80706231|FG000|Overall Study|Administrative reason|0|||
27691216|NCT00560066|80706232|FG001|Overall Study|Administrative reason|5|||
27691217|NCT00560066|80706231|FG000|Overall Study|Missing primary reason|0|||
27691218|NCT00560066|80706232|FG001|Overall Study|Missing primary reason|2|||
27691219|NCT01079663|80706233|FG000|Overall Study|Adverse Event|0|||
27691220|NCT01079663|80706234|FG001|Overall Study|Adverse Event|2|||
27691221|NCT01079663|80706233|FG000|Overall Study|Protocol Violation|0|||
27691222|NCT01079663|80706234|FG001|Overall Study|Protocol Violation|2|||
27691223|NCT00346632|80706235|FG000|Overall Study|Progressive Disease|2|||
27691224|NCT00346632|80706236|FG001|Overall Study|Progressive Disease|2|||
27691225|NCT00346632|80706237|FG002|Overall Study|Progressive Disease|4|||
27691226|NCT00346632|80706238|FG003|Overall Study|Progressive Disease|3|||
27691227|NCT00346632|80706239|FG004|Overall Study|Progressive Disease|3|||
27817245|NCT03527745|81162854|FG004|Overall Study|Lost to Follow-up|0|||
27817246|NCT03527745|81162855|FG005|Overall Study|Lost to Follow-up|2|||
27817247|NCT03527745|81162856|FG006|Overall Study|Lost to Follow-up|3|||
27817248|NCT03527745|81162857|FG007|Overall Study|Lost to Follow-up|2|||
27817249|NCT03527745|81162858|FG008|Overall Study|Lost to Follow-up|3|||
27817250|NCT03527745|81162859|FG009|Overall Study|Lost to Follow-up|2|||
27817251|NCT03527745|81162860|FG010|Overall Study|Lost to Follow-up|1|||
27817252|NCT03527745|81162861|FG011|Overall Study|Lost to Follow-up|1|||
27817253|NCT03527745|81162862|FG012|Overall Study|Lost to Follow-up|0|||
27817254|NCT03527745|81162863|FG013|Overall Study|Lost to Follow-up|0|||
27817255|NCT03527745|81162864|FG014|Overall Study|Lost to Follow-up|0|||
27817256|NCT03527745|81162865|FG015|Overall Study|Lost to Follow-up|0|||
27817257|NCT03527745|81162866|FG016|Overall Study|Lost to Follow-up|1|||
27817258|NCT03527745|81162867|FG017|Overall Study|Lost to Follow-up|0|||
27817259|NCT03527745|81162868|FG018|Overall Study|Lost to Follow-up|0|||
27691228|NCT00346632|80706240|FG005|Overall Study|Progressive Disease|1|||
27691229|NCT00346632|80706241|FG006|Overall Study|Progressive Disease|2|||
27691230|NCT00346632|80706242|FG007|Overall Study|Progressive Disease|2|||
27691231|NCT00346632|80706243|FG008|Overall Study|Progressive Disease|2|||
27691232|NCT00346632|80706244|FG009|Overall Study|Progressive Disease|2|||
27691233|NCT00346632|80706235|FG000|Overall Study|Adverse Event|0|||
27691234|NCT00346632|80706236|FG001|Overall Study|Adverse Event|0|||
27691235|NCT00346632|80706237|FG002|Overall Study|Adverse Event|0|||
27691236|NCT00346632|80706238|FG003|Overall Study|Adverse Event|0|||
27817260|NCT03527745|81162869|FG019|Overall Study|Lost to Follow-up|1|||
27691237|NCT00346632|80706239|FG004|Overall Study|Adverse Event|1|||
27691238|NCT00346632|80706240|FG005|Overall Study|Adverse Event|1|||
27691239|NCT00346632|80706241|FG006|Overall Study|Adverse Event|1|||
27691240|NCT00346632|80706242|FG007|Overall Study|Adverse Event|0|||
27691241|NCT00346632|80706243|FG008|Overall Study|Adverse Event|0|||
27691242|NCT00346632|80706244|FG009|Overall Study|Adverse Event|0|||
27691243|NCT00346632|80706235|FG000|Overall Study|Death|0|||
27691244|NCT00346632|80706236|FG001|Overall Study|Death|0|||
27691245|NCT00346632|80706237|FG002|Overall Study|Death|1|||
27691246|NCT00346632|80706238|FG003|Overall Study|Death|0|||
27691247|NCT00346632|80706239|FG004|Overall Study|Death|0|||
27691248|NCT00346632|80706240|FG005|Overall Study|Death|0|||
27691249|NCT00346632|80706241|FG006|Overall Study|Death|0|||
27691250|NCT00346632|80706242|FG007|Overall Study|Death|0|||
27817261|NCT03527745|81162870|FG020|Overall Study|Lost to Follow-up|1|||
27691251|NCT00346632|80706243|FG008|Overall Study|Death|0|||
27879028|NCT03852472|81391383|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
27879029|NCT03852472|81391384|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
27879030|NCT03852472|81391385|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
27879031|NCT03852472|81391386|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
27879032|NCT03852472|81391382|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
27879033|NCT03852472|81391383|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
27879034|NCT03852472|81391384|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
27879035|NCT03852472|81391385|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
27879036|NCT03852472|81391386|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
27879037|NCT03852472|81391382|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
27817262|NCT03527745|81162871|FG021|Overall Study|Lost to Follow-up|5|||
27879038|NCT03852472|81391383|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
27879039|NCT03852472|81391384|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
27879040|NCT03852472|81391385|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
27879041|NCT03852472|81391386|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
27879042|NCT03852472|81391382|FG000|Period 2 - Week 44|Adverse Event|0|||
27879043|NCT03852472|81391383|FG001|Period 2 - Week 44|Adverse Event|3|||
27879044|NCT03852472|81391384|FG002|Period 2 - Week 44|Adverse Event|1|||
27879045|NCT03852472|81391385|FG003|Period 2 - Week 44|Adverse Event|2|||
27879046|NCT03852472|81391386|FG004|Period 2 - Week 44|Adverse Event|2|||
27879047|NCT03852472|81391382|FG000|Period 2 - Week 44|COVID-19 Related|0|||
27879048|NCT03852472|81391383|FG001|Period 2 - Week 44|COVID-19 Related|0|||
27879049|NCT03852472|81391384|FG002|Period 2 - Week 44|COVID-19 Related|0|||
27879050|NCT03852472|81391385|FG003|Period 2 - Week 44|COVID-19 Related|1|||
27879051|NCT03852472|81391386|FG004|Period 2 - Week 44|COVID-19 Related|0|||
27879052|NCT03852472|81391382|FG000|Period 2 - Week 44|Reason not stated|0|||
27879053|NCT03852472|81391383|FG001|Period 2 - Week 44|Reason not stated|0|||
27817263|NCT03527745|81162872|FG022|Overall Study|Lost to Follow-up|6|||
27817264|NCT03527745|81162873|FG023|Overall Study|Lost to Follow-up|8|||
27817265|NCT03527745|81162874|FG024|Overall Study|Lost to Follow-up|1|||
27817266|NCT03527745|81162875|FG025|Overall Study|Lost to Follow-up|3|||
27817267|NCT00663871|81162878|FG000|Overall Study|Lost to Follow-up|5|||
27817268|NCT00663871|81162879|FG001|Overall Study|Lost to Follow-up|5|||
27817269|NCT00663871|81162878|FG000|Overall Study|Withdrawal by Subject|5|||
27817270|NCT00663871|81162879|FG001|Overall Study|Withdrawal by Subject|2|||
27817271|NCT00220337|81162880|FG000|Overall Study|Adverse Event|70|||
27817272|NCT00220337|81162880|FG000|Overall Study|Lack of Efficacy|17|||
27817273|NCT00220337|81162880|FG000|Overall Study|Withdrawal by Subject|68|||
27817274|NCT00220337|81162880|FG000|Overall Study|Protocol Violation|2|||
27879054|NCT03852472|81391384|FG002|Period 2 - Week 44|Reason not stated|0|||
27879055|NCT03852472|81391385|FG003|Period 2 - Week 44|Reason not stated|0|||
27879056|NCT03852472|81391386|FG004|Period 2 - Week 44|Reason not stated|1|||
27879057|NCT00077207|81391387|FG000|Overall Study|Adverse Event|5|||
27879058|NCT00077207|81391387|FG000|Overall Study|Lack of Efficacy|12|||
27879059|NCT00077207|81391387|FG000|Overall Study|Physician Decision|6|||
27691252|NCT00346632|80706244|FG009|Overall Study|Death|0|||
27691253|NCT00346632|80706235|FG000|Overall Study|Protocol Violation|0|||
27691254|NCT00346632|80706236|FG001|Overall Study|Protocol Violation|0|||
27691255|NCT00346632|80706237|FG002|Overall Study|Protocol Violation|0|||
27817275|NCT00220337|81162880|FG000|Overall Study|Lost to Follow-up|5|||
27817276|NCT00220337|81162880|FG000|Overall Study|Other|12|||
27817277|NCT00220337|81162880|FG000|Overall Study|Unsatisfactory compliance|5|||
27691256|NCT00346632|80706238|FG003|Overall Study|Protocol Violation|0|||
27691257|NCT00346632|80706239|FG004|Overall Study|Protocol Violation|0|||
27691258|NCT00346632|80706240|FG005|Overall Study|Protocol Violation|0|||
27691259|NCT00346632|80706241|FG006|Overall Study|Protocol Violation|1|||
27817278|NCT00175019|81162884|FG000|Overall Study|Adverse Event|54|||
27817279|NCT00175019|81162885|FG001|Overall Study|Adverse Event|22|||
27817280|NCT00175019|81162886|FG002|Overall Study|Adverse Event|2|||
27817281|NCT00175019|81162884|FG000|Overall Study|Protocol Violation|6|||
27817282|NCT00175019|81162885|FG001|Overall Study|Protocol Violation|3|||
27817283|NCT00175019|81162886|FG002|Overall Study|Protocol Violation|3|||
27817284|NCT00175019|81162884|FG000|Overall Study|Lost to Follow-up|42|||
27817285|NCT00175019|81162885|FG001|Overall Study|Lost to Follow-up|39|||
27817286|NCT00175019|81162886|FG002|Overall Study|Lost to Follow-up|9|||
27817287|NCT00175019|81162884|FG000|Overall Study|Did not continue under Amendment 4|1|||
27590845|NCT02811861|80344763|FG002|Overall Study|Adverse Event|41|||
27590846|NCT02811861|80344761|FG000|Overall Study|Lost to Follow-up|0|||
27590847|NCT02811861|80344762|FG001|Overall Study|Lost to Follow-up|0|||
27590848|NCT02811861|80344763|FG002|Overall Study|Lost to Follow-up|1|||
27590849|NCT02811861|80344761|FG000|Overall Study|Subject Choice|29|||
27817288|NCT00175019|81162885|FG001|Overall Study|Did not continue under Amendment 4|1|||
27817289|NCT00175019|81162886|FG002|Overall Study|Did not continue under Amendment 4|2|||
27817290|NCT00175019|81162884|FG000|Overall Study|Personal Reason(s)|39|||
27590850|NCT02811861|80344762|FG001|Overall Study|Subject Choice|17|||
27817291|NCT00175019|81162885|FG001|Overall Study|Personal Reason(s)|31|||
27590851|NCT02811861|80344763|FG002|Overall Study|Subject Choice|23|||
27817292|NCT00175019|81162886|FG002|Overall Study|Personal Reason(s)|8|||
27590852|NCT02811861|80344761|FG000|Overall Study|Withdrawal by Subject|4|||
27590853|NCT02811861|80344762|FG001|Overall Study|Withdrawal by Subject|4|||
27590854|NCT02811861|80344763|FG002|Overall Study|Withdrawal by Subject|9|||
27590855|NCT02811861|80344761|FG000|Overall Study|Other|4|||
27590856|NCT02811861|80344762|FG001|Overall Study|Other|13|||
27590857|NCT02811861|80344763|FG002|Overall Study|Other|3|||
27590858|NCT02811861|80344761|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
27590859|NCT02811861|80344762|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
27590860|NCT02811861|80344763|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
27691260|NCT00346632|80706242|FG007|Overall Study|Protocol Violation|0|||
27691261|NCT00346632|80706243|FG008|Overall Study|Protocol Violation|0|||
27691262|NCT00346632|80706244|FG009|Overall Study|Protocol Violation|0|||
27691263|NCT00346632|80706235|FG000|Overall Study|Withdrawal by Subject|0|||
27691264|NCT00346632|80706236|FG001|Overall Study|Withdrawal by Subject|0|||
27590861|NCT02811861|80344761|FG000|Overall Study|Randomized but not treated|2|||
27590862|NCT02811861|80344762|FG001|Overall Study|Randomized but not treated|3|||
27590863|NCT02811861|80344763|FG002|Overall Study|Randomized but not treated|17|||
27590864|NCT01517802|80344764|FG000|Overall Study|Death|1|||
27590865|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
27590866|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
27590867|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
27590868|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
27590869|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
27590870|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
27590871|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
27590872|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
27590873|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
27590874|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
27590875|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
27590876|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
27590877|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
27590878|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
27590879|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
27590880|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
27590881|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
27590882|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
27590883|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
27590884|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
27590885|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
27590886|NCT01781572|80344765|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
27590887|NCT01781572|80344766|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
27590888|NCT01781572|80344767|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
27590889|NCT01781572|80344765|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
27590890|NCT01781572|80344766|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
27590891|NCT01781572|80344767|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
27590892|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
27590893|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
27590894|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
27590895|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
27590896|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
27590897|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
27590898|NCT01781572|80344765|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
27590899|NCT01781572|80344766|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
27590900|NCT01781572|80344767|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
27590901|NCT01781572|80344765|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
27590902|NCT01781572|80344766|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
27590903|NCT01781572|80344767|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
27590904|NCT01781572|80344765|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
27590905|NCT01781572|80344766|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
27590906|NCT01781572|80344767|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
27590907|NCT01781572|80344765|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
27590908|NCT01781572|80344766|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
27590909|NCT01781572|80344767|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
27590910|NCT01781572|80344765|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
27590911|NCT01781572|80344766|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
27590912|NCT01781572|80344767|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
27590913|NCT01781572|80344765|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
27590914|NCT01781572|80344766|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
27590915|NCT01781572|80344767|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
27590916|NCT01781572|80344765|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
27590917|NCT01781572|80344766|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
27590918|NCT01781572|80344767|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
27590919|NCT03732209|80344768|FG000|Overall Study|Lost to Follow-up|4|||
27590920|NCT03732209|80344769|FG001|Overall Study|Lost to Follow-up|4|||
27590921|NCT03732209|80344768|FG000|Overall Study|Withdrawal by Subject|8|||
27691265|NCT00346632|80706237|FG002|Overall Study|Withdrawal by Subject|0|||
27691266|NCT00346632|80706238|FG003|Overall Study|Withdrawal by Subject|0|||
27691267|NCT00346632|80706239|FG004|Overall Study|Withdrawal by Subject|0|||
27590922|NCT03732209|80344769|FG001|Overall Study|Withdrawal by Subject|9|||
27590923|NCT02653482|80344772|FG000|Overall Study|Death|1|||
27590924|NCT02653482|80344773|FG001|Overall Study|Death|1|||
27590925|NCT00325468|80344774|FG000|Overall Study|Adverse Event|1|||
27590926|NCT00325468|80344775|FG001|Overall Study|Adverse Event|1|||
27590927|NCT00325468|80344776|FG002|Overall Study|Adverse Event|0|||
27590928|NCT00325468|80344777|FG003|Overall Study|Adverse Event|5|||
27590929|NCT00325468|80344778|FG004|Overall Study|Adverse Event|1|||
27590930|NCT00325468|80344774|FG000|Overall Study|Death|2|||
27691268|NCT00346632|80706240|FG005|Overall Study|Withdrawal by Subject|0|||
27691269|NCT00346632|80706241|FG006|Overall Study|Withdrawal by Subject|1|||
27590931|NCT00325468|80344775|FG001|Overall Study|Death|0|||
27590932|NCT00325468|80344776|FG002|Overall Study|Death|2|||
27590933|NCT00325468|80344777|FG003|Overall Study|Death|4|||
27590934|NCT00325468|80344778|FG004|Overall Study|Death|0|||
27590935|NCT00325468|80344774|FG000|Overall Study|Lost to Follow-up|0|||
27590936|NCT00325468|80344775|FG001|Overall Study|Lost to Follow-up|0|||
27590937|NCT00325468|80344776|FG002|Overall Study|Lost to Follow-up|1|||
27590938|NCT00325468|80344777|FG003|Overall Study|Lost to Follow-up|2|||
27590939|NCT00325468|80344778|FG004|Overall Study|Lost to Follow-up|2|||
27590940|NCT00325468|80344774|FG000|Overall Study|Physician Decision|1|||
27590941|NCT00325468|80344775|FG001|Overall Study|Physician Decision|1|||
27590942|NCT00325468|80344776|FG002|Overall Study|Physician Decision|0|||
27590943|NCT00325468|80344777|FG003|Overall Study|Physician Decision|1|||
27590944|NCT00325468|80344778|FG004|Overall Study|Physician Decision|0|||
27590945|NCT00325468|80344774|FG000|Overall Study|Withdrawal by Subject|3|||
27590946|NCT00325468|80344775|FG001|Overall Study|Withdrawal by Subject|1|||
27590947|NCT00325468|80344776|FG002|Overall Study|Withdrawal by Subject|0|||
27590948|NCT00325468|80344777|FG003|Overall Study|Withdrawal by Subject|14|||
27590949|NCT00325468|80344778|FG004|Overall Study|Withdrawal by Subject|4|||
27590950|NCT00325468|80344774|FG000|Overall Study|site closure etc|4|||
27590951|NCT00325468|80344775|FG001|Overall Study|site closure etc|2|||
27590952|NCT00325468|80344776|FG002|Overall Study|site closure etc|1|||
27590953|NCT00325468|80344777|FG003|Overall Study|site closure etc|8|||
27590954|NCT00325468|80344778|FG004|Overall Study|site closure etc|1|||
27590955|NCT04482647|80344779|FG000|Overall Study|Time constraints|2|||
27590956|NCT04482647|80344779|FG000|Overall Study|Health issues|1|||
27590957|NCT04482647|80344779|FG000|Overall Study|Death in the family|1|||
27590958|NCT04482647|80344779|FG000|Overall Study|Disliked the intervention|1|||
27590959|NCT04482647|80344779|FG000|Overall Study|No reasons specified|7|||
27590960|NCT06281548|80344780|FG000|Overall Study|Lost to Follow-up|3|||
27691270|NCT00346632|80706242|FG007|Overall Study|Withdrawal by Subject|0|||
27691271|NCT00346632|80706243|FG008|Overall Study|Withdrawal by Subject|0|||
27691272|NCT00346632|80706244|FG009|Overall Study|Withdrawal by Subject|0|||
27691273|NCT00346632|80706235|FG000|Overall Study|Switched to alternative treatment|0|||
27691274|NCT00346632|80706236|FG001|Overall Study|Switched to alternative treatment|0|||
27691275|NCT00346632|80706237|FG002|Overall Study|Switched to alternative treatment|1|||
27691276|NCT00346632|80706238|FG003|Overall Study|Switched to alternative treatment|0|||
27691277|NCT00346632|80706239|FG004|Overall Study|Switched to alternative treatment|0|||
27691278|NCT00346632|80706240|FG005|Overall Study|Switched to alternative treatment|0|||
27691279|NCT00346632|80706241|FG006|Overall Study|Switched to alternative treatment|0|||
27691280|NCT00346632|80706242|FG007|Overall Study|Switched to alternative treatment|0|||
27691281|NCT00346632|80706243|FG008|Overall Study|Switched to alternative treatment|0|||
27691282|NCT00346632|80706244|FG009|Overall Study|Switched to alternative treatment|0|||
27691283|NCT00346632|80706235|FG000|Overall Study|Not Stated|1|||
27691284|NCT00346632|80706236|FG001|Overall Study|Not Stated|1|||
27691285|NCT00346632|80706237|FG002|Overall Study|Not Stated|0|||
27691286|NCT00346632|80706238|FG003|Overall Study|Not Stated|0|||
27691287|NCT00346632|80706239|FG004|Overall Study|Not Stated|0|||
27691288|NCT00346632|80706240|FG005|Overall Study|Not Stated|0|||
27817293|NCT00175019|81162884|FG000|Overall Study|Therapeutic Failure|10|||
27817294|NCT00175019|81162885|FG001|Overall Study|Therapeutic Failure|38|||
27817295|NCT00175019|81162886|FG002|Overall Study|Therapeutic Failure|22|||
27817296|NCT00175019|81162884|FG000|Overall Study|Gout Flare|2|||
27817297|NCT00175019|81162885|FG001|Overall Study|Gout Flare|3|||
27817298|NCT00175019|81162886|FG002|Overall Study|Gout Flare|0|||
27817299|NCT00175019|81162884|FG000|Overall Study|Reason Not Specified|40|||
27817300|NCT00175019|81162885|FG001|Overall Study|Reason Not Specified|34|||
27817301|NCT00175019|81162886|FG002|Overall Study|Reason Not Specified|11|||
27817302|NCT00623779|81162889|FG000|Overall Study|Adverse Event|1|||
27817303|NCT00623779|81162890|FG001|Overall Study|Adverse Event|3|||
27817304|NCT00623779|81162891|FG002|Overall Study|Adverse Event|0|||
27817305|NCT00623779|81162889|FG000|Overall Study|Criteria from CSR|2|||
27817306|NCT00623779|81162890|FG001|Overall Study|Criteria from CSR|0|||
27817307|NCT00623779|81162891|FG002|Overall Study|Criteria from CSR|1|||
27590961|NCT04177758|80344781|FG000|Overall Study|Lost to Follow-up|19|||
27590962|NCT04177758|80344782|FG001|Overall Study|Lost to Follow-up|11|||
27590963|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
27590964|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
27590965|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
27590966|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
27691289|NCT00346632|80706241|FG006|Overall Study|Not Stated|0|||
27691290|NCT00346632|80706242|FG007|Overall Study|Not Stated|2|||
27817308|NCT00440557|81162894|FG000|Overall Study|Withdrawal by Subject|10|||
27590967|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
27590968|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
27817309|NCT00440557|81162895|FG001|Overall Study|Withdrawal by Subject|5|||
27817310|NCT00440557|81162896|FG002|Overall Study|Withdrawal by Subject|11|||
27879060|NCT00077207|81391387|FG000|Overall Study|Withdrawal by Subject|6|||
27879061|NCT00077207|81391387|FG000|Overall Study|Ineligible|1|||
27879062|NCT02547428|81391388|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
27879063|NCT02547428|81391389|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
27879064|NCT02547428|81391388|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
27879065|NCT02547428|81391389|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
27879066|NCT02547428|81391388|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
27879067|NCT02547428|81391389|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
27879068|NCT02547428|81391388|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
27879069|NCT02547428|81391389|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
27879070|NCT02547428|81391388|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
27590969|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
27590970|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
27590971|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
27590972|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
27590973|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
27590974|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
27590975|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
27590976|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
27590977|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
27590978|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
27590979|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
27590980|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
27590981|NCT00833638|80344786|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
27590982|NCT00833638|80344787|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
27590983|NCT00833638|80344788|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
27590984|NCT00833638|80344786|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
27590985|NCT00833638|80344787|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
27590986|NCT00833638|80344788|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
27590987|NCT00833638|80344786|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
27879071|NCT02547428|81391389|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
27879072|NCT02547428|81391388|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
27590988|NCT00833638|80344787|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
27590989|NCT00833638|80344788|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
27879073|NCT02547428|81391389|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
27879074|NCT02547428|81391388|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
27879075|NCT02547428|81391389|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
27879076|NCT02547428|81391388|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
27879077|NCT02547428|81391389|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
27879078|NCT03225105|81391390|FG000|Overall Study|Withdrawal by Subject|1|||
27879079|NCT03225105|81391391|FG001|Overall Study|Withdrawal by Subject|0|||
27879080|NCT03225105|81391392|FG002|Overall Study|Withdrawal by Subject|0|||
27879081|NCT03225105|81391393|FG003|Overall Study|Withdrawal by Subject|0|||
27879082|NCT03225105|81391390|FG000|Overall Study|Death|0|||
27879083|NCT03225105|81391391|FG001|Overall Study|Death|4|||
27590990|NCT02734212|80344791|FG000|Overall Study|Lost to Follow-up|5|||
27590991|NCT02734212|80344792|FG001|Overall Study|Lost to Follow-up|10|||
27590992|NCT04969250|80344793|FG000|Overall Study|Protocol Violation|0|||
27590993|NCT04969250|80344794|FG001|Overall Study|Protocol Violation|2|||
27590994|NCT04969250|80344795|FG002|Overall Study|Protocol Violation|3|||
27590995|NCT04969250|80344796|FG003|Overall Study|Protocol Violation|8|||
27590996|NCT04969250|80344793|FG000|Overall Study|Withdrawal by Subject|0|||
27590997|NCT04969250|80344794|FG001|Overall Study|Withdrawal by Subject|1|||
27590998|NCT04969250|80344795|FG002|Overall Study|Withdrawal by Subject|0|||
27590999|NCT04969250|80344796|FG003|Overall Study|Withdrawal by Subject|0|||
27879084|NCT03225105|81391392|FG002|Overall Study|Death|2|||
27879085|NCT03225105|81391393|FG003|Overall Study|Death|0|||
27879086|NCT03225105|81391390|FG000|Overall Study|Study termination per Sponsor Decision|2|||
27879087|NCT03225105|81391391|FG001|Overall Study|Study termination per Sponsor Decision|0|||
27879088|NCT03225105|81391392|FG002|Overall Study|Study termination per Sponsor Decision|3|||
27879089|NCT03225105|81391393|FG003|Overall Study|Study termination per Sponsor Decision|3|||
27879090|NCT03866512|81391396|FG000|Overall Study|Lost to Follow-up|1|||
27591000|NCT05132699|80344797|FG000|Overall Study|Withdrawal by Subject|3|||
27591001|NCT05132699|80344798|FG001|Overall Study|Withdrawal by Subject|0|||
27591002|NCT01026974|80344799|FG000|Overall Study|Withdrawal by Subject|0|||
27591003|NCT01026974|80344800|FG001|Overall Study|Withdrawal by Subject|1|||
27591004|NCT01026974|80344801|FG002|Overall Study|Withdrawal by Subject|7|||
27591005|NCT01026974|80344802|FG003|Overall Study|Withdrawal by Subject|2|||
27591006|NCT01026974|80344799|FG000|Overall Study|Lost to Follow-up|1|||
27591007|NCT01026974|80344800|FG001|Overall Study|Lost to Follow-up|1|||
27591008|NCT01026974|80344801|FG002|Overall Study|Lost to Follow-up|4|||
27591009|NCT01026974|80344802|FG003|Overall Study|Lost to Follow-up|0|||
27591010|NCT01026974|80344799|FG000|Overall Study|Adverse Event|0|||
27591011|NCT01026974|80344800|FG001|Overall Study|Adverse Event|0|||
27591012|NCT01026974|80344801|FG002|Overall Study|Adverse Event|0|||
27591013|NCT01026974|80344802|FG003|Overall Study|Adverse Event|1|||
27591014|NCT01026974|80344799|FG000|Overall Study|Inappropriate enrollment|0|||
27591015|NCT01026974|80344800|FG001|Overall Study|Inappropriate enrollment|0|||
27591016|NCT01026974|80344801|FG002|Overall Study|Inappropriate enrollment|1|||
27591017|NCT01026974|80344802|FG003|Overall Study|Inappropriate enrollment|0|||
27591018|NCT02097472|80344806|FG000|Received Vaccination 2|Adverse Event|0|||
27591019|NCT02097472|80344807|FG001|Received Vaccination 2|Adverse Event|0|||
27591020|NCT02097472|80344808|FG002|Received Vaccination 2|Adverse Event|0|||
27591021|NCT02097472|80344809|FG003|Received Vaccination 2|Adverse Event|0|||
27591022|NCT02097472|80344810|FG004|Received Vaccination 2|Adverse Event|0|||
27591023|NCT02097472|80344811|FG005|Received Vaccination 2|Adverse Event|0|||
27591024|NCT02097472|80344812|FG006|Received Vaccination 2|Adverse Event|1|||
27591025|NCT02097472|80344813|FG007|Received Vaccination 2|Adverse Event|0|||
27591026|NCT00987467|80344814|FG000|Overall Study|Lost to Follow-up|2|||
27591027|NCT01585103|80344818|FG000|Overall Study|Unable to swallow Cytosponge|6|||
27591028|NCT02479412|80344821|FG000|Overall Study|Adverse Event|0|||
27591029|NCT02479412|80344822|FG001|Overall Study|Adverse Event|0|||
27591030|NCT02479412|80344823|FG002|Overall Study|Adverse Event|1|||
27591031|NCT02479412|80344824|FG003|Overall Study|Adverse Event|0|||
27591032|NCT02479412|80344825|FG004|Overall Study|Adverse Event|0|||
27591033|NCT02479412|80344826|FG005|Overall Study|Adverse Event|0|||
27591034|NCT02479412|80344827|FG006|Overall Study|Adverse Event|0|||
27591035|NCT02479412|80344828|FG007|Overall Study|Adverse Event|0|||
27591036|NCT02479412|80344829|FG008|Overall Study|Adverse Event|0|||
27591037|NCT02479412|80344821|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27879091|NCT03866512|81391397|FG001|Overall Study|Lost to Follow-up|2|||
27591038|NCT02479412|80344822|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27591039|NCT02479412|80344823|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27591040|NCT02479412|80344824|FG003|Overall Study|Study-specific withdrawal criteria|1|||
27591041|NCT02479412|80344825|FG004|Overall Study|Study-specific withdrawal criteria|0|||
27691291|NCT00346632|80706243|FG008|Overall Study|Not Stated|2|||
27691292|NCT00346632|80706244|FG009|Overall Study|Not Stated|1|||
27691293|NCT00709852|80706245|FG000|Period 1|Adverse Event|2|||
27691294|NCT00709852|80706246|FG001|Period 1|Adverse Event|0|||
27691295|NCT00709852|80706245|FG000|Period 1|Withdrawal by Subject|4|||
27691296|NCT00709852|80706246|FG001|Period 1|Withdrawal by Subject|2|||
27691297|NCT00709852|80706245|FG000|Period 1|Protocol Violation|1|||
27691298|NCT00709852|80706246|FG001|Period 1|Protocol Violation|0|||
27691299|NCT00709852|80706245|FG000|Period 1|Defective scanner|0|||
27691300|NCT00709852|80706246|FG001|Period 1|Defective scanner|1|||
27691301|NCT00709852|80706245|FG000|Period 1|Lost to Follow-up|1|||
27691302|NCT00709852|80706246|FG001|Period 1|Lost to Follow-up|0|||
27691303|NCT00709852|80706245|FG000|Period 2|Protocol Violation|4|||
27691304|NCT00709852|80706246|FG001|Period 2|Protocol Violation|1|||
27691305|NCT00709852|80706245|FG000|Period 2|Adverse Event|1|||
27691306|NCT00709852|80706246|FG001|Period 2|Adverse Event|1|||
27691307|NCT00709852|80706245|FG000|Period 2|Lost to Follow-up|1|||
27691308|NCT00709852|80706246|FG001|Period 2|Lost to Follow-up|0|||
27691309|NCT00709852|80706245|FG000|Period 2|No 72-hour follow-up|3|||
27691310|NCT00709852|80706246|FG001|Period 2|No 72-hour follow-up|0|||
27691311|NCT04161495|80706248|FG000|Overall Study|Withdrawal by Subject|3|||
27691312|NCT04161495|80706249|FG001|Overall Study|Withdrawal by Subject|0|||
27691313|NCT04161495|80706248|FG000|Overall Study|Protocol Violation|1|||
27691314|NCT04161495|80706249|FG001|Overall Study|Protocol Violation|0|||
27691315|NCT04161495|80706248|FG000|Overall Study|Prohibited concomitant medication|3|||
27691316|NCT04161495|80706249|FG001|Overall Study|Prohibited concomitant medication|0|||
27691317|NCT04161495|80706248|FG000|Overall Study|Adverse Event|1|||
27691318|NCT04161495|80706249|FG001|Overall Study|Adverse Event|0|||
27691319|NCT04161495|80706248|FG000|Overall Study|Other - Unspecified|1|||
27691320|NCT04161495|80706249|FG001|Overall Study|Other - Unspecified|0|||
27691321|NCT04161495|80706248|FG000|Overall Study|Death|0|||
27691322|NCT04161495|80706249|FG001|Overall Study|Death|1|||
27691323|NCT04375761|80706251|FG000|Overall Study|Death|1|||
27691324|NCT04375761|80706252|FG001|Overall Study|Death|2|||
27691325|NCT04375761|80706251|FG000|Overall Study|Lost to Follow-up|203|||
27691326|NCT04375761|80706252|FG001|Overall Study|Lost to Follow-up|380|||
27691327|NCT04375761|80706251|FG000|Overall Study|Withdrawal by Subject|47|||
27691328|NCT04375761|80706252|FG001|Overall Study|Withdrawal by Subject|98|||
27691329|NCT04375761|80706251|FG000|Overall Study|Noncompliance with study procedure|121|||
27691330|NCT04375761|80706252|FG001|Overall Study|Noncompliance with study procedure|251|||
27591042|NCT02479412|80344826|FG005|Overall Study|Study-specific withdrawal criteria|0|||
27591043|NCT02479412|80344827|FG006|Overall Study|Study-specific withdrawal criteria|0|||
27591044|NCT02479412|80344828|FG007|Overall Study|Study-specific withdrawal criteria|1|||
27591045|NCT02479412|80344829|FG008|Overall Study|Study-specific withdrawal criteria|1|||
27691331|NCT04375761|80706251|FG000|Overall Study|Reimbursement not enough|1|||
27691332|NCT04375761|80706252|FG001|Overall Study|Reimbursement not enough|2|||
27691333|NCT04375761|80706251|FG000|Overall Study|Unforeseen family circumstances|1|||
27691334|NCT04375761|80706252|FG001|Overall Study|Unforeseen family circumstances|3|||
27691335|NCT04375761|80706251|FG000|Overall Study|Test too painful|1|||
27691336|NCT04375761|80706252|FG001|Overall Study|Test too painful|1|||
27691337|NCT04375761|80706251|FG000|Overall Study|Moved|0|||
27691338|NCT04375761|80706252|FG001|Overall Study|Moved|2|||
27691339|NCT04375761|80706251|FG000|Overall Study|Nonresponsive|0|||
27691340|NCT04375761|80706252|FG001|Overall Study|Nonresponsive|5|||
27691341|NCT04882995|80706253|FG000|Overall Study|Withdrawal by Subject|1|||
27691342|NCT04882995|80706254|FG001|Overall Study|Withdrawal by Subject|2|||
27691343|NCT04882995|80706253|FG000|Overall Study|Protocol Violation|4|||
27691344|NCT04882995|80706254|FG001|Overall Study|Protocol Violation|4|||
27691345|NCT04882995|80706253|FG000|Overall Study|Surgery postponed due to COVID|1|||
27691346|NCT04882995|80706254|FG001|Overall Study|Surgery postponed due to COVID|1|||
27691347|NCT01696942|80706257|FG000|Overall Study|Withdrawal by Subject|1|||
27691348|NCT01696942|80706258|FG001|Overall Study|Withdrawal by Subject|0|||
27691349|NCT01696942|80706257|FG000|Overall Study|Protocol Violation|1|||
27691350|NCT01696942|80706258|FG001|Overall Study|Protocol Violation|2|||
27691351|NCT01696942|80706257|FG000|Overall Study|screen failure|0|||
27691352|NCT01696942|80706258|FG001|Overall Study|screen failure|1|||
27691353|NCT02730598|80706259|FG000|Overall Study|Withdrawal by Subject|3|||
27817311|NCT00440557|81162894|FG000|Overall Study|Lost to Follow-up|1|||
27817312|NCT00440557|81162895|FG001|Overall Study|Lost to Follow-up|2|||
27817313|NCT00440557|81162896|FG002|Overall Study|Lost to Follow-up|6|||
27817314|NCT00440557|81162894|FG000|Overall Study|Adverse Event|3|||
27817315|NCT00440557|81162895|FG001|Overall Study|Adverse Event|3|||
27817316|NCT00440557|81162896|FG002|Overall Study|Adverse Event|5|||
27817317|NCT00440557|81162894|FG000|Overall Study|Death|2|||
27691354|NCT02730598|80706260|FG001|Overall Study|Withdrawal by Subject|3|||
27817318|NCT00440557|81162895|FG001|Overall Study|Death|6|||
27817319|NCT00440557|81162896|FG002|Overall Study|Death|3|||
27817320|NCT00440557|81162894|FG000|Overall Study|Began Dialysis|4|||
27691355|NCT02730598|80706259|FG000|Overall Study|Protocol Violation|0|||
27691356|NCT02730598|80706260|FG001|Overall Study|Protocol Violation|1|||
27817321|NCT00440557|81162895|FG001|Overall Study|Began Dialysis|1|||
27817322|NCT00440557|81162896|FG002|Overall Study|Began Dialysis|4|||
27691357|NCT02730598|80706259|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
27691358|NCT02730598|80706260|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
27691359|NCT02040584|80706261|FG000|Overall Study|Adverse Event|13|||
27691360|NCT02040584|80706262|FG001|Overall Study|Adverse Event|6|||
27691361|NCT02040584|80706261|FG000|Overall Study|Protocol Violation|9|||
27691362|NCT02040584|80706262|FG001|Overall Study|Protocol Violation|11|||
27817323|NCT00440557|81162894|FG000|Overall Study|Principal Investigator decision|0|||
27817324|NCT00440557|81162895|FG001|Overall Study|Principal Investigator decision|3|||
27817325|NCT00440557|81162896|FG002|Overall Study|Principal Investigator decision|1|||
27817326|NCT00440557|81162894|FG000|Overall Study|Patient moved|1|||
27691363|NCT02040584|80706261|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27691364|NCT02040584|80706262|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27691365|NCT02040584|80706261|FG000|Overall Study|Death|6|||
27691366|NCT02040584|80706262|FG001|Overall Study|Death|3|||
27691367|NCT02040584|80706261|FG000|Overall Study|Transplant rejection/retransplant|0|||
27691368|NCT02040584|80706262|FG001|Overall Study|Transplant rejection/retransplant|1|||
27691369|NCT02040584|80706261|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
27691370|NCT02040584|80706262|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
27691371|NCT02910739|80706263|FG000|Overall Study|Adverse Event|1|||
27691372|NCT02910739|80706264|FG001|Overall Study|Adverse Event|0|||
27691373|NCT02910739|80706265|FG002|Overall Study|Adverse Event|0|||
27691374|NCT02910739|80706266|FG003|Overall Study|Adverse Event|0|||
27691375|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
27691376|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
27691377|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
27691378|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
27691379|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
27691380|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
27691381|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
27691382|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
27691383|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
27691384|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
27691385|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
27691386|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
27691387|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
27691388|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
27691389|NCT00757588|80706267|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
27691390|NCT00757588|80706268|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
27691391|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
27691392|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
27691393|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
27691394|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
27691395|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
27691396|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
27691397|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
27691398|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
27691399|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
27691400|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
27691401|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
27691402|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
27691403|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
27691404|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
27691405|NCT00757588|80706267|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
27691406|NCT00757588|80706268|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
27691407|NCT00812331|80706271|FG000|Overall Study|Adverse Event|1|||
27691408|NCT00812331|80706272|FG001|Overall Study|Adverse Event|0|||
27691409|NCT00812331|80706273|FG002|Overall Study|Adverse Event|0|||
27691410|NCT00812331|80706274|FG003|Overall Study|Adverse Event|0|||
27691411|NCT00812331|80706275|FG004|Overall Study|Adverse Event|0|||
27691412|NCT00790751|80706276|FG000|Overall Study|Protocol non-compliance|16|||
27691413|NCT00790751|80706277|FG001|Overall Study|Protocol non-compliance|16|||
27691414|NCT00790751|80706278|FG002|Overall Study|Protocol non-compliance|10|||
27817327|NCT00440557|81162895|FG001|Overall Study|Patient moved|2|||
27691415|NCT00790751|80706279|FG003|Overall Study|Protocol non-compliance|11|||
27691416|NCT00790751|80706276|FG000|Overall Study|Lost to Follow-up|4|||
27691417|NCT00790751|80706277|FG001|Overall Study|Lost to Follow-up|9|||
27691418|NCT00790751|80706278|FG002|Overall Study|Lost to Follow-up|4|||
27691419|NCT00790751|80706279|FG003|Overall Study|Lost to Follow-up|5|||
27691420|NCT00790751|80706276|FG000|Overall Study|Adverse Event|5|||
27691421|NCT00790751|80706277|FG001|Overall Study|Adverse Event|3|||
27691422|NCT00790751|80706278|FG002|Overall Study|Adverse Event|5|||
27691423|NCT00790751|80706279|FG003|Overall Study|Adverse Event|4|||
27691424|NCT00790751|80706276|FG000|Overall Study|Requirement for restricted medication|0|||
27691425|NCT00790751|80706277|FG001|Overall Study|Requirement for restricted medication|2|||
27691426|NCT00790751|80706278|FG002|Overall Study|Requirement for restricted medication|0|||
27691427|NCT00790751|80706279|FG003|Overall Study|Requirement for restricted medication|0|||
27817328|NCT00440557|81162896|FG002|Overall Study|Patient moved|1|||
27879092|NCT03866512|81391398|FG002|Overall Study|Lost to Follow-up|1|||
27691428|NCT00790751|80706276|FG000|Overall Study|Death|0|||
27691429|NCT00790751|80706277|FG001|Overall Study|Death|0|||
27691430|NCT00790751|80706278|FG002|Overall Study|Death|1|||
27691431|NCT00790751|80706279|FG003|Overall Study|Death|0|||
27691432|NCT00790751|80706276|FG000|Overall Study|Physician Decision|0|||
27691433|NCT00790751|80706277|FG001|Overall Study|Physician Decision|0|||
27691434|NCT00790751|80706278|FG002|Overall Study|Physician Decision|0|||
27691435|NCT00790751|80706279|FG003|Overall Study|Physician Decision|1|||
27691436|NCT00249002|80706283|FG000|Overall Study|Adverse Event|2|||
27691437|NCT00249002|80706283|FG000|Overall Study|Study cancellation|3|||
27691438|NCT00249002|80706283|FG000|Overall Study|Other|2|||
27691439|NCT02572882|80706285|FG000|Overall Study|Withdrawal by Subject|1|||
27691440|NCT02572882|80706285|FG000|Overall Study|Participant received kidney transplant|1|||
27691441|NCT00946101|80706286|FG000|Overall Study|Lost to Follow-up|2|||
27691442|NCT00946101|80706287|FG001|Overall Study|Lost to Follow-up|1|||
27691443|NCT00946101|80706286|FG000|Overall Study|Withdrawal of consent|2|||
27691444|NCT00946101|80706287|FG001|Overall Study|Withdrawal of consent|0|||
27691445|NCT00946101|80706286|FG000|Overall Study|Physician Decision|0|||
27691446|NCT00946101|80706287|FG001|Overall Study|Physician Decision|1|||
27691447|NCT00122460|80706288|FG000|Overall Study|investigational study phase ongoing|7|||
27691448|NCT00122460|80706289|FG001|Overall Study|investigational study phase ongoing|1|||
27691449|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
27691450|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
27691451|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
27691452|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
27691453|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
27691454|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
27691455|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
27691456|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
27691457|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
27691458|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
27691459|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
27691460|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
27817329|NCT00440557|81162894|FG000|Overall Study|Principal Investigator's office closed|3|||
27817330|NCT00440557|81162895|FG001|Overall Study|Principal Investigator's office closed|6|||
27817331|NCT00440557|81162896|FG002|Overall Study|Principal Investigator's office closed|4|||
27817332|NCT00440557|81162894|FG000|Overall Study|Patient transferred to nursing home|0|||
27817333|NCT00440557|81162895|FG001|Overall Study|Patient transferred to nursing home|1|||
27817334|NCT00440557|81162896|FG002|Overall Study|Patient transferred to nursing home|0|||
27691461|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Death|1|||
27691462|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Death|2|||
27691463|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Death|2|||
27691464|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Death|0|||
27691465|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Death|0|||
27691466|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Death|0|||
27691467|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
27691468|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
27691469|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
27691470|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
27691471|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
27691472|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
27691473|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
27691474|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
27691475|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
27691476|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
27691477|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
27691478|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
27691479|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
27691480|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
27691481|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
27691482|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
27691483|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
27691484|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
27691485|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
27691486|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
27691487|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
27691488|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
27691489|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
27691490|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
27691491|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
27691492|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
27691493|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
27691494|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
27691495|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
27691496|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
27691497|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
27691498|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
27591046|NCT02479412|80344821|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
27591047|NCT02479412|80344822|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
27591048|NCT02479412|80344823|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
27591049|NCT02479412|80344824|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
27691499|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
27691500|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
27691501|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
27691502|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
27691503|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
27817335|NCT00440557|81162894|FG000|Overall Study|Patient had surgery|1|||
27817336|NCT00440557|81162895|FG001|Overall Study|Patient had surgery|0|||
27817337|NCT00440557|81162896|FG002|Overall Study|Patient had surgery|0|||
27817338|NCT00543309|81162905|FG000|Overall Study|Physician Decision|0|||
27817339|NCT00543309|81162906|FG001|Overall Study|Physician Decision|1|||
27817340|NCT00543309|81162907|FG002|Overall Study|Physician Decision|0|||
27817341|NCT00958243|81162908|FG000|Overall Study|Withdrawal by Subject|0|||
27817342|NCT00958243|81162909|FG001|Overall Study|Withdrawal by Subject|1|||
27817343|NCT00958243|81162910|FG002|Overall Study|Withdrawal by Subject|3|||
27817344|NCT00958243|81162911|FG003|Overall Study|Withdrawal by Subject|1|||
27817345|NCT00958243|81162912|FG004|Overall Study|Withdrawal by Subject|1|||
27817346|NCT00958243|81162913|FG005|Overall Study|Withdrawal by Subject|5|||
27817347|NCT00958243|81162908|FG000|Overall Study|Lost to Follow-up|2|||
27817348|NCT00958243|81162909|FG001|Overall Study|Lost to Follow-up|5|||
27817349|NCT00958243|81162910|FG002|Overall Study|Lost to Follow-up|11|||
27817350|NCT00958243|81162911|FG003|Overall Study|Lost to Follow-up|2|||
27817351|NCT00958243|81162912|FG004|Overall Study|Lost to Follow-up|8|||
27817352|NCT00958243|81162913|FG005|Overall Study|Lost to Follow-up|5|||
27817353|NCT00920140|81162915|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
27817354|NCT00920140|81162916|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
27817355|NCT00920140|81162917|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
27817356|NCT00920140|81162918|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
27817357|NCT00920140|81162919|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
27591050|NCT02479412|80344825|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
27591051|NCT02479412|80344826|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
27691504|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
27691505|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
27691506|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
27691507|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
27691508|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
27691509|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Site closure|0|||
27691510|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Site closure|0|||
27691511|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Site closure|1|||
27691512|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Site closure|0|||
27691513|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Site closure|0|||
27691514|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Site closure|0|||
27691515|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
27691516|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
27691517|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
27691518|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
27691519|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
27691520|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
27691521|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
27691522|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
27691523|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
27691524|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
27691525|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
27691526|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
27691527|NCT03439254|80706290|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
27691528|NCT03439254|80706291|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
27691529|NCT03439254|80706292|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
27691530|NCT03439254|80706293|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
27691531|NCT03439254|80706294|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
27691532|NCT03439254|80706295|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
27691533|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
27691534|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
27691535|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
27691536|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
27691537|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
27691538|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
27691539|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
27691540|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
27691541|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
27691542|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
27691543|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
27691544|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
27691545|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
27691546|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
27691547|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
27691548|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
27691549|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
27817358|NCT00920140|81162915|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
27817359|NCT00920140|81162916|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
27817360|NCT00920140|81162917|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
27817361|NCT00920140|81162918|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
27817362|NCT00920140|81162919|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
27817363|NCT00920140|81162915|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27817364|NCT00920140|81162916|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
27817365|NCT00920140|81162917|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27817366|NCT00920140|81162918|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27817367|NCT00920140|81162919|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
27879093|NCT03866512|81391396|FG000|Overall Study|Cannulation issues|0|||
27879094|NCT03866512|81391397|FG001|Overall Study|Cannulation issues|1|||
27879095|NCT03866512|81391398|FG002|Overall Study|Cannulation issues|2|||
27879096|NCT01051791|81391401|FG000|Overall Study|Failed screening|3|||
27817368|NCT00920140|81162915|FG000|Phase 2|Adverse Event|0|||
27817369|NCT00920140|81162916|FG001|Phase 2|Adverse Event|0|||
27817370|NCT00920140|81162917|FG002|Phase 2|Adverse Event|14|||
27817371|NCT00920140|81162918|FG003|Phase 2|Adverse Event|2|||
27817372|NCT00920140|81162919|FG004|Phase 2|Adverse Event|3|||
27817373|NCT00920140|81162915|FG000|Phase 2|Lack of Efficacy|0|||
27879097|NCT01051791|81391401|FG000|Overall Study|Withdrawal by Subject|1|||
27879098|NCT00092118|81391402|FG000|Overall Study|Adverse Event|35|||
27879099|NCT00092118|81391403|FG001|Overall Study|Adverse Event|32|||
27879100|NCT00092118|81391402|FG000|Overall Study|Lack of Efficacy|12|||
27879101|NCT00092118|81391403|FG001|Overall Study|Lack of Efficacy|14|||
27879102|NCT00092118|81391402|FG000|Overall Study|Lost to Follow-up|4|||
27879103|NCT00092118|81391403|FG001|Overall Study|Lost to Follow-up|3|||
27879104|NCT00092118|81391402|FG000|Overall Study|Protocol Violation|23|||
27879105|NCT00092118|81391403|FG001|Overall Study|Protocol Violation|25|||
27879106|NCT00092118|81391402|FG000|Overall Study|Withdrawal by Subject|4|||
27879107|NCT00092118|81391403|FG001|Overall Study|Withdrawal by Subject|10|||
27879108|NCT00092118|81391402|FG000|Overall Study|Other|6|||
27879109|NCT00092118|81391403|FG001|Overall Study|Other|5|||
27879110|NCT01703260|81391406|FG000|Overall Study|Adverse Event|1|||
27879111|NCT01703260|81391407|FG001|Overall Study|Adverse Event|2|||
27879112|NCT01703260|81391408|FG002|Overall Study|Adverse Event|2|||
27879113|NCT01703260|81391406|FG000|Overall Study|Lost to Follow-up|1|||
27879114|NCT01703260|81391407|FG001|Overall Study|Lost to Follow-up|0|||
27879115|NCT01703260|81391408|FG002|Overall Study|Lost to Follow-up|0|||
27879116|NCT01703260|81391406|FG000|Overall Study|Withdrawal by Subject|0|||
27879117|NCT01703260|81391407|FG001|Overall Study|Withdrawal by Subject|0|||
27879118|NCT01703260|81391408|FG002|Overall Study|Withdrawal by Subject|1|||
27879119|NCT01703260|81391406|FG000|Overall Study|Study Termination|1|||
27879120|NCT01703260|81391407|FG001|Overall Study|Study Termination|2|||
27879121|NCT01703260|81391408|FG002|Overall Study|Study Termination|0|||
27879122|NCT01256450|81391409|FG000|Open-label Titration|Adverse Event|39|||
27879123|NCT01256450|81391410|FG001|Open-label Titration|Adverse Event|0|||
27879124|NCT01256450|81391411|FG002|Open-label Titration|Adverse Event|0|||
27879125|NCT01256450|81391409|FG000|Open-label Titration|Lost to Follow-up|7|||
27879126|NCT01256450|81391410|FG001|Open-label Titration|Lost to Follow-up|0|||
27879127|NCT01256450|81391411|FG002|Open-label Titration|Lost to Follow-up|0|||
27879128|NCT01256450|81391409|FG000|Open-label Titration|Lack of analgesic effect|30|||
27879129|NCT01256450|81391410|FG001|Open-label Titration|Lack of analgesic effect|0|||
27691550|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
27691551|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
27879130|NCT01256450|81391411|FG002|Open-label Titration|Lack of analgesic effect|0|||
27879131|NCT01256450|81391409|FG000|Open-label Titration|Non-compliance|9|||
27879132|NCT01256450|81391410|FG001|Open-label Titration|Non-compliance|0|||
27879133|NCT01256450|81391411|FG002|Open-label Titration|Non-compliance|0|||
27879134|NCT01256450|81391409|FG000|Open-label Titration|Screen failure|1|||
27879135|NCT01256450|81391410|FG001|Open-label Titration|Screen failure|0|||
27879136|NCT01256450|81391411|FG002|Open-label Titration|Screen failure|0|||
27879137|NCT01256450|81391409|FG000|Open-label Titration|Other|13|||
27879138|NCT01256450|81391410|FG001|Open-label Titration|Other|0|||
27879139|NCT01256450|81391411|FG002|Open-label Titration|Other|0|||
27691552|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
27691553|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
27691554|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
27691555|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
27691556|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
27691557|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
27691558|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
27691559|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
27691560|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
27691561|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
27691562|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
27691563|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
27591052|NCT02479412|80344827|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
27591053|NCT02479412|80344828|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
27591054|NCT02479412|80344829|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
27691564|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
27691565|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
27691566|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
27691567|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
27691568|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
27691569|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
27691570|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
27691571|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
27691572|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
27691573|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
27691574|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
27691575|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
27691576|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
27691577|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
27691578|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
27691579|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
27691580|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
27691581|NCT03439254|80706290|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
27691582|NCT03439254|80706291|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
27691583|NCT03439254|80706292|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
27691584|NCT03439254|80706293|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
27817374|NCT00920140|81162916|FG001|Phase 2|Lack of Efficacy|0|||
27817375|NCT00920140|81162917|FG002|Phase 2|Lack of Efficacy|29|||
27817376|NCT00920140|81162918|FG003|Phase 2|Lack of Efficacy|14|||
27817377|NCT00920140|81162919|FG004|Phase 2|Lack of Efficacy|5|||
27817378|NCT00920140|81162915|FG000|Phase 2|Lost to Follow-up|0|||
27817379|NCT00920140|81162916|FG001|Phase 2|Lost to Follow-up|0|||
27591071|NCT01572727|80344832|FG000|Overall Study|Adverse Event|43|||
27591072|NCT01572727|80344833|FG001|Overall Study|Adverse Event|15|||
27691585|NCT03439254|80706294|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
27691586|NCT03439254|80706295|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
27691587|NCT00591370|80706296|FG000|Overall Study|Not Treated|2|||
27691588|NCT01210664|80706297|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
27691589|NCT01210664|80706298|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
27691590|NCT01210664|80706299|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
27691591|NCT01210664|80706300|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
27691592|NCT01210664|80706297|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
27691593|NCT01210664|80706298|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
27691594|NCT01210664|80706299|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
27691595|NCT01210664|80706300|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
27691596|NCT01210664|80706297|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
27691597|NCT01210664|80706298|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
27691598|NCT01210664|80706299|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
27691599|NCT01210664|80706300|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
27691600|NCT04256629|80706301|FG000|Overall Study|Adverse Event|0|||
27691601|NCT04256629|80706302|FG001|Overall Study|Adverse Event|0|||
27691602|NCT04256629|80706303|FG002|Overall Study|Adverse Event|0|||
27691603|NCT04256629|80706304|FG003|Overall Study|Adverse Event|0|||
27691604|NCT04256629|80706305|FG004|Overall Study|Adverse Event|0|||
27691605|NCT04256629|80706306|FG005|Overall Study|Adverse Event|1|||
27691606|NCT04256629|80706301|FG000|Overall Study|Protocol Violation|0|||
27691607|NCT04256629|80706302|FG001|Overall Study|Protocol Violation|1|||
27691608|NCT04256629|80706303|FG002|Overall Study|Protocol Violation|0|||
27691609|NCT04256629|80706304|FG003|Overall Study|Protocol Violation|0|||
27691610|NCT04256629|80706305|FG004|Overall Study|Protocol Violation|0|||
27691611|NCT04256629|80706306|FG005|Overall Study|Protocol Violation|0|||
27691612|NCT03929757|80706311|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
27691613|NCT03929757|80706312|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
27817380|NCT00920140|81162917|FG002|Phase 2|Lost to Follow-up|0|||
27817381|NCT00920140|81162918|FG003|Phase 2|Lost to Follow-up|1|||
27817382|NCT00920140|81162919|FG004|Phase 2|Lost to Follow-up|0|||
27591073|NCT01572727|80344832|FG000|Overall Study|Lost to Follow-up|1|||
27691614|NCT03929757|80706313|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
27691615|NCT03929757|80706311|FG000|Main Study: Up to Day 365|Other|1|||
27817383|NCT00920140|81162915|FG000|Phase 2|Physician Decision|0|||
27817384|NCT00920140|81162916|FG001|Phase 2|Physician Decision|0|||
27691616|NCT03929757|80706312|FG001|Main Study: Up to Day 365|Other|0|||
27817385|NCT00920140|81162917|FG002|Phase 2|Physician Decision|3|||
27817386|NCT00920140|81162918|FG003|Phase 2|Physician Decision|3|||
27691617|NCT03929757|80706313|FG002|Main Study: Up to Day 365|Other|0|||
27691618|NCT03929757|80706311|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
27691619|NCT03929757|80706312|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
27591074|NCT01572727|80344833|FG001|Overall Study|Lost to Follow-up|1|||
27591075|NCT01572727|80344832|FG000|Overall Study|Physician Decision|23|||
27591076|NCT01572727|80344833|FG001|Overall Study|Physician Decision|9|||
27591077|NCT01572727|80344832|FG000|Overall Study|Progressive disease|59|||
27591078|NCT01572727|80344833|FG001|Overall Study|Progressive disease|82|||
27591079|NCT01572727|80344832|FG000|Overall Study|Protocol Violation|0|||
27591080|NCT01572727|80344833|FG001|Overall Study|Protocol Violation|1|||
27591081|NCT01572727|80344832|FG000|Overall Study|Study terminated by sponsor|61|||
27591082|NCT01572727|80344833|FG001|Overall Study|Study terminated by sponsor|83|||
27591083|NCT01572727|80344832|FG000|Overall Study|Parent/guardian decision|14|||
27591084|NCT01572727|80344833|FG001|Overall Study|Parent/guardian decision|9|||
27591085|NCT01572727|80344832|FG000|Overall Study|Death|2|||
27591086|NCT01572727|80344833|FG001|Overall Study|Death|2|||
27591087|NCT01572727|80344832|FG000|Overall Study|Untreated|4|||
27591088|NCT01572727|80344833|FG001|Overall Study|Untreated|7|||
27591089|NCT03586648|80344835|FG000|Period 1|Withdrawal by Subject|0|||
27591090|NCT03586648|80344836|FG001|Period 1|Withdrawal by Subject|1|||
27591091|NCT03586648|80344835|FG000|Period 1|Lost to Follow-up|1|||
27591092|NCT03586648|80344836|FG001|Period 1|Lost to Follow-up|1|||
27691620|NCT03929757|80706313|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
27591093|NCT03586648|80344835|FG000|Period 1|Adverse Event|1|||
27591094|NCT03586648|80344836|FG001|Period 1|Adverse Event|0|||
27591095|NCT03586648|80344835|FG000|Period 1|Study related symptoms or complaints|2|||
27591096|NCT03586648|80344836|FG001|Period 1|Study related symptoms or complaints|1|||
27691621|NCT00983931|80706317|FG000|14 Day Washout Period|Physician Decision|1|||
27691622|NCT01012739|80709459|FG000|Treatment Period 1|Adverse Event|0|||
27691623|NCT01012739|80709460|FG001|Treatment Period 1|Adverse Event|0|||
27691624|NCT01012739|80709461|FG002|Treatment Period 1|Adverse Event|0|||
27691625|NCT01012739|80709462|FG003|Treatment Period 1|Adverse Event|1|||
27691626|NCT01012739|80709459|FG000|Treatment Period 2|Abnormal test procedure results|0|||
27691627|NCT01012739|80709460|FG001|Treatment Period 2|Abnormal test procedure results|0|||
27691628|NCT01012739|80709461|FG002|Treatment Period 2|Abnormal test procedure results|0|||
27691629|NCT01012739|80709462|FG003|Treatment Period 2|Abnormal test procedure results|1|||
27691630|NCT02292927|80709463|FG000|Overall Study|Protocol Violation|13|||
27691631|NCT02292927|80709464|FG001|Overall Study|Protocol Violation|7|||
27691632|NCT00731120|80709465|FG000|Overall Study|Adverse Event|7|||
27691633|NCT00731120|80709466|FG001|Overall Study|Adverse Event|6|||
27691634|NCT00731120|80709467|FG002|Overall Study|Adverse Event|8|||
27691635|NCT00731120|80709465|FG000|Overall Study|Lack of Efficacy|4|||
27691636|NCT00731120|80709466|FG001|Overall Study|Lack of Efficacy|5|||
27691637|NCT00731120|80709467|FG002|Overall Study|Lack of Efficacy|4|||
27691638|NCT00731120|80709465|FG000|Overall Study|Noncompliance with Study Drug|3|||
27691639|NCT00731120|80709466|FG001|Overall Study|Noncompliance with Study Drug|3|||
27691640|NCT00731120|80709467|FG002|Overall Study|Noncompliance with Study Drug|1|||
27691641|NCT00731120|80709465|FG000|Overall Study|Protocol Deviations|1|||
27691642|NCT00731120|80709466|FG001|Overall Study|Protocol Deviations|6|||
27691643|NCT00731120|80709467|FG002|Overall Study|Protocol Deviations|1|||
27691644|NCT00731120|80709465|FG000|Overall Study|Withdrawal of Consent|13|||
27691645|NCT00731120|80709466|FG001|Overall Study|Withdrawal of Consent|8|||
27691646|NCT00731120|80709467|FG002|Overall Study|Withdrawal of Consent|4|||
27691647|NCT00731120|80709465|FG000|Overall Study|Lost to Follow-up|10|||
27691648|NCT00731120|80709466|FG001|Overall Study|Lost to Follow-up|15|||
27691649|NCT00731120|80709467|FG002|Overall Study|Lost to Follow-up|17|||
27691650|NCT00731120|80709465|FG000|Overall Study|Other|4|||
27691651|NCT00731120|80709466|FG001|Overall Study|Other|0|||
27691652|NCT00731120|80709467|FG002|Overall Study|Other|1|||
27691653|NCT01210118|80709471|FG000|Overall Study|Lost to Follow-up|1|||
27691654|NCT01210118|80709472|FG001|Overall Study|Lost to Follow-up|1|||
27691655|NCT01210118|80709471|FG000|Overall Study|Protocol Violation|1|||
27691656|NCT01210118|80709472|FG001|Overall Study|Protocol Violation|1|||
27591097|NCT03586648|80344835|FG000|Period 1|Physician Decision|0|||
27691657|NCT01210118|80709471|FG000|Overall Study|Spontaneous abortion|1|||
27691658|NCT01210118|80709472|FG001|Overall Study|Spontaneous abortion|3|||
27691659|NCT03143166|80709482|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
27691660|NCT02270515|80709483|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
27691661|NCT02270515|80709483|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
27691662|NCT02270515|80709483|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
27691663|NCT02270515|80709483|FG000|Intervention Period 1: 0-6 Months|Death|7|||
27691664|NCT02270515|80709483|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
27691665|NCT02270515|80709483|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
27691666|NCT02270515|80709483|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
27691667|NCT02270515|80709483|FG000|Intervention Period 2: 6-12 Months|Death|5|||
27691668|NCT02270515|80709483|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
27691669|NCT02270515|80709483|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
27691670|NCT02270515|80709483|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
27691671|NCT02270515|80709483|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
27691672|NCT02270515|80709483|FG000|Intervention Period 3: 12-18 Months|Death|3|||
27691673|NCT02270515|80709483|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
27691674|NCT02481947|80709484|FG000|Overall Study|Withdrawal by Subject|24|||
27691675|NCT02481947|80709485|FG001|Overall Study|Withdrawal by Subject|10|||
27691676|NCT02481947|80709484|FG000|Overall Study|Lost to Follow-up|11|||
27817387|NCT00920140|81162919|FG004|Phase 2|Physician Decision|2|||
27817388|NCT00920140|81162915|FG000|Phase 2|Withdrawal by Subject|0|||
27591098|NCT03586648|80344836|FG001|Period 1|Physician Decision|1|||
27591099|NCT03586648|80344835|FG000|Period 2|Adverse Event|1|||
27591100|NCT03586648|80344836|FG001|Period 2|Adverse Event|0|||
27591101|NCT00626522|80344840|FG000|Overall Study|Protocol Violation|0|||
27591102|NCT00626522|80344841|FG001|Overall Study|Protocol Violation|0|||
27591103|NCT00626522|80344842|FG002|Overall Study|Protocol Violation|0|||
27591104|NCT00626522|80344843|FG003|Overall Study|Protocol Violation|0|||
27591105|NCT00626522|80344844|FG004|Overall Study|Protocol Violation|1|||
27591106|NCT00626522|80344845|FG005|Overall Study|Protocol Violation|0|||
27591107|NCT00626522|80344840|FG000|Overall Study|Adverse Event|2|||
27591108|NCT00626522|80344841|FG001|Overall Study|Adverse Event|1|||
27591109|NCT00626522|80344842|FG002|Overall Study|Adverse Event|2|||
27591110|NCT00626522|80344843|FG003|Overall Study|Adverse Event|0|||
27591111|NCT00626522|80344844|FG004|Overall Study|Adverse Event|1|||
27591112|NCT00626522|80344845|FG005|Overall Study|Adverse Event|1|||
27591113|NCT00626522|80344840|FG000|Overall Study|Withdrawal by Subject|2|||
27591114|NCT00626522|80344841|FG001|Overall Study|Withdrawal by Subject|5|||
27591115|NCT00626522|80344842|FG002|Overall Study|Withdrawal by Subject|5|||
27591116|NCT00626522|80344843|FG003|Overall Study|Withdrawal by Subject|0|||
27591117|NCT00626522|80344844|FG004|Overall Study|Withdrawal by Subject|4|||
27591118|NCT00626522|80344845|FG005|Overall Study|Withdrawal by Subject|1|||
27591119|NCT00626522|80344840|FG000|Overall Study|COPD exacerbation|0|||
27591120|NCT00626522|80344841|FG001|Overall Study|COPD exacerbation|0|||
27591121|NCT00626522|80344842|FG002|Overall Study|COPD exacerbation|0|||
27591122|NCT00626522|80344843|FG003|Overall Study|COPD exacerbation|1|||
27591123|NCT00626522|80344844|FG004|Overall Study|COPD exacerbation|1|||
27591124|NCT00626522|80344845|FG005|Overall Study|COPD exacerbation|0|||
27591125|NCT00626522|80344840|FG000|Overall Study|Lost to Follow-up|0|||
27817389|NCT00920140|81162916|FG001|Phase 2|Withdrawal by Subject|0|||
27591126|NCT00626522|80344841|FG001|Overall Study|Lost to Follow-up|1|||
27591127|NCT00626522|80344842|FG002|Overall Study|Lost to Follow-up|0|||
27591128|NCT00626522|80344843|FG003|Overall Study|Lost to Follow-up|0|||
27591129|NCT00626522|80344844|FG004|Overall Study|Lost to Follow-up|0|||
27591130|NCT00626522|80344845|FG005|Overall Study|Lost to Follow-up|0|||
27591131|NCT00626522|80344840|FG000|Overall Study|Inconsistent reason reported|1|||
27591132|NCT00626522|80344841|FG001|Overall Study|Inconsistent reason reported|0|||
27591133|NCT00626522|80344842|FG002|Overall Study|Inconsistent reason reported|0|||
27591134|NCT00626522|80344843|FG003|Overall Study|Inconsistent reason reported|0|||
27591135|NCT00626522|80344844|FG004|Overall Study|Inconsistent reason reported|0|||
27591136|NCT00626522|80344845|FG005|Overall Study|Inconsistent reason reported|0|||
27591137|NCT00626522|80344840|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
27591138|NCT00626522|80344841|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
27591139|NCT00626522|80344842|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
27591140|NCT00626522|80344843|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
27591141|NCT00626522|80344844|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
27591142|NCT00626522|80344845|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
27691677|NCT02481947|80709485|FG001|Overall Study|Lost to Follow-up|5|||
27691678|NCT02481947|80709484|FG000|Overall Study|Adverse Event|6|||
27691679|NCT02481947|80709485|FG001|Overall Study|Adverse Event|11|||
27691680|NCT02481947|80709484|FG000|Overall Study|Physician Decision|4|||
27879140|NCT01256450|81391409|FG000|Double-blind Treatment|Adverse Event|0|||
27879141|NCT01256450|81391410|FG001|Double-blind Treatment|Adverse Event|8|||
27691681|NCT02481947|80709485|FG001|Overall Study|Physician Decision|5|||
27691682|NCT02481947|80709484|FG000|Overall Study|Protocol Violation|1|||
27691683|NCT02481947|80709485|FG001|Overall Study|Protocol Violation|5|||
27691684|NCT00424385|80709488|FG000|Cohort 0|Withdrawal by Subject|5|||
27691685|NCT00424385|80709488|FG000|Cohort 0|Physician Decision|1|||
27817390|NCT00920140|81162917|FG002|Phase 2|Withdrawal by Subject|4|||
27691686|NCT00424385|80709488|FG000|Cohort 1|Withdrawal by Subject|1|||
27691687|NCT03562247|80709489|FG000|Overall Study|Lost to Follow-up|3|||
27691688|NCT03562247|80709490|FG001|Overall Study|Lost to Follow-up|1|||
27691689|NCT03562247|80709491|FG002|Overall Study|Lost to Follow-up|1|||
27817391|NCT00920140|81162918|FG003|Phase 2|Withdrawal by Subject|2|||
27817392|NCT00920140|81162919|FG004|Phase 2|Withdrawal by Subject|1|||
27817393|NCT00727571|81162934|FG000|Overall Study|Ineligibility determined|1|||
27817394|NCT00727571|81162935|FG001|Overall Study|Ineligibility determined|1|||
27817395|NCT00727571|81162936|FG002|Overall Study|Ineligibility determined|1|||
27817396|NCT00727571|81162937|FG003|Overall Study|Ineligibility determined|0|||
27817397|NCT00727571|81162934|FG000|Overall Study|Death|0|||
27817398|NCT00727571|81162935|FG001|Overall Study|Death|19|||
27691690|NCT00901186|80709507|FG000|Overall Study|Lack of Efficacy|0|||
27691691|NCT00901186|80709508|FG001|Overall Study|Lack of Efficacy|1|||
27817399|NCT00727571|81162936|FG002|Overall Study|Death|5|||
27817400|NCT00727571|81162937|FG003|Overall Study|Death|1|||
27817401|NCT00727571|81162934|FG000|Overall Study|Physician Decision|0|||
27817402|NCT00727571|81162935|FG001|Overall Study|Physician Decision|5|||
27817403|NCT00727571|81162936|FG002|Overall Study|Physician Decision|0|||
27817404|NCT00727571|81162937|FG003|Overall Study|Physician Decision|0|||
27817405|NCT00727571|81162934|FG000|Overall Study|Withdrawal by Subject|0|||
27817406|NCT00727571|81162935|FG001|Overall Study|Withdrawal by Subject|10|||
27817407|NCT00727571|81162936|FG002|Overall Study|Withdrawal by Subject|11|||
27817408|NCT00727571|81162937|FG003|Overall Study|Withdrawal by Subject|0|||
27817409|NCT00727571|81162934|FG000|Overall Study|Subject Non Compliance|0|||
27817410|NCT00727571|81162935|FG001|Overall Study|Subject Non Compliance|6|||
27817411|NCT00727571|81162936|FG002|Overall Study|Subject Non Compliance|0|||
27817412|NCT00727571|81162937|FG003|Overall Study|Subject Non Compliance|4|||
27817413|NCT00727571|81162934|FG000|Overall Study|Dismissed from nursing home|0|||
27691692|NCT00901186|80709507|FG000|Overall Study|Abnormal laboratory values|0|||
27691693|NCT00901186|80709508|FG001|Overall Study|Abnormal laboratory values|1|||
27817414|NCT00727571|81162935|FG001|Overall Study|Dismissed from nursing home|9|||
27817415|NCT00727571|81162936|FG002|Overall Study|Dismissed from nursing home|5|||
27817416|NCT00727571|81162937|FG003|Overall Study|Dismissed from nursing home|0|||
27817417|NCT00727571|81162934|FG000|Overall Study|Hospitalization|0|||
27691694|NCT00901186|80709507|FG000|Overall Study|Lost to Follow-up|2|||
27817418|NCT00727571|81162935|FG001|Overall Study|Hospitalization|1|||
27817419|NCT00727571|81162936|FG002|Overall Study|Hospitalization|0|||
27817420|NCT00727571|81162937|FG003|Overall Study|Hospitalization|1|||
27817421|NCT00727571|81162934|FG000|Overall Study|AE not leading to hospitalization|0|||
27817422|NCT00727571|81162935|FG001|Overall Study|AE not leading to hospitalization|0|||
27817423|NCT00727571|81162936|FG002|Overall Study|AE not leading to hospitalization|2|||
27817424|NCT00727571|81162937|FG003|Overall Study|AE not leading to hospitalization|0|||
27817425|NCT00727571|81162934|FG000|Overall Study|Other|0|||
27691695|NCT00901186|80709508|FG001|Overall Study|Lost to Follow-up|0|||
27691696|NCT00901186|80709507|FG000|Overall Study|Adverse Event|2|||
27691697|NCT00901186|80709508|FG001|Overall Study|Adverse Event|4|||
27691698|NCT00901186|80709507|FG000|Overall Study|Administration problems|0|||
27691699|NCT00901186|80709508|FG001|Overall Study|Administration problems|1|||
27691700|NCT00901186|80709507|FG000|Overall Study|Protocol deviations|5|||
27691701|NCT00901186|80709508|FG001|Overall Study|Protocol deviations|4|||
27691702|NCT01774487|80709511|FG000|Overall Study|Did not tolerate taste|4|||
27691703|NCT01774487|80709512|FG001|Overall Study|Did not tolerate taste|4|||
27691704|NCT01878214|80709513|FG000|Overall Study|Withdrawal by Subject|18|||
27691705|NCT01878214|80709514|FG001|Overall Study|Withdrawal by Subject|7|||
27691706|NCT01878214|80709513|FG000|Overall Study|Death|0|||
27691707|NCT01878214|80709514|FG001|Overall Study|Death|1|||
27691708|NCT01878214|80709513|FG000|Overall Study|Lost to Follow-up|35|||
27691709|NCT01878214|80709514|FG001|Overall Study|Lost to Follow-up|36|||
27691710|NCT02951767|80709515|FG000|Overall Study|Study Terminated By Sponsor|9|||
27691711|NCT02951767|80709515|FG000|Overall Study|Withdrawal by Subject|11|||
27817426|NCT00727571|81162935|FG001|Overall Study|Other|4|||
27817427|NCT00727571|81162936|FG002|Overall Study|Other|6|||
27817428|NCT00727571|81162937|FG003|Overall Study|Other|0|||
27817429|NCT01225146|81162938|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
27817430|NCT01225146|81162939|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
27817431|NCT03309956|81162940|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
27817432|NCT02097290|81162941|FG000|Overall Study|Death|6|||
27817433|NCT02097290|81162941|FG000|Overall Study|Total Withdrawals|3|||
27691712|NCT02951767|80709515|FG000|Overall Study|Death|96|||
27691713|NCT02951767|80709515|FG000|Overall Study|Lost to Follow-up|2|||
27691714|NCT02951767|80709515|FG000|Overall Study|Physician Decision|1|||
27691715|NCT02875977|80709516|FG000|Overall Study|Lost to Follow-up|42|||
27691716|NCT02875977|80709517|FG001|Overall Study|Lost to Follow-up|29|||
27691717|NCT01347762|80709518|FG000|Overall Study|Lost to Follow-up|0|||
27691718|NCT01347762|80709519|FG001|Overall Study|Lost to Follow-up|1|||
27691719|NCT01347762|80709520|FG002|Overall Study|Lost to Follow-up|6|||
27817434|NCT02097290|81162941|FG000|Overall Study|Attempt|8|||
27817435|NCT00520741|81162945|FG000|Overall Study|Adverse Event|16|||
27817436|NCT00520741|81162946|FG001|Overall Study|Adverse Event|56|||
27817437|NCT00520741|81162945|FG000|Overall Study|Lack of Efficacy|11|||
27817438|NCT00520741|81162946|FG001|Overall Study|Lack of Efficacy|30|||
27817439|NCT00520741|81162945|FG000|Overall Study|Withdrawal by Subject|0|||
27817440|NCT00520741|81162946|FG001|Overall Study|Withdrawal by Subject|11|||
27817441|NCT00520741|81162945|FG000|Overall Study|Protocol Violation|2|||
27817442|NCT00520741|81162946|FG001|Overall Study|Protocol Violation|15|||
27817443|NCT00520741|81162945|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
27817444|NCT00520741|81162946|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
27817445|NCT00520741|81162945|FG000|Overall Study|Lost to Follow-up|4|||
27817446|NCT00520741|81162946|FG001|Overall Study|Lost to Follow-up|4|||
27817447|NCT00520741|81162945|FG000|Overall Study|Other reasons for premature termination|0|||
27817448|NCT00520741|81162946|FG001|Overall Study|Other reasons for premature termination|6|||
27817449|NCT02974153|81162947|FG000|Overall Study|Adverse Event|6|||
27817450|NCT02974153|81162948|FG001|Overall Study|Adverse Event|0|||
27817451|NCT02974153|81162949|FG002|Overall Study|Adverse Event|1|||
27879142|NCT01256450|81391411|FG002|Double-blind Treatment|Adverse Event|6|||
27879143|NCT01256450|81391409|FG000|Double-blind Treatment|Lost to Follow-up|0|||
27879144|NCT01256450|81391410|FG001|Double-blind Treatment|Lost to Follow-up|1|||
27879145|NCT01256450|81391411|FG002|Double-blind Treatment|Lost to Follow-up|7|||
27691720|NCT01347762|80709521|FG003|Overall Study|Lost to Follow-up|5|||
27691721|NCT01347762|80709518|FG000|Overall Study|Withdrawal by Subject|4|||
27691722|NCT01347762|80709519|FG001|Overall Study|Withdrawal by Subject|1|||
27691723|NCT01347762|80709520|FG002|Overall Study|Withdrawal by Subject|3|||
27691724|NCT01347762|80709521|FG003|Overall Study|Withdrawal by Subject|3|||
27879146|NCT01256450|81391409|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
27691725|NCT00423930|80709523|FG000|Overall Study|Withdrawal by Subject|2|||
27691726|NCT01079130|80709531|FG000|Overall Study|Adverse Event|1|||
27691727|NCT01079130|80709532|FG001|Overall Study|Adverse Event|1|||
27691728|NCT01079130|80709533|FG002|Overall Study|Adverse Event|0|||
27691729|NCT01079130|80709534|FG003|Overall Study|Adverse Event|1|||
27691730|NCT01079130|80709535|FG004|Overall Study|Adverse Event|5|||
27691731|NCT01079130|80709536|FG005|Overall Study|Adverse Event|1|||
27691732|NCT01079130|80709531|FG000|Overall Study|Administrative problems|1|||
27691733|NCT01079130|80709532|FG001|Overall Study|Administrative problems|3|||
27691734|NCT01079130|80709533|FG002|Overall Study|Administrative problems|0|||
27691735|NCT01079130|80709534|FG003|Overall Study|Administrative problems|0|||
27691736|NCT01079130|80709535|FG004|Overall Study|Administrative problems|0|||
27691737|NCT01079130|80709536|FG005|Overall Study|Administrative problems|1|||
27691738|NCT01079130|80709531|FG000|Overall Study|Withdrawal by Subject|0|||
27691739|NCT01079130|80709532|FG001|Overall Study|Withdrawal by Subject|1|||
27691740|NCT01079130|80709533|FG002|Overall Study|Withdrawal by Subject|0|||
27691741|NCT01079130|80709534|FG003|Overall Study|Withdrawal by Subject|0|||
27691742|NCT01079130|80709535|FG004|Overall Study|Withdrawal by Subject|1|||
27691743|NCT01079130|80709536|FG005|Overall Study|Withdrawal by Subject|3|||
27691744|NCT01079130|80709531|FG000|Overall Study|Protocol deviation|0|||
27691745|NCT01079130|80709532|FG001|Overall Study|Protocol deviation|2|||
27691746|NCT01079130|80709533|FG002|Overall Study|Protocol deviation|1|||
27691747|NCT01079130|80709534|FG003|Overall Study|Protocol deviation|2|||
27691748|NCT01079130|80709535|FG004|Overall Study|Protocol deviation|0|||
27691749|NCT01079130|80709536|FG005|Overall Study|Protocol deviation|0|||
27691750|NCT01079130|80709531|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27691751|NCT01079130|80709532|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27691752|NCT01079130|80709533|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27691753|NCT01079130|80709534|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27691754|NCT01079130|80709535|FG004|Overall Study|Abnormal test procedure result(s)|1|||
27691755|NCT01079130|80709536|FG005|Overall Study|Abnormal test procedure result(s)|0|||
27691756|NCT01079130|80709531|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27691757|NCT01079130|80709532|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27691758|NCT01079130|80709533|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27691759|NCT01079130|80709534|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27691760|NCT01079130|80709535|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
27691761|NCT01079130|80709536|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
27691762|NCT01079130|80709531|FG000|Overall Study|Lost to Follow-up|0|||
27817452|NCT02974153|81162947|FG000|Overall Study|Lack of Efficacy|6|||
27817453|NCT02974153|81162948|FG001|Overall Study|Lack of Efficacy|5|||
27691763|NCT01079130|80709532|FG001|Overall Study|Lost to Follow-up|0|||
27691764|NCT01079130|80709533|FG002|Overall Study|Lost to Follow-up|0|||
27691765|NCT01079130|80709534|FG003|Overall Study|Lost to Follow-up|0|||
27691766|NCT01079130|80709535|FG004|Overall Study|Lost to Follow-up|1|||
27691767|NCT01079130|80709536|FG005|Overall Study|Lost to Follow-up|0|||
27691768|NCT02009761|80709539|FG000|Overall Study|Adverse Event|4|||
27691769|NCT01650246|80709540|FG000|Overall Study|Adverse Event|23|||
27691770|NCT01650246|80709540|FG000|Overall Study|Protocol Violation|5|||
27691771|NCT01650246|80709540|FG000|Overall Study|Sponsor terminated study|53|||
27691772|NCT01650246|80709540|FG000|Overall Study|Lost to Follow-up|5|||
27691773|NCT01650246|80709540|FG000|Overall Study|Withdrawal by Subject|26|||
27691774|NCT01650246|80709540|FG000|Overall Study|Death|1|||
27691775|NCT01650246|80709540|FG000|Overall Study|Lack of Efficacy|30|||
27691776|NCT00552240|80709544|FG000|Overall Study|Adverse Event|9|||
27691777|NCT00552240|80709545|FG001|Overall Study|Adverse Event|9|||
27691778|NCT00552240|80709544|FG000|Overall Study|Protocol Violation|1|||
27691779|NCT00552240|80709545|FG001|Overall Study|Protocol Violation|1|||
27691780|NCT00552240|80709544|FG000|Overall Study|Lost to Follow-up|5|||
27691781|NCT00552240|80709545|FG001|Overall Study|Lost to Follow-up|6|||
27691782|NCT00552240|80709544|FG000|Overall Study|Withdrawal by Subject|2|||
27691783|NCT00552240|80709545|FG001|Overall Study|Withdrawal by Subject|2|||
27691784|NCT00552240|80709544|FG000|Overall Study|Lack of Efficacy|6|||
27691785|NCT00552240|80709545|FG001|Overall Study|Lack of Efficacy|0|||
27691786|NCT00552240|80709544|FG000|Overall Study|Other|1|||
27691787|NCT00552240|80709545|FG001|Overall Study|Other|0|||
27691788|NCT02041520|80709546|FG000|Overall Study|Adverse Event|2|||
27691789|NCT02041520|80709547|FG001|Overall Study|Adverse Event|1|||
27691790|NCT02041520|80709546|FG000|Overall Study|Withdrawal by Subject|3|||
27691791|NCT02041520|80709547|FG001|Overall Study|Withdrawal by Subject|4|||
27691792|NCT02041520|80709546|FG000|Overall Study|Protocol Violation|1|||
27691793|NCT02041520|80709547|FG001|Overall Study|Protocol Violation|0|||
27691794|NCT02041520|80709546|FG000|Overall Study|Lost to Follow-up|0|||
27691795|NCT02041520|80709547|FG001|Overall Study|Lost to Follow-up|1|||
27691796|NCT02041520|80709546|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
27691797|NCT02041520|80709547|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
27691798|NCT00095498|80709548|FG000|Overall Study|Physician Decision|9|||
27691799|NCT00095498|80709549|FG001|Overall Study|Physician Decision|10|||
27691800|NCT00095498|80709550|FG002|Overall Study|Physician Decision|8|||
27691801|NCT00095498|80709548|FG000|Overall Study|Adverse Event|1|||
27691802|NCT00095498|80709549|FG001|Overall Study|Adverse Event|0|||
27691803|NCT00095498|80709550|FG002|Overall Study|Adverse Event|1|||
27691804|NCT00095498|80709548|FG000|Overall Study|Withdrawal by Subject|15|||
27691805|NCT00095498|80709549|FG001|Overall Study|Withdrawal by Subject|16|||
27691806|NCT00095498|80709550|FG002|Overall Study|Withdrawal by Subject|15|||
27691807|NCT00095498|80709548|FG000|Overall Study|Disease progression|0|||
27691808|NCT00095498|80709549|FG001|Overall Study|Disease progression|1|||
27691809|NCT00095498|80709550|FG002|Overall Study|Disease progression|1|||
27691810|NCT00095498|80709548|FG000|Overall Study|Ineligibility determined|3|||
27691811|NCT00095498|80709549|FG001|Overall Study|Ineligibility determined|0|||
27691812|NCT00095498|80709550|FG002|Overall Study|Ineligibility determined|2|||
27691813|NCT00095498|80709548|FG000|Overall Study|Lost to Follow-up|1|||
27691814|NCT00095498|80709549|FG001|Overall Study|Lost to Follow-up|1|||
27691815|NCT00095498|80709550|FG002|Overall Study|Lost to Follow-up|2|||
27691816|NCT00095498|80709548|FG000|Overall Study|Noncompliance|1|||
27691817|NCT00095498|80709549|FG001|Overall Study|Noncompliance|0|||
27691818|NCT00095498|80709550|FG002|Overall Study|Noncompliance|1|||
27691819|NCT00095498|80709548|FG000|Overall Study|Other|6|||
27691820|NCT00095498|80709549|FG001|Overall Study|Other|7|||
27691821|NCT00095498|80709550|FG002|Overall Study|Other|6|||
27691822|NCT00095498|80709548|FG000|Overall Study|Protocol Violation|0|||
27691823|NCT00095498|80709549|FG001|Overall Study|Protocol Violation|0|||
27691824|NCT00095498|80709550|FG002|Overall Study|Protocol Violation|1|||
27691825|NCT00095498|80709548|FG000|Overall Study|Requirement for alternative therapy|1|||
27691826|NCT00095498|80709549|FG001|Overall Study|Requirement for alternative therapy|0|||
27691827|NCT00095498|80709550|FG002|Overall Study|Requirement for alternative therapy|2|||
27691828|NCT00978627|80709551|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
27691829|NCT00978627|80709552|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
27691830|NCT00978627|80709551|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
27691831|NCT00978627|80709552|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
27691832|NCT00978627|80709551|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
27691833|NCT00978627|80709552|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
27691834|NCT00978627|80709551|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
27691835|NCT00978627|80709552|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
27817454|NCT02974153|81162949|FG002|Overall Study|Lack of Efficacy|10|||
27817455|NCT02974153|81162947|FG000|Overall Study|Lost to Follow-up|9|||
27817456|NCT02974153|81162948|FG001|Overall Study|Lost to Follow-up|10|||
27817457|NCT02974153|81162949|FG002|Overall Study|Lost to Follow-up|17|||
27817458|NCT02974153|81162947|FG000|Overall Study|Physician Decision|0|||
27817459|NCT02974153|81162948|FG001|Overall Study|Physician Decision|2|||
27817460|NCT02974153|81162949|FG002|Overall Study|Physician Decision|1|||
27817461|NCT02974153|81162947|FG000|Overall Study|Withdrawal by Subject|9|||
27691836|NCT00978627|80709551|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
27691837|NCT00978627|80709552|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
27691838|NCT00978627|80709551|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
27691839|NCT00978627|80709552|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
27691840|NCT00978627|80709551|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
27691841|NCT00978627|80709552|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
27691842|NCT00978627|80709551|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
27691843|NCT00978627|80709552|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
27691844|NCT00978627|80709551|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
27691845|NCT00978627|80709552|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
27691846|NCT01078454|80709553|FG000|Overall Study|Adverse Event|1|||
27691847|NCT01078454|80709554|FG001|Overall Study|Adverse Event|1|||
27691848|NCT01078454|80709553|FG000|Overall Study|Death|0|||
27691849|NCT01078454|80709554|FG001|Overall Study|Death|1|||
27691850|NCT00262951|80709555|FG000|Overall Study|Progressive disease/relapse|3|||
27817462|NCT02974153|81162948|FG001|Overall Study|Withdrawal by Subject|16|||
27817463|NCT02974153|81162949|FG002|Overall Study|Withdrawal by Subject|11|||
27817464|NCT02974153|81162947|FG000|Overall Study|Study Burden|8|||
27817465|NCT02974153|81162948|FG001|Overall Study|Study Burden|7|||
27817466|NCT02974153|81162949|FG002|Overall Study|Study Burden|3|||
27817467|NCT02974153|81162947|FG000|Overall Study|Other|14|||
27817468|NCT02974153|81162948|FG001|Overall Study|Other|8|||
27817469|NCT02974153|81162949|FG002|Overall Study|Other|7|||
27817470|NCT02863575|81162950|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
27817471|NCT02863575|81162951|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
27817472|NCT02863575|81162952|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
27817473|NCT02863575|81162950|FG000|Overall Study|Withdrawal by Subject|0|||
27817474|NCT02863575|81162951|FG001|Overall Study|Withdrawal by Subject|1|||
27817475|NCT02863575|81162952|FG002|Overall Study|Withdrawal by Subject|1|||
27817476|NCT02863575|81162950|FG000|Overall Study|Adverse Event|0|||
27817477|NCT02863575|81162951|FG001|Overall Study|Adverse Event|1|||
27817478|NCT02863575|81162952|FG002|Overall Study|Adverse Event|0|||
27817479|NCT03311646|81166491|FG000|Overall Study|Physician Decision|1|||
27817480|NCT03311646|81166491|FG000|Overall Study|Withdrawal by Subject|5|||
27817481|NCT03311646|81166491|FG000|Overall Study|Lost to Follow-up|5|||
27817482|NCT03311646|81166491|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
27817483|NCT02143102|81166495|FG000|Overall Study|Lost to Follow-up|11|||
27817484|NCT02143102|81166496|FG001|Overall Study|Lost to Follow-up|0|||
27817485|NCT01505530|81166499|FG000|Overall Study|Progressive Disease|19|||
27817486|NCT01505530|81166500|FG001|Overall Study|Progressive Disease|17|||
27817487|NCT01505530|81166501|FG002|Overall Study|Progressive Disease|18|||
27817488|NCT01505530|81166499|FG000|Overall Study|Adverse Event|1|||
27691851|NCT00262951|80709555|FG000|Overall Study|Adverse Event|7|||
27817489|NCT01505530|81166500|FG001|Overall Study|Adverse Event|1|||
27879147|NCT01256450|81391410|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
27879148|NCT01256450|81391411|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
27879149|NCT01256450|81391409|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
27879150|NCT01256450|81391410|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
27879151|NCT01256450|81391411|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
27879152|NCT01256450|81391409|FG000|Double-blind Treatment|Non-compliance|0|||
27879153|NCT01256450|81391410|FG001|Double-blind Treatment|Non-compliance|5|||
27879154|NCT01256450|81391411|FG002|Double-blind Treatment|Non-compliance|4|||
27879155|NCT01256450|81391409|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
27879156|NCT01256450|81391410|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
27879157|NCT01256450|81391411|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
27879158|NCT01256450|81391409|FG000|Double-blind Treatment|Other|0|||
27879159|NCT01256450|81391410|FG001|Double-blind Treatment|Other|9|||
27879160|NCT01256450|81391411|FG002|Double-blind Treatment|Other|12|||
27879161|NCT00824772|81391412|FG000|Overall Study|Withdrawal by Subject|8|||
27879162|NCT03123393|81391417|FG000|Overall Study|Study Terminated by Sponsor|6|||
27879163|NCT03123393|81391418|FG001|Overall Study|Study Terminated by Sponsor|9|||
27879164|NCT03123393|81391417|FG000|Overall Study|Withdrawal by Subject|2|||
27879165|NCT03123393|81391418|FG001|Overall Study|Withdrawal by Subject|1|||
27879166|NCT03123393|81391417|FG000|Overall Study|Reason not Specified|13|||
27879167|NCT03123393|81391418|FG001|Overall Study|Reason not Specified|13|||
27879168|NCT01671007|81391419|FG000|Overall Study|Other reasons than listed|166|||
27879169|NCT01671007|81391420|FG001|Overall Study|Other reasons than listed|373|||
27879170|NCT01671007|81391421|FG002|Overall Study|Other reasons than listed|197|||
27879171|NCT01671007|81391422|FG003|Overall Study|Other reasons than listed|228|||
27879172|NCT01671007|81391423|FG004|Overall Study|Other reasons than listed|14|||
27879173|NCT01671007|81391424|FG005|Overall Study|Other reasons than listed|71|||
27879174|NCT01671007|81391425|FG006|Overall Study|Other reasons than listed|17|||
27879175|NCT01671007|81391426|FG007|Overall Study|Other reasons than listed|66|||
27879176|NCT01671007|81391427|FG008|Overall Study|Other reasons than listed|0|||
27879177|NCT01671007|81391419|FG000|Overall Study|Withdrawal by Subject|36|||
27879178|NCT01671007|81391420|FG001|Overall Study|Withdrawal by Subject|59|||
27879179|NCT01671007|81391421|FG002|Overall Study|Withdrawal by Subject|53|||
27879180|NCT01671007|81391422|FG003|Overall Study|Withdrawal by Subject|58|||
27879181|NCT01671007|81391423|FG004|Overall Study|Withdrawal by Subject|4|||
27879182|NCT01671007|81391424|FG005|Overall Study|Withdrawal by Subject|15|||
27879183|NCT01671007|81391425|FG006|Overall Study|Withdrawal by Subject|1|||
27691852|NCT00262951|80709555|FG000|Overall Study|Death|1|||
27817490|NCT01505530|81166501|FG002|Overall Study|Adverse Event|0|||
27817491|NCT01505530|81166499|FG000|Overall Study|Withdrawal by Subject|7|||
27817492|NCT01505530|81166500|FG001|Overall Study|Withdrawal by Subject|8|||
27817493|NCT01505530|81166501|FG002|Overall Study|Withdrawal by Subject|6|||
27817494|NCT01505530|81166499|FG000|Overall Study|Physician Decision|6|||
27817495|NCT01505530|81166500|FG001|Overall Study|Physician Decision|2|||
27817496|NCT01505530|81166501|FG002|Overall Study|Physician Decision|5|||
27691853|NCT00262951|80709555|FG000|Overall Study|Withdrawal by Subject|1|||
27691854|NCT00262951|80709555|FG000|Overall Study|Alternative treatment|3|||
27817497|NCT01505530|81166499|FG000|Overall Study|Sponsor Decision|1|||
27879184|NCT01671007|81391426|FG007|Overall Study|Withdrawal by Subject|19|||
27879185|NCT01671007|81391427|FG008|Overall Study|Withdrawal by Subject|0|||
27879186|NCT01671007|81391419|FG000|Overall Study|Lost to Follow-up|93|||
27879187|NCT01671007|81391420|FG001|Overall Study|Lost to Follow-up|142|||
27879188|NCT01671007|81391421|FG002|Overall Study|Lost to Follow-up|91|||
27691855|NCT00262951|80709555|FG000|Overall Study|Off treatment for other disease|1|||
27879189|NCT01671007|81391422|FG003|Overall Study|Lost to Follow-up|63|||
27879190|NCT01671007|81391423|FG004|Overall Study|Lost to Follow-up|7|||
27879191|NCT01671007|81391424|FG005|Overall Study|Lost to Follow-up|20|||
27879192|NCT01671007|81391425|FG006|Overall Study|Lost to Follow-up|2|||
27879193|NCT01671007|81391426|FG007|Overall Study|Lost to Follow-up|28|||
27879194|NCT01671007|81391427|FG008|Overall Study|Lost to Follow-up|0|||
27879195|NCT01671007|81391419|FG000|Overall Study|No end of study case report form|3|||
27879196|NCT01671007|81391420|FG001|Overall Study|No end of study case report form|1|||
27879197|NCT01671007|81391421|FG002|Overall Study|No end of study case report form|0|||
27879198|NCT01671007|81391422|FG003|Overall Study|No end of study case report form|2|||
27879199|NCT01671007|81391423|FG004|Overall Study|No end of study case report form|0|||
27879200|NCT01671007|81391424|FG005|Overall Study|No end of study case report form|0|||
27879201|NCT01671007|81391425|FG006|Overall Study|No end of study case report form|0|||
27879202|NCT01671007|81391426|FG007|Overall Study|No end of study case report form|0|||
27879203|NCT01671007|81391427|FG008|Overall Study|No end of study case report form|0|||
27879204|NCT01671007|81391419|FG000|Overall Study|Not eligible|23|||
27879205|NCT01671007|81391420|FG001|Overall Study|Not eligible|76|||
27879206|NCT01671007|81391421|FG002|Overall Study|Not eligible|25|||
27879207|NCT01671007|81391422|FG003|Overall Study|Not eligible|17|||
27879208|NCT01671007|81391423|FG004|Overall Study|Not eligible|0|||
27879209|NCT01671007|81391424|FG005|Overall Study|Not eligible|6|||
27879210|NCT01671007|81391425|FG006|Overall Study|Not eligible|1|||
27879211|NCT01671007|81391426|FG007|Overall Study|Not eligible|19|||
27879212|NCT01671007|81391427|FG008|Overall Study|Not eligible|0|||
27879213|NCT02841995|81391428|FG000|Overall Study|Disease progression|5|||
27879214|NCT02841995|81391429|FG001|Overall Study|Disease progression|11|||
27879215|NCT02841995|81391430|FG002|Overall Study|Disease progression|8|||
27879216|NCT02841995|81391428|FG000|Overall Study|Withdrawal by Subject|2|||
27879217|NCT02841995|81391429|FG001|Overall Study|Withdrawal by Subject|4|||
27879218|NCT02841995|81391430|FG002|Overall Study|Withdrawal by Subject|4|||
27879219|NCT02841995|81391428|FG000|Overall Study|Adverse Event|2|||
27879220|NCT02841995|81391429|FG001|Overall Study|Adverse Event|0|||
27879221|NCT02841995|81391430|FG002|Overall Study|Adverse Event|1|||
27879222|NCT02841995|81391428|FG000|Overall Study|Investigator decision|2|||
27879223|NCT02841995|81391429|FG001|Overall Study|Investigator decision|0|||
27879224|NCT02841995|81391430|FG002|Overall Study|Investigator decision|1|||
27879225|NCT02841995|81391428|FG000|Overall Study|Death|0|||
27879226|NCT02841995|81391429|FG001|Overall Study|Death|0|||
27879227|NCT02841995|81391430|FG002|Overall Study|Death|2|||
27879228|NCT02841995|81391428|FG000|Overall Study|Noncompliance to protocol|1|||
27879229|NCT02841995|81391429|FG001|Overall Study|Noncompliance to protocol|0|||
27879230|NCT02841995|81391430|FG002|Overall Study|Noncompliance to protocol|0|||
27879231|NCT02841995|81391428|FG000|Overall Study|Sponsor decision|1|||
27879232|NCT02841995|81391429|FG001|Overall Study|Sponsor decision|0|||
27879233|NCT02841995|81391430|FG002|Overall Study|Sponsor decision|0|||
27879234|NCT02841995|81391428|FG000|Overall Study|Other|4|||
27879235|NCT02841995|81391429|FG001|Overall Study|Other|1|||
27879236|NCT02841995|81391430|FG002|Overall Study|Other|5|||
27879237|NCT00478777|81391434|FG000|Overall Study|Adverse Event|29|||
27879238|NCT00478777|81391434|FG000|Overall Study|Lack of Efficacy|23|||
27879239|NCT00478777|81391434|FG000|Overall Study|Withdrawal by Subject|4|||
27879240|NCT00478777|81391434|FG000|Overall Study|Death|3|||
27879241|NCT00478777|81391434|FG000|Overall Study|Protocol Violation|3|||
27879242|NCT00478777|81391434|FG000|Overall Study|Lost to Follow-up|3|||
27879243|NCT00478777|81391434|FG000|Overall Study|Physician Decision|1|||
27691856|NCT00427895|80709557|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691857|NCT00427895|80709558|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691858|NCT00427895|80709559|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691859|NCT00427895|80709560|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
27691860|NCT00427895|80709561|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691861|NCT00427895|80709562|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691862|NCT00427895|80709563|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691863|NCT00427895|80709564|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
27691864|NCT00427895|80709557|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27817498|NCT01505530|81166500|FG001|Overall Study|Sponsor Decision|8|||
27591143|NCT01571362|80344846|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
27817499|NCT01505530|81166501|FG002|Overall Study|Sponsor Decision|7|||
27817500|NCT01505530|81166499|FG000|Overall Study|Death|7|||
27817501|NCT01505530|81166500|FG001|Overall Study|Death|6|||
27817502|NCT01505530|81166501|FG002|Overall Study|Death|5|||
27817503|NCT01505530|81166499|FG000|Overall Study|entry criteria not met|0|||
27817504|NCT01505530|81166500|FG001|Overall Study|entry criteria not met|1|||
27817505|NCT01505530|81166501|FG002|Overall Study|entry criteria not met|0|||
27879244|NCT00478777|81391434|FG000|Overall Study|Intolerance of therapy|1|||
27591144|NCT01571362|80344847|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
27591145|NCT01571362|80344848|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
27591146|NCT01571362|80344846|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
27817506|NCT01000337|81166505|FG000|Overall Study|Lost to Follow-up|4|||
27879245|NCT00478777|81391434|FG000|Overall Study|Lack of compliance|1|||
27817507|NCT01000337|81166506|FG001|Overall Study|Lost to Follow-up|3|||
27817508|NCT01469364|81166507|FG000|Overall Study|Adverse Event|1|||
27817509|NCT01469364|81166507|FG000|Overall Study|Withdrawal by Subject|1|||
27817510|NCT02227862|81166511|FG000|Overall Study|Protocol Violation|7|||
27817511|NCT02227862|81166512|FG001|Overall Study|Protocol Violation|9|||
27817512|NCT02227862|81166511|FG000|Overall Study|Other|0|||
27817513|NCT02227862|81166512|FG001|Overall Study|Other|2|||
27591147|NCT01571362|80344847|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
27817514|NCT02227862|81166511|FG000|Overall Study|Adverse Event|4|||
27817515|NCT02227862|81166512|FG001|Overall Study|Adverse Event|3|||
27817516|NCT02227862|81166511|FG000|Overall Study|Withdrawal by Subject|7|||
27591148|NCT01571362|80344848|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
27591149|NCT01571362|80344846|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
27691865|NCT00427895|80709558|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27691866|NCT00427895|80709559|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27691867|NCT00427895|80709560|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27691868|NCT00427895|80709561|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27691869|NCT00427895|80709562|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27817517|NCT02227862|81166512|FG001|Overall Study|Withdrawal by Subject|6|||
27817518|NCT02227862|81166511|FG000|Overall Study|Lost to Follow-up|1|||
27691870|NCT00427895|80709563|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
27817519|NCT02227862|81166512|FG001|Overall Study|Lost to Follow-up|2|||
27817520|NCT00950807|81166515|FG000|Treatment Period 1|Lack of Efficacy|1|||
27691871|NCT00427895|80709564|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
27691872|NCT00427895|80709557|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
27691873|NCT00427895|80709558|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
27691874|NCT00427895|80709559|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
27691875|NCT00427895|80709560|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
27591150|NCT01571362|80344847|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
27591151|NCT01571362|80344848|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
27591152|NCT01571362|80344846|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
27591153|NCT01571362|80344847|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
27591154|NCT01571362|80344848|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
27591155|NCT01571362|80344846|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
27591156|NCT01571362|80344847|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
27591157|NCT01571362|80344848|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
27591158|NCT01571362|80344846|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
27591159|NCT01571362|80344847|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
27591160|NCT01571362|80344848|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
27591161|NCT01571362|80344846|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27591162|NCT01571362|80344847|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
27591163|NCT01571362|80344848|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
27591164|NCT01571362|80344846|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27591165|NCT01571362|80344847|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
27691876|NCT00427895|80709561|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
27691877|NCT00427895|80709562|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
27691878|NCT00427895|80709563|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
27691879|NCT00427895|80709564|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
27691880|NCT00427895|80709557|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
27817521|NCT00950807|81166516|FG001|Treatment Period 1|Lack of Efficacy|0|||
27817522|NCT00950807|81166517|FG002|Treatment Period 1|Lack of Efficacy|0|||
27817523|NCT00950807|81166518|FG003|Treatment Period 1|Lack of Efficacy|0|||
27817524|NCT00950807|81166519|FG004|Treatment Period 1|Lack of Efficacy|0|||
27817525|NCT00950807|81166520|FG005|Treatment Period 1|Lack of Efficacy|1|||
27817526|NCT00950807|81166521|FG006|Treatment Period 1|Lack of Efficacy|0|||
27817527|NCT00950807|81166522|FG007|Treatment Period 1|Lack of Efficacy|0|||
27817528|NCT00950807|81166523|FG008|Treatment Period 1|Lack of Efficacy|0|||
27691881|NCT00427895|80709558|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
27691882|NCT00427895|80709559|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
27691883|NCT00427895|80709560|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
27817529|NCT00950807|81166524|FG009|Treatment Period 1|Lack of Efficacy|0|||
27817530|NCT00950807|81166515|FG000|Treatment Period 1|Protocol Violation|1|||
27817531|NCT00950807|81166516|FG001|Treatment Period 1|Protocol Violation|0|||
27817532|NCT00950807|81166517|FG002|Treatment Period 1|Protocol Violation|0|||
27817533|NCT00950807|81166518|FG003|Treatment Period 1|Protocol Violation|0|||
27817534|NCT00950807|81166519|FG004|Treatment Period 1|Protocol Violation|0|||
27817535|NCT00950807|81166520|FG005|Treatment Period 1|Protocol Violation|0|||
27817536|NCT00950807|81166521|FG006|Treatment Period 1|Protocol Violation|0|||
27817537|NCT00950807|81166522|FG007|Treatment Period 1|Protocol Violation|0|||
27817538|NCT00950807|81166523|FG008|Treatment Period 1|Protocol Violation|0|||
27817539|NCT00950807|81166524|FG009|Treatment Period 1|Protocol Violation|0|||
27817540|NCT00950807|81166515|FG000|Treatment Period 1|Lost to Follow-up|0|||
27817541|NCT00950807|81166516|FG001|Treatment Period 1|Lost to Follow-up|0|||
27817542|NCT00950807|81166517|FG002|Treatment Period 1|Lost to Follow-up|1|||
27817543|NCT00950807|81166518|FG003|Treatment Period 1|Lost to Follow-up|0|||
27817544|NCT00950807|81166519|FG004|Treatment Period 1|Lost to Follow-up|0|||
27817545|NCT00950807|81166520|FG005|Treatment Period 1|Lost to Follow-up|0|||
27817546|NCT00950807|81166521|FG006|Treatment Period 1|Lost to Follow-up|0|||
27817547|NCT00950807|81166522|FG007|Treatment Period 1|Lost to Follow-up|0|||
27817548|NCT00950807|81166523|FG008|Treatment Period 1|Lost to Follow-up|0|||
27817549|NCT00950807|81166524|FG009|Treatment Period 1|Lost to Follow-up|0|||
27817550|NCT00950807|81166515|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27817551|NCT00950807|81166516|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27817552|NCT00950807|81166517|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27817553|NCT00950807|81166518|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27817554|NCT00950807|81166519|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27817555|NCT00950807|81166520|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27817556|NCT00950807|81166521|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27817557|NCT00950807|81166522|FG007|Treatment Period 1|Withdrawal by Subject|0|||
27817558|NCT00950807|81166523|FG008|Treatment Period 1|Withdrawal by Subject|1|||
27817559|NCT00950807|81166524|FG009|Treatment Period 1|Withdrawal by Subject|0|||
27817560|NCT00950807|81166515|FG000|Treatment Period 1|Adverse Event|0|||
27817561|NCT00950807|81166516|FG001|Treatment Period 1|Adverse Event|0|||
27817562|NCT00950807|81166517|FG002|Treatment Period 1|Adverse Event|0|||
27817563|NCT00950807|81166518|FG003|Treatment Period 1|Adverse Event|0|||
27817564|NCT00950807|81166519|FG004|Treatment Period 1|Adverse Event|0|||
27817565|NCT00950807|81166520|FG005|Treatment Period 1|Adverse Event|1|||
27817566|NCT00950807|81166521|FG006|Treatment Period 1|Adverse Event|0|||
27817567|NCT00950807|81166522|FG007|Treatment Period 1|Adverse Event|0|||
27817568|NCT00950807|81166523|FG008|Treatment Period 1|Adverse Event|0|||
27817569|NCT00950807|81166524|FG009|Treatment Period 1|Adverse Event|0|||
27817570|NCT00950807|81166515|FG000|Washout Period 1|Lack of Efficacy|0|||
27817571|NCT00950807|81166516|FG001|Washout Period 1|Lack of Efficacy|0|||
27817572|NCT00950807|81166517|FG002|Washout Period 1|Lack of Efficacy|0|||
27817573|NCT00950807|81166518|FG003|Washout Period 1|Lack of Efficacy|0|||
27817574|NCT00950807|81166519|FG004|Washout Period 1|Lack of Efficacy|0|||
27817575|NCT00950807|81166520|FG005|Washout Period 1|Lack of Efficacy|0|||
27817576|NCT00950807|81166521|FG006|Washout Period 1|Lack of Efficacy|1|||
27817577|NCT00950807|81166522|FG007|Washout Period 1|Lack of Efficacy|0|||
27691884|NCT00427895|80709561|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
27591166|NCT01571362|80344848|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
27691885|NCT00427895|80709562|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
27691886|NCT00427895|80709563|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
27691887|NCT00427895|80709564|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
27691888|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
27691889|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
27691890|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
27691891|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
27691892|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
27691893|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
27691894|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
27691895|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
27691896|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
27691897|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
27691898|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
27691899|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
27691900|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
27691901|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
27691902|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
27691903|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
27691904|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
27691905|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
27691906|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
27691907|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
27691908|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
27691909|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
27691910|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
27691911|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
27691912|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
27691913|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
27691914|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
27691915|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
27691916|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
27691917|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
27691918|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
27691919|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
27691920|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27691921|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27691922|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27691923|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
27691924|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27691925|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27691926|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27591167|NCT01571362|80344846|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27591168|NCT01571362|80344847|FG001|Double-Blind Treatment Period|Adverse Event|9|||
27591169|NCT01571362|80344848|FG002|Double-Blind Treatment Period|Adverse Event|14|||
27591170|NCT01571362|80344846|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27591171|NCT01571362|80344847|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
27591172|NCT01571362|80344848|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
27591173|NCT01571362|80344846|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
27591174|NCT01571362|80344847|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
27591175|NCT01571362|80344848|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
27591176|NCT01571362|80344846|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
27591177|NCT01571362|80344847|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
27591178|NCT01571362|80344848|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
27591179|NCT00966940|80344853|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
27691927|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
27691928|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
27691929|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
27691930|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
27691931|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
27691932|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
27691933|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
27691934|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
27691935|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
27691936|NCT00427895|80709557|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
27691937|NCT00427895|80709558|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
27691938|NCT00427895|80709559|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
27691939|NCT00427895|80709560|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
27691940|NCT00427895|80709561|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
27691941|NCT00427895|80709562|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
27691942|NCT00427895|80709563|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
27691943|NCT00427895|80709564|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
27691944|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
27691945|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
27691946|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
27691947|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
27691948|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
27691949|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
27691950|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
27591180|NCT00966940|80344854|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
27591181|NCT00966940|80344853|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
27591182|NCT00966940|80344854|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
27591183|NCT02412137|80344855|FG000|Overall Study|Withdrawal by Subject|2|||
27591184|NCT02412137|80344856|FG001|Overall Study|Withdrawal by Subject|0|||
27591185|NCT02412137|80344855|FG000|Overall Study|Lost to Follow-up|21|||
27591186|NCT02412137|80344856|FG001|Overall Study|Lost to Follow-up|14|||
27591187|NCT02412137|80344855|FG000|Overall Study|Physician Decision|28|||
27591188|NCT02412137|80344856|FG001|Overall Study|Physician Decision|9|||
27591189|NCT00574080|80344865|FG000|Overall Study|Death|10|||
27591190|NCT00574080|80344866|FG001|Overall Study|Death|10|||
27591191|NCT00476476|80344867|FG000|Overall Study|Adverse Event|2|||
27591192|NCT00476476|80344868|FG001|Overall Study|Adverse Event|7|||
27591193|NCT00476476|80344867|FG000|Overall Study|Progressive Disease|0|||
27591194|NCT00476476|80344868|FG001|Overall Study|Progressive Disease|17|||
27591195|NCT01491854|80344869|FG000|Overall Study|mainly due to premature termination|93|||
27591196|NCT01491854|80344869|FG000|Overall Study|Death|1|||
27691951|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
27691952|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
27591197|NCT01491854|80344869|FG000|Overall Study|Withdrawal by Subject|3|||
27591198|NCT01491854|80344869|FG000|Overall Study|Lost to Follow-up|33|||
27591199|NCT03996473|80344870|FG000|Treatment Assignment|Withdrawal by Subject|1|||
27591200|NCT03996473|80344870|FG000|Treatment Assignment|Progressive disease|6|||
27591201|NCT03996473|80344870|FG000|Treatment Assignment|Study drug never administered|1|||
27591202|NCT03996473|80344870|FG000|Active Follow-up|Death|1|||
27591203|NCT03996473|80344870|FG000|Long-term Follow-up|Death|5|||
27591204|NCT00920426|80344871|FG000|ITZ111451|Adverse Event|1|||
27591205|NCT00920426|80344872|FG001|ITZ111451|Adverse Event|0|||
27591206|NCT00920426|80344873|FG002|ITZ111451|Adverse Event|0|||
27591207|NCT00920426|80344874|FG003|ITZ111451|Adverse Event|0|||
27591208|NCT02625623|80344875|FG000|Overall Study|Participants randomized but not treated|9|||
27591209|NCT02625623|80344876|FG001|Overall Study|Participants randomized but not treated|1|||
27591210|NCT03069482|80344879|FG000|Overall Study|Lost to Follow-up|0|||
27591211|NCT03069482|80344880|FG001|Overall Study|Lost to Follow-up|1|||
27591212|NCT03069482|80344879|FG000|Overall Study|Physician Decision|1|||
27591213|NCT03069482|80344880|FG001|Overall Study|Physician Decision|0|||
27591214|NCT03581305|80344881|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
27591215|NCT03581305|80344882|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
27591216|NCT03581305|80344881|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
27691953|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
27691954|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
27691955|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
27691956|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
27691957|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
27691958|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
27691959|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
27691960|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
27691961|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
27691962|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
27691963|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
27691964|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
27691965|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
27691966|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
27691967|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
27691968|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27591217|NCT03581305|80344882|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
27591218|NCT03581305|80344881|FG000|Serotonergic Study|Withdrawal by Subject|5|||
27591219|NCT03581305|80344882|FG001|Serotonergic Study|Withdrawal by Subject|1|||
27591220|NCT00317772|80344883|FG000|Overall Study|Adverse Event|0|||
27691969|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
27691970|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27691971|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27691972|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27691973|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27691974|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27691975|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
27691976|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Death|1|||
27691977|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Death|0|||
27691978|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Death|0|||
27691979|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Death|0|||
27691980|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Death|0|||
27691981|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Death|0|||
27817578|NCT00950807|81166523|FG008|Washout Period 1|Lack of Efficacy|0|||
27817579|NCT00950807|81166524|FG009|Washout Period 1|Lack of Efficacy|0|||
27817580|NCT00950807|81166515|FG000|Washout Period 1|Withdrawal by Subject|0|||
27817581|NCT00950807|81166516|FG001|Washout Period 1|Withdrawal by Subject|0|||
27817582|NCT00950807|81166517|FG002|Washout Period 1|Withdrawal by Subject|0|||
27817583|NCT00950807|81166518|FG003|Washout Period 1|Withdrawal by Subject|0|||
27817584|NCT00950807|81166519|FG004|Washout Period 1|Withdrawal by Subject|0|||
27817585|NCT00950807|81166520|FG005|Washout Period 1|Withdrawal by Subject|0|||
27817586|NCT00950807|81166521|FG006|Washout Period 1|Withdrawal by Subject|0|||
27817587|NCT00950807|81166522|FG007|Washout Period 1|Withdrawal by Subject|0|||
27817588|NCT00950807|81166523|FG008|Washout Period 1|Withdrawal by Subject|1|||
27817589|NCT00950807|81166524|FG009|Washout Period 1|Withdrawal by Subject|0|||
27817590|NCT00950807|81166515|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
27817591|NCT00950807|81166516|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27817592|NCT00950807|81166517|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27817593|NCT00950807|81166518|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27817594|NCT00950807|81166519|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27817595|NCT00950807|81166520|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27691982|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Death|0|||
27691983|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Death|0|||
27817596|NCT00950807|81166521|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
27591221|NCT00317772|80344884|FG001|Overall Study|Adverse Event|0|||
27591222|NCT00317772|80344885|FG002|Overall Study|Adverse Event|0|||
27591223|NCT00317772|80344886|FG003|Overall Study|Adverse Event|2|||
27691984|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
27817597|NCT00950807|81166522|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
27817598|NCT00950807|81166523|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27817599|NCT00950807|81166524|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
27591224|NCT00317772|80344883|FG000|Overall Study|Disease Progression|2|||
27691985|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
27691986|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
27691987|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
27691988|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
27691989|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
27691990|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
27691991|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
27691992|NCT00427895|80709557|FG000|Vax 1/Year 1 Follow-up|Other|0|||
27691993|NCT00427895|80709558|FG001|Vax 1/Year 1 Follow-up|Other|0|||
27691994|NCT00427895|80709559|FG002|Vax 1/Year 1 Follow-up|Other|0|||
27691995|NCT00427895|80709560|FG003|Vax 1/Year 1 Follow-up|Other|2|||
27691996|NCT00427895|80709561|FG004|Vax 1/Year 1 Follow-up|Other|0|||
27691997|NCT00427895|80709562|FG005|Vax 1/Year 1 Follow-up|Other|0|||
27691998|NCT00427895|80709563|FG006|Vax 1/Year 1 Follow-up|Other|0|||
27691999|NCT00427895|80709564|FG007|Vax 1/Year 1 Follow-up|Other|0|||
27692000|NCT00427895|80709557|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
27817600|NCT00950807|81166515|FG000|Washout Period 1|Adverse Event|2|||
27817601|NCT00950807|81166516|FG001|Washout Period 1|Adverse Event|0|||
27817602|NCT00950807|81166517|FG002|Washout Period 1|Adverse Event|0|||
27817603|NCT00950807|81166518|FG003|Washout Period 1|Adverse Event|1|||
27817604|NCT00950807|81166519|FG004|Washout Period 1|Adverse Event|1|||
27817605|NCT00950807|81166520|FG005|Washout Period 1|Adverse Event|0|||
27817606|NCT00950807|81166521|FG006|Washout Period 1|Adverse Event|0|||
27817607|NCT00950807|81166522|FG007|Washout Period 1|Adverse Event|0|||
27817608|NCT00950807|81166523|FG008|Washout Period 1|Adverse Event|0|||
27817609|NCT00950807|81166524|FG009|Washout Period 1|Adverse Event|0|||
27817610|NCT00950807|81166515|FG000|Treatment Period 2|Lack of Efficacy|1|||
27817611|NCT00950807|81166516|FG001|Treatment Period 2|Lack of Efficacy|0|||
27817612|NCT00950807|81166517|FG002|Treatment Period 2|Lack of Efficacy|0|||
27817613|NCT00950807|81166518|FG003|Treatment Period 2|Lack of Efficacy|0|||
27817614|NCT00950807|81166519|FG004|Treatment Period 2|Lack of Efficacy|0|||
27817615|NCT00950807|81166520|FG005|Treatment Period 2|Lack of Efficacy|0|||
27817616|NCT00950807|81166521|FG006|Treatment Period 2|Lack of Efficacy|0|||
27817617|NCT00950807|81166522|FG007|Treatment Period 2|Lack of Efficacy|0|||
27817618|NCT00950807|81166523|FG008|Treatment Period 2|Lack of Efficacy|0|||
27817619|NCT00950807|81166524|FG009|Treatment Period 2|Lack of Efficacy|0|||
27817620|NCT00950807|81166515|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27817621|NCT00950807|81166516|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27817622|NCT00950807|81166517|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27817623|NCT00950807|81166518|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27817624|NCT00950807|81166519|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27817625|NCT00950807|81166520|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27817626|NCT00950807|81166521|FG006|Treatment Period 2|Withdrawal by Subject|1|||
27817627|NCT00950807|81166522|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27817628|NCT00950807|81166523|FG008|Treatment Period 2|Withdrawal by Subject|0|||
27817629|NCT00950807|81166524|FG009|Treatment Period 2|Withdrawal by Subject|0|||
27817630|NCT00950807|81166515|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
27817631|NCT00950807|81166516|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817632|NCT00950807|81166517|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817633|NCT00950807|81166518|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817634|NCT00950807|81166519|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817635|NCT00950807|81166520|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817636|NCT00950807|81166521|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817637|NCT00950807|81166522|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817638|NCT00950807|81166523|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817639|NCT00950807|81166524|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27817640|NCT00950807|81166515|FG000|Treatment Period 2|Adverse Event|0|||
27817641|NCT00950807|81166516|FG001|Treatment Period 2|Adverse Event|1|||
27817642|NCT00950807|81166517|FG002|Treatment Period 2|Adverse Event|0|||
27817643|NCT00950807|81166518|FG003|Treatment Period 2|Adverse Event|1|||
27817644|NCT00950807|81166519|FG004|Treatment Period 2|Adverse Event|0|||
27817645|NCT00950807|81166520|FG005|Treatment Period 2|Adverse Event|1|||
27817646|NCT00950807|81166521|FG006|Treatment Period 2|Adverse Event|0|||
27692001|NCT00427895|80709558|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
27692002|NCT00427895|80709559|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
27817647|NCT00950807|81166522|FG007|Treatment Period 2|Adverse Event|1|||
27817648|NCT00950807|81166523|FG008|Treatment Period 2|Adverse Event|0|||
27817649|NCT00950807|81166524|FG009|Treatment Period 2|Adverse Event|0|||
27817650|NCT00950807|81166515|FG000|Washout Period 2|Lack of Efficacy|1|||
27817651|NCT00950807|81166516|FG001|Washout Period 2|Lack of Efficacy|0|||
27817652|NCT00950807|81166517|FG002|Washout Period 2|Lack of Efficacy|0|||
27817653|NCT00950807|81166518|FG003|Washout Period 2|Lack of Efficacy|0|||
27817654|NCT00950807|81166519|FG004|Washout Period 2|Lack of Efficacy|0|||
27591225|NCT00317772|80344884|FG001|Overall Study|Disease Progression|2|||
27692003|NCT00427895|80709560|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
27591226|NCT00317772|80344885|FG002|Overall Study|Disease Progression|1|||
27591227|NCT00317772|80344886|FG003|Overall Study|Disease Progression|7|||
27591228|NCT03526250|80344887|FG000|Overall Study|Adverse Event|4|||
27591229|NCT03526250|80344887|FG000|Overall Study|Progressive Disease|16|||
27692004|NCT00427895|80709561|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
27817655|NCT00950807|81166520|FG005|Washout Period 2|Lack of Efficacy|0|||
27817656|NCT00950807|81166521|FG006|Washout Period 2|Lack of Efficacy|0|||
27817657|NCT00950807|81166522|FG007|Washout Period 2|Lack of Efficacy|0|||
27817658|NCT00950807|81166523|FG008|Washout Period 2|Lack of Efficacy|0|||
27817659|NCT00950807|81166524|FG009|Washout Period 2|Lack of Efficacy|0|||
27817660|NCT00950807|81166515|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27817661|NCT00950807|81166516|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27817662|NCT00950807|81166517|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27817663|NCT00950807|81166518|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27817664|NCT00950807|81166519|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27817665|NCT00950807|81166520|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27817666|NCT00950807|81166521|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27817667|NCT00950807|81166522|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
27817668|NCT00950807|81166523|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27817669|NCT00950807|81166524|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
27817670|NCT00950807|81166515|FG000|Washout Period 2|Adverse Event|3|||
27817671|NCT00950807|81166516|FG001|Washout Period 2|Adverse Event|0|||
27817672|NCT00950807|81166517|FG002|Washout Period 2|Adverse Event|0|||
27817673|NCT00950807|81166518|FG003|Washout Period 2|Adverse Event|1|||
27817674|NCT00950807|81166519|FG004|Washout Period 2|Adverse Event|0|||
27817675|NCT00950807|81166520|FG005|Washout Period 2|Adverse Event|0|||
27817676|NCT00950807|81166521|FG006|Washout Period 2|Adverse Event|0|||
27817677|NCT00950807|81166522|FG007|Washout Period 2|Adverse Event|0|||
27817678|NCT00950807|81166523|FG008|Washout Period 2|Adverse Event|0|||
27817679|NCT00950807|81166524|FG009|Washout Period 2|Adverse Event|0|||
27817680|NCT00950807|81166515|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27817681|NCT00950807|81166516|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27817682|NCT00950807|81166517|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27817683|NCT00950807|81166518|FG003|Treatment Period 3|Withdrawal by Subject|0|||
27817684|NCT00950807|81166519|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27817685|NCT00950807|81166520|FG005|Treatment Period 3|Withdrawal by Subject|0|||
27591230|NCT03526250|80344887|FG000|Overall Study|No Treatment|3|||
27692005|NCT00427895|80709562|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
27692006|NCT00427895|80709563|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
27817686|NCT00950807|81166521|FG006|Treatment Period 3|Withdrawal by Subject|0|||
27692007|NCT00427895|80709564|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
27817687|NCT00950807|81166522|FG007|Treatment Period 3|Withdrawal by Subject|0|||
27817688|NCT00950807|81166523|FG008|Treatment Period 3|Withdrawal by Subject|0|||
27817689|NCT00950807|81166524|FG009|Treatment Period 3|Withdrawal by Subject|1|||
27817690|NCT00950807|81166515|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
27591231|NCT05557942|80344888|FG000|Overall Study|Death|0|||
27591232|NCT05557942|80344889|FG001|Overall Study|Death|0|||
27817691|NCT00950807|81166516|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817692|NCT00950807|81166517|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817693|NCT00950807|81166518|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817694|NCT00950807|81166519|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817695|NCT00950807|81166520|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817696|NCT00950807|81166521|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817697|NCT00950807|81166522|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
27817698|NCT00950807|81166523|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27817699|NCT00950807|81166524|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27591233|NCT05557942|80344890|FG002|Overall Study|Death|0|||
27692008|NCT03038438|80709565|FG000|Overall Study|Death|3|||
27692009|NCT03038438|80709565|FG000|Overall Study|Lost to Follow-up|8|||
27692010|NCT03038438|80709565|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
27692011|NCT03038438|80709565|FG000|Overall Study|Withdrawal by Subject|5|||
27817700|NCT00950807|81166515|FG000|Treatment Period 3|Adverse Event|0|||
27817701|NCT00950807|81166516|FG001|Treatment Period 3|Adverse Event|0|||
27817702|NCT00950807|81166517|FG002|Treatment Period 3|Adverse Event|0|||
27817703|NCT00950807|81166518|FG003|Treatment Period 3|Adverse Event|0|||
27817704|NCT00950807|81166519|FG004|Treatment Period 3|Adverse Event|0|||
27817705|NCT00950807|81166520|FG005|Treatment Period 3|Adverse Event|0|||
27817706|NCT00950807|81166521|FG006|Treatment Period 3|Adverse Event|1|||
27817707|NCT00950807|81166522|FG007|Treatment Period 3|Adverse Event|0|||
27817708|NCT00950807|81166523|FG008|Treatment Period 3|Adverse Event|0|||
27817709|NCT00950807|81166524|FG009|Treatment Period 3|Adverse Event|0|||
27817710|NCT00818623|81166529|FG000|Overall Study|Adverse Event|1|||
27817711|NCT00818623|81166530|FG001|Overall Study|Adverse Event|0|||
27817712|NCT00818623|81166531|FG002|Overall Study|Adverse Event|1|||
27817713|NCT00818623|81166532|FG003|Overall Study|Adverse Event|0|||
27692012|NCT03038438|80709565|FG000|Overall Study|No 36-Month Follow-Up|18|||
27817714|NCT00818623|81166533|FG004|Overall Study|Adverse Event|0|||
27817715|NCT00818623|81166534|FG005|Overall Study|Adverse Event|1|||
27817716|NCT00818623|81166535|FG006|Overall Study|Adverse Event|0|||
27879246|NCT00478777|81391434|FG000|Overall Study|Lymphocytes infusion|1|||
27879247|NCT00478777|81391434|FG000|Overall Study|End of therapy|2|||
27879248|NCT00478777|81391434|FG000|Overall Study|Not treated with lenalidomide|6|||
27879249|NCT02157376|81391435|FG000|Overall Study|Death|10|||
27879250|NCT02157376|81391436|FG001|Overall Study|Death|4|||
27879251|NCT02157376|81391435|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27879252|NCT02157376|81391436|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27879253|NCT02157376|81391435|FG000|Overall Study|Withdrawal by Subject|3|||
27879254|NCT02157376|81391436|FG001|Overall Study|Withdrawal by Subject|8|||
27879255|NCT02157376|81391435|FG000|Overall Study|Not treated|8|||
27879256|NCT02157376|81391436|FG001|Overall Study|Not treated|3|||
27879257|NCT02157376|81391435|FG000|Overall Study|Investigator's misjudgement|1|||
27879258|NCT02157376|81391436|FG001|Overall Study|Investigator's misjudgement|2|||
27591234|NCT05557942|80344891|FG003|Overall Study|Death|2|||
27879259|NCT01568892|81391437|FG000|Open-label Phase|Adverse Event|2|||
27879260|NCT01568892|81391438|FG001|Open-label Phase|Adverse Event|0|||
27879261|NCT01568892|81391437|FG000|Open-label Phase|Lack of Efficacy|4|||
27591235|NCT05557942|80344892|FG004|Overall Study|Death|1|||
27591236|NCT05557942|80344893|FG005|Overall Study|Death|1|||
27591237|NCT05557942|80344888|FG000|Overall Study|Physician Decision|1|||
27817717|NCT00818623|81166536|FG007|Overall Study|Adverse Event|0|||
27817718|NCT00818623|81166529|FG000|Overall Study|Bad prostate specific antigen response|0|||
27817719|NCT00818623|81166530|FG001|Overall Study|Bad prostate specific antigen response|3|||
27817720|NCT00818623|81166531|FG002|Overall Study|Bad prostate specific antigen response|2|||
27817721|NCT00818623|81166532|FG003|Overall Study|Bad prostate specific antigen response|5|||
27817722|NCT00818623|81166533|FG004|Overall Study|Bad prostate specific antigen response|0|||
27817723|NCT00818623|81166534|FG005|Overall Study|Bad prostate specific antigen response|1|||
27817724|NCT00818623|81166535|FG006|Overall Study|Bad prostate specific antigen response|0|||
27817725|NCT00818623|81166536|FG007|Overall Study|Bad prostate specific antigen response|0|||
27817726|NCT00818623|81166529|FG000|Overall Study|Withdrawal by Subject|0|||
27817727|NCT00818623|81166530|FG001|Overall Study|Withdrawal by Subject|1|||
27817728|NCT00818623|81166531|FG002|Overall Study|Withdrawal by Subject|1|||
27817729|NCT00818623|81166532|FG003|Overall Study|Withdrawal by Subject|0|||
27817730|NCT00818623|81166533|FG004|Overall Study|Withdrawal by Subject|0|||
27817731|NCT00818623|81166534|FG005|Overall Study|Withdrawal by Subject|1|||
27817732|NCT00818623|81166535|FG006|Overall Study|Withdrawal by Subject|1|||
27817733|NCT00818623|81166536|FG007|Overall Study|Withdrawal by Subject|1|||
27817734|NCT00818623|81166529|FG000|Overall Study|Protocol Violation|1|||
27817735|NCT00818623|81166530|FG001|Overall Study|Protocol Violation|0|||
27817736|NCT00818623|81166531|FG002|Overall Study|Protocol Violation|0|||
27817737|NCT00818623|81166532|FG003|Overall Study|Protocol Violation|0|||
27817738|NCT00818623|81166533|FG004|Overall Study|Protocol Violation|1|||
27817739|NCT00818623|81166534|FG005|Overall Study|Protocol Violation|0|||
27817740|NCT00818623|81166535|FG006|Overall Study|Protocol Violation|1|||
27817741|NCT00818623|81166536|FG007|Overall Study|Protocol Violation|0|||
27817742|NCT00818623|81166529|FG000|Overall Study|Need of additional treatment|0|||
27879262|NCT01568892|81391438|FG001|Open-label Phase|Lack of Efficacy|2|||
27692013|NCT00561951|80709567|FG000|Overall Study|Adverse Event|11|||
27817743|NCT00818623|81166530|FG001|Overall Study|Need of additional treatment|0|||
27817744|NCT00818623|81166531|FG002|Overall Study|Need of additional treatment|0|||
27817745|NCT00818623|81166532|FG003|Overall Study|Need of additional treatment|0|||
27817746|NCT00818623|81166533|FG004|Overall Study|Need of additional treatment|1|||
27817747|NCT00818623|81166534|FG005|Overall Study|Need of additional treatment|0|||
27817748|NCT00818623|81166535|FG006|Overall Study|Need of additional treatment|0|||
27817749|NCT00818623|81166536|FG007|Overall Study|Need of additional treatment|0|||
27591238|NCT05557942|80344889|FG001|Overall Study|Physician Decision|1|||
27591239|NCT05557942|80344890|FG002|Overall Study|Physician Decision|2|||
27591240|NCT05557942|80344891|FG003|Overall Study|Physician Decision|3|||
27591241|NCT05557942|80344892|FG004|Overall Study|Physician Decision|0|||
27591242|NCT05557942|80344893|FG005|Overall Study|Physician Decision|2|||
27591243|NCT05557942|80344888|FG000|Overall Study|Study terminated by sponsor|17|||
27591244|NCT05557942|80344889|FG001|Overall Study|Study terminated by sponsor|17|||
27591245|NCT05557942|80344890|FG002|Overall Study|Study terminated by sponsor|14|||
27591246|NCT05557942|80344891|FG003|Overall Study|Study terminated by sponsor|40|||
27591247|NCT05557942|80344892|FG004|Overall Study|Study terminated by sponsor|45|||
27591248|NCT05557942|80344893|FG005|Overall Study|Study terminated by sponsor|37|||
27591249|NCT05557942|80344888|FG000|Overall Study|Protocol Violation|0|||
27591250|NCT05557942|80344889|FG001|Overall Study|Protocol Violation|0|||
27591251|NCT05557942|80344890|FG002|Overall Study|Protocol Violation|0|||
27591252|NCT05557942|80344891|FG003|Overall Study|Protocol Violation|0|||
27591253|NCT05557942|80344892|FG004|Overall Study|Protocol Violation|0|||
27591254|NCT05557942|80344893|FG005|Overall Study|Protocol Violation|1|||
27591255|NCT05557942|80344888|FG000|Overall Study|Withdrawal by Subject|0|||
27591256|NCT05557942|80344889|FG001|Overall Study|Withdrawal by Subject|0|||
27591257|NCT05557942|80344890|FG002|Overall Study|Withdrawal by Subject|0|||
27591258|NCT05557942|80344891|FG003|Overall Study|Withdrawal by Subject|0|||
27591259|NCT05557942|80344892|FG004|Overall Study|Withdrawal by Subject|2|||
27591260|NCT05557942|80344893|FG005|Overall Study|Withdrawal by Subject|0|||
27591261|NCT01983293|80344898|FG000|Overall Study|Withdrawal by Subject|29|||
27591262|NCT01983293|80344899|FG001|Overall Study|Withdrawal by Subject|15|||
27591263|NCT01983293|80344898|FG000|Overall Study|Missing 12-month visit|3|||
27591264|NCT01983293|80344899|FG001|Overall Study|Missing 12-month visit|3|||
27591265|NCT01983293|80344898|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
27591266|NCT01983293|80344899|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
27817750|NCT00818623|81166529|FG000|Overall Study|Lack of trial drug at site|0|||
27591267|NCT01962493|80344902|FG000|Overall Study|Adverse Event|1|||
27591268|NCT01962493|80344903|FG001|Overall Study|Adverse Event|2|||
27591269|NCT01962493|80344902|FG000|Overall Study|Protocol Violation|0|||
27591270|NCT01962493|80344903|FG001|Overall Study|Protocol Violation|1|||
27591271|NCT01962493|80344902|FG000|Overall Study|Withdrawal by Subject|4|||
27591272|NCT01962493|80344903|FG001|Overall Study|Withdrawal by Subject|2|||
27692014|NCT00561951|80709568|FG001|Overall Study|Adverse Event|14|||
27692015|NCT00561951|80709569|FG002|Overall Study|Adverse Event|14|||
27817751|NCT00818623|81166530|FG001|Overall Study|Lack of trial drug at site|0|||
27817752|NCT00818623|81166531|FG002|Overall Study|Lack of trial drug at site|0|||
27817753|NCT00818623|81166532|FG003|Overall Study|Lack of trial drug at site|0|||
27817754|NCT00818623|81166533|FG004|Overall Study|Lack of trial drug at site|2|||
27817755|NCT00818623|81166534|FG005|Overall Study|Lack of trial drug at site|0|||
27817756|NCT00818623|81166535|FG006|Overall Study|Lack of trial drug at site|1|||
27817757|NCT00818623|81166536|FG007|Overall Study|Lack of trial drug at site|0|||
27817758|NCT00818623|81166529|FG000|Overall Study|Disease progression|0|||
27817759|NCT00818623|81166530|FG001|Overall Study|Disease progression|0|||
27817760|NCT00818623|81166531|FG002|Overall Study|Disease progression|0|||
27817761|NCT00818623|81166532|FG003|Overall Study|Disease progression|0|||
27817762|NCT00818623|81166533|FG004|Overall Study|Disease progression|0|||
27817763|NCT00818623|81166534|FG005|Overall Study|Disease progression|0|||
27817764|NCT00818623|81166535|FG006|Overall Study|Disease progression|1|||
27817765|NCT00818623|81166536|FG007|Overall Study|Disease progression|0|||
27817766|NCT01124149|81166549|FG000|Acute Phase|Withdrawal by Subject|22|||
27817767|NCT01124149|81166549|FG000|Acute Phase|Adverse Event|21|||
27817768|NCT01124149|81166549|FG000|Acute Phase|Lack of Efficacy|17|||
27817769|NCT01124149|81166549|FG000|Acute Phase|Protocol Violation|14|||
27817770|NCT01124149|81166549|FG000|Acute Phase|Lost to Follow-up|2|||
27817771|NCT01124149|81166549|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
27817772|NCT01124149|81166549|FG000|Acute Phase|Sponsor request|1|||
27817773|NCT01124149|81166549|FG000|Acute Phase|UC symptoms not ameliorated|1|||
27817774|NCT01124149|81166549|FG000|Acute Phase|Non-compliance|1|||
27817775|NCT01124149|81166549|FG000|Acute Phase|Low hemoglobin|1|||
27817776|NCT01124149|81166549|FG000|Acute Phase|Travelling to another country|1|||
27817777|NCT01124149|81166549|FG000|Acute Phase|Sponsor decision|1|||
27817778|NCT01124149|81166549|FG000|Maintenance Phase|Lack of Efficacy|40|||
27817779|NCT01124149|81166549|FG000|Maintenance Phase|Adverse Event|24|||
27817780|NCT01124149|81166549|FG000|Maintenance Phase|Lost to Follow-up|15|||
27817781|NCT01124149|81166549|FG000|Maintenance Phase|Withdrawal by Subject|10|||
27817782|NCT01124149|81166549|FG000|Maintenance Phase|Protocol Violation|5|||
27817783|NCT01124149|81166549|FG000|Maintenance Phase|Coordinator error|1|||
27817784|NCT01124149|81166549|FG000|Maintenance Phase|Non-compliance|1|||
27817785|NCT03883906|81166551|FG000|Overall Study|Withdrawal by Subject|2|||
27817786|NCT03883906|81166551|FG000|Overall Study|Physician Decision|5|||
27817787|NCT03831048|81166553|FG000|Overall Study|Protocol Violation|9|||
27817788|NCT03831048|81166554|FG001|Overall Study|Protocol Violation|3|||
27817789|NCT03831048|81166553|FG000|Overall Study|Death|4|||
27817790|NCT03831048|81166554|FG001|Overall Study|Death|9|||
27817791|NCT03831048|81166553|FG000|Overall Study|Re-transplant|0|||
27817792|NCT03831048|81166554|FG001|Overall Study|Re-transplant|2|||
27817793|NCT03831048|81166553|FG000|Overall Study|Protocol violation and death|1|||
27817794|NCT03831048|81166554|FG001|Overall Study|Protocol violation and death|1|||
27817795|NCT03805438|81166557|FG000|Overall Study|Lack of Efficacy|1|||
27817796|NCT03805438|81166557|FG000|Overall Study|Protocol Violation|1|||
27879263|NCT01568892|81391437|FG000|Open-label Phase|Lost to Follow-up|0|||
27879264|NCT01568892|81391438|FG001|Open-label Phase|Lost to Follow-up|1|||
27879265|NCT02362360|81391441|FG000|Period 1|Lack of Efficacy|1|||
27879266|NCT02362360|81391442|FG001|Period 1|Lack of Efficacy|0|||
27879267|NCT02362360|81391441|FG000|Period 1|Withdrawal by Subject|2|||
27817797|NCT00770510|81166558|FG000|Overall Study|Lost to Follow-up|2|||
27879268|NCT02362360|81391442|FG001|Period 1|Withdrawal by Subject|1|||
27879269|NCT02929589|81391443|FG000|Overall Study|Withdrawal by Subject|1|||
27879270|NCT02929589|81391444|FG001|Overall Study|Withdrawal by Subject|0|||
27879271|NCT02929589|81391445|FG002|Overall Study|Withdrawal by Subject|0|||
27879272|NCT02929589|81391446|FG003|Overall Study|Withdrawal by Subject|0|||
27879273|NCT02929589|81391443|FG000|Overall Study|Physician Decision|2|||
27879274|NCT02929589|81391444|FG001|Overall Study|Physician Decision|0|||
27879275|NCT02929589|81391445|FG002|Overall Study|Physician Decision|0|||
27879276|NCT02929589|81391446|FG003|Overall Study|Physician Decision|0|||
27879277|NCT01209520|81391451|FG000|Overall Study|Withdrawal by Subject|3|||
27879278|NCT00420420|81391452|FG000|Overall Study|Adverse Event|5|||
27879279|NCT00420420|81391453|FG001|Overall Study|Adverse Event|3|||
27879280|NCT00420420|81391452|FG000|Overall Study|Protocol Violation|1|||
27879281|NCT00420420|81391453|FG001|Overall Study|Protocol Violation|1|||
27879282|NCT00420420|81391452|FG000|Overall Study|Withdrawal by Subject|1|||
27879283|NCT00420420|81391453|FG001|Overall Study|Withdrawal by Subject|0|||
27879284|NCT00420420|81391452|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
27817798|NCT00770510|81166558|FG000|Overall Study|Pregnancy|1|||
27879285|NCT00420420|81391453|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
27817799|NCT00770510|81166558|FG000|Overall Study|Withdrawal by Subject|2|||
27817800|NCT04538170|81166559|FG000|Overall Study|Withdrawal by Subject|104|||
27692016|NCT00561951|80709567|FG000|Overall Study|Lack of Efficacy|5|||
27817801|NCT04538170|81166560|FG001|Overall Study|Withdrawal by Subject|210|||
27817802|NCT01273181|81166564|FG000|Phase I, Dose 1|Study termination|1|||
27817803|NCT01273181|81166565|FG001|Phase I, Dose 1|Study termination|0|||
27817804|NCT01273181|81166566|FG002|Phase I, Dose 1|Study termination|0|||
27817805|NCT01273181|81166567|FG003|Phase I, Dose 1|Study termination|0|||
27817806|NCT01273181|81166564|FG000|Phase I, Dose 2|Death during treatment|0|||
27817807|NCT01273181|81166565|FG001|Phase I, Dose 2|Death during treatment|1|||
27817808|NCT01273181|81166566|FG002|Phase I, Dose 2|Death during treatment|0|||
27817809|NCT01273181|81166567|FG003|Phase I, Dose 2|Death during treatment|0|||
27817810|NCT01273181|81166564|FG000|Phase 2, Dose 1|Study termination|0|||
27817811|NCT01273181|81166565|FG001|Phase 2, Dose 1|Study termination|0|||
27817812|NCT01273181|81166566|FG002|Phase 2, Dose 1|Study termination|1|||
27817813|NCT01273181|81166567|FG003|Phase 2, Dose 1|Study termination|0|||
27817814|NCT01273181|81166564|FG000|Phase 2, Dose 2|Death during treatment|0|||
27879286|NCT04200651|81391456|FG000|Overall Study|Moved to another country during follow-up|2|||
27879287|NCT04200651|81391457|FG001|Overall Study|Moved to another country during follow-up|2|||
27879288|NCT04200651|81391456|FG000|Overall Study|Lost to Follow-up|1|||
27879289|NCT04200651|81391457|FG001|Overall Study|Lost to Follow-up|3|||
27879290|NCT03776357|81391458|FG000|Overall Study|Lost to Follow-up|3|||
27817815|NCT01273181|81166565|FG001|Phase 2, Dose 2|Death during treatment|0|||
27879291|NCT03473925|81391462|FG000|Overall Study|Death|48|||
27879292|NCT03473925|81391463|FG001|Overall Study|Death|44|||
27879293|NCT03473925|81391462|FG000|Overall Study|Sponsor Decision|2|||
27879294|NCT03473925|81391463|FG001|Overall Study|Sponsor Decision|7|||
27879295|NCT03473925|81391462|FG000|Overall Study|Withdrawal by Subject|1|||
27879296|NCT03473925|81391463|FG001|Overall Study|Withdrawal by Subject|3|||
27879297|NCT03473925|81391462|FG000|Overall Study|Not Treated|1|||
27879298|NCT03473925|81391463|FG001|Overall Study|Not Treated|1|||
27879299|NCT00767455|81391467|FG000|Overall Study|Investigator error|19|||
27879300|NCT00603473|81391472|FG000|Overall Study|Adverse Event|4|||
27879301|NCT00603473|81391472|FG000|Overall Study|Lack of Efficacy|4|||
27879302|NCT00603473|81391472|FG000|Overall Study|Protocol Violation|1|||
27879303|NCT04463251|81391473|FG000|Overall Study|Death|1|||
27879304|NCT04463251|81391474|FG001|Overall Study|Death|0|||
27879305|NCT04463251|81391475|FG002|Overall Study|Death|1|||
27879306|NCT04463251|81391473|FG000|Overall Study|Adverse Event|0|||
27879307|NCT04463251|81391474|FG001|Overall Study|Adverse Event|1|||
27879308|NCT04463251|81391475|FG002|Overall Study|Adverse Event|0|||
27692017|NCT00561951|80709568|FG001|Overall Study|Lack of Efficacy|3|||
27817816|NCT01273181|81166566|FG002|Phase 2, Dose 2|Death during treatment|0|||
27879309|NCT04463251|81391473|FG000|Overall Study|Lost to Follow-up|0|||
27879310|NCT04463251|81391474|FG001|Overall Study|Lost to Follow-up|1|||
27879311|NCT04463251|81391475|FG002|Overall Study|Lost to Follow-up|0|||
27879312|NCT04463251|81391473|FG000|Overall Study|Withdrawal by Subject|0|||
27879313|NCT04463251|81391474|FG001|Overall Study|Withdrawal by Subject|2|||
27817817|NCT01273181|81166567|FG003|Phase 2, Dose 2|Death during treatment|1|||
27879314|NCT04463251|81391475|FG002|Overall Study|Withdrawal by Subject|2|||
27817818|NCT01475838|81166568|FG000|Randomized Phase|Randomized but Not Treated|0|||
27879315|NCT04031846|81391478|FG000|Overall Study|Lost to Follow-up|4|||
27879316|NCT04031846|81391479|FG001|Overall Study|Lost to Follow-up|4|||
27879317|NCT04031846|81391478|FG000|Overall Study|Physician Decision|0|||
27879318|NCT04031846|81391479|FG001|Overall Study|Physician Decision|1|||
27879319|NCT04031846|81391478|FG000|Overall Study|Protocol Violation|1|||
27879320|NCT04031846|81391479|FG001|Overall Study|Protocol Violation|1|||
27879321|NCT04031846|81391478|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
27879322|NCT04031846|81391479|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
27817819|NCT01475838|81166569|FG001|Randomized Phase|Randomized but Not Treated|5|||
27817820|NCT01475838|81166568|FG000|Randomized Phase|Adverse Event|6|||
27817821|NCT01475838|81166569|FG001|Randomized Phase|Adverse Event|1|||
27817822|NCT01475838|81166568|FG000|Randomized Phase|Pregnancy|0|||
27817823|NCT01475838|81166569|FG001|Randomized Phase|Pregnancy|1|||
27817824|NCT01475838|81166568|FG000|Randomized Phase|Investigators Discretion|1|||
27817825|NCT01475838|81166569|FG001|Randomized Phase|Investigators Discretion|2|||
27817826|NCT01475838|81166568|FG000|Randomized Phase|Withdrew Consent|10|||
27817827|NCT01475838|81166569|FG001|Randomized Phase|Withdrew Consent|14|||
27817828|NCT01475838|81166568|FG000|Randomized Phase|Lost to Follow-up|3|||
27817829|NCT01475838|81166569|FG001|Randomized Phase|Lost to Follow-up|4|||
27817830|NCT01475838|81166568|FG000|Randomized Phase|Participant Noncompliance|1|||
27817831|NCT01475838|81166569|FG001|Randomized Phase|Participant Noncompliance|5|||
27817832|NCT01475838|81166568|FG000|Randomized Phase|Protocol Violation|9|||
27692018|NCT00561951|80709569|FG002|Overall Study|Lack of Efficacy|2|||
27692019|NCT00561951|80709567|FG000|Overall Study|Lost to Follow-up|1|||
27879323|NCT02755103|81391481|FG000|Overall Study|Lost to Follow-up|17|||
27692020|NCT00561951|80709568|FG001|Overall Study|Lost to Follow-up|1|||
27692021|NCT00561951|80709569|FG002|Overall Study|Lost to Follow-up|0|||
27692022|NCT00561951|80709567|FG000|Overall Study|Withdrawal by Subject|10|||
27692023|NCT00561951|80709568|FG001|Overall Study|Withdrawal by Subject|9|||
27692024|NCT00561951|80709569|FG002|Overall Study|Withdrawal by Subject|10|||
27692025|NCT00561951|80709567|FG000|Overall Study|Protocol Violation|4|||
27692026|NCT00561951|80709568|FG001|Overall Study|Protocol Violation|3|||
27692027|NCT00561951|80709569|FG002|Overall Study|Protocol Violation|4|||
27692028|NCT00561951|80709567|FG000|Overall Study|Physician Decision|1|||
27692029|NCT00561951|80709568|FG001|Overall Study|Physician Decision|0|||
27692030|NCT00561951|80709569|FG002|Overall Study|Physician Decision|0|||
27692031|NCT00561951|80709567|FG000|Overall Study|Pregnancy|0|||
27692032|NCT00561951|80709568|FG001|Overall Study|Pregnancy|1|||
27692033|NCT00561951|80709569|FG002|Overall Study|Pregnancy|0|||
27692034|NCT00561951|80709567|FG000|Overall Study|Meet Withdrawal Criterion|0|||
27692035|NCT00561951|80709568|FG001|Overall Study|Meet Withdrawal Criterion|1|||
27692036|NCT00561951|80709569|FG002|Overall Study|Meet Withdrawal Criterion|1|||
27692037|NCT00561951|80709567|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
27692038|NCT00561951|80709568|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
27692039|NCT00561951|80709569|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
27692040|NCT00336895|80709570|FG000|Overall Study|diarrhea|1|||
27692041|NCT00336895|80709570|FG000|Overall Study|nausea and upset stomach|1|||
27692042|NCT00336895|80709570|FG000|Overall Study|Physician Decision|1|||
27692043|NCT00336895|80709570|FG000|Overall Study|screen failed|1|||
27692044|NCT03010176|80709577|FG000|Overall Study|Death|21|||
27692045|NCT03010176|80709578|FG001|Overall Study|Death|35|||
27692046|NCT03010176|80709579|FG002|Overall Study|Death|19|||
27692047|NCT03010176|80709580|FG003|Overall Study|Death|19|||
27692048|NCT03010176|80709581|FG004|Overall Study|Death|14|||
27692049|NCT03010176|80709582|FG005|Overall Study|Death|0|||
27692050|NCT03010176|80709577|FG000|Overall Study|Lost to Follow-up|0|||
27692051|NCT03010176|80709578|FG001|Overall Study|Lost to Follow-up|0|||
27692052|NCT03010176|80709579|FG002|Overall Study|Lost to Follow-up|0|||
27692053|NCT03010176|80709580|FG003|Overall Study|Lost to Follow-up|0|||
27692054|NCT03010176|80709581|FG004|Overall Study|Lost to Follow-up|1|||
27692055|NCT03010176|80709582|FG005|Overall Study|Lost to Follow-up|0|||
27692056|NCT03010176|80709577|FG000|Overall Study|Physician Decision|0|||
27692057|NCT03010176|80709578|FG001|Overall Study|Physician Decision|4|||
27692058|NCT03010176|80709579|FG002|Overall Study|Physician Decision|0|||
27692059|NCT03010176|80709580|FG003|Overall Study|Physician Decision|1|||
27692060|NCT03010176|80709581|FG004|Overall Study|Physician Decision|0|||
27692061|NCT03010176|80709582|FG005|Overall Study|Physician Decision|0|||
27692062|NCT03010176|80709577|FG000|Overall Study|Sponsor Decision|0|||
27692063|NCT03010176|80709578|FG001|Overall Study|Sponsor Decision|4|||
27692064|NCT03010176|80709579|FG002|Overall Study|Sponsor Decision|4|||
27692065|NCT03010176|80709580|FG003|Overall Study|Sponsor Decision|1|||
27692066|NCT03010176|80709581|FG004|Overall Study|Sponsor Decision|6|||
27692067|NCT03010176|80709582|FG005|Overall Study|Sponsor Decision|0|||
27692068|NCT03010176|80709577|FG000|Overall Study|Withdrawal by Subject|11|||
27692069|NCT03010176|80709578|FG001|Overall Study|Withdrawal by Subject|9|||
27692070|NCT03010176|80709579|FG002|Overall Study|Withdrawal by Subject|3|||
27879324|NCT02755103|81391482|FG001|Overall Study|Lost to Follow-up|15|||
27879325|NCT02755103|81391481|FG000|Overall Study|Death|0|||
27879326|NCT02755103|81391482|FG001|Overall Study|Death|1|||
27879327|NCT02755103|81391481|FG000|Overall Study|Physician Decision|0|||
27879328|NCT02755103|81391482|FG001|Overall Study|Physician Decision|1|||
27879329|NCT02755103|81391481|FG000|Overall Study|Pregnancy|0|||
27879330|NCT02755103|81391482|FG001|Overall Study|Pregnancy|1|||
27879331|NCT02755103|81391481|FG000|Overall Study|Withdrawal by Subject|3|||
27879332|NCT02755103|81391482|FG001|Overall Study|Withdrawal by Subject|0|||
27692071|NCT03010176|80709580|FG003|Overall Study|Withdrawal by Subject|0|||
27692072|NCT03010176|80709581|FG004|Overall Study|Withdrawal by Subject|4|||
27879333|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
27879334|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
27692073|NCT03010176|80709582|FG005|Overall Study|Withdrawal by Subject|0|||
27692074|NCT01313689|80709583|FG000|24-Week Randomization 1|Adverse Event|10|||
27692075|NCT01313689|80709584|FG001|24-Week Randomization 1|Adverse Event|5|||
27692076|NCT01313689|80709585|FG002|24-Week Randomization 1|Adverse Event|0|||
27692077|NCT01313689|80709586|FG003|24-Week Randomization 1|Adverse Event|0|||
27692078|NCT01313689|80709587|FG004|24-Week Randomization 1|Adverse Event|0|||
27692079|NCT01313689|80709583|FG000|24-Week Randomization 1|Physician Decision|4|||
27879335|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
27692080|NCT01313689|80709584|FG001|24-Week Randomization 1|Physician Decision|5|||
27692081|NCT01313689|80709585|FG002|24-Week Randomization 1|Physician Decision|0|||
27692082|NCT01313689|80709586|FG003|24-Week Randomization 1|Physician Decision|0|||
27692083|NCT01313689|80709587|FG004|24-Week Randomization 1|Physician Decision|0|||
27692084|NCT01313689|80709583|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
27692085|NCT01313689|80709584|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
27692086|NCT01313689|80709585|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
27692087|NCT01313689|80709586|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
27692088|NCT01313689|80709587|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
27692089|NCT01313689|80709583|FG000|24-Week Randomization 2|Adverse Event|0|||
27692090|NCT01313689|80709584|FG001|24-Week Randomization 2|Adverse Event|0|||
27692091|NCT01313689|80709585|FG002|24-Week Randomization 2|Adverse Event|2|||
27692092|NCT01313689|80709586|FG003|24-Week Randomization 2|Adverse Event|0|||
27692093|NCT01313689|80709587|FG004|24-Week Randomization 2|Adverse Event|8|||
27692094|NCT01313689|80709583|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
27692095|NCT01313689|80709584|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
27692096|NCT01313689|80709585|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
27692097|NCT01313689|80709586|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
27692098|NCT01313689|80709587|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
27692099|NCT01313689|80709583|FG000|24-Week Randomization 2|Physician Decision|0|||
27692100|NCT01313689|80709584|FG001|24-Week Randomization 2|Physician Decision|0|||
27692101|NCT01313689|80709585|FG002|24-Week Randomization 2|Physician Decision|0|||
27692102|NCT01313689|80709586|FG003|24-Week Randomization 2|Physician Decision|0|||
27692103|NCT01313689|80709587|FG004|24-Week Randomization 2|Physician Decision|4|||
27692104|NCT04675151|80709588|FG000|Overall Study|Protocol Violation|1|||
27692105|NCT04675151|80709589|FG001|Overall Study|Protocol Violation|0|||
27692106|NCT04675151|80709590|FG002|Overall Study|Protocol Violation|0|||
27692107|NCT04675151|80709591|FG003|Overall Study|Protocol Violation|1|||
27692108|NCT03271021|80709594|FG000|Overall Study|Adverse Event|3|||
27692109|NCT03271021|80709595|FG001|Overall Study|Adverse Event|2|||
27692110|NCT03271021|80709594|FG000|Overall Study|Withdrawal by Subject|36|||
27692111|NCT03271021|80709595|FG001|Overall Study|Withdrawal by Subject|53|||
27692112|NCT03271021|80709594|FG000|Overall Study|Lost to Follow-up|34|||
27692113|NCT03271021|80709595|FG001|Overall Study|Lost to Follow-up|39|||
27692114|NCT03271021|80709594|FG000|Overall Study|Protocol Violation|6|||
27692115|NCT03271021|80709595|FG001|Overall Study|Protocol Violation|4|||
27692116|NCT03271021|80709594|FG000|Overall Study|Abnormal Lab Results|1|||
27692117|NCT03271021|80709595|FG001|Overall Study|Abnormal Lab Results|0|||
27692118|NCT03271021|80709594|FG000|Overall Study|Miscellaneous|9|||
27692119|NCT03271021|80709595|FG001|Overall Study|Miscellaneous|8|||
27692120|NCT00394082|80709596|FG000|Overall Study|Unacceptable toxicity|15|||
27692121|NCT00394082|80709596|FG000|Overall Study|Adverse Event|4|||
27692122|NCT00394082|80709596|FG000|Overall Study|Physician Decision|4|||
27692123|NCT00394082|80709596|FG000|Overall Study|Withdrawal by Subject|2|||
27692124|NCT00394082|80709596|FG000|Overall Study|Other|1|||
27692125|NCT03730480|80709597|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
27692126|NCT01575028|80709598|FG000|Overall Study|Physician Decision|0|||
27692127|NCT01575028|80709599|FG001|Overall Study|Physician Decision|1|||
27692128|NCT01411839|80709600|FG000|Overall Study|Lost to Follow-up|4|||
27692129|NCT01411839|80709601|FG001|Overall Study|Lost to Follow-up|3|||
27692130|NCT01639495|80709602|FG000|Overall Study|Lost to Follow-up|6|||
27692131|NCT01639495|80709602|FG000|Overall Study|Consented but didn't have study catheter|4|||
27879336|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
27879337|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
27692132|NCT01639495|80709602|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
27692133|NCT01639495|80709602|FG000|Overall Study|No radiofrequency energy applied|2|||
27692134|NCT01952054|80709605|FG000|Overall Study|Physician Decision|1|||
27692135|NCT02240693|80709606|FG000|Overall Study|Adverse Event|0|||
27692136|NCT02240693|80709607|FG001|Overall Study|Adverse Event|0|||
27692137|NCT02240693|80709608|FG002|Overall Study|Adverse Event|0|||
27692138|NCT02240693|80709609|FG003|Overall Study|Adverse Event|0|||
27692139|NCT02240693|80709610|FG004|Overall Study|Adverse Event|1|||
27692140|NCT02240693|80709606|FG000|Overall Study|Withdrawal by Subject|0|||
27692141|NCT02240693|80709607|FG001|Overall Study|Withdrawal by Subject|0|||
27692142|NCT02240693|80709608|FG002|Overall Study|Withdrawal by Subject|2|||
27692143|NCT02240693|80709609|FG003|Overall Study|Withdrawal by Subject|1|||
27692144|NCT02240693|80709610|FG004|Overall Study|Withdrawal by Subject|0|||
27692145|NCT02240693|80709606|FG000|Overall Study|Other than specified|0|||
27692146|NCT02240693|80709607|FG001|Overall Study|Other than specified|0|||
27692147|NCT02240693|80709608|FG002|Overall Study|Other than specified|2|||
27692148|NCT02240693|80709609|FG003|Overall Study|Other than specified|0|||
27692149|NCT02240693|80709610|FG004|Overall Study|Other than specified|0|||
27692150|NCT05056987|80709611|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
27692151|NCT05056987|80709612|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
27692152|NCT05056987|80709611|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
27692153|NCT05056987|80709612|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
27692154|NCT01759368|80709616|FG000|Overall Study|Lost to Follow-up|1|||
27692155|NCT01759368|80709617|FG001|Overall Study|Lost to Follow-up|0|||
27692156|NCT01290315|80709619|FG000|Overall Study|Adverse Event|0|||
27692157|NCT01290315|80709620|FG001|Overall Study|Adverse Event|0|||
27692158|NCT01290315|80709621|FG002|Overall Study|Adverse Event|0|||
27692159|NCT01290315|80709622|FG003|Overall Study|Adverse Event|3|||
27692160|NCT01290315|80709619|FG000|Overall Study|Selection criteria/compliance|2|||
27692161|NCT01290315|80709620|FG001|Overall Study|Selection criteria/compliance|1|||
27692162|NCT01290315|80709621|FG002|Overall Study|Selection criteria/compliance|0|||
27692163|NCT01290315|80709622|FG003|Overall Study|Selection criteria/compliance|2|||
27692164|NCT01290315|80709619|FG000|Overall Study|Lost to Follow-up|0|||
27692165|NCT01290315|80709620|FG001|Overall Study|Lost to Follow-up|1|||
27692166|NCT01290315|80709621|FG002|Overall Study|Lost to Follow-up|0|||
27692167|NCT01290315|80709622|FG003|Overall Study|Lost to Follow-up|0|||
27692168|NCT01290315|80709619|FG000|Overall Study|Withdrawal by Subject|1|||
27692169|NCT01290315|80709620|FG001|Overall Study|Withdrawal by Subject|1|||
27692170|NCT01290315|80709621|FG002|Overall Study|Withdrawal by Subject|0|||
27692171|NCT01290315|80709622|FG003|Overall Study|Withdrawal by Subject|0|||
27692172|NCT00705679|80709623|FG000|Overall Study|Adverse Event|1|||
27692173|NCT00705679|80709624|FG001|Overall Study|Adverse Event|1|||
27692174|NCT00705679|80709625|FG002|Overall Study|Adverse Event|0|||
27692175|NCT00705679|80709626|FG003|Overall Study|Adverse Event|0|||
27692176|NCT00705679|80709627|FG004|Overall Study|Adverse Event|0|||
27692177|NCT00705679|80709623|FG000|Overall Study|Death|0|||
27692178|NCT00705679|80709624|FG001|Overall Study|Death|0|||
27692179|NCT00705679|80709625|FG002|Overall Study|Death|3|||
27692180|NCT00705679|80709626|FG003|Overall Study|Death|2|||
27692181|NCT00705679|80709627|FG004|Overall Study|Death|1|||
27692182|NCT00705679|80709623|FG000|Overall Study|Lost to Follow-up|32|||
27692183|NCT00705679|80709624|FG001|Overall Study|Lost to Follow-up|60|||
27692184|NCT00705679|80709625|FG002|Overall Study|Lost to Follow-up|44|||
27591273|NCT01064739|80344904|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
27591274|NCT01220557|80344907|FG000|Overall Study|Lost to Follow-up|5|||
27591275|NCT01220557|80344908|FG001|Overall Study|Lost to Follow-up|3|||
27591276|NCT01220557|80344907|FG000|Overall Study|attended less than 6 lessons|1|||
27591277|NCT01220557|80344908|FG001|Overall Study|attended less than 6 lessons|2|||
27591278|NCT02347761|80344909|FG000|All Collected|Death|1|||
27692185|NCT00705679|80709626|FG003|Overall Study|Lost to Follow-up|30|||
27692186|NCT00705679|80709627|FG004|Overall Study|Lost to Follow-up|35|||
27692187|NCT00705679|80709623|FG000|Overall Study|Physician Decision|0|||
27692188|NCT00705679|80709624|FG001|Overall Study|Physician Decision|1|||
27692189|NCT00705679|80709625|FG002|Overall Study|Physician Decision|0|||
27692190|NCT00705679|80709626|FG003|Overall Study|Physician Decision|1|||
27692191|NCT00705679|80709627|FG004|Overall Study|Physician Decision|0|||
27692192|NCT00705679|80709623|FG000|Overall Study|Withdrawal by Subject|32|||
27692193|NCT00705679|80709624|FG001|Overall Study|Withdrawal by Subject|77|||
27692194|NCT00705679|80709625|FG002|Overall Study|Withdrawal by Subject|68|||
27692195|NCT00705679|80709626|FG003|Overall Study|Withdrawal by Subject|47|||
27692196|NCT00705679|80709627|FG004|Overall Study|Withdrawal by Subject|33|||
27692197|NCT01948908|80709628|FG000|Overall Study|Protocol Violation|1|||
27692198|NCT01948908|80709629|FG001|Overall Study|Protocol Violation|0|||
27817833|NCT01475838|81166569|FG001|Randomized Phase|Protocol Violation|4|||
27817834|NCT01475838|81166568|FG000|Extension Phase|Participant Noncompliance|1|||
27817835|NCT01475838|81166569|FG001|Extension Phase|Participant Noncompliance|0|||
27817836|NCT01717976|81166570|FG000|Overall Study|Protocol Violation|0|||
27817837|NCT01717976|81166571|FG001|Overall Study|Protocol Violation|1|||
27817838|NCT05150964|81166572|FG000|Overall Study|Lost to Follow-up|2|||
27817839|NCT01860976|81166574|FG000|Blinded Treatment|Adverse Event|1|||
27817840|NCT01860976|81166575|FG001|Blinded Treatment|Adverse Event|3|||
27591279|NCT02347761|80344910|FG001|All Collected|Death|0|||
27817841|NCT01860976|81166574|FG000|Blinded Treatment|Lack of Efficacy|5|||
27817842|NCT01860976|81166575|FG001|Blinded Treatment|Lack of Efficacy|12|||
27591280|NCT02347761|80344911|FG002|All Collected|Death|0|||
27692199|NCT01948908|80709630|FG002|Overall Study|Protocol Violation|2|||
27692200|NCT01668667|80709633|FG000|Overall Study|Adverse Event|3|||
27692201|NCT01668667|80709634|FG001|Overall Study|Adverse Event|6|||
27692202|NCT01668667|80709635|FG002|Overall Study|Adverse Event|4|||
27692203|NCT01668667|80709636|FG003|Overall Study|Adverse Event|4|||
27692204|NCT01668667|80709633|FG000|Overall Study|Lack of Efficacy|3|||
27692205|NCT01668667|80709634|FG001|Overall Study|Lack of Efficacy|2|||
27692206|NCT01668667|80709635|FG002|Overall Study|Lack of Efficacy|2|||
27692207|NCT01668667|80709636|FG003|Overall Study|Lack of Efficacy|3|||
27692208|NCT01668667|80709633|FG000|Overall Study|Protocol Violation|6|||
27692209|NCT01668667|80709634|FG001|Overall Study|Protocol Violation|10|||
27692210|NCT01668667|80709635|FG002|Overall Study|Protocol Violation|12|||
27692211|NCT01668667|80709636|FG003|Overall Study|Protocol Violation|5|||
27692212|NCT01668667|80709633|FG000|Overall Study|Lost to Follow-up|9|||
27692213|NCT01668667|80709634|FG001|Overall Study|Lost to Follow-up|4|||
27692214|NCT01668667|80709635|FG002|Overall Study|Lost to Follow-up|7|||
27692215|NCT01668667|80709636|FG003|Overall Study|Lost to Follow-up|6|||
27692216|NCT01668667|80709633|FG000|Overall Study|Physician Decision|3|||
27692217|NCT01668667|80709634|FG001|Overall Study|Physician Decision|0|||
27692218|NCT01668667|80709635|FG002|Overall Study|Physician Decision|1|||
27692219|NCT01668667|80709636|FG003|Overall Study|Physician Decision|0|||
27692220|NCT01668667|80709633|FG000|Overall Study|Withdrawal by Subject|7|||
27692221|NCT01668667|80709634|FG001|Overall Study|Withdrawal by Subject|4|||
27692222|NCT01668667|80709635|FG002|Overall Study|Withdrawal by Subject|5|||
27692223|NCT01668667|80709636|FG003|Overall Study|Withdrawal by Subject|5|||
27692224|NCT01154010|80709639|FG000|Overall Study|Lost to Follow-up|0|||
27692225|NCT01154010|80709640|FG001|Overall Study|Lost to Follow-up|1|||
27692226|NCT03725085|80709641|FG000|Overall Study|Lost to Follow-up|2|||
27692227|NCT00682890|80709642|FG000|Overall Study|Lost to Follow-up|1|||
27692228|NCT00682890|80709643|FG001|Overall Study|Lost to Follow-up|1|||
27692229|NCT00682890|80709642|FG000|Overall Study|subject moved away|0|||
27692230|NCT00682890|80709643|FG001|Overall Study|subject moved away|1|||
27692231|NCT00682890|80709642|FG000|Overall Study|heavy menstrual bleeding|1|||
27692232|NCT00682890|80709643|FG001|Overall Study|heavy menstrual bleeding|0|||
27692233|NCT01007448|80709649|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
27692234|NCT01007448|80709650|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
27692235|NCT01007448|80709649|FG000|Overall Study|Staph Skin Infection Flare|1|||
27692236|NCT01007448|80709650|FG001|Overall Study|Staph Skin Infection Flare|0|||
27692237|NCT01007448|80709649|FG000|Overall Study|Participant Leaving the Country|1|||
27692238|NCT01007448|80709650|FG001|Overall Study|Participant Leaving the Country|0|||
27692239|NCT01007448|80709649|FG000|Overall Study|Participant Given Prohibited Medication|1|||
27692240|NCT01007448|80709650|FG001|Overall Study|Participant Given Prohibited Medication|0|||
27692241|NCT01007448|80709649|FG000|Overall Study|Progressive Disease|1|||
27692242|NCT01007448|80709650|FG001|Overall Study|Progressive Disease|2|||
27692243|NCT01007448|80709649|FG000|Overall Study|Lack of Efficacy|2|||
27692244|NCT01007448|80709650|FG001|Overall Study|Lack of Efficacy|0|||
27692245|NCT01007448|80709649|FG000|Overall Study|Withdrawal by Subject|2|||
27692246|NCT01007448|80709650|FG001|Overall Study|Withdrawal by Subject|3|||
27692247|NCT01007448|80709649|FG000|Overall Study|Adverse Event|1|||
27692248|NCT01007448|80709650|FG001|Overall Study|Adverse Event|4|||
27692249|NCT00818649|80709653|FG000|Overall Study|Declining performance status|2|||
27692250|NCT00818649|80709653|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
27692251|NCT00818649|80709653|FG000|Overall Study|Adverse Event|1|||
27692252|NCT02729831|80709654|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
27692253|NCT02729831|80709655|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
27692254|NCT02729831|80709656|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
27692255|NCT02729831|80709657|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
27692256|NCT02729831|80709654|FG000|1 Week Post-visit|Lost to Follow-up|43|||
27692257|NCT02729831|80709655|FG001|1 Week Post-visit|Lost to Follow-up|40|||
27692258|NCT02729831|80709656|FG002|1 Week Post-visit|Lost to Follow-up|38|||
27692259|NCT02729831|80709657|FG003|1 Week Post-visit|Lost to Follow-up|36|||
27692260|NCT02729831|80709654|FG000|6 Month Follow-up|Lost to Follow-up|54|||
27692261|NCT02729831|80709655|FG001|6 Month Follow-up|Lost to Follow-up|51|||
27692262|NCT02729831|80709656|FG002|6 Month Follow-up|Lost to Follow-up|48|||
27692263|NCT02729831|80709657|FG003|6 Month Follow-up|Lost to Follow-up|42|||
27692264|NCT02729831|80709654|FG000|6 Month Follow-up|Death|1|||
27692265|NCT02729831|80709655|FG001|6 Month Follow-up|Death|3|||
27692266|NCT02729831|80709656|FG002|6 Month Follow-up|Death|0|||
27692267|NCT02729831|80709657|FG003|6 Month Follow-up|Death|1|||
27692268|NCT02679573|80709670|FG000|Overall Study|Adverse Event|13|||
27692269|NCT02679573|80709671|FG001|Overall Study|Adverse Event|6|||
27692270|NCT02679573|80709670|FG000|Overall Study|Lack of Efficacy|12|||
27692271|NCT02679573|80709671|FG001|Overall Study|Lack of Efficacy|15|||
27692272|NCT02679573|80709670|FG000|Overall Study|Could not complete required study visits|6|||
27692273|NCT02679573|80709671|FG001|Overall Study|Could not complete required study visits|2|||
27879338|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
27692274|NCT02679573|80709670|FG000|Overall Study|Withdrawal by Subject|2|||
27692275|NCT02679573|80709671|FG001|Overall Study|Withdrawal by Subject|9|||
27692276|NCT02679573|80709670|FG000|Overall Study|Death|2|||
27692277|NCT02679573|80709671|FG001|Overall Study|Death|0|||
27692278|NCT02679573|80709670|FG000|Overall Study|Physician Decision|2|||
27692279|NCT02679573|80709671|FG001|Overall Study|Physician Decision|4|||
27692280|NCT02679573|80709670|FG000|Overall Study|Lost to Follow-up|0|||
27692281|NCT02679573|80709671|FG001|Overall Study|Lost to Follow-up|3|||
27692282|NCT00690443|80709672|FG000|Overall Study|Adverse Event|1|||
27692283|NCT00690443|80709673|FG001|Overall Study|Adverse Event|2|||
27692284|NCT00784693|80709674|FG000|Overall Study|Lost to Follow-up|0|||
27692285|NCT00784693|80709675|FG001|Overall Study|Lost to Follow-up|1|||
27692286|NCT00784693|80709674|FG000|Overall Study|Lack of Efficacy|1|||
27692287|NCT00784693|80709675|FG001|Overall Study|Lack of Efficacy|1|||
27692288|NCT00784693|80709674|FG000|Overall Study|Withdrawal by Subject|0|||
27692289|NCT00784693|80709675|FG001|Overall Study|Withdrawal by Subject|4|||
27692290|NCT00784693|80709674|FG000|Overall Study|Randomized but not Treated|1|||
27692291|NCT00784693|80709675|FG001|Overall Study|Randomized but not Treated|0|||
27692292|NCT00784693|80709674|FG000|Overall Study|Other|1|||
27692293|NCT00784693|80709675|FG001|Overall Study|Other|0|||
27692294|NCT00687973|80709676|FG000|Overall Study|Adverse Event|18|||
27692295|NCT00687973|80709677|FG001|Overall Study|Adverse Event|28|||
27692296|NCT00687973|80709676|FG000|Overall Study|Lack of Efficacy|2|||
27692297|NCT00687973|80709677|FG001|Overall Study|Lack of Efficacy|3|||
27692298|NCT00687973|80709676|FG000|Overall Study|Protocol Violation|1|||
27692299|NCT00687973|80709677|FG001|Overall Study|Protocol Violation|2|||
27692300|NCT00687973|80709676|FG000|Overall Study|Administrative Reasons|0|||
27692301|NCT00687973|80709677|FG001|Overall Study|Administrative Reasons|2|||
27692302|NCT00687973|80709676|FG000|Overall Study|Withdrawal by Subject|3|||
27692303|NCT00687973|80709677|FG001|Overall Study|Withdrawal by Subject|3|||
27692304|NCT01853137|80709678|FG000|Overall Study|Lost to Follow-up|4|||
27692305|NCT01853137|80709679|FG001|Overall Study|Lost to Follow-up|1|||
27692306|NCT02924428|80709680|FG000|Overall Study|Adverse Event|1|||
27692307|NCT02924428|80709681|FG001|Overall Study|Adverse Event|0|||
27692308|NCT02924428|80709680|FG000|Overall Study|Physician Decision|1|||
27692309|NCT02924428|80709681|FG001|Overall Study|Physician Decision|0|||
27692310|NCT02924428|80709680|FG000|Overall Study|Lost to Follow-up|2|||
27692311|NCT02924428|80709681|FG001|Overall Study|Lost to Follow-up|4|||
27692312|NCT02924428|80709680|FG000|Overall Study|Pregnancy|0|||
27692313|NCT02924428|80709681|FG001|Overall Study|Pregnancy|1|||
27692314|NCT03305731|80709682|FG000|Overall Study|Protocol Violation|1|||
27692315|NCT00848926|80709688|FG000|Treatment Period|Progressive disease|45|||
27692316|NCT00848926|80709688|FG000|Treatment Period|Adverse Event|20|||
27692317|NCT00848926|80709688|FG000|Treatment Period|Physician Decision|12|||
27692318|NCT00848926|80709688|FG000|Treatment Period|Withdrawal by Subject|7|||
27692319|NCT00848926|80709688|FG000|Follow-up Period|Lost to Follow-up|7|||
27692320|NCT00848926|80709688|FG000|Follow-up Period|Withdrawal by Subject|3|||
27692321|NCT00848926|80709688|FG000|Follow-up Period|Other|2|||
27692322|NCT00421707|80709691|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
27692323|NCT00421707|80709692|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
27692324|NCT00421707|80709691|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
27692325|NCT00421707|80709692|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
27692326|NCT00421707|80709691|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
27692327|NCT00421707|80709692|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
27692328|NCT00421707|80709691|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
27692329|NCT00421707|80709692|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
27692330|NCT00421707|80709691|FG000|Period 2: Washout|Adverse Event|1|||
27692331|NCT00421707|80709692|FG001|Period 2: Washout|Adverse Event|1|||
27692332|NCT00421707|80709691|FG000|Period 2: Washout|Withdrawal by Subject|0|||
27692333|NCT00421707|80709692|FG001|Period 2: Washout|Withdrawal by Subject|1|||
27692334|NCT00421707|80709691|FG000|Period 2: Washout|Lost to Follow-up|0|||
27692335|NCT00421707|80709692|FG001|Period 2: Washout|Lost to Follow-up|1|||
27692336|NCT00421707|80709691|FG000|Period 2: Washout|Other: Pregnancy|0|||
27692337|NCT00421707|80709692|FG001|Period 2: Washout|Other: Pregnancy|1|||
27692338|NCT00421707|80709691|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
27692339|NCT00421707|80709692|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
27692340|NCT00421707|80709691|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
27692341|NCT00421707|80709692|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
27692342|NCT00421707|80709691|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
27692343|NCT00421707|80709692|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
27692344|NCT01296347|80709693|FG000|Allocation|Withdrawal by Subject|1|||
27692345|NCT01296347|80709694|FG001|Allocation|Withdrawal by Subject|2|||
27692346|NCT01296347|80709693|FG000|Allocation|Lack of Efficacy|1|||
27692347|NCT01296347|80709694|FG001|Allocation|Lack of Efficacy|2|||
27692348|NCT01296347|80709693|FG000|Allocation|not received infusion|1|||
27692349|NCT01296347|80709694|FG001|Allocation|not received infusion|0|||
27692350|NCT01296347|80709693|FG000|6 Week Follow up|Death|0|||
27692351|NCT01296347|80709694|FG001|6 Week Follow up|Death|1|||
27692352|NCT01296347|80709693|FG000|3 Month Follow up|Death|1|||
27692353|NCT01296347|80709694|FG001|3 Month Follow up|Death|0|||
27692354|NCT01296347|80709693|FG000|3 Month Follow up|Lost to Follow-up|0|||
27692355|NCT01296347|80709694|FG001|3 Month Follow up|Lost to Follow-up|1|||
27692356|NCT01296347|80709693|FG000|6 Month Follow up|Death|2|||
27692357|NCT01296347|80709694|FG001|6 Month Follow up|Death|1|||
27692358|NCT01296347|80709693|FG000|6 Month Follow up|Lost to Follow-up|0|||
27692359|NCT01296347|80709694|FG001|6 Month Follow up|Lost to Follow-up|1|||
27692360|NCT01296347|80709693|FG000|12 Month Follow up|Lost to Follow-up|3|||
27692361|NCT01296347|80709694|FG001|12 Month Follow up|Lost to Follow-up|1|||
27692362|NCT01296347|80709693|FG000|12 Month Follow up|Death|1|||
27692363|NCT01296347|80709694|FG001|12 Month Follow up|Death|1|||
27692364|NCT01296347|80709693|FG000|12 Month Follow up|Withdrawal by Subject|0|||
27692365|NCT01296347|80709694|FG001|12 Month Follow up|Withdrawal by Subject|1|||
27692366|NCT00372229|80709695|FG000|Study Phase|Graft loss|0|||
27692367|NCT00372229|80709696|FG001|Study Phase|Graft loss|3|||
27692368|NCT00372229|80709695|FG000|Study Phase|Protocol Violation|3|||
27692369|NCT00372229|80709696|FG001|Study Phase|Protocol Violation|4|||
27692370|NCT00372229|80709695|FG000|Study Phase|Consent withdrawn|16|||
27692371|NCT00372229|80709696|FG001|Study Phase|Consent withdrawn|14|||
27692372|NCT00372229|80709695|FG000|Study Phase|Refused treatment/did not cooperate|3|||
27692373|NCT00372229|80709696|FG001|Study Phase|Refused treatment/did not cooperate|1|||
27692374|NCT00372229|80709695|FG000|Study Phase|Death|3|||
27692375|NCT00372229|80709696|FG001|Study Phase|Death|2|||
27692376|NCT00372229|80709695|FG000|Study Phase|Reason not specified|3|||
27692377|NCT00372229|80709696|FG001|Study Phase|Reason not specified|2|||
27692378|NCT00372229|80709695|FG000|Study Phase|Lost to Follow-up|3|||
27692379|NCT00372229|80709696|FG001|Study Phase|Lost to Follow-up|3|||
27692380|NCT00372229|80709695|FG000|Follow-Up Phase|Graft loss|8|||
27692381|NCT00372229|80709696|FG001|Follow-Up Phase|Graft loss|7|||
27692382|NCT00372229|80709695|FG000|Follow-Up Phase|Consent withdrawn|13|||
27692383|NCT00372229|80709696|FG001|Follow-Up Phase|Consent withdrawn|19|||
27692384|NCT00372229|80709695|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
27692385|NCT00372229|80709696|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
27692386|NCT00372229|80709695|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
27692387|NCT00372229|80709696|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
27692388|NCT00372229|80709695|FG000|Follow-Up Phase|Death|9|||
27692389|NCT00372229|80709696|FG001|Follow-Up Phase|Death|12|||
27692390|NCT00372229|80709695|FG000|Follow-Up Phase|Administrative|1|||
27692391|NCT00372229|80709696|FG001|Follow-Up Phase|Administrative|0|||
27692392|NCT00372229|80709695|FG000|Follow-Up Phase|Reason not specified|2|||
27692393|NCT00372229|80709696|FG001|Follow-Up Phase|Reason not specified|3|||
27692394|NCT00372229|80709695|FG000|Follow-Up Phase|Lost to Follow-up|12|||
27692395|NCT00372229|80709696|FG001|Follow-Up Phase|Lost to Follow-up|10|||
27692396|NCT00723021|80709697|FG000|Intervention Period 4|Adverse Event|0|||
27692397|NCT00723021|80709698|FG001|Intervention Period 4|Adverse Event|0|||
27692398|NCT00723021|80709699|FG002|Intervention Period 4|Adverse Event|0|||
27692399|NCT00723021|80709700|FG003|Intervention Period 4|Adverse Event|0|||
27879339|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
27879340|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
27879341|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
27879342|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
27879343|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
27879344|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
27879345|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
27879346|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
27879347|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
27879348|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
27879349|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
27879350|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
27879351|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
27879352|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
27879353|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
27879354|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
27879355|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
27879356|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
27879357|NCT02513160|81391483|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
27879358|NCT02513160|81391484|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
27879359|NCT02513160|81391485|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
27879360|NCT02513160|81391486|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
27879361|NCT02513160|81391483|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
27879362|NCT02513160|81391484|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
27879363|NCT02513160|81391485|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
27879364|NCT02513160|81391486|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
27879365|NCT02513160|81391483|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
27692400|NCT00723021|80709701|FG004|Intervention Period 4|Adverse Event|1|||
27692401|NCT03235284|80709703|FG000|Overall Study|Adverse Event|1|||
27692402|NCT03235284|80709704|FG001|Overall Study|Adverse Event|2|||
27692403|NCT03235284|80709705|FG002|Overall Study|Adverse Event|1|||
27692404|NCT04058366|80709709|FG000|Overall Study|Adverse Event|14|||
27692405|NCT04058366|80709709|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
27692406|NCT04058366|80709709|FG000|Overall Study|Commercial drug is available for participants|6|||
27692407|NCT04058366|80709709|FG000|Overall Study|Death|1|||
27692408|NCT04058366|80709709|FG000|Overall Study|Other non-compliance|2|||
27692409|NCT04058366|80709709|FG000|Overall Study|Other|6|||
27692410|NCT01745848|80709710|FG000|Overall Study|Adverse Event|6|||
27692411|NCT01211288|80709718|FG000|Overall Study|Lost to Follow-up|1|||
27692412|NCT01211288|80709719|FG001|Overall Study|Lost to Follow-up|1|||
27692413|NCT01945060|80709721|FG000|Overall Study|Lost to follow up|1|||
27692414|NCT01945060|80709722|FG001|Overall Study|Lost to follow up|0|||
27692415|NCT01945060|80709721|FG000|Overall Study|Distress related to IV access|0|||
27692416|NCT01945060|80709722|FG001|Overall Study|Distress related to IV access|1|||
27692417|NCT03291587|80709723|FG000|Overall Study|Lost to Follow-up|62|||
27692418|NCT03291587|80709724|FG001|Overall Study|Lost to Follow-up|43|||
27692419|NCT03291587|80709723|FG000|Overall Study|Refused to Answer|5|||
27692420|NCT03291587|80709724|FG001|Overall Study|Refused to Answer|2|||
27692421|NCT03291587|80709723|FG000|Overall Study|Death|2|||
27692422|NCT03291587|80709724|FG001|Overall Study|Death|4|||
27692423|NCT03291587|80709723|FG000|Overall Study|Not interested in participating|8|||
27692424|NCT03291587|80709724|FG001|Overall Study|Not interested in participating|6|||
27692425|NCT03291587|80709723|FG000|Overall Study|Too busy to participate|4|||
27692426|NCT03291587|80709724|FG001|Overall Study|Too busy to participate|2|||
27692427|NCT00585195|80709725|FG000|Overall Study|Adverse Event|0|||
27692428|NCT00585195|80709726|FG001|Overall Study|Adverse Event|0|||
27692429|NCT00585195|80709727|FG002|Overall Study|Adverse Event|0|||
27692430|NCT00585195|80709728|FG003|Overall Study|Adverse Event|0|||
27692431|NCT00585195|80709729|FG004|Overall Study|Adverse Event|2|||
27692432|NCT00585195|80709730|FG005|Overall Study|Adverse Event|1|||
27692433|NCT00585195|80709731|FG006|Overall Study|Adverse Event|0|||
27692434|NCT00585195|80709732|FG007|Overall Study|Adverse Event|1|||
27692435|NCT00585195|80709733|FG008|Overall Study|Adverse Event|0|||
27692436|NCT00585195|80709734|FG009|Overall Study|Adverse Event|0|||
27692437|NCT00585195|80709735|FG010|Overall Study|Adverse Event|3|||
27692438|NCT00585195|80709736|FG011|Overall Study|Adverse Event|0|||
27692439|NCT00585195|80709737|FG012|Overall Study|Adverse Event|8|||
27692440|NCT00585195|80709738|FG013|Overall Study|Adverse Event|6|||
27692441|NCT00585195|80709739|FG014|Overall Study|Adverse Event|4|||
27692442|NCT00585195|80709740|FG015|Overall Study|Adverse Event|1|||
27692443|NCT00585195|80709741|FG016|Overall Study|Adverse Event|14|||
27692444|NCT00585195|80709742|FG017|Overall Study|Adverse Event|9|||
27692445|NCT00585195|80709743|FG018|Overall Study|Adverse Event|2|||
27692446|NCT00585195|80709744|FG019|Overall Study|Adverse Event|3|||
27692447|NCT00585195|80709745|FG020|Overall Study|Adverse Event|1|||
27692448|NCT00585195|80709725|FG000|Overall Study|Progressive Disease|2|||
27692449|NCT00585195|80709726|FG001|Overall Study|Progressive Disease|2|||
27692450|NCT00585195|80709727|FG002|Overall Study|Progressive Disease|5|||
27692451|NCT00585195|80709728|FG003|Overall Study|Progressive Disease|4|||
27692452|NCT00585195|80709729|FG004|Overall Study|Progressive Disease|6|||
27692453|NCT00585195|80709730|FG005|Overall Study|Progressive Disease|4|||
27692454|NCT00585195|80709731|FG006|Overall Study|Progressive Disease|6|||
27692455|NCT00585195|80709732|FG007|Overall Study|Progressive Disease|3|||
27692456|NCT00585195|80709733|FG008|Overall Study|Progressive Disease|0|||
27692457|NCT00585195|80709734|FG009|Overall Study|Progressive Disease|5|||
27692458|NCT00585195|80709735|FG010|Overall Study|Progressive Disease|2|||
27692459|NCT00585195|80709736|FG011|Overall Study|Progressive Disease|25|||
27692460|NCT00585195|80709737|FG012|Overall Study|Progressive Disease|29|||
27692461|NCT00585195|80709738|FG013|Overall Study|Progressive Disease|26|||
27692462|NCT00585195|80709739|FG014|Overall Study|Progressive Disease|21|||
27692463|NCT00585195|80709740|FG015|Overall Study|Progressive Disease|12|||
27692464|NCT00585195|80709741|FG016|Overall Study|Progressive Disease|94|||
27692465|NCT00585195|80709742|FG017|Overall Study|Progressive Disease|42|||
27692466|NCT00585195|80709743|FG018|Overall Study|Progressive Disease|4|||
27692467|NCT00585195|80709744|FG019|Overall Study|Progressive Disease|9|||
27692468|NCT00585195|80709745|FG020|Overall Study|Progressive Disease|8|||
27692469|NCT00585195|80709725|FG000|Overall Study|Withdrawal by Subject|1|||
27692470|NCT00585195|80709726|FG001|Overall Study|Withdrawal by Subject|1|||
27692471|NCT00585195|80709727|FG002|Overall Study|Withdrawal by Subject|2|||
27692472|NCT00585195|80709728|FG003|Overall Study|Withdrawal by Subject|2|||
27692473|NCT00585195|80709729|FG004|Overall Study|Withdrawal by Subject|0|||
27692474|NCT00585195|80709730|FG005|Overall Study|Withdrawal by Subject|0|||
27692475|NCT00585195|80709731|FG006|Overall Study|Withdrawal by Subject|0|||
27692476|NCT00585195|80709732|FG007|Overall Study|Withdrawal by Subject|1|||
27692477|NCT00585195|80709733|FG008|Overall Study|Withdrawal by Subject|0|||
27692478|NCT00585195|80709734|FG009|Overall Study|Withdrawal by Subject|0|||
27692479|NCT00585195|80709735|FG010|Overall Study|Withdrawal by Subject|3|||
27692480|NCT00585195|80709736|FG011|Overall Study|Withdrawal by Subject|8|||
27692481|NCT00585195|80709737|FG012|Overall Study|Withdrawal by Subject|15|||
27692482|NCT00585195|80709738|FG013|Overall Study|Withdrawal by Subject|0|||
27692483|NCT00585195|80709739|FG014|Overall Study|Withdrawal by Subject|3|||
27692484|NCT00585195|80709740|FG015|Overall Study|Withdrawal by Subject|0|||
27692485|NCT00585195|80709741|FG016|Overall Study|Withdrawal by Subject|7|||
27692486|NCT00585195|80709742|FG017|Overall Study|Withdrawal by Subject|1|||
27692487|NCT00585195|80709743|FG018|Overall Study|Withdrawal by Subject|2|||
27692488|NCT00585195|80709744|FG019|Overall Study|Withdrawal by Subject|2|||
27692489|NCT00585195|80709745|FG020|Overall Study|Withdrawal by Subject|0|||
27692490|NCT00585195|80709725|FG000|Overall Study|Other|0|||
27692491|NCT00585195|80709726|FG001|Overall Study|Other|1|||
27692492|NCT00585195|80709727|FG002|Overall Study|Other|1|||
27692493|NCT00585195|80709728|FG003|Overall Study|Other|1|||
27692494|NCT00585195|80709729|FG004|Overall Study|Other|0|||
27692495|NCT00585195|80709730|FG005|Overall Study|Other|1|||
27692496|NCT00585195|80709731|FG006|Overall Study|Other|0|||
27692497|NCT00585195|80709732|FG007|Overall Study|Other|0|||
27692498|NCT00585195|80709733|FG008|Overall Study|Other|2|||
27692499|NCT00585195|80709734|FG009|Overall Study|Other|1|||
27692500|NCT00585195|80709735|FG010|Overall Study|Other|0|||
27692501|NCT00585195|80709736|FG011|Overall Study|Other|19|||
27692502|NCT00585195|80709737|FG012|Overall Study|Other|24|||
27692503|NCT00585195|80709738|FG013|Overall Study|Other|7|||
27692504|NCT00585195|80709739|FG014|Overall Study|Other|11|||
27692505|NCT00585195|80709740|FG015|Overall Study|Other|3|||
27692506|NCT00585195|80709741|FG016|Overall Study|Other|28|||
27692507|NCT00585195|80709742|FG017|Overall Study|Other|12|||
27692508|NCT00585195|80709743|FG018|Overall Study|Other|10|||
27692509|NCT00585195|80709744|FG019|Overall Study|Other|4|||
27692510|NCT00585195|80709745|FG020|Overall Study|Other|2|||
27692511|NCT00585195|80709725|FG000|Overall Study|Randomized not treated|0|||
27692512|NCT00585195|80709726|FG001|Overall Study|Randomized not treated|0|||
27692513|NCT00585195|80709727|FG002|Overall Study|Randomized not treated|1|||
27692514|NCT00585195|80709728|FG003|Overall Study|Randomized not treated|0|||
27692515|NCT00585195|80709729|FG004|Overall Study|Randomized not treated|1|||
27692516|NCT00585195|80709730|FG005|Overall Study|Randomized not treated|0|||
27692517|NCT00585195|80709731|FG006|Overall Study|Randomized not treated|1|||
27692518|NCT00585195|80709732|FG007|Overall Study|Randomized not treated|0|||
27692519|NCT00585195|80709733|FG008|Overall Study|Randomized not treated|0|||
27692520|NCT00585195|80709734|FG009|Overall Study|Randomized not treated|0|||
27692521|NCT00585195|80709735|FG010|Overall Study|Randomized not treated|2|||
27692522|NCT00585195|80709736|FG011|Overall Study|Randomized not treated|0|||
27692523|NCT00585195|80709737|FG012|Overall Study|Randomized not treated|0|||
27692524|NCT00585195|80709738|FG013|Overall Study|Randomized not treated|0|||
27692525|NCT00585195|80709739|FG014|Overall Study|Randomized not treated|0|||
27692526|NCT00585195|80709740|FG015|Overall Study|Randomized not treated|1|||
27692527|NCT00585195|80709741|FG016|Overall Study|Randomized not treated|0|||
27692528|NCT00585195|80709742|FG017|Overall Study|Randomized not treated|1|||
27692529|NCT00585195|80709743|FG018|Overall Study|Randomized not treated|3|||
27692530|NCT00585195|80709744|FG019|Overall Study|Randomized not treated|0|||
27692531|NCT00585195|80709745|FG020|Overall Study|Randomized not treated|2|||
27692532|NCT00585195|80709725|FG000|Overall Study|Death|0|||
27692533|NCT00585195|80709726|FG001|Overall Study|Death|0|||
27692534|NCT00585195|80709727|FG002|Overall Study|Death|0|||
27692535|NCT00585195|80709728|FG003|Overall Study|Death|0|||
27692536|NCT00585195|80709729|FG004|Overall Study|Death|0|||
27692537|NCT00585195|80709730|FG005|Overall Study|Death|0|||
27692538|NCT00585195|80709731|FG006|Overall Study|Death|0|||
27692539|NCT00585195|80709732|FG007|Overall Study|Death|0|||
27692540|NCT00585195|80709733|FG008|Overall Study|Death|1|||
27692541|NCT00585195|80709734|FG009|Overall Study|Death|0|||
27692542|NCT00585195|80709735|FG010|Overall Study|Death|1|||
27692543|NCT00585195|80709736|FG011|Overall Study|Death|1|||
27692544|NCT00585195|80709737|FG012|Overall Study|Death|7|||
27692545|NCT00585195|80709738|FG013|Overall Study|Death|2|||
27692546|NCT00585195|80709739|FG014|Overall Study|Death|8|||
27692547|NCT00585195|80709740|FG015|Overall Study|Death|2|||
27692548|NCT00585195|80709741|FG016|Overall Study|Death|11|||
27692549|NCT00585195|80709742|FG017|Overall Study|Death|0|||
27692550|NCT00585195|80709743|FG018|Overall Study|Death|0|||
27692551|NCT00585195|80709744|FG019|Overall Study|Death|0|||
27692552|NCT00585195|80709745|FG020|Overall Study|Death|1|||
27692553|NCT00585195|80709725|FG000|Overall Study|Lost to Follow-up|0|||
27692554|NCT00585195|80709726|FG001|Overall Study|Lost to Follow-up|0|||
27692555|NCT00585195|80709727|FG002|Overall Study|Lost to Follow-up|0|||
27692556|NCT00585195|80709728|FG003|Overall Study|Lost to Follow-up|0|||
27692557|NCT00585195|80709729|FG004|Overall Study|Lost to Follow-up|0|||
27692558|NCT00585195|80709730|FG005|Overall Study|Lost to Follow-up|0|||
27692559|NCT00585195|80709731|FG006|Overall Study|Lost to Follow-up|0|||
27692560|NCT00585195|80709732|FG007|Overall Study|Lost to Follow-up|0|||
27692561|NCT00585195|80709733|FG008|Overall Study|Lost to Follow-up|0|||
27692562|NCT00585195|80709734|FG009|Overall Study|Lost to Follow-up|0|||
27692563|NCT00585195|80709735|FG010|Overall Study|Lost to Follow-up|0|||
27692564|NCT00585195|80709736|FG011|Overall Study|Lost to Follow-up|0|||
27692565|NCT00585195|80709737|FG012|Overall Study|Lost to Follow-up|1|||
27692566|NCT00585195|80709738|FG013|Overall Study|Lost to Follow-up|0|||
27692567|NCT00585195|80709739|FG014|Overall Study|Lost to Follow-up|0|||
27692568|NCT00585195|80709740|FG015|Overall Study|Lost to Follow-up|0|||
27692569|NCT00585195|80709741|FG016|Overall Study|Lost to Follow-up|0|||
27692570|NCT00585195|80709742|FG017|Overall Study|Lost to Follow-up|2|||
27692571|NCT00585195|80709743|FG018|Overall Study|Lost to Follow-up|0|||
27692572|NCT00585195|80709744|FG019|Overall Study|Lost to Follow-up|0|||
27692573|NCT00585195|80709745|FG020|Overall Study|Lost to Follow-up|0|||
27692574|NCT00585195|80709725|FG000|Overall Study|Site Terminated by Sponsor|0|||
27692575|NCT00585195|80709726|FG001|Overall Study|Site Terminated by Sponsor|0|||
27692576|NCT00585195|80709727|FG002|Overall Study|Site Terminated by Sponsor|0|||
27692577|NCT00585195|80709728|FG003|Overall Study|Site Terminated by Sponsor|0|||
27692578|NCT00585195|80709729|FG004|Overall Study|Site Terminated by Sponsor|0|||
27692579|NCT00585195|80709730|FG005|Overall Study|Site Terminated by Sponsor|0|||
27692580|NCT00585195|80709731|FG006|Overall Study|Site Terminated by Sponsor|0|||
27692581|NCT00585195|80709732|FG007|Overall Study|Site Terminated by Sponsor|0|||
27692582|NCT00585195|80709733|FG008|Overall Study|Site Terminated by Sponsor|0|||
27879366|NCT02513160|81391484|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
27879367|NCT02513160|81391485|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
27879368|NCT02513160|81391486|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
27879369|NCT02513160|81391483|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
27591281|NCT02347761|80344909|FG000|All Collected|Lost to Follow-up|3|||
27692583|NCT00585195|80709734|FG009|Overall Study|Site Terminated by Sponsor|0|||
27692584|NCT00585195|80709735|FG010|Overall Study|Site Terminated by Sponsor|0|||
27692585|NCT00585195|80709736|FG011|Overall Study|Site Terminated by Sponsor|0|||
27692586|NCT00585195|80709737|FG012|Overall Study|Site Terminated by Sponsor|1|||
27692587|NCT00585195|80709738|FG013|Overall Study|Site Terminated by Sponsor|0|||
27692588|NCT00585195|80709739|FG014|Overall Study|Site Terminated by Sponsor|0|||
27817843|NCT01860976|81166574|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
27817844|NCT01860976|81166575|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
27817845|NCT01860976|81166574|FG000|Blinded Treatment|Withdrawal by Subject|3|||
27817846|NCT01860976|81166575|FG001|Blinded Treatment|Withdrawal by Subject|5|||
27817847|NCT01860976|81166574|FG000|Blinded Treatment|Subject no longer met criteria|1|||
27817848|NCT01860976|81166575|FG001|Blinded Treatment|Subject no longer met criteria|0|||
27817849|NCT01860976|81166574|FG000|Blinded Treatment|Entered Open-Label in error|0|||
27817850|NCT01860976|81166575|FG001|Blinded Treatment|Entered Open-Label in error|1|||
27817851|NCT01860976|81166574|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
27817852|NCT01860976|81166575|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
27817853|NCT01860976|81166574|FG000|Open-Label|Adverse Event|2|||
27817854|NCT01860976|81166575|FG001|Open-Label|Adverse Event|4|||
27817855|NCT01860976|81166574|FG000|Open-Label|Lack of Efficacy|16|||
27817856|NCT01860976|81166575|FG001|Open-Label|Lack of Efficacy|8|||
27817857|NCT01860976|81166574|FG000|Open-Label|Lost to Follow-up|1|||
27817858|NCT01860976|81166575|FG001|Open-Label|Lost to Follow-up|2|||
27817859|NCT01860976|81166574|FG000|Open-Label|Subject request discontinue treatment|4|||
27692589|NCT00585195|80709740|FG015|Overall Study|Site Terminated by Sponsor|0|||
27692590|NCT00585195|80709741|FG016|Overall Study|Site Terminated by Sponsor|0|||
27692591|NCT00585195|80709742|FG017|Overall Study|Site Terminated by Sponsor|0|||
27817860|NCT01860976|81166575|FG001|Open-Label|Subject request discontinue treatment|3|||
27692592|NCT00585195|80709743|FG018|Overall Study|Site Terminated by Sponsor|0|||
27692593|NCT00585195|80709744|FG019|Overall Study|Site Terminated by Sponsor|0|||
27879370|NCT02513160|81391484|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
27879371|NCT02513160|81391485|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
27879372|NCT02513160|81391486|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
27879373|NCT02513160|81391483|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
27879374|NCT02513160|81391484|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
27879375|NCT02513160|81391485|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
27879376|NCT02513160|81391486|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
27879377|NCT02513160|81391483|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
27879378|NCT02513160|81391484|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
27879379|NCT02513160|81391485|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
27879380|NCT02513160|81391486|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
27879381|NCT01051960|81391487|FG000|Overall Study|Adverse Event|1|||
27879382|NCT02195869|81391491|FG000|Overall Study|cGVHD Progression|5|||
27879383|NCT02195869|81391491|FG000|Overall Study|Malignancy Progression/relapse|2|||
27879384|NCT02195869|81391491|FG000|Overall Study|Adverse Event|15|||
27879385|NCT02195869|81391491|FG000|Overall Study|Withdrawal by Subject|7|||
27879386|NCT02195869|81391491|FG000|Overall Study|Physician Decision|4|||
27692594|NCT00585195|80709745|FG020|Overall Study|Site Terminated by Sponsor|0|||
27692595|NCT00585195|80709725|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
27879387|NCT02195869|81391491|FG000|Overall Study|Study Terminated by Sponsor|7|||
27879388|NCT02195869|81391491|FG000|Overall Study|Noncompliance with study drug|2|||
27692596|NCT00585195|80709726|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
27692597|NCT00585195|80709727|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
27817861|NCT01860976|81166574|FG000|Open-Label|Withdrawal by Subject|4|||
27879389|NCT02275819|81391493|FG000|Overall Study|Adverse Event|0|||
27879390|NCT02275819|81391494|FG001|Overall Study|Adverse Event|1|||
27879391|NCT00444535|81391495|FG000|Overall Study|Withdrawal by Subject|5|||
27879392|NCT00444535|81391495|FG000|Overall Study|Physician Decision|5|||
27879393|NCT00444535|81391495|FG000|Overall Study|progressive disease|1|||
27879394|NCT00444535|81391495|FG000|Overall Study|Adverse Event|2|||
27817862|NCT01860976|81166575|FG001|Open-Label|Withdrawal by Subject|1|||
27817863|NCT01860976|81166574|FG000|Open-Label|Other Reasons|1|||
27817864|NCT01860976|81166575|FG001|Open-Label|Other Reasons|1|||
27817865|NCT01860976|81166574|FG000|Long Term Extension|Adverse Event|4|||
27817866|NCT01860976|81166575|FG001|Long Term Extension|Adverse Event|0|||
27817867|NCT01860976|81166574|FG000|Long Term Extension|Lack of Efficacy|2|||
27817868|NCT01860976|81166575|FG001|Long Term Extension|Lack of Efficacy|0|||
27817869|NCT01860976|81166574|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
27817870|NCT01860976|81166575|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
27817871|NCT01860976|81166574|FG000|Long Term Extension|Lost to Follow-up|2|||
27817872|NCT01860976|81166575|FG001|Long Term Extension|Lost to Follow-up|0|||
27817873|NCT01860976|81166574|FG000|Long Term Extension|subject withdrew consent|7|||
27817874|NCT01860976|81166575|FG001|Long Term Extension|subject withdrew consent|0|||
27817875|NCT01856309|81166576|FG000|Overall Study|Death|4|||
27817876|NCT01856309|81166577|FG001|Overall Study|Death|6|||
27817877|NCT01856309|81166578|FG002|Overall Study|Death|11|||
27817878|NCT01856309|81166579|FG003|Overall Study|Death|6|||
27817879|NCT01856309|81166576|FG000|Overall Study|Lost to Follow-up|6|||
27817880|NCT01856309|81166577|FG001|Overall Study|Lost to Follow-up|2|||
27817881|NCT01856309|81166578|FG002|Overall Study|Lost to Follow-up|4|||
27817882|NCT01856309|81166579|FG003|Overall Study|Lost to Follow-up|8|||
27817883|NCT01856309|81166576|FG000|Overall Study|Withdrawal by Subject|11|||
27817884|NCT01856309|81166577|FG001|Overall Study|Withdrawal by Subject|13|||
27817885|NCT01856309|81166578|FG002|Overall Study|Withdrawal by Subject|28|||
27817886|NCT01856309|81166579|FG003|Overall Study|Withdrawal by Subject|26|||
27879395|NCT03511105|81391496|FG000|Overall Study|Adverse Event|1|||
27879396|NCT03511105|81391497|FG001|Overall Study|Adverse Event|0|||
27879397|NCT03511105|81391496|FG000|Overall Study|Withdrew consent|1|||
27817887|NCT01856309|81166576|FG000|Overall Study|Other|227|||
27879398|NCT03511105|81391497|FG001|Overall Study|Withdrew consent|0|||
27879399|NCT02172664|81391498|FG000|Overall Study|Lost to Follow-up|4|||
27879400|NCT02172664|81391499|FG001|Overall Study|Lost to Follow-up|4|||
27879401|NCT02172664|81391498|FG000|Overall Study|Death|1|||
27879402|NCT02172664|81391499|FG001|Overall Study|Death|1|||
27879403|NCT02172664|81391498|FG000|Overall Study|Moved out of area|1|||
27879404|NCT02172664|81391499|FG001|Overall Study|Moved out of area|1|||
27879405|NCT04305327|81391500|FG000|Overall Study|Study early termination|2|||
27879406|NCT04305327|81391501|FG001|Overall Study|Study early termination|5|||
27879407|NCT04305327|81391502|FG002|Overall Study|Study early termination|2|||
27879408|NCT04305327|81391503|FG003|Overall Study|Study early termination|2|||
27879409|NCT04305327|81391500|FG000|Overall Study|Withdrawal by Subject|0|||
27879410|NCT04305327|81391501|FG001|Overall Study|Withdrawal by Subject|1|||
27879411|NCT04305327|81391502|FG002|Overall Study|Withdrawal by Subject|0|||
27879412|NCT04305327|81391503|FG003|Overall Study|Withdrawal by Subject|0|||
27879413|NCT01790984|81391507|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
27879414|NCT01790984|81391508|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
27879415|NCT01790984|81391509|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
27879416|NCT01790984|81391510|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
27879417|NCT01662635|81391511|FG000|Overall Study|scarce samples for evaluation|30|||
27879418|NCT00461630|81391512|FG000|Overall Study|Death|798|||
27879419|NCT00461630|81391513|FG001|Overall Study|Death|732|||
27879420|NCT00461630|81391512|FG000|Overall Study|Lost to Follow-up|108|||
27879421|NCT00461630|81391513|FG001|Overall Study|Lost to Follow-up|95|||
27879422|NCT00683618|81391514|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
27879423|NCT00683618|81391515|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
27879424|NCT00683618|81391516|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
27879425|NCT00683618|81391514|FG000|Randomised Treatment Period|Protocol Violation|0|||
27879426|NCT00683618|81391515|FG001|Randomised Treatment Period|Protocol Violation|1|||
27879427|NCT00683618|81391516|FG002|Randomised Treatment Period|Protocol Violation|0|||
27879428|NCT00683618|81391514|FG000|Randomised Treatment Period|Adverse Event|2|||
27879429|NCT00683618|81391515|FG001|Randomised Treatment Period|Adverse Event|0|||
27879430|NCT00683618|81391516|FG002|Randomised Treatment Period|Adverse Event|2|||
27879431|NCT00683618|81391514|FG000|Randomised Treatment Period|Reason not provided|0|||
27879432|NCT00683618|81391515|FG001|Randomised Treatment Period|Reason not provided|0|||
27879433|NCT00683618|81391516|FG002|Randomised Treatment Period|Reason not provided|2|||
27879434|NCT00683618|81391514|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
27879435|NCT00683618|81391515|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27692598|NCT00585195|80709728|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
27692599|NCT00585195|80709729|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
27692600|NCT00585195|80709730|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
27692601|NCT00585195|80709731|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
27692602|NCT00585195|80709732|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
27879436|NCT00683618|81391516|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
27879437|NCT00683618|81391514|FG000|Extension Treatment Period|Adverse Event|1|||
27879438|NCT00683618|81391515|FG001|Extension Treatment Period|Adverse Event|0|||
27879439|NCT00683618|81391516|FG002|Extension Treatment Period|Adverse Event|0|||
27879440|NCT00683618|81391514|FG000|Extension Treatment Period|Protocol Violation|1|||
27692603|NCT00585195|80709733|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
27591282|NCT02347761|80344910|FG001|All Collected|Lost to Follow-up|2|||
27591283|NCT02347761|80344911|FG002|All Collected|Lost to Follow-up|3|||
27879441|NCT00683618|81391515|FG001|Extension Treatment Period|Protocol Violation|0|||
27879442|NCT00683618|81391516|FG002|Extension Treatment Period|Protocol Violation|0|||
27879443|NCT05506046|81391517|FG000|Overall Study|Lost to Follow-up|89|||
27879444|NCT05506046|81391518|FG001|Overall Study|Lost to Follow-up|101|||
27879445|NCT05506046|81391519|FG002|Overall Study|Lost to Follow-up|102|||
27879446|NCT05506046|81391520|FG003|Overall Study|Lost to Follow-up|99|||
27879447|NCT00462709|81391521|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
27879448|NCT00462709|81391521|FG000|Overall Study|Lost to Follow-up|10|||
27879449|NCT00462709|81391521|FG000|Overall Study|Withdrawal by Subject|8|||
27879450|NCT00462709|81391521|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
27879451|NCT00462709|81391521|FG000|Overall Study|Death|2|||
27879452|NCT00462709|81391521|FG000|Overall Study|Logistical reasons|2|||
27879453|NCT00462709|81391521|FG000|Overall Study|Physician Decision|1|||
27879454|NCT00462709|81391521|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
27879455|NCT01464424|81391522|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
27879456|NCT01464424|81391523|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
27879457|NCT04227197|81391526|FG000|Randomization|Protocol Violation|1|||
27879458|NCT04227197|81391527|FG001|Randomization|Protocol Violation|0|||
27879459|NCT04227197|81391526|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
27879460|NCT04227197|81391527|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
27879461|NCT04227197|81391526|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
27879462|NCT04227197|81391527|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
27879463|NCT04227197|81391526|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
27879464|NCT04227197|81391527|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
27879465|NCT04227197|81391526|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
27879466|NCT04227197|81391527|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
27879467|NCT04227197|81391526|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
27879468|NCT04227197|81391527|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
27879469|NCT04227197|81391526|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
27879470|NCT04227197|81391527|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
27879471|NCT00347958|81391528|FG000|Overall Study|Adverse Event|1|||
27879472|NCT00347958|81391528|FG000|Overall Study|Protocol Violation|2|||
27879473|NCT00347958|81391528|FG000|Overall Study|Withdrawal by Subject|1|||
27879474|NCT03340454|81391538|FG000|Overall Study|Lost to Follow-up|0|||
27879475|NCT03340454|81391539|FG001|Overall Study|Lost to Follow-up|4|||
27879476|NCT01467713|81391540|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
27879477|NCT01467713|81391541|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
27879478|NCT01467713|81391542|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
27879479|NCT01467713|81391543|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
27879480|NCT01467713|81391540|FG000|Overall Study|Major Protocol Deviation|2|||
27879481|NCT01467713|81391541|FG001|Overall Study|Major Protocol Deviation|4|||
27879482|NCT01467713|81391542|FG002|Overall Study|Major Protocol Deviation|4|||
27879483|NCT01467713|81391543|FG003|Overall Study|Major Protocol Deviation|1|||
27879484|NCT01467713|81391540|FG000|Overall Study|Lost to Follow-up|9|||
27879485|NCT01467713|81391541|FG001|Overall Study|Lost to Follow-up|12|||
27879486|NCT01467713|81391542|FG002|Overall Study|Lost to Follow-up|6|||
27879487|NCT01467713|81391543|FG003|Overall Study|Lost to Follow-up|9|||
27879488|NCT01467713|81391540|FG000|Overall Study|Voluntary Withdrawal|18|||
27879489|NCT01467713|81391541|FG001|Overall Study|Voluntary Withdrawal|14|||
27879490|NCT01467713|81391542|FG002|Overall Study|Voluntary Withdrawal|21|||
27879491|NCT01467713|81391543|FG003|Overall Study|Voluntary Withdrawal|20|||
27879492|NCT01467713|81391540|FG000|Overall Study|Study Termination|23|||
27879493|NCT01467713|81391541|FG001|Overall Study|Study Termination|33|||
27879494|NCT01467713|81391542|FG002|Overall Study|Study Termination|28|||
27879495|NCT01467713|81391543|FG003|Overall Study|Study Termination|29|||
27879496|NCT01467713|81391540|FG000|Overall Study|Pregnancy|0|||
27879497|NCT01467713|81391541|FG001|Overall Study|Pregnancy|1|||
27879498|NCT01467713|81391542|FG002|Overall Study|Pregnancy|1|||
27879499|NCT01467713|81391543|FG003|Overall Study|Pregnancy|3|||
27879500|NCT01467713|81391540|FG000|Overall Study|Relapse|35|||
27879501|NCT01467713|81391541|FG001|Overall Study|Relapse|25|||
27591284|NCT02347761|80344909|FG000|All Collected|Withdrawal by Subject|11|||
27879502|NCT01467713|81391542|FG002|Overall Study|Relapse|28|||
27879503|NCT01467713|81391543|FG003|Overall Study|Relapse|35|||
27879504|NCT01467713|81391540|FG000|Overall Study|Reason not Specified|6|||
27879505|NCT01467713|81391541|FG001|Overall Study|Reason not Specified|11|||
27879506|NCT01467713|81391542|FG002|Overall Study|Reason not Specified|8|||
27879507|NCT01467713|81391543|FG003|Overall Study|Reason not Specified|7|||
27879508|NCT01074268|81391544|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
27879509|NCT01074268|81391545|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
27879510|NCT01074268|81391544|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
27879511|NCT01074268|81391545|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
27879512|NCT01074268|81391544|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
27879513|NCT01074268|81391545|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
27879514|NCT01074268|81391544|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
27879515|NCT01074268|81391545|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
27879516|NCT01074268|81391544|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
27879517|NCT01074268|81391545|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
27879518|NCT01074268|81391544|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
27879519|NCT01074268|81391545|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
27879520|NCT01074268|81391544|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
27879521|NCT01074268|81391545|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
27879522|NCT01074268|81391544|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
27879523|NCT01074268|81391545|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
27879524|NCT01074268|81391544|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
27879525|NCT01074268|81391545|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
27817888|NCT01856309|81166577|FG001|Overall Study|Other|225|||
27817889|NCT01856309|81166578|FG002|Overall Study|Other|447|||
27817890|NCT01856309|81166579|FG003|Overall Study|Other|469|||
27817891|NCT01856309|81166576|FG000|Overall Study|Lack of Efficacy|14|||
27817892|NCT01856309|81166577|FG001|Overall Study|Lack of Efficacy|9|||
27817893|NCT01856309|81166578|FG002|Overall Study|Lack of Efficacy|40|||
27817894|NCT01856309|81166579|FG003|Overall Study|Lack of Efficacy|25|||
27817895|NCT01856309|81166576|FG000|Overall Study|Adverse Event|31|||
27817896|NCT01856309|81166577|FG001|Overall Study|Adverse Event|31|||
27817897|NCT01856309|81166578|FG002|Overall Study|Adverse Event|55|||
27817898|NCT01856309|81166579|FG003|Overall Study|Adverse Event|65|||
27817899|NCT01856309|81166576|FG000|Overall Study|Pregnancy|0|||
27817900|NCT01856309|81166577|FG001|Overall Study|Pregnancy|0|||
27817901|NCT01856309|81166578|FG002|Overall Study|Pregnancy|0|||
27817902|NCT01856309|81166579|FG003|Overall Study|Pregnancy|1|||
27817903|NCT01856309|81166576|FG000|Overall Study|Physician Decision|6|||
27817904|NCT01856309|81166577|FG001|Overall Study|Physician Decision|1|||
27817905|NCT01856309|81166578|FG002|Overall Study|Physician Decision|6|||
27817906|NCT01856309|81166579|FG003|Overall Study|Physician Decision|8|||
27817907|NCT01856309|81166576|FG000|Overall Study|Noncompliance With Study Drug|0|||
27817908|NCT01856309|81166577|FG001|Overall Study|Noncompliance With Study Drug|1|||
27817909|NCT01856309|81166578|FG002|Overall Study|Noncompliance With Study Drug|4|||
27817910|NCT01856309|81166579|FG003|Overall Study|Noncompliance With Study Drug|1|||
27817911|NCT00728949|81166580|FG000|Overall Study|Adverse Event|8|||
27817912|NCT00728949|81166581|FG001|Overall Study|Adverse Event|0|||
27817913|NCT00728949|81166580|FG000|Overall Study|Withdrawal by Subject|2|||
27817914|NCT00728949|81166581|FG001|Overall Study|Withdrawal by Subject|2|||
27817915|NCT00728949|81166580|FG000|Overall Study|Abnormal Lab Results|0|||
27817916|NCT00728949|81166581|FG001|Overall Study|Abnormal Lab Results|2|||
27817917|NCT00728949|81166580|FG000|Overall Study|On treatment at cutoff date|1|||
27817918|NCT00728949|81166581|FG001|Overall Study|On treatment at cutoff date|0|||
27817919|NCT00162123|81166584|FG000|Overall Study|Disease progression|27|||
27879526|NCT01966120|81391548|FG000|Overall Study|Withdrawal by Subject|0|||
27817920|NCT00162123|81166585|FG001|Overall Study|Disease progression|19|||
27817921|NCT00162123|81166586|FG002|Overall Study|Disease progression|10|||
27817922|NCT00162123|81166587|FG003|Overall Study|Disease progression|4|||
27879527|NCT01966120|81391549|FG001|Overall Study|Withdrawal by Subject|5|||
27879528|NCT01966120|81391548|FG000|Overall Study|Lost to Follow-up|1|||
27817923|NCT00162123|81166588|FG004|Overall Study|Disease progression|8|||
27591285|NCT02347761|80344910|FG001|All Collected|Withdrawal by Subject|11|||
27591286|NCT02347761|80344911|FG002|All Collected|Withdrawal by Subject|22|||
27692604|NCT00585195|80709734|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
27692605|NCT00585195|80709735|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
27817924|NCT00162123|81166589|FG005|Overall Study|Disease progression|3|||
27817925|NCT00162123|81166590|FG006|Overall Study|Disease progression|1|||
27817926|NCT00162123|81166591|FG007|Overall Study|Disease progression|0|||
27817927|NCT00162123|81166584|FG000|Overall Study|Study drug toxicity|6|||
27817928|NCT00162123|81166585|FG001|Overall Study|Study drug toxicity|1|||
27817929|NCT00162123|81166586|FG002|Overall Study|Study drug toxicity|5|||
27817930|NCT00162123|81166587|FG003|Overall Study|Study drug toxicity|0|||
27817931|NCT00162123|81166588|FG004|Overall Study|Study drug toxicity|4|||
27817932|NCT00162123|81166589|FG005|Overall Study|Study drug toxicity|1|||
27817933|NCT00162123|81166590|FG006|Overall Study|Study drug toxicity|1|||
27817934|NCT00162123|81166591|FG007|Overall Study|Study drug toxicity|0|||
27817935|NCT00162123|81166584|FG000|Overall Study|Death|3|||
27817936|NCT00162123|81166585|FG001|Overall Study|Death|3|||
27817937|NCT00162123|81166586|FG002|Overall Study|Death|1|||
27817938|NCT00162123|81166587|FG003|Overall Study|Death|1|||
27817939|NCT00162123|81166588|FG004|Overall Study|Death|1|||
27817940|NCT00162123|81166589|FG005|Overall Study|Death|1|||
27817941|NCT00162123|81166590|FG006|Overall Study|Death|0|||
27817942|NCT00162123|81166591|FG007|Overall Study|Death|0|||
27817943|NCT00162123|81166584|FG000|Overall Study|Withdrawal by Subject|2|||
27817944|NCT00162123|81166585|FG001|Overall Study|Withdrawal by Subject|0|||
27817945|NCT00162123|81166586|FG002|Overall Study|Withdrawal by Subject|2|||
27817946|NCT00162123|81166587|FG003|Overall Study|Withdrawal by Subject|1|||
27817947|NCT00162123|81166588|FG004|Overall Study|Withdrawal by Subject|1|||
27817948|NCT00162123|81166589|FG005|Overall Study|Withdrawal by Subject|2|||
27817949|NCT00162123|81166590|FG006|Overall Study|Withdrawal by Subject|1|||
27817950|NCT00162123|81166591|FG007|Overall Study|Withdrawal by Subject|0|||
27817951|NCT00162123|81166584|FG000|Overall Study|Deterioration without progression|2|||
27817952|NCT00162123|81166585|FG001|Overall Study|Deterioration without progression|2|||
27879529|NCT01966120|81391549|FG001|Overall Study|Lost to Follow-up|1|||
27879530|NCT01295827|81391550|FG000|Overall Study|Adverse Event|1|||
27879531|NCT01295827|81391551|FG001|Overall Study|Adverse Event|2|||
27879532|NCT01295827|81391552|FG002|Overall Study|Adverse Event|2|||
27879533|NCT01295827|81391553|FG003|Overall Study|Adverse Event|1|||
27879534|NCT01295827|81391554|FG004|Overall Study|Adverse Event|1|||
27879535|NCT01295827|81391555|FG005|Overall Study|Adverse Event|4|||
27879536|NCT01295827|81391556|FG006|Overall Study|Adverse Event|15|||
27879537|NCT01295827|81391557|FG007|Overall Study|Adverse Event|49|||
27879538|NCT01295827|81391558|FG008|Overall Study|Adverse Event|22|||
27879539|NCT01295827|81391559|FG009|Overall Study|Adverse Event|7|||
27879540|NCT01295827|81391560|FG010|Overall Study|Adverse Event|50|||
27879541|NCT01295827|81391561|FG011|Overall Study|Adverse Event|21|||
27879542|NCT01295827|81391562|FG012|Overall Study|Adverse Event|0|||
27879543|NCT01295827|81391563|FG013|Overall Study|Adverse Event|0|||
27879544|NCT01295827|81391564|FG014|Overall Study|Adverse Event|0|||
27879545|NCT01295827|81391550|FG000|Overall Study|Lost to Follow-up|0|||
27879546|NCT01295827|81391551|FG001|Overall Study|Lost to Follow-up|0|||
27879547|NCT01295827|81391552|FG002|Overall Study|Lost to Follow-up|3|||
27879548|NCT01295827|81391553|FG003|Overall Study|Lost to Follow-up|0|||
27879549|NCT01295827|81391554|FG004|Overall Study|Lost to Follow-up|1|||
27879550|NCT01295827|81391555|FG005|Overall Study|Lost to Follow-up|0|||
27879551|NCT01295827|81391556|FG006|Overall Study|Lost to Follow-up|4|||
27879552|NCT01295827|81391557|FG007|Overall Study|Lost to Follow-up|8|||
27879553|NCT01295827|81391558|FG008|Overall Study|Lost to Follow-up|7|||
27879554|NCT01295827|81391559|FG009|Overall Study|Lost to Follow-up|4|||
27879555|NCT01295827|81391560|FG010|Overall Study|Lost to Follow-up|7|||
27879556|NCT01295827|81391561|FG011|Overall Study|Lost to Follow-up|3|||
27879557|NCT01295827|81391562|FG012|Overall Study|Lost to Follow-up|0|||
27879558|NCT01295827|81391563|FG013|Overall Study|Lost to Follow-up|0|||
27879559|NCT01295827|81391564|FG014|Overall Study|Lost to Follow-up|0|||
27879560|NCT01295827|81391550|FG000|Overall Study|Not Reported|0|||
27879561|NCT01295827|81391551|FG001|Overall Study|Not Reported|0|||
27879562|NCT01295827|81391552|FG002|Overall Study|Not Reported|0|||
27879563|NCT01295827|81391553|FG003|Overall Study|Not Reported|1|||
27879564|NCT01295827|81391554|FG004|Overall Study|Not Reported|0|||
27879565|NCT01295827|81391555|FG005|Overall Study|Not Reported|0|||
27879566|NCT01295827|81391556|FG006|Overall Study|Not Reported|24|||
27879567|NCT01295827|81391557|FG007|Overall Study|Not Reported|58|||
27879568|NCT01295827|81391558|FG008|Overall Study|Not Reported|41|||
27879569|NCT01295827|81391559|FG009|Overall Study|Not Reported|2|||
27879570|NCT01295827|81391560|FG010|Overall Study|Not Reported|23|||
27879571|NCT01295827|81391561|FG011|Overall Study|Not Reported|13|||
27879572|NCT01295827|81391562|FG012|Overall Study|Not Reported|0|||
27879573|NCT01295827|81391563|FG013|Overall Study|Not Reported|0|||
27879574|NCT01295827|81391564|FG014|Overall Study|Not Reported|0|||
27879575|NCT01295827|81391550|FG000|Overall Study|Progressive Disease|2|||
27879576|NCT01295827|81391551|FG001|Overall Study|Progressive Disease|1|||
27879577|NCT01295827|81391552|FG002|Overall Study|Progressive Disease|5|||
27879578|NCT01295827|81391553|FG003|Overall Study|Progressive Disease|2|||
27879579|NCT01295827|81391554|FG004|Overall Study|Progressive Disease|0|||
27879580|NCT01295827|81391555|FG005|Overall Study|Progressive Disease|1|||
27879581|NCT01295827|81391556|FG006|Overall Study|Progressive Disease|87|||
27879582|NCT01295827|81391557|FG007|Overall Study|Progressive Disease|144|||
27879583|NCT01295827|81391558|FG008|Overall Study|Progressive Disease|85|||
27879584|NCT01295827|81391559|FG009|Overall Study|Progressive Disease|40|||
27879585|NCT01295827|81391560|FG010|Overall Study|Progressive Disease|175|||
27879586|NCT01295827|81391561|FG011|Overall Study|Progressive Disease|136|||
27879587|NCT01295827|81391562|FG012|Overall Study|Progressive Disease|0|||
27879588|NCT01295827|81391563|FG013|Overall Study|Progressive Disease|0|||
27879589|NCT01295827|81391564|FG014|Overall Study|Progressive Disease|0|||
27879590|NCT01295827|81391550|FG000|Overall Study|Screen Failure|0|||
27879591|NCT01295827|81391551|FG001|Overall Study|Screen Failure|0|||
27879592|NCT01295827|81391552|FG002|Overall Study|Screen Failure|0|||
27879593|NCT01295827|81391553|FG003|Overall Study|Screen Failure|0|||
27879594|NCT01295827|81391554|FG004|Overall Study|Screen Failure|0|||
27879595|NCT01295827|81391555|FG005|Overall Study|Screen Failure|0|||
27879596|NCT01295827|81391556|FG006|Overall Study|Screen Failure|2|||
27879597|NCT01295827|81391557|FG007|Overall Study|Screen Failure|2|||
27879598|NCT01295827|81391558|FG008|Overall Study|Screen Failure|2|||
27879599|NCT01295827|81391559|FG009|Overall Study|Screen Failure|0|||
27879600|NCT01295827|81391560|FG010|Overall Study|Screen Failure|1|||
27879601|NCT01295827|81391561|FG011|Overall Study|Screen Failure|0|||
27879602|NCT01295827|81391562|FG012|Overall Study|Screen Failure|0|||
27879603|NCT01295827|81391563|FG013|Overall Study|Screen Failure|0|||
27879604|NCT01295827|81391564|FG014|Overall Study|Screen Failure|0|||
27879605|NCT01295827|81391550|FG000|Overall Study|Withdrawal by Subject|1|||
27879606|NCT01295827|81391551|FG001|Overall Study|Withdrawal by Subject|0|||
27879607|NCT01295827|81391552|FG002|Overall Study|Withdrawal by Subject|2|||
27879608|NCT01295827|81391553|FG003|Overall Study|Withdrawal by Subject|0|||
27879609|NCT01295827|81391554|FG004|Overall Study|Withdrawal by Subject|0|||
27879610|NCT01295827|81391555|FG005|Overall Study|Withdrawal by Subject|1|||
27879611|NCT01295827|81391556|FG006|Overall Study|Withdrawal by Subject|13|||
27879612|NCT01295827|81391557|FG007|Overall Study|Withdrawal by Subject|35|||
27879613|NCT01295827|81391558|FG008|Overall Study|Withdrawal by Subject|11|||
27879614|NCT01295827|81391559|FG009|Overall Study|Withdrawal by Subject|2|||
27879615|NCT01295827|81391560|FG010|Overall Study|Withdrawal by Subject|18|||
27879616|NCT01295827|81391561|FG011|Overall Study|Withdrawal by Subject|13|||
27879617|NCT01295827|81391562|FG012|Overall Study|Withdrawal by Subject|0|||
27879618|NCT01295827|81391563|FG013|Overall Study|Withdrawal by Subject|0|||
27817953|NCT00162123|81166586|FG002|Overall Study|Deterioration without progression|3|||
27817954|NCT00162123|81166587|FG003|Overall Study|Deterioration without progression|0|||
27817955|NCT00162123|81166588|FG004|Overall Study|Deterioration without progression|1|||
27817956|NCT00162123|81166589|FG005|Overall Study|Deterioration without progression|0|||
27817957|NCT00162123|81166590|FG006|Overall Study|Deterioration without progression|0|||
27817958|NCT00162123|81166591|FG007|Overall Study|Deterioration without progression|0|||
27817959|NCT00162123|81166584|FG000|Overall Study|Adverse Event|1|||
27817960|NCT00162123|81166585|FG001|Overall Study|Adverse Event|2|||
27817961|NCT00162123|81166586|FG002|Overall Study|Adverse Event|0|||
27817962|NCT00162123|81166587|FG003|Overall Study|Adverse Event|2|||
27817963|NCT00162123|81166588|FG004|Overall Study|Adverse Event|1|||
27817964|NCT00162123|81166589|FG005|Overall Study|Adverse Event|0|||
27817965|NCT00162123|81166590|FG006|Overall Study|Adverse Event|0|||
27817966|NCT00162123|81166591|FG007|Overall Study|Adverse Event|0|||
27817967|NCT00162123|81166584|FG000|Overall Study|Not specified (before treatment)|2|||
27817968|NCT00162123|81166585|FG001|Overall Study|Not specified (before treatment)|0|||
27817969|NCT00162123|81166586|FG002|Overall Study|Not specified (before treatment)|0|||
27817970|NCT00162123|81166587|FG003|Overall Study|Not specified (before treatment)|0|||
27817971|NCT00162123|81166588|FG004|Overall Study|Not specified (before treatment)|12|||
27817972|NCT00162123|81166589|FG005|Overall Study|Not specified (before treatment)|1|||
27817973|NCT00162123|81166590|FG006|Overall Study|Not specified (before treatment)|0|||
27817974|NCT00162123|81166591|FG007|Overall Study|Not specified (before treatment)|0|||
27817975|NCT00162123|81166584|FG000|Overall Study|Not specified (after start of treatment)|0|||
27817976|NCT00162123|81166585|FG001|Overall Study|Not specified (after start of treatment)|0|||
27817977|NCT00162123|81166586|FG002|Overall Study|Not specified (after start of treatment)|0|||
27817978|NCT00162123|81166587|FG003|Overall Study|Not specified (after start of treatment)|0|||
27817979|NCT00162123|81166588|FG004|Overall Study|Not specified (after start of treatment)|3|||
27817980|NCT00162123|81166589|FG005|Overall Study|Not specified (after start of treatment)|0|||
27817981|NCT00162123|81166590|FG006|Overall Study|Not specified (after start of treatment)|0|||
27817982|NCT00162123|81166591|FG007|Overall Study|Not specified (after start of treatment)|0|||
27817983|NCT00162123|81166584|FG000|Overall Study|Physician Decision|1|||
27817984|NCT00162123|81166585|FG001|Overall Study|Physician Decision|2|||
27817985|NCT00162123|81166586|FG002|Overall Study|Physician Decision|0|||
27817986|NCT00162123|81166587|FG003|Overall Study|Physician Decision|0|||
27817987|NCT00162123|81166588|FG004|Overall Study|Physician Decision|0|||
27817988|NCT00162123|81166589|FG005|Overall Study|Physician Decision|1|||
27817989|NCT00162123|81166590|FG006|Overall Study|Physician Decision|1|||
27817990|NCT00162123|81166591|FG007|Overall Study|Physician Decision|0|||
27817991|NCT00162123|81166584|FG000|Overall Study|Tumor assessment only (not treated)|0|||
27817992|NCT00162123|81166585|FG001|Overall Study|Tumor assessment only (not treated)|0|||
27817993|NCT00162123|81166586|FG002|Overall Study|Tumor assessment only (not treated)|0|||
27817994|NCT00162123|81166587|FG003|Overall Study|Tumor assessment only (not treated)|0|||
27817995|NCT00162123|81166588|FG004|Overall Study|Tumor assessment only (not treated)|0|||
27817996|NCT00162123|81166589|FG005|Overall Study|Tumor assessment only (not treated)|0|||
27817997|NCT00162123|81166590|FG006|Overall Study|Tumor assessment only (not treated)|0|||
27817998|NCT00162123|81166591|FG007|Overall Study|Tumor assessment only (not treated)|1|||
27817999|NCT00162123|81166584|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
27818000|NCT00162123|81166585|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
27879619|NCT01295827|81391564|FG014|Overall Study|Withdrawal by Subject|0|||
27879620|NCT01295827|81391550|FG000|Overall Study|Other|0|||
27879621|NCT01295827|81391551|FG001|Overall Study|Other|0|||
27818001|NCT00162123|81166586|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
27818002|NCT00162123|81166587|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
27818003|NCT00162123|81166588|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
27818004|NCT00162123|81166589|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
27818005|NCT00162123|81166590|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
27879622|NCT01295827|81391552|FG002|Overall Study|Other|0|||
27818006|NCT00162123|81166591|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
27879623|NCT01295827|81391553|FG003|Overall Study|Other|0|||
27879624|NCT01295827|81391554|FG004|Overall Study|Other|0|||
27879625|NCT01295827|81391555|FG005|Overall Study|Other|0|||
27879626|NCT01295827|81391556|FG006|Overall Study|Other|1|||
27879627|NCT01295827|81391557|FG007|Overall Study|Other|1|||
27879628|NCT01295827|81391558|FG008|Overall Study|Other|1|||
27879629|NCT01295827|81391559|FG009|Overall Study|Other|0|||
27879630|NCT01295827|81391560|FG010|Overall Study|Other|2|||
27879631|NCT01295827|81391561|FG011|Overall Study|Other|0|||
27879632|NCT01295827|81391562|FG012|Overall Study|Other|0|||
27879633|NCT01295827|81391563|FG013|Overall Study|Other|0|||
27879634|NCT01295827|81391564|FG014|Overall Study|Other|0|||
27879635|NCT03478644|81391568|FG000|Phase 2|Withdrawal by Subject|2|||
27818007|NCT01720264|81166592|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
27818008|NCT01720264|81166592|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
27818009|NCT01720264|81166592|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
27818010|NCT01644500|81166594|FG000|Overall Study|Adverse Event|6|||
27818011|NCT01644500|81166595|FG001|Overall Study|Adverse Event|1|||
27818012|NCT01644500|81166596|FG002|Overall Study|Adverse Event|2|||
27818013|NCT01644500|81166594|FG000|Overall Study|Death|0|||
27879636|NCT03478644|81391569|FG001|Phase 2|Withdrawal by Subject|1|||
27879637|NCT03478644|81391568|FG000|Phase 2|Lost to Follow-up|1|||
27818014|NCT01644500|81166595|FG001|Overall Study|Death|1|||
27818015|NCT01644500|81166596|FG002|Overall Study|Death|0|||
27879638|NCT03478644|81391569|FG001|Phase 2|Lost to Follow-up|0|||
27879639|NCT00554515|81391571|FG000|Overall Study|Withdrawal by Subject|3|||
27818016|NCT01644500|81166594|FG000|Overall Study|Lost to Follow-up|3|||
27879640|NCT00554515|81391571|FG000|Overall Study|Disease progression|52|||
27879641|NCT00554515|81391571|FG000|Overall Study|Physician Decision|18|||
27879642|NCT00554515|81391571|FG000|Overall Study|Withdrawal by Subject|11|||
27879643|NCT00554515|81391571|FG000|Overall Study|Adverse Event|9|||
27879644|NCT00554515|81391571|FG000|Overall Study|Death|2|||
27879645|NCT00554515|81391571|FG000|Overall Study|Achieved Stable Disease|7|||
27879646|NCT00554515|81391571|FG000|Overall Study|Other|1|||
27879647|NCT00554515|81391571|FG000|Overall Study|Misc|15|||
27879648|NCT02640664|81391572|FG000|Epoch 1|Withdrawal of informed consent|1|||
27879649|NCT02640664|81391573|FG001|Epoch 1|Withdrawal of informed consent|0|||
27879650|NCT02640664|81391574|FG002|Epoch 1|Withdrawal of informed consent|0|||
27879651|NCT02640664|81391572|FG000|Epoch 1|Death|0|||
27879652|NCT02640664|81391573|FG001|Epoch 1|Death|0|||
27879653|NCT02640664|81391574|FG002|Epoch 1|Death|1|||
27879654|NCT02640664|81391572|FG000|Epoch 2|Withdrawal of informed consent|3|||
27879655|NCT02640664|81391573|FG001|Epoch 2|Withdrawal of informed consent|4|||
27879656|NCT02640664|81391574|FG002|Epoch 2|Withdrawal of informed consent|2|||
27879657|NCT02640664|81391572|FG000|Epoch 2|Subject/guardian decision|0|||
27879658|NCT02640664|81391573|FG001|Epoch 2|Subject/guardian decision|2|||
27879659|NCT02640664|81391574|FG002|Epoch 2|Subject/guardian decision|2|||
27879660|NCT02640664|81391572|FG000|Epoch 2|Lost to Follow-up|3|||
27879661|NCT02640664|81391573|FG001|Epoch 2|Lost to Follow-up|4|||
27879662|NCT02640664|81391574|FG002|Epoch 2|Lost to Follow-up|1|||
27879663|NCT02640664|81391572|FG000|Epoch 2|Death|0|||
27879664|NCT02640664|81391573|FG001|Epoch 2|Death|0|||
27879665|NCT02640664|81391574|FG002|Epoch 2|Death|1|||
27879666|NCT00502242|81391575|FG000|Overall Study|Lack of Efficacy|1|||
27879667|NCT00502242|81391576|FG001|Overall Study|Lack of Efficacy|11|||
27879668|NCT00502242|81391575|FG000|Overall Study|Adverse Event|31|||
27879669|NCT00502242|81391576|FG001|Overall Study|Adverse Event|20|||
27879670|NCT00502242|81391575|FG000|Overall Study|Physician Decision|2|||
27879671|NCT00502242|81391576|FG001|Overall Study|Physician Decision|3|||
27879672|NCT00502242|81391575|FG000|Overall Study|Other - Unspecified|8|||
27879673|NCT00502242|81391576|FG001|Overall Study|Other - Unspecified|14|||
27879674|NCT00502242|81391575|FG000|Overall Study|Protocol Violation|3|||
27879675|NCT00502242|81391576|FG001|Overall Study|Protocol Violation|1|||
27879676|NCT00502242|81391575|FG000|Overall Study|Withdrawal by Subject|6|||
27879677|NCT00502242|81391576|FG001|Overall Study|Withdrawal by Subject|7|||
27879678|NCT01445730|81391577|FG000|Overall Study|Adverse Event|1|||
27879679|NCT01445730|81391577|FG000|Overall Study|For the advice of a dentist|1|||
27879680|NCT01445730|81391577|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
27879681|NCT04565145|81391579|FG000|Overall Study|Withdrawal by Subject|1|||
27879682|NCT04565145|81391580|FG001|Overall Study|Withdrawal by Subject|1|||
27879683|NCT01973439|81391582|FG000|Overall Study|Lost samples from one PK Day|2|||
27879684|NCT01973439|81391582|FG000|Overall Study|Vomiting after commencing once daily|1|||
27879685|NCT01973439|81391582|FG000|Overall Study|PK curve incomplete|2|||
27879686|NCT03376789|81391583|FG000|Overall Study|Withdrawal by Subject|3|||
27879687|NCT03376789|81391584|FG001|Overall Study|Withdrawal by Subject|5|||
27879688|NCT03376789|81391583|FG000|Overall Study|Protocol Violation|0|||
27879689|NCT03376789|81391584|FG001|Overall Study|Protocol Violation|1|||
27879690|NCT03376789|81391583|FG000|Overall Study|Adverse Event|0|||
27879691|NCT03376789|81391584|FG001|Overall Study|Adverse Event|1|||
27879692|NCT03376789|81391583|FG000|Overall Study|Lost to Follow-up|1|||
27879693|NCT03376789|81391584|FG001|Overall Study|Lost to Follow-up|1|||
27879694|NCT03376789|81391583|FG000|Overall Study|Per sponsor due to noncompliance|1|||
27879695|NCT03376789|81391584|FG001|Overall Study|Per sponsor due to noncompliance|0|||
27879696|NCT03376789|81391583|FG000|Overall Study|Subject off study medication|0|||
27879697|NCT03376789|81391584|FG001|Overall Study|Subject off study medication|1|||
27879698|NCT01996241|81391586|FG000|Overall Study|Lost to Follow-up|252|||
27879699|NCT01996241|81391587|FG001|Overall Study|Lost to Follow-up|235|||
27879700|NCT04630002|81391590|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
27879701|NCT04630002|81391591|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
27879702|NCT04630002|81391592|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
27879703|NCT04630002|81391590|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
27879704|NCT04630002|81391591|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
27591287|NCT02347761|80344909|FG000|All Collected|invetigator disretion|2|||
27879705|NCT04630002|81391592|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
27879706|NCT04630002|81391590|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
27879707|NCT04630002|81391591|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
27879708|NCT04630002|81391592|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
27879709|NCT04630002|81391590|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
27591288|NCT02347761|80344910|FG001|All Collected|invetigator disretion|0|||
27879710|NCT04630002|81391591|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
27879711|NCT04630002|81391592|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
27879712|NCT04630002|81391590|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
27879713|NCT04630002|81391591|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
27879714|NCT04630002|81391592|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
27879715|NCT04630002|81391590|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
27879716|NCT04630002|81391591|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
27879717|NCT04630002|81391592|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
27879718|NCT04630002|81391590|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
27879719|NCT04630002|81391591|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
27879720|NCT04630002|81391592|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
27879721|NCT04630002|81391590|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
27879722|NCT04630002|81391591|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
27879723|NCT04630002|81391592|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
27879724|NCT01367886|81391595|FG000|Overall Study|Lost to Follow-up|4|||
27879725|NCT01367886|81391595|FG000|Overall Study|Lack of Efficacy|2|||
27879726|NCT01367886|81391595|FG000|Overall Study|Death|1|||
27879727|NCT02484456|81391596|FG000|Washout Period|Withdrawal by Subject|0|||
27879728|NCT02484456|81391597|FG001|Washout Period|Withdrawal by Subject|1|||
27879729|NCT02484456|81391596|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
27879730|NCT02484456|81391597|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
27879731|NCT02484456|81391596|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
27879732|NCT02484456|81391597|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
27879733|NCT02484456|81391596|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
27879734|NCT02484456|81391597|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
27879735|NCT00302328|81391598|FG000|Overall Study|Physician Decision|0|||
27879736|NCT00302328|81391599|FG001|Overall Study|Physician Decision|1|||
27879737|NCT00302328|81391600|FG002|Overall Study|Physician Decision|0|||
27879738|NCT03349060|81391601|FG000|Overall Study|Adverse Event|9|||
27879739|NCT03349060|81391602|FG001|Overall Study|Adverse Event|9|||
27879740|NCT03349060|81391603|FG002|Overall Study|Adverse Event|7|||
27879741|NCT03349060|81391601|FG000|Overall Study|Lack of Efficacy|1|||
27879742|NCT03349060|81391602|FG001|Overall Study|Lack of Efficacy|0|||
27879743|NCT03349060|81391603|FG002|Overall Study|Lack of Efficacy|2|||
27879744|NCT03349060|81391601|FG000|Overall Study|Lost to Follow-up|2|||
27879745|NCT03349060|81391602|FG001|Overall Study|Lost to Follow-up|1|||
27879746|NCT03349060|81391603|FG002|Overall Study|Lost to Follow-up|1|||
27879747|NCT03349060|81391601|FG000|Overall Study|Protocol Violation|2|||
27879748|NCT03349060|81391602|FG001|Overall Study|Protocol Violation|2|||
27879749|NCT03349060|81391603|FG002|Overall Study|Protocol Violation|1|||
27879750|NCT03349060|81391601|FG000|Overall Study|Withdrawal by Subject|5|||
27879751|NCT03349060|81391602|FG001|Overall Study|Withdrawal by Subject|3|||
27879752|NCT03349060|81391603|FG002|Overall Study|Withdrawal by Subject|4|||
27879753|NCT03349060|81391601|FG000|Overall Study|Medication error,no linked adverse event|0|||
27879754|NCT03349060|81391602|FG001|Overall Study|Medication error,no linked adverse event|0|||
27591289|NCT02347761|80344911|FG002|All Collected|invetigator disretion|0|||
27818017|NCT01644500|81166595|FG001|Overall Study|Lost to Follow-up|8|||
27818018|NCT01644500|81166596|FG002|Overall Study|Lost to Follow-up|0|||
27818019|NCT01644500|81166594|FG000|Overall Study|Protocol Violation|1|||
27818020|NCT01644500|81166595|FG001|Overall Study|Protocol Violation|1|||
27818021|NCT01644500|81166596|FG002|Overall Study|Protocol Violation|0|||
27818022|NCT01644500|81166594|FG000|Overall Study|Withdrawal by Subject|11|||
27818023|NCT01644500|81166595|FG001|Overall Study|Withdrawal by Subject|12|||
27818024|NCT01644500|81166596|FG002|Overall Study|Withdrawal by Subject|12|||
27818025|NCT01644500|81166594|FG000|Overall Study|Physician Decision|1|||
27818026|NCT01644500|81166595|FG001|Overall Study|Physician Decision|1|||
27818027|NCT01644500|81166596|FG002|Overall Study|Physician Decision|1|||
27818028|NCT00883090|81166597|FG000|Overall Study|Sponsor's decision|1|||
27818029|NCT00883090|81166597|FG000|Overall Study|Withdrawal by Subject|1|||
27818030|NCT00683293|81166599|FG000|Overall Study|Withdrawal by Subject|2|||
27818031|NCT00683293|81166600|FG001|Overall Study|Withdrawal by Subject|3|||
27818032|NCT01739790|81166605|FG000|Overall Study|Early Trial Termination|2|||
27818033|NCT01739790|81166606|FG001|Overall Study|Early Trial Termination|4|||
27879755|NCT03349060|81391603|FG002|Overall Study|Medication error,no linked adverse event|1|||
27879756|NCT03349060|81391601|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27879757|NCT03349060|81391602|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
27879758|NCT03349060|81391603|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
27879759|NCT03349060|81391601|FG000|Overall Study|Other|2|||
27879760|NCT03349060|81391602|FG001|Overall Study|Other|1|||
27818034|NCT02979353|81166607|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
27818035|NCT02979353|81166608|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
27818036|NCT02979353|81166607|FG000|Overall Study|Withdrawal by Subject|16|||
27818037|NCT02979353|81166608|FG001|Overall Study|Withdrawal by Subject|12|||
27818038|NCT02979353|81166607|FG000|Overall Study|Death|10|||
27879761|NCT03349060|81391603|FG002|Overall Study|Other|0|||
27591290|NCT02347761|80344909|FG000|All Collected|instillation site pain|0|||
27591291|NCT02347761|80344910|FG001|All Collected|instillation site pain|0|||
27591292|NCT02347761|80344911|FG002|All Collected|instillation site pain|1|||
27591293|NCT02347761|80344909|FG000|All Collected|exacerbation of COPD|0|||
27591294|NCT02347761|80344910|FG001|All Collected|exacerbation of COPD|0|||
27591295|NCT02347761|80344911|FG002|All Collected|exacerbation of COPD|1|||
27591296|NCT02347761|80344909|FG000|All Collected|moved/travel|0|||
27591297|NCT02347761|80344910|FG001|All Collected|moved/travel|1|||
27591298|NCT02347761|80344911|FG002|All Collected|moved/travel|0|||
27591299|NCT02347761|80344909|FG000|On Study Treatment|Lack of Efficacy|2|||
27591300|NCT02347761|80344910|FG001|On Study Treatment|Lack of Efficacy|3|||
27591301|NCT02347761|80344911|FG002|On Study Treatment|Lack of Efficacy|4|||
27591302|NCT02347761|80344909|FG000|On Study Treatment|non-compliance with study medication|0|||
27591303|NCT02347761|80344910|FG001|On Study Treatment|non-compliance with study medication|0|||
27591304|NCT02347761|80344911|FG002|On Study Treatment|non-compliance with study medication|2|||
27692606|NCT00585195|80709736|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
27692607|NCT00585195|80709737|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
27879762|NCT01609296|81391604|FG000|Overall Study|Death|253|||
27879763|NCT01609296|81391604|FG000|Overall Study|Withdrawal by Subject|151|||
27879764|NCT01609296|81391604|FG000|Overall Study|Lost to Follow-up|21|||
27879765|NCT01609296|81391604|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
27879766|NCT01609296|81391604|FG000|Overall Study|missed visit but known to be alive|28|||
27879767|NCT00558467|81391607|FG000|Overall Study|Adverse Event|1|||
27879768|NCT00558467|81391608|FG001|Overall Study|Adverse Event|2|||
27879769|NCT00558467|81391607|FG000|Overall Study|Lack of Efficacy|0|||
27879770|NCT00558467|81391608|FG001|Overall Study|Lack of Efficacy|1|||
27879771|NCT00558467|81391607|FG000|Overall Study|Patient moving out of state|0|||
27879772|NCT00558467|81391608|FG001|Overall Study|Patient moving out of state|1|||
27879773|NCT02549859|81391609|FG000|Long-term 60 Hz DBS|Study Closed|1|||
27879774|NCT00403481|81391612|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
27879775|NCT00403481|81391612|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
27879776|NCT00403481|81391612|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
27879777|NCT00403481|81391612|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
27879778|NCT00403481|81391612|FG000|Olm 40 mg|Adverse Event|2|||
27879779|NCT00403481|81391612|FG000|Olm 40 mg|Protocol Violation|1|||
27879780|NCT00403481|81391612|FG000|Olm 40 mg|Withdrawal by Subject|1|||
27879781|NCT00403481|81391612|FG000|Olm 40 mg|Other|1|||
27879782|NCT00403481|81391612|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
27879783|NCT00403481|81391612|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
27879784|NCT00403481|81391612|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
27879785|NCT00403481|81391612|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
27879786|NCT00403481|81391612|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
27879787|NCT00403481|81391612|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
27879788|NCT00351468|81391613|FG000|Overall Study|Adverse Event|42|||
27879789|NCT00351468|81391613|FG000|Overall Study|Withdrawal by Subject|39|||
27879790|NCT00351468|81391613|FG000|Overall Study|Various -follow up w clinical team|39|||
27879791|NCT00351468|81391613|FG000|Overall Study|Lack of Efficacy|32|||
27879792|NCT00351468|81391613|FG000|Overall Study|Non-compliance|8|||
27879793|NCT00351468|81391613|FG000|Overall Study|Lost to Follow-up|4|||
27879794|NCT00351468|81391613|FG000|Overall Study|Protocol Violation|3|||
27879795|NCT02151851|81391614|FG000|Overall Study|Lack of Efficacy|67|||
27692608|NCT00585195|80709738|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
27879796|NCT02151851|81391615|FG001|Overall Study|Lack of Efficacy|94|||
27879797|NCT02151851|81391614|FG000|Overall Study|Protocol Violation|0|||
27591305|NCT02347761|80344909|FG000|On Study Treatment|Withdrawal by Subject|7|||
27879798|NCT02151851|81391615|FG001|Overall Study|Protocol Violation|1|||
27879799|NCT02151851|81391614|FG000|Overall Study|Withdrawal by Subject|2|||
27879800|NCT02151851|81391615|FG001|Overall Study|Withdrawal by Subject|5|||
27591306|NCT02347761|80344910|FG001|On Study Treatment|Withdrawal by Subject|3|||
27591307|NCT02347761|80344911|FG002|On Study Treatment|Withdrawal by Subject|5|||
27591308|NCT02347761|80344909|FG000|On Study Treatment|move/travel|2|||
27591309|NCT02347761|80344910|FG001|On Study Treatment|move/travel|6|||
27591310|NCT02347761|80344911|FG002|On Study Treatment|move/travel|5|||
27591311|NCT02347761|80344909|FG000|On Study Treatment|dissastisfaction with device|2|||
27591312|NCT02347761|80344910|FG001|On Study Treatment|dissastisfaction with device|1|||
27591313|NCT02347761|80344911|FG002|On Study Treatment|dissastisfaction with device|4|||
27591314|NCT02347761|80344909|FG000|On Study Treatment|Lost to Follow-up|2|||
27591315|NCT02347761|80344910|FG001|On Study Treatment|Lost to Follow-up|1|||
27591316|NCT02347761|80344911|FG002|On Study Treatment|Lost to Follow-up|1|||
27591317|NCT02347761|80344909|FG000|On Study Treatment|investigator discretion|2|||
27591318|NCT02347761|80344910|FG001|On Study Treatment|investigator discretion|0|||
27591319|NCT02347761|80344911|FG002|On Study Treatment|investigator discretion|0|||
27591320|NCT02347761|80344909|FG000|On Study Treatment|durg not working|0|||
27591321|NCT02347761|80344910|FG001|On Study Treatment|durg not working|1|||
27591322|NCT02347761|80344911|FG002|On Study Treatment|durg not working|1|||
27591323|NCT02347761|80344909|FG000|On Study Treatment|Adverse Event|10|||
27591324|NCT02347761|80344910|FG001|On Study Treatment|Adverse Event|8|||
27591325|NCT02347761|80344911|FG002|On Study Treatment|Adverse Event|20|||
27591326|NCT03727750|80344912|FG000|Overall Study|Death|45|||
27591327|NCT03727750|80344912|FG000|Overall Study|Withdrawal by Subject|2|||
27591328|NCT03727750|80344912|FG000|Overall Study|Lost to Follow-up|1|||
27591329|NCT03727750|80344912|FG000|Overall Study|Other|1|||
27591330|NCT01764945|80344913|FG000|Overall Study|Adverse Event|0|||
27591331|NCT01764945|80344914|FG001|Overall Study|Adverse Event|1|||
27591332|NCT01764945|80344915|FG002|Overall Study|Adverse Event|0|||
27591333|NCT01764945|80344916|FG003|Overall Study|Adverse Event|0|||
27879801|NCT02151851|81391614|FG000|Overall Study|Medical impairment|1|||
27879802|NCT02151851|81391615|FG001|Overall Study|Medical impairment|0|||
27879803|NCT02151851|81391614|FG000|Overall Study|Low compliance to study visits|0|||
27879804|NCT02151851|81391615|FG001|Overall Study|Low compliance to study visits|1|||
27879805|NCT02151851|81391614|FG000|Overall Study|Subject entered into study in error|0|||
27879806|NCT02151851|81391615|FG001|Overall Study|Subject entered into study in error|1|||
27879807|NCT02151851|81391614|FG000|Overall Study|Adverse Event|6|||
27879808|NCT02151851|81391615|FG001|Overall Study|Adverse Event|28|||
27591334|NCT01764945|80344917|FG004|Overall Study|Adverse Event|0|||
27591335|NCT01764945|80344918|FG005|Overall Study|Adverse Event|0|||
27591336|NCT01764945|80344919|FG006|Overall Study|Adverse Event|1|||
27591337|NCT01764945|80344920|FG007|Overall Study|Adverse Event|0|||
27591338|NCT01454583|80344925|FG000|1st Year|Lost to Follow-up|1057|||
27591339|NCT01454583|80344926|FG001|1st Year|Lost to Follow-up|318|||
27591340|NCT01454583|80344927|FG002|1st Year|Lost to Follow-up|180|||
27879809|NCT00318474|81394281|FG000|Overall Study|Adverse Event|1|||
27591341|NCT01454583|80344925|FG000|2nd Year|Lost to Follow-up|3965|||
27591342|NCT01454583|80344926|FG001|2nd Year|Lost to Follow-up|1049|||
27591343|NCT01454583|80344927|FG002|2nd Year|Lost to Follow-up|737|||
27591344|NCT01454583|80344925|FG000|3rd Year|Lost to Follow-up|1959|||
27591345|NCT01454583|80344926|FG001|3rd Year|Lost to Follow-up|512|||
27591346|NCT01454583|80344927|FG002|3rd Year|Lost to Follow-up|297|||
27591347|NCT02952924|80344928|FG000|Overall Study|Protocol Violation|0|||
27818039|NCT02979353|81166608|FG001|Overall Study|Death|11|||
27818040|NCT02979353|81166607|FG000|Overall Study|Transfer to Hospice Care|19|||
27818041|NCT02979353|81166608|FG001|Overall Study|Transfer to Hospice Care|14|||
27591348|NCT02952924|80344929|FG001|Overall Study|Protocol Violation|0|||
27818042|NCT02979353|81166607|FG000|Overall Study|Lost to Follow-up|1|||
27818043|NCT02979353|81166608|FG001|Overall Study|Lost to Follow-up|5|||
27818044|NCT00662025|81166609|FG000|Overall Study|Objective progression or relapse|51|||
27818045|NCT00662025|81166609|FG000|Overall Study|Adverse Event|7|||
27818046|NCT00662025|81166609|FG000|Overall Study|Withdrawal by Subject|1|||
27818047|NCT00662025|81166609|FG000|Overall Study|Results of other clinical study|2|||
27818048|NCT00662025|81166609|FG000|Overall Study|Target lesion cannot be evaluated|1|||
27818049|NCT00662025|81166609|FG000|Overall Study|Domestic circumstances|1|||
27818050|NCT02016170|81166612|FG000|Overall Study|Adverse Event|1|||
27818051|NCT02016170|81166613|FG001|Overall Study|Adverse Event|1|||
27818052|NCT02016170|81166614|FG002|Overall Study|Adverse Event|0|||
27818053|NCT02016170|81166612|FG000|Overall Study|Protocol Violation|1|||
27818054|NCT02016170|81166613|FG001|Overall Study|Protocol Violation|0|||
27818055|NCT02016170|81166614|FG002|Overall Study|Protocol Violation|0|||
27818056|NCT02849652|81166617|FG000|Overall Study|Lost to Follow-up|104|||
27818057|NCT02849652|81166618|FG001|Overall Study|Lost to Follow-up|35|||
27818058|NCT02849652|81166619|FG002|Overall Study|Lost to Follow-up|116|||
27818059|NCT02849652|81166620|FG003|Overall Study|Lost to Follow-up|22|||
27818060|NCT02849652|81166617|FG000|Overall Study|Withdrawal by Subject|10|||
27818061|NCT02849652|81166618|FG001|Overall Study|Withdrawal by Subject|2|||
27818062|NCT02849652|81166619|FG002|Overall Study|Withdrawal by Subject|8|||
27591349|NCT02952924|80344930|FG002|Overall Study|Protocol Violation|0|||
27591350|NCT02952924|80344931|FG003|Overall Study|Protocol Violation|0|||
27591351|NCT02952924|80344932|FG004|Overall Study|Protocol Violation|0|||
27591352|NCT02952924|80344933|FG005|Overall Study|Protocol Violation|0|||
27591353|NCT02952924|80344934|FG006|Overall Study|Protocol Violation|0|||
27591354|NCT02952924|80344935|FG007|Overall Study|Protocol Violation|0|||
27591355|NCT02952924|80344936|FG008|Overall Study|Protocol Violation|0|||
27591356|NCT02952924|80344937|FG009|Overall Study|Protocol Violation|0|||
27591357|NCT02952924|80344938|FG010|Overall Study|Protocol Violation|0|||
27591358|NCT02952924|80344939|FG011|Overall Study|Protocol Violation|0|||
27591359|NCT02952924|80344940|FG012|Overall Study|Protocol Violation|0|||
27591360|NCT02952924|80344941|FG013|Overall Study|Protocol Violation|0|||
27591361|NCT02952924|80344942|FG014|Overall Study|Protocol Violation|0|||
27818063|NCT02849652|81166620|FG003|Overall Study|Withdrawal by Subject|4|||
27818064|NCT01439165|81166626|FG000|Overall Study|Protocol Violation|3|||
27818065|NCT01439165|81166627|FG001|Overall Study|Protocol Violation|0|||
27818066|NCT01439165|81166626|FG000|Overall Study|Lost to Follow-up|11|||
27818067|NCT01439165|81166627|FG001|Overall Study|Lost to Follow-up|1|||
27818068|NCT01439165|81166626|FG000|Overall Study|Withdrawal by Subject|7|||
27818069|NCT01439165|81166627|FG001|Overall Study|Withdrawal by Subject|1|||
27591362|NCT02952924|80344943|FG015|Overall Study|Protocol Violation|0|||
27591363|NCT02952924|80344944|FG016|Overall Study|Protocol Violation|0|||
27591364|NCT02952924|80344945|FG017|Overall Study|Protocol Violation|0|||
27591365|NCT02952924|80344946|FG018|Overall Study|Protocol Violation|0|||
27591366|NCT02952924|80344947|FG019|Overall Study|Protocol Violation|1|||
27591367|NCT02952924|80344948|FG020|Overall Study|Protocol Violation|0|||
27591368|NCT02952924|80344949|FG021|Overall Study|Protocol Violation|0|||
27591369|NCT02952924|80344928|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
27591370|NCT02952924|80344929|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
27591371|NCT02952924|80344930|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
27692609|NCT00585195|80709739|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
27692610|NCT00585195|80709740|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
27692611|NCT00585195|80709741|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
27692612|NCT00585195|80709742|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
27692613|NCT00585195|80709743|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
27692614|NCT00585195|80709744|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
27692615|NCT00585195|80709745|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
27692616|NCT03541174|80709746|FG000|Part 1 Double-Blind|Adverse Event|6|||
27692617|NCT03541174|80709747|FG001|Part 1 Double-Blind|Adverse Event|5|||
27692618|NCT03541174|80709748|FG002|Part 1 Double-Blind|Adverse Event|2|||
27692619|NCT03541174|80709749|FG003|Part 1 Double-Blind|Adverse Event|0|||
27692620|NCT03541174|80709750|FG004|Part 1 Double-Blind|Adverse Event|0|||
27692621|NCT03541174|80709751|FG005|Part 1 Double-Blind|Adverse Event|0|||
27692622|NCT03541174|80709746|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
27692623|NCT03541174|80709747|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
27692624|NCT03541174|80709748|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
27692625|NCT03541174|80709749|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
27692626|NCT03541174|80709750|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
27692627|NCT03541174|80709751|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
27692628|NCT03541174|80709746|FG000|Part 1 Double-Blind|Other reasons|3|||
27692629|NCT03541174|80709747|FG001|Part 1 Double-Blind|Other reasons|2|||
27692630|NCT03541174|80709748|FG002|Part 1 Double-Blind|Other reasons|3|||
27692631|NCT03541174|80709749|FG003|Part 1 Double-Blind|Other reasons|0|||
27692632|NCT03541174|80709750|FG004|Part 1 Double-Blind|Other reasons|0|||
27692633|NCT03541174|80709751|FG005|Part 1 Double-Blind|Other reasons|0|||
27692634|NCT03541174|80709746|FG000|Part 2 Single-Blind|Adverse Event|0|||
27591372|NCT02952924|80344931|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
27591373|NCT02952924|80344932|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
27591374|NCT02952924|80344933|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
27591375|NCT02952924|80344934|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
27692635|NCT03541174|80709747|FG001|Part 2 Single-Blind|Adverse Event|0|||
27692636|NCT03541174|80709748|FG002|Part 2 Single-Blind|Adverse Event|0|||
27692637|NCT03541174|80709749|FG003|Part 2 Single-Blind|Adverse Event|25|||
27818070|NCT02433678|81166628|FG000|Overall Study|Lost to Follow-up|1|||
27818071|NCT02433678|81166629|FG001|Overall Study|Lost to Follow-up|2|||
27818072|NCT00048568|81166638|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
27818073|NCT00048568|81166639|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
27591376|NCT02952924|80344935|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
27591377|NCT02952924|80344936|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
27591378|NCT02952924|80344937|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
27591379|NCT02952924|80344938|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
27591380|NCT02952924|80344939|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
27591381|NCT02952924|80344940|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
27591382|NCT02952924|80344941|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
27591383|NCT02952924|80344942|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
27591384|NCT02952924|80344943|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
27591385|NCT02952924|80344944|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
27591386|NCT02952924|80344945|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
27591387|NCT02952924|80344946|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
27692638|NCT03541174|80709750|FG004|Part 2 Single-Blind|Adverse Event|0|||
27818074|NCT00048568|81166640|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
27818075|NCT00048568|81166638|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
27818076|NCT00048568|81166639|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
27818077|NCT00048568|81166640|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
27818078|NCT00048568|81166638|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
27818079|NCT00048568|81166639|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
27818080|NCT00048568|81166640|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
27818081|NCT00048568|81166638|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
27818082|NCT00048568|81166639|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
27692639|NCT03541174|80709751|FG005|Part 2 Single-Blind|Adverse Event|0|||
27818083|NCT00048568|81166640|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
27692640|NCT03541174|80709746|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
27692641|NCT03541174|80709747|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
27818084|NCT00048568|81166638|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
27818085|NCT00048568|81166639|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
27818086|NCT00048568|81166640|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
27818087|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|Death|1|||
27818088|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|Death|1|||
27818089|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|Death|0|||
27818090|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
27818091|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
27818092|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
27818093|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
27818094|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
27818095|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
27818096|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
27591388|NCT02952924|80344947|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
27591389|NCT02952924|80344948|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
27591390|NCT02952924|80344949|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
27692642|NCT03541174|80709748|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
27692643|NCT03541174|80709749|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
27692644|NCT03541174|80709750|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
27692645|NCT03541174|80709751|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
27692646|NCT03541174|80709746|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
27692647|NCT03541174|80709747|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
27692648|NCT03541174|80709748|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
27692649|NCT03541174|80709749|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
27692650|NCT03541174|80709750|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
27692651|NCT03541174|80709751|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
27692652|NCT03541174|80709746|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
27692653|NCT03541174|80709747|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
27692654|NCT03541174|80709748|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
27692655|NCT03541174|80709749|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
27692656|NCT03541174|80709750|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
27692657|NCT03541174|80709751|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
27692658|NCT03541174|80709746|FG000|Part 2 Single-Blind|Death|0|||
27692659|NCT03541174|80709747|FG001|Part 2 Single-Blind|Death|0|||
27692660|NCT03541174|80709748|FG002|Part 2 Single-Blind|Death|0|||
27692661|NCT03541174|80709749|FG003|Part 2 Single-Blind|Death|5|||
27692662|NCT03541174|80709750|FG004|Part 2 Single-Blind|Death|0|||
27692663|NCT03541174|80709751|FG005|Part 2 Single-Blind|Death|0|||
27692664|NCT03541174|80709746|FG000|Part 2 Single-Blind|Pregnancy|0|||
27692665|NCT03541174|80709747|FG001|Part 2 Single-Blind|Pregnancy|0|||
27692666|NCT03541174|80709748|FG002|Part 2 Single-Blind|Pregnancy|0|||
27692667|NCT03541174|80709749|FG003|Part 2 Single-Blind|Pregnancy|1|||
27692668|NCT03541174|80709750|FG004|Part 2 Single-Blind|Pregnancy|0|||
27692669|NCT03541174|80709751|FG005|Part 2 Single-Blind|Pregnancy|0|||
27692670|NCT03541174|80709746|FG000|Part 2 Single-Blind|Other reasons|0|||
27692671|NCT03541174|80709747|FG001|Part 2 Single-Blind|Other reasons|0|||
27692672|NCT03541174|80709748|FG002|Part 2 Single-Blind|Other reasons|0|||
27692673|NCT03541174|80709749|FG003|Part 2 Single-Blind|Other reasons|32|||
27692674|NCT03541174|80709750|FG004|Part 2 Single-Blind|Other reasons|0|||
27692675|NCT03541174|80709751|FG005|Part 2 Single-Blind|Other reasons|0|||
27692676|NCT03541174|80709746|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27692677|NCT03541174|80709747|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27692678|NCT03541174|80709748|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27692679|NCT03541174|80709749|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
27692680|NCT03541174|80709750|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
27692681|NCT03541174|80709751|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
27692682|NCT03541174|80709746|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27692683|NCT03541174|80709747|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27692684|NCT03541174|80709748|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27692685|NCT03541174|80709749|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
27692686|NCT03541174|80709750|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
27692687|NCT03541174|80709751|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
27692688|NCT03541174|80709746|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27692689|NCT03541174|80709747|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27692690|NCT03541174|80709748|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27692691|NCT03541174|80709749|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27692692|NCT03541174|80709750|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
27692693|NCT03541174|80709751|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
27692694|NCT03541174|80709746|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27692695|NCT03541174|80709747|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27692696|NCT03541174|80709748|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27692697|NCT03541174|80709749|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
27692698|NCT03541174|80709750|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
27692699|NCT03541174|80709751|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
27692700|NCT03541174|80709746|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27692701|NCT03541174|80709747|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27879810|NCT00318474|81394282|FG001|Overall Study|Adverse Event|1|||
27692702|NCT03541174|80709748|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27692703|NCT03541174|80709749|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27701010|NCT03933397|80741293|FG000|Overall Study|Missed emergency department visit|25|||
27692704|NCT03541174|80709750|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
27692705|NCT03541174|80709751|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
27692706|NCT00153062|80709752|FG000|Overall Study|Death|360|||
27692707|NCT00153062|80709753|FG001|Overall Study|Death|352|||
27692708|NCT00153062|80709754|FG002|Overall Study|Death|369|||
27692709|NCT00153062|80709755|FG003|Overall Study|Death|365|||
27692710|NCT00153062|80709752|FG000|Overall Study|Withdrawal by Subject|14|||
27692711|NCT00153062|80709753|FG001|Overall Study|Withdrawal by Subject|30|||
27692712|NCT00153062|80709754|FG002|Overall Study|Withdrawal by Subject|27|||
27692713|NCT00153062|80709755|FG003|Overall Study|Withdrawal by Subject|28|||
27692714|NCT00153062|80709752|FG000|Overall Study|Lost to Follow-up|12|||
27692715|NCT00153062|80709753|FG001|Overall Study|Lost to Follow-up|20|||
27692716|NCT00153062|80709754|FG002|Overall Study|Lost to Follow-up|15|||
27692717|NCT00153062|80709755|FG003|Overall Study|Lost to Follow-up|16|||
27692718|NCT00153062|80709752|FG000|Overall Study|Adverse Event|0|||
27692719|NCT00153062|80709753|FG001|Overall Study|Adverse Event|1|||
27692720|NCT00153062|80709754|FG002|Overall Study|Adverse Event|1|||
27692721|NCT00153062|80709755|FG003|Overall Study|Adverse Event|0|||
27692722|NCT00153062|80709752|FG000|Overall Study|Protocol Violation|0|||
27692723|NCT00153062|80709753|FG001|Overall Study|Protocol Violation|2|||
27692724|NCT00153062|80709754|FG002|Overall Study|Protocol Violation|1|||
27692725|NCT00153062|80709755|FG003|Overall Study|Protocol Violation|1|||
27692726|NCT00153062|80709752|FG000|Overall Study|No disposition data available|1|||
27692727|NCT00153062|80709753|FG001|Overall Study|No disposition data available|1|||
27692728|NCT00153062|80709754|FG002|Overall Study|No disposition data available|1|||
27692729|NCT00153062|80709755|FG003|Overall Study|No disposition data available|1|||
27692730|NCT00153062|80709752|FG000|Overall Study|Other|0|||
27692731|NCT00153062|80709753|FG001|Overall Study|Other|0|||
27692732|NCT00153062|80709754|FG002|Overall Study|Other|1|||
27692733|NCT00153062|80709755|FG003|Overall Study|Other|0|||
27692734|NCT00158860|80709756|FG000|Overall Study|Adverse Event|3|||
27692735|NCT00158860|80709757|FG001|Overall Study|Adverse Event|6|||
27692736|NCT00158860|80709756|FG000|Overall Study|Lost to Follow-up|11|||
27692737|NCT00158860|80709757|FG001|Overall Study|Lost to Follow-up|17|||
27692738|NCT00158860|80709756|FG000|Overall Study|Protocol Violation|8|||
27692739|NCT00158860|80709757|FG001|Overall Study|Protocol Violation|23|||
27692740|NCT00158860|80709756|FG000|Overall Study|Withdrawal by Subject|7|||
27692741|NCT00158860|80709757|FG001|Overall Study|Withdrawal by Subject|17|||
27692742|NCT00158860|80709756|FG000|Overall Study|MOVING OUT OF STATE|1|||
27692743|NCT00158860|80709757|FG001|Overall Study|MOVING OUT OF STATE|0|||
27692744|NCT00158860|80709756|FG000|Overall Study|Pregnancy|3|||
27692745|NCT00158860|80709757|FG001|Overall Study|Pregnancy|3|||
27692746|NCT00158860|80709756|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
27692747|NCT00158860|80709757|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
27692748|NCT00158860|80709756|FG000|Overall Study|SPONSOR REQUEST|0|||
27692749|NCT00158860|80709757|FG001|Overall Study|SPONSOR REQUEST|1|||
27692750|NCT00158860|80709756|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
27879811|NCT00318474|81394281|FG000|Overall Study|Lost to Follow-up|0|||
27692751|NCT00158860|80709757|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
27692752|NCT00158860|80709756|FG000|Overall Study|Closed per sponsor|0|||
27692753|NCT00158860|80709757|FG001|Overall Study|Closed per sponsor|1|||
27692754|NCT01012713|80709759|FG000|Overall Study|Lack of Efficacy|3|||
27818097|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
27818098|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
27818099|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
27818100|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
27818101|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
27818102|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
27818103|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
27818104|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
27818105|NCT00048568|81166638|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
27818106|NCT00048568|81166639|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
27879812|NCT00318474|81394282|FG001|Overall Study|Lost to Follow-up|1|||
27879813|NCT00318474|81394281|FG000|Overall Study|Pregnancy|0|||
27879814|NCT00318474|81394282|FG001|Overall Study|Pregnancy|2|||
27879815|NCT00318474|81394281|FG000|Overall Study|Protocol Violation|1|||
27879816|NCT00318474|81394282|FG001|Overall Study|Protocol Violation|0|||
27692755|NCT01874431|80709760|FG000|Overall Study|Physician Decision|0|||
27692756|NCT01874431|80709761|FG001|Overall Study|Physician Decision|0|||
27692757|NCT01874431|80709762|FG002|Overall Study|Physician Decision|1|||
27692758|NCT01874431|80709763|FG003|Overall Study|Physician Decision|0|||
27879817|NCT00318474|81394281|FG000|Overall Study|Withdrawal by Subject|3|||
27879818|NCT00318474|81394282|FG001|Overall Study|Withdrawal by Subject|2|||
27692759|NCT01874431|80709764|FG004|Overall Study|Physician Decision|0|||
27879819|NCT00318474|81394281|FG000|Overall Study|Fall in GFR|3|||
27879820|NCT00318474|81394282|FG001|Overall Study|Fall in GFR|3|||
27879821|NCT00318474|81394281|FG000|Overall Study|Post-therapy hyperflycemia|0|||
27879822|NCT00318474|81394282|FG001|Overall Study|Post-therapy hyperflycemia|1|||
27879823|NCT00318474|81394281|FG000|Overall Study|Trial terminated|10|||
27879824|NCT00318474|81394282|FG001|Overall Study|Trial terminated|7|||
27879825|NCT03319732|81394286|FG000|Overall Study|Adverse Event|40|||
27879826|NCT03319732|81394286|FG000|Overall Study|Withdrawal by Subject|50|||
27879827|NCT03319732|81394286|FG000|Overall Study|MS relapse|10|||
27879828|NCT03319732|81394286|FG000|Overall Study|reason not specified|5|||
27879829|NCT01592786|81394292|FG000|Overall Study|Adverse Event|60|||
27879830|NCT01592786|81394292|FG000|Overall Study|Lack of Efficacy|19|||
27879831|NCT01592786|81394292|FG000|Overall Study|Protocol Violation|14|||
27879832|NCT01592786|81394292|FG000|Overall Study|Withdrawal by Subject|23|||
27879833|NCT01592786|81394292|FG000|Overall Study|Lost to Follow-up|19|||
27879834|NCT01592786|81394292|FG000|Overall Study|Other|3|||
27879835|NCT00031590|81394293|FG000|Overall Study|Adverse Event|1|||
27879836|NCT00031590|81394293|FG000|Overall Study|Withdrawal by parents|2|||
27879837|NCT03382834|81394297|FG000|Step 1|Lost to Follow-up|0|||
27879838|NCT03382834|81394298|FG001|Step 1|Lost to Follow-up|1|||
27879839|NCT03382834|81394297|FG000|Step 2|Death|1|||
27879840|NCT03382834|81394298|FG001|Step 2|Death|0|||
27879841|NCT03382834|81394297|FG000|Step 2|Lost to Follow-up|2|||
27879842|NCT03382834|81394298|FG001|Step 2|Lost to Follow-up|2|||
27879843|NCT03382834|81394297|FG000|Step 2|Site Terminated by Sponsor|1|||
27879844|NCT03382834|81394298|FG001|Step 2|Site Terminated by Sponsor|0|||
27879845|NCT00684411|81394299|FG000|Overall Study|New Primary Cancer|1|||
27879846|NCT00684411|81394299|FG000|Overall Study|Disease Progression|10|||
27879847|NCT00684411|81394299|FG000|Overall Study|Adverse Event|1|||
27879848|NCT00687271|81394306|FG000|Overall Study|Adverse Event|1|||
27879849|NCT00687271|81394307|FG001|Overall Study|Adverse Event|3|||
27879850|NCT00687271|81394308|FG002|Overall Study|Adverse Event|1|||
27879851|NCT00687271|81394309|FG003|Overall Study|Adverse Event|0|||
27879852|NCT00687271|81394306|FG000|Overall Study|Lost to Follow-up|0|||
27879853|NCT00687271|81394307|FG001|Overall Study|Lost to Follow-up|1|||
27879854|NCT00687271|81394308|FG002|Overall Study|Lost to Follow-up|0|||
27879855|NCT00687271|81394309|FG003|Overall Study|Lost to Follow-up|0|||
27879856|NCT00687271|81394306|FG000|Overall Study|Protocol Violation|2|||
27879857|NCT00687271|81394307|FG001|Overall Study|Protocol Violation|1|||
27879858|NCT00687271|81394308|FG002|Overall Study|Protocol Violation|1|||
27879859|NCT00687271|81394309|FG003|Overall Study|Protocol Violation|0|||
27879860|NCT00687271|81394306|FG000|Overall Study|Withdrawal by Subject|0|||
27879861|NCT00687271|81394307|FG001|Overall Study|Withdrawal by Subject|1|||
27879862|NCT00687271|81394308|FG002|Overall Study|Withdrawal by Subject|3|||
27879863|NCT00687271|81394309|FG003|Overall Study|Withdrawal by Subject|0|||
27879864|NCT02522884|81394317|FG000|Overall Study|Withdrawal by Subject|6|||
27879865|NCT02522884|81394317|FG000|Overall Study|Death|3|||
27879866|NCT02522884|81394317|FG000|Overall Study|Missed 12-month Follow-up|9|||
27879867|NCT02285361|81394318|FG000|Overall Study|Protocol Violation|43|||
27879868|NCT02285361|81394318|FG000|Overall Study|Lost to Follow-up|5|||
27879869|NCT02285361|81394318|FG000|Overall Study|Not taken GIOTRIF|2|||
27879870|NCT02285361|81394318|FG000|Overall Study|Consented prior to the contract date|1|||
27879871|NCT00314340|81394319|FG000|Overall Study|lost interest|1|||
27879872|NCT03777436|81394320|FG000|Placebo-controlled Phase|Adverse Event|8|||
27879873|NCT03777436|81394321|FG001|Placebo-controlled Phase|Adverse Event|10|||
27879874|NCT03777436|81394322|FG002|Placebo-controlled Phase|Adverse Event|0|||
27879875|NCT03777436|81394320|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
27879876|NCT03777436|81394321|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
27879877|NCT03777436|81394322|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
27879878|NCT03777436|81394320|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
27879879|NCT03777436|81394321|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
27879880|NCT03777436|81394322|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
27879881|NCT03777436|81394320|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
27879882|NCT03777436|81394321|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
27879883|NCT03777436|81394322|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
27879884|NCT03777436|81394320|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
27879885|NCT03777436|81394321|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
27879886|NCT03777436|81394322|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
27879887|NCT03777436|81394320|FG000|Placebo-controlled Phase|Physician Decision|0|||
27879888|NCT03777436|81394321|FG001|Placebo-controlled Phase|Physician Decision|1|||
27879889|NCT03777436|81394322|FG002|Placebo-controlled Phase|Physician Decision|0|||
27879890|NCT03777436|81394320|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
27879891|NCT03777436|81394321|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
27879892|NCT03777436|81394322|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
27879893|NCT03777436|81394320|FG000|Apremilast Extension Phase|Adverse Event|0|||
27879894|NCT03777436|81394321|FG001|Apremilast Extension Phase|Adverse Event|0|||
27879895|NCT03777436|81394322|FG002|Apremilast Extension Phase|Adverse Event|6|||
27879896|NCT03777436|81394320|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
27879897|NCT03777436|81394321|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
27879898|NCT03777436|81394322|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
27879899|NCT03777436|81394320|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
27879900|NCT03777436|81394321|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
27879901|NCT03777436|81394322|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
27879902|NCT03777436|81394320|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
27879903|NCT03777436|81394321|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
27879904|NCT03777436|81394322|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
27879905|NCT03777436|81394320|FG000|Apremilast Extension Phase|Miscellaneous|0|||
27879906|NCT03777436|81394321|FG001|Apremilast Extension Phase|Miscellaneous|0|||
27879907|NCT03777436|81394322|FG002|Apremilast Extension Phase|Miscellaneous|1|||
27879908|NCT00862823|81394323|FG000|First Intervention|Withdrawal by Subject|1|||
27879909|NCT00862823|81394324|FG001|First Intervention|Withdrawal by Subject|1|||
27879910|NCT01516008|81394325|FG000|Overall Study|Adverse Event|0|||
27879911|NCT01516008|81394326|FG001|Overall Study|Adverse Event|2|||
27879912|NCT01516008|81394327|FG002|Overall Study|Adverse Event|7|||
27879913|NCT01516008|81394325|FG000|Overall Study|Lack of Efficacy|44|||
27879914|NCT01516008|81394326|FG001|Overall Study|Lack of Efficacy|14|||
27879915|NCT01516008|81394327|FG002|Overall Study|Lack of Efficacy|10|||
27879916|NCT01516008|81394325|FG000|Overall Study|Protocol Violation|1|||
27879917|NCT01516008|81394326|FG001|Overall Study|Protocol Violation|0|||
27879918|NCT01516008|81394327|FG002|Overall Study|Protocol Violation|0|||
27879919|NCT01516008|81394325|FG000|Overall Study|Reason not specified|0|||
27879920|NCT01516008|81394326|FG001|Overall Study|Reason not specified|0|||
27879921|NCT01516008|81394327|FG002|Overall Study|Reason not specified|1|||
27879922|NCT01776840|81394328|FG000|Overall Study|Lost to Follow-up|4|||
27879923|NCT01776840|81394329|FG001|Overall Study|Lost to Follow-up|4|||
27879924|NCT01776840|81394328|FG000|Overall Study|Withdrawal by Subject|42|||
27879925|NCT01776840|81394329|FG001|Overall Study|Withdrawal by Subject|22|||
27879926|NCT01776840|81394328|FG000|Overall Study|Ongoing|112|||
27879927|NCT01776840|81394329|FG001|Overall Study|Ongoing|129|||
27879928|NCT02792062|81394337|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
27879929|NCT02792062|81394338|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
27879930|NCT02792062|81394339|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
27879931|NCT02792062|81394340|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
27879932|NCT02792062|81394341|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
27879933|NCT02792062|81394342|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
27879934|NCT02525783|81394343|FG000|Overall Study|Lost to Follow-up|10|||
27879935|NCT01743560|81394345|FG000|Overall Study|Disease progression|26|||
27879936|NCT01743560|81394345|FG000|Overall Study|Adverse Event|8|||
27879937|NCT01743560|81394345|FG000|Overall Study|Death|3|||
27879938|NCT01743560|81394345|FG000|Overall Study|Withdrawal by Subject|2|||
27879939|NCT01743560|81394345|FG000|Overall Study|Protocol Violation|1|||
27879940|NCT01743560|81394345|FG000|Overall Study|>1 dose of study drug|3|||
27879941|NCT04185220|81394346|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
27879942|NCT04185220|81394347|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
27879943|NCT04185220|81394346|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
27879944|NCT04185220|81394347|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
27879945|NCT01131455|81394348|FG000|Overall Study|Death of PI|6|||
27879946|NCT01131455|81394349|FG001|Overall Study|Death of PI|4|||
27879947|NCT01131455|81394350|FG002|Overall Study|Death of PI|0|||
27879948|NCT02176655|81394351|FG000|Overall Study|Subjects did not treat|6|||
27692760|NCT01874431|80709765|FG005|Overall Study|Physician Decision|0|||
27879949|NCT02431676|81394352|FG000|Overall Study|no lab obtained|0|||
27879950|NCT02431676|81394353|FG001|Overall Study|no lab obtained|1|||
27879951|NCT02431676|81394354|FG002|Overall Study|no lab obtained|2|||
27879952|NCT00550043|81394355|FG000|Overall Study|Adverse Event|0|||
27879953|NCT00550043|81394356|FG001|Overall Study|Adverse Event|0|||
27879954|NCT00550043|81394357|FG002|Overall Study|Adverse Event|0|||
27879955|NCT00550043|81394358|FG003|Overall Study|Adverse Event|1|||
27879956|NCT00550043|81394359|FG004|Overall Study|Adverse Event|1|||
27879957|NCT00550043|81394355|FG000|Overall Study|Subject Withdrew Consent|0|||
27879958|NCT00550043|81394356|FG001|Overall Study|Subject Withdrew Consent|2|||
27879959|NCT00550043|81394357|FG002|Overall Study|Subject Withdrew Consent|1|||
27879960|NCT00550043|81394358|FG003|Overall Study|Subject Withdrew Consent|0|||
27879961|NCT00550043|81394359|FG004|Overall Study|Subject Withdrew Consent|0|||
27879962|NCT00550043|81394355|FG000|Overall Study|Other Reasons- Unspecified|0|||
27879963|NCT00550043|81394356|FG001|Overall Study|Other Reasons- Unspecified|1|||
27879964|NCT00550043|81394357|FG002|Overall Study|Other Reasons- Unspecified|0|||
27879965|NCT00550043|81394358|FG003|Overall Study|Other Reasons- Unspecified|1|||
27879966|NCT00550043|81394359|FG004|Overall Study|Other Reasons- Unspecified|0|||
27879967|NCT02644668|81394360|FG000|Overall Study|Adverse Event|2|||
27879968|NCT02644668|81394361|FG001|Overall Study|Adverse Event|0|||
27879969|NCT02644668|81394362|FG002|Overall Study|Adverse Event|1|||
27879970|NCT02644668|81394360|FG000|Overall Study|Protocol Violation|0|||
27879971|NCT02644668|81394361|FG001|Overall Study|Protocol Violation|0|||
27879972|NCT02644668|81394362|FG002|Overall Study|Protocol Violation|1|||
27879973|NCT02644668|81394360|FG000|Overall Study|Withdrawal by Subject|0|||
27879974|NCT02644668|81394361|FG001|Overall Study|Withdrawal by Subject|0|||
27879975|NCT02644668|81394362|FG002|Overall Study|Withdrawal by Subject|1|||
27879976|NCT02366689|81394367|FG000|Overall Study|Withdrawal by Subject|1|||
27879977|NCT02366689|81394368|FG001|Overall Study|Withdrawal by Subject|0|||
27879978|NCT02366689|81394369|FG002|Overall Study|Withdrawal by Subject|1|||
27879979|NCT02366689|81394367|FG000|Overall Study|Lost to Follow-up|3|||
27879980|NCT02366689|81394368|FG001|Overall Study|Lost to Follow-up|2|||
27879981|NCT02366689|81394369|FG002|Overall Study|Lost to Follow-up|0|||
27879982|NCT02366689|81394367|FG000|Overall Study|Pregnancy|0|||
27879983|NCT02366689|81394368|FG001|Overall Study|Pregnancy|1|||
27879984|NCT02366689|81394369|FG002|Overall Study|Pregnancy|1|||
27879985|NCT00891020|81394370|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
27879986|NCT00891020|81394371|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
27879987|NCT00891020|81394372|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
27879988|NCT00891020|81394370|FG000|24 Week Treatment Period|Death|0|||
27879989|NCT00891020|81394371|FG001|24 Week Treatment Period|Death|2|||
27879990|NCT00891020|81394372|FG002|24 Week Treatment Period|Death|0|||
27692761|NCT01874431|80709766|FG006|Overall Study|Physician Decision|0|||
27879991|NCT00891020|81394370|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
27879992|NCT00891020|81394371|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
27591391|NCT02952924|80344928|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591392|NCT02952924|80344929|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591393|NCT02952924|80344930|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591394|NCT02952924|80344931|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591395|NCT02952924|80344932|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591396|NCT02952924|80344933|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
27692762|NCT01874431|80709767|FG007|Overall Study|Physician Decision|0|||
27818107|NCT00048568|81166640|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
27818108|NCT00048568|81166638|FG000|Open-Label Period|Death|0|||
27818109|NCT00048568|81166639|FG001|Open-Label Period|Death|0|||
27818110|NCT00048568|81166640|FG002|Open-Label Period|Death|13|||
27818111|NCT00048568|81166638|FG000|Open-Label Period|Adverse Event|0|||
27818112|NCT00048568|81166639|FG001|Open-Label Period|Adverse Event|0|||
27818113|NCT00048568|81166640|FG002|Open-Label Period|Adverse Event|49|||
27818114|NCT00048568|81166638|FG000|Open-Label Period|Lack of Efficacy|0|||
27818115|NCT00048568|81166639|FG001|Open-Label Period|Lack of Efficacy|0|||
27818116|NCT00048568|81166640|FG002|Open-Label Period|Lack of Efficacy|32|||
27818117|NCT00048568|81166638|FG000|Open-Label Period|Withdrawal by Subject|0|||
27818118|NCT00048568|81166639|FG001|Open-Label Period|Withdrawal by Subject|0|||
27818119|NCT00048568|81166640|FG002|Open-Label Period|Withdrawal by Subject|26|||
27818120|NCT00048568|81166638|FG000|Open-Label Period|Pregnancy|0|||
27818121|NCT00048568|81166639|FG001|Open-Label Period|Pregnancy|0|||
27818122|NCT00048568|81166640|FG002|Open-Label Period|Pregnancy|5|||
27818123|NCT00048568|81166638|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
27818124|NCT00048568|81166639|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
27818125|NCT00048568|81166640|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
27818126|NCT00048568|81166638|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
27818127|NCT00048568|81166639|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
27879993|NCT00891020|81394372|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
27879994|NCT00891020|81394370|FG000|24 Week Treatment Period|Failure to return|4|||
27879995|NCT00891020|81394371|FG001|24 Week Treatment Period|Failure to return|5|||
27879996|NCT00891020|81394372|FG002|24 Week Treatment Period|Failure to return|5|||
27879997|NCT00891020|81394370|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
27879998|NCT00891020|81394371|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
27879999|NCT00891020|81394372|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
27880000|NCT00891020|81394370|FG000|24 Week Treatment Period|Other protocol violation|1|||
27880001|NCT00891020|81394371|FG001|24 Week Treatment Period|Other protocol violation|1|||
27880002|NCT00891020|81394372|FG002|24 Week Treatment Period|Other protocol violation|2|||
27880003|NCT00891020|81394370|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
27880004|NCT00891020|81394371|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
27880005|NCT00891020|81394372|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
27880006|NCT00891020|81394370|FG000|24 Week Treatment Period|Withdrew consent|6|||
27880007|NCT00891020|81394371|FG001|24 Week Treatment Period|Withdrew consent|3|||
27880008|NCT00891020|81394372|FG002|24 Week Treatment Period|Withdrew consent|15|||
27880009|NCT00891020|81394370|FG000|24 Week Treatment Period|Administrative/Other|5|||
27880010|NCT00891020|81394371|FG001|24 Week Treatment Period|Administrative/Other|6|||
27880011|NCT00891020|81394372|FG002|24 Week Treatment Period|Administrative/Other|1|||
27880012|NCT00891020|81394370|FG000|Long-term Extension Period|Adverse Event|1|||
27880013|NCT00891020|81394371|FG001|Long-term Extension Period|Adverse Event|11|||
27880014|NCT00891020|81394372|FG002|Long-term Extension Period|Adverse Event|10|||
27880015|NCT00891020|81394370|FG000|Long-term Extension Period|Death|0|||
27880016|NCT00891020|81394371|FG001|Long-term Extension Period|Death|0|||
27880017|NCT00891020|81394372|FG002|Long-term Extension Period|Death|1|||
27880018|NCT00891020|81394370|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
27880019|NCT00891020|81394371|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
27880020|NCT00891020|81394372|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
27880021|NCT00891020|81394370|FG000|Long-term Extension Period|Protocol Violation|0|||
27880022|NCT00891020|81394371|FG001|Long-term Extension Period|Protocol Violation|1|||
27880023|NCT00891020|81394372|FG002|Long-term Extension Period|Protocol Violation|1|||
27880024|NCT00891020|81394370|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
27880025|NCT00891020|81394371|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
27880026|NCT00891020|81394372|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
27880027|NCT00891020|81394370|FG000|Long-term Extension Period|Failure to return|0|||
27880028|NCT00891020|81394371|FG001|Long-term Extension Period|Failure to return|2|||
27880029|NCT00891020|81394372|FG002|Long-term Extension Period|Failure to return|3|||
27880030|NCT00891020|81394370|FG000|Long-term Extension Period|Administrative|1|||
27880031|NCT00891020|81394371|FG001|Long-term Extension Period|Administrative|2|||
27880032|NCT00891020|81394372|FG002|Long-term Extension Period|Administrative|2|||
27880033|NCT00634803|81394376|FG000|Overall Study|Lost to Follow-up|6|||
27880034|NCT00634803|81394377|FG001|Overall Study|Lost to Follow-up|7|||
27880035|NCT00634803|81394378|FG002|Overall Study|Lost to Follow-up|7|||
27880036|NCT00568451|81394383|FG000|Overall Study|Disease Progression|0|||
27880037|NCT00568451|81394384|FG001|Overall Study|Disease Progression|0|||
27880038|NCT00568451|81394385|FG002|Overall Study|Disease Progression|2|||
27692763|NCT01874431|80709760|FG000|Overall Study|Adverse Event|5|||
27880039|NCT00568451|81394386|FG003|Overall Study|Disease Progression|7|||
27880040|NCT02968173|81394387|FG000|Overall Study|Withdrawal by Subject|1|||
27880041|NCT00757042|81394388|FG000|Overall Study|Lost to Follow-up|0|||
27880042|NCT00757042|81394389|FG001|Overall Study|Lost to Follow-up|0|||
27880043|NCT00757042|81394390|FG002|Overall Study|Lost to Follow-up|0|||
27880044|NCT00757042|81394391|FG003|Overall Study|Lost to Follow-up|0|||
27880045|NCT00757042|81394392|FG004|Overall Study|Lost to Follow-up|0|||
27880046|NCT00757042|81394393|FG005|Overall Study|Lost to Follow-up|0|||
27880047|NCT00757042|81394394|FG006|Overall Study|Lost to Follow-up|0|||
27880048|NCT00757042|81394395|FG007|Overall Study|Lost to Follow-up|0|||
27880049|NCT00757042|81394396|FG008|Overall Study|Lost to Follow-up|1|||
27880050|NCT00757042|81394397|FG009|Overall Study|Lost to Follow-up|0|||
27880051|NCT00757042|81394398|FG010|Overall Study|Lost to Follow-up|0|||
27880052|NCT00757042|81394388|FG000|Overall Study|Ineligibility Determined|0|||
27880053|NCT00757042|81394389|FG001|Overall Study|Ineligibility Determined|0|||
27880054|NCT00757042|81394390|FG002|Overall Study|Ineligibility Determined|0|||
27880055|NCT00757042|81394391|FG003|Overall Study|Ineligibility Determined|0|||
27880056|NCT00757042|81394392|FG004|Overall Study|Ineligibility Determined|0|||
27880057|NCT00757042|81394393|FG005|Overall Study|Ineligibility Determined|0|||
27880058|NCT00757042|81394394|FG006|Overall Study|Ineligibility Determined|0|||
27880059|NCT00757042|81394395|FG007|Overall Study|Ineligibility Determined|0|||
27880060|NCT00757042|81394396|FG008|Overall Study|Ineligibility Determined|0|||
27818128|NCT00048568|81166640|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
27818129|NCT00048568|81166638|FG000|Open-Label Period|Unknown Reasons|0|||
27818130|NCT00048568|81166639|FG001|Open-Label Period|Unknown Reasons|0|||
27818131|NCT00048568|81166640|FG002|Open-Label Period|Unknown Reasons|25|||
27818132|NCT00048568|81166638|FG000|Open-Label Period|Lost to Follow-up|0|||
27692764|NCT01874431|80709761|FG001|Overall Study|Adverse Event|4|||
27692765|NCT01874431|80709762|FG002|Overall Study|Adverse Event|6|||
27818133|NCT00048568|81166639|FG001|Open-Label Period|Lost to Follow-up|0|||
27818134|NCT00048568|81166640|FG002|Open-Label Period|Lost to Follow-up|7|||
27818135|NCT04652453|81166643|FG000|Overall Study|Death|8|||
27818136|NCT04652453|81166644|FG001|Overall Study|Death|2|||
27818137|NCT04652453|81166645|FG002|Overall Study|Death|0|||
27818138|NCT04652453|81166643|FG000|Overall Study|Hospice|5|||
27880061|NCT00757042|81394397|FG009|Overall Study|Ineligibility Determined|0|||
27880062|NCT00757042|81394398|FG010|Overall Study|Ineligibility Determined|1|||
27880063|NCT00757042|81394388|FG000|Overall Study|Withdrawal by Subject|0|||
27880064|NCT00757042|81394389|FG001|Overall Study|Withdrawal by Subject|0|||
27880065|NCT00757042|81394390|FG002|Overall Study|Withdrawal by Subject|0|||
27818139|NCT04652453|81166644|FG001|Overall Study|Hospice|5|||
27818140|NCT04652453|81166645|FG002|Overall Study|Hospice|0|||
27818141|NCT04652453|81166643|FG000|Overall Study|Withdrawal by Subject|2|||
27818142|NCT04652453|81166644|FG001|Overall Study|Withdrawal by Subject|0|||
27818143|NCT04652453|81166645|FG002|Overall Study|Withdrawal by Subject|0|||
27818144|NCT00101582|81166646|FG000|Overall Study|Ineligibility determined|0|||
27818145|NCT00101582|81166647|FG001|Overall Study|Ineligibility determined|1|||
27818146|NCT00101582|81166646|FG000|Overall Study|Adverse Event|1|||
27818147|NCT00101582|81166647|FG001|Overall Study|Adverse Event|4|||
27818148|NCT00101582|81166646|FG000|Overall Study|Withdrawal by Subject|6|||
27818149|NCT00101582|81166647|FG001|Overall Study|Withdrawal by Subject|4|||
27818150|NCT00101582|81166646|FG000|Overall Study|Physician Decision|1|||
27818151|NCT00101582|81166647|FG001|Overall Study|Physician Decision|0|||
27818152|NCT00101582|81166646|FG000|Overall Study|Death|3|||
27818153|NCT00101582|81166647|FG001|Overall Study|Death|5|||
27818154|NCT00101582|81166646|FG000|Overall Study|Other|0|||
27818155|NCT00101582|81166647|FG001|Overall Study|Other|1|||
27818156|NCT00094302|81166650|FG000|Overall Study|Lost to Follow-up|43|||
27818157|NCT00094302|81166651|FG001|Overall Study|Lost to Follow-up|41|||
27818158|NCT00094302|81166650|FG000|Overall Study|Physician Decision|5|||
27818159|NCT00094302|81166651|FG001|Overall Study|Physician Decision|8|||
27818160|NCT00094302|81166650|FG000|Overall Study|Withdrawal by Subject|103|||
27818161|NCT00094302|81166651|FG001|Overall Study|Withdrawal by Subject|111|||
27818162|NCT00094302|81166650|FG000|Overall Study|Death|266|||
27818163|NCT00094302|81166651|FG001|Overall Study|Death|246|||
27818164|NCT00973700|81166652|FG000|Overall Study|Withdrawal by Subject|2|||
27818165|NCT00973700|81166653|FG001|Overall Study|Withdrawal by Subject|2|||
27818166|NCT00973700|81166654|FG002|Overall Study|Withdrawal by Subject|8|||
27818167|NCT00973700|81166655|FG003|Overall Study|Withdrawal by Subject|4|||
27818168|NCT00973700|81166656|FG004|Overall Study|Withdrawal by Subject|4|||
27818169|NCT00973700|81166652|FG000|Overall Study|Lost to Follow-up|5|||
27818170|NCT00973700|81166653|FG001|Overall Study|Lost to Follow-up|0|||
27818171|NCT00973700|81166654|FG002|Overall Study|Lost to Follow-up|1|||
27818172|NCT00973700|81166655|FG003|Overall Study|Lost to Follow-up|8|||
27818173|NCT00973700|81166656|FG004|Overall Study|Lost to Follow-up|5|||
27818174|NCT00973700|81166652|FG000|Overall Study|Inappropriate enrolment|0|||
27818175|NCT00973700|81166653|FG001|Overall Study|Inappropriate enrolment|0|||
27818176|NCT00973700|81166654|FG002|Overall Study|Inappropriate enrolment|0|||
27818177|NCT00973700|81166655|FG003|Overall Study|Inappropriate enrolment|4|||
27818178|NCT00973700|81166656|FG004|Overall Study|Inappropriate enrolment|0|||
27818179|NCT00973700|81166652|FG000|Overall Study|Unable to Classify|0|||
27818180|NCT00973700|81166653|FG001|Overall Study|Unable to Classify|0|||
27818181|NCT00973700|81166654|FG002|Overall Study|Unable to Classify|1|||
27818182|NCT00973700|81166655|FG003|Overall Study|Unable to Classify|2|||
27818183|NCT00973700|81166656|FG004|Overall Study|Unable to Classify|1|||
27818184|NCT01402908|81166657|FG000|Overall Study|Withdrawal by Subject|30|||
27818185|NCT01402908|81166658|FG001|Overall Study|Withdrawal by Subject|17|||
27818186|NCT01402908|81166657|FG000|Overall Study|Lost to Follow-up|3|||
27818187|NCT01402908|81166658|FG001|Overall Study|Lost to Follow-up|1|||
27818188|NCT01402908|81166657|FG000|Overall Study|Physician Decision|1|||
27818189|NCT01402908|81166658|FG001|Overall Study|Physician Decision|0|||
27818190|NCT03730103|81166665|FG000|Overall Study|Did not meet inclusion criteria|0|||
27818191|NCT03730103|81166666|FG001|Overall Study|Did not meet inclusion criteria|5|||
27818192|NCT03544138|81166667|FG000|Overall Study|Lost to Follow-up|29|||
27818193|NCT01893905|81166670|FG000|Overall Study|Withdrawal by Subject|1|||
27818194|NCT01893905|81166671|FG001|Overall Study|Withdrawal by Subject|0|||
27818195|NCT01893905|81166670|FG000|Overall Study|Adverse Event|9|||
27818196|NCT01893905|81166671|FG001|Overall Study|Adverse Event|3|||
27818197|NCT01893905|81166670|FG000|Overall Study|Lack of Efficacy|5|||
27818198|NCT01893905|81166671|FG001|Overall Study|Lack of Efficacy|7|||
27818199|NCT01893905|81166670|FG000|Overall Study|Lost to Follow-up|1|||
27818200|NCT01893905|81166671|FG001|Overall Study|Lost to Follow-up|0|||
27818201|NCT01893905|81166670|FG000|Overall Study|Protocol Violation|6|||
27818202|NCT01893905|81166671|FG001|Overall Study|Protocol Violation|1|||
27818203|NCT01893905|81166670|FG000|Overall Study|Lack of adherence to treatment|2|||
27818204|NCT01893905|81166671|FG001|Overall Study|Lack of adherence to treatment|0|||
27818205|NCT01893905|81166670|FG000|Overall Study|Other reason|1|||
27818206|NCT01893905|81166671|FG001|Overall Study|Other reason|3|||
27818207|NCT01402947|81166672|FG000|First Intervention|Adverse Event|0|||
27818208|NCT01402947|81166673|FG001|First Intervention|Adverse Event|1|||
27818209|NCT00365300|81166682|FG000|Open-label Phase|Adverse Event|4|||
27818210|NCT00365300|81166683|FG001|Open-label Phase|Adverse Event|0|||
27818211|NCT00365300|81166682|FG000|Open-label Phase|Failed to Return|1|||
27818212|NCT00365300|81166683|FG001|Open-label Phase|Failed to Return|0|||
27818213|NCT00365300|81166682|FG000|Open-label Phase|Physician Decision|1|||
27880066|NCT00757042|81394391|FG003|Overall Study|Withdrawal by Subject|0|||
27880067|NCT00757042|81394392|FG004|Overall Study|Withdrawal by Subject|0|||
27880068|NCT00757042|81394393|FG005|Overall Study|Withdrawal by Subject|0|||
27880069|NCT00757042|81394394|FG006|Overall Study|Withdrawal by Subject|0|||
27880070|NCT00757042|81394395|FG007|Overall Study|Withdrawal by Subject|0|||
27880071|NCT00757042|81394396|FG008|Overall Study|Withdrawal by Subject|0|||
27880072|NCT00757042|81394397|FG009|Overall Study|Withdrawal by Subject|1|||
27880073|NCT00757042|81394398|FG010|Overall Study|Withdrawal by Subject|0|||
27880074|NCT01620138|81394399|FG000|Overall Study|Withdrawal by Subject|3|||
27880075|NCT01620138|81394400|FG001|Overall Study|Withdrawal by Subject|0|||
27880076|NCT01620138|81394399|FG000|Overall Study|Lack of Efficacy|1|||
27880077|NCT01620138|81394400|FG001|Overall Study|Lack of Efficacy|0|||
27880078|NCT01620138|81394399|FG000|Overall Study|Adverse Event|2|||
27880079|NCT01620138|81394400|FG001|Overall Study|Adverse Event|0|||
27880080|NCT02091089|81394401|FG000|Overall Study|Lost to Follow-up|2|||
27880081|NCT01019694|81394402|FG000|Overall Study|Adverse Event|12|||
27880082|NCT01019694|81394403|FG001|Overall Study|Adverse Event|16|||
27880083|NCT01019694|81394404|FG002|Overall Study|Adverse Event|19|||
27880084|NCT01019694|81394402|FG000|Overall Study|Protocol Violation|2|||
27880085|NCT01019694|81394403|FG001|Overall Study|Protocol Violation|6|||
27880086|NCT01019694|81394404|FG002|Overall Study|Protocol Violation|4|||
27880087|NCT01019694|81394402|FG000|Overall Study|Lost to Follow-up|5|||
27880088|NCT01019694|81394403|FG001|Overall Study|Lost to Follow-up|3|||
27880089|NCT01019694|81394404|FG002|Overall Study|Lost to Follow-up|3|||
27880090|NCT01019694|81394402|FG000|Overall Study|Withdrawal by Subject|4|||
27880091|NCT01019694|81394403|FG001|Overall Study|Withdrawal by Subject|6|||
27880092|NCT01019694|81394404|FG002|Overall Study|Withdrawal by Subject|12|||
27880093|NCT01019694|81394402|FG000|Overall Study|Not treated|0|||
27818214|NCT00365300|81166683|FG001|Open-label Phase|Physician Decision|0|||
27818215|NCT00365300|81166682|FG000|Open-label Phase|Noncompliance|9|||
27818216|NCT00365300|81166683|FG001|Open-label Phase|Noncompliance|0|||
27818217|NCT00365300|81166682|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
27818218|NCT00365300|81166683|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
27818219|NCT00365300|81166682|FG000|Open-label Phase|Protocol Violation|1|||
27818220|NCT00365300|81166683|FG001|Open-label Phase|Protocol Violation|0|||
27818221|NCT00365300|81166682|FG000|Open-label Phase|Lack of Efficacy|1|||
27818222|NCT00365300|81166683|FG001|Open-label Phase|Lack of Efficacy|0|||
27818223|NCT00365300|81166682|FG000|Open-label Phase|Patient skipped open label phase|1|||
27818224|NCT00365300|81166683|FG001|Open-label Phase|Patient skipped open label phase|0|||
27818225|NCT00365300|81166682|FG000|Double-blind Phase|Failed to return|1|||
27818226|NCT00365300|81166683|FG001|Double-blind Phase|Failed to return|0|||
27818227|NCT00365300|81166682|FG000|Double-blind Phase|Noncompliance|1|||
27818228|NCT00365300|81166683|FG001|Double-blind Phase|Noncompliance|1|||
27818229|NCT00365300|81166682|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27818230|NCT00365300|81166683|FG001|Double-blind Phase|Withdrawal by Subject|1|||
27818231|NCT00365300|81166682|FG000|Double-blind Phase|Protocol Violation|3|||
27818232|NCT00365300|81166683|FG001|Double-blind Phase|Protocol Violation|1|||
27818233|NCT00365300|81166682|FG000|Double-blind Phase|Lack of Efficacy|6|||
27818234|NCT00365300|81166683|FG001|Double-blind Phase|Lack of Efficacy|6|||
27818235|NCT01126736|81166692|FG000|Overall Study|Death|2|||
27818236|NCT01126736|81166693|FG001|Overall Study|Death|2|||
27818237|NCT01126736|81166694|FG002|Overall Study|Death|1|||
27818238|NCT01126736|81166695|FG003|Overall Study|Death|19|||
27818239|NCT01126736|81166696|FG004|Overall Study|Death|19|||
27818240|NCT01126736|81166692|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
27818241|NCT01126736|81166693|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
27818242|NCT01126736|81166694|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
27818243|NCT01126736|81166695|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
27818244|NCT01126736|81166696|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
27818245|NCT01126736|81166692|FG000|Overall Study|Lost to Follow-up|0|||
27818246|NCT01126736|81166693|FG001|Overall Study|Lost to Follow-up|0|||
27818247|NCT01126736|81166694|FG002|Overall Study|Lost to Follow-up|0|||
27880094|NCT01019694|81394403|FG001|Overall Study|Not treated|2|||
27880095|NCT01019694|81394404|FG002|Overall Study|Not treated|3|||
27880096|NCT01019694|81394402|FG000|Overall Study|Other reason (not specified)|1|||
27880097|NCT01019694|81394403|FG001|Overall Study|Other reason (not specified)|5|||
27692766|NCT01874431|80709763|FG003|Overall Study|Adverse Event|5|||
27880098|NCT01019694|81394404|FG002|Overall Study|Other reason (not specified)|6|||
27880099|NCT00428246|81394405|FG000|Overall Study|Withdrawal by Subject|0|||
27818248|NCT01126736|81166695|FG003|Overall Study|Lost to Follow-up|1|||
27818249|NCT01126736|81166696|FG004|Overall Study|Lost to Follow-up|1|||
27818250|NCT01126736|81166692|FG000|Overall Study|Administrative reasons|0|||
27880100|NCT00428246|81394406|FG001|Overall Study|Withdrawal by Subject|0|||
27880101|NCT00428246|81394407|FG002|Overall Study|Withdrawal by Subject|1|||
27880102|NCT00428246|81394405|FG000|Overall Study|Adverse Event|1|||
27880103|NCT00428246|81394406|FG001|Overall Study|Adverse Event|0|||
27880104|NCT00428246|81394407|FG002|Overall Study|Adverse Event|0|||
27880105|NCT00454246|81394408|FG000|Overall Study|Adverse Event|2|||
27880106|NCT00454246|81394409|FG001|Overall Study|Adverse Event|2|||
27880107|NCT00454246|81394410|FG002|Overall Study|Adverse Event|0|||
27880108|NCT00454246|81394408|FG000|Overall Study|Violation of selection criteria at entry|6|||
27880109|NCT00454246|81394409|FG001|Overall Study|Violation of selection criteria at entry|0|||
27880110|NCT00454246|81394410|FG002|Overall Study|Violation of selection criteria at entry|0|||
27880111|NCT00454246|81394408|FG000|Overall Study|Protocol Violation|1|||
27880112|NCT00454246|81394409|FG001|Overall Study|Protocol Violation|0|||
27880113|NCT00454246|81394410|FG002|Overall Study|Protocol Violation|0|||
27880114|NCT00454246|81394408|FG000|Overall Study|Refused Treatment|1|||
27880115|NCT00454246|81394409|FG001|Overall Study|Refused Treatment|1|||
27880116|NCT00454246|81394410|FG002|Overall Study|Refused Treatment|0|||
27880117|NCT00454246|81394408|FG000|Overall Study|Failure to return|1|||
27880118|NCT00454246|81394409|FG001|Overall Study|Failure to return|0|||
27880119|NCT00454246|81394410|FG002|Overall Study|Failure to return|0|||
27880120|NCT00454246|81394408|FG000|Overall Study|Early termination of study|62|||
27880121|NCT00454246|81394409|FG001|Overall Study|Early termination of study|26|||
27880122|NCT00454246|81394410|FG002|Overall Study|Early termination of study|9|||
27880123|NCT01823328|81394418|FG000|Overall Study|Withdrawal by Subject|8|||
27880124|NCT01823328|81394419|FG001|Overall Study|Withdrawal by Subject|6|||
27880125|NCT00765336|81394421|FG000|Overall Study|Protocol Violation|4|||
27880126|NCT00765336|81394422|FG001|Overall Study|Protocol Violation|2|||
27880127|NCT00765336|81394421|FG000|Overall Study|Withdrawal by Subject|6|||
27880128|NCT00765336|81394422|FG001|Overall Study|Withdrawal by Subject|4|||
27692767|NCT01874431|80709764|FG004|Overall Study|Adverse Event|2|||
27818251|NCT01126736|81166693|FG001|Overall Study|Administrative reasons|0|||
27818252|NCT01126736|81166694|FG002|Overall Study|Administrative reasons|0|||
27818253|NCT01126736|81166695|FG003|Overall Study|Administrative reasons|0|||
27818254|NCT01126736|81166696|FG004|Overall Study|Administrative reasons|1|||
27818255|NCT01126736|81166692|FG000|Overall Study|Progressive disease|0|||
27818256|NCT01126736|81166693|FG001|Overall Study|Progressive disease|0|||
27818257|NCT01126736|81166694|FG002|Overall Study|Progressive disease|0|||
27818258|NCT01126736|81166695|FG003|Overall Study|Progressive disease|2|||
27818259|NCT01126736|81166696|FG004|Overall Study|Progressive disease|1|||
27818260|NCT01126736|81166692|FG000|Overall Study|Withdrawal by Subject|0|||
27818261|NCT01126736|81166693|FG001|Overall Study|Withdrawal by Subject|0|||
27818262|NCT01126736|81166694|FG002|Overall Study|Withdrawal by Subject|0|||
27880129|NCT00765336|81394421|FG000|Overall Study|Lost to Follow-up|7|||
27880130|NCT00765336|81394422|FG001|Overall Study|Lost to Follow-up|9|||
27880131|NCT00765336|81394421|FG000|Overall Study|Adverse Event|2|||
27880132|NCT00765336|81394422|FG001|Overall Study|Adverse Event|1|||
27880133|NCT00386360|81394425|FG000|Overall Study|Adverse Event|4|||
27880134|NCT00386360|81394426|FG001|Overall Study|Adverse Event|2|||
27880135|NCT00386360|81394425|FG000|Overall Study|Physician Decision|2|||
27880136|NCT00386360|81394426|FG001|Overall Study|Physician Decision|2|||
27880137|NCT00386360|81394425|FG000|Overall Study|Lost to Follow-up|0|||
27880138|NCT00386360|81394426|FG001|Overall Study|Lost to Follow-up|2|||
27880139|NCT00386360|81394425|FG000|Overall Study|Protocol Violation|0|||
27880140|NCT00386360|81394426|FG001|Overall Study|Protocol Violation|3|||
27880141|NCT00386360|81394425|FG000|Overall Study|Withdrawal by Subject|3|||
27880142|NCT00386360|81394426|FG001|Overall Study|Withdrawal by Subject|6|||
27880143|NCT00386360|81394425|FG000|Overall Study|Did not take any study medication|0|||
27880144|NCT00386360|81394426|FG001|Overall Study|Did not take any study medication|2|||
27880145|NCT03193853|81394427|FG000|Overall Study|Death|6|||
27880146|NCT03051100|81394428|FG000|Overall Study|Withdrawal by Subject|1|||
27880147|NCT03051100|81394429|FG001|Overall Study|Withdrawal by Subject|0|||
27880148|NCT00679211|81394430|FG000|Overall Study|Progressive disease|82|||
27880149|NCT00679211|81394430|FG000|Overall Study|Adverse Event|7|||
27880150|NCT00679211|81394430|FG000|Overall Study|Withdrawal by Subject|2|||
27880151|NCT00679211|81394430|FG000|Overall Study|Physician Decision|5|||
27591397|NCT02952924|80344934|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591398|NCT02952924|80344935|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591399|NCT02952924|80344936|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591400|NCT02952924|80344937|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
27692768|NCT01874431|80709765|FG005|Overall Study|Adverse Event|8|||
27692769|NCT01874431|80709766|FG006|Overall Study|Adverse Event|2|||
27692770|NCT01874431|80709767|FG007|Overall Study|Adverse Event|3|||
27692771|NCT01874431|80709760|FG000|Overall Study|Protocol Violation|1|||
27692772|NCT01874431|80709761|FG001|Overall Study|Protocol Violation|1|||
27591401|NCT02952924|80344938|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591402|NCT02952924|80344939|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591403|NCT02952924|80344940|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591404|NCT02952924|80344941|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591405|NCT02952924|80344942|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591406|NCT02952924|80344943|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591407|NCT02952924|80344944|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591408|NCT02952924|80344945|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591409|NCT02952924|80344946|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591410|NCT02952924|80344947|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
27692773|NCT01874431|80709762|FG002|Overall Study|Protocol Violation|1|||
27692774|NCT01874431|80709763|FG003|Overall Study|Protocol Violation|0|||
27591411|NCT02952924|80344948|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
27591412|NCT02952924|80344949|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
27591413|NCT02952924|80344928|FG000|Overall Study|Noncompliance with study drug|0|||
27591414|NCT02952924|80344929|FG001|Overall Study|Noncompliance with study drug|0|||
27591415|NCT02952924|80344930|FG002|Overall Study|Noncompliance with study drug|0|||
27692775|NCT01874431|80709764|FG004|Overall Study|Protocol Violation|3|||
27692776|NCT01874431|80709765|FG005|Overall Study|Protocol Violation|2|||
27692777|NCT01874431|80709766|FG006|Overall Study|Protocol Violation|1|||
27692778|NCT01874431|80709767|FG007|Overall Study|Protocol Violation|1|||
27880152|NCT00679211|81394430|FG000|Overall Study|Refused to undergo protocol procedures|1|||
27880153|NCT00679211|81394430|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
27880154|NCT00679211|81394430|FG000|Overall Study|Other|1|||
27880155|NCT00288626|81394431|FG000|Overall Study|Death|3|||
27880156|NCT00288626|81394431|FG000|Overall Study|Withdrawal by Subject|4|||
27880157|NCT01218087|81394432|FG000|Overall Study|Death|2|||
27880158|NCT01218087|81394433|FG001|Overall Study|Death|1|||
27591416|NCT02952924|80344931|FG003|Overall Study|Noncompliance with study drug|0|||
27591417|NCT02952924|80344932|FG004|Overall Study|Noncompliance with study drug|0|||
27591418|NCT02952924|80344933|FG005|Overall Study|Noncompliance with study drug|0|||
27591419|NCT02952924|80344934|FG006|Overall Study|Noncompliance with study drug|0|||
27591420|NCT02952924|80344935|FG007|Overall Study|Noncompliance with study drug|0|||
27591421|NCT02952924|80344936|FG008|Overall Study|Noncompliance with study drug|0|||
27591422|NCT02952924|80344937|FG009|Overall Study|Noncompliance with study drug|0|||
27591423|NCT02952924|80344938|FG010|Overall Study|Noncompliance with study drug|0|||
27591424|NCT02952924|80344939|FG011|Overall Study|Noncompliance with study drug|0|||
27591425|NCT02952924|80344940|FG012|Overall Study|Noncompliance with study drug|0|||
27591426|NCT02952924|80344941|FG013|Overall Study|Noncompliance with study drug|0|||
27591427|NCT02952924|80344942|FG014|Overall Study|Noncompliance with study drug|0|||
27591428|NCT02952924|80344943|FG015|Overall Study|Noncompliance with study drug|0|||
27591429|NCT02952924|80344944|FG016|Overall Study|Noncompliance with study drug|0|||
27591430|NCT02952924|80344945|FG017|Overall Study|Noncompliance with study drug|0|||
27591431|NCT02952924|80344946|FG018|Overall Study|Noncompliance with study drug|0|||
27591432|NCT02952924|80344947|FG019|Overall Study|Noncompliance with study drug|0|||
27591433|NCT02952924|80344948|FG020|Overall Study|Noncompliance with study drug|0|||
27591434|NCT02952924|80344949|FG021|Overall Study|Noncompliance with study drug|1|||
27591435|NCT02310750|80344950|FG000|HP Period 1|Lost to Follow-up|0|||
27591436|NCT02310750|80344951|FG001|HP Period 1|Lost to Follow-up|0|||
27591437|NCT02310750|80344952|FG002|HP Period 1|Lost to Follow-up|0|||
27591438|NCT02310750|80344953|FG003|HP Period 1|Lost to Follow-up|0|||
27591439|NCT02310750|80344954|FG004|HP Period 1|Lost to Follow-up|0|||
27591440|NCT02310750|80344955|FG005|HP Period 1|Lost to Follow-up|0|||
27591441|NCT02310750|80344956|FG006|HP Period 1|Lost to Follow-up|1|||
27591442|NCT02310750|80344957|FG007|HP Period 1|Lost to Follow-up|0|||
27591443|NCT02310750|80344958|FG008|HP Period 1|Lost to Follow-up|0|||
27591444|NCT02310750|80344959|FG009|HP Period 1|Lost to Follow-up|0|||
27591445|NCT02310750|80344960|FG010|HP Period 1|Lost to Follow-up|0|||
27591446|NCT02310750|80344961|FG011|HP Period 1|Lost to Follow-up|0|||
27591447|NCT02310750|80344962|FG012|HP Period 1|Lost to Follow-up|0|||
27591448|NCT02310750|80344963|FG013|HP Period 1|Lost to Follow-up|0|||
27591449|NCT02310750|80344964|FG014|HP Period 1|Lost to Follow-up|0|||
27591450|NCT02310750|80344965|FG015|HP Period 1|Lost to Follow-up|0|||
27591451|NCT02310750|80344950|FG000|HP Period 1|Withdrawal by Subject|1|||
27591452|NCT02310750|80344951|FG001|HP Period 1|Withdrawal by Subject|0|||
27591453|NCT02310750|80344952|FG002|HP Period 1|Withdrawal by Subject|0|||
27591454|NCT02310750|80344953|FG003|HP Period 1|Withdrawal by Subject|1|||
27591455|NCT02310750|80344954|FG004|HP Period 1|Withdrawal by Subject|0|||
27591456|NCT02310750|80344955|FG005|HP Period 1|Withdrawal by Subject|0|||
27591457|NCT02310750|80344956|FG006|HP Period 1|Withdrawal by Subject|0|||
27591458|NCT02310750|80344957|FG007|HP Period 1|Withdrawal by Subject|0|||
27591459|NCT02310750|80344958|FG008|HP Period 1|Withdrawal by Subject|0|||
27591460|NCT02310750|80344959|FG009|HP Period 1|Withdrawal by Subject|0|||
27591461|NCT02310750|80344960|FG010|HP Period 1|Withdrawal by Subject|0|||
27591462|NCT02310750|80344961|FG011|HP Period 1|Withdrawal by Subject|0|||
27591463|NCT02310750|80344962|FG012|HP Period 1|Withdrawal by Subject|0|||
27591464|NCT02310750|80344963|FG013|HP Period 1|Withdrawal by Subject|0|||
27591465|NCT02310750|80344964|FG014|HP Period 1|Withdrawal by Subject|0|||
27591466|NCT02310750|80344965|FG015|HP Period 1|Withdrawal by Subject|0|||
27591467|NCT02310750|80344950|FG000|HP Washout 1|Lost to Follow-up|0|||
27591468|NCT02310750|80344951|FG001|HP Washout 1|Lost to Follow-up|0|||
27591469|NCT02310750|80344952|FG002|HP Washout 1|Lost to Follow-up|1|||
27591470|NCT02310750|80344953|FG003|HP Washout 1|Lost to Follow-up|1|||
27591471|NCT02310750|80344954|FG004|HP Washout 1|Lost to Follow-up|2|||
27591472|NCT02310750|80344955|FG005|HP Washout 1|Lost to Follow-up|2|||
27591473|NCT02310750|80344956|FG006|HP Washout 1|Lost to Follow-up|3|||
27591474|NCT02310750|80344957|FG007|HP Washout 1|Lost to Follow-up|0|||
27591475|NCT02310750|80344958|FG008|HP Washout 1|Lost to Follow-up|0|||
27591476|NCT02310750|80344959|FG009|HP Washout 1|Lost to Follow-up|0|||
27818263|NCT01126736|81166695|FG003|Overall Study|Withdrawal by Subject|1|||
27818264|NCT01126736|81166696|FG004|Overall Study|Withdrawal by Subject|1|||
27818265|NCT01126736|81166692|FG000|Overall Study|Other|2|||
27818266|NCT01126736|81166693|FG001|Overall Study|Other|4|||
27818267|NCT01126736|81166694|FG002|Overall Study|Other|4|||
27818268|NCT01126736|81166695|FG003|Overall Study|Other|16|||
27818269|NCT01126736|81166696|FG004|Overall Study|Other|15|||
27818270|NCT02402166|81166707|FG000|Overall Study|Adverse Event|2|||
27818271|NCT02402166|81166707|FG000|Overall Study|Withdrawal by Subject|2|||
27818272|NCT02402166|81166707|FG000|Overall Study|Lost to Follow-up|1|||
27818273|NCT01936948|81166708|FG000|Overall Study|no 30-day follow-up data|0|||
27818274|NCT01936948|81166709|FG001|Overall Study|no 30-day follow-up data|3|||
27591477|NCT02310750|80344960|FG010|HP Washout 1|Lost to Follow-up|0|||
27591478|NCT02310750|80344961|FG011|HP Washout 1|Lost to Follow-up|0|||
27591479|NCT02310750|80344962|FG012|HP Washout 1|Lost to Follow-up|0|||
27818275|NCT01936948|81166710|FG002|Overall Study|no 30-day follow-up data|3|||
27591480|NCT02310750|80344963|FG013|HP Washout 1|Lost to Follow-up|0|||
27591481|NCT02310750|80344964|FG014|HP Washout 1|Lost to Follow-up|0|||
27591482|NCT02310750|80344965|FG015|HP Washout 1|Lost to Follow-up|0|||
27591483|NCT02310750|80344950|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591484|NCT02310750|80344951|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591485|NCT02310750|80344952|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591486|NCT02310750|80344953|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
27591487|NCT02310750|80344954|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591488|NCT02310750|80344955|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
27591489|NCT02310750|80344956|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591490|NCT02310750|80344957|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591491|NCT02310750|80344958|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
27591492|NCT02310750|80344959|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
27591493|NCT02310750|80344960|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591494|NCT02310750|80344961|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591495|NCT02310750|80344962|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591496|NCT02310750|80344963|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27692779|NCT01874431|80709760|FG000|Overall Study|Non-compliance|0|||
27692780|NCT01874431|80709761|FG001|Overall Study|Non-compliance|0|||
27692781|NCT01874431|80709762|FG002|Overall Study|Non-compliance|0|||
27591497|NCT02310750|80344964|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591498|NCT02310750|80344965|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
27591499|NCT02310750|80344950|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591500|NCT02310750|80344951|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591501|NCT02310750|80344952|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591502|NCT02310750|80344953|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591503|NCT02310750|80344954|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591504|NCT02310750|80344955|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591505|NCT02310750|80344956|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591506|NCT02310750|80344957|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591507|NCT02310750|80344958|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591508|NCT02310750|80344959|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
27591509|NCT02310750|80344960|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591510|NCT02310750|80344961|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591511|NCT02310750|80344962|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591512|NCT02310750|80344963|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591513|NCT02310750|80344964|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591514|NCT02310750|80344965|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
27591515|NCT02310750|80344950|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591516|NCT02310750|80344951|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591517|NCT02310750|80344952|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591518|NCT02310750|80344953|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591519|NCT02310750|80344954|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591520|NCT02310750|80344955|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591521|NCT02310750|80344956|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591522|NCT02310750|80344957|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
27591523|NCT02310750|80344958|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
27591524|NCT02310750|80344959|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
27591525|NCT02310750|80344960|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591526|NCT02310750|80344961|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591527|NCT02310750|80344962|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591528|NCT02310750|80344963|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27692782|NCT01874431|80709763|FG003|Overall Study|Non-compliance|0|||
27692783|NCT01874431|80709764|FG004|Overall Study|Non-compliance|1|||
27591529|NCT02310750|80344964|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591530|NCT02310750|80344965|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
27591531|NCT02310750|80344950|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591532|NCT02310750|80344951|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591533|NCT02310750|80344952|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591534|NCT02310750|80344953|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591535|NCT02310750|80344954|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591536|NCT02310750|80344955|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591537|NCT02310750|80344956|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591538|NCT02310750|80344957|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
27591539|NCT02310750|80344958|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
27591540|NCT02310750|80344959|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591541|NCT02310750|80344960|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591542|NCT02310750|80344961|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591543|NCT02310750|80344962|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591544|NCT02310750|80344963|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591545|NCT02310750|80344964|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591546|NCT02310750|80344965|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
27591547|NCT02310750|80344950|FG000|HP Washout 2|Lost to Follow-up|0|||
27591548|NCT02310750|80344951|FG001|HP Washout 2|Lost to Follow-up|0|||
27591549|NCT02310750|80344952|FG002|HP Washout 2|Lost to Follow-up|0|||
27591550|NCT02310750|80344953|FG003|HP Washout 2|Lost to Follow-up|0|||
27591551|NCT02310750|80344954|FG004|HP Washout 2|Lost to Follow-up|1|||
27591552|NCT02310750|80344955|FG005|HP Washout 2|Lost to Follow-up|0|||
27591553|NCT02310750|80344956|FG006|HP Washout 2|Lost to Follow-up|7|||
27591554|NCT02310750|80344957|FG007|HP Washout 2|Lost to Follow-up|0|||
27591555|NCT02310750|80344958|FG008|HP Washout 2|Lost to Follow-up|0|||
27591556|NCT02310750|80344959|FG009|HP Washout 2|Lost to Follow-up|0|||
27591557|NCT02310750|80344960|FG010|HP Washout 2|Lost to Follow-up|0|||
27591558|NCT02310750|80344961|FG011|HP Washout 2|Lost to Follow-up|0|||
27591559|NCT02310750|80344962|FG012|HP Washout 2|Lost to Follow-up|0|||
27591560|NCT02310750|80344963|FG013|HP Washout 2|Lost to Follow-up|0|||
27591561|NCT02310750|80344964|FG014|HP Washout 2|Lost to Follow-up|0|||
27818276|NCT01936948|81166711|FG003|Overall Study|no 30-day follow-up data|3|||
27591562|NCT02310750|80344965|FG015|HP Washout 2|Lost to Follow-up|0|||
27591563|NCT05608629|80344971|FG000|Overall Study|Lost to Follow-up|2|||
27818277|NCT01706926|81166712|FG000|Overall Study|Lost to Follow-up|0|||
27818278|NCT01706926|81166713|FG001|Overall Study|Lost to Follow-up|0|||
27818279|NCT01706926|81166714|FG002|Overall Study|Lost to Follow-up|1|||
27818280|NCT01706926|81166715|FG003|Overall Study|Lost to Follow-up|0|||
27818281|NCT01706926|81166712|FG000|Overall Study|Withdrawal by Subject|2|||
27818282|NCT01706926|81166713|FG001|Overall Study|Withdrawal by Subject|0|||
27818283|NCT01706926|81166714|FG002|Overall Study|Withdrawal by Subject|1|||
27591564|NCT03019536|80344972|FG000|Overall Study|Withdrawal by Subject|1|||
27591565|NCT03019536|80344973|FG001|Overall Study|Withdrawal by Subject|1|||
27692784|NCT01874431|80709765|FG005|Overall Study|Non-compliance|0|||
27818284|NCT01706926|81166715|FG003|Overall Study|Withdrawal by Subject|2|||
27818285|NCT01706926|81166712|FG000|Overall Study|Other|4|||
27818286|NCT01706926|81166713|FG001|Overall Study|Other|4|||
27591566|NCT03019536|80344974|FG002|Overall Study|Withdrawal by Subject|0|||
27591567|NCT03019536|80344972|FG000|Overall Study|Adverse Event|0|||
27591568|NCT03019536|80344973|FG001|Overall Study|Adverse Event|0|||
27591569|NCT03019536|80344974|FG002|Overall Study|Adverse Event|2|||
27818287|NCT01706926|81166714|FG002|Overall Study|Other|4|||
27818288|NCT01706926|81166715|FG003|Overall Study|Other|3|||
27591570|NCT01109992|80344975|FG000|Overall Study|Withdrawal by Subject|0|||
27591571|NCT01109992|80344976|FG001|Overall Study|Withdrawal by Subject|1|||
27591572|NCT01109992|80344975|FG000|Overall Study|Movement during rest scan.|0|||
27818289|NCT04524364|81166722|FG000|Overall Study|Physician Decision|3|||
27818290|NCT04524364|81166723|FG001|Overall Study|Physician Decision|6|||
27591573|NCT01109992|80344976|FG001|Overall Study|Movement during rest scan.|1|||
27591574|NCT02959437|80344977|FG000|Overall Study|Death|33|||
27591575|NCT02959437|80344978|FG001|Overall Study|Death|3|||
27818291|NCT04524364|81166722|FG000|Overall Study|Adverse Event|0|||
27591576|NCT02959437|80344979|FG002|Overall Study|Death|0|||
27591577|NCT02959437|80344980|FG003|Overall Study|Death|0|||
27591578|NCT02959437|80344977|FG000|Overall Study|Lost to Follow-up|3|||
27591579|NCT02959437|80344978|FG001|Overall Study|Lost to Follow-up|1|||
27591580|NCT02959437|80344979|FG002|Overall Study|Lost to Follow-up|0|||
27591581|NCT02959437|80344980|FG003|Overall Study|Lost to Follow-up|0|||
27591582|NCT02959437|80344977|FG000|Overall Study|Withdrawal by Subject|11|||
27591583|NCT02959437|80344978|FG001|Overall Study|Withdrawal by Subject|3|||
27591584|NCT02959437|80344979|FG002|Overall Study|Withdrawal by Subject|0|||
27591585|NCT02959437|80344980|FG003|Overall Study|Withdrawal by Subject|0|||
27591586|NCT02959437|80344977|FG000|Overall Study|Progressive Disease|9|||
27591587|NCT02959437|80344978|FG001|Overall Study|Progressive Disease|1|||
27591588|NCT02959437|80344979|FG002|Overall Study|Progressive Disease|0|||
27591589|NCT02959437|80344980|FG003|Overall Study|Progressive Disease|0|||
27591590|NCT02959437|80344977|FG000|Overall Study|Study Terminated by Sponsor|4|||
27591591|NCT02959437|80344978|FG001|Overall Study|Study Terminated by Sponsor|0|||
27591592|NCT02959437|80344979|FG002|Overall Study|Study Terminated by Sponsor|0|||
27591593|NCT02959437|80344980|FG003|Overall Study|Study Terminated by Sponsor|0|||
27591594|NCT02959437|80344977|FG000|Overall Study|Other Unspecified|2|||
27591595|NCT02959437|80344978|FG001|Overall Study|Other Unspecified|0|||
27591596|NCT02959437|80344979|FG002|Overall Study|Other Unspecified|0|||
27591597|NCT02959437|80344980|FG003|Overall Study|Other Unspecified|0|||
27591598|NCT01380327|80344981|FG000|Overall Study|Lost to Follow-up|0|||
27591599|NCT01380327|80344982|FG001|Overall Study|Lost to Follow-up|1|||
27591600|NCT01380327|80344983|FG002|Overall Study|Lost to Follow-up|1|||
27591601|NCT01380327|80344981|FG000|Overall Study|Protocol Violation|3|||
27591602|NCT01380327|80344982|FG001|Overall Study|Protocol Violation|2|||
27591603|NCT01380327|80344983|FG002|Overall Study|Protocol Violation|3|||
27591604|NCT01380327|80344981|FG000|Overall Study|Withdrawal by Subject|0|||
27591605|NCT01380327|80344982|FG001|Overall Study|Withdrawal by Subject|0|||
27591606|NCT01380327|80344983|FG002|Overall Study|Withdrawal by Subject|1|||
27692785|NCT01874431|80709766|FG006|Overall Study|Non-compliance|1|||
27591607|NCT01380327|80344981|FG000|Overall Study|Housing situation precluded ability to k|0|||
27591608|NCT01380327|80344982|FG001|Overall Study|Housing situation precluded ability to k|0|||
27591609|NCT01380327|80344983|FG002|Overall Study|Housing situation precluded ability to k|1|||
27591610|NCT01380327|80344981|FG000|Overall Study|Questionable onset of epilepsy|0|||
27692786|NCT01874431|80709767|FG007|Overall Study|Non-compliance|0|||
27591611|NCT01380327|80344982|FG001|Overall Study|Questionable onset of epilepsy|0|||
27591612|NCT01380327|80344983|FG002|Overall Study|Questionable onset of epilepsy|1|||
27591613|NCT01358968|80344984|FG000|Period 2|Adverse Event|0|||
27692787|NCT01874431|80709760|FG000|Overall Study|Logistical difficulties|0|||
27692788|NCT01874431|80709761|FG001|Overall Study|Logistical difficulties|0|||
27692789|NCT01874431|80709762|FG002|Overall Study|Logistical difficulties|0|||
27692790|NCT01874431|80709763|FG003|Overall Study|Logistical difficulties|0|||
27692791|NCT01874431|80709764|FG004|Overall Study|Logistical difficulties|0|||
27692792|NCT01874431|80709765|FG005|Overall Study|Logistical difficulties|0|||
27692793|NCT01874431|80709766|FG006|Overall Study|Logistical difficulties|1|||
27692794|NCT01874431|80709767|FG007|Overall Study|Logistical difficulties|0|||
27692795|NCT01874431|80709760|FG000|Overall Study|Withdrawal by Subject|0|||
27692796|NCT01874431|80709761|FG001|Overall Study|Withdrawal by Subject|0|||
27692797|NCT01874431|80709762|FG002|Overall Study|Withdrawal by Subject|1|||
27692798|NCT01874431|80709763|FG003|Overall Study|Withdrawal by Subject|2|||
27692799|NCT01874431|80709764|FG004|Overall Study|Withdrawal by Subject|1|||
27692800|NCT01874431|80709765|FG005|Overall Study|Withdrawal by Subject|1|||
27692801|NCT01874431|80709766|FG006|Overall Study|Withdrawal by Subject|3|||
27692802|NCT01874431|80709767|FG007|Overall Study|Withdrawal by Subject|0|||
27692803|NCT01874431|80709760|FG000|Overall Study|Sponsor decision|0|||
27692804|NCT01874431|80709761|FG001|Overall Study|Sponsor decision|0|||
27692805|NCT01874431|80709762|FG002|Overall Study|Sponsor decision|0|||
27692806|NCT01874431|80709763|FG003|Overall Study|Sponsor decision|0|||
27692807|NCT01874431|80709764|FG004|Overall Study|Sponsor decision|1|||
27692808|NCT01874431|80709765|FG005|Overall Study|Sponsor decision|0|||
27692809|NCT01874431|80709766|FG006|Overall Study|Sponsor decision|0|||
27692810|NCT01874431|80709767|FG007|Overall Study|Sponsor decision|0|||
27692811|NCT01874431|80709760|FG000|Overall Study|Lost to Follow-up|0|||
27692812|NCT01874431|80709761|FG001|Overall Study|Lost to Follow-up|0|||
27692813|NCT01874431|80709762|FG002|Overall Study|Lost to Follow-up|1|||
27692814|NCT01874431|80709763|FG003|Overall Study|Lost to Follow-up|0|||
27692815|NCT01874431|80709764|FG004|Overall Study|Lost to Follow-up|0|||
27692816|NCT01874431|80709765|FG005|Overall Study|Lost to Follow-up|0|||
27692817|NCT01874431|80709766|FG006|Overall Study|Lost to Follow-up|0|||
27692818|NCT01874431|80709767|FG007|Overall Study|Lost to Follow-up|0|||
27692819|NCT00319839|80709768|FG000|Overall Study|Adverse Event|5|||
27692820|NCT00319839|80709768|FG000|Overall Study|Withdrawal by Subject|1|||
27692821|NCT00642772|80709769|FG000|Overall Study|Lost to Follow-up|3|||
27692822|NCT00642772|80709769|FG000|Overall Study|Withdrawal by Subject|7|||
27692823|NCT01209143|80713464|FG000|Overall Study|Adverse Event|2|||
27692824|NCT01209143|80713465|FG001|Overall Study|Adverse Event|1|||
27692825|NCT01209143|80713464|FG000|Overall Study|Death|0|||
27692826|NCT01209143|80713465|FG001|Overall Study|Death|1|||
27692827|NCT01209143|80713464|FG000|Overall Study|Physician Decision|3|||
27692828|NCT01209143|80713465|FG001|Overall Study|Physician Decision|1|||
27692829|NCT01209143|80713464|FG000|Overall Study|Lost to Follow-up|1|||
27692830|NCT01209143|80713465|FG001|Overall Study|Lost to Follow-up|0|||
27692831|NCT01209143|80713464|FG000|Overall Study|Withdrawal by Subject|2|||
27692832|NCT01209143|80713465|FG001|Overall Study|Withdrawal by Subject|1|||
27692833|NCT01209143|80713464|FG000|Overall Study|Disease progression|11|||
27692834|NCT01209143|80713465|FG001|Overall Study|Disease progression|16|||
27692835|NCT00775463|80713466|FG000|Overall Study|Withdrawal by Subject|0|||
27591614|NCT01358968|80344985|FG001|Period 2|Adverse Event|1|||
27692836|NCT00775463|80713467|FG001|Overall Study|Withdrawal by Subject|1|||
27692837|NCT00775463|80713466|FG000|Overall Study|Adverse Event|7|||
27692838|NCT00775463|80713467|FG001|Overall Study|Adverse Event|9|||
27692839|NCT00775463|80713466|FG000|Overall Study|Protocol Violation|2|||
27692840|NCT00775463|80713467|FG001|Overall Study|Protocol Violation|2|||
27692841|NCT00775463|80713466|FG000|Overall Study|Lost to Follow-up|1|||
27692842|NCT00775463|80713467|FG001|Overall Study|Lost to Follow-up|0|||
27692843|NCT00775463|80713466|FG000|Overall Study|Lack of Efficacy|1|||
27692844|NCT00775463|80713467|FG001|Overall Study|Lack of Efficacy|1|||
27880159|NCT01218087|81394432|FG000|Overall Study|Withdrawal by Subject|5|||
27692845|NCT02915302|80713468|FG000|Overall Study|Adverse Event|3|||
27692846|NCT02915302|80713469|FG001|Overall Study|Adverse Event|0|||
27692847|NCT02915302|80713468|FG000|Overall Study|Protocol Violation|20|||
27692848|NCT02915302|80713469|FG001|Overall Study|Protocol Violation|27|||
27692849|NCT02915302|80713468|FG000|Overall Study|Lost to Follow-up|19|||
27692850|NCT02915302|80713469|FG001|Overall Study|Lost to Follow-up|22|||
27692851|NCT02915302|80713468|FG000|Overall Study|Withdrawal by Subject|22|||
27692852|NCT02915302|80713469|FG001|Overall Study|Withdrawal by Subject|29|||
27692853|NCT02915302|80713468|FG000|Overall Study|Other|1|||
27692854|NCT02915302|80713469|FG001|Overall Study|Other|0|||
27692855|NCT02499770|80713473|FG000|Overall Study|Death|17|||
27692856|NCT02499770|80713474|FG001|Overall Study|Death|56|||
27692857|NCT02499770|80713473|FG000|Overall Study|Study completion|1|||
27692858|NCT02499770|80713474|FG001|Overall Study|Study completion|10|||
27692859|NCT02499770|80713473|FG000|Overall Study|Withdrawal by Subject|0|||
27692860|NCT02499770|80713474|FG001|Overall Study|Withdrawal by Subject|7|||
27692861|NCT02499770|80713473|FG000|Overall Study|Lost to Follow-up|0|||
27692862|NCT02499770|80713474|FG001|Overall Study|Lost to Follow-up|2|||
27692863|NCT02499770|80713473|FG000|Overall Study|Subject declined further treatment|1|||
27692864|NCT02499770|80713474|FG001|Overall Study|Subject declined further treatment|0|||
27692865|NCT02499770|80713473|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
27692866|NCT02499770|80713474|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
27692867|NCT02499770|80713473|FG000|Overall Study|Randomized but not enrolled|0|||
27692868|NCT02499770|80713474|FG001|Overall Study|Randomized but not enrolled|1|||
27692869|NCT05249829|80713475|FG000|Overall Study|Participant Relocation|0|||
27692870|NCT05249829|80713476|FG001|Overall Study|Participant Relocation|1|||
27692871|NCT05249829|80713477|FG002|Overall Study|Participant Relocation|2|||
27692872|NCT05249829|80713478|FG003|Overall Study|Participant Relocation|2|||
27692873|NCT05249829|80713475|FG000|Overall Study|Withdrawal by Subject|9|||
27692874|NCT05249829|80713476|FG001|Overall Study|Withdrawal by Subject|17|||
27692875|NCT05249829|80713477|FG002|Overall Study|Withdrawal by Subject|40|||
27692876|NCT05249829|80713478|FG003|Overall Study|Withdrawal by Subject|35|||
27692877|NCT05249829|80713475|FG000|Overall Study|Physician Decision|1|||
27692878|NCT05249829|80713476|FG001|Overall Study|Physician Decision|0|||
27692879|NCT05249829|80713477|FG002|Overall Study|Physician Decision|0|||
27692880|NCT05249829|80713478|FG003|Overall Study|Physician Decision|0|||
27692881|NCT05249829|80713475|FG000|Overall Study|Lost to Follow-up|16|||
27692882|NCT05249829|80713476|FG001|Overall Study|Lost to Follow-up|16|||
27692883|NCT05249829|80713477|FG002|Overall Study|Lost to Follow-up|57|||
27692884|NCT05249829|80713478|FG003|Overall Study|Lost to Follow-up|60|||
27692885|NCT05249829|80713475|FG000|Overall Study|Adverse Event|2|||
27692886|NCT05249829|80713476|FG001|Overall Study|Adverse Event|2|||
27692887|NCT05249829|80713477|FG002|Overall Study|Adverse Event|2|||
27692888|NCT05249829|80713478|FG003|Overall Study|Adverse Event|2|||
27692889|NCT05249829|80713475|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
27692890|NCT05249829|80713476|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
27692891|NCT05249829|80713477|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
27692892|NCT05249829|80713478|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
27692893|NCT05249829|80713475|FG000|Overall Study|Protocol Violation|2|||
27692894|NCT05249829|80713476|FG001|Overall Study|Protocol Violation|0|||
27880160|NCT01218087|81394433|FG001|Overall Study|Withdrawal by Subject|0|||
27591615|NCT01358968|80344986|FG002|Period 2|Adverse Event|0|||
27692895|NCT05249829|80713477|FG002|Overall Study|Protocol Violation|5|||
27692896|NCT05249829|80713478|FG003|Overall Study|Protocol Violation|3|||
27818292|NCT04524364|81166723|FG001|Overall Study|Adverse Event|1|||
27818293|NCT04524364|81166722|FG000|Overall Study|Investigational device deficiency|0|||
27818294|NCT04524364|81166723|FG001|Overall Study|Investigational device deficiency|1|||
27818295|NCT04524364|81166722|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
27818296|NCT04524364|81166723|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
27818297|NCT04524364|81166722|FG000|Overall Study|Device unavailability|0|||
27818298|NCT04524364|81166723|FG001|Overall Study|Device unavailability|2|||
27818299|NCT04524364|81166722|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
27692897|NCT05249829|80713475|FG000|Overall Study|Death|0|||
27692898|NCT05249829|80713476|FG001|Overall Study|Death|1|||
27692899|NCT05249829|80713477|FG002|Overall Study|Death|2|||
27692900|NCT05249829|80713478|FG003|Overall Study|Death|4|||
27880161|NCT01218087|81394432|FG000|Overall Study|Transferred|8|||
27880162|NCT01218087|81394433|FG001|Overall Study|Transferred|5|||
27880163|NCT00171210|81394437|FG000|Overall Study|Adverse Event|16|||
27880164|NCT00171210|81394438|FG001|Overall Study|Adverse Event|27|||
27880165|NCT00171210|81394437|FG000|Overall Study|Abnormal laboratory value(s)|6|||
27880166|NCT00171210|81394438|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27880167|NCT00171210|81394437|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27880168|NCT00171210|81394438|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27880169|NCT00171210|81394437|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
27880170|NCT00171210|81394438|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
27880171|NCT00171210|81394437|FG000|Overall Study|Protocol Violation|0|||
27880172|NCT00171210|81394438|FG001|Overall Study|Protocol Violation|2|||
27880173|NCT00171210|81394437|FG000|Overall Study|Withdrawal by Subject|32|||
27880174|NCT00171210|81394438|FG001|Overall Study|Withdrawal by Subject|30|||
27880175|NCT00171210|81394437|FG000|Overall Study|Lost to Follow-up|1|||
27880176|NCT00171210|81394438|FG001|Overall Study|Lost to Follow-up|0|||
27880177|NCT00171210|81394437|FG000|Overall Study|Administrative problems|1|||
27880178|NCT00171210|81394438|FG001|Overall Study|Administrative problems|1|||
27880179|NCT00171210|81394437|FG000|Overall Study|Death|2|||
27880180|NCT00171210|81394438|FG001|Overall Study|Death|3|||
27880181|NCT00171210|81394437|FG000|Overall Study|Stopped at end of core|0|||
27880182|NCT00171210|81394438|FG001|Overall Study|Stopped at end of core|32|||
27880183|NCT00171210|81394437|FG000|Overall Study|Stopped at end of extension 1|0|||
27880184|NCT00171210|81394438|FG001|Overall Study|Stopped at end of extension 1|1|||
27880185|NCT02914613|81394447|FG000|Overall Study|Withdrawal by Subject|1|||
27880186|NCT02914613|81394448|FG001|Overall Study|Withdrawal by Subject|2|||
27880187|NCT02914613|81394447|FG000|Overall Study|Adverse Event|1|||
27880188|NCT02914613|81394448|FG001|Overall Study|Adverse Event|0|||
27880189|NCT02198664|81394449|FG000|Overall Study|Adverse Event|2|||
27880190|NCT02198664|81394450|FG001|Overall Study|Adverse Event|0|||
27880191|NCT02198664|81394449|FG000|Overall Study|Withdrawal by Subject|11|||
27880192|NCT02198664|81394450|FG001|Overall Study|Withdrawal by Subject|8|||
27880193|NCT02198664|81394449|FG000|Overall Study|Failure to tolerate|2|||
27880194|NCT02198664|81394450|FG001|Overall Study|Failure to tolerate|0|||
27880195|NCT02198664|81394449|FG000|Overall Study|Not stated|1|||
27880196|NCT02198664|81394450|FG001|Overall Study|Not stated|0|||
27880197|NCT01753310|81394453|FG000|Overall Study|Entered into open label extension study|25|||
27880198|NCT01753310|81394454|FG001|Overall Study|Entered into open label extension study|22|||
27880199|NCT01753310|81394453|FG000|Overall Study|Adverse Event|1|||
27880200|NCT01753310|81394454|FG001|Overall Study|Adverse Event|0|||
27880201|NCT01753310|81394453|FG000|Overall Study|Lost to Follow-up|2|||
27880202|NCT01753310|81394454|FG001|Overall Study|Lost to Follow-up|0|||
27880203|NCT01753310|81394453|FG000|Overall Study|Subject decision|2|||
27880204|NCT01753310|81394454|FG001|Overall Study|Subject decision|2|||
27880205|NCT01753310|81394453|FG000|Overall Study|Sponsor decision|1|||
27880206|NCT01753310|81394454|FG001|Overall Study|Sponsor decision|0|||
27880207|NCT01753310|81394453|FG000|Overall Study|Withdrawal by Subject|1|||
27880208|NCT01753310|81394454|FG001|Overall Study|Withdrawal by Subject|0|||
27880209|NCT02821754|81394455|FG000|Overall Study|Procedure not required prior to amendment change|13|||
27880210|NCT02821754|81394456|FG001|Overall Study|Procedure not required prior to amendment change|11|||
27880211|NCT02821754|81394457|FG002|Overall Study|Procedure not required prior to amendment change|0|||
27880212|NCT02821754|81394455|FG000|Overall Study|Participant's Clinical status|2|||
27880213|NCT02821754|81394456|FG001|Overall Study|Participant's Clinical status|0|||
27591616|NCT01358968|80344987|FG003|Period 2|Adverse Event|0|||
27591617|NCT01358968|80344984|FG000|Continued Access Phase|Progression of Disease|0|||
27880214|NCT02821754|81394457|FG002|Overall Study|Participant's Clinical status|0|||
27880215|NCT02821754|81394455|FG000|Overall Study|Participant removed for noncompliance|1|||
27880216|NCT02821754|81394456|FG001|Overall Study|Participant removed for noncompliance|0|||
27880217|NCT02821754|81394457|FG002|Overall Study|Participant removed for noncompliance|0|||
27880218|NCT02821754|81394455|FG000|Overall Study|Drug not available.|0|||
27880219|NCT02821754|81394456|FG001|Overall Study|Drug not available.|0|||
27880220|NCT02821754|81394457|FG002|Overall Study|Drug not available.|1|||
27880221|NCT02821754|81394455|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
27880222|NCT02821754|81394456|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
27880223|NCT02821754|81394457|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
27880224|NCT00086619|81394458|FG000|Overall Study|Withdrawal by Subject|6|||
27880225|NCT00086619|81394459|FG001|Overall Study|Withdrawal by Subject|6|||
27880226|NCT00086619|81394458|FG000|Overall Study|Adverse Event|8|||
27880227|NCT00086619|81394459|FG001|Overall Study|Adverse Event|10|||
27880228|NCT00086619|81394458|FG000|Overall Study|Protocol Violation|1|||
27880229|NCT00086619|81394459|FG001|Overall Study|Protocol Violation|1|||
27880230|NCT02593097|81394460|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
27591618|NCT01358968|80344985|FG001|Continued Access Phase|Progression of Disease|0|||
27591619|NCT01358968|80344986|FG002|Continued Access Phase|Progression of Disease|8|||
27591620|NCT01358968|80344987|FG003|Continued Access Phase|Progression of Disease|4|||
27591621|NCT01358968|80344984|FG000|Continued Access Phase|Protocol Violation|0|||
27591622|NCT01358968|80344985|FG001|Continued Access Phase|Protocol Violation|0|||
27591623|NCT01358968|80344986|FG002|Continued Access Phase|Protocol Violation|0|||
27591624|NCT01358968|80344987|FG003|Continued Access Phase|Protocol Violation|2|||
27591625|NCT01358968|80344984|FG000|Continued Access Phase|Withdrawal by Subject|0|||
27591626|NCT01358968|80344985|FG001|Continued Access Phase|Withdrawal by Subject|0|||
27591627|NCT01358968|80344986|FG002|Continued Access Phase|Withdrawal by Subject|3|||
27591628|NCT01358968|80344987|FG003|Continued Access Phase|Withdrawal by Subject|0|||
27591629|NCT01358968|80344984|FG000|Continued Access Phase|Death|0|||
27591630|NCT01358968|80344985|FG001|Continued Access Phase|Death|0|||
27591631|NCT01358968|80344986|FG002|Continued Access Phase|Death|1|||
27591632|NCT01358968|80344987|FG003|Continued Access Phase|Death|1|||
27591633|NCT03077724|80344988|FG000|Overall Study|Lost to Follow-up|5|||
27591634|NCT03077724|80344989|FG001|Overall Study|Lost to Follow-up|1|||
27591635|NCT03077724|80344988|FG000|Overall Study|Withdrawal by Subject|3|||
27591636|NCT03077724|80344989|FG001|Overall Study|Withdrawal by Subject|1|||
27591637|NCT01217073|80344990|FG000|Base Period|Adverse Event|1|||
27591638|NCT01217073|80344991|FG001|Base Period|Adverse Event|0|||
27591639|NCT01217073|80344992|FG002|Base Period|Adverse Event|1|||
27591640|NCT01217073|80344993|FG003|Base Period|Adverse Event|0|||
27692901|NCT00448279|80713483|FG000|Overall Study|Lost to Follow-up|2|||
27591641|NCT01217073|80344994|FG004|Base Period|Adverse Event|4|||
27591642|NCT01217073|80344995|FG005|Base Period|Adverse Event|1|||
27880231|NCT02593097|81394461|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
27591643|NCT01217073|80344996|FG006|Base Period|Adverse Event|0|||
27591644|NCT01217073|80344997|FG007|Base Period|Adverse Event|0|||
27591645|NCT01217073|80344990|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
27591646|NCT01217073|80344991|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27591647|NCT01217073|80344992|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27692902|NCT00448279|80713484|FG001|Overall Study|Lost to Follow-up|2|||
27880232|NCT02593097|81394460|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27692903|NCT00448279|80713483|FG000|Overall Study|Adverse Event|1|||
27818300|NCT04524364|81166723|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
27818301|NCT04524364|81166722|FG000|Overall Study|Low International normalized ratio (INR)|1|||
27692904|NCT00448279|80713484|FG001|Overall Study|Adverse Event|1|||
27692905|NCT00448279|80713483|FG000|Overall Study|Disease progression|16|||
27692906|NCT00448279|80713484|FG001|Overall Study|Disease progression|18|||
27818302|NCT04524364|81166723|FG001|Overall Study|Low International normalized ratio (INR)|0|||
27818303|NCT03465904|81166725|FG000|Overall Study|Withdrawal by Subject|9|||
27818304|NCT03465904|81166726|FG001|Overall Study|Withdrawal by Subject|5|||
27818305|NCT03465904|81166725|FG000|Overall Study|Lost to Follow-up|10|||
27818306|NCT03465904|81166726|FG001|Overall Study|Lost to Follow-up|9|||
27818307|NCT03465904|81166725|FG000|Overall Study|Protocol Violation|8|||
27692907|NCT00448279|80713483|FG000|Overall Study|Withdrawal by Subject|4|||
27818308|NCT03465904|81166726|FG001|Overall Study|Protocol Violation|5|||
27818309|NCT03465904|81166725|FG000|Overall Study|Ineligible for mITT analysis|62|||
27818310|NCT03465904|81166726|FG001|Overall Study|Ineligible for mITT analysis|47|||
27818311|NCT00560235|81166738|FG000|Phase 1|Discontinued|8|||
27818312|NCT00560235|81166739|FG001|Phase 1|Discontinued|0|||
27818313|NCT00560235|81166740|FG002|Phase 1|Discontinued|0|||
27818314|NCT00560235|81166738|FG000|Phase 1B|Discontinued|0|||
27818315|NCT00560235|81166739|FG001|Phase 1B|Discontinued|19|||
27692908|NCT00448279|80713484|FG001|Overall Study|Withdrawal by Subject|3|||
27692909|NCT00448279|80713483|FG000|Overall Study|Other|6|||
27692910|NCT00448279|80713484|FG001|Overall Study|Other|4|||
27692911|NCT00448279|80713483|FG000|Overall Study|Protocol Violation|0|||
27692912|NCT00448279|80713484|FG001|Overall Study|Protocol Violation|1|||
27692913|NCT01688830|80713485|FG000|Overall Study|Lost to Follow-up|0|||
27692914|NCT01688830|80713486|FG001|Overall Study|Lost to Follow-up|0|||
27692915|NCT01688830|80713487|FG002|Overall Study|Lost to Follow-up|0|||
27692916|NCT01688830|80713488|FG003|Overall Study|Lost to Follow-up|0|||
27692917|NCT01688830|80713489|FG004|Overall Study|Lost to Follow-up|0|||
27692918|NCT01688830|80713490|FG005|Overall Study|Lost to Follow-up|0|||
27692919|NCT01688830|80713491|FG006|Overall Study|Lost to Follow-up|0|||
27692920|NCT01688830|80713492|FG007|Overall Study|Lost to Follow-up|0|||
27692921|NCT01688830|80713493|FG008|Overall Study|Lost to Follow-up|0|||
27692922|NCT01688830|80713494|FG009|Overall Study|Lost to Follow-up|0|||
27692923|NCT01688830|80713495|FG010|Overall Study|Lost to Follow-up|1|||
27818316|NCT00560235|81166740|FG002|Phase 1B|Discontinued|0|||
27818317|NCT00560235|81166738|FG000|Phase 2|Discontinued|0|||
27818318|NCT00560235|81166739|FG001|Phase 2|Discontinued|0|||
27818319|NCT00560235|81166740|FG002|Phase 2|Discontinued|96|||
27818320|NCT00560235|81166738|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
27818321|NCT00560235|81166739|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
27818322|NCT00560235|81166740|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
27818323|NCT00117949|81166746|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
27818324|NCT00117949|81166747|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
27818325|NCT00117949|81166748|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
27818326|NCT00117949|81166749|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
27818327|NCT00117949|81166746|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
27818328|NCT00117949|81166747|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
27818329|NCT00117949|81166748|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
27818330|NCT00117949|81166749|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
27818331|NCT00117949|81166746|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
27818332|NCT00117949|81166747|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
27818333|NCT00117949|81166748|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
27818334|NCT00117949|81166749|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
27880233|NCT02593097|81394461|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
27880234|NCT02593097|81394460|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
27818335|NCT00117949|81166746|FG000|Overall Study|PSA increase >=10ng/mL|0|||
27818336|NCT00117949|81166747|FG001|Overall Study|PSA increase >=10ng/mL|1|||
27880235|NCT02593097|81394461|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
27591648|NCT01217073|80344993|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27692924|NCT01688830|80713496|FG011|Overall Study|Lost to Follow-up|0|||
27692925|NCT01688830|80713497|FG012|Overall Study|Lost to Follow-up|0|||
27692926|NCT01688830|80713498|FG013|Overall Study|Lost to Follow-up|0|||
27692927|NCT01688830|80713499|FG014|Overall Study|Lost to Follow-up|0|||
27880236|NCT02593097|81394460|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
27880237|NCT02593097|81394461|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
27880238|NCT02593097|81394460|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
27880239|NCT02593097|81394461|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
27880240|NCT02569801|81394462|FG000|Overall Study|Withdrawal by Subject|9|||
27880241|NCT02569801|81394463|FG001|Overall Study|Withdrawal by Subject|9|||
27880242|NCT02569801|81394462|FG000|Overall Study|Sponsor Decision|13|||
27880243|NCT02569801|81394463|FG001|Overall Study|Sponsor Decision|14|||
27880244|NCT02569801|81394462|FG000|Overall Study|Progressive Disease|2|||
27880245|NCT02569801|81394463|FG001|Overall Study|Progressive Disease|7|||
27692928|NCT01688830|80713500|FG015|Overall Study|Lost to Follow-up|0|||
27692929|NCT01688830|80713501|FG016|Overall Study|Lost to Follow-up|0|||
27692930|NCT01688830|80713502|FG017|Overall Study|Lost to Follow-up|0|||
27692931|NCT01688830|80713503|FG018|Overall Study|Lost to Follow-up|0|||
27692932|NCT01688830|80713504|FG019|Overall Study|Lost to Follow-up|0|||
27692933|NCT01688830|80713505|FG020|Overall Study|Lost to Follow-up|0|||
27692934|NCT02294227|80713508|FG000|Overall Study|Death|0|||
27692935|NCT02294227|80713509|FG001|Overall Study|Death|0|||
27692936|NCT02294227|80713510|FG002|Overall Study|Death|1|||
27692937|NCT02294227|80713508|FG000|Overall Study|Subject/Guardian Decision|6|||
27692938|NCT02294227|80713509|FG001|Overall Study|Subject/Guardian Decision|3|||
27692939|NCT02294227|80713510|FG002|Overall Study|Subject/Guardian Decision|7|||
27692940|NCT02294227|80713508|FG000|Overall Study|Physician Decision|1|||
27692941|NCT02294227|80713509|FG001|Overall Study|Physician Decision|2|||
27818337|NCT00117949|81166748|FG002|Overall Study|PSA increase >=10ng/mL|1|||
27818338|NCT00117949|81166749|FG003|Overall Study|PSA increase >=10ng/mL|0|||
27818339|NCT00117949|81166746|FG000|Overall Study|PSA reduction <=50%|0|||
27818340|NCT00117949|81166747|FG001|Overall Study|PSA reduction <=50%|2|||
27818341|NCT00117949|81166748|FG002|Overall Study|PSA reduction <=50%|2|||
27818342|NCT00117949|81166749|FG003|Overall Study|PSA reduction <=50%|4|||
27818343|NCT00117949|81166746|FG000|Overall Study|Hepatic abnormalities|0|||
27818344|NCT00117949|81166747|FG001|Overall Study|Hepatic abnormalities|1|||
27818345|NCT00117949|81166748|FG002|Overall Study|Hepatic abnormalities|0|||
27818346|NCT00117949|81166749|FG003|Overall Study|Hepatic abnormalities|1|||
27818347|NCT00090857|81166752|FG000|Overall Study|Lost to Follow-up|0|||
27818348|NCT00090857|81166753|FG001|Overall Study|Lost to Follow-up|1|||
27818349|NCT00090857|81166752|FG000|Overall Study|Withdrawal by Subject|2|||
27818350|NCT00090857|81166753|FG001|Overall Study|Withdrawal by Subject|0|||
27818351|NCT00090857|81166752|FG000|Overall Study|Adverse Event|2|||
27818352|NCT00090857|81166753|FG001|Overall Study|Adverse Event|2|||
27818353|NCT04149964|81166755|FG000|Overall Study|Lost to Follow-up|19|||
27692942|NCT02294227|80713510|FG002|Overall Study|Physician Decision|1|||
27818354|NCT04149964|81166756|FG001|Overall Study|Lost to Follow-up|18|||
27818355|NCT01545076|81166757|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
27818356|NCT01545076|81166758|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
27818357|NCT01545076|81166759|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
27692943|NCT02294227|80713508|FG000|Overall Study|Lost to Follow-up|1|||
27692944|NCT02294227|80713509|FG001|Overall Study|Lost to Follow-up|0|||
27880246|NCT02569801|81394462|FG000|Overall Study|Lost to Follow-up|0|||
27818358|NCT01545076|81166760|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
27591649|NCT01217073|80344994|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27591650|NCT01217073|80344995|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27591651|NCT01217073|80344996|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27591652|NCT01217073|80344997|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
27591653|NCT01217073|80344990|FG000|Base Period|Excluded medication|0|||
27591654|NCT01217073|80344991|FG001|Base Period|Excluded medication|0|||
27591655|NCT01217073|80344992|FG002|Base Period|Excluded medication|0|||
27591656|NCT01217073|80344993|FG003|Base Period|Excluded medication|0|||
27591657|NCT01217073|80344994|FG004|Base Period|Excluded medication|1|||
27591658|NCT01217073|80344995|FG005|Base Period|Excluded medication|0|||
27591659|NCT01217073|80344996|FG006|Base Period|Excluded medication|0|||
27591660|NCT01217073|80344997|FG007|Base Period|Excluded medication|0|||
27591661|NCT01217073|80344990|FG000|Base Period|Lack of Efficacy|0|||
27591662|NCT01217073|80344991|FG001|Base Period|Lack of Efficacy|0|||
27591663|NCT01217073|80344992|FG002|Base Period|Lack of Efficacy|0|||
27591664|NCT01217073|80344993|FG003|Base Period|Lack of Efficacy|0|||
27591665|NCT01217073|80344994|FG004|Base Period|Lack of Efficacy|0|||
27591666|NCT01217073|80344995|FG005|Base Period|Lack of Efficacy|1|||
27591667|NCT01217073|80344996|FG006|Base Period|Lack of Efficacy|0|||
27591668|NCT01217073|80344997|FG007|Base Period|Lack of Efficacy|0|||
27591669|NCT01217073|80344990|FG000|Base Period|Lost to Follow-up|0|||
27591670|NCT01217073|80344991|FG001|Base Period|Lost to Follow-up|0|||
27591671|NCT01217073|80344992|FG002|Base Period|Lost to Follow-up|1|||
27591672|NCT01217073|80344993|FG003|Base Period|Lost to Follow-up|1|||
27591673|NCT01217073|80344994|FG004|Base Period|Lost to Follow-up|3|||
27591674|NCT01217073|80344995|FG005|Base Period|Lost to Follow-up|0|||
27591675|NCT01217073|80344996|FG006|Base Period|Lost to Follow-up|0|||
27591676|NCT01217073|80344997|FG007|Base Period|Lost to Follow-up|0|||
27591677|NCT01217073|80344990|FG000|Base Period|Physician Decision|0|||
27591678|NCT01217073|80344991|FG001|Base Period|Physician Decision|0|||
27818359|NCT01545076|81166761|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
27818360|NCT01545076|81166757|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
27818361|NCT01545076|81166758|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
27591679|NCT01217073|80344992|FG002|Base Period|Physician Decision|0|||
27591680|NCT01217073|80344993|FG003|Base Period|Physician Decision|0|||
27591681|NCT01217073|80344994|FG004|Base Period|Physician Decision|1|||
27591682|NCT01217073|80344995|FG005|Base Period|Physician Decision|0|||
27591683|NCT01217073|80344996|FG006|Base Period|Physician Decision|0|||
27591684|NCT01217073|80344997|FG007|Base Period|Physician Decision|0|||
27591685|NCT01217073|80344990|FG000|Base Period|Protocol Violation|1|||
27591686|NCT01217073|80344991|FG001|Base Period|Protocol Violation|0|||
27591687|NCT01217073|80344992|FG002|Base Period|Protocol Violation|0|||
27818362|NCT01545076|81166759|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
27591688|NCT01217073|80344993|FG003|Base Period|Protocol Violation|0|||
27591689|NCT01217073|80344994|FG004|Base Period|Protocol Violation|1|||
27591690|NCT01217073|80344995|FG005|Base Period|Protocol Violation|2|||
27591691|NCT01217073|80344996|FG006|Base Period|Protocol Violation|0|||
27591692|NCT01217073|80344997|FG007|Base Period|Protocol Violation|0|||
27591693|NCT01217073|80344990|FG000|Base Period|Withdrawal by Subject|4|||
27591694|NCT01217073|80344991|FG001|Base Period|Withdrawal by Subject|5|||
27591695|NCT01217073|80344992|FG002|Base Period|Withdrawal by Subject|5|||
27591696|NCT01217073|80344993|FG003|Base Period|Withdrawal by Subject|1|||
27591697|NCT01217073|80344994|FG004|Base Period|Withdrawal by Subject|5|||
27591698|NCT01217073|80344995|FG005|Base Period|Withdrawal by Subject|5|||
27591699|NCT01217073|80344996|FG006|Base Period|Withdrawal by Subject|0|||
27591700|NCT01217073|80344997|FG007|Base Period|Withdrawal by Subject|0|||
27591701|NCT01217073|80344990|FG000|Extension Period|Adverse Event|0|||
27591702|NCT01217073|80344991|FG001|Extension Period|Adverse Event|0|||
27591703|NCT01217073|80344992|FG002|Extension Period|Adverse Event|0|||
27591704|NCT01217073|80344993|FG003|Extension Period|Adverse Event|0|||
27591705|NCT01217073|80344994|FG004|Extension Period|Adverse Event|0|||
27591706|NCT01217073|80344995|FG005|Extension Period|Adverse Event|0|||
27591707|NCT01217073|80344996|FG006|Extension Period|Adverse Event|19|||
27591708|NCT01217073|80344997|FG007|Extension Period|Adverse Event|5|||
27591709|NCT01217073|80344990|FG000|Extension Period|ALT/AST|0|||
27591710|NCT01217073|80344991|FG001|Extension Period|ALT/AST|0|||
27591711|NCT01217073|80344992|FG002|Extension Period|ALT/AST|0|||
27591712|NCT01217073|80344993|FG003|Extension Period|ALT/AST|0|||
27591713|NCT01217073|80344994|FG004|Extension Period|ALT/AST|0|||
27591714|NCT01217073|80344995|FG005|Extension Period|ALT/AST|0|||
27591715|NCT01217073|80344996|FG006|Extension Period|ALT/AST|2|||
27591716|NCT01217073|80344997|FG007|Extension Period|ALT/AST|0|||
27591717|NCT01217073|80344990|FG000|Extension Period|Contraindication to study medication|0|||
27591718|NCT01217073|80344991|FG001|Extension Period|Contraindication to study medication|0|||
27591719|NCT01217073|80344992|FG002|Extension Period|Contraindication to study medication|0|||
27591720|NCT01217073|80344993|FG003|Extension Period|Contraindication to study medication|0|||
27591721|NCT01217073|80344994|FG004|Extension Period|Contraindication to study medication|0|||
27591722|NCT01217073|80344995|FG005|Extension Period|Contraindication to study medication|0|||
27591723|NCT01217073|80344996|FG006|Extension Period|Contraindication to study medication|1|||
27591724|NCT01217073|80344997|FG007|Extension Period|Contraindication to study medication|0|||
27591725|NCT01217073|80344990|FG000|Extension Period|Creatinine/eGFR|0|||
27591726|NCT01217073|80344991|FG001|Extension Period|Creatinine/eGFR|0|||
27591727|NCT01217073|80344992|FG002|Extension Period|Creatinine/eGFR|0|||
27591728|NCT01217073|80344993|FG003|Extension Period|Creatinine/eGFR|0|||
27591729|NCT01217073|80344994|FG004|Extension Period|Creatinine/eGFR|0|||
27591730|NCT01217073|80344995|FG005|Extension Period|Creatinine/eGFR|0|||
27591731|NCT01217073|80344996|FG006|Extension Period|Creatinine/eGFR|11|||
27591732|NCT01217073|80344997|FG007|Extension Period|Creatinine/eGFR|1|||
27591733|NCT01217073|80344990|FG000|Extension Period|Death|0|||
27591734|NCT01217073|80344991|FG001|Extension Period|Death|0|||
27591735|NCT01217073|80344992|FG002|Extension Period|Death|0|||
27591736|NCT01217073|80344993|FG003|Extension Period|Death|0|||
27591737|NCT01217073|80344994|FG004|Extension Period|Death|0|||
27591738|NCT01217073|80344995|FG005|Extension Period|Death|0|||
27591739|NCT01217073|80344996|FG006|Extension Period|Death|1|||
27591740|NCT01217073|80344997|FG007|Extension Period|Death|0|||
27591741|NCT01217073|80344990|FG000|Extension Period|Excluded medication|0|||
27591742|NCT01217073|80344991|FG001|Extension Period|Excluded medication|0|||
27591743|NCT01217073|80344992|FG002|Extension Period|Excluded medication|0|||
27591744|NCT01217073|80344993|FG003|Extension Period|Excluded medication|0|||
27591745|NCT01217073|80344994|FG004|Extension Period|Excluded medication|0|||
27591746|NCT01217073|80344995|FG005|Extension Period|Excluded medication|0|||
27591747|NCT01217073|80344996|FG006|Extension Period|Excluded medication|2|||
27591748|NCT01217073|80344997|FG007|Extension Period|Excluded medication|0|||
27591749|NCT01217073|80344990|FG000|Extension Period|Lack of Efficacy|0|||
27591750|NCT01217073|80344991|FG001|Extension Period|Lack of Efficacy|0|||
27591751|NCT01217073|80344992|FG002|Extension Period|Lack of Efficacy|0|||
27591752|NCT01217073|80344993|FG003|Extension Period|Lack of Efficacy|0|||
27591753|NCT01217073|80344994|FG004|Extension Period|Lack of Efficacy|0|||
27591754|NCT01217073|80344995|FG005|Extension Period|Lack of Efficacy|0|||
27591755|NCT01217073|80344996|FG006|Extension Period|Lack of Efficacy|3|||
27591756|NCT01217073|80344997|FG007|Extension Period|Lack of Efficacy|0|||
27591757|NCT01217073|80344990|FG000|Extension Period|Lost to Follow-up|0|||
27591758|NCT01217073|80344991|FG001|Extension Period|Lost to Follow-up|0|||
27591759|NCT01217073|80344992|FG002|Extension Period|Lost to Follow-up|0|||
27818363|NCT01545076|81166760|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
27818364|NCT01545076|81166761|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
27818365|NCT01545076|81166757|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
27591760|NCT01217073|80344993|FG003|Extension Period|Lost to Follow-up|0|||
27591761|NCT01217073|80344994|FG004|Extension Period|Lost to Follow-up|0|||
27591762|NCT01217073|80344995|FG005|Extension Period|Lost to Follow-up|0|||
27591763|NCT01217073|80344996|FG006|Extension Period|Lost to Follow-up|9|||
27591764|NCT01217073|80344997|FG007|Extension Period|Lost to Follow-up|1|||
27591765|NCT01217073|80344990|FG000|Extension Period|Non-compliance with study drug|0|||
27591766|NCT01217073|80344991|FG001|Extension Period|Non-compliance with study drug|0|||
27591767|NCT01217073|80344992|FG002|Extension Period|Non-compliance with study drug|0|||
27591768|NCT01217073|80344993|FG003|Extension Period|Non-compliance with study drug|0|||
27591769|NCT01217073|80344994|FG004|Extension Period|Non-compliance with study drug|0|||
27591770|NCT01217073|80344995|FG005|Extension Period|Non-compliance with study drug|0|||
27591771|NCT01217073|80344996|FG006|Extension Period|Non-compliance with study drug|0|||
27591772|NCT01217073|80344997|FG007|Extension Period|Non-compliance with study drug|1|||
27591773|NCT01217073|80344990|FG000|Extension Period|Physician Decision|0|||
27591774|NCT01217073|80344991|FG001|Extension Period|Physician Decision|0|||
27591775|NCT01217073|80344992|FG002|Extension Period|Physician Decision|0|||
27591776|NCT01217073|80344993|FG003|Extension Period|Physician Decision|0|||
27591777|NCT01217073|80344994|FG004|Extension Period|Physician Decision|0|||
27591778|NCT01217073|80344995|FG005|Extension Period|Physician Decision|0|||
27591779|NCT01217073|80344996|FG006|Extension Period|Physician Decision|4|||
27591780|NCT01217073|80344997|FG007|Extension Period|Physician Decision|1|||
27591781|NCT01217073|80344990|FG000|Extension Period|Protocol Violation|0|||
27591782|NCT01217073|80344991|FG001|Extension Period|Protocol Violation|0|||
27591783|NCT01217073|80344992|FG002|Extension Period|Protocol Violation|0|||
27591784|NCT01217073|80344993|FG003|Extension Period|Protocol Violation|0|||
27591785|NCT01217073|80344994|FG004|Extension Period|Protocol Violation|0|||
27591786|NCT01217073|80344995|FG005|Extension Period|Protocol Violation|0|||
27591787|NCT01217073|80344996|FG006|Extension Period|Protocol Violation|2|||
27591788|NCT01217073|80344997|FG007|Extension Period|Protocol Violation|1|||
27591789|NCT01217073|80344990|FG000|Extension Period|Site discontinued study participation|0|||
27591790|NCT01217073|80344991|FG001|Extension Period|Site discontinued study participation|0|||
27591791|NCT01217073|80344992|FG002|Extension Period|Site discontinued study participation|0|||
27591792|NCT01217073|80344993|FG003|Extension Period|Site discontinued study participation|0|||
27591793|NCT01217073|80344994|FG004|Extension Period|Site discontinued study participation|0|||
27591794|NCT01217073|80344995|FG005|Extension Period|Site discontinued study participation|0|||
27591795|NCT01217073|80344996|FG006|Extension Period|Site discontinued study participation|7|||
27591796|NCT01217073|80344997|FG007|Extension Period|Site discontinued study participation|2|||
27591797|NCT01217073|80344990|FG000|Extension Period|Withdrawal by Subject|0|||
27591798|NCT01217073|80344991|FG001|Extension Period|Withdrawal by Subject|0|||
27591799|NCT01217073|80344992|FG002|Extension Period|Withdrawal by Subject|0|||
27591800|NCT01217073|80344993|FG003|Extension Period|Withdrawal by Subject|0|||
27591801|NCT01217073|80344994|FG004|Extension Period|Withdrawal by Subject|0|||
27591802|NCT01217073|80344995|FG005|Extension Period|Withdrawal by Subject|0|||
27818366|NCT01545076|81166758|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
27818367|NCT01545076|81166759|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
27818368|NCT01545076|81166760|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
27818369|NCT01545076|81166761|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
27818370|NCT01545076|81166757|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
27818371|NCT01545076|81166758|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27818372|NCT01545076|81166759|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27818373|NCT01545076|81166760|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27818374|NCT01545076|81166761|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
27818375|NCT01545076|81166757|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
27818376|NCT01545076|81166758|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27818377|NCT01545076|81166759|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27818378|NCT01545076|81166760|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27818379|NCT01545076|81166761|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
27818380|NCT01545076|81166757|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27818381|NCT01545076|81166758|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27818382|NCT01545076|81166759|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27818383|NCT01545076|81166760|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
27818384|NCT01545076|81166761|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
27818385|NCT01545076|81166757|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
27818386|NCT01545076|81166758|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
27818387|NCT01545076|81166759|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
27818388|NCT01545076|81166760|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
27818389|NCT01545076|81166761|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
27818390|NCT01545076|81166757|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
27818391|NCT01545076|81166758|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
27818392|NCT01545076|81166759|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
27591803|NCT01217073|80344996|FG006|Extension Period|Withdrawal by Subject|30|||
27591804|NCT01217073|80344997|FG007|Extension Period|Withdrawal by Subject|8|||
27591805|NCT01917526|80344998|FG000|Overall Study|Protocol Violation|1|||
27591806|NCT01917526|80344999|FG001|Overall Study|Protocol Violation|1|||
27591807|NCT02341417|80345002|FG000|Overall Study|Withdrawal by Subject|0|||
27818393|NCT01545076|81166760|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
27818394|NCT01545076|81166761|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
27818395|NCT01545076|81166757|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
27818396|NCT01545076|81166758|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
27818397|NCT01545076|81166759|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
27818398|NCT01545076|81166760|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
27818399|NCT01545076|81166761|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
27818400|NCT00154102|81166766|FG000|Overall Study|investigational study phase ongoing|7|||
27818401|NCT00154102|81166767|FG001|Overall Study|investigational study phase ongoing|2|||
27818402|NCT00755326|81166768|FG000|Overall Study|Lost to Follow-up|2|||
27818403|NCT00755326|81166769|FG001|Overall Study|Lost to Follow-up|3|||
27818404|NCT00048048|81166775|FG000|Core Treatment|Withdrawal by Subject|0|||
27818405|NCT00048048|81166776|FG001|Core Treatment|Withdrawal by Subject|0|||
27818406|NCT00048048|81166777|FG002|Core Treatment|Withdrawal by Subject|1|||
27818407|NCT00048048|81166778|FG003|Core Treatment|Withdrawal by Subject|0|||
27818408|NCT00048048|81166779|FG004|Core Treatment|Withdrawal by Subject|0|||
27818409|NCT00048048|81166780|FG005|Core Treatment|Withdrawal by Subject|0|||
27818410|NCT00048048|81166781|FG006|Core Treatment|Withdrawal by Subject|0|||
27818411|NCT00048048|81166782|FG007|Core Treatment|Withdrawal by Subject|0|||
27818412|NCT00048048|81166783|FG008|Core Treatment|Withdrawal by Subject|0|||
27818413|NCT00048048|81166784|FG009|Core Treatment|Withdrawal by Subject|0|||
27818414|NCT00048048|81166785|FG010|Core Treatment|Withdrawal by Subject|0|||
27818415|NCT00048048|81166786|FG011|Core Treatment|Withdrawal by Subject|0|||
27818416|NCT00048048|81166775|FG000|Core Treatment|Adverse Event|0|||
27818417|NCT00048048|81166776|FG001|Core Treatment|Adverse Event|0|||
27818418|NCT00048048|81166777|FG002|Core Treatment|Adverse Event|0|||
27818419|NCT00048048|81166778|FG003|Core Treatment|Adverse Event|0|||
27818420|NCT00048048|81166779|FG004|Core Treatment|Adverse Event|0|||
27880247|NCT02569801|81394463|FG001|Overall Study|Lost to Follow-up|1|||
27880248|NCT02569801|81394462|FG000|Overall Study|Death|12|||
27880249|NCT02569801|81394463|FG001|Overall Study|Death|4|||
27880250|NCT00030901|81394467|FG000|Initial Registration|Ineligible|167|||
27880251|NCT00030901|81394468|FG001|Initial Registration|Ineligible|0|||
27818421|NCT00048048|81166780|FG005|Core Treatment|Adverse Event|0|||
27818422|NCT00048048|81166781|FG006|Core Treatment|Adverse Event|0|||
27880252|NCT00030901|81394469|FG002|Initial Registration|Ineligible|0|||
27880253|NCT00030901|81394467|FG000|Randomization|Adverse Event|0|||
27591808|NCT02341417|80345003|FG001|Overall Study|Withdrawal by Subject|2|||
27591809|NCT02341417|80345004|FG002|Overall Study|Withdrawal by Subject|0|||
27591810|NCT02341417|80345002|FG000|Overall Study|Decision by sponsor|2|||
27591811|NCT02341417|80345003|FG001|Overall Study|Decision by sponsor|0|||
27818423|NCT00048048|81166782|FG007|Core Treatment|Adverse Event|1|||
27818424|NCT00048048|81166783|FG008|Core Treatment|Adverse Event|0|||
27818425|NCT00048048|81166784|FG009|Core Treatment|Adverse Event|0|||
27818426|NCT00048048|81166785|FG010|Core Treatment|Adverse Event|0|||
27591812|NCT02341417|80345004|FG002|Overall Study|Decision by sponsor|0|||
27591813|NCT02341417|80345002|FG000|Overall Study|Death|0|||
27591814|NCT02341417|80345003|FG001|Overall Study|Death|0|||
27818427|NCT00048048|81166786|FG011|Core Treatment|Adverse Event|0|||
27818428|NCT00048048|81166775|FG000|Extension Year 1|Early withdrawals|0|||
27818429|NCT00048048|81166776|FG001|Extension Year 1|Early withdrawals|0|||
27818430|NCT00048048|81166777|FG002|Extension Year 1|Early withdrawals|0|||
27818431|NCT00048048|81166778|FG003|Extension Year 1|Early withdrawals|0|||
27818432|NCT00048048|81166779|FG004|Extension Year 1|Early withdrawals|0|||
27818433|NCT00048048|81166780|FG005|Extension Year 1|Early withdrawals|0|||
27818434|NCT00048048|81166781|FG006|Extension Year 1|Early withdrawals|0|||
27818435|NCT00048048|81166782|FG007|Extension Year 1|Early withdrawals|0|||
27818436|NCT00048048|81166783|FG008|Extension Year 1|Early withdrawals|0|||
27818437|NCT00048048|81166784|FG009|Extension Year 1|Early withdrawals|2|||
27818438|NCT00048048|81166785|FG010|Extension Year 1|Early withdrawals|2|||
27818439|NCT00048048|81166786|FG011|Extension Year 1|Early withdrawals|4|||
27818440|NCT00048048|81166775|FG000|Extension Year 2|Early withdrawals|0|||
27818441|NCT00048048|81166776|FG001|Extension Year 2|Early withdrawals|0|||
27818442|NCT00048048|81166777|FG002|Extension Year 2|Early withdrawals|0|||
27818443|NCT00048048|81166778|FG003|Extension Year 2|Early withdrawals|0|||
27818444|NCT00048048|81166779|FG004|Extension Year 2|Early withdrawals|0|||
27818445|NCT00048048|81166780|FG005|Extension Year 2|Early withdrawals|0|||
27818446|NCT00048048|81166781|FG006|Extension Year 2|Early withdrawals|0|||
27818447|NCT00048048|81166782|FG007|Extension Year 2|Early withdrawals|0|||
27818448|NCT00048048|81166783|FG008|Extension Year 2|Early withdrawals|0|||
27818449|NCT00048048|81166784|FG009|Extension Year 2|Early withdrawals|0|||
27818450|NCT00048048|81166785|FG010|Extension Year 2|Early withdrawals|4|||
27818451|NCT00048048|81166786|FG011|Extension Year 2|Early withdrawals|2|||
27818452|NCT01045096|81166787|FG000|Overall Study|Withdrawal by Subject|2|||
27818453|NCT01045096|81166788|FG001|Overall Study|Withdrawal by Subject|0|||
27818454|NCT01045096|81166789|FG002|Overall Study|Withdrawal by Subject|0|||
27818455|NCT01045096|81166787|FG000|Overall Study|Other|1|||
27591815|NCT02341417|80345004|FG002|Overall Study|Death|1|||
27818456|NCT01045096|81166788|FG001|Overall Study|Other|0|||
27818457|NCT01045096|81166789|FG002|Overall Study|Other|0|||
27818458|NCT00822926|81166790|FG000|Second Injection Visit|Lost to Follow-up|1|||
27818459|NCT00822926|81166791|FG001|Second Injection Visit|Lost to Follow-up|0|||
27818460|NCT00822926|81166790|FG000|Second Injection Visit|Withdrawal by Subject|0|||
27818461|NCT00822926|81166791|FG001|Second Injection Visit|Withdrawal by Subject|1|||
27818462|NCT00788125|81166792|FG000|Overall Study|Death|6|||
27818463|NCT00385684|81166795|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
27818464|NCT00385684|81166796|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
27818465|NCT00385684|81166795|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
27818466|NCT00385684|81166796|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
27818467|NCT00385684|81166795|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
27818468|NCT00385684|81166796|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
27818469|NCT02581345|81166802|FG000|Part 1: up to Week 16|Adverse Event|3|||
27818470|NCT02581345|81166803|FG001|Part 1: up to Week 16|Adverse Event|8|||
27818471|NCT02581345|81166804|FG002|Part 1: up to Week 16|Adverse Event|0|||
27818472|NCT02581345|81166805|FG003|Part 1: up to Week 16|Adverse Event|0|||
27818473|NCT02581345|81166802|FG000|Part 1: up to Week 16|Physician Decision|2|||
27818474|NCT02581345|81166803|FG001|Part 1: up to Week 16|Physician Decision|4|||
27818475|NCT02581345|81166804|FG002|Part 1: up to Week 16|Physician Decision|0|||
27818476|NCT02581345|81166805|FG003|Part 1: up to Week 16|Physician Decision|0|||
27818477|NCT02581345|81166802|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
27880254|NCT00030901|81394468|FG001|Randomization|Adverse Event|11|||
27880255|NCT00030901|81394469|FG002|Randomization|Adverse Event|7|||
27880256|NCT00030901|81394467|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
27880257|NCT00030901|81394468|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
27591816|NCT02012491|80345005|FG000|Overall Study|Lost to Follow-up|1|||
27591817|NCT02012491|80345006|FG001|Overall Study|Lost to Follow-up|0|||
27591818|NCT02012491|80345005|FG000|Overall Study|Protocol Violation|0|||
27591819|NCT02012491|80345006|FG001|Overall Study|Protocol Violation|1|||
27591820|NCT02012491|80345005|FG000|Overall Study|Withdrawal by Subject|1|||
27591821|NCT02012491|80345006|FG001|Overall Study|Withdrawal by Subject|0|||
27591822|NCT03273946|80345011|FG000|Overall Study|Withdrawal by Subject|5|||
27591823|NCT03273946|80345011|FG000|Overall Study|Unwillingness of the guardian|1|||
27591824|NCT03273946|80345011|FG000|Overall Study|Participant refused to use the drug|2|||
27591825|NCT03273946|80345011|FG000|Overall Study|Participant relative refused to use drug|1|||
27591826|NCT01667432|80348437|FG000|Overall Study|Premature Study Termination|26|||
27591827|NCT01667432|80348437|FG000|Overall Study|Failure to Return|10|||
27591828|NCT01667432|80348437|FG000|Overall Study|Moved to Another Center|3|||
27591829|NCT01667432|80348437|FG000|Overall Study|Lost to Follow-up|3|||
27591830|NCT01667432|80348437|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
27591831|NCT01667432|80348437|FG000|Overall Study|Insufficient Therapeutic Response|4|||
27591832|NCT01667432|80348437|FG000|Overall Study|Adverse Event|1|||
27591833|NCT01667432|80348437|FG000|Overall Study|Protocol Deviation|2|||
27591834|NCT01667432|80348437|FG000|Overall Study|Principal Investigator Decision|1|||
27591835|NCT01667432|80348437|FG000|Overall Study|Reason Not Specified|2|||
27591836|NCT01667432|80348437|FG000|Overall Study|Missing Information|4|||
27591837|NCT01640808|80348438|FG000|Overall Study|Unable to continue dynamic CT|14|||
27591838|NCT01640808|80348439|FG001|Overall Study|Unable to continue dynamic CT|4|||
27591839|NCT01640808|80348438|FG000|Overall Study|Withdrawal by Subject|12|||
27591840|NCT01640808|80348439|FG001|Overall Study|Withdrawal by Subject|4|||
27591841|NCT01640808|80348438|FG000|Overall Study|Lost to Follow-up|4|||
27591842|NCT01640808|80348439|FG001|Overall Study|Lost to Follow-up|0|||
27591843|NCT01640808|80348438|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
27591844|NCT01640808|80348439|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
27591845|NCT01640808|80348438|FG000|Overall Study|Administration of anticancer drugs|2|||
27591846|NCT01640808|80348439|FG001|Overall Study|Administration of anticancer drugs|1|||
27591847|NCT01640808|80348438|FG000|Overall Study|Physician Decision|19|||
27591848|NCT01640808|80348439|FG001|Overall Study|Physician Decision|5|||
27591849|NCT01640808|80348438|FG000|Overall Study|Randomized but not treated|4|||
27591850|NCT01640808|80348439|FG001|Overall Study|Randomized but not treated|2|||
27591851|NCT02277106|80348441|FG000|Stage 2|Adverse Event|0|||
27591852|NCT02277106|80348442|FG001|Stage 2|Adverse Event|0|||
27591853|NCT02277106|80348443|FG002|Stage 2|Adverse Event|1|||
27880258|NCT00030901|81394469|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
27880259|NCT00030901|81394467|FG000|Randomization|Progression/Relapse|0|||
27880260|NCT00030901|81394468|FG001|Randomization|Progression/Relapse|22|||
27880261|NCT00030901|81394469|FG002|Randomization|Progression/Relapse|21|||
27880262|NCT00030901|81394467|FG000|Randomization|Death|0|||
27880263|NCT00030901|81394468|FG001|Randomization|Death|1|||
27880264|NCT00030901|81394469|FG002|Randomization|Death|3|||
27880265|NCT00030901|81394467|FG000|Randomization|Other|0|||
27591854|NCT04827212|80348444|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
27591855|NCT04827212|80348445|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
27818478|NCT02581345|81166803|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
27818479|NCT02581345|81166804|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
27818480|NCT02581345|81166805|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
27880266|NCT00030901|81394468|FG001|Randomization|Other|36|||
27880267|NCT00030901|81394469|FG002|Randomization|Other|33|||
27880268|NCT00030901|81394467|FG000|Randomization|Ineligible|0|||
27818481|NCT02581345|81166802|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
27818482|NCT02581345|81166803|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
27818483|NCT02581345|81166804|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
27818484|NCT02581345|81166805|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
27818485|NCT02581345|81166802|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
27818486|NCT02581345|81166803|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
27818487|NCT02581345|81166804|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
27818488|NCT02581345|81166805|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
27818489|NCT02581345|81166802|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
27818490|NCT02581345|81166803|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
27818491|NCT02581345|81166804|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
27818492|NCT02581345|81166805|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
27818493|NCT02581345|81166802|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
27818494|NCT02581345|81166803|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
27818495|NCT02581345|81166804|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
27818496|NCT02581345|81166805|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
27818497|NCT02581345|81166802|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
27818498|NCT02581345|81166803|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
27818499|NCT02581345|81166804|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
27818500|NCT02581345|81166805|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
27818501|NCT02581345|81166802|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
27818502|NCT02581345|81166803|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
27818503|NCT02581345|81166804|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
27818504|NCT02581345|81166805|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
27818505|NCT02581345|81166802|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
27818506|NCT02581345|81166803|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
27818507|NCT02581345|81166804|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
27818508|NCT02581345|81166805|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
27818509|NCT02581345|81166802|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
27880269|NCT00030901|81394468|FG001|Randomization|Ineligible|15|||
27880270|NCT00030901|81394469|FG002|Randomization|Ineligible|14|||
27880271|NCT01806051|81394471|FG000|Overall Study|Withdrawal by Subject|6|||
27880272|NCT03448419|81394473|FG000|Overall Study|Adverse Event|10|||
27880273|NCT03448419|81394474|FG001|Overall Study|Adverse Event|9|||
27880274|NCT03448419|81394473|FG000|Overall Study|Lost to Follow-up|0|||
27880275|NCT03448419|81394474|FG001|Overall Study|Lost to Follow-up|2|||
27880276|NCT03448419|81394473|FG000|Overall Study|Withdrawal by Subject|3|||
27880277|NCT03448419|81394474|FG001|Overall Study|Withdrawal by Subject|1|||
27880278|NCT03448419|81394473|FG000|Overall Study|Not treated|0|||
27880279|NCT03448419|81394474|FG001|Overall Study|Not treated|1|||
27880280|NCT03448419|81394473|FG000|Overall Study|Patient did not attend all visits|0|||
27880281|NCT03448419|81394474|FG001|Overall Study|Patient did not attend all visits|2|||
27880282|NCT03448419|81394473|FG000|Overall Study|Withdrawn by Sponsor|0|||
27880283|NCT03448419|81394474|FG001|Overall Study|Withdrawn by Sponsor|1|||
27880284|NCT02564900|81394475|FG000|Dose Escalation|Progressive disease per RECIST|2|||
27880285|NCT02564900|81394476|FG001|Dose Escalation|Progressive disease per RECIST|3|||
27880286|NCT02564900|81394477|FG002|Dose Escalation|Progressive disease per RECIST|3|||
27880287|NCT02564900|81394478|FG003|Dose Escalation|Progressive disease per RECIST|3|||
27880288|NCT02564900|81394479|FG004|Dose Escalation|Progressive disease per RECIST|3|||
27880289|NCT02564900|81394480|FG005|Dose Escalation|Progressive disease per RECIST|1|||
27880290|NCT02564900|81394481|FG006|Dose Escalation|Progressive disease per RECIST|0|||
27880291|NCT02564900|81394482|FG007|Dose Escalation|Progressive disease per RECIST|0|||
27880292|NCT02564900|81394483|FG008|Dose Escalation|Progressive disease per RECIST|0|||
27880293|NCT02564900|81394484|FG009|Dose Escalation|Progressive disease per RECIST|0|||
27880294|NCT02564900|81394485|FG010|Dose Escalation|Progressive disease per RECIST|0|||
27880295|NCT02564900|81394486|FG011|Dose Escalation|Progressive disease per RECIST|0|||
27880296|NCT02564900|81394487|FG012|Dose Escalation|Progressive disease per RECIST|0|||
27880297|NCT02564900|81394488|FG013|Dose Escalation|Progressive disease per RECIST|0|||
27591856|NCT04827212|80348444|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
27880298|NCT02564900|81394489|FG014|Dose Escalation|Progressive disease per RECIST|0|||
27880299|NCT02564900|81394475|FG000|Dose Escalation|Ongoing|1|||
27880300|NCT02564900|81394476|FG001|Dose Escalation|Ongoing|0|||
27880301|NCT02564900|81394477|FG002|Dose Escalation|Ongoing|0|||
27880302|NCT02564900|81394478|FG003|Dose Escalation|Ongoing|2|||
27880303|NCT02564900|81394479|FG004|Dose Escalation|Ongoing|2|||
27818510|NCT02581345|81166803|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
27818511|NCT02581345|81166804|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
27692945|NCT02294227|80713510|FG002|Overall Study|Lost to Follow-up|0|||
27692946|NCT02294227|80713508|FG000|Overall Study|Lack of Efficacy|11|||
27692947|NCT02294227|80713509|FG001|Overall Study|Lack of Efficacy|12|||
27692948|NCT02294227|80713510|FG002|Overall Study|Lack of Efficacy|8|||
27692949|NCT02294227|80713508|FG000|Overall Study|Adverse Event|6|||
27692950|NCT02294227|80713509|FG001|Overall Study|Adverse Event|8|||
27692951|NCT02294227|80713510|FG002|Overall Study|Adverse Event|2|||
27818512|NCT02581345|81166805|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
27818513|NCT02581345|81166802|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
27692952|NCT03945825|80713511|FG000|Overall Study|Enrolled but treatment not administered|0|||
27692953|NCT03945825|80713512|FG001|Overall Study|Enrolled but treatment not administered|0|||
27818514|NCT02581345|81166803|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
27692954|NCT03945825|80713513|FG002|Overall Study|Enrolled but treatment not administered|0|||
27818515|NCT02581345|81166804|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
27692955|NCT03945825|80713514|FG003|Overall Study|Enrolled but treatment not administered|0|||
27692956|NCT03945825|80713515|FG004|Overall Study|Enrolled but treatment not administered|1|||
27692957|NCT03945825|80713516|FG005|Overall Study|Enrolled but treatment not administered|0|||
27692958|NCT03945825|80713511|FG000|Overall Study|Lost to Follow-up|1|||
27692959|NCT03945825|80713512|FG001|Overall Study|Lost to Follow-up|5|||
27692960|NCT03945825|80713513|FG002|Overall Study|Lost to Follow-up|0|||
27692961|NCT03945825|80713514|FG003|Overall Study|Lost to Follow-up|1|||
27692962|NCT03945825|80713515|FG004|Overall Study|Lost to Follow-up|2|||
27692963|NCT03945825|80713516|FG005|Overall Study|Lost to Follow-up|2|||
27692964|NCT03945825|80713511|FG000|Overall Study|Withdrawal by Subject|1|||
27692965|NCT03945825|80713512|FG001|Overall Study|Withdrawal by Subject|0|||
27692966|NCT03945825|80713513|FG002|Overall Study|Withdrawal by Subject|1|||
27692967|NCT03945825|80713514|FG003|Overall Study|Withdrawal by Subject|1|||
27692968|NCT03945825|80713515|FG004|Overall Study|Withdrawal by Subject|0|||
27692969|NCT03945825|80713516|FG005|Overall Study|Withdrawal by Subject|1|||
27692970|NCT01506609|80713519|FG000|Overall Study|Adverse Event Related to Progression|0|||
27692971|NCT01506609|80713520|FG001|Overall Study|Adverse Event Related to Progression|0|||
27692972|NCT01506609|80713521|FG002|Overall Study|Adverse Event Related to Progression|0|||
27692973|NCT01506609|80713522|FG003|Overall Study|Adverse Event Related to Progression|3|||
27692974|NCT01506609|80713523|FG004|Overall Study|Adverse Event Related to Progression|7|||
27692975|NCT01506609|80713524|FG005|Overall Study|Adverse Event Related to Progression|3|||
27692976|NCT01506609|80713519|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
27692977|NCT01506609|80713520|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
27692978|NCT01506609|80713521|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
27692979|NCT01506609|80713522|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
27692980|NCT01506609|80713523|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
27692981|NCT01506609|80713524|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
27692982|NCT01506609|80713519|FG000|Overall Study|Withdrawal by Subject|0|||
27692983|NCT01506609|80713520|FG001|Overall Study|Withdrawal by Subject|0|||
27692984|NCT01506609|80713521|FG002|Overall Study|Withdrawal by Subject|0|||
27692985|NCT01506609|80713522|FG003|Overall Study|Withdrawal by Subject|9|||
27692986|NCT01506609|80713523|FG004|Overall Study|Withdrawal by Subject|7|||
27692987|NCT01506609|80713524|FG005|Overall Study|Withdrawal by Subject|7|||
27692988|NCT01506609|80713519|FG000|Overall Study|Lost to Follow-up|0|||
27692989|NCT01506609|80713520|FG001|Overall Study|Lost to Follow-up|0|||
27692990|NCT01506609|80713521|FG002|Overall Study|Lost to Follow-up|0|||
27692991|NCT01506609|80713522|FG003|Overall Study|Lost to Follow-up|1|||
27692992|NCT01506609|80713523|FG004|Overall Study|Lost to Follow-up|2|||
27692993|NCT01506609|80713524|FG005|Overall Study|Lost to Follow-up|0|||
27692994|NCT01506609|80713519|FG000|Overall Study|Sponsor Discontinued Study|0|||
27692995|NCT01506609|80713520|FG001|Overall Study|Sponsor Discontinued Study|0|||
27692996|NCT01506609|80713521|FG002|Overall Study|Sponsor Discontinued Study|0|||
27692997|NCT01506609|80713522|FG003|Overall Study|Sponsor Discontinued Study|2|||
27692998|NCT01506609|80713523|FG004|Overall Study|Sponsor Discontinued Study|2|||
27692999|NCT01506609|80713524|FG005|Overall Study|Sponsor Discontinued Study|0|||
27693000|NCT01506609|80713519|FG000|Overall Study|Progressive Disease per Protocol|1|||
27693001|NCT01506609|80713520|FG001|Overall Study|Progressive Disease per Protocol|0|||
27693002|NCT01506609|80713521|FG002|Overall Study|Progressive Disease per Protocol|0|||
27693003|NCT01506609|80713522|FG003|Overall Study|Progressive Disease per Protocol|64|||
27693004|NCT01506609|80713523|FG004|Overall Study|Progressive Disease per Protocol|57|||
27693005|NCT01506609|80713524|FG005|Overall Study|Progressive Disease per Protocol|74|||
27693006|NCT01506609|80713519|FG000|Overall Study|Other, Not Specified|0|||
27693007|NCT01506609|80713520|FG001|Overall Study|Other, Not Specified|0|||
27693008|NCT01506609|80713521|FG002|Overall Study|Other, Not Specified|0|||
27693009|NCT01506609|80713522|FG003|Overall Study|Other, Not Specified|10|||
27693010|NCT01506609|80713523|FG004|Overall Study|Other, Not Specified|7|||
27693011|NCT01506609|80713524|FG005|Overall Study|Other, Not Specified|3|||
27693012|NCT01506609|80713519|FG000|Overall Study|Missing / Unknown Reason|1|||
27693013|NCT01506609|80713520|FG001|Overall Study|Missing / Unknown Reason|0|||
27693014|NCT01506609|80713521|FG002|Overall Study|Missing / Unknown Reason|1|||
27693015|NCT01506609|80713522|FG003|Overall Study|Missing / Unknown Reason|4|||
27693016|NCT01506609|80713523|FG004|Overall Study|Missing / Unknown Reason|4|||
27693017|NCT01506609|80713524|FG005|Overall Study|Missing / Unknown Reason|2|||
27693018|NCT00824161|80713530|FG000|Overall Study|Withdrawal by Subject|1|||
27693019|NCT00824161|80713530|FG000|Overall Study|Screen Failure|1|||
27818516|NCT02581345|81166805|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
27818517|NCT00436007|81166808|FG000|Overall Study|Withdrawal by Subject|5|||
27818518|NCT00436007|81166809|FG001|Overall Study|Withdrawal by Subject|3|||
27818519|NCT00436007|81166810|FG002|Overall Study|Withdrawal by Subject|4|||
27818520|NCT00436007|81166808|FG000|Overall Study|Lost to Follow-up|14|||
27693020|NCT01227577|80713531|FG000|Overall Study|Protocol deviation|3|||
27818521|NCT00436007|81166809|FG001|Overall Study|Lost to Follow-up|10|||
27818522|NCT00436007|81166810|FG002|Overall Study|Lost to Follow-up|13|||
27818523|NCT00436007|81166808|FG000|Overall Study|Physician Decision|0|||
27693021|NCT01227577|80713531|FG000|Overall Study|Death|3|||
27693022|NCT01227577|80713531|FG000|Overall Study|Administrative problems|2|||
27693023|NCT01227577|80713531|FG000|Overall Study|Lost to Follow-up|1|||
27693024|NCT01227577|80713531|FG000|Overall Study|Withdrawal by Subject|4|||
27693025|NCT01227577|80713531|FG000|Overall Study|Lack of Efficacy|5|||
27693026|NCT01227577|80713531|FG000|Overall Study|Adverse Event|17|||
27693027|NCT01491672|80713532|FG000|Overall Study|Lost to Follow-up|0|||
27693028|NCT01491672|80713533|FG001|Overall Study|Lost to Follow-up|4|||
27693029|NCT01491672|80713534|FG002|Overall Study|Lost to Follow-up|1|||
27693030|NCT01491672|80713532|FG000|Overall Study|Withdrawal by Subject|6|||
27693031|NCT01491672|80713533|FG001|Overall Study|Withdrawal by Subject|7|||
27693032|NCT01491672|80713534|FG002|Overall Study|Withdrawal by Subject|0|||
27693033|NCT01491672|80713532|FG000|Overall Study|Adverse Event|8|||
27693034|NCT01491672|80713533|FG001|Overall Study|Adverse Event|10|||
27693035|NCT01491672|80713534|FG002|Overall Study|Adverse Event|4|||
27693036|NCT01491672|80713532|FG000|Overall Study|Disease progression|42|||
27693037|NCT01491672|80713533|FG001|Overall Study|Disease progression|34|||
27693038|NCT01491672|80713534|FG002|Overall Study|Disease progression|6|||
27693039|NCT01491672|80713532|FG000|Overall Study|Protocol deviation|0|||
27693040|NCT01491672|80713533|FG001|Overall Study|Protocol deviation|1|||
27693041|NCT01491672|80713534|FG002|Overall Study|Protocol deviation|0|||
27693042|NCT01491672|80713532|FG000|Overall Study|Death|0|||
27693043|NCT01491672|80713533|FG001|Overall Study|Death|4|||
27693044|NCT01491672|80713534|FG002|Overall Study|Death|0|||
27693045|NCT02668185|80713535|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
27693046|NCT02668185|80713536|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
27693047|NCT02668185|80713535|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
27693048|NCT02668185|80713536|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
27693049|NCT02668185|80713535|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
27693050|NCT02668185|80713536|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
27693051|NCT02668185|80713535|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
27693052|NCT02668185|80713536|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
27693053|NCT02963610|80713537|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
27693054|NCT02175004|80713538|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
27693055|NCT02175004|80713539|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
27693056|NCT02175004|80713538|FG000|Overall Study|Investigator Judgment|1|||
27693057|NCT02175004|80713539|FG001|Overall Study|Investigator Judgment|4|||
27693058|NCT02175004|80713538|FG000|Overall Study|Voluntary Withdrawal|6|||
27693059|NCT02175004|80713539|FG001|Overall Study|Voluntary Withdrawal|19|||
27693060|NCT02175004|80713538|FG000|Overall Study|Liver Transplant|1|||
27693061|NCT02175004|80713539|FG001|Overall Study|Liver Transplant|0|||
27693062|NCT02175004|80713538|FG000|Overall Study|Disease Progression|1|||
27693063|NCT02175004|80713539|FG001|Overall Study|Disease Progression|0|||
27693064|NCT02175004|80713538|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
27693065|NCT02175004|80713539|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
27693066|NCT00757783|80713540|FG000|Overall Study|Adverse Event|0|||
27693067|NCT00757783|80713541|FG001|Overall Study|Adverse Event|2|||
27693068|NCT00757783|80713540|FG000|Overall Study|Lost to Follow-up|1|||
27693069|NCT00757783|80713541|FG001|Overall Study|Lost to Follow-up|1|||
27693070|NCT00757783|80713540|FG000|Overall Study|Protocol Violation|1|||
27693071|NCT00757783|80713541|FG001|Overall Study|Protocol Violation|0|||
27693072|NCT00757783|80713540|FG000|Overall Study|Withdrawal by Subject|2|||
27693073|NCT00757783|80713541|FG001|Overall Study|Withdrawal by Subject|1|||
27693074|NCT00757783|80713540|FG000|Overall Study|Other|1|||
27693075|NCT00757783|80713541|FG001|Overall Study|Other|2|||
27693076|NCT01013597|80713542|FG000|Overall Study|Withdrawal by Subject|1|||
27693077|NCT03401229|80713543|FG000|Overall Study|Lost to Follow-up|2|||
27693078|NCT03401229|80713544|FG001|Overall Study|Lost to Follow-up|1|||
27693079|NCT03401229|80713543|FG000|Overall Study|Other|1|||
27693080|NCT03401229|80713544|FG001|Overall Study|Other|3|||
27693081|NCT03401229|80713543|FG000|Overall Study|Adverse Event|8|||
27693082|NCT03401229|80713544|FG001|Overall Study|Adverse Event|6|||
27693083|NCT03401229|80713543|FG000|Overall Study|Withdrawal by Subject|29|||
27818524|NCT00436007|81166809|FG001|Overall Study|Physician Decision|0|||
27818525|NCT00436007|81166810|FG002|Overall Study|Physician Decision|2|||
27693084|NCT03401229|80713544|FG001|Overall Study|Withdrawal by Subject|26|||
27693085|NCT03401229|80713543|FG000|Overall Study|COVID-19|0|||
27818526|NCT00436007|81166808|FG000|Overall Study|Death|0|||
27693086|NCT03401229|80713544|FG001|Overall Study|COVID-19|1|||
27693087|NCT01340651|80713547|FG000|Overall Study|Adverse Event|3|||
27693088|NCT01340651|80713547|FG000|Overall Study|Consent Withdrawn|2|||
27693089|NCT01340651|80713547|FG000|Overall Study|Commercial Supply per Sponsor|12|||
27693090|NCT02134977|80713548|FG000|Overall Study|Protocol Deviation|102|||
27693091|NCT00932113|80713551|FG000|Overall Study|Lost to Follow-up|1|||
27693092|NCT00932113|80713552|FG001|Overall Study|Lost to Follow-up|0|||
27818527|NCT00436007|81166809|FG001|Overall Study|Death|1|||
27693093|NCT02483585|80713554|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
27693094|NCT02483585|80713555|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
27693095|NCT02483585|80713554|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
27591857|NCT04827212|80348445|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
27591858|NCT01022762|80348447|FG000|Overall Study|Adverse Event|3|||
27693096|NCT02483585|80713555|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
27693097|NCT02483585|80713554|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
27693098|NCT02483585|80713555|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
27693099|NCT02483585|80713554|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
27693100|NCT02483585|80713555|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
27693101|NCT02483585|80713554|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
27693102|NCT02483585|80713555|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
27693103|NCT02483585|80713554|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
27693104|NCT02483585|80713555|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
27693105|NCT02483585|80713554|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
27693106|NCT02483585|80713555|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
27693107|NCT02649946|80713556|FG000|Overall Study|Withdrawal by Subject|1|||
27693108|NCT02649946|80713557|FG001|Overall Study|Withdrawal by Subject|1|||
27693109|NCT02649946|80713556|FG000|Overall Study|Death|7|||
27693110|NCT02649946|80713557|FG001|Overall Study|Death|9|||
27818528|NCT00436007|81166810|FG002|Overall Study|Death|3|||
27818529|NCT00436007|81166808|FG000|Overall Study|Other|0|||
27818530|NCT00436007|81166809|FG001|Overall Study|Other|0|||
27818531|NCT00436007|81166810|FG002|Overall Study|Other|1|||
27818532|NCT02720510|81166813|FG000|Overall Study|Study Terminated by the sponsor|2|||
27818533|NCT02720510|81166814|FG001|Overall Study|Study Terminated by the sponsor|0|||
27818534|NCT02720510|81166813|FG000|Overall Study|Adverse Event|0|||
27818535|NCT02720510|81166814|FG001|Overall Study|Adverse Event|1|||
27818536|NCT02720510|81166813|FG000|Overall Study|Physician Decision|1|||
27818537|NCT02720510|81166814|FG001|Overall Study|Physician Decision|2|||
27818538|NCT03127137|81166819|FG000|Overall Study|Requested sedation after consent|1|||
27818539|NCT03127137|81166820|FG001|Overall Study|Requested sedation after consent|0|||
27818540|NCT03127137|81166819|FG000|Overall Study|Malfunction in electronic data collection|1|||
27818541|NCT03127137|81166820|FG001|Overall Study|Malfunction in electronic data collection|0|||
27818542|NCT03127137|81166819|FG000|Overall Study|Post procedure testing could not be obtained|0|||
27818543|NCT03127137|81166820|FG001|Overall Study|Post procedure testing could not be obtained|1|||
27818544|NCT01074554|81166821|FG000|Overall Study|Adverse Event|3|||
27818545|NCT01074554|81166822|FG001|Overall Study|Adverse Event|3|||
27818546|NCT01074554|81166821|FG000|Overall Study|Lost to Follow-up|0|||
27818547|NCT01074554|81166822|FG001|Overall Study|Lost to Follow-up|1|||
27818548|NCT02365207|81166823|FG000|Overall Study|Withdrawal by Subject|1|||
27818549|NCT02365207|81166823|FG000|Overall Study|Physician Decision|1|||
27818550|NCT04799158|81166825|FG000|Run-In Period|Adverse Event|6|||
27818551|NCT04799158|81166826|FG001|Run-In Period|Adverse Event|0|||
27818552|NCT04799158|81166827|FG002|Run-In Period|Adverse Event|0|||
27818553|NCT04799158|81166828|FG003|Run-In Period|Adverse Event|0|||
27818554|NCT04799158|81166829|FG004|Run-In Period|Adverse Event|0|||
27818555|NCT04799158|81166825|FG000|Run-In Period|Lost to Follow-up|4|||
27818556|NCT04799158|81166826|FG001|Run-In Period|Lost to Follow-up|0|||
27818557|NCT04799158|81166827|FG002|Run-In Period|Lost to Follow-up|0|||
27818558|NCT04799158|81166828|FG003|Run-In Period|Lost to Follow-up|0|||
27818559|NCT04799158|81166829|FG004|Run-In Period|Lost to Follow-up|0|||
27818560|NCT04799158|81166825|FG000|Run-In Period|Significant Protocol Deviation|1|||
27591859|NCT01022762|80348448|FG001|Overall Study|Adverse Event|1|||
27591860|NCT01022762|80348447|FG000|Overall Study|Lack of Efficacy|0|||
27818561|NCT04799158|81166826|FG001|Run-In Period|Significant Protocol Deviation|0|||
27818562|NCT04799158|81166827|FG002|Run-In Period|Significant Protocol Deviation|0|||
27818563|NCT04799158|81166828|FG003|Run-In Period|Significant Protocol Deviation|0|||
27818564|NCT04799158|81166829|FG004|Run-In Period|Significant Protocol Deviation|0|||
27818565|NCT04799158|81166825|FG000|Run-In Period|Withdrawal by Subject|11|||
27818566|NCT04799158|81166826|FG001|Run-In Period|Withdrawal by Subject|0|||
27818567|NCT04799158|81166827|FG002|Run-In Period|Withdrawal by Subject|0|||
27818568|NCT04799158|81166828|FG003|Run-In Period|Withdrawal by Subject|0|||
27818569|NCT04799158|81166829|FG004|Run-In Period|Withdrawal by Subject|0|||
27818570|NCT04799158|81166825|FG000|Run-In Period|Miscellaneous|3|||
27818571|NCT04799158|81166826|FG001|Run-In Period|Miscellaneous|0|||
27818572|NCT04799158|81166827|FG002|Run-In Period|Miscellaneous|0|||
27818573|NCT04799158|81166828|FG003|Run-In Period|Miscellaneous|0|||
27818574|NCT04799158|81166829|FG004|Run-In Period|Miscellaneous|0|||
27818575|NCT04799158|81166825|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
27818576|NCT04799158|81166826|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
27818577|NCT04799158|81166827|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
27818578|NCT04799158|81166828|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
27880304|NCT02564900|81394480|FG005|Dose Escalation|Ongoing|2|||
27880305|NCT02564900|81394481|FG006|Dose Escalation|Ongoing|0|||
27880306|NCT02564900|81394482|FG007|Dose Escalation|Ongoing|0|||
27880307|NCT02564900|81394483|FG008|Dose Escalation|Ongoing|0|||
27880308|NCT02564900|81394484|FG009|Dose Escalation|Ongoing|0|||
27880309|NCT02564900|81394485|FG010|Dose Escalation|Ongoing|0|||
27880310|NCT02564900|81394486|FG011|Dose Escalation|Ongoing|0|||
27880311|NCT02564900|81394487|FG012|Dose Escalation|Ongoing|0|||
27880312|NCT02564900|81394488|FG013|Dose Escalation|Ongoing|0|||
27880313|NCT02564900|81394489|FG014|Dose Escalation|Ongoing|0|||
27880314|NCT02564900|81394475|FG000|Dose Escalation|Adverse Event|0|||
27880315|NCT02564900|81394476|FG001|Dose Escalation|Adverse Event|0|||
27880316|NCT02564900|81394477|FG002|Dose Escalation|Adverse Event|0|||
27880317|NCT02564900|81394478|FG003|Dose Escalation|Adverse Event|1|||
27880318|NCT02564900|81394479|FG004|Dose Escalation|Adverse Event|1|||
27880319|NCT02564900|81394480|FG005|Dose Escalation|Adverse Event|3|||
27880320|NCT02564900|81394481|FG006|Dose Escalation|Adverse Event|0|||
27880321|NCT02564900|81394482|FG007|Dose Escalation|Adverse Event|0|||
27880322|NCT02564900|81394483|FG008|Dose Escalation|Adverse Event|0|||
27693111|NCT02649946|80713556|FG000|Overall Study|Physician Decision|1|||
27693112|NCT02649946|80713557|FG001|Overall Study|Physician Decision|0|||
27693113|NCT02649946|80713556|FG000|Overall Study|Lost to Follow-up|2|||
27693114|NCT02649946|80713557|FG001|Overall Study|Lost to Follow-up|1|||
27693115|NCT02649946|80713556|FG000|Overall Study|Erroneously enrolled|1|||
27693116|NCT02649946|80713557|FG001|Overall Study|Erroneously enrolled|0|||
27693117|NCT02649946|80713556|FG000|Overall Study|Missed 6-month follow-up visit|0|||
27693118|NCT02649946|80713557|FG001|Overall Study|Missed 6-month follow-up visit|4|||
27693119|NCT00413972|80713563|FG000|Overall Study|Adverse Event|2|||
27693120|NCT00413972|80713564|FG001|Overall Study|Adverse Event|1|||
27693121|NCT00413972|80713565|FG002|Overall Study|Adverse Event|0|||
27693122|NCT00413972|80713566|FG003|Overall Study|Adverse Event|0|||
27693123|NCT00413972|80713563|FG000|Overall Study|Lost to Follow-up|1|||
27693124|NCT00413972|80713564|FG001|Overall Study|Lost to Follow-up|2|||
27880323|NCT02564900|81394484|FG009|Dose Escalation|Adverse Event|0|||
27880324|NCT02564900|81394485|FG010|Dose Escalation|Adverse Event|0|||
27880325|NCT02564900|81394486|FG011|Dose Escalation|Adverse Event|0|||
27880326|NCT02564900|81394487|FG012|Dose Escalation|Adverse Event|0|||
27880327|NCT02564900|81394488|FG013|Dose Escalation|Adverse Event|0|||
27880328|NCT02564900|81394489|FG014|Dose Escalation|Adverse Event|0|||
27880329|NCT02564900|81394475|FG000|Dose Expansion|Progressive disease per RECIST|0|||
27880330|NCT02564900|81394476|FG001|Dose Expansion|Progressive disease per RECIST|0|||
27880331|NCT02564900|81394477|FG002|Dose Expansion|Progressive disease per RECIST|0|||
27880332|NCT02564900|81394478|FG003|Dose Expansion|Progressive disease per RECIST|0|||
27880333|NCT02564900|81394479|FG004|Dose Expansion|Progressive disease per RECIST|0|||
27880334|NCT02564900|81394480|FG005|Dose Expansion|Progressive disease per RECIST|0|||
27880335|NCT02564900|81394481|FG006|Dose Expansion|Progressive disease per RECIST|19|||
27880336|NCT02564900|81394482|FG007|Dose Expansion|Progressive disease per RECIST|17|||
27880337|NCT02564900|81394483|FG008|Dose Expansion|Progressive disease per RECIST|8|||
27880338|NCT02564900|81394484|FG009|Dose Expansion|Progressive disease per RECIST|16|||
27880339|NCT02564900|81394485|FG010|Dose Expansion|Progressive disease per RECIST|13|||
27880340|NCT02564900|81394486|FG011|Dose Expansion|Progressive disease per RECIST|19|||
27880341|NCT02564900|81394487|FG012|Dose Expansion|Progressive disease per RECIST|10|||
27880342|NCT02564900|81394488|FG013|Dose Expansion|Progressive disease per RECIST|13|||
27880343|NCT02564900|81394489|FG014|Dose Expansion|Progressive disease per RECIST|11|||
27880344|NCT02564900|81394475|FG000|Dose Expansion|Clinical progression|0|||
27880345|NCT02564900|81394476|FG001|Dose Expansion|Clinical progression|0|||
27693125|NCT00413972|80713565|FG002|Overall Study|Lost to Follow-up|1|||
27880346|NCT02564900|81394477|FG002|Dose Expansion|Clinical progression|0|||
27880347|NCT02564900|81394478|FG003|Dose Expansion|Clinical progression|0|||
27880348|NCT02564900|81394479|FG004|Dose Expansion|Clinical progression|0|||
27880349|NCT02564900|81394480|FG005|Dose Expansion|Clinical progression|0|||
27880350|NCT02564900|81394481|FG006|Dose Expansion|Clinical progression|5|||
27880351|NCT02564900|81394482|FG007|Dose Expansion|Clinical progression|12|||
27880352|NCT02564900|81394483|FG008|Dose Expansion|Clinical progression|0|||
27818579|NCT04799158|81166829|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
27880353|NCT02564900|81394484|FG009|Dose Expansion|Clinical progression|3|||
27880354|NCT02564900|81394485|FG010|Dose Expansion|Clinical progression|2|||
27880355|NCT02564900|81394486|FG011|Dose Expansion|Clinical progression|0|||
27880356|NCT02564900|81394487|FG012|Dose Expansion|Clinical progression|1|||
27880357|NCT02564900|81394488|FG013|Dose Expansion|Clinical progression|3|||
27591861|NCT01022762|80348448|FG001|Overall Study|Lack of Efficacy|1|||
27591862|NCT01022762|80348447|FG000|Overall Study|Protocol Violation|7|||
27818580|NCT04799158|81166825|FG000|On-Demand Treatment Period|Adverse Event|0|||
27818581|NCT04799158|81166826|FG001|On-Demand Treatment Period|Adverse Event|1|||
27818582|NCT04799158|81166827|FG002|On-Demand Treatment Period|Adverse Event|0|||
27818583|NCT04799158|81166828|FG003|On-Demand Treatment Period|Adverse Event|0|||
27818584|NCT04799158|81166829|FG004|On-Demand Treatment Period|Adverse Event|1|||
27818585|NCT04799158|81166825|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
27818586|NCT04799158|81166826|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
27818587|NCT04799158|81166827|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
27818588|NCT04799158|81166828|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
27591863|NCT01022762|80348448|FG001|Overall Study|Protocol Violation|6|||
27591864|NCT01022762|80348447|FG000|Overall Study|Unclassified|12|||
27591865|NCT01022762|80348448|FG001|Overall Study|Unclassified|20|||
27591866|NCT03597568|80348449|FG000|Overall Study|Withdrawal by Subject|1|||
27591867|NCT03597568|80348450|FG001|Overall Study|Withdrawal by Subject|1|||
27591868|NCT03597568|80348449|FG000|Overall Study|Unable to analyze vascular data|1|||
27591869|NCT03597568|80348450|FG001|Overall Study|Unable to analyze vascular data|1|||
27591870|NCT02187991|80348451|FG000|Overall Study|Adverse Event|13|||
27591871|NCT02187991|80348452|FG001|Overall Study|Adverse Event|14|||
27591872|NCT02187991|80348453|FG002|Overall Study|Adverse Event|3|||
27591873|NCT02187991|80348454|FG003|Overall Study|Adverse Event|2|||
27591874|NCT02187991|80348451|FG000|Overall Study|Withdrawal by Subject|9|||
27591875|NCT02187991|80348452|FG001|Overall Study|Withdrawal by Subject|6|||
27591876|NCT02187991|80348453|FG002|Overall Study|Withdrawal by Subject|3|||
27591877|NCT02187991|80348454|FG003|Overall Study|Withdrawal by Subject|2|||
27591878|NCT02187991|80348451|FG000|Overall Study|Physician Decision|4|||
27591879|NCT02187991|80348452|FG001|Overall Study|Physician Decision|4|||
27591880|NCT02187991|80348453|FG002|Overall Study|Physician Decision|0|||
27591881|NCT02187991|80348454|FG003|Overall Study|Physician Decision|2|||
27591882|NCT02187991|80348451|FG000|Overall Study|Other, unrelated complication|7|||
27591883|NCT02187991|80348452|FG001|Overall Study|Other, unrelated complication|1|||
27591884|NCT02187991|80348453|FG002|Overall Study|Other, unrelated complication|1|||
27591885|NCT02187991|80348454|FG003|Overall Study|Other, unrelated complication|2|||
27591886|NCT02187991|80348451|FG000|Overall Study|Death|1|||
27591887|NCT02187991|80348452|FG001|Overall Study|Death|3|||
27591888|NCT02187991|80348453|FG002|Overall Study|Death|0|||
27591889|NCT02187991|80348454|FG003|Overall Study|Death|0|||
27591890|NCT02041195|80348455|FG000|Overall Study|Adverse Event|1|||
27591891|NCT02041195|80348456|FG001|Overall Study|Adverse Event|2|||
27591892|NCT02041195|80348457|FG002|Overall Study|Adverse Event|0|||
27591893|NCT02041195|80348458|FG003|Overall Study|Adverse Event|0|||
27591894|NCT02041195|80348459|FG004|Overall Study|Adverse Event|0|||
27591895|NCT02041195|80348460|FG005|Overall Study|Adverse Event|0|||
27591896|NCT02041195|80348461|FG006|Overall Study|Adverse Event|3|||
27591897|NCT02041195|80348462|FG007|Overall Study|Adverse Event|0|||
27591898|NCT02041195|80348455|FG000|Overall Study|Withdrawal by Subject|1|||
27591899|NCT02041195|80348456|FG001|Overall Study|Withdrawal by Subject|0|||
27591900|NCT02041195|80348457|FG002|Overall Study|Withdrawal by Subject|0|||
27591901|NCT02041195|80348458|FG003|Overall Study|Withdrawal by Subject|0|||
27591902|NCT02041195|80348459|FG004|Overall Study|Withdrawal by Subject|0|||
27880358|NCT02564900|81394489|FG014|Dose Expansion|Clinical progression|1|||
27880359|NCT02564900|81394475|FG000|Dose Expansion|Adverse Event|0|||
27880360|NCT02564900|81394476|FG001|Dose Expansion|Adverse Event|0|||
27880361|NCT02564900|81394477|FG002|Dose Expansion|Adverse Event|0|||
27591903|NCT02041195|80348460|FG005|Overall Study|Withdrawal by Subject|0|||
27591904|NCT02041195|80348461|FG006|Overall Study|Withdrawal by Subject|4|||
27591905|NCT02041195|80348462|FG007|Overall Study|Withdrawal by Subject|3|||
27591906|NCT02041195|80348455|FG000|Overall Study|Unable to comply with study visits|0|||
27591907|NCT02041195|80348456|FG001|Overall Study|Unable to comply with study visits|1|||
27591908|NCT02041195|80348457|FG002|Overall Study|Unable to comply with study visits|0|||
27591909|NCT02041195|80348458|FG003|Overall Study|Unable to comply with study visits|0|||
27591910|NCT02041195|80348459|FG004|Overall Study|Unable to comply with study visits|1|||
27818589|NCT04799158|81166829|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
27818590|NCT04799158|81166825|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
27818591|NCT04799158|81166826|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
27818592|NCT04799158|81166827|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
27818593|NCT04799158|81166828|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
27818594|NCT04799158|81166829|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
27818595|NCT04799158|81166825|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
27818596|NCT04799158|81166826|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
27818597|NCT04799158|81166827|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
27818598|NCT04799158|81166828|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
27818599|NCT04799158|81166829|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
27818600|NCT04799158|81166825|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
27818601|NCT04799158|81166826|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
27818602|NCT04799158|81166827|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
27818603|NCT04799158|81166828|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
27818604|NCT04799158|81166829|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
27818605|NCT04799158|81166825|FG000|On-Demand Treatment Period|Miscellaneous|0|||
27818606|NCT04799158|81166826|FG001|On-Demand Treatment Period|Miscellaneous|0|||
27818607|NCT04799158|81166827|FG002|On-Demand Treatment Period|Miscellaneous|0|||
27818608|NCT04799158|81166828|FG003|On-Demand Treatment Period|Miscellaneous|0|||
27818609|NCT04799158|81166829|FG004|On-Demand Treatment Period|Miscellaneous|1|||
27818610|NCT01139164|81166830|FG000|Overall Study|Withdrawn prior to study start|0|||
27818611|NCT01139164|81166831|FG001|Overall Study|Withdrawn prior to study start|2|||
27818612|NCT01139164|81166832|FG002|Overall Study|Withdrawn prior to study start|0|||
27818613|NCT03125200|81166839|FG000|Overall Study|Study Termination|0|||
27818614|NCT03125200|81166840|FG001|Overall Study|Study Termination|0|||
27818615|NCT03125200|81166841|FG002|Overall Study|Study Termination|0|||
27818616|NCT03125200|81166842|FG003|Overall Study|Study Termination|1|||
27818617|NCT03125200|81166843|FG004|Overall Study|Study Termination|1|||
27818618|NCT03125200|81166844|FG005|Overall Study|Study Termination|2|||
27818619|NCT03125200|81166845|FG006|Overall Study|Study Termination|1|||
27818620|NCT03125200|81166839|FG000|Overall Study|Clinical Progression|0|||
27818621|NCT03125200|81166840|FG001|Overall Study|Clinical Progression|0|||
27880362|NCT02564900|81394478|FG003|Dose Expansion|Adverse Event|0|||
27880363|NCT02564900|81394479|FG004|Dose Expansion|Adverse Event|0|||
27818622|NCT03125200|81166841|FG002|Overall Study|Clinical Progression|0|||
27818623|NCT03125200|81166842|FG003|Overall Study|Clinical Progression|1|||
27818624|NCT03125200|81166843|FG004|Overall Study|Clinical Progression|0|||
27818625|NCT03125200|81166844|FG005|Overall Study|Clinical Progression|1|||
27818626|NCT03125200|81166845|FG006|Overall Study|Clinical Progression|0|||
27880364|NCT02564900|81394480|FG005|Dose Expansion|Adverse Event|0|||
27880365|NCT02564900|81394481|FG006|Dose Expansion|Adverse Event|9|||
27880366|NCT02564900|81394482|FG007|Dose Expansion|Adverse Event|22|||
27880367|NCT02564900|81394483|FG008|Dose Expansion|Adverse Event|0|||
27880368|NCT02564900|81394484|FG009|Dose Expansion|Adverse Event|11|||
27880369|NCT02564900|81394485|FG010|Dose Expansion|Adverse Event|0|||
27880370|NCT02564900|81394486|FG011|Dose Expansion|Adverse Event|5|||
27880371|NCT02564900|81394487|FG012|Dose Expansion|Adverse Event|2|||
27880372|NCT02564900|81394488|FG013|Dose Expansion|Adverse Event|2|||
27880373|NCT02564900|81394489|FG014|Dose Expansion|Adverse Event|1|||
27880374|NCT02564900|81394475|FG000|Dose Expansion|Ongoing|0|||
27880375|NCT02564900|81394476|FG001|Dose Expansion|Ongoing|0|||
27880376|NCT02564900|81394477|FG002|Dose Expansion|Ongoing|0|||
27880377|NCT02564900|81394478|FG003|Dose Expansion|Ongoing|0|||
27880378|NCT02564900|81394479|FG004|Dose Expansion|Ongoing|0|||
27880379|NCT02564900|81394480|FG005|Dose Expansion|Ongoing|0|||
27880380|NCT02564900|81394481|FG006|Dose Expansion|Ongoing|9|||
27880381|NCT02564900|81394482|FG007|Dose Expansion|Ongoing|10|||
27880382|NCT02564900|81394483|FG008|Dose Expansion|Ongoing|11|||
27880383|NCT02564900|81394484|FG009|Dose Expansion|Ongoing|3|||
27880384|NCT02564900|81394485|FG010|Dose Expansion|Ongoing|0|||
27880385|NCT02564900|81394486|FG011|Dose Expansion|Ongoing|0|||
27880386|NCT02564900|81394487|FG012|Dose Expansion|Ongoing|4|||
27880387|NCT02564900|81394488|FG013|Dose Expansion|Ongoing|0|||
27880388|NCT02564900|81394489|FG014|Dose Expansion|Ongoing|6|||
27880389|NCT02564900|81394475|FG000|Dose Expansion|Death|0|||
27880390|NCT02564900|81394476|FG001|Dose Expansion|Death|0|||
27880391|NCT02564900|81394477|FG002|Dose Expansion|Death|0|||
27880392|NCT02564900|81394478|FG003|Dose Expansion|Death|0|||
27880393|NCT02564900|81394479|FG004|Dose Expansion|Death|0|||
27880394|NCT02564900|81394480|FG005|Dose Expansion|Death|0|||
27880395|NCT02564900|81394481|FG006|Dose Expansion|Death|1|||
27880396|NCT02564900|81394482|FG007|Dose Expansion|Death|0|||
27880397|NCT02564900|81394483|FG008|Dose Expansion|Death|0|||
27880398|NCT02564900|81394484|FG009|Dose Expansion|Death|0|||
27880399|NCT02564900|81394485|FG010|Dose Expansion|Death|1|||
27880400|NCT02564900|81394486|FG011|Dose Expansion|Death|0|||
27880401|NCT02564900|81394487|FG012|Dose Expansion|Death|1|||
27880402|NCT02564900|81394488|FG013|Dose Expansion|Death|1|||
27880403|NCT02564900|81394489|FG014|Dose Expansion|Death|0|||
27880404|NCT02564900|81394475|FG000|Dose Expansion|Withdrawal by Subject|0|||
27880405|NCT02564900|81394476|FG001|Dose Expansion|Withdrawal by Subject|0|||
27880406|NCT02564900|81394477|FG002|Dose Expansion|Withdrawal by Subject|0|||
27880407|NCT02564900|81394478|FG003|Dose Expansion|Withdrawal by Subject|0|||
27880408|NCT02564900|81394479|FG004|Dose Expansion|Withdrawal by Subject|0|||
27880409|NCT02564900|81394480|FG005|Dose Expansion|Withdrawal by Subject|0|||
27880410|NCT02564900|81394481|FG006|Dose Expansion|Withdrawal by Subject|4|||
27880411|NCT02564900|81394482|FG007|Dose Expansion|Withdrawal by Subject|0|||
27880412|NCT02564900|81394483|FG008|Dose Expansion|Withdrawal by Subject|0|||
27591911|NCT02041195|80348460|FG005|Overall Study|Unable to comply with study visits|0|||
27591912|NCT02041195|80348461|FG006|Overall Study|Unable to comply with study visits|0|||
27591913|NCT02041195|80348462|FG007|Overall Study|Unable to comply with study visits|0|||
27591914|NCT00971048|80348463|FG000|Overall Study|Protocol Violation|1|||
27591915|NCT00971048|80348464|FG001|Overall Study|Protocol Violation|2|||
27591916|NCT00971048|80348465|FG002|Overall Study|Protocol Violation|0|||
27591917|NCT00971048|80348466|FG003|Overall Study|Protocol Violation|1|||
27591918|NCT00971048|80348463|FG000|Overall Study|Adverse Event|0|||
27591919|NCT00971048|80348464|FG001|Overall Study|Adverse Event|0|||
27591920|NCT00971048|80348465|FG002|Overall Study|Adverse Event|1|||
27591921|NCT00971048|80348466|FG003|Overall Study|Adverse Event|0|||
27591922|NCT00971048|80348463|FG000|Overall Study|Physician Decision|0|||
27591923|NCT00971048|80348464|FG001|Overall Study|Physician Decision|0|||
27818627|NCT03125200|81166839|FG000|Overall Study|Progressive Disease|2|||
27818628|NCT03125200|81166840|FG001|Overall Study|Progressive Disease|1|||
27818629|NCT03125200|81166841|FG002|Overall Study|Progressive Disease|2|||
27818630|NCT03125200|81166842|FG003|Overall Study|Progressive Disease|1|||
27818631|NCT03125200|81166843|FG004|Overall Study|Progressive Disease|2|||
27818632|NCT03125200|81166844|FG005|Overall Study|Progressive Disease|0|||
27818633|NCT03125200|81166845|FG006|Overall Study|Progressive Disease|1|||
27818634|NCT03125200|81166839|FG000|Overall Study|Lack of Efficacy|0|||
27818635|NCT03125200|81166840|FG001|Overall Study|Lack of Efficacy|0|||
27591924|NCT00971048|80348465|FG002|Overall Study|Physician Decision|0|||
27591925|NCT00971048|80348466|FG003|Overall Study|Physician Decision|1|||
27591926|NCT01343407|80348474|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
27693126|NCT00413972|80713566|FG003|Overall Study|Lost to Follow-up|0|||
27693127|NCT00413972|80713563|FG000|Overall Study|Withdrawal by Subject|4|||
27818636|NCT03125200|81166841|FG002|Overall Study|Lack of Efficacy|0|||
27818637|NCT03125200|81166842|FG003|Overall Study|Lack of Efficacy|1|||
27818638|NCT03125200|81166843|FG004|Overall Study|Lack of Efficacy|0|||
27818639|NCT03125200|81166844|FG005|Overall Study|Lack of Efficacy|0|||
27818640|NCT03125200|81166845|FG006|Overall Study|Lack of Efficacy|0|||
27818641|NCT03125200|81166839|FG000|Overall Study|Toxicity|0|||
27880413|NCT02564900|81394484|FG009|Dose Expansion|Withdrawal by Subject|0|||
27880414|NCT02564900|81394485|FG010|Dose Expansion|Withdrawal by Subject|1|||
27880415|NCT02564900|81394486|FG011|Dose Expansion|Withdrawal by Subject|0|||
27693128|NCT00413972|80713564|FG001|Overall Study|Withdrawal by Subject|5|||
27591927|NCT01343407|80348475|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
27591928|NCT01343407|80348476|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
27591929|NCT01343407|80348477|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
27818642|NCT03125200|81166840|FG001|Overall Study|Toxicity|0|||
27818643|NCT03125200|81166841|FG002|Overall Study|Toxicity|0|||
27818644|NCT03125200|81166842|FG003|Overall Study|Toxicity|1|||
27818645|NCT03125200|81166843|FG004|Overall Study|Toxicity|0|||
27818646|NCT03125200|81166844|FG005|Overall Study|Toxicity|0|||
27818647|NCT03125200|81166845|FG006|Overall Study|Toxicity|0|||
27818648|NCT03125200|81166839|FG000|Overall Study|Consent Withdrawn by Subject|0|||
27818649|NCT03125200|81166840|FG001|Overall Study|Consent Withdrawn by Subject|1|||
27818650|NCT03125200|81166841|FG002|Overall Study|Consent Withdrawn by Subject|0|||
27818651|NCT03125200|81166842|FG003|Overall Study|Consent Withdrawn by Subject|0|||
27818652|NCT03125200|81166843|FG004|Overall Study|Consent Withdrawn by Subject|1|||
27818653|NCT03125200|81166844|FG005|Overall Study|Consent Withdrawn by Subject|0|||
27818654|NCT03125200|81166845|FG006|Overall Study|Consent Withdrawn by Subject|1|||
27818655|NCT03500692|81169966|FG000|Overall Study|Death|163|||
27818656|NCT03500692|81169966|FG000|Overall Study|Lost to Follow-up|75|||
27818657|NCT03500692|81169966|FG000|Overall Study|Termination Reasons|3|||
27818658|NCT02460159|81169969|FG000|Overall Study|Adverse Event|4|||
27818659|NCT02460159|81169970|FG001|Overall Study|Adverse Event|1|||
27818660|NCT02460159|81169969|FG000|Overall Study|Withdrawal by Subject|2|||
27818661|NCT02460159|81169970|FG001|Overall Study|Withdrawal by Subject|0|||
27818662|NCT01210001|81169971|FG000|Overall Study|Not treated|1|||
27818663|NCT01210001|81169972|FG001|Overall Study|Not treated|0|||
27818664|NCT01210001|81169973|FG002|Overall Study|Not treated|0|||
27818665|NCT01210001|81169971|FG000|Overall Study|Adverse Event|4|||
27818666|NCT01210001|81169972|FG001|Overall Study|Adverse Event|2|||
27591930|NCT01343407|80348478|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
27591931|NCT01343407|80348479|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
27591932|NCT01343407|80348474|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
27591933|NCT01343407|80348475|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
27591934|NCT01343407|80348476|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
27591935|NCT01343407|80348477|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
27591936|NCT01343407|80348478|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
27591937|NCT01343407|80348479|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
27591938|NCT00113568|80348480|FG000|Overall Study|Adverse Event|97|||
27591939|NCT00113568|80348480|FG000|Overall Study|Death|1|||
27591940|NCT00113568|80348480|FG000|Overall Study|Lack of Efficacy|30|||
27591941|NCT00113568|80348480|FG000|Overall Study|Lost to Follow-up|156|||
27591942|NCT00113568|80348480|FG000|Overall Study|Protocol Violation|32|||
27818667|NCT01210001|81169973|FG002|Overall Study|Adverse Event|5|||
27818668|NCT01210001|81169971|FG000|Overall Study|Non compliant with protocol|2|||
27818669|NCT01210001|81169972|FG001|Overall Study|Non compliant with protocol|2|||
27818670|NCT01210001|81169973|FG002|Overall Study|Non compliant with protocol|3|||
27591943|NCT00113568|80348480|FG000|Overall Study|Withdrawal by Subject|117|||
27591944|NCT00113568|80348480|FG000|Overall Study|Other|112|||
27591945|NCT02232893|80348481|FG000|Overall Study|Withdrawal by Subject|4|||
27591946|NCT02232893|80348482|FG001|Overall Study|Withdrawal by Subject|1|||
27591947|NCT02232893|80348481|FG000|Overall Study|Adverse Event|0|||
27591948|NCT02232893|80348482|FG001|Overall Study|Adverse Event|1|||
27591949|NCT02232893|80348481|FG000|Overall Study|Sponsor request early termination|0|||
27591950|NCT02232893|80348482|FG001|Overall Study|Sponsor request early termination|1|||
27591951|NCT02232893|80348481|FG000|Overall Study|Developed exclusion criteria|0|||
27591952|NCT02232893|80348482|FG001|Overall Study|Developed exclusion criteria|1|||
27591953|NCT02232893|80348481|FG000|Overall Study|Other|0|||
27591954|NCT02232893|80348482|FG001|Overall Study|Other|3|||
27591955|NCT02239679|80348485|FG000|Overall Study|Lost to Follow-up|1|||
27591956|NCT02239679|80348486|FG001|Overall Study|Lost to Follow-up|0|||
27591957|NCT02239679|80348487|FG002|Overall Study|Lost to Follow-up|0|||
27591958|NCT02239679|80348485|FG000|Overall Study|Withdrawal by Subject|2|||
27591959|NCT02239679|80348486|FG001|Overall Study|Withdrawal by Subject|3|||
27591960|NCT02239679|80348487|FG002|Overall Study|Withdrawal by Subject|1|||
27591961|NCT02216123|80348488|FG000|Overall Study|Lost to Follow-up|4|||
27591962|NCT02216123|80348489|FG001|Overall Study|Lost to Follow-up|2|||
27591963|NCT02216123|80348488|FG000|Overall Study|Withdrawal by Subject|2|||
27591964|NCT02216123|80348489|FG001|Overall Study|Withdrawal by Subject|0|||
27818671|NCT01210001|81169971|FG000|Overall Study|Lost to Follow-up|4|||
27818672|NCT01210001|81169972|FG001|Overall Study|Lost to Follow-up|3|||
27591965|NCT00454051|80348497|FG000|Overall Study|Adverse Event|1|||
27591966|NCT00454051|80348498|FG001|Overall Study|Adverse Event|2|||
27591967|NCT00454051|80348497|FG000|Overall Study|Withdrawal by Subject|1|||
27591968|NCT00454051|80348498|FG001|Overall Study|Withdrawal by Subject|0|||
27591969|NCT00454051|80348497|FG000|Overall Study|Protocol Violation|1|||
27591970|NCT00454051|80348498|FG001|Overall Study|Protocol Violation|1|||
27591971|NCT01128413|80348499|FG000|Overall Study|Withdrawal by Subject|1|||
27591972|NCT01128413|80348500|FG001|Overall Study|Withdrawal by Subject|0|||
27591973|NCT01128413|80348499|FG000|Overall Study|NICOM Monitor Problems|2|||
27591974|NCT01128413|80348500|FG001|Overall Study|NICOM Monitor Problems|1|||
27591975|NCT01128413|80348499|FG000|Overall Study|Pt made DNR|1|||
27591976|NCT01128413|80348500|FG001|Overall Study|Pt made DNR|0|||
27591977|NCT01260350|80348502|FG000|Overall Study|Lack of Efficacy|0|||
27591978|NCT01260350|80348503|FG001|Overall Study|Lack of Efficacy|0|||
27591979|NCT01260350|80348504|FG002|Overall Study|Lack of Efficacy|0|||
27591980|NCT01260350|80348505|FG003|Overall Study|Lack of Efficacy|0|||
27591981|NCT01260350|80348506|FG004|Overall Study|Lack of Efficacy|0|||
27591982|NCT01260350|80348507|FG005|Overall Study|Lack of Efficacy|0|||
27591983|NCT01260350|80348508|FG006|Overall Study|Lack of Efficacy|0|||
27591984|NCT01260350|80348509|FG007|Overall Study|Lack of Efficacy|0|||
27591985|NCT01260350|80348510|FG008|Overall Study|Lack of Efficacy|0|||
27591986|NCT01260350|80348511|FG009|Overall Study|Lack of Efficacy|0|||
27591987|NCT01260350|80348512|FG010|Overall Study|Lack of Efficacy|0|||
27591988|NCT01260350|80348513|FG011|Overall Study|Lack of Efficacy|0|||
27591989|NCT01260350|80348514|FG012|Overall Study|Lack of Efficacy|0|||
27591990|NCT01260350|80348515|FG013|Overall Study|Lack of Efficacy|0|||
27591991|NCT01260350|80348516|FG014|Overall Study|Lack of Efficacy|0|||
27591992|NCT01260350|80348517|FG015|Overall Study|Lack of Efficacy|0|||
27591993|NCT01260350|80348518|FG016|Overall Study|Lack of Efficacy|0|||
27591994|NCT01260350|80348519|FG017|Overall Study|Lack of Efficacy|1|||
27591995|NCT01260350|80348520|FG018|Overall Study|Lack of Efficacy|0|||
27591996|NCT01260350|80348521|FG019|Overall Study|Lack of Efficacy|0|||
27591997|NCT01260350|80348522|FG020|Overall Study|Lack of Efficacy|3|||
27591998|NCT01260350|80348523|FG021|Overall Study|Lack of Efficacy|0|||
27591999|NCT01260350|80348502|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592000|NCT01260350|80348503|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592001|NCT01260350|80348504|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592002|NCT01260350|80348505|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592003|NCT01260350|80348506|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592004|NCT01260350|80348507|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592005|NCT01260350|80348508|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592006|NCT01260350|80348509|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592007|NCT01260350|80348510|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
27592008|NCT01260350|80348511|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592009|NCT01260350|80348512|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592010|NCT01260350|80348513|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592011|NCT01260350|80348514|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592012|NCT01260350|80348515|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592013|NCT01260350|80348516|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592014|NCT01260350|80348517|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592015|NCT01260350|80348518|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592016|NCT01260350|80348519|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592017|NCT01260350|80348520|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592018|NCT01260350|80348521|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592019|NCT01260350|80348522|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592020|NCT01260350|80348523|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
27592021|NCT02834780|80348531|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
27592022|NCT02834780|80348532|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
27592023|NCT02834780|80348533|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
27880416|NCT02564900|81394487|FG012|Dose Expansion|Withdrawal by Subject|0|||
27592024|NCT02834780|80348534|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
27592025|NCT02834780|80348535|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
27592026|NCT02834780|80348536|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
27592027|NCT02834780|80348537|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
27592028|NCT02834780|80348538|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
27592029|NCT02834780|80348539|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
27592030|NCT02834780|80348540|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
27592031|NCT02834780|80348541|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
27592032|NCT02834780|80348542|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
27592033|NCT02834780|80348543|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
27592034|NCT02834780|80348531|FG000|Overall Study|Withdrawal by Subject|0|||
27592035|NCT02834780|80348532|FG001|Overall Study|Withdrawal by Subject|0|||
27592036|NCT02834780|80348533|FG002|Overall Study|Withdrawal by Subject|1|||
27592037|NCT02834780|80348534|FG003|Overall Study|Withdrawal by Subject|0|||
27592038|NCT02834780|80348535|FG004|Overall Study|Withdrawal by Subject|0|||
27818673|NCT01210001|81169973|FG002|Overall Study|Lost to Follow-up|2|||
27818674|NCT01210001|81169971|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
27818675|NCT01210001|81169972|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
27818676|NCT01210001|81169973|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
27818677|NCT01210001|81169971|FG000|Overall Study|Other reason not defined above|2|||
27818678|NCT01210001|81169972|FG001|Overall Study|Other reason not defined above|2|||
27818679|NCT01210001|81169973|FG002|Overall Study|Other reason not defined above|1|||
27880417|NCT02564900|81394488|FG013|Dose Expansion|Withdrawal by Subject|1|||
27880418|NCT02564900|81394489|FG014|Dose Expansion|Withdrawal by Subject|1|||
27880419|NCT02564900|81394475|FG000|Dose Expansion|Other|0|||
27880420|NCT02564900|81394476|FG001|Dose Expansion|Other|0|||
27880421|NCT02564900|81394477|FG002|Dose Expansion|Other|0|||
27880422|NCT02564900|81394478|FG003|Dose Expansion|Other|0|||
27818680|NCT01991470|81169974|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
27818681|NCT01991470|81169974|FG000|Enlite 1 Period|Adverse Event|1|||
27818682|NCT01991470|81169974|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
27818683|NCT01991470|81169974|FG000|Enlite 3 Period|Lost to Follow-up|1|||
27818684|NCT01991470|81169974|FG000|Enlite 3 Period|Physician Decision|2|||
27818685|NCT01991470|81169974|FG000|Enlite 3 Period|Physician Decision|8|||
27880423|NCT02564900|81394479|FG004|Dose Expansion|Other|0|||
27880424|NCT02564900|81394480|FG005|Dose Expansion|Other|0|||
27592039|NCT02834780|80348536|FG005|Overall Study|Withdrawal by Subject|0|||
27818686|NCT01991470|81169974|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
27818687|NCT02946385|81169982|FG000|Overall Study|Lost to Follow-up|0|||
27818688|NCT02946385|81169983|FG001|Overall Study|Lost to Follow-up|0|||
27818689|NCT02946385|81169984|FG002|Overall Study|Lost to Follow-up|3|||
27818690|NCT02946385|81169985|FG003|Overall Study|Lost to Follow-up|0|||
27818691|NCT02946385|81169986|FG004|Overall Study|Lost to Follow-up|2|||
27818692|NCT02946385|81169987|FG005|Overall Study|Lost to Follow-up|1|||
27818693|NCT00076102|81169988|FG000|Overall Study|Clinical progression|1|||
27818694|NCT00076102|81169988|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
27818695|NCT00076102|81169988|FG000|Overall Study|plexiform neurofibroma surgery|1|||
27818696|NCT00076102|81169988|FG000|Overall Study|refusal of further therapy|2|||
27818697|NCT00912288|81169989|FG000|Overall Study|Death|0|||
27818698|NCT00912288|81169990|FG001|Overall Study|Death|1|||
27818699|NCT00912288|81169989|FG000|Overall Study|Adverse Event|1|||
27818700|NCT00912288|81169990|FG001|Overall Study|Adverse Event|1|||
27818701|NCT00912288|81169989|FG000|Overall Study|Lost to Follow-up|1|||
27818702|NCT00912288|81169990|FG001|Overall Study|Lost to Follow-up|0|||
27880425|NCT02564900|81394481|FG006|Dose Expansion|Other|1|||
27880426|NCT02564900|81394482|FG007|Dose Expansion|Other|0|||
27880427|NCT02564900|81394483|FG008|Dose Expansion|Other|1|||
27880428|NCT02564900|81394484|FG009|Dose Expansion|Other|0|||
27880429|NCT02564900|81394485|FG010|Dose Expansion|Other|0|||
27693129|NCT00413972|80713565|FG002|Overall Study|Withdrawal by Subject|7|||
27880430|NCT02564900|81394486|FG011|Dose Expansion|Other|0|||
27880431|NCT02564900|81394487|FG012|Dose Expansion|Other|0|||
27880432|NCT02564900|81394488|FG013|Dose Expansion|Other|0|||
27880433|NCT02564900|81394489|FG014|Dose Expansion|Other|1|||
27693130|NCT00413972|80713566|FG003|Overall Study|Withdrawal by Subject|2|||
27693131|NCT00413972|80713563|FG000|Overall Study|Protocol Violation|0|||
27818703|NCT00912288|81169989|FG000|Overall Study|Protocol Violation|1|||
27880434|NCT02564900|81394475|FG000|Dose Expansion|Did not receive treatment|0|||
27880435|NCT02564900|81394476|FG001|Dose Expansion|Did not receive treatment|0|||
27880436|NCT02564900|81394477|FG002|Dose Expansion|Did not receive treatment|0|||
27693132|NCT00413972|80713564|FG001|Overall Study|Protocol Violation|0|||
27693133|NCT00413972|80713565|FG002|Overall Study|Protocol Violation|2|||
27693134|NCT00413972|80713566|FG003|Overall Study|Protocol Violation|0|||
27693135|NCT00413972|80713563|FG000|Overall Study|Other|0|||
27693136|NCT00413972|80713564|FG001|Overall Study|Other|0|||
27693137|NCT00413972|80713565|FG002|Overall Study|Other|0|||
27693138|NCT00413972|80713566|FG003|Overall Study|Other|1|||
27693139|NCT02354508|80713567|FG000|Period 1: Core Phase|Adverse Event|1|||
27693140|NCT02354508|80713568|FG001|Period 1: Core Phase|Adverse Event|1|||
27818704|NCT00912288|81169990|FG001|Overall Study|Protocol Violation|0|||
27818705|NCT00912288|81169989|FG000|Overall Study|Withdrawal by Subject|3|||
27818706|NCT00912288|81169990|FG001|Overall Study|Withdrawal by Subject|3|||
27818707|NCT00912288|81169989|FG000|Overall Study|Study terminated by sponsor|34|||
27818708|NCT00912288|81169990|FG001|Overall Study|Study terminated by sponsor|35|||
27818709|NCT00912288|81169989|FG000|Overall Study|Other|1|||
27818710|NCT00912288|81169990|FG001|Overall Study|Other|0|||
27818711|NCT01318499|81169991|FG000|Overall Study|Adverse Event|16|||
27818712|NCT01318499|81169992|FG001|Overall Study|Adverse Event|11|||
27693141|NCT02354508|80713569|FG002|Period 1: Core Phase|Adverse Event|2|||
27693142|NCT02354508|80713567|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
27693143|NCT02354508|80713568|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
27693144|NCT02354508|80713569|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
27693145|NCT02354508|80713567|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
27693146|NCT02354508|80713568|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
27693147|NCT02354508|80713569|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
27818713|NCT01318499|81169993|FG002|Overall Study|Adverse Event|6|||
27693148|NCT02354508|80713567|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
27693149|NCT02354508|80713568|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
27818714|NCT01318499|81169991|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
27693150|NCT02354508|80713569|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
27693151|NCT02354508|80713567|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
27693152|NCT02354508|80713568|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
27693153|NCT02354508|80713569|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
27693154|NCT02354508|80713567|FG000|Period 2: Extension Phase|Physician Decision|5|||
27693155|NCT02354508|80713568|FG001|Period 2: Extension Phase|Physician Decision|0|||
27693156|NCT02354508|80713569|FG002|Period 2: Extension Phase|Physician Decision|1|||
27693157|NCT02354508|80713567|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
27818715|NCT01318499|81169992|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
27818716|NCT01318499|81169993|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
27818717|NCT01318499|81169991|FG000|Overall Study|Noncompliance|2|||
27818718|NCT01318499|81169992|FG001|Overall Study|Noncompliance|3|||
27818719|NCT01318499|81169993|FG002|Overall Study|Noncompliance|0|||
27818720|NCT01318499|81169991|FG000|Overall Study|Treatment Failure|19|||
27818721|NCT01318499|81169992|FG001|Overall Study|Treatment Failure|19|||
27818722|NCT01318499|81169993|FG002|Overall Study|Treatment Failure|101|||
27818723|NCT01318499|81169991|FG000|Overall Study|Protocol Violation|2|||
27818724|NCT01318499|81169992|FG001|Overall Study|Protocol Violation|4|||
27818725|NCT01318499|81169993|FG002|Overall Study|Protocol Violation|2|||
27818726|NCT01318499|81169991|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
27818727|NCT01318499|81169992|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
27818728|NCT01318499|81169993|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
27818729|NCT01318499|81169991|FG000|Overall Study|Other|7|||
27818730|NCT01318499|81169992|FG001|Overall Study|Other|10|||
27818731|NCT01318499|81169993|FG002|Overall Study|Other|22|||
27818732|NCT02017964|81169994|FG000|Overall Study|Patient deemed ineligible|1|||
27818733|NCT00659607|81170000|FG000|Overall Study|No blood pressure recorded|147|||
27818734|NCT00659607|81170000|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
27818735|NCT00659607|81170000|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
27818736|NCT00659607|81170000|FG000|Overall Study|No recorded efficacy data|15|||
27818737|NCT00659607|81170000|FG000|Overall Study|Inconsistent BP measuring date|2|||
27818738|NCT00620763|81170001|FG000|Period: First Intervention|Withdrawal by Subject|0|||
27818739|NCT00620763|81170002|FG001|Period: First Intervention|Withdrawal by Subject|2|||
27818740|NCT00620763|81170001|FG000|Period: First Intervention|Protocol Violation|0|||
27818741|NCT00620763|81170002|FG001|Period: First Intervention|Protocol Violation|3|||
27818742|NCT00620763|81170001|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
27818743|NCT00620763|81170002|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
27818744|NCT03340727|81170004|FG000|Overall Study|Death|1|||
27818745|NCT03340727|81170005|FG001|Overall Study|Death|0|||
27818746|NCT03340727|81170004|FG000|Overall Study|Lost to Follow-up|31|||
27818747|NCT03340727|81170005|FG001|Overall Study|Lost to Follow-up|35|||
27818748|NCT03340727|81170004|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
27818749|NCT03340727|81170005|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
27818750|NCT03340727|81170004|FG000|Overall Study|Transferred to another facility|10|||
27818751|NCT03340727|81170005|FG001|Overall Study|Transferred to another facility|7|||
27818752|NCT03340727|81170004|FG000|Overall Study|Withdrawal by Subject|28|||
27818753|NCT03340727|81170005|FG001|Overall Study|Withdrawal by Subject|17|||
27818754|NCT02194998|81170010|FG000|On-HCV Treatment|Did not pick up study medication|0|||
27818755|NCT02194998|81170011|FG001|On-HCV Treatment|Did not pick up study medication|1|||
27818756|NCT02194998|81170012|FG002|On-HCV Treatment|Did not pick up study medication|0|||
27818757|NCT02194998|81170013|FG003|On-HCV Treatment|Did not pick up study medication|0|||
27818758|NCT02194998|81170010|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
27818759|NCT02194998|81170011|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
27818760|NCT02194998|81170012|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
27818761|NCT02194998|81170013|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
27818762|NCT04091971|81170014|FG000|Overall Study|Withdrawal by Subject|1|||
27818763|NCT04091971|81170014|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
27818764|NCT04091971|81170014|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
27880437|NCT02564900|81394478|FG003|Dose Expansion|Did not receive treatment|0|||
27880438|NCT02564900|81394479|FG004|Dose Expansion|Did not receive treatment|0|||
27880439|NCT02564900|81394480|FG005|Dose Expansion|Did not receive treatment|0|||
27880440|NCT02564900|81394481|FG006|Dose Expansion|Did not receive treatment|1|||
27880441|NCT02564900|81394482|FG007|Dose Expansion|Did not receive treatment|1|||
27880442|NCT02564900|81394483|FG008|Dose Expansion|Did not receive treatment|0|||
27880443|NCT02564900|81394484|FG009|Dose Expansion|Did not receive treatment|0|||
27880444|NCT02564900|81394485|FG010|Dose Expansion|Did not receive treatment|0|||
27880445|NCT02564900|81394486|FG011|Dose Expansion|Did not receive treatment|0|||
27880446|NCT02564900|81394487|FG012|Dose Expansion|Did not receive treatment|0|||
27880447|NCT02564900|81394488|FG013|Dose Expansion|Did not receive treatment|0|||
27880448|NCT02564900|81394489|FG014|Dose Expansion|Did not receive treatment|1|||
27880449|NCT02211209|81394490|FG000|Overall Study|Investigator judgment|0|||
27880450|NCT02211209|81394491|FG001|Overall Study|Investigator judgment|1|||
27880451|NCT02211209|81394490|FG000|Overall Study|Voluntary withdrawal|1|||
27880452|NCT02211209|81394491|FG001|Overall Study|Voluntary withdrawal|4|||
27880453|NCT02211209|81394490|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
27880454|NCT02211209|81394491|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
27880455|NCT02211209|81394490|FG000|Overall Study|Reason Not Specified|1|||
27880456|NCT02211209|81394491|FG001|Overall Study|Reason Not Specified|0|||
27880457|NCT02095691|81394494|FG000|Overall Study|Physician Decision|1|||
27880458|NCT01562782|81394499|FG000|Overall Study|Withdrawal by Subject|3|||
27880459|NCT01562782|81394500|FG001|Overall Study|Withdrawal by Subject|3|||
27880460|NCT01562782|81394499|FG000|Overall Study|screen failure|1|||
27880461|NCT01562782|81394500|FG001|Overall Study|screen failure|2|||
27880462|NCT01031680|81394501|FG000|Overall Study|Adverse Event|8|||
27880463|NCT01031680|81394502|FG001|Overall Study|Adverse Event|3|||
27880464|NCT01031680|81394501|FG000|Overall Study|Lost to Follow-up|2|||
27880465|NCT01031680|81394502|FG001|Overall Study|Lost to Follow-up|10|||
27880466|NCT01031680|81394501|FG000|Overall Study|Withdrawal by Subject|12|||
27880467|NCT01031680|81394502|FG001|Overall Study|Withdrawal by Subject|16|||
27880468|NCT01031680|81394501|FG000|Overall Study|Death|2|||
27880469|NCT01031680|81394502|FG001|Overall Study|Death|1|||
27880470|NCT01031680|81394501|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
27880471|NCT01031680|81394502|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
27880472|NCT01031680|81394501|FG000|Overall Study|Poor/Non-compliance|5|||
27880473|NCT01031680|81394502|FG001|Overall Study|Poor/Non-compliance|6|||
27880474|NCT01031680|81394501|FG000|Overall Study|Safety|1|||
27880475|NCT01031680|81394502|FG001|Overall Study|Safety|0|||
27880476|NCT01031680|81394501|FG000|Overall Study|Incorrect Enrolment|1|||
27880477|NCT01031680|81394502|FG001|Overall Study|Incorrect Enrolment|2|||
27880478|NCT01031680|81394501|FG000|Overall Study|Administrative Reason by Sponsor|0|||
27880479|NCT01031680|81394502|FG001|Overall Study|Administrative Reason by Sponsor|1|||
27880480|NCT01031680|81394501|FG000|Overall Study|Various|0|||
27880481|NCT01031680|81394502|FG001|Overall Study|Various|2|||
27880482|NCT01139125|81394503|FG000|Overall Study|Withdrawal by Subject|1|||
27880483|NCT02019472|81394504|FG000|Overall Study|Adverse Event|14|||
27880484|NCT02019472|81394505|FG001|Overall Study|Adverse Event|23|||
27880485|NCT02019472|81394506|FG002|Overall Study|Adverse Event|17|||
27880486|NCT02019472|81394504|FG000|Overall Study|Death|0|||
27880487|NCT02019472|81394505|FG001|Overall Study|Death|1|||
27880488|NCT02019472|81394506|FG002|Overall Study|Death|1|||
27880489|NCT02019472|81394504|FG000|Overall Study|Lack of Efficacy|7|||
27880490|NCT02019472|81394505|FG001|Overall Study|Lack of Efficacy|4|||
27880491|NCT02019472|81394506|FG002|Overall Study|Lack of Efficacy|4|||
27880492|NCT02019472|81394504|FG000|Overall Study|Lost to Follow-up|0|||
27880493|NCT02019472|81394505|FG001|Overall Study|Lost to Follow-up|2|||
27880494|NCT02019472|81394506|FG002|Overall Study|Lost to Follow-up|1|||
27880495|NCT02019472|81394504|FG000|Overall Study|Physician Decision|1|||
27880496|NCT02019472|81394505|FG001|Overall Study|Physician Decision|2|||
27880497|NCT02019472|81394506|FG002|Overall Study|Physician Decision|0|||
27880498|NCT02019472|81394504|FG000|Overall Study|Pregnancy|1|||
27880499|NCT02019472|81394505|FG001|Overall Study|Pregnancy|2|||
27880500|NCT02019472|81394506|FG002|Overall Study|Pregnancy|2|||
27880501|NCT02019472|81394504|FG000|Overall Study|Withdrawal by Subject|11|||
27880502|NCT02019472|81394505|FG001|Overall Study|Withdrawal by Subject|10|||
27880503|NCT02019472|81394506|FG002|Overall Study|Withdrawal by Subject|11|||
27880504|NCT02019472|81394504|FG000|Overall Study|Other|3|||
27880505|NCT02019472|81394505|FG001|Overall Study|Other|8|||
27880506|NCT02019472|81394506|FG002|Overall Study|Other|6|||
27880507|NCT02028767|81394509|FG000|Treatment Period 2|Non compliant with protocol|1|||
27880508|NCT02028767|81394510|FG001|Treatment Period 2|Non compliant with protocol|0|||
27880509|NCT02028767|81394509|FG000|Treatment Period 2|Reason other than those specified above|1|||
27880510|NCT02028767|81394510|FG001|Treatment Period 2|Reason other than those specified above|0|||
27880511|NCT01928472|81394513|FG000|Overall Study|Death|0|||
27880512|NCT01928472|81394514|FG001|Overall Study|Death|0|||
27880513|NCT01928472|81394515|FG002|Overall Study|Death|1|||
27880514|NCT01928472|81394516|FG003|Overall Study|Death|0|||
27880515|NCT01928472|81394513|FG000|Overall Study|Withdrawal by Subject|4|||
27880516|NCT01928472|81394514|FG001|Overall Study|Withdrawal by Subject|4|||
27880517|NCT01928472|81394515|FG002|Overall Study|Withdrawal by Subject|1|||
27880518|NCT01928472|81394516|FG003|Overall Study|Withdrawal by Subject|2|||
27880519|NCT01928472|81394513|FG000|Overall Study|Lost to Follow-up|2|||
27880520|NCT01928472|81394514|FG001|Overall Study|Lost to Follow-up|3|||
27880521|NCT01928472|81394515|FG002|Overall Study|Lost to Follow-up|4|||
27880522|NCT01928472|81394516|FG003|Overall Study|Lost to Follow-up|0|||
27880523|NCT01928472|81394513|FG000|Overall Study|Administrative Reason|2|||
27880524|NCT01928472|81394514|FG001|Overall Study|Administrative Reason|1|||
27880525|NCT01928472|81394515|FG002|Overall Study|Administrative Reason|0|||
27880526|NCT01928472|81394516|FG003|Overall Study|Administrative Reason|0|||
27880527|NCT01928472|81394513|FG000|Overall Study|Unclassified|0|||
27880528|NCT01928472|81394514|FG001|Overall Study|Unclassified|0|||
27880529|NCT01928472|81394515|FG002|Overall Study|Unclassified|1|||
27880530|NCT01928472|81394516|FG003|Overall Study|Unclassified|0|||
27880531|NCT03526861|81394517|FG000|Initial Treatment Period|Not dosed|1|||
27880532|NCT03526861|81394518|FG001|Initial Treatment Period|Not dosed|1|||
27693158|NCT02354508|80713568|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
27880533|NCT03526861|81394519|FG002|Initial Treatment Period|Not dosed|1|||
27880534|NCT03526861|81394520|FG003|Initial Treatment Period|Not dosed|0|||
27880535|NCT03526861|81394521|FG004|Initial Treatment Period|Not dosed|0|||
27693159|NCT02354508|80713569|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
27880536|NCT03526861|81394522|FG005|Initial Treatment Period|Not dosed|0|||
27880537|NCT03526861|81394523|FG006|Initial Treatment Period|Not dosed|0|||
27880538|NCT03526861|81394524|FG007|Initial Treatment Period|Not dosed|0|||
27880539|NCT03526861|81394525|FG008|Initial Treatment Period|Not dosed|0|||
27880540|NCT03526861|81394517|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
27880541|NCT03526861|81394518|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
27880542|NCT03526861|81394519|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
27880543|NCT03526861|81394520|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27886633|NCT01938430|81418144|FG008|Overall Study|Randomized but Not Treated|0|||
27592040|NCT02834780|80348537|FG006|Overall Study|Withdrawal by Subject|0|||
27592041|NCT02834780|80348538|FG007|Overall Study|Withdrawal by Subject|0|||
27592042|NCT02834780|80348539|FG008|Overall Study|Withdrawal by Subject|0|||
27592043|NCT02834780|80348540|FG009|Overall Study|Withdrawal by Subject|0|||
27592044|NCT02834780|80348541|FG010|Overall Study|Withdrawal by Subject|1|||
27592045|NCT02834780|80348542|FG011|Overall Study|Withdrawal by Subject|0|||
27592046|NCT02834780|80348543|FG012|Overall Study|Withdrawal by Subject|0|||
27592047|NCT02834780|80348531|FG000|Overall Study|Adverse Event|0|||
27592048|NCT02834780|80348532|FG001|Overall Study|Adverse Event|0|||
27592049|NCT02834780|80348533|FG002|Overall Study|Adverse Event|0|||
27592050|NCT02834780|80348534|FG003|Overall Study|Adverse Event|0|||
27592051|NCT02834780|80348535|FG004|Overall Study|Adverse Event|1|||
27592052|NCT02834780|80348536|FG005|Overall Study|Adverse Event|0|||
27592053|NCT02834780|80348537|FG006|Overall Study|Adverse Event|1|||
27592054|NCT02834780|80348538|FG007|Overall Study|Adverse Event|1|||
27592055|NCT02834780|80348539|FG008|Overall Study|Adverse Event|0|||
27592056|NCT02834780|80348540|FG009|Overall Study|Adverse Event|2|||
27592057|NCT02834780|80348541|FG010|Overall Study|Adverse Event|0|||
27693160|NCT02354508|80713567|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
27693161|NCT02354508|80713568|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
27693162|NCT02354508|80713569|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
27693163|NCT02354508|80713567|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
27693164|NCT02354508|80713568|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
27693165|NCT02354508|80713569|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
27693166|NCT01116882|80713570|FG000|30-day|Lost to Follow-up|50|||
27693167|NCT01116882|80713571|FG001|30-day|Lost to Follow-up|21|||
27693168|NCT01116882|80713570|FG000|30-day|Withdrawal by Subject|2|||
27693169|NCT01116882|80713571|FG001|30-day|Withdrawal by Subject|4|||
27693170|NCT01116882|80713570|FG000|30-day|Other Reasons|16|||
27693171|NCT01116882|80713571|FG001|30-day|Other Reasons|6|||
27693172|NCT01116882|80713570|FG000|12-month|Lost to Follow-up|111|||
27693173|NCT01116882|80713571|FG001|12-month|Lost to Follow-up|42|||
27693174|NCT01116882|80713570|FG000|12-month|Other Reasons|151|||
27693175|NCT01116882|80713571|FG001|12-month|Other Reasons|49|||
27693176|NCT01116882|80713570|FG000|12-month|Withdrawal by Subject|5|||
27693177|NCT01116882|80713571|FG001|12-month|Withdrawal by Subject|8|||
27693178|NCT01036763|80713574|FG000|Overall Study|Adverse Event|25|||
27693179|NCT01036763|80713574|FG000|Overall Study|Lost to Follow-up|28|||
27693180|NCT01036763|80713574|FG000|Overall Study|Other reason (not specified)|40|||
27693181|NCT00252733|80713575|FG000|Overall Study|Withdrawal by Subject|73|||
27693182|NCT00252733|80713576|FG001|Overall Study|Withdrawal by Subject|67|||
27693183|NCT00252733|80713575|FG000|Overall Study|Death|7|||
27693184|NCT00252733|80713576|FG001|Overall Study|Death|5|||
27693185|NCT00252733|80713575|FG000|Overall Study|Lost to Follow-up|12|||
27693186|NCT00252733|80713576|FG001|Overall Study|Lost to Follow-up|6|||
27693187|NCT00252733|80713575|FG000|Overall Study|Multiple Reasons|14|||
27693188|NCT00252733|80713576|FG001|Overall Study|Multiple Reasons|14|||
27693189|NCT04097301|80713577|FG000|Overall Study|Death|1|||
27693190|NCT04097301|80713577|FG000|Overall Study|Withdrawal by Subject|1|||
27693191|NCT04097301|80713577|FG000|Overall Study|Screening Failure|5|||
27693192|NCT01777269|80713578|FG000|Overall Study|Adverse Event|24|||
27693193|NCT01777269|80713579|FG001|Overall Study|Adverse Event|33|||
27693194|NCT01777269|80713578|FG000|Overall Study|Lack of Efficacy|8|||
27693195|NCT01777269|80713579|FG001|Overall Study|Lack of Efficacy|10|||
27693196|NCT01777269|80713578|FG000|Overall Study|Protocol Violation|4|||
27818765|NCT02066922|81170017|FG000|Overall Study|Adverse Event|1|||
27592058|NCT02834780|80348542|FG011|Overall Study|Adverse Event|3|||
27693197|NCT01777269|80713579|FG001|Overall Study|Protocol Violation|4|||
27693198|NCT01777269|80713578|FG000|Overall Study|Participants reached stopping criteria|1|||
27693199|NCT01777269|80713579|FG001|Overall Study|Participants reached stopping criteria|1|||
27693200|NCT01777269|80713578|FG000|Overall Study|Lost to Follow-up|4|||
27818766|NCT01052116|81170018|FG000|Overall Study|Lost to Follow-up|11|||
27818767|NCT01052116|81170019|FG001|Overall Study|Lost to Follow-up|17|||
27592059|NCT02834780|80348543|FG012|Overall Study|Adverse Event|2|||
27592060|NCT02834780|80348531|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
27592061|NCT02834780|80348532|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
27880544|NCT03526861|81394521|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880545|NCT03526861|81394522|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880546|NCT03526861|81394523|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880547|NCT03526861|81394524|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880548|NCT03526861|81394525|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880549|NCT03526861|81394517|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
27880550|NCT03526861|81394518|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
27880551|NCT03526861|81394519|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
27880552|NCT03526861|81394520|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
27693201|NCT01777269|80713579|FG001|Overall Study|Lost to Follow-up|0|||
27693202|NCT01777269|80713578|FG000|Overall Study|Physician Decision|5|||
27818768|NCT01052116|81170018|FG000|Overall Study|Withdrawal by Subject|3|||
27818769|NCT01052116|81170019|FG001|Overall Study|Withdrawal by Subject|6|||
27818770|NCT01052116|81170018|FG000|Overall Study|Spirometry not performed|0|||
27818771|NCT01052116|81170019|FG001|Overall Study|Spirometry not performed|4|||
27818772|NCT01941030|81170020|FG000|Overall Study|Death|3|||
27592062|NCT02834780|80348533|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
27592063|NCT02834780|80348534|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
27592064|NCT02834780|80348535|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
27592065|NCT02834780|80348536|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
27592066|NCT02834780|80348537|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
27592067|NCT02834780|80348538|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
27592068|NCT02834780|80348539|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
27592069|NCT02834780|80348540|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
27693203|NCT01777269|80713579|FG001|Overall Study|Physician Decision|2|||
27693204|NCT01777269|80713578|FG000|Overall Study|Withdrawal by Subject|9|||
27693205|NCT01777269|80713579|FG001|Overall Study|Withdrawal by Subject|9|||
27693206|NCT00511901|80713580|FG000|Overall Study|Withdrawal by Subject|1|||
27693207|NCT00511901|80713581|FG001|Overall Study|Withdrawal by Subject|3|||
27592070|NCT02834780|80348541|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
27592071|NCT02834780|80348542|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
27592072|NCT02834780|80348543|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
27818773|NCT01941030|81170021|FG001|Overall Study|Death|2|||
27818774|NCT01941030|81170020|FG000|Overall Study|Lost to Follow-up|6|||
27818775|NCT01941030|81170021|FG001|Overall Study|Lost to Follow-up|5|||
27693208|NCT02090959|80713582|FG000|Overall Study|Withdrawal by Subject|10|||
27693209|NCT02090959|80713582|FG000|Overall Study|Adverse Event|1|||
27693210|NCT02090959|80713582|FG000|Overall Study|Investigator decision|2|||
27693211|NCT02090959|80713582|FG000|Overall Study|Study termination|6|||
27693212|NCT02090959|80713582|FG000|Overall Study|Enrolled but not treated|1|||
27693213|NCT02090959|80713582|FG000|Overall Study|Transfer for compassionate use medicine|4|||
27818776|NCT01941030|81170020|FG000|Overall Study|Withdrawal by Subject|4|||
27880553|NCT03526861|81394521|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
27592073|NCT02834780|80348531|FG000|Overall Study|Other|1|||
27592074|NCT02834780|80348532|FG001|Overall Study|Other|0|||
27592075|NCT02834780|80348533|FG002|Overall Study|Other|1|||
27592076|NCT02834780|80348534|FG003|Overall Study|Other|2|||
27592077|NCT02834780|80348535|FG004|Overall Study|Other|0|||
27592078|NCT02834780|80348536|FG005|Overall Study|Other|0|||
27592079|NCT02834780|80348537|FG006|Overall Study|Other|0|||
27592080|NCT02834780|80348538|FG007|Overall Study|Other|0|||
27592081|NCT02834780|80348539|FG008|Overall Study|Other|0|||
27592082|NCT02834780|80348540|FG009|Overall Study|Other|0|||
27592083|NCT02834780|80348541|FG010|Overall Study|Other|0|||
27592084|NCT02834780|80348542|FG011|Overall Study|Other|0|||
27592085|NCT02834780|80348543|FG012|Overall Study|Other|1|||
27592086|NCT05239039|80348544|FG000|Overall Study|Withdrawal by Subject|0|||
27592087|NCT05239039|80348545|FG001|Overall Study|Withdrawal by Subject|1|||
27592088|NCT00058123|80348554|FG000|Overall Study|Wrong histology|9|||
27818777|NCT01941030|81170021|FG001|Overall Study|Withdrawal by Subject|6|||
27818778|NCT01087970|81170022|FG000|Overall Study|Protocol Violation|2|||
27818779|NCT00677365|81170023|FG000|Overall Study|Adverse Event|2|||
27818780|NCT00677365|81170024|FG001|Overall Study|Adverse Event|1|||
27880554|NCT03526861|81394522|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
27880555|NCT03526861|81394523|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
27880556|NCT03526861|81394524|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
27880557|NCT03526861|81394525|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
27592089|NCT00058123|80348554|FG000|Overall Study|Received >3 prior treatments|1|||
27818781|NCT00677365|81170025|FG002|Overall Study|Adverse Event|1|||
27818782|NCT00677365|81170026|FG003|Overall Study|Adverse Event|2|||
27880558|NCT03526861|81394517|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880559|NCT03526861|81394518|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880560|NCT03526861|81394519|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880561|NCT03526861|81394520|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
27880562|NCT03526861|81394521|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
27818783|NCT00677365|81170023|FG000|Overall Study|Withdrawal by Subject|0|||
27818784|NCT00677365|81170024|FG001|Overall Study|Withdrawal by Subject|0|||
27818785|NCT00677365|81170025|FG002|Overall Study|Withdrawal by Subject|1|||
27592090|NCT03182868|80348555|FG000|Overall Study|Protocol Violation|3|||
27592091|NCT03182868|80348556|FG001|Overall Study|Protocol Violation|0|||
27592092|NCT03182868|80348557|FG002|Overall Study|Protocol Violation|4|||
27592093|NCT03182868|80348558|FG003|Overall Study|Protocol Violation|1|||
27592094|NCT03182868|80348559|FG004|Overall Study|Protocol Violation|8|||
27818786|NCT00677365|81170026|FG003|Overall Study|Withdrawal by Subject|0|||
27592095|NCT02130193|80348560|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
27818787|NCT00677365|81170023|FG000|Overall Study|Other reason|0|||
27818788|NCT00677365|81170024|FG001|Overall Study|Other reason|0|||
27592096|NCT02130193|80348561|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
27592097|NCT02130193|80348562|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
27592098|NCT02130193|80348560|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
27592099|NCT02130193|80348561|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
27592100|NCT02130193|80348562|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
27592101|NCT02130193|80348560|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
27592102|NCT02130193|80348561|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
27592103|NCT02130193|80348562|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
27592104|NCT02130193|80348560|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
27592105|NCT02130193|80348561|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
27592106|NCT02130193|80348562|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
27592107|NCT00127101|80348563|FG000|Base Protocol|Adverse Event|0|||
27592108|NCT00127101|80348564|FG001|Base Protocol|Adverse Event|2|||
27592109|NCT00127101|80348565|FG002|Base Protocol|Adverse Event|1|||
27592110|NCT00127101|80348566|FG003|Base Protocol|Adverse Event|0|||
27592111|NCT00127101|80348567|FG004|Base Protocol|Adverse Event|0|||
27592112|NCT00127101|80348568|FG005|Base Protocol|Adverse Event|0|||
27592113|NCT00127101|80348563|FG000|Base Protocol|Lack of Efficacy|1|||
27592114|NCT00127101|80348564|FG001|Base Protocol|Lack of Efficacy|0|||
27592115|NCT00127101|80348565|FG002|Base Protocol|Lack of Efficacy|0|||
27592116|NCT00127101|80348566|FG003|Base Protocol|Lack of Efficacy|0|||
27693214|NCT02090959|80713582|FG000|Overall Study|Move to medical need program|3|||
27693215|NCT02090959|80713582|FG000|Overall Study|Entered in to other study|34|||
27693216|NCT02090959|80713582|FG000|Overall Study|Switched to commercial supply|88|||
27693217|NCT02090959|80713582|FG000|Overall Study|Other than specified|2|||
27693218|NCT01411215|80713583|FG000|Overall Study|Adverse Event|1|||
27693219|NCT01411215|80713584|FG001|Overall Study|Adverse Event|2|||
27693220|NCT01411215|80713583|FG000|Overall Study|Lack of Efficacy|2|||
27693221|NCT01411215|80713584|FG001|Overall Study|Lack of Efficacy|4|||
27693222|NCT01411215|80713583|FG000|Overall Study|Lost to Follow-up|12|||
27880563|NCT03526861|81394522|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880564|NCT03526861|81394523|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
27693223|NCT01411215|80713584|FG001|Overall Study|Lost to Follow-up|18|||
27693224|NCT01411215|80713583|FG000|Overall Study|Did not meet entrance criteria|0|||
27693225|NCT01411215|80713584|FG001|Overall Study|Did not meet entrance criteria|1|||
27693226|NCT01411215|80713583|FG000|Overall Study|Study terminated by sponsor|2|||
27693227|NCT01411215|80713584|FG001|Overall Study|Study terminated by sponsor|15|||
27693228|NCT01411215|80713583|FG000|Overall Study|Protocol Violation|3|||
27693229|NCT01411215|80713584|FG001|Overall Study|Protocol Violation|5|||
27693230|NCT01411215|80713583|FG000|Overall Study|Withdrawal by Subject|34|||
27693231|NCT01411215|80713584|FG001|Overall Study|Withdrawal by Subject|21|||
27693232|NCT01411215|80713583|FG000|Overall Study|Other|12|||
27693233|NCT01411215|80713584|FG001|Overall Study|Other|17|||
27693234|NCT01411215|80713583|FG000|Overall Study|Screen failure|0|||
27693235|NCT01411215|80713584|FG001|Overall Study|Screen failure|1|||
27693236|NCT00370331|80713585|FG000|Overall Study|Adverse Event|4|||
27693237|NCT00370331|80713586|FG001|Overall Study|Adverse Event|13|||
27693238|NCT00370331|80713585|FG000|Overall Study|Withdrawal by Subject|2|||
27693239|NCT00370331|80713586|FG001|Overall Study|Withdrawal by Subject|4|||
27693240|NCT00370331|80713585|FG000|Overall Study|Lost to Follow-up|0|||
27693241|NCT00370331|80713586|FG001|Overall Study|Lost to Follow-up|3|||
27693242|NCT00370331|80713585|FG000|Overall Study|Lack of Efficacy|0|||
27693243|NCT00370331|80713586|FG001|Overall Study|Lack of Efficacy|1|||
27693244|NCT00370331|80713585|FG000|Overall Study|Non-compliance|0|||
27693245|NCT00370331|80713586|FG001|Overall Study|Non-compliance|1|||
27693246|NCT00370331|80713585|FG000|Overall Study|Protocol Violation|1|||
27693247|NCT00370331|80713586|FG001|Overall Study|Protocol Violation|1|||
27693248|NCT00372385|80713587|FG000|Overall Study|Adverse Event|6|||
27693249|NCT00372385|80713588|FG001|Overall Study|Adverse Event|11|||
27693250|NCT00372385|80713589|FG002|Overall Study|Adverse Event|9|||
27693251|NCT00372385|80713590|FG003|Overall Study|Adverse Event|7|||
27693252|NCT00372385|80713587|FG000|Overall Study|Noncompliance|0|||
27880565|NCT03526861|81394524|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880566|NCT03526861|81394525|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880567|NCT03526861|81394517|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
27693253|NCT00372385|80713588|FG001|Overall Study|Noncompliance|1|||
27693254|NCT00372385|80713589|FG002|Overall Study|Noncompliance|1|||
27592117|NCT00127101|80348567|FG004|Base Protocol|Lack of Efficacy|2|||
27592118|NCT00127101|80348568|FG005|Base Protocol|Lack of Efficacy|0|||
27592119|NCT00127101|80348563|FG000|Base Protocol|Withdrawal by Subject|1|||
27592120|NCT00127101|80348564|FG001|Base Protocol|Withdrawal by Subject|2|||
27592121|NCT00127101|80348565|FG002|Base Protocol|Withdrawal by Subject|1|||
27592122|NCT00127101|80348566|FG003|Base Protocol|Withdrawal by Subject|0|||
27693255|NCT00372385|80713590|FG003|Overall Study|Noncompliance|1|||
27693256|NCT00372385|80713587|FG000|Overall Study|Physician Decision|1|||
27693257|NCT00372385|80713588|FG001|Overall Study|Physician Decision|0|||
27693258|NCT00372385|80713589|FG002|Overall Study|Physician Decision|0|||
27693259|NCT00372385|80713590|FG003|Overall Study|Physician Decision|0|||
27693260|NCT00372385|80713587|FG000|Overall Study|Lost to Follow-up|2|||
27693261|NCT00372385|80713588|FG001|Overall Study|Lost to Follow-up|0|||
27693262|NCT00372385|80713589|FG002|Overall Study|Lost to Follow-up|0|||
27693263|NCT00372385|80713590|FG003|Overall Study|Lost to Follow-up|0|||
27693264|NCT00372385|80713587|FG000|Overall Study|Withdrawal by Subject|2|||
27693265|NCT00372385|80713588|FG001|Overall Study|Withdrawal by Subject|1|||
27693266|NCT00372385|80713589|FG002|Overall Study|Withdrawal by Subject|0|||
27693267|NCT00372385|80713590|FG003|Overall Study|Withdrawal by Subject|0|||
27693268|NCT00372385|80713587|FG000|Overall Study|Refusal of Treatment|3|||
27693269|NCT00372385|80713588|FG001|Overall Study|Refusal of Treatment|6|||
27693270|NCT00372385|80713589|FG002|Overall Study|Refusal of Treatment|0|||
27693271|NCT00372385|80713590|FG003|Overall Study|Refusal of Treatment|0|||
27693272|NCT00372385|80713587|FG000|Overall Study|No Response|1|||
27693273|NCT00372385|80713588|FG001|Overall Study|No Response|1|||
27693274|NCT00372385|80713589|FG002|Overall Study|No Response|0|||
27693275|NCT00372385|80713590|FG003|Overall Study|No Response|0|||
27693276|NCT00372385|80713587|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
27693277|NCT00372385|80713588|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
27693278|NCT00372385|80713589|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
27693279|NCT00372385|80713590|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
27693280|NCT00372385|80713587|FG000|Overall Study|Virologic Stopping Rule|17|||
27693281|NCT00372385|80713588|FG001|Overall Study|Virologic Stopping Rule|0|||
27693282|NCT00372385|80713589|FG002|Overall Study|Virologic Stopping Rule|0|||
27693283|NCT00372385|80713590|FG003|Overall Study|Virologic Stopping Rule|0|||
27693284|NCT01506453|80713599|FG000|Overall Study|Withdrawal prior to treatment|0|||
27693285|NCT01506453|80713600|FG001|Overall Study|Withdrawal prior to treatment|2|||
27693286|NCT02958267|80713601|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
27693287|NCT02958267|80713602|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
27693288|NCT02958267|80713601|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
27693289|NCT02958267|80713602|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
27693290|NCT02958267|80713601|FG000|Follow-up Visits|Additional treatment pursued|2|||
27693291|NCT02958267|80713602|FG001|Follow-up Visits|Additional treatment pursued|1|||
27693292|NCT01236339|80713603|FG000|Overall Study|Termination of study by sponsor|11|||
27693293|NCT01236339|80713604|FG001|Overall Study|Termination of study by sponsor|13|||
27693294|NCT00323856|80713605|FG000|Overall Study|Withdrawal by Subject|1|||
27693295|NCT00323856|80713605|FG000|Overall Study|Was uncooperative and noncompliant|1|||
27693296|NCT00323856|80713605|FG000|Overall Study|Reason not specified|1|||
27818789|NCT00677365|81170025|FG002|Overall Study|Other reason|0|||
27818790|NCT00677365|81170026|FG003|Overall Study|Other reason|1|||
27592123|NCT00127101|80348567|FG004|Base Protocol|Withdrawal by Subject|0|||
27592124|NCT00127101|80348568|FG005|Base Protocol|Withdrawal by Subject|1|||
27592125|NCT00127101|80348563|FG000|Continuation Phase|Adverse Event|0|||
27592126|NCT00127101|80348564|FG001|Continuation Phase|Adverse Event|0|||
27592127|NCT00127101|80348565|FG002|Continuation Phase|Adverse Event|0|||
27592128|NCT00127101|80348566|FG003|Continuation Phase|Adverse Event|0|||
27592129|NCT00127101|80348567|FG004|Continuation Phase|Adverse Event|1|||
27592130|NCT00127101|80348568|FG005|Continuation Phase|Adverse Event|1|||
27592131|NCT00127101|80348563|FG000|Continuation Phase|Lack of Efficacy|0|||
27693297|NCT00323856|80713605|FG000|Overall Study|Missing|2|||
27693298|NCT01898923|80713606|FG000|Overall Study|Lack of Efficacy|5|||
27693299|NCT01898923|80713607|FG001|Overall Study|Lack of Efficacy|6|||
27693300|NCT01898923|80713606|FG000|Overall Study|Adverse Event|3|||
27693301|NCT01898923|80713607|FG001|Overall Study|Adverse Event|1|||
27592132|NCT00127101|80348564|FG001|Continuation Phase|Lack of Efficacy|0|||
27592133|NCT00127101|80348565|FG002|Continuation Phase|Lack of Efficacy|0|||
27592134|NCT00127101|80348566|FG003|Continuation Phase|Lack of Efficacy|0|||
27693302|NCT01898923|80713606|FG000|Overall Study|Lost to Follow-up|0|||
27693303|NCT01898923|80713607|FG001|Overall Study|Lost to Follow-up|1|||
27693304|NCT01898923|80713606|FG000|Overall Study|Withdrawal by Subject|4|||
27818791|NCT00385593|81170031|FG000|Overall Study|Adverse Event|3|||
27693305|NCT01898923|80713607|FG001|Overall Study|Withdrawal by Subject|7|||
27693306|NCT01898923|80713606|FG000|Overall Study|Physician Decision|3|||
27693307|NCT01898923|80713607|FG001|Overall Study|Physician Decision|4|||
27693308|NCT01898923|80713606|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
27693309|NCT01898923|80713607|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
27693310|NCT04025580|80713608|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
27693311|NCT04025580|80713609|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
27693312|NCT04025580|80713610|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
27693313|NCT03733899|80713614|FG000|Period 1|Protocol Violation|0|||
27693314|NCT03733899|80713615|FG001|Period 1|Protocol Violation|0|||
27693315|NCT03733899|80713616|FG002|Period 1|Protocol Violation|0|||
27693316|NCT03733899|80713617|FG003|Period 1|Protocol Violation|0|||
27693317|NCT03733899|80713618|FG004|Period 1|Protocol Violation|0|||
27693318|NCT03733899|80713619|FG005|Period 1|Protocol Violation|1|||
27693319|NCT03733899|80713614|FG000|Period 2|Unscuccessful Treatment|0|||
27693320|NCT03733899|80713615|FG001|Period 2|Unscuccessful Treatment|1|||
27693321|NCT03733899|80713616|FG002|Period 2|Unscuccessful Treatment|0|||
27693322|NCT03733899|80713617|FG003|Period 2|Unscuccessful Treatment|0|||
27693323|NCT03733899|80713618|FG004|Period 2|Unscuccessful Treatment|0|||
27693324|NCT03733899|80713619|FG005|Period 2|Unscuccessful Treatment|0|||
27693325|NCT03733899|80713614|FG000|Period 3|Withdrawal by Subject|1|||
27693326|NCT03733899|80713615|FG001|Period 3|Withdrawal by Subject|0|||
27693327|NCT03733899|80713616|FG002|Period 3|Withdrawal by Subject|0|||
27693328|NCT03733899|80713617|FG003|Period 3|Withdrawal by Subject|0|||
27693329|NCT03733899|80713618|FG004|Period 3|Withdrawal by Subject|0|||
27693330|NCT03733899|80713619|FG005|Period 3|Withdrawal by Subject|0|||
27693331|NCT02630693|80713623|FG000|Overall Study|No receive treatment|0|||
27693332|NCT02630693|80713624|FG001|Overall Study|No receive treatment|1|||
27693333|NCT00777946|80713627|FG000|Overall Study|Adverse Event|11|||
27693334|NCT00777946|80713628|FG001|Overall Study|Adverse Event|1|||
27693335|NCT00777946|80713629|FG002|Overall Study|Adverse Event|3|||
27693336|NCT00777946|80713627|FG000|Overall Study|Lack of Efficacy|0|||
27693337|NCT00777946|80713628|FG001|Overall Study|Lack of Efficacy|0|||
27693338|NCT00777946|80713629|FG002|Overall Study|Lack of Efficacy|9|||
27693339|NCT00777946|80713627|FG000|Overall Study|Condition no longer required study drug|1|||
27693340|NCT00777946|80713628|FG001|Overall Study|Condition no longer required study drug|0|||
27693341|NCT00777946|80713629|FG002|Overall Study|Condition no longer required study drug|0|||
27693342|NCT00777946|80713627|FG000|Overall Study|Patient withdrew consent|3|||
27693343|NCT00777946|80713628|FG001|Overall Study|Patient withdrew consent|2|||
27693344|NCT00777946|80713629|FG002|Overall Study|Patient withdrew consent|3|||
27693345|NCT00777946|80713627|FG000|Overall Study|Lost to Follow-up|3|||
27693346|NCT00777946|80713628|FG001|Overall Study|Lost to Follow-up|1|||
27693347|NCT00777946|80713629|FG002|Overall Study|Lost to Follow-up|0|||
27693348|NCT00777946|80713627|FG000|Overall Study|Protocol deviation|2|||
27693349|NCT00777946|80713628|FG001|Overall Study|Protocol deviation|1|||
27693350|NCT00777946|80713629|FG002|Overall Study|Protocol deviation|1|||
27693351|NCT00777946|80713627|FG000|Overall Study|Randomized in error|1|||
27693352|NCT00777946|80713628|FG001|Overall Study|Randomized in error|1|||
27693353|NCT00777946|80713629|FG002|Overall Study|Randomized in error|0|||
27693354|NCT02667587|80713630|FG000|Pre-Treatment|Not reported|1|||
27693355|NCT02667587|80713631|FG001|Pre-Treatment|Not reported|0|||
27693356|NCT02667587|80713630|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
27693357|NCT02667587|80713631|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
27693358|NCT02667587|80713630|FG000|Pre-Treatment|Participant withdrew consent|0|||
27693359|NCT02667587|80713631|FG001|Pre-Treatment|Participant withdrew consent|1|||
27693360|NCT02667587|80713630|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
27693361|NCT02667587|80713631|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
27693362|NCT02667587|80713630|FG000|End of Treatment|Other reasons|11|||
27693363|NCT02667587|80713631|FG001|End of Treatment|Other reasons|8|||
27693364|NCT02667587|80713630|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
27693365|NCT02667587|80713631|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
27693366|NCT02667587|80713630|FG000|End of Treatment|Poor/Non-Compliance|0|||
27693367|NCT02667587|80713631|FG001|End of Treatment|Poor/Non-Compliance|1|||
27693368|NCT02667587|80713630|FG000|End of Treatment|Maximum Clinical Benefit|3|||
27693369|NCT02667587|80713631|FG001|End of Treatment|Maximum Clinical Benefit|3|||
27693370|NCT02667587|80713630|FG000|End of Treatment|Participant Withdrew Consent|5|||
27693371|NCT02667587|80713631|FG001|End of Treatment|Participant Withdrew Consent|6|||
27693372|NCT02667587|80713630|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
27693373|NCT02667587|80713631|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
27693374|NCT02667587|80713630|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
27693375|NCT02667587|80713631|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
27693376|NCT02667587|80713630|FG000|End of Treatment|Death|2|||
27693377|NCT02667587|80713631|FG001|End of Treatment|Death|1|||
27693378|NCT02667587|80713630|FG000|End of Treatment|Study Drug Toxicity|74|||
27693379|NCT02667587|80713631|FG001|End of Treatment|Study Drug Toxicity|18|||
27693380|NCT02667587|80713630|FG000|End of Treatment|Disease progression|177|||
27693381|NCT02667587|80713631|FG001|End of Treatment|Disease progression|222|||
27693382|NCT02667587|80713630|FG000|End of Treatment|Lost to Follow-up|1|||
27693383|NCT02667587|80713631|FG001|End of Treatment|Lost to Follow-up|3|||
27693384|NCT03809429|80713642|FG000|Overall Study|Withdrawal by Subject|7|||
27693385|NCT03809429|80713643|FG001|Overall Study|Withdrawal by Subject|3|||
27693386|NCT03809429|80713642|FG000|Overall Study|Adverse Event|6|||
27693387|NCT03809429|80713643|FG001|Overall Study|Adverse Event|9|||
27693388|NCT03809429|80713642|FG000|Overall Study|COVID-19|3|||
27693389|NCT03809429|80713643|FG001|Overall Study|COVID-19|1|||
27693390|NCT03809429|80713642|FG000|Overall Study|Participant was discontinued by investigator|12|||
27693391|NCT03809429|80713643|FG001|Overall Study|Participant was discontinued by investigator|7|||
27693392|NCT02678247|80713644|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
27693393|NCT02678247|80713645|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
27693394|NCT02678247|80713644|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
27693395|NCT02678247|80713645|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
27693396|NCT02678247|80713644|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
27818792|NCT00385593|81170032|FG001|Overall Study|Adverse Event|2|||
27818793|NCT00385593|81170031|FG000|Overall Study|Withdrawal by Subject|17|||
27880568|NCT03526861|81394518|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
27880569|NCT03526861|81394519|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
27880570|NCT03526861|81394520|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
27880571|NCT03526861|81394521|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
27880572|NCT03526861|81394522|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
27880573|NCT03526861|81394523|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
27880574|NCT03526861|81394524|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
27880575|NCT03526861|81394525|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
27693397|NCT02678247|80713645|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
27818794|NCT00385593|81170032|FG001|Overall Study|Withdrawal by Subject|7|||
27818795|NCT00385593|81170031|FG000|Overall Study|Lost to Follow-up|12|||
27818796|NCT00385593|81170032|FG001|Overall Study|Lost to Follow-up|8|||
27818797|NCT00385593|81170031|FG000|Overall Study|Protocol Violation|7|||
27818798|NCT00385593|81170032|FG001|Overall Study|Protocol Violation|4|||
27818799|NCT00385593|81170031|FG000|Overall Study|Several reasons|17|||
27818800|NCT00385593|81170032|FG001|Overall Study|Several reasons|15|||
27818801|NCT00385593|81170031|FG000|Overall Study|Incorrect inclusion|2|||
27818802|NCT00385593|81170032|FG001|Overall Study|Incorrect inclusion|0|||
27818803|NCT00385593|81170031|FG000|Overall Study|Incorrect randomization|0|||
27818804|NCT00385593|81170032|FG001|Overall Study|Incorrect randomization|1|||
27818805|NCT00463606|81170033|FG000|Overall Study|Adverse Event|21|||
27818806|NCT00463606|81170034|FG001|Overall Study|Adverse Event|18|||
27818807|NCT00463606|81170035|FG002|Overall Study|Adverse Event|11|||
27818808|NCT00463606|81170033|FG000|Overall Study|Withdrawal by Subject|11|||
27818809|NCT00463606|81170034|FG001|Overall Study|Withdrawal by Subject|11|||
27818810|NCT00463606|81170035|FG002|Overall Study|Withdrawal by Subject|5|||
27818811|NCT00463606|81170033|FG000|Overall Study|Lost to Follow-up|2|||
27818812|NCT00463606|81170034|FG001|Overall Study|Lost to Follow-up|2|||
27818813|NCT00463606|81170035|FG002|Overall Study|Lost to Follow-up|3|||
27818814|NCT00463606|81170033|FG000|Overall Study|Subject noncompliance|1|||
27818815|NCT00463606|81170034|FG001|Overall Study|Subject noncompliance|1|||
27818816|NCT00463606|81170035|FG002|Overall Study|Subject noncompliance|0|||
27818817|NCT00463606|81170033|FG000|Overall Study|Subject moved out of town|1|||
27818818|NCT00463606|81170034|FG001|Overall Study|Subject moved out of town|0|||
27818819|NCT00463606|81170035|FG002|Overall Study|Subject moved out of town|0|||
27818820|NCT00463606|81170033|FG000|Overall Study|Physician Decision|0|||
27693398|NCT02678247|80713644|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
27693399|NCT02678247|80713645|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
27693400|NCT02678247|80713644|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
27818821|NCT00463606|81170034|FG001|Overall Study|Physician Decision|1|||
27818822|NCT00463606|81170035|FG002|Overall Study|Physician Decision|0|||
27818823|NCT00463606|81170033|FG000|Overall Study|Sponsor request|0|||
27818824|NCT00463606|81170034|FG001|Overall Study|Sponsor request|1|||
27818825|NCT00463606|81170035|FG002|Overall Study|Sponsor request|0|||
27818826|NCT00463606|81170033|FG000|Overall Study|Exclusion criteria violation|2|||
27693401|NCT02678247|80713645|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
27693402|NCT02678247|80713644|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
27693403|NCT02678247|80713645|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
27693404|NCT00903630|80713646|FG000|Phase 2|Adverse Event|0|||
27693405|NCT00903630|80713647|FG001|Phase 2|Adverse Event|0|||
27693406|NCT00903630|80713648|FG002|Phase 2|Adverse Event|1|||
27693407|NCT00836095|80713652|FG000|Overall Study|Physician Decision|0|||
27693408|NCT00836095|80713653|FG001|Overall Study|Physician Decision|3|||
27693409|NCT01324440|80713658|FG000|Overall Study|Subject moved|0|||
27693410|NCT01324440|80713659|FG001|Overall Study|Subject moved|1|||
27693411|NCT02893930|80713662|FG000|Overall Study|Adverse Event|3|||
27693412|NCT02893930|80713662|FG000|Overall Study|Death|1|||
27693413|NCT02893930|80713662|FG000|Overall Study|Disease progression|5|||
27693414|NCT02893930|80713662|FG000|Overall Study|Withdrawal by Subject|2|||
27693415|NCT02893930|80713662|FG000|Overall Study|Physician Decision|1|||
27693416|NCT02893930|80713662|FG000|Overall Study|Ineligible|1|||
27693417|NCT02520284|80713663|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
27693418|NCT02520284|80713664|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
27693419|NCT02520284|80713665|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
27693420|NCT02520284|80713663|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
27693421|NCT02520284|80713664|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
27693422|NCT02520284|80713665|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
27693423|NCT02520284|80713663|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
27693424|NCT02520284|80713664|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
27693425|NCT02520284|80713665|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
27693426|NCT02520284|80713663|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
27693427|NCT02520284|80713664|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
27693428|NCT02520284|80713665|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
27693429|NCT02520284|80713663|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
27693430|NCT02520284|80713664|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
27693431|NCT02520284|80713665|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
27693432|NCT02520284|80713663|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
27693433|NCT02520284|80713664|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
27693434|NCT02520284|80713665|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
27693435|NCT02520284|80713663|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
27693436|NCT02520284|80713664|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
27693437|NCT02520284|80713665|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
27693438|NCT02520284|80713663|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
27693439|NCT02520284|80713664|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
27693440|NCT02520284|80713665|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
27693441|NCT02520284|80713663|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
27693442|NCT02520284|80713664|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
27693443|NCT02520284|80713665|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
27693444|NCT02520284|80713663|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
27693445|NCT02520284|80713664|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
27693446|NCT02520284|80713665|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
27818827|NCT00463606|81170034|FG001|Overall Study|Exclusion criteria violation|0|||
27818828|NCT00463606|81170035|FG002|Overall Study|Exclusion criteria violation|0|||
27818829|NCT00463606|81170033|FG000|Overall Study|Coordinator error|1|||
27818830|NCT00463606|81170034|FG001|Overall Study|Coordinator error|0|||
27818831|NCT00463606|81170035|FG002|Overall Study|Coordinator error|0|||
27818832|NCT00463606|81170033|FG000|Overall Study|Patient randomized in error|1|||
27818833|NCT00463606|81170034|FG001|Overall Study|Patient randomized in error|0|||
27818834|NCT00463606|81170035|FG002|Overall Study|Patient randomized in error|0|||
27818835|NCT00463606|81170033|FG000|Overall Study|Participation in another ABT-335 trial|1|||
27818836|NCT00463606|81170034|FG001|Overall Study|Participation in another ABT-335 trial|0|||
27818837|NCT00463606|81170035|FG002|Overall Study|Participation in another ABT-335 trial|0|||
27818838|NCT00463606|81170033|FG000|Overall Study|Protocol Violation|0|||
27818839|NCT00463606|81170034|FG001|Overall Study|Protocol Violation|0|||
27818840|NCT00463606|81170035|FG002|Overall Study|Protocol Violation|1|||
27693447|NCT02520284|80713663|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
27693448|NCT02520284|80713664|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
27693449|NCT02520284|80713665|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
27693450|NCT02699983|80713668|FG000|Overall Study|Withdrawal by Subject|1|||
27693451|NCT02699983|80713669|FG001|Overall Study|Withdrawal by Subject|0|||
27693452|NCT04187989|80713672|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
27693453|NCT04187989|80713673|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
27818841|NCT03708211|81170036|FG000|Overall Study|Progressive Disease|10|||
27818842|NCT03708211|81170037|FG001|Overall Study|Progressive Disease|7|||
27818843|NCT03708211|81170036|FG000|Overall Study|Withdrawal by Subject|0|||
27818844|NCT03708211|81170037|FG001|Overall Study|Withdrawal by Subject|1|||
27818845|NCT03708211|81170036|FG000|Overall Study|Other|2|||
27818846|NCT03708211|81170037|FG001|Overall Study|Other|0|||
27818847|NCT03048500|81170046|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
27818848|NCT03048500|81170046|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
27818849|NCT03048500|81170046|FG000|Reached 1st Response/Continued Treatment|Death|1|||
27818850|NCT03048500|81170046|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
27818851|NCT03048500|81170046|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
27693454|NCT04187989|80713672|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
27693455|NCT04187989|80713673|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
27880576|NCT03526861|81394517|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27693456|NCT01285609|80713675|FG000|Randomized|Progressive Disease|41|||
27818852|NCT03048500|81170046|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
27818853|NCT03048500|81170046|FG000|Follow up for 3 Years|Death|12|||
27880577|NCT03526861|81394518|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880578|NCT03526861|81394519|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880579|NCT03526861|81394520|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
27880580|NCT03526861|81394521|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880581|NCT03526861|81394522|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880582|NCT03526861|81394523|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880583|NCT03526861|81394524|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880584|NCT03526861|81394525|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880585|NCT03526861|81394517|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880586|NCT03526861|81394518|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880587|NCT03526861|81394519|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880588|NCT03526861|81394520|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27818854|NCT00796822|81170047|FG000|Overall Study|Lost to Follow-up|2|||
27818855|NCT00796822|81170048|FG001|Overall Study|Lost to Follow-up|0|||
27818856|NCT00796822|81170047|FG000|Overall Study|Adverse Event|1|||
27818857|NCT00796822|81170048|FG001|Overall Study|Adverse Event|0|||
27818858|NCT00984295|81170053|FG000|Overall Study|Lost to Follow-up|31|||
27818859|NCT00984295|81170054|FG001|Overall Study|Lost to Follow-up|12|||
27818860|NCT00984295|81170055|FG002|Overall Study|Lost to Follow-up|13|||
27818861|NCT00984295|81170053|FG000|Overall Study|Protocol Violation|2|||
27818862|NCT00984295|81170054|FG001|Overall Study|Protocol Violation|1|||
27818863|NCT00984295|81170055|FG002|Overall Study|Protocol Violation|4|||
27818864|NCT00984295|81170053|FG000|Overall Study|Withdrawal by Subject|18|||
27818865|NCT00984295|81170054|FG001|Overall Study|Withdrawal by Subject|9|||
27818866|NCT00984295|81170055|FG002|Overall Study|Withdrawal by Subject|12|||
27818867|NCT00984295|81170053|FG000|Overall Study|CAE - discontinued test vaccine|0|||
27818868|NCT00984295|81170054|FG001|Overall Study|CAE - discontinued test vaccine|1|||
27818869|NCT00984295|81170055|FG002|Overall Study|CAE - discontinued test vaccine|3|||
27818870|NCT00984295|81170053|FG000|Overall Study|Missed one or more blood samplings|3|||
27818871|NCT00984295|81170054|FG001|Overall Study|Missed one or more blood samplings|7|||
27818872|NCT00984295|81170055|FG002|Overall Study|Missed one or more blood samplings|2|||
27818873|NCT00984295|81170053|FG000|Overall Study|Incomplete safety follow-up|11|||
27818874|NCT00984295|81170054|FG001|Overall Study|Incomplete safety follow-up|2|||
27818875|NCT00984295|81170055|FG002|Overall Study|Incomplete safety follow-up|3|||
27818876|NCT01919190|81170058|FG000|Overall Study|Intra-op findings, etc.|3|||
27693457|NCT01285609|80713676|FG001|Randomized|Progressive Disease|61|||
27693458|NCT01285609|80713675|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
27693459|NCT01285609|80713676|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
27693460|NCT01285609|80713675|FG000|Randomized|Study Drug Toxicity|13|||
27693461|NCT01285609|80713676|FG001|Randomized|Study Drug Toxicity|14|||
27693462|NCT01285609|80713675|FG000|Randomized|Death|5|||
27693463|NCT01285609|80713676|FG001|Randomized|Death|7|||
27693464|NCT01285609|80713675|FG000|Randomized|Withdrawal by Subject|8|||
27693465|NCT01285609|80713676|FG001|Randomized|Withdrawal by Subject|11|||
27693466|NCT01285609|80713675|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
27693467|NCT01285609|80713676|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
27693468|NCT01285609|80713675|FG000|Randomized|Undisclosed Reasons|1|||
27693469|NCT01285609|80713676|FG001|Randomized|Undisclosed Reasons|0|||
27693470|NCT01285609|80713675|FG000|Randomized|Randomized but not Treated|4|||
27693471|NCT01285609|80713676|FG001|Randomized|Randomized but not Treated|4|||
27693472|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
27693473|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
27693474|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
27693475|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
27693476|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
27693477|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
27693478|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
27693479|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
27693480|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Death|11|||
27693481|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Death|3|||
27693482|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
27693483|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
27693484|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Not Reported|0|||
27693485|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Not Reported|2|||
27693486|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
27693487|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
27693488|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
27693489|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
27693490|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
27693491|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
27693492|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
27693493|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
27693494|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
27693495|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
27693496|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
27693497|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
27693498|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
27693499|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
27693500|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
27693501|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
27693502|NCT01285609|80713675|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
27693503|NCT01285609|80713676|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
27693504|NCT01285609|80713675|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
27693505|NCT01285609|80713676|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
27693506|NCT02325557|80713677|FG000|Overall Study|Progressive disease|1|||
27693507|NCT02325557|80713678|FG001|Overall Study|Progressive disease|0|||
27693508|NCT02325557|80713679|FG002|Overall Study|Progressive disease|0|||
27693509|NCT02325557|80713680|FG003|Overall Study|Progressive disease|0|||
27693510|NCT02325557|80713677|FG000|Overall Study|Withdrawal by Subject|4|||
27693511|NCT02325557|80713678|FG001|Overall Study|Withdrawal by Subject|0|||
27693512|NCT02325557|80713679|FG002|Overall Study|Withdrawal by Subject|0|||
27693513|NCT02325557|80713680|FG003|Overall Study|Withdrawal by Subject|15|||
27693514|NCT02325557|80713677|FG000|Overall Study|Death|5|||
27693515|NCT02325557|80713678|FG001|Overall Study|Death|1|||
27693516|NCT02325557|80713679|FG002|Overall Study|Death|1|||
27693517|NCT02325557|80713680|FG003|Overall Study|Death|16|||
27693518|NCT02325557|80713677|FG000|Overall Study|Lost to Follow-up|0|||
27818877|NCT01919190|81170059|FG001|Overall Study|Intra-op findings, etc.|0|||
27818878|NCT02626949|81170060|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
27693519|NCT02325557|80713678|FG001|Overall Study|Lost to Follow-up|0|||
27693520|NCT02325557|80713679|FG002|Overall Study|Lost to Follow-up|1|||
27693521|NCT02325557|80713680|FG003|Overall Study|Lost to Follow-up|1|||
27693522|NCT02325557|80713677|FG000|Overall Study|Other|0|||
27693523|NCT02325557|80713678|FG001|Overall Study|Other|0|||
27592135|NCT00127101|80348567|FG004|Continuation Phase|Lack of Efficacy|0|||
27592136|NCT00127101|80348568|FG005|Continuation Phase|Lack of Efficacy|1|||
27592137|NCT00127101|80348563|FG000|Continuation Phase|Withdrawal by Subject|0|||
27592138|NCT00127101|80348564|FG001|Continuation Phase|Withdrawal by Subject|0|||
27592139|NCT00127101|80348565|FG002|Continuation Phase|Withdrawal by Subject|1|||
27592140|NCT00127101|80348566|FG003|Continuation Phase|Withdrawal by Subject|0|||
27693524|NCT02325557|80713679|FG002|Overall Study|Other|0|||
27693525|NCT02325557|80713680|FG003|Overall Study|Other|5|||
27693526|NCT01959516|80713681|FG000|Epoch 1|Adverse Event|4|||
27693527|NCT01959516|80713682|FG001|Epoch 1|Adverse Event|1|||
27693528|NCT01959516|80713681|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
27693529|NCT01959516|80713682|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
27693530|NCT01959516|80713681|FG000|Epoch 1|Subject withdrew consent|3|||
27693531|NCT01959516|80713682|FG001|Epoch 1|Subject withdrew consent|2|||
27693532|NCT01959516|80713681|FG000|Epoch 1|Administrative problems|1|||
27693533|NCT01959516|80713682|FG001|Epoch 1|Administrative problems|0|||
27693534|NCT01959516|80713681|FG000|Epoch 1|Use of prohibited treatment|1|||
27693535|NCT01959516|80713682|FG001|Epoch 1|Use of prohibited treatment|0|||
27592141|NCT00127101|80348567|FG004|Continuation Phase|Withdrawal by Subject|2|||
27592142|NCT00127101|80348568|FG005|Continuation Phase|Withdrawal by Subject|1|||
27592143|NCT04656847|80348569|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
27592144|NCT04486716|80348571|FG000|Overall Study|Subject decision|6|||
27592145|NCT04486716|80348571|FG000|Overall Study|Adverse Event|5|||
27592146|NCT04486716|80348571|FG000|Overall Study|Lost to Follow-up|1|||
27693536|NCT01959516|80713681|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
27693537|NCT01959516|80713682|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
27693538|NCT01959516|80713681|FG000|Epoch 1|Protocol deviation|0|||
27693539|NCT01959516|80713682|FG001|Epoch 1|Protocol deviation|1|||
27693540|NCT01959516|80713681|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
27693541|NCT01959516|80713682|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
27693542|NCT01959516|80713681|FG000|Epoch 2|Subject withdrew consent|1|||
27818879|NCT02626949|81170061|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
27818880|NCT02626949|81170060|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
27818881|NCT02626949|81170061|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
27818882|NCT02626949|81170060|FG000|Enrolled|Lost to Follow-up|7|||
27592147|NCT04486716|80348571|FG000|Overall Study|Physician Decision|1|||
27592148|NCT04486716|80348571|FG000|Overall Study|Enrolled subjects not treated|9|||
27592149|NCT00700401|80348572|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
27592150|NCT00700401|80348572|FG000|Overall Study|Adverse Event|5|||
27592151|NCT00700401|80348572|FG000|Overall Study|Refused Treatment|2|||
27693543|NCT01959516|80713682|FG001|Epoch 2|Subject withdrew consent|0|||
27693544|NCT01959516|80713681|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
27693545|NCT01959516|80713682|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
27693546|NCT02578862|80713683|FG000|Overall Study|Withdrawal by Subject|0|||
27693547|NCT02578862|80713684|FG001|Overall Study|Withdrawal by Subject|1|||
27693548|NCT02578862|80713683|FG000|Overall Study|Unplanned unilateral procedure|0|||
27693549|NCT02578862|80713684|FG001|Overall Study|Unplanned unilateral procedure|1|||
27693550|NCT00505284|80713685|FG000|Overall Study|Adverse Event|3|||
27693551|NCT00505284|80713686|FG001|Overall Study|Adverse Event|7|||
27693552|NCT00505284|80713687|FG002|Overall Study|Adverse Event|9|||
27818883|NCT02626949|81170061|FG001|Enrolled|Lost to Follow-up|6|||
27818884|NCT02626949|81170060|FG000|Enrolled|Withdrawal by Subject|3|||
27818885|NCT02626949|81170061|FG001|Enrolled|Withdrawal by Subject|2|||
27818886|NCT03687736|81170062|FG000|Overall Study|Lost to Follow-up|7|||
27818887|NCT03687736|81170062|FG000|Overall Study|Withdrawal by Subject|3|||
27818888|NCT02193880|81170063|FG000|Overall Study|patients did not collect enough HPC|3|||
27818889|NCT01259869|81170065|FG000|Overall Study|Duplicated registration|1|||
27818890|NCT02684344|81170066|FG000|Overall Study|Withdrawal by Subject|0|||
27818891|NCT02684344|81170067|FG001|Overall Study|Withdrawal by Subject|1|||
27818892|NCT02430870|81170072|FG000|Part 2|Voluntary Withdrawal|0|||
27818893|NCT02430870|81170073|FG001|Part 2|Voluntary Withdrawal|0|||
27818894|NCT02430870|81170074|FG002|Part 2|Voluntary Withdrawal|0|||
27818895|NCT02430870|81170075|FG003|Part 2|Voluntary Withdrawal|0|||
27818896|NCT02430870|81170076|FG004|Part 2|Voluntary Withdrawal|0|||
27818897|NCT02430870|81170077|FG005|Part 2|Voluntary Withdrawal|0|||
27818898|NCT02430870|81170078|FG006|Part 2|Voluntary Withdrawal|1|||
27818899|NCT02430870|81170079|FG007|Part 2|Voluntary Withdrawal|0|||
27818900|NCT02430870|81170072|FG000|Part 2|Other Reason Not Specified|0|||
27818901|NCT02430870|81170073|FG001|Part 2|Other Reason Not Specified|0|||
27818902|NCT02430870|81170074|FG002|Part 2|Other Reason Not Specified|0|||
27818903|NCT02430870|81170075|FG003|Part 2|Other Reason Not Specified|0|||
27818904|NCT02430870|81170076|FG004|Part 2|Other Reason Not Specified|0|||
27818905|NCT02430870|81170077|FG005|Part 2|Other Reason Not Specified|0|||
27818906|NCT02430870|81170078|FG006|Part 2|Other Reason Not Specified|0|||
27818907|NCT02430870|81170079|FG007|Part 2|Other Reason Not Specified|1|||
27818908|NCT04646109|81170084|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
27818909|NCT04646109|81170085|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
27818910|NCT00841100|81170088|FG000|Phase 1 (28 Days)|Adverse Event|1|||
27818911|NCT00841100|81170088|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
27818912|NCT01619800|81170089|FG000|Overall Study|study terminated|2|||
27818913|NCT01619800|81170090|FG001|Overall Study|study terminated|0|||
27818914|NCT00553280|81170092|FG000|Overall Study|Adverse Event|19|||
27818915|NCT00553280|81170092|FG000|Overall Study|Lack of Efficacy|3|||
27818916|NCT00553280|81170092|FG000|Overall Study|Withdrawal by Subject|3|||
27818917|NCT00553280|81170092|FG000|Overall Study|Physician Decision|1|||
27818918|NCT00352690|81170093|FG000|Overall Study|Determined to be ineligible|2|||
27818919|NCT00352690|81170094|FG001|Overall Study|Determined to be ineligible|0|||
27818920|NCT03661528|81170098|FG000|Overall Study|Death|1|||
27818921|NCT03661528|81170099|FG001|Overall Study|Death|0|||
27818922|NCT03661528|81170098|FG000|Overall Study|Physician Decision|3|||
27818923|NCT03661528|81170099|FG001|Overall Study|Physician Decision|1|||
27818924|NCT03661528|81170098|FG000|Overall Study|Other than Specified|5|||
27818925|NCT03661528|81170099|FG001|Overall Study|Other than Specified|2|||
27818926|NCT03661528|81170098|FG000|Overall Study|Withdrawal by Subject|5|||
27818927|NCT03661528|81170099|FG001|Overall Study|Withdrawal by Subject|3|||
27818928|NCT03661528|81170098|FG000|Overall Study|Disease Progression|8|||
27818929|NCT03661528|81170099|FG001|Overall Study|Disease Progression|13|||
27818930|NCT03661528|81170098|FG000|Overall Study|Adverse Event|61|||
27818931|NCT03661528|81170099|FG001|Overall Study|Adverse Event|55|||
27818932|NCT00048581|81170100|FG000|Double-Blind Period|Adverse Event|9|||
27818933|NCT00048581|81170101|FG001|Double-Blind Period|Adverse Event|5|||
27818934|NCT00048581|81170102|FG002|Double-Blind Period|Adverse Event|0|||
27818935|NCT00048581|81170100|FG000|Double-Blind Period|Lack of Efficacy|14|||
27818936|NCT00048581|81170101|FG001|Double-Blind Period|Lack of Efficacy|27|||
27818937|NCT00048581|81170102|FG002|Double-Blind Period|Lack of Efficacy|0|||
27818938|NCT00048581|81170100|FG000|Double-Blind Period|Lost to Follow-up|5|||
27880589|NCT03526861|81394521|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880590|NCT03526861|81394522|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880591|NCT03526861|81394523|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27880592|NCT03526861|81394524|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
27693553|NCT00505284|80713688|FG003|Overall Study|Adverse Event|14|||
27818939|NCT00048581|81170101|FG001|Double-Blind Period|Lost to Follow-up|0|||
27818940|NCT00048581|81170102|FG002|Double-Blind Period|Lost to Follow-up|0|||
27818941|NCT00048581|81170100|FG000|Double-Blind Period|Withdrawal by Subject|5|||
27818942|NCT00048581|81170101|FG001|Double-Blind Period|Withdrawal by Subject|2|||
27818943|NCT00048581|81170102|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27818944|NCT00048581|81170100|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
27592152|NCT00700401|80348572|FG000|Overall Study|Lost to Follow-up|1|||
27592153|NCT00700401|80348572|FG000|Overall Study|Treatment never started|1|||
27592154|NCT00700401|80348572|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
27592155|NCT00700401|80348572|FG000|Overall Study|Withdrawal by Subject|2|||
27592156|NCT03695172|80348573|FG000|Overall Study|Withdrawal by Subject|1|||
27592157|NCT03695172|80348574|FG001|Overall Study|Withdrawal by Subject|1|||
27592158|NCT03695172|80348575|FG002|Overall Study|Withdrawal by Subject|0|||
27592159|NCT01178086|80348576|FG000|Overall Study|Participant refusal|7|||
27592160|NCT01178086|80348576|FG000|Overall Study|Physician Decision|44|||
27592161|NCT01178086|80348576|FG000|Overall Study|Switch to other CLL therapy|113|||
27592162|NCT01178086|80348576|FG000|Overall Study|Death|59|||
27592163|NCT01178086|80348576|FG000|Overall Study|Other unspecified|89|||
27592164|NCT01178086|80348576|FG000|Overall Study|Excluded from EAS|20|||
27592165|NCT01388816|80348577|FG000|Overall Study|Adverse Event|0|||
27592166|NCT01388816|80348578|FG001|Overall Study|Adverse Event|2|||
27592167|NCT01388816|80348579|FG002|Overall Study|Adverse Event|0|||
27592168|NCT01388816|80348580|FG003|Overall Study|Adverse Event|0|||
27592169|NCT01388816|80348577|FG000|Overall Study|Lost to Follow-up|0|||
27818945|NCT00048581|81170101|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
27818946|NCT00048581|81170102|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
27818947|NCT00048581|81170100|FG000|Double-Blind Period|Investigator Decision|1|||
27818948|NCT00048581|81170101|FG001|Double-Blind Period|Investigator Decision|0|||
27880593|NCT03526861|81394525|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
27880594|NCT03526861|81394517|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880595|NCT03526861|81394518|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880596|NCT03526861|81394519|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27818949|NCT00048581|81170102|FG002|Double-Blind Period|Investigator Decision|0|||
27818950|NCT00048581|81170100|FG000|Open-Label Period|Death|0|||
27818951|NCT00048581|81170101|FG001|Open-Label Period|Death|0|||
27818952|NCT00048581|81170102|FG002|Open-Label Period|Death|4|||
27818953|NCT00048581|81170100|FG000|Open-Label Period|Adverse Event|0|||
27818954|NCT00048581|81170101|FG001|Open-Label Period|Adverse Event|0|||
27818955|NCT00048581|81170102|FG002|Open-Label Period|Adverse Event|37|||
27818956|NCT00048581|81170100|FG000|Open-Label Period|Lack of Efficacy|0|||
27818957|NCT00048581|81170101|FG001|Open-Label Period|Lack of Efficacy|0|||
27818958|NCT00048581|81170102|FG002|Open-Label Period|Lack of Efficacy|69|||
27818959|NCT00048581|81170100|FG000|Open-Label Period|Lost to Follow-up|0|||
27818960|NCT00048581|81170101|FG001|Open-Label Period|Lost to Follow-up|0|||
27818961|NCT00048581|81170102|FG002|Open-Label Period|Lost to Follow-up|14|||
27818962|NCT00048581|81170100|FG000|Open-Label Period|Withdrawal by Subject|0|||
27818963|NCT00048581|81170101|FG001|Open-Label Period|Withdrawal by Subject|0|||
27818964|NCT00048581|81170102|FG002|Open-Label Period|Withdrawal by Subject|20|||
27818965|NCT00048581|81170100|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
27818966|NCT00048581|81170101|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
27818967|NCT00048581|81170102|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
27818968|NCT00048581|81170100|FG000|Open-Label Period|Poor/Non-compliance|0|||
27818969|NCT00048581|81170101|FG001|Open-Label Period|Poor/Non-compliance|0|||
27818970|NCT00048581|81170102|FG002|Open-Label Period|Poor/Non-compliance|5|||
27818971|NCT00048581|81170100|FG000|Open-Label Period|Pregnancy|0|||
27818972|NCT00048581|81170101|FG001|Open-Label Period|Pregnancy|0|||
27818973|NCT00048581|81170102|FG002|Open-Label Period|Pregnancy|7|||
27818974|NCT00048581|81170100|FG000|Open-Label Period|Study Site Closure|0|||
27818975|NCT00048581|81170101|FG001|Open-Label Period|Study Site Closure|0|||
27818976|NCT00048581|81170102|FG002|Open-Label Period|Study Site Closure|2|||
27818977|NCT00048581|81170100|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
27818978|NCT00048581|81170101|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
27818979|NCT00048581|81170102|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
27818980|NCT00048581|81170100|FG000|Open-Label Period|Problem With Transportation To Site|0|||
27818981|NCT00048581|81170101|FG001|Open-Label Period|Problem With Transportation To Site|0|||
27592170|NCT01388816|80348578|FG001|Overall Study|Lost to Follow-up|1|||
27592171|NCT01388816|80348579|FG002|Overall Study|Lost to Follow-up|0|||
27592172|NCT01388816|80348580|FG003|Overall Study|Lost to Follow-up|0|||
27592173|NCT01388816|80348577|FG000|Overall Study|Withdrawal by Subject|2|||
27818982|NCT00048581|81170102|FG002|Open-Label Period|Problem With Transportation To Site|1|||
27818983|NCT00048581|81170100|FG000|Open-Label Period|Primary Investigator Retired|0|||
27880597|NCT03526861|81394520|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880598|NCT03526861|81394521|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880599|NCT03526861|81394522|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880600|NCT03526861|81394523|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880601|NCT03526861|81394524|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
27880602|NCT03526861|81394525|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
27880603|NCT03526861|81394517|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880604|NCT03526861|81394518|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880605|NCT03526861|81394519|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880606|NCT03526861|81394520|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880607|NCT03526861|81394521|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880608|NCT03526861|81394522|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880609|NCT03526861|81394523|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880610|NCT03526861|81394524|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
27880611|NCT03526861|81394525|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
27880612|NCT00113763|81394526|FG000|Overall Study|Adverse Event|5|||
27880613|NCT00113763|81394527|FG001|Overall Study|Adverse Event|2|||
27880614|NCT00113763|81394526|FG000|Overall Study|Disease Progression|28|||
27880615|NCT00113763|81394527|FG001|Overall Study|Disease Progression|14|||
27880616|NCT00113763|81394526|FG000|Overall Study|Lost to Follow-up|10|||
27880617|NCT00113763|81394527|FG001|Overall Study|Lost to Follow-up|0|||
27880618|NCT00113763|81394526|FG000|Overall Study|Withdrawal by Subject|1|||
27880619|NCT00113763|81394527|FG001|Overall Study|Withdrawal by Subject|4|||
27880620|NCT00113763|81394526|FG000|Overall Study|Other|27|||
27880621|NCT00113763|81394527|FG001|Overall Study|Other|6|||
27880622|NCT00113763|81394526|FG000|Overall Study|Non-compliance|1|||
27880623|NCT00113763|81394527|FG001|Overall Study|Non-compliance|0|||
27880624|NCT00113763|81394526|FG000|Overall Study|Ongoing|1|||
27880625|NCT00113763|81394527|FG001|Overall Study|Ongoing|0|||
27880626|NCT01749826|81394528|FG000|Overall Study|Study Terminated|20|||
27880627|NCT01749826|81394529|FG001|Overall Study|Study Terminated|0|||
27880628|NCT00463047|81394531|FG000|Titration Period 1|Adverse Event|10|||
27880629|NCT00463047|81394532|FG001|Titration Period 1|Adverse Event|8|||
27880630|NCT00463047|81394531|FG000|Titration Period 1|Lack of Efficacy|10|||
27880631|NCT00463047|81394532|FG001|Titration Period 1|Lack of Efficacy|4|||
27880632|NCT00463047|81394531|FG000|Titration Period 1|Lost to Follow-up|2|||
27880633|NCT00463047|81394532|FG001|Titration Period 1|Lost to Follow-up|0|||
27880634|NCT00463047|81394531|FG000|Titration Period 1|Non-compliance with study medication|3|||
27880635|NCT00463047|81394532|FG001|Titration Period 1|Non-compliance with study medication|5|||
27592174|NCT01388816|80348578|FG001|Overall Study|Withdrawal by Subject|1|||
27592175|NCT01388816|80348579|FG002|Overall Study|Withdrawal by Subject|1|||
27592176|NCT01388816|80348580|FG003|Overall Study|Withdrawal by Subject|0|||
27592177|NCT01388816|80348577|FG000|Overall Study|Protocol Violation|0|||
27592178|NCT01388816|80348578|FG001|Overall Study|Protocol Violation|0|||
27880636|NCT00463047|81394531|FG000|Titration Period 1|Protocol Violation|5|||
27880637|NCT00463047|81394532|FG001|Titration Period 1|Protocol Violation|5|||
27880638|NCT00463047|81394531|FG000|Titration Period 1|Withdrawal by Subject|3|||
27880639|NCT00463047|81394532|FG001|Titration Period 1|Withdrawal by Subject|5|||
27880640|NCT00463047|81394531|FG000|Titration Period 1|Non-compliance procedures|4|||
27880641|NCT00463047|81394532|FG001|Titration Period 1|Non-compliance procedures|10|||
27880642|NCT00463047|81394531|FG000|Titration Period 1|Other|0|||
27880643|NCT00463047|81394532|FG001|Titration Period 1|Other|2|||
27880644|NCT00463047|81394531|FG000|Titration Period 2|Adverse Event|9|||
27880645|NCT00463047|81394532|FG001|Titration Period 2|Adverse Event|9|||
27592179|NCT01388816|80348579|FG002|Overall Study|Protocol Violation|2|||
27592180|NCT01388816|80348580|FG003|Overall Study|Protocol Violation|0|||
27592181|NCT03147248|80348581|FG000|Overall Study|Adverse Event|0|||
27592182|NCT03147248|80348582|FG001|Overall Study|Adverse Event|2|||
27592183|NCT03147248|80348583|FG002|Overall Study|Adverse Event|2|||
27592184|NCT03147248|80348584|FG003|Overall Study|Adverse Event|2|||
27592185|NCT03147248|80348585|FG004|Overall Study|Adverse Event|6|||
27592186|NCT03147248|80348586|FG005|Overall Study|Adverse Event|11|||
27592187|NCT03147248|80348581|FG000|Overall Study|Disease progression|1|||
27592188|NCT03147248|80348582|FG001|Overall Study|Disease progression|0|||
27592189|NCT03147248|80348583|FG002|Overall Study|Disease progression|0|||
27592190|NCT03147248|80348584|FG003|Overall Study|Disease progression|0|||
27592191|NCT03147248|80348585|FG004|Overall Study|Disease progression|0|||
27592192|NCT03147248|80348586|FG005|Overall Study|Disease progression|2|||
27592193|NCT03147248|80348581|FG000|Overall Study|Withdrawal by Subject|0|||
27592194|NCT03147248|80348582|FG001|Overall Study|Withdrawal by Subject|0|||
27592195|NCT03147248|80348583|FG002|Overall Study|Withdrawal by Subject|0|||
27592196|NCT03147248|80348584|FG003|Overall Study|Withdrawal by Subject|0|||
27592197|NCT03147248|80348585|FG004|Overall Study|Withdrawal by Subject|12|||
27592198|NCT03147248|80348586|FG005|Overall Study|Withdrawal by Subject|9|||
27592199|NCT03147248|80348581|FG000|Overall Study|Protocol Violation|0|||
27592200|NCT03147248|80348582|FG001|Overall Study|Protocol Violation|0|||
27592201|NCT03147248|80348583|FG002|Overall Study|Protocol Violation|0|||
27592202|NCT03147248|80348584|FG003|Overall Study|Protocol Violation|0|||
27592203|NCT03147248|80348585|FG004|Overall Study|Protocol Violation|2|||
27592204|NCT03147248|80348586|FG005|Overall Study|Protocol Violation|0|||
27592205|NCT03147248|80348581|FG000|Overall Study|Lost to Follow-up|0|||
27592206|NCT03147248|80348582|FG001|Overall Study|Lost to Follow-up|0|||
27592207|NCT03147248|80348583|FG002|Overall Study|Lost to Follow-up|0|||
27592208|NCT03147248|80348584|FG003|Overall Study|Lost to Follow-up|0|||
27592209|NCT03147248|80348585|FG004|Overall Study|Lost to Follow-up|2|||
27592210|NCT03147248|80348586|FG005|Overall Study|Lost to Follow-up|0|||
27592211|NCT03147248|80348581|FG000|Overall Study|Pregnancy|0|||
27592212|NCT03147248|80348582|FG001|Overall Study|Pregnancy|0|||
27592213|NCT03147248|80348583|FG002|Overall Study|Pregnancy|0|||
27592214|NCT03147248|80348584|FG003|Overall Study|Pregnancy|0|||
27592215|NCT03147248|80348585|FG004|Overall Study|Pregnancy|1|||
27592216|NCT03147248|80348586|FG005|Overall Study|Pregnancy|0|||
27592217|NCT03147248|80348581|FG000|Overall Study|Death|0|||
27592218|NCT03147248|80348582|FG001|Overall Study|Death|0|||
27592219|NCT03147248|80348583|FG002|Overall Study|Death|0|||
27592220|NCT03147248|80348584|FG003|Overall Study|Death|0|||
27592221|NCT03147248|80348585|FG004|Overall Study|Death|0|||
27592222|NCT03147248|80348586|FG005|Overall Study|Death|4|||
27592223|NCT03147248|80348581|FG000|Overall Study|Physician Decision|0|||
27592224|NCT03147248|80348582|FG001|Overall Study|Physician Decision|0|||
27592225|NCT03147248|80348583|FG002|Overall Study|Physician Decision|0|||
27592226|NCT03147248|80348584|FG003|Overall Study|Physician Decision|0|||
27592227|NCT03147248|80348585|FG004|Overall Study|Physician Decision|2|||
27592228|NCT03147248|80348586|FG005|Overall Study|Physician Decision|4|||
27592229|NCT03147248|80348581|FG000|Overall Study|Prolonged Dosing Interval|0|||
27592230|NCT03147248|80348582|FG001|Overall Study|Prolonged Dosing Interval|0|||
27592231|NCT03147248|80348583|FG002|Overall Study|Prolonged Dosing Interval|0|||
27592232|NCT03147248|80348584|FG003|Overall Study|Prolonged Dosing Interval|0|||
27592233|NCT03147248|80348585|FG004|Overall Study|Prolonged Dosing Interval|1|||
27592234|NCT03147248|80348586|FG005|Overall Study|Prolonged Dosing Interval|1|||
27592235|NCT01349569|80348589|FG000|Overall Study|Lack of Efficacy|4|||
27592236|NCT01453595|80348593|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27592237|NCT01453595|80348594|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27592238|NCT01453595|80348595|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27592239|NCT02298192|80348596|FG000|Overall Study|Unclassified|3|||
27592240|NCT02298192|80348597|FG001|Overall Study|Unclassified|2|||
27592241|NCT02298192|80348596|FG000|Overall Study|Withdrawal criteria|2|||
27592242|NCT02298192|80348597|FG001|Overall Study|Withdrawal criteria|0|||
27592243|NCT02298192|80348596|FG000|Overall Study|Withdrawal by Subject|6|||
27880646|NCT00463047|81394531|FG000|Titration Period 2|Lack of Efficacy|6|||
27880647|NCT00463047|81394532|FG001|Titration Period 2|Lack of Efficacy|4|||
27880648|NCT00463047|81394531|FG000|Titration Period 2|Withdrawal by Subject|1|||
27880649|NCT00463047|81394532|FG001|Titration Period 2|Withdrawal by Subject|0|||
27880650|NCT00463047|81394531|FG000|Titration Period 2|Protocol Violation|2|||
27880651|NCT00463047|81394532|FG001|Titration Period 2|Protocol Violation|3|||
27880652|NCT00463047|81394531|FG000|Titration Period 2|Lost to Follow-up|1|||
27880653|NCT00463047|81394532|FG001|Titration Period 2|Lost to Follow-up|2|||
27880654|NCT00463047|81394531|FG000|Titration Period 2|Non-compliance study medication|4|||
27592244|NCT02298192|80348597|FG001|Overall Study|Withdrawal by Subject|1|||
27880655|NCT00463047|81394532|FG001|Titration Period 2|Non-compliance study medication|2|||
27592245|NCT02298192|80348596|FG000|Overall Study|Lost to Follow-up|2|||
27592246|NCT02298192|80348597|FG001|Overall Study|Lost to Follow-up|1|||
27592247|NCT02298192|80348596|FG000|Overall Study|Adverse Event|6|||
27592248|NCT02298192|80348597|FG001|Overall Study|Adverse Event|2|||
27592249|NCT00381940|80348598|FG000|Overall Study|Lack of Efficacy|3|||
27592250|NCT00381940|80348598|FG000|Overall Study|Protocol Violation|1|||
27592251|NCT00381940|80348598|FG000|Overall Study|Ineligible|1|||
27592252|NCT03166618|80348599|FG000|Overall Study|Study was Terminated|0|||
27592253|NCT03166618|80348600|FG001|Overall Study|Study was Terminated|1|||
27592254|NCT00717860|80348601|FG000|Overall Study|Clinical adverse experience|5|||
27592255|NCT00717860|80348602|FG001|Overall Study|Clinical adverse experience|9|||
27693554|NCT00505284|80713689|FG004|Overall Study|Adverse Event|22|||
27818984|NCT00048581|81170101|FG001|Open-Label Period|Primary Investigator Retired|0|||
27818985|NCT00048581|81170102|FG002|Open-Label Period|Primary Investigator Retired|2|||
27818986|NCT00048581|81170100|FG000|Open-Label Period|Study Ended By Sponsor|0|||
27818987|NCT00048581|81170101|FG001|Open-Label Period|Study Ended By Sponsor|0|||
27818988|NCT00048581|81170102|FG002|Open-Label Period|Study Ended By Sponsor|1|||
27818989|NCT01492361|81170103|FG000|Overall Study|Withdrawal by Subject|281|||
27818990|NCT01492361|81170104|FG001|Overall Study|Withdrawal by Subject|297|||
27818991|NCT01492361|81170103|FG000|Overall Study|Physician Decision|12|||
27818992|NCT01492361|81170104|FG001|Overall Study|Physician Decision|12|||
27818993|NCT01492361|81170103|FG000|Overall Study|Lost to Follow-up|6|||
27818994|NCT01492361|81170104|FG001|Overall Study|Lost to Follow-up|13|||
27818995|NCT01492361|81170103|FG000|Overall Study|Other than specified above|106|||
27818996|NCT01492361|81170104|FG001|Overall Study|Other than specified above|138|||
27818997|NCT00686959|81170105|FG000|Overall Study|Participants censored (no death events)|124|||
27818998|NCT00686959|81170106|FG001|Overall Study|Participants censored (no death events)|117|||
27818999|NCT00313703|81170114|FG000|Overall Study|Lost to Follow-up|11|||
27819000|NCT00313703|81170115|FG001|Overall Study|Lost to Follow-up|2|||
27819001|NCT00313703|81170116|FG002|Overall Study|Lost to Follow-up|5|||
27819002|NCT00313703|81170117|FG003|Overall Study|Lost to Follow-up|12|||
27819003|NCT02178722|81170118|FG000|Overall Study|Withdrawal by Subject|0|||
27819004|NCT02178722|81170119|FG001|Overall Study|Withdrawal by Subject|0|||
27819005|NCT02178722|81170120|FG002|Overall Study|Withdrawal by Subject|0|||
27819006|NCT02178722|81170121|FG003|Overall Study|Withdrawal by Subject|2|||
27819007|NCT02178722|81170122|FG004|Overall Study|Withdrawal by Subject|33|||
27819008|NCT02178722|81170118|FG000|Overall Study|Death|2|||
27819009|NCT02178722|81170119|FG001|Overall Study|Death|13|||
27819010|NCT02178722|81170120|FG002|Overall Study|Death|12|||
27819011|NCT02178722|81170121|FG003|Overall Study|Death|12|||
27819012|NCT02178722|81170122|FG004|Overall Study|Death|205|||
27819013|NCT02178722|81170118|FG000|Overall Study|Lost to Follow-up|0|||
27819014|NCT02178722|81170119|FG001|Overall Study|Lost to Follow-up|0|||
27819015|NCT02178722|81170120|FG002|Overall Study|Lost to Follow-up|0|||
27819016|NCT02178722|81170121|FG003|Overall Study|Lost to Follow-up|2|||
27819017|NCT02178722|81170122|FG004|Overall Study|Lost to Follow-up|11|||
27819018|NCT02178722|81170118|FG000|Overall Study|Study terminated by Sponsor|2|||
27819019|NCT02178722|81170119|FG001|Overall Study|Study terminated by Sponsor|7|||
27819020|NCT02178722|81170120|FG002|Overall Study|Study terminated by Sponsor|6|||
27819021|NCT02178722|81170121|FG003|Overall Study|Study terminated by Sponsor|4|||
27819022|NCT02178722|81170122|FG004|Overall Study|Study terminated by Sponsor|128|||
27819023|NCT02178722|81170118|FG000|Overall Study|Physician Decision|0|||
27819024|NCT02178722|81170119|FG001|Overall Study|Physician Decision|0|||
27819025|NCT02178722|81170120|FG002|Overall Study|Physician Decision|0|||
27819026|NCT02178722|81170121|FG003|Overall Study|Physician Decision|0|||
27819027|NCT02178722|81170122|FG004|Overall Study|Physician Decision|3|||
27819028|NCT02178722|81170118|FG000|Overall Study|Other|0|||
27819029|NCT02178722|81170119|FG001|Overall Study|Other|0|||
27819030|NCT02178722|81170120|FG002|Overall Study|Other|0|||
27819031|NCT02178722|81170121|FG003|Overall Study|Other|0|||
27819032|NCT02178722|81170122|FG004|Overall Study|Other|2|||
27819033|NCT01703832|81170123|FG000|Overall Study|Withdrawal by Subject|1|||
27819034|NCT01703832|81170124|FG001|Overall Study|Withdrawal by Subject|0|||
27819035|NCT01434693|81170125|FG000|Overall Study|Adverse Event|1|||
27819036|NCT01434693|81170126|FG001|Overall Study|Adverse Event|0|||
27880656|NCT00463047|81394531|FG000|Titration Period 2|Non-compliance procedures|4|||
27693555|NCT00505284|80713685|FG000|Overall Study|Protocol Violation|0|||
27819037|NCT01434693|81170127|FG002|Overall Study|Adverse Event|0|||
27819038|NCT01434693|81170128|FG003|Overall Study|Adverse Event|0|||
27819039|NCT01434693|81170125|FG000|Overall Study|Withdrawal by Subject|1|||
27819040|NCT01434693|81170126|FG001|Overall Study|Withdrawal by Subject|0|||
27819041|NCT01434693|81170127|FG002|Overall Study|Withdrawal by Subject|1|||
27819042|NCT01434693|81170128|FG003|Overall Study|Withdrawal by Subject|1|||
27819043|NCT01434693|81170125|FG000|Overall Study|Lost to Follow-up|1|||
27819044|NCT01434693|81170126|FG001|Overall Study|Lost to Follow-up|0|||
27819045|NCT01434693|81170127|FG002|Overall Study|Lost to Follow-up|0|||
27819046|NCT01434693|81170128|FG003|Overall Study|Lost to Follow-up|0|||
27819047|NCT04625114|81170133|FG000|Overall Study|Adverse Event|3|||
27819048|NCT04625114|81170134|FG001|Overall Study|Adverse Event|1|||
27819049|NCT04625114|81170133|FG000|Overall Study|Withdrawal by Subject|2|||
27819050|NCT04625114|81170134|FG001|Overall Study|Withdrawal by Subject|0|||
27819051|NCT01626079|81170135|FG000|Overall Study|Death|167|||
27819052|NCT01626079|81170136|FG001|Overall Study|Death|192|||
27819053|NCT01626079|81170137|FG002|Overall Study|Death|39|||
27819054|NCT01626079|81170135|FG000|Overall Study|Withdrawal by Subject|23|||
27819055|NCT01626079|81170136|FG001|Overall Study|Withdrawal by Subject|37|||
27819056|NCT01626079|81170137|FG002|Overall Study|Withdrawal by Subject|5|||
27819057|NCT01626079|81170135|FG000|Overall Study|Lost to Follow-up|7|||
27819058|NCT01626079|81170136|FG001|Overall Study|Lost to Follow-up|4|||
27819059|NCT01626079|81170137|FG002|Overall Study|Lost to Follow-up|2|||
27819060|NCT01626079|81170135|FG000|Overall Study|Missed Visits|1|||
27819061|NCT01626079|81170136|FG001|Overall Study|Missed Visits|4|||
27819062|NCT01626079|81170137|FG002|Overall Study|Missed Visits|6|||
27819063|NCT01790568|81170140|FG000|Overall Study|Progression prior to transplant|0|||
27819064|NCT01790568|81170141|FG001|Overall Study|Progression prior to transplant|1|||
27819065|NCT01734772|81170142|FG000|Overall Study|Adverse Event|1|||
27819066|NCT01734772|81170143|FG001|Overall Study|Adverse Event|2|||
27819067|NCT01734772|81170142|FG000|Overall Study|Withdrawal by Subject|0|||
27819068|NCT01734772|81170143|FG001|Overall Study|Withdrawal by Subject|1|||
27819069|NCT02796664|81170145|FG000|Overall Study|Withdrawal by Subject|0|||
27819070|NCT02796664|81170146|FG001|Overall Study|Withdrawal by Subject|3|||
27819071|NCT02796664|81170145|FG000|Overall Study|Noncompliance|1|||
27819072|NCT02796664|81170146|FG001|Overall Study|Noncompliance|1|||
27819073|NCT02796664|81170145|FG000|Overall Study|Death|0|||
27819074|NCT02796664|81170146|FG001|Overall Study|Death|1|||
27819075|NCT01203878|81170151|FG000|Overall Study|Withdrawal by Subject|0|||
27819076|NCT01203878|81170152|FG001|Overall Study|Withdrawal by Subject|0|||
27592256|NCT00717860|80348601|FG000|Overall Study|Laboratory adverse experience|2|||
27592257|NCT00717860|80348602|FG001|Overall Study|Laboratory adverse experience|2|||
27592258|NCT00717860|80348601|FG000|Overall Study|Lack of Efficacy|7|||
27592259|NCT00717860|80348602|FG001|Overall Study|Lack of Efficacy|13|||
27592260|NCT00717860|80348601|FG000|Overall Study|Discontinued for other reason|6|||
27592261|NCT00717860|80348602|FG001|Overall Study|Discontinued for other reason|1|||
27819077|NCT01203878|81170153|FG002|Overall Study|Withdrawal by Subject|1|||
27819078|NCT01203878|81170151|FG000|Overall Study|Adverse Event|0|||
27819079|NCT01203878|81170152|FG001|Overall Study|Adverse Event|0|||
27819080|NCT01203878|81170153|FG002|Overall Study|Adverse Event|2|||
27819081|NCT02246920|81170155|FG000|Overall Study|Adverse Event|3|||
27819082|NCT02246920|81170156|FG001|Overall Study|Adverse Event|1|||
27819083|NCT02246920|81170157|FG002|Overall Study|Adverse Event|1|||
27819084|NCT02246920|81170155|FG000|Overall Study|Lost to Follow-up|2|||
27819085|NCT02246920|81170156|FG001|Overall Study|Lost to Follow-up|1|||
27819086|NCT02246920|81170157|FG002|Overall Study|Lost to Follow-up|0|||
27880657|NCT00463047|81394532|FG001|Titration Period 2|Non-compliance procedures|1|||
27880658|NCT00463047|81394531|FG000|Titration Period 2|Other|3|||
27880659|NCT00463047|81394532|FG001|Titration Period 2|Other|2|||
27880660|NCT00463047|81394531|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
27880661|NCT00463047|81394532|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
27880662|NCT00463047|81394531|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
27880663|NCT00463047|81394532|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
27880664|NCT00463047|81394531|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
27880665|NCT00463047|81394532|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
27880666|NCT00463047|81394531|FG000|Double-Blind Treatment Period 1|Other|1|||
27880667|NCT00463047|81394532|FG001|Double-Blind Treatment Period 1|Other|0|||
27880668|NCT00463047|81394531|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
27880669|NCT00463047|81394532|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
27880670|NCT00463047|81394531|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
27880671|NCT00463047|81394532|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
27880672|NCT00463047|81394531|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
27880673|NCT00463047|81394532|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
27880674|NCT03588910|81394533|FG000|Overall Study|Withdrawal by Subject|1|||
27592262|NCT00717860|80348601|FG000|Overall Study|Withdrew consent|7|||
27592263|NCT00717860|80348602|FG001|Overall Study|Withdrew consent|3|||
27819087|NCT02246920|81170155|FG000|Overall Study|Protocol Violation|2|||
27819088|NCT02246920|81170156|FG001|Overall Study|Protocol Violation|5|||
27819089|NCT02246920|81170157|FG002|Overall Study|Protocol Violation|1|||
27880675|NCT03588910|81394534|FG001|Overall Study|Withdrawal by Subject|0|||
27592264|NCT00263666|80348604|FG000|Overall Study|Adverse Event|6|||
27819090|NCT02246920|81170155|FG000|Overall Study|Withdrawal by Subject|0|||
27819091|NCT02246920|81170156|FG001|Overall Study|Withdrawal by Subject|0|||
27819092|NCT02246920|81170157|FG002|Overall Study|Withdrawal by Subject|1|||
27592265|NCT00263666|80348605|FG001|Overall Study|Adverse Event|8|||
27592266|NCT00263666|80348604|FG000|Overall Study|Lost to Follow-up|1|||
27592267|NCT00263666|80348605|FG001|Overall Study|Lost to Follow-up|2|||
27819093|NCT02173704|81170158|FG000|Overall Study|Adverse Event|1|||
27819094|NCT02173704|81170159|FG001|Overall Study|Adverse Event|0|||
27819095|NCT02173704|81170158|FG000|Overall Study|Lost to Follow-up|1|||
27819096|NCT02173704|81170159|FG001|Overall Study|Lost to Follow-up|0|||
27819097|NCT02173704|81170158|FG000|Overall Study|Other|1|||
27819098|NCT02173704|81170159|FG001|Overall Study|Other|0|||
27819099|NCT02173704|81170158|FG000|Overall Study|Protocol Violation|1|||
27819100|NCT02173704|81170159|FG001|Overall Study|Protocol Violation|0|||
27819101|NCT02173704|81170158|FG000|Overall Study|Withdrawal by Subject|9|||
27819102|NCT02173704|81170159|FG001|Overall Study|Withdrawal by Subject|4|||
27819103|NCT00001849|81170164|FG000|Overall Study|Death|4|||
27819104|NCT00001849|81170164|FG000|Overall Study|Lost to Follow-up|2|||
27819105|NCT00001849|81170164|FG000|Overall Study|Withdrawal by Subject|2|||
27819106|NCT00001849|81170164|FG000|Overall Study|tumor remained occult|6|||
27819107|NCT05419908|81170165|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
27819108|NCT05419908|81170166|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
27819109|NCT05419908|81170165|FG000|Overall Study|Serious Adverse Event|0|||
27819110|NCT05419908|81170166|FG001|Overall Study|Serious Adverse Event|2|||
27819111|NCT05419908|81170165|FG000|Overall Study|Withdrawal by Subject|2|||
27819112|NCT05419908|81170166|FG001|Overall Study|Withdrawal by Subject|0|||
27819113|NCT05419908|81170165|FG000|Overall Study|Miscellaneous|1|||
27819114|NCT05419908|81170166|FG001|Overall Study|Miscellaneous|1|||
27819115|NCT03583606|81170167|FG000|Overall Study|Lost to Follow-up|0|||
27819116|NCT03583606|81170168|FG001|Overall Study|Lost to Follow-up|1|||
27819117|NCT03583606|81170169|FG002|Overall Study|Lost to Follow-up|0|||
27819118|NCT03583606|81170167|FG000|Overall Study|Ineligible at baseline|1|||
27592268|NCT00263666|80348604|FG000|Overall Study|Withdrawal by Subject|0|||
27592269|NCT00263666|80348605|FG001|Overall Study|Withdrawal by Subject|1|||
27592270|NCT05224050|80348609|FG000|Overall Study|Withdrawal by Subject|9|||
27819119|NCT03583606|81170168|FG001|Overall Study|Ineligible at baseline|0|||
27819120|NCT03583606|81170169|FG002|Overall Study|Ineligible at baseline|0|||
27592271|NCT05224050|80348609|FG000|Overall Study|Lost to Follow-up|3|||
27819121|NCT02906709|81170170|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
27819122|NCT02906709|81170171|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
27819123|NCT02906709|81170170|FG000|Phase A (Week 0 to Week 16)|Death|0|||
27819124|NCT02906709|81170171|FG001|Phase A (Week 0 to Week 16)|Death|1|||
27819125|NCT02906709|81170170|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
27819126|NCT02906709|81170171|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
27819127|NCT02906709|81170170|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
27819128|NCT02906709|81170171|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
27819129|NCT02216071|81170172|FG000|Overall Study|Withdrawal by Subject|7|||
27819130|NCT02216071|81170173|FG001|Overall Study|Withdrawal by Subject|2|||
27819131|NCT02216071|81170172|FG000|Overall Study|Lost to Follow-up|3|||
27819132|NCT02216071|81170173|FG001|Overall Study|Lost to Follow-up|3|||
27880676|NCT03588910|81394533|FG000|Overall Study|Allergy|2|||
27880677|NCT03588910|81394534|FG001|Overall Study|Allergy|0|||
27880678|NCT03588910|81394533|FG000|Overall Study|Protocol Violation|0|||
27880679|NCT03588910|81394534|FG001|Overall Study|Protocol Violation|3|||
27880680|NCT03588910|81394533|FG000|Overall Study|Did not complete Day 1 Survey|5|||
27880681|NCT03588910|81394534|FG001|Overall Study|Did not complete Day 1 Survey|10|||
27880682|NCT03588910|81394533|FG000|Overall Study|Did not complete Day 7 Survey|5|||
27880683|NCT03588910|81394534|FG001|Overall Study|Did not complete Day 7 Survey|2|||
27880684|NCT02547220|81394535|FG000|Overall Study|Withdrawal by Subject|1|||
27880685|NCT02547220|81394536|FG001|Overall Study|Withdrawal by Subject|0|||
27880686|NCT02547220|81394535|FG000|Overall Study|Study terminated by sponsor|18|||
27819133|NCT02216071|81170172|FG000|Overall Study|Protocol Violation|3|||
27880687|NCT02547220|81394536|FG001|Overall Study|Study terminated by sponsor|20|||
27880688|NCT04013672|81394540|FG000|Overall Study|Withdrawal by Subject|3|||
27819134|NCT02216071|81170173|FG001|Overall Study|Protocol Violation|5|||
27880689|NCT04013672|81394541|FG001|Overall Study|Withdrawal by Subject|0|||
27880690|NCT04013672|81394540|FG000|Overall Study|Death|1|||
27880691|NCT04013672|81394541|FG001|Overall Study|Death|0|||
27880692|NCT04013672|81394540|FG000|Overall Study|Physician Decision|5|||
27819135|NCT02216071|81170172|FG000|Overall Study|Other|2|||
27819136|NCT02216071|81170173|FG001|Overall Study|Other|2|||
27819137|NCT02166697|81170174|FG000|Overall Study|Protocol Violation|347|||
27819138|NCT03361228|81170177|FG000|Overall Study|Other|1|||
27819139|NCT03361228|81170178|FG001|Overall Study|Other|1|||
27819140|NCT03361228|81170177|FG000|Overall Study|Death|3|||
27819141|NCT03361228|81170178|FG001|Overall Study|Death|0|||
27819142|NCT01179048|81170183|FG000|Overall Study|Withdrawn - does not allow contact|4|||
27819143|NCT01179048|81170184|FG001|Overall Study|Withdrawn - does not allow contact|8|||
27819144|NCT01179048|81170183|FG000|Overall Study|Lost to Follow-up|8|||
27819145|NCT01179048|81170184|FG001|Overall Study|Lost to Follow-up|9|||
27819146|NCT01179048|81170183|FG000|Overall Study|Alive|127|||
27819147|NCT01179048|81170184|FG001|Overall Study|Alive|142|||
27819148|NCT01781637|81170185|FG000|Overall Study|Adverse Event|1|||
27880693|NCT04013672|81394541|FG001|Overall Study|Physician Decision|0|||
27880694|NCT01294696|81394542|FG000|Overall Study|Screening failures|7|||
27880695|NCT01294696|81394542|FG000|Overall Study|Protocol Violation|8|||
27880696|NCT01294696|81394542|FG000|Overall Study|Missing BPI Response|7|||
27880697|NCT01294696|81394542|FG000|Overall Study|Site closure|52|||
27880698|NCT00630825|81394545|FG000|Overall Study|Adverse Event|4|||
27880699|NCT00630825|81394546|FG001|Overall Study|Adverse Event|4|||
27880700|NCT00630825|81394547|FG002|Overall Study|Adverse Event|3|||
27880701|NCT00630825|81394548|FG003|Overall Study|Adverse Event|1|||
27880702|NCT00630825|81394545|FG000|Overall Study|Entry Criteria Not Met|1|||
27880703|NCT00630825|81394546|FG001|Overall Study|Entry Criteria Not Met|0|||
27880704|NCT00630825|81394547|FG002|Overall Study|Entry Criteria Not Met|2|||
27819149|NCT01781637|81170186|FG001|Overall Study|Adverse Event|0|||
27819150|NCT01781637|81170185|FG000|Overall Study|Lack of Efficacy|2|||
27819151|NCT01781637|81170186|FG001|Overall Study|Lack of Efficacy|6|||
27819152|NCT01781637|81170185|FG000|Overall Study|Withdrawal by Subject|1|||
27880705|NCT00630825|81394548|FG003|Overall Study|Entry Criteria Not Met|1|||
27880706|NCT00630825|81394545|FG000|Overall Study|Lost to Follow-up|1|||
27880707|NCT00630825|81394546|FG001|Overall Study|Lost to Follow-up|1|||
27592272|NCT03585244|80348610|FG000|Overall Study|Withdrawal by Subject|15|||
27592273|NCT01990950|80348612|FG000|Overall Study|Death|3|||
27592274|NCT01990950|80348612|FG000|Overall Study|Lost to Follow-up|2|||
27592275|NCT01990950|80348612|FG000|Overall Study|Withdrawal by Subject|6|||
27592276|NCT01650259|80348613|FG000|Overall Study|Improvement|105|||
27592277|NCT01650259|80348614|FG001|Overall Study|Improvement|0|||
27592278|NCT01650259|80348613|FG000|Overall Study|Adverse Event|127|||
27592279|NCT01650259|80348614|FG001|Overall Study|Adverse Event|0|||
27592280|NCT01650259|80348613|FG000|Overall Study|Lack of Efficacy|143|||
27592281|NCT01650259|80348614|FG001|Overall Study|Lack of Efficacy|0|||
27592282|NCT01650259|80348613|FG000|Overall Study|Lost to Follow-up|435|||
27592283|NCT01650259|80348614|FG001|Overall Study|Lost to Follow-up|0|||
27693556|NCT00505284|80713686|FG001|Overall Study|Protocol Violation|1|||
27693557|NCT00505284|80713687|FG002|Overall Study|Protocol Violation|1|||
27693558|NCT00505284|80713688|FG003|Overall Study|Protocol Violation|0|||
27693559|NCT00505284|80713689|FG004|Overall Study|Protocol Violation|0|||
27819153|NCT01781637|81170186|FG001|Overall Study|Withdrawal by Subject|0|||
27819154|NCT02079532|81170189|FG000|Overall Study|Adverse Event|7|||
27819155|NCT02079532|81170189|FG000|Overall Study|Additional or changed therapy|2|||
27592284|NCT01650259|80348613|FG000|Overall Study|Patients had no visit after entry|70|||
27693560|NCT00505284|80713685|FG000|Overall Study|Withdrawal by Subject|2|||
27693561|NCT00505284|80713686|FG001|Overall Study|Withdrawal by Subject|6|||
27693562|NCT00505284|80713687|FG002|Overall Study|Withdrawal by Subject|1|||
27819156|NCT02079532|81170189|FG000|Overall Study|Lack of Efficacy|9|||
27819157|NCT02079532|81170189|FG000|Overall Study|Protocol Violation|3|||
27819158|NCT02079532|81170189|FG000|Overall Study|Withdrawal by Subject|1|||
27819159|NCT02079532|81170189|FG000|Overall Study|Administrative problems|1|||
27819160|NCT02079532|81170189|FG000|Overall Study|Inclusion into ReFIRST|3|||
27819161|NCT02079532|81170189|FG000|Overall Study|Other|3|||
27819162|NCT00854100|81170190|FG000|Overall Study|Inability to complete the study visits|0|||
27819163|NCT00854100|81170191|FG001|Overall Study|Inability to complete the study visits|0|||
27819164|NCT00854100|81170192|FG002|Overall Study|Inability to complete the study visits|1|||
27819165|NCT00854100|81170190|FG000|Overall Study|Lost to Follow-up|2|||
27880708|NCT00630825|81394547|FG002|Overall Study|Lost to Follow-up|1|||
27880709|NCT00630825|81394548|FG003|Overall Study|Lost to Follow-up|1|||
27880710|NCT00630825|81394545|FG000|Overall Study|Physician Decision|1|||
27880711|NCT00630825|81394546|FG001|Overall Study|Physician Decision|0|||
27880712|NCT00630825|81394547|FG002|Overall Study|Physician Decision|0|||
27880713|NCT00630825|81394548|FG003|Overall Study|Physician Decision|0|||
27880714|NCT00630825|81394545|FG000|Overall Study|Withdrawal by Subject|2|||
27880715|NCT00630825|81394546|FG001|Overall Study|Withdrawal by Subject|2|||
27880716|NCT00630825|81394547|FG002|Overall Study|Withdrawal by Subject|2|||
27592285|NCT01650259|80348614|FG001|Overall Study|Patients had no visit after entry|0|||
27592286|NCT01650259|80348613|FG000|Overall Study|CRF not collected|98|||
27592287|NCT01650259|80348614|FG001|Overall Study|CRF not collected|82|||
27693563|NCT00505284|80713688|FG003|Overall Study|Withdrawal by Subject|0|||
27693564|NCT00505284|80713689|FG004|Overall Study|Withdrawal by Subject|6|||
27880717|NCT00630825|81394548|FG003|Overall Study|Withdrawal by Subject|3|||
27880718|NCT00078767|81394552|FG000|Overall Study|Withdrawal by Subject|1|||
27880719|NCT00078767|81394553|FG001|Overall Study|Withdrawal by Subject|1|||
27592288|NCT01650259|80348613|FG000|Overall Study|Not treated|1|||
27592289|NCT01650259|80348614|FG001|Overall Study|Not treated|7|||
27592290|NCT01650259|80348613|FG000|Overall Study|Other than listed|64|||
27592291|NCT01650259|80348614|FG001|Overall Study|Other than listed|146|||
27592292|NCT02384954|80348615|FG000|Phase 1|Progressive Disease|2|||
27592293|NCT02384954|80348616|FG001|Phase 1|Progressive Disease|0|||
27592294|NCT02384954|80348617|FG002|Phase 1|Progressive Disease|1|||
27592295|NCT02384954|80348618|FG003|Phase 1|Progressive Disease|1|||
27592296|NCT02384954|80348619|FG004|Phase 1|Progressive Disease|0|||
27592297|NCT02384954|80348620|FG005|Phase 1|Progressive Disease|0|||
27592298|NCT02384954|80348621|FG006|Phase 1|Progressive Disease|0|||
27592299|NCT02384954|80348622|FG007|Phase 1|Progressive Disease|0|||
27592300|NCT02384954|80348623|FG008|Phase 1|Progressive Disease|0|||
27592301|NCT02384954|80348615|FG000|Phase 1|Adverse Event|0|||
27592302|NCT02384954|80348616|FG001|Phase 1|Adverse Event|0|||
27592303|NCT02384954|80348617|FG002|Phase 1|Adverse Event|1|||
27592304|NCT02384954|80348618|FG003|Phase 1|Adverse Event|0|||
27693565|NCT00505284|80713685|FG000|Overall Study|Lack of Efficacy|0|||
27693566|NCT00505284|80713686|FG001|Overall Study|Lack of Efficacy|1|||
27693567|NCT00505284|80713687|FG002|Overall Study|Lack of Efficacy|1|||
27693568|NCT00505284|80713688|FG003|Overall Study|Lack of Efficacy|1|||
27693569|NCT00505284|80713689|FG004|Overall Study|Lack of Efficacy|1|||
27693570|NCT00505284|80713685|FG000|Overall Study|Physician Decision|0|||
27693571|NCT00505284|80713686|FG001|Overall Study|Physician Decision|1|||
27693572|NCT00505284|80713687|FG002|Overall Study|Physician Decision|0|||
27693573|NCT00505284|80713688|FG003|Overall Study|Physician Decision|0|||
27693574|NCT00505284|80713689|FG004|Overall Study|Physician Decision|0|||
27693575|NCT00505284|80713685|FG000|Overall Study|Other|5|||
27693576|NCT00505284|80713686|FG001|Overall Study|Other|0|||
27693577|NCT00505284|80713687|FG002|Overall Study|Other|0|||
27693578|NCT00505284|80713688|FG003|Overall Study|Other|4|||
27819166|NCT00854100|81170191|FG001|Overall Study|Lost to Follow-up|0|||
27819167|NCT00854100|81170192|FG002|Overall Study|Lost to Follow-up|3|||
27819168|NCT00854100|81170190|FG000|Overall Study|Withdrawal by Subject|3|||
27819169|NCT00854100|81170191|FG001|Overall Study|Withdrawal by Subject|1|||
27819170|NCT00854100|81170192|FG002|Overall Study|Withdrawal by Subject|2|||
27819171|NCT00854100|81170190|FG000|Overall Study|Protocol Violation|2|||
27819172|NCT00854100|81170191|FG001|Overall Study|Protocol Violation|4|||
27819173|NCT00854100|81170192|FG002|Overall Study|Protocol Violation|3|||
27819174|NCT00854100|81170190|FG000|Overall Study|Adverse Event|2|||
27819175|NCT00854100|81170191|FG001|Overall Study|Adverse Event|1|||
27819176|NCT00854100|81170192|FG002|Overall Study|Adverse Event|2|||
27819177|NCT03338972|81170194|FG000|Overall Study|Death|1|||
27819178|NCT03338972|81170195|FG001|Overall Study|Death|1|||
27819179|NCT03338972|81170196|FG002|Overall Study|Death|0|||
27819180|NCT03338972|81170197|FG003|Overall Study|Death|0|||
27819181|NCT03338972|81170194|FG000|Overall Study|Withdrawal by Subject|1|||
27819182|NCT03338972|81170195|FG001|Overall Study|Withdrawal by Subject|0|||
27819183|NCT03338972|81170196|FG002|Overall Study|Withdrawal by Subject|0|||
27819184|NCT03338972|81170197|FG003|Overall Study|Withdrawal by Subject|0|||
27819185|NCT00854308|81170198|FG000|Overall Study|Disease progression|42|||
27819186|NCT00854308|81170199|FG001|Overall Study|Disease progression|50|||
27819187|NCT00854308|81170198|FG000|Overall Study|Adverse Event|8|||
27819188|NCT00854308|81170199|FG001|Overall Study|Adverse Event|3|||
27819189|NCT00854308|81170198|FG000|Overall Study|Death|2|||
27819190|NCT00854308|81170199|FG001|Overall Study|Death|5|||
27819191|NCT00854308|81170198|FG000|Overall Study|Physician Decision|6|||
27819192|NCT00854308|81170199|FG001|Overall Study|Physician Decision|6|||
27819193|NCT00854308|81170198|FG000|Overall Study|Withdrawal by Subject|4|||
27819194|NCT00854308|81170199|FG001|Overall Study|Withdrawal by Subject|2|||
27693579|NCT00505284|80713689|FG004|Overall Study|Other|4|||
27693580|NCT00887432|80713690|FG000|Overall Study|Start Excluded Therapy|3|||
27693581|NCT00887432|80713691|FG001|Overall Study|Start Excluded Therapy|0|||
27693582|NCT00887432|80713690|FG000|Overall Study|Did not complete treatment|6|||
27693583|NCT00887432|80713691|FG001|Overall Study|Did not complete treatment|8|||
27693584|NCT00887432|80713690|FG000|Overall Study|Protocol Violation|2|||
27693585|NCT00887432|80713691|FG001|Overall Study|Protocol Violation|3|||
27880720|NCT02907177|81394554|FG000|Overall Study|Death|0|||
27880721|NCT02907177|81394555|FG001|Overall Study|Death|1|||
27880722|NCT02907177|81394554|FG000|Overall Study|Physician Decision|3|||
27880723|NCT02907177|81394555|FG001|Overall Study|Physician Decision|3|||
27880724|NCT02907177|81394554|FG000|Overall Study|Withdrawal by Subject|15|||
27880725|NCT02907177|81394555|FG001|Overall Study|Withdrawal by Subject|7|||
27880726|NCT02907177|81394554|FG000|Overall Study|Sponsor's Decision|50|||
27880727|NCT02907177|81394555|FG001|Overall Study|Sponsor's Decision|57|||
27880728|NCT01611935|81394556|FG000|Overall Study|Family Declined Participation|1|||
27880729|NCT01611935|81394557|FG001|Overall Study|Family Declined Participation|0|||
27880730|NCT00651261|81394558|FG000|Overall Study|Adverse Event|32|||
27880731|NCT00651261|81394559|FG001|Overall Study|Adverse Event|22|||
27880732|NCT00651261|81394558|FG000|Overall Study|Death|18|||
27880733|NCT00651261|81394559|FG001|Overall Study|Death|18|||
27880734|NCT00651261|81394558|FG000|Overall Study|Withdrawal by Subject|22|||
27880735|NCT00651261|81394559|FG001|Overall Study|Withdrawal by Subject|40|||
27693586|NCT00887432|80713690|FG000|Overall Study|Withdrawal by Subject|3|||
27693587|NCT00887432|80713691|FG001|Overall Study|Withdrawal by Subject|2|||
27693588|NCT00887432|80713690|FG000|Overall Study|Lost to Follow-up|1|||
27693589|NCT00887432|80713691|FG001|Overall Study|Lost to Follow-up|0|||
27693590|NCT00887432|80713690|FG000|Overall Study|No reason provided|0|||
27693591|NCT00887432|80713691|FG001|Overall Study|No reason provided|1|||
27693592|NCT02076178|80713692|FG000|Oral Phase|Adverse Event|0|||
27819195|NCT00854308|81170198|FG000|Overall Study|Sponsor's decision to terminate study|0|||
27592305|NCT02384954|80348619|FG004|Phase 1|Adverse Event|0|||
27592306|NCT02384954|80348620|FG005|Phase 1|Adverse Event|0|||
27592307|NCT02384954|80348621|FG006|Phase 1|Adverse Event|0|||
27592308|NCT02384954|80348622|FG007|Phase 1|Adverse Event|0|||
27592309|NCT02384954|80348623|FG008|Phase 1|Adverse Event|0|||
27592310|NCT02384954|80348615|FG000|Phase 2|Progressive Disease|0|||
27592311|NCT02384954|80348616|FG001|Phase 2|Progressive Disease|0|||
27592312|NCT02384954|80348617|FG002|Phase 2|Progressive Disease|0|||
27592313|NCT02384954|80348618|FG003|Phase 2|Progressive Disease|0|||
27592314|NCT02384954|80348619|FG004|Phase 2|Progressive Disease|0|||
27592315|NCT02384954|80348620|FG005|Phase 2|Progressive Disease|0|||
27592316|NCT02384954|80348621|FG006|Phase 2|Progressive Disease|0|||
27592317|NCT02384954|80348622|FG007|Phase 2|Progressive Disease|1|||
27592318|NCT02384954|80348623|FG008|Phase 2|Progressive Disease|2|||
27592319|NCT02384954|80348615|FG000|Phase 2|Adverse Event|0|||
27592320|NCT02384954|80348616|FG001|Phase 2|Adverse Event|0|||
27592321|NCT02384954|80348617|FG002|Phase 2|Adverse Event|0|||
27592322|NCT02384954|80348618|FG003|Phase 2|Adverse Event|0|||
27592323|NCT02384954|80348619|FG004|Phase 2|Adverse Event|0|||
27592324|NCT02384954|80348620|FG005|Phase 2|Adverse Event|0|||
27592325|NCT02384954|80348621|FG006|Phase 2|Adverse Event|0|||
27592326|NCT02384954|80348622|FG007|Phase 2|Adverse Event|1|||
27592327|NCT02384954|80348623|FG008|Phase 2|Adverse Event|1|||
27592328|NCT02384954|80348615|FG000|Phase 2|Failure to meet continuation criteria|0|||
27592329|NCT02384954|80348616|FG001|Phase 2|Failure to meet continuation criteria|0|||
27819196|NCT00854308|81170199|FG001|Overall Study|Sponsor's decision to terminate study|1|||
27819197|NCT01735630|81170200|FG000|Overall Study|Adverse Event|8|||
27819198|NCT01735630|81170201|FG001|Overall Study|Adverse Event|7|||
27819199|NCT01735630|81170200|FG000|Overall Study|Lost to Follow-up|1|||
27819200|NCT01735630|81170201|FG001|Overall Study|Lost to Follow-up|0|||
27819201|NCT01735630|81170200|FG000|Overall Study|Physician Decision|0|||
27819202|NCT01735630|81170201|FG001|Overall Study|Physician Decision|1|||
27819203|NCT01735630|81170200|FG000|Overall Study|Sponsor Decision|2|||
27819204|NCT01735630|81170201|FG001|Overall Study|Sponsor Decision|1|||
27819205|NCT01735630|81170200|FG000|Overall Study|Withdrawal by Subject|7|||
27592330|NCT02384954|80348617|FG002|Phase 2|Failure to meet continuation criteria|0|||
27592331|NCT02384954|80348618|FG003|Phase 2|Failure to meet continuation criteria|0|||
27819206|NCT01735630|81170201|FG001|Overall Study|Withdrawal by Subject|9|||
27592332|NCT02384954|80348619|FG004|Phase 2|Failure to meet continuation criteria|0|||
27592333|NCT02384954|80348620|FG005|Phase 2|Failure to meet continuation criteria|0|||
27693593|NCT02076178|80713693|FG001|Oral Phase|Adverse Event|7|||
27693594|NCT02076178|80713692|FG000|Oral Phase|Withdrawal by Subject|0|||
27693595|NCT02076178|80713693|FG001|Oral Phase|Withdrawal by Subject|4|||
27693596|NCT02076178|80713692|FG000|Oral Phase|Physician Decision|0|||
27819207|NCT02920996|81170202|FG000|Overall Study|Adverse Event|8|||
27880736|NCT00651261|81394558|FG000|Overall Study|Induction failure|24|||
27880737|NCT00651261|81394559|FG001|Overall Study|Induction failure|35|||
27880738|NCT00651261|81394558|FG000|Overall Study|Disease progression|58|||
27880739|NCT00651261|81394559|FG001|Overall Study|Disease progression|58|||
27880740|NCT00651261|81394558|FG000|Overall Study|Alternative therapy|109|||
27693597|NCT02076178|80713693|FG001|Oral Phase|Physician Decision|1|||
27693598|NCT02076178|80713692|FG000|Injection Phase|Protocol defined stopping criteria|1|||
27693599|NCT02076178|80713693|FG001|Injection Phase|Protocol defined stopping criteria|0|||
27693600|NCT02076178|80713692|FG000|Injection Phase|Withdrawal by Subject|0|||
27693601|NCT02076178|80713693|FG001|Injection Phase|Withdrawal by Subject|3|||
27693602|NCT02076178|80713692|FG000|Injection Phase|Physician Decision|0|||
27693603|NCT02076178|80713693|FG001|Injection Phase|Physician Decision|3|||
27693604|NCT02076178|80713692|FG000|Injection Phase|Lost to Follow-up|0|||
27693605|NCT02076178|80713693|FG001|Injection Phase|Lost to Follow-up|1|||
27693606|NCT02935452|80713694|FG000|Overall Study|work and life commintment|3|||
27693607|NCT02935452|80713695|FG001|Overall Study|work and life commintment|1|||
27693608|NCT02075541|80713696|FG000|Overall Study|Serious Adverse Event|1|||
27880741|NCT00651261|81394559|FG001|Overall Study|Alternative therapy|107|||
27880742|NCT00651261|81394558|FG000|Overall Study|Other disease or participant decisions|23|||
27880743|NCT00651261|81394559|FG001|Overall Study|Other disease or participant decisions|23|||
27592334|NCT02384954|80348621|FG006|Phase 2|Failure to meet continuation criteria|0|||
27592335|NCT02384954|80348622|FG007|Phase 2|Failure to meet continuation criteria|1|||
27880744|NCT00651261|81394558|FG000|Overall Study|Never treated|5|||
27880745|NCT00651261|81394559|FG001|Overall Study|Never treated|3|||
27880746|NCT02169271|81394564|FG000|Overall Study|Protocol Violation|1|||
27880747|NCT02169271|81394565|FG001|Overall Study|Protocol Violation|2|||
27880748|NCT04577404|81394568|FG000|Overall Study|Adverse Event|31|||
27880749|NCT04577404|81394568|FG000|Overall Study|Death|1|||
27880750|NCT04577404|81394568|FG000|Overall Study|Lack of Efficacy|3|||
27880751|NCT04577404|81394568|FG000|Overall Study|Physician Decision|7|||
27880752|NCT04577404|81394568|FG000|Overall Study|Withdrawal by Subject|21|||
27880753|NCT04577404|81394568|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
27880754|NCT01778530|81397766|FG000|Overall Study|Progression on study|1|||
27880755|NCT01778530|81397766|FG000|Overall Study|Adverse event/side effect|1|||
27880756|NCT01464333|81397767|FG000|Overall Study|Adverse Event|34|||
27880757|NCT01464333|81397767|FG000|Overall Study|Lack of Efficacy|72|||
27880758|NCT01464333|81397767|FG000|Overall Study|Withdrawal by Subject|11|||
27880759|NCT01464333|81397767|FG000|Overall Study|Other|4|||
27880760|NCT01464333|81397767|FG000|Overall Study|No Hospital Visit|42|||
27880761|NCT06110494|81397768|FG000|Overall Study|Protocol Violation|2|||
27880762|NCT06110494|81397769|FG001|Overall Study|Protocol Violation|0|||
27880763|NCT06110494|81397770|FG002|Overall Study|Protocol Violation|1|||
27880764|NCT06110494|81397768|FG000|Overall Study|Dixon's test for outlier analysis|1|||
27880765|NCT06110494|81397769|FG001|Overall Study|Dixon's test for outlier analysis|1|||
27880766|NCT06110494|81397770|FG002|Overall Study|Dixon's test for outlier analysis|0|||
27880767|NCT04578457|81397771|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
27880768|NCT04578457|81397771|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
27880769|NCT04578457|81397771|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
27880770|NCT04578457|81397771|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
27592336|NCT02384954|80348623|FG008|Phase 2|Failure to meet continuation criteria|0|||
27592337|NCT03643952|80348628|FG000|Overall Study|Lack of Efficacy|1|||
27880771|NCT00686829|81397776|FG000|Overall Study|Adverse Event|5|||
27592338|NCT03568318|80348629|FG000|Overall Study|Adverse Event|3|||
27592339|NCT03568318|80348630|FG001|Overall Study|Adverse Event|1|||
27880772|NCT00686829|81397776|FG000|Overall Study|Lack of Efficacy|6|||
27693609|NCT02075541|80713697|FG001|Overall Study|Serious Adverse Event|4|||
27693610|NCT02075541|80713696|FG000|Overall Study|Protocol Violation|1|||
27880773|NCT00686829|81397776|FG000|Overall Study|Lost to Follow-up|4|||
27819208|NCT02920996|81170203|FG001|Overall Study|Adverse Event|0|||
27819209|NCT02920996|81170202|FG000|Overall Study|Physician Decision|1|||
27819210|NCT02920996|81170203|FG001|Overall Study|Physician Decision|0|||
27819211|NCT02920996|81170202|FG000|Overall Study|Death|1|||
27819212|NCT02920996|81170203|FG001|Overall Study|Death|0|||
27819213|NCT02920996|81170202|FG000|Overall Study|Missing|1|||
27819214|NCT02920996|81170203|FG001|Overall Study|Missing|0|||
27819215|NCT02920996|81170202|FG000|Overall Study|Subject Non-Compliance|1|||
27819216|NCT02920996|81170203|FG001|Overall Study|Subject Non-Compliance|0|||
27819217|NCT02458638|81170204|FG000|Overall Study|Death|309|||
27819218|NCT02458638|81170204|FG000|Overall Study|End of Cohort/End of Study|67|||
27819219|NCT02458638|81170204|FG000|Overall Study|Lost to Follow-up|31|||
27819220|NCT02458638|81170204|FG000|Overall Study|Other Reasons|4|||
27819221|NCT02458638|81170204|FG000|Overall Study|Physician Decision|1|||
27819222|NCT02458638|81170204|FG000|Overall Study|Withdrawal by Subject|47|||
27819223|NCT01239121|81170205|FG000|Overall Study|Withdrawal by Subject|2|||
27819224|NCT01239121|81170206|FG001|Overall Study|Withdrawal by Subject|4|||
27819225|NCT01239121|81170207|FG002|Overall Study|Withdrawal by Subject|0|||
27819226|NCT00486837|81170208|FG000|Overall Study|Withdrawal by Subject|1|||
27819227|NCT00486837|81170209|FG001|Overall Study|Withdrawal by Subject|0|||
27819228|NCT00486837|81170208|FG000|Overall Study|Adverse Event|1|||
27819229|NCT00486837|81170209|FG001|Overall Study|Adverse Event|1|||
27819230|NCT00486837|81170208|FG000|Overall Study|Protocol Violation|4|||
27819231|NCT00486837|81170209|FG001|Overall Study|Protocol Violation|2|||
27819232|NCT00486837|81170208|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
27819233|NCT00486837|81170209|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
27819234|NCT00395226|81170210|FG000|Overall Study|Adverse Event|4|||
27819235|NCT00395226|81170211|FG001|Overall Study|Adverse Event|3|||
27819236|NCT00395226|81170210|FG000|Overall Study|Withdrawal by Subject|0|||
27819237|NCT00395226|81170211|FG001|Overall Study|Withdrawal by Subject|1|||
27819238|NCT00395226|81170210|FG000|Overall Study|Lost to Follow-up|0|||
27819239|NCT00395226|81170211|FG001|Overall Study|Lost to Follow-up|1|||
27819240|NCT00304083|81170212|FG000|Overall Study|Withdrawal by Subject|4|||
27819241|NCT00304083|81170213|FG001|Overall Study|Withdrawal by Subject|2|||
27819242|NCT00304083|81170212|FG000|Overall Study|Physician Decision|8|||
27819243|NCT00304083|81170213|FG001|Overall Study|Physician Decision|3|||
27819244|NCT00304083|81170212|FG000|Overall Study|Disease Progression|5|||
27819245|NCT00304083|81170213|FG001|Overall Study|Disease Progression|1|||
27819246|NCT00304083|81170212|FG000|Overall Study|Other|5|||
27819247|NCT00304083|81170213|FG001|Overall Study|Other|2|||
27819248|NCT01044732|81170216|FG000|Overall Study|Lost to Follow-up|2|||
27819249|NCT01044732|81170217|FG001|Overall Study|Lost to Follow-up|1|||
27819250|NCT01044732|81170216|FG000|Overall Study|Physician Decision|5|||
27819251|NCT01044732|81170217|FG001|Overall Study|Physician Decision|3|||
27819252|NCT01044732|81170216|FG000|Overall Study|Protocol Violation|11|||
27819253|NCT01044732|81170217|FG001|Overall Study|Protocol Violation|12|||
27819254|NCT01044732|81170216|FG000|Overall Study|Withdrawal by Subject|0|||
27819255|NCT01044732|81170217|FG001|Overall Study|Withdrawal by Subject|1|||
27819256|NCT01044732|81170216|FG000|Overall Study|Inadequate bowel preparation|11|||
27819257|NCT01044732|81170217|FG001|Overall Study|Inadequate bowel preparation|17|||
27819258|NCT01044732|81170216|FG000|Overall Study|Inability to reach cecum|5|||
27819259|NCT01044732|81170217|FG001|Overall Study|Inability to reach cecum|2|||
27819260|NCT01044732|81170216|FG000|Overall Study|Technical error or malfunction|15|||
27819261|NCT01044732|81170217|FG001|Overall Study|Technical error or malfunction|14|||
27819262|NCT03561883|81170218|FG000|Overall Study|Adverse Event|10|||
27819263|NCT03561883|81170219|FG001|Overall Study|Adverse Event|13|||
27819264|NCT03561883|81170218|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27819265|NCT03561883|81170219|FG001|Overall Study|Non-Compliance With Study Drug|2|||
27819266|NCT03561883|81170218|FG000|Overall Study|Protocol Violation|2|||
27819267|NCT03561883|81170219|FG001|Overall Study|Protocol Violation|3|||
27819268|NCT03561883|81170218|FG000|Overall Study|Withdrawal by Subject|14|||
27819269|NCT03561883|81170219|FG001|Overall Study|Withdrawal by Subject|6|||
27819270|NCT03561883|81170218|FG000|Overall Study|Lost to Follow-up|2|||
27819271|NCT03561883|81170219|FG001|Overall Study|Lost to Follow-up|6|||
27819272|NCT03561883|81170218|FG000|Overall Study|Study Terminated by Sponsor|12|||
27819273|NCT03561883|81170219|FG001|Overall Study|Study Terminated by Sponsor|11|||
27819274|NCT03561883|81170218|FG000|Overall Study|Physician Decision|1|||
27819275|NCT03561883|81170219|FG001|Overall Study|Physician Decision|0|||
27819276|NCT03561883|81170218|FG000|Overall Study|Randomized by Mistake|1|||
27819277|NCT03561883|81170219|FG001|Overall Study|Randomized by Mistake|0|||
27819278|NCT03561883|81170218|FG000|Overall Study|Other, Not Specified|3|||
27819279|NCT03561883|81170219|FG001|Overall Study|Other, Not Specified|2|||
27592340|NCT03568318|80348631|FG002|Overall Study|Adverse Event|1|||
27592341|NCT03568318|80348632|FG003|Overall Study|Adverse Event|0|||
27819280|NCT02848326|81172346|FG000|Treatment Period|Adverse Event|5|||
27819281|NCT02848326|81172347|FG001|Treatment Period|Adverse Event|4|||
27819282|NCT02848326|81172348|FG002|Treatment Period|Adverse Event|11|||
27819283|NCT02848326|81172349|FG003|Treatment Period|Adverse Event|6|||
27819284|NCT02848326|81172350|FG004|Treatment Period|Adverse Event|5|||
27693611|NCT02075541|80713697|FG001|Overall Study|Protocol Violation|0|||
27693612|NCT02075541|80713696|FG000|Overall Study|Withdrawal by Subject|1|||
27693613|NCT02075541|80713697|FG001|Overall Study|Withdrawal by Subject|3|||
27693614|NCT02075541|80713696|FG000|Overall Study|Sponsor study termination|0|||
27693615|NCT02075541|80713697|FG001|Overall Study|Sponsor study termination|1|||
27693616|NCT02075541|80713696|FG000|Overall Study|Other- unable to perform study procedure|1|||
27880774|NCT00686829|81397776|FG000|Overall Study|Withdrawal by Subject|14|||
27880775|NCT00686829|81397776|FG000|Overall Study|Protocol Violation|3|||
27880776|NCT00686829|81397776|FG000|Overall Study|Sponsor discontinued VCV|47|||
27880777|NCT00789373|81397777|FG000|Induction|Adverse Event|64|||
27880778|NCT00789373|81397778|FG001|Induction|Adverse Event|0|||
27880779|NCT00789373|81397779|FG002|Induction|Adverse Event|0|||
27880780|NCT00789373|81397777|FG000|Induction|Death Due to study disease|24|||
27880781|NCT00789373|81397778|FG001|Induction|Death Due to study disease|0|||
27880782|NCT00789373|81397779|FG002|Induction|Death Due to study disease|0|||
27880783|NCT00789373|81397777|FG000|Induction|Death due to adverse event|19|||
27880784|NCT00789373|81397778|FG001|Induction|Death due to adverse event|0|||
27880785|NCT00789373|81397779|FG002|Induction|Death due to adverse event|0|||
27693617|NCT02075541|80713697|FG001|Overall Study|Other- unable to perform study procedure|0|||
27693618|NCT03536754|80713698|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
27693619|NCT03536754|80713699|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
27693620|NCT03536754|80713700|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
27693621|NCT03536754|80713701|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
27693622|NCT03536754|80713702|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
27693623|NCT03536754|80713698|FG000|Open Label Extension|Other|0|||
27693624|NCT03536754|80713699|FG001|Open Label Extension|Other|0|||
27819285|NCT02848326|81172351|FG005|Treatment Period|Adverse Event|7|||
27819286|NCT02848326|81172346|FG000|Treatment Period|Withdrawal of Consent|20|||
27819287|NCT02848326|81172347|FG001|Treatment Period|Withdrawal of Consent|6|||
27819288|NCT02848326|81172348|FG002|Treatment Period|Withdrawal of Consent|9|||
27819289|NCT02848326|81172349|FG003|Treatment Period|Withdrawal of Consent|6|||
27819290|NCT02848326|81172350|FG004|Treatment Period|Withdrawal of Consent|9|||
27819291|NCT02848326|81172351|FG005|Treatment Period|Withdrawal of Consent|6|||
27819292|NCT02848326|81172346|FG000|Treatment Period|Lost to Follow-up|5|||
27819293|NCT02848326|81172347|FG001|Treatment Period|Lost to Follow-up|1|||
27819294|NCT02848326|81172348|FG002|Treatment Period|Lost to Follow-up|11|||
27880786|NCT00789373|81397777|FG000|Induction|Death due to toxicity|11|||
27880787|NCT00789373|81397778|FG001|Induction|Death due to toxicity|0|||
27880788|NCT00789373|81397779|FG002|Induction|Death due to toxicity|0|||
27693625|NCT03536754|80713700|FG002|Open Label Extension|Other|0|||
27880789|NCT00789373|81397777|FG000|Induction|Death due to procedure|1|||
27880790|NCT00789373|81397778|FG001|Induction|Death due to procedure|0|||
27880791|NCT00789373|81397779|FG002|Induction|Death due to procedure|0|||
27880792|NCT00789373|81397777|FG000|Induction|Investigator decision|7|||
27880793|NCT00789373|81397778|FG001|Induction|Investigator decision|0|||
27693626|NCT03536754|80713701|FG003|Open Label Extension|Other|0|||
27693627|NCT03536754|80713702|FG004|Open Label Extension|Other|1|||
27819295|NCT02848326|81172349|FG003|Treatment Period|Lost to Follow-up|7|||
27819296|NCT02848326|81172350|FG004|Treatment Period|Lost to Follow-up|2|||
27880794|NCT00789373|81397779|FG002|Induction|Investigator decision|0|||
27693628|NCT01145755|80713703|FG000|Overall Study|Adverse Event|2|||
27693629|NCT01145755|80713704|FG001|Overall Study|Adverse Event|4|||
27693630|NCT01145755|80713705|FG002|Overall Study|Adverse Event|2|||
27693631|NCT01145755|80713703|FG000|Overall Study|Withdrawal by Subject|2|||
27819297|NCT02848326|81172351|FG005|Treatment Period|Lost to Follow-up|3|||
27819298|NCT02848326|81172346|FG000|Treatment Period|Pregnancy|0|||
27819299|NCT02848326|81172347|FG001|Treatment Period|Pregnancy|0|||
27819300|NCT02848326|81172348|FG002|Treatment Period|Pregnancy|1|||
27819301|NCT02848326|81172349|FG003|Treatment Period|Pregnancy|1|||
27819302|NCT02848326|81172350|FG004|Treatment Period|Pregnancy|0|||
27819303|NCT02848326|81172351|FG005|Treatment Period|Pregnancy|1|||
27819304|NCT02848326|81172346|FG000|Treatment Period|Protocol Violation|4|||
27819305|NCT02848326|81172347|FG001|Treatment Period|Protocol Violation|3|||
27819306|NCT02848326|81172348|FG002|Treatment Period|Protocol Violation|4|||
27880795|NCT00789373|81397777|FG000|Induction|Protocol entry criteria not met|9|||
27880796|NCT00789373|81397778|FG001|Induction|Protocol entry criteria not met|0|||
27880797|NCT00789373|81397779|FG002|Induction|Protocol entry criteria not met|0|||
27880798|NCT00789373|81397777|FG000|Induction|Lost to Follow-up|6|||
27880799|NCT00789373|81397778|FG001|Induction|Lost to Follow-up|0|||
27880800|NCT00789373|81397779|FG002|Induction|Lost to Follow-up|0|||
27880801|NCT00789373|81397777|FG000|Induction|Protocol Violation|1|||
27880802|NCT00789373|81397778|FG001|Induction|Protocol Violation|0|||
27880803|NCT00789373|81397779|FG002|Induction|Protocol Violation|0|||
27880804|NCT00789373|81397777|FG000|Induction|Progressive Disease|220|||
27880805|NCT00789373|81397778|FG001|Induction|Progressive Disease|0|||
27880806|NCT00789373|81397779|FG002|Induction|Progressive Disease|0|||
27880807|NCT00789373|81397777|FG000|Induction|Withdrawal by Subject|37|||
27880808|NCT00789373|81397778|FG001|Induction|Withdrawal by Subject|0|||
27880809|NCT00789373|81397779|FG002|Induction|Withdrawal by Subject|0|||
27880810|NCT00789373|81397777|FG000|Maintenance|Adverse Event|0|||
27880811|NCT00789373|81397778|FG001|Maintenance|Adverse Event|65|||
27880812|NCT00789373|81397779|FG002|Maintenance|Adverse Event|12|||
27880813|NCT00789373|81397777|FG000|Maintenance|Death due to study disease|0|||
27880814|NCT00789373|81397778|FG001|Maintenance|Death due to study disease|3|||
27880815|NCT00789373|81397779|FG002|Maintenance|Death due to study disease|1|||
27880816|NCT00789373|81397777|FG000|Maintenance|Death due to adverse event|0|||
27880817|NCT00789373|81397778|FG001|Maintenance|Death due to adverse event|4|||
27880818|NCT00789373|81397779|FG002|Maintenance|Death due to adverse event|1|||
27880819|NCT00789373|81397777|FG000|Maintenance|Death due to toxicity|0|||
27880820|NCT00789373|81397778|FG001|Maintenance|Death due to toxicity|1|||
27880821|NCT00789373|81397779|FG002|Maintenance|Death due to toxicity|2|||
27880822|NCT00789373|81397777|FG000|Maintenance|Investigator Decision|0|||
27819307|NCT02848326|81172349|FG003|Treatment Period|Protocol Violation|2|||
27819308|NCT02848326|81172350|FG004|Treatment Period|Protocol Violation|3|||
27819309|NCT02848326|81172351|FG005|Treatment Period|Protocol Violation|3|||
27819310|NCT02848326|81172346|FG000|Treatment Period|Non-compliance with Study Drug|4|||
27819311|NCT02848326|81172347|FG001|Treatment Period|Non-compliance with Study Drug|0|||
27819312|NCT02848326|81172348|FG002|Treatment Period|Non-compliance with Study Drug|0|||
27819313|NCT02848326|81172349|FG003|Treatment Period|Non-compliance with Study Drug|1|||
27880823|NCT00789373|81397778|FG001|Maintenance|Investigator Decision|4|||
27880824|NCT00789373|81397779|FG002|Maintenance|Investigator Decision|2|||
27819314|NCT02848326|81172350|FG004|Treatment Period|Non-compliance with Study Drug|0|||
27819315|NCT02848326|81172351|FG005|Treatment Period|Non-compliance with Study Drug|0|||
27819316|NCT02848326|81172346|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
27819317|NCT02848326|81172347|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
27819318|NCT02848326|81172348|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
27819319|NCT02848326|81172349|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
27880825|NCT00789373|81397777|FG000|Maintenance|Protocol entry criteria not met|0|||
27880826|NCT00789373|81397778|FG001|Maintenance|Protocol entry criteria not met|2|||
27880827|NCT00789373|81397779|FG002|Maintenance|Protocol entry criteria not met|0|||
27880828|NCT00789373|81397777|FG000|Maintenance|Lost to Follow-up|0|||
27880829|NCT00789373|81397778|FG001|Maintenance|Lost to Follow-up|2|||
27880830|NCT00789373|81397779|FG002|Maintenance|Lost to Follow-up|0|||
27693632|NCT01145755|80713704|FG001|Overall Study|Withdrawal by Subject|2|||
27880831|NCT00789373|81397777|FG000|Maintenance|Progressive Disease|0|||
27880832|NCT00789373|81397778|FG001|Maintenance|Progressive Disease|253|||
27592342|NCT03568318|80348633|FG004|Overall Study|Adverse Event|1|||
27880833|NCT00789373|81397779|FG002|Maintenance|Progressive Disease|152|||
27880834|NCT00789373|81397777|FG000|Maintenance|Withdrawal by Subject|0|||
27880835|NCT00789373|81397778|FG001|Maintenance|Withdrawal by Subject|21|||
27880836|NCT00789373|81397779|FG002|Maintenance|Withdrawal by Subject|8|||
27880837|NCT00789373|81397777|FG000|Maintenance|Sponsor Decision|0|||
27880838|NCT00789373|81397778|FG001|Maintenance|Sponsor Decision|0|||
27880839|NCT00789373|81397779|FG002|Maintenance|Sponsor Decision|2|||
27880840|NCT00789373|81397777|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
27880841|NCT00789373|81397778|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
27880842|NCT00789373|81397779|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
27880843|NCT00427648|81397789|FG000|Overall Study|Protocol Violation|1|||
27880844|NCT00427648|81397790|FG001|Overall Study|Protocol Violation|2|||
27880845|NCT00427648|81397789|FG000|Overall Study|Adverse Event|0|||
27880846|NCT00427648|81397790|FG001|Overall Study|Adverse Event|1|||
27880847|NCT01346059|81397791|FG000|Overall Study|Withdrawal by Subject|1|||
27880848|NCT01346059|81397792|FG001|Overall Study|Withdrawal by Subject|0|||
27819320|NCT02848326|81172350|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
27819321|NCT02848326|81172351|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
27819322|NCT02848326|81172346|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
27819323|NCT02848326|81172347|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
27819324|NCT02848326|81172348|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
27819325|NCT02848326|81172349|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
27819326|NCT02848326|81172350|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
27819327|NCT02848326|81172351|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
27819328|NCT02480764|81172358|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
27819329|NCT02480764|81172359|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
27819330|NCT02480764|81172360|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
27819331|NCT02480764|81172358|FG000|Overall Study|Major Protocol Deviation|1|||
27819332|NCT02480764|81172359|FG001|Overall Study|Major Protocol Deviation|4|||
27819333|NCT02480764|81172360|FG002|Overall Study|Major Protocol Deviation|3|||
27819334|NCT02480764|81172358|FG000|Overall Study|Lost to Follow-up|0|||
27819335|NCT02480764|81172359|FG001|Overall Study|Lost to Follow-up|1|||
27819336|NCT02480764|81172360|FG002|Overall Study|Lost to Follow-up|2|||
27819337|NCT02480764|81172358|FG000|Overall Study|Voluntary Withdrawal|6|||
27819338|NCT02480764|81172359|FG001|Overall Study|Voluntary Withdrawal|5|||
27819339|NCT02480764|81172360|FG002|Overall Study|Voluntary Withdrawal|10|||
27819340|NCT02480764|81172358|FG000|Overall Study|Lack of Efficacy|0|||
27819341|NCT02480764|81172359|FG001|Overall Study|Lack of Efficacy|3|||
27819342|NCT02480764|81172360|FG002|Overall Study|Lack of Efficacy|3|||
27819343|NCT02480764|81172358|FG000|Overall Study|Reason not Specified|0|||
27819344|NCT02480764|81172359|FG001|Overall Study|Reason not Specified|1|||
27819345|NCT02480764|81172360|FG002|Overall Study|Reason not Specified|0|||
27819346|NCT00105196|81172361|FG000|Overall Study|Lack of Efficacy|2|||
27819347|NCT00105196|81172362|FG001|Overall Study|Lack of Efficacy|3|||
27819348|NCT00105196|81172361|FG000|Overall Study|Adverse Event|11|||
27819349|NCT00105196|81172362|FG001|Overall Study|Adverse Event|3|||
27819350|NCT00105196|81172361|FG000|Overall Study|Withdrawal by Subject|6|||
27819351|NCT00105196|81172362|FG001|Overall Study|Withdrawal by Subject|6|||
27819352|NCT00105196|81172361|FG000|Overall Study|Lost to Follow-up|3|||
27819353|NCT00105196|81172362|FG001|Overall Study|Lost to Follow-up|2|||
27819354|NCT00105196|81172361|FG000|Overall Study|Poor/noncompliance|3|||
27819355|NCT00105196|81172362|FG001|Overall Study|Poor/noncompliance|4|||
27819356|NCT00105196|81172361|FG000|Overall Study|Protocol Violation|5|||
27819357|NCT00105196|81172362|FG001|Overall Study|Protocol Violation|2|||
27880849|NCT02612623|81397793|FG000|Overall Study|Withdrawal by Subject|0|||
27880850|NCT02612623|81397794|FG001|Overall Study|Withdrawal by Subject|1|||
27880851|NCT02612623|81397795|FG002|Overall Study|Withdrawal by Subject|0|||
27880852|NCT02612623|81397796|FG003|Overall Study|Withdrawal by Subject|0|||
27592343|NCT03568318|80348634|FG005|Overall Study|Adverse Event|0|||
27592344|NCT03568318|80348629|FG000|Overall Study|Withdrawal by Subject|6|||
27819358|NCT00105196|81172361|FG000|Overall Study|pending surgery|0|||
27592345|NCT03568318|80348630|FG001|Overall Study|Withdrawal by Subject|5|||
27592346|NCT03568318|80348631|FG002|Overall Study|Withdrawal by Subject|2|||
27592347|NCT03568318|80348632|FG003|Overall Study|Withdrawal by Subject|1|||
27693633|NCT01145755|80713705|FG002|Overall Study|Withdrawal by Subject|2|||
27880853|NCT02612623|81397793|FG000|Overall Study|Adverse Event|1|||
27880854|NCT02612623|81397794|FG001|Overall Study|Adverse Event|0|||
27880855|NCT02612623|81397795|FG002|Overall Study|Adverse Event|1|||
27880856|NCT02612623|81397796|FG003|Overall Study|Adverse Event|0|||
27880857|NCT03482453|81397797|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880858|NCT03482453|81397798|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880859|NCT03482453|81397799|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880860|NCT03482453|81397800|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880861|NCT03482453|81397801|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880862|NCT03482453|81397802|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880863|NCT03482453|81397803|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880864|NCT03482453|81397804|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880865|NCT03482453|81397805|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880866|NCT03482453|81397806|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880867|NCT03482453|81397807|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
27880868|NCT03482453|81397808|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
27880869|NCT04411810|81397809|FG000|Overall Study|Screen failure|1|||
27880870|NCT04411810|81397809|FG000|Overall Study|Withdrawal by Subject|1|||
27880871|NCT02019264|81397812|FG000|Overall Study|Not treated|6|||
27693634|NCT01145755|80713703|FG000|Overall Study|Lost to Follow-up|2|||
27880872|NCT02019264|81397813|FG001|Overall Study|Not treated|4|||
27880873|NCT02019264|81397812|FG000|Overall Study|Lost to Follow-up|50|||
27592348|NCT03568318|80348633|FG004|Overall Study|Withdrawal by Subject|0|||
27880874|NCT02019264|81397813|FG001|Overall Study|Lost to Follow-up|47|||
27693635|NCT01145755|80713704|FG001|Overall Study|Lost to Follow-up|3|||
27592349|NCT03568318|80348634|FG005|Overall Study|Withdrawal by Subject|0|||
27592350|NCT03568318|80348629|FG000|Overall Study|Lost to Follow-up|3|||
27592351|NCT03568318|80348630|FG001|Overall Study|Lost to Follow-up|2|||
27592352|NCT03568318|80348631|FG002|Overall Study|Lost to Follow-up|2|||
27592353|NCT03568318|80348632|FG003|Overall Study|Lost to Follow-up|2|||
27819359|NCT00105196|81172362|FG001|Overall Study|pending surgery|1|||
27819360|NCT00105196|81172361|FG000|Overall Study|marijuana use|0|||
27819361|NCT00105196|81172362|FG001|Overall Study|marijuana use|1|||
27819362|NCT00105196|81172361|FG000|Overall Study|Subject became unblinded|0|||
27819363|NCT00105196|81172362|FG001|Overall Study|Subject became unblinded|1|||
27819364|NCT02353169|81172369|FG000|Overall Study|QTc > 450 msec|1|||
27819365|NCT02353169|81172370|FG001|Overall Study|QTc > 450 msec|1|||
27819366|NCT02353169|81172371|FG002|Overall Study|QTc > 450 msec|1|||
27819367|NCT02353169|81172372|FG003|Overall Study|QTc > 450 msec|1|||
27819368|NCT02353169|81172369|FG000|Overall Study|OR team declined|2|||
27819369|NCT02353169|81172370|FG001|Overall Study|OR team declined|0|||
27819370|NCT02353169|81172371|FG002|Overall Study|OR team declined|0|||
27819371|NCT02353169|81172372|FG003|Overall Study|OR team declined|0|||
27819372|NCT02353169|81172369|FG000|Overall Study|Inhalational induction|0|||
27819373|NCT02353169|81172370|FG001|Overall Study|Inhalational induction|2|||
27819374|NCT02353169|81172371|FG002|Overall Study|Inhalational induction|0|||
27819375|NCT02353169|81172372|FG003|Overall Study|Inhalational induction|0|||
27819376|NCT02353169|81172369|FG000|Overall Study|ECG data error|0|||
27819377|NCT02353169|81172370|FG001|Overall Study|ECG data error|3|||
27819378|NCT02353169|81172371|FG002|Overall Study|ECG data error|2|||
27819379|NCT02353169|81172372|FG003|Overall Study|ECG data error|2|||
27819380|NCT02353169|81172369|FG000|Overall Study|Pre-op medication|0|||
27819381|NCT02353169|81172370|FG001|Overall Study|Pre-op medication|0|||
27819382|NCT02353169|81172371|FG002|Overall Study|Pre-op medication|1|||
27819383|NCT02353169|81172372|FG003|Overall Study|Pre-op medication|0|||
27819384|NCT00667862|81172374|FG000|Overall Study|Adverse Event|9|||
27819385|NCT00667862|81172374|FG000|Overall Study|Death|1|||
27819386|NCT00667862|81172374|FG000|Overall Study|Disease Progression|22|||
27819387|NCT00667862|81172374|FG000|Overall Study|Withdrawal by Subject|3|||
27819388|NCT02999178|81172375|FG000|Overall Study|Adverse Event|85|||
27819389|NCT02999178|81172376|FG001|Overall Study|Adverse Event|62|||
27819390|NCT02999178|81172375|FG000|Overall Study|Protocol Violation|1|||
27819391|NCT02999178|81172376|FG001|Overall Study|Protocol Violation|2|||
27819392|NCT02999178|81172375|FG000|Overall Study|Lost to Follow-up|0|||
27819393|NCT02999178|81172376|FG001|Overall Study|Lost to Follow-up|2|||
27819394|NCT02999178|81172375|FG000|Overall Study|Withdrawal by Subject|21|||
27592354|NCT03568318|80348633|FG004|Overall Study|Lost to Follow-up|1|||
27819395|NCT02999178|81172376|FG001|Overall Study|Withdrawal by Subject|21|||
27819396|NCT02999178|81172375|FG000|Overall Study|Other reason not defined above|7|||
27880875|NCT02019264|81397812|FG000|Overall Study|Withdrawal by Subject|142|||
27592355|NCT03568318|80348634|FG005|Overall Study|Lost to Follow-up|0|||
27819397|NCT02999178|81172376|FG001|Overall Study|Other reason not defined above|13|||
27819398|NCT04109222|81172377|FG000|Overall Study|Adverse Event|1|||
27819399|NCT04109222|81172378|FG001|Overall Study|Adverse Event|0|||
27592356|NCT03568318|80348629|FG000|Overall Study|Other|3|||
27819400|NCT04109222|81172379|FG002|Overall Study|Adverse Event|0|||
27819401|NCT02495857|81172380|FG000|Overall Study|Adverse Event|5|||
27819402|NCT02495857|81172381|FG001|Overall Study|Adverse Event|0|||
27819403|NCT02495857|81172382|FG002|Overall Study|Adverse Event|1|||
27819404|NCT02495857|81172380|FG000|Overall Study|Withdrawal by Subject|9|||
27819405|NCT02495857|81172381|FG001|Overall Study|Withdrawal by Subject|6|||
27819406|NCT02495857|81172382|FG002|Overall Study|Withdrawal by Subject|10|||
27819407|NCT02495857|81172380|FG000|Overall Study|Physician Decision|0|||
27819408|NCT02495857|81172381|FG001|Overall Study|Physician Decision|1|||
27819409|NCT02495857|81172382|FG002|Overall Study|Physician Decision|0|||
27819410|NCT02495857|81172380|FG000|Overall Study|Protocol Violation|1|||
27819411|NCT02495857|81172381|FG001|Overall Study|Protocol Violation|1|||
27819412|NCT02495857|81172382|FG002|Overall Study|Protocol Violation|2|||
27880876|NCT02019264|81397813|FG001|Overall Study|Withdrawal by Subject|117|||
27592357|NCT03568318|80348630|FG001|Overall Study|Other|1|||
27880877|NCT02019264|81397812|FG000|Overall Study|Administrative reason|36|||
27880878|NCT02019264|81397813|FG001|Overall Study|Administrative reason|28|||
27880879|NCT02019264|81397812|FG000|Overall Study|Missing|14|||
27880880|NCT02019264|81397813|FG001|Overall Study|Missing|11|||
27880881|NCT03048747|81397822|FG000|Overall Study|Adverse Event|2|||
27819413|NCT02495857|81172380|FG000|Overall Study|Lost to Follow-up|4|||
27819414|NCT02495857|81172381|FG001|Overall Study|Lost to Follow-up|5|||
27592358|NCT03568318|80348631|FG002|Overall Study|Other|3|||
27880882|NCT03048747|81397822|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
27592359|NCT03568318|80348632|FG003|Overall Study|Other|0|||
27592360|NCT03568318|80348633|FG004|Overall Study|Other|0|||
27592361|NCT03568318|80348634|FG005|Overall Study|Other|0|||
27592362|NCT03568318|80348629|FG000|Overall Study|Ongoing at Time of Analysis|5|||
27819415|NCT02495857|81172382|FG002|Overall Study|Lost to Follow-up|3|||
27819416|NCT02495857|81172380|FG000|Overall Study|Other|3|||
27819417|NCT02495857|81172381|FG001|Overall Study|Other|3|||
27819418|NCT02495857|81172382|FG002|Overall Study|Other|2|||
27819419|NCT02924038|81172394|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
27819420|NCT02924038|81172395|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
27819421|NCT02109042|81172396|FG000|Overall Study|Sponsor Decision|15|||
27819422|NCT02684578|81172409|FG000|Overall Study|Withdrawal by Subject|10|||
27819423|NCT02684578|81172410|FG001|Overall Study|Withdrawal by Subject|7|||
27819424|NCT02684578|81172409|FG000|Overall Study|Lost to Follow-up|0|||
27819425|NCT02684578|81172410|FG001|Overall Study|Lost to Follow-up|3|||
27819426|NCT02684578|81172409|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
27819427|NCT02684578|81172410|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
27819428|NCT02684578|81172409|FG000|Overall Study|Missing follow-up data|0|||
27819429|NCT02684578|81172410|FG001|Overall Study|Missing follow-up data|1|||
27819430|NCT00862979|81172411|FG000|Overall Study|Adverse Event|6|||
27819431|NCT00862979|81172412|FG001|Overall Study|Adverse Event|3|||
27819432|NCT00862979|81172411|FG000|Overall Study|Protocol Violation|0|||
27819433|NCT00862979|81172412|FG001|Overall Study|Protocol Violation|1|||
27819434|NCT00862979|81172411|FG000|Overall Study|Patient withdrew consent|2|||
27819435|NCT00862979|81172412|FG001|Overall Study|Patient withdrew consent|1|||
27819436|NCT00862979|81172411|FG000|Overall Study|Administrative problems|0|||
27819437|NCT00862979|81172412|FG001|Overall Study|Administrative problems|1|||
27819438|NCT00862979|81172411|FG000|Overall Study|Death|0|||
27819439|NCT00862979|81172412|FG001|Overall Study|Death|1|||
27819440|NCT00051025|81172413|FG000|Overall Study|Progressive Disease|1|||
27819441|NCT00051025|81172414|FG001|Overall Study|Progressive Disease|1|||
27819442|NCT00051025|81172413|FG000|Overall Study|Adverse Event|1|||
27819443|NCT00051025|81172414|FG001|Overall Study|Adverse Event|1|||
27819444|NCT00051025|81172413|FG000|Overall Study|Withdrawal by Subject|0|||
27819445|NCT00051025|81172414|FG001|Overall Study|Withdrawal by Subject|1|||
27819446|NCT00051025|81172413|FG000|Overall Study|Death|0|||
27819447|NCT00051025|81172414|FG001|Overall Study|Death|1|||
27819448|NCT02246478|81172415|FG000|Multiple-dose Phase|Protocol Violation|1|||
27819449|NCT02246478|81172416|FG001|Multiple-dose Phase|Protocol Violation|0|||
27819450|NCT02246478|81172417|FG002|Multiple-dose Phase|Protocol Violation|0|||
27819451|NCT02246478|81172418|FG003|Multiple-dose Phase|Protocol Violation|1|||
27819452|NCT01374919|81172419|FG000|Overall Study|Withdrawal by Subject|2|||
27819453|NCT00832377|81172420|FG000|Overall Study|Protocol Violation|1|||
27819454|NCT00220701|81172421|FG000|Overall Study|Lost to Follow-up|5|||
27819455|NCT00220701|81172422|FG001|Overall Study|Lost to Follow-up|4|||
27819456|NCT01706536|81172423|FG000|Overall Study|Withdrawal by Subject|1|||
27819457|NCT01706536|81172424|FG001|Overall Study|Withdrawal by Subject|0|||
27819458|NCT01706536|81172425|FG002|Overall Study|Withdrawal by Subject|1|||
27819459|NCT01706536|81172426|FG003|Overall Study|Withdrawal by Subject|0|||
27819460|NCT01706536|81172427|FG004|Overall Study|Withdrawal by Subject|0|||
27880883|NCT03048747|81397822|FG000|Overall Study|Physician Decision|1|||
27880884|NCT00927862|81397823|FG000|Overall Study|Missing data needed for endpt analyses|27|||
27880885|NCT00927862|81397824|FG001|Overall Study|Missing data needed for endpt analyses|45|||
27880886|NCT01134107|81397827|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
27880887|NCT01134107|81397828|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
27880888|NCT01134107|81397827|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
27880889|NCT01134107|81397828|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
27880890|NCT01134107|81397827|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
27880891|NCT01134107|81397828|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
27880892|NCT01134107|81397827|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
27592363|NCT03568318|80348630|FG001|Overall Study|Ongoing at Time of Analysis|3|||
27592364|NCT03568318|80348631|FG002|Overall Study|Ongoing at Time of Analysis|2|||
27693636|NCT01145755|80713705|FG002|Overall Study|Lost to Follow-up|1|||
27693637|NCT01145755|80713703|FG000|Overall Study|Protocol Violation|0|||
27693638|NCT01145755|80713704|FG001|Overall Study|Protocol Violation|3|||
27819461|NCT01706536|81172423|FG000|Overall Study|Adverse Event|2|||
27819462|NCT01706536|81172424|FG001|Overall Study|Adverse Event|3|||
27819463|NCT01706536|81172425|FG002|Overall Study|Adverse Event|4|||
27819464|NCT01706536|81172426|FG003|Overall Study|Adverse Event|3|||
27819465|NCT01706536|81172427|FG004|Overall Study|Adverse Event|2|||
27819466|NCT01706536|81172423|FG000|Overall Study|Lack of Efficacy|1|||
27819467|NCT01706536|81172424|FG001|Overall Study|Lack of Efficacy|0|||
27819468|NCT01706536|81172425|FG002|Overall Study|Lack of Efficacy|0|||
27819469|NCT01706536|81172426|FG003|Overall Study|Lack of Efficacy|1|||
27880893|NCT01134107|81397828|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
27693639|NCT01145755|80713705|FG002|Overall Study|Protocol Violation|1|||
27592365|NCT03568318|80348632|FG003|Overall Study|Ongoing at Time of Analysis|1|||
27592366|NCT03568318|80348633|FG004|Overall Study|Ongoing at Time of Analysis|0|||
27592367|NCT03568318|80348634|FG005|Overall Study|Ongoing at Time of Analysis|0|||
27592368|NCT02576678|80348637|FG000|Overall Study|Adverse Event|0|||
27592369|NCT02576678|80348638|FG001|Overall Study|Adverse Event|0|||
27592370|NCT02576678|80348639|FG002|Overall Study|Adverse Event|2|||
27592371|NCT02576678|80348637|FG000|Overall Study|Withdrawal by Subject|3|||
27592372|NCT02576678|80348638|FG001|Overall Study|Withdrawal by Subject|1|||
27693640|NCT01145755|80713703|FG000|Overall Study|Study Closure|14|||
27693641|NCT01145755|80713704|FG001|Overall Study|Study Closure|14|||
27693642|NCT01145755|80713705|FG002|Overall Study|Study Closure|17|||
27693643|NCT01145755|80713703|FG000|Overall Study|Lack of Efficacy|0|||
27693644|NCT01145755|80713704|FG001|Overall Study|Lack of Efficacy|1|||
27693645|NCT01145755|80713705|FG002|Overall Study|Lack of Efficacy|0|||
27592373|NCT02576678|80348639|FG002|Overall Study|Withdrawal by Subject|2|||
27592374|NCT02576678|80348637|FG000|Overall Study|Lost to Follow-up|0|||
27592375|NCT02576678|80348638|FG001|Overall Study|Lost to Follow-up|0|||
27592376|NCT02576678|80348639|FG002|Overall Study|Lost to Follow-up|1|||
27592377|NCT02576678|80348637|FG000|Overall Study|Miscellaneous|2|||
27592378|NCT02576678|80348638|FG001|Overall Study|Miscellaneous|0|||
27592379|NCT02576678|80348639|FG002|Overall Study|Miscellaneous|0|||
27592380|NCT00487162|80348643|FG000|Overall Study|Adverse Event|0|||
27592381|NCT00487162|80348644|FG001|Overall Study|Adverse Event|1|||
27592382|NCT00487162|80348643|FG000|Overall Study|Physician Decision|0|||
27592383|NCT00487162|80348644|FG001|Overall Study|Physician Decision|1|||
27592384|NCT00487162|80348643|FG000|Overall Study|Withdrawal by Subject|2|||
27592385|NCT00487162|80348644|FG001|Overall Study|Withdrawal by Subject|3|||
27592386|NCT00047879|80348645|FG000|Overall Study|Progressive disease|4|||
27592387|NCT00047879|80348646|FG001|Overall Study|Progressive disease|3|||
27592388|NCT00996996|80348647|FG000|Overall Study|Progressive Disease|10|||
27592389|NCT00996996|80348647|FG000|Overall Study|Non-compliance|8|||
27592390|NCT00996996|80348647|FG000|Overall Study|Lost to Follow-up|9|||
27592391|NCT00996996|80348647|FG000|Overall Study|Death|5|||
27693646|NCT01145755|80713703|FG000|Overall Study|Patient could not swollow medication|0|||
27592392|NCT00996996|80348647|FG000|Overall Study|Did Not Receive Study Medications|1|||
27592393|NCT00784810|80348648|FG000|Overall Study|Adverse Event|32|||
27592394|NCT00784810|80348649|FG001|Overall Study|Adverse Event|20|||
27592395|NCT00784810|80348648|FG000|Overall Study|Lack of Efficacy|14|||
27592396|NCT00784810|80348649|FG001|Overall Study|Lack of Efficacy|11|||
27592397|NCT00784810|80348648|FG000|Overall Study|Withdrawal by Subject|11|||
27592398|NCT00784810|80348649|FG001|Overall Study|Withdrawal by Subject|9|||
27592399|NCT00784810|80348648|FG000|Overall Study|Administrative|5|||
27592400|NCT00784810|80348649|FG001|Overall Study|Administrative|8|||
27592401|NCT00784810|80348648|FG000|Overall Study|Lost to Follow-up|1|||
27592402|NCT00784810|80348649|FG001|Overall Study|Lost to Follow-up|1|||
27592403|NCT00352365|80348652|FG000|Induction Therapy|Adverse Event|7|||
27592404|NCT00352365|80348652|FG000|Induction Therapy|Progression/Relapse|8|||
27592405|NCT00352365|80348652|FG000|Induction Therapy|Death|7|||
27693647|NCT01145755|80713704|FG001|Overall Study|Patient could not swollow medication|0|||
27592406|NCT00352365|80348652|FG000|Induction Therapy|Not protocol specified|1|||
27693648|NCT01145755|80713705|FG002|Overall Study|Patient could not swollow medication|1|||
27693649|NCT01145755|80713703|FG000|Overall Study|Withdrawal by Subject|0|||
27592407|NCT00352365|80348652|FG000|Induction Therapy|Not eligible|3|||
27592408|NCT00352365|80348652|FG000|Induction Therapy|Death before starting protocol therapy|1|||
27592409|NCT00352365|80348652|FG000|Maintenance Therapy|Progression/Relapse|3|||
27592410|NCT00352365|80348652|FG000|Maintenance Therapy|Death|2|||
27592411|NCT00352365|80348652|FG000|Maintenance Therapy|Not protocol specified|3|||
27592412|NCT00352365|80348652|FG000|Maintenance Therapy|Not eligible|4|||
27592413|NCT00423176|80348654|FG000|Overall Study|Adverse Event|4|||
27693650|NCT01145755|80713704|FG001|Overall Study|Withdrawal by Subject|0|||
27592414|NCT00423176|80348655|FG001|Overall Study|Adverse Event|6|||
27592415|NCT00423176|80348654|FG000|Overall Study|Treatment Failure|1|||
27592416|NCT00423176|80348655|FG001|Overall Study|Treatment Failure|6|||
27592417|NCT00423176|80348654|FG000|Overall Study|Lost to Follow-up|4|||
27592418|NCT00423176|80348655|FG001|Overall Study|Lost to Follow-up|7|||
27592419|NCT00423176|80348654|FG000|Overall Study|Withdrawal by Subject|4|||
27592420|NCT00423176|80348655|FG001|Overall Study|Withdrawal by Subject|3|||
27592421|NCT00423176|80348654|FG000|Overall Study|Protocol Violation|1|||
27592422|NCT00423176|80348655|FG001|Overall Study|Protocol Violation|3|||
27592423|NCT00423176|80348654|FG000|Overall Study|Did not meet protocol eligibility|2|||
27592424|NCT00423176|80348655|FG001|Overall Study|Did not meet protocol eligibility|4|||
27592425|NCT04391023|80348656|FG000|Overall Study|Withdrawal by Subject|2|||
27592426|NCT04391023|80348657|FG001|Overall Study|Withdrawal by Subject|2|||
27592427|NCT02148250|80348658|FG000|Screening|Withdrawal by Subject|5|||
27592428|NCT02148250|80348659|FG001|Screening|Withdrawal by Subject|0|||
27592429|NCT04137380|80348662|FG000|Overall Study|Physician Decision|0|||
27592430|NCT04137380|80348663|FG001|Overall Study|Physician Decision|0|||
27592431|NCT04137380|80348664|FG002|Overall Study|Physician Decision|0|||
27592432|NCT04137380|80348665|FG003|Overall Study|Physician Decision|1|||
27592433|NCT04137380|80348666|FG004|Overall Study|Physician Decision|0|||
27592434|NCT04137380|80348667|FG005|Overall Study|Physician Decision|0|||
27592435|NCT04137380|80348668|FG006|Overall Study|Physician Decision|0|||
27592436|NCT01581281|80348670|FG000|Overall Study|Early Study Closure|15|||
27592437|NCT01581281|80348671|FG001|Overall Study|Early Study Closure|6|||
27592438|NCT01581281|80348672|FG002|Overall Study|Early Study Closure|12|||
27592439|NCT01618838|80348674|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
27592440|NCT02081846|80348676|FG000|Overall Study|Withdrawal by Subject|1|||
27592441|NCT02081846|80348677|FG001|Overall Study|Withdrawal by Subject|0|||
27592442|NCT02081846|80348676|FG000|Overall Study|invalid consent|1|||
27592443|NCT02081846|80348677|FG001|Overall Study|invalid consent|0|||
27592444|NCT02301143|80348685|FG000|Induction Period|Enrolled But Not Treated|1|||
27592445|NCT02301143|80348686|FG001|Induction Period|Enrolled But Not Treated|0|||
27592446|NCT02301143|80348685|FG000|Induction Period|Death|1|||
27592447|NCT02301143|80348686|FG001|Induction Period|Death|0|||
27592448|NCT02301143|80348685|FG000|Induction Period|Adverse Event|22|||
27592449|NCT02301143|80348686|FG001|Induction Period|Adverse Event|0|||
27592450|NCT02301143|80348685|FG000|Induction Period|Progressive Disease|8|||
27592451|NCT02301143|80348686|FG001|Induction Period|Progressive Disease|0|||
27592452|NCT02301143|80348685|FG000|Induction Period|Withdrawal by Subject|3|||
27592453|NCT02301143|80348686|FG001|Induction Period|Withdrawal by Subject|0|||
27592454|NCT02301143|80348685|FG000|Induction Period|Noncompliance with Study Drug|1|||
27592455|NCT02301143|80348686|FG001|Induction Period|Noncompliance with Study Drug|0|||
27592456|NCT02301143|80348685|FG000|Induction Period|Physician Decision|4|||
27592457|NCT02301143|80348686|FG001|Induction Period|Physician Decision|0|||
27592458|NCT02301143|80348685|FG000|Induction Period|Symptomatic Deterioration|2|||
27592459|NCT02301143|80348686|FG001|Induction Period|Symptomatic Deterioration|0|||
27592460|NCT02301143|80348685|FG000|Induction Period|Protocol Violation|2|||
27592461|NCT02301143|80348686|FG001|Induction Period|Protocol Violation|0|||
27592462|NCT02301143|80348685|FG000|Induction Period|Other|1|||
27592463|NCT02301143|80348686|FG001|Induction Period|Other|0|||
27592464|NCT02301143|80348685|FG000|Investigator's Choice|Adverse Event|0|||
27592465|NCT02301143|80348686|FG001|Investigator's Choice|Adverse Event|3|||
27592466|NCT02301143|80348685|FG000|Investigator's Choice|Progressive Disease|0|||
27592467|NCT02301143|80348686|FG001|Investigator's Choice|Progressive Disease|3|||
27592468|NCT02301143|80348685|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
27592469|NCT02301143|80348686|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
27592470|NCT02301143|80348685|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
27592471|NCT02301143|80348686|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
27592472|NCT02301143|80348685|FG000|Investigator's Choice|Other|0|||
27592473|NCT02301143|80348686|FG001|Investigator's Choice|Other|1|||
27592474|NCT02301143|80348685|FG000|Investigator's Choice|Unresectable Surgery|0|||
27592475|NCT02301143|80348686|FG001|Investigator's Choice|Unresectable Surgery|1|||
27592476|NCT00695903|80348688|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
27880894|NCT01134107|81397827|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
27880895|NCT01134107|81397828|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
27880896|NCT01134107|81397827|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
27592477|NCT00695903|80348689|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
27592478|NCT00695903|80348688|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
27592479|NCT00695903|80348689|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
27592480|NCT00695903|80348688|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
27592481|NCT00695903|80348689|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
27592482|NCT00695903|80348688|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
27592483|NCT00695903|80348689|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
27592484|NCT00695903|80348688|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
27880897|NCT01134107|81397828|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
27880898|NCT01134107|81397827|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
27880899|NCT01134107|81397828|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
27880900|NCT00072280|81397831|FG000|Treatment|Found ineligible|1|||
27880901|NCT00072280|81397832|FG001|Treatment|Found ineligible|2|||
27880902|NCT00072280|81397831|FG000|Follow-up|Early termination of study|2|||
27880903|NCT00072280|81397832|FG001|Follow-up|Early termination of study|2|||
27880904|NCT01208974|81397833|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
27880905|NCT01208974|81397834|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
27880906|NCT01208974|81397835|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
27880907|NCT01208974|81397836|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
27880908|NCT01208974|81397833|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
27880909|NCT01208974|81397834|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
27880910|NCT01208974|81397835|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
27880911|NCT01208974|81397836|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
27880912|NCT01208974|81397833|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
27880913|NCT01208974|81397834|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
27880914|NCT01208974|81397835|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
27880915|NCT01208974|81397836|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
27880916|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
27880917|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
27880918|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
27880919|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
27880920|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
27880921|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
27880922|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
27880923|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
27880924|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
27880925|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
27880926|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
27880927|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
27880928|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
27880929|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27880930|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27880931|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27880932|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
27880933|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
27880934|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
27880935|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
27592485|NCT00695903|80348689|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
27592486|NCT00695903|80348688|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
27592487|NCT00695903|80348689|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
27592488|NCT00695903|80348688|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
27592489|NCT00695903|80348689|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
27592490|NCT00695903|80348688|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
27592491|NCT00695903|80348689|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
27592492|NCT00695903|80348688|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
27592493|NCT00695903|80348689|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
27592494|NCT00707031|80348690|FG000|Overall Study|Adverse Event|45|||
27592495|NCT00707031|80348691|FG001|Overall Study|Adverse Event|45|||
27592496|NCT00707031|80348690|FG000|Overall Study|Lack of Efficacy|19|||
27592497|NCT00707031|80348691|FG001|Overall Study|Lack of Efficacy|6|||
27592498|NCT00707031|80348690|FG000|Overall Study|Lost to Follow-up|2|||
27592499|NCT00707031|80348691|FG001|Overall Study|Lost to Follow-up|1|||
27592500|NCT00707031|80348690|FG000|Overall Study|Protocol Violation|1|||
27592501|NCT00707031|80348691|FG001|Overall Study|Protocol Violation|0|||
27592502|NCT00707031|80348690|FG000|Overall Study|Withdrawal by Subject|7|||
27880936|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
27592503|NCT00707031|80348691|FG001|Overall Study|Withdrawal by Subject|8|||
27592504|NCT00707031|80348690|FG000|Overall Study|Poor Compliance to Protocol|7|||
27693651|NCT01145755|80713705|FG002|Overall Study|Withdrawal by Subject|1|||
27693652|NCT01145755|80713703|FG000|Overall Study|Positive urine ethanol|0|||
27693653|NCT01145755|80713704|FG001|Overall Study|Positive urine ethanol|1|||
27693654|NCT01145755|80713705|FG002|Overall Study|Positive urine ethanol|0|||
27693655|NCT01313117|80713706|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
27693656|NCT01313117|80713706|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
27693657|NCT01941719|80713707|FG000|Overall Study|Lost to Follow-up|20|||
27880937|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27880938|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27693658|NCT01941719|80713708|FG001|Overall Study|Lost to Follow-up|19|||
27819470|NCT01706536|81172427|FG004|Overall Study|Lack of Efficacy|0|||
27819471|NCT01706536|81172423|FG000|Overall Study|non compliance|0|||
27819472|NCT01706536|81172424|FG001|Overall Study|non compliance|1|||
27819473|NCT01706536|81172425|FG002|Overall Study|non compliance|0|||
27819474|NCT01706536|81172426|FG003|Overall Study|non compliance|0|||
27819475|NCT01706536|81172427|FG004|Overall Study|non compliance|0|||
27819476|NCT03227445|81172442|FG000|Period 1 (28 Days)|Adverse Event|1|||
27880939|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27880940|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
27880941|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
27880942|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
27880943|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
27880944|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
27880945|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
27880946|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
27880947|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
27880948|NCT00506415|81397848|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
27880949|NCT00506415|81397849|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
27880950|NCT00506415|81397850|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
27880951|NCT00506415|81397851|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
27880952|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
27880953|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
27880954|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
27880955|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
27880956|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
27880957|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
27880958|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
27880959|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
27880960|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
27819477|NCT03227445|81172443|FG001|Period 1 (28 Days)|Adverse Event|2|||
27819478|NCT03227445|81172444|FG002|Period 1 (28 Days)|Adverse Event|0|||
27819479|NCT03227445|81172445|FG003|Period 1 (28 Days)|Adverse Event|1|||
27819480|NCT03227445|81172442|FG000|Period 1 (28 Days)|Protocol Violation|1|||
27819481|NCT03227445|81172443|FG001|Period 1 (28 Days)|Protocol Violation|0|||
27819482|NCT03227445|81172444|FG002|Period 1 (28 Days)|Protocol Violation|0|||
27819483|NCT03227445|81172445|FG003|Period 1 (28 Days)|Protocol Violation|0|||
27819484|NCT03227445|81172442|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
27819485|NCT03227445|81172443|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
27819486|NCT03227445|81172444|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
27819487|NCT03227445|81172445|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
27819488|NCT03227445|81172442|FG000|Period 2 (28 Days)|Adverse Event|1|||
27819489|NCT03227445|81172443|FG001|Period 2 (28 Days)|Adverse Event|0|||
27819490|NCT03227445|81172444|FG002|Period 2 (28 Days)|Adverse Event|2|||
27819491|NCT03227445|81172445|FG003|Period 2 (28 Days)|Adverse Event|1|||
27819492|NCT03227445|81172442|FG000|Period 2 (28 Days)|Protocol Violation|0|||
27819493|NCT03227445|81172443|FG001|Period 2 (28 Days)|Protocol Violation|0|||
27819494|NCT03227445|81172444|FG002|Period 2 (28 Days)|Protocol Violation|0|||
27819495|NCT03227445|81172445|FG003|Period 2 (28 Days)|Protocol Violation|1|||
27819496|NCT03227445|81172442|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
27819497|NCT03227445|81172443|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
27819498|NCT03227445|81172444|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
27819499|NCT03227445|81172445|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
27819500|NCT03830164|81172446|FG000|Overall Study|Adverse Event|0|||
27819501|NCT03830164|81172447|FG001|Overall Study|Adverse Event|2|||
27819502|NCT03830164|81172448|FG002|Overall Study|Adverse Event|0|||
27819503|NCT03830164|81172446|FG000|Overall Study|Lack of Efficacy|1|||
27819504|NCT03830164|81172447|FG001|Overall Study|Lack of Efficacy|5|||
27819505|NCT03830164|81172448|FG002|Overall Study|Lack of Efficacy|0|||
27819506|NCT03830164|81172446|FG000|Overall Study|Lost to Follow-up|0|||
27819507|NCT03830164|81172447|FG001|Overall Study|Lost to Follow-up|1|||
27819508|NCT03830164|81172448|FG002|Overall Study|Lost to Follow-up|0|||
27819509|NCT03830164|81172446|FG000|Overall Study|Withdrawal by Subject|1|||
27819510|NCT03830164|81172447|FG001|Overall Study|Withdrawal by Subject|0|||
27819511|NCT03830164|81172448|FG002|Overall Study|Withdrawal by Subject|0|||
27819512|NCT00591630|81172449|FG000|Overall Study|Death|0|||
27819513|NCT00591630|81172450|FG001|Overall Study|Death|0|||
27819514|NCT00591630|81172451|FG002|Overall Study|Death|1|||
27819515|NCT00591630|81172452|FG003|Overall Study|Death|0|||
27819516|NCT00762086|81172453|FG000|Overall Study|Adverse Event|2|||
27819517|NCT00762086|81172454|FG001|Overall Study|Adverse Event|0|||
27819518|NCT00762086|81172453|FG000|Overall Study|Lost to Follow-up|0|||
27819519|NCT00762086|81172454|FG001|Overall Study|Lost to Follow-up|2|||
27819520|NCT00762086|81172453|FG000|Overall Study|Non compliance|1|||
27819521|NCT00762086|81172454|FG001|Overall Study|Non compliance|0|||
27819522|NCT00762086|81172453|FG000|Overall Study|Withdrawal by Subject|2|||
27819523|NCT00762086|81172454|FG001|Overall Study|Withdrawal by Subject|2|||
27819524|NCT00762086|81172453|FG000|Overall Study|Ineligible to participate in the study|1|||
27819525|NCT00762086|81172454|FG001|Overall Study|Ineligible to participate in the study|0|||
27819526|NCT00755196|81172456|FG000|Overall Study|Lost to Follow-up|1|||
27819527|NCT00755196|81172456|FG000|Overall Study|Lack of Efficiency|1|||
27819528|NCT02073643|81172457|FG000|Overall Study|Lost to Follow-up|24|||
27819529|NCT00667095|81172460|FG000|Overall Study|Withdrawal by Subject|0|||
27819530|NCT00667095|81172461|FG001|Overall Study|Withdrawal by Subject|1|||
27819531|NCT02242201|81172467|FG000|Overall Study|preoperative identified neuropathy|2|||
27819532|NCT02242201|81172468|FG001|Overall Study|preoperative identified neuropathy|0|||
27819533|NCT02242201|81172469|FG002|Overall Study|preoperative identified neuropathy|0|||
27819534|NCT02242201|81172467|FG000|Overall Study|planned post-op anticoagulation|1|||
27819535|NCT02242201|81172468|FG001|Overall Study|planned post-op anticoagulation|0|||
27819536|NCT02242201|81172469|FG002|Overall Study|planned post-op anticoagulation|0|||
27819537|NCT02242201|81172467|FG000|Overall Study|changed surgical procedure|1|||
27819538|NCT02242201|81172468|FG001|Overall Study|changed surgical procedure|0|||
27819539|NCT02242201|81172469|FG002|Overall Study|changed surgical procedure|0|||
27819540|NCT02242201|81172467|FG000|Overall Study|postponed surgery|0|||
27819541|NCT02242201|81172468|FG001|Overall Study|postponed surgery|0|||
27819542|NCT02242201|81172469|FG002|Overall Study|postponed surgery|1|||
27819543|NCT02242201|81172467|FG000|Overall Study|preoperative opioid consumption|0|||
27819544|NCT02242201|81172468|FG001|Overall Study|preoperative opioid consumption|1|||
27819545|NCT02242201|81172469|FG002|Overall Study|preoperative opioid consumption|0|||
27819546|NCT03553823|81172470|FG000|Overall Study|Physician Decision|0|||
27819547|NCT03553823|81172471|FG001|Overall Study|Physician Decision|1|||
27819548|NCT02395822|81172472|FG000|Overall Study|Withdrawal by Subject|1|||
27819549|NCT02395822|81172472|FG000|Overall Study|Death|1|||
27819550|NCT00813293|81172473|FG000|Overall Study|Intercurrent illness|1|||
27819551|NCT00813293|81172474|FG001|Overall Study|Intercurrent illness|0|||
27819552|NCT00813293|81172473|FG000|Overall Study|Adverse Event|0|||
27819553|NCT00813293|81172474|FG001|Overall Study|Adverse Event|1|||
27819554|NCT00679367|81172475|FG000|Overall Study|Adverse Event|7|||
27819555|NCT00679367|81172475|FG000|Overall Study|inability to swallow oral drugs|1|||
27819556|NCT00679367|81172475|FG000|Overall Study|Lack of Efficacy|3|||
27819557|NCT00679367|81172475|FG000|Overall Study|Withdrawal by Subject|1|||
27819558|NCT02899338|81172476|FG000|Overall Study|Adverse Event|1|||
27819559|NCT02899338|81172477|FG001|Overall Study|Adverse Event|2|||
27819560|NCT02899338|81172476|FG000|Overall Study|Withdrawal by Subject|2|||
27819561|NCT02899338|81172477|FG001|Overall Study|Withdrawal by Subject|0|||
27819562|NCT00264797|81172478|FG000|Overall Study|Withdrawal by Subject|11|||
27819563|NCT00264797|81172479|FG001|Overall Study|Withdrawal by Subject|11|||
27819564|NCT00264797|81172478|FG000|Overall Study|Lost to Follow-up|9|||
27819565|NCT00264797|81172479|FG001|Overall Study|Lost to Follow-up|17|||
27819566|NCT00264797|81172478|FG000|Overall Study|Moved from area|3|||
27819567|NCT00264797|81172479|FG001|Overall Study|Moved from area|1|||
27819568|NCT00264797|81172478|FG000|Overall Study|Practical Problems|2|||
27819569|NCT00264797|81172479|FG001|Overall Study|Practical Problems|3|||
27819570|NCT00264797|81172478|FG000|Overall Study|Incarceration|4|||
27819571|NCT00264797|81172479|FG001|Overall Study|Incarceration|5|||
27819572|NCT00264797|81172478|FG000|Overall Study|Pressure/advice from Outsiders|1|||
27819573|NCT00264797|81172479|FG001|Overall Study|Pressure/advice from Outsiders|1|||
27819574|NCT00264797|81172478|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
27819575|NCT00264797|81172479|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
27819576|NCT00264797|81172478|FG000|Overall Study|Other|3|||
27819577|NCT00264797|81172479|FG001|Overall Study|Other|4|||
27819578|NCT04088760|81172480|FG000|Overall Study|Physician Decision|1|||
27819579|NCT01370408|81172481|FG000|Overall Study|treatment failure|9|||
27819580|NCT05593965|81172482|FG000|1st Intervention (1 Day)|Technical error|1|||
27819581|NCT05593965|81172483|FG001|1st Intervention (1 Day)|Technical error|0|||
27819582|NCT02193178|81172485|FG000|Overall Study|Lost to Follow-up|1|||
27819583|NCT02193178|81172485|FG000|Overall Study|Dry eyes|1|||
27819584|NCT01682083|81172486|FG000|Overall Study|Lost to Follow-up|11|||
27819585|NCT01682083|81172487|FG001|Overall Study|Lost to Follow-up|18|||
27819586|NCT01682083|81172486|FG000|Overall Study|Withdrawal by Subject|31|||
27819587|NCT01682083|81172487|FG001|Overall Study|Withdrawal by Subject|40|||
27819588|NCT01682083|81172486|FG000|Overall Study|Death|60|||
27819589|NCT01682083|81172487|FG001|Overall Study|Death|93|||
27819590|NCT01682083|81172486|FG000|Overall Study|Physician Decision|5|||
27819591|NCT01682083|81172487|FG001|Overall Study|Physician Decision|4|||
27819592|NCT02907203|81172495|FG000|Overall Study|Death|1|||
27819593|NCT02907203|81172495|FG000|Overall Study|Lost to Follow-up|3|||
27819594|NCT02907203|81172495|FG000|Overall Study|Withdrawal by Subject|3|||
27819595|NCT02907203|81172495|FG000|Overall Study|Surgical bypass|1|||
27819596|NCT01648166|81172496|FG000|Overall Study|inadequate toenail samples|53|||
27819597|NCT01648166|81172497|FG001|Overall Study|inadequate toenail samples|100|||
27819598|NCT03049488|81172506|FG000|Overall Study|Lost to Follow-up|1|||
27819599|NCT03049488|81172507|FG001|Overall Study|Lost to Follow-up|1|||
27819600|NCT03049488|81172508|FG002|Overall Study|Lost to Follow-up|0|||
27819601|NCT03049488|81172509|FG003|Overall Study|Lost to Follow-up|0|||
27819602|NCT03049488|81172510|FG004|Overall Study|Lost to Follow-up|0|||
27819603|NCT03049488|81172511|FG005|Overall Study|Lost to Follow-up|0|||
27819604|NCT03049488|81172506|FG000|Overall Study|Moved from Area|1|||
27819605|NCT03049488|81172507|FG001|Overall Study|Moved from Area|0|||
27819606|NCT03049488|81172508|FG002|Overall Study|Moved from Area|0|||
27819607|NCT03049488|81172509|FG003|Overall Study|Moved from Area|1|||
27819608|NCT03049488|81172510|FG004|Overall Study|Moved from Area|1|||
27819609|NCT03049488|81172511|FG005|Overall Study|Moved from Area|0|||
27819610|NCT03049488|81172506|FG000|Overall Study|Physician Decision|0|||
27819611|NCT03049488|81172507|FG001|Overall Study|Physician Decision|1|||
27819612|NCT03049488|81172508|FG002|Overall Study|Physician Decision|0|||
27819613|NCT03049488|81172509|FG003|Overall Study|Physician Decision|0|||
27819614|NCT03049488|81172510|FG004|Overall Study|Physician Decision|0|||
27819615|NCT03049488|81172511|FG005|Overall Study|Physician Decision|0|||
27819616|NCT03049488|81172506|FG000|Overall Study|Withdrawal by Subject|0|||
27819617|NCT03049488|81172507|FG001|Overall Study|Withdrawal by Subject|0|||
27819618|NCT03049488|81172508|FG002|Overall Study|Withdrawal by Subject|0|||
27819619|NCT03049488|81172509|FG003|Overall Study|Withdrawal by Subject|1|||
27819620|NCT03049488|81172510|FG004|Overall Study|Withdrawal by Subject|1|||
27819621|NCT03049488|81172511|FG005|Overall Study|Withdrawal by Subject|0|||
27819622|NCT03312530|81172512|FG000|Overall Study|Death|5|||
27819623|NCT03312530|81172513|FG001|Overall Study|Death|5|||
27819624|NCT03312530|81172514|FG002|Overall Study|Death|4|||
27819625|NCT03312530|81172515|FG003|Overall Study|Death|10|||
27819626|NCT03312530|81172516|FG004|Overall Study|Death|8|||
27819627|NCT03312530|81172512|FG000|Overall Study|Lost to Follow-up|0|||
27819628|NCT03312530|81172513|FG001|Overall Study|Lost to Follow-up|0|||
27819629|NCT03312530|81172514|FG002|Overall Study|Lost to Follow-up|0|||
27819630|NCT03312530|81172515|FG003|Overall Study|Lost to Follow-up|1|||
27819631|NCT03312530|81172516|FG004|Overall Study|Lost to Follow-up|0|||
27819632|NCT03312530|81172512|FG000|Overall Study|Participant in another sponsor study.|0|||
27819633|NCT03312530|81172513|FG001|Overall Study|Participant in another sponsor study.|0|||
27819634|NCT03312530|81172514|FG002|Overall Study|Participant in another sponsor study.|0|||
27819635|NCT03312530|81172515|FG003|Overall Study|Participant in another sponsor study.|1|||
27819636|NCT03312530|81172516|FG004|Overall Study|Participant in another sponsor study.|0|||
27819637|NCT03312530|81172512|FG000|Overall Study|Study terminated by sponsor|1|||
27819638|NCT03312530|81172513|FG001|Overall Study|Study terminated by sponsor|0|||
27819639|NCT03312530|81172514|FG002|Overall Study|Study terminated by sponsor|2|||
27819640|NCT03312530|81172515|FG003|Overall Study|Study terminated by sponsor|3|||
27819641|NCT03312530|81172516|FG004|Overall Study|Study terminated by sponsor|7|||
27819642|NCT03312530|81172512|FG000|Overall Study|Withdrawal by Subject|0|||
27819643|NCT03312530|81172513|FG001|Overall Study|Withdrawal by Subject|1|||
27819644|NCT03312530|81172514|FG002|Overall Study|Withdrawal by Subject|0|||
27819645|NCT03312530|81172515|FG003|Overall Study|Withdrawal by Subject|0|||
27819646|NCT03312530|81172516|FG004|Overall Study|Withdrawal by Subject|0|||
27819647|NCT03312530|81172512|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27819648|NCT03312530|81172513|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27819649|NCT03312530|81172514|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27819650|NCT03312530|81172515|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
27819651|NCT03312530|81172516|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
27819652|NCT01287013|81172517|FG000|Overall Study|Non-evaluable|3|||
27819653|NCT01287013|81172518|FG001|Overall Study|Non-evaluable|5|||
27819654|NCT01287013|81172519|FG002|Overall Study|Non-evaluable|21|||
27819655|NCT00552669|81172520|FG000|Overall Study|Death|3|||
27819656|NCT00552669|81172521|FG001|Overall Study|Death|7|||
27819657|NCT00436553|81172522|FG000|Overall Study|Adverse Event|4|||
27819658|NCT00436553|81172523|FG001|Overall Study|Adverse Event|3|||
27819659|NCT00436553|81172524|FG002|Overall Study|Adverse Event|4|||
27819660|NCT00436553|81172522|FG000|Overall Study|Death|3|||
27819661|NCT00436553|81172523|FG001|Overall Study|Death|1|||
27819662|NCT00436553|81172524|FG002|Overall Study|Death|3|||
27819663|NCT00436553|81172522|FG000|Overall Study|Lost to Follow-up|0|||
27819664|NCT00436553|81172523|FG001|Overall Study|Lost to Follow-up|2|||
27819665|NCT00436553|81172524|FG002|Overall Study|Lost to Follow-up|0|||
27819666|NCT00436553|81172522|FG000|Overall Study|Protocol Violation|1|||
27819667|NCT00436553|81172523|FG001|Overall Study|Protocol Violation|0|||
27819668|NCT00436553|81172524|FG002|Overall Study|Protocol Violation|0|||
27819669|NCT00436553|81172522|FG000|Overall Study|Withdrawal by Subject|5|||
27819670|NCT00436553|81172523|FG001|Overall Study|Withdrawal by Subject|6|||
27819671|NCT00436553|81172524|FG002|Overall Study|Withdrawal by Subject|3|||
27819672|NCT02202850|81172525|FG000|Overall Study|Other|2|||
27819673|NCT02202850|81172526|FG001|Overall Study|Other|2|||
27592505|NCT00707031|80348691|FG001|Overall Study|Poor Compliance to Protocol|13|||
27592506|NCT00707031|80348690|FG000|Overall Study|Familial or Personal Reasons|12|||
27693659|NCT02084056|80713709|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
27819674|NCT02202850|81172525|FG000|Overall Study|Enbrel treatment discontinued|15|||
27819675|NCT02202850|81172526|FG001|Overall Study|Enbrel treatment discontinued|3|||
27819676|NCT02202850|81172525|FG000|Overall Study|Lost to Follow-up|7|||
27819677|NCT02202850|81172526|FG001|Overall Study|Lost to Follow-up|1|||
27819678|NCT02228382|81172527|FG000|Overall Study|Death|5|||
27819679|NCT02228382|81172528|FG001|Overall Study|Death|7|||
27819680|NCT02228382|81172529|FG002|Overall Study|Death|5|||
27819681|NCT02228382|81172530|FG003|Overall Study|Death|0|||
27819682|NCT02228382|81172531|FG004|Overall Study|Death|2|||
27819683|NCT02228382|81172527|FG000|Overall Study|Participant refused further follow-up|0|||
27819684|NCT02228382|81172528|FG001|Overall Study|Participant refused further follow-up|0|||
27819685|NCT02228382|81172529|FG002|Overall Study|Participant refused further follow-up|1|||
27693660|NCT02084056|80713710|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27819686|NCT02228382|81172530|FG003|Overall Study|Participant refused further follow-up|0|||
27819687|NCT02228382|81172531|FG004|Overall Study|Participant refused further follow-up|0|||
27819688|NCT02228382|81172527|FG000|Overall Study|Study terminated by sponsor|3|||
27819689|NCT02228382|81172528|FG001|Overall Study|Study terminated by sponsor|5|||
27819690|NCT02228382|81172529|FG002|Overall Study|Study terminated by sponsor|7|||
27819691|NCT02228382|81172530|FG003|Overall Study|Study terminated by sponsor|0|||
27819692|NCT02228382|81172531|FG004|Overall Study|Study terminated by sponsor|0|||
27819693|NCT02228382|81172527|FG000|Overall Study|Lost to Follow-up|0|||
27819694|NCT02228382|81172528|FG001|Overall Study|Lost to Follow-up|0|||
27819695|NCT02228382|81172529|FG002|Overall Study|Lost to Follow-up|3|||
27819696|NCT02228382|81172530|FG003|Overall Study|Lost to Follow-up|1|||
27819697|NCT02228382|81172531|FG004|Overall Study|Lost to Follow-up|0|||
27819698|NCT02228382|81172527|FG000|Overall Study|Withdrawal by Subject|0|||
27819699|NCT02228382|81172528|FG001|Overall Study|Withdrawal by Subject|3|||
27819700|NCT02228382|81172529|FG002|Overall Study|Withdrawal by Subject|2|||
27819701|NCT02228382|81172530|FG003|Overall Study|Withdrawal by Subject|1|||
27819702|NCT02228382|81172531|FG004|Overall Study|Withdrawal by Subject|0|||
27819703|NCT02228382|81172527|FG000|Overall Study|Other|2|||
27819704|NCT02228382|81172528|FG001|Overall Study|Other|3|||
27592507|NCT00707031|80348691|FG001|Overall Study|Familial or Personal Reasons|15|||
27819705|NCT02228382|81172529|FG002|Overall Study|Other|3|||
27592508|NCT00707031|80348690|FG000|Overall Study|Serious Noncompliance|2|||
27819706|NCT02228382|81172530|FG003|Overall Study|Other|0|||
27819707|NCT02228382|81172531|FG004|Overall Study|Other|0|||
27819708|NCT05612724|81172533|FG000|Overall Study|Lost to Follow-up|4|||
27819709|NCT01406795|81172534|FG000|Overall Study|Withdrawal by Subject|1|||
27819710|NCT00095212|81172535|FG000|Overall Study|Withdrawal by Subject|1|||
27819711|NCT00095212|81172536|FG001|Overall Study|Withdrawal by Subject|3|||
27819712|NCT01572948|81172539|FG000|Overall Study|Lost to Follow-up|1|||
27819713|NCT01572948|81172540|FG001|Overall Study|Lost to Follow-up|0|||
27819714|NCT01572948|81172539|FG000|Overall Study|unable to contact|0|||
27819715|NCT01572948|81172540|FG001|Overall Study|unable to contact|1|||
27819716|NCT01536405|81172541|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
27819717|NCT01536405|81172542|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
27819718|NCT01536405|81172541|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
27819719|NCT01536405|81172542|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
27819720|NCT01536405|81172541|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
27819721|NCT01536405|81172542|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
27819722|NCT01536405|81172541|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
27819723|NCT01536405|81172542|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
27819724|NCT01536405|81172541|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
27819725|NCT01536405|81172542|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
27819726|NCT01536405|81172541|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
27819727|NCT01536405|81172542|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
27819728|NCT01536405|81172541|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
27819729|NCT01536405|81172542|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
27819730|NCT01536405|81172541|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
27819731|NCT01536405|81172542|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
27819732|NCT01536405|81172541|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
27819733|NCT01536405|81172542|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
27819734|NCT01536405|81172541|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
27819735|NCT01536405|81172542|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
27819736|NCT01536405|81172541|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
27819737|NCT01536405|81172542|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
27819738|NCT01536405|81172541|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
27592509|NCT00707031|80348691|FG001|Overall Study|Serious Noncompliance|3|||
27819739|NCT01536405|81172542|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
27819740|NCT01536405|81172541|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
27819741|NCT01536405|81172542|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
27819742|NCT01492400|81172545|FG000|Overall Study|Miscellaneous Reasons|2|||
27819743|NCT01492400|81172546|FG001|Overall Study|Miscellaneous Reasons|3|||
27592510|NCT00707031|80348690|FG000|Overall Study|Sponsor Decision|9|||
27592511|NCT00707031|80348691|FG001|Overall Study|Sponsor Decision|8|||
27592512|NCT01549613|80348692|FG000|Overall Study|Lost to Follow-up|11|||
27592513|NCT01549613|80348693|FG001|Overall Study|Lost to Follow-up|11|||
27819744|NCT01492400|81172545|FG000|Overall Study|Personal Reasons|0|||
27819745|NCT01492400|81172546|FG001|Overall Study|Personal Reasons|5|||
27819746|NCT01492400|81172545|FG000|Overall Study|Lost to Follow-up|3|||
27819747|NCT01492400|81172546|FG001|Overall Study|Lost to Follow-up|1|||
27819748|NCT01492400|81172545|FG000|Overall Study|Pregnancy|0|||
27819749|NCT01492400|81172546|FG001|Overall Study|Pregnancy|1|||
27819750|NCT01492400|81172545|FG000|Overall Study|Lack of Efficacy|1|||
27819751|NCT01492400|81172546|FG001|Overall Study|Lack of Efficacy|1|||
27819752|NCT01492400|81172545|FG000|Overall Study|Adverse Event|10|||
27819753|NCT01492400|81172546|FG001|Overall Study|Adverse Event|5|||
27819754|NCT03025880|81172547|FG000|Overall Study|Adverse Event|1|||
27819755|NCT03025880|81172548|FG001|Overall Study|Adverse Event|0|||
27819756|NCT03025880|81172547|FG000|Overall Study|Death|1|||
27819757|NCT03025880|81172548|FG001|Overall Study|Death|1|||
27819758|NCT03025880|81172547|FG000|Overall Study|Withdrawal by Subject|0|||
27819759|NCT03025880|81172548|FG001|Overall Study|Withdrawal by Subject|1|||
27819760|NCT03025880|81172547|FG000|Overall Study|Physician Decision|0|||
27819761|NCT03025880|81172548|FG001|Overall Study|Physician Decision|1|||
27880961|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
27880962|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
27693661|NCT02084056|80713711|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27819762|NCT03025880|81172547|FG000|Overall Study|Progressive Disease|12|||
27819763|NCT03025880|81172548|FG001|Overall Study|Progressive Disease|19|||
27819764|NCT00419770|81172549|FG000|Overall Study|Withdrawal by Subject|5|||
27819765|NCT00419770|81172550|FG001|Overall Study|Withdrawal by Subject|1|||
27819766|NCT00995410|81172560|FG000|Overall Study|Adverse Event|51|||
27819767|NCT00995410|81172560|FG000|Overall Study|Withdrawal by Subject|7|||
27819768|NCT00995410|81172560|FG000|Overall Study|Lost to Follow-up|2|||
27819769|NCT00995410|81172560|FG000|Overall Study|Misc|28|||
27819770|NCT01451762|81172561|FG000|Overall Study|Lost to Follow-up|3|||
27819771|NCT01451762|81172562|FG001|Overall Study|Lost to Follow-up|6|||
27819772|NCT01451762|81172563|FG002|Overall Study|Lost to Follow-up|6|||
27819773|NCT00064753|81172565|FG000|Overall Study|Death|251|||
27819774|NCT00064753|81172566|FG001|Overall Study|Death|242|||
27819775|NCT00064753|81172565|FG000|Overall Study|Withdrawal by Subject|198|||
27819776|NCT00064753|81172566|FG001|Overall Study|Withdrawal by Subject|171|||
27819777|NCT00064753|81172565|FG000|Overall Study|Lost to Follow-up|225|||
27819778|NCT00064753|81172566|FG001|Overall Study|Lost to Follow-up|235|||
27819779|NCT02032888|81172567|FG000|Treatment Period|Poor compliance/noncompliance|1|||
27819780|NCT02032888|81172568|FG001|Treatment Period|Poor compliance/noncompliance|1|||
27819781|NCT02032888|81172569|FG002|Treatment Period|Poor compliance/noncompliance|0|||
27819782|NCT02032888|81172567|FG000|Treatment Period|Other|1|||
27819783|NCT02032888|81172568|FG001|Treatment Period|Other|1|||
27819784|NCT02032888|81172569|FG002|Treatment Period|Other|0|||
27819785|NCT02032888|81172567|FG000|Follow-up Period|Lost to Follow-up|1|||
27819786|NCT02032888|81172568|FG001|Follow-up Period|Lost to Follow-up|1|||
27819787|NCT02032888|81172569|FG002|Follow-up Period|Lost to Follow-up|0|||
27819788|NCT02032888|81172567|FG000|Follow-up Period|Death|1|||
27819789|NCT02032888|81172568|FG001|Follow-up Period|Death|1|||
27819790|NCT02032888|81172569|FG002|Follow-up Period|Death|0|||
27819791|NCT02032888|81172567|FG000|Follow-up Period|Other|1|||
27819792|NCT02032888|81172568|FG001|Follow-up Period|Other|0|||
27819793|NCT02032888|81172569|FG002|Follow-up Period|Other|0|||
27819794|NCT01424644|81172573|FG000|Overall Study|Adverse Event|2|||
27693662|NCT02084056|80713712|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27693663|NCT02084056|80713709|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
27693664|NCT02084056|80713710|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27693665|NCT02084056|80713711|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27819795|NCT01424644|81172574|FG001|Overall Study|Adverse Event|0|||
27819796|NCT01424644|81172573|FG000|Overall Study|Withdrawal by Subject|9|||
27819797|NCT01424644|81172574|FG001|Overall Study|Withdrawal by Subject|12|||
27819798|NCT01424644|81172573|FG000|Overall Study|Lost to Follow-up|16|||
27819799|NCT01424644|81172574|FG001|Overall Study|Lost to Follow-up|12|||
27819800|NCT01424644|81172573|FG000|Overall Study|Protocol Violation|4|||
27819801|NCT01424644|81172574|FG001|Overall Study|Protocol Violation|3|||
27819802|NCT01424644|81172573|FG000|Overall Study|Administrative Reason|1|||
27819803|NCT01424644|81172574|FG001|Overall Study|Administrative Reason|0|||
27819804|NCT01424644|81172573|FG000|Overall Study|Unable to Classify|1|||
27819805|NCT01424644|81172574|FG001|Overall Study|Unable to Classify|0|||
27819806|NCT03952143|81172575|FG000|Lead-In Period|Adverse Event|2|||
27880963|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
27693666|NCT02084056|80713712|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27819807|NCT03952143|81172576|FG001|Lead-In Period|Adverse Event|0|||
27880964|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
27819808|NCT03952143|81172577|FG002|Lead-In Period|Adverse Event|0|||
27819809|NCT03952143|81172575|FG000|Lead-In Period|Lack of Efficacy|2|||
27819810|NCT03952143|81172576|FG001|Lead-In Period|Lack of Efficacy|0|||
27592514|NCT03595904|80348694|FG000|Overall Study|Protocol Violation|3|||
27592515|NCT03595904|80348695|FG001|Overall Study|Protocol Violation|1|||
27592516|NCT03595904|80348694|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
27592517|NCT03595904|80348695|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
27592518|NCT03595904|80348694|FG000|Overall Study|Insurance complications|1|||
27592519|NCT03595904|80348695|FG001|Overall Study|Insurance complications|0|||
27592520|NCT03595904|80348694|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
27592521|NCT03595904|80348695|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
27592522|NCT04794803|80348696|FG000|Overall Study|Death|1|||
27592523|NCT04794803|80348697|FG001|Overall Study|Death|3|||
27592524|NCT04794803|80348696|FG000|Overall Study|Lost to Follow-up|2|||
27592525|NCT04794803|80348697|FG001|Overall Study|Lost to Follow-up|2|||
27592526|NCT04794803|80348696|FG000|Overall Study|Withdrawal by Subject|1|||
27880965|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
27880966|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
27880967|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
27880968|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
27880969|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
27880970|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
27592527|NCT04794803|80348697|FG001|Overall Study|Withdrawal by Subject|0|||
27592528|NCT04794803|80348696|FG000|Overall Study|Physician Decision|1|||
27592529|NCT04794803|80348697|FG001|Overall Study|Physician Decision|1|||
27819811|NCT03952143|81172577|FG002|Lead-In Period|Lack of Efficacy|0|||
27819812|NCT03952143|81172575|FG000|Lead-In Period|Physician Decision|5|||
27819813|NCT03952143|81172576|FG001|Lead-In Period|Physician Decision|0|||
27819814|NCT03952143|81172577|FG002|Lead-In Period|Physician Decision|0|||
27880971|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
27880972|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
27819815|NCT03952143|81172575|FG000|Lead-In Period|Protocol Violation|5|||
27819816|NCT03952143|81172576|FG001|Lead-In Period|Protocol Violation|0|||
27819817|NCT03952143|81172577|FG002|Lead-In Period|Protocol Violation|0|||
27819818|NCT03952143|81172575|FG000|Lead-In Period|Withdrawal by Subject|19|||
27819819|NCT03952143|81172576|FG001|Lead-In Period|Withdrawal by Subject|0|||
27819820|NCT03952143|81172577|FG002|Lead-In Period|Withdrawal by Subject|0|||
27819821|NCT03952143|81172575|FG000|Treatment Period|Adverse Event|0|||
27819822|NCT03952143|81172576|FG001|Treatment Period|Adverse Event|0|||
27819823|NCT03952143|81172577|FG002|Treatment Period|Adverse Event|1|||
27819824|NCT03952143|81172575|FG000|Treatment Period|Lost to Follow-up|0|||
27819825|NCT03952143|81172576|FG001|Treatment Period|Lost to Follow-up|2|||
27819826|NCT03952143|81172577|FG002|Treatment Period|Lost to Follow-up|0|||
27592530|NCT04794803|80348696|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
27592531|NCT04794803|80348697|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
27880973|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
27592532|NCT04794803|80348696|FG000|Overall Study|Refused to continue the treatment|1|||
27592533|NCT04794803|80348697|FG001|Overall Study|Refused to continue the treatment|0|||
27819827|NCT03952143|81172575|FG000|Treatment Period|Physician Decision|0|||
27819828|NCT03952143|81172576|FG001|Treatment Period|Physician Decision|0|||
27880974|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
27880975|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
27880976|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
27880977|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
27880978|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
27880979|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
27880980|NCT00506415|81397848|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
27880981|NCT00506415|81397849|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
27819829|NCT03952143|81172577|FG002|Treatment Period|Physician Decision|2|||
27819830|NCT03952143|81172575|FG000|Treatment Period|Protocol Violation|0|||
27880982|NCT00506415|81397850|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
27880983|NCT00506415|81397851|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
27693667|NCT01589237|80713717|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
27693668|NCT01589237|80713718|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
27693669|NCT01589237|80713719|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
27693670|NCT01589237|80713720|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
27819831|NCT03952143|81172576|FG001|Treatment Period|Protocol Violation|0|||
27880984|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
27880985|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
27880986|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
27819832|NCT03952143|81172577|FG002|Treatment Period|Protocol Violation|1|||
27819833|NCT03952143|81172575|FG000|Treatment Period|Withdrawal by Subject|0|||
27819834|NCT03952143|81172576|FG001|Treatment Period|Withdrawal by Subject|5|||
27819835|NCT03952143|81172577|FG002|Treatment Period|Withdrawal by Subject|26|||
27819836|NCT03952143|81172575|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
27819837|NCT03952143|81172576|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
27819838|NCT03952143|81172577|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
27819839|NCT03952143|81172575|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
27819840|NCT03952143|81172576|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
27592534|NCT04794803|80348696|FG000|Overall Study|Patient admitted to ICU|0|||
27592535|NCT04794803|80348697|FG001|Overall Study|Patient admitted to ICU|1|||
27592536|NCT00529399|80348698|FG000|Overall Study|Lost to Follow-up|1|||
27592537|NCT00529399|80348699|FG001|Overall Study|Lost to Follow-up|0|||
27693671|NCT01589237|80713717|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
27693672|NCT01589237|80713718|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
27693673|NCT01589237|80713719|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
27693674|NCT01589237|80713720|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
27693675|NCT01589237|80713717|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
27693676|NCT01589237|80713718|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
27693677|NCT01589237|80713719|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
27693678|NCT01589237|80713720|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
27693679|NCT01589237|80713717|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
27693680|NCT01589237|80713718|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
27693681|NCT01589237|80713719|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
27693682|NCT01589237|80713720|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
27693683|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
27693684|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
27693685|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Death|0|||
27693686|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Death|2|||
27693687|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
27693688|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
27693689|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
27693690|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
27693691|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
27693692|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
27693693|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
27693694|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
27693695|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
27693696|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
27693697|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
27693698|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
27693699|NCT00343252|80713721|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
27693700|NCT00343252|80713722|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
27693701|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
27693702|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
27693703|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Death|3|||
27693704|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Death|3|||
27693705|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
27819841|NCT03952143|81172577|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
27592538|NCT00529399|80348700|FG002|Overall Study|Lost to Follow-up|1|||
27693706|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
27693707|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
27693708|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
27819842|NCT03787680|81172585|FG000|Overall Study|Physician Decision|2|||
27592539|NCT00529399|80348698|FG000|Overall Study|Withdrawal by Subject|1|||
27819843|NCT03787680|81172586|FG001|Overall Study|Physician Decision|3|||
27819844|NCT03787680|81172585|FG000|Overall Study|Adverse Event|7|||
27819845|NCT03787680|81172586|FG001|Overall Study|Adverse Event|3|||
27819846|NCT03787680|81172585|FG000|Overall Study|Withdrawal by Subject|2|||
27819847|NCT03787680|81172586|FG001|Overall Study|Withdrawal by Subject|1|||
27819848|NCT00950872|81172587|FG000|Overall Study|Withdrawal by Subject|1|||
27819849|NCT00950872|81172587|FG000|Overall Study|Did not have surgery|2|||
27819850|NCT00565448|81172588|FG000|Overall Study|Adverse Event|1|||
27819851|NCT00565448|81172589|FG001|Overall Study|Adverse Event|2|||
27819852|NCT00565448|81172588|FG000|Overall Study|Disease progression|1|||
27819853|NCT00565448|81172589|FG001|Overall Study|Disease progression|0|||
27819854|NCT00565448|81172588|FG000|Overall Study|Withdrawal by Subject|1|||
27819855|NCT00565448|81172589|FG001|Overall Study|Withdrawal by Subject|0|||
27819856|NCT02170688|81172594|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
27819857|NCT02170688|81172595|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
27819858|NCT02170688|81172596|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
27819859|NCT02170688|81172597|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
27693709|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
27693710|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
27693711|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
27693712|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
27693713|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
27819860|NCT02170688|81172598|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
27819861|NCT02170688|81172594|FG000|Overall Study|Full dose not received|0|||
27819862|NCT02170688|81172595|FG001|Overall Study|Full dose not received|1|||
27819863|NCT02170688|81172596|FG002|Overall Study|Full dose not received|0|||
27693714|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
27693715|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
27693716|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
27693717|NCT00343252|80713721|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
27693718|NCT00343252|80713722|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
27693719|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
27693720|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
27693721|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Death|4|||
27819864|NCT02170688|81172597|FG003|Overall Study|Full dose not received|0|||
27819865|NCT02170688|81172598|FG004|Overall Study|Full dose not received|0|||
27819866|NCT02170688|81172594|FG000|Overall Study|Physician Decision|0|||
27693722|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Death|5|||
27693723|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
27819867|NCT02170688|81172595|FG001|Overall Study|Physician Decision|0|||
27819868|NCT02170688|81172596|FG002|Overall Study|Physician Decision|1|||
27819869|NCT02170688|81172597|FG003|Overall Study|Physician Decision|0|||
27819870|NCT02170688|81172598|FG004|Overall Study|Physician Decision|0|||
27819871|NCT00324168|81172601|FG000|Overall Study|Lost to Follow-up|19|||
27819872|NCT00324168|81172602|FG001|Overall Study|Lost to Follow-up|18|||
27819873|NCT00324168|81172601|FG000|Overall Study|Death|3|||
27819874|NCT00324168|81172602|FG001|Overall Study|Death|3|||
27819875|NCT00324168|81172601|FG000|Overall Study|Patient did not visit in f/u window|6|||
27693724|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
27819876|NCT00324168|81172602|FG001|Overall Study|Patient did not visit in f/u window|9|||
27819877|NCT05097326|81172609|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
27819878|NCT05097326|81172610|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
27819879|NCT01422538|81172613|FG000|Overall Study|Lost to Follow-up|0|||
27819880|NCT01422538|81172614|FG001|Overall Study|Lost to Follow-up|1|||
27819881|NCT01422538|81172615|FG002|Overall Study|Lost to Follow-up|1|||
27693725|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
27693726|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
27693727|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
27693728|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
27819882|NCT01422538|81172613|FG000|Overall Study|Missed visit|0|||
27819883|NCT01422538|81172614|FG001|Overall Study|Missed visit|1|||
27819884|NCT01422538|81172615|FG002|Overall Study|Missed visit|1|||
27819885|NCT01471093|81175943|FG000|Overall Study|Adverse Event|1|||
27819886|NCT01471093|81175944|FG001|Overall Study|Adverse Event|0|||
27819887|NCT01471093|81175945|FG002|Overall Study|Adverse Event|0|||
27819888|NCT01471093|81175946|FG003|Overall Study|Adverse Event|0|||
27819889|NCT02457520|81175949|FG000|Active Treatment Phase|Adverse Event|10|||
27819890|NCT02457520|81175949|FG000|Active Treatment Phase|Lost to Follow-up|8|||
27819891|NCT02457520|81175949|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
27819892|NCT02457520|81175949|FG000|Active Treatment Phase|other|4|||
27819893|NCT02457520|81175949|FG000|Active Treatment Phase|Physician Decision|1|||
27819894|NCT02457520|81175949|FG000|Active Treatment Phase|Protocol Violation|1|||
27819895|NCT02457520|81175949|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
27819896|NCT02457520|81175949|FG000|Post-treatment Period|Other: Retreatment Required|7|||
27819897|NCT02457520|81175949|FG000|Post-treatment Period|Lost to Follow-up|23|||
27819898|NCT02457520|81175949|FG000|Post-treatment Period|Other|3|||
27819899|NCT02457520|81175949|FG000|Post-treatment Period|Physician Decision|1|||
27819900|NCT02457520|81175949|FG000|Post-treatment Period|Withdrawal by Subject|14|||
27819901|NCT01389102|81175958|FG000|Overall Study|Adverse Event|1|||
27819902|NCT01389102|81175959|FG001|Overall Study|Adverse Event|3|||
27592540|NCT00529399|80348699|FG001|Overall Study|Withdrawal by Subject|0|||
27693729|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
27693730|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
27693731|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
27693732|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
27693733|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
27693734|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
27819903|NCT01389102|81175960|FG002|Overall Study|Adverse Event|2|||
27693735|NCT00343252|80713721|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
27819904|NCT01389102|81175961|FG003|Overall Study|Adverse Event|2|||
27819905|NCT01389102|81175962|FG004|Overall Study|Adverse Event|2|||
27819906|NCT01389102|81175963|FG005|Overall Study|Adverse Event|2|||
27592541|NCT00529399|80348700|FG002|Overall Study|Withdrawal by Subject|1|||
27819907|NCT01389102|81175958|FG000|Overall Study|Hurricane Katrina|4|||
27819908|NCT01389102|81175959|FG001|Overall Study|Hurricane Katrina|2|||
27693736|NCT00343252|80713722|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
27693737|NCT01439360|80713723|FG000|Overall Study|Adverse Event|4|||
27693738|NCT01439360|80713724|FG001|Overall Study|Adverse Event|16|||
27693739|NCT01439360|80713723|FG000|Overall Study|Lost to Follow-up|43|||
27693740|NCT01439360|80713724|FG001|Overall Study|Lost to Follow-up|58|||
27693741|NCT01439360|80713723|FG000|Overall Study|Others|10|||
27693742|NCT01439360|80713724|FG001|Overall Study|Others|5|||
27693743|NCT01439360|80713723|FG000|Overall Study|Protocol Violation|1|||
27693744|NCT01439360|80713724|FG001|Overall Study|Protocol Violation|0|||
27693745|NCT01439360|80713723|FG000|Overall Study|Withdrawal by Subject|140|||
27693746|NCT01439360|80713724|FG001|Overall Study|Withdrawal by Subject|129|||
27693747|NCT00390910|80713725|FG000|Overall Study|Adverse Event|1|||
27693748|NCT00390910|80713726|FG001|Overall Study|Adverse Event|0|||
27693749|NCT00390910|80713727|FG002|Overall Study|Adverse Event|0|||
27693750|NCT00390910|80713725|FG000|Overall Study|Lost to Follow-up|0|||
27693751|NCT00390910|80713726|FG001|Overall Study|Lost to Follow-up|1|||
27693752|NCT00390910|80713727|FG002|Overall Study|Lost to Follow-up|5|||
27693753|NCT00390910|80713725|FG000|Overall Study|Withdrawal by Subject|1|||
27693754|NCT00390910|80713726|FG001|Overall Study|Withdrawal by Subject|3|||
27693755|NCT00390910|80713727|FG002|Overall Study|Withdrawal by Subject|2|||
27693756|NCT00390910|80713725|FG000|Overall Study|Migrated/moved from study area|0|||
27693757|NCT00390910|80713726|FG001|Overall Study|Migrated/moved from study area|0|||
27693758|NCT00390910|80713727|FG002|Overall Study|Migrated/moved from study area|3|||
27693759|NCT00738582|80713730|FG000|Combination Therapy|Completed Combination Therapy|1|||
27693760|NCT00738582|80713731|FG001|Combination Therapy|Completed Combination Therapy|0|||
27693761|NCT00738582|80713730|FG000|Combination Therapy|Physician Decision|1|||
27693762|NCT00738582|80713731|FG001|Combination Therapy|Physician Decision|0|||
27693763|NCT00738582|80713730|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
27693764|NCT00738582|80713731|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
27693765|NCT00738582|80713730|FG000|Combination Therapy|Other|5|||
27693766|NCT00738582|80713731|FG001|Combination Therapy|Other|0|||
27693767|NCT00738582|80713730|FG000|Combination Therapy|Adverse Event|16|||
27693768|NCT00738582|80713731|FG001|Combination Therapy|Adverse Event|0|||
27693769|NCT00738582|80713730|FG000|Combination Therapy|Progressive Disease|9|||
27693770|NCT00738582|80713731|FG001|Combination Therapy|Progressive Disease|0|||
27693771|NCT00738582|80713730|FG000|Maintenance Therapy|Other|0|||
27819909|NCT01389102|81175960|FG002|Overall Study|Hurricane Katrina|3|||
27819910|NCT01389102|81175961|FG003|Overall Study|Hurricane Katrina|0|||
27819911|NCT01389102|81175962|FG004|Overall Study|Hurricane Katrina|3|||
27819912|NCT01389102|81175963|FG005|Overall Study|Hurricane Katrina|1|||
27819913|NCT01389102|81175958|FG000|Overall Study|Lost to Follow-up|4|||
27819914|NCT01389102|81175959|FG001|Overall Study|Lost to Follow-up|1|||
27819915|NCT01389102|81175960|FG002|Overall Study|Lost to Follow-up|1|||
27819916|NCT01389102|81175961|FG003|Overall Study|Lost to Follow-up|2|||
27819917|NCT01389102|81175962|FG004|Overall Study|Lost to Follow-up|4|||
27819918|NCT01389102|81175963|FG005|Overall Study|Lost to Follow-up|1|||
27819919|NCT01389102|81175958|FG000|Overall Study|Protocol Violation|0|||
27819920|NCT01389102|81175959|FG001|Overall Study|Protocol Violation|0|||
27693772|NCT00738582|80713731|FG001|Maintenance Therapy|Other|2|||
27693773|NCT00738582|80713730|FG000|Maintenance Therapy|Adverse Event|0|||
27693774|NCT00738582|80713731|FG001|Maintenance Therapy|Adverse Event|6|||
27693775|NCT00738582|80713730|FG000|Maintenance Therapy|Progressive Disease|0|||
27819921|NCT01389102|81175960|FG002|Overall Study|Protocol Violation|3|||
27819922|NCT01389102|81175961|FG003|Overall Study|Protocol Violation|0|||
27819923|NCT01389102|81175962|FG004|Overall Study|Protocol Violation|1|||
27693776|NCT00738582|80713731|FG001|Maintenance Therapy|Progressive Disease|47|||
27693777|NCT00738582|80713730|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
27693778|NCT00738582|80713731|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
27693779|NCT02680002|80713732|FG000|Overall Study|Lost to Follow-up|5|||
27693780|NCT02680002|80713733|FG001|Overall Study|Lost to Follow-up|1|||
27693781|NCT02680002|80713734|FG002|Overall Study|Lost to Follow-up|4|||
27819924|NCT01389102|81175963|FG005|Overall Study|Protocol Violation|1|||
27693782|NCT02680002|80713735|FG003|Overall Study|Lost to Follow-up|2|||
27693783|NCT02680002|80713736|FG004|Overall Study|Lost to Follow-up|0|||
27693784|NCT02680002|80713737|FG005|Overall Study|Lost to Follow-up|2|||
27693785|NCT02680002|80713732|FG000|Overall Study|Physician Decision|5|||
27693786|NCT02680002|80713733|FG001|Overall Study|Physician Decision|1|||
27693787|NCT02680002|80713734|FG002|Overall Study|Physician Decision|1|||
27693788|NCT02680002|80713735|FG003|Overall Study|Physician Decision|1|||
27693789|NCT02680002|80713736|FG004|Overall Study|Physician Decision|1|||
27693790|NCT02680002|80713737|FG005|Overall Study|Physician Decision|1|||
27693791|NCT02680002|80713732|FG000|Overall Study|Protocol Violation|1|||
27693792|NCT02680002|80713733|FG001|Overall Study|Protocol Violation|0|||
27693793|NCT02680002|80713734|FG002|Overall Study|Protocol Violation|1|||
27693794|NCT02680002|80713735|FG003|Overall Study|Protocol Violation|0|||
27693795|NCT02680002|80713736|FG004|Overall Study|Protocol Violation|1|||
27693796|NCT02680002|80713737|FG005|Overall Study|Protocol Violation|2|||
27693797|NCT02680002|80713732|FG000|Overall Study|Withdrawal by Subject|0|||
27693798|NCT02680002|80713733|FG001|Overall Study|Withdrawal by Subject|0|||
27693799|NCT02680002|80713734|FG002|Overall Study|Withdrawal by Subject|1|||
27693800|NCT02680002|80713735|FG003|Overall Study|Withdrawal by Subject|0|||
27693801|NCT02680002|80713736|FG004|Overall Study|Withdrawal by Subject|2|||
27693802|NCT02680002|80713737|FG005|Overall Study|Withdrawal by Subject|2|||
27693803|NCT02680002|80713732|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
27693804|NCT02680002|80713733|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
27819925|NCT01389102|81175958|FG000|Overall Study|Withdrawal by Subject|7|||
27819926|NCT01389102|81175959|FG001|Overall Study|Withdrawal by Subject|4|||
27819927|NCT01389102|81175960|FG002|Overall Study|Withdrawal by Subject|9|||
27819928|NCT01389102|81175961|FG003|Overall Study|Withdrawal by Subject|2|||
27819929|NCT01389102|81175962|FG004|Overall Study|Withdrawal by Subject|3|||
27819930|NCT01389102|81175963|FG005|Overall Study|Withdrawal by Subject|3|||
27819931|NCT01389102|81175958|FG000|Overall Study|Subject Traveling Out of Country|0|||
27819932|NCT01389102|81175959|FG001|Overall Study|Subject Traveling Out of Country|0|||
27819933|NCT01389102|81175960|FG002|Overall Study|Subject Traveling Out of Country|0|||
27819934|NCT01389102|81175961|FG003|Overall Study|Subject Traveling Out of Country|1|||
27819935|NCT01389102|81175962|FG004|Overall Study|Subject Traveling Out of Country|0|||
27819936|NCT01389102|81175963|FG005|Overall Study|Subject Traveling Out of Country|0|||
27819937|NCT01389102|81175958|FG000|Overall Study|Subject Moved|2|||
27819938|NCT01389102|81175959|FG001|Overall Study|Subject Moved|0|||
27819939|NCT01389102|81175960|FG002|Overall Study|Subject Moved|1|||
27592542|NCT00529399|80348698|FG000|Overall Study|Non-compliant|0|||
27592543|NCT00529399|80348699|FG001|Overall Study|Non-compliant|1|||
27592544|NCT00529399|80348700|FG002|Overall Study|Non-compliant|0|||
27592545|NCT02065336|80348714|FG000|Extension Phase|Study Terminated by Sponsor|0|||
27592546|NCT02065336|80348715|FG001|Extension Phase|Study Terminated by Sponsor|0|||
27592547|NCT02065336|80348716|FG002|Extension Phase|Study Terminated by Sponsor|0|||
27592548|NCT02065336|80348717|FG003|Extension Phase|Study Terminated by Sponsor|0|||
27819940|NCT01389102|81175961|FG003|Overall Study|Subject Moved|0|||
27880987|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
27880988|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
27880989|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
27880990|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
27880991|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
27819941|NCT01389102|81175962|FG004|Overall Study|Subject Moved|0|||
27819942|NCT01389102|81175963|FG005|Overall Study|Subject Moved|0|||
27819943|NCT01389102|81175958|FG000|Overall Study|Unavailable due to husband's illness|0|||
27819944|NCT01389102|81175959|FG001|Overall Study|Unavailable due to husband's illness|1|||
27819945|NCT01389102|81175960|FG002|Overall Study|Unavailable due to husband's illness|0|||
27819946|NCT01389102|81175961|FG003|Overall Study|Unavailable due to husband's illness|0|||
27592549|NCT02065336|80348718|FG004|Extension Phase|Study Terminated by Sponsor|0|||
27693805|NCT02680002|80713734|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
27693806|NCT02680002|80713735|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
27693807|NCT02680002|80713736|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
27693808|NCT02680002|80713737|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
27693809|NCT02680002|80713732|FG000|Overall Study|Other|0|||
27693810|NCT02680002|80713733|FG001|Overall Study|Other|1|||
27880992|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27880993|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27880994|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
27880995|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
27880996|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
27880997|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
27880998|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
27880999|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
27881000|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
27881001|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
27881002|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
27881003|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
27881004|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27881005|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27881006|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
27819947|NCT01389102|81175962|FG004|Overall Study|Unavailable due to husband's illness|0|||
27819948|NCT01389102|81175963|FG005|Overall Study|Unavailable due to husband's illness|0|||
27819949|NCT01389102|81175958|FG000|Overall Study|Investigator Judgement|0|||
27819950|NCT01389102|81175959|FG001|Overall Study|Investigator Judgement|1|||
27819951|NCT01389102|81175960|FG002|Overall Study|Investigator Judgement|0|||
27819952|NCT01389102|81175961|FG003|Overall Study|Investigator Judgement|0|||
27819953|NCT01389102|81175962|FG004|Overall Study|Investigator Judgement|0|||
27819954|NCT01389102|81175963|FG005|Overall Study|Investigator Judgement|0|||
27819955|NCT00414765|81175964|FG000|Overall Study|Adverse Event|5|||
27881007|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
27881008|NCT00506415|81397848|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
27881009|NCT00506415|81397849|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
27819956|NCT00414765|81175965|FG001|Overall Study|Adverse Event|9|||
27819957|NCT00414765|81175964|FG000|Overall Study|Withdrawal by Subject|1|||
27881010|NCT00506415|81397850|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
27881011|NCT00506415|81397851|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
27881012|NCT01441765|81397852|FG000|Overall Study|Death|1|||
27881013|NCT01441765|81397853|FG001|Overall Study|Death|0|||
27881014|NCT01921101|81397854|FG000|Overall Study|Death|16|||
27881015|NCT01921101|81397855|FG001|Overall Study|Death|6|||
27819958|NCT00414765|81175965|FG001|Overall Study|Withdrawal by Subject|1|||
27819959|NCT00414765|81175964|FG000|Overall Study|Disease Progression|0|||
27819960|NCT00414765|81175965|FG001|Overall Study|Disease Progression|1|||
27819961|NCT00389064|81175967|FG000|Overall Study|Adverse Event|11|||
27819962|NCT00389064|81175968|FG001|Overall Study|Adverse Event|3|||
27819963|NCT00389064|81175967|FG000|Overall Study|Lack of Efficacy|3|||
27819964|NCT00389064|81175968|FG001|Overall Study|Lack of Efficacy|14|||
27819965|NCT00389064|81175967|FG000|Overall Study|Withdrawal by Subject|17|||
27819966|NCT00389064|81175968|FG001|Overall Study|Withdrawal by Subject|27|||
27819967|NCT00389064|81175967|FG000|Overall Study|Physician Decision|2|||
27819968|NCT00389064|81175968|FG001|Overall Study|Physician Decision|2|||
27819969|NCT00389064|81175967|FG000|Overall Study|Lost to Follow-up|1|||
27819970|NCT00389064|81175968|FG001|Overall Study|Lost to Follow-up|2|||
27819971|NCT00389064|81175967|FG000|Overall Study|Protocol Violation|2|||
27819972|NCT00389064|81175968|FG001|Overall Study|Protocol Violation|0|||
27819973|NCT00389064|81175967|FG000|Overall Study|Multiple Reasons|9|||
27819974|NCT00389064|81175968|FG001|Overall Study|Multiple Reasons|11|||
27819975|NCT01458405|81175971|FG000|Phase 1 (up to 12 Months)|Other|0|||
27819976|NCT01458405|81175972|FG001|Phase 1 (up to 12 Months)|Other|1|||
27819977|NCT01458405|81175973|FG002|Phase 1 (up to 12 Months)|Other|0|||
27819978|NCT01458405|81175974|FG003|Phase 1 (up to 12 Months)|Other|0|||
27819979|NCT01458405|81175971|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
27819980|NCT01458405|81175972|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
27819981|NCT01458405|81175973|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
27819982|NCT01458405|81175974|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
27819983|NCT01458405|81175971|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
27819984|NCT01458405|81175972|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
27819985|NCT01458405|81175973|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
27819986|NCT01458405|81175974|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
27819987|NCT01458405|81175971|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
27819988|NCT01458405|81175972|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
27819989|NCT01458405|81175973|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
27819990|NCT01458405|81175974|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
27819991|NCT02731157|81175977|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
27819992|NCT00528606|81175980|FG000|Overall Study|Withdrew consent|4|||
27819993|NCT00528606|81175981|FG001|Overall Study|Withdrew consent|3|||
27819994|NCT00528606|81175980|FG000|Overall Study|Lost to Follow-up|4|||
27819995|NCT00528606|81175981|FG001|Overall Study|Lost to Follow-up|1|||
27819996|NCT00528606|81175980|FG000|Overall Study|Adverse Event|3|||
27819997|NCT00528606|81175981|FG001|Overall Study|Adverse Event|0|||
27819998|NCT00528606|81175980|FG000|Overall Study|Other|2|||
27819999|NCT00528606|81175981|FG001|Overall Study|Other|0|||
27820000|NCT01223365|81175984|FG000|Open-label Titration Period|Enrolled but not treated|1|||
27820001|NCT01223365|81175984|FG000|Open-label Titration Period|Adverse Event|23|||
27820002|NCT01223365|81175984|FG000|Open-label Titration Period|Lack of Efficacy|3|||
27820003|NCT01223365|81175984|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
27820004|NCT01223365|81175984|FG000|Open-label Titration Period|Protocol Violation|1|||
27820005|NCT01223365|81175984|FG000|Open-label Titration Period|Lost to Follow-up|2|||
27820006|NCT01223365|81175984|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
27820007|NCT01223365|81175984|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
27820008|NCT01223365|81175984|FG000|Open-label Titration Period|Starting physical therapy|1|||
27820009|NCT01223365|81175984|FG000|Open-label Treatment Period|Adverse Event|39|||
27820010|NCT01223365|81175984|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
27820011|NCT01223365|81175984|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
27820012|NCT01223365|81175984|FG000|Open-label Treatment Period|Protocol Violation|15|||
27820013|NCT01223365|81175984|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
27820014|NCT01223365|81175984|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
27820015|NCT01223365|81175984|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
27820016|NCT01223365|81175984|FG000|Open-label Treatment Period|Moved out of area|2|||
27820017|NCT01223365|81175984|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
27820018|NCT01223365|81175984|FG000|Open-label Treatment Period|"Out of window"|1|||
27820019|NCT01223365|81175984|FG000|Open-label Treatment Period|Starting physical therapy|1|||
27820020|NCT01223365|81175984|FG000|Open-label Treatment Period|Physician Decision|2|||
27820021|NCT00874237|81175985|FG000|Overall Study|Physician Decision|0|||
27820022|NCT00874237|81175986|FG001|Overall Study|Physician Decision|1|||
27820023|NCT00874237|81175987|FG002|Overall Study|Physician Decision|0|||
27820024|NCT00874237|81175988|FG003|Overall Study|Physician Decision|0|||
27820025|NCT00874237|81175989|FG004|Overall Study|Physician Decision|0|||
27820026|NCT00874237|81175990|FG005|Overall Study|Physician Decision|0|||
27820027|NCT00874237|81175985|FG000|Overall Study|Withdrawal by Subject|0|||
27820028|NCT00874237|81175986|FG001|Overall Study|Withdrawal by Subject|0|||
27820029|NCT00874237|81175987|FG002|Overall Study|Withdrawal by Subject|1|||
27820030|NCT00874237|81175988|FG003|Overall Study|Withdrawal by Subject|0|||
27820031|NCT00874237|81175989|FG004|Overall Study|Withdrawal by Subject|0|||
27820032|NCT00874237|81175990|FG005|Overall Study|Withdrawal by Subject|0|||
27820033|NCT01974141|81175992|FG000|Overall Study|Other Reasons|28|||
27881016|NCT02062450|81397857|FG000|Overall Study|No follow-up visit|124|||
27820034|NCT01974141|81175993|FG001|Overall Study|Other Reasons|18|||
27820035|NCT01974141|81175992|FG000|Overall Study|Protocol Violation|2|||
27820036|NCT01974141|81175993|FG001|Overall Study|Protocol Violation|6|||
27820037|NCT01974141|81175992|FG000|Overall Study|Personal Reasons|21|||
27820038|NCT01974141|81175993|FG001|Overall Study|Personal Reasons|20|||
27820039|NCT01974141|81175992|FG000|Overall Study|Lost to Follow-up|38|||
27820040|NCT01974141|81175993|FG001|Overall Study|Lost to Follow-up|29|||
27820041|NCT01974141|81175992|FG000|Overall Study|Pregnancy|3|||
27820042|NCT01974141|81175993|FG001|Overall Study|Pregnancy|3|||
27820043|NCT01974141|81175992|FG000|Overall Study|Lack of Efficacy|0|||
27820044|NCT01974141|81175993|FG001|Overall Study|Lack of Efficacy|1|||
27820045|NCT01974141|81175992|FG000|Overall Study|Adverse Event|4|||
27820046|NCT01974141|81175993|FG001|Overall Study|Adverse Event|5|||
27881017|NCT02859337|81397858|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
27820047|NCT02924883|81175996|FG000|Overall Study|Death|39|||
27820048|NCT02924883|81175997|FG001|Overall Study|Death|20|||
27820049|NCT02924883|81175996|FG000|Overall Study|Lost to Follow-up|1|||
27820050|NCT02924883|81175997|FG001|Overall Study|Lost to Follow-up|0|||
27820051|NCT02924883|81175996|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
27820052|NCT02924883|81175997|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
27820053|NCT02924883|81175996|FG000|Overall Study|Protocol Violation|1|||
27820054|NCT02924883|81175997|FG001|Overall Study|Protocol Violation|0|||
27592550|NCT02065336|80348719|FG005|Extension Phase|Study Terminated by Sponsor|0|||
27592551|NCT02065336|80348720|FG006|Extension Phase|Study Terminated by Sponsor|0|||
27592552|NCT02065336|80348721|FG007|Extension Phase|Study Terminated by Sponsor|0|||
27592553|NCT02065336|80348722|FG008|Extension Phase|Study Terminated by Sponsor|2|||
27592554|NCT02065336|80348723|FG009|Extension Phase|Study Terminated by Sponsor|8|||
27592555|NCT02526693|80348724|FG000|Overall Study|Physician Decision|3|||
27592556|NCT02526693|80348725|FG001|Overall Study|Physician Decision|1|||
27592557|NCT01474681|80348726|FG000|Overall Study|Death|0|||
27592558|NCT01474681|80348727|FG001|Overall Study|Death|3|||
27592559|NCT01474681|80348728|FG002|Overall Study|Death|2|||
27592560|NCT01474681|80348729|FG003|Overall Study|Death|6|||
27592561|NCT00553267|80348731|FG000|Overall Study|Adverse Event|8|||
27592562|NCT00553267|80348732|FG001|Overall Study|Adverse Event|10|||
27592563|NCT00553267|80348733|FG002|Overall Study|Adverse Event|5|||
27592564|NCT00553267|80348731|FG000|Overall Study|Non compliant with protocol|3|||
27592565|NCT00553267|80348732|FG001|Overall Study|Non compliant with protocol|3|||
27592566|NCT00553267|80348733|FG002|Overall Study|Non compliant with protocol|2|||
27592567|NCT00553267|80348731|FG000|Overall Study|Lost to Follow-up|0|||
27592568|NCT00553267|80348732|FG001|Overall Study|Lost to Follow-up|0|||
27592569|NCT00553267|80348733|FG002|Overall Study|Lost to Follow-up|1|||
27592570|NCT00553267|80348731|FG000|Overall Study|Consent withdrawn|2|||
27592571|NCT00553267|80348732|FG001|Overall Study|Consent withdrawn|3|||
27592572|NCT00553267|80348733|FG002|Overall Study|Consent withdrawn|1|||
27693811|NCT02680002|80713734|FG002|Overall Study|Other|0|||
27693812|NCT02680002|80713735|FG003|Overall Study|Other|0|||
27820055|NCT02924883|81175996|FG000|Overall Study|Withdrawal by Subject|22|||
27820056|NCT02924883|81175997|FG001|Overall Study|Withdrawal by Subject|16|||
27820057|NCT02924883|81175996|FG000|Overall Study|Progressive Disease|1|||
27820058|NCT02924883|81175997|FG001|Overall Study|Progressive Disease|0|||
27820059|NCT02924883|81175996|FG000|Overall Study|Study Terminated by Sponsor|69|||
27820060|NCT02924883|81175997|FG001|Overall Study|Study Terminated by Sponsor|32|||
27820061|NCT04786184|81176000|FG000|Overall Study|Adverse Event|4|||
27820062|NCT04786184|81176001|FG001|Overall Study|Adverse Event|0|||
27820063|NCT04786184|81176000|FG000|Overall Study|Withdrawal by Subject|3|||
27592573|NCT00553267|80348731|FG000|Overall Study|Specified category|1|||
27592574|NCT00553267|80348732|FG001|Overall Study|Specified category|2|||
27693813|NCT02680002|80713736|FG004|Overall Study|Other|1|||
27693814|NCT02680002|80713737|FG005|Overall Study|Other|0|||
27592575|NCT00553267|80348733|FG002|Overall Study|Specified category|1|||
27693815|NCT02680002|80713732|FG000|Overall Study|Adverse Event|0|||
27820064|NCT04786184|81176001|FG001|Overall Study|Withdrawal by Subject|1|||
27592576|NCT00251745|80348734|FG000|Overall Study|Adverse Event|7|||
27693816|NCT02680002|80713733|FG001|Overall Study|Adverse Event|0|||
27820065|NCT04786184|81176000|FG000|Overall Study|Lost to Follow-up|4|||
27820066|NCT04786184|81176001|FG001|Overall Study|Lost to Follow-up|2|||
27881018|NCT02859337|81397859|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
27881019|NCT02859337|81397860|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
27881020|NCT02859337|81397858|FG000|Overall Study|Withdrawal by Subject|3|||
27881021|NCT02859337|81397859|FG001|Overall Study|Withdrawal by Subject|1|||
27881022|NCT02859337|81397860|FG002|Overall Study|Withdrawal by Subject|0|||
27881023|NCT02859337|81397858|FG000|Overall Study|Lost to Follow-up|1|||
27881024|NCT02859337|81397859|FG001|Overall Study|Lost to Follow-up|0|||
27881025|NCT02859337|81397860|FG002|Overall Study|Lost to Follow-up|0|||
27881026|NCT03682848|81397861|FG000|Overall Study|Withdrawal by Subject|2|||
27881027|NCT03682848|81397861|FG000|Overall Study|Site closed|5|||
27881028|NCT03682848|81397861|FG000|Overall Study|Protocol Deviation|1|||
27881029|NCT03682848|81397861|FG000|Overall Study|Adverse Event|1|||
27881030|NCT00957801|81397862|FG000|Overall Study|Withdrawal by Subject|0|||
27881031|NCT00957801|81397863|FG001|Overall Study|Withdrawal by Subject|0|||
27881032|NCT00957801|81397864|FG002|Overall Study|Withdrawal by Subject|0|||
27881033|NCT00957801|81397865|FG003|Overall Study|Withdrawal by Subject|1|||
27881034|NCT00931528|81397869|FG000|Overall Study|Protocol Violation|9|||
27881035|NCT00931528|81397870|FG001|Overall Study|Protocol Violation|12|||
27881036|NCT00931528|81397869|FG000|Overall Study|Withdrawal by Subject|4|||
27881037|NCT00931528|81397870|FG001|Overall Study|Withdrawal by Subject|12|||
27881038|NCT00931528|81397869|FG000|Overall Study|Lost to Follow-up|6|||
27881039|NCT00931528|81397870|FG001|Overall Study|Lost to Follow-up|13|||
27881040|NCT00931528|81397869|FG000|Overall Study|Assessment outside of Time Frame|22|||
27881041|NCT00931528|81397870|FG001|Overall Study|Assessment outside of Time Frame|23|||
27881042|NCT02097745|81397871|FG000|Overall Study|Adverse Event|25|||
27881043|NCT02097745|81397871|FG000|Overall Study|Death|16|||
27881044|NCT02097745|81397871|FG000|Overall Study|Failure to Return|14|||
27881045|NCT02097745|81397871|FG000|Overall Study|Administrative/Other|27|||
27881046|NCT02097745|81397871|FG000|Overall Study|Reason Not Specified|96|||
27881047|NCT01314872|81397878|FG000|Treatment Period 1|Protocol Violation|2|||
27881048|NCT01314872|81397879|FG001|Treatment Period 1|Protocol Violation|1|||
27881049|NCT01314872|81397880|FG002|Treatment Period 1|Protocol Violation|1|||
27881050|NCT01314872|81397881|FG003|Treatment Period 1|Protocol Violation|0|||
27881051|NCT01314872|81397882|FG004|Treatment Period 1|Protocol Violation|1|||
27881052|NCT01314872|81397883|FG005|Treatment Period 1|Protocol Violation|0|||
27881053|NCT01314872|81397884|FG006|Treatment Period 1|Protocol Violation|0|||
27881054|NCT01314872|81397885|FG007|Treatment Period 1|Protocol Violation|0|||
27881055|NCT01314872|81397886|FG008|Treatment Period 1|Protocol Violation|0|||
27881056|NCT01314872|81397887|FG009|Treatment Period 1|Protocol Violation|1|||
27881057|NCT01314872|81397888|FG010|Treatment Period 1|Protocol Violation|1|||
27881058|NCT01314872|81397889|FG011|Treatment Period 1|Protocol Violation|0|||
27881059|NCT01314872|81397890|FG012|Treatment Period 1|Protocol Violation|0|||
27881060|NCT01314872|81397891|FG013|Treatment Period 1|Protocol Violation|0|||
27881061|NCT01314872|81397892|FG014|Treatment Period 1|Protocol Violation|0|||
27881062|NCT01314872|81397878|FG000|Treatment Period 1|Physician Decision|0|||
27881063|NCT01314872|81397879|FG001|Treatment Period 1|Physician Decision|1|||
27881064|NCT01314872|81397880|FG002|Treatment Period 1|Physician Decision|0|||
27881065|NCT01314872|81397881|FG003|Treatment Period 1|Physician Decision|1|||
27881066|NCT01314872|81397882|FG004|Treatment Period 1|Physician Decision|0|||
27881067|NCT01314872|81397883|FG005|Treatment Period 1|Physician Decision|0|||
27881068|NCT01314872|81397884|FG006|Treatment Period 1|Physician Decision|0|||
27881069|NCT01314872|81397885|FG007|Treatment Period 1|Physician Decision|0|||
27881070|NCT01314872|81397886|FG008|Treatment Period 1|Physician Decision|0|||
27881071|NCT01314872|81397887|FG009|Treatment Period 1|Physician Decision|1|||
27881072|NCT01314872|81397888|FG010|Treatment Period 1|Physician Decision|0|||
27881073|NCT01314872|81397889|FG011|Treatment Period 1|Physician Decision|0|||
27881074|NCT01314872|81397890|FG012|Treatment Period 1|Physician Decision|0|||
27881075|NCT01314872|81397891|FG013|Treatment Period 1|Physician Decision|0|||
27881076|NCT01314872|81397892|FG014|Treatment Period 1|Physician Decision|0|||
27881077|NCT01314872|81397878|FG000|Treatment Period 1|Lack of Efficacy|1|||
27881078|NCT01314872|81397879|FG001|Treatment Period 1|Lack of Efficacy|0|||
27881079|NCT01314872|81397880|FG002|Treatment Period 1|Lack of Efficacy|0|||
27881080|NCT01314872|81397881|FG003|Treatment Period 1|Lack of Efficacy|0|||
27881081|NCT01314872|81397882|FG004|Treatment Period 1|Lack of Efficacy|0|||
27881082|NCT01314872|81397883|FG005|Treatment Period 1|Lack of Efficacy|1|||
27881083|NCT01314872|81397884|FG006|Treatment Period 1|Lack of Efficacy|0|||
27820067|NCT01449630|81176005|FG000|Period 1|Physician Decision|1|||
27820068|NCT01449630|81176006|FG001|Period 1|Physician Decision|0|||
27820069|NCT01449630|81176007|FG002|Period 1|Physician Decision|0|||
27820070|NCT01449630|81176008|FG003|Period 1|Physician Decision|1|||
27820071|NCT01449630|81176009|FG004|Period 1|Physician Decision|0|||
27820072|NCT01449630|81176010|FG005|Period 1|Physician Decision|0|||
27820073|NCT01449630|81176011|FG006|Period 1|Physician Decision|0|||
27820074|NCT01449630|81176012|FG007|Period 1|Physician Decision|0|||
27820075|NCT01449630|81176013|FG008|Period 1|Physician Decision|0|||
27820076|NCT01449630|81176005|FG000|Period 1|Sponsor Decision|0|||
27820077|NCT01449630|81176006|FG001|Period 1|Sponsor Decision|0|||
27820078|NCT01449630|81176007|FG002|Period 1|Sponsor Decision|0|||
27820079|NCT01449630|81176008|FG003|Period 1|Sponsor Decision|0|||
27820080|NCT01449630|81176009|FG004|Period 1|Sponsor Decision|0|||
27820081|NCT01449630|81176010|FG005|Period 1|Sponsor Decision|1|||
27820082|NCT01449630|81176011|FG006|Period 1|Sponsor Decision|0|||
27820083|NCT01449630|81176012|FG007|Period 1|Sponsor Decision|0|||
27820084|NCT01449630|81176013|FG008|Period 1|Sponsor Decision|0|||
27820085|NCT01449630|81176005|FG000|Period 2|Sponsor Decision|0|||
27820086|NCT01449630|81176006|FG001|Period 2|Sponsor Decision|0|||
27820087|NCT01449630|81176007|FG002|Period 2|Sponsor Decision|0|||
27820088|NCT01449630|81176008|FG003|Period 2|Sponsor Decision|0|||
27820089|NCT01449630|81176009|FG004|Period 2|Sponsor Decision|0|||
27881084|NCT01314872|81397885|FG007|Treatment Period 1|Lack of Efficacy|2|||
27881085|NCT01314872|81397886|FG008|Treatment Period 1|Lack of Efficacy|0|||
27881086|NCT01314872|81397887|FG009|Treatment Period 1|Lack of Efficacy|0|||
27881087|NCT01314872|81397888|FG010|Treatment Period 1|Lack of Efficacy|0|||
27820090|NCT01449630|81176010|FG005|Period 2|Sponsor Decision|0|||
27881088|NCT01314872|81397889|FG011|Treatment Period 1|Lack of Efficacy|0|||
27881089|NCT01314872|81397890|FG012|Treatment Period 1|Lack of Efficacy|0|||
27820091|NCT01449630|81176011|FG006|Period 2|Sponsor Decision|1|||
27881090|NCT01314872|81397891|FG013|Treatment Period 1|Lack of Efficacy|0|||
27820092|NCT01449630|81176012|FG007|Period 2|Sponsor Decision|0|||
27820093|NCT01449630|81176013|FG008|Period 2|Sponsor Decision|0|||
27820094|NCT00397488|81176014|FG000|Overall Study|Withdrawal by Subject|3|||
27820095|NCT00397488|81176014|FG000|Overall Study|Adverse Event|3|||
27820096|NCT00397488|81176014|FG000|Overall Study|Death|1|||
27820097|NCT00527423|81176018|FG000|Overall Study|Protocol Violation|1|||
27881091|NCT01314872|81397892|FG014|Treatment Period 1|Lack of Efficacy|0|||
27881092|NCT01314872|81397878|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
27881093|NCT01314872|81397879|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
27881094|NCT01314872|81397880|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
27881095|NCT01314872|81397881|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
27881096|NCT01314872|81397882|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
27881097|NCT01314872|81397883|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
27881098|NCT01314872|81397884|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
27881099|NCT01314872|81397885|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
27820098|NCT00527423|81176018|FG000|Overall Study|Adverse Event|5|||
27820099|NCT00527423|81176018|FG000|Overall Study|Physician Decision|4|||
27820100|NCT00527423|81176018|FG000|Overall Study|Withdrawal by Subject|10|||
27820101|NCT00527423|81176018|FG000|Overall Study|Lost to Follow-up|4|||
27820102|NCT00527423|81176018|FG000|Overall Study|OTHER|4|||
27820103|NCT00527423|81176018|FG000|Overall Study|Death|9|||
27820104|NCT00880568|81176023|FG000|Overall Study|Disease progression|3|||
27820105|NCT00880568|81176024|FG001|Overall Study|Disease progression|3|||
27820106|NCT00880568|81176025|FG002|Overall Study|Disease progression|3|||
27820107|NCT00880568|81176026|FG003|Overall Study|Disease progression|1|||
27820108|NCT00880568|81176027|FG004|Overall Study|Disease progression|3|||
27881100|NCT01314872|81397886|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
27881101|NCT01314872|81397887|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
27881102|NCT01314872|81397888|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
27881103|NCT01314872|81397889|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
27881104|NCT01314872|81397890|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
27881105|NCT01314872|81397891|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
27881106|NCT01314872|81397892|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
27881107|NCT01314872|81397878|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27881108|NCT01314872|81397879|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27881109|NCT01314872|81397880|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27881110|NCT01314872|81397881|FG003|Treatment Period 1|Withdrawal by Subject|2|||
27881111|NCT01314872|81397882|FG004|Treatment Period 1|Withdrawal by Subject|3|||
27881112|NCT01314872|81397883|FG005|Treatment Period 1|Withdrawal by Subject|1|||
27592577|NCT00251745|80348735|FG001|Overall Study|Adverse Event|9|||
27592578|NCT00251745|80348736|FG002|Overall Study|Adverse Event|11|||
27592579|NCT00251745|80348734|FG000|Overall Study|Lost to Follow-up|4|||
27820109|NCT00880568|81176028|FG005|Overall Study|Disease progression|3|||
27820110|NCT00880568|81176029|FG006|Overall Study|Disease progression|5|||
27820111|NCT00880568|81176030|FG007|Overall Study|Disease progression|0|||
27820112|NCT00880568|81176031|FG008|Overall Study|Disease progression|3|||
27820113|NCT00880568|81176023|FG000|Overall Study|Adverse Event|0|||
27820114|NCT00880568|81176024|FG001|Overall Study|Adverse Event|0|||
27820115|NCT00880568|81176025|FG002|Overall Study|Adverse Event|0|||
27820116|NCT00880568|81176026|FG003|Overall Study|Adverse Event|0|||
27820117|NCT00880568|81176027|FG004|Overall Study|Adverse Event|0|||
27592580|NCT00251745|80348735|FG001|Overall Study|Lost to Follow-up|2|||
27592581|NCT00251745|80348736|FG002|Overall Study|Lost to Follow-up|5|||
27820118|NCT00880568|81176028|FG005|Overall Study|Adverse Event|0|||
27820119|NCT00880568|81176029|FG006|Overall Study|Adverse Event|1|||
27820120|NCT00880568|81176030|FG007|Overall Study|Adverse Event|1|||
27820121|NCT00880568|81176031|FG008|Overall Study|Adverse Event|0|||
27820122|NCT00880568|81176023|FG000|Overall Study|Withdrawal by Subject|0|||
27820123|NCT00880568|81176024|FG001|Overall Study|Withdrawal by Subject|0|||
27820124|NCT00880568|81176025|FG002|Overall Study|Withdrawal by Subject|0|||
27820125|NCT00880568|81176026|FG003|Overall Study|Withdrawal by Subject|0|||
27820126|NCT00880568|81176027|FG004|Overall Study|Withdrawal by Subject|0|||
27820127|NCT00880568|81176028|FG005|Overall Study|Withdrawal by Subject|0|||
27820128|NCT00880568|81176029|FG006|Overall Study|Withdrawal by Subject|0|||
27820129|NCT00880568|81176030|FG007|Overall Study|Withdrawal by Subject|1|||
27820130|NCT00880568|81176031|FG008|Overall Study|Withdrawal by Subject|0|||
27820131|NCT01387022|81176034|FG000|Overall Study|Death|1|||
27820132|NCT01387022|81176035|FG001|Overall Study|Death|1|||
27820133|NCT01387022|81176034|FG000|Overall Study|Lost to Follow-up|0|||
27820134|NCT01387022|81176035|FG001|Overall Study|Lost to Follow-up|3|||
27592582|NCT00251745|80348734|FG000|Overall Study|Withdrawal by Subject|13|||
27592583|NCT00251745|80348735|FG001|Overall Study|Withdrawal by Subject|7|||
27592584|NCT00251745|80348736|FG002|Overall Study|Withdrawal by Subject|3|||
27881113|NCT01314872|81397884|FG006|Treatment Period 1|Withdrawal by Subject|3|||
27592585|NCT00251745|80348734|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
27592586|NCT00251745|80348735|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
27592587|NCT00251745|80348736|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
27592588|NCT00251745|80348734|FG000|Overall Study|Lack of Efficacy|3|||
27592589|NCT00251745|80348735|FG001|Overall Study|Lack of Efficacy|0|||
27592590|NCT00251745|80348736|FG002|Overall Study|Lack of Efficacy|0|||
27592591|NCT00251745|80348734|FG000|Overall Study|Noncompliant|0|||
27592592|NCT00251745|80348735|FG001|Overall Study|Noncompliant|2|||
27592593|NCT00251745|80348736|FG002|Overall Study|Noncompliant|2|||
27592594|NCT00251745|80348734|FG000|Overall Study|Pregnancy|0|||
27592595|NCT00251745|80348735|FG001|Overall Study|Pregnancy|1|||
27592596|NCT00251745|80348736|FG002|Overall Study|Pregnancy|0|||
27592597|NCT00251745|80348734|FG000|Overall Study|Per Subject Request|0|||
27881114|NCT01314872|81397885|FG007|Treatment Period 1|Withdrawal by Subject|2|||
27592598|NCT00251745|80348735|FG001|Overall Study|Per Subject Request|0|||
27592599|NCT00251745|80348736|FG002|Overall Study|Per Subject Request|1|||
27592600|NCT00251745|80348734|FG000|Overall Study|Per Investigator Request|1|||
27592601|NCT00251745|80348735|FG001|Overall Study|Per Investigator Request|0|||
27820135|NCT02272777|81176036|FG000|Overall Study|Adverse Event|0|||
27820136|NCT02272777|81176037|FG001|Overall Study|Adverse Event|1|||
27820137|NCT02272777|81176036|FG000|Overall Study|Withdrawal by Subject|0|||
27592602|NCT00251745|80348736|FG002|Overall Study|Per Investigator Request|0|||
27820138|NCT02272777|81176037|FG001|Overall Study|Withdrawal by Subject|3|||
27592603|NCT00808808|80348737|FG000|Overall Study|Vaccinated; survey not completed|131|||
27592604|NCT00808808|80348738|FG001|Overall Study|Vaccinated; survey not completed|169|||
27592605|NCT00808808|80348739|FG002|Overall Study|Vaccinated; survey not completed|302|||
27592606|NCT00808808|80348737|FG000|Overall Study|Employee was not vaccinated.|2686|||
27592607|NCT00808808|80348738|FG001|Overall Study|Employee was not vaccinated.|2268|||
27592608|NCT00808808|80348739|FG002|Overall Study|Employee was not vaccinated.|2255|||
27592609|NCT00722761|80348740|FG000|Overall Study|Lost to Follow-up|1|||
27592610|NCT00722761|80348741|FG001|Overall Study|Lost to Follow-up|4|||
27592611|NCT00722761|80348740|FG000|Overall Study|Withdrawal by Subject|5|||
27592612|NCT00722761|80348741|FG001|Overall Study|Withdrawal by Subject|2|||
27592613|NCT00605280|80348742|FG000|Year 1|Protocol Violation|0|||
27592614|NCT00605280|80348743|FG001|Year 1|Protocol Violation|0|||
27592615|NCT00605280|80348744|FG002|Year 1|Protocol Violation|0|||
27592616|NCT00605280|80348745|FG003|Year 1|Protocol Violation|1|||
27592617|NCT00605280|80348742|FG000|Year 1|Adverse Event|3|||
27592618|NCT00605280|80348743|FG001|Year 1|Adverse Event|1|||
27820139|NCT02272777|81176036|FG000|Overall Study|Lost to Follow-up|2|||
27820140|NCT02272777|81176037|FG001|Overall Study|Lost to Follow-up|0|||
27820141|NCT02272777|81176036|FG000|Overall Study|Other|2|||
27820142|NCT02272777|81176037|FG001|Overall Study|Other|0|||
27820143|NCT02008565|81176038|FG000|Overall Study|Protocol Violation|1|||
27820144|NCT02008565|81176039|FG001|Overall Study|Protocol Violation|1|||
27820145|NCT02008565|81176040|FG002|Overall Study|Protocol Violation|2|||
27820146|NCT02008565|81176041|FG003|Overall Study|Protocol Violation|0|||
27820147|NCT02865538|81176043|FG000|Overall Study|Withdrawal by Subject|0|||
27820148|NCT02865538|81176044|FG001|Overall Study|Withdrawal by Subject|0|||
27820149|NCT02865538|81176045|FG002|Overall Study|Withdrawal by Subject|1|||
27820150|NCT02865538|81176046|FG003|Overall Study|Withdrawal by Subject|0|||
27820151|NCT02865538|81176047|FG004|Overall Study|Withdrawal by Subject|0|||
27820152|NCT02865538|81176043|FG000|Overall Study|Lost to Follow-up|1|||
27820153|NCT02865538|81176044|FG001|Overall Study|Lost to Follow-up|0|||
27820154|NCT02865538|81176045|FG002|Overall Study|Lost to Follow-up|0|||
27820155|NCT02865538|81176046|FG003|Overall Study|Lost to Follow-up|0|||
27820156|NCT02865538|81176047|FG004|Overall Study|Lost to Follow-up|0|||
27820157|NCT02473640|81176048|FG000|Treatment Period 1|Adverse Event|1|||
27820158|NCT00406848|81176049|FG000|Overall Study|Withdrawal by Subject|27|||
27820159|NCT00406848|81176050|FG001|Overall Study|Withdrawal by Subject|22|||
27820160|NCT00406848|81176049|FG000|Overall Study|Adverse Event|38|||
27820161|NCT00406848|81176050|FG001|Overall Study|Adverse Event|7|||
27820162|NCT00406848|81176049|FG000|Overall Study|Lack of Efficacy|9|||
27820163|NCT00406848|81176050|FG001|Overall Study|Lack of Efficacy|14|||
27820164|NCT00406848|81176049|FG000|Overall Study|Protocol Violation|10|||
27881115|NCT01314872|81397886|FG008|Treatment Period 1|Withdrawal by Subject|2|||
27881116|NCT01314872|81397887|FG009|Treatment Period 1|Withdrawal by Subject|2|||
27881117|NCT01314872|81397888|FG010|Treatment Period 1|Withdrawal by Subject|1|||
27592619|NCT00605280|80348744|FG002|Year 1|Adverse Event|1|||
27592620|NCT00605280|80348745|FG003|Year 1|Adverse Event|5|||
27592621|NCT00605280|80348742|FG000|Year 1|Physician Decision|7|||
27820165|NCT00406848|81176050|FG001|Overall Study|Protocol Violation|6|||
27820166|NCT00406848|81176049|FG000|Overall Study|Lost to Follow-up|6|||
27820167|NCT00406848|81176050|FG001|Overall Study|Lost to Follow-up|2|||
27820168|NCT00406848|81176049|FG000|Overall Study|Physician Decision|2|||
27820169|NCT00406848|81176050|FG001|Overall Study|Physician Decision|2|||
27592622|NCT00605280|80348743|FG001|Year 1|Physician Decision|4|||
27881118|NCT01314872|81397889|FG011|Treatment Period 1|Withdrawal by Subject|0|||
27881119|NCT01314872|81397890|FG012|Treatment Period 1|Withdrawal by Subject|0|||
27881120|NCT01314872|81397891|FG013|Treatment Period 1|Withdrawal by Subject|0|||
27881121|NCT01314872|81397892|FG014|Treatment Period 1|Withdrawal by Subject|0|||
27881122|NCT01314872|81397878|FG000|Treatment Period 1|Lost to Follow-up|0|||
27881123|NCT01314872|81397879|FG001|Treatment Period 1|Lost to Follow-up|1|||
27881124|NCT01314872|81397880|FG002|Treatment Period 1|Lost to Follow-up|2|||
27881125|NCT01314872|81397881|FG003|Treatment Period 1|Lost to Follow-up|2|||
27881126|NCT01314872|81397882|FG004|Treatment Period 1|Lost to Follow-up|1|||
27881127|NCT01314872|81397883|FG005|Treatment Period 1|Lost to Follow-up|1|||
27881128|NCT01314872|81397884|FG006|Treatment Period 1|Lost to Follow-up|1|||
27881129|NCT01314872|81397885|FG007|Treatment Period 1|Lost to Follow-up|1|||
27881130|NCT01314872|81397886|FG008|Treatment Period 1|Lost to Follow-up|1|||
27881131|NCT01314872|81397887|FG009|Treatment Period 1|Lost to Follow-up|0|||
27881132|NCT01314872|81397888|FG010|Treatment Period 1|Lost to Follow-up|0|||
27592623|NCT00605280|80348744|FG002|Year 1|Physician Decision|0|||
27592624|NCT00605280|80348745|FG003|Year 1|Physician Decision|6|||
27592625|NCT00605280|80348742|FG000|Year 1|Withdrawal by Subject|2|||
27592626|NCT00605280|80348743|FG001|Year 1|Withdrawal by Subject|4|||
27592627|NCT00605280|80348744|FG002|Year 1|Withdrawal by Subject|0|||
27592628|NCT00605280|80348745|FG003|Year 1|Withdrawal by Subject|4|||
27592629|NCT00605280|80348742|FG000|Year 1|Other|2|||
27592630|NCT00605280|80348743|FG001|Year 1|Other|1|||
27592631|NCT00605280|80348744|FG002|Year 1|Other|0|||
27592632|NCT00605280|80348745|FG003|Year 1|Other|1|||
27592633|NCT00605280|80348742|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
27592634|NCT00605280|80348743|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
27592635|NCT00605280|80348744|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
27592636|NCT00605280|80348745|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
27693817|NCT02680002|80713734|FG002|Overall Study|Adverse Event|0|||
27820170|NCT00406848|81176049|FG000|Overall Study|Sponsor Decision|1|||
27820171|NCT00406848|81176050|FG001|Overall Study|Sponsor Decision|1|||
27820172|NCT02726581|81176051|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
27820173|NCT02726581|81176052|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
27820174|NCT02726581|81176053|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
27820175|NCT02726581|81176051|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
27592637|NCT00605280|80348742|FG000|Year 2|Adverse Event|4|||
27592638|NCT00605280|80348743|FG001|Year 2|Adverse Event|0|||
27592639|NCT00605280|80348744|FG002|Year 2|Adverse Event|2|||
27592640|NCT00605280|80348745|FG003|Year 2|Adverse Event|4|||
27592641|NCT00605280|80348742|FG000|Year 2|Physician Decision|11|||
27592642|NCT00605280|80348743|FG001|Year 2|Physician Decision|6|||
27592643|NCT00605280|80348744|FG002|Year 2|Physician Decision|4|||
27592644|NCT00605280|80348745|FG003|Year 2|Physician Decision|11|||
27592645|NCT00605280|80348742|FG000|Year 2|Withdrawal by Subject|4|||
27592646|NCT00605280|80348743|FG001|Year 2|Withdrawal by Subject|0|||
27592647|NCT00605280|80348744|FG002|Year 2|Withdrawal by Subject|0|||
27592648|NCT00605280|80348745|FG003|Year 2|Withdrawal by Subject|4|||
27592649|NCT00605280|80348742|FG000|Year 2|Other|1|||
27592650|NCT00605280|80348743|FG001|Year 2|Other|0|||
27592651|NCT00605280|80348744|FG002|Year 2|Other|0|||
27592652|NCT00605280|80348745|FG003|Year 2|Other|1|||
27592653|NCT00605280|80348742|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
27592654|NCT00605280|80348743|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
27592655|NCT00605280|80348744|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
27592656|NCT00605280|80348745|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
27592657|NCT00605280|80348742|FG000|Year 3 Extension|Adverse Event|2|||
27592658|NCT00605280|80348743|FG001|Year 3 Extension|Adverse Event|0|||
27592659|NCT00605280|80348744|FG002|Year 3 Extension|Adverse Event|0|||
27592660|NCT00605280|80348745|FG003|Year 3 Extension|Adverse Event|2|||
27592661|NCT00605280|80348742|FG000|Year 3 Extension|Physician Decision|0|||
27592662|NCT00605280|80348743|FG001|Year 3 Extension|Physician Decision|0|||
27592663|NCT00605280|80348744|FG002|Year 3 Extension|Physician Decision|0|||
27592664|NCT00605280|80348745|FG003|Year 3 Extension|Physician Decision|2|||
27592665|NCT00605280|80348742|FG000|Year 3 Extension|Withdrawal by Subject|2|||
27592666|NCT00605280|80348743|FG001|Year 3 Extension|Withdrawal by Subject|0|||
27592667|NCT00605280|80348744|FG002|Year 3 Extension|Withdrawal by Subject|0|||
27592668|NCT00605280|80348745|FG003|Year 3 Extension|Withdrawal by Subject|5|||
27592669|NCT00605280|80348742|FG000|Year 3 Extension|Other|2|||
27592670|NCT00605280|80348743|FG001|Year 3 Extension|Other|0|||
27592671|NCT00605280|80348744|FG002|Year 3 Extension|Other|0|||
27820176|NCT02726581|81176052|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
27820177|NCT02726581|81176053|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
27820178|NCT02726581|81176051|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27820179|NCT02726581|81176052|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27820180|NCT02726581|81176053|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27820181|NCT02726581|81176051|FG000|Treatment Period|Disease progression|47|||
27820182|NCT02726581|81176052|FG001|Treatment Period|Disease progression|50|||
27820183|NCT02726581|81176053|FG002|Treatment Period|Disease progression|16|||
27820184|NCT02726581|81176051|FG000|Treatment Period|Other reasons|9|||
27820185|NCT02726581|81176052|FG001|Treatment Period|Other reasons|8|||
27820186|NCT02726581|81176053|FG002|Treatment Period|Other reasons|2|||
27820187|NCT02726581|81176051|FG000|Treatment Period|Study drug toxicity|6|||
27820188|NCT02726581|81176052|FG001|Treatment Period|Study drug toxicity|3|||
27820189|NCT02726581|81176053|FG002|Treatment Period|Study drug toxicity|2|||
27820190|NCT02726581|81176051|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
27820191|NCT02726581|81176052|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
27592672|NCT00605280|80348745|FG003|Year 3 Extension|Other|0|||
27592673|NCT00605280|80348742|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
27592674|NCT00605280|80348743|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
27592675|NCT00605280|80348744|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
27592676|NCT00605280|80348745|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
27820192|NCT02726581|81176053|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
27820193|NCT02726581|81176051|FG000|Treatment Period|Participant withdrew consent|3|||
27820194|NCT02726581|81176052|FG001|Treatment Period|Participant withdrew consent|1|||
27592677|NCT00679939|80348746|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
27592678|NCT00679939|80348747|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
27592679|NCT00679939|80348746|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
27592680|NCT00679939|80348747|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
27592681|NCT00679939|80348746|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
27592682|NCT00679939|80348747|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
27592683|NCT00679939|80348746|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
27592684|NCT00679939|80348747|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
27592685|NCT00679939|80348746|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
27592686|NCT00679939|80348747|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
27592687|NCT00679939|80348746|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
27592688|NCT00679939|80348747|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
27592689|NCT00679939|80348746|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
27592690|NCT00679939|80348747|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
27592691|NCT00679939|80348746|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
27592692|NCT00679939|80348747|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
27592693|NCT00679939|80348746|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
27592694|NCT00679939|80348747|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
27592695|NCT00679939|80348746|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
27592696|NCT00679939|80348747|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
27592697|NCT03137303|80348748|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
27592698|NCT03137303|80348749|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
27592699|NCT03137303|80348748|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
27592700|NCT03137303|80348749|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
27592701|NCT03137303|80348748|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
27592702|NCT03137303|80348749|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
27592703|NCT03137303|80348748|FG000|T3: 9-month Follow-up|Death|1|||
27592704|NCT03137303|80348749|FG001|T3: 9-month Follow-up|Death|0|||
27592705|NCT03137303|80348748|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
27592706|NCT03137303|80348749|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
27592707|NCT03137303|80348748|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
27592708|NCT03137303|80348749|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
27592709|NCT03137303|80348748|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
27592710|NCT03137303|80348749|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
27592711|NCT02522494|80348752|FG000|Overall Study|Lost to Follow-up|6|||
27592712|NCT02522494|80348753|FG001|Overall Study|Lost to Follow-up|2|||
27592713|NCT02522494|80348752|FG000|Overall Study|Withdrawal by Subject|1|||
27592714|NCT02522494|80348753|FG001|Overall Study|Withdrawal by Subject|0|||
27592715|NCT02522494|80348752|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
27592716|NCT02522494|80348753|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
27592717|NCT02522494|80348752|FG000|Overall Study|Participant did not watch the video|1|||
27592718|NCT02522494|80348753|FG001|Overall Study|Participant did not watch the video|0|||
27592719|NCT02522494|80348752|FG000|Overall Study|Death|0|||
27592720|NCT02522494|80348753|FG001|Overall Study|Death|1|||
27881133|NCT01314872|81397889|FG011|Treatment Period 1|Lost to Follow-up|0|||
27881134|NCT01314872|81397890|FG012|Treatment Period 1|Lost to Follow-up|0|||
27881135|NCT01314872|81397891|FG013|Treatment Period 1|Lost to Follow-up|0|||
27881136|NCT01314872|81397892|FG014|Treatment Period 1|Lost to Follow-up|0|||
27881137|NCT01314872|81397878|FG000|Period 2|Protocol Violation|0|||
27881138|NCT01314872|81397879|FG001|Period 2|Protocol Violation|0|||
27881139|NCT01314872|81397880|FG002|Period 2|Protocol Violation|0|||
27881140|NCT01314872|81397881|FG003|Period 2|Protocol Violation|0|||
27881141|NCT01314872|81397882|FG004|Period 2|Protocol Violation|0|||
27881142|NCT01314872|81397883|FG005|Period 2|Protocol Violation|0|||
27881143|NCT01314872|81397884|FG006|Period 2|Protocol Violation|0|||
27881144|NCT01314872|81397885|FG007|Period 2|Protocol Violation|0|||
27881145|NCT01314872|81397886|FG008|Period 2|Protocol Violation|0|||
27881146|NCT01314872|81397887|FG009|Period 2|Protocol Violation|0|||
27881147|NCT01314872|81397888|FG010|Period 2|Protocol Violation|0|||
27881148|NCT01314872|81397889|FG011|Period 2|Protocol Violation|3|||
27881149|NCT01314872|81397890|FG012|Period 2|Protocol Violation|3|||
27881150|NCT01314872|81397891|FG013|Period 2|Protocol Violation|2|||
27881151|NCT01314872|81397892|FG014|Period 2|Protocol Violation|0|||
27881152|NCT01314872|81397878|FG000|Period 2|Non-compliance with study drug|0|||
27881153|NCT01314872|81397879|FG001|Period 2|Non-compliance with study drug|0|||
27881154|NCT01314872|81397880|FG002|Period 2|Non-compliance with study drug|0|||
27881155|NCT01314872|81397881|FG003|Period 2|Non-compliance with study drug|0|||
27881156|NCT01314872|81397882|FG004|Period 2|Non-compliance with study drug|0|||
27592721|NCT01275625|80348754|FG000|Overall Study|Death|1|||
27592722|NCT01275625|80348754|FG000|Overall Study|Lack of Efficacy|2|||
27592723|NCT01275625|80348754|FG000|Overall Study|Lost to Follow-up|1|||
27592724|NCT01275625|80348754|FG000|Overall Study|Withdrawal by Subject|3|||
27592725|NCT01275625|80348754|FG000|Overall Study|Protocol Violation|1|||
27592726|NCT01275625|80348754|FG000|Overall Study|Adverse Event|4|||
27592727|NCT01275625|80348754|FG000|Overall Study|Other|1|||
27592728|NCT02388724|80348755|FG000|Overall Study|Reason not Specified|0|||
27592729|NCT02388724|80348756|FG001|Overall Study|Reason not Specified|1|||
27592730|NCT02388724|80348755|FG000|Overall Study|Major Protocol Deviation|3|||
27881157|NCT01314872|81397883|FG005|Period 2|Non-compliance with study drug|0|||
27881158|NCT01314872|81397884|FG006|Period 2|Non-compliance with study drug|0|||
27881159|NCT01314872|81397885|FG007|Period 2|Non-compliance with study drug|0|||
27881160|NCT01314872|81397886|FG008|Period 2|Non-compliance with study drug|0|||
27881161|NCT01314872|81397887|FG009|Period 2|Non-compliance with study drug|0|||
27881162|NCT01314872|81397888|FG010|Period 2|Non-compliance with study drug|0|||
27881163|NCT01314872|81397889|FG011|Period 2|Non-compliance with study drug|3|||
27881164|NCT01314872|81397890|FG012|Period 2|Non-compliance with study drug|3|||
27881165|NCT01314872|81397891|FG013|Period 2|Non-compliance with study drug|1|||
27881166|NCT01314872|81397892|FG014|Period 2|Non-compliance with study drug|2|||
27881167|NCT01314872|81397878|FG000|Period 2|Lack of Efficacy|0|||
27881168|NCT01314872|81397879|FG001|Period 2|Lack of Efficacy|0|||
27881169|NCT01314872|81397880|FG002|Period 2|Lack of Efficacy|0|||
27881170|NCT01314872|81397881|FG003|Period 2|Lack of Efficacy|0|||
27881171|NCT01314872|81397882|FG004|Period 2|Lack of Efficacy|0|||
27881172|NCT01314872|81397883|FG005|Period 2|Lack of Efficacy|0|||
27881173|NCT01314872|81397884|FG006|Period 2|Lack of Efficacy|0|||
27881174|NCT01314872|81397885|FG007|Period 2|Lack of Efficacy|0|||
27881175|NCT01314872|81397886|FG008|Period 2|Lack of Efficacy|0|||
27881176|NCT01314872|81397887|FG009|Period 2|Lack of Efficacy|0|||
27881177|NCT01314872|81397888|FG010|Period 2|Lack of Efficacy|0|||
27881178|NCT01314872|81397889|FG011|Period 2|Lack of Efficacy|7|||
27881179|NCT01314872|81397890|FG012|Period 2|Lack of Efficacy|12|||
27881180|NCT01314872|81397891|FG013|Period 2|Lack of Efficacy|9|||
27881181|NCT01314872|81397892|FG014|Period 2|Lack of Efficacy|2|||
27881182|NCT01314872|81397878|FG000|Period 2|Pregnancy|0|||
27881183|NCT01314872|81397879|FG001|Period 2|Pregnancy|0|||
27881184|NCT01314872|81397880|FG002|Period 2|Pregnancy|0|||
27881185|NCT01314872|81397881|FG003|Period 2|Pregnancy|0|||
27820195|NCT02726581|81176053|FG002|Treatment Period|Participant withdrew consent|1|||
27820196|NCT02726581|81176051|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
27820197|NCT02726581|81176052|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
27820198|NCT02726581|81176053|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
27820199|NCT02726581|81176051|FG000|Treatment Period|Maximum clinical benefit|0|||
27592731|NCT02388724|80348756|FG001|Overall Study|Major Protocol Deviation|3|||
27592732|NCT02388724|80348755|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
27592733|NCT02388724|80348756|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27820200|NCT02726581|81176052|FG001|Treatment Period|Maximum clinical benefit|2|||
27820201|NCT02726581|81176053|FG002|Treatment Period|Maximum clinical benefit|0|||
27820202|NCT02726581|81176051|FG000|Treatment Period|Death|1|||
27820203|NCT02726581|81176052|FG001|Treatment Period|Death|0|||
27820204|NCT02726581|81176053|FG002|Treatment Period|Death|0|||
27820205|NCT02726581|81176051|FG000|Treatment Period|Poor/non-compliance|1|||
27820206|NCT02726581|81176052|FG001|Treatment Period|Poor/non-compliance|0|||
27820207|NCT02726581|81176053|FG002|Treatment Period|Poor/non-compliance|0|||
27820208|NCT02726581|81176051|FG000|Treatment Period|Participant no longer meets study criteria|0|||
27820209|NCT02726581|81176052|FG001|Treatment Period|Participant no longer meets study criteria|1|||
27820210|NCT02726581|81176053|FG002|Treatment Period|Participant no longer meets study criteria|0|||
27820211|NCT02319148|81176056|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
27820212|NCT02319148|81176057|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
27820213|NCT02319148|81176058|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
27820214|NCT02319148|81176059|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
27820215|NCT02319148|81176056|FG000|Second Intervention Period|No longer willing to participate|0|||
27592734|NCT02388724|80348755|FG000|Overall Study|Voluntary Withdrawal|6|||
27592735|NCT02388724|80348756|FG001|Overall Study|Voluntary Withdrawal|5|||
27592736|NCT02388724|80348755|FG000|Overall Study|Randomized but not Treated|0|||
27592737|NCT02388724|80348756|FG001|Overall Study|Randomized but not Treated|2|||
27820216|NCT02319148|81176057|FG001|Second Intervention Period|No longer willing to participate|1|||
27820217|NCT02319148|81176058|FG002|Second Intervention Period|No longer willing to participate|0|||
27881186|NCT01314872|81397882|FG004|Period 2|Pregnancy|0|||
27881187|NCT01314872|81397883|FG005|Period 2|Pregnancy|0|||
27881188|NCT01314872|81397884|FG006|Period 2|Pregnancy|0|||
27881189|NCT01314872|81397885|FG007|Period 2|Pregnancy|0|||
27881190|NCT01314872|81397886|FG008|Period 2|Pregnancy|0|||
27881191|NCT01314872|81397887|FG009|Period 2|Pregnancy|0|||
27881192|NCT01314872|81397888|FG010|Period 2|Pregnancy|0|||
27881193|NCT01314872|81397889|FG011|Period 2|Pregnancy|0|||
27820218|NCT02319148|81176059|FG003|Second Intervention Period|No longer willing to participate|0|||
27820219|NCT02319148|81176056|FG000|Second Intervention Period|Other|0|||
27820220|NCT02319148|81176057|FG001|Second Intervention Period|Other|0|||
27820221|NCT02319148|81176058|FG002|Second Intervention Period|Other|0|||
27820222|NCT02319148|81176059|FG003|Second Intervention Period|Other|1|||
27820223|NCT00694551|81176060|FG000|Overall Study|Disease Progression|1|||
27592738|NCT00989287|80348757|FG000|Overall Study|Adverse Event|1|||
27592739|NCT00989287|80348758|FG001|Overall Study|Adverse Event|0|||
27592740|NCT00989287|80348757|FG000|Overall Study|Lost to Follow-up|0|||
27592741|NCT00989287|80348758|FG001|Overall Study|Lost to Follow-up|1|||
27592742|NCT01747772|80348759|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
27592743|NCT01475136|80348760|FG000|Overall Study|Sponsor Decision|0|||
27592744|NCT01475136|80348761|FG001|Overall Study|Sponsor Decision|1|||
27592745|NCT01475136|80348762|FG002|Overall Study|Sponsor Decision|0|||
27592746|NCT01475136|80348763|FG003|Overall Study|Sponsor Decision|0|||
27592747|NCT01475136|80348760|FG000|Overall Study|Entry Criteria Not Met|0|||
27592748|NCT01475136|80348761|FG001|Overall Study|Entry Criteria Not Met|2|||
27592749|NCT01475136|80348762|FG002|Overall Study|Entry Criteria Not Met|3|||
27592750|NCT01475136|80348763|FG003|Overall Study|Entry Criteria Not Met|1|||
27592751|NCT01475136|80348760|FG000|Overall Study|Withdrawal by Subject|0|||
27592752|NCT01475136|80348761|FG001|Overall Study|Withdrawal by Subject|0|||
27592753|NCT01475136|80348762|FG002|Overall Study|Withdrawal by Subject|0|||
27592754|NCT01475136|80348763|FG003|Overall Study|Withdrawal by Subject|2|||
27592755|NCT01475136|80348760|FG000|Overall Study|Adverse Event|1|||
27592756|NCT01475136|80348761|FG001|Overall Study|Adverse Event|0|||
27592757|NCT01475136|80348762|FG002|Overall Study|Adverse Event|0|||
27592758|NCT01475136|80348763|FG003|Overall Study|Adverse Event|1|||
27592759|NCT01475136|80348760|FG000|Overall Study|Death|0|||
27592760|NCT01475136|80348761|FG001|Overall Study|Death|0|||
27592761|NCT01475136|80348762|FG002|Overall Study|Death|0|||
27820224|NCT00694551|81176061|FG001|Overall Study|Disease Progression|0|||
27820225|NCT00694551|81176062|FG002|Overall Study|Disease Progression|1|||
27881194|NCT01314872|81397890|FG012|Period 2|Pregnancy|0|||
27592762|NCT01475136|80348763|FG003|Overall Study|Death|1|||
27592763|NCT02062632|80348766|FG000|Overall Study|No treatment data|1|||
27592764|NCT03834779|80348767|FG000|Overall Study|Death|1|||
27592765|NCT03834779|80348768|FG001|Overall Study|Death|2|||
27592766|NCT03834779|80348767|FG000|Overall Study|Lost to Follow-up|6|||
27592767|NCT03834779|80348768|FG001|Overall Study|Lost to Follow-up|4|||
27820226|NCT04638153|81176063|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27820227|NCT04638153|81176064|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27592768|NCT00771810|80348771|FG000|Overall Study|Adverse Event|3|||
27592769|NCT00771810|80348772|FG001|Overall Study|Adverse Event|0|||
27592770|NCT00771810|80348773|FG002|Overall Study|Adverse Event|2|||
27592771|NCT00771810|80348771|FG000|Overall Study|Lost to Follow-up|0|||
27820228|NCT04638153|81176065|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27881195|NCT01314872|81397891|FG013|Period 2|Pregnancy|0|||
27881196|NCT01314872|81397892|FG014|Period 2|Pregnancy|1|||
27881197|NCT01314872|81397878|FG000|Period 2|Study terminated by Sponsor|0|||
27881198|NCT01314872|81397879|FG001|Period 2|Study terminated by Sponsor|0|||
27881199|NCT01314872|81397880|FG002|Period 2|Study terminated by Sponsor|0|||
27881200|NCT01314872|81397881|FG003|Period 2|Study terminated by Sponsor|0|||
27881201|NCT01314872|81397882|FG004|Period 2|Study terminated by Sponsor|0|||
27820229|NCT04638153|81176063|FG000|Overall Study|Study terminated by sponsor|4|||
27820230|NCT04638153|81176064|FG001|Overall Study|Study terminated by sponsor|2|||
27820231|NCT04638153|81176065|FG002|Overall Study|Study terminated by sponsor|14|||
27820232|NCT04276883|81176072|FG000|Overall Study|Withdrawal by Subject|2|||
27820233|NCT04276883|81176073|FG001|Overall Study|Withdrawal by Subject|3|||
27820234|NCT04276883|81176074|FG002|Overall Study|Withdrawal by Subject|6|||
27820235|NCT04276883|81176072|FG000|Overall Study|Lost to Follow-up|1|||
27820236|NCT04276883|81176073|FG001|Overall Study|Lost to Follow-up|3|||
27820237|NCT04276883|81176074|FG002|Overall Study|Lost to Follow-up|0|||
27820238|NCT04276883|81176072|FG000|Overall Study|Adverse Event|0|||
27820239|NCT04276883|81176073|FG001|Overall Study|Adverse Event|1|||
27820240|NCT04276883|81176074|FG002|Overall Study|Adverse Event|0|||
27820241|NCT04276883|81176072|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
27820242|NCT04276883|81176073|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
27820243|NCT04276883|81176074|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
27820244|NCT02152566|81176075|FG000|Overall Study|Lost to Follow-up|1|||
27820245|NCT02152566|81176075|FG000|Overall Study|Withdrawal by Subject|2|||
27820246|NCT03482882|81176079|FG000|Overall Study|Adverse Event|3|||
27820247|NCT03482882|81176079|FG000|Overall Study|Lost to Follow-up|1|||
27820248|NCT03482882|81176079|FG000|Overall Study|Protocol Violation|2|||
27820249|NCT03482882|81176079|FG000|Overall Study|Not further specified|1|||
27820250|NCT00376623|81176084|FG000|Overall Study|Progressive disease|35|||
27820251|NCT00376623|81176085|FG001|Overall Study|Progressive disease|22|||
27820252|NCT00376623|81176086|FG002|Overall Study|Progressive disease|17|||
27820253|NCT00376623|81176084|FG000|Overall Study|Lost to Follow-up|0|||
27820254|NCT00376623|81176085|FG001|Overall Study|Lost to Follow-up|1|||
27820255|NCT00376623|81176086|FG002|Overall Study|Lost to Follow-up|0|||
27820256|NCT00376623|81176084|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
27820257|NCT00376623|81176085|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
27820258|NCT00376623|81176086|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
27820259|NCT00376623|81176084|FG000|Overall Study|Not treated with BI 2536|1|||
27820260|NCT00376623|81176085|FG001|Overall Study|Not treated with BI 2536|0|||
27820261|NCT00376623|81176086|FG002|Overall Study|Not treated with BI 2536|0|||
27820262|NCT00376623|81176084|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
27820263|NCT00376623|81176085|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
27820264|NCT00376623|81176086|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
27820265|NCT00376623|81176084|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
27820266|NCT00376623|81176085|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
27820267|NCT00376623|81176086|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
27820268|NCT00376623|81176084|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
27820269|NCT00376623|81176085|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
27820270|NCT00376623|81176086|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
27820271|NCT00376623|81176084|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
27820272|NCT00376623|81176085|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
27881202|NCT01314872|81397883|FG005|Period 2|Study terminated by Sponsor|0|||
27881203|NCT01314872|81397884|FG006|Period 2|Study terminated by Sponsor|0|||
27881204|NCT01314872|81397885|FG007|Period 2|Study terminated by Sponsor|0|||
27881205|NCT01314872|81397886|FG008|Period 2|Study terminated by Sponsor|0|||
27881206|NCT01314872|81397887|FG009|Period 2|Study terminated by Sponsor|0|||
27881207|NCT01314872|81397888|FG010|Period 2|Study terminated by Sponsor|0|||
27881208|NCT01314872|81397889|FG011|Period 2|Study terminated by Sponsor|2|||
27881209|NCT01314872|81397890|FG012|Period 2|Study terminated by Sponsor|2|||
27881210|NCT01314872|81397891|FG013|Period 2|Study terminated by Sponsor|3|||
27881211|NCT01314872|81397892|FG014|Period 2|Study terminated by Sponsor|0|||
27881212|NCT01314872|81397878|FG000|Period 2|Adverse event, non-fatal|0|||
27881213|NCT01314872|81397879|FG001|Period 2|Adverse event, non-fatal|0|||
27881214|NCT01314872|81397880|FG002|Period 2|Adverse event, non-fatal|0|||
27881215|NCT01314872|81397881|FG003|Period 2|Adverse event, non-fatal|0|||
27881216|NCT01314872|81397882|FG004|Period 2|Adverse event, non-fatal|0|||
27592772|NCT00771810|80348772|FG001|Overall Study|Lost to Follow-up|0|||
27592773|NCT00771810|80348773|FG002|Overall Study|Lost to Follow-up|1|||
27592774|NCT00771810|80348771|FG000|Overall Study|Physician Decision|1|||
27820273|NCT00376623|81176086|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
27820274|NCT00376623|81176084|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
27820275|NCT00376623|81176085|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
27820276|NCT00376623|81176086|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
27820277|NCT00376623|81176084|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
27820278|NCT00376623|81176085|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
27820279|NCT00376623|81176086|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
27820280|NCT00376623|81176084|FG000|Overall Study|Increase of tumour markers|0|||
27820281|NCT00376623|81176085|FG001|Overall Study|Increase of tumour markers|1|||
27820282|NCT00376623|81176086|FG002|Overall Study|Increase of tumour markers|0|||
27820283|NCT00376623|81176084|FG000|Overall Study|Bone metastasis|1|||
27820284|NCT00376623|81176085|FG001|Overall Study|Bone metastasis|0|||
27820285|NCT00376623|81176086|FG002|Overall Study|Bone metastasis|0|||
27820286|NCT00604500|81176087|FG000|Overall Study|Adverse Event|2|||
27820287|NCT00604500|81176087|FG000|Overall Study|Protocol Violation|2|||
27820288|NCT00604500|81176087|FG000|Overall Study|Treatment Failure|1|||
27820289|NCT00604500|81176087|FG000|Overall Study|Withdrawal by Subject|4|||
27820290|NCT00604500|81176087|FG000|Overall Study|Administrative|1|||
27820291|NCT00604500|81176087|FG000|Overall Study|Did not meet protocol eligibility|1|||
27820292|NCT00302952|81176094|FG000|Overall Study|Physician Decision|1|||
27820293|NCT00302952|81176095|FG001|Overall Study|Physician Decision|1|||
27820294|NCT00302952|81176094|FG000|Overall Study|Withdrawal by Subject|2|||
27820295|NCT00302952|81176095|FG001|Overall Study|Withdrawal by Subject|3|||
27820296|NCT00302952|81176094|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
27820297|NCT00302952|81176095|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
27820298|NCT02930005|81176096|FG000|Overall Study|Lost to Follow-up|1|||
27820299|NCT02930005|81176097|FG001|Overall Study|Lost to Follow-up|5|||
27820300|NCT00723528|81176101|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
27820301|NCT00723528|81176102|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
27820302|NCT00723528|81176103|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
27820303|NCT00723528|81176104|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
27820304|NCT00723528|81176105|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
27820305|NCT00723528|81176106|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
27820306|NCT00723528|81176107|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
27820307|NCT00723528|81176101|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
27820308|NCT00723528|81176102|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
27820309|NCT00723528|81176103|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
27820310|NCT00723528|81176104|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
27820311|NCT00723528|81176105|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
27820312|NCT00723528|81176106|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
27820313|NCT00723528|81176107|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
27820314|NCT00723528|81176101|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
27820315|NCT00723528|81176102|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
27820316|NCT00723528|81176103|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
27820317|NCT00723528|81176104|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
27820318|NCT00723528|81176105|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
27820319|NCT00723528|81176106|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
27820320|NCT00723528|81176107|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
27592775|NCT00771810|80348772|FG001|Overall Study|Physician Decision|2|||
27592776|NCT00771810|80348773|FG002|Overall Study|Physician Decision|2|||
27592777|NCT00771810|80348771|FG000|Overall Study|Protocol Violation|0|||
27592778|NCT00771810|80348772|FG001|Overall Study|Protocol Violation|1|||
27592779|NCT00771810|80348773|FG002|Overall Study|Protocol Violation|1|||
27693818|NCT02680002|80713735|FG003|Overall Study|Adverse Event|0|||
27881217|NCT01314872|81397883|FG005|Period 2|Adverse event, non-fatal|0|||
27881218|NCT01314872|81397884|FG006|Period 2|Adverse event, non-fatal|0|||
27693819|NCT02680002|80713736|FG004|Overall Study|Adverse Event|1|||
27693820|NCT02680002|80713737|FG005|Overall Study|Adverse Event|2|||
27592780|NCT00771810|80348771|FG000|Overall Study|Withdrawal by Subject|1|||
27820321|NCT00723528|81176101|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
27881219|NCT01314872|81397885|FG007|Period 2|Adverse event, non-fatal|0|||
27592781|NCT00771810|80348772|FG001|Overall Study|Withdrawal by Subject|2|||
27592782|NCT00771810|80348773|FG002|Overall Study|Withdrawal by Subject|0|||
27592783|NCT00771810|80348771|FG000|Overall Study|Other|0|||
27693821|NCT00609765|80713738|FG000|Overall Study|Study ended prior to 12 months|1|||
27693822|NCT01209780|80713742|FG000|Overall Study|Adverse Event|0|||
27820322|NCT00723528|81176102|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
27820323|NCT00723528|81176103|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
27820324|NCT00723528|81176104|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
27820325|NCT00723528|81176105|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
27820326|NCT00723528|81176106|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
27820327|NCT00723528|81176107|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
27820328|NCT00723528|81176101|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
27820329|NCT00723528|81176102|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
27820330|NCT00723528|81176103|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
27820331|NCT00723528|81176104|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
27820332|NCT00723528|81176105|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
27820333|NCT00723528|81176106|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
27820334|NCT00723528|81176107|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
27820335|NCT00723528|81176101|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
27820336|NCT00723528|81176102|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
27820337|NCT00723528|81176103|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
27820338|NCT00723528|81176104|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
27820339|NCT00723528|81176105|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
27820340|NCT00723528|81176106|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
27820341|NCT00723528|81176107|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
27820342|NCT00723528|81176101|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
27820343|NCT00723528|81176102|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
27881220|NCT01314872|81397886|FG008|Period 2|Adverse event, non-fatal|0|||
27881221|NCT01314872|81397887|FG009|Period 2|Adverse event, non-fatal|0|||
27881222|NCT01314872|81397888|FG010|Period 2|Adverse event, non-fatal|0|||
27881223|NCT01314872|81397889|FG011|Period 2|Adverse event, non-fatal|13|||
27881224|NCT01314872|81397890|FG012|Period 2|Adverse event, non-fatal|16|||
27881225|NCT01314872|81397891|FG013|Period 2|Adverse event, non-fatal|24|||
27881226|NCT01314872|81397892|FG014|Period 2|Adverse event, non-fatal|9|||
27881227|NCT01314872|81397878|FG000|Period 2|Withdrawal by Subject|0|||
27881228|NCT01314872|81397879|FG001|Period 2|Withdrawal by Subject|0|||
27881229|NCT01314872|81397880|FG002|Period 2|Withdrawal by Subject|0|||
27881230|NCT01314872|81397881|FG003|Period 2|Withdrawal by Subject|0|||
27693823|NCT01209780|80713743|FG001|Overall Study|Adverse Event|1|||
27693824|NCT01209780|80713744|FG002|Overall Study|Adverse Event|0|||
27693825|NCT01209780|80713745|FG003|Overall Study|Adverse Event|0|||
27693826|NCT01209780|80713746|FG004|Overall Study|Adverse Event|0|||
27881231|NCT01314872|81397882|FG004|Period 2|Withdrawal by Subject|0|||
27881232|NCT01314872|81397883|FG005|Period 2|Withdrawal by Subject|0|||
27881233|NCT01314872|81397884|FG006|Period 2|Withdrawal by Subject|0|||
27881234|NCT01314872|81397885|FG007|Period 2|Withdrawal by Subject|0|||
27881235|NCT01314872|81397886|FG008|Period 2|Withdrawal by Subject|0|||
27881236|NCT01314872|81397887|FG009|Period 2|Withdrawal by Subject|0|||
27881237|NCT01314872|81397888|FG010|Period 2|Withdrawal by Subject|0|||
27881238|NCT01314872|81397889|FG011|Period 2|Withdrawal by Subject|14|||
27881239|NCT01314872|81397890|FG012|Period 2|Withdrawal by Subject|17|||
27881240|NCT01314872|81397891|FG013|Period 2|Withdrawal by Subject|12|||
27881241|NCT01314872|81397892|FG014|Period 2|Withdrawal by Subject|4|||
27881242|NCT01314872|81397878|FG000|Period 2|Lost to Follow-up|0|||
27881243|NCT01314872|81397879|FG001|Period 2|Lost to Follow-up|0|||
27881244|NCT01314872|81397880|FG002|Period 2|Lost to Follow-up|0|||
27881245|NCT01314872|81397881|FG003|Period 2|Lost to Follow-up|0|||
27881246|NCT01314872|81397882|FG004|Period 2|Lost to Follow-up|0|||
27881247|NCT01314872|81397883|FG005|Period 2|Lost to Follow-up|0|||
27881248|NCT01314872|81397884|FG006|Period 2|Lost to Follow-up|0|||
27881249|NCT01314872|81397885|FG007|Period 2|Lost to Follow-up|0|||
27881250|NCT01314872|81397886|FG008|Period 2|Lost to Follow-up|0|||
27881251|NCT01314872|81397887|FG009|Period 2|Lost to Follow-up|0|||
27592784|NCT00771810|80348772|FG001|Overall Study|Other|0|||
27592785|NCT00771810|80348773|FG002|Overall Study|Other|1|||
27881252|NCT01314872|81397888|FG010|Period 2|Lost to Follow-up|0|||
27881253|NCT01314872|81397889|FG011|Period 2|Lost to Follow-up|6|||
27881254|NCT01314872|81397890|FG012|Period 2|Lost to Follow-up|7|||
27881255|NCT01314872|81397891|FG013|Period 2|Lost to Follow-up|2|||
27881256|NCT01314872|81397892|FG014|Period 2|Lost to Follow-up|6|||
27881257|NCT00425750|81397893|FG000|Overall Study|Death|1|||
27592786|NCT04154956|80352175|FG000|Overall Study|Death|109|||
27592787|NCT04154956|80352176|FG001|Overall Study|Death|110|||
27592788|NCT04154956|80352175|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
27881258|NCT00425750|81397893|FG000|Overall Study|Withdrawal by Subject|3|||
27820344|NCT00723528|81176103|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
27881259|NCT00425750|81397893|FG000|Overall Study|Adverse Event|3|||
27881260|NCT00425750|81397893|FG000|Overall Study|Progression of disease|18|||
27881261|NCT02518048|81397895|FG000|Overall Study|Withdrawal by Subject|1|||
27881262|NCT05047211|81397896|FG000|Overall Study|Lost to Follow-up|8|||
27881263|NCT05047211|81397897|FG001|Overall Study|Lost to Follow-up|5|||
27881264|NCT00245466|81397898|FG000|Overall Study|Adverse Event|2|||
27881265|NCT00245466|81397899|FG001|Overall Study|Adverse Event|8|||
27881266|NCT00245466|81397900|FG002|Overall Study|Adverse Event|4|||
27881267|NCT00245466|81397898|FG000|Overall Study|Low prostate specific antigen suppr|16|||
27881268|NCT00245466|81397899|FG001|Overall Study|Low prostate specific antigen suppr|14|||
27881269|NCT00245466|81397900|FG002|Overall Study|Low prostate specific antigen suppr|5|||
27881270|NCT00245466|81397898|FG000|Overall Study|Insufficient testosterone suppr|12|||
27881271|NCT00245466|81397899|FG001|Overall Study|Insufficient testosterone suppr|12|||
27820345|NCT00723528|81176104|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
27592789|NCT04154956|80352176|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
27592790|NCT04154956|80352175|FG000|Overall Study|Withdrawal by Subject|1|||
27592791|NCT04154956|80352176|FG001|Overall Study|Withdrawal by Subject|7|||
27592792|NCT04154956|80352175|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
27820346|NCT00723528|81176105|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
27820347|NCT00723528|81176106|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
27820348|NCT00723528|81176107|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
27592793|NCT04154956|80352176|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
27592794|NCT00003298|80352182|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
27592795|NCT00003298|80352182|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
27592796|NCT00003298|80352182|FG000|Surgery|Unresectable at surgery|3|||
27592797|NCT00003298|80352182|FG000|Surgery|Progression before surgery|2|||
27592798|NCT00003298|80352182|FG000|Surgery|Unevaluable and off study|2|||
27592799|NCT00003298|80352182|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
27592800|NCT00003298|80352182|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
27592801|NCT00003298|80352182|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
27592802|NCT00003298|80352182|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
27592803|NCT00003298|80352182|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
27592804|NCT00003298|80352182|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
27592805|NCT00003298|80352182|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
27592806|NCT00003298|80352182|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
27592807|NCT00003298|80352182|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
27592808|NCT00003298|80352182|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
27592809|NCT01262651|80352183|FG000|Overall Study|Adverse Event|40|||
27592810|NCT01262651|80352184|FG001|Overall Study|Adverse Event|35|||
27592811|NCT01262651|80352183|FG000|Overall Study|Withdrawal by Subject|15|||
27820349|NCT00723528|81176101|FG000|Period 2: After Controlled Period|Other|0|||
27820350|NCT00723528|81176102|FG001|Period 2: After Controlled Period|Other|0|||
27820351|NCT00723528|81176103|FG002|Period 2: After Controlled Period|Other|0|||
27820352|NCT00723528|81176104|FG003|Period 2: After Controlled Period|Other|0|||
27820353|NCT00723528|81176105|FG004|Period 2: After Controlled Period|Other|1|||
27820354|NCT00723528|81176106|FG005|Period 2: After Controlled Period|Other|4|||
27820355|NCT00723528|81176107|FG006|Period 2: After Controlled Period|Other|0|||
27820356|NCT00723528|81176101|FG000|Period 2: After Controlled Period|Adverse Event|0|||
27820357|NCT00723528|81176102|FG001|Period 2: After Controlled Period|Adverse Event|0|||
27881272|NCT00245466|81397900|FG002|Overall Study|Insufficient testosterone suppr|21|||
27881273|NCT00245466|81397898|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
27881274|NCT00245466|81397899|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
27881275|NCT00245466|81397900|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
27592812|NCT01262651|80352184|FG001|Overall Study|Withdrawal by Subject|11|||
27592813|NCT01262651|80352183|FG000|Overall Study|Withdrawal by Investigator|2|||
27881276|NCT00245466|81397898|FG000|Overall Study|Withdrawal by Subject|2|||
27693827|NCT01209780|80713742|FG000|Overall Study|Withdrawal by Subject|9|||
27693828|NCT01209780|80713743|FG001|Overall Study|Withdrawal by Subject|2|||
27592814|NCT01262651|80352184|FG001|Overall Study|Withdrawal by Investigator|2|||
27592815|NCT01262651|80352183|FG000|Overall Study|Met Withdrawal Criteria|1|||
27592816|NCT01262651|80352184|FG001|Overall Study|Met Withdrawal Criteria|0|||
27592817|NCT02491671|80352185|FG000|Overall Study|Adverse Event|6|||
27592818|NCT02491671|80352186|FG001|Overall Study|Adverse Event|8|||
27592819|NCT02491671|80352185|FG000|Overall Study|Death|0|||
27592820|NCT02491671|80352186|FG001|Overall Study|Death|2|||
27592821|NCT02491671|80352185|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
27592822|NCT02491671|80352186|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
27820358|NCT00723528|81176103|FG002|Period 2: After Controlled Period|Adverse Event|0|||
27820359|NCT00723528|81176104|FG003|Period 2: After Controlled Period|Adverse Event|0|||
27820360|NCT00723528|81176105|FG004|Period 2: After Controlled Period|Adverse Event|1|||
27820361|NCT00723528|81176106|FG005|Period 2: After Controlled Period|Adverse Event|0|||
27820362|NCT00723528|81176107|FG006|Period 2: After Controlled Period|Adverse Event|1|||
27820363|NCT00723528|81176101|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
27820364|NCT00723528|81176102|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
27820365|NCT00723528|81176103|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
27881277|NCT00245466|81397899|FG001|Overall Study|Withdrawal by Subject|2|||
27881278|NCT00245466|81397900|FG002|Overall Study|Withdrawal by Subject|1|||
27881279|NCT00245466|81397898|FG000|Overall Study|Lost to Follow-up|3|||
27881280|NCT00245466|81397899|FG001|Overall Study|Lost to Follow-up|0|||
27881281|NCT00245466|81397900|FG002|Overall Study|Lost to Follow-up|0|||
27881282|NCT00245466|81397898|FG000|Overall Study|Disease progression|0|||
27881283|NCT00245466|81397899|FG001|Overall Study|Disease progression|3|||
27881284|NCT00245466|81397900|FG002|Overall Study|Disease progression|1|||
27881285|NCT00245466|81397898|FG000|Overall Study|Protocol Violation|1|||
27881286|NCT00245466|81397899|FG001|Overall Study|Protocol Violation|2|||
27881287|NCT00245466|81397900|FG002|Overall Study|Protocol Violation|2|||
27881288|NCT00245466|81397898|FG000|Overall Study|Death|0|||
27881289|NCT00245466|81397899|FG001|Overall Study|Death|2|||
27881290|NCT00245466|81397900|FG002|Overall Study|Death|0|||
27881291|NCT00245466|81397898|FG000|Overall Study|Administrative reasons|0|||
27881292|NCT00245466|81397899|FG001|Overall Study|Administrative reasons|1|||
27820366|NCT00723528|81176104|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
27592823|NCT04085328|80352187|FG000|Overall Study|Witihdrew Consent|16|||
27820367|NCT00723528|81176105|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
27881293|NCT00245466|81397900|FG002|Overall Study|Administrative reasons|0|||
27881294|NCT01288937|81397908|FG000|Overall Study|Adverse Event|1|||
27881295|NCT01288937|81397909|FG001|Overall Study|Adverse Event|0|||
27881296|NCT00855894|81397910|FG000|Overall Study|Death|31|||
27881297|NCT00855894|81397910|FG000|Overall Study|Patient's decision|1|||
27592824|NCT04085328|80352188|FG001|Overall Study|Witihdrew Consent|16|||
27592825|NCT04085328|80352187|FG000|Overall Study|Adverse Event|8|||
27592826|NCT04085328|80352188|FG001|Overall Study|Adverse Event|7|||
27881298|NCT00855894|81397910|FG000|Overall Study|Disease progression|1|||
27881299|NCT01168232|81397913|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
27881300|NCT01168232|81397913|FG000|Overall Study|Ineligible- Wrong cell type|6|||
27881301|NCT01168232|81397913|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
27881302|NCT01741688|81397916|FG000|Overall Study|Lack of insurance coverage|2|||
27881303|NCT01741688|81397916|FG000|Overall Study|Withdrawal by Subject|1|||
27881304|NCT01284348|81397917|FG000|Overall Study|Death|1|||
27881305|NCT01284348|81397918|FG001|Overall Study|Death|1|||
27881306|NCT01284348|81397917|FG000|Overall Study|Withdrew consent|0|||
27881307|NCT01284348|81397918|FG001|Overall Study|Withdrew consent|1|||
27881308|NCT01284348|81397917|FG000|Overall Study|Status not recorded|9|||
27881309|NCT01284348|81397918|FG001|Overall Study|Status not recorded|10|||
27881310|NCT02684097|81397920|FG000|Overall Study|Lack of Efficacy|13|||
27881311|NCT02684097|81397921|FG001|Overall Study|Lack of Efficacy|6|||
27881312|NCT02356588|81397923|FG000|Overall Study|Lack of Efficacy|4|||
27881313|NCT02356588|81397924|FG001|Overall Study|Lack of Efficacy|10|||
27881314|NCT02356588|81397923|FG000|Overall Study|Adverse Event|0|||
27881315|NCT02356588|81397924|FG001|Overall Study|Adverse Event|2|||
27881316|NCT02356588|81397923|FG000|Overall Study|Withdrawal by Subject|1|||
27881317|NCT02356588|81397924|FG001|Overall Study|Withdrawal by Subject|0|||
27820368|NCT00723528|81176106|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
27820369|NCT00723528|81176107|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
27820370|NCT00723528|81176101|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
27820371|NCT00723528|81176102|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
27820372|NCT00723528|81176103|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
27820373|NCT00723528|81176104|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
27820374|NCT00723528|81176105|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
27820375|NCT00723528|81176106|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
27820376|NCT00723528|81176107|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
27881318|NCT02356588|81397923|FG000|Overall Study|Protocol Violation|0|||
27881319|NCT02356588|81397924|FG001|Overall Study|Protocol Violation|1|||
27881320|NCT03103152|81397926|FG000|Overall Study|Physician Decision|5|||
27881321|NCT03103152|81397927|FG001|Overall Study|Physician Decision|2|||
27820377|NCT00533273|81176108|FG000|Double-blind|Withdrew consent|0|||
27820378|NCT00533273|81176109|FG001|Double-blind|Withdrew consent|2|||
27881322|NCT03103152|81397928|FG002|Overall Study|Physician Decision|6|||
27881323|NCT03103152|81397929|FG003|Overall Study|Physician Decision|3|||
27881324|NCT03103152|81397930|FG004|Overall Study|Physician Decision|3|||
27881325|NCT03103152|81397931|FG005|Overall Study|Physician Decision|1|||
27881326|NCT03103152|81397926|FG000|Overall Study|Protocol Violation|2|||
27881327|NCT03103152|81397927|FG001|Overall Study|Protocol Violation|2|||
27881328|NCT03103152|81397928|FG002|Overall Study|Protocol Violation|1|||
27592827|NCT04085328|80352187|FG000|Overall Study|Lost to Follow-up|7|||
27592828|NCT04085328|80352188|FG001|Overall Study|Lost to Follow-up|2|||
27592829|NCT04085328|80352187|FG000|Overall Study|Physician Decision|0|||
27592830|NCT04085328|80352188|FG001|Overall Study|Physician Decision|1|||
27592831|NCT04085328|80352187|FG000|Overall Study|Pregnancy|0|||
27592832|NCT04085328|80352188|FG001|Overall Study|Pregnancy|1|||
27592833|NCT04085328|80352187|FG000|Overall Study|Reasons Related to COVID-19|5|||
27592834|NCT04085328|80352188|FG001|Overall Study|Reasons Related to COVID-19|8|||
27592835|NCT04085328|80352187|FG000|Overall Study|Did not meet inclusion criteria|1|||
27592836|NCT04085328|80352188|FG001|Overall Study|Did not meet inclusion criteria|1|||
27592837|NCT04085328|80352187|FG000|Overall Study|Early termination|1|||
27592838|NCT04085328|80352188|FG001|Overall Study|Early termination|0|||
27592839|NCT00608582|80352189|FG000|Overall Study|Lost to Follow-up|2|||
27592840|NCT00608582|80352190|FG001|Overall Study|Lost to Follow-up|0|||
27592841|NCT00608582|80352189|FG000|Overall Study|No Best Response in Phase 1 located|1|||
27592842|NCT00608582|80352190|FG001|Overall Study|No Best Response in Phase 1 located|1|||
27592843|NCT00608582|80352189|FG000|Overall Study|Illicit Drug Use|1|||
27592844|NCT00608582|80352190|FG001|Overall Study|Illicit Drug Use|0|||
27592845|NCT00608582|80352189|FG000|Overall Study|Early stage Design Change|0|||
27592846|NCT00608582|80352190|FG001|Overall Study|Early stage Design Change|3|||
27592847|NCT03461003|80352192|FG000|Overall Study|Lost to Follow-up|2|||
27592848|NCT03461003|80352193|FG001|Overall Study|Lost to Follow-up|2|||
27592849|NCT03461003|80352192|FG000|Overall Study|Withdrawal by Subject|3|||
27592850|NCT03461003|80352193|FG001|Overall Study|Withdrawal by Subject|1|||
27592851|NCT04988308|80352194|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
27592852|NCT04988308|80352195|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
27592853|NCT04988308|80352196|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
27592854|NCT04988308|80352197|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27592855|NCT04988308|80352198|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27592856|NCT04988308|80352199|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
27592857|NCT04988308|80352194|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
27592858|NCT04988308|80352195|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
27693829|NCT01209780|80713744|FG002|Overall Study|Withdrawal by Subject|1|||
27693830|NCT01209780|80713745|FG003|Overall Study|Withdrawal by Subject|1|||
27693831|NCT01209780|80713746|FG004|Overall Study|Withdrawal by Subject|0|||
27693832|NCT01209780|80713742|FG000|Overall Study|Lost to Follow-up|17|||
27693833|NCT01209780|80713743|FG001|Overall Study|Lost to Follow-up|12|||
27592859|NCT04988308|80352196|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
27592860|NCT04988308|80352197|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
27693834|NCT01209780|80713744|FG002|Overall Study|Lost to Follow-up|3|||
27693835|NCT01209780|80713745|FG003|Overall Study|Lost to Follow-up|9|||
27693836|NCT01209780|80713746|FG004|Overall Study|Lost to Follow-up|4|||
27693837|NCT01209780|80713742|FG000|Overall Study|Protocol Violation|0|||
27693838|NCT01209780|80713743|FG001|Overall Study|Protocol Violation|1|||
27693839|NCT01209780|80713744|FG002|Overall Study|Protocol Violation|0|||
27693840|NCT01209780|80713745|FG003|Overall Study|Protocol Violation|0|||
27881329|NCT03103152|81397929|FG003|Overall Study|Protocol Violation|2|||
27881330|NCT03103152|81397930|FG004|Overall Study|Protocol Violation|1|||
27881331|NCT03103152|81397931|FG005|Overall Study|Protocol Violation|1|||
27693841|NCT01209780|80713746|FG004|Overall Study|Protocol Violation|0|||
27693842|NCT01209780|80713742|FG000|Overall Study|Inappropriate enrollment|0|||
27693843|NCT01209780|80713743|FG001|Overall Study|Inappropriate enrollment|2|||
27693844|NCT01209780|80713744|FG002|Overall Study|Inappropriate enrollment|0|||
27820379|NCT00533273|81176108|FG000|Open-label|Withdrawal by Subject|6|||
27820380|NCT00533273|81176109|FG001|Open-label|Withdrawal by Subject|0|||
27820381|NCT02674477|81176110|FG000|Overall Study|Protocol Violation|8|||
27881332|NCT03103152|81397926|FG000|Overall Study|Inter-current illness|0|||
27881333|NCT03103152|81397927|FG001|Overall Study|Inter-current illness|0|||
27881334|NCT03103152|81397928|FG002|Overall Study|Inter-current illness|1|||
27881335|NCT03103152|81397929|FG003|Overall Study|Inter-current illness|0|||
27881336|NCT03103152|81397930|FG004|Overall Study|Inter-current illness|0|||
27881337|NCT03103152|81397931|FG005|Overall Study|Inter-current illness|0|||
27881338|NCT03103152|81397926|FG000|Overall Study|Death|0|||
27881339|NCT03103152|81397927|FG001|Overall Study|Death|1|||
27881340|NCT03103152|81397928|FG002|Overall Study|Death|0|||
27881341|NCT03103152|81397929|FG003|Overall Study|Death|0|||
27881342|NCT03103152|81397930|FG004|Overall Study|Death|0|||
27881343|NCT03103152|81397931|FG005|Overall Study|Death|0|||
27881344|NCT03103152|81397926|FG000|Overall Study|Adverse Event|0|||
27881345|NCT03103152|81397927|FG001|Overall Study|Adverse Event|0|||
27881346|NCT03103152|81397928|FG002|Overall Study|Adverse Event|1|||
27881347|NCT03103152|81397929|FG003|Overall Study|Adverse Event|0|||
27881348|NCT03103152|81397930|FG004|Overall Study|Adverse Event|0|||
27881349|NCT03103152|81397931|FG005|Overall Study|Adverse Event|1|||
27881350|NCT03103152|81397926|FG000|Overall Study|Withdrawal by Subject|1|||
27881351|NCT03103152|81397927|FG001|Overall Study|Withdrawal by Subject|0|||
27693845|NCT01209780|80713745|FG003|Overall Study|Inappropriate enrollment|0|||
27693846|NCT01209780|80713746|FG004|Overall Study|Inappropriate enrollment|1|||
27693847|NCT01635920|80713747|FG000|Overall Study|Adverse Event|1|||
27693848|NCT01635920|80713748|FG001|Overall Study|Adverse Event|0|||
27820382|NCT02674477|81176111|FG001|Overall Study|Protocol Violation|2|||
27820383|NCT00119379|81176113|FG000|Overall Study|Adverse Event|4|||
27820384|NCT00119379|81176114|FG001|Overall Study|Adverse Event|1|||
27820385|NCT03693430|81176115|FG000|Overall Study|Lost to Follow-up|3|||
27820386|NCT03693430|81176116|FG001|Overall Study|Lost to Follow-up|14|||
27820387|NCT03693430|81176115|FG000|Overall Study|Death|1|||
27820388|NCT03693430|81176116|FG001|Overall Study|Death|0|||
27820389|NCT03693430|81176115|FG000|Overall Study|Withdrawal by Subject|0|||
27820390|NCT03693430|81176116|FG001|Overall Study|Withdrawal by Subject|4|||
27820391|NCT00893464|81176118|FG000|Overall Study|Did not complete therapy/experience PD|0|||
27820392|NCT00893464|81176119|FG001|Overall Study|Did not complete therapy/experience PD|0|||
27820393|NCT00893464|81176120|FG002|Overall Study|Did not complete therapy/experience PD|0|||
27820394|NCT00893464|81176121|FG003|Overall Study|Did not complete therapy/experience PD|0|||
27820395|NCT00893464|81176122|FG004|Overall Study|Did not complete therapy/experience PD|0|||
27820396|NCT00893464|81176123|FG005|Overall Study|Did not complete therapy/experience PD|0|||
27881352|NCT03103152|81397928|FG002|Overall Study|Withdrawal by Subject|1|||
27881353|NCT03103152|81397929|FG003|Overall Study|Withdrawal by Subject|1|||
27693849|NCT01635920|80713747|FG000|Overall Study|Lost to Follow-up|0|||
27881354|NCT03103152|81397930|FG004|Overall Study|Withdrawal by Subject|1|||
27881355|NCT03103152|81397931|FG005|Overall Study|Withdrawal by Subject|1|||
27881356|NCT03103152|81397926|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
27881357|NCT03103152|81397927|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
27881358|NCT03103152|81397928|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
27881359|NCT03103152|81397929|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
27693850|NCT01635920|80713748|FG001|Overall Study|Lost to Follow-up|1|||
27881360|NCT03103152|81397930|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
27881361|NCT03103152|81397931|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
27881362|NCT03103152|81397926|FG000|Overall Study|Unacceptable side effects|0|||
27881363|NCT03103152|81397927|FG001|Overall Study|Unacceptable side effects|0|||
27881364|NCT03103152|81397928|FG002|Overall Study|Unacceptable side effects|0|||
27881365|NCT03103152|81397929|FG003|Overall Study|Unacceptable side effects|0|||
27881366|NCT03103152|81397930|FG004|Overall Study|Unacceptable side effects|0|||
27881367|NCT03103152|81397931|FG005|Overall Study|Unacceptable side effects|1|||
27881368|NCT03103152|81397926|FG000|Overall Study|Lost to Follow-up|0|||
27881369|NCT03103152|81397927|FG001|Overall Study|Lost to Follow-up|1|||
27881370|NCT03103152|81397928|FG002|Overall Study|Lost to Follow-up|0|||
27881371|NCT03103152|81397929|FG003|Overall Study|Lost to Follow-up|1|||
27881372|NCT03103152|81397930|FG004|Overall Study|Lost to Follow-up|0|||
27881373|NCT03103152|81397931|FG005|Overall Study|Lost to Follow-up|1|||
27881374|NCT03103152|81397926|FG000|Overall Study|Testicular pain|0|||
27881375|NCT03103152|81397927|FG001|Overall Study|Testicular pain|0|||
27881376|NCT03103152|81397928|FG002|Overall Study|Testicular pain|0|||
27881377|NCT03103152|81397929|FG003|Overall Study|Testicular pain|1|||
27881378|NCT03103152|81397930|FG004|Overall Study|Testicular pain|0|||
27881379|NCT03103152|81397931|FG005|Overall Study|Testicular pain|0|||
27881380|NCT02898597|81397932|FG000|Overall Study|Protocol Violation|4|||
27881381|NCT02898597|81397933|FG001|Overall Study|Protocol Violation|2|||
27881382|NCT02898597|81397932|FG000|Overall Study|Lost to Follow-up|0|||
27881383|NCT02898597|81397933|FG001|Overall Study|Lost to Follow-up|9|||
27881384|NCT02898597|81397932|FG000|Overall Study|Death|0|||
27881385|NCT02898597|81397933|FG001|Overall Study|Death|1|||
27881386|NCT00777296|81397934|FG000|Overall Study|Adverse Event|0|||
27881387|NCT00777296|81397935|FG001|Overall Study|Adverse Event|1|||
27881388|NCT00777296|81397936|FG002|Overall Study|Adverse Event|0|||
27881389|NCT00777296|81397937|FG003|Overall Study|Adverse Event|1|||
27881390|NCT00777296|81397934|FG000|Overall Study|Withdrawal by Subject|1|||
27881391|NCT00777296|81397935|FG001|Overall Study|Withdrawal by Subject|0|||
27693851|NCT01635920|80713747|FG000|Overall Study|Subject decision|2|||
27693852|NCT01635920|80713748|FG001|Overall Study|Subject decision|0|||
27820397|NCT00893464|81176124|FG006|Overall Study|Did not complete therapy/experience PD|2|||
27820398|NCT00893464|81176125|FG007|Overall Study|Did not complete therapy/experience PD|2|||
27820399|NCT02781727|81176126|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
27820400|NCT02781727|81176127|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
27820401|NCT02781727|81176126|FG000|Treatment Period|Withdrawal by Subject|1|||
27820402|NCT02781727|81176127|FG001|Treatment Period|Withdrawal by Subject|0|||
27820403|NCT02781727|81176126|FG000|Treatment Period|Lost to Follow-up|0|||
27820404|NCT02781727|81176127|FG001|Treatment Period|Lost to Follow-up|1|||
27820405|NCT01001208|81176131|FG000|Overall Study|Adverse Event|10|||
27820406|NCT01001208|81176132|FG001|Overall Study|Adverse Event|5|||
27820407|NCT01001208|81176131|FG000|Overall Study|Lost to Follow-up|5|||
27820408|NCT01001208|81176132|FG001|Overall Study|Lost to Follow-up|9|||
27820409|NCT01001208|81176131|FG000|Overall Study|Physician Decision|1|||
27820410|NCT01001208|81176132|FG001|Overall Study|Physician Decision|0|||
27820411|NCT01001208|81176131|FG000|Overall Study|Withdrawal by Subject|4|||
27820412|NCT01001208|81176132|FG001|Overall Study|Withdrawal by Subject|5|||
27820413|NCT01001208|81176131|FG000|Overall Study|Ineligibility Determined|4|||
27820414|NCT01001208|81176132|FG001|Overall Study|Ineligibility Determined|2|||
27820415|NCT01001208|81176131|FG000|Overall Study|Noncompliance|4|||
27820416|NCT01001208|81176132|FG001|Overall Study|Noncompliance|7|||
27820417|NCT01001208|81176131|FG000|Overall Study|Disease Progression|0|||
27820418|NCT01001208|81176132|FG001|Overall Study|Disease Progression|3|||
27820419|NCT01001208|81176131|FG000|Overall Study|Other|0|||
27820420|NCT01001208|81176132|FG001|Overall Study|Other|2|||
27881392|NCT00777296|81397936|FG002|Overall Study|Withdrawal by Subject|0|||
27693853|NCT01689337|80713749|FG000|Overall Study|Study Discontinuation|1|||
27693854|NCT00368992|80713750|FG000|Overall Study|Ineligible|5|||
27820421|NCT00454909|81176133|FG000|Overall Study|Withdrawal by Subject|1|||
27820422|NCT00454909|81176134|FG001|Overall Study|Withdrawal by Subject|0|||
27881393|NCT00777296|81397937|FG003|Overall Study|Withdrawal by Subject|0|||
27881394|NCT00777296|81397934|FG000|Overall Study|CRF form not completed|0|||
27881395|NCT00777296|81397935|FG001|Overall Study|CRF form not completed|0|||
27881396|NCT00777296|81397936|FG002|Overall Study|CRF form not completed|2|||
27881397|NCT00777296|81397937|FG003|Overall Study|CRF form not completed|0|||
27881398|NCT03259425|81397938|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
27881399|NCT01323387|81397940|FG000|Overall Study|Withdrawal by Subject|41|||
27881400|NCT01323387|81397940|FG000|Overall Study|Radiographic Data Unavailable|1|||
27881401|NCT01323387|81397940|FG000|Overall Study|Revision|14|||
27881402|NCT01323387|81397940|FG000|Overall Study|Protocol Violation|12|||
27881403|NCT01323387|81397940|FG000|Overall Study|Randomized but Never Treated|16|||
27820423|NCT00454909|81176135|FG002|Overall Study|Withdrawal by Subject|0|||
27820424|NCT00454909|81176133|FG000|Overall Study|Migrated/moved from study area|0|||
27820425|NCT00454909|81176134|FG001|Overall Study|Migrated/moved from study area|0|||
27881404|NCT02576847|81397943|FG000|Overall Study|Adverse Event|27|||
27881405|NCT02576847|81397943|FG000|Overall Study|Lost to Follow-up|22|||
27881406|NCT02576847|81397943|FG000|Overall Study|Physician Decision|1|||
27881407|NCT02576847|81397943|FG000|Overall Study|Pregnancy|1|||
27881408|NCT02576847|81397943|FG000|Overall Study|Protocol Violation|3|||
27881409|NCT02576847|81397943|FG000|Overall Study|Withdrawal by Subject|78|||
27881410|NCT02576847|81397943|FG000|Overall Study|Other|5|||
27881411|NCT01706939|81397944|FG000|Pre Randomization|Screen Failure|1|||
27881412|NCT01706939|81397945|FG001|Pre Randomization|Screen Failure|0|||
27881413|NCT01706939|81397946|FG002|Pre Randomization|Screen Failure|0|||
27881414|NCT01706939|81397944|FG000|Pre Randomization|Ineligible for Randomization|1|||
27881415|NCT01706939|81397945|FG001|Pre Randomization|Ineligible for Randomization|0|||
27881416|NCT01706939|81397946|FG002|Pre Randomization|Ineligible for Randomization|0|||
27881417|NCT01706939|81397944|FG000|Pre Randomization|Withdrawal by Subject|1|||
27881418|NCT01706939|81397945|FG001|Pre Randomization|Withdrawal by Subject|0|||
27881419|NCT01706939|81397946|FG002|Pre Randomization|Withdrawal by Subject|0|||
27881420|NCT01706939|81397944|FG000|Randomization|Insufficient QoL survey compliance|0|||
27881421|NCT01706939|81397945|FG001|Randomization|Insufficient QoL survey compliance|1|||
27881422|NCT01706939|81397946|FG002|Randomization|Insufficient QoL survey compliance|1|||
27881423|NCT01706939|81397944|FG000|Randomization|Progression of disease|0|||
27881424|NCT01706939|81397945|FG001|Randomization|Progression of disease|2|||
27881425|NCT01706939|81397946|FG002|Randomization|Progression of disease|1|||
27881426|NCT02406027|81397949|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
27881427|NCT02406027|81397950|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
27881428|NCT02406027|81397951|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
27881429|NCT02406027|81397952|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
27881430|NCT02406027|81397953|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
27693855|NCT00368992|80713750|FG000|Overall Study|Refused treatment|3|||
27693856|NCT00368992|80713750|FG000|Overall Study|Lack of Efficacy|63|||
27693857|NCT00368992|80713750|FG000|Overall Study|Adverse Event|26|||
27693858|NCT00368992|80713750|FG000|Overall Study|Death|4|||
27881431|NCT02406027|81397954|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
27881432|NCT02406027|81397955|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
27881433|NCT02406027|81397949|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
27881434|NCT02406027|81397950|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
27881435|NCT02406027|81397951|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
27881436|NCT02406027|81397952|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
27881437|NCT02406027|81397953|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
27881438|NCT02406027|81397954|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
27881439|NCT02406027|81397955|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
27881440|NCT02406027|81397949|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
27881441|NCT02406027|81397950|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
27881442|NCT02406027|81397951|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
27881443|NCT02406027|81397952|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
27881444|NCT02406027|81397953|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
27693859|NCT00368992|80713750|FG000|Overall Study|Other|9|||
27693860|NCT01966471|80713753|FG000|Overall Study|Death|44|||
27693861|NCT01966471|80713754|FG001|Overall Study|Death|56|||
27693862|NCT01966471|80713753|FG000|Overall Study|Lost to Follow-up|46|||
27693863|NCT01966471|80713754|FG001|Overall Study|Lost to Follow-up|39|||
27693864|NCT01966471|80713753|FG000|Overall Study|Various reasons|4|||
27693865|NCT01966471|80713754|FG001|Overall Study|Various reasons|4|||
27693866|NCT01966471|80713753|FG000|Overall Study|Physician Decision|7|||
27693867|NCT01966471|80713754|FG001|Overall Study|Physician Decision|5|||
27693868|NCT01966471|80713753|FG000|Overall Study|Study Terminated By Sponsor|758|||
27693869|NCT01966471|80713754|FG001|Overall Study|Study Terminated By Sponsor|773|||
27693870|NCT01966471|80713753|FG000|Overall Study|Withdrawal by Subject|59|||
27881445|NCT02406027|81397954|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
27881446|NCT02406027|81397955|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
27881447|NCT02406027|81397949|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
27881448|NCT02406027|81397950|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
27693871|NCT01966471|80713754|FG001|Overall Study|Withdrawal by Subject|51|||
27693872|NCT01580969|80713755|FG000|Overall Study|Physician Decision|3|||
27881449|NCT02406027|81397951|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
27881450|NCT02406027|81397952|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
27881451|NCT02406027|81397953|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
27881452|NCT02406027|81397954|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
27693873|NCT01580969|80713756|FG001|Overall Study|Physician Decision|0|||
27693874|NCT01580969|80713757|FG002|Overall Study|Physician Decision|0|||
27693875|NCT00966277|80716580|FG000|Overall Study|Withdrawal by Subject|3|||
27881453|NCT02406027|81397955|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
27881454|NCT02406027|81397949|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
27881455|NCT02406027|81397950|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
27881456|NCT02406027|81397951|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
27881457|NCT02406027|81397952|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
27881458|NCT02406027|81397953|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
27881459|NCT02406027|81397954|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
27881460|NCT02406027|81397955|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
27881461|NCT02406027|81397949|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
27881462|NCT02406027|81397950|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
27881463|NCT02406027|81397951|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
27881464|NCT02406027|81397952|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
27881465|NCT02406027|81397953|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
27881466|NCT02406027|81397954|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
27881467|NCT02406027|81397955|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
27881468|NCT02406027|81397949|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
27881469|NCT02406027|81397950|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
27881470|NCT02406027|81397951|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
27881471|NCT02406027|81397952|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
27881472|NCT02406027|81397953|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
27881473|NCT02406027|81397954|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
27881474|NCT02406027|81397955|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
27881475|NCT02406027|81397949|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
27881476|NCT02406027|81397950|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
27592861|NCT04988308|80352198|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
27592862|NCT04988308|80352199|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
27592863|NCT04988308|80352194|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
27592864|NCT04988308|80352195|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
27592865|NCT04988308|80352196|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
27592866|NCT04988308|80352197|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
27592867|NCT04988308|80352198|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
27592868|NCT04988308|80352199|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
27592869|NCT04988308|80352194|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
27592870|NCT04988308|80352195|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
27592871|NCT04988308|80352196|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
27592872|NCT04988308|80352197|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27592873|NCT04988308|80352198|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27592874|NCT04988308|80352199|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
27592875|NCT04988308|80352194|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
27592876|NCT04988308|80352195|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
27592877|NCT04988308|80352196|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
27592878|NCT04988308|80352197|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
27592879|NCT04988308|80352198|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
27592880|NCT04988308|80352199|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
27592881|NCT04988308|80352194|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27592882|NCT04988308|80352195|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27592883|NCT04988308|80352196|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
27592884|NCT04988308|80352197|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
27592885|NCT04988308|80352198|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
27592886|NCT04988308|80352199|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
27592887|NCT04988308|80352194|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27592888|NCT04988308|80352195|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27592889|NCT04988308|80352196|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
27592890|NCT04988308|80352197|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
27592891|NCT04988308|80352198|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
27592892|NCT04988308|80352199|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
27592893|NCT04988308|80352194|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27881477|NCT02406027|81397951|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
27881478|NCT02406027|81397952|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
27881479|NCT02406027|81397953|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
27881480|NCT02406027|81397954|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
27881481|NCT02406027|81397955|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
27592894|NCT04988308|80352195|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27592895|NCT04988308|80352196|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
27592896|NCT04988308|80352197|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
27592897|NCT04988308|80352198|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
27592898|NCT04988308|80352199|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
27592899|NCT04988308|80352194|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
27592900|NCT04988308|80352195|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
27592901|NCT04988308|80352196|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
27592902|NCT04988308|80352197|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
27592903|NCT04988308|80352198|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
27592904|NCT04988308|80352199|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
27592905|NCT04537923|80352200|FG000|Overall Study|Adverse Event|2|||
27592906|NCT04537923|80352201|FG001|Overall Study|Adverse Event|1|||
27592907|NCT04537923|80352202|FG002|Overall Study|Adverse Event|2|||
27592908|NCT04537923|80352203|FG003|Overall Study|Adverse Event|4|||
27592909|NCT04537923|80352200|FG000|Overall Study|Death|3|||
27820426|NCT00454909|81176135|FG002|Overall Study|Migrated/moved from study area|1|||
27820427|NCT00454909|81176133|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
27820428|NCT00454909|81176134|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
27820429|NCT00454909|81176135|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
27820430|NCT00454909|81176133|FG000|Overall Study|Others|1|||
27820431|NCT00454909|81176134|FG001|Overall Study|Others|0|||
27820432|NCT00454909|81176135|FG002|Overall Study|Others|0|||
27820433|NCT00617305|81176136|FG000|Overall Study|Adverse Event|4|||
27820434|NCT00617305|81176137|FG001|Overall Study|Adverse Event|0|||
27820435|NCT00617305|81176138|FG002|Overall Study|Adverse Event|0|||
27820436|NCT00617305|81176136|FG000|Overall Study|Death|1|||
27820437|NCT00617305|81176137|FG001|Overall Study|Death|0|||
27820438|NCT00617305|81176138|FG002|Overall Study|Death|0|||
27592910|NCT04537923|80352201|FG001|Overall Study|Death|3|||
27592911|NCT04537923|80352202|FG002|Overall Study|Death|1|||
27592912|NCT04537923|80352203|FG003|Overall Study|Death|11|||
27592913|NCT04537923|80352200|FG000|Overall Study|Lost to Follow-up|1|||
27820439|NCT00617305|81176136|FG000|Overall Study|Physician Decision|1|||
27820440|NCT00617305|81176137|FG001|Overall Study|Physician Decision|0|||
27820441|NCT00617305|81176138|FG002|Overall Study|Physician Decision|0|||
27820442|NCT00617305|81176136|FG000|Overall Study|Protocol Violation|1|||
27820443|NCT00617305|81176137|FG001|Overall Study|Protocol Violation|0|||
27820444|NCT00617305|81176138|FG002|Overall Study|Protocol Violation|1|||
27820445|NCT00617305|81176136|FG000|Overall Study|Withdrawal by Subject|1|||
27592914|NCT04537923|80352201|FG001|Overall Study|Lost to Follow-up|2|||
27592915|NCT04537923|80352202|FG002|Overall Study|Lost to Follow-up|1|||
27592916|NCT04537923|80352203|FG003|Overall Study|Lost to Follow-up|6|||
27592917|NCT04537923|80352200|FG000|Overall Study|Physician Decision|1|||
27592918|NCT04537923|80352201|FG001|Overall Study|Physician Decision|0|||
27592919|NCT04537923|80352202|FG002|Overall Study|Physician Decision|2|||
27592920|NCT04537923|80352203|FG003|Overall Study|Physician Decision|5|||
27592921|NCT04537923|80352200|FG000|Overall Study|Pregnancy|1|||
27592922|NCT04537923|80352201|FG001|Overall Study|Pregnancy|0|||
27592923|NCT04537923|80352202|FG002|Overall Study|Pregnancy|0|||
27592924|NCT04537923|80352203|FG003|Overall Study|Pregnancy|0|||
27592925|NCT04537923|80352200|FG000|Overall Study|Withdrawal by Subject|4|||
27592926|NCT04537923|80352201|FG001|Overall Study|Withdrawal by Subject|4|||
27592927|NCT04537923|80352202|FG002|Overall Study|Withdrawal by Subject|4|||
27592928|NCT04537923|80352203|FG003|Overall Study|Withdrawal by Subject|58|||
27592929|NCT04537923|80352200|FG000|Overall Study|Missed study visits|2|||
27592930|NCT04537923|80352201|FG001|Overall Study|Missed study visits|0|||
27592931|NCT04537923|80352202|FG002|Overall Study|Missed study visits|0|||
27820446|NCT00617305|81176137|FG001|Overall Study|Withdrawal by Subject|0|||
27592932|NCT04537923|80352203|FG003|Overall Study|Missed study visits|3|||
27592933|NCT04537923|80352200|FG000|Overall Study|Sponsor's decision|0|||
27592934|NCT04537923|80352201|FG001|Overall Study|Sponsor's decision|0|||
27592935|NCT04537923|80352202|FG002|Overall Study|Sponsor's decision|1|||
27592936|NCT04537923|80352203|FG003|Overall Study|Sponsor's decision|1|||
27592937|NCT04537923|80352200|FG000|Overall Study|Safety reasons|1|||
27592938|NCT04537923|80352201|FG001|Overall Study|Safety reasons|0|||
27820447|NCT00617305|81176138|FG002|Overall Study|Withdrawal by Subject|0|||
27820448|NCT02015390|81176141|FG000|Overall Study|Lost to Follow-up|1|||
27820449|NCT02015390|81176142|FG001|Overall Study|Lost to Follow-up|0|||
27820450|NCT02015390|81176141|FG000|Overall Study|Adverse Event|0|||
27820451|NCT02015390|81176142|FG001|Overall Study|Adverse Event|3|||
27820452|NCT02015390|81176141|FG000|Overall Study|Physician Decision|0|||
27820453|NCT02015390|81176142|FG001|Overall Study|Physician Decision|1|||
27881482|NCT02406027|81397949|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
27881483|NCT02406027|81397950|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
27881484|NCT02406027|81397951|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
27881485|NCT02406027|81397952|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
27881486|NCT02406027|81397953|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
27820454|NCT03262012|81176146|FG000|Overall Study|Withdrawal by Subject|15|||
27820455|NCT03262012|81176147|FG001|Overall Study|Withdrawal by Subject|13|||
27820456|NCT03262012|81176148|FG002|Overall Study|Withdrawal by Subject|8|||
27820457|NCT03262012|81176149|FG003|Overall Study|Withdrawal by Subject|7|||
27820458|NCT03262012|81176146|FG000|Overall Study|Adverse Event|10|||
27820459|NCT03262012|81176147|FG001|Overall Study|Adverse Event|12|||
27820460|NCT03262012|81176148|FG002|Overall Study|Adverse Event|4|||
27820461|NCT03262012|81176149|FG003|Overall Study|Adverse Event|6|||
27820462|NCT03262012|81176146|FG000|Overall Study|Physician Decision|2|||
27820463|NCT03262012|81176147|FG001|Overall Study|Physician Decision|5|||
27820464|NCT03262012|81176148|FG002|Overall Study|Physician Decision|1|||
27820465|NCT03262012|81176149|FG003|Overall Study|Physician Decision|0|||
27820466|NCT03262012|81176146|FG000|Overall Study|Lack of Efficacy|0|||
27820467|NCT03262012|81176147|FG001|Overall Study|Lack of Efficacy|5|||
27820468|NCT03262012|81176148|FG002|Overall Study|Lack of Efficacy|1|||
27820469|NCT03262012|81176149|FG003|Overall Study|Lack of Efficacy|2|||
27820470|NCT03262012|81176146|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
27820471|NCT03262012|81176147|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
27820472|NCT03262012|81176148|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
27820473|NCT03262012|81176149|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
27820474|NCT02421952|81176150|FG000|Overall Study|Diary Not Returned|93|||
27820475|NCT02421952|81176150|FG000|Overall Study|Failed seriation task|13|||
27820476|NCT02421952|81176150|FG000|Overall Study|Subject uncooperative for baseline test|2|||
27820477|NCT02421952|81176150|FG000|Overall Study|Surgery cancelled|1|||
27820478|NCT00366899|81176151|FG000|Infant Series|Withdrawal by Subject|4|||
27881487|NCT02406027|81397954|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
27881488|NCT02406027|81397955|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
27881489|NCT02406027|81397949|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
27881490|NCT02406027|81397950|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
27881491|NCT02406027|81397951|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
27881492|NCT02406027|81397952|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
27881493|NCT02406027|81397953|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
27881494|NCT02406027|81397954|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
27881495|NCT02406027|81397955|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
27881496|NCT02068508|81397961|FG000|Overall Study|Case report forms uncollected|27|||
27881497|NCT02068508|81397961|FG000|Overall Study|Patient did not visit the study site|1|||
27881498|NCT02068508|81397961|FG000|Overall Study|Protocol Violation|4|||
27881499|NCT04938180|81397962|FG000|Overall Study|Adverse Event|1|||
27881500|NCT00782626|81397963|FG000|Overall Study|Adverse Event|1|||
27881501|NCT00782626|81397963|FG000|Overall Study|Progressive Disease|5|||
27881502|NCT00782626|81397963|FG000|Overall Study|Other Complicating Disease|1|||
27881503|NCT02764762|81397964|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27881504|NCT02764762|81397964|FG000|Overall Study|Lost to Follow-up|4|||
27881505|NCT02764762|81397964|FG000|Overall Study|Voluntary Withdrawal|8|||
27881506|NCT02764762|81397964|FG000|Overall Study|Site Termination|1|||
27881507|NCT02764762|81397964|FG000|Overall Study|Lack of Efficacy|16|||
27881508|NCT02764762|81397964|FG000|Overall Study|Reason not Specified|1|||
27881509|NCT01627574|81397965|FG000|Overall Study|Withdrawal by Subject|8|||
27881510|NCT01627574|81397966|FG001|Overall Study|Withdrawal by Subject|5|||
27881511|NCT01627574|81397965|FG000|Overall Study|Lost to Follow-up|13|||
27881512|NCT01627574|81397966|FG001|Overall Study|Lost to Follow-up|13|||
27881513|NCT02155283|81397967|FG000|Overall Study|Lost to Follow-up|3|||
27881514|NCT02155283|81397967|FG000|Overall Study|Withdrawal by Subject|1|||
27881515|NCT02155283|81397967|FG000|Overall Study|Protocol Violation|3|||
27881516|NCT00110396|81397968|FG000|Overall Study|Adverse Event|15|||
27881517|NCT00110396|81397968|FG000|Overall Study|Lost to Follow-up|1|||
27881518|NCT00110396|81397968|FG000|Overall Study|Administration of plasmapheresis|1|||
27881519|NCT00110396|81397968|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
27881520|NCT00110396|81397968|FG000|Overall Study|Lack of Efficacy|1|||
27693876|NCT00966277|80716581|FG001|Overall Study|Withdrawal by Subject|0|||
27820479|NCT00366899|81176152|FG001|Infant Series|Withdrawal by Subject|7|||
27820480|NCT00366899|81176151|FG000|Infant Series|Protocol Violation|2|||
27820481|NCT00366899|81176152|FG001|Infant Series|Protocol Violation|1|||
27820482|NCT00366899|81176151|FG000|Infant Series|Failed to return|1|||
27820483|NCT00366899|81176152|FG001|Infant Series|Failed to return|1|||
27820484|NCT00366899|81176151|FG000|Infant Series|Lost to Follow-up|0|||
27881521|NCT00110396|81397968|FG000|Overall Study|Decided not to continue treatment|1|||
27881522|NCT00110396|81397968|FG000|Overall Study|Patient non-compliance|1|||
27881523|NCT00110396|81397968|FG000|Overall Study|Patient refused to continue|1|||
27881524|NCT00110396|81397968|FG000|Overall Study|Patient refused to participate|1|||
27881525|NCT00110396|81397968|FG000|Overall Study|Patient will|1|||
27881526|NCT00110396|81397968|FG000|Overall Study|Patient's decision|1|||
27881527|NCT00110396|81397968|FG000|Overall Study|Participation in MS vaccine study|1|||
27881528|NCT00110396|81397968|FG000|Overall Study|Pregnancy|1|||
27881529|NCT00110396|81397968|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
27881530|NCT00110396|81397968|FG000|Overall Study|Protocol Violation|2|||
27881531|NCT00110396|81397968|FG000|Overall Study|Patient refused to come back|1|||
27881532|NCT00110396|81397968|FG000|Overall Study|The patient has refused|2|||
27881533|NCT00110396|81397968|FG000|Overall Study|The patient has refused to visit site|1|||
27881534|NCT00110396|81397968|FG000|Overall Study|Patient is to be administered copaxone|1|||
27881535|NCT02872714|81397971|FG000|Overall Study|Progressive Disease|1|||
27592939|NCT04537923|80352202|FG002|Overall Study|Safety reasons|0|||
27881536|NCT02872714|81397972|FG001|Overall Study|Progressive Disease|2|||
27881537|NCT02872714|81397973|FG002|Overall Study|Progressive Disease|0|||
27881538|NCT02872714|81397974|FG003|Overall Study|Progressive Disease|0|||
27881539|NCT02872714|81397975|FG004|Overall Study|Progressive Disease|0|||
27881540|NCT02872714|81397971|FG000|Overall Study|Death|87|||
27881541|NCT02872714|81397972|FG001|Overall Study|Death|36|||
27881542|NCT02872714|81397973|FG002|Overall Study|Death|8|||
27881543|NCT02872714|81397974|FG003|Overall Study|Death|81|||
27881544|NCT02872714|81397975|FG004|Overall Study|Death|2|||
27881545|NCT02872714|81397971|FG000|Overall Study|Lost to Follow-up|2|||
27881546|NCT02872714|81397972|FG001|Overall Study|Lost to Follow-up|1|||
27881547|NCT02872714|81397973|FG002|Overall Study|Lost to Follow-up|0|||
27881548|NCT02872714|81397974|FG003|Overall Study|Lost to Follow-up|3|||
27881549|NCT02872714|81397975|FG004|Overall Study|Lost to Follow-up|0|||
27881550|NCT02872714|81397971|FG000|Overall Study|Physician Decision|0|||
27881551|NCT02872714|81397972|FG001|Overall Study|Physician Decision|0|||
27881552|NCT02872714|81397973|FG002|Overall Study|Physician Decision|0|||
27881553|NCT02872714|81397974|FG003|Overall Study|Physician Decision|1|||
27881554|NCT02872714|81397975|FG004|Overall Study|Physician Decision|0|||
27881555|NCT02872714|81397971|FG000|Overall Study|Withdrawal by Subject|1|||
27881556|NCT02872714|81397972|FG001|Overall Study|Withdrawal by Subject|3|||
27881557|NCT02872714|81397973|FG002|Overall Study|Withdrawal by Subject|0|||
27881558|NCT02872714|81397974|FG003|Overall Study|Withdrawal by Subject|2|||
27881559|NCT02872714|81397975|FG004|Overall Study|Withdrawal by Subject|0|||
27881560|NCT02872714|81397971|FG000|Overall Study|Captured as Other|2|||
27881561|NCT02872714|81397972|FG001|Overall Study|Captured as Other|0|||
27881562|NCT02872714|81397973|FG002|Overall Study|Captured as Other|0|||
27881563|NCT02872714|81397974|FG003|Overall Study|Captured as Other|1|||
27881564|NCT02872714|81397975|FG004|Overall Study|Captured as Other|0|||
27881565|NCT00961350|81397978|FG000|Overall Study|Adverse Event|18|||
27881566|NCT00961350|81397979|FG001|Overall Study|Adverse Event|33|||
27881567|NCT00961350|81397978|FG000|Overall Study|Withdrawal by Subject|10|||
27881568|NCT00961350|81397979|FG001|Overall Study|Withdrawal by Subject|10|||
27881569|NCT00961350|81397978|FG000|Overall Study|Lost to Follow-up|3|||
27881570|NCT00961350|81397979|FG001|Overall Study|Lost to Follow-up|3|||
27881571|NCT00961350|81397978|FG000|Overall Study|Misc|16|||
27881572|NCT00961350|81397979|FG001|Overall Study|Misc|21|||
27881573|NCT01073605|81397980|FG000|Overall Study|Ongoing at Cutoff Date|1|||
27881574|NCT01073605|81397981|FG001|Overall Study|Ongoing at Cutoff Date|1|||
27881575|NCT01073605|81397982|FG002|Overall Study|Ongoing at Cutoff Date|0|||
27881576|NCT01073605|81397980|FG000|Overall Study|Adverse Event|2|||
27881577|NCT01073605|81397981|FG001|Overall Study|Adverse Event|1|||
27881578|NCT01073605|81397982|FG002|Overall Study|Adverse Event|0|||
27881579|NCT01073605|81397980|FG000|Overall Study|Lost to Follow-up|3|||
27881580|NCT01073605|81397981|FG001|Overall Study|Lost to Follow-up|4|||
27881581|NCT01073605|81397982|FG002|Overall Study|Lost to Follow-up|9|||
27881582|NCT01073605|81397980|FG000|Overall Study|Other|25|||
27881583|NCT01073605|81397981|FG001|Overall Study|Other|21|||
27881584|NCT01073605|81397982|FG002|Overall Study|Other|29|||
27881585|NCT01073605|81397980|FG000|Overall Study|Withdrawal by Subject|31|||
27881586|NCT01073605|81397981|FG001|Overall Study|Withdrawal by Subject|39|||
27881587|NCT01073605|81397982|FG002|Overall Study|Withdrawal by Subject|22|||
27881588|NCT01073605|81397980|FG000|Overall Study|Randomized But Not Treated|0|||
27881589|NCT01073605|81397981|FG001|Overall Study|Randomized But Not Treated|1|||
27881590|NCT01073605|81397982|FG002|Overall Study|Randomized But Not Treated|1|||
27881591|NCT01896128|81397983|FG000|Overall Study|Withdrawal by Subject|3|||
27881592|NCT01896128|81397984|FG001|Overall Study|Withdrawal by Subject|3|||
27881593|NCT01483027|81397985|FG000|Overall Study|Administrative Reasons|2|||
27881594|NCT01483027|81397986|FG001|Overall Study|Administrative Reasons|1|||
27881595|NCT01483027|81397985|FG000|Overall Study|Withdrawal by Subject|21|||
27881596|NCT01483027|81397986|FG001|Overall Study|Withdrawal by Subject|32|||
27881597|NCT01483027|81397985|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
27881598|NCT01483027|81397986|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
27881599|NCT01483027|81397985|FG000|Overall Study|Lost to Follow-up|1|||
27881600|NCT01483027|81397986|FG001|Overall Study|Lost to Follow-up|1|||
27881601|NCT01483027|81397985|FG000|Overall Study|Adverse Event|0|||
27881602|NCT01483027|81397986|FG001|Overall Study|Adverse Event|1|||
27881603|NCT01483027|81397985|FG000|Overall Study|Withdrawal by Subject|0|||
27881604|NCT01483027|81397986|FG001|Overall Study|Withdrawal by Subject|1|||
27881605|NCT02476578|81397987|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
27881606|NCT02476578|81397988|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
27693877|NCT00966277|80716580|FG000|Overall Study|Ineligible|1|||
27693878|NCT00966277|80716581|FG001|Overall Study|Ineligible|3|||
27693879|NCT00966277|80716580|FG000|Overall Study|Treatment Plan Changed|0|||
27693880|NCT00966277|80716581|FG001|Overall Study|Treatment Plan Changed|1|||
27693881|NCT02054741|80716582|FG000|Overall Study|Protocol Violation|13|||
27881607|NCT02476578|81397987|FG000|Overall Study|Lost to Follow-up|6|||
27881608|NCT02476578|81397988|FG001|Overall Study|Lost to Follow-up|13|||
27881609|NCT04179838|81397989|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
27592940|NCT04537923|80352203|FG003|Overall Study|Safety reasons|0|||
27592941|NCT05054374|80352204|FG000|Overall Study|Withdrawal by Subject|1|||
27592942|NCT05054374|80352205|FG001|Overall Study|Withdrawal by Subject|0|||
27693882|NCT02054741|80716583|FG001|Overall Study|Protocol Violation|2|||
27693883|NCT02054741|80716582|FG000|Overall Study|Withdrawal by Subject|10|||
27693884|NCT02054741|80716583|FG001|Overall Study|Withdrawal by Subject|5|||
27693885|NCT02054741|80716582|FG000|Overall Study|Death|94|||
27693886|NCT02054741|80716583|FG001|Overall Study|Death|90|||
27693887|NCT02054741|80716582|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
27820485|NCT00366899|81176152|FG001|Infant Series|Lost to Follow-up|2|||
27820486|NCT00366899|81176151|FG000|Infant Series|Adverse Event|0|||
27820487|NCT00366899|81176152|FG001|Infant Series|Adverse Event|1|||
27820488|NCT00366899|81176151|FG000|Infant Series|Physician Decision|1|||
27820489|NCT00366899|81176152|FG001|Infant Series|Physician Decision|0|||
27820490|NCT00366899|81176151|FG000|Infant Series|Randomized but not consented|1|||
27820491|NCT00366899|81176152|FG001|Infant Series|Randomized but not consented|0|||
27820492|NCT00366899|81176151|FG000|After Infant Series|Lost to Follow-up|4|||
27820493|NCT00366899|81176152|FG001|After Infant Series|Lost to Follow-up|3|||
27820494|NCT00366899|81176151|FG000|After Infant Series|Withdrawal by Subject|1|||
27820495|NCT00366899|81176152|FG001|After Infant Series|Withdrawal by Subject|4|||
27881610|NCT04179838|81397990|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
27881611|NCT04179838|81397989|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
27592943|NCT05054374|80352206|FG002|Overall Study|Withdrawal by Subject|0|||
27693888|NCT02054741|80716583|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
27881612|NCT04179838|81397990|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
27820496|NCT00366899|81176151|FG000|After Infant Series|Adverse Event|1|||
27820497|NCT00366899|81176152|FG001|After Infant Series|Adverse Event|2|||
27820498|NCT00366899|81176151|FG000|After Infant Series|Protocol Violation|1|||
27881613|NCT00912743|81397991|FG000|Overall Study|Adverse Event|3|||
27881614|NCT00912743|81397992|FG001|Overall Study|Adverse Event|1|||
27881615|NCT00912743|81397991|FG000|Overall Study|Lack of Efficacy|9|||
27881616|NCT00912743|81397992|FG001|Overall Study|Lack of Efficacy|18|||
27881617|NCT00912743|81397991|FG000|Overall Study|Toxicity|0|||
27881618|NCT00912743|81397992|FG001|Overall Study|Toxicity|1|||
27881619|NCT00912743|81397991|FG000|Overall Study|End of treatment form was not collected|1|||
27881620|NCT00912743|81397992|FG001|Overall Study|End of treatment form was not collected|0|||
27881621|NCT04075682|81397993|FG000|Overall Study|Lost to Follow-up|5|||
27881622|NCT04075682|81397994|FG001|Overall Study|Lost to Follow-up|5|||
27881623|NCT04075682|81397995|FG002|Overall Study|Lost to Follow-up|2|||
27881624|NCT04075682|81397996|FG003|Overall Study|Lost to Follow-up|2|||
27881625|NCT04075682|81397993|FG000|Overall Study|Withdrawal by Subject|1|||
27881626|NCT04075682|81397994|FG001|Overall Study|Withdrawal by Subject|0|||
27693889|NCT04335812|80716584|FG000|Overall Study|Withdrawal by Subject|1|||
27820499|NCT00366899|81176152|FG001|After Infant Series|Protocol Violation|0|||
27820500|NCT00366899|81176151|FG000|Toddler Dose|Withdrawal by Subject|1|||
27820501|NCT00366899|81176152|FG001|Toddler Dose|Withdrawal by Subject|1|||
27820502|NCT00366899|81176151|FG000|Toddler Dose|Protocol Violation|1|||
27820503|NCT00366899|81176152|FG001|Toddler Dose|Protocol Violation|0|||
27820504|NCT03450070|81176153|FG000|Overall Study|Withdrawal by Subject|8|||
27820505|NCT03471078|81176156|FG000|Overall Study|Withdrawal by Subject|9|||
27820506|NCT03471078|81176157|FG001|Overall Study|Withdrawal by Subject|1|||
27820507|NCT03471078|81176156|FG000|Overall Study|Adverse Event|4|||
27820508|NCT03471078|81176157|FG001|Overall Study|Adverse Event|1|||
27820509|NCT03471078|81176156|FG000|Overall Study|Physician Decision|3|||
27820510|NCT03471078|81176157|FG001|Overall Study|Physician Decision|2|||
27820511|NCT03471078|81176156|FG000|Overall Study|Death|2|||
27820512|NCT03471078|81176157|FG001|Overall Study|Death|0|||
27820513|NCT03471078|81176156|FG000|Overall Study|Other|3|||
27820514|NCT03471078|81176157|FG001|Overall Study|Other|2|||
27820515|NCT02910037|81176160|FG000|Overall Study|Withdrawal by Subject|4|||
27820516|NCT02910037|81176160|FG000|Overall Study|Lost to Follow-up|6|||
27820517|NCT00440297|81176161|FG000|Overall Study|Adverse Event|8|||
27820518|NCT00440297|81176162|FG001|Overall Study|Adverse Event|5|||
27820519|NCT00440297|81176161|FG000|Overall Study|Lost to Follow-up|1|||
27820520|NCT00440297|81176162|FG001|Overall Study|Lost to Follow-up|0|||
27820521|NCT00440297|81176161|FG000|Overall Study|Physician Decision|1|||
27820522|NCT00440297|81176162|FG001|Overall Study|Physician Decision|0|||
27820523|NCT00440297|81176161|FG000|Overall Study|Protocol Violation|11|||
27820524|NCT00440297|81176162|FG001|Overall Study|Protocol Violation|7|||
27820525|NCT00440297|81176161|FG000|Overall Study|Withdrawal by Subject|1|||
27820526|NCT00440297|81176162|FG001|Overall Study|Withdrawal by Subject|6|||
27820527|NCT00440297|81176161|FG000|Overall Study|Randomized by mistake|1|||
27820528|NCT00440297|81176162|FG001|Overall Study|Randomized by mistake|0|||
27820529|NCT01387737|81176163|FG000|Overall Study|Adverse Event|20|||
27881627|NCT04075682|81397995|FG002|Overall Study|Withdrawal by Subject|1|||
27820530|NCT01387737|81176164|FG001|Overall Study|Adverse Event|30|||
27820531|NCT01387737|81176163|FG000|Overall Study|Lack of Efficacy|1|||
27820532|NCT01387737|81176164|FG001|Overall Study|Lack of Efficacy|0|||
27820533|NCT01387737|81176163|FG000|Overall Study|Physician Decision|3|||
27820534|NCT01387737|81176164|FG001|Overall Study|Physician Decision|10|||
27820535|NCT01387737|81176163|FG000|Overall Study|Withdrawal by Subject|27|||
27820536|NCT01387737|81176164|FG001|Overall Study|Withdrawal by Subject|31|||
27820537|NCT01387737|81176163|FG000|Overall Study|Clearly not eligible for the study|1|||
27820538|NCT01387737|81176164|FG001|Overall Study|Clearly not eligible for the study|3|||
27820539|NCT02076022|81176165|FG000|Overall Study|Withdrawal by Subject|2|||
27820540|NCT02076022|81176166|FG001|Overall Study|Withdrawal by Subject|0|||
27820541|NCT00414466|81176171|FG000|Overall Study|Adverse Event|0|||
27820542|NCT00414466|81176172|FG001|Overall Study|Adverse Event|0|||
27820543|NCT00414466|81176173|FG002|Overall Study|Adverse Event|1|||
27820544|NCT00414466|81176174|FG003|Overall Study|Adverse Event|1|||
27820545|NCT00414466|81176171|FG000|Overall Study|Lack of Efficacy|1|||
27820546|NCT00414466|81176172|FG001|Overall Study|Lack of Efficacy|0|||
27820547|NCT00414466|81176173|FG002|Overall Study|Lack of Efficacy|0|||
27820548|NCT00414466|81176174|FG003|Overall Study|Lack of Efficacy|0|||
27820549|NCT00414466|81176171|FG000|Overall Study|Withdrawn by Sponsor|1|||
27820550|NCT00414466|81176172|FG001|Overall Study|Withdrawn by Sponsor|0|||
27820551|NCT00414466|81176173|FG002|Overall Study|Withdrawn by Sponsor|0|||
27820552|NCT00414466|81176174|FG003|Overall Study|Withdrawn by Sponsor|0|||
27820553|NCT00336479|81176186|FG000|Overall Study|Adverse Event|8|||
27881628|NCT04075682|81397996|FG003|Overall Study|Withdrawal by Subject|0|||
27881629|NCT04075682|81397993|FG000|Overall Study|Protocol Violation|0|||
27592944|NCT05054374|80352207|FG003|Overall Study|Withdrawal by Subject|0|||
27592945|NCT05054374|80352204|FG000|Overall Study|Progressive Disease|5|||
27592946|NCT05054374|80352205|FG001|Overall Study|Progressive Disease|0|||
27592947|NCT05054374|80352206|FG002|Overall Study|Progressive Disease|0|||
27592948|NCT05054374|80352207|FG003|Overall Study|Progressive Disease|0|||
27592949|NCT01362140|80352214|FG000|Overall Study|Noncompliance|1|||
27592950|NCT01362140|80352215|FG001|Overall Study|Noncompliance|0|||
27592951|NCT01362140|80352214|FG000|Overall Study|Adverse Event|2|||
27592952|NCT01362140|80352215|FG001|Overall Study|Adverse Event|2|||
27820554|NCT00336479|81176187|FG001|Overall Study|Adverse Event|11|||
27820555|NCT00336479|81176188|FG002|Overall Study|Adverse Event|18|||
27881630|NCT04075682|81397994|FG001|Overall Study|Protocol Violation|1|||
27881631|NCT04075682|81397995|FG002|Overall Study|Protocol Violation|1|||
27881632|NCT04075682|81397996|FG003|Overall Study|Protocol Violation|0|||
27881633|NCT04075682|81397993|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
27881634|NCT04075682|81397994|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
27881635|NCT04075682|81397995|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
27881636|NCT04075682|81397996|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
27881637|NCT04075682|81397993|FG000|Overall Study|Lost study phone the first day of study participation|0|||
27881638|NCT04075682|81397994|FG001|Overall Study|Lost study phone the first day of study participation|1|||
27881639|NCT04075682|81397995|FG002|Overall Study|Lost study phone the first day of study participation|0|||
27881640|NCT04075682|81397996|FG003|Overall Study|Lost study phone the first day of study participation|0|||
27881641|NCT05027451|81397999|FG000|Overall Study|Lost to Follow-up|1|||
27820556|NCT00336479|81176189|FG003|Overall Study|Adverse Event|4|||
27592953|NCT01362140|80352214|FG000|Overall Study|Withdrawal by Subject|3|||
27592954|NCT01362140|80352215|FG001|Overall Study|Withdrawal by Subject|3|||
27693890|NCT04335812|80716585|FG001|Overall Study|Withdrawal by Subject|3|||
27820557|NCT00336479|81176186|FG000|Overall Study|Noncompliant|1|||
27820558|NCT00336479|81176187|FG001|Overall Study|Noncompliant|7|||
27820559|NCT00336479|81176188|FG002|Overall Study|Noncompliant|3|||
27881642|NCT05027451|81398000|FG001|Overall Study|Lost to Follow-up|1|||
27881643|NCT02962648|81398002|FG000|Overall Study|Withdrawal by Subject|3|||
27881644|NCT02962648|81398002|FG000|Overall Study|Lost to Follow-up|3|||
27881645|NCT02962648|81398002|FG000|Overall Study|Physician Decision|1|||
27881646|NCT02962648|81398002|FG000|Overall Study|Subject had problems with transportation|2|||
27881647|NCT00326716|81398006|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
27881648|NCT00326716|81398007|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
27881649|NCT00326716|81398008|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
27881650|NCT00326716|81398009|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
27881651|NCT01479465|81398011|FG000|Overall Study|Disease Progression|9|||
27881652|NCT01479465|81398012|FG001|Overall Study|Disease Progression|61|||
27881653|NCT01479465|81398013|FG002|Overall Study|Disease Progression|65|||
27881654|NCT01479465|81398014|FG003|Overall Study|Disease Progression|70|||
27881655|NCT01479465|81398011|FG000|Overall Study|Study Discontinued by Sponsor|0|||
27881656|NCT01479465|81398012|FG001|Overall Study|Study Discontinued by Sponsor|7|||
27881657|NCT01479465|81398013|FG002|Overall Study|Study Discontinued by Sponsor|5|||
27881658|NCT01479465|81398014|FG003|Overall Study|Study Discontinued by Sponsor|3|||
27881659|NCT01479465|81398011|FG000|Overall Study|Adverse Event|0|||
27881660|NCT01479465|81398012|FG001|Overall Study|Adverse Event|3|||
27881661|NCT01479465|81398013|FG002|Overall Study|Adverse Event|6|||
27881662|NCT01479465|81398014|FG003|Overall Study|Adverse Event|4|||
27881663|NCT01479465|81398011|FG000|Overall Study|Investigator Discretion|1|||
27881664|NCT01479465|81398012|FG001|Overall Study|Investigator Discretion|4|||
27881665|NCT01479465|81398013|FG002|Overall Study|Investigator Discretion|2|||
27881666|NCT01479465|81398014|FG003|Overall Study|Investigator Discretion|4|||
27881667|NCT01479465|81398011|FG000|Overall Study|Subject Request|1|||
27881668|NCT01479465|81398012|FG001|Overall Study|Subject Request|3|||
27881669|NCT01479465|81398013|FG002|Overall Study|Subject Request|4|||
27881670|NCT01479465|81398014|FG003|Overall Study|Subject Request|2|||
27881671|NCT01479465|81398011|FG000|Overall Study|Subject Withdrew Consent|0|||
27881672|NCT01479465|81398012|FG001|Overall Study|Subject Withdrew Consent|5|||
27881673|NCT01479465|81398013|FG002|Overall Study|Subject Withdrew Consent|2|||
27881674|NCT01479465|81398014|FG003|Overall Study|Subject Withdrew Consent|1|||
27881675|NCT01479465|81398011|FG000|Overall Study|Protocol Violation|0|||
27881676|NCT01479465|81398012|FG001|Overall Study|Protocol Violation|1|||
27881677|NCT01479465|81398013|FG002|Overall Study|Protocol Violation|1|||
27881678|NCT01479465|81398014|FG003|Overall Study|Protocol Violation|0|||
27881679|NCT01479465|81398011|FG000|Overall Study|Death|0|||
27881680|NCT01479465|81398012|FG001|Overall Study|Death|0|||
27881681|NCT01479465|81398013|FG002|Overall Study|Death|0|||
27881682|NCT01479465|81398014|FG003|Overall Study|Death|1|||
27881683|NCT01479465|81398011|FG000|Overall Study|Lost to Follow-up|0|||
27881684|NCT01479465|81398012|FG001|Overall Study|Lost to Follow-up|0|||
27881685|NCT01479465|81398013|FG002|Overall Study|Lost to Follow-up|1|||
27881686|NCT01479465|81398014|FG003|Overall Study|Lost to Follow-up|0|||
27881687|NCT00558701|81398015|FG000|Overall Study|Protocol Deviations|1|||
27881688|NCT00558701|81398016|FG001|Overall Study|Protocol Deviations|4|||
27881689|NCT02283268|81398020|FG000|Overall Study|Withdrawal by Subject|1|||
27881690|NCT04168112|81398021|FG000|Overall Study|Lost to Follow-up|1|||
27881691|NCT04168112|81398022|FG001|Overall Study|Lost to Follow-up|0|||
27881692|NCT04168112|81398021|FG000|Overall Study|Withdrawal by Subject|1|||
27881693|NCT04168112|81398022|FG001|Overall Study|Withdrawal by Subject|0|||
27881694|NCT04390503|81398023|FG000|Overall Study|Physician Decision|2|||
27592955|NCT01362140|80352214|FG000|Overall Study|Administrative Decision|0|||
27592956|NCT01362140|80352215|FG001|Overall Study|Administrative Decision|1|||
27881695|NCT04390503|81398024|FG001|Overall Study|Physician Decision|1|||
27881696|NCT04390503|81398023|FG000|Overall Study|Adverse Event|1|||
27881697|NCT04390503|81398024|FG001|Overall Study|Adverse Event|0|||
27881698|NCT04498182|81398028|FG000|Overall Study|Adverse Event|2|||
27881699|NCT04498182|81398029|FG001|Overall Study|Adverse Event|3|||
27881700|NCT04498182|81398030|FG002|Overall Study|Adverse Event|2|||
27881701|NCT04498182|81398028|FG000|Overall Study|Withdrawal of Consent|3|||
27881702|NCT04498182|81398029|FG001|Overall Study|Withdrawal of Consent|4|||
27881703|NCT04498182|81398030|FG002|Overall Study|Withdrawal of Consent|3|||
27592957|NCT01362140|80352214|FG000|Overall Study|Death|2|||
27592958|NCT01362140|80352215|FG001|Overall Study|Death|1|||
27592959|NCT01362140|80352214|FG000|Overall Study|Other|1|||
27881704|NCT04498182|81398028|FG000|Overall Study|Non-Compliant|1|||
27881705|NCT04498182|81398029|FG001|Overall Study|Non-Compliant|0|||
27881706|NCT04498182|81398030|FG002|Overall Study|Non-Compliant|1|||
27881707|NCT04498182|81398028|FG000|Overall Study|Lost to Follow-up|0|||
27881708|NCT04498182|81398029|FG001|Overall Study|Lost to Follow-up|0|||
27881709|NCT04498182|81398030|FG002|Overall Study|Lost to Follow-up|1|||
27592960|NCT01362140|80352215|FG001|Overall Study|Other|1|||
27592961|NCT01362140|80352214|FG000|Overall Study|Protocol-specified Criteria|1|||
27592962|NCT01362140|80352215|FG001|Overall Study|Protocol-specified Criteria|2|||
27592963|NCT01362140|80352214|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
27592964|NCT01362140|80352215|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
27592965|NCT01618162|80352224|FG000|Overall Study|Protocol Violation|13|||
27592966|NCT01618162|80352225|FG001|Overall Study|Protocol Violation|10|||
27592967|NCT01618162|80352224|FG000|Overall Study|Adverse Event|9|||
27592968|NCT01618162|80352225|FG001|Overall Study|Adverse Event|2|||
27592969|NCT01618162|80352224|FG000|Overall Study|Withdrawal Criteria|2|||
27820560|NCT00336479|81176189|FG003|Overall Study|Noncompliant|0|||
27820561|NCT00336479|81176186|FG000|Overall Study|Physician Decision|2|||
27820562|NCT00336479|81176187|FG001|Overall Study|Physician Decision|3|||
27820563|NCT00336479|81176188|FG002|Overall Study|Physician Decision|1|||
27820564|NCT00336479|81176189|FG003|Overall Study|Physician Decision|0|||
27820565|NCT00336479|81176186|FG000|Overall Study|Lost to Follow-up|3|||
27820566|NCT00336479|81176187|FG001|Overall Study|Lost to Follow-up|2|||
27820567|NCT00336479|81176188|FG002|Overall Study|Lost to Follow-up|0|||
27881710|NCT04498182|81398028|FG000|Overall Study|Investigator Decision|0|||
27881711|NCT04498182|81398029|FG001|Overall Study|Investigator Decision|0|||
27881712|NCT04498182|81398030|FG002|Overall Study|Investigator Decision|1|||
27881713|NCT04498182|81398028|FG000|Overall Study|Protocol Violation|1|||
27881714|NCT04498182|81398029|FG001|Overall Study|Protocol Violation|0|||
27881715|NCT04498182|81398030|FG002|Overall Study|Protocol Violation|2|||
27881716|NCT02729025|81398032|FG000|Overall Study|Sponsor Decision|0|||
27881717|NCT02729025|81398033|FG001|Overall Study|Sponsor Decision|1|||
27881718|NCT02519348|81398034|FG000|Overall Study|Death|31|||
27881719|NCT02519348|81398035|FG001|Overall Study|Death|74|||
27820568|NCT00336479|81176189|FG003|Overall Study|Lost to Follow-up|0|||
27820569|NCT00336479|81176186|FG000|Overall Study|Withdrawal by Subject|3|||
27820570|NCT00336479|81176187|FG001|Overall Study|Withdrawal by Subject|2|||
27820571|NCT00336479|81176188|FG002|Overall Study|Withdrawal by Subject|3|||
27592970|NCT01618162|80352225|FG001|Overall Study|Withdrawal Criteria|10|||
27592971|NCT01618162|80352224|FG000|Overall Study|Unclassified|14|||
27592972|NCT01618162|80352225|FG001|Overall Study|Unclassified|13|||
27592973|NCT00829387|80352226|FG000|Overall Study|Withdrawal by Subject|2|||
27592974|NCT00829387|80352227|FG001|Overall Study|Withdrawal by Subject|3|||
27592975|NCT00829387|80352226|FG000|Overall Study|Disqualified by PI|1|||
27592976|NCT00829387|80352227|FG001|Overall Study|Disqualified by PI|0|||
27592977|NCT01625897|80352230|FG000|Overall Study|Adverse Event|27|||
27592978|NCT01625897|80352231|FG001|Overall Study|Adverse Event|10|||
27592979|NCT01625897|80352230|FG000|Overall Study|Physician Decision|0|||
27592980|NCT01625897|80352231|FG001|Overall Study|Physician Decision|1|||
27592981|NCT01625897|80352230|FG000|Overall Study|Withdrawal by Subject|25|||
27592982|NCT01625897|80352231|FG001|Overall Study|Withdrawal by Subject|3|||
27820572|NCT00336479|81176189|FG003|Overall Study|Withdrawal by Subject|0|||
27820573|NCT00336479|81176186|FG000|Overall Study|Other|0|||
27881720|NCT02519348|81398036|FG002|Overall Study|Death|47|||
27881721|NCT02519348|81398037|FG003|Overall Study|Death|54|||
27881722|NCT02519348|81398038|FG004|Overall Study|Death|63|||
27881723|NCT02519348|81398039|FG005|Overall Study|Death|18|||
27592983|NCT04084314|80352234|FG000|Overall Study|Subject/guardian decision|91|||
27592984|NCT04084314|80352234|FG000|Overall Study|Adverse Event|24|||
27592985|NCT04084314|80352234|FG000|Overall Study|Lost to Follow-up|19|||
27693891|NCT04335812|80716584|FG000|Overall Study|Lost to Follow-up|12|||
27820574|NCT00336479|81176187|FG001|Overall Study|Other|0|||
27881724|NCT02519348|81398040|FG006|Overall Study|Death|2|||
27820575|NCT00336479|81176188|FG002|Overall Study|Other|1|||
27820576|NCT00336479|81176189|FG003|Overall Study|Other|0|||
27820577|NCT00336479|81176186|FG000|Overall Study|Virologic Stopping Rule|20|||
27820578|NCT00336479|81176187|FG001|Overall Study|Virologic Stopping Rule|0|||
27820579|NCT00336479|81176188|FG002|Overall Study|Virologic Stopping Rule|0|||
27820580|NCT00336479|81176189|FG003|Overall Study|Virologic Stopping Rule|0|||
27592986|NCT04084314|80352234|FG000|Overall Study|New therapy for study indication|9|||
27592987|NCT04084314|80352234|FG000|Overall Study|Pregnancy|9|||
27592988|NCT04084314|80352234|FG000|Overall Study|Withdrawal of informed consent|8|||
27592989|NCT04084314|80352234|FG000|Overall Study|Physician Decision|4|||
27592990|NCT04084314|80352234|FG000|Overall Study|Protocol Deviation|3|||
27592991|NCT04313881|80352235|FG000|Overall Study|Death|138|||
27592992|NCT04313881|80352236|FG001|Overall Study|Death|126|||
27592993|NCT04313881|80352235|FG000|Overall Study|Study terminated by sponsor|108|||
27820581|NCT02262377|81176190|FG000|Overall Study|Lost to Follow-up|5|||
27820582|NCT02262377|81176191|FG001|Overall Study|Lost to Follow-up|6|||
27820583|NCT02262377|81176190|FG000|Overall Study|Found ineligible after enrollment|3|||
27820584|NCT02262377|81176191|FG001|Overall Study|Found ineligible after enrollment|0|||
27820585|NCT02262377|81176190|FG000|Overall Study|Withdrawal by Subject|4|||
27820586|NCT02262377|81176191|FG001|Overall Study|Withdrawal by Subject|0|||
27592994|NCT04313881|80352236|FG001|Overall Study|Study terminated by sponsor|129|||
27592995|NCT04313881|80352235|FG000|Overall Study|Consent withdrawn|19|||
27592996|NCT04313881|80352236|FG001|Overall Study|Consent withdrawn|15|||
27592997|NCT04313881|80352235|FG000|Overall Study|Reason not Specified|3|||
27592998|NCT04313881|80352236|FG001|Overall Study|Reason not Specified|1|||
27592999|NCT03178266|80352240|FG000|Overall Study|Death|0|||
27693892|NCT04335812|80716585|FG001|Overall Study|Lost to Follow-up|12|||
27820587|NCT03897088|81176192|FG000|Overall Study|Withdrawal by Subject|12|||
27881725|NCT02519348|81398041|FG007|Overall Study|Death|5|||
27820588|NCT03897088|81176193|FG001|Overall Study|Withdrawal by Subject|12|||
27820589|NCT03897088|81176192|FG000|Overall Study|Lost to Follow-up|7|||
27593000|NCT03178266|80352241|FG001|Overall Study|Death|1|||
27593001|NCT03178266|80352240|FG000|Overall Study|Disont. Early|0|||
27820590|NCT03897088|81176193|FG001|Overall Study|Lost to Follow-up|15|||
27593002|NCT03178266|80352241|FG001|Overall Study|Disont. Early|1|||
27593003|NCT03178266|80352240|FG000|Overall Study|Withdrawal by Subject|0|||
27820591|NCT03897088|81176192|FG000|Overall Study|Sponsor Decision|1|||
27820592|NCT03897088|81176193|FG001|Overall Study|Sponsor Decision|2|||
27820593|NCT03897088|81176192|FG000|Overall Study|COVID-19|2|||
27820594|NCT03897088|81176193|FG001|Overall Study|COVID-19|0|||
27820595|NCT03897088|81176192|FG000|Overall Study|Other|3|||
27820596|NCT03897088|81176193|FG001|Overall Study|Other|0|||
27820597|NCT03897088|81176192|FG000|Overall Study|Non-compliance with Study Drug|1|||
27820598|NCT03897088|81176193|FG001|Overall Study|Non-compliance with Study Drug|1|||
27820599|NCT03897088|81176192|FG000|Overall Study|Pregnancy|0|||
27820600|NCT03897088|81176193|FG001|Overall Study|Pregnancy|1|||
27820601|NCT04213326|81176194|FG000|Overall Study|Consent withdrawn|51|||
27820602|NCT04213326|81176195|FG001|Overall Study|Consent withdrawn|241|||
27820603|NCT04213326|81176194|FG000|Overall Study|Lost to Follow-up|50|||
27593004|NCT03178266|80352241|FG001|Overall Study|Withdrawal by Subject|2|||
27593005|NCT02477696|80352242|FG000|Overall Study|Death|89|||
27593006|NCT02477696|80352243|FG001|Overall Study|Death|106|||
27593007|NCT02477696|80352242|FG000|Overall Study|Lost to Follow-up|7|||
27593008|NCT02477696|80352243|FG001|Overall Study|Lost to Follow-up|5|||
27593009|NCT02477696|80352242|FG000|Overall Study|Withdrawal by Subject|37|||
27593010|NCT02477696|80352243|FG001|Overall Study|Withdrawal by Subject|34|||
27593011|NCT02477696|80352242|FG000|Overall Study|Physician Decision|7|||
27593012|NCT02477696|80352243|FG001|Overall Study|Physician Decision|9|||
27693893|NCT04335812|80716584|FG000|Overall Study|Did not engage in the intervention|22|||
27693894|NCT04335812|80716585|FG001|Overall Study|Did not engage in the intervention|18|||
27693895|NCT02966301|80716586|FG000|Overall Study|Death|2|||
27820604|NCT04213326|81176195|FG001|Overall Study|Lost to Follow-up|902|||
27820605|NCT04213326|81176194|FG000|Overall Study|Protocol Violation|3|||
27820606|NCT04213326|81176195|FG001|Overall Study|Protocol Violation|25|||
27820607|NCT04213326|81176194|FG000|Overall Study|Participant eligibility changed|106|||
27820608|NCT04213326|81176195|FG001|Overall Study|Participant eligibility changed|19|||
27820609|NCT04213326|81176194|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
27820610|NCT04213326|81176195|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
27820611|NCT04213326|81176194|FG000|Overall Study|Incomplete study visit|0|||
27593013|NCT02477696|80352242|FG000|Overall Study|Study terminated by sponsor|103|||
27593014|NCT02477696|80352243|FG001|Overall Study|Study terminated by sponsor|99|||
27820612|NCT04213326|81176195|FG001|Overall Study|Incomplete study visit|367|||
27593015|NCT02477696|80352242|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
27593016|NCT02477696|80352243|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
27593017|NCT02477696|80352242|FG000|Overall Study|Missing/Unknown|2|||
27593018|NCT02477696|80352243|FG001|Overall Study|Missing/Unknown|0|||
27593019|NCT00983073|80352246|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
27593020|NCT00983073|80352246|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
27593021|NCT00983073|80352246|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
27593022|NCT00983073|80352246|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
27593023|NCT00983073|80352246|FG000|Titration and Optimal Dose Period|Other reason|4|||
27593024|NCT00983073|80352246|FG000|Maintenance Period|Adverse Event|5|||
27593025|NCT00983073|80352246|FG000|Maintenance Period|Withdrawal by Subject|2|||
27593026|NCT00983073|80352246|FG000|Maintenance Period|Lack of Efficacy|2|||
27593027|NCT00983073|80352246|FG000|Maintenance Period|Other Reason|7|||
27593028|NCT02621931|80352247|FG000|Overall Study|Death|0|||
27593029|NCT02621931|80352248|FG001|Overall Study|Death|1|||
27593030|NCT02621931|80352249|FG002|Overall Study|Death|0|||
27881726|NCT02519348|81398042|FG008|Overall Study|Death|5|||
27881727|NCT02519348|81398034|FG000|Overall Study|Withdrawal by Subject|4|||
27881728|NCT02519348|81398035|FG001|Overall Study|Withdrawal by Subject|7|||
27881729|NCT02519348|81398036|FG002|Overall Study|Withdrawal by Subject|4|||
27881730|NCT02519348|81398037|FG003|Overall Study|Withdrawal by Subject|3|||
27881731|NCT02519348|81398038|FG004|Overall Study|Withdrawal by Subject|3|||
27881732|NCT02519348|81398039|FG005|Overall Study|Withdrawal by Subject|2|||
27881733|NCT02519348|81398040|FG006|Overall Study|Withdrawal by Subject|0|||
27881734|NCT02519348|81398041|FG007|Overall Study|Withdrawal by Subject|0|||
27881735|NCT02519348|81398042|FG008|Overall Study|Withdrawal by Subject|1|||
27593031|NCT02621931|80352247|FG000|Overall Study|Adverse Event|8|||
27881736|NCT02519348|81398034|FG000|Overall Study|Lost to Follow-up|0|||
27593032|NCT02621931|80352248|FG001|Overall Study|Adverse Event|5|||
27593033|NCT02621931|80352249|FG002|Overall Study|Adverse Event|7|||
27593034|NCT02621931|80352247|FG000|Overall Study|Withdrawal by Subject|12|||
27881737|NCT02519348|81398035|FG001|Overall Study|Lost to Follow-up|0|||
27881738|NCT02519348|81398036|FG002|Overall Study|Lost to Follow-up|1|||
27881739|NCT02519348|81398037|FG003|Overall Study|Lost to Follow-up|0|||
27881740|NCT02519348|81398038|FG004|Overall Study|Lost to Follow-up|2|||
27881741|NCT02519348|81398039|FG005|Overall Study|Lost to Follow-up|1|||
27881742|NCT02519348|81398040|FG006|Overall Study|Lost to Follow-up|1|||
27881743|NCT02519348|81398041|FG007|Overall Study|Lost to Follow-up|0|||
27881744|NCT02519348|81398042|FG008|Overall Study|Lost to Follow-up|0|||
27693896|NCT02966301|80716586|FG000|Overall Study|Withdrawal by Subject|1|||
27693897|NCT00940108|80716587|FG000|Overall Study|Adverse Event|2|||
27693898|NCT00940108|80716588|FG001|Overall Study|Adverse Event|4|||
27693899|NCT00940108|80716589|FG002|Overall Study|Adverse Event|0|||
27693900|NCT00940108|80716590|FG003|Overall Study|Adverse Event|2|||
27820613|NCT03292653|81176198|FG000|Overall Study|Adverse Event|0|||
27820614|NCT03292653|81176199|FG001|Overall Study|Adverse Event|0|||
27820615|NCT03292653|81176200|FG002|Overall Study|Adverse Event|1|||
27820616|NCT03292653|81176198|FG000|Overall Study|Did not Receive Treatment|1|||
27820617|NCT03292653|81176199|FG001|Overall Study|Did not Receive Treatment|0|||
27820618|NCT03292653|81176200|FG002|Overall Study|Did not Receive Treatment|0|||
27820619|NCT03123471|81176201|FG000|Placebo-controlled Phase|Adverse Event|3|||
27820620|NCT03123471|81176202|FG001|Placebo-controlled Phase|Adverse Event|8|||
27820621|NCT03123471|81176201|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
27820622|NCT03123471|81176202|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
27820623|NCT03123471|81176201|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
27820624|NCT03123471|81176202|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
27820625|NCT03123471|81176201|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
27820626|NCT03123471|81176202|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
27820627|NCT03123471|81176201|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
27820628|NCT03123471|81176202|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
27820629|NCT03123471|81176201|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
27820630|NCT03123471|81176202|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
27820631|NCT03123471|81176201|FG000|Placebo-controlled Phase|Miscellaneous|0|||
27820632|NCT03123471|81176202|FG001|Placebo-controlled Phase|Miscellaneous|1|||
27820633|NCT03123471|81176201|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
27820634|NCT03123471|81176202|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
27820635|NCT03123471|81176201|FG000|Apremilast Extension Phase|Adverse Event|1|||
27820636|NCT03123471|81176202|FG001|Apremilast Extension Phase|Adverse Event|5|||
27820637|NCT03123471|81176201|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
27820638|NCT03123471|81176202|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
27820639|NCT03123471|81176201|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
27820640|NCT03123471|81176202|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
27820641|NCT01391793|81176204|FG000|Overall Study|Ineligible|3|||
27820642|NCT01391793|81176205|FG001|Overall Study|Ineligible|0|||
27820643|NCT01391793|81176204|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
27820644|NCT01391793|81176205|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
27820645|NCT01391793|81176204|FG000|Overall Study|No DMSA|73|||
27820646|NCT01391793|81176205|FG001|Overall Study|No DMSA|57|||
27820647|NCT00630305|81176210|FG000|Overall Study|Withdrawal by Subject|1|||
27820648|NCT00630305|81176210|FG000|Overall Study|Inability to insert contact lens|1|||
27820649|NCT01546545|81176211|FG000|Overall Study|Withdrawal by Subject|1|||
27820650|NCT00150462|81176212|FG000|Overall Study|Disease Progression or Relapse|3|||
27820651|NCT00150462|81176213|FG001|Overall Study|Disease Progression or Relapse|1|||
27820652|NCT00150462|81176214|FG002|Overall Study|Disease Progression or Relapse|2|||
27820653|NCT00150462|81176215|FG003|Overall Study|Disease Progression or Relapse|1|||
27820654|NCT00150462|81176216|FG004|Overall Study|Disease Progression or Relapse|2|||
27693901|NCT00940108|80716587|FG000|Overall Study|Withdrew Consent|2|||
27693902|NCT00940108|80716588|FG001|Overall Study|Withdrew Consent|1|||
27693903|NCT00940108|80716589|FG002|Overall Study|Withdrew Consent|0|||
27693904|NCT00940108|80716590|FG003|Overall Study|Withdrew Consent|1|||
27820655|NCT00150462|81176217|FG005|Overall Study|Disease Progression or Relapse|2|||
27881745|NCT02519348|81398034|FG000|Overall Study|Other|0|||
27881746|NCT02519348|81398035|FG001|Overall Study|Other|3|||
27881747|NCT02519348|81398036|FG002|Overall Study|Other|0|||
27881748|NCT02519348|81398037|FG003|Overall Study|Other|0|||
27881749|NCT02519348|81398038|FG004|Overall Study|Other|1|||
27881750|NCT02519348|81398039|FG005|Overall Study|Other|0|||
27881751|NCT02519348|81398040|FG006|Overall Study|Other|0|||
27881752|NCT02519348|81398041|FG007|Overall Study|Other|0|||
27881753|NCT02519348|81398042|FG008|Overall Study|Other|0|||
27881754|NCT02519348|81398034|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
27881755|NCT02519348|81398035|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
27881756|NCT02519348|81398036|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
27881757|NCT02519348|81398037|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
27881758|NCT02519348|81398038|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
27881759|NCT02519348|81398039|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
27881760|NCT02519348|81398040|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
27881761|NCT02519348|81398041|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
27881762|NCT02519348|81398042|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
27881763|NCT03691207|81398043|FG000|Overall Study|Death|41|||
27881764|NCT03691207|81398044|FG001|Overall Study|Death|26|||
27820656|NCT00150462|81176218|FG006|Overall Study|Disease Progression or Relapse|3|||
27820657|NCT00150462|81176219|FG007|Overall Study|Disease Progression or Relapse|5|||
27881765|NCT03691207|81398043|FG000|Overall Study|Lost to Follow-up|1|||
27881766|NCT03691207|81398044|FG001|Overall Study|Lost to Follow-up|1|||
27881767|NCT03691207|81398043|FG000|Overall Study|Withdrawal by Subject|2|||
27881768|NCT03691207|81398044|FG001|Overall Study|Withdrawal by Subject|8|||
27881769|NCT03691207|81398043|FG000|Overall Study|Sponsor decision|1|||
27820658|NCT00150462|81176220|FG008|Overall Study|Disease Progression or Relapse|5|||
27820659|NCT00150462|81176221|FG009|Overall Study|Disease Progression or Relapse|3|||
27693905|NCT00940108|80716587|FG000|Overall Study|Dose 2 contraindicated|1|||
27693906|NCT00940108|80716588|FG001|Overall Study|Dose 2 contraindicated|1|||
27693907|NCT00940108|80716589|FG002|Overall Study|Dose 2 contraindicated|0|||
27820660|NCT00150462|81176222|FG010|Overall Study|Disease Progression or Relapse|2|||
27820661|NCT00150462|81176212|FG000|Overall Study|Withdrawal by Subject|0|||
27820662|NCT00150462|81176213|FG001|Overall Study|Withdrawal by Subject|1|||
27820663|NCT00150462|81176214|FG002|Overall Study|Withdrawal by Subject|1|||
27820664|NCT00150462|81176215|FG003|Overall Study|Withdrawal by Subject|0|||
27820665|NCT00150462|81176216|FG004|Overall Study|Withdrawal by Subject|1|||
27820666|NCT00150462|81176217|FG005|Overall Study|Withdrawal by Subject|2|||
27820667|NCT00150462|81176218|FG006|Overall Study|Withdrawal by Subject|0|||
27881770|NCT03691207|81398044|FG001|Overall Study|Sponsor decision|7|||
27881771|NCT03889418|81398050|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
27881772|NCT03889418|81398051|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27881773|NCT03889418|81398052|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27881774|NCT03889418|81398053|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27820668|NCT00150462|81176219|FG007|Overall Study|Withdrawal by Subject|1|||
27820669|NCT00150462|81176220|FG008|Overall Study|Withdrawal by Subject|0|||
27820670|NCT00150462|81176221|FG009|Overall Study|Withdrawal by Subject|1|||
27820671|NCT00150462|81176222|FG010|Overall Study|Withdrawal by Subject|0|||
27820672|NCT00150462|81176212|FG000|Overall Study|Death|0|||
27820673|NCT00150462|81176213|FG001|Overall Study|Death|1|||
27820674|NCT00150462|81176214|FG002|Overall Study|Death|0|||
27820675|NCT00150462|81176215|FG003|Overall Study|Death|0|||
27820676|NCT00150462|81176216|FG004|Overall Study|Death|0|||
27820677|NCT00150462|81176217|FG005|Overall Study|Death|0|||
27881775|NCT03889418|81398054|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27881776|NCT03889418|81398055|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27881777|NCT03889418|81398056|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27693908|NCT00940108|80716590|FG003|Overall Study|Dose 2 contraindicated|1|||
27881778|NCT03889418|81398057|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27881779|NCT03889418|81398058|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27881780|NCT03889418|81398059|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
27693909|NCT00940108|80716587|FG000|Overall Study|Declined further vaccination|0|||
27693910|NCT00940108|80716588|FG001|Overall Study|Declined further vaccination|1|||
27693911|NCT00940108|80716589|FG002|Overall Study|Declined further vaccination|3|||
27820678|NCT00150462|81176218|FG006|Overall Study|Death|0|||
27820679|NCT00150462|81176219|FG007|Overall Study|Death|0|||
27820680|NCT00150462|81176220|FG008|Overall Study|Death|1|||
27820681|NCT00150462|81176221|FG009|Overall Study|Death|0|||
27881781|NCT03889418|81398050|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27881782|NCT03889418|81398051|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
27881783|NCT03889418|81398052|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
27881784|NCT03889418|81398053|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27820682|NCT00150462|81176222|FG010|Overall Study|Death|0|||
27820683|NCT00150462|81176212|FG000|Overall Study|Adverse Event|0|||
27820684|NCT00150462|81176213|FG001|Overall Study|Adverse Event|0|||
27820685|NCT00150462|81176214|FG002|Overall Study|Adverse Event|0|||
27820686|NCT00150462|81176215|FG003|Overall Study|Adverse Event|1|||
27820687|NCT00150462|81176216|FG004|Overall Study|Adverse Event|0|||
27820688|NCT00150462|81176217|FG005|Overall Study|Adverse Event|0|||
27820689|NCT00150462|81176218|FG006|Overall Study|Adverse Event|0|||
27820690|NCT00150462|81176219|FG007|Overall Study|Adverse Event|2|||
27820691|NCT00150462|81176220|FG008|Overall Study|Adverse Event|0|||
27820692|NCT00150462|81176221|FG009|Overall Study|Adverse Event|1|||
27820693|NCT00150462|81176222|FG010|Overall Study|Adverse Event|0|||
27820694|NCT00150462|81176212|FG000|Overall Study|Physician Decision|0|||
27820695|NCT00150462|81176213|FG001|Overall Study|Physician Decision|0|||
27820696|NCT00150462|81176214|FG002|Overall Study|Physician Decision|1|||
27820697|NCT00150462|81176215|FG003|Overall Study|Physician Decision|1|||
27820698|NCT00150462|81176216|FG004|Overall Study|Physician Decision|0|||
27820699|NCT00150462|81176217|FG005|Overall Study|Physician Decision|0|||
27820700|NCT00150462|81176218|FG006|Overall Study|Physician Decision|0|||
27820701|NCT00150462|81176219|FG007|Overall Study|Physician Decision|0|||
27820702|NCT00150462|81176220|FG008|Overall Study|Physician Decision|0|||
27820703|NCT00150462|81176221|FG009|Overall Study|Physician Decision|0|||
27820704|NCT00150462|81176222|FG010|Overall Study|Physician Decision|0|||
27820705|NCT00150462|81176212|FG000|Overall Study|Other|0|||
27820706|NCT00150462|81176213|FG001|Overall Study|Other|0|||
27820707|NCT00150462|81176214|FG002|Overall Study|Other|0|||
27820708|NCT00150462|81176215|FG003|Overall Study|Other|0|||
27820709|NCT00150462|81176216|FG004|Overall Study|Other|0|||
27820710|NCT00150462|81176217|FG005|Overall Study|Other|0|||
27820711|NCT00150462|81176218|FG006|Overall Study|Other|0|||
27820712|NCT00150462|81176219|FG007|Overall Study|Other|0|||
27820713|NCT00150462|81176220|FG008|Overall Study|Other|0|||
27820714|NCT00150462|81176221|FG009|Overall Study|Other|1|||
27820715|NCT00150462|81176222|FG010|Overall Study|Other|1|||
27820716|NCT01700621|81176225|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
27820717|NCT01700621|81176226|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
27820718|NCT01700621|81176225|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
27820719|NCT01700621|81176226|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
27820720|NCT01700621|81176225|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
27820721|NCT01700621|81176226|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
27820722|NCT01675622|81176230|FG000|Overall Study|Withdrawal by Subject|2|||
27820723|NCT01675622|81176231|FG001|Overall Study|Withdrawal by Subject|2|||
27820724|NCT01675622|81176230|FG000|Overall Study|Adverse Event|12|||
27820725|NCT01675622|81176231|FG001|Overall Study|Adverse Event|10|||
27820726|NCT01675622|81176230|FG000|Overall Study|Protocol Violation|4|||
27820727|NCT01675622|81176231|FG001|Overall Study|Protocol Violation|1|||
27820728|NCT01675622|81176230|FG000|Overall Study|Lack of Efficacy|2|||
27820729|NCT01675622|81176231|FG001|Overall Study|Lack of Efficacy|4|||
27820730|NCT01675622|81176230|FG000|Overall Study|Lost to Follow-up|1|||
27820731|NCT01675622|81176231|FG001|Overall Study|Lost to Follow-up|3|||
27820732|NCT01675622|81176230|FG000|Overall Study|Other|5|||
27820733|NCT01675622|81176231|FG001|Overall Study|Other|4|||
27820734|NCT03639311|81176232|FG000|Maintenance Phase|Lost to Follow-up|1|||
27820735|NCT03639311|81176233|FG001|Maintenance Phase|Lost to Follow-up|0|||
27820736|NCT03639311|81176234|FG002|Maintenance Phase|Lost to Follow-up|0|||
27820737|NCT03639311|81176232|FG000|Maintenance Phase|Adverse Event|1|||
27820738|NCT03639311|81176233|FG001|Maintenance Phase|Adverse Event|0|||
27820739|NCT03639311|81176234|FG002|Maintenance Phase|Adverse Event|0|||
27820740|NCT03639311|81176232|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
27820741|NCT03639311|81176233|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
27820742|NCT03639311|81176234|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
27820743|NCT03639311|81176232|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
27820744|NCT03639311|81176233|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
27820745|NCT03639311|81176234|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
27820746|NCT03639311|81176232|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
27820747|NCT03639311|81176233|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
27820748|NCT03639311|81176234|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
27820749|NCT03639311|81176232|FG000|Maintenance Phase|Lack of Efficacy|1|||
27820750|NCT03639311|81176233|FG001|Maintenance Phase|Lack of Efficacy|0|||
27820751|NCT03639311|81176234|FG002|Maintenance Phase|Lack of Efficacy|0|||
27820752|NCT02780687|81176235|FG000|Overall Study|Adverse Event|1|||
27820753|NCT02780687|81176236|FG001|Overall Study|Adverse Event|1|||
27820754|NCT02780687|81176235|FG000|Overall Study|Withdrawal by Subject|2|||
27820755|NCT02780687|81176236|FG001|Overall Study|Withdrawal by Subject|1|||
27693912|NCT00940108|80716590|FG003|Overall Study|Declined further vaccination|0|||
27820756|NCT02780687|81176235|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
27820757|NCT02780687|81176236|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
27820758|NCT02780687|81176235|FG000|Overall Study|progressive disease|29|||
27820759|NCT02780687|81176236|FG001|Overall Study|progressive disease|6|||
27820760|NCT02465567|81176237|FG000|Overall Study|Adverse Event|118|||
27820761|NCT02465567|81176238|FG001|Overall Study|Adverse Event|113|||
27820762|NCT02465567|81176239|FG002|Overall Study|Adverse Event|147|||
27820763|NCT02465567|81176240|FG003|Overall Study|Adverse Event|138|||
27820764|NCT02465567|81176237|FG000|Overall Study|Lack of Efficacy|103|||
27820765|NCT02465567|81176238|FG001|Overall Study|Lack of Efficacy|102|||
27820766|NCT02465567|81176239|FG002|Overall Study|Lack of Efficacy|171|||
27820767|NCT02465567|81176240|FG003|Overall Study|Lack of Efficacy|135|||
27820768|NCT02465567|81176237|FG000|Overall Study|Withdrawal by Subject|104|||
27820769|NCT02465567|81176238|FG001|Overall Study|Withdrawal by Subject|94|||
27820770|NCT02465567|81176239|FG002|Overall Study|Withdrawal by Subject|123|||
27820771|NCT02465567|81176240|FG003|Overall Study|Withdrawal by Subject|130|||
27820772|NCT02465567|81176237|FG000|Overall Study|Physician Decision|23|||
27820773|NCT02465567|81176238|FG001|Overall Study|Physician Decision|33|||
27820774|NCT02465567|81176239|FG002|Overall Study|Physician Decision|38|||
27820775|NCT02465567|81176240|FG003|Overall Study|Physician Decision|28|||
27820776|NCT02465567|81176237|FG000|Overall Study|Major Protocol Deviation|24|||
27820777|NCT02465567|81176238|FG001|Overall Study|Major Protocol Deviation|26|||
27820778|NCT02465567|81176239|FG002|Overall Study|Major Protocol Deviation|22|||
27820779|NCT02465567|81176240|FG003|Overall Study|Major Protocol Deviation|25|||
27820780|NCT02465567|81176237|FG000|Overall Study|Lost to Follow-up|25|||
27820781|NCT02465567|81176238|FG001|Overall Study|Lost to Follow-up|21|||
27820782|NCT02465567|81176239|FG002|Overall Study|Lost to Follow-up|19|||
27820783|NCT02465567|81176240|FG003|Overall Study|Lost to Follow-up|15|||
27820784|NCT02465567|81176237|FG000|Overall Study|Protocol Specified Criteria|20|||
27820785|NCT02465567|81176238|FG001|Overall Study|Protocol Specified Criteria|10|||
27820786|NCT02465567|81176239|FG002|Overall Study|Protocol Specified Criteria|9|||
27820787|NCT02465567|81176240|FG003|Overall Study|Protocol Specified Criteria|12|||
27820788|NCT02465567|81176237|FG000|Overall Study|Administrative Reasons|12|||
27820789|NCT02465567|81176238|FG001|Overall Study|Administrative Reasons|9|||
27820790|NCT02465567|81176239|FG002|Overall Study|Administrative Reasons|11|||
27820791|NCT02465567|81176240|FG003|Overall Study|Administrative Reasons|5|||
27820792|NCT02465567|81176237|FG000|Overall Study|Randomized but not treated|1|||
27820793|NCT02465567|81176238|FG001|Overall Study|Randomized but not treated|5|||
27820794|NCT02465567|81176239|FG002|Overall Study|Randomized but not treated|4|||
27820795|NCT02465567|81176240|FG003|Overall Study|Randomized but not treated|5|||
27820796|NCT02465567|81176237|FG000|Overall Study|enrolled in >1 studies|18|||
27820797|NCT02465567|81176238|FG001|Overall Study|enrolled in >1 studies|11|||
27820798|NCT02465567|81176239|FG002|Overall Study|enrolled in >1 studies|19|||
27820799|NCT02465567|81176240|FG003|Overall Study|enrolled in >1 studies|15|||
27820800|NCT02465567|81176237|FG000|Overall Study|missing PI Signature|1|||
27820801|NCT02465567|81176238|FG001|Overall Study|missing PI Signature|0|||
27820802|NCT02465567|81176239|FG002|Overall Study|missing PI Signature|0|||
27820803|NCT02465567|81176240|FG003|Overall Study|missing PI Signature|0|||
27820804|NCT02612337|81176241|FG000|Overall Study|Lack of Efficacy|1|||
27820805|NCT02612337|81176242|FG001|Overall Study|Lack of Efficacy|0|||
27820806|NCT02612337|81176241|FG000|Overall Study|Withdrawal by Subject|2|||
27820807|NCT02612337|81176242|FG001|Overall Study|Withdrawal by Subject|2|||
27820808|NCT02612337|81176241|FG000|Overall Study|Did not receive study drug|0|||
27820809|NCT02612337|81176242|FG001|Overall Study|Did not receive study drug|1|||
27820810|NCT03725605|81176243|FG000|Overall Study|Unsuccessful TIL expansion|2|||
27820811|NCT03206177|81176244|FG000|Overall Study|Withdrawal by Subject|1|||
27820812|NCT01697696|81176245|FG000|Overall Study|Study terminated by sponsor|0|||
27820813|NCT01697696|81176246|FG001|Overall Study|Study terminated by sponsor|3|||
27820814|NCT01697696|81176245|FG000|Overall Study|Protocol deviation|1|||
27820815|NCT01697696|81176246|FG001|Overall Study|Protocol deviation|0|||
27820816|NCT01697696|81176245|FG000|Overall Study|Physician Decision|1|||
27820817|NCT01697696|81176246|FG001|Overall Study|Physician Decision|0|||
27820818|NCT01697696|81176245|FG000|Overall Study|Death|4|||
27820819|NCT01697696|81176246|FG001|Overall Study|Death|2|||
27820820|NCT01697696|81176245|FG000|Overall Study|Lost to Follow-up|10|||
27820821|NCT01697696|81176246|FG001|Overall Study|Lost to Follow-up|7|||
27820822|NCT01697696|81176245|FG000|Overall Study|Subject/guardian decision|31|||
27820823|NCT01697696|81176246|FG001|Overall Study|Subject/guardian decision|35|||
27820824|NCT00259012|81176247|FG000|Overall Study|Adverse Event|0|||
27820825|NCT00259012|81176248|FG001|Overall Study|Adverse Event|1|||
27820826|NCT00259012|81176247|FG000|Overall Study|Withdrawal by Subject|1|||
27820827|NCT00259012|81176248|FG001|Overall Study|Withdrawal by Subject|0|||
27820828|NCT00259012|81176247|FG000|Overall Study|Physician Decision|0|||
27820829|NCT00259012|81176248|FG001|Overall Study|Physician Decision|1|||
27820830|NCT00259012|81176247|FG000|Overall Study|Lost to Follow-up|0|||
27820831|NCT00259012|81176248|FG001|Overall Study|Lost to Follow-up|1|||
27820832|NCT00259012|81176247|FG000|Overall Study|Protocol Violation|1|||
27820833|NCT00259012|81176248|FG001|Overall Study|Protocol Violation|1|||
27820834|NCT03420300|81176252|FG000|Overall Study|Death|2|||
27820835|NCT03546842|81176253|FG000|Overall Study|Protocol Violation|1|||
27820836|NCT03546842|81176253|FG000|Overall Study|Withdrawal by Subject|2|||
27820837|NCT03601637|81176254|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
27820838|NCT03601637|81176255|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
27820839|NCT03601637|81176254|FG000|Overall Study|Adverse Event|1|||
27820840|NCT03601637|81176255|FG001|Overall Study|Adverse Event|1|||
27820841|NCT03601637|81176254|FG000|Overall Study|Other|0|||
27820842|NCT03601637|81176255|FG001|Overall Study|Other|1|||
27820843|NCT00386009|81176259|FG000|Overall Study|Adverse Event|0|||
27820844|NCT00386009|81176260|FG001|Overall Study|Adverse Event|2|||
27820845|NCT00386009|81176259|FG000|Overall Study|Death|1|||
27820846|NCT00386009|81176260|FG001|Overall Study|Death|0|||
27820847|NCT00386009|81176259|FG000|Overall Study|Entry Criteria Not Met|0|||
27820848|NCT00386009|81176260|FG001|Overall Study|Entry Criteria Not Met|2|||
27820849|NCT00386009|81176259|FG000|Overall Study|Lost to Follow-up|1|||
27820850|NCT00386009|81176260|FG001|Overall Study|Lost to Follow-up|1|||
27820851|NCT00386009|81176259|FG000|Overall Study|Protocol Violation|1|||
27820852|NCT00386009|81176260|FG001|Overall Study|Protocol Violation|0|||
27820853|NCT00386009|81176259|FG000|Overall Study|Sponsor Decision|1|||
27820854|NCT00386009|81176260|FG001|Overall Study|Sponsor Decision|1|||
27820855|NCT00386009|81176259|FG000|Overall Study|Withdrawal by Subject|5|||
27820856|NCT00386009|81176260|FG001|Overall Study|Withdrawal by Subject|4|||
27820857|NCT04657770|81178758|FG000|Overall Study|Withdrawal by Subject|3|||
27820858|NCT04657770|81178758|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
27820859|NCT01367457|81178759|FG000|Overall Study|Death|2|||
27820860|NCT01367457|81178760|FG001|Overall Study|Death|0|||
27820861|NCT01367457|81178761|FG002|Overall Study|Death|0|||
27820862|NCT01367457|81178759|FG000|Overall Study|Investigator's decision|2|||
27820863|NCT01367457|81178760|FG001|Overall Study|Investigator's decision|0|||
27820864|NCT01367457|81178761|FG002|Overall Study|Investigator's decision|0|||
27820865|NCT01367457|81178759|FG000|Overall Study|Clinical decline (CD)|2|||
27820866|NCT01367457|81178760|FG001|Overall Study|Clinical decline (CD)|0|||
27820867|NCT01367457|81178761|FG002|Overall Study|Clinical decline (CD)|0|||
27820868|NCT01367457|81178759|FG000|Overall Study|Progression and death|8|||
27820869|NCT01367457|81178760|FG001|Overall Study|Progression and death|0|||
27820870|NCT01367457|81178761|FG002|Overall Study|Progression and death|0|||
27693913|NCT00940108|80716587|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
27820871|NCT01367457|81178759|FG000|Overall Study|Toxicity|16|||
27820872|NCT01367457|81178760|FG001|Overall Study|Toxicity|0|||
27820873|NCT01367457|81178761|FG002|Overall Study|Toxicity|0|||
27820874|NCT01367457|81178759|FG000|Overall Study|Progression|137|||
27820875|NCT01367457|81178760|FG001|Overall Study|Progression|0|||
27820876|NCT01367457|81178761|FG002|Overall Study|Progression|0|||
27820877|NCT01367457|81178759|FG000|Overall Study|Patient asks for rest + slow progression|1|||
27820878|NCT01367457|81178760|FG001|Overall Study|Patient asks for rest + slow progression|0|||
27820879|NCT01367457|81178761|FG002|Overall Study|Patient asks for rest + slow progression|0|||
27820880|NCT01367457|81178759|FG000|Overall Study|Investigator's opinion, stable disease|1|||
27820881|NCT01367457|81178760|FG001|Overall Study|Investigator's opinion, stable disease|0|||
27820882|NCT01367457|81178761|FG002|Overall Study|Investigator's opinion, stable disease|0|||
27820883|NCT01367457|81178759|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
27820884|NCT01367457|81178760|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
27820885|NCT01367457|81178761|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
27820886|NCT01367457|81178759|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
27820887|NCT01367457|81178760|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
27820888|NCT01367457|81178761|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
27820889|NCT01367457|81178759|FG000|Overall Study|low grade toxicities + stable disease|1|||
27820890|NCT01367457|81178760|FG001|Overall Study|low grade toxicities + stable disease|0|||
27820891|NCT01367457|81178761|FG002|Overall Study|low grade toxicities + stable disease|0|||
27820892|NCT01367457|81178759|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
27820893|NCT01367457|81178760|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
27820894|NCT01367457|81178761|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
27820895|NCT01367457|81178759|FG000|Overall Study|Withdrawal by Subject|1|||
27820896|NCT01367457|81178760|FG001|Overall Study|Withdrawal by Subject|0|||
27820897|NCT01367457|81178761|FG002|Overall Study|Withdrawal by Subject|0|||
27820898|NCT01367457|81178759|FG000|Overall Study|CD, associated leukaemia|1|||
27820899|NCT01367457|81178760|FG001|Overall Study|CD, associated leukaemia|0|||
27820900|NCT01367457|81178761|FG002|Overall Study|CD, associated leukaemia|0|||
27820901|NCT01367457|81178759|FG000|Overall Study|Uncontrolled pain|1|||
27820902|NCT01367457|81178760|FG001|Overall Study|Uncontrolled pain|0|||
27820903|NCT01367457|81178761|FG002|Overall Study|Uncontrolled pain|0|||
27820904|NCT01367457|81178759|FG000|Overall Study|Overall status worsens to grade 4|1|||
27820905|NCT01367457|81178760|FG001|Overall Study|Overall status worsens to grade 4|0|||
27820906|NCT01367457|81178761|FG002|Overall Study|Overall status worsens to grade 4|0|||
27820907|NCT01367457|81178759|FG000|Overall Study|Stabilisation + frequent infections|1|||
27820908|NCT01367457|81178760|FG001|Overall Study|Stabilisation + frequent infections|0|||
27820909|NCT01367457|81178761|FG002|Overall Study|Stabilisation + frequent infections|0|||
27820910|NCT01367457|81178759|FG000|Overall Study|No clinical benefit|1|||
27820911|NCT01367457|81178760|FG001|Overall Study|No clinical benefit|0|||
27820912|NCT01367457|81178761|FG002|Overall Study|No clinical benefit|0|||
27820913|NCT01367457|81178759|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
27820914|NCT01367457|81178760|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
27820915|NCT01367457|81178761|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
27820916|NCT01367457|81178759|FG000|Overall Study|Overall decline|1|||
27820917|NCT01367457|81178760|FG001|Overall Study|Overall decline|0|||
27820918|NCT01367457|81178761|FG002|Overall Study|Overall decline|0|||
27820919|NCT01367457|81178759|FG000|Overall Study|Rejection of treatment|1|||
27820920|NCT01367457|81178760|FG001|Overall Study|Rejection of treatment|0|||
27820921|NCT01367457|81178761|FG002|Overall Study|Rejection of treatment|0|||
27820922|NCT01367457|81178759|FG000|Overall Study|Lost to Follow-up|1|||
27820923|NCT01367457|81178760|FG001|Overall Study|Lost to Follow-up|0|||
27820924|NCT01367457|81178761|FG002|Overall Study|Lost to Follow-up|0|||
27820925|NCT01367457|81178759|FG000|Overall Study|Death from septic shock|1|||
27820926|NCT01367457|81178760|FG001|Overall Study|Death from septic shock|0|||
27820927|NCT01367457|81178761|FG002|Overall Study|Death from septic shock|0|||
27820928|NCT01367457|81178759|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
27820929|NCT01367457|81178760|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
27820930|NCT01367457|81178761|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
27820931|NCT01367457|81178759|FG000|Overall Study|Patient's Wish|1|||
27820932|NCT01367457|81178760|FG001|Overall Study|Patient's Wish|0|||
27820933|NCT01367457|81178761|FG002|Overall Study|Patient's Wish|0|||
27820934|NCT01367457|81178759|FG000|Overall Study|Palliative. Overall decline|1|||
27820935|NCT01367457|81178760|FG001|Overall Study|Palliative. Overall decline|0|||
27820936|NCT01367457|81178761|FG002|Overall Study|Palliative. Overall decline|0|||
27820937|NCT01367457|81178759|FG000|Overall Study|Suspected DP/suspected active infection|1|||
27820938|NCT01367457|81178760|FG001|Overall Study|Suspected DP/suspected active infection|0|||
27820939|NCT01367457|81178761|FG002|Overall Study|Suspected DP/suspected active infection|0|||
27820940|NCT03616106|81178763|FG000|Overall Study|Removed by PI|6|||
27820941|NCT03616106|81178764|FG001|Overall Study|Removed by PI|0|||
27820942|NCT03616106|81178763|FG000|Overall Study|Withdrawal by Subject|1|||
27820943|NCT03616106|81178764|FG001|Overall Study|Withdrawal by Subject|1|||
27820944|NCT03616106|81178763|FG000|Overall Study|Lost to Follow-up|7|||
27820945|NCT03616106|81178764|FG001|Overall Study|Lost to Follow-up|0|||
27820946|NCT02645409|81178765|FG000|Overall Study|Withdrawal by Subject|3|||
27820947|NCT02645409|81178766|FG001|Overall Study|Withdrawal by Subject|0|||
27820948|NCT02645409|81178765|FG000|Overall Study|Physician Decision|1|||
27820949|NCT02645409|81178766|FG001|Overall Study|Physician Decision|0|||
27820950|NCT01110005|81178768|FG000|Overall Study|ineligible|1|||
27820951|NCT01110005|81178769|FG001|Overall Study|ineligible|2|||
27820952|NCT01110005|81178768|FG000|Overall Study|missing consent|3|||
27820953|NCT01110005|81178769|FG001|Overall Study|missing consent|2|||
27820954|NCT01110005|81178768|FG000|Overall Study|Withdrawal by Subject|0|||
27820955|NCT01110005|81178769|FG001|Overall Study|Withdrawal by Subject|1|||
27820956|NCT01042522|81178774|FG000|Overall Study|Adverse Event|1|||
27820957|NCT01042522|81178775|FG001|Overall Study|Adverse Event|2|||
27820958|NCT01042522|81178774|FG000|Overall Study|Disease Progression|5|||
27820959|NCT01042522|81178775|FG001|Overall Study|Disease Progression|0|||
27820960|NCT01042522|81178774|FG000|Overall Study|Death|1|||
27820961|NCT01042522|81178775|FG001|Overall Study|Death|0|||
27820962|NCT01042522|81178774|FG000|Overall Study|Patient Refused|0|||
27820963|NCT01042522|81178775|FG001|Overall Study|Patient Refused|3|||
27820964|NCT01042522|81178774|FG000|Overall Study|Withdrawal by Subject|1|||
27820965|NCT01042522|81178775|FG001|Overall Study|Withdrawal by Subject|1|||
27820966|NCT05067647|81178780|FG000|Overall Study|Lost to Follow-up|1|||
27820967|NCT03603314|81178781|FG000|Overall Study|Lost to Follow-up|0|||
27820968|NCT03603314|81178782|FG001|Overall Study|Lost to Follow-up|3|||
27820969|NCT03603314|81178783|FG002|Overall Study|Lost to Follow-up|0|||
27820970|NCT03603314|81178781|FG000|Overall Study|Protocol Violation|0|||
27820971|NCT03603314|81178782|FG001|Overall Study|Protocol Violation|1|||
27820972|NCT03603314|81178783|FG002|Overall Study|Protocol Violation|0|||
27820973|NCT03603314|81178781|FG000|Overall Study|Adverse Event|2|||
27820974|NCT03603314|81178782|FG001|Overall Study|Adverse Event|0|||
27820975|NCT03603314|81178783|FG002|Overall Study|Adverse Event|0|||
27820976|NCT03603314|81178781|FG000|Overall Study|Physician Decision|1|||
27820977|NCT03603314|81178782|FG001|Overall Study|Physician Decision|1|||
27820978|NCT03603314|81178783|FG002|Overall Study|Physician Decision|0|||
27820979|NCT03603314|81178781|FG000|Overall Study|Withdrawal by Subject|4|||
27820980|NCT03603314|81178782|FG001|Overall Study|Withdrawal by Subject|5|||
27820981|NCT03603314|81178783|FG002|Overall Study|Withdrawal by Subject|3|||
27820982|NCT03603314|81178781|FG000|Overall Study|Other|0|||
27820983|NCT03603314|81178782|FG001|Overall Study|Other|1|||
27820984|NCT03603314|81178783|FG002|Overall Study|Other|0|||
27820985|NCT00569374|81178784|FG000|Overall Study|Withdrawal by Subject|4|||
27820986|NCT02087904|81178788|FG000|Overall Study|Did Not Receive Study Drug|0|||
27820987|NCT02087904|81178789|FG001|Overall Study|Did Not Receive Study Drug|0|||
27820988|NCT02087904|81178790|FG002|Overall Study|Did Not Receive Study Drug|2|||
27820989|NCT02087904|81178791|FG003|Overall Study|Did Not Receive Study Drug|1|||
27820990|NCT02087904|81178788|FG000|Overall Study|Adverse Event|8|||
27820991|NCT02087904|81178789|FG001|Overall Study|Adverse Event|4|||
27820992|NCT02087904|81178790|FG002|Overall Study|Adverse Event|4|||
27820993|NCT02087904|81178791|FG003|Overall Study|Adverse Event|12|||
27820994|NCT02087904|81178788|FG000|Overall Study|Lack of Efficacy|3|||
27881785|NCT03889418|81398054|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27593035|NCT02621931|80352248|FG001|Overall Study|Withdrawal by Subject|10|||
27820995|NCT02087904|81178789|FG001|Overall Study|Lack of Efficacy|6|||
27820996|NCT02087904|81178790|FG002|Overall Study|Lack of Efficacy|3|||
27820997|NCT02087904|81178791|FG003|Overall Study|Lack of Efficacy|2|||
27820998|NCT02087904|81178788|FG000|Overall Study|Other|6|||
27820999|NCT02087904|81178789|FG001|Overall Study|Other|2|||
27821000|NCT02087904|81178790|FG002|Overall Study|Other|4|||
27821001|NCT02087904|81178791|FG003|Overall Study|Other|4|||
27821002|NCT02087904|81178788|FG000|Overall Study|Withdrawal by Subject|8|||
27821003|NCT02087904|81178789|FG001|Overall Study|Withdrawal by Subject|3|||
27821004|NCT02087904|81178790|FG002|Overall Study|Withdrawal by Subject|7|||
27821005|NCT02087904|81178791|FG003|Overall Study|Withdrawal by Subject|4|||
27821006|NCT02087904|81178788|FG000|Overall Study|Lost to Follow-up|0|||
27821007|NCT02087904|81178789|FG001|Overall Study|Lost to Follow-up|4|||
27821008|NCT02087904|81178790|FG002|Overall Study|Lost to Follow-up|2|||
27821009|NCT02087904|81178791|FG003|Overall Study|Lost to Follow-up|2|||
27821010|NCT04274686|81178794|FG000|Overall Study|Physician Decision|1|||
27821011|NCT04274686|81178795|FG001|Overall Study|Physician Decision|0|||
27821012|NCT04060147|81178796|FG000|Overall Study|Withdrew consent|1|||
27821013|NCT01027143|81178797|FG000|Overall Study|Lost to Follow-up|9|||
27821014|NCT01027143|81178798|FG001|Overall Study|Lost to Follow-up|4|||
27821015|NCT03785548|81178799|FG000|Overall Study|age > 80|1|||
27821016|NCT03785548|81178800|FG001|Overall Study|age > 80|0|||
27821017|NCT03785548|81178799|FG000|Overall Study|no Postop queries|1|||
27821018|NCT03785548|81178800|FG001|Overall Study|no Postop queries|0|||
27821019|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Adverse Event|11|||
27821020|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Adverse Event|23|||
27821021|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Adverse Event|29|||
27821022|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Adverse Event|2|||
27593036|NCT02621931|80352249|FG002|Overall Study|Withdrawal by Subject|11|||
27593037|NCT02621931|80352247|FG000|Overall Study|Protocol Violation|2|||
27593038|NCT02621931|80352248|FG001|Overall Study|Protocol Violation|2|||
27593039|NCT02621931|80352249|FG002|Overall Study|Protocol Violation|2|||
27593040|NCT02621931|80352247|FG000|Overall Study|Pregnancy|2|||
27593041|NCT02621931|80352248|FG001|Overall Study|Pregnancy|0|||
27821023|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Adverse Event|8|||
27821024|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
27593042|NCT02621931|80352249|FG002|Overall Study|Pregnancy|0|||
27593043|NCT02621931|80352247|FG000|Overall Study|Noncompliance to study procedures|0|||
27593044|NCT02621931|80352248|FG001|Overall Study|Noncompliance to study procedures|1|||
27593045|NCT02621931|80352249|FG002|Overall Study|Noncompliance to study procedures|2|||
27593046|NCT02621931|80352247|FG000|Overall Study|Lost to Follow-up|8|||
27593047|NCT02621931|80352248|FG001|Overall Study|Lost to Follow-up|7|||
27593048|NCT02621931|80352249|FG002|Overall Study|Lost to Follow-up|10|||
27593049|NCT02621931|80352247|FG000|Overall Study|Lack of Efficacy|0|||
27593050|NCT02621931|80352248|FG001|Overall Study|Lack of Efficacy|0|||
27593051|NCT02621931|80352249|FG002|Overall Study|Lack of Efficacy|1|||
27593052|NCT02621931|80352247|FG000|Overall Study|Other|1|||
27593053|NCT02621931|80352248|FG001|Overall Study|Other|1|||
27593054|NCT02621931|80352249|FG002|Overall Study|Other|3|||
27593055|NCT00162370|80352252|FG000|Efficacy Population|Lost to Follow-up|51|||
27593056|NCT01912612|80352253|FG000|Overall Study|Adverse Event|4|||
27821025|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
27821026|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
27821027|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
27821028|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
27881786|NCT03889418|81398055|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27881787|NCT03889418|81398056|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27881788|NCT03889418|81398057|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27881789|NCT03889418|81398058|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27881790|NCT03889418|81398059|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
27881791|NCT03889418|81398050|FG000|October-December 2019 (Month 7-9)|Death|0|||
27881792|NCT03889418|81398051|FG001|October-December 2019 (Month 7-9)|Death|0|||
27881793|NCT03889418|81398052|FG002|October-December 2019 (Month 7-9)|Death|0|||
27881794|NCT03889418|81398053|FG003|October-December 2019 (Month 7-9)|Death|0|||
27881795|NCT03889418|81398054|FG004|October-December 2019 (Month 7-9)|Death|0|||
27881796|NCT03889418|81398055|FG005|October-December 2019 (Month 7-9)|Death|0|||
27881797|NCT03889418|81398056|FG006|October-December 2019 (Month 7-9)|Death|0|||
27881798|NCT03889418|81398057|FG007|October-December 2019 (Month 7-9)|Death|0|||
27881799|NCT03889418|81398058|FG008|October-December 2019 (Month 7-9)|Death|1|||
27881800|NCT03889418|81398059|FG009|October-December 2019 (Month 7-9)|Death|0|||
27881801|NCT03889418|81398050|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27881802|NCT03889418|81398051|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27593057|NCT01912612|80352254|FG001|Overall Study|Adverse Event|0|||
27593058|NCT01912612|80352255|FG002|Overall Study|Adverse Event|0|||
27593059|NCT01912612|80352253|FG000|Overall Study|Withdrew consent|1|||
27821029|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
27821030|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
27593060|NCT01912612|80352254|FG001|Overall Study|Withdrew consent|0|||
27821031|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
27881803|NCT03889418|81398052|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27593061|NCT01912612|80352255|FG002|Overall Study|Withdrew consent|0|||
27821032|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
27821033|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
27821034|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
27821035|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
27821036|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
27821037|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
27821038|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
27821039|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
27821040|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
27821041|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
27821042|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
27821043|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
27821044|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
27821045|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
27821046|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
27821047|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
27821048|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
27821049|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
27821050|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
27821051|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
27821052|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
27821053|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
27821054|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Move|0|||
27821055|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Move|1|||
27821056|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Move|0|||
27821057|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Move|0|||
27821058|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Move|0|||
27821059|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
27821060|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
27821061|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
27821062|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
27593062|NCT01912612|80352253|FG000|Overall Study|Study design change|0|||
27593063|NCT01912612|80352254|FG001|Overall Study|Study design change|0|||
27593064|NCT01912612|80352255|FG002|Overall Study|Study design change|3|||
27821063|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
27821064|NCT00318461|81178807|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
27821065|NCT00318461|81178808|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
27821066|NCT00318461|81178809|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
27821067|NCT00318461|81178810|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
27821068|NCT00318461|81178811|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
27821069|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Work commitment|0|||
27821070|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Work commitment|0|||
27821071|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Work commitment|0|||
27821072|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Work commitment|0|||
27821073|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Work commitment|1|||
27821074|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Investigator decision|0|||
27821075|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Investigator decision|0|||
27821076|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Investigator decision|0|||
27821077|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Investigator decision|0|||
27821078|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Investigator decision|1|||
27821079|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Lack of time|1|||
27821080|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Lack of time|0|||
27821081|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Lack of time|0|||
27821082|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Lack of time|0|||
27821083|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Lack of time|0|||
27821084|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
27821085|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
27821086|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
27881804|NCT03889418|81398053|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
27881805|NCT03889418|81398054|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27881806|NCT03889418|81398055|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27881807|NCT03889418|81398056|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27881808|NCT03889418|81398057|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
27881809|NCT03889418|81398058|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27881810|NCT03889418|81398059|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
27593065|NCT03707977|80352256|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
27593066|NCT03707977|80352257|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
27593067|NCT03707977|80352258|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
27593068|NCT03707977|80352256|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
27593069|NCT03707977|80352257|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
27881811|NCT03889418|81398050|FG000|April - June 2020 (Month 13-15)|Death|0|||
27881812|NCT03889418|81398051|FG001|April - June 2020 (Month 13-15)|Death|1|||
27881813|NCT03889418|81398052|FG002|April - June 2020 (Month 13-15)|Death|0|||
27881814|NCT03889418|81398053|FG003|April - June 2020 (Month 13-15)|Death|0|||
27881815|NCT03889418|81398054|FG004|April - June 2020 (Month 13-15)|Death|0|||
27881816|NCT03889418|81398055|FG005|April - June 2020 (Month 13-15)|Death|0|||
27881817|NCT03889418|81398056|FG006|April - June 2020 (Month 13-15)|Death|0|||
27881818|NCT03889418|81398057|FG007|April - June 2020 (Month 13-15)|Death|0|||
27881819|NCT03889418|81398058|FG008|April - June 2020 (Month 13-15)|Death|0|||
27881820|NCT03889418|81398059|FG009|April - June 2020 (Month 13-15)|Death|0|||
27881821|NCT03889418|81398050|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27881822|NCT03889418|81398051|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27881823|NCT03889418|81398052|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27881824|NCT03889418|81398053|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
27693914|NCT00940108|80716588|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
27593070|NCT03707977|80352258|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
27693915|NCT00940108|80716589|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
27693916|NCT00940108|80716590|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
27693917|NCT00940108|80716587|FG000|Overall Study|Viral illness after Dose 1|0|||
27693918|NCT00940108|80716588|FG001|Overall Study|Viral illness after Dose 1|1|||
27693919|NCT00940108|80716589|FG002|Overall Study|Viral illness after Dose 1|0|||
27881825|NCT03889418|81398054|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27593071|NCT01880424|80352259|FG000|Overall Study|Adverse Event|7|||
27593072|NCT01880424|80352260|FG001|Overall Study|Adverse Event|6|||
27593073|NCT01880424|80352259|FG000|Overall Study|Lack of Efficacy|1|||
27821087|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
27821088|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
27821089|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
27821090|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
27593074|NCT01880424|80352260|FG001|Overall Study|Lack of Efficacy|4|||
27593075|NCT01880424|80352259|FG000|Overall Study|Lost to Follow-up|3|||
27593076|NCT01880424|80352260|FG001|Overall Study|Lost to Follow-up|2|||
27593077|NCT01880424|80352259|FG000|Overall Study|Protocol Violation|11|||
27593078|NCT01880424|80352260|FG001|Overall Study|Protocol Violation|13|||
27593079|NCT01880424|80352259|FG000|Overall Study|Withdrawal by Subject|10|||
27593080|NCT01880424|80352260|FG001|Overall Study|Withdrawal by Subject|30|||
27593081|NCT01880424|80352259|FG000|Overall Study|Other|1|||
27593082|NCT01880424|80352260|FG001|Overall Study|Other|0|||
27593083|NCT02300220|80352261|FG000|Overall Study|Lost to Follow-up|1|||
27821091|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
27821092|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
27821093|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
27821094|NCT00318461|81178807|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
27821095|NCT00318461|81178808|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
27821096|NCT00318461|81178809|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
27821097|NCT00318461|81178810|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
27821098|NCT00318461|81178811|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
27821099|NCT00318461|81178807|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
27821100|NCT00318461|81178808|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
27821101|NCT00318461|81178809|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
27821102|NCT00318461|81178810|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
27821103|NCT00318461|81178811|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
27821104|NCT00318461|81178807|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
27821105|NCT00318461|81178808|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
27821106|NCT00318461|81178809|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
27821107|NCT00318461|81178810|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
27821108|NCT00318461|81178811|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
27821109|NCT00318461|81178807|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
27821110|NCT00318461|81178808|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
27821111|NCT00318461|81178809|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
27821112|NCT00318461|81178810|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
27821113|NCT00318461|81178811|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
27821114|NCT00318461|81178807|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
27821115|NCT00318461|81178808|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
27821116|NCT00318461|81178809|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
27821117|NCT00318461|81178810|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
27821118|NCT00318461|81178811|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
27821119|NCT00318461|81178807|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
27821120|NCT00318461|81178808|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
27821121|NCT00318461|81178809|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
27881826|NCT03889418|81398055|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27593084|NCT02300220|80352262|FG001|Overall Study|Lost to Follow-up|2|||
27593085|NCT02300220|80352261|FG000|Overall Study|Death|1|||
27593086|NCT02300220|80352262|FG001|Overall Study|Death|1|||
27593087|NCT02300220|80352261|FG000|Overall Study|Adverse Event|1|||
27593088|NCT02300220|80352262|FG001|Overall Study|Adverse Event|1|||
27593089|NCT02300220|80352261|FG000|Overall Study|Protocol Violation|1|||
27593090|NCT02300220|80352262|FG001|Overall Study|Protocol Violation|0|||
27593091|NCT02300220|80352261|FG000|Overall Study|Withdrawal by Subject|0|||
27593092|NCT02300220|80352262|FG001|Overall Study|Withdrawal by Subject|2|||
27593093|NCT02300220|80352261|FG000|Overall Study|Did not tolerate IMP|0|||
27593094|NCT02300220|80352262|FG001|Overall Study|Did not tolerate IMP|1|||
27593095|NCT01392560|80352268|FG000|Overall Study|Adverse Event|2|||
27593096|NCT01392560|80352268|FG000|Overall Study|not entered|8|||
27593097|NCT01392560|80352268|FG000|Overall Study|discontinued during placebo run-in|2|||
27593098|NCT00791765|80352273|FG000|Weeks 1 to 12|Adverse Event|0|||
27593099|NCT00791765|80352274|FG001|Weeks 1 to 12|Adverse Event|1|||
27593100|NCT00791765|80352273|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
27593101|NCT00791765|80352274|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
27593102|NCT00791765|80352273|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
27593103|NCT00791765|80352274|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
27593104|NCT00791765|80352273|FG000|Weeks 1 to 12|Physician Decision|1|||
27593105|NCT00791765|80352274|FG001|Weeks 1 to 12|Physician Decision|0|||
27593106|NCT00791765|80352273|FG000|Weeks 1 to 12|Disease progression|3|||
27593107|NCT00791765|80352274|FG001|Weeks 1 to 12|Disease progression|0|||
27593108|NCT00791765|80352273|FG000|Weeks 1 to 12|Ineligibility determined|0|||
27593109|NCT00791765|80352274|FG001|Weeks 1 to 12|Ineligibility determined|3|||
27593110|NCT00791765|80352273|FG000|Weeks 13 to 24|Protocol deviation|2|||
27593111|NCT00791765|80352274|FG001|Weeks 13 to 24|Protocol deviation|0|||
27593112|NCT00791765|80352273|FG000|Weeks 13 to 24|Adverse Event|0|||
27593113|NCT00791765|80352274|FG001|Weeks 13 to 24|Adverse Event|3|||
27593114|NCT00791765|80352273|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
27593115|NCT00791765|80352274|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
27593116|NCT00791765|80352273|FG000|Weeks 13 to 24|Disease progression|0|||
27593117|NCT00791765|80352274|FG001|Weeks 13 to 24|Disease progression|1|||
27593118|NCT00791765|80352273|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
27593119|NCT00791765|80352274|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
27593120|NCT00791765|80352273|FG000|Weeks 13 to 24|Other|0|||
27593121|NCT00791765|80352274|FG001|Weeks 13 to 24|Other|1|||
27593122|NCT02119416|80352275|FG000|Overall Study|Protocol Violation|1|||
27593123|NCT02119416|80352276|FG001|Overall Study|Protocol Violation|1|||
27593124|NCT02119416|80352277|FG002|Overall Study|Protocol Violation|1|||
27593125|NCT02119416|80352275|FG000|Overall Study|wrong pubertal stage|1|||
27593126|NCT02119416|80352276|FG001|Overall Study|wrong pubertal stage|0|||
27593127|NCT02119416|80352277|FG002|Overall Study|wrong pubertal stage|1|||
27593128|NCT02278328|80352278|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
27593129|NCT02278328|80352279|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
27593130|NCT02278328|80352280|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
27593131|NCT02278328|80352278|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
27593132|NCT02278328|80352279|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
27593133|NCT02278328|80352280|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
27593134|NCT02278328|80352278|FG000|Neuropsych Screening|incomplete consent|0|||
27593135|NCT02278328|80352279|FG001|Neuropsych Screening|incomplete consent|0|||
27593136|NCT02278328|80352280|FG002|Neuropsych Screening|incomplete consent|2|||
27593137|NCT01798927|80352285|FG000|Overall Study|Withdrawal by Subject|1|||
27593138|NCT03053050|80352286|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
27593139|NCT03053050|80352287|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
27593140|NCT03053050|80352288|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
27593141|NCT03053050|80352289|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
27593142|NCT03053050|80352286|FG000|Randomized Phase|Withdrew Consent|16|||
27593143|NCT03053050|80352287|FG001|Randomized Phase|Withdrew Consent|8|||
27593144|NCT03053050|80352288|FG002|Randomized Phase|Withdrew Consent|9|||
27593145|NCT03053050|80352289|FG003|Randomized Phase|Withdrew Consent|0|||
27593146|NCT03053050|80352286|FG000|Randomized Phase|Investigator's Discretion|6|||
27593147|NCT03053050|80352287|FG001|Randomized Phase|Investigator's Discretion|6|||
27593148|NCT03053050|80352288|FG002|Randomized Phase|Investigator's Discretion|3|||
27593149|NCT03053050|80352289|FG003|Randomized Phase|Investigator's Discretion|0|||
27593150|NCT03053050|80352286|FG000|Randomized Phase|Lost to Follow-up|5|||
27593151|NCT03053050|80352287|FG001|Randomized Phase|Lost to Follow-up|1|||
27593152|NCT03053050|80352288|FG002|Randomized Phase|Lost to Follow-up|1|||
27593153|NCT03053050|80352289|FG003|Randomized Phase|Lost to Follow-up|0|||
27593154|NCT03053050|80352286|FG000|Randomized Phase|Adverse Event|0|||
27593155|NCT03053050|80352287|FG001|Randomized Phase|Adverse Event|1|||
27593156|NCT03053050|80352288|FG002|Randomized Phase|Adverse Event|0|||
27693920|NCT00940108|80716590|FG003|Overall Study|Viral illness after Dose 1|0|||
27593157|NCT03053050|80352289|FG003|Randomized Phase|Adverse Event|0|||
27593158|NCT03053050|80352286|FG000|Randomized Phase|Randomized but Never Treated|2|||
27593159|NCT03053050|80352287|FG001|Randomized Phase|Randomized but Never Treated|2|||
27593160|NCT03053050|80352288|FG002|Randomized Phase|Randomized but Never Treated|2|||
27593161|NCT03053050|80352289|FG003|Randomized Phase|Randomized but Never Treated|0|||
27593162|NCT03053050|80352286|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
27593163|NCT03053050|80352287|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
27593164|NCT03053050|80352288|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
27593165|NCT03053050|80352289|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
27593166|NCT03053050|80352286|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
27593167|NCT03053050|80352287|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
27593168|NCT03053050|80352288|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
27593169|NCT03053050|80352289|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
27593170|NCT03053050|80352286|FG000|Open-label Phase|Withdrew Consent|0|||
27593171|NCT03053050|80352287|FG001|Open-label Phase|Withdrew Consent|0|||
27593172|NCT03053050|80352288|FG002|Open-label Phase|Withdrew Consent|0|||
27593173|NCT03053050|80352289|FG003|Open-label Phase|Withdrew Consent|6|||
27593174|NCT03053050|80352286|FG000|Open-label Phase|Investigator's Discretion|0|||
27593175|NCT03053050|80352287|FG001|Open-label Phase|Investigator's Discretion|0|||
27593176|NCT03053050|80352288|FG002|Open-label Phase|Investigator's Discretion|0|||
27593177|NCT03053050|80352289|FG003|Open-label Phase|Investigator's Discretion|4|||
27593178|NCT01261338|80352290|FG000|Overall Study|Withdrawal by Subject|3|||
27593179|NCT01261338|80352291|FG001|Overall Study|Withdrawal by Subject|2|||
27593180|NCT01662310|80352292|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
27593181|NCT01662310|80352293|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
27593182|NCT01662310|80352294|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
27593183|NCT01662310|80352295|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
27593184|NCT01662310|80352296|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
27693921|NCT00940108|80716587|FG000|Overall Study|Diagnosed with H1N1|0|||
27693922|NCT00940108|80716588|FG001|Overall Study|Diagnosed with H1N1|0|||
27693923|NCT00940108|80716589|FG002|Overall Study|Diagnosed with H1N1|0|||
27693924|NCT00940108|80716590|FG003|Overall Study|Diagnosed with H1N1|1|||
27693925|NCT00448123|80716591|FG000|Overall Study|Lost to Follow-up|9|||
27693926|NCT00448123|80716592|FG001|Overall Study|Lost to Follow-up|6|||
27693927|NCT00448123|80716591|FG000|Overall Study|Physician Decision|6|||
27693928|NCT00448123|80716592|FG001|Overall Study|Physician Decision|6|||
27693929|NCT03718533|80716593|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
27693930|NCT03718533|80716593|FG000|Overall Study|Protocol deviation|1|||
27693931|NCT03718533|80716593|FG000|Overall Study|Disease progression|1|||
27693932|NCT03718533|80716593|FG000|Overall Study|Relapse|1|||
27693933|NCT03718533|80716593|FG000|Overall Study|Physician Decision|2|||
27693934|NCT03718533|80716593|FG000|Overall Study|Physician Decision and Adverse Event|1|||
27693935|NCT03426267|80716596|FG000|Overall Study|Physician Decision|1|||
27693936|NCT03426267|80716597|FG001|Overall Study|Physician Decision|4|||
27693937|NCT03426267|80716596|FG000|Overall Study|Lost to Follow-up|1|||
27693938|NCT03426267|80716597|FG001|Overall Study|Lost to Follow-up|0|||
27693939|NCT03426267|80716596|FG000|Overall Study|Withdrawal by Subject|4|||
27693940|NCT03426267|80716597|FG001|Overall Study|Withdrawal by Subject|10|||
27693941|NCT03426267|80716596|FG000|Overall Study|Protocol Violation|1|||
27693942|NCT03426267|80716597|FG001|Overall Study|Protocol Violation|3|||
27693943|NCT03426267|80716596|FG000|Overall Study|Adverse Event|9|||
27693944|NCT03426267|80716597|FG001|Overall Study|Adverse Event|27|||
27693945|NCT03426267|80716596|FG000|Overall Study|Prohibited Treatment Intake|2|||
27693946|NCT03426267|80716597|FG001|Overall Study|Prohibited Treatment Intake|3|||
27693947|NCT03426267|80716596|FG000|Overall Study|Lack of Efficacy|0|||
27693948|NCT03426267|80716597|FG001|Overall Study|Lack of Efficacy|25|||
27693949|NCT03426267|80716596|FG000|Overall Study|other|3|||
27693950|NCT03426267|80716597|FG001|Overall Study|other|0|||
27693951|NCT00971243|80716598|FG000|Double Blind Period|Adverse Event|2|||
27693952|NCT00971243|80716599|FG001|Double Blind Period|Adverse Event|3|||
27693953|NCT00971243|80716600|FG002|Double Blind Period|Adverse Event|2|||
27693954|NCT00971243|80716601|FG003|Double Blind Period|Adverse Event|2|||
27693955|NCT00971243|80716602|FG004|Double Blind Period|Adverse Event|3|||
27693956|NCT00971243|80716598|FG000|Double Blind Period|Lost to Follow-up|0|||
27821122|NCT00318461|81178810|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
27821123|NCT00318461|81178811|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
27821124|NCT01604850|81178816|FG000|Overall Study|Enrolled but never treated|0|||
27821125|NCT01604850|81178817|FG001|Overall Study|Enrolled but never treated|1|||
27821126|NCT01604850|81178816|FG000|Overall Study|Efficacy Failure|50|||
27821127|NCT01604850|81178817|FG001|Overall Study|Efficacy Failure|29|||
27821128|NCT01604850|81178816|FG000|Overall Study|Lost to Follow-up|1|||
27821129|NCT01604850|81178817|FG001|Overall Study|Lost to Follow-up|0|||
27593185|NCT01662310|80352292|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
27693957|NCT00971243|80716599|FG001|Double Blind Period|Lost to Follow-up|1|||
27693958|NCT00971243|80716600|FG002|Double Blind Period|Lost to Follow-up|1|||
27693959|NCT00971243|80716601|FG003|Double Blind Period|Lost to Follow-up|0|||
27693960|NCT00971243|80716602|FG004|Double Blind Period|Lost to Follow-up|1|||
27693961|NCT00971243|80716598|FG000|Double Blind Period|Physician Decision|10|||
27693962|NCT00971243|80716599|FG001|Double Blind Period|Physician Decision|6|||
27693963|NCT00971243|80716600|FG002|Double Blind Period|Physician Decision|7|||
27693964|NCT00971243|80716601|FG003|Double Blind Period|Physician Decision|6|||
27821130|NCT01604850|81178816|FG000|Overall Study|Subject withdrew consent|1|||
27821131|NCT01604850|81178817|FG001|Overall Study|Subject withdrew consent|0|||
27821132|NCT02100228|81178821|FG000|Overall Study|Other|19|||
27821133|NCT02100228|81178822|FG001|Overall Study|Other|19|||
27821134|NCT02100228|81178821|FG000|Overall Study|Administrative reason|0|||
27821135|NCT02100228|81178822|FG001|Overall Study|Administrative reason|1|||
27821136|NCT02100228|81178821|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
27821137|NCT02100228|81178822|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
27821138|NCT02100228|81178821|FG000|Overall Study|Non-compliance|0|||
27821139|NCT02100228|81178822|FG001|Overall Study|Non-compliance|3|||
27821140|NCT02100228|81178821|FG000|Overall Study|Lost to Follow-up|0|||
27821141|NCT02100228|81178822|FG001|Overall Study|Lost to Follow-up|1|||
27821142|NCT02100228|81178821|FG000|Overall Study|Withdrawal by Subject|27|||
27821143|NCT02100228|81178822|FG001|Overall Study|Withdrawal by Subject|37|||
27821144|NCT02100228|81178821|FG000|Overall Study|Adverse Event|16|||
27821145|NCT02100228|81178822|FG001|Overall Study|Adverse Event|12|||
27821146|NCT02100228|81178821|FG000|Overall Study|Death|1|||
27821147|NCT02100228|81178822|FG001|Overall Study|Death|1|||
27821148|NCT01263704|81178824|FG000|Overall Study|Progressive disease|18|||
27821149|NCT01263704|81178824|FG000|Overall Study|Adverse Event|3|||
27821150|NCT01263704|81178824|FG000|Overall Study|Death|2|||
27821151|NCT01263704|81178824|FG000|Overall Study|Patient withdrew consent|2|||
27821152|NCT01263704|81178824|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
27821153|NCT01263704|81178824|FG000|Overall Study|Lost to Follow-up|1|||
27821154|NCT01263704|81178824|FG000|Overall Study|Colon metastases|1|||
27821155|NCT01263704|81178824|FG000|Overall Study|Principal Investigator (PI) decision|1|||
27821156|NCT01993030|81178825|FG000|Overall Study|Adverse Event|0|||
27821157|NCT01993030|81178826|FG001|Overall Study|Adverse Event|4|||
27821158|NCT02079766|81178833|FG000|Overall Study|Physician Decision|1|||
27821159|NCT02079766|81178834|FG001|Overall Study|Physician Decision|0|||
27821160|NCT02079766|81178833|FG000|Overall Study|Withdrawal by Subject|1|||
27593186|NCT01662310|80352293|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
27593187|NCT01662310|80352294|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
27593188|NCT01662310|80352295|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
27593189|NCT01662310|80352296|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
27593190|NCT01662310|80352292|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
27593191|NCT01662310|80352293|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
27593192|NCT01662310|80352294|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
27593193|NCT01662310|80352295|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
27593194|NCT01662310|80352296|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
27593195|NCT01662310|80352292|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
27593196|NCT01662310|80352293|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
27593197|NCT01662310|80352294|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
27593198|NCT01662310|80352295|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
27593199|NCT01662310|80352296|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
27593200|NCT01662310|80352292|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
27593201|NCT01662310|80352293|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
27593202|NCT01662310|80352294|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
27593203|NCT01662310|80352295|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
27593204|NCT01662310|80352296|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
27593205|NCT01662310|80352292|FG000|Run-In or Stabilization Phase|Other|1|||
27593206|NCT01662310|80352293|FG001|Run-In or Stabilization Phase|Other|0|||
27593207|NCT01662310|80352294|FG002|Run-In or Stabilization Phase|Other|0|||
27593208|NCT01662310|80352295|FG003|Run-In or Stabilization Phase|Other|0|||
27593209|NCT01662310|80352296|FG004|Run-In or Stabilization Phase|Other|0|||
27593210|NCT01662310|80352292|FG000|Double-Blind Phase|Adverse Event|0|||
27593211|NCT01662310|80352293|FG001|Double-Blind Phase|Adverse Event|0|||
27593212|NCT01662310|80352294|FG002|Double-Blind Phase|Adverse Event|1|||
27593213|NCT01662310|80352295|FG003|Double-Blind Phase|Adverse Event|0|||
27593214|NCT01662310|80352296|FG004|Double-Blind Phase|Adverse Event|0|||
27593215|NCT01662310|80352292|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27593216|NCT01662310|80352293|FG001|Double-Blind Phase|Lost to Follow-up|3|||
27593217|NCT01662310|80352294|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27821161|NCT02079766|81178834|FG001|Overall Study|Withdrawal by Subject|0|||
27821162|NCT00863746|81178835|FG000|Treatment|Not treated|4|||
27821163|NCT00863746|81178836|FG001|Treatment|Not treated|2|||
27821164|NCT00863746|81178835|FG000|Treatment|Adverse Event|41|||
27593218|NCT01662310|80352295|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27593219|NCT01662310|80352296|FG004|Double-Blind Phase|Lost to Follow-up|0|||
27593220|NCT01662310|80352292|FG000|Double-Blind Phase|Pregnancy|0|||
27593221|NCT01662310|80352293|FG001|Double-Blind Phase|Pregnancy|2|||
27593222|NCT01662310|80352294|FG002|Double-Blind Phase|Pregnancy|0|||
27821165|NCT00863746|81178836|FG001|Treatment|Adverse Event|16|||
27821166|NCT00863746|81178835|FG000|Treatment|non-compliant with study medication|4|||
27821167|NCT00863746|81178836|FG001|Treatment|non-compliant with study medication|0|||
27821168|NCT00863746|81178835|FG000|Treatment|Consent withdrawn|15|||
27821169|NCT00863746|81178836|FG001|Treatment|Consent withdrawn|14|||
27693965|NCT00971243|80716602|FG004|Double Blind Period|Physician Decision|7|||
27693966|NCT00971243|80716598|FG000|Double Blind Period|Protocol Violation|2|||
27693967|NCT00971243|80716599|FG001|Double Blind Period|Protocol Violation|0|||
27693968|NCT00971243|80716600|FG002|Double Blind Period|Protocol Violation|3|||
27693969|NCT00971243|80716601|FG003|Double Blind Period|Protocol Violation|2|||
27693970|NCT00971243|80716602|FG004|Double Blind Period|Protocol Violation|2|||
27693971|NCT00971243|80716598|FG000|Double Blind Period|Withdrawal by Subject|4|||
27693972|NCT00971243|80716599|FG001|Double Blind Period|Withdrawal by Subject|1|||
27693973|NCT00971243|80716600|FG002|Double Blind Period|Withdrawal by Subject|4|||
27693974|NCT00971243|80716601|FG003|Double Blind Period|Withdrawal by Subject|4|||
27693975|NCT00971243|80716602|FG004|Double Blind Period|Withdrawal by Subject|4|||
27593223|NCT01662310|80352295|FG003|Double-Blind Phase|Pregnancy|0|||
27593224|NCT01662310|80352296|FG004|Double-Blind Phase|Pregnancy|0|||
27593225|NCT01662310|80352292|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27593226|NCT01662310|80352293|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
27593227|NCT01662310|80352294|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
27593228|NCT01662310|80352295|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27593229|NCT01662310|80352296|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
27593230|NCT01662310|80352292|FG000|Double-Blind Phase|Other|0|||
27593231|NCT01662310|80352293|FG001|Double-Blind Phase|Other|0|||
27593232|NCT01662310|80352294|FG002|Double-Blind Phase|Other|1|||
27593233|NCT01662310|80352295|FG003|Double-Blind Phase|Other|0|||
27593234|NCT01662310|80352296|FG004|Double-Blind Phase|Other|0|||
27593235|NCT01662310|80352292|FG000|Double-Blind Phase|Randomized but not treated|0|||
27593236|NCT01662310|80352293|FG001|Double-Blind Phase|Randomized but not treated|1|||
27593237|NCT01662310|80352294|FG002|Double-Blind Phase|Randomized but not treated|0|||
27593238|NCT01662310|80352295|FG003|Double-Blind Phase|Randomized but not treated|0|||
27593239|NCT01662310|80352296|FG004|Double-Blind Phase|Randomized but not treated|0|||
27593240|NCT01662310|80352292|FG000|Open-Label Extension Phase|Adverse Event|0|||
27593241|NCT01662310|80352293|FG001|Open-Label Extension Phase|Adverse Event|0|||
27593242|NCT01662310|80352294|FG002|Open-Label Extension Phase|Adverse Event|0|||
27593243|NCT01662310|80352295|FG003|Open-Label Extension Phase|Adverse Event|3|||
27593244|NCT01662310|80352296|FG004|Open-Label Extension Phase|Adverse Event|0|||
27593245|NCT01662310|80352292|FG000|Open-Label Extension Phase|Death|0|||
27593246|NCT01662310|80352293|FG001|Open-Label Extension Phase|Death|0|||
27593247|NCT01662310|80352294|FG002|Open-Label Extension Phase|Death|0|||
27593248|NCT01662310|80352295|FG003|Open-Label Extension Phase|Death|1|||
27593249|NCT01662310|80352296|FG004|Open-Label Extension Phase|Death|0|||
27593250|NCT01662310|80352292|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
27593251|NCT01662310|80352293|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
27593252|NCT01662310|80352294|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
27593253|NCT01662310|80352295|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
27593254|NCT01662310|80352296|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
27693976|NCT00971243|80716598|FG000|Double Blind Period|Other reasons|1|||
27593255|NCT01662310|80352292|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27593256|NCT01662310|80352293|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27593257|NCT01662310|80352294|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27593258|NCT01662310|80352295|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
27593259|NCT01662310|80352296|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
27593260|NCT01662310|80352292|FG000|Open-Label Extension Phase|Pregnancy|0|||
27593261|NCT01662310|80352293|FG001|Open-Label Extension Phase|Pregnancy|0|||
27593262|NCT01662310|80352294|FG002|Open-Label Extension Phase|Pregnancy|0|||
27593263|NCT01662310|80352295|FG003|Open-Label Extension Phase|Pregnancy|1|||
27593264|NCT01662310|80352296|FG004|Open-Label Extension Phase|Pregnancy|0|||
27593265|NCT01662310|80352292|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
27593266|NCT01662310|80352293|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
27593267|NCT01662310|80352294|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
27593268|NCT01662310|80352295|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
27593269|NCT01662310|80352296|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
27593270|NCT03950739|80352299|FG000|Treatment Phase|Adverse Event|2|||
27593271|NCT03950739|80352299|FG000|Optional Extension Phase|Death|1|||
27593272|NCT03950739|80352299|FG000|Optional Extension Phase|Progressive Disease|5|||
27593273|NCT03950739|80352299|FG000|Optional Extension Phase|Adverse Event|7|||
27593274|NCT03950739|80352299|FG000|Optional Extension Phase|Lost to Follow-up|2|||
27593275|NCT03950739|80352299|FG000|Optional Extension Phase|Site Closure|2|||
27593276|NCT03950739|80352299|FG000|Optional Extension Phase|Pregnancy|1|||
27593277|NCT02564523|80352300|FG000|Overall Study|Withdrawal by Subject|3|||
27593278|NCT02564523|80352301|FG001|Overall Study|Withdrawal by Subject|0|||
27593279|NCT02564523|80352302|FG002|Overall Study|Withdrawal by Subject|1|||
27593280|NCT02564523|80352303|FG003|Overall Study|Withdrawal by Subject|0|||
27593281|NCT02564523|80352304|FG004|Overall Study|Withdrawal by Subject|1|||
27593282|NCT02564523|80352305|FG005|Overall Study|Withdrawal by Subject|0|||
27821170|NCT00863746|81178835|FG000|Treatment|Lost to Follow-up|1|||
27821171|NCT00863746|81178836|FG001|Treatment|Lost to Follow-up|0|||
27821172|NCT00863746|81178835|FG000|Treatment|Protocol Violation|5|||
27821173|NCT00863746|81178836|FG001|Treatment|Protocol Violation|3|||
27821174|NCT00863746|81178835|FG000|Treatment|Other|1|||
27821175|NCT00863746|81178836|FG001|Treatment|Other|0|||
27821176|NCT00863746|81178835|FG000|Survival Follow up|Death|244|||
27821177|NCT00863746|81178836|FG001|Survival Follow up|Death|271|||
27821178|NCT00863746|81178835|FG000|Survival Follow up|Lost to Follow-up|2|||
27821179|NCT00863746|81178836|FG001|Survival Follow up|Lost to Follow-up|1|||
27821180|NCT00863746|81178835|FG000|Survival Follow up|Consent Withdrawn|7|||
27821181|NCT00863746|81178836|FG001|Survival Follow up|Consent Withdrawn|8|||
27821182|NCT01273805|81178838|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
27821183|NCT01273805|81178839|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
27821184|NCT00995553|81178850|FG000|Overall Study|Withdrawal by Subject|2|||
27821185|NCT00995553|81178851|FG001|Overall Study|Withdrawal by Subject|6|||
27821186|NCT01396278|81178852|FG000|Overall Study|Adverse Event|0|||
27821187|NCT01396278|81178853|FG001|Overall Study|Adverse Event|0|||
27821188|NCT01396278|81178854|FG002|Overall Study|Adverse Event|0|||
27821189|NCT01396278|81178855|FG003|Overall Study|Adverse Event|2|||
27821190|NCT01396278|81178856|FG004|Overall Study|Adverse Event|0|||
27821191|NCT01396278|81178852|FG000|Overall Study|Withdraw due to trial termination|2|||
27821192|NCT01396278|81178853|FG001|Overall Study|Withdraw due to trial termination|1|||
27821193|NCT01396278|81178854|FG002|Overall Study|Withdraw due to trial termination|1|||
27821194|NCT01396278|81178855|FG003|Overall Study|Withdraw due to trial termination|0|||
27821195|NCT01396278|81178856|FG004|Overall Study|Withdraw due to trial termination|2|||
27821196|NCT04885296|81178857|FG000|Period 1|Covid-19 Related|1|||
27821197|NCT04885296|81178858|FG001|Period 1|Covid-19 Related|0|||
27821198|NCT04885296|81178857|FG000|Period 1|Adverse Event|0|||
27821199|NCT04885296|81178858|FG001|Period 1|Adverse Event|1|||
27821200|NCT04885296|81178857|FG000|Period 1|Withdrawal by Subject|1|||
27821201|NCT04885296|81178858|FG001|Period 1|Withdrawal by Subject|1|||
27821202|NCT04885296|81178857|FG000|Period 1|Test Article No Longer Available|1|||
27821203|NCT04885296|81178858|FG001|Period 1|Test Article No Longer Available|0|||
27821204|NCT04885296|81178857|FG000|Period 1|Dispensed Study lens in Error|1|||
27821205|NCT04885296|81178858|FG001|Period 1|Dispensed Study lens in Error|0|||
27821206|NCT04885296|81178857|FG000|Period 1|Lost to Follow-up|1|||
27821207|NCT04885296|81178858|FG001|Period 1|Lost to Follow-up|0|||
27821208|NCT04885296|81178857|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
27821209|NCT04885296|81178858|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
27821210|NCT01059903|81178859|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
27821211|NCT01059903|81178860|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
27593283|NCT02564523|80352306|FG006|Overall Study|Withdrawal by Subject|1|||
27593284|NCT02564523|80352307|FG007|Overall Study|Withdrawal by Subject|0|||
27593285|NCT02564523|80352308|FG008|Overall Study|Withdrawal by Subject|0|||
27593286|NCT02564523|80352309|FG009|Overall Study|Withdrawal by Subject|0|||
27593287|NCT02564523|80352310|FG010|Overall Study|Withdrawal by Subject|1|||
27593288|NCT02564523|80352311|FG011|Overall Study|Withdrawal by Subject|0|||
27593289|NCT02564523|80352312|FG012|Overall Study|Withdrawal by Subject|1|||
27593290|NCT02564523|80352313|FG013|Overall Study|Withdrawal by Subject|0|||
27593291|NCT02564523|80352314|FG014|Overall Study|Withdrawal by Subject|0|||
27593292|NCT02564523|80352315|FG015|Overall Study|Withdrawal by Subject|0|||
27821212|NCT03480425|81178861|FG000|Overall Study|Force transducer technical failure|1|||
27821213|NCT00075478|81178862|FG000|Overall Study|not eligible|1|||
27821214|NCT00075478|81178863|FG001|Overall Study|not eligible|0|||
27881827|NCT03889418|81398056|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27881828|NCT03889418|81398057|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27881829|NCT03889418|81398058|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27881830|NCT03889418|81398059|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
27693977|NCT00971243|80716599|FG001|Double Blind Period|Other reasons|0|||
27821215|NCT00075478|81178862|FG000|Overall Study|Physician Decision|0|||
27821216|NCT00075478|81178863|FG001|Overall Study|Physician Decision|1|||
27821217|NCT03365375|81178864|FG000|Overall Study|Withdrawal by Subject|0|||
27821218|NCT03365375|81178865|FG001|Overall Study|Withdrawal by Subject|1|||
27821219|NCT03365375|81178864|FG000|Overall Study|Lost to Follow-up|0|||
27821220|NCT03365375|81178865|FG001|Overall Study|Lost to Follow-up|4|||
27821221|NCT00860405|81178866|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
27821222|NCT00860405|81178867|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
27821223|NCT01876706|81178868|FG000|Overall Study|BPH Intervention|9|||
27821224|NCT01876706|81178868|FG000|Overall Study|Lost to Follow-up|7|||
27821225|NCT01876706|81178868|FG000|Overall Study|Withdrawals|6|||
27821226|NCT01876706|81178868|FG000|Overall Study|Death|3|||
27821227|NCT00615069|81178871|FG000|Overall Study|Death|10|||
27821228|NCT00615069|81178871|FG000|Overall Study|Physician Decision|2|||
27821229|NCT00615069|81178871|FG000|Overall Study|Withdrawal by Subject|4|||
27821230|NCT01079988|81178872|FG000|Overall Study|Lost to Follow-up|0|||
27821231|NCT01079988|81178873|FG001|Overall Study|Lost to Follow-up|0|||
27821232|NCT01079988|81178874|FG002|Overall Study|Lost to Follow-up|0|||
27821233|NCT01079988|81178875|FG003|Overall Study|Lost to Follow-up|1|||
27821234|NCT01079988|81178876|FG004|Overall Study|Lost to Follow-up|0|||
27821235|NCT01079988|81178872|FG000|Overall Study|Lack of Efficacy|1|||
27821236|NCT01079988|81178873|FG001|Overall Study|Lack of Efficacy|0|||
27821237|NCT01079988|81178874|FG002|Overall Study|Lack of Efficacy|0|||
27821238|NCT01079988|81178875|FG003|Overall Study|Lack of Efficacy|0|||
27821239|NCT01079988|81178876|FG004|Overall Study|Lack of Efficacy|0|||
27821240|NCT01079988|81178872|FG000|Overall Study|Other|0|||
27821241|NCT01079988|81178873|FG001|Overall Study|Other|0|||
27821242|NCT01079988|81178874|FG002|Overall Study|Other|0|||
27821243|NCT01079988|81178875|FG003|Overall Study|Other|2|||
27821244|NCT01079988|81178876|FG004|Overall Study|Other|1|||
27821245|NCT01781286|81178877|FG000|Overall Study|Lost to Follow-up|0|||
27821246|NCT01781286|81178878|FG001|Overall Study|Lost to Follow-up|0|||
27821247|NCT01781286|81178879|FG002|Overall Study|Lost to Follow-up|0|||
27821248|NCT01781286|81178880|FG003|Overall Study|Lost to Follow-up|0|||
27821249|NCT01781286|81178881|FG004|Overall Study|Lost to Follow-up|0|||
27821250|NCT01781286|81178882|FG005|Overall Study|Lost to Follow-up|1|||
27821251|NCT01781286|81178877|FG000|Overall Study|Time Constraints|2|||
27821252|NCT01781286|81178878|FG001|Overall Study|Time Constraints|0|||
27821253|NCT01781286|81178879|FG002|Overall Study|Time Constraints|2|||
27821254|NCT01781286|81178880|FG003|Overall Study|Time Constraints|0|||
27821255|NCT01781286|81178881|FG004|Overall Study|Time Constraints|0|||
27821256|NCT01781286|81178882|FG005|Overall Study|Time Constraints|0|||
27821257|NCT01781286|81178877|FG000|Overall Study|Noncompliance|0|||
27821258|NCT01781286|81178878|FG001|Overall Study|Noncompliance|0|||
27821259|NCT01781286|81178879|FG002|Overall Study|Noncompliance|0|||
27821260|NCT01781286|81178880|FG003|Overall Study|Noncompliance|1|||
27821261|NCT01781286|81178881|FG004|Overall Study|Noncompliance|0|||
27821262|NCT01781286|81178882|FG005|Overall Study|Noncompliance|0|||
27821263|NCT04453202|81178883|FG000|Overall Study|Adverse Event|0|||
27821264|NCT04453202|81178884|FG001|Overall Study|Adverse Event|0|||
27821265|NCT04453202|81178885|FG002|Overall Study|Adverse Event|0|||
27821266|NCT04453202|81178886|FG003|Overall Study|Adverse Event|0|||
27821267|NCT04453202|81178887|FG004|Overall Study|Adverse Event|0|||
27821268|NCT04453202|81178888|FG005|Overall Study|Adverse Event|0|||
27821269|NCT04453202|81178889|FG006|Overall Study|Adverse Event|1|||
27821270|NCT04453202|81178890|FG007|Overall Study|Adverse Event|0|||
27821271|NCT04453202|81178891|FG008|Overall Study|Adverse Event|0|||
27881831|NCT03889418|81398050|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
27881832|NCT03889418|81398051|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
27821272|NCT04453202|81178892|FG009|Overall Study|Adverse Event|0|||
27821273|NCT04453202|81178893|FG010|Overall Study|Adverse Event|0|||
27821274|NCT04453202|81178883|FG000|Overall Study|Death|0|||
27821275|NCT04453202|81178884|FG001|Overall Study|Death|0|||
27821276|NCT04453202|81178885|FG002|Overall Study|Death|0|||
27821277|NCT04453202|81178886|FG003|Overall Study|Death|0|||
27821278|NCT04453202|81178887|FG004|Overall Study|Death|0|||
27821279|NCT04453202|81178888|FG005|Overall Study|Death|0|||
27821280|NCT04453202|81178889|FG006|Overall Study|Death|0|||
27821281|NCT04453202|81178890|FG007|Overall Study|Death|0|||
27821282|NCT04453202|81178891|FG008|Overall Study|Death|0|||
27821283|NCT04453202|81178892|FG009|Overall Study|Death|1|||
27821284|NCT04453202|81178893|FG010|Overall Study|Death|0|||
27821285|NCT04453202|81178883|FG000|Overall Study|Lost to Follow-up|0|||
27821286|NCT04453202|81178884|FG001|Overall Study|Lost to Follow-up|1|||
27821287|NCT04453202|81178885|FG002|Overall Study|Lost to Follow-up|0|||
27821288|NCT04453202|81178886|FG003|Overall Study|Lost to Follow-up|1|||
27821289|NCT04453202|81178887|FG004|Overall Study|Lost to Follow-up|0|||
27821290|NCT04453202|81178888|FG005|Overall Study|Lost to Follow-up|0|||
27821291|NCT04453202|81178889|FG006|Overall Study|Lost to Follow-up|0|||
27821292|NCT04453202|81178890|FG007|Overall Study|Lost to Follow-up|0|||
27821293|NCT04453202|81178891|FG008|Overall Study|Lost to Follow-up|0|||
27821294|NCT04453202|81178892|FG009|Overall Study|Lost to Follow-up|1|||
27881833|NCT03889418|81398052|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
27881834|NCT03889418|81398053|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
27881835|NCT03889418|81398054|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
27881836|NCT03889418|81398055|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
27881837|NCT03889418|81398056|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
27881838|NCT03889418|81398057|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
27881839|NCT03889418|81398058|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
27881840|NCT03889418|81398059|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
27821295|NCT04453202|81178893|FG010|Overall Study|Lost to Follow-up|1|||
27821296|NCT04453202|81178883|FG000|Overall Study|Withdrawal by Subject|1|||
27821297|NCT04453202|81178884|FG001|Overall Study|Withdrawal by Subject|2|||
27821298|NCT04453202|81178885|FG002|Overall Study|Withdrawal by Subject|1|||
27821299|NCT04453202|81178886|FG003|Overall Study|Withdrawal by Subject|2|||
27821300|NCT04453202|81178887|FG004|Overall Study|Withdrawal by Subject|1|||
27821301|NCT04453202|81178888|FG005|Overall Study|Withdrawal by Subject|1|||
27821302|NCT04453202|81178889|FG006|Overall Study|Withdrawal by Subject|0|||
27821303|NCT04453202|81178890|FG007|Overall Study|Withdrawal by Subject|0|||
27821304|NCT04453202|81178891|FG008|Overall Study|Withdrawal by Subject|0|||
27821305|NCT04453202|81178892|FG009|Overall Study|Withdrawal by Subject|1|||
27821306|NCT04453202|81178893|FG010|Overall Study|Withdrawal by Subject|0|||
27821307|NCT04453202|81178883|FG000|Overall Study|Adverse Event|0|||
27821308|NCT04453202|81178884|FG001|Overall Study|Adverse Event|0|||
27821309|NCT04453202|81178885|FG002|Overall Study|Adverse Event|0|||
27821310|NCT04453202|81178886|FG003|Overall Study|Adverse Event|0|||
27821311|NCT04453202|81178887|FG004|Overall Study|Adverse Event|0|||
27821312|NCT04453202|81178888|FG005|Overall Study|Adverse Event|1|||
27821313|NCT04453202|81178889|FG006|Overall Study|Adverse Event|0|||
27821314|NCT04453202|81178890|FG007|Overall Study|Adverse Event|0|||
27821315|NCT04453202|81178891|FG008|Overall Study|Adverse Event|0|||
27821316|NCT04453202|81178892|FG009|Overall Study|Adverse Event|0|||
27821317|NCT04453202|81178893|FG010|Overall Study|Adverse Event|0|||
27881841|NCT03889418|81398050|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
27881842|NCT03889418|81398051|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
27881843|NCT03889418|81398052|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
27881844|NCT03889418|81398053|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
27881845|NCT03889418|81398054|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
27881846|NCT03889418|81398055|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
27881847|NCT03889418|81398056|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
27881848|NCT03889418|81398057|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
27881849|NCT03889418|81398058|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
27881850|NCT03889418|81398059|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
27881851|NCT00952068|81398062|FG000|Overall Study|Adverse Event|3|||
27881852|NCT00952068|81398062|FG000|Overall Study|Withdrawal by Subject|4|||
27881853|NCT00806403|81398067|FG000|Overall Study|Death|4|||
27881854|NCT00806403|81398068|FG001|Overall Study|Death|3|||
27881855|NCT00454363|81398069|FG000|Overall Study|Adverse Event|1|||
27881856|NCT00454363|81398070|FG001|Overall Study|Adverse Event|2|||
27881857|NCT00454363|81398069|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
27881858|NCT00454363|81398070|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
27881859|NCT00746564|81398073|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
27881860|NCT00410813|81398078|FG000|Overall Study|Adverse Event|6|||
27881861|NCT00410813|81398079|FG001|Overall Study|Adverse Event|11|||
27881862|NCT00410813|81398078|FG000|Overall Study|Progression|32|||
27821318|NCT00262223|81178901|FG000|Treatment Phase|Withdrawal by Subject|3|||
27821319|NCT00262223|81178902|FG001|Treatment Phase|Withdrawal by Subject|6|||
27821320|NCT00262223|81178901|FG000|Treatment Phase|Adverse Event|1|||
27821321|NCT00262223|81178902|FG001|Treatment Phase|Adverse Event|2|||
27821322|NCT00262223|81178901|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
27821323|NCT00262223|81178902|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
27821324|NCT00262223|81178901|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
27821325|NCT00262223|81178902|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
27881863|NCT00410813|81398079|FG001|Overall Study|Progression|21|||
27881864|NCT00410813|81398078|FG000|Overall Study|Not protocol specified|3|||
27881865|NCT00410813|81398079|FG001|Overall Study|Not protocol specified|4|||
27881866|NCT00410813|81398078|FG000|Overall Study|Ineligible|2|||
27881867|NCT00410813|81398079|FG001|Overall Study|Ineligible|4|||
27881868|NCT00410813|81398078|FG000|Overall Study|Death|0|||
27821326|NCT00262223|81178901|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
27821327|NCT00262223|81178902|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
27821328|NCT02419937|81178904|FG000|Overall Study|Lost to Follow-up|1|||
27821329|NCT02419937|81178905|FG001|Overall Study|Lost to Follow-up|0|||
27821330|NCT04611789|81178906|FG000|Overall Study|Lost to Follow-up|1|||
27821331|NCT04611789|81178907|FG001|Overall Study|Lost to Follow-up|0|||
27821332|NCT04611789|81178908|FG002|Overall Study|Lost to Follow-up|0|||
27821333|NCT02231749|81178909|FG000|Overall Study|Disease progression|229|||
27821334|NCT02231749|81178910|FG001|Overall Study|Disease progression|297|||
27821335|NCT02231749|81178909|FG000|Overall Study|Study Drug Toxicity|134|||
27821336|NCT02231749|81178910|FG001|Overall Study|Study Drug Toxicity|63|||
27821337|NCT02231749|81178909|FG000|Overall Study|Death|1|||
27821338|NCT02231749|81178910|FG001|Overall Study|Death|1|||
27821339|NCT02231749|81178909|FG000|Overall Study|AE unrelated to Study drug|32|||
27821340|NCT02231749|81178910|FG001|Overall Study|AE unrelated to Study drug|31|||
27881869|NCT00410813|81398079|FG001|Overall Study|Death|2|||
27881870|NCT00471822|81398089|FG000|Overall Study|Protocol Violation|2|||
27593293|NCT02564523|80352316|FG016|Overall Study|Withdrawal by Subject|0|||
27593294|NCT02564523|80352317|FG017|Overall Study|Withdrawal by Subject|0|||
27821341|NCT02231749|81178909|FG000|Overall Study|Participant's request to discontinue|10|||
27821342|NCT02231749|81178910|FG001|Overall Study|Participant's request to discontinue|21|||
27821343|NCT02231749|81178909|FG000|Overall Study|Participant withdrew Consent|8|||
27821344|NCT02231749|81178910|FG001|Overall Study|Participant withdrew Consent|15|||
27821345|NCT02231749|81178909|FG000|Overall Study|Lost to Follow-up|1|||
27821346|NCT02231749|81178910|FG001|Overall Study|Lost to Follow-up|2|||
27881871|NCT03168711|81398090|FG000|Overall Study|Adverse Event|2|||
27881872|NCT03168711|81398091|FG001|Overall Study|Adverse Event|0|||
27881873|NCT03168711|81398090|FG000|Overall Study|Withdrawal by Subject|0|||
27881874|NCT03168711|81398091|FG001|Overall Study|Withdrawal by Subject|1|||
27881875|NCT03168711|81398090|FG000|Overall Study|Death|0|||
27881876|NCT03168711|81398091|FG001|Overall Study|Death|1|||
27881877|NCT00507455|81398095|FG000|Overall Study|Adverse Event|3|||
27881878|NCT00507455|81398096|FG001|Overall Study|Adverse Event|3|||
27881879|NCT00507455|81398097|FG002|Overall Study|Adverse Event|6|||
27881880|NCT00507455|81398095|FG000|Overall Study|Withdrawal by Subject|2|||
27881881|NCT00507455|81398096|FG001|Overall Study|Withdrawal by Subject|1|||
27881882|NCT00507455|81398097|FG002|Overall Study|Withdrawal by Subject|2|||
27881883|NCT00507455|81398095|FG000|Overall Study|Protocol Violation|4|||
27881884|NCT00507455|81398096|FG001|Overall Study|Protocol Violation|1|||
27881885|NCT00507455|81398097|FG002|Overall Study|Protocol Violation|1|||
27881886|NCT00507455|81398095|FG000|Overall Study|Lost to Follow-up|2|||
27881887|NCT00507455|81398096|FG001|Overall Study|Lost to Follow-up|0|||
27881888|NCT00507455|81398097|FG002|Overall Study|Lost to Follow-up|2|||
27881889|NCT00507455|81398095|FG000|Overall Study|Lack of Efficacy|0|||
27881890|NCT00507455|81398096|FG001|Overall Study|Lack of Efficacy|1|||
27821347|NCT02231749|81178909|FG000|Overall Study|Maximum Clinical Benefit|5|||
27821348|NCT02231749|81178910|FG001|Overall Study|Maximum Clinical Benefit|8|||
27821349|NCT02231749|81178909|FG000|Overall Study|Poor/Non-Compliance|0|||
27821350|NCT02231749|81178910|FG001|Overall Study|Poor/Non-Compliance|3|||
27821351|NCT02231749|81178909|FG000|Overall Study|Pregnancy|1|||
27821352|NCT02231749|81178910|FG001|Overall Study|Pregnancy|0|||
27821353|NCT02231749|81178909|FG000|Overall Study|other|0|||
27821354|NCT02231749|81178910|FG001|Overall Study|other|8|||
27821355|NCT02231749|81178909|FG000|Overall Study|No longer meets Study Criteria|1|||
27821356|NCT02231749|81178910|FG001|Overall Study|No longer meets Study Criteria|0|||
27821357|NCT02458469|81178911|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27821358|NCT02458469|81178912|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27821359|NCT02458469|81178913|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
27821360|NCT02458469|81178914|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27821361|NCT02458469|81178915|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27821362|NCT02458469|81178916|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
27821363|NCT02458469|81178911|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
27821364|NCT02458469|81178912|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
27821365|NCT02458469|81178913|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
27821366|NCT02458469|81178914|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
27821367|NCT02458469|81178915|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
27593295|NCT02564523|80352300|FG000|Overall Study|Adverse Event|0|||
27593296|NCT02564523|80352301|FG001|Overall Study|Adverse Event|0|||
27593297|NCT02564523|80352302|FG002|Overall Study|Adverse Event|0|||
27593298|NCT02564523|80352303|FG003|Overall Study|Adverse Event|0|||
27593299|NCT02564523|80352304|FG004|Overall Study|Adverse Event|0|||
27593300|NCT02564523|80352305|FG005|Overall Study|Adverse Event|0|||
27593301|NCT02564523|80352306|FG006|Overall Study|Adverse Event|0|||
27593302|NCT02564523|80352307|FG007|Overall Study|Adverse Event|0|||
27593303|NCT02564523|80352308|FG008|Overall Study|Adverse Event|0|||
27593304|NCT02564523|80352309|FG009|Overall Study|Adverse Event|0|||
27593305|NCT02564523|80352310|FG010|Overall Study|Adverse Event|0|||
27593306|NCT02564523|80352311|FG011|Overall Study|Adverse Event|0|||
27593307|NCT02564523|80352312|FG012|Overall Study|Adverse Event|0|||
27593308|NCT02564523|80352313|FG013|Overall Study|Adverse Event|0|||
27593309|NCT02564523|80352314|FG014|Overall Study|Adverse Event|0|||
27593310|NCT02564523|80352315|FG015|Overall Study|Adverse Event|0|||
27593311|NCT02564523|80352316|FG016|Overall Study|Adverse Event|0|||
27593312|NCT02564523|80352317|FG017|Overall Study|Adverse Event|1|||
27593313|NCT02564523|80352300|FG000|Overall Study|Death|0|||
27593314|NCT02564523|80352301|FG001|Overall Study|Death|0|||
27593315|NCT02564523|80352302|FG002|Overall Study|Death|0|||
27593316|NCT02564523|80352303|FG003|Overall Study|Death|0|||
27593317|NCT02564523|80352304|FG004|Overall Study|Death|0|||
27593318|NCT02564523|80352305|FG005|Overall Study|Death|0|||
27593319|NCT02564523|80352306|FG006|Overall Study|Death|1|||
27821368|NCT02458469|81178916|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
27821369|NCT02458469|81178911|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27821370|NCT02458469|81178912|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27593320|NCT02564523|80352307|FG007|Overall Study|Death|0|||
27593321|NCT02564523|80352308|FG008|Overall Study|Death|0|||
27593322|NCT02564523|80352309|FG009|Overall Study|Death|0|||
27593323|NCT02564523|80352310|FG010|Overall Study|Death|1|||
27821371|NCT02458469|81178913|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27593324|NCT02564523|80352311|FG011|Overall Study|Death|0|||
27593325|NCT02564523|80352312|FG012|Overall Study|Death|0|||
27593326|NCT02564523|80352313|FG013|Overall Study|Death|0|||
27593327|NCT02564523|80352314|FG014|Overall Study|Death|0|||
27593328|NCT02564523|80352315|FG015|Overall Study|Death|0|||
27821372|NCT02458469|81178914|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27821373|NCT02458469|81178915|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
27881891|NCT00507455|81398097|FG002|Overall Study|Lack of Efficacy|0|||
27821374|NCT02458469|81178916|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
27821375|NCT00576056|81178920|FG000|Overall Study|Adverse Event|1|||
27821376|NCT00576056|81178920|FG000|Overall Study|Death|1|||
27821377|NCT00576056|81178920|FG000|Overall Study|Lack of Efficacy|1|||
27821378|NCT00576056|81178920|FG000|Overall Study|Withdrawal by Subject|2|||
27821379|NCT00576056|81178920|FG000|Overall Study|did not meet eligibility criteria|8|||
27821380|NCT00576056|81178920|FG000|Overall Study|Physician Decision|1|||
27821381|NCT03018249|81178921|FG000|Overall Study|Withdrawal by Subject|2|||
27821382|NCT03018249|81178922|FG001|Overall Study|Withdrawal by Subject|2|||
27821383|NCT00620022|81178923|FG000|Treatment Period 1|Adverse Event|4|||
27821384|NCT00620022|81178924|FG001|Treatment Period 1|Adverse Event|6|||
27821385|NCT00620022|81178923|FG000|Treatment Period 1|Subject withdrew consent|1|||
27821386|NCT00620022|81178924|FG001|Treatment Period 1|Subject withdrew consent|0|||
27821387|NCT00620022|81178923|FG000|Treatment Period 2|Adverse Event|2|||
27821388|NCT00620022|81178924|FG001|Treatment Period 2|Adverse Event|2|||
27821389|NCT04185909|81178934|FG000|Overall Study|Lost to Follow-up|1|||
27821390|NCT01691508|81178935|FG000|Overall Study|Adverse Event|3|||
27821391|NCT01691508|81178936|FG001|Overall Study|Adverse Event|3|||
27821392|NCT01691508|81178935|FG000|Overall Study|Withdrawal by Subject|1|||
27821393|NCT01691508|81178936|FG001|Overall Study|Withdrawal by Subject|0|||
27821394|NCT04419311|81178937|FG000|Overall Study|Lost to Follow-up|1|||
27821395|NCT04419311|81178938|FG001|Overall Study|Lost to Follow-up|0|||
27821396|NCT01395030|81178939|FG000|Overall Study|Did not complete FCH PET/CT|7|||
27821397|NCT04188106|81178946|FG000|Overall Study|Lost to Follow-up|5|||
27821398|NCT04188106|81178946|FG000|Overall Study|Non-Compliance|1|||
27821399|NCT02637232|81178950|FG000|Overall Study|Lost to Follow-up|42|||
27821400|NCT02637232|81178950|FG000|Overall Study|Adverse Event|11|||
27821401|NCT02637232|81178950|FG000|Overall Study|patient 's decision|2|||
27821402|NCT02656706|81178951|FG000|Overall Study|Insurance Denial|1|||
27821403|NCT02374853|81178952|FG000|Overall Study|Surgery Cancelled|5|||
27821404|NCT02374853|81178953|FG001|Overall Study|Surgery Cancelled|11|||
27821405|NCT03586726|81178955|FG000|Overall Study|Withdrawal by Subject|1|||
27821406|NCT02678286|81178958|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
27821407|NCT02678286|81178959|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
27821408|NCT02678286|81178958|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
27821409|NCT02678286|81178959|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
27821410|NCT02678286|81178958|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
27821411|NCT02678286|81178959|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
27821412|NCT02678286|81178958|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
27821413|NCT02678286|81178959|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
27821414|NCT02678286|81178958|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
27821415|NCT02678286|81178959|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
27821416|NCT00056160|81178963|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
27821417|NCT00056160|81178964|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
27821418|NCT00056160|81178963|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
27821419|NCT00056160|81178964|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
27821420|NCT00056160|81178963|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
27821421|NCT00056160|81178964|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
27821422|NCT00056160|81178963|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
27821423|NCT00056160|81178964|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
27821424|NCT00056160|81178963|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
27821425|NCT00056160|81178964|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
27821426|NCT00056160|81178963|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
27821427|NCT00056160|81178964|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
27821428|NCT00056160|81178963|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
27821429|NCT00056160|81178964|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
27821430|NCT00056160|81178963|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
27821431|NCT00056160|81178964|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
27821432|NCT00056160|81178963|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
27821433|NCT00056160|81178964|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
27821434|NCT00056160|81178963|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
27821435|NCT00056160|81178964|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
27821436|NCT00056160|81178963|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
27821437|NCT00056160|81178964|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
27821438|NCT00056160|81178963|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
27821439|NCT00056160|81178964|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
27821440|NCT00056160|81178963|FG000|Final Follow-up|Transferred into expanded access study.|3|||
27821441|NCT00056160|81178964|FG001|Final Follow-up|Transferred into expanded access study.|0|||
27821442|NCT00056160|81178963|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
27821443|NCT00056160|81178964|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
27821444|NCT00056160|81178963|FG000|Final Follow-up|Adverse Event|1|||
27821445|NCT00056160|81178964|FG001|Final Follow-up|Adverse Event|0|||
27821446|NCT02587962|81178965|FG000|Overall Study|Adverse Event|0|||
27821447|NCT02587962|81178966|FG001|Overall Study|Adverse Event|0|||
27821448|NCT02587962|81178967|FG002|Overall Study|Adverse Event|1|||
27821449|NCT02587962|81178968|FG003|Overall Study|Adverse Event|0|||
27821450|NCT02587962|81178969|FG004|Overall Study|Adverse Event|0|||
27821451|NCT02587962|81178965|FG000|Overall Study|Withdrawal by Subject|0|||
27821452|NCT02587962|81178966|FG001|Overall Study|Withdrawal by Subject|0|||
27821453|NCT02587962|81178967|FG002|Overall Study|Withdrawal by Subject|1|||
27821454|NCT02587962|81178968|FG003|Overall Study|Withdrawal by Subject|1|||
27821455|NCT02587962|81178969|FG004|Overall Study|Withdrawal by Subject|4|||
27821456|NCT02587962|81178965|FG000|Overall Study|Radiological progression|2|||
27821457|NCT02587962|81178966|FG001|Overall Study|Radiological progression|2|||
27821458|NCT02587962|81178967|FG002|Overall Study|Radiological progression|2|||
27821459|NCT02587962|81178968|FG003|Overall Study|Radiological progression|5|||
27821460|NCT02587962|81178969|FG004|Overall Study|Radiological progression|10|||
27821461|NCT02587962|81178965|FG000|Overall Study|Clinical progression|0|||
27821462|NCT02587962|81178966|FG001|Overall Study|Clinical progression|1|||
27821463|NCT02587962|81178967|FG002|Overall Study|Clinical progression|2|||
27821464|NCT02587962|81178968|FG003|Overall Study|Clinical progression|0|||
27821465|NCT02587962|81178969|FG004|Overall Study|Clinical progression|1|||
27821466|NCT01010542|81178970|FG000|Overall Study|Adverse Event|0|||
27821467|NCT01010542|81178971|FG001|Overall Study|Adverse Event|1|||
27821468|NCT01010542|81178972|FG002|Overall Study|Adverse Event|0|||
27821469|NCT01010542|81178970|FG000|Overall Study|Lost to Follow-up|0|||
27821470|NCT01010542|81178971|FG001|Overall Study|Lost to Follow-up|1|||
27821471|NCT01010542|81178972|FG002|Overall Study|Lost to Follow-up|0|||
27821472|NCT01010542|81178970|FG000|Overall Study|Withdrawal by Subject|0|||
27821473|NCT01010542|81178971|FG001|Overall Study|Withdrawal by Subject|3|||
27593329|NCT02564523|80352316|FG016|Overall Study|Death|0|||
27593330|NCT02564523|80352317|FG017|Overall Study|Death|0|||
27593331|NCT02564523|80352300|FG000|Overall Study|Lost to Follow-up|2|||
27593332|NCT02564523|80352301|FG001|Overall Study|Lost to Follow-up|1|||
27693978|NCT00971243|80716600|FG002|Double Blind Period|Other reasons|2|||
27693979|NCT00971243|80716601|FG003|Double Blind Period|Other reasons|0|||
27693980|NCT00971243|80716602|FG004|Double Blind Period|Other reasons|1|||
27821474|NCT01010542|81178972|FG002|Overall Study|Withdrawal by Subject|2|||
27821475|NCT04869787|81178979|FG000|Screening|Physician Decision|1|||
27821476|NCT04869787|81178979|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
27821477|NCT02719522|81178982|FG000|Overall Study|Implant Failure|4|||
27821478|NCT02719522|81178982|FG000|Overall Study|Death|2|||
27821479|NCT02719522|81178982|FG000|Overall Study|Lost to Follow-up|5|||
27821480|NCT01035060|81178987|FG000|Overall Study|Lost to Follow-up|0|||
27821481|NCT01035060|81178988|FG001|Overall Study|Lost to Follow-up|7|||
27821482|NCT01035060|81178987|FG000|Overall Study|Did not quality after 2nd screening|14|||
27821483|NCT01035060|81178988|FG001|Overall Study|Did not quality after 2nd screening|1|||
27821484|NCT01035060|81178987|FG000|Overall Study|Withdrawal by Subject|8|||
27821485|NCT01035060|81178988|FG001|Overall Study|Withdrawal by Subject|6|||
27821486|NCT01035060|81178987|FG000|Overall Study|Physician Decision|2|||
27821487|NCT01035060|81178988|FG001|Overall Study|Physician Decision|0|||
27821488|NCT01471522|81178994|FG000|Overall Study|Withdrawal by Subject|28|||
27821489|NCT01471522|81178995|FG001|Overall Study|Withdrawal by Subject|22|||
27881892|NCT00507455|81398095|FG000|Overall Study|Other - miscellaneous reason|1|||
27881893|NCT00507455|81398096|FG001|Overall Study|Other - miscellaneous reason|0|||
27881894|NCT00507455|81398097|FG002|Overall Study|Other - miscellaneous reason|1|||
27881895|NCT01470248|81398100|FG000|Overall Study|Withdrawal by Subject|1|||
27881896|NCT03058705|81400995|FG000|Overall Study|Withdrawal by Subject|2|||
27881897|NCT03058705|81400995|FG000|Overall Study|Physician Decision|2|||
27881898|NCT03056638|81400997|FG000|Overall Study|Death|1|||
27881899|NCT03056638|81400998|FG001|Overall Study|Death|0|||
27593333|NCT02564523|80352302|FG002|Overall Study|Lost to Follow-up|4|||
27821490|NCT01471522|81178994|FG000|Overall Study|Lost to Follow-up|36|||
27821491|NCT01471522|81178995|FG001|Overall Study|Lost to Follow-up|26|||
27821492|NCT00814463|81178996|FG000|Overall Study|Lost to Follow-up|1|||
27593334|NCT02564523|80352303|FG003|Overall Study|Lost to Follow-up|0|||
27881900|NCT00135512|81401006|FG000|Overall Study|Adverse Event|56|||
27593335|NCT02564523|80352304|FG004|Overall Study|Lost to Follow-up|1|||
27693981|NCT00971243|80716598|FG000|Open-label Period|Adverse Event|1|||
27821493|NCT00984126|81178999|FG000|Overall Study|Protocol Violation|0|||
27821494|NCT00984126|81179000|FG001|Overall Study|Protocol Violation|0|||
27821495|NCT00984126|81179001|FG002|Overall Study|Protocol Violation|1|||
27821496|NCT00984126|81179002|FG003|Overall Study|Protocol Violation|2|||
27821497|NCT00984126|81178999|FG000|Overall Study|Adverse Event|0|||
27821498|NCT00984126|81179000|FG001|Overall Study|Adverse Event|0|||
27821499|NCT00984126|81179001|FG002|Overall Study|Adverse Event|0|||
27821500|NCT00984126|81179002|FG003|Overall Study|Adverse Event|2|||
27821501|NCT00984126|81178999|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
27821502|NCT00984126|81179000|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
27821503|NCT00984126|81179001|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
27821504|NCT00984126|81179002|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
27821505|NCT00984126|81178999|FG000|Overall Study|Withdrawal criteria|0|||
27821506|NCT00984126|81179000|FG001|Overall Study|Withdrawal criteria|1|||
27821507|NCT00984126|81179001|FG002|Overall Study|Withdrawal criteria|3|||
27821508|NCT00984126|81179002|FG003|Overall Study|Withdrawal criteria|9|||
27821509|NCT02728102|81179003|FG000|Overall Study|Death|3|||
27821510|NCT02728102|81179004|FG001|Overall Study|Death|0|||
27821511|NCT02728102|81179005|FG002|Overall Study|Death|1|||
27821512|NCT02728102|81179003|FG000|Overall Study|Withdrawal by Subject|0|||
27821513|NCT02728102|81179004|FG001|Overall Study|Withdrawal by Subject|2|||
27821514|NCT02728102|81179005|FG002|Overall Study|Withdrawal by Subject|3|||
27821515|NCT02728102|81179003|FG000|Overall Study|Physician Decision|1|||
27821516|NCT02728102|81179004|FG001|Overall Study|Physician Decision|1|||
27821517|NCT02728102|81179005|FG002|Overall Study|Physician Decision|0|||
27821518|NCT02728102|81179003|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
27821519|NCT02728102|81179004|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
27821520|NCT02728102|81179005|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
27821521|NCT02728102|81179003|FG000|Overall Study|Covid|0|||
27821522|NCT02728102|81179004|FG001|Overall Study|Covid|0|||
27821523|NCT02728102|81179005|FG002|Overall Study|Covid|1|||
27821524|NCT00119015|81179006|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
27821525|NCT00119015|81179007|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
27821526|NCT00119015|81179008|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
27821527|NCT02024932|81179017|FG000|Overall Study|Adverse Event|2|||
27693982|NCT00971243|80716599|FG001|Open-label Period|Adverse Event|0|||
27693983|NCT00971243|80716600|FG002|Open-label Period|Adverse Event|1|||
27693984|NCT00971243|80716601|FG003|Open-label Period|Adverse Event|1|||
27693985|NCT00971243|80716602|FG004|Open-label Period|Adverse Event|0|||
27693986|NCT00971243|80716598|FG000|Open-label Period|Physician Decision|5|||
27693987|NCT00971243|80716599|FG001|Open-label Period|Physician Decision|9|||
27693988|NCT00971243|80716600|FG002|Open-label Period|Physician Decision|3|||
27693989|NCT00971243|80716601|FG003|Open-label Period|Physician Decision|7|||
27693990|NCT00971243|80716602|FG004|Open-label Period|Physician Decision|2|||
27693991|NCT00971243|80716598|FG000|Open-label Period|Protocol Violation|1|||
27693992|NCT00971243|80716599|FG001|Open-label Period|Protocol Violation|1|||
27693993|NCT00971243|80716600|FG002|Open-label Period|Protocol Violation|1|||
27693994|NCT00971243|80716601|FG003|Open-label Period|Protocol Violation|0|||
27693995|NCT00971243|80716602|FG004|Open-label Period|Protocol Violation|1|||
27693996|NCT00971243|80716598|FG000|Open-label Period|Withdrawal by Subject|1|||
27593336|NCT02564523|80352305|FG005|Overall Study|Lost to Follow-up|0|||
27593337|NCT02564523|80352306|FG006|Overall Study|Lost to Follow-up|1|||
27593338|NCT02564523|80352307|FG007|Overall Study|Lost to Follow-up|0|||
27593339|NCT02564523|80352308|FG008|Overall Study|Lost to Follow-up|0|||
27593340|NCT02564523|80352309|FG009|Overall Study|Lost to Follow-up|0|||
27593341|NCT02564523|80352310|FG010|Overall Study|Lost to Follow-up|0|||
27593342|NCT02564523|80352311|FG011|Overall Study|Lost to Follow-up|1|||
27593343|NCT02564523|80352312|FG012|Overall Study|Lost to Follow-up|1|||
27593344|NCT02564523|80352313|FG013|Overall Study|Lost to Follow-up|0|||
27593345|NCT02564523|80352314|FG014|Overall Study|Lost to Follow-up|0|||
27593346|NCT02564523|80352315|FG015|Overall Study|Lost to Follow-up|0|||
27593347|NCT02564523|80352316|FG016|Overall Study|Lost to Follow-up|0|||
27593348|NCT02564523|80352317|FG017|Overall Study|Lost to Follow-up|0|||
27593349|NCT02564523|80352300|FG000|Overall Study|Physician Decision|0|||
27593350|NCT02564523|80352301|FG001|Overall Study|Physician Decision|0|||
27593351|NCT02564523|80352302|FG002|Overall Study|Physician Decision|0|||
27593352|NCT02564523|80352303|FG003|Overall Study|Physician Decision|0|||
27593353|NCT02564523|80352304|FG004|Overall Study|Physician Decision|1|||
27593354|NCT02564523|80352305|FG005|Overall Study|Physician Decision|0|||
27593355|NCT02564523|80352306|FG006|Overall Study|Physician Decision|0|||
27593356|NCT02564523|80352307|FG007|Overall Study|Physician Decision|0|||
27593357|NCT02564523|80352308|FG008|Overall Study|Physician Decision|0|||
27593358|NCT02564523|80352309|FG009|Overall Study|Physician Decision|0|||
27593359|NCT02564523|80352310|FG010|Overall Study|Physician Decision|1|||
27593360|NCT02564523|80352311|FG011|Overall Study|Physician Decision|0|||
27593361|NCT02564523|80352312|FG012|Overall Study|Physician Decision|0|||
27593362|NCT02564523|80352313|FG013|Overall Study|Physician Decision|0|||
27593363|NCT02564523|80352314|FG014|Overall Study|Physician Decision|0|||
27593364|NCT02564523|80352315|FG015|Overall Study|Physician Decision|0|||
27593365|NCT02564523|80352316|FG016|Overall Study|Physician Decision|0|||
27593366|NCT02564523|80352317|FG017|Overall Study|Physician Decision|0|||
27593367|NCT02564523|80352300|FG000|Overall Study|Protocol Violation|2|||
27593368|NCT02564523|80352301|FG001|Overall Study|Protocol Violation|2|||
27593369|NCT02564523|80352302|FG002|Overall Study|Protocol Violation|5|||
27593370|NCT02564523|80352303|FG003|Overall Study|Protocol Violation|0|||
27593371|NCT02564523|80352304|FG004|Overall Study|Protocol Violation|1|||
27593372|NCT02564523|80352305|FG005|Overall Study|Protocol Violation|0|||
27593373|NCT02564523|80352306|FG006|Overall Study|Protocol Violation|0|||
27593374|NCT02564523|80352307|FG007|Overall Study|Protocol Violation|0|||
27593375|NCT02564523|80352308|FG008|Overall Study|Protocol Violation|0|||
27593376|NCT02564523|80352309|FG009|Overall Study|Protocol Violation|0|||
27593377|NCT02564523|80352310|FG010|Overall Study|Protocol Violation|0|||
27593378|NCT02564523|80352311|FG011|Overall Study|Protocol Violation|0|||
27593379|NCT02564523|80352312|FG012|Overall Study|Protocol Violation|0|||
27593380|NCT02564523|80352313|FG013|Overall Study|Protocol Violation|0|||
27593381|NCT02564523|80352314|FG014|Overall Study|Protocol Violation|0|||
27593382|NCT02564523|80352315|FG015|Overall Study|Protocol Violation|0|||
27593383|NCT02564523|80352316|FG016|Overall Study|Protocol Violation|0|||
27593384|NCT02564523|80352317|FG017|Overall Study|Protocol Violation|0|||
27593385|NCT02564523|80352300|FG000|Overall Study|Other|3|||
27593386|NCT02564523|80352301|FG001|Overall Study|Other|0|||
27593387|NCT02564523|80352302|FG002|Overall Study|Other|0|||
27593388|NCT02564523|80352303|FG003|Overall Study|Other|1|||
27593389|NCT02564523|80352304|FG004|Overall Study|Other|0|||
27593390|NCT02564523|80352305|FG005|Overall Study|Other|0|||
27593391|NCT02564523|80352306|FG006|Overall Study|Other|0|||
27593392|NCT02564523|80352307|FG007|Overall Study|Other|0|||
27593393|NCT02564523|80352308|FG008|Overall Study|Other|0|||
27593394|NCT02564523|80352309|FG009|Overall Study|Other|0|||
27593395|NCT02564523|80352310|FG010|Overall Study|Other|0|||
27593396|NCT02564523|80352311|FG011|Overall Study|Other|0|||
27593397|NCT02564523|80352312|FG012|Overall Study|Other|0|||
27593398|NCT02564523|80352313|FG013|Overall Study|Other|0|||
27593399|NCT02564523|80352314|FG014|Overall Study|Other|0|||
27593400|NCT02564523|80352315|FG015|Overall Study|Other|0|||
27593401|NCT02564523|80352316|FG016|Overall Study|Other|0|||
27593402|NCT02564523|80352317|FG017|Overall Study|Other|0|||
27593403|NCT00605293|80352318|FG000|Overall Study|Death|2|||
27593404|NCT00605293|80352319|FG001|Overall Study|Death|1|||
27593405|NCT00605293|80352318|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27593406|NCT00605293|80352319|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27593407|NCT00605293|80352318|FG000|Overall Study|Adverse Event|1|||
27593408|NCT00605293|80352319|FG001|Overall Study|Adverse Event|0|||
27593409|NCT00605293|80352318|FG000|Overall Study|Holidays Dialysis Out|1|||
27593410|NCT00605293|80352319|FG001|Overall Study|Holidays Dialysis Out|0|||
27593411|NCT00605293|80352318|FG000|Overall Study|Blood Transfusion|7|||
27593412|NCT00605293|80352319|FG001|Overall Study|Blood Transfusion|1|||
27821528|NCT02024932|81179018|FG001|Overall Study|Adverse Event|3|||
27593413|NCT00605293|80352318|FG000|Overall Study|Renal Transplantation|3|||
27593414|NCT00605293|80352319|FG001|Overall Study|Renal Transplantation|1|||
27593415|NCT00605293|80352318|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
27593416|NCT00605293|80352319|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
27593417|NCT00605293|80352318|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
27593418|NCT00605293|80352319|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
27593419|NCT00605293|80352318|FG000|Overall Study|Principal Investigator Decision|0|||
27593420|NCT00605293|80352319|FG001|Overall Study|Principal Investigator Decision|1|||
27593421|NCT00092534|80352320|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
27593422|NCT00092534|80352321|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
27593423|NCT00092534|80352322|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27593424|NCT00092534|80352323|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27593425|NCT00092534|80352324|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27593426|NCT00092534|80352320|FG000|Base Study Vaccination Period|Adverse Event|3|||
27593427|NCT00092534|80352321|FG001|Base Study Vaccination Period|Adverse Event|1|||
27593428|NCT00092534|80352322|FG002|Base Study Vaccination Period|Adverse Event|0|||
27593429|NCT00092534|80352323|FG003|Base Study Vaccination Period|Adverse Event|0|||
27593430|NCT00092534|80352324|FG004|Base Study Vaccination Period|Adverse Event|0|||
27593431|NCT00092534|80352320|FG000|Base Study Vaccination Period|Death|5|||
27593432|NCT00092534|80352321|FG001|Base Study Vaccination Period|Death|4|||
27593433|NCT00092534|80352322|FG002|Base Study Vaccination Period|Death|0|||
27593434|NCT00092534|80352323|FG003|Base Study Vaccination Period|Death|0|||
27593435|NCT00092534|80352324|FG004|Base Study Vaccination Period|Death|0|||
27593436|NCT00092534|80352320|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
27593437|NCT00092534|80352321|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
27593438|NCT00092534|80352322|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
27593439|NCT00092534|80352323|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
27593440|NCT00092534|80352324|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
27593441|NCT00092534|80352320|FG000|Base Study Vaccination Period|Physician Decision|1|||
27593442|NCT00092534|80352321|FG001|Base Study Vaccination Period|Physician Decision|0|||
27593443|NCT00092534|80352322|FG002|Base Study Vaccination Period|Physician Decision|0|||
27593444|NCT00092534|80352323|FG003|Base Study Vaccination Period|Physician Decision|0|||
27593445|NCT00092534|80352324|FG004|Base Study Vaccination Period|Physician Decision|0|||
27593446|NCT00092534|80352320|FG000|Base Study Vaccination Period|Pregnancy|9|||
27593447|NCT00092534|80352321|FG001|Base Study Vaccination Period|Pregnancy|7|||
27593448|NCT00092534|80352322|FG002|Base Study Vaccination Period|Pregnancy|0|||
27593449|NCT00092534|80352323|FG003|Base Study Vaccination Period|Pregnancy|0|||
27593450|NCT00092534|80352324|FG004|Base Study Vaccination Period|Pregnancy|0|||
27593451|NCT00092534|80352320|FG000|Base Study Vaccination Period|Protocol Violation|2|||
27593452|NCT00092534|80352321|FG001|Base Study Vaccination Period|Protocol Violation|1|||
27593453|NCT00092534|80352322|FG002|Base Study Vaccination Period|Protocol Violation|0|||
27593454|NCT00092534|80352323|FG003|Base Study Vaccination Period|Protocol Violation|0|||
27693997|NCT00971243|80716599|FG001|Open-label Period|Withdrawal by Subject|0|||
27693998|NCT00971243|80716600|FG002|Open-label Period|Withdrawal by Subject|0|||
27693999|NCT00971243|80716601|FG003|Open-label Period|Withdrawal by Subject|2|||
27694000|NCT00971243|80716602|FG004|Open-label Period|Withdrawal by Subject|1|||
27881901|NCT00135512|81401006|FG000|Overall Study|Lack of Efficacy|25|||
27881902|NCT00135512|81401006|FG000|Overall Study|Other|42|||
27881903|NCT00831311|81401008|FG000|Overall Study|Definitive Contraindication|3|||
27881904|NCT00831311|81401009|FG001|Overall Study|Definitive Contraindication|3|||
27881905|NCT00831311|81401008|FG000|Overall Study|Lost to Follow-up|3|||
27881906|NCT00831311|81401009|FG001|Overall Study|Lost to Follow-up|0|||
27881907|NCT00831311|81401008|FG000|Overall Study|Physician Decision|0|||
27881908|NCT00831311|81401009|FG001|Overall Study|Physician Decision|1|||
27694001|NCT00971243|80716598|FG000|Open-label Period|Other reason|0|||
27694002|NCT00971243|80716599|FG001|Open-label Period|Other reason|0|||
27881909|NCT00831311|81401008|FG000|Overall Study|Withdrawal by Subject|6|||
27881910|NCT00831311|81401009|FG001|Overall Study|Withdrawal by Subject|4|||
27593455|NCT00092534|80352324|FG004|Base Study Vaccination Period|Protocol Violation|0|||
27694003|NCT00971243|80716600|FG002|Open-label Period|Other reason|0|||
27881911|NCT00552396|81401015|FG000|Overall Study|protocol withdrawal criteria|3|||
27694004|NCT00971243|80716601|FG003|Open-label Period|Other reason|0|||
27593456|NCT00092534|80352320|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
27593457|NCT00092534|80352321|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
27593458|NCT00092534|80352322|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
27593459|NCT00092534|80352323|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
27593460|NCT00092534|80352324|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
27593461|NCT00092534|80352320|FG000|Base Study Vaccination Period|Moved|14|||
27593462|NCT00092534|80352321|FG001|Base Study Vaccination Period|Moved|12|||
27593463|NCT00092534|80352322|FG002|Base Study Vaccination Period|Moved|0|||
27593464|NCT00092534|80352323|FG003|Base Study Vaccination Period|Moved|0|||
27593465|NCT00092534|80352324|FG004|Base Study Vaccination Period|Moved|0|||
27593466|NCT00092534|80352320|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
27593467|NCT00092534|80352321|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
27593468|NCT00092534|80352322|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
27593469|NCT00092534|80352323|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
27593470|NCT00092534|80352324|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
27694005|NCT00971243|80716602|FG004|Open-label Period|Other reason|2|||
27694006|NCT01919814|80716604|FG000|Overall Study|Adverse Event|1|||
27694007|NCT01919814|80716605|FG001|Overall Study|Adverse Event|0|||
27694008|NCT01919814|80716604|FG000|Overall Study|Protocol Violation|1|||
27694009|NCT01919814|80716605|FG001|Overall Study|Protocol Violation|0|||
27694010|NCT01919814|80716604|FG000|Overall Study|Withdrawal by Subject|1|||
27694011|NCT01919814|80716605|FG001|Overall Study|Withdrawal by Subject|0|||
27694012|NCT00759915|80716606|FG000|Overall Study|Withdrawal by Subject|1|||
27694013|NCT00759915|80716607|FG001|Overall Study|Withdrawal by Subject|0|||
27694014|NCT00759915|80716606|FG000|Overall Study|Adverse Event|0|||
27694015|NCT00759915|80716607|FG001|Overall Study|Adverse Event|1|||
27694016|NCT00810394|80716612|FG000|Overall Study|Withdrawal by Subject|3|||
27694017|NCT00744523|80716613|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
27694018|NCT00744523|80716614|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
27694019|NCT00971932|80716615|FG000|Overall Study|Withdrawal by Subject|1|||
27694020|NCT00971932|80716615|FG000|Overall Study|Investigator's decision|2|||
27694021|NCT00971932|80716615|FG000|Overall Study|Ongoing|4|||
27694022|NCT03513588|80716619|FG000|Overall Study|Lost to Follow-up|0|||
27694023|NCT03513588|80716620|FG001|Overall Study|Lost to Follow-up|1|||
27694024|NCT03513588|80716621|FG002|Overall Study|Lost to Follow-up|1|||
27694025|NCT03513588|80716619|FG000|Overall Study|Study dosing paused by sponsor|1|||
27694026|NCT03513588|80716620|FG001|Overall Study|Study dosing paused by sponsor|1|||
27694027|NCT03513588|80716621|FG002|Overall Study|Study dosing paused by sponsor|0|||
27694028|NCT03513588|80716619|FG000|Overall Study|Death|0|||
27694029|NCT03513588|80716620|FG001|Overall Study|Death|0|||
27694030|NCT03513588|80716621|FG002|Overall Study|Death|1|||
27694031|NCT01201317|80716622|FG000|Overall Study|Withdrawal by Subject|5|||
27821529|NCT02024932|81179019|FG002|Overall Study|Adverse Event|0|||
27821530|NCT02024932|81179020|FG003|Overall Study|Adverse Event|0|||
27821531|NCT02024932|81179021|FG004|Overall Study|Adverse Event|2|||
27821532|NCT02024932|81179022|FG005|Overall Study|Adverse Event|0|||
27821533|NCT02024932|81179017|FG000|Overall Study|Abnormal laboratory value|0|||
27821534|NCT02024932|81179018|FG001|Overall Study|Abnormal laboratory value|0|||
27821535|NCT02024932|81179019|FG002|Overall Study|Abnormal laboratory value|0|||
27694032|NCT01201317|80716623|FG001|Overall Study|Withdrawal by Subject|0|||
27821536|NCT02024932|81179020|FG003|Overall Study|Abnormal laboratory value|2|||
27821537|NCT02024932|81179021|FG004|Overall Study|Abnormal laboratory value|0|||
27821538|NCT02024932|81179022|FG005|Overall Study|Abnormal laboratory value|0|||
27821539|NCT02336165|81179023|FG000|Overall Study|Death|3|||
27694033|NCT01201317|80716624|FG002|Overall Study|Withdrawal by Subject|3|||
27694034|NCT01201317|80716622|FG000|Overall Study|Adverse Event|2|||
27694035|NCT01201317|80716623|FG001|Overall Study|Adverse Event|2|||
27694036|NCT01201317|80716624|FG002|Overall Study|Adverse Event|2|||
27821540|NCT02336165|81179024|FG001|Overall Study|Death|0|||
27821541|NCT02336165|81179025|FG002|Overall Study|Death|0|||
27821542|NCT02336165|81179026|FG003|Overall Study|Death|0|||
27881912|NCT00552396|81401016|FG001|Overall Study|protocol withdrawal criteria|3|||
27881913|NCT00552396|81401017|FG002|Overall Study|protocol withdrawal criteria|3|||
27881914|NCT00552396|81401018|FG003|Overall Study|protocol withdrawal criteria|6|||
27881915|NCT00552396|81401019|FG004|Overall Study|protocol withdrawal criteria|3|||
27881916|NCT00552396|81401020|FG005|Overall Study|protocol withdrawal criteria|3|||
27881917|NCT00552396|81401021|FG006|Overall Study|protocol withdrawal criteria|9|||
27881918|NCT00766636|81401022|FG000|Overall Study|Withdrawal by Subject|1|||
27881919|NCT00766636|81401023|FG001|Overall Study|Withdrawal by Subject|1|||
27881920|NCT00766636|81401022|FG000|Overall Study|Incomplete Treatment|0|||
27881921|NCT00766636|81401023|FG001|Overall Study|Incomplete Treatment|1|||
27881922|NCT00766636|81401022|FG000|Overall Study|Adverse Event|1|||
27881923|NCT00766636|81401023|FG001|Overall Study|Adverse Event|0|||
27881924|NCT00766636|81401022|FG000|Overall Study|Disease Progression|1|||
27881925|NCT00766636|81401023|FG001|Overall Study|Disease Progression|0|||
27881926|NCT04164732|81401024|FG000|Treatment run-in Period|Adverse Event|4|||
27881927|NCT04164732|81401025|FG001|Treatment run-in Period|Adverse Event|0|||
27881928|NCT04164732|81401026|FG002|Treatment run-in Period|Adverse Event|0|||
27881929|NCT04164732|81401024|FG000|Treatment run-in Period|Physician Decision|1|||
27881930|NCT04164732|81401025|FG001|Treatment run-in Period|Physician Decision|0|||
27881931|NCT04164732|81401026|FG002|Treatment run-in Period|Physician Decision|0|||
27881932|NCT04164732|81401024|FG000|Treatment run-in Period|Screen Failure|1|||
27881933|NCT04164732|81401025|FG001|Treatment run-in Period|Screen Failure|0|||
27881934|NCT04164732|81401026|FG002|Treatment run-in Period|Screen Failure|0|||
27881935|NCT04164732|81401024|FG000|Randomized Treatment Period|Adverse Event|0|||
27881936|NCT04164732|81401025|FG001|Randomized Treatment Period|Adverse Event|1|||
27881937|NCT04164732|81401026|FG002|Randomized Treatment Period|Adverse Event|0|||
27881938|NCT04164732|81401024|FG000|Randomized Treatment Period|Protocol Deviation|0|||
27881939|NCT04164732|81401025|FG001|Randomized Treatment Period|Protocol Deviation|1|||
27881940|NCT04164732|81401026|FG002|Randomized Treatment Period|Protocol Deviation|1|||
27593471|NCT00092534|80352320|FG000|Base Study Vaccination Period|Travel|1|||
27593472|NCT00092534|80352321|FG001|Base Study Vaccination Period|Travel|0|||
27593473|NCT00092534|80352322|FG002|Base Study Vaccination Period|Travel|0|||
27593474|NCT00092534|80352323|FG003|Base Study Vaccination Period|Travel|0|||
27593475|NCT00092534|80352324|FG004|Base Study Vaccination Period|Travel|0|||
27593476|NCT00092534|80352320|FG000|Base Study Vaccination Period|Site Closed|0|||
27593477|NCT00092534|80352321|FG001|Base Study Vaccination Period|Site Closed|1|||
27593478|NCT00092534|80352322|FG002|Base Study Vaccination Period|Site Closed|0|||
27593479|NCT00092534|80352323|FG003|Base Study Vaccination Period|Site Closed|0|||
27593480|NCT00092534|80352324|FG004|Base Study Vaccination Period|Site Closed|0|||
27593481|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Adverse Event|2|||
27881941|NCT04164732|81401024|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
27881942|NCT04164732|81401025|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
27881943|NCT04164732|81401026|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
27593482|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Adverse Event|4|||
27593483|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Adverse Event|0|||
27593484|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Adverse Event|0|||
27881944|NCT03321968|81401027|FG000|Overall Study|Withdrawal by Subject|1|||
27881945|NCT03321968|81401028|FG001|Overall Study|Withdrawal by Subject|2|||
27881946|NCT03321968|81401029|FG002|Overall Study|Withdrawal by Subject|1|||
27593485|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Adverse Event|0|||
27593486|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Death|2|||
27593487|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Death|1|||
27593488|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Death|0|||
27593489|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Death|0|||
27593490|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Death|0|||
27593491|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
27593492|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
27593493|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
27593494|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
27593495|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
27593496|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Pregnancy|6|||
27593497|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Pregnancy|10|||
27593498|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Pregnancy|0|||
27593499|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Pregnancy|0|||
27593500|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Pregnancy|0|||
27593501|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
27593502|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
27593503|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
27694037|NCT01201317|80716622|FG000|Overall Study|Screen failure|1|||
27593504|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
27593505|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
27694038|NCT01201317|80716623|FG001|Overall Study|Screen failure|1|||
27694039|NCT01201317|80716624|FG002|Overall Study|Screen failure|0|||
27881947|NCT03321968|81401027|FG000|Overall Study|Lost to Follow-up|2|||
27881948|NCT03321968|81401028|FG001|Overall Study|Lost to Follow-up|0|||
27881949|NCT03321968|81401029|FG002|Overall Study|Lost to Follow-up|1|||
27881950|NCT03321968|81401027|FG000|Overall Study|Other than specified|0|||
27881951|NCT03321968|81401028|FG001|Overall Study|Other than specified|0|||
27881952|NCT03321968|81401029|FG002|Overall Study|Other than specified|1|||
27881953|NCT03806933|81401032|FG000|Main Period|Physician Decision|0|||
27881954|NCT03806933|81401033|FG001|Main Period|Physician Decision|0|||
27881955|NCT03806933|81401034|FG002|Main Period|Physician Decision|0|||
27881956|NCT03806933|81401035|FG003|Main Period|Physician Decision|1|||
27881957|NCT03806933|81401032|FG000|Main Period|Pregnancy|0|||
27881958|NCT03806933|81401033|FG001|Main Period|Pregnancy|0|||
27881959|NCT03806933|81401034|FG002|Main Period|Pregnancy|1|||
27881960|NCT03806933|81401035|FG003|Main Period|Pregnancy|0|||
27881961|NCT03806933|81401032|FG000|Main Period|Withdrawal by Subject|2|||
27881962|NCT03806933|81401033|FG001|Main Period|Withdrawal by Subject|1|||
27881963|NCT03806933|81401034|FG002|Main Period|Withdrawal by Subject|1|||
27881964|NCT03806933|81401035|FG003|Main Period|Withdrawal by Subject|2|||
27881965|NCT03806933|81401032|FG000|Main Period|Lost to Follow-up|2|||
27881966|NCT03806933|81401033|FG001|Main Period|Lost to Follow-up|2|||
27881967|NCT03806933|81401034|FG002|Main Period|Lost to Follow-up|0|||
27881968|NCT03806933|81401035|FG003|Main Period|Lost to Follow-up|0|||
27881969|NCT03806933|81401032|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
27881970|NCT03806933|81401033|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
27881971|NCT03806933|81401034|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
27821543|NCT02336165|81179027|FG004|Overall Study|Death|1|||
27821544|NCT02336165|81179023|FG000|Overall Study|Physician Decision|2|||
27821545|NCT02336165|81179024|FG001|Overall Study|Physician Decision|2|||
27821546|NCT02336165|81179025|FG002|Overall Study|Physician Decision|1|||
27821547|NCT02336165|81179026|FG003|Overall Study|Physician Decision|1|||
27821548|NCT02336165|81179027|FG004|Overall Study|Physician Decision|0|||
27821549|NCT02336165|81179023|FG000|Overall Study|Withdrawal by Subject|0|||
27821550|NCT02336165|81179024|FG001|Overall Study|Withdrawal by Subject|0|||
27821551|NCT02336165|81179025|FG002|Overall Study|Withdrawal by Subject|1|||
27821552|NCT02336165|81179026|FG003|Overall Study|Withdrawal by Subject|0|||
27821553|NCT02336165|81179027|FG004|Overall Study|Withdrawal by Subject|1|||
27821554|NCT02336165|81179023|FG000|Overall Study|Adverse Event|4|||
27593506|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
27593507|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
27593508|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
27593509|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
27593510|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
27593511|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Moved|62|||
27593512|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Moved|58|||
27821555|NCT02336165|81179024|FG001|Overall Study|Adverse Event|1|||
27821556|NCT02336165|81179025|FG002|Overall Study|Adverse Event|2|||
27821557|NCT02336165|81179026|FG003|Overall Study|Adverse Event|4|||
27821558|NCT02336165|81179027|FG004|Overall Study|Adverse Event|1|||
27821559|NCT02336165|81179023|FG000|Overall Study|Progressive disease|23|||
27821560|NCT02336165|81179024|FG001|Overall Study|Progressive disease|22|||
27593513|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Moved|0|||
27821561|NCT02336165|81179025|FG002|Overall Study|Progressive disease|27|||
27821562|NCT02336165|81179026|FG003|Overall Study|Progressive disease|24|||
27821563|NCT02336165|81179027|FG004|Overall Study|Progressive disease|19|||
27593514|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Moved|0|||
27821564|NCT02336165|81179023|FG000|Overall Study|Non-compliance|1|||
27821565|NCT02336165|81179024|FG001|Overall Study|Non-compliance|0|||
27821566|NCT02336165|81179025|FG002|Overall Study|Non-compliance|0|||
27593515|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Moved|0|||
27593516|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Travel|10|||
27593517|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Travel|7|||
27593518|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Travel|0|||
27593519|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Travel|0|||
27593520|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Travel|0|||
27593521|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Site Closed|0|||
27593522|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Site Closed|2|||
27593523|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Site Closed|0|||
27593524|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Site Closed|0|||
27593525|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Site Closed|0|||
27593526|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
27593527|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
27593528|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
27593529|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
27593530|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
27593531|NCT00092534|80352320|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
27593532|NCT00092534|80352321|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
27593533|NCT00092534|80352322|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
27593534|NCT00092534|80352323|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
27593535|NCT00092534|80352324|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
27593536|NCT00092534|80352320|FG000|Base Study EXT|Lost to Follow-up|0|||
27593537|NCT00092534|80352321|FG001|Base Study EXT|Lost to Follow-up|0|||
27593538|NCT00092534|80352322|FG002|Base Study EXT|Lost to Follow-up|41|||
27593539|NCT00092534|80352323|FG003|Base Study EXT|Lost to Follow-up|0|||
27593540|NCT00092534|80352324|FG004|Base Study EXT|Lost to Follow-up|0|||
27593541|NCT00092534|80352320|FG000|Base Study EXT|Physician Decision|0|||
27593542|NCT00092534|80352321|FG001|Base Study EXT|Physician Decision|0|||
27593543|NCT00092534|80352322|FG002|Base Study EXT|Physician Decision|1|||
27593544|NCT00092534|80352323|FG003|Base Study EXT|Physician Decision|0|||
27593545|NCT00092534|80352324|FG004|Base Study EXT|Physician Decision|0|||
27593546|NCT00092534|80352320|FG000|Base Study EXT|Pregnancy|0|||
27821567|NCT02336165|81179026|FG003|Overall Study|Non-compliance|1|||
27821568|NCT02336165|81179027|FG004|Overall Study|Non-compliance|0|||
27821569|NCT02336165|81179023|FG000|Overall Study|Other|1|||
27821570|NCT02336165|81179024|FG001|Overall Study|Other|0|||
27821571|NCT02336165|81179025|FG002|Overall Study|Other|0|||
27821572|NCT02336165|81179026|FG003|Overall Study|Other|1|||
27821573|NCT02336165|81179027|FG004|Overall Study|Other|0|||
27821574|NCT00905840|81179028|FG000|Overall Study|Lost to Follow-up|11|||
27821575|NCT00905840|81179028|FG000|Overall Study|Death|3|||
27821576|NCT00905840|81179028|FG000|Overall Study|Withdrawal by Subject|1|||
27821577|NCT00905840|81179028|FG000|Overall Study|Adverse Event|1|||
27821578|NCT03552393|81179029|FG000|Core Period|Kidney Transplant|1|||
27821579|NCT03552393|81179029|FG000|Core Period|Prohibited Medication|1|||
27821580|NCT03552393|81179029|FG000|Safety Extension Period|Kidney Transplant|4|||
27821581|NCT02373098|81179030|FG000|Overall Study|Lost to Follow-up|1|||
27821582|NCT02373098|81179031|FG001|Overall Study|Lost to Follow-up|0|||
27821583|NCT02373098|81179030|FG000|Overall Study|Protocol Violation|3|||
27821584|NCT02373098|81179031|FG001|Overall Study|Protocol Violation|0|||
27821585|NCT02373098|81179030|FG000|Overall Study|Withdrawal by Subject|5|||
27821586|NCT02373098|81179031|FG001|Overall Study|Withdrawal by Subject|0|||
27881972|NCT03806933|81401035|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
27881973|NCT00818766|81401039|FG000|Overall Study|Could not be Contacted on Day 28|11|||
27881974|NCT00818766|81401040|FG001|Overall Study|Could not be Contacted on Day 28|10|||
27881975|NCT00818766|81401039|FG000|Overall Study|Death|1|||
27821587|NCT02373098|81179030|FG000|Overall Study|Adverse Event|3|||
27821588|NCT02373098|81179031|FG001|Overall Study|Adverse Event|0|||
27821589|NCT00625443|81179034|FG000|Overall Study|Adverse Event|1|||
27821590|NCT00625443|81179035|FG001|Overall Study|Adverse Event|4|||
27881976|NCT00818766|81401040|FG001|Overall Study|Death|0|||
27881977|NCT00818766|81401039|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
27881978|NCT00818766|81401040|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
27821591|NCT00625443|81179036|FG002|Overall Study|Adverse Event|0|||
27821592|NCT00625443|81179034|FG000|Overall Study|Non-compliance with protocol|0|||
27821593|NCT00625443|81179035|FG001|Overall Study|Non-compliance with protocol|1|||
27881979|NCT01757184|81401041|FG000|Double-blind Period|Adverse Event|1|||
27821594|NCT00625443|81179036|FG002|Overall Study|Non-compliance with protocol|0|||
27821595|NCT00625443|81179034|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
27821596|NCT00625443|81179035|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
27821597|NCT00625443|81179036|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
27821598|NCT00625443|81179034|FG000|Overall Study|Withdrawal by Subject|0|||
27821599|NCT00625443|81179035|FG001|Overall Study|Withdrawal by Subject|1|||
27821600|NCT00625443|81179036|FG002|Overall Study|Withdrawal by Subject|2|||
27821601|NCT00625443|81179034|FG000|Overall Study|Physician Decision|0|||
27821602|NCT00625443|81179035|FG001|Overall Study|Physician Decision|4|||
27821603|NCT00625443|81179036|FG002|Overall Study|Physician Decision|2|||
27821604|NCT00625443|81179034|FG000|Overall Study|Other|0|||
27821605|NCT00625443|81179035|FG001|Overall Study|Other|1|||
27821606|NCT00625443|81179036|FG002|Overall Study|Other|1|||
27821607|NCT01248247|81179039|FG000|Overall Study|Adverse Event|2|||
27821608|NCT01248247|81179040|FG001|Overall Study|Adverse Event|4|||
27821609|NCT01248247|81179041|FG002|Overall Study|Adverse Event|4|||
27821610|NCT01248247|81179042|FG003|Overall Study|Adverse Event|2|||
27821611|NCT01248247|81179039|FG000|Overall Study|Death|0|||
27821612|NCT01248247|81179040|FG001|Overall Study|Death|1|||
27821613|NCT01248247|81179041|FG002|Overall Study|Death|4|||
27821614|NCT01248247|81179042|FG003|Overall Study|Death|7|||
27821615|NCT01248247|81179039|FG000|Overall Study|Lost to Follow-up|0|||
27821616|NCT01248247|81179040|FG001|Overall Study|Lost to Follow-up|1|||
27821617|NCT01248247|81179041|FG002|Overall Study|Lost to Follow-up|1|||
27821618|NCT01248247|81179042|FG003|Overall Study|Lost to Follow-up|0|||
27821619|NCT01248247|81179039|FG000|Overall Study|Alternative treatment|0|||
27821620|NCT01248247|81179040|FG001|Overall Study|Alternative treatment|1|||
27593547|NCT00092534|80352321|FG001|Base Study EXT|Pregnancy|0|||
27593548|NCT00092534|80352322|FG002|Base Study EXT|Pregnancy|12|||
27593549|NCT00092534|80352323|FG003|Base Study EXT|Pregnancy|0|||
27593550|NCT00092534|80352324|FG004|Base Study EXT|Pregnancy|0|||
27593551|NCT00092534|80352320|FG000|Base Study EXT|Withdrawal by Subject|0|||
27881980|NCT01757184|81401042|FG001|Double-blind Period|Adverse Event|0|||
27593552|NCT00092534|80352321|FG001|Base Study EXT|Withdrawal by Subject|0|||
27593553|NCT00092534|80352322|FG002|Base Study EXT|Withdrawal by Subject|18|||
27821621|NCT01248247|81179041|FG002|Overall Study|Alternative treatment|0|||
27821622|NCT01248247|81179042|FG003|Overall Study|Alternative treatment|0|||
27821623|NCT01248247|81179039|FG000|Overall Study|Other|2|||
27821624|NCT01248247|81179040|FG001|Overall Study|Other|8|||
27821625|NCT01248247|81179041|FG002|Overall Study|Other|8|||
27593554|NCT00092534|80352323|FG003|Base Study EXT|Withdrawal by Subject|0|||
27593555|NCT00092534|80352324|FG004|Base Study EXT|Withdrawal by Subject|0|||
27593556|NCT00092534|80352320|FG000|Base Study EXT|Participant moved|0|||
27593557|NCT00092534|80352321|FG001|Base Study EXT|Participant moved|0|||
27593558|NCT00092534|80352322|FG002|Base Study EXT|Participant moved|6|||
27593559|NCT00092534|80352323|FG003|Base Study EXT|Participant moved|0|||
27593560|NCT00092534|80352324|FG004|Base Study EXT|Participant moved|0|||
27593561|NCT00092534|80352320|FG000|Base Study EXT|Travel|0|||
27593562|NCT00092534|80352321|FG001|Base Study EXT|Travel|0|||
27593563|NCT00092534|80352322|FG002|Base Study EXT|Travel|2|||
27593564|NCT00092534|80352323|FG003|Base Study EXT|Travel|0|||
27593565|NCT00092534|80352324|FG004|Base Study EXT|Travel|0|||
27593566|NCT00092534|80352320|FG000|Base Study EXT|Site closed|0|||
27593567|NCT00092534|80352321|FG001|Base Study EXT|Site closed|0|||
27881981|NCT01757184|81401043|FG002|Double-blind Period|Adverse Event|0|||
27881982|NCT01757184|81401044|FG003|Double-blind Period|Adverse Event|0|||
27881983|NCT01757184|81401041|FG000|Open-label Period|Lost to Follow-up|0|||
27881984|NCT01757184|81401042|FG001|Open-label Period|Lost to Follow-up|0|||
27881985|NCT01757184|81401043|FG002|Open-label Period|Lost to Follow-up|2|||
27881986|NCT01757184|81401044|FG003|Open-label Period|Lost to Follow-up|0|||
27881987|NCT01757184|81401041|FG000|Open-label Period|Withdrawal by Subject|0|||
27881988|NCT01757184|81401042|FG001|Open-label Period|Withdrawal by Subject|0|||
27881989|NCT01757184|81401043|FG002|Open-label Period|Withdrawal by Subject|1|||
27881990|NCT01757184|81401044|FG003|Open-label Period|Withdrawal by Subject|1|||
27881991|NCT01757184|81401041|FG000|Open-label Period|Discontinued by Sponsor|0|||
27881992|NCT01757184|81401042|FG001|Open-label Period|Discontinued by Sponsor|0|||
27881993|NCT01757184|81401043|FG002|Open-label Period|Discontinued by Sponsor|1|||
27881994|NCT01757184|81401044|FG003|Open-label Period|Discontinued by Sponsor|2|||
27881995|NCT01996254|81401046|FG000|Overall Study|Change in Eligibility|0|||
27881996|NCT01996254|81401047|FG001|Overall Study|Change in Eligibility|2|||
27881997|NCT01996254|81401048|FG002|Overall Study|Change in Eligibility|0|||
27881998|NCT01996254|81401046|FG000|Overall Study|Withdrawal by Subject|0|||
27881999|NCT01996254|81401047|FG001|Overall Study|Withdrawal by Subject|3|||
27882000|NCT01996254|81401048|FG002|Overall Study|Withdrawal by Subject|4|||
27593568|NCT00092534|80352322|FG002|Base Study EXT|Site closed|21|||
27694040|NCT01201317|80716622|FG000|Overall Study|Protocol Violation|0|||
27593569|NCT00092534|80352323|FG003|Base Study EXT|Site closed|0|||
27593570|NCT00092534|80352324|FG004|Base Study EXT|Site closed|0|||
27593571|NCT00092534|80352320|FG000|Base Study EXT|Study ended|0|||
27593572|NCT00092534|80352321|FG001|Base Study EXT|Study ended|0|||
27593573|NCT00092534|80352322|FG002|Base Study EXT|Study ended|29|||
27882001|NCT01996254|81401046|FG000|Overall Study|Lost to Follow-up|1|||
27882002|NCT01996254|81401047|FG001|Overall Study|Lost to Follow-up|0|||
27593574|NCT00092534|80352323|FG003|Base Study EXT|Study ended|0|||
27882003|NCT01996254|81401048|FG002|Overall Study|Lost to Follow-up|4|||
27882004|NCT03318861|81401049|FG000|Overall Study|Death|2|||
27593575|NCT00092534|80352324|FG004|Base Study EXT|Study ended|0|||
27593576|NCT00092534|80352320|FG000|Base Study EXT|Protocol Violation|0|||
27821626|NCT01248247|81179042|FG003|Overall Study|Other|5|||
27821627|NCT01248247|81179039|FG000|Overall Study|Progression|18|||
27821628|NCT01248247|81179040|FG001|Overall Study|Progression|27|||
27821629|NCT01248247|81179041|FG002|Overall Study|Progression|56|||
27821630|NCT01248247|81179042|FG003|Overall Study|Progression|44|||
27821631|NCT01248247|81179039|FG000|Overall Study|Refuse further treatment|0|||
27821632|NCT01248247|81179040|FG001|Overall Study|Refuse further treatment|0|||
27821633|NCT01248247|81179041|FG002|Overall Study|Refuse further treatment|1|||
27882005|NCT03318861|81401050|FG001|Overall Study|Death|3|||
27882006|NCT03318861|81401051|FG002|Overall Study|Death|3|||
27882007|NCT03318861|81401052|FG003|Overall Study|Death|2|||
27882008|NCT03318861|81401053|FG004|Overall Study|Death|2|||
27882009|NCT03318861|81401049|FG000|Overall Study|Enrolled But Never Treated|0|||
27882010|NCT03318861|81401050|FG001|Overall Study|Enrolled But Never Treated|1|||
27882011|NCT03318861|81401051|FG002|Overall Study|Enrolled But Never Treated|0|||
27882012|NCT03318861|81401052|FG003|Overall Study|Enrolled But Never Treated|1|||
27882013|NCT03318861|81401053|FG004|Overall Study|Enrolled But Never Treated|1|||
27882014|NCT03318861|81401049|FG000|Overall Study|Informed Consent Withdraw|0|||
27882015|NCT03318861|81401050|FG001|Overall Study|Informed Consent Withdraw|0|||
27882016|NCT03318861|81401051|FG002|Overall Study|Informed Consent Withdraw|0|||
27882017|NCT03318861|81401052|FG003|Overall Study|Informed Consent Withdraw|1|||
27882018|NCT03318861|81401053|FG004|Overall Study|Informed Consent Withdraw|0|||
27882019|NCT03318861|81401049|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
27882020|NCT03318861|81401050|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
27882021|NCT03318861|81401051|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
27882022|NCT03318861|81401052|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
27882023|NCT03318861|81401053|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
27882024|NCT02729051|81401055|FG000|Overall Study|Adverse Event|21|||
27882025|NCT02729051|81401056|FG001|Overall Study|Adverse Event|11|||
27882026|NCT02729051|81401055|FG000|Overall Study|Lack of Efficacy|1|||
27882027|NCT02729051|81401056|FG001|Overall Study|Lack of Efficacy|1|||
27882028|NCT02729051|81401055|FG000|Overall Study|Lost to Follow-up|1|||
27882029|NCT02729051|81401056|FG001|Overall Study|Lost to Follow-up|2|||
27694041|NCT01201317|80716623|FG001|Overall Study|Protocol Violation|1|||
27821634|NCT01248247|81179042|FG003|Overall Study|Refuse further treatment|2|||
27821635|NCT01248247|81179039|FG000|Overall Study|Complicating disease|0|||
27882030|NCT02729051|81401055|FG000|Overall Study|Physician Decision|1|||
27882031|NCT02729051|81401056|FG001|Overall Study|Physician Decision|1|||
27882032|NCT02729051|81401055|FG000|Overall Study|Withdrawal by Subject|6|||
27882033|NCT02729051|81401056|FG001|Overall Study|Withdrawal by Subject|17|||
27882034|NCT02780713|81401059|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27882035|NCT02780713|81401060|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27882036|NCT02780713|81401061|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
27882037|NCT02780713|81401062|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27882038|NCT02780713|81401063|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
27882039|NCT02887183|81401064|FG000|Overall Study|Adverse Event|44|||
27882040|NCT02887183|81401064|FG000|Overall Study|Death|30|||
27882041|NCT02887183|81401064|FG000|Overall Study|Pregnancy|1|||
27882042|NCT02887183|81401064|FG000|Overall Study|Protocol Violation|6|||
27882043|NCT02887183|81401064|FG000|Overall Study|Technical Problems|2|||
27882044|NCT02887183|81401064|FG000|Overall Study|Lost to Follow-up|13|||
27593577|NCT00092534|80352321|FG001|Base Study EXT|Protocol Violation|0|||
27882045|NCT02887183|81401064|FG000|Overall Study|Physician Decision|10|||
27882046|NCT02887183|81401064|FG000|Overall Study|Withdrawal by Subject|35|||
27882047|NCT04654468|81401067|FG000|Overall Study|Death|1|||
27882048|NCT04654468|81401067|FG000|Overall Study|Ongoing in the Study|50|||
27882049|NCT03809663|81401068|FG000|Overall Study|Decision by sponsor|24|||
27882050|NCT03809663|81401069|FG001|Overall Study|Decision by sponsor|18|||
27882051|NCT03809663|81401070|FG002|Overall Study|Decision by sponsor|20|||
27882052|NCT03809663|81401071|FG003|Overall Study|Decision by sponsor|20|||
27882053|NCT03809663|81401072|FG004|Overall Study|Decision by sponsor|0|||
27882054|NCT03809663|81401073|FG005|Overall Study|Decision by sponsor|0|||
27882055|NCT03809663|81401068|FG000|Overall Study|Withdrawal by Subject|26|||
27882056|NCT03809663|81401069|FG001|Overall Study|Withdrawal by Subject|22|||
27882057|NCT03809663|81401070|FG002|Overall Study|Withdrawal by Subject|27|||
27882058|NCT03809663|81401071|FG003|Overall Study|Withdrawal by Subject|26|||
27882059|NCT03809663|81401072|FG004|Overall Study|Withdrawal by Subject|0|||
27882060|NCT03809663|81401073|FG005|Overall Study|Withdrawal by Subject|0|||
27882061|NCT03809663|81401068|FG000|Overall Study|Lost to Follow-up|1|||
27882062|NCT03809663|81401069|FG001|Overall Study|Lost to Follow-up|4|||
27882063|NCT03809663|81401070|FG002|Overall Study|Lost to Follow-up|1|||
27882064|NCT03809663|81401071|FG003|Overall Study|Lost to Follow-up|1|||
27882065|NCT03809663|81401072|FG004|Overall Study|Lost to Follow-up|0|||
27882066|NCT03809663|81401073|FG005|Overall Study|Lost to Follow-up|0|||
27882067|NCT04707469|81401074|FG000|Overall Study|Site closure|0|||
27882068|NCT04707469|81401075|FG001|Overall Study|Site closure|2|||
27593578|NCT00092534|80352322|FG002|Base Study EXT|Protocol Violation|15|||
27694042|NCT01201317|80716624|FG002|Overall Study|Protocol Violation|1|||
27821636|NCT01248247|81179040|FG001|Overall Study|Complicating disease|0|||
27821637|NCT01248247|81179041|FG002|Overall Study|Complicating disease|1|||
27821638|NCT01248247|81179042|FG003|Overall Study|Complicating disease|1|||
27821639|NCT01199861|81179045|FG000|Overall Study|Administrative problems|1|||
27821640|NCT01199861|81179046|FG001|Overall Study|Administrative problems|0|||
27821641|NCT01199861|81179045|FG000|Overall Study|Adverse Event|1|||
27821642|NCT01199861|81179046|FG001|Overall Study|Adverse Event|0|||
27821643|NCT00473330|81179047|FG000|Core Study|Adverse Event|4|||
27821644|NCT00473330|81179048|FG001|Core Study|Adverse Event|4|||
27821645|NCT00473330|81179049|FG002|Core Study|Adverse Event|1|||
27882069|NCT04707469|81401076|FG002|Overall Study|Site closure|0|||
27882070|NCT04707469|81401074|FG000|Overall Study|Physician Decision|2|||
27593579|NCT00092534|80352323|FG003|Base Study EXT|Protocol Violation|0|||
27593580|NCT00092534|80352324|FG004|Base Study EXT|Protocol Violation|0|||
27821646|NCT00473330|81179047|FG000|Core Study|Death|6|||
27882071|NCT04707469|81401075|FG001|Overall Study|Physician Decision|2|||
27882072|NCT04707469|81401076|FG002|Overall Study|Physician Decision|2|||
27882073|NCT04707469|81401074|FG000|Overall Study|Death|1|||
27882074|NCT04707469|81401075|FG001|Overall Study|Death|6|||
27882075|NCT04707469|81401076|FG002|Overall Study|Death|2|||
27821647|NCT00473330|81179048|FG001|Core Study|Death|4|||
27821648|NCT00473330|81179049|FG002|Core Study|Death|4|||
27821649|NCT00473330|81179047|FG000|Core Study|Lost to Follow-up|5|||
27882076|NCT04707469|81401074|FG000|Overall Study|Lost to Follow-up|9|||
27593581|NCT00092534|80352320|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
27593582|NCT00092534|80352321|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
27882077|NCT04707469|81401075|FG001|Overall Study|Lost to Follow-up|19|||
27882078|NCT04707469|81401076|FG002|Overall Study|Lost to Follow-up|14|||
27882079|NCT04707469|81401074|FG000|Overall Study|Withdrawal by Subject|17|||
27882080|NCT04707469|81401075|FG001|Overall Study|Withdrawal by Subject|16|||
27882081|NCT04707469|81401076|FG002|Overall Study|Withdrawal by Subject|12|||
27882082|NCT01120184|81401077|FG000|Overall Study|Adverse Event|0|||
27882083|NCT01120184|81401078|FG001|Overall Study|Adverse Event|1|||
27882084|NCT01120184|81401079|FG002|Overall Study|Adverse Event|0|||
27882085|NCT01120184|81401077|FG000|Overall Study|Lost to Follow-up|13|||
27882086|NCT01120184|81401078|FG001|Overall Study|Lost to Follow-up|13|||
27882087|NCT01120184|81401079|FG002|Overall Study|Lost to Follow-up|11|||
27882088|NCT01120184|81401077|FG000|Overall Study|Physician Decision|9|||
27882089|NCT01120184|81401078|FG001|Overall Study|Physician Decision|1|||
27882090|NCT01120184|81401079|FG002|Overall Study|Physician Decision|3|||
27882091|NCT01120184|81401077|FG000|Overall Study|Reason not Specified|8|||
27882092|NCT01120184|81401078|FG001|Overall Study|Reason not Specified|3|||
27882093|NCT01120184|81401079|FG002|Overall Study|Reason not Specified|12|||
27882094|NCT01120184|81401077|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
27882095|NCT01120184|81401078|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
27882096|NCT01120184|81401079|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
27882097|NCT01120184|81401077|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
27882098|NCT01120184|81401078|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
27882099|NCT01120184|81401079|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
27882100|NCT01120184|81401077|FG000|Overall Study|Death|170|||
27882101|NCT01120184|81401078|FG001|Overall Study|Death|176|||
27882102|NCT01120184|81401079|FG002|Overall Study|Death|169|||
27882103|NCT01100086|81401080|FG000|Period 1|Withdrawal by Subject|1|||
27882104|NCT01100086|81401081|FG001|Period 1|Withdrawal by Subject|0|||
27882105|NCT02964208|81401084|FG000|Overall Study|Death|103|||
27882106|NCT02964208|81401084|FG000|Overall Study|Withdrawal by Subject|6|||
27882107|NCT02964208|81401084|FG000|Overall Study|Lost to Follow-up|6|||
27882108|NCT02964208|81401084|FG000|Overall Study|Unsuccessful Procedure|5|||
27882109|NCT02964208|81401084|FG000|Overall Study|Device Explant|1|||
27882110|NCT02964208|81401084|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
27882111|NCT02858583|81401085|FG000|Overall Study|Declined consent|1|||
27882112|NCT02858583|81401086|FG001|Overall Study|Declined consent|1|||
27882113|NCT00546377|81401091|FG000|Overall Study|Deemed ineligible|1|||
27882114|NCT00546377|81401091|FG000|Overall Study|Adverse Event|6|||
27882115|NCT02187198|81401092|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
27882116|NCT02187198|81401093|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
27882117|NCT02187198|81401092|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
27882118|NCT02187198|81401093|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
27882119|NCT02556775|81401094|FG000|Overall Study|Withdrawal by Subject|1|||
27882120|NCT02556775|81401095|FG001|Overall Study|Withdrawal by Subject|0|||
27882121|NCT02556775|81401096|FG002|Overall Study|Withdrawal by Subject|1|||
27882122|NCT02556775|81401097|FG003|Overall Study|Withdrawal by Subject|0|||
27882123|NCT02556775|81401094|FG000|Overall Study|Lost to Follow-up|1|||
27882124|NCT02556775|81401095|FG001|Overall Study|Lost to Follow-up|0|||
27882125|NCT02556775|81401096|FG002|Overall Study|Lost to Follow-up|0|||
27882126|NCT02556775|81401097|FG003|Overall Study|Lost to Follow-up|0|||
27882127|NCT00955955|81401098|FG000|Overall Study|Lost to Follow-up|2|||
27882128|NCT00955955|81401099|FG001|Overall Study|Lost to Follow-up|0|||
27882129|NCT00955955|81401100|FG002|Overall Study|Lost to Follow-up|0|||
27882130|NCT00356148|81401101|FG000|Overall Study|Reoperation within 30 days|2|||
27882131|NCT00356148|81401102|FG001|Overall Study|Reoperation within 30 days|1|||
27882132|NCT00917852|81401104|FG000|Overall Study|Death|6|||
27882133|NCT02596971|81401105|FG000|Overall Study|Death|5|||
27882134|NCT02596971|81401106|FG001|Overall Study|Death|1|||
27882135|NCT02596971|81401107|FG002|Overall Study|Death|5|||
27882136|NCT02596971|81401105|FG000|Overall Study|Withdrawal by Subject|5|||
27882137|NCT02596971|81401106|FG001|Overall Study|Withdrawal by Subject|1|||
27882138|NCT02596971|81401107|FG002|Overall Study|Withdrawal by Subject|4|||
27882139|NCT00179660|81401113|FG000|Overall Study|Adverse Event|7|||
27882140|NCT00179660|81401113|FG000|Overall Study|Lack of therapeutic effect|28|||
27882141|NCT00179660|81401113|FG000|Overall Study|Withdrawal by Subject|2|||
27882142|NCT00179660|81401113|FG000|Overall Study|Lost to Follow-up|1|||
27882143|NCT00179660|81401113|FG000|Overall Study|Death|3|||
27882144|NCT00179660|81401113|FG000|Overall Study|Other - Unspecified|9|||
27882145|NCT01732640|81401114|FG000|Overall Study|Adverse Event|0|||
27882146|NCT01732640|81401115|FG001|Overall Study|Adverse Event|1|||
27882147|NCT01732640|81401114|FG000|Overall Study|Death|0|||
27882148|NCT01732640|81401115|FG001|Overall Study|Death|1|||
27882149|NCT01379768|81401116|FG000|Overall Study|Adverse Event|1|||
27882150|NCT01379768|81401117|FG001|Overall Study|Adverse Event|1|||
27882151|NCT01379768|81401118|FG002|Overall Study|Adverse Event|0|||
27882152|NCT01379768|81401116|FG000|Overall Study|Lost to Follow-up|2|||
27882153|NCT01379768|81401117|FG001|Overall Study|Lost to Follow-up|0|||
27882154|NCT01379768|81401118|FG002|Overall Study|Lost to Follow-up|0|||
27882155|NCT03474731|81401121|FG000|Overall Study|Withdrawal by Subject|36|||
27882156|NCT03474731|81401122|FG001|Overall Study|Withdrawal by Subject|29|||
27882157|NCT03474731|81401123|FG002|Overall Study|Withdrawal by Subject|11|||
27882158|NCT03474731|81401124|FG003|Overall Study|Withdrawal by Subject|27|||
27882159|NCT03474731|81401121|FG000|Overall Study|COVID|0|||
27882160|NCT03474731|81401122|FG001|Overall Study|COVID|23|||
27882161|NCT03474731|81401123|FG002|Overall Study|COVID|0|||
27882162|NCT03474731|81401124|FG003|Overall Study|COVID|0|||
27882163|NCT03474731|81401121|FG000|Overall Study|Participant moved from area|1|||
27882164|NCT03474731|81401122|FG001|Overall Study|Participant moved from area|0|||
27882165|NCT03474731|81401123|FG002|Overall Study|Participant moved from area|0|||
27882166|NCT03474731|81401124|FG003|Overall Study|Participant moved from area|0|||
27882167|NCT03474731|81401121|FG000|Overall Study|Lost to Follow-up|11|||
27882168|NCT03474731|81401122|FG001|Overall Study|Lost to Follow-up|3|||
27882169|NCT03474731|81401123|FG002|Overall Study|Lost to Follow-up|18|||
27882170|NCT03474731|81401124|FG003|Overall Study|Lost to Follow-up|17|||
27882171|NCT03474731|81401121|FG000|Overall Study|Death|0|||
27882172|NCT03474731|81401122|FG001|Overall Study|Death|1|||
27882173|NCT03474731|81401123|FG002|Overall Study|Death|0|||
27882174|NCT03474731|81401124|FG003|Overall Study|Death|0|||
27882175|NCT03474731|81401121|FG000|Overall Study|Participant Removed|0|||
27882176|NCT03474731|81401122|FG001|Overall Study|Participant Removed|0|||
27882177|NCT03474731|81401123|FG002|Overall Study|Participant Removed|0|||
27882178|NCT03474731|81401124|FG003|Overall Study|Participant Removed|1|||
27882179|NCT00282113|81401125|FG000|Overall Study|Removed at parents request|1|||
27882180|NCT00282113|81401126|FG001|Overall Study|Removed at parents request|0|||
27882181|NCT00282113|81401127|FG002|Overall Study|Removed at parents request|0|||
27882182|NCT02088905|81401133|FG000|Overall Study|Withdrawal by Subject|5|||
27882183|NCT02088905|81401134|FG001|Overall Study|Withdrawal by Subject|1|||
27882184|NCT00154284|81401135|FG000|Overall Study|Adverse Event|6|||
27882185|NCT00154284|81401136|FG001|Overall Study|Adverse Event|9|||
27882186|NCT00154284|81401135|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27882187|NCT00154284|81401136|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27882188|NCT00154284|81401135|FG000|Overall Study|Lack of Efficacy|1|||
27882189|NCT00154284|81401136|FG001|Overall Study|Lack of Efficacy|2|||
27882190|NCT00154284|81401135|FG000|Overall Study|Protocol Violation|0|||
27882191|NCT00154284|81401136|FG001|Overall Study|Protocol Violation|1|||
27882192|NCT02395848|81401137|FG000|Overall Study|Lost to Follow-up|2|||
27882193|NCT01057810|81401138|FG000|Overall Study|Disease progression|156|||
27882194|NCT01057810|81401139|FG001|Overall Study|Disease progression|197|||
27882195|NCT01057810|81401138|FG000|Overall Study|Study drug toxicity|5|||
27882196|NCT01057810|81401139|FG001|Overall Study|Study drug toxicity|114|||
27882197|NCT01057810|81401138|FG000|Overall Study|Adverse event unrelated to study drug|13|||
27882198|NCT01057810|81401139|FG001|Overall Study|Adverse event unrelated to study drug|29|||
27882199|NCT01057810|81401138|FG000|Overall Study|Withdrawal by Subject|10|||
27882200|NCT01057810|81401139|FG001|Overall Study|Withdrawal by Subject|25|||
27882201|NCT01057810|81401138|FG000|Overall Study|Death|2|||
27882202|NCT01057810|81401139|FG001|Overall Study|Death|12|||
27882203|NCT01057810|81401138|FG000|Overall Study|Maximum clinical benefit|5|||
27882204|NCT01057810|81401139|FG001|Overall Study|Maximum clinical benefit|5|||
27882205|NCT01057810|81401138|FG000|Overall Study|Poor/non-compliance|0|||
27882206|NCT01057810|81401139|FG001|Overall Study|Poor/non-compliance|1|||
27882207|NCT01057810|81401138|FG000|Overall Study|No longer met study criteria|0|||
27882208|NCT01057810|81401139|FG001|Overall Study|No longer met study criteria|1|||
27882209|NCT01057810|81401138|FG000|Overall Study|Other|7|||
27882210|NCT01057810|81401139|FG001|Overall Study|Other|14|||
27882211|NCT01894841|81401144|FG000|Overall Study|Withdrawal by Subject|9|||
27882212|NCT01894841|81401145|FG001|Overall Study|Withdrawal by Subject|4|||
27882213|NCT01894841|81401144|FG000|Overall Study|Withdrawn by investigator|2|||
27882214|NCT01894841|81401145|FG001|Overall Study|Withdrawn by investigator|2|||
27882215|NCT01894841|81401144|FG000|Overall Study|Lost to Follow-up|7|||
27882216|NCT01894841|81401145|FG001|Overall Study|Lost to Follow-up|3|||
27882217|NCT01931475|81401146|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
27882218|NCT01931475|81401147|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
27882219|NCT01931475|81401146|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
27593583|NCT00092534|80352322|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
27593584|NCT00092534|80352323|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
27593585|NCT00092534|80352324|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
27593586|NCT03905655|80352327|FG000|Overall Study|Adverse Event|1|||
27593587|NCT03905655|80352328|FG001|Overall Study|Adverse Event|0|||
27593588|NCT03905655|80352329|FG002|Overall Study|Adverse Event|1|||
27593589|NCT03905655|80352330|FG003|Overall Study|Adverse Event|1|||
27821650|NCT00473330|81179048|FG001|Core Study|Lost to Follow-up|5|||
27821651|NCT00473330|81179049|FG002|Core Study|Lost to Follow-up|10|||
27821652|NCT00473330|81179047|FG000|Core Study|Physician Decision|2|||
27821653|NCT00473330|81179048|FG001|Core Study|Physician Decision|1|||
27821654|NCT00473330|81179049|FG002|Core Study|Physician Decision|3|||
27821655|NCT00473330|81179047|FG000|Core Study|Subject Non-compliance|1|||
27821656|NCT00473330|81179048|FG001|Core Study|Subject Non-compliance|2|||
27821657|NCT00473330|81179049|FG002|Core Study|Subject Non-compliance|1|||
27821658|NCT00473330|81179047|FG000|Core Study|Subject Required Other Therapy|0|||
27821659|NCT00473330|81179048|FG001|Core Study|Subject Required Other Therapy|1|||
27821660|NCT00473330|81179049|FG002|Core Study|Subject Required Other Therapy|3|||
27821661|NCT00473330|81179047|FG000|Core Study|Subject's Decision|9|||
27821662|NCT00473330|81179048|FG001|Core Study|Subject's Decision|8|||
27821663|NCT00473330|81179049|FG002|Core Study|Subject's Decision|19|||
27821664|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
27821665|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
27821666|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
27821667|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Death|2|||
27821668|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Death|0|||
27821669|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Death|0|||
27821670|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
27821671|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
27821672|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
27821673|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
27821674|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
27593590|NCT01212770|80352331|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
27593591|NCT01212770|80352332|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
27593592|NCT01212770|80352333|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
27593593|NCT01212770|80352334|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27593594|NCT01212770|80352335|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27593595|NCT01212770|80352336|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27821675|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
27821676|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
27821677|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
27821678|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
27821679|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
27821680|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
27821681|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
27821682|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
27821683|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
27882220|NCT01931475|81401147|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
27882221|NCT01931475|81401146|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
27882222|NCT01931475|81401147|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
27882223|NCT01931475|81401146|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
27882224|NCT01931475|81401147|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
27882225|NCT01931475|81401146|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
27882226|NCT01931475|81401147|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
27821684|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
27882227|NCT01931475|81401146|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
27882228|NCT01931475|81401147|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
27882229|NCT01931475|81401146|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
27882230|NCT01931475|81401147|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
27882231|NCT01931475|81401146|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
27882232|NCT01931475|81401147|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
27882233|NCT01931475|81401146|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
27882234|NCT01931475|81401147|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
27882235|NCT01931475|81401146|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
27593596|NCT01212770|80352337|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27593597|NCT01212770|80352338|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27882236|NCT01931475|81401147|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
27882237|NCT01931475|81401146|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
27882238|NCT01931475|81401147|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
27882239|NCT00789698|81401148|FG000|Overall Study|Lack of Efficacy|10|||
27882240|NCT00789698|81401149|FG001|Overall Study|Lack of Efficacy|4|||
27882241|NCT00789698|81401150|FG002|Overall Study|Lack of Efficacy|5|||
27882242|NCT00789698|81401151|FG003|Overall Study|Lack of Efficacy|18|||
27882243|NCT00789698|81401148|FG000|Overall Study|Adverse Event|5|||
27882244|NCT00789698|81401149|FG001|Overall Study|Adverse Event|5|||
27882245|NCT00789698|81401150|FG002|Overall Study|Adverse Event|3|||
27882246|NCT00789698|81401151|FG003|Overall Study|Adverse Event|4|||
27882247|NCT00789698|81401148|FG000|Overall Study|Lost to Follow-up|5|||
27882248|NCT00789698|81401149|FG001|Overall Study|Lost to Follow-up|5|||
27593598|NCT01212770|80352339|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27694043|NCT01201317|80716622|FG000|Overall Study|Death|0|||
27694044|NCT01201317|80716623|FG001|Overall Study|Death|1|||
27882249|NCT00789698|81401150|FG002|Overall Study|Lost to Follow-up|2|||
27882250|NCT00789698|81401151|FG003|Overall Study|Lost to Follow-up|9|||
27593599|NCT01212770|80352331|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
27593600|NCT01212770|80352332|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
27694045|NCT01201317|80716624|FG002|Overall Study|Death|0|||
27694046|NCT01201317|80716622|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27882251|NCT00789698|81401148|FG000|Overall Study|Protocol Violation|6|||
27882252|NCT00789698|81401149|FG001|Overall Study|Protocol Violation|1|||
27882253|NCT00789698|81401150|FG002|Overall Study|Protocol Violation|2|||
27882254|NCT00789698|81401151|FG003|Overall Study|Protocol Violation|1|||
27882255|NCT00789698|81401148|FG000|Overall Study|Withdrawal by Subject|14|||
27882256|NCT00789698|81401149|FG001|Overall Study|Withdrawal by Subject|15|||
27593601|NCT01212770|80352333|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
27593602|NCT01212770|80352334|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27593603|NCT01212770|80352335|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27593604|NCT01212770|80352336|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27593605|NCT01212770|80352337|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27593606|NCT01212770|80352338|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27593607|NCT01212770|80352339|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27593608|NCT01212770|80352331|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
27593609|NCT01212770|80352332|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
27593610|NCT01212770|80352333|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
27593611|NCT01212770|80352334|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27593612|NCT01212770|80352335|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27593613|NCT01212770|80352336|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27593614|NCT01212770|80352337|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27593615|NCT01212770|80352338|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27593616|NCT01212770|80352339|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27593617|NCT01212770|80352331|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27593618|NCT01212770|80352332|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593619|NCT01212770|80352333|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
27593620|NCT01212770|80352334|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593621|NCT01212770|80352335|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593622|NCT01212770|80352336|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593623|NCT01212770|80352337|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593624|NCT01212770|80352338|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593625|NCT01212770|80352339|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27593626|NCT01212770|80352331|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593627|NCT01212770|80352332|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593628|NCT01212770|80352333|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27593629|NCT01212770|80352334|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593630|NCT01212770|80352335|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593631|NCT01212770|80352336|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593632|NCT01212770|80352337|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593633|NCT01212770|80352338|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593634|NCT01212770|80352339|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27593635|NCT01212770|80352331|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
27593636|NCT01212770|80352332|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
27593637|NCT01212770|80352333|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
27593638|NCT01212770|80352334|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27593639|NCT01212770|80352335|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27593640|NCT01212770|80352336|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27593641|NCT01212770|80352337|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27593642|NCT01212770|80352338|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27593643|NCT01212770|80352339|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
27593644|NCT01212770|80352331|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27593645|NCT01212770|80352332|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
27593646|NCT01212770|80352333|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
27593647|NCT01212770|80352334|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
27593648|NCT01212770|80352335|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27593649|NCT01212770|80352336|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27694047|NCT01201317|80716623|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27821685|NCT00473330|81179047|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
27593650|NCT01212770|80352337|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
27593651|NCT01212770|80352338|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27593652|NCT01212770|80352339|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
27593653|NCT01212770|80352331|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27593654|NCT01212770|80352332|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
27593655|NCT01212770|80352333|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
27593656|NCT01212770|80352334|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
27593657|NCT01212770|80352335|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
27593658|NCT01212770|80352336|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
27593659|NCT01212770|80352337|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27593660|NCT01212770|80352338|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27593661|NCT01212770|80352339|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
27593662|NCT01212770|80352331|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
27593663|NCT01212770|80352332|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
27593664|NCT01212770|80352333|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
27593665|NCT01212770|80352334|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
27593666|NCT01212770|80352335|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
27593667|NCT01212770|80352336|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
27593668|NCT01212770|80352337|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
27593669|NCT01212770|80352338|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
27593670|NCT01212770|80352339|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
27593671|NCT01212770|80352331|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593672|NCT01212770|80352332|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593673|NCT01212770|80352333|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
27593674|NCT01212770|80352334|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593675|NCT01212770|80352335|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593676|NCT01212770|80352336|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593677|NCT01212770|80352337|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593678|NCT01212770|80352338|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593679|NCT01212770|80352339|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
27593680|NCT01212770|80352331|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593681|NCT01212770|80352332|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593682|NCT01212770|80352333|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593683|NCT01212770|80352334|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
27593684|NCT01212770|80352335|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593685|NCT01212770|80352336|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593686|NCT01212770|80352337|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593687|NCT01212770|80352338|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593688|NCT01212770|80352339|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
27593689|NCT01212770|80352331|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593690|NCT01212770|80352332|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593691|NCT01212770|80352333|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
27593692|NCT01212770|80352334|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
27593693|NCT01212770|80352335|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593694|NCT01212770|80352336|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593695|NCT01212770|80352337|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593696|NCT01212770|80352338|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593697|NCT01212770|80352339|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
27593698|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27593699|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
27593700|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
27593701|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27593702|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27593703|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27593704|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27593705|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27593706|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
27593707|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27593708|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
27593709|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
27593710|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27593711|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27593712|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27593713|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27593714|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
27593715|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
27593716|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593717|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
27593718|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593719|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593720|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593721|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593722|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593723|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593724|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
27593725|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27593726|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
27593727|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
27593728|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27593729|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27593730|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27593731|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27593732|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
27593733|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
27593734|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27593735|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
27593736|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
27593737|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27593738|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27593739|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27593740|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
27593741|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
27593742|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
27593743|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27593744|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
27593745|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27593746|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27593747|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27593748|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27593749|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27593750|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27593751|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27593752|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27593753|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27593754|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27593755|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27593756|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27593757|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27593758|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27593759|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27593760|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
27593761|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27593762|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
27694048|NCT01201317|80716624|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27694049|NCT01201317|80716622|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
27694050|NCT01201317|80716623|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
27821686|NCT00473330|81179048|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
27821687|NCT00473330|81179049|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
27593763|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
27821688|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
27882257|NCT00789698|81401150|FG002|Overall Study|Withdrawal by Subject|12|||
27882258|NCT00789698|81401151|FG003|Overall Study|Withdrawal by Subject|19|||
27882259|NCT00789698|81401148|FG000|Overall Study|Administrative|0|||
27882260|NCT00789698|81401149|FG001|Overall Study|Administrative|3|||
27882261|NCT00789698|81401150|FG002|Overall Study|Administrative|3|||
27593764|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27593765|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27593766|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27882262|NCT00789698|81401151|FG003|Overall Study|Administrative|1|||
27882263|NCT01754129|81401152|FG000|Overall Study|Death|13|||
27882264|NCT01754129|81401152|FG000|Overall Study|Duodopa discontinuation|9|||
27882265|NCT01754129|81401152|FG000|Overall Study|Lost to Follow-up|7|||
27882266|NCT01754129|81401152|FG000|Overall Study|Withdrew consent|1|||
27882267|NCT01754129|81401152|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
27882268|NCT00026494|81401153|FG000|Overall Study|Withdrawal by Subject|1|||
27882269|NCT00026494|81401154|FG001|Overall Study|Withdrawal by Subject|0|||
27593767|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27593768|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
27593769|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
27593770|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27593771|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
27593772|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
27593773|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27593774|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27593775|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27593776|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27593777|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27821689|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
27821690|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
27821691|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Death|2|||
27821692|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Death|2|||
27821693|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Death|1|||
27821694|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
27821695|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
27821696|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
27821697|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
27821698|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
27821699|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
27821700|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
27821701|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
27821702|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
27821703|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
27821704|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
27821705|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
27821706|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
27882270|NCT00026494|81401155|FG002|Overall Study|Withdrawal by Subject|1|||
27882271|NCT00026494|81401156|FG003|Overall Study|Withdrawal by Subject|0|||
27882272|NCT00026494|81401153|FG000|Overall Study|Patient non-compliance|1|||
27882273|NCT00026494|81401154|FG001|Overall Study|Patient non-compliance|0|||
27593778|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27882274|NCT00026494|81401155|FG002|Overall Study|Patient non-compliance|0|||
27882275|NCT00026494|81401156|FG003|Overall Study|Patient non-compliance|0|||
27821707|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
27821708|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
27821709|NCT00473330|81179047|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
27821710|NCT00473330|81179048|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
27821711|NCT00473330|81179049|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
27821712|NCT01722877|81179050|FG000|Overall Study|Death|1|||
27821713|NCT01722877|81179050|FG000|Overall Study|Lost to Follow-up|1|||
27821714|NCT00282048|81179051|FG000|Overall Study|Lack of Efficacy|30|||
27821715|NCT00282048|81179051|FG000|Overall Study|Adverse Event|22|||
27821716|NCT00282048|81179051|FG000|Overall Study|Withdrawal by Subject|1|||
27821717|NCT00282048|81179051|FG000|Overall Study|Other|8|||
27821718|NCT00282048|81179051|FG000|Overall Study|Ongoing|1|||
27593779|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593780|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
27593781|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593782|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593783|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593784|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593785|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593786|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593787|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27593788|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593789|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593790|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593791|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593792|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593793|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593794|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593795|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
27593796|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
27593797|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27593798|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
27593799|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27593800|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27593801|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27593802|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27821719|NCT00214422|81179061|FG000|Overall Study|Physician Decision|2|||
27821720|NCT00214422|81179062|FG001|Overall Study|Physician Decision|0|||
27821721|NCT00214422|81179063|FG002|Overall Study|Physician Decision|0|||
27821722|NCT00214422|81179061|FG000|Overall Study|Developed esophageal ca|1|||
27821723|NCT00214422|81179062|FG001|Overall Study|Developed esophageal ca|0|||
27821724|NCT00214422|81179063|FG002|Overall Study|Developed esophageal ca|0|||
27821725|NCT00214422|81179061|FG000|Overall Study|Pt taken off study|1|||
27821726|NCT00214422|81179062|FG001|Overall Study|Pt taken off study|1|||
27821727|NCT00214422|81179063|FG002|Overall Study|Pt taken off study|0|||
27821728|NCT00214422|81179061|FG000|Overall Study|Disease progression on study|1|||
27821729|NCT00214422|81179062|FG001|Overall Study|Disease progression on study|0|||
27821730|NCT00214422|81179063|FG002|Overall Study|Disease progression on study|0|||
27821731|NCT00214422|81179061|FG000|Overall Study|Unable to make a radiation treatment|0|||
27821732|NCT00214422|81179062|FG001|Overall Study|Unable to make a radiation treatment|0|||
27821733|NCT00214422|81179063|FG002|Overall Study|Unable to make a radiation treatment|1|||
27821734|NCT02883452|81181517|FG000|Overall Study|Withdrawal by Subject|1|||
27593803|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27593804|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27593805|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27593806|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27593807|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
27593808|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
27593809|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27593810|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27593811|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27593812|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27593813|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27593814|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
27821735|NCT02883452|81181518|FG001|Overall Study|Withdrawal by Subject|1|||
27821736|NCT02883452|81181519|FG002|Overall Study|Withdrawal by Subject|3|||
27821737|NCT02883452|81181520|FG003|Overall Study|Withdrawal by Subject|0|||
27593815|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27593816|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
27821738|NCT02883452|81181521|FG004|Overall Study|Withdrawal by Subject|2|||
27821739|NCT02883452|81181522|FG005|Overall Study|Withdrawal by Subject|5|||
27821740|NCT02883452|81181517|FG000|Overall Study|Disease progression|1|||
27821741|NCT02883452|81181518|FG001|Overall Study|Disease progression|0|||
27821742|NCT02883452|81181519|FG002|Overall Study|Disease progression|0|||
27821743|NCT02883452|81181520|FG003|Overall Study|Disease progression|1|||
27821744|NCT02883452|81181521|FG004|Overall Study|Disease progression|4|||
27821745|NCT02883452|81181522|FG005|Overall Study|Disease progression|5|||
27821746|NCT02883452|81181517|FG000|Overall Study|Adverse Event|2|||
27821747|NCT02883452|81181518|FG001|Overall Study|Adverse Event|1|||
27821748|NCT02883452|81181519|FG002|Overall Study|Adverse Event|1|||
27821749|NCT02883452|81181520|FG003|Overall Study|Adverse Event|1|||
27821750|NCT02883452|81181521|FG004|Overall Study|Adverse Event|1|||
27821751|NCT02883452|81181522|FG005|Overall Study|Adverse Event|3|||
27821752|NCT02883452|81181517|FG000|Overall Study|Physician Decision|0|||
27821753|NCT02883452|81181518|FG001|Overall Study|Physician Decision|0|||
27821754|NCT02883452|81181519|FG002|Overall Study|Physician Decision|0|||
27821755|NCT02883452|81181520|FG003|Overall Study|Physician Decision|0|||
27821756|NCT02883452|81181521|FG004|Overall Study|Physician Decision|4|||
27821757|NCT02883452|81181522|FG005|Overall Study|Physician Decision|1|||
27821758|NCT02883452|81181517|FG000|Overall Study|Death|1|||
27821759|NCT02883452|81181518|FG001|Overall Study|Death|0|||
27821760|NCT02883452|81181519|FG002|Overall Study|Death|1|||
27821761|NCT02883452|81181520|FG003|Overall Study|Death|0|||
27821762|NCT02883452|81181521|FG004|Overall Study|Death|0|||
27821763|NCT02883452|81181522|FG005|Overall Study|Death|0|||
27821764|NCT02883452|81181517|FG000|Overall Study|Other|0|||
27821765|NCT02883452|81181518|FG001|Overall Study|Other|0|||
27821766|NCT02883452|81181519|FG002|Overall Study|Other|0|||
27821767|NCT02883452|81181520|FG003|Overall Study|Other|0|||
27821768|NCT02883452|81181521|FG004|Overall Study|Other|0|||
27821769|NCT02883452|81181522|FG005|Overall Study|Other|1|||
27821770|NCT03497897|81181524|FG000|Overall Study|Adverse Event|1|||
27821771|NCT03497897|81181525|FG001|Overall Study|Adverse Event|1|||
27821772|NCT03497897|81181526|FG002|Overall Study|Adverse Event|1|||
27821773|NCT03497897|81181524|FG000|Overall Study|Lost to Follow-up|2|||
27821774|NCT03497897|81181525|FG001|Overall Study|Lost to Follow-up|0|||
27821775|NCT03497897|81181526|FG002|Overall Study|Lost to Follow-up|2|||
27821776|NCT03497897|81181524|FG000|Overall Study|Physician Decision|1|||
27821777|NCT03497897|81181525|FG001|Overall Study|Physician Decision|0|||
27821778|NCT03497897|81181526|FG002|Overall Study|Physician Decision|0|||
27821779|NCT03497897|81181524|FG000|Overall Study|Subject/Guardian Decision|2|||
27821780|NCT03497897|81181525|FG001|Overall Study|Subject/Guardian Decision|1|||
27821781|NCT03497897|81181526|FG002|Overall Study|Subject/Guardian Decision|3|||
27821782|NCT03733925|81181527|FG000|Overall Study|Lost to Follow-up|1|||
27821783|NCT03733925|81181527|FG000|Overall Study|Withdrawal by Subject|2|||
27821784|NCT03733925|81181527|FG000|Overall Study|Adverse Event|2|||
27821785|NCT03733925|81181527|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27821786|NCT01496183|81181528|FG000|Overall Study|Physician Decision|3|||
27821787|NCT01496183|81181529|FG001|Overall Study|Physician Decision|1|||
27821788|NCT01496183|81181528|FG000|Overall Study|Withdrawal by Subject|0|||
27821789|NCT01496183|81181529|FG001|Overall Study|Withdrawal by Subject|1|||
27821790|NCT03351335|81181530|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
27821791|NCT03351335|81181531|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
27821792|NCT03351335|81181532|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
27821793|NCT02475954|81181536|FG000|Overall Study|Withdrawal by Subject|2|||
27821794|NCT02475954|81181537|FG001|Overall Study|Withdrawal by Subject|2|||
27821795|NCT02475954|81181536|FG000|Overall Study|Lost to Follow-up|11|||
27821796|NCT02475954|81181537|FG001|Overall Study|Lost to Follow-up|9|||
27821797|NCT02475954|81181536|FG000|Overall Study|Death|1|||
27821798|NCT02475954|81181537|FG001|Overall Study|Death|1|||
27821799|NCT02770820|81181543|FG000|Overall Study|Death|1|||
27821800|NCT02770820|81181543|FG000|Overall Study|Physician Decision|2|||
27821801|NCT01399736|81181546|FG000|Overall Study|Withdrawal by Subject|4|||
27821802|NCT01399736|81181547|FG001|Overall Study|Withdrawal by Subject|2|||
27821803|NCT01399736|81181546|FG000|Overall Study|Lost to Follow-up|0|||
27821804|NCT01399736|81181547|FG001|Overall Study|Lost to Follow-up|2|||
27821805|NCT01417078|81181548|FG000|Overall Study|Withdrawal by Subject|1|||
27821806|NCT02661295|81181551|FG000|Overall Study|Death|1|||
27821807|NCT02661295|81181551|FG000|Overall Study|Transferred Out|1|||
27821808|NCT02661295|81181551|FG000|Overall Study|Kidney Transplant|1|||
27821809|NCT02661295|81181551|FG000|Overall Study|Withdrawn due to side effects|8|||
27821810|NCT02661295|81181551|FG000|Overall Study|Withdrawn due to access type|1|||
27821811|NCT02661295|81181551|FG000|Overall Study|Withdrawn due to allergies|1|||
27821812|NCT02661295|81181551|FG000|Overall Study|Withdrawn due to non-compliance|1|||
27821813|NCT02661295|81181551|FG000|Overall Study|Withdrawal by Subject|3|||
27821814|NCT02661295|81181551|FG000|Overall Study|Failed screening|2|||
27821815|NCT04753437|81181552|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27821816|NCT04753437|81181553|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27821817|NCT04753437|81181552|FG000|Overall Study|Liver Function Test Abnormalities|2|||
27821818|NCT04753437|81181553|FG001|Overall Study|Liver Function Test Abnormalities|4|||
27821819|NCT00635492|81181557|FG000|Overall Study|Death|12|||
27821820|NCT00635492|81181558|FG001|Overall Study|Death|40|||
27593817|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
27593818|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27694051|NCT01201317|80716624|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
27821821|NCT00635492|81181557|FG000|Overall Study|Lost to Follow-up|151|||
27821822|NCT00635492|81181558|FG001|Overall Study|Lost to Follow-up|172|||
27593819|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27593820|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27593821|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27593822|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
27593823|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27593824|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27593825|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
27593826|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
27593827|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27593828|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27593829|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27593830|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27593831|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
27593832|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
27593833|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27593834|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
27593835|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
27593836|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27694052|NCT01201317|80716622|FG000|Overall Study|Decrease in renal function|0|||
27694053|NCT01201317|80716623|FG001|Overall Study|Decrease in renal function|1|||
27694054|NCT01201317|80716624|FG002|Overall Study|Decrease in renal function|0|||
27882276|NCT00026494|81401153|FG000|Overall Study|Patient not treated|0|||
27694055|NCT01201317|80716622|FG000|Overall Study|Lack of Efficacy|1|||
27882277|NCT00026494|81401154|FG001|Overall Study|Patient not treated|0|||
27882278|NCT00026494|81401155|FG002|Overall Study|Patient not treated|2|||
27882279|NCT00026494|81401156|FG003|Overall Study|Patient not treated|0|||
27882280|NCT00026494|81401153|FG000|Overall Study|Clinical progression|0|||
27882281|NCT00026494|81401154|FG001|Overall Study|Clinical progression|0|||
27882282|NCT00026494|81401155|FG002|Overall Study|Clinical progression|3|||
27882283|NCT00026494|81401156|FG003|Overall Study|Clinical progression|0|||
27882284|NCT00940823|81401157|FG000|Overall Study|Death|8|||
27694056|NCT01201317|80716623|FG001|Overall Study|Lack of Efficacy|0|||
27694057|NCT01201317|80716624|FG002|Overall Study|Lack of Efficacy|0|||
27694058|NCT01201317|80716622|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
27694059|NCT01201317|80716623|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
27593837|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27694060|NCT01201317|80716624|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
27694061|NCT02709096|80716625|FG000|Overall Study|non-compliance|1|||
27694062|NCT02709096|80716626|FG001|Overall Study|non-compliance|1|||
27694063|NCT04214600|80716627|FG000|Overall Study|Lost to Follow-up|9|||
27694064|NCT04214600|80716628|FG001|Overall Study|Lost to Follow-up|14|||
27882285|NCT00940823|81401158|FG001|Overall Study|Death|12|||
27882286|NCT00940823|81401157|FG000|Overall Study|Lost to Follow-up|27|||
27882287|NCT00940823|81401158|FG001|Overall Study|Lost to Follow-up|20|||
27882288|NCT00839800|81401159|FG000|Overall Study|Adverse Event|8|||
27882289|NCT00839800|81401160|FG001|Overall Study|Adverse Event|12|||
27882290|NCT00839800|81401159|FG000|Overall Study|Lost to Follow-up|31|||
27882291|NCT00839800|81401160|FG001|Overall Study|Lost to Follow-up|26|||
27882292|NCT00839800|81401159|FG000|Overall Study|Withdrawal by Subject|28|||
27882293|NCT00839800|81401160|FG001|Overall Study|Withdrawal by Subject|34|||
27882294|NCT00839800|81401159|FG000|Overall Study|Incorrect Enrolment|3|||
27882295|NCT00839800|81401160|FG001|Overall Study|Incorrect Enrolment|3|||
27882296|NCT00839800|81401159|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
27882297|NCT00839800|81401160|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
27882298|NCT00839800|81401159|FG000|Overall Study|Safety Reasons|2|||
27882299|NCT00839800|81401160|FG001|Overall Study|Safety Reasons|1|||
27882300|NCT00839800|81401159|FG000|Overall Study|Other|8|||
27882301|NCT00839800|81401160|FG001|Overall Study|Other|14|||
27882302|NCT00839800|81401159|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
27882303|NCT00839800|81401160|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
27882304|NCT00492648|81401167|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
27882305|NCT00492648|81401168|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
27882306|NCT02955355|81401176|FG000|Overall Study|Adverse Event|4|||
27882307|NCT02955355|81401176|FG000|Overall Study|Death|1|||
27882308|NCT02955355|81401176|FG000|Overall Study|Physician Decision|21|||
27882309|NCT02955355|81401176|FG000|Overall Study|Site Terminated by Sponsor|35|||
27882310|NCT02955355|81401176|FG000|Overall Study|Withdrawal by Subject|19|||
27694065|NCT03037931|80716637|FG000|Overall Study|Death|354|||
27694066|NCT03037931|80716638|FG001|Overall Study|Death|367|||
27882311|NCT02955355|81401176|FG000|Overall Study|Reason Not Specified|5|||
27882312|NCT01372995|81401186|FG000|Overall Study|Spouse withdrew participant from study|0|||
27882313|NCT01372995|81401187|FG001|Overall Study|Spouse withdrew participant from study|1|||
27882314|NCT01372995|81401188|FG002|Overall Study|Spouse withdrew participant from study|0|||
27882315|NCT01372995|81401186|FG000|Overall Study|Physician Decision|0|||
27882316|NCT01372995|81401187|FG001|Overall Study|Physician Decision|0|||
27882317|NCT01372995|81401188|FG002|Overall Study|Physician Decision|1|||
27882318|NCT00591565|81401189|FG000|Overall Study|lost follow up, withdrawn|5|||
27882319|NCT02147158|81401197|FG000|Treatment Course 1|Adverse Event|1|||
27694067|NCT03037931|80716637|FG000|Overall Study|Lost to Follow-up|7|||
27821823|NCT00635492|81181557|FG000|Overall Study|Physician Decision|32|||
27821824|NCT00635492|81181558|FG001|Overall Study|Physician Decision|22|||
27821825|NCT00635492|81181557|FG000|Overall Study|Sponsor decision|2|||
27821826|NCT00635492|81181558|FG001|Overall Study|Sponsor decision|3|||
27821827|NCT00635492|81181557|FG000|Overall Study|Withdrawal by Subject|82|||
27821828|NCT00635492|81181558|FG001|Overall Study|Withdrawal by Subject|45|||
27821829|NCT01066143|81181559|FG000|Overall Study|ineligible for the study|8|||
27821830|NCT00468286|81181560|FG000|Overall Study|Adverse Event|1|||
27821831|NCT00468286|81181561|FG001|Overall Study|Adverse Event|6|||
27821832|NCT00468286|81181560|FG000|Overall Study|Protocol Violation|2|||
27821833|NCT00468286|81181561|FG001|Overall Study|Protocol Violation|2|||
27821834|NCT00468286|81181560|FG000|Overall Study|Withdrawal by Subject|4|||
27821835|NCT00468286|81181561|FG001|Overall Study|Withdrawal by Subject|3|||
27821836|NCT00468286|81181560|FG000|Overall Study|Physician Decision|0|||
27821837|NCT00468286|81181561|FG001|Overall Study|Physician Decision|1|||
27821838|NCT04320849|81181562|FG000|Overall Study|Withdrawal by Subject|4|||
27821839|NCT04320849|81181562|FG000|Overall Study|Imaging data unavailable|2|||
27821840|NCT04320849|81181562|FG000|Overall Study|Incomplete imaging|2|||
27821841|NCT05275205|81181563|FG000|Overall Study|Adverse Event|1|||
27821842|NCT05275205|81181564|FG001|Overall Study|Adverse Event|2|||
27821843|NCT05275205|81181563|FG000|Overall Study|Physician Decision|1|||
27821844|NCT05275205|81181564|FG001|Overall Study|Physician Decision|1|||
27821845|NCT05275205|81181563|FG000|Overall Study|Withdrawal by Subject|2|||
27821846|NCT05275205|81181564|FG001|Overall Study|Withdrawal by Subject|3|||
27821847|NCT05275205|81181563|FG000|Overall Study|Death|1|||
27821848|NCT05275205|81181564|FG001|Overall Study|Death|0|||
27821849|NCT05275205|81181563|FG000|Overall Study|Patient unable to attend visits|1|||
27882320|NCT02147158|81401198|FG001|Treatment Course 1|Adverse Event|4|||
27882321|NCT02147158|81401199|FG002|Treatment Course 1|Adverse Event|3|||
27882322|NCT02147158|81401200|FG003|Treatment Course 1|Adverse Event|4|||
27882323|NCT02147158|81401201|FG004|Treatment Course 1|Adverse Event|1|||
27882324|NCT02147158|81401202|FG005|Treatment Course 1|Adverse Event|2|||
27882325|NCT02147158|81401197|FG000|Treatment Course 1|Lost to Follow-up|2|||
27882326|NCT02147158|81401198|FG001|Treatment Course 1|Lost to Follow-up|4|||
27882327|NCT02147158|81401199|FG002|Treatment Course 1|Lost to Follow-up|3|||
27882328|NCT02147158|81401200|FG003|Treatment Course 1|Lost to Follow-up|3|||
27882329|NCT02147158|81401201|FG004|Treatment Course 1|Lost to Follow-up|2|||
27882330|NCT02147158|81401202|FG005|Treatment Course 1|Lost to Follow-up|4|||
27882331|NCT02147158|81401197|FG000|Treatment Course 1|Protocol Violation|0|||
27882332|NCT02147158|81401198|FG001|Treatment Course 1|Protocol Violation|0|||
27882333|NCT02147158|81401199|FG002|Treatment Course 1|Protocol Violation|1|||
27882334|NCT02147158|81401200|FG003|Treatment Course 1|Protocol Violation|1|||
27882335|NCT02147158|81401201|FG004|Treatment Course 1|Protocol Violation|0|||
27882336|NCT02147158|81401202|FG005|Treatment Course 1|Protocol Violation|0|||
27882337|NCT02147158|81401197|FG000|Treatment Course 1|Withdrawal of Consent|1|||
27882338|NCT02147158|81401198|FG001|Treatment Course 1|Withdrawal of Consent|1|||
27882339|NCT02147158|81401199|FG002|Treatment Course 1|Withdrawal of Consent|1|||
27882340|NCT02147158|81401200|FG003|Treatment Course 1|Withdrawal of Consent|5|||
27882341|NCT02147158|81401201|FG004|Treatment Course 1|Withdrawal of Consent|3|||
27882342|NCT02147158|81401202|FG005|Treatment Course 1|Withdrawal of Consent|2|||
27882343|NCT02147158|81401197|FG000|Off-Treatment Interval 1|Adverse Event|1|||
27882344|NCT02147158|81401198|FG001|Off-Treatment Interval 1|Adverse Event|0|||
27882345|NCT02147158|81401199|FG002|Off-Treatment Interval 1|Adverse Event|0|||
27882346|NCT02147158|81401200|FG003|Off-Treatment Interval 1|Adverse Event|1|||
27882347|NCT02147158|81401201|FG004|Off-Treatment Interval 1|Adverse Event|0|||
27882348|NCT02147158|81401202|FG005|Off-Treatment Interval 1|Adverse Event|0|||
27882349|NCT02147158|81401197|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
27882350|NCT02147158|81401198|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
27882351|NCT02147158|81401199|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
27882352|NCT02147158|81401200|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
27882353|NCT02147158|81401201|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
27882354|NCT02147158|81401202|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
27882355|NCT02147158|81401197|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
27882356|NCT02147158|81401198|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
27882357|NCT02147158|81401199|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
27882358|NCT02147158|81401200|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
27694068|NCT03037931|80716638|FG001|Overall Study|Lost to Follow-up|4|||
27882359|NCT02147158|81401201|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
27882360|NCT02147158|81401202|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
27821850|NCT05275205|81181564|FG001|Overall Study|Patient unable to attend visits|0|||
27821851|NCT00735904|81181565|FG000|Overall Study|Adverse Event|3|||
27821852|NCT00735904|81181565|FG000|Overall Study|Death|20|||
27821853|NCT00735904|81181565|FG000|Overall Study|Protocol Violation|1|||
27821854|NCT00735904|81181565|FG000|Overall Study|Withdrawal by Subject|1|||
27821855|NCT00735904|81181565|FG000|Overall Study|Study Terminated by Sponsor|5|||
27821856|NCT00735904|81181565|FG000|Overall Study|Other|8|||
27821857|NCT01085045|81181566|FG000|Part A|Withdrawal by Subject|4|||
27821858|NCT01085045|81181566|FG000|Part A|Adverse Event|6|||
27821859|NCT01085045|81181566|FG000|Part A|Protocol Violation|1|||
27821860|NCT01085045|81181566|FG000|Part A|Protocol Specified Criteria|7|||
27821861|NCT01085045|81181566|FG000|Part B|Withdrawal by Subject|2|||
27821862|NCT01085045|81181566|FG000|Part B|Protocol Specified Criteria|6|||
27821863|NCT01085045|81181566|FG000|Part B|Lost to Follow-up|1|||
27821864|NCT01085045|81181566|FG000|Part B|Adverse Event|6|||
27821865|NCT03991494|81181572|FG000|Overall Study|Progressive Disease|4|||
27821866|NCT00819741|81181576|FG000|Overall Study|Adverse Event|5|||
27821867|NCT00819741|81181577|FG001|Overall Study|Adverse Event|2|||
27821868|NCT00819741|81181576|FG000|Overall Study|Lack of Efficacy|0|||
27821869|NCT00819741|81181577|FG001|Overall Study|Lack of Efficacy|2|||
27821870|NCT00819741|81181576|FG000|Overall Study|Lost to Follow-up|3|||
27593838|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27694069|NCT03037931|80716637|FG000|Overall Study|Withdrawal by Subject|48|||
27882361|NCT02147158|81401197|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
27882362|NCT02147158|81401198|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
27882363|NCT02147158|81401199|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
27882364|NCT02147158|81401200|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
27882365|NCT02147158|81401201|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
27882366|NCT02147158|81401202|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
27882367|NCT02147158|81401197|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
27882368|NCT02147158|81401198|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
27882369|NCT02147158|81401199|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
27882370|NCT02147158|81401200|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
27882371|NCT02147158|81401201|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
27882372|NCT02147158|81401202|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
27882373|NCT02147158|81401197|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
27882374|NCT02147158|81401198|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
27882375|NCT02147158|81401199|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
27882376|NCT02147158|81401200|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
27882377|NCT02147158|81401201|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
27882378|NCT02147158|81401202|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
27882379|NCT02147158|81401197|FG000|Treatment Course 2|Adverse Event|0|||
27882380|NCT02147158|81401198|FG001|Treatment Course 2|Adverse Event|4|||
27882381|NCT02147158|81401199|FG002|Treatment Course 2|Adverse Event|2|||
27593839|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27821871|NCT00819741|81181577|FG001|Overall Study|Lost to Follow-up|1|||
27821872|NCT00819741|81181576|FG000|Overall Study|Protocol Violation|3|||
27821873|NCT00819741|81181577|FG001|Overall Study|Protocol Violation|4|||
27821874|NCT00819741|81181576|FG000|Overall Study|Withdrawal by Subject|2|||
27821875|NCT00819741|81181577|FG001|Overall Study|Withdrawal by Subject|2|||
27821876|NCT00819741|81181576|FG000|Overall Study|Unclassified|6|||
27821877|NCT00819741|81181577|FG001|Overall Study|Unclassified|0|||
27821878|NCT00819741|81181576|FG000|Overall Study|Reasons unknown|3|||
27821879|NCT00819741|81181577|FG001|Overall Study|Reasons unknown|3|||
27821880|NCT00274937|81181578|FG000|Overall Study|Physician Decision|10|||
27821881|NCT00274937|81181578|FG000|Overall Study|Withdrawal by Subject|6|||
27821882|NCT00274937|81181578|FG000|Overall Study|Progressive Disease|4|||
27821883|NCT04384978|81181579|FG000|Overall Study|Withdrawal by Subject|4|||
27821884|NCT04384978|81181580|FG001|Overall Study|Withdrawal by Subject|0|||
27821885|NCT03629249|81181581|FG000|Overall Study|Study terminated by sponsor|197|||
27821886|NCT03629249|81181582|FG001|Overall Study|Study terminated by sponsor|197|||
27821887|NCT03629249|81181583|FG002|Overall Study|Study terminated by sponsor|194|||
27821888|NCT03629249|81181581|FG000|Overall Study|Protocol deviation|0|||
27821889|NCT03629249|81181582|FG001|Overall Study|Protocol deviation|2|||
27821890|NCT03629249|81181583|FG002|Overall Study|Protocol deviation|5|||
27821891|NCT03629249|81181581|FG000|Overall Study|Subject decision|1|||
27821892|NCT03629249|81181582|FG001|Overall Study|Subject decision|1|||
27821893|NCT03629249|81181583|FG002|Overall Study|Subject decision|3|||
27821894|NCT03629249|81181581|FG000|Overall Study|Adverse Event|1|||
27821895|NCT03629249|81181582|FG001|Overall Study|Adverse Event|1|||
27821896|NCT03629249|81181583|FG002|Overall Study|Adverse Event|0|||
27882382|NCT02147158|81401200|FG003|Treatment Course 2|Adverse Event|1|||
27882383|NCT02147158|81401201|FG004|Treatment Course 2|Adverse Event|0|||
27821897|NCT03629249|81181581|FG000|Overall Study|Death|1|||
27821898|NCT03629249|81181582|FG001|Overall Study|Death|0|||
27882384|NCT02147158|81401202|FG005|Treatment Course 2|Adverse Event|1|||
27821899|NCT03629249|81181583|FG002|Overall Study|Death|0|||
27593840|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27593841|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27593842|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27593843|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27882385|NCT02147158|81401197|FG000|Treatment Course 2|Withdrawal of Consent|0|||
27882386|NCT02147158|81401198|FG001|Treatment Course 2|Withdrawal of Consent|1|||
27593844|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
27882387|NCT02147158|81401199|FG002|Treatment Course 2|Withdrawal of Consent|2|||
27882388|NCT02147158|81401200|FG003|Treatment Course 2|Withdrawal of Consent|3|||
27882389|NCT02147158|81401201|FG004|Treatment Course 2|Withdrawal of Consent|0|||
27882390|NCT02147158|81401202|FG005|Treatment Course 2|Withdrawal of Consent|0|||
27882391|NCT02147158|81401197|FG000|Treatment Course 2|Lost to Follow-up|1|||
27882392|NCT02147158|81401198|FG001|Treatment Course 2|Lost to Follow-up|0|||
27882393|NCT02147158|81401199|FG002|Treatment Course 2|Lost to Follow-up|1|||
27882394|NCT02147158|81401200|FG003|Treatment Course 2|Lost to Follow-up|1|||
27882395|NCT02147158|81401201|FG004|Treatment Course 2|Lost to Follow-up|0|||
27882396|NCT02147158|81401202|FG005|Treatment Course 2|Lost to Follow-up|1|||
27882397|NCT02147158|81401197|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
27882398|NCT02147158|81401198|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
27593845|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27882399|NCT02147158|81401199|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
27882400|NCT02147158|81401200|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
27882401|NCT02147158|81401201|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
27882402|NCT02147158|81401202|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
27593846|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27694070|NCT03037931|80716638|FG001|Overall Study|Withdrawal by Subject|41|||
27593847|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27593848|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27593849|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27593850|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27593851|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27593852|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
27593853|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27593854|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27593855|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27593856|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27593857|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27694071|NCT00959647|80716642|FG000|Overall Study|Adverse Event|2|||
27694072|NCT00959647|80716642|FG000|Overall Study|Progressive disease|6|||
27694073|NCT00959647|80716642|FG000|Overall Study|Study terminated by sponsor|4|||
27694074|NCT00959647|80716642|FG000|Overall Study|Withdrawal by Subject|7|||
27694075|NCT01163916|80716643|FG000|Overall Study|Withdrawal by Subject|2|||
27694076|NCT01163916|80716644|FG001|Overall Study|Withdrawal by Subject|0|||
27694077|NCT01163916|80716645|FG002|Overall Study|Withdrawal by Subject|2|||
27694078|NCT01163916|80716643|FG000|Overall Study|Adverse Event|2|||
27694079|NCT01163916|80716644|FG001|Overall Study|Adverse Event|0|||
27882403|NCT02147158|81401197|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
27593858|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27593859|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
27694080|NCT01163916|80716645|FG002|Overall Study|Adverse Event|1|||
27694081|NCT01163916|80716643|FG000|Overall Study|Lack of Efficacy|2|||
27694082|NCT01163916|80716644|FG001|Overall Study|Lack of Efficacy|0|||
27694083|NCT01163916|80716645|FG002|Overall Study|Lack of Efficacy|1|||
27694084|NCT01163916|80716643|FG000|Overall Study|Other|24|||
27694085|NCT01163916|80716644|FG001|Overall Study|Other|4|||
27694086|NCT01163916|80716645|FG002|Overall Study|Other|16|||
27694087|NCT01768117|80716646|FG000|Overall Study|Lost to Follow-up|1|||
27694088|NCT01768117|80716646|FG000|Overall Study|Withdrawal by Subject|2|||
27694089|NCT01768117|80716646|FG000|Overall Study|Protocol Violation|3|||
27694090|NCT00031551|80716647|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
27694091|NCT00031551|80716648|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
27694092|NCT02973048|80716651|FG000|Overall Study|Epidural catheter insertion failure|1|||
27694093|NCT02973048|80716652|FG001|Overall Study|Epidural catheter insertion failure|0|||
27694094|NCT02973048|80716651|FG000|Overall Study|Withdrawal by Subject|0|||
27694095|NCT02973048|80716652|FG001|Overall Study|Withdrawal by Subject|3|||
27694096|NCT02783768|80716660|FG000|Overall Study|Lost to Follow-up|1|||
27694097|NCT02783768|80716661|FG001|Overall Study|Lost to Follow-up|0|||
27694098|NCT00596427|80716664|FG000|Overall Study|Withdrawal by Subject|2|||
27694099|NCT00596427|80716665|FG001|Overall Study|Withdrawal by Subject|2|||
27694100|NCT00596427|80716664|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
27694101|NCT00596427|80716665|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
27694102|NCT00596427|80716664|FG000|Overall Study|Protocol Violation|1|||
27694103|NCT00596427|80716665|FG001|Overall Study|Protocol Violation|0|||
27694104|NCT02960854|80716666|FG000|Overall Study|Not Disclosed|2|||
27694105|NCT02960854|80716667|FG001|Overall Study|Not Disclosed|2|||
27694106|NCT02960854|80716666|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
27694107|NCT02960854|80716667|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
27821900|NCT03629249|81181581|FG000|Overall Study|Physician Decision|1|||
27821901|NCT03629249|81181582|FG001|Overall Study|Physician Decision|0|||
27821902|NCT03629249|81181583|FG002|Overall Study|Physician Decision|0|||
27821903|NCT00856388|81181585|FG000|Overall Study|Other|1|||
27821904|NCT00086996|81181586|FG000|Overall Study|Adverse Event|29|||
27821905|NCT00086996|81181586|FG000|Overall Study|Death|4|||
27821906|NCT00086996|81181586|FG000|Overall Study|progression/relapse|7|||
27821907|NCT00086996|81181586|FG000|Overall Study|Withdrawal by Subject|13|||
27821908|NCT00086996|81181586|FG000|Overall Study|Other|6|||
27821909|NCT00086996|81181586|FG000|Overall Study|not eligible|5|||
27821910|NCT00184600|81181587|FG000|Overall Study|Adverse Event|9|||
27821911|NCT00184600|81181588|FG001|Overall Study|Adverse Event|0|||
27821912|NCT00184600|81181589|FG002|Overall Study|Adverse Event|5|||
27821913|NCT00184600|81181587|FG000|Overall Study|Death|3|||
27821914|NCT00184600|81181588|FG001|Overall Study|Death|9|||
27821915|NCT00184600|81181589|FG002|Overall Study|Death|7|||
27821916|NCT00184600|81181587|FG000|Overall Study|Lack of Efficacy|3|||
27821917|NCT00184600|81181588|FG001|Overall Study|Lack of Efficacy|1|||
27821918|NCT00184600|81181589|FG002|Overall Study|Lack of Efficacy|3|||
27821919|NCT00184600|81181587|FG000|Overall Study|Lost to Follow-up|4|||
27821920|NCT00184600|81181588|FG001|Overall Study|Lost to Follow-up|6|||
27821921|NCT00184600|81181589|FG002|Overall Study|Lost to Follow-up|1|||
27821922|NCT00184600|81181587|FG000|Overall Study|Protocol Violation|2|||
27821923|NCT00184600|81181588|FG001|Overall Study|Protocol Violation|2|||
27821924|NCT00184600|81181589|FG002|Overall Study|Protocol Violation|3|||
27821925|NCT00184600|81181587|FG000|Overall Study|Withdrawal by Subject|20|||
27821926|NCT00184600|81181588|FG001|Overall Study|Withdrawal by Subject|28|||
27821927|NCT00184600|81181589|FG002|Overall Study|Withdrawal by Subject|12|||
27821928|NCT00184600|81181587|FG000|Overall Study|Unclassified|4|||
27821929|NCT00184600|81181588|FG001|Overall Study|Unclassified|5|||
27821930|NCT00184600|81181589|FG002|Overall Study|Unclassified|3|||
27821931|NCT01918397|81181591|FG000|Overall Study|Never started treatment|2|||
27821932|NCT01918397|81181592|FG001|Overall Study|Never started treatment|1|||
27821933|NCT01918397|81181593|FG002|Overall Study|Never started treatment|0|||
27821934|NCT01918397|81181594|FG003|Overall Study|Never started treatment|0|||
27821935|NCT01918397|81181591|FG000|Overall Study|Adverse Event|1|||
27821936|NCT01918397|81181592|FG001|Overall Study|Adverse Event|1|||
27694108|NCT02960854|80716666|FG000|Overall Study|Subject Withdrew Consent|0|||
27694109|NCT02960854|80716667|FG001|Overall Study|Subject Withdrew Consent|1|||
27694110|NCT02960854|80716666|FG000|Overall Study|Death|4|||
27694111|NCT02960854|80716667|FG001|Overall Study|Death|6|||
27694112|NCT00091169|80716668|FG000|Overall Study|Disease progression|3|||
27694113|NCT00091169|80716669|FG001|Overall Study|Disease progression|1|||
27694114|NCT00091169|80716668|FG000|Overall Study|Adverse Event|11|||
27694115|NCT00091169|80716669|FG001|Overall Study|Adverse Event|17|||
27821937|NCT01918397|81181593|FG002|Overall Study|Adverse Event|1|||
27821938|NCT01918397|81181594|FG003|Overall Study|Adverse Event|0|||
27821939|NCT01918397|81181591|FG000|Overall Study|Lack of compliance|2|||
27593860|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
27593861|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
27593862|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
27593863|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
27593864|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
27593865|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
27593866|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
27593867|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
27593868|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
27593869|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593870|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593871|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
27593872|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593873|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593874|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593875|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593876|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27593877|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27821940|NCT01918397|81181592|FG001|Overall Study|Lack of compliance|2|||
27821941|NCT01918397|81181593|FG002|Overall Study|Lack of compliance|3|||
27821942|NCT01918397|81181594|FG003|Overall Study|Lack of compliance|0|||
27593878|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27821943|NCT01918397|81181591|FG000|Overall Study|Pregnancy|0|||
27821944|NCT01918397|81181592|FG001|Overall Study|Pregnancy|1|||
27821945|NCT01918397|81181593|FG002|Overall Study|Pregnancy|0|||
27821946|NCT01918397|81181594|FG003|Overall Study|Pregnancy|0|||
27882404|NCT02147158|81401198|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
27882405|NCT02147158|81401199|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
27593879|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27593880|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
27821947|NCT01918397|81181591|FG000|Overall Study|Rifampin susceptible|0|||
27821948|NCT01918397|81181592|FG001|Overall Study|Rifampin susceptible|0|||
27821949|NCT01918397|81181593|FG002|Overall Study|Rifampin susceptible|0|||
27821950|NCT01918397|81181594|FG003|Overall Study|Rifampin susceptible|2|||
27821951|NCT01918397|81181591|FG000|Overall Study|Treatment failure|0|||
27821952|NCT01918397|81181592|FG001|Overall Study|Treatment failure|0|||
27821953|NCT01918397|81181593|FG002|Overall Study|Treatment failure|0|||
27821954|NCT01918397|81181594|FG003|Overall Study|Treatment failure|1|||
27821955|NCT01918397|81181591|FG000|Overall Study|Withdrawal by Subject|3|||
27821956|NCT01918397|81181592|FG001|Overall Study|Withdrawal by Subject|2|||
27821957|NCT01918397|81181593|FG002|Overall Study|Withdrawal by Subject|1|||
27821958|NCT01918397|81181594|FG003|Overall Study|Withdrawal by Subject|1|||
27821959|NCT01918397|81181591|FG000|Overall Study|XDR at baseline|0|||
27821960|NCT01918397|81181592|FG001|Overall Study|XDR at baseline|0|||
27821961|NCT01918397|81181593|FG002|Overall Study|XDR at baseline|1|||
27821962|NCT01918397|81181594|FG003|Overall Study|XDR at baseline|0|||
27821963|NCT01918397|81181591|FG000|Overall Study|Lost to Follow-up|2|||
27821964|NCT01918397|81181592|FG001|Overall Study|Lost to Follow-up|1|||
27821965|NCT01918397|81181593|FG002|Overall Study|Lost to Follow-up|1|||
27821966|NCT01918397|81181594|FG003|Overall Study|Lost to Follow-up|1|||
27821967|NCT01918397|81181591|FG000|Overall Study|Increased QTc|1|||
27821968|NCT01918397|81181592|FG001|Overall Study|Increased QTc|0|||
27821969|NCT01918397|81181593|FG002|Overall Study|Increased QTc|0|||
27821970|NCT01918397|81181594|FG003|Overall Study|Increased QTc|1|||
27821971|NCT01918397|81181591|FG000|Overall Study|Death|0|||
27821972|NCT01918397|81181592|FG001|Overall Study|Death|0|||
27821973|NCT01918397|81181593|FG002|Overall Study|Death|1|||
27821974|NCT01918397|81181594|FG003|Overall Study|Death|0|||
27821975|NCT01918397|81181591|FG000|Overall Study|Involved in another investigative trial|0|||
27821976|NCT01918397|81181592|FG001|Overall Study|Involved in another investigative trial|0|||
27821977|NCT01918397|81181593|FG002|Overall Study|Involved in another investigative trial|0|||
27821978|NCT01918397|81181594|FG003|Overall Study|Involved in another investigative trial|1|||
27821979|NCT00050778|81181595|FG000|Overall Study|Adverse Event|13|||
27821980|NCT00050778|81181596|FG001|Overall Study|Adverse Event|3|||
27821981|NCT00050778|81181597|FG002|Overall Study|Adverse Event|2|||
27821982|NCT00050778|81181595|FG000|Overall Study|Death|0|||
27821983|NCT00050778|81181596|FG001|Overall Study|Death|1|||
27821984|NCT00050778|81181597|FG002|Overall Study|Death|1|||
27821985|NCT00050778|81181595|FG000|Overall Study|Lack of Efficacy|16|||
27821986|NCT00050778|81181596|FG001|Overall Study|Lack of Efficacy|2|||
27821987|NCT00050778|81181597|FG002|Overall Study|Lack of Efficacy|2|||
27821988|NCT00050778|81181595|FG000|Overall Study|Lost to Follow-up|0|||
27821989|NCT00050778|81181596|FG001|Overall Study|Lost to Follow-up|2|||
27821990|NCT00050778|81181597|FG002|Overall Study|Lost to Follow-up|4|||
27821991|NCT00050778|81181595|FG000|Overall Study|Physician Decision|3|||
27821992|NCT00050778|81181596|FG001|Overall Study|Physician Decision|0|||
27821993|NCT00050778|81181597|FG002|Overall Study|Physician Decision|2|||
27821994|NCT00050778|81181595|FG000|Overall Study|Protocol Violation|2|||
27821995|NCT00050778|81181596|FG001|Overall Study|Protocol Violation|0|||
27821996|NCT00050778|81181597|FG002|Overall Study|Protocol Violation|1|||
27821997|NCT00050778|81181595|FG000|Overall Study|Withdrawal by Subject|6|||
27821998|NCT00050778|81181596|FG001|Overall Study|Withdrawal by Subject|8|||
27821999|NCT00050778|81181597|FG002|Overall Study|Withdrawal by Subject|4|||
27822000|NCT00050778|81181595|FG000|Overall Study|Randomized but not treated|4|||
27822001|NCT00050778|81181596|FG001|Overall Study|Randomized but not treated|5|||
27822002|NCT00050778|81181597|FG002|Overall Study|Randomized but not treated|2|||
27822003|NCT00050778|81181595|FG000|Overall Study|Familial and personal reasons|1|||
27822004|NCT00050778|81181596|FG001|Overall Study|Familial and personal reasons|0|||
27822005|NCT00050778|81181597|FG002|Overall Study|Familial and personal reasons|0|||
27822006|NCT02937701|81181603|FG000|Day 1 to Week 22|Adverse Event|11|||
27822007|NCT02937701|81181604|FG001|Day 1 to Week 22|Adverse Event|14|||
27882406|NCT02147158|81401200|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
27882407|NCT02147158|81401201|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
27882408|NCT02147158|81401202|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
27882409|NCT02147158|81401197|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
27593881|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27822008|NCT02937701|81181605|FG002|Day 1 to Week 22|Adverse Event|0|||
27822009|NCT02937701|81181606|FG003|Day 1 to Week 22|Adverse Event|0|||
27882410|NCT02147158|81401198|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
27822010|NCT02937701|81181607|FG004|Day 1 to Week 22|Adverse Event|0|||
27822011|NCT02937701|81181603|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
27822012|NCT02937701|81181604|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
27822013|NCT02937701|81181605|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
27822014|NCT02937701|81181606|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
27822015|NCT02937701|81181607|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
27822016|NCT02937701|81181603|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
27822017|NCT02937701|81181604|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
27822018|NCT02937701|81181605|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
27822019|NCT02937701|81181606|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
27822020|NCT02937701|81181607|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
27822021|NCT02937701|81181603|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
27822022|NCT02937701|81181604|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
27822023|NCT02937701|81181605|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
27822024|NCT02937701|81181606|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
27822025|NCT02937701|81181607|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
27822026|NCT02937701|81181603|FG000|Day 1 to Week 22|Death|1|||
27822027|NCT02937701|81181604|FG001|Day 1 to Week 22|Death|1|||
27822028|NCT02937701|81181605|FG002|Day 1 to Week 22|Death|0|||
27882411|NCT02147158|81401199|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
27882412|NCT02147158|81401200|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
27882413|NCT02147158|81401201|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
27882414|NCT02147158|81401202|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
27882415|NCT02147158|81401197|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
27882416|NCT02147158|81401198|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
27882417|NCT02147158|81401199|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
27882418|NCT02147158|81401200|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
27822029|NCT02937701|81181606|FG003|Day 1 to Week 22|Death|0|||
27822030|NCT02937701|81181607|FG004|Day 1 to Week 22|Death|0|||
27822031|NCT02937701|81181603|FG000|Day 1 to Week 22|Protocol Violation|1|||
27822032|NCT02937701|81181604|FG001|Day 1 to Week 22|Protocol Violation|1|||
27822033|NCT02937701|81181605|FG002|Day 1 to Week 22|Protocol Violation|0|||
27822034|NCT02937701|81181606|FG003|Day 1 to Week 22|Protocol Violation|0|||
27822035|NCT02937701|81181607|FG004|Day 1 to Week 22|Protocol Violation|0|||
27882419|NCT02147158|81401201|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
27882420|NCT02147158|81401202|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
27822036|NCT02937701|81181603|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
27882421|NCT02147158|81401197|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
27882422|NCT02147158|81401198|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
27882423|NCT02147158|81401199|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
27822037|NCT02937701|81181604|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
27822038|NCT02937701|81181605|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
27822039|NCT02937701|81181606|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
27822040|NCT02937701|81181607|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
27822041|NCT02937701|81181603|FG000|Day 1 to Week 22|Physician Decision|2|||
27593882|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27822042|NCT02937701|81181604|FG001|Day 1 to Week 22|Physician Decision|0|||
27822043|NCT02937701|81181605|FG002|Day 1 to Week 22|Physician Decision|0|||
27822044|NCT02937701|81181606|FG003|Day 1 to Week 22|Physician Decision|0|||
27822045|NCT02937701|81181607|FG004|Day 1 to Week 22|Physician Decision|0|||
27822046|NCT02937701|81181603|FG000|Day 1 to Week 22|Other|1|||
27822047|NCT02937701|81181604|FG001|Day 1 to Week 22|Other|0|||
27822048|NCT02937701|81181605|FG002|Day 1 to Week 22|Other|0|||
27593883|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27822049|NCT02937701|81181606|FG003|Day 1 to Week 22|Other|0|||
27822050|NCT02937701|81181607|FG004|Day 1 to Week 22|Other|0|||
27822051|NCT02937701|81181603|FG000|Week 22 to Week 50|Adverse Event|0|||
27822052|NCT02937701|81181604|FG001|Week 22 to Week 50|Adverse Event|0|||
27822053|NCT02937701|81181605|FG002|Week 22 to Week 50|Adverse Event|10|||
27822054|NCT02937701|81181606|FG003|Week 22 to Week 50|Adverse Event|3|||
27822055|NCT02937701|81181607|FG004|Week 22 to Week 50|Adverse Event|3|||
27822056|NCT02937701|81181603|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
27822057|NCT02937701|81181604|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
27822058|NCT02937701|81181605|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
27822059|NCT02937701|81181606|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
27822060|NCT02937701|81181607|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
27822061|NCT02937701|81181603|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
27822062|NCT02937701|81181604|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
27822063|NCT02937701|81181605|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
27822064|NCT02937701|81181606|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
27822065|NCT02937701|81181607|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
27822066|NCT02937701|81181603|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
27822067|NCT02937701|81181604|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
27822068|NCT02937701|81181605|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
27822069|NCT02937701|81181606|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
27822070|NCT02937701|81181607|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
27822071|NCT02937701|81181603|FG000|Week 22 to Week 50|Physician Decision|0|||
27822072|NCT02937701|81181604|FG001|Week 22 to Week 50|Physician Decision|0|||
27822073|NCT02937701|81181605|FG002|Week 22 to Week 50|Physician Decision|2|||
27822074|NCT02937701|81181606|FG003|Week 22 to Week 50|Physician Decision|0|||
27822075|NCT02937701|81181607|FG004|Week 22 to Week 50|Physician Decision|1|||
27822076|NCT02937701|81181603|FG000|Week 22 to Week 50|Other|0|||
27822077|NCT02937701|81181604|FG001|Week 22 to Week 50|Other|0|||
27822078|NCT02937701|81181605|FG002|Week 22 to Week 50|Other|0|||
27822079|NCT02937701|81181606|FG003|Week 22 to Week 50|Other|0|||
27822080|NCT02937701|81181607|FG004|Week 22 to Week 50|Other|1|||
27822081|NCT02648347|81181608|FG000|Overall Study|Death|174|||
27822082|NCT02648347|81181609|FG001|Overall Study|Death|167|||
27593884|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27593885|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27593886|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
27593887|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593888|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593889|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
27593890|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593891|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593892|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593893|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593894|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593895|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27593896|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27593897|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
27593898|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27593899|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27593900|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27593901|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27593902|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27593903|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27593904|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27593905|NCT01212770|80352331|FG000|Long-term Safety Phase (Year 5)|Death|0|||
27593906|NCT01212770|80352332|FG001|Long-term Safety Phase (Year 5)|Death|0|||
27593907|NCT01212770|80352333|FG002|Long-term Safety Phase (Year 5)|Death|0|||
27593908|NCT01212770|80352334|FG003|Long-term Safety Phase (Year 5)|Death|0|||
27593909|NCT01212770|80352335|FG004|Long-term Safety Phase (Year 5)|Death|0|||
27593910|NCT01212770|80352336|FG005|Long-term Safety Phase (Year 5)|Death|0|||
27593911|NCT01212770|80352337|FG006|Long-term Safety Phase (Year 5)|Death|0|||
27593912|NCT01212770|80352338|FG007|Long-term Safety Phase (Year 5)|Death|1|||
27593913|NCT01212770|80352339|FG008|Long-term Safety Phase (Year 5)|Death|0|||
27593914|NCT02261493|80352340|FG000|Overall Study|Noncompliance|0|||
27593915|NCT02261493|80352341|FG001|Overall Study|Noncompliance|0|||
27593916|NCT02261493|80352342|FG002|Overall Study|Noncompliance|2|||
27593917|NCT02261493|80352340|FG000|Overall Study|Physician Decision|0|||
27593918|NCT02261493|80352341|FG001|Overall Study|Physician Decision|1|||
27593919|NCT02261493|80352342|FG002|Overall Study|Physician Decision|0|||
27593920|NCT02261493|80352340|FG000|Overall Study|Undisclosed alcohol abuse|0|||
27593921|NCT02261493|80352341|FG001|Overall Study|Undisclosed alcohol abuse|1|||
27593922|NCT02261493|80352342|FG002|Overall Study|Undisclosed alcohol abuse|0|||
27593923|NCT02261493|80352340|FG000|Overall Study|Protocol Violation|1|||
27822083|NCT02648347|81181608|FG000|Overall Study|Withdrawal by Subject|16|||
27882424|NCT02147158|81401200|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
27882425|NCT02147158|81401201|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
27882426|NCT02147158|81401202|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
27882427|NCT01684943|81401203|FG000|Overall Study|Inadequate Venous Access|3|||
27882428|NCT01684943|81401204|FG001|Overall Study|Inadequate Venous Access|0|||
27882429|NCT01684943|81401205|FG002|Overall Study|Inadequate Venous Access|0|||
27882430|NCT01684943|81401203|FG000|Overall Study|Principal Investigator Determination|1|||
27882431|NCT01684943|81401204|FG001|Overall Study|Principal Investigator Determination|0|||
27882432|NCT01684943|81401205|FG002|Overall Study|Principal Investigator Determination|0|||
27882433|NCT01684943|81401203|FG000|Overall Study|Excluded from Analysis|1|||
27882434|NCT01684943|81401204|FG001|Overall Study|Excluded from Analysis|1|||
27882435|NCT01684943|81401205|FG002|Overall Study|Excluded from Analysis|1|||
27882436|NCT01684943|81401203|FG000|Overall Study|Lost to Follow-up|3|||
27882437|NCT01684943|81401204|FG001|Overall Study|Lost to Follow-up|0|||
27882438|NCT01684943|81401205|FG002|Overall Study|Lost to Follow-up|0|||
27882439|NCT01684943|81401203|FG000|Overall Study|Planning Pregnancy|1|||
27882440|NCT01684943|81401204|FG001|Overall Study|Planning Pregnancy|0|||
27882441|NCT01684943|81401205|FG002|Overall Study|Planning Pregnancy|0|||
27882442|NCT02134015|81401206|FG000|Overall Study|Protocol Violation|0|||
27882443|NCT02134015|81401207|FG001|Overall Study|Protocol Violation|1|||
27882444|NCT02134015|81401206|FG000|Overall Study|Death|2|||
27882445|NCT02134015|81401207|FG001|Overall Study|Death|1|||
27882446|NCT02134015|81401206|FG000|Overall Study|Reason not provided|1|||
27882447|NCT02134015|81401207|FG001|Overall Study|Reason not provided|2|||
27882448|NCT02134015|81401206|FG000|Overall Study|Clinical progression|14|||
27882449|NCT02134015|81401207|FG001|Overall Study|Clinical progression|7|||
27882450|NCT02134015|81401206|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
27882451|NCT02134015|81401207|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
27882452|NCT02134015|81401206|FG000|Overall Study|Study terminated by sponsor|2|||
27882453|NCT02134015|81401207|FG001|Overall Study|Study terminated by sponsor|3|||
27882454|NCT02134015|81401206|FG000|Overall Study|Adverse Event|9|||
27882455|NCT02134015|81401207|FG001|Overall Study|Adverse Event|10|||
27882456|NCT02134015|81401206|FG000|Overall Study|Withdrawal by Subject|3|||
27882457|NCT02134015|81401207|FG001|Overall Study|Withdrawal by Subject|7|||
27882458|NCT03963232|81401208|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27882459|NCT03963232|81401209|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
27882460|NCT03963232|81401208|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
27882461|NCT03963232|81401209|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
27882462|NCT03963232|81401208|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
27882463|NCT03963232|81401209|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
27882464|NCT03963232|81401208|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
27882465|NCT03963232|81401209|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
27882466|NCT03963232|81401208|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
27882467|NCT03963232|81401209|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
27882468|NCT03963232|81401208|FG000|Open-Label Treatment Phase|Adverse Event|1|||
27882469|NCT03963232|81401209|FG001|Open-Label Treatment Phase|Adverse Event|2|||
27882470|NCT03963232|81401208|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
27822084|NCT02648347|81181609|FG001|Overall Study|Withdrawal by Subject|9|||
27822085|NCT02648347|81181608|FG000|Overall Study|Lost to Follow-up|18|||
27822086|NCT02648347|81181609|FG001|Overall Study|Lost to Follow-up|21|||
27822087|NCT02648347|81181608|FG000|Overall Study|Missing|1|||
27822088|NCT02648347|81181609|FG001|Overall Study|Missing|0|||
27822089|NCT02511782|81181611|FG000|Overall Study|Withdrawal by Subject|1|||
27822090|NCT02511782|81181612|FG001|Overall Study|Withdrawal by Subject|0|||
27822091|NCT02511782|81181613|FG002|Overall Study|Withdrawal by Subject|0|||
27822092|NCT03099538|81181614|FG000|Overall Study|Lack of Efficacy|3|||
27822093|NCT00496964|81181615|FG000|Overall Study|Withdrawal by Subject|0|||
27822094|NCT00496964|81181616|FG001|Overall Study|Withdrawal by Subject|1|||
27822095|NCT03164772|81181625|FG000|Overall Study|Death|4|||
27822096|NCT03164772|81181626|FG001|Overall Study|Death|2|||
27822097|NCT03164772|81181625|FG000|Overall Study|Adverse Event|1|||
27882471|NCT03963232|81401209|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
27882472|NCT03963232|81401208|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
27882473|NCT03963232|81401209|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
27882474|NCT03963232|81401208|FG000|Open-Label Treatment Phase|Pregnancy|1|||
27882475|NCT03963232|81401209|FG001|Open-Label Treatment Phase|Pregnancy|0|||
27593924|NCT02261493|80352341|FG001|Overall Study|Protocol Violation|0|||
27593925|NCT02261493|80352342|FG002|Overall Study|Protocol Violation|0|||
27882476|NCT03963232|81401208|FG000|Follow-up Phase|Withdrawal by Subject|7|||
27882477|NCT03963232|81401209|FG001|Follow-up Phase|Withdrawal by Subject|5|||
27882478|NCT03963232|81401208|FG000|Follow-up Phase|Protocol Violation|0|||
27593926|NCT02261493|80352340|FG000|Overall Study|Personal Reasons|14|||
27822098|NCT03164772|81181626|FG001|Overall Study|Adverse Event|4|||
27822099|NCT03164772|81181625|FG000|Overall Study|Progressive Disease|11|||
27882479|NCT03963232|81401209|FG001|Follow-up Phase|Protocol Violation|2|||
27822100|NCT03164772|81181626|FG001|Overall Study|Progressive Disease|21|||
27822101|NCT03164772|81181625|FG000|Overall Study|Physician Decision|2|||
27822102|NCT03164772|81181626|FG001|Overall Study|Physician Decision|0|||
27822103|NCT03164772|81181625|FG000|Overall Study|Withdrawal by Subject|0|||
27822104|NCT03164772|81181626|FG001|Overall Study|Withdrawal by Subject|4|||
27822105|NCT02682602|81181629|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
27822106|NCT02682602|81181630|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
27822107|NCT02682602|81181629|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
27822108|NCT02682602|81181630|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
27822109|NCT01544127|81181631|FG000|Overall Study|Lost to Follow-up|4|||
27822110|NCT01544127|81181632|FG001|Overall Study|Lost to Follow-up|2|||
27822111|NCT01544127|81181633|FG002|Overall Study|Lost to Follow-up|9|||
27822112|NCT01544127|81181631|FG000|Overall Study|Withdrawal by Subject|2|||
27822113|NCT01544127|81181632|FG001|Overall Study|Withdrawal by Subject|2|||
27822114|NCT01544127|81181633|FG002|Overall Study|Withdrawal by Subject|1|||
27822115|NCT01544127|81181631|FG000|Overall Study|Discharged out of catchment area|1|||
27882480|NCT03963232|81401208|FG000|Follow-up Phase|Adverse Event|0|||
27882481|NCT03963232|81401209|FG001|Follow-up Phase|Adverse Event|1|||
27882482|NCT03963232|81401208|FG000|Follow-up Phase|Lost to Follow-up|0|||
27882483|NCT03963232|81401209|FG001|Follow-up Phase|Lost to Follow-up|1|||
27882484|NCT00791778|81401210|FG000|Double-blind Treatment|Adverse Event|49|||
27882485|NCT00791778|81401211|FG001|Double-blind Treatment|Adverse Event|9|||
27882486|NCT00791778|81401210|FG000|Double-blind Treatment|Physician Decision|6|||
27882487|NCT00791778|81401211|FG001|Double-blind Treatment|Physician Decision|26|||
27882488|NCT00791778|81401210|FG000|Double-blind Treatment|Protocol Violation|0|||
27882489|NCT00791778|81401211|FG001|Double-blind Treatment|Protocol Violation|4|||
27882490|NCT00791778|81401210|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
27882491|NCT00791778|81401211|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
27882492|NCT00791778|81401210|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
27882493|NCT00791778|81401211|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
27822116|NCT01544127|81181632|FG001|Overall Study|Discharged out of catchment area|1|||
27882494|NCT00791778|81401210|FG000|Follow-up|Withdrawal by Subject|3|||
27882495|NCT00791778|81401211|FG001|Follow-up|Withdrawal by Subject|0|||
27882496|NCT00791778|81401210|FG000|Follow-up|Lost to Follow-up|2|||
27882497|NCT00791778|81401211|FG001|Follow-up|Lost to Follow-up|1|||
27882498|NCT01464164|81401213|FG000|Overall Study|Screen failure|0|||
27882499|NCT01464164|81401214|FG001|Overall Study|Screen failure|1|||
27882500|NCT01464164|81401215|FG002|Overall Study|Screen failure|2|||
27882501|NCT01464164|81401216|FG003|Overall Study|Screen failure|0|||
27882502|NCT01464164|81401217|FG004|Overall Study|Screen failure|0|||
27882503|NCT01464164|81401218|FG005|Overall Study|Screen failure|0|||
27882504|NCT01464164|81401219|FG006|Overall Study|Screen failure|0|||
27882505|NCT01464164|81401213|FG000|Overall Study|Physician Decision|0|||
27882506|NCT01464164|81401214|FG001|Overall Study|Physician Decision|1|||
27882507|NCT01464164|81401215|FG002|Overall Study|Physician Decision|0|||
27882508|NCT01464164|81401216|FG003|Overall Study|Physician Decision|0|||
27882509|NCT01464164|81401217|FG004|Overall Study|Physician Decision|0|||
27882510|NCT01464164|81401218|FG005|Overall Study|Physician Decision|0|||
27882511|NCT01464164|81401219|FG006|Overall Study|Physician Decision|2|||
27882512|NCT01623310|81401222|FG000|Overall Study|Adverse Event|21|||
27882513|NCT01623310|81401222|FG000|Overall Study|Lost to Follow-up|18|||
27882514|NCT01623310|81401222|FG000|Overall Study|Lack of Efficacy|6|||
27882515|NCT01623310|81401222|FG000|Overall Study|Protocol Violation|6|||
27882516|NCT01623310|81401222|FG000|Overall Study|Withdrawal by Subject|25|||
27882517|NCT01623310|81401222|FG000|Overall Study|Became potentially child-bearing|1|||
27882518|NCT01623310|81401222|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
27882519|NCT01623310|81401222|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
27882520|NCT00789854|81401225|FG000|Overall Study|Adverse Event|28|||
27882521|NCT00789854|81401226|FG001|Overall Study|Adverse Event|23|||
27882522|NCT00789854|81401227|FG002|Overall Study|Adverse Event|18|||
27882523|NCT00789854|81401225|FG000|Overall Study|Lost to Follow-up|1|||
27882524|NCT00789854|81401226|FG001|Overall Study|Lost to Follow-up|1|||
27882525|NCT00789854|81401227|FG002|Overall Study|Lost to Follow-up|4|||
27882526|NCT00789854|81401225|FG000|Overall Study|Withdrawal by Subject|9|||
27882527|NCT00789854|81401226|FG001|Overall Study|Withdrawal by Subject|6|||
27882528|NCT00789854|81401227|FG002|Overall Study|Withdrawal by Subject|17|||
27882529|NCT00789854|81401225|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27882530|NCT00789854|81401226|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
27882531|NCT00789854|81401227|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27882532|NCT00789854|81401225|FG000|Overall Study|Severe non-compliance to the protocol|3|||
27882533|NCT00789854|81401226|FG001|Overall Study|Severe non-compliance to the protocol|0|||
27882534|NCT00789854|81401227|FG002|Overall Study|Severe non-compliance to the protocol|0|||
27882535|NCT00789854|81401225|FG000|Overall Study|Safety reasons|0|||
27882536|NCT00789854|81401226|FG001|Overall Study|Safety reasons|0|||
27882537|NCT00789854|81401227|FG002|Overall Study|Safety reasons|2|||
27882538|NCT00789854|81401225|FG000|Overall Study|Other|6|||
27593927|NCT02261493|80352341|FG001|Overall Study|Personal Reasons|14|||
27882539|NCT00789854|81401226|FG001|Overall Study|Other|0|||
27882540|NCT00789854|81401227|FG002|Overall Study|Other|5|||
27882541|NCT01735916|81401237|FG000|Overall Study|Subject not eligible to be randomized|11|||
27882542|NCT01735916|81401238|FG001|Overall Study|Subject not eligible to be randomized|0|||
27882543|NCT01735916|81401239|FG002|Overall Study|Subject not eligible to be randomized|0|||
27882544|NCT01735916|81401237|FG000|Overall Study|Early termination of study by sponsor|4|||
27882545|NCT01735916|81401238|FG001|Overall Study|Early termination of study by sponsor|19|||
27882546|NCT01735916|81401239|FG002|Overall Study|Early termination of study by sponsor|7|||
27882547|NCT01735916|81401237|FG000|Overall Study|Withdrawal by Subject|3|||
27882548|NCT01735916|81401238|FG001|Overall Study|Withdrawal by Subject|0|||
27882549|NCT01735916|81401239|FG002|Overall Study|Withdrawal by Subject|0|||
27882550|NCT01017874|81401240|FG000|Overall Study|Withdrawal by Subject|23|||
27882551|NCT01017874|81401241|FG001|Overall Study|Withdrawal by Subject|20|||
27882552|NCT01017874|81401240|FG000|Overall Study|Sponsor decision|3|||
27882553|NCT01017874|81401241|FG001|Overall Study|Sponsor decision|1|||
27882554|NCT01017874|81401240|FG000|Overall Study|Lost to Follow-up|3|||
27882555|NCT01017874|81401241|FG001|Overall Study|Lost to Follow-up|2|||
27882556|NCT01017874|81401240|FG000|Overall Study|Physician Decision|1|||
27882557|NCT01017874|81401241|FG001|Overall Study|Physician Decision|3|||
27882558|NCT01757535|81401242|FG000|Overall Study|Disease Relapse|143|||
27882559|NCT01757535|81401243|FG001|Overall Study|Disease Relapse|180|||
27822117|NCT01544127|81181633|FG002|Overall Study|Discharged out of catchment area|1|||
27822118|NCT01544127|81181631|FG000|Overall Study|Death|1|||
27822119|NCT01544127|81181632|FG001|Overall Study|Death|0|||
27822120|NCT01544127|81181633|FG002|Overall Study|Death|0|||
27822121|NCT01544127|81181631|FG000|Overall Study|Jail or Prison|1|||
27822122|NCT01544127|81181632|FG001|Overall Study|Jail or Prison|1|||
27822123|NCT01544127|81181633|FG002|Overall Study|Jail or Prison|2|||
27822124|NCT01544127|81181631|FG000|Overall Study|Became Psychotic|1|||
27822125|NCT01544127|81181632|FG001|Overall Study|Became Psychotic|0|||
27822126|NCT01544127|81181633|FG002|Overall Study|Became Psychotic|0|||
27822127|NCT01544127|81181631|FG000|Overall Study|Researcher withdrew|1|||
27822128|NCT01544127|81181632|FG001|Overall Study|Researcher withdrew|0|||
27822129|NCT01544127|81181633|FG002|Overall Study|Researcher withdrew|0|||
27822130|NCT01544127|81181631|FG000|Overall Study|Went active duty|0|||
27822131|NCT01544127|81181632|FG001|Overall Study|Went active duty|0|||
27822132|NCT01544127|81181633|FG002|Overall Study|Went active duty|1|||
27822133|NCT03595657|81181638|FG000|Overall Study|Adverse Event|14|||
27822134|NCT03595657|81181638|FG000|Overall Study|Death|1|||
27822135|NCT03595657|81181638|FG000|Overall Study|Lack of Efficacy|40|||
27822136|NCT03595657|81181638|FG000|Overall Study|Withdrawal by Subject|10|||
27822137|NCT03595657|81181638|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
27822138|NCT03595657|81181638|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
27822139|NCT03555305|81181643|FG000|Period 1|Physician Decision|0|||
27822140|NCT03555305|81181644|FG001|Period 1|Physician Decision|1|||
27822141|NCT03555305|81181643|FG000|Period 1|Adverse Event|0|||
27822142|NCT03555305|81181644|FG001|Period 1|Adverse Event|1|||
27822143|NCT03496623|81181645|FG000|Run-In Period (2 Weeks)|Death|1|||
27822144|NCT03496623|81181646|FG001|Run-In Period (2 Weeks)|Death|0|||
27822145|NCT03496623|81181647|FG002|Run-In Period (2 Weeks)|Death|0|||
27822146|NCT03496623|81181648|FG003|Run-In Period (2 Weeks)|Death|0|||
27822147|NCT03496623|81181649|FG004|Run-In Period (2 Weeks)|Death|0|||
27822148|NCT03496623|81181645|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
27822149|NCT03496623|81181646|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
27822150|NCT03496623|81181647|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
27822151|NCT03496623|81181648|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
27822152|NCT03496623|81181649|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
27822153|NCT03496623|81181645|FG000|Period 1 (12 Weeks)|Death|0|||
27822154|NCT03496623|81181646|FG001|Period 1 (12 Weeks)|Death|3|||
27822155|NCT03496623|81181647|FG002|Period 1 (12 Weeks)|Death|0|||
27822156|NCT03496623|81181648|FG003|Period 1 (12 Weeks)|Death|0|||
27822157|NCT03496623|81181649|FG004|Period 1 (12 Weeks)|Death|0|||
27822158|NCT03496623|81181645|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
27822159|NCT03496623|81181646|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
27822160|NCT03496623|81181647|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
27882560|NCT01757535|81401242|FG000|Overall Study|Adverse Event|29|||
27822161|NCT03496623|81181648|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
27822162|NCT03496623|81181649|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
27822163|NCT03496623|81181645|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27822164|NCT03496623|81181646|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
27882561|NCT01757535|81401243|FG001|Overall Study|Adverse Event|11|||
27882562|NCT01757535|81401242|FG000|Overall Study|Withdrawal by Subject|9|||
27822165|NCT03496623|81181647|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
27882563|NCT01757535|81401243|FG001|Overall Study|Withdrawal by Subject|13|||
27882564|NCT01757535|81401242|FG000|Overall Study|Miscellaneous|5|||
27882565|NCT01757535|81401243|FG001|Overall Study|Miscellaneous|2|||
27882566|NCT01757535|81401242|FG000|Overall Study|Physician Decision|6|||
27882567|NCT01757535|81401243|FG001|Overall Study|Physician Decision|0|||
27882568|NCT01757535|81401242|FG000|Overall Study|Death|1|||
27882569|NCT01757535|81401243|FG001|Overall Study|Death|2|||
27882570|NCT00740792|81401244|FG000|Overall Study|Adverse Event|3|||
27882571|NCT00740792|81401245|FG001|Overall Study|Adverse Event|1|||
27882572|NCT00740792|81401246|FG002|Overall Study|Adverse Event|1|||
27882573|NCT00740792|81401247|FG003|Overall Study|Adverse Event|3|||
27882574|NCT00740792|81401244|FG000|Overall Study|Lack of Efficacy|1|||
27882575|NCT00740792|81401245|FG001|Overall Study|Lack of Efficacy|1|||
27882576|NCT00740792|81401246|FG002|Overall Study|Lack of Efficacy|0|||
27822166|NCT03496623|81181648|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27822167|NCT03496623|81181649|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27822168|NCT03496623|81181645|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
27822169|NCT03496623|81181646|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
27822170|NCT03496623|81181647|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
27822171|NCT03496623|81181648|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
27822172|NCT03496623|81181649|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
27822173|NCT03496623|81181645|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27822174|NCT03496623|81181646|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27882577|NCT00740792|81401247|FG003|Overall Study|Lack of Efficacy|3|||
27882578|NCT00740792|81401244|FG000|Overall Study|Lost to Follow-up|2|||
27694116|NCT00091169|80716668|FG000|Overall Study|Death|4|||
27694117|NCT00091169|80716669|FG001|Overall Study|Death|1|||
27694118|NCT00091169|80716668|FG000|Overall Study|Withdrawal by Subject|10|||
27694119|NCT00091169|80716669|FG001|Overall Study|Withdrawal by Subject|13|||
27694120|NCT00091169|80716668|FG000|Overall Study|Other|3|||
27694121|NCT00091169|80716669|FG001|Overall Study|Other|4|||
27694122|NCT00091169|80716668|FG000|Overall Study|Not start protocol therapy|26|||
27694123|NCT00091169|80716669|FG001|Overall Study|Not start protocol therapy|17|||
27694124|NCT01139021|80716670|FG000|Overall Study|Adverse Event|0|||
27694125|NCT01139021|80716671|FG001|Overall Study|Adverse Event|0|||
27694126|NCT01139021|80716672|FG002|Overall Study|Adverse Event|0|||
27694127|NCT01139021|80716673|FG003|Overall Study|Adverse Event|0|||
27694128|NCT01139021|80716674|FG004|Overall Study|Adverse Event|1|||
27694129|NCT01139021|80716675|FG005|Overall Study|Adverse Event|0|||
27822175|NCT03496623|81181647|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
27822176|NCT03496623|81181648|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27822177|NCT03496623|81181649|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27822178|NCT03496623|81181645|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
27822179|NCT03496623|81181646|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
27822180|NCT03496623|81181647|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
27822181|NCT03496623|81181648|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
27822182|NCT03496623|81181649|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
27822183|NCT03496623|81181645|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27822184|NCT03496623|81181646|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
27822185|NCT03496623|81181647|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27822186|NCT03496623|81181648|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27822187|NCT03496623|81181649|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27822188|NCT00624065|81181650|FG000|Overall Study|Adverse Event|5|||
27822189|NCT00624065|81181651|FG001|Overall Study|Adverse Event|6|||
27822190|NCT00624065|81181650|FG000|Overall Study|Lost to Follow-up|4|||
27822191|NCT00624065|81181651|FG001|Overall Study|Lost to Follow-up|1|||
27882579|NCT00740792|81401245|FG001|Overall Study|Lost to Follow-up|1|||
27822192|NCT00624065|81181650|FG000|Overall Study|Consent withdrawn|6|||
27882580|NCT00740792|81401246|FG002|Overall Study|Lost to Follow-up|0|||
27882581|NCT00740792|81401247|FG003|Overall Study|Lost to Follow-up|0|||
27882582|NCT00740792|81401244|FG000|Overall Study|Protocol Violation|0|||
27882583|NCT00740792|81401245|FG001|Overall Study|Protocol Violation|1|||
27882584|NCT00740792|81401246|FG002|Overall Study|Protocol Violation|0|||
27882585|NCT00740792|81401247|FG003|Overall Study|Protocol Violation|2|||
27882586|NCT00740792|81401244|FG000|Overall Study|Withdrawal by Subject|1|||
27882587|NCT00740792|81401245|FG001|Overall Study|Withdrawal by Subject|1|||
27882588|NCT00740792|81401246|FG002|Overall Study|Withdrawal by Subject|0|||
27882589|NCT00740792|81401247|FG003|Overall Study|Withdrawal by Subject|0|||
27882590|NCT00740792|81401244|FG000|Overall Study|administrative|3|||
27882591|NCT00740792|81401245|FG001|Overall Study|administrative|3|||
27882592|NCT00740792|81401246|FG002|Overall Study|administrative|8|||
27882593|NCT00740792|81401247|FG003|Overall Study|administrative|2|||
27882594|NCT00430573|81401248|FG000|Overall Study|Withdrawal by Subject|5|||
27882595|NCT00582608|81401249|FG000|Overall Study|Not Treated|7|||
27882596|NCT00582608|81401249|FG000|Overall Study|Patient Ineligible|1|||
27882597|NCT00582608|81401249|FG000|Overall Study|Lack of accrual|4|||
27882598|NCT01560234|81401253|FG000|Overall Study|Lost to Follow-up|3|||
27882599|NCT01560234|81401254|FG001|Overall Study|Lost to Follow-up|0|||
27882600|NCT01560234|81401255|FG002|Overall Study|Lost to Follow-up|1|||
27882601|NCT01560234|81401256|FG003|Overall Study|Lost to Follow-up|0|||
27882602|NCT01560234|81401257|FG004|Overall Study|Lost to Follow-up|0|||
27694130|NCT01139021|80716670|FG000|Overall Study|Lost to Follow-up|0|||
27694131|NCT01139021|80716671|FG001|Overall Study|Lost to Follow-up|0|||
27694132|NCT01139021|80716672|FG002|Overall Study|Lost to Follow-up|0|||
27694133|NCT01139021|80716673|FG003|Overall Study|Lost to Follow-up|0|||
27822193|NCT00624065|81181651|FG001|Overall Study|Consent withdrawn|5|||
27882603|NCT01560234|81401258|FG005|Overall Study|Lost to Follow-up|2|||
27882604|NCT01560234|81401259|FG006|Overall Study|Lost to Follow-up|0|||
27882605|NCT01560234|81401260|FG007|Overall Study|Lost to Follow-up|2|||
27694134|NCT01139021|80716674|FG004|Overall Study|Lost to Follow-up|2|||
27694135|NCT01139021|80716675|FG005|Overall Study|Lost to Follow-up|0|||
27694136|NCT01139021|80716670|FG000|Overall Study|Protocol Violation|1|||
27694137|NCT01139021|80716671|FG001|Overall Study|Protocol Violation|0|||
27694138|NCT01139021|80716672|FG002|Overall Study|Protocol Violation|0|||
27822194|NCT00624065|81181650|FG000|Overall Study|Lack of Efficacy|0|||
27822195|NCT00624065|81181651|FG001|Overall Study|Lack of Efficacy|3|||
27593928|NCT02261493|80352342|FG002|Overall Study|Personal Reasons|16|||
27593929|NCT02261493|80352340|FG000|Overall Study|Lost to Follow-up|14|||
27593930|NCT02261493|80352341|FG001|Overall Study|Lost to Follow-up|27|||
27593931|NCT02261493|80352342|FG002|Overall Study|Lost to Follow-up|8|||
27593932|NCT02261493|80352340|FG000|Overall Study|Pregnancy|1|||
27593933|NCT02261493|80352341|FG001|Overall Study|Pregnancy|2|||
27593934|NCT02261493|80352342|FG002|Overall Study|Pregnancy|0|||
27593935|NCT02261493|80352340|FG000|Overall Study|Lack of Efficacy|0|||
27593936|NCT02261493|80352341|FG001|Overall Study|Lack of Efficacy|1|||
27593937|NCT02261493|80352342|FG002|Overall Study|Lack of Efficacy|0|||
27593938|NCT02261493|80352340|FG000|Overall Study|Adverse Event|0|||
27593939|NCT02261493|80352341|FG001|Overall Study|Adverse Event|1|||
27593940|NCT02261493|80352342|FG002|Overall Study|Adverse Event|0|||
27593941|NCT02605954|80352345|FG000|Overall Study|Adverse Event|5|||
27593942|NCT02605954|80352346|FG001|Overall Study|Adverse Event|1|||
27593943|NCT02605954|80352345|FG000|Overall Study|Investigator's Discretion|1|||
27593944|NCT02605954|80352346|FG001|Overall Study|Investigator's Discretion|0|||
27822196|NCT00624065|81181650|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
27822197|NCT00624065|81181651|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
27822198|NCT02932878|81181658|FG000|Overall Study|Due to Lab Results|2|||
27822199|NCT02932878|81181659|FG001|Overall Study|Due to Lab Results|1|||
27822200|NCT00727961|81181661|FG000|Overall Study|Lost to Follow-up|1|||
27822201|NCT00727961|81181661|FG000|Overall Study|Adverse Event|4|||
27822202|NCT00727961|81181661|FG000|Overall Study|Patient's refusal|2|||
27822203|NCT00727961|81181661|FG000|Overall Study|Progression|30|||
27822204|NCT03567174|81181662|FG000|Overall Study|Death|24|||
27822205|NCT03567174|81181663|FG001|Overall Study|Death|31|||
27822206|NCT03567174|81181662|FG000|Overall Study|Lost to Follow-up|165|||
27822207|NCT03567174|81181663|FG001|Overall Study|Lost to Follow-up|174|||
27822208|NCT03657160|81181664|FG000|Overall Study|Adverse Event|5|||
27822209|NCT03657160|81181665|FG001|Overall Study|Adverse Event|6|||
27822210|NCT03657160|81181664|FG000|Overall Study|Protocol Deviation|3|||
27822211|NCT03657160|81181665|FG001|Overall Study|Protocol Deviation|0|||
27822212|NCT03657160|81181664|FG000|Overall Study|Withdrawal by Subject|18|||
27822213|NCT03657160|81181665|FG001|Overall Study|Withdrawal by Subject|16|||
27822214|NCT03657160|81181664|FG000|Overall Study|Site Termination|1|||
27822215|NCT03657160|81181665|FG001|Overall Study|Site Termination|0|||
27822216|NCT03657160|81181664|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
27822217|NCT03657160|81181665|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
27822218|NCT03657160|81181664|FG000|Overall Study|Death|33|||
27822219|NCT03657160|81181665|FG001|Overall Study|Death|26|||
27822220|NCT03657160|81181664|FG000|Overall Study|Death (COVID-19-Related)|1|||
27822221|NCT03657160|81181665|FG001|Overall Study|Death (COVID-19-Related)|0|||
27822222|NCT03657160|81181664|FG000|Overall Study|Reason Not Specified|5|||
27822223|NCT03657160|81181665|FG001|Overall Study|Reason Not Specified|5|||
27822224|NCT03657160|81181664|FG000|Overall Study|Other (COVID-19-Related)|0|||
27822225|NCT03657160|81181665|FG001|Overall Study|Other (COVID-19-Related)|1|||
27822226|NCT01880593|81181666|FG000|Overall Study|Adverse Event|1|||
27822227|NCT01880593|81181667|FG001|Overall Study|Adverse Event|0|||
27822228|NCT01880593|81181666|FG000|Overall Study|Lack of Efficacy|1|||
27822229|NCT01880593|81181667|FG001|Overall Study|Lack of Efficacy|5|||
27822230|NCT01880593|81181666|FG000|Overall Study|Withdrawal by Subject|6|||
27593945|NCT02605954|80352345|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27593946|NCT02605954|80352346|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27593947|NCT02605954|80352345|FG000|Overall Study|Withdrew Consent|2|||
27593948|NCT02605954|80352346|FG001|Overall Study|Withdrew Consent|2|||
27593949|NCT02605954|80352345|FG000|Overall Study|Lost to Follow-up|3|||
27822231|NCT01880593|81181667|FG001|Overall Study|Withdrawal by Subject|1|||
27822232|NCT03122457|81181668|FG000|Overall Study|Withdrawal by Subject|6|||
27822233|NCT01439880|81181669|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
27822234|NCT01439880|81181670|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
27822235|NCT01439880|81181669|FG000|SOC-controlled Period (Year 1)|Death|2|||
27822236|NCT01439880|81181670|FG001|SOC-controlled Period (Year 1)|Death|1|||
27822237|NCT01439880|81181669|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
27822238|NCT01439880|81181670|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
27822239|NCT01439880|81181669|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
27822240|NCT01439880|81181670|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
27822241|NCT01439880|81181669|FG000|SOC-controlled Period (Year 1)|Other|8|||
27822242|NCT01439880|81181670|FG001|SOC-controlled Period (Year 1)|Other|13|||
27822243|NCT01439880|81181669|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
27822244|NCT01439880|81181670|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
27822245|NCT01439880|81181669|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
27822246|NCT01439880|81181670|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
27822247|NCT01439880|81181669|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
27822248|NCT01439880|81181670|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
27822249|NCT01439880|81181669|FG000|All-IP Period (Years 2 to 5)|Death|3|||
27593950|NCT02605954|80352346|FG001|Overall Study|Lost to Follow-up|0|||
27822250|NCT01439880|81181670|FG001|All-IP Period (Years 2 to 5)|Death|13|||
27822251|NCT01439880|81181669|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
27822252|NCT01439880|81181670|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
27822253|NCT01439880|81181669|FG000|All-IP Period (Years 2 to 5)|Other|14|||
27822254|NCT01439880|81181670|FG001|All-IP Period (Years 2 to 5)|Other|31|||
27822255|NCT01439880|81181669|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
27822256|NCT01439880|81181670|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
27822257|NCT00855738|81181671|FG000|Overall Study|Lost to Follow-up|2|||
27822258|NCT00855738|81181671|FG000|Overall Study|Adverse Event|1|||
27822259|NCT00855738|81181671|FG000|Overall Study|Subject Defaulted|1|||
27822260|NCT00855738|81181671|FG000|Overall Study|Death|1|||
27822261|NCT01520909|81181672|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
27822262|NCT01520909|81181673|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
27822263|NCT01520909|81181674|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
27822264|NCT01520909|81181672|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
27822265|NCT01520909|81181673|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
27822266|NCT01520909|81181674|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
27882606|NCT01091662|81401268|FG000|Overall Study|Adverse Event|1|||
27882607|NCT01091662|81401269|FG001|Overall Study|Adverse Event|9|||
27882608|NCT01091662|81401268|FG000|Overall Study|Physician Decision|1|||
27882609|NCT01091662|81401269|FG001|Overall Study|Physician Decision|1|||
27882610|NCT01091662|81401268|FG000|Overall Study|Withdrawal by Subject|7|||
27882611|NCT01091662|81401269|FG001|Overall Study|Withdrawal by Subject|6|||
27882612|NCT01091662|81401268|FG000|Overall Study|met exit criteria|7|||
27882613|NCT01091662|81401269|FG001|Overall Study|met exit criteria|13|||
27882614|NCT01091662|81401268|FG000|Overall Study|met exclusion criteria|1|||
27882615|NCT01091662|81401269|FG001|Overall Study|met exclusion criteria|0|||
27593951|NCT02605954|80352345|FG000|Overall Study|Randomized but not treated|0|||
27822267|NCT01520909|81181672|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
27822268|NCT01520909|81181673|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
27822269|NCT01520909|81181674|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
27822270|NCT01520909|81181672|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
27822271|NCT01520909|81181673|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
27822272|NCT01520909|81181674|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
27822273|NCT03329027|81181692|FG000|Overall Study|Lost to Follow-up|1|||
27822274|NCT03329027|81181693|FG001|Overall Study|Lost to Follow-up|0|||
27822275|NCT03329027|81181694|FG002|Overall Study|Lost to Follow-up|1|||
27822276|NCT03329027|81181692|FG000|Overall Study|Protocol Violation|9|||
27822277|NCT03329027|81181693|FG001|Overall Study|Protocol Violation|5|||
27822278|NCT03329027|81181694|FG002|Overall Study|Protocol Violation|7|||
27822279|NCT02711852|81181695|FG000|Overall Study|Death|5|||
27822280|NCT02711852|81181695|FG000|Overall Study|Lost to Follow-up|1|||
27822281|NCT02711852|81181695|FG000|Overall Study|Completed follow-up|3|||
27822282|NCT02711852|81181695|FG000|Overall Study|Withdrawal by Subject|1|||
27822283|NCT01772537|81181696|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
27822284|NCT01772537|81181697|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
27822285|NCT01772537|81181698|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
27822286|NCT02098876|81181699|FG000|Overall Study|Withdrawal by Subject|5|||
27822287|NCT02098876|81181700|FG001|Overall Study|Withdrawal by Subject|5|||
27882616|NCT01091662|81401268|FG000|Overall Study|Lost to Follow-up|0|||
27882617|NCT01091662|81401269|FG001|Overall Study|Lost to Follow-up|1|||
27882618|NCT01091662|81401268|FG000|Overall Study|Pregnancy|0|||
27882619|NCT01091662|81401269|FG001|Overall Study|Pregnancy|1|||
27882620|NCT01091662|81401268|FG000|Overall Study|Protocol Violation|0|||
27882621|NCT01091662|81401269|FG001|Overall Study|Protocol Violation|2|||
27882622|NCT01091662|81401268|FG000|Overall Study|unable to swallow capsule|0|||
27882623|NCT01091662|81401269|FG001|Overall Study|unable to swallow capsule|1|||
27882624|NCT00083759|81401274|FG000|Overall Study|Adverse Event|5|||
27882625|NCT00083759|81401275|FG001|Overall Study|Adverse Event|3|||
27882626|NCT00083759|81401274|FG000|Overall Study|Lost to Follow-up|1|||
27882627|NCT00083759|81401275|FG001|Overall Study|Lost to Follow-up|0|||
27882628|NCT00083759|81401274|FG000|Overall Study|Death|1|||
27882629|NCT00083759|81401275|FG001|Overall Study|Death|1|||
27882630|NCT00083759|81401274|FG000|Overall Study|Inadequate Therapeutic Response|32|||
27882631|NCT00083759|81401275|FG001|Overall Study|Inadequate Therapeutic Response|35|||
27882632|NCT00083759|81401274|FG000|Overall Study|Subject Withdrew Consent|2|||
27882633|NCT00083759|81401275|FG001|Overall Study|Subject Withdrew Consent|2|||
27882634|NCT00083759|81401274|FG000|Overall Study|Non-Compliance|1|||
27882635|NCT00083759|81401275|FG001|Overall Study|Non-Compliance|0|||
27882636|NCT00083759|81401274|FG000|Overall Study|Sponsor's Discretion|28|||
27882637|NCT00083759|81401275|FG001|Overall Study|Sponsor's Discretion|29|||
27882638|NCT00083759|81401274|FG000|Overall Study|Other|14|||
27882639|NCT00083759|81401275|FG001|Overall Study|Other|13|||
27593952|NCT02605954|80352346|FG001|Overall Study|Randomized but not treated|1|||
27822288|NCT01900730|81181701|FG000|Overall Study|Withdrawal by Subject|1|||
27822289|NCT01900730|81181702|FG001|Overall Study|Withdrawal by Subject|0|||
27822290|NCT01900730|81181701|FG000|Overall Study|Screen Failure|1|||
27822291|NCT01900730|81181702|FG001|Overall Study|Screen Failure|0|||
27822292|NCT00846495|81181714|FG000|Overall Study|Lost to Follow-up|1|||
27822293|NCT00846495|81181715|FG001|Overall Study|Lost to Follow-up|0|||
27822294|NCT00846495|81181714|FG000|Overall Study|Adverse Event|5|||
27822295|NCT00846495|81181715|FG001|Overall Study|Adverse Event|1|||
27822296|NCT00846495|81181714|FG000|Overall Study|Lack of Efficacy|1|||
27822297|NCT00846495|81181715|FG001|Overall Study|Lack of Efficacy|2|||
27882640|NCT02347774|81401283|FG000|Study Participation|Lost to Follow-up|3|||
27882641|NCT02347774|81401284|FG001|Study Participation|Lost to Follow-up|6|||
27882642|NCT02347774|81401285|FG002|Study Participation|Lost to Follow-up|2|||
27882643|NCT02347774|81401283|FG000|Study Participation|Withdrawal by Subject|8|||
27882644|NCT02347774|81401284|FG001|Study Participation|Withdrawal by Subject|9|||
27882645|NCT02347774|81401285|FG002|Study Participation|Withdrawal by Subject|15|||
27593953|NCT00725296|80352347|FG000|Overall Study|Adverse Event|11|||
27822298|NCT00846495|81181714|FG000|Overall Study|Physician Decision|1|||
27822299|NCT00846495|81181715|FG001|Overall Study|Physician Decision|0|||
27822300|NCT01355081|81181716|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
27822301|NCT01355081|81181717|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
27882646|NCT02347774|81401283|FG000|Study Participation|Adverse Event|1|||
27882647|NCT02347774|81401284|FG001|Study Participation|Adverse Event|4|||
27822302|NCT01355081|81181718|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
27822303|NCT01355081|81181716|FG000|Overall Study|Major Protocol Deviation|0|||
27822304|NCT01355081|81181717|FG001|Overall Study|Major Protocol Deviation|1|||
27822305|NCT01355081|81181718|FG002|Overall Study|Major Protocol Deviation|0|||
27822306|NCT01355081|81181716|FG000|Overall Study|Lost to Follow-up|0|||
27822307|NCT01355081|81181717|FG001|Overall Study|Lost to Follow-up|0|||
27822308|NCT01355081|81181718|FG002|Overall Study|Lost to Follow-up|1|||
27822309|NCT01355081|81181716|FG000|Overall Study|Withdrawal of Consent|2|||
27822310|NCT01355081|81181717|FG001|Overall Study|Withdrawal of Consent|3|||
27822311|NCT01355081|81181718|FG002|Overall Study|Withdrawal of Consent|3|||
27822312|NCT01355081|81181716|FG000|Overall Study|Lack of Efficacy|2|||
27822313|NCT01355081|81181717|FG001|Overall Study|Lack of Efficacy|1|||
27822314|NCT01355081|81181718|FG002|Overall Study|Lack of Efficacy|1|||
27822315|NCT01355081|81181716|FG000|Overall Study|Non Compliance with Study Medication|0|||
27822316|NCT01355081|81181717|FG001|Overall Study|Non Compliance with Study Medication|1|||
27822317|NCT01355081|81181718|FG002|Overall Study|Non Compliance with Study Medication|0|||
27822318|NCT00965185|81181724|FG000|Overall Study|Lost to Follow-up|2|||
27822319|NCT00965185|81181725|FG001|Overall Study|Lost to Follow-up|0|||
27822320|NCT00965185|81181724|FG000|Overall Study|Withdrawal by Subject|0|||
27822321|NCT00965185|81181725|FG001|Overall Study|Withdrawal by Subject|1|||
27822322|NCT02732210|81181726|FG000|Overall Study|Site Closed|0|||
27822323|NCT02732210|81181727|FG001|Overall Study|Site Closed|11|||
27822324|NCT02732210|81181726|FG000|Overall Study|Study Ended|13|||
27822325|NCT02732210|81181727|FG001|Overall Study|Study Ended|13|||
27822326|NCT02732210|81181726|FG000|Overall Study|Withdrawal by Subject|28|||
27822327|NCT02732210|81181727|FG001|Overall Study|Withdrawal by Subject|87|||
27822328|NCT02732210|81181726|FG000|Overall Study|Lost to Follow-up|5|||
27822329|NCT02732210|81181727|FG001|Overall Study|Lost to Follow-up|57|||
27822330|NCT02732210|81181726|FG000|Overall Study|Death|4|||
27822331|NCT02732210|81181727|FG001|Overall Study|Death|15|||
27822332|NCT02732210|81181726|FG000|Overall Study|Other|35|||
27822333|NCT02732210|81181727|FG001|Overall Study|Other|103|||
27822334|NCT02732210|81181726|FG000|Overall Study|Missing|0|||
27882648|NCT02347774|81401285|FG002|Study Participation|Adverse Event|6|||
27882649|NCT02347774|81401283|FG000|Study Participation|withdrew consent|1|||
27882650|NCT02347774|81401284|FG001|Study Participation|withdrew consent|1|||
27882651|NCT02347774|81401285|FG002|Study Participation|withdrew consent|1|||
27882652|NCT02347774|81401283|FG000|Study Participation|Met Prolonged QT criteria|1|||
27882653|NCT02347774|81401284|FG001|Study Participation|Met Prolonged QT criteria|0|||
27882654|NCT02347774|81401285|FG002|Study Participation|Met Prolonged QT criteria|0|||
27882655|NCT02347774|81401283|FG000|Study Participation|non-compliance with study drug|0|||
27882656|NCT02347774|81401284|FG001|Study Participation|non-compliance with study drug|1|||
27882657|NCT02347774|81401285|FG002|Study Participation|non-compliance with study drug|0|||
27882658|NCT02347774|81401283|FG000|Study Participation|incarceration|1|||
27882659|NCT02347774|81401284|FG001|Study Participation|incarceration|0|||
27882660|NCT02347774|81401285|FG002|Study Participation|incarceration|0|||
27822335|NCT02732210|81181727|FG001|Overall Study|Missing|8|||
27822336|NCT03203447|81181728|FG000|Overall Study|Withdrawal by Subject|2|||
27822337|NCT03203447|81181729|FG001|Overall Study|Withdrawal by Subject|1|||
27822338|NCT03203447|81181728|FG000|Overall Study|Lost to Follow-up|1|||
27882661|NCT02347774|81401283|FG000|Study Participation|randomized in error|0|||
27882662|NCT02347774|81401284|FG001|Study Participation|randomized in error|0|||
27882663|NCT02347774|81401285|FG002|Study Participation|randomized in error|1|||
27882664|NCT02347774|81401283|FG000|On Study Treatment|Adverse Event|9|||
27882665|NCT02347774|81401284|FG001|On Study Treatment|Adverse Event|15|||
27882666|NCT02347774|81401285|FG002|On Study Treatment|Adverse Event|19|||
27882667|NCT02347774|81401283|FG000|On Study Treatment|Lack of Efficacy|3|||
27882668|NCT02347774|81401284|FG001|On Study Treatment|Lack of Efficacy|0|||
27882669|NCT02347774|81401285|FG002|On Study Treatment|Lack of Efficacy|2|||
27882670|NCT02347774|81401283|FG000|On Study Treatment|non-complicance with study medication|0|||
27882671|NCT02347774|81401284|FG001|On Study Treatment|non-complicance with study medication|2|||
27882672|NCT02347774|81401285|FG002|On Study Treatment|non-complicance with study medication|0|||
27882673|NCT02347774|81401283|FG000|On Study Treatment|Protocol Violation|0|||
27882674|NCT02347774|81401284|FG001|On Study Treatment|Protocol Violation|0|||
27822339|NCT03203447|81181729|FG001|Overall Study|Lost to Follow-up|10|||
27822340|NCT03203447|81181728|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
27822341|NCT03203447|81181729|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
27822342|NCT00301366|81181732|FG000|Overall Study|Adverse Event|1|||
27822343|NCT01866319|81181733|FG000|Overall Study|Adverse Event|12|||
27822344|NCT01866319|81181734|FG001|Overall Study|Adverse Event|5|||
27822345|NCT01866319|81181735|FG002|Overall Study|Adverse Event|9|||
27822346|NCT01866319|81181733|FG000|Overall Study|Clinical progression|3|||
27822347|NCT01866319|81181734|FG001|Overall Study|Clinical progression|2|||
27822348|NCT01866319|81181735|FG002|Overall Study|Clinical progression|2|||
27822349|NCT01866319|81181733|FG000|Overall Study|Death|153|||
27822350|NCT01866319|81181734|FG001|Overall Study|Death|154|||
27822351|NCT01866319|81181735|FG002|Overall Study|Death|147|||
27822352|NCT01866319|81181733|FG000|Overall Study|Lost to Follow-up|6|||
27822353|NCT01866319|81181734|FG001|Overall Study|Lost to Follow-up|3|||
27822354|NCT01866319|81181735|FG002|Overall Study|Lost to Follow-up|8|||
27822355|NCT01866319|81181733|FG000|Overall Study|Physician Decision|1|||
27822356|NCT01866319|81181734|FG001|Overall Study|Physician Decision|0|||
27822357|NCT01866319|81181735|FG002|Overall Study|Physician Decision|1|||
27882675|NCT02347774|81401285|FG002|On Study Treatment|Protocol Violation|1|||
27822358|NCT01866319|81181733|FG000|Overall Study|Protocol Violation|0|||
27882676|NCT02347774|81401283|FG000|On Study Treatment|withdrew consent|9|||
27822359|NCT01866319|81181734|FG001|Overall Study|Protocol Violation|0|||
27822360|NCT01866319|81181735|FG002|Overall Study|Protocol Violation|1|||
27822361|NCT01866319|81181733|FG000|Overall Study|Withdrawal by Subject|32|||
27822362|NCT01866319|81181734|FG001|Overall Study|Withdrawal by Subject|14|||
27822363|NCT01866319|81181735|FG002|Overall Study|Withdrawal by Subject|12|||
27882677|NCT02347774|81401284|FG001|On Study Treatment|withdrew consent|8|||
27882678|NCT02347774|81401285|FG002|On Study Treatment|withdrew consent|12|||
27882679|NCT02347774|81401283|FG000|On Study Treatment|Lost to Follow-up|2|||
27822364|NCT02331394|81181736|FG000|Overall Study|Disease progression|1|||
27822365|NCT02127281|81181737|FG000|Overall Study|Lost to Follow-up|1|||
27822366|NCT02127281|81181738|FG001|Overall Study|Lost to Follow-up|0|||
27822367|NCT02468778|81181739|FG000|Overall Study|Death|2|||
27822368|NCT02468778|81181740|FG001|Overall Study|Death|1|||
27822369|NCT02468778|81181741|FG002|Overall Study|Death|0|||
27822370|NCT02468778|81181739|FG000|Overall Study|Lost to Follow-up|1|||
27822371|NCT02468778|81181740|FG001|Overall Study|Lost to Follow-up|2|||
27822372|NCT02468778|81181741|FG002|Overall Study|Lost to Follow-up|2|||
27822373|NCT02468778|81181739|FG000|Overall Study|Withdrawal by Subject|0|||
27822374|NCT02468778|81181740|FG001|Overall Study|Withdrawal by Subject|1|||
27822375|NCT02468778|81181741|FG002|Overall Study|Withdrawal by Subject|1|||
27822376|NCT04510285|81181742|FG000|Overall Study|Death|1|||
27822377|NCT02414152|81181743|FG000|Overall Study|Withdrawal by Subject|1|||
27822378|NCT02414152|81181743|FG000|Overall Study|Lack of Efficacy|1|||
27822379|NCT03447262|81181745|FG000|Overall Study|Adverse Event|7|||
27822380|NCT03447262|81181745|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
27822381|NCT03447262|81181745|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
27822382|NCT03447262|81181745|FG000|Overall Study|Death|2|||
27822383|NCT03447262|81181745|FG000|Overall Study|Study Termination by Sponsor|455|||
27822384|NCT03447262|81181745|FG000|Overall Study|Other|4|||
27822385|NCT03478397|81181746|FG000|Overall Study|Refused to participate|31|||
27882680|NCT02347774|81401284|FG001|On Study Treatment|Lost to Follow-up|6|||
27882681|NCT02347774|81401285|FG002|On Study Treatment|Lost to Follow-up|1|||
27882682|NCT02347774|81401283|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
27882683|NCT02347774|81401284|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
27882684|NCT02347774|81401285|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
27882685|NCT02347774|81401283|FG000|On Study Treatment|ranomized in error|0|||
27882686|NCT02347774|81401284|FG001|On Study Treatment|ranomized in error|0|||
27882687|NCT02347774|81401285|FG002|On Study Treatment|ranomized in error|1|||
27882688|NCT00442897|81401286|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
27882689|NCT00442897|81401287|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
27882690|NCT00442897|81401286|FG000|Base Study (12 Week Follow-up)|Death|0|||
27882691|NCT00442897|81401287|FG001|Base Study (12 Week Follow-up)|Death|1|||
27882692|NCT00442897|81401286|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
27882693|NCT00442897|81401287|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
27882694|NCT00442897|81401286|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
27882695|NCT00442897|81401287|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
27882696|NCT00442897|81401286|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
27882697|NCT00442897|81401287|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
27882698|NCT00442897|81401286|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
27882699|NCT00442897|81401287|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
27882700|NCT00442897|81401286|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
27882701|NCT00442897|81401287|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
27882702|NCT00442897|81401286|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
27882703|NCT00442897|81401287|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
27882704|NCT00356603|81401288|FG000|Overall Study|Other|6|||
27882705|NCT00356603|81401289|FG001|Overall Study|Other|3|||
27882706|NCT00961571|81401290|FG000|Overall Study|Physician Decision|39|||
27882707|NCT02589626|81401293|FG000|Overall Study|Other than the reason specified|1|||
27882708|NCT02589626|81401294|FG001|Overall Study|Other than the reason specified|0|||
27882709|NCT02589626|81401293|FG000|Overall Study|Withdrawal by Subject|1|||
27882710|NCT02589626|81401294|FG001|Overall Study|Withdrawal by Subject|1|||
27882711|NCT02589626|81401293|FG000|Overall Study|Adverse Event|1|||
27882712|NCT02589626|81401294|FG001|Overall Study|Adverse Event|1|||
27882713|NCT02073929|81401295|FG000|Overall Study|Lost to Follow-up|2|||
27822386|NCT03478397|81181747|FG001|Overall Study|Refused to participate|7|||
27822387|NCT02817841|81181748|FG000|Overall Study|Lost to Follow-up|287|||
27822388|NCT02817841|81181748|FG000|Overall Study|Withdrawal by Subject|183|||
27822389|NCT02817841|81181748|FG000|Overall Study|Adverse event not related to bleeding|131|||
27822390|NCT02817841|81181748|FG000|Overall Study|Adverse event related to bleeding|51|||
27822391|NCT02817841|81181748|FG000|Overall Study|Pregnancy|32|||
27822392|NCT02817841|81181748|FG000|Overall Study|Pregnancy wish|17|||
27822393|NCT02817841|81181748|FG000|Overall Study|Other reasons|53|||
27822394|NCT02817841|81181748|FG000|Overall Study|Protocol Violation|94|||
27822395|NCT00485472|81181751|FG000|Overall Study|Adverse Event|8|||
27822396|NCT00485472|81181752|FG001|Overall Study|Adverse Event|5|||
27822397|NCT00485472|81181751|FG000|Overall Study|Lack of Efficacy|5|||
27822398|NCT00485472|81181752|FG001|Overall Study|Lack of Efficacy|4|||
27822399|NCT00485472|81181751|FG000|Overall Study|Withdrawal by Subject|1|||
27822400|NCT00485472|81181752|FG001|Overall Study|Withdrawal by Subject|0|||
27822401|NCT00485472|81181751|FG000|Overall Study|Protocol Violation|0|||
27822402|NCT00485472|81181752|FG001|Overall Study|Protocol Violation|1|||
27822403|NCT00485472|81181751|FG000|Overall Study|Other|2|||
27822404|NCT00485472|81181752|FG001|Overall Study|Other|1|||
27822405|NCT00485472|81181751|FG000|Overall Study|Lost to Follow-up|0|||
27822406|NCT00485472|81181752|FG001|Overall Study|Lost to Follow-up|1|||
27822407|NCT00864097|81181759|FG000|Overall Study|Death|0|||
27822408|NCT00864097|81181760|FG001|Overall Study|Death|1|||
27822409|NCT00864097|81181761|FG002|Overall Study|Death|0|||
27822410|NCT00864097|81181762|FG003|Overall Study|Death|0|||
27822411|NCT00864097|81181759|FG000|Overall Study|Adverse Event|6|||
27822412|NCT00864097|81181760|FG001|Overall Study|Adverse Event|8|||
27822413|NCT00864097|81181761|FG002|Overall Study|Adverse Event|11|||
27822414|NCT00864097|81181762|FG003|Overall Study|Adverse Event|9|||
27822415|NCT00864097|81181759|FG000|Overall Study|Lack of Efficacy|9|||
27822416|NCT00864097|81181760|FG001|Overall Study|Lack of Efficacy|3|||
27822417|NCT00864097|81181761|FG002|Overall Study|Lack of Efficacy|7|||
27822418|NCT00864097|81181762|FG003|Overall Study|Lack of Efficacy|2|||
27822419|NCT00864097|81181759|FG000|Overall Study|Lost to Follow-up|0|||
27822420|NCT00864097|81181760|FG001|Overall Study|Lost to Follow-up|1|||
27822421|NCT00864097|81181761|FG002|Overall Study|Lost to Follow-up|0|||
27822422|NCT00864097|81181762|FG003|Overall Study|Lost to Follow-up|1|||
27822423|NCT00864097|81181759|FG000|Overall Study|Withdrawal by Subject|15|||
27822424|NCT00864097|81181760|FG001|Overall Study|Withdrawal by Subject|11|||
27822425|NCT00864097|81181761|FG002|Overall Study|Withdrawal by Subject|11|||
27822426|NCT00864097|81181762|FG003|Overall Study|Withdrawal by Subject|12|||
27822427|NCT00864097|81181759|FG000|Overall Study|Protocol Violation|2|||
27822428|NCT00864097|81181760|FG001|Overall Study|Protocol Violation|1|||
27822429|NCT00864097|81181761|FG002|Overall Study|Protocol Violation|0|||
27822430|NCT00864097|81181762|FG003|Overall Study|Protocol Violation|1|||
27822431|NCT00864097|81181759|FG000|Overall Study|Terminated by sponsor|105|||
27822432|NCT00864097|81181760|FG001|Overall Study|Terminated by sponsor|112|||
27822433|NCT00864097|81181761|FG002|Overall Study|Terminated by sponsor|102|||
27822434|NCT00864097|81181762|FG003|Overall Study|Terminated by sponsor|99|||
27822435|NCT00864097|81181759|FG000|Overall Study|Randomized but not treated|2|||
27822436|NCT00864097|81181760|FG001|Overall Study|Randomized but not treated|0|||
27822437|NCT00864097|81181761|FG002|Overall Study|Randomized but not treated|1|||
27822438|NCT00864097|81181762|FG003|Overall Study|Randomized but not treated|0|||
27822439|NCT00864097|81181759|FG000|Overall Study|Other|0|||
27822440|NCT00864097|81181760|FG001|Overall Study|Other|0|||
27822441|NCT00864097|81181761|FG002|Overall Study|Other|0|||
27822442|NCT00864097|81181762|FG003|Overall Study|Other|1|||
27822443|NCT00696020|81181763|FG000|Overall Study|Adverse Event|3|||
27822444|NCT00696020|81181764|FG001|Overall Study|Adverse Event|1|||
27822445|NCT00696020|81181765|FG002|Overall Study|Adverse Event|2|||
27822446|NCT00696020|81181766|FG003|Overall Study|Adverse Event|1|||
27822447|NCT00696020|81181763|FG000|Overall Study|Lack of Efficacy|1|||
27822448|NCT00696020|81181764|FG001|Overall Study|Lack of Efficacy|0|||
27822449|NCT00696020|81181765|FG002|Overall Study|Lack of Efficacy|0|||
27822450|NCT00696020|81181766|FG003|Overall Study|Lack of Efficacy|0|||
27822451|NCT00696020|81181763|FG000|Overall Study|Protocol Violation|0|||
27822452|NCT00696020|81181764|FG001|Overall Study|Protocol Violation|0|||
27822453|NCT00696020|81181765|FG002|Overall Study|Protocol Violation|0|||
27822454|NCT00696020|81181766|FG003|Overall Study|Protocol Violation|1|||
27822455|NCT00696020|81181763|FG000|Overall Study|Withdrawal by Subject|0|||
27822456|NCT00696020|81181764|FG001|Overall Study|Withdrawal by Subject|1|||
27822457|NCT00696020|81181765|FG002|Overall Study|Withdrawal by Subject|0|||
27822458|NCT00696020|81181766|FG003|Overall Study|Withdrawal by Subject|1|||
27822459|NCT00696020|81181763|FG000|Overall Study|Other not stated above|0|||
27822460|NCT00696020|81181764|FG001|Overall Study|Other not stated above|0|||
27822461|NCT00696020|81181765|FG002|Overall Study|Other not stated above|1|||
27882714|NCT02073929|81401296|FG001|Overall Study|Lost to Follow-up|1|||
27882715|NCT02073929|81401295|FG000|Overall Study|Adverse Event|2|||
27882716|NCT02073929|81401296|FG001|Overall Study|Adverse Event|1|||
27882717|NCT02073929|81401295|FG000|Overall Study|Withdrawal by Subject|0|||
27882718|NCT02073929|81401296|FG001|Overall Study|Withdrawal by Subject|1|||
27882719|NCT03850496|81401298|FG000|Overall Study|Withdrawal by Subject|1|||
27882720|NCT03850496|81401299|FG001|Overall Study|Withdrawal by Subject|0|||
27882721|NCT03850496|81401300|FG002|Overall Study|Withdrawal by Subject|0|||
27882722|NCT03850496|81401298|FG000|Overall Study|Lost to Follow-up|0|||
27882723|NCT03850496|81401299|FG001|Overall Study|Lost to Follow-up|1|||
27882724|NCT03850496|81401300|FG002|Overall Study|Lost to Follow-up|4|||
27882725|NCT01028014|81401301|FG000|Overall Study|Lost to Follow-up|1|||
27882726|NCT01028014|81401302|FG001|Overall Study|Lost to Follow-up|2|||
27882727|NCT01028014|81401303|FG002|Overall Study|Lost to Follow-up|0|||
27882728|NCT01028014|81401304|FG003|Overall Study|Lost to Follow-up|1|||
27882729|NCT01028014|81401305|FG004|Overall Study|Lost to Follow-up|1|||
27882730|NCT01028014|81401306|FG005|Overall Study|Lost to Follow-up|2|||
27882731|NCT01002989|81401311|FG000|Overall Study|exclusion criteria, no consent|5|||
27882732|NCT02589639|81401314|FG000|Overall Study|Lost to Follow-up|1|||
27882733|NCT02589639|81401315|FG001|Overall Study|Lost to Follow-up|0|||
27882734|NCT02589639|81401316|FG002|Overall Study|Lost to Follow-up|0|||
27882735|NCT02589639|81401314|FG000|Overall Study|Protocol Violation|1|||
27882736|NCT02589639|81401315|FG001|Overall Study|Protocol Violation|0|||
27882737|NCT02589639|81401316|FG002|Overall Study|Protocol Violation|0|||
27882738|NCT02589639|81401314|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
27882739|NCT02589639|81401315|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
27882740|NCT02589639|81401316|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
27882741|NCT02589639|81401314|FG000|Overall Study|Adverse Event|4|||
27882742|NCT02589639|81401315|FG001|Overall Study|Adverse Event|5|||
27882743|NCT02589639|81401316|FG002|Overall Study|Adverse Event|3|||
27882744|NCT02589639|81401314|FG000|Overall Study|Other reason than specified above|1|||
27882745|NCT02589639|81401315|FG001|Overall Study|Other reason than specified above|2|||
27882746|NCT02589639|81401316|FG002|Overall Study|Other reason than specified above|1|||
27882747|NCT02589639|81401314|FG000|Overall Study|Not Treated|0|||
27882748|NCT02589639|81401315|FG001|Overall Study|Not Treated|3|||
27882749|NCT02589639|81401316|FG002|Overall Study|Not Treated|0|||
27882750|NCT04520997|81404448|FG000|Overall Study|Lost to Follow-up|1|||
27593954|NCT00725296|80352347|FG000|Overall Study|Lack of Efficacy|7|||
27593955|NCT00725296|80352347|FG000|Overall Study|Withdrawal by Subject|3|||
27882751|NCT04520997|81404449|FG001|Overall Study|Lost to Follow-up|1|||
27882752|NCT04520997|81404448|FG000|Overall Study|Withdrawal by Subject|1|||
27882753|NCT04520997|81404449|FG001|Overall Study|Withdrawal by Subject|0|||
27882754|NCT04520997|81404448|FG000|Overall Study|Not Treated|0|||
27882755|NCT04520997|81404449|FG001|Overall Study|Not Treated|1|||
27882756|NCT01964222|81404452|FG000|Overall Study|Lost to Follow-up|7|||
27882757|NCT01964222|81404453|FG001|Overall Study|Lost to Follow-up|5|||
27882758|NCT01964222|81404452|FG000|Overall Study|Withdrawal by Subject|6|||
27882759|NCT01964222|81404453|FG001|Overall Study|Withdrawal by Subject|6|||
27882760|NCT01964222|81404452|FG000|Overall Study|Screening Failure|2|||
27882761|NCT01964222|81404453|FG001|Overall Study|Screening Failure|0|||
27882762|NCT03515811|81404456|FG000|Overall Study|Lost to Follow-up|2|||
27882763|NCT03515811|81404457|FG001|Overall Study|Lost to Follow-up|1|||
27882764|NCT03515811|81404456|FG000|Overall Study|Protocol Violation|1|||
27882765|NCT03515811|81404457|FG001|Overall Study|Protocol Violation|1|||
27882766|NCT03515811|81404456|FG000|Overall Study|Death|1|||
27882767|NCT03515811|81404457|FG001|Overall Study|Death|1|||
27593956|NCT00725296|80352347|FG000|Overall Study|Non-Compliance|2|||
27882768|NCT03515811|81404456|FG000|Overall Study|Withdrawal by Subject|0|||
27882769|NCT03515811|81404457|FG001|Overall Study|Withdrawal by Subject|2|||
27593957|NCT00725296|80352347|FG000|Overall Study|Lost to Follow-up|1|||
27882770|NCT03515811|81404456|FG000|Overall Study|Technical Problems|1|||
27882771|NCT03515811|81404457|FG001|Overall Study|Technical Problems|0|||
27882772|NCT03515811|81404456|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
27882773|NCT03515811|81404457|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
27882774|NCT03515811|81404456|FG000|Overall Study|COVID-19|0|||
27882775|NCT03515811|81404457|FG001|Overall Study|COVID-19|1|||
27882776|NCT00729612|81404458|FG000|Overall Study|Non evaluable for response|10|||
27593958|NCT00725296|80352347|FG000|Overall Study|Other|38|||
27882777|NCT02230904|81404459|FG000|Overall Study|Safety follow up could not take place|0|||
27882778|NCT02230904|81404460|FG001|Overall Study|Safety follow up could not take place|1|||
27882779|NCT02844933|81404461|FG000|Overall Study|Discontinued due to premature termination of study|3|||
27593959|NCT03750552|80352348|FG000|Overall Study|Adverse Event|5|||
27593960|NCT03750552|80352349|FG001|Overall Study|Adverse Event|1|||
27593961|NCT03750552|80352348|FG000|Overall Study|Withdrawal by Subject|1|||
27593962|NCT03750552|80352349|FG001|Overall Study|Withdrawal by Subject|1|||
27822462|NCT00696020|81181766|FG003|Overall Study|Other not stated above|1|||
27822463|NCT04006171|81181767|FG000|Overall Study|Withdrawal by Subject|8|||
27822464|NCT04006171|81181768|FG001|Overall Study|Withdrawal by Subject|7|||
27822465|NCT04006171|81181767|FG000|Overall Study|missing serum samples|2|||
27822466|NCT04006171|81181768|FG001|Overall Study|missing serum samples|2|||
27822467|NCT04006171|81181767|FG000|Overall Study|insufficient sample volume|2|||
27822468|NCT04006171|81181768|FG001|Overall Study|insufficient sample volume|3|||
27822469|NCT01363765|81181771|FG000|Overall Study|non-diagnostic|2621|||
27822470|NCT01363765|81181772|FG001|Overall Study|non-diagnostic|1124|||
27822471|NCT01363765|81181771|FG000|Overall Study|duplicate records|736|||
27822472|NCT01363765|81181772|FG001|Overall Study|duplicate records|3177|||
27822473|NCT01363765|81181771|FG000|Overall Study|non-resident|156|||
27822474|NCT01363765|81181772|FG001|Overall Study|non-resident|76|||
27822475|NCT01363765|81181771|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
27822476|NCT01363765|81181772|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
27822477|NCT01363765|81181771|FG000|Overall Study|smear during intervention|2170|||
27822478|NCT01363765|81181772|FG001|Overall Study|smear during intervention|0|||
27822479|NCT00424047|81181773|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
27822480|NCT00424047|81181774|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
27822481|NCT00424047|81181773|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
27822482|NCT00424047|81181774|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
27822483|NCT00424047|81181773|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
27822484|NCT00424047|81181774|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
27822485|NCT00424047|81181773|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
27822486|NCT00424047|81181774|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
27822487|NCT00424047|81181773|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
27822488|NCT00424047|81181774|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
27822489|NCT00424047|81181773|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
27822490|NCT00424047|81181774|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
27822491|NCT00424047|81181773|FG000|On Study at Time of Unblinding|Adverse Event|22|||
27822492|NCT00424047|81181774|FG001|On Study at Time of Unblinding|Adverse Event|12|||
27822493|NCT00424047|81181773|FG000|On Study at Time of Unblinding|Progression of disease|92|||
27822494|NCT00424047|81181774|FG001|On Study at Time of Unblinding|Progression of disease|128|||
27822495|NCT00424047|81181773|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
27822496|NCT00424047|81181774|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
27822497|NCT00424047|81181773|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
27822498|NCT00424047|81181774|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
27822499|NCT00424047|81181773|FG000|On Study at Time of Unblinding|Death|11|||
27822500|NCT00424047|81181774|FG001|On Study at Time of Unblinding|Death|11|||
27822501|NCT00424047|81181773|FG000|On Study at Time of Unblinding|Other|5|||
27822502|NCT00424047|81181774|FG001|On Study at Time of Unblinding|Other|4|||
27822503|NCT00424047|81181773|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
27822504|NCT00424047|81181774|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
27882780|NCT02844933|81404462|FG001|Overall Study|Discontinued due to premature termination of study|2|||
27882781|NCT00022698|81404463|FG000|Overall Study|Adverse Event|5|||
27882782|NCT00022698|81404464|FG001|Overall Study|Adverse Event|9|||
27882783|NCT00022698|81404463|FG000|Overall Study|Death|0|||
27882784|NCT00022698|81404464|FG001|Overall Study|Death|2|||
27882785|NCT00022698|81404463|FG000|Overall Study|Failure to return|0|||
27882786|NCT00022698|81404464|FG001|Overall Study|Failure to return|1|||
27882787|NCT00022698|81404463|FG000|Overall Study|Refused treatment|0|||
27822505|NCT00424047|81181773|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
27822506|NCT00424047|81181774|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
27822507|NCT00424047|81181773|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
27822508|NCT00424047|81181774|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
27822509|NCT00424047|81181773|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
27822510|NCT00424047|81181774|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
27822511|NCT00424047|81181773|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
27822512|NCT00424047|81181774|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
27822513|NCT00550537|81181777|FG000|Overall Study|Death|18|||
27822514|NCT00550537|81181777|FG000|Overall Study|Adverse Event|20|||
27822515|NCT00550537|81181777|FG000|Overall Study|Disease progression before|46|||
27822516|NCT00550537|81181777|FG000|Overall Study|Withdrawal by Subject|7|||
27882788|NCT00022698|81404464|FG001|Overall Study|Refused treatment|2|||
27822517|NCT00550537|81181777|FG000|Overall Study|Change in treatment plan|4|||
27882789|NCT00022698|81404463|FG000|Overall Study|Insufficient therapeutic response|2|||
27822518|NCT00550537|81181777|FG000|Overall Study|Other complicating ilness|3|||
27822519|NCT00550537|81181777|FG000|Overall Study|Declining performance status|2|||
27822520|NCT00550537|81181777|FG000|Overall Study|Treated closer to home|4|||
27593963|NCT03750552|80352348|FG000|Overall Study|Other|2|||
27593964|NCT03750552|80352349|FG001|Overall Study|Other|0|||
27593965|NCT04393441|80352350|FG000|Overall Study|Adverse Event|0|||
27882790|NCT00022698|81404464|FG001|Overall Study|Insufficient therapeutic response|14|||
27882791|NCT00022698|81404463|FG000|Overall Study|Administrative /other|1|||
27882792|NCT00022698|81404464|FG001|Overall Study|Administrative /other|7|||
27882793|NCT01266291|81404477|FG000|Overall Study|Adverse Event|1|||
27882794|NCT02504827|81404478|FG000|Overall Study|Could not produce sputum|1|||
27882795|NCT00406367|81404479|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
27882796|NCT00406367|81404480|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
27882797|NCT00406367|81404479|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
27882798|NCT00406367|81404480|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
27882799|NCT00406367|81404479|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
27694139|NCT01139021|80716673|FG003|Overall Study|Protocol Violation|0|||
27694140|NCT01139021|80716674|FG004|Overall Study|Protocol Violation|2|||
27822521|NCT00441467|81181778|FG000|Overall Study|Adverse Event|6|||
27822522|NCT00441467|81181778|FG000|Overall Study|Withdrawal by Subject|3|||
27882800|NCT00406367|81404480|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
27822523|NCT00441467|81181778|FG000|Overall Study|Progressive disease|9|||
27822524|NCT01457053|81185190|FG000|Overall Study|Unable to undergo selected treatment|1|||
27822525|NCT01457053|81185191|FG001|Overall Study|Unable to undergo selected treatment|1|||
27822526|NCT02445339|81185195|FG000|Overall Study|Physician Decision|1|||
27822527|NCT02445339|81185196|FG001|Overall Study|Physician Decision|0|||
27822528|NCT02445339|81185195|FG000|Overall Study|Lost to Follow-up|11|||
27822529|NCT02445339|81185196|FG001|Overall Study|Lost to Follow-up|15|||
27822530|NCT01959672|81185197|FG000|Overall Study|Death|1|||
27822531|NCT00089661|81185198|FG000|Overall Study|Adverse Event|0|||
27822532|NCT00089661|81185199|FG001|Overall Study|Adverse Event|2|||
27822533|NCT00089661|81185198|FG000|Overall Study|Death|1|||
27822534|NCT00089661|81185199|FG001|Overall Study|Death|0|||
27822535|NCT00089661|81185198|FG000|Overall Study|Lost to Follow-up|0|||
27822536|NCT00089661|81185199|FG001|Overall Study|Lost to Follow-up|3|||
27822537|NCT00089661|81185198|FG000|Overall Study|Withdrawal by Subject|11|||
27822538|NCT00089661|81185199|FG001|Overall Study|Withdrawal by Subject|9|||
27822539|NCT00089661|81185198|FG000|Overall Study|Disease progression|1|||
27822540|NCT00089661|81185199|FG001|Overall Study|Disease progression|3|||
27822541|NCT00089661|81185198|FG000|Overall Study|Ineligibility determined|4|||
27822542|NCT00089661|81185199|FG001|Overall Study|Ineligibility determined|4|||
27822543|NCT00089661|81185198|FG000|Overall Study|Noncompliance|2|||
27822544|NCT00089661|81185199|FG001|Overall Study|Noncompliance|4|||
27822545|NCT00089661|81185198|FG000|Overall Study|Other|2|||
27822546|NCT00089661|81185199|FG001|Overall Study|Other|1|||
27822547|NCT03243630|81185200|FG000|Overall Study|Protocol Violation|1|||
27822548|NCT03243630|81185200|FG000|Overall Study|Physician Decision|1|||
27822549|NCT00467896|81185201|FG000|Overall Study|Consent Withdrawal|18|||
27822550|NCT00467896|81185201|FG000|Overall Study|Adverse Event|7|||
27822551|NCT00467896|81185201|FG000|Overall Study|Serious Adverse Event|13|||
27822552|NCT00467896|81185201|FG000|Overall Study|Non-compliance|3|||
27822553|NCT00467896|81185201|FG000|Overall Study|Changed therapy|2|||
27822554|NCT00467896|81185201|FG000|Overall Study|Patient received transplant|2|||
27822555|NCT00467896|81185201|FG000|Overall Study|Patient had atrial septostomy|1|||
27822556|NCT00467896|81185201|FG000|Overall Study|Patient weaned off iloprost|1|||
27822557|NCT00467896|81185201|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
27822558|NCT00467896|81185201|FG000|Overall Study|Started intravenous prostacyclin|1|||
27822559|NCT00467896|81185201|FG000|Overall Study|Started inhaled Remodulin|1|||
27822560|NCT00467896|81185201|FG000|Overall Study|Patient had no improvement|1|||
27822561|NCT00396279|81185202|FG000|Overall Study|Ongoing in study|26|||
27822562|NCT00396279|81185202|FG000|Overall Study|Disease progression|2|||
27822563|NCT00396279|81185202|FG000|Overall Study|Withdrawal by Subject|1|||
27822564|NCT00396279|81185202|FG000|Overall Study|Physician Decision|1|||
27822565|NCT01675765|81185207|FG000|Overall Study|Progressive disease|4|||
27822566|NCT01675765|81185208|FG001|Overall Study|Progressive disease|4|||
27822567|NCT01675765|81185207|FG000|Overall Study|Adverse Event|1|||
27822568|NCT01675765|81185208|FG001|Overall Study|Adverse Event|2|||
27822569|NCT01675765|81185207|FG000|Overall Study|Withdrawal by Subject|2|||
27822570|NCT01675765|81185208|FG001|Overall Study|Withdrawal by Subject|0|||
27822571|NCT01675765|81185207|FG000|Overall Study|Death|1|||
27822572|NCT01675765|81185208|FG001|Overall Study|Death|0|||
27822573|NCT01675765|81185207|FG000|Overall Study|Clinical progression|3|||
27822574|NCT01675765|81185208|FG001|Overall Study|Clinical progression|2|||
27822575|NCT01185821|81185209|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27822576|NCT01185821|81185210|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27822577|NCT01185821|81185211|FG002|Overall Study|Abnormal laboratory value(s)|1|||
27822578|NCT01185821|81185212|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27822579|NCT01185821|81185213|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27822580|NCT01185821|81185209|FG000|Overall Study|Protocol Violation|0|||
27822581|NCT01185821|81185210|FG001|Overall Study|Protocol Violation|0|||
27822582|NCT01185821|81185211|FG002|Overall Study|Protocol Violation|0|||
27822583|NCT01185821|81185212|FG003|Overall Study|Protocol Violation|1|||
27822584|NCT01185821|81185213|FG004|Overall Study|Protocol Violation|1|||
27822585|NCT01185821|81185209|FG000|Overall Study|Abnormal test procedure result|0|||
27822586|NCT01185821|81185210|FG001|Overall Study|Abnormal test procedure result|0|||
27822587|NCT01185821|81185211|FG002|Overall Study|Abnormal test procedure result|0|||
27822588|NCT01185821|81185212|FG003|Overall Study|Abnormal test procedure result|0|||
27822589|NCT01185821|81185213|FG004|Overall Study|Abnormal test procedure result|1|||
27822590|NCT01185821|81185209|FG000|Overall Study|Death|0|||
27822591|NCT01185821|81185210|FG001|Overall Study|Death|1|||
27822592|NCT01185821|81185211|FG002|Overall Study|Death|0|||
27822593|NCT01185821|81185212|FG003|Overall Study|Death|0|||
27822594|NCT01185821|81185213|FG004|Overall Study|Death|0|||
27822595|NCT01185821|81185209|FG000|Overall Study|Condition no longer required study drug|0|||
27822596|NCT01185821|81185210|FG001|Overall Study|Condition no longer required study drug|0|||
27822597|NCT01185821|81185211|FG002|Overall Study|Condition no longer required study drug|0|||
27822598|NCT01185821|81185212|FG003|Overall Study|Condition no longer required study drug|0|||
27822599|NCT01185821|81185213|FG004|Overall Study|Condition no longer required study drug|1|||
27822600|NCT01185821|81185209|FG000|Overall Study|Adverse Event|2|||
27822601|NCT01185821|81185210|FG001|Overall Study|Adverse Event|3|||
27822602|NCT01185821|81185211|FG002|Overall Study|Adverse Event|1|||
27822603|NCT01185821|81185212|FG003|Overall Study|Adverse Event|2|||
27822604|NCT01185821|81185213|FG004|Overall Study|Adverse Event|5|||
27822605|NCT01185821|81185209|FG000|Overall Study|Lack of Efficacy|0|||
27822606|NCT01185821|81185210|FG001|Overall Study|Lack of Efficacy|0|||
27822607|NCT01185821|81185211|FG002|Overall Study|Lack of Efficacy|3|||
27822608|NCT01185821|81185212|FG003|Overall Study|Lack of Efficacy|0|||
27822609|NCT01185821|81185213|FG004|Overall Study|Lack of Efficacy|9|||
27822610|NCT01185821|81185209|FG000|Overall Study|Withdrawal by Subject|3|||
27822611|NCT01185821|81185210|FG001|Overall Study|Withdrawal by Subject|2|||
27822612|NCT01185821|81185211|FG002|Overall Study|Withdrawal by Subject|2|||
27822613|NCT01185821|81185212|FG003|Overall Study|Withdrawal by Subject|1|||
27822614|NCT01185821|81185213|FG004|Overall Study|Withdrawal by Subject|3|||
27822615|NCT01185821|81185209|FG000|Overall Study|Lost to Follow-up|1|||
27822616|NCT01185821|81185210|FG001|Overall Study|Lost to Follow-up|1|||
27822617|NCT01185821|81185211|FG002|Overall Study|Lost to Follow-up|2|||
27822618|NCT01185821|81185212|FG003|Overall Study|Lost to Follow-up|1|||
27822619|NCT01185821|81185213|FG004|Overall Study|Lost to Follow-up|2|||
27822620|NCT01185821|81185209|FG000|Overall Study|Administrative problems|0|||
27822621|NCT01185821|81185210|FG001|Overall Study|Administrative problems|0|||
27822622|NCT01185821|81185211|FG002|Overall Study|Administrative problems|1|||
27822623|NCT01185821|81185212|FG003|Overall Study|Administrative problems|1|||
27822624|NCT01185821|81185213|FG004|Overall Study|Administrative problems|2|||
27822625|NCT00746798|81185216|FG000|Overall Study|Protocol Violation|0|||
27822626|NCT00746798|81185217|FG001|Overall Study|Protocol Violation|1|||
27822627|NCT00746798|81185218|FG002|Overall Study|Protocol Violation|0|||
27822628|NCT00746798|81185219|FG003|Overall Study|Protocol Violation|0|||
27822629|NCT00746798|81185216|FG000|Overall Study|Withdrawal by Subject|0|||
27822630|NCT00746798|81185217|FG001|Overall Study|Withdrawal by Subject|1|||
27822631|NCT00746798|81185218|FG002|Overall Study|Withdrawal by Subject|1|||
27822632|NCT00746798|81185219|FG003|Overall Study|Withdrawal by Subject|0|||
27822633|NCT00746798|81185216|FG000|Overall Study|Death|0|||
27822634|NCT00746798|81185217|FG001|Overall Study|Death|0|||
27822635|NCT00746798|81185218|FG002|Overall Study|Death|2|||
27822636|NCT00746798|81185219|FG003|Overall Study|Death|0|||
27822637|NCT00746798|81185216|FG000|Overall Study|Participant unable to return for visit|1|||
27822638|NCT00746798|81185217|FG001|Overall Study|Participant unable to return for visit|0|||
27822639|NCT00746798|81185218|FG002|Overall Study|Participant unable to return for visit|0|||
27822640|NCT00746798|81185219|FG003|Overall Study|Participant unable to return for visit|0|||
27822641|NCT01474551|81185221|FG000|Overall Study|Death|1|||
27822642|NCT02543203|81185230|FG000|Overall Study|Unpalatable Fragrance|2|||
27822643|NCT02543203|81185231|FG001|Overall Study|Unpalatable Fragrance|2|||
27822644|NCT02543203|81185230|FG000|Overall Study|Lost to Follow-up|1|||
27822645|NCT02543203|81185231|FG001|Overall Study|Lost to Follow-up|0|||
27822646|NCT02543203|81185230|FG000|Overall Study|Increased Irritability|1|||
27822647|NCT02543203|81185231|FG001|Overall Study|Increased Irritability|0|||
27822648|NCT02543203|81185230|FG000|Overall Study|Family|1|||
27822649|NCT02543203|81185231|FG001|Overall Study|Family|2|||
27822650|NCT02543203|81185230|FG000|Overall Study|Negative Behavior|1|||
27822651|NCT02543203|81185231|FG001|Overall Study|Negative Behavior|0|||
27822652|NCT02543203|81185230|FG000|Overall Study|Withdrawal by Subject|0|||
27822653|NCT02543203|81185231|FG001|Overall Study|Withdrawal by Subject|1|||
27822654|NCT02549092|81185232|FG000|Treatment Period|Adverse Event|2|||
27822655|NCT02549092|81185233|FG001|Treatment Period|Adverse Event|2|||
27822656|NCT02549092|81185232|FG000|Treatment Period|Withdrawal by Subject|1|||
27822657|NCT02549092|81185233|FG001|Treatment Period|Withdrawal by Subject|3|||
27822658|NCT02549092|81185232|FG000|Treatment Period|Lack of Efficacy|0|||
27822659|NCT02549092|81185233|FG001|Treatment Period|Lack of Efficacy|2|||
27822660|NCT02549092|81185232|FG000|Extension/Transition Period|Adverse Event|1|||
27822661|NCT02549092|81185233|FG001|Extension/Transition Period|Adverse Event|1|||
27822662|NCT02549092|81185232|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
27822663|NCT02549092|81185233|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
27822664|NCT02549092|81185232|FG000|Extension/Transition Period|Other, Not Specified|4|||
27822665|NCT02549092|81185233|FG001|Extension/Transition Period|Other, Not Specified|2|||
27822666|NCT01390844|81185236|FG000|Treatment Phase|Adverse Event|12|||
27882801|NCT00406367|81404479|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
27882802|NCT00406367|81404480|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
27882803|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
27882804|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
27882805|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
27882806|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
27882807|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
27882808|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
27882809|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
27882810|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
27882811|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
27882812|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
27882813|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
27694141|NCT01139021|80716675|FG005|Overall Study|Protocol Violation|0|||
27882814|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
27822667|NCT01390844|81185237|FG001|Treatment Phase|Adverse Event|2|||
27694142|NCT01139021|80716670|FG000|Overall Study|Withdrawal by Subject|0|||
27822668|NCT01390844|81185238|FG002|Treatment Phase|Adverse Event|3|||
27822669|NCT01390844|81185239|FG003|Treatment Phase|Adverse Event|2|||
27822670|NCT01390844|81185236|FG000|Treatment Phase|Treatment Failure|23|||
27822671|NCT01390844|81185237|FG001|Treatment Phase|Treatment Failure|25|||
27822672|NCT01390844|81185238|FG002|Treatment Phase|Treatment Failure|10|||
27822673|NCT01390844|81185239|FG003|Treatment Phase|Treatment Failure|13|||
27822674|NCT01390844|81185236|FG000|Treatment Phase|Non-Medical Reasons|5|||
27822675|NCT01390844|81185237|FG001|Treatment Phase|Non-Medical Reasons|1|||
27822676|NCT01390844|81185238|FG002|Treatment Phase|Non-Medical Reasons|8|||
27822677|NCT01390844|81185239|FG003|Treatment Phase|Non-Medical Reasons|1|||
27822678|NCT01390844|81185236|FG000|Treatment Phase|Non-GCP Compliant|0|||
27822679|NCT01390844|81185237|FG001|Treatment Phase|Non-GCP Compliant|0|||
27822680|NCT01390844|81185238|FG002|Treatment Phase|Non-GCP Compliant|10|||
27822681|NCT01390844|81185239|FG003|Treatment Phase|Non-GCP Compliant|3|||
27822682|NCT01390844|81185236|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
27822683|NCT01390844|81185237|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
27822684|NCT01390844|81185238|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
27822685|NCT01390844|81185239|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
27822686|NCT05017480|81185240|FG000|Stage 1 Study|Withdrawal by Subject|8|||
27822687|NCT05017480|81185241|FG001|Stage 1 Study|Withdrawal by Subject|6|||
27822688|NCT05017480|81185242|FG002|Stage 1 Study|Withdrawal by Subject|0|||
27822689|NCT05017480|81185243|FG003|Stage 1 Study|Withdrawal by Subject|0|||
27822690|NCT05017480|81185244|FG004|Stage 1 Study|Withdrawal by Subject|0|||
27822691|NCT05017480|81185240|FG000|Stage 1 Study|Adverse Event|1|||
27822692|NCT05017480|81185241|FG001|Stage 1 Study|Adverse Event|1|||
27822693|NCT05017480|81185242|FG002|Stage 1 Study|Adverse Event|0|||
27822694|NCT05017480|81185243|FG003|Stage 1 Study|Adverse Event|0|||
27822695|NCT05017480|81185244|FG004|Stage 1 Study|Adverse Event|0|||
27822696|NCT05017480|81185240|FG000|Stage 1 Study|Poor Compliance|1|||
27822697|NCT05017480|81185241|FG001|Stage 1 Study|Poor Compliance|1|||
27822698|NCT05017480|81185242|FG002|Stage 1 Study|Poor Compliance|0|||
27822699|NCT05017480|81185243|FG003|Stage 1 Study|Poor Compliance|0|||
27822700|NCT05017480|81185244|FG004|Stage 1 Study|Poor Compliance|0|||
27822701|NCT05017480|81185240|FG000|Stage 1 Study|Physician Decision|0|||
27822702|NCT05017480|81185241|FG001|Stage 1 Study|Physician Decision|1|||
27822703|NCT05017480|81185242|FG002|Stage 1 Study|Physician Decision|0|||
27822704|NCT05017480|81185243|FG003|Stage 1 Study|Physician Decision|0|||
27822705|NCT05017480|81185244|FG004|Stage 1 Study|Physician Decision|0|||
27822706|NCT05017480|81185240|FG000|Stage 2 Study|Withdrawal by Subject|0|||
27822707|NCT05017480|81185241|FG001|Stage 2 Study|Withdrawal by Subject|0|||
27822708|NCT05017480|81185242|FG002|Stage 2 Study|Withdrawal by Subject|6|||
27822709|NCT05017480|81185243|FG003|Stage 2 Study|Withdrawal by Subject|9|||
27694143|NCT01139021|80716671|FG001|Overall Study|Withdrawal by Subject|0|||
27822710|NCT05017480|81185244|FG004|Stage 2 Study|Withdrawal by Subject|11|||
27822711|NCT05017480|81185240|FG000|Stage 2 Study|Lost to Follow-up|0|||
27822712|NCT05017480|81185241|FG001|Stage 2 Study|Lost to Follow-up|0|||
27822713|NCT05017480|81185242|FG002|Stage 2 Study|Lost to Follow-up|0|||
27822714|NCT05017480|81185243|FG003|Stage 2 Study|Lost to Follow-up|2|||
27822715|NCT05017480|81185244|FG004|Stage 2 Study|Lost to Follow-up|1|||
27822716|NCT05017480|81185240|FG000|Stage 2 Study|Adverse Event|0|||
27822717|NCT05017480|81185241|FG001|Stage 2 Study|Adverse Event|0|||
27822718|NCT05017480|81185242|FG002|Stage 2 Study|Adverse Event|0|||
27882815|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
27882816|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
27882817|NCT00406367|81404479|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
27882818|NCT00406367|81404480|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
27882819|NCT00300885|81404481|FG000|Treatment|Adverse Event|134|||
27882820|NCT00300885|81404482|FG001|Treatment|Adverse Event|82|||
27882821|NCT00300885|81404481|FG000|Treatment|Death|20|||
27882822|NCT00300885|81404482|FG001|Treatment|Death|7|||
27882823|NCT00300885|81404481|FG000|Treatment|Lack of Efficacy|1|||
27882824|NCT00300885|81404482|FG001|Treatment|Lack of Efficacy|1|||
27882825|NCT00300885|81404481|FG000|Treatment|Lost to Follow-up|3|||
27882826|NCT00300885|81404482|FG001|Treatment|Lost to Follow-up|2|||
27882827|NCT00300885|81404481|FG000|Treatment|Physician Decision|4|||
27882828|NCT00300885|81404482|FG001|Treatment|Physician Decision|5|||
27882829|NCT00300885|81404481|FG000|Treatment|Protocol Violation|11|||
27882830|NCT00300885|81404482|FG001|Treatment|Protocol Violation|11|||
27882831|NCT00300885|81404481|FG000|Treatment|Withdrawal by Subject|26|||
27882832|NCT00300885|81404482|FG001|Treatment|Withdrawal by Subject|23|||
27882833|NCT00300885|81404481|FG000|Treatment|Disease progression|171|||
27882834|NCT00300885|81404482|FG001|Treatment|Disease progression|238|||
27882835|NCT00300885|81404481|FG000|Treatment|Random code broken (subject died)|0|||
27882836|NCT00300885|81404482|FG001|Treatment|Random code broken (subject died)|1|||
27882837|NCT00300885|81404481|FG000|Treatment|Non-compliant with study medication|3|||
27882838|NCT00300885|81404482|FG001|Treatment|Non-compliant with study medication|4|||
27882839|NCT00300885|81404481|FG000|Follow-up|Death|141|||
27882840|NCT00300885|81404482|FG001|Follow-up|Death|163|||
27882841|NCT00300885|81404481|FG000|Follow-up|Lost to Follow-up|11|||
27882842|NCT00300885|81404482|FG001|Follow-up|Lost to Follow-up|7|||
27882843|NCT00300885|81404481|FG000|Follow-up|Withdrawal by Subject|26|||
27882844|NCT00300885|81404482|FG001|Follow-up|Withdrawal by Subject|25|||
27882845|NCT06098339|81404483|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
27882846|NCT06098339|81404484|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
27882847|NCT06098339|81404483|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
27882848|NCT06098339|81404484|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
27882849|NCT04471428|81404491|FG000|Overall Study|Withdrawal by Subject|29|||
27882850|NCT04471428|81404492|FG001|Overall Study|Withdrawal by Subject|1|||
27882851|NCT04471428|81404491|FG000|Overall Study|Physician Decision|0|||
27882852|NCT04471428|81404492|FG001|Overall Study|Physician Decision|1|||
27882853|NCT04471428|81404491|FG000|Overall Study|Reason Not Specified|0|||
27882854|NCT04471428|81404492|FG001|Overall Study|Reason Not Specified|2|||
27882855|NCT04471428|81404491|FG000|Overall Study|Death|106|||
27882856|NCT04471428|81404492|FG001|Overall Study|Death|114|||
27882857|NCT04471428|81404491|FG000|Overall Study|Ongoing in the study|45|||
27882858|NCT04471428|81404492|FG001|Overall Study|Ongoing in the study|68|||
27882859|NCT04478695|81404493|FG000|Overall Study|Death|1|||
27882860|NCT04478695|81404494|FG001|Overall Study|Death|0|||
27882861|NCT03476187|81404495|FG000|Overall Study|Protocol Violation|7|||
27882862|NCT03476187|81404495|FG000|Overall Study|Physician Decision|5|||
27882863|NCT05253573|81404496|FG000|Overall Study|Death|1|||
27882864|NCT05253573|81404497|FG001|Overall Study|Death|0|||
27882865|NCT01129102|81404498|FG000|Overall Study|No study drug treatment|2|||
27882866|NCT01129102|81404499|FG001|Overall Study|No study drug treatment|3|||
27882867|NCT01129102|81404500|FG002|Overall Study|No study drug treatment|1|||
27882868|NCT01129102|81404498|FG000|Overall Study|Withdrawal by Subject|2|||
27882869|NCT01129102|81404499|FG001|Overall Study|Withdrawal by Subject|0|||
27882870|NCT01129102|81404500|FG002|Overall Study|Withdrawal by Subject|3|||
27882871|NCT01129102|81404498|FG000|Overall Study|Protocol Violation|0|||
27882872|NCT01129102|81404499|FG001|Overall Study|Protocol Violation|1|||
27822719|NCT05017480|81185243|FG003|Stage 2 Study|Adverse Event|1|||
27822720|NCT05017480|81185244|FG004|Stage 2 Study|Adverse Event|0|||
27822721|NCT05017480|81185240|FG000|Stage 2 Study|COVID-19|0|||
27822722|NCT05017480|81185241|FG001|Stage 2 Study|COVID-19|0|||
27822723|NCT05017480|81185242|FG002|Stage 2 Study|COVID-19|0|||
27822724|NCT05017480|81185243|FG003|Stage 2 Study|COVID-19|1|||
27822725|NCT05017480|81185244|FG004|Stage 2 Study|COVID-19|0|||
27822726|NCT05017480|81185240|FG000|Stage 2 Study|Pregnancy|0|||
27882873|NCT01129102|81404500|FG002|Overall Study|Protocol Violation|1|||
27882874|NCT01129102|81404498|FG000|Overall Study|Pregnancy|0|||
27882875|NCT01129102|81404499|FG001|Overall Study|Pregnancy|0|||
27882876|NCT01129102|81404500|FG002|Overall Study|Pregnancy|1|||
27822727|NCT05017480|81185241|FG001|Stage 2 Study|Pregnancy|0|||
27822728|NCT05017480|81185242|FG002|Stage 2 Study|Pregnancy|0|||
27822729|NCT05017480|81185243|FG003|Stage 2 Study|Pregnancy|0|||
27882877|NCT01129102|81404498|FG000|Overall Study|Adverse Event|2|||
27882878|NCT01129102|81404499|FG001|Overall Study|Adverse Event|2|||
27882879|NCT01129102|81404500|FG002|Overall Study|Adverse Event|1|||
27882880|NCT01129102|81404498|FG000|Overall Study|Lost to Follow-up|2|||
27882881|NCT01129102|81404499|FG001|Overall Study|Lost to Follow-up|0|||
27882882|NCT01129102|81404500|FG002|Overall Study|Lost to Follow-up|0|||
27882883|NCT03512210|81404504|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
27882884|NCT03512210|81404504|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
27882885|NCT03512210|81404504|FG000|Step 2:Post-MINMON|Death|2|||
27882886|NCT03512210|81404504|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
27882887|NCT03512210|81404504|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
27882888|NCT03793842|81404505|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
27694144|NCT01139021|80716672|FG002|Overall Study|Withdrawal by Subject|0|||
27822730|NCT05017480|81185244|FG004|Stage 2 Study|Pregnancy|1|||
27822731|NCT00651820|81185247|FG000|Overall Study|Lost to Follow-up|2|||
27822732|NCT00939003|81185248|FG000|Double-blind Treatment Period|Adverse Event|1|||
27822733|NCT00939003|81185249|FG001|Double-blind Treatment Period|Adverse Event|1|||
27694145|NCT01139021|80716673|FG003|Overall Study|Withdrawal by Subject|1|||
27694146|NCT01139021|80716674|FG004|Overall Study|Withdrawal by Subject|4|||
27694147|NCT01139021|80716675|FG005|Overall Study|Withdrawal by Subject|0|||
27694148|NCT02121834|80716676|FG000|Overall Study|Protocol Violation|0|||
27822734|NCT00939003|81185248|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27822735|NCT00939003|81185249|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
27822736|NCT00939003|81185248|FG000|Double-blind Treatment Period|Pregnancy|0|||
27822737|NCT00939003|81185249|FG001|Double-blind Treatment Period|Pregnancy|1|||
27822738|NCT00939003|81185248|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
27822739|NCT00939003|81185249|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
27822740|NCT00939003|81185248|FG000|Open-label Treatment Period|Adverse Event|4|||
27822741|NCT00939003|81185249|FG001|Open-label Treatment Period|Adverse Event|8|||
27822742|NCT00939003|81185248|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
27822743|NCT00939003|81185249|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
27822744|NCT00939003|81185248|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
27822745|NCT00939003|81185249|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
27822746|NCT00939003|81185248|FG000|Open-label Treatment Period|Pregnancy|1|||
27822747|NCT00939003|81185249|FG001|Open-label Treatment Period|Pregnancy|1|||
27822748|NCT00939003|81185248|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
27822749|NCT00939003|81185249|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
27822750|NCT00939003|81185248|FG000|Open-label Treatment Period|Site Closure|3|||
27822751|NCT00939003|81185249|FG001|Open-label Treatment Period|Site Closure|4|||
27822752|NCT01921062|81185252|FG000|Overall Study|Withdrawal by Subject|0|||
27822753|NCT01921062|81185253|FG001|Overall Study|Withdrawal by Subject|7|||
27822754|NCT01921062|81185252|FG000|Overall Study|Adverse Event|5|||
27822755|NCT01921062|81185253|FG001|Overall Study|Adverse Event|6|||
27822756|NCT01921062|81185252|FG000|Overall Study|Protocol Violation|0|||
27822757|NCT01921062|81185253|FG001|Overall Study|Protocol Violation|1|||
27822758|NCT01921062|81185252|FG000|Overall Study|VMIQ score > 72|4|||
27822759|NCT01921062|81185253|FG001|Overall Study|VMIQ score > 72|1|||
27822760|NCT01921062|81185252|FG000|Overall Study|Logistic error|0|||
27822761|NCT01921062|81185253|FG001|Overall Study|Logistic error|1|||
27822762|NCT02188303|81185254|FG000|Overall Study|Adverse Event|0|||
27822763|NCT02188303|81185255|FG001|Overall Study|Adverse Event|0|||
27822764|NCT02188303|81185256|FG002|Overall Study|Adverse Event|0|||
27822765|NCT02188303|81185257|FG003|Overall Study|Adverse Event|0|||
27822766|NCT02188303|81185258|FG004|Overall Study|Adverse Event|0|||
27822767|NCT02188303|81185259|FG005|Overall Study|Adverse Event|2|||
27822768|NCT02188303|81185260|FG006|Overall Study|Adverse Event|0|||
27822769|NCT02188303|81185261|FG007|Overall Study|Adverse Event|2|||
27822770|NCT02188303|81185254|FG000|Overall Study|Dose Termination Criteria Met|0|||
27822771|NCT02188303|81185255|FG001|Overall Study|Dose Termination Criteria Met|0|||
27822772|NCT02188303|81185256|FG002|Overall Study|Dose Termination Criteria Met|0|||
27822773|NCT02188303|81185257|FG003|Overall Study|Dose Termination Criteria Met|0|||
27822774|NCT02188303|81185258|FG004|Overall Study|Dose Termination Criteria Met|0|||
27694149|NCT02121834|80716677|FG001|Overall Study|Protocol Violation|1|||
27694150|NCT02121834|80716678|FG002|Overall Study|Protocol Violation|0|||
27822775|NCT02188303|81185259|FG005|Overall Study|Dose Termination Criteria Met|0|||
27822776|NCT02188303|81185260|FG006|Overall Study|Dose Termination Criteria Met|2|||
27822777|NCT02188303|81185261|FG007|Overall Study|Dose Termination Criteria Met|4|||
27822778|NCT00448019|81185262|FG000|Overall Study|Withdrawal by Subject|3|||
27822779|NCT00448019|81185262|FG000|Overall Study|Disease progression|1|||
27822780|NCT00448019|81185262|FG000|Overall Study|Death|2|||
27822781|NCT00448019|81185262|FG000|Overall Study|Insurance Issues|1|||
27694151|NCT02121834|80716679|FG003|Overall Study|Protocol Violation|0|||
27694152|NCT02121834|80716680|FG004|Overall Study|Protocol Violation|0|||
27694153|NCT02121834|80716681|FG005|Overall Study|Protocol Violation|0|||
27694154|NCT02121834|80716682|FG006|Overall Study|Protocol Violation|0|||
27694155|NCT02121834|80716676|FG000|Overall Study|Withdrawal by Subject|0|||
27694156|NCT02121834|80716677|FG001|Overall Study|Withdrawal by Subject|1|||
27694157|NCT02121834|80716678|FG002|Overall Study|Withdrawal by Subject|1|||
27694158|NCT02121834|80716679|FG003|Overall Study|Withdrawal by Subject|0|||
27694159|NCT02121834|80716680|FG004|Overall Study|Withdrawal by Subject|0|||
27822782|NCT02327130|81185272|FG000|Overall Study|Discharged in less than 5 days|5|||
27822783|NCT02327130|81185272|FG000|Overall Study|Physician Decision|2|||
27822784|NCT02327130|81185272|FG000|Overall Study|Unable to provide breath sample|1|||
27822785|NCT02327130|81185272|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
27822786|NCT02327130|81185272|FG000|Overall Study|Met exclusion criteria|3|||
27822787|NCT00579670|81185285|FG000|Overall Study|Death|1|||
27822788|NCT00579670|81185286|FG001|Overall Study|Death|0|||
27822789|NCT00579670|81185287|FG002|Overall Study|Death|0|||
27822790|NCT00579670|81185288|FG003|Overall Study|Death|0|||
27822791|NCT00579670|81185289|FG004|Overall Study|Death|0|||
27822792|NCT00579670|81185285|FG000|Overall Study|Adverse Event|1|||
27822793|NCT00579670|81185286|FG001|Overall Study|Adverse Event|0|||
27822794|NCT00579670|81185287|FG002|Overall Study|Adverse Event|1|||
27822795|NCT00579670|81185288|FG003|Overall Study|Adverse Event|2|||
27822796|NCT00579670|81185289|FG004|Overall Study|Adverse Event|0|||
27822797|NCT00579670|81185285|FG000|Overall Study|Lack of Efficacy|0|||
27822798|NCT00579670|81185286|FG001|Overall Study|Lack of Efficacy|0|||
27822799|NCT00579670|81185287|FG002|Overall Study|Lack of Efficacy|1|||
27822800|NCT00579670|81185288|FG003|Overall Study|Lack of Efficacy|14|||
27822801|NCT00579670|81185289|FG004|Overall Study|Lack of Efficacy|0|||
27822802|NCT00579670|81185285|FG000|Overall Study|Lost to Follow-up|0|||
27822803|NCT00579670|81185286|FG001|Overall Study|Lost to Follow-up|1|||
27822804|NCT00579670|81185287|FG002|Overall Study|Lost to Follow-up|0|||
27822805|NCT00579670|81185288|FG003|Overall Study|Lost to Follow-up|4|||
27822806|NCT00579670|81185289|FG004|Overall Study|Lost to Follow-up|0|||
27822807|NCT00579670|81185285|FG000|Overall Study|Other|0|||
27822808|NCT00579670|81185286|FG001|Overall Study|Other|0|||
27822809|NCT00579670|81185287|FG002|Overall Study|Other|1|||
27822810|NCT00579670|81185288|FG003|Overall Study|Other|2|||
27822811|NCT00579670|81185289|FG004|Overall Study|Other|0|||
27822812|NCT00579670|81185285|FG000|Overall Study|Withdrawal by Subject|0|||
27822813|NCT00579670|81185286|FG001|Overall Study|Withdrawal by Subject|0|||
27822814|NCT00579670|81185287|FG002|Overall Study|Withdrawal by Subject|1|||
27822815|NCT00579670|81185288|FG003|Overall Study|Withdrawal by Subject|0|||
27822816|NCT00579670|81185289|FG004|Overall Study|Withdrawal by Subject|0|||
27822817|NCT00320112|81185294|FG000|Overall Study|Lost to Follow-up|3|||
27822818|NCT00320112|81185295|FG001|Overall Study|Lost to Follow-up|4|||
27822819|NCT00320112|81185294|FG000|Overall Study|Withdrawal by Subject|3|||
27822820|NCT00320112|81185295|FG001|Overall Study|Withdrawal by Subject|0|||
27822821|NCT00320112|81185294|FG000|Overall Study|Death|2|||
27822822|NCT00320112|81185295|FG001|Overall Study|Death|1|||
27822823|NCT00794963|81185297|FG000|Overall Study|Withdrawal by Subject|1|||
27822824|NCT00794963|81185298|FG001|Overall Study|Withdrawal by Subject|4|||
27822825|NCT04349917|81185303|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
27822826|NCT04349917|81185304|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
27822827|NCT04349917|81185303|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
27822828|NCT04349917|81185304|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
27822829|NCT01037114|81185305|FG000|Year 20|Others|1|||
27822830|NCT01536574|81185308|FG000|Overall Study|Adverse Event|4|||
27822831|NCT01536574|81185309|FG001|Overall Study|Adverse Event|5|||
27822832|NCT01536574|81185308|FG000|Overall Study|Withdrawal by Subject|1|||
27822833|NCT01536574|81185309|FG001|Overall Study|Withdrawal by Subject|2|||
27822834|NCT01536574|81185308|FG000|Overall Study|Lack of Efficacy|1|||
27882889|NCT03793842|81404506|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
27822835|NCT01536574|81185309|FG001|Overall Study|Lack of Efficacy|0|||
27822836|NCT00263588|81185310|FG000|Overall Study|Death|54|||
27822837|NCT00263588|81185311|FG001|Overall Study|Death|90|||
27882890|NCT03793842|81404505|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
27694160|NCT02121834|80716681|FG005|Overall Study|Withdrawal by Subject|0|||
27694161|NCT02121834|80716682|FG006|Overall Study|Withdrawal by Subject|0|||
27694162|NCT02121834|80716676|FG000|Overall Study|Lost to Follow-up|0|||
27694163|NCT02121834|80716677|FG001|Overall Study|Lost to Follow-up|0|||
27822838|NCT00263588|81185310|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
27822839|NCT00263588|81185311|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
27822840|NCT00263588|81185310|FG000|Overall Study|Lost to Follow-up|7|||
27822841|NCT00263588|81185311|FG001|Overall Study|Lost to Follow-up|10|||
27822842|NCT00263588|81185310|FG000|Overall Study|Withdrawal by Subject|3|||
27822843|NCT00263588|81185311|FG001|Overall Study|Withdrawal by Subject|4|||
27822844|NCT00263588|81185310|FG000|Overall Study|Protocol Violation|0|||
27822845|NCT00263588|81185311|FG001|Overall Study|Protocol Violation|1|||
27822846|NCT00263588|81185310|FG000|Overall Study|Investigator decision|7|||
27822847|NCT00263588|81185311|FG001|Overall Study|Investigator decision|15|||
27822848|NCT00263588|81185310|FG000|Overall Study|Sponsor terminated study|0|||
27822849|NCT00263588|81185311|FG001|Overall Study|Sponsor terminated study|1|||
27822850|NCT02057458|81185312|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
27822851|NCT02057458|81185313|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
27822852|NCT02057458|81185314|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
27822853|NCT02057458|81185312|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
27822854|NCT02057458|81185313|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
27822855|NCT02057458|81185314|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
27822856|NCT02057458|81185312|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
27822857|NCT02057458|81185313|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
27822858|NCT02057458|81185314|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
27822859|NCT00445003|81185315|FG000|Overall Study|Death|1|||
27822860|NCT00445003|81185316|FG001|Overall Study|Death|2|||
27822861|NCT00445003|81185317|FG002|Overall Study|Death|1|||
27822862|NCT00445003|81185315|FG000|Overall Study|Missed Visit|3|||
27822863|NCT00445003|81185316|FG001|Overall Study|Missed Visit|5|||
27822864|NCT00445003|81185317|FG002|Overall Study|Missed Visit|1|||
27822865|NCT00445003|81185315|FG000|Overall Study|Dropped|1|||
27822866|NCT00445003|81185316|FG001|Overall Study|Dropped|3|||
27822867|NCT00445003|81185317|FG002|Overall Study|Dropped|2|||
27822868|NCT02918877|81185318|FG000|Overall Study|Withdrawal by Subject|2|||
27822869|NCT02918877|81185319|FG001|Overall Study|Withdrawal by Subject|2|||
27822870|NCT02918877|81185318|FG000|Overall Study|Surgery cancelled|1|||
27822871|NCT02918877|81185319|FG001|Overall Study|Surgery cancelled|0|||
27822872|NCT02918877|81185318|FG000|Overall Study|Physician Decision|1|||
27822873|NCT02918877|81185319|FG001|Overall Study|Physician Decision|0|||
27822874|NCT02918877|81185318|FG000|Overall Study|Received intraoperative steroids|1|||
27822875|NCT02918877|81185319|FG001|Overall Study|Received intraoperative steroids|0|||
27822876|NCT02918877|81185318|FG000|Overall Study|Unable to obtain lab samples|1|||
27822877|NCT02918877|81185319|FG001|Overall Study|Unable to obtain lab samples|0|||
27822878|NCT02918877|81185318|FG000|Overall Study|Unsafe to perform BAL|0|||
27822879|NCT02918877|81185319|FG001|Overall Study|Unsafe to perform BAL|1|||
27822880|NCT02979522|81185320|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
27822881|NCT02979522|81185321|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
27822882|NCT02979522|81185320|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
27822883|NCT02979522|81185321|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
27822884|NCT00877032|81185323|FG000|Overall Study|Did not meet entrance criteria|0|||
27822885|NCT00877032|81185324|FG001|Overall Study|Did not meet entrance criteria|0|||
27822886|NCT00877032|81185325|FG002|Overall Study|Did not meet entrance criteria|0|||
27822887|NCT00877032|81185326|FG003|Overall Study|Did not meet entrance criteria|1|||
27822888|NCT00877032|81185327|FG004|Overall Study|Did not meet entrance criteria|0|||
27822889|NCT00877032|81185328|FG005|Overall Study|Did not meet entrance criteria|0|||
27822890|NCT00877032|81185329|FG006|Overall Study|Did not meet entrance criteria|2|||
27822891|NCT03195491|81185332|FG000|Overall Study|Study drug toxicity|25|||
27822892|NCT03195491|81185333|FG001|Overall Study|Study drug toxicity|3|||
27882891|NCT03793842|81404506|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
27882892|NCT03309943|81404509|FG000|Overall Study|Withdrawal by Subject|0|||
27882893|NCT03309943|81404510|FG001|Overall Study|Withdrawal by Subject|1|||
27822893|NCT03195491|81185332|FG000|Overall Study|Maximum clinical benefit|5|||
27822894|NCT03195491|81185333|FG001|Overall Study|Maximum clinical benefit|0|||
27822895|NCT03195491|81185332|FG000|Overall Study|Lost to Follow-up|1|||
27822896|NCT03195491|81185333|FG001|Overall Study|Lost to Follow-up|0|||
27822897|NCT03195491|81185332|FG000|Overall Study|Death|3|||
27822898|NCT03195491|81185333|FG001|Overall Study|Death|0|||
27822899|NCT03195491|81185332|FG000|Overall Study|Adverse event unrelated to study drug|19|||
27822900|NCT03195491|81185333|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27882894|NCT03309943|81404509|FG000|Overall Study|Inappropriate behavior towards staff|0|||
27822901|NCT03195491|81185332|FG000|Overall Study|Disease progression|266|||
27694164|NCT02121834|80716678|FG002|Overall Study|Lost to Follow-up|1|||
27694165|NCT02121834|80716679|FG003|Overall Study|Lost to Follow-up|0|||
27822902|NCT03195491|81185333|FG001|Overall Study|Disease progression|8|||
27822903|NCT03195491|81185332|FG000|Overall Study|Other reasons|10|||
27822904|NCT03195491|81185333|FG001|Overall Study|Other reasons|0|||
27822905|NCT03195491|81185332|FG000|Overall Study|Participant withdrew consent|8|||
27822906|NCT03195491|81185333|FG001|Overall Study|Participant withdrew consent|1|||
27822907|NCT03195491|81185332|FG000|Overall Study|Participant no longer meets study criteria|0|||
27822908|NCT03195491|81185333|FG001|Overall Study|Participant no longer meets study criteria|1|||
27822909|NCT03195491|81185332|FG000|Overall Study|Participant request to discontinue study treatment|10|||
27822910|NCT03195491|81185333|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27822911|NCT00323882|81185334|FG000|Overall Study|Adverse Event|2|||
27822912|NCT00323882|81185335|FG001|Overall Study|Adverse Event|1|||
27822913|NCT00323882|81185336|FG002|Overall Study|Adverse Event|1|||
27822914|NCT00323882|81185337|FG003|Overall Study|Adverse Event|1|||
27822915|NCT00323882|81185338|FG004|Overall Study|Adverse Event|3|||
27822916|NCT00323882|81185334|FG000|Overall Study|Disease Progression|6|||
27822917|NCT00323882|81185335|FG001|Overall Study|Disease Progression|4|||
27822918|NCT00323882|81185336|FG002|Overall Study|Disease Progression|10|||
27822919|NCT00323882|81185337|FG003|Overall Study|Disease Progression|5|||
27822920|NCT00323882|81185338|FG004|Overall Study|Disease Progression|22|||
27822921|NCT00323882|81185334|FG000|Overall Study|Death|0|||
27822922|NCT00323882|81185335|FG001|Overall Study|Death|1|||
27822923|NCT00323882|81185336|FG002|Overall Study|Death|1|||
27822924|NCT00323882|81185337|FG003|Overall Study|Death|0|||
27822925|NCT00323882|81185338|FG004|Overall Study|Death|5|||
27822926|NCT00323882|81185334|FG000|Overall Study|Lost to Follow-up|0|||
27822927|NCT00323882|81185335|FG001|Overall Study|Lost to Follow-up|0|||
27822928|NCT00323882|81185336|FG002|Overall Study|Lost to Follow-up|1|||
27822929|NCT00323882|81185337|FG003|Overall Study|Lost to Follow-up|0|||
27822930|NCT00323882|81185338|FG004|Overall Study|Lost to Follow-up|1|||
27822931|NCT00323882|81185334|FG000|Overall Study|Other|0|||
27822932|NCT00323882|81185335|FG001|Overall Study|Other|0|||
27822933|NCT00323882|81185336|FG002|Overall Study|Other|0|||
27822934|NCT00323882|81185337|FG003|Overall Study|Other|1|||
27822935|NCT00323882|81185338|FG004|Overall Study|Other|1|||
27822936|NCT00437658|81185339|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
27822937|NCT00437658|81185340|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
27822938|NCT00437658|81185341|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
27822939|NCT00437658|81185339|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
27822940|NCT00437658|81185340|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
27822941|NCT00437658|81185341|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
27822942|NCT00437658|81185339|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
27822943|NCT00437658|81185340|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
27822944|NCT00437658|81185341|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
27822945|NCT00437658|81185339|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
27822946|NCT00437658|81185340|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
27822947|NCT00437658|81185341|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
27822948|NCT00437658|81185339|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
27822949|NCT00437658|81185340|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
27822950|NCT00437658|81185341|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
27822951|NCT00437658|81185339|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
27822952|NCT00437658|81185340|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
27822953|NCT00437658|81185341|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
27822954|NCT00437658|81185339|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
27694166|NCT02121834|80716680|FG004|Overall Study|Lost to Follow-up|0|||
27694167|NCT02121834|80716681|FG005|Overall Study|Lost to Follow-up|0|||
27694168|NCT02121834|80716682|FG006|Overall Study|Lost to Follow-up|0|||
27694169|NCT00645801|80716683|FG000|Overall Study|unclear if patient took all the medication.|1|||
27822955|NCT00437658|81185340|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
27822956|NCT00437658|81185341|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
27822957|NCT00437658|81185339|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
27822958|NCT00437658|81185340|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
27822959|NCT00437658|81185341|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
27822960|NCT00437658|81185339|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
27822961|NCT00437658|81185340|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
27822962|NCT00437658|81185341|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
27822963|NCT00437658|81185339|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
27822964|NCT00437658|81185340|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
27822965|NCT00437658|81185341|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
27822966|NCT00437658|81185339|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
27822967|NCT00437658|81185340|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
27822968|NCT00437658|81185341|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
27822969|NCT00437658|81185339|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
27822970|NCT00437658|81185340|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
27822971|NCT00437658|81185341|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
27822972|NCT02682238|81185344|FG000|Overall Study|Lost to Follow-up|0|||
27822973|NCT02682238|81185345|FG001|Overall Study|Lost to Follow-up|2|||
27822974|NCT02682238|81185344|FG000|Overall Study|Withdrawal by Subject|1|||
27822975|NCT02682238|81185345|FG001|Overall Study|Withdrawal by Subject|0|||
27822976|NCT02682238|81185344|FG000|Overall Study|Adverse Event|1|||
27822977|NCT02682238|81185345|FG001|Overall Study|Adverse Event|0|||
27822978|NCT02682238|81185344|FG000|Overall Study|Non-compliance with Study Drug|1|||
27822979|NCT02682238|81185345|FG001|Overall Study|Non-compliance with Study Drug|0|||
27822980|NCT02682238|81185344|FG000|Overall Study|Non-compliance with Protocol|0|||
27822981|NCT02682238|81185345|FG001|Overall Study|Non-compliance with Protocol|2|||
27822982|NCT05341622|81185347|FG000|Overall Study|Death|0|||
27822983|NCT05341622|81185348|FG001|Overall Study|Death|0|||
27822984|NCT05341622|81185349|FG002|Overall Study|Death|0|||
27822985|NCT05341622|81185350|FG003|Overall Study|Death|0|||
27822986|NCT05341622|81185351|FG004|Overall Study|Death|1|||
27822987|NCT05341622|81185352|FG005|Overall Study|Death|0|||
27822988|NCT05341622|81185353|FG006|Overall Study|Death|0|||
27882895|NCT03309943|81404510|FG001|Overall Study|Inappropriate behavior towards staff|1|||
27822989|NCT05341622|81185354|FG007|Overall Study|Death|1|||
27882896|NCT03020992|81404512|FG000|Overall Study|Adverse Event|5|||
27882897|NCT03020992|81404512|FG000|Overall Study|Withdrawal by Subject|1|||
27882898|NCT02530125|81404513|FG000|Completed Treatment|Early termination of study|1|||
27882899|NCT02530125|81404513|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
27882900|NCT04177095|81404514|FG000|Overall Study|Withdrawal by Subject|3|||
27882901|NCT04177095|81404514|FG000|Overall Study|Screen Failure|3|||
27882902|NCT04177095|81404514|FG000|Overall Study|Problems with the Trugraf assay|1|||
27882903|NCT01868022|81404518|FG000|Overall Study|Withdrawal by Subject|0|||
27882904|NCT01868022|81404519|FG001|Overall Study|Withdrawal by Subject|0|||
27882905|NCT01868022|81404520|FG002|Overall Study|Withdrawal by Subject|1|||
27882906|NCT01868022|81404521|FG003|Overall Study|Withdrawal by Subject|1|||
27882907|NCT01868022|81404522|FG004|Overall Study|Withdrawal by Subject|0|||
27882908|NCT01868022|81404523|FG005|Overall Study|Withdrawal by Subject|0|||
27882909|NCT01868022|81404524|FG006|Overall Study|Withdrawal by Subject|0|||
27882910|NCT01868022|81404525|FG007|Overall Study|Withdrawal by Subject|1|||
27882911|NCT01868022|81404526|FG008|Overall Study|Withdrawal by Subject|0|||
27882912|NCT01868022|81404518|FG000|Overall Study|Adverse Event|0|||
27882913|NCT01868022|81404519|FG001|Overall Study|Adverse Event|0|||
27882914|NCT01868022|81404520|FG002|Overall Study|Adverse Event|0|||
27882915|NCT01868022|81404521|FG003|Overall Study|Adverse Event|0|||
27882916|NCT01868022|81404522|FG004|Overall Study|Adverse Event|2|||
27822990|NCT05341622|81185347|FG000|Overall Study|Invalid Address|0|||
27822991|NCT05341622|81185348|FG001|Overall Study|Invalid Address|1|||
27822992|NCT05341622|81185349|FG002|Overall Study|Invalid Address|0|||
27822993|NCT05341622|81185350|FG003|Overall Study|Invalid Address|0|||
27882917|NCT01868022|81404523|FG005|Overall Study|Adverse Event|0|||
27882918|NCT01868022|81404524|FG006|Overall Study|Adverse Event|0|||
27882919|NCT01868022|81404525|FG007|Overall Study|Adverse Event|2|||
27882920|NCT01868022|81404526|FG008|Overall Study|Adverse Event|2|||
27882921|NCT01868022|81404518|FG000|Overall Study|Physician Decision|0|||
27882922|NCT01868022|81404519|FG001|Overall Study|Physician Decision|0|||
27882923|NCT01868022|81404520|FG002|Overall Study|Physician Decision|0|||
27882924|NCT01868022|81404521|FG003|Overall Study|Physician Decision|0|||
27882925|NCT01868022|81404522|FG004|Overall Study|Physician Decision|0|||
27882926|NCT01868022|81404523|FG005|Overall Study|Physician Decision|1|||
27882927|NCT01868022|81404524|FG006|Overall Study|Physician Decision|0|||
27882928|NCT01868022|81404525|FG007|Overall Study|Physician Decision|2|||
27882929|NCT01868022|81404526|FG008|Overall Study|Physician Decision|0|||
27882930|NCT01868022|81404518|FG000|Overall Study|Study closed/terminated|0|||
27882931|NCT01868022|81404519|FG001|Overall Study|Study closed/terminated|0|||
27882932|NCT01868022|81404520|FG002|Overall Study|Study closed/terminated|0|||
27882933|NCT01868022|81404521|FG003|Overall Study|Study closed/terminated|0|||
27882934|NCT01868022|81404522|FG004|Overall Study|Study closed/terminated|0|||
27882935|NCT01868022|81404523|FG005|Overall Study|Study closed/terminated|0|||
27694170|NCT00645801|80716684|FG001|Overall Study|unclear if patient took all the medication.|0|||
27822994|NCT05341622|81185351|FG004|Overall Study|Invalid Address|0|||
27822995|NCT05341622|81185352|FG005|Overall Study|Invalid Address|0|||
27822996|NCT05341622|81185353|FG006|Overall Study|Invalid Address|0|||
27822997|NCT05341622|81185354|FG007|Overall Study|Invalid Address|0|||
27822998|NCT05341622|81185347|FG000|Overall Study|Ineligible|26|||
27822999|NCT05341622|81185348|FG001|Overall Study|Ineligible|21|||
27823000|NCT05341622|81185349|FG002|Overall Study|Ineligible|28|||
27823001|NCT05341622|81185350|FG003|Overall Study|Ineligible|24|||
27823002|NCT05341622|81185351|FG004|Overall Study|Ineligible|29|||
27823003|NCT05341622|81185352|FG005|Overall Study|Ineligible|31|||
27823004|NCT05341622|81185353|FG006|Overall Study|Ineligible|28|||
27823005|NCT05341622|81185354|FG007|Overall Study|Ineligible|26|||
27823006|NCT02996682|81185357|FG000|Overall Study|Death|0|||
27823007|NCT02996682|81185358|FG001|Overall Study|Death|3|||
27882936|NCT01868022|81404524|FG006|Overall Study|Study closed/terminated|0|||
27882937|NCT01868022|81404525|FG007|Overall Study|Study closed/terminated|1|||
27882938|NCT01868022|81404526|FG008|Overall Study|Study closed/terminated|0|||
27882939|NCT01868022|81404518|FG000|Overall Study|Ongoing|0|||
27882940|NCT01868022|81404519|FG001|Overall Study|Ongoing|0|||
27882941|NCT01868022|81404520|FG002|Overall Study|Ongoing|0|||
27882942|NCT01868022|81404521|FG003|Overall Study|Ongoing|0|||
27593966|NCT04393441|80352351|FG001|Overall Study|Adverse Event|3|||
27823008|NCT02089685|81185360|FG000|Overall Study|Adverse Event|1|||
27823009|NCT02089685|81185361|FG001|Overall Study|Adverse Event|0|||
27823010|NCT02089685|81185362|FG002|Overall Study|Adverse Event|0|||
27823011|NCT02089685|81185363|FG003|Overall Study|Adverse Event|0|||
27694171|NCT00645801|80716683|FG000|Overall Study|Lost to Follow-up|19|||
27694172|NCT00645801|80716684|FG001|Overall Study|Lost to Follow-up|15|||
27694173|NCT00953407|80716685|FG000|Overall Study|Failed inclusion criteria|1|||
27694174|NCT00953407|80716686|FG001|Overall Study|Failed inclusion criteria|1|||
27694175|NCT00953407|80716687|FG002|Overall Study|Failed inclusion criteria|1|||
27694176|NCT00953407|80716688|FG003|Overall Study|Failed inclusion criteria|1|||
27694177|NCT00953407|80716689|FG004|Overall Study|Failed inclusion criteria|1|||
27694178|NCT00953407|80716685|FG000|Overall Study|Lost to Follow-up|0|||
27694179|NCT00953407|80716686|FG001|Overall Study|Lost to Follow-up|0|||
27694180|NCT00953407|80716687|FG002|Overall Study|Lost to Follow-up|0|||
27694181|NCT00953407|80716688|FG003|Overall Study|Lost to Follow-up|1|||
27694182|NCT00953407|80716689|FG004|Overall Study|Lost to Follow-up|0|||
27694183|NCT03226275|80716692|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
27694184|NCT03226275|80716693|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
27694185|NCT03226275|80716694|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
27694186|NCT03226275|80716695|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
27694187|NCT03226275|80716692|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
27694188|NCT03226275|80716693|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
27694189|NCT03226275|80716694|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
27694190|NCT03226275|80716695|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
27694191|NCT01275131|80716696|FG000|Period 1|Withdrawal by Subject|1|||
27694192|NCT01275131|80716697|FG001|Period 1|Withdrawal by Subject|0|||
27694193|NCT01275131|80716698|FG002|Period 1|Withdrawal by Subject|3|||
27694194|NCT01275131|80716699|FG003|Period 1|Withdrawal by Subject|2|||
27694195|NCT01275131|80716696|FG000|Period 1|Physician Decision|1|||
27694196|NCT01275131|80716697|FG001|Period 1|Physician Decision|0|||
27694197|NCT01275131|80716698|FG002|Period 1|Physician Decision|0|||
27694198|NCT01275131|80716699|FG003|Period 1|Physician Decision|0|||
27694199|NCT01275131|80716696|FG000|Period 2 (Crossover)|Adverse Event|0|||
27694200|NCT01275131|80716697|FG001|Period 2 (Crossover)|Adverse Event|1|||
27694201|NCT01275131|80716698|FG002|Period 2 (Crossover)|Adverse Event|0|||
27694202|NCT01275131|80716699|FG003|Period 2 (Crossover)|Adverse Event|0|||
27694203|NCT01275131|80716696|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
27694204|NCT01275131|80716697|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
27694205|NCT01275131|80716698|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
27694206|NCT01275131|80716699|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
27694207|NCT01801735|80716705|FG000|Overall Study|Adverse Event|79|||
27694208|NCT01801735|80716705|FG000|Overall Study|Lack of Efficacy|28|||
27694209|NCT01801735|80716705|FG000|Overall Study|Withdrawal by Subject|27|||
27694210|NCT01801735|80716705|FG000|Overall Study|Protocol Violation|25|||
27694211|NCT01801735|80716705|FG000|Overall Study|Lost to Follow-up|15|||
27694212|NCT01801735|80716705|FG000|Overall Study|Non-compliance with Trial Drug|13|||
27694213|NCT01801735|80716705|FG000|Overall Study|Physician Decision|3|||
27694214|NCT01801735|80716705|FG000|Overall Study|Death|1|||
27694215|NCT01801735|80716705|FG000|Overall Study|Other, including site closure|19|||
27694216|NCT00406653|80716712|FG000|Induction Period|Adverse Event|1|||
27694217|NCT00406653|80716713|FG001|Induction Period|Adverse Event|10|||
27694218|NCT00406653|80716714|FG002|Induction Period|Adverse Event|4|||
27694219|NCT00406653|80716715|FG003|Induction Period|Adverse Event|11|||
27694220|NCT00406653|80716716|FG004|Induction Period|Adverse Event|0|||
27694221|NCT00406653|80716717|FG005|Induction Period|Adverse Event|0|||
27694222|NCT00406653|80716718|FG006|Induction Period|Adverse Event|0|||
27823012|NCT02089685|81185364|FG004|Overall Study|Adverse Event|1|||
27823013|NCT02089685|81185365|FG005|Overall Study|Adverse Event|0|||
27823014|NCT02089685|81185360|FG000|Overall Study|Clinical Progression|4|||
27823015|NCT02089685|81185361|FG001|Overall Study|Clinical Progression|0|||
27823016|NCT02089685|81185362|FG002|Overall Study|Clinical Progression|0|||
27823017|NCT02089685|81185363|FG003|Overall Study|Clinical Progression|5|||
27823018|NCT02089685|81185364|FG004|Overall Study|Clinical Progression|1|||
27823019|NCT02089685|81185365|FG005|Overall Study|Clinical Progression|2|||
27823020|NCT02089685|81185360|FG000|Overall Study|Excluded Medication|1|||
27823021|NCT02089685|81185361|FG001|Overall Study|Excluded Medication|0|||
27823022|NCT02089685|81185362|FG002|Overall Study|Excluded Medication|0|||
27823023|NCT02089685|81185363|FG003|Overall Study|Excluded Medication|11|||
27823024|NCT02089685|81185364|FG004|Overall Study|Excluded Medication|2|||
27823025|NCT02089685|81185365|FG005|Overall Study|Excluded Medication|1|||
27823026|NCT02089685|81185360|FG000|Overall Study|Progressive disease|13|||
27823027|NCT02089685|81185361|FG001|Overall Study|Progressive disease|10|||
27823028|NCT02089685|81185362|FG002|Overall Study|Progressive disease|3|||
27823029|NCT02089685|81185363|FG003|Overall Study|Progressive disease|51|||
27823030|NCT02089685|81185364|FG004|Overall Study|Progressive disease|17|||
27823031|NCT02089685|81185365|FG005|Overall Study|Progressive disease|12|||
27823032|NCT02089685|81185360|FG000|Overall Study|Follow up ended by sponsor|2|||
27823033|NCT02089685|81185361|FG001|Overall Study|Follow up ended by sponsor|2|||
27823034|NCT02089685|81185362|FG002|Overall Study|Follow up ended by sponsor|0|||
27823035|NCT02089685|81185363|FG003|Overall Study|Follow up ended by sponsor|70|||
27823036|NCT02089685|81185364|FG004|Overall Study|Follow up ended by sponsor|26|||
27823037|NCT02089685|81185365|FG005|Overall Study|Follow up ended by sponsor|26|||
27823038|NCT02089685|81185360|FG000|Overall Study|Withdrawal by Subject|0|||
27823039|NCT02089685|81185361|FG001|Overall Study|Withdrawal by Subject|2|||
27823040|NCT02089685|81185362|FG002|Overall Study|Withdrawal by Subject|0|||
27823041|NCT02089685|81185363|FG003|Overall Study|Withdrawal by Subject|8|||
27823042|NCT02089685|81185364|FG004|Overall Study|Withdrawal by Subject|1|||
27823043|NCT02089685|81185365|FG005|Overall Study|Withdrawal by Subject|1|||
27823044|NCT02089685|81185360|FG000|Overall Study|Status not recorded|1|||
27823045|NCT02089685|81185361|FG001|Overall Study|Status not recorded|0|||
27823046|NCT02089685|81185362|FG002|Overall Study|Status not recorded|0|||
27823047|NCT02089685|81185363|FG003|Overall Study|Status not recorded|0|||
27823048|NCT02089685|81185364|FG004|Overall Study|Status not recorded|1|||
27823049|NCT02089685|81185365|FG005|Overall Study|Status not recorded|0|||
27823050|NCT02089685|81185360|FG000|Overall Study|Death|0|||
27823051|NCT02089685|81185361|FG001|Overall Study|Death|0|||
27823052|NCT02089685|81185362|FG002|Overall Study|Death|0|||
27823053|NCT02089685|81185363|FG003|Overall Study|Death|7|||
27823054|NCT02089685|81185364|FG004|Overall Study|Death|2|||
27823055|NCT02089685|81185365|FG005|Overall Study|Death|5|||
27823056|NCT02089685|81185360|FG000|Overall Study|Lost to Follow-up|0|||
27823057|NCT02089685|81185361|FG001|Overall Study|Lost to Follow-up|0|||
27694223|NCT00406653|80716712|FG000|Induction Period|Lack of Efficacy|11|||
27694224|NCT00406653|80716713|FG001|Induction Period|Lack of Efficacy|14|||
27694225|NCT00406653|80716714|FG002|Induction Period|Lack of Efficacy|8|||
27694226|NCT00406653|80716715|FG003|Induction Period|Lack of Efficacy|10|||
27694227|NCT00406653|80716716|FG004|Induction Period|Lack of Efficacy|0|||
27694228|NCT00406653|80716717|FG005|Induction Period|Lack of Efficacy|0|||
27823058|NCT02089685|81185362|FG002|Overall Study|Lost to Follow-up|0|||
27823059|NCT02089685|81185363|FG003|Overall Study|Lost to Follow-up|1|||
27694229|NCT00406653|80716718|FG006|Induction Period|Lack of Efficacy|0|||
27694230|NCT00406653|80716712|FG000|Induction Period|Lost to Follow-up|0|||
27694231|NCT00406653|80716713|FG001|Induction Period|Lost to Follow-up|2|||
27694232|NCT00406653|80716714|FG002|Induction Period|Lost to Follow-up|0|||
27823060|NCT02089685|81185364|FG004|Overall Study|Lost to Follow-up|0|||
27823061|NCT02089685|81185365|FG005|Overall Study|Lost to Follow-up|0|||
27694233|NCT00406653|80716715|FG003|Induction Period|Lost to Follow-up|0|||
27823062|NCT02089685|81185360|FG000|Overall Study|Physician Decision|0|||
27823063|NCT02089685|81185361|FG001|Overall Study|Physician Decision|0|||
27823064|NCT02089685|81185362|FG002|Overall Study|Physician Decision|0|||
27823065|NCT02089685|81185363|FG003|Overall Study|Physician Decision|0|||
27823066|NCT02089685|81185364|FG004|Overall Study|Physician Decision|0|||
27823067|NCT02089685|81185365|FG005|Overall Study|Physician Decision|4|||
27823068|NCT02089685|81185360|FG000|Overall Study|Screen failure|1|||
27823069|NCT02089685|81185361|FG001|Overall Study|Screen failure|0|||
27823070|NCT02089685|81185362|FG002|Overall Study|Screen failure|0|||
27882943|NCT01868022|81404522|FG004|Overall Study|Ongoing|0|||
27882944|NCT01868022|81404523|FG005|Overall Study|Ongoing|0|||
27882945|NCT01868022|81404524|FG006|Overall Study|Ongoing|0|||
27882946|NCT01868022|81404525|FG007|Overall Study|Ongoing|3|||
27882947|NCT01868022|81404526|FG008|Overall Study|Ongoing|0|||
27694234|NCT00406653|80716716|FG004|Induction Period|Lost to Follow-up|0|||
27823071|NCT02089685|81185363|FG003|Overall Study|Screen failure|0|||
27882948|NCT02490371|81404527|FG000|Overall Study|Lost to Follow-up|1|||
27823072|NCT02089685|81185364|FG004|Overall Study|Screen failure|0|||
27823073|NCT02089685|81185365|FG005|Overall Study|Screen failure|0|||
27823074|NCT03929393|81185366|FG000|Overall Study|Death|1|||
27823075|NCT03929393|81185367|FG001|Overall Study|Death|0|||
27823076|NCT03929393|81185366|FG000|Overall Study|Time Commitment|2|||
27823077|NCT03929393|81185367|FG001|Overall Study|Time Commitment|5|||
27823078|NCT03929393|81185366|FG000|Overall Study|Motor Vehicle Accident|0|||
27823079|NCT03929393|81185367|FG001|Overall Study|Motor Vehicle Accident|1|||
27823080|NCT03929393|81185366|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
27823081|NCT03929393|81185367|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
27823082|NCT03929393|81185366|FG000|Overall Study|Other|1|||
27823083|NCT03929393|81185367|FG001|Overall Study|Other|3|||
27823084|NCT00416520|81185371|FG000|Open-label Period|Adverse Event|28|||
27882949|NCT02490371|81404528|FG001|Overall Study|Lost to Follow-up|1|||
27882950|NCT02159053|81404531|FG000|Overall Study|Death|2|||
27823085|NCT00416520|81185372|FG001|Open-label Period|Adverse Event|10|||
27882951|NCT02159053|81404532|FG001|Overall Study|Death|0|||
27882952|NCT02159053|81404533|FG002|Overall Study|Death|1|||
27882953|NCT02159053|81404531|FG000|Overall Study|Physician Decision|0|||
27882954|NCT02159053|81404532|FG001|Overall Study|Physician Decision|1|||
27882955|NCT02159053|81404533|FG002|Overall Study|Physician Decision|1|||
27823086|NCT00416520|81185373|FG002|Open-label Period|Adverse Event|0|||
27823087|NCT00416520|81185374|FG003|Open-label Period|Adverse Event|0|||
27823088|NCT00416520|81185371|FG000|Open-label Period|Death|2|||
27823089|NCT00416520|81185372|FG001|Open-label Period|Death|1|||
27823090|NCT00416520|81185373|FG002|Open-label Period|Death|0|||
27823091|NCT00416520|81185374|FG003|Open-label Period|Death|0|||
27823092|NCT00416520|81185371|FG000|Open-label Period|Lack of Efficacy|8|||
27823093|NCT00416520|81185372|FG001|Open-label Period|Lack of Efficacy|1|||
27823094|NCT00416520|81185373|FG002|Open-label Period|Lack of Efficacy|0|||
27823095|NCT00416520|81185374|FG003|Open-label Period|Lack of Efficacy|0|||
27823096|NCT00416520|81185371|FG000|Open-label Period|Protocol Violation|3|||
27823097|NCT00416520|81185372|FG001|Open-label Period|Protocol Violation|3|||
27823098|NCT00416520|81185373|FG002|Open-label Period|Protocol Violation|0|||
27823099|NCT00416520|81185374|FG003|Open-label Period|Protocol Violation|0|||
27823100|NCT00416520|81185371|FG000|Open-label Period|Withdrawal by Subject|16|||
27823101|NCT00416520|81185372|FG001|Open-label Period|Withdrawal by Subject|5|||
27823102|NCT00416520|81185373|FG002|Open-label Period|Withdrawal by Subject|0|||
27823103|NCT00416520|81185374|FG003|Open-label Period|Withdrawal by Subject|0|||
27823104|NCT00416520|81185371|FG000|Open-label Period|Other Reasons|3|||
27823105|NCT00416520|81185372|FG001|Open-label Period|Other Reasons|12|||
27823106|NCT00416520|81185373|FG002|Open-label Period|Other Reasons|0|||
27823107|NCT00416520|81185374|FG003|Open-label Period|Other Reasons|0|||
27823108|NCT00416520|81185371|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
27823109|NCT00416520|81185372|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
27823110|NCT00416520|81185373|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
27823111|NCT00416520|81185374|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
27823112|NCT00416520|81185371|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
27823113|NCT00416520|81185372|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
27823114|NCT00416520|81185373|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
27823115|NCT00416520|81185374|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
27823116|NCT00416520|81185371|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
27823117|NCT00416520|81185372|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
27823118|NCT00416520|81185373|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
27823119|NCT00416520|81185374|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
27823120|NCT04605094|81185375|FG000|Overall Study|Adverse Event|2|||
27823121|NCT04605094|81185376|FG001|Overall Study|Adverse Event|2|||
27823122|NCT04605094|81185375|FG000|Overall Study|Lost to Follow-up|1|||
27823123|NCT04605094|81185376|FG001|Overall Study|Lost to Follow-up|4|||
27823124|NCT04605094|81185375|FG000|Overall Study|Physician Decision|2|||
27823125|NCT04605094|81185376|FG001|Overall Study|Physician Decision|2|||
27823126|NCT04605094|81185375|FG000|Overall Study|Study terminated by Sponsor|31|||
27823127|NCT04605094|81185376|FG001|Overall Study|Study terminated by Sponsor|33|||
27823128|NCT04605094|81185375|FG000|Overall Study|Withdrawal by Subject|22|||
27823129|NCT04605094|81185376|FG001|Overall Study|Withdrawal by Subject|19|||
27823130|NCT04605094|81185375|FG000|Overall Study|Other|1|||
27823131|NCT04605094|81185376|FG001|Overall Study|Other|1|||
27823132|NCT03627091|81185377|FG000|Overall Study|Adverse Event|0|||
27823133|NCT03627091|81185378|FG001|Overall Study|Adverse Event|0|||
27823134|NCT03627091|81185379|FG002|Overall Study|Adverse Event|2|||
27823135|NCT03627091|81185377|FG000|Overall Study|Withdrawal by Subject|2|||
27823136|NCT03627091|81185378|FG001|Overall Study|Withdrawal by Subject|0|||
27823137|NCT03627091|81185379|FG002|Overall Study|Withdrawal by Subject|2|||
27882956|NCT02159053|81404531|FG000|Overall Study|Lack of Efficacy|3|||
27882957|NCT02159053|81404532|FG001|Overall Study|Lack of Efficacy|4|||
27882958|NCT02159053|81404533|FG002|Overall Study|Lack of Efficacy|7|||
27882959|NCT02159053|81404531|FG000|Overall Study|Adverse Event|7|||
27882960|NCT02159053|81404532|FG001|Overall Study|Adverse Event|6|||
27882961|NCT02159053|81404533|FG002|Overall Study|Adverse Event|5|||
27882962|NCT02159053|81404531|FG000|Overall Study|Participants/guardian decision|8|||
27882963|NCT02159053|81404532|FG001|Overall Study|Participants/guardian decision|10|||
27882964|NCT02159053|81404533|FG002|Overall Study|Participants/guardian decision|6|||
27882965|NCT01068678|81404534|FG000|Overall Study|Lack of Efficacy|3|||
27882966|NCT01068678|81404535|FG001|Overall Study|Lack of Efficacy|2|||
27882967|NCT01068678|81404534|FG000|Overall Study|Protocol Violation|5|||
27882968|NCT01068678|81404535|FG001|Overall Study|Protocol Violation|1|||
27882969|NCT01068678|81404534|FG000|Overall Study|Withdrawal criteria|12|||
27882970|NCT01068678|81404535|FG001|Overall Study|Withdrawal criteria|6|||
27882971|NCT01068678|81404534|FG000|Overall Study|Unclassified|18|||
27882972|NCT01068678|81404535|FG001|Overall Study|Unclassified|15|||
27882973|NCT00955409|81404536|FG000|Overall Study|Lack of Efficacy|1|||
27882974|NCT00955409|81404537|FG001|Overall Study|Lack of Efficacy|0|||
27882975|NCT00955409|81404538|FG002|Overall Study|Lack of Efficacy|0|||
27882976|NCT00955409|81404539|FG003|Overall Study|Lack of Efficacy|0|||
27882977|NCT00955409|81404540|FG004|Overall Study|Lack of Efficacy|0|||
27882978|NCT00955409|81404541|FG005|Overall Study|Lack of Efficacy|0|||
27882979|NCT00955409|81404542|FG006|Overall Study|Lack of Efficacy|0|||
27882980|NCT00955409|81404543|FG007|Overall Study|Lack of Efficacy|0|||
27882981|NCT00955409|81404544|FG008|Overall Study|Lack of Efficacy|0|||
27882982|NCT00955409|81404545|FG009|Overall Study|Lack of Efficacy|0|||
27882983|NCT00955409|81404536|FG000|Overall Study|Withdrawal by Subject|1|||
27882984|NCT00955409|81404537|FG001|Overall Study|Withdrawal by Subject|0|||
27882985|NCT00955409|81404538|FG002|Overall Study|Withdrawal by Subject|5|||
27882986|NCT00955409|81404539|FG003|Overall Study|Withdrawal by Subject|2|||
27882987|NCT00955409|81404540|FG004|Overall Study|Withdrawal by Subject|0|||
27882988|NCT00955409|81404541|FG005|Overall Study|Withdrawal by Subject|0|||
27882989|NCT00955409|81404542|FG006|Overall Study|Withdrawal by Subject|2|||
27882990|NCT00955409|81404543|FG007|Overall Study|Withdrawal by Subject|0|||
27882991|NCT00955409|81404544|FG008|Overall Study|Withdrawal by Subject|1|||
27882992|NCT00955409|81404545|FG009|Overall Study|Withdrawal by Subject|0|||
27882993|NCT00955409|81404536|FG000|Overall Study|Caregiver Request|2|||
27823138|NCT03627091|81185377|FG000|Overall Study|Physician Decision|2|||
27823139|NCT03627091|81185378|FG001|Overall Study|Physician Decision|0|||
27823140|NCT03627091|81185379|FG002|Overall Study|Physician Decision|0|||
27823141|NCT03627091|81185377|FG000|Overall Study|Site terminated by sponsor|0|||
27823142|NCT03627091|81185378|FG001|Overall Study|Site terminated by sponsor|1|||
27823143|NCT03627091|81185379|FG002|Overall Study|Site terminated by sponsor|0|||
27823144|NCT03627091|81185377|FG000|Overall Study|Disease relapse|7|||
27823145|NCT03627091|81185378|FG001|Overall Study|Disease relapse|5|||
27823146|NCT03627091|81185379|FG002|Overall Study|Disease relapse|1|||
27823147|NCT03627091|81185377|FG000|Overall Study|Other|1|||
27823148|NCT03627091|81185378|FG001|Overall Study|Other|0|||
27823149|NCT03627091|81185379|FG002|Overall Study|Other|0|||
27823150|NCT00705536|81185380|FG000|Start Period 1|Withdrawal by Subject|0|||
27823151|NCT00705536|81185381|FG001|Start Period 1|Withdrawal by Subject|0|||
27823152|NCT00705536|81185382|FG002|Start Period 1|Withdrawal by Subject|0|||
27823153|NCT00705536|81185383|FG003|Start Period 1|Withdrawal by Subject|1|||
27823154|NCT03136380|81185386|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27823155|NCT03136380|81185387|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
27823156|NCT03136380|81185388|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27823157|NCT03136380|81185389|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27823158|NCT03136380|81185390|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
27823159|NCT00358449|81185396|FG000|Overall Study|Adverse Event|1|||
27823160|NCT00358449|81185397|FG001|Overall Study|Adverse Event|0|||
27823161|NCT00358449|81185398|FG002|Overall Study|Adverse Event|1|||
27823162|NCT00358449|81185396|FG000|Overall Study|Lost to Follow-up|1|||
27823163|NCT00358449|81185397|FG001|Overall Study|Lost to Follow-up|0|||
27823164|NCT00358449|81185398|FG002|Overall Study|Lost to Follow-up|0|||
27823165|NCT00358449|81185396|FG000|Overall Study|Withdrawal by Subject|2|||
27823166|NCT00358449|81185397|FG001|Overall Study|Withdrawal by Subject|0|||
27823167|NCT00358449|81185398|FG002|Overall Study|Withdrawal by Subject|0|||
27823168|NCT00358449|81185396|FG000|Overall Study|Lack of Efficacy|0|||
27823169|NCT00358449|81185397|FG001|Overall Study|Lack of Efficacy|1|||
27823170|NCT00358449|81185398|FG002|Overall Study|Lack of Efficacy|0|||
27823171|NCT00358449|81185396|FG000|Overall Study|Steriod Inhaler was Increased|0|||
27823172|NCT00358449|81185397|FG001|Overall Study|Steriod Inhaler was Increased|0|||
27823173|NCT00358449|81185398|FG002|Overall Study|Steriod Inhaler was Increased|1|||
27823174|NCT01710657|81185399|FG000|Overall Study|Lost to Follow-up|2|||
27823175|NCT01710657|81185400|FG001|Overall Study|Lost to Follow-up|0|||
27823176|NCT01710657|81185401|FG002|Overall Study|Lost to Follow-up|1|||
27823177|NCT01710657|81185399|FG000|Overall Study|Protocol Violation|2|||
27823178|NCT01710657|81185400|FG001|Overall Study|Protocol Violation|2|||
27823179|NCT01710657|81185401|FG002|Overall Study|Protocol Violation|0|||
27823180|NCT01710657|81185399|FG000|Overall Study|Adverse Event|14|||
27823181|NCT01710657|81185400|FG001|Overall Study|Adverse Event|8|||
27823182|NCT01710657|81185401|FG002|Overall Study|Adverse Event|28|||
27823183|NCT01710657|81185399|FG000|Overall Study|Withdrawal by Subject|0|||
27823184|NCT01710657|81185400|FG001|Overall Study|Withdrawal by Subject|1|||
27823185|NCT01710657|81185401|FG002|Overall Study|Withdrawal by Subject|2|||
27823186|NCT01710657|81185399|FG000|Overall Study|Lack of Efficacy|0|||
27823187|NCT01710657|81185400|FG001|Overall Study|Lack of Efficacy|1|||
27823188|NCT01710657|81185401|FG002|Overall Study|Lack of Efficacy|1|||
27823189|NCT03880266|81185405|FG000|Overall Study|Withdrawal by Subject|0|||
27823190|NCT03880266|81185406|FG001|Overall Study|Withdrawal by Subject|1|||
27823191|NCT03880266|81185407|FG002|Overall Study|Withdrawal by Subject|1|||
27823192|NCT03880266|81185408|FG003|Overall Study|Withdrawal by Subject|0|||
27823193|NCT03880266|81185409|FG004|Overall Study|Withdrawal by Subject|0|||
27823194|NCT03880266|81185410|FG005|Overall Study|Withdrawal by Subject|0|||
27823195|NCT03880266|81185411|FG006|Overall Study|Withdrawal by Subject|0|||
27823196|NCT03880266|81185412|FG007|Overall Study|Withdrawal by Subject|0|||
27823197|NCT01838941|81185413|FG000|Overall Study|Adverse Event|1|||
27823198|NCT01838941|81185413|FG000|Overall Study|Withdrawal by Subject|1|||
27823199|NCT01661686|81185414|FG000|Overall Study|Lost to Follow-up|2|||
27823200|NCT01661686|81185415|FG001|Overall Study|Lost to Follow-up|1|||
27823201|NCT01661686|81185414|FG000|Overall Study|did not receive allocated intervention|0|||
27823202|NCT01661686|81185415|FG001|Overall Study|did not receive allocated intervention|1|||
27823203|NCT00657553|81185416|FG000|Overall Study|low accrual, no analysis run|5|||
27823204|NCT00657553|81185417|FG001|Overall Study|low accrual, no analysis run|5|||
27823205|NCT00433147|81185418|FG000|Overall Study|Adverse Event|0|||
27823206|NCT00433147|81185419|FG001|Overall Study|Adverse Event|1|||
27823207|NCT00433147|81185420|FG002|Overall Study|Adverse Event|0|||
27823208|NCT00433147|81185421|FG003|Overall Study|Adverse Event|0|||
27823209|NCT04646213|81185436|FG000|Overall Study|Physician Decision|3|||
27823210|NCT04646213|81185436|FG000|Overall Study|Withdrawal by Subject|2|||
27823211|NCT00286754|81185437|FG000|Overall Study|Adverse Event|2|||
27823212|NCT00286754|81185438|FG001|Overall Study|Adverse Event|2|||
27823213|NCT00286754|81185439|FG002|Overall Study|Adverse Event|3|||
27823214|NCT00286754|81185437|FG000|Overall Study|Withdrawal by Subject|6|||
27823215|NCT00286754|81185438|FG001|Overall Study|Withdrawal by Subject|2|||
27823216|NCT00286754|81185439|FG002|Overall Study|Withdrawal by Subject|0|||
27823217|NCT00286754|81185437|FG000|Overall Study|Lost to Follow-up|12|||
27823218|NCT00286754|81185438|FG001|Overall Study|Lost to Follow-up|14|||
27823219|NCT00286754|81185439|FG002|Overall Study|Lost to Follow-up|6|||
27823220|NCT00286754|81185437|FG000|Overall Study|Moved out of state|0|||
27823221|NCT00286754|81185438|FG001|Overall Study|Moved out of state|0|||
27823222|NCT00286754|81185439|FG002|Overall Study|Moved out of state|1|||
27823223|NCT02739997|81185440|FG000|Overall Study|Death|1|||
27823224|NCT02739997|81185440|FG000|Overall Study|Withdrawal by Subject|1|||
27823225|NCT01841554|81185443|FG000|Overall Study|Death|7|||
27823226|NCT01841554|81185443|FG000|Overall Study|No Implantation|1|||
27823227|NCT01841554|81185443|FG000|Overall Study|Discontinued Follow Up|5|||
27823228|NCT01841554|81185443|FG000|Overall Study|Study exit due to secondary intervention|6|||
27823229|NCT04526210|81185444|FG000|Overall Study|Sponsor decision|7|||
27823230|NCT04526210|81185445|FG001|Overall Study|Sponsor decision|5|||
27823231|NCT04526210|81185444|FG000|Overall Study|Withdrawal by Subject|3|||
27823232|NCT04526210|81185445|FG001|Overall Study|Withdrawal by Subject|2|||
27823233|NCT00669942|81185447|FG000|Parts 2 and 3|Adverse Event|0|||
27823234|NCT00669942|81185448|FG001|Parts 2 and 3|Adverse Event|0|||
27823235|NCT00669942|81185449|FG002|Parts 2 and 3|Adverse Event|0|||
27823236|NCT00669942|81185450|FG003|Parts 2 and 3|Adverse Event|0|||
27823237|NCT00669942|81185451|FG004|Parts 2 and 3|Adverse Event|0|||
27823238|NCT00669942|81185452|FG005|Parts 2 and 3|Adverse Event|0|||
27823239|NCT00669942|81185453|FG006|Parts 2 and 3|Adverse Event|0|||
27823240|NCT00669942|81185454|FG007|Parts 2 and 3|Adverse Event|2|||
27823241|NCT00669942|81185455|FG008|Parts 2 and 3|Adverse Event|1|||
27823242|NCT00669942|81185456|FG009|Parts 2 and 3|Adverse Event|0|||
27823243|NCT00669942|81185457|FG010|Parts 2 and 3|Adverse Event|0|||
27823244|NCT00669942|81185458|FG011|Parts 2 and 3|Adverse Event|0|||
27823245|NCT00669942|81185447|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
27823246|NCT00669942|81185448|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
27823247|NCT00669942|81185449|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
27823248|NCT00669942|81185450|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
27882994|NCT00955409|81404537|FG001|Overall Study|Caregiver Request|0|||
27882995|NCT00955409|81404538|FG002|Overall Study|Caregiver Request|6|||
27882996|NCT00955409|81404539|FG003|Overall Study|Caregiver Request|5|||
27882997|NCT00955409|81404540|FG004|Overall Study|Caregiver Request|0|||
27882998|NCT00955409|81404541|FG005|Overall Study|Caregiver Request|2|||
27882999|NCT00955409|81404542|FG006|Overall Study|Caregiver Request|3|||
27883000|NCT00955409|81404543|FG007|Overall Study|Caregiver Request|1|||
27883001|NCT00955409|81404544|FG008|Overall Study|Caregiver Request|3|||
27883002|NCT00955409|81404545|FG009|Overall Study|Caregiver Request|0|||
27883003|NCT00955409|81404536|FG000|Overall Study|Investigator Request|0|||
27883004|NCT00955409|81404537|FG001|Overall Study|Investigator Request|0|||
27883005|NCT00955409|81404538|FG002|Overall Study|Investigator Request|1|||
27883006|NCT00955409|81404539|FG003|Overall Study|Investigator Request|0|||
27883007|NCT00955409|81404540|FG004|Overall Study|Investigator Request|0|||
27883008|NCT00955409|81404541|FG005|Overall Study|Investigator Request|0|||
27883009|NCT00955409|81404542|FG006|Overall Study|Investigator Request|0|||
27883010|NCT00955409|81404543|FG007|Overall Study|Investigator Request|0|||
27883011|NCT00955409|81404544|FG008|Overall Study|Investigator Request|0|||
27883012|NCT00955409|81404545|FG009|Overall Study|Investigator Request|0|||
27883013|NCT00955409|81404536|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
27883014|NCT00955409|81404537|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27883015|NCT00955409|81404538|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
27883016|NCT00955409|81404539|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27883017|NCT00955409|81404540|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
27694235|NCT00406653|80716717|FG005|Induction Period|Lost to Follow-up|0|||
27823249|NCT00669942|81185451|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
27823250|NCT00669942|81185452|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
27823251|NCT00669942|81185453|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
27823252|NCT00669942|81185454|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
27823253|NCT00669942|81185455|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
27823254|NCT00669942|81185456|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
27823255|NCT00669942|81185457|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
27883018|NCT00955409|81404541|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
27883019|NCT00955409|81404542|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
27883020|NCT00955409|81404543|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
27823256|NCT00669942|81185458|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
27823257|NCT00669942|81185447|FG000|Parts 2 and 3|Protocol Violation|0|||
27823258|NCT00669942|81185448|FG001|Parts 2 and 3|Protocol Violation|0|||
27823259|NCT00669942|81185449|FG002|Parts 2 and 3|Protocol Violation|0|||
27823260|NCT00669942|81185450|FG003|Parts 2 and 3|Protocol Violation|0|||
27823261|NCT00669942|81185451|FG004|Parts 2 and 3|Protocol Violation|0|||
27823262|NCT00669942|81185452|FG005|Parts 2 and 3|Protocol Violation|1|||
27823263|NCT00669942|81185453|FG006|Parts 2 and 3|Protocol Violation|0|||
27823264|NCT00669942|81185454|FG007|Parts 2 and 3|Protocol Violation|0|||
27823265|NCT00669942|81185455|FG008|Parts 2 and 3|Protocol Violation|0|||
27823266|NCT00669942|81185456|FG009|Parts 2 and 3|Protocol Violation|0|||
27823267|NCT00669942|81185457|FG010|Parts 2 and 3|Protocol Violation|0|||
27823268|NCT00669942|81185458|FG011|Parts 2 and 3|Protocol Violation|0|||
27823269|NCT01448057|81185459|FG000|Overall Study|Protocol Violation|3|||
27823270|NCT01448057|81185460|FG001|Overall Study|Protocol Violation|2|||
27823271|NCT01448057|81185459|FG000|Overall Study|Lost to Follow-up|3|||
27823272|NCT01448057|81185460|FG001|Overall Study|Lost to Follow-up|0|||
27823273|NCT01448057|81185459|FG000|Overall Study|Adverse Event|0|||
27823274|NCT01448057|81185460|FG001|Overall Study|Adverse Event|2|||
27823275|NCT01448057|81185459|FG000|Overall Study|Withdrawal by Subject|2|||
27823276|NCT01448057|81185460|FG001|Overall Study|Withdrawal by Subject|0|||
27823277|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
27823278|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
27823279|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
27823280|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
27823281|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
27823282|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
27823283|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
27823284|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
27823285|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
27823286|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
27823287|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
27823288|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
27823289|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
27883021|NCT00955409|81404544|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
27883022|NCT00955409|81404545|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
27883023|NCT00955409|81404536|FG000|Overall Study|Lost to Follow-up|0|||
27883024|NCT00955409|81404537|FG001|Overall Study|Lost to Follow-up|0|||
27883025|NCT00955409|81404538|FG002|Overall Study|Lost to Follow-up|1|||
27883026|NCT00955409|81404539|FG003|Overall Study|Lost to Follow-up|0|||
27883027|NCT00955409|81404540|FG004|Overall Study|Lost to Follow-up|0|||
27883028|NCT00955409|81404541|FG005|Overall Study|Lost to Follow-up|0|||
27883029|NCT00955409|81404542|FG006|Overall Study|Lost to Follow-up|1|||
27883030|NCT00955409|81404543|FG007|Overall Study|Lost to Follow-up|0|||
27883031|NCT00955409|81404544|FG008|Overall Study|Lost to Follow-up|0|||
27883032|NCT00955409|81404545|FG009|Overall Study|Lost to Follow-up|0|||
27883033|NCT00955409|81404536|FG000|Overall Study|Failed to Return|2|||
27883034|NCT00955409|81404537|FG001|Overall Study|Failed to Return|0|||
27883035|NCT00955409|81404538|FG002|Overall Study|Failed to Return|0|||
27883036|NCT00955409|81404539|FG003|Overall Study|Failed to Return|0|||
27883037|NCT00955409|81404540|FG004|Overall Study|Failed to Return|0|||
27883038|NCT00955409|81404541|FG005|Overall Study|Failed to Return|0|||
27883039|NCT00955409|81404542|FG006|Overall Study|Failed to Return|0|||
27883040|NCT00955409|81404543|FG007|Overall Study|Failed to Return|2|||
27883041|NCT00955409|81404544|FG008|Overall Study|Failed to Return|0|||
27883042|NCT00955409|81404545|FG009|Overall Study|Failed to Return|0|||
27883043|NCT00955409|81404536|FG000|Overall Study|Adverse Event (AE)|2|||
27883044|NCT00955409|81404537|FG001|Overall Study|Adverse Event (AE)|0|||
27883045|NCT00955409|81404538|FG002|Overall Study|Adverse Event (AE)|0|||
27883046|NCT00955409|81404539|FG003|Overall Study|Adverse Event (AE)|0|||
27883047|NCT00955409|81404540|FG004|Overall Study|Adverse Event (AE)|0|||
27883048|NCT00955409|81404541|FG005|Overall Study|Adverse Event (AE)|1|||
27883049|NCT00955409|81404542|FG006|Overall Study|Adverse Event (AE)|2|||
27823290|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
27823291|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
27823292|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
27823293|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
27823294|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
27823295|NCT01667679|81185461|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
27823296|NCT01667679|81185462|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
27823297|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
27823298|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
27823299|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
27823300|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
27823301|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
27823302|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
27823303|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
27823304|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
27883050|NCT00955409|81404543|FG007|Overall Study|Adverse Event (AE)|0|||
27883051|NCT00955409|81404544|FG008|Overall Study|Adverse Event (AE)|2|||
27883052|NCT00955409|81404545|FG009|Overall Study|Adverse Event (AE)|0|||
27883053|NCT00955409|81404536|FG000|Overall Study|Reason not Specified|2|||
27883054|NCT00955409|81404537|FG001|Overall Study|Reason not Specified|1|||
27883055|NCT00955409|81404538|FG002|Overall Study|Reason not Specified|13|||
27883056|NCT00955409|81404539|FG003|Overall Study|Reason not Specified|1|||
27883057|NCT00955409|81404540|FG004|Overall Study|Reason not Specified|2|||
27823305|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
27823306|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
27694236|NCT00406653|80716718|FG006|Induction Period|Lost to Follow-up|0|||
27823307|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
27823308|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
27823309|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
27593967|NCT04393441|80352350|FG000|Overall Study|Withdrawal by Subject|5|||
27593968|NCT04393441|80352351|FG001|Overall Study|Withdrawal by Subject|7|||
27593969|NCT04393441|80352350|FG000|Overall Study|Lost to Follow-up|0|||
27593970|NCT04393441|80352351|FG001|Overall Study|Lost to Follow-up|2|||
27593971|NCT04393441|80352350|FG000|Overall Study|Protocol Deviation|2|||
27593972|NCT04393441|80352351|FG001|Overall Study|Protocol Deviation|1|||
27593973|NCT04393441|80352350|FG000|Overall Study|Reason not Specified|1|||
27593974|NCT04393441|80352351|FG001|Overall Study|Reason not Specified|1|||
27593975|NCT02269670|80352352|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
27593976|NCT03896035|80352370|FG000|Overall Study|Lost to Follow-up|2|||
27593977|NCT03896035|80352371|FG001|Overall Study|Lost to Follow-up|6|||
27593978|NCT03896035|80352370|FG000|Overall Study|Withdrawal by Subject|0|||
27593979|NCT03896035|80352371|FG001|Overall Study|Withdrawal by Subject|1|||
27593980|NCT03896035|80352370|FG000|Overall Study|Health/family health issues during COVID|0|||
27593981|NCT03896035|80352371|FG001|Overall Study|Health/family health issues during COVID|4|||
27593982|NCT03230916|80352372|FG000|Overall Study|Withdrawal by Subject|0|||
27593983|NCT03230916|80352373|FG001|Overall Study|Withdrawal by Subject|0|||
27593984|NCT03230916|80352374|FG002|Overall Study|Withdrawal by Subject|0|||
27593985|NCT03230916|80352375|FG003|Overall Study|Withdrawal by Subject|0|||
27593986|NCT03230916|80352376|FG004|Overall Study|Withdrawal by Subject|0|||
27593987|NCT03230916|80352377|FG005|Overall Study|Withdrawal by Subject|1|||
27593988|NCT03230916|80352378|FG006|Overall Study|Withdrawal by Subject|0|||
27593989|NCT03230916|80352379|FG007|Overall Study|Withdrawal by Subject|0|||
27593990|NCT03230916|80352380|FG008|Overall Study|Withdrawal by Subject|0|||
27823310|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
27593991|NCT03230916|80352381|FG009|Overall Study|Withdrawal by Subject|0|||
27593992|NCT03230916|80352382|FG010|Overall Study|Withdrawal by Subject|0|||
27593993|NCT01857531|80352389|FG000|Overall Study|Withdrawal by Subject|4|||
27823311|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
27823312|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
27823313|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
27823314|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
27883058|NCT00955409|81404541|FG005|Overall Study|Reason not Specified|0|||
27823315|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
27823316|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
27823317|NCT01667679|81185461|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
27823318|NCT01667679|81185462|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
27823319|NCT03100903|81185463|FG000|Overall Study|Withdrawal by Subject|0|||
27823320|NCT03100903|81185464|FG001|Overall Study|Withdrawal by Subject|0|||
27823321|NCT03100903|81185465|FG002|Overall Study|Withdrawal by Subject|1|||
27823322|NCT01511939|81185468|FG000|Overall Study|Withdrawal by Subject|2|||
27823323|NCT01511939|81185469|FG001|Overall Study|Withdrawal by Subject|1|||
27823324|NCT01511939|81185470|FG002|Overall Study|Withdrawal by Subject|0|||
27823325|NCT03966365|81185471|FG000|Overall Study|Protocol Violation|1|||
27823326|NCT03966365|81185472|FG001|Overall Study|Protocol Violation|0|||
27823327|NCT01313273|81185473|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
27823328|NCT01313273|81185474|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
27823329|NCT01313273|81185473|FG000|Overall Study|Withdrawal by Subject|1|||
27823330|NCT01313273|81185474|FG001|Overall Study|Withdrawal by Subject|0|||
27823331|NCT01313273|81185473|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
27823332|NCT01313273|81185474|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
27823333|NCT01848938|81185477|FG000|Overall Study|Lost to Follow-up|1|||
27823334|NCT01848938|81185478|FG001|Overall Study|Lost to Follow-up|1|||
27823335|NCT01882257|81185486|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
27823336|NCT01882257|81185487|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
27823337|NCT01882257|81185488|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
27823338|NCT01882257|81185486|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
27823339|NCT01882257|81185487|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
27823340|NCT01882257|81185488|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
27823341|NCT01118312|81185493|FG000|Overall Study|Lost to Follow-up|33|||
27823342|NCT01118312|81185494|FG001|Overall Study|Lost to Follow-up|32|||
27823343|NCT01118312|81185493|FG000|Overall Study|Withdrawal by Subject|1|||
27823344|NCT01118312|81185494|FG001|Overall Study|Withdrawal by Subject|3|||
27823345|NCT03002077|81185495|FG000|Overall Study|Non-compliance with Study Drug|4|||
27883059|NCT00955409|81404542|FG006|Overall Study|Reason not Specified|16|||
27593994|NCT01627327|80352390|FG000|Overall Study|Adverse Event|6|||
27823346|NCT03002077|81185495|FG000|Overall Study|Non-compliance w/Background ADT|1|||
27823347|NCT03002077|81185495|FG000|Overall Study|Study Terminated by Sponsor|257|||
27823348|NCT03002077|81185495|FG000|Overall Study|Site Terminated by Sponsor|5|||
27823349|NCT03002077|81185495|FG000|Overall Study|Miscellaneous Reasons|10|||
27593995|NCT01627327|80352391|FG001|Overall Study|Adverse Event|12|||
27593996|NCT01627327|80352390|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
27823350|NCT03002077|81185495|FG000|Overall Study|Adverse Event|23|||
27823351|NCT03002077|81185495|FG000|Overall Study|Lack of Efficacy|20|||
27823352|NCT03002077|81185495|FG000|Overall Study|Withdrawal by Subject|72|||
27823353|NCT03002077|81185495|FG000|Overall Study|Lost to Follow-up|21|||
27823354|NCT03002077|81185495|FG000|Overall Study|Pregnancy|4|||
27823355|NCT03002077|81185495|FG000|Overall Study|Protocol Violation|21|||
27823356|NCT01029340|81185496|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
27823357|NCT01029340|81185497|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
27823358|NCT01029340|81185498|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
27823359|NCT01029340|81185499|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
27823360|NCT01029340|81185500|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
27823361|NCT01029340|81185501|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
27823362|NCT01029340|81185496|FG000|Part B Treatment Period|Protocol Violation|0|||
27823363|NCT01029340|81185497|FG001|Part B Treatment Period|Protocol Violation|0|||
27823364|NCT01029340|81185498|FG002|Part B Treatment Period|Protocol Violation|1|||
27823365|NCT01029340|81185499|FG003|Part B Treatment Period|Protocol Violation|0|||
27823366|NCT01029340|81185500|FG004|Part B Treatment Period|Protocol Violation|0|||
27823367|NCT01029340|81185501|FG005|Part B Treatment Period|Protocol Violation|0|||
27823368|NCT01029340|81185496|FG000|Extension Period|Adverse Event|0|||
27883060|NCT00955409|81404543|FG007|Overall Study|Reason not Specified|0|||
27823369|NCT01029340|81185497|FG001|Extension Period|Adverse Event|0|||
27823370|NCT01029340|81185498|FG002|Extension Period|Adverse Event|0|||
27593997|NCT01627327|80352391|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
27823371|NCT01029340|81185499|FG003|Extension Period|Adverse Event|0|||
27823372|NCT01029340|81185500|FG004|Extension Period|Adverse Event|0|||
27823373|NCT01029340|81185501|FG005|Extension Period|Adverse Event|1|||
27823374|NCT01029340|81185496|FG000|Extension Period|starting another study|0|||
27823375|NCT01029340|81185497|FG001|Extension Period|starting another study|0|||
27823376|NCT01029340|81185498|FG002|Extension Period|starting another study|0|||
27823377|NCT01029340|81185499|FG003|Extension Period|starting another study|0|||
27823378|NCT01029340|81185500|FG004|Extension Period|starting another study|0|||
27823379|NCT01029340|81185501|FG005|Extension Period|starting another study|8|||
27823380|NCT01029340|81185496|FG000|Extension Period|non-compliance|0|||
27823381|NCT01029340|81185497|FG001|Extension Period|non-compliance|0|||
27823382|NCT01029340|81185498|FG002|Extension Period|non-compliance|0|||
27593998|NCT01627327|80352390|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
27593999|NCT01627327|80352391|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
27594000|NCT01627327|80352390|FG000|Overall Study|Protocol Violation|4|||
27594001|NCT01627327|80352391|FG001|Overall Study|Protocol Violation|10|||
27594002|NCT01627327|80352390|FG000|Overall Study|Lost to Follow-up|1|||
27594003|NCT01627327|80352391|FG001|Overall Study|Lost to Follow-up|3|||
27594004|NCT01627327|80352390|FG000|Overall Study|Physician Decision|1|||
27594005|NCT01627327|80352391|FG001|Overall Study|Physician Decision|0|||
27594006|NCT01627327|80352390|FG000|Overall Study|Withdrawal by Subject|3|||
27594007|NCT01627327|80352391|FG001|Overall Study|Withdrawal by Subject|3|||
27594008|NCT00322348|80352392|FG000|Overall Study|Adverse Event|0|||
27594009|NCT00322348|80352393|FG001|Overall Study|Adverse Event|1|||
27594010|NCT00322348|80352392|FG000|Overall Study|Withdrawal by Subject|1|||
27594011|NCT00322348|80352393|FG001|Overall Study|Withdrawal by Subject|4|||
27594012|NCT00322348|80352392|FG000|Overall Study|Lost to Follow-up|1|||
27594013|NCT00322348|80352393|FG001|Overall Study|Lost to Follow-up|0|||
27594014|NCT00322348|80352392|FG000|Overall Study|Death|0|||
27594015|NCT00322348|80352393|FG001|Overall Study|Death|2|||
27594016|NCT00322348|80352392|FG000|Overall Study|Disease Progression|30|||
27594017|NCT00322348|80352393|FG001|Overall Study|Disease Progression|25|||
27594018|NCT00322348|80352392|FG000|Overall Study|Reasons not specified|5|||
27594019|NCT00322348|80352393|FG001|Overall Study|Reasons not specified|1|||
27594020|NCT00417079|80352394|FG000|Overall Study|Disease progression|267|||
27823383|NCT01029340|81185499|FG003|Extension Period|non-compliance|0|||
27823384|NCT01029340|81185500|FG004|Extension Period|non-compliance|0|||
27823385|NCT01029340|81185501|FG005|Extension Period|non-compliance|1|||
27594021|NCT00417079|80352395|FG001|Overall Study|Disease progression|180|||
27594022|NCT00417079|80352394|FG000|Overall Study|Adverse Event|32|||
27594023|NCT00417079|80352395|FG001|Overall Study|Adverse Event|67|||
27823386|NCT01029340|81185496|FG000|Extension Period|Withdrawal by Subject|0|||
27823387|NCT01029340|81185497|FG001|Extension Period|Withdrawal by Subject|0|||
27823388|NCT01029340|81185498|FG002|Extension Period|Withdrawal by Subject|0|||
27823389|NCT01029340|81185499|FG003|Extension Period|Withdrawal by Subject|0|||
27823390|NCT01029340|81185500|FG004|Extension Period|Withdrawal by Subject|0|||
27823391|NCT01029340|81185501|FG005|Extension Period|Withdrawal by Subject|1|||
27823392|NCT01029340|81185496|FG000|Extension Period|Physician Decision|0|||
27823393|NCT01029340|81185497|FG001|Extension Period|Physician Decision|0|||
27823394|NCT01029340|81185498|FG002|Extension Period|Physician Decision|0|||
27883061|NCT00955409|81404544|FG008|Overall Study|Reason not Specified|8|||
27883062|NCT00955409|81404545|FG009|Overall Study|Reason not Specified|1|||
27883063|NCT04537234|81404546|FG000|Overall Study|Withdrawal by Subject|2|||
27883064|NCT04537234|81404547|FG001|Overall Study|Withdrawal by Subject|0|||
27883065|NCT03656068|81404548|FG000|Overall Study|Withdrawal by Subject|4|||
27883066|NCT03656068|81404548|FG000|Overall Study|Adverse Event|1|||
27883067|NCT03645395|81404552|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
27883068|NCT03645395|81404553|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
27883069|NCT03645395|81404554|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
27883070|NCT03645395|81404555|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
27883071|NCT03645395|81404552|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
27883072|NCT03645395|81404553|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
27883073|NCT03645395|81404554|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
27883074|NCT03645395|81404555|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
27883075|NCT03645395|81404552|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
27883076|NCT03645395|81404553|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
27823395|NCT01029340|81185499|FG003|Extension Period|Physician Decision|0|||
27823396|NCT01029340|81185500|FG004|Extension Period|Physician Decision|0|||
27883077|NCT03645395|81404554|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
27883078|NCT03645395|81404555|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
27823397|NCT01029340|81185501|FG005|Extension Period|Physician Decision|1|||
27823398|NCT04720664|81185506|FG000|Overall Study|Adverse Event|2|||
27823399|NCT04720664|81185506|FG000|Overall Study|Lack of Efficacy|9|||
27823400|NCT02131129|81185507|FG000|Overall Study|Withdrawal by Subject|1|||
27823401|NCT02131129|81185508|FG001|Overall Study|Withdrawal by Subject|0|||
27823402|NCT03988803|81185509|FG000|Period 2|Prematurely discontinued from medication|2|||
27823403|NCT03988803|81185509|FG000|Period 2|Adverse Event|1|||
27823404|NCT02794974|81185512|FG000|Overall Study|Physician Decision|0|||
27823405|NCT02794974|81185513|FG001|Overall Study|Physician Decision|1|||
27823406|NCT01949662|81185516|FG000|Overall Study|Death|9|||
27823407|NCT01949662|81185517|FG001|Overall Study|Death|7|||
27823408|NCT01949662|81185516|FG000|Overall Study|Discharged before an agitation event|8|||
27823409|NCT01949662|81185517|FG001|Overall Study|Discharged before an agitation event|3|||
27823410|NCT01949662|81185516|FG000|Overall Study|Dropped out|1|||
27823411|NCT01949662|81185517|FG001|Overall Study|Dropped out|3|||
27823412|NCT01949662|81185516|FG000|Overall Study|Ineligible|0|||
27823413|NCT01949662|81185517|FG001|Overall Study|Ineligible|1|||
27823414|NCT01591785|81185518|FG000|Overall Study|worsening condition|1|||
27823415|NCT01591785|81185519|FG001|Overall Study|worsening condition|2|||
27823416|NCT01591785|81185518|FG000|Overall Study|Protocol Violation|2|||
27823417|NCT01591785|81185519|FG001|Overall Study|Protocol Violation|0|||
27823418|NCT01591785|81185518|FG000|Overall Study|Lost to Follow-up|1|||
27823419|NCT01591785|81185519|FG001|Overall Study|Lost to Follow-up|0|||
27823420|NCT01244126|81185520|FG000|Overall Study|Protocol Violation|3|||
27823421|NCT01244126|81185521|FG001|Overall Study|Protocol Violation|3|||
27823422|NCT01244126|81185522|FG002|Overall Study|Protocol Violation|9|||
27823423|NCT01038856|81185523|FG000|Overall Study|Adverse Event|2|||
27823424|NCT00415363|81185524|FG000|Overall Study|Withdrawal by Subject|4|||
27823425|NCT00415363|81185525|FG001|Overall Study|Withdrawal by Subject|4|||
27883079|NCT03645395|81404552|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
27883080|NCT03645395|81404553|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
27883081|NCT03645395|81404554|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
27883082|NCT03645395|81404555|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
27883083|NCT00441129|81404557|FG000|Overall Study|Withdrawal by Subject|6|||
27883084|NCT00441129|81404558|FG001|Overall Study|Withdrawal by Subject|14|||
27883085|NCT01704495|81404559|FG000|Subjects Randomized|Other Reason|3|||
27883086|NCT01704495|81404560|FG001|Subjects Randomized|Other Reason|2|||
27883087|NCT01704495|81404561|FG002|Subjects Randomized|Other Reason|3|||
27883088|NCT01704495|81404562|FG003|Subjects Randomized|Other Reason|2|||
27883089|NCT01704495|81404559|FG000|Subjects Randomized|Discontinuation criteria met|4|||
27883090|NCT01704495|81404560|FG001|Subjects Randomized|Discontinuation criteria met|2|||
27883091|NCT01704495|81404561|FG002|Subjects Randomized|Discontinuation criteria met|2|||
27823426|NCT00415363|81185524|FG000|Overall Study|Adverse Event|4|||
27823427|NCT00415363|81185525|FG001|Overall Study|Adverse Event|4|||
27883092|NCT01704495|81404562|FG003|Subjects Randomized|Discontinuation criteria met|0|||
27823428|NCT00415363|81185524|FG000|Overall Study|Lost to Follow-up|2|||
27823429|NCT00415363|81185525|FG001|Overall Study|Lost to Follow-up|1|||
27823430|NCT00415363|81185524|FG000|Overall Study|Physician Decision|3|||
27823431|NCT00415363|81185525|FG001|Overall Study|Physician Decision|1|||
27823432|NCT00415363|81185524|FG000|Overall Study|Death|16|||
27823433|NCT00415363|81185525|FG001|Overall Study|Death|12|||
27823434|NCT00415363|81185524|FG000|Overall Study|Progressive disease|26|||
27823435|NCT00415363|81185525|FG001|Overall Study|Progressive disease|32|||
27823436|NCT00312663|81185526|FG000|Immunization Phase|Adverse Event|0|||
27823437|NCT00312663|81185527|FG001|Immunization Phase|Adverse Event|1|||
27823438|NCT00312663|81185528|FG002|Immunization Phase|Adverse Event|0|||
27594024|NCT00417079|80352394|FG000|Overall Study|Non-compliance to protocol|0|||
27823439|NCT01435265|81185530|FG000|Overall Study|Lost to Follow-up|0|||
27823440|NCT01435265|81185531|FG001|Overall Study|Lost to Follow-up|1|||
27823441|NCT01844375|81189043|FG000|Overall Study|Protocol Violation|1|||
27823442|NCT01844375|81189044|FG001|Overall Study|Protocol Violation|1|||
27823443|NCT02140060|81189050|FG000|Overall Study|Adverse Event|0|||
27823444|NCT02140060|81189051|FG001|Overall Study|Adverse Event|0|||
27823445|NCT02140060|81189052|FG002|Overall Study|Adverse Event|0|||
27823446|NCT02140060|81189053|FG003|Overall Study|Adverse Event|1|||
27823447|NCT02140060|81189054|FG004|Overall Study|Adverse Event|1|||
27823448|NCT02140060|81189055|FG005|Overall Study|Adverse Event|1|||
27823449|NCT02140060|81189050|FG000|Overall Study|Lack of Efficacy|0|||
27823450|NCT02140060|81189051|FG001|Overall Study|Lack of Efficacy|0|||
27823451|NCT02140060|81189052|FG002|Overall Study|Lack of Efficacy|0|||
27823452|NCT02140060|81189053|FG003|Overall Study|Lack of Efficacy|1|||
27823453|NCT02140060|81189054|FG004|Overall Study|Lack of Efficacy|0|||
27823454|NCT02140060|81189055|FG005|Overall Study|Lack of Efficacy|0|||
27823455|NCT02077465|81189056|FG000|Overall Study|Withdrew Consent|0|||
27823456|NCT02077465|81189057|FG001|Overall Study|Withdrew Consent|1|||
27823457|NCT02077465|81189056|FG000|Overall Study|Lost to Follow-up|1|||
27823458|NCT02077465|81189057|FG001|Overall Study|Lost to Follow-up|0|||
27823459|NCT00102440|81189058|FG000|Overall Study|Lost to Follow-up|25|||
27823460|NCT00102440|81189059|FG001|Overall Study|Lost to Follow-up|18|||
27823461|NCT00102440|81189060|FG002|Overall Study|Lost to Follow-up|21|||
27823462|NCT00102440|81189058|FG000|Overall Study|Adverse Event|16|||
27823463|NCT00102440|81189059|FG001|Overall Study|Adverse Event|23|||
27823464|NCT00102440|81189060|FG002|Overall Study|Adverse Event|8|||
27823465|NCT00102440|81189058|FG000|Overall Study|Gout Flare|10|||
27823466|NCT00102440|81189059|FG001|Overall Study|Gout Flare|28|||
27823467|NCT00102440|81189060|FG002|Overall Study|Gout Flare|9|||
27823468|NCT00102440|81189058|FG000|Overall Study|Personal Reason(s)|19|||
27823469|NCT00102440|81189059|FG001|Overall Study|Personal Reason(s)|13|||
27823470|NCT00102440|81189060|FG002|Overall Study|Personal Reason(s)|13|||
27823471|NCT00102440|81189058|FG000|Overall Study|Other|11|||
27823472|NCT00102440|81189059|FG001|Overall Study|Other|14|||
27823473|NCT00102440|81189060|FG002|Overall Study|Other|14|||
27823474|NCT00102440|81189058|FG000|Overall Study|Protocol Violation|7|||
27823475|NCT00102440|81189059|FG001|Overall Study|Protocol Violation|2|||
27823476|NCT00102440|81189060|FG002|Overall Study|Protocol Violation|1|||
27823477|NCT03020615|81189063|FG000|Overall Study|Physician Decision|3|||
27823478|NCT03020615|81189064|FG001|Overall Study|Physician Decision|1|||
27823479|NCT03020615|81189065|FG002|Overall Study|Physician Decision|2|||
27823480|NCT03020615|81189063|FG000|Overall Study|Parent/guardian/patient choice|3|||
27823481|NCT03020615|81189064|FG001|Overall Study|Parent/guardian/patient choice|0|||
27883093|NCT01704495|81404559|FG000|Subjects Randomized|Adverse Event|8|||
27823482|NCT03020615|81189065|FG002|Overall Study|Parent/guardian/patient choice|4|||
27823483|NCT03020615|81189063|FG000|Overall Study|Screen failure|0|||
27823484|NCT03020615|81189064|FG001|Overall Study|Screen failure|0|||
27823485|NCT03020615|81189065|FG002|Overall Study|Screen failure|1|||
27823486|NCT03020615|81189063|FG000|Overall Study|Death|1|||
27823487|NCT03020615|81189064|FG001|Overall Study|Death|0|||
27823488|NCT03020615|81189065|FG002|Overall Study|Death|0|||
27823489|NCT03020615|81189063|FG000|Overall Study|Lost to Follow-up|0|||
27823490|NCT03020615|81189064|FG001|Overall Study|Lost to Follow-up|1|||
27823491|NCT03020615|81189065|FG002|Overall Study|Lost to Follow-up|0|||
27823492|NCT02646124|81189066|FG000|Overall Study|Lost to Follow-up|0|||
27883094|NCT01704495|81404560|FG001|Subjects Randomized|Adverse Event|2|||
27823493|NCT02646124|81189067|FG001|Overall Study|Lost to Follow-up|2|||
27823494|NCT03686033|81189073|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
27823495|NCT03686033|81189074|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
27823496|NCT03686033|81189075|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
27823497|NCT03686033|81189076|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
27823498|NCT03686033|81189077|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
27823499|NCT03686033|81189078|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
27823500|NCT03699020|81189080|FG000|Overall Study|Withdrawal by Subject|3|||
27823501|NCT03699020|81189081|FG001|Overall Study|Withdrawal by Subject|2|||
27823502|NCT03135834|81189082|FG000|Stage 1|Adverse Event|1|||
27823503|NCT03135834|81189083|FG001|Stage 1|Adverse Event|2|||
27823504|NCT03135834|81189084|FG002|Stage 1|Adverse Event|2|||
27823505|NCT03135834|81189085|FG003|Stage 1|Adverse Event|1|||
27823506|NCT03135834|81189082|FG000|Stage 1|Death|1|||
27823507|NCT03135834|81189083|FG001|Stage 1|Death|0|||
27823508|NCT03135834|81189084|FG002|Stage 1|Death|0|||
27883095|NCT01704495|81404561|FG002|Subjects Randomized|Adverse Event|0|||
27883096|NCT01704495|81404562|FG003|Subjects Randomized|Adverse Event|7|||
27883097|NCT01704495|81404559|FG000|Subjects Randomized|Withdrawal by Subject|5|||
27883098|NCT01704495|81404560|FG001|Subjects Randomized|Withdrawal by Subject|5|||
27883099|NCT01704495|81404561|FG002|Subjects Randomized|Withdrawal by Subject|5|||
27883100|NCT01704495|81404562|FG003|Subjects Randomized|Withdrawal by Subject|5|||
27883101|NCT01704495|81404559|FG000|Subjects Randomized|Protocol Violation|1|||
27883102|NCT01704495|81404560|FG001|Subjects Randomized|Protocol Violation|1|||
27883103|NCT01704495|81404561|FG002|Subjects Randomized|Protocol Violation|2|||
27883104|NCT01704495|81404562|FG003|Subjects Randomized|Protocol Violation|0|||
27883105|NCT01704495|81404559|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
27883106|NCT01704495|81404560|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
27883107|NCT01704495|81404561|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
27883108|NCT01704495|81404562|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
27883109|NCT01704495|81404559|FG000|Optional Safety Extension|Adverse Event|0|||
27883110|NCT01704495|81404560|FG001|Optional Safety Extension|Adverse Event|4|||
27883111|NCT01704495|81404561|FG002|Optional Safety Extension|Adverse Event|0|||
27883112|NCT01704495|81404562|FG003|Optional Safety Extension|Adverse Event|1|||
27883113|NCT01704495|81404559|FG000|Optional Safety Extension|Other reason|27|||
27883114|NCT01704495|81404560|FG001|Optional Safety Extension|Other reason|29|||
27883115|NCT01704495|81404561|FG002|Optional Safety Extension|Other reason|30|||
27883116|NCT01704495|81404562|FG003|Optional Safety Extension|Other reason|28|||
27594025|NCT00417079|80352395|FG001|Overall Study|Non-compliance to protocol|1|||
27594026|NCT00417079|80352394|FG000|Overall Study|Lost to Follow-up|2|||
27823509|NCT03135834|81189085|FG003|Stage 1|Death|0|||
27883117|NCT01704495|81404559|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
27883118|NCT01704495|81404560|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
27883119|NCT01704495|81404561|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
27883120|NCT01704495|81404562|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
27883121|NCT02492984|81404563|FG000|Overall Study|Adverse Event|1|||
27883122|NCT02492984|81404564|FG001|Overall Study|Adverse Event|0|||
27823510|NCT03135834|81189082|FG000|Stage 1|Lost to Follow-up|17|||
27823511|NCT03135834|81189083|FG001|Stage 1|Lost to Follow-up|24|||
27823512|NCT03135834|81189084|FG002|Stage 1|Lost to Follow-up|21|||
27823513|NCT03135834|81189085|FG003|Stage 1|Lost to Follow-up|38|||
27823514|NCT03135834|81189082|FG000|Stage 1|No longer met eligibility criteria|1|||
27823515|NCT03135834|81189083|FG001|Stage 1|No longer met eligibility criteria|6|||
27823516|NCT03135834|81189084|FG002|Stage 1|No longer met eligibility criteria|2|||
27823517|NCT03135834|81189085|FG003|Stage 1|No longer met eligibility criteria|5|||
27823518|NCT03135834|81189082|FG000|Stage 1|Other|0|||
27823519|NCT03135834|81189083|FG001|Stage 1|Other|2|||
27823520|NCT03135834|81189084|FG002|Stage 1|Other|1|||
27823521|NCT03135834|81189085|FG003|Stage 1|Other|0|||
27823522|NCT03135834|81189082|FG000|Stage 1|Physician Decision|0|||
27823523|NCT03135834|81189083|FG001|Stage 1|Physician Decision|1|||
27823524|NCT03135834|81189084|FG002|Stage 1|Physician Decision|0|||
27823525|NCT03135834|81189085|FG003|Stage 1|Physician Decision|0|||
27823526|NCT03135834|81189082|FG000|Stage 1|Pregnancy|0|||
27823527|NCT03135834|81189083|FG001|Stage 1|Pregnancy|4|||
27823528|NCT03135834|81189084|FG002|Stage 1|Pregnancy|2|||
27823529|NCT03135834|81189085|FG003|Stage 1|Pregnancy|4|||
27823530|NCT03135834|81189082|FG000|Stage 1|Protocol Violation|1|||
27823531|NCT03135834|81189083|FG001|Stage 1|Protocol Violation|1|||
27823532|NCT03135834|81189084|FG002|Stage 1|Protocol Violation|2|||
27823533|NCT03135834|81189085|FG003|Stage 1|Protocol Violation|1|||
27823534|NCT03135834|81189082|FG000|Stage 1|Withdrawal by parent/guardian|2|||
27823535|NCT03135834|81189083|FG001|Stage 1|Withdrawal by parent/guardian|10|||
27823536|NCT03135834|81189084|FG002|Stage 1|Withdrawal by parent/guardian|2|||
27823537|NCT03135834|81189085|FG003|Stage 1|Withdrawal by parent/guardian|1|||
27823538|NCT03135834|81189082|FG000|Stage 1|Withdrawal by Subject|16|||
27823539|NCT03135834|81189083|FG001|Stage 1|Withdrawal by Subject|22|||
27823540|NCT03135834|81189084|FG002|Stage 1|Withdrawal by Subject|7|||
27823541|NCT03135834|81189085|FG003|Stage 1|Withdrawal by Subject|10|||
27823542|NCT03135834|81189082|FG000|Stage 1|Randomized but not Vaccinated|0|||
27823543|NCT03135834|81189083|FG001|Stage 1|Randomized but not Vaccinated|3|||
27823544|NCT03135834|81189084|FG002|Stage 1|Randomized but not Vaccinated|1|||
27823545|NCT03135834|81189085|FG003|Stage 1|Randomized but not Vaccinated|6|||
27823546|NCT03135834|81189082|FG000|Stage 2|Lost to Follow-up|0|||
27823547|NCT03135834|81189083|FG001|Stage 2|Lost to Follow-up|1|||
27823548|NCT03135834|81189084|FG002|Stage 2|Lost to Follow-up|0|||
27823549|NCT03135834|81189085|FG003|Stage 2|Lost to Follow-up|0|||
27823550|NCT03135834|81189082|FG000|Stage 2|Withdrawal by Subject|0|||
27823551|NCT03135834|81189083|FG001|Stage 2|Withdrawal by Subject|1|||
27823552|NCT03135834|81189084|FG002|Stage 2|Withdrawal by Subject|0|||
27823553|NCT03135834|81189085|FG003|Stage 2|Withdrawal by Subject|0|||
27823554|NCT03135834|81189082|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
27823555|NCT03135834|81189083|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
27823556|NCT03135834|81189084|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
27823557|NCT03135834|81189085|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
27823558|NCT03135834|81189082|FG000|Stage 2|Did not receive Booster Vaccination|1|||
27823559|NCT03135834|81189083|FG001|Stage 2|Did not receive Booster Vaccination|1|||
27823560|NCT03135834|81189084|FG002|Stage 2|Did not receive Booster Vaccination|0|||
27823561|NCT03135834|81189085|FG003|Stage 2|Did not receive Booster Vaccination|0|||
27823562|NCT03435081|81189090|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
27823563|NCT03435081|81189091|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
27823564|NCT03435081|81189092|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
27823565|NCT03435081|81189090|FG000|Week 0 to Week 16|Adverse Event|2|||
27823566|NCT03435081|81189091|FG001|Week 0 to Week 16|Adverse Event|2|||
27823567|NCT03435081|81189092|FG002|Week 0 to Week 16|Adverse Event|2|||
27823568|NCT03435081|81189090|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
27823569|NCT03435081|81189091|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
27823570|NCT03435081|81189092|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
27823571|NCT03435081|81189090|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
27823572|NCT03435081|81189091|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
27823573|NCT03435081|81189092|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
27823574|NCT03435081|81189090|FG000|Week 0 to Week 16|Pregnancy|1|||
27823575|NCT03435081|81189091|FG001|Week 0 to Week 16|Pregnancy|0|||
27823576|NCT03435081|81189092|FG002|Week 0 to Week 16|Pregnancy|0|||
27823577|NCT03435081|81189090|FG000|Week 0 to Week 16|Non-compliance|1|||
27823578|NCT03435081|81189091|FG001|Week 0 to Week 16|Non-compliance|0|||
27823579|NCT03435081|81189092|FG002|Week 0 to Week 16|Non-compliance|2|||
27823580|NCT03435081|81189090|FG000|Week 0 to Week 16|Inadequate Response|0|||
27823581|NCT03435081|81189091|FG001|Week 0 to Week 16|Inadequate Response|1|||
27823582|NCT03435081|81189092|FG002|Week 0 to Week 16|Inadequate Response|0|||
27823583|NCT03435081|81189090|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
27823584|NCT03435081|81189091|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
27823585|NCT03435081|81189092|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
27823586|NCT03435081|81189090|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
27823587|NCT03435081|81189091|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
27823588|NCT03435081|81189092|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
27823589|NCT03435081|81189090|FG000|Week 16 to Week 104|Adverse Event|1|||
27823590|NCT03435081|81189091|FG001|Week 16 to Week 104|Adverse Event|0|||
27823591|NCT03435081|81189092|FG002|Week 16 to Week 104|Adverse Event|2|||
27823592|NCT03435081|81189090|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
27823593|NCT03435081|81189091|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
27594027|NCT00417079|80352395|FG001|Overall Study|Lost to Follow-up|0|||
27594028|NCT00417079|80352394|FG000|Overall Study|Withdrawal by Subject|17|||
27594029|NCT00417079|80352395|FG001|Overall Study|Withdrawal by Subject|8|||
27823594|NCT03435081|81189092|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
27823595|NCT03435081|81189090|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
27823596|NCT03435081|81189091|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
27823597|NCT03435081|81189092|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
27823598|NCT03435081|81189090|FG000|Week 16 to Week 104|Non--Compliance|0|||
27823599|NCT03435081|81189091|FG001|Week 16 to Week 104|Non--Compliance|0|||
27823600|NCT03435081|81189092|FG002|Week 16 to Week 104|Non--Compliance|1|||
27823601|NCT01270503|81189097|FG000|Overall Study|Lost to Follow-up|1|||
27823602|NCT02189941|81189101|FG000|Overall Study|Non-compliance|0|||
27823603|NCT02189941|81189102|FG001|Overall Study|Non-compliance|0|||
27823604|NCT02189941|81189103|FG002|Overall Study|Non-compliance|1|||
27823605|NCT02472366|81189105|FG000|Overall Study|Lost to Follow-up|1|||
27823606|NCT02472366|81189106|FG001|Overall Study|Lost to Follow-up|0|||
27823607|NCT00465270|81189110|FG000|Overall Study|Death|7|||
27823608|NCT00465270|81189111|FG001|Overall Study|Death|11|||
27823609|NCT00465270|81189110|FG000|Overall Study|Withdrawal by Subject|34|||
27823610|NCT00465270|81189111|FG001|Overall Study|Withdrawal by Subject|78|||
27823611|NCT00465270|81189110|FG000|Overall Study|Lost to Follow-up|60|||
27823612|NCT00465270|81189111|FG001|Overall Study|Lost to Follow-up|67|||
27823613|NCT00465270|81189110|FG000|Overall Study|Investigator request|3|||
27823614|NCT00465270|81189111|FG001|Overall Study|Investigator request|4|||
27823615|NCT01792635|81189112|FG000|Part B|Adverse Event|0|||
27823616|NCT01792635|81189113|FG001|Part B|Adverse Event|0|||
27823617|NCT01792635|81189114|FG002|Part B|Adverse Event|1|||
27823618|NCT01792635|81189112|FG000|Part B|Study terminated|0|||
27823619|NCT01792635|81189113|FG001|Part B|Study terminated|4|||
27823620|NCT01792635|81189114|FG002|Part B|Study terminated|3|||
27823621|NCT02392000|81189115|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
27823622|NCT02392000|81189115|FG000|Overall Study|Withdrawal by Subject|1|||
27823623|NCT02392000|81189115|FG000|Overall Study|Lost to Follow-up|8|||
27823624|NCT02107092|81189116|FG000|Overall Study|Miscellaneous|3|||
27823625|NCT02107092|81189116|FG000|Overall Study|Subject compliance|3|||
27823626|NCT02107092|81189116|FG000|Overall Study|Hypo-or hyperkalemia|2|||
27823627|NCT02107092|81189116|FG000|Overall Study|Met ECG withdrawal criteria|3|||
27823628|NCT02107092|81189116|FG000|Overall Study|Physician Decision|3|||
27823629|NCT02107092|81189116|FG000|Overall Study|Lost to Follow-up|2|||
27823630|NCT02107092|81189116|FG000|Overall Study|Withdrawal by Subject|9|||
27823631|NCT02107092|81189116|FG000|Overall Study|Adverse Event|7|||
27823632|NCT02107092|81189116|FG000|Overall Study|Expected progression of CKD|12|||
27823633|NCT01804270|81189117|FG000|Overall Study|Withdrawal by Subject|1|||
27823634|NCT01804270|81189118|FG001|Overall Study|Withdrawal by Subject|1|||
27823635|NCT02058498|81189119|FG000|Overall Study|Withdrawal by Subject|4|||
27823636|NCT01185548|81189120|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
27823637|NCT02943447|81189123|FG000|Blinded Study Phase|Withdrew Consent|1|||
27823638|NCT02943447|81189124|FG001|Blinded Study Phase|Withdrew Consent|2|||
27823639|NCT02943447|81189125|FG002|Blinded Study Phase|Withdrew Consent|1|||
27823640|NCT02943447|81189123|FG000|Blinded Study Phase|Adverse Event|3|||
27823641|NCT02943447|81189124|FG001|Blinded Study Phase|Adverse Event|0|||
27823642|NCT02943447|81189125|FG002|Blinded Study Phase|Adverse Event|0|||
27823643|NCT02943447|81189123|FG000|Blinded Study Phase|Investigator's discretion|1|||
27823644|NCT02943447|81189124|FG001|Blinded Study Phase|Investigator's discretion|0|||
27823645|NCT02943447|81189125|FG002|Blinded Study Phase|Investigator's discretion|0|||
27823646|NCT02943447|81189123|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
27823647|NCT02943447|81189124|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
27823648|NCT02943447|81189125|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
27823649|NCT02943447|81189123|FG000|Open-Label Extension Phase|Adverse Event|4|||
27823650|NCT02943447|81189124|FG001|Open-Label Extension Phase|Adverse Event|7|||
27823651|NCT02943447|81189125|FG002|Open-Label Extension Phase|Adverse Event|3|||
27823652|NCT02943447|81189123|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
27823653|NCT02943447|81189124|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
27823654|NCT02943447|81189125|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
27823655|NCT02943447|81189123|FG000|Open-Label Extension Phase|Withdrew consent|1|||
27823656|NCT02943447|81189124|FG001|Open-Label Extension Phase|Withdrew consent|1|||
27823657|NCT02943447|81189125|FG002|Open-Label Extension Phase|Withdrew consent|1|||
27823658|NCT02943447|81189123|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27823659|NCT02943447|81189124|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
27823660|NCT02943447|81189125|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27823661|NCT03041025|81189131|FG000|Overall Study|Adverse Event|0|||
27823662|NCT03041025|81189132|FG001|Overall Study|Adverse Event|0|||
27823663|NCT03041025|81189133|FG002|Overall Study|Adverse Event|1|||
27823664|NCT03041025|81189131|FG000|Overall Study|Lost to Follow-up|1|||
27883123|NCT02492984|81404563|FG000|Overall Study|Protocol Violation|1|||
27883124|NCT02492984|81404564|FG001|Overall Study|Protocol Violation|0|||
27883125|NCT02492984|81404563|FG000|Overall Study|Withdrawal by Subject|1|||
27883126|NCT02492984|81404564|FG001|Overall Study|Withdrawal by Subject|0|||
27883127|NCT01842633|81404565|FG000|Overall Study|Screen Failure|1|||
27883128|NCT01842633|81404566|FG001|Overall Study|Screen Failure|0|||
27883129|NCT01842633|81404567|FG002|Overall Study|Screen Failure|0|||
27883130|NCT01842633|81404565|FG000|Overall Study|Adverse Event|1|||
27883131|NCT01842633|81404566|FG001|Overall Study|Adverse Event|1|||
27883132|NCT01842633|81404567|FG002|Overall Study|Adverse Event|0|||
27883133|NCT01842633|81404565|FG000|Overall Study|Withdrawal by Subject|0|||
27883134|NCT01842633|81404566|FG001|Overall Study|Withdrawal by Subject|1|||
27883135|NCT01842633|81404567|FG002|Overall Study|Withdrawal by Subject|0|||
27883136|NCT01842633|81404565|FG000|Overall Study|Technical issues|1|||
27883137|NCT01842633|81404566|FG001|Overall Study|Technical issues|0|||
27883138|NCT01842633|81404567|FG002|Overall Study|Technical issues|0|||
27883139|NCT00593684|81404583|FG000|Overall Study|Death|2|||
27883140|NCT00593684|81404584|FG001|Overall Study|Death|1|||
27883141|NCT00997373|81404586|FG000|Overall Study|Withdrawal by Subject|5|||
27883142|NCT00997373|81404587|FG001|Overall Study|Withdrawal by Subject|0|||
27883143|NCT00997373|81404586|FG000|Overall Study|wrong tumor type|4|||
27883144|NCT00997373|81404587|FG001|Overall Study|wrong tumor type|0|||
27883145|NCT00997373|81404586|FG000|Overall Study|could not have hysterectomy|6|||
27883146|NCT00997373|81404587|FG001|Overall Study|could not have hysterectomy|0|||
27883147|NCT00347009|81404590|FG000|Overall Study|Death|1|||
27883148|NCT00347009|81404590|FG000|Overall Study|Adverse Event|6|||
27883149|NCT00347009|81404590|FG000|Overall Study|Withdrawal by Subject|3|||
27883150|NCT00347009|81404590|FG000|Overall Study|Physician Decision|5|||
27883151|NCT00347009|81404590|FG000|Overall Study|Lost to Follow-up|4|||
27823665|NCT03041025|81189132|FG001|Overall Study|Lost to Follow-up|0|||
27823666|NCT03041025|81189133|FG002|Overall Study|Lost to Follow-up|0|||
27823667|NCT03041025|81189131|FG000|Overall Study|Withdrawal by Subject|0|||
27823668|NCT03041025|81189132|FG001|Overall Study|Withdrawal by Subject|0|||
27823669|NCT03041025|81189133|FG002|Overall Study|Withdrawal by Subject|1|||
27823670|NCT01108094|81189140|FG000|Overall Study|Adverse Event|2|||
27823671|NCT01108094|81189141|FG001|Overall Study|Adverse Event|0|||
27823672|NCT01108094|81189142|FG002|Overall Study|Adverse Event|0|||
27823673|NCT01108094|81189143|FG003|Overall Study|Adverse Event|0|||
27823674|NCT01108094|81189140|FG000|Overall Study|Withdrawal by Subject|1|||
27823675|NCT01108094|81189141|FG001|Overall Study|Withdrawal by Subject|0|||
27823676|NCT01108094|81189142|FG002|Overall Study|Withdrawal by Subject|0|||
27823677|NCT01108094|81189143|FG003|Overall Study|Withdrawal by Subject|0|||
27823678|NCT02017223|81189144|FG000|Overall Study|Algorithm problems|2|||
27823679|NCT05214560|81189145|FG000|Overall Study|Screening Failure|1|||
27823680|NCT05214560|81189145|FG000|Overall Study|Physician Decision|4|||
27823681|NCT05214560|81189145|FG000|Overall Study|Withdrawal by Subject|1|||
27883152|NCT00347009|81404590|FG000|Overall Study|Protocol Violation|2|||
27883153|NCT00347009|81404590|FG000|Overall Study|Adverse Laboratory Experience|1|||
27883154|NCT00347009|81404590|FG000|Overall Study|Insufficient Viral Suppression|3|||
27823682|NCT05214560|81189145|FG000|Overall Study|Lost to Follow-up|2|||
27883155|NCT00347009|81404590|FG000|Overall Study|Increased ALT/HBV DNA|1|||
27883156|NCT00347009|81404590|FG000|Overall Study|Serious Adverse Event|1|||
27883157|NCT00576420|81404591|FG000|Overall Study|Death|0|||
27883158|NCT00576420|81404592|FG001|Overall Study|Death|0|||
27883159|NCT00576420|81404593|FG002|Overall Study|Death|1|||
27594030|NCT00417079|80352394|FG000|Overall Study|Not treated|6|||
27594031|NCT00417079|80352395|FG001|Overall Study|Not treated|7|||
27594032|NCT00417079|80352394|FG000|Overall Study|Screened failure|2|||
27594033|NCT00417079|80352395|FG001|Overall Study|Screened failure|1|||
27594034|NCT00417079|80352394|FG000|Overall Study|Investigator's decision|1|||
27594035|NCT00417079|80352395|FG001|Overall Study|Investigator's decision|4|||
27594036|NCT00417079|80352394|FG000|Overall Study|Non-confirmed Disease progression|1|||
27594037|NCT00417079|80352395|FG001|Overall Study|Non-confirmed Disease progression|1|||
27594038|NCT00417079|80352394|FG000|Overall Study|Clinical deterioration|1|||
27594039|NCT00417079|80352395|FG001|Overall Study|Clinical deterioration|0|||
27594040|NCT00417079|80352394|FG000|Overall Study|Screening error|2|||
27594041|NCT00417079|80352395|FG001|Overall Study|Screening error|1|||
27594042|NCT00417079|80352394|FG000|Overall Study|Withdrawal by subject's family|0|||
27594043|NCT00417079|80352395|FG001|Overall Study|Withdrawal by subject's family|1|||
27594044|NCT00417079|80352394|FG000|Overall Study|Patient unable to come to the clinic|0|||
27594045|NCT00417079|80352395|FG001|Overall Study|Patient unable to come to the clinic|1|||
27594046|NCT00417079|80352394|FG000|Overall Study|abnormal liver function tests|0|||
27594047|NCT00417079|80352395|FG001|Overall Study|abnormal liver function tests|1|||
27594048|NCT00558428|80352407|FG000|Overall Study|Adverse Event|6|||
27594049|NCT00558428|80352408|FG001|Overall Study|Adverse Event|22|||
27594050|NCT00558428|80352409|FG002|Overall Study|Adverse Event|3|||
27823683|NCT05214560|81189145|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
27823684|NCT05214560|81189145|FG000|Overall Study|Study physician not available for the anesthesia|3|||
27694237|NCT00406653|80716712|FG000|Induction Period|Withdrawal of Consent|2|||
27823685|NCT05214560|81189145|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
27823686|NCT05214560|81189145|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
27823687|NCT05214560|81189145|FG000|Overall Study|Surgery not performed|3|||
27823688|NCT00251979|81189146|FG000|Overall Study|Protocol Violation|3|||
27823689|NCT00251979|81189147|FG001|Overall Study|Protocol Violation|5|||
27823690|NCT00251979|81189146|FG000|Overall Study|Adverse Event|11|||
27823691|NCT00251979|81189147|FG001|Overall Study|Adverse Event|17|||
27823692|NCT00251979|81189146|FG000|Overall Study|Withdrawal by Subject|13|||
27823693|NCT00251979|81189147|FG001|Overall Study|Withdrawal by Subject|7|||
27823694|NCT00251979|81189146|FG000|Overall Study|Lost to Follow-up|8|||
27823695|NCT00251979|81189147|FG001|Overall Study|Lost to Follow-up|6|||
27823696|NCT00251979|81189146|FG000|Overall Study|Death|3|||
27823697|NCT00251979|81189147|FG001|Overall Study|Death|5|||
27823698|NCT04407806|81189148|FG000|Overall Study|Withdrawal by Subject|1|||
27823699|NCT04407806|81189149|FG001|Overall Study|Withdrawal by Subject|2|||
27823700|NCT03134222|81189153|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
27823701|NCT03134222|81189154|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
27823702|NCT03134222|81189155|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
27823703|NCT03134222|81189156|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
27823704|NCT03134222|81189157|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
27823705|NCT03134222|81189153|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
27823706|NCT03134222|81189154|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
27823707|NCT03134222|81189155|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
27883160|NCT00728468|81404595|FG000|Overall Study|Enrolled but not treated|1|||
27883161|NCT00728468|81404595|FG000|Overall Study|Death|1|||
27883162|NCT00728468|81404595|FG000|Overall Study|Protocol Violation|4|||
27883163|NCT00728468|81404595|FG000|Overall Study|Objective progression or relapse|9|||
27883164|NCT00728468|81404595|FG000|Overall Study|Study terminated by sponsor|1|||
27883165|NCT04657198|81404596|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
27883166|NCT04657198|81404597|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
27883167|NCT04657198|81404598|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
27883168|NCT01326104|81404599|FG000|Overall Study|progressed prior to vaccine|0|||
27883169|NCT01326104|81404600|FG001|Overall Study|progressed prior to vaccine|2|||
27883170|NCT01326104|81404599|FG000|Overall Study|unable to make vaccine|0|||
27883171|NCT01326104|81404600|FG001|Overall Study|unable to make vaccine|2|||
27883172|NCT02861586|81404603|FG000|Overall Study|Withdrawal by Subject|1|||
27883173|NCT02861586|81404604|FG001|Overall Study|Withdrawal by Subject|2|||
27883174|NCT02861586|81404605|FG002|Overall Study|Withdrawal by Subject|0|||
27883175|NCT02861586|81404606|FG003|Overall Study|Withdrawal by Subject|0|||
27883176|NCT02861586|81404607|FG004|Overall Study|Withdrawal by Subject|0|||
27883177|NCT02861586|81404608|FG005|Overall Study|Withdrawal by Subject|1|||
27883178|NCT02861586|81404609|FG006|Overall Study|Withdrawal by Subject|1|||
27883179|NCT02861586|81404610|FG007|Overall Study|Withdrawal by Subject|0|||
27883180|NCT02861586|81404603|FG000|Overall Study|Lost to Follow-up|3|||
27883181|NCT02861586|81404604|FG001|Overall Study|Lost to Follow-up|1|||
27694238|NCT00406653|80716713|FG001|Induction Period|Withdrawal of Consent|5|||
27823708|NCT03134222|81189156|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
27823709|NCT03134222|81189157|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
27823710|NCT03134222|81189153|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
27823711|NCT03134222|81189154|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
27823712|NCT03134222|81189155|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
27823713|NCT03134222|81189156|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
27883182|NCT02861586|81404605|FG002|Overall Study|Lost to Follow-up|1|||
27823714|NCT03134222|81189157|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
27823715|NCT03134222|81189153|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
27823716|NCT03134222|81189154|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
27823717|NCT03134222|81189155|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
27823718|NCT03134222|81189156|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
27823719|NCT03134222|81189157|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
27823720|NCT03134222|81189153|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
27823721|NCT03134222|81189154|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
27823722|NCT03134222|81189155|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
27823723|NCT03134222|81189156|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
27823724|NCT03134222|81189157|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
27823725|NCT03134222|81189153|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
27823726|NCT03134222|81189154|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
27823727|NCT03134222|81189155|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
27823728|NCT03134222|81189156|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
27823729|NCT03134222|81189157|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
27823730|NCT03134222|81189153|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
27823731|NCT03134222|81189154|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
27823732|NCT03134222|81189155|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
27823733|NCT03134222|81189156|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
27823734|NCT03134222|81189157|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
27823735|NCT03134222|81189153|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
27823736|NCT03134222|81189154|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
27823737|NCT03134222|81189155|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
27823738|NCT03134222|81189156|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
27823739|NCT03134222|81189157|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
27823740|NCT00537979|81189158|FG000|Overall Study|Adverse Event|2|||
27823741|NCT00537979|81189159|FG001|Overall Study|Adverse Event|2|||
27823742|NCT00537979|81189158|FG000|Overall Study|Withdrawal by Subject|1|||
27823743|NCT00537979|81189159|FG001|Overall Study|Withdrawal by Subject|4|||
27823744|NCT00537979|81189158|FG000|Overall Study|Lost to Follow-up|1|||
27823745|NCT00537979|81189159|FG001|Overall Study|Lost to Follow-up|4|||
27823746|NCT00537979|81189158|FG000|Overall Study|Lack of Efficacy|0|||
27823747|NCT00537979|81189159|FG001|Overall Study|Lack of Efficacy|1|||
27823748|NCT00537979|81189158|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
27823749|NCT00537979|81189159|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
27823750|NCT00537979|81189158|FG000|Overall Study|Death|0|||
27823751|NCT00537979|81189159|FG001|Overall Study|Death|3|||
27823752|NCT00537979|81189158|FG000|Overall Study|Kidney transplant|0|||
27823753|NCT00537979|81189159|FG001|Overall Study|Kidney transplant|3|||
27823754|NCT00537979|81189158|FG000|Overall Study|Heart failure|0|||
27823755|NCT00537979|81189159|FG001|Overall Study|Heart failure|1|||
27823756|NCT02942264|81189160|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823757|NCT02942264|81189161|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
27823758|NCT02942264|81189162|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823759|NCT02942264|81189163|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823760|NCT02942264|81189164|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823761|NCT02942264|81189165|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823762|NCT02942264|81189166|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
27823763|NCT02942264|81189167|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823764|NCT02942264|81189168|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
27823765|NCT02942264|81189160|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823766|NCT02942264|81189161|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823767|NCT02942264|81189162|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823768|NCT02942264|81189163|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823769|NCT02942264|81189164|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823770|NCT02942264|81189165|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823771|NCT02942264|81189166|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823772|NCT02942264|81189167|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
27823773|NCT02942264|81189168|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
27823774|NCT01171989|81189169|FG000|Overall Study|Lost to Follow-up|0|||
27823775|NCT01171989|81189170|FG001|Overall Study|Lost to Follow-up|0|||
27823776|NCT01171989|81189171|FG002|Overall Study|Lost to Follow-up|1|||
27823777|NCT03290781|81189172|FG000|Overall Study|Adverse Event|5|||
27823778|NCT03290781|81189173|FG001|Overall Study|Adverse Event|7|||
27823779|NCT03290781|81189174|FG002|Overall Study|Adverse Event|4|||
27823780|NCT03290781|81189175|FG003|Overall Study|Adverse Event|1|||
27823781|NCT03290781|81189176|FG004|Overall Study|Adverse Event|0|||
27823782|NCT03290781|81189177|FG005|Overall Study|Adverse Event|0|||
27823783|NCT03290781|81189178|FG006|Overall Study|Adverse Event|0|||
27883183|NCT02861586|81404606|FG003|Overall Study|Lost to Follow-up|0|||
27823784|NCT03290781|81189172|FG000|Overall Study|Death|0|||
27823785|NCT03290781|81189173|FG001|Overall Study|Death|0|||
27823786|NCT03290781|81189174|FG002|Overall Study|Death|1|||
27823787|NCT03290781|81189175|FG003|Overall Study|Death|0|||
27823788|NCT03290781|81189176|FG004|Overall Study|Death|1|||
27823789|NCT03290781|81189177|FG005|Overall Study|Death|0|||
27823790|NCT03290781|81189178|FG006|Overall Study|Death|0|||
27823791|NCT03290781|81189172|FG000|Overall Study|Withdrawal by Subject|6|||
27823792|NCT03290781|81189173|FG001|Overall Study|Withdrawal by Subject|5|||
27823793|NCT03290781|81189174|FG002|Overall Study|Withdrawal by Subject|9|||
27823794|NCT03290781|81189175|FG003|Overall Study|Withdrawal by Subject|10|||
27823795|NCT03290781|81189176|FG004|Overall Study|Withdrawal by Subject|1|||
27823796|NCT03290781|81189177|FG005|Overall Study|Withdrawal by Subject|2|||
27823797|NCT03290781|81189178|FG006|Overall Study|Withdrawal by Subject|0|||
27823798|NCT03290781|81189172|FG000|Overall Study|Physician Decision|0|||
27823799|NCT03290781|81189173|FG001|Overall Study|Physician Decision|1|||
27823800|NCT03290781|81189174|FG002|Overall Study|Physician Decision|0|||
27823801|NCT03290781|81189175|FG003|Overall Study|Physician Decision|0|||
27823802|NCT03290781|81189176|FG004|Overall Study|Physician Decision|0|||
27823803|NCT03290781|81189177|FG005|Overall Study|Physician Decision|0|||
27823804|NCT03290781|81189178|FG006|Overall Study|Physician Decision|0|||
27823805|NCT03290781|81189172|FG000|Overall Study|Site Terminated by Sponsor|1|||
27823806|NCT03290781|81189173|FG001|Overall Study|Site Terminated by Sponsor|0|||
27823807|NCT03290781|81189174|FG002|Overall Study|Site Terminated by Sponsor|2|||
27823808|NCT03290781|81189175|FG003|Overall Study|Site Terminated by Sponsor|1|||
27823809|NCT03290781|81189176|FG004|Overall Study|Site Terminated by Sponsor|0|||
27823810|NCT03290781|81189177|FG005|Overall Study|Site Terminated by Sponsor|0|||
27823811|NCT03290781|81189178|FG006|Overall Study|Site Terminated by Sponsor|0|||
27823812|NCT03290781|81189172|FG000|Overall Study|Lost to Follow-up|0|||
27823813|NCT03290781|81189173|FG001|Overall Study|Lost to Follow-up|0|||
27883184|NCT02861586|81404607|FG004|Overall Study|Lost to Follow-up|0|||
27883185|NCT02861586|81404608|FG005|Overall Study|Lost to Follow-up|3|||
27883186|NCT02861586|81404609|FG006|Overall Study|Lost to Follow-up|0|||
27883187|NCT02861586|81404610|FG007|Overall Study|Lost to Follow-up|0|||
27883188|NCT02861586|81404603|FG000|Overall Study|Adverse Event|0|||
27883189|NCT02861586|81404604|FG001|Overall Study|Adverse Event|0|||
27883190|NCT02861586|81404605|FG002|Overall Study|Adverse Event|0|||
27883191|NCT02861586|81404606|FG003|Overall Study|Adverse Event|0|||
27883192|NCT02861586|81404607|FG004|Overall Study|Adverse Event|0|||
27883193|NCT02861586|81404608|FG005|Overall Study|Adverse Event|1|||
27883194|NCT02861586|81404609|FG006|Overall Study|Adverse Event|0|||
27883195|NCT02861586|81404610|FG007|Overall Study|Adverse Event|0|||
27883196|NCT01827267|81404613|FG000|Overall Study|Did not receive study drug|1|||
27883197|NCT01827267|81404614|FG001|Overall Study|Did not receive study drug|1|||
27883198|NCT01827267|81404613|FG000|Overall Study|Physician Decision|1|||
27883199|NCT01827267|81404614|FG001|Overall Study|Physician Decision|0|||
27883200|NCT01827267|81404613|FG000|Overall Study|Disease Progression|1|||
27823814|NCT03290781|81189174|FG002|Overall Study|Lost to Follow-up|0|||
27823815|NCT03290781|81189175|FG003|Overall Study|Lost to Follow-up|1|||
27823816|NCT03290781|81189176|FG004|Overall Study|Lost to Follow-up|0|||
27823817|NCT03290781|81189177|FG005|Overall Study|Lost to Follow-up|0|||
27823818|NCT03290781|81189178|FG006|Overall Study|Lost to Follow-up|0|||
27823819|NCT03290781|81189172|FG000|Overall Study|Protocol Deviation|2|||
27823820|NCT03290781|81189173|FG001|Overall Study|Protocol Deviation|0|||
27823821|NCT03290781|81189174|FG002|Overall Study|Protocol Deviation|0|||
27823822|NCT03290781|81189175|FG003|Overall Study|Protocol Deviation|1|||
27823823|NCT03290781|81189176|FG004|Overall Study|Protocol Deviation|0|||
27823824|NCT03290781|81189177|FG005|Overall Study|Protocol Deviation|0|||
27823825|NCT03290781|81189178|FG006|Overall Study|Protocol Deviation|0|||
27823826|NCT03290781|81189172|FG000|Overall Study|Disease Relapse|32|||
27823827|NCT03290781|81189173|FG001|Overall Study|Disease Relapse|5|||
27823828|NCT03290781|81189174|FG002|Overall Study|Disease Relapse|38|||
27883201|NCT01827267|81404614|FG001|Overall Study|Disease Progression|1|||
27823829|NCT03290781|81189175|FG003|Overall Study|Disease Relapse|7|||
27883202|NCT01827267|81404613|FG000|Overall Study|Sponsor Discontinued Study|2|||
27823830|NCT03290781|81189176|FG004|Overall Study|Disease Relapse|3|||
27823831|NCT03290781|81189177|FG005|Overall Study|Disease Relapse|1|||
27823832|NCT03290781|81189178|FG006|Overall Study|Disease Relapse|4|||
27823833|NCT03290781|81189172|FG000|Overall Study|Other|3|||
27823834|NCT03290781|81189173|FG001|Overall Study|Other|0|||
27823835|NCT03290781|81189174|FG002|Overall Study|Other|2|||
27823836|NCT03290781|81189175|FG003|Overall Study|Other|2|||
27823837|NCT03290781|81189176|FG004|Overall Study|Other|0|||
27823838|NCT03290781|81189177|FG005|Overall Study|Other|0|||
27823839|NCT03290781|81189178|FG006|Overall Study|Other|0|||
27823840|NCT04175808|81189185|FG000|Part A|Miscellaneous|2|||
27823841|NCT04175808|81189186|FG001|Part A|Miscellaneous|0|||
27883203|NCT01827267|81404614|FG001|Overall Study|Sponsor Discontinued Study|8|||
27883204|NCT01827267|81404613|FG000|Overall Study|Still on study|0|||
27594051|NCT00558428|80352410|FG003|Overall Study|Adverse Event|4|||
27823842|NCT04175808|81189187|FG002|Part A|Miscellaneous|0|||
27823843|NCT04175808|81189188|FG003|Part A|Miscellaneous|0|||
27823844|NCT04175808|81189189|FG004|Part A|Miscellaneous|0|||
27823845|NCT04175808|81189190|FG005|Part A|Miscellaneous|0|||
27823846|NCT04175808|81189191|FG006|Part A|Miscellaneous|0|||
27823847|NCT00392665|81189194|FG000|Overall Study|Death|16|||
27823848|NCT00392665|81189195|FG001|Overall Study|Death|14|||
27594052|NCT00558428|80352407|FG000|Overall Study|Lost to Follow-up|0|||
27823849|NCT00392665|81189194|FG000|Overall Study|Lost to Follow-up|1|||
27823850|NCT00392665|81189195|FG001|Overall Study|Lost to Follow-up|1|||
27823851|NCT02914600|81189196|FG000|Overall Study|Adverse Event|298|||
27823852|NCT02914600|81189197|FG001|Overall Study|Adverse Event|35|||
27823853|NCT02914600|81189198|FG002|Overall Study|Adverse Event|25|||
27883205|NCT01827267|81404614|FG001|Overall Study|Still on study|2|||
27883206|NCT00561392|81404615|FG000|Overall Study|Adverse Event|38|||
27883207|NCT00561392|81404615|FG000|Overall Study|Lack of Efficacy|2|||
27883208|NCT00561392|81404615|FG000|Overall Study|Protocol Violation|1|||
27823854|NCT02914600|81189196|FG000|Overall Study|Sponsors decision|287|||
27823855|NCT02914600|81189197|FG001|Overall Study|Sponsors decision|41|||
27823856|NCT02914600|81189198|FG002|Overall Study|Sponsors decision|12|||
27823857|NCT02914600|81189196|FG000|Overall Study|Withdrawal by Subject|158|||
27823858|NCT02914600|81189197|FG001|Overall Study|Withdrawal by Subject|20|||
27823859|NCT02914600|81189198|FG002|Overall Study|Withdrawal by Subject|18|||
27823860|NCT02914600|81189196|FG000|Overall Study|Investigators discretion|169|||
27823861|NCT02914600|81189197|FG001|Overall Study|Investigators discretion|14|||
27823862|NCT02914600|81189198|FG002|Overall Study|Investigators discretion|13|||
27823863|NCT02914600|81189196|FG000|Overall Study|Lost to Follow-up|10|||
27823864|NCT02914600|81189197|FG001|Overall Study|Lost to Follow-up|4|||
27823865|NCT02914600|81189198|FG002|Overall Study|Lost to Follow-up|0|||
27823866|NCT02914600|81189196|FG000|Overall Study|Pregnancy|8|||
27823867|NCT02914600|81189197|FG001|Overall Study|Pregnancy|0|||
27823868|NCT02914600|81189198|FG002|Overall Study|Pregnancy|0|||
27823869|NCT02914600|81189196|FG000|Overall Study|Protocol Violation|5|||
27823870|NCT02914600|81189197|FG001|Overall Study|Protocol Violation|3|||
27823871|NCT02914600|81189198|FG002|Overall Study|Protocol Violation|0|||
27823872|NCT02914600|81189196|FG000|Overall Study|Non-compliance with study drug|6|||
27823873|NCT02914600|81189197|FG001|Overall Study|Non-compliance with study drug|1|||
27823874|NCT02914600|81189198|FG002|Overall Study|Non-compliance with study drug|0|||
27823875|NCT02914600|81189196|FG000|Overall Study|Death|3|||
27823876|NCT02914600|81189197|FG001|Overall Study|Death|1|||
27823877|NCT02914600|81189198|FG002|Overall Study|Death|1|||
27823878|NCT02914600|81189196|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
27823879|NCT02914600|81189197|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
27823880|NCT02914600|81189198|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
27823881|NCT02914600|81189196|FG000|Overall Study|Enrolled but not treated|1|||
27823882|NCT02914600|81189197|FG001|Overall Study|Enrolled but not treated|0|||
27594053|NCT00558428|80352408|FG001|Overall Study|Lost to Follow-up|1|||
27594054|NCT00558428|80352409|FG002|Overall Study|Lost to Follow-up|0|||
27594055|NCT00558428|80352410|FG003|Overall Study|Lost to Follow-up|0|||
27594056|NCT00558428|80352407|FG000|Overall Study|Lack of Efficacy|0|||
27594057|NCT00558428|80352408|FG001|Overall Study|Lack of Efficacy|0|||
27823883|NCT02914600|81189198|FG002|Overall Study|Enrolled but not treated|0|||
27823884|NCT01954394|81189201|FG000|Overall Study|Enrolled but not treated|1|||
27823885|NCT01954394|81189202|FG001|Overall Study|Enrolled but not treated|0|||
27823886|NCT01954394|81189201|FG000|Overall Study|Adverse Event|10|||
27823887|NCT01954394|81189202|FG001|Overall Study|Adverse Event|23|||
27823888|NCT01954394|81189201|FG000|Overall Study|Poor compliance to protocol|7|||
27883209|NCT00561392|81404615|FG000|Overall Study|Withdrawal by Subject|8|||
27594058|NCT00558428|80352409|FG002|Overall Study|Lack of Efficacy|1|||
27594059|NCT00558428|80352410|FG003|Overall Study|Lack of Efficacy|2|||
27823889|NCT01954394|81189202|FG001|Overall Study|Poor compliance to protocol|7|||
27823890|NCT01954394|81189201|FG000|Overall Study|Participant Moved|0|||
27823891|NCT01954394|81189202|FG001|Overall Study|Participant Moved|4|||
27823892|NCT01954394|81189201|FG000|Overall Study|Related to Study Drug administration|2|||
27823893|NCT01954394|81189202|FG001|Overall Study|Related to Study Drug administration|2|||
27823894|NCT01954394|81189201|FG000|Overall Study|Other than specified above|10|||
27823895|NCT01954394|81189202|FG001|Overall Study|Other than specified above|21|||
27823896|NCT02159183|81189205|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
27823897|NCT02159183|81189206|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
27823898|NCT02159183|81189205|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
27823899|NCT02159183|81189206|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
27823900|NCT02159183|81189205|FG000|Analysis After the 36 Months Follow-up|Death|0|||
27823901|NCT02159183|81189206|FG001|Analysis After the 36 Months Follow-up|Death|1|||
27823902|NCT02159183|81189205|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
27823903|NCT02159183|81189206|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
27823904|NCT02159183|81189205|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
27823905|NCT02159183|81189206|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
27823906|NCT00837486|81189207|FG000|Blinded-treatment Phase|Physician Decision|1|||
27823907|NCT00837486|81189208|FG001|Blinded-treatment Phase|Physician Decision|0|||
27823908|NCT00837486|81189207|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
27823909|NCT00837486|81189208|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
27823910|NCT00837486|81189207|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
27823911|NCT00837486|81189208|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
27823912|NCT00837486|81189207|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
27823913|NCT00837486|81189208|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
27823914|NCT00773253|81189209|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
27823915|NCT00773253|81189210|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
27823916|NCT01182415|81189211|FG000|Overall Study|Lost to Follow-up|1|||
27823917|NCT00004562|81189212|FG000|Overall Study|Lost to Follow-up|102|||
27823918|NCT00004562|81189213|FG001|Overall Study|Lost to Follow-up|91|||
27823919|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
27823920|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
27823921|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
27823922|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
27823923|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
27823924|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
27823925|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
27823926|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
27823927|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
27823928|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
27823929|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
27823930|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
27823931|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
27823932|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
27823933|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
27823934|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
27823935|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
27823936|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
27823937|NCT01045161|81189214|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
27823938|NCT01045161|81189215|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
27823939|NCT01045161|81189216|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
27823940|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
27823941|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
27823942|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
27823943|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
27823944|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
27823945|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
27823946|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
27823947|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
27823948|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
27823949|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
27823950|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
27823951|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
27823952|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
27823953|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
27823954|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
27823955|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
27883210|NCT00561392|81404615|FG000|Overall Study|Administrative problems|4|||
27883211|NCT02748213|81404616|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
27883212|NCT02748213|81404617|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
27883213|NCT02748213|81404616|FG000|Overall Study|Abnormal Laboratory Test|1|||
27823956|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
27823957|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
27823958|NCT01045161|81189214|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
27823959|NCT01045161|81189215|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
27823960|NCT01045161|81189216|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
27823961|NCT03752528|81189217|FG000|Part A|Lost to Follow-up|1|||
27823962|NCT03752528|81189217|FG000|Part A|Protocol Violation|1|||
27823963|NCT03752528|81189217|FG000|Part B|Protocol Violation|1|||
27823964|NCT03752528|81189217|FG000|Part B|Study terminated by sponsor|3|||
27823965|NCT05376319|81189218|FG000|Overall Study|Funding termination|2|||
27823966|NCT05376319|81189219|FG001|Overall Study|Funding termination|4|||
27823967|NCT02089997|81189220|FG000|Overall Study|Case report forms uncollected|99|||
27823968|NCT02089997|81189220|FG000|Overall Study|Protocol Violation|147|||
27823969|NCT01061866|81189221|FG000|Overall Study|Adverse Event|2|||
27823970|NCT02388191|81189223|FG000|Overall Study|Patient did not receive IUD|1|||
27823971|NCT02388191|81189224|FG001|Overall Study|Patient did not receive IUD|0|||
27823972|NCT02760368|81189227|FG000|Overall Study|Withdrawal by Subject|8|||
27823973|NCT02760368|81189228|FG001|Overall Study|Withdrawal by Subject|12|||
27823974|NCT02760368|81189229|FG002|Overall Study|Withdrawal by Subject|9|||
27823975|NCT02760368|81189227|FG000|Overall Study|Screen Failure|0|||
27823976|NCT02760368|81189228|FG001|Overall Study|Screen Failure|0|||
27823977|NCT02760368|81189229|FG002|Overall Study|Screen Failure|1|||
27823978|NCT02760368|81189227|FG000|Overall Study|Death|0|||
27823979|NCT02760368|81189228|FG001|Overall Study|Death|1|||
27823980|NCT02760368|81189229|FG002|Overall Study|Death|0|||
27823981|NCT02760368|81189227|FG000|Overall Study|Withdrawal by Sponsor|0|||
27823982|NCT02760368|81189228|FG001|Overall Study|Withdrawal by Sponsor|0|||
27823983|NCT02760368|81189229|FG002|Overall Study|Withdrawal by Sponsor|1|||
27823984|NCT03233724|81189230|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
27823985|NCT03233724|81189231|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
27823986|NCT03233724|81189232|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
27823987|NCT03233724|81189233|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
27823988|NCT03233724|81189234|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
27823989|NCT03233724|81189230|FG000|Phase I Dose Escalation|Best interest of participant|1|||
27823990|NCT03233724|81189231|FG001|Phase I Dose Escalation|Best interest of participant|1|||
27823991|NCT03233724|81189232|FG002|Phase I Dose Escalation|Best interest of participant|1|||
27823992|NCT03233724|81189233|FG003|Phase I Dose Escalation|Best interest of participant|0|||
27823993|NCT03233724|81189234|FG004|Phase I Dose Escalation|Best interest of participant|0|||
27823994|NCT03233724|81189230|FG000|Phase I Dose Escalation|Physician Decision|0|||
27823995|NCT03233724|81189231|FG001|Phase I Dose Escalation|Physician Decision|0|||
27823996|NCT03233724|81189232|FG002|Phase I Dose Escalation|Physician Decision|1|||
27823997|NCT03233724|81189233|FG003|Phase I Dose Escalation|Physician Decision|0|||
27823998|NCT03233724|81189234|FG004|Phase I Dose Escalation|Physician Decision|0|||
27823999|NCT03233724|81189230|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
27824000|NCT03233724|81189231|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
27824001|NCT03233724|81189232|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
27824002|NCT03233724|81189233|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
27824003|NCT03233724|81189234|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
27824004|NCT04129346|81189238|FG000|Overall Study|Death|1|||
27824005|NCT04129346|81189239|FG001|Overall Study|Death|0|||
27824006|NCT01328093|81189240|FG000|Double-Blind Phase|Adverse Event|78|||
27824007|NCT01328093|81189241|FG001|Double-Blind Phase|Adverse Event|15|||
27824008|NCT01328093|81189240|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
27824009|NCT01328093|81189241|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
27824010|NCT01328093|81189240|FG000|Double-Blind Phase|Lost to Follow-up|39|||
27824011|NCT01328093|81189241|FG001|Double-Blind Phase|Lost to Follow-up|14|||
27824012|NCT01328093|81189240|FG000|Double-Blind Phase|Protocol Violation|30|||
27824013|NCT01328093|81189241|FG001|Double-Blind Phase|Protocol Violation|10|||
27824014|NCT01328093|81189240|FG000|Double-Blind Phase|Lack of Efficacy|55|||
27824015|NCT01328093|81189241|FG001|Double-Blind Phase|Lack of Efficacy|13|||
27824016|NCT01328093|81189240|FG000|Double-Blind Phase|Sponsor Decision|17|||
27824017|NCT01328093|81189241|FG001|Double-Blind Phase|Sponsor Decision|3|||
27824018|NCT01328093|81189240|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
27824019|NCT01328093|81189241|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
27824020|NCT01328093|81189240|FG000|Double-Blind Phase|Scheduling conflict|8|||
27824021|NCT01328093|81189241|FG001|Double-Blind Phase|Scheduling conflict|3|||
27824022|NCT01328093|81189240|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
27824023|NCT01328093|81189241|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
27824024|NCT01328093|81189240|FG000|Double-Blind Phase|Death|1|||
27824025|NCT01328093|81189241|FG001|Double-Blind Phase|Death|0|||
27824026|NCT01328093|81189240|FG000|Open-Label Phase|Sponsor Decision|98|||
27824027|NCT01328093|81189241|FG001|Open-Label Phase|Sponsor Decision|34|||
27824028|NCT01328093|81189240|FG000|Open-Label Phase|Protocol Violation|8|||
27824029|NCT01328093|81189241|FG001|Open-Label Phase|Protocol Violation|3|||
27824030|NCT01328093|81189240|FG000|Open-Label Phase|Lost to Follow-up|10|||
27824031|NCT01328093|81189241|FG001|Open-Label Phase|Lost to Follow-up|1|||
27824032|NCT01328093|81189240|FG000|Open-Label Phase|Adverse Event|10|||
27883214|NCT02748213|81404617|FG001|Overall Study|Abnormal Laboratory Test|0|||
27883215|NCT02748213|81404616|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
27883216|NCT02748213|81404617|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
27883217|NCT02748213|81404616|FG000|Overall Study|Death|5|||
27824033|NCT01328093|81189241|FG001|Open-Label Phase|Adverse Event|4|||
27824034|NCT01328093|81189240|FG000|Open-Label Phase|Lack of Efficacy|5|||
27824035|NCT01328093|81189241|FG001|Open-Label Phase|Lack of Efficacy|6|||
27824036|NCT01328093|81189240|FG000|Open-Label Phase|Withdrawal by Subject|4|||
27824037|NCT01328093|81189241|FG001|Open-Label Phase|Withdrawal by Subject|1|||
27824038|NCT01328093|81189240|FG000|Open-Label Phase|Scheduling conflict|2|||
27824039|NCT01328093|81189241|FG001|Open-Label Phase|Scheduling conflict|1|||
27824040|NCT01328093|81189240|FG000|Open-Label Phase|Subject is moving or has moved|2|||
27824041|NCT01328093|81189241|FG001|Open-Label Phase|Subject is moving or has moved|0|||
27824042|NCT01328093|81189240|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
27824043|NCT01328093|81189241|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
27824044|NCT00520130|81189242|FG000|Overall Study|Disease progression on study|4|||
27824045|NCT00520130|81189243|FG001|Overall Study|Disease progression on study|0|||
27824046|NCT00520130|81189242|FG000|Overall Study|Physician Decision|1|||
27824047|NCT00520130|81189243|FG001|Overall Study|Physician Decision|1|||
27824048|NCT02909907|81189244|FG000|Overall Study|Withdrawal by Subject|0|||
27824049|NCT02909907|81189245|FG001|Overall Study|Withdrawal by Subject|1|||
27824050|NCT00857623|81189246|FG000|Overall Study|Adverse Event|5|||
27824051|NCT00857623|81189247|FG001|Overall Study|Adverse Event|2|||
27824052|NCT00857623|81189246|FG000|Overall Study|Study-specific discontinuation criteria|5|||
27824053|NCT00857623|81189247|FG001|Overall Study|Study-specific discontinuation criteria|3|||
27824054|NCT00857623|81189246|FG000|Overall Study|Withdrawal by Subject|2|||
27824055|NCT00857623|81189247|FG001|Overall Study|Withdrawal by Subject|1|||
27824056|NCT00857623|81189246|FG000|Overall Study|Lack of Efficacy|1|||
27824057|NCT00857623|81189247|FG001|Overall Study|Lack of Efficacy|1|||
27824058|NCT00857623|81189246|FG000|Overall Study|Severe non-compliance to protocol|1|||
27824059|NCT00857623|81189247|FG001|Overall Study|Severe non-compliance to protocol|1|||
27824060|NCT00857623|81189246|FG000|Overall Study|Intake of prohibited medication|0|||
27824061|NCT00857623|81189247|FG001|Overall Study|Intake of prohibited medication|1|||
27824062|NCT00857623|81189246|FG000|Overall Study|Positive for HEP C|0|||
27824063|NCT00857623|81189247|FG001|Overall Study|Positive for HEP C|1|||
27824064|NCT03247972|81189248|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
27824065|NCT03247972|81189248|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
27824066|NCT02530905|81189249|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
27824067|NCT02530905|81189250|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
27824068|NCT02530905|81189251|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
27824069|NCT03021018|81189252|FG000|Overall Study|Adverse Event|1|||
27824070|NCT03021018|81189253|FG001|Overall Study|Adverse Event|0|||
27824071|NCT03021018|81189254|FG002|Overall Study|Adverse Event|0|||
27824072|NCT03021018|81189252|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
27824073|NCT03021018|81189253|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
27824074|NCT03021018|81189254|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
27824075|NCT01981720|81189257|FG000|Overall Study|Adverse Event|1|||
27824076|NCT01981720|81189257|FG000|Overall Study|Withdrawal by Subject|3|||
27824077|NCT01981720|81189257|FG000|Overall Study|Pregnancy|1|||
27824078|NCT01878292|81189259|FG000|Randomized|Protocol Violation|1|||
27824079|NCT01878292|81189260|FG001|Randomized|Protocol Violation|0|||
27824080|NCT01878292|81189261|FG002|Randomized|Protocol Violation|0|||
27824081|NCT01878292|81189259|FG000|Randomized|Lost to Follow-up|1|||
27824082|NCT01878292|81189260|FG001|Randomized|Lost to Follow-up|0|||
27824083|NCT01878292|81189261|FG002|Randomized|Lost to Follow-up|0|||
27883218|NCT02748213|81404617|FG001|Overall Study|Death|3|||
27883219|NCT02748213|81404616|FG000|Overall Study|Insufficient Therapeutic Response|56|||
27824084|NCT01878292|81189259|FG000|Randomized|Adverse Event|1|||
27824085|NCT01878292|81189260|FG001|Randomized|Adverse Event|0|||
27824086|NCT01878292|81189261|FG002|Randomized|Adverse Event|0|||
27824087|NCT01878292|81189259|FG000|Double-blind Treatment Period|Other Reasons|2|||
27824088|NCT01878292|81189260|FG001|Double-blind Treatment Period|Other Reasons|0|||
27824089|NCT01878292|81189261|FG002|Double-blind Treatment Period|Other Reasons|0|||
27824090|NCT01878292|81189259|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
27824091|NCT01878292|81189260|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
27824092|NCT01878292|81189261|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27824093|NCT01878292|81189259|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
27824094|NCT01878292|81189260|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
27824095|NCT01878292|81189261|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
27824096|NCT01878292|81189259|FG000|Double-blind Treatment Period|Protocol Violation|3|||
27883220|NCT02748213|81404617|FG001|Overall Study|Insufficient Therapeutic Response|57|||
27883221|NCT02748213|81404616|FG000|Overall Study|Violation of Selection Criteria|2|||
27883222|NCT02748213|81404617|FG001|Overall Study|Violation of Selection Criteria|0|||
27883223|NCT02748213|81404616|FG000|Overall Study|Protocol Violation|6|||
27883224|NCT02748213|81404617|FG001|Overall Study|Protocol Violation|4|||
27883225|NCT02748213|81404616|FG000|Overall Study|Refused Treatment*|6|||
27883226|NCT02748213|81404617|FG001|Overall Study|Refused Treatment*|6|||
27883227|NCT02748213|81404616|FG000|Overall Study|Failure to Return|1|||
27883228|NCT02748213|81404617|FG001|Overall Study|Failure to Return|0|||
27883229|NCT02748213|81404616|FG000|Overall Study|Other|30|||
27883230|NCT02748213|81404617|FG001|Overall Study|Other|29|||
27883231|NCT02343939|81404618|FG000|Overall Study|Death|0|||
27883232|NCT02343939|81404619|FG001|Overall Study|Death|15|||
27883233|NCT02343939|81404620|FG002|Overall Study|Death|4|||
27883234|NCT02343939|81404621|FG003|Overall Study|Death|2|||
27883235|NCT02343939|81404622|FG004|Overall Study|Death|5|||
27824097|NCT01878292|81189260|FG001|Double-blind Treatment Period|Protocol Violation|4|||
27824098|NCT01878292|81189261|FG002|Double-blind Treatment Period|Protocol Violation|2|||
27824099|NCT01878292|81189259|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
27824100|NCT01878292|81189260|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
27824101|NCT01878292|81189261|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27824102|NCT01878292|81189259|FG000|Double-blind Treatment Period|Adverse Event|4|||
27824103|NCT01878292|81189260|FG001|Double-blind Treatment Period|Adverse Event|9|||
27824104|NCT01878292|81189261|FG002|Double-blind Treatment Period|Adverse Event|8|||
27824105|NCT01878292|81189259|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
27824106|NCT01878292|81189260|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
27824107|NCT01878292|81189261|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
27824108|NCT01576042|81189262|FG000|Overall Study|Physician Decision|2|||
27883236|NCT02343939|81404623|FG005|Overall Study|Death|11|||
27883237|NCT02343939|81404624|FG006|Overall Study|Death|8|||
27883238|NCT02343939|81404625|FG007|Overall Study|Death|22|||
27883239|NCT02343939|81404626|FG008|Overall Study|Death|1|||
27883240|NCT02343939|81404618|FG000|Overall Study|Study terminated by sponsor|0|||
27883241|NCT02343939|81404619|FG001|Overall Study|Study terminated by sponsor|27|||
27883242|NCT02343939|81404620|FG002|Overall Study|Study terminated by sponsor|0|||
27883243|NCT02343939|81404621|FG003|Overall Study|Study terminated by sponsor|1|||
27883244|NCT02343939|81404622|FG004|Overall Study|Study terminated by sponsor|1|||
27883245|NCT02343939|81404623|FG005|Overall Study|Study terminated by sponsor|5|||
27883246|NCT02343939|81404624|FG006|Overall Study|Study terminated by sponsor|3|||
27883247|NCT02343939|81404625|FG007|Overall Study|Study terminated by sponsor|4|||
27883248|NCT02343939|81404626|FG008|Overall Study|Study terminated by sponsor|0|||
27883249|NCT02343939|81404618|FG000|Overall Study|Withdrew consent|3|||
27883250|NCT02343939|81404619|FG001|Overall Study|Withdrew consent|6|||
27883251|NCT02343939|81404620|FG002|Overall Study|Withdrew consent|1|||
27883252|NCT02343939|81404621|FG003|Overall Study|Withdrew consent|2|||
27883253|NCT02343939|81404622|FG004|Overall Study|Withdrew consent|2|||
27883254|NCT02343939|81404623|FG005|Overall Study|Withdrew consent|0|||
27883255|NCT02343939|81404624|FG006|Overall Study|Withdrew consent|0|||
27883256|NCT02343939|81404625|FG007|Overall Study|Withdrew consent|8|||
27824109|NCT01576042|81189263|FG001|Overall Study|Physician Decision|0|||
27824110|NCT00986245|81189264|FG000|First Intervention|Poor compliance|8|||
27824111|NCT00986245|81189265|FG001|First Intervention|Poor compliance|4|||
27824112|NCT00986245|81189264|FG000|First Intervention|Lack of Efficacy|1|||
27824113|NCT00986245|81189265|FG001|First Intervention|Lack of Efficacy|2|||
27824114|NCT00986245|81189264|FG000|First Intervention|Withdrawal by Subject|0|||
27824115|NCT00986245|81189265|FG001|First Intervention|Withdrawal by Subject|1|||
27824116|NCT00986245|81189264|FG000|First Intervention|Protocol Violation|0|||
27824117|NCT00986245|81189265|FG001|First Intervention|Protocol Violation|1|||
27824118|NCT00986245|81189264|FG000|First Intervention|Out of indication|1|||
27824119|NCT00986245|81189265|FG001|First Intervention|Out of indication|0|||
27824120|NCT00986245|81189264|FG000|Second Intervention|Poor compliance|1|||
27824121|NCT00986245|81189265|FG001|Second Intervention|Poor compliance|0|||
27824122|NCT00986245|81189264|FG000|Second Intervention|Lost to Follow-up|1|||
27824123|NCT00986245|81189265|FG001|Second Intervention|Lost to Follow-up|0|||
27824124|NCT00986245|81189264|FG000|Second Intervention|Protocol Violation|0|||
27824125|NCT00986245|81189265|FG001|Second Intervention|Protocol Violation|1|||
27824126|NCT02459951|81189266|FG000|Overall Study|Unable to meet holding requirement|1|||
27824127|NCT02937870|81189267|FG000|Overall Study|Adverse Event|1|||
27824128|NCT02937870|81189267|FG000|Overall Study|Protocol Deviation|2|||
27824129|NCT01864174|81189268|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
27824130|NCT01864174|81189269|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
27824131|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
27824132|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
27824133|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
27824134|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
27824135|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
27824136|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
27824137|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Death|1|||
27824138|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Death|0|||
27824139|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
27883257|NCT02343939|81404626|FG008|Overall Study|Withdrew consent|6|||
27883258|NCT02343939|81404618|FG000|Overall Study|Treatment failure|0|||
27883259|NCT02343939|81404619|FG001|Overall Study|Treatment failure|0|||
27883260|NCT02343939|81404620|FG002|Overall Study|Treatment failure|0|||
27883261|NCT02343939|81404621|FG003|Overall Study|Treatment failure|0|||
27883262|NCT02343939|81404622|FG004|Overall Study|Treatment failure|0|||
27883263|NCT02343939|81404623|FG005|Overall Study|Treatment failure|0|||
27594060|NCT00558428|80352407|FG000|Overall Study|Non compliant with protocol|1|||
27594061|NCT00558428|80352408|FG001|Overall Study|Non compliant with protocol|0|||
27594062|NCT00558428|80352409|FG002|Overall Study|Non compliant with protocol|0|||
27594063|NCT00558428|80352410|FG003|Overall Study|Non compliant with protocol|3|||
27594064|NCT00558428|80352407|FG000|Overall Study|Consent withdrawn|2|||
27594065|NCT00558428|80352408|FG001|Overall Study|Consent withdrawn|1|||
27883264|NCT02343939|81404624|FG006|Overall Study|Treatment failure|2|||
27883265|NCT02343939|81404625|FG007|Overall Study|Treatment failure|1|||
27883266|NCT02343939|81404626|FG008|Overall Study|Treatment failure|0|||
27883267|NCT02343939|81404618|FG000|Overall Study|Investigator's discretion|0|||
27883268|NCT02343939|81404619|FG001|Overall Study|Investigator's discretion|0|||
27883269|NCT02343939|81404620|FG002|Overall Study|Investigator's discretion|0|||
27883270|NCT02343939|81404621|FG003|Overall Study|Investigator's discretion|1|||
27883271|NCT02343939|81404622|FG004|Overall Study|Investigator's discretion|0|||
27883272|NCT02343939|81404623|FG005|Overall Study|Investigator's discretion|0|||
27883273|NCT02343939|81404624|FG006|Overall Study|Investigator's discretion|1|||
27883274|NCT02343939|81404625|FG007|Overall Study|Investigator's discretion|0|||
27883275|NCT02343939|81404626|FG008|Overall Study|Investigator's discretion|0|||
27883276|NCT02343939|81404618|FG000|Overall Study|Adverse Event|0|||
27883277|NCT02343939|81404619|FG001|Overall Study|Adverse Event|0|||
27883278|NCT02343939|81404620|FG002|Overall Study|Adverse Event|0|||
27883279|NCT02343939|81404621|FG003|Overall Study|Adverse Event|0|||
27883280|NCT02343939|81404622|FG004|Overall Study|Adverse Event|0|||
27883281|NCT02343939|81404623|FG005|Overall Study|Adverse Event|1|||
27883282|NCT02343939|81404624|FG006|Overall Study|Adverse Event|0|||
27883283|NCT02343939|81404625|FG007|Overall Study|Adverse Event|0|||
27883284|NCT02343939|81404626|FG008|Overall Study|Adverse Event|0|||
27883285|NCT02343939|81404618|FG000|Overall Study|Never Treated With ENTO|0|||
27883286|NCT02343939|81404619|FG001|Overall Study|Never Treated With ENTO|0|||
27883287|NCT02343939|81404620|FG002|Overall Study|Never Treated With ENTO|0|||
27883288|NCT02343939|81404621|FG003|Overall Study|Never Treated With ENTO|0|||
27883289|NCT02343939|81404622|FG004|Overall Study|Never Treated With ENTO|0|||
27883290|NCT02343939|81404623|FG005|Overall Study|Never Treated With ENTO|0|||
27883291|NCT02343939|81404624|FG006|Overall Study|Never Treated With ENTO|1|||
27883292|NCT02343939|81404625|FG007|Overall Study|Never Treated With ENTO|2|||
27594066|NCT00558428|80352409|FG002|Overall Study|Consent withdrawn|0|||
27594067|NCT00558428|80352410|FG003|Overall Study|Consent withdrawn|1|||
27594068|NCT00558428|80352407|FG000|Overall Study|Other|3|||
27594069|NCT00558428|80352408|FG001|Overall Study|Other|0|||
27594070|NCT00558428|80352409|FG002|Overall Study|Other|0|||
27594071|NCT00558428|80352410|FG003|Overall Study|Other|1|||
27594072|NCT02925455|80352411|FG000|Overall Study|Withdrawal by Subject|2|||
27594073|NCT02925455|80352412|FG001|Overall Study|Withdrawal by Subject|0|||
27594074|NCT04575467|80352413|FG000|Overall Study|Adverse Event|0|||
27594075|NCT04575467|80352414|FG001|Overall Study|Adverse Event|1|||
27594076|NCT04575467|80352415|FG002|Overall Study|Adverse Event|0|||
27594077|NCT04575467|80352416|FG003|Overall Study|Adverse Event|0|||
27594078|NCT02105116|80352417|FG000|Overall Study|not eligible for step 2 of trial|5|||
27594079|NCT02105116|80352417|FG000|Overall Study|Death|1|||
27594080|NCT02280044|80352423|FG000|Overall Study|Planned alternate|0|||
27594081|NCT02280044|80352424|FG001|Overall Study|Planned alternate|2|||
27594082|NCT00802074|80352427|FG000|Overall Study|Adverse Event|1|||
27594083|NCT00802074|80352428|FG001|Overall Study|Adverse Event|1|||
27594084|NCT00802074|80352429|FG002|Overall Study|Adverse Event|1|||
27594085|NCT00802074|80352430|FG003|Overall Study|Adverse Event|0|||
27883293|NCT02343939|81404626|FG008|Overall Study|Never Treated With ENTO|0|||
27883294|NCT01401361|81404627|FG000|Overall Study|Withdrawal by Subject|16|||
27594086|NCT00802074|80352431|FG004|Overall Study|Adverse Event|0|||
27594087|NCT00802074|80352432|FG005|Overall Study|Adverse Event|0|||
27594088|NCT00802074|80352427|FG000|Overall Study|Withdrawal by Subject|1|||
27594089|NCT00802074|80352428|FG001|Overall Study|Withdrawal by Subject|0|||
27594090|NCT00802074|80352429|FG002|Overall Study|Withdrawal by Subject|0|||
27883295|NCT01401361|81404627|FG000|Overall Study|Lack of Efficacy|6|||
27883296|NCT01401361|81404627|FG000|Overall Study|Physician Decision|1|||
27824140|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
27824141|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
27824142|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
27824143|NCT01864174|81189268|FG000|Double Blind - Compliant Randomized|Other|6|||
27824144|NCT01864174|81189269|FG001|Double Blind - Compliant Randomized|Other|10|||
27824145|NCT01864174|81189268|FG000|Off Treatment Follow-Up|Other|2|||
27824146|NCT01864174|81189269|FG001|Off Treatment Follow-Up|Other|0|||
27883297|NCT01401361|81404627|FG000|Overall Study|Lost to Follow-up|3|||
27883298|NCT01401361|81404627|FG000|Overall Study|Subject/family decision post procedure|2|||
27883299|NCT02097238|81404630|FG000|Overall Study|Death|1|||
27694239|NCT00406653|80716714|FG002|Induction Period|Withdrawal of Consent|1|||
27883300|NCT02097238|81404630|FG000|Overall Study|Physician Decision|1|||
27883301|NCT02097238|81404630|FG000|Overall Study|Progressive Disease|17|||
27883302|NCT00758485|81404631|FG000|Overall Study|Lost to Follow-up|0|||
27883303|NCT00758485|81404632|FG001|Overall Study|Lost to Follow-up|1|||
27883304|NCT00758485|81404631|FG000|Overall Study|Not Treated|1|||
27883305|NCT00758485|81404632|FG001|Overall Study|Not Treated|2|||
27883306|NCT03423173|81404634|FG000|Overall Study|Randomized but not vaccinated|1|||
27883307|NCT03423173|81404635|FG001|Overall Study|Randomized but not vaccinated|0|||
27883308|NCT03423173|81404636|FG002|Overall Study|Randomized but not vaccinated|2|||
27883309|NCT03423173|81404637|FG003|Overall Study|Randomized but not vaccinated|1|||
27883310|NCT03423173|81404634|FG000|Overall Study|Adverse Event|1|||
27883311|NCT03423173|81404635|FG001|Overall Study|Adverse Event|1|||
27883312|NCT03423173|81404636|FG002|Overall Study|Adverse Event|1|||
27883313|NCT03423173|81404637|FG003|Overall Study|Adverse Event|1|||
27883314|NCT03423173|81404634|FG000|Overall Study|Lost to Follow-up|10|||
27883315|NCT03423173|81404635|FG001|Overall Study|Lost to Follow-up|19|||
27883316|NCT03423173|81404636|FG002|Overall Study|Lost to Follow-up|17|||
27883317|NCT03423173|81404637|FG003|Overall Study|Lost to Follow-up|22|||
27883318|NCT03423173|81404634|FG000|Overall Study|Withdrawal of consent|4|||
27883319|NCT03423173|81404635|FG001|Overall Study|Withdrawal of consent|10|||
27883320|NCT03423173|81404636|FG002|Overall Study|Withdrawal of consent|4|||
27883321|NCT03423173|81404637|FG003|Overall Study|Withdrawal of consent|5|||
27883322|NCT03423173|81404634|FG000|Overall Study|Death|1|||
27883323|NCT03423173|81404635|FG001|Overall Study|Death|0|||
27883324|NCT03423173|81404636|FG002|Overall Study|Death|0|||
27883325|NCT03423173|81404637|FG003|Overall Study|Death|0|||
27883326|NCT03423173|81404634|FG000|Overall Study|Reason not Specified|2|||
27883327|NCT03423173|81404635|FG001|Overall Study|Reason not Specified|5|||
27883328|NCT03423173|81404636|FG002|Overall Study|Reason not Specified|3|||
27883329|NCT03423173|81404637|FG003|Overall Study|Reason not Specified|1|||
27883330|NCT02920008|81404639|FG000|Overall Study|Death|117|||
27883331|NCT02920008|81404640|FG001|Overall Study|Death|127|||
27883332|NCT02920008|81404639|FG000|Overall Study|Withdrawal by Subject|3|||
27883333|NCT02920008|81404640|FG001|Overall Study|Withdrawal by Subject|6|||
27883334|NCT02920008|81404639|FG000|Overall Study|Lost to Follow-up|0|||
27883335|NCT02920008|81404640|FG001|Overall Study|Lost to Follow-up|1|||
27883336|NCT00833105|81404641|FG000|Overall Study|Withdrawal by Subject|1|||
27883337|NCT00833105|81404641|FG000|Overall Study|Adverse Event|2|||
27883338|NCT01500382|81404642|FG000|Washout Period|Study site went out of business|0|||
27694240|NCT00406653|80716715|FG003|Induction Period|Withdrawal of Consent|2|||
27883339|NCT01500382|81404643|FG001|Washout Period|Study site went out of business|0|||
27883340|NCT01500382|81404644|FG002|Washout Period|Study site went out of business|1|||
27883341|NCT01500382|81404645|FG003|Washout Period|Study site went out of business|0|||
27883342|NCT02393950|81404646|FG000|Overall Study|Adverse Event|1|||
27883343|NCT02393950|81404647|FG001|Overall Study|Adverse Event|0|||
27552514|NCT00903695|80211210|FG000|Overall Study|medical exclusion after 1st testing|1|||
27552515|NCT00903695|80211211|FG001|Overall Study|medical exclusion after 1st testing|0|||
27552516|NCT00903695|80211210|FG000|Overall Study|lung cancer|1|||
27552517|NCT00903695|80211211|FG001|Overall Study|lung cancer|0|||
27824147|NCT01864174|81189268|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
27824148|NCT01864174|81189269|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
27824149|NCT01534520|81189270|FG000|Overall Study|Adverse Event|0|||
27824150|NCT01534520|81189271|FG001|Overall Study|Adverse Event|1|||
27824151|NCT04627038|81189273|FG000|Overall Study|Adverse Event|36|||
27824152|NCT04627038|81189274|FG001|Overall Study|Adverse Event|8|||
27824153|NCT04627038|81189273|FG000|Overall Study|Lost to Follow-up|1|||
27824154|NCT04627038|81189274|FG001|Overall Study|Lost to Follow-up|0|||
27824155|NCT04627038|81189273|FG000|Overall Study|Physician Decision|0|||
27824156|NCT04627038|81189274|FG001|Overall Study|Physician Decision|1|||
27824157|NCT04627038|81189273|FG000|Overall Study|Protocol Violation|3|||
27824158|NCT04627038|81189274|FG001|Overall Study|Protocol Violation|1|||
27824159|NCT04627038|81189273|FG000|Overall Study|Withdrawal by Subject|13|||
27824160|NCT04627038|81189274|FG001|Overall Study|Withdrawal by Subject|3|||
27824161|NCT04627038|81189273|FG000|Overall Study|Non-compliance with study drug|0|||
27824162|NCT04627038|81189274|FG001|Overall Study|Non-compliance with study drug|1|||
27824163|NCT04627038|81189273|FG000|Overall Study|Prohibited Concomitant Medication|1|||
27824164|NCT04627038|81189274|FG001|Overall Study|Prohibited Concomitant Medication|0|||
27824165|NCT00328926|81189282|FG000|Overall Study|Pregnancy|2|||
27824166|NCT00328926|81189283|FG001|Overall Study|Pregnancy|1|||
27824167|NCT00328926|81189284|FG002|Overall Study|Pregnancy|0|||
27824168|NCT00328926|81189282|FG000|Overall Study|Lost to Follow-up|0|||
27824169|NCT00328926|81189283|FG001|Overall Study|Lost to Follow-up|1|||
27824170|NCT00328926|81189284|FG002|Overall Study|Lost to Follow-up|0|||
27824171|NCT00328926|81189282|FG000|Overall Study|Death|0|||
27824172|NCT00328926|81189283|FG001|Overall Study|Death|0|||
27824173|NCT00328926|81189284|FG002|Overall Study|Death|1|||
27824174|NCT00328926|81189282|FG000|Overall Study|In vitro fertilization treatment|0|||
27824175|NCT00328926|81189283|FG001|Overall Study|In vitro fertilization treatment|0|||
27824176|NCT00328926|81189284|FG002|Overall Study|In vitro fertilization treatment|1|||
27824177|NCT00328926|81189282|FG000|Overall Study|Lack of ovarian response|0|||
27824178|NCT00328926|81189283|FG001|Overall Study|Lack of ovarian response|1|||
27824179|NCT00328926|81189284|FG002|Overall Study|Lack of ovarian response|0|||
27824180|NCT01214850|81189285|FG000|Overall Study|Withdrawal by Subject|38|||
27824181|NCT01214850|81189286|FG001|Overall Study|Withdrawal by Subject|31|||
27824182|NCT01214850|81189287|FG002|Overall Study|Withdrawal by Subject|28|||
27824183|NCT01214850|81189285|FG000|Overall Study|Lost to Follow-up|124|||
27824184|NCT01214850|81189286|FG001|Overall Study|Lost to Follow-up|98|||
27824185|NCT01214850|81189287|FG002|Overall Study|Lost to Follow-up|123|||
27824186|NCT01214850|81189285|FG000|Overall Study|Protocol Violation|5|||
27824187|NCT01214850|81189286|FG001|Overall Study|Protocol Violation|5|||
27824188|NCT01214850|81189287|FG002|Overall Study|Protocol Violation|6|||
27824189|NCT01214850|81189285|FG000|Overall Study|Adverse event or death|11|||
27824190|NCT01214850|81189286|FG001|Overall Study|Adverse event or death|8|||
27824191|NCT01214850|81189287|FG002|Overall Study|Adverse event or death|3|||
27552518|NCT01366209|80211212|FG000|Overall Study|Adverse Event|6|||
27552519|NCT01366209|80211213|FG001|Overall Study|Adverse Event|7|||
27552520|NCT01366209|80211212|FG000|Overall Study|Withdrawal by Subject|4|||
27552521|NCT01366209|80211213|FG001|Overall Study|Withdrawal by Subject|4|||
27552522|NCT01366209|80211212|FG000|Overall Study|Death|12|||
27552523|NCT01366209|80211213|FG001|Overall Study|Death|19|||
27552524|NCT01366209|80211212|FG000|Overall Study|Lung transplantation|6|||
27552525|NCT01366209|80211213|FG001|Overall Study|Lung transplantation|1|||
27552526|NCT01366209|80211212|FG000|Overall Study|Lost to Follow-up|2|||
27552527|NCT01366209|80211213|FG001|Overall Study|Lost to Follow-up|1|||
27824192|NCT01214850|81189285|FG000|Overall Study|Inappropriate enrollment|2|||
27824193|NCT01214850|81189286|FG001|Overall Study|Inappropriate enrollment|1|||
27824194|NCT01214850|81189287|FG002|Overall Study|Inappropriate enrollment|0|||
27824195|NCT01214850|81189285|FG000|Overall Study|Administrative reason|1|||
27824196|NCT01214850|81189286|FG001|Overall Study|Administrative reason|0|||
27552528|NCT01366209|80211212|FG000|Overall Study|Physician Decision|1|||
27552529|NCT01366209|80211213|FG001|Overall Study|Physician Decision|0|||
27824197|NCT01214850|81189287|FG002|Overall Study|Administrative reason|0|||
27552530|NCT01366209|80211212|FG000|Overall Study|Sponsors decision|0|||
27824198|NCT01214850|81189285|FG000|Overall Study|Unable to classify|2|||
27824199|NCT01214850|81189286|FG001|Overall Study|Unable to classify|1|||
27824200|NCT01214850|81189287|FG002|Overall Study|Unable to classify|1|||
27824201|NCT00296647|81189288|FG000|Overall Study|Death|4|||
27883344|NCT02393950|81404646|FG000|Overall Study|Withdrawal by Subject|0|||
27883345|NCT02393950|81404647|FG001|Overall Study|Withdrawal by Subject|1|||
27883346|NCT02027545|81404650|FG000|Overall Study|Failed to sign HIPAA|0|||
27883347|NCT02027545|81404651|FG001|Overall Study|Failed to sign HIPAA|2|||
27883348|NCT02027545|81404650|FG000|Overall Study|Failed to attend study visit|2|||
27883349|NCT02027545|81404651|FG001|Overall Study|Failed to attend study visit|0|||
27883350|NCT02027545|81404650|FG000|Overall Study|Protocol Violation|1|||
27883351|NCT02027545|81404651|FG001|Overall Study|Protocol Violation|0|||
27883352|NCT03759587|81404652|FG000|Overall Study|Adverse Event|5|||
27883353|NCT03759587|81404652|FG000|Overall Study|Progressive Disease|10|||
27883354|NCT03759587|81404652|FG000|Overall Study|Site Terminated by Sponsor|3|||
27824202|NCT00296647|81189289|FG001|Overall Study|Death|1|||
27824203|NCT00296647|81189290|FG002|Overall Study|Death|2|||
27824204|NCT00296647|81189291|FG003|Overall Study|Death|1|||
27824205|NCT00296647|81189292|FG004|Overall Study|Death|1|||
27824206|NCT00296647|81189288|FG000|Overall Study|Withdrawal by Subject|28|||
27883355|NCT03759587|81404652|FG000|Overall Study|Withdrawal by Subject|1|||
27883356|NCT03226769|81404653|FG000|Overall Study|Withdrawal by Subject|0|||
27883357|NCT03226769|81404654|FG001|Overall Study|Withdrawal by Subject|1|||
27883358|NCT03876743|81404655|FG000|Overall Study|Lost to Follow-up|6|||
27824207|NCT00296647|81189289|FG001|Overall Study|Withdrawal by Subject|27|||
27824208|NCT00296647|81189290|FG002|Overall Study|Withdrawal by Subject|32|||
27824209|NCT00296647|81189291|FG003|Overall Study|Withdrawal by Subject|16|||
27824210|NCT00296647|81189292|FG004|Overall Study|Withdrawal by Subject|19|||
27824211|NCT01215981|81189293|FG000|Overall Study|Physician Decision|0|||
27824212|NCT01215981|81189294|FG001|Overall Study|Physician Decision|1|||
27824213|NCT01215981|81189293|FG000|Overall Study|Protocol Violation|1|||
27824214|NCT01215981|81189294|FG001|Overall Study|Protocol Violation|0|||
27824215|NCT01215981|81189293|FG000|Overall Study|Withdrawal by Subject|1|||
27824216|NCT01215981|81189294|FG001|Overall Study|Withdrawal by Subject|0|||
27824217|NCT01190930|81189295|FG000|Induction|Adverse Event|17|||
27824218|NCT01190930|81189296|FG001|Induction|Adverse Event|0|||
27824219|NCT01190930|81189297|FG002|Induction|Adverse Event|0|||
27824220|NCT01190930|81189298|FG003|Induction|Adverse Event|0|||
27824221|NCT01190930|81189299|FG004|Induction|Adverse Event|0|||
27824222|NCT01190930|81189300|FG005|Induction|Adverse Event|0|||
27824223|NCT01190930|81189301|FG006|Induction|Adverse Event|0|||
27824224|NCT01190930|81189302|FG007|Induction|Adverse Event|0|||
27824225|NCT01190930|81189303|FG008|Induction|Adverse Event|0|||
27824226|NCT01190930|81189304|FG009|Induction|Adverse Event|0|||
27824227|NCT01190930|81189295|FG000|Induction|Death|34|||
27824228|NCT01190930|81189296|FG001|Induction|Death|0|||
27824229|NCT01190930|81189297|FG002|Induction|Death|0|||
27883359|NCT03876743|81404656|FG001|Overall Study|Lost to Follow-up|4|||
27883360|NCT03876743|81404657|FG002|Overall Study|Lost to Follow-up|4|||
27883361|NCT03876743|81404658|FG003|Overall Study|Lost to Follow-up|7|||
27552531|NCT01366209|80211213|FG001|Overall Study|Sponsors decision|1|||
27824230|NCT01190930|81189298|FG003|Induction|Death|0|||
27824231|NCT01190930|81189299|FG004|Induction|Death|0|||
27883362|NCT03337113|81404661|FG000|Overall Study|Adverse Event|1|||
27824232|NCT01190930|81189300|FG005|Induction|Death|0|||
27824233|NCT01190930|81189301|FG006|Induction|Death|0|||
27824234|NCT01190930|81189302|FG007|Induction|Death|0|||
27552532|NCT01366209|80211212|FG000|Overall Study|Withdrew consent|4|||
27552533|NCT01366209|80211213|FG001|Overall Study|Withdrew consent|3|||
27552534|NCT04203238|80211214|FG000|Overall Study|Withdrawal by Subject|1|||
27552535|NCT04203238|80211215|FG001|Overall Study|Withdrawal by Subject|1|||
27824235|NCT01190930|81189303|FG008|Induction|Death|0|||
27824236|NCT01190930|81189304|FG009|Induction|Death|0|||
27824237|NCT01190930|81189295|FG000|Induction|Lost to Follow-up|1|||
27824238|NCT01190930|81189296|FG001|Induction|Lost to Follow-up|0|||
27824239|NCT01190930|81189297|FG002|Induction|Lost to Follow-up|0|||
27824240|NCT01190930|81189298|FG003|Induction|Lost to Follow-up|0|||
27824241|NCT01190930|81189299|FG004|Induction|Lost to Follow-up|0|||
27824242|NCT01190930|81189300|FG005|Induction|Lost to Follow-up|0|||
27824243|NCT01190930|81189301|FG006|Induction|Lost to Follow-up|0|||
27824244|NCT01190930|81189302|FG007|Induction|Lost to Follow-up|0|||
27883363|NCT03337113|81404662|FG001|Overall Study|Adverse Event|1|||
27883364|NCT03337113|81404663|FG002|Overall Study|Adverse Event|0|||
27883365|NCT03337113|81404664|FG003|Overall Study|Adverse Event|1|||
27883366|NCT03337113|81404661|FG000|Overall Study|Physician Decision|0|||
27552536|NCT04203238|80211214|FG000|Overall Study|Covid-19|3|||
27694241|NCT00406653|80716716|FG004|Induction Period|Withdrawal of Consent|0|||
27824245|NCT01190930|81189303|FG008|Induction|Lost to Follow-up|0|||
27824246|NCT01190930|81189304|FG009|Induction|Lost to Follow-up|0|||
27824247|NCT01190930|81189295|FG000|Induction|Physician Decision|125|||
27824248|NCT01190930|81189296|FG001|Induction|Physician Decision|3|||
27883367|NCT03337113|81404662|FG001|Overall Study|Physician Decision|2|||
27883368|NCT03337113|81404663|FG002|Overall Study|Physician Decision|0|||
27883369|NCT03337113|81404664|FG003|Overall Study|Physician Decision|1|||
27883370|NCT03337113|81404661|FG000|Overall Study|Withdrawal by Subject|0|||
27552537|NCT04203238|80211215|FG001|Overall Study|Covid-19|0|||
27552538|NCT00837811|80211218|FG000|Overall Study|Adverse Event|4|||
27552539|NCT00837811|80211219|FG001|Overall Study|Adverse Event|6|||
27824249|NCT01190930|81189297|FG002|Induction|Physician Decision|0|||
27824250|NCT01190930|81189298|FG003|Induction|Physician Decision|0|||
27824251|NCT01190930|81189299|FG004|Induction|Physician Decision|0|||
27824252|NCT01190930|81189300|FG005|Induction|Physician Decision|0|||
27824253|NCT01190930|81189301|FG006|Induction|Physician Decision|0|||
27824254|NCT01190930|81189302|FG007|Induction|Physician Decision|0|||
27824255|NCT01190930|81189303|FG008|Induction|Physician Decision|0|||
27824256|NCT01190930|81189304|FG009|Induction|Physician Decision|0|||
27824257|NCT01190930|81189295|FG000|Induction|Withdrawal by Subject|9|||
27824258|NCT01190930|81189296|FG001|Induction|Withdrawal by Subject|0|||
27824259|NCT01190930|81189297|FG002|Induction|Withdrawal by Subject|0|||
27824260|NCT01190930|81189298|FG003|Induction|Withdrawal by Subject|0|||
27824261|NCT01190930|81189299|FG004|Induction|Withdrawal by Subject|0|||
27824262|NCT01190930|81189300|FG005|Induction|Withdrawal by Subject|0|||
27824263|NCT01190930|81189301|FG006|Induction|Withdrawal by Subject|0|||
27883371|NCT03337113|81404662|FG001|Overall Study|Withdrawal by Subject|0|||
27883372|NCT03337113|81404663|FG002|Overall Study|Withdrawal by Subject|1|||
27883373|NCT03337113|81404664|FG003|Overall Study|Withdrawal by Subject|0|||
27824264|NCT01190930|81189302|FG007|Induction|Withdrawal by Subject|0|||
27824265|NCT01190930|81189303|FG008|Induction|Withdrawal by Subject|0|||
27824266|NCT01190930|81189304|FG009|Induction|Withdrawal by Subject|0|||
27824267|NCT01190930|81189295|FG000|Induction|Refusal|235|||
27824268|NCT01190930|81189296|FG001|Induction|Refusal|0|||
27824269|NCT01190930|81189297|FG002|Induction|Refusal|0|||
27824270|NCT01190930|81189298|FG003|Induction|Refusal|0|||
27824271|NCT01190930|81189299|FG004|Induction|Refusal|0|||
27824272|NCT01190930|81189300|FG005|Induction|Refusal|0|||
27824273|NCT01190930|81189301|FG006|Induction|Refusal|0|||
27824274|NCT01190930|81189302|FG007|Induction|Refusal|0|||
27824275|NCT01190930|81189303|FG008|Induction|Refusal|0|||
27824276|NCT01190930|81189304|FG009|Induction|Refusal|0|||
27824277|NCT01190930|81189295|FG000|Induction|Inevaluable|23|||
27824278|NCT01190930|81189296|FG001|Induction|Inevaluable|1|||
27824279|NCT01190930|81189297|FG002|Induction|Inevaluable|0|||
27824280|NCT01190930|81189298|FG003|Induction|Inevaluable|0|||
27824281|NCT01190930|81189299|FG004|Induction|Inevaluable|0|||
27824282|NCT01190930|81189300|FG005|Induction|Inevaluable|0|||
27824283|NCT01190930|81189301|FG006|Induction|Inevaluable|0|||
27824284|NCT01190930|81189302|FG007|Induction|Inevaluable|0|||
27824285|NCT01190930|81189303|FG008|Induction|Inevaluable|0|||
27824286|NCT01190930|81189304|FG009|Induction|Inevaluable|0|||
27824287|NCT01190930|81189295|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
27824288|NCT01190930|81189296|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824289|NCT01190930|81189297|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824290|NCT01190930|81189298|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824291|NCT01190930|81189299|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824292|NCT01190930|81189300|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824293|NCT01190930|81189301|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824294|NCT01190930|81189302|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824295|NCT01190930|81189303|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824296|NCT01190930|81189304|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
27824297|NCT01190930|81189295|FG000|Induction|High Risk Downs|80|||
27824298|NCT01190930|81189296|FG001|Induction|High Risk Downs|0|||
27824299|NCT01190930|81189297|FG002|Induction|High Risk Downs|0|||
27883374|NCT03018080|81404670|FG000|Overall Study|Death|12|||
27824300|NCT01190930|81189298|FG003|Induction|High Risk Downs|0|||
27824301|NCT01190930|81189299|FG004|Induction|High Risk Downs|0|||
27824302|NCT01190930|81189300|FG005|Induction|High Risk Downs|0|||
27824303|NCT01190930|81189301|FG006|Induction|High Risk Downs|0|||
27824304|NCT01190930|81189302|FG007|Induction|High Risk Downs|0|||
27824305|NCT01190930|81189303|FG008|Induction|High Risk Downs|0|||
27824306|NCT01190930|81189304|FG009|Induction|High Risk Downs|0|||
27824307|NCT01190930|81189295|FG000|Induction|Enrollment onto another COG Protocol|1|||
27824308|NCT01190930|81189296|FG001|Induction|Enrollment onto another COG Protocol|0|||
27824309|NCT01190930|81189297|FG002|Induction|Enrollment onto another COG Protocol|0|||
27824310|NCT01190930|81189298|FG003|Induction|Enrollment onto another COG Protocol|0|||
27824311|NCT01190930|81189299|FG004|Induction|Enrollment onto another COG Protocol|0|||
27824312|NCT01190930|81189300|FG005|Induction|Enrollment onto another COG Protocol|0|||
27824313|NCT01190930|81189301|FG006|Induction|Enrollment onto another COG Protocol|0|||
27824314|NCT01190930|81189302|FG007|Induction|Enrollment onto another COG Protocol|0|||
27824315|NCT01190930|81189303|FG008|Induction|Enrollment onto another COG Protocol|0|||
27824316|NCT01190930|81189304|FG009|Induction|Enrollment onto another COG Protocol|0|||
27824317|NCT01190930|81189295|FG000|Induction|Average Risk|1847|||
27824318|NCT01190930|81189296|FG001|Induction|Average Risk|0|||
27824319|NCT01190930|81189297|FG002|Induction|Average Risk|0|||
27824320|NCT01190930|81189298|FG003|Induction|Average Risk|0|||
27824321|NCT01190930|81189299|FG004|Induction|Average Risk|0|||
27824322|NCT01190930|81189300|FG005|Induction|Average Risk|0|||
27824323|NCT01190930|81189301|FG006|Induction|Average Risk|0|||
27824324|NCT01190930|81189302|FG007|Induction|Average Risk|0|||
27824325|NCT01190930|81189303|FG008|Induction|Average Risk|0|||
27824326|NCT01190930|81189304|FG009|Induction|Average Risk|0|||
27824327|NCT01190930|81189295|FG000|Induction|High Risk|1227|||
27824328|NCT01190930|81189296|FG001|Induction|High Risk|0|||
27824329|NCT01190930|81189297|FG002|Induction|High Risk|0|||
27824330|NCT01190930|81189298|FG003|Induction|High Risk|0|||
27824331|NCT01190930|81189299|FG004|Induction|High Risk|0|||
27824332|NCT01190930|81189300|FG005|Induction|High Risk|0|||
27824333|NCT01190930|81189301|FG006|Induction|High Risk|0|||
27824334|NCT01190930|81189302|FG007|Induction|High Risk|0|||
27824335|NCT01190930|81189303|FG008|Induction|High Risk|0|||
27824336|NCT01190930|81189304|FG009|Induction|High Risk|0|||
27824337|NCT01190930|81189295|FG000|Induction|Low Risk|443|||
27824338|NCT01190930|81189296|FG001|Induction|Low Risk|0|||
27824339|NCT01190930|81189297|FG002|Induction|Low Risk|0|||
27824340|NCT01190930|81189298|FG003|Induction|Low Risk|0|||
27824341|NCT01190930|81189299|FG004|Induction|Low Risk|0|||
27824342|NCT01190930|81189300|FG005|Induction|Low Risk|0|||
27824343|NCT01190930|81189301|FG006|Induction|Low Risk|0|||
27824344|NCT01190930|81189302|FG007|Induction|Low Risk|0|||
27824345|NCT01190930|81189303|FG008|Induction|Low Risk|0|||
27824346|NCT01190930|81189304|FG009|Induction|Low Risk|0|||
27824347|NCT01190930|81189295|FG000|Induction|Very High Risk|1012|||
27824348|NCT01190930|81189296|FG001|Induction|Very High Risk|0|||
27824349|NCT01190930|81189297|FG002|Induction|Very High Risk|0|||
27824350|NCT01190930|81189298|FG003|Induction|Very High Risk|0|||
27824351|NCT01190930|81189299|FG004|Induction|Very High Risk|0|||
27824352|NCT01190930|81189300|FG005|Induction|Very High Risk|0|||
27552540|NCT00837811|80211220|FG002|Overall Study|Adverse Event|0|||
27824353|NCT01190930|81189301|FG006|Induction|Very High Risk|0|||
27824354|NCT01190930|81189302|FG007|Induction|Very High Risk|0|||
27824355|NCT01190930|81189303|FG008|Induction|Very High Risk|0|||
27824356|NCT01190930|81189304|FG009|Induction|Very High Risk|0|||
27824357|NCT01190930|81189295|FG000|Induction|Philadelphia chromosome-positive|99|||
27824358|NCT01190930|81189296|FG001|Induction|Philadelphia chromosome-positive|0|||
27824359|NCT01190930|81189297|FG002|Induction|Philadelphia chromosome-positive|0|||
27824360|NCT01190930|81189298|FG003|Induction|Philadelphia chromosome-positive|0|||
27824361|NCT01190930|81189299|FG004|Induction|Philadelphia chromosome-positive|0|||
27824362|NCT01190930|81189300|FG005|Induction|Philadelphia chromosome-positive|0|||
27824363|NCT01190930|81189301|FG006|Induction|Philadelphia chromosome-positive|0|||
27824364|NCT01190930|81189302|FG007|Induction|Philadelphia chromosome-positive|0|||
27824365|NCT01190930|81189303|FG008|Induction|Philadelphia chromosome-positive|0|||
27824366|NCT01190930|81189304|FG009|Induction|Philadelphia chromosome-positive|0|||
27824367|NCT01190930|81189295|FG000|Induction|Incomplete Induction data|63|||
27694242|NCT00406653|80716717|FG005|Induction Period|Withdrawal of Consent|0|||
27824368|NCT01190930|81189296|FG001|Induction|Incomplete Induction data|0|||
27824369|NCT01190930|81189297|FG002|Induction|Incomplete Induction data|0|||
27824370|NCT01190930|81189298|FG003|Induction|Incomplete Induction data|0|||
27824371|NCT01190930|81189299|FG004|Induction|Incomplete Induction data|0|||
27824372|NCT01190930|81189300|FG005|Induction|Incomplete Induction data|0|||
27824373|NCT01190930|81189301|FG006|Induction|Incomplete Induction data|0|||
27824374|NCT01190930|81189302|FG007|Induction|Incomplete Induction data|0|||
27824375|NCT01190930|81189303|FG008|Induction|Incomplete Induction data|0|||
27824376|NCT01190930|81189304|FG009|Induction|Incomplete Induction data|0|||
27824377|NCT01190930|81189295|FG000|Induction|Progressive disease|0|||
27824378|NCT01190930|81189296|FG001|Induction|Progressive disease|1|||
27824379|NCT01190930|81189297|FG002|Induction|Progressive disease|0|||
27824380|NCT01190930|81189298|FG003|Induction|Progressive disease|0|||
27824381|NCT01190930|81189299|FG004|Induction|Progressive disease|0|||
27824382|NCT01190930|81189300|FG005|Induction|Progressive disease|0|||
27824383|NCT01190930|81189301|FG006|Induction|Progressive disease|0|||
27824384|NCT01190930|81189302|FG007|Induction|Progressive disease|0|||
27824385|NCT01190930|81189303|FG008|Induction|Progressive disease|0|||
27824386|NCT01190930|81189304|FG009|Induction|Progressive disease|0|||
27824387|NCT01190930|81189295|FG000|Induction|No treatment|3|||
27824388|NCT01190930|81189296|FG001|Induction|No treatment|0|||
27824389|NCT01190930|81189297|FG002|Induction|No treatment|0|||
27824390|NCT01190930|81189298|FG003|Induction|No treatment|0|||
27824391|NCT01190930|81189299|FG004|Induction|No treatment|0|||
27824392|NCT01190930|81189300|FG005|Induction|No treatment|0|||
27824393|NCT01190930|81189301|FG006|Induction|No treatment|0|||
27824394|NCT01190930|81189302|FG007|Induction|No treatment|0|||
27824395|NCT01190930|81189303|FG008|Induction|No treatment|0|||
27824396|NCT01190930|81189304|FG009|Induction|No treatment|0|||
27824397|NCT01190930|81189295|FG000|Induction|Ineligible|69|||
27824398|NCT01190930|81189296|FG001|Induction|Ineligible|4|||
27824399|NCT01190930|81189297|FG002|Induction|Ineligible|0|||
27824400|NCT01190930|81189298|FG003|Induction|Ineligible|0|||
27883375|NCT03018080|81404671|FG001|Overall Study|Death|19|||
27883376|NCT00566020|81404673|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
27883377|NCT00566020|81404674|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
27883378|NCT00566020|81404673|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
27824401|NCT01190930|81189299|FG004|Induction|Ineligible|0|||
27824402|NCT01190930|81189300|FG005|Induction|Ineligible|0|||
27824403|NCT01190930|81189301|FG006|Induction|Ineligible|0|||
27824404|NCT01190930|81189302|FG007|Induction|Ineligible|0|||
27883379|NCT00566020|81404674|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
27824405|NCT01190930|81189303|FG008|Induction|Ineligible|0|||
27824406|NCT01190930|81189304|FG009|Induction|Ineligible|0|||
27824407|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
27824408|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
27824409|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
27824410|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
27824411|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
27824412|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
27824413|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
27824414|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
27824415|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
27824416|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
27824417|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Death|0|||
27824418|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Death|0|||
27824419|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Death|8|||
27824420|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Death|4|||
27824421|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Death|0|||
27824422|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Death|0|||
27824423|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Death|0|||
27824424|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Death|0|||
27824425|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Death|0|||
27824426|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Death|0|||
27824427|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
27824428|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
27824429|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
27824430|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
27824431|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
27824432|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
27824433|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
27824434|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
27824435|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
27824436|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
27824437|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27824438|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
27824439|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
27824440|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
27824441|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27824442|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27552541|NCT00837811|80211218|FG000|Overall Study|Death|1|||
27552542|NCT00837811|80211219|FG001|Overall Study|Death|1|||
27552543|NCT00837811|80211220|FG002|Overall Study|Death|0|||
27552544|NCT00837811|80211218|FG000|Overall Study|Lack of Efficacy|0|||
27552545|NCT00837811|80211219|FG001|Overall Study|Lack of Efficacy|11|||
27552546|NCT00837811|80211220|FG002|Overall Study|Lack of Efficacy|0|||
27552547|NCT00837811|80211218|FG000|Overall Study|Lost to Follow-up|1|||
27552548|NCT00837811|80211219|FG001|Overall Study|Lost to Follow-up|3|||
27552549|NCT00837811|80211220|FG002|Overall Study|Lost to Follow-up|0|||
27552550|NCT00837811|80211218|FG000|Overall Study|Physician Decision|0|||
27552551|NCT00837811|80211219|FG001|Overall Study|Physician Decision|2|||
27552552|NCT00837811|80211220|FG002|Overall Study|Physician Decision|1|||
27552553|NCT00837811|80211218|FG000|Overall Study|Withdrawal by Subject|1|||
27552554|NCT00837811|80211219|FG001|Overall Study|Withdrawal by Subject|9|||
27552555|NCT00837811|80211220|FG002|Overall Study|Withdrawal by Subject|0|||
27552556|NCT00837811|80211218|FG000|Overall Study|Sponsor Decision|0|||
27552557|NCT00837811|80211219|FG001|Overall Study|Sponsor Decision|2|||
27552558|NCT00837811|80211220|FG002|Overall Study|Sponsor Decision|0|||
27552559|NCT02670083|80211221|FG000|Overall Study|Adverse Event|16|||
27552560|NCT02670083|80211222|FG001|Overall Study|Adverse Event|13|||
27552561|NCT02670083|80211221|FG000|Overall Study|Death|4|||
27552562|NCT02670083|80211222|FG001|Overall Study|Death|6|||
27552563|NCT02670083|80211221|FG000|Overall Study|Lost to Follow-up|2|||
27824443|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27824444|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27824445|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27824446|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
27552564|NCT02670083|80211222|FG001|Overall Study|Lost to Follow-up|2|||
27824447|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Refusal|0|||
27824448|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Refusal|2|||
27552565|NCT02670083|80211221|FG000|Overall Study|Multiple Reasons|9|||
27552566|NCT02670083|80211222|FG001|Overall Study|Multiple Reasons|9|||
27552567|NCT02670083|80211221|FG000|Overall Study|Physician Decision|0|||
27552568|NCT02670083|80211222|FG001|Overall Study|Physician Decision|2|||
27824449|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Refusal|694|||
27552569|NCT02670083|80211221|FG000|Overall Study|Study Terminated By Sponsor|257|||
27824450|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Refusal|4|||
27883380|NCT00566020|81404673|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
27883381|NCT00566020|81404674|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
27552570|NCT02670083|80211222|FG001|Overall Study|Study Terminated By Sponsor|254|||
27552571|NCT02670083|80211221|FG000|Overall Study|Symptomatic Deterioration|0|||
27552572|NCT02670083|80211222|FG001|Overall Study|Symptomatic Deterioration|2|||
27824451|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Refusal|0|||
27824452|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Refusal|3|||
27824453|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Refusal|0|||
27824454|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Refusal|0|||
27824455|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Refusal|0|||
27824456|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Refusal|0|||
27824457|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
27824458|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
27824459|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
27552573|NCT02670083|80211221|FG000|Overall Study|Withdrawal by Subject|32|||
27552574|NCT02670083|80211222|FG001|Overall Study|Withdrawal by Subject|31|||
27552575|NCT02670083|80211221|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27824460|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
27824461|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
27824462|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
27824463|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
27824464|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
27824465|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
27824466|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
27824467|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824468|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
27824469|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824470|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824471|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824472|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824473|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824474|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824475|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824476|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
27824477|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
27824478|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
27824479|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
27824480|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
27824481|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
27824482|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
27824483|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
27824484|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
27824485|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
27824486|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
27824487|NCT01190930|81189295|FG000|Post Induction Pre-Maintenance|Relapse|0|||
27824488|NCT01190930|81189296|FG001|Post Induction Pre-Maintenance|Relapse|0|||
27824489|NCT01190930|81189297|FG002|Post Induction Pre-Maintenance|Relapse|1|||
27824490|NCT01190930|81189298|FG003|Post Induction Pre-Maintenance|Relapse|0|||
27824491|NCT01190930|81189299|FG004|Post Induction Pre-Maintenance|Relapse|0|||
27824492|NCT01190930|81189300|FG005|Post Induction Pre-Maintenance|Relapse|0|||
27824493|NCT01190930|81189301|FG006|Post Induction Pre-Maintenance|Relapse|0|||
27824494|NCT01190930|81189302|FG007|Post Induction Pre-Maintenance|Relapse|0|||
27824495|NCT01190930|81189303|FG008|Post Induction Pre-Maintenance|Relapse|0|||
27824496|NCT01190930|81189304|FG009|Post Induction Pre-Maintenance|Relapse|0|||
27824497|NCT01190930|81189295|FG000|Maintenance|Adverse Event|0|||
27824498|NCT01190930|81189296|FG001|Maintenance|Adverse Event|0|||
27824499|NCT01190930|81189297|FG002|Maintenance|Adverse Event|0|||
27824500|NCT01190930|81189298|FG003|Maintenance|Adverse Event|0|||
27824501|NCT01190930|81189299|FG004|Maintenance|Adverse Event|0|||
27824502|NCT01190930|81189300|FG005|Maintenance|Adverse Event|1|||
27824503|NCT01190930|81189301|FG006|Maintenance|Adverse Event|1|||
27824504|NCT01190930|81189302|FG007|Maintenance|Adverse Event|3|||
27824505|NCT01190930|81189303|FG008|Maintenance|Adverse Event|3|||
27824506|NCT01190930|81189304|FG009|Maintenance|Adverse Event|0|||
27824507|NCT01190930|81189295|FG000|Maintenance|Death|0|||
27824508|NCT01190930|81189296|FG001|Maintenance|Death|0|||
27824509|NCT01190930|81189297|FG002|Maintenance|Death|0|||
27824510|NCT01190930|81189298|FG003|Maintenance|Death|1|||
27824511|NCT01190930|81189299|FG004|Maintenance|Death|0|||
27883382|NCT00566020|81404673|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
27883383|NCT00566020|81404674|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
27883384|NCT00566020|81404673|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
27824512|NCT01190930|81189300|FG005|Maintenance|Death|0|||
27824513|NCT01190930|81189301|FG006|Maintenance|Death|2|||
27824514|NCT01190930|81189302|FG007|Maintenance|Death|2|||
27824515|NCT01190930|81189303|FG008|Maintenance|Death|2|||
27824516|NCT01190930|81189304|FG009|Maintenance|Death|2|||
27824517|NCT01190930|81189295|FG000|Maintenance|Lost to Follow-up|0|||
27824518|NCT01190930|81189296|FG001|Maintenance|Lost to Follow-up|0|||
27824519|NCT01190930|81189297|FG002|Maintenance|Lost to Follow-up|0|||
27824520|NCT01190930|81189298|FG003|Maintenance|Lost to Follow-up|0|||
27824521|NCT01190930|81189299|FG004|Maintenance|Lost to Follow-up|0|||
27824522|NCT01190930|81189300|FG005|Maintenance|Lost to Follow-up|0|||
27824523|NCT01190930|81189301|FG006|Maintenance|Lost to Follow-up|1|||
27824524|NCT01190930|81189302|FG007|Maintenance|Lost to Follow-up|1|||
27824525|NCT01190930|81189303|FG008|Maintenance|Lost to Follow-up|1|||
27824526|NCT01190930|81189304|FG009|Maintenance|Lost to Follow-up|0|||
27824527|NCT01190930|81189295|FG000|Maintenance|Physician Decision|0|||
27883385|NCT00566020|81404674|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
27824528|NCT01190930|81189296|FG001|Maintenance|Physician Decision|1|||
27824529|NCT01190930|81189297|FG002|Maintenance|Physician Decision|0|||
27824530|NCT01190930|81189298|FG003|Maintenance|Physician Decision|5|||
27824531|NCT01190930|81189299|FG004|Maintenance|Physician Decision|9|||
27824532|NCT01190930|81189300|FG005|Maintenance|Physician Decision|4|||
27824533|NCT01190930|81189301|FG006|Maintenance|Physician Decision|8|||
27824534|NCT01190930|81189302|FG007|Maintenance|Physician Decision|8|||
27883386|NCT00566020|81404673|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
27883387|NCT00566020|81404674|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
27883388|NCT00468481|81404675|FG000|Overall Study|Adverse Event|13|||
27883389|NCT00468481|81404676|FG001|Overall Study|Adverse Event|3|||
27883390|NCT00468481|81404675|FG000|Overall Study|Lost to Follow-up|25|||
27883391|NCT00468481|81404676|FG001|Overall Study|Lost to Follow-up|8|||
27883392|NCT00468481|81404675|FG000|Overall Study|Pregnancy|2|||
27883393|NCT00468481|81404676|FG001|Overall Study|Pregnancy|0|||
27883394|NCT00468481|81404675|FG000|Overall Study|Protocol Violation|18|||
27883395|NCT00468481|81404676|FG001|Overall Study|Protocol Violation|8|||
27883396|NCT00468481|81404675|FG000|Overall Study|Withdrawal by Subject|12|||
27883397|NCT00468481|81404676|FG001|Overall Study|Withdrawal by Subject|3|||
27883398|NCT00468481|81404675|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
27883399|NCT00468481|81404676|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
27883400|NCT00468481|81404675|FG000|Overall Study|Prohibited Medication|1|||
27883401|NCT00468481|81404676|FG001|Overall Study|Prohibited Medication|1|||
27883402|NCT00468481|81404675|FG000|Overall Study|Egg Donor|1|||
27824535|NCT01190930|81189303|FG008|Maintenance|Physician Decision|10|||
27824536|NCT01190930|81189304|FG009|Maintenance|Physician Decision|17|||
27824537|NCT01190930|81189295|FG000|Maintenance|Withdrawal by Subject|0|||
27824538|NCT01190930|81189296|FG001|Maintenance|Withdrawal by Subject|0|||
27824539|NCT01190930|81189297|FG002|Maintenance|Withdrawal by Subject|0|||
27824540|NCT01190930|81189298|FG003|Maintenance|Withdrawal by Subject|0|||
27824541|NCT01190930|81189299|FG004|Maintenance|Withdrawal by Subject|0|||
27824542|NCT01190930|81189300|FG005|Maintenance|Withdrawal by Subject|0|||
27824543|NCT01190930|81189301|FG006|Maintenance|Withdrawal by Subject|2|||
27824544|NCT01190930|81189302|FG007|Maintenance|Withdrawal by Subject|1|||
27824545|NCT01190930|81189303|FG008|Maintenance|Withdrawal by Subject|4|||
27824546|NCT01190930|81189304|FG009|Maintenance|Withdrawal by Subject|1|||
27824547|NCT01190930|81189295|FG000|Maintenance|Refusal|0|||
27824548|NCT01190930|81189296|FG001|Maintenance|Refusal|1|||
27883403|NCT00468481|81404676|FG001|Overall Study|Egg Donor|0|||
27883404|NCT00468481|81404675|FG000|Overall Study|Moved out of area|4|||
27883405|NCT00468481|81404676|FG001|Overall Study|Moved out of area|1|||
27883406|NCT00468481|81404675|FG000|Overall Study|Non-Compliance|5|||
27824549|NCT01190930|81189297|FG002|Maintenance|Refusal|0|||
27824550|NCT01190930|81189298|FG003|Maintenance|Refusal|2|||
27824551|NCT01190930|81189299|FG004|Maintenance|Refusal|0|||
27824552|NCT01190930|81189300|FG005|Maintenance|Refusal|4|||
27824553|NCT01190930|81189301|FG006|Maintenance|Refusal|5|||
27824554|NCT01190930|81189302|FG007|Maintenance|Refusal|17|||
27824555|NCT01190930|81189303|FG008|Maintenance|Refusal|13|||
27824556|NCT01190930|81189304|FG009|Maintenance|Refusal|6|||
27824557|NCT01190930|81189295|FG000|Maintenance|second malignant neoplasm|0|||
27824558|NCT01190930|81189296|FG001|Maintenance|second malignant neoplasm|0|||
27824559|NCT01190930|81189297|FG002|Maintenance|second malignant neoplasm|0|||
27824560|NCT01190930|81189298|FG003|Maintenance|second malignant neoplasm|1|||
27824561|NCT01190930|81189299|FG004|Maintenance|second malignant neoplasm|0|||
27824562|NCT01190930|81189300|FG005|Maintenance|second malignant neoplasm|1|||
27824563|NCT01190930|81189301|FG006|Maintenance|second malignant neoplasm|0|||
27824564|NCT01190930|81189302|FG007|Maintenance|second malignant neoplasm|0|||
27824565|NCT01190930|81189303|FG008|Maintenance|second malignant neoplasm|1|||
27824566|NCT01190930|81189304|FG009|Maintenance|second malignant neoplasm|0|||
27694243|NCT00406653|80716718|FG006|Induction Period|Withdrawal of Consent|0|||
27824567|NCT01190930|81189295|FG000|Maintenance|Inevaluable|0|||
27552576|NCT02670083|80211222|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27824568|NCT01190930|81189296|FG001|Maintenance|Inevaluable|0|||
27824569|NCT01190930|81189297|FG002|Maintenance|Inevaluable|0|||
27824570|NCT01190930|81189298|FG003|Maintenance|Inevaluable|0|||
27824571|NCT01190930|81189299|FG004|Maintenance|Inevaluable|0|||
27883407|NCT00468481|81404676|FG001|Overall Study|Non-Compliance|0|||
27883408|NCT00468481|81404675|FG000|Overall Study|Other|6|||
27883409|NCT00468481|81404676|FG001|Overall Study|Other|0|||
27824572|NCT01190930|81189300|FG005|Maintenance|Inevaluable|1|||
27824573|NCT01190930|81189301|FG006|Maintenance|Inevaluable|1|||
27824574|NCT01190930|81189302|FG007|Maintenance|Inevaluable|1|||
27824575|NCT01190930|81189303|FG008|Maintenance|Inevaluable|0|||
27824576|NCT01190930|81189304|FG009|Maintenance|Inevaluable|0|||
27824577|NCT01190930|81189295|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
27824578|NCT01190930|81189296|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
27824579|NCT01190930|81189297|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
27824580|NCT01190930|81189298|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
27824581|NCT01190930|81189299|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
27824582|NCT01190930|81189300|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
27824583|NCT01190930|81189301|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
27824584|NCT01190930|81189302|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
27824585|NCT01190930|81189303|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
27824586|NCT01190930|81189304|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
27824587|NCT01190930|81189295|FG000|Maintenance|Relapse|0|||
27824588|NCT01190930|81189296|FG001|Maintenance|Relapse|0|||
27824589|NCT01190930|81189297|FG002|Maintenance|Relapse|0|||
27824590|NCT01190930|81189298|FG003|Maintenance|Relapse|2|||
27824591|NCT01190930|81189299|FG004|Maintenance|Relapse|0|||
27824592|NCT01190930|81189300|FG005|Maintenance|Relapse|1|||
27824593|NCT01190930|81189301|FG006|Maintenance|Relapse|6|||
27824594|NCT01190930|81189302|FG007|Maintenance|Relapse|13|||
27824595|NCT01190930|81189303|FG008|Maintenance|Relapse|11|||
27824596|NCT01190930|81189304|FG009|Maintenance|Relapse|11|||
27883410|NCT01081769|81404680|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
27824597|NCT01190930|81189295|FG000|Maintenance|Still on therapy|0|||
27824598|NCT01190930|81189296|FG001|Maintenance|Still on therapy|8|||
27824599|NCT01190930|81189297|FG002|Maintenance|Still on therapy|0|||
27883411|NCT01081769|81404681|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
27883412|NCT01081769|81404680|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
27883413|NCT01081769|81404681|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
27883414|NCT01081769|81404680|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
27883415|NCT01081769|81404681|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
27883416|NCT01081769|81404680|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
27883417|NCT01081769|81404681|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
27883418|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Adverse Event|14|||
27883419|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Adverse Event|11|||
27883420|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Death|1|||
27883421|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Death|1|||
27883422|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
27883423|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
27883424|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
27883425|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
27883426|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Pregnancy|1|||
27883427|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Pregnancy|0|||
27883428|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
27883429|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
27883430|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
27883431|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
27883432|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Other|0|||
27694244|NCT00406653|80716712|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
27694245|NCT00406653|80716713|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
27694246|NCT00406653|80716714|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
27694247|NCT00406653|80716715|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
27883433|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Other|1|||
27883434|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Ineligibility|3|||
27883435|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Ineligibility|4|||
27883436|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
27883437|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
27883438|NCT01081769|81404680|FG000|CORE Intent-To-Treat|Patient Moved|2|||
27883439|NCT01081769|81404681|FG001|CORE Intent-To-Treat|Patient Moved|2|||
27883440|NCT01628198|81404682|FG000|Overall Study|Lost to Follow-up|7|||
27883441|NCT01628198|81404682|FG000|Overall Study|Withdrawal by Subject|10|||
27824600|NCT01190930|81189298|FG003|Maintenance|Still on therapy|29|||
27824601|NCT01190930|81189299|FG004|Maintenance|Still on therapy|0|||
27824602|NCT01190930|81189300|FG005|Maintenance|Still on therapy|0|||
27824603|NCT01190930|81189301|FG006|Maintenance|Still on therapy|0|||
27824604|NCT01190930|81189302|FG007|Maintenance|Still on therapy|0|||
27824605|NCT01190930|81189303|FG008|Maintenance|Still on therapy|0|||
27824606|NCT01190930|81189304|FG009|Maintenance|Still on therapy|0|||
27824607|NCT04567186|81189305|FG000|Period 1|COVID-19 related|1|||
27824608|NCT04567186|81189306|FG001|Period 1|COVID-19 related|0|||
27824609|NCT04567186|81189305|FG000|Period 1|Protocol Violation|0|||
27694248|NCT00406653|80716716|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
27824610|NCT04567186|81189306|FG001|Period 1|Protocol Violation|1|||
27824611|NCT04567186|81189305|FG000|Period 1|Adverse Event|0|||
27824612|NCT04567186|81189306|FG001|Period 1|Adverse Event|2|||
27824613|NCT04567186|81189305|FG000|Period 2|COVID-19 Related|0|||
27824614|NCT04567186|81189306|FG001|Period 2|COVID-19 Related|1|||
27824615|NCT04567186|81189305|FG000|Period 2|Protocol Violation|0|||
27824616|NCT04567186|81189306|FG001|Period 2|Protocol Violation|1|||
27824617|NCT04567186|81189305|FG000|Period 2|Lost to Follow-up|0|||
27824618|NCT04567186|81189306|FG001|Period 2|Lost to Follow-up|1|||
27824619|NCT04567186|81189305|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
27824620|NCT04567186|81189306|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
27824621|NCT00096265|81189307|FG000|Overall Study|Ineligible|1|||
27824622|NCT00096265|81189308|FG001|Overall Study|Ineligible|0|||
27824623|NCT00096265|81189309|FG002|Overall Study|Ineligible|0|||
27824624|NCT02438722|81189313|FG000|Overall Study|Adverse Event|12|||
27824625|NCT02438722|81189314|FG001|Overall Study|Adverse Event|9|||
27824626|NCT02438722|81189313|FG000|Overall Study|Refusal unrelated to AE|2|||
27824627|NCT02438722|81189314|FG001|Overall Study|Refusal unrelated to AE|5|||
27824628|NCT02438722|81189313|FG000|Overall Study|Disease progression/relapse|46|||
27824629|NCT02438722|81189314|FG001|Overall Study|Disease progression/relapse|51|||
27824630|NCT02438722|81189313|FG000|Overall Study|Death|0|||
27824631|NCT02438722|81189314|FG001|Overall Study|Death|3|||
27824632|NCT02438722|81189313|FG000|Overall Study|Physician Decision|2|||
27824633|NCT02438722|81189314|FG001|Overall Study|Physician Decision|2|||
27824634|NCT02438722|81189313|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
27824635|NCT02438722|81189314|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
27824636|NCT02438722|81189313|FG000|Overall Study|Withdrawal by Subject|0|||
27824637|NCT02438722|81189314|FG001|Overall Study|Withdrawal by Subject|1|||
27824638|NCT02438722|81189313|FG000|Overall Study|On protocol treatment|15|||
27824639|NCT02438722|81189314|FG001|Overall Study|On protocol treatment|14|||
27883442|NCT01628198|81404682|FG000|Overall Study|Screen failure|1|||
27883443|NCT00975611|81404685|FG000|Overall Study|Screen Fail|16|||
27883444|NCT00975611|81404685|FG000|Overall Study|Physician Decision|1|||
27883445|NCT02875613|81404686|FG000|Overall Study|Withdrawal by Subject|1|||
27883446|NCT02875613|81404686|FG000|Overall Study|Screen Failure|1|||
27883447|NCT03668119|81404687|FG000|Pre-treatment|Disease Progression|1|||
27883448|NCT03668119|81404688|FG001|Pre-treatment|Disease Progression|0|||
27883449|NCT03668119|81404687|FG000|Treatment|Disease Progression|76|||
27883450|NCT03668119|81404688|FG001|Treatment|Disease Progression|57|||
27883451|NCT03668119|81404687|FG000|Treatment|Study drug toxicity|19|||
27883452|NCT03668119|81404688|FG001|Treatment|Study drug toxicity|1|||
27883453|NCT03668119|81404687|FG000|Treatment|Death|3|||
27883454|NCT03668119|81404688|FG001|Treatment|Death|0|||
27883455|NCT03668119|81404687|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
27883456|NCT03668119|81404688|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
27883457|NCT03668119|81404687|FG000|Treatment|Withdrawal by Subject|1|||
27883458|NCT03668119|81404688|FG001|Treatment|Withdrawal by Subject|1|||
27883459|NCT03668119|81404687|FG000|Treatment|Participant request to discontinue study treatment|3|||
27883460|NCT03668119|81404688|FG001|Treatment|Participant request to discontinue study treatment|1|||
27883461|NCT03668119|81404687|FG000|Treatment|Maximum Clinical Benefit|0|||
27883462|NCT03668119|81404688|FG001|Treatment|Maximum Clinical Benefit|1|||
27883463|NCT03668119|81404687|FG000|Treatment|Participants completed treatment|27|||
27552577|NCT02728076|80211230|FG000|Overall Study|Physician Decision|4|||
27824640|NCT02438722|81189313|FG000|Overall Study|Did not receive protocol treatment|5|||
27883464|NCT03668119|81404688|FG001|Treatment|Participants completed treatment|11|||
27883465|NCT03668119|81404687|FG000|Treatment|Other reasons|2|||
27883466|NCT03668119|81404688|FG001|Treatment|Other reasons|1|||
27883467|NCT03656692|81404689|FG000|Overall Study|Worsening of disease activity|2|||
27883468|NCT03656692|81404689|FG000|Overall Study|Physician Decision|1|||
27883469|NCT00333983|81404692|FG000|Overall Study|Lost to Follow-up|2|||
27883470|NCT00333983|81404693|FG001|Overall Study|Lost to Follow-up|1|||
27883471|NCT00333983|81404694|FG002|Overall Study|Lost to Follow-up|0|||
27883472|NCT00333983|81404692|FG000|Overall Study|Adverse Event|1|||
27883473|NCT00333983|81404693|FG001|Overall Study|Adverse Event|1|||
27883474|NCT00333983|81404694|FG002|Overall Study|Adverse Event|1|||
27883475|NCT00333983|81404692|FG000|Overall Study|Withdrawal by Subject|0|||
27883476|NCT00333983|81404693|FG001|Overall Study|Withdrawal by Subject|3|||
27824641|NCT02438722|81189314|FG001|Overall Study|Did not receive protocol treatment|0|||
27883477|NCT00333983|81404694|FG002|Overall Study|Withdrawal by Subject|1|||
27552578|NCT00553514|80211231|FG000|Overall Study|Protocol deviation|0|||
27824642|NCT00450190|81189316|FG000|Overall Study|Withdrawal by Subject|2|||
27824643|NCT02039908|81189317|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
27824644|NCT02039908|81189318|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
27824645|NCT02039908|81189319|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
27824646|NCT02039908|81189320|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
27824647|NCT02039908|81189317|FG000|Phase 1-Summer|Protocol Violation|6|||
27824648|NCT02039908|81189318|FG001|Phase 1-Summer|Protocol Violation|0|||
27824649|NCT02039908|81189319|FG002|Phase 1-Summer|Protocol Violation|0|||
27824650|NCT02039908|81189320|FG003|Phase 1-Summer|Protocol Violation|0|||
27824651|NCT02039908|81189317|FG000|Phase 2-School Year|Lost to Follow-up|0|||
27824652|NCT02039908|81189318|FG001|Phase 2-School Year|Lost to Follow-up|0|||
27824653|NCT02039908|81189319|FG002|Phase 2-School Year|Lost to Follow-up|1|||
27824654|NCT02039908|81189320|FG003|Phase 2-School Year|Lost to Follow-up|3|||
27824655|NCT02039908|81189317|FG000|Phase 2-School Year|Protocol Violation|0|||
27824656|NCT02039908|81189318|FG001|Phase 2-School Year|Protocol Violation|0|||
27824657|NCT02039908|81189319|FG002|Phase 2-School Year|Protocol Violation|3|||
27824658|NCT02039908|81189320|FG003|Phase 2-School Year|Protocol Violation|0|||
27824659|NCT02039908|81189317|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
27824660|NCT02039908|81189318|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
27824661|NCT02039908|81189319|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
27824662|NCT02039908|81189320|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
27824663|NCT00453362|81189326|FG000|Overall Study|Adverse Event|5|||
27552579|NCT00553514|80211232|FG001|Overall Study|Protocol deviation|0|||
27694249|NCT00406653|80716717|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
27694250|NCT00406653|80716718|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
27694251|NCT00406653|80716712|FG000|Induction Period|Pregnancy|1|||
27694252|NCT00406653|80716713|FG001|Induction Period|Pregnancy|0|||
27694253|NCT00406653|80716714|FG002|Induction Period|Pregnancy|0|||
27694254|NCT00406653|80716715|FG003|Induction Period|Pregnancy|0|||
27694255|NCT00406653|80716716|FG004|Induction Period|Pregnancy|0|||
27694256|NCT00406653|80716717|FG005|Induction Period|Pregnancy|0|||
27694257|NCT00406653|80716718|FG006|Induction Period|Pregnancy|0|||
27694258|NCT00406653|80716712|FG000|Induction Period|Declined participation but followup done|0|||
27694259|NCT00406653|80716713|FG001|Induction Period|Declined participation but followup done|2|||
27694260|NCT00406653|80716714|FG002|Induction Period|Declined participation but followup done|1|||
27694261|NCT00406653|80716715|FG003|Induction Period|Declined participation but followup done|1|||
27694262|NCT00406653|80716716|FG004|Induction Period|Declined participation but followup done|0|||
27694263|NCT00406653|80716717|FG005|Induction Period|Declined participation but followup done|0|||
27824664|NCT00453362|81189326|FG000|Overall Study|Death|7|||
27824665|NCT00453362|81189326|FG000|Overall Study|Physician Decision|2|||
27824666|NCT00453362|81189326|FG000|Overall Study|Withdrawal by Subject|3|||
27824667|NCT00453362|81189326|FG000|Overall Study|Progression of disease|56|||
27824668|NCT00453362|81189326|FG000|Overall Study|Screening Failure|14|||
27824669|NCT04499963|81189329|FG000|Overall Study|Adverse Event|3|||
27824670|NCT04499963|81189330|FG001|Overall Study|Adverse Event|0|||
27824671|NCT04499963|81189329|FG000|Overall Study|Death|3|||
27824672|NCT04499963|81189330|FG001|Overall Study|Death|0|||
27824673|NCT04499963|81189329|FG000|Overall Study|Lack of Efficacy|7|||
27824674|NCT04499963|81189330|FG001|Overall Study|Lack of Efficacy|0|||
27824675|NCT04499963|81189329|FG000|Overall Study|Lost to Follow-up|2|||
27824676|NCT04499963|81189330|FG001|Overall Study|Lost to Follow-up|0|||
27824677|NCT02847650|81189334|FG000|Overall Study|Adverse Event|2|||
27824678|NCT02847650|81189335|FG001|Overall Study|Adverse Event|4|||
27824679|NCT02847650|81189334|FG000|Overall Study|Lost to Follow-up|1|||
27824680|NCT02847650|81189335|FG001|Overall Study|Lost to Follow-up|0|||
27824681|NCT02847650|81189334|FG000|Overall Study|Protocol Violation|0|||
27824682|NCT02847650|81189335|FG001|Overall Study|Protocol Violation|1|||
27824683|NCT02847650|81189334|FG000|Overall Study|Withdrawal by Subject|1|||
27824684|NCT02847650|81189335|FG001|Overall Study|Withdrawal by Subject|1|||
27824685|NCT04089735|81189336|FG000|Overall Study|Adverse Event|1|||
27552580|NCT00553514|80211233|FG002|Overall Study|Protocol deviation|0|||
27552581|NCT00553514|80211234|FG003|Overall Study|Protocol deviation|1|||
27824686|NCT04089735|81189337|FG001|Overall Study|Adverse Event|0|||
27694264|NCT00406653|80716718|FG006|Induction Period|Declined participation but followup done|0|||
27694265|NCT00406653|80716712|FG000|Induction Period|Given prohibited drug|0|||
27824687|NCT04089735|81189338|FG002|Overall Study|Adverse Event|1|||
27824688|NCT04089735|81189339|FG003|Overall Study|Adverse Event|1|||
27824689|NCT04089735|81189340|FG004|Overall Study|Adverse Event|0|||
27552582|NCT00553514|80211235|FG004|Overall Study|Protocol deviation|0|||
27824690|NCT04089735|81189341|FG005|Overall Study|Adverse Event|0|||
27824691|NCT04089735|81189336|FG000|Overall Study|Physician Decision|0|||
27883478|NCT02473250|81404696|FG000|Overall Study|Lost to Follow-up|10|||
27883479|NCT02473250|81404696|FG000|Overall Study|Physician Decision|5|||
27883480|NCT02473250|81404696|FG000|Overall Study|Did not tolerate medication washout|3|||
27883481|NCT02473250|81404696|FG000|Overall Study|Antidepressant effect of divalproex|2|||
27883482|NCT05326529|81404699|FG000|Overall Study|Lack of Efficacy|0|||
27883483|NCT05326529|81404700|FG001|Overall Study|Lack of Efficacy|1|||
27883484|NCT05326529|81404701|FG002|Overall Study|Lack of Efficacy|0|||
27883485|NCT05326529|81404699|FG000|Overall Study|Physician Decision|0|||
27883486|NCT05326529|81404700|FG001|Overall Study|Physician Decision|0|||
27883487|NCT05326529|81404701|FG002|Overall Study|Physician Decision|2|||
27883488|NCT03674112|81404702|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
27883489|NCT03674112|81404703|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
27694266|NCT00406653|80716713|FG001|Induction Period|Given prohibited drug|1|||
27694267|NCT00406653|80716714|FG002|Induction Period|Given prohibited drug|2|||
27694268|NCT00406653|80716715|FG003|Induction Period|Given prohibited drug|0|||
27694269|NCT00406653|80716716|FG004|Induction Period|Given prohibited drug|0|||
27694270|NCT00406653|80716717|FG005|Induction Period|Given prohibited drug|0|||
27694271|NCT00406653|80716718|FG006|Induction Period|Given prohibited drug|0|||
27694272|NCT00406653|80716712|FG000|Induction Period|Incarcerated|0|||
27694273|NCT00406653|80716713|FG001|Induction Period|Incarcerated|0|||
27694274|NCT00406653|80716714|FG002|Induction Period|Incarcerated|1|||
27694275|NCT00406653|80716715|FG003|Induction Period|Incarcerated|0|||
27694276|NCT00406653|80716716|FG004|Induction Period|Incarcerated|0|||
27694277|NCT00406653|80716717|FG005|Induction Period|Incarcerated|0|||
27694278|NCT00406653|80716718|FG006|Induction Period|Incarcerated|0|||
27824692|NCT04089735|81189337|FG001|Overall Study|Physician Decision|3|||
27824693|NCT04089735|81189338|FG002|Overall Study|Physician Decision|0|||
27824694|NCT04089735|81189339|FG003|Overall Study|Physician Decision|0|||
27824695|NCT04089735|81189340|FG004|Overall Study|Physician Decision|0|||
27824696|NCT04089735|81189341|FG005|Overall Study|Physician Decision|0|||
27824697|NCT04089735|81189336|FG000|Overall Study|Withdrawal by Subject|0|||
27824698|NCT04089735|81189337|FG001|Overall Study|Withdrawal by Subject|0|||
27824699|NCT04089735|81189338|FG002|Overall Study|Withdrawal by Subject|1|||
27824700|NCT04089735|81189339|FG003|Overall Study|Withdrawal by Subject|0|||
27824701|NCT04089735|81189340|FG004|Overall Study|Withdrawal by Subject|0|||
27824702|NCT04089735|81189341|FG005|Overall Study|Withdrawal by Subject|0|||
27824703|NCT04089735|81189336|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
27824704|NCT04089735|81189337|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
27824705|NCT04089735|81189338|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
27883490|NCT03674112|81404702|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
27883491|NCT03674112|81404703|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
27883492|NCT03674112|81404702|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
27883493|NCT03674112|81404703|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
27883494|NCT03674112|81404702|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
27883495|NCT03674112|81404703|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
27883496|NCT03674112|81404702|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
27883497|NCT03674112|81404703|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
27883498|NCT03674112|81404702|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
27694279|NCT00406653|80716712|FG000|Induction Period|Patient relocated|0|||
27694280|NCT00406653|80716713|FG001|Induction Period|Patient relocated|0|||
27694281|NCT00406653|80716714|FG002|Induction Period|Patient relocated|1|||
27694282|NCT00406653|80716715|FG003|Induction Period|Patient relocated|0|||
27694283|NCT00406653|80716716|FG004|Induction Period|Patient relocated|0|||
27694284|NCT00406653|80716717|FG005|Induction Period|Patient relocated|0|||
27694285|NCT00406653|80716718|FG006|Induction Period|Patient relocated|0|||
27694286|NCT00406653|80716712|FG000|Maintenance Period|Adverse Event|0|||
27694287|NCT00406653|80716713|FG001|Maintenance Period|Adverse Event|0|||
27694288|NCT00406653|80716714|FG002|Maintenance Period|Adverse Event|0|||
27694289|NCT00406653|80716715|FG003|Maintenance Period|Adverse Event|0|||
27694290|NCT00406653|80716716|FG004|Maintenance Period|Adverse Event|1|||
27694291|NCT00406653|80716717|FG005|Maintenance Period|Adverse Event|1|||
27694292|NCT00406653|80716718|FG006|Maintenance Period|Adverse Event|0|||
27694293|NCT00406653|80716712|FG000|Maintenance Period|Lack of Efficacy|0|||
27694294|NCT00406653|80716713|FG001|Maintenance Period|Lack of Efficacy|0|||
27824706|NCT04089735|81189339|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
27883499|NCT03674112|81404703|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
27883500|NCT03674112|81404702|FG000|Follow-Up Period (≥3 Years)|Death|2|||
27883501|NCT03674112|81404703|FG001|Follow-Up Period (≥3 Years)|Death|0|||
27883502|NCT03674112|81404702|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
27883503|NCT03674112|81404703|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
27883504|NCT03291431|81404704|FG000|Overall Study|Protocol Violation|2|||
27883505|NCT03291431|81404705|FG001|Overall Study|Protocol Violation|1|||
27694295|NCT00406653|80716714|FG002|Maintenance Period|Lack of Efficacy|0|||
27824707|NCT04089735|81189340|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
27824708|NCT04089735|81189341|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
27824709|NCT00316186|81189342|FG000|Overall Study|Adverse Event|6|||
27824710|NCT00316186|81189342|FG000|Overall Study|Disease Progression|4|||
27824711|NCT00316186|81189342|FG000|Overall Study|Lost to Follow-up|1|||
27824712|NCT00316186|81189342|FG000|Overall Study|Other|1|||
27824713|NCT01768858|81189345|FG000|Overall Study|Lost to Follow-up|9|||
27694296|NCT00406653|80716715|FG003|Maintenance Period|Lack of Efficacy|0|||
27694297|NCT00406653|80716716|FG004|Maintenance Period|Lack of Efficacy|20|||
27694298|NCT00406653|80716717|FG005|Maintenance Period|Lack of Efficacy|26|||
27694299|NCT00406653|80716718|FG006|Maintenance Period|Lack of Efficacy|0|||
27824714|NCT01768858|81189345|FG000|Overall Study|Lack of Efficacy|8|||
27824715|NCT01768858|81189345|FG000|Overall Study|Serious Adverse Event|1|||
27883506|NCT03291431|81404704|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
27883507|NCT03291431|81404705|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
27883508|NCT03291431|81404704|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
27883509|NCT03291431|81404705|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
27883510|NCT00644917|81404706|FG000|Overall Study|Withdrawal by Subject|2|||
27883511|NCT01580670|81407946|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
27883512|NCT01580670|81407946|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
27883513|NCT00708214|81407947|FG000|Overall Study|Other Adverse Event|3|||
27883514|NCT00708214|81407948|FG001|Overall Study|Other Adverse Event|6|||
27824716|NCT01768858|81189345|FG000|Overall Study|Participant moved to Germany|1|||
27824717|NCT01768858|81189345|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
27824718|NCT01768858|81189345|FG000|Overall Study|Exanthema|1|||
27824719|NCT01768858|81189345|FG000|Overall Study|Withdrawal by Subject|1|||
27824720|NCT00488774|81189347|FG000|Overall Study|Withdrawal of consent|2|||
27824721|NCT00488774|81189348|FG001|Overall Study|Withdrawal of consent|2|||
27824722|NCT00488774|81189349|FG002|Overall Study|Withdrawal of consent|2|||
27824723|NCT00488774|81189350|FG003|Overall Study|Withdrawal of consent|0|||
27824724|NCT00488774|81189347|FG000|Overall Study|Other|6|||
27824725|NCT00488774|81189348|FG001|Overall Study|Other|3|||
27824726|NCT00488774|81189349|FG002|Overall Study|Other|2|||
27824727|NCT00488774|81189350|FG003|Overall Study|Other|2|||
27824728|NCT00488774|81189347|FG000|Overall Study|Lost to Follow-up|0|||
27824729|NCT00488774|81189348|FG001|Overall Study|Lost to Follow-up|0|||
27824730|NCT00488774|81189349|FG002|Overall Study|Lost to Follow-up|1|||
27824731|NCT00488774|81189350|FG003|Overall Study|Lost to Follow-up|1|||
27824732|NCT00772941|81189351|FG000|Overall Study|CRFs not available|195|||
27824733|NCT00772941|81189351|FG000|Overall Study|Study not completed|16|||
27824734|NCT00772941|81189351|FG000|Overall Study|Missed Visits|374|||
27824735|NCT00772941|81189351|FG000|Overall Study|Poor Compliance|7|||
27824736|NCT00772941|81189351|FG000|Overall Study|GPSP Violation|90|||
27824737|NCT03600376|81189352|FG000|Overall Study|Adverse Event|1|||
27824738|NCT03600376|81189353|FG001|Overall Study|Adverse Event|1|||
27824739|NCT03600376|81189352|FG000|Overall Study|Transferred to other facility|1|||
27824740|NCT03600376|81189353|FG001|Overall Study|Transferred to other facility|0|||
27824741|NCT03600376|81189352|FG000|Overall Study|Investigator Decision|0|||
27824742|NCT03600376|81189353|FG001|Overall Study|Investigator Decision|4|||
27824743|NCT03600376|81189352|FG000|Overall Study|Determined to be ineligible for study|0|||
27824744|NCT03600376|81189353|FG001|Overall Study|Determined to be ineligible for study|1|||
27824745|NCT02159950|81189354|FG000|Overall Study|Adverse Event|0|||
27824746|NCT02159950|81189355|FG001|Overall Study|Adverse Event|1|||
27824747|NCT02159950|81189354|FG000|Overall Study|Progression|0|||
27824748|NCT02159950|81189355|FG001|Overall Study|Progression|1|||
27824749|NCT01629381|81189358|FG000|Overall Study|Withdrawal by Subject|2|||
27824750|NCT01629381|81189359|FG001|Overall Study|Withdrawal by Subject|5|||
27824751|NCT03459807|81189360|FG000|Overall Study|Withdrawal due to transplant|0|||
27824752|NCT03459807|81189361|FG001|Overall Study|Withdrawal due to transplant|1|||
27824753|NCT03161405|81189363|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
27824754|NCT01873586|81189364|FG000|Overall Study|Lost to Follow-up|3|||
27824755|NCT00830206|81189366|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
27824756|NCT00830206|81189367|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
27883515|NCT00708214|81407949|FG002|Overall Study|Other Adverse Event|2|||
27883516|NCT00708214|81407947|FG000|Overall Study|Other|0|||
27552583|NCT00553514|80211231|FG000|Overall Study|Lack of ovarian response|4|||
27824757|NCT01900626|81189377|FG000|Overall Study|study was closed due to low enrollment|1|||
27824758|NCT01900626|81189378|FG001|Overall Study|study was closed due to low enrollment|1|||
27824759|NCT02865122|81189382|FG000|Overall Study|Adverse Event|1|||
27824760|NCT02865122|81189383|FG001|Overall Study|Adverse Event|0|||
27824761|NCT02865122|81189384|FG002|Overall Study|Adverse Event|0|||
27824762|NCT03020641|81189385|FG000|Overall Study|Lost to Follow-up|0|||
27883517|NCT00708214|81407948|FG001|Overall Study|Other|1|||
27824763|NCT03020641|81189386|FG001|Overall Study|Lost to Follow-up|1|||
27824764|NCT03020641|81189385|FG000|Overall Study|Converted to open surgery|2|||
27824765|NCT03020641|81189386|FG001|Overall Study|Converted to open surgery|1|||
27824766|NCT03020641|81189385|FG000|Overall Study|for surgery not performed|0|||
27824767|NCT03020641|81189386|FG001|Overall Study|for surgery not performed|1|||
27824768|NCT04405570|81189387|FG000|Overall Study|Adverse Event|0|||
27824769|NCT04405570|81189388|FG001|Overall Study|Adverse Event|1|||
27824770|NCT04405570|81189389|FG002|Overall Study|Adverse Event|1|||
27824771|NCT04405570|81189390|FG003|Overall Study|Adverse Event|1|||
27824772|NCT04405570|81189387|FG000|Overall Study|Lost to Follow-up|0|||
27824773|NCT04405570|81189388|FG001|Overall Study|Lost to Follow-up|1|||
27824774|NCT04405570|81189389|FG002|Overall Study|Lost to Follow-up|0|||
27824775|NCT04405570|81189390|FG003|Overall Study|Lost to Follow-up|0|||
27824776|NCT04405570|81189387|FG000|Overall Study|Physician Decision|0|||
27824777|NCT04405570|81189388|FG001|Overall Study|Physician Decision|0|||
27824778|NCT04405570|81189389|FG002|Overall Study|Physician Decision|1|||
27824779|NCT04405570|81189390|FG003|Overall Study|Physician Decision|0|||
27552584|NCT00553514|80211232|FG001|Overall Study|Lack of ovarian response|5|||
27824780|NCT04405570|81189387|FG000|Overall Study|Withdrawal by Subject|0|||
27824781|NCT04405570|81189388|FG001|Overall Study|Withdrawal by Subject|1|||
27824782|NCT04405570|81189389|FG002|Overall Study|Withdrawal by Subject|1|||
27824783|NCT04405570|81189390|FG003|Overall Study|Withdrawal by Subject|0|||
27824784|NCT04405570|81189387|FG000|Overall Study|Randomized not dosed|0|||
27552585|NCT00553514|80211233|FG002|Overall Study|Lack of ovarian response|5|||
27883518|NCT00708214|81407949|FG002|Overall Study|Other|1|||
27552586|NCT00553514|80211234|FG003|Overall Study|Lack of ovarian response|5|||
27824785|NCT04405570|81189388|FG001|Overall Study|Randomized not dosed|2|||
27883519|NCT00708214|81407947|FG000|Overall Study|Progressive Disease|4|||
27552587|NCT00553514|80211235|FG004|Overall Study|Lack of ovarian response|6|||
27824786|NCT04405570|81189389|FG002|Overall Study|Randomized not dosed|0|||
27824787|NCT04405570|81189390|FG003|Overall Study|Randomized not dosed|0|||
27824788|NCT02196675|81189391|FG000|Overall Study|Withdrawal by Subject|1|||
27824789|NCT02196675|81189392|FG001|Overall Study|Withdrawal by Subject|0|||
27694300|NCT00406653|80716712|FG000|Maintenance Period|Lost to Follow-up|0|||
27824790|NCT02196675|81189393|FG002|Overall Study|Withdrawal by Subject|0|||
27824791|NCT02196675|81189391|FG000|Overall Study|Intra-operative surgical exclusion|1|||
27824792|NCT02196675|81189392|FG001|Overall Study|Intra-operative surgical exclusion|1|||
27824793|NCT02196675|81189393|FG002|Overall Study|Intra-operative surgical exclusion|0|||
27824794|NCT02196675|81189391|FG000|Overall Study|Protocol Violation|0|||
27824795|NCT02196675|81189392|FG001|Overall Study|Protocol Violation|1|||
27824796|NCT02196675|81189393|FG002|Overall Study|Protocol Violation|0|||
27824797|NCT02196675|81189391|FG000|Overall Study|Death|0|||
27824798|NCT02196675|81189392|FG001|Overall Study|Death|0|||
27824799|NCT02196675|81189393|FG002|Overall Study|Death|1|||
27824800|NCT00420238|81189394|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
27824801|NCT00420238|81189395|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
27824802|NCT00420238|81189394|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
27824803|NCT00420238|81189395|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
27824804|NCT00420238|81189394|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
27824805|NCT00420238|81189395|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
27824806|NCT00420238|81189394|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
27694301|NCT00406653|80716713|FG001|Maintenance Period|Lost to Follow-up|0|||
27824807|NCT00420238|81189395|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
27883520|NCT00708214|81407948|FG001|Overall Study|Progressive Disease|6|||
27883521|NCT00708214|81407949|FG002|Overall Study|Progressive Disease|5|||
27883522|NCT01295671|81407950|FG000|Overall Study|Lost to Follow-up|4|||
27883523|NCT01295671|81407951|FG001|Overall Study|Lost to Follow-up|6|||
27883524|NCT01295671|81407952|FG002|Overall Study|Lost to Follow-up|3|||
27883525|NCT01295671|81407950|FG000|Overall Study|Withdrawal by Subject|3|||
27883526|NCT01295671|81407951|FG001|Overall Study|Withdrawal by Subject|1|||
27883527|NCT01295671|81407952|FG002|Overall Study|Withdrawal by Subject|0|||
27883528|NCT03055338|81407953|FG000|Overall Study|Lost to Follow-up|9|||
27883529|NCT03055338|81407954|FG001|Overall Study|Lost to Follow-up|2|||
27883530|NCT03055338|81407955|FG002|Overall Study|Lost to Follow-up|3|||
27883531|NCT03055338|81407953|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
27883532|NCT03055338|81407954|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
27883533|NCT03055338|81407955|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
27883534|NCT03055338|81407953|FG000|Overall Study|Physician Decision|0|||
27883535|NCT03055338|81407954|FG001|Overall Study|Physician Decision|0|||
27883536|NCT03055338|81407955|FG002|Overall Study|Physician Decision|2|||
27883537|NCT03055338|81407953|FG000|Overall Study|Withdrawal by Subject|9|||
27883538|NCT03055338|81407954|FG001|Overall Study|Withdrawal by Subject|8|||
27883539|NCT03055338|81407955|FG002|Overall Study|Withdrawal by Subject|7|||
27883540|NCT03412734|81407956|FG000|Overall Study|Incorrect labeling of samples|2|||
27883541|NCT03412734|81407957|FG001|Overall Study|Incorrect labeling of samples|0|||
27883542|NCT03412734|81407956|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
27883543|NCT03412734|81407957|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
27883544|NCT00994461|81407958|FG000|Overall Study|Adverse Event|2|||
27883545|NCT00994461|81407959|FG001|Overall Study|Adverse Event|1|||
27883546|NCT00994461|81407960|FG002|Overall Study|Adverse Event|0|||
27883547|NCT00485732|81407961|FG000|Overall Study|Protocol Violation|1|||
27883548|NCT00485732|81407962|FG001|Overall Study|Protocol Violation|3|||
27883549|NCT00485732|81407961|FG000|Overall Study|Withdrawal by Subject|5|||
27883550|NCT00485732|81407962|FG001|Overall Study|Withdrawal by Subject|4|||
27883551|NCT00485732|81407961|FG000|Overall Study|Lost to Follow-up|2|||
27883552|NCT00485732|81407962|FG001|Overall Study|Lost to Follow-up|2|||
27883553|NCT00178685|81407967|FG000|Overall Study|Death|3|||
27883554|NCT00178685|81407968|FG001|Overall Study|Death|3|||
27824808|NCT00420238|81189394|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
27824809|NCT00420238|81189395|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
27824810|NCT00420238|81189394|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
27883555|NCT00178685|81407969|FG002|Overall Study|Death|6|||
27883556|NCT00178685|81407967|FG000|Overall Study|Lost to Follow-up|100|||
27883557|NCT00178685|81407968|FG001|Overall Study|Lost to Follow-up|187|||
27883558|NCT00178685|81407969|FG002|Overall Study|Lost to Follow-up|183|||
27883559|NCT00178685|81407967|FG000|Overall Study|Withdrawal by Subject|8|||
27883560|NCT00178685|81407968|FG001|Overall Study|Withdrawal by Subject|14|||
27883561|NCT00178685|81407969|FG002|Overall Study|Withdrawal by Subject|7|||
27883562|NCT01186692|81407970|FG000|Overall Study|Not Catheterized|11|||
27883563|NCT01186692|81407970|FG000|Overall Study|Futher testing contraindicated implant|19|||
27883564|NCT01186692|81407970|FG000|Overall Study|Adverse Event|2|||
27883565|NCT01732458|81407974|FG000|Overall Study|Lost to Follow-up|0|||
27883566|NCT01732458|81407975|FG001|Overall Study|Lost to Follow-up|2|||
27883567|NCT01732458|81407976|FG002|Overall Study|Lost to Follow-up|0|||
27883568|NCT01732458|81407977|FG003|Overall Study|Lost to Follow-up|0|||
27883569|NCT01732458|81407974|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27883570|NCT01732458|81407975|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27883571|NCT01732458|81407976|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27883572|NCT01732458|81407977|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27883573|NCT01732458|81407974|FG000|Overall Study|Physician Decision|1|||
27883574|NCT01732458|81407975|FG001|Overall Study|Physician Decision|2|||
27883575|NCT01732458|81407976|FG002|Overall Study|Physician Decision|2|||
27883576|NCT01732458|81407977|FG003|Overall Study|Physician Decision|0|||
27883577|NCT01732458|81407974|FG000|Overall Study|Protocol Violation|2|||
27883578|NCT01732458|81407975|FG001|Overall Study|Protocol Violation|0|||
27883579|NCT01732458|81407976|FG002|Overall Study|Protocol Violation|0|||
27883580|NCT01732458|81407977|FG003|Overall Study|Protocol Violation|2|||
27883581|NCT01732458|81407974|FG000|Overall Study|Screen Failure|0|||
27883582|NCT01732458|81407975|FG001|Overall Study|Screen Failure|1|||
27883583|NCT01732458|81407976|FG002|Overall Study|Screen Failure|0|||
27883584|NCT01732458|81407977|FG003|Overall Study|Screen Failure|0|||
27883585|NCT00782795|81407978|FG000|Overall Study|Withdrawal by Subject|1|||
27883586|NCT00782795|81407979|FG001|Overall Study|Withdrawal by Subject|2|||
27883587|NCT04606394|81407980|FG000|Overall Study|Withdrawal by Subject|3|||
27883588|NCT04606394|81407980|FG000|Overall Study|Exclusion criteria screen failure|12|||
27883589|NCT01681212|81407981|FG000|Overall Study|No longer met study criteria|5|||
27883590|NCT01681212|81407981|FG000|Overall Study|Administrative reason by sponsor|1|||
27883591|NCT03878446|81407985|FG000|Overall Study|Withdrawn by parent or guardian|1|||
27883592|NCT03878446|81407986|FG001|Overall Study|Withdrawn by parent or guardian|0|||
27883593|NCT03878446|81407987|FG002|Overall Study|Withdrawn by parent or guardian|0|||
27883594|NCT03878446|81407988|FG003|Overall Study|Withdrawn by parent or guardian|0|||
27883595|NCT03878446|81407989|FG004|Overall Study|Withdrawn by parent or guardian|0|||
27883596|NCT00356122|81408003|FG000|TREATMENT|Lack of Efficacy|26|||
27883597|NCT00356122|81408003|FG000|TREATMENT|Adverse Event|10|||
27883598|NCT00356122|81408003|FG000|TREATMENT|Subject's request|4|||
27883599|NCT00356122|81408003|FG000|TREATMENT|Other|4|||
27883600|NCT00356122|81408003|FG000|TREATMENT|Did not receive study medication|1|||
27883601|NCT00356122|81408003|FG000|FOLLOW-UP|Death|37|||
27883602|NCT00356122|81408003|FG000|FOLLOW-UP|Lost to Follow-up|2|||
27883603|NCT00356122|81408003|FG000|FOLLOW-UP|Other|2|||
27883604|NCT01876810|81408004|FG000|Overall Study|Physician Decision|0|||
27883605|NCT01876810|81408005|FG001|Overall Study|Physician Decision|1|||
27883606|NCT01582854|81408006|FG000|Overall Study|Death|8|||
27883607|NCT01582854|81408007|FG001|Overall Study|Death|5|||
27883608|NCT01582854|81408006|FG000|Overall Study|Adverse Event|2|||
27883609|NCT01582854|81408007|FG001|Overall Study|Adverse Event|3|||
27883610|NCT01582854|81408006|FG000|Overall Study|Withdrawal by Participant|8|||
27883611|NCT01582854|81408007|FG001|Overall Study|Withdrawal by Participant|11|||
27883612|NCT01582854|81408006|FG000|Overall Study|Lost to Follow-up|1|||
27883613|NCT01582854|81408007|FG001|Overall Study|Lost to Follow-up|2|||
27883614|NCT01582854|81408006|FG000|Overall Study|Physician Decision|0|||
27883615|NCT01582854|81408007|FG001|Overall Study|Physician Decision|1|||
27883616|NCT01582854|81408006|FG000|Overall Study|Recurrent Stroke|13|||
27883617|NCT01582854|81408007|FG001|Overall Study|Recurrent Stroke|8|||
27883618|NCT01582854|81408006|FG000|Overall Study|Disallowed Concomitant Medication|3|||
27883619|NCT01582854|81408007|FG001|Overall Study|Disallowed Concomitant Medication|2|||
27883620|NCT01582854|81408006|FG000|Overall Study|Carotid or Neurosurgery|0|||
27883621|NCT01582854|81408007|FG001|Overall Study|Carotid or Neurosurgery|1|||
27883622|NCT01582854|81408006|FG000|Overall Study|General Anaesthesia|0|||
27883623|NCT01582854|81408007|FG001|Overall Study|General Anaesthesia|1|||
27883624|NCT01582854|81408006|FG000|Overall Study|Other Miscellaneous Reason|1|||
27883625|NCT01582854|81408007|FG001|Overall Study|Other Miscellaneous Reason|0|||
27883626|NCT02737930|81408010|FG000|Overall Study|Withdrawal by Subject|0|||
27883627|NCT02737930|81408011|FG001|Overall Study|Withdrawal by Subject|1|||
27883628|NCT03003494|81408016|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
27883629|NCT00984568|81408017|FG000|Overall Study|Withdrawal by Subject|1|||
27883630|NCT00984568|81408018|FG001|Overall Study|Withdrawal by Subject|2|||
27883631|NCT00984568|81408017|FG000|Overall Study|Lack of Efficacy|2|||
27883632|NCT00984568|81408018|FG001|Overall Study|Lack of Efficacy|0|||
27883633|NCT00984568|81408017|FG000|Overall Study|Adverse Event|2|||
27883634|NCT00984568|81408018|FG001|Overall Study|Adverse Event|0|||
27883635|NCT00984568|81408017|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
27552588|NCT00553514|80211231|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
27552589|NCT00553514|80211232|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27552590|NCT00553514|80211233|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27552591|NCT00553514|80211234|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27552592|NCT00553514|80211235|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27552593|NCT00553514|80211231|FG000|Overall Study|Risk of multiple pregnancy|0|||
27552594|NCT00553514|80211232|FG001|Overall Study|Risk of multiple pregnancy|2|||
27552595|NCT00553514|80211233|FG002|Overall Study|Risk of multiple pregnancy|0|||
27552596|NCT00553514|80211234|FG003|Overall Study|Risk of multiple pregnancy|1|||
27552597|NCT00553514|80211235|FG004|Overall Study|Risk of multiple pregnancy|0|||
27552598|NCT00553514|80211231|FG000|Overall Study|Other|1|||
27552599|NCT00553514|80211232|FG001|Overall Study|Other|1|||
27552600|NCT00553514|80211233|FG002|Overall Study|Other|0|||
27552601|NCT00553514|80211234|FG003|Overall Study|Other|0|||
27552602|NCT00553514|80211235|FG004|Overall Study|Other|1|||
27552603|NCT02289898|80211236|FG000|Overall Study|Death|5|||
27552604|NCT02289898|80211237|FG001|Overall Study|Death|4|||
27552605|NCT02289898|80211238|FG002|Overall Study|Death|3|||
27552606|NCT02289898|80211236|FG000|Overall Study|Physician Decision|2|||
27552607|NCT02289898|80211237|FG001|Overall Study|Physician Decision|5|||
27552608|NCT02289898|80211238|FG002|Overall Study|Physician Decision|2|||
27552609|NCT02289898|80211236|FG000|Overall Study|Withdrawal by Subject|0|||
27552610|NCT02289898|80211237|FG001|Overall Study|Withdrawal by Subject|4|||
27552611|NCT02289898|80211238|FG002|Overall Study|Withdrawal by Subject|1|||
27552612|NCT02289898|80211236|FG000|Overall Study|Adverse Event|3|||
27552613|NCT02289898|80211237|FG001|Overall Study|Adverse Event|5|||
27552614|NCT02289898|80211238|FG002|Overall Study|Adverse Event|5|||
27552615|NCT02289898|80211236|FG000|Overall Study|Disease progression|34|||
27552616|NCT02289898|80211237|FG001|Overall Study|Disease progression|28|||
27552617|NCT02289898|80211238|FG002|Overall Study|Disease progression|34|||
27552618|NCT02289898|80211236|FG000|Overall Study|Use of another anticancer therapy|0|||
27552619|NCT02289898|80211237|FG001|Overall Study|Use of another anticancer therapy|0|||
27552620|NCT02289898|80211238|FG002|Overall Study|Use of another anticancer therapy|1|||
27552621|NCT02289898|80211236|FG000|Overall Study|Other|8|||
27552622|NCT02289898|80211237|FG001|Overall Study|Other|7|||
27552623|NCT02289898|80211238|FG002|Overall Study|Other|10|||
27552624|NCT00911820|80211241|FG000|Overall Study|RECIST progression|12|||
27552625|NCT00911820|80211242|FG001|Overall Study|RECIST progression|8|||
27552626|NCT00911820|80211241|FG000|Overall Study|Adverse Event|8|||
27552627|NCT00911820|80211242|FG001|Overall Study|Adverse Event|8|||
27552628|NCT00911820|80211241|FG000|Overall Study|Clinical Progression|7|||
27552629|NCT00911820|80211242|FG001|Overall Study|Clinical Progression|5|||
27824811|NCT00420238|81189395|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
27824812|NCT03912337|81189396|FG000|Overall Study|Withdrawal of Consent From Study|1|||
27824813|NCT03912337|81189397|FG001|Overall Study|Withdrawal of Consent From Study|0|||
27824814|NCT03912337|81189396|FG000|Overall Study|Lost to Follow-up|1|||
27824815|NCT03912337|81189397|FG001|Overall Study|Lost to Follow-up|1|||
27824816|NCT00319735|81192327|FG000|Overall Study|Death|2|||
27824817|NCT01204294|81192332|FG000|Overall Study|Adverse Event|2|||
27824818|NCT01204294|81192333|FG001|Overall Study|Adverse Event|6|||
27824819|NCT01204294|81192334|FG002|Overall Study|Adverse Event|0|||
27552630|NCT00911820|80211241|FG000|Overall Study|Physician Decision|5|||
27552631|NCT00911820|80211242|FG001|Overall Study|Physician Decision|9|||
27824820|NCT01204294|81192335|FG003|Overall Study|Adverse Event|7|||
27824821|NCT01204294|81192336|FG004|Overall Study|Adverse Event|1|||
27552632|NCT00911820|80211241|FG000|Overall Study|Decline in Performance Status|4|||
27824822|NCT01204294|81192337|FG005|Overall Study|Adverse Event|4|||
27824823|NCT01204294|81192338|FG006|Overall Study|Adverse Event|0|||
27552633|NCT00911820|80211242|FG001|Overall Study|Decline in Performance Status|2|||
27552634|NCT00911820|80211241|FG000|Overall Study|Withdrawal by Subject|3|||
27552635|NCT00911820|80211242|FG001|Overall Study|Withdrawal by Subject|4|||
27552636|NCT00911820|80211241|FG000|Overall Study|Death|1|||
27552637|NCT00911820|80211242|FG001|Overall Study|Death|2|||
27824824|NCT01204294|81192332|FG000|Overall Study|Protocol Violation|1|||
27824825|NCT01204294|81192333|FG001|Overall Study|Protocol Violation|0|||
27552638|NCT00911820|80211241|FG000|Overall Study|Pursue surgery|1|||
27552639|NCT00911820|80211242|FG001|Overall Study|Pursue surgery|1|||
27552640|NCT00911820|80211241|FG000|Overall Study|Pursue Radiation|1|||
27552641|NCT00911820|80211242|FG001|Overall Study|Pursue Radiation|0|||
27824826|NCT01204294|81192334|FG002|Overall Study|Protocol Violation|2|||
27552642|NCT00911820|80211241|FG000|Overall Study|Still on Therapy|2|||
27552643|NCT00911820|80211242|FG001|Overall Study|Still on Therapy|2|||
27552644|NCT00911820|80211241|FG000|Overall Study|Pathology Not Confirmed|1|||
27552645|NCT00911820|80211242|FG001|Overall Study|Pathology Not Confirmed|0|||
27552646|NCT00911820|80211241|FG000|Overall Study|Withdraw before Receive Treatment|0|||
27552647|NCT00911820|80211242|FG001|Overall Study|Withdraw before Receive Treatment|2|||
27552648|NCT03965962|80211243|FG000|Overall Study|Adverse Event|1|||
27552649|NCT03965962|80211244|FG001|Overall Study|Adverse Event|0|||
27552650|NCT03965962|80211245|FG002|Overall Study|Adverse Event|0|||
27552651|NCT03965962|80211246|FG003|Overall Study|Adverse Event|0|||
27552652|NCT03965962|80211243|FG000|Overall Study|Protocol Violation|21|||
27552653|NCT03965962|80211244|FG001|Overall Study|Protocol Violation|4|||
27552654|NCT03965962|80211245|FG002|Overall Study|Protocol Violation|10|||
27552655|NCT03965962|80211246|FG003|Overall Study|Protocol Violation|5|||
27552656|NCT03965962|80211243|FG000|Overall Study|Lost to Follow-up|0|||
27552657|NCT03965962|80211244|FG001|Overall Study|Lost to Follow-up|1|||
27552658|NCT03965962|80211245|FG002|Overall Study|Lost to Follow-up|0|||
27552659|NCT03965962|80211246|FG003|Overall Study|Lost to Follow-up|0|||
27552660|NCT03965962|80211243|FG000|Overall Study|Withdrawal by Subject|3|||
27552661|NCT03965962|80211244|FG001|Overall Study|Withdrawal by Subject|0|||
27552662|NCT03965962|80211245|FG002|Overall Study|Withdrawal by Subject|0|||
27552663|NCT03965962|80211246|FG003|Overall Study|Withdrawal by Subject|1|||
27552664|NCT02846779|80211250|FG000|Overall Study|Lost Enrollment|83|||
27552665|NCT02846779|80211251|FG001|Overall Study|Lost Enrollment|82|||
27552666|NCT02846779|80211252|FG002|Overall Study|Lost Enrollment|86|||
27552667|NCT02846779|80211250|FG000|Overall Study|Less than 31 days of follow-up|56|||
27552668|NCT02846779|80211251|FG001|Overall Study|Less than 31 days of follow-up|45|||
27552669|NCT02846779|80211252|FG002|Overall Study|Less than 31 days of follow-up|52|||
27552670|NCT02782780|80211254|FG000|Overall Study|dropped out after randomization.|7|||
27552671|NCT02782780|80211255|FG001|Overall Study|dropped out after randomization.|5|||
27552672|NCT02782780|80211254|FG000|Overall Study|Protocol Violation|0|||
27552673|NCT02782780|80211255|FG001|Overall Study|Protocol Violation|2|||
27552674|NCT01442493|80211259|FG000|Overall Study|withdrawn from study|3|||
27552675|NCT01442493|80211260|FG001|Overall Study|withdrawn from study|2|||
27824827|NCT01204294|81192335|FG003|Overall Study|Protocol Violation|1|||
27552676|NCT02239978|80211261|FG000|Overall Study|Withdrawal by Subject|2|||
27552677|NCT02239978|80211262|FG001|Overall Study|Withdrawal by Subject|0|||
27552678|NCT00684307|80211264|FG000|Overall Study|Adverse Event|11|||
27552679|NCT00684307|80211265|FG001|Overall Study|Adverse Event|6|||
27552680|NCT00684307|80211266|FG002|Overall Study|Adverse Event|15|||
27552681|NCT00684307|80211267|FG003|Overall Study|Adverse Event|16|||
27552682|NCT00684307|80211268|FG004|Overall Study|Adverse Event|8|||
27552683|NCT00684307|80211264|FG000|Overall Study|Development of increasing Liver Function|0|||
27824828|NCT01204294|81192336|FG004|Overall Study|Protocol Violation|0|||
27824829|NCT01204294|81192337|FG005|Overall Study|Protocol Violation|0|||
27824830|NCT01204294|81192338|FG006|Overall Study|Protocol Violation|0|||
27824831|NCT01204294|81192332|FG000|Overall Study|Withdrawal by Subject|0|||
27824832|NCT01204294|81192333|FG001|Overall Study|Withdrawal by Subject|2|||
27824833|NCT01204294|81192334|FG002|Overall Study|Withdrawal by Subject|2|||
27824834|NCT01204294|81192335|FG003|Overall Study|Withdrawal by Subject|1|||
27824835|NCT01204294|81192336|FG004|Overall Study|Withdrawal by Subject|1|||
27824836|NCT01204294|81192337|FG005|Overall Study|Withdrawal by Subject|1|||
27552684|NCT00684307|80211265|FG001|Overall Study|Development of increasing Liver Function|2|||
27552685|NCT00684307|80211266|FG002|Overall Study|Development of increasing Liver Function|0|||
27552686|NCT00684307|80211267|FG003|Overall Study|Development of increasing Liver Function|1|||
27552687|NCT00684307|80211268|FG004|Overall Study|Development of increasing Liver Function|0|||
27552688|NCT00684307|80211264|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
27552689|NCT00684307|80211265|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
27552690|NCT00684307|80211266|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
27552691|NCT00684307|80211267|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
27552692|NCT00684307|80211268|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
27824837|NCT01204294|81192338|FG006|Overall Study|Withdrawal by Subject|2|||
27824838|NCT01204294|81192332|FG000|Overall Study|Lack of Efficacy|0|||
27824839|NCT01204294|81192333|FG001|Overall Study|Lack of Efficacy|0|||
27824840|NCT01204294|81192334|FG002|Overall Study|Lack of Efficacy|0|||
27824841|NCT01204294|81192335|FG003|Overall Study|Lack of Efficacy|2|||
27824842|NCT01204294|81192336|FG004|Overall Study|Lack of Efficacy|0|||
27824843|NCT01204294|81192337|FG005|Overall Study|Lack of Efficacy|0|||
27824844|NCT01204294|81192338|FG006|Overall Study|Lack of Efficacy|0|||
27824845|NCT01204294|81192332|FG000|Overall Study|Other (house moving)|0|||
27824846|NCT01204294|81192333|FG001|Overall Study|Other (house moving)|0|||
27824847|NCT01204294|81192334|FG002|Overall Study|Other (house moving)|1|||
27824848|NCT01204294|81192335|FG003|Overall Study|Other (house moving)|0|||
27824849|NCT01204294|81192336|FG004|Overall Study|Other (house moving)|0|||
27824850|NCT01204294|81192337|FG005|Overall Study|Other (house moving)|0|||
27824851|NCT01204294|81192338|FG006|Overall Study|Other (house moving)|0|||
27824852|NCT01353664|81192339|FG000|Overall Study|Other|3|||
27824853|NCT01353664|81192339|FG000|Overall Study|Disease Progression|16|||
27824854|NCT03620747|81192340|FG000|Overall Study|Participant decision|7|||
27824855|NCT03620747|81192340|FG000|Overall Study|Adverse Event|6|||
27824856|NCT03620747|81192340|FG000|Overall Study|Lack of Efficacy|1|||
27824857|NCT03620747|81192340|FG000|Overall Study|Poor compliance to protocol|2|||
27824858|NCT03620747|81192340|FG000|Overall Study|Other-unspecified|3|||
27824859|NCT01723397|81192341|FG000|Study Period 1|Protocol Violation|0|||
27824860|NCT01723397|81192342|FG001|Study Period 1|Protocol Violation|1|||
27824861|NCT01723397|81192341|FG000|Study Period 2|Protocol Violation|0|||
27824862|NCT01723397|81192342|FG001|Study Period 2|Protocol Violation|1|||
27824863|NCT01294917|81192343|FG000|Overall Study|Relocation|5|||
27883636|NCT00984568|81408018|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
27824864|NCT01294917|81192343|FG000|Overall Study|Inconvenience|1|||
27824865|NCT01518972|81192349|FG000|Overall Study|Lost to Follow-up|2|||
27824866|NCT01518972|81192350|FG001|Overall Study|Lost to Follow-up|1|||
27824867|NCT01518972|81192349|FG000|Overall Study|Withdrawal by Subject|1|||
27824868|NCT01518972|81192350|FG001|Overall Study|Withdrawal by Subject|0|||
27824869|NCT01518972|81192349|FG000|Overall Study|Moved from area|1|||
27824870|NCT01518972|81192350|FG001|Overall Study|Moved from area|0|||
27824871|NCT01518972|81192349|FG000|Overall Study|Transportation problems|1|||
27824872|NCT01518972|81192350|FG001|Overall Study|Transportation problems|0|||
27824873|NCT01518972|81192349|FG000|Overall Study|Exclusionary medical condition|1|||
27824874|NCT01518972|81192350|FG001|Overall Study|Exclusionary medical condition|0|||
27824875|NCT01518972|81192349|FG000|Overall Study|Missed safety visits|0|||
27824876|NCT01518972|81192350|FG001|Overall Study|Missed safety visits|1|||
27824877|NCT01518972|81192349|FG000|Overall Study|Exclusionary medication|0|||
27824878|NCT01518972|81192350|FG001|Overall Study|Exclusionary medication|1|||
27824879|NCT01518972|81192349|FG000|Overall Study|Declined medication starting on day 12|0|||
27883637|NCT00984568|81408017|FG000|Overall Study|Lost to Follow-up|0|||
27824880|NCT01518972|81192350|FG001|Overall Study|Declined medication starting on day 12|1|||
27883638|NCT00984568|81408018|FG001|Overall Study|Lost to Follow-up|1|||
27883639|NCT00984568|81408017|FG000|Overall Study|Opportunistic Infection|1|||
27883640|NCT00984568|81408018|FG001|Overall Study|Opportunistic Infection|0|||
27883641|NCT00984568|81408017|FG000|Overall Study|Unknown Reason|1|||
27883642|NCT00984568|81408018|FG001|Overall Study|Unknown Reason|3|||
27883643|NCT02285166|81408019|FG000|Overall Study|Case Report Forms Uncollected|564|||
27883644|NCT02285166|81408019|FG000|Overall Study|Protocol Deviation|402|||
27883645|NCT04134767|81408020|FG000|Overall Study|Death|0|||
27883646|NCT04134767|81408021|FG001|Overall Study|Death|1|||
27883647|NCT04134767|81408020|FG000|Overall Study|Removed for harassing staff|0|||
27883648|NCT04134767|81408021|FG001|Overall Study|Removed for harassing staff|1|||
27883649|NCT04134767|81408020|FG000|Overall Study|Lost to Follow-up|44|||
27883650|NCT04134767|81408021|FG001|Overall Study|Lost to Follow-up|40|||
27883651|NCT01682226|81408022|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
27883652|NCT01682226|81408022|FG000|Overall Study|Participants did not receive treatment|2|||
27883653|NCT01682226|81408022|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
27883654|NCT00458536|81408023|FG000|Overall Study|Disease progression prior to treatment|7|||
27883655|NCT00458536|81408023|FG000|Overall Study|Unable to make vaccine|3|||
27824881|NCT03707912|81192352|FG000|Overall Study|Violation of inclusion criteria|1|||
27824882|NCT03707912|81192353|FG001|Overall Study|Violation of inclusion criteria|0|||
27824883|NCT02289963|81192354|FG000|Overall Study|Adverse Event|1|||
27824884|NCT02289963|81192355|FG001|Overall Study|Adverse Event|2|||
27883656|NCT00458536|81408023|FG000|Overall Study|No measurable disease after surgery|2|||
27883657|NCT00458536|81408023|FG000|Overall Study|Did not have renal cell carcinoma|2|||
27824885|NCT02289963|81192354|FG000|Overall Study|Poor compliance to protocol|1|||
27824886|NCT02289963|81192355|FG001|Overall Study|Poor compliance to protocol|0|||
27824887|NCT02289963|81192354|FG000|Overall Study|Withdrawal by Subject|1|||
27824888|NCT02289963|81192355|FG001|Overall Study|Withdrawal by Subject|0|||
27552693|NCT00684307|80211264|FG000|Overall Study|Incorrect enrolment or randomization|4|||
27552694|NCT00684307|80211265|FG001|Overall Study|Incorrect enrolment or randomization|0|||
27552695|NCT00684307|80211266|FG002|Overall Study|Incorrect enrolment or randomization|0|||
27552696|NCT00684307|80211267|FG003|Overall Study|Incorrect enrolment or randomization|0|||
27552697|NCT00684307|80211268|FG004|Overall Study|Incorrect enrolment or randomization|0|||
27694302|NCT00406653|80716714|FG002|Maintenance Period|Lost to Follow-up|0|||
27552698|NCT00684307|80211264|FG000|Overall Study|Interupted IP for more than 7 days|0|||
27552699|NCT00684307|80211265|FG001|Overall Study|Interupted IP for more than 7 days|4|||
27552700|NCT00684307|80211266|FG002|Overall Study|Interupted IP for more than 7 days|1|||
27552701|NCT00684307|80211267|FG003|Overall Study|Interupted IP for more than 7 days|3|||
27552702|NCT00684307|80211268|FG004|Overall Study|Interupted IP for more than 7 days|3|||
27552703|NCT00684307|80211264|FG000|Overall Study|Severe non compliance to protocol|1|||
27552704|NCT00684307|80211265|FG001|Overall Study|Severe non compliance to protocol|0|||
27552705|NCT00684307|80211266|FG002|Overall Study|Severe non compliance to protocol|0|||
27552706|NCT00684307|80211267|FG003|Overall Study|Severe non compliance to protocol|1|||
27552707|NCT00684307|80211268|FG004|Overall Study|Severe non compliance to protocol|2|||
27552708|NCT00684307|80211264|FG000|Overall Study|Participant not willing to continue|7|||
27552709|NCT00684307|80211265|FG001|Overall Study|Participant not willing to continue|10|||
27552710|NCT00684307|80211266|FG002|Overall Study|Participant not willing to continue|11|||
27552711|NCT00684307|80211267|FG003|Overall Study|Participant not willing to continue|5|||
27552712|NCT00684307|80211268|FG004|Overall Study|Participant not willing to continue|8|||
27552713|NCT00684307|80211264|FG000|Overall Study|Criteria from the CSR|0|||
27552714|NCT00684307|80211265|FG001|Overall Study|Criteria from the CSR|0|||
27552715|NCT00684307|80211266|FG002|Overall Study|Criteria from the CSR|1|||
27552716|NCT00684307|80211267|FG003|Overall Study|Criteria from the CSR|3|||
27552717|NCT00684307|80211268|FG004|Overall Study|Criteria from the CSR|3|||
27552718|NCT02585960|80211269|FG000|PK/Safety Assessment Period|Physician Decision|0|||
27552719|NCT02585960|80211270|FG001|PK/Safety Assessment Period|Physician Decision|1|||
27552720|NCT02585960|80211271|FG002|PK/Safety Assessment Period|Physician Decision|0|||
27552721|NCT02585960|80211269|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
27552722|NCT02585960|80211270|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
27552723|NCT02585960|80211271|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
27552724|NCT02585960|80211269|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
27552725|NCT02585960|80211270|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
27552726|NCT02585960|80211271|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
27552727|NCT02585960|80211269|FG000|PK/Safety Assessment Period|Other|4|||
27552728|NCT02585960|80211270|FG001|PK/Safety Assessment Period|Other|4|||
27883658|NCT00458536|81408023|FG000|Overall Study|Patient did not have surgery|1|||
27552729|NCT02585960|80211271|FG002|PK/Safety Assessment Period|Other|0|||
27552730|NCT02585960|80211269|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
27552731|NCT02585960|80211270|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
27883659|NCT00458536|81408023|FG000|Overall Study|Ineligible due to toxicity|1|||
27883660|NCT00458536|81408023|FG000|Overall Study|Withdrawal by Subject|1|||
27694303|NCT00406653|80716715|FG003|Maintenance Period|Lost to Follow-up|0|||
27694304|NCT00406653|80716716|FG004|Maintenance Period|Lost to Follow-up|2|||
27694305|NCT00406653|80716717|FG005|Maintenance Period|Lost to Follow-up|1|||
27694306|NCT00406653|80716718|FG006|Maintenance Period|Lost to Follow-up|0|||
27694307|NCT00406653|80716712|FG000|Maintenance Period|Withdrawal of Consent|0|||
27694308|NCT00406653|80716713|FG001|Maintenance Period|Withdrawal of Consent|0|||
27694309|NCT00406653|80716714|FG002|Maintenance Period|Withdrawal of Consent|0|||
27824889|NCT02289963|81192354|FG000|Overall Study|Last injection missed|2|||
27824890|NCT02289963|81192355|FG001|Overall Study|Last injection missed|2|||
27824891|NCT02289963|81192354|FG000|Overall Study|End treatment visit outside visit window|0|||
27824892|NCT02289963|81192355|FG001|Overall Study|End treatment visit outside visit window|4|||
27824893|NCT02289963|81192354|FG000|Overall Study|Other than specified above|0|||
27824894|NCT02289963|81192355|FG001|Overall Study|Other than specified above|2|||
27824895|NCT02422264|81192360|FG000|Overall Study|Serious Adverse Event|1|||
27824896|NCT02422264|81192361|FG001|Overall Study|Serious Adverse Event|0|||
27824897|NCT02422264|81192360|FG000|Overall Study|Withdrawal by Subject|1|||
27824898|NCT02422264|81192361|FG001|Overall Study|Withdrawal by Subject|2|||
27824899|NCT02422264|81192360|FG000|Overall Study|Migrated/moved from study area|3|||
27824900|NCT02422264|81192361|FG001|Overall Study|Migrated/moved from study area|1|||
27824901|NCT02422264|81192360|FG000|Overall Study|Subject vaccinated outside of the study|0|||
27824902|NCT02422264|81192361|FG001|Overall Study|Subject vaccinated outside of the study|1|||
27824903|NCT01615198|81192362|FG000|Overall Study|Withdrawal by Subject|5|||
27824904|NCT01615198|81192363|FG001|Overall Study|Withdrawal by Subject|5|||
27824905|NCT01615198|81192362|FG000|Overall Study|Protocol deviation|1|||
27824906|NCT01615198|81192363|FG001|Overall Study|Protocol deviation|1|||
27824907|NCT01615198|81192362|FG000|Overall Study|Physician Decision|5|||
27824908|NCT01615198|81192363|FG001|Overall Study|Physician Decision|1|||
27824909|NCT01615198|81192362|FG000|Overall Study|Lost to Follow-up|1|||
27824910|NCT01615198|81192363|FG001|Overall Study|Lost to Follow-up|1|||
27824911|NCT01615198|81192362|FG000|Overall Study|Lack of Efficacy|1|||
27824912|NCT01615198|81192363|FG001|Overall Study|Lack of Efficacy|6|||
27694310|NCT00406653|80716715|FG003|Maintenance Period|Withdrawal of Consent|0|||
27824913|NCT01615198|81192362|FG000|Overall Study|Adverse Event|11|||
27824914|NCT01615198|81192363|FG001|Overall Study|Adverse Event|5|||
27824915|NCT00585689|81192364|FG000|Overall Study|Received different ABI-007 schedule|3|||
27694311|NCT00406653|80716716|FG004|Maintenance Period|Withdrawal of Consent|2|||
27824916|NCT00585689|81192364|FG000|Overall Study|Adverse Event|1|||
27552732|NCT02585960|80211271|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
27552733|NCT02585960|80211269|FG000|PK/Safety Assessment Period|Screen Failure|0|||
27552734|NCT02585960|80211270|FG001|PK/Safety Assessment Period|Screen Failure|0|||
27552735|NCT02585960|80211271|FG002|PK/Safety Assessment Period|Screen Failure|1|||
27552736|NCT02585960|80211269|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
27552737|NCT02585960|80211270|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
27552738|NCT02585960|80211271|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
27552739|NCT02585960|80211269|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
27552740|NCT02585960|80211270|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
27824917|NCT00585689|81192364|FG000|Overall Study|Patient Declined Surgery|1|||
27824918|NCT00585689|81192364|FG000|Overall Study|Patient had unresectable disease|1|||
27824919|NCT00585689|81192364|FG000|Overall Study|Death|1|||
27824920|NCT01839279|81192365|FG000|Overall Study|Adverse Event|4|||
27824921|NCT01839279|81192366|FG001|Overall Study|Adverse Event|1|||
27824922|NCT01839279|81192367|FG002|Overall Study|Adverse Event|1|||
27824923|NCT01839279|81192365|FG000|Overall Study|Withdrawal by Subject|4|||
27824924|NCT01839279|81192366|FG001|Overall Study|Withdrawal by Subject|1|||
27824925|NCT01839279|81192367|FG002|Overall Study|Withdrawal by Subject|1|||
27824926|NCT01839279|81192365|FG000|Overall Study|Classified as 'Other'|5|||
27824927|NCT01839279|81192366|FG001|Overall Study|Classified as 'Other'|0|||
27824928|NCT01839279|81192367|FG002|Overall Study|Classified as 'Other'|0|||
27824929|NCT00163657|81192369|FG000|Overall Study|Death|12|||
27824930|NCT00163657|81192370|FG001|Overall Study|Death|14|||
27824931|NCT00163657|81192371|FG002|Overall Study|Death|19|||
27824932|NCT00163657|81192369|FG000|Overall Study|graft loss|4|||
27824933|NCT00163657|81192370|FG001|Overall Study|graft loss|1|||
27824934|NCT00163657|81192371|FG002|Overall Study|graft loss|2|||
27824935|NCT00163657|81192369|FG000|Overall Study|Withdrawal by Subject|2|||
27824936|NCT00163657|81192370|FG001|Overall Study|Withdrawal by Subject|3|||
27824937|NCT00163657|81192371|FG002|Overall Study|Withdrawal by Subject|2|||
27824938|NCT00163657|81192369|FG000|Overall Study|Physician Decision|0|||
27824939|NCT00163657|81192370|FG001|Overall Study|Physician Decision|1|||
27824940|NCT00163657|81192371|FG002|Overall Study|Physician Decision|1|||
27824941|NCT00163657|81192369|FG000|Overall Study|Non Compliance|1|||
27824942|NCT00163657|81192370|FG001|Overall Study|Non Compliance|0|||
27824943|NCT00163657|81192371|FG002|Overall Study|Non Compliance|0|||
27824944|NCT00163657|81192369|FG000|Overall Study|Lost to Follow-up|1|||
27824945|NCT00163657|81192370|FG001|Overall Study|Lost to Follow-up|3|||
27824946|NCT00163657|81192371|FG002|Overall Study|Lost to Follow-up|10|||
27824947|NCT00163657|81192369|FG000|Overall Study|Other reason|0|||
27824948|NCT00163657|81192370|FG001|Overall Study|Other reason|1|||
27824949|NCT00163657|81192371|FG002|Overall Study|Other reason|3|||
27824950|NCT00505622|81192372|FG000|Overall Study|Adverse Event|5|||
27824951|NCT00505622|81192373|FG001|Overall Study|Adverse Event|6|||
27824952|NCT00505622|81192374|FG002|Overall Study|Adverse Event|4|||
27824953|NCT00505622|81192372|FG000|Overall Study|Protocol Violation|1|||
27824954|NCT00505622|81192373|FG001|Overall Study|Protocol Violation|1|||
27824955|NCT00505622|81192374|FG002|Overall Study|Protocol Violation|0|||
27824956|NCT00505622|81192372|FG000|Overall Study|Withdrawal by Subject|0|||
27824957|NCT00505622|81192373|FG001|Overall Study|Withdrawal by Subject|3|||
27824958|NCT00505622|81192374|FG002|Overall Study|Withdrawal by Subject|2|||
27824959|NCT00505622|81192372|FG000|Overall Study|Study termination by sponsor|115|||
27824960|NCT00505622|81192373|FG001|Overall Study|Study termination by sponsor|98|||
27824961|NCT00505622|81192374|FG002|Overall Study|Study termination by sponsor|90|||
27824962|NCT02128997|81192379|FG000|Overall Study|Lost to Follow-up|6|||
27824963|NCT02128997|81192380|FG001|Overall Study|Lost to Follow-up|11|||
27824964|NCT00933686|81192381|FG000|Overall Study|Protocol Violation|0|||
27824965|NCT00933686|81192382|FG001|Overall Study|Protocol Violation|1|||
27824966|NCT00933686|81192381|FG000|Overall Study|Lost to Follow-up|2|||
27824967|NCT00933686|81192382|FG001|Overall Study|Lost to Follow-up|2|||
27824968|NCT00933686|81192381|FG000|Overall Study|Withdrawal by Subject|6|||
27824969|NCT00933686|81192382|FG001|Overall Study|Withdrawal by Subject|5|||
27824970|NCT00933686|81192381|FG000|Overall Study|Adverse Event|1|||
27824971|NCT00933686|81192382|FG001|Overall Study|Adverse Event|1|||
27552741|NCT02585960|80211271|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
27824972|NCT00933686|81192381|FG000|Overall Study|Physician Decision|1|||
27824973|NCT00933686|81192382|FG001|Overall Study|Physician Decision|0|||
27824974|NCT00933686|81192381|FG000|Overall Study|Failure to show up at endpoint visits|0|||
27824975|NCT00933686|81192382|FG001|Overall Study|Failure to show up at endpoint visits|2|||
27824976|NCT02294786|81192383|FG000|Overall Study|Withdrawal by Subject|0|||
27824977|NCT02294786|81192384|FG001|Overall Study|Withdrawal by Subject|1|||
27824978|NCT02294786|81192383|FG000|Overall Study|Physician Decision|6|||
27824979|NCT02294786|81192384|FG001|Overall Study|Physician Decision|7|||
27824980|NCT02294786|81192383|FG000|Overall Study|Lost to Follow-up|1|||
27824981|NCT02294786|81192384|FG001|Overall Study|Lost to Follow-up|2|||
27824982|NCT02294786|81192383|FG000|Overall Study|Protocol Violation|1|||
27824983|NCT02294786|81192384|FG001|Overall Study|Protocol Violation|0|||
27824984|NCT02294786|81192383|FG000|Overall Study|Adverse Event|1|||
27824985|NCT02294786|81192384|FG001|Overall Study|Adverse Event|1|||
27694312|NCT00406653|80716717|FG005|Maintenance Period|Withdrawal of Consent|0|||
27824986|NCT02294786|81192383|FG000|Overall Study|Death|2|||
27824987|NCT02294786|81192384|FG001|Overall Study|Death|3|||
27824988|NCT01175018|81192385|FG000|Overall Study|Adverse Event|3|||
27824989|NCT01175018|81192386|FG001|Overall Study|Adverse Event|1|||
27824990|NCT02424097|81192401|FG000|Overall Study|Lost to Follow-up|1|||
27824991|NCT02424097|81192402|FG001|Overall Study|Lost to Follow-up|2|||
27824992|NCT00910663|81192404|FG000|Period 1|Withdrawal by Subject|0|||
27824993|NCT00910663|81192405|FG001|Period 1|Withdrawal by Subject|1|||
27824994|NCT03084471|81192408|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
27824995|NCT03084471|81192408|FG000|Overall Study|Condition under investigation worsened|84|||
27824996|NCT03084471|81192408|FG000|Overall Study|Lack of therapeutic response|2|||
27824997|NCT03084471|81192408|FG000|Overall Study|Protocol Violation|1|||
27824998|NCT03084471|81192408|FG000|Overall Study|Adverse Event|73|||
27824999|NCT03084471|81192408|FG000|Overall Study|Withdrawal by Subject|12|||
27825000|NCT03084471|81192408|FG000|Overall Study|Disease relapse|181|||
27825001|NCT03084471|81192408|FG000|Overall Study|Subjective disease progression|359|||
27825002|NCT03084471|81192408|FG000|Overall Study|Other (as recorded)|33|||
27825003|NCT03084471|81192408|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
27825004|NCT00858845|81192409|FG000|Overall Study|Patient underwent heart transplant.|0|||
27825005|NCT00858845|81192410|FG001|Overall Study|Patient underwent heart transplant.|1|||
27825006|NCT03075761|81192414|FG000|Overall Study|Lost to Follow-up|1|||
27825007|NCT03075761|81192415|FG001|Overall Study|Lost to Follow-up|6|||
27825008|NCT03235739|81192416|FG000|Overall Study|Withdrawal by Subject|2|||
27825009|NCT03235739|81192417|FG001|Overall Study|Withdrawal by Subject|2|||
27825010|NCT03235739|81192416|FG000|Overall Study|Physician Decision|0|||
27825011|NCT03235739|81192417|FG001|Overall Study|Physician Decision|1|||
27825012|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
27825013|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
27825014|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
27825015|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
27825016|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
27825017|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
27825018|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
27825019|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
27825020|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
27825021|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
27825022|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
27825023|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
27825024|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
27825025|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
27825026|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
27825027|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
27825028|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
27825029|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
27825030|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
27825031|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
27825032|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Death|0|||
27825033|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Death|1|||
27825034|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Death|0|||
27552742|NCT02266225|80211275|FG000|Overall Study|Lost to Follow-up|2|||
27552743|NCT02266225|80211275|FG000|Overall Study|Death|1|||
27825035|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Death|0|||
27825036|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
27825037|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
27825038|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
27552744|NCT02266225|80211275|FG000|Overall Study|Withdrawal by Subject|13|||
27825039|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
27825040|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
27552745|NCT02835820|80211277|FG000|Overall Study|Baseline Screen Failure|0|||
27552746|NCT02835820|80211278|FG001|Overall Study|Baseline Screen Failure|3|||
27552747|NCT00938639|80211279|FG000|Overall Study|Moved away from study area|0|||
27552748|NCT00938639|80211280|FG001|Overall Study|Moved away from study area|1|||
27552749|NCT00938639|80211279|FG000|Overall Study|Lost to Follow-up|1|||
27552750|NCT00938639|80211280|FG001|Overall Study|Lost to Follow-up|2|||
27552751|NCT00938639|80211279|FG000|Overall Study|Family issues|1|||
27552752|NCT00938639|80211280|FG001|Overall Study|Family issues|1|||
27552753|NCT00938639|80211279|FG000|Overall Study|Participant noncompliance|1|||
27552754|NCT00938639|80211280|FG001|Overall Study|Participant noncompliance|0|||
27552755|NCT01658072|80211281|FG000|Overall Study|Protocol Violation|4|||
27552756|NCT01658072|80211282|FG001|Overall Study|Protocol Violation|2|||
27552757|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Death|3|||
27552758|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Death|3|||
27552759|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Death|0|||
27552760|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Death|0|||
27552761|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
27552762|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
27552763|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
27552764|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
27552765|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
27552766|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
27825041|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
27825042|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
27825043|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
27825044|NCT01940341|81192418|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
27825045|NCT01940341|81192419|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
27825046|NCT01940341|81192420|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
27825047|NCT01940341|81192421|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
27825048|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
27825049|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
27825050|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
27552767|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
27552768|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
27552769|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
27552770|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
27552771|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
27552772|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
27552773|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
27552774|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
27552775|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
27552776|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
27552777|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
27552778|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
27552779|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
27552780|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
27552781|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
27552782|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
27552783|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
27552784|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
27552785|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Other|6|||
27552786|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Other|3|||
27552787|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Other|0|||
27552788|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Other|0|||
27552789|NCT02051608|80211285|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
27552790|NCT02051608|80211286|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
27552791|NCT02051608|80211287|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
27552792|NCT02051608|80211288|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
27552793|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Adverse Event|0|||
27552794|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Adverse Event|0|||
27552795|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Adverse Event|6|||
27552796|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Adverse Event|8|||
27552797|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Death|0|||
27552798|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Death|0|||
27552799|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Death|7|||
27552800|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Death|4|||
27552801|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
27552802|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
27552803|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
27552804|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
27552805|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
27552806|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
27552807|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
27552808|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
27552809|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
27552810|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
27552811|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
27552812|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
27552813|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
27552814|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
27552815|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
27552816|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
27552817|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Physician Decision|0|||
27552818|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Physician Decision|0|||
27552819|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Physician Decision|8|||
27694313|NCT00406653|80716718|FG006|Maintenance Period|Withdrawal of Consent|0|||
27694314|NCT00406653|80716712|FG000|Maintenance Period|Pregnancy|0|||
27883661|NCT00458536|81408023|FG000|Overall Study|Progressive disease during treatment|2|||
27883662|NCT01920958|81408027|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
27883663|NCT01029782|81408028|FG000|Overall Study|Lost to Follow-up|2|||
27552820|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Physician Decision|5|||
27552821|NCT02051608|80211285|FG000|Part 2: Open-label Extension|Other|0|||
27552822|NCT02051608|80211286|FG001|Part 2: Open-label Extension|Other|0|||
27552823|NCT02051608|80211287|FG002|Part 2: Open-label Extension|Other|9|||
27552824|NCT02051608|80211288|FG003|Part 2: Open-label Extension|Other|9|||
27552825|NCT01962207|80211291|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
27552826|NCT01962207|80211292|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
27552827|NCT01962207|80211293|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
27552828|NCT01962207|80211294|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
27552829|NCT01962207|80211291|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
27552830|NCT01962207|80211292|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
27552831|NCT01962207|80211293|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
27552832|NCT01962207|80211294|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
27552833|NCT01962207|80211291|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
27552834|NCT01962207|80211292|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
27552835|NCT01962207|80211293|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
27552836|NCT01962207|80211294|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
27552837|NCT01962207|80211291|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
27552838|NCT01962207|80211292|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
27552839|NCT01962207|80211293|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
27552840|NCT01962207|80211294|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
27552841|NCT01962207|80211291|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
27552842|NCT01962207|80211292|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
27552843|NCT01962207|80211293|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
27552844|NCT01962207|80211294|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
27552845|NCT01962207|80211291|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
27552846|NCT01962207|80211292|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
27552847|NCT01962207|80211293|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
27552848|NCT01962207|80211294|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
27552849|NCT00429104|80211295|FG000|Overall Study|Protocol Violation|1|||
27552850|NCT00592384|80211298|FG000|Overall Study|Withdrawal by Subject|5|||
27552851|NCT00592384|80211299|FG001|Overall Study|Withdrawal by Subject|6|||
27552852|NCT02707991|80211302|FG000|Overall Study|Protocol Violation|1|||
27552853|NCT02707991|80211303|FG001|Overall Study|Protocol Violation|0|||
27552854|NCT02707991|80211302|FG000|Overall Study|Became ineligible|0|||
27825051|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
27825052|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
27825053|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
27825054|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
27825055|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
27825056|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
27825057|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
27825058|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
27825059|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
27825060|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
27825061|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
27825062|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
27825063|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
27825064|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
27825065|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
27825066|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
27825067|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
27825068|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
27825069|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
27825070|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
27825071|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
27825072|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
27825073|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
27825074|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
27552855|NCT02707991|80211303|FG001|Overall Study|Became ineligible|1|||
27552856|NCT00848081|80211304|FG000|Overall Study|Adverse Event|6|||
27552857|NCT00848081|80211305|FG001|Overall Study|Adverse Event|7|||
27552858|NCT00848081|80211304|FG000|Overall Study|Protocol Violation|8|||
27552859|NCT00848081|80211305|FG001|Overall Study|Protocol Violation|5|||
27552860|NCT00848081|80211304|FG000|Overall Study|Lost to Follow-up|1|||
27552861|NCT00848081|80211305|FG001|Overall Study|Lost to Follow-up|0|||
27552862|NCT00848081|80211304|FG000|Overall Study|Physician Decision|0|||
27552863|NCT00848081|80211305|FG001|Overall Study|Physician Decision|3|||
27552864|NCT00848081|80211304|FG000|Overall Study|Withdrawal by Subject|5|||
27552865|NCT00848081|80211305|FG001|Overall Study|Withdrawal by Subject|3|||
27552866|NCT00644995|80211311|FG000|Overall Study|Lost to Follow-up|1|||
27552867|NCT00644995|80211312|FG001|Overall Study|Lost to Follow-up|4|||
27552868|NCT00644995|80211311|FG000|Overall Study|Refused|1|||
27552869|NCT00644995|80211312|FG001|Overall Study|Refused|0|||
27552870|NCT01709162|80211313|FG000|Overall Study|Disease progression|3|||
27552871|NCT01709162|80211314|FG001|Overall Study|Disease progression|3|||
27552872|NCT01709162|80211313|FG000|Overall Study|Study drug toxicity|2|||
27552873|NCT01709162|80211314|FG001|Overall Study|Study drug toxicity|0|||
27552874|NCT01709162|80211313|FG000|Overall Study|Administrative reason by sponsor|0|||
27825075|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
27825076|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
27825077|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
27825078|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
27825079|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
27825080|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
27825081|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
27552875|NCT01709162|80211314|FG001|Overall Study|Administrative reason by sponsor|1|||
27825082|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
27825083|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
27825084|NCT01940341|81192418|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
27825085|NCT01940341|81192419|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
27825086|NCT01940341|81192420|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
27825087|NCT01940341|81192421|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
27825088|NCT01383486|81192423|FG000|Overall Study|Lost to Follow-up|10|||
27825089|NCT01383486|81192423|FG000|Overall Study|Incomplete information for analysis|2|||
27825090|NCT01383486|81192423|FG000|Overall Study|Did not take any product|6|||
27825091|NCT00787254|81192430|FG000|Overall Study|Adverse Event|24|||
27825092|NCT00787254|81192431|FG001|Overall Study|Adverse Event|23|||
27825093|NCT00787254|81192430|FG000|Overall Study|Protocol Violation|26|||
27825094|NCT00787254|81192431|FG001|Overall Study|Protocol Violation|23|||
27825095|NCT00787254|81192430|FG000|Overall Study|Withdrawal by Subject|16|||
27825096|NCT00787254|81192431|FG001|Overall Study|Withdrawal by Subject|11|||
27825097|NCT00787254|81192430|FG000|Overall Study|Lack of Efficacy|4|||
27825098|NCT00787254|81192431|FG001|Overall Study|Lack of Efficacy|15|||
27825099|NCT00787254|81192430|FG000|Overall Study|NSAIDs discontinuation|1|||
27825100|NCT00787254|81192431|FG001|Overall Study|NSAIDs discontinuation|2|||
27825101|NCT00787254|81192430|FG000|Overall Study|Institution closed|1|||
27825102|NCT00787254|81192431|FG001|Overall Study|Institution closed|0|||
27825103|NCT00787254|81192430|FG000|Overall Study|Physician Decision|4|||
27825104|NCT00787254|81192431|FG001|Overall Study|Physician Decision|8|||
27552876|NCT01709162|80211313|FG000|Overall Study|Other|1|||
27694315|NCT00406653|80716713|FG001|Maintenance Period|Pregnancy|0|||
27825105|NCT03503318|81192432|FG000|Overall Study|Death|1|||
27825106|NCT03503318|81192433|FG001|Overall Study|Death|0|||
27552877|NCT01709162|80211314|FG001|Overall Study|Other|0|||
27552878|NCT01709162|80211313|FG000|Overall Study|Withdrawal by Subject|0|||
27825107|NCT03503318|81192434|FG002|Overall Study|Death|4|||
27825108|NCT03503318|81192432|FG000|Overall Study|Adverse Event|3|||
27825109|NCT03503318|81192433|FG001|Overall Study|Adverse Event|4|||
27825110|NCT03503318|81192434|FG002|Overall Study|Adverse Event|2|||
27825111|NCT03503318|81192432|FG000|Overall Study|Withdrawal by Subject|12|||
27825112|NCT03503318|81192433|FG001|Overall Study|Withdrawal by Subject|17|||
27825113|NCT03503318|81192434|FG002|Overall Study|Withdrawal by Subject|16|||
27825114|NCT03503318|81192432|FG000|Overall Study|Protocol Violation|5|||
27825115|NCT03503318|81192433|FG001|Overall Study|Protocol Violation|0|||
27825116|NCT03503318|81192434|FG002|Overall Study|Protocol Violation|3|||
27825117|NCT03503318|81192432|FG000|Overall Study|Lost to Follow-up|17|||
27825118|NCT03503318|81192433|FG001|Overall Study|Lost to Follow-up|15|||
27825119|NCT03503318|81192434|FG002|Overall Study|Lost to Follow-up|12|||
27825120|NCT03503318|81192432|FG000|Overall Study|Other than specified|1|||
27825121|NCT03503318|81192433|FG001|Overall Study|Other than specified|3|||
27825122|NCT03503318|81192434|FG002|Overall Study|Other than specified|3|||
27825123|NCT01404988|81192436|FG000|Overall Study|Death|2|||
27825124|NCT01404988|81192437|FG001|Overall Study|Death|0|||
27825125|NCT01404988|81192438|FG002|Overall Study|Death|2|||
27825126|NCT01404988|81192436|FG000|Overall Study|Adverse Event|1|||
27552879|NCT01709162|80211314|FG001|Overall Study|Withdrawal by Subject|1|||
27552880|NCT00759031|80211315|FG000|First Intervention (1 Day)|Physician Decision|1|||
27552881|NCT00759031|80211316|FG001|First Intervention (1 Day)|Physician Decision|0|||
27552882|NCT00759031|80211315|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
27825127|NCT01404988|81192437|FG001|Overall Study|Adverse Event|0|||
27825128|NCT01404988|81192438|FG002|Overall Study|Adverse Event|0|||
27825129|NCT01404988|81192436|FG000|Overall Study|Withdrawal by Subject|2|||
27825130|NCT01404988|81192437|FG001|Overall Study|Withdrawal by Subject|2|||
27825131|NCT01404988|81192438|FG002|Overall Study|Withdrawal by Subject|0|||
27825132|NCT01404988|81192436|FG000|Overall Study|Lost to Follow-up|1|||
27825133|NCT01404988|81192437|FG001|Overall Study|Lost to Follow-up|2|||
27825134|NCT01404988|81192438|FG002|Overall Study|Lost to Follow-up|1|||
27552883|NCT00759031|80211316|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
27552884|NCT00759031|80211315|FG000|First Intervention (1 Day)|Screening failure|1|||
27552885|NCT00759031|80211316|FG001|First Intervention (1 Day)|Screening failure|0|||
27552886|NCT00085631|80211317|FG000|Overall Study|Missing Data|4|||
27552887|NCT00085631|80211318|FG001|Overall Study|Missing Data|11|||
27552888|NCT00085631|80211319|FG002|Overall Study|Missing Data|7|||
27552889|NCT03915496|80211322|FG000|Overall Study|Adverse Event|2|||
27552890|NCT03915496|80211323|FG001|Overall Study|Adverse Event|1|||
27552891|NCT03915496|80211324|FG002|Overall Study|Adverse Event|2|||
27552892|NCT01634360|80211326|FG000|Overall Study|Adverse Event|10|||
27552893|NCT01634360|80211327|FG001|Overall Study|Adverse Event|34|||
27552894|NCT01634360|80211326|FG000|Overall Study|subject withdrew consent|13|||
27552895|NCT01634360|80211327|FG001|Overall Study|subject withdrew consent|23|||
27552896|NCT01634360|80211326|FG000|Overall Study|Protocol Violation|1|||
27552897|NCT01634360|80211327|FG001|Overall Study|Protocol Violation|1|||
27552898|NCT01634360|80211326|FG000|Overall Study|Lack of Efficacy|4|||
27552899|NCT01634360|80211327|FG001|Overall Study|Lack of Efficacy|14|||
27552900|NCT01634360|80211326|FG000|Overall Study|Other|3|||
27552901|NCT01634360|80211327|FG001|Overall Study|Other|20|||
27825135|NCT02441309|81192443|FG000|Overall Study|Disease progression|2|||
27825136|NCT02441309|81192444|FG001|Overall Study|Disease progression|1|||
27825137|NCT02441309|81192445|FG002|Overall Study|Disease progression|2|||
27825138|NCT02441309|81192443|FG000|Overall Study|Adverse Event|0|||
27825139|NCT02441309|81192444|FG001|Overall Study|Adverse Event|1|||
27552902|NCT01634360|80211326|FG000|Overall Study|Study termination by sponsor|18|||
27552903|NCT01634360|80211327|FG001|Overall Study|Study termination by sponsor|44|||
27552904|NCT04285879|80211329|FG000|Overall Study|Lost to Follow-up|1|||
27552905|NCT04285879|80211330|FG001|Overall Study|Lost to Follow-up|8|||
27552906|NCT04285879|80211329|FG000|Overall Study|medical/surgical exclusion|16|||
27552907|NCT04285879|80211330|FG001|Overall Study|medical/surgical exclusion|0|||
27552908|NCT03266094|80211331|FG000|Overall Study|Lost to Follow-up|1|||
27552909|NCT03266094|80211331|FG000|Overall Study|Withdrawal by Subject|1|||
27552910|NCT00284050|80211332|FG000|Overall Study|Adverse Event|1|||
27552911|NCT00284050|80211333|FG001|Overall Study|Adverse Event|1|||
27552912|NCT00284050|80211334|FG002|Overall Study|Adverse Event|1|||
27552913|NCT00284050|80211332|FG000|Overall Study|Lack of Efficacy|0|||
27552914|NCT00284050|80211333|FG001|Overall Study|Lack of Efficacy|1|||
27552915|NCT00284050|80211334|FG002|Overall Study|Lack of Efficacy|3|||
27825140|NCT02441309|81192445|FG002|Overall Study|Adverse Event|0|||
27825141|NCT02441309|81192443|FG000|Overall Study|Withdrawal by Subject|1|||
27825142|NCT02441309|81192444|FG001|Overall Study|Withdrawal by Subject|0|||
27825143|NCT02441309|81192445|FG002|Overall Study|Withdrawal by Subject|1|||
27825144|NCT01602419|81192446|FG000|Overall Study|Not treated with Wilate|9|||
27552916|NCT00284050|80211332|FG000|Overall Study|Protocol Violation|0|||
27552917|NCT00284050|80211333|FG001|Overall Study|Protocol Violation|1|||
27552918|NCT00284050|80211334|FG002|Overall Study|Protocol Violation|2|||
27552919|NCT00284050|80211332|FG000|Overall Study|Withdrawal by Subject|2|||
27552920|NCT00284050|80211333|FG001|Overall Study|Withdrawal by Subject|2|||
27552921|NCT00284050|80211334|FG002|Overall Study|Withdrawal by Subject|2|||
27552922|NCT00284050|80211332|FG000|Overall Study|Lost to Follow-up|1|||
27552923|NCT00284050|80211333|FG001|Overall Study|Lost to Follow-up|0|||
27552924|NCT00284050|80211334|FG002|Overall Study|Lost to Follow-up|1|||
27552925|NCT00284050|80211332|FG000|Overall Study|Death|1|||
27552926|NCT00284050|80211333|FG001|Overall Study|Death|0|||
27552927|NCT00284050|80211334|FG002|Overall Study|Death|0|||
27825145|NCT01602419|81192446|FG000|Overall Study|Adverse Drug Reaction|4|||
27825146|NCT01602419|81192446|FG000|Overall Study|Insurance issues|3|||
27552928|NCT03334448|80211335|FG000|Washout|Personal Reason|0|||
27552929|NCT03334448|80211336|FG001|Washout|Personal Reason|1|||
27552930|NCT03334448|80211337|FG002|Washout|Personal Reason|0|||
27552931|NCT03334448|80211338|FG003|Washout|Personal Reason|0|||
27552932|NCT03334448|80211335|FG000|Washout|Protocol Violation|0|||
27552933|NCT03334448|80211336|FG001|Washout|Protocol Violation|0|||
27552934|NCT03334448|80211337|FG002|Washout|Protocol Violation|0|||
27552935|NCT03334448|80211338|FG003|Washout|Protocol Violation|1|||
27552936|NCT03454893|80211339|FG000|Overall Study|Study Terminated by the Sponsor|5|||
27552937|NCT03454893|80211339|FG000|Overall Study|Did not pass screening|4|||
27552938|NCT03171415|80211341|FG000|Overall Study|Lost to Follow-up|0|||
27552939|NCT03171415|80211342|FG001|Overall Study|Lost to Follow-up|0|||
27552940|NCT03171415|80211343|FG002|Overall Study|Lost to Follow-up|0|||
27552941|NCT03171415|80211344|FG003|Overall Study|Lost to Follow-up|0|||
27552942|NCT03171415|80211345|FG004|Overall Study|Lost to Follow-up|2|||
27552943|NCT00420927|80211346|FG000|Period 1|Adverse Event|19|||
27552944|NCT00420927|80211347|FG001|Period 1|Adverse Event|15|||
27552945|NCT00420927|80211348|FG002|Period 1|Adverse Event|0|||
27552946|NCT00420927|80211349|FG003|Period 1|Adverse Event|0|||
27552947|NCT00420927|80211350|FG004|Period 1|Adverse Event|0|||
27552948|NCT00420927|80211351|FG005|Period 1|Adverse Event|0|||
27552949|NCT00420927|80211352|FG006|Period 1|Adverse Event|0|||
27552950|NCT00420927|80211346|FG000|Period 1|Withdrawal by Subject|7|||
27552951|NCT00420927|80211347|FG001|Period 1|Withdrawal by Subject|12|||
27552952|NCT00420927|80211348|FG002|Period 1|Withdrawal by Subject|0|||
27552953|NCT00420927|80211349|FG003|Period 1|Withdrawal by Subject|0|||
27552954|NCT00420927|80211350|FG004|Period 1|Withdrawal by Subject|0|||
27552955|NCT00420927|80211351|FG005|Period 1|Withdrawal by Subject|0|||
27552956|NCT00420927|80211352|FG006|Period 1|Withdrawal by Subject|0|||
27552957|NCT00420927|80211346|FG000|Period 1|Lost to Follow-up|8|||
27552958|NCT00420927|80211347|FG001|Period 1|Lost to Follow-up|6|||
27552959|NCT00420927|80211348|FG002|Period 1|Lost to Follow-up|0|||
27552960|NCT00420927|80211349|FG003|Period 1|Lost to Follow-up|0|||
27552961|NCT00420927|80211350|FG004|Period 1|Lost to Follow-up|0|||
27552962|NCT00420927|80211351|FG005|Period 1|Lost to Follow-up|0|||
27552963|NCT00420927|80211352|FG006|Period 1|Lost to Follow-up|0|||
27552964|NCT00420927|80211346|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
27552965|NCT00420927|80211347|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
27552966|NCT00420927|80211348|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
27552967|NCT00420927|80211349|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
27552968|NCT00420927|80211350|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
27552969|NCT00420927|80211351|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
27552970|NCT00420927|80211352|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
27552971|NCT00420927|80211346|FG000|Period 1|Death|2|||
27552972|NCT00420927|80211347|FG001|Period 1|Death|0|||
27552973|NCT00420927|80211348|FG002|Period 1|Death|0|||
27552974|NCT00420927|80211349|FG003|Period 1|Death|0|||
27552975|NCT00420927|80211350|FG004|Period 1|Death|0|||
27552976|NCT00420927|80211351|FG005|Period 1|Death|0|||
27552977|NCT00420927|80211352|FG006|Period 1|Death|0|||
27552978|NCT00420927|80211346|FG000|Period 1|Subject moved/relocated|0|||
27552979|NCT00420927|80211347|FG001|Period 1|Subject moved/relocated|2|||
27552980|NCT00420927|80211348|FG002|Period 1|Subject moved/relocated|0|||
27552981|NCT00420927|80211349|FG003|Period 1|Subject moved/relocated|0|||
27552982|NCT00420927|80211350|FG004|Period 1|Subject moved/relocated|0|||
27552983|NCT00420927|80211351|FG005|Period 1|Subject moved/relocated|0|||
27552984|NCT00420927|80211352|FG006|Period 1|Subject moved/relocated|0|||
27552985|NCT00420927|80211346|FG000|Period 1|Noncompliant with study drug|1|||
27552986|NCT00420927|80211347|FG001|Period 1|Noncompliant with study drug|1|||
27552987|NCT00420927|80211348|FG002|Period 1|Noncompliant with study drug|0|||
27552988|NCT00420927|80211349|FG003|Period 1|Noncompliant with study drug|0|||
27552989|NCT00420927|80211350|FG004|Period 1|Noncompliant with study drug|0|||
27552990|NCT00420927|80211351|FG005|Period 1|Noncompliant with study drug|0|||
27552991|NCT00420927|80211352|FG006|Period 1|Noncompliant with study drug|0|||
27694316|NCT00406653|80716714|FG002|Maintenance Period|Pregnancy|0|||
27552992|NCT00420927|80211346|FG000|Period 1|Randomization error|1|||
27552993|NCT00420927|80211347|FG001|Period 1|Randomization error|0|||
27552994|NCT00420927|80211348|FG002|Period 1|Randomization error|0|||
27552995|NCT00420927|80211349|FG003|Period 1|Randomization error|0|||
27552996|NCT00420927|80211350|FG004|Period 1|Randomization error|0|||
27552997|NCT00420927|80211351|FG005|Period 1|Randomization error|0|||
27552998|NCT00420927|80211352|FG006|Period 1|Randomization error|0|||
27552999|NCT00420927|80211346|FG000|Period 1|Suspected tuberculosis/positive test|1|||
27553000|NCT00420927|80211347|FG001|Period 1|Suspected tuberculosis/positive test|1|||
27553001|NCT00420927|80211348|FG002|Period 1|Suspected tuberculosis/positive test|0|||
27553002|NCT00420927|80211349|FG003|Period 1|Suspected tuberculosis/positive test|0|||
27825147|NCT01602419|81192446|FG000|Overall Study|Changed treatment centre|1|||
27553003|NCT00420927|80211350|FG004|Period 1|Suspected tuberculosis/positive test|0|||
27553004|NCT00420927|80211351|FG005|Period 1|Suspected tuberculosis/positive test|0|||
27553005|NCT00420927|80211352|FG006|Period 1|Suspected tuberculosis/positive test|0|||
27553006|NCT00420927|80211346|FG000|Period 1|Study site closure|0|||
27553007|NCT00420927|80211347|FG001|Period 1|Study site closure|1|||
27553008|NCT00420927|80211348|FG002|Period 1|Study site closure|0|||
27553009|NCT00420927|80211349|FG003|Period 1|Study site closure|0|||
27553010|NCT00420927|80211350|FG004|Period 1|Study site closure|0|||
27553011|NCT00420927|80211351|FG005|Period 1|Study site closure|0|||
27553012|NCT00420927|80211352|FG006|Period 1|Study site closure|0|||
27553013|NCT00420927|80211346|FG000|Period 1|Subject received new diagnosis|0|||
27553014|NCT00420927|80211347|FG001|Period 1|Subject received new diagnosis|2|||
27553015|NCT00420927|80211348|FG002|Period 1|Subject received new diagnosis|0|||
27553016|NCT00420927|80211349|FG003|Period 1|Subject received new diagnosis|0|||
27553017|NCT00420927|80211350|FG004|Period 1|Subject received new diagnosis|0|||
27553018|NCT00420927|80211351|FG005|Period 1|Subject received new diagnosis|0|||
27694317|NCT00406653|80716715|FG003|Maintenance Period|Pregnancy|0|||
27694318|NCT00406653|80716716|FG004|Maintenance Period|Pregnancy|0|||
27694319|NCT00406653|80716717|FG005|Maintenance Period|Pregnancy|1|||
27694320|NCT00406653|80716718|FG006|Maintenance Period|Pregnancy|0|||
27553019|NCT00420927|80211352|FG006|Period 1|Subject received new diagnosis|0|||
27694321|NCT00406653|80716712|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
27694322|NCT00406653|80716713|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
27694323|NCT00406653|80716714|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
27694324|NCT00406653|80716715|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
27694325|NCT00406653|80716716|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
27694326|NCT00406653|80716717|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
27694327|NCT00406653|80716718|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
27694328|NCT00406653|80716712|FG000|Maintenance Period|Error in disease score evaluation|0|||
27694329|NCT00406653|80716713|FG001|Maintenance Period|Error in disease score evaluation|0|||
27694330|NCT00406653|80716714|FG002|Maintenance Period|Error in disease score evaluation|0|||
27694331|NCT00406653|80716715|FG003|Maintenance Period|Error in disease score evaluation|0|||
27694332|NCT00406653|80716716|FG004|Maintenance Period|Error in disease score evaluation|1|||
27694333|NCT00406653|80716717|FG005|Maintenance Period|Error in disease score evaluation|0|||
27825148|NCT01602419|81192446|FG000|Overall Study|Treatment centre closed|1|||
27825149|NCT01602419|81192446|FG000|Overall Study|Withdrawal by Subject|5|||
27825150|NCT01602419|81192446|FG000|Overall Study|Lost to Follow-up|6|||
27825151|NCT02139826|81192447|FG000|Overall Study|Adverse Event|1|||
27825152|NCT05041361|81192448|FG000|Overall Study|Lost to Follow-up|1|||
27825153|NCT05041361|81192449|FG001|Overall Study|Lost to Follow-up|3|||
27825154|NCT01136382|81192450|FG000|Overall Study|Other|8|||
27825155|NCT01136382|81192451|FG001|Overall Study|Other|3|||
27825156|NCT01136382|81192450|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
27825157|NCT01136382|81192451|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
27825158|NCT01136382|81192450|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
27825159|NCT01136382|81192451|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27825160|NCT01136382|81192450|FG000|Overall Study|Withdrawal by Subject|4|||
27825161|NCT01136382|81192451|FG001|Overall Study|Withdrawal by Subject|1|||
27825162|NCT01746017|81192452|FG000|Period 1|Withdrawal by Subject|0|||
27825163|NCT01746017|81192453|FG001|Period 1|Withdrawal by Subject|0|||
27825164|NCT01746017|81192454|FG002|Period 1|Withdrawal by Subject|0|||
27825165|NCT01746017|81192455|FG003|Period 1|Withdrawal by Subject|0|||
27825166|NCT01746017|81192456|FG004|Period 1|Withdrawal by Subject|0|||
27825167|NCT01746017|81192457|FG005|Period 1|Withdrawal by Subject|0|||
27825168|NCT01746017|81192458|FG006|Period 1|Withdrawal by Subject|1|||
27825169|NCT01746017|81192459|FG007|Period 1|Withdrawal by Subject|0|||
27825170|NCT01746017|81192460|FG008|Period 1|Withdrawal by Subject|0|||
27825171|NCT01746017|81192461|FG009|Period 1|Withdrawal by Subject|0|||
27553020|NCT00420927|80211346|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
27553021|NCT00420927|80211347|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
27553022|NCT00420927|80211348|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
27825172|NCT01746017|81192462|FG010|Period 1|Withdrawal by Subject|0|||
27825173|NCT01746017|81192452|FG000|Period 3|Withdrawal by Subject|0|||
27825174|NCT01746017|81192453|FG001|Period 3|Withdrawal by Subject|0|||
27694334|NCT00406653|80716718|FG006|Maintenance Period|Error in disease score evaluation|0|||
27694335|NCT00406653|80716712|FG000|Open-Label Period|Death|0|||
27694336|NCT00406653|80716713|FG001|Open-Label Period|Death|0|||
27694337|NCT00406653|80716714|FG002|Open-Label Period|Death|0|||
27694338|NCT00406653|80716715|FG003|Open-Label Period|Death|0|||
27694339|NCT00406653|80716716|FG004|Open-Label Period|Death|0|||
27694340|NCT00406653|80716717|FG005|Open-Label Period|Death|0|||
27694341|NCT00406653|80716718|FG006|Open-Label Period|Death|1|||
27553023|NCT00420927|80211349|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
27553024|NCT00420927|80211350|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
27553025|NCT00420927|80211351|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
27553026|NCT00420927|80211352|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
27553027|NCT00420927|80211346|FG000|Period 1|Failed to meet entry criteria|8|||
27553028|NCT00420927|80211347|FG001|Period 1|Failed to meet entry criteria|7|||
27553029|NCT00420927|80211348|FG002|Period 1|Failed to meet entry criteria|0|||
27553030|NCT00420927|80211349|FG003|Period 1|Failed to meet entry criteria|0|||
27553031|NCT00420927|80211350|FG004|Period 1|Failed to meet entry criteria|0|||
27694342|NCT00406653|80716712|FG000|Open-Label Period|Adverse Event|0|||
27825175|NCT01746017|81192454|FG002|Period 3|Withdrawal by Subject|0|||
27825176|NCT01746017|81192455|FG003|Period 3|Withdrawal by Subject|0|||
27553032|NCT00420927|80211351|FG005|Period 1|Failed to meet entry criteria|0|||
27553033|NCT00420927|80211352|FG006|Period 1|Failed to meet entry criteria|0|||
27553034|NCT00420927|80211346|FG000|Period 1|Took prohibited medication|1|||
27553035|NCT00420927|80211347|FG001|Period 1|Took prohibited medication|3|||
27553036|NCT00420927|80211348|FG002|Period 1|Took prohibited medication|0|||
27553037|NCT00420927|80211349|FG003|Period 1|Took prohibited medication|0|||
27553038|NCT00420927|80211350|FG004|Period 1|Took prohibited medication|0|||
27553039|NCT00420927|80211351|FG005|Period 1|Took prohibited medication|0|||
27553040|NCT00420927|80211352|FG006|Period 1|Took prohibited medication|0|||
27553041|NCT00420927|80211346|FG000|Period 2|Adverse Event|0|||
27553042|NCT00420927|80211347|FG001|Period 2|Adverse Event|0|||
27553043|NCT00420927|80211348|FG002|Period 2|Adverse Event|7|||
27553044|NCT00420927|80211349|FG003|Period 2|Adverse Event|3|||
27553045|NCT00420927|80211350|FG004|Period 2|Adverse Event|17|||
27553046|NCT00420927|80211351|FG005|Period 2|Adverse Event|6|||
27553047|NCT00420927|80211352|FG006|Period 2|Adverse Event|20|||
27553048|NCT00420927|80211346|FG000|Period 2|Withdrawal by Subject|0|||
27553049|NCT00420927|80211347|FG001|Period 2|Withdrawal by Subject|0|||
27553050|NCT00420927|80211348|FG002|Period 2|Withdrawal by Subject|1|||
27553051|NCT00420927|80211349|FG003|Period 2|Withdrawal by Subject|3|||
27553052|NCT00420927|80211350|FG004|Period 2|Withdrawal by Subject|11|||
27694343|NCT00406653|80716713|FG001|Open-Label Period|Adverse Event|0|||
27694344|NCT00406653|80716714|FG002|Open-Label Period|Adverse Event|0|||
27825177|NCT01746017|81192456|FG004|Period 3|Withdrawal by Subject|0|||
27825178|NCT01746017|81192457|FG005|Period 3|Withdrawal by Subject|1|||
27825179|NCT01746017|81192458|FG006|Period 3|Withdrawal by Subject|0|||
27825180|NCT01746017|81192459|FG007|Period 3|Withdrawal by Subject|0|||
27825181|NCT01746017|81192460|FG008|Period 3|Withdrawal by Subject|0|||
27825182|NCT01746017|81192461|FG009|Period 3|Withdrawal by Subject|0|||
27825183|NCT01746017|81192462|FG010|Period 3|Withdrawal by Subject|0|||
27825184|NCT01403194|81192463|FG000|Overall Study|Screen Failure|2|||
27825185|NCT01403194|81192463|FG000|Overall Study|Lost to Follow-up|8|||
27553053|NCT00420927|80211351|FG005|Period 2|Withdrawal by Subject|2|||
27553054|NCT00420927|80211352|FG006|Period 2|Withdrawal by Subject|12|||
27553055|NCT00420927|80211346|FG000|Period 2|Lost to Follow-up|0|||
27553056|NCT00420927|80211347|FG001|Period 2|Lost to Follow-up|0|||
27553057|NCT00420927|80211348|FG002|Period 2|Lost to Follow-up|2|||
27553058|NCT00420927|80211349|FG003|Period 2|Lost to Follow-up|2|||
27553059|NCT00420927|80211350|FG004|Period 2|Lost to Follow-up|6|||
27553060|NCT00420927|80211351|FG005|Period 2|Lost to Follow-up|3|||
27553061|NCT00420927|80211352|FG006|Period 2|Lost to Follow-up|9|||
27553062|NCT00420927|80211346|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
27553063|NCT00420927|80211347|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
27825186|NCT02605928|81192464|FG000|Overall Study|Model tuning phase|28|||
27553064|NCT00420927|80211348|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
27553065|NCT00420927|80211349|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
27553066|NCT00420927|80211350|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
27553067|NCT00420927|80211351|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
27553068|NCT00420927|80211352|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
27553069|NCT00420927|80211346|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
27553070|NCT00420927|80211347|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
27694345|NCT00406653|80716715|FG003|Open-Label Period|Adverse Event|0|||
27694346|NCT00406653|80716716|FG004|Open-Label Period|Adverse Event|0|||
27825187|NCT02605928|81192464|FG000|Overall Study|Lack of Efficacy|5|||
27883664|NCT01029782|81408029|FG001|Overall Study|Lost to Follow-up|2|||
27553071|NCT00420927|80211348|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
27553072|NCT00420927|80211349|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
27553073|NCT00420927|80211350|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
27553074|NCT00420927|80211351|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
27553075|NCT00420927|80211352|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
27553076|NCT00420927|80211346|FG000|Period 2|Subject unable to find transportation|0|||
27553077|NCT00420927|80211347|FG001|Period 2|Subject unable to find transportation|0|||
27825188|NCT00537030|81192470|FG000|Overall Study|Physician Decision|2|||
27825189|NCT00537030|81192470|FG000|Overall Study|Withdrawal by Subject|2|||
27825190|NCT00537030|81192470|FG000|Overall Study|≥ Grade 2 allergy|7|||
27825191|NCT00537030|81192470|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
27825192|NCT00537030|81192470|FG000|Overall Study|Ineligible|2|||
27825193|NCT00537030|81192470|FG000|Overall Study|Inevaluable|2|||
27825194|NCT03236311|81192472|FG000|Overall Study|Study terminated by sponsor|0|||
27825195|NCT03236311|81192473|FG001|Overall Study|Study terminated by sponsor|2|||
27825196|NCT03236311|81192472|FG000|Overall Study|Adverse Event|0|||
27825197|NCT03236311|81192473|FG001|Overall Study|Adverse Event|1|||
27825198|NCT02158663|81192474|FG000|Overall Study|Withdrawal by Subject|5|||
27825199|NCT02158663|81192475|FG001|Overall Study|Withdrawal by Subject|4|||
27825200|NCT01472341|81192476|FG000|Overall Study|Started insulin therapy|55|||
27825201|NCT01472341|81192476|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
27825202|NCT01472341|81192476|FG000|Overall Study|Withdrawal by Subject|39|||
27825203|NCT01472341|81192476|FG000|Overall Study|Lost to Follow-up|52|||
27825204|NCT01472341|81192476|FG000|Overall Study|Laboratory parameters unavailable|25|||
27825205|NCT01472341|81192476|FG000|Overall Study|Death|9|||
27825206|NCT01370733|81192477|FG000|Overall Study|Withdrawal by Subject|8|||
27825207|NCT01370733|81192478|FG001|Overall Study|Withdrawal by Subject|8|||
27825208|NCT01370733|81192477|FG000|Overall Study|Lost to Follow-up|3|||
27825209|NCT01370733|81192478|FG001|Overall Study|Lost to Follow-up|0|||
27825210|NCT01370733|81192477|FG000|Overall Study|Adverse Event|2|||
27825211|NCT01370733|81192478|FG001|Overall Study|Adverse Event|4|||
27825212|NCT01370733|81192477|FG000|Overall Study|Lack of Efficacy|3|||
27825213|NCT01370733|81192478|FG001|Overall Study|Lack of Efficacy|5|||
27825214|NCT01370733|81192477|FG000|Overall Study|Physician Decision|0|||
27825215|NCT01370733|81192478|FG001|Overall Study|Physician Decision|2|||
27825216|NCT01370733|81192477|FG000|Overall Study|Protocol Violation|1|||
27825217|NCT01370733|81192478|FG001|Overall Study|Protocol Violation|3|||
27825218|NCT02481830|81192479|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
27825219|NCT02481830|81192480|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
27825220|NCT02481830|81192479|FG000|Pre-treatment|Withdrawal by Subject|0|||
27825221|NCT02481830|81192480|FG001|Pre-treatment|Withdrawal by Subject|10|||
27825222|NCT02481830|81192479|FG000|Pre-treatment|Disease Progression|1|||
27825223|NCT02481830|81192480|FG001|Pre-treatment|Disease Progression|1|||
27825224|NCT02481830|81192479|FG000|Pre-treatment|Other reasons|0|||
27825225|NCT02481830|81192480|FG001|Pre-treatment|Other reasons|1|||
27825226|NCT02481830|81192479|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
27825227|NCT02481830|81192480|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
27825228|NCT02481830|81192479|FG000|Treatment|Disease Progression|233|||
27825229|NCT02481830|81192480|FG001|Treatment|Disease Progression|171|||
27825230|NCT02481830|81192479|FG000|Treatment|Study drug toxicity|18|||
27825231|NCT02481830|81192480|FG001|Treatment|Study drug toxicity|38|||
27825232|NCT02481830|81192479|FG000|Treatment|Death|1|||
27825233|NCT02481830|81192480|FG001|Treatment|Death|1|||
27825234|NCT02481830|81192479|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
27825235|NCT02481830|81192480|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
27825236|NCT02481830|81192479|FG000|Treatment|Participants request to discontinue Study treatment|6|||
27825237|NCT02481830|81192480|FG001|Treatment|Participants request to discontinue Study treatment|34|||
27825238|NCT02481830|81192479|FG000|Treatment|Withdrawal by Subject|2|||
27825239|NCT02481830|81192480|FG001|Treatment|Withdrawal by Subject|3|||
27553078|NCT00420927|80211348|FG002|Period 2|Subject unable to find transportation|0|||
27553079|NCT00420927|80211349|FG003|Period 2|Subject unable to find transportation|0|||
27553080|NCT00420927|80211350|FG004|Period 2|Subject unable to find transportation|0|||
27553081|NCT00420927|80211351|FG005|Period 2|Subject unable to find transportation|0|||
27553082|NCT00420927|80211352|FG006|Period 2|Subject unable to find transportation|1|||
27825240|NCT02481830|81192479|FG000|Treatment|Lost to Follow-up|1|||
27825241|NCT02481830|81192480|FG001|Treatment|Lost to Follow-up|0|||
27825242|NCT02481830|81192479|FG000|Treatment|Maximum Clinical Benefit|0|||
27825243|NCT02481830|81192480|FG001|Treatment|Maximum Clinical Benefit|5|||
27825244|NCT02481830|81192479|FG000|Treatment|Administrative reason by sponsor|1|||
27553083|NCT00420927|80211346|FG000|Period 2|Physician Decision|0|||
27825245|NCT02481830|81192480|FG001|Treatment|Administrative reason by sponsor|1|||
27825246|NCT02481830|81192479|FG000|Treatment|Other reasons|6|||
27825247|NCT02481830|81192480|FG001|Treatment|Other reasons|1|||
27825248|NCT01279486|81192481|FG000|Overall Study|Lost to Follow-up|1|||
27825249|NCT03649477|81192485|FG000|Overall Study|Adverse Event|2|||
27553084|NCT00420927|80211347|FG001|Period 2|Physician Decision|0|||
27553085|NCT00420927|80211348|FG002|Period 2|Physician Decision|0|||
27553086|NCT00420927|80211349|FG003|Period 2|Physician Decision|0|||
27553087|NCT00420927|80211350|FG004|Period 2|Physician Decision|1|||
27553088|NCT00420927|80211351|FG005|Period 2|Physician Decision|1|||
27553089|NCT00420927|80211352|FG006|Period 2|Physician Decision|0|||
27553090|NCT00420927|80211346|FG000|Period 2|Sponsor decision|0|||
27553091|NCT00420927|80211347|FG001|Period 2|Sponsor decision|0|||
27553092|NCT00420927|80211348|FG002|Period 2|Sponsor decision|1|||
27553093|NCT00420927|80211349|FG003|Period 2|Sponsor decision|0|||
27553094|NCT00420927|80211350|FG004|Period 2|Sponsor decision|0|||
27553095|NCT00420927|80211351|FG005|Period 2|Sponsor decision|0|||
27553096|NCT00420927|80211352|FG006|Period 2|Sponsor decision|1|||
27553097|NCT00420927|80211346|FG000|Period 2|Randomization error|0|||
27553098|NCT00420927|80211347|FG001|Period 2|Randomization error|0|||
27553099|NCT00420927|80211348|FG002|Period 2|Randomization error|0|||
27553100|NCT00420927|80211349|FG003|Period 2|Randomization error|0|||
27553101|NCT00420927|80211350|FG004|Period 2|Randomization error|1|||
27553102|NCT00420927|80211351|FG005|Period 2|Randomization error|1|||
27553103|NCT00420927|80211352|FG006|Period 2|Randomization error|0|||
27553104|NCT00420927|80211346|FG000|Period 2|Noncompliant with study drug|0|||
27553105|NCT00420927|80211347|FG001|Period 2|Noncompliant with study drug|0|||
27553106|NCT00420927|80211348|FG002|Period 2|Noncompliant with study drug|0|||
27553107|NCT00420927|80211349|FG003|Period 2|Noncompliant with study drug|1|||
27553108|NCT00420927|80211350|FG004|Period 2|Noncompliant with study drug|0|||
27553109|NCT00420927|80211351|FG005|Period 2|Noncompliant with study drug|0|||
27553110|NCT00420927|80211352|FG006|Period 2|Noncompliant with study drug|2|||
27553111|NCT00420927|80211346|FG000|Period 2|Methotrexate intolerance|0|||
27553112|NCT00420927|80211347|FG001|Period 2|Methotrexate intolerance|0|||
27553113|NCT00420927|80211348|FG002|Period 2|Methotrexate intolerance|0|||
27553114|NCT00420927|80211349|FG003|Period 2|Methotrexate intolerance|0|||
27553115|NCT00420927|80211350|FG004|Period 2|Methotrexate intolerance|0|||
27553116|NCT00420927|80211351|FG005|Period 2|Methotrexate intolerance|0|||
27553117|NCT00420927|80211352|FG006|Period 2|Methotrexate intolerance|1|||
27553118|NCT00420927|80211346|FG000|Period 2|Took prohibited medication|0|||
27553119|NCT00420927|80211347|FG001|Period 2|Took prohibited medication|0|||
27553120|NCT00420927|80211348|FG002|Period 2|Took prohibited medication|0|||
27553121|NCT00420927|80211349|FG003|Period 2|Took prohibited medication|0|||
27553122|NCT00420927|80211350|FG004|Period 2|Took prohibited medication|1|||
27553123|NCT00420927|80211351|FG005|Period 2|Took prohibited medication|0|||
27553124|NCT00420927|80211352|FG006|Period 2|Took prohibited medication|0|||
27553125|NCT01417234|80211353|FG000|Overall Study|Subject non-compliant|3|||
27553126|NCT00726661|80211354|FG000|Overall Study|Lost to Follow-up|36|||
27553127|NCT00726661|80211355|FG001|Overall Study|Lost to Follow-up|11|||
27553128|NCT00726661|80211354|FG000|Overall Study|Withdrawal by Subject|17|||
27553129|NCT00726661|80211355|FG001|Overall Study|Withdrawal by Subject|13|||
27553130|NCT00726661|80211354|FG000|Overall Study|Trial terminated by sponsor|214|||
27553131|NCT00726661|80211355|FG001|Overall Study|Trial terminated by sponsor|187|||
27553132|NCT00726661|80211354|FG000|Overall Study|Death|475|||
27553133|NCT00726661|80211355|FG001|Overall Study|Death|159|||
27553134|NCT00726661|80211354|FG000|Overall Study|Physician Decision|25|||
27553135|NCT00726661|80211355|FG001|Overall Study|Physician Decision|13|||
27553136|NCT00726661|80211354|FG000|Overall Study|Other|47|||
27553137|NCT00726661|80211355|FG001|Overall Study|Other|35|||
27553138|NCT00936910|80211356|FG000|Overall Study|Lack of Efficacy|3|||
27553139|NCT01074450|80211357|FG000|First Intervention|Emesis in Dosing Interval|0|||
27553140|NCT01074450|80211358|FG001|First Intervention|Emesis in Dosing Interval|2|||
27553141|NCT01074450|80211357|FG000|Second Intervention|Protocol Violation|1|||
27553142|NCT01074450|80211358|FG001|Second Intervention|Protocol Violation|0|||
27694347|NCT00406653|80716717|FG005|Open-Label Period|Adverse Event|0|||
27553143|NCT01074450|80211357|FG000|Second Intervention|Physician Decision|0|||
27553144|NCT01074450|80211358|FG001|Second Intervention|Physician Decision|1|||
27553145|NCT00005937|80211361|FG000|Overall Study|Lack of Efficacy|5|||
27553146|NCT04118166|80211362|FG000|Overall Study|Adverse Event|1|||
27553147|NCT02407704|80211363|FG000|Overall Study|Lost to Follow-up|0|||
27553148|NCT02407704|80211364|FG001|Overall Study|Lost to Follow-up|0|||
27553149|NCT02407704|80211365|FG002|Overall Study|Lost to Follow-up|0|||
27553150|NCT02407704|80211366|FG003|Overall Study|Lost to Follow-up|2|||
27553151|NCT02407704|80211363|FG000|Overall Study|Protocol Violation|0|||
27553152|NCT02407704|80211364|FG001|Overall Study|Protocol Violation|0|||
27553153|NCT02407704|80211365|FG002|Overall Study|Protocol Violation|0|||
27553154|NCT02407704|80211366|FG003|Overall Study|Protocol Violation|1|||
27553155|NCT02407704|80211363|FG000|Overall Study|Withdrawal by Subject|0|||
27553156|NCT02407704|80211364|FG001|Overall Study|Withdrawal by Subject|0|||
27553157|NCT02407704|80211365|FG002|Overall Study|Withdrawal by Subject|1|||
27553158|NCT02407704|80211366|FG003|Overall Study|Withdrawal by Subject|0|||
27553159|NCT04952402|80211367|FG000|Overall Study|Lost to Follow-up|1|||
27553160|NCT04952402|80211368|FG001|Overall Study|Lost to Follow-up|3|||
27553161|NCT04952402|80211367|FG000|Overall Study|Lack Of Venous Access|0|||
27553162|NCT04952402|80211368|FG001|Overall Study|Lack Of Venous Access|1|||
27553163|NCT04016285|80211371|FG000|Overall Study|Did not progress to surgery|2|||
27553164|NCT04016285|80211372|FG001|Overall Study|Did not progress to surgery|5|||
27553165|NCT04016285|80211371|FG000|Overall Study|Failed to collect outcome data|5|||
27553166|NCT04016285|80211372|FG001|Overall Study|Failed to collect outcome data|3|||
27553167|NCT02329730|80211375|FG000|Overall Study|Protocol Violation|0|||
27553168|NCT02329730|80211376|FG001|Overall Study|Protocol Violation|0|||
27553169|NCT02329730|80211377|FG002|Overall Study|Protocol Violation|0|||
27553170|NCT02329730|80211378|FG003|Overall Study|Protocol Violation|0|||
27553171|NCT02329730|80211379|FG004|Overall Study|Protocol Violation|2|||
27553172|NCT02329730|80211380|FG005|Overall Study|Protocol Violation|2|||
27553173|NCT02329730|80211381|FG006|Overall Study|Protocol Violation|0|||
27553174|NCT02329730|80211382|FG007|Overall Study|Protocol Violation|0|||
27553175|NCT02329730|80211383|FG008|Overall Study|Protocol Violation|0|||
27553176|NCT02329730|80211384|FG009|Overall Study|Protocol Violation|0|||
27553177|NCT02329730|80211385|FG010|Overall Study|Protocol Violation|0|||
27553178|NCT02329730|80211386|FG011|Overall Study|Protocol Violation|0|||
27553179|NCT02329730|80211375|FG000|Overall Study|Withdrawal by Subject|0|||
27553180|NCT02329730|80211376|FG001|Overall Study|Withdrawal by Subject|0|||
27553181|NCT02329730|80211377|FG002|Overall Study|Withdrawal by Subject|0|||
27553182|NCT02329730|80211378|FG003|Overall Study|Withdrawal by Subject|0|||
27553183|NCT02329730|80211379|FG004|Overall Study|Withdrawal by Subject|1|||
27553184|NCT02329730|80211380|FG005|Overall Study|Withdrawal by Subject|0|||
27553185|NCT02329730|80211381|FG006|Overall Study|Withdrawal by Subject|1|||
27553186|NCT02329730|80211382|FG007|Overall Study|Withdrawal by Subject|1|||
27553187|NCT02329730|80211383|FG008|Overall Study|Withdrawal by Subject|1|||
27553188|NCT02329730|80211384|FG009|Overall Study|Withdrawal by Subject|1|||
27553189|NCT02329730|80211385|FG010|Overall Study|Withdrawal by Subject|0|||
27553190|NCT02329730|80211386|FG011|Overall Study|Withdrawal by Subject|0|||
27553191|NCT00720434|80211388|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
27553192|NCT00720434|80211389|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
27694348|NCT00406653|80716718|FG006|Open-Label Period|Adverse Event|18|||
27553193|NCT00720434|80211390|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
27553194|NCT00720434|80211391|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
27553195|NCT00720434|80211388|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
27553196|NCT00720434|80211389|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
27553197|NCT00720434|80211390|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
27553198|NCT00720434|80211391|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
27553199|NCT00720434|80211388|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
27553200|NCT00720434|80211389|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
27553201|NCT00720434|80211390|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
27553202|NCT00720434|80211391|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
27553203|NCT00720434|80211388|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
27553204|NCT00720434|80211389|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
27553205|NCT00720434|80211390|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
27553206|NCT00720434|80211391|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
27553207|NCT00720434|80211388|FG000|Open-Label Period (Week 5-72)|Other|4|||
27553208|NCT00720434|80211389|FG001|Open-Label Period (Week 5-72)|Other|3|||
27553209|NCT00720434|80211390|FG002|Open-Label Period (Week 5-72)|Other|3|||
27553210|NCT00720434|80211391|FG003|Open-Label Period (Week 5-72)|Other|2|||
27553211|NCT03716024|80211392|FG000|Overall Study|Randomized, not Treated|7|||
27553212|NCT03716024|80211393|FG001|Overall Study|Randomized, not Treated|8|||
27553213|NCT03716024|80211392|FG000|Overall Study|Adverse Event|1|||
27553214|NCT03716024|80211393|FG001|Overall Study|Adverse Event|2|||
27553215|NCT03716024|80211392|FG000|Overall Study|Treatment Failure|1|||
27553216|NCT03716024|80211393|FG001|Overall Study|Treatment Failure|0|||
27553217|NCT03716024|80211392|FG000|Overall Study|Lost to Follow-up|2|||
27553218|NCT03716024|80211393|FG001|Overall Study|Lost to Follow-up|6|||
27553219|NCT03716024|80211392|FG000|Overall Study|Withdrawal by Subject|0|||
27553220|NCT03716024|80211393|FG001|Overall Study|Withdrawal by Subject|1|||
27553221|NCT03716024|80211392|FG000|Overall Study|Missing Reason|0|||
27553222|NCT03716024|80211393|FG001|Overall Study|Missing Reason|1|||
27553223|NCT01850524|80211396|FG000|Overall Study|Lost to Follow-up|5|||
27553224|NCT01850524|80211397|FG001|Overall Study|Lost to Follow-up|10|||
27553225|NCT01850524|80211396|FG000|Overall Study|Withdrawal by Subject|24|||
27553226|NCT01850524|80211397|FG001|Overall Study|Withdrawal by Subject|22|||
27553227|NCT01850524|80211396|FG000|Overall Study|Reason not Specified|142|||
27553228|NCT01850524|80211397|FG001|Overall Study|Reason not Specified|141|||
27694349|NCT00406653|80716712|FG000|Open-Label Period|Lack of Efficacy|0|||
27694350|NCT00406653|80716713|FG001|Open-Label Period|Lack of Efficacy|0|||
27553229|NCT00001596|80211400|FG000|Overall Study|Death|1|||
27553230|NCT00001596|80211401|FG001|Overall Study|Death|0|||
27694351|NCT00406653|80716714|FG002|Open-Label Period|Lack of Efficacy|0|||
27553231|NCT00001596|80211400|FG000|Overall Study|Withdrawal by Subject|3|||
27553232|NCT00001596|80211401|FG001|Overall Study|Withdrawal by Subject|1|||
27553233|NCT00001596|80211400|FG000|Overall Study|Study Termination|12|||
27553234|NCT00001596|80211401|FG001|Overall Study|Study Termination|9|||
27553235|NCT00001596|80211400|FG000|Overall Study|Adverse Event|1|||
27553236|NCT00001596|80211401|FG001|Overall Study|Adverse Event|0|||
27553237|NCT03291808|80211404|FG000|Overall Study|Lost to Follow-up|6|||
27553238|NCT03291808|80211404|FG000|Overall Study|Research burden|4|||
27553239|NCT01214629|80211418|FG000|Overall Study|Progressive Disease|1|||
27553240|NCT01214629|80211419|FG001|Overall Study|Progressive Disease|1|||
27553241|NCT01214629|80211420|FG002|Overall Study|Progressive Disease|0|||
27553242|NCT01214629|80211421|FG003|Overall Study|Progressive Disease|1|||
27553243|NCT01214629|80211422|FG004|Overall Study|Progressive Disease|2|||
27553244|NCT01214629|80211423|FG005|Overall Study|Progressive Disease|3|||
27553245|NCT01214629|80211424|FG006|Overall Study|Progressive Disease|1|||
27553246|NCT01214629|80211425|FG007|Overall Study|Progressive Disease|1|||
27553247|NCT01214629|80211426|FG008|Overall Study|Progressive Disease|1|||
27553248|NCT01214629|80211427|FG009|Overall Study|Progressive Disease|5|||
27553249|NCT01214629|80211428|FG010|Overall Study|Progressive Disease|1|||
27553250|NCT01214629|80211418|FG000|Overall Study|Adverse Event|0|||
27553251|NCT01214629|80211419|FG001|Overall Study|Adverse Event|0|||
27553252|NCT01214629|80211420|FG002|Overall Study|Adverse Event|0|||
27553253|NCT01214629|80211421|FG003|Overall Study|Adverse Event|1|||
27553254|NCT01214629|80211422|FG004|Overall Study|Adverse Event|0|||
27553255|NCT01214629|80211423|FG005|Overall Study|Adverse Event|1|||
27553256|NCT01214629|80211424|FG006|Overall Study|Adverse Event|0|||
27553257|NCT01214629|80211425|FG007|Overall Study|Adverse Event|0|||
27553258|NCT01214629|80211426|FG008|Overall Study|Adverse Event|0|||
27553259|NCT01214629|80211427|FG009|Overall Study|Adverse Event|1|||
27553260|NCT01214629|80211428|FG010|Overall Study|Adverse Event|0|||
27553261|NCT01214629|80211418|FG000|Overall Study|Physician Decision|0|||
27553262|NCT01214629|80211419|FG001|Overall Study|Physician Decision|0|||
27553263|NCT01214629|80211420|FG002|Overall Study|Physician Decision|0|||
27553264|NCT01214629|80211421|FG003|Overall Study|Physician Decision|0|||
27553265|NCT01214629|80211422|FG004|Overall Study|Physician Decision|0|||
27553266|NCT01214629|80211423|FG005|Overall Study|Physician Decision|0|||
27553267|NCT01214629|80211424|FG006|Overall Study|Physician Decision|0|||
27553268|NCT01214629|80211425|FG007|Overall Study|Physician Decision|0|||
27553269|NCT01214629|80211426|FG008|Overall Study|Physician Decision|0|||
27553270|NCT01214629|80211427|FG009|Overall Study|Physician Decision|0|||
27553271|NCT01214629|80211428|FG010|Overall Study|Physician Decision|1|||
27553272|NCT01214629|80211418|FG000|Overall Study|Withdrawal by Subject|0|||
27553273|NCT01214629|80211419|FG001|Overall Study|Withdrawal by Subject|0|||
27553274|NCT01214629|80211420|FG002|Overall Study|Withdrawal by Subject|0|||
27553275|NCT01214629|80211421|FG003|Overall Study|Withdrawal by Subject|0|||
27553276|NCT01214629|80211422|FG004|Overall Study|Withdrawal by Subject|0|||
27553277|NCT01214629|80211423|FG005|Overall Study|Withdrawal by Subject|0|||
27553278|NCT01214629|80211424|FG006|Overall Study|Withdrawal by Subject|0|||
27553279|NCT01214629|80211425|FG007|Overall Study|Withdrawal by Subject|0|||
27553280|NCT01214629|80211426|FG008|Overall Study|Withdrawal by Subject|0|||
27553281|NCT01214629|80211427|FG009|Overall Study|Withdrawal by Subject|1|||
27553282|NCT01214629|80211428|FG010|Overall Study|Withdrawal by Subject|0|||
27553283|NCT00290888|80211431|FG000|Overall Study|Physician Decision|3|||
27553284|NCT00290888|80211432|FG001|Overall Study|Physician Decision|1|||
27553285|NCT04140292|80211439|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
27553286|NCT04140292|80211440|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
27553287|NCT02507505|80211443|FG000|Overall Study|Withdrawal by Subject|13|||
27553288|NCT02507505|80211444|FG001|Overall Study|Withdrawal by Subject|11|||
27553289|NCT02507505|80211443|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
27553290|NCT02507505|80211444|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
27553291|NCT02507505|80211443|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
27553292|NCT02507505|80211444|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
27553293|NCT02507505|80211443|FG000|Overall Study|Death before receipt of anesthesia|0|||
27553294|NCT02507505|80211444|FG001|Overall Study|Death before receipt of anesthesia|1|||
27553295|NCT00001723|80211445|FG000|Overall Study|Lack of Efficacy|6|||
27553296|NCT00001723|80211446|FG001|Overall Study|Lack of Efficacy|7|||
27553297|NCT00001723|80211445|FG000|Overall Study|Lack of family interest|4|||
27553298|NCT00001723|80211446|FG001|Overall Study|Lack of family interest|5|||
27553299|NCT00001723|80211445|FG000|Overall Study|Lost to Follow-up|2|||
27553300|NCT00001723|80211446|FG001|Overall Study|Lost to Follow-up|2|||
27553301|NCT00001723|80211445|FG000|Overall Study|medication intolerance|1|||
27553302|NCT00001723|80211446|FG001|Overall Study|medication intolerance|2|||
27553303|NCT01907815|80211447|FG000|Overall Study|Withdrawal by Subject|1|||
27553304|NCT01907815|80211448|FG001|Overall Study|Withdrawal by Subject|0|||
27553305|NCT01315678|80211449|FG000|Overall Study|Withdrawal by Subject|7|||
27553306|NCT01315678|80211450|FG001|Overall Study|Withdrawal by Subject|3|||
27553307|NCT01315678|80211449|FG000|Overall Study|Adverse Event|3|||
27553308|NCT01315678|80211450|FG001|Overall Study|Adverse Event|1|||
27553309|NCT01315678|80211449|FG000|Overall Study|Lost to Follow-up|1|||
27553310|NCT01315678|80211450|FG001|Overall Study|Lost to Follow-up|0|||
27553311|NCT01315678|80211449|FG000|Overall Study|similar reason to those listed above|3|||
27553312|NCT01315678|80211450|FG001|Overall Study|similar reason to those listed above|2|||
27553313|NCT01291173|80211451|FG000|Overall Study|Adverse Event|0|||
27553314|NCT01291173|80211452|FG001|Overall Study|Adverse Event|3|||
27553315|NCT01291173|80211453|FG002|Overall Study|Adverse Event|1|||
27553316|NCT01291173|80211454|FG003|Overall Study|Adverse Event|3|||
27553317|NCT01291173|80211451|FG000|Overall Study|Protocol Violation|7|||
27553318|NCT01291173|80211452|FG001|Overall Study|Protocol Violation|2|||
27553319|NCT01291173|80211453|FG002|Overall Study|Protocol Violation|2|||
27553320|NCT01291173|80211454|FG003|Overall Study|Protocol Violation|5|||
27553321|NCT01291173|80211451|FG000|Overall Study|Withdrawal by Subject|6|||
27553322|NCT01291173|80211452|FG001|Overall Study|Withdrawal by Subject|4|||
27553323|NCT01291173|80211453|FG002|Overall Study|Withdrawal by Subject|4|||
27553324|NCT01291173|80211454|FG003|Overall Study|Withdrawal by Subject|2|||
27553325|NCT01291173|80211451|FG000|Overall Study|Lost to Follow-up|4|||
27553326|NCT01291173|80211452|FG001|Overall Study|Lost to Follow-up|6|||
27553327|NCT01291173|80211453|FG002|Overall Study|Lost to Follow-up|3|||
27553328|NCT01291173|80211454|FG003|Overall Study|Lost to Follow-up|2|||
27553329|NCT01291173|80211451|FG000|Overall Study|Unable to meet visit schedule|0|||
27553330|NCT01291173|80211452|FG001|Overall Study|Unable to meet visit schedule|0|||
27553331|NCT01291173|80211453|FG002|Overall Study|Unable to meet visit schedule|1|||
27553332|NCT01291173|80211454|FG003|Overall Study|Unable to meet visit schedule|0|||
27553333|NCT01291173|80211451|FG000|Overall Study|Lack of compliance|0|||
27553334|NCT01291173|80211452|FG001|Overall Study|Lack of compliance|0|||
27553335|NCT01291173|80211453|FG002|Overall Study|Lack of compliance|0|||
27553336|NCT01291173|80211454|FG003|Overall Study|Lack of compliance|1|||
27553337|NCT01291173|80211451|FG000|Overall Study|Subject was unblinded|0|||
27553338|NCT01291173|80211452|FG001|Overall Study|Subject was unblinded|0|||
27553339|NCT01291173|80211453|FG002|Overall Study|Subject was unblinded|1|||
27553340|NCT01291173|80211454|FG003|Overall Study|Subject was unblinded|0|||
27553341|NCT01291173|80211451|FG000|Overall Study|Excluded therapy|0|||
27553342|NCT01291173|80211452|FG001|Overall Study|Excluded therapy|0|||
27553343|NCT01291173|80211453|FG002|Overall Study|Excluded therapy|1|||
27553344|NCT01291173|80211454|FG003|Overall Study|Excluded therapy|0|||
27553345|NCT01955733|80211455|FG000|Period 1|Lost to Follow-up|1|||
27553346|NCT01955733|80211456|FG001|Period 1|Lost to Follow-up|0|||
27553347|NCT01955733|80211457|FG002|Period 1|Lost to Follow-up|0|||
27553348|NCT01955733|80211455|FG000|Period 2|Adverse Event|1|||
27553349|NCT01955733|80211456|FG001|Period 2|Adverse Event|0|||
27553350|NCT01955733|80211457|FG002|Period 2|Adverse Event|0|||
27553351|NCT01955733|80211455|FG000|Period 2|Physician Decision|0|||
27553352|NCT01955733|80211456|FG001|Period 2|Physician Decision|0|||
27553353|NCT01955733|80211457|FG002|Period 2|Physician Decision|1|||
27553354|NCT01955733|80211455|FG000|Period 2|Withdrawal by Subject|1|||
27553355|NCT01955733|80211456|FG001|Period 2|Withdrawal by Subject|3|||
27553356|NCT01955733|80211457|FG002|Period 2|Withdrawal by Subject|2|||
27553357|NCT01955733|80211455|FG000|Period 2|Study terminated by sponsor|8|||
27553358|NCT01955733|80211456|FG001|Period 2|Study terminated by sponsor|14|||
27553359|NCT01955733|80211457|FG002|Period 2|Study terminated by sponsor|16|||
27553360|NCT01955733|80211455|FG000|Period 2|Lost to Follow-up|2|||
27553361|NCT01955733|80211456|FG001|Period 2|Lost to Follow-up|0|||
27553362|NCT01955733|80211457|FG002|Period 2|Lost to Follow-up|0|||
27553363|NCT01955733|80211455|FG000|Period 2|Other not defined above|0|||
27553364|NCT01955733|80211456|FG001|Period 2|Other not defined above|2|||
27553365|NCT01955733|80211457|FG002|Period 2|Other not defined above|2|||
27553366|NCT03998189|80211458|FG000|Overall Study|Lack of Efficacy|0|||
27553367|NCT03998189|80211459|FG001|Overall Study|Lack of Efficacy|1|||
27553368|NCT04900220|80211460|FG000|Overall Study|Lost to Follow-up|1|||
27553369|NCT04900220|80211461|FG001|Overall Study|Lost to Follow-up|1|||
27553370|NCT01276353|80211462|FG000|Double-blind|Adverse Event|2|||
27553371|NCT01276353|80211463|FG001|Double-blind|Adverse Event|0|||
27553372|NCT01276353|80211462|FG000|Double-blind|Withdrawal by Subject|1|||
27553373|NCT01276353|80211463|FG001|Double-blind|Withdrawal by Subject|0|||
27553374|NCT01276353|80211462|FG000|Extension|Adverse Event|2|||
27553375|NCT01276353|80211463|FG001|Extension|Adverse Event|5|||
27553376|NCT01276353|80211462|FG000|Extension|Withdrawal by Subject|1|||
27553377|NCT01276353|80211463|FG001|Extension|Withdrawal by Subject|2|||
27694352|NCT00406653|80716715|FG003|Open-Label Period|Lack of Efficacy|0|||
27883665|NCT01029782|81408028|FG000|Overall Study|Diagnosis changed|1|||
27883666|NCT01029782|81408029|FG001|Overall Study|Diagnosis changed|1|||
27883667|NCT01029782|81408028|FG000|Overall Study|Adverse Event|0|||
27883668|NCT01029782|81408029|FG001|Overall Study|Adverse Event|1|||
27883669|NCT01029782|81408028|FG000|Overall Study|Physician Decision|0|||
27883670|NCT01029782|81408029|FG001|Overall Study|Physician Decision|1|||
27883671|NCT01029782|81408028|FG000|Overall Study|Protocol Violation|0|||
27883672|NCT01029782|81408029|FG001|Overall Study|Protocol Violation|2|||
27883673|NCT01029782|81408028|FG000|Overall Study|Withdrawal by Subject|0|||
27883674|NCT01029782|81408029|FG001|Overall Study|Withdrawal by Subject|1|||
27883675|NCT01430754|81408036|FG000|Run-In Phase|Circadian Period Ineligible|24|||
27883676|NCT01430754|81408037|FG001|Run-In Phase|Circadian Period Ineligible|0|||
27694353|NCT00406653|80716716|FG004|Open-Label Period|Lack of Efficacy|0|||
27694354|NCT00406653|80716717|FG005|Open-Label Period|Lack of Efficacy|0|||
27694355|NCT00406653|80716718|FG006|Open-Label Period|Lack of Efficacy|160|||
27825250|NCT03649477|81192486|FG001|Overall Study|Adverse Event|0|||
27825251|NCT03649477|81192487|FG002|Overall Study|Adverse Event|0|||
27825252|NCT01401647|81192489|FG000|Overall Study|Withdrawal by Subject|1|||
27825253|NCT01401647|81192490|FG001|Overall Study|Withdrawal by Subject|5|||
27825254|NCT01401647|81192491|FG002|Overall Study|Withdrawal by Subject|2|||
27825255|NCT01401647|81192489|FG000|Overall Study|Lost to Follow-up|3|||
27883677|NCT01430754|81408036|FG000|Run-In Phase|Protocol Violation|6|||
27883678|NCT01430754|81408037|FG001|Run-In Phase|Protocol Violation|0|||
27883679|NCT01430754|81408036|FG000|Run-In Phase|Adverse Event|2|||
27883680|NCT01430754|81408037|FG001|Run-In Phase|Adverse Event|0|||
27883681|NCT01430754|81408036|FG000|Run-In Phase|Other|2|||
27825256|NCT01401647|81192490|FG001|Overall Study|Lost to Follow-up|3|||
27883682|NCT01430754|81408037|FG001|Run-In Phase|Other|0|||
27883683|NCT01430754|81408036|FG000|Run-In Phase|Withdrawal by Subject|2|||
27883684|NCT01430754|81408037|FG001|Run-In Phase|Withdrawal by Subject|0|||
27883685|NCT01430754|81408036|FG000|Run-In Phase|Lost to Follow-up|1|||
27883686|NCT01430754|81408037|FG001|Run-In Phase|Lost to Follow-up|0|||
27694356|NCT00406653|80716712|FG000|Open-Label Period|Lost to Follow-up|0|||
27825257|NCT01401647|81192491|FG002|Overall Study|Lost to Follow-up|1|||
27553378|NCT01276353|80211462|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
27553379|NCT01276353|80211463|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
27553380|NCT01276353|80211462|FG000|Extension|Physician Decision|1|||
27553381|NCT01276353|80211463|FG001|Extension|Physician Decision|0|||
27694357|NCT00406653|80716713|FG001|Open-Label Period|Lost to Follow-up|0|||
27825258|NCT02294604|81192495|FG000|Overall Study|Did not provide samples for culture|0|||
27825259|NCT02294604|81192496|FG001|Overall Study|Did not provide samples for culture|1|||
27825260|NCT02294604|81192497|FG002|Overall Study|Did not provide samples for culture|0|||
27825261|NCT02294604|81192495|FG000|Overall Study|Culture contamination|1|||
27825262|NCT02294604|81192496|FG001|Overall Study|Culture contamination|2|||
27825263|NCT02294604|81192497|FG002|Overall Study|Culture contamination|0|||
27825264|NCT02655679|81192501|FG000|Overall Study|Adverse Event|0|||
27825265|NCT02655679|81192502|FG001|Overall Study|Adverse Event|1|||
27825266|NCT02655679|81192503|FG002|Overall Study|Adverse Event|0|||
27825267|NCT02655679|81192504|FG003|Overall Study|Adverse Event|0|||
27825268|NCT02655679|81192505|FG004|Overall Study|Adverse Event|0|||
27825269|NCT02655679|81192501|FG000|Overall Study|Withdrawal by Subject|1|||
27553382|NCT01276353|80211462|FG000|Extension|Prohibited concomitant medications|0|||
27883687|NCT00267969|81408044|FG000|Controlled Period|Adverse Event|6|||
27694358|NCT00406653|80716714|FG002|Open-Label Period|Lost to Follow-up|0|||
27825270|NCT02655679|81192502|FG001|Overall Study|Withdrawal by Subject|1|||
27825271|NCT02655679|81192503|FG002|Overall Study|Withdrawal by Subject|0|||
27825272|NCT02655679|81192504|FG003|Overall Study|Withdrawal by Subject|3|||
27825273|NCT02655679|81192505|FG004|Overall Study|Withdrawal by Subject|1|||
27825274|NCT02655679|81192501|FG000|Overall Study|Inability to Comply with the Protocol|1|||
27825275|NCT02655679|81192502|FG001|Overall Study|Inability to Comply with the Protocol|0|||
27825276|NCT02655679|81192503|FG002|Overall Study|Inability to Comply with the Protocol|0|||
27883688|NCT00267969|81408045|FG001|Controlled Period|Adverse Event|0|||
27883689|NCT00267969|81408046|FG002|Controlled Period|Adverse Event|2|||
27883690|NCT00267969|81408047|FG003|Controlled Period|Adverse Event|0|||
27883691|NCT00267969|81408048|FG004|Controlled Period|Adverse Event|0|||
27883692|NCT00267969|81408049|FG005|Controlled Period|Adverse Event|0|||
27883693|NCT00267969|81408050|FG006|Controlled Period|Adverse Event|0|||
27883694|NCT00267969|81408044|FG000|Controlled Period|Lack of Efficacy|3|||
27883695|NCT00267969|81408045|FG001|Controlled Period|Lack of Efficacy|0|||
27883696|NCT00267969|81408046|FG002|Controlled Period|Lack of Efficacy|1|||
27825277|NCT02655679|81192504|FG003|Overall Study|Inability to Comply with the Protocol|0|||
27825278|NCT02655679|81192505|FG004|Overall Study|Inability to Comply with the Protocol|0|||
27883697|NCT00267969|81408047|FG003|Controlled Period|Lack of Efficacy|0|||
27825279|NCT02655679|81192501|FG000|Overall Study|Lost to Follow-up|0|||
27825280|NCT02655679|81192502|FG001|Overall Study|Lost to Follow-up|1|||
27825281|NCT02655679|81192503|FG002|Overall Study|Lost to Follow-up|1|||
27825282|NCT02655679|81192504|FG003|Overall Study|Lost to Follow-up|1|||
27825283|NCT02655679|81192505|FG004|Overall Study|Lost to Follow-up|0|||
27883698|NCT00267969|81408048|FG004|Controlled Period|Lack of Efficacy|0|||
27883699|NCT00267969|81408049|FG005|Controlled Period|Lack of Efficacy|0|||
27883700|NCT00267969|81408050|FG006|Controlled Period|Lack of Efficacy|0|||
27825284|NCT02655679|81192501|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27825285|NCT02655679|81192502|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27825286|NCT02655679|81192503|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27825287|NCT02655679|81192504|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27825288|NCT02655679|81192505|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27825289|NCT01648582|81192506|FG000|Overall Study|Adverse Event|6|||
27825290|NCT01648582|81192507|FG001|Overall Study|Adverse Event|11|||
27825291|NCT01648582|81192508|FG002|Overall Study|Adverse Event|2|||
27825292|NCT01648582|81192506|FG000|Overall Study|Lost to Follow-up|9|||
27825293|NCT01648582|81192507|FG001|Overall Study|Lost to Follow-up|6|||
27825294|NCT01648582|81192508|FG002|Overall Study|Lost to Follow-up|8|||
27825295|NCT01648582|81192506|FG000|Overall Study|Protocol Violation|1|||
27825296|NCT01648582|81192507|FG001|Overall Study|Protocol Violation|2|||
27825297|NCT01648582|81192508|FG002|Overall Study|Protocol Violation|1|||
27825298|NCT01648582|81192506|FG000|Overall Study|Withdrawal by Subject|15|||
27825299|NCT01648582|81192507|FG001|Overall Study|Withdrawal by Subject|17|||
27825300|NCT01648582|81192508|FG002|Overall Study|Withdrawal by Subject|17|||
27825301|NCT01648582|81192506|FG000|Overall Study|Physician Decision|0|||
27825302|NCT01648582|81192507|FG001|Overall Study|Physician Decision|1|||
27825303|NCT01648582|81192508|FG002|Overall Study|Physician Decision|3|||
27825304|NCT01648582|81192506|FG000|Overall Study|Death|1|||
27825305|NCT01648582|81192507|FG001|Overall Study|Death|0|||
27825306|NCT01648582|81192508|FG002|Overall Study|Death|0|||
27825307|NCT01648582|81192506|FG000|Overall Study|Sponsor Decision|0|||
27825308|NCT01648582|81192507|FG001|Overall Study|Sponsor Decision|1|||
27825309|NCT01648582|81192508|FG002|Overall Study|Sponsor Decision|1|||
27825310|NCT01498120|81192509|FG000|Overall Study|Lost to Follow-up|1|||
27825311|NCT01498120|81192509|FG000|Overall Study|Withdrawal by Subject|5|||
27825312|NCT01498120|81192509|FG000|Overall Study|AE, non-serious non-fatal|3|||
27825313|NCT01498120|81192509|FG000|Overall Study|Other|4|||
27825314|NCT00096447|81192520|FG000|Overall Study|Never treated|1|||
27825315|NCT03197883|81192521|FG000|Overall Study|Adverse Event|1|||
27825316|NCT03197883|81192522|FG001|Overall Study|Adverse Event|1|||
27825317|NCT03197883|81192521|FG000|Overall Study|Lost to Follow-up|1|||
27825318|NCT03197883|81192522|FG001|Overall Study|Lost to Follow-up|0|||
27825319|NCT03197883|81192521|FG000|Overall Study|Protocol Violation|1|||
27825320|NCT03197883|81192522|FG001|Overall Study|Protocol Violation|0|||
27825321|NCT03197883|81192521|FG000|Overall Study|Other (Not Specified)|0|||
27825322|NCT03197883|81192522|FG001|Overall Study|Other (Not Specified)|5|||
27825323|NCT00239577|81192525|FG000|Primary Phase|Adverse Event|0|||
27825324|NCT00239577|81192526|FG001|Primary Phase|Adverse Event|0|||
27825325|NCT00239577|81192527|FG002|Primary Phase|Adverse Event|1|||
27825326|NCT00239577|81192528|FG003|Primary Phase|Adverse Event|0|||
27825327|NCT00239577|81192525|FG000|Primary Phase|Other|5|||
27825328|NCT00239577|81192526|FG001|Primary Phase|Other|3|||
27825329|NCT00239577|81192527|FG002|Primary Phase|Other|2|||
27825330|NCT00239577|81192528|FG003|Primary Phase|Other|0|||
27825331|NCT02865850|81192529|FG000|Overall Study|Death|15|||
27825332|NCT02865850|81192530|FG001|Overall Study|Death|19|||
27825333|NCT02865850|81192529|FG000|Overall Study|Withdrawal by Subject|3|||
27825334|NCT02865850|81192530|FG001|Overall Study|Withdrawal by Subject|2|||
27825335|NCT02865850|81192529|FG000|Overall Study|Lost to Follow-up|3|||
27825336|NCT02865850|81192530|FG001|Overall Study|Lost to Follow-up|2|||
27825337|NCT03165994|81192531|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
27825338|NCT03165994|81192531|FG000|Overall Study|Death|2|||
27825339|NCT03165994|81192531|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
27825340|NCT03165994|81192531|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
27825341|NCT03165994|81192531|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
27825342|NCT03165994|81192531|FG000|Overall Study|Miscellaneous|1|||
27825343|NCT02246166|81192534|FG000|Overall Study|Protocol Violation|1|||
27825344|NCT02246166|81192535|FG001|Overall Study|Protocol Violation|0|||
27825345|NCT02682784|81192536|FG000|Overall Study|Withdrawal by Subject|0|||
27825346|NCT02682784|81192537|FG001|Overall Study|Withdrawal by Subject|2|||
27825347|NCT02682784|81192538|FG002|Overall Study|Withdrawal by Subject|1|||
27825348|NCT02682784|81192539|FG003|Overall Study|Withdrawal by Subject|2|||
27825349|NCT02682784|81192536|FG000|Overall Study|Physician Decision|1|||
27825350|NCT02682784|81192537|FG001|Overall Study|Physician Decision|0|||
27825351|NCT02682784|81192538|FG002|Overall Study|Physician Decision|1|||
27825352|NCT02682784|81192539|FG003|Overall Study|Physician Decision|1|||
27825353|NCT00834795|81192545|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
27825354|NCT00834795|81192546|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
27825355|NCT00834795|81192545|FG000|Second Intervention|Adverse Event|1|||
27825356|NCT00834795|81192546|FG001|Second Intervention|Adverse Event|0|||
27825357|NCT00001703|81192553|FG000|Overall Study|progressed disease|2|||
27825358|NCT00001703|81192553|FG000|Overall Study|No evidence of disease|1|||
27825359|NCT00001703|81192553|FG000|Overall Study|recurrent disease|2|||
27825360|NCT00519194|81192554|FG000|Overall Study|Withdrawal by Subject|9|||
27883701|NCT00267969|81408044|FG000|Controlled Period|Lost to Follow-up|1|||
27883702|NCT00267969|81408045|FG001|Controlled Period|Lost to Follow-up|0|||
27883703|NCT00267969|81408046|FG002|Controlled Period|Lost to Follow-up|1|||
27883704|NCT00267969|81408047|FG003|Controlled Period|Lost to Follow-up|0|||
27883705|NCT00267969|81408048|FG004|Controlled Period|Lost to Follow-up|0|||
27825361|NCT00519194|81192554|FG000|Overall Study|Death|9|||
27825362|NCT00519194|81192554|FG000|Overall Study|Lost to Follow-up|3|||
27825363|NCT01597245|81192559|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
27825364|NCT01597245|81192560|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
27825365|NCT01597245|81192561|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
27825366|NCT01597245|81192562|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
27825367|NCT01597245|81192563|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825368|NCT01597245|81192564|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825369|NCT01597245|81192565|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825370|NCT01597245|81192566|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825371|NCT01597245|81192567|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825372|NCT01597245|81192568|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27883706|NCT00267969|81408049|FG005|Controlled Period|Lost to Follow-up|0|||
27883707|NCT00267969|81408050|FG006|Controlled Period|Lost to Follow-up|0|||
27883708|NCT00267969|81408044|FG000|Controlled Period|Randomized but not treated|0|||
27883709|NCT00267969|81408045|FG001|Controlled Period|Randomized but not treated|0|||
27883710|NCT00267969|81408046|FG002|Controlled Period|Randomized but not treated|1|||
27883711|NCT00267969|81408047|FG003|Controlled Period|Randomized but not treated|0|||
27883712|NCT00267969|81408048|FG004|Controlled Period|Randomized but not treated|0|||
27883713|NCT00267969|81408049|FG005|Controlled Period|Randomized but not treated|0|||
27553383|NCT01276353|80211463|FG001|Extension|Prohibited concomitant medications|1|||
27553384|NCT03018704|80211464|FG000|Overall Study|Lost to Follow-up|1|||
27553385|NCT03018704|80211465|FG001|Overall Study|Lost to Follow-up|1|||
27553386|NCT00573534|80211466|FG000|Overall Study|oppositional behavior|3|||
27883714|NCT00267969|81408050|FG006|Controlled Period|Randomized but not treated|0|||
27883715|NCT00267969|81408044|FG000|Controlled Period|Other|2|||
27883716|NCT00267969|81408045|FG001|Controlled Period|Other|1|||
27883717|NCT00267969|81408046|FG002|Controlled Period|Other|6|||
27883718|NCT00267969|81408047|FG003|Controlled Period|Other|0|||
27553387|NCT03902574|80211472|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
27553388|NCT03902574|80211473|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
27553389|NCT03902574|80211474|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
27553390|NCT01937559|80211475|FG000|Overall Study|Physician Decision|3|||
27825373|NCT01597245|81192569|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825374|NCT01597245|81192570|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27553391|NCT01937559|80211476|FG001|Overall Study|Physician Decision|3|||
27553392|NCT01937559|80211477|FG002|Overall Study|Physician Decision|0|||
27883719|NCT00267969|81408048|FG004|Controlled Period|Other|0|||
27825375|NCT01597245|81192571|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825376|NCT01597245|81192572|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825377|NCT01597245|81192573|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27883720|NCT00267969|81408049|FG005|Controlled Period|Other|0|||
27825378|NCT01597245|81192574|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27883721|NCT00267969|81408050|FG006|Controlled Period|Other|0|||
27883722|NCT00267969|81408044|FG000|After Controlled Period|Adverse Event|0|||
27825379|NCT01597245|81192575|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825380|NCT01597245|81192576|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825381|NCT01597245|81192577|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825382|NCT01597245|81192578|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825383|NCT01597245|81192579|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
27825384|NCT01597245|81192559|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
27825385|NCT01597245|81192560|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
27825386|NCT01597245|81192561|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
27825387|NCT01597245|81192562|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
27825388|NCT01597245|81192563|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825389|NCT01597245|81192564|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825390|NCT01597245|81192565|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825391|NCT01597245|81192566|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825392|NCT01597245|81192567|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825393|NCT01597245|81192568|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825394|NCT01597245|81192569|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825395|NCT01597245|81192570|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825396|NCT01597245|81192571|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825397|NCT01597245|81192572|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825398|NCT01597245|81192573|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825399|NCT01597245|81192574|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825400|NCT01597245|81192575|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825401|NCT01597245|81192576|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825402|NCT01597245|81192577|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825403|NCT01597245|81192578|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825404|NCT01597245|81192579|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
27825405|NCT01597245|81192559|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
27825406|NCT01597245|81192560|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
27825407|NCT01597245|81192561|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
27825408|NCT01597245|81192562|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
27825409|NCT01597245|81192563|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825410|NCT01597245|81192564|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825411|NCT01597245|81192565|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825412|NCT01597245|81192566|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825413|NCT01597245|81192567|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825414|NCT01597245|81192568|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825415|NCT01597245|81192569|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825416|NCT01597245|81192570|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825417|NCT01597245|81192571|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825418|NCT01597245|81192572|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825419|NCT01597245|81192573|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825420|NCT01597245|81192574|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825421|NCT01597245|81192575|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825422|NCT01597245|81192576|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825423|NCT01597245|81192577|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825424|NCT01597245|81192578|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825425|NCT01597245|81192579|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
27825426|NCT01597245|81192559|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
27825427|NCT01597245|81192560|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
27553393|NCT01937559|80211475|FG000|Overall Study|Withdrawal by Subject|6|||
27553394|NCT01937559|80211476|FG001|Overall Study|Withdrawal by Subject|4|||
27553395|NCT01937559|80211477|FG002|Overall Study|Withdrawal by Subject|0|||
27553396|NCT01937559|80211475|FG000|Overall Study|screen fail|2|||
27553397|NCT01937559|80211476|FG001|Overall Study|screen fail|4|||
27553398|NCT01937559|80211477|FG002|Overall Study|screen fail|0|||
27553399|NCT01713686|80211478|FG000|Overall Study|Lost to Follow-up|9|||
27553400|NCT01713686|80211478|FG000|Overall Study|Withdrawal by Subject|6|||
27553401|NCT03982368|80211481|FG000|Overall Study|Adverse Event|6|||
27553402|NCT03982368|80211482|FG001|Overall Study|Adverse Event|4|||
27553403|NCT03982368|80211483|FG002|Overall Study|Adverse Event|3|||
27553404|NCT03982368|80211481|FG000|Overall Study|Lost to Follow-up|2|||
27553405|NCT03982368|80211482|FG001|Overall Study|Lost to Follow-up|1|||
27553406|NCT03982368|80211483|FG002|Overall Study|Lost to Follow-up|0|||
27553407|NCT03982368|80211481|FG000|Overall Study|Withdrawal by Subject|1|||
27553408|NCT03982368|80211482|FG001|Overall Study|Withdrawal by Subject|2|||
27553409|NCT03982368|80211483|FG002|Overall Study|Withdrawal by Subject|0|||
27553410|NCT03982368|80211481|FG000|Overall Study|unknow|4|||
27553411|NCT03982368|80211482|FG001|Overall Study|unknow|0|||
27553412|NCT03982368|80211483|FG002|Overall Study|unknow|2|||
27553413|NCT01438424|80211492|FG000|Overall Study|Continuing treatment|29|||
27553414|NCT01438424|80211492|FG000|Overall Study|Minimal virologic response|95|||
27553415|NCT01438424|80211492|FG000|Overall Study|Not identified|55|||
27553416|NCT01438424|80211492|FG000|Overall Study|Withdrawal by Subject|104|||
27553417|NCT01438424|80211492|FG000|Overall Study|Progression of chronic hepatitis B|22|||
27553418|NCT01438424|80211492|FG000|Overall Study|Death|22|||
27553419|NCT01438424|80211492|FG000|Overall Study|Adverse Event|17|||
27553420|NCT01438424|80211492|FG000|Overall Study|Lost to Follow-up|17|||
27553421|NCT01438424|80211492|FG000|Overall Study|Abnormal laboratory test result|14|||
27553422|NCT01438424|80211492|FG000|Overall Study|Need for drug prohibited by protocol|14|||
27553423|NCT01438424|80211492|FG000|Overall Study|Pregnancy|7|||
27553424|NCT01438424|80211492|FG000|Overall Study|No longer met inclusion criteria|1|||
27553425|NCT01438424|80211492|FG000|Overall Study|Participant noncompliance|20|||
27694359|NCT00406653|80716715|FG003|Open-Label Period|Lost to Follow-up|0|||
27694360|NCT00406653|80716716|FG004|Open-Label Period|Lost to Follow-up|0|||
27825428|NCT01597245|81192561|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
27825429|NCT01597245|81192562|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825430|NCT01597245|81192563|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27553426|NCT01524692|80211495|FG000|Overall Study|Withdrawal by Subject|3|||
27553427|NCT03789318|80211507|FG000|Overall Study|Adverse Event|0|||
27553428|NCT03789318|80211508|FG001|Overall Study|Adverse Event|0|||
27553429|NCT03789318|80211509|FG002|Overall Study|Adverse Event|1|||
27553430|NCT03789318|80211510|FG003|Overall Study|Adverse Event|1|||
27553431|NCT03789318|80211511|FG004|Overall Study|Adverse Event|0|||
27553432|NCT03789318|80211507|FG000|Overall Study|Lost to Follow-up|0|||
27553433|NCT03789318|80211508|FG001|Overall Study|Lost to Follow-up|0|||
27553434|NCT03789318|80211509|FG002|Overall Study|Lost to Follow-up|1|||
27694361|NCT00406653|80716717|FG005|Open-Label Period|Lost to Follow-up|0|||
27553435|NCT03789318|80211510|FG003|Overall Study|Lost to Follow-up|0|||
27553436|NCT03789318|80211511|FG004|Overall Study|Lost to Follow-up|0|||
27553437|NCT03789318|80211507|FG000|Overall Study|Withdrawal by Subject|0|||
27553438|NCT03789318|80211508|FG001|Overall Study|Withdrawal by Subject|0|||
27553439|NCT03789318|80211509|FG002|Overall Study|Withdrawal by Subject|1|||
27553440|NCT03789318|80211510|FG003|Overall Study|Withdrawal by Subject|0|||
27553441|NCT03789318|80211511|FG004|Overall Study|Withdrawal by Subject|0|||
27553442|NCT02501473|80211514|FG000|Overall Study|Study Terminated|2|||
27553443|NCT02501473|80211515|FG001|Overall Study|Study Terminated|3|||
27553444|NCT02501473|80211516|FG002|Overall Study|Study Terminated|7|||
27553445|NCT02501473|80211517|FG003|Overall Study|Study Terminated|9|||
27553446|NCT02501473|80211518|FG004|Overall Study|Study Terminated|2|||
27553447|NCT02501473|80211519|FG005|Overall Study|Study Terminated|10|||
27553448|NCT02501473|80211520|FG006|Overall Study|Study Terminated|1|||
27553449|NCT02501473|80211521|FG007|Overall Study|Study Terminated|0|||
27553450|NCT02501473|80211514|FG000|Overall Study|Withdrawal by Subject|0|||
27553451|NCT02501473|80211515|FG001|Overall Study|Withdrawal by Subject|0|||
27553452|NCT02501473|80211516|FG002|Overall Study|Withdrawal by Subject|3|||
27553453|NCT02501473|80211517|FG003|Overall Study|Withdrawal by Subject|3|||
27553454|NCT02501473|80211518|FG004|Overall Study|Withdrawal by Subject|2|||
27553455|NCT02501473|80211519|FG005|Overall Study|Withdrawal by Subject|2|||
27553456|NCT02501473|80211520|FG006|Overall Study|Withdrawal by Subject|0|||
27553457|NCT02501473|80211521|FG007|Overall Study|Withdrawal by Subject|0|||
27553458|NCT02501473|80211514|FG000|Overall Study|Death|0|||
27553459|NCT02501473|80211515|FG001|Overall Study|Death|0|||
27553460|NCT02501473|80211516|FG002|Overall Study|Death|1|||
27553461|NCT02501473|80211517|FG003|Overall Study|Death|1|||
27553462|NCT02501473|80211518|FG004|Overall Study|Death|0|||
27553463|NCT02501473|80211519|FG005|Overall Study|Death|1|||
27553464|NCT02501473|80211520|FG006|Overall Study|Death|0|||
27553465|NCT02501473|80211521|FG007|Overall Study|Death|0|||
27553466|NCT02501473|80211514|FG000|Overall Study|Lost to Follow-up|1|||
27553467|NCT02501473|80211515|FG001|Overall Study|Lost to Follow-up|0|||
27553468|NCT02501473|80211516|FG002|Overall Study|Lost to Follow-up|1|||
27553469|NCT02501473|80211517|FG003|Overall Study|Lost to Follow-up|0|||
27553470|NCT02501473|80211518|FG004|Overall Study|Lost to Follow-up|0|||
27553471|NCT02501473|80211519|FG005|Overall Study|Lost to Follow-up|1|||
27553472|NCT02501473|80211520|FG006|Overall Study|Lost to Follow-up|0|||
27553473|NCT02501473|80211521|FG007|Overall Study|Lost to Follow-up|0|||
27553474|NCT02501473|80211514|FG000|Overall Study|Reason not specified|0|||
27553475|NCT02501473|80211515|FG001|Overall Study|Reason not specified|0|||
27553476|NCT02501473|80211516|FG002|Overall Study|Reason not specified|1|||
27553477|NCT02501473|80211517|FG003|Overall Study|Reason not specified|1|||
27553478|NCT02501473|80211518|FG004|Overall Study|Reason not specified|0|||
27553479|NCT02501473|80211519|FG005|Overall Study|Reason not specified|0|||
27553480|NCT02501473|80211520|FG006|Overall Study|Reason not specified|0|||
27553481|NCT02501473|80211521|FG007|Overall Study|Reason not specified|0|||
27553482|NCT01987505|80211522|FG000|Overall Study|Other|9|||
27553483|NCT01987505|80211522|FG000|Overall Study|Withdrawal by Subject|2|||
27553484|NCT01987505|80211522|FG000|Overall Study|Other Reason|2|||
27553485|NCT01987505|80211522|FG000|Overall Study|Lost to Follow-up|15|||
27694362|NCT00406653|80716718|FG006|Open-Label Period|Lost to Follow-up|6|||
27694363|NCT00406653|80716712|FG000|Open-Label Period|Withdrawal of Consent|0|||
27694364|NCT00406653|80716713|FG001|Open-Label Period|Withdrawal of Consent|0|||
27694365|NCT00406653|80716714|FG002|Open-Label Period|Withdrawal of Consent|0|||
27694366|NCT00406653|80716715|FG003|Open-Label Period|Withdrawal of Consent|0|||
27694367|NCT00406653|80716716|FG004|Open-Label Period|Withdrawal of Consent|0|||
27694368|NCT00406653|80716717|FG005|Open-Label Period|Withdrawal of Consent|0|||
27553486|NCT01987505|80211522|FG000|Overall Study|Investigator Decision|2|||
27553487|NCT01987505|80211522|FG000|Overall Study|Death|4|||
27553488|NCT03247530|80211523|FG000|Overall Study|Withdrawal by caregiver|19|||
27553489|NCT03247530|80211524|FG001|Overall Study|Withdrawal by caregiver|8|||
27553490|NCT03247530|80211525|FG002|Overall Study|Withdrawal by caregiver|10|||
27553491|NCT03247530|80211523|FG000|Overall Study|Lost to Follow-up|3|||
27553492|NCT03247530|80211524|FG001|Overall Study|Lost to Follow-up|9|||
27553493|NCT03247530|80211525|FG002|Overall Study|Lost to Follow-up|6|||
27694369|NCT00406653|80716718|FG006|Open-Label Period|Withdrawal of Consent|11|||
27553494|NCT03247530|80211523|FG000|Overall Study|Adverse Event|2|||
27553495|NCT03247530|80211524|FG001|Overall Study|Adverse Event|5|||
27553496|NCT03247530|80211525|FG002|Overall Study|Adverse Event|2|||
27553497|NCT03247530|80211523|FG000|Overall Study|Failure to follow procedure|1|||
27553498|NCT03247530|80211524|FG001|Overall Study|Failure to follow procedure|1|||
27553499|NCT03247530|80211525|FG002|Overall Study|Failure to follow procedure|1|||
27553500|NCT03247530|80211523|FG000|Overall Study|Withdrawal by Subject|1|||
27553501|NCT03247530|80211524|FG001|Overall Study|Withdrawal by Subject|1|||
27694370|NCT00406653|80716712|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
27694371|NCT00406653|80716713|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
27553502|NCT03247530|80211525|FG002|Overall Study|Withdrawal by Subject|0|||
27553503|NCT03247530|80211523|FG000|Overall Study|Study medication misuse|0|||
27553504|NCT03247530|80211524|FG001|Overall Study|Study medication misuse|1|||
27553505|NCT03247530|80211525|FG002|Overall Study|Study medication misuse|0|||
27553506|NCT03247530|80211523|FG000|Overall Study|Other, multiple categories|1|||
27694372|NCT00406653|80716714|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
27694373|NCT00406653|80716715|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
27694374|NCT00406653|80716716|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
27694375|NCT00406653|80716717|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
27694376|NCT00406653|80716718|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
27694377|NCT00406653|80716712|FG000|Open-Label Period|Pregnancy|0|||
27694378|NCT00406653|80716713|FG001|Open-Label Period|Pregnancy|0|||
27694379|NCT00406653|80716714|FG002|Open-Label Period|Pregnancy|0|||
27694380|NCT00406653|80716715|FG003|Open-Label Period|Pregnancy|0|||
27694381|NCT00406653|80716716|FG004|Open-Label Period|Pregnancy|0|||
27694382|NCT00406653|80716717|FG005|Open-Label Period|Pregnancy|0|||
27694383|NCT00406653|80716718|FG006|Open-Label Period|Pregnancy|2|||
27694384|NCT00406653|80716712|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
27694385|NCT00406653|80716713|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
27694386|NCT00406653|80716714|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
27694387|NCT00406653|80716715|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
27694388|NCT00406653|80716716|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
27694389|NCT00406653|80716717|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
27694390|NCT00406653|80716718|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
27694391|NCT00406653|80716712|FG000|Open-Label Period|Declined participation but followup done|0|||
27694392|NCT00406653|80716713|FG001|Open-Label Period|Declined participation but followup done|0|||
27694393|NCT00406653|80716714|FG002|Open-Label Period|Declined participation but followup done|0|||
27694394|NCT00406653|80716715|FG003|Open-Label Period|Declined participation but followup done|0|||
27694395|NCT00406653|80716716|FG004|Open-Label Period|Declined participation but followup done|0|||
27694396|NCT00406653|80716717|FG005|Open-Label Period|Declined participation but followup done|0|||
27694397|NCT00406653|80716718|FG006|Open-Label Period|Declined participation but followup done|8|||
27694398|NCT00406653|80716712|FG000|Open-Label Period|Discontinued by Sponsor|0|||
27825431|NCT01597245|81192564|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825432|NCT01597245|81192565|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825433|NCT01597245|81192566|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825434|NCT01597245|81192567|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825435|NCT01597245|81192568|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825436|NCT01597245|81192569|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825437|NCT01597245|81192570|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825438|NCT01597245|81192571|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825439|NCT01597245|81192572|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825440|NCT01597245|81192573|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825441|NCT01597245|81192574|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825442|NCT01597245|81192575|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825443|NCT01597245|81192576|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27553507|NCT03247530|80211524|FG001|Overall Study|Other, multiple categories|3|||
27694399|NCT00406653|80716713|FG001|Open-Label Period|Discontinued by Sponsor|0|||
27825444|NCT01597245|81192577|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27553508|NCT03247530|80211525|FG002|Overall Study|Other, multiple categories|1|||
27553509|NCT02193867|80211526|FG000|Overall Study|Death|2|||
27553510|NCT02193867|80211526|FG000|Overall Study|Sponsor Study Termination|2|||
27553511|NCT03547687|80211527|FG000|Overall Study|Withdrawal by Subject|1|||
27553512|NCT03547687|80211527|FG000|Overall Study|Death|1|||
27553513|NCT00160251|80211528|FG000|Prior to Amendment 2|Adverse Event|2|||
27825445|NCT01597245|81192578|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825446|NCT01597245|81192579|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
27825447|NCT01597245|81192559|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
27825448|NCT01597245|81192560|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27553514|NCT00160251|80211529|FG001|Prior to Amendment 2|Adverse Event|1|||
27553515|NCT00160251|80211530|FG002|Prior to Amendment 2|Adverse Event|3|||
27553516|NCT00160251|80211531|FG003|Prior to Amendment 2|Adverse Event|1|||
27553517|NCT00160251|80211532|FG004|Prior to Amendment 2|Adverse Event|1|||
27553518|NCT00160251|80211533|FG005|Prior to Amendment 2|Adverse Event|1|||
27553519|NCT00160251|80211534|FG006|Prior to Amendment 2|Adverse Event|1|||
27553520|NCT00160251|80211535|FG007|Prior to Amendment 2|Adverse Event|0|||
27553521|NCT00160251|80211528|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
27825449|NCT01597245|81192561|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825450|NCT01597245|81192562|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
27825451|NCT01597245|81192563|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825452|NCT01597245|81192564|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825453|NCT01597245|81192565|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825454|NCT01597245|81192566|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825455|NCT01597245|81192567|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825456|NCT01597245|81192568|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825457|NCT01597245|81192569|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825458|NCT01597245|81192570|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825459|NCT01597245|81192571|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825460|NCT01597245|81192572|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825461|NCT01597245|81192573|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825462|NCT01597245|81192574|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825463|NCT01597245|81192575|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825464|NCT01597245|81192576|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825465|NCT01597245|81192577|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825466|NCT01597245|81192578|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825467|NCT01597245|81192579|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
27825468|NCT01597245|81192559|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
27825469|NCT01597245|81192560|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
27825470|NCT01597245|81192561|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
27825471|NCT01597245|81192562|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825472|NCT01597245|81192563|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825473|NCT01597245|81192564|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27553522|NCT00160251|80211529|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
27553523|NCT00160251|80211530|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
27553524|NCT00160251|80211531|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
27883723|NCT00267969|81408045|FG001|After Controlled Period|Adverse Event|0|||
27825474|NCT01597245|81192565|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825475|NCT01597245|81192566|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825476|NCT01597245|81192567|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825477|NCT01597245|81192568|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825478|NCT01597245|81192569|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825479|NCT01597245|81192570|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825480|NCT01597245|81192571|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825481|NCT01597245|81192572|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825482|NCT01597245|81192573|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825483|NCT01597245|81192574|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825484|NCT01597245|81192575|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825485|NCT01597245|81192576|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825486|NCT01597245|81192577|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825487|NCT01597245|81192578|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825488|NCT01597245|81192579|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
27825489|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825490|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825491|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825492|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825493|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825494|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
27825495|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
27825496|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825497|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825498|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27553525|NCT00160251|80211532|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
27553526|NCT00160251|80211533|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
27553527|NCT00160251|80211534|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
27553528|NCT00160251|80211535|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
27553529|NCT00160251|80211528|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
27553530|NCT00160251|80211529|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
27553531|NCT00160251|80211530|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
27553532|NCT00160251|80211531|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
27553533|NCT00160251|80211532|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
27553534|NCT00160251|80211533|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
27553535|NCT00160251|80211534|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
27553536|NCT00160251|80211535|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
27553537|NCT00160251|80211528|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
27553538|NCT00160251|80211529|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
27553539|NCT00160251|80211530|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
27553540|NCT00160251|80211531|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
27825499|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825500|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825501|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825502|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825503|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825504|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27553541|NCT00160251|80211532|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
27553542|NCT00160251|80211533|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
27553543|NCT00160251|80211534|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
27694400|NCT00406653|80716714|FG002|Open-Label Period|Discontinued by Sponsor|0|||
27694401|NCT00406653|80716715|FG003|Open-Label Period|Discontinued by Sponsor|0|||
27694402|NCT00406653|80716716|FG004|Open-Label Period|Discontinued by Sponsor|0|||
27825505|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825506|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825507|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825508|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825509|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
27825510|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825511|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825512|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825513|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825514|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
27825515|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
27825516|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
27825517|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
27825518|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825519|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
27825520|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825521|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825522|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825523|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825524|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825525|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825526|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825527|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825528|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825529|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825530|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
27825531|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825532|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825533|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825534|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825535|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825536|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
27825537|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825538|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825539|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
27825540|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825541|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
27825542|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
27825543|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
27825544|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825545|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825546|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825547|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825548|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825549|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825550|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825551|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
27825552|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825553|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825554|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825555|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825556|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
27825557|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
27825558|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
27825559|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
27825560|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
27825561|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
27825562|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
27825563|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
27825564|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
27825565|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825566|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825567|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825568|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825569|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825570|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825571|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825572|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
27825573|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825574|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825575|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825576|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825577|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
27825578|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
27825579|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
27825580|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825581|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
27825582|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
27825583|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
27825584|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
27825585|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
27825586|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825587|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825588|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825589|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825590|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825591|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825592|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825593|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
27825594|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825595|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825596|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825597|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825598|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
27825599|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825600|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825601|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825602|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
27825603|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
27825604|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
27825605|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825606|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
27825607|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825608|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825609|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825610|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825611|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825612|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825613|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825614|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
27825615|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825616|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825617|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825618|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825619|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
27825620|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
27825621|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
27825622|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825623|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
27825624|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
27825625|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
27553544|NCT00160251|80211535|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
27883724|NCT00267969|81408046|FG002|After Controlled Period|Adverse Event|0|||
27883725|NCT00267969|81408047|FG003|After Controlled Period|Adverse Event|7|||
27553545|NCT00160251|80211528|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
27825626|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
27825627|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
27825628|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825629|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825630|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27553546|NCT00160251|80211529|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
27825631|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825632|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825633|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825634|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825635|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
27825636|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825637|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825638|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825639|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825640|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825641|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27825642|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825643|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825644|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27825645|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27825646|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27825647|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
27825648|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825649|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825650|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825651|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825652|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825653|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825654|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825655|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825656|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
27825657|NCT01597245|81192559|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825658|NCT01597245|81192560|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825659|NCT01597245|81192561|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825660|NCT01597245|81192562|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825661|NCT01597245|81192563|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825662|NCT01597245|81192564|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825663|NCT01597245|81192565|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825664|NCT01597245|81192566|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825665|NCT01597245|81192567|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825666|NCT01597245|81192568|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825667|NCT01597245|81192569|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
27825668|NCT01597245|81192570|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825669|NCT01597245|81192571|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825670|NCT01597245|81192572|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825671|NCT01597245|81192573|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825672|NCT01597245|81192574|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825673|NCT01597245|81192575|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825674|NCT01597245|81192576|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825675|NCT01597245|81192577|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825676|NCT01597245|81192578|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27694403|NCT00406653|80716717|FG005|Open-Label Period|Discontinued by Sponsor|0|||
27553547|NCT00160251|80211530|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
27553548|NCT00160251|80211531|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
27553549|NCT00160251|80211532|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
27553550|NCT00160251|80211533|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
27553551|NCT00160251|80211534|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
27553552|NCT00160251|80211535|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
27553553|NCT00160251|80211528|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
27553554|NCT00160251|80211529|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
27553555|NCT00160251|80211530|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
27553556|NCT00160251|80211531|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
27553557|NCT00160251|80211532|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
27553558|NCT00160251|80211533|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
27553559|NCT00160251|80211534|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
27553560|NCT00160251|80211535|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
27553561|NCT00160251|80211528|FG000|Post-amendment 2|Adverse Event|0|||
27553562|NCT00160251|80211529|FG001|Post-amendment 2|Adverse Event|0|||
27553563|NCT00160251|80211530|FG002|Post-amendment 2|Adverse Event|0|||
27553564|NCT00160251|80211531|FG003|Post-amendment 2|Adverse Event|0|||
27553565|NCT00160251|80211532|FG004|Post-amendment 2|Adverse Event|0|||
27553566|NCT00160251|80211533|FG005|Post-amendment 2|Adverse Event|0|||
27553567|NCT00160251|80211534|FG006|Post-amendment 2|Adverse Event|0|||
27553568|NCT00160251|80211535|FG007|Post-amendment 2|Adverse Event|20|||
27553569|NCT00160251|80211528|FG000|Post-amendment 2|Lack of Efficacy|0|||
27553570|NCT00160251|80211529|FG001|Post-amendment 2|Lack of Efficacy|0|||
27553571|NCT00160251|80211530|FG002|Post-amendment 2|Lack of Efficacy|0|||
27553572|NCT00160251|80211531|FG003|Post-amendment 2|Lack of Efficacy|0|||
27553573|NCT00160251|80211532|FG004|Post-amendment 2|Lack of Efficacy|0|||
27553574|NCT00160251|80211533|FG005|Post-amendment 2|Lack of Efficacy|0|||
27553575|NCT00160251|80211534|FG006|Post-amendment 2|Lack of Efficacy|0|||
27553576|NCT00160251|80211535|FG007|Post-amendment 2|Lack of Efficacy|24|||
27553577|NCT00160251|80211528|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27553578|NCT00160251|80211529|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27825677|NCT01597245|81192579|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
27825678|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825679|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825680|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825681|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825682|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825683|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825684|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825685|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825686|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825687|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825688|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825689|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825690|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27553579|NCT00160251|80211530|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27553580|NCT00160251|80211531|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27553581|NCT00160251|80211532|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27553582|NCT00160251|80211533|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27553583|NCT00160251|80211534|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
27553584|NCT00160251|80211535|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
27553585|NCT02170051|80211536|FG000|Overall Study|Withdrawal by Subject|10|||
27553586|NCT02170051|80211537|FG001|Overall Study|Withdrawal by Subject|10|||
27553587|NCT02170051|80211536|FG000|Overall Study|Lost to Follow-up|1|||
27553588|NCT02170051|80211537|FG001|Overall Study|Lost to Follow-up|3|||
27553589|NCT01244425|80211538|FG000|Overall Study|Withdrawal by Subject|2|||
27553590|NCT01244425|80211539|FG001|Overall Study|Withdrawal by Subject|2|||
27553591|NCT01244425|80211538|FG000|Overall Study|Adverse Event|1|||
27825691|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
27825692|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
27825693|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
27553592|NCT01244425|80211539|FG001|Overall Study|Adverse Event|1|||
27553593|NCT00599924|80211540|FG000|Overall Study|Lack of Efficacy|3|||
27553594|NCT00599924|80211541|FG001|Overall Study|Lack of Efficacy|5|||
27553595|NCT00599924|80211542|FG002|Overall Study|Lack of Efficacy|1|||
27553596|NCT00599924|80211543|FG003|Overall Study|Lack of Efficacy|2|||
27553597|NCT00599924|80211544|FG004|Overall Study|Lack of Efficacy|3|||
27553598|NCT00599924|80211545|FG005|Overall Study|Lack of Efficacy|2|||
27553599|NCT00599924|80211546|FG006|Overall Study|Lack of Efficacy|0|||
27553600|NCT00599924|80211540|FG000|Overall Study|Adverse Event|0|||
27553601|NCT00599924|80211541|FG001|Overall Study|Adverse Event|0|||
27553602|NCT00599924|80211542|FG002|Overall Study|Adverse Event|0|||
27553603|NCT00599924|80211543|FG003|Overall Study|Adverse Event|2|||
27553604|NCT00599924|80211544|FG004|Overall Study|Adverse Event|0|||
27553605|NCT00599924|80211545|FG005|Overall Study|Adverse Event|0|||
27553606|NCT00599924|80211546|FG006|Overall Study|Adverse Event|2|||
27553607|NCT00599924|80211540|FG000|Overall Study|Death|0|||
27553608|NCT00599924|80211541|FG001|Overall Study|Death|0|||
27553609|NCT00599924|80211542|FG002|Overall Study|Death|0|||
27553610|NCT00599924|80211543|FG003|Overall Study|Death|2|||
27553611|NCT00599924|80211544|FG004|Overall Study|Death|0|||
27553612|NCT00599924|80211545|FG005|Overall Study|Death|2|||
27553613|NCT00599924|80211546|FG006|Overall Study|Death|1|||
27553614|NCT00599924|80211540|FG000|Overall Study|Protocol Violation|0|||
27553615|NCT00599924|80211541|FG001|Overall Study|Protocol Violation|0|||
27553616|NCT00599924|80211542|FG002|Overall Study|Protocol Violation|0|||
27553617|NCT00599924|80211543|FG003|Overall Study|Protocol Violation|1|||
27553618|NCT00599924|80211544|FG004|Overall Study|Protocol Violation|0|||
27553619|NCT00599924|80211545|FG005|Overall Study|Protocol Violation|0|||
27553620|NCT00599924|80211546|FG006|Overall Study|Protocol Violation|0|||
27553621|NCT00599924|80211540|FG000|Overall Study|Withdrawal by Subject|0|||
27553622|NCT00599924|80211541|FG001|Overall Study|Withdrawal by Subject|0|||
27825694|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825695|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27553623|NCT00599924|80211542|FG002|Overall Study|Withdrawal by Subject|1|||
27553624|NCT00599924|80211543|FG003|Overall Study|Withdrawal by Subject|0|||
27553625|NCT00599924|80211544|FG004|Overall Study|Withdrawal by Subject|1|||
27553626|NCT00599924|80211545|FG005|Overall Study|Withdrawal by Subject|0|||
27694404|NCT00406653|80716718|FG006|Open-Label Period|Discontinued by Sponsor|1|||
27825696|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825697|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27553627|NCT00599924|80211546|FG006|Overall Study|Withdrawal by Subject|0|||
27553628|NCT00599924|80211540|FG000|Overall Study|Other|0|||
27553629|NCT00599924|80211541|FG001|Overall Study|Other|0|||
27553630|NCT00599924|80211542|FG002|Overall Study|Other|0|||
27553631|NCT00599924|80211543|FG003|Overall Study|Other|1|||
27553632|NCT00599924|80211544|FG004|Overall Study|Other|2|||
27553633|NCT00599924|80211545|FG005|Overall Study|Other|0|||
27825698|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
27825699|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825700|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27694405|NCT00406653|80716712|FG000|Open-Label Period|Refused followup|0|||
27694406|NCT00406653|80716713|FG001|Open-Label Period|Refused followup|0|||
27694407|NCT00406653|80716714|FG002|Open-Label Period|Refused followup|0|||
27694408|NCT00406653|80716715|FG003|Open-Label Period|Refused followup|0|||
27694409|NCT00406653|80716716|FG004|Open-Label Period|Refused followup|0|||
27694410|NCT00406653|80716717|FG005|Open-Label Period|Refused followup|0|||
27694411|NCT00406653|80716718|FG006|Open-Label Period|Refused followup|1|||
27694412|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
27694413|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
27694414|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
27694415|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
27694416|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
27694417|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
27694418|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
27694419|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
27694420|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
27694421|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
27694422|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
27825701|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825702|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825703|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27553634|NCT00599924|80211546|FG006|Overall Study|Other|2|||
27553635|NCT00679302|80211549|FG000|Overall Study|Lost to Follow-up|8|||
27553636|NCT00679302|80211550|FG001|Overall Study|Lost to Follow-up|4|||
27553637|NCT01342796|80211551|FG000|Overall Study|Withdrawal by Subject|2|||
27553638|NCT01342796|80211552|FG001|Overall Study|Withdrawal by Subject|0|||
27553639|NCT01342796|80211551|FG000|Overall Study|Lost to Follow-up|0|||
27553640|NCT01342796|80211552|FG001|Overall Study|Lost to Follow-up|3|||
27553641|NCT01342796|80211551|FG000|Overall Study|Inappropriate enrollment|1|||
27553642|NCT01342796|80211552|FG001|Overall Study|Inappropriate enrollment|0|||
27553643|NCT02743520|80211553|FG000|Overall Study|Withdrawal by Subject|1|||
27553644|NCT04343261|80211554|FG000|Overall Study|Adverse Event|1|||
27553645|NCT04343261|80211554|FG000|Overall Study|received inadequate amount of antibodies|7|||
27553646|NCT01892293|80211555|FG000|Overall Study|Apheresed but not treated|4|||
27553647|NCT03049280|80211557|FG000|Overall Study|Physician Decision|1|||
27553648|NCT02708121|80215220|FG000|Overall Study|Withdrawn by Study Team|1|||
27553649|NCT02708121|80215221|FG001|Overall Study|Withdrawn by Study Team|1|||
27553650|NCT02708121|80215220|FG000|Overall Study|Withdrawal by Subject|0|||
27553651|NCT02708121|80215221|FG001|Overall Study|Withdrawal by Subject|4|||
27553652|NCT00459667|80215222|FG000|Overall Study|Adverse Event|9|||
27553653|NCT00459667|80215223|FG001|Overall Study|Adverse Event|12|||
27553654|NCT00459667|80215224|FG002|Overall Study|Adverse Event|8|||
27553655|NCT00459667|80215222|FG000|Overall Study|Lost to Follow-up|5|||
27553656|NCT00459667|80215223|FG001|Overall Study|Lost to Follow-up|9|||
27825704|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825705|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825706|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27553657|NCT00459667|80215224|FG002|Overall Study|Lost to Follow-up|3|||
27553658|NCT00459667|80215222|FG000|Overall Study|Pregnancy|1|||
27553659|NCT00459667|80215223|FG001|Overall Study|Pregnancy|1|||
27553660|NCT00459667|80215224|FG002|Overall Study|Pregnancy|1|||
27553661|NCT00459667|80215222|FG000|Overall Study|Protocol Violation|1|||
27553662|NCT00459667|80215223|FG001|Overall Study|Protocol Violation|0|||
27553663|NCT00459667|80215224|FG002|Overall Study|Protocol Violation|0|||
27553664|NCT00459667|80215222|FG000|Overall Study|Withdrawal by Subject|3|||
27553665|NCT00459667|80215223|FG001|Overall Study|Withdrawal by Subject|5|||
27553666|NCT00459667|80215224|FG002|Overall Study|Withdrawal by Subject|5|||
27553667|NCT00459667|80215222|FG000|Overall Study|Other disease modifying treatment|1|||
27553668|NCT00459667|80215223|FG001|Overall Study|Other disease modifying treatment|2|||
27553669|NCT00459667|80215224|FG002|Overall Study|Other disease modifying treatment|1|||
27825707|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825708|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825709|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825710|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825711|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825712|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
27825713|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
27825714|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
27825715|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825716|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825717|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825718|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825719|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
27825720|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825721|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825722|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825723|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825724|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825725|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825726|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825727|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825728|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825729|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825730|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825731|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825732|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825733|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825734|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
27825735|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
27825736|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27553670|NCT00459667|80215222|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
27553671|NCT00459667|80215223|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
27825737|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825738|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825739|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825740|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
27825741|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825742|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825743|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27883726|NCT00267969|81408048|FG004|After Controlled Period|Adverse Event|8|||
27883727|NCT00267969|81408049|FG005|After Controlled Period|Adverse Event|23|||
27883728|NCT00267969|81408050|FG006|After Controlled Period|Adverse Event|21|||
27553672|NCT00459667|80215224|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
27694423|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
27825744|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825745|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825746|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825747|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825748|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825749|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27553673|NCT00459667|80215222|FG000|Overall Study|No treatment administered|6|||
27553674|NCT00459667|80215223|FG001|Overall Study|No treatment administered|3|||
27553675|NCT00459667|80215224|FG002|Overall Study|No treatment administered|1|||
27553676|NCT04533438|80215232|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
27553677|NCT04533438|80215233|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
27553678|NCT00587639|80215239|FG000|Overall Study|Withdrawal by Subject|1|||
27553679|NCT02005445|80215240|FG000|Overall Study|Dual study enrollment|0|||
27553680|NCT02005445|80215241|FG001|Overall Study|Dual study enrollment|1|||
27553681|NCT00674700|80215242|FG000|Year 1|Adverse Event|17|||
27553682|NCT00674700|80215243|FG001|Year 1|Adverse Event|20|||
27553683|NCT00674700|80215244|FG002|Year 1|Adverse Event|5|||
27553684|NCT00674700|80215242|FG000|Year 1|Withdrawal by Subject|7|||
27553685|NCT00674700|80215243|FG001|Year 1|Withdrawal by Subject|7|||
27553686|NCT00674700|80215244|FG002|Year 1|Withdrawal by Subject|6|||
27553687|NCT00674700|80215242|FG000|Year 1|Any other reason not above-mentioned|7|||
27553688|NCT00674700|80215243|FG001|Year 1|Any other reason not above-mentioned|7|||
27553689|NCT00674700|80215244|FG002|Year 1|Any other reason not above-mentioned|6|||
27553690|NCT00674700|80215242|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
27553691|NCT00674700|80215243|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
27553692|NCT00674700|80215244|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
27553693|NCT00674700|80215242|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
27553694|NCT00674700|80215243|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
27553695|NCT00674700|80215244|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
27553696|NCT00674700|80215242|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
27694424|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
27694425|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
27694426|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
27825750|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825751|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825752|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825753|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825754|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825755|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
27694427|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
27825756|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
27825757|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825758|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825759|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27883729|NCT00267969|81408044|FG000|After Controlled Period|Death|0|||
27553697|NCT00674700|80215243|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
27553698|NCT00674700|80215244|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
27825760|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825761|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
27825762|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825763|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825764|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825765|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825766|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825767|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825768|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825769|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825770|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825771|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825772|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825773|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825774|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825775|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
27825776|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
27825777|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
27825778|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825779|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825780|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825781|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825782|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
27825783|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825784|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825785|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825786|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825787|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825788|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825789|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825790|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825791|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825792|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825793|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825794|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825795|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825796|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825797|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
27825798|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
27825799|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825800|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825801|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825802|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825803|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
27825804|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825805|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825806|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825807|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825808|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825809|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825810|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825811|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825812|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825813|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825814|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825815|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825816|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825817|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825818|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
27825819|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
27883730|NCT00267969|81408045|FG001|After Controlled Period|Death|0|||
27883731|NCT00267969|81408046|FG002|After Controlled Period|Death|0|||
27883732|NCT00267969|81408047|FG003|After Controlled Period|Death|1|||
27825820|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825821|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825822|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825823|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825824|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
27825825|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825826|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825827|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825828|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825829|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825830|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825831|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825832|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825833|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825834|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825835|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825836|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825837|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825838|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825839|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
27825840|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
27825841|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825842|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825843|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825844|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825845|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
27825846|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825847|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825848|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825849|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825850|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825851|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825852|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825853|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825854|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825855|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825856|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825857|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825858|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825859|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825860|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
27825861|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
27825862|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825863|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825864|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825865|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27825866|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
27553699|NCT01059799|80215245|FG000|Overall Study|Adverse Event|2|||
27825867|NCT01597245|81192559|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27883733|NCT00267969|81408048|FG004|After Controlled Period|Death|2|||
27553700|NCT01059799|80215246|FG001|Overall Study|Adverse Event|3|||
27553701|NCT01059799|80215245|FG000|Overall Study|Lack of Efficacy|1|||
27553702|NCT01059799|80215246|FG001|Overall Study|Lack of Efficacy|0|||
27553703|NCT01059799|80215245|FG000|Overall Study|Protocol Violation|3|||
27553704|NCT01059799|80215246|FG001|Overall Study|Protocol Violation|2|||
27553705|NCT01059799|80215245|FG000|Overall Study|Withdrawal criteria|13|||
27553706|NCT01059799|80215246|FG001|Overall Study|Withdrawal criteria|2|||
27553707|NCT01059799|80215245|FG000|Overall Study|Other|12|||
27553708|NCT01059799|80215246|FG001|Overall Study|Other|3|||
27553709|NCT02057406|80215252|FG000|Overall Study|Physician Decision|0|||
27553710|NCT02057406|80215253|FG001|Overall Study|Physician Decision|0|||
27553711|NCT02057406|80215254|FG002|Overall Study|Physician Decision|2|||
27553712|NCT02057406|80215252|FG000|Overall Study|Withdrawal by Subject|0|||
27553713|NCT02057406|80215253|FG001|Overall Study|Withdrawal by Subject|2|||
27553714|NCT02057406|80215254|FG002|Overall Study|Withdrawal by Subject|0|||
27553715|NCT02057406|80215252|FG000|Overall Study|Lost to Follow-up|0|||
27553716|NCT02057406|80215253|FG001|Overall Study|Lost to Follow-up|0|||
27553717|NCT02057406|80215254|FG002|Overall Study|Lost to Follow-up|1|||
27553718|NCT02057406|80215252|FG000|Overall Study|Death|1|||
27825868|NCT01597245|81192560|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27553719|NCT02057406|80215253|FG001|Overall Study|Death|0|||
27553720|NCT02057406|80215254|FG002|Overall Study|Death|0|||
27553721|NCT02057406|80215252|FG000|Overall Study|Protocol Violation|0|||
27553722|NCT02057406|80215253|FG001|Overall Study|Protocol Violation|1|||
27553723|NCT02057406|80215254|FG002|Overall Study|Protocol Violation|0|||
27825869|NCT01597245|81192561|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825870|NCT01597245|81192562|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825871|NCT01597245|81192563|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825872|NCT01597245|81192564|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825873|NCT01597245|81192565|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825874|NCT01597245|81192566|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825875|NCT01597245|81192567|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825876|NCT01597245|81192568|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825877|NCT01597245|81192569|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825878|NCT01597245|81192570|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27553724|NCT02057406|80215252|FG000|Overall Study|Patient transportation issues|0|||
27553725|NCT02057406|80215253|FG001|Overall Study|Patient transportation issues|0|||
27553726|NCT02057406|80215254|FG002|Overall Study|Patient transportation issues|1|||
27553727|NCT01401283|80215255|FG000|Overall Study|surgery cancelled|5|||
27553728|NCT01401283|80215256|FG001|Overall Study|surgery cancelled|8|||
27553729|NCT01401283|80215255|FG000|Overall Study|preoperative arrhythmia|5|||
27553730|NCT01401283|80215256|FG001|Overall Study|preoperative arrhythmia|0|||
27553731|NCT01401283|80215255|FG000|Overall Study|no central venous access|0|||
27553732|NCT01401283|80215256|FG001|Overall Study|no central venous access|1|||
27553733|NCT01401283|80215255|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
27553734|NCT01401283|80215256|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
27553735|NCT00489541|80215257|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
27553736|NCT00489541|80215258|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
27553737|NCT00489541|80215257|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
27553738|NCT00489541|80215258|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
27553739|NCT00489541|80215257|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
27553740|NCT00489541|80215258|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
27553741|NCT00489541|80215257|FG000|12-Month Clinical Follow-up|Death|3|||
27553742|NCT00489541|80215258|FG001|12-Month Clinical Follow-up|Death|2|||
27553743|NCT00489541|80215257|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
27553744|NCT00489541|80215258|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
27553745|NCT00489541|80215257|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
27553746|NCT00489541|80215258|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
27825879|NCT01597245|81192571|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825880|NCT01597245|81192572|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
27825881|NCT01597245|81192573|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27553747|NCT02483520|80215259|FG000|Overall Study|Lost to Follow-up|3|||
27553748|NCT02483520|80215260|FG001|Overall Study|Lost to Follow-up|4|||
27553749|NCT02483520|80215259|FG000|Overall Study|Withdrawal by Subject|4|||
27553750|NCT02483520|80215260|FG001|Overall Study|Withdrawal by Subject|14|||
27553751|NCT02483520|80215259|FG000|Overall Study|Hospitalized|2|||
27553752|NCT02483520|80215260|FG001|Overall Study|Hospitalized|3|||
27553753|NCT02483520|80215259|FG000|Overall Study|Moved to LTC|2|||
27553754|NCT02483520|80215260|FG001|Overall Study|Moved to LTC|3|||
27553755|NCT01749514|80215261|FG000|Overall Study|Lost to Follow-up|0|||
27553756|NCT01749514|80215262|FG001|Overall Study|Lost to Follow-up|0|||
27553757|NCT01749514|80215263|FG002|Overall Study|Lost to Follow-up|0|||
27553758|NCT01749514|80215264|FG003|Overall Study|Lost to Follow-up|0|||
27553759|NCT01749514|80215265|FG004|Overall Study|Lost to Follow-up|0|||
27553760|NCT01749514|80215266|FG005|Overall Study|Lost to Follow-up|0|||
27553761|NCT01749514|80215267|FG006|Overall Study|Lost to Follow-up|0|||
27553762|NCT01749514|80215268|FG007|Overall Study|Lost to Follow-up|1|||
27553763|NCT01749514|80215261|FG000|Overall Study|Withdrawal by Subject|0|||
27553764|NCT01749514|80215262|FG001|Overall Study|Withdrawal by Subject|0|||
27553765|NCT01749514|80215263|FG002|Overall Study|Withdrawal by Subject|0|||
27553766|NCT01749514|80215264|FG003|Overall Study|Withdrawal by Subject|0|||
27553767|NCT01749514|80215265|FG004|Overall Study|Withdrawal by Subject|0|||
27553768|NCT01749514|80215266|FG005|Overall Study|Withdrawal by Subject|1|||
27553769|NCT01749514|80215267|FG006|Overall Study|Withdrawal by Subject|0|||
27553770|NCT01749514|80215268|FG007|Overall Study|Withdrawal by Subject|1|||
27553771|NCT01749514|80215261|FG000|Overall Study|Not Reported|0|||
27553772|NCT01749514|80215262|FG001|Overall Study|Not Reported|0|||
27553773|NCT01749514|80215263|FG002|Overall Study|Not Reported|0|||
27553774|NCT01749514|80215264|FG003|Overall Study|Not Reported|0|||
27553775|NCT01749514|80215265|FG004|Overall Study|Not Reported|0|||
27553776|NCT01749514|80215266|FG005|Overall Study|Not Reported|0|||
27553777|NCT01749514|80215267|FG006|Overall Study|Not Reported|0|||
27553778|NCT01749514|80215268|FG007|Overall Study|Not Reported|5|||
27553779|NCT01005745|80215278|FG000|Overall Study|No TIL growth|1|||
27553780|NCT01005745|80215278|FG000|Overall Study|Disease progressed during TIL growth|3|||
27553781|NCT01005745|80215278|FG000|Overall Study|Death prior to treatment|1|||
27553782|NCT01005745|80215278|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
27553783|NCT00696696|80215279|FG000|Overall Study|Adverse Event|5|||
27553784|NCT00696696|80215279|FG000|Overall Study|Withdrawal by Subject|8|||
27553785|NCT00696696|80215279|FG000|Overall Study|Physician Decision|2|||
27553786|NCT00696696|80215279|FG000|Overall Study|Death|3|||
27553787|NCT02692716|80215280|FG000|Overall Study|Lost to Follow-up|2|||
27553788|NCT02692716|80215281|FG001|Overall Study|Lost to Follow-up|5|||
27553789|NCT02692716|80215280|FG000|Overall Study|Withdrawal by Subject|3|||
27553790|NCT02692716|80215281|FG001|Overall Study|Withdrawal by Subject|1|||
27553791|NCT04128267|80215282|FG000|Overall Study|Withdrawal by Subject|6|||
27553792|NCT04128267|80215282|FG000|Overall Study|Death|2|||
27553793|NCT04128267|80215282|FG000|Overall Study|Disease progression|1|||
27553794|NCT04128267|80215282|FG000|Overall Study|Participant had other medical issues|4|||
27553795|NCT04128267|80215282|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
27553796|NCT00040664|80215283|FG000|Overall Study|Adverse Event|12|||
27553797|NCT00040664|80215284|FG001|Overall Study|Adverse Event|3|||
27553798|NCT00040664|80215285|FG002|Overall Study|Adverse Event|2|||
27553799|NCT00040664|80215286|FG003|Overall Study|Adverse Event|7|||
27553800|NCT00040664|80215283|FG000|Overall Study|Lack of Efficacy|9|||
27553801|NCT00040664|80215284|FG001|Overall Study|Lack of Efficacy|2|||
27553802|NCT00040664|80215285|FG002|Overall Study|Lack of Efficacy|3|||
27553803|NCT00040664|80215286|FG003|Overall Study|Lack of Efficacy|4|||
27553804|NCT00040664|80215283|FG000|Overall Study|Insufficient CD4 response|1|||
27553805|NCT00040664|80215284|FG001|Overall Study|Insufficient CD4 response|0|||
27553806|NCT00040664|80215285|FG002|Overall Study|Insufficient CD4 response|1|||
27553807|NCT00040664|80215286|FG003|Overall Study|Insufficient CD4 response|0|||
27553808|NCT00040664|80215283|FG000|Overall Study|Lost to Follow-up|4|||
27553809|NCT00040664|80215284|FG001|Overall Study|Lost to Follow-up|2|||
27553810|NCT00040664|80215285|FG002|Overall Study|Lost to Follow-up|0|||
27553811|NCT00040664|80215286|FG003|Overall Study|Lost to Follow-up|2|||
27553812|NCT00040664|80215283|FG000|Overall Study|Protocol Violation|2|||
27553813|NCT00040664|80215284|FG001|Overall Study|Protocol Violation|1|||
27553814|NCT00040664|80215285|FG002|Overall Study|Protocol Violation|0|||
27553815|NCT00040664|80215286|FG003|Overall Study|Protocol Violation|1|||
27553816|NCT00040664|80215283|FG000|Overall Study|Withdrawal by Subject|7|||
27553817|NCT00040664|80215284|FG001|Overall Study|Withdrawal by Subject|0|||
27553818|NCT00040664|80215285|FG002|Overall Study|Withdrawal by Subject|3|||
27553819|NCT00040664|80215286|FG003|Overall Study|Withdrawal by Subject|4|||
27553820|NCT00040664|80215283|FG000|Overall Study|Pregnancy|3|||
27553821|NCT00040664|80215284|FG001|Overall Study|Pregnancy|0|||
27553822|NCT00040664|80215285|FG002|Overall Study|Pregnancy|0|||
27553823|NCT00040664|80215286|FG003|Overall Study|Pregnancy|3|||
27553824|NCT00040664|80215283|FG000|Overall Study|Medication adherence/compliance problems|8|||
27553825|NCT00040664|80215284|FG001|Overall Study|Medication adherence/compliance problems|2|||
27553826|NCT00040664|80215285|FG002|Overall Study|Medication adherence/compliance problems|1|||
27553827|NCT00040664|80215286|FG003|Overall Study|Medication adherence/compliance problems|5|||
27553828|NCT00040664|80215283|FG000|Overall Study|Poor taste|2|||
27553829|NCT00040664|80215284|FG001|Overall Study|Poor taste|0|||
27553830|NCT00040664|80215285|FG002|Overall Study|Poor taste|2|||
27553831|NCT00040664|80215286|FG003|Overall Study|Poor taste|0|||
27553832|NCT00040664|80215283|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
27553833|NCT00040664|80215284|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
27825882|NCT01597245|81192574|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825883|NCT01597245|81192575|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825884|NCT01597245|81192576|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825885|NCT01597245|81192577|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825886|NCT01597245|81192578|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825887|NCT01597245|81192579|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
27825888|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825889|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825890|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825891|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825892|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825893|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825894|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825895|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825896|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825897|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27553834|NCT00040664|80215285|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
27825898|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825899|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825900|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825901|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825902|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825903|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
27825904|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
27825905|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
27825906|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
27825907|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
27825908|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
27825909|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825910|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825911|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825912|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825913|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825914|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825915|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825916|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825917|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825918|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825919|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825920|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825921|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825922|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27553835|NCT00040664|80215286|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
27553836|NCT00040664|80215283|FG000|Overall Study|Change of formulation|2|||
27553837|NCT00040664|80215284|FG001|Overall Study|Change of formulation|2|||
27553838|NCT00040664|80215285|FG002|Overall Study|Change of formulation|0|||
27553839|NCT00040664|80215286|FG003|Overall Study|Change of formulation|0|||
27694428|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
27694429|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
27694430|NCT02480153|80716721|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
27694431|NCT02480153|80716722|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
27694432|NCT02480153|80716723|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
27694433|NCT02480153|80716721|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
27694434|NCT02480153|80716722|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
27694435|NCT02480153|80716723|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
27694436|NCT02480153|80716721|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
27694437|NCT02480153|80716722|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
27694438|NCT02480153|80716723|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
27694439|NCT02480153|80716721|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
27694440|NCT02480153|80716722|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
27694441|NCT02480153|80716723|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
27694442|NCT02480153|80716721|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
27694443|NCT02480153|80716722|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
27694444|NCT02480153|80716723|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
27694445|NCT02480153|80716721|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
27694446|NCT02480153|80716722|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
27694447|NCT02480153|80716723|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
27694448|NCT02480153|80716721|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
27694449|NCT02480153|80716722|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
27694450|NCT02480153|80716723|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
27694451|NCT02480153|80716721|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
27694452|NCT02480153|80716722|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
27694453|NCT02480153|80716723|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
27694454|NCT02480153|80716721|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
27694455|NCT02480153|80716722|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
27694456|NCT02480153|80716723|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
27694457|NCT02480153|80716721|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
27694458|NCT02480153|80716722|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
27694459|NCT02480153|80716723|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
27694460|NCT02480153|80716721|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
27694461|NCT02480153|80716722|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
27694462|NCT02480153|80716723|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
27694463|NCT02480153|80716721|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
27553840|NCT00040664|80215283|FG000|Overall Study|Non-viability of oral suspension|1|||
27553841|NCT00040664|80215284|FG001|Overall Study|Non-viability of oral suspension|0|||
27553842|NCT00040664|80215285|FG002|Overall Study|Non-viability of oral suspension|1|||
27694464|NCT02480153|80716722|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
27883734|NCT00267969|81408049|FG005|After Controlled Period|Death|0|||
27694465|NCT02480153|80716723|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
27694466|NCT01839487|80716724|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
27694467|NCT01839487|80716725|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27694468|NCT01839487|80716726|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27694469|NCT01839487|80716727|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27553843|NCT00040664|80215286|FG003|Overall Study|Non-viability of oral suspension|0|||
27694470|NCT01839487|80716728|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27694471|NCT01839487|80716729|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
27694472|NCT01839487|80716724|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
27694473|NCT01839487|80716725|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
27825923|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27553844|NCT05131646|80215289|FG000|Overall Study|Withdrawal by Subject|1|||
27553845|NCT05131646|80215290|FG001|Overall Study|Withdrawal by Subject|0|||
27553846|NCT05131646|80215291|FG002|Overall Study|Withdrawal by Subject|0|||
27553847|NCT00126568|80215295|FG000|Overall Study|Death|2|||
27553848|NCT01104493|80215296|FG000|Overall Study|Lost to Follow-up|0|||
27553849|NCT01104493|80215297|FG001|Overall Study|Lost to Follow-up|2|||
27553850|NCT00750204|80215298|FG000|Overall Study|study halted prematurely|1|||
27883735|NCT00267969|81408050|FG006|After Controlled Period|Death|1|||
27883736|NCT00267969|81408044|FG000|After Controlled Period|Lack of Efficacy|0|||
27553851|NCT00750204|80215299|FG001|Overall Study|study halted prematurely|1|||
27553852|NCT03194321|80215305|FG000|Overall Study|Withdrawal by Subject|1|||
27553853|NCT03194321|80215305|FG000|Overall Study|Lost to Follow-up|1|||
27553854|NCT03194321|80215305|FG000|Overall Study|Travel for Follow-up|1|||
27553855|NCT04294472|80215306|FG000|Overall Study|Adverse Event|0|||
27553856|NCT04294472|80215307|FG001|Overall Study|Adverse Event|1|||
27553857|NCT04294472|80215308|FG002|Overall Study|Adverse Event|1|||
27825924|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27825925|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
27883737|NCT00267969|81408045|FG001|After Controlled Period|Lack of Efficacy|0|||
27883738|NCT00267969|81408046|FG002|After Controlled Period|Lack of Efficacy|0|||
27825926|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
27825927|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
27825928|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
27883739|NCT00267969|81408047|FG003|After Controlled Period|Lack of Efficacy|10|||
27883740|NCT00267969|81408048|FG004|After Controlled Period|Lack of Efficacy|6|||
27883741|NCT00267969|81408049|FG005|After Controlled Period|Lack of Efficacy|28|||
27825929|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
27825930|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825931|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825932|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27883742|NCT00267969|81408050|FG006|After Controlled Period|Lack of Efficacy|15|||
27883743|NCT00267969|81408044|FG000|After Controlled Period|Lost to Follow-up|0|||
27883744|NCT00267969|81408045|FG001|After Controlled Period|Lost to Follow-up|0|||
27883745|NCT00267969|81408046|FG002|After Controlled Period|Lost to Follow-up|0|||
27883746|NCT00267969|81408047|FG003|After Controlled Period|Lost to Follow-up|5|||
27883747|NCT00267969|81408048|FG004|After Controlled Period|Lost to Follow-up|8|||
27883748|NCT00267969|81408049|FG005|After Controlled Period|Lost to Follow-up|9|||
27883749|NCT00267969|81408050|FG006|After Controlled Period|Lost to Follow-up|10|||
27883750|NCT00267969|81408044|FG000|After Controlled Period|Other|0|||
27883751|NCT00267969|81408045|FG001|After Controlled Period|Other|0|||
27883752|NCT00267969|81408046|FG002|After Controlled Period|Other|0|||
27883753|NCT00267969|81408047|FG003|After Controlled Period|Other|13|||
27883754|NCT00267969|81408048|FG004|After Controlled Period|Other|11|||
27883755|NCT00267969|81408049|FG005|After Controlled Period|Other|22|||
27883756|NCT00267969|81408050|FG006|After Controlled Period|Other|25|||
27883757|NCT03491462|81408051|FG000|Overall Study|Lost to Follow-up|2|||
27883758|NCT03491462|81408052|FG001|Overall Study|Lost to Follow-up|0|||
27883759|NCT03491462|81408051|FG000|Overall Study|Adverse Event|11|||
27883760|NCT03491462|81408052|FG001|Overall Study|Adverse Event|1|||
27883761|NCT03491462|81408051|FG000|Overall Study|Physician Decision|3|||
27883762|NCT03491462|81408052|FG001|Overall Study|Physician Decision|0|||
27553858|NCT04294472|80215306|FG000|Overall Study|Randomized but not treated|0|||
27553859|NCT04294472|80215307|FG001|Overall Study|Randomized but not treated|1|||
27553860|NCT04294472|80215308|FG002|Overall Study|Randomized but not treated|1|||
27883763|NCT03491462|81408051|FG000|Overall Study|Withdrawal by Subject|22|||
27883764|NCT03491462|81408052|FG001|Overall Study|Withdrawal by Subject|15|||
27883765|NCT02582684|81408053|FG000|Overall Study|Unable to contact subject/parent|4|||
27553861|NCT01995825|80215309|FG000|Overall Study|Withdrawal by Subject|1|||
27553862|NCT01995825|80215310|FG001|Overall Study|Withdrawal by Subject|0|||
27553863|NCT02282020|80215319|FG000|Overall Study|Objective Disease Progression|128|||
27553864|NCT02282020|80215320|FG001|Overall Study|Objective Disease Progression|30|||
27553865|NCT02282020|80215319|FG000|Overall Study|Adverse Event|18|||
27553866|NCT02282020|80215320|FG001|Overall Study|Adverse Event|15|||
27883766|NCT02582684|81408053|FG000|Overall Study|Subject not able to get to clinic|10|||
27883767|NCT02582684|81408053|FG000|Overall Study|Subject withdrew consent|1|||
27883768|NCT02582684|81408053|FG000|Overall Study|Found to be ineligible after enrollment|2|||
27883769|NCT01986933|81408054|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
27883770|NCT01986933|81408055|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
27883771|NCT01986933|81408056|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
27883772|NCT01986933|81408057|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
27883773|NCT01986933|81408058|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
27883774|NCT01986933|81408054|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
27883775|NCT01986933|81408055|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
27553867|NCT02282020|80215319|FG000|Overall Study|Withdrawal by Subject|7|||
27553868|NCT02282020|80215320|FG001|Overall Study|Withdrawal by Subject|10|||
27883776|NCT01986933|81408056|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
27883777|NCT01986933|81408057|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
27553869|NCT02282020|80215319|FG000|Overall Study|Miscellaneous|5|||
27883778|NCT01986933|81408058|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
27553870|NCT02282020|80215320|FG001|Overall Study|Miscellaneous|19|||
27553871|NCT02282020|80215319|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
27553872|NCT02282020|80215320|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
27553873|NCT02282020|80215319|FG000|Overall Study|Developed Discontinuation Criteria|0|||
27553874|NCT02282020|80215320|FG001|Overall Study|Developed Discontinuation Criteria|2|||
27553875|NCT02282020|80215319|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
27553876|NCT02282020|80215320|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
27553877|NCT02899988|80215321|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
27553878|NCT02899988|80215322|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
27553879|NCT02899988|80215323|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553880|NCT02899988|80215324|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553881|NCT02899988|80215325|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553882|NCT02899988|80215326|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553883|NCT02899988|80215327|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553884|NCT02899988|80215328|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553885|NCT02899988|80215329|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553886|NCT02899988|80215330|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553887|NCT02899988|80215331|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27553888|NCT02899988|80215321|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
27553889|NCT02899988|80215322|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
27553890|NCT02899988|80215323|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
27553891|NCT02899988|80215324|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
27553892|NCT02899988|80215325|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
27553893|NCT02899988|80215326|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
27553894|NCT02899988|80215327|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
27553895|NCT02899988|80215328|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
27553896|NCT02899988|80215329|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
27553897|NCT02899988|80215330|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
27553898|NCT02899988|80215331|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
27553899|NCT02899988|80215321|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
27553900|NCT02899988|80215322|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
27553901|NCT02899988|80215323|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
27553902|NCT02899988|80215324|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
27553903|NCT02899988|80215325|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
27553904|NCT02899988|80215326|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
27553905|NCT02899988|80215327|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
27553906|NCT02899988|80215328|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
27553907|NCT02899988|80215329|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
27553908|NCT02899988|80215330|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
27553909|NCT02899988|80215331|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
27553910|NCT02899988|80215321|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
27553911|NCT02899988|80215322|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
27553912|NCT02899988|80215323|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
27553913|NCT02899988|80215324|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
27553914|NCT02899988|80215325|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
27553915|NCT02899988|80215326|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
27553916|NCT02899988|80215327|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
27553917|NCT02899988|80215328|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
27553918|NCT02899988|80215329|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
27553919|NCT02899988|80215330|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
27553920|NCT02899988|80215331|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
27553921|NCT02899988|80215321|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553922|NCT02899988|80215322|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553923|NCT02899988|80215323|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553924|NCT02899988|80215324|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553925|NCT02899988|80215325|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553926|NCT02899988|80215326|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
27553927|NCT02899988|80215327|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27825933|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825934|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825935|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825936|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825937|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825938|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27553928|NCT02899988|80215328|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
27553929|NCT02899988|80215329|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553930|NCT02899988|80215330|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553931|NCT02899988|80215331|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
27553932|NCT02899988|80215321|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27825939|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27553933|NCT02899988|80215322|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27553934|NCT02899988|80215323|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27553935|NCT02899988|80215324|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27553936|NCT02899988|80215325|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
27553937|NCT02899988|80215326|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27553938|NCT02899988|80215327|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
27553939|NCT02899988|80215328|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
27553940|NCT02899988|80215329|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
27553941|NCT02899988|80215330|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
27553942|NCT02899988|80215331|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
27553943|NCT00883116|80215332|FG000|Overall Study|Adverse event unrelated to study drug|5|||
27553944|NCT00883116|80215333|FG001|Overall Study|Adverse event unrelated to study drug|10|||
27553945|NCT00883116|80215332|FG000|Overall Study|Death|6|||
27553946|NCT00883116|80215333|FG001|Overall Study|Death|2|||
27553947|NCT00883116|80215332|FG000|Overall Study|Disease progression|130|||
27553948|NCT00883116|80215333|FG001|Overall Study|Disease progression|128|||
27553949|NCT00883116|80215332|FG000|Overall Study|Lost to Follow-up|0|||
27553950|NCT00883116|80215333|FG001|Overall Study|Lost to Follow-up|1|||
27553951|NCT00883116|80215332|FG000|Overall Study|Maximum clinical benefit|13|||
27553952|NCT00883116|80215333|FG001|Overall Study|Maximum clinical benefit|46|||
27553953|NCT00883116|80215332|FG000|Overall Study|Not identified|3|||
27553954|NCT00883116|80215333|FG001|Overall Study|Not identified|6|||
27553955|NCT00883116|80215332|FG000|Overall Study|Study drug toxicity|36|||
27553956|NCT00883116|80215333|FG001|Overall Study|Study drug toxicity|16|||
27553957|NCT00883116|80215332|FG000|Overall Study|Withdrawal by Subject|14|||
27553958|NCT00883116|80215333|FG001|Overall Study|Withdrawal by Subject|8|||
27553959|NCT00883116|80215332|FG000|Overall Study|No longer meets study criteria|2|||
27553960|NCT00883116|80215333|FG001|Overall Study|No longer meets study criteria|2|||
27553961|NCT02433483|80215336|FG000|Overall Study|Unacceptable toxicity|1|||
27553962|NCT02433483|80215336|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
27553963|NCT02663674|80215337|FG000|Overall Study|Lost to Follow-up|5|||
27553964|NCT02663674|80215338|FG001|Overall Study|Lost to Follow-up|4|||
27553965|NCT02663674|80215337|FG000|Overall Study|Withdrawal by Subject|1|||
27553966|NCT02663674|80215338|FG001|Overall Study|Withdrawal by Subject|4|||
27553967|NCT02663674|80215337|FG000|Overall Study|Physician Decision|1|||
27553968|NCT02663674|80215338|FG001|Overall Study|Physician Decision|1|||
27553969|NCT02663674|80215337|FG000|Overall Study|Other Event (Health Related)|0|||
27553970|NCT02663674|80215338|FG001|Overall Study|Other Event (Health Related)|1|||
27553971|NCT03552198|80215339|FG000|Overall Study|Lost to Follow-up|42|||
27553972|NCT03552198|80215340|FG001|Overall Study|Lost to Follow-up|48|||
27553973|NCT03552198|80215341|FG002|Overall Study|Lost to Follow-up|15|||
27553974|NCT03552198|80215342|FG003|Overall Study|Lost to Follow-up|19|||
27553975|NCT03552198|80215339|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
27553976|NCT03552198|80215340|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
27553977|NCT03552198|80215341|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
27553978|NCT03552198|80215342|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
27553979|NCT03552198|80215339|FG000|Overall Study|Did not receive air alerts|1|||
27553980|NCT03552198|80215340|FG001|Overall Study|Did not receive air alerts|0|||
27553981|NCT03552198|80215341|FG002|Overall Study|Did not receive air alerts|0|||
27553982|NCT03552198|80215342|FG003|Overall Study|Did not receive air alerts|1|||
27694474|NCT01839487|80716726|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27694475|NCT01839487|80716727|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27694476|NCT01839487|80716728|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27553983|NCT02450903|80215343|FG000|Overall Study|Adverse Event|3|||
27553984|NCT02450903|80215343|FG000|Overall Study|Progressive disease|15|||
27553985|NCT02450903|80215343|FG000|Overall Study|Switched to commercial drug|1|||
27553986|NCT02450903|80215343|FG000|Overall Study|Subject/guardian decision|1|||
27553987|NCT02049957|80215348|FG000|Overall Study|Progressive Disease|5|||
27553988|NCT02049957|80215349|FG001|Overall Study|Progressive Disease|4|||
27553989|NCT02049957|80215350|FG002|Overall Study|Progressive Disease|2|||
27553990|NCT02049957|80215351|FG003|Overall Study|Progressive Disease|2|||
27553991|NCT02049957|80215352|FG004|Overall Study|Progressive Disease|6|||
27553992|NCT02049957|80215353|FG005|Overall Study|Progressive Disease|35|||
27553993|NCT02049957|80215354|FG006|Overall Study|Progressive Disease|7|||
27553994|NCT02049957|80215355|FG007|Overall Study|Progressive Disease|26|||
27553995|NCT02049957|80215356|FG008|Overall Study|Progressive Disease|6|||
27553996|NCT02049957|80215348|FG000|Overall Study|Adverse Event|1|||
27553997|NCT02049957|80215349|FG001|Overall Study|Adverse Event|1|||
27553998|NCT02049957|80215350|FG002|Overall Study|Adverse Event|1|||
27553999|NCT02049957|80215351|FG003|Overall Study|Adverse Event|0|||
27554000|NCT02049957|80215352|FG004|Overall Study|Adverse Event|0|||
27554001|NCT02049957|80215353|FG005|Overall Study|Adverse Event|5|||
27554002|NCT02049957|80215354|FG006|Overall Study|Adverse Event|0|||
27554003|NCT02049957|80215355|FG007|Overall Study|Adverse Event|6|||
27554004|NCT02049957|80215356|FG008|Overall Study|Adverse Event|1|||
27554005|NCT02049957|80215348|FG000|Overall Study|Study Terminated by Sponsor|0|||
27554006|NCT02049957|80215349|FG001|Overall Study|Study Terminated by Sponsor|1|||
27554007|NCT02049957|80215350|FG002|Overall Study|Study Terminated by Sponsor|0|||
27554008|NCT02049957|80215351|FG003|Overall Study|Study Terminated by Sponsor|0|||
27554009|NCT02049957|80215352|FG004|Overall Study|Study Terminated by Sponsor|0|||
27554010|NCT02049957|80215353|FG005|Overall Study|Study Terminated by Sponsor|0|||
27554011|NCT02049957|80215354|FG006|Overall Study|Study Terminated by Sponsor|1|||
27554012|NCT02049957|80215355|FG007|Overall Study|Study Terminated by Sponsor|0|||
27554013|NCT02049957|80215356|FG008|Overall Study|Study Terminated by Sponsor|0|||
27554014|NCT02049957|80215348|FG000|Overall Study|Withdrawal by Subject|0|||
27554015|NCT02049957|80215349|FG001|Overall Study|Withdrawal by Subject|0|||
27825940|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27554016|NCT02049957|80215350|FG002|Overall Study|Withdrawal by Subject|0|||
27554017|NCT02049957|80215351|FG003|Overall Study|Withdrawal by Subject|1|||
27554018|NCT02049957|80215352|FG004|Overall Study|Withdrawal by Subject|0|||
27554019|NCT02049957|80215353|FG005|Overall Study|Withdrawal by Subject|2|||
27554020|NCT02049957|80215354|FG006|Overall Study|Withdrawal by Subject|0|||
27554021|NCT02049957|80215355|FG007|Overall Study|Withdrawal by Subject|3|||
27554022|NCT02049957|80215356|FG008|Overall Study|Withdrawal by Subject|1|||
27554023|NCT02049957|80215348|FG000|Overall Study|Physician Decision|0|||
27554024|NCT02049957|80215349|FG001|Overall Study|Physician Decision|0|||
27554025|NCT02049957|80215350|FG002|Overall Study|Physician Decision|0|||
27554026|NCT02049957|80215351|FG003|Overall Study|Physician Decision|0|||
27554027|NCT02049957|80215352|FG004|Overall Study|Physician Decision|0|||
27694477|NCT01839487|80716729|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
27554028|NCT02049957|80215353|FG005|Overall Study|Physician Decision|1|||
27825941|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825942|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825943|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27554029|NCT02049957|80215354|FG006|Overall Study|Physician Decision|0|||
27554030|NCT02049957|80215355|FG007|Overall Study|Physician Decision|0|||
27554031|NCT02049957|80215356|FG008|Overall Study|Physician Decision|0|||
27554032|NCT01782495|80215366|FG000|Overall Study|Adverse Event|0|||
27554033|NCT01782495|80215367|FG001|Overall Study|Adverse Event|0|||
27554034|NCT01782495|80215368|FG002|Overall Study|Adverse Event|0|||
27554035|NCT01782495|80215369|FG003|Overall Study|Adverse Event|0|||
27554036|NCT01782495|80215370|FG004|Overall Study|Adverse Event|0|||
27825944|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825945|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825946|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
27825947|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825948|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
27825949|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
27825950|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
27825951|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825952|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825953|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825954|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825955|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825956|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825957|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825958|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825959|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825960|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825961|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825962|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825963|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825964|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825965|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825966|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825967|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825968|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
27825969|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
27883779|NCT01986933|81408054|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
27883780|NCT01986933|81408055|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
27825970|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
27825971|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
27825972|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825973|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825974|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825975|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825976|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27554037|NCT01782495|80215371|FG005|Overall Study|Adverse Event|0|||
27554038|NCT01782495|80215372|FG006|Overall Study|Adverse Event|0|||
27554039|NCT01782495|80215373|FG007|Overall Study|Adverse Event|2|||
27554040|NCT01782495|80215374|FG008|Overall Study|Adverse Event|0|||
27554041|NCT01782495|80215375|FG009|Overall Study|Adverse Event|0|||
27554042|NCT01782495|80215376|FG010|Overall Study|Adverse Event|0|||
27825977|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825978|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825979|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825980|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825981|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825982|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825983|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825984|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825985|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825986|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825987|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825988|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
27554043|NCT01782495|80215366|FG000|Overall Study|Withdrew Consent|0|||
27554044|NCT01782495|80215367|FG001|Overall Study|Withdrew Consent|1|||
27554045|NCT01782495|80215368|FG002|Overall Study|Withdrew Consent|0|||
27554046|NCT01782495|80215369|FG003|Overall Study|Withdrew Consent|0|||
27554047|NCT01782495|80215370|FG004|Overall Study|Withdrew Consent|0|||
27825989|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27825990|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
27554048|NCT01782495|80215371|FG005|Overall Study|Withdrew Consent|0|||
27554049|NCT01782495|80215372|FG006|Overall Study|Withdrew Consent|0|||
27554050|NCT01782495|80215373|FG007|Overall Study|Withdrew Consent|1|||
27554051|NCT01782495|80215374|FG008|Overall Study|Withdrew Consent|0|||
27554052|NCT01782495|80215375|FG009|Overall Study|Withdrew Consent|0|||
27554053|NCT01782495|80215376|FG010|Overall Study|Withdrew Consent|0|||
27554054|NCT02117648|80215377|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
27554055|NCT02117648|80215377|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
27554056|NCT02117648|80215377|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
27554057|NCT02117648|80215377|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
27554058|NCT02117648|80215377|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
27554059|NCT02117648|80215377|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
27554060|NCT02117648|80215377|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
27554061|NCT02117648|80215377|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
27554062|NCT02117648|80215377|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
27554063|NCT02117648|80215377|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
27554064|NCT02117648|80215377|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
27554065|NCT01549860|80215380|FG000|Overall Study|Withdrawal by Subject|1|||
27554066|NCT01549860|80215381|FG001|Overall Study|Withdrawal by Subject|0|||
27554067|NCT01549860|80215380|FG000|Overall Study|Physician Decision|1|||
27554068|NCT01549860|80215381|FG001|Overall Study|Physician Decision|1|||
27554069|NCT01018186|80215386|FG000|2-week Run-in Period|Protocol Violation|1|||
27554070|NCT01018186|80215387|FG001|2-week Run-in Period|Protocol Violation|0|||
27554071|NCT01018186|80215388|FG002|2-week Run-in Period|Protocol Violation|0|||
27554072|NCT01018186|80215389|FG003|2-week Run-in Period|Protocol Violation|0|||
27554073|NCT01018186|80215386|FG000|2-week Run-in Period|Lost to Follow-up|2|||
27554074|NCT01018186|80215387|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27554075|NCT01018186|80215388|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27554076|NCT01018186|80215389|FG003|2-week Run-in Period|Lost to Follow-up|0|||
27554077|NCT01018186|80215386|FG000|2-week Run-in Period|Physician Decision|3|||
27554078|NCT01018186|80215387|FG001|2-week Run-in Period|Physician Decision|0|||
27554079|NCT01018186|80215388|FG002|2-week Run-in Period|Physician Decision|0|||
27554080|NCT01018186|80215389|FG003|2-week Run-in Period|Physician Decision|0|||
27554081|NCT01018186|80215386|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
27554082|NCT01018186|80215387|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27554083|NCT01018186|80215388|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27694478|NCT01839487|80716724|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27825991|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
27554084|NCT01018186|80215389|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
27554085|NCT01018186|80215386|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
27554086|NCT01018186|80215387|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27554087|NCT01018186|80215388|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27554088|NCT01018186|80215389|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27554089|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
27554090|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
27554091|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
27554092|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
27554093|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
27554094|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
27554095|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
27554096|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
27554097|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
27554098|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
27554099|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
27554100|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
27554101|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
27554102|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
27554103|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
27554104|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
27554105|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
27554106|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
27554107|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
27554108|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
27554109|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
27554110|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
27554111|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
27554112|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
27554113|NCT01018186|80215386|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27554114|NCT01018186|80215387|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
27554115|NCT01018186|80215388|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
27554116|NCT01018186|80215389|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
27554117|NCT01324999|80215390|FG000|Overall Study|Adverse Event|3|||
27554118|NCT01324999|80215390|FG000|Overall Study|Withdrawal by Subject|2|||
27554119|NCT02573311|80215394|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
27554120|NCT02573311|80215395|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
27554121|NCT02573311|80215394|FG000|Disposition for Part 2|Physician Decision|25|||
27825992|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
27825993|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27825994|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27825995|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27554122|NCT02573311|80215395|FG001|Disposition for Part 2|Physician Decision|7|||
27554123|NCT02573311|80215394|FG000|Disposition for Part 2|Adverse Event|36|||
27554124|NCT02573311|80215395|FG001|Disposition for Part 2|Adverse Event|5|||
27554125|NCT02573311|80215394|FG000|Disposition for Part 2|Lost to Follow-up|76|||
27554126|NCT02573311|80215395|FG001|Disposition for Part 2|Lost to Follow-up|7|||
27554127|NCT02573311|80215394|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
27554128|NCT02573311|80215395|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
27554129|NCT02573311|80215394|FG000|Disposition for Part 2|Investigator decision|0|||
27554130|NCT02573311|80215395|FG001|Disposition for Part 2|Investigator decision|1|||
27554131|NCT02573311|80215394|FG000|Disposition for Part 2|Other than specified above|13|||
27554132|NCT02573311|80215395|FG001|Disposition for Part 2|Other than specified above|3|||
27554133|NCT00459953|80215396|FG000|Overall Study|not analyzed-household member in study|1|||
27554134|NCT00459953|80215397|FG001|Overall Study|not analyzed-household member in study|1|||
27554135|NCT03510884|80215398|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
27554136|NCT03510884|80215399|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
27554137|NCT03510884|80215400|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
27554138|NCT03510884|80215401|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
27554139|NCT03510884|80215398|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
27554140|NCT03510884|80215399|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
27554141|NCT03510884|80215400|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
27554142|NCT03510884|80215401|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
27554143|NCT03510884|80215398|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
27554144|NCT03510884|80215399|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
27554145|NCT03510884|80215400|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
27554146|NCT03510884|80215401|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
27554147|NCT03510884|80215398|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
27554148|NCT03510884|80215399|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
27554149|NCT03510884|80215400|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
27554150|NCT03510884|80215401|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
27554151|NCT03510884|80215398|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
27554152|NCT03510884|80215399|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
27554153|NCT03510884|80215400|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
27554154|NCT03510884|80215401|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
27554155|NCT03510884|80215398|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
27554156|NCT03510884|80215399|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
27554157|NCT03510884|80215400|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
27554158|NCT03510884|80215401|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
27554159|NCT03510884|80215398|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
27554160|NCT03510884|80215399|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
27554161|NCT03510884|80215400|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
27554162|NCT03510884|80215401|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
27825996|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27825997|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27694479|NCT01839487|80716725|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
27694480|NCT01839487|80716726|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27694481|NCT01839487|80716727|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27694482|NCT01839487|80716728|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27694483|NCT01839487|80716729|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
27694484|NCT01839487|80716724|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
27694485|NCT01839487|80716725|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27694486|NCT01839487|80716726|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27694487|NCT01839487|80716727|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27694488|NCT01839487|80716728|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27694489|NCT01839487|80716729|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
27694490|NCT01839487|80716724|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
27694491|NCT01839487|80716725|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
27694492|NCT01839487|80716726|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
27694493|NCT01839487|80716727|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
27694494|NCT01839487|80716728|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
27694495|NCT01839487|80716729|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
27694496|NCT01839487|80716724|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
27694497|NCT01839487|80716725|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
27694498|NCT01839487|80716726|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
27694499|NCT01839487|80716727|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
27694500|NCT01839487|80716728|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
27694501|NCT01839487|80716729|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
27694502|NCT01839487|80716724|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27694503|NCT01839487|80716725|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27694504|NCT01839487|80716726|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
27694505|NCT01839487|80716727|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27694506|NCT01839487|80716728|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
27694507|NCT01839487|80716729|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
27694508|NCT01839487|80716724|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
27694509|NCT01839487|80716725|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
27694510|NCT01839487|80716726|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
27694511|NCT01839487|80716727|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
27694512|NCT01839487|80716728|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
27694513|NCT01839487|80716729|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
27694514|NCT01839487|80716724|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
27694515|NCT01839487|80716725|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
27694516|NCT01839487|80716726|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
27825998|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27825999|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27694517|NCT01839487|80716727|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
27694518|NCT01839487|80716728|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
27694519|NCT01839487|80716729|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
27694520|NCT03278106|80716730|FG000|Overall Study|No protocol treatment|1|||
27694521|NCT01403610|80716731|FG000|Overall Study|Withdrawal by Subject|2|||
27694522|NCT01403610|80716732|FG001|Overall Study|Withdrawal by Subject|0|||
27694523|NCT01403610|80716733|FG002|Overall Study|Withdrawal by Subject|0|||
27694524|NCT01403610|80716734|FG003|Overall Study|Withdrawal by Subject|0|||
27694525|NCT01403610|80716731|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
27694526|NCT01403610|80716732|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
27694527|NCT01403610|80716733|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
27694528|NCT01403610|80716734|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
27694529|NCT01498653|80716737|FG000|Overall Study|Adverse Event|2|||
27694530|NCT01498653|80716738|FG001|Overall Study|Adverse Event|2|||
27694531|NCT01498653|80716737|FG000|Overall Study|Lack of Efficacy|12|||
27694532|NCT01498653|80716738|FG001|Overall Study|Lack of Efficacy|26|||
27694533|NCT01498653|80716737|FG000|Overall Study|Protocol Violation|0|||
27694534|NCT01498653|80716738|FG001|Overall Study|Protocol Violation|4|||
27694535|NCT01498653|80716737|FG000|Overall Study|Lost to Follow-up|1|||
27694536|NCT01498653|80716738|FG001|Overall Study|Lost to Follow-up|0|||
27694537|NCT01498653|80716737|FG000|Overall Study|Physician Decision|2|||
27694538|NCT01498653|80716738|FG001|Overall Study|Physician Decision|0|||
27694539|NCT01498653|80716737|FG000|Overall Study|Withdrawal by Subject|2|||
27694540|NCT01498653|80716738|FG001|Overall Study|Withdrawal by Subject|3|||
27694541|NCT00577473|80716739|FG000|Overall Study|Protocol Violation|1|||
27554163|NCT03510884|80215398|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
27554164|NCT03510884|80215399|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
27554165|NCT03510884|80215400|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
27554166|NCT03510884|80215401|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
27554167|NCT03510884|80215398|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
27554168|NCT03510884|80215399|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
27554169|NCT03510884|80215400|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
27554170|NCT03510884|80215401|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
27554171|NCT03510884|80215398|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
27554172|NCT03510884|80215399|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
27554173|NCT03510884|80215400|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
27554174|NCT03510884|80215401|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
27554175|NCT03187197|80215404|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
27554176|NCT03187197|80215405|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
27554177|NCT03187197|80215406|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
27554178|NCT03187197|80215404|FG000|Overall Study|Withdrawal by Subject|8|||
27554179|NCT03187197|80215405|FG001|Overall Study|Withdrawal by Subject|63|||
27554180|NCT03187197|80215406|FG002|Overall Study|Withdrawal by Subject|4|||
27554181|NCT03187197|80215404|FG000|Overall Study|Lost to Follow-up|1|||
27554182|NCT03187197|80215405|FG001|Overall Study|Lost to Follow-up|60|||
27554183|NCT03187197|80215406|FG002|Overall Study|Lost to Follow-up|7|||
27554184|NCT03187197|80215404|FG000|Overall Study|Adverse Event|6|||
27694542|NCT00577473|80716740|FG001|Overall Study|Protocol Violation|4|||
27694543|NCT00577473|80716739|FG000|Overall Study|Adverse Event|8|||
27826000|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27826001|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27694544|NCT00577473|80716740|FG001|Overall Study|Adverse Event|5|||
27826002|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27554185|NCT03187197|80215405|FG001|Overall Study|Adverse Event|29|||
27694545|NCT00577473|80716739|FG000|Overall Study|Withdrawal by Subject|2|||
27694546|NCT00577473|80716740|FG001|Overall Study|Withdrawal by Subject|6|||
27694547|NCT00577473|80716739|FG000|Overall Study|Physician Decision|2|||
27694548|NCT00577473|80716740|FG001|Overall Study|Physician Decision|2|||
27694549|NCT00577473|80716739|FG000|Overall Study|Lack of Efficacy|8|||
27694550|NCT00577473|80716740|FG001|Overall Study|Lack of Efficacy|7|||
27694551|NCT01030198|80716741|FG000|Overall Study|Could not measure efficacy accurately|0|||
27694552|NCT01030198|80716742|FG001|Overall Study|Could not measure efficacy accurately|7|||
27694553|NCT03170154|80716745|FG000|Overall Study|Lost to Follow-up|4|||
27694554|NCT03170154|80716745|FG000|Overall Study|Death|2|||
27694555|NCT03170154|80716745|FG000|Overall Study|Withdrawal by Subject|2|||
27694556|NCT00950950|80716749|FG000|Overall Study|Adverse Event|1|||
27694557|NCT00950950|80716750|FG001|Overall Study|Adverse Event|0|||
27694558|NCT00950950|80716749|FG000|Overall Study|Withdrawal by Subject|0|||
27694559|NCT00950950|80716750|FG001|Overall Study|Withdrawal by Subject|1|||
27694560|NCT02684357|80716755|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
27694561|NCT02684357|80716756|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
27694562|NCT02684357|80716757|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
27826003|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27694563|NCT02684357|80716758|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
27694564|NCT02684357|80716759|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
27694565|NCT02684357|80716760|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
27694566|NCT02684357|80716755|FG000|Part A|Lost to Follow-up|0|||
27694567|NCT02684357|80716756|FG001|Part A|Lost to Follow-up|2|||
27694568|NCT02684357|80716757|FG002|Part A|Lost to Follow-up|2|||
27694569|NCT02684357|80716758|FG003|Part A|Lost to Follow-up|0|||
27694570|NCT02684357|80716759|FG004|Part A|Lost to Follow-up|0|||
27694571|NCT02684357|80716760|FG005|Part A|Lost to Follow-up|0|||
27826004|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27826005|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27826006|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27694572|NCT02684357|80716755|FG000|Part A|Withdrawal by Subject|3|||
27694573|NCT02684357|80716756|FG001|Part A|Withdrawal by Subject|0|||
27554186|NCT03187197|80215406|FG002|Overall Study|Adverse Event|0|||
27694574|NCT02684357|80716757|FG002|Part A|Withdrawal by Subject|0|||
27694575|NCT02684357|80716758|FG003|Part A|Withdrawal by Subject|0|||
27694576|NCT02684357|80716759|FG004|Part A|Withdrawal by Subject|0|||
27826007|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27554187|NCT03187197|80215404|FG000|Overall Study|Death|0|||
27554188|NCT03187197|80215405|FG001|Overall Study|Death|11|||
27554189|NCT03187197|80215406|FG002|Overall Study|Death|0|||
27554190|NCT03187197|80215404|FG000|Overall Study|Administrative problem|1|||
27554191|NCT03187197|80215405|FG001|Overall Study|Administrative problem|1|||
27554192|NCT03187197|80215406|FG002|Overall Study|Administrative problem|0|||
27554193|NCT03187197|80215404|FG000|Overall Study|Reason not listed|2|||
27554194|NCT03187197|80215405|FG001|Overall Study|Reason not listed|54|||
27554195|NCT03187197|80215406|FG002|Overall Study|Reason not listed|1|||
27554196|NCT03187197|80215404|FG000|Overall Study|Missing|1|||
27554197|NCT03187197|80215405|FG001|Overall Study|Missing|32|||
27554198|NCT03187197|80215406|FG002|Overall Study|Missing|3|||
27554199|NCT03187197|80215404|FG000|Overall Study|Status missing|2|||
27554200|NCT03187197|80215405|FG001|Overall Study|Status missing|33|||
27554201|NCT03187197|80215406|FG002|Overall Study|Status missing|3|||
27554202|NCT03187197|80215404|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
27554203|NCT03187197|80215405|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
27554204|NCT03187197|80215406|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
27554205|NCT01314443|80215407|FG000|Overall Study|Withdrawal by Subject|2|||
27554206|NCT01314443|80215408|FG001|Overall Study|Withdrawal by Subject|1|||
27554207|NCT01314443|80215409|FG002|Overall Study|Withdrawal by Subject|1|||
27554208|NCT01314443|80215410|FG003|Overall Study|Withdrawal by Subject|1|||
27554209|NCT01314443|80215407|FG000|Overall Study|Protocol Violation|2|||
27554210|NCT01314443|80215408|FG001|Overall Study|Protocol Violation|2|||
27554211|NCT01314443|80215409|FG002|Overall Study|Protocol Violation|1|||
27554212|NCT01314443|80215410|FG003|Overall Study|Protocol Violation|1|||
27554213|NCT00779467|80215414|FG000|Overall Study|Lack of Efficacy|11|||
27554214|NCT00779467|80215415|FG001|Overall Study|Lack of Efficacy|2|||
27554215|NCT00779467|80215416|FG002|Overall Study|Lack of Efficacy|6|||
27554216|NCT00779467|80215417|FG003|Overall Study|Lack of Efficacy|11|||
27554217|NCT00779467|80215414|FG000|Overall Study|failed inclusion criteria|3|||
27554218|NCT00779467|80215415|FG001|Overall Study|failed inclusion criteria|3|||
27554219|NCT00779467|80215416|FG002|Overall Study|failed inclusion criteria|1|||
27554220|NCT00779467|80215417|FG003|Overall Study|failed inclusion criteria|2|||
27554221|NCT00779467|80215414|FG000|Overall Study|missing data|1|||
27554222|NCT00779467|80215415|FG001|Overall Study|missing data|0|||
27554223|NCT00779467|80215416|FG002|Overall Study|missing data|1|||
27554224|NCT00779467|80215417|FG003|Overall Study|missing data|4|||
27554225|NCT00779467|80215414|FG000|Overall Study|technical issue|0|||
27554226|NCT00779467|80215415|FG001|Overall Study|technical issue|0|||
27554227|NCT00779467|80215416|FG002|Overall Study|technical issue|2|||
27554228|NCT00779467|80215417|FG003|Overall Study|technical issue|1|||
27554229|NCT00779467|80215414|FG000|Overall Study|unavailable research staff|0|||
27554230|NCT00779467|80215415|FG001|Overall Study|unavailable research staff|0|||
27554231|NCT00779467|80215416|FG002|Overall Study|unavailable research staff|0|||
27554232|NCT00779467|80215417|FG003|Overall Study|unavailable research staff|1|||
27554233|NCT00004978|80215424|FG000|Overall Study|Death|107|||
27694577|NCT02684357|80716760|FG005|Part A|Withdrawal by Subject|0|||
27694578|NCT02684357|80716755|FG000|Part A|Other|0|||
27554234|NCT00004978|80215425|FG001|Overall Study|Death|116|||
27554235|NCT00004978|80215424|FG000|Overall Study|Lost to Follow-up|101|||
27554236|NCT00004978|80215425|FG001|Overall Study|Lost to Follow-up|108|||
27554237|NCT00004978|80215424|FG000|Overall Study|Withdrawal by Subject|17|||
27554238|NCT00004978|80215425|FG001|Overall Study|Withdrawal by Subject|26|||
27554239|NCT00004978|80215424|FG000|Overall Study|site closure - not in analysis cohort|19|||
27554240|NCT00004978|80215425|FG001|Overall Study|site closure - not in analysis cohort|20|||
27826008|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27826009|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
27826010|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27826011|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
27826012|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
27826013|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
27826014|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826015|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826016|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826017|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826018|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826019|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826020|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826021|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826022|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826023|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826024|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826025|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826026|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826027|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27554241|NCT03128892|80215426|FG000|Overall Study|Withdrawal by Subject|2|||
27554242|NCT03128892|80215426|FG000|Overall Study|Physician Decision|1|||
27554243|NCT02260921|80215428|FG000|Overall Study|Adverse Event|1|||
27554244|NCT02260921|80215429|FG001|Overall Study|Adverse Event|0|||
27554245|NCT02260921|80215428|FG000|Overall Study|Lost to Follow-up|4|||
27554246|NCT02260921|80215429|FG001|Overall Study|Lost to Follow-up|3|||
27554247|NCT02260921|80215428|FG000|Overall Study|Withdraw Consent|4|||
27883781|NCT01986933|81408056|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
27883782|NCT01986933|81408057|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
27883783|NCT01986933|81408058|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
27883784|NCT01986933|81408054|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
27554248|NCT02260921|80215429|FG001|Overall Study|Withdraw Consent|1|||
27554249|NCT02260921|80215428|FG000|Overall Study|Death|1|||
27554250|NCT02260921|80215429|FG001|Overall Study|Death|0|||
27554251|NCT02260921|80215428|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
27554252|NCT02260921|80215429|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
27694579|NCT02684357|80716756|FG001|Part A|Other|1|||
27883785|NCT01986933|81408055|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
27883786|NCT01986933|81408056|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
27883787|NCT01986933|81408057|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
27694580|NCT02684357|80716757|FG002|Part A|Other|0|||
27694581|NCT02684357|80716758|FG003|Part A|Other|0|||
27694582|NCT02684357|80716759|FG004|Part A|Other|0|||
27554253|NCT02509156|80215430|FG000|Randomized Phase|Death|1|||
27694583|NCT02684357|80716760|FG005|Part A|Other|0|||
27694584|NCT02684357|80716755|FG000|Part B|Adverse Event (Other)|0|||
27826028|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826029|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826030|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
27826031|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826032|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826033|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
27554254|NCT02509156|80215431|FG001|Randomized Phase|Death|0|||
27554255|NCT02509156|80215430|FG000|Randomized Phase|Withdrawal by Subject|1|||
27554256|NCT02509156|80215431|FG001|Randomized Phase|Withdrawal by Subject|1|||
27554257|NCT03156543|80215435|FG000|Overall Study|Withdrawal by Subject|1|||
27554258|NCT03156543|80215436|FG001|Overall Study|Withdrawal by Subject|0|||
27554259|NCT02664441|80215437|FG000|Randomization|Withdrawal by Subject|0|||
27554260|NCT02664441|80215438|FG001|Randomization|Withdrawal by Subject|1|||
27554261|NCT02664441|80215437|FG000|36-week Randomized Trial|Adverse Event|2|||
27554262|NCT02664441|80215438|FG001|36-week Randomized Trial|Adverse Event|0|||
27554263|NCT02664441|80215437|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
27554264|NCT02664441|80215438|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
27554265|NCT02664441|80215437|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
27554266|NCT02664441|80215438|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
27554267|NCT02664441|80215437|FG000|18-week Open Label Extension|Adverse Event|1|||
27554268|NCT02664441|80215438|FG001|18-week Open Label Extension|Adverse Event|0|||
27554269|NCT02664441|80215437|FG000|18-week Open Label Extension|Physician Decision|1|||
27554270|NCT02664441|80215438|FG001|18-week Open Label Extension|Physician Decision|0|||
27694585|NCT02684357|80716756|FG001|Part B|Adverse Event (Other)|0|||
27694586|NCT02684357|80716757|FG002|Part B|Adverse Event (Other)|0|||
27554271|NCT02664441|80215437|FG000|18-week Open Label Extension|Death|1|||
27554272|NCT02664441|80215438|FG001|18-week Open Label Extension|Death|0|||
27694587|NCT02684357|80716758|FG003|Part B|Adverse Event (Other)|1|||
27694588|NCT02684357|80716759|FG004|Part B|Adverse Event (Other)|1|||
27554273|NCT02664441|80215437|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
27554274|NCT02664441|80215438|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
27554275|NCT00617123|80215441|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
27554276|NCT00617123|80215442|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
27554277|NCT00617123|80215441|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
27554278|NCT00617123|80215442|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
27554279|NCT00617123|80215441|FG000|Referral Screening Period|Adverse Event|0|||
27554280|NCT00617123|80215442|FG001|Referral Screening Period|Adverse Event|1|||
27554281|NCT00617123|80215441|FG000|Study Treatment Period|Withdrawal by Subject|8|||
27554282|NCT00617123|80215442|FG001|Study Treatment Period|Withdrawal by Subject|12|||
27554283|NCT00617123|80215441|FG000|Study Treatment Period|Adverse Event|7|||
27554284|NCT00617123|80215442|FG001|Study Treatment Period|Adverse Event|3|||
27554285|NCT00617123|80215441|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
27554286|NCT00617123|80215442|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
27554287|NCT00617123|80215441|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
27554288|NCT00617123|80215442|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
27554289|NCT01798004|80215443|FG000|Overall Study|Death|2|||
27554290|NCT01798004|80215443|FG000|Overall Study|Lack of Efficacy|8|||
27554291|NCT01798004|80215443|FG000|Overall Study|Physician Decision|25|||
27554292|NCT01798004|80215443|FG000|Overall Study|Withdrawal by Subject|4|||
27694589|NCT02684357|80716760|FG005|Part B|Adverse Event (Other)|1|||
27826034|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
27826035|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826036|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826037|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826038|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826039|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826040|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826041|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826042|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826043|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826044|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27554293|NCT01798004|80215443|FG000|Overall Study|Ineligible|4|||
27554294|NCT01798004|80215443|FG000|Overall Study|Patient/parent refusal|7|||
27554295|NCT01798004|80215443|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
27694590|NCT02684357|80716755|FG000|Part B|Lost to Follow-up|0|||
27554296|NCT01798004|80215443|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
27554297|NCT01581931|80215444|FG000|Washout|Adverse Event|0|||
27554298|NCT01581931|80215445|FG001|Washout|Adverse Event|1|||
27554299|NCT01698801|80215461|FG000|Treatment Phase|Adverse Event|4|||
27554300|NCT01698801|80215461|FG000|Treatment Phase|Protocol Violation|1|||
27554301|NCT01698801|80215461|FG000|Treatment Phase|Other|4|||
27554302|NCT01698801|80215461|FG000|Treatment Phase|Withdrawal by Subject|1|||
27554303|NCT01698801|80215461|FG000|Treatment Phase|Disease progression|1|||
27554304|NCT01698801|80215461|FG000|Follow Up Phase|Withdrawal by Subject|1|||
27554305|NCT01698801|80215461|FG000|Follow Up Phase|Death|4|||
27554306|NCT01195415|80215462|FG000|Overall Study|No repeat biopsy due to progression|2|||
27554307|NCT03958955|80215463|FG000|Overall Study|Adverse Event|1|||
27554308|NCT00456521|80215464|FG000|Overall Study|Adverse Event|150|||
27554309|NCT00456521|80215465|FG001|Overall Study|Adverse Event|25|||
27554310|NCT00456521|80215464|FG000|Overall Study|Withdrawal by Subject|43|||
27554311|NCT00456521|80215465|FG001|Overall Study|Withdrawal by Subject|24|||
27554312|NCT00456521|80215464|FG000|Overall Study|Lost to Follow-up|22|||
27694591|NCT02684357|80716756|FG001|Part B|Lost to Follow-up|0|||
27694592|NCT02684357|80716757|FG002|Part B|Lost to Follow-up|0|||
27694593|NCT02684357|80716758|FG003|Part B|Lost to Follow-up|1|||
27694594|NCT02684357|80716759|FG004|Part B|Lost to Follow-up|1|||
27694595|NCT02684357|80716760|FG005|Part B|Lost to Follow-up|7|||
27694596|NCT02684357|80716755|FG000|Part B|Withdrawal by Subject|0|||
27694597|NCT02684357|80716756|FG001|Part B|Withdrawal by Subject|0|||
27694598|NCT02684357|80716757|FG002|Part B|Withdrawal by Subject|0|||
27694599|NCT02684357|80716758|FG003|Part B|Withdrawal by Subject|0|||
27694600|NCT02684357|80716759|FG004|Part B|Withdrawal by Subject|2|||
27694601|NCT02684357|80716760|FG005|Part B|Withdrawal by Subject|4|||
27694602|NCT02684357|80716755|FG000|Part B|Other|0|||
27694603|NCT02684357|80716756|FG001|Part B|Other|0|||
27694604|NCT02684357|80716757|FG002|Part B|Other|0|||
27694605|NCT02684357|80716758|FG003|Part B|Other|1|||
27694606|NCT02684357|80716759|FG004|Part B|Other|0|||
27694607|NCT02684357|80716760|FG005|Part B|Other|1|||
27694608|NCT00081770|80716761|FG000|Overall Study|Adverse Event|130|||
27694609|NCT00081770|80716762|FG001|Overall Study|Adverse Event|98|||
27694610|NCT00081770|80716763|FG002|Overall Study|Adverse Event|136|||
27694611|NCT00081770|80716761|FG000|Overall Study|Lack of Efficacy|262|||
27694612|NCT00081770|80716762|FG001|Overall Study|Lack of Efficacy|357|||
27694613|NCT00081770|80716763|FG002|Overall Study|Lack of Efficacy|211|||
27694614|NCT00081770|80716761|FG000|Overall Study|Lost to Follow-up|45|||
27694615|NCT00081770|80716762|FG001|Overall Study|Lost to Follow-up|34|||
27694616|NCT00081770|80716763|FG002|Overall Study|Lost to Follow-up|45|||
27694617|NCT00081770|80716761|FG000|Overall Study|Protocol Violation|15|||
27694618|NCT00081770|80716762|FG001|Overall Study|Protocol Violation|10|||
27694619|NCT00081770|80716763|FG002|Overall Study|Protocol Violation|10|||
27694620|NCT00081770|80716761|FG000|Overall Study|Withdrawal by Subject|45|||
27554313|NCT00456521|80215465|FG001|Overall Study|Lost to Follow-up|17|||
27554314|NCT00456521|80215464|FG000|Overall Study|Lack of Efficacy|3|||
27554315|NCT00456521|80215465|FG001|Overall Study|Lack of Efficacy|6|||
27554316|NCT00456521|80215464|FG000|Overall Study|Protocol Violation|4|||
27554317|NCT00456521|80215465|FG001|Overall Study|Protocol Violation|0|||
27554318|NCT00456521|80215464|FG000|Overall Study|Pregnancy|1|||
27554319|NCT00456521|80215465|FG001|Overall Study|Pregnancy|1|||
27694621|NCT00081770|80716762|FG001|Overall Study|Withdrawal by Subject|40|||
27694622|NCT00081770|80716763|FG002|Overall Study|Withdrawal by Subject|42|||
27554320|NCT00456521|80215464|FG000|Overall Study|Drug non-compliance, moved, other|26|||
27554321|NCT00456521|80215465|FG001|Overall Study|Drug non-compliance, moved, other|11|||
27554322|NCT02709785|80215466|FG000|Overall Study|Withdrawal by Subject|1|||
27694623|NCT00081770|80716761|FG000|Overall Study|Did not meet protocol eligibility|2|||
27694624|NCT00081770|80716762|FG001|Overall Study|Did not meet protocol eligibility|0|||
27694625|NCT00081770|80716763|FG002|Overall Study|Did not meet protocol eligibility|3|||
27694626|NCT00081770|80716761|FG000|Overall Study|Administrative|1|||
27554323|NCT02709785|80215467|FG001|Overall Study|Withdrawal by Subject|2|||
27694627|NCT00081770|80716762|FG001|Overall Study|Administrative|0|||
27694628|NCT00081770|80716763|FG002|Overall Study|Administrative|1|||
27694629|NCT00081770|80716761|FG000|Overall Study|Other|2|||
27554324|NCT02709785|80215468|FG002|Overall Study|Withdrawal by Subject|1|||
27554325|NCT01979016|80215469|FG000|Overall Study|Withdrawal by Subject|2|||
27554326|NCT01979016|80215470|FG001|Overall Study|Withdrawal by Subject|0|||
27554327|NCT01979016|80215469|FG000|Overall Study|Adverse Event|0|||
27554328|NCT01979016|80215470|FG001|Overall Study|Adverse Event|1|||
27554329|NCT02167893|80215471|FG000|Overall Study|Investigator transferred|85|||
27554330|NCT02167893|80215471|FG000|Overall Study|Investigator health reasons|10|||
27554331|NCT02167893|80215471|FG000|Overall Study|Case report forms not collected|68|||
27554332|NCT03068130|80215473|FG000|Overall Study|Adverse Event|19|||
27554333|NCT03068130|80215473|FG000|Overall Study|Death|14|||
27554334|NCT03068130|80215473|FG000|Overall Study|Lost to Follow-up|4|||
27554335|NCT03068130|80215473|FG000|Overall Study|Withdrawal by Subject|26|||
27554336|NCT03068130|80215473|FG000|Overall Study|Administrative Reasons|3|||
27554337|NCT03068130|80215473|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
27554338|NCT03068130|80215473|FG000|Overall Study|Study terminated by sponsor|194|||
27554339|NCT00241280|80215475|FG000|Overall Study|Adverse Event|2|||
27554340|NCT00241280|80215476|FG001|Overall Study|Adverse Event|6|||
27554341|NCT00241280|80215475|FG000|Overall Study|Discomfort|11|||
27554342|NCT00241280|80215476|FG001|Overall Study|Discomfort|16|||
27554343|NCT00241280|80215475|FG000|Overall Study|Pregnancy|1|||
27554344|NCT00241280|80215476|FG001|Overall Study|Pregnancy|5|||
27554345|NCT00241280|80215475|FG000|Overall Study|Lost to Follow-up|5|||
27554346|NCT00241280|80215476|FG001|Overall Study|Lost to Follow-up|8|||
27554347|NCT00241280|80215475|FG000|Overall Study|Withdrawal by Subject|7|||
27554348|NCT00241280|80215476|FG001|Overall Study|Withdrawal by Subject|4|||
27554349|NCT00241280|80215475|FG000|Overall Study|Protocol Violation|4|||
27554350|NCT00241280|80215476|FG001|Overall Study|Protocol Violation|10|||
27554351|NCT00241280|80215475|FG000|Overall Study|Relocation|4|||
27554352|NCT00241280|80215476|FG001|Overall Study|Relocation|4|||
27554353|NCT00241280|80215475|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
27554354|NCT00241280|80215476|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
27554355|NCT00241280|80215475|FG000|Overall Study|Unsatisfactory Visual Response|1|||
27554356|NCT00241280|80215476|FG001|Overall Study|Unsatisfactory Visual Response|1|||
27554357|NCT00241280|80215475|FG000|Overall Study|Diabetic|1|||
27554358|NCT00241280|80215476|FG001|Overall Study|Diabetic|0|||
27554359|NCT00241280|80215475|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
27554360|NCT00241280|80215476|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
27554361|NCT00241280|80215475|FG000|Overall Study|Dispensed incorrect test article|1|||
27554362|NCT00241280|80215476|FG001|Overall Study|Dispensed incorrect test article|2|||
27554363|NCT00241280|80215475|FG000|Overall Study|Unacceptable Fit|0|||
27554364|NCT00241280|80215476|FG001|Overall Study|Unacceptable Fit|1|||
27554365|NCT00241280|80215475|FG000|Overall Study|Scheduling Conflict|0|||
27554366|NCT00241280|80215476|FG001|Overall Study|Scheduling Conflict|2|||
27554367|NCT00241280|80215475|FG000|Overall Study|History of Ocular Surgery|0|||
27554368|NCT00241280|80215476|FG001|Overall Study|History of Ocular Surgery|1|||
27554369|NCT00241280|80215475|FG000|Overall Study|Coating on Lens|1|||
27554370|NCT00241280|80215476|FG001|Overall Study|Coating on Lens|0|||
27554371|NCT00241280|80215475|FG000|Overall Study|Excessive Dryness|0|||
27554372|NCT00241280|80215476|FG001|Overall Study|Excessive Dryness|1|||
27554373|NCT01824394|80215477|FG000|Overall Study|Early Termination|1|||
27554374|NCT01824394|80215478|FG001|Overall Study|Early Termination|1|||
27554375|NCT01824394|80215479|FG002|Overall Study|Early Termination|3|||
27694630|NCT00081770|80716762|FG001|Overall Study|Other|7|||
27694631|NCT00081770|80716763|FG002|Overall Study|Other|8|||
27694632|NCT02344004|80716765|FG000|Overall Study|Adverse Event|11|||
27826045|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826046|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27554376|NCT01824394|80215477|FG000|Overall Study|Withdrawn due to Study Termination|91|||
27554377|NCT01824394|80215478|FG001|Overall Study|Withdrawn due to Study Termination|83|||
27554378|NCT01824394|80215479|FG002|Overall Study|Withdrawn due to Study Termination|41|||
27554379|NCT01824394|80215477|FG000|Overall Study|Lost to Follow-up|0|||
27554380|NCT01824394|80215478|FG001|Overall Study|Lost to Follow-up|9|||
27694633|NCT02344004|80716766|FG001|Overall Study|Adverse Event|1|||
27554381|NCT01824394|80215479|FG002|Overall Study|Lost to Follow-up|3|||
27554382|NCT01824394|80215477|FG000|Overall Study|Death|3|||
27554383|NCT01824394|80215478|FG001|Overall Study|Death|2|||
27694634|NCT02344004|80716765|FG000|Overall Study|Death|9|||
27554384|NCT01824394|80215479|FG002|Overall Study|Death|4|||
27554385|NCT01824394|80215477|FG000|Overall Study|Discontinued Subjects|1|||
27554386|NCT01824394|80215478|FG001|Overall Study|Discontinued Subjects|1|||
27554387|NCT01824394|80215479|FG002|Overall Study|Discontinued Subjects|2|||
27554388|NCT01824394|80215477|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
27554389|NCT01824394|80215478|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
27554390|NCT01824394|80215479|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
27554391|NCT01385202|80215483|FG000|Overall Study|Lost to Follow-up|6|||
27694635|NCT02344004|80716766|FG001|Overall Study|Death|7|||
27554392|NCT01385202|80215483|FG000|Overall Study|Not Eligible|11|||
27554393|NCT01385202|80215483|FG000|Overall Study|Withdrawn|1|||
27554394|NCT00662363|80215484|FG000|Overall Study|Withdrawal by Subject|6|||
27554395|NCT00662363|80215485|FG001|Overall Study|Withdrawal by Subject|5|||
27554396|NCT00662363|80215484|FG000|Overall Study|Adverse Event|0|||
27554397|NCT00662363|80215485|FG001|Overall Study|Adverse Event|3|||
27554398|NCT00662363|80215484|FG000|Overall Study|Discharged early from rehab|4|||
27554399|NCT00662363|80215485|FG001|Overall Study|Discharged early from rehab|1|||
27883788|NCT01986933|81408058|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
27883789|NCT01986933|81408054|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
27883790|NCT01986933|81408055|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
27883791|NCT01986933|81408056|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
27883792|NCT01986933|81408057|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
27883793|NCT01986933|81408058|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
27883794|NCT01986933|81408054|FG000|Active-to-active (Part B)|Adverse Event|0|||
27554400|NCT00662363|80215484|FG000|Overall Study|Protocol Violation|1|||
27554401|NCT00662363|80215485|FG001|Overall Study|Protocol Violation|1|||
27554402|NCT01396148|80215488|FG000|Overall Study|Patient Decision|1|||
27554403|NCT01338792|80215498|FG000|Overall Study|Adverse Event|2|||
27554404|NCT01338792|80215498|FG000|Overall Study|Death|1|||
27554405|NCT01338792|80215498|FG000|Overall Study|Withdrawal by Subject|1|||
27554406|NCT00545168|80215501|FG000|Overall Study|Lost to Follow-up|5|||
27554407|NCT00545168|80215502|FG001|Overall Study|Lost to Follow-up|5|||
27554408|NCT00545168|80215503|FG002|Overall Study|Lost to Follow-up|5|||
27554409|NCT00545168|80215501|FG000|Overall Study|Withdrawal by Subject|9|||
27554410|NCT00545168|80215502|FG001|Overall Study|Withdrawal by Subject|0|||
27554411|NCT00545168|80215503|FG002|Overall Study|Withdrawal by Subject|13|||
27554412|NCT00545168|80215501|FG000|Overall Study|Protocol Violation|1|||
27554413|NCT00545168|80215502|FG001|Overall Study|Protocol Violation|0|||
27554414|NCT00545168|80215503|FG002|Overall Study|Protocol Violation|1|||
27554415|NCT00545168|80215501|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
27554416|NCT00545168|80215502|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
27554417|NCT00545168|80215503|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
27554418|NCT01031069|80215505|FG000|Overall Study|Serious Adverse Event|0|||
27554419|NCT01031069|80215506|FG001|Overall Study|Serious Adverse Event|1|||
27554420|NCT01031069|80215507|FG002|Overall Study|Serious Adverse Event|0|||
27554421|NCT01031069|80215508|FG003|Overall Study|Serious Adverse Event|0|||
27554422|NCT01031069|80215505|FG000|Overall Study|Withdrawal by Subject|2|||
27554423|NCT01031069|80215506|FG001|Overall Study|Withdrawal by Subject|3|||
27554424|NCT01031069|80215507|FG002|Overall Study|Withdrawal by Subject|18|||
27554425|NCT01031069|80215508|FG003|Overall Study|Withdrawal by Subject|18|||
27554426|NCT01031069|80215505|FG000|Overall Study|Migrated/moved from study area|1|||
27554427|NCT01031069|80215506|FG001|Overall Study|Migrated/moved from study area|2|||
27554428|NCT01031069|80215507|FG002|Overall Study|Migrated/moved from study area|1|||
27554429|NCT01031069|80215508|FG003|Overall Study|Migrated/moved from study area|1|||
27694636|NCT02344004|80716765|FG000|Overall Study|Physician Decision|4|||
27694637|NCT02344004|80716766|FG001|Overall Study|Physician Decision|1|||
27826047|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826048|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826049|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826050|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826051|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
27826052|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826053|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826054|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
27826055|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
27826056|NCT01597245|81192559|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826057|NCT01597245|81192560|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826058|NCT01597245|81192561|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826059|NCT01597245|81192562|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826060|NCT01597245|81192563|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826061|NCT01597245|81192564|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826062|NCT01597245|81192565|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826063|NCT01597245|81192566|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27883795|NCT01986933|81408055|FG001|Active-to-active (Part B)|Adverse Event|2|||
27554430|NCT01031069|80215505|FG000|Overall Study|Lost to Follow-up|9|||
27554431|NCT01031069|80215506|FG001|Overall Study|Lost to Follow-up|5|||
27694638|NCT02344004|80716765|FG000|Overall Study|Withdrawal by Subject|22|||
27554432|NCT01031069|80215507|FG002|Overall Study|Lost to Follow-up|21|||
27554433|NCT01031069|80215508|FG003|Overall Study|Lost to Follow-up|15|||
27554434|NCT01031069|80215505|FG000|Overall Study|Other|0|||
27694639|NCT02344004|80716766|FG001|Overall Study|Withdrawal by Subject|5|||
27554435|NCT01031069|80215506|FG001|Overall Study|Other|0|||
27554436|NCT01031069|80215507|FG002|Overall Study|Other|1|||
27554437|NCT01031069|80215508|FG003|Overall Study|Other|0|||
27554438|NCT00555321|80215509|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
27554439|NCT00555321|80215510|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
27554440|NCT00555321|80215511|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
27554441|NCT00555321|80215512|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
27554442|NCT00555321|80215513|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
27554443|NCT00555321|80215509|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
27554444|NCT00555321|80215510|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
27554445|NCT00555321|80215511|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
27554446|NCT00555321|80215512|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
27554447|NCT00555321|80215513|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
27554448|NCT00555321|80215509|FG000|Treatment Phase up to 12-months|Death|2|||
27554449|NCT00555321|80215510|FG001|Treatment Phase up to 12-months|Death|1|||
27554450|NCT00555321|80215511|FG002|Treatment Phase up to 12-months|Death|4|||
27554451|NCT00555321|80215512|FG003|Treatment Phase up to 12-months|Death|0|||
27554452|NCT00555321|80215513|FG004|Treatment Phase up to 12-months|Death|0|||
27554453|NCT00555321|80215509|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
27554454|NCT00555321|80215510|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
27554455|NCT00555321|80215511|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
27554456|NCT00555321|80215512|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
27554457|NCT00555321|80215513|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
27554458|NCT00555321|80215509|FG000|Treatment Phase up to 12-months|Other Reason|1|||
27554459|NCT00555321|80215510|FG001|Treatment Phase up to 12-months|Other Reason|3|||
27554460|NCT00555321|80215511|FG002|Treatment Phase up to 12-months|Other Reason|2|||
27554461|NCT00555321|80215512|FG003|Treatment Phase up to 12-months|Other Reason|0|||
27554462|NCT00555321|80215513|FG004|Treatment Phase up to 12-months|Other Reason|0|||
27554463|NCT00555321|80215509|FG000|Treatment Phase up to 12-months|Never treated|2|||
27554464|NCT00555321|80215510|FG001|Treatment Phase up to 12-months|Never treated|3|||
27554465|NCT00555321|80215511|FG002|Treatment Phase up to 12-months|Never treated|1|||
27554466|NCT00555321|80215512|FG003|Treatment Phase up to 12-months|Never treated|0|||
27554467|NCT00555321|80215513|FG004|Treatment Phase up to 12-months|Never treated|4|||
27554468|NCT00555321|80215509|FG000|Long-term Extension Phase|Adverse Event|2|||
27554469|NCT00555321|80215510|FG001|Long-term Extension Phase|Adverse Event|5|||
27554470|NCT00555321|80215511|FG002|Long-term Extension Phase|Adverse Event|2|||
27554471|NCT00555321|80215512|FG003|Long-term Extension Phase|Adverse Event|1|||
27554472|NCT00555321|80215513|FG004|Long-term Extension Phase|Adverse Event|0|||
27554473|NCT00555321|80215509|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
27554474|NCT00555321|80215510|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
27554475|NCT00555321|80215511|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
27554476|NCT00555321|80215512|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
27554477|NCT00555321|80215513|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
27554478|NCT00555321|80215509|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
27554479|NCT00555321|80215510|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
27554480|NCT00555321|80215511|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
27554481|NCT00555321|80215512|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
27554482|NCT00555321|80215513|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
27826064|NCT01597245|81192567|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826065|NCT01597245|81192568|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826066|NCT01597245|81192569|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826067|NCT01597245|81192570|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826068|NCT01597245|81192571|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826069|NCT01597245|81192572|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826070|NCT01597245|81192573|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826071|NCT01597245|81192574|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826072|NCT01597245|81192575|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826073|NCT01597245|81192576|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826074|NCT01597245|81192577|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826075|NCT01597245|81192578|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
27826076|NCT01597245|81192579|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
27826077|NCT04000815|81192580|FG000|Overall Study|Lost to Follow-up|9|||
27826078|NCT04000815|81192581|FG001|Overall Study|Lost to Follow-up|2|||
27826079|NCT04000815|81192582|FG002|Overall Study|Lost to Follow-up|3|||
27826080|NCT04000815|81192580|FG000|Overall Study|Withdrawal by Subject|4|||
27826081|NCT04000815|81192581|FG001|Overall Study|Withdrawal by Subject|3|||
27554483|NCT00555321|80215509|FG000|Long-term Extension Phase|Death|2|||
27826082|NCT04000815|81192582|FG002|Overall Study|Withdrawal by Subject|2|||
27883796|NCT01986933|81408056|FG002|Active-to-active (Part B)|Adverse Event|0|||
27554484|NCT00555321|80215510|FG001|Long-term Extension Phase|Death|0|||
27554485|NCT00555321|80215511|FG002|Long-term Extension Phase|Death|0|||
27554486|NCT00555321|80215512|FG003|Long-term Extension Phase|Death|3|||
27554487|NCT00555321|80215513|FG004|Long-term Extension Phase|Death|0|||
27554488|NCT00555321|80215509|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
27554489|NCT00555321|80215510|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
27554490|NCT00555321|80215511|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
27554491|NCT00555321|80215512|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
27554492|NCT00555321|80215513|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
27554493|NCT00555321|80215509|FG000|Long-term Extension Phase|Other Reason|1|||
27554494|NCT00555321|80215510|FG001|Long-term Extension Phase|Other Reason|0|||
27554495|NCT00555321|80215511|FG002|Long-term Extension Phase|Other Reason|2|||
27554496|NCT00555321|80215512|FG003|Long-term Extension Phase|Other Reason|0|||
27554497|NCT00555321|80215513|FG004|Long-term Extension Phase|Other Reason|0|||
27554498|NCT00609492|80215514|FG000|Overall Study|Withdrawal by Subject|0|||
27554499|NCT00609492|80215515|FG001|Overall Study|Withdrawal by Subject|2|||
27554500|NCT00609492|80215516|FG002|Overall Study|Withdrawal by Subject|3|||
27554501|NCT00609492|80215514|FG000|Overall Study|Lost to Follow-up|1|||
27554502|NCT00609492|80215515|FG001|Overall Study|Lost to Follow-up|1|||
27554503|NCT00609492|80215516|FG002|Overall Study|Lost to Follow-up|4|||
27554504|NCT01829191|80215517|FG000|Overall Study|Relocation|0|||
27554505|NCT01829191|80215518|FG001|Overall Study|Relocation|1|||
27554506|NCT01829191|80215517|FG000|Overall Study|Lens discomfort|0|||
27554507|NCT01829191|80215518|FG001|Overall Study|Lens discomfort|3|||
27554508|NCT01829191|80215517|FG000|Overall Study|Lens handling difficulty|1|||
27554509|NCT01829191|80215518|FG001|Overall Study|Lens handling difficulty|4|||
27554510|NCT01829191|80215517|FG000|Overall Study|Protocol Violation|4|||
27554511|NCT01829191|80215518|FG001|Overall Study|Protocol Violation|1|||
27554512|NCT01829191|80215517|FG000|Overall Study|Withdrawal by Subject|2|||
27554513|NCT01829191|80215518|FG001|Overall Study|Withdrawal by Subject|3|||
27554514|NCT01829191|80215517|FG000|Overall Study|Lost to Follow-up|0|||
27554515|NCT01829191|80215518|FG001|Overall Study|Lost to Follow-up|1|||
27554516|NCT01829191|80215517|FG000|Overall Study|Subject was fit for ortho - k|0|||
27554517|NCT01829191|80215518|FG001|Overall Study|Subject was fit for ortho - k|1|||
27554518|NCT02548650|80215521|FG000|Triple Therapy|Adverse Event|1|||
27554519|NCT02548650|80215522|FG001|Triple Therapy|Adverse Event|0|||
27554520|NCT02548650|80215521|FG000|Triple Therapy|Withdrawal by Subject|0|||
27554521|NCT02548650|80215522|FG001|Triple Therapy|Withdrawal by Subject|4|||
27554522|NCT02548650|80215521|FG000|Double Therapy|Adverse Event|1|||
27554523|NCT02548650|80215522|FG001|Double Therapy|Adverse Event|1|||
27554524|NCT02548650|80215521|FG000|Double Therapy|Withdrawal by Subject|0|||
27554525|NCT02548650|80215522|FG001|Double Therapy|Withdrawal by Subject|1|||
27554526|NCT02669433|80215523|FG000|Overall Study|Protocol Violation|0|||
27554527|NCT02669433|80215524|FG001|Overall Study|Protocol Violation|4|||
27554528|NCT02669433|80215525|FG002|Overall Study|Protocol Violation|1|||
27554529|NCT02669433|80215523|FG000|Overall Study|Disease Progression|1|||
27554530|NCT02669433|80215524|FG001|Overall Study|Disease Progression|0|||
27554531|NCT02669433|80215525|FG002|Overall Study|Disease Progression|0|||
27554532|NCT02669433|80215523|FG000|Overall Study|Physician Decision|1|||
27554533|NCT02669433|80215524|FG001|Overall Study|Physician Decision|1|||
27554534|NCT02669433|80215525|FG002|Overall Study|Physician Decision|0|||
27883797|NCT01986933|81408057|FG003|Active-to-active (Part B)|Adverse Event|1|||
27883798|NCT01986933|81408058|FG004|Active-to-active (Part B)|Adverse Event|3|||
27883799|NCT01986933|81408054|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
27883800|NCT01986933|81408055|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
27883801|NCT01986933|81408056|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
27883802|NCT01986933|81408057|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
27883803|NCT01986933|81408058|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
27883804|NCT01986933|81408054|FG000|Active-to-active (Part B)|Pregnancy|0|||
27883805|NCT01986933|81408055|FG001|Active-to-active (Part B)|Pregnancy|0|||
27883806|NCT01986933|81408056|FG002|Active-to-active (Part B)|Pregnancy|0|||
27883807|NCT01986933|81408057|FG003|Active-to-active (Part B)|Pregnancy|0|||
27883808|NCT01986933|81408058|FG004|Active-to-active (Part B)|Pregnancy|1|||
27554535|NCT02669433|80215523|FG000|Overall Study|Adverse Event|6|||
27554536|NCT02669433|80215524|FG001|Overall Study|Adverse Event|7|||
27554537|NCT02669433|80215525|FG002|Overall Study|Adverse Event|10|||
27554538|NCT02669433|80215523|FG000|Overall Study|Sponsor Termination|1|||
27554539|NCT02669433|80215524|FG001|Overall Study|Sponsor Termination|0|||
27554540|NCT02669433|80215525|FG002|Overall Study|Sponsor Termination|1|||
27554541|NCT02669433|80215523|FG000|Overall Study|Withdrawal by Subject|5|||
27554542|NCT02669433|80215524|FG001|Overall Study|Withdrawal by Subject|1|||
27554543|NCT02669433|80215525|FG002|Overall Study|Withdrawal by Subject|0|||
27554544|NCT02669433|80215523|FG000|Overall Study|Withdrawal by Caregiver|1|||
27883809|NCT01986933|81408054|FG000|Active-to-active (Part B)|Physician Decision|0|||
27554545|NCT02669433|80215524|FG001|Overall Study|Withdrawal by Caregiver|0|||
27554546|NCT02669433|80215525|FG002|Overall Study|Withdrawal by Caregiver|2|||
27554547|NCT02669433|80215523|FG000|Overall Study|Death|0|||
27554548|NCT02669433|80215524|FG001|Overall Study|Death|1|||
27554549|NCT02669433|80215525|FG002|Overall Study|Death|1|||
27554550|NCT01599234|80215526|FG000|Overall Study|Adverse Event|9|||
27554551|NCT01599234|80215527|FG001|Overall Study|Adverse Event|5|||
27554552|NCT01599234|80215526|FG000|Overall Study|Withdrawal by Subject|2|||
27554553|NCT01599234|80215527|FG001|Overall Study|Withdrawal by Subject|1|||
27554554|NCT01599234|80215526|FG000|Overall Study|Lost to Follow-up|1|||
27554555|NCT01599234|80215527|FG001|Overall Study|Lost to Follow-up|2|||
27554556|NCT01599234|80215526|FG000|Overall Study|Lack of Efficacy|2|||
27554557|NCT01599234|80215527|FG001|Overall Study|Lack of Efficacy|4|||
27554558|NCT01599234|80215526|FG000|Overall Study|Unable to operate spray|1|||
27554559|NCT01599234|80215527|FG001|Overall Study|Unable to operate spray|0|||
27554560|NCT01599234|80215526|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
27554561|NCT01599234|80215527|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
27554562|NCT01599234|80215526|FG000|Overall Study|Death|1|||
27554563|NCT01599234|80215527|FG001|Overall Study|Death|0|||
27554564|NCT01599234|80215526|FG000|Overall Study|Patient would not stop driving|1|||
27554565|NCT01599234|80215527|FG001|Overall Study|Patient would not stop driving|0|||
27554566|NCT01599234|80215526|FG000|Overall Study|Contra-indication discovered|0|||
27554567|NCT01599234|80215527|FG001|Overall Study|Contra-indication discovered|1|||
27554568|NCT01599234|80215526|FG000|Overall Study|Pregnancy|0|||
27554569|NCT01599234|80215527|FG001|Overall Study|Pregnancy|1|||
27554570|NCT02013791|80215528|FG000|Period 1|Lost to Follow-up|0|||
27554571|NCT02013791|80215529|FG001|Period 1|Lost to Follow-up|0|||
27554572|NCT02013791|80215530|FG002|Period 1|Lost to Follow-up|0|||
27554573|NCT02013791|80215531|FG003|Period 1|Lost to Follow-up|1|||
27554574|NCT02013791|80215532|FG004|Period 1|Lost to Follow-up|0|||
27554575|NCT02013791|80215533|FG005|Period 1|Lost to Follow-up|0|||
27554576|NCT02013791|80215534|FG006|Period 1|Lost to Follow-up|1|||
27554577|NCT02013791|80215535|FG007|Period 1|Lost to Follow-up|1|||
27554578|NCT02013791|80215536|FG008|Period 1|Lost to Follow-up|0|||
27554579|NCT02013791|80215528|FG000|Period 1|Other Miscellaneous Reasons|0|||
27554580|NCT02013791|80215529|FG001|Period 1|Other Miscellaneous Reasons|2|||
27554581|NCT02013791|80215530|FG002|Period 1|Other Miscellaneous Reasons|0|||
27554582|NCT02013791|80215531|FG003|Period 1|Other Miscellaneous Reasons|0|||
27694640|NCT02344004|80716765|FG000|Overall Study|Rescue Medication|2|||
27554583|NCT02013791|80215532|FG004|Period 1|Other Miscellaneous Reasons|0|||
27554584|NCT02013791|80215533|FG005|Period 1|Other Miscellaneous Reasons|0|||
27883810|NCT01986933|81408055|FG001|Active-to-active (Part B)|Physician Decision|0|||
27883811|NCT01986933|81408056|FG002|Active-to-active (Part B)|Physician Decision|1|||
27883812|NCT01986933|81408057|FG003|Active-to-active (Part B)|Physician Decision|1|||
27883813|NCT01986933|81408058|FG004|Active-to-active (Part B)|Physician Decision|0|||
27883814|NCT01986933|81408054|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
27883815|NCT01986933|81408055|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
27883816|NCT01986933|81408056|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
27883817|NCT01986933|81408057|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
27883818|NCT01986933|81408058|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
27883819|NCT01986933|81408054|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
27883820|NCT01986933|81408055|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
27883821|NCT01986933|81408056|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
27883822|NCT01986933|81408057|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
27883823|NCT01986933|81408058|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
27883824|NCT01986933|81408054|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
27883825|NCT01986933|81408055|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
27883826|NCT01986933|81408056|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
27883827|NCT01986933|81408057|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
27883828|NCT01986933|81408058|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
27883829|NCT01986933|81408054|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
27883830|NCT01986933|81408055|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
27883831|NCT01986933|81408056|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
27883832|NCT01986933|81408057|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
27883833|NCT01986933|81408058|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
27883834|NCT01986933|81408054|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
27883835|NCT01986933|81408055|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
27883836|NCT01986933|81408056|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
27883837|NCT01986933|81408057|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
27883838|NCT01986933|81408058|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
27883839|NCT01986933|81408054|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
27883840|NCT01986933|81408055|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
27883841|NCT01986933|81408056|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
27883842|NCT01986933|81408057|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
27883843|NCT01986933|81408058|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
27883844|NCT01986933|81408054|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
27883845|NCT01986933|81408055|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
27883846|NCT01986933|81408056|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
27883847|NCT01986933|81408057|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
27883848|NCT01986933|81408058|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
27883849|NCT01986933|81408054|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
27883850|NCT01986933|81408055|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
27883851|NCT01986933|81408056|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
27883852|NCT01986933|81408057|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
27883853|NCT01986933|81408058|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
27883854|NCT03192306|81408059|FG000|Overall Study|Did not treat cold sore during study|149|||
27883855|NCT03192306|81408060|FG001|Overall Study|Did not treat cold sore during study|143|||
27883856|NCT03192306|81408059|FG000|Overall Study|Withdrawal by Subject|1|||
27883857|NCT03192306|81408060|FG001|Overall Study|Withdrawal by Subject|1|||
27883858|NCT03192306|81408059|FG000|Overall Study|Lost to Follow-up|1|||
27883859|NCT03192306|81408060|FG001|Overall Study|Lost to Follow-up|0|||
27883860|NCT03192306|81408059|FG000|Overall Study|Protocol Violation|1|||
27883861|NCT03192306|81408060|FG001|Overall Study|Protocol Violation|1|||
27883862|NCT01262287|81408071|FG000|Overall Study|Lost to Follow-up|2|||
27883863|NCT01262287|81408072|FG001|Overall Study|Lost to Follow-up|1|||
27883864|NCT00489307|81408080|FG000|Overall Study|Death|1|||
27883865|NCT00489307|81408081|FG001|Overall Study|Death|1|||
27883866|NCT00489307|81408080|FG000|Overall Study|Lost to Follow-up|2|||
27883867|NCT00489307|81408081|FG001|Overall Study|Lost to Follow-up|2|||
27883868|NCT00489307|81408080|FG000|Overall Study|Physician Decision|1|||
27883869|NCT00489307|81408081|FG001|Overall Study|Physician Decision|0|||
27883870|NCT00489307|81408080|FG000|Overall Study|Withdrawal by Subject|2|||
27554585|NCT02013791|80215534|FG006|Period 1|Other Miscellaneous Reasons|0|||
27554586|NCT02013791|80215535|FG007|Period 1|Other Miscellaneous Reasons|0|||
27554587|NCT02013791|80215536|FG008|Period 1|Other Miscellaneous Reasons|0|||
27554588|NCT01753856|80215537|FG000|Overall Study|Adverse Event|1|||
27694641|NCT02344004|80716766|FG001|Overall Study|Rescue Medication|0|||
27883871|NCT00489307|81408081|FG001|Overall Study|Withdrawal by Subject|4|||
27883872|NCT00489307|81408080|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
27883873|NCT00489307|81408081|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
27883874|NCT00489307|81408080|FG000|Overall Study|Surgery after assignment|1|||
27554589|NCT01753856|80215538|FG001|Overall Study|Adverse Event|0|||
27554590|NCT01753856|80215537|FG000|Overall Study|Withdrawal by Subject|0|||
27554591|NCT01753856|80215538|FG001|Overall Study|Withdrawal by Subject|2|||
27554592|NCT01753856|80215537|FG000|Overall Study|Sponsor Decision|2|||
27826083|NCT04000815|81192580|FG000|Overall Study|Right ovarian cyst occured|1|||
27883875|NCT00489307|81408081|FG001|Overall Study|Surgery after assignment|0|||
27883876|NCT00489307|81408080|FG000|Overall Study|Did not fill up the forms|2|||
27883877|NCT00489307|81408081|FG001|Overall Study|Did not fill up the forms|1|||
27883878|NCT00489307|81408080|FG000|Overall Study|Patient or family refusal|5|||
27883879|NCT00489307|81408081|FG001|Overall Study|Patient or family refusal|9|||
27883880|NCT02748356|81408082|FG000|Overall Study|Withdrawal by Subject|1|||
27883881|NCT00356135|81408085|FG000|Overall Study|Protocol Violation|1|||
27883882|NCT00356135|81408086|FG001|Overall Study|Protocol Violation|0|||
27883883|NCT00356135|81408087|FG002|Overall Study|Protocol Violation|0|||
27883884|NCT00356135|81408085|FG000|Overall Study|Adverse Event|1|||
27883885|NCT00356135|81408086|FG001|Overall Study|Adverse Event|0|||
27883886|NCT00356135|81408087|FG002|Overall Study|Adverse Event|0|||
27826084|NCT04000815|81192581|FG001|Overall Study|Right ovarian cyst occured|0|||
27826085|NCT04000815|81192582|FG002|Overall Study|Right ovarian cyst occured|0|||
27826086|NCT04000815|81192580|FG000|Overall Study|Hypertension occured on follow up|0|||
27826087|NCT04000815|81192581|FG001|Overall Study|Hypertension occured on follow up|0|||
27826088|NCT04000815|81192582|FG002|Overall Study|Hypertension occured on follow up|2|||
27826089|NCT01237054|81192583|FG000|Overall Study|imaging 10C0096|1|||
27826090|NCT01929863|81192584|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
27826091|NCT01929863|81192585|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
27883887|NCT00356135|81408085|FG000|Overall Study|Lost to Follow-up|0|||
27826092|NCT01929863|81192584|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
27826093|NCT01929863|81192585|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
27826094|NCT01929863|81192584|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
27826095|NCT01929863|81192585|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
27826096|NCT03673670|81192586|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
27826097|NCT03673670|81192587|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
27826098|NCT03673670|81192588|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
27883888|NCT00356135|81408086|FG001|Overall Study|Lost to Follow-up|0|||
27883889|NCT00356135|81408087|FG002|Overall Study|Lost to Follow-up|1|||
27883890|NCT00356135|81408085|FG000|Overall Study|Physician Decision|1|||
27883891|NCT00356135|81408086|FG001|Overall Study|Physician Decision|1|||
27883892|NCT00356135|81408087|FG002|Overall Study|Physician Decision|1|||
27883893|NCT00356135|81408085|FG000|Overall Study|Subject non-compliance|1|||
27883894|NCT00356135|81408086|FG001|Overall Study|Subject non-compliance|1|||
27883895|NCT00356135|81408087|FG002|Overall Study|Subject non-compliance|3|||
27883896|NCT02203721|81408088|FG000|Overall Study|Lost to Follow-up|1|||
27694642|NCT02344004|80716765|FG000|Overall Study|Other Not Specified|12|||
27554593|NCT01753856|80215538|FG001|Overall Study|Sponsor Decision|0|||
27554594|NCT01905657|80215539|FG000|Overall Study|Adverse Event|23|||
27554595|NCT01905657|80215540|FG001|Overall Study|Adverse Event|17|||
27694643|NCT02344004|80716766|FG001|Overall Study|Other Not Specified|0|||
27694644|NCT02344004|80716765|FG000|Overall Study|Protocol Violation|1|||
27883897|NCT02203721|81408089|FG001|Overall Study|Lost to Follow-up|0|||
27883898|NCT02203721|81408088|FG000|Overall Study|Death|0|||
27883899|NCT02203721|81408089|FG001|Overall Study|Death|2|||
27554596|NCT01905657|80215541|FG002|Overall Study|Adverse Event|18|||
27826099|NCT03673670|81192589|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
27883900|NCT02203721|81408088|FG000|Overall Study|Illness|0|||
27883901|NCT02203721|81408089|FG001|Overall Study|Illness|1|||
27554597|NCT01905657|80215539|FG000|Overall Study|Clinical Progression|103|||
27554598|NCT01905657|80215540|FG001|Overall Study|Clinical Progression|78|||
27554599|NCT01905657|80215541|FG002|Overall Study|Clinical Progression|59|||
27554600|NCT01905657|80215539|FG000|Overall Study|Death|40|||
27554601|NCT01905657|80215540|FG001|Overall Study|Death|43|||
27554602|NCT01905657|80215541|FG002|Overall Study|Death|47|||
27554603|NCT01905657|80215539|FG000|Overall Study|Excluded Medication|13|||
27554604|NCT01905657|80215540|FG001|Overall Study|Excluded Medication|16|||
27554605|NCT01905657|80215541|FG002|Overall Study|Excluded Medication|9|||
27554606|NCT01905657|80215539|FG000|Overall Study|Lost to Follow-up|1|||
27554607|NCT01905657|80215540|FG001|Overall Study|Lost to Follow-up|2|||
27554608|NCT01905657|80215541|FG002|Overall Study|Lost to Follow-up|1|||
27554609|NCT01905657|80215539|FG000|Overall Study|Physician Decision|5|||
27826100|NCT03673670|81192590|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
27826101|NCT03673670|81192591|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
27826102|NCT03673670|81192586|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
27826103|NCT03673670|81192587|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
27826104|NCT03673670|81192588|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
27826105|NCT03673670|81192589|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
27826106|NCT03673670|81192590|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
27883902|NCT01455597|81408090|FG000|Overall Study|Adverse Event|7|||
27883903|NCT01455597|81408091|FG001|Overall Study|Adverse Event|0|||
27554610|NCT01905657|80215540|FG001|Overall Study|Physician Decision|8|||
27826107|NCT03673670|81192591|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
27554611|NCT01905657|80215541|FG002|Overall Study|Physician Decision|12|||
27554612|NCT01905657|80215539|FG000|Overall Study|Protocol Violation|2|||
27826108|NCT03673670|81192586|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
27826109|NCT03673670|81192587|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
27883904|NCT01455597|81408092|FG002|Overall Study|Adverse Event|5|||
27883905|NCT01455597|81408093|FG003|Overall Study|Adverse Event|1|||
27554613|NCT01905657|80215540|FG001|Overall Study|Protocol Violation|1|||
27554614|NCT01905657|80215541|FG002|Overall Study|Protocol Violation|1|||
27554615|NCT01905657|80215539|FG000|Overall Study|Screen Failure|0|||
27554616|NCT01905657|80215540|FG001|Overall Study|Screen Failure|1|||
27554617|NCT01905657|80215541|FG002|Overall Study|Screen Failure|0|||
27554618|NCT01905657|80215539|FG000|Overall Study|Withdrawal by Subject|15|||
27554619|NCT01905657|80215540|FG001|Overall Study|Withdrawal by Subject|21|||
27554620|NCT01905657|80215541|FG002|Overall Study|Withdrawal by Subject|53|||
27554621|NCT01905657|80215539|FG000|Overall Study|Sponsor Decision|1|||
27554622|NCT01905657|80215540|FG001|Overall Study|Sponsor Decision|0|||
27694645|NCT02344004|80716766|FG001|Overall Study|Protocol Violation|0|||
27694646|NCT00495586|80716769|FG000|Overall Study|Withdrawal by Subject|4|||
27554623|NCT01905657|80215541|FG002|Overall Study|Sponsor Decision|0|||
27554624|NCT00884312|80215542|FG000|Overall Study|Non-fatal Progressive Disease|0|||
27694647|NCT00495586|80716770|FG001|Overall Study|Withdrawal by Subject|4|||
27694648|NCT01122862|80716771|FG000|Period 1|Protocol Violation|0|||
27694649|NCT01122862|80716772|FG001|Period 1|Protocol Violation|1|||
27694650|NCT01122862|80716773|FG002|Period 1|Protocol Violation|0|||
27694651|NCT01122862|80716771|FG000|Period 2|Adverse Event|0|||
27694652|NCT01122862|80716772|FG001|Period 2|Adverse Event|0|||
27694653|NCT01122862|80716773|FG002|Period 2|Adverse Event|1|||
27694654|NCT01853982|80716776|FG000|Overall Study|Withdrawal by Subject|1|||
27694655|NCT01853982|80716777|FG001|Overall Study|Withdrawal by Subject|0|||
27694656|NCT01853982|80716776|FG000|Overall Study|Death|1|||
27694657|NCT01853982|80716777|FG001|Overall Study|Death|0|||
27694658|NCT01853982|80716776|FG000|Overall Study|Lost to Follow-up|0|||
27694659|NCT01853982|80716777|FG001|Overall Study|Lost to Follow-up|1|||
27694660|NCT00601419|80716778|FG000|Overall Study|Lost to Follow-up|3|||
27694661|NCT00601419|80716778|FG000|Overall Study|Missed Visits|1|||
27694662|NCT02768870|80716779|FG000|Overall Study|Death|1|||
27694663|NCT02768870|80716779|FG000|Overall Study|Reoperation|6|||
27554625|NCT00884312|80215543|FG001|Overall Study|Non-fatal Progressive Disease|8|||
27554626|NCT00884312|80215542|FG000|Overall Study|Fatal Progressive Disease|0|||
27554627|NCT00884312|80215543|FG001|Overall Study|Fatal Progressive Disease|1|||
27554628|NCT00884312|80215542|FG000|Overall Study|Non-fatal Adverse Event|1|||
27554629|NCT00884312|80215543|FG001|Overall Study|Non-fatal Adverse Event|0|||
27554630|NCT00884312|80215542|FG000|Overall Study|Fatal Adverse Event|1|||
27554631|NCT00884312|80215543|FG001|Overall Study|Fatal Adverse Event|4|||
27554632|NCT00884312|80215542|FG000|Overall Study|Withdrawal by Subject|0|||
27554633|NCT00884312|80215543|FG001|Overall Study|Withdrawal by Subject|6|||
27554634|NCT00884312|80215542|FG000|Overall Study|Physician Decision|0|||
27554635|NCT00884312|80215543|FG001|Overall Study|Physician Decision|1|||
27554636|NCT00884312|80215542|FG000|Overall Study|Other|0|||
27554637|NCT00884312|80215543|FG001|Overall Study|Other|4|||
27554638|NCT00884312|80215542|FG000|Overall Study|Did Not Receive Study Drug|0|||
27554639|NCT00884312|80215543|FG001|Overall Study|Did Not Receive Study Drug|1|||
27554640|NCT02692703|80215544|FG000|Overall Study|Lost to Follow-up|1|||
27554641|NCT02692703|80215544|FG000|Overall Study|Other|1|||
27554642|NCT01508650|80215545|FG000|Overall Study|Lost to Follow-up|0|||
27554643|NCT01508650|80215546|FG001|Overall Study|Lost to Follow-up|3|||
27554644|NCT00638378|80215547|FG000|Overall Study|Death|2|||
27554645|NCT00638378|80215547|FG000|Overall Study|Adverse Event|1|||
27554646|NCT00638378|80215547|FG000|Overall Study|Disease progression|15|||
27554647|NCT00638378|80215547|FG000|Overall Study|Physician Decision|4|||
27554648|NCT03055260|80218393|FG000|Overall Study|Withdrawal by Subject|1|||
27554649|NCT03055260|80218394|FG001|Overall Study|Withdrawal by Subject|0|||
27554650|NCT02733991|80218396|FG000|Overall Study|Adverse Event|1|||
27554651|NCT02733991|80218397|FG001|Overall Study|Adverse Event|0|||
27826110|NCT03673670|81192588|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
27826111|NCT03673670|81192589|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
27826112|NCT03673670|81192590|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
27554652|NCT02733991|80218396|FG000|Overall Study|Withdrawal by Subject|0|||
27554653|NCT02733991|80218397|FG001|Overall Study|Withdrawal by Subject|5|||
27554654|NCT02326025|80218403|FG000|Overall Study|Adverse Event|3|||
27694664|NCT02768870|80716779|FG000|Overall Study|Lost to Follow-up|1|||
27694665|NCT02768870|80716779|FG000|Overall Study|Exit|4|||
27694666|NCT01098097|80716780|FG000|Overall Study|Adverse Event|17|||
27694667|NCT01098097|80716780|FG000|Overall Study|Lost to Follow-up|18|||
27694668|NCT01098097|80716780|FG000|Overall Study|Status unknown|16|||
27554655|NCT02326025|80218404|FG001|Overall Study|Adverse Event|0|||
27554656|NCT02326025|80218403|FG000|Overall Study|Physician Decision|1|||
27554657|NCT02326025|80218404|FG001|Overall Study|Physician Decision|2|||
27554658|NCT02326025|80218403|FG000|Overall Study|Physician and Participant Decision|1|||
27554659|NCT02326025|80218404|FG001|Overall Study|Physician and Participant Decision|0|||
27554660|NCT02326025|80218403|FG000|Overall Study|Withdrawal by Subject|0|||
27554661|NCT02326025|80218404|FG001|Overall Study|Withdrawal by Subject|2|||
27554662|NCT02326025|80218403|FG000|Overall Study|Protocol Violation|0|||
27554663|NCT02326025|80218404|FG001|Overall Study|Protocol Violation|1|||
27554664|NCT02730455|80218407|FG000|Overall Study|Death|5|||
27554665|NCT02730455|80218408|FG001|Overall Study|Death|6|||
27554666|NCT02730455|80218409|FG002|Overall Study|Death|4|||
27554667|NCT02730455|80218407|FG000|Overall Study|Consent withdrawn|2|||
27554668|NCT02730455|80218408|FG001|Overall Study|Consent withdrawn|4|||
27554669|NCT02730455|80218409|FG002|Overall Study|Consent withdrawn|1|||
27554670|NCT02730455|80218407|FG000|Overall Study|Lost to Follow-up|3|||
27554671|NCT02730455|80218408|FG001|Overall Study|Lost to Follow-up|1|||
27554672|NCT02730455|80218409|FG002|Overall Study|Lost to Follow-up|4|||
27554673|NCT02730455|80218407|FG000|Overall Study|Other|1|||
27554674|NCT02730455|80218408|FG001|Overall Study|Other|1|||
27554675|NCT02730455|80218409|FG002|Overall Study|Other|2|||
27554676|NCT02730455|80218407|FG000|Overall Study|Other|2|||
27554677|NCT02730455|80218408|FG001|Overall Study|Other|2|||
27554678|NCT02730455|80218409|FG002|Overall Study|Other|0|||
27554679|NCT04557371|80218410|FG000|Overall Study|Covid-19-related|0|||
27554680|NCT04557371|80218411|FG001|Overall Study|Covid-19-related|1|||
27554681|NCT04557371|80218412|FG002|Overall Study|Covid-19-related|0|||
27554682|NCT04557371|80218410|FG000|Overall Study|Withdrawal by Subject|0|||
27554683|NCT04557371|80218411|FG001|Overall Study|Withdrawal by Subject|1|||
27554684|NCT04557371|80218412|FG002|Overall Study|Withdrawal by Subject|0|||
27554685|NCT04557371|80218410|FG000|Overall Study|Adverse Event|1|||
27554686|NCT04557371|80218411|FG001|Overall Study|Adverse Event|0|||
27554687|NCT04557371|80218412|FG002|Overall Study|Adverse Event|0|||
27554688|NCT00418314|80218419|FG000|Overall Study|Withdrawal by Subject|1|||
27554689|NCT00418314|80218420|FG001|Overall Study|Withdrawal by Subject|2|||
27554690|NCT02041286|80218421|FG000|Overall Study|Adverse Event|1|||
27554691|NCT01852110|80218424|FG000|Overall Study|Adverse Event|12|||
27554692|NCT01852110|80218425|FG001|Overall Study|Adverse Event|5|||
27554693|NCT01852110|80218426|FG002|Overall Study|Adverse Event|0|||
27554694|NCT01852110|80218427|FG003|Overall Study|Adverse Event|0|||
27554695|NCT01852110|80218428|FG004|Overall Study|Adverse Event|0|||
27554696|NCT01852110|80218429|FG005|Overall Study|Adverse Event|0|||
27554697|NCT01852110|80218424|FG000|Overall Study|Lost to Follow-up|1|||
27554698|NCT01852110|80218425|FG001|Overall Study|Lost to Follow-up|3|||
27694669|NCT01098097|80716780|FG000|Overall Study|No reason reported|31|||
27694670|NCT04634825|80716781|FG000|Overall Study|Death|10|||
27694671|NCT04634825|80716782|FG001|Overall Study|Death|3|||
27694672|NCT04634825|80716781|FG000|Overall Study|Lost to Follow-up|1|||
27694673|NCT04634825|80716782|FG001|Overall Study|Lost to Follow-up|0|||
27694674|NCT04634825|80716781|FG000|Overall Study|Study terminated by sponsor|35|||
27694675|NCT04634825|80716782|FG001|Overall Study|Study terminated by sponsor|11|||
27694676|NCT04634825|80716781|FG000|Overall Study|Withdrawal by Subject|2|||
27694677|NCT04634825|80716782|FG001|Overall Study|Withdrawal by Subject|0|||
27826113|NCT03673670|81192591|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
27826114|NCT03673670|81192586|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
27826115|NCT03673670|81192587|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
27694678|NCT01912456|80716783|FG000|Period 1|Physician Decision|0|||
27826116|NCT03673670|81192588|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
27826117|NCT03673670|81192589|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
27694679|NCT01912456|80716784|FG001|Period 1|Physician Decision|0|||
27554699|NCT01852110|80218426|FG002|Overall Study|Lost to Follow-up|0|||
27554700|NCT01852110|80218427|FG003|Overall Study|Lost to Follow-up|0|||
27554701|NCT01852110|80218428|FG004|Overall Study|Lost to Follow-up|0|||
27554702|NCT01852110|80218429|FG005|Overall Study|Lost to Follow-up|0|||
27554703|NCT01852110|80218424|FG000|Overall Study|Non-compliance with Study Drug|2|||
27554704|NCT01852110|80218425|FG001|Overall Study|Non-compliance with Study Drug|1|||
27554705|NCT01852110|80218426|FG002|Overall Study|Non-compliance with Study Drug|0|||
27554706|NCT01852110|80218427|FG003|Overall Study|Non-compliance with Study Drug|0|||
27554707|NCT01852110|80218428|FG004|Overall Study|Non-compliance with Study Drug|0|||
27554708|NCT01852110|80218429|FG005|Overall Study|Non-compliance with Study Drug|0|||
27554709|NCT01852110|80218424|FG000|Overall Study|Physician Decision|1|||
27554710|NCT01852110|80218425|FG001|Overall Study|Physician Decision|0|||
27554711|NCT01852110|80218426|FG002|Overall Study|Physician Decision|0|||
27554712|NCT01852110|80218427|FG003|Overall Study|Physician Decision|0|||
27554713|NCT01852110|80218428|FG004|Overall Study|Physician Decision|0|||
27554714|NCT01852110|80218429|FG005|Overall Study|Physician Decision|0|||
27554715|NCT01852110|80218424|FG000|Overall Study|Protocol Violation|0|||
27554716|NCT01852110|80218425|FG001|Overall Study|Protocol Violation|1|||
27554717|NCT01852110|80218426|FG002|Overall Study|Protocol Violation|0|||
27554718|NCT01852110|80218427|FG003|Overall Study|Protocol Violation|0|||
27554719|NCT01852110|80218428|FG004|Overall Study|Protocol Violation|0|||
27554720|NCT01852110|80218429|FG005|Overall Study|Protocol Violation|0|||
27554721|NCT01852110|80218424|FG000|Overall Study|Study Terminated by Sponsor|30|||
27554722|NCT01852110|80218425|FG001|Overall Study|Study Terminated by Sponsor|32|||
27554723|NCT01852110|80218426|FG002|Overall Study|Study Terminated by Sponsor|0|||
27554724|NCT01852110|80218427|FG003|Overall Study|Study Terminated by Sponsor|0|||
27554725|NCT01852110|80218428|FG004|Overall Study|Study Terminated by Sponsor|0|||
27554726|NCT01852110|80218429|FG005|Overall Study|Study Terminated by Sponsor|0|||
27554727|NCT01852110|80218424|FG000|Overall Study|Withdrawal by Subject|4|||
27554728|NCT01852110|80218425|FG001|Overall Study|Withdrawal by Subject|4|||
27554729|NCT01852110|80218426|FG002|Overall Study|Withdrawal by Subject|0|||
27554730|NCT01852110|80218427|FG003|Overall Study|Withdrawal by Subject|0|||
27554731|NCT01852110|80218428|FG004|Overall Study|Withdrawal by Subject|0|||
27554732|NCT01852110|80218429|FG005|Overall Study|Withdrawal by Subject|0|||
27554733|NCT01957553|80218434|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
27554734|NCT01957553|80218435|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
27554735|NCT01957553|80218434|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
27554736|NCT01957553|80218435|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
27554737|NCT01957553|80218434|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
27554738|NCT01957553|80218435|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
27554739|NCT01957553|80218434|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
27554740|NCT01957553|80218435|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
27554741|NCT01957553|80218434|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
27554742|NCT01957553|80218435|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
27554743|NCT01957553|80218434|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
27554744|NCT01957553|80218435|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
27554745|NCT01957553|80218434|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
27554746|NCT01957553|80218435|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
27554747|NCT01957553|80218434|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
27554748|NCT01957553|80218435|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
27554749|NCT01957553|80218434|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
27554750|NCT01957553|80218435|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
27554751|NCT03070782|80218436|FG000|Overall Study|Adverse Event|3|||
27554752|NCT03070782|80218437|FG001|Overall Study|Adverse Event|0|||
27554753|NCT03070782|80218438|FG002|Overall Study|Adverse Event|3|||
27554754|NCT03070782|80218439|FG003|Overall Study|Adverse Event|1|||
27554755|NCT03070782|80218440|FG004|Overall Study|Adverse Event|6|||
27554756|NCT03070782|80218441|FG005|Overall Study|Adverse Event|2|||
27554757|NCT03070782|80218436|FG000|Overall Study|Withdrawal by Subject|2|||
27554758|NCT03070782|80218437|FG001|Overall Study|Withdrawal by Subject|1|||
27554759|NCT03070782|80218438|FG002|Overall Study|Withdrawal by Subject|1|||
27554760|NCT03070782|80218439|FG003|Overall Study|Withdrawal by Subject|0|||
27554761|NCT03070782|80218440|FG004|Overall Study|Withdrawal by Subject|4|||
27554762|NCT03070782|80218441|FG005|Overall Study|Withdrawal by Subject|3|||
27554763|NCT03070782|80218436|FG000|Overall Study|Reason Not Specified|2|||
27554764|NCT03070782|80218437|FG001|Overall Study|Reason Not Specified|0|||
27554765|NCT03070782|80218438|FG002|Overall Study|Reason Not Specified|0|||
27554766|NCT03070782|80218439|FG003|Overall Study|Reason Not Specified|1|||
27554767|NCT03070782|80218440|FG004|Overall Study|Reason Not Specified|2|||
27554768|NCT03070782|80218441|FG005|Overall Study|Reason Not Specified|1|||
27554769|NCT03070782|80218436|FG000|Overall Study|Ineligibility|0|||
27554770|NCT03070782|80218437|FG001|Overall Study|Ineligibility|0|||
27554771|NCT03070782|80218438|FG002|Overall Study|Ineligibility|0|||
27554772|NCT03070782|80218439|FG003|Overall Study|Ineligibility|1|||
27554773|NCT03070782|80218440|FG004|Overall Study|Ineligibility|0|||
27554774|NCT03070782|80218441|FG005|Overall Study|Ineligibility|1|||
27554775|NCT03070782|80218436|FG000|Overall Study|Pregnancy|0|||
27554776|NCT03070782|80218437|FG001|Overall Study|Pregnancy|0|||
27554777|NCT03070782|80218438|FG002|Overall Study|Pregnancy|0|||
27554778|NCT03070782|80218439|FG003|Overall Study|Pregnancy|1|||
27554779|NCT03070782|80218440|FG004|Overall Study|Pregnancy|0|||
27554780|NCT03070782|80218441|FG005|Overall Study|Pregnancy|0|||
27554781|NCT03070782|80218436|FG000|Overall Study|Investigator Judgement|0|||
27554782|NCT03070782|80218437|FG001|Overall Study|Investigator Judgement|0|||
27554783|NCT03070782|80218438|FG002|Overall Study|Investigator Judgement|0|||
27554784|NCT03070782|80218439|FG003|Overall Study|Investigator Judgement|1|||
27554785|NCT03070782|80218440|FG004|Overall Study|Investigator Judgement|0|||
27554786|NCT03070782|80218441|FG005|Overall Study|Investigator Judgement|0|||
27554787|NCT01386554|80218449|FG000|Overall Study|Lost to Follow-up|0|||
27554788|NCT01386554|80218450|FG001|Overall Study|Lost to Follow-up|0|||
27554789|NCT01386554|80218451|FG002|Overall Study|Lost to Follow-up|1|||
27554790|NCT01386554|80218449|FG000|Overall Study|Adverse Event|2|||
27554791|NCT01386554|80218450|FG001|Overall Study|Adverse Event|5|||
27554792|NCT01386554|80218451|FG002|Overall Study|Adverse Event|2|||
27694680|NCT01912456|80716785|FG002|Period 1|Physician Decision|1|||
27694681|NCT01912456|80716786|FG003|Period 1|Physician Decision|0|||
27694682|NCT01912456|80716783|FG000|Period 1|non-compliance|1|||
27694683|NCT01912456|80716784|FG001|Period 1|non-compliance|0|||
27694684|NCT01912456|80716785|FG002|Period 1|non-compliance|0|||
27694685|NCT01912456|80716786|FG003|Period 1|non-compliance|1|||
27694686|NCT01912456|80716783|FG000|Period 1|Adverse Event|1|||
27694687|NCT01912456|80716784|FG001|Period 1|Adverse Event|0|||
27694688|NCT01912456|80716785|FG002|Period 1|Adverse Event|0|||
27694689|NCT01912456|80716786|FG003|Period 1|Adverse Event|1|||
27694690|NCT01912456|80716783|FG000|Period 1|Withdrawal by Subject|0|||
27694691|NCT01912456|80716784|FG001|Period 1|Withdrawal by Subject|1|||
27694692|NCT01912456|80716785|FG002|Period 1|Withdrawal by Subject|1|||
27554793|NCT01386554|80218449|FG000|Overall Study|Progressive disease|1|||
27554794|NCT01386554|80218450|FG001|Overall Study|Progressive disease|2|||
27554795|NCT01386554|80218451|FG002|Overall Study|Progressive disease|2|||
27694693|NCT01912456|80716786|FG003|Period 1|Withdrawal by Subject|1|||
27694694|NCT01912456|80716783|FG000|Period 2|Lack of Efficacy|0|||
27694695|NCT01912456|80716784|FG001|Period 2|Lack of Efficacy|2|||
27694696|NCT01912456|80716785|FG002|Period 2|Lack of Efficacy|0|||
27694697|NCT01912456|80716786|FG003|Period 2|Lack of Efficacy|0|||
27554796|NCT01386554|80218449|FG000|Overall Study|Administration of live vaccines|0|||
27554797|NCT01386554|80218450|FG001|Overall Study|Administration of live vaccines|1|||
27554798|NCT01386554|80218451|FG002|Overall Study|Administration of live vaccines|0|||
27554799|NCT01386554|80218449|FG000|Overall Study|Investigator discretion|0|||
27554800|NCT01386554|80218450|FG001|Overall Study|Investigator discretion|0|||
27554801|NCT01386554|80218451|FG002|Overall Study|Investigator discretion|1|||
27554802|NCT01386554|80218449|FG000|Overall Study|Reason not collected|0|||
27554803|NCT01386554|80218450|FG001|Overall Study|Reason not collected|1|||
27554804|NCT01386554|80218451|FG002|Overall Study|Reason not collected|0|||
27694698|NCT01912456|80716783|FG000|Period 2|Adverse Event|0|||
27694699|NCT01912456|80716784|FG001|Period 2|Adverse Event|0|||
27694700|NCT01912456|80716785|FG002|Period 2|Adverse Event|0|||
27694701|NCT01912456|80716786|FG003|Period 2|Adverse Event|1|||
27694702|NCT00753272|80716787|FG000|Overall Study|Adverse Event|878|||
27694703|NCT00753272|80716788|FG001|Overall Study|Adverse Event|869|||
27694704|NCT00753272|80716787|FG000|Overall Study|Protocol Violation|28|||
27694705|NCT00753272|80716788|FG001|Overall Study|Protocol Violation|46|||
27694706|NCT00753272|80716787|FG000|Overall Study|Withdrawal by Subject|2481|||
27694707|NCT00753272|80716788|FG001|Overall Study|Withdrawal by Subject|2407|||
27694708|NCT00753272|80716787|FG000|Overall Study|Lost to Follow-up|491|||
27883906|NCT01455597|81408090|FG000|Overall Study|Lack of Efficacy|0|||
27554805|NCT02064868|80218452|FG000|Overall Study|Lost to Follow-up|14|||
27554806|NCT02064868|80218453|FG001|Overall Study|Lost to Follow-up|8|||
27554807|NCT02064868|80218452|FG000|Overall Study|Physician Decision|1|||
27554808|NCT02064868|80218453|FG001|Overall Study|Physician Decision|0|||
27554809|NCT02064868|80218452|FG000|Overall Study|Withdrawal by Subject|14|||
27554810|NCT02064868|80218453|FG001|Overall Study|Withdrawal by Subject|3|||
27554811|NCT02064868|80218452|FG000|Overall Study|Technical Problems or Missing|5|||
27554812|NCT02064868|80218453|FG001|Overall Study|Technical Problems or Missing|2|||
27554813|NCT03241342|80218454|FG000|Overall Study|Adverse Event|5|||
27554814|NCT03241342|80218455|FG001|Overall Study|Adverse Event|8|||
27554815|NCT03241342|80218456|FG002|Overall Study|Adverse Event|4|||
27554816|NCT03241342|80218454|FG000|Overall Study|Lack of Efficacy|0|||
27554817|NCT03241342|80218455|FG001|Overall Study|Lack of Efficacy|0|||
27554818|NCT03241342|80218456|FG002|Overall Study|Lack of Efficacy|1|||
27554819|NCT03241342|80218454|FG000|Overall Study|noncompliance with study drug|2|||
27554820|NCT03241342|80218455|FG001|Overall Study|noncompliance with study drug|1|||
27554821|NCT03241342|80218456|FG002|Overall Study|noncompliance with study drug|1|||
27554822|NCT03241342|80218454|FG000|Overall Study|sponsor decision|0|||
27554823|NCT03241342|80218455|FG001|Overall Study|sponsor decision|1|||
27554824|NCT03241342|80218456|FG002|Overall Study|sponsor decision|2|||
27554825|NCT03241342|80218454|FG000|Overall Study|not reported|15|||
27554826|NCT03241342|80218455|FG001|Overall Study|not reported|21|||
27554827|NCT03241342|80218456|FG002|Overall Study|not reported|19|||
27554828|NCT02763189|80218457|FG000|Overall Study|Device failure|0|||
27554829|NCT02763189|80218458|FG001|Overall Study|Device failure|2|||
27554830|NCT01948050|80218459|FG000|Overall Study|Withdrawal by Subject|0|||
27554831|NCT01948050|80218460|FG001|Overall Study|Withdrawal by Subject|1|||
27554832|NCT04501666|80218463|FG000|Overall Study|Physician Decision|0|||
27694709|NCT00753272|80716788|FG001|Overall Study|Lost to Follow-up|497|||
27694710|NCT00753272|80716787|FG000|Overall Study|Other|1104|||
27554833|NCT04501666|80218464|FG001|Overall Study|Physician Decision|1|||
27554834|NCT04501666|80218463|FG000|Overall Study|Adverse Event|12|||
27554835|NCT04501666|80218464|FG001|Overall Study|Adverse Event|4|||
27554836|NCT04501666|80218463|FG000|Overall Study|Subject's request|10|||
27554837|NCT04501666|80218464|FG001|Overall Study|Subject's request|6|||
27554838|NCT04501666|80218463|FG000|Overall Study|Protocol Deviation|2|||
27554839|NCT04501666|80218464|FG001|Overall Study|Protocol Deviation|1|||
27554840|NCT04501666|80218463|FG000|Overall Study|Other-- site permanently closing|0|||
27554841|NCT04501666|80218464|FG001|Overall Study|Other-- site permanently closing|1|||
27554842|NCT00429273|80218465|FG000|Overall Study|Lost to Follow-up|1|||
27826118|NCT03673670|81192590|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
27826119|NCT03673670|81192591|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
27826120|NCT03673670|81192586|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
27826121|NCT03673670|81192587|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
27826122|NCT03673670|81192588|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
27826123|NCT03673670|81192589|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
27826124|NCT03673670|81192590|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
27826125|NCT03673670|81192591|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
27826126|NCT03673670|81192586|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
27826127|NCT03673670|81192587|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
27826128|NCT03673670|81192588|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
27826129|NCT03673670|81192589|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
27826130|NCT03673670|81192590|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
27826131|NCT03673670|81192591|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
27826132|NCT03673670|81192586|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
27554843|NCT00429273|80218466|FG001|Overall Study|Lost to Follow-up|2|||
27554844|NCT00429273|80218467|FG002|Overall Study|Lost to Follow-up|2|||
27554845|NCT00429273|80218465|FG000|Overall Study|Physician Decision|6|||
27554846|NCT00429273|80218466|FG001|Overall Study|Physician Decision|5|||
27554847|NCT00429273|80218467|FG002|Overall Study|Physician Decision|5|||
27554848|NCT00429273|80218465|FG000|Overall Study|Adverse Event|1|||
27554849|NCT00429273|80218466|FG001|Overall Study|Adverse Event|1|||
27554850|NCT00429273|80218467|FG002|Overall Study|Adverse Event|2|||
27554851|NCT01714635|80218468|FG000|Overall Study|Discontinued|1|||
27554852|NCT01714635|80218469|FG001|Overall Study|Discontinued|0|||
27554853|NCT01714635|80218470|FG002|Overall Study|Discontinued|2|||
27554854|NCT01714635|80218468|FG000|Overall Study|Missed 6-month exam|1|||
27554855|NCT01714635|80218469|FG001|Overall Study|Missed 6-month exam|0|||
27554856|NCT01714635|80218470|FG002|Overall Study|Missed 6-month exam|0|||
27554857|NCT02891850|80218471|FG000|Overall Study|Adverse Event|3|||
27554858|NCT02891850|80218472|FG001|Overall Study|Adverse Event|0|||
27554859|NCT02891850|80218471|FG000|Overall Study|Death|0|||
27554860|NCT02891850|80218472|FG001|Overall Study|Death|4|||
27554861|NCT02891850|80218471|FG000|Overall Study|Physician Decision|1|||
27554862|NCT02891850|80218472|FG001|Overall Study|Physician Decision|0|||
27554863|NCT02891850|80218471|FG000|Overall Study|Pregnancy|1|||
27554864|NCT02891850|80218472|FG001|Overall Study|Pregnancy|0|||
27554865|NCT02891850|80218471|FG000|Overall Study|Withdrawal by Subject|2|||
27554866|NCT02891850|80218472|FG001|Overall Study|Withdrawal by Subject|3|||
27554867|NCT01083576|80218473|FG000|Overall Study|Treatment Failure|6|||
27554868|NCT01083576|80218474|FG001|Overall Study|Treatment Failure|1|||
27554869|NCT01996982|80218475|FG000|Overall Study|PI/team left institution|7|||
27554870|NCT01320085|80218486|FG000|Overall Study|Disease Progression|26|||
27554871|NCT01320085|80218487|FG001|Overall Study|Disease Progression|93|||
27554872|NCT01320085|80218488|FG002|Overall Study|Disease Progression|17|||
27554873|NCT01320085|80218486|FG000|Overall Study|Adverse Event|12|||
27554874|NCT01320085|80218487|FG001|Overall Study|Adverse Event|20|||
27554875|NCT01320085|80218488|FG002|Overall Study|Adverse Event|5|||
27554876|NCT01320085|80218486|FG000|Overall Study|Withdrawal by Subject|2|||
27554877|NCT01320085|80218487|FG001|Overall Study|Withdrawal by Subject|4|||
27554878|NCT01320085|80218488|FG002|Overall Study|Withdrawal by Subject|1|||
27554879|NCT01320085|80218486|FG000|Overall Study|Protocol Deviation|1|||
27554880|NCT01320085|80218487|FG001|Overall Study|Protocol Deviation|0|||
27554881|NCT01320085|80218488|FG002|Overall Study|Protocol Deviation|1|||
27554882|NCT01320085|80218486|FG000|Overall Study|Administrative problems|0|||
27554883|NCT01320085|80218487|FG001|Overall Study|Administrative problems|0|||
27554884|NCT01320085|80218488|FG002|Overall Study|Administrative problems|1|||
27554885|NCT00742001|80218489|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
27554886|NCT00742001|80218490|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
27554887|NCT00742001|80218491|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
27554888|NCT00142584|80218497|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
27554889|NCT00142584|80218498|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
27554890|NCT00142584|80218497|FG000|Overall Study|Withdrawal by Subject|30|||
27554891|NCT00142584|80218498|FG001|Overall Study|Withdrawal by Subject|16|||
27554892|NCT00142584|80218497|FG000|Overall Study|Lost to Follow-up|22|||
27554893|NCT00142584|80218498|FG001|Overall Study|Lost to Follow-up|12|||
27554894|NCT00142584|80218497|FG000|Overall Study|Adverse Event|14|||
27554895|NCT00142584|80218498|FG001|Overall Study|Adverse Event|5|||
27554896|NCT00142584|80218497|FG000|Overall Study|Protocol Violation|4|||
27554897|NCT00142584|80218498|FG001|Overall Study|Protocol Violation|7|||
27554898|NCT00142584|80218497|FG000|Overall Study|Treatment Failure|2|||
27554899|NCT00142584|80218498|FG001|Overall Study|Treatment Failure|0|||
27554900|NCT04840615|80218508|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
27554901|NCT04840615|80218509|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
27554902|NCT04840615|80218510|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
27554903|NCT03855280|80218511|FG000|Treatment Phase|Adverse Event|1|||
27554904|NCT03855280|80218511|FG000|Treatment Phase|Withdrawal by Subject|1|||
27554905|NCT03855280|80218511|FG000|Continuation Phase|Protocol Violation|1|||
27554906|NCT03855280|80218511|FG000|Continuation Phase|Adverse Event|1|||
27554907|NCT03855280|80218511|FG000|Continuation Phase|Sponsor Concluded Study|1|||
27554908|NCT02205814|80218512|FG000|Overall Study|Lost to Follow-up|0|||
27554909|NCT02205814|80218513|FG001|Overall Study|Lost to Follow-up|0|||
27554910|NCT02205814|80218514|FG002|Overall Study|Lost to Follow-up|0|||
27554911|NCT02205814|80218515|FG003|Overall Study|Lost to Follow-up|1|||
27554912|NCT02205814|80218512|FG000|Overall Study|Lack of Efficacy|1|||
27554913|NCT02205814|80218513|FG001|Overall Study|Lack of Efficacy|0|||
27554914|NCT02205814|80218514|FG002|Overall Study|Lack of Efficacy|1|||
27554915|NCT02205814|80218515|FG003|Overall Study|Lack of Efficacy|1|||
27554916|NCT02205814|80218512|FG000|Overall Study|Physician Decision|0|||
27554917|NCT02205814|80218513|FG001|Overall Study|Physician Decision|0|||
27554918|NCT02205814|80218514|FG002|Overall Study|Physician Decision|1|||
27554919|NCT02205814|80218515|FG003|Overall Study|Physician Decision|0|||
27554920|NCT02205814|80218512|FG000|Overall Study|Protocol Violation|1|||
27554921|NCT02205814|80218513|FG001|Overall Study|Protocol Violation|0|||
27554922|NCT02205814|80218514|FG002|Overall Study|Protocol Violation|0|||
27554923|NCT02205814|80218515|FG003|Overall Study|Protocol Violation|1|||
27554924|NCT02205814|80218512|FG000|Overall Study|Withdrawal by Subject|0|||
27554925|NCT02205814|80218513|FG001|Overall Study|Withdrawal by Subject|1|||
27554926|NCT02205814|80218514|FG002|Overall Study|Withdrawal by Subject|2|||
27554927|NCT02205814|80218515|FG003|Overall Study|Withdrawal by Subject|1|||
27554928|NCT02205814|80218512|FG000|Overall Study|not compliant with study procedures|0|||
27554929|NCT02205814|80218513|FG001|Overall Study|not compliant with study procedures|0|||
27554930|NCT02205814|80218514|FG002|Overall Study|not compliant with study procedures|1|||
27554931|NCT02205814|80218515|FG003|Overall Study|not compliant with study procedures|0|||
27554932|NCT00580606|80218516|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
27554933|NCT00580606|80218517|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
27554934|NCT00580606|80218516|FG000|Open Label (OL)|Withdrawal by Subject|4|||
27554935|NCT00580606|80218517|FG001|Open Label (OL)|Withdrawal by Subject|6|||
27554936|NCT00580606|80218516|FG000|Open Label (OL)|Dosing Symptoms|0|||
27554937|NCT00580606|80218517|FG001|Open Label (OL)|Dosing Symptoms|1|||
27554938|NCT00580606|80218516|FG000|Open Label (OL)|Lost to Follow-up|0|||
27554939|NCT00580606|80218517|FG001|Open Label (OL)|Lost to Follow-up|1|||
27554940|NCT00580606|80218516|FG000|Open Label (OL)|Pregnancy|0|||
27554941|NCT00580606|80218517|FG001|Open Label (OL)|Pregnancy|1|||
27554942|NCT00580606|80218516|FG000|Open Label (OL)|Non-compliance|2|||
27554943|NCT00580606|80218517|FG001|Open Label (OL)|Non-compliance|0|||
27554944|NCT00580606|80218516|FG000|Open Label (OL)|Physician Decision|1|||
27694711|NCT00753272|80716788|FG001|Overall Study|Other|1088|||
27554945|NCT00580606|80218517|FG001|Open Label (OL)|Physician Decision|1|||
27554946|NCT00580606|80218516|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
27554947|NCT00580606|80218517|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
27554948|NCT00459108|80218518|FG000|Overall Study|Withdrawal by Subject|5|||
27554949|NCT00459108|80218518|FG000|Overall Study|Adverse Event|3|||
27554950|NCT00459108|80218518|FG000|Overall Study|Death|2|||
27554951|NCT00459108|80218518|FG000|Overall Study|Progression|1|||
27554952|NCT02496533|80218519|FG000|Overall Study|Lack of data on outcome|3|||
27554953|NCT02496533|80218520|FG001|Overall Study|Lack of data on outcome|0|||
27554954|NCT02496533|80218519|FG000|Overall Study|Patient did not complete all measures|0|||
27554955|NCT02496533|80218520|FG001|Overall Study|Patient did not complete all measures|4|||
27554956|NCT02496533|80218519|FG000|Overall Study|Late for radiologic testing|0|||
27554957|NCT02496533|80218520|FG001|Overall Study|Late for radiologic testing|2|||
27554958|NCT03562481|80218521|FG000|First Intervention|Lost to Follow-up|1|||
27554959|NCT03562481|80218522|FG001|First Intervention|Lost to Follow-up|0|||
27554960|NCT02373202|80218523|FG000|Overall Study|Adverse Event|2|||
27554961|NCT02373202|80218524|FG001|Overall Study|Adverse Event|5|||
27554962|NCT02373202|80218525|FG002|Overall Study|Adverse Event|2|||
27554963|NCT02373202|80218526|FG003|Overall Study|Adverse Event|1|||
27554964|NCT02373202|80218523|FG000|Overall Study|Lack of Efficacy|0|||
27554965|NCT02373202|80218524|FG001|Overall Study|Lack of Efficacy|0|||
27554966|NCT02373202|80218525|FG002|Overall Study|Lack of Efficacy|1|||
27554967|NCT02373202|80218526|FG003|Overall Study|Lack of Efficacy|0|||
27554968|NCT02373202|80218523|FG000|Overall Study|Other|0|||
27554969|NCT02373202|80218524|FG001|Overall Study|Other|1|||
27554970|NCT02373202|80218525|FG002|Overall Study|Other|0|||
27554971|NCT02373202|80218526|FG003|Overall Study|Other|0|||
27554972|NCT03489720|80218527|FG000|Overall Study|Withdrawal by Subject|2|||
27554973|NCT03489720|80218528|FG001|Overall Study|Withdrawal by Subject|0|||
27554974|NCT00381095|80218531|FG000|Overall Study|Death|3|||
27554975|NCT00381095|80218532|FG001|Overall Study|Death|4|||
27554976|NCT00381095|80218531|FG000|Overall Study|Lack of Efficacy|2|||
27554977|NCT00381095|80218532|FG001|Overall Study|Lack of Efficacy|4|||
27554978|NCT00381095|80218531|FG000|Overall Study|Other|2|||
27554979|NCT00381095|80218532|FG001|Overall Study|Other|2|||
27554980|NCT00381095|80218531|FG000|Overall Study|Protocol Violation|1|||
27554981|NCT00381095|80218532|FG001|Overall Study|Protocol Violation|1|||
27554982|NCT00381095|80218531|FG000|Overall Study|Withdrawal by Subject|3|||
27554983|NCT00381095|80218532|FG001|Overall Study|Withdrawal by Subject|3|||
27554984|NCT00381095|80218531|FG000|Overall Study|Adverse Event|2|||
27554985|NCT00381095|80218532|FG001|Overall Study|Adverse Event|7|||
27554986|NCT05035550|80218534|FG000|Overall Study|Withdrawal by Subject|3|||
27554987|NCT05035550|80218535|FG001|Overall Study|Withdrawal by Subject|0|||
27554988|NCT00667368|80218536|FG000|Overall Study|Lost to Follow-up|176|||
27554989|NCT00667368|80218537|FG001|Overall Study|Lost to Follow-up|155|||
27554990|NCT00667368|80218536|FG000|Overall Study|Discontinued early|24|||
27554991|NCT00667368|80218537|FG001|Overall Study|Discontinued early|17|||
27554992|NCT00856284|80218538|FG000|Overall Study|Hyperglycemic rescue|231|||
27554993|NCT00856284|80218539|FG001|Overall Study|Hyperglycemic rescue|201|||
27554994|NCT00856284|80218540|FG002|Overall Study|Hyperglycemic rescue|235|||
27554995|NCT00856284|80218538|FG000|Overall Study|Adverse Event|60|||
27554996|NCT00856284|80218539|FG001|Overall Study|Adverse Event|74|||
27554997|NCT00856284|80218540|FG002|Overall Study|Adverse Event|82|||
27554998|NCT00856284|80218538|FG000|Overall Study|Major protocol deviation|24|||
27554999|NCT00856284|80218539|FG001|Overall Study|Major protocol deviation|16|||
27555000|NCT00856284|80218540|FG002|Overall Study|Major protocol deviation|15|||
27555001|NCT00856284|80218538|FG000|Overall Study|Lost to Follow-up|20|||
27555002|NCT00856284|80218539|FG001|Overall Study|Lost to Follow-up|22|||
27826133|NCT03673670|81192587|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
27826134|NCT03673670|81192588|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
27826135|NCT03673670|81192589|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
27555003|NCT00856284|80218540|FG002|Overall Study|Lost to Follow-up|28|||
27555004|NCT00856284|80218538|FG000|Overall Study|Voluntary withdrawal|48|||
27555005|NCT00856284|80218539|FG001|Overall Study|Voluntary withdrawal|52|||
27555006|NCT00856284|80218540|FG002|Overall Study|Voluntary withdrawal|62|||
27555007|NCT00856284|80218538|FG000|Overall Study|Pregnancy|1|||
27555008|NCT00856284|80218539|FG001|Overall Study|Pregnancy|2|||
27555009|NCT00856284|80218540|FG002|Overall Study|Pregnancy|0|||
27555010|NCT00856284|80218538|FG000|Overall Study|Investigator discretion|9|||
27555011|NCT00856284|80218539|FG001|Overall Study|Investigator discretion|8|||
27555012|NCT00856284|80218540|FG002|Overall Study|Investigator discretion|10|||
27555013|NCT00856284|80218538|FG000|Overall Study|Other|15|||
27555014|NCT00856284|80218539|FG001|Overall Study|Other|17|||
27555015|NCT00856284|80218540|FG002|Overall Study|Other|14|||
27555016|NCT00856284|80218538|FG000|Overall Study|Randomized in error|0|||
27555017|NCT00856284|80218539|FG001|Overall Study|Randomized in error|0|||
27555018|NCT00856284|80218540|FG002|Overall Study|Randomized in error|1|||
27555019|NCT00715078|80218541|FG000|Overall Study|Death|29|||
27555020|NCT00715078|80218542|FG001|Overall Study|Death|36|||
27555021|NCT00715078|80218543|FG002|Overall Study|Death|36|||
27555022|NCT00715078|80218541|FG000|Overall Study|Withdrawal by Subject|1|||
27555023|NCT00715078|80218542|FG001|Overall Study|Withdrawal by Subject|0|||
27555024|NCT00715078|80218543|FG002|Overall Study|Withdrawal by Subject|1|||
27555025|NCT00715078|80218541|FG000|Overall Study|Unable to start due to disease prog.|0|||
27555026|NCT00715078|80218542|FG001|Overall Study|Unable to start due to disease prog.|0|||
27555027|NCT00715078|80218543|FG002|Overall Study|Unable to start due to disease prog.|1|||
27555028|NCT01648205|80218544|FG000|Placebo|Pregnancy|1|||
27555029|NCT01648205|80218544|FG000|Placebo|Withdrawal by Subject|1|||
27555030|NCT01648205|80218544|FG000|Placebo|Protocol Violation|2|||
27555031|NCT01648205|80218544|FG000|Ranolazine|Death|1|||
27555032|NCT01648205|80218544|FG000|Ranolazine|Withdrawal by Subject|1|||
27555033|NCT01648205|80218544|FG000|Ranolazine|Protocol Violation|3|||
27555034|NCT00296374|80218545|FG000|Overall Study|Adverse Event|14|||
27555035|NCT00296374|80218546|FG001|Overall Study|Adverse Event|10|||
27555036|NCT00296374|80218547|FG002|Overall Study|Adverse Event|7|||
27555037|NCT00296374|80218545|FG000|Overall Study|Withdrawal by Subject|3|||
27555038|NCT00296374|80218546|FG001|Overall Study|Withdrawal by Subject|5|||
27555039|NCT00296374|80218547|FG002|Overall Study|Withdrawal by Subject|11|||
27555040|NCT00296374|80218545|FG000|Overall Study|Incorrect enrollment|3|||
27555041|NCT00296374|80218546|FG001|Overall Study|Incorrect enrollment|3|||
27555042|NCT00296374|80218547|FG002|Overall Study|Incorrect enrollment|4|||
27826136|NCT03673670|81192590|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
27555043|NCT00296374|80218545|FG000|Overall Study|Protocol Violation|1|||
27555044|NCT00296374|80218546|FG001|Overall Study|Protocol Violation|2|||
27555045|NCT00296374|80218547|FG002|Overall Study|Protocol Violation|3|||
27555046|NCT00296374|80218545|FG000|Overall Study|Lost to Follow-up|3|||
27555047|NCT00296374|80218546|FG001|Overall Study|Lost to Follow-up|1|||
27555048|NCT00296374|80218547|FG002|Overall Study|Lost to Follow-up|1|||
27555049|NCT00296374|80218545|FG000|Overall Study|Relocated to another state|1|||
27826137|NCT03673670|81192591|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
27826138|NCT02724462|81192599|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
27826139|NCT02724462|81192600|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
27826140|NCT02724462|81192599|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
27826141|NCT02724462|81192600|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
27826142|NCT02724462|81192599|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
27826143|NCT02724462|81192600|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
27826144|NCT02724462|81192599|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
27826145|NCT02724462|81192600|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
27555050|NCT00296374|80218546|FG001|Overall Study|Relocated to another state|0|||
27555051|NCT00296374|80218547|FG002|Overall Study|Relocated to another state|0|||
27555052|NCT00296374|80218545|FG000|Overall Study|Stopped drug before end of study visit|0|||
27555053|NCT00296374|80218546|FG001|Overall Study|Stopped drug before end of study visit|1|||
27555054|NCT00296374|80218547|FG002|Overall Study|Stopped drug before end of study visit|0|||
27555055|NCT00296374|80218545|FG000|Overall Study|Nephrologist introduced ACE|0|||
27555056|NCT00296374|80218546|FG001|Overall Study|Nephrologist introduced ACE|1|||
27555057|NCT00296374|80218547|FG002|Overall Study|Nephrologist introduced ACE|0|||
27555058|NCT00296374|80218545|FG000|Overall Study|Pregnancy|0|||
27555059|NCT00296374|80218546|FG001|Overall Study|Pregnancy|0|||
27555060|NCT00296374|80218547|FG002|Overall Study|Pregnancy|2|||
27555061|NCT00296374|80218545|FG000|Overall Study|Other|0|||
27555062|NCT00296374|80218546|FG001|Overall Study|Other|0|||
27555063|NCT00296374|80218547|FG002|Overall Study|Other|1|||
27555064|NCT04160091|80218548|FG000|Overall Study|Terminated by Sponsor|7|||
27555065|NCT04160091|80218549|FG001|Overall Study|Terminated by Sponsor|3|||
27826146|NCT02724462|81192599|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
27555066|NCT04160091|80218550|FG002|Overall Study|Terminated by Sponsor|5|||
27555067|NCT04160091|80218551|FG003|Overall Study|Terminated by Sponsor|2|||
27555068|NCT04160091|80218548|FG000|Overall Study|Noncompliance|0|||
27555069|NCT04160091|80218549|FG001|Overall Study|Noncompliance|0|||
27555070|NCT04160091|80218550|FG002|Overall Study|Noncompliance|0|||
27555071|NCT04160091|80218551|FG003|Overall Study|Noncompliance|1|||
27555072|NCT04160091|80218548|FG000|Overall Study|Withdrawal by Subject|0|||
27555073|NCT04160091|80218549|FG001|Overall Study|Withdrawal by Subject|0|||
27555074|NCT04160091|80218550|FG002|Overall Study|Withdrawal by Subject|0|||
27555075|NCT04160091|80218551|FG003|Overall Study|Withdrawal by Subject|1|||
27555076|NCT00166114|80218556|FG000|Overall Study|Protocol Violation|2|||
27555077|NCT00166114|80218557|FG001|Overall Study|Protocol Violation|1|||
27555078|NCT00166114|80218556|FG000|Overall Study|Withdrawal by Subject|10|||
27555079|NCT00166114|80218557|FG001|Overall Study|Withdrawal by Subject|4|||
27555080|NCT00166114|80218556|FG000|Overall Study|Adverse Event|2|||
27555081|NCT00166114|80218557|FG001|Overall Study|Adverse Event|1|||
27555082|NCT00967798|80218558|FG000|Overall Study|Withdrawal by Subject|5|||
27555083|NCT00967798|80218559|FG001|Overall Study|Withdrawal by Subject|2|||
27555084|NCT00967798|80218558|FG000|Overall Study|Lost to Follow-up|4|||
27555085|NCT00967798|80218559|FG001|Overall Study|Lost to Follow-up|1|||
27555086|NCT01344161|80218565|FG000|Overall Study|Lost to Follow-up|4|||
27555087|NCT01344161|80218566|FG001|Overall Study|Lost to Follow-up|1|||
27555088|NCT01344161|80218565|FG000|Overall Study|Pregnancy|0|||
27555089|NCT01344161|80218566|FG001|Overall Study|Pregnancy|1|||
27555090|NCT01344161|80218565|FG000|Overall Study|Protocol Violation|1|||
27555091|NCT01344161|80218566|FG001|Overall Study|Protocol Violation|1|||
27555092|NCT01896531|80218567|FG000|Overall Study|Death|57|||
27555093|NCT01896531|80218568|FG001|Overall Study|Death|59|||
27555094|NCT01896531|80218567|FG000|Overall Study|Lost to Follow-up|3|||
27555095|NCT01896531|80218568|FG001|Overall Study|Lost to Follow-up|0|||
27555096|NCT01896531|80218567|FG000|Overall Study|Non-compliance|0|||
27555097|NCT01896531|80218568|FG001|Overall Study|Non-compliance|1|||
27555098|NCT01896531|80218567|FG000|Overall Study|Study Ended by Sponsor|7|||
27555099|NCT01896531|80218568|FG001|Overall Study|Study Ended by Sponsor|20|||
27555100|NCT01896531|80218567|FG000|Overall Study|Withdrawal by Subject|3|||
27555101|NCT01896531|80218568|FG001|Overall Study|Withdrawal by Subject|2|||
27555102|NCT01896531|80218567|FG000|Overall Study|Death Prior to Treatment|1|||
27555103|NCT01896531|80218568|FG001|Overall Study|Death Prior to Treatment|0|||
27555104|NCT02154490|80218576|FG000|Overall Study|No tissue submitted|23|||
27555105|NCT02154490|80218576|FG000|Overall Study|No biomarker results|167|||
27555106|NCT02154490|80218576|FG000|Overall Study|Not assigned to a sub-study|270|||
27555107|NCT02154490|80218576|FG000|Overall Study|Did not register to a sub-study|749|||
27555108|NCT01113801|80218582|FG000|Overall Study|Adverse Event|4|||
27555109|NCT01113801|80218583|FG001|Overall Study|Adverse Event|0|||
27555110|NCT01113801|80218584|FG002|Overall Study|Adverse Event|2|||
27555111|NCT01113801|80218585|FG003|Overall Study|Adverse Event|6|||
27555112|NCT01113801|80218582|FG000|Overall Study|Death|4|||
27555113|NCT01113801|80218583|FG001|Overall Study|Death|5|||
27555114|NCT01113801|80218584|FG002|Overall Study|Death|3|||
27555115|NCT01113801|80218585|FG003|Overall Study|Death|4|||
27555116|NCT01113801|80218582|FG000|Overall Study|Protocol Violation|0|||
27555117|NCT01113801|80218583|FG001|Overall Study|Protocol Violation|1|||
27555118|NCT01113801|80218584|FG002|Overall Study|Protocol Violation|0|||
27555119|NCT01113801|80218585|FG003|Overall Study|Protocol Violation|0|||
27555120|NCT01113801|80218582|FG000|Overall Study|Withdrawal by Subject|9|||
27694712|NCT01614197|80716791|FG000|Overall Study|Withdrawal by Subject|0|||
27694713|NCT01614197|80716792|FG001|Overall Study|Withdrawal by Subject|1|||
27694714|NCT01614197|80716793|FG002|Overall Study|Withdrawal by Subject|0|||
27694715|NCT01614197|80716794|FG003|Overall Study|Withdrawal by Subject|0|||
27694716|NCT01442779|80716795|FG000|Overall Study|Withdrawal by Subject|3|||
27694717|NCT01442779|80716795|FG000|Overall Study|Death|3|||
27555121|NCT01113801|80218583|FG001|Overall Study|Withdrawal by Subject|7|||
27555122|NCT01113801|80218584|FG002|Overall Study|Withdrawal by Subject|7|||
27555123|NCT01113801|80218585|FG003|Overall Study|Withdrawal by Subject|8|||
27555124|NCT01113801|80218582|FG000|Overall Study|Physician Decision|2|||
27555125|NCT01113801|80218583|FG001|Overall Study|Physician Decision|2|||
27883907|NCT01455597|81408091|FG001|Overall Study|Lack of Efficacy|1|||
27883908|NCT01455597|81408092|FG002|Overall Study|Lack of Efficacy|2|||
27555126|NCT01113801|80218584|FG002|Overall Study|Physician Decision|3|||
27555127|NCT01113801|80218585|FG003|Overall Study|Physician Decision|3|||
27694718|NCT01442779|80716795|FG000|Overall Study|Non-compliance|1|||
27555128|NCT01113801|80218582|FG000|Overall Study|Sponsor Decision|15|||
27555129|NCT01113801|80218583|FG001|Overall Study|Sponsor Decision|21|||
27555130|NCT01113801|80218584|FG002|Overall Study|Sponsor Decision|20|||
27555131|NCT01113801|80218585|FG003|Overall Study|Sponsor Decision|15|||
27555132|NCT01113801|80218582|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
27555133|NCT01113801|80218583|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
27555134|NCT01113801|80218584|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
27555135|NCT01113801|80218585|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
27555136|NCT02279173|80218592|FG000|Overall Study|Protocol-specified Criteria|67|||
27555137|NCT02279173|80218592|FG000|Overall Study|Withdrawal by Subject|20|||
27555138|NCT02279173|80218592|FG000|Overall Study|Decision by Sponsor|4|||
27555139|NCT02279173|80218592|FG000|Overall Study|Lost to Follow-up|3|||
27555140|NCT00642941|80218593|FG000|Overall Study|Physician Decision|3|||
27555141|NCT00642941|80218594|FG001|Overall Study|Physician Decision|1|||
27555142|NCT00642941|80218595|FG002|Overall Study|Physician Decision|0|||
27555143|NCT00642941|80218596|FG003|Overall Study|Physician Decision|0|||
27555144|NCT00642941|80218597|FG004|Overall Study|Physician Decision|0|||
27555145|NCT00642941|80218598|FG005|Overall Study|Physician Decision|0|||
27555146|NCT00642941|80218599|FG006|Overall Study|Physician Decision|1|||
27555147|NCT00642941|80218600|FG007|Overall Study|Physician Decision|0|||
27555148|NCT00642941|80218601|FG008|Overall Study|Physician Decision|0|||
27555149|NCT00642941|80218602|FG009|Overall Study|Physician Decision|1|||
27555150|NCT00642941|80218603|FG010|Overall Study|Physician Decision|0|||
27555151|NCT00642941|80218604|FG011|Overall Study|Physician Decision|1|||
27826147|NCT02724462|81192600|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
27826148|NCT02724462|81192599|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
27826149|NCT02724462|81192600|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
27826150|NCT01111461|81192607|FG000|Overall Study|Adverse Event|32|||
27826151|NCT01111461|81192607|FG000|Overall Study|Participant choice|11|||
27826152|NCT01111461|81192607|FG000|Overall Study|Lost to Follow-up|1|||
27826153|NCT01111461|81192607|FG000|Overall Study|Withdrawal by Subject|1|||
27826154|NCT01111461|81192607|FG000|Overall Study|Other|6|||
27826155|NCT00834340|81192608|FG000|Washout|Adverse Event|1|||
27826156|NCT00834340|81192609|FG001|Washout|Adverse Event|0|||
27826157|NCT00834340|81192608|FG000|Washout|Withdrawal by Subject|1|||
27826158|NCT00834340|81192609|FG001|Washout|Withdrawal by Subject|0|||
27826159|NCT00252720|81195289|FG000|Overall Study|Withdrawal by Subject|95|||
27826160|NCT00252720|81195290|FG001|Overall Study|Withdrawal by Subject|97|||
27826161|NCT00252720|81195289|FG000|Overall Study|Death|7|||
27826162|NCT00252720|81195290|FG001|Overall Study|Death|8|||
27826163|NCT00252720|81195289|FG000|Overall Study|Moving|23|||
27826164|NCT00252720|81195290|FG001|Overall Study|Moving|42|||
27826165|NCT00252720|81195289|FG000|Overall Study|Mainly patients lost to follow-up|7|||
27826166|NCT00252720|81195290|FG001|Overall Study|Mainly patients lost to follow-up|18|||
27826167|NCT01854047|81195291|FG000|Overall Study|Lack of Efficacy|1|||
27826168|NCT01854047|81195292|FG001|Overall Study|Lack of Efficacy|0|||
27826169|NCT01854047|81195293|FG002|Overall Study|Lack of Efficacy|0|||
27826170|NCT01854047|81195294|FG003|Overall Study|Lack of Efficacy|0|||
27826171|NCT01854047|81195295|FG004|Overall Study|Lack of Efficacy|0|||
27826172|NCT01854047|81195291|FG000|Overall Study|Poor compliance to protocol|3|||
27826173|NCT01854047|81195292|FG001|Overall Study|Poor compliance to protocol|0|||
27826174|NCT01854047|81195293|FG002|Overall Study|Poor compliance to protocol|2|||
27826175|NCT01854047|81195294|FG003|Overall Study|Poor compliance to protocol|0|||
27826176|NCT01854047|81195295|FG004|Overall Study|Poor compliance to protocol|0|||
27826177|NCT01854047|81195291|FG000|Overall Study|Adverse Event|5|||
27826178|NCT01854047|81195292|FG001|Overall Study|Adverse Event|4|||
27826179|NCT01854047|81195293|FG002|Overall Study|Adverse Event|6|||
27826180|NCT01854047|81195294|FG003|Overall Study|Adverse Event|10|||
27826181|NCT01854047|81195295|FG004|Overall Study|Adverse Event|7|||
27826182|NCT01854047|81195291|FG000|Overall Study|Randomized but not treated|0|||
27826183|NCT01854047|81195292|FG001|Overall Study|Randomized but not treated|1|||
27826184|NCT01854047|81195293|FG002|Overall Study|Randomized but not treated|2|||
27826185|NCT01854047|81195294|FG003|Overall Study|Randomized but not treated|0|||
27826186|NCT01854047|81195295|FG004|Overall Study|Randomized but not treated|4|||
27883909|NCT01455597|81408093|FG003|Overall Study|Lack of Efficacy|0|||
27883910|NCT01455597|81408090|FG000|Overall Study|Lost to Follow-up|3|||
27826187|NCT01854047|81195291|FG000|Overall Study|Other than specified above|3|||
27826188|NCT01854047|81195292|FG001|Overall Study|Other than specified above|3|||
27555152|NCT00642941|80218593|FG000|Overall Study|Death|4|||
27555153|NCT00642941|80218594|FG001|Overall Study|Death|0|||
27555154|NCT00642941|80218595|FG002|Overall Study|Death|1|||
27555155|NCT00642941|80218596|FG003|Overall Study|Death|1|||
27826189|NCT01854047|81195293|FG002|Overall Study|Other than specified above|3|||
27555156|NCT00642941|80218597|FG004|Overall Study|Death|2|||
27555157|NCT00642941|80218598|FG005|Overall Study|Death|1|||
27555158|NCT00642941|80218599|FG006|Overall Study|Death|0|||
27555159|NCT00642941|80218600|FG007|Overall Study|Death|0|||
27555160|NCT00642941|80218601|FG008|Overall Study|Death|0|||
27555161|NCT00642941|80218602|FG009|Overall Study|Death|0|||
27555162|NCT00642941|80218603|FG010|Overall Study|Death|0|||
27555163|NCT00642941|80218604|FG011|Overall Study|Death|1|||
27555164|NCT00642941|80218593|FG000|Overall Study|Study closed by Sponsor|0|||
27555165|NCT00642941|80218594|FG001|Overall Study|Study closed by Sponsor|1|||
27555166|NCT00642941|80218595|FG002|Overall Study|Study closed by Sponsor|0|||
27555167|NCT00642941|80218596|FG003|Overall Study|Study closed by Sponsor|0|||
27555168|NCT00642941|80218597|FG004|Overall Study|Study closed by Sponsor|0|||
27555169|NCT00642941|80218598|FG005|Overall Study|Study closed by Sponsor|0|||
27555170|NCT00642941|80218599|FG006|Overall Study|Study closed by Sponsor|0|||
27555171|NCT00642941|80218600|FG007|Overall Study|Study closed by Sponsor|0|||
27555172|NCT00642941|80218601|FG008|Overall Study|Study closed by Sponsor|0|||
27555173|NCT00642941|80218602|FG009|Overall Study|Study closed by Sponsor|0|||
27555174|NCT00642941|80218603|FG010|Overall Study|Study closed by Sponsor|0|||
27826190|NCT01854047|81195294|FG003|Overall Study|Other than specified above|5|||
27826191|NCT01854047|81195295|FG004|Overall Study|Other than specified above|8|||
27826192|NCT02632344|81195296|FG000|Overall Study|Adverse Event|3|||
27826193|NCT02632344|81195296|FG000|Overall Study|Lack of Efficacy|3|||
27826194|NCT02632344|81195296|FG000|Overall Study|Withdrawal by Subject|2|||
27826195|NCT03514017|81195297|FG000|Overall Study|Death|1|||
27826196|NCT03514017|81195297|FG000|Overall Study|Adverse Event|1|||
27826197|NCT00124618|81195299|FG000|Overall Study|Ineligible|1|||
27826198|NCT03804983|81195300|FG000|Overall Study|Adverse Event|0|||
27826199|NCT03804983|81195301|FG001|Overall Study|Adverse Event|1|||
27555175|NCT00642941|80218604|FG011|Overall Study|Study closed by Sponsor|0|||
27555176|NCT00642941|80218593|FG000|Overall Study|Withdrawal by Subject|1|||
27826200|NCT03804983|81195300|FG000|Overall Study|Family Obligation|1|||
27826201|NCT03804983|81195301|FG001|Overall Study|Family Obligation|0|||
27826202|NCT02146105|81195302|FG000|Overall Study|Adverse Event|1|||
27826203|NCT02146105|81195302|FG000|Overall Study|Withdrawal by Subject|5|||
27826204|NCT00610363|81195303|FG000|Overall Study|Non-compliance with protocol|0|||
27826205|NCT00610363|81195304|FG001|Overall Study|Non-compliance with protocol|1|||
27826206|NCT00610363|81195303|FG000|Overall Study|Adverse Event|3|||
27555177|NCT00642941|80218594|FG001|Overall Study|Withdrawal by Subject|0|||
27555178|NCT00642941|80218595|FG002|Overall Study|Withdrawal by Subject|0|||
27555179|NCT00642941|80218596|FG003|Overall Study|Withdrawal by Subject|2|||
27555180|NCT00642941|80218597|FG004|Overall Study|Withdrawal by Subject|0|||
27555181|NCT00642941|80218598|FG005|Overall Study|Withdrawal by Subject|0|||
27555182|NCT00642941|80218599|FG006|Overall Study|Withdrawal by Subject|2|||
27826207|NCT00610363|81195304|FG001|Overall Study|Adverse Event|1|||
27826208|NCT00610363|81195303|FG000|Overall Study|Lack of Efficacy|2|||
27826209|NCT00610363|81195304|FG001|Overall Study|Lack of Efficacy|0|||
27555183|NCT00642941|80218600|FG007|Overall Study|Withdrawal by Subject|0|||
27555184|NCT00642941|80218601|FG008|Overall Study|Withdrawal by Subject|1|||
27555185|NCT00642941|80218602|FG009|Overall Study|Withdrawal by Subject|0|||
27555186|NCT00642941|80218603|FG010|Overall Study|Withdrawal by Subject|0|||
27555187|NCT00642941|80218604|FG011|Overall Study|Withdrawal by Subject|1|||
27555188|NCT00642941|80218593|FG000|Overall Study|Protocol Violation|0|||
27555189|NCT00642941|80218594|FG001|Overall Study|Protocol Violation|0|||
27555190|NCT00642941|80218595|FG002|Overall Study|Protocol Violation|0|||
27555191|NCT00642941|80218596|FG003|Overall Study|Protocol Violation|0|||
27555192|NCT00642941|80218597|FG004|Overall Study|Protocol Violation|0|||
27555193|NCT00642941|80218598|FG005|Overall Study|Protocol Violation|0|||
27826210|NCT00610363|81195303|FG000|Overall Study|Lost to Follow-up|4|||
27555194|NCT00642941|80218599|FG006|Overall Study|Protocol Violation|1|||
27555195|NCT00642941|80218600|FG007|Overall Study|Protocol Violation|0|||
27555196|NCT00642941|80218601|FG008|Overall Study|Protocol Violation|0|||
27555197|NCT00642941|80218602|FG009|Overall Study|Protocol Violation|0|||
27826211|NCT00610363|81195304|FG001|Overall Study|Lost to Follow-up|0|||
27826212|NCT00610363|81195303|FG000|Overall Study|Withdrawal by Subject|1|||
27826213|NCT00610363|81195304|FG001|Overall Study|Withdrawal by Subject|0|||
27826214|NCT00610363|81195303|FG000|Overall Study|Other than specified above|1|||
27826215|NCT00610363|81195304|FG001|Overall Study|Other than specified above|1|||
27826216|NCT02714062|81195305|FG000|Overall Study|Adverse Event|0|||
27826217|NCT02714062|81195306|FG001|Overall Study|Adverse Event|0|||
27826218|NCT02714062|81195307|FG002|Overall Study|Adverse Event|2|||
27826219|NCT02714062|81195305|FG000|Overall Study|Withdrawal by Subject|1|||
27826220|NCT02714062|81195306|FG001|Overall Study|Withdrawal by Subject|0|||
27826221|NCT02714062|81195307|FG002|Overall Study|Withdrawal by Subject|1|||
27826222|NCT02714062|81195305|FG000|Overall Study|Protocol Violation|0|||
27826223|NCT02714062|81195306|FG001|Overall Study|Protocol Violation|1|||
27826224|NCT02714062|81195307|FG002|Overall Study|Protocol Violation|0|||
27826225|NCT00934050|81195308|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
27826226|NCT00934050|81195309|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27826227|NCT00934050|81195310|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27826228|NCT00934050|81195311|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
27826229|NCT00934050|81195312|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27826230|NCT00934050|81195313|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
27826231|NCT00934050|81195308|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
27826232|NCT00934050|81195309|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
27826233|NCT00934050|81195310|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
27826234|NCT00934050|81195311|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
27826235|NCT00934050|81195312|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
27826236|NCT00934050|81195313|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
27826237|NCT00934050|81195308|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27826238|NCT00934050|81195309|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27555198|NCT00642941|80218603|FG010|Overall Study|Protocol Violation|0|||
27555199|NCT00642941|80218604|FG011|Overall Study|Protocol Violation|0|||
27826239|NCT00934050|81195310|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
27826240|NCT00934050|81195311|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27826241|NCT00934050|81195312|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27883911|NCT01455597|81408091|FG001|Overall Study|Lost to Follow-up|0|||
27883912|NCT01455597|81408092|FG002|Overall Study|Lost to Follow-up|2|||
27883913|NCT01455597|81408093|FG003|Overall Study|Lost to Follow-up|1|||
27883914|NCT01455597|81408090|FG000|Overall Study|Withdrew Consent|6|||
27555200|NCT00642941|80218593|FG000|Overall Study|Adverse Event|1|||
27555201|NCT00642941|80218594|FG001|Overall Study|Adverse Event|1|||
27826242|NCT00934050|81195313|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
27826243|NCT00934050|81195308|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
27826244|NCT00934050|81195309|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
27826245|NCT00934050|81195310|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
27826246|NCT00934050|81195311|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
27826247|NCT00934050|81195312|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
27826248|NCT00934050|81195313|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
27826249|NCT00934050|81195308|FG000|Enrolled After 15 Dec 2009|Death|0|||
27555202|NCT00642941|80218595|FG002|Overall Study|Adverse Event|0|||
27694719|NCT03486457|80716797|FG000|Up to Month 3|Adverse Event|2|||
27694720|NCT03486457|80716798|FG001|Up to Month 3|Adverse Event|5|||
27826250|NCT00934050|81195309|FG001|Enrolled After 15 Dec 2009|Death|0|||
27555203|NCT00642941|80218596|FG003|Overall Study|Adverse Event|0|||
27555204|NCT00642941|80218597|FG004|Overall Study|Adverse Event|0|||
27555205|NCT00642941|80218598|FG005|Overall Study|Adverse Event|0|||
27555206|NCT00642941|80218599|FG006|Overall Study|Adverse Event|1|||
27555207|NCT00642941|80218600|FG007|Overall Study|Adverse Event|1|||
27555208|NCT00642941|80218601|FG008|Overall Study|Adverse Event|0|||
27555209|NCT00642941|80218602|FG009|Overall Study|Adverse Event|1|||
27555210|NCT00642941|80218603|FG010|Overall Study|Adverse Event|0|||
27555211|NCT00642941|80218604|FG011|Overall Study|Adverse Event|0|||
27555212|NCT00642941|80218593|FG000|Overall Study|Other|1|||
27555213|NCT00642941|80218594|FG001|Overall Study|Other|1|||
27555214|NCT00642941|80218595|FG002|Overall Study|Other|1|||
27555215|NCT00642941|80218596|FG003|Overall Study|Other|1|||
27555216|NCT00642941|80218597|FG004|Overall Study|Other|0|||
27555217|NCT00642941|80218598|FG005|Overall Study|Other|1|||
27555218|NCT00642941|80218599|FG006|Overall Study|Other|0|||
27555219|NCT00642941|80218600|FG007|Overall Study|Other|1|||
27555220|NCT00642941|80218601|FG008|Overall Study|Other|0|||
27555221|NCT00642941|80218602|FG009|Overall Study|Other|0|||
27555222|NCT00642941|80218603|FG010|Overall Study|Other|0|||
27555223|NCT00642941|80218604|FG011|Overall Study|Other|1|||
27555224|NCT00642941|80218593|FG000|Overall Study|Disease progression|60|||
27555225|NCT00642941|80218594|FG001|Overall Study|Disease progression|50|||
27555226|NCT00642941|80218595|FG002|Overall Study|Disease progression|5|||
27555227|NCT00642941|80218596|FG003|Overall Study|Disease progression|36|||
27555228|NCT00642941|80218597|FG004|Overall Study|Disease progression|23|||
27555229|NCT00642941|80218598|FG005|Overall Study|Disease progression|39|||
27555230|NCT00642941|80218599|FG006|Overall Study|Disease progression|18|||
27555231|NCT00642941|80218600|FG007|Overall Study|Disease progression|12|||
27555232|NCT00642941|80218601|FG008|Overall Study|Disease progression|10|||
27555233|NCT00642941|80218602|FG009|Overall Study|Disease progression|7|||
27555234|NCT00642941|80218603|FG010|Overall Study|Disease progression|12|||
27555235|NCT00642941|80218604|FG011|Overall Study|Disease progression|7|||
27694721|NCT03486457|80716797|FG000|Up to Month 3|Lack of Efficacy|1|||
27694722|NCT03486457|80716798|FG001|Up to Month 3|Lack of Efficacy|0|||
27694723|NCT03486457|80716797|FG000|Up to Month 3|Withdrawal by Subject|1|||
27555236|NCT03944954|80218605|FG000|Overall Study|Withdrawal by Subject|22|||
27555237|NCT03944954|80218606|FG001|Overall Study|Withdrawal by Subject|4|||
27555238|NCT03944954|80218605|FG000|Overall Study|Lost to Follow-up|18|||
27555239|NCT03944954|80218606|FG001|Overall Study|Lost to Follow-up|0|||
27826251|NCT00934050|81195310|FG002|Enrolled After 15 Dec 2009|Death|0|||
27826252|NCT00934050|81195311|FG003|Enrolled After 15 Dec 2009|Death|0|||
27555240|NCT03944954|80218605|FG000|Overall Study|Failed Medical Screening|7|||
27555241|NCT03944954|80218606|FG001|Overall Study|Failed Medical Screening|0|||
27826253|NCT00934050|81195312|FG004|Enrolled After 15 Dec 2009|Death|0|||
27555242|NCT02887521|80218609|FG000|Overall Study|Withdrawal by Subject|0|||
27826254|NCT00934050|81195313|FG005|Enrolled After 15 Dec 2009|Death|1|||
27826255|NCT00934050|81195308|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27555243|NCT02887521|80218610|FG001|Overall Study|Withdrawal by Subject|3|||
27555244|NCT03402386|80218611|FG000|Overall Study|Adverse Event|3|||
27555245|NCT03402386|80218611|FG000|Overall Study|Physician Decision|1|||
27555246|NCT03402386|80218611|FG000|Overall Study|Difficult to control Hb|2|||
27555247|NCT00754624|80218612|FG000|Overall Study|Adverse Event|16|||
27555248|NCT00754624|80218612|FG000|Overall Study|Death|1|||
27555249|NCT00754624|80218612|FG000|Overall Study|Physician Decision|8|||
27555250|NCT00754624|80218612|FG000|Overall Study|Protocol Violation|1|||
27555251|NCT00754624|80218612|FG000|Overall Study|Withdrawal by Subject|28|||
27555252|NCT00754624|80218612|FG000|Overall Study|Various|12|||
27555253|NCT00754624|80218612|FG000|Overall Study|Lost to Follow-up|3|||
27555254|NCT00390858|80218613|FG000|Overall Study|Adverse Event|6|||
27555255|NCT00390858|80218614|FG001|Overall Study|Adverse Event|2|||
27555256|NCT00390858|80218613|FG000|Overall Study|Lack of Efficacy|0|||
27555257|NCT00390858|80218614|FG001|Overall Study|Lack of Efficacy|1|||
27555258|NCT00390858|80218613|FG000|Overall Study|Withdrawal by Subject|3|||
27555259|NCT00390858|80218614|FG001|Overall Study|Withdrawal by Subject|4|||
27555260|NCT01366521|80218615|FG000|Overall Study|Adverse Event|1|||
27555261|NCT01366521|80218616|FG001|Overall Study|Adverse Event|0|||
27555262|NCT01366521|80218617|FG002|Overall Study|Adverse Event|0|||
27555263|NCT01366521|80218618|FG003|Overall Study|Adverse Event|0|||
27555264|NCT01366521|80218615|FG000|Overall Study|Protocol Violation|0|||
27555265|NCT01366521|80218616|FG001|Overall Study|Protocol Violation|0|||
27555266|NCT01366521|80218617|FG002|Overall Study|Protocol Violation|1|||
27555267|NCT01366521|80218618|FG003|Overall Study|Protocol Violation|0|||
27555268|NCT01366521|80218615|FG000|Overall Study|Physician Decision|0|||
27555269|NCT01366521|80218616|FG001|Overall Study|Physician Decision|0|||
27555270|NCT01366521|80218617|FG002|Overall Study|Physician Decision|1|||
27555271|NCT01366521|80218618|FG003|Overall Study|Physician Decision|0|||
27555272|NCT01366521|80218615|FG000|Overall Study|Withdrawal by Subject|0|||
27555273|NCT01366521|80218616|FG001|Overall Study|Withdrawal by Subject|1|||
27555274|NCT01366521|80218617|FG002|Overall Study|Withdrawal by Subject|0|||
27555275|NCT01366521|80218618|FG003|Overall Study|Withdrawal by Subject|0|||
27555276|NCT02999854|80218622|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
27555277|NCT02999854|80218623|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
27555278|NCT02999854|80218622|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
27555279|NCT02999854|80218623|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
27555280|NCT02999854|80218622|FG000|Active Study Phase (up to 18 Months)|Death|7|||
27555281|NCT02999854|80218623|FG001|Active Study Phase (up to 18 Months)|Death|5|||
27555282|NCT02999854|80218622|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
27555283|NCT02999854|80218623|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
27555284|NCT02999854|80218622|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
27555285|NCT02999854|80218623|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
27555286|NCT02999854|80218622|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
27555287|NCT02999854|80218623|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
27555288|NCT02999854|80218622|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
27555289|NCT02999854|80218623|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
27555290|NCT02999854|80218622|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
27555291|NCT02999854|80218623|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
27555292|NCT00877383|80218624|FG000|Overall Study|Adverse Event|13|||
27555293|NCT00877383|80218625|FG001|Overall Study|Adverse Event|14|||
27555294|NCT00877383|80218624|FG000|Overall Study|Lost to Follow-up|5|||
27555295|NCT00877383|80218625|FG001|Overall Study|Lost to Follow-up|3|||
27883915|NCT01455597|81408091|FG001|Overall Study|Withdrew Consent|5|||
27555296|NCT00877383|80218624|FG000|Overall Study|Subject withdrew consent|3|||
27555297|NCT00877383|80218625|FG001|Overall Study|Subject withdrew consent|12|||
27555298|NCT00877383|80218624|FG000|Overall Study|Subject no longer requires study drug|2|||
27555299|NCT00877383|80218625|FG001|Overall Study|Subject no longer requires study drug|0|||
27555300|NCT00877383|80218624|FG000|Overall Study|Administrative problems|2|||
27555301|NCT00877383|80218625|FG001|Overall Study|Administrative problems|0|||
27555302|NCT00877383|80218624|FG000|Overall Study|Protocol deviation|2|||
27555303|NCT00877383|80218625|FG001|Overall Study|Protocol deviation|6|||
27555304|NCT00877383|80218624|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27555305|NCT00877383|80218625|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27555306|NCT00877383|80218624|FG000|Overall Study|Death|1|||
27555307|NCT00877383|80218625|FG001|Overall Study|Death|2|||
27555308|NCT02825992|80218626|FG000|Overall Study|Withdrawal by Subject|4|||
27555309|NCT02825992|80218626|FG000|Overall Study|Lost to Follow-up|2|||
27883916|NCT01455597|81408092|FG002|Overall Study|Withdrew Consent|8|||
27883917|NCT01455597|81408093|FG003|Overall Study|Withdrew Consent|5|||
27555310|NCT02825992|80218626|FG000|Overall Study|Procedure terminated|2|||
27555311|NCT00137046|80218627|FG000|Overall Study|Death|2|||
27555312|NCT00137046|80218628|FG001|Overall Study|Death|1|||
27555313|NCT00137046|80218627|FG000|Overall Study|Adverse Event|16|||
27555314|NCT00137046|80218628|FG001|Overall Study|Adverse Event|5|||
27826256|NCT00934050|81195309|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27826257|NCT00934050|81195310|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27555315|NCT00137046|80218627|FG000|Overall Study|Laboratory Abnormality|2|||
27555316|NCT00137046|80218628|FG001|Overall Study|Laboratory Abnormality|0|||
27555317|NCT00137046|80218627|FG000|Overall Study|Lack of Efficacy|13|||
27555318|NCT00137046|80218628|FG001|Overall Study|Lack of Efficacy|1|||
27555319|NCT00137046|80218627|FG000|Overall Study|Lost to Follow-up|8|||
27826258|NCT00934050|81195311|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27826259|NCT00934050|81195312|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
27826260|NCT00934050|81195313|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
27826261|NCT00934050|81195308|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27826262|NCT00934050|81195309|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27826263|NCT00934050|81195310|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27826264|NCT00934050|81195311|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
27826265|NCT00934050|81195312|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
27826266|NCT00934050|81195313|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
27826267|NCT03173547|81195314|FG000|Overall Study|Adverse Event|2|||
27826268|NCT03173547|81195315|FG001|Overall Study|Adverse Event|0|||
27826269|NCT03173547|81195314|FG000|Overall Study|Withdrawal by Subject|2|||
27826270|NCT03173547|81195315|FG001|Overall Study|Withdrawal by Subject|2|||
27826271|NCT02453386|81195316|FG000|Overall Study|Adverse Event|22|||
27826272|NCT02453386|81195317|FG001|Overall Study|Adverse Event|30|||
27826273|NCT02453386|81195318|FG002|Overall Study|Adverse Event|15|||
27826274|NCT02453386|81195316|FG000|Overall Study|Protocol Violation|1|||
27826275|NCT02453386|81195317|FG001|Overall Study|Protocol Violation|0|||
27826276|NCT02453386|81195318|FG002|Overall Study|Protocol Violation|1|||
27826277|NCT02453386|81195316|FG000|Overall Study|Withdrawal by Subject|10|||
27826278|NCT02453386|81195317|FG001|Overall Study|Withdrawal by Subject|9|||
27826279|NCT02453386|81195318|FG002|Overall Study|Withdrawal by Subject|9|||
27826280|NCT02453386|81195316|FG000|Overall Study|Sponsor Terminated Study|14|||
27826281|NCT02453386|81195317|FG001|Overall Study|Sponsor Terminated Study|8|||
27826282|NCT02453386|81195318|FG002|Overall Study|Sponsor Terminated Study|11|||
27826283|NCT02453386|81195316|FG000|Overall Study|Subject Terminated by Sponsor|1|||
27555320|NCT00137046|80218628|FG001|Overall Study|Lost to Follow-up|24|||
27555321|NCT00137046|80218627|FG000|Overall Study|Other|23|||
27826284|NCT02453386|81195317|FG001|Overall Study|Subject Terminated by Sponsor|1|||
27826285|NCT02453386|81195318|FG002|Overall Study|Subject Terminated by Sponsor|1|||
27555322|NCT00137046|80218628|FG001|Overall Study|Other|19|||
27555323|NCT00137046|80218627|FG000|Overall Study|Withdrawal by Subject|33|||
27826286|NCT02453386|81195316|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
27826287|NCT02453386|81195317|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
27826288|NCT02453386|81195318|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
27826289|NCT02453386|81195316|FG000|Overall Study|Lost to Follow-up|0|||
27826290|NCT02453386|81195317|FG001|Overall Study|Lost to Follow-up|0|||
27826291|NCT02453386|81195318|FG002|Overall Study|Lost to Follow-up|1|||
27826292|NCT02453386|81195316|FG000|Overall Study|Other|1|||
27826293|NCT02453386|81195317|FG001|Overall Study|Other|0|||
27826294|NCT02453386|81195318|FG002|Overall Study|Other|1|||
27826295|NCT03663179|81195320|FG000|Overall Study|Withdrawal by Subject|2|||
27826296|NCT03663179|81195321|FG001|Overall Study|Withdrawal by Subject|0|||
27826297|NCT03663179|81195320|FG000|Overall Study|Lost to Follow-up|1|||
27826298|NCT03663179|81195321|FG001|Overall Study|Lost to Follow-up|1|||
27826299|NCT03663179|81195320|FG000|Overall Study|Revealed exclusionary condition|1|||
27555324|NCT00137046|80218628|FG001|Overall Study|Withdrawal by Subject|42|||
27555325|NCT00137046|80218627|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
27555326|NCT00137046|80218628|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
27555327|NCT00137046|80218627|FG000|Overall Study|Withdrew prior to study treatment|1|||
27555328|NCT00137046|80218628|FG001|Overall Study|Withdrew prior to study treatment|1|||
27555329|NCT01585194|80218638|FG000|Overall Study|Withdrawal by Subject|1|||
27555330|NCT01585194|80218638|FG000|Overall Study|Physician Decision|2|||
27555331|NCT01585194|80218638|FG000|Overall Study|Lack of insurance|1|||
27555332|NCT00885105|80218639|FG000|Overall Study|Withdrawal by Subject|0|||
27555333|NCT00885105|80218640|FG001|Overall Study|Withdrawal by Subject|8|||
27555334|NCT00885105|80218639|FG000|Overall Study|Adverse Event|1|||
27555335|NCT00885105|80218640|FG001|Overall Study|Adverse Event|0|||
27555336|NCT00885105|80218639|FG000|Overall Study|Protocol Violation|0|||
27555337|NCT00885105|80218640|FG001|Overall Study|Protocol Violation|2|||
27555338|NCT00617773|80218641|FG000|Overall Study|Physician Decision|1|||
27555339|NCT00617773|80218641|FG000|Overall Study|Lack of compliance with the protocol|1|||
27555340|NCT00617773|80218641|FG000|Overall Study|Withdrawal by Subject|1|||
27555341|NCT00617773|80218641|FG000|Overall Study|Death|1|||
27555342|NCT00617773|80218641|FG000|Overall Study|Progressive disease|19|||
27555343|NCT00617773|80218641|FG000|Overall Study|Protocol Violation|1|||
27555344|NCT03406104|80218642|FG000|Overall Study|Lost to Follow-up|2|||
27555345|NCT03406104|80218642|FG000|Overall Study|Withdrawal by Subject|2|||
27555346|NCT03406104|80218642|FG000|Overall Study|due to Covid patient did not want to travel|1|||
27555347|NCT03406104|80218642|FG000|Overall Study|Death|2|||
27555348|NCT01806545|80218643|FG000|Overall Study|Adverse Event|2|||
27555349|NCT01806545|80218644|FG001|Overall Study|Adverse Event|3|||
27555350|NCT01806545|80218643|FG000|Overall Study|Lost to Follow-up|1|||
27555351|NCT01806545|80218644|FG001|Overall Study|Lost to Follow-up|0|||
27555352|NCT01806545|80218643|FG000|Overall Study|Withdrawal by Subject|3|||
27555353|NCT01806545|80218644|FG001|Overall Study|Withdrawal by Subject|2|||
27555354|NCT00450450|80218646|FG000|Overall Study|Death|1|||
27555355|NCT00450450|80218647|FG001|Overall Study|Death|3|||
27555356|NCT00450450|80218646|FG000|Overall Study|Relapse|2|||
27555357|NCT00450450|80218647|FG001|Overall Study|Relapse|0|||
27555358|NCT00450450|80218646|FG000|Overall Study|Missing Data|2|||
27555359|NCT00450450|80218647|FG001|Overall Study|Missing Data|0|||
27555360|NCT00464087|80218648|FG000|Overall Study|No PCI per inclusion criteria|0|||
27555361|NCT00464087|80218649|FG001|Overall Study|No PCI per inclusion criteria|0|||
27555362|NCT00464087|80218650|FG002|Overall Study|No PCI per inclusion criteria|29|||
27555363|NCT01829230|80218651|FG000|Overall Study|Protocol Violation|0|||
27555364|NCT01829230|80218652|FG001|Overall Study|Protocol Violation|2|||
27555365|NCT01829230|80218651|FG000|Overall Study|Withdrawal by Subject|0|||
27555366|NCT01829230|80218652|FG001|Overall Study|Withdrawal by Subject|1|||
27555367|NCT01829230|80218651|FG000|Overall Study|Lost to Follow-up|1|||
27555368|NCT01829230|80218652|FG001|Overall Study|Lost to Follow-up|1|||
27555369|NCT02196558|80218657|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
27555370|NCT02196558|80218658|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
27555371|NCT02196558|80218659|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
27555372|NCT02196558|80218657|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
27555373|NCT02196558|80218658|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
27555374|NCT02196558|80218659|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
27555375|NCT02196558|80218657|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
27555376|NCT02196558|80218658|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
27555377|NCT02196558|80218659|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
27555378|NCT02196558|80218657|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
27555379|NCT02196558|80218658|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
27555380|NCT02196558|80218659|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
27555381|NCT02196558|80218657|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
27826300|NCT03663179|81195321|FG001|Overall Study|Revealed exclusionary condition|0|||
27826301|NCT03098394|81195326|FG000|Overall Study|Pregnancy|0|||
27826302|NCT03098394|81195327|FG001|Overall Study|Pregnancy|1|||
27826303|NCT02563561|81195328|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
27555382|NCT02196558|80218658|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
27555383|NCT02196558|80218659|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
27555384|NCT01601626|80218660|FG000|Overall Study|Death|1|||
27555385|NCT01601626|80218661|FG001|Overall Study|Death|1|||
27555386|NCT01601626|80218662|FG002|Overall Study|Death|1|||
27555387|NCT01601626|80218660|FG000|Overall Study|Lost to Follow-up|1|||
27555388|NCT01601626|80218661|FG001|Overall Study|Lost to Follow-up|2|||
27555389|NCT01601626|80218662|FG002|Overall Study|Lost to Follow-up|0|||
27555390|NCT01601626|80218660|FG000|Overall Study|Unable to Get to Clinic|0|||
27555391|NCT01601626|80218661|FG001|Overall Study|Unable to Get to Clinic|1|||
27555392|NCT01601626|80218662|FG002|Overall Study|Unable to Get to Clinic|0|||
27555393|NCT01601626|80218660|FG000|Overall Study|Withdrawal by Subject|0|||
27555394|NCT01601626|80218661|FG001|Overall Study|Withdrawal by Subject|1|||
27555395|NCT01601626|80218662|FG002|Overall Study|Withdrawal by Subject|1|||
27555396|NCT01601626|80218660|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
27555397|NCT01601626|80218661|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
27555398|NCT01601626|80218662|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
27555399|NCT03655691|80218663|FG000|Overall Study|Adverse Event|0|||
27555400|NCT03655691|80218664|FG001|Overall Study|Adverse Event|0|||
27555401|NCT03655691|80218665|FG002|Overall Study|Adverse Event|1|||
27555402|NCT03655691|80218663|FG000|Overall Study|Lost to Follow-up|1|||
27555403|NCT03655691|80218664|FG001|Overall Study|Lost to Follow-up|1|||
27555404|NCT03655691|80218665|FG002|Overall Study|Lost to Follow-up|2|||
27555405|NCT03655691|80218663|FG000|Overall Study|Protocol Violation|0|||
27555406|NCT03655691|80218664|FG001|Overall Study|Protocol Violation|1|||
27555407|NCT03655691|80218665|FG002|Overall Study|Protocol Violation|0|||
27555408|NCT03655691|80218663|FG000|Overall Study|Withdrawal by Subject|1|||
27555409|NCT03655691|80218664|FG001|Overall Study|Withdrawal by Subject|1|||
27555410|NCT03655691|80218665|FG002|Overall Study|Withdrawal by Subject|0|||
27555411|NCT00540514|80218667|FG000|Overall Study|Still on treatment|3|||
27555412|NCT00540514|80218668|FG001|Overall Study|Still on treatment|0|||
27555413|NCT00540514|80218667|FG000|Overall Study|Unacceptable Toxicity|61|||
27555414|NCT00540514|80218668|FG001|Overall Study|Unacceptable Toxicity|62|||
27555415|NCT00540514|80218667|FG000|Overall Study|Adverse Event|20|||
27555416|NCT00540514|80218668|FG001|Overall Study|Adverse Event|24|||
27555417|NCT00540514|80218667|FG000|Overall Study|Physician Decision|86|||
27555418|NCT00540514|80218668|FG001|Overall Study|Physician Decision|99|||
27555419|NCT00540514|80218667|FG000|Overall Study|Protocol Deviation|3|||
27555420|NCT00540514|80218668|FG001|Overall Study|Protocol Deviation|4|||
27555421|NCT00540514|80218667|FG000|Overall Study|Lost to Follow-up|1|||
27555422|NCT00540514|80218668|FG001|Overall Study|Lost to Follow-up|1|||
27555423|NCT00540514|80218667|FG000|Overall Study|Withdrawal by Subject|65|||
27555424|NCT00540514|80218668|FG001|Overall Study|Withdrawal by Subject|67|||
27555425|NCT00540514|80218667|FG000|Overall Study|Excluded prior to treatment|7|||
27555426|NCT00540514|80218668|FG001|Overall Study|Excluded prior to treatment|7|||
27555427|NCT00540514|80218667|FG000|Overall Study|Paclitaxel not available|0|||
27555428|NCT00540514|80218668|FG001|Overall Study|Paclitaxel not available|2|||
27555429|NCT01438957|80218671|FG000|Overall Study|Physician Decision|1|||
27555430|NCT01438957|80218672|FG001|Overall Study|Physician Decision|1|||
27555431|NCT01438957|80218673|FG002|Overall Study|Physician Decision|0|||
27826304|NCT02563561|81195329|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
27826305|NCT02563561|81195330|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
27826306|NCT02563561|81195328|FG000|Overall Study|Withdrew of Consent|1|||
27826307|NCT02563561|81195329|FG001|Overall Study|Withdrew of Consent|1|||
27826308|NCT02563561|81195330|FG002|Overall Study|Withdrew of Consent|2|||
27826309|NCT02563561|81195328|FG000|Overall Study|Lost to Follow-up|1|||
27826310|NCT02563561|81195329|FG001|Overall Study|Lost to Follow-up|1|||
27826311|NCT02563561|81195330|FG002|Overall Study|Lost to Follow-up|0|||
27826312|NCT02563561|81195328|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
27826313|NCT02563561|81195329|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
27826314|NCT02563561|81195330|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
27826315|NCT02563561|81195328|FG000|Overall Study|Investigator Decision|3|||
27826316|NCT02563561|81195329|FG001|Overall Study|Investigator Decision|4|||
27826317|NCT02563561|81195330|FG002|Overall Study|Investigator Decision|2|||
27555432|NCT01438957|80218674|FG003|Overall Study|Physician Decision|1|||
27555433|NCT01438957|80218675|FG004|Overall Study|Physician Decision|0|||
27555434|NCT04059094|80218676|FG000|Overall Study|Adverse Event|0|||
27555435|NCT04059094|80218677|FG001|Overall Study|Adverse Event|0|||
27555436|NCT04059094|80218678|FG002|Overall Study|Adverse Event|0|||
27555437|NCT04059094|80218679|FG003|Overall Study|Adverse Event|0|||
27555438|NCT04059094|80218680|FG004|Overall Study|Adverse Event|1|||
27883918|NCT01455597|81408090|FG000|Overall Study|Reason not Specified|1|||
27555439|NCT04059094|80218676|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
27555440|NCT04059094|80218677|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
27555441|NCT04059094|80218678|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
27826318|NCT02563561|81195328|FG000|Overall Study|Sponsor Decision|5|||
27555442|NCT04059094|80218679|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
27555443|NCT04059094|80218680|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
27555444|NCT00477971|80218681|FG000|Overall Study|Disease progression|6|||
27555445|NCT00477971|80218682|FG001|Overall Study|Disease progression|0|||
27555446|NCT00477971|80218681|FG000|Overall Study|Withdrawal by Subject|3|||
27555447|NCT00477971|80218682|FG001|Overall Study|Withdrawal by Subject|1|||
27555448|NCT00477971|80218681|FG000|Overall Study|Adverse Event|3|||
27555449|NCT00477971|80218682|FG001|Overall Study|Adverse Event|0|||
27555450|NCT00477971|80218681|FG000|Overall Study|Death|2|||
27555451|NCT00477971|80218682|FG001|Overall Study|Death|4|||
27555452|NCT00477971|80218681|FG000|Overall Study|Alternative treatment|3|||
27555453|NCT00477971|80218682|FG001|Overall Study|Alternative treatment|1|||
27826319|NCT02563561|81195329|FG001|Overall Study|Sponsor Decision|2|||
27826320|NCT02563561|81195330|FG002|Overall Study|Sponsor Decision|4|||
27826321|NCT02563561|81195328|FG000|Overall Study|Other|1|||
27826322|NCT02563561|81195329|FG001|Overall Study|Other|5|||
27826323|NCT02563561|81195330|FG002|Overall Study|Other|2|||
27826324|NCT03104374|81195331|FG000|Overall Study|Adverse Event|7|||
27826325|NCT03104374|81195332|FG001|Overall Study|Adverse Event|6|||
27826326|NCT03104374|81195333|FG002|Overall Study|Adverse Event|12|||
27826327|NCT03104374|81195334|FG003|Overall Study|Adverse Event|15|||
27826328|NCT03104374|81195331|FG000|Overall Study|Withdrawal by Subject|18|||
27826329|NCT03104374|81195332|FG001|Overall Study|Withdrawal by Subject|10|||
27826330|NCT03104374|81195333|FG002|Overall Study|Withdrawal by Subject|10|||
27826331|NCT03104374|81195334|FG003|Overall Study|Withdrawal by Subject|17|||
27826332|NCT03104374|81195331|FG000|Overall Study|Lost to Follow-up|4|||
27826333|NCT03104374|81195332|FG001|Overall Study|Lost to Follow-up|4|||
27826334|NCT03104374|81195333|FG002|Overall Study|Lost to Follow-up|6|||
27826335|NCT03104374|81195334|FG003|Overall Study|Lost to Follow-up|8|||
27826336|NCT03104374|81195331|FG000|Overall Study|Lack of Efficacy|6|||
27826337|NCT03104374|81195332|FG001|Overall Study|Lack of Efficacy|7|||
27826338|NCT03104374|81195333|FG002|Overall Study|Lack of Efficacy|12|||
27826339|NCT03104374|81195334|FG003|Overall Study|Lack of Efficacy|6|||
27826340|NCT03104374|81195331|FG000|Overall Study|Other|2|||
27826341|NCT03104374|81195332|FG001|Overall Study|Other|2|||
27826342|NCT03104374|81195333|FG002|Overall Study|Other|4|||
27826343|NCT03104374|81195334|FG003|Overall Study|Other|7|||
27826344|NCT02301975|81195335|FG000|Overall Study|Adverse Event|8|||
27826345|NCT02301975|81195336|FG001|Overall Study|Adverse Event|3|||
27826346|NCT02301975|81195337|FG002|Overall Study|Adverse Event|2|||
27826347|NCT02301975|81195335|FG000|Overall Study|Lack of Efficacy|1|||
27826348|NCT02301975|81195336|FG001|Overall Study|Lack of Efficacy|1|||
27826349|NCT02301975|81195337|FG002|Overall Study|Lack of Efficacy|1|||
27826350|NCT02301975|81195335|FG000|Overall Study|Protocol Violation|3|||
27826351|NCT02301975|81195336|FG001|Overall Study|Protocol Violation|5|||
27826352|NCT02301975|81195337|FG002|Overall Study|Protocol Violation|3|||
27826353|NCT02301975|81195335|FG000|Overall Study|Lost to Follow-up|0|||
27826354|NCT02301975|81195336|FG001|Overall Study|Lost to Follow-up|2|||
27826355|NCT02301975|81195337|FG002|Overall Study|Lost to Follow-up|2|||
27826356|NCT02301975|81195335|FG000|Overall Study|Physician Decision|4|||
27826357|NCT02301975|81195336|FG001|Overall Study|Physician Decision|2|||
27826358|NCT02301975|81195337|FG002|Overall Study|Physician Decision|3|||
27826359|NCT02301975|81195335|FG000|Overall Study|Withdrawal by Subject|15|||
27826360|NCT02301975|81195336|FG001|Overall Study|Withdrawal by Subject|12|||
27826361|NCT02301975|81195337|FG002|Overall Study|Withdrawal by Subject|11|||
27826362|NCT03128723|81195338|FG000|Overall Study|Withdrawal by Subject|2|||
27826363|NCT00436163|81195341|FG000|Overall Study|Lost to Follow-up|2|||
27826364|NCT00436163|81195341|FG000|Overall Study|Adverse Event|1|||
27826365|NCT00448591|81195342|FG000|Overall Study|Withdrawal by Subject|178|||
27826366|NCT00448591|81195342|FG000|Overall Study|Progressive Disease|1382|||
27826367|NCT00448591|81195342|FG000|Overall Study|Adverse Event|382|||
27826368|NCT00448591|81195342|FG000|Overall Study|Protocol Violation|41|||
27826369|NCT00448591|81195342|FG000|Overall Study|Lost to Follow-up|19|||
27555454|NCT01411228|80218683|FG000|Overall Study|Lost to Follow-up|0|||
27826370|NCT00448591|81195342|FG000|Overall Study|Treatment Regimen Completed|70|||
27826371|NCT00448591|81195342|FG000|Overall Study|Other|154|||
27555455|NCT01411228|80218684|FG001|Overall Study|Lost to Follow-up|0|||
27826372|NCT00448591|81195342|FG000|Overall Study|Termination of Study|70|||
27826373|NCT02880761|81195343|FG000|Overall Study|Death|6|||
27555456|NCT01411228|80218685|FG002|Overall Study|Lost to Follow-up|1|||
27555457|NCT01411228|80218683|FG000|Overall Study|Withdrawal by Subject|1|||
27555458|NCT01411228|80218684|FG001|Overall Study|Withdrawal by Subject|0|||
27826374|NCT02880761|81195344|FG001|Overall Study|Death|8|||
27826375|NCT02880761|81195343|FG000|Overall Study|Withdrawal by Subject|3|||
27826376|NCT02880761|81195344|FG001|Overall Study|Withdrawal by Subject|6|||
27826377|NCT02880761|81195343|FG000|Overall Study|Protocol Violation|4|||
27826378|NCT02880761|81195344|FG001|Overall Study|Protocol Violation|3|||
27826379|NCT02880761|81195343|FG000|Overall Study|Lost to Follow-up|3|||
27826380|NCT02880761|81195344|FG001|Overall Study|Lost to Follow-up|4|||
27826381|NCT00834522|81195345|FG000|Washout|Adverse Event|1|||
27826382|NCT00834522|81195346|FG001|Washout|Adverse Event|0|||
27826383|NCT00834522|81195345|FG000|Washout|Withdrawal by Subject|2|||
27555459|NCT01411228|80218685|FG002|Overall Study|Withdrawal by Subject|0|||
27555460|NCT03559257|80218686|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
27555461|NCT03559257|80218687|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
27555462|NCT03559257|80218686|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27555463|NCT03559257|80218687|FG001|Double Blind Treatment Period|Protocol Violation|4|||
27555464|NCT03559257|80218686|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
27555465|NCT03559257|80218687|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
27555466|NCT03559257|80218686|FG000|Double Blind Treatment Period|Adverse Event|0|||
27555467|NCT03559257|80218687|FG001|Double Blind Treatment Period|Adverse Event|1|||
27555468|NCT03559257|80218686|FG000|Double Blind Treatment Period|Screen Failure|0|||
27555469|NCT03559257|80218687|FG001|Double Blind Treatment Period|Screen Failure|1|||
27555470|NCT03559257|80218686|FG000|Open-label Treatment Period|Adverse Event|1|||
27555471|NCT03559257|80218687|FG001|Open-label Treatment Period|Adverse Event|4|||
27555472|NCT03559257|80218686|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
27555473|NCT03559257|80218687|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
27555474|NCT03559257|80218686|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
27555475|NCT03559257|80218687|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27555476|NCT03559257|80218686|FG000|Open-label Treatment Period|Protocol Violation|2|||
27555477|NCT03559257|80218687|FG001|Open-label Treatment Period|Protocol Violation|0|||
27555478|NCT03559257|80218686|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
27555479|NCT03559257|80218687|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
27555480|NCT03559257|80218686|FG000|Open-label Treatment Period|Physician Decision|0|||
27555481|NCT03559257|80218687|FG001|Open-label Treatment Period|Physician Decision|1|||
27555482|NCT01134783|80218688|FG000|Overall Study|Pregnancy|16|||
27555483|NCT01134783|80218689|FG001|Overall Study|Pregnancy|8|||
27826384|NCT00834522|81195346|FG001|Washout|Withdrawal by Subject|1|||
27555484|NCT01134783|80218688|FG000|Overall Study|Withdrawal by Subject|15|||
27555485|NCT01134783|80218689|FG001|Overall Study|Withdrawal by Subject|9|||
27555486|NCT01134783|80218688|FG000|Overall Study|Lost to Follow-up|5|||
27555487|NCT01134783|80218689|FG001|Overall Study|Lost to Follow-up|20|||
27826385|NCT00850174|81195347|FG000|Washout: One Week|Withdrawal by Subject|0|||
27826386|NCT00850174|81195348|FG001|Washout: One Week|Withdrawal by Subject|2|||
27826387|NCT00850174|81195347|FG000|Second Intervention|Withdrawal by Subject|1|||
27826388|NCT00850174|81195348|FG001|Second Intervention|Withdrawal by Subject|0|||
27826389|NCT01139047|81195352|FG000|Overall Study|Withdrawal by Subject|1|||
27826390|NCT00549718|81195355|FG000|Overall Study|Insufficient clinical response|20|||
27826391|NCT00549718|81195356|FG001|Overall Study|Insufficient clinical response|7|||
27826392|NCT00549718|81195357|FG002|Overall Study|Insufficient clinical response|18|||
27826393|NCT00549718|81195358|FG003|Overall Study|Insufficient clinical response|32|||
27826394|NCT00549718|81195355|FG000|Overall Study|Adverse Event|6|||
27826395|NCT00549718|81195356|FG001|Overall Study|Adverse Event|8|||
27826396|NCT00549718|81195357|FG002|Overall Study|Adverse Event|7|||
27826397|NCT00549718|81195358|FG003|Overall Study|Adverse Event|3|||
27826398|NCT00549718|81195355|FG000|Overall Study|Lost to Follow-up|4|||
27826399|NCT00549718|81195356|FG001|Overall Study|Lost to Follow-up|2|||
27826400|NCT00549718|81195357|FG002|Overall Study|Lost to Follow-up|0|||
27826401|NCT00549718|81195358|FG003|Overall Study|Lost to Follow-up|6|||
27826402|NCT00549718|81195355|FG000|Overall Study|Withdrawal by Subject|9|||
27826403|NCT00549718|81195356|FG001|Overall Study|Withdrawal by Subject|18|||
27826404|NCT00549718|81195357|FG002|Overall Study|Withdrawal by Subject|12|||
27826405|NCT00549718|81195358|FG003|Overall Study|Withdrawal by Subject|13|||
27826406|NCT00549718|81195355|FG000|Overall Study|Administrative|2|||
27826407|NCT00549718|81195356|FG001|Overall Study|Administrative|2|||
27826408|NCT00549718|81195357|FG002|Overall Study|Administrative|2|||
27826409|NCT00549718|81195358|FG003|Overall Study|Administrative|1|||
27826410|NCT01513174|81195364|FG000|Overall Study|Inclusion Error|1|||
27826411|NCT01513174|81195365|FG001|Overall Study|Inclusion Error|7|||
27826412|NCT01513174|81195364|FG000|Overall Study|Not receive study treatment|3|||
27826413|NCT01513174|81195365|FG001|Overall Study|Not receive study treatment|1|||
27826414|NCT02601560|81195370|FG000|Overall Study|Other|0|||
27826415|NCT02601560|81195371|FG001|Overall Study|Other|0|||
27826416|NCT02601560|81195372|FG002|Overall Study|Other|0|||
27826417|NCT02601560|81195373|FG003|Overall Study|Other|0|||
27826418|NCT02601560|81195374|FG004|Overall Study|Other|0|||
27826419|NCT02601560|81195375|FG005|Overall Study|Other|0|||
27826420|NCT02601560|81195376|FG006|Overall Study|Other|1|||
27826421|NCT02601560|81195377|FG007|Overall Study|Other|0|||
27826422|NCT02412852|81195380|FG000|Overall Study|Withdrawal by Subject|0|||
27826423|NCT02412852|81195381|FG001|Overall Study|Withdrawal by Subject|1|||
27826424|NCT02412852|81195382|FG002|Overall Study|Withdrawal by Subject|0|||
27826425|NCT02412852|81195383|FG003|Overall Study|Withdrawal by Subject|0|||
27826426|NCT02412852|81195380|FG000|Overall Study|Physician Decision|0|||
27826427|NCT02412852|81195381|FG001|Overall Study|Physician Decision|0|||
27555488|NCT00003479|80218690|FG000|Overall Study|Not evaluable|3|||
27555489|NCT02961751|80218691|FG000|Overall Study|Lost to Follow-up|11|||
27555490|NCT02961751|80218691|FG000|Overall Study|Physician Decision|2|||
27555491|NCT02961751|80218691|FG000|Overall Study|Not Eligible at Enrollment|1|||
27555492|NCT02961751|80218691|FG000|Overall Study|Protocol Violation|1|||
27555493|NCT02425046|80218695|FG000|Overall Study|Lost to Follow-up|52|||
27555494|NCT02425046|80218696|FG001|Overall Study|Lost to Follow-up|50|||
27555495|NCT02425046|80218697|FG002|Overall Study|Lost to Follow-up|56|||
27826428|NCT02412852|81195382|FG002|Overall Study|Physician Decision|0|||
27826429|NCT02412852|81195383|FG003|Overall Study|Physician Decision|1|||
27826430|NCT02514122|81195384|FG000|Overall Study|Withdrawal by Subject|2|||
27555496|NCT02425046|80218695|FG000|Overall Study|Withdrawal by Subject|16|||
27555497|NCT02425046|80218696|FG001|Overall Study|Withdrawal by Subject|12|||
27826431|NCT02514122|81195385|FG001|Overall Study|Withdrawal by Subject|0|||
27826432|NCT00112463|81195390|FG000|Overall Study|Physician Decision|1|||
27826433|NCT00112463|81195390|FG000|Overall Study|Progression|30|||
27826434|NCT00112463|81195390|FG000|Overall Study|Second Primary|1|||
27826435|NCT00112463|81195390|FG000|Overall Study|Toxicity|3|||
27826436|NCT00112463|81195390|FG000|Overall Study|Withdrawal by Subject|2|||
27826437|NCT00112463|81195390|FG000|Overall Study|Never started treatment|2|||
27826438|NCT02659150|81195393|FG000|Subject Enrollment|Physician Decision|3|||
27826439|NCT02659150|81195393|FG000|Subject Enrollment|Withdrawal by Subject|2|||
27826440|NCT02659150|81195393|FG000|Baseline Imaging|Withdrawal by Subject|1|||
27826441|NCT02659150|81195393|FG000|Baseline Imaging|Physician Decision|1|||
27826442|NCT02659150|81195393|FG000|Study Drug Dosing|Adverse Event|1|||
27826443|NCT01348789|81195394|FG000|Overall Study|Protocol Violation|2|||
27826444|NCT01348789|81195394|FG000|Overall Study|Withdrawal by Subject|2|||
27826445|NCT03351244|81195395|FG000|Overall Study|Adverse Event|7|||
27826446|NCT03351244|81195396|FG001|Overall Study|Adverse Event|11|||
27826447|NCT03351244|81195397|FG002|Overall Study|Adverse Event|12|||
27826448|NCT03351244|81195395|FG000|Overall Study|Investigator's decision|0|||
27826449|NCT03351244|81195396|FG001|Overall Study|Investigator's decision|0|||
27826450|NCT03351244|81195397|FG002|Overall Study|Investigator's decision|2|||
27826451|NCT03351244|81195395|FG000|Overall Study|System error|0|||
27826452|NCT03351244|81195396|FG001|Overall Study|System error|0|||
27826453|NCT03351244|81195397|FG002|Overall Study|System error|2|||
27826454|NCT03351244|81195395|FG000|Overall Study|COVID-19 restrictions|3|||
27826455|NCT03351244|81195396|FG001|Overall Study|COVID-19 restrictions|0|||
27826456|NCT03351244|81195397|FG002|Overall Study|COVID-19 restrictions|1|||
27826457|NCT03351244|81195395|FG000|Overall Study|Non-compliance|2|||
27826458|NCT03351244|81195396|FG001|Overall Study|Non-compliance|5|||
27826459|NCT03351244|81195397|FG002|Overall Study|Non-compliance|0|||
27826460|NCT03351244|81195395|FG000|Overall Study|Withdrawal by Subject|11|||
27826461|NCT03351244|81195396|FG001|Overall Study|Withdrawal by Subject|16|||
27826462|NCT03351244|81195397|FG002|Overall Study|Withdrawal by Subject|13|||
27826463|NCT03351244|81195395|FG000|Overall Study|Lost to Follow-up|2|||
27826464|NCT03351244|81195396|FG001|Overall Study|Lost to Follow-up|6|||
27826465|NCT03351244|81195397|FG002|Overall Study|Lost to Follow-up|4|||
27826466|NCT03351244|81195395|FG000|Overall Study|Protocol Violation|2|||
27826467|NCT03351244|81195396|FG001|Overall Study|Protocol Violation|2|||
27826468|NCT03351244|81195397|FG002|Overall Study|Protocol Violation|0|||
27826469|NCT01313780|81195398|FG000|Overall Study|Lack of Efficacy|4|||
27826470|NCT01313780|81195399|FG001|Overall Study|Lack of Efficacy|2|||
27826471|NCT01313780|81195398|FG000|Overall Study|Adverse Event|6|||
27826472|NCT01313780|81195399|FG001|Overall Study|Adverse Event|11|||
27826473|NCT01313780|81195398|FG000|Overall Study|Withdrawal by Subject|2|||
27826474|NCT01313780|81195399|FG001|Overall Study|Withdrawal by Subject|8|||
27826475|NCT01313780|81195398|FG000|Overall Study|Protocol Violation|10|||
27826476|NCT01313780|81195399|FG001|Overall Study|Protocol Violation|4|||
27826477|NCT01313780|81195398|FG000|Overall Study|missing data|3|||
27826478|NCT01313780|81195399|FG001|Overall Study|missing data|3|||
27826479|NCT01473953|81195403|FG000|Overall Study|Other|1|||
27826480|NCT01473953|81195404|FG001|Overall Study|Other|0|||
27826481|NCT01473953|81195405|FG002|Overall Study|Other|0|||
27826482|NCT01473953|81195406|FG003|Overall Study|Other|0|||
27826483|NCT01473953|81195407|FG004|Overall Study|Other|0|||
27826484|NCT01244620|81195410|FG000|Overall Study|Study terminated|4|||
27826485|NCT01244620|81195411|FG001|Overall Study|Study terminated|4|||
27826486|NCT01244620|81195412|FG002|Overall Study|Study terminated|4|||
27826487|NCT01244620|81195413|FG003|Overall Study|Study terminated|4|||
27826488|NCT03114891|81195415|FG000|First Treatment Round|Lost to Follow-up|0|||
27826489|NCT03114891|81195416|FG001|First Treatment Round|Lost to Follow-up|1|||
27826490|NCT03114891|81195417|FG002|First Treatment Round|Lost to Follow-up|1|||
27826491|NCT03114891|81195418|FG003|First Treatment Round|Lost to Follow-up|0|||
27826492|NCT03114891|81195415|FG000|First Treatment Round|Withdrawal by Subject|0|||
27826493|NCT03114891|81195416|FG001|First Treatment Round|Withdrawal by Subject|2|||
27826494|NCT03114891|81195417|FG002|First Treatment Round|Withdrawal by Subject|0|||
27826495|NCT03114891|81195418|FG003|First Treatment Round|Withdrawal by Subject|1|||
27826496|NCT03114891|81195415|FG000|3 Week Break|Lost to Follow-up|1|||
27826497|NCT03114891|81195416|FG001|3 Week Break|Lost to Follow-up|0|||
27826498|NCT03114891|81195417|FG002|3 Week Break|Lost to Follow-up|0|||
27826499|NCT03114891|81195418|FG003|3 Week Break|Lost to Follow-up|1|||
27826500|NCT03114891|81195415|FG000|3 Week Break|Withdrawal by Subject|0|||
27826501|NCT03114891|81195416|FG001|3 Week Break|Withdrawal by Subject|1|||
27826502|NCT03114891|81195417|FG002|3 Week Break|Withdrawal by Subject|0|||
27826503|NCT03114891|81195418|FG003|3 Week Break|Withdrawal by Subject|0|||
27826504|NCT03114891|81195415|FG000|Second Treatment Round|Lost to Follow-up|1|||
27826505|NCT03114891|81195416|FG001|Second Treatment Round|Lost to Follow-up|0|||
27826506|NCT03114891|81195417|FG002|Second Treatment Round|Lost to Follow-up|0|||
27826507|NCT03114891|81195418|FG003|Second Treatment Round|Lost to Follow-up|0|||
27826508|NCT03114891|81195415|FG000|Second Treatment Round|Physician Decision|1|||
27826509|NCT03114891|81195416|FG001|Second Treatment Round|Physician Decision|0|||
27826510|NCT03114891|81195417|FG002|Second Treatment Round|Physician Decision|0|||
27826511|NCT03114891|81195418|FG003|Second Treatment Round|Physician Decision|0|||
27826512|NCT04166630|81195419|FG000|Overall Study|Withdrawal by Subject|0|||
27826513|NCT04166630|81195420|FG001|Overall Study|Withdrawal by Subject|1|||
27826514|NCT00813592|81195421|FG000|Overall Study|Disease assessment was not completed per|2|||
27555498|NCT02425046|80218697|FG002|Overall Study|Withdrawal by Subject|0|||
27555499|NCT02485574|80222155|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
27555500|NCT00511667|80222159|FG000|Overall Study|Adverse Event|1|||
27555501|NCT00511667|80222160|FG001|Overall Study|Adverse Event|0|||
27555502|NCT00511667|80222159|FG000|Overall Study|Protocol Violation|1|||
27555503|NCT00511667|80222160|FG001|Overall Study|Protocol Violation|1|||
27555504|NCT00511667|80222159|FG000|Overall Study|Withdrawal by Subject|2|||
27555505|NCT00511667|80222160|FG001|Overall Study|Withdrawal by Subject|0|||
27555506|NCT00511667|80222159|FG000|Overall Study|Site terminated|6|||
27555507|NCT00511667|80222160|FG001|Overall Study|Site terminated|1|||
27555508|NCT00511667|80222159|FG000|Overall Study|Other|2|||
27555509|NCT00511667|80222160|FG001|Overall Study|Other|1|||
27555510|NCT02642614|80222165|FG000|Overall Study|Adverse Event|1|||
27555511|NCT02642614|80222166|FG001|Overall Study|Adverse Event|1|||
27555512|NCT02642614|80222167|FG002|Overall Study|Adverse Event|2|||
27555513|NCT02642614|80222168|FG003|Overall Study|Adverse Event|2|||
27555514|NCT02642614|80222165|FG000|Overall Study|Lost to Follow-up|1|||
27555515|NCT02642614|80222166|FG001|Overall Study|Lost to Follow-up|0|||
27555516|NCT02642614|80222167|FG002|Overall Study|Lost to Follow-up|0|||
27555517|NCT02642614|80222168|FG003|Overall Study|Lost to Follow-up|0|||
27555518|NCT02642614|80222165|FG000|Overall Study|Withdrawal by Subject|1|||
27555519|NCT02642614|80222166|FG001|Overall Study|Withdrawal by Subject|1|||
27555520|NCT02642614|80222167|FG002|Overall Study|Withdrawal by Subject|0|||
27555521|NCT02642614|80222168|FG003|Overall Study|Withdrawal by Subject|0|||
27555522|NCT03042533|80222172|FG000|Overall Study|MD left program|1|||
27555523|NCT03042533|80222173|FG001|Overall Study|MD left program|4|||
27555524|NCT03042533|80222174|FG002|Overall Study|MD left program|1|||
27555525|NCT04350788|80222175|FG000|Overall Study|Lost to Follow-up|6|||
27555526|NCT04350788|80222176|FG001|Overall Study|Lost to Follow-up|2|||
27555527|NCT04350788|80222175|FG000|Overall Study|Withdrawal by Subject|2|||
27555528|NCT04350788|80222176|FG001|Overall Study|Withdrawal by Subject|4|||
27555529|NCT04350788|80222175|FG000|Overall Study|Protocol Violation|4|||
27555530|NCT04350788|80222176|FG001|Overall Study|Protocol Violation|0|||
27555531|NCT03804879|80222178|FG000|Overall Study|Adverse Event|3|||
27555532|NCT03804879|80222179|FG001|Overall Study|Adverse Event|0|||
27555533|NCT03804879|80222178|FG000|Overall Study|Study Terminated By Sponsor|10|||
27555534|NCT03804879|80222179|FG001|Overall Study|Study Terminated By Sponsor|12|||
27555535|NCT03804879|80222178|FG000|Overall Study|Withdrawal by Subject|3|||
27555536|NCT03804879|80222179|FG001|Overall Study|Withdrawal by Subject|1|||
27555537|NCT00533845|80222182|FG000|Overall Study|Physician Decision|1|||
27555538|NCT00533845|80222183|FG001|Overall Study|Physician Decision|0|||
27555539|NCT02927080|80222184|FG000|Overall Study|Withdrawal by Subject|0|||
27555540|NCT02927080|80222185|FG001|Overall Study|Withdrawal by Subject|0|||
27555541|NCT02927080|80222186|FG002|Overall Study|Withdrawal by Subject|0|||
27555542|NCT02927080|80222187|FG003|Overall Study|Withdrawal by Subject|0|||
27555543|NCT02927080|80222188|FG004|Overall Study|Withdrawal by Subject|1|||
27555544|NCT02927080|80222189|FG005|Overall Study|Withdrawal by Subject|0|||
27555545|NCT02927080|80222190|FG006|Overall Study|Withdrawal by Subject|1|||
27555546|NCT02927080|80222191|FG007|Overall Study|Withdrawal by Subject|1|||
27555547|NCT02927080|80222192|FG008|Overall Study|Withdrawal by Subject|0|||
27555548|NCT02927080|80222193|FG009|Overall Study|Withdrawal by Subject|2|||
27555549|NCT02927080|80222184|FG000|Overall Study|Willingness to comply with protocol|0|||
27555550|NCT02927080|80222185|FG001|Overall Study|Willingness to comply with protocol|0|||
27555551|NCT02927080|80222186|FG002|Overall Study|Willingness to comply with protocol|0|||
27555552|NCT02927080|80222187|FG003|Overall Study|Willingness to comply with protocol|0|||
27555553|NCT02927080|80222188|FG004|Overall Study|Willingness to comply with protocol|0|||
27555554|NCT02927080|80222189|FG005|Overall Study|Willingness to comply with protocol|0|||
27555555|NCT02927080|80222190|FG006|Overall Study|Willingness to comply with protocol|0|||
27555556|NCT02927080|80222191|FG007|Overall Study|Willingness to comply with protocol|0|||
27555557|NCT02927080|80222192|FG008|Overall Study|Willingness to comply with protocol|0|||
27555558|NCT02927080|80222193|FG009|Overall Study|Willingness to comply with protocol|1|||
27555559|NCT02927080|80222184|FG000|Overall Study|Study terminated by Sponsor|0|||
27555560|NCT02927080|80222185|FG001|Overall Study|Study terminated by Sponsor|0|||
27555561|NCT02927080|80222186|FG002|Overall Study|Study terminated by Sponsor|0|||
27555562|NCT02927080|80222187|FG003|Overall Study|Study terminated by Sponsor|0|||
27555563|NCT02927080|80222188|FG004|Overall Study|Study terminated by Sponsor|0|||
27555564|NCT02927080|80222189|FG005|Overall Study|Study terminated by Sponsor|0|||
27555565|NCT02927080|80222190|FG006|Overall Study|Study terminated by Sponsor|6|||
27555566|NCT02927080|80222191|FG007|Overall Study|Study terminated by Sponsor|7|||
27555567|NCT02927080|80222192|FG008|Overall Study|Study terminated by Sponsor|2|||
27555568|NCT02927080|80222193|FG009|Overall Study|Study terminated by Sponsor|3|||
27555569|NCT02927080|80222184|FG000|Overall Study|Adverse Event|0|||
27555570|NCT02927080|80222185|FG001|Overall Study|Adverse Event|1|||
27555571|NCT02927080|80222186|FG002|Overall Study|Adverse Event|0|||
27694724|NCT03486457|80716798|FG001|Up to Month 3|Withdrawal by Subject|0|||
27694725|NCT03486457|80716797|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
27694726|NCT03486457|80716798|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
27694727|NCT03486457|80716797|FG000|Up to Month 3|Other|1|||
27694728|NCT03486457|80716798|FG001|Up to Month 3|Other|0|||
27694729|NCT03486457|80716797|FG000|Month 3 to Month 6|Adverse Event|2|||
27694730|NCT03486457|80716798|FG001|Month 3 to Month 6|Adverse Event|0|||
27694731|NCT03486457|80716797|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
27694732|NCT03486457|80716798|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
27694733|NCT03486457|80716797|FG000|Month 3 to Month 6|Pregnancy|0|||
27694734|NCT03486457|80716798|FG001|Month 3 to Month 6|Pregnancy|1|||
27694735|NCT03486457|80716797|FG000|Month 3 to Month 6|Other|1|||
27694736|NCT03486457|80716798|FG001|Month 3 to Month 6|Other|0|||
27694737|NCT02057523|80716801|FG000|Overall Study|Withdrawal by Subject|1|||
27694738|NCT02057523|80716801|FG000|Overall Study|Lack of Efficacy|1|||
27694739|NCT02401867|80716802|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
27694740|NCT02401867|80716802|FG000|Analysis|Cervical assay could not be conducted|9|||
27694741|NCT01127139|80716803|FG000|Overall Study|Adverse Event|40|||
27694742|NCT01127139|80716803|FG000|Overall Study|Incompliance|12|||
27694743|NCT01127139|80716803|FG000|Overall Study|Lack of Efficacy|4|||
27694744|NCT01127139|80716803|FG000|Overall Study|Reason not specified|1|||
27694745|NCT00770341|80716808|FG000|Overall Study|Did not meet eligibility criteria|1|||
27694746|NCT00770341|80716809|FG001|Overall Study|Did not meet eligibility criteria|0|||
27694747|NCT00770341|80716810|FG002|Overall Study|Did not meet eligibility criteria|0|||
27694748|NCT00770341|80716808|FG000|Overall Study|Withdrawal by Subject|0|||
27694749|NCT00770341|80716809|FG001|Overall Study|Withdrawal by Subject|1|||
27694750|NCT00770341|80716810|FG002|Overall Study|Withdrawal by Subject|0|||
27694751|NCT00770341|80716808|FG000|Overall Study|Clinical Adverse Event|3|||
27694752|NCT00770341|80716809|FG001|Overall Study|Clinical Adverse Event|1|||
27694753|NCT00770341|80716810|FG002|Overall Study|Clinical Adverse Event|2|||
27694754|NCT00770341|80716808|FG000|Overall Study|Laboratory adverse event|3|||
27694755|NCT00770341|80716809|FG001|Overall Study|Laboratory adverse event|3|||
27694756|NCT00770341|80716810|FG002|Overall Study|Laboratory adverse event|0|||
27694757|NCT00770341|80716808|FG000|Overall Study|Lack of Efficacy|3|||
27694758|NCT00770341|80716809|FG001|Overall Study|Lack of Efficacy|0|||
27694759|NCT00770341|80716810|FG002|Overall Study|Lack of Efficacy|1|||
27694760|NCT00770341|80716808|FG000|Overall Study|Other|1|||
27694761|NCT00770341|80716809|FG001|Overall Study|Other|0|||
27694762|NCT00770341|80716810|FG002|Overall Study|Other|0|||
27694763|NCT00770341|80716808|FG000|Overall Study|Not treated|1|||
27694764|NCT00770341|80716809|FG001|Overall Study|Not treated|0|||
27694765|NCT00770341|80716810|FG002|Overall Study|Not treated|0|||
27694766|NCT00799513|80716814|FG000|Overall Study|Physician Decision|1|||
27694767|NCT00799513|80716814|FG000|Overall Study|Adverse Event|1|||
27694768|NCT01337115|80716815|FG000|Overall Study|Protocol Violation|2|||
27694769|NCT01337115|80716816|FG001|Overall Study|Protocol Violation|0|||
27694770|NCT01193920|80716819|FG000|Overall Study|Withdrawal by Subject|1|||
27826515|NCT00609674|81195422|FG000|Overall Study|Adverse Event|1|||
27826516|NCT00609674|81195423|FG001|Overall Study|Adverse Event|1|||
27826517|NCT00609674|81195422|FG000|Overall Study|Protocol Violation|3|||
27826518|NCT00609674|81195423|FG001|Overall Study|Protocol Violation|5|||
27826519|NCT00609674|81195422|FG000|Overall Study|Lost to Follow-up|1|||
27826520|NCT00609674|81195423|FG001|Overall Study|Lost to Follow-up|0|||
27826521|NCT00609674|81195422|FG000|Overall Study|Withdrew consent|2|||
27826522|NCT00609674|81195423|FG001|Overall Study|Withdrew consent|1|||
27826523|NCT00707161|81195424|FG000|Overall Study|Physician Decision|6|||
27826524|NCT03925532|81195427|FG000|Overall Study|Lost to Follow-up|1|||
27826525|NCT01745120|81195428|FG000|Overall Study|Investigator decision|1|||
27826526|NCT01745120|81195429|FG001|Overall Study|Investigator decision|0|||
27826527|NCT02255097|81195430|FG000|Overall Study|Death|151|||
27826528|NCT02255097|81195430|FG000|Overall Study|Lost to Follow-up|5|||
27826529|NCT02255097|81195430|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
27826530|NCT02255097|81195430|FG000|Overall Study|Withdrawal by Subject|7|||
27826531|NCT02255097|81195430|FG000|Overall Study|Allocated but not treated|1|||
27826532|NCT01882647|81195431|FG000|Overall Study|Lost to Follow-up|2|||
27826533|NCT01882647|81195432|FG001|Overall Study|Lost to Follow-up|2|||
27826534|NCT01882647|81195431|FG000|Overall Study|Withdrawal by Subject|0|||
27826535|NCT01882647|81195432|FG001|Overall Study|Withdrawal by Subject|4|||
27826536|NCT00359281|81195444|FG000|Overall Study|Adverse Event|1|||
27826537|NCT00359281|81195445|FG001|Overall Study|Adverse Event|0|||
27826538|NCT00359281|81195446|FG002|Overall Study|Adverse Event|0|||
27826539|NCT00359281|81195447|FG003|Overall Study|Adverse Event|0|||
27826540|NCT00359281|81195448|FG004|Overall Study|Adverse Event|0|||
27826541|NCT00359281|81195449|FG005|Overall Study|Adverse Event|0|||
27826542|NCT00359281|81195450|FG006|Overall Study|Adverse Event|1|||
27826543|NCT00359281|81195451|FG007|Overall Study|Adverse Event|0|||
27826544|NCT00359281|81195452|FG008|Overall Study|Adverse Event|0|||
27826545|NCT00359281|81195444|FG000|Overall Study|Withdrawal by Subject|0|||
27694771|NCT01193920|80716820|FG001|Overall Study|Withdrawal by Subject|0|||
27694772|NCT01193920|80716821|FG002|Overall Study|Withdrawal by Subject|5|||
27826546|NCT00359281|81195445|FG001|Overall Study|Withdrawal by Subject|0|||
27826547|NCT00359281|81195446|FG002|Overall Study|Withdrawal by Subject|0|||
27826548|NCT00359281|81195447|FG003|Overall Study|Withdrawal by Subject|0|||
27694773|NCT01193920|80716822|FG003|Overall Study|Withdrawal by Subject|1|||
27694774|NCT01193920|80716823|FG004|Overall Study|Withdrawal by Subject|3|||
27694775|NCT01193920|80716824|FG005|Overall Study|Withdrawal by Subject|1|||
27694776|NCT01193920|80716825|FG006|Overall Study|Withdrawal by Subject|3|||
27694777|NCT01193920|80716826|FG007|Overall Study|Withdrawal by Subject|0|||
27694778|NCT01193920|80716827|FG008|Overall Study|Withdrawal by Subject|1|||
27694779|NCT01193920|80716828|FG009|Overall Study|Withdrawal by Subject|0|||
27694780|NCT01193920|80716819|FG000|Overall Study|Lost to Follow-up|1|||
27694781|NCT01193920|80716820|FG001|Overall Study|Lost to Follow-up|0|||
27694782|NCT01193920|80716821|FG002|Overall Study|Lost to Follow-up|1|||
27694783|NCT01193920|80716822|FG003|Overall Study|Lost to Follow-up|1|||
27694784|NCT01193920|80716823|FG004|Overall Study|Lost to Follow-up|3|||
27826549|NCT00359281|81195448|FG004|Overall Study|Withdrawal by Subject|0|||
27694785|NCT01193920|80716824|FG005|Overall Study|Lost to Follow-up|3|||
27826550|NCT00359281|81195449|FG005|Overall Study|Withdrawal by Subject|0|||
27694786|NCT01193920|80716825|FG006|Overall Study|Lost to Follow-up|1|||
27826551|NCT00359281|81195450|FG006|Overall Study|Withdrawal by Subject|1|||
27694787|NCT01193920|80716826|FG007|Overall Study|Lost to Follow-up|0|||
27826552|NCT00359281|81195451|FG007|Overall Study|Withdrawal by Subject|0|||
27694788|NCT01193920|80716827|FG008|Overall Study|Lost to Follow-up|2|||
27694789|NCT01193920|80716828|FG009|Overall Study|Lost to Follow-up|3|||
27826553|NCT00359281|81195452|FG008|Overall Study|Withdrawal by Subject|0|||
27694790|NCT01193920|80716819|FG000|Overall Study|Protocol Violation|1|||
27694791|NCT01193920|80716820|FG001|Overall Study|Protocol Violation|0|||
27694792|NCT01193920|80716821|FG002|Overall Study|Protocol Violation|0|||
27694793|NCT01193920|80716822|FG003|Overall Study|Protocol Violation|0|||
27694794|NCT01193920|80716823|FG004|Overall Study|Protocol Violation|0|||
27694795|NCT01193920|80716824|FG005|Overall Study|Protocol Violation|0|||
27694796|NCT01193920|80716825|FG006|Overall Study|Protocol Violation|0|||
27694797|NCT01193920|80716826|FG007|Overall Study|Protocol Violation|0|||
27694798|NCT01193920|80716827|FG008|Overall Study|Protocol Violation|0|||
27694799|NCT01193920|80716828|FG009|Overall Study|Protocol Violation|0|||
27694800|NCT01193920|80716819|FG000|Overall Study|Death|0|||
27694801|NCT01193920|80716820|FG001|Overall Study|Death|0|||
27694802|NCT01193920|80716821|FG002|Overall Study|Death|0|||
27694803|NCT01193920|80716822|FG003|Overall Study|Death|1|||
27826554|NCT00185458|81195453|FG000|Contraception Phase|Adverse Event|37|||
27826555|NCT00185458|81195453|FG000|Contraception Phase|Lost to Follow-up|10|||
27826556|NCT00185458|81195453|FG000|Contraception Phase|Protocol Violation|2|||
27826557|NCT00185458|81195453|FG000|Contraception Phase|Physician Decision|2|||
27694804|NCT01193920|80716823|FG004|Overall Study|Death|0|||
27694805|NCT01193920|80716824|FG005|Overall Study|Death|0|||
27694806|NCT01193920|80716825|FG006|Overall Study|Death|2|||
27826558|NCT00185458|81195453|FG000|Contraception Phase|Withdrawal by Subject|7|||
27826559|NCT00185458|81195453|FG000|HRT Phase|Adverse Event|18|||
27694807|NCT01193920|80716826|FG007|Overall Study|Death|3|||
27694808|NCT01193920|80716827|FG008|Overall Study|Death|2|||
27694809|NCT01193920|80716828|FG009|Overall Study|Death|4|||
27826560|NCT00185458|81195453|FG000|HRT Phase|Lost to Follow-up|4|||
27826561|NCT00185458|81195453|FG000|HRT Phase|Protocol Violation|2|||
27694810|NCT01193920|80716819|FG000|Overall Study|Unable to classify|0|||
27694811|NCT01193920|80716820|FG001|Overall Study|Unable to classify|0|||
27694812|NCT01193920|80716821|FG002|Overall Study|Unable to classify|0|||
27694813|NCT01193920|80716822|FG003|Overall Study|Unable to classify|1|||
27826562|NCT00185458|81195453|FG000|HRT Phase|Withdrawal by Subject|3|||
27826563|NCT05038293|81195454|FG000|Overall Study|device was not operating properly for one subject.|1|||
27826564|NCT05038293|81195455|FG001|Overall Study|device was not operating properly for one subject.|0|||
27826565|NCT05038293|81195454|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
27826566|NCT05038293|81195455|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
27826567|NCT01190865|81195456|FG000|Overall Study|Withdrawal by Subject|1|||
27826568|NCT01190865|81195456|FG000|Overall Study|Non-compliance|2|||
27826569|NCT00312897|81195457|FG000|Overall Study|Adverse Event|1|||
27826570|NCT00312897|81195458|FG001|Overall Study|Adverse Event|0|||
27826571|NCT00312897|81195457|FG000|Overall Study|Lost to Follow-up|2|||
27826572|NCT00312897|81195458|FG001|Overall Study|Lost to Follow-up|0|||
27826573|NCT00312897|81195457|FG000|Overall Study|Physician Decision|1|||
27826574|NCT00312897|81195458|FG001|Overall Study|Physician Decision|0|||
27826575|NCT00312897|81195457|FG000|Overall Study|Withdrawal by Subject|1|||
27826576|NCT00312897|81195458|FG001|Overall Study|Withdrawal by Subject|3|||
27826577|NCT00312897|81195457|FG000|Overall Study|Pregnancy|1|||
27826578|NCT00312897|81195458|FG001|Overall Study|Pregnancy|0|||
27826579|NCT00312897|81195457|FG000|Overall Study|discontinued prior to getting treatment|0|||
27826580|NCT00312897|81195458|FG001|Overall Study|discontinued prior to getting treatment|3|||
27826581|NCT00268905|81195463|FG000|Overall Study|Adverse Event|3|||
27826582|NCT00268905|81195464|FG001|Overall Study|Adverse Event|0|||
27694814|NCT01193920|80716823|FG004|Overall Study|Unable to classify|0|||
27826583|NCT00268905|81195465|FG002|Overall Study|Adverse Event|4|||
27826584|NCT00268905|81195463|FG000|Overall Study|Lost to Follow-up|0|||
27826585|NCT00268905|81195464|FG001|Overall Study|Lost to Follow-up|1|||
27826586|NCT00268905|81195465|FG002|Overall Study|Lost to Follow-up|0|||
27826587|NCT00268905|81195463|FG000|Overall Study|Withdrawal by Subject|0|||
27826588|NCT00268905|81195464|FG001|Overall Study|Withdrawal by Subject|0|||
27826589|NCT00268905|81195465|FG002|Overall Study|Withdrawal by Subject|3|||
27694815|NCT01193920|80716824|FG005|Overall Study|Unable to classify|0|||
27694816|NCT01193920|80716825|FG006|Overall Study|Unable to classify|0|||
27694817|NCT01193920|80716826|FG007|Overall Study|Unable to classify|1|||
27694818|NCT01193920|80716827|FG008|Overall Study|Unable to classify|0|||
27694819|NCT01193920|80716828|FG009|Overall Study|Unable to classify|0|||
27694820|NCT01596621|80716829|FG000|Overall Study|Death|4|||
27694821|NCT01596621|80716829|FG000|Overall Study|Withdrawal by Subject|9|||
27694822|NCT01596621|80716829|FG000|Overall Study|Disease Progression|49|||
27694823|NCT01596621|80716829|FG000|Overall Study|Lost to Follow-up|3|||
27694824|NCT01596621|80716829|FG000|Overall Study|Other than specified|13|||
27555572|NCT02927080|80222187|FG003|Overall Study|Adverse Event|0|||
27826590|NCT00268905|81195463|FG000|Overall Study|Progressive Disease|28|||
27826591|NCT00268905|81195464|FG001|Overall Study|Progressive Disease|4|||
27826592|NCT00268905|81195465|FG002|Overall Study|Progressive Disease|3|||
27826593|NCT00268905|81195463|FG000|Overall Study|Physician Decision|3|||
27826594|NCT00268905|81195464|FG001|Overall Study|Physician Decision|0|||
27826595|NCT00268905|81195465|FG002|Overall Study|Physician Decision|1|||
27826596|NCT00268905|81195463|FG000|Overall Study|Clinical Progression|9|||
27826597|NCT00268905|81195464|FG001|Overall Study|Clinical Progression|4|||
27826598|NCT00268905|81195465|FG002|Overall Study|Clinical Progression|1|||
27694825|NCT02739360|80716835|FG000|Overall Study|Adverse Event|1|||
27694826|NCT02739360|80716835|FG000|Overall Study|Study terminated by Sponsor|2|||
27694827|NCT02937454|80716838|FG000|Overall Study|Adverse Event|0|||
27694828|NCT02937454|80716839|FG001|Overall Study|Adverse Event|1|||
27694829|NCT02937454|80716838|FG000|Overall Study|Death|98|||
27694830|NCT02937454|80716839|FG001|Overall Study|Death|95|||
27694831|NCT02937454|80716838|FG000|Overall Study|Lost to Follow-up|1|||
27694832|NCT02937454|80716839|FG001|Overall Study|Lost to Follow-up|1|||
27694833|NCT02937454|80716838|FG000|Overall Study|Physician Decision|0|||
27694834|NCT02937454|80716839|FG001|Overall Study|Physician Decision|1|||
27694835|NCT02937454|80716838|FG000|Overall Study|Protocol Violation|6|||
27694836|NCT02937454|80716839|FG001|Overall Study|Protocol Violation|10|||
27694837|NCT02937454|80716838|FG000|Overall Study|Withdrawal by Subject|27|||
27694838|NCT02937454|80716839|FG001|Overall Study|Withdrawal by Subject|15|||
27694839|NCT02937454|80716838|FG000|Overall Study|Other|8|||
27694840|NCT02937454|80716839|FG001|Overall Study|Other|5|||
27694841|NCT01759407|80716840|FG000|Overall Study|Protocol Violation|0|||
27694842|NCT01759407|80716841|FG001|Overall Study|Protocol Violation|2|||
27694843|NCT04788511|80716842|FG000|Overall Study|Withdrawal by Subject|2|||
27694844|NCT04788511|80716843|FG001|Overall Study|Withdrawal by Subject|1|||
27694845|NCT04788511|80716842|FG000|Overall Study|Lost to Follow-up|2|||
27694846|NCT04788511|80716843|FG001|Overall Study|Lost to Follow-up|7|||
27694847|NCT04788511|80716842|FG000|Overall Study|Death|3|||
27694848|NCT04788511|80716843|FG001|Overall Study|Death|4|||
27694849|NCT03371381|80716844|FG000|Overall Study|Death|5|||
27694850|NCT03371381|80716844|FG000|Overall Study|Study terminated by sponsor|3|||
27694851|NCT03371381|80716844|FG000|Overall Study|Other|4|||
27694852|NCT02208999|80716845|FG000|Overall Study|Lost to Follow-up|1|||
27883919|NCT01455597|81408091|FG001|Overall Study|Reason not Specified|2|||
27826599|NCT00950989|81195466|FG000|Overall Study|Death|0|||
27694853|NCT00547365|80716853|FG000|Overall Study|Physician Decision|1|||
27694854|NCT00547365|80716853|FG000|Overall Study|Lost to Follow-up|1|||
27694855|NCT00547365|80716853|FG000|Overall Study|Protocol Violation|2|||
27694856|NCT00547365|80716853|FG000|Overall Study|death (not related to study)|4|||
27694857|NCT03646656|80716854|FG000|Overall Study|Lost to Follow-up|1|||
27694858|NCT03646656|80716855|FG001|Overall Study|Lost to Follow-up|0|||
27694859|NCT03646656|80716854|FG000|Overall Study|Withdrawal by Subject|2|||
27694860|NCT03646656|80716855|FG001|Overall Study|Withdrawal by Subject|0|||
27694861|NCT03215810|80716856|FG000|Overall Study|Still responding to nivolumab|1|||
27694862|NCT03215810|80716856|FG000|Overall Study|Insufficient TIL growth|1|||
27694863|NCT03215810|80716856|FG000|Overall Study|Decline in performance status|1|||
27694864|NCT03215810|80716856|FG000|Overall Study|Withdrawal by Subject|1|||
27694865|NCT03213457|80716857|FG000|Overall Study|Not Treated|1|||
27694866|NCT03213457|80716858|FG001|Overall Study|Not Treated|1|||
27694867|NCT03213457|80716859|FG002|Overall Study|Not Treated|0|||
27694868|NCT03213457|80716857|FG000|Overall Study|Adverse Event|16|||
27694869|NCT03213457|80716858|FG001|Overall Study|Adverse Event|9|||
27694870|NCT03213457|80716859|FG002|Overall Study|Adverse Event|41|||
27694871|NCT03213457|80716857|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27694872|NCT03213457|80716858|FG001|Overall Study|Non-Compliance With Study Drug|2|||
27694873|NCT03213457|80716859|FG002|Overall Study|Non-Compliance With Study Drug|7|||
27694874|NCT03213457|80716857|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
27694875|NCT03213457|80716858|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
27694876|NCT03213457|80716859|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
27694877|NCT03213457|80716857|FG000|Overall Study|Withdrawal by Subject|18|||
27694878|NCT03213457|80716858|FG001|Overall Study|Withdrawal by Subject|7|||
27694879|NCT03213457|80716859|FG002|Overall Study|Withdrawal by Subject|35|||
27694880|NCT03213457|80716857|FG000|Overall Study|Lost to Follow-up|12|||
27694881|NCT03213457|80716858|FG001|Overall Study|Lost to Follow-up|12|||
27694882|NCT03213457|80716859|FG002|Overall Study|Lost to Follow-up|33|||
27694883|NCT03213457|80716857|FG000|Overall Study|Pregnancy|11|||
27694884|NCT03213457|80716858|FG001|Overall Study|Pregnancy|0|||
27694885|NCT03213457|80716859|FG002|Overall Study|Pregnancy|7|||
27694886|NCT03213457|80716857|FG000|Overall Study|Protocol Violation|1|||
27694887|NCT03213457|80716858|FG001|Overall Study|Protocol Violation|1|||
27694888|NCT03213457|80716859|FG002|Overall Study|Protocol Violation|6|||
27694889|NCT03213457|80716857|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
27694890|NCT03213457|80716858|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
27694891|NCT03213457|80716859|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
27694892|NCT03213457|80716857|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
27694893|NCT03213457|80716858|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
27694894|NCT03213457|80716859|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
27694895|NCT03213457|80716857|FG000|Overall Study|Lack of Efficacy|12|||
27694896|NCT03213457|80716858|FG001|Overall Study|Lack of Efficacy|2|||
27694897|NCT03213457|80716859|FG002|Overall Study|Lack of Efficacy|9|||
27694898|NCT03213457|80716857|FG000|Overall Study|Other, Not Specified|11|||
27694899|NCT03213457|80716858|FG001|Overall Study|Other, Not Specified|3|||
27694900|NCT03213457|80716859|FG002|Overall Study|Other, Not Specified|26|||
27694901|NCT02752074|80716860|FG000|Overall Study|Lost to Follow-up|1|||
27694902|NCT02752074|80716861|FG001|Overall Study|Lost to Follow-up|4|||
27694903|NCT02752074|80716860|FG000|Overall Study|Death|146|||
27694904|NCT02752074|80716861|FG001|Overall Study|Death|129|||
27694905|NCT02752074|80716860|FG000|Overall Study|Withdrawal by Subject|9|||
27694906|NCT02752074|80716861|FG001|Overall Study|Withdrawal by Subject|10|||
27694907|NCT00960531|80716863|FG000|Overall Study|Lack of Efficacy|1|||
27694908|NCT00960531|80716864|FG001|Overall Study|Lack of Efficacy|0|||
27694909|NCT00960531|80716865|FG002|Overall Study|Lack of Efficacy|0|||
27694910|NCT00960531|80716866|FG003|Overall Study|Lack of Efficacy|0|||
27694911|NCT00960531|80716867|FG004|Overall Study|Lack of Efficacy|0|||
27694912|NCT00960531|80716868|FG005|Overall Study|Lack of Efficacy|0|||
27694913|NCT00960531|80716869|FG006|Overall Study|Lack of Efficacy|0|||
27694914|NCT00960531|80716870|FG007|Overall Study|Lack of Efficacy|0|||
27694915|NCT00960531|80716871|FG008|Overall Study|Lack of Efficacy|0|||
27694916|NCT00960531|80716872|FG009|Overall Study|Lack of Efficacy|0|||
27694917|NCT00960531|80716863|FG000|Overall Study|Withdrawal by Subject|1|||
27694918|NCT00960531|80716864|FG001|Overall Study|Withdrawal by Subject|0|||
27694919|NCT00960531|80716865|FG002|Overall Study|Withdrawal by Subject|5|||
27694920|NCT00960531|80716866|FG003|Overall Study|Withdrawal by Subject|2|||
27694921|NCT00960531|80716867|FG004|Overall Study|Withdrawal by Subject|0|||
27694922|NCT00960531|80716868|FG005|Overall Study|Withdrawal by Subject|0|||
27694923|NCT00960531|80716869|FG006|Overall Study|Withdrawal by Subject|2|||
27694924|NCT00960531|80716870|FG007|Overall Study|Withdrawal by Subject|0|||
27694925|NCT00960531|80716871|FG008|Overall Study|Withdrawal by Subject|1|||
27694926|NCT00960531|80716872|FG009|Overall Study|Withdrawal by Subject|0|||
27694927|NCT00960531|80716863|FG000|Overall Study|Caregiver Request|2|||
27694928|NCT00960531|80716864|FG001|Overall Study|Caregiver Request|0|||
27694929|NCT00960531|80716865|FG002|Overall Study|Caregiver Request|6|||
27694930|NCT00960531|80716866|FG003|Overall Study|Caregiver Request|5|||
27694931|NCT00960531|80716867|FG004|Overall Study|Caregiver Request|0|||
27694932|NCT00960531|80716868|FG005|Overall Study|Caregiver Request|2|||
27694933|NCT00960531|80716869|FG006|Overall Study|Caregiver Request|3|||
27694934|NCT00960531|80716870|FG007|Overall Study|Caregiver Request|1|||
27694935|NCT00960531|80716871|FG008|Overall Study|Caregiver Request|3|||
27694936|NCT00960531|80716872|FG009|Overall Study|Caregiver Request|0|||
27694937|NCT00960531|80716863|FG000|Overall Study|Investigator Request|0|||
27694938|NCT00960531|80716864|FG001|Overall Study|Investigator Request|0|||
27826600|NCT00950989|81195467|FG001|Overall Study|Death|0|||
27826601|NCT00950989|81195468|FG002|Overall Study|Death|1|||
27826602|NCT00950989|81195469|FG003|Overall Study|Death|0|||
27826603|NCT00950989|81195466|FG000|Overall Study|Administrative Decision|0|||
27826604|NCT00950989|81195467|FG001|Overall Study|Administrative Decision|1|||
27826605|NCT00950989|81195468|FG002|Overall Study|Administrative Decision|0|||
27826606|NCT00950989|81195469|FG003|Overall Study|Administrative Decision|0|||
27826607|NCT00950989|81195466|FG000|Overall Study|Disease Progression|0|||
27826608|NCT00950989|81195467|FG001|Overall Study|Disease Progression|0|||
27826609|NCT00950989|81195468|FG002|Overall Study|Disease Progression|1|||
27826610|NCT00950989|81195469|FG003|Overall Study|Disease Progression|0|||
27694939|NCT00960531|80716865|FG002|Overall Study|Investigator Request|1|||
27694940|NCT00960531|80716866|FG003|Overall Study|Investigator Request|0|||
27694941|NCT00960531|80716867|FG004|Overall Study|Investigator Request|0|||
27694942|NCT00960531|80716868|FG005|Overall Study|Investigator Request|0|||
27694943|NCT00960531|80716869|FG006|Overall Study|Investigator Request|0|||
27694944|NCT00960531|80716870|FG007|Overall Study|Investigator Request|0|||
27826611|NCT00950989|81195466|FG000|Overall Study|Withdrawal by Subject|2|||
27826612|NCT00950989|81195467|FG001|Overall Study|Withdrawal by Subject|1|||
27826613|NCT00950989|81195468|FG002|Overall Study|Withdrawal by Subject|0|||
27826614|NCT00950989|81195469|FG003|Overall Study|Withdrawal by Subject|0|||
27694945|NCT00960531|80716871|FG008|Overall Study|Investigator Request|0|||
27694946|NCT00960531|80716872|FG009|Overall Study|Investigator Request|0|||
27694947|NCT00960531|80716863|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
27694948|NCT00960531|80716864|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27694949|NCT00960531|80716865|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
27694950|NCT00960531|80716866|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27694951|NCT00960531|80716867|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
27694952|NCT00960531|80716868|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
27694953|NCT00960531|80716869|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
27694954|NCT00960531|80716870|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
27694955|NCT00960531|80716871|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
27694956|NCT00960531|80716872|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
27694957|NCT00960531|80716863|FG000|Overall Study|Lost to Follow-up|0|||
27555573|NCT02927080|80222188|FG004|Overall Study|Adverse Event|0|||
27694958|NCT00960531|80716864|FG001|Overall Study|Lost to Follow-up|0|||
27694959|NCT00960531|80716865|FG002|Overall Study|Lost to Follow-up|1|||
27694960|NCT00960531|80716866|FG003|Overall Study|Lost to Follow-up|0|||
27694961|NCT00960531|80716867|FG004|Overall Study|Lost to Follow-up|0|||
27694962|NCT00960531|80716868|FG005|Overall Study|Lost to Follow-up|0|||
27694963|NCT00960531|80716869|FG006|Overall Study|Lost to Follow-up|1|||
27826615|NCT00950989|81195466|FG000|Overall Study|Adverse Event|2|||
27826616|NCT00950989|81195467|FG001|Overall Study|Adverse Event|1|||
27694964|NCT00960531|80716870|FG007|Overall Study|Lost to Follow-up|0|||
27826617|NCT00950989|81195468|FG002|Overall Study|Adverse Event|1|||
27694965|NCT00960531|80716871|FG008|Overall Study|Lost to Follow-up|0|||
27694966|NCT00960531|80716872|FG009|Overall Study|Lost to Follow-up|0|||
27694967|NCT00960531|80716863|FG000|Overall Study|Failed to Return|2|||
27694968|NCT00960531|80716864|FG001|Overall Study|Failed to Return|0|||
27694969|NCT00960531|80716865|FG002|Overall Study|Failed to Return|0|||
27694970|NCT00960531|80716866|FG003|Overall Study|Failed to Return|0|||
27694971|NCT00960531|80716867|FG004|Overall Study|Failed to Return|0|||
27694972|NCT00960531|80716868|FG005|Overall Study|Failed to Return|0|||
27694973|NCT00960531|80716869|FG006|Overall Study|Failed to Return|0|||
27694974|NCT00960531|80716870|FG007|Overall Study|Failed to Return|2|||
27694975|NCT00960531|80716871|FG008|Overall Study|Failed to Return|0|||
27694976|NCT00960531|80716872|FG009|Overall Study|Failed to Return|0|||
27694977|NCT00960531|80716863|FG000|Overall Study|Adverse Event (AE)|2|||
27694978|NCT00960531|80716864|FG001|Overall Study|Adverse Event (AE)|0|||
27694979|NCT00960531|80716865|FG002|Overall Study|Adverse Event (AE)|0|||
27694980|NCT00960531|80716866|FG003|Overall Study|Adverse Event (AE)|0|||
27694981|NCT00960531|80716867|FG004|Overall Study|Adverse Event (AE)|0|||
27694982|NCT00960531|80716868|FG005|Overall Study|Adverse Event (AE)|1|||
27694983|NCT00960531|80716869|FG006|Overall Study|Adverse Event (AE)|2|||
27694984|NCT00960531|80716870|FG007|Overall Study|Adverse Event (AE)|0|||
27694985|NCT00960531|80716871|FG008|Overall Study|Adverse Event (AE)|2|||
27694986|NCT00960531|80716872|FG009|Overall Study|Adverse Event (AE)|0|||
27694987|NCT00960531|80716863|FG000|Overall Study|Reason not Specified|2|||
27694988|NCT00960531|80716864|FG001|Overall Study|Reason not Specified|1|||
27826618|NCT00950989|81195469|FG003|Overall Study|Adverse Event|0|||
27826619|NCT01702987|81195470|FG000|Overall Study|Withdrawal by Subject|1|||
27826620|NCT01702987|81195471|FG001|Overall Study|Withdrawal by Subject|0|||
27826621|NCT01149473|81195472|FG000|First Intervention|Adverse Event|1|||
27826622|NCT01149473|81195473|FG001|First Intervention|Adverse Event|1|||
27826623|NCT01149473|81195472|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27826624|NCT01149473|81195473|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27826625|NCT01370317|81195477|FG000|Overall Study|Participant withdrew consent|1|||
27826626|NCT01370317|81195478|FG001|Overall Study|Participant withdrew consent|0|||
27826627|NCT01370317|81195477|FG000|Overall Study|Protocol deviation|0|||
27826628|NCT01370317|81195478|FG001|Overall Study|Protocol deviation|1|||
27826629|NCT03522675|81195485|FG000|Overall Study|Screen fail|1|||
27826630|NCT03522675|81195485|FG000|Overall Study|Non-reactive to histamine|1|||
27826631|NCT03733730|81195486|FG000|Overall Study|Lost to Follow-up|1|||
27826632|NCT03733730|81195487|FG001|Overall Study|Lost to Follow-up|32|||
27826633|NCT03733730|81195486|FG000|Overall Study|Other|1|||
27826634|NCT03733730|81195487|FG001|Overall Study|Other|0|||
27694989|NCT00960531|80716865|FG002|Overall Study|Reason not Specified|13|||
27694990|NCT00960531|80716866|FG003|Overall Study|Reason not Specified|1|||
27694991|NCT00960531|80716867|FG004|Overall Study|Reason not Specified|2|||
27826635|NCT03733730|81195486|FG000|Overall Study|Adverse Event|0|||
27826636|NCT03733730|81195487|FG001|Overall Study|Adverse Event|4|||
27826637|NCT03733730|81195486|FG000|Overall Study|Death|0|||
27694992|NCT00960531|80716868|FG005|Overall Study|Reason not Specified|0|||
27694993|NCT00960531|80716869|FG006|Overall Study|Reason not Specified|16|||
27694994|NCT00960531|80716870|FG007|Overall Study|Reason not Specified|0|||
27694995|NCT00960531|80716871|FG008|Overall Study|Reason not Specified|8|||
27694996|NCT00960531|80716872|FG009|Overall Study|Reason not Specified|1|||
27694997|NCT00063154|80716873|FG000|Overall Study|Disease progression|27|||
27694998|NCT00063154|80716873|FG000|Overall Study|Adverse Event|2|||
27826638|NCT03733730|81195487|FG001|Overall Study|Death|5|||
27826639|NCT03733730|81195486|FG000|Overall Study|Withdrawal by Subject|0|||
27826640|NCT03733730|81195487|FG001|Overall Study|Withdrawal by Subject|8|||
27826641|NCT01802320|81195490|FG000|Overall Study|Death|1|||
27826642|NCT01802320|81195490|FG000|Overall Study|Withdrawal by Subject|1|||
27826643|NCT02476994|81195492|FG000|Overall Study|Based on feedback from FDA|1|||
27826644|NCT02476994|81195493|FG001|Overall Study|Based on feedback from FDA|0|||
27883920|NCT01455597|81408092|FG002|Overall Study|Reason not Specified|3|||
27883921|NCT01455597|81408093|FG003|Overall Study|Reason not Specified|3|||
27694999|NCT00063154|80716873|FG000|Overall Study|Physician Decision|10|||
27695000|NCT00063154|80716873|FG000|Overall Study|Death|3|||
27695001|NCT00063154|80716873|FG000|Overall Study|Reason unspecified|1|||
27695002|NCT00063154|80716873|FG000|Overall Study|Did not receive treatment|8|||
27695003|NCT03527173|80716874|FG000|Overall Study|Lost to Follow-up|4|||
27695004|NCT03527173|80716875|FG001|Overall Study|Lost to Follow-up|2|||
27695005|NCT03527173|80716874|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
27695006|NCT03527173|80716875|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
27695007|NCT03527173|80716874|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
27695008|NCT03527173|80716875|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
27695009|NCT03527173|80716874|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
27695010|NCT03527173|80716875|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27695011|NCT01249274|80716876|FG000|Overall Study|Lost to Follow-up|3|||
27695012|NCT01249274|80716877|FG001|Overall Study|Lost to Follow-up|4|||
27695013|NCT01249274|80716876|FG000|Overall Study|Received inpatient substance treatment|1|||
27695014|NCT01249274|80716877|FG001|Overall Study|Received inpatient substance treatment|2|||
27695015|NCT01190514|80716878|FG000|First Intervention (Period 1)|Adverse Event|1|||
27695016|NCT01190514|80716879|FG001|First Intervention (Period 1)|Adverse Event|0|||
27695017|NCT01190514|80716880|FG002|First Intervention (Period 1)|Adverse Event|0|||
27695018|NCT01190514|80716881|FG003|First Intervention (Period 1)|Adverse Event|0|||
27883922|NCT02308540|81408096|FG000|Overall Study|Lost to Follow-up|0|||
27826645|NCT04608188|81195494|FG000|Overall Study|Withdrawal by Subject|4|||
27826646|NCT04608188|81195495|FG001|Overall Study|Withdrawal by Subject|8|||
27826647|NCT01171963|81195496|FG000|Overall Study|Adverse Event|10|||
27826648|NCT01171963|81195497|FG001|Overall Study|Adverse Event|15|||
27826649|NCT01171963|81195496|FG000|Overall Study|Lost to Follow-up|23|||
27826650|NCT01171963|81195497|FG001|Overall Study|Lost to Follow-up|24|||
27826651|NCT01171963|81195496|FG000|Overall Study|Other - diarrhoea|1|||
27826652|NCT01171963|81195497|FG001|Overall Study|Other - diarrhoea|0|||
27826653|NCT01171963|81195496|FG000|Overall Study|Withdrawal by Subject|114|||
27826654|NCT01171963|81195497|FG001|Overall Study|Withdrawal by Subject|129|||
27826655|NCT03204539|81195498|FG000|Overall Study|Loss of funding|0|||
27826656|NCT03204539|81195499|FG001|Overall Study|Loss of funding|1|||
27826657|NCT03733444|81195500|FG000|Overall Study|Adverse Event|8|||
27695019|NCT01190514|80716878|FG000|Third Intervention (Period 3)|Adverse Event|1|||
27695020|NCT01190514|80716879|FG001|Third Intervention (Period 3)|Adverse Event|0|||
27695021|NCT01190514|80716880|FG002|Third Intervention (Period 3)|Adverse Event|0|||
27695022|NCT01190514|80716881|FG003|Third Intervention (Period 3)|Adverse Event|0|||
27695023|NCT01270971|80716882|FG000|Overall Study|Withdrawal by Subject|24|||
27695024|NCT01270971|80716883|FG001|Overall Study|Withdrawal by Subject|11|||
27695025|NCT01270971|80716882|FG000|Overall Study|Lost to Follow-up|18|||
27695026|NCT01270971|80716883|FG001|Overall Study|Lost to Follow-up|5|||
27695027|NCT01270971|80716882|FG000|Overall Study|Adverse Event|1|||
27695028|NCT01270971|80716883|FG001|Overall Study|Adverse Event|2|||
27695029|NCT01270971|80716882|FG000|Overall Study|Non compliance|2|||
27695030|NCT01270971|80716883|FG001|Overall Study|Non compliance|2|||
27826658|NCT03733444|81195501|FG001|Overall Study|Adverse Event|10|||
27826659|NCT03733444|81195502|FG002|Overall Study|Adverse Event|5|||
27695031|NCT01270971|80716882|FG000|Overall Study|Non-specific|7|||
27695032|NCT01270971|80716883|FG001|Overall Study|Non-specific|3|||
27826660|NCT03733444|81195500|FG000|Overall Study|Death|20|||
27826661|NCT03733444|81195501|FG001|Overall Study|Death|19|||
27826662|NCT03733444|81195502|FG002|Overall Study|Death|11|||
27826663|NCT03733444|81195500|FG000|Overall Study|Lost to Follow-up|3|||
27826664|NCT03733444|81195501|FG001|Overall Study|Lost to Follow-up|0|||
27826665|NCT03733444|81195502|FG002|Overall Study|Lost to Follow-up|1|||
27826666|NCT03733444|81195500|FG000|Overall Study|Lack of Efficacy|0|||
27826667|NCT03733444|81195501|FG001|Overall Study|Lack of Efficacy|1|||
27826668|NCT03733444|81195502|FG002|Overall Study|Lack of Efficacy|1|||
27826669|NCT03733444|81195500|FG000|Overall Study|Physician Decision|2|||
27826670|NCT03733444|81195501|FG001|Overall Study|Physician Decision|1|||
27826671|NCT03733444|81195502|FG002|Overall Study|Physician Decision|0|||
27826672|NCT03733444|81195500|FG000|Overall Study|Protocol Violation|2|||
27826673|NCT03733444|81195501|FG001|Overall Study|Protocol Violation|1|||
27826674|NCT03733444|81195502|FG002|Overall Study|Protocol Violation|0|||
27826675|NCT03733444|81195500|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
27826676|NCT03733444|81195501|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
27826677|NCT03733444|81195502|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
27826678|NCT03733444|81195500|FG000|Overall Study|Study Terminated by Sponsor|203|||
27826679|NCT03733444|81195501|FG001|Overall Study|Study Terminated by Sponsor|209|||
27826680|NCT03733444|81195502|FG002|Overall Study|Study Terminated by Sponsor|221|||
27826681|NCT03733444|81195500|FG000|Overall Study|Withdrawal by Subject|19|||
27826682|NCT03733444|81195501|FG001|Overall Study|Withdrawal by Subject|18|||
27826683|NCT03733444|81195502|FG002|Overall Study|Withdrawal by Subject|16|||
27826684|NCT03733444|81195500|FG000|Overall Study|Miscellaneous|1|||
27826685|NCT03733444|81195501|FG001|Overall Study|Miscellaneous|0|||
27826686|NCT03733444|81195502|FG002|Overall Study|Miscellaneous|1|||
27826687|NCT03733444|81195500|FG000|Overall Study|Not Treated|1|||
27826688|NCT03733444|81195501|FG001|Overall Study|Not Treated|2|||
27826689|NCT03733444|81195502|FG002|Overall Study|Not Treated|1|||
27826690|NCT02624050|81195504|FG000|Overall Study|Physician Decision|4|||
27826691|NCT02624050|81195505|FG001|Overall Study|Physician Decision|0|||
27826692|NCT02624050|81195504|FG000|Overall Study|Protocol Violation|2|||
27826693|NCT02624050|81195505|FG001|Overall Study|Protocol Violation|0|||
27826694|NCT01188681|81195509|FG000|Overall Study|bladder cancer|0|||
27826695|NCT01188681|81195510|FG001|Overall Study|bladder cancer|0|||
27826696|NCT01188681|81195511|FG002|Overall Study|bladder cancer|1|||
27826697|NCT01188681|81195512|FG003|Overall Study|bladder cancer|0|||
27826698|NCT01188681|81195509|FG000|Overall Study|Withdrawal by Subject|0|||
27826699|NCT01188681|81195510|FG001|Overall Study|Withdrawal by Subject|0|||
27826700|NCT01188681|81195511|FG002|Overall Study|Withdrawal by Subject|0|||
27826701|NCT01188681|81195512|FG003|Overall Study|Withdrawal by Subject|1|||
27695033|NCT01802567|80716888|FG000|Overall Study|Withdrawal by Subject|2|||
27826702|NCT01247701|81195513|FG000|Overall Study|Death|2|||
27826703|NCT01247701|81195513|FG000|Overall Study|Relapsed|8|||
27826704|NCT00849901|81195514|FG000|Acute Treatment Phase|Adverse Event|9|||
27826705|NCT00849901|81195515|FG001|Acute Treatment Phase|Adverse Event|1|||
27826706|NCT00849901|81195516|FG002|Acute Treatment Phase|Adverse Event|3|||
27826707|NCT00849901|81195514|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
27826708|NCT00849901|81195515|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
27826709|NCT00849901|81195516|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
27826710|NCT00849901|81195514|FG000|Acute Treatment Phase|Protocol Violation|0|||
27826711|NCT00849901|81195515|FG001|Acute Treatment Phase|Protocol Violation|2|||
27826712|NCT00849901|81195516|FG002|Acute Treatment Phase|Protocol Violation|1|||
27826713|NCT00849901|81195514|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
27826714|NCT00849901|81195515|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
27695034|NCT01802567|80716888|FG000|Overall Study|Physician Decision|1|||
27695035|NCT01802567|80716888|FG000|Overall Study|Lack of Efficacy|7|||
27695036|NCT01802567|80716888|FG000|Overall Study|Consented but did not start therapy|7|||
27695037|NCT01802567|80716888|FG000|Overall Study|Protocol Violation|1|||
27695038|NCT02409368|80716890|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
27695039|NCT02409368|80716891|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
27695040|NCT02409368|80716892|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
27695041|NCT02409368|80716893|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
27695042|NCT02409368|80716890|FG000|ECOG Reclassification|Death|1|||
27695043|NCT02409368|80716891|FG001|ECOG Reclassification|Death|5|||
27695044|NCT02409368|80716892|FG002|ECOG Reclassification|Death|0|||
27695045|NCT02409368|80716893|FG003|ECOG Reclassification|Death|0|||
27695046|NCT02409368|80716890|FG000|ECOG Reclassification|Disease Progression|113|||
27695047|NCT02409368|80716891|FG001|ECOG Reclassification|Disease Progression|382|||
27695048|NCT02409368|80716892|FG002|ECOG Reclassification|Disease Progression|70|||
27695049|NCT02409368|80716893|FG003|ECOG Reclassification|Disease Progression|1|||
27695050|NCT02409368|80716890|FG000|ECOG Reclassification|Lost to Follow-up|1|||
27695051|NCT02409368|80716891|FG001|ECOG Reclassification|Lost to Follow-up|5|||
27826715|NCT00849901|81195516|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
27826716|NCT00849901|81195514|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
27826717|NCT00849901|81195515|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
27826718|NCT00849901|81195516|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
27826719|NCT00849901|81195514|FG000|Acute Treatment Phase|Physician Decision|1|||
27826720|NCT00849901|81195515|FG001|Acute Treatment Phase|Physician Decision|1|||
27826721|NCT00849901|81195516|FG002|Acute Treatment Phase|Physician Decision|1|||
27826722|NCT00849901|81195514|FG000|Acute Treatment Phase|Sponsor Decision|1|||
27826723|NCT00849901|81195515|FG001|Acute Treatment Phase|Sponsor Decision|0|||
27826724|NCT00849901|81195516|FG002|Acute Treatment Phase|Sponsor Decision|0|||
27826725|NCT00849901|81195514|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
27826726|NCT00849901|81195515|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
27826727|NCT00849901|81195516|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
27883923|NCT02308540|81408097|FG001|Overall Study|Lost to Follow-up|0|||
27883924|NCT02308540|81408098|FG002|Overall Study|Lost to Follow-up|0|||
27695052|NCT02409368|80716892|FG002|ECOG Reclassification|Lost to Follow-up|0|||
27695053|NCT02409368|80716893|FG003|ECOG Reclassification|Lost to Follow-up|0|||
27695054|NCT02409368|80716890|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
27695055|NCT02409368|80716891|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
27695056|NCT02409368|80716892|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
27695057|NCT02409368|80716893|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
27826728|NCT00849901|81195514|FG000|Extension Phase|Adverse Event|2|||
27826729|NCT00849901|81195515|FG001|Extension Phase|Adverse Event|8|||
27883925|NCT02308540|81408099|FG003|Overall Study|Lost to Follow-up|0|||
27826730|NCT00849901|81195516|FG002|Extension Phase|Adverse Event|4|||
27695058|NCT02409368|80716890|FG000|ECOG Reclassification|Poor/non-compliance|0|||
27695059|NCT02409368|80716891|FG001|ECOG Reclassification|Poor/non-compliance|3|||
27695060|NCT02409368|80716892|FG002|ECOG Reclassification|Poor/non-compliance|2|||
27695061|NCT02409368|80716893|FG003|ECOG Reclassification|Poor/non-compliance|0|||
27695062|NCT02409368|80716890|FG000|ECOG Reclassification|Study drug toxicity|17|||
27695063|NCT02409368|80716891|FG001|ECOG Reclassification|Study drug toxicity|42|||
27695064|NCT02409368|80716892|FG002|ECOG Reclassification|Study drug toxicity|7|||
27695065|NCT02409368|80716893|FG003|ECOG Reclassification|Study drug toxicity|0|||
27695066|NCT02409368|80716890|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
27695067|NCT02409368|80716891|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
27695068|NCT02409368|80716892|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
27695069|NCT02409368|80716893|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
27695070|NCT02409368|80716890|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
27695071|NCT02409368|80716891|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
27695072|NCT02409368|80716892|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
27695073|NCT02409368|80716893|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
27695074|NCT02409368|80716890|FG000|ECOG Reclassification|Participant withdrew consent|2|||
27695075|NCT02409368|80716891|FG001|ECOG Reclassification|Participant withdrew consent|3|||
27695076|NCT02409368|80716892|FG002|ECOG Reclassification|Participant withdrew consent|4|||
27695077|NCT02409368|80716893|FG003|ECOG Reclassification|Participant withdrew consent|0|||
27695078|NCT02409368|80716890|FG000|ECOG Reclassification|Other Reasons|5|||
27695079|NCT02409368|80716891|FG001|ECOG Reclassification|Other Reasons|26|||
27695080|NCT02409368|80716892|FG002|ECOG Reclassification|Other Reasons|2|||
27695081|NCT02409368|80716893|FG003|ECOG Reclassification|Other Reasons|0|||
27695082|NCT02409368|80716890|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
27695083|NCT02409368|80716891|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
27695084|NCT02409368|80716892|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
27695085|NCT02409368|80716893|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
27695086|NCT00835120|80719876|FG000|Overall Study|Lack of Efficacy|1|||
27695087|NCT00835120|80719876|FG000|Overall Study|Lost to Follow-up|3|||
27695088|NCT00835120|80719876|FG000|Overall Study|Adverse Event|2|||
27695089|NCT00835120|80719876|FG000|Overall Study|Withdrawal by Subject|2|||
27695090|NCT01502631|80719881|FG000|Overall Study|Adverse Event|5|||
27695091|NCT01502631|80719882|FG001|Overall Study|Adverse Event|8|||
27695092|NCT01502631|80719881|FG000|Overall Study|Lost to Follow-up|2|||
27695093|NCT01502631|80719882|FG001|Overall Study|Lost to Follow-up|2|||
27695094|NCT01502631|80719881|FG000|Overall Study|Participant withdrew consent|2|||
27695095|NCT01502631|80719882|FG001|Overall Study|Participant withdrew consent|4|||
27695096|NCT01502631|80719881|FG000|Overall Study|Participant non-compliant|1|||
27695097|NCT01502631|80719882|FG001|Overall Study|Participant non-compliant|0|||
27695098|NCT01502631|80719881|FG000|Overall Study|Investigator's decision|0|||
27695099|NCT01502631|80719882|FG001|Overall Study|Investigator's decision|1|||
27695100|NCT01502631|80719881|FG000|Overall Study|Other|10|||
27695101|NCT01502631|80719882|FG001|Overall Study|Other|5|||
27695102|NCT01718353|80719883|FG000|Overall Study|Lost to Follow-up|0|||
27695103|NCT01718353|80719884|FG001|Overall Study|Lost to Follow-up|1|||
27695104|NCT01718353|80719883|FG000|Overall Study|Principal Investigator's Decision|10|||
27695105|NCT01718353|80719884|FG001|Overall Study|Principal Investigator's Decision|4|||
27695106|NCT01718353|80719883|FG000|Overall Study|Randomized but not treated|2|||
27695107|NCT01718353|80719884|FG001|Overall Study|Randomized but not treated|0|||
27695108|NCT03588728|80719885|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
27695109|NCT03588728|80719886|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
27695110|NCT03588728|80719887|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
27695111|NCT03588728|80719888|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
27695112|NCT03588728|80719885|FG000|Overall Study|Lab shut down due to COVID-19|0|||
27695113|NCT03588728|80719886|FG001|Overall Study|Lab shut down due to COVID-19|0|||
27695114|NCT03588728|80719887|FG002|Overall Study|Lab shut down due to COVID-19|0|||
27695115|NCT03588728|80719888|FG003|Overall Study|Lab shut down due to COVID-19|1|||
27695116|NCT03588728|80719885|FG000|Overall Study|multiple technical issues|1|||
27826731|NCT00849901|81195514|FG000|Extension Phase|Lost to Follow-up|3|||
27826732|NCT00849901|81195515|FG001|Extension Phase|Lost to Follow-up|0|||
27826733|NCT00849901|81195516|FG002|Extension Phase|Lost to Follow-up|1|||
27826734|NCT00849901|81195514|FG000|Extension Phase|Protocol Violation|2|||
27826735|NCT00849901|81195515|FG001|Extension Phase|Protocol Violation|2|||
27826736|NCT00849901|81195516|FG002|Extension Phase|Protocol Violation|4|||
27826737|NCT00849901|81195514|FG000|Extension Phase|Withdrawal by Subject|7|||
27826738|NCT00849901|81195515|FG001|Extension Phase|Withdrawal by Subject|6|||
27826739|NCT00849901|81195516|FG002|Extension Phase|Withdrawal by Subject|3|||
27826740|NCT00849901|81195514|FG000|Extension Phase|Parent or Caregiver Decision|10|||
27826741|NCT00849901|81195515|FG001|Extension Phase|Parent or Caregiver Decision|4|||
27826742|NCT00849901|81195516|FG002|Extension Phase|Parent or Caregiver Decision|4|||
27826743|NCT00849901|81195514|FG000|Extension Phase|Physician Decision|1|||
27826744|NCT00849901|81195515|FG001|Extension Phase|Physician Decision|2|||
27826745|NCT00849901|81195516|FG002|Extension Phase|Physician Decision|0|||
27695117|NCT03588728|80719886|FG001|Overall Study|multiple technical issues|0|||
27695118|NCT03588728|80719887|FG002|Overall Study|multiple technical issues|0|||
27695119|NCT03588728|80719888|FG003|Overall Study|multiple technical issues|0|||
27695120|NCT03588728|80719885|FG000|Overall Study|Hospitalized for COVID|1|||
27695121|NCT03588728|80719886|FG001|Overall Study|Hospitalized for COVID|0|||
27695122|NCT03588728|80719887|FG002|Overall Study|Hospitalized for COVID|0|||
27695123|NCT03588728|80719888|FG003|Overall Study|Hospitalized for COVID|0|||
27695124|NCT03588728|80719885|FG000|Overall Study|Schedule change unable to attend sessions|1|||
27695125|NCT03588728|80719886|FG001|Overall Study|Schedule change unable to attend sessions|0|||
27695126|NCT03588728|80719887|FG002|Overall Study|Schedule change unable to attend sessions|0|||
27695127|NCT03588728|80719888|FG003|Overall Study|Schedule change unable to attend sessions|0|||
27695128|NCT00666679|80719889|FG000|First Intervention|Lost to Follow-up|1|||
27695129|NCT00666679|80719890|FG001|First Intervention|Lost to Follow-up|0|||
27695130|NCT00666679|80719889|FG000|First Intervention|Protocol Violation|1|||
27695131|NCT00666679|80719890|FG001|First Intervention|Protocol Violation|0|||
27695132|NCT00666679|80719889|FG000|First Intervention|Withdrawal by Subject|1|||
27695133|NCT00666679|80719890|FG001|First Intervention|Withdrawal by Subject|0|||
27695134|NCT00666679|80719889|FG000|First Intervention|Randomized did not start treatment|1|||
27695135|NCT00666679|80719890|FG001|First Intervention|Randomized did not start treatment|1|||
27695136|NCT00666679|80719889|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
27695137|NCT00666679|80719890|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
27695138|NCT00666679|80719889|FG000|Washout Period of 1 Week|Protocol Violation|0|||
27695139|NCT00666679|80719890|FG001|Washout Period of 1 Week|Protocol Violation|1|||
27695140|NCT00666679|80719889|FG000|Second Intervention|Adverse Event|1|||
27695141|NCT00666679|80719890|FG001|Second Intervention|Adverse Event|0|||
27695142|NCT00666679|80719889|FG000|Second Intervention|Death|0|||
27695143|NCT00666679|80719890|FG001|Second Intervention|Death|1|||
27695144|NCT01658150|80719891|FG000|Overall Study|Withdrawal by Subject|1|||
27695145|NCT01222507|80719892|FG000|Overall Study|Physician Decision|1|||
27695146|NCT01222507|80719892|FG000|Overall Study|Withdrawal by Subject|1|||
27695147|NCT02074553|80719893|FG000|Intervention Period 1|Family Emergency|0|||
27695148|NCT02074553|80719894|FG001|Intervention Period 1|Family Emergency|0|||
27695149|NCT02074553|80719895|FG002|Intervention Period 1|Family Emergency|0|||
27695150|NCT02074553|80719896|FG003|Intervention Period 1|Family Emergency|1|||
27695151|NCT02074553|80719897|FG004|Intervention Period 1|Family Emergency|0|||
27695152|NCT02074553|80719898|FG005|Intervention Period 1|Family Emergency|0|||
27695153|NCT02074553|80719899|FG006|Intervention Period 1|Family Emergency|0|||
27695154|NCT02074553|80719900|FG007|Intervention Period 1|Family Emergency|0|||
27695155|NCT02074553|80719893|FG000|Washout Period 1|Adverse Event|1|||
27695156|NCT02074553|80719894|FG001|Washout Period 1|Adverse Event|0|||
27695157|NCT02074553|80719895|FG002|Washout Period 1|Adverse Event|0|||
27695158|NCT02074553|80719896|FG003|Washout Period 1|Adverse Event|0|||
27826746|NCT00849901|81195514|FG000|Extension Phase|Lack of Efficacy|2|||
27826747|NCT00849901|81195515|FG001|Extension Phase|Lack of Efficacy|4|||
27826748|NCT00849901|81195516|FG002|Extension Phase|Lack of Efficacy|1|||
27826749|NCT03375463|81195517|FG000|Period 1|Lost to Follow-up|0|||
27826750|NCT03375463|81195518|FG001|Period 1|Lost to Follow-up|0|||
27826751|NCT03375463|81195519|FG002|Period 1|Lost to Follow-up|1|||
27695159|NCT02074553|80719897|FG004|Washout Period 1|Adverse Event|0|||
27695160|NCT02074553|80719898|FG005|Washout Period 1|Adverse Event|0|||
27695161|NCT02074553|80719899|FG006|Washout Period 1|Adverse Event|0|||
27695162|NCT02074553|80719900|FG007|Washout Period 1|Adverse Event|0|||
27695163|NCT02074553|80719893|FG000|Washout Period 1|Physician Decision|0|||
27695164|NCT02074553|80719894|FG001|Washout Period 1|Physician Decision|0|||
27695165|NCT02074553|80719895|FG002|Washout Period 1|Physician Decision|0|||
27695166|NCT02074553|80719896|FG003|Washout Period 1|Physician Decision|1|||
27695167|NCT02074553|80719897|FG004|Washout Period 1|Physician Decision|0|||
27695168|NCT02074553|80719898|FG005|Washout Period 1|Physician Decision|0|||
27695169|NCT02074553|80719899|FG006|Washout Period 1|Physician Decision|0|||
27695170|NCT02074553|80719900|FG007|Washout Period 1|Physician Decision|0|||
27695171|NCT02074553|80719893|FG000|Washout Period 1|Other|0|||
27826752|NCT03375463|81195520|FG003|Period 1|Lost to Follow-up|0|||
27695172|NCT02074553|80719894|FG001|Washout Period 1|Other|0|||
27826753|NCT03375463|81195521|FG004|Period 1|Lost to Follow-up|0|||
27826754|NCT03375463|81195522|FG005|Period 1|Lost to Follow-up|0|||
27826755|NCT03375463|81195517|FG000|Period 1|Adverse Event|0|||
27826756|NCT03375463|81195518|FG001|Period 1|Adverse Event|0|||
27695173|NCT02074553|80719895|FG002|Washout Period 1|Other|0|||
27695174|NCT02074553|80719896|FG003|Washout Period 1|Other|0|||
27695175|NCT02074553|80719897|FG004|Washout Period 1|Other|0|||
27826757|NCT03375463|81195519|FG002|Period 1|Adverse Event|0|||
27695176|NCT02074553|80719898|FG005|Washout Period 1|Other|1|||
27695177|NCT02074553|80719899|FG006|Washout Period 1|Other|0|||
27695178|NCT02074553|80719900|FG007|Washout Period 1|Other|0|||
27695179|NCT02074553|80719893|FG000|Washout Period 2|Adverse Event|0|||
27695180|NCT02074553|80719894|FG001|Washout Period 2|Adverse Event|0|||
27695181|NCT02074553|80719895|FG002|Washout Period 2|Adverse Event|0|||
27695182|NCT02074553|80719896|FG003|Washout Period 2|Adverse Event|0|||
27695183|NCT02074553|80719897|FG004|Washout Period 2|Adverse Event|0|||
27695184|NCT02074553|80719898|FG005|Washout Period 2|Adverse Event|0|||
27695185|NCT02074553|80719899|FG006|Washout Period 2|Adverse Event|1|||
27695186|NCT02074553|80719900|FG007|Washout Period 2|Adverse Event|0|||
27695187|NCT02074553|80719893|FG000|Washout Period 2|Physician Decision|0|||
27695188|NCT02074553|80719894|FG001|Washout Period 2|Physician Decision|0|||
27695189|NCT02074553|80719895|FG002|Washout Period 2|Physician Decision|0|||
27695190|NCT02074553|80719896|FG003|Washout Period 2|Physician Decision|0|||
27695191|NCT02074553|80719897|FG004|Washout Period 2|Physician Decision|0|||
27695192|NCT02074553|80719898|FG005|Washout Period 2|Physician Decision|1|||
27695193|NCT02074553|80719899|FG006|Washout Period 2|Physician Decision|0|||
27695194|NCT02074553|80719900|FG007|Washout Period 2|Physician Decision|0|||
27695195|NCT02074553|80719893|FG000|Washout Period 2|Lost to Follow-up|0|||
27695196|NCT02074553|80719894|FG001|Washout Period 2|Lost to Follow-up|0|||
27695197|NCT02074553|80719895|FG002|Washout Period 2|Lost to Follow-up|1|||
27695198|NCT02074553|80719896|FG003|Washout Period 2|Lost to Follow-up|0|||
27695199|NCT02074553|80719897|FG004|Washout Period 2|Lost to Follow-up|0|||
27695200|NCT02074553|80719898|FG005|Washout Period 2|Lost to Follow-up|0|||
27695201|NCT02074553|80719899|FG006|Washout Period 2|Lost to Follow-up|0|||
27695202|NCT02074553|80719900|FG007|Washout Period 2|Lost to Follow-up|0|||
27695203|NCT02074553|80719893|FG000|Washout Period 3|Physician Decision|0|||
27695204|NCT02074553|80719894|FG001|Washout Period 3|Physician Decision|0|||
27695205|NCT02074553|80719895|FG002|Washout Period 3|Physician Decision|0|||
27695206|NCT02074553|80719896|FG003|Washout Period 3|Physician Decision|0|||
27695207|NCT02074553|80719897|FG004|Washout Period 3|Physician Decision|0|||
27695208|NCT02074553|80719898|FG005|Washout Period 3|Physician Decision|0|||
27695209|NCT02074553|80719899|FG006|Washout Period 3|Physician Decision|0|||
27695210|NCT02074553|80719900|FG007|Washout Period 3|Physician Decision|1|||
27695211|NCT01272804|80719901|FG000|Overall Study|Adverse Event|1|||
27695212|NCT01272804|80719902|FG001|Overall Study|Adverse Event|0|||
27695213|NCT01272804|80719903|FG002|Overall Study|Adverse Event|0|||
27695214|NCT01272804|80719904|FG003|Overall Study|Adverse Event|0|||
27695215|NCT01272804|80719905|FG004|Overall Study|Adverse Event|2|||
27695216|NCT01272804|80719906|FG005|Overall Study|Adverse Event|1|||
27695217|NCT01174160|80719907|FG000|Overall Study|Adverse Event|1|||
27695218|NCT01174160|80719908|FG001|Overall Study|Adverse Event|0|||
27695219|NCT01174160|80719907|FG000|Overall Study|Lost to Follow-up|1|||
27695220|NCT01174160|80719908|FG001|Overall Study|Lost to Follow-up|0|||
27695221|NCT01174160|80719907|FG000|Overall Study|Physician Decision|1|||
27695222|NCT01174160|80719908|FG001|Overall Study|Physician Decision|0|||
27695223|NCT01174160|80719907|FG000|Overall Study|Protocol Violation|4|||
27695224|NCT01174160|80719908|FG001|Overall Study|Protocol Violation|6|||
27695225|NCT01174160|80719907|FG000|Overall Study|Withdrawal by Subject|1|||
27695226|NCT01174160|80719908|FG001|Overall Study|Withdrawal by Subject|0|||
27695227|NCT00504881|80719911|FG000|Overall Study|Lack of Efficacy|1|||
27695228|NCT00504881|80719912|FG001|Overall Study|Lack of Efficacy|5|||
27695229|NCT00504881|80719911|FG000|Overall Study|Lost to Follow-up|0|||
27695230|NCT00504881|80719912|FG001|Overall Study|Lost to Follow-up|2|||
27695231|NCT00504881|80719911|FG000|Overall Study|Withdrawal by Subject|1|||
27695232|NCT00504881|80719912|FG001|Overall Study|Withdrawal by Subject|4|||
27695233|NCT00504881|80719911|FG000|Overall Study|Non-Compliance|1|||
27695234|NCT00504881|80719912|FG001|Overall Study|Non-Compliance|0|||
27695235|NCT00504881|80719911|FG000|Overall Study|No Birth Control|0|||
27695236|NCT00504881|80719912|FG001|Overall Study|No Birth Control|1|||
27695237|NCT00504881|80719911|FG000|Overall Study|Safety Visit not performed|0|||
27695238|NCT00504881|80719912|FG001|Overall Study|Safety Visit not performed|1|||
27695239|NCT00504881|80719911|FG000|Overall Study|AE, serious fatal|0|||
27695240|NCT00504881|80719912|FG001|Overall Study|AE, serious fatal|1|||
27695241|NCT00504881|80719911|FG000|Overall Study|SAE, non-fatal|2|||
27695242|NCT00504881|80719912|FG001|Overall Study|SAE, non-fatal|6|||
27695243|NCT00504881|80719911|FG000|Overall Study|AE, non-serious non-fatal|4|||
27695244|NCT00504881|80719912|FG001|Overall Study|AE, non-serious non-fatal|14|||
27695245|NCT00504881|80719911|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27695246|NCT00504881|80719912|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
27695247|NCT00504881|80719911|FG000|Overall Study|AE of unknown type|1|||
27695248|NCT00504881|80719912|FG001|Overall Study|AE of unknown type|0|||
27695249|NCT04875676|80719914|FG000|Overall Study|Lost to Follow-up|1|||
27695250|NCT04875676|80719915|FG001|Overall Study|Lost to Follow-up|0|||
27695251|NCT04875676|80719916|FG002|Overall Study|Lost to Follow-up|0|||
27695252|NCT03603028|80719917|FG000|Overall Study|Withdrawal by Subject|1|||
27695253|NCT03658668|80719924|FG000|Overall Study|Time Commitment|1|||
27695254|NCT03658668|80719925|FG001|Overall Study|Time Commitment|1|||
27695255|NCT03214094|80719927|FG000|Overall Study|Case Report Forms Uncollected|14|||
27695256|NCT03214094|80719927|FG000|Overall Study|Protocol Deviation|46|||
27695257|NCT04526197|80719930|FG000|Period 1|Adverse Event|0|||
27695258|NCT04526197|80719931|FG001|Period 1|Adverse Event|1|||
27695259|NCT04526197|80719930|FG000|Period 1|Withdrawal by Subject|1|||
27695260|NCT04526197|80719931|FG001|Period 1|Withdrawal by Subject|0|||
27695261|NCT04526197|80719930|FG000|Period 2|Adverse Event|0|||
27695262|NCT04526197|80719931|FG001|Period 2|Adverse Event|1|||
27695263|NCT04526197|80719930|FG000|Period 2|Withdrawal by Subject|0|||
27695264|NCT04526197|80719931|FG001|Period 2|Withdrawal by Subject|1|||
27695265|NCT00985946|80719932|FG000|Overall Study|Lost to Follow-up|6|||
27695266|NCT00985946|80719932|FG000|Overall Study|Withdrawal by Subject|1|||
27695267|NCT01664598|80719933|FG000|Overall Study|Sponsor Decision|1|||
27695268|NCT01664598|80719933|FG000|Overall Study|Withdrawal of Informed Consent|4|||
27695269|NCT01664598|80719933|FG000|Overall Study|Adverse Event|1|||
27695270|NCT01111474|80719934|FG000|Overall Study|Lost to Follow-up|12|||
27695271|NCT02647320|80719936|FG000|Overall Study|Adverse Event|0|||
27695272|NCT02647320|80719937|FG001|Overall Study|Adverse Event|1|||
27695273|NCT02647320|80719938|FG002|Overall Study|Adverse Event|3|||
27695274|NCT02647320|80719939|FG003|Overall Study|Adverse Event|2|||
27695275|NCT02647320|80719940|FG004|Overall Study|Adverse Event|1|||
27695276|NCT02647320|80719936|FG000|Overall Study|Protocol Violation|0|||
27695277|NCT02647320|80719937|FG001|Overall Study|Protocol Violation|0|||
27695278|NCT02647320|80719938|FG002|Overall Study|Protocol Violation|3|||
27695279|NCT02647320|80719939|FG003|Overall Study|Protocol Violation|0|||
27695280|NCT02647320|80719940|FG004|Overall Study|Protocol Violation|0|||
27695281|NCT02647320|80719936|FG000|Overall Study|Withdrawal by Subject|7|||
27695282|NCT02647320|80719937|FG001|Overall Study|Withdrawal by Subject|4|||
27695283|NCT02647320|80719938|FG002|Overall Study|Withdrawal by Subject|2|||
27695284|NCT02647320|80719939|FG003|Overall Study|Withdrawal by Subject|2|||
27695285|NCT02647320|80719940|FG004|Overall Study|Withdrawal by Subject|7|||
27826758|NCT03375463|81195520|FG003|Period 1|Adverse Event|0|||
27826759|NCT03375463|81195521|FG004|Period 1|Adverse Event|1|||
27826760|NCT03375463|81195522|FG005|Period 1|Adverse Event|0|||
27826761|NCT03375463|81195517|FG000|Period 2|Lost to Follow-up|1|||
27826762|NCT03375463|81195518|FG001|Period 2|Lost to Follow-up|1|||
27695286|NCT02647320|80719936|FG000|Overall Study|Persistent hyperglycemia|0|||
27695287|NCT02647320|80719937|FG001|Overall Study|Persistent hyperglycemia|1|||
27695288|NCT02647320|80719938|FG002|Overall Study|Persistent hyperglycemia|1|||
27695289|NCT02647320|80719939|FG003|Overall Study|Persistent hyperglycemia|1|||
27695290|NCT02647320|80719940|FG004|Overall Study|Persistent hyperglycemia|1|||
27695291|NCT02647320|80719936|FG000|Overall Study|Study terminated by sponsor|1|||
27695292|NCT02647320|80719937|FG001|Overall Study|Study terminated by sponsor|1|||
27695293|NCT02647320|80719938|FG002|Overall Study|Study terminated by sponsor|1|||
27695294|NCT02647320|80719939|FG003|Overall Study|Study terminated by sponsor|1|||
27695295|NCT02647320|80719940|FG004|Overall Study|Study terminated by sponsor|2|||
27695296|NCT02647320|80719936|FG000|Overall Study|Reason not provided|0|||
27695297|NCT02647320|80719937|FG001|Overall Study|Reason not provided|0|||
27695298|NCT02647320|80719938|FG002|Overall Study|Reason not provided|1|||
27695299|NCT02647320|80719939|FG003|Overall Study|Reason not provided|0|||
27695300|NCT02647320|80719940|FG004|Overall Study|Reason not provided|2|||
27695301|NCT02647320|80719936|FG000|Overall Study|Lost to Follow-up|1|||
27695302|NCT02647320|80719937|FG001|Overall Study|Lost to Follow-up|1|||
27695303|NCT02647320|80719938|FG002|Overall Study|Lost to Follow-up|0|||
27695304|NCT02647320|80719939|FG003|Overall Study|Lost to Follow-up|0|||
27695305|NCT02647320|80719940|FG004|Overall Study|Lost to Follow-up|0|||
27695306|NCT02647320|80719936|FG000|Overall Study|Develop anemia|1|||
27695307|NCT02647320|80719937|FG001|Overall Study|Develop anemia|0|||
27695308|NCT02647320|80719938|FG002|Overall Study|Develop anemia|0|||
27695309|NCT02647320|80719939|FG003|Overall Study|Develop anemia|0|||
27695310|NCT02647320|80719940|FG004|Overall Study|Develop anemia|0|||
27695311|NCT02647320|80719936|FG000|Overall Study|Lack of Efficacy|0|||
27695312|NCT02647320|80719937|FG001|Overall Study|Lack of Efficacy|0|||
27695313|NCT02647320|80719938|FG002|Overall Study|Lack of Efficacy|0|||
27695314|NCT02647320|80719939|FG003|Overall Study|Lack of Efficacy|1|||
27695315|NCT02647320|80719940|FG004|Overall Study|Lack of Efficacy|0|||
27695316|NCT02647320|80719936|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
27695317|NCT02647320|80719937|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
27695318|NCT02647320|80719938|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
27695319|NCT02647320|80719939|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
27695320|NCT02647320|80719940|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
27695321|NCT03353350|80719944|FG000|30-week Core Treatment Period|Protocol Violation|1|||
27695322|NCT03353350|80719945|FG001|30-week Core Treatment Period|Protocol Violation|1|||
27695323|NCT03353350|80719946|FG002|30-week Core Treatment Period|Protocol Violation|1|||
27695324|NCT03353350|80719947|FG003|30-week Core Treatment Period|Protocol Violation|0|||
27695325|NCT03353350|80719944|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
27695326|NCT03353350|80719945|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
27695327|NCT03353350|80719946|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
27695328|NCT03353350|80719947|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
27695329|NCT03353350|80719944|FG000|30-week Core Treatment Period|Adverse Event|0|||
27695330|NCT03353350|80719945|FG001|30-week Core Treatment Period|Adverse Event|4|||
27695331|NCT03353350|80719946|FG002|30-week Core Treatment Period|Adverse Event|2|||
27695332|NCT03353350|80719947|FG003|30-week Core Treatment Period|Adverse Event|3|||
27695333|NCT03353350|80719944|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
27695334|NCT03353350|80719945|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
27695335|NCT03353350|80719946|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
27695336|NCT03353350|80719947|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
27695337|NCT03353350|80719944|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
27695338|NCT03353350|80719945|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
27695339|NCT03353350|80719946|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
27695340|NCT03353350|80719947|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
27695341|NCT03353350|80719944|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
27695342|NCT03353350|80719945|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
27695343|NCT03353350|80719946|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
27695344|NCT03353350|80719947|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
27695345|NCT03353350|80719944|FG000|26-week Treatment Extension Period|Adverse Event|1|||
27695346|NCT03353350|80719945|FG001|26-week Treatment Extension Period|Adverse Event|0|||
27695347|NCT03353350|80719946|FG002|26-week Treatment Extension Period|Adverse Event|0|||
27695348|NCT03353350|80719947|FG003|26-week Treatment Extension Period|Adverse Event|1|||
27695349|NCT03353350|80719944|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
27695350|NCT03353350|80719945|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
27695351|NCT03353350|80719946|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
27695352|NCT03353350|80719947|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
27695353|NCT02640157|80719954|FG000|Overall Study|Adverse Event|2|||
27695354|NCT02640157|80719955|FG001|Overall Study|Adverse Event|2|||
27695355|NCT02640157|80719956|FG002|Overall Study|Adverse Event|1|||
27695356|NCT02640157|80719954|FG000|Overall Study|Withdrew consent|2|||
27695357|NCT02640157|80719955|FG001|Overall Study|Withdrew consent|0|||
27695358|NCT02640157|80719956|FG002|Overall Study|Withdrew consent|2|||
27695359|NCT02640157|80719954|FG000|Overall Study|Lost to Follow-up|9|||
27695360|NCT02640157|80719955|FG001|Overall Study|Lost to Follow-up|2|||
27695361|NCT02640157|80719956|FG002|Overall Study|Lost to Follow-up|7|||
27695362|NCT02640157|80719954|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
27695363|NCT02640157|80719955|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
27695364|NCT02640157|80719956|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
27695365|NCT01485354|80719958|FG000|Overall Study|Withdrawal by Subject|5|||
27695366|NCT00332189|80719961|FG000|Overall Study|Adverse Event|3|||
27695367|NCT00332189|80719961|FG000|Overall Study|Uncooperative/Noncompliant|3|||
27695368|NCT00332189|80719961|FG000|Overall Study|Withdrawal by Subject|9|||
27695369|NCT00332189|80719961|FG000|Overall Study|Lack of Efficacy|4|||
27695370|NCT00332189|80719961|FG000|Overall Study|Moved out of country|2|||
27695371|NCT00899548|80719962|FG000|Overall Study|Physician Decision|3|||
27695372|NCT01658826|80719965|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
27695373|NCT01658826|80719966|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
27695374|NCT01658826|80719965|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
27695375|NCT01658826|80719966|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
27695376|NCT01658826|80719965|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
27695377|NCT01658826|80719966|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
27695378|NCT01658826|80719965|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
27695379|NCT01658826|80719966|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
27695380|NCT01658826|80719965|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
27695381|NCT01658826|80719966|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
27695382|NCT01658826|80719965|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
27695383|NCT01658826|80719966|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
27695384|NCT01658826|80719965|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
27695385|NCT01658826|80719966|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
27695386|NCT01658826|80719965|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
27695387|NCT01658826|80719966|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
27695388|NCT01658826|80719965|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
27695389|NCT01658826|80719966|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
27695390|NCT02683876|80719967|FG000|Overall Study|samples damaged during shipping|2|||
27695391|NCT02683876|80719968|FG001|Overall Study|samples damaged during shipping|0|||
27695392|NCT01313637|80719969|FG000|Overall Study|Adverse Event|17|||
27695393|NCT01313637|80719970|FG001|Overall Study|Adverse Event|24|||
27695394|NCT01313637|80719971|FG002|Overall Study|Adverse Event|25|||
27695395|NCT01313637|80719972|FG003|Overall Study|Adverse Event|18|||
27695396|NCT01313637|80719969|FG000|Overall Study|Lack of Efficacy|44|||
27695397|NCT01313637|80719970|FG001|Overall Study|Lack of Efficacy|38|||
27695398|NCT01313637|80719971|FG002|Overall Study|Lack of Efficacy|37|||
27695399|NCT01313637|80719972|FG003|Overall Study|Lack of Efficacy|24|||
27695400|NCT01313637|80719969|FG000|Overall Study|Protocol Violation|4|||
27695401|NCT01313637|80719970|FG001|Overall Study|Protocol Violation|3|||
27695402|NCT01313637|80719971|FG002|Overall Study|Protocol Violation|11|||
27695403|NCT01313637|80719972|FG003|Overall Study|Protocol Violation|5|||
27695404|NCT01313637|80719969|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
27695405|NCT01313637|80719970|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
27695406|NCT01313637|80719971|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
27695407|NCT01313637|80719972|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
27695408|NCT01313637|80719969|FG000|Overall Study|Lost to Follow-up|0|||
27695409|NCT01313637|80719970|FG001|Overall Study|Lost to Follow-up|2|||
27695410|NCT01313637|80719971|FG002|Overall Study|Lost to Follow-up|1|||
27695411|NCT01313637|80719972|FG003|Overall Study|Lost to Follow-up|3|||
27695412|NCT01313637|80719969|FG000|Overall Study|Withdrawal by Subject|11|||
27695413|NCT01313637|80719970|FG001|Overall Study|Withdrawal by Subject|13|||
27695414|NCT01313637|80719971|FG002|Overall Study|Withdrawal by Subject|18|||
27695415|NCT01313637|80719972|FG003|Overall Study|Withdrawal by Subject|15|||
27695416|NCT02070588|80719973|FG000|Overall Study|Withdrawal by Subject|29|||
27695417|NCT02070588|80719974|FG001|Overall Study|Withdrawal by Subject|1|||
27695418|NCT02070588|80719975|FG002|Overall Study|Withdrawal by Subject|0|||
27695419|NCT02070588|80719973|FG000|Overall Study|Writhdrawal due to early termination|9|||
27695420|NCT02070588|80719974|FG001|Overall Study|Writhdrawal due to early termination|0|||
27695421|NCT02070588|80719975|FG002|Overall Study|Writhdrawal due to early termination|0|||
27695422|NCT02070588|80719973|FG000|Overall Study|Adverse Event|1|||
27695423|NCT02070588|80719974|FG001|Overall Study|Adverse Event|0|||
27695424|NCT02070588|80719975|FG002|Overall Study|Adverse Event|0|||
27695425|NCT00250679|80719976|FG000|Overall Study|Adverse Event|12|||
27695426|NCT00250679|80719977|FG001|Overall Study|Adverse Event|15|||
27695427|NCT00250679|80719978|FG002|Overall Study|Adverse Event|16|||
27695428|NCT00250679|80719976|FG000|Overall Study|Protocol Violation|2|||
27695429|NCT00250679|80719977|FG001|Overall Study|Protocol Violation|4|||
27695430|NCT00250679|80719978|FG002|Overall Study|Protocol Violation|3|||
27695431|NCT00250679|80719976|FG000|Overall Study|Withdrawal by Subject|15|||
27695432|NCT00250679|80719977|FG001|Overall Study|Withdrawal by Subject|18|||
27695433|NCT00250679|80719978|FG002|Overall Study|Withdrawal by Subject|15|||
27695434|NCT00250679|80719976|FG000|Overall Study|Lost to Follow-up|3|||
27695435|NCT00250679|80719977|FG001|Overall Study|Lost to Follow-up|4|||
27695436|NCT00250679|80719978|FG002|Overall Study|Lost to Follow-up|2|||
27695437|NCT00250679|80719976|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
27695438|NCT00250679|80719977|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
27695439|NCT00250679|80719978|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
27695440|NCT00250679|80719976|FG000|Overall Study|Lack of Efficacy|0|||
27695441|NCT00250679|80719977|FG001|Overall Study|Lack of Efficacy|1|||
27695442|NCT00250679|80719978|FG002|Overall Study|Lack of Efficacy|3|||
27695443|NCT00250679|80719976|FG000|Overall Study|Technical Holter issues|1|||
27695444|NCT00250679|80719977|FG001|Overall Study|Technical Holter issues|0|||
27695445|NCT00250679|80719978|FG002|Overall Study|Technical Holter issues|2|||
27695446|NCT00250679|80719976|FG000|Overall Study|Moved|1|||
27695447|NCT00250679|80719977|FG001|Overall Study|Moved|1|||
27695448|NCT00250679|80719978|FG002|Overall Study|Moved|0|||
27695449|NCT00250679|80719976|FG000|Overall Study|Non-compliance|1|||
27695450|NCT00250679|80719977|FG001|Overall Study|Non-compliance|1|||
27695451|NCT00250679|80719978|FG002|Overall Study|Non-compliance|0|||
27695452|NCT00250679|80719976|FG000|Overall Study|various single events: hip surgery,diary|3|||
27695453|NCT00250679|80719977|FG001|Overall Study|various single events: hip surgery,diary|1|||
27695454|NCT00250679|80719978|FG002|Overall Study|various single events: hip surgery,diary|1|||
27695455|NCT00141726|80719979|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
27695456|NCT00717067|80719980|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27695457|NCT00717067|80719981|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27695458|NCT00717067|80719982|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
27695459|NCT00717067|80719983|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27695460|NCT00717067|80719984|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
27695461|NCT02164383|80719985|FG000|Overall Study|Lost to Follow-up|1|||
27695462|NCT02164383|80719986|FG001|Overall Study|Lost to Follow-up|0|||
27695463|NCT01136772|80719987|FG000|Overall Study|Adverse Event|15|||
27695464|NCT01136772|80719988|FG001|Overall Study|Adverse Event|14|||
27695465|NCT01136772|80719987|FG000|Overall Study|Lack of Efficacy|42|||
27695466|NCT01136772|80719988|FG001|Overall Study|Lack of Efficacy|39|||
27695467|NCT01136772|80719987|FG000|Overall Study|Administrative|14|||
27695468|NCT01136772|80719988|FG001|Overall Study|Administrative|12|||
27695469|NCT01136772|80719987|FG000|Overall Study|Withdrawal by Subject|33|||
27695470|NCT01136772|80719988|FG001|Overall Study|Withdrawal by Subject|36|||
27695471|NCT01136772|80719987|FG000|Overall Study|Did not receive injection|10|||
27695472|NCT01136772|80719988|FG001|Overall Study|Did not receive injection|7|||
27695473|NCT01136772|80719987|FG000|Overall Study|Did not follow up after first injection|2|||
27695474|NCT01136772|80719988|FG001|Overall Study|Did not follow up after first injection|2|||
27695475|NCT00690820|80719989|FG000|Period 1|Withdrawal by Subject|0|||
27695476|NCT00690820|80719990|FG001|Period 1|Withdrawal by Subject|1|||
27695477|NCT02318797|80719993|FG000|Overall Study|Death|3|||
27695478|NCT02318797|80719994|FG001|Overall Study|Death|6|||
27695479|NCT02318797|80719993|FG000|Overall Study|Lost to Follow-up|85|||
27695480|NCT02318797|80719994|FG001|Overall Study|Lost to Follow-up|96|||
27695481|NCT02054520|80719995|FG000|Overall Study|Adverse Event|1|||
27695482|NCT02054520|80719996|FG001|Overall Study|Adverse Event|4|||
27695483|NCT02054520|80719997|FG002|Overall Study|Adverse Event|2|||
27695484|NCT02054520|80719998|FG003|Overall Study|Adverse Event|1|||
27695485|NCT02054520|80719999|FG004|Overall Study|Adverse Event|1|||
27695486|NCT02054520|80720000|FG005|Overall Study|Adverse Event|0|||
27695487|NCT02054520|80719995|FG000|Overall Study|Lack of Efficacy|7|||
27695488|NCT02054520|80719996|FG001|Overall Study|Lack of Efficacy|0|||
27695489|NCT02054520|80719997|FG002|Overall Study|Lack of Efficacy|2|||
27695490|NCT02054520|80719998|FG003|Overall Study|Lack of Efficacy|1|||
27695491|NCT02054520|80719999|FG004|Overall Study|Lack of Efficacy|3|||
27695492|NCT02054520|80720000|FG005|Overall Study|Lack of Efficacy|2|||
27695493|NCT02054520|80719995|FG000|Overall Study|Withdrawal by Subject|1|||
27695494|NCT02054520|80719996|FG001|Overall Study|Withdrawal by Subject|0|||
27695495|NCT02054520|80719997|FG002|Overall Study|Withdrawal by Subject|0|||
27695496|NCT02054520|80719998|FG003|Overall Study|Withdrawal by Subject|2|||
27695497|NCT02054520|80719999|FG004|Overall Study|Withdrawal by Subject|1|||
27695498|NCT02054520|80720000|FG005|Overall Study|Withdrawal by Subject|0|||
27695499|NCT02054520|80719995|FG000|Overall Study|Physician Decision|0|||
27695500|NCT02054520|80719996|FG001|Overall Study|Physician Decision|1|||
27695501|NCT02054520|80719997|FG002|Overall Study|Physician Decision|0|||
27695502|NCT02054520|80719998|FG003|Overall Study|Physician Decision|1|||
27695503|NCT02054520|80719999|FG004|Overall Study|Physician Decision|0|||
27695504|NCT02054520|80720000|FG005|Overall Study|Physician Decision|1|||
27695505|NCT02054520|80719995|FG000|Overall Study|Study terminated by Sponsor|0|||
27695506|NCT02054520|80719996|FG001|Overall Study|Study terminated by Sponsor|0|||
27695507|NCT02054520|80719997|FG002|Overall Study|Study terminated by Sponsor|2|||
27695508|NCT02054520|80719998|FG003|Overall Study|Study terminated by Sponsor|1|||
27695509|NCT02054520|80719999|FG004|Overall Study|Study terminated by Sponsor|0|||
27695510|NCT02054520|80720000|FG005|Overall Study|Study terminated by Sponsor|0|||
27695511|NCT03240874|80720001|FG000|Overall Study|Lost to Follow-up|0|||
27695512|NCT03240874|80720002|FG001|Overall Study|Lost to Follow-up|2|||
27695513|NCT03240874|80720003|FG002|Overall Study|Lost to Follow-up|4|||
27695514|NCT03240874|80720004|FG003|Overall Study|Lost to Follow-up|1|||
27695515|NCT01828073|80720005|FG000|Overall Study|Lost to Follow-up|1|||
27695516|NCT01828073|80720006|FG001|Overall Study|Lost to Follow-up|2|||
27695517|NCT02019927|80720009|FG000|Overall Study|Lost to Follow-up|2|||
27695518|NCT02019927|80720010|FG001|Overall Study|Lost to Follow-up|4|||
27695519|NCT02019927|80720011|FG002|Overall Study|Lost to Follow-up|1|||
27695520|NCT02019927|80720012|FG003|Overall Study|Lost to Follow-up|2|||
27695521|NCT02019927|80720013|FG004|Overall Study|Lost to Follow-up|3|||
27695522|NCT02019927|80720014|FG005|Overall Study|Lost to Follow-up|1|||
27695523|NCT00852540|80720019|FG000|Overall Study|Adverse Event|10|||
27695524|NCT00852540|80720020|FG001|Overall Study|Adverse Event|3|||
27695525|NCT00852540|80720019|FG000|Overall Study|Lack of Efficacy|15|||
27695526|NCT00852540|80720020|FG001|Overall Study|Lack of Efficacy|3|||
27695527|NCT00852540|80720019|FG000|Overall Study|Protocol Violation|1|||
27695528|NCT00852540|80720020|FG001|Overall Study|Protocol Violation|2|||
27695529|NCT00852540|80720019|FG000|Overall Study|Lost to Follow-up|2|||
27695530|NCT00852540|80720020|FG001|Overall Study|Lost to Follow-up|3|||
27695531|NCT00852540|80720019|FG000|Overall Study|Investigator Discretion|2|||
27695532|NCT00852540|80720020|FG001|Overall Study|Investigator Discretion|3|||
27695533|NCT00852540|80720019|FG000|Overall Study|Withdrawal by Subject|3|||
27695534|NCT00852540|80720020|FG001|Overall Study|Withdrawal by Subject|1|||
27695535|NCT00852540|80720019|FG000|Overall Study|Did Not Receive Study Drug|3|||
27695536|NCT00852540|80720020|FG001|Overall Study|Did Not Receive Study Drug|3|||
27695537|NCT00743275|80720021|FG000|Overall Study|Protocol Violation|0|||
27695538|NCT00743275|80720022|FG001|Overall Study|Protocol Violation|1|||
27695539|NCT00796120|80720024|FG000|Overall Study|Death|3|||
27695540|NCT00796120|80720025|FG001|Overall Study|Death|0|||
27695541|NCT00796120|80720024|FG000|Overall Study|Adverse Event|11|||
27695542|NCT00796120|80720025|FG001|Overall Study|Adverse Event|6|||
27695543|NCT00796120|80720024|FG000|Overall Study|Progressive disease|22|||
27695544|NCT00796120|80720025|FG001|Overall Study|Progressive disease|13|||
27695545|NCT00796120|80720024|FG000|Overall Study|Participant refusal|3|||
27695546|NCT00796120|80720025|FG001|Overall Study|Participant refusal|4|||
27695547|NCT00796120|80720024|FG000|Overall Study|Other|6|||
27695548|NCT00796120|80720025|FG001|Overall Study|Other|17|||
27695549|NCT00796120|80720024|FG000|Overall Study|Physician Decision|16|||
27695550|NCT00796120|80720025|FG001|Overall Study|Physician Decision|17|||
27695551|NCT00796120|80720024|FG000|Overall Study|Randomized but not treated|0|||
27695552|NCT00796120|80720025|FG001|Overall Study|Randomized but not treated|3|||
27695553|NCT00400985|80720026|FG000|Overall Study|Withdrawal by Subject|5|||
27695554|NCT00400985|80720026|FG000|Overall Study|system modification|8|||
27695555|NCT00400985|80720026|FG000|Overall Study|Death|30|||
27695556|NCT00400985|80720026|FG000|Overall Study|Lost to Follow-up|9|||
27695557|NCT03587974|80720027|FG000|Overall Study|caregiver demented, care recipient died|3|||
27695558|NCT03587974|80720028|FG001|Overall Study|caregiver demented, care recipient died|3|||
27695559|NCT03587974|80720027|FG000|Overall Study|Withdrawal by Subject|2|||
27695560|NCT03587974|80720028|FG001|Overall Study|Withdrawal by Subject|1|||
27695561|NCT04751656|80720029|FG000|Overall Study|Lost to Follow-up|1|||
27695562|NCT03628898|80720030|FG000|Overall Study|Device deficiency|1|||
27826763|NCT03375463|81195519|FG002|Period 2|Lost to Follow-up|0|||
27695563|NCT02434939|80720037|FG000|Overall Study|Lack of Efficacy|34|||
27695564|NCT02434939|80720038|FG001|Overall Study|Lack of Efficacy|48|||
27695565|NCT02434939|80720037|FG000|Overall Study|Withdrawal by Subject|3|||
27695566|NCT02434939|80720038|FG001|Overall Study|Withdrawal by Subject|0|||
27695567|NCT02434939|80720037|FG000|Overall Study|Adverse Event|0|||
27695568|NCT02434939|80720038|FG001|Overall Study|Adverse Event|1|||
27695569|NCT04433585|80720039|FG000|Overall Study|Withdrawal by Subject|15|||
27695570|NCT04433585|80720040|FG001|Overall Study|Withdrawal by Subject|3|||
27695571|NCT04433585|80720041|FG002|Overall Study|Withdrawal by Subject|15|||
27695572|NCT04433585|80720042|FG003|Overall Study|Withdrawal by Subject|6|||
27695573|NCT04433585|80720039|FG000|Overall Study|Adverse Event|10|||
27695574|NCT04433585|80720040|FG001|Overall Study|Adverse Event|4|||
27695575|NCT04433585|80720041|FG002|Overall Study|Adverse Event|1|||
27695576|NCT04433585|80720042|FG003|Overall Study|Adverse Event|0|||
27695577|NCT04433585|80720039|FG000|Overall Study|Due to the conflict in Ukraine|2|||
27695578|NCT04433585|80720040|FG001|Overall Study|Due to the conflict in Ukraine|1|||
27695579|NCT04433585|80720041|FG002|Overall Study|Due to the conflict in Ukraine|1|||
27695580|NCT04433585|80720042|FG003|Overall Study|Due to the conflict in Ukraine|2|||
27695581|NCT04433585|80720039|FG000|Overall Study|Physician Decision|1|||
27695582|NCT04433585|80720040|FG001|Overall Study|Physician Decision|2|||
27695583|NCT04433585|80720041|FG002|Overall Study|Physician Decision|0|||
27695584|NCT04433585|80720042|FG003|Overall Study|Physician Decision|0|||
27695585|NCT04433585|80720039|FG000|Overall Study|Lost to Follow-up|1|||
27695586|NCT04433585|80720040|FG001|Overall Study|Lost to Follow-up|1|||
27695587|NCT04433585|80720041|FG002|Overall Study|Lost to Follow-up|1|||
27695588|NCT04433585|80720042|FG003|Overall Study|Lost to Follow-up|0|||
27695589|NCT04433585|80720039|FG000|Overall Study|Lack of Efficacy|0|||
27695590|NCT04433585|80720040|FG001|Overall Study|Lack of Efficacy|1|||
27695591|NCT04433585|80720041|FG002|Overall Study|Lack of Efficacy|1|||
27695592|NCT04433585|80720042|FG003|Overall Study|Lack of Efficacy|1|||
27695593|NCT04433585|80720039|FG000|Overall Study|Death|0|||
27695594|NCT04433585|80720040|FG001|Overall Study|Death|1|||
27695595|NCT04433585|80720041|FG002|Overall Study|Death|0|||
27695596|NCT04433585|80720042|FG003|Overall Study|Death|0|||
27695597|NCT01636960|80720045|FG000|Induction Phase|Adverse Event|2|||
27695598|NCT01636960|80720045|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
27695599|NCT01636960|80720045|FG000|Maintenance Phase|Adverse Event|3|||
27695600|NCT01636960|80720045|FG000|Maintenance Phase|Progressive disease|1|||
27695601|NCT01136811|80720046|FG000|Overall Study|Physician Decision|11|||
27695602|NCT00409773|80720047|FG000|Overall Study|Adverse Event|3|||
27695603|NCT00409773|80720048|FG001|Overall Study|Adverse Event|4|||
27695604|NCT00409773|80720049|FG002|Overall Study|Adverse Event|4|||
27695605|NCT00409773|80720050|FG003|Overall Study|Adverse Event|2|||
27695606|NCT00409773|80720051|FG004|Overall Study|Adverse Event|6|||
27695607|NCT00409773|80720047|FG000|Overall Study|Lost to Follow-up|6|||
27695608|NCT00409773|80720048|FG001|Overall Study|Lost to Follow-up|1|||
27695609|NCT00409773|80720049|FG002|Overall Study|Lost to Follow-up|2|||
27695610|NCT00409773|80720050|FG003|Overall Study|Lost to Follow-up|3|||
27695611|NCT00409773|80720051|FG004|Overall Study|Lost to Follow-up|1|||
27695612|NCT00409773|80720047|FG000|Overall Study|Physician Decision|0|||
27695613|NCT00409773|80720048|FG001|Overall Study|Physician Decision|0|||
27695614|NCT00409773|80720049|FG002|Overall Study|Physician Decision|0|||
27695615|NCT00409773|80720050|FG003|Overall Study|Physician Decision|2|||
27695616|NCT00409773|80720051|FG004|Overall Study|Physician Decision|0|||
27695617|NCT00409773|80720047|FG000|Overall Study|Protocol Violation|0|||
27695618|NCT00409773|80720048|FG001|Overall Study|Protocol Violation|2|||
27695619|NCT00409773|80720049|FG002|Overall Study|Protocol Violation|3|||
27695620|NCT00409773|80720050|FG003|Overall Study|Protocol Violation|3|||
27695621|NCT00409773|80720051|FG004|Overall Study|Protocol Violation|1|||
27695622|NCT00409773|80720047|FG000|Overall Study|Withdrawal by Subject|0|||
27695623|NCT00409773|80720048|FG001|Overall Study|Withdrawal by Subject|0|||
27695624|NCT00409773|80720049|FG002|Overall Study|Withdrawal by Subject|0|||
27695625|NCT00409773|80720050|FG003|Overall Study|Withdrawal by Subject|2|||
27695626|NCT00409773|80720051|FG004|Overall Study|Withdrawal by Subject|1|||
27695627|NCT00409773|80720047|FG000|Overall Study|Lack of Eligibility|0|||
27695628|NCT00409773|80720048|FG001|Overall Study|Lack of Eligibility|0|||
27695629|NCT00409773|80720049|FG002|Overall Study|Lack of Eligibility|0|||
27695630|NCT00409773|80720050|FG003|Overall Study|Lack of Eligibility|0|||
27695631|NCT00409773|80720051|FG004|Overall Study|Lack of Eligibility|1|||
27695632|NCT00494481|80720052|FG000|Overall Study|Condition under investigation worsened|11|||
27695633|NCT00494481|80720053|FG001|Overall Study|Condition under investigation worsened|13|||
27695634|NCT00494481|80720052|FG000|Overall Study|Adverse Event|15|||
27695635|NCT00494481|80720053|FG001|Overall Study|Adverse Event|11|||
27695636|NCT00494481|80720052|FG000|Overall Study|Other|1|||
27695637|NCT00494481|80720053|FG001|Overall Study|Other|0|||
27695638|NCT00494481|80720052|FG000|Overall Study|Never received IP|2|||
27695639|NCT00494481|80720053|FG001|Overall Study|Never received IP|0|||
27695640|NCT02216357|80720054|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
27695641|NCT02216357|80720055|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
27695642|NCT00346268|80720056|FG000|Overall Study|Adverse Event|1|||
27695643|NCT00346268|80720057|FG001|Overall Study|Adverse Event|0|||
27695644|NCT00346268|80720056|FG000|Overall Study|Protocol Violation|1|||
27695645|NCT00346268|80720057|FG001|Overall Study|Protocol Violation|0|||
27695646|NCT00346268|80720056|FG000|Overall Study|Participant refused|0|||
27695647|NCT00346268|80720057|FG001|Overall Study|Participant refused|3|||
27695648|NCT00679627|80720061|FG000|Overall Study|Death|41|||
27695649|NCT00679627|80720062|FG001|Overall Study|Death|29|||
27695650|NCT00679627|80720061|FG000|Overall Study|Adverse Event|43|||
27695651|NCT00679627|80720062|FG001|Overall Study|Adverse Event|53|||
27695652|NCT00679627|80720061|FG000|Overall Study|Withdrawal by Subject|168|||
27695653|NCT00679627|80720062|FG001|Overall Study|Withdrawal by Subject|172|||
27695654|NCT00679627|80720061|FG000|Overall Study|Lost to Follow-up|22|||
27695655|NCT00679627|80720062|FG001|Overall Study|Lost to Follow-up|26|||
27695656|NCT00679627|80720061|FG000|Overall Study|Early Study Closure|425|||
27695657|NCT00679627|80720062|FG001|Overall Study|Early Study Closure|405|||
27695658|NCT04975438|80720067|FG000|Overall Study|Lost to Follow-up|1|||
27695659|NCT04975438|80720068|FG001|Overall Study|Lost to Follow-up|0|||
27695660|NCT04975438|80720069|FG002|Overall Study|Lost to Follow-up|1|||
27695661|NCT04975438|80720070|FG003|Overall Study|Lost to Follow-up|0|||
27695662|NCT04975438|80720067|FG000|Overall Study|Withdrawal by Subject|1|||
27695663|NCT04975438|80720068|FG001|Overall Study|Withdrawal by Subject|0|||
27695664|NCT04975438|80720069|FG002|Overall Study|Withdrawal by Subject|0|||
27695665|NCT04975438|80720070|FG003|Overall Study|Withdrawal by Subject|0|||
27695666|NCT02027623|80720071|FG000|Overall Study|Lost to Follow-up|3|||
27695667|NCT02027623|80720072|FG001|Overall Study|Lost to Follow-up|3|||
27695668|NCT02027623|80720071|FG000|Overall Study|Withdrawal by Subject|6|||
27695669|NCT02027623|80720072|FG001|Overall Study|Withdrawal by Subject|9|||
27695670|NCT00593957|80720075|FG000|Overall Study|Physician Decision|0|||
27695671|NCT00593957|80720076|FG001|Overall Study|Physician Decision|1|||
27695672|NCT00593957|80720077|FG002|Overall Study|Physician Decision|2|||
27695673|NCT01003990|80720082|FG000|Overall Study|Adverse Event|8|||
27695674|NCT01003990|80720083|FG001|Overall Study|Adverse Event|5|||
27695675|NCT01003990|80720084|FG002|Overall Study|Adverse Event|11|||
27695676|NCT01003990|80720082|FG000|Overall Study|Death|0|||
27695677|NCT01003990|80720083|FG001|Overall Study|Death|8|||
27695678|NCT01003990|80720084|FG002|Overall Study|Death|1|||
27695679|NCT01003990|80720082|FG000|Overall Study|Lack of Efficacy|10|||
27695680|NCT01003990|80720083|FG001|Overall Study|Lack of Efficacy|2|||
27695681|NCT01003990|80720084|FG002|Overall Study|Lack of Efficacy|3|||
27695682|NCT01003990|80720082|FG000|Overall Study|Lost to Follow-up|30|||
27695683|NCT01003990|80720083|FG001|Overall Study|Lost to Follow-up|12|||
27695684|NCT01003990|80720084|FG002|Overall Study|Lost to Follow-up|7|||
27695685|NCT01003990|80720082|FG000|Overall Study|Reasons Not Identified|14|||
27695686|NCT01003990|80720083|FG001|Overall Study|Reasons Not Identified|13|||
27695687|NCT01003990|80720084|FG002|Overall Study|Reasons Not Identified|8|||
27695688|NCT01003990|80720082|FG000|Overall Study|Poor/Non-compliance|4|||
27695689|NCT01003990|80720083|FG001|Overall Study|Poor/Non-compliance|3|||
27695690|NCT01003990|80720084|FG002|Overall Study|Poor/Non-compliance|2|||
27695691|NCT01003990|80720082|FG000|Overall Study|Pregnancy|10|||
27695692|NCT01003990|80720083|FG001|Overall Study|Pregnancy|2|||
27695693|NCT01003990|80720084|FG002|Overall Study|Pregnancy|4|||
27695694|NCT01003990|80720082|FG000|Overall Study|No Longer Met Study Criteria|4|||
27695695|NCT01003990|80720083|FG001|Overall Study|No Longer Met Study Criteria|1|||
27695696|NCT01003990|80720084|FG002|Overall Study|No Longer Met Study Criteria|0|||
27695697|NCT01003990|80720082|FG000|Overall Study|Subject Withdrew Consent|12|||
27695698|NCT01003990|80720083|FG001|Overall Study|Subject Withdrew Consent|5|||
27826764|NCT03375463|81195520|FG003|Period 2|Lost to Follow-up|0|||
27826765|NCT03375463|81195521|FG004|Period 2|Lost to Follow-up|0|||
27826766|NCT03375463|81195522|FG005|Period 2|Lost to Follow-up|0|||
27826767|NCT01757392|81195523|FG000|Overall Study|Withdrawal by Subject|1|||
27695699|NCT01003990|80720084|FG002|Overall Study|Subject Withdrew Consent|7|||
27695700|NCT01146054|80720087|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
27695701|NCT01146054|80720087|FG000|Overall Study|Rapid tumor progression|2|||
27695702|NCT01146054|80720087|FG000|Overall Study|Other illness precluded treatment|2|||
27826768|NCT01757392|81195523|FG000|Overall Study|Screen Fail|3|||
27826769|NCT03772522|81195524|FG000|Pre-intervention|Withdrawal by Subject|3|||
27695703|NCT01146054|80720087|FG000|Overall Study|Lost to Follow-up|1|||
27695704|NCT03435497|80720088|FG000|Overall Study|Lost to Follow-up|1|||
27695705|NCT03435497|80720089|FG001|Overall Study|Lost to Follow-up|0|||
27695706|NCT03435497|80720088|FG000|Overall Study|Death|1|||
27695707|NCT03435497|80720089|FG001|Overall Study|Death|0|||
27695708|NCT03435497|80720088|FG000|Overall Study|Withdrawal by Subject|0|||
27695709|NCT03435497|80720089|FG001|Overall Study|Withdrawal by Subject|4|||
27826770|NCT03772522|81195525|FG001|Pre-intervention|Withdrawal by Subject|4|||
27695710|NCT03435497|80720088|FG000|Overall Study|Wrong survey administered|0|||
27695711|NCT03435497|80720089|FG001|Overall Study|Wrong survey administered|2|||
27695712|NCT02092220|80720096|FG000|Period 1|Unrelated Illness|0|||
27695713|NCT02092220|80720097|FG001|Period 1|Unrelated Illness|2|||
27695714|NCT02092220|80720096|FG000|Period 2|Severe Hypoglycaemia|1|||
27695715|NCT02092220|80720097|FG001|Period 2|Severe Hypoglycaemia|0|||
27695716|NCT02092220|80720096|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
27695717|NCT02092220|80720097|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
27695718|NCT00551460|80720098|FG000|Overall Study|Adverse Event|1|||
27695719|NCT00551460|80720098|FG000|Overall Study|Withdrawal by Subject|1|||
27695720|NCT00551460|80720098|FG000|Overall Study|Physician Decision|1|||
27695721|NCT00551460|80720098|FG000|Overall Study|Death|7|||
27695722|NCT00551460|80720098|FG000|Overall Study|Ineligible|4|||
27695723|NCT00551460|80720098|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
27695724|NCT01217957|80720101|FG000|Phase 1|Withdrawal by Patient|1|||
27695725|NCT01217957|80720102|FG001|Phase 1|Withdrawal by Patient|0|||
27695726|NCT01217957|80720103|FG002|Phase 1|Withdrawal by Patient|1|||
27695727|NCT01217957|80720104|FG003|Phase 1|Withdrawal by Patient|1|||
27695728|NCT01217957|80720105|FG004|Phase 1|Withdrawal by Patient|0|||
27695729|NCT01217957|80720101|FG000|Phase 2|Withdrawal by Patient|0|||
27695730|NCT01217957|80720102|FG001|Phase 2|Withdrawal by Patient|0|||
27695731|NCT01217957|80720103|FG002|Phase 2|Withdrawal by Patient|0|||
27695732|NCT01217957|80720104|FG003|Phase 2|Withdrawal by Patient|0|||
27695733|NCT01217957|80720105|FG004|Phase 2|Withdrawal by Patient|1|||
27695734|NCT03384654|80720106|FG000|Overall Study|Withdrawal by Subject|0|||
27695735|NCT03384654|80720107|FG001|Overall Study|Withdrawal by Subject|0|||
27695736|NCT03384654|80720108|FG002|Overall Study|Withdrawal by Subject|1|||
27695737|NCT03384654|80720109|FG003|Overall Study|Withdrawal by Subject|0|||
27695738|NCT04281004|80720113|FG000|Overall Study|Physician Decision|1|||
27695739|NCT04281004|80720114|FG001|Overall Study|Physician Decision|0|||
27695740|NCT02513745|80720115|FG000|Overall Study|Criteria at time of surgery not met.|3|||
27695741|NCT02513745|80720116|FG001|Overall Study|Criteria at time of surgery not met.|3|||
27695742|NCT00938860|80720117|FG000|Overall Study|Adverse Event|2|||
27695743|NCT00938860|80720118|FG001|Overall Study|Adverse Event|1|||
27695744|NCT00938860|80720117|FG000|Overall Study|Abnormal laboratory values|2|||
27695745|NCT00938860|80720118|FG001|Overall Study|Abnormal laboratory values|2|||
27695746|NCT00938860|80720117|FG000|Overall Study|Withdrawal by Subject|11|||
27695747|NCT00938860|80720118|FG001|Overall Study|Withdrawal by Subject|8|||
27695748|NCT00938860|80720117|FG000|Overall Study|Lost to Follow-up|4|||
27695749|NCT00938860|80720118|FG001|Overall Study|Lost to Follow-up|4|||
27695750|NCT00938860|80720117|FG000|Overall Study|Administration problems|2|||
27695751|NCT00938860|80720118|FG001|Overall Study|Administration problems|0|||
27695752|NCT00938860|80720117|FG000|Overall Study|Death|1|||
27695753|NCT00938860|80720118|FG001|Overall Study|Death|1|||
27695754|NCT00938860|80720117|FG000|Overall Study|Protocol Violation|3|||
27695755|NCT00938860|80720118|FG001|Overall Study|Protocol Violation|1|||
27826771|NCT03772522|81195524|FG000|Intervention|Withdrawal by Subject|1|||
27826772|NCT03772522|81195525|FG001|Intervention|Withdrawal by Subject|0|||
27826773|NCT03772522|81195524|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
27826774|NCT03772522|81195525|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
27826775|NCT00003659|81195526|FG000|Overall Study|Withdrawal by Subject|3|||
27826776|NCT01566721|81195527|FG000|Treatment Period|Withdrawal by Subject|35|||
27826777|NCT01566721|81195528|FG001|Treatment Period|Withdrawal by Subject|9|||
27826778|NCT01566721|81195527|FG000|Treatment Period|Disease Progression/Recurrence|37|||
27826779|NCT01566721|81195528|FG001|Treatment Period|Disease Progression/Recurrence|13|||
27826780|NCT01566721|81195527|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
27826781|NCT01566721|81195528|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
27826782|NCT01566721|81195527|FG000|Treatment Period|Other|13|||
27826783|NCT01566721|81195528|FG001|Treatment Period|Other|2|||
27826784|NCT01566721|81195527|FG000|Treatment Period|Lack of Compliance|5|||
27826785|NCT01566721|81195528|FG001|Treatment Period|Lack of Compliance|1|||
27826786|NCT01566721|81195527|FG000|Treatment Period|Adverse Event|100|||
27826787|NCT01566721|81195528|FG001|Treatment Period|Adverse Event|30|||
27826788|NCT01566721|81195527|FG000|Treatment Period|Pregnancy|1|||
27826789|NCT01566721|81195528|FG001|Treatment Period|Pregnancy|0|||
27826790|NCT01566721|81195527|FG000|Safety Follow-up|Physician Decision|6|||
27695756|NCT01498679|80720119|FG000|Overall Study|Adverse Event|1|||
27695757|NCT01498679|80720120|FG001|Overall Study|Adverse Event|4|||
27695758|NCT01498679|80720119|FG000|Overall Study|Lack of Efficacy|72|||
27695759|NCT01498679|80720120|FG001|Overall Study|Lack of Efficacy|12|||
27826791|NCT01566721|81195528|FG001|Safety Follow-up|Physician Decision|4|||
27695760|NCT01498679|80720119|FG000|Overall Study|Protocol Violation|4|||
27695761|NCT01498679|80720120|FG001|Overall Study|Protocol Violation|0|||
27695762|NCT01498679|80720119|FG000|Overall Study|Physician Decision|0|||
27695763|NCT01498679|80720120|FG001|Overall Study|Physician Decision|2|||
27695764|NCT01498679|80720119|FG000|Overall Study|Withdrawal by Subject|12|||
27826792|NCT01566721|81195527|FG000|Safety Follow-up|Lost to Follow-up|101|||
27695765|NCT01498679|80720120|FG001|Overall Study|Withdrawal by Subject|4|||
27695766|NCT00896051|80720121|FG000|Overall Study|Adverse Event|2|||
27695767|NCT00896051|80720122|FG001|Overall Study|Adverse Event|1|||
27695768|NCT00896051|80720121|FG000|Overall Study|Lost to Follow-up|3|||
27695769|NCT00896051|80720122|FG001|Overall Study|Lost to Follow-up|2|||
27826793|NCT01566721|81195528|FG001|Safety Follow-up|Lost to Follow-up|48|||
27826794|NCT01566721|81195527|FG000|Safety Follow-up|Withdrawal by Subject|155|||
27826795|NCT01566721|81195528|FG001|Safety Follow-up|Withdrawal by Subject|49|||
27826796|NCT01566721|81195527|FG000|Safety Follow-up|Death|28|||
27826797|NCT01566721|81195528|FG001|Safety Follow-up|Death|4|||
27826798|NCT01566721|81195527|FG000|Safety Follow-up|Non-compliance|7|||
27826799|NCT01566721|81195528|FG001|Safety Follow-up|Non-compliance|3|||
27695770|NCT00896051|80720121|FG000|Overall Study|Withdrawal by Subject|3|||
27695771|NCT00896051|80720122|FG001|Overall Study|Withdrawal by Subject|2|||
27695772|NCT00896051|80720121|FG000|Overall Study|Subject noncompliant|1|||
27695773|NCT00896051|80720122|FG001|Overall Study|Subject noncompliant|3|||
27695774|NCT00896051|80720121|FG000|Overall Study|Other|1|||
27695775|NCT00896051|80720122|FG001|Overall Study|Other|1|||
27695776|NCT00686725|80720130|FG000|Overall Study|Adverse Event|1|||
27695777|NCT00686725|80720131|FG001|Overall Study|Adverse Event|1|||
27695778|NCT00686725|80720130|FG000|Overall Study|Progressive Disease|17|||
27695779|NCT00686725|80720131|FG001|Overall Study|Progressive Disease|23|||
27695780|NCT00686725|80720130|FG000|Overall Study|Lost to Follow-up|7|||
27695781|NCT00686725|80720131|FG001|Overall Study|Lost to Follow-up|5|||
27695782|NCT00686725|80720130|FG000|Overall Study|Death|6|||
27695783|NCT00686725|80720131|FG001|Overall Study|Death|3|||
27695784|NCT00686725|80720130|FG000|Overall Study|Withdrawal by Subject|13|||
27695785|NCT00686725|80720131|FG001|Overall Study|Withdrawal by Subject|4|||
27695786|NCT00686725|80720130|FG000|Overall Study|Protocol Violation|1|||
27695787|NCT00686725|80720131|FG001|Overall Study|Protocol Violation|3|||
27695788|NCT00686725|80720130|FG000|Overall Study|Other|1|||
27695789|NCT00686725|80720131|FG001|Overall Study|Other|3|||
27695790|NCT03740997|80720132|FG000|Overall Study|Withdrawal by Subject|1|||
27695791|NCT03740997|80720133|FG001|Overall Study|Withdrawal by Subject|0|||
27695792|NCT03740997|80720132|FG000|Overall Study|Participant was unable to complete study procedures|1|||
27695793|NCT03740997|80720133|FG001|Overall Study|Participant was unable to complete study procedures|0|||
27826800|NCT01566721|81195527|FG000|Safety Follow-up|Protocol Violation|7|||
27826801|NCT01566721|81195528|FG001|Safety Follow-up|Protocol Violation|0|||
27695794|NCT01551212|80720134|FG000|Overall Study|Graft loss/Retransplantation|0|||
27695795|NCT01551212|80720135|FG001|Overall Study|Graft loss/Retransplantation|1|||
27695796|NCT01551212|80720134|FG000|Overall Study|Administrative problems|1|||
27695797|NCT01551212|80720135|FG001|Overall Study|Administrative problems|2|||
27695798|NCT01551212|80720134|FG000|Overall Study|Lost to Follow-up|0|||
27695799|NCT01551212|80720135|FG001|Overall Study|Lost to Follow-up|1|||
27695800|NCT01551212|80720134|FG000|Overall Study|Protocol Violation|0|||
27695801|NCT01551212|80720135|FG001|Overall Study|Protocol Violation|1|||
27695802|NCT01551212|80720134|FG000|Overall Study|Withdrawal by Subject|0|||
27695803|NCT01551212|80720135|FG001|Overall Study|Withdrawal by Subject|7|||
27826802|NCT01566721|81195527|FG000|Safety Follow-up|Site closure|2|||
27695804|NCT01551212|80720134|FG000|Overall Study|Death|2|||
27695805|NCT01551212|80720135|FG001|Overall Study|Death|4|||
27695806|NCT01551212|80720134|FG000|Overall Study|Never Received Study Treatment|2|||
27826803|NCT01566721|81195528|FG001|Safety Follow-up|Site closure|3|||
27826804|NCT01566721|81195527|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
27826805|NCT01566721|81195528|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
27826806|NCT01566721|81195527|FG000|Safety Follow-up|Missing|7|||
27826807|NCT01566721|81195528|FG001|Safety Follow-up|Missing|2|||
27826808|NCT01566721|81195527|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
27826809|NCT01566721|81195528|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
27826810|NCT01566721|81195527|FG000|Safety Follow-up|Sponsor decision|1|||
27826811|NCT01566721|81195528|FG001|Safety Follow-up|Sponsor decision|0|||
27826812|NCT01566721|81195527|FG000|Safety Follow-up|Adverse Event|8|||
27826813|NCT01566721|81195528|FG001|Safety Follow-up|Adverse Event|4|||
27826814|NCT00244764|81195534|FG000|Overall Study|Adverse Event|37|||
27826815|NCT00244764|81195534|FG000|Overall Study|Lost to Follow-up|23|||
27826816|NCT00244764|81195534|FG000|Overall Study|Withdrawal by Subject|12|||
27695807|NCT01551212|80720135|FG001|Overall Study|Never Received Study Treatment|4|||
27695808|NCT00928447|80720140|FG000|Overall Study|Withdrawal by Subject|1|||
27695809|NCT00928447|80720140|FG000|Overall Study|Investigator's decision|1|||
27695810|NCT01001832|80720141|FG000|Short-term Period|Adverse Event|2|||
27695811|NCT01001832|80720142|FG001|Short-term Period|Adverse Event|3|||
27695812|NCT01001832|80720141|FG000|Long-term Period|Adverse Event|2|||
27695813|NCT01001832|80720142|FG001|Long-term Period|Adverse Event|1|||
27695814|NCT01001832|80720141|FG000|Long-term Period|Withdrawal by Subject|1|||
27695815|NCT01001832|80720142|FG001|Long-term Period|Withdrawal by Subject|0|||
27695816|NCT01001832|80720141|FG000|Long-term Period|Lack of Efficacy|0|||
27695817|NCT01001832|80720142|FG001|Long-term Period|Lack of Efficacy|2|||
27695818|NCT01001832|80720141|FG000|Long-term Period|Other|1|||
27695819|NCT01001832|80720142|FG001|Long-term Period|Other|2|||
27695820|NCT01001832|80720141|FG000|Follow-up Period|Withdrawal by Subject|1|||
27695821|NCT01001832|80720142|FG001|Follow-up Period|Withdrawal by Subject|0|||
27695822|NCT01001832|80720141|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
27695823|NCT01001832|80720142|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
27695824|NCT01001832|80720141|FG000|Follow-up Period|Other|2|||
27695825|NCT01001832|80720142|FG001|Follow-up Period|Other|1|||
27695826|NCT02634346|80720145|FG000|Overall Study|Withdrawal by Subject|8|||
27695827|NCT02634346|80720146|FG001|Overall Study|Withdrawal by Subject|9|||
27695828|NCT02634346|80720147|FG002|Overall Study|Withdrawal by Subject|8|||
27695829|NCT02634346|80720145|FG000|Overall Study|Adverse Event|2|||
27695830|NCT02634346|80720146|FG001|Overall Study|Adverse Event|2|||
27695831|NCT02634346|80720147|FG002|Overall Study|Adverse Event|7|||
27695832|NCT02634346|80720145|FG000|Overall Study|Lack of Efficacy|1|||
27695833|NCT02634346|80720146|FG001|Overall Study|Lack of Efficacy|2|||
27695834|NCT02634346|80720147|FG002|Overall Study|Lack of Efficacy|8|||
27695835|NCT02634346|80720145|FG000|Overall Study|Lost to Follow-up|1|||
27695836|NCT02634346|80720146|FG001|Overall Study|Lost to Follow-up|0|||
27695837|NCT02634346|80720147|FG002|Overall Study|Lost to Follow-up|0|||
27555574|NCT02927080|80222189|FG005|Overall Study|Adverse Event|0|||
27555575|NCT02927080|80222190|FG006|Overall Study|Adverse Event|0|||
27555576|NCT02927080|80222191|FG007|Overall Study|Adverse Event|1|||
27555577|NCT02927080|80222192|FG008|Overall Study|Adverse Event|0|||
27555578|NCT02927080|80222193|FG009|Overall Study|Adverse Event|1|||
27555579|NCT02927080|80222184|FG000|Overall Study|Other|0|||
27555580|NCT02927080|80222185|FG001|Overall Study|Other|0|||
27555581|NCT02927080|80222186|FG002|Overall Study|Other|0|||
27555582|NCT02927080|80222187|FG003|Overall Study|Other|0|||
27695838|NCT02634346|80720145|FG000|Overall Study|Protocol Violation|0|||
27695839|NCT02634346|80720146|FG001|Overall Study|Protocol Violation|1|||
27695840|NCT02634346|80720147|FG002|Overall Study|Protocol Violation|0|||
27695841|NCT01740323|80723594|FG000|Overall Study|Adverse Event|1|||
27695842|NCT01740323|80723595|FG001|Overall Study|Adverse Event|0|||
27695843|NCT01740323|80723594|FG000|Overall Study|Randomized but did not take study drug|1|||
27826817|NCT00244764|81195534|FG000|Overall Study|Disease Progression|13|||
27826818|NCT00244764|81195534|FG000|Overall Study|Protocol Violation|2|||
27695844|NCT01740323|80723595|FG001|Overall Study|Randomized but did not take study drug|0|||
27695845|NCT04508023|80723596|FG000|Overall Study|Withdrawal by Subject|1|||
27695846|NCT04508023|80723597|FG001|Overall Study|Withdrawal by Subject|2|||
27695847|NCT00705523|80723598|FG000|Overall Study|Lost to Follow-up|2|||
27695848|NCT00705523|80723599|FG001|Overall Study|Lost to Follow-up|3|||
27695849|NCT01280812|80723603|FG000|Overall Study|Withdrawal by Subject|2|||
27695850|NCT01280812|80723604|FG001|Overall Study|Withdrawal by Subject|1|||
27826819|NCT00244764|81195534|FG000|Overall Study|Death|1|||
27826820|NCT00244764|81195534|FG000|Overall Study|Off Study Medication for >21 Days|1|||
27555583|NCT02927080|80222188|FG004|Overall Study|Other|0|||
27555584|NCT02927080|80222189|FG005|Overall Study|Other|0|||
27555585|NCT02927080|80222190|FG006|Overall Study|Other|1|||
27555586|NCT02927080|80222191|FG007|Overall Study|Other|0|||
27555587|NCT02927080|80222192|FG008|Overall Study|Other|1|||
27555588|NCT02927080|80222193|FG009|Overall Study|Other|0|||
27695851|NCT01280812|80723605|FG002|Overall Study|Withdrawal by Subject|0|||
27695852|NCT01280812|80723603|FG000|Overall Study|Lost to Follow-up|1|||
27826821|NCT00244764|81195534|FG000|Overall Study|Declining Performance Status|1|||
27555589|NCT01059825|80222197|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27555590|NCT01059825|80222198|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27555591|NCT01059825|80222199|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27555592|NCT01059825|80222200|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27555593|NCT01059825|80222201|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27555594|NCT01059825|80222202|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
27555595|NCT01059825|80222203|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
27555596|NCT01059825|80222197|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27555597|NCT01059825|80222198|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27555598|NCT01059825|80222199|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27555599|NCT01059825|80222200|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27555600|NCT01059825|80222201|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27555601|NCT01059825|80222202|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
27555602|NCT01059825|80222203|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
27555603|NCT01059825|80222197|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
27555604|NCT01059825|80222198|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
27555605|NCT01059825|80222199|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
27555606|NCT01059825|80222200|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
27555607|NCT01059825|80222201|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
27555608|NCT01059825|80222202|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
27555609|NCT01059825|80222203|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
27555610|NCT01059825|80222197|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27555611|NCT01059825|80222198|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27555612|NCT01059825|80222199|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27555613|NCT01059825|80222200|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27555614|NCT01059825|80222201|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27555615|NCT01059825|80222202|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
27555616|NCT01059825|80222203|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
27555617|NCT01059825|80222197|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
27555618|NCT01059825|80222198|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
27555619|NCT01059825|80222199|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
27555620|NCT01059825|80222200|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
27555621|NCT01059825|80222201|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
27555622|NCT01059825|80222202|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
27555623|NCT01059825|80222203|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
27555624|NCT01059825|80222197|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
27555625|NCT01059825|80222198|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
27555626|NCT01059825|80222199|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
27555627|NCT01059825|80222200|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
27555628|NCT01059825|80222201|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
27555629|NCT01059825|80222202|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
27555630|NCT01059825|80222203|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
27555631|NCT01059825|80222197|FG000|Treatment Period|Lost to Follow-up|2|||
27555632|NCT01059825|80222198|FG001|Treatment Period|Lost to Follow-up|1|||
27555633|NCT01059825|80222199|FG002|Treatment Period|Lost to Follow-up|0|||
27555634|NCT01059825|80222200|FG003|Treatment Period|Lost to Follow-up|1|||
27555635|NCT01059825|80222201|FG004|Treatment Period|Lost to Follow-up|2|||
27555636|NCT01059825|80222202|FG005|Treatment Period|Lost to Follow-up|0|||
27555637|NCT01059825|80222203|FG006|Treatment Period|Lost to Follow-up|0|||
27555638|NCT01059825|80222197|FG000|Treatment Period|Withdrawal by Subject|3|||
27555639|NCT01059825|80222198|FG001|Treatment Period|Withdrawal by Subject|0|||
27555640|NCT01059825|80222199|FG002|Treatment Period|Withdrawal by Subject|1|||
27555641|NCT01059825|80222200|FG003|Treatment Period|Withdrawal by Subject|5|||
27555642|NCT01059825|80222201|FG004|Treatment Period|Withdrawal by Subject|4|||
27555643|NCT01059825|80222202|FG005|Treatment Period|Withdrawal by Subject|1|||
27555644|NCT01059825|80222203|FG006|Treatment Period|Withdrawal by Subject|0|||
27555645|NCT01059825|80222197|FG000|Treatment Period|Other reason not specified|1|||
27555646|NCT01059825|80222198|FG001|Treatment Period|Other reason not specified|2|||
27555647|NCT01059825|80222199|FG002|Treatment Period|Other reason not specified|1|||
27555648|NCT01059825|80222200|FG003|Treatment Period|Other reason not specified|2|||
27555649|NCT01059825|80222201|FG004|Treatment Period|Other reason not specified|0|||
27555650|NCT01059825|80222202|FG005|Treatment Period|Other reason not specified|0|||
27555651|NCT01059825|80222203|FG006|Treatment Period|Other reason not specified|0|||
27555652|NCT01059825|80222197|FG000|Treatment Period|Protocol Violation|0|||
27555653|NCT01059825|80222198|FG001|Treatment Period|Protocol Violation|0|||
27555654|NCT01059825|80222199|FG002|Treatment Period|Protocol Violation|1|||
27555655|NCT01059825|80222200|FG003|Treatment Period|Protocol Violation|1|||
27555656|NCT01059825|80222201|FG004|Treatment Period|Protocol Violation|1|||
27555657|NCT01059825|80222202|FG005|Treatment Period|Protocol Violation|1|||
27555658|NCT01059825|80222203|FG006|Treatment Period|Protocol Violation|0|||
27555659|NCT01059825|80222197|FG000|Treatment Period|Adverse event related to study drug|1|||
27555660|NCT01059825|80222198|FG001|Treatment Period|Adverse event related to study drug|0|||
27555661|NCT01059825|80222199|FG002|Treatment Period|Adverse event related to study drug|1|||
27555662|NCT01059825|80222200|FG003|Treatment Period|Adverse event related to study drug|1|||
27555663|NCT01059825|80222201|FG004|Treatment Period|Adverse event related to study drug|0|||
27555664|NCT01059825|80222202|FG005|Treatment Period|Adverse event related to study drug|0|||
27555665|NCT01059825|80222203|FG006|Treatment Period|Adverse event related to study drug|0|||
27555666|NCT01059825|80222197|FG000|Treatment Period|Insufficient clinical response|3|||
27555667|NCT01059825|80222198|FG001|Treatment Period|Insufficient clinical response|0|||
27555668|NCT01059825|80222199|FG002|Treatment Period|Insufficient clinical response|0|||
27555669|NCT01059825|80222200|FG003|Treatment Period|Insufficient clinical response|0|||
27826822|NCT00244764|81195534|FG000|Overall Study|Participant was Hospitalized until Death|1|||
27826823|NCT00244764|81195534|FG000|Overall Study|Primary Investigator Discretion|2|||
27826824|NCT00244764|81195534|FG000|Overall Study|Sponsor Terminated Study|2|||
27826825|NCT00244764|81195534|FG000|Overall Study|Developed Secondary Malignancy|1|||
27826826|NCT03276754|81195535|FG000|Overall Study|Withdrawal of informed consent|4|||
27826827|NCT03276754|81195535|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
27826828|NCT03276754|81195535|FG000|Overall Study|Lost to Follow-up|27|||
27826829|NCT03276754|81195535|FG000|Overall Study|No data reported at Month 24|31|||
27826830|NCT03276754|81195535|FG000|Overall Study|Death|39|||
27826831|NCT03154047|81195540|FG000|Overall Study|Death|1|||
27826832|NCT03154047|81195540|FG000|Overall Study|Study terminated by sponsor|76|||
27826833|NCT03154047|81195540|FG000|Overall Study|Withdrawal by Subject|3|||
27826834|NCT02849457|81195543|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
27826835|NCT02849457|81195544|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
27826836|NCT02849457|81195545|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
27555670|NCT01059825|80222201|FG004|Treatment Period|Insufficient clinical response|0|||
27826837|NCT02849457|81195546|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
27826838|NCT00829673|81195547|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27555671|NCT01059825|80222202|FG005|Treatment Period|Insufficient clinical response|0|||
27555672|NCT01059825|80222203|FG006|Treatment Period|Insufficient clinical response|0|||
27555673|NCT01059825|80222197|FG000|Treatment Period|Adverse event not related to study drug|0|||
27555674|NCT01059825|80222198|FG001|Treatment Period|Adverse event not related to study drug|1|||
27555675|NCT01059825|80222199|FG002|Treatment Period|Adverse event not related to study drug|2|||
27555676|NCT01059825|80222200|FG003|Treatment Period|Adverse event not related to study drug|1|||
27555677|NCT01059825|80222201|FG004|Treatment Period|Adverse event not related to study drug|1|||
27555678|NCT01059825|80222202|FG005|Treatment Period|Adverse event not related to study drug|1|||
27555679|NCT01059825|80222203|FG006|Treatment Period|Adverse event not related to study drug|0|||
27555680|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
27555681|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
27555682|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
27555683|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
27555684|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
27555685|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
27555686|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
27555687|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
27555688|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
27555689|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
27555690|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
27555691|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
27555692|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
27555693|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
27555694|NCT00293254|80222204|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
27555695|NCT00293254|80222205|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
27555696|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
27555697|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
27555698|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Death|4|||
27555699|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Death|1|||
27555700|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
27555701|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
27555702|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
27555703|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
27555704|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
27555705|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
27555706|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
27555707|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
27555708|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
27555709|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
27555710|NCT00293254|80222204|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
27555711|NCT00293254|80222205|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
27555712|NCT00293254|80222204|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
27555713|NCT00293254|80222205|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
27555714|NCT00293254|80222204|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
27555715|NCT00293254|80222205|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
27555716|NCT00293254|80222204|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
27555717|NCT00293254|80222205|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
27555718|NCT00293254|80222204|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
27555719|NCT00293254|80222205|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
27555720|NCT00293254|80222204|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
27555721|NCT00293254|80222205|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
27555722|NCT00293254|80222204|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
27555723|NCT00293254|80222205|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
27555724|NCT00293254|80222204|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
27555725|NCT00293254|80222205|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
27555726|NCT00293254|80222204|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
27555727|NCT00293254|80222205|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
27555728|NCT00293254|80222204|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
27555729|NCT00293254|80222205|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
27555730|NCT00293254|80222204|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
27555731|NCT00293254|80222205|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
27555732|NCT00293254|80222204|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
27555733|NCT00293254|80222205|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
27555734|NCT02598076|80222206|FG000|Overall Study|Lost to Follow-up|2|||
27555735|NCT02598076|80222207|FG001|Overall Study|Lost to Follow-up|3|||
27555736|NCT03824912|80222209|FG000|Overall Study|Lost to Follow-up|18|||
27555737|NCT03824912|80222210|FG001|Overall Study|Lost to Follow-up|15|||
27555738|NCT03824912|80222211|FG002|Overall Study|Lost to Follow-up|8|||
27555739|NCT03824912|80222209|FG000|Overall Study|Negative Baseline Culture Result|118|||
27555740|NCT03824912|80222210|FG001|Overall Study|Negative Baseline Culture Result|112|||
27555741|NCT03824912|80222211|FG002|Overall Study|Negative Baseline Culture Result|57|||
27555742|NCT03824912|80222209|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27555743|NCT03824912|80222210|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27555744|NCT03824912|80222211|FG002|Overall Study|Non-Compliance with Study Drug|1|||
27555745|NCT03824912|80222209|FG000|Overall Study|Protocol Violation|1|||
27555746|NCT03824912|80222210|FG001|Overall Study|Protocol Violation|4|||
27555747|NCT03824912|80222211|FG002|Overall Study|Protocol Violation|1|||
27555748|NCT03824912|80222209|FG000|Overall Study|Withdrawal by Subject|3|||
27555749|NCT03824912|80222210|FG001|Overall Study|Withdrawal by Subject|2|||
27555750|NCT03824912|80222211|FG002|Overall Study|Withdrawal by Subject|1|||
27555751|NCT03824912|80222209|FG000|Overall Study|Participation in another study|0|||
27555752|NCT03824912|80222210|FG001|Overall Study|Participation in another study|1|||
27555753|NCT03824912|80222211|FG002|Overall Study|Participation in another study|0|||
27555754|NCT02671422|80222212|FG000|Overall Study|Lost to Follow-up|1|||
27555755|NCT02671422|80222212|FG000|Overall Study|Adverse Event|68|||
27555756|NCT02671422|80222212|FG000|Overall Study|Lack of Efficacy|1|||
27555757|NCT02671422|80222212|FG000|Overall Study|Lost to Follow-up|4|||
27555758|NCT02671422|80222212|FG000|Overall Study|Withdrawal by Subject|7|||
27555759|NCT02671422|80222212|FG000|Overall Study|Progressive Disease|156|||
27555760|NCT02671422|80222212|FG000|Overall Study|Worsening of Disease|4|||
27555761|NCT02671422|80222212|FG000|Overall Study|Sponsor decision|5|||
27555762|NCT02671422|80222212|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
27555763|NCT02671422|80222212|FG000|Overall Study|Not treated with Vargatef®|3|||
27555764|NCT02671422|80222212|FG000|Overall Study|Other not defined above|3|||
27555765|NCT03187262|80222213|FG000|Induction|Lack of Efficacy|2|||
27555766|NCT03187262|80222213|FG000|Induction|Progressive Disease|4|||
27555767|NCT03187262|80222213|FG000|Consolidation|Progressive Disease|5|||
27555768|NCT04772755|80222221|FG000|Overall Study|Withdrawal by Subject|1|||
27555769|NCT04772755|80222222|FG001|Overall Study|Withdrawal by Subject|0|||
27555770|NCT04772755|80222221|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
27555771|NCT04772755|80222222|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
27555772|NCT03506815|80222223|FG000|Overall Study|Adverse Event|8|||
27555773|NCT03506815|80222224|FG001|Overall Study|Adverse Event|0|||
27555774|NCT03506815|80222223|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
27555775|NCT03506815|80222224|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
27555776|NCT03506815|80222223|FG000|Overall Study|Protocol Violation|1|||
27555777|NCT03506815|80222224|FG001|Overall Study|Protocol Violation|0|||
27555778|NCT03506815|80222223|FG000|Overall Study|Elective Surgery|1|||
27555779|NCT03506815|80222224|FG001|Overall Study|Elective Surgery|0|||
27555780|NCT00416078|80222225|FG000|Overall Study|Death|3|||
27555781|NCT00416078|80222226|FG001|Overall Study|Death|4|||
27555782|NCT00416078|80222225|FG000|Overall Study|Withdrawal by Subject|3|||
27826839|NCT00829673|81195548|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27826840|NCT02043132|81195549|FG000|Overall Study|Lost to Follow-up|1|||
27826841|NCT02043132|81195550|FG001|Overall Study|Lost to Follow-up|1|||
27826842|NCT02043132|81195549|FG000|Overall Study|screen failures|4|||
27826843|NCT02043132|81195550|FG001|Overall Study|screen failures|8|||
27826844|NCT01686477|81195551|FG000|Feeding Intervention|Death|1|||
27826845|NCT01686477|81195552|FG001|Feeding Intervention|Death|0|||
27826846|NCT01686477|81195553|FG002|Feeding Intervention|Death|1|||
27826847|NCT01686477|81195551|FG000|Feeding Intervention|Withdrawal by Subject|0|||
27555783|NCT00416078|80222226|FG001|Overall Study|Withdrawal by Subject|2|||
27555784|NCT00416078|80222225|FG000|Overall Study|Physician Decision|1|||
27555785|NCT00416078|80222226|FG001|Overall Study|Physician Decision|0|||
27826848|NCT01686477|81195552|FG001|Feeding Intervention|Withdrawal by Subject|6|||
27826849|NCT01686477|81195553|FG002|Feeding Intervention|Withdrawal by Subject|0|||
27555786|NCT00416078|80222225|FG000|Overall Study|Lost to Follow-up|4|||
27555787|NCT00416078|80222226|FG001|Overall Study|Lost to Follow-up|2|||
27555788|NCT02738151|80222231|FG000|Overall Study|Randomized but not treated|4|||
27826850|NCT01686477|81195551|FG000|Feeding Intervention|Physician Decision|1|||
27555789|NCT02738151|80222232|FG001|Overall Study|Randomized but not treated|1|||
27555790|NCT02738151|80222231|FG000|Overall Study|Adverse Event|4|||
27555791|NCT02738151|80222232|FG001|Overall Study|Adverse Event|5|||
27555792|NCT02738151|80222231|FG000|Overall Study|Hypoglycemia|0|||
27555793|NCT02738151|80222232|FG001|Overall Study|Hypoglycemia|1|||
27555794|NCT02738151|80222231|FG000|Overall Study|Poor Compliance to Protocol|4|||
27555795|NCT02738151|80222232|FG001|Overall Study|Poor Compliance to Protocol|3|||
27555796|NCT02738151|80222231|FG000|Overall Study|Other than specified above|11|||
27555797|NCT02738151|80222232|FG001|Overall Study|Other than specified above|21|||
27555798|NCT01064401|80222237|FG000|Overall Study|Adverse Event|47|||
27555799|NCT01064401|80222238|FG001|Overall Study|Adverse Event|56|||
27555800|NCT01064401|80222237|FG000|Overall Study|Lack of Efficacy|46|||
27555801|NCT01064401|80222238|FG001|Overall Study|Lack of Efficacy|23|||
27555802|NCT01064401|80222237|FG000|Overall Study|Lost to Follow-up|12|||
27555803|NCT01064401|80222238|FG001|Overall Study|Lost to Follow-up|9|||
27555804|NCT01064401|80222237|FG000|Overall Study|Consent Withdrawn|98|||
27555805|NCT01064401|80222238|FG001|Overall Study|Consent Withdrawn|80|||
27555806|NCT01064401|80222237|FG000|Overall Study|Investigator Decision|4|||
27555807|NCT01064401|80222238|FG001|Overall Study|Investigator Decision|6|||
27555808|NCT01064401|80222237|FG000|Overall Study|Death|4|||
27555809|NCT01064401|80222238|FG001|Overall Study|Death|0|||
27555810|NCT01064401|80222237|FG000|Overall Study|Pregnancy|4|||
27555811|NCT01064401|80222238|FG001|Overall Study|Pregnancy|7|||
27555812|NCT01064401|80222237|FG000|Overall Study|Noncompliance|7|||
27555813|NCT01064401|80222238|FG001|Overall Study|Noncompliance|8|||
27555814|NCT01064401|80222237|FG000|Overall Study|Site Closure|4|||
27555815|NCT01064401|80222238|FG001|Overall Study|Site Closure|5|||
27555816|NCT01064401|80222237|FG000|Overall Study|Other|2|||
27555817|NCT01064401|80222238|FG001|Overall Study|Other|1|||
27555818|NCT00558025|80222244|FG000|Overall Study|Adverse Event|1|||
27555819|NCT00558025|80222245|FG001|Overall Study|Adverse Event|1|||
27555820|NCT00558025|80222244|FG000|Overall Study|Withdrawal by Subject|2|||
27555821|NCT00558025|80222245|FG001|Overall Study|Withdrawal by Subject|2|||
27555822|NCT00558025|80222244|FG000|Overall Study|Protocol Violation|1|||
27555823|NCT00558025|80222245|FG001|Overall Study|Protocol Violation|0|||
27555824|NCT01084174|80222246|FG000|Overall Study|gastrointestinal symptoms|1|||
27555825|NCT01084174|80222247|FG001|Overall Study|gastrointestinal symptoms|1|||
27555826|NCT01084174|80222246|FG000|Overall Study|Eosinophilic esophagitis|0|||
27555827|NCT01084174|80222247|FG001|Overall Study|Eosinophilic esophagitis|1|||
27555828|NCT01084174|80222246|FG000|Overall Study|Anaphylaxis|0|||
27555829|NCT01084174|80222247|FG001|Overall Study|Anaphylaxis|1|||
27555830|NCT01084174|80222246|FG000|Overall Study|Participant noncompliance|0|||
27555831|NCT01084174|80222247|FG001|Overall Study|Participant noncompliance|1|||
27555832|NCT01170091|80222248|FG000|Overall Study|Missing efficacy evaluation|3|||
27555833|NCT01170091|80222248|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
27555834|NCT02485301|80222249|FG000|Overall Study|Serious Adverse Events|2|||
27555835|NCT02485301|80222250|FG001|Overall Study|Serious Adverse Events|1|||
27555836|NCT02485301|80222249|FG000|Overall Study|Protocol Violation|0|||
27555837|NCT02485301|80222250|FG001|Overall Study|Protocol Violation|1|||
27555838|NCT02485301|80222249|FG000|Overall Study|Withdrawal by Subject|6|||
27555839|NCT02485301|80222250|FG001|Overall Study|Withdrawal by Subject|7|||
27555840|NCT02485301|80222249|FG000|Overall Study|Migrated/moved from study area|10|||
27555841|NCT02485301|80222250|FG001|Overall Study|Migrated/moved from study area|19|||
27555842|NCT02485301|80222249|FG000|Overall Study|Lost to Follow-up|17|||
27555843|NCT02485301|80222250|FG001|Overall Study|Lost to Follow-up|17|||
27555844|NCT02485301|80222249|FG000|Overall Study|Other|3|||
27883926|NCT02308540|81408100|FG004|Overall Study|Lost to Follow-up|0|||
27883927|NCT02308540|81408101|FG005|Overall Study|Lost to Follow-up|1|||
27883928|NCT00464490|81408103|FG000|Overall Study|Physician Decision|11|||
27883929|NCT00464490|81408104|FG001|Overall Study|Physician Decision|11|||
27555845|NCT02485301|80222250|FG001|Overall Study|Other|4|||
27555846|NCT03138889|80222251|FG000|Overall Study|Withdrawal by Subject|5|||
27555847|NCT03138889|80222252|FG001|Overall Study|Withdrawal by Subject|5|||
27555848|NCT03138889|80222253|FG002|Overall Study|Withdrawal by Subject|0|||
27555849|NCT03138889|80222254|FG003|Overall Study|Withdrawal by Subject|2|||
27555850|NCT03138889|80222255|FG004|Overall Study|Withdrawal by Subject|1|||
27555851|NCT03138889|80222256|FG005|Overall Study|Withdrawal by Subject|3|||
27555852|NCT03138889|80222257|FG006|Overall Study|Withdrawal by Subject|0|||
27555853|NCT03138889|80222258|FG007|Overall Study|Withdrawal by Subject|1|||
27555854|NCT00556712|80222259|FG000|Overall Study|Adverse Event|7|||
27555855|NCT00556712|80222260|FG001|Overall Study|Adverse Event|19|||
27883930|NCT00877487|81408105|FG000|Open-label Treatment Phase|Adverse Event|1|||
27826851|NCT01686477|81195552|FG001|Feeding Intervention|Physician Decision|2|||
27826852|NCT01686477|81195553|FG002|Feeding Intervention|Physician Decision|0|||
27826853|NCT01686477|81195551|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
27826854|NCT01686477|81195552|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
27826855|NCT01686477|81195553|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
27826856|NCT01686477|81195551|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
27826857|NCT01686477|81195552|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
27826858|NCT01686477|81195553|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
27826859|NCT01686477|81195551|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
27826860|NCT01686477|81195552|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
27826861|NCT01686477|81195553|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
27826862|NCT01686477|81195551|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
27826863|NCT01686477|81195552|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
27826864|NCT01686477|81195553|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
27826865|NCT01686477|81195551|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
27826866|NCT01686477|81195552|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
27826867|NCT01686477|81195553|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
27826868|NCT01686477|81195551|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
27826869|NCT01686477|81195552|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
27826870|NCT01686477|81195553|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
27555856|NCT00556712|80222259|FG000|Overall Study|Death|5|||
27555857|NCT00556712|80222260|FG001|Overall Study|Death|10|||
27555858|NCT00556712|80222259|FG000|Overall Study|Progressive Disease|383|||
27555859|NCT00556712|80222260|FG001|Overall Study|Progressive Disease|320|||
27555860|NCT00556712|80222259|FG000|Overall Study|Protocol Violation|3|||
27555861|NCT00556712|80222260|FG001|Overall Study|Protocol Violation|2|||
27555862|NCT00556712|80222259|FG000|Overall Study|Refused Treatment|17|||
27555863|NCT00556712|80222260|FG001|Overall Study|Refused Treatment|16|||
27555864|NCT00556712|80222259|FG000|Overall Study|Failure to Return|2|||
27555865|NCT00556712|80222260|FG001|Overall Study|Failure to Return|3|||
27555866|NCT00556712|80222259|FG000|Overall Study|Other|2|||
27555867|NCT00556712|80222260|FG001|Overall Study|Other|2|||
27555868|NCT00556712|80222259|FG000|Overall Study|Ongoing at Data Cutoff|32|||
27555869|NCT00556712|80222260|FG001|Overall Study|Ongoing at Data Cutoff|66|||
27826871|NCT01686477|81195551|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
27826872|NCT01686477|81195552|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
27555870|NCT00110149|80222261|FG000|Overall Study|Physician Decision|3|||
27555871|NCT01463878|80222266|FG000|Overall Study|no longer met criteria for tube feed|2|||
27826873|NCT01686477|81195553|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
27826874|NCT03194217|81195554|FG000|Overall Study|Adverse Event|0|||
27826875|NCT03194217|81195555|FG001|Overall Study|Adverse Event|2|||
27826876|NCT03194217|81195556|FG002|Overall Study|Adverse Event|3|||
27826877|NCT03194217|81195557|FG003|Overall Study|Adverse Event|3|||
27826878|NCT03194217|81195554|FG000|Overall Study|Failure to meet randomisation criteria|0|||
27826879|NCT03194217|81195555|FG001|Overall Study|Failure to meet randomisation criteria|0|||
27826880|NCT03194217|81195556|FG002|Overall Study|Failure to meet randomisation criteria|0|||
27826881|NCT03194217|81195557|FG003|Overall Study|Failure to meet randomisation criteria|1|||
27826882|NCT03194217|81195554|FG000|Overall Study|Other|0|||
27826883|NCT03194217|81195555|FG001|Overall Study|Other|1|||
27826884|NCT03194217|81195556|FG002|Overall Study|Other|1|||
27826885|NCT03194217|81195557|FG003|Overall Study|Other|0|||
27555872|NCT01463878|80222267|FG001|Overall Study|no longer met criteria for tube feed|2|||
27555873|NCT04007094|80222268|FG000|Overall Study|Lost to Follow-up|1|||
27555874|NCT04007094|80222269|FG001|Overall Study|Lost to Follow-up|1|||
27555875|NCT01288469|80222270|FG000|Overall Study|Adverse Event|4|||
27555876|NCT01288469|80222271|FG001|Overall Study|Adverse Event|1|||
27555877|NCT01288469|80222272|FG002|Overall Study|Adverse Event|1|||
27555878|NCT01288469|80222270|FG000|Overall Study|Poor compliance to protocol|0|||
27826886|NCT04400890|81195558|FG000|Overall Study|Withdrawal by Subject|3|||
27826887|NCT04400890|81195559|FG001|Overall Study|Withdrawal by Subject|2|||
27826888|NCT04206332|81198848|FG000|Part A|Lost to Follow-up|0|||
27826889|NCT04206332|81198849|FG001|Part A|Lost to Follow-up|1|||
27826890|NCT04206332|81198850|FG002|Part A|Lost to Follow-up|0|||
27826891|NCT04206332|81198851|FG003|Part A|Lost to Follow-up|0|||
27826892|NCT04206332|81198852|FG004|Part A|Lost to Follow-up|0|||
27826893|NCT04206332|81198853|FG005|Part A|Lost to Follow-up|0|||
27826894|NCT04206332|81198854|FG006|Part A|Lost to Follow-up|0|||
27826895|NCT04206332|81198855|FG007|Part A|Lost to Follow-up|0|||
27826896|NCT04206332|81198856|FG008|Part A|Lost to Follow-up|0|||
27826897|NCT04206332|81198857|FG009|Part A|Lost to Follow-up|0|||
27826898|NCT04206332|81198858|FG010|Part A|Lost to Follow-up|0|||
27826899|NCT04206332|81198859|FG011|Part A|Lost to Follow-up|0|||
27826900|NCT04206332|81198860|FG012|Part A|Lost to Follow-up|0|||
27826901|NCT04206332|81198861|FG013|Part A|Lost to Follow-up|0|||
27826902|NCT04206332|81198862|FG014|Part A|Lost to Follow-up|0|||
27826903|NCT04206332|81198863|FG015|Part A|Lost to Follow-up|0|||
27826904|NCT04206332|81198864|FG016|Part A|Lost to Follow-up|0|||
27826905|NCT04206332|81198848|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826906|NCT04206332|81198849|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826907|NCT04206332|81198850|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826908|NCT04206332|81198851|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826909|NCT04206332|81198852|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826910|NCT04206332|81198853|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
27826911|NCT04206332|81198854|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826912|NCT04206332|81198855|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826913|NCT04206332|81198856|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826914|NCT04206332|81198857|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826915|NCT04206332|81198858|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826916|NCT04206332|81198859|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826917|NCT04206332|81198860|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826918|NCT04206332|81198861|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826919|NCT04206332|81198862|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826920|NCT04206332|81198863|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826921|NCT04206332|81198864|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
27826922|NCT04206332|81198848|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826923|NCT04206332|81198849|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826924|NCT04206332|81198850|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826925|NCT04206332|81198851|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826926|NCT04206332|81198852|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27883931|NCT00877487|81408106|FG001|Open-label Treatment Phase|Adverse Event|0|||
27826927|NCT04206332|81198853|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27883932|NCT00877487|81408105|FG000|Open-label Treatment Phase|Protocol Violation|3|||
27555879|NCT01288469|80222271|FG001|Overall Study|Poor compliance to protocol|1|||
27826928|NCT04206332|81198854|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826929|NCT04206332|81198855|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
27695853|NCT01280812|80723604|FG001|Overall Study|Lost to Follow-up|1|||
27826930|NCT04206332|81198856|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826931|NCT04206332|81198857|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826932|NCT04206332|81198858|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
27826933|NCT04206332|81198859|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826934|NCT04206332|81198860|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826935|NCT04206332|81198861|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27883933|NCT00877487|81408106|FG001|Open-label Treatment Phase|Protocol Violation|0|||
27883934|NCT00877487|81408105|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
27695854|NCT01280812|80723605|FG002|Overall Study|Lost to Follow-up|1|||
27826936|NCT04206332|81198862|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826937|NCT04206332|81198863|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826938|NCT04206332|81198864|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826939|NCT04206332|81198848|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826940|NCT04206332|81198849|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826941|NCT04206332|81198850|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826942|NCT04206332|81198851|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826943|NCT04206332|81198852|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826944|NCT04206332|81198853|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27555880|NCT01288469|80222272|FG002|Overall Study|Poor compliance to protocol|0|||
27555881|NCT01288469|80222270|FG000|Overall Study|Participant Moved|1|||
27555882|NCT01288469|80222271|FG001|Overall Study|Participant Moved|0|||
27555883|NCT01288469|80222272|FG002|Overall Study|Participant Moved|0|||
27555884|NCT01288469|80222270|FG000|Overall Study|Consent withdrawn by subject|1|||
27555885|NCT01288469|80222271|FG001|Overall Study|Consent withdrawn by subject|1|||
27555886|NCT01288469|80222272|FG002|Overall Study|Consent withdrawn by subject|1|||
27555887|NCT01288469|80222270|FG000|Overall Study|Exclusion criteria finally met|1|||
27555888|NCT01288469|80222271|FG001|Overall Study|Exclusion criteria finally met|0|||
27555889|NCT01288469|80222272|FG002|Overall Study|Exclusion criteria finally met|0|||
27555890|NCT01949051|80222275|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
27555891|NCT01949051|80222276|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27555892|NCT01949051|80222277|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27555893|NCT01949051|80222278|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
27555894|NCT01949051|80222279|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27555895|NCT01949051|80222280|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
27555896|NCT01949051|80222275|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
27555897|NCT01949051|80222276|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27555898|NCT01949051|80222277|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27695855|NCT00871780|80723608|FG000|Overall Study|Enrolled But Not Treated|6|||
27555899|NCT01949051|80222278|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27555900|NCT01949051|80222279|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27555901|NCT01949051|80222280|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27555902|NCT01949051|80222275|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27695856|NCT00871780|80723608|FG000|Overall Study|Withdrawal by Subject|9|||
27826945|NCT04206332|81198854|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826946|NCT04206332|81198855|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826947|NCT04206332|81198856|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826948|NCT04206332|81198857|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826949|NCT04206332|81198858|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826950|NCT04206332|81198859|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826951|NCT04206332|81198860|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826952|NCT04206332|81198861|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826953|NCT04206332|81198862|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826954|NCT04206332|81198863|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
27826955|NCT04206332|81198864|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
27826956|NCT04206332|81198848|FG000|Part C|Withdrawal by Subject|0|||
27826957|NCT04206332|81198849|FG001|Part C|Withdrawal by Subject|0|||
27826958|NCT04206332|81198850|FG002|Part C|Withdrawal by Subject|0|||
27826959|NCT04206332|81198851|FG003|Part C|Withdrawal by Subject|0|||
27826960|NCT04206332|81198852|FG004|Part C|Withdrawal by Subject|0|||
27695857|NCT00871780|80723608|FG000|Overall Study|Adverse Event|6|||
27695858|NCT00871780|80723608|FG000|Overall Study|Voluntary Discontinuation|4|||
27695859|NCT00871780|80723608|FG000|Overall Study|Death|1|||
27826961|NCT04206332|81198853|FG005|Part C|Withdrawal by Subject|0|||
27826962|NCT04206332|81198854|FG006|Part C|Withdrawal by Subject|0|||
27826963|NCT04206332|81198855|FG007|Part C|Withdrawal by Subject|0|||
27826964|NCT04206332|81198856|FG008|Part C|Withdrawal by Subject|0|||
27826965|NCT04206332|81198857|FG009|Part C|Withdrawal by Subject|0|||
27826966|NCT04206332|81198858|FG010|Part C|Withdrawal by Subject|0|||
27826967|NCT04206332|81198859|FG011|Part C|Withdrawal by Subject|0|||
27826968|NCT04206332|81198860|FG012|Part C|Withdrawal by Subject|0|||
27826969|NCT04206332|81198861|FG013|Part C|Withdrawal by Subject|0|||
27826970|NCT04206332|81198862|FG014|Part C|Withdrawal by Subject|2|||
27826971|NCT04206332|81198863|FG015|Part C|Withdrawal by Subject|0|||
27826972|NCT04206332|81198864|FG016|Part C|Withdrawal by Subject|0|||
27555903|NCT01949051|80222276|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27555904|NCT01949051|80222277|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27555905|NCT01949051|80222278|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27555906|NCT01949051|80222279|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
27555907|NCT01949051|80222280|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
27555908|NCT01949051|80222275|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27555909|NCT01949051|80222276|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
27555910|NCT01949051|80222277|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27555911|NCT01949051|80222278|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27555912|NCT01949051|80222279|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27555913|NCT01949051|80222280|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
27555914|NCT01949051|80222275|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27555915|NCT01949051|80222276|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27555916|NCT01949051|80222277|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
27555917|NCT01949051|80222278|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27555918|NCT01949051|80222279|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27555919|NCT01949051|80222280|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
27555920|NCT03266107|80222281|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
27555921|NCT03266107|80222281|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
27555922|NCT03266107|80222281|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
27555923|NCT03266107|80222281|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
27555924|NCT00592839|80222284|FG000|Overall Study|Withdrawal by Subject|1|||
27555925|NCT00592839|80222285|FG001|Overall Study|Withdrawal by Subject|1|||
27555926|NCT00592839|80222286|FG002|Overall Study|Withdrawal by Subject|3|||
27555927|NCT00592839|80222284|FG000|Overall Study|Protocol Violation|1|||
27555928|NCT00592839|80222285|FG001|Overall Study|Protocol Violation|1|||
27555929|NCT00592839|80222286|FG002|Overall Study|Protocol Violation|2|||
27555930|NCT00592839|80222284|FG000|Overall Study|Adverse Event|0|||
27555931|NCT00592839|80222285|FG001|Overall Study|Adverse Event|1|||
27555932|NCT00592839|80222286|FG002|Overall Study|Adverse Event|0|||
27555933|NCT00592839|80222284|FG000|Overall Study|Lost to Follow-up|0|||
27555934|NCT00592839|80222285|FG001|Overall Study|Lost to Follow-up|1|||
27555935|NCT00592839|80222286|FG002|Overall Study|Lost to Follow-up|1|||
27555936|NCT04690751|80222287|FG000|Overall Study|Protocol Violation|0|||
27555937|NCT04690751|80222288|FG001|Overall Study|Protocol Violation|1|||
27826973|NCT01519661|81198865|FG000|Overall Study|Protocol deviation|6|||
27826974|NCT01519661|81198865|FG000|Overall Study|Lost to Follow-up|3|||
27555938|NCT04690751|80222289|FG002|Overall Study|Protocol Violation|0|||
27555939|NCT04690751|80222290|FG003|Overall Study|Protocol Violation|1|||
27555940|NCT04690751|80222291|FG004|Overall Study|Protocol Violation|2|||
27555941|NCT04690751|80222292|FG005|Overall Study|Protocol Violation|0|||
27555942|NCT04690751|80222287|FG000|Overall Study|Adverse Event|0|||
27555943|NCT04690751|80222288|FG001|Overall Study|Adverse Event|0|||
27555944|NCT04690751|80222289|FG002|Overall Study|Adverse Event|1|||
27555945|NCT04690751|80222290|FG003|Overall Study|Adverse Event|0|||
27555946|NCT04690751|80222291|FG004|Overall Study|Adverse Event|0|||
27555947|NCT04690751|80222292|FG005|Overall Study|Adverse Event|0|||
27555948|NCT04690751|80222287|FG000|Overall Study|Positive urine drug screen test|0|||
27555949|NCT04690751|80222288|FG001|Overall Study|Positive urine drug screen test|0|||
27555950|NCT04690751|80222289|FG002|Overall Study|Positive urine drug screen test|0|||
27555951|NCT04690751|80222290|FG003|Overall Study|Positive urine drug screen test|0|||
27555952|NCT04690751|80222291|FG004|Overall Study|Positive urine drug screen test|1|||
27555953|NCT04690751|80222292|FG005|Overall Study|Positive urine drug screen test|0|||
27555954|NCT04626297|80222293|FG000|Overall Study|Adverse Event|5|||
27555955|NCT04626297|80222294|FG001|Overall Study|Adverse Event|3|||
27555956|NCT04626297|80222293|FG000|Overall Study|Lost to Follow-up|7|||
27555957|NCT04626297|80222294|FG001|Overall Study|Lost to Follow-up|3|||
27555958|NCT04626297|80222293|FG000|Overall Study|Protocol Violation|5|||
27555959|NCT04626297|80222294|FG001|Overall Study|Protocol Violation|1|||
27555960|NCT04626297|80222293|FG000|Overall Study|Withdrawal by Subject|20|||
27555961|NCT04626297|80222294|FG001|Overall Study|Withdrawal by Subject|6|||
27555962|NCT04626297|80222293|FG000|Overall Study|Sponsor decision|2|||
27555963|NCT04626297|80222294|FG001|Overall Study|Sponsor decision|1|||
27555964|NCT04080297|80222295|FG000|Overall Study|Adverse Event|1|||
27555965|NCT04080297|80222296|FG001|Overall Study|Adverse Event|3|||
27555966|NCT04080297|80222295|FG000|Overall Study|concurrent illness|1|||
27555967|NCT04080297|80222296|FG001|Overall Study|concurrent illness|0|||
27555968|NCT03414424|80222297|FG000|Overall Study|Screened out after consent|0|||
27555969|NCT03414424|80222298|FG001|Overall Study|Screened out after consent|2|||
27555970|NCT03414424|80222297|FG000|Overall Study|Lost to Follow-up|0|||
27555971|NCT03414424|80222298|FG001|Overall Study|Lost to Follow-up|1|||
27555972|NCT03585504|80222299|FG000|Overall Study|Lost to Follow-up|26|||
27555973|NCT03585504|80222300|FG001|Overall Study|Lost to Follow-up|29|||
27555974|NCT03336333|80222301|FG000|Overall Study|Remained on study at time of data cut-off|202|||
27555975|NCT03336333|80222302|FG001|Overall Study|Remained on study at time of data cut-off|219|||
27555976|NCT03336333|80222303|FG002|Overall Study|Remained on study at time of data cut-off|102|||
27555977|NCT03336333|80222301|FG000|Overall Study|Death|14|||
27555978|NCT03336333|80222302|FG001|Overall Study|Death|16|||
27555979|NCT03336333|80222303|FG002|Overall Study|Death|8|||
27555980|NCT03336333|80222301|FG000|Overall Study|Withdrawal by Subject|16|||
27555981|NCT03336333|80222302|FG001|Overall Study|Withdrawal by Subject|5|||
27555982|NCT03336333|80222303|FG002|Overall Study|Withdrawal by Subject|1|||
27555983|NCT03336333|80222301|FG000|Overall Study|Physician Decision|5|||
27555984|NCT03336333|80222302|FG001|Overall Study|Physician Decision|1|||
27555985|NCT03336333|80222303|FG002|Overall Study|Physician Decision|0|||
27555986|NCT03336333|80222301|FG000|Overall Study|Lost to Follow-up|1|||
27826975|NCT01519661|81198865|FG000|Overall Study|Withdrawal by Subject|17|||
27826976|NCT01519661|81198865|FG000|Overall Study|Lack of Efficacy|6|||
27826977|NCT01519661|81198865|FG000|Overall Study|Adverse Event|29|||
27826978|NCT00147498|81198866|FG000|Overall Study|Adverse Event|1|||
27826979|NCT00147498|81198867|FG001|Overall Study|Adverse Event|6|||
27826980|NCT00147498|81198868|FG002|Overall Study|Adverse Event|7|||
27826981|NCT00147498|81198869|FG003|Overall Study|Adverse Event|3|||
27826982|NCT00147498|81198866|FG000|Overall Study|Lack of Efficacy|1|||
27826983|NCT00147498|81198867|FG001|Overall Study|Lack of Efficacy|1|||
27826984|NCT00147498|81198868|FG002|Overall Study|Lack of Efficacy|1|||
27826985|NCT00147498|81198869|FG003|Overall Study|Lack of Efficacy|8|||
27826986|NCT00147498|81198866|FG000|Overall Study|Laboratory abnormality|0|||
27826987|NCT00147498|81198867|FG001|Overall Study|Laboratory abnormality|0|||
27826988|NCT00147498|81198868|FG002|Overall Study|Laboratory abnormality|2|||
27826989|NCT00147498|81198869|FG003|Overall Study|Laboratory abnormality|0|||
27555987|NCT03336333|80222302|FG001|Overall Study|Lost to Follow-up|0|||
27555988|NCT03336333|80222303|FG002|Overall Study|Lost to Follow-up|0|||
27555989|NCT03021265|80222308|FG000|Overall Study|Adverse Event|29|||
27826990|NCT00147498|81198866|FG000|Overall Study|Participant defaulted|0|||
27555990|NCT03021265|80222308|FG000|Overall Study|Lack of Efficacy|3|||
27555991|NCT03021265|80222308|FG000|Overall Study|Improved|17|||
27555992|NCT03021265|80222308|FG000|Overall Study|Lost to Follow-up|67|||
27555993|NCT03021265|80222308|FG000|Overall Study|No reason given|2|||
27555994|NCT03021265|80222308|FG000|Overall Study|No visit since the first visit|4|||
27555995|NCT01574326|80222309|FG000|Overall Study|Randomized but not treated|0|||
27555996|NCT01574326|80222310|FG001|Overall Study|Randomized but not treated|1|||
27555997|NCT01574326|80222309|FG000|Overall Study|Withdrawal by Participant|2|||
27555998|NCT01574326|80222310|FG001|Overall Study|Withdrawal by Participant|4|||
27695860|NCT00871780|80723608|FG000|Overall Study|Physician Decision|1|||
27826991|NCT00147498|81198867|FG001|Overall Study|Participant defaulted|1|||
27826992|NCT00147498|81198868|FG002|Overall Study|Participant defaulted|4|||
27555999|NCT01574326|80222309|FG000|Overall Study|Physician Decision|5|||
27556000|NCT01574326|80222310|FG001|Overall Study|Physician Decision|3|||
27826993|NCT00147498|81198869|FG003|Overall Study|Participant defaulted|3|||
27556001|NCT01574326|80222309|FG000|Overall Study|Adverse Event|1|||
27556002|NCT01574326|80222310|FG001|Overall Study|Adverse Event|3|||
27556003|NCT01574326|80222309|FG000|Overall Study|Other: Mainly kidney transplant|8|||
27556004|NCT01574326|80222310|FG001|Overall Study|Other: Mainly kidney transplant|8|||
27556005|NCT04044716|80222311|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
27556006|NCT04044716|80222312|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
27556007|NCT04044716|80222313|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
27556008|NCT04044716|80222311|FG000|Overall Study|Lost to Follow-up|2|||
27556009|NCT04044716|80222312|FG001|Overall Study|Lost to Follow-up|3|||
27556010|NCT04044716|80222313|FG002|Overall Study|Lost to Follow-up|0|||
27556011|NCT00793403|80222314|FG000|Overall Study|Other|73|||
27556012|NCT00524368|80222325|FG000|Overall Study|Adverse Event|10|||
27556013|NCT00524368|80222326|FG001|Overall Study|Adverse Event|12|||
27556014|NCT00524368|80222325|FG000|Overall Study|Lost to Follow-up|9|||
27556015|NCT00524368|80222326|FG001|Overall Study|Lost to Follow-up|13|||
27556016|NCT00524368|80222325|FG000|Overall Study|Withdrawal by Subject|4|||
27556017|NCT00524368|80222326|FG001|Overall Study|Withdrawal by Subject|5|||
27556018|NCT00524368|80222325|FG000|Overall Study|Non-compliant|8|||
27556019|NCT00524368|80222326|FG001|Overall Study|Non-compliant|9|||
27556020|NCT00524368|80222325|FG000|Overall Study|Reached a Virologic Endpoint|3|||
27556021|NCT00524368|80222326|FG001|Overall Study|Reached a Virologic Endpoint|2|||
27556022|NCT00524368|80222325|FG000|Overall Study|Sponsor's Decision|2|||
27556023|NCT00524368|80222326|FG001|Overall Study|Sponsor's Decision|0|||
27556024|NCT00524368|80222325|FG000|Overall Study|Ineligible to Continue the study|2|||
27556025|NCT00524368|80222326|FG001|Overall Study|Ineligible to Continue the study|5|||
27556026|NCT00524368|80222325|FG000|Overall Study|Other|3|||
27556027|NCT00524368|80222326|FG001|Overall Study|Other|2|||
27556028|NCT01721330|80222327|FG000|Overall Study|Withdrawal by Subject|0|||
27556029|NCT01721330|80222328|FG001|Overall Study|Withdrawal by Subject|1|||
27556030|NCT02759471|80222329|FG000|Overall Study|discomfort|2|||
27556031|NCT02511184|80222330|FG000|Overall Study|Death|1|||
27556032|NCT02511184|80222331|FG001|Overall Study|Death|0|||
27556033|NCT02511184|80222330|FG000|Overall Study|Lost to Follow-up|0|||
27556034|NCT02511184|80222331|FG001|Overall Study|Lost to Follow-up|1|||
27556035|NCT02511184|80222330|FG000|Overall Study|Study terminated by sponsor|1|||
27695861|NCT02342743|80723609|FG000|Baseline Period|Withdrawal by Subject|3|||
27695862|NCT02342743|80723609|FG000|Baseline Period|Lost to Follow-up|2|||
27695863|NCT02342743|80723609|FG000|Baseline Period|Change in prophylactic medication|3|||
27695864|NCT02342743|80723609|FG000|Baseline Period|Screening failure regarding baseline|7|||
27695865|NCT02342743|80723609|FG000|Treatment Period|Withdrawal by Subject|2|||
27556036|NCT02511184|80222331|FG001|Overall Study|Study terminated by sponsor|5|||
27695866|NCT02342743|80723609|FG000|Treatment Period|Lost to Follow-up|8|||
27695867|NCT02342743|80723609|FG000|Treatment Period|Change in prophylactic medication|1|||
27695868|NCT01079741|80723610|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27695869|NCT01079741|80723611|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
27695870|NCT01079741|80723612|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27695871|NCT01079741|80723613|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27695872|NCT01079741|80723614|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
27695873|NCT01079741|80723610|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27695874|NCT01079741|80723611|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27695875|NCT01079741|80723612|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27556037|NCT02511184|80222330|FG000|Overall Study|Withdrawal by Subject|0|||
27556038|NCT02511184|80222331|FG001|Overall Study|Withdrawal by Subject|1|||
27556039|NCT01409564|80222332|FG000|Overall Study|low medication compliance|4|||
27556040|NCT01409564|80222333|FG001|Overall Study|low medication compliance|3|||
27695876|NCT01079741|80723613|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
27826994|NCT00147498|81198866|FG000|Overall Study|Other|1|||
27826995|NCT00147498|81198867|FG001|Overall Study|Other|1|||
27695877|NCT01079741|80723614|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
27695878|NCT02502097|80723617|FG000|Period 1|Adverse Event|0|||
27695879|NCT02502097|80723618|FG001|Period 1|Adverse Event|0|||
27695880|NCT02502097|80723619|FG002|Period 1|Adverse Event|1|||
27695881|NCT02502097|80723620|FG003|Period 1|Adverse Event|0|||
27695882|NCT02502097|80723617|FG000|Wash Out Period|Adverse Event|0|||
27695883|NCT02502097|80723618|FG001|Wash Out Period|Adverse Event|1|||
27695884|NCT02502097|80723619|FG002|Wash Out Period|Adverse Event|1|||
27695885|NCT02502097|80723620|FG003|Wash Out Period|Adverse Event|1|||
27695886|NCT02502097|80723617|FG000|Period 2|Adverse Event|0|||
27695887|NCT02502097|80723618|FG001|Period 2|Adverse Event|0|||
27695888|NCT02502097|80723619|FG002|Period 2|Adverse Event|1|||
27695889|NCT02502097|80723620|FG003|Period 2|Adverse Event|0|||
27695890|NCT01155375|80723621|FG000|Overall Study|Adverse Event|1|||
27695891|NCT01155375|80723622|FG001|Overall Study|Adverse Event|0|||
27695892|NCT00069238|80723623|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
27695893|NCT00069238|80723624|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
27695894|NCT00069238|80723625|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
27695895|NCT00069238|80723623|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
27695896|NCT00069238|80723624|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
27695897|NCT00069238|80723625|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
27695898|NCT00069238|80723623|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
27695899|NCT00069238|80723624|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
27695900|NCT00069238|80723625|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
27695901|NCT00232141|80723627|FG000|Overall Study|Adverse Event|9|||
27695902|NCT00232141|80723628|FG001|Overall Study|Adverse Event|4|||
27695903|NCT00232141|80723627|FG000|Overall Study|Lack of Efficacy|0|||
27695904|NCT00232141|80723628|FG001|Overall Study|Lack of Efficacy|3|||
27695905|NCT00232141|80723627|FG000|Overall Study|Lost to Follow-up|9|||
27695906|NCT00232141|80723628|FG001|Overall Study|Lost to Follow-up|6|||
27695907|NCT00232141|80723627|FG000|Overall Study|Other|8|||
27695908|NCT00232141|80723628|FG001|Overall Study|Other|10|||
27695909|NCT00232141|80723627|FG000|Overall Study|Withdrawal by Subject|5|||
27695910|NCT00232141|80723628|FG001|Overall Study|Withdrawal by Subject|3|||
27695911|NCT00447382|80723629|FG000|Overall Study|Adverse Event|1|||
27695912|NCT00447382|80723630|FG001|Overall Study|Adverse Event|1|||
27695913|NCT00447382|80723629|FG000|Overall Study|Lack of Efficacy|1|||
27695914|NCT00447382|80723630|FG001|Overall Study|Lack of Efficacy|0|||
27695915|NCT00447382|80723629|FG000|Overall Study|Protocol Violation|2|||
27695916|NCT00447382|80723630|FG001|Overall Study|Protocol Violation|0|||
27695917|NCT00447382|80723629|FG000|Overall Study|Unclassified|2|||
27695918|NCT00447382|80723630|FG001|Overall Study|Unclassified|5|||
27695919|NCT02370043|80723631|FG000|Overall Study|Withdrawal by Subject|0|||
27695920|NCT02370043|80723632|FG001|Overall Study|Withdrawal by Subject|0|||
27695921|NCT02370043|80723633|FG002|Overall Study|Withdrawal by Subject|0|||
27695922|NCT02370043|80723634|FG003|Overall Study|Withdrawal by Subject|0|||
27695923|NCT02370043|80723635|FG004|Overall Study|Withdrawal by Subject|1|||
27695924|NCT02370043|80723636|FG005|Overall Study|Withdrawal by Subject|1|||
27695925|NCT02795429|80723637|FG000|Overall Study|Adverse Event|1|||
27695926|NCT02795429|80723638|FG001|Overall Study|Adverse Event|2|||
27695927|NCT02795429|80723639|FG002|Overall Study|Adverse Event|1|||
27695928|NCT02795429|80723640|FG003|Overall Study|Adverse Event|2|||
27695929|NCT02795429|80723641|FG004|Overall Study|Adverse Event|1|||
27695930|NCT02795429|80723637|FG000|Overall Study|Death|1|||
27695931|NCT02795429|80723638|FG001|Overall Study|Death|0|||
27695932|NCT02795429|80723639|FG002|Overall Study|Death|1|||
27695933|NCT02795429|80723640|FG003|Overall Study|Death|2|||
27695934|NCT02795429|80723641|FG004|Overall Study|Death|1|||
27695935|NCT02795429|80723637|FG000|Overall Study|Physician Decision|0|||
27695936|NCT02795429|80723638|FG001|Overall Study|Physician Decision|0|||
27695937|NCT02795429|80723639|FG002|Overall Study|Physician Decision|2|||
27695938|NCT02795429|80723640|FG003|Overall Study|Physician Decision|1|||
27695939|NCT02795429|80723641|FG004|Overall Study|Physician Decision|5|||
27695940|NCT02795429|80723637|FG000|Overall Study|Progressive disease|3|||
27695941|NCT02795429|80723638|FG001|Overall Study|Progressive disease|7|||
27695942|NCT02795429|80723639|FG002|Overall Study|Progressive disease|6|||
27695943|NCT02795429|80723640|FG003|Overall Study|Progressive disease|26|||
27695944|NCT02795429|80723641|FG004|Overall Study|Progressive disease|20|||
27695945|NCT02795429|80723637|FG000|Overall Study|Subject/guardian decision|1|||
27695946|NCT02795429|80723638|FG001|Overall Study|Subject/guardian decision|1|||
27695947|NCT02795429|80723639|FG002|Overall Study|Subject/guardian decision|1|||
27695948|NCT02795429|80723640|FG003|Overall Study|Subject/guardian decision|1|||
27695949|NCT02795429|80723641|FG004|Overall Study|Subject/guardian decision|3|||
27695950|NCT03451162|80723644|FG000|Overall Study|Lost to Follow-up|1|||
27695951|NCT03451162|80723645|FG001|Overall Study|Lost to Follow-up|0|||
27695952|NCT03451162|80723646|FG002|Overall Study|Lost to Follow-up|0|||
27695953|NCT03451162|80723647|FG003|Overall Study|Lost to Follow-up|0|||
27695954|NCT03451162|80723648|FG004|Overall Study|Lost to Follow-up|0|||
27695955|NCT03451162|80723644|FG000|Overall Study|Physician Decision|0|||
27695956|NCT03451162|80723645|FG001|Overall Study|Physician Decision|1|||
27695957|NCT03451162|80723646|FG002|Overall Study|Physician Decision|0|||
27695958|NCT03451162|80723647|FG003|Overall Study|Physician Decision|0|||
27695959|NCT03451162|80723648|FG004|Overall Study|Physician Decision|0|||
27695960|NCT03451162|80723644|FG000|Overall Study|Withdrawal by Subject|1|||
27695961|NCT03451162|80723645|FG001|Overall Study|Withdrawal by Subject|1|||
27695962|NCT03451162|80723646|FG002|Overall Study|Withdrawal by Subject|0|||
27695963|NCT03451162|80723647|FG003|Overall Study|Withdrawal by Subject|0|||
27556041|NCT01409564|80222332|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
27556042|NCT01409564|80222333|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
27556043|NCT01943292|80222336|FG000|Overall Study|Withdrawal by Subject|1|||
27556044|NCT01943292|80222337|FG001|Overall Study|Withdrawal by Subject|0|||
27556045|NCT01943292|80222338|FG002|Overall Study|Withdrawal by Subject|0|||
27556046|NCT01244906|80222339|FG000|Overall Study|Death|2|||
27556047|NCT01244906|80222339|FG000|Overall Study|Progression of disease post treatment|6|||
27556048|NCT04876274|80222340|FG000|Overall Study|Lost to Follow-up|9|||
27556049|NCT04876274|80222341|FG001|Overall Study|Lost to Follow-up|12|||
27556050|NCT01414114|80222342|FG000|Overall Study|Adverse Event|2|||
27556051|NCT01414114|80222342|FG000|Overall Study|Withdrawal by Subject|1|||
27556052|NCT01414114|80222342|FG000|Overall Study|Other|2|||
27556053|NCT00931762|80222345|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
27556054|NCT00931762|80222345|FG000|Overall Study|Administrative Problems|5|||
27556055|NCT00931762|80222345|FG000|Overall Study|Death|1|||
27556056|NCT00931762|80222345|FG000|Overall Study|Disease Progression|3|||
27556057|NCT00931762|80222345|FG000|Overall Study|Adverse Event (s)|11|||
27556058|NCT00931762|80222345|FG000|Overall Study|Subject withdrew consent|13|||
27556059|NCT02626520|80222346|FG000|Overall Study|Physician Decision|1|||
27556060|NCT02626520|80222347|FG001|Overall Study|Physician Decision|1|||
27556061|NCT02626520|80222346|FG000|Overall Study|Adverse Event|0|||
27556062|NCT02626520|80222347|FG001|Overall Study|Adverse Event|4|||
27556063|NCT02626520|80222346|FG000|Overall Study|Lack of Efficacy|0|||
27556064|NCT02626520|80222347|FG001|Overall Study|Lack of Efficacy|2|||
27556065|NCT02626520|80222346|FG000|Overall Study|Did not start protocol therapy|0|||
27556066|NCT02626520|80222347|FG001|Overall Study|Did not start protocol therapy|2|||
27556067|NCT02626520|80222346|FG000|Overall Study|Study terminated|0|||
27556068|NCT02626520|80222347|FG001|Overall Study|Study terminated|1|||
27556069|NCT04271605|80222348|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
27556070|NCT02700815|80222353|FG000|Overall Study|Adverse Event|0|||
27556071|NCT02700815|80222354|FG001|Overall Study|Adverse Event|6|||
27556072|NCT02700815|80222355|FG002|Overall Study|Adverse Event|2|||
27556073|NCT02700815|80222356|FG003|Overall Study|Adverse Event|3|||
27556074|NCT02700815|80222353|FG000|Overall Study|Lack of Efficacy|0|||
27556075|NCT02700815|80222354|FG001|Overall Study|Lack of Efficacy|0|||
27556076|NCT02700815|80222355|FG002|Overall Study|Lack of Efficacy|1|||
27556077|NCT02700815|80222356|FG003|Overall Study|Lack of Efficacy|2|||
27556078|NCT02700815|80222353|FG000|Overall Study|Lost to Follow-up|1|||
27556079|NCT02700815|80222354|FG001|Overall Study|Lost to Follow-up|0|||
27556080|NCT02700815|80222355|FG002|Overall Study|Lost to Follow-up|0|||
27556081|NCT02700815|80222356|FG003|Overall Study|Lost to Follow-up|1|||
27556082|NCT02700815|80222353|FG000|Overall Study|Refusal to continue medication|0|||
27556083|NCT02700815|80222354|FG001|Overall Study|Refusal to continue medication|1|||
27556084|NCT02700815|80222355|FG002|Overall Study|Refusal to continue medication|0|||
27556085|NCT02700815|80222356|FG003|Overall Study|Refusal to continue medication|1|||
27556086|NCT02700815|80222353|FG000|Overall Study|Withdrawal by Subject|0|||
27556087|NCT02700815|80222354|FG001|Overall Study|Withdrawal by Subject|0|||
27556088|NCT02700815|80222355|FG002|Overall Study|Withdrawal by Subject|1|||
27695964|NCT03451162|80723648|FG004|Overall Study|Withdrawal by Subject|0|||
27556089|NCT02700815|80222356|FG003|Overall Study|Withdrawal by Subject|0|||
27695965|NCT01230788|80723655|FG000|Overall Study|Prescribed exclusion drug|1|||
27556090|NCT01414075|80222359|FG000|Overall Study|Adverse Event|1|||
27556091|NCT01414075|80222360|FG001|Overall Study|Adverse Event|0|||
27556092|NCT01414075|80222361|FG002|Overall Study|Adverse Event|1|||
27695966|NCT04507126|80723656|FG000|Overall Study|Withdrawal by Subject|1|||
27695967|NCT04507126|80723656|FG000|Overall Study|Protocol Violation|2|||
27556093|NCT01414075|80222362|FG003|Overall Study|Adverse Event|0|||
27556094|NCT01414075|80222359|FG000|Overall Study|Death|1|||
27556095|NCT01414075|80222360|FG001|Overall Study|Death|0|||
27556096|NCT01414075|80222361|FG002|Overall Study|Death|0|||
27556097|NCT01414075|80222362|FG003|Overall Study|Death|1|||
27556098|NCT01414075|80222359|FG000|Overall Study|Withdrawal by Subject|0|||
27556099|NCT01414075|80222360|FG001|Overall Study|Withdrawal by Subject|0|||
27556100|NCT01414075|80222361|FG002|Overall Study|Withdrawal by Subject|0|||
27556101|NCT01414075|80222362|FG003|Overall Study|Withdrawal by Subject|1|||
27556102|NCT01414075|80222359|FG000|Overall Study|Other than specified|1|||
27556103|NCT01414075|80222360|FG001|Overall Study|Other than specified|0|||
27556104|NCT01414075|80222361|FG002|Overall Study|Other than specified|1|||
27556105|NCT01414075|80222362|FG003|Overall Study|Other than specified|0|||
27556106|NCT00881712|80222369|FG000|Overall Study|Death|1|||
27556107|NCT00881712|80222370|FG001|Overall Study|Death|0|||
27556108|NCT00881712|80222371|FG002|Overall Study|Death|0|||
27556109|NCT00881712|80222369|FG000|Overall Study|Withdrawal by Subject|1|||
27556110|NCT00881712|80222370|FG001|Overall Study|Withdrawal by Subject|0|||
27556111|NCT00881712|80222371|FG002|Overall Study|Withdrawal by Subject|0|||
27556112|NCT02989194|80222374|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
27556113|NCT02989194|80222375|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
27556114|NCT02989194|80222376|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
27556115|NCT02989194|80222374|FG000|Overall Study|Lost to Follow-up|0|||
27556116|NCT02989194|80222375|FG001|Overall Study|Lost to Follow-up|1|||
27556117|NCT02989194|80222376|FG002|Overall Study|Lost to Follow-up|0|||
27556118|NCT02989194|80222374|FG000|Overall Study|Withdrawal by Subject|0|||
27556119|NCT02989194|80222375|FG001|Overall Study|Withdrawal by Subject|1|||
27556120|NCT02989194|80222376|FG002|Overall Study|Withdrawal by Subject|0|||
27556121|NCT02064894|80222381|FG000|Overall Study|Withdrawal by Subject|43|||
27556122|NCT02064894|80222382|FG001|Overall Study|Withdrawal by Subject|102|||
27556123|NCT02064894|80222383|FG002|Overall Study|Withdrawal by Subject|115|||
27556124|NCT02557646|80222384|FG000|Overall Study|Adverse Event|40|||
27556125|NCT02557646|80222384|FG000|Overall Study|Death|1|||
27556126|NCT02557646|80222384|FG000|Overall Study|Lack of Efficacy|186|||
27556127|NCT02557646|80222384|FG000|Overall Study|Withdrawal by Subject|18|||
27556128|NCT02557646|80222384|FG000|Overall Study|Lost to Follow-up|17|||
27556129|NCT02557646|80222384|FG000|Overall Study|Other|14|||
27556130|NCT02289079|80222386|FG000|Overall Study|Physician Decision|2|||
27556131|NCT02289079|80222387|FG001|Overall Study|Physician Decision|0|||
27556132|NCT02289079|80222386|FG000|Overall Study|Lost to Follow-up|0|||
27556133|NCT02289079|80222387|FG001|Overall Study|Lost to Follow-up|1|||
27556134|NCT00143403|80222388|FG000|Overall Study|Adverse Event|3|||
27556135|NCT00143403|80222389|FG001|Overall Study|Adverse Event|8|||
27556136|NCT00143403|80222388|FG000|Overall Study|Death|1|||
27556137|NCT00143403|80222389|FG001|Overall Study|Death|0|||
27556138|NCT00143403|80222388|FG000|Overall Study|Withdrawal by Subject|3|||
27556139|NCT00143403|80222389|FG001|Overall Study|Withdrawal by Subject|12|||
27556140|NCT00143403|80222388|FG000|Overall Study|Relapse|15|||
27556141|NCT00143403|80222389|FG001|Overall Study|Relapse|7|||
27556142|NCT00143403|80222388|FG000|Overall Study|Protocol Violation|2|||
27556143|NCT00143403|80222389|FG001|Overall Study|Protocol Violation|2|||
27556144|NCT00143403|80222388|FG000|Overall Study|specified by site|4|||
27556145|NCT00143403|80222389|FG001|Overall Study|specified by site|9|||
27556146|NCT00143403|80222388|FG000|Overall Study|Randomized Not Treated|7|||
27556147|NCT00143403|80222389|FG001|Overall Study|Randomized Not Treated|8|||
27556148|NCT02514447|80222392|FG000|Overall Study|Withdrawal by Subject|3|||
27556149|NCT02514447|80222393|FG001|Overall Study|Withdrawal by Subject|1|||
27883935|NCT00877487|81408106|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
27556150|NCT02514447|80222394|FG002|Overall Study|Withdrawal by Subject|1|||
27556151|NCT02514447|80222395|FG003|Overall Study|Withdrawal by Subject|0|||
27556152|NCT02514447|80222396|FG004|Overall Study|Withdrawal by Subject|0|||
27556153|NCT02514447|80222397|FG005|Overall Study|Withdrawal by Subject|0|||
27556154|NCT02514447|80222398|FG006|Overall Study|Withdrawal by Subject|0|||
27556155|NCT02514447|80222399|FG007|Overall Study|Withdrawal by Subject|1|||
27556156|NCT02514447|80222400|FG008|Overall Study|Withdrawal by Subject|1|||
27556157|NCT02514447|80222392|FG000|Overall Study|Death|24|||
27556158|NCT02514447|80222393|FG001|Overall Study|Death|28|||
27556159|NCT02514447|80222394|FG002|Overall Study|Death|29|||
27556160|NCT02514447|80222395|FG003|Overall Study|Death|0|||
27556161|NCT02514447|80222396|FG004|Overall Study|Death|3|||
27556162|NCT02514447|80222397|FG005|Overall Study|Death|4|||
27556163|NCT02514447|80222398|FG006|Overall Study|Death|8|||
27556164|NCT02514447|80222399|FG007|Overall Study|Death|6|||
27556165|NCT02514447|80222400|FG008|Overall Study|Death|5|||
27556166|NCT02514447|80222392|FG000|Overall Study|Lost to Follow-up|1|||
27556167|NCT02514447|80222393|FG001|Overall Study|Lost to Follow-up|0|||
27556168|NCT02514447|80222394|FG002|Overall Study|Lost to Follow-up|0|||
27556169|NCT02514447|80222395|FG003|Overall Study|Lost to Follow-up|0|||
27556170|NCT02514447|80222396|FG004|Overall Study|Lost to Follow-up|0|||
27556171|NCT02514447|80222397|FG005|Overall Study|Lost to Follow-up|0|||
27556172|NCT02514447|80222398|FG006|Overall Study|Lost to Follow-up|0|||
27556173|NCT02514447|80222399|FG007|Overall Study|Lost to Follow-up|0|||
27556174|NCT02514447|80222400|FG008|Overall Study|Lost to Follow-up|1|||
27556175|NCT02514447|80222392|FG000|Overall Study|Sponsor Termination of Study|0|||
27556176|NCT02514447|80222393|FG001|Overall Study|Sponsor Termination of Study|1|||
27556177|NCT02514447|80222394|FG002|Overall Study|Sponsor Termination of Study|1|||
27556178|NCT02514447|80222395|FG003|Overall Study|Sponsor Termination of Study|0|||
27556179|NCT02514447|80222396|FG004|Overall Study|Sponsor Termination of Study|0|||
27556180|NCT02514447|80222397|FG005|Overall Study|Sponsor Termination of Study|0|||
27556181|NCT02514447|80222398|FG006|Overall Study|Sponsor Termination of Study|0|||
27556182|NCT02514447|80222399|FG007|Overall Study|Sponsor Termination of Study|0|||
27556183|NCT02514447|80222400|FG008|Overall Study|Sponsor Termination of Study|0|||
27556184|NCT02514447|80222392|FG000|Overall Study|Study completion per Investigator|1|||
27556185|NCT02514447|80222393|FG001|Overall Study|Study completion per Investigator|0|||
27556186|NCT02514447|80222394|FG002|Overall Study|Study completion per Investigator|1|||
27556187|NCT02514447|80222395|FG003|Overall Study|Study completion per Investigator|2|||
27556188|NCT02514447|80222396|FG004|Overall Study|Study completion per Investigator|0|||
27556189|NCT02514447|80222397|FG005|Overall Study|Study completion per Investigator|0|||
27556190|NCT02514447|80222398|FG006|Overall Study|Study completion per Investigator|0|||
27556191|NCT02514447|80222399|FG007|Overall Study|Study completion per Investigator|0|||
27556192|NCT02514447|80222400|FG008|Overall Study|Study completion per Investigator|1|||
27556193|NCT01218204|80222401|FG000|Part B Washout|Adverse Event|0|||
27556194|NCT01218204|80222402|FG001|Part B Washout|Adverse Event|1|||
27556195|NCT01218204|80222403|FG002|Part B Washout|Adverse Event|0|||
27556196|NCT01218204|80222404|FG003|Part B Washout|Adverse Event|0|||
27556197|NCT01218204|80222401|FG000|Part B Washout|Lost to Follow-up|0|||
27556198|NCT01218204|80222402|FG001|Part B Washout|Lost to Follow-up|2|||
27556199|NCT01218204|80222403|FG002|Part B Washout|Lost to Follow-up|0|||
27556200|NCT01218204|80222404|FG003|Part B Washout|Lost to Follow-up|0|||
27556201|NCT01218204|80222401|FG000|Part B Washout|Physician Decision|0|||
27556202|NCT01218204|80222402|FG001|Part B Washout|Physician Decision|14|||
27556203|NCT01218204|80222403|FG002|Part B Washout|Physician Decision|0|||
27556204|NCT01218204|80222404|FG003|Part B Washout|Physician Decision|0|||
27556205|NCT01218204|80222401|FG000|Part B Washout|Withdrawal by Subject|0|||
27556206|NCT01218204|80222402|FG001|Part B Washout|Withdrawal by Subject|14|||
27556207|NCT01218204|80222403|FG002|Part B Washout|Withdrawal by Subject|0|||
27556208|NCT01218204|80222404|FG003|Part B Washout|Withdrawal by Subject|0|||
27556209|NCT01218204|80222401|FG000|Part B Washout|Reached defined stopping criteria|0|||
27556210|NCT01218204|80222402|FG001|Part B Washout|Reached defined stopping criteria|2|||
27556211|NCT01218204|80222403|FG002|Part B Washout|Reached defined stopping criteria|0|||
27556212|NCT01218204|80222404|FG003|Part B Washout|Reached defined stopping criteria|0|||
27556213|NCT01218204|80222401|FG000|Part B Washout|Did not meet continuation criteria|0|||
27556214|NCT01218204|80222402|FG001|Part B Washout|Did not meet continuation criteria|112|||
27556215|NCT01218204|80222403|FG002|Part B Washout|Did not meet continuation criteria|0|||
27556216|NCT01218204|80222404|FG003|Part B Washout|Did not meet continuation criteria|0|||
27556217|NCT01218204|80222401|FG000|Part B Run-in|Adverse Event|0|||
27556218|NCT01218204|80222402|FG001|Part B Run-in|Adverse Event|0|||
27556219|NCT01218204|80222403|FG002|Part B Run-in|Adverse Event|1|||
27556220|NCT01218204|80222404|FG003|Part B Run-in|Adverse Event|0|||
27556221|NCT01218204|80222401|FG000|Part B Run-in|Protocol Violation|0|||
27556222|NCT01218204|80222402|FG001|Part B Run-in|Protocol Violation|0|||
27556223|NCT01218204|80222403|FG002|Part B Run-in|Protocol Violation|2|||
27556224|NCT01218204|80222404|FG003|Part B Run-in|Protocol Violation|0|||
27556225|NCT01218204|80222401|FG000|Part B Run-in|Withdrawal by Subject|0|||
27556226|NCT01218204|80222402|FG001|Part B Run-in|Withdrawal by Subject|0|||
27556227|NCT01218204|80222403|FG002|Part B Run-in|Withdrawal by Subject|3|||
27556228|NCT01218204|80222404|FG003|Part B Run-in|Withdrawal by Subject|0|||
27556229|NCT01218204|80222401|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
27556230|NCT01218204|80222402|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
27556231|NCT01218204|80222403|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
27556232|NCT01218204|80222404|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
27556233|NCT01218204|80222401|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
27556234|NCT01218204|80222402|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
27556235|NCT01218204|80222403|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
27556236|NCT01218204|80222404|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
27556237|NCT00661622|80222409|FG000|Overall Study|Protocol Violation|1|||
27556238|NCT00661622|80222410|FG001|Overall Study|Protocol Violation|0|||
27556239|NCT02259582|80222413|FG000|Overall Study|Physician Decision|0|||
27556240|NCT02259582|80222414|FG001|Overall Study|Physician Decision|1|||
27556241|NCT02259582|80222415|FG002|Overall Study|Physician Decision|0|||
27556242|NCT02259582|80222413|FG000|Overall Study|Death|0|||
27556243|NCT02259582|80222414|FG001|Overall Study|Death|0|||
27556244|NCT02259582|80222415|FG002|Overall Study|Death|1|||
27556245|NCT02259582|80222413|FG000|Overall Study|Adverse Event|1|||
27556246|NCT02259582|80222414|FG001|Overall Study|Adverse Event|0|||
27556247|NCT02259582|80222415|FG002|Overall Study|Adverse Event|1|||
27556248|NCT02259582|80222413|FG000|Overall Study|Withdrawal by Subject|0|||
27556249|NCT02259582|80222414|FG001|Overall Study|Withdrawal by Subject|0|||
27556250|NCT02259582|80222415|FG002|Overall Study|Withdrawal by Subject|1|||
27556251|NCT02259582|80222413|FG000|Overall Study|Disease progression|14|||
27556252|NCT02259582|80222414|FG001|Overall Study|Disease progression|15|||
27556253|NCT02259582|80222415|FG002|Overall Study|Disease progression|17|||
27556254|NCT02259582|80222413|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
27556255|NCT02259582|80222414|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
27556256|NCT02259582|80222415|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
27556257|NCT00759954|80222417|FG000|Overall Study|Personal reason|1|||
27556258|NCT00759954|80222418|FG001|Overall Study|Personal reason|0|||
27556259|NCT00759954|80222417|FG000|Overall Study|Adverse Event|1|||
27556260|NCT00759954|80222418|FG001|Overall Study|Adverse Event|2|||
27556261|NCT02865187|80222419|FG000|Overall Study|Lost to Follow-up|12|||
27556262|NCT02865187|80222420|FG001|Overall Study|Lost to Follow-up|7|||
27556263|NCT02865187|80222419|FG000|Overall Study|Adverse Event|1|||
27556264|NCT02865187|80222420|FG001|Overall Study|Adverse Event|0|||
27556265|NCT01285310|80222421|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
27556266|NCT01285310|80222422|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
27556267|NCT01285310|80222423|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
27556268|NCT01285310|80222424|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
27556269|NCT01285310|80222425|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
27556270|NCT01285310|80222421|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
27556271|NCT01285310|80222422|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
27826996|NCT00147498|81198868|FG002|Overall Study|Other|3|||
27556272|NCT01285310|80222423|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
27556273|NCT01285310|80222424|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
27556274|NCT01285310|80222425|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
27556275|NCT01285310|80222421|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
27826997|NCT00147498|81198869|FG003|Overall Study|Other|3|||
27556276|NCT01285310|80222422|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
27556277|NCT01285310|80222423|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
27556278|NCT01285310|80222424|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
27556279|NCT01285310|80222425|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
27556280|NCT01285310|80222421|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
27556281|NCT01285310|80222422|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
27556282|NCT01285310|80222423|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
27556283|NCT01285310|80222424|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
27556284|NCT01285310|80222425|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
27556285|NCT01285310|80222421|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
27556286|NCT01285310|80222422|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
27556287|NCT01285310|80222423|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
27556288|NCT01285310|80222424|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
27556289|NCT01285310|80222425|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
27556290|NCT01285310|80222421|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
27883936|NCT00877487|81408105|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
27883937|NCT00877487|81408106|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
27556291|NCT01285310|80222422|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
27556292|NCT01285310|80222423|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
27556293|NCT01285310|80222424|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
27556294|NCT01285310|80222425|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
27556295|NCT01285310|80222421|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
27556296|NCT01285310|80222422|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
27556297|NCT01285310|80222423|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
27556298|NCT01285310|80222424|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
27556299|NCT01285310|80222425|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
27556300|NCT01285310|80222421|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
27556301|NCT01285310|80222422|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
27556302|NCT01285310|80222423|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
27556303|NCT01285310|80222424|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
27556304|NCT01285310|80222425|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
27556305|NCT01285310|80222421|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
27556306|NCT01285310|80222422|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
27556307|NCT01285310|80222423|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
27556308|NCT01285310|80222424|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
27556309|NCT01285310|80222425|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
27556310|NCT01285310|80222421|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
27556311|NCT01285310|80222422|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
27556312|NCT01285310|80222423|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
27556313|NCT01285310|80222424|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
27556314|NCT01285310|80222425|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
27556315|NCT01285310|80222421|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
27556316|NCT01285310|80222422|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
27556317|NCT01285310|80222423|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
27556318|NCT01285310|80222424|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
27556319|NCT01285310|80222425|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
27556320|NCT01285310|80222421|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
27556321|NCT01285310|80222422|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
27556322|NCT01285310|80222423|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
27556323|NCT01285310|80222424|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
27556324|NCT01285310|80222425|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
27556325|NCT01124422|80222426|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
27556326|NCT01124422|80222427|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
27556327|NCT01124422|80222428|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
27556328|NCT01124422|80222426|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
27556329|NCT01124422|80222427|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
27556330|NCT01124422|80222428|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
27556331|NCT01124422|80222426|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
27556332|NCT01124422|80222427|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
27556333|NCT01124422|80222428|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
27556334|NCT01124422|80222426|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
27556335|NCT01124422|80222427|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
27556336|NCT01124422|80222428|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
27556337|NCT01124422|80222426|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
27556338|NCT01124422|80222427|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
27556339|NCT01124422|80222428|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
27556340|NCT01124422|80222426|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
27556341|NCT01124422|80222427|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
27556342|NCT01124422|80222428|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
27556343|NCT01124422|80222426|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
27695968|NCT04507126|80723656|FG000|Overall Study|Physician Decision|1|||
27695969|NCT05105789|80723662|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
27695970|NCT02319525|80723664|FG000|Overall Study|Withdrawal by Subject|2|||
27695971|NCT02319525|80723665|FG001|Overall Study|Withdrawal by Subject|1|||
27695972|NCT00995020|80723666|FG000|Overall Study|margin analysis not performed|2|||
27695973|NCT00995020|80723667|FG001|Overall Study|margin analysis not performed|5|||
27695974|NCT00995020|80723666|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
27695975|NCT00995020|80723667|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
27695976|NCT00402597|80723669|FG000|Overall Study|Death|15|||
27695977|NCT00402597|80723670|FG001|Overall Study|Death|7|||
27695978|NCT00402597|80723671|FG002|Overall Study|Death|6|||
27695979|NCT00402597|80723672|FG003|Overall Study|Death|4|||
27695980|NCT00402597|80723673|FG004|Overall Study|Death|6|||
27695981|NCT00402597|80723669|FG000|Overall Study|Adverse Event|81|||
27695982|NCT00402597|80723670|FG001|Overall Study|Adverse Event|18|||
27695983|NCT00402597|80723671|FG002|Overall Study|Adverse Event|106|||
27695984|NCT00402597|80723672|FG003|Overall Study|Adverse Event|39|||
27695985|NCT00402597|80723673|FG004|Overall Study|Adverse Event|71|||
27695986|NCT00402597|80723669|FG000|Overall Study|Lost to Follow-up|8|||
27695987|NCT00402597|80723670|FG001|Overall Study|Lost to Follow-up|1|||
27826998|NCT00113386|81198870|FG000|Overall Study|Withdrawal by Subject|1|||
27826999|NCT00113386|81198871|FG001|Overall Study|Withdrawal by Subject|0|||
27695988|NCT00402597|80723671|FG002|Overall Study|Lost to Follow-up|8|||
27695989|NCT00402597|80723672|FG003|Overall Study|Lost to Follow-up|2|||
27827000|NCT00113386|81198870|FG000|Overall Study|Physician Decision|0|||
27695990|NCT00402597|80723673|FG004|Overall Study|Lost to Follow-up|3|||
27695991|NCT00402597|80723669|FG000|Overall Study|Withdrawal by Subject|57|||
27695992|NCT00402597|80723670|FG001|Overall Study|Withdrawal by Subject|16|||
27695993|NCT00402597|80723671|FG002|Overall Study|Withdrawal by Subject|65|||
27695994|NCT00402597|80723672|FG003|Overall Study|Withdrawal by Subject|15|||
27695995|NCT00402597|80723673|FG004|Overall Study|Withdrawal by Subject|24|||
27695996|NCT00402597|80723669|FG000|Overall Study|reason not specified|30|||
27695997|NCT00402597|80723670|FG001|Overall Study|reason not specified|4|||
27695998|NCT00402597|80723671|FG002|Overall Study|reason not specified|27|||
27695999|NCT00402597|80723672|FG003|Overall Study|reason not specified|14|||
27696000|NCT00402597|80723673|FG004|Overall Study|reason not specified|20|||
27696001|NCT00846391|80723674|FG000|Overall Study|Physician Decision|0|||
27696002|NCT00846391|80723675|FG001|Overall Study|Physician Decision|0|||
27696003|NCT00846391|80723676|FG002|Overall Study|Physician Decision|1|||
27696004|NCT00846391|80723674|FG000|Overall Study|Study Terminated by Sponsor|1|||
27696005|NCT00846391|80723675|FG001|Overall Study|Study Terminated by Sponsor|2|||
27696006|NCT00846391|80723676|FG002|Overall Study|Study Terminated by Sponsor|2|||
27696007|NCT01029652|80723677|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
27696008|NCT01029652|80723678|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
27696009|NCT01029652|80723677|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
27696010|NCT01029652|80723678|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
27696011|NCT01029652|80723677|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
27696012|NCT01029652|80723678|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
27696013|NCT01029652|80723677|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
27696014|NCT01029652|80723678|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
27696015|NCT01029652|80723677|FG000|Core Study (0-12 Weeks)|Death|0|||
27696016|NCT01029652|80723678|FG001|Core Study (0-12 Weeks)|Death|1|||
27696017|NCT01029652|80723677|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
27696018|NCT01029652|80723678|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
27696019|NCT01029652|80723677|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
27696020|NCT01029652|80723678|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
27696021|NCT01029652|80723677|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
27696022|NCT01029652|80723678|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
27696023|NCT01029652|80723677|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
27696024|NCT01029652|80723678|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
27696025|NCT01029652|80723677|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
27696026|NCT01029652|80723678|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
27696027|NCT01029652|80723677|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
27696028|NCT01029652|80723678|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
27696029|NCT01029652|80723677|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
27696030|NCT01029652|80723678|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
27696031|NCT01376349|80723679|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
27696032|NCT01376349|80723680|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
27696033|NCT01376349|80723681|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
27696034|NCT01376349|80723679|FG000|Raondomized Treatment|Adverse Event|13|||
27696035|NCT01376349|80723680|FG001|Raondomized Treatment|Adverse Event|17|||
27696036|NCT01376349|80723681|FG002|Raondomized Treatment|Adverse Event|14|||
27696037|NCT01376349|80723679|FG000|Raondomized Treatment|Unkown|1|||
27696038|NCT01376349|80723680|FG001|Raondomized Treatment|Unkown|2|||
27696039|NCT01376349|80723681|FG002|Raondomized Treatment|Unkown|1|||
27556344|NCT01124422|80222427|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
27696040|NCT01376349|80723679|FG000|Raondomized Treatment|Alternative Treatment|0|||
27696041|NCT01376349|80723680|FG001|Raondomized Treatment|Alternative Treatment|0|||
27696042|NCT01376349|80723681|FG002|Raondomized Treatment|Alternative Treatment|1|||
27696043|NCT02569957|80723683|FG000|Overall Study|Withdrawal by Subject|0|||
27696044|NCT02569957|80723684|FG001|Overall Study|Withdrawal by Subject|1|||
27696045|NCT01211522|80723687|FG000|Overall Study|Withdrawal by Subject|3|||
27696046|NCT01211522|80723688|FG001|Overall Study|Withdrawal by Subject|7|||
27696047|NCT01211522|80723689|FG002|Overall Study|Withdrawal by Subject|5|||
27696048|NCT02796560|80723690|FG000|Overall Study|Adverse Event|2|||
27696049|NCT02796560|80723691|FG001|Overall Study|Adverse Event|0|||
27696050|NCT02796560|80723690|FG000|Overall Study|Withdrawal by Subject|2|||
27696051|NCT02796560|80723691|FG001|Overall Study|Withdrawal by Subject|2|||
27696052|NCT02527343|80723692|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
27696053|NCT02527343|80723693|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27696054|NCT02527343|80723694|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27827001|NCT00113386|81198871|FG001|Overall Study|Physician Decision|1|||
27696055|NCT02527343|80723695|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27696056|NCT02527343|80723696|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27696057|NCT02527343|80723697|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
27696058|NCT02527343|80723692|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
27696059|NCT02527343|80723693|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27883938|NCT00877487|81408105|FG000|Open-label Treatment Phase|Out of country for business|1|||
27883939|NCT00877487|81408106|FG001|Open-label Treatment Phase|Out of country for business|0|||
27883940|NCT00877487|81408105|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
27883941|NCT00877487|81408106|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
27883942|NCT00877487|81408105|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
27883943|NCT00877487|81408106|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
27883944|NCT00877487|81408105|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
27883945|NCT00877487|81408106|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
27883946|NCT00877487|81408105|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
27883947|NCT00877487|81408106|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
27883948|NCT02201108|81408107|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
27883949|NCT02201108|81408108|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
27883950|NCT02201108|81408107|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
27883951|NCT02201108|81408108|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
27883952|NCT02201108|81408107|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
27883953|NCT02201108|81408108|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
27883954|NCT02201108|81408107|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
27883955|NCT02201108|81408108|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
27556345|NCT01124422|80222428|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
27696060|NCT02527343|80723694|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27696061|NCT02527343|80723695|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27696062|NCT02527343|80723696|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27696063|NCT02527343|80723697|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
27696064|NCT02527343|80723692|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27827002|NCT00113386|81198870|FG000|Overall Study|Toxicity|3|||
27827003|NCT00113386|81198871|FG001|Overall Study|Toxicity|0|||
27827004|NCT00113386|81198870|FG000|Overall Study|Ineligible|1|||
27827005|NCT00113386|81198871|FG001|Overall Study|Ineligible|2|||
27827006|NCT00113386|81198870|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
27827007|NCT00113386|81198871|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
27827008|NCT00960297|81198879|FG000|Overall Study|Physician Decision|1|||
27827009|NCT00960297|81198879|FG000|Overall Study|Venous port infection|1|||
27827010|NCT00960297|81198879|FG000|Overall Study|Disease progression|1|||
27827011|NCT04263649|81198882|FG000|Overall Study|Adverse Event|53|||
27827012|NCT04263649|81198882|FG000|Overall Study|Lost to Follow-up|3|||
27701011|NCT03933397|80741294|FG001|Overall Study|Missed emergency department visit|30|||
27696065|NCT02527343|80723693|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
27696066|NCT02527343|80723694|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27696067|NCT02527343|80723695|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27696068|NCT02527343|80723696|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27696069|NCT02527343|80723697|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27696070|NCT02527343|80723692|FG000|RT Period: Weeks 1 to 52|Other|4|||
27696071|NCT02527343|80723693|FG001|RT Period: Weeks 1 to 52|Other|3|||
27696072|NCT02527343|80723694|FG002|RT Period: Weeks 1 to 52|Other|0|||
27696073|NCT02527343|80723695|FG003|RT Period: Weeks 1 to 52|Other|0|||
27696074|NCT02527343|80723696|FG004|RT Period: Weeks 1 to 52|Other|0|||
27696075|NCT02527343|80723697|FG005|RT Period: Weeks 1 to 52|Other|0|||
27696076|NCT02527343|80723692|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27696077|NCT02527343|80723693|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27696078|NCT02527343|80723694|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
27696079|NCT02527343|80723695|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27696080|NCT02527343|80723696|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27696081|NCT02527343|80723697|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
27696082|NCT02527343|80723692|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27696083|NCT02527343|80723693|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27696084|NCT02527343|80723694|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27696085|NCT02527343|80723695|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
27696086|NCT02527343|80723696|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27696087|NCT02527343|80723697|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
27696088|NCT02527343|80723692|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27696089|NCT02527343|80723693|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27696090|NCT02527343|80723694|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27696091|NCT02527343|80723695|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27696092|NCT02527343|80723696|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
27696093|NCT02527343|80723697|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
27696094|NCT02527343|80723692|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27696095|NCT02527343|80723693|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27696096|NCT02527343|80723694|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27696097|NCT02527343|80723695|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
27696098|NCT02527343|80723696|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
27696099|NCT02527343|80723697|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
27696100|NCT02527343|80723692|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27696101|NCT02527343|80723693|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27696102|NCT02527343|80723694|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27696103|NCT02527343|80723695|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
27696104|NCT02527343|80723696|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
27696105|NCT02527343|80723697|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
27696106|NCT02527343|80723692|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
27696107|NCT02527343|80723693|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
27696108|NCT02527343|80723694|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
27696109|NCT02527343|80723695|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
27696110|NCT02527343|80723696|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
27696111|NCT02527343|80723697|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
27696112|NCT02527343|80723692|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
27696113|NCT02527343|80723693|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
27827013|NCT04263649|81198882|FG000|Overall Study|Death|29|||
27556346|NCT01124422|80222426|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
27696114|NCT02527343|80723694|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
27696115|NCT02527343|80723695|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
27696116|NCT02527343|80723696|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
27696117|NCT02527343|80723697|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
27696118|NCT02527343|80723692|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27696119|NCT02527343|80723693|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27696120|NCT02527343|80723694|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27696121|NCT02527343|80723695|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27696122|NCT02527343|80723696|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
27696123|NCT02527343|80723697|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
27696124|NCT02527343|80723692|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
27696125|NCT02527343|80723693|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
27696126|NCT02527343|80723694|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
27696127|NCT02527343|80723695|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
27696128|NCT02527343|80723696|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
27696129|NCT02527343|80723697|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
27696130|NCT02095951|80723698|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
27696131|NCT02095951|80723699|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
27696132|NCT04754477|80723702|FG000|Overall Study|Withdrawal by Subject|1|||
27696133|NCT01602562|80723703|FG000|Overall Study|Adverse Event|3|||
27696134|NCT01602562|80723704|FG001|Overall Study|Adverse Event|1|||
27696135|NCT01602562|80723703|FG000|Overall Study|Physician Decision|1|||
27696136|NCT01602562|80723704|FG001|Overall Study|Physician Decision|1|||
27696137|NCT01602562|80723703|FG000|Overall Study|Withdrawal by Subject|1|||
27696138|NCT01602562|80723704|FG001|Overall Study|Withdrawal by Subject|1|||
27696139|NCT03118674|80723705|FG000|Overall Study|Lost to Follow-up|2|||
27696140|NCT03118674|80723705|FG000|Overall Study|Screen Faliure|8|||
27696141|NCT03118674|80723705|FG000|Overall Study|Withdrawal by Subject|5|||
27696142|NCT00512317|80723706|FG000|Overall Study|Insufficient clinical response|36|||
27696143|NCT00512317|80723706|FG000|Overall Study|Withdrawal by Subject|23|||
27696144|NCT00512317|80723706|FG000|Overall Study|Sponsor closure of study|21|||
27696145|NCT00512317|80723706|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
27696146|NCT00512317|80723706|FG000|Overall Study|Adverse Event|13|||
27696147|NCT00512317|80723706|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
27696148|NCT00512317|80723706|FG000|Overall Study|Lost to Follow-up|2|||
27696149|NCT00512317|80723706|FG000|Overall Study|Other|2|||
27696150|NCT01588496|80723707|FG000|Overall Study|Withdrawal by Subject|0|||
27696151|NCT01588496|80723708|FG001|Overall Study|Withdrawal by Subject|1|||
27696152|NCT01588496|80723709|FG002|Overall Study|Withdrawal by Subject|0|||
27696153|NCT00203476|80723710|FG000|Overall Study|Lost to Follow-up|1|||
27696154|NCT00203476|80723711|FG001|Overall Study|Lost to Follow-up|0|||
27696155|NCT00203476|80723712|FG002|Overall Study|Lost to Follow-up|0|||
27696156|NCT00203476|80723710|FG000|Overall Study|Withdrawal by Subject|0|||
27696157|NCT00203476|80723711|FG001|Overall Study|Withdrawal by Subject|1|||
27696158|NCT00203476|80723712|FG002|Overall Study|Withdrawal by Subject|0|||
27696159|NCT00402363|80723724|FG000|Overall Study|Adverse Event|9|||
27696160|NCT00402363|80723725|FG001|Overall Study|Adverse Event|14|||
27696161|NCT00402363|80723726|FG002|Overall Study|Adverse Event|2|||
27696162|NCT00402363|80723727|FG003|Overall Study|Adverse Event|2|||
27696163|NCT00402363|80723724|FG000|Overall Study|Withdrew Consent|10|||
27696164|NCT00402363|80723725|FG001|Overall Study|Withdrew Consent|5|||
27696165|NCT00402363|80723726|FG002|Overall Study|Withdrew Consent|2|||
27696166|NCT00402363|80723727|FG003|Overall Study|Withdrew Consent|1|||
27696167|NCT00402363|80723724|FG000|Overall Study|Protocol Violation|3|||
27696168|NCT00402363|80723725|FG001|Overall Study|Protocol Violation|5|||
27696169|NCT00402363|80723726|FG002|Overall Study|Protocol Violation|0|||
27556347|NCT01124422|80222427|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
27696170|NCT00402363|80723727|FG003|Overall Study|Protocol Violation|3|||
27696171|NCT00402363|80723724|FG000|Overall Study|Lost to Follow-up|5|||
27696172|NCT00402363|80723725|FG001|Overall Study|Lost to Follow-up|4|||
27696173|NCT00402363|80723726|FG002|Overall Study|Lost to Follow-up|0|||
27696174|NCT00402363|80723727|FG003|Overall Study|Lost to Follow-up|2|||
27696175|NCT00402363|80723724|FG000|Overall Study|"Captured as Other"|6|||
27696176|NCT00402363|80723725|FG001|Overall Study|"Captured as Other"|2|||
27696177|NCT00402363|80723726|FG002|Overall Study|"Captured as Other"|2|||
27696178|NCT00402363|80723727|FG003|Overall Study|"Captured as Other"|2|||
27696179|NCT00711529|80723728|FG000|Overall Study|Protocol Violation|2|||
27696180|NCT00711529|80723729|FG001|Overall Study|Protocol Violation|0|||
27696181|NCT00711529|80723728|FG000|Overall Study|Withdrawal by Subject|2|||
27696182|NCT00711529|80723729|FG001|Overall Study|Withdrawal by Subject|6|||
27696183|NCT01037244|80723732|FG000|Overall Study|Adverse Event|3|||
27696184|NCT01037244|80723733|FG001|Overall Study|Adverse Event|2|||
27696185|NCT01037244|80723734|FG002|Overall Study|Adverse Event|6|||
27696186|NCT01037244|80723735|FG003|Overall Study|Adverse Event|3|||
27696187|NCT01037244|80723732|FG000|Overall Study|Lack of Efficacy|1|||
27696188|NCT01037244|80723733|FG001|Overall Study|Lack of Efficacy|1|||
27696189|NCT01037244|80723734|FG002|Overall Study|Lack of Efficacy|0|||
27696190|NCT01037244|80723735|FG003|Overall Study|Lack of Efficacy|1|||
27696191|NCT01037244|80723732|FG000|Overall Study|Lost to Follow-up|3|||
27696192|NCT01037244|80723733|FG001|Overall Study|Lost to Follow-up|3|||
27696193|NCT01037244|80723734|FG002|Overall Study|Lost to Follow-up|4|||
27696194|NCT01037244|80723735|FG003|Overall Study|Lost to Follow-up|4|||
27696195|NCT01037244|80723732|FG000|Overall Study|Withdrawal by Subject|1|||
27696196|NCT01037244|80723733|FG001|Overall Study|Withdrawal by Subject|5|||
27696197|NCT01037244|80723734|FG002|Overall Study|Withdrawal by Subject|3|||
27696198|NCT01037244|80723735|FG003|Overall Study|Withdrawal by Subject|5|||
27696199|NCT01037244|80723732|FG000|Overall Study|Partner Withdrew Consent|2|||
27696200|NCT01037244|80723733|FG001|Overall Study|Partner Withdrew Consent|1|||
27696201|NCT01037244|80723734|FG002|Overall Study|Partner Withdrew Consent|0|||
27696202|NCT01037244|80723735|FG003|Overall Study|Partner Withdrew Consent|0|||
27696203|NCT01037244|80723732|FG000|Overall Study|Various|3|||
27696204|NCT01037244|80723733|FG001|Overall Study|Various|2|||
27696205|NCT01037244|80723734|FG002|Overall Study|Various|1|||
27696206|NCT01037244|80723735|FG003|Overall Study|Various|1|||
27696207|NCT03021954|80723737|FG000|Overall Study|Lost to Follow-up|10|||
27696208|NCT03021954|80723738|FG001|Overall Study|Lost to Follow-up|43|||
27696209|NCT03021954|80723737|FG000|Overall Study|Subjects had avulsion trauma|4|||
27696210|NCT03021954|80723738|FG001|Overall Study|Subjects had avulsion trauma|1|||
27696211|NCT00926211|80723739|FG000|Overall Study|Lost to Follow-up|1|||
27696212|NCT00537485|80723744|FG000|Overall Study|Adverse Event|10|||
27696213|NCT00537485|80723745|FG001|Overall Study|Adverse Event|5|||
27696214|NCT00537485|80723744|FG000|Overall Study|Withdrawal by Subject|3|||
27696215|NCT00537485|80723745|FG001|Overall Study|Withdrawal by Subject|2|||
27696216|NCT00537485|80723744|FG000|Overall Study|Withdrawal by Subject|1|||
27696217|NCT00537485|80723745|FG001|Overall Study|Withdrawal by Subject|3|||
27696218|NCT00537485|80723744|FG000|Overall Study|Physician Decision|1|||
27696219|NCT00537485|80723745|FG001|Overall Study|Physician Decision|0|||
27696220|NCT00320541|80723746|FG000|Overall Study|Adverse Event|21|||
27696221|NCT00320541|80723747|FG001|Overall Study|Adverse Event|19|||
27696222|NCT00320541|80723746|FG000|Overall Study|Protocol Violation|0|||
27696223|NCT00320541|80723747|FG001|Overall Study|Protocol Violation|1|||
27696224|NCT00320541|80723746|FG000|Overall Study|Withdrawal by Subject|12|||
27696225|NCT00320541|80723747|FG001|Overall Study|Withdrawal by Subject|16|||
27696226|NCT00320541|80723746|FG000|Overall Study|Physician Decision|9|||
27696227|NCT00320541|80723747|FG001|Overall Study|Physician Decision|13|||
27696228|NCT00320541|80723746|FG000|Overall Study|Other|3|||
27696229|NCT00320541|80723747|FG001|Overall Study|Other|4|||
27696230|NCT00320541|80723746|FG000|Overall Study|Sponsor Decision|2|||
27696231|NCT00320541|80723747|FG001|Overall Study|Sponsor Decision|1|||
27696232|NCT00320541|80723746|FG000|Overall Study|Death due to Study Disease|1|||
27696233|NCT00320541|80723747|FG001|Overall Study|Death due to Study Disease|3|||
27696234|NCT00320541|80723746|FG000|Overall Study|Death due to Adverse Event(s)|1|||
27696235|NCT00320541|80723747|FG001|Overall Study|Death due to Adverse Event(s)|0|||
27696236|NCT00320541|80723746|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
27696237|NCT00320541|80723747|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
27696238|NCT03739437|80723748|FG000|Overall Study|Lost to Follow-up|2|||
27696239|NCT03739437|80723749|FG001|Overall Study|Lost to Follow-up|5|||
27696240|NCT02647866|80723755|FG000|Overall Study|Adverse Event|0|||
27696241|NCT02647866|80723756|FG001|Overall Study|Adverse Event|0|||
27696242|NCT02647866|80723757|FG002|Overall Study|Adverse Event|2|||
27696243|NCT02647866|80723758|FG003|Overall Study|Adverse Event|2|||
27696244|NCT02647866|80723759|FG004|Overall Study|Adverse Event|1|||
27696245|NCT02647866|80723755|FG000|Overall Study|Disease Worsening|3|||
27696246|NCT02647866|80723756|FG001|Overall Study|Disease Worsening|1|||
27696247|NCT02647866|80723757|FG002|Overall Study|Disease Worsening|0|||
27696248|NCT02647866|80723758|FG003|Overall Study|Disease Worsening|0|||
27696249|NCT02647866|80723759|FG004|Overall Study|Disease Worsening|1|||
27696250|NCT02647866|80723755|FG000|Overall Study|Withdrawal by Subject|1|||
27696251|NCT02647866|80723756|FG001|Overall Study|Withdrawal by Subject|1|||
27696252|NCT02647866|80723757|FG002|Overall Study|Withdrawal by Subject|2|||
27696253|NCT02647866|80723758|FG003|Overall Study|Withdrawal by Subject|4|||
27696254|NCT02647866|80723759|FG004|Overall Study|Withdrawal by Subject|4|||
27696255|NCT02647866|80723755|FG000|Overall Study|Physician Decision|0|||
27696256|NCT02647866|80723756|FG001|Overall Study|Physician Decision|1|||
27696257|NCT02647866|80723757|FG002|Overall Study|Physician Decision|1|||
27696258|NCT02647866|80723758|FG003|Overall Study|Physician Decision|0|||
27696259|NCT02647866|80723759|FG004|Overall Study|Physician Decision|2|||
27696260|NCT02647866|80723755|FG000|Overall Study|Death|0|||
27696261|NCT02647866|80723756|FG001|Overall Study|Death|1|||
27696262|NCT02647866|80723757|FG002|Overall Study|Death|0|||
27696263|NCT02647866|80723758|FG003|Overall Study|Death|0|||
27696264|NCT02647866|80723759|FG004|Overall Study|Death|0|||
27696265|NCT02647866|80723755|FG000|Overall Study|Subject moved to different country|1|||
27696266|NCT02647866|80723756|FG001|Overall Study|Subject moved to different country|0|||
27696267|NCT02647866|80723757|FG002|Overall Study|Subject moved to different country|0|||
27696268|NCT02647866|80723758|FG003|Overall Study|Subject moved to different country|0|||
27696269|NCT02647866|80723759|FG004|Overall Study|Subject moved to different country|0|||
27696270|NCT01699789|80723769|FG000|Overall Study|Withdrawal by Subject|18|||
27696271|NCT01699789|80723770|FG001|Overall Study|Withdrawal by Subject|23|||
27696272|NCT01699789|80723769|FG000|Overall Study|Death|1|||
27696273|NCT01699789|80723770|FG001|Overall Study|Death|2|||
27696274|NCT01699789|80723769|FG000|Overall Study|Lost to Follow-up|83|||
27696275|NCT01699789|80723770|FG001|Overall Study|Lost to Follow-up|101|||
27696276|NCT01350336|80723771|FG000|Overall Study|Lost to Follow-up|31|||
27696277|NCT01350336|80723771|FG000|Overall Study|Withdrawal by Subject|14|||
27696278|NCT01350336|80723771|FG000|Overall Study|Physician Decision|8|||
27696279|NCT01350336|80723771|FG000|Overall Study|Death|4|||
27696280|NCT02313233|80723772|FG000|Overall Study|Withdrawal by Subject|1|||
27696281|NCT02313233|80723773|FG001|Overall Study|Withdrawal by Subject|2|||
27696282|NCT02313233|80723772|FG000|Overall Study|Administrative reason|1|||
27696283|NCT02313233|80723773|FG001|Overall Study|Administrative reason|1|||
27696284|NCT00762970|80723778|FG000|Overall Study|Withdrawal by Subject|7|||
27696285|NCT00762970|80723779|FG001|Overall Study|Withdrawal by Subject|4|||
27696286|NCT00762970|80723780|FG002|Overall Study|Withdrawal by Subject|0|||
27696287|NCT00762970|80723778|FG000|Overall Study|Protocol Violation|3|||
27696288|NCT00762970|80723779|FG001|Overall Study|Protocol Violation|1|||
27696289|NCT00762970|80723780|FG002|Overall Study|Protocol Violation|1|||
27696290|NCT00762970|80723778|FG000|Overall Study|Lost to Follow-up|1|||
27696291|NCT00762970|80723779|FG001|Overall Study|Lost to Follow-up|2|||
27696292|NCT00762970|80723780|FG002|Overall Study|Lost to Follow-up|0|||
27696293|NCT00762970|80723778|FG000|Overall Study|Difficulty of handling lens|1|||
27696294|NCT00762970|80723779|FG001|Overall Study|Difficulty of handling lens|2|||
27696295|NCT00762970|80723780|FG002|Overall Study|Difficulty of handling lens|0|||
27696296|NCT02043678|80723781|FG000|Overall Study|Never treated|11|||
27696297|NCT02043678|80723782|FG001|Overall Study|Never treated|9|||
27696298|NCT02043678|80723781|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
27696299|NCT02043678|80723782|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
27696300|NCT02043678|80723781|FG000|Overall Study|AE without clinical PD|51|||
27696301|NCT02043678|80723782|FG001|Overall Study|AE without clinical PD|34|||
27696302|NCT02043678|80723781|FG000|Overall Study|Lost to Follow-up|1|||
27696303|NCT02043678|80723782|FG001|Overall Study|Lost to Follow-up|1|||
27696304|NCT02043678|80723781|FG000|Overall Study|Other|19|||
27696305|NCT02043678|80723782|FG001|Overall Study|Other|16|||
27696306|NCT02043678|80723781|FG000|Overall Study|Clinical PD|108|||
27696307|NCT02043678|80723782|FG001|Overall Study|Clinical PD|138|||
27696308|NCT02043678|80723781|FG000|Overall Study|Radiological PD|91|||
27696309|NCT02043678|80723782|FG001|Overall Study|Radiological PD|80|||
27883956|NCT02201108|81408107|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
27696310|NCT02043678|80723781|FG000|Overall Study|Protocol-driven decision point|56|||
27883957|NCT02201108|81408108|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
27696311|NCT02043678|80723782|FG001|Overall Study|Protocol-driven decision point|56|||
27696312|NCT02043678|80723781|FG000|Overall Study|Withdrawal by Subject|12|||
27696313|NCT02043678|80723782|FG001|Overall Study|Withdrawal by Subject|15|||
27696314|NCT02043678|80723781|FG000|Overall Study|Ongoing with treatment|34|||
27696315|NCT02043678|80723782|FG001|Overall Study|Ongoing with treatment|38|||
27696316|NCT02186223|80723783|FG000|Overall Study|Not eligible for device placement|6|||
27696317|NCT02186223|80723783|FG000|Overall Study|Unable to obtain femoral access|3|||
27696318|NCT02186223|80723783|FG000|Overall Study|Death|3|||
27696319|NCT02186223|80723783|FG000|Overall Study|Device in place less than 48 hours|9|||
27696320|NCT00701779|80723784|FG000|Overall Study|Adverse Event|6|||
27696321|NCT00701779|80723784|FG000|Overall Study|Lost to Follow-up|1|||
27696322|NCT00701779|80723784|FG000|Overall Study|Withdrawal by Subject|2|||
27696323|NCT00866723|80723789|FG000|Overall Study|Withdrawal by Subject|1|||
27696324|NCT00866723|80723789|FG000|Overall Study|Disease Progression|4|||
27696325|NCT01313650|80723790|FG000|Overall Study|Adverse Event|9|||
27696326|NCT01313650|80723791|FG001|Overall Study|Adverse Event|34|||
27696327|NCT01313650|80723792|FG002|Overall Study|Adverse Event|24|||
27696328|NCT01313650|80723793|FG003|Overall Study|Adverse Event|23|||
27696329|NCT01313650|80723790|FG000|Overall Study|Lack of Efficacy|37|||
27696330|NCT01313650|80723791|FG001|Overall Study|Lack of Efficacy|20|||
27696331|NCT01313650|80723792|FG002|Overall Study|Lack of Efficacy|32|||
27696332|NCT01313650|80723793|FG003|Overall Study|Lack of Efficacy|20|||
27696333|NCT01313650|80723790|FG000|Overall Study|Lost to Follow-up|1|||
27696334|NCT01313650|80723791|FG001|Overall Study|Lost to Follow-up|0|||
27696335|NCT01313650|80723792|FG002|Overall Study|Lost to Follow-up|3|||
27696336|NCT01313650|80723793|FG003|Overall Study|Lost to Follow-up|2|||
27696337|NCT01313650|80723790|FG000|Overall Study|Withdrawal by Subject|16|||
27696338|NCT01313650|80723791|FG001|Overall Study|Withdrawal by Subject|20|||
27696339|NCT01313650|80723792|FG002|Overall Study|Withdrawal by Subject|15|||
27696340|NCT01313650|80723793|FG003|Overall Study|Withdrawal by Subject|15|||
27696341|NCT01313650|80723790|FG000|Overall Study|Protocol Violation|4|||
27696342|NCT01313650|80723791|FG001|Overall Study|Protocol Violation|7|||
27696343|NCT01313650|80723792|FG002|Overall Study|Protocol Violation|5|||
27696344|NCT01313650|80723793|FG003|Overall Study|Protocol Violation|6|||
27696345|NCT01313650|80723790|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
27696346|NCT01313650|80723791|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
27696347|NCT01313650|80723792|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
27696348|NCT01313650|80723793|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
27696349|NCT01142596|80723795|FG000|Overall Study|Withdrawal by Subject|9|||
27696350|NCT01142596|80723796|FG001|Overall Study|Withdrawal by Subject|35|||
27696351|NCT01142596|80723795|FG000|Overall Study|Adverse Event|8|||
27696352|NCT01142596|80723796|FG001|Overall Study|Adverse Event|35|||
27696353|NCT01142596|80723795|FG000|Overall Study|Lack of Efficacy|5|||
27696354|NCT01142596|80723796|FG001|Overall Study|Lack of Efficacy|9|||
27696355|NCT01142596|80723795|FG000|Overall Study|Lost to Follow-up|2|||
27696356|NCT01142596|80723796|FG001|Overall Study|Lost to Follow-up|3|||
27696357|NCT01142596|80723795|FG000|Overall Study|Other reason (not specified)|5|||
27696358|NCT01142596|80723796|FG001|Overall Study|Other reason (not specified)|4|||
27696359|NCT00511472|80723797|FG000|Overall Study|Clinical Adverse Event|1|||
27696360|NCT00511472|80723798|FG001|Overall Study|Clinical Adverse Event|2|||
27696361|NCT00511472|80723797|FG000|Overall Study|Laboratory Adverse Event|0|||
27696362|NCT00511472|80723798|FG001|Overall Study|Laboratory Adverse Event|2|||
27696363|NCT00511472|80723797|FG000|Overall Study|Not reported|2|||
27696364|NCT00511472|80723798|FG001|Overall Study|Not reported|2|||
27696365|NCT04615247|80723799|FG000|Overall Study|Adverse Event|0|||
27696366|NCT04615247|80723800|FG001|Overall Study|Adverse Event|2|||
27696367|NCT04615247|80723799|FG000|Overall Study|Withdrawal by Subject|1|||
27696368|NCT04615247|80723800|FG001|Overall Study|Withdrawal by Subject|1|||
27696369|NCT00607022|80723801|FG000|Overall Study|Withdrawal by Subject|1|||
27696370|NCT00607022|80723802|FG001|Overall Study|Withdrawal by Subject|0|||
27696371|NCT00607022|80723803|FG002|Overall Study|Withdrawal by Subject|0|||
27556348|NCT01124422|80222428|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
27696372|NCT01100034|80723807|FG000|Overall Study|Lost to Follow-up|11|||
27696373|NCT01100034|80723807|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
27696374|NCT01100034|80723807|FG000|Overall Study|Withdrawal by Subject|4|||
27696375|NCT01100034|80723807|FG000|Overall Study|Sponsor decision|21|||
27696376|NCT01100034|80723807|FG000|Overall Study|Participated in another clinical trial|1|||
27696377|NCT01100034|80723807|FG000|Overall Study|Participants moved to another hospital|4|||
27696378|NCT01100034|80723807|FG000|Overall Study|Site closed due to non-responsiveness|1|||
27696379|NCT02038543|80723808|FG000|Overall Study|Screen Failure|0|||
27696380|NCT02038543|80723809|FG001|Overall Study|Screen Failure|0|||
27696381|NCT02038543|80723810|FG002|Overall Study|Screen Failure|0|||
27696382|NCT02038543|80723811|FG003|Overall Study|Screen Failure|1|||
27696383|NCT02038543|80723808|FG000|Overall Study|Withdrawal by Subject|0|||
27696384|NCT02038543|80723809|FG001|Overall Study|Withdrawal by Subject|0|||
27696385|NCT02038543|80723810|FG002|Overall Study|Withdrawal by Subject|0|||
27696386|NCT02038543|80723811|FG003|Overall Study|Withdrawal by Subject|1|||
27696387|NCT00655863|80723814|FG000|Overall Study|Lost to Follow-up|0|||
27696388|NCT00655863|80723815|FG001|Overall Study|Lost to Follow-up|0|||
27696389|NCT00655863|80723816|FG002|Overall Study|Lost to Follow-up|1|||
27696390|NCT02245672|80723817|FG000|Overall Study|Adverse Event|4|||
27696391|NCT02245672|80723818|FG001|Overall Study|Adverse Event|4|||
27696392|NCT02245672|80723819|FG002|Overall Study|Adverse Event|4|||
27696393|NCT02245672|80723817|FG000|Overall Study|Lost to Follow-up|3|||
27696394|NCT02245672|80723818|FG001|Overall Study|Lost to Follow-up|5|||
27696395|NCT02245672|80723819|FG002|Overall Study|Lost to Follow-up|1|||
27696396|NCT02245672|80723817|FG000|Overall Study|Withdrawal by Subject|6|||
27696397|NCT02245672|80723818|FG001|Overall Study|Withdrawal by Subject|3|||
27556349|NCT01124422|80222426|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
27696398|NCT02245672|80723819|FG002|Overall Study|Withdrawal by Subject|0|||
27696399|NCT02245672|80723817|FG000|Overall Study|Randomized in error (not treated)|0|||
27696400|NCT02245672|80723818|FG001|Overall Study|Randomized in error (not treated)|1|||
27696401|NCT02245672|80723819|FG002|Overall Study|Randomized in error (not treated)|0|||
27696402|NCT02435966|80723821|FG000|Overall Study|Withdrawal by Subject|0|||
27696403|NCT02435966|80723822|FG001|Overall Study|Withdrawal by Subject|1|||
27696404|NCT02435966|80723823|FG002|Overall Study|Withdrawal by Subject|0|||
27827014|NCT04263649|81198882|FG000|Overall Study|Device deficiency|19|||
27827015|NCT04263649|81198882|FG000|Overall Study|other reasons|11|||
27696405|NCT03681951|80723826|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
27696406|NCT03681951|80723827|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696407|NCT03681951|80723828|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696408|NCT03681951|80723829|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696409|NCT03681951|80723830|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696410|NCT03681951|80723831|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696411|NCT03681951|80723832|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696412|NCT03681951|80723833|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
27696413|NCT03681951|80723826|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
27696414|NCT03681951|80723827|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696415|NCT03681951|80723828|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696416|NCT03681951|80723829|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696417|NCT03681951|80723830|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696418|NCT03681951|80723831|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696419|NCT03681951|80723832|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696420|NCT03681951|80723833|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
27696421|NCT03681951|80723826|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
27696422|NCT03681951|80723827|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696423|NCT03681951|80723828|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696424|NCT03681951|80723829|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696425|NCT03681951|80723830|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696426|NCT03681951|80723831|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696427|NCT03681951|80723832|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696428|NCT03681951|80723833|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
27696429|NCT00275262|80723836|FG000|Overall Study|Adverse Event|2|||
27696430|NCT00275262|80723837|FG001|Overall Study|Adverse Event|0|||
27696431|NCT00275262|80723836|FG000|Overall Study|Disease progression|2|||
27696432|NCT00275262|80723837|FG001|Overall Study|Disease progression|5|||
27696433|NCT00275262|80723836|FG000|Overall Study|Lost to Follow-up|0|||
27696434|NCT00275262|80723837|FG001|Overall Study|Lost to Follow-up|2|||
27827016|NCT05327491|81198883|FG000|Periods 1 & 2|Miscellaneous|0|||
27556350|NCT01124422|80222427|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
27556351|NCT01124422|80222428|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
27556352|NCT01124422|80222426|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
27556353|NCT01124422|80222427|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
27556354|NCT01124422|80222428|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
27556355|NCT00512707|80222429|FG000|Overall Study|Lost to Follow-up|5|||
27556356|NCT00512707|80222430|FG001|Overall Study|Lost to Follow-up|11|||
27556357|NCT00512707|80222429|FG000|Overall Study|Developed skin irritation|2|||
27696435|NCT00275262|80723836|FG000|Overall Study|Protocol Violation|0|||
27696436|NCT00275262|80723837|FG001|Overall Study|Protocol Violation|2|||
27696437|NCT00275262|80723836|FG000|Overall Study|Death|1|||
27696438|NCT00275262|80723837|FG001|Overall Study|Death|0|||
27696439|NCT00275262|80723836|FG000|Overall Study|Started Chemotherapy|1|||
27696440|NCT00275262|80723837|FG001|Overall Study|Started Chemotherapy|0|||
27556358|NCT00512707|80222430|FG001|Overall Study|Developed skin irritation|1|||
27556359|NCT00512707|80222429|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
27556360|NCT00512707|80222430|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
27556361|NCT00512707|80222429|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
27556362|NCT00512707|80222430|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
27556363|NCT01986985|80222431|FG000|Overall Study|Withdrawal by Subject|4|||
27556364|NCT01986985|80222431|FG000|Overall Study|Scan not completed due to malfunction|3|||
27696441|NCT00475033|80723838|FG000|Infant Series|Failed to return|3|||
27827017|NCT05327491|81198884|FG001|Periods 1 & 2|Miscellaneous|1|||
27556365|NCT03934931|80222438|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
27827018|NCT05327491|81198885|FG002|Periods 1 & 2|Miscellaneous|0|||
27556366|NCT03934931|80222439|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
27556367|NCT03934931|80222440|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
27556368|NCT00865124|80222441|FG000|Overall Study|Physician Decision|2|||
27556369|NCT00865124|80222442|FG001|Overall Study|Physician Decision|1|||
27556370|NCT00865124|80222443|FG002|Overall Study|Physician Decision|0|||
27556371|NCT00865124|80222441|FG000|Overall Study|Withdrawn consent|2|||
27556372|NCT00865124|80222442|FG001|Overall Study|Withdrawn consent|0|||
27556373|NCT00865124|80222443|FG002|Overall Study|Withdrawn consent|0|||
27556374|NCT02268864|80222444|FG000|Overall Study|Withdrawal by Subject|2|||
27556375|NCT02268864|80222445|FG001|Overall Study|Withdrawal by Subject|0|||
27556376|NCT02268864|80222446|FG002|Overall Study|Withdrawal by Subject|0|||
27556377|NCT02268864|80222444|FG000|Overall Study|Death|0|||
27556378|NCT02268864|80222445|FG001|Overall Study|Death|1|||
27556379|NCT02268864|80222446|FG002|Overall Study|Death|0|||
27556380|NCT05620563|80222447|FG000|Overall Study|Adverse Event|3|||
27556381|NCT05620563|80222448|FG001|Overall Study|Adverse Event|1|||
27556382|NCT05620563|80222447|FG000|Overall Study|Lost to Follow-up|0|||
27556383|NCT05620563|80222448|FG001|Overall Study|Lost to Follow-up|2|||
27556384|NCT05620563|80222447|FG000|Overall Study|Protocol Deviation|1|||
27556385|NCT05620563|80222448|FG001|Overall Study|Protocol Deviation|2|||
27556386|NCT05620563|80222447|FG000|Overall Study|Withdrawal by Subject|3|||
27556387|NCT05620563|80222448|FG001|Overall Study|Withdrawal by Subject|3|||
27556388|NCT05620563|80222447|FG000|Overall Study|Physician Decision|0|||
27556389|NCT05620563|80222448|FG001|Overall Study|Physician Decision|1|||
27556390|NCT02288559|80222455|FG000|Overall Study|Adverse Event|1|||
27556391|NCT02288559|80222456|FG001|Overall Study|Adverse Event|1|||
27556392|NCT02288559|80222457|FG002|Overall Study|Adverse Event|5|||
27556393|NCT02288559|80222458|FG003|Overall Study|Adverse Event|0|||
27556394|NCT02288559|80222455|FG000|Overall Study|Death|0|||
27556395|NCT02288559|80222456|FG001|Overall Study|Death|0|||
27556396|NCT02288559|80222457|FG002|Overall Study|Death|1|||
27556397|NCT02288559|80222458|FG003|Overall Study|Death|0|||
27556398|NCT02288559|80222455|FG000|Overall Study|Lost to Follow-up|0|||
27696442|NCT00475033|80723839|FG001|Infant Series|Failed to return|4|||
27556399|NCT02288559|80222456|FG001|Overall Study|Lost to Follow-up|0|||
27556400|NCT02288559|80222457|FG002|Overall Study|Lost to Follow-up|0|||
27556401|NCT02288559|80222458|FG003|Overall Study|Lost to Follow-up|1|||
27556402|NCT02288559|80222455|FG000|Overall Study|Withdrawal by Subject|0|||
27556403|NCT02288559|80222456|FG001|Overall Study|Withdrawal by Subject|0|||
27827019|NCT05327491|81198886|FG003|Periods 1 & 2|Miscellaneous|0|||
27827020|NCT05327491|81198883|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
27827021|NCT05327491|81198884|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
27827022|NCT05327491|81198885|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
27827023|NCT05327491|81198886|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
27827024|NCT01294787|81198887|FG000|Period 1|Adverse Event|0|||
27827025|NCT01294787|81198888|FG001|Period 1|Adverse Event|0|||
27827026|NCT01294787|81198889|FG002|Period 1|Adverse Event|0|||
27827027|NCT01294787|81198890|FG003|Period 1|Adverse Event|0|||
27827028|NCT01294787|81198891|FG004|Period 1|Adverse Event|1|||
27827029|NCT01294787|81198892|FG005|Period 1|Adverse Event|0|||
27827030|NCT01294787|81198887|FG000|Period 1|Withdrawal by Subject|0|||
27827031|NCT01294787|81198888|FG001|Period 1|Withdrawal by Subject|0|||
27827032|NCT01294787|81198889|FG002|Period 1|Withdrawal by Subject|0|||
27827033|NCT01294787|81198890|FG003|Period 1|Withdrawal by Subject|1|||
27827034|NCT01294787|81198891|FG004|Period 1|Withdrawal by Subject|1|||
27827035|NCT01294787|81198892|FG005|Period 1|Withdrawal by Subject|1|||
27827036|NCT01294787|81198887|FG000|Period 1|Administrative problem|0|||
27827037|NCT01294787|81198888|FG001|Period 1|Administrative problem|0|||
27827038|NCT01294787|81198889|FG002|Period 1|Administrative problem|1|||
27827039|NCT01294787|81198890|FG003|Period 1|Administrative problem|0|||
27827040|NCT01294787|81198891|FG004|Period 1|Administrative problem|0|||
27827041|NCT01294787|81198892|FG005|Period 1|Administrative problem|1|||
27827042|NCT01294787|81198887|FG000|Period 2|Adverse Event|0|||
27827043|NCT01294787|81198888|FG001|Period 2|Adverse Event|3|||
27827044|NCT01294787|81198889|FG002|Period 2|Adverse Event|0|||
27827045|NCT01294787|81198890|FG003|Period 2|Adverse Event|1|||
27827046|NCT01294787|81198891|FG004|Period 2|Adverse Event|0|||
27827047|NCT01294787|81198892|FG005|Period 2|Adverse Event|0|||
27827048|NCT01294787|81198887|FG000|Period 2|No longer needs study drug|0|||
27827049|NCT01294787|81198888|FG001|Period 2|No longer needs study drug|0|||
27827050|NCT01294787|81198889|FG002|Period 2|No longer needs study drug|0|||
27827051|NCT01294787|81198890|FG003|Period 2|No longer needs study drug|1|||
27827052|NCT01294787|81198891|FG004|Period 2|No longer needs study drug|0|||
27827053|NCT01294787|81198892|FG005|Period 2|No longer needs study drug|0|||
27827054|NCT01294787|81198887|FG000|Period 3|Adverse Event|0|||
27827055|NCT01294787|81198888|FG001|Period 3|Adverse Event|0|||
27827056|NCT01294787|81198889|FG002|Period 3|Adverse Event|0|||
27827057|NCT01294787|81198890|FG003|Period 3|Adverse Event|0|||
27827058|NCT01294787|81198891|FG004|Period 3|Adverse Event|1|||
27827059|NCT01294787|81198892|FG005|Period 3|Adverse Event|0|||
27827060|NCT02193165|81198893|FG000|4 Week Product Use|Lost to Follow-up|1|||
27827061|NCT02193165|81198894|FG001|4 Week Product Use|Lost to Follow-up|1|||
27827062|NCT02193165|81198895|FG002|4 Week Product Use|Lost to Follow-up|1|||
27827063|NCT02193165|81198893|FG000|6 Week Product Use|Lost to Follow-up|0|||
27827064|NCT02193165|81198894|FG001|6 Week Product Use|Lost to Follow-up|1|||
27827065|NCT02193165|81198895|FG002|6 Week Product Use|Lost to Follow-up|0|||
27827066|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Adverse Event|22|||
27827067|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Adverse Event|0|||
27827068|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
27827069|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
27827070|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
27827071|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
27827072|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
27827073|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
27827074|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
27827075|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
27827076|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
27827077|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
27827078|NCT02493868|81198896|FG000|Induction Phase: DE Participants|Other|8|||
27827079|NCT02493868|81198897|FG001|Induction Phase: DE Participants|Other|0|||
27827080|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
27827081|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
27827082|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
27827083|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
27556404|NCT02288559|80222457|FG002|Overall Study|Withdrawal by Subject|2|||
27556405|NCT02288559|80222458|FG003|Overall Study|Withdrawal by Subject|1|||
27556406|NCT02288559|80222455|FG000|Overall Study|Reason Not Specified|0|||
27556407|NCT02288559|80222456|FG001|Overall Study|Reason Not Specified|0|||
27556408|NCT02288559|80222457|FG002|Overall Study|Reason Not Specified|3|||
27556409|NCT02288559|80222458|FG003|Overall Study|Reason Not Specified|0|||
27556410|NCT00105482|80222459|FG000|Overall Study|Adverse Event|1|||
27556411|NCT00105482|80222460|FG001|Overall Study|Adverse Event|1|||
27556412|NCT00105482|80222459|FG000|Overall Study|Lost to Follow-up|26|||
27556413|NCT00105482|80222460|FG001|Overall Study|Lost to Follow-up|17|||
27827084|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
27827085|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
27556414|NCT00105482|80222459|FG000|Overall Study|Withdrawal by Subject|0|||
27556415|NCT00105482|80222460|FG001|Overall Study|Withdrawal by Subject|1|||
27556416|NCT00105482|80222459|FG000|Overall Study|Lost Interest|29|||
27556417|NCT00105482|80222460|FG001|Overall Study|Lost Interest|32|||
27556418|NCT00105482|80222459|FG000|Overall Study|Scheduling Conflict|2|||
27556419|NCT00105482|80222460|FG001|Overall Study|Scheduling Conflict|3|||
27556420|NCT00105482|80222459|FG000|Overall Study|Withdrawn by PI|1|||
27556421|NCT00105482|80222460|FG001|Overall Study|Withdrawn by PI|1|||
27556422|NCT02625259|80222461|FG000|First Intervention (Day 1)|Other|0|||
27556423|NCT02625259|80222462|FG001|First Intervention (Day 1)|Other|0|||
27556424|NCT02625259|80222463|FG002|First Intervention (Day 1)|Other|1|||
27556425|NCT02625259|80222464|FG003|First Intervention (Day 1)|Other|0|||
27556426|NCT02625259|80222465|FG004|First Intervention (Day 1)|Other|0|||
27556427|NCT02625259|80222461|FG000|First Intervention (Day 1)|Adverse Event|2|||
27556428|NCT02625259|80222462|FG001|First Intervention (Day 1)|Adverse Event|1|||
27556429|NCT02625259|80222463|FG002|First Intervention (Day 1)|Adverse Event|0|||
27556430|NCT02625259|80222464|FG003|First Intervention (Day 1)|Adverse Event|0|||
27556431|NCT02625259|80222465|FG004|First Intervention (Day 1)|Adverse Event|0|||
27556432|NCT02625259|80222461|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
27556433|NCT02625259|80222462|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
27556434|NCT02625259|80222463|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27827086|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
27827087|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
27556435|NCT02625259|80222464|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
27556436|NCT02625259|80222465|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
27556437|NCT00680043|80222466|FG000|Overall Study|Withdrawal by Subject|1|||
27556438|NCT00680043|80222467|FG001|Overall Study|Withdrawal by Subject|0|||
27556439|NCT00680043|80222468|FG002|Overall Study|Withdrawal by Subject|0|||
27556440|NCT00680043|80222466|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
27556441|NCT00680043|80222467|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
27556442|NCT00680043|80222468|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
27556443|NCT00680043|80222466|FG000|Overall Study|Renal Transplant|1|||
27556444|NCT00680043|80222467|FG001|Overall Study|Renal Transplant|0|||
27556445|NCT00680043|80222468|FG002|Overall Study|Renal Transplant|4|||
27556446|NCT01922089|80222471|FG000|Overall Study|Adverse Event|18|||
27556447|NCT01922089|80222472|FG001|Overall Study|Adverse Event|13|||
27556448|NCT01922089|80222471|FG000|Overall Study|Protocol Deviation|10|||
27556449|NCT01922089|80222472|FG001|Overall Study|Protocol Deviation|7|||
27556450|NCT01922089|80222471|FG000|Overall Study|Withdrawal by Subject|3|||
27556451|NCT01922089|80222472|FG001|Overall Study|Withdrawal by Subject|4|||
27556452|NCT01922089|80222471|FG000|Overall Study|administrative problems|4|||
27556453|NCT01922089|80222472|FG001|Overall Study|administrative problems|1|||
27556454|NCT01922089|80222471|FG000|Overall Study|Physician Decision|2|||
27556455|NCT01922089|80222472|FG001|Overall Study|Physician Decision|3|||
27556456|NCT01922089|80222471|FG000|Overall Study|Death|2|||
27556457|NCT01922089|80222472|FG001|Overall Study|Death|1|||
27556458|NCT01922089|80222471|FG000|Overall Study|Lost to Follow-up|0|||
27556459|NCT01922089|80222472|FG001|Overall Study|Lost to Follow-up|1|||
27556460|NCT02345850|80222474|FG000|Overall Study|Not transplanted|10|||
27556461|NCT02345850|80222475|FG001|Overall Study|Not transplanted|5|||
27556462|NCT02345850|80222476|FG002|Overall Study|Not transplanted|4|||
27556463|NCT02345850|80222474|FG000|Overall Study|Lost to Follow-up|2|||
27556464|NCT02345850|80222475|FG001|Overall Study|Lost to Follow-up|3|||
27556465|NCT02345850|80222476|FG002|Overall Study|Lost to Follow-up|2|||
27556466|NCT02345850|80222474|FG000|Overall Study|Withdrawal by Subject|1|||
27556467|NCT02345850|80222475|FG001|Overall Study|Withdrawal by Subject|0|||
27556468|NCT02345850|80222476|FG002|Overall Study|Withdrawal by Subject|0|||
27556469|NCT00770289|80225963|FG000|Overall Study|Other|6|||
27556470|NCT02200445|80225965|FG000|Overall Study|Lack of Efficacy|1|||
27556471|NCT02200445|80225966|FG001|Overall Study|Lack of Efficacy|2|||
27556472|NCT02200445|80225967|FG002|Overall Study|Lack of Efficacy|2|||
27556473|NCT02200445|80225965|FG000|Overall Study|Adverse Event|0|||
27556474|NCT02200445|80225966|FG001|Overall Study|Adverse Event|2|||
27556475|NCT02200445|80225967|FG002|Overall Study|Adverse Event|0|||
27556476|NCT03641651|80225968|FG000|Overall Study|organizational issues at one study site|1|||
27556477|NCT01164956|80225971|FG000|Overall Study|Side Effects|1|||
27556478|NCT01164956|80225972|FG001|Overall Study|Side Effects|0|||
27556479|NCT01164956|80225973|FG002|Overall Study|Side Effects|1|||
27556480|NCT01327885|80225974|FG000|Overall Study|Disease progression-according to RECIST|173|||
27556481|NCT01327885|80225975|FG001|Overall Study|Disease progression-according to RECIST|165|||
27556482|NCT01327885|80225974|FG000|Overall Study|Clinical progression|24|||
27556483|NCT01327885|80225975|FG001|Overall Study|Clinical progression|27|||
27696443|NCT00475033|80723838|FG000|Infant Series|Parent or legal guardian request|1|||
27556484|NCT01327885|80225974|FG000|Overall Study|Adverse Event|14|||
27556485|NCT01327885|80225975|FG001|Overall Study|Adverse Event|10|||
27556486|NCT01327885|80225974|FG000|Overall Study|Subject choice|5|||
27556487|NCT01327885|80225975|FG001|Overall Study|Subject choice|10|||
27556488|NCT01327885|80225974|FG000|Overall Study|Other|8|||
27556489|NCT01327885|80225975|FG001|Overall Study|Other|6|||
27556490|NCT01327885|80225974|FG000|Overall Study|Withdrawal of consent from study|3|||
27696444|NCT00475033|80723839|FG001|Infant Series|Parent or legal guardian request|5|||
27556491|NCT01327885|80225975|FG001|Overall Study|Withdrawal of consent from study|4|||
27556492|NCT01327885|80225974|FG000|Overall Study|Not treated|1|||
27556493|NCT01327885|80225975|FG001|Overall Study|Not treated|1|||
27556494|NCT01327885|80225974|FG000|Overall Study|Administrative decision|0|||
27556495|NCT01327885|80225975|FG001|Overall Study|Administrative decision|1|||
27556496|NCT01110707|80225977|FG000|Overall Study|Protocol Violation|0|||
27556497|NCT01110707|80225978|FG001|Overall Study|Protocol Violation|3|||
27556498|NCT00975481|80225979|FG000|Second Intervention Period|Adverse Event|2|||
27556499|NCT00975481|80225980|FG001|Second Intervention Period|Adverse Event|1|||
27556500|NCT00975481|80225981|FG002|Second Intervention Period|Adverse Event|0|||
27556501|NCT00975481|80225982|FG003|Second Intervention Period|Adverse Event|0|||
27556502|NCT00975481|80225983|FG004|Second Intervention Period|Adverse Event|0|||
27556503|NCT00975481|80225984|FG005|Second Intervention Period|Adverse Event|0|||
27556504|NCT00975481|80225979|FG000|Second Intervention Period|Withdrawal by Subject|0|||
27556505|NCT00975481|80225980|FG001|Second Intervention Period|Withdrawal by Subject|0|||
27556506|NCT00975481|80225981|FG002|Second Intervention Period|Withdrawal by Subject|1|||
27556507|NCT00975481|80225982|FG003|Second Intervention Period|Withdrawal by Subject|0|||
27556508|NCT00975481|80225983|FG004|Second Intervention Period|Withdrawal by Subject|0|||
27556509|NCT00975481|80225984|FG005|Second Intervention Period|Withdrawal by Subject|0|||
27556510|NCT00975481|80225979|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
27556511|NCT00975481|80225980|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
27556512|NCT00975481|80225981|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
27556513|NCT00975481|80225982|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
27556514|NCT00975481|80225983|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
27556515|NCT00975481|80225984|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
27556516|NCT00975481|80225979|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
27556517|NCT00975481|80225980|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
27556518|NCT00975481|80225981|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
27556519|NCT00975481|80225982|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
27556520|NCT00975481|80225983|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
27556521|NCT00975481|80225984|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
27556522|NCT00232817|80225985|FG000|Overall Study|Protocol Violation|2|||
27556523|NCT00232817|80225986|FG001|Overall Study|Protocol Violation|1|||
27556524|NCT02436889|80225990|FG000|Overall Study|No improvement in symptoms|1|||
27556525|NCT02436889|80225991|FG001|Overall Study|No improvement in symptoms|0|||
27556526|NCT02436889|80225990|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
27556527|NCT02436889|80225991|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
27556528|NCT01252940|80225992|FG000|Main Study Phase|Randomized but not treated|4|||
27556529|NCT01252940|80225993|FG001|Main Study Phase|Randomized but not treated|2|||
27556530|NCT01252940|80225992|FG000|Main Study Phase|Adverse Event|3|||
27556531|NCT01252940|80225993|FG001|Main Study Phase|Adverse Event|1|||
27556532|NCT01252940|80225992|FG000|Main Study Phase|Lack of Efficacy|1|||
27556533|NCT01252940|80225993|FG001|Main Study Phase|Lack of Efficacy|0|||
27556534|NCT01252940|80225992|FG000|Main Study Phase|Lost to Follow-up|6|||
27556535|NCT01252940|80225993|FG001|Main Study Phase|Lost to Follow-up|1|||
27556536|NCT01252940|80225992|FG000|Main Study Phase|Physician Decision|1|||
27556537|NCT01252940|80225993|FG001|Main Study Phase|Physician Decision|0|||
27556538|NCT01252940|80225992|FG000|Main Study Phase|Protocol Violation|4|||
27556539|NCT01252940|80225993|FG001|Main Study Phase|Protocol Violation|2|||
27556540|NCT01252940|80225992|FG000|Main Study Phase|Withdrawal by Subject|6|||
27556541|NCT01252940|80225993|FG001|Main Study Phase|Withdrawal by Subject|5|||
27556542|NCT01252940|80225992|FG000|Main Study Phase|Subject Non-compliance|1|||
27556543|NCT01252940|80225993|FG001|Main Study Phase|Subject Non-compliance|1|||
27556544|NCT01252940|80225992|FG000|Extension Phase|Adverse Event|2|||
27556545|NCT01252940|80225993|FG001|Extension Phase|Adverse Event|1|||
27696445|NCT00475033|80723838|FG000|Infant Series|Protocol Violation|1|||
27696446|NCT00475033|80723839|FG001|Infant Series|Protocol Violation|2|||
27696447|NCT00475033|80723838|FG000|Infant Series|Lost to Follow-up|2|||
27696448|NCT00475033|80723839|FG001|Infant Series|Lost to Follow-up|0|||
27696449|NCT00475033|80723838|FG000|Infant Series|Adverse Event|0|||
27696450|NCT00475033|80723839|FG001|Infant Series|Adverse Event|2|||
27696451|NCT00475033|80723838|FG000|After the Infant Series|Adverse Event|0|||
27696452|NCT00475033|80723839|FG001|After the Infant Series|Adverse Event|4|||
27696453|NCT00475033|80723838|FG000|After the Infant Series|Parent or legal guardian request|2|||
27696454|NCT00475033|80723839|FG001|After the Infant Series|Parent or legal guardian request|2|||
27696455|NCT00475033|80723838|FG000|After the Infant Series|Failed to return|2|||
27696456|NCT00475033|80723839|FG001|After the Infant Series|Failed to return|1|||
27696457|NCT00475033|80723838|FG000|After the Infant Series|Protocol Violation|1|||
27696458|NCT00475033|80723839|FG001|After the Infant Series|Protocol Violation|0|||
27696459|NCT00475033|80723838|FG000|After the Infant Series|Lost to Follow-up|1|||
27696460|NCT00475033|80723839|FG001|After the Infant Series|Lost to Follow-up|0|||
27696461|NCT00475033|80723838|FG000|After the Infant Series|Other|0|||
27696462|NCT00475033|80723839|FG001|After the Infant Series|Other|1|||
27696463|NCT00475033|80723838|FG000|Toddler Dose|Parent or legal guardian request|2|||
27696464|NCT00475033|80723839|FG001|Toddler Dose|Parent or legal guardian request|0|||
27696465|NCT00475033|80723838|FG000|Toddler Dose|Failed to return|1|||
27696466|NCT00475033|80723839|FG001|Toddler Dose|Failed to return|0|||
27696467|NCT00475033|80723838|FG000|Toddler Dose|Lost to Follow-up|1|||
27696468|NCT00475033|80723839|FG001|Toddler Dose|Lost to Follow-up|0|||
27696469|NCT01054846|80723842|FG000|Overall Study|Lost to Follow-up|76|||
27696470|NCT01054846|80723843|FG001|Overall Study|Lost to Follow-up|17|||
27696471|NCT01672723|80723849|FG000|First Intervention|Adverse Event|3|||
27696472|NCT01672723|80723850|FG001|First Intervention|Adverse Event|0|||
27696473|NCT00820027|80723851|FG000|Overall Study|Adverse Event|15|||
27696474|NCT00820027|80723852|FG001|Overall Study|Adverse Event|8|||
27696475|NCT00820027|80723853|FG002|Overall Study|Adverse Event|10|||
27696476|NCT00820027|80723854|FG003|Overall Study|Adverse Event|5|||
27696477|NCT00820027|80723851|FG000|Overall Study|Lack of Efficacy|2|||
27696478|NCT00820027|80723852|FG001|Overall Study|Lack of Efficacy|1|||
27696479|NCT00820027|80723853|FG002|Overall Study|Lack of Efficacy|2|||
27696480|NCT00820027|80723854|FG003|Overall Study|Lack of Efficacy|2|||
27696481|NCT00820027|80723851|FG000|Overall Study|Physician Decision|0|||
27696482|NCT00820027|80723852|FG001|Overall Study|Physician Decision|1|||
27696483|NCT00820027|80723853|FG002|Overall Study|Physician Decision|1|||
27696484|NCT00820027|80723854|FG003|Overall Study|Physician Decision|0|||
27696485|NCT00820027|80723851|FG000|Overall Study|Protocol Violation|3|||
27696486|NCT00820027|80723852|FG001|Overall Study|Protocol Violation|0|||
27556546|NCT01252940|80225992|FG000|Extension Phase|Lack of Efficacy|1|||
27556547|NCT01252940|80225993|FG001|Extension Phase|Lack of Efficacy|0|||
27696487|NCT00820027|80723853|FG002|Overall Study|Protocol Violation|4|||
27696488|NCT00820027|80723854|FG003|Overall Study|Protocol Violation|0|||
27696489|NCT00820027|80723851|FG000|Overall Study|Withdrawal by Subject|6|||
27696490|NCT00820027|80723852|FG001|Overall Study|Withdrawal by Subject|4|||
27696491|NCT00820027|80723853|FG002|Overall Study|Withdrawal by Subject|4|||
27696492|NCT00820027|80723854|FG003|Overall Study|Withdrawal by Subject|6|||
27696493|NCT00881608|80723855|FG000|Overall Study|Study prematurely terminated|11|||
27696494|NCT03019185|80723858|FG000|Overall Study|Lost to Follow-up|3|||
27696495|NCT03019185|80723859|FG001|Overall Study|Lost to Follow-up|0|||
27696496|NCT03019185|80723860|FG002|Overall Study|Lost to Follow-up|2|||
27696497|NCT03019185|80723858|FG000|Overall Study|Withdrawal by Subject|1|||
27696498|NCT03019185|80723859|FG001|Overall Study|Withdrawal by Subject|1|||
27696499|NCT03019185|80723860|FG002|Overall Study|Withdrawal by Subject|0|||
27696500|NCT03019185|80723858|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
27696501|NCT03019185|80723859|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
27556548|NCT01252940|80225992|FG000|Extension Phase|Lost to Follow-up|5|||
27556549|NCT01252940|80225993|FG001|Extension Phase|Lost to Follow-up|0|||
27556550|NCT01252940|80225992|FG000|Extension Phase|Physician Decision|0|||
27556551|NCT01252940|80225993|FG001|Extension Phase|Physician Decision|1|||
27556552|NCT01252940|80225992|FG000|Extension Phase|Subject Non-compliance|1|||
27556553|NCT01252940|80225993|FG001|Extension Phase|Subject Non-compliance|0|||
27556554|NCT01252940|80225992|FG000|Extension Phase|Withdrawal by Subject|1|||
27883958|NCT02201108|81408107|FG000|Open Label Period (up to Week 192)|Other reason|4|||
27883959|NCT02201108|81408108|FG001|Open Label Period (up to Week 192)|Other reason|7|||
27556555|NCT01252940|80225993|FG001|Extension Phase|Withdrawal by Subject|1|||
27827088|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
27827089|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
27827090|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
27827091|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
27827092|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
27827093|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
27827094|NCT02493868|81198896|FG000|Optimization Phase: DE+TE Participants|Other|10|||
27827095|NCT02493868|81198897|FG001|Optimization Phase: DE+TE Participants|Other|2|||
27827096|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
27827097|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
27827098|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
27827099|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
27827100|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
27827101|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
27827102|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
27827103|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
27827104|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
27827105|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
27827106|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
27827107|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
27827108|NCT02493868|81198896|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
27827109|NCT02493868|81198897|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
27827110|NCT02493868|81198896|FG000|Follow-up Phase|Lost to Follow-up|1|||
27827111|NCT02493868|81198897|FG001|Follow-up Phase|Lost to Follow-up|0|||
27827112|NCT02493868|81198896|FG000|Follow-up Phase|Withdrawal by Subject|3|||
27827113|NCT02493868|81198897|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27827114|NCT02493868|81198896|FG000|Follow-up Phase|Investigator Decision|5|||
27556556|NCT02446990|80225998|FG000|Overall Study|Death|485|||
27556557|NCT02446990|80225999|FG001|Overall Study|Death|458|||
27556558|NCT02446990|80225998|FG000|Overall Study|Lost to Follow-up|3|||
27556559|NCT02446990|80225999|FG001|Overall Study|Lost to Follow-up|1|||
27556560|NCT02446990|80225998|FG000|Overall Study|Physician Decision|1|||
27827115|NCT02493868|81198897|FG001|Follow-up Phase|Investigator Decision|1|||
27827116|NCT02493868|81198896|FG000|Follow-up Phase|Other|2|||
27827117|NCT02493868|81198897|FG001|Follow-up Phase|Other|1|||
27883960|NCT02201108|81408107|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
27827118|NCT01208337|81198898|FG000|Overall Study|Death|3|||
27827119|NCT03818581|81198899|FG000|Overall Study|Adverse Event|1|||
27556561|NCT02446990|80225999|FG001|Overall Study|Physician Decision|0|||
27556562|NCT02446990|80225998|FG000|Overall Study|Withdrawal by Subject|231|||
27556563|NCT02446990|80225999|FG001|Overall Study|Withdrawal by Subject|199|||
27556564|NCT03277105|80226000|FG000|Overall Study|Death|129|||
27556565|NCT03277105|80226001|FG001|Overall Study|Death|124|||
27556566|NCT03277105|80226000|FG000|Overall Study|Lost to Follow-up|2|||
27556567|NCT03277105|80226001|FG001|Overall Study|Lost to Follow-up|4|||
27556568|NCT03277105|80226000|FG000|Overall Study|Withdrawal by Subject|10|||
27556569|NCT03277105|80226001|FG001|Overall Study|Withdrawal by Subject|10|||
27827120|NCT03818581|81198900|FG001|Overall Study|Adverse Event|0|||
27827121|NCT03818581|81198901|FG002|Overall Study|Adverse Event|0|||
27556570|NCT03277105|80226000|FG000|Overall Study|Other|118|||
27556571|NCT03277105|80226001|FG001|Overall Study|Other|125|||
27556572|NCT00514540|80226004|FG000|First-Line Chemo|Withdrawal by Subject|1|||
27556573|NCT00514540|80226004|FG000|First-Line Chemo|Protocol Violation|7|||
27556574|NCT00514540|80226004|FG000|Second-Line|Physician/Patient Decision|31|||
27556575|NCT00748033|80226005|FG000|Overall Study|Adverse Event|0|||
27556576|NCT00748033|80226006|FG001|Overall Study|Adverse Event|1|||
27827122|NCT03818581|81198902|FG003|Overall Study|Adverse Event|0|||
27827123|NCT03818581|81198903|FG004|Overall Study|Adverse Event|0|||
27827124|NCT03818581|81198899|FG000|Overall Study|Covid-19|2|||
27827125|NCT03818581|81198900|FG001|Overall Study|Covid-19|0|||
27827126|NCT03818581|81198901|FG002|Overall Study|Covid-19|0|||
27827127|NCT03818581|81198902|FG003|Overall Study|Covid-19|0|||
27827128|NCT03818581|81198903|FG004|Overall Study|Covid-19|1|||
27827129|NCT03818581|81198899|FG000|Overall Study|Withdrawal by Subject|0|||
27827130|NCT03818581|81198900|FG001|Overall Study|Withdrawal by Subject|0|||
27827131|NCT03818581|81198901|FG002|Overall Study|Withdrawal by Subject|0|||
27827132|NCT03818581|81198902|FG003|Overall Study|Withdrawal by Subject|0|||
27696502|NCT03019185|80723860|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
27696503|NCT03019185|80723858|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
27696504|NCT03019185|80723859|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
27696505|NCT03019185|80723860|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
27827133|NCT03818581|81198903|FG004|Overall Study|Withdrawal by Subject|1|||
27827134|NCT03818581|81198899|FG000|Overall Study|No longer met study criteria|0|||
27827135|NCT03818581|81198900|FG001|Overall Study|No longer met study criteria|0|||
27827136|NCT03818581|81198901|FG002|Overall Study|No longer met study criteria|0|||
27827137|NCT03818581|81198902|FG003|Overall Study|No longer met study criteria|0|||
27827138|NCT03818581|81198903|FG004|Overall Study|No longer met study criteria|1|||
27827139|NCT00446563|81198905|FG000|Overall Study|Adverse Event|4|||
27827140|NCT00446563|81198906|FG001|Overall Study|Adverse Event|3|||
27827141|NCT00446563|81198905|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27827142|NCT00446563|81198906|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27827143|NCT00446563|81198905|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27827144|NCT00446563|81198906|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27827145|NCT00446563|81198905|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27827146|NCT00446563|81198906|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27827147|NCT00446563|81198905|FG000|Overall Study|Withdrawal by Subject|2|||
27827148|NCT00446563|81198906|FG001|Overall Study|Withdrawal by Subject|1|||
27827149|NCT00446563|81198905|FG000|Overall Study|Administrative problems|0|||
27827150|NCT00446563|81198906|FG001|Overall Study|Administrative problems|1|||
27827151|NCT02832063|81198907|FG000|Overall Study|Adverse Event|2|||
27827152|NCT02832063|81198908|FG001|Overall Study|Adverse Event|1|||
27827153|NCT02832063|81198907|FG000|Overall Study|Physician Decision|5|||
27883961|NCT02201108|81408108|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
27696506|NCT03153137|80723861|FG000|Overall Study|Lost to Follow-up|1|||
27827154|NCT02832063|81198908|FG001|Overall Study|Physician Decision|7|||
27827155|NCT02832063|81198907|FG000|Overall Study|Lost to Follow-up|15|||
27827156|NCT02832063|81198908|FG001|Overall Study|Lost to Follow-up|8|||
27827157|NCT02832063|81198907|FG000|Overall Study|Withdrawal by Subject|10|||
27827158|NCT02832063|81198908|FG001|Overall Study|Withdrawal by Subject|21|||
27827159|NCT02832063|81198907|FG000|Overall Study|Other|2|||
27827160|NCT02832063|81198908|FG001|Overall Study|Other|1|||
27827161|NCT00207090|81198910|FG000|Overall Study|Study drug toxicity|3|||
27827162|NCT00207090|81198910|FG000|Overall Study|Chest wall mass larger|1|||
27883962|NCT00723008|81408109|FG000|Enrollment|Lost to Follow-up|1|||
27827163|NCT00207090|81198910|FG000|Overall Study|Disease progression/relapse|2|||
27827164|NCT00207090|81198910|FG000|Overall Study|Physician Decision|1|||
27827165|NCT03500341|81198920|FG000|Overall Study|Withdrawn prior to Completion|2|||
27883963|NCT00723008|81408110|FG001|Enrollment|Lost to Follow-up|0|||
27883964|NCT00723008|81408109|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
27827166|NCT02152163|81198923|FG000|Overall Study|Physician Decision|12|||
27827167|NCT02152163|81198924|FG001|Overall Study|Physician Decision|13|||
27556589|NCT02902965|80226010|FG000|Overall Study|Withdrawal by Subject|10|||
27556590|NCT00847704|80226011|FG000|Overall Study|Withdrawal by Subject|1|||
27556591|NCT01594125|80226012|FG000|Overall Study|Withdrawal by Subject|1|||
27556592|NCT01594125|80226013|FG001|Overall Study|Withdrawal by Subject|0|||
27556593|NCT01594125|80226014|FG002|Overall Study|Withdrawal by Subject|0|||
27556594|NCT01594125|80226015|FG003|Overall Study|Withdrawal by Subject|1|||
27556595|NCT01594125|80226016|FG004|Overall Study|Withdrawal by Subject|0|||
27556596|NCT01594125|80226012|FG000|Overall Study|Progressive Disease|3|||
27556597|NCT01594125|80226013|FG001|Overall Study|Progressive Disease|12|||
27556598|NCT01594125|80226014|FG002|Overall Study|Progressive Disease|3|||
27556599|NCT01594125|80226015|FG003|Overall Study|Progressive Disease|3|||
27556600|NCT01594125|80226016|FG004|Overall Study|Progressive Disease|7|||
27556601|NCT00996216|80226019|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
27556602|NCT00996216|80226019|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
27556603|NCT00996216|80226019|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
27556604|NCT01702454|80226020|FG000|Overall Study|Consent withdrawal|0|||
27556605|NCT01702454|80226021|FG001|Overall Study|Consent withdrawal|1|||
27556606|NCT01702454|80226020|FG000|Overall Study|Migrated/moved from study area|0|||
27556607|NCT01702454|80226021|FG001|Overall Study|Migrated/moved from study area|1|||
27556608|NCT01702454|80226020|FG000|Overall Study|Lost to Follow-up|3|||
27556609|NCT01702454|80226021|FG001|Overall Study|Lost to Follow-up|6|||
27556610|NCT02611778|80226024|FG000|Overall Study|Withdrawal by Subject|2|||
27556611|NCT02611778|80226025|FG001|Overall Study|Withdrawal by Subject|8|||
27556612|NCT02611778|80226024|FG000|Overall Study|Adverse Event|1|||
27556613|NCT02611778|80226025|FG001|Overall Study|Adverse Event|2|||
27556614|NCT02611778|80226024|FG000|Overall Study|Death|2|||
27556615|NCT02611778|80226025|FG001|Overall Study|Death|1|||
27556616|NCT02611778|80226024|FG000|Overall Study|Protocol Violation|1|||
27556617|NCT02611778|80226025|FG001|Overall Study|Protocol Violation|0|||
27556618|NCT02611778|80226024|FG000|Overall Study|Lost to Follow-up|3|||
27556619|NCT02611778|80226025|FG001|Overall Study|Lost to Follow-up|1|||
27556620|NCT02611778|80226024|FG000|Overall Study|Need for alternative treatment|1|||
27556621|NCT02611778|80226025|FG001|Overall Study|Need for alternative treatment|0|||
27556622|NCT02611778|80226024|FG000|Overall Study|Other Reason|2|||
27556623|NCT02611778|80226025|FG001|Overall Study|Other Reason|1|||
27827168|NCT02822235|81198927|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
27556624|NCT00818662|80226026|FG000|Overall Study|Adverse Event|5|||
27556625|NCT00818662|80226027|FG001|Overall Study|Adverse Event|14|||
27556626|NCT00818662|80226028|FG002|Overall Study|Adverse Event|4|||
27556627|NCT00818662|80226029|FG003|Overall Study|Adverse Event|3|||
27556628|NCT00818662|80226026|FG000|Overall Study|Withdrawal by Subject|5|||
27556629|NCT00818662|80226027|FG001|Overall Study|Withdrawal by Subject|4|||
27556630|NCT00818662|80226028|FG002|Overall Study|Withdrawal by Subject|2|||
27556631|NCT00818662|80226029|FG003|Overall Study|Withdrawal by Subject|2|||
27556632|NCT00818662|80226026|FG000|Overall Study|Death|1|||
27556633|NCT00818662|80226027|FG001|Overall Study|Death|3|||
27827169|NCT02822235|81198928|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
27827170|NCT02822235|81198927|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
27827171|NCT02822235|81198928|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
27827172|NCT02822235|81198927|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
27827173|NCT02822235|81198928|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
27827174|NCT02822235|81198927|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
27556634|NCT00818662|80226028|FG002|Overall Study|Death|0|||
27556635|NCT00818662|80226029|FG003|Overall Study|Death|0|||
27556636|NCT00818662|80226026|FG000|Overall Study|Physician Decision|1|||
27556637|NCT00818662|80226027|FG001|Overall Study|Physician Decision|0|||
27556638|NCT00818662|80226028|FG002|Overall Study|Physician Decision|0|||
27556639|NCT00818662|80226029|FG003|Overall Study|Physician Decision|0|||
27556640|NCT00818662|80226026|FG000|Overall Study|Lost to Follow-up|0|||
27556641|NCT00818662|80226027|FG001|Overall Study|Lost to Follow-up|0|||
27556642|NCT00818662|80226028|FG002|Overall Study|Lost to Follow-up|0|||
27556643|NCT00818662|80226029|FG003|Overall Study|Lost to Follow-up|1|||
27556644|NCT00818662|80226026|FG000|Overall Study|Unwilling or Unable to Participate|4|||
27556645|NCT00818662|80226027|FG001|Overall Study|Unwilling or Unable to Participate|6|||
27556646|NCT00818662|80226028|FG002|Overall Study|Unwilling or Unable to Participate|2|||
27827175|NCT02822235|81198928|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
27827176|NCT02822235|81198927|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
27556647|NCT00818662|80226029|FG003|Overall Study|Unwilling or Unable to Participate|4|||
27556648|NCT00818662|80226026|FG000|Overall Study|Protocol Violation|1|||
27556649|NCT00818662|80226027|FG001|Overall Study|Protocol Violation|1|||
27556650|NCT00818662|80226028|FG002|Overall Study|Protocol Violation|0|||
27556651|NCT00818662|80226029|FG003|Overall Study|Protocol Violation|0|||
27556652|NCT00818662|80226026|FG000|Overall Study|Requires a Prohibited Medication|1|||
27556653|NCT00818662|80226027|FG001|Overall Study|Requires a Prohibited Medication|0|||
27556654|NCT00818662|80226028|FG002|Overall Study|Requires a Prohibited Medication|0|||
27556655|NCT00818662|80226029|FG003|Overall Study|Requires a Prohibited Medication|0|||
27556656|NCT00818662|80226026|FG000|Overall Study|Safety Risk|1|||
27556657|NCT00818662|80226027|FG001|Overall Study|Safety Risk|1|||
27556658|NCT00818662|80226028|FG002|Overall Study|Safety Risk|0|||
27556659|NCT00818662|80226029|FG003|Overall Study|Safety Risk|1|||
27556660|NCT00818662|80226026|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
27827177|NCT02822235|81198928|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
27556661|NCT00818662|80226027|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
27556662|NCT00818662|80226028|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
27556663|NCT00818662|80226029|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
27556664|NCT00818662|80226026|FG000|Overall Study|Participant's health declined|0|||
27556665|NCT00818662|80226027|FG001|Overall Study|Participant's health declined|0|||
27556666|NCT00818662|80226028|FG002|Overall Study|Participant's health declined|0|||
27556667|NCT00818662|80226029|FG003|Overall Study|Participant's health declined|1|||
27556668|NCT00818662|80226026|FG000|Overall Study|Caregiver to pursue other treatment|0|||
27556669|NCT00818662|80226027|FG001|Overall Study|Caregiver to pursue other treatment|1|||
27556670|NCT00818662|80226028|FG002|Overall Study|Caregiver to pursue other treatment|0|||
27556671|NCT00818662|80226029|FG003|Overall Study|Caregiver to pursue other treatment|0|||
27827178|NCT02822235|81198927|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
27827179|NCT02822235|81198928|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
27556672|NCT00818662|80226026|FG000|Overall Study|Moving out of state|0|||
27827180|NCT00834756|81198930|FG000|First Intervention|Adverse Event|1|||
27827181|NCT00834756|81198931|FG001|First Intervention|Adverse Event|0|||
27827182|NCT00834756|81198930|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
27556673|NCT00818662|80226027|FG001|Overall Study|Moving out of state|0|||
27827183|NCT00834756|81198931|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
27556674|NCT00818662|80226028|FG002|Overall Study|Moving out of state|0|||
27556675|NCT00818662|80226029|FG003|Overall Study|Moving out of state|1|||
27556676|NCT00818662|80226026|FG000|Overall Study|Declined move to another study site|1|||
27556677|NCT00818662|80226027|FG001|Overall Study|Declined move to another study site|0|||
27556678|NCT00818662|80226028|FG002|Overall Study|Declined move to another study site|0|||
27556679|NCT00818662|80226029|FG003|Overall Study|Declined move to another study site|0|||
27556680|NCT00818662|80226026|FG000|Overall Study|Change in living situation|0|||
27556681|NCT00818662|80226027|FG001|Overall Study|Change in living situation|0|||
27556682|NCT00818662|80226028|FG002|Overall Study|Change in living situation|0|||
27556683|NCT00818662|80226029|FG003|Overall Study|Change in living situation|1|||
27556684|NCT00818662|80226026|FG000|Overall Study|Study partner decision|0|||
27556685|NCT00818662|80226027|FG001|Overall Study|Study partner decision|0|||
27556686|NCT00818662|80226028|FG002|Overall Study|Study partner decision|0|||
27556687|NCT00818662|80226029|FG003|Overall Study|Study partner decision|1|||
27556688|NCT00818662|80226026|FG000|Overall Study|Admitted to long term nursing care|0|||
27556689|NCT00818662|80226027|FG001|Overall Study|Admitted to long term nursing care|1|||
27556690|NCT00818662|80226028|FG002|Overall Study|Admitted to long term nursing care|0|||
27556691|NCT00818662|80226029|FG003|Overall Study|Admitted to long term nursing care|0|||
27556692|NCT01751867|80226030|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
27556693|NCT01751867|80226031|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
27556694|NCT01751867|80226030|FG000|Overall Study|Diease Progression|4|||
27556695|NCT01751867|80226031|FG001|Overall Study|Diease Progression|18|||
27556696|NCT01751867|80226030|FG000|Overall Study|Adverse Event|8|||
27556697|NCT01751867|80226031|FG001|Overall Study|Adverse Event|15|||
27556698|NCT01751867|80226030|FG000|Overall Study|Poor Compliance|0|||
27556699|NCT01751867|80226031|FG001|Overall Study|Poor Compliance|5|||
27556700|NCT01751867|80226030|FG000|Overall Study|Withdrawal by Subject|3|||
27556701|NCT01751867|80226031|FG001|Overall Study|Withdrawal by Subject|1|||
27556702|NCT01751867|80226030|FG000|Overall Study|Physician Decision|4|||
27556703|NCT01751867|80226031|FG001|Overall Study|Physician Decision|7|||
27556704|NCT01751867|80226030|FG000|Overall Study|Protocol Violation|0|||
27556705|NCT01751867|80226031|FG001|Overall Study|Protocol Violation|2|||
27556706|NCT01751867|80226030|FG000|Overall Study|Death|0|||
27556707|NCT01751867|80226031|FG001|Overall Study|Death|5|||
27827184|NCT00840411|81198932|FG000|First Intervention|Adverse Event|1|||
27827185|NCT00840411|81198933|FG001|First Intervention|Adverse Event|0|||
27556708|NCT01751867|80226030|FG000|Overall Study|Other|11|||
27556709|NCT01751867|80226031|FG001|Overall Study|Other|37|||
27556710|NCT01751867|80226030|FG000|Overall Study|Randomized but not treated.|2|||
27556711|NCT01751867|80226031|FG001|Overall Study|Randomized but not treated.|1|||
27696507|NCT03153137|80723862|FG001|Overall Study|Lost to Follow-up|0|||
27696508|NCT03153137|80723861|FG000|Overall Study|Withdrawal by Subject|2|||
27696509|NCT03153137|80723862|FG001|Overall Study|Withdrawal by Subject|1|||
27696510|NCT03153137|80723861|FG000|Overall Study|Physician Decision|0|||
27696511|NCT03153137|80723862|FG001|Overall Study|Physician Decision|3|||
27696512|NCT00440700|80723863|FG000|Overall Study|Withdrawal by Subject|8|||
27696513|NCT00440700|80723864|FG001|Overall Study|Withdrawal by Subject|8|||
27696514|NCT00440700|80723865|FG002|Overall Study|Withdrawal by Subject|4|||
27696515|NCT01778023|80723866|FG000|Overall Study|Withdrawal by Subject|0|||
27696516|NCT01778023|80723867|FG001|Overall Study|Withdrawal by Subject|3|||
27696517|NCT00718640|80723870|FG000|Overall Study|Adverse Event|4|||
27696518|NCT00718640|80723870|FG000|Overall Study|Death|1|||
27696519|NCT00718640|80723870|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
27696520|NCT00093808|80723871|FG000|Overall Study|Cancel participation before receiving tx|1|||
27696521|NCT00093808|80723871|FG000|Overall Study|Protocol Violation|1|||
27696522|NCT03437278|80723872|FG000|Overall Study|Adverse Event|0|||
27696523|NCT03437278|80723873|FG001|Overall Study|Adverse Event|0|||
27696524|NCT03437278|80723874|FG002|Overall Study|Adverse Event|1|||
27696525|NCT03437278|80723872|FG000|Overall Study|Progressive disease|1|||
27696526|NCT03437278|80723873|FG001|Overall Study|Progressive disease|0|||
27556712|NCT03358290|80226032|FG000|Overall Study|Study discontinued by Sponsor|0|||
27696527|NCT03437278|80723874|FG002|Overall Study|Progressive disease|0|||
27696528|NCT03437278|80723872|FG000|Overall Study|Physician Decision|1|||
27556713|NCT03358290|80226033|FG001|Overall Study|Study discontinued by Sponsor|1|||
27696529|NCT03437278|80723873|FG001|Overall Study|Physician Decision|0|||
27696530|NCT03437278|80723874|FG002|Overall Study|Physician Decision|1|||
27827186|NCT00840411|81198932|FG000|Washout|Withdrawal by Subject|1|||
27827187|NCT00840411|81198933|FG001|Washout|Withdrawal by Subject|0|||
27827188|NCT00678639|81198936|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
27827189|NCT00678639|81198937|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
27827190|NCT00640562|81198946|FG000|Overall Study|Adverse Event|8|||
27827191|NCT00640562|81198947|FG001|Overall Study|Adverse Event|5|||
27827192|NCT00640562|81198946|FG000|Overall Study|Lack of Efficacy|1|||
27827193|NCT00640562|81198947|FG001|Overall Study|Lack of Efficacy|4|||
27827194|NCT00640562|81198946|FG000|Overall Study|Protocol Violation|2|||
27827195|NCT00640562|81198947|FG001|Overall Study|Protocol Violation|4|||
27827196|NCT00640562|81198946|FG000|Overall Study|Withdrawal by Subject|6|||
27827197|NCT00640562|81198947|FG001|Overall Study|Withdrawal by Subject|10|||
27827198|NCT00640562|81198946|FG000|Overall Study|Known risperidone intolerance|0|||
27827199|NCT00640562|81198947|FG001|Overall Study|Known risperidone intolerance|1|||
27827200|NCT00640562|81198946|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
27827201|NCT00640562|81198947|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
27827202|NCT00640562|81198946|FG000|Overall Study|Low study drug dose|0|||
27827203|NCT00640562|81198947|FG001|Overall Study|Low study drug dose|1|||
27827204|NCT00640562|81198946|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
27827205|NCT00640562|81198947|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
27827206|NCT00796653|81198948|FG000|Overall Study|Adverse Event|19|||
27827207|NCT00796653|81198949|FG001|Overall Study|Adverse Event|16|||
27827208|NCT00796653|81198950|FG002|Overall Study|Adverse Event|16|||
27827209|NCT00796653|81198951|FG003|Overall Study|Adverse Event|16|||
27827210|NCT00796653|81198948|FG000|Overall Study|Lost to Follow-up|2|||
27827211|NCT00796653|81198949|FG001|Overall Study|Lost to Follow-up|1|||
27827212|NCT00796653|81198950|FG002|Overall Study|Lost to Follow-up|2|||
27827213|NCT00796653|81198951|FG003|Overall Study|Lost to Follow-up|3|||
27827214|NCT00796653|81198948|FG000|Overall Study|Withdrawal by Subject|16|||
27827215|NCT00796653|81198949|FG001|Overall Study|Withdrawal by Subject|8|||
27827216|NCT00796653|81198950|FG002|Overall Study|Withdrawal by Subject|8|||
27827217|NCT00796653|81198951|FG003|Overall Study|Withdrawal by Subject|13|||
27827218|NCT00796653|81198948|FG000|Overall Study|Lack of Efficacy|8|||
27827219|NCT00796653|81198949|FG001|Overall Study|Lack of Efficacy|1|||
27827220|NCT00796653|81198950|FG002|Overall Study|Lack of Efficacy|3|||
27827221|NCT00796653|81198951|FG003|Overall Study|Lack of Efficacy|2|||
27827222|NCT00796653|81198948|FG000|Overall Study|Non compliance with protocol|2|||
27827223|NCT00796653|81198949|FG001|Overall Study|Non compliance with protocol|2|||
27827224|NCT00796653|81198950|FG002|Overall Study|Non compliance with protocol|0|||
27827225|NCT00796653|81198951|FG003|Overall Study|Non compliance with protocol|2|||
27827226|NCT00796653|81198948|FG000|Overall Study|Other reason not described above|4|||
27827227|NCT00796653|81198949|FG001|Overall Study|Other reason not described above|9|||
27827228|NCT00796653|81198950|FG002|Overall Study|Other reason not described above|7|||
27827229|NCT00796653|81198951|FG003|Overall Study|Other reason not described above|4|||
27827230|NCT00909610|81198952|FG000|Period: First Intervention|Adverse Event|0|||
27827231|NCT00909610|81198953|FG001|Period: First Intervention|Adverse Event|1|||
27827232|NCT00909610|81198952|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
27827233|NCT00909610|81198953|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
27827234|NCT00909610|81198952|FG000|Period: Second Intervention|Adverse Event|1|||
27827235|NCT00909610|81198953|FG001|Period: Second Intervention|Adverse Event|0|||
27827236|NCT00777023|81198954|FG000|Overall Study|Adverse Event|15|||
27556714|NCT03358290|80226034|FG002|Overall Study|Study discontinued by Sponsor|1|||
27556715|NCT03358290|80226035|FG003|Overall Study|Study discontinued by Sponsor|0|||
27556716|NCT03358290|80226036|FG004|Overall Study|Study discontinued by Sponsor|0|||
27556717|NCT03358290|80226032|FG000|Overall Study|Adverse Event|0|||
27556718|NCT03358290|80226033|FG001|Overall Study|Adverse Event|0|||
27696531|NCT02079610|80723875|FG000|Overall Study|Withdrawal by Subject|1|||
27696532|NCT02079610|80723876|FG001|Overall Study|Withdrawal by Subject|1|||
27556719|NCT03358290|80226034|FG002|Overall Study|Adverse Event|1|||
27556720|NCT03358290|80226035|FG003|Overall Study|Adverse Event|2|||
27556721|NCT03358290|80226036|FG004|Overall Study|Adverse Event|0|||
27556722|NCT03358290|80226032|FG000|Overall Study|Withdrawal by Subject|0|||
27556723|NCT03358290|80226033|FG001|Overall Study|Withdrawal by Subject|0|||
27556724|NCT03358290|80226034|FG002|Overall Study|Withdrawal by Subject|0|||
27556725|NCT03358290|80226035|FG003|Overall Study|Withdrawal by Subject|0|||
27556726|NCT03358290|80226036|FG004|Overall Study|Withdrawal by Subject|1|||
27556727|NCT03316131|80226037|FG000|Treatment Period 2|Protocol deviation|1|||
27556728|NCT03316131|80226038|FG001|Treatment Period 2|Protocol deviation|0|||
27556729|NCT00267046|80226039|FG000|Overall Study|Disease progression|4|||
27556730|NCT00267046|80226040|FG001|Overall Study|Disease progression|2|||
27556731|NCT00267046|80226039|FG000|Overall Study|Chemotoxicity|2|||
27556732|NCT00267046|80226040|FG001|Overall Study|Chemotoxicity|0|||
27556733|NCT00267046|80226039|FG000|Overall Study|Open-label palifermin|2|||
27556734|NCT00267046|80226040|FG001|Overall Study|Open-label palifermin|7|||
27556735|NCT00267046|80226039|FG000|Overall Study|Surgery|3|||
27556736|NCT00267046|80226040|FG001|Overall Study|Surgery|1|||
27556737|NCT00267046|80226039|FG000|Overall Study|Withdrawal by Subject|1|||
27556738|NCT00267046|80226040|FG001|Overall Study|Withdrawal by Subject|0|||
27556739|NCT00267046|80226039|FG000|Overall Study|Radiation|0|||
27556740|NCT00267046|80226040|FG001|Overall Study|Radiation|1|||
27556741|NCT03527966|80226041|FG000|Overall Study|Lost to Follow-up|3|||
27556742|NCT03527966|80226042|FG001|Overall Study|Lost to Follow-up|0|||
27556743|NCT01502423|80226045|FG000|Overall Study|Withdrawal by Subject|0|||
27556744|NCT01502423|80226046|FG001|Overall Study|Withdrawal by Subject|1|||
27696533|NCT02471833|80723877|FG000|Overall Study|Lost to Follow-up|1|||
27827237|NCT00777023|81198955|FG001|Overall Study|Adverse Event|21|||
27827238|NCT00777023|81198956|FG002|Overall Study|Adverse Event|8|||
27827239|NCT00777023|81198954|FG000|Overall Study|Lack of Efficacy|1|||
27827240|NCT00777023|81198955|FG001|Overall Study|Lack of Efficacy|0|||
27827241|NCT00777023|81198956|FG002|Overall Study|Lack of Efficacy|14|||
27827242|NCT00777023|81198954|FG000|Overall Study|Protocol Violation|2|||
27827243|NCT00777023|81198955|FG001|Overall Study|Protocol Violation|1|||
27827244|NCT00777023|81198956|FG002|Overall Study|Protocol Violation|1|||
27827245|NCT00777023|81198954|FG000|Overall Study|Lost to Follow-up|2|||
27827246|NCT00777023|81198955|FG001|Overall Study|Lost to Follow-up|3|||
27556745|NCT00372112|80226047|FG000|Overall Study|Adverse Event|0|||
27556746|NCT00372112|80226048|FG001|Overall Study|Adverse Event|1|||
27556747|NCT00372112|80226049|FG002|Overall Study|Adverse Event|1|||
27556748|NCT00372112|80226050|FG003|Overall Study|Adverse Event|1|||
27696534|NCT02471833|80723878|FG001|Overall Study|Lost to Follow-up|0|||
27827247|NCT00777023|81198956|FG002|Overall Study|Lost to Follow-up|3|||
27556749|NCT00372112|80226047|FG000|Overall Study|Withdrawal by Subject|0|||
27556750|NCT00372112|80226048|FG001|Overall Study|Withdrawal by Subject|0|||
27556751|NCT00372112|80226049|FG002|Overall Study|Withdrawal by Subject|2|||
27556752|NCT00372112|80226050|FG003|Overall Study|Withdrawal by Subject|1|||
27556753|NCT00372112|80226047|FG000|Overall Study|Exacerbation|0|||
27827248|NCT00777023|81198954|FG000|Overall Study|Death|0|||
27827249|NCT00777023|81198955|FG001|Overall Study|Death|1|||
27827250|NCT00777023|81198956|FG002|Overall Study|Death|0|||
27827251|NCT00777023|81198954|FG000|Overall Study|Withdrawal by Subject|7|||
27827252|NCT00777023|81198955|FG001|Overall Study|Withdrawal by Subject|7|||
27827253|NCT00777023|81198956|FG002|Overall Study|Withdrawal by Subject|8|||
27827254|NCT00777023|81198954|FG000|Overall Study|Missing data|1|||
27827255|NCT00777023|81198955|FG001|Overall Study|Missing data|1|||
27696535|NCT02471833|80723879|FG002|Overall Study|Lost to Follow-up|0|||
27827256|NCT00777023|81198956|FG002|Overall Study|Missing data|0|||
27827257|NCT00777023|81198954|FG000|Overall Study|Reasons not specified|4|||
27827258|NCT00777023|81198955|FG001|Overall Study|Reasons not specified|4|||
27827259|NCT00777023|81198956|FG002|Overall Study|Reasons not specified|2|||
27827260|NCT00777023|81198954|FG000|Overall Study|Last dose date unknown|3|||
27827261|NCT00777023|81198955|FG001|Overall Study|Last dose date unknown|3|||
27827262|NCT00777023|81198956|FG002|Overall Study|Last dose date unknown|1|||
27827263|NCT01577381|81198959|FG000|Overall Study|Discontinued|2|||
27827264|NCT01577381|81198960|FG001|Overall Study|Discontinued|1|||
27696536|NCT02471833|80723877|FG000|Overall Study|Withdrawal by Subject|2|||
27883965|NCT00723008|81408110|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
27883966|NCT00723008|81408109|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
27696537|NCT02471833|80723878|FG001|Overall Study|Withdrawal by Subject|1|||
27696538|NCT02471833|80723879|FG002|Overall Study|Withdrawal by Subject|5|||
27827265|NCT01577381|81198961|FG002|Overall Study|Discontinued|2|||
27827266|NCT01577381|81198962|FG003|Overall Study|Discontinued|2|||
27827267|NCT01577381|81198959|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
27827268|NCT01577381|81198960|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
27827269|NCT01577381|81198961|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
27696539|NCT00381303|80723880|FG000|Overall Study|Lost to Follow-up|25|||
27696540|NCT00381303|80723881|FG001|Overall Study|Lost to Follow-up|9|||
27696541|NCT00381303|80723880|FG000|Overall Study|AE/HIV-related event|22|||
27696542|NCT00381303|80723881|FG001|Overall Study|AE/HIV-related event|6|||
27696543|NCT00381303|80723880|FG000|Overall Study|Non-Adherence|13|||
27696544|NCT00381303|80723881|FG001|Overall Study|Non-Adherence|6|||
27696545|NCT00381303|80723880|FG000|Overall Study|Withdrawal by Subject|13|||
27696546|NCT00381303|80723881|FG001|Overall Study|Withdrawal by Subject|6|||
27696547|NCT00381303|80723880|FG000|Overall Study|Virologic failure|6|||
27696548|NCT00381303|80723881|FG001|Overall Study|Virologic failure|4|||
27696549|NCT00381303|80723880|FG000|Overall Study|Ineligible to continue the trial|2|||
27696550|NCT00381303|80723881|FG001|Overall Study|Ineligible to continue the trial|1|||
27696551|NCT00381303|80723880|FG000|Overall Study|Pregnancy|2|||
27696552|NCT00381303|80723881|FG001|Overall Study|Pregnancy|0|||
27696553|NCT00381303|80723880|FG000|Overall Study|Physician Decision|1|||
27696554|NCT00381303|80723881|FG001|Overall Study|Physician Decision|0|||
27696555|NCT00381303|80723880|FG000|Overall Study|Physician's decision to close the site|3|||
27696556|NCT00381303|80723881|FG001|Overall Study|Physician's decision to close the site|1|||
27696557|NCT00381303|80723880|FG000|Overall Study|Subject moved out of state|2|||
27696558|NCT00381303|80723881|FG001|Overall Study|Subject moved out of state|0|||
27696559|NCT00381303|80723880|FG000|Overall Study|Subject taking too many different meds|1|||
27696560|NCT00381303|80723881|FG001|Overall Study|Subject taking too many different meds|0|||
27696561|NCT00381303|80723880|FG000|Overall Study|No virologic response by week 12|1|||
27696562|NCT00381303|80723881|FG001|Overall Study|No virologic response by week 12|0|||
27696563|NCT00381303|80723880|FG000|Overall Study|Subject was too busy for appointments|1|||
27696564|NCT00381303|80723881|FG001|Overall Study|Subject was too busy for appointments|0|||
27696565|NCT00381303|80723880|FG000|Overall Study|Subject did not continue visits|1|||
27696566|NCT00381303|80723881|FG001|Overall Study|Subject did not continue visits|0|||
27696567|NCT00381303|80723880|FG000|Overall Study|Subject primary physician's decision|1|||
27696568|NCT00381303|80723881|FG001|Overall Study|Subject primary physician's decision|0|||
27696569|NCT00892723|80723882|FG000|Overall Study|Lost to Follow-up|1|||
27696570|NCT00892723|80723883|FG001|Overall Study|Lost to Follow-up|3|||
27696571|NCT00892723|80723884|FG002|Overall Study|Lost to Follow-up|1|||
27696572|NCT00892723|80723882|FG000|Overall Study|Withdrawal by Subject|1|||
27696573|NCT00892723|80723883|FG001|Overall Study|Withdrawal by Subject|1|||
27696574|NCT00892723|80723884|FG002|Overall Study|Withdrawal by Subject|1|||
27696575|NCT01386788|80723885|FG000|Overall Study|Lost to Follow-up|2|||
27827270|NCT01577381|81198962|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
27827271|NCT01097577|81198967|FG000|Overall Study|Adverse Event|0|||
27827272|NCT01097577|81198968|FG001|Overall Study|Adverse Event|1|||
27696576|NCT03618823|80723890|FG000|Overall Study|Lost to Follow-up|63|||
27696577|NCT03618823|80723891|FG001|Overall Study|Lost to Follow-up|61|||
27827273|NCT03238781|81198973|FG000|Overall Study|Adverse Event|1|||
27696578|NCT00769860|80723892|FG000|Overall Study|Withdrawal by Subject|2|||
27696579|NCT00769860|80723893|FG001|Overall Study|Withdrawal by Subject|0|||
27696580|NCT03103763|80723897|FG000|Overall Study|Death|15|||
27696581|NCT03103763|80723898|FG001|Overall Study|Death|5|||
27696582|NCT03103763|80723899|FG002|Overall Study|Death|5|||
27696583|NCT03103763|80723897|FG000|Overall Study|Withdrawal by Subject|0|||
27696584|NCT03103763|80723898|FG001|Overall Study|Withdrawal by Subject|3|||
27696585|NCT03103763|80723899|FG002|Overall Study|Withdrawal by Subject|2|||
27696586|NCT02170389|80723900|FG000|Overall Study|Study terminated prior to start of treat|1|||
27696587|NCT00688181|80727000|FG000|Overall Study|Lost to Follow-up|17|||
27696588|NCT00688181|80727000|FG000|Overall Study|Unknown Reason|4|||
27696589|NCT00688181|80727000|FG000|Overall Study|Non-clinical Reason|2|||
27696590|NCT01026454|80727001|FG000|Second Intervention|Pregnancy|1|||
27696591|NCT01026454|80727002|FG001|Second Intervention|Pregnancy|1|||
27696592|NCT01340196|80727008|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
27696593|NCT02308020|80727009|FG000|Overall Study|Lost to Follow-up|1|||
27696594|NCT02308020|80727010|FG001|Overall Study|Lost to Follow-up|7|||
27696595|NCT02308020|80727011|FG002|Overall Study|Lost to Follow-up|0|||
27696596|NCT02308020|80727012|FG003|Overall Study|Lost to Follow-up|0|||
27696597|NCT02308020|80727013|FG004|Overall Study|Lost to Follow-up|1|||
27696598|NCT02308020|80727014|FG005|Overall Study|Lost to Follow-up|2|||
27696599|NCT02308020|80727009|FG000|Overall Study|Sponsor Decision|0|||
27696600|NCT02308020|80727010|FG001|Overall Study|Sponsor Decision|8|||
27696601|NCT02308020|80727011|FG002|Overall Study|Sponsor Decision|0|||
27696602|NCT02308020|80727012|FG003|Overall Study|Sponsor Decision|2|||
27696603|NCT02308020|80727013|FG004|Overall Study|Sponsor Decision|2|||
27696604|NCT02308020|80727014|FG005|Overall Study|Sponsor Decision|1|||
27696605|NCT02308020|80727009|FG000|Overall Study|Withdrawal by Subject|3|||
27696606|NCT02308020|80727010|FG001|Overall Study|Withdrawal by Subject|5|||
27696607|NCT02308020|80727011|FG002|Overall Study|Withdrawal by Subject|3|||
27696608|NCT02308020|80727012|FG003|Overall Study|Withdrawal by Subject|2|||
27696609|NCT02308020|80727013|FG004|Overall Study|Withdrawal by Subject|1|||
27696610|NCT02308020|80727014|FG005|Overall Study|Withdrawal by Subject|2|||
27696611|NCT01072877|80727015|FG000|Overall Study|Lost to Follow-up|1|||
27696612|NCT01072877|80727016|FG001|Overall Study|Lost to Follow-up|1|||
27696613|NCT01072877|80727017|FG002|Overall Study|Lost to Follow-up|0|||
27696614|NCT01072877|80727018|FG003|Overall Study|Lost to Follow-up|2|||
27696615|NCT01072877|80727019|FG004|Overall Study|Lost to Follow-up|0|||
27696616|NCT03678103|80727027|FG000|Overall Study|Withdrawn prior to completion|4|||
27696617|NCT00807235|80727033|FG000|Overall Study|Adverse Event|1|||
27696618|NCT00807235|80727034|FG001|Overall Study|Adverse Event|0|||
27696619|NCT03333837|80727052|FG000|Overall Study|Adverse Event|2|||
27696620|NCT03333837|80727053|FG001|Overall Study|Adverse Event|1|||
27696621|NCT03333837|80727054|FG002|Overall Study|Adverse Event|1|||
27696622|NCT03333837|80727055|FG003|Overall Study|Adverse Event|1|||
27696623|NCT03333837|80727056|FG004|Overall Study|Adverse Event|0|||
27696624|NCT03333837|80727052|FG000|Overall Study|Caregiver withdrew|0|||
27696625|NCT03333837|80727053|FG001|Overall Study|Caregiver withdrew|2|||
27696626|NCT03333837|80727054|FG002|Overall Study|Caregiver withdrew|1|||
27696627|NCT03333837|80727055|FG003|Overall Study|Caregiver withdrew|0|||
27696628|NCT03333837|80727056|FG004|Overall Study|Caregiver withdrew|0|||
27696629|NCT03333837|80727052|FG000|Overall Study|Withdrawal by Subject|0|||
27696630|NCT03333837|80727053|FG001|Overall Study|Withdrawal by Subject|0|||
27696631|NCT03333837|80727054|FG002|Overall Study|Withdrawal by Subject|1|||
27696632|NCT03333837|80727055|FG003|Overall Study|Withdrawal by Subject|1|||
27696633|NCT03333837|80727056|FG004|Overall Study|Withdrawal by Subject|3|||
27696634|NCT03333837|80727052|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
27696635|NCT03333837|80727053|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
27696636|NCT03333837|80727054|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
27696637|NCT03333837|80727055|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
27696638|NCT03333837|80727056|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
27696639|NCT01259284|80727059|FG000|Overall Study|Study Termination|2|||
27696640|NCT01259284|80727060|FG001|Overall Study|Study Termination|0|||
27696641|NCT01259284|80727061|FG002|Overall Study|Study Termination|0|||
27696642|NCT00007345|80727062|FG000|Overall Study|Refused further treatment|0|||
27696643|NCT00007345|80727063|FG001|Overall Study|Refused further treatment|7|||
27556754|NCT00372112|80226048|FG001|Overall Study|Exacerbation|0|||
27696644|NCT00007345|80727062|FG000|Overall Study|Switched to alternative treatment|0|||
27696645|NCT00007345|80727063|FG001|Overall Study|Switched to alternative treatment|3|||
27696646|NCT00007345|80727062|FG000|Overall Study|Intercurrent illness|1|||
27696647|NCT00007345|80727063|FG001|Overall Study|Intercurrent illness|0|||
27696648|NCT00007345|80727062|FG000|Overall Study|Death on study|1|||
27696649|NCT00007345|80727063|FG001|Overall Study|Death on study|1|||
27696650|NCT03421431|80727066|FG000|Overall Study|Adverse Event|2|||
27696651|NCT03421431|80727067|FG001|Overall Study|Adverse Event|1|||
27696652|NCT03421431|80727068|FG002|Overall Study|Adverse Event|12|||
27696653|NCT03421431|80727066|FG000|Overall Study|Lost to Follow-up|1|||
27696654|NCT03421431|80727067|FG001|Overall Study|Lost to Follow-up|1|||
27696655|NCT03421431|80727068|FG002|Overall Study|Lost to Follow-up|1|||
27696656|NCT03421431|80727066|FG000|Overall Study|Withdrawal by Subject|3|||
27696657|NCT03421431|80727067|FG001|Overall Study|Withdrawal by Subject|2|||
27696658|NCT03421431|80727068|FG002|Overall Study|Withdrawal by Subject|1|||
27696659|NCT03421431|80727066|FG000|Overall Study|Protocol Violation|0|||
27696660|NCT03421431|80727067|FG001|Overall Study|Protocol Violation|1|||
27696661|NCT03421431|80727068|FG002|Overall Study|Protocol Violation|0|||
27696662|NCT03421431|80727066|FG000|Overall Study|Participant met Stopping Rules|0|||
27696663|NCT03421431|80727067|FG001|Overall Study|Participant met Stopping Rules|1|||
27696664|NCT03421431|80727068|FG002|Overall Study|Participant met Stopping Rules|0|||
27696665|NCT02349360|80727072|FG000|Overall Study|Withdrawal by Subject|0|||
27696666|NCT02349360|80727073|FG001|Overall Study|Withdrawal by Subject|1|||
27696667|NCT02986334|80727081|FG000|Overall Study|Withdrawal by Subject|0|||
27696668|NCT02986334|80727082|FG001|Overall Study|Withdrawal by Subject|1|||
27696669|NCT02986334|80727083|FG002|Overall Study|Withdrawal by Subject|2|||
27696670|NCT02986334|80727081|FG000|Overall Study|Lost to Follow-up|1|||
27696671|NCT02986334|80727082|FG001|Overall Study|Lost to Follow-up|2|||
27696672|NCT02986334|80727083|FG002|Overall Study|Lost to Follow-up|1|||
27696673|NCT02986334|80727081|FG000|Overall Study|Adverse Event|0|||
27696674|NCT02986334|80727082|FG001|Overall Study|Adverse Event|2|||
27696675|NCT02986334|80727083|FG002|Overall Study|Adverse Event|1|||
27696676|NCT02986334|80727081|FG000|Overall Study|non compliance in phone ratings|2|||
27696677|NCT02986334|80727082|FG001|Overall Study|non compliance in phone ratings|1|||
27696678|NCT02986334|80727083|FG002|Overall Study|non compliance in phone ratings|2|||
27696679|NCT02986334|80727081|FG000|Overall Study|undisclosed comorbidities|0|||
27696680|NCT02986334|80727082|FG001|Overall Study|undisclosed comorbidities|1|||
27696681|NCT02986334|80727083|FG002|Overall Study|undisclosed comorbidities|1|||
27696682|NCT01206777|80727084|FG000|Overall Study|Death|1|||
27696683|NCT01206777|80727084|FG000|Overall Study|Adverse Event|1|||
27696684|NCT00908232|80727085|FG000|Cycle 1 to 4|Death|5|||
27696685|NCT00908232|80727086|FG001|Cycle 1 to 4|Death|0|||
27696686|NCT00908232|80727087|FG002|Cycle 1 to 4|Death|0|||
27696687|NCT00908232|80727088|FG003|Cycle 1 to 4|Death|0|||
27696688|NCT00908232|80727085|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
27696689|NCT00908232|80727086|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
27696690|NCT00908232|80727087|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
27696691|NCT00908232|80727088|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
27696692|NCT00908232|80727085|FG000|Cycle 1 to 4|Progressive Disease|6|||
27696693|NCT00908232|80727086|FG001|Cycle 1 to 4|Progressive Disease|0|||
27696694|NCT00908232|80727087|FG002|Cycle 1 to 4|Progressive Disease|0|||
27696695|NCT00908232|80727088|FG003|Cycle 1 to 4|Progressive Disease|0|||
27696696|NCT00908232|80727085|FG000|Cycle 1 to 4|Adverse Event|12|||
27696697|NCT00908232|80727086|FG001|Cycle 1 to 4|Adverse Event|0|||
27696698|NCT00908232|80727087|FG002|Cycle 1 to 4|Adverse Event|0|||
27696699|NCT00908232|80727088|FG003|Cycle 1 to 4|Adverse Event|0|||
27696700|NCT00908232|80727085|FG000|Cycle 1 to 4|Other|1|||
27696701|NCT00908232|80727086|FG001|Cycle 1 to 4|Other|0|||
27696702|NCT00908232|80727087|FG002|Cycle 1 to 4|Other|0|||
27696703|NCT00908232|80727088|FG003|Cycle 1 to 4|Other|0|||
27696704|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
27696705|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
27696706|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
27696707|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
27696708|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
27696709|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
27696710|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
27696711|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
27696712|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
27696713|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
27696714|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
27696715|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
27696716|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
27696717|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
27696718|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
27696719|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
27696720|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
27696721|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
27696722|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
27696723|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
27696724|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
27696725|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
27696726|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
27696727|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
27696728|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
27696729|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
27696730|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
27696731|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
27696732|NCT00908232|80727085|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
27696733|NCT00908232|80727086|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
27696734|NCT00908232|80727087|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
27696735|NCT00908232|80727088|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
27696736|NCT01620255|80727089|FG000|Overall Study|Withdrawal by Subject|4|||
27696737|NCT01620255|80727090|FG001|Overall Study|Withdrawal by Subject|1|||
27696738|NCT01620255|80727091|FG002|Overall Study|Withdrawal by Subject|1|||
27696739|NCT01620255|80727092|FG003|Overall Study|Withdrawal by Subject|2|||
27696740|NCT01620255|80727093|FG004|Overall Study|Withdrawal by Subject|4|||
27696741|NCT01620255|80727089|FG000|Overall Study|Participant underwent fecal transplant|0|||
27696742|NCT01620255|80727090|FG001|Overall Study|Participant underwent fecal transplant|0|||
27696743|NCT01620255|80727091|FG002|Overall Study|Participant underwent fecal transplant|1|||
27696744|NCT01620255|80727092|FG003|Overall Study|Participant underwent fecal transplant|0|||
27696745|NCT01620255|80727093|FG004|Overall Study|Participant underwent fecal transplant|0|||
27696746|NCT01620255|80727089|FG000|Overall Study|Non-compliance|0|||
27696747|NCT01620255|80727090|FG001|Overall Study|Non-compliance|1|||
27696748|NCT01620255|80727091|FG002|Overall Study|Non-compliance|0|||
27696749|NCT01620255|80727092|FG003|Overall Study|Non-compliance|0|||
27696750|NCT01620255|80727093|FG004|Overall Study|Non-compliance|0|||
27696751|NCT01620255|80727089|FG000|Overall Study|Adverse Event|0|||
27696752|NCT01620255|80727090|FG001|Overall Study|Adverse Event|4|||
27696753|NCT01620255|80727091|FG002|Overall Study|Adverse Event|0|||
27696754|NCT01620255|80727092|FG003|Overall Study|Adverse Event|1|||
27696755|NCT01620255|80727093|FG004|Overall Study|Adverse Event|1|||
27696756|NCT01620255|80727089|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
27696757|NCT01620255|80727090|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
27696758|NCT01620255|80727091|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
27696759|NCT01620255|80727092|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
27696760|NCT01620255|80727093|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
27696761|NCT00756470|80727097|FG000|Overall Study|Withdrawal by Subject|1|||
27696762|NCT00756470|80727097|FG000|Overall Study|Adverse Event|4|||
27696763|NCT03575143|80727098|FG000|Overall Study|Lost to Follow-up|0|||
27696764|NCT03575143|80727099|FG001|Overall Study|Lost to Follow-up|0|||
27696765|NCT03575143|80727100|FG002|Overall Study|Lost to Follow-up|4|||
27696766|NCT03575143|80727098|FG000|Overall Study|Withdrawal by Subject|0|||
27696767|NCT03575143|80727099|FG001|Overall Study|Withdrawal by Subject|0|||
27696768|NCT03575143|80727100|FG002|Overall Study|Withdrawal by Subject|5|||
27696769|NCT03575143|80727098|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
27696770|NCT03575143|80727099|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
27696771|NCT03575143|80727100|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
27696772|NCT02027701|80727101|FG000|Overall Study|Adverse Event|3|||
27696773|NCT02027701|80727101|FG000|Overall Study|Lack of Efficacy|8|||
27696774|NCT02027701|80727101|FG000|Overall Study|Physician Decision|2|||
27696775|NCT02027701|80727101|FG000|Overall Study|Withdrawal by Subject|3|||
27696776|NCT03604523|80727102|FG000|Overall Study|Physician Decision|1|||
27696777|NCT03604523|80727103|FG001|Overall Study|Physician Decision|0|||
27696778|NCT01295034|80727108|FG000|Overall Study|Lost to Follow-up|5|||
27696779|NCT01295034|80727109|FG001|Overall Study|Lost to Follow-up|5|||
27696780|NCT01906346|80727112|FG000|Overall Study|AEs|1|||
27696781|NCT02808143|80727114|FG000|Maintenance Phase|Disease recurrence|1|||
27696782|NCT02808143|80727115|FG001|Maintenance Phase|Disease recurrence|3|||
27696783|NCT02808143|80727114|FG000|Maintenance Phase|Disease progression|1|||
27696784|NCT02808143|80727115|FG001|Maintenance Phase|Disease progression|2|||
27696785|NCT02808143|80727114|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
27696786|NCT02808143|80727115|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
27696787|NCT02808143|80727114|FG000|Survival Follow-Up|Disease recurrence|0|||
27696788|NCT02808143|80727115|FG001|Survival Follow-Up|Disease recurrence|2|||
27696789|NCT02808143|80727114|FG000|Survival Follow-Up|Adverse Event|0|||
27696790|NCT02808143|80727115|FG001|Survival Follow-Up|Adverse Event|1|||
27696791|NCT02808143|80727114|FG000|Survival Follow-Up|Death|1|||
27696792|NCT02808143|80727115|FG001|Survival Follow-Up|Death|0|||
27696793|NCT02196714|80727117|FG000|Overall Study|Protocol Violation|0|||
27696794|NCT02196714|80727118|FG001|Overall Study|Protocol Violation|0|||
27696795|NCT02196714|80727119|FG002|Overall Study|Protocol Violation|1|||
27696796|NCT02196714|80727120|FG003|Overall Study|Protocol Violation|0|||
27696797|NCT03442985|80727126|FG000|Overall Study|Sponsor Request|55|||
27696798|NCT03442985|80727127|FG001|Overall Study|Sponsor Request|60|||
27696799|NCT03442985|80727128|FG002|Overall Study|Sponsor Request|54|||
27696800|NCT03442985|80727126|FG000|Overall Study|Lost to Follow-up|5|||
27696801|NCT03442985|80727127|FG001|Overall Study|Lost to Follow-up|2|||
27696802|NCT03442985|80727128|FG002|Overall Study|Lost to Follow-up|7|||
27696803|NCT03442985|80727126|FG000|Overall Study|Withdrawal by Subject|2|||
27696804|NCT03442985|80727127|FG001|Overall Study|Withdrawal by Subject|3|||
27696805|NCT03442985|80727128|FG002|Overall Study|Withdrawal by Subject|4|||
27696806|NCT03442985|80727126|FG000|Overall Study|Adverse Event|0|||
27696807|NCT03442985|80727127|FG001|Overall Study|Adverse Event|1|||
27696808|NCT03442985|80727128|FG002|Overall Study|Adverse Event|0|||
27696809|NCT03040622|80727129|FG000|Overall Study|unable to implant device|3|||
27696810|NCT01324323|80727130|FG000|Overall Study|Withdrawal by Subject|1|||
27696811|NCT00104676|80727131|FG000|Overall Study|Death|3|||
27696812|NCT00104676|80727132|FG001|Overall Study|Death|2|||
27696813|NCT00104676|80727131|FG000|Overall Study|Withdrawal by Subject|0|||
27696814|NCT00104676|80727132|FG001|Overall Study|Withdrawal by Subject|2|||
27696815|NCT00104676|80727131|FG000|Overall Study|treatment interruption|4|||
27696816|NCT00104676|80727132|FG001|Overall Study|treatment interruption|10|||
27696817|NCT00051363|80727133|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
27696818|NCT00051363|80727134|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
27696819|NCT00051363|80727133|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
27696820|NCT00051363|80727134|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
27696821|NCT00051363|80727133|FG000|Overall Study|Death|2|||
27696822|NCT00051363|80727134|FG001|Overall Study|Death|2|||
27696823|NCT00051363|80727133|FG000|Overall Study|Excluded Pre-Randomization|2|||
27696824|NCT00051363|80727134|FG001|Overall Study|Excluded Pre-Randomization|5|||
27696825|NCT02446886|80727135|FG000|Overall Study|Adverse Event|1|||
27696826|NCT02446886|80727136|FG001|Overall Study|Adverse Event|3|||
27696827|NCT02446886|80727135|FG000|Overall Study|Withdrawal by Subject|1|||
27696828|NCT02446886|80727136|FG001|Overall Study|Withdrawal by Subject|1|||
27696829|NCT02147353|80727139|FG000|Overall Study|Lost to Follow-up|2|||
27696830|NCT02147353|80727140|FG001|Overall Study|Lost to Follow-up|0|||
27696831|NCT02147353|80727139|FG000|Overall Study|unable to make visits|4|||
27696832|NCT02147353|80727140|FG001|Overall Study|unable to make visits|0|||
27696833|NCT02147353|80727139|FG000|Overall Study|medication noncompliance|3|||
27696834|NCT02147353|80727140|FG001|Overall Study|medication noncompliance|0|||
27696835|NCT02720536|80727141|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
27696836|NCT02720536|80727141|FG000|Overall Study|PR - pregnancy|2|||
27696837|NCT02720536|80727141|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
27696838|NCT02720536|80727141|FG000|Overall Study|PR - death|1|||
27696839|NCT02720536|80727141|FG000|Overall Study|PR - adverse event|1|||
27696840|NCT02720536|80727141|FG000|Overall Study|PR - abnormal lab value(s)|1|||
27696841|NCT02720536|80727141|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
27696842|NCT01498289|80727142|FG000|Overall Study|Adverse Event|16|||
27696843|NCT01498289|80727143|FG001|Overall Study|Adverse Event|18|||
27696844|NCT01498289|80727142|FG000|Overall Study|Death|6|||
27696845|NCT01498289|80727143|FG001|Overall Study|Death|8|||
27696846|NCT01498289|80727142|FG000|Overall Study|Withdrawal unrelated to AE|16|||
27696847|NCT01498289|80727143|FG001|Overall Study|Withdrawal unrelated to AE|16|||
27696848|NCT01498289|80727142|FG000|Overall Study|Progression/relapse|53|||
27696849|NCT01498289|80727143|FG001|Overall Study|Progression/relapse|59|||
27696850|NCT01498289|80727142|FG000|Overall Study|Not protocol specified|7|||
27696851|NCT01498289|80727143|FG001|Overall Study|Not protocol specified|2|||
27696852|NCT01498289|80727142|FG000|Overall Study|Reason under review|0|||
27696853|NCT01498289|80727143|FG001|Overall Study|Reason under review|1|||
27696854|NCT05208866|80727144|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
27696855|NCT01971203|80727145|FG000|Overall Study|Protocol Violation|3|||
27696856|NCT01971203|80727146|FG001|Overall Study|Protocol Violation|2|||
27696857|NCT01971203|80727145|FG000|Overall Study|Withdrawal by Subject|5|||
27696858|NCT01971203|80727146|FG001|Overall Study|Withdrawal by Subject|6|||
27696859|NCT01971203|80727145|FG000|Overall Study|Adverse Event|1|||
27696860|NCT01971203|80727146|FG001|Overall Study|Adverse Event|0|||
27696861|NCT00876928|80727148|FG000|Overall Study|Lost to Follow-up|2|||
27696862|NCT00876928|80727149|FG001|Overall Study|Lost to Follow-up|5|||
27696863|NCT00876928|80727148|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
27696864|NCT00876928|80727149|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
27696865|NCT01272947|80727150|FG000|Overall Study|Abnormal Laboratory Value|2|||
27696866|NCT01272947|80727151|FG001|Overall Study|Abnormal Laboratory Value|2|||
27696867|NCT00221195|80727152|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
27696868|NCT00221195|80727153|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
27696869|NCT00221195|80727152|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
27696870|NCT00221195|80727153|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
27696871|NCT00221195|80727152|FG000|Washout Period (Months 7-9)|Death|0|||
27696872|NCT00221195|80727153|FG001|Washout Period (Months 7-9)|Death|1|||
27696873|NCT00221195|80727152|FG000|Therapy 2 (Months 10-15)|Death|1|||
27696874|NCT00221195|80727153|FG001|Therapy 2 (Months 10-15)|Death|0|||
27696875|NCT00221195|80727152|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
27696876|NCT00221195|80727153|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
27696877|NCT03357952|80727167|FG000|Overall Study|Withdrawal by Subject|0|||
27696878|NCT03357952|80727168|FG001|Overall Study|Withdrawal by Subject|1|||
27696879|NCT03357952|80727167|FG000|Overall Study|Sponsor Decision|9|||
27696880|NCT03357952|80727168|FG001|Overall Study|Sponsor Decision|0|||
27696881|NCT00838929|80727169|FG000|Overall Study|Protocol Violation|0|||
27696882|NCT00838929|80727170|FG001|Overall Study|Protocol Violation|1|||
27696883|NCT00838929|80727171|FG002|Overall Study|Protocol Violation|0|||
27696884|NCT00838929|80727169|FG000|Overall Study|Disease progression|0|||
27696885|NCT00838929|80727170|FG001|Overall Study|Disease progression|2|||
27696886|NCT00838929|80727171|FG002|Overall Study|Disease progression|1|||
27696887|NCT01444456|80727172|FG000|Overall Study|Withdrawal by Subject|21|||
27696888|NCT01444456|80727172|FG000|Overall Study|Physician Decision|9|||
27696889|NCT01444456|80727172|FG000|Overall Study|Lost to Follow-up|37|||
27696890|NCT01444456|80727172|FG000|Overall Study|Death|73|||
27696891|NCT01444456|80727172|FG000|Overall Study|Ineligibility determined|23|||
27696892|NCT01444456|80727172|FG000|Overall Study|Other|18|||
27696893|NCT01444456|80727172|FG000|Overall Study|Not treated|104|||
27696894|NCT01607554|80727173|FG000|Overall Study|Disease progression|2|||
27696895|NCT01271803|80727174|FG000|Overall Study|Progressive disease|0|||
27827274|NCT03238781|81198974|FG001|Overall Study|Adverse Event|1|||
27696896|NCT01271803|80727175|FG001|Overall Study|Progressive disease|0|||
27827275|NCT03238781|81198975|FG002|Overall Study|Adverse Event|2|||
27827276|NCT03238781|81198973|FG000|Overall Study|Lost to Follow-up|2|||
27696897|NCT01271803|80727176|FG002|Overall Study|Progressive disease|2|||
27696898|NCT01271803|80727174|FG000|Overall Study|Death|53|||
27696899|NCT01271803|80727175|FG001|Overall Study|Death|34|||
27696900|NCT01271803|80727176|FG002|Overall Study|Death|0|||
27696901|NCT01271803|80727174|FG000|Overall Study|Withdrawal by Subject|1|||
27696902|NCT01271803|80727175|FG001|Overall Study|Withdrawal by Subject|5|||
27696903|NCT01271803|80727176|FG002|Overall Study|Withdrawal by Subject|0|||
27696904|NCT01271803|80727174|FG000|Overall Study|Lost to Follow-up|1|||
27827277|NCT03238781|81198974|FG001|Overall Study|Lost to Follow-up|1|||
27696905|NCT01271803|80727175|FG001|Overall Study|Lost to Follow-up|0|||
27696906|NCT01271803|80727176|FG002|Overall Study|Lost to Follow-up|0|||
27696907|NCT03057977|80727179|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
27696908|NCT03057977|80727180|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
27827278|NCT03238781|81198975|FG002|Overall Study|Lost to Follow-up|2|||
27827279|NCT03238781|81198973|FG000|Overall Study|Withdrawal by Subject|23|||
27827280|NCT03238781|81198974|FG001|Overall Study|Withdrawal by Subject|14|||
27696909|NCT03057977|80727179|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
27696910|NCT03057977|80727180|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
27556755|NCT00372112|80226049|FG002|Overall Study|Exacerbation|0|||
27556756|NCT00372112|80226050|FG003|Overall Study|Exacerbation|1|||
27556757|NCT00372112|80226047|FG000|Overall Study|PR >240 at Visit 3|0|||
27556758|NCT00372112|80226048|FG001|Overall Study|PR >240 at Visit 3|0|||
27556759|NCT00372112|80226049|FG002|Overall Study|PR >240 at Visit 3|0|||
27556760|NCT00372112|80226050|FG003|Overall Study|PR >240 at Visit 3|1|||
27556761|NCT00372112|80226047|FG000|Overall Study|Hepatitis B|1|||
27556762|NCT00372112|80226048|FG001|Overall Study|Hepatitis B|0|||
27556763|NCT00372112|80226049|FG002|Overall Study|Hepatitis B|0|||
27556764|NCT00372112|80226050|FG003|Overall Study|Hepatitis B|0|||
27556765|NCT00372112|80226047|FG000|Overall Study|Other-protocol violation|0|||
27556766|NCT00372112|80226048|FG001|Overall Study|Other-protocol violation|0|||
27556767|NCT00372112|80226049|FG002|Overall Study|Other-protocol violation|1|||
27556768|NCT00372112|80226050|FG003|Overall Study|Other-protocol violation|0|||
27556769|NCT01722071|80226051|FG000|Overall Study|Protocol Violation|1|||
27556770|NCT01722071|80226052|FG001|Overall Study|Protocol Violation|0|||
27556771|NCT00529542|80226053|FG000|Overall Study|Withdrawal by Subject|1|||
27556772|NCT00529542|80226054|FG001|Overall Study|Withdrawal by Subject|0|||
27556773|NCT00529542|80226053|FG000|Overall Study|Lost to Follow-up|0|||
27556774|NCT00529542|80226054|FG001|Overall Study|Lost to Follow-up|1|||
27556775|NCT00330616|80226057|FG000|Overall Study|Adverse Event|13|||
27556776|NCT00330616|80226057|FG000|Overall Study|Lack of Efficacy|1|||
27556777|NCT00330616|80226057|FG000|Overall Study|Lost to Follow-up|2|||
27556778|NCT00330616|80226057|FG000|Overall Study|Withdrawal by Subject|4|||
27556779|NCT00330616|80226057|FG000|Overall Study|Other|1|||
27556780|NCT01413191|80226063|FG000|Overall Study|Lost to Follow-up|5|||
27556781|NCT01413191|80226063|FG000|Overall Study|Disease Progression|5|||
27556782|NCT01413191|80226063|FG000|Overall Study|Death|1|||
27556783|NCT02457910|80226067|FG000|Overall Study|Withdrawal by Subject|0|||
27827281|NCT03238781|81198975|FG002|Overall Study|Withdrawal by Subject|16|||
27827282|NCT03238781|81198973|FG000|Overall Study|Decision by sponsor|0|||
27827283|NCT03238781|81198974|FG001|Overall Study|Decision by sponsor|1|||
27827284|NCT03238781|81198975|FG002|Overall Study|Decision by sponsor|0|||
27556784|NCT02457910|80226068|FG001|Overall Study|Withdrawal by Subject|0|||
27556785|NCT02457910|80226069|FG002|Overall Study|Withdrawal by Subject|0|||
27556786|NCT02457910|80226070|FG003|Overall Study|Withdrawal by Subject|0|||
27556787|NCT02457910|80226071|FG004|Overall Study|Withdrawal by Subject|0|||
27556788|NCT02457910|80226072|FG005|Overall Study|Withdrawal by Subject|1|||
27556789|NCT02457910|80226067|FG000|Overall Study|Adverse Event|0|||
27556790|NCT02457910|80226068|FG001|Overall Study|Adverse Event|2|||
27556791|NCT02457910|80226069|FG002|Overall Study|Adverse Event|1|||
27556792|NCT02457910|80226070|FG003|Overall Study|Adverse Event|1|||
27556793|NCT02457910|80226071|FG004|Overall Study|Adverse Event|1|||
27827285|NCT03181594|81198979|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
27827286|NCT03181594|81198979|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
27827287|NCT03181594|81198979|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
27827288|NCT03181594|81198979|FG000|Initial Study Protocol (12-month FU)|Death|1|||
27556794|NCT02457910|80226072|FG005|Overall Study|Adverse Event|3|||
27556795|NCT02457910|80226067|FG000|Overall Study|Disease progression|3|||
27556796|NCT02457910|80226068|FG001|Overall Study|Disease progression|3|||
27556797|NCT02457910|80226069|FG002|Overall Study|Disease progression|1|||
27556798|NCT02457910|80226070|FG003|Overall Study|Disease progression|1|||
27556799|NCT02457910|80226071|FG004|Overall Study|Disease progression|4|||
27556800|NCT02457910|80226072|FG005|Overall Study|Disease progression|6|||
27556801|NCT02457910|80226067|FG000|Overall Study|Other complicating illness|0|||
27556802|NCT02457910|80226068|FG001|Overall Study|Other complicating illness|0|||
27556803|NCT02457910|80226069|FG002|Overall Study|Other complicating illness|0|||
27556804|NCT02457910|80226070|FG003|Overall Study|Other complicating illness|0|||
27827289|NCT03181594|81198979|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
27827290|NCT03181594|81198979|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
27827291|NCT02736721|81198980|FG000|Overall Study|Adverse Event|8|||
27827292|NCT02736721|81198980|FG000|Overall Study|Lost to Follow-up|3|||
27827293|NCT02736721|81198980|FG000|Overall Study|Other|5|||
27827294|NCT04123548|81198981|FG000|Overall Study|Withdrawal by Subject|1|||
27827295|NCT04123548|81198981|FG000|Overall Study|Lost to Follow-up|8|||
27827296|NCT04123548|81198981|FG000|Overall Study|Death|4|||
27827297|NCT04123548|81198981|FG000|Overall Study|Reason Not Specified|1|||
27827298|NCT01535222|81198982|FG000|Overall Study|Inclusion/exclusion|0|||
27827299|NCT01535222|81198983|FG001|Overall Study|Inclusion/exclusion|0|||
27827300|NCT01535222|81198984|FG002|Overall Study|Inclusion/exclusion|1|||
27827301|NCT01535222|81198985|FG003|Overall Study|Inclusion/exclusion|0|||
27827302|NCT01535222|81198986|FG004|Overall Study|Inclusion/exclusion|0|||
27827303|NCT01535222|81198987|FG005|Overall Study|Inclusion/exclusion|0|||
27827304|NCT02622386|81198988|FG000|First Assignment|Withdrawal by Subject|3|||
27827305|NCT02622386|81198989|FG001|First Assignment|Withdrawal by Subject|2|||
27827306|NCT02622386|81198988|FG000|Washout|Withdrawal by Subject|4|||
27827307|NCT02622386|81198989|FG001|Washout|Withdrawal by Subject|4|||
27827308|NCT02622386|81198988|FG000|Second Assignment|Withdrawal by Subject|0|||
27827309|NCT02622386|81198989|FG001|Second Assignment|Withdrawal by Subject|2|||
27827310|NCT05099380|81198990|FG000|Overall Study|Subject enrolled in error|1|||
27827311|NCT05099380|81198991|FG001|Overall Study|Subject enrolled in error|0|||
27827312|NCT05099380|81198990|FG000|Overall Study|Study Procedure|1|||
27827313|NCT05099380|81198991|FG001|Overall Study|Study Procedure|0|||
27827314|NCT05099380|81198990|FG000|Overall Study|Protocol Violation|1|||
27827315|NCT05099380|81198991|FG001|Overall Study|Protocol Violation|0|||
27827316|NCT05099380|81198990|FG000|Overall Study|Adverse Event|1|||
27827317|NCT05099380|81198991|FG001|Overall Study|Adverse Event|1|||
27827318|NCT05099380|81198990|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
27827319|NCT05099380|81198991|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
27827320|NCT02642653|81198992|FG000|Overall Study|Adverse Event|2|||
27827321|NCT02642653|81198993|FG001|Overall Study|Adverse Event|0|||
27827322|NCT00245063|81198998|FG000|Overall Study|Adverse Event|6|||
27827323|NCT00245063|81198999|FG001|Overall Study|Adverse Event|5|||
27827324|NCT00245063|81198998|FG000|Overall Study|Death|1|||
27827325|NCT00245063|81198999|FG001|Overall Study|Death|0|||
27827326|NCT02378935|81199000|FG000|Overall Study|Lack of Efficacy|10|||
27827327|NCT02378935|81199001|FG001|Overall Study|Lack of Efficacy|0|||
27827328|NCT02378935|81199002|FG002|Overall Study|Lack of Efficacy|2|||
27827329|NCT02378935|81199003|FG003|Overall Study|Lack of Efficacy|6|||
27827330|NCT02378935|81199004|FG004|Overall Study|Lack of Efficacy|0|||
27827331|NCT02378935|81199005|FG005|Overall Study|Lack of Efficacy|0|||
27827332|NCT02378935|81199006|FG006|Overall Study|Lack of Efficacy|0|||
27827333|NCT02378935|81199000|FG000|Overall Study|Death|0|||
27827334|NCT02378935|81199001|FG001|Overall Study|Death|0|||
27827335|NCT02378935|81199002|FG002|Overall Study|Death|1|||
27827336|NCT02378935|81199003|FG003|Overall Study|Death|0|||
27827337|NCT02378935|81199004|FG004|Overall Study|Death|0|||
27827338|NCT02378935|81199005|FG005|Overall Study|Death|0|||
27827339|NCT02378935|81199006|FG006|Overall Study|Death|0|||
27827340|NCT00927069|81199007|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
27556805|NCT02457910|80226071|FG004|Overall Study|Other complicating illness|0|||
27556806|NCT02457910|80226072|FG005|Overall Study|Other complicating illness|1|||
27556807|NCT02457910|80226067|FG000|Overall Study|Death|0|||
27556808|NCT02457910|80226068|FG001|Overall Study|Death|0|||
27556809|NCT02457910|80226069|FG002|Overall Study|Death|1|||
27556810|NCT02457910|80226070|FG003|Overall Study|Death|0|||
27556811|NCT02457910|80226071|FG004|Overall Study|Death|0|||
27556812|NCT02457910|80226072|FG005|Overall Study|Death|0|||
27556813|NCT01333059|80226073|FG000|Overall Study|Physician Decision|3|||
27556814|NCT01333059|80226074|FG001|Overall Study|Physician Decision|3|||
27556815|NCT01333059|80226073|FG000|Overall Study|Protocol Violation|3|||
27556816|NCT01333059|80226074|FG001|Overall Study|Protocol Violation|0|||
27556817|NCT00531050|80226077|FG000|Part 1: Period 1|Adverse Event|0|||
27696911|NCT03057977|80727179|FG000|Discontinuation From Treatment|Protocol Violation|6|||
27696912|NCT03057977|80727180|FG001|Discontinuation From Treatment|Protocol Violation|5|||
27827341|NCT00927069|81199008|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
27827342|NCT00927069|81199009|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
27827343|NCT00927069|81199010|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
27827344|NCT00927069|81199007|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
27827345|NCT00927069|81199008|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
27827346|NCT00927069|81199009|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
27827347|NCT00927069|81199010|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
27556818|NCT00531050|80226078|FG001|Part 1: Period 1|Adverse Event|1|||
27556819|NCT00531050|80226079|FG002|Part 1: Period 1|Adverse Event|0|||
27556820|NCT00531050|80226080|FG003|Part 1: Period 1|Adverse Event|0|||
27827348|NCT00927069|81199007|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
27827349|NCT00927069|81199008|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
27556821|NCT00531050|80226081|FG004|Part 1: Period 1|Adverse Event|0|||
27556822|NCT00531050|80226082|FG005|Part 1: Period 1|Adverse Event|0|||
27556823|NCT00531050|80226077|FG000|Part 1: Period 1|Protocol Deviation|0|||
27556824|NCT00531050|80226078|FG001|Part 1: Period 1|Protocol Deviation|0|||
27556825|NCT00531050|80226079|FG002|Part 1: Period 1|Protocol Deviation|0|||
27556826|NCT00531050|80226080|FG003|Part 1: Period 1|Protocol Deviation|1|||
27556827|NCT00531050|80226081|FG004|Part 1: Period 1|Protocol Deviation|0|||
27556828|NCT00531050|80226082|FG005|Part 1: Period 1|Protocol Deviation|0|||
27827350|NCT00927069|81199009|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
27556829|NCT00531050|80226077|FG000|Part 1: Period 3|Adverse Event|1|||
27556830|NCT00531050|80226078|FG001|Part 1: Period 3|Adverse Event|0|||
27556831|NCT00531050|80226079|FG002|Part 1: Period 3|Adverse Event|0|||
27827351|NCT00927069|81199010|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
27827352|NCT00927069|81199007|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
27827353|NCT00927069|81199008|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
27827354|NCT00927069|81199009|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
27556832|NCT00531050|80226080|FG003|Part 1: Period 3|Adverse Event|0|||
27827355|NCT00927069|81199010|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
27827356|NCT00927069|81199007|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
27827357|NCT00927069|81199008|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
27827358|NCT00927069|81199009|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
27827359|NCT00927069|81199010|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
27827360|NCT01913405|81199011|FG000|Overall Study|Withdrawal by Subject|1|||
27827361|NCT01913405|81199011|FG000|Overall Study|Adverse Event|1|||
27827362|NCT02186821|81199012|FG000|Overall Study|Adverse Event|9|||
27827363|NCT02186821|81199012|FG000|Overall Study|Death|2|||
27827364|NCT02186821|81199012|FG000|Overall Study|Disease progression|32|||
27827365|NCT02186821|81199012|FG000|Overall Study|Protocol Violation|1|||
27827366|NCT02186821|81199012|FG000|Overall Study|Physician Decision|1|||
27827367|NCT02186821|81199012|FG000|Overall Study|Study terminated by sponsor|2|||
27827368|NCT03803774|81199013|FG000|Dose Escalation|Withdrawal by Subject|0|||
27827369|NCT03803774|81199014|FG001|Dose Escalation|Withdrawal by Subject|0|||
27556833|NCT00531050|80226081|FG004|Part 1: Period 3|Adverse Event|0|||
27827370|NCT03803774|81199015|FG002|Dose Escalation|Withdrawal by Subject|0|||
27556834|NCT00531050|80226082|FG005|Part 1: Period 3|Adverse Event|0|||
27556835|NCT00531050|80226077|FG000|Part 2: Period 1|Adverse Event|0|||
27556836|NCT00531050|80226078|FG001|Part 2: Period 1|Adverse Event|0|||
27696913|NCT03057977|80727179|FG000|Discontinuation From Treatment|Not treated|4|||
27827371|NCT03803774|81199016|FG003|Dose Escalation|Withdrawal by Subject|1|||
27556837|NCT00531050|80226079|FG002|Part 2: Period 1|Adverse Event|0|||
27556838|NCT00531050|80226080|FG003|Part 2: Period 1|Adverse Event|0|||
27827372|NCT03803774|81199017|FG004|Dose Escalation|Withdrawal by Subject|0|||
27827373|NCT00905346|81199021|FG000|Period 1|Withdrawal by Subject|1|||
27827374|NCT00905346|81199022|FG001|Period 1|Withdrawal by Subject|0|||
27827375|NCT03792477|81199023|FG000|Overall Study|Adverse Event|0|||
27827376|NCT03792477|81199024|FG001|Overall Study|Adverse Event|0|||
27827377|NCT03792477|81199025|FG002|Overall Study|Adverse Event|0|||
27827378|NCT03792477|81199026|FG003|Overall Study|Adverse Event|1|||
27827379|NCT03792477|81199027|FG004|Overall Study|Adverse Event|0|||
27827380|NCT03792477|81199023|FG000|Overall Study|Lost to Follow-up|0|||
27827381|NCT03792477|81199024|FG001|Overall Study|Lost to Follow-up|0|||
27827382|NCT03792477|81199025|FG002|Overall Study|Lost to Follow-up|2|||
27827383|NCT03792477|81199026|FG003|Overall Study|Lost to Follow-up|0|||
27827384|NCT03792477|81199027|FG004|Overall Study|Lost to Follow-up|0|||
27827385|NCT03792477|81199023|FG000|Overall Study|Other|0|||
27827386|NCT03792477|81199024|FG001|Overall Study|Other|0|||
27827387|NCT03792477|81199025|FG002|Overall Study|Other|0|||
27827388|NCT03792477|81199026|FG003|Overall Study|Other|0|||
27827389|NCT03792477|81199027|FG004|Overall Study|Other|1|||
27827390|NCT00723710|81199028|FG000|Overall Study|Disease progression|48|||
27827391|NCT00723710|81199028|FG000|Overall Study|Adverse Event|88|||
27827392|NCT00723710|81199028|FG000|Overall Study|Withdrawal by Subject|36|||
27556839|NCT00531050|80226081|FG004|Part 2: Period 1|Adverse Event|0|||
27556840|NCT00531050|80226082|FG005|Part 2: Period 1|Adverse Event|1|||
27556841|NCT00531050|80226077|FG000|Part 2: Period 3|Abnormal test procedure|1|||
27556842|NCT00531050|80226078|FG001|Part 2: Period 3|Abnormal test procedure|0|||
27556843|NCT00531050|80226079|FG002|Part 2: Period 3|Abnormal test procedure|0|||
27556844|NCT00531050|80226080|FG003|Part 2: Period 3|Abnormal test procedure|0|||
27556845|NCT00531050|80226081|FG004|Part 2: Period 3|Abnormal test procedure|0|||
27556846|NCT00531050|80226082|FG005|Part 2: Period 3|Abnormal test procedure|1|||
27556847|NCT01286012|80226086|FG000|Overall Study|Adverse Event|3|||
27556848|NCT01286012|80226087|FG001|Overall Study|Adverse Event|3|||
27556849|NCT01286012|80226086|FG000|Overall Study|Death|2|||
27556850|NCT01286012|80226087|FG001|Overall Study|Death|3|||
27556851|NCT01286012|80226086|FG000|Overall Study|Protocol Violation|1|||
27556852|NCT01286012|80226087|FG001|Overall Study|Protocol Violation|1|||
27556853|NCT01286012|80226086|FG000|Overall Study|Withdrawal by Subject|4|||
27556854|NCT01286012|80226087|FG001|Overall Study|Withdrawal by Subject|4|||
27556855|NCT01286012|80226086|FG000|Overall Study|Physician Decision|2|||
27827393|NCT00723710|81199028|FG000|Overall Study|Physician Decision|2|||
27827394|NCT02321098|81199029|FG000|12 Weeks Treament|Lost to Follow-up|1|||
27827395|NCT02321098|81199030|FG001|12 Weeks Treament|Lost to Follow-up|1|||
27556856|NCT01286012|80226087|FG001|Overall Study|Physician Decision|0|||
27556857|NCT01286012|80226086|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
27827396|NCT02321098|81199031|FG002|12 Weeks Treament|Lost to Follow-up|0|||
27556858|NCT01286012|80226087|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
27556859|NCT01957644|80226088|FG000|Overall Study|Adverse Event|4|||
27556860|NCT01957644|80226089|FG001|Overall Study|Adverse Event|2|||
27827397|NCT02321098|81199029|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
27827398|NCT02321098|81199030|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
27556861|NCT01957644|80226090|FG002|Overall Study|Adverse Event|0|||
27883967|NCT00723008|81408110|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
27883968|NCT00723008|81408109|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
27556862|NCT01957644|80226091|FG003|Overall Study|Adverse Event|0|||
27556863|NCT01957644|80226092|FG004|Overall Study|Adverse Event|1|||
27556864|NCT01957644|80226088|FG000|Overall Study|Progressive disease / relapse|0|||
27556865|NCT01957644|80226089|FG001|Overall Study|Progressive disease / relapse|1|||
27556866|NCT01957644|80226090|FG002|Overall Study|Progressive disease / relapse|0|||
27556867|NCT01957644|80226091|FG003|Overall Study|Progressive disease / relapse|1|||
27556868|NCT01957644|80226092|FG004|Overall Study|Progressive disease / relapse|0|||
27556869|NCT01957644|80226088|FG000|Overall Study|Other reason|1|||
27556870|NCT01957644|80226089|FG001|Overall Study|Other reason|2|||
27556871|NCT01957644|80226090|FG002|Overall Study|Other reason|1|||
27827399|NCT02321098|81199031|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
27827400|NCT02321098|81199029|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
27827401|NCT02321098|81199030|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
27827402|NCT02321098|81199031|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
27696914|NCT03057977|80727180|FG001|Discontinuation From Treatment|Not treated|0|||
27827403|NCT02321098|81199029|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
27827404|NCT02321098|81199030|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
27556872|NCT01957644|80226091|FG003|Overall Study|Other reason|1|||
27556873|NCT01957644|80226092|FG004|Overall Study|Other reason|0|||
27556874|NCT01957644|80226088|FG000|Overall Study|Withdrawal by Subject|1|||
27556875|NCT01957644|80226089|FG001|Overall Study|Withdrawal by Subject|0|||
27556876|NCT01957644|80226090|FG002|Overall Study|Withdrawal by Subject|0|||
27556877|NCT01957644|80226091|FG003|Overall Study|Withdrawal by Subject|0|||
27696915|NCT03057977|80727179|FG000|Discontinuation From Treatment|Adverse Event|343|||
27696916|NCT03057977|80727180|FG001|Discontinuation From Treatment|Adverse Event|337|||
27696917|NCT03057977|80727179|FG000|Discontinuation From Treatment|Reason Unknown|0|||
27696918|NCT03057977|80727180|FG001|Discontinuation From Treatment|Reason Unknown|1|||
27696919|NCT03057977|80727179|FG000|Discontinuation From Treatment|Personal Reasons|1|||
27696920|NCT03057977|80727180|FG001|Discontinuation From Treatment|Personal Reasons|1|||
27696921|NCT03057977|80727179|FG000|Discontinuation From Treatment|Unblinded medication|1|||
27696922|NCT03057977|80727180|FG001|Discontinuation From Treatment|Unblinded medication|0|||
27696923|NCT03057977|80727179|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
27696924|NCT03057977|80727180|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
27696925|NCT03057977|80727179|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
27696926|NCT03057977|80727180|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
27696927|NCT03057977|80727179|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
27696928|NCT03057977|80727180|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
27696929|NCT03057977|80727179|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
27556878|NCT01957644|80226092|FG004|Overall Study|Withdrawal by Subject|0|||
27556879|NCT01957644|80226088|FG000|Overall Study|Protocol Violation|0|||
27556880|NCT01957644|80226089|FG001|Overall Study|Protocol Violation|1|||
27556881|NCT01957644|80226090|FG002|Overall Study|Protocol Violation|0|||
27556882|NCT01957644|80226091|FG003|Overall Study|Protocol Violation|0|||
27556883|NCT01957644|80226092|FG004|Overall Study|Protocol Violation|0|||
27556884|NCT01961323|80226094|FG000|Overall Study|Withdrawal by Subject|7|||
27556885|NCT01961323|80226094|FG000|Overall Study|Lost to Follow-up|8|||
27556886|NCT01961323|80226094|FG000|Overall Study|screen failure|34|||
27556887|NCT00518986|80226095|FG000|Overall Study|Adverse Event|12|||
27556888|NCT00518986|80226096|FG001|Overall Study|Adverse Event|7|||
27556889|NCT00518986|80226095|FG000|Overall Study|Lack of Efficacy|0|||
27556890|NCT00518986|80226096|FG001|Overall Study|Lack of Efficacy|2|||
27556891|NCT00518986|80226095|FG000|Overall Study|Lost to Follow-up|3|||
27556892|NCT00518986|80226096|FG001|Overall Study|Lost to Follow-up|2|||
27696930|NCT03057977|80727180|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
27556893|NCT00518986|80226095|FG000|Overall Study|Physician Decision|0|||
27556894|NCT00518986|80226096|FG001|Overall Study|Physician Decision|3|||
27556895|NCT00518986|80226095|FG000|Overall Study|Protocol Violation|5|||
27556896|NCT00518986|80226096|FG001|Overall Study|Protocol Violation|7|||
27696931|NCT03057977|80727179|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
27696932|NCT03057977|80727180|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
27696933|NCT03057977|80727179|FG000|Discontinuation From Treatment|Not attending study visit|3|||
27696934|NCT03057977|80727180|FG001|Discontinuation From Treatment|Not attending study visit|10|||
27696935|NCT03057977|80727179|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
27696936|NCT03057977|80727180|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
27696937|NCT03057977|80727179|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
27696938|NCT03057977|80727180|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
27696939|NCT03057977|80727179|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
27696940|NCT03057977|80727180|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
27696941|NCT03057977|80727179|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
27696942|NCT03057977|80727180|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
27696943|NCT03057977|80727179|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
27696944|NCT03057977|80727180|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
27696945|NCT00639223|80727181|FG000|Overall Study|Lost to Follow-up|0|||
27696946|NCT00639223|80727182|FG001|Overall Study|Lost to Follow-up|2|||
27696947|NCT02359877|80727191|FG000|Overall Study|Withdrawal by Subject|1|||
27696948|NCT02359877|80727192|FG001|Overall Study|Withdrawal by Subject|0|||
27696949|NCT02359877|80727193|FG002|Overall Study|Withdrawal by Subject|0|||
27696950|NCT02359877|80727194|FG003|Overall Study|Withdrawal by Subject|2|||
27696951|NCT02359877|80727191|FG000|Overall Study|Adverse Event|0|||
27696952|NCT02359877|80727192|FG001|Overall Study|Adverse Event|0|||
27696953|NCT02359877|80727193|FG002|Overall Study|Adverse Event|0|||
27696954|NCT02359877|80727194|FG003|Overall Study|Adverse Event|1|||
27696955|NCT01139658|80727195|FG000|Overall Study|Adverse Event|10|||
27696956|NCT01139658|80727196|FG001|Overall Study|Adverse Event|27|||
27696957|NCT01139658|80727195|FG000|Overall Study|Lack of Efficacy|15|||
27696958|NCT01139658|80727196|FG001|Overall Study|Lack of Efficacy|7|||
27696959|NCT01139658|80727195|FG000|Overall Study|Withdrawal by Subject|2|||
27696960|NCT01139658|80727196|FG001|Overall Study|Withdrawal by Subject|4|||
27696961|NCT01139658|80727195|FG000|Overall Study|No documentation of treatment|1|||
27696962|NCT01139658|80727196|FG001|Overall Study|No documentation of treatment|0|||
27696963|NCT01139658|80727195|FG000|Overall Study|Other|28|||
27696964|NCT01139658|80727196|FG001|Overall Study|Other|75|||
27696965|NCT01592864|80727197|FG000|Overall Study|Withdrawal by Subject|0|||
27696966|NCT01592864|80727198|FG001|Overall Study|Withdrawal by Subject|1|||
27696967|NCT00985166|80727201|FG000|Overall Study|Lost to Follow-up|3|||
27696968|NCT00985166|80727202|FG001|Overall Study|Lost to Follow-up|2|||
27696969|NCT00985166|80727203|FG002|Overall Study|Lost to Follow-up|2|||
27696970|NCT00985166|80727201|FG000|Overall Study|Withdrawal by Subject|3|||
27696971|NCT00985166|80727202|FG001|Overall Study|Withdrawal by Subject|2|||
27696972|NCT00985166|80727203|FG002|Overall Study|Withdrawal by Subject|0|||
27696973|NCT00985166|80727201|FG000|Overall Study|Test not done|2|||
27696974|NCT00985166|80727202|FG001|Overall Study|Test not done|0|||
27696975|NCT00985166|80727203|FG002|Overall Study|Test not done|4|||
27696976|NCT00985166|80727201|FG000|Overall Study|Other|1|||
27696977|NCT00985166|80727202|FG001|Overall Study|Other|0|||
27696978|NCT00985166|80727203|FG002|Overall Study|Other|1|||
27696979|NCT02683941|80727204|FG000|Double-blind Phase|Adverse Event|0|||
27696980|NCT02683941|80727205|FG001|Double-blind Phase|Adverse Event|1|||
27696981|NCT02683941|80727204|FG000|Double-blind Phase|Withdrawal by Subject|4|||
27696982|NCT02683941|80727205|FG001|Double-blind Phase|Withdrawal by Subject|2|||
27696983|NCT02683941|80727204|FG000|Double-blind Phase|Lost to Follow-up|1|||
27696984|NCT02683941|80727205|FG001|Double-blind Phase|Lost to Follow-up|0|||
27696985|NCT02683941|80727204|FG000|Double-blind Phase|Disease Progression|5|||
27696986|NCT02683941|80727205|FG001|Double-blind Phase|Disease Progression|2|||
27696987|NCT02683941|80727204|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
27696988|NCT02683941|80727205|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
27696989|NCT02683941|80727204|FG000|Open-label Treatment Phase|Disease Progression|1|||
27696990|NCT02683941|80727205|FG001|Open-label Treatment Phase|Disease Progression|2|||
27696991|NCT02683941|80727204|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
27696992|NCT02683941|80727205|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
27696993|NCT02683941|80727204|FG000|Open-label Treatment Phase|Other|1|||
27696994|NCT02683941|80727205|FG001|Open-label Treatment Phase|Other|0|||
27696995|NCT02683941|80727204|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
27696996|NCT02683941|80727205|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
27696997|NCT02683941|80727204|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
27696998|NCT02683941|80727205|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
27696999|NCT02683941|80727204|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
27827405|NCT02321098|81199031|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
27827406|NCT03769025|81199032|FG000|Overall Study|Withdrawal by Subject|1|||
27827407|NCT03769025|81199033|FG001|Overall Study|Withdrawal by Subject|1|||
27827408|NCT03769025|81199032|FG000|Overall Study|Lost to Follow-up|4|||
27697000|NCT02683941|80727205|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
27697001|NCT02683941|80727204|FG000|Open-label Follow-up Phase|Other|8|||
27697002|NCT02683941|80727205|FG001|Open-label Follow-up Phase|Other|1|||
27697003|NCT01020448|80727207|FG000|Pre-assignment|Adverse Event|6|||
27697004|NCT01020448|80727207|FG000|Pre-assignment|Withdrawal by Subject|5|||
27697005|NCT01020448|80727207|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
27697006|NCT01020448|80727207|FG000|Treatment|Adverse Event|11|||
27697007|NCT01020448|80727207|FG000|Treatment|Consent Withdrawn|3|||
27697008|NCT01020448|80727207|FG000|Treatment|Disease Progression|2|||
27697009|NCT01020448|80727207|FG000|Treatment|Lack of Efficacy|8|||
27697010|NCT01020448|80727207|FG000|Treatment|Lost to Follow-up|2|||
27697011|NCT04484831|80727209|FG000|Overall Study|Withdrawal by Subject|1|||
27697012|NCT04484831|80727210|FG001|Overall Study|Withdrawal by Subject|0|||
27697013|NCT01716117|80727211|FG000|Overall Study|Death|5|||
27697014|NCT01716117|80727212|FG001|Overall Study|Death|2|||
27697015|NCT01716117|80727211|FG000|Overall Study|Withdrawal by Subject|2|||
27697016|NCT01716117|80727212|FG001|Overall Study|Withdrawal by Subject|0|||
27697017|NCT01794923|80727221|FG000|Overall Study|Adverse Event|0|||
27697018|NCT01794923|80727222|FG001|Overall Study|Adverse Event|0|||
27697019|NCT01794923|80727223|FG002|Overall Study|Adverse Event|1|||
27697020|NCT01395316|80727224|FG000|Overall Study|Lost to Follow-up|2|||
27697021|NCT01395316|80727224|FG000|Overall Study|poor MRI quality|1|||
27697022|NCT01637623|80727225|FG000|Overall Study|Lost to Follow-up|0|||
27697023|NCT01637623|80727226|FG001|Overall Study|Lost to Follow-up|0|||
27697024|NCT01637623|80727227|FG002|Overall Study|Lost to Follow-up|2|||
27697025|NCT01637623|80727225|FG000|Overall Study|Physician Decision|1|||
27697026|NCT01637623|80727226|FG001|Overall Study|Physician Decision|0|||
27697027|NCT01637623|80727227|FG002|Overall Study|Physician Decision|1|||
27697028|NCT00975507|80727228|FG000|Overall Study|Adverse Event|1|||
27697029|NCT00975507|80727229|FG001|Overall Study|Adverse Event|0|||
27697030|NCT00975507|80727228|FG000|Overall Study|Lost to Follow-up|7|||
27556897|NCT00518986|80226095|FG000|Overall Study|Withdrawal by Subject|4|||
27556898|NCT00518986|80226096|FG001|Overall Study|Withdrawal by Subject|4|||
27556899|NCT00518986|80226095|FG000|Overall Study|Non-Specific|2|||
27556900|NCT00518986|80226096|FG001|Overall Study|Non-Specific|1|||
27556901|NCT03226392|80226097|FG000|Overall Study|Protocol Deviation|1|||
27556902|NCT03226392|80226098|FG001|Overall Study|Protocol Deviation|0|||
27556903|NCT03226392|80226097|FG000|Overall Study|Physician Decision|1|||
27556904|NCT03226392|80226098|FG001|Overall Study|Physician Decision|0|||
27556905|NCT03226392|80226097|FG000|Overall Study|Lost to Follow-up|1|||
27556906|NCT03226392|80226098|FG001|Overall Study|Lost to Follow-up|0|||
27556907|NCT03226392|80226097|FG000|Overall Study|Adverse Event|1|||
27556908|NCT03226392|80226098|FG001|Overall Study|Adverse Event|0|||
27556909|NCT03226392|80226097|FG000|Overall Study|Technical Problems|0|||
27556910|NCT03226392|80226098|FG001|Overall Study|Technical Problems|2|||
27556911|NCT03226392|80226097|FG000|Overall Study|Subject/Guardian Decision|7|||
27556912|NCT03226392|80226098|FG001|Overall Study|Subject/Guardian Decision|6|||
27556913|NCT01980992|80226099|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
27556914|NCT01980992|80226100|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
27556915|NCT01980992|80226099|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
27556916|NCT01980992|80226100|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
27556917|NCT01980992|80226099|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
27556918|NCT01980992|80226100|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
27697031|NCT00975507|80727229|FG001|Overall Study|Lost to Follow-up|1|||
27556919|NCT01980992|80226099|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
27697032|NCT00975507|80727228|FG000|Overall Study|Protocol Violation|2|||
27697033|NCT00975507|80727229|FG001|Overall Study|Protocol Violation|0|||
27697034|NCT00975507|80727228|FG000|Overall Study|Withdrawal by Subject|10|||
27697035|NCT00975507|80727229|FG001|Overall Study|Withdrawal by Subject|3|||
27697036|NCT05220254|80727230|FG000|Overall Study|Withdrawal by Subject|4|||
27697037|NCT05220254|80727230|FG000|Overall Study|Removed due to ineligibility|1|||
27697038|NCT05220254|80727230|FG000|Overall Study|Lost to Follow-up|7|||
27556920|NCT01980992|80226100|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
27556921|NCT01980992|80226099|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
27556922|NCT01980992|80226100|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
27556923|NCT01980992|80226099|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
27556924|NCT01980992|80226100|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
27697039|NCT02038920|80727231|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
27697040|NCT02038920|80727232|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
27697041|NCT02038920|80727233|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27697042|NCT02038920|80727234|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27697043|NCT02038920|80727235|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27697044|NCT02038920|80727236|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
27697045|NCT02038920|80727231|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
27697046|NCT02038920|80727232|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27697047|NCT02038920|80727233|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27697048|NCT02038920|80727234|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27697049|NCT02038920|80727235|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27697050|NCT02038920|80727236|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
27697051|NCT02038920|80727231|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
27697052|NCT02038920|80727232|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
27556925|NCT04977583|80226101|FG000|Overall Study|Lost to Follow-up|8|||
27556926|NCT04977583|80226102|FG001|Overall Study|Lost to Follow-up|4|||
27556927|NCT04977583|80226103|FG002|Overall Study|Lost to Follow-up|13|||
27556928|NCT04977583|80226101|FG000|Overall Study|Withdrawal by Subject|3|||
27697053|NCT02038920|80727233|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27556929|NCT04977583|80226102|FG001|Overall Study|Withdrawal by Subject|2|||
27697054|NCT02038920|80727234|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27697055|NCT02038920|80727235|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27697056|NCT02038920|80727236|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
27697057|NCT02038920|80727231|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
27827409|NCT03769025|81199033|FG001|Overall Study|Lost to Follow-up|3|||
27827410|NCT04827394|81199034|FG000|Overall Study|Physician Decision|0|||
27556930|NCT04977583|80226103|FG002|Overall Study|Withdrawal by Subject|1|||
27697058|NCT02038920|80727232|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
27697059|NCT02038920|80727233|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
27697060|NCT02038920|80727234|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
27827411|NCT04827394|81199035|FG001|Overall Study|Physician Decision|2|||
27827412|NCT00469417|81199036|FG000|Overall Study|Treatment failure all lesions|18|||
27827413|NCT00469417|81199037|FG001|Overall Study|Treatment failure all lesions|11|||
27827414|NCT00469417|81199036|FG000|Overall Study|Consent withdrawn|1|||
27827415|NCT00469417|81199037|FG001|Overall Study|Consent withdrawn|1|||
27827416|NCT00469417|81199036|FG000|Overall Study|Adverse Event|8|||
27827417|NCT00469417|81199037|FG001|Overall Study|Adverse Event|2|||
27827418|NCT00469417|81199036|FG000|Overall Study|Lost to Follow-up|1|||
27883969|NCT00723008|81408110|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
27883970|NCT00723008|81408109|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
27556931|NCT04481750|80226107|FG000|Period 1 (Fasted)|Adverse Event|0|||
27697061|NCT02038920|80727235|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
27697062|NCT02038920|80727236|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
27697063|NCT02038920|80727231|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27697064|NCT02038920|80727232|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27697065|NCT02038920|80727233|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
27697066|NCT02038920|80727234|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27697067|NCT02038920|80727235|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27556932|NCT04481750|80226108|FG001|Period 1 (Fasted)|Adverse Event|0|||
27556933|NCT04481750|80226109|FG002|Period 1 (Fasted)|Adverse Event|1|||
27556934|NCT04481750|80226110|FG003|Period 1 (Fasted)|Adverse Event|0|||
27556935|NCT04481750|80226111|FG004|Period 1 (Fasted)|Adverse Event|0|||
27556936|NCT04481750|80226112|FG005|Period 1 (Fasted)|Adverse Event|0|||
27556937|NCT04481750|80226113|FG006|Period 1 (Fasted)|Adverse Event|0|||
27556938|NCT04481750|80226114|FG007|Period 1 (Fasted)|Adverse Event|0|||
27556939|NCT04481750|80226115|FG008|Period 1 (Fasted)|Adverse Event|0|||
27556940|NCT04481750|80226116|FG009|Period 1 (Fasted)|Adverse Event|0|||
27556941|NCT04481750|80226117|FG010|Period 1 (Fasted)|Adverse Event|0|||
27556942|NCT00461682|80226118|FG000|Overall Study|Protocol Violation|1|||
27556943|NCT04326231|80226119|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
27556944|NCT02289690|80226120|FG000|Overall Study|Adverse Event Related to Progression|0|||
27556945|NCT02289690|80226121|FG001|Overall Study|Adverse Event Related to Progression|1|||
27556946|NCT02289690|80226122|FG002|Overall Study|Adverse Event Related to Progression|1|||
27556947|NCT02289690|80226123|FG003|Overall Study|Adverse Event Related to Progression|0|||
27556948|NCT02289690|80226124|FG004|Overall Study|Adverse Event Related to Progression|1|||
27556949|NCT02289690|80226125|FG005|Overall Study|Adverse Event Related to Progression|0|||
27556950|NCT02289690|80226126|FG006|Overall Study|Adverse Event Related to Progression|1|||
27556951|NCT02289690|80226127|FG007|Overall Study|Adverse Event Related to Progression|0|||
27556952|NCT02289690|80226128|FG008|Overall Study|Adverse Event Related to Progression|0|||
27556953|NCT02289690|80226129|FG009|Overall Study|Adverse Event Related to Progression|0|||
27697068|NCT02038920|80727236|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
27697069|NCT02038920|80727231|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
27697070|NCT02038920|80727232|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
27697071|NCT02038920|80727233|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
27556954|NCT02289690|80226120|FG000|Overall Study|Withdrawal by Subject|1|||
27556955|NCT02289690|80226121|FG001|Overall Study|Withdrawal by Subject|0|||
27556956|NCT02289690|80226122|FG002|Overall Study|Withdrawal by Subject|0|||
27556957|NCT02289690|80226123|FG003|Overall Study|Withdrawal by Subject|0|||
27556958|NCT02289690|80226124|FG004|Overall Study|Withdrawal by Subject|1|||
27556959|NCT02289690|80226125|FG005|Overall Study|Withdrawal by Subject|1|||
27556960|NCT02289690|80226126|FG006|Overall Study|Withdrawal by Subject|0|||
27556961|NCT02289690|80226127|FG007|Overall Study|Withdrawal by Subject|0|||
27556962|NCT02289690|80226128|FG008|Overall Study|Withdrawal by Subject|4|||
27556963|NCT02289690|80226129|FG009|Overall Study|Withdrawal by Subject|2|||
27556964|NCT02289690|80226120|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
27556965|NCT02289690|80226121|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
27556966|NCT02289690|80226122|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
27556967|NCT02289690|80226123|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
27556968|NCT02289690|80226124|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
27556969|NCT02289690|80226125|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
27556970|NCT02289690|80226126|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
27556971|NCT02289690|80226127|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
27556972|NCT02289690|80226128|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
27556973|NCT02289690|80226129|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
27556974|NCT02289690|80226120|FG000|Overall Study|Lost to Follow-up|0|||
27556975|NCT02289690|80226121|FG001|Overall Study|Lost to Follow-up|0|||
27556976|NCT02289690|80226122|FG002|Overall Study|Lost to Follow-up|0|||
27556977|NCT02289690|80226123|FG003|Overall Study|Lost to Follow-up|0|||
27556978|NCT02289690|80226124|FG004|Overall Study|Lost to Follow-up|0|||
27556979|NCT02289690|80226125|FG005|Overall Study|Lost to Follow-up|0|||
27556980|NCT02289690|80226126|FG006|Overall Study|Lost to Follow-up|0|||
27556981|NCT02289690|80226127|FG007|Overall Study|Lost to Follow-up|1|||
27556982|NCT02289690|80226128|FG008|Overall Study|Lost to Follow-up|0|||
27556983|NCT02289690|80226129|FG009|Overall Study|Lost to Follow-up|2|||
27556984|NCT02289690|80226120|FG000|Overall Study|Death|0|||
27556985|NCT02289690|80226121|FG001|Overall Study|Death|0|||
27556986|NCT02289690|80226122|FG002|Overall Study|Death|0|||
27556987|NCT02289690|80226123|FG003|Overall Study|Death|0|||
27556988|NCT02289690|80226124|FG004|Overall Study|Death|0|||
27556989|NCT02289690|80226125|FG005|Overall Study|Death|0|||
27556990|NCT02289690|80226126|FG006|Overall Study|Death|0|||
27556991|NCT02289690|80226127|FG007|Overall Study|Death|49|||
27827419|NCT00469417|81199037|FG001|Overall Study|Lost to Follow-up|2|||
27827420|NCT00469417|81199036|FG000|Overall Study|Intercurrent disease|0|||
27827421|NCT00469417|81199037|FG001|Overall Study|Intercurrent disease|1|||
27827422|NCT00469417|81199036|FG000|Overall Study|Randomized but not treated|2|||
27827423|NCT00469417|81199037|FG001|Overall Study|Randomized but not treated|0|||
27827424|NCT01926119|81199041|FG000|Overall Study|Withdrawal by Subject|1|||
27827425|NCT01705574|81199042|FG000|Double-Blind Phase|Lost to Follow-up|12|||
27827426|NCT01705574|81199043|FG001|Double-Blind Phase|Lost to Follow-up|16|||
27556992|NCT02289690|80226128|FG008|Overall Study|Death|45|||
27556993|NCT02289690|80226129|FG009|Overall Study|Death|41|||
27556994|NCT02289690|80226120|FG000|Overall Study|Sponsor Discontinued Study|0|||
27556995|NCT02289690|80226121|FG001|Overall Study|Sponsor Discontinued Study|0|||
27556996|NCT02289690|80226122|FG002|Overall Study|Sponsor Discontinued Study|0|||
27556997|NCT02289690|80226123|FG003|Overall Study|Sponsor Discontinued Study|0|||
27556998|NCT02289690|80226124|FG004|Overall Study|Sponsor Discontinued Study|0|||
27556999|NCT02289690|80226125|FG005|Overall Study|Sponsor Discontinued Study|0|||
27557000|NCT02289690|80226126|FG006|Overall Study|Sponsor Discontinued Study|0|||
27827427|NCT01705574|81199044|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27827428|NCT01705574|81199045|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27557001|NCT02289690|80226127|FG007|Overall Study|Sponsor Discontinued Study|9|||
27827429|NCT01705574|81199042|FG000|Double-Blind Phase|Adverse Event|3|||
27557002|NCT02289690|80226128|FG008|Overall Study|Sponsor Discontinued Study|7|||
27827430|NCT01705574|81199043|FG001|Double-Blind Phase|Adverse Event|10|||
27827431|NCT01705574|81199044|FG002|Double-Blind Phase|Adverse Event|0|||
27827432|NCT01705574|81199045|FG003|Double-Blind Phase|Adverse Event|0|||
27827433|NCT01705574|81199042|FG000|Double-Blind Phase|Withdrew Consent|8|||
27827434|NCT01705574|81199043|FG001|Double-Blind Phase|Withdrew Consent|5|||
27827435|NCT01705574|81199044|FG002|Double-Blind Phase|Withdrew Consent|0|||
27827436|NCT01705574|81199045|FG003|Double-Blind Phase|Withdrew Consent|0|||
27827437|NCT01705574|81199042|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
27827438|NCT01705574|81199043|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
27827439|NCT01705574|81199044|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
27827440|NCT01705574|81199045|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
27827441|NCT01705574|81199042|FG000|Double-Blind Phase|Pregnancy|1|||
27827442|NCT01705574|81199043|FG001|Double-Blind Phase|Pregnancy|1|||
27827443|NCT01705574|81199044|FG002|Double-Blind Phase|Pregnancy|0|||
27827444|NCT01705574|81199045|FG003|Double-Blind Phase|Pregnancy|0|||
27827445|NCT01705574|81199042|FG000|Double-Blind Phase|Protocol Violation|1|||
27827446|NCT01705574|81199043|FG001|Double-Blind Phase|Protocol Violation|0|||
27827447|NCT01705574|81199044|FG002|Double-Blind Phase|Protocol Violation|0|||
27827448|NCT01705574|81199045|FG003|Double-Blind Phase|Protocol Violation|0|||
27827449|NCT01705574|81199042|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
27827450|NCT01705574|81199043|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
27827451|NCT01705574|81199044|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
27827452|NCT01705574|81199045|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
27827453|NCT01705574|81199042|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
27827454|NCT01705574|81199043|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27827455|NCT01705574|81199044|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
27827456|NCT01705574|81199045|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
27827457|NCT01705574|81199042|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
27827458|NCT01705574|81199043|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
27827459|NCT01705574|81199044|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
27827460|NCT01705574|81199045|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
27827461|NCT01705574|81199042|FG000|Open-Label Extension Phase|Adverse Event|3|||
27827462|NCT01705574|81199043|FG001|Open-Label Extension Phase|Adverse Event|0|||
27827463|NCT01705574|81199044|FG002|Open-Label Extension Phase|Adverse Event|0|||
27827464|NCT01705574|81199045|FG003|Open-Label Extension Phase|Adverse Event|1|||
27827465|NCT01705574|81199042|FG000|Open-Label Extension Phase|Death|2|||
27827466|NCT01705574|81199043|FG001|Open-Label Extension Phase|Death|0|||
27827467|NCT01705574|81199044|FG002|Open-Label Extension Phase|Death|1|||
27827468|NCT01705574|81199045|FG003|Open-Label Extension Phase|Death|0|||
27827469|NCT01705574|81199042|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
27827470|NCT01705574|81199043|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
27827471|NCT01705574|81199044|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
27697072|NCT02038920|80727234|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
27697073|NCT02038920|80727235|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
27827472|NCT01705574|81199045|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
27827473|NCT01705574|81199042|FG000|Open-Label Extension Phase|Physician Decision|0|||
27827474|NCT01705574|81199043|FG001|Open-Label Extension Phase|Physician Decision|0|||
27827475|NCT01705574|81199044|FG002|Open-Label Extension Phase|Physician Decision|2|||
27827476|NCT01705574|81199045|FG003|Open-Label Extension Phase|Physician Decision|0|||
27827477|NCT01705574|81199042|FG000|Open-Label Extension Phase|Pregnancy|0|||
27827478|NCT01705574|81199043|FG001|Open-Label Extension Phase|Pregnancy|0|||
27827479|NCT01705574|81199044|FG002|Open-Label Extension Phase|Pregnancy|1|||
27827480|NCT01705574|81199045|FG003|Open-Label Extension Phase|Pregnancy|1|||
27827481|NCT02409355|81199049|FG000|Overall Study|Withdrawal by Subject|1|||
27827482|NCT02409355|81199050|FG001|Overall Study|Withdrawal by Subject|0|||
27827483|NCT02409355|81199049|FG000|Overall Study|Death|1|||
27827484|NCT02409355|81199050|FG001|Overall Study|Death|1|||
27827485|NCT02409355|81199049|FG000|Overall Study|Study terminated by Sponsor|2|||
27827486|NCT02409355|81199050|FG001|Overall Study|Study terminated by Sponsor|3|||
27827487|NCT01963728|81199051|FG000|Overall Study|Study terminated early|0|||
27827488|NCT01963728|81199052|FG001|Overall Study|Study terminated early|1|||
27827489|NCT01507051|81199053|FG000|Overall Study|Withdrawal by Subject|1|||
27827490|NCT01507051|81199054|FG001|Overall Study|Withdrawal by Subject|3|||
27827491|NCT01507051|81199055|FG002|Overall Study|Withdrawal by Subject|1|||
27827492|NCT01507051|81199056|FG003|Overall Study|Withdrawal by Subject|6|||
27827493|NCT01507051|81199053|FG000|Overall Study|Physician Decision|0|||
27827494|NCT01507051|81199054|FG001|Overall Study|Physician Decision|0|||
27827495|NCT01507051|81199055|FG002|Overall Study|Physician Decision|0|||
27827496|NCT01507051|81199056|FG003|Overall Study|Physician Decision|1|||
27827497|NCT01507051|81199053|FG000|Overall Study|Adverse Event|1|||
27827498|NCT01507051|81199054|FG001|Overall Study|Adverse Event|0|||
27827499|NCT01507051|81199055|FG002|Overall Study|Adverse Event|0|||
27827500|NCT01507051|81199056|FG003|Overall Study|Adverse Event|0|||
27827501|NCT01030133|81199057|FG000|Overall Study|failed to experience pain at level 7/10|2|||
27827502|NCT01030133|81199058|FG001|Overall Study|failed to experience pain at level 7/10|2|||
27827503|NCT02335658|81199059|FG000|Overall Study|Adverse Event|18|||
27827504|NCT02335658|81199060|FG001|Overall Study|Adverse Event|12|||
27827505|NCT02335658|81199059|FG000|Overall Study|Lack of Efficacy|4|||
27827506|NCT02335658|81199060|FG001|Overall Study|Lack of Efficacy|5|||
27827507|NCT02335658|81199059|FG000|Overall Study|Pregnancy|1|||
27827508|NCT02335658|81199060|FG001|Overall Study|Pregnancy|0|||
27827509|NCT02335658|81199059|FG000|Overall Study|Withdrawal by Subject|13|||
27827510|NCT02335658|81199060|FG001|Overall Study|Withdrawal by Subject|21|||
27827511|NCT02335658|81199059|FG000|Overall Study|non-compliance|2|||
27827512|NCT02335658|81199060|FG001|Overall Study|non-compliance|3|||
27827513|NCT02335658|81199059|FG000|Overall Study|other reason|2|||
27827514|NCT02335658|81199060|FG001|Overall Study|other reason|3|||
27827515|NCT00365846|81199065|FG000|Overall Study|Lost to Follow-up|1|||
27827516|NCT00731783|81199068|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
27827517|NCT00731783|81199069|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
27827518|NCT00731783|81199068|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
27827519|NCT00731783|81199069|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
27827520|NCT00731783|81199068|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
27827521|NCT00731783|81199069|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
27827522|NCT00731783|81199068|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
27827523|NCT00731783|81199069|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
27827524|NCT00834067|81199070|FG000|Washout of 21 Days|Protocol Violation|0|||
27827525|NCT00834067|81199071|FG001|Washout of 21 Days|Protocol Violation|1|||
27827526|NCT00682461|81199072|FG000|Overall Study|Adverse Event|5|||
27827527|NCT00682461|81199073|FG001|Overall Study|Adverse Event|7|||
27827528|NCT00682461|81199072|FG000|Overall Study|Lost to Follow-up|8|||
27827529|NCT00682461|81199073|FG001|Overall Study|Lost to Follow-up|5|||
27827530|NCT00682461|81199072|FG000|Overall Study|Withdrawal by Subject|12|||
27827531|NCT00682461|81199073|FG001|Overall Study|Withdrawal by Subject|19|||
27827532|NCT01838681|81199074|FG000|Period A|Adverse Event|39|||
27557003|NCT02289690|80226129|FG009|Overall Study|Sponsor Discontinued Study|15|||
27557004|NCT02289690|80226120|FG000|Overall Study|Other|0|||
27697074|NCT02038920|80727236|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
27827533|NCT01838681|81199075|FG001|Period A|Adverse Event|0|||
27827534|NCT01838681|81199076|FG002|Period A|Adverse Event|0|||
27827535|NCT01838681|81199077|FG003|Period A|Adverse Event|0|||
27827536|NCT01838681|81199074|FG000|Period A|Lack of Efficacy|21|||
27827537|NCT01838681|81199075|FG001|Period A|Lack of Efficacy|0|||
27827538|NCT01838681|81199076|FG002|Period A|Lack of Efficacy|0|||
27827539|NCT01838681|81199077|FG003|Period A|Lack of Efficacy|0|||
27827540|NCT01838681|81199074|FG000|Period A|Early response|148|||
27827541|NCT01838681|81199075|FG001|Period A|Early response|0|||
27827542|NCT01838681|81199076|FG002|Period A|Early response|0|||
27827543|NCT01838681|81199077|FG003|Period A|Early response|0|||
27827544|NCT01838681|81199074|FG000|Period A|Withdrawal by Subject|70|||
27557005|NCT02289690|80226121|FG001|Overall Study|Other|0|||
27557006|NCT02289690|80226122|FG002|Overall Study|Other|0|||
27557007|NCT02289690|80226123|FG003|Overall Study|Other|1|||
27557008|NCT02289690|80226124|FG004|Overall Study|Other|1|||
27557009|NCT02289690|80226125|FG005|Overall Study|Other|0|||
27557010|NCT02289690|80226126|FG006|Overall Study|Other|1|||
27557011|NCT02289690|80226127|FG007|Overall Study|Other|2|||
27557012|NCT02289690|80226128|FG008|Overall Study|Other|3|||
27557013|NCT02289690|80226129|FG009|Overall Study|Other|1|||
27557014|NCT00137423|80226132|FG000|Overall Study|Adverse Event|7|||
27557015|NCT00137423|80226133|FG001|Overall Study|Adverse Event|9|||
27557016|NCT00137423|80226132|FG000|Overall Study|consent withdrawn|1|||
27557017|NCT00137423|80226133|FG001|Overall Study|consent withdrawn|1|||
27557018|NCT00137423|80226132|FG000|Overall Study|Lack of Efficacy|31|||
27557019|NCT00137423|80226133|FG001|Overall Study|Lack of Efficacy|33|||
27557020|NCT00137423|80226132|FG000|Overall Study|Death|0|||
27557021|NCT00137423|80226133|FG001|Overall Study|Death|1|||
27557022|NCT02452398|80226134|FG000|Overall Study|Adverse Event|1|||
27557023|NCT02452398|80226134|FG000|Overall Study|Lost to Follow-up|28|||
27557024|NCT02452398|80226134|FG000|Overall Study|Physician Decision|2|||
27557025|NCT02452398|80226134|FG000|Overall Study|Withdrawal by Subject|6|||
27557026|NCT02452398|80226134|FG000|Overall Study|Moved away|4|||
27557027|NCT00467259|80226137|FG000|Overall Study|Adverse Event|24|||
27557028|NCT00467259|80226138|FG001|Overall Study|Adverse Event|90|||
27557029|NCT00467259|80226137|FG000|Overall Study|Protocol Violation|1|||
27557030|NCT00467259|80226138|FG001|Overall Study|Protocol Violation|7|||
27557031|NCT00467259|80226137|FG000|Overall Study|Withdrawal by Subject|34|||
27557032|NCT00467259|80226138|FG001|Overall Study|Withdrawal by Subject|108|||
27883971|NCT00723008|81408110|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
27883972|NCT00723008|81408109|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
27883973|NCT00723008|81408110|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
27883974|NCT02042950|81408111|FG000|Overall Study|Progressive Disease|4|||
27883975|NCT05107492|81408112|FG000|Overall Study|Lost to Follow-up|1|||
27883976|NCT05107492|81408113|FG001|Overall Study|Lost to Follow-up|0|||
27883977|NCT01436370|81408115|FG000|Overall Study|Lost to Follow-up|0|||
27883978|NCT01436370|81408116|FG001|Overall Study|Lost to Follow-up|0|||
27883979|NCT01436370|81408117|FG002|Overall Study|Lost to Follow-up|0|||
27883980|NCT01436370|81408118|FG003|Overall Study|Lost to Follow-up|0|||
27883981|NCT01436370|81408119|FG004|Overall Study|Lost to Follow-up|1|||
27557033|NCT00467259|80226137|FG000|Overall Study|Physician Decision|0|||
27557034|NCT00467259|80226138|FG001|Overall Study|Physician Decision|2|||
27557035|NCT00467259|80226137|FG000|Overall Study|Lost to Follow-up|14|||
27557036|NCT00467259|80226138|FG001|Overall Study|Lost to Follow-up|34|||
27883982|NCT01436370|81408120|FG005|Overall Study|Lost to Follow-up|0|||
27883983|NCT01436370|81408121|FG006|Overall Study|Lost to Follow-up|0|||
27883984|NCT01436370|81408122|FG007|Overall Study|Lost to Follow-up|0|||
27697075|NCT02038920|80727231|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27697076|NCT02038920|80727232|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27697077|NCT02038920|80727233|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27883985|NCT02112045|81408128|FG000|Overall Study|Withdrawal by Subject|1|||
27557037|NCT00467259|80226137|FG000|Overall Study|Site Closed|2|||
27883986|NCT02112045|81408129|FG001|Overall Study|Withdrawal by Subject|0|||
27883987|NCT02654977|81408130|FG000|Overall Study|Death|1|||
27883988|NCT02654977|81408130|FG000|Overall Study|Lost to Follow-up|1|||
27557038|NCT00467259|80226138|FG001|Overall Study|Site Closed|1|||
27557039|NCT02744391|80226139|FG000|Overall Study|Lost to Follow-up|9|||
27557040|NCT02744391|80226139|FG000|Overall Study|Physician Decision|2|||
27557041|NCT02744391|80226139|FG000|Overall Study|Withdrawal by Subject|3|||
27883989|NCT02654977|81408130|FG000|Overall Study|Adverse Event|1|||
27883990|NCT02654977|81408130|FG000|Overall Study|Withdrawal by Subject|1|||
27557042|NCT02157298|80226140|FG000|Overall Study|Adverse Event|1|||
27883991|NCT02654977|81408130|FG000|Overall Study|Lack of Efficacy|3|||
27883992|NCT04157296|81408131|FG000|Overall Study|Withdrawal by Subject|0|||
27883993|NCT04157296|81408132|FG001|Overall Study|Withdrawal by Subject|1|||
27557043|NCT02157298|80226141|FG001|Overall Study|Adverse Event|0|||
27557044|NCT02157298|80226140|FG000|Overall Study|Subject no longer meets study criteria|1|||
27557045|NCT02157298|80226141|FG001|Overall Study|Subject no longer meets study criteria|2|||
27557046|NCT02157298|80226140|FG000|Overall Study|Poor/Non-compliance|1|||
27557047|NCT02157298|80226141|FG001|Overall Study|Poor/Non-compliance|0|||
27557048|NCT02157298|80226140|FG000|Overall Study|Withdrawal by Subject|1|||
27557049|NCT02157298|80226141|FG001|Overall Study|Withdrawal by Subject|0|||
27557050|NCT00937157|80226142|FG000|Overall Study|Pregnancy|1|||
27557051|NCT00937157|80226142|FG000|Overall Study|Lost to Follow-up|3|||
27557052|NCT01506479|80226143|FG000|Overall Study|Lost to Follow-up|1|||
27557053|NCT01506479|80226144|FG001|Overall Study|Lost to Follow-up|2|||
27557054|NCT01506479|80226145|FG002|Overall Study|Lost to Follow-up|2|||
27883994|NCT04157296|81408131|FG000|Overall Study|Did not obtain second fMRI.|0|||
27883995|NCT04157296|81408132|FG001|Overall Study|Did not obtain second fMRI.|1|||
27883996|NCT04157296|81408131|FG000|Overall Study|MRI failed/no second fMRI|0|||
27883997|NCT04157296|81408132|FG001|Overall Study|MRI failed/no second fMRI|1|||
27883998|NCT00568061|81408133|FG000|Overall Study|Inclusion / exclusion criteria|5|||
27557055|NCT01506479|80226143|FG000|Overall Study|Withdrawal by Subject|1|||
27557056|NCT01506479|80226144|FG001|Overall Study|Withdrawal by Subject|2|||
27827545|NCT01838681|81199075|FG001|Period A|Withdrawal by Subject|0|||
27827546|NCT01838681|81199076|FG002|Period A|Withdrawal by Subject|0|||
27827547|NCT01838681|81199077|FG003|Period A|Withdrawal by Subject|0|||
27557057|NCT01506479|80226145|FG002|Overall Study|Withdrawal by Subject|1|||
27557058|NCT01506479|80226143|FG000|Overall Study|Missing assessment|1|||
27827548|NCT01838681|81199074|FG000|Period A|Protocol Violation|16|||
27827549|NCT01838681|81199075|FG001|Period A|Protocol Violation|0|||
27827550|NCT01838681|81199076|FG002|Period A|Protocol Violation|0|||
27827551|NCT01838681|81199077|FG003|Period A|Protocol Violation|0|||
27827552|NCT01838681|81199074|FG000|Period A|Non-compliance with IMP|6|||
27827553|NCT01838681|81199075|FG001|Period A|Non-compliance with IMP|0|||
27827554|NCT01838681|81199076|FG002|Period A|Non-compliance with IMP|0|||
27827555|NCT01838681|81199077|FG003|Period A|Non-compliance with IMP|0|||
27827556|NCT01838681|81199074|FG000|Period A|Lost to Follow-up|4|||
27827557|NCT01838681|81199075|FG001|Period A|Lost to Follow-up|0|||
27827558|NCT01838681|81199076|FG002|Period A|Lost to Follow-up|0|||
27827559|NCT01838681|81199077|FG003|Period A|Lost to Follow-up|0|||
27827560|NCT01838681|81199074|FG000|Period A|Withdrawal before treatment|4|||
27827561|NCT01838681|81199075|FG001|Period A|Withdrawal before treatment|0|||
27827562|NCT01838681|81199076|FG002|Period A|Withdrawal before treatment|0|||
27827563|NCT01838681|81199077|FG003|Period A|Withdrawal before treatment|0|||
27827564|NCT01838681|81199074|FG000|Period A|Administrative or other reasons|17|||
27827565|NCT01838681|81199075|FG001|Period A|Administrative or other reasons|0|||
27827566|NCT01838681|81199076|FG002|Period A|Administrative or other reasons|0|||
27827567|NCT01838681|81199077|FG003|Period A|Administrative or other reasons|0|||
27883999|NCT00568061|81408134|FG001|Overall Study|Inclusion / exclusion criteria|1|||
27827568|NCT01838681|81199074|FG000|Period B/A+|Adverse Event|0|||
27827569|NCT01838681|81199075|FG001|Period B/A+|Adverse Event|13|||
27827570|NCT01838681|81199076|FG002|Period B/A+|Adverse Event|27|||
27827571|NCT01838681|81199077|FG003|Period B/A+|Adverse Event|16|||
27884000|NCT00568061|81408133|FG000|Overall Study|Adverse Event|0|||
27557059|NCT01506479|80226144|FG001|Overall Study|Missing assessment|0|||
27557060|NCT01506479|80226145|FG002|Overall Study|Missing assessment|0|||
27557061|NCT01506479|80226143|FG000|Overall Study|Adverse Event|0|||
27557062|NCT01506479|80226144|FG001|Overall Study|Adverse Event|1|||
27557063|NCT01506479|80226145|FG002|Overall Study|Adverse Event|0|||
27557064|NCT02107482|80226146|FG000|Overall Study|inconveinence|2|||
27557065|NCT02107482|80226146|FG000|Overall Study|Lost to Follow-up|1|||
27557066|NCT02107482|80226146|FG000|Overall Study|Lack of Efficacy|1|||
27557067|NCT02528643|80226150|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
27557068|NCT02528643|80226151|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
27557069|NCT02528643|80226150|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
27557070|NCT02528643|80226151|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
27557071|NCT02528643|80226150|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
27557072|NCT02528643|80226151|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
27557073|NCT02528643|80226150|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
27557074|NCT02528643|80226151|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
27557075|NCT02528643|80226150|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
27884001|NCT00568061|81408134|FG001|Overall Study|Adverse Event|1|||
27884002|NCT04112043|81408135|FG000|Overall Study|Withdrawal by Subject|1|||
27884003|NCT04112043|81408136|FG001|Overall Study|Withdrawal by Subject|1|||
27557076|NCT02528643|80226151|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
27557077|NCT02528643|80226150|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
27557078|NCT02528643|80226151|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
27557079|NCT02528643|80226150|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
27557080|NCT02528643|80226151|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
27884004|NCT04112043|81408137|FG002|Overall Study|Withdrawal by Subject|1|||
27827572|NCT01838681|81199074|FG000|Period B/A+|Lack of Efficacy|0|||
27827573|NCT01838681|81199075|FG001|Period B/A+|Lack of Efficacy|9|||
27827574|NCT01838681|81199076|FG002|Period B/A+|Lack of Efficacy|11|||
27827575|NCT01838681|81199077|FG003|Period B/A+|Lack of Efficacy|6|||
27827576|NCT01838681|81199074|FG000|Period B/A+|Withdrawal by Subject|0|||
27557081|NCT01484873|80226152|FG000|Overall Study|Withdrawal by Subject|2|||
27884005|NCT04112043|81408135|FG000|Overall Study|Taking NR supplement|1|||
27557082|NCT02643082|80226155|FG000|Period 1|Adverse Event|1|||
27557083|NCT02643082|80226156|FG001|Period 1|Adverse Event|0|||
27557084|NCT01741701|80226157|FG000|Overall Study|Adverse Event|5|||
27557085|NCT01741701|80226158|FG001|Overall Study|Adverse Event|1|||
27557086|NCT01741701|80226157|FG000|Overall Study|Withdrawal by Subject|0|||
27557087|NCT01741701|80226158|FG001|Overall Study|Withdrawal by Subject|1|||
27557088|NCT02255981|80226159|FG000|Overall Study|Lost to Follow-up|3|||
27557089|NCT02255981|80226159|FG000|Overall Study|Withdrawal by Subject|1|||
27557090|NCT01881776|80226160|FG000|Overall Study|Lost to Follow-up|1|||
27557091|NCT01881776|80226161|FG001|Overall Study|Lost to Follow-up|2|||
27557092|NCT01881776|80226162|FG002|Overall Study|Lost to Follow-up|1|||
27557093|NCT01881776|80226160|FG000|Overall Study|Protocol Violation|0|||
27557094|NCT01881776|80226161|FG001|Overall Study|Protocol Violation|2|||
27557095|NCT01881776|80226162|FG002|Overall Study|Protocol Violation|1|||
27557096|NCT03227029|80226163|FG000|Overall Study|Child Wheezed (no treatment)|0|||
27557097|NCT03227029|80226164|FG001|Overall Study|Child Wheezed (no treatment)|1|||
27557098|NCT03227029|80226165|FG002|Overall Study|Child Wheezed (no treatment)|0|||
27557099|NCT03227029|80226163|FG000|Overall Study|No post RSV season visit due to COVID|3|||
27557100|NCT03227029|80226164|FG001|Overall Study|No post RSV season visit due to COVID|3|||
27557101|NCT03227029|80226165|FG002|Overall Study|No post RSV season visit due to COVID|2|||
27557102|NCT03227029|80226163|FG000|Overall Study|Not able to get to clinic|0|||
27557103|NCT03227029|80226164|FG001|Overall Study|Not able to get to clinic|0|||
27557104|NCT03227029|80226165|FG002|Overall Study|Not able to get to clinic|1|||
27557105|NCT03227029|80226163|FG000|Overall Study|Withdrawal by Subject|1|||
27557106|NCT03227029|80226164|FG001|Overall Study|Withdrawal by Subject|0|||
27557107|NCT03227029|80226165|FG002|Overall Study|Withdrawal by Subject|0|||
27557108|NCT03227029|80226163|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
27557109|NCT03227029|80226164|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
27557110|NCT03227029|80226165|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
27557111|NCT00788151|80226166|FG000|Overall Study|Other adverse event|0|||
27557112|NCT00788151|80226167|FG001|Overall Study|Other adverse event|2|||
27557113|NCT00788151|80226166|FG000|Overall Study|Protocol Violation|0|||
27557114|NCT00788151|80226167|FG001|Overall Study|Protocol Violation|1|||
27884006|NCT04112043|81408136|FG001|Overall Study|Taking NR supplement|0|||
27884007|NCT04112043|81408137|FG002|Overall Study|Taking NR supplement|0|||
27884008|NCT04112043|81408135|FG000|Overall Study|Adverse Event|0|||
27884009|NCT04112043|81408136|FG001|Overall Study|Adverse Event|1|||
27557115|NCT00788151|80226166|FG000|Overall Study|Withdrawal by Subject|13|||
27557116|NCT00788151|80226167|FG001|Overall Study|Withdrawal by Subject|6|||
27557117|NCT00788151|80226166|FG000|Overall Study|Enrolled but not treated|1|||
27557118|NCT00788151|80226167|FG001|Overall Study|Enrolled but not treated|1|||
27557119|NCT02554812|80226168|FG000|Overall Study|Adverse Event|2|||
27884010|NCT04112043|81408137|FG002|Overall Study|Adverse Event|0|||
27697078|NCT02038920|80727234|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27697079|NCT02038920|80727235|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
27697080|NCT02038920|80727236|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
27697081|NCT02038920|80727231|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27697082|NCT02038920|80727232|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27697083|NCT02038920|80727233|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27697084|NCT02038920|80727234|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27697085|NCT02038920|80727235|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
27697086|NCT02038920|80727236|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
27697087|NCT02038920|80727231|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27697088|NCT02038920|80727232|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27697089|NCT02038920|80727233|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27697090|NCT02038920|80727234|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27697091|NCT02038920|80727235|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
27697092|NCT02038920|80727236|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
27697093|NCT02038920|80727231|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27697094|NCT02038920|80727232|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27697095|NCT02038920|80727233|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27697096|NCT02038920|80727234|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27697097|NCT02038920|80727235|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
27697098|NCT02038920|80727236|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
27697099|NCT02038920|80727231|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27697100|NCT02038920|80727232|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27697101|NCT02038920|80727233|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27697102|NCT02038920|80727234|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27697103|NCT02038920|80727235|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
27697104|NCT02038920|80727236|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
27697105|NCT02038920|80727231|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27697106|NCT02038920|80727232|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27697107|NCT02038920|80727233|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27827577|NCT01838681|81199075|FG001|Period B/A+|Withdrawal by Subject|28|||
27827578|NCT01838681|81199076|FG002|Period B/A+|Withdrawal by Subject|35|||
27827579|NCT01838681|81199077|FG003|Period B/A+|Withdrawal by Subject|47|||
27827580|NCT01838681|81199074|FG000|Period B/A+|Protocol Violation|0|||
27827581|NCT01838681|81199075|FG001|Period B/A+|Protocol Violation|1|||
27827582|NCT01838681|81199076|FG002|Period B/A+|Protocol Violation|4|||
27827583|NCT01838681|81199077|FG003|Period B/A+|Protocol Violation|6|||
27827584|NCT01838681|81199074|FG000|Period B/A+|Non-compliance with IMP|0|||
27827585|NCT01838681|81199075|FG001|Period B/A+|Non-compliance with IMP|2|||
27827586|NCT01838681|81199076|FG002|Period B/A+|Non-compliance with IMP|3|||
27827587|NCT01838681|81199077|FG003|Period B/A+|Non-compliance with IMP|3|||
27827588|NCT01838681|81199074|FG000|Period B/A+|Lost to Follow-up|0|||
27827589|NCT01838681|81199075|FG001|Period B/A+|Lost to Follow-up|2|||
27827590|NCT01838681|81199076|FG002|Period B/A+|Lost to Follow-up|5|||
27827591|NCT01838681|81199077|FG003|Period B/A+|Lost to Follow-up|11|||
27827592|NCT01838681|81199074|FG000|Period B/A+|Withdrawal before treatment|0|||
27827593|NCT01838681|81199075|FG001|Period B/A+|Withdrawal before treatment|1|||
27827594|NCT01838681|81199076|FG002|Period B/A+|Withdrawal before treatment|0|||
27827595|NCT01838681|81199077|FG003|Period B/A+|Withdrawal before treatment|0|||
27827596|NCT01838681|81199074|FG000|Period B/A+|Administrative or other reasons|0|||
27827597|NCT01838681|81199075|FG001|Period B/A+|Administrative or other reasons|6|||
27827598|NCT01838681|81199076|FG002|Period B/A+|Administrative or other reasons|10|||
27827599|NCT01838681|81199077|FG003|Period B/A+|Administrative or other reasons|28|||
27827600|NCT04533594|81199081|FG000|Overall Study|Death|26|||
27827601|NCT00573066|81199082|FG000|Overall Study|Exclusion criteria|18|||
27827602|NCT00573066|81199082|FG000|Overall Study|IV malfunction|1|||
27827603|NCT00573066|81199082|FG000|Overall Study|Postoperative bleeding|1|||
27827604|NCT03600805|81199083|FG000|Overall Study|Adverse Event|2|||
27827605|NCT03600805|81199084|FG001|Overall Study|Adverse Event|1|||
27827606|NCT03600805|81199085|FG002|Overall Study|Adverse Event|1|||
27827607|NCT03600805|81199086|FG003|Overall Study|Adverse Event|7|||
27827608|NCT03600805|81199083|FG000|Overall Study|Lack of Efficacy|2|||
27827609|NCT03600805|81199084|FG001|Overall Study|Lack of Efficacy|1|||
27827610|NCT03600805|81199085|FG002|Overall Study|Lack of Efficacy|0|||
27827611|NCT03600805|81199086|FG003|Overall Study|Lack of Efficacy|0|||
27827612|NCT03600805|81199083|FG000|Overall Study|Withdrawal by Subject|1|||
27827613|NCT03600805|81199084|FG001|Overall Study|Withdrawal by Subject|0|||
27827614|NCT03600805|81199085|FG002|Overall Study|Withdrawal by Subject|0|||
27827615|NCT03600805|81199086|FG003|Overall Study|Withdrawal by Subject|1|||
27827616|NCT03600805|81199083|FG000|Overall Study|Other unspecified|14|||
27827617|NCT03600805|81199084|FG001|Overall Study|Other unspecified|6|||
27557120|NCT02554812|80226169|FG001|Overall Study|Adverse Event|5|||
27557121|NCT02554812|80226170|FG002|Overall Study|Adverse Event|3|||
27557122|NCT02554812|80226171|FG003|Overall Study|Adverse Event|0|||
27557123|NCT02554812|80226172|FG004|Overall Study|Adverse Event|5|||
27557124|NCT02554812|80226173|FG005|Overall Study|Adverse Event|0|||
27557125|NCT02554812|80226174|FG006|Overall Study|Adverse Event|1|||
27884011|NCT00820248|81408138|FG000|Overall Study|No treated|4|||
27884012|NCT00820248|81408139|FG001|Overall Study|No treated|1|||
27884013|NCT00713258|81408140|FG000|Overall Study|Adverse Event|2|||
27884014|NCT00713258|81408141|FG001|Overall Study|Adverse Event|4|||
27884015|NCT00713258|81408140|FG000|Overall Study|Non-Compliance|2|||
27884016|NCT00713258|81408141|FG001|Overall Study|Non-Compliance|1|||
27884017|NCT00713258|81408140|FG000|Overall Study|Other|1|||
27884018|NCT00713258|81408141|FG001|Overall Study|Other|1|||
27884019|NCT01106911|81408142|FG000|Overall Study|Physician Decision|2|||
27884020|NCT01106911|81408142|FG000|Overall Study|deemed ineligible after screening|3|||
27884021|NCT03386994|81408143|FG000|Overall Study|Lung transplant|1|||
27884022|NCT03386994|81408143|FG000|Overall Study|Adverse Event|14|||
27884023|NCT03386994|81408143|FG000|Overall Study|Lost to Follow-up|4|||
27884024|NCT03386994|81408143|FG000|Overall Study|Withdrawal by Subject|3|||
27884025|NCT03386994|81408143|FG000|Overall Study|Death|16|||
27557126|NCT02554812|80226175|FG007|Overall Study|Adverse Event|6|||
27697108|NCT02038920|80727234|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27697109|NCT02038920|80727235|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
27697110|NCT02038920|80727236|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
27697111|NCT01326533|80727249|FG000|Overall Study|Lost to Follow-up|2|||
27697112|NCT01326533|80727250|FG001|Overall Study|Lost to Follow-up|0|||
27697113|NCT01326533|80727249|FG000|Overall Study|Withdrawal by Subject|1|||
27697114|NCT01326533|80727250|FG001|Overall Study|Withdrawal by Subject|0|||
27697115|NCT01326533|80727249|FG000|Overall Study|Adverse Event|1|||
27697116|NCT01326533|80727250|FG001|Overall Study|Adverse Event|0|||
27697117|NCT00822172|80727251|FG000|Overall Study|Adverse Event|10|||
27697118|NCT00822172|80727252|FG001|Overall Study|Adverse Event|12|||
27697119|NCT00822172|80727251|FG000|Overall Study|Death|1|||
27697120|NCT00822172|80727252|FG001|Overall Study|Death|0|||
27697121|NCT00822172|80727251|FG000|Overall Study|Lost to Follow-up|3|||
27697122|NCT00822172|80727252|FG001|Overall Study|Lost to Follow-up|1|||
27697123|NCT00822172|80727251|FG000|Overall Study|Withdrawal by Subject|1|||
27697124|NCT00822172|80727252|FG001|Overall Study|Withdrawal by Subject|4|||
27697125|NCT00822172|80727251|FG000|Overall Study|site closed|0|||
27697126|NCT00822172|80727252|FG001|Overall Study|site closed|1|||
27697127|NCT00822172|80727251|FG000|Overall Study|Other|0|||
27697128|NCT00822172|80727252|FG001|Overall Study|Other|1|||
27697129|NCT01143038|80727253|FG000|Overall Study|Withdrawal by Subject|4|||
27697130|NCT01143038|80727253|FG000|Overall Study|Requirement for alternative therapy|5|||
27697131|NCT01143038|80727253|FG000|Overall Study|Adverse Event|3|||
27697132|NCT01143038|80727253|FG000|Overall Study|Lost to Follow-up|2|||
27697133|NCT01143038|80727253|FG000|Overall Study|Protocol Deviation|1|||
27697134|NCT01143038|80727253|FG000|Overall Study|Death|1|||
27697135|NCT03267940|80727254|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
27697136|NCT03267940|80727255|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
27697137|NCT03267940|80727256|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
27884026|NCT01340872|81408144|FG000|Double-blind Phase|Adverse Event|6|||
27884027|NCT01340872|81408145|FG001|Double-blind Phase|Adverse Event|4|||
27884028|NCT01340872|81408146|FG002|Double-blind Phase|Adverse Event|0|||
27697138|NCT03267940|80727257|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
27697139|NCT03267940|80727258|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
27697140|NCT03267940|80727259|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
27557127|NCT02554812|80226176|FG008|Overall Study|Adverse Event|2|||
27697141|NCT03267940|80727254|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
27697142|NCT03267940|80727255|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
27884029|NCT01340872|81408147|FG003|Double-blind Phase|Adverse Event|0|||
27884030|NCT01340872|81408144|FG000|Double-blind Phase|Withdrawal by Subject|3|||
27884031|NCT01340872|81408145|FG001|Double-blind Phase|Withdrawal by Subject|5|||
27884032|NCT01340872|81408146|FG002|Double-blind Phase|Withdrawal by Subject|0|||
27697143|NCT03267940|80727256|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
27697144|NCT03267940|80727257|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
27697145|NCT03267940|80727258|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
27697146|NCT03267940|80727259|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
27697147|NCT03267940|80727254|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
27697148|NCT03267940|80727255|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
27697149|NCT03267940|80727256|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
27697150|NCT03267940|80727257|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
27697151|NCT03267940|80727258|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
27697152|NCT03267940|80727259|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
27557128|NCT02554812|80226177|FG009|Overall Study|Adverse Event|2|||
27697153|NCT03267940|80727254|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
27697154|NCT03267940|80727255|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
27697155|NCT03267940|80727256|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
27697156|NCT03267940|80727257|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
27557129|NCT02554812|80226178|FG010|Overall Study|Adverse Event|1|||
27827618|NCT03600805|81199085|FG002|Overall Study|Other unspecified|7|||
27557130|NCT02554812|80226179|FG011|Overall Study|Adverse Event|2|||
27557131|NCT02554812|80226180|FG012|Overall Study|Adverse Event|0|||
27557132|NCT02554812|80226181|FG013|Overall Study|Adverse Event|3|||
27557133|NCT02554812|80226182|FG014|Overall Study|Adverse Event|2|||
27557134|NCT02554812|80226183|FG015|Overall Study|Adverse Event|1|||
27557135|NCT02554812|80226184|FG016|Overall Study|Adverse Event|0|||
27557136|NCT02554812|80226185|FG017|Overall Study|Adverse Event|1|||
27557137|NCT02554812|80226186|FG018|Overall Study|Adverse Event|0|||
27557138|NCT02554812|80226187|FG019|Overall Study|Adverse Event|0|||
27557139|NCT02554812|80226188|FG020|Overall Study|Adverse Event|0|||
27557140|NCT02554812|80226189|FG021|Overall Study|Adverse Event|2|||
27557141|NCT02554812|80226190|FG022|Overall Study|Adverse Event|1|||
27557142|NCT02554812|80226191|FG023|Overall Study|Adverse Event|1|||
27827619|NCT03600805|81199086|FG003|Overall Study|Other unspecified|11|||
27557143|NCT02554812|80226192|FG024|Overall Study|Adverse Event|1|||
27557144|NCT02554812|80226193|FG025|Overall Study|Adverse Event|2|||
27557145|NCT02554812|80226194|FG026|Overall Study|Adverse Event|1|||
27557146|NCT02554812|80226168|FG000|Overall Study|Death|1|||
27827620|NCT02956460|81199087|FG000|Lens 1|Lost to Follow-up|1|||
27557147|NCT02554812|80226169|FG001|Overall Study|Death|2|||
27557148|NCT02554812|80226170|FG002|Overall Study|Death|2|||
27557149|NCT02554812|80226171|FG003|Overall Study|Death|2|||
27827621|NCT02956460|81199088|FG001|Lens 1|Lost to Follow-up|0|||
27884033|NCT01340872|81408147|FG003|Double-blind Phase|Withdrawal by Subject|0|||
27884034|NCT01340872|81408144|FG000|Double-blind Phase|Lost to Follow-up|0|||
27884035|NCT01340872|81408145|FG001|Double-blind Phase|Lost to Follow-up|1|||
27884036|NCT01340872|81408146|FG002|Double-blind Phase|Lost to Follow-up|0|||
27884037|NCT01340872|81408147|FG003|Double-blind Phase|Lost to Follow-up|0|||
27884038|NCT01340872|81408144|FG000|Double-blind Phase|Protocol Violation|0|||
27827622|NCT00968812|81199091|FG000|Overall Study|Adverse Event|30|||
27827623|NCT00968812|81199092|FG001|Overall Study|Adverse Event|46|||
27827624|NCT00968812|81199093|FG002|Overall Study|Adverse Event|33|||
27827625|NCT00968812|81199091|FG000|Overall Study|Death|2|||
27827626|NCT00968812|81199092|FG001|Overall Study|Death|2|||
27557150|NCT02554812|80226172|FG004|Overall Study|Death|0|||
27557151|NCT02554812|80226173|FG005|Overall Study|Death|1|||
27557152|NCT02554812|80226174|FG006|Overall Study|Death|1|||
27557153|NCT02554812|80226175|FG007|Overall Study|Death|1|||
27557154|NCT02554812|80226176|FG008|Overall Study|Death|0|||
27557155|NCT02554812|80226177|FG009|Overall Study|Death|0|||
27884039|NCT01340872|81408145|FG001|Double-blind Phase|Protocol Violation|1|||
27884040|NCT01340872|81408146|FG002|Double-blind Phase|Protocol Violation|0|||
27884041|NCT01340872|81408147|FG003|Double-blind Phase|Protocol Violation|0|||
27884042|NCT01340872|81408144|FG000|Open-label Phase|Physician Decision|0|||
27884043|NCT01340872|81408145|FG001|Open-label Phase|Physician Decision|0|||
27884044|NCT01340872|81408146|FG002|Open-label Phase|Physician Decision|2|||
27884045|NCT01340872|81408147|FG003|Open-label Phase|Physician Decision|1|||
27884046|NCT01340872|81408144|FG000|Open-label Phase|Pregnancy|0|||
27884047|NCT01340872|81408145|FG001|Open-label Phase|Pregnancy|0|||
27884048|NCT01340872|81408146|FG002|Open-label Phase|Pregnancy|1|||
27884049|NCT01340872|81408147|FG003|Open-label Phase|Pregnancy|0|||
27884050|NCT01340872|81408144|FG000|Open-label Phase|Adverse Event|0|||
27884051|NCT01340872|81408145|FG001|Open-label Phase|Adverse Event|0|||
27884052|NCT01340872|81408146|FG002|Open-label Phase|Adverse Event|8|||
27884053|NCT01340872|81408147|FG003|Open-label Phase|Adverse Event|4|||
27884054|NCT01340872|81408144|FG000|Open-label Phase|Withdrawal by Subject|0|||
27884055|NCT01340872|81408145|FG001|Open-label Phase|Withdrawal by Subject|0|||
27884056|NCT01340872|81408146|FG002|Open-label Phase|Withdrawal by Subject|1|||
27884057|NCT01340872|81408147|FG003|Open-label Phase|Withdrawal by Subject|6|||
27884058|NCT01340872|81408144|FG000|Open-label Phase|Worsening of IBD|0|||
27884059|NCT01340872|81408145|FG001|Open-label Phase|Worsening of IBD|0|||
27884060|NCT01340872|81408146|FG002|Open-label Phase|Worsening of IBD|1|||
27884061|NCT01340872|81408147|FG003|Open-label Phase|Worsening of IBD|0|||
27884062|NCT00708552|81408149|FG000|Overall Study|Adverse Event|10|||
27884063|NCT00708552|81408150|FG001|Overall Study|Adverse Event|3|||
27884064|NCT00708552|81408151|FG002|Overall Study|Adverse Event|4|||
27884065|NCT00708552|81408152|FG003|Overall Study|Adverse Event|6|||
27884066|NCT00708552|81408149|FG000|Overall Study|Lack of Efficacy|0|||
27884067|NCT00708552|81408150|FG001|Overall Study|Lack of Efficacy|4|||
27884068|NCT00708552|81408151|FG002|Overall Study|Lack of Efficacy|1|||
27884069|NCT00708552|81408152|FG003|Overall Study|Lack of Efficacy|0|||
27884070|NCT00708552|81408149|FG000|Overall Study|Protocol Violation|0|||
27884071|NCT00708552|81408150|FG001|Overall Study|Protocol Violation|0|||
27557156|NCT02554812|80226178|FG010|Overall Study|Death|0|||
27557157|NCT02554812|80226179|FG011|Overall Study|Death|0|||
27557158|NCT02554812|80226180|FG012|Overall Study|Death|0|||
27557159|NCT02554812|80226181|FG013|Overall Study|Death|0|||
27827627|NCT00968812|81199093|FG002|Overall Study|Death|1|||
27827628|NCT00968812|81199091|FG000|Overall Study|Lack of Efficacy|9|||
27827629|NCT00968812|81199092|FG001|Overall Study|Lack of Efficacy|7|||
27827630|NCT00968812|81199093|FG002|Overall Study|Lack of Efficacy|16|||
27827631|NCT00968812|81199091|FG000|Overall Study|Lost to Follow-up|17|||
27827632|NCT00968812|81199092|FG001|Overall Study|Lost to Follow-up|12|||
27827633|NCT00968812|81199093|FG002|Overall Study|Lost to Follow-up|11|||
27827634|NCT00968812|81199091|FG000|Overall Study|Physician Decision|8|||
27827635|NCT00968812|81199092|FG001|Overall Study|Physician Decision|5|||
27827636|NCT00968812|81199093|FG002|Overall Study|Physician Decision|9|||
27827637|NCT00968812|81199091|FG000|Overall Study|Protocol Violation|7|||
27827638|NCT00968812|81199092|FG001|Overall Study|Protocol Violation|4|||
27827639|NCT00968812|81199093|FG002|Overall Study|Protocol Violation|3|||
27827640|NCT00968812|81199091|FG000|Overall Study|Withdrawal by Subject|17|||
27827641|NCT00968812|81199092|FG001|Overall Study|Withdrawal by Subject|23|||
27827642|NCT00968812|81199093|FG002|Overall Study|Withdrawal by Subject|25|||
27827643|NCT00968812|81199091|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
27827644|NCT00968812|81199092|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
27827645|NCT00968812|81199093|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
27827646|NCT00968812|81199091|FG000|Overall Study|Noncompliance with study drug|4|||
27557160|NCT02554812|80226182|FG014|Overall Study|Death|1|||
27557161|NCT02554812|80226183|FG015|Overall Study|Death|1|||
27557162|NCT02554812|80226184|FG016|Overall Study|Death|1|||
27557163|NCT02554812|80226185|FG017|Overall Study|Death|0|||
27557164|NCT02554812|80226186|FG018|Overall Study|Death|1|||
27557165|NCT02554812|80226187|FG019|Overall Study|Death|2|||
27557166|NCT02554812|80226188|FG020|Overall Study|Death|0|||
27557167|NCT02554812|80226189|FG021|Overall Study|Death|1|||
27557168|NCT02554812|80226190|FG022|Overall Study|Death|1|||
27557169|NCT02554812|80226191|FG023|Overall Study|Death|0|||
27557170|NCT02554812|80226192|FG024|Overall Study|Death|0|||
27557171|NCT02554812|80226193|FG025|Overall Study|Death|0|||
27557172|NCT02554812|80226194|FG026|Overall Study|Death|0|||
27557173|NCT02554812|80226168|FG000|Overall Study|Lost to Follow-up|0|||
27557174|NCT02554812|80226169|FG001|Overall Study|Lost to Follow-up|1|||
27557175|NCT02554812|80226170|FG002|Overall Study|Lost to Follow-up|0|||
27557176|NCT02554812|80226171|FG003|Overall Study|Lost to Follow-up|0|||
27557177|NCT02554812|80226172|FG004|Overall Study|Lost to Follow-up|0|||
27557178|NCT02554812|80226173|FG005|Overall Study|Lost to Follow-up|0|||
27557179|NCT02554812|80226174|FG006|Overall Study|Lost to Follow-up|0|||
27557180|NCT02554812|80226175|FG007|Overall Study|Lost to Follow-up|0|||
27557181|NCT02554812|80226176|FG008|Overall Study|Lost to Follow-up|0|||
27557182|NCT02554812|80226177|FG009|Overall Study|Lost to Follow-up|0|||
27557183|NCT02554812|80226178|FG010|Overall Study|Lost to Follow-up|0|||
27557184|NCT02554812|80226179|FG011|Overall Study|Lost to Follow-up|0|||
27557185|NCT02554812|80226180|FG012|Overall Study|Lost to Follow-up|0|||
27557186|NCT02554812|80226181|FG013|Overall Study|Lost to Follow-up|0|||
27557187|NCT02554812|80226182|FG014|Overall Study|Lost to Follow-up|0|||
27557188|NCT02554812|80226183|FG015|Overall Study|Lost to Follow-up|0|||
27557189|NCT02554812|80226184|FG016|Overall Study|Lost to Follow-up|0|||
27557190|NCT02554812|80226185|FG017|Overall Study|Lost to Follow-up|0|||
27557191|NCT02554812|80226186|FG018|Overall Study|Lost to Follow-up|0|||
27557192|NCT02554812|80226187|FG019|Overall Study|Lost to Follow-up|0|||
27557193|NCT02554812|80226188|FG020|Overall Study|Lost to Follow-up|0|||
27557194|NCT02554812|80226189|FG021|Overall Study|Lost to Follow-up|0|||
27557195|NCT02554812|80226190|FG022|Overall Study|Lost to Follow-up|0|||
27557196|NCT02554812|80226191|FG023|Overall Study|Lost to Follow-up|0|||
27557197|NCT02554812|80226192|FG024|Overall Study|Lost to Follow-up|0|||
27557198|NCT02554812|80226193|FG025|Overall Study|Lost to Follow-up|0|||
27557199|NCT02554812|80226194|FG026|Overall Study|Lost to Follow-up|0|||
27557200|NCT02554812|80226168|FG000|Overall Study|Global deterioration of health status|4|||
27557201|NCT02554812|80226169|FG001|Overall Study|Global deterioration of health status|3|||
27557202|NCT02554812|80226170|FG002|Overall Study|Global deterioration of health status|3|||
27557203|NCT02554812|80226171|FG003|Overall Study|Global deterioration of health status|2|||
27557204|NCT02554812|80226172|FG004|Overall Study|Global deterioration of health status|5|||
27557205|NCT02554812|80226173|FG005|Overall Study|Global deterioration of health status|0|||
27557206|NCT02554812|80226174|FG006|Overall Study|Global deterioration of health status|2|||
27557207|NCT02554812|80226175|FG007|Overall Study|Global deterioration of health status|1|||
27557208|NCT02554812|80226176|FG008|Overall Study|Global deterioration of health status|1|||
27557209|NCT02554812|80226177|FG009|Overall Study|Global deterioration of health status|1|||
27557210|NCT02554812|80226178|FG010|Overall Study|Global deterioration of health status|2|||
27557211|NCT02554812|80226179|FG011|Overall Study|Global deterioration of health status|1|||
27557212|NCT02554812|80226180|FG012|Overall Study|Global deterioration of health status|0|||
27557213|NCT02554812|80226181|FG013|Overall Study|Global deterioration of health status|0|||
27557214|NCT02554812|80226182|FG014|Overall Study|Global deterioration of health status|0|||
27557215|NCT02554812|80226183|FG015|Overall Study|Global deterioration of health status|1|||
27557216|NCT02554812|80226184|FG016|Overall Study|Global deterioration of health status|0|||
27557217|NCT02554812|80226185|FG017|Overall Study|Global deterioration of health status|0|||
27557218|NCT02554812|80226186|FG018|Overall Study|Global deterioration of health status|0|||
27884072|NCT00708552|81408151|FG002|Overall Study|Protocol Violation|2|||
27884073|NCT00708552|81408152|FG003|Overall Study|Protocol Violation|4|||
27884074|NCT00708552|81408149|FG000|Overall Study|Lost to Follow-up|4|||
27884075|NCT00708552|81408150|FG001|Overall Study|Lost to Follow-up|2|||
27557219|NCT02554812|80226187|FG019|Overall Study|Global deterioration of health status|0|||
27557220|NCT02554812|80226188|FG020|Overall Study|Global deterioration of health status|0|||
27557221|NCT02554812|80226189|FG021|Overall Study|Global deterioration of health status|0|||
27557222|NCT02554812|80226190|FG022|Overall Study|Global deterioration of health status|0|||
27557223|NCT02554812|80226191|FG023|Overall Study|Global deterioration of health status|0|||
27557224|NCT02554812|80226192|FG024|Overall Study|Global deterioration of health status|0|||
27557225|NCT02554812|80226193|FG025|Overall Study|Global deterioration of health status|0|||
27557226|NCT02554812|80226194|FG026|Overall Study|Global deterioration of health status|0|||
27557227|NCT02554812|80226168|FG000|Overall Study|Progressive disease|20|||
27557228|NCT02554812|80226169|FG001|Overall Study|Progressive disease|16|||
27557229|NCT02554812|80226170|FG002|Overall Study|Progressive disease|19|||
27557230|NCT02554812|80226171|FG003|Overall Study|Progressive disease|18|||
27557231|NCT02554812|80226172|FG004|Overall Study|Progressive disease|21|||
27557232|NCT02554812|80226173|FG005|Overall Study|Progressive disease|15|||
27557233|NCT02554812|80226174|FG006|Overall Study|Progressive disease|6|||
27557234|NCT02554812|80226175|FG007|Overall Study|Progressive disease|13|||
27557235|NCT02554812|80226176|FG008|Overall Study|Progressive disease|6|||
27557236|NCT02554812|80226177|FG009|Overall Study|Progressive disease|6|||
27557237|NCT02554812|80226178|FG010|Overall Study|Progressive disease|8|||
27557238|NCT02554812|80226179|FG011|Overall Study|Progressive disease|8|||
27557239|NCT02554812|80226180|FG012|Overall Study|Progressive disease|6|||
27557240|NCT02554812|80226181|FG013|Overall Study|Progressive disease|10|||
27697157|NCT03267940|80727258|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
27884076|NCT00708552|81408151|FG002|Overall Study|Lost to Follow-up|0|||
27884077|NCT00708552|81408152|FG003|Overall Study|Lost to Follow-up|1|||
27884078|NCT00708552|81408149|FG000|Overall Study|Physician Decision|1|||
27884079|NCT00708552|81408150|FG001|Overall Study|Physician Decision|2|||
27884080|NCT00708552|81408151|FG002|Overall Study|Physician Decision|0|||
27884081|NCT00708552|81408152|FG003|Overall Study|Physician Decision|0|||
27884082|NCT00708552|81408149|FG000|Overall Study|Withdrawal by Subject|12|||
27884083|NCT00708552|81408150|FG001|Overall Study|Withdrawal by Subject|7|||
27557241|NCT02554812|80226182|FG014|Overall Study|Progressive disease|20|||
27557242|NCT02554812|80226183|FG015|Overall Study|Progressive disease|6|||
27557243|NCT02554812|80226184|FG016|Overall Study|Progressive disease|3|||
27557244|NCT02554812|80226185|FG017|Overall Study|Progressive disease|3|||
27557245|NCT02554812|80226186|FG018|Overall Study|Progressive disease|11|||
27557246|NCT02554812|80226187|FG019|Overall Study|Progressive disease|7|||
27557247|NCT02554812|80226188|FG020|Overall Study|Progressive disease|11|||
27557248|NCT02554812|80226189|FG021|Overall Study|Progressive disease|6|||
27557249|NCT02554812|80226190|FG022|Overall Study|Progressive disease|9|||
27557250|NCT02554812|80226191|FG023|Overall Study|Progressive disease|9|||
27557251|NCT02554812|80226192|FG024|Overall Study|Progressive disease|4|||
27557252|NCT02554812|80226193|FG025|Overall Study|Progressive disease|5|||
27827647|NCT00968812|81199092|FG001|Overall Study|Noncompliance with study drug|1|||
27827648|NCT00968812|81199093|FG002|Overall Study|Noncompliance with study drug|6|||
27827649|NCT00968812|81199091|FG000|Overall Study|Unable to take rescue therapy|12|||
27827650|NCT00968812|81199092|FG001|Overall Study|Unable to take rescue therapy|12|||
27827651|NCT00968812|81199093|FG002|Overall Study|Unable to take rescue therapy|17|||
27827652|NCT00968812|81199091|FG000|Overall Study|Other|25|||
27827653|NCT00968812|81199092|FG001|Overall Study|Other|37|||
27827654|NCT00968812|81199093|FG002|Overall Study|Other|40|||
27827655|NCT00440518|81199094|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
27827656|NCT00440518|81199095|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
27827657|NCT00440518|81199096|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
27884084|NCT00708552|81408151|FG002|Overall Study|Withdrawal by Subject|8|||
27557253|NCT02554812|80226194|FG026|Overall Study|Progressive disease|5|||
27557254|NCT02554812|80226168|FG000|Overall Study|Other|0|||
27557255|NCT02554812|80226169|FG001|Overall Study|Other|0|||
27557256|NCT02554812|80226170|FG002|Overall Study|Other|2|||
27827658|NCT00440518|81199094|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
27827659|NCT00440518|81199095|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
27827660|NCT00440518|81199096|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
27827661|NCT00440518|81199094|FG000|Randomized /Titration Period|Protocol Deviation|1|||
27827662|NCT00440518|81199095|FG001|Randomized /Titration Period|Protocol Deviation|0|||
27827663|NCT00440518|81199096|FG002|Randomized /Titration Period|Protocol Deviation|0|||
27827664|NCT00440518|81199094|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
27827665|NCT00440518|81199095|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
27827666|NCT00440518|81199096|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
27827667|NCT00440518|81199094|FG000|Randomized /Titration Period|Other|1|||
27557257|NCT02554812|80226171|FG003|Overall Study|Other|3|||
27557258|NCT02554812|80226172|FG004|Overall Study|Other|2|||
27557259|NCT02554812|80226173|FG005|Overall Study|Other|1|||
27557260|NCT02554812|80226174|FG006|Overall Study|Other|0|||
27557261|NCT02554812|80226175|FG007|Overall Study|Other|0|||
27557262|NCT02554812|80226176|FG008|Overall Study|Other|1|||
27827668|NCT00440518|81199095|FG001|Randomized /Titration Period|Other|0|||
27827669|NCT00440518|81199096|FG002|Randomized /Titration Period|Other|0|||
27827670|NCT00440518|81199094|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
27827671|NCT00440518|81199095|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
27827672|NCT00440518|81199096|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
27827673|NCT00440518|81199094|FG000|Randomized /Titration Period|Adverse Event|2|||
27557263|NCT02554812|80226177|FG009|Overall Study|Other|1|||
27557264|NCT02554812|80226178|FG010|Overall Study|Other|0|||
27557265|NCT02554812|80226179|FG011|Overall Study|Other|0|||
27557266|NCT02554812|80226180|FG012|Overall Study|Other|1|||
27557267|NCT02554812|80226181|FG013|Overall Study|Other|0|||
27557268|NCT02554812|80226182|FG014|Overall Study|Other|1|||
27557269|NCT02554812|80226183|FG015|Overall Study|Other|0|||
27557270|NCT02554812|80226184|FG016|Overall Study|Other|0|||
27557271|NCT02554812|80226185|FG017|Overall Study|Other|0|||
27557272|NCT02554812|80226186|FG018|Overall Study|Other|0|||
27697158|NCT03267940|80727259|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
27884085|NCT00708552|81408152|FG003|Overall Study|Withdrawal by Subject|10|||
27884086|NCT03811093|81408156|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
27884087|NCT03811093|81408157|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
27884088|NCT03811093|81408156|FG000|Overall Study|Unable to measure body fat percentage|2|||
27884089|NCT03811093|81408157|FG001|Overall Study|Unable to measure body fat percentage|0|||
27884090|NCT00529308|81408164|FG000|Overall Study|Withdrawal by Subject|1|||
27884091|NCT00529308|81408165|FG001|Overall Study|Withdrawal by Subject|1|||
27884092|NCT00039871|81408171|FG000|Overall Study|Adverse Event|165|||
27884093|NCT00039871|81408171|FG000|Overall Study|Lost to Follow-up|18|||
27884094|NCT00039871|81408171|FG000|Overall Study|Protocol Violation|24|||
27884095|NCT00039871|81408171|FG000|Overall Study|Withdrawal by Subject|97|||
27884096|NCT00039871|81408171|FG000|Overall Study|Did not meet eligibility criteria|11|||
27884097|NCT00039871|81408171|FG000|Overall Study|Administrative|1|||
27884098|NCT00039871|81408171|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
27884099|NCT00039871|81408171|FG000|Overall Study|Never entered follow-up|7|||
27884100|NCT02199795|81408174|FG000|Overall Study|no longer met inclusion criteria|1|||
27884101|NCT02199795|81408175|FG001|Overall Study|no longer met inclusion criteria|0|||
27884102|NCT02199795|81408174|FG000|Overall Study|withdrew due to shoulder pain|1|||
27884103|NCT02199795|81408175|FG001|Overall Study|withdrew due to shoulder pain|0|||
27884104|NCT04747886|81408180|FG000|Overall Study|Withdrawal by Subject|1|||
27884105|NCT04747886|81408181|FG001|Overall Study|Withdrawal by Subject|4|||
27884106|NCT03693612|81408184|FG000|Overall Study|Lost to Follow-up|0|||
27884107|NCT03693612|81408185|FG001|Overall Study|Lost to Follow-up|0|||
27884108|NCT03693612|81408186|FG002|Overall Study|Lost to Follow-up|0|||
27884109|NCT03693612|81408187|FG003|Overall Study|Lost to Follow-up|0|||
27884110|NCT03693612|81408188|FG004|Overall Study|Lost to Follow-up|1|||
27884111|NCT03693612|81408189|FG005|Overall Study|Lost to Follow-up|0|||
27557273|NCT02554812|80226187|FG019|Overall Study|Other|0|||
27557274|NCT02554812|80226188|FG020|Overall Study|Other|0|||
27557275|NCT02554812|80226189|FG021|Overall Study|Other|2|||
27557276|NCT02554812|80226190|FG022|Overall Study|Other|0|||
27557277|NCT02554812|80226191|FG023|Overall Study|Other|0|||
27557278|NCT02554812|80226192|FG024|Overall Study|Other|0|||
27884112|NCT03693612|81408190|FG006|Overall Study|Lost to Follow-up|0|||
27884113|NCT03693612|81408184|FG000|Overall Study|Withdrawal by Subject|0|||
27884114|NCT03693612|81408185|FG001|Overall Study|Withdrawal by Subject|0|||
27884115|NCT03693612|81408186|FG002|Overall Study|Withdrawal by Subject|1|||
27557279|NCT02554812|80226193|FG025|Overall Study|Other|0|||
27557280|NCT02554812|80226194|FG026|Overall Study|Other|0|||
27557281|NCT02554812|80226168|FG000|Overall Study|Withdrawal by Subject|1|||
27557282|NCT02554812|80226169|FG001|Overall Study|Withdrawal by Subject|0|||
27557283|NCT02554812|80226170|FG002|Overall Study|Withdrawal by Subject|0|||
27557284|NCT02554812|80226171|FG003|Overall Study|Withdrawal by Subject|2|||
27557285|NCT02554812|80226172|FG004|Overall Study|Withdrawal by Subject|2|||
27557286|NCT02554812|80226173|FG005|Overall Study|Withdrawal by Subject|3|||
27557287|NCT02554812|80226174|FG006|Overall Study|Withdrawal by Subject|0|||
27557288|NCT02554812|80226175|FG007|Overall Study|Withdrawal by Subject|0|||
27557289|NCT02554812|80226176|FG008|Overall Study|Withdrawal by Subject|1|||
27557290|NCT02554812|80226177|FG009|Overall Study|Withdrawal by Subject|1|||
27557291|NCT02554812|80226178|FG010|Overall Study|Withdrawal by Subject|0|||
27557292|NCT02554812|80226179|FG011|Overall Study|Withdrawal by Subject|1|||
27557293|NCT02554812|80226180|FG012|Overall Study|Withdrawal by Subject|1|||
27557294|NCT02554812|80226181|FG013|Overall Study|Withdrawal by Subject|1|||
27557295|NCT02554812|80226182|FG014|Overall Study|Withdrawal by Subject|1|||
27557296|NCT02554812|80226183|FG015|Overall Study|Withdrawal by Subject|1|||
27557297|NCT02554812|80226184|FG016|Overall Study|Withdrawal by Subject|3|||
27557298|NCT02554812|80226185|FG017|Overall Study|Withdrawal by Subject|1|||
27557299|NCT02554812|80226186|FG018|Overall Study|Withdrawal by Subject|0|||
27557300|NCT02554812|80226187|FG019|Overall Study|Withdrawal by Subject|2|||
27557301|NCT02554812|80226188|FG020|Overall Study|Withdrawal by Subject|0|||
27557302|NCT02554812|80226189|FG021|Overall Study|Withdrawal by Subject|1|||
27557303|NCT02554812|80226190|FG022|Overall Study|Withdrawal by Subject|0|||
27557304|NCT02554812|80226191|FG023|Overall Study|Withdrawal by Subject|1|||
27557305|NCT02554812|80226192|FG024|Overall Study|Withdrawal by Subject|0|||
27557306|NCT02554812|80226193|FG025|Overall Study|Withdrawal by Subject|0|||
27557307|NCT02554812|80226194|FG026|Overall Study|Withdrawal by Subject|1|||
27557308|NCT02554812|80226168|FG000|Overall Study|Physician Decision|1|||
27557309|NCT02554812|80226169|FG001|Overall Study|Physician Decision|0|||
27557310|NCT02554812|80226170|FG002|Overall Study|Physician Decision|0|||
27557311|NCT02554812|80226171|FG003|Overall Study|Physician Decision|1|||
27557312|NCT02554812|80226172|FG004|Overall Study|Physician Decision|0|||
27557313|NCT02554812|80226173|FG005|Overall Study|Physician Decision|1|||
27557314|NCT02554812|80226174|FG006|Overall Study|Physician Decision|0|||
27557315|NCT02554812|80226175|FG007|Overall Study|Physician Decision|0|||
27557316|NCT02554812|80226176|FG008|Overall Study|Physician Decision|0|||
27557317|NCT02554812|80226177|FG009|Overall Study|Physician Decision|0|||
27557318|NCT02554812|80226178|FG010|Overall Study|Physician Decision|1|||
27557319|NCT02554812|80226179|FG011|Overall Study|Physician Decision|0|||
27884116|NCT03693612|81408187|FG003|Overall Study|Withdrawal by Subject|0|||
27884117|NCT03693612|81408188|FG004|Overall Study|Withdrawal by Subject|2|||
27884118|NCT03693612|81408189|FG005|Overall Study|Withdrawal by Subject|0|||
27884119|NCT03693612|81408190|FG006|Overall Study|Withdrawal by Subject|0|||
27884120|NCT03693612|81408184|FG000|Overall Study|Study Terminated by Sponsor|0|||
27884121|NCT03693612|81408185|FG001|Overall Study|Study Terminated by Sponsor|1|||
27884122|NCT03693612|81408186|FG002|Overall Study|Study Terminated by Sponsor|0|||
27884123|NCT03693612|81408187|FG003|Overall Study|Study Terminated by Sponsor|0|||
27557320|NCT02554812|80226180|FG012|Overall Study|Physician Decision|0|||
27557321|NCT02554812|80226181|FG013|Overall Study|Physician Decision|0|||
27557322|NCT02554812|80226182|FG014|Overall Study|Physician Decision|0|||
27557323|NCT02554812|80226183|FG015|Overall Study|Physician Decision|0|||
27557324|NCT02554812|80226184|FG016|Overall Study|Physician Decision|1|||
27557325|NCT02554812|80226185|FG017|Overall Study|Physician Decision|1|||
27557326|NCT02554812|80226186|FG018|Overall Study|Physician Decision|0|||
27557327|NCT02554812|80226187|FG019|Overall Study|Physician Decision|1|||
27557328|NCT02554812|80226188|FG020|Overall Study|Physician Decision|1|||
27557329|NCT02554812|80226189|FG021|Overall Study|Physician Decision|0|||
27557330|NCT02554812|80226190|FG022|Overall Study|Physician Decision|1|||
27557331|NCT02554812|80226191|FG023|Overall Study|Physician Decision|0|||
27557332|NCT02554812|80226192|FG024|Overall Study|Physician Decision|0|||
27557333|NCT02554812|80226193|FG025|Overall Study|Physician Decision|0|||
27557334|NCT02554812|80226194|FG026|Overall Study|Physician Decision|0|||
27557335|NCT02554812|80226168|FG000|Overall Study|Study terminated by sponsor|0|||
27557336|NCT02554812|80226169|FG001|Overall Study|Study terminated by sponsor|0|||
27557337|NCT02554812|80226170|FG002|Overall Study|Study terminated by sponsor|0|||
27557338|NCT02554812|80226171|FG003|Overall Study|Study terminated by sponsor|0|||
27557339|NCT02554812|80226172|FG004|Overall Study|Study terminated by sponsor|0|||
27557340|NCT02554812|80226173|FG005|Overall Study|Study terminated by sponsor|0|||
27557341|NCT02554812|80226174|FG006|Overall Study|Study terminated by sponsor|0|||
27557342|NCT02554812|80226175|FG007|Overall Study|Study terminated by sponsor|0|||
27557343|NCT02554812|80226176|FG008|Overall Study|Study terminated by sponsor|0|||
27557344|NCT02554812|80226177|FG009|Overall Study|Study terminated by sponsor|0|||
27557345|NCT02554812|80226178|FG010|Overall Study|Study terminated by sponsor|0|||
27557346|NCT02554812|80226179|FG011|Overall Study|Study terminated by sponsor|0|||
27557347|NCT02554812|80226180|FG012|Overall Study|Study terminated by sponsor|0|||
27557348|NCT02554812|80226181|FG013|Overall Study|Study terminated by sponsor|0|||
27557349|NCT02554812|80226182|FG014|Overall Study|Study terminated by sponsor|0|||
27557350|NCT02554812|80226183|FG015|Overall Study|Study terminated by sponsor|0|||
27557351|NCT02554812|80226184|FG016|Overall Study|Study terminated by sponsor|0|||
27557352|NCT02554812|80226185|FG017|Overall Study|Study terminated by sponsor|0|||
27557353|NCT02554812|80226186|FG018|Overall Study|Study terminated by sponsor|0|||
27557354|NCT02554812|80226187|FG019|Overall Study|Study terminated by sponsor|0|||
27557355|NCT02554812|80226188|FG020|Overall Study|Study terminated by sponsor|0|||
27557356|NCT02554812|80226189|FG021|Overall Study|Study terminated by sponsor|0|||
27557357|NCT02554812|80226190|FG022|Overall Study|Study terminated by sponsor|0|||
27557358|NCT02554812|80226191|FG023|Overall Study|Study terminated by sponsor|0|||
27557359|NCT02554812|80226192|FG024|Overall Study|Study terminated by sponsor|1|||
27557360|NCT02554812|80226193|FG025|Overall Study|Study terminated by sponsor|0|||
27557361|NCT02554812|80226194|FG026|Overall Study|Study terminated by sponsor|0|||
27557362|NCT02554812|80226168|FG000|Overall Study|No longer meets eligibility criteria|0|||
27557363|NCT02554812|80226169|FG001|Overall Study|No longer meets eligibility criteria|1|||
27557364|NCT02554812|80226170|FG002|Overall Study|No longer meets eligibility criteria|0|||
27557365|NCT02554812|80226171|FG003|Overall Study|No longer meets eligibility criteria|0|||
27557366|NCT02554812|80226172|FG004|Overall Study|No longer meets eligibility criteria|0|||
27557367|NCT02554812|80226173|FG005|Overall Study|No longer meets eligibility criteria|0|||
27557368|NCT02554812|80226174|FG006|Overall Study|No longer meets eligibility criteria|0|||
27557369|NCT02554812|80226175|FG007|Overall Study|No longer meets eligibility criteria|0|||
27557370|NCT02554812|80226176|FG008|Overall Study|No longer meets eligibility criteria|0|||
27557371|NCT02554812|80226177|FG009|Overall Study|No longer meets eligibility criteria|0|||
27557372|NCT02554812|80226178|FG010|Overall Study|No longer meets eligibility criteria|0|||
27557373|NCT02554812|80226179|FG011|Overall Study|No longer meets eligibility criteria|0|||
27557374|NCT02554812|80226180|FG012|Overall Study|No longer meets eligibility criteria|0|||
27557375|NCT02554812|80226181|FG013|Overall Study|No longer meets eligibility criteria|0|||
27557376|NCT02554812|80226182|FG014|Overall Study|No longer meets eligibility criteria|0|||
27557377|NCT02554812|80226183|FG015|Overall Study|No longer meets eligibility criteria|0|||
27557378|NCT02554812|80226184|FG016|Overall Study|No longer meets eligibility criteria|0|||
27557379|NCT02554812|80226185|FG017|Overall Study|No longer meets eligibility criteria|0|||
27557380|NCT02554812|80226186|FG018|Overall Study|No longer meets eligibility criteria|0|||
27557381|NCT02554812|80226187|FG019|Overall Study|No longer meets eligibility criteria|0|||
27557382|NCT02554812|80226188|FG020|Overall Study|No longer meets eligibility criteria|0|||
27557383|NCT02554812|80226189|FG021|Overall Study|No longer meets eligibility criteria|0|||
27557384|NCT02554812|80226190|FG022|Overall Study|No longer meets eligibility criteria|0|||
27557385|NCT02554812|80226191|FG023|Overall Study|No longer meets eligibility criteria|0|||
27557386|NCT02554812|80226192|FG024|Overall Study|No longer meets eligibility criteria|0|||
27557387|NCT02554812|80226193|FG025|Overall Study|No longer meets eligibility criteria|0|||
27557388|NCT02554812|80226194|FG026|Overall Study|No longer meets eligibility criteria|0|||
27557389|NCT03045328|80226195|FG000|Overall Study|Withdrawal by Subject|2|||
27557390|NCT02415127|80226196|FG000|Overall Study|Adverse Event|1|||
27557391|NCT02415127|80226197|FG001|Overall Study|Adverse Event|0|||
27884124|NCT03693612|81408188|FG004|Overall Study|Study Terminated by Sponsor|3|||
27884125|NCT03693612|81408189|FG005|Overall Study|Study Terminated by Sponsor|0|||
27884126|NCT03693612|81408190|FG006|Overall Study|Study Terminated by Sponsor|0|||
27557392|NCT01752907|80226202|FG000|Overall Study|Withdrawal by Subject|4|||
27557393|NCT01752907|80226203|FG001|Overall Study|Withdrawal by Subject|10|||
27557394|NCT01752907|80226202|FG000|Overall Study|Lost to Follow-up|2|||
27557395|NCT01752907|80226203|FG001|Overall Study|Lost to Follow-up|1|||
27557396|NCT01752907|80226202|FG000|Overall Study|Decision by Sponsor|6|||
27557397|NCT01752907|80226203|FG001|Overall Study|Decision by Sponsor|9|||
27884127|NCT02275546|81408194|FG000|Treatment Period 2|Withdrawal by Subject|2|||
27884128|NCT02275546|81408195|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27557398|NCT02385045|80226205|FG000|Overall Study|Endoscopy could not be completed|4|||
27557399|NCT00396591|80226206|FG000|Overall Study|Disease Progression|13|||
27557400|NCT00396591|80226206|FG000|Overall Study|Adverse Event|2|||
27557401|NCT00396591|80226206|FG000|Overall Study|Participant request|1|||
27557402|NCT01831544|80226207|FG000|Overall Study|Death|1|||
27557403|NCT01831544|80226207|FG000|Overall Study|Still on original MVAD device|2|||
27557404|NCT01499667|80226208|FG000|Overall Study|administrative problems|4|||
27557405|NCT01499667|80226209|FG001|Overall Study|administrative problems|5|||
27557406|NCT01499667|80226210|FG002|Overall Study|administrative problems|5|||
27557407|NCT01499667|80226208|FG000|Overall Study|Protocol Violation|1|||
27557408|NCT01499667|80226209|FG001|Overall Study|Protocol Violation|3|||
27557409|NCT01499667|80226210|FG002|Overall Study|Protocol Violation|2|||
27557410|NCT01499667|80226208|FG000|Overall Study|Adverse Event|0|||
27557411|NCT01499667|80226209|FG001|Overall Study|Adverse Event|2|||
27557412|NCT01499667|80226210|FG002|Overall Study|Adverse Event|2|||
27557413|NCT01499667|80226208|FG000|Overall Study|Withdrawal by Subject|2|||
27557414|NCT01499667|80226209|FG001|Overall Study|Withdrawal by Subject|1|||
27697159|NCT03267940|80727254|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
27697160|NCT03267940|80727255|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
27827674|NCT00440518|81199095|FG001|Randomized /Titration Period|Adverse Event|3|||
27827675|NCT00440518|81199096|FG002|Randomized /Titration Period|Adverse Event|0|||
27827676|NCT00440518|81199094|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
27827677|NCT00440518|81199095|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
27827678|NCT00440518|81199096|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
27827679|NCT00440518|81199094|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
27827680|NCT00440518|81199095|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
27827681|NCT00440518|81199096|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
27827682|NCT00440518|81199094|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
27827683|NCT00440518|81199095|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
27827684|NCT00440518|81199096|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
27827685|NCT00440518|81199094|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
27827686|NCT00440518|81199095|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
27827687|NCT00440518|81199096|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
27827688|NCT00440518|81199094|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
27827689|NCT00440518|81199095|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
27827690|NCT00440518|81199096|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
27827691|NCT00440518|81199094|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
27827692|NCT00440518|81199095|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
27827693|NCT00440518|81199096|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
27827694|NCT00836056|81199105|FG000|First Intervention|Adverse Event|1|||
27827695|NCT00836056|81199106|FG001|First Intervention|Adverse Event|0|||
27827696|NCT00834743|81199110|FG000|Second Intervention|Withdrawal by Subject|1|||
27827697|NCT00834743|81199111|FG001|Second Intervention|Withdrawal by Subject|0|||
27827698|NCT00272779|81199117|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
27827699|NCT00272779|81199118|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
27827700|NCT00272779|81199117|FG000|Baseline Through Week 48|Death before Week 48|4|||
27827701|NCT00272779|81199118|FG001|Baseline Through Week 48|Death before Week 48|4|||
27827702|NCT00272779|81199117|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
27827703|NCT00272779|81199118|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
27827704|NCT00272779|81199117|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
27827705|NCT00272779|81199118|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
27827706|NCT00272779|81199117|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
27827707|NCT00272779|81199118|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
27827708|NCT00272779|81199117|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
27827709|NCT00272779|81199118|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
27827710|NCT00272779|81199117|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
27827711|NCT00272779|81199118|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
27827712|NCT00272779|81199117|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
27827713|NCT00272779|81199118|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
27557415|NCT01499667|80226210|FG002|Overall Study|Withdrawal by Subject|1|||
27697161|NCT03267940|80727256|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
27827714|NCT00272779|81199117|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
27827715|NCT00272779|81199118|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
27827716|NCT00272779|81199117|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
27827717|NCT00272779|81199118|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
27557416|NCT01499667|80226208|FG000|Overall Study|Lack of Efficacy|2|||
27557417|NCT01499667|80226209|FG001|Overall Study|Lack of Efficacy|0|||
27884129|NCT02275546|81408194|FG000|Treatment Period 2|Protocol Violation|0|||
27884130|NCT02275546|81408195|FG001|Treatment Period 2|Protocol Violation|1|||
27884131|NCT00931255|81408198|FG000|Overall Study|Follow up biopsy not done|2|||
27884132|NCT00931255|81408199|FG001|Overall Study|Follow up biopsy not done|3|||
27557418|NCT01499667|80226210|FG002|Overall Study|Lack of Efficacy|0|||
27884133|NCT00734162|81408202|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
27884134|NCT00734162|81408203|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
27884135|NCT00734162|81408204|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
27884136|NCT00734162|81408205|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
27884137|NCT00734162|81408202|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
27884138|NCT00734162|81408203|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
27884139|NCT00734162|81408204|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
27884140|NCT00734162|81408205|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
27884141|NCT00734162|81408202|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
27884142|NCT00734162|81408203|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
27884143|NCT00734162|81408204|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
27884144|NCT00734162|81408205|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
27557419|NCT03051607|80226219|FG000|Overall Study|Adverse Event|66|||
27557420|NCT02066233|80226220|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
27557421|NCT02066233|80226221|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
27557422|NCT02392247|80226222|FG000|Overall Study|Withdrawal by Subject|1|||
27557423|NCT02392247|80226222|FG000|Overall Study|Surgery cancelled; no data|1|||
27557424|NCT03557151|80226226|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
27557425|NCT03557151|80226227|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
27827718|NCT00272779|81199117|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
27827719|NCT00272779|81199118|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
27827720|NCT00272779|81199117|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
27827721|NCT00272779|81199118|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
27827722|NCT00272779|81199117|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
27827723|NCT00272779|81199118|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
27827724|NCT00272779|81199117|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
27827725|NCT00272779|81199118|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
27827726|NCT00272779|81199117|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
27827727|NCT00272779|81199118|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
27827728|NCT00272779|81199117|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
27827729|NCT00272779|81199118|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
27827730|NCT00272779|81199117|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
27827731|NCT00272779|81199118|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
27827732|NCT00272779|81199117|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
27827733|NCT00272779|81199118|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
27557426|NCT03557151|80226226|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
27557427|NCT03557151|80226227|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
27557428|NCT03557151|80226226|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
27557429|NCT03557151|80226227|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
27557430|NCT03061331|80226228|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
27557431|NCT03061331|80226229|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
27557432|NCT02733367|80226230|FG000|Overall Study|Withdrawal by Subject|6|||
27557433|NCT02335489|80226244|FG000|Overall Study|Sponsor terminated study|4|||
27827734|NCT00272779|81199117|FG000|Baseline Through Week 48|Continuing treatment|385|||
27827735|NCT00272779|81199118|FG001|Baseline Through Week 48|Continuing treatment|368|||
27884145|NCT00734162|81408202|FG000|Open-Label Phase|Withdrew Consent|1|||
27884146|NCT00734162|81408203|FG001|Open-Label Phase|Withdrew Consent|0|||
27884147|NCT00734162|81408204|FG002|Open-Label Phase|Withdrew Consent|1|||
27884148|NCT00734162|81408205|FG003|Open-Label Phase|Withdrew Consent|1|||
27884149|NCT00734162|81408202|FG000|Open-Label Phase|Lost to Follow-up|1|||
27884150|NCT00734162|81408203|FG001|Open-Label Phase|Lost to Follow-up|2|||
27557434|NCT02335489|80226244|FG000|Overall Study|Lost to Follow-up|1|||
27557435|NCT02335489|80226244|FG000|Overall Study|Withdrawal by Subject|2|||
27557436|NCT02335489|80226244|FG000|Overall Study|Physician Decision|2|||
27827736|NCT00272779|81199117|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
27827737|NCT00272779|81199118|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
27827738|NCT00272779|81199117|FG000|Baseline Through Week 48|Never treated|2|||
27827739|NCT00272779|81199118|FG001|Baseline Through Week 48|Never treated|3|||
27827740|NCT00272779|81199117|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
27827741|NCT00272779|81199118|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
27827742|NCT00272779|81199117|FG000|Baseline Through Week 96|Death before Week 96|6|||
27827743|NCT00272779|81199118|FG001|Baseline Through Week 96|Death before Week 96|5|||
27827744|NCT00272779|81199117|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
27827745|NCT00272779|81199118|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
27827746|NCT00272779|81199117|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
27827747|NCT00272779|81199118|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
27827748|NCT00272779|81199117|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
27557437|NCT02335489|80226244|FG000|Overall Study|Lack of Efficacy|1|||
27557438|NCT03338855|80226245|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
27557439|NCT03338855|80226246|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
27557440|NCT00380978|80226247|FG000|Overall Study|Refused allocated intervention|0|||
27827749|NCT00272779|81199118|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
27827750|NCT00272779|81199117|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
27827751|NCT00272779|81199118|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
27827752|NCT00272779|81199117|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
27827753|NCT00272779|81199118|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
27827754|NCT00272779|81199117|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
27827755|NCT00272779|81199118|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
27827756|NCT00272779|81199117|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
27827757|NCT00272779|81199118|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
27827758|NCT00272779|81199117|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
27557441|NCT00380978|80226248|FG001|Overall Study|Refused allocated intervention|6|||
27557442|NCT00380978|80226247|FG000|Overall Study|Wrong study envelope|0|||
27557443|NCT00380978|80226248|FG001|Overall Study|Wrong study envelope|2|||
27557444|NCT00380978|80226247|FG000|Overall Study|Allocation prior to analgesia request|1|||
27557445|NCT00380978|80226248|FG001|Overall Study|Allocation prior to analgesia request|2|||
27557446|NCT00380978|80226247|FG000|Overall Study|Parous patient|1|||
27557447|NCT00380978|80226248|FG001|Overall Study|Parous patient|0|||
27557448|NCT00003492|80226249|FG000|Overall Study|Not evaluable|6|||
27557449|NCT00356369|80226250|FG000|Active Phase|Withdrawal by Subject|2|||
27697162|NCT03267940|80727257|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
27697163|NCT03267940|80727258|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
27697164|NCT03267940|80727259|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
27697165|NCT03267940|80727254|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
27827759|NCT00272779|81199118|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
27827760|NCT00272779|81199117|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
27557450|NCT00356369|80226251|FG001|Active Phase|Withdrawal by Subject|1|||
27827761|NCT00272779|81199118|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
27827762|NCT00272779|81199117|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
27827763|NCT00272779|81199118|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
27827764|NCT00272779|81199117|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
27827765|NCT00272779|81199118|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
27827766|NCT00272779|81199117|FG000|Baseline Through Week 96|Never treated|2|||
27827767|NCT00272779|81199118|FG001|Baseline Through Week 96|Never treated|3|||
27827768|NCT00272779|81199117|FG000|Baseline Through Week 96|Continuing on treatment|61|||
27827769|NCT00272779|81199118|FG001|Baseline Through Week 96|Continuing on treatment|38|||
27827770|NCT01534663|81199121|FG000|Overall Study|Lost to Follow-up|0|||
27827771|NCT01534663|81199122|FG001|Overall Study|Lost to Follow-up|2|||
27827772|NCT01534663|81199121|FG000|Overall Study|Adverse Event|2|||
27827773|NCT01534663|81199122|FG001|Overall Study|Adverse Event|1|||
27827774|NCT03017885|81199125|FG000|Overall Study|Adverse Event|2|||
27827775|NCT03017885|81199126|FG001|Overall Study|Adverse Event|0|||
27827776|NCT03017885|81199127|FG002|Overall Study|Adverse Event|0|||
27827777|NCT03017885|81199128|FG003|Overall Study|Adverse Event|0|||
27827778|NCT03017885|81199129|FG004|Overall Study|Adverse Event|0|||
27827779|NCT03017885|81199130|FG005|Overall Study|Adverse Event|0|||
27884151|NCT00734162|81408204|FG002|Open-Label Phase|Lost to Follow-up|0|||
27557451|NCT01166178|80226254|FG000|Overall Study|Withdrawal by Subject|1|||
27884152|NCT00734162|81408205|FG003|Open-Label Phase|Lost to Follow-up|1|||
27884153|NCT00734162|81408202|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27884154|NCT00734162|81408203|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27884155|NCT00734162|81408204|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
27884156|NCT00734162|81408205|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
27884157|NCT03991299|81408206|FG000|Overall Study|Study closed, sponsor decision|3|||
27884158|NCT03991299|81408206|FG000|Overall Study|Withdrawal by Subject|1|||
27884159|NCT00656292|81408207|FG000|Overall Study|Withdrawal by Subject|2|||
27884160|NCT00656292|81408208|FG001|Overall Study|Withdrawal by Subject|3|||
27884161|NCT00656292|81408207|FG000|Overall Study|Screen failure|1|||
27884162|NCT00656292|81408208|FG001|Overall Study|Screen failure|2|||
27884163|NCT02282813|81408209|FG000|Overall Study|Withdrawal by Subject|4|||
27884164|NCT02282813|81408210|FG001|Overall Study|Withdrawal by Subject|5|||
27884165|NCT02282813|81408211|FG002|Overall Study|Withdrawal by Subject|0|||
27884166|NCT02282813|81408209|FG000|Overall Study|Adverse Event|3|||
27557452|NCT01166178|80226255|FG001|Overall Study|Withdrawal by Subject|0|||
27557453|NCT01166178|80226254|FG000|Overall Study|Study was terminated|20|||
27557454|NCT01166178|80226255|FG001|Overall Study|Study was terminated|8|||
27557455|NCT00619801|80226256|FG000|Overall Study|Lack of Efficacy|0|||
27557456|NCT00619801|80226257|FG001|Overall Study|Lack of Efficacy|1|||
27557457|NCT00619801|80226256|FG000|Overall Study|Withdrawal by Subject|1|||
27557458|NCT00619801|80226257|FG001|Overall Study|Withdrawal by Subject|1|||
27557459|NCT00619801|80226256|FG000|Overall Study|Loss of efficacy|0|||
27557460|NCT00619801|80226257|FG001|Overall Study|Loss of efficacy|1|||
27557461|NCT02659631|80226260|FG000|Overall Study|Lost to Follow-up|0|||
27557462|NCT02659631|80226261|FG001|Overall Study|Lost to Follow-up|0|||
27884167|NCT02282813|81408210|FG001|Overall Study|Adverse Event|10|||
27884168|NCT02282813|81408211|FG002|Overall Study|Adverse Event|1|||
27884169|NCT02282813|81408209|FG000|Overall Study|Subject non-compliance|1|||
27884170|NCT02282813|81408210|FG001|Overall Study|Subject non-compliance|4|||
27557463|NCT02659631|80226262|FG002|Overall Study|Lost to Follow-up|2|||
27827780|NCT03017885|81199125|FG000|Overall Study|Progression of disease|4|||
27827781|NCT03017885|81199126|FG001|Overall Study|Progression of disease|3|||
27884171|NCT02282813|81408211|FG002|Overall Study|Subject non-compliance|0|||
27557464|NCT02659631|80226263|FG003|Overall Study|Lost to Follow-up|0|||
27884172|NCT02282813|81408209|FG000|Overall Study|Physician Decision|0|||
27884173|NCT02282813|81408210|FG001|Overall Study|Physician Decision|3|||
27884174|NCT02282813|81408211|FG002|Overall Study|Physician Decision|1|||
27884175|NCT02282813|81408209|FG000|Overall Study|Lost to Follow-up|2|||
27827782|NCT03017885|81199127|FG002|Overall Study|Progression of disease|4|||
27827783|NCT03017885|81199128|FG003|Overall Study|Progression of disease|0|||
27827784|NCT03017885|81199129|FG004|Overall Study|Progression of disease|0|||
27827785|NCT03017885|81199130|FG005|Overall Study|Progression of disease|0|||
27827786|NCT03017885|81199125|FG000|Overall Study|Other than listed|1|||
27827787|NCT03017885|81199126|FG001|Overall Study|Other than listed|2|||
27827788|NCT03017885|81199127|FG002|Overall Study|Other than listed|1|||
27827789|NCT03017885|81199128|FG003|Overall Study|Other than listed|0|||
27827790|NCT03017885|81199129|FG004|Overall Study|Other than listed|0|||
27827791|NCT03017885|81199130|FG005|Overall Study|Other than listed|0|||
27827792|NCT03017885|81199125|FG000|Overall Study|Lost to Follow-up|2|||
27827793|NCT03017885|81199126|FG001|Overall Study|Lost to Follow-up|0|||
27827794|NCT03017885|81199127|FG002|Overall Study|Lost to Follow-up|3|||
27827795|NCT03017885|81199128|FG003|Overall Study|Lost to Follow-up|0|||
27827796|NCT03017885|81199129|FG004|Overall Study|Lost to Follow-up|0|||
27557465|NCT02659631|80226264|FG004|Overall Study|Lost to Follow-up|0|||
27557466|NCT02659631|80226265|FG005|Overall Study|Lost to Follow-up|1|||
27827797|NCT03017885|81199130|FG005|Overall Study|Lost to Follow-up|0|||
27827798|NCT03017885|81199125|FG000|Overall Study|Change to other anti-cancer therapy|0|||
27827799|NCT03017885|81199126|FG001|Overall Study|Change to other anti-cancer therapy|0|||
27827800|NCT03017885|81199127|FG002|Overall Study|Change to other anti-cancer therapy|1|||
27827801|NCT03017885|81199128|FG003|Overall Study|Change to other anti-cancer therapy|0|||
27697166|NCT03267940|80727255|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
27697167|NCT03267940|80727256|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
27697168|NCT03267940|80727257|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
27697169|NCT03267940|80727258|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
27697170|NCT03267940|80727259|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
27697171|NCT03267940|80727254|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
27697172|NCT03267940|80727255|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
27697173|NCT03267940|80727256|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
27697174|NCT03267940|80727257|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
27697175|NCT03267940|80727258|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
27697176|NCT03267940|80727259|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
27697177|NCT03267940|80727254|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
27697178|NCT03267940|80727255|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
27697179|NCT03267940|80727256|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
27697180|NCT03267940|80727257|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
27697181|NCT03267940|80727258|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
27697182|NCT03267940|80727259|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
27697183|NCT03267940|80727254|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
27697184|NCT03267940|80727255|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
27697185|NCT03267940|80727256|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
27697186|NCT03267940|80727257|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
27697187|NCT03267940|80727258|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
27697188|NCT03267940|80727259|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
27697189|NCT02260882|80727260|FG000|Overall Study|Protocol Violation|0|||
27697190|NCT02260882|80727261|FG001|Overall Study|Protocol Violation|1|||
27697191|NCT02080221|80727262|FG000|Overall Study|Withdrawal by Subject|1|||
27697192|NCT02080221|80727262|FG000|Overall Study|Clinical Progression of Disease|1|||
27697193|NCT00938470|80727263|FG000|Overall Study|Disease Progression|3|||
27697194|NCT00938470|80727264|FG001|Overall Study|Disease Progression|0|||
27697195|NCT00938470|80727263|FG000|Overall Study|Alternate Treatment|1|||
27697196|NCT00938470|80727264|FG001|Overall Study|Alternate Treatment|0|||
27697197|NCT00938470|80727263|FG000|Overall Study|Death|3|||
27697198|NCT00938470|80727264|FG001|Overall Study|Death|2|||
27697199|NCT00938470|80727263|FG000|Overall Study|Other Reason|0|||
27697200|NCT00938470|80727264|FG001|Overall Study|Other Reason|1|||
27697201|NCT00138671|80727265|FG000|Overall Study|Death|0|||
27697202|NCT00138671|80727266|FG001|Overall Study|Death|3|||
27697203|NCT00138671|80727265|FG000|Overall Study|Adverse Event|6|||
27697204|NCT00138671|80727266|FG001|Overall Study|Adverse Event|3|||
27827802|NCT03017885|81199129|FG004|Overall Study|Change to other anti-cancer therapy|0|||
27827803|NCT03017885|81199130|FG005|Overall Study|Change to other anti-cancer therapy|0|||
27827804|NCT02178787|81199135|FG000|Overall Study|Lost to Follow-up|1|||
27827805|NCT02178787|81199136|FG001|Overall Study|Lost to Follow-up|0|||
27827806|NCT02178787|81199135|FG000|Overall Study|Withdrawal by Subject|0|||
27827807|NCT02178787|81199136|FG001|Overall Study|Withdrawal by Subject|2|||
27827808|NCT02178787|81199135|FG000|Overall Study|No TCD window|3|||
27697205|NCT00138671|80727265|FG000|Overall Study|Lost to Follow-up|1|||
27697206|NCT00138671|80727266|FG001|Overall Study|Lost to Follow-up|2|||
27697207|NCT00138671|80727265|FG000|Overall Study|Withdrawal by Subject|3|||
27697208|NCT00138671|80727266|FG001|Overall Study|Withdrawal by Subject|5|||
27697209|NCT00138671|80727265|FG000|Overall Study|Other|3|||
27827809|NCT02178787|81199136|FG001|Overall Study|No TCD window|7|||
27827810|NCT02178787|81199135|FG000|Overall Study|Physician Decision|1|||
27827811|NCT02178787|81199136|FG001|Overall Study|Physician Decision|0|||
27827812|NCT00365365|81199138|FG000|Overall Study|Randomized but not treated|0|||
27697210|NCT00138671|80727266|FG001|Overall Study|Other|3|||
27697211|NCT02301936|80727269|FG000|Overall Study|Lost to Follow-up|1|||
27697212|NCT02301936|80727270|FG001|Overall Study|Lost to Follow-up|0|||
27697213|NCT00706433|80727271|FG000|Overall Study|Lost to Follow-up|3|||
27827813|NCT00365365|81199139|FG001|Overall Study|Randomized but not treated|2|||
27827814|NCT00365365|81199140|FG002|Overall Study|Randomized but not treated|0|||
27827815|NCT00365365|81199138|FG000|Overall Study|Poor compliance to protocol|0|||
27827816|NCT00365365|81199139|FG001|Overall Study|Poor compliance to protocol|1|||
27827817|NCT00365365|81199140|FG002|Overall Study|Poor compliance to protocol|0|||
27827818|NCT00365365|81199138|FG000|Overall Study|Lost to Follow-up|3|||
27827819|NCT00365365|81199139|FG001|Overall Study|Lost to Follow-up|3|||
27827820|NCT00365365|81199140|FG002|Overall Study|Lost to Follow-up|3|||
27827821|NCT00365365|81199138|FG000|Overall Study|Death|1|||
27827822|NCT00365365|81199139|FG001|Overall Study|Death|3|||
27827823|NCT00365365|81199140|FG002|Overall Study|Death|0|||
27827824|NCT00365365|81199138|FG000|Overall Study|Subject's request|11|||
27827825|NCT00365365|81199139|FG001|Overall Study|Subject's request|13|||
27827826|NCT00365365|81199140|FG002|Overall Study|Subject's request|1|||
27827827|NCT00365365|81199138|FG000|Overall Study|Disease progression/relapse|9|||
27827828|NCT00365365|81199139|FG001|Overall Study|Disease progression/relapse|6|||
27827829|NCT00365365|81199140|FG002|Overall Study|Disease progression/relapse|7|||
27827830|NCT00365365|81199138|FG000|Overall Study|Adverse Event|6|||
27827831|NCT00365365|81199139|FG001|Overall Study|Adverse Event|6|||
27827832|NCT00365365|81199140|FG002|Overall Study|Adverse Event|3|||
27557467|NCT02659631|80226266|FG006|Overall Study|Lost to Follow-up|0|||
27827833|NCT00365365|81199138|FG000|Overall Study|Moved|2|||
27827834|NCT00365365|81199139|FG001|Overall Study|Moved|0|||
27827835|NCT00365365|81199140|FG002|Overall Study|Moved|0|||
27827836|NCT00365365|81199138|FG000|Overall Study|New cancer|1|||
27827837|NCT00365365|81199139|FG001|Overall Study|New cancer|0|||
27827838|NCT00365365|81199140|FG002|Overall Study|New cancer|0|||
27827839|NCT00365365|81199138|FG000|Overall Study|Withdrew consent|1|||
27827840|NCT00365365|81199139|FG001|Overall Study|Withdrew consent|1|||
27827841|NCT00365365|81199140|FG002|Overall Study|Withdrew consent|0|||
27827842|NCT00365365|81199138|FG000|Overall Study|Second malignancy|0|||
27827843|NCT00365365|81199139|FG001|Overall Study|Second malignancy|1|||
27827844|NCT00365365|81199140|FG002|Overall Study|Second malignancy|0|||
27827845|NCT00365365|81199138|FG000|Overall Study|Patient/physician decision|0|||
27827846|NCT00365365|81199139|FG001|Overall Study|Patient/physician decision|0|||
27827847|NCT00365365|81199140|FG002|Overall Study|Patient/physician decision|1|||
27827848|NCT01250912|81199141|FG000|Overall Study|Lost to Follow-up|1|||
27827849|NCT01415986|81199144|FG000|Overall Study|Lost to Follow-up|1|||
27827850|NCT01444378|81199145|FG000|Overall Study|Lost to Follow-up|1|||
27827851|NCT01444378|81199145|FG000|Overall Study|Withdrawal by Subject|1|||
27827852|NCT01444378|81199145|FG000|Overall Study|Death|3|||
27827853|NCT01444378|81199145|FG000|Overall Study|Administrative Closure Of The Study|2|||
27827854|NCT01444378|81199145|FG000|Overall Study|Missed Visits|10|||
27827855|NCT03872128|81199146|FG000|Overall Study|Dropped out before treatment|1|||
27827856|NCT03872128|81199147|FG001|Overall Study|Dropped out before treatment|0|||
27827857|NCT03872128|81199148|FG002|Overall Study|Dropped out before treatment|4|||
27557468|NCT02659631|80226267|FG007|Overall Study|Lost to Follow-up|0|||
27557469|NCT02659631|80226268|FG008|Overall Study|Lost to Follow-up|0|||
27557470|NCT02659631|80226269|FG009|Overall Study|Lost to Follow-up|0|||
27827858|NCT03872128|81199146|FG000|Overall Study|Lost to Follow-up|2|||
27827859|NCT03872128|81199147|FG001|Overall Study|Lost to Follow-up|5|||
27827860|NCT03872128|81199148|FG002|Overall Study|Lost to Follow-up|8|||
27827861|NCT02820350|81202734|FG000|Overall Study|Withdrawal by Subject|3|||
27827862|NCT02820350|81202734|FG000|Overall Study|Death|4|||
27827863|NCT01376167|81202736|FG000|Overall Study|Lost to Follow-up|2|||
27827864|NCT01376167|81202737|FG001|Overall Study|Lost to Follow-up|4|||
27827865|NCT01376167|81202738|FG002|Overall Study|Lost to Follow-up|2|||
27827866|NCT01376167|81202736|FG000|Overall Study|Physician Decision|1|||
27557471|NCT02659631|80226260|FG000|Overall Study|Withdrawal prior to treatment|0|||
27827867|NCT01376167|81202737|FG001|Overall Study|Physician Decision|1|||
27827868|NCT01376167|81202738|FG002|Overall Study|Physician Decision|0|||
27827869|NCT01376167|81202736|FG000|Overall Study|Withdrawal by Subject|1|||
27827870|NCT01376167|81202737|FG001|Overall Study|Withdrawal by Subject|5|||
27827871|NCT01376167|81202738|FG002|Overall Study|Withdrawal by Subject|4|||
27827872|NCT00747565|81202739|FG000|Overall Study|Withdrawal by Subject|10|||
27827873|NCT00747565|81202740|FG001|Overall Study|Withdrawal by Subject|6|||
27827874|NCT00747565|81202739|FG000|Overall Study|Lost to Follow-up|4|||
27827875|NCT00747565|81202740|FG001|Overall Study|Lost to Follow-up|1|||
27827876|NCT03965091|81202741|FG000|Overall Study|Adverse Event|0|||
27827877|NCT03965091|81202742|FG001|Overall Study|Adverse Event|2|||
27827878|NCT03965091|81202743|FG002|Overall Study|Adverse Event|3|||
27827879|NCT03965091|81202741|FG000|Overall Study|Withdrawal by Subject|11|||
27827880|NCT03965091|81202742|FG001|Overall Study|Withdrawal by Subject|3|||
27827881|NCT03965091|81202743|FG002|Overall Study|Withdrawal by Subject|5|||
27827882|NCT03965091|81202741|FG000|Overall Study|Non-compliance with study drug|0|||
27827883|NCT03965091|81202742|FG001|Overall Study|Non-compliance with study drug|0|||
27827884|NCT03965091|81202743|FG002|Overall Study|Non-compliance with study drug|1|||
27827885|NCT03965091|81202741|FG000|Overall Study|Lost to Follow-up|1|||
27827886|NCT03965091|81202742|FG001|Overall Study|Lost to Follow-up|1|||
27827887|NCT03965091|81202743|FG002|Overall Study|Lost to Follow-up|1|||
27827888|NCT03965091|81202741|FG000|Overall Study|Lack of Efficacy|2|||
27827889|NCT03965091|81202742|FG001|Overall Study|Lack of Efficacy|0|||
27827890|NCT03965091|81202743|FG002|Overall Study|Lack of Efficacy|0|||
27827891|NCT03965091|81202741|FG000|Overall Study|Other than specified|9|||
27827892|NCT03965091|81202742|FG001|Overall Study|Other than specified|11|||
27827893|NCT03965091|81202743|FG002|Overall Study|Other than specified|8|||
27827894|NCT01900691|81202744|FG000|Overall Study|Death|7|||
27827895|NCT01900691|81202744|FG000|Overall Study|Lost to Follow-up|4|||
27827896|NCT01900691|81202744|FG000|Overall Study|Study Device Not Placed|3|||
27827897|NCT01900691|81202744|FG000|Overall Study|Non study stent placed|2|||
27827898|NCT01900691|81202744|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
27827899|NCT01900691|81202744|FG000|Overall Study|Complete stent migration through digestive tract|1|||
27827900|NCT04032977|81202745|FG000|Overall Study|Withdrawal by Subject|6|||
27827901|NCT04032977|81202746|FG001|Overall Study|Withdrawal by Subject|1|||
27827902|NCT04032977|81202745|FG000|Overall Study|Lost to Follow-up|2|||
27827903|NCT04032977|81202746|FG001|Overall Study|Lost to Follow-up|7|||
27827904|NCT04032977|81202745|FG000|Overall Study|Pregnancy|1|||
27827905|NCT04032977|81202746|FG001|Overall Study|Pregnancy|0|||
27827906|NCT04278560|81202747|FG000|Overall Study|Adverse Event|1|||
27827907|NCT04278560|81202748|FG001|Overall Study|Adverse Event|2|||
27827908|NCT04278560|81202747|FG000|Overall Study|Withdrawal by Subject|0|||
27827909|NCT04278560|81202748|FG001|Overall Study|Withdrawal by Subject|1|||
27827910|NCT00904215|81202749|FG000|Overall Study|Adverse Event|25|||
27827911|NCT00904215|81202749|FG000|Overall Study|Protocol Violation|10|||
27827912|NCT00904215|81202749|FG000|Overall Study|Lost to Follow-up|63|||
27827913|NCT00904215|81202749|FG000|Overall Study|Withdrawal by Subject|9|||
27827914|NCT00904215|81202749|FG000|Overall Study|Other|28|||
27827915|NCT00088829|81202750|FG000|Overall Study|PI left institution and study was close|22|||
27827916|NCT03987191|81202757|FG000|Overall Study|COVID-19 related research disruption|0|||
27827917|NCT03987191|81202758|FG001|Overall Study|COVID-19 related research disruption|2|||
27827918|NCT04408794|81202759|FG000|Overall Study|Adverse Event|43|||
27827919|NCT04408794|81202759|FG000|Overall Study|Infrequent study drug usage|43|||
27827920|NCT04408794|81202759|FG000|Overall Study|Lack of Efficacy|61|||
27827921|NCT04408794|81202759|FG000|Overall Study|Lost to Follow-up|33|||
27827922|NCT04408794|81202759|FG000|Overall Study|Non-compliance|6|||
27827923|NCT04408794|81202759|FG000|Overall Study|Physician Decision|1|||
27827924|NCT04408794|81202759|FG000|Overall Study|Pregnancy|6|||
27827925|NCT04408794|81202759|FG000|Overall Study|Protocol Deviation|9|||
27827926|NCT04408794|81202759|FG000|Overall Study|Sheehan-STS Result|1|||
27827927|NCT04408794|81202759|FG000|Overall Study|Withdrawal by Subject|57|||
27827928|NCT04408794|81202759|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
27827929|NCT04408794|81202759|FG000|Overall Study|Never Treated Migraine|5|||
27827930|NCT00420303|81202760|FG000|Overall Study|Serious Adverse Event|1|||
27827931|NCT00420303|81202761|FG001|Overall Study|Serious Adverse Event|0|||
27827932|NCT00420303|81202760|FG000|Overall Study|Lack of Efficacy|0|||
27697214|NCT00706433|80727272|FG001|Overall Study|Lost to Follow-up|1|||
27827933|NCT00420303|81202761|FG001|Overall Study|Lack of Efficacy|3|||
27827934|NCT00420303|81202760|FG000|Overall Study|Physician Decision|0|||
27827935|NCT00420303|81202761|FG001|Overall Study|Physician Decision|1|||
27827936|NCT04852978|81202762|FG000|Overall Study|Physician Decision|0|||
27827937|NCT04852978|81202763|FG001|Overall Study|Physician Decision|1|||
27827938|NCT04852978|81202764|FG002|Overall Study|Physician Decision|0|||
27827939|NCT04852978|81202765|FG003|Overall Study|Physician Decision|0|||
27827940|NCT04852978|81202766|FG004|Overall Study|Physician Decision|0|||
27697215|NCT00706433|80727273|FG002|Overall Study|Lost to Follow-up|6|||
27697216|NCT00706433|80727274|FG003|Overall Study|Lost to Follow-up|0|||
27697217|NCT00706433|80727271|FG000|Overall Study|Withdrawal by Subject|1|||
27697218|NCT00706433|80727272|FG001|Overall Study|Withdrawal by Subject|2|||
27697219|NCT00706433|80727273|FG002|Overall Study|Withdrawal by Subject|3|||
27697220|NCT00706433|80727274|FG003|Overall Study|Withdrawal by Subject|1|||
27697221|NCT00706433|80727271|FG000|Overall Study|Adverse Event|0|||
27697222|NCT00706433|80727272|FG001|Overall Study|Adverse Event|0|||
27697223|NCT00706433|80727273|FG002|Overall Study|Adverse Event|1|||
27697224|NCT00706433|80727274|FG003|Overall Study|Adverse Event|0|||
27697225|NCT00706433|80727271|FG000|Overall Study|Protocol Violation|1|||
27697226|NCT00706433|80727272|FG001|Overall Study|Protocol Violation|0|||
27697227|NCT00706433|80727273|FG002|Overall Study|Protocol Violation|0|||
27697228|NCT00706433|80727274|FG003|Overall Study|Protocol Violation|0|||
27697229|NCT00706433|80727271|FG000|Overall Study|new job|0|||
27884176|NCT02282813|81408210|FG001|Overall Study|Lost to Follow-up|0|||
27884177|NCT02282813|81408211|FG002|Overall Study|Lost to Follow-up|1|||
27884178|NCT02282813|81408209|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
27884179|NCT02282813|81408210|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
27884180|NCT02282813|81408211|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
27884181|NCT02282813|81408209|FG000|Overall Study|Lack of Efficacy|1|||
27884182|NCT02282813|81408210|FG001|Overall Study|Lack of Efficacy|0|||
27884183|NCT02282813|81408211|FG002|Overall Study|Lack of Efficacy|0|||
27884184|NCT02282813|81408209|FG000|Overall Study|Administrative reasons|0|||
27884185|NCT02282813|81408210|FG001|Overall Study|Administrative reasons|1|||
27884186|NCT02282813|81408211|FG002|Overall Study|Administrative reasons|0|||
27884187|NCT02122887|81408214|FG000|Overall Study|Withdrawal by Subject|20|||
27884188|NCT02122887|81408215|FG001|Overall Study|Withdrawal by Subject|2|||
27884189|NCT00996125|81408216|FG000|Overall Study|Adverse Event|0|||
27884190|NCT00996125|81408217|FG001|Overall Study|Adverse Event|2|||
27884191|NCT00996125|81408216|FG000|Overall Study|Lost to Follow-up|1|||
27884192|NCT00996125|81408217|FG001|Overall Study|Lost to Follow-up|6|||
27697230|NCT00706433|80727272|FG001|Overall Study|new job|0|||
27697231|NCT00706433|80727273|FG002|Overall Study|new job|0|||
27697232|NCT00706433|80727274|FG003|Overall Study|new job|1|||
27697233|NCT02244996|80727275|FG000|Overall Study|Lack of Efficacy|2|||
27697234|NCT02244996|80727276|FG001|Overall Study|Lack of Efficacy|6|||
27697235|NCT00117845|80727277|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
27697236|NCT01295281|80727279|FG000|First Intervention (7 Days)|Death|0|||
27697237|NCT01295281|80727280|FG001|First Intervention (7 Days)|Death|1|||
27697238|NCT01480674|80727282|FG000|Overall Study|Death|23|||
27697239|NCT01480674|80727282|FG000|Overall Study|Lost to Follow-up|2|||
27884193|NCT00996125|81408216|FG000|Overall Study|Withdrawal by Subject|4|||
27884194|NCT00996125|81408217|FG001|Overall Study|Withdrawal by Subject|3|||
27884195|NCT00423332|81408218|FG000|Overall Study|Adverse Event|6|||
27697240|NCT01480674|80727282|FG000|Overall Study|visit not done|10|||
27697241|NCT03881553|80729706|FG000|Overall Study|Discharged prior to participation|1|||
27697242|NCT03881553|80729707|FG001|Overall Study|Discharged prior to participation|1|||
27884196|NCT00423332|81408219|FG001|Overall Study|Adverse Event|2|||
27884197|NCT00423332|81408218|FG000|Overall Study|Withdrawal by Subject|1|||
27884198|NCT00423332|81408219|FG001|Overall Study|Withdrawal by Subject|0|||
27884199|NCT00423332|81408218|FG000|Overall Study|Condition under investigation worsened|1|||
27697243|NCT03881553|80729708|FG002|Overall Study|Discharged prior to participation|0|||
27697244|NCT03881553|80729706|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
27697245|NCT03881553|80729707|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
27697246|NCT03881553|80729708|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
27697247|NCT01180998|80729709|FG000|Overall Study|Poor Vision|0|||
27697248|NCT01180998|80729710|FG001|Overall Study|Poor Vision|2|||
27697249|NCT01180998|80729711|FG002|Overall Study|Poor Vision|2|||
27697250|NCT01180998|80729709|FG000|Overall Study|Lost to Follow-up|0|||
27697251|NCT01180998|80729710|FG001|Overall Study|Lost to Follow-up|0|||
27697252|NCT01180998|80729711|FG002|Overall Study|Lost to Follow-up|1|||
27827941|NCT04852978|81202767|FG005|Overall Study|Physician Decision|0|||
27827942|NCT04852978|81202768|FG006|Overall Study|Physician Decision|0|||
27827943|NCT04852978|81202769|FG007|Overall Study|Physician Decision|2|||
27827944|NCT04852978|81202770|FG008|Overall Study|Physician Decision|0|||
27827945|NCT04852978|81202762|FG000|Overall Study|Sponsor request|0|||
27827946|NCT04852978|81202763|FG001|Overall Study|Sponsor request|0|||
27827947|NCT04852978|81202764|FG002|Overall Study|Sponsor request|1|||
27827948|NCT04852978|81202765|FG003|Overall Study|Sponsor request|0|||
27827949|NCT04852978|81202766|FG004|Overall Study|Sponsor request|0|||
27827950|NCT04852978|81202767|FG005|Overall Study|Sponsor request|0|||
27827951|NCT04852978|81202768|FG006|Overall Study|Sponsor request|0|||
27827952|NCT04852978|81202769|FG007|Overall Study|Sponsor request|0|||
27827953|NCT04852978|81202770|FG008|Overall Study|Sponsor request|0|||
27827954|NCT04852978|81202762|FG000|Overall Study|Death|0|||
27827955|NCT04852978|81202763|FG001|Overall Study|Death|0|||
27827956|NCT04852978|81202764|FG002|Overall Study|Death|0|||
27827957|NCT04852978|81202765|FG003|Overall Study|Death|0|||
27827958|NCT04852978|81202766|FG004|Overall Study|Death|0|||
27827959|NCT04852978|81202767|FG005|Overall Study|Death|0|||
27827960|NCT04852978|81202768|FG006|Overall Study|Death|1|||
27827961|NCT04852978|81202769|FG007|Overall Study|Death|0|||
27827962|NCT04852978|81202770|FG008|Overall Study|Death|0|||
27827963|NCT04852978|81202762|FG000|Overall Study|Lost to Follow-up|3|||
27827964|NCT04852978|81202763|FG001|Overall Study|Lost to Follow-up|2|||
27827965|NCT04852978|81202764|FG002|Overall Study|Lost to Follow-up|2|||
27827966|NCT04852978|81202765|FG003|Overall Study|Lost to Follow-up|0|||
27697253|NCT01180998|80729709|FG000|Overall Study|Protocol Violation|1|||
27697254|NCT01180998|80729710|FG001|Overall Study|Protocol Violation|2|||
27827967|NCT04852978|81202766|FG004|Overall Study|Lost to Follow-up|2|||
27827968|NCT04852978|81202767|FG005|Overall Study|Lost to Follow-up|4|||
27557472|NCT02659631|80226261|FG001|Overall Study|Withdrawal prior to treatment|0|||
27557473|NCT02659631|80226262|FG002|Overall Study|Withdrawal prior to treatment|0|||
27557474|NCT02659631|80226263|FG003|Overall Study|Withdrawal prior to treatment|0|||
27557475|NCT02659631|80226264|FG004|Overall Study|Withdrawal prior to treatment|1|||
27557476|NCT02659631|80226265|FG005|Overall Study|Withdrawal prior to treatment|0|||
27557477|NCT02659631|80226266|FG006|Overall Study|Withdrawal prior to treatment|0|||
27557478|NCT02659631|80226267|FG007|Overall Study|Withdrawal prior to treatment|0|||
27557479|NCT02659631|80226268|FG008|Overall Study|Withdrawal prior to treatment|0|||
27557480|NCT02659631|80226269|FG009|Overall Study|Withdrawal prior to treatment|0|||
27557481|NCT02659631|80226260|FG000|Overall Study|Participant refused further follow-up|0|||
27557482|NCT02659631|80226261|FG001|Overall Study|Participant refused further follow-up|0|||
27557483|NCT02659631|80226262|FG002|Overall Study|Participant refused further follow-up|0|||
27557484|NCT02659631|80226263|FG003|Overall Study|Participant refused further follow-up|1|||
27557485|NCT02659631|80226264|FG004|Overall Study|Participant refused further follow-up|0|||
27557486|NCT02659631|80226265|FG005|Overall Study|Participant refused further follow-up|0|||
27557487|NCT02659631|80226266|FG006|Overall Study|Participant refused further follow-up|0|||
27557488|NCT02659631|80226267|FG007|Overall Study|Participant refused further follow-up|0|||
27557489|NCT02659631|80226268|FG008|Overall Study|Participant refused further follow-up|1|||
27557490|NCT02659631|80226269|FG009|Overall Study|Participant refused further follow-up|0|||
27557491|NCT02659631|80226260|FG000|Overall Study|Death (follow-up phase)|1|||
27557492|NCT02659631|80226261|FG001|Overall Study|Death (follow-up phase)|2|||
27557493|NCT02659631|80226262|FG002|Overall Study|Death (follow-up phase)|1|||
27557494|NCT02659631|80226263|FG003|Overall Study|Death (follow-up phase)|1|||
27557495|NCT02659631|80226264|FG004|Overall Study|Death (follow-up phase)|3|||
27557496|NCT02659631|80226265|FG005|Overall Study|Death (follow-up phase)|2|||
27557497|NCT02659631|80226266|FG006|Overall Study|Death (follow-up phase)|0|||
27557498|NCT02659631|80226267|FG007|Overall Study|Death (follow-up phase)|3|||
27557499|NCT02659631|80226268|FG008|Overall Study|Death (follow-up phase)|1|||
27557500|NCT02659631|80226269|FG009|Overall Study|Death (follow-up phase)|0|||
27557501|NCT02659631|80226260|FG000|Overall Study|Death (treatment phase)|0|||
27557502|NCT02659631|80226261|FG001|Overall Study|Death (treatment phase)|0|||
27557503|NCT02659631|80226262|FG002|Overall Study|Death (treatment phase)|0|||
27557504|NCT02659631|80226263|FG003|Overall Study|Death (treatment phase)|0|||
27557505|NCT02659631|80226264|FG004|Overall Study|Death (treatment phase)|1|||
27557506|NCT02659631|80226265|FG005|Overall Study|Death (treatment phase)|0|||
27827969|NCT04852978|81202768|FG006|Overall Study|Lost to Follow-up|1|||
27557507|NCT02659631|80226266|FG006|Overall Study|Death (treatment phase)|1|||
27827970|NCT04852978|81202769|FG007|Overall Study|Lost to Follow-up|2|||
27557508|NCT02659631|80226267|FG007|Overall Study|Death (treatment phase)|0|||
27827971|NCT04852978|81202770|FG008|Overall Study|Lost to Follow-up|2|||
27827972|NCT04852978|81202762|FG000|Overall Study|Withdrawal by Subject|4|||
27827973|NCT04852978|81202763|FG001|Overall Study|Withdrawal by Subject|2|||
27697255|NCT01180998|80729711|FG002|Overall Study|Protocol Violation|0|||
27697256|NCT01180998|80729709|FG000|Overall Study|Withdrawal by Subject|0|||
27697257|NCT01180998|80729710|FG001|Overall Study|Withdrawal by Subject|0|||
27697258|NCT01180998|80729711|FG002|Overall Study|Withdrawal by Subject|1|||
27697259|NCT01180998|80729709|FG000|Overall Study|Poor comfort|3|||
27697260|NCT01180998|80729710|FG001|Overall Study|Poor comfort|0|||
27697261|NCT01180998|80729711|FG002|Overall Study|Poor comfort|4|||
27884200|NCT00423332|81408219|FG001|Overall Study|Condition under investigation worsened|1|||
27884201|NCT00423332|81408218|FG000|Overall Study|Progressive at Week 6|0|||
27884202|NCT00423332|81408219|FG001|Overall Study|Progressive at Week 6|1|||
27884203|NCT00423332|81408218|FG000|Overall Study|Unblinded before 12 weeks|1|||
27697262|NCT01180998|80729709|FG000|Overall Study|Poor lens handling|0|||
27697263|NCT01180998|80729710|FG001|Overall Study|Poor lens handling|0|||
27697264|NCT01180998|80729711|FG002|Overall Study|Poor lens handling|2|||
27697265|NCT01440374|80729713|FG000|Part 1: Open-label Phase|Adverse Event|5|||
27697266|NCT01440374|80729714|FG001|Part 1: Open-label Phase|Adverse Event|0|||
27697267|NCT01440374|80729715|FG002|Part 1: Open-label Phase|Adverse Event|0|||
27697268|NCT01440374|80729716|FG003|Part 1: Open-label Phase|Adverse Event|0|||
27697269|NCT01440374|80729713|FG000|Part 1: Open-label Phase|Physician Decision|1|||
27697270|NCT01440374|80729714|FG001|Part 1: Open-label Phase|Physician Decision|0|||
27697271|NCT01440374|80729715|FG002|Part 1: Open-label Phase|Physician Decision|0|||
27697272|NCT01440374|80729716|FG003|Part 1: Open-label Phase|Physician Decision|0|||
27697273|NCT01440374|80729713|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
27884204|NCT00423332|81408219|FG001|Overall Study|Unblinded before 12 weeks|3|||
27884205|NCT00402688|81408220|FG000|Overall Study|Adverse Event|12|||
27884206|NCT00402688|81408221|FG001|Overall Study|Adverse Event|9|||
27884207|NCT00402688|81408222|FG002|Overall Study|Adverse Event|3|||
27884208|NCT00402688|81408220|FG000|Overall Study|Withdrawal by Subject|3|||
27884209|NCT00402688|81408221|FG001|Overall Study|Withdrawal by Subject|1|||
27884210|NCT00402688|81408222|FG002|Overall Study|Withdrawal by Subject|1|||
27884211|NCT00402688|81408220|FG000|Overall Study|Physician Decision|0|||
27884212|NCT00402688|81408221|FG001|Overall Study|Physician Decision|0|||
27884213|NCT00402688|81408222|FG002|Overall Study|Physician Decision|1|||
27884214|NCT00402688|81408220|FG000|Overall Study|Lack of Efficacy|4|||
27884215|NCT00402688|81408221|FG001|Overall Study|Lack of Efficacy|4|||
27884216|NCT00402688|81408222|FG002|Overall Study|Lack of Efficacy|5|||
27884217|NCT00402688|81408220|FG000|Overall Study|Protocol Violation|1|||
27884218|NCT00402688|81408221|FG001|Overall Study|Protocol Violation|1|||
27884219|NCT00402688|81408222|FG002|Overall Study|Protocol Violation|1|||
27884220|NCT00402688|81408220|FG000|Overall Study|Lost to Follow-up|1|||
27884221|NCT00402688|81408221|FG001|Overall Study|Lost to Follow-up|0|||
27884222|NCT00402688|81408222|FG002|Overall Study|Lost to Follow-up|2|||
27884223|NCT00402688|81408220|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
27884224|NCT00402688|81408221|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
27884225|NCT00402688|81408222|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
27884226|NCT00402688|81408220|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
27884227|NCT00402688|81408221|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
27884228|NCT00402688|81408222|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
27884229|NCT00402688|81408220|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
27884230|NCT00402688|81408221|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
27884231|NCT00402688|81408222|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
27697274|NCT01440374|80729714|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
27697275|NCT01440374|80729715|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
27697276|NCT01440374|80729716|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
27884232|NCT01417156|81408230|FG000|Overall Study|Adverse Event|12|||
27884233|NCT01417156|81408230|FG000|Overall Study|Protocol Violation|2|||
27884234|NCT00101166|81411735|FG000|Overall Study|progressive disease|10|||
27884235|NCT00892151|81411736|FG000|Overall Study|Protocol Violation|1|||
27697277|NCT01440374|80729713|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
27884236|NCT04109391|81411737|FG000|Overall Study|Adverse Event|2|||
27884237|NCT04109391|81411738|FG001|Overall Study|Adverse Event|2|||
27827974|NCT04852978|81202764|FG002|Overall Study|Withdrawal by Subject|2|||
27827975|NCT04852978|81202765|FG003|Overall Study|Withdrawal by Subject|1|||
27884238|NCT04109391|81411739|FG002|Overall Study|Adverse Event|0|||
27884239|NCT04109391|81411737|FG000|Overall Study|Withdrawal by Subject|2|||
27884240|NCT04109391|81411738|FG001|Overall Study|Withdrawal by Subject|0|||
27557509|NCT02659631|80226268|FG008|Overall Study|Death (treatment phase)|0|||
27557510|NCT02659631|80226269|FG009|Overall Study|Death (treatment phase)|0|||
27557511|NCT03654651|80226270|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27557512|NCT03654651|80226271|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
27557513|NCT05286307|80226272|FG000|Overall Study|Incomplete outcome assessments|2|||
27557514|NCT05286307|80226273|FG001|Overall Study|Incomplete outcome assessments|1|||
27557515|NCT05286307|80226272|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
27557516|NCT05286307|80226273|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
27557517|NCT05286307|80226272|FG000|Overall Study|Lost to follow up at 6 months|25|||
27557518|NCT05286307|80226273|FG001|Overall Study|Lost to follow up at 6 months|35|||
27557519|NCT05286307|80226272|FG000|Overall Study|Study medication not available|1|||
27557520|NCT05286307|80226273|FG001|Overall Study|Study medication not available|1|||
27557521|NCT01338493|80226274|FG000|Enrolled|Withdrawal by Subject|1|||
27557522|NCT01338493|80226274|FG000|Enrolled|Patient not implanted|4|||
27557523|NCT01338493|80226274|FG000|Discharge|Death|1|||
27697278|NCT01440374|80729714|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
27697279|NCT01440374|80729715|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
27697280|NCT01440374|80729716|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
27697281|NCT01440374|80729713|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
27697282|NCT01440374|80729714|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
27697283|NCT01440374|80729715|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
27697284|NCT01440374|80729716|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
27697285|NCT01440374|80729713|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
27697286|NCT01440374|80729714|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
27697287|NCT01440374|80729715|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
27697288|NCT01440374|80729716|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
27697289|NCT01440374|80729713|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
27697290|NCT01440374|80729714|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
27697291|NCT01440374|80729715|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
27697292|NCT01440374|80729716|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
27557524|NCT01338493|80226274|FG000|Discharge|Missed visit|1|||
27697293|NCT01440374|80729713|FG000|Part 2; Double-blind Phase|Not treated|0|||
27697294|NCT01440374|80729714|FG001|Part 2; Double-blind Phase|Not treated|0|||
27557525|NCT01338493|80226274|FG000|6 Months Follow up|Lost to Follow-up|11|||
27557526|NCT01338493|80226274|FG000|6 Months Follow up|Missed visit|8|||
27827976|NCT04852978|81202766|FG004|Overall Study|Withdrawal by Subject|5|||
27827977|NCT04852978|81202767|FG005|Overall Study|Withdrawal by Subject|3|||
27827978|NCT04852978|81202768|FG006|Overall Study|Withdrawal by Subject|2|||
27557527|NCT01338493|80226274|FG000|12 Months Follow up|Lost to Follow-up|9|||
27557528|NCT01059786|80229417|FG000|Overall Study|Did not receive 6 cycles.|0|||
27557529|NCT01059786|80229418|FG001|Overall Study|Did not receive 6 cycles.|0|||
27827979|NCT04852978|81202769|FG007|Overall Study|Withdrawal by Subject|2|||
27827980|NCT04852978|81202770|FG008|Overall Study|Withdrawal by Subject|1|||
27827981|NCT01537887|81202771|FG000|Period 1|Physician Decision|0|||
27827982|NCT01537887|81202772|FG001|Period 1|Physician Decision|0|||
27827983|NCT01537887|81202773|FG002|Period 1|Physician Decision|0|||
27827984|NCT01537887|81202774|FG003|Period 1|Physician Decision|0|||
27827985|NCT01537887|81202775|FG004|Period 1|Physician Decision|1|||
27827986|NCT01537887|81202776|FG005|Period 1|Physician Decision|1|||
27827987|NCT01537887|81202771|FG000|Period 1|Did not receive treatment|0|||
27827988|NCT01537887|81202772|FG001|Period 1|Did not receive treatment|0|||
27827989|NCT01537887|81202773|FG002|Period 1|Did not receive treatment|1|||
27827990|NCT01537887|81202774|FG003|Period 1|Did not receive treatment|0|||
27827991|NCT01537887|81202775|FG004|Period 1|Did not receive treatment|0|||
27827992|NCT01537887|81202776|FG005|Period 1|Did not receive treatment|0|||
27827993|NCT01537887|81202771|FG000|Period 2|Withdrawal by Subject|0|||
27827994|NCT01537887|81202772|FG001|Period 2|Withdrawal by Subject|1|||
27557530|NCT01059786|80229419|FG002|Overall Study|Did not receive 6 cycles.|4|||
27557531|NCT01059786|80229420|FG003|Overall Study|Did not receive 6 cycles.|1|||
27557532|NCT01059786|80229421|FG004|Overall Study|Did not receive 6 cycles.|0|||
27557533|NCT01549392|80229422|FG000|Overall Study|Withdrawal by Subject|1|||
27557534|NCT01549392|80229423|FG001|Overall Study|Withdrawal by Subject|0|||
27557535|NCT01361464|80229427|FG000|Overall Study|Death|1|||
27557536|NCT01361464|80229427|FG000|Overall Study|Withdrawal by Subject|2|||
27557537|NCT03108027|80229434|FG000|Period 1|Subject/Guardian Decision|0|||
27884241|NCT04109391|81411739|FG002|Overall Study|Withdrawal by Subject|0|||
27884242|NCT04109391|81411737|FG000|Overall Study|Pregnancy|1|||
27884243|NCT04109391|81411738|FG001|Overall Study|Pregnancy|0|||
27884244|NCT04109391|81411739|FG002|Overall Study|Pregnancy|0|||
27884245|NCT04109391|81411737|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
27884246|NCT04109391|81411738|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
27884247|NCT04109391|81411739|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
27884248|NCT04109391|81411737|FG000|Overall Study|Lost to Follow-up|0|||
27884249|NCT04109391|81411738|FG001|Overall Study|Lost to Follow-up|0|||
27884250|NCT04109391|81411739|FG002|Overall Study|Lost to Follow-up|1|||
27884251|NCT04109391|81411737|FG000|Overall Study|Lack of Efficacy|2|||
27884252|NCT04109391|81411738|FG001|Overall Study|Lack of Efficacy|2|||
27557538|NCT03108027|80229435|FG001|Period 1|Subject/Guardian Decision|0|||
27557539|NCT03108027|80229436|FG002|Period 1|Subject/Guardian Decision|0|||
27557540|NCT03108027|80229437|FG003|Period 1|Subject/Guardian Decision|2|||
27557541|NCT03108027|80229438|FG004|Period 1|Subject/Guardian Decision|0|||
27557542|NCT03108027|80229439|FG005|Period 1|Subject/Guardian Decision|0|||
27557543|NCT03108027|80229434|FG000|Period 3|Adverse Event|0|||
27557544|NCT03108027|80229435|FG001|Period 3|Adverse Event|1|||
27557545|NCT03108027|80229436|FG002|Period 3|Adverse Event|0|||
27557546|NCT03108027|80229437|FG003|Period 3|Adverse Event|0|||
27557547|NCT03108027|80229438|FG004|Period 3|Adverse Event|0|||
27557548|NCT03108027|80229439|FG005|Period 3|Adverse Event|0|||
27557549|NCT03635957|80229440|FG000|Run-In Period|Lost to Follow-up|1|||
27557550|NCT03635957|80229440|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
27557551|NCT00006903|80229441|FG000|Overall Study|Still receiving treatment|0|||
27827995|NCT01537887|81202773|FG002|Period 2|Withdrawal by Subject|0|||
27827996|NCT01537887|81202774|FG003|Period 2|Withdrawal by Subject|0|||
27827997|NCT01537887|81202775|FG004|Period 2|Withdrawal by Subject|0|||
27827998|NCT01537887|81202776|FG005|Period 2|Withdrawal by Subject|0|||
27827999|NCT01537887|81202771|FG000|Period 3|Adverse Event|0|||
27828000|NCT01537887|81202772|FG001|Period 3|Adverse Event|0|||
27557552|NCT00006903|80229442|FG001|Overall Study|Still receiving treatment|0|||
27557553|NCT00006903|80229443|FG002|Overall Study|Still receiving treatment|1|||
27884253|NCT04109391|81411739|FG002|Overall Study|Lack of Efficacy|3|||
27557554|NCT00006903|80229441|FG000|Overall Study|Refused further treatment|0|||
27557555|NCT00006903|80229442|FG001|Overall Study|Refused further treatment|2|||
27557556|NCT00006903|80229443|FG002|Overall Study|Refused further treatment|1|||
27557557|NCT00006903|80229441|FG000|Overall Study|Adverse Event|0|||
27828001|NCT01537887|81202773|FG002|Period 3|Adverse Event|1|||
27557558|NCT00006903|80229442|FG001|Overall Study|Adverse Event|0|||
27828002|NCT01537887|81202774|FG003|Period 3|Adverse Event|0|||
27828003|NCT01537887|81202775|FG004|Period 3|Adverse Event|0|||
27828004|NCT01537887|81202776|FG005|Period 3|Adverse Event|0|||
27557559|NCT00006903|80229443|FG002|Overall Study|Adverse Event|1|||
27557560|NCT00006903|80229441|FG000|Overall Study|Death|0|||
27557561|NCT00006903|80229442|FG001|Overall Study|Death|1|||
27557562|NCT00006903|80229443|FG002|Overall Study|Death|0|||
27557563|NCT00006903|80229441|FG000|Overall Study|Patient never treated|0|||
27557564|NCT00006903|80229442|FG001|Overall Study|Patient never treated|0|||
27557565|NCT00006903|80229443|FG002|Overall Study|Patient never treated|1|||
27557566|NCT00006903|80229441|FG000|Overall Study|Ineligible|10|||
27557567|NCT00006903|80229442|FG001|Overall Study|Ineligible|1|||
27557568|NCT00006903|80229443|FG002|Overall Study|Ineligible|2|||
27557569|NCT00180414|80229444|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
27557570|NCT00180414|80229445|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
27828005|NCT01537887|81202771|FG000|Period 3|Withdrawal by Subject|0|||
27828006|NCT01537887|81202772|FG001|Period 3|Withdrawal by Subject|1|||
27828007|NCT01537887|81202773|FG002|Period 3|Withdrawal by Subject|0|||
27828008|NCT01537887|81202774|FG003|Period 3|Withdrawal by Subject|0|||
27828009|NCT01537887|81202775|FG004|Period 3|Withdrawal by Subject|0|||
27828010|NCT01537887|81202776|FG005|Period 3|Withdrawal by Subject|0|||
27828011|NCT00467363|81202785|FG000|Overall Study|Lost to Follow-up|80|||
27828012|NCT00467363|81202786|FG001|Overall Study|Lost to Follow-up|70|||
27828013|NCT01309672|81202787|FG000|Overall Study|Lack of Efficacy|20|||
27828014|NCT01309672|81202787|FG000|Overall Study|Other|9|||
27828015|NCT01309672|81202787|FG000|Overall Study|Adverse Event|5|||
27557571|NCT00513474|80229447|FG000|Overall Study|Death|6|||
27557572|NCT00513474|80229448|FG001|Overall Study|Death|9|||
27557573|NCT00513474|80229447|FG000|Overall Study|Participant Withdrew Consent|1|||
27557574|NCT00513474|80229448|FG001|Overall Study|Participant Withdrew Consent|0|||
27557575|NCT01641692|80229449|FG000|Treatment Period 1|Adverse Event|1|||
27557576|NCT01641692|80229450|FG001|Treatment Period 1|Adverse Event|0|||
27557577|NCT01641692|80229451|FG002|Treatment Period 1|Adverse Event|0|||
27557578|NCT01641692|80229452|FG003|Treatment Period 1|Adverse Event|0|||
27557579|NCT01641692|80229453|FG004|Treatment Period 1|Adverse Event|0|||
27557580|NCT01641692|80229454|FG005|Treatment Period 1|Adverse Event|0|||
27557581|NCT01641692|80229455|FG006|Treatment Period 1|Adverse Event|0|||
27557582|NCT01641692|80229456|FG007|Treatment Period 1|Adverse Event|0|||
27557583|NCT01641692|80229449|FG000|Treatment Period 1|Lack of Efficacy|0|||
27557584|NCT01641692|80229450|FG001|Treatment Period 1|Lack of Efficacy|0|||
27828016|NCT01309672|81202787|FG000|Overall Study|Withdrawal by Subject|3|||
27828017|NCT00833937|81202788|FG000|Washout|Withdrawal by Subject|1|||
27828018|NCT00833937|81202789|FG001|Washout|Withdrawal by Subject|0|||
27828019|NCT00579345|81202790|FG000|Overall Study|Withdrawal by Subject|2|||
27828020|NCT00579345|81202791|FG001|Overall Study|Withdrawal by Subject|0|||
27828021|NCT00579345|81202792|FG002|Overall Study|Withdrawal by Subject|0|||
27828022|NCT00579345|81202793|FG003|Overall Study|Withdrawal by Subject|0|||
27828023|NCT00579345|81202794|FG004|Overall Study|Withdrawal by Subject|0|||
27828024|NCT00579345|81202795|FG005|Overall Study|Withdrawal by Subject|0|||
27828025|NCT00579345|81202796|FG006|Overall Study|Withdrawal by Subject|0|||
27828026|NCT00579345|81202797|FG007|Overall Study|Withdrawal by Subject|1|||
27828027|NCT00579345|81202790|FG000|Overall Study|Lost to Follow-up|1|||
27828028|NCT00579345|81202791|FG001|Overall Study|Lost to Follow-up|0|||
27828029|NCT00579345|81202792|FG002|Overall Study|Lost to Follow-up|0|||
27828030|NCT00579345|81202793|FG003|Overall Study|Lost to Follow-up|0|||
27557585|NCT01641692|80229451|FG002|Treatment Period 1|Lack of Efficacy|0|||
27557586|NCT01641692|80229452|FG003|Treatment Period 1|Lack of Efficacy|0|||
27828031|NCT00579345|81202794|FG004|Overall Study|Lost to Follow-up|0|||
27828032|NCT00579345|81202795|FG005|Overall Study|Lost to Follow-up|0|||
27557587|NCT01641692|80229453|FG004|Treatment Period 1|Lack of Efficacy|0|||
27557588|NCT01641692|80229454|FG005|Treatment Period 1|Lack of Efficacy|0|||
27557589|NCT01641692|80229455|FG006|Treatment Period 1|Lack of Efficacy|0|||
27557590|NCT01641692|80229456|FG007|Treatment Period 1|Lack of Efficacy|1|||
27557591|NCT01641692|80229449|FG000|Treatment Period 1|Protocol Violation|1|||
27557592|NCT01641692|80229450|FG001|Treatment Period 1|Protocol Violation|0|||
27557593|NCT01641692|80229451|FG002|Treatment Period 1|Protocol Violation|0|||
27828033|NCT00579345|81202796|FG006|Overall Study|Lost to Follow-up|0|||
27828034|NCT00579345|81202797|FG007|Overall Study|Lost to Follow-up|0|||
27828035|NCT00579345|81202790|FG000|Overall Study|Adverse Event|0|||
27828036|NCT00579345|81202791|FG001|Overall Study|Adverse Event|0|||
27828037|NCT00579345|81202792|FG002|Overall Study|Adverse Event|1|||
27557594|NCT01641692|80229452|FG003|Treatment Period 1|Protocol Violation|0|||
27557595|NCT01641692|80229453|FG004|Treatment Period 1|Protocol Violation|2|||
27557596|NCT01641692|80229454|FG005|Treatment Period 1|Protocol Violation|0|||
27557597|NCT01641692|80229455|FG006|Treatment Period 1|Protocol Violation|0|||
27557598|NCT01641692|80229456|FG007|Treatment Period 1|Protocol Violation|0|||
27557599|NCT01641692|80229449|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27557600|NCT01641692|80229450|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27557601|NCT01641692|80229451|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27557602|NCT01641692|80229452|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27557603|NCT01641692|80229453|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
27557604|NCT01641692|80229454|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27557605|NCT01641692|80229455|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
27557606|NCT01641692|80229456|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
27557607|NCT01641692|80229449|FG000|Treatment Period 1|Lost to Follow-up|0|||
27557608|NCT01641692|80229450|FG001|Treatment Period 1|Lost to Follow-up|0|||
27557609|NCT01641692|80229451|FG002|Treatment Period 1|Lost to Follow-up|1|||
27557610|NCT01641692|80229452|FG003|Treatment Period 1|Lost to Follow-up|0|||
27557611|NCT01641692|80229453|FG004|Treatment Period 1|Lost to Follow-up|0|||
27557612|NCT01641692|80229454|FG005|Treatment Period 1|Lost to Follow-up|0|||
27557613|NCT01641692|80229455|FG006|Treatment Period 1|Lost to Follow-up|0|||
27557614|NCT01641692|80229456|FG007|Treatment Period 1|Lost to Follow-up|0|||
27557615|NCT01641692|80229449|FG000|Treatment Period 1|Physician Decision|0|||
27828038|NCT00579345|81202793|FG003|Overall Study|Adverse Event|0|||
27828039|NCT00579345|81202794|FG004|Overall Study|Adverse Event|0|||
27828040|NCT00579345|81202795|FG005|Overall Study|Adverse Event|0|||
27557616|NCT01641692|80229450|FG001|Treatment Period 1|Physician Decision|0|||
27557617|NCT01641692|80229451|FG002|Treatment Period 1|Physician Decision|0|||
27557618|NCT01641692|80229452|FG003|Treatment Period 1|Physician Decision|0|||
27557619|NCT01641692|80229453|FG004|Treatment Period 1|Physician Decision|1|||
27557620|NCT01641692|80229454|FG005|Treatment Period 1|Physician Decision|0|||
27557621|NCT01641692|80229455|FG006|Treatment Period 1|Physician Decision|0|||
27557622|NCT01641692|80229456|FG007|Treatment Period 1|Physician Decision|0|||
27557623|NCT01641692|80229449|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27557624|NCT01641692|80229450|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27557625|NCT01641692|80229451|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27557626|NCT01641692|80229452|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27557627|NCT01641692|80229453|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27557628|NCT01641692|80229454|FG005|Treatment Period 1|Withdrawal by Subject|2|||
27557629|NCT01641692|80229455|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27557630|NCT01641692|80229456|FG007|Treatment Period 1|Withdrawal by Subject|1|||
27557631|NCT01641692|80229449|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
27557632|NCT01641692|80229450|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557633|NCT01641692|80229451|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557634|NCT01641692|80229452|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557635|NCT01641692|80229453|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557636|NCT01641692|80229454|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557637|NCT01641692|80229455|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557638|NCT01641692|80229456|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
27557639|NCT01641692|80229449|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27557640|NCT01641692|80229450|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27557641|NCT01641692|80229451|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27557642|NCT01641692|80229452|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27557643|NCT01641692|80229453|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27828041|NCT00579345|81202796|FG006|Overall Study|Adverse Event|0|||
27828042|NCT00579345|81202797|FG007|Overall Study|Adverse Event|0|||
27828043|NCT00579345|81202790|FG000|Overall Study|Protocol Violation|1|||
27828044|NCT00579345|81202791|FG001|Overall Study|Protocol Violation|0|||
27828045|NCT00579345|81202792|FG002|Overall Study|Protocol Violation|0|||
27828046|NCT00579345|81202793|FG003|Overall Study|Protocol Violation|0|||
27828047|NCT00579345|81202794|FG004|Overall Study|Protocol Violation|0|||
27828048|NCT00579345|81202795|FG005|Overall Study|Protocol Violation|0|||
27828049|NCT00579345|81202796|FG006|Overall Study|Protocol Violation|0|||
27828050|NCT00579345|81202797|FG007|Overall Study|Protocol Violation|1|||
27828051|NCT00579345|81202790|FG000|Overall Study|Death|1|||
27828052|NCT00579345|81202791|FG001|Overall Study|Death|1|||
27557644|NCT01641692|80229454|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27828053|NCT00579345|81202792|FG002|Overall Study|Death|1|||
27557645|NCT01641692|80229455|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
27828054|NCT00579345|81202793|FG003|Overall Study|Death|1|||
27828055|NCT00579345|81202794|FG004|Overall Study|Death|0|||
27557646|NCT01641692|80229456|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
27828056|NCT00579345|81202795|FG005|Overall Study|Death|0|||
27828057|NCT00579345|81202796|FG006|Overall Study|Death|0|||
27828058|NCT00579345|81202797|FG007|Overall Study|Death|0|||
27557647|NCT01641692|80229449|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27557648|NCT01641692|80229450|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27557649|NCT01641692|80229451|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
27557650|NCT01641692|80229452|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27557651|NCT01641692|80229453|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
27557652|NCT01641692|80229454|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27557653|NCT01641692|80229455|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27557654|NCT01641692|80229456|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27557655|NCT01641692|80229449|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27557656|NCT01641692|80229450|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27557657|NCT01641692|80229451|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27557658|NCT01641692|80229452|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27557659|NCT01641692|80229453|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27557660|NCT01641692|80229454|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27557661|NCT01641692|80229455|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
27557662|NCT01641692|80229456|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
27557663|NCT01641692|80229449|FG000|Treatment Period 2|Lack of Efficacy|1|||
27557664|NCT01641692|80229450|FG001|Treatment Period 2|Lack of Efficacy|0|||
27557665|NCT01641692|80229451|FG002|Treatment Period 2|Lack of Efficacy|0|||
27557666|NCT01641692|80229452|FG003|Treatment Period 2|Lack of Efficacy|0|||
27557667|NCT01641692|80229453|FG004|Treatment Period 2|Lack of Efficacy|0|||
27557668|NCT01641692|80229454|FG005|Treatment Period 2|Lack of Efficacy|0|||
27557669|NCT01641692|80229455|FG006|Treatment Period 2|Lack of Efficacy|0|||
27557670|NCT01641692|80229456|FG007|Treatment Period 2|Lack of Efficacy|0|||
27557671|NCT01641692|80229449|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
27557672|NCT01641692|80229450|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557673|NCT01641692|80229451|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557674|NCT01641692|80229452|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557675|NCT01641692|80229453|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557676|NCT01641692|80229454|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557677|NCT01641692|80229455|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557678|NCT01641692|80229456|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
27557679|NCT01641692|80229449|FG000|Treatment Period 2|Lost to Follow-up|0|||
27557680|NCT01641692|80229450|FG001|Treatment Period 2|Lost to Follow-up|0|||
27557681|NCT01641692|80229451|FG002|Treatment Period 2|Lost to Follow-up|0|||
27557682|NCT01641692|80229452|FG003|Treatment Period 2|Lost to Follow-up|0|||
27557683|NCT01641692|80229453|FG004|Treatment Period 2|Lost to Follow-up|0|||
27557684|NCT01641692|80229454|FG005|Treatment Period 2|Lost to Follow-up|1|||
27557685|NCT01641692|80229455|FG006|Treatment Period 2|Lost to Follow-up|0|||
27557686|NCT01641692|80229456|FG007|Treatment Period 2|Lost to Follow-up|0|||
27557687|NCT01641692|80229449|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27557688|NCT01641692|80229450|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27557689|NCT01641692|80229451|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27557690|NCT01641692|80229452|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27557691|NCT01641692|80229453|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27557692|NCT01641692|80229454|FG005|Treatment Period 2|Withdrawal by Subject|1|||
27557693|NCT01641692|80229455|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27557694|NCT01641692|80229456|FG007|Treatment Period 2|Withdrawal by Subject|1|||
27828059|NCT02392195|81202802|FG000|Overall Study|Lost to Follow-up|4|||
27828060|NCT02392195|81202802|FG000|Overall Study|Withdrawal by Subject|4|||
27828061|NCT02963259|81202803|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
27828062|NCT02963259|81202803|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
27828063|NCT02963259|81202803|FG000|Overall Study|Death|1|||
27828064|NCT02963259|81202803|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
27828065|NCT00561015|81202804|FG000|Overall Study|Adverse Event|0|||
27828066|NCT00561015|81202805|FG001|Overall Study|Adverse Event|0|||
27828067|NCT00561015|81202806|FG002|Overall Study|Adverse Event|0|||
27828068|NCT00561015|81202807|FG003|Overall Study|Adverse Event|0|||
27557695|NCT01641692|80229449|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27557696|NCT01641692|80229450|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27828069|NCT00561015|81202808|FG004|Overall Study|Adverse Event|1|||
27828070|NCT00561015|81202809|FG005|Overall Study|Adverse Event|0|||
27828071|NCT00561015|81202804|FG000|Overall Study|Lost to Follow-up|2|||
27828072|NCT00561015|81202805|FG001|Overall Study|Lost to Follow-up|0|||
27828073|NCT00561015|81202806|FG002|Overall Study|Lost to Follow-up|0|||
27828074|NCT00561015|81202807|FG003|Overall Study|Lost to Follow-up|1|||
27828075|NCT00561015|81202808|FG004|Overall Study|Lost to Follow-up|0|||
27828076|NCT00561015|81202809|FG005|Overall Study|Lost to Follow-up|3|||
27828077|NCT00561015|81202804|FG000|Overall Study|Participant non-compliance|2|||
27828078|NCT00561015|81202805|FG001|Overall Study|Participant non-compliance|0|||
27828079|NCT00561015|81202806|FG002|Overall Study|Participant non-compliance|0|||
27828080|NCT00561015|81202807|FG003|Overall Study|Participant non-compliance|0|||
27828081|NCT00561015|81202808|FG004|Overall Study|Participant non-compliance|0|||
27828082|NCT00561015|81202809|FG005|Overall Study|Participant non-compliance|0|||
27828083|NCT01056484|81202810|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
27828084|NCT01056484|81202811|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
27884254|NCT00471081|81411750|FG000|Active Phase|Protocol Violation|1|||
27828085|NCT01056484|81202810|FG000|Randomized Controlled Trial|Physician Decision|1|||
27828086|NCT01056484|81202811|FG001|Randomized Controlled Trial|Physician Decision|0|||
27828087|NCT01056484|81202810|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
27828088|NCT01056484|81202811|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
27828089|NCT02601625|81202812|FG000|Overall Study|Lost to Follow-up|0|||
27828090|NCT02601625|81202813|FG001|Overall Study|Lost to Follow-up|0|||
27828091|NCT02601625|81202814|FG002|Overall Study|Lost to Follow-up|1|||
27828092|NCT02601625|81202815|FG003|Overall Study|Lost to Follow-up|1|||
27828093|NCT01380782|81202818|FG000|Overall Study|Adverse Event|0|||
27557697|NCT01641692|80229451|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27828094|NCT01380782|81202819|FG001|Overall Study|Adverse Event|1|||
27828095|NCT01380782|81202820|FG002|Overall Study|Adverse Event|0|||
27828096|NCT01380782|81202821|FG003|Overall Study|Adverse Event|0|||
27828097|NCT01380782|81202818|FG000|Overall Study|Death|1|||
27828098|NCT01380782|81202819|FG001|Overall Study|Death|0|||
27828099|NCT01380782|81202820|FG002|Overall Study|Death|0|||
27828100|NCT01380782|81202821|FG003|Overall Study|Death|0|||
27828101|NCT01380782|81202818|FG000|Overall Study|Lack of Efficacy|10|||
27828102|NCT01380782|81202819|FG001|Overall Study|Lack of Efficacy|9|||
27697295|NCT01440374|80729715|FG002|Part 2; Double-blind Phase|Not treated|1|||
27828103|NCT01380782|81202820|FG002|Overall Study|Lack of Efficacy|10|||
27828104|NCT01380782|81202821|FG003|Overall Study|Lack of Efficacy|3|||
27828105|NCT01380782|81202818|FG000|Overall Study|Physician Decision|1|||
27828106|NCT01380782|81202819|FG001|Overall Study|Physician Decision|0|||
27828107|NCT01380782|81202820|FG002|Overall Study|Physician Decision|0|||
27828108|NCT01380782|81202821|FG003|Overall Study|Physician Decision|0|||
27828109|NCT01380782|81202818|FG000|Overall Study|Withdrawal by Subject|0|||
27828110|NCT01380782|81202819|FG001|Overall Study|Withdrawal by Subject|0|||
27828111|NCT01380782|81202820|FG002|Overall Study|Withdrawal by Subject|1|||
27828112|NCT01380782|81202821|FG003|Overall Study|Withdrawal by Subject|1|||
27828113|NCT01168856|81202824|FG000|Overall Study|Lost to Follow-up|4|||
27828114|NCT01168856|81202825|FG001|Overall Study|Lost to Follow-up|34|||
27828115|NCT01168856|81202824|FG000|Overall Study|Withdrawal by Subject|6|||
27828116|NCT01168856|81202825|FG001|Overall Study|Withdrawal by Subject|8|||
27828117|NCT01168856|81202824|FG000|Overall Study|Physician Decision|2|||
27828118|NCT01168856|81202825|FG001|Overall Study|Physician Decision|1|||
27884255|NCT00471081|81411751|FG001|Active Phase|Protocol Violation|1|||
27828119|NCT01168856|81202824|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
27828120|NCT01168856|81202825|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
27828121|NCT01168856|81202824|FG000|Overall Study|Participant received anti-HCV treatment|1|||
27828122|NCT01168856|81202825|FG001|Overall Study|Participant received anti-HCV treatment|0|||
27828123|NCT01168856|81202824|FG000|Overall Study|Death|0|||
27828124|NCT01168856|81202825|FG001|Overall Study|Death|2|||
27828125|NCT01168856|81202824|FG000|Overall Study|Other|1|||
27828126|NCT01168856|81202825|FG001|Overall Study|Other|291|||
27828127|NCT01168856|81202824|FG000|Overall Study|Protocol Violation|4|||
27828128|NCT01168856|81202825|FG001|Overall Study|Protocol Violation|6|||
27828129|NCT03447353|81202826|FG000|Overall Study|Failure at Screening Visit|2|||
27828130|NCT03447353|81202826|FG000|Overall Study|Lost to Follow-up|4|||
27828131|NCT03447353|81202826|FG000|Overall Study|Scheduling Conflicts|3|||
27828132|NCT03447353|81202826|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
27828133|NCT01289262|81202834|FG000|Overall Study|Lost to Follow-up|29|||
27828134|NCT01289262|81202835|FG001|Overall Study|Lost to Follow-up|16|||
27828135|NCT01289262|81202834|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
27828136|NCT01289262|81202835|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
27828137|NCT01987765|81202837|FG000|Overall Study|Protocol Violation|65|||
27828138|NCT01987765|81202837|FG000|Overall Study|Lost to Follow-up|37|||
27828139|NCT01796171|81202838|FG000|Enrolled|Death|0|||
27828140|NCT01796171|81202839|FG001|Enrolled|Death|0|||
27828141|NCT01796171|81202840|FG002|Enrolled|Death|0|||
27828142|NCT01796171|81202841|FG003|Enrolled|Death|0|||
27828143|NCT01796171|81202842|FG004|Enrolled|Death|0|||
27828144|NCT01796171|81202843|FG005|Enrolled|Death|0|||
27828145|NCT01796171|81202844|FG006|Enrolled|Death|0|||
27828146|NCT01796171|81202845|FG007|Enrolled|Death|0|||
27828147|NCT01796171|81202846|FG008|Enrolled|Death|0|||
27828148|NCT01796171|81202847|FG009|Enrolled|Death|0|||
27828149|NCT01796171|81202848|FG010|Enrolled|Death|0|||
27828150|NCT01796171|81202849|FG011|Enrolled|Death|0|||
27828151|NCT01796171|81202850|FG012|Enrolled|Death|0|||
27828152|NCT01796171|81202851|FG013|Enrolled|Death|0|||
27828153|NCT01796171|81202852|FG014|Enrolled|Death|1|||
27828154|NCT01796171|81202838|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
27828155|NCT01796171|81202839|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
27828156|NCT01796171|81202840|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
27828157|NCT01796171|81202841|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
27828158|NCT01796171|81202842|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
27828159|NCT01796171|81202843|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
27828160|NCT01796171|81202844|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
27828161|NCT01796171|81202845|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
27828162|NCT01796171|81202846|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
27828163|NCT01796171|81202847|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
27828164|NCT01796171|81202848|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
27828165|NCT01796171|81202849|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
27828166|NCT01796171|81202850|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
27828167|NCT01796171|81202851|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
27828168|NCT01796171|81202852|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
27828169|NCT01796171|81202838|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828170|NCT01796171|81202839|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828171|NCT01796171|81202840|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828172|NCT01796171|81202841|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828173|NCT01796171|81202842|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27697296|NCT01440374|80729716|FG003|Part 2; Double-blind Phase|Not treated|0|||
27697297|NCT01440374|80729713|FG000|Part 3: Extension|Withdrawal by Subject|0|||
27697298|NCT01440374|80729714|FG001|Part 3: Extension|Withdrawal by Subject|0|||
27697299|NCT01440374|80729715|FG002|Part 3: Extension|Withdrawal by Subject|0|||
27697300|NCT01440374|80729716|FG003|Part 3: Extension|Withdrawal by Subject|5|||
27697301|NCT01440374|80729713|FG000|Part 3: Extension|Adverse Event|0|||
27697302|NCT01440374|80729714|FG001|Part 3: Extension|Adverse Event|0|||
27697303|NCT01440374|80729715|FG002|Part 3: Extension|Adverse Event|0|||
27697304|NCT01440374|80729716|FG003|Part 3: Extension|Adverse Event|13|||
27697305|NCT01440374|80729713|FG000|Part 3: Extension|Physician Decision|0|||
27697306|NCT01440374|80729714|FG001|Part 3: Extension|Physician Decision|0|||
27697307|NCT01440374|80729715|FG002|Part 3: Extension|Physician Decision|0|||
27697308|NCT01440374|80729716|FG003|Part 3: Extension|Physician Decision|14|||
27697309|NCT00876694|80729717|FG000|Overall Study|Adverse Event|10|||
27697310|NCT00876694|80729718|FG001|Overall Study|Adverse Event|7|||
27697311|NCT00876694|80729717|FG000|Overall Study|Subject withdrew consent|6|||
27697312|NCT00876694|80729718|FG001|Overall Study|Subject withdrew consent|4|||
27697313|NCT00876694|80729717|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27697314|NCT00876694|80729718|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27697315|NCT00876694|80729717|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27697316|NCT00876694|80729718|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27697317|NCT00876694|80729717|FG000|Overall Study|Administrative problems|1|||
27697318|NCT00876694|80729718|FG001|Overall Study|Administrative problems|1|||
27697319|NCT00876694|80729717|FG000|Overall Study|Death|1|||
27697320|NCT00876694|80729718|FG001|Overall Study|Death|0|||
27697321|NCT01214187|80729721|FG000|Overall Study|Adverse Event|6|||
27697322|NCT01214187|80729722|FG001|Overall Study|Adverse Event|2|||
27697323|NCT01214187|80729721|FG000|Overall Study|Death|1|||
27697324|NCT01214187|80729722|FG001|Overall Study|Death|1|||
27828174|NCT01796171|81202843|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27697325|NCT01214187|80729721|FG000|Overall Study|Withdrawal by Subject|0|||
27828175|NCT01796171|81202844|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828176|NCT01796171|81202845|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828177|NCT01796171|81202846|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828178|NCT01796171|81202847|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828179|NCT01796171|81202848|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27557698|NCT01641692|80229452|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27697326|NCT01214187|80729722|FG001|Overall Study|Withdrawal by Subject|3|||
27697327|NCT02901041|80729723|FG000|Overall Study|Withdrawal by PI|4|||
27697328|NCT02901041|80729724|FG001|Overall Study|Withdrawal by PI|8|||
27557699|NCT01641692|80229453|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
27828180|NCT01796171|81202849|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828181|NCT01796171|81202850|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828182|NCT01796171|81202851|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
27828183|NCT01796171|81202852|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
27828184|NCT01796171|81202838|FG000|Treatment Period With Betalutin|Progressive disease|0|||
27557700|NCT01641692|80229454|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27697329|NCT02901041|80729723|FG000|Overall Study|Withdrawal by Subject|7|||
27697330|NCT02901041|80729724|FG001|Overall Study|Withdrawal by Subject|3|||
27697331|NCT02594163|80729725|FG000|Treatment Period|Progressive disease|2|||
27828185|NCT01796171|81202839|FG001|Treatment Period With Betalutin|Progressive disease|1|||
27557701|NCT01641692|80229455|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
27557702|NCT01641692|80229456|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
27557703|NCT01641692|80229449|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27557704|NCT01641692|80229450|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27557705|NCT01641692|80229451|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27557706|NCT01641692|80229452|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27557707|NCT01641692|80229453|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27557708|NCT01641692|80229454|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27557709|NCT01641692|80229455|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
27557710|NCT01641692|80229456|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
27557711|NCT01641692|80229449|FG000|Treatment Period 3|Adverse Event|0|||
27557712|NCT01641692|80229450|FG001|Treatment Period 3|Adverse Event|0|||
27557713|NCT01641692|80229451|FG002|Treatment Period 3|Adverse Event|0|||
27557714|NCT01641692|80229452|FG003|Treatment Period 3|Adverse Event|0|||
27557715|NCT01641692|80229453|FG004|Treatment Period 3|Adverse Event|0|||
27557716|NCT01641692|80229454|FG005|Treatment Period 3|Adverse Event|0|||
27557717|NCT01641692|80229455|FG006|Treatment Period 3|Adverse Event|1|||
27557718|NCT01641692|80229456|FG007|Treatment Period 3|Adverse Event|0|||
27557719|NCT01641692|80229449|FG000|Treatment Period 3|Protocol Violation|0|||
27557720|NCT01641692|80229450|FG001|Treatment Period 3|Protocol Violation|0|||
27557721|NCT01641692|80229451|FG002|Treatment Period 3|Protocol Violation|1|||
27557722|NCT01641692|80229452|FG003|Treatment Period 3|Protocol Violation|0|||
27557723|NCT01641692|80229453|FG004|Treatment Period 3|Protocol Violation|0|||
27557724|NCT01641692|80229454|FG005|Treatment Period 3|Protocol Violation|0|||
27557725|NCT01641692|80229455|FG006|Treatment Period 3|Protocol Violation|0|||
27557726|NCT01641692|80229456|FG007|Treatment Period 3|Protocol Violation|0|||
27557727|NCT01641692|80229449|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27557728|NCT01641692|80229450|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27884256|NCT00471081|81411750|FG000|Active Phase|Withdrawal by Subject|0|||
27884257|NCT00471081|81411751|FG001|Active Phase|Withdrawal by Subject|3|||
27884258|NCT00471081|81411750|FG000|Active Phase|Lost to Follow-up|0|||
27884259|NCT00471081|81411751|FG001|Active Phase|Lost to Follow-up|1|||
27884260|NCT00471081|81411750|FG000|Active Phase|Lost health plan/insurance|1|||
27884261|NCT00471081|81411751|FG001|Active Phase|Lost health plan/insurance|8|||
27884262|NCT00471081|81411750|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
27557729|NCT01641692|80229451|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27557730|NCT01641692|80229452|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27557731|NCT01641692|80229453|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27557732|NCT01641692|80229454|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27557733|NCT01641692|80229455|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
27557734|NCT01641692|80229456|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
27557735|NCT01641692|80229449|FG000|Treatment Period 3|Lost to Follow-up|0|||
27557736|NCT01641692|80229450|FG001|Treatment Period 3|Lost to Follow-up|1|||
27884263|NCT00471081|81411751|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
27884264|NCT00471081|81411750|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
27884265|NCT00471081|81411751|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
27884266|NCT00471081|81411750|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
27884267|NCT00471081|81411751|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
27884268|NCT04740827|81411752|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
27884269|NCT04740827|81411753|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
27884270|NCT04740827|81411752|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
27884271|NCT04740827|81411753|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
27697332|NCT02594163|80729726|FG001|Treatment Period|Progressive disease|3|||
27697333|NCT02594163|80729725|FG000|Treatment Period|Adverse Event|1|||
27557737|NCT01641692|80229451|FG002|Treatment Period 3|Lost to Follow-up|0|||
27557738|NCT01641692|80229452|FG003|Treatment Period 3|Lost to Follow-up|0|||
27557739|NCT01641692|80229453|FG004|Treatment Period 3|Lost to Follow-up|0|||
27557740|NCT01641692|80229454|FG005|Treatment Period 3|Lost to Follow-up|0|||
27557741|NCT01641692|80229455|FG006|Treatment Period 3|Lost to Follow-up|0|||
27557742|NCT01641692|80229456|FG007|Treatment Period 3|Lost to Follow-up|0|||
27557743|NCT01641692|80229449|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557744|NCT01641692|80229450|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557745|NCT01641692|80229451|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557746|NCT01641692|80229452|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557747|NCT01641692|80229453|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557748|NCT01641692|80229454|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
27557749|NCT01641692|80229455|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557750|NCT01641692|80229456|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
27557751|NCT01641692|80229449|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27557752|NCT01641692|80229450|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
27557753|NCT01641692|80229451|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27557754|NCT01641692|80229452|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27557755|NCT01641692|80229453|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
27557756|NCT01641692|80229454|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27557757|NCT01641692|80229455|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
27557758|NCT01641692|80229456|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
27697334|NCT02594163|80729726|FG001|Treatment Period|Adverse Event|5|||
27557759|NCT01500629|80229457|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
27557760|NCT01500629|80229458|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
27557761|NCT00157950|80229461|FG000|Overall Study|Death|1|||
27557762|NCT00157950|80229462|FG001|Overall Study|Death|0|||
27557763|NCT00723892|80229464|FG000|Overall Study|Participant not tracked|33|||
27557764|NCT00723892|80229465|FG001|Overall Study|Participant not tracked|35|||
27557765|NCT00723892|80229464|FG000|Overall Study|Virological criterion|24|||
27557766|NCT00723892|80229465|FG001|Overall Study|Virological criterion|9|||
27557767|NCT00723892|80229464|FG000|Overall Study|Withdrawal by Subject|6|||
27557768|NCT00723892|80229465|FG001|Overall Study|Withdrawal by Subject|9|||
27557769|NCT00723892|80229464|FG000|Overall Study|End planned|11|||
27557770|NCT00723892|80229465|FG001|Overall Study|End planned|7|||
27557771|NCT00723892|80229464|FG000|Overall Study|Bad tolerance|5|||
27557772|NCT00723892|80229465|FG001|Overall Study|Bad tolerance|5|||
27557773|NCT00723892|80229464|FG000|Overall Study|Multiple reasons|17|||
27557774|NCT00723892|80229465|FG001|Overall Study|Multiple reasons|12|||
27884272|NCT04740827|81411752|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
27884273|NCT04740827|81411753|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
27884274|NCT04740827|81411752|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
27884275|NCT04740827|81411753|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
27884276|NCT04740827|81411752|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
27557775|NCT00723892|80229464|FG000|Overall Study|Other|6|||
27557776|NCT00723892|80229465|FG001|Overall Study|Other|3|||
27557777|NCT00723892|80229464|FG000|Overall Study|Study end|1|||
27557778|NCT00723892|80229465|FG001|Overall Study|Study end|3|||
27557779|NCT00723892|80229464|FG000|Overall Study|Weight loss|1|||
27557780|NCT00723892|80229465|FG001|Overall Study|Weight loss|3|||
27697335|NCT02594163|80729725|FG000|Treatment Period|Physician Decision|1|||
27884277|NCT04740827|81411753|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
27884278|NCT04740827|81411752|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
27557781|NCT00723892|80229464|FG000|Overall Study|Alcohol abuse|0|||
27557782|NCT00723892|80229465|FG001|Overall Study|Alcohol abuse|1|||
27557783|NCT00723892|80229464|FG000|Overall Study|Intercurrent infection|2|||
27557784|NCT00723892|80229465|FG001|Overall Study|Intercurrent infection|0|||
27557785|NCT00723892|80229464|FG000|Overall Study|Drug addiction|1|||
27557786|NCT00723892|80229465|FG001|Overall Study|Drug addiction|0|||
27557787|NCT02377466|80229466|FG000|Overall Study|Other: Randomized and not treated|0|||
27557788|NCT02377466|80229467|FG001|Overall Study|Other: Randomized and not treated|2|||
27557789|NCT00271609|80229468|FG000|Overall Study|Adverse Event|11|||
27557790|NCT00271609|80229469|FG001|Overall Study|Adverse Event|3|||
27557791|NCT00271609|80229468|FG000|Overall Study|Withdrawal by Subject|2|||
27828186|NCT01796171|81202840|FG002|Treatment Period With Betalutin|Progressive disease|0|||
27828187|NCT01796171|81202841|FG003|Treatment Period With Betalutin|Progressive disease|0|||
27557792|NCT00271609|80229469|FG001|Overall Study|Withdrawal by Subject|0|||
27557793|NCT01991067|80229471|FG000|Overall Study|Lost to Follow-up|6|||
27557794|NCT01991067|80229472|FG001|Overall Study|Lost to Follow-up|5|||
27557795|NCT01614067|80229473|FG000|Overall Study|Pregnancy|1|||
27557796|NCT01614067|80229474|FG001|Overall Study|Pregnancy|0|||
27557797|NCT01614067|80229473|FG000|Overall Study|Physician Decision|6|||
27557798|NCT01614067|80229474|FG001|Overall Study|Physician Decision|5|||
27557799|NCT01614067|80229473|FG000|Overall Study|Withdrawal by Subject|0|||
27557800|NCT01614067|80229474|FG001|Overall Study|Withdrawal by Subject|1|||
27557801|NCT01614067|80229473|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
27557802|NCT01614067|80229474|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
27557803|NCT00362115|80229476|FG000|Overall Study|Adverse Event|0|||
27828188|NCT01796171|81202842|FG004|Treatment Period With Betalutin|Progressive disease|0|||
27828189|NCT01796171|81202843|FG005|Treatment Period With Betalutin|Progressive disease|0|||
27828190|NCT01796171|81202844|FG006|Treatment Period With Betalutin|Progressive disease|0|||
27828191|NCT01796171|81202845|FG007|Treatment Period With Betalutin|Progressive disease|0|||
27828192|NCT01796171|81202846|FG008|Treatment Period With Betalutin|Progressive disease|0|||
27828193|NCT01796171|81202847|FG009|Treatment Period With Betalutin|Progressive disease|0|||
27828194|NCT01796171|81202848|FG010|Treatment Period With Betalutin|Progressive disease|0|||
27828195|NCT01796171|81202849|FG011|Treatment Period With Betalutin|Progressive disease|0|||
27557804|NCT00362115|80229477|FG001|Overall Study|Adverse Event|1|||
27557805|NCT00362115|80229478|FG002|Overall Study|Adverse Event|1|||
27557806|NCT00362115|80229479|FG003|Overall Study|Adverse Event|1|||
27557807|NCT00362115|80229480|FG004|Overall Study|Adverse Event|2|||
27557808|NCT00362115|80229481|FG005|Overall Study|Adverse Event|2|||
27828196|NCT01796171|81202850|FG012|Treatment Period With Betalutin|Progressive disease|0|||
27828197|NCT01796171|81202851|FG013|Treatment Period With Betalutin|Progressive disease|0|||
27828198|NCT01796171|81202852|FG014|Treatment Period With Betalutin|Progressive disease|0|||
27828199|NCT01796171|81202838|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828200|NCT01796171|81202839|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828201|NCT01796171|81202840|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828202|NCT01796171|81202841|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828203|NCT01796171|81202842|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828204|NCT01796171|81202843|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27557809|NCT00362115|80229482|FG006|Overall Study|Adverse Event|1|||
27557810|NCT00362115|80229476|FG000|Overall Study|Protocol Violation|0|||
27557811|NCT00362115|80229477|FG001|Overall Study|Protocol Violation|0|||
27557812|NCT00362115|80229478|FG002|Overall Study|Protocol Violation|0|||
27557813|NCT00362115|80229479|FG003|Overall Study|Protocol Violation|0|||
27557814|NCT00362115|80229480|FG004|Overall Study|Protocol Violation|0|||
27557815|NCT00362115|80229481|FG005|Overall Study|Protocol Violation|1|||
27557816|NCT00362115|80229482|FG006|Overall Study|Protocol Violation|0|||
27557817|NCT00362115|80229476|FG000|Overall Study|Lost to Follow-up|0|||
27557818|NCT00362115|80229477|FG001|Overall Study|Lost to Follow-up|1|||
27557819|NCT00362115|80229478|FG002|Overall Study|Lost to Follow-up|0|||
27557820|NCT00362115|80229479|FG003|Overall Study|Lost to Follow-up|0|||
27557821|NCT00362115|80229480|FG004|Overall Study|Lost to Follow-up|2|||
27557822|NCT00362115|80229481|FG005|Overall Study|Lost to Follow-up|0|||
27557823|NCT00362115|80229482|FG006|Overall Study|Lost to Follow-up|1|||
27557824|NCT00362115|80229476|FG000|Overall Study|Withdrawal by Subject|1|||
27557825|NCT00362115|80229477|FG001|Overall Study|Withdrawal by Subject|3|||
27557826|NCT00362115|80229478|FG002|Overall Study|Withdrawal by Subject|1|||
27557827|NCT00362115|80229479|FG003|Overall Study|Withdrawal by Subject|0|||
27557828|NCT00362115|80229480|FG004|Overall Study|Withdrawal by Subject|1|||
27828205|NCT01796171|81202844|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828206|NCT01796171|81202845|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828207|NCT01796171|81202846|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
27828208|NCT01796171|81202847|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828209|NCT01796171|81202848|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
27828210|NCT01796171|81202849|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
27828211|NCT01796171|81202850|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27557829|NCT00362115|80229481|FG005|Overall Study|Withdrawal by Subject|3|||
27557830|NCT00362115|80229482|FG006|Overall Study|Withdrawal by Subject|4|||
27557831|NCT00362115|80229476|FG000|Overall Study|Lack of Efficacy|1|||
27557832|NCT00362115|80229477|FG001|Overall Study|Lack of Efficacy|0|||
27557833|NCT00362115|80229478|FG002|Overall Study|Lack of Efficacy|5|||
27557834|NCT00362115|80229479|FG003|Overall Study|Lack of Efficacy|2|||
27557835|NCT00362115|80229480|FG004|Overall Study|Lack of Efficacy|2|||
27557836|NCT00362115|80229481|FG005|Overall Study|Lack of Efficacy|0|||
27557837|NCT00362115|80229482|FG006|Overall Study|Lack of Efficacy|3|||
27557838|NCT00362115|80229476|FG000|Overall Study|Physician Decision|0|||
27557839|NCT00362115|80229477|FG001|Overall Study|Physician Decision|0|||
27557840|NCT00362115|80229478|FG002|Overall Study|Physician Decision|0|||
27557841|NCT00362115|80229479|FG003|Overall Study|Physician Decision|0|||
27828212|NCT01796171|81202851|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828213|NCT01796171|81202852|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
27828214|NCT01796171|81202838|FG000|Treatment Period With Betalutin|Physician Decision|0|||
27828215|NCT01796171|81202839|FG001|Treatment Period With Betalutin|Physician Decision|0|||
27828216|NCT01796171|81202840|FG002|Treatment Period With Betalutin|Physician Decision|0|||
27828217|NCT01796171|81202841|FG003|Treatment Period With Betalutin|Physician Decision|0|||
27828218|NCT01796171|81202842|FG004|Treatment Period With Betalutin|Physician Decision|0|||
27828219|NCT01796171|81202843|FG005|Treatment Period With Betalutin|Physician Decision|0|||
27828220|NCT01796171|81202844|FG006|Treatment Period With Betalutin|Physician Decision|0|||
27828221|NCT01796171|81202845|FG007|Treatment Period With Betalutin|Physician Decision|0|||
27557842|NCT00362115|80229480|FG004|Overall Study|Physician Decision|0|||
27557843|NCT00362115|80229481|FG005|Overall Study|Physician Decision|0|||
27557844|NCT00362115|80229482|FG006|Overall Study|Physician Decision|3|||
27557845|NCT00362115|80229476|FG000|Overall Study|Other|0|||
27557846|NCT00362115|80229477|FG001|Overall Study|Other|1|||
27557847|NCT00362115|80229478|FG002|Overall Study|Other|0|||
27557848|NCT00362115|80229479|FG003|Overall Study|Other|1|||
27557849|NCT00362115|80229480|FG004|Overall Study|Other|0|||
27828222|NCT01796171|81202846|FG008|Treatment Period With Betalutin|Physician Decision|0|||
27828223|NCT01796171|81202847|FG009|Treatment Period With Betalutin|Physician Decision|0|||
27557850|NCT00362115|80229481|FG005|Overall Study|Other|1|||
27557851|NCT00362115|80229482|FG006|Overall Study|Other|0|||
27557852|NCT02057198|80229483|FG000|Overall Study|Death|0|||
27557853|NCT02057198|80229484|FG001|Overall Study|Death|0|||
27557854|NCT02057198|80229485|FG002|Overall Study|Death|1|||
27557855|NCT02057198|80229483|FG000|Overall Study|Discharged early; lost to followup|0|||
27828224|NCT01796171|81202848|FG010|Treatment Period With Betalutin|Physician Decision|5|||
27828225|NCT01796171|81202849|FG011|Treatment Period With Betalutin|Physician Decision|1|||
27884279|NCT04740827|81411753|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
27884280|NCT05486091|81411757|FG000|Overall Study|Withdrawal by Subject|1|||
27557856|NCT02057198|80229484|FG001|Overall Study|Discharged early; lost to followup|1|||
27557857|NCT02057198|80229485|FG002|Overall Study|Discharged early; lost to followup|0|||
27557858|NCT00680745|80229486|FG000|Overall Study|Withdrawal by Subject|8|||
27557859|NCT00680745|80229487|FG001|Overall Study|Withdrawal by Subject|3|||
27557860|NCT00680745|80229488|FG002|Overall Study|Withdrawal by Subject|2|||
27557861|NCT00680745|80229489|FG003|Overall Study|Withdrawal by Subject|8|||
27828226|NCT01796171|81202850|FG012|Treatment Period With Betalutin|Physician Decision|1|||
27828227|NCT01796171|81202851|FG013|Treatment Period With Betalutin|Physician Decision|0|||
27828228|NCT01796171|81202852|FG014|Treatment Period With Betalutin|Physician Decision|0|||
27828229|NCT01796171|81202838|FG000|Treatment Period With Betalutin|Death|0|||
27884281|NCT05486091|81411757|FG000|Overall Study|Lost to Follow-up|2|||
27557862|NCT00680745|80229486|FG000|Overall Study|Lost to Follow-up|0|||
27557863|NCT00680745|80229487|FG001|Overall Study|Lost to Follow-up|1|||
27557864|NCT00680745|80229488|FG002|Overall Study|Lost to Follow-up|1|||
27557865|NCT00680745|80229489|FG003|Overall Study|Lost to Follow-up|0|||
27557866|NCT00680745|80229486|FG000|Overall Study|Death|1|||
27557867|NCT00680745|80229487|FG001|Overall Study|Death|0|||
27557868|NCT00680745|80229488|FG002|Overall Study|Death|1|||
27557869|NCT00680745|80229489|FG003|Overall Study|Death|0|||
27557870|NCT00680745|80229486|FG000|Overall Study|Adverse Event|5|||
27557871|NCT00680745|80229487|FG001|Overall Study|Adverse Event|3|||
27557872|NCT00680745|80229488|FG002|Overall Study|Adverse Event|3|||
27557873|NCT00680745|80229489|FG003|Overall Study|Adverse Event|3|||
27557874|NCT00680745|80229486|FG000|Overall Study|Poor/Non-compliance|0|||
27557875|NCT00680745|80229487|FG001|Overall Study|Poor/Non-compliance|3|||
27557876|NCT00680745|80229488|FG002|Overall Study|Poor/Non-compliance|0|||
27557877|NCT00680745|80229489|FG003|Overall Study|Poor/Non-compliance|0|||
27557878|NCT00680745|80229486|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
27557879|NCT00680745|80229487|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
27557880|NCT00680745|80229488|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
27557881|NCT00680745|80229489|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
27557882|NCT00680745|80229486|FG000|Overall Study|False Treatment|0|||
27557883|NCT00680745|80229487|FG001|Overall Study|False Treatment|1|||
27557884|NCT00680745|80229488|FG002|Overall Study|False Treatment|3|||
27557885|NCT00680745|80229489|FG003|Overall Study|False Treatment|0|||
27557886|NCT03342690|80229491|FG000|Overall Study|Missing Information|9|||
27557887|NCT03342690|80229491|FG000|Overall Study|Protocol Violation|16|||
27557888|NCT00056407|80229495|FG000|Overall Study|Adverse Event|282|||
27557889|NCT00056407|80229496|FG001|Overall Study|Adverse Event|364|||
27557890|NCT00056407|80229495|FG000|Overall Study|Withdrawal by Subject|377|||
27557891|NCT00056407|80229496|FG001|Overall Study|Withdrawal by Subject|361|||
27557892|NCT00056407|80229495|FG000|Overall Study|Lost to Follow-up|123|||
27557893|NCT00056407|80229496|FG001|Overall Study|Lost to Follow-up|113|||
27557894|NCT00056407|80229495|FG000|Overall Study|Protocol Violation|104|||
27557895|NCT00056407|80229496|FG001|Overall Study|Protocol Violation|95|||
27557896|NCT00056407|80229495|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
27557897|NCT00056407|80229496|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
27884282|NCT03831113|81411758|FG000|Overall Study|Withdrawal by Subject|0|||
27557898|NCT00056407|80229495|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
27557899|NCT00056407|80229496|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
27557900|NCT00056407|80229495|FG000|Overall Study|Missing|25|||
27557901|NCT00056407|80229496|FG001|Overall Study|Missing|34|||
27557902|NCT03251079|80229502|FG000|Overall Study|Withdrawal by Subject|1|||
27557903|NCT03182829|80229510|FG000|Overall Study|Protocol Violation|12|||
27557904|NCT03182829|80229511|FG001|Overall Study|Protocol Violation|12|||
27557905|NCT03182829|80229510|FG000|Overall Study|Other|4|||
27557906|NCT03182829|80229511|FG001|Overall Study|Other|3|||
27557907|NCT01529346|80229515|FG000|Overall Study|Lost to Follow-up|2|||
27557908|NCT01529346|80229516|FG001|Overall Study|Lost to Follow-up|0|||
27557909|NCT01529346|80229517|FG002|Overall Study|Lost to Follow-up|1|||
27557910|NCT01529346|80229518|FG003|Overall Study|Lost to Follow-up|0|||
27557911|NCT01529346|80229519|FG004|Overall Study|Lost to Follow-up|0|||
27557912|NCT01529346|80229515|FG000|Overall Study|Other|0|||
27557913|NCT01529346|80229516|FG001|Overall Study|Other|1|||
27557914|NCT01529346|80229517|FG002|Overall Study|Other|1|||
27557915|NCT01529346|80229518|FG003|Overall Study|Other|0|||
27697336|NCT02594163|80729726|FG001|Treatment Period|Physician Decision|3|||
27697337|NCT02594163|80729725|FG000|Treatment Period|Study termination by sponsor|2|||
27697338|NCT02594163|80729726|FG001|Treatment Period|Study termination by sponsor|1|||
27697339|NCT02594163|80729725|FG000|Treatment Period|Other, Non-AE|1|||
27697340|NCT02594163|80729726|FG001|Treatment Period|Other, Non-AE|0|||
27697341|NCT02594163|80729725|FG000|Follow-up Period|Withdrawal by Subject|0|||
27697342|NCT02594163|80729726|FG001|Follow-up Period|Withdrawal by Subject|1|||
27697343|NCT02594163|80729725|FG000|Follow-up Period|Study Termination by Sponsor|6|||
27557916|NCT01529346|80229519|FG004|Overall Study|Other|0|||
27557917|NCT02746874|80229524|FG000|Overall Study|Withdrawal by Subject|0|||
27557918|NCT02746874|80229525|FG001|Overall Study|Withdrawal by Subject|1|||
27557919|NCT02746874|80229524|FG000|Overall Study|Surgery Date Changed|0|||
27557920|NCT02746874|80229525|FG001|Overall Study|Surgery Date Changed|2|||
27557921|NCT01750242|80229530|FG000|Overall Study|Unreadable Images|3|||
27557922|NCT00488345|80229531|FG000|Overall Study|Adverse Event|0|||
27557923|NCT00488345|80229532|FG001|Overall Study|Adverse Event|1|||
27557924|NCT00488345|80229533|FG002|Overall Study|Adverse Event|1|||
27557925|NCT00488345|80229531|FG000|Overall Study|Unable to administer antibiotics at home|0|||
27557926|NCT00488345|80229532|FG001|Overall Study|Unable to administer antibiotics at home|1|||
27557927|NCT00488345|80229533|FG002|Overall Study|Unable to administer antibiotics at home|0|||
27557928|NCT00488345|80229531|FG000|Overall Study|Institutional Review Board review|0|||
27557929|NCT00488345|80229532|FG001|Overall Study|Institutional Review Board review|0|||
27557930|NCT00488345|80229533|FG002|Overall Study|Institutional Review Board review|1|||
27557931|NCT00488345|80229531|FG000|Overall Study|Surgical team recommendation|0|||
27557932|NCT00488345|80229532|FG001|Overall Study|Surgical team recommendation|1|||
27557933|NCT00488345|80229533|FG002|Overall Study|Surgical team recommendation|0|||
27557934|NCT00488345|80229531|FG000|Overall Study|Parent/legal guardian request|0|||
27557935|NCT00488345|80229532|FG001|Overall Study|Parent/legal guardian request|1|||
27557936|NCT00488345|80229533|FG002|Overall Study|Parent/legal guardian request|1|||
27557937|NCT02953314|80229535|FG000|Overall Study|Adverse Event|0|||
27557938|NCT02953314|80229536|FG001|Overall Study|Adverse Event|1|||
27557939|NCT02953314|80229535|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
27557940|NCT02953314|80229536|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
27697344|NCT02594163|80729726|FG001|Follow-up Period|Study Termination by Sponsor|4|||
27697345|NCT02594163|80729725|FG000|Follow-up Period|Lost to Follow-up|1|||
27697346|NCT02594163|80729726|FG001|Follow-up Period|Lost to Follow-up|0|||
27697347|NCT02594163|80729725|FG000|Follow-up Period|Death|2|||
27557941|NCT00613938|80229537|FG000|Overall Study|Withdrawal by Subject|2|||
27557942|NCT00613938|80229538|FG001|Overall Study|Withdrawal by Subject|4|||
27557943|NCT00613938|80229539|FG002|Overall Study|Withdrawal by Subject|9|||
27557944|NCT00613938|80229540|FG003|Overall Study|Withdrawal by Subject|9|||
27557945|NCT00613938|80229537|FG000|Overall Study|Adverse Event|1|||
27697348|NCT02594163|80729726|FG001|Follow-up Period|Death|5|||
27828230|NCT01796171|81202839|FG001|Treatment Period With Betalutin|Death|0|||
27828231|NCT01796171|81202840|FG002|Treatment Period With Betalutin|Death|0|||
27828232|NCT01796171|81202841|FG003|Treatment Period With Betalutin|Death|0|||
27828233|NCT01796171|81202842|FG004|Treatment Period With Betalutin|Death|0|||
27828234|NCT01796171|81202843|FG005|Treatment Period With Betalutin|Death|0|||
27828235|NCT01796171|81202844|FG006|Treatment Period With Betalutin|Death|0|||
27828236|NCT01796171|81202845|FG007|Treatment Period With Betalutin|Death|0|||
27828237|NCT01796171|81202846|FG008|Treatment Period With Betalutin|Death|0|||
27828238|NCT01796171|81202847|FG009|Treatment Period With Betalutin|Death|0|||
27828239|NCT01796171|81202848|FG010|Treatment Period With Betalutin|Death|2|||
27828240|NCT01796171|81202849|FG011|Treatment Period With Betalutin|Death|0|||
27828241|NCT01796171|81202850|FG012|Treatment Period With Betalutin|Death|0|||
27828242|NCT01796171|81202851|FG013|Treatment Period With Betalutin|Death|0|||
27557946|NCT00613938|80229538|FG001|Overall Study|Adverse Event|4|||
27557947|NCT00613938|80229539|FG002|Overall Study|Adverse Event|8|||
27557948|NCT00613938|80229540|FG003|Overall Study|Adverse Event|5|||
27557949|NCT00613938|80229537|FG000|Overall Study|Lack of Efficacy|16|||
27557950|NCT00613938|80229538|FG001|Overall Study|Lack of Efficacy|18|||
27557951|NCT00613938|80229539|FG002|Overall Study|Lack of Efficacy|5|||
27557952|NCT00613938|80229540|FG003|Overall Study|Lack of Efficacy|9|||
27557953|NCT00613938|80229537|FG000|Overall Study|Other|1|||
27557954|NCT00613938|80229538|FG001|Overall Study|Other|2|||
27557955|NCT00613938|80229539|FG002|Overall Study|Other|1|||
27557956|NCT00613938|80229540|FG003|Overall Study|Other|3|||
27697349|NCT02594163|80729725|FG000|Follow-up Period|Adverse Event|0|||
27828243|NCT01796171|81202852|FG014|Treatment Period With Betalutin|Death|0|||
27828244|NCT01796171|81202838|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
27828245|NCT01796171|81202839|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
27828246|NCT01796171|81202840|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
27828247|NCT01796171|81202841|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
27828248|NCT01796171|81202842|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
27828249|NCT01796171|81202843|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
27828250|NCT01796171|81202844|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
27697350|NCT02594163|80729726|FG001|Follow-up Period|Adverse Event|1|||
27828251|NCT01796171|81202845|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
27828252|NCT01796171|81202846|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
27557957|NCT01472081|80229541|FG000|Overall Study|Continuing treatment at time of analysis|1|||
27557958|NCT01472081|80229542|FG001|Overall Study|Continuing treatment at time of analysis|4|||
27557959|NCT01472081|80229543|FG002|Overall Study|Continuing treatment at time of analysis|1|||
27828253|NCT01796171|81202847|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
27828254|NCT01796171|81202848|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
27828255|NCT01796171|81202849|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
27828256|NCT01796171|81202850|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
27828257|NCT01796171|81202851|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
27828258|NCT01796171|81202852|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
27828259|NCT01796171|81202838|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828260|NCT01796171|81202839|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828261|NCT01796171|81202840|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828262|NCT01796171|81202841|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27557960|NCT01472081|80229544|FG003|Overall Study|Continuing treatment at time of analysis|8|||
27557961|NCT01472081|80229545|FG004|Overall Study|Continuing treatment at time of analysis|9|||
27557962|NCT01472081|80229546|FG005|Overall Study|Continuing treatment at time of analysis|0|||
27557963|NCT01472081|80229541|FG000|Overall Study|Disease Progression|4|||
27557964|NCT01472081|80229542|FG001|Overall Study|Disease Progression|10|||
27557965|NCT01472081|80229543|FG002|Overall Study|Disease Progression|12|||
27557966|NCT01472081|80229544|FG003|Overall Study|Disease Progression|31|||
27557967|NCT01472081|80229545|FG004|Overall Study|Disease Progression|22|||
27557968|NCT01472081|80229546|FG005|Overall Study|Disease Progression|3|||
27557969|NCT01472081|80229541|FG000|Overall Study|Study drug toxicity|2|||
27557970|NCT01472081|80229542|FG001|Overall Study|Study drug toxicity|9|||
27557971|NCT01472081|80229543|FG002|Overall Study|Study drug toxicity|4|||
27557972|NCT01472081|80229544|FG003|Overall Study|Study drug toxicity|6|||
27557973|NCT01472081|80229545|FG004|Overall Study|Study drug toxicity|13|||
27557974|NCT01472081|80229546|FG005|Overall Study|Study drug toxicity|2|||
27557975|NCT01472081|80229541|FG000|Overall Study|Death|0|||
27557976|NCT01472081|80229542|FG001|Overall Study|Death|0|||
27828263|NCT01796171|81202842|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828264|NCT01796171|81202843|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828265|NCT01796171|81202844|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828266|NCT01796171|81202845|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27557977|NCT01472081|80229543|FG002|Overall Study|Death|0|||
27557978|NCT01472081|80229544|FG003|Overall Study|Death|0|||
27557979|NCT01472081|80229545|FG004|Overall Study|Death|1|||
27557980|NCT01472081|80229546|FG005|Overall Study|Death|0|||
27828267|NCT01796171|81202846|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828268|NCT01796171|81202847|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828269|NCT01796171|81202848|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
27557981|NCT01472081|80229541|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
27557982|NCT01472081|80229542|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
27557983|NCT01472081|80229543|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
27557984|NCT01472081|80229544|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
27557985|NCT01472081|80229545|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
27828270|NCT01796171|81202849|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
27697351|NCT02594163|80729725|FG000|Follow-up Period|Progressive Disease|2|||
27697352|NCT02594163|80729726|FG001|Follow-up Period|Progressive Disease|0|||
27697353|NCT02594163|80729725|FG000|Follow-up Period|Physician Decision|0|||
27697354|NCT02594163|80729726|FG001|Follow-up Period|Physician Decision|1|||
27697355|NCT01016977|80729727|FG000|Overall Study|Lost to Follow-up|1|||
27697356|NCT01016977|80729728|FG001|Overall Study|Lost to Follow-up|0|||
27697357|NCT01016977|80729727|FG000|Overall Study|Withdrawal by Subject|2|||
27697358|NCT01016977|80729728|FG001|Overall Study|Withdrawal by Subject|2|||
27697359|NCT00092495|80729729|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
27697360|NCT00092495|80729730|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
27697361|NCT00092495|80729731|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
27697362|NCT00092495|80729732|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
27697363|NCT00092495|80729733|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
27697364|NCT00092495|80729729|FG000|Base Study Vaccination Period|Extended|0|||
27697365|NCT00092495|80729730|FG001|Base Study Vaccination Period|Extended|0|||
27697366|NCT00092495|80729731|FG002|Base Study Vaccination Period|Extended|0|||
27697367|NCT00092495|80729732|FG003|Base Study Vaccination Period|Extended|1|||
27697368|NCT00092495|80729733|FG004|Base Study Vaccination Period|Extended|0|||
27697369|NCT00092495|80729729|FG000|Base Study Vaccination Period|*Clinical AE|1|||
27697370|NCT00092495|80729730|FG001|Base Study Vaccination Period|*Clinical AE|0|||
27697371|NCT00092495|80729731|FG002|Base Study Vaccination Period|*Clinical AE|1|||
27697372|NCT00092495|80729732|FG003|Base Study Vaccination Period|*Clinical AE|2|||
27557986|NCT01472081|80229546|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
27557987|NCT01472081|80229541|FG000|Overall Study|Withdrawal by Subject|0|||
27697373|NCT00092495|80729733|FG004|Base Study Vaccination Period|*Clinical AE|0|||
27697374|NCT00092495|80729729|FG000|Base Study Vaccination Period|*Other reasons|1|||
27697375|NCT00092495|80729730|FG001|Base Study Vaccination Period|*Other reasons|0|||
27697376|NCT00092495|80729731|FG002|Base Study Vaccination Period|*Other reasons|0|||
27557988|NCT01472081|80229542|FG001|Overall Study|Withdrawal by Subject|0|||
27557989|NCT01472081|80229543|FG002|Overall Study|Withdrawal by Subject|0|||
27557990|NCT01472081|80229544|FG003|Overall Study|Withdrawal by Subject|0|||
27557991|NCT01472081|80229545|FG004|Overall Study|Withdrawal by Subject|0|||
27557992|NCT01472081|80229546|FG005|Overall Study|Withdrawal by Subject|1|||
27557993|NCT01472081|80229541|FG000|Overall Study|Poor/non-compliance|0|||
27557994|NCT01472081|80229542|FG001|Overall Study|Poor/non-compliance|0|||
27557995|NCT01472081|80229543|FG002|Overall Study|Poor/non-compliance|1|||
27557996|NCT01472081|80229544|FG003|Overall Study|Poor/non-compliance|0|||
27557997|NCT01472081|80229545|FG004|Overall Study|Poor/non-compliance|1|||
27557998|NCT01472081|80229546|FG005|Overall Study|Poor/non-compliance|0|||
27557999|NCT01472081|80229541|FG000|Overall Study|No longer meets study criteria|0|||
27558000|NCT01472081|80229542|FG001|Overall Study|No longer meets study criteria|0|||
27558001|NCT01472081|80229543|FG002|Overall Study|No longer meets study criteria|1|||
27558002|NCT01472081|80229544|FG003|Overall Study|No longer meets study criteria|0|||
27558003|NCT01472081|80229545|FG004|Overall Study|No longer meets study criteria|0|||
27558004|NCT01472081|80229546|FG005|Overall Study|No longer meets study criteria|0|||
27558005|NCT01472081|80229541|FG000|Overall Study|Subject request to discontinue treatment|0|||
27558006|NCT01472081|80229542|FG001|Overall Study|Subject request to discontinue treatment|3|||
27697377|NCT00092495|80729732|FG003|Base Study Vaccination Period|*Other reasons|1|||
27697378|NCT00092495|80729733|FG004|Base Study Vaccination Period|*Other reasons|0|||
27697379|NCT00092495|80729729|FG000|Base Study Vaccination Period|*Pregnancy|0|||
27697380|NCT00092495|80729730|FG001|Base Study Vaccination Period|*Pregnancy|2|||
27697381|NCT00092495|80729731|FG002|Base Study Vaccination Period|*Pregnancy|5|||
27697382|NCT00092495|80729732|FG003|Base Study Vaccination Period|*Pregnancy|7|||
27697383|NCT00092495|80729733|FG004|Base Study Vaccination Period|*Pregnancy|0|||
27697384|NCT00092495|80729729|FG000|Base Study Vaccination Period|Adverse Event|1|||
27697385|NCT00092495|80729730|FG001|Base Study Vaccination Period|Adverse Event|0|||
27697386|NCT00092495|80729731|FG002|Base Study Vaccination Period|Adverse Event|0|||
27697387|NCT00092495|80729732|FG003|Base Study Vaccination Period|Adverse Event|3|||
27697388|NCT00092495|80729733|FG004|Base Study Vaccination Period|Adverse Event|0|||
27697389|NCT00092495|80729729|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
27697390|NCT00092495|80729730|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
27697391|NCT00092495|80729731|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
27697392|NCT00092495|80729732|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
27697393|NCT00092495|80729733|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
27697394|NCT00092495|80729729|FG000|Base Study Vaccination Period|Moved|3|||
27697395|NCT00092495|80729730|FG001|Base Study Vaccination Period|Moved|1|||
27697396|NCT00092495|80729731|FG002|Base Study Vaccination Period|Moved|2|||
27697397|NCT00092495|80729732|FG003|Base Study Vaccination Period|Moved|2|||
27697398|NCT00092495|80729733|FG004|Base Study Vaccination Period|Moved|0|||
27697399|NCT00092495|80729729|FG000|Base Study Vaccination Period|Other|1|||
27697400|NCT00092495|80729730|FG001|Base Study Vaccination Period|Other|1|||
27697401|NCT00092495|80729731|FG002|Base Study Vaccination Period|Other|0|||
27697402|NCT00092495|80729732|FG003|Base Study Vaccination Period|Other|2|||
27697403|NCT00092495|80729733|FG004|Base Study Vaccination Period|Other|0|||
27697404|NCT00092495|80729729|FG000|Base Study Vaccination Period|Pregnancy|2|||
27697405|NCT00092495|80729730|FG001|Base Study Vaccination Period|Pregnancy|0|||
27697406|NCT00092495|80729731|FG002|Base Study Vaccination Period|Pregnancy|0|||
27697407|NCT00092495|80729732|FG003|Base Study Vaccination Period|Pregnancy|0|||
27697408|NCT00092495|80729733|FG004|Base Study Vaccination Period|Pregnancy|0|||
27697409|NCT00092495|80729729|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
27697410|NCT00092495|80729730|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
27697411|NCT00092495|80729731|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
27697412|NCT00092495|80729732|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
27697413|NCT00092495|80729733|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
27697414|NCT00092495|80729729|FG000|Base Study Vaccination Period|Protocol Violation|1|||
27697415|NCT00092495|80729730|FG001|Base Study Vaccination Period|Protocol Violation|0|||
27697416|NCT00092495|80729731|FG002|Base Study Vaccination Period|Protocol Violation|0|||
27697417|NCT00092495|80729732|FG003|Base Study Vaccination Period|Protocol Violation|0|||
27697418|NCT00092495|80729733|FG004|Base Study Vaccination Period|Protocol Violation|0|||
27697419|NCT00092495|80729729|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
27697420|NCT00092495|80729730|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
27697421|NCT00092495|80729731|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
27697422|NCT00092495|80729732|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
27697423|NCT00092495|80729733|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
27697424|NCT00092495|80729729|FG000|Base Study Follow-up Period|Extended|0|||
27697425|NCT00092495|80729730|FG001|Base Study Follow-up Period|Extended|0|||
27697426|NCT00092495|80729731|FG002|Base Study Follow-up Period|Extended|1|||
27697427|NCT00092495|80729732|FG003|Base Study Follow-up Period|Extended|2|||
27697428|NCT00092495|80729733|FG004|Base Study Follow-up Period|Extended|0|||
27697429|NCT00092495|80729729|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
27697430|NCT00092495|80729730|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
27697431|NCT00092495|80729731|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
27697432|NCT00092495|80729732|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
27697433|NCT00092495|80729733|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
27697434|NCT00092495|80729729|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
27697435|NCT00092495|80729730|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
27828271|NCT01796171|81202850|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27697436|NCT00092495|80729731|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
27697437|NCT00092495|80729732|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
27697438|NCT00092495|80729733|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
27697439|NCT00655486|80729734|FG000|Overall Study|Adverse Event|10|||
27697440|NCT00655486|80729734|FG000|Overall Study|Lack of Efficacy|8|||
27697441|NCT00655486|80729734|FG000|Overall Study|Withdrawal by Subject|4|||
27697442|NCT00655486|80729734|FG000|Overall Study|Protocol Violation|1|||
27697443|NCT00655486|80729734|FG000|Overall Study|Unsatisfactory compliance|2|||
27697444|NCT00655486|80729734|FG000|Overall Study|Other: Pregnancy|1|||
27697445|NCT00655486|80729734|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
27697446|NCT00655486|80729734|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
27697447|NCT03707925|80729736|FG000|Overall Study|Inevaluable|1|||
27697448|NCT01640054|80729737|FG000|Overall Study|Study-specific disc criteria|1|||
27697449|NCT01640054|80729737|FG000|Overall Study|Lack of Efficacy|3|||
27697450|NCT01640054|80729737|FG000|Overall Study|Adverse Event|2|||
27697451|NCT00395460|80729738|FG000|Overall Study|Withdrawal by Subject|1|||
27697452|NCT00395460|80729739|FG001|Overall Study|Withdrawal by Subject|0|||
27697453|NCT02982187|80729744|FG000|Overall Study|Withdrawal by Subject|0|||
27697454|NCT02982187|80729745|FG001|Overall Study|Withdrawal by Subject|0|||
27697455|NCT02982187|80729746|FG002|Overall Study|Withdrawal by Subject|0|||
27697456|NCT02982187|80729747|FG003|Overall Study|Withdrawal by Subject|0|||
27697457|NCT02982187|80729748|FG004|Overall Study|Withdrawal by Subject|0|||
27697458|NCT02982187|80729749|FG005|Overall Study|Withdrawal by Subject|0|||
27697459|NCT02982187|80729750|FG006|Overall Study|Withdrawal by Subject|1|||
27697460|NCT02982187|80729751|FG007|Overall Study|Withdrawal by Subject|0|||
27697461|NCT00041067|80729752|FG000|Overall Study|Adverse Event|20|||
27697462|NCT00041067|80729752|FG000|Overall Study|Progression|19|||
27697463|NCT00041067|80729752|FG000|Overall Study|Patient refusal|12|||
27697464|NCT00041067|80729752|FG000|Overall Study|Other reasons|23|||
27697465|NCT00041067|80729752|FG000|Overall Study|Ineligible|2|||
27697466|NCT03294109|80729753|FG000|Overall Study|Withdrawal by Subject|6|||
27697467|NCT03294109|80729754|FG001|Overall Study|Withdrawal by Subject|5|||
27697468|NCT01477333|80729755|FG000|Overall Study|Adverse Event|1|||
27697469|NCT01477333|80729755|FG000|Overall Study|Withdrawal by Subject|1|||
27697470|NCT01477333|80729755|FG000|Overall Study|Clinical Deterioration|1|||
27697471|NCT00394953|80729758|FG000|First Treatment Period|Adverse Event|1|||
27697472|NCT00394953|80729759|FG001|First Treatment Period|Adverse Event|2|||
27697473|NCT00394953|80729758|FG000|First Treatment Period|Death|6|||
27697474|NCT00394953|80729759|FG001|First Treatment Period|Death|7|||
27697475|NCT00394953|80729758|FG000|First Treatment Period|Lack of Efficacy|1|||
27697476|NCT00394953|80729759|FG001|First Treatment Period|Lack of Efficacy|1|||
27697477|NCT00394953|80729758|FG000|First Treatment Period|Withdrawal by Subject|6|||
27697478|NCT00394953|80729759|FG001|First Treatment Period|Withdrawal by Subject|3|||
27697479|NCT00394953|80729758|FG000|First Treatment Period|Lost to Follow-up|0|||
27697480|NCT00394953|80729759|FG001|First Treatment Period|Lost to Follow-up|1|||
27697481|NCT00394953|80729758|FG000|First Treatment Period|Renal transplant|11|||
27697482|NCT00394953|80729759|FG001|First Treatment Period|Renal transplant|7|||
27558007|NCT01472081|80229543|FG002|Overall Study|Subject request to discontinue treatment|1|||
27697483|NCT00394953|80729758|FG000|First Treatment Period|Not defined|4|||
27697484|NCT00394953|80729759|FG001|First Treatment Period|Not defined|1|||
27697485|NCT00394953|80729758|FG000|Second Treatment Period|Adverse Event|2|||
27697486|NCT00394953|80729759|FG001|Second Treatment Period|Adverse Event|5|||
27697487|NCT00394953|80729758|FG000|Second Treatment Period|Death|8|||
27697488|NCT00394953|80729759|FG001|Second Treatment Period|Death|4|||
27697489|NCT00394953|80729758|FG000|Second Treatment Period|Lack of Efficacy|9|||
27697490|NCT00394953|80729759|FG001|Second Treatment Period|Lack of Efficacy|47|||
27697491|NCT00394953|80729758|FG000|Second Treatment Period|Withdrawal by Subject|3|||
27697492|NCT00394953|80729759|FG001|Second Treatment Period|Withdrawal by Subject|3|||
27697493|NCT00394953|80729758|FG000|Second Treatment Period|Lost to Follow-up|0|||
27697494|NCT00394953|80729759|FG001|Second Treatment Period|Lost to Follow-up|1|||
27697495|NCT00394953|80729758|FG000|Second Treatment Period|Renal transplant|4|||
27697496|NCT00394953|80729759|FG001|Second Treatment Period|Renal transplant|6|||
27697497|NCT00394953|80729758|FG000|Second Treatment Period|Not defined|3|||
27697498|NCT00394953|80729759|FG001|Second Treatment Period|Not defined|8|||
27697499|NCT00288509|80729766|FG000|Treatment Cycle 1|Adverse Event|1|||
27697500|NCT00288509|80729766|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
27697501|NCT00288509|80729766|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
27697502|NCT00288509|80729766|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
27697503|NCT00288509|80729766|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
27697504|NCT00288509|80729766|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
27697505|NCT00288509|80729766|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
27697506|NCT00288509|80729766|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
27697507|NCT00288509|80729766|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
27697508|NCT00288509|80729766|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
27697509|NCT00288509|80729766|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
27697510|NCT00288509|80729766|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
27697511|NCT00288509|80729766|FG000|Treatment Cycle 4|Physician Decision|4|||
27697512|NCT00288509|80729766|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
27697513|NCT01000636|80729771|FG000|Overall Study|Withdrawal by Subject|1|||
27697514|NCT01000636|80729771|FG000|Overall Study|Adverse Event|1|||
27697515|NCT02168842|80729772|FG000|Overall Study|Withdrawal by Subject|5|||
27697516|NCT02168842|80729773|FG001|Overall Study|Withdrawal by Subject|3|||
27697517|NCT02168842|80729772|FG000|Overall Study|Lost to Follow-up|0|||
27697518|NCT02168842|80729773|FG001|Overall Study|Lost to Follow-up|2|||
27697519|NCT02168842|80729772|FG000|Overall Study|Death|2|||
27697520|NCT02168842|80729773|FG001|Overall Study|Death|1|||
27697521|NCT02168842|80729772|FG000|Overall Study|Physician Decision|1|||
27697522|NCT02168842|80729773|FG001|Overall Study|Physician Decision|2|||
27697523|NCT00455325|80729774|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
27697524|NCT00455325|80729775|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
27697525|NCT00455325|80729776|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
27697526|NCT00455325|80729777|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
27697527|NCT00455325|80729774|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
27697528|NCT00455325|80729775|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
27697529|NCT00455325|80729776|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
27697530|NCT00455325|80729777|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
27697531|NCT00455325|80729774|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
27697532|NCT00455325|80729775|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
27697533|NCT00455325|80729776|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
27697534|NCT00455325|80729777|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
27697535|NCT00455325|80729774|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
27697536|NCT00455325|80729775|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
27697537|NCT00455325|80729776|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
27697538|NCT00455325|80729777|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
27697539|NCT00455325|80729774|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
27697540|NCT00455325|80729775|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
27828272|NCT01796171|81202851|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27828273|NCT01796171|81202852|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
27697541|NCT00455325|80729776|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
27697542|NCT00455325|80729777|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
27697543|NCT00455325|80729774|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
27697544|NCT00455325|80729775|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
27828274|NCT01796171|81202838|FG000|Follow-up Period|Start of further anticancer therapy|4|||
27697545|NCT00455325|80729776|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
27697546|NCT00455325|80729777|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
27828275|NCT01796171|81202839|FG001|Follow-up Period|Start of further anticancer therapy|25|||
27558008|NCT01472081|80229544|FG003|Overall Study|Subject request to discontinue treatment|1|||
27828276|NCT01796171|81202840|FG002|Follow-up Period|Start of further anticancer therapy|2|||
27828277|NCT01796171|81202841|FG003|Follow-up Period|Start of further anticancer therapy|1|||
27828278|NCT01796171|81202842|FG004|Follow-up Period|Start of further anticancer therapy|2|||
27828279|NCT01796171|81202843|FG005|Follow-up Period|Start of further anticancer therapy|2|||
27828280|NCT01796171|81202844|FG006|Follow-up Period|Start of further anticancer therapy|1|||
27828281|NCT01796171|81202845|FG007|Follow-up Period|Start of further anticancer therapy|15|||
27828282|NCT01796171|81202846|FG008|Follow-up Period|Start of further anticancer therapy|2|||
27828283|NCT01796171|81202847|FG009|Follow-up Period|Start of further anticancer therapy|0|||
27828284|NCT01796171|81202848|FG010|Follow-up Period|Start of further anticancer therapy|0|||
27828285|NCT01796171|81202849|FG011|Follow-up Period|Start of further anticancer therapy|0|||
27828286|NCT01796171|81202850|FG012|Follow-up Period|Start of further anticancer therapy|0|||
27828287|NCT01796171|81202851|FG013|Follow-up Period|Start of further anticancer therapy|0|||
27828288|NCT01796171|81202852|FG014|Follow-up Period|Start of further anticancer therapy|0|||
27828289|NCT01796171|81202838|FG000|Follow-up Period|Progressive disease|0|||
27828290|NCT01796171|81202839|FG001|Follow-up Period|Progressive disease|1|||
27828291|NCT01796171|81202840|FG002|Follow-up Period|Progressive disease|0|||
27828292|NCT01796171|81202841|FG003|Follow-up Period|Progressive disease|0|||
27828293|NCT01796171|81202842|FG004|Follow-up Period|Progressive disease|0|||
27828294|NCT01796171|81202843|FG005|Follow-up Period|Progressive disease|0|||
27828295|NCT01796171|81202844|FG006|Follow-up Period|Progressive disease|0|||
27828296|NCT01796171|81202845|FG007|Follow-up Period|Progressive disease|3|||
27828297|NCT01796171|81202846|FG008|Follow-up Period|Progressive disease|0|||
27828298|NCT01796171|81202847|FG009|Follow-up Period|Progressive disease|0|||
27828299|NCT01796171|81202848|FG010|Follow-up Period|Progressive disease|0|||
27828300|NCT01796171|81202849|FG011|Follow-up Period|Progressive disease|0|||
27828301|NCT01796171|81202850|FG012|Follow-up Period|Progressive disease|0|||
27828302|NCT01796171|81202851|FG013|Follow-up Period|Progressive disease|0|||
27828303|NCT01796171|81202852|FG014|Follow-up Period|Progressive disease|0|||
27828304|NCT01796171|81202838|FG000|Follow-up Period|Physician Decision|0|||
27828305|NCT01796171|81202839|FG001|Follow-up Period|Physician Decision|2|||
27828306|NCT01796171|81202840|FG002|Follow-up Period|Physician Decision|0|||
27828307|NCT01796171|81202841|FG003|Follow-up Period|Physician Decision|0|||
27828308|NCT01796171|81202842|FG004|Follow-up Period|Physician Decision|0|||
27828309|NCT01796171|81202843|FG005|Follow-up Period|Physician Decision|0|||
27828310|NCT01796171|81202844|FG006|Follow-up Period|Physician Decision|0|||
27828311|NCT01796171|81202845|FG007|Follow-up Period|Physician Decision|0|||
27828312|NCT01796171|81202846|FG008|Follow-up Period|Physician Decision|0|||
27828313|NCT01796171|81202847|FG009|Follow-up Period|Physician Decision|0|||
27828314|NCT01796171|81202848|FG010|Follow-up Period|Physician Decision|5|||
27828315|NCT01796171|81202849|FG011|Follow-up Period|Physician Decision|0|||
27828316|NCT01796171|81202850|FG012|Follow-up Period|Physician Decision|0|||
27828317|NCT01796171|81202851|FG013|Follow-up Period|Physician Decision|0|||
27828318|NCT01796171|81202852|FG014|Follow-up Period|Physician Decision|0|||
27828319|NCT01796171|81202838|FG000|Follow-up Period|Withdrawal by Subject|0|||
27828320|NCT01796171|81202839|FG001|Follow-up Period|Withdrawal by Subject|1|||
27828321|NCT01796171|81202840|FG002|Follow-up Period|Withdrawal by Subject|0|||
27828322|NCT01796171|81202841|FG003|Follow-up Period|Withdrawal by Subject|0|||
27828323|NCT01796171|81202842|FG004|Follow-up Period|Withdrawal by Subject|0|||
27828324|NCT01796171|81202843|FG005|Follow-up Period|Withdrawal by Subject|1|||
27828325|NCT01796171|81202844|FG006|Follow-up Period|Withdrawal by Subject|0|||
27828326|NCT01796171|81202845|FG007|Follow-up Period|Withdrawal by Subject|0|||
27828327|NCT01796171|81202846|FG008|Follow-up Period|Withdrawal by Subject|0|||
27828328|NCT01796171|81202847|FG009|Follow-up Period|Withdrawal by Subject|0|||
27828329|NCT01796171|81202848|FG010|Follow-up Period|Withdrawal by Subject|3|||
27828330|NCT01796171|81202849|FG011|Follow-up Period|Withdrawal by Subject|1|||
27828331|NCT01796171|81202850|FG012|Follow-up Period|Withdrawal by Subject|0|||
27828332|NCT01796171|81202851|FG013|Follow-up Period|Withdrawal by Subject|0|||
27828333|NCT01796171|81202852|FG014|Follow-up Period|Withdrawal by Subject|0|||
27828334|NCT01796171|81202838|FG000|Follow-up Period|Death|0|||
27828335|NCT01796171|81202839|FG001|Follow-up Period|Death|0|||
27828336|NCT01796171|81202840|FG002|Follow-up Period|Death|0|||
27828337|NCT01796171|81202841|FG003|Follow-up Period|Death|0|||
27828338|NCT01796171|81202842|FG004|Follow-up Period|Death|0|||
27828339|NCT01796171|81202843|FG005|Follow-up Period|Death|0|||
27828340|NCT01796171|81202844|FG006|Follow-up Period|Death|1|||
27828341|NCT01796171|81202845|FG007|Follow-up Period|Death|0|||
27828342|NCT01796171|81202846|FG008|Follow-up Period|Death|0|||
27828343|NCT01796171|81202847|FG009|Follow-up Period|Death|0|||
27884283|NCT03831113|81411759|FG001|Overall Study|Withdrawal by Subject|2|||
27828344|NCT01796171|81202848|FG010|Follow-up Period|Death|17|||
27828345|NCT01796171|81202849|FG011|Follow-up Period|Death|9|||
27828346|NCT01796171|81202850|FG012|Follow-up Period|Death|1|||
27828347|NCT01796171|81202851|FG013|Follow-up Period|Death|0|||
27828348|NCT01796171|81202852|FG014|Follow-up Period|Death|0|||
27697547|NCT00455325|80729774|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
27697548|NCT00455325|80729775|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
27697549|NCT00455325|80729776|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
27697550|NCT00455325|80729777|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
27697551|NCT01774110|80729778|FG000|Overall Study|Lost to Follow-up|7|||
27697552|NCT01259726|80729782|FG000|Overall Study|Death|1|||
27697553|NCT01259726|80729783|FG001|Overall Study|Death|0|||
27697554|NCT01259726|80729784|FG002|Overall Study|Death|0|||
27697555|NCT01259726|80729785|FG003|Overall Study|Death|0|||
27697556|NCT01259726|80729782|FG000|Overall Study|Physician Decision|2|||
27697557|NCT01259726|80729783|FG001|Overall Study|Physician Decision|0|||
27697558|NCT01259726|80729784|FG002|Overall Study|Physician Decision|1|||
27697559|NCT01259726|80729785|FG003|Overall Study|Physician Decision|1|||
27697560|NCT01259726|80729782|FG000|Overall Study|Withdrawal by Subject|1|||
27697561|NCT01259726|80729783|FG001|Overall Study|Withdrawal by Subject|3|||
27697562|NCT01259726|80729784|FG002|Overall Study|Withdrawal by Subject|2|||
27697563|NCT01259726|80729785|FG003|Overall Study|Withdrawal by Subject|1|||
27697564|NCT01259726|80729782|FG000|Overall Study|Lost to Follow-up|1|||
27697565|NCT01259726|80729783|FG001|Overall Study|Lost to Follow-up|1|||
27697566|NCT01259726|80729784|FG002|Overall Study|Lost to Follow-up|1|||
27558009|NCT01472081|80229545|FG004|Overall Study|Subject request to discontinue treatment|0|||
27558010|NCT01472081|80229546|FG005|Overall Study|Subject request to discontinue treatment|0|||
27558011|NCT00268996|80229547|FG000|Overall Study|Adverse Event|11|||
27558012|NCT00268996|80229548|FG001|Overall Study|Adverse Event|7|||
27558013|NCT00268996|80229547|FG000|Overall Study|Lost to Follow-up|3|||
27558014|NCT00268996|80229548|FG001|Overall Study|Lost to Follow-up|1|||
27558015|NCT00268996|80229547|FG000|Overall Study|Withdrawal by Subject|5|||
27558016|NCT00268996|80229548|FG001|Overall Study|Withdrawal by Subject|11|||
27558017|NCT00268996|80229547|FG000|Overall Study|Non-compliance|1|||
27558018|NCT00268996|80229548|FG001|Overall Study|Non-compliance|0|||
27558019|NCT00268996|80229547|FG000|Overall Study|Other|1|||
27558020|NCT00268996|80229548|FG001|Overall Study|Other|1|||
27558021|NCT04446377|80229549|FG000|Overall Study|Withdrawal by Subject|6|||
27558022|NCT04446377|80229550|FG001|Overall Study|Withdrawal by Subject|1|||
27558023|NCT04446377|80229549|FG000|Overall Study|Physician Decision|1|||
27558024|NCT04446377|80229550|FG001|Overall Study|Physician Decision|1|||
27558025|NCT04446377|80229549|FG000|Overall Study|Lost to Follow-up|0|||
27558026|NCT04446377|80229550|FG001|Overall Study|Lost to Follow-up|2|||
27558027|NCT04446377|80229549|FG000|Overall Study|Not eligible|0|||
27558028|NCT04446377|80229550|FG001|Overall Study|Not eligible|1|||
27558029|NCT00643682|80229551|FG000|Overall Study|did not keep appointment|522|||
27558030|NCT00643682|80229552|FG001|Overall Study|did not keep appointment|509|||
27558031|NCT02904512|80229565|FG000|Overall Study|Withdrawal by Subject|1|||
27558032|NCT02904512|80229566|FG001|Overall Study|Withdrawal by Subject|0|||
27558033|NCT02904512|80229565|FG000|Overall Study|Transferred to ICU|1|||
27558034|NCT02904512|80229566|FG001|Overall Study|Transferred to ICU|0|||
27558035|NCT02904512|80229565|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
27558036|NCT02904512|80229566|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
27558037|NCT02905331|80229569|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
27558038|NCT02905331|80229570|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
27558039|NCT02905331|80229571|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
27558040|NCT02905331|80229569|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
27558041|NCT02905331|80229570|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
27558042|NCT02905331|80229571|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
27558043|NCT02905331|80229569|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
27558044|NCT02905331|80229570|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
27558045|NCT02905331|80229571|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
27558046|NCT02905331|80229569|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
27558047|NCT02905331|80229570|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
27884284|NCT03831113|81411758|FG000|Overall Study|Protocol Violation|0|||
27884285|NCT03831113|81411759|FG001|Overall Study|Protocol Violation|9|||
27558048|NCT02905331|80229571|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
27558049|NCT02905331|80229569|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
27558050|NCT02905331|80229570|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
27558051|NCT02905331|80229571|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
27558052|NCT01712854|80229572|FG000|Overall Study|Physician Decision|1|||
27558053|NCT00708643|80229573|FG000|Overall Study|Adverse Event|0|||
27558054|NCT00708643|80229574|FG001|Overall Study|Adverse Event|1|||
27558055|NCT01647282|80229575|FG000|Overall Study|Physician Decision|7|||
27558056|NCT01647282|80229576|FG001|Overall Study|Physician Decision|5|||
27558057|NCT00423150|80229577|FG000|Overall Study|Adverse Event|11|||
27558058|NCT00423150|80229577|FG000|Overall Study|Progression of disease being studied|69|||
27884286|NCT02844543|81411760|FG000|Overall Study|Withdrawal by Subject|4|||
27558059|NCT00423150|80229577|FG000|Overall Study|Withdrawal by Subject|1|||
27558060|NCT00423150|80229577|FG000|Overall Study|Non-compliance with protocol|1|||
27558061|NCT00423150|80229577|FG000|Overall Study|Administrative|4|||
27558062|NCT03235154|80229585|FG000|Overall Study|Withdrawal by Subject|1|||
27558063|NCT03235154|80229585|FG000|Overall Study|Adverse Event|1|||
27558064|NCT03235154|80229585|FG000|Overall Study|Lost to Follow-up|2|||
27558065|NCT02772081|80229586|FG000|Overall Study|Physician Decision|1|||
27558066|NCT02772081|80229587|FG001|Overall Study|Physician Decision|1|||
27558067|NCT02772081|80229586|FG000|Overall Study|Death|1|||
27558068|NCT02772081|80229587|FG001|Overall Study|Death|1|||
27697567|NCT01259726|80729785|FG003|Overall Study|Lost to Follow-up|3|||
27884287|NCT02844543|81411760|FG000|Overall Study|Did not meet eligibility criteria|1|||
27558069|NCT03036072|80229591|FG000|Overall Study|Death|0|||
27558070|NCT03036072|80229592|FG001|Overall Study|Death|1|||
27558071|NCT03036072|80229591|FG000|Overall Study|Withdrawal by Subject|0|||
27558072|NCT03036072|80229592|FG001|Overall Study|Withdrawal by Subject|1|||
27558073|NCT03036072|80229591|FG000|Overall Study|Physician Decision|0|||
27558074|NCT03036072|80229592|FG001|Overall Study|Physician Decision|1|||
27828349|NCT01796171|81202838|FG000|Follow-up Period|Patient transferred to other hospital|0|||
27828350|NCT01796171|81202839|FG001|Follow-up Period|Patient transferred to other hospital|1|||
27828351|NCT01796171|81202840|FG002|Follow-up Period|Patient transferred to other hospital|0|||
27828352|NCT01796171|81202841|FG003|Follow-up Period|Patient transferred to other hospital|0|||
27828353|NCT01796171|81202842|FG004|Follow-up Period|Patient transferred to other hospital|0|||
27828354|NCT01796171|81202843|FG005|Follow-up Period|Patient transferred to other hospital|0|||
27828355|NCT01796171|81202844|FG006|Follow-up Period|Patient transferred to other hospital|0|||
27828356|NCT01796171|81202845|FG007|Follow-up Period|Patient transferred to other hospital|0|||
27828357|NCT01796171|81202846|FG008|Follow-up Period|Patient transferred to other hospital|0|||
27828358|NCT01796171|81202847|FG009|Follow-up Period|Patient transferred to other hospital|0|||
27828359|NCT01796171|81202848|FG010|Follow-up Period|Patient transferred to other hospital|0|||
27828360|NCT01796171|81202849|FG011|Follow-up Period|Patient transferred to other hospital|0|||
27884288|NCT02222545|81411761|FG000|Overall Study|Adverse Event|1|||
27558075|NCT00010374|80229593|FG000|Overall Study|False positive phrenic nerve test|1|||
27558076|NCT04741074|80229595|FG000|Overall Study|Withdrawal by Subject|1|||
27558077|NCT04741074|80229596|FG001|Overall Study|Withdrawal by Subject|1|||
27558078|NCT04741074|80229595|FG000|Overall Study|Study terminated prematurely|1|||
27558079|NCT04741074|80229596|FG001|Overall Study|Study terminated prematurely|0|||
27558080|NCT01387347|80229597|FG000|Overall Study|Lost to Follow-up|2|||
27558081|NCT01387347|80229598|FG001|Overall Study|Lost to Follow-up|1|||
27558082|NCT00463346|80229599|FG000|Overall Study|Withdrawal by Subject|3|||
27558083|NCT00463346|80229600|FG001|Overall Study|Withdrawal by Subject|3|||
27558084|NCT00503009|80229601|FG000|Overall Study|Protocol Violation|1|||
27558085|NCT00503009|80229602|FG001|Overall Study|Protocol Violation|0|||
27558086|NCT00503009|80229603|FG002|Overall Study|Protocol Violation|1|||
27558087|NCT00503009|80229601|FG000|Overall Study|Withdrawal by Subject|0|||
27558088|NCT00503009|80229602|FG001|Overall Study|Withdrawal by Subject|1|||
27558089|NCT00503009|80229603|FG002|Overall Study|Withdrawal by Subject|1|||
27558090|NCT00503009|80229601|FG000|Overall Study|Physician Decision|0|||
27558091|NCT00503009|80229602|FG001|Overall Study|Physician Decision|1|||
27558092|NCT00503009|80229603|FG002|Overall Study|Physician Decision|1|||
27558093|NCT00969150|80229604|FG000|Overall Study|Adverse Event|4|||
27558094|NCT00969150|80229605|FG001|Overall Study|Adverse Event|14|||
27558095|NCT00969150|80229604|FG000|Overall Study|Lack of Efficacy|1|||
27558096|NCT00969150|80229605|FG001|Overall Study|Lack of Efficacy|1|||
27558097|NCT00969150|80229604|FG000|Overall Study|Protocol Violation|9|||
27558098|NCT00969150|80229605|FG001|Overall Study|Protocol Violation|12|||
27558099|NCT00969150|80229604|FG000|Overall Study|Withdrawal by Subject|13|||
27558100|NCT00969150|80229605|FG001|Overall Study|Withdrawal by Subject|9|||
27558101|NCT00969150|80229604|FG000|Overall Study|Lost to Follow-up|5|||
27558102|NCT00969150|80229605|FG001|Overall Study|Lost to Follow-up|4|||
27558103|NCT00969150|80229604|FG000|Overall Study|Other reasons|1|||
27558104|NCT00969150|80229605|FG001|Overall Study|Other reasons|0|||
27558105|NCT01103284|80229606|FG000|Overall Study|Death|2|||
27828361|NCT01796171|81202850|FG012|Follow-up Period|Patient transferred to other hospital|0|||
27828362|NCT01796171|81202851|FG013|Follow-up Period|Patient transferred to other hospital|0|||
27828363|NCT01796171|81202852|FG014|Follow-up Period|Patient transferred to other hospital|0|||
27828364|NCT01796171|81202838|FG000|Follow-up Period|Sponsor Decision|0|||
27828365|NCT01796171|81202839|FG001|Follow-up Period|Sponsor Decision|0|||
27828366|NCT01796171|81202840|FG002|Follow-up Period|Sponsor Decision|0|||
27828367|NCT01796171|81202841|FG003|Follow-up Period|Sponsor Decision|0|||
27828368|NCT01796171|81202842|FG004|Follow-up Period|Sponsor Decision|0|||
27828369|NCT01796171|81202843|FG005|Follow-up Period|Sponsor Decision|0|||
27828370|NCT01796171|81202844|FG006|Follow-up Period|Sponsor Decision|0|||
27828371|NCT01796171|81202845|FG007|Follow-up Period|Sponsor Decision|0|||
27828372|NCT01796171|81202846|FG008|Follow-up Period|Sponsor Decision|0|||
27828373|NCT01796171|81202847|FG009|Follow-up Period|Sponsor Decision|0|||
27828374|NCT01796171|81202848|FG010|Follow-up Period|Sponsor Decision|40|||
27828375|NCT01796171|81202849|FG011|Follow-up Period|Sponsor Decision|15|||
27828376|NCT01796171|81202850|FG012|Follow-up Period|Sponsor Decision|7|||
27828377|NCT01796171|81202851|FG013|Follow-up Period|Sponsor Decision|0|||
27558106|NCT01103284|80229607|FG001|Overall Study|Death|0|||
27828378|NCT01796171|81202852|FG014|Follow-up Period|Sponsor Decision|0|||
27828379|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
27828380|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
27828381|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
27558107|NCT01103284|80229606|FG000|Overall Study|Lost to Follow-up|9|||
27558108|NCT01103284|80229607|FG001|Overall Study|Lost to Follow-up|10|||
27828382|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
27558109|NCT01103284|80229606|FG000|Overall Study|Pregnancy|3|||
27558110|NCT01103284|80229607|FG001|Overall Study|Pregnancy|1|||
27558111|NCT01103284|80229606|FG000|Overall Study|Protocol Violation|12|||
27558112|NCT01103284|80229607|FG001|Overall Study|Protocol Violation|5|||
27558113|NCT01103284|80229606|FG000|Overall Study|Adverse Event|0|||
27558114|NCT01103284|80229607|FG001|Overall Study|Adverse Event|5|||
27558115|NCT01103284|80229606|FG000|Overall Study|Withdrawal by Subject|14|||
27828383|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
27828384|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
27558116|NCT01103284|80229607|FG001|Overall Study|Withdrawal by Subject|18|||
27558117|NCT01103284|80229606|FG000|Overall Study|Dermal Hypersensitivity|0|||
27558118|NCT01103284|80229607|FG001|Overall Study|Dermal Hypersensitivity|1|||
27558119|NCT01103284|80229606|FG000|Overall Study|Termination by the Sponsor|0|||
27828385|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
27828386|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
27828387|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
27828388|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
27828389|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
27828390|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
27828391|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
27828392|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
27828393|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
27828394|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
27828395|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
27828396|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
27558120|NCT01103284|80229607|FG001|Overall Study|Termination by the Sponsor|1|||
27697568|NCT00323297|80729787|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
27697569|NCT00323297|80729788|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
27697570|NCT00323297|80729787|FG000|Part A (Double Blind Randomized)|Death|0|||
27697571|NCT00323297|80729788|FG001|Part A (Double Blind Randomized)|Death|1|||
27697572|NCT00323297|80729787|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
27697573|NCT00323297|80729788|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
27697574|NCT00323297|80729787|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
27697575|NCT00323297|80729788|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
27697576|NCT00323297|80729787|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
27828397|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
27828398|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
27828399|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
27828400|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
27828401|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
27828402|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
27828403|NCT00073307|81202853|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
27828404|NCT00073307|81202854|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
27828405|NCT00073307|81202855|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
27828406|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
27828407|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
27828408|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
27828409|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
27828410|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
27828411|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
27828412|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
27828413|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
27828414|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
27828415|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
27828416|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
27828417|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
27828418|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
27828419|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
27828420|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
27828421|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
27828422|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
27828423|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
27828424|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
27828425|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
27828426|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
27828427|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
27828428|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
27828429|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
27697577|NCT00323297|80729788|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
27697578|NCT00323297|80729787|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
27697579|NCT00323297|80729788|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
27828430|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
27828431|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
27828432|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
27828433|NCT00073307|81202853|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
27828434|NCT00073307|81202854|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
27828435|NCT00073307|81202855|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
27828436|NCT01136174|81202858|FG000|Overall Study|Adverse Event|0|||
27828437|NCT01136174|81202859|FG001|Overall Study|Adverse Event|0|||
27828438|NCT01136174|81202860|FG002|Overall Study|Adverse Event|0|||
27828439|NCT01136174|81202861|FG003|Overall Study|Adverse Event|4|||
27828440|NCT00824291|81202862|FG000|Overall Study|Adverse Event|15|||
27828441|NCT00824291|81202863|FG001|Overall Study|Adverse Event|6|||
27828442|NCT00824291|81202862|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
27828443|NCT00824291|81202863|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
27828444|NCT00824291|81202862|FG000|Overall Study|Lost to Follow-up|11|||
27828445|NCT00824291|81202863|FG001|Overall Study|Lost to Follow-up|9|||
27828446|NCT00824291|81202862|FG000|Overall Study|Non-compliance|1|||
27828447|NCT00824291|81202863|FG001|Overall Study|Non-compliance|1|||
27828448|NCT00824291|81202862|FG000|Overall Study|Protocol Violation|4|||
27828449|NCT00824291|81202863|FG001|Overall Study|Protocol Violation|1|||
27828450|NCT00824291|81202862|FG000|Overall Study|Withdrawal by Subject|14|||
27828451|NCT00824291|81202863|FG001|Overall Study|Withdrawal by Subject|8|||
27828452|NCT00824291|81202862|FG000|Overall Study|Lack of Efficacy|7|||
27828453|NCT00824291|81202863|FG001|Overall Study|Lack of Efficacy|8|||
27828454|NCT00824291|81202862|FG000|Overall Study|Participant on prohibited medication|1|||
27828455|NCT00824291|81202863|FG001|Overall Study|Participant on prohibited medication|0|||
27828456|NCT01442155|81202866|FG000|Overall Study|Complete remission|35|||
27828457|NCT01442155|81202866|FG000|Overall Study|Recurrence|26|||
27828458|NCT01442155|81202866|FG000|Overall Study|Adverse Event|2|||
27828459|NCT01442155|81202866|FG000|Overall Study|Lost to Follow-up|2|||
27828460|NCT02890992|81202867|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828461|NCT02890992|81202868|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
27828462|NCT02890992|81202869|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828463|NCT02890992|81202870|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828464|NCT02890992|81202871|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828465|NCT02890992|81202872|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828466|NCT02890992|81202873|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828467|NCT02890992|81202874|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
27828468|NCT02890992|81202867|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
27828469|NCT02890992|81202868|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
27828470|NCT02890992|81202869|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
27828471|NCT02890992|81202870|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
27828472|NCT02890992|81202871|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
27828473|NCT02890992|81202872|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
27828474|NCT02890992|81202873|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
27828475|NCT02890992|81202874|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
27828476|NCT02890992|81202867|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828477|NCT02890992|81202868|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
27828478|NCT02890992|81202869|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828479|NCT02890992|81202870|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828480|NCT02890992|81202871|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828481|NCT02890992|81202872|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828482|NCT02890992|81202873|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828483|NCT02890992|81202874|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
27828484|NCT00835991|81202878|FG000|First Intervention|Adverse Event|0|||
27828485|NCT00835991|81202879|FG001|First Intervention|Adverse Event|1|||
27828486|NCT00835991|81202878|FG000|Washout|Protocol Violation|0|||
27828487|NCT00835991|81202879|FG001|Washout|Protocol Violation|2|||
27828488|NCT00835991|81202878|FG000|Washout|Withdrawal by Subject|3|||
27828489|NCT00835991|81202879|FG001|Washout|Withdrawal by Subject|1|||
27828490|NCT01778010|81202880|FG000|Overall Study|Withdrawal by Subject|2|||
27828491|NCT01778010|81202880|FG000|Overall Study|abnormal ECG before meds|1|||
27828492|NCT01778010|81202880|FG000|Overall Study|Arrested|1|||
27828493|NCT01778010|81202880|FG000|Overall Study|rash while on placebo|1|||
27828494|NCT01421277|81202881|FG000|Overall Study|Lack of qualifying event|0|||
27828495|NCT01421277|81202882|FG001|Overall Study|Lack of qualifying event|61|||
27828496|NCT01421277|81202881|FG000|Overall Study|Incomplete baseline data|0|||
27828497|NCT01421277|81202882|FG001|Overall Study|Incomplete baseline data|31|||
27828498|NCT02760927|81202885|FG000|Overall Study|Tube Slippage from Device|1|||
27828499|NCT03031847|81202886|FG000|Overall Study|Death|1|||
27828500|NCT03031847|81202887|FG001|Overall Study|Death|1|||
27828501|NCT03031847|81202888|FG002|Overall Study|Death|2|||
27828502|NCT03031847|81202889|FG003|Overall Study|Death|3|||
27828503|NCT03031847|81202886|FG000|Overall Study|Lost to Follow-up|1|||
27828504|NCT03031847|81202887|FG001|Overall Study|Lost to Follow-up|1|||
27828505|NCT03031847|81202888|FG002|Overall Study|Lost to Follow-up|2|||
27828506|NCT03031847|81202889|FG003|Overall Study|Lost to Follow-up|3|||
27828507|NCT01855750|81202892|FG000|Overall Study|Death|78|||
27558121|NCT01103284|80229606|FG000|Overall Study|Not described|2|||
27558122|NCT01103284|80229607|FG001|Overall Study|Not described|1|||
27558123|NCT01103284|80229606|FG000|Overall Study|Missing CRF entries for study completion|0|||
27558124|NCT01103284|80229607|FG001|Overall Study|Missing CRF entries for study completion|2|||
27558125|NCT02892760|80229608|FG000|Overall Study|Withdrawal by Subject|3|||
27558126|NCT04492618|80229611|FG000|Overall Study|Withdrawal by Subject|1|||
27828508|NCT01855750|81202893|FG001|Overall Study|Death|78|||
27828509|NCT01855750|81202892|FG000|Overall Study|Lost to Follow-up|9|||
27828510|NCT01855750|81202893|FG001|Overall Study|Lost to Follow-up|23|||
27828511|NCT01855750|81202892|FG000|Overall Study|Withdrawal by Subject|35|||
27828512|NCT01855750|81202893|FG001|Overall Study|Withdrawal by Subject|28|||
27828513|NCT01855750|81202892|FG000|Overall Study|Sponsor ends the study|297|||
27828514|NCT01855750|81202893|FG001|Overall Study|Sponsor ends the study|290|||
27828515|NCT00354835|81202895|FG000|Overall Study|Death|1|||
27828516|NCT00354835|81202896|FG001|Overall Study|Death|1|||
27828517|NCT00354835|81202895|FG000|Overall Study|Physician Decision|8|||
27828518|NCT00354835|81202896|FG001|Overall Study|Physician Decision|13|||
27828519|NCT00354835|81202895|FG000|Overall Study|Withdrawal by Subject|2|||
27828520|NCT00354835|81202896|FG001|Overall Study|Withdrawal by Subject|1|||
27828521|NCT00354835|81202895|FG000|Overall Study|Ineligible|17|||
27828522|NCT00354835|81202896|FG001|Overall Study|Ineligible|16|||
27828523|NCT00354835|81202895|FG000|Overall Study|Disease progression or relapse|15|||
27828524|NCT00354835|81202896|FG001|Overall Study|Disease progression or relapse|22|||
27828525|NCT00354835|81202895|FG000|Overall Study|Adverse Event|6|||
27828526|NCT00354835|81202896|FG001|Overall Study|Adverse Event|0|||
27828527|NCT00354835|81202895|FG000|Overall Study|Refusal of further therapy|3|||
27828528|NCT00354835|81202896|FG001|Overall Study|Refusal of further therapy|8|||
27828529|NCT03325881|81202899|FG000|Overall Study|Protocol Violation|0|||
27828530|NCT03325881|81202900|FG001|Overall Study|Protocol Violation|1|||
27828531|NCT03325881|81202899|FG000|Overall Study|Withdrawal by Subject|0|||
27828532|NCT03325881|81202900|FG001|Overall Study|Withdrawal by Subject|2|||
27828533|NCT03325881|81202899|FG000|Overall Study|Lack of Efficacy|2|||
27828534|NCT03325881|81202900|FG001|Overall Study|Lack of Efficacy|0|||
27558127|NCT04053023|80229616|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
27558128|NCT04053023|80229617|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
27558129|NCT02998840|80229618|FG000|Overall Study|Lost to Follow-up|1|||
27828535|NCT03325881|81202899|FG000|Overall Study|Not treated|1|||
27828536|NCT03325881|81202900|FG001|Overall Study|Not treated|0|||
27828537|NCT02106156|81202901|FG000|Overall Study|Patient Died|19|||
27828538|NCT02106156|81202902|FG001|Overall Study|Patient Died|0|||
27828539|NCT02106156|81202903|FG002|Overall Study|Patient Died|0|||
27828540|NCT02106156|81202901|FG000|Overall Study|Lack of Tolerability|305|||
27828541|NCT02106156|81202902|FG001|Overall Study|Lack of Tolerability|3|||
27828542|NCT02106156|81202903|FG002|Overall Study|Lack of Tolerability|0|||
27828543|NCT02106156|81202901|FG000|Overall Study|Lack of Virological Response|1044|||
27828544|NCT02106156|81202902|FG001|Overall Study|Lack of Virological Response|8|||
27828545|NCT02106156|81202903|FG002|Overall Study|Lack of Virological Response|0|||
27828546|NCT02106156|81202901|FG000|Overall Study|Concomitant Disease|74|||
27828547|NCT02106156|81202902|FG001|Overall Study|Concomitant Disease|2|||
27558130|NCT02998840|80229619|FG001|Overall Study|Lost to Follow-up|1|||
27558131|NCT02998840|80229620|FG002|Overall Study|Lost to Follow-up|2|||
27558132|NCT02998840|80229621|FG003|Overall Study|Lost to Follow-up|3|||
27558133|NCT02998840|80229618|FG000|Overall Study|Withdrawal by Subject|1|||
27558134|NCT02998840|80229619|FG001|Overall Study|Withdrawal by Subject|1|||
27558135|NCT02998840|80229620|FG002|Overall Study|Withdrawal by Subject|0|||
27558136|NCT02998840|80229621|FG003|Overall Study|Withdrawal by Subject|1|||
27558137|NCT02998840|80229618|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
27558138|NCT02998840|80229619|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
27558139|NCT02998840|80229620|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
27558140|NCT02998840|80229621|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
27558141|NCT01408914|80229632|FG000|Overall Study|Could not complete tx in protocol period|5|||
27558142|NCT01408914|80229633|FG001|Overall Study|Could not complete tx in protocol period|5|||
27558143|NCT01408914|80229634|FG002|Overall Study|Could not complete tx in protocol period|6|||
27558144|NCT01408914|80229632|FG000|Overall Study|Lost to Follow-up|4|||
27558145|NCT01408914|80229633|FG001|Overall Study|Lost to Follow-up|1|||
27558146|NCT01408914|80229634|FG002|Overall Study|Lost to Follow-up|2|||
27558147|NCT01408914|80229632|FG000|Overall Study|Physician Decision|1|||
27558148|NCT01408914|80229633|FG001|Overall Study|Physician Decision|1|||
27558149|NCT01408914|80229634|FG002|Overall Study|Physician Decision|0|||
27558150|NCT01408914|80229632|FG000|Overall Study|Withdrawal by Subject|1|||
27828548|NCT02106156|81202903|FG002|Overall Study|Concomitant Disease|0|||
27828549|NCT02106156|81202901|FG000|Overall Study|Lack of Compliance|211|||
27828550|NCT02106156|81202902|FG001|Overall Study|Lack of Compliance|7|||
27558151|NCT01408914|80229633|FG001|Overall Study|Withdrawal by Subject|0|||
27697580|NCT00323297|80729787|FG000|Part B (Open-label)|Death|0|||
27697581|NCT00323297|80729788|FG001|Part B (Open-label)|Death|1|||
27697582|NCT00323297|80729787|FG000|Part B (Open-label)|Reason unspecified|0|||
27697583|NCT00323297|80729788|FG001|Part B (Open-label)|Reason unspecified|1|||
27697584|NCT00323297|80729787|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
27697585|NCT00323297|80729788|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
27697586|NCT00323297|80729787|FG000|Part B (Open-label)|Lack of Efficacy|3|||
27697587|NCT00323297|80729788|FG001|Part B (Open-label)|Lack of Efficacy|1|||
27828551|NCT02106156|81202903|FG002|Overall Study|Lack of Compliance|0|||
27828552|NCT02106156|81202901|FG000|Overall Study|Patients Request|307|||
27828553|NCT02106156|81202902|FG001|Overall Study|Patients Request|9|||
27828554|NCT02106156|81202903|FG002|Overall Study|Patients Request|0|||
27828555|NCT02106156|81202901|FG000|Overall Study|Lost to Follow-up|451|||
27828556|NCT02106156|81202902|FG001|Overall Study|Lost to Follow-up|8|||
27828557|NCT02106156|81202903|FG002|Overall Study|Lost to Follow-up|0|||
27828558|NCT02106156|81202901|FG000|Overall Study|Unplanned Event|82|||
27828559|NCT02106156|81202902|FG001|Overall Study|Unplanned Event|2|||
27828560|NCT02106156|81202903|FG002|Overall Study|Unplanned Event|0|||
27558152|NCT01408914|80229634|FG002|Overall Study|Withdrawal by Subject|1|||
27558153|NCT01408914|80229632|FG000|Overall Study|Moved out of study jurisdiction|1|||
27558154|NCT01408914|80229633|FG001|Overall Study|Moved out of study jurisdiction|1|||
27558155|NCT01408914|80229634|FG002|Overall Study|Moved out of study jurisdiction|0|||
27558156|NCT01408914|80229632|FG000|Overall Study|Late exclusion|0|||
27558157|NCT01408914|80229633|FG001|Overall Study|Late exclusion|3|||
27558158|NCT01408914|80229634|FG002|Overall Study|Late exclusion|3|||
27558159|NCT01408914|80229632|FG000|Overall Study|Change in local TB/HIV norms|0|||
27697588|NCT00323297|80729787|FG000|Part B (Open-label)|Adverse Event|5|||
27697589|NCT00323297|80729788|FG001|Part B (Open-label)|Adverse Event|5|||
27828561|NCT02106156|81202901|FG000|Overall Study|Change of Laboratory Parameter|10|||
27558160|NCT01408914|80229633|FG001|Overall Study|Change in local TB/HIV norms|1|||
27558161|NCT01408914|80229634|FG002|Overall Study|Change in local TB/HIV norms|1|||
27697590|NCT00323297|80729787|FG000|Part B (Open-label)|Protocol Violation|0|||
27697591|NCT00323297|80729788|FG001|Part B (Open-label)|Protocol Violation|1|||
27828562|NCT02106156|81202902|FG001|Overall Study|Change of Laboratory Parameter|0|||
27828563|NCT02106156|81202903|FG002|Overall Study|Change of Laboratory Parameter|0|||
27828564|NCT02106156|81202901|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
27828565|NCT02106156|81202902|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
27558162|NCT00759863|80229635|FG000|Overall Study|Death, moved, or lost contact|20|||
27558163|NCT00759863|80229636|FG001|Overall Study|Death, moved, or lost contact|18|||
27558164|NCT03090152|80229639|FG000|Overall Study|Withdrawal by Subject|0|||
27558165|NCT03090152|80229640|FG001|Overall Study|Withdrawal by Subject|2|||
27558166|NCT03090152|80229641|FG002|Overall Study|Withdrawal by Subject|1|||
27558167|NCT03090152|80229639|FG000|Overall Study|Surgery Canceled|1|||
27558168|NCT03090152|80229640|FG001|Overall Study|Surgery Canceled|0|||
27558169|NCT03090152|80229641|FG002|Overall Study|Surgery Canceled|0|||
27558170|NCT03090152|80229639|FG000|Overall Study|Epidural catheter could not be placed|0|||
27558171|NCT03090152|80229640|FG001|Overall Study|Epidural catheter could not be placed|2|||
27558172|NCT03090152|80229641|FG002|Overall Study|Epidural catheter could not be placed|0|||
27558173|NCT03630120|80229642|FG000|Overall Study|Disease progression|0|||
27558174|NCT03630120|80229643|FG001|Overall Study|Disease progression|1|||
27558175|NCT03630120|80229644|FG002|Overall Study|Disease progression|1|||
27558176|NCT03630120|80229645|FG003|Overall Study|Disease progression|1|||
27558177|NCT02118012|80229656|FG000|Overall Study|Adverse Event|0|||
27558178|NCT02118012|80229657|FG001|Overall Study|Adverse Event|1|||
27828566|NCT02106156|81202903|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
27828567|NCT02106156|81202901|FG000|Overall Study|Relocation/Change of Physician|40|||
27828568|NCT02106156|81202902|FG001|Overall Study|Relocation/Change of Physician|1|||
27828569|NCT02106156|81202903|FG002|Overall Study|Relocation/Change of Physician|0|||
27828570|NCT01494532|81202910|FG000|Overall Study|Adverse Event|4|||
27828571|NCT01494532|81202911|FG001|Overall Study|Adverse Event|1|||
27828572|NCT01494532|81202912|FG002|Overall Study|Adverse Event|8|||
27828573|NCT01494532|81202913|FG003|Overall Study|Adverse Event|6|||
27828574|NCT01494532|81202914|FG004|Overall Study|Adverse Event|5|||
27828575|NCT01494532|81202915|FG005|Overall Study|Adverse Event|0|||
27828576|NCT01494532|81202910|FG000|Overall Study|Lack of Efficacy|0|||
27828577|NCT01494532|81202911|FG001|Overall Study|Lack of Efficacy|0|||
27828578|NCT01494532|81202912|FG002|Overall Study|Lack of Efficacy|0|||
27828579|NCT01494532|81202913|FG003|Overall Study|Lack of Efficacy|0|||
27828580|NCT01494532|81202914|FG004|Overall Study|Lack of Efficacy|2|||
27828581|NCT01494532|81202915|FG005|Overall Study|Lack of Efficacy|0|||
27828582|NCT01494532|81202910|FG000|Overall Study|Protocol deviation|2|||
27828583|NCT01494532|81202911|FG001|Overall Study|Protocol deviation|1|||
27828584|NCT01494532|81202912|FG002|Overall Study|Protocol deviation|3|||
27828585|NCT01494532|81202913|FG003|Overall Study|Protocol deviation|2|||
27828586|NCT01494532|81202914|FG004|Overall Study|Protocol deviation|3|||
27828587|NCT01494532|81202915|FG005|Overall Study|Protocol deviation|0|||
27828588|NCT01494532|81202910|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27828589|NCT01494532|81202911|FG001|Overall Study|Protocol-defined stopping criteria|0|||
27697592|NCT00973362|80729789|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
27697593|NCT00973362|80729790|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
27697594|NCT00973362|80729789|FG000|Baseline Evaluation|No colposcopy visit|62|||
27697595|NCT00973362|80729790|FG001|Baseline Evaluation|No colposcopy visit|0|||
27697596|NCT00973362|80729789|FG000|Baseline Evaluation|Inevaluable|686|||
27828590|NCT01494532|81202912|FG002|Overall Study|Protocol-defined stopping criteria|1|||
27828591|NCT01494532|81202913|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27558179|NCT02118012|80229656|FG000|Overall Study|Physician Decision|0|||
27558180|NCT02118012|80229657|FG001|Overall Study|Physician Decision|1|||
27558181|NCT00449540|80229658|FG000|Pretreatment Phase|No migraine experienced|66|||
27558182|NCT00449540|80229659|FG001|Pretreatment Phase|No migraine experienced|0|||
27828592|NCT01494532|81202914|FG004|Overall Study|Protocol-defined stopping criteria|0|||
27828593|NCT01494532|81202915|FG005|Overall Study|Protocol-defined stopping criteria|0|||
27828594|NCT01494532|81202910|FG000|Overall Study|Lost to Follow-up|1|||
27828595|NCT01494532|81202911|FG001|Overall Study|Lost to Follow-up|0|||
27828596|NCT01494532|81202912|FG002|Overall Study|Lost to Follow-up|0|||
27884289|NCT02222545|81411762|FG001|Overall Study|Adverse Event|0|||
27884290|NCT02222545|81411763|FG002|Overall Study|Adverse Event|2|||
27558183|NCT00449540|80229660|FG002|Pretreatment Phase|No migraine experienced|0|||
27558184|NCT00449540|80229658|FG000|Treatment Phase|did not experience or treat migraine|0|||
27828597|NCT01494532|81202913|FG003|Overall Study|Lost to Follow-up|2|||
27828598|NCT01494532|81202914|FG004|Overall Study|Lost to Follow-up|0|||
27828599|NCT01494532|81202915|FG005|Overall Study|Lost to Follow-up|0|||
27828600|NCT01494532|81202910|FG000|Overall Study|Physician Decision|0|||
27558185|NCT00449540|80229659|FG001|Treatment Phase|did not experience or treat migraine|20|||
27828601|NCT01494532|81202911|FG001|Overall Study|Physician Decision|1|||
27828602|NCT01494532|81202912|FG002|Overall Study|Physician Decision|1|||
27828603|NCT01494532|81202913|FG003|Overall Study|Physician Decision|2|||
27828604|NCT01494532|81202914|FG004|Overall Study|Physician Decision|0|||
27828605|NCT01494532|81202915|FG005|Overall Study|Physician Decision|0|||
27828606|NCT01494532|81202910|FG000|Overall Study|Withdrawal by Subject|3|||
27828607|NCT01494532|81202911|FG001|Overall Study|Withdrawal by Subject|1|||
27828608|NCT01494532|81202912|FG002|Overall Study|Withdrawal by Subject|4|||
27828609|NCT01494532|81202913|FG003|Overall Study|Withdrawal by Subject|3|||
27828610|NCT01494532|81202914|FG004|Overall Study|Withdrawal by Subject|2|||
27828611|NCT01494532|81202915|FG005|Overall Study|Withdrawal by Subject|0|||
27828612|NCT01319383|81202920|FG000|Overall Study|No ex vivo or in vivo response|4|||
27828613|NCT01319383|81202921|FG001|Overall Study|No ex vivo or in vivo response|0|||
27828614|NCT01319383|81202920|FG000|Overall Study|Physician Decision|3|||
27828615|NCT01319383|81202921|FG001|Overall Study|Physician Decision|0|||
27828616|NCT01319383|81202920|FG000|Overall Study|Lack of Efficacy|5|||
27828617|NCT01319383|81202921|FG001|Overall Study|Lack of Efficacy|9|||
27828618|NCT01319383|81202920|FG000|Overall Study|No in vivo response to interval doses|0|||
27828619|NCT01319383|81202921|FG001|Overall Study|No in vivo response to interval doses|1|||
27828620|NCT02911792|81202922|FG000|Overall Study|Lost to Follow-up|3|||
27828621|NCT02911792|81202923|FG001|Overall Study|Lost to Follow-up|3|||
27828622|NCT02911792|81202924|FG002|Overall Study|Lost to Follow-up|3|||
27828623|NCT02911792|81202925|FG003|Overall Study|Lost to Follow-up|3|||
27828624|NCT03381274|81202927|FG000|Overall Study|Death|2|||
27828625|NCT03381274|81202928|FG001|Overall Study|Death|9|||
27828626|NCT03381274|81202929|FG002|Overall Study|Death|3|||
27828627|NCT03381274|81202930|FG003|Overall Study|Death|2|||
27828628|NCT03381274|81202931|FG004|Overall Study|Death|3|||
27828629|NCT03381274|81202927|FG000|Overall Study|Lost to Follow-up|0|||
27828630|NCT03381274|81202928|FG001|Overall Study|Lost to Follow-up|0|||
27828631|NCT03381274|81202929|FG002|Overall Study|Lost to Follow-up|0|||
27697597|NCT00973362|80729790|FG001|Baseline Evaluation|Inevaluable|223|||
27697598|NCT00973362|80729789|FG000|3-Year Follow-up|Lost to Follow-up|17|||
27697599|NCT00973362|80729790|FG001|3-Year Follow-up|Lost to Follow-up|0|||
27697600|NCT01929980|80729791|FG000|Overall Study|Physician Decision|1|||
27697601|NCT04744285|80729794|FG000|Overall Study|Withdrawal by Subject|1|||
27697602|NCT04744285|80729795|FG001|Overall Study|Withdrawal by Subject|1|||
27697603|NCT04744285|80729796|FG002|Overall Study|Withdrawal by Subject|2|||
27697604|NCT04744285|80729797|FG003|Overall Study|Withdrawal by Subject|1|||
27697605|NCT03610165|80729798|FG000|Overall Study|Device didn't work|0|||
27697606|NCT03610165|80729799|FG001|Overall Study|Device didn't work|1|||
27697607|NCT01978262|80729801|FG000|Overall Study|Withdrawal by Subject|9|||
27697608|NCT01978262|80729801|FG000|Overall Study|Lost to Follow-up|2|||
27697609|NCT00047320|80729804|FG000|Overall Study|Lack of Efficacy|8|||
27697610|NCT00047320|80729804|FG000|Overall Study|Lost to Follow-up|1|||
27697611|NCT00047320|80729804|FG000|Overall Study|Physician Decision|8|||
27697612|NCT00047320|80729804|FG000|Overall Study|Withdrawal by Subject|9|||
27828632|NCT03381274|81202930|FG003|Overall Study|Lost to Follow-up|1|||
27828633|NCT03381274|81202931|FG004|Overall Study|Lost to Follow-up|0|||
27828634|NCT03381274|81202927|FG000|Overall Study|Withdrawal by Subject|2|||
27828635|NCT03381274|81202928|FG001|Overall Study|Withdrawal by Subject|1|||
27828636|NCT03381274|81202929|FG002|Overall Study|Withdrawal by Subject|3|||
27828637|NCT03381274|81202930|FG003|Overall Study|Withdrawal by Subject|1|||
27697613|NCT00047320|80729804|FG000|Overall Study|Ineligible|2|||
27697614|NCT00634010|80729805|FG000|Overall Study|Adverse Event|2|||
27828638|NCT03381274|81202931|FG004|Overall Study|Withdrawal by Subject|0|||
27697615|NCT00634010|80729806|FG001|Overall Study|Adverse Event|5|||
27828639|NCT03381274|81202927|FG000|Overall Study|Other|1|||
27558186|NCT00449540|80229660|FG002|Treatment Phase|did not experience or treat migraine|17|||
27558187|NCT00773292|80229661|FG000|Treatment 48 Weeks|Adverse Event|1|||
27558188|NCT00773292|80229661|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
27558189|NCT02769247|80229668|FG000|Overall Study|Withdrawal by Subject|1|||
27558190|NCT02769247|80229669|FG001|Overall Study|Withdrawal by Subject|0|||
27558191|NCT02769247|80229670|FG002|Overall Study|Withdrawal by Subject|0|||
27558192|NCT02769247|80229671|FG003|Overall Study|Withdrawal by Subject|1|||
27558193|NCT02769247|80229668|FG000|Overall Study|Protocol Violation|0|||
27558194|NCT02769247|80229669|FG001|Overall Study|Protocol Violation|0|||
27558195|NCT02769247|80229670|FG002|Overall Study|Protocol Violation|1|||
27558196|NCT02769247|80229671|FG003|Overall Study|Protocol Violation|0|||
27558197|NCT02769247|80229668|FG000|Overall Study|Physician Decision|1|||
27558198|NCT02769247|80229669|FG001|Overall Study|Physician Decision|0|||
27884291|NCT02222545|81411761|FG000|Overall Study|Death|0|||
27884292|NCT02222545|81411762|FG001|Overall Study|Death|0|||
27884293|NCT02222545|81411763|FG002|Overall Study|Death|9|||
27884294|NCT02222545|81411761|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
27884295|NCT02222545|81411762|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
27884296|NCT02222545|81411763|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
27884297|NCT02222545|81411761|FG000|Overall Study|Withdrawal by Subject|0|||
27884298|NCT02222545|81411762|FG001|Overall Study|Withdrawal by Subject|0|||
27884299|NCT02222545|81411763|FG002|Overall Study|Withdrawal by Subject|3|||
27884300|NCT02222545|81411761|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
27884301|NCT02222545|81411762|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
27884302|NCT02222545|81411763|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
27884303|NCT01068730|81411764|FG000|Period 3|Personal reason|1|||
27884304|NCT01068730|81411765|FG001|Period 3|Personal reason|0|||
27884305|NCT01068730|81411766|FG002|Period 3|Personal reason|0|||
27884306|NCT01068730|81411767|FG003|Period 3|Personal reason|0|||
27884307|NCT01068730|81411764|FG000|Period 4|Family emergency|0|||
27884308|NCT01068730|81411765|FG001|Period 4|Family emergency|1|||
27884309|NCT01068730|81411766|FG002|Period 4|Family emergency|0|||
27884310|NCT01068730|81411767|FG003|Period 4|Family emergency|0|||
27884311|NCT04087720|81411768|FG000|Overall Study|Withdrawal by Subject|2|||
27558199|NCT02769247|80229670|FG002|Overall Study|Physician Decision|0|||
27558200|NCT02769247|80229671|FG003|Overall Study|Physician Decision|0|||
27558201|NCT00799487|80229676|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
27558202|NCT00799487|80229677|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
27558203|NCT00799487|80229678|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
27558204|NCT00799487|80229676|FG000|Dose Adjustment Period|Adverse Event|2|||
27558205|NCT00799487|80229677|FG001|Dose Adjustment Period|Adverse Event|0|||
27558206|NCT00799487|80229678|FG002|Dose Adjustment Period|Adverse Event|0|||
27558207|NCT00799487|80229676|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
27828640|NCT03381274|81202928|FG001|Overall Study|Other|11|||
27828641|NCT03381274|81202929|FG002|Overall Study|Other|0|||
27828642|NCT03381274|81202930|FG003|Overall Study|Other|2|||
27828643|NCT03381274|81202931|FG004|Overall Study|Other|2|||
27828644|NCT03868891|81202933|FG000|Overall Study|Adverse Event|1|||
27828645|NCT03868891|81202934|FG001|Overall Study|Adverse Event|0|||
27828646|NCT03868891|81202933|FG000|Overall Study|Lost to Follow-up|2|||
27828647|NCT03868891|81202934|FG001|Overall Study|Lost to Follow-up|1|||
27828648|NCT03868891|81202933|FG000|Overall Study|COVID-19 Restrictions|1|||
27828649|NCT03868891|81202934|FG001|Overall Study|COVID-19 Restrictions|2|||
27558208|NCT00799487|80229677|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
27697616|NCT00634010|80729805|FG000|Overall Study|Withdrawal by Subject|5|||
27697617|NCT00634010|80729806|FG001|Overall Study|Withdrawal by Subject|6|||
27697618|NCT00634010|80729805|FG000|Overall Study|Physician Decision|1|||
27697619|NCT00634010|80729806|FG001|Overall Study|Physician Decision|1|||
27558209|NCT00799487|80229678|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
27558210|NCT00799487|80229676|FG000|Dose Adjustment Period|Investigator Discretion|2|||
27558211|NCT00799487|80229677|FG001|Dose Adjustment Period|Investigator Discretion|0|||
27558212|NCT00799487|80229678|FG002|Dose Adjustment Period|Investigator Discretion|0|||
27697620|NCT00634010|80729805|FG000|Overall Study|Disease Progression|1|||
27828650|NCT01265056|81202940|FG000|Initial Study Period|Withdrawal by Subject|1|||
27558213|NCT00799487|80229676|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
27558214|NCT00799487|80229677|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
27558215|NCT00799487|80229678|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
27558216|NCT00799487|80229676|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
27828651|NCT01265056|81202941|FG001|Initial Study Period|Withdrawal by Subject|1|||
27828652|NCT01265056|81202940|FG000|Initial Study Period|Withdrawal by Subject|1|||
27828653|NCT01265056|81202941|FG001|Initial Study Period|Withdrawal by Subject|1|||
27884312|NCT04087720|81411768|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
27884313|NCT00125242|81411769|FG000|Overall Study|did not qualify|7|||
27884314|NCT00125242|81411770|FG001|Overall Study|did not qualify|2|||
27697621|NCT00634010|80729806|FG001|Overall Study|Disease Progression|1|||
27697622|NCT00634010|80729805|FG000|Overall Study|Non-Compliant|1|||
27697623|NCT00634010|80729806|FG001|Overall Study|Non-Compliant|1|||
27697624|NCT01175356|80729807|FG000|Overall Study|Death|1|||
27697625|NCT01175356|80729807|FG000|Overall Study|Lack of Efficacy|12|||
27697626|NCT01175356|80729807|FG000|Overall Study|Lost to Follow-up|1|||
27697627|NCT01175356|80729807|FG000|Overall Study|Physician Decision|23|||
27697628|NCT01175356|80729807|FG000|Overall Study|Ineligible|1|||
27697629|NCT01175356|80729807|FG000|Overall Study|Treatment Slot Not Available|18|||
27697630|NCT01175356|80729807|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
27697631|NCT01175356|80729807|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
27697632|NCT01175356|80729807|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
27697633|NCT01175356|80729807|FG000|Overall Study|Inadequate stem cell for transplant|1|||
27697634|NCT01175356|80729807|FG000|Overall Study|Initiation other tx prior to completion|9|||
27697635|NCT01298518|80729808|FG000|Overall Study|Withdrawal by Subject|0|||
27697636|NCT01298518|80729809|FG001|Overall Study|Withdrawal by Subject|0|||
27697637|NCT01298518|80729810|FG002|Overall Study|Withdrawal by Subject|1|||
27697638|NCT00147823|80729811|FG000|Overall Study|Lost to Follow-up|6|||
27697639|NCT00147823|80729812|FG001|Overall Study|Lost to Follow-up|12|||
27697640|NCT00147823|80729811|FG000|Overall Study|Physician Decision|1|||
27697641|NCT00147823|80729812|FG001|Overall Study|Physician Decision|0|||
27697642|NCT00147823|80729811|FG000|Overall Study|Withdrawal by Subject|0|||
27697643|NCT00147823|80729812|FG001|Overall Study|Withdrawal by Subject|1|||
27697644|NCT00147823|80729811|FG000|Overall Study|Did not receive vitoss due to infection|6|||
27697645|NCT00147823|80729812|FG001|Overall Study|Did not receive vitoss due to infection|2|||
27697646|NCT01137955|80729826|FG000|Overall Study|Withdrawal by Subject|5|||
27697647|NCT01137955|80729827|FG001|Overall Study|Withdrawal by Subject|4|||
27697648|NCT02054325|80729828|FG000|Overall Study|Lost to Follow-up|8|||
27697649|NCT02054325|80729829|FG001|Overall Study|Lost to Follow-up|5|||
27697650|NCT00084266|80729840|FG000|Overall Study|Death|42|||
27697651|NCT00084266|80729841|FG001|Overall Study|Death|39|||
27697652|NCT00084266|80729840|FG000|Overall Study|Adverse Event|8|||
27697653|NCT00084266|80729841|FG001|Overall Study|Adverse Event|5|||
27697654|NCT00084266|80729840|FG000|Overall Study|Lack of Efficacy|2|||
27697655|NCT00084266|80729841|FG001|Overall Study|Lack of Efficacy|4|||
27697656|NCT00084266|80729840|FG000|Overall Study|Lost to Follow-up|5|||
27697657|NCT00084266|80729841|FG001|Overall Study|Lost to Follow-up|3|||
27697658|NCT00084266|80729840|FG000|Overall Study|Participant not willing to participate|3|||
27697659|NCT00084266|80729841|FG001|Overall Study|Participant not willing to participate|8|||
27697660|NCT00084266|80729840|FG000|Overall Study|Other|360|||
27697661|NCT00084266|80729841|FG001|Overall Study|Other|344|||
27697662|NCT00084266|80729840|FG000|Overall Study|Randomized not treated|21|||
27697663|NCT00084266|80729841|FG001|Overall Study|Randomized not treated|20|||
27697664|NCT01369511|80729846|FG000|Overall Study|Adverse Event|1|||
27697665|NCT01369511|80729847|FG001|Overall Study|Adverse Event|1|||
27697666|NCT01369511|80729848|FG002|Overall Study|Adverse Event|5|||
27697667|NCT01369511|80729849|FG003|Overall Study|Adverse Event|0|||
27697668|NCT01369511|80729846|FG000|Overall Study|Entry criteria not met|2|||
27697669|NCT01369511|80729847|FG001|Overall Study|Entry criteria not met|0|||
27697670|NCT01369511|80729848|FG002|Overall Study|Entry criteria not met|0|||
27697671|NCT01369511|80729849|FG003|Overall Study|Entry criteria not met|1|||
27697672|NCT01369511|80729846|FG000|Overall Study|Lost to Follow-up|0|||
27697673|NCT01369511|80729847|FG001|Overall Study|Lost to Follow-up|1|||
27697674|NCT01369511|80729848|FG002|Overall Study|Lost to Follow-up|1|||
27697675|NCT01369511|80729849|FG003|Overall Study|Lost to Follow-up|2|||
27697676|NCT01369511|80729846|FG000|Overall Study|Protocol Violation|0|||
27697677|NCT01369511|80729847|FG001|Overall Study|Protocol Violation|1|||
27697678|NCT01369511|80729848|FG002|Overall Study|Protocol Violation|0|||
27697679|NCT01369511|80729849|FG003|Overall Study|Protocol Violation|2|||
27697680|NCT01369511|80729846|FG000|Overall Study|Physician Decision|3|||
27828654|NCT01265056|81202940|FG000|Follow up|Lost to Follow-up|7|||
27558217|NCT00799487|80229677|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
27558218|NCT00799487|80229678|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
27697681|NCT01369511|80729847|FG001|Overall Study|Physician Decision|4|||
27697682|NCT01369511|80729848|FG002|Overall Study|Physician Decision|0|||
27697683|NCT01369511|80729849|FG003|Overall Study|Physician Decision|0|||
27697684|NCT01369511|80729846|FG000|Overall Study|Sponsor decision|2|||
27828655|NCT01265056|81202941|FG001|Follow up|Lost to Follow-up|3|||
27697685|NCT01369511|80729847|FG001|Overall Study|Sponsor decision|0|||
27697686|NCT01369511|80729848|FG002|Overall Study|Sponsor decision|1|||
27697687|NCT01369511|80729849|FG003|Overall Study|Sponsor decision|0|||
27697688|NCT01369511|80729846|FG000|Overall Study|Withdrawal by Subject|5|||
27697689|NCT01369511|80729847|FG001|Overall Study|Withdrawal by Subject|6|||
27697690|NCT01369511|80729848|FG002|Overall Study|Withdrawal by Subject|4|||
27697691|NCT01369511|80729849|FG003|Overall Study|Withdrawal by Subject|6|||
27697692|NCT01078675|80729850|FG000|Overall Study|Withdrawal by Subject|7|||
27697693|NCT01078675|80729851|FG001|Overall Study|Withdrawal by Subject|3|||
27828656|NCT01173692|81202942|FG000|Overall Study|Adverse Event|1|||
27697694|NCT01078675|80729850|FG000|Overall Study|Protocol Violation|56|||
27697695|NCT01078675|80729851|FG001|Overall Study|Protocol Violation|0|||
27697696|NCT01078675|80729850|FG000|Overall Study|Provided in CRF for specific reasons|2|||
27697697|NCT01078675|80729851|FG001|Overall Study|Provided in CRF for specific reasons|3|||
27697698|NCT01078675|80729850|FG000|Overall Study|Adverse Event|3|||
27697699|NCT01078675|80729851|FG001|Overall Study|Adverse Event|0|||
27697700|NCT01786174|80729854|FG000|Overall Study|Discontinued Study Drug|2|||
27697701|NCT01786174|80729855|FG001|Overall Study|Discontinued Study Drug|0|||
27697702|NCT00764751|80729856|FG000|Overall Study|Adverse Event|1|||
27697703|NCT00764751|80729857|FG001|Overall Study|Adverse Event|1|||
27697704|NCT00764751|80729856|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
27697705|NCT00764751|80729857|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
27697706|NCT02604433|80729858|FG000|Overall Study|Withdrawal by Subject|37|||
27697707|NCT02604433|80729859|FG001|Overall Study|Withdrawal by Subject|16|||
27697708|NCT02604433|80729858|FG000|Overall Study|Adverse Event|4|||
27697709|NCT02604433|80729859|FG001|Overall Study|Adverse Event|0|||
27697710|NCT02604433|80729858|FG000|Overall Study|Other reasons|3|||
27697711|NCT02604433|80729859|FG001|Overall Study|Other reasons|5|||
27697712|NCT02604433|80729858|FG000|Overall Study|Death|4|||
27697713|NCT02604433|80729859|FG001|Overall Study|Death|1|||
27697714|NCT02604433|80729858|FG000|Overall Study|Transition to Rollover Protocol|169|||
27697715|NCT02604433|80729859|FG001|Overall Study|Transition to Rollover Protocol|82|||
27697716|NCT02604433|80729858|FG000|Overall Study|Physician Decision|1|||
27697717|NCT02604433|80729859|FG001|Overall Study|Physician Decision|1|||
27697718|NCT02604433|80729858|FG000|Overall Study|Lack of Efficacy|0|||
27697719|NCT02604433|80729859|FG001|Overall Study|Lack of Efficacy|1|||
27697720|NCT01422850|80729860|FG000|Overall Study|Physician Decision|3|||
27697721|NCT04014361|80729861|FG000|Period 2|Physician Decision|0|||
27697722|NCT04014361|80729862|FG001|Period 2|Physician Decision|0|||
27697723|NCT04014361|80729863|FG002|Period 2|Physician Decision|0|||
27697724|NCT04014361|80729864|FG003|Period 2|Physician Decision|1|||
27697725|NCT04014361|80729865|FG004|Period 2|Physician Decision|0|||
27697726|NCT04014361|80729866|FG005|Period 2|Physician Decision|0|||
27697727|NCT04014361|80729867|FG006|Period 2|Physician Decision|0|||
27697728|NCT04014361|80729868|FG007|Period 2|Physician Decision|0|||
27697729|NCT02349451|80729869|FG000|Overall Study|Withdrawal by Subject|0|||
27697730|NCT02349451|80729870|FG001|Overall Study|Withdrawal by Subject|1|||
27697731|NCT02349451|80729871|FG002|Overall Study|Withdrawal by Subject|2|||
27697732|NCT02349451|80729872|FG003|Overall Study|Withdrawal by Subject|1|||
27697733|NCT01388790|80729878|FG000|Overall Study|Ongoing at data cut-off date|8|||
27697734|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
27697735|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
27697736|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
27697737|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
27697738|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
27697739|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
27697740|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
27697741|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
27697742|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
27828657|NCT01173692|81202943|FG001|Overall Study|Adverse Event|2|||
27828658|NCT01173692|81202942|FG000|Overall Study|Withdrawal by Subject|1|||
27828659|NCT01173692|81202943|FG001|Overall Study|Withdrawal by Subject|3|||
27828660|NCT03956862|81202946|FG000|Overall Study|Lost to Follow-up|1|||
27828661|NCT03956862|81202947|FG001|Overall Study|Lost to Follow-up|1|||
27828662|NCT03956862|81202946|FG000|Overall Study|Withdrawal by Subject|1|||
27828663|NCT03956862|81202947|FG001|Overall Study|Withdrawal by Subject|1|||
27828664|NCT04239872|81202948|FG000|Overall Study|Lost to Follow-up|0|||
27828665|NCT04239872|81202949|FG001|Overall Study|Lost to Follow-up|1|||
27828666|NCT00745420|81202954|FG000|Overall Study|Ineligible|1|||
27697743|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
27697744|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
27697745|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
27697746|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
27697747|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
27828667|NCT03249454|81202957|FG000|Overall Study|Withdrawal by Subject|0|||
27828668|NCT03249454|81202958|FG001|Overall Study|Withdrawal by Subject|0|||
27828669|NCT03249454|81202959|FG002|Overall Study|Withdrawal by Subject|0|||
27828670|NCT03249454|81202960|FG003|Overall Study|Withdrawal by Subject|0|||
27697748|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
27697749|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
27697750|NCT01231516|80729879|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
27558219|NCT00799487|80229676|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
27558220|NCT00799487|80229677|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
27828671|NCT03249454|81202961|FG004|Overall Study|Withdrawal by Subject|0|||
27828672|NCT03249454|81202962|FG005|Overall Study|Withdrawal by Subject|0|||
27558221|NCT00799487|80229678|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
27558222|NCT00799487|80229676|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
27558223|NCT00799487|80229677|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
27828673|NCT03249454|81202963|FG006|Overall Study|Withdrawal by Subject|0|||
27828674|NCT03249454|81202964|FG007|Overall Study|Withdrawal by Subject|0|||
27828675|NCT03249454|81202965|FG008|Overall Study|Withdrawal by Subject|0|||
27828676|NCT03249454|81202966|FG009|Overall Study|Withdrawal by Subject|1|||
27828677|NCT03249454|81202967|FG010|Overall Study|Withdrawal by Subject|1|||
27828678|NCT04022954|81202968|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
27828679|NCT04022954|81202968|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
27828680|NCT04022954|81202968|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
27828681|NCT02281084|81202970|FG000|Overall Study|Death|21|||
27828682|NCT02281084|81202971|FG001|Overall Study|Death|18|||
27828683|NCT02281084|81202972|FG002|Overall Study|Death|3|||
27828684|NCT02281084|81202973|FG003|Overall Study|Death|5|||
27828685|NCT02281084|81202970|FG000|Overall Study|Adverse Event|1|||
27828686|NCT02281084|81202971|FG001|Overall Study|Adverse Event|0|||
27828687|NCT02281084|81202972|FG002|Overall Study|Adverse Event|0|||
27558224|NCT00799487|80229678|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
27558225|NCT00799487|80229676|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
27558226|NCT00799487|80229677|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
27558227|NCT00799487|80229678|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
27828688|NCT02281084|81202973|FG003|Overall Study|Adverse Event|0|||
27828689|NCT02281084|81202970|FG000|Overall Study|Withdrawal by Subject|2|||
27828690|NCT02281084|81202971|FG001|Overall Study|Withdrawal by Subject|2|||
27828691|NCT02281084|81202972|FG002|Overall Study|Withdrawal by Subject|0|||
27828692|NCT02281084|81202973|FG003|Overall Study|Withdrawal by Subject|0|||
27828693|NCT02281084|81202970|FG000|Overall Study|Site Closure by Sponsor|5|||
27558228|NCT00799487|80229676|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
27558229|NCT00799487|80229677|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
27558230|NCT00799487|80229678|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
27558231|NCT00799487|80229676|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
27558232|NCT00799487|80229677|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
27558233|NCT00799487|80229678|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
27558234|NCT00799487|80229676|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
27558235|NCT00799487|80229677|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
27884315|NCT02411396|81411783|FG000|Overall Study|Lost to Follow-up|31|||
27558236|NCT00799487|80229678|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
27558237|NCT02738450|80229679|FG000|Overall Study|Withdrawal by Subject|0|||
27558238|NCT02738450|80229680|FG001|Overall Study|Withdrawal by Subject|2|||
27558239|NCT02738450|80229681|FG002|Overall Study|Withdrawal by Subject|0|||
27558240|NCT00323115|80229685|FG000|Vaccine Administration|Adverse Event|1|||
27558241|NCT00323115|80229685|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
27558242|NCT00549302|80229686|FG000|Double-Blind|Death|2|||
27558243|NCT00549302|80229687|FG001|Double-Blind|Death|9|||
27558244|NCT00549302|80229688|FG002|Double-Blind|Death|0|||
27558245|NCT00549302|80229686|FG000|Double-Blind|Adverse Event|3|||
27558246|NCT00549302|80229687|FG001|Double-Blind|Adverse Event|16|||
27828694|NCT02281084|81202971|FG001|Overall Study|Site Closure by Sponsor|1|||
27828695|NCT02281084|81202972|FG002|Overall Study|Site Closure by Sponsor|2|||
27558247|NCT00549302|80229688|FG002|Double-Blind|Adverse Event|0|||
27558248|NCT00549302|80229686|FG000|Double-Blind|Withdrawal by Subject|3|||
27558249|NCT00549302|80229687|FG001|Double-Blind|Withdrawal by Subject|8|||
27558250|NCT00549302|80229688|FG002|Double-Blind|Withdrawal by Subject|0|||
27828696|NCT02281084|81202973|FG003|Overall Study|Site Closure by Sponsor|0|||
27828697|NCT01827163|81202974|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
27828698|NCT01827163|81202974|FG000|Overall Study|Adverse Event|9|||
27828699|NCT00909753|81202977|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
27828700|NCT00909753|81202978|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
27828701|NCT00909753|81202977|FG000|Period: Second Intervention|Protocol Violation|1|||
27828702|NCT00909753|81202978|FG001|Period: Second Intervention|Protocol Violation|0|||
27828703|NCT00620074|81202981|FG000|Overall Study|Adverse Event|1|||
27828704|NCT01975948|81202982|FG000|Overall Study|Withdrawal by Subject|17|||
27828705|NCT01975948|81202983|FG001|Overall Study|Withdrawal by Subject|21|||
27828706|NCT01975948|81202984|FG002|Overall Study|Withdrawal by Subject|7|||
27828707|NCT01975948|81202985|FG003|Overall Study|Withdrawal by Subject|6|||
27828708|NCT03122535|81202988|FG000|Overall Study|Lost to Follow-up|68|||
27828709|NCT03122535|81202989|FG001|Overall Study|Lost to Follow-up|68|||
27828710|NCT03122535|81202988|FG000|Overall Study|Physician Decision|3|||
27828711|NCT03122535|81202989|FG001|Overall Study|Physician Decision|3|||
27828712|NCT03122535|81202988|FG000|Overall Study|Withdrawal by Subject|2|||
27828713|NCT03122535|81202989|FG001|Overall Study|Withdrawal by Subject|2|||
27828714|NCT02647944|81202992|FG000|Overall Study|Withdrawal by Subject|0|||
27828715|NCT02647944|81202993|FG001|Overall Study|Withdrawal by Subject|3|||
27828716|NCT02647944|81202992|FG000|Overall Study|Adverse Event|2|||
27828717|NCT02647944|81202993|FG001|Overall Study|Adverse Event|0|||
27828718|NCT03100344|81202997|FG000|Overall Study|Adverse Event|0|||
27828719|NCT03100344|81202998|FG001|Overall Study|Adverse Event|3|||
27828720|NCT03100344|81202999|FG002|Overall Study|Adverse Event|2|||
27828721|NCT03100344|81203000|FG003|Overall Study|Adverse Event|3|||
27828722|NCT03100344|81202997|FG000|Overall Study|Lack of Efficacy|2|||
27828723|NCT03100344|81202998|FG001|Overall Study|Lack of Efficacy|0|||
27884316|NCT02411396|81411783|FG000|Overall Study|Death|10|||
27558251|NCT00549302|80229686|FG000|Double-Blind|Investigator Decision|1|||
27884317|NCT00550745|81411784|FG000|Overall Study|Death|20|||
27884318|NCT00550745|81411785|FG001|Overall Study|Death|16|||
27884319|NCT00550745|81411784|FG000|Overall Study|Lost to Follow-up|45|||
27884320|NCT00550745|81411785|FG001|Overall Study|Lost to Follow-up|30|||
27884321|NCT00550745|81411784|FG000|Overall Study|Physician Decision|0|||
27884322|NCT00550745|81411785|FG001|Overall Study|Physician Decision|2|||
27884323|NCT00550745|81411784|FG000|Overall Study|Protocol Violation|4|||
27884324|NCT00550745|81411785|FG001|Overall Study|Protocol Violation|2|||
27884325|NCT00550745|81411784|FG000|Overall Study|Withdrawal by Subject|17|||
27884326|NCT00550745|81411785|FG001|Overall Study|Withdrawal by Subject|10|||
27558252|NCT00549302|80229687|FG001|Double-Blind|Investigator Decision|5|||
27558253|NCT00549302|80229688|FG002|Double-Blind|Investigator Decision|0|||
27558254|NCT00549302|80229686|FG000|Double-Blind|Sponsor Decision|0|||
27558255|NCT00549302|80229687|FG001|Double-Blind|Sponsor Decision|1|||
27697751|NCT01231516|80729880|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
27697752|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
27697753|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
27697754|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
27558256|NCT00549302|80229688|FG002|Double-Blind|Sponsor Decision|0|||
27558257|NCT00549302|80229686|FG000|Double-Blind|Lost to Follow-up|1|||
27558258|NCT00549302|80229687|FG001|Double-Blind|Lost to Follow-up|2|||
27558259|NCT00549302|80229688|FG002|Double-Blind|Lost to Follow-up|0|||
27558260|NCT00549302|80229686|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
27558261|NCT00549302|80229687|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
27558262|NCT00549302|80229688|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
27558263|NCT00549302|80229686|FG000|Double-Blind|New condition or starts new therapy|0|||
27558264|NCT00549302|80229687|FG001|Double-Blind|New condition or starts new therapy|2|||
27558265|NCT00549302|80229688|FG002|Double-Blind|New condition or starts new therapy|0|||
27558266|NCT00549302|80229686|FG000|Open-Label|Adverse Event|0|||
27558267|NCT00549302|80229687|FG001|Open-Label|Adverse Event|0|||
27558268|NCT00549302|80229688|FG002|Open-Label|Adverse Event|11|||
27558269|NCT00549302|80229686|FG000|Open-Label|Death|0|||
27558270|NCT00549302|80229687|FG001|Open-Label|Death|0|||
27558271|NCT00549302|80229688|FG002|Open-Label|Death|40|||
27558272|NCT00549302|80229686|FG000|Open-Label|Investigator Decision|0|||
27558273|NCT00549302|80229687|FG001|Open-Label|Investigator Decision|0|||
27558274|NCT00549302|80229688|FG002|Open-Label|Investigator Decision|5|||
27558275|NCT00549302|80229686|FG000|Open-Label|Lost to Follow-up|0|||
27558276|NCT00549302|80229687|FG001|Open-Label|Lost to Follow-up|0|||
27558277|NCT00549302|80229688|FG002|Open-Label|Lost to Follow-up|2|||
27558278|NCT00549302|80229686|FG000|Open-Label|Other|0|||
27558279|NCT00549302|80229687|FG001|Open-Label|Other|0|||
27558280|NCT00549302|80229688|FG002|Open-Label|Other|3|||
27558281|NCT00549302|80229686|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
27558282|NCT00549302|80229687|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
27558283|NCT00549302|80229688|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
27558284|NCT00549302|80229686|FG000|Open-Label|Withdrawal by Subject|0|||
27558285|NCT00549302|80229687|FG001|Open-Label|Withdrawal by Subject|0|||
27558286|NCT00549302|80229688|FG002|Open-Label|Withdrawal by Subject|6|||
27558287|NCT01946425|80229689|FG000|Overall Study|Protocol Violation|1|||
27558288|NCT01946425|80229690|FG001|Overall Study|Protocol Violation|0|||
27558289|NCT01946425|80229689|FG000|Overall Study|Withdrawal by Subject|1|||
27558290|NCT01946425|80229690|FG001|Overall Study|Withdrawal by Subject|0|||
27558291|NCT00927784|80229691|FG000|Overall Study|Death|1|||
27558292|NCT00927784|80229692|FG001|Overall Study|Death|0|||
27558293|NCT00927784|80229691|FG000|Overall Study|Withdrawal by Subject|1|||
27558294|NCT00927784|80229692|FG001|Overall Study|Withdrawal by Subject|0|||
27697755|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
27884327|NCT00550745|81411784|FG000|Overall Study|Screen failure|1|||
27884328|NCT00550745|81411785|FG001|Overall Study|Screen failure|0|||
27884329|NCT02058537|81411786|FG000|Overall Study|Withdrawal by Subject|1|||
27558295|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Adverse Event|82|||
27558296|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Death|6|||
27558297|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
27558298|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
27558299|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
27558300|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
27697756|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
27697757|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
27697758|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
27697759|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
27697760|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
27697761|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
27697762|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
27558301|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
27828724|NCT03100344|81202999|FG002|Overall Study|Lack of Efficacy|0|||
27828725|NCT03100344|81203000|FG003|Overall Study|Lack of Efficacy|0|||
27828726|NCT03100344|81202997|FG000|Overall Study|Protocol Violation|1|||
27828727|NCT03100344|81202998|FG001|Overall Study|Protocol Violation|0|||
27828728|NCT03100344|81202999|FG002|Overall Study|Protocol Violation|0|||
27828729|NCT03100344|81203000|FG003|Overall Study|Protocol Violation|0|||
27828730|NCT03100344|81202997|FG000|Overall Study|Withdrawal by Subject|10|||
27828731|NCT03100344|81202998|FG001|Overall Study|Withdrawal by Subject|7|||
27558302|NCT00195676|80229693|FG000|Period O - Open-label Treatment|Other reasons|68|||
27697763|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
27558303|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
27828732|NCT03100344|81202999|FG002|Overall Study|Withdrawal by Subject|4|||
27828733|NCT03100344|81203000|FG003|Overall Study|Withdrawal by Subject|8|||
27884330|NCT02616146|81411792|FG000|Overall Study|Adverse Event|64|||
27884331|NCT02616146|81411793|FG001|Overall Study|Adverse Event|24|||
27884332|NCT02616146|81411792|FG000|Overall Study|Lost to Follow-up|23|||
27884333|NCT02616146|81411793|FG001|Overall Study|Lost to Follow-up|13|||
27884334|NCT02616146|81411792|FG000|Overall Study|Non-compliance with study protocol|2|||
27884335|NCT02616146|81411793|FG001|Overall Study|Non-compliance with study protocol|0|||
27884336|NCT02616146|81411792|FG000|Overall Study|Non-compliance with study drug|4|||
27828734|NCT03100344|81202997|FG000|Overall Study|Lost to Follow-up|1|||
27828735|NCT03100344|81202998|FG001|Overall Study|Lost to Follow-up|1|||
27828736|NCT03100344|81202999|FG002|Overall Study|Lost to Follow-up|1|||
27828737|NCT03100344|81203000|FG003|Overall Study|Lost to Follow-up|1|||
27828738|NCT02213263|81203009|FG000|Overall Study|Insufficient clinical response|4|||
27828739|NCT02213263|81203010|FG001|Overall Study|Insufficient clinical response|3|||
27828740|NCT02213263|81203009|FG000|Overall Study|Lost to Follow-up|0|||
27828741|NCT02213263|81203010|FG001|Overall Study|Lost to Follow-up|1|||
27828742|NCT02213263|81203009|FG000|Overall Study|No longer willing to participate|3|||
27828743|NCT02213263|81203010|FG001|Overall Study|No longer willing to participate|4|||
27828744|NCT02213263|81203009|FG000|Overall Study|Progressive disease|20|||
27828745|NCT02213263|81203010|FG001|Overall Study|Progressive disease|14|||
27828746|NCT02213263|81203009|FG000|Overall Study|Protocol Violation|0|||
27828747|NCT02213263|81203010|FG001|Overall Study|Protocol Violation|1|||
27828748|NCT02213263|81203009|FG000|Overall Study|Adverse Event|1|||
27828749|NCT02213263|81203010|FG001|Overall Study|Adverse Event|3|||
27828750|NCT00835081|81203016|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27828751|NCT00835081|81203017|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27828752|NCT01049334|81203018|FG000|Overall Study|Withdrawal by Subject|5|||
27828753|NCT01049334|81203019|FG001|Overall Study|Withdrawal by Subject|3|||
27828754|NCT01049334|81203018|FG000|Overall Study|Adverse Event|2|||
27828755|NCT01049334|81203019|FG001|Overall Study|Adverse Event|3|||
27828756|NCT01049334|81203018|FG000|Overall Study|Physician Decision|2|||
27828757|NCT01049334|81203019|FG001|Overall Study|Physician Decision|0|||
27884337|NCT02616146|81411793|FG001|Overall Study|Non-compliance with study drug|2|||
27828758|NCT01049334|81203018|FG000|Overall Study|Protocol Violation|0|||
27828759|NCT01049334|81203019|FG001|Overall Study|Protocol Violation|1|||
27828760|NCT00905606|81203020|FG000|Period 1|Adverse Event|0|||
27828761|NCT00905606|81203021|FG001|Period 1|Adverse Event|1|||
27828762|NCT00905606|81203020|FG000|Washout|Withdrawal by Subject|1|||
27828763|NCT00905606|81203021|FG001|Washout|Withdrawal by Subject|0|||
27828764|NCT02075463|81203028|FG000|Overall Study|Adverse Event|3|||
27884338|NCT02616146|81411792|FG000|Overall Study|Pregnancy|2|||
27828765|NCT02075463|81203028|FG000|Overall Study|Par. reached stopping criteria|4|||
27884339|NCT02616146|81411793|FG001|Overall Study|Pregnancy|2|||
27828766|NCT02075463|81203028|FG000|Overall Study|Withdrawal by Subject|1|||
27558304|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
27558305|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
27884340|NCT02616146|81411792|FG000|Overall Study|Pregnancy wish|3|||
27884341|NCT02616146|81411793|FG001|Overall Study|Pregnancy wish|0|||
27884342|NCT02616146|81411792|FG000|Overall Study|Protocol Violation|6|||
27884343|NCT02616146|81411793|FG001|Overall Study|Protocol Violation|3|||
27884344|NCT02616146|81411792|FG000|Overall Study|Study terminated by sponsor|1372|||
27884345|NCT02616146|81411793|FG001|Overall Study|Study terminated by sponsor|432|||
27884346|NCT02616146|81411792|FG000|Overall Study|Participant moved|4|||
27884347|NCT02616146|81411793|FG001|Overall Study|Participant moved|3|||
27884348|NCT02616146|81411792|FG000|Overall Study|Withdrawal by Subject|30|||
27884349|NCT02616146|81411793|FG001|Overall Study|Withdrawal by Subject|24|||
27884350|NCT02616146|81411792|FG000|Overall Study|Physician Decision|2|||
27884351|NCT02616146|81411793|FG001|Overall Study|Physician Decision|1|||
27884352|NCT01166438|81411796|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
27884353|NCT01166438|81411797|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
27884354|NCT01166438|81411796|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
27884355|NCT01166438|81411797|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
27884356|NCT01166438|81411796|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
27884357|NCT01166438|81411797|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
27884358|NCT01166438|81411796|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
27884359|NCT01166438|81411797|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
27884360|NCT01166438|81411796|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
27884361|NCT01166438|81411797|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
27884362|NCT01166438|81411796|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
27884363|NCT01166438|81411797|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
27884364|NCT02964507|81411800|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
27884365|NCT02964507|81411801|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
27884366|NCT02964507|81411802|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
27884367|NCT02964507|81411803|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
27884368|NCT02964507|81411804|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
27884369|NCT02964507|81411805|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
27884370|NCT02964507|81411806|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
27884371|NCT02964507|81411807|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
27884372|NCT02964507|81411800|FG000|Overall Study|Study terminated by Sponsor|9|||
27884373|NCT02964507|81411801|FG001|Overall Study|Study terminated by Sponsor|1|||
27884374|NCT02964507|81411802|FG002|Overall Study|Study terminated by Sponsor|9|||
27884375|NCT02964507|81411803|FG003|Overall Study|Study terminated by Sponsor|3|||
27558306|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
27558307|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
27558308|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
27697764|NCT01231516|80729879|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
27884376|NCT02964507|81411804|FG004|Overall Study|Study terminated by Sponsor|3|||
27884377|NCT02964507|81411805|FG005|Overall Study|Study terminated by Sponsor|2|||
27884378|NCT02964507|81411806|FG006|Overall Study|Study terminated by Sponsor|0|||
27884379|NCT02964507|81411807|FG007|Overall Study|Study terminated by Sponsor|0|||
27884380|NCT02964507|81411800|FG000|Overall Study|Other|3|||
27884381|NCT02964507|81411801|FG001|Overall Study|Other|0|||
27884382|NCT02964507|81411802|FG002|Overall Study|Other|0|||
27884383|NCT02964507|81411803|FG003|Overall Study|Other|0|||
27697765|NCT01231516|80729880|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
27884384|NCT02964507|81411804|FG004|Overall Study|Other|1|||
27884385|NCT02964507|81411805|FG005|Overall Study|Other|0|||
27884386|NCT02964507|81411806|FG006|Overall Study|Other|0|||
27884387|NCT02964507|81411807|FG007|Overall Study|Other|0|||
27884388|NCT02964507|81411800|FG000|Overall Study|Death|11|||
27884389|NCT02964507|81411801|FG001|Overall Study|Death|9|||
27884390|NCT02964507|81411802|FG002|Overall Study|Death|12|||
27884391|NCT02964507|81411803|FG003|Overall Study|Death|2|||
27884392|NCT02964507|81411804|FG004|Overall Study|Death|10|||
27828767|NCT04078022|81203032|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
27828768|NCT04078022|81203033|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
27828769|NCT01531894|81203034|FG000|Overall Study|Physician Decision|8|||
27828770|NCT01531894|81203034|FG000|Overall Study|Death|1|||
27828771|NCT00834249|81203036|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27828772|NCT00834249|81203037|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
27828773|NCT00834249|81203036|FG000|Second Intervention|Adverse Event|1|||
27828774|NCT00834249|81203037|FG001|Second Intervention|Adverse Event|0|||
27828775|NCT00835536|81203041|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
27828776|NCT00835536|81203042|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
27828777|NCT00811655|81203047|FG000|Overall Study|Physician Decision|1|||
27828778|NCT00633594|81203048|FG000|Overall Study|Adverse Event|0|||
27828779|NCT00633594|81203049|FG001|Overall Study|Adverse Event|4|||
27828780|NCT00633594|81203050|FG002|Overall Study|Adverse Event|7|||
27828781|NCT00633594|81203048|FG000|Overall Study|Death|0|||
27828782|NCT00633594|81203049|FG001|Overall Study|Death|1|||
27828783|NCT00633594|81203050|FG002|Overall Study|Death|2|||
27828784|NCT00633594|81203048|FG000|Overall Study|Disease Progression|0|||
27828785|NCT00633594|81203049|FG001|Overall Study|Disease Progression|0|||
27828786|NCT00633594|81203050|FG002|Overall Study|Disease Progression|1|||
27828787|NCT00804856|81203058|FG000|Overall Study|Progressive Disease|3|||
27828788|NCT00804856|81203059|FG001|Overall Study|Progressive Disease|2|||
27828789|NCT00804856|81203060|FG002|Overall Study|Progressive Disease|4|||
27828790|NCT00804856|81203061|FG003|Overall Study|Progressive Disease|6|||
27828791|NCT00804856|81203062|FG004|Overall Study|Progressive Disease|4|||
27828792|NCT00804856|81203063|FG005|Overall Study|Progressive Disease|1|||
27828793|NCT00804856|81203064|FG006|Overall Study|Progressive Disease|8|||
27828794|NCT00804856|81203065|FG007|Overall Study|Progressive Disease|2|||
27828795|NCT00804856|81203066|FG008|Overall Study|Progressive Disease|4|||
27828796|NCT00804856|81203067|FG009|Overall Study|Progressive Disease|5|||
27828797|NCT00804856|81203068|FG010|Overall Study|Progressive Disease|12|||
27828798|NCT00804856|81203069|FG011|Overall Study|Progressive Disease|2|||
27828799|NCT00804856|81203070|FG012|Overall Study|Progressive Disease|2|||
27828800|NCT00804856|81203071|FG013|Overall Study|Progressive Disease|26|||
27828801|NCT00804856|81203072|FG014|Overall Study|Progressive Disease|20|||
27828802|NCT00804856|81203058|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828803|NCT00804856|81203059|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828804|NCT00804856|81203060|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828805|NCT00804856|81203061|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828806|NCT00804856|81203062|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27828807|NCT00804856|81203063|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828808|NCT00804856|81203064|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828809|NCT00804856|81203065|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828810|NCT00804856|81203066|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828811|NCT00804856|81203067|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828812|NCT00804856|81203068|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828813|NCT00804856|81203069|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27697766|NCT04079803|80729881|FG000|Overall Study|Withdrawal by Subject|0|||
27828814|NCT00804856|81203070|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27697767|NCT04079803|80729882|FG001|Overall Study|Withdrawal by Subject|0|||
27697768|NCT04079803|80729883|FG002|Overall Study|Withdrawal by Subject|1|||
27697769|NCT01372410|80729884|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
27697770|NCT01372410|80729885|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
27828815|NCT00804856|81203071|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27828816|NCT00804856|81203072|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27828817|NCT00804856|81203058|FG000|Overall Study|Other Adverse Event|1|||
27697771|NCT01372410|80729886|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27828818|NCT00804856|81203059|FG001|Overall Study|Other Adverse Event|1|||
27828819|NCT00804856|81203060|FG002|Overall Study|Other Adverse Event|1|||
27828820|NCT00804856|81203061|FG003|Overall Study|Other Adverse Event|2|||
27828821|NCT00804856|81203062|FG004|Overall Study|Other Adverse Event|2|||
27828822|NCT00804856|81203063|FG005|Overall Study|Other Adverse Event|1|||
27828823|NCT00804856|81203064|FG006|Overall Study|Other Adverse Event|3|||
27828824|NCT00804856|81203065|FG007|Overall Study|Other Adverse Event|0|||
27828825|NCT00804856|81203066|FG008|Overall Study|Other Adverse Event|0|||
27558309|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
27558310|NCT00195676|80229693|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
27558311|NCT00195676|80229693|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
27558312|NCT00195676|80229693|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
27558313|NCT00195676|80229693|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
27558314|NCT00195676|80229693|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
27558315|NCT00195676|80229693|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
27558316|NCT01892501|80229695|FG000|Overall Study|Protocol Violation|2|||
27558317|NCT01892501|80229695|FG000|Overall Study|Puncture not carried out|9|||
27558318|NCT01892501|80229695|FG000|Overall Study|Radiological monitoring not carried out|5|||
27558319|NCT01892501|80229695|FG000|Overall Study|Non-contributory histological result|12|||
27558320|NCT00810407|80229696|FG000|Overall Study|Protocol Violation|3|||
27558321|NCT00810407|80229696|FG000|Overall Study|No Visit After First Day of Treatment|3|||
27697772|NCT01372410|80729887|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27828826|NCT00804856|81203067|FG009|Overall Study|Other Adverse Event|1|||
27828827|NCT00804856|81203068|FG010|Overall Study|Other Adverse Event|5|||
27558322|NCT01603459|80229697|FG000|Overall Study|Adverse Event|5|||
27697773|NCT01372410|80729888|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
27697774|NCT01372410|80729889|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27697775|NCT01372410|80729890|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27697776|NCT01372410|80729891|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
27697777|NCT01372410|80729884|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
27697778|NCT01372410|80729885|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
27697779|NCT01372410|80729886|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
27697780|NCT01372410|80729887|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
27697781|NCT01372410|80729888|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
27697782|NCT01372410|80729889|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
27697783|NCT01372410|80729890|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
27697784|NCT01372410|80729891|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
27697785|NCT01372410|80729884|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697786|NCT01372410|80729885|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697787|NCT01372410|80729886|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697788|NCT01372410|80729887|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697789|NCT01372410|80729888|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
27697790|NCT01372410|80729889|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697791|NCT01372410|80729890|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697792|NCT01372410|80729891|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
27697793|NCT01372410|80729884|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697794|NCT01372410|80729885|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697795|NCT01372410|80729886|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697796|NCT01372410|80729887|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697797|NCT01372410|80729888|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697798|NCT01372410|80729889|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697799|NCT01372410|80729890|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
27697800|NCT01372410|80729891|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
27697801|NCT01372410|80729884|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
27828828|NCT00804856|81203069|FG011|Overall Study|Other Adverse Event|2|||
27828829|NCT00804856|81203070|FG012|Overall Study|Other Adverse Event|0|||
27828830|NCT00804856|81203071|FG013|Overall Study|Other Adverse Event|6|||
27697802|NCT01372410|80729885|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27828831|NCT00804856|81203072|FG014|Overall Study|Other Adverse Event|13|||
27828832|NCT00804856|81203058|FG000|Overall Study|Non compliance with protocol|0|||
27697803|NCT01372410|80729886|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27697804|NCT01372410|80729887|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27697805|NCT01372410|80729888|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27697806|NCT01372410|80729889|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27697807|NCT01372410|80729890|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
27697808|NCT01372410|80729891|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
27697809|NCT01372410|80729884|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697810|NCT01372410|80729885|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697811|NCT01372410|80729886|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697812|NCT01372410|80729887|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697813|NCT01372410|80729888|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
27697814|NCT01372410|80729889|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697815|NCT01372410|80729890|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697816|NCT01372410|80729891|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
27697817|NCT01372410|80729884|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27697818|NCT01372410|80729885|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27697819|NCT01372410|80729886|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27697820|NCT01372410|80729887|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27697821|NCT01372410|80729888|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
27697822|NCT01372410|80729889|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
27697823|NCT01372410|80729890|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
27697824|NCT01372410|80729891|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
27697825|NCT01372410|80729884|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697826|NCT01372410|80729885|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697827|NCT01372410|80729886|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697828|NCT01372410|80729887|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697829|NCT01372410|80729888|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697830|NCT01372410|80729889|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697831|NCT01372410|80729890|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
27697832|NCT01372410|80729891|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
27697833|NCT01372410|80729884|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697834|NCT01372410|80729885|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697835|NCT01372410|80729886|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
27697836|NCT01372410|80729887|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697837|NCT01372410|80729888|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697838|NCT01372410|80729889|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697839|NCT01372410|80729890|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697840|NCT01372410|80729891|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
27697841|NCT01372410|80729884|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697842|NCT01372410|80729885|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697843|NCT01372410|80729886|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697844|NCT01372410|80729887|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697845|NCT01372410|80729888|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697846|NCT01372410|80729889|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
27697847|NCT01372410|80729890|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697848|NCT01372410|80729891|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
27697849|NCT03406260|80729892|FG000|Period 1|Adverse Event|0|||
27697850|NCT03406260|80729893|FG001|Period 1|Adverse Event|0|||
27697851|NCT03406260|80729894|FG002|Period 1|Adverse Event|0|||
27697852|NCT03406260|80729895|FG003|Period 1|Adverse Event|0|||
27697853|NCT03406260|80729896|FG004|Period 1|Adverse Event|1|||
27697854|NCT03406260|80729897|FG005|Period 1|Adverse Event|0|||
27697855|NCT01480284|80729898|FG000|Overall Study|Withdrawal by Subject|2|||
27697856|NCT01480284|80729899|FG001|Overall Study|Withdrawal by Subject|0|||
27697857|NCT01480284|80729898|FG000|Overall Study|Adverse Event|1|||
27697858|NCT01480284|80729899|FG001|Overall Study|Adverse Event|0|||
27884393|NCT02964507|81411805|FG005|Overall Study|Death|5|||
27558323|NCT01603459|80229697|FG000|Overall Study|Withdrawal by Subject|5|||
27697859|NCT01480284|80729898|FG000|Overall Study|Study closed/terminated|3|||
27697860|NCT01480284|80729899|FG001|Overall Study|Study closed/terminated|0|||
27697861|NCT01480284|80729898|FG000|Overall Study|Lost to Follow-up|1|||
27697862|NCT01480284|80729899|FG001|Overall Study|Lost to Follow-up|0|||
27697863|NCT01480284|80729898|FG000|Overall Study|Physician Decision|1|||
27558324|NCT01603459|80229697|FG000|Overall Study|Lost to Follow-up|3|||
27697864|NCT01480284|80729899|FG001|Overall Study|Physician Decision|0|||
27697865|NCT00026208|80729900|FG000|Overall Study|Complications of auto accident|1|||
27697866|NCT00026208|80729901|FG001|Overall Study|Complications of auto accident|0|||
27697867|NCT00171704|80729902|FG000|Overall Study|Adverse Event|24|||
27697868|NCT00171704|80729903|FG001|Overall Study|Adverse Event|33|||
27697869|NCT00171704|80729902|FG000|Overall Study|Disease Progression|14|||
27697870|NCT00171704|80729903|FG001|Overall Study|Disease Progression|9|||
27697871|NCT00171704|80729902|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
27697872|NCT00171704|80729903|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
27697873|NCT00171704|80729902|FG000|Overall Study|Administrative Problems|2|||
27697874|NCT00171704|80729903|FG001|Overall Study|Administrative Problems|1|||
27697875|NCT00171704|80729902|FG000|Overall Study|Death|2|||
27697876|NCT00171704|80729903|FG001|Overall Study|Death|2|||
27697877|NCT00171704|80729902|FG000|Overall Study|Withdrawal by Subject|1|||
27697878|NCT00171704|80729903|FG001|Overall Study|Withdrawal by Subject|3|||
27697879|NCT00171704|80729902|FG000|Overall Study|Protocol Violation|0|||
27697880|NCT00171704|80729903|FG001|Overall Study|Protocol Violation|1|||
27697881|NCT01765192|80729909|FG000|Treatment Period 1|Adverse Event|0|||
27697882|NCT01765192|80729910|FG001|Treatment Period 1|Adverse Event|1|||
27697883|NCT01765192|80729909|FG000|Washout Period|Voluntary Withdrawal|1|||
27697884|NCT01765192|80729910|FG001|Washout Period|Voluntary Withdrawal|1|||
27697885|NCT01765192|80729909|FG000|Washout Period|Reason not specified|1|||
27697886|NCT01765192|80729910|FG001|Washout Period|Reason not specified|0|||
27697887|NCT01765192|80729909|FG000|Treatment Period 2|Reason not specified|0|||
27697888|NCT01765192|80729910|FG001|Treatment Period 2|Reason not specified|2|||
27697889|NCT01765192|80729909|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
27697890|NCT01765192|80729910|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
27697891|NCT01890148|80729911|FG000|Overall Study|Adverse Event|1|||
27697892|NCT01831856|80729912|FG000|Overall Study|Adverse Event|5|||
27697893|NCT01831856|80729913|FG001|Overall Study|Adverse Event|8|||
27697894|NCT01831856|80729912|FG000|Overall Study|Lack of Efficacy|13|||
27697895|NCT01831856|80729913|FG001|Overall Study|Lack of Efficacy|11|||
27697896|NCT01831856|80729912|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
27697897|NCT01831856|80729913|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
27697898|NCT01101477|80729914|FG000|Overall Study|Protocol Violation|5|||
27697899|NCT01101477|80729915|FG001|Overall Study|Protocol Violation|3|||
27697900|NCT01101477|80729916|FG002|Overall Study|Protocol Violation|1|||
27697901|NCT02101034|80729922|FG000|Overall Study|Enrolled but did not start treatment|0|||
27697902|NCT02101034|80729923|FG001|Overall Study|Enrolled but did not start treatment|0|||
27697903|NCT02101034|80729924|FG002|Overall Study|Enrolled but did not start treatment|1|||
27697904|NCT02101034|80729925|FG003|Overall Study|Enrolled but did not start treatment|0|||
27697905|NCT02101034|80729926|FG004|Overall Study|Enrolled but did not start treatment|0|||
27697906|NCT01177787|80729928|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
27697907|NCT01177787|80729928|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
27697908|NCT01177787|80729928|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
27697909|NCT02804178|80729930|FG000|Overall Study|Adverse Event|1|||
27697910|NCT01016964|80729931|FG000|Overall Study|Lost to Follow-up|3|||
27697911|NCT01016964|80729932|FG001|Overall Study|Lost to Follow-up|3|||
27697912|NCT04051827|80729933|FG000|Overall Study|Death|1|||
27697913|NCT04051827|80729933|FG000|Overall Study|Withdrawal by Subject|4|||
27697914|NCT04051827|80729933|FG000|Overall Study|Progressive disease|16|||
27697915|NCT04051827|80729933|FG000|Overall Study|Physician Decision|1|||
27697916|NCT04051827|80729933|FG000|Overall Study|Other|4|||
27697917|NCT01019317|80729940|FG000|Overall Study|Not Eligible|4|||
27697918|NCT01178671|80729943|FG000|Overall Study|Adverse Event|4|||
27697919|NCT01178671|80729944|FG001|Overall Study|Adverse Event|6|||
27697920|NCT01178671|80729943|FG000|Overall Study|Protocol Violation|1|||
27697921|NCT01178671|80729944|FG001|Overall Study|Protocol Violation|1|||
27697922|NCT01178671|80729943|FG000|Overall Study|Lack of Efficacy|0|||
27697923|NCT01178671|80729944|FG001|Overall Study|Lack of Efficacy|1|||
27697924|NCT01178671|80729943|FG000|Overall Study|Lost to Follow-up|3|||
27697925|NCT01178671|80729944|FG001|Overall Study|Lost to Follow-up|1|||
27697926|NCT01178671|80729943|FG000|Overall Study|Physician Decision|4|||
27697927|NCT01178671|80729944|FG001|Overall Study|Physician Decision|6|||
27697928|NCT02374021|80729945|FG000|Overall Study|Adverse Event|1|||
27697929|NCT02374021|80729946|FG001|Overall Study|Adverse Event|0|||
27697930|NCT02374021|80729945|FG000|Overall Study|Lost to Follow-up|3|||
27697931|NCT02374021|80729946|FG001|Overall Study|Lost to Follow-up|2|||
27697932|NCT02374021|80729945|FG000|Overall Study|Physician Decision|0|||
27697933|NCT02374021|80729946|FG001|Overall Study|Physician Decision|3|||
27697934|NCT02374021|80729945|FG000|Overall Study|Withdrawal by Subject|6|||
27697935|NCT02374021|80729946|FG001|Overall Study|Withdrawal by Subject|5|||
27697936|NCT02374021|80729945|FG000|Overall Study|Poor Adherence|0|||
27697937|NCT02374021|80729946|FG001|Overall Study|Poor Adherence|1|||
27697938|NCT02374021|80729945|FG000|Overall Study|Scan protocol not followed|0|||
27697939|NCT02374021|80729946|FG001|Overall Study|Scan protocol not followed|1|||
27697940|NCT02374021|80729945|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
27697941|NCT02374021|80729946|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
27697942|NCT04427501|80729948|FG000|Overall Study|Death|0|||
27697943|NCT04427501|80729949|FG001|Overall Study|Death|0|||
27697944|NCT04427501|80729950|FG002|Overall Study|Death|0|||
27697945|NCT04427501|80729951|FG003|Overall Study|Death|0|||
27697946|NCT04427501|80729952|FG004|Overall Study|Death|0|||
27697947|NCT04427501|80729953|FG005|Overall Study|Death|15|||
27697948|NCT04427501|80729954|FG006|Overall Study|Death|0|||
27697949|NCT04427501|80729955|FG007|Overall Study|Death|0|||
27697950|NCT04427501|80729956|FG008|Overall Study|Death|0|||
27697951|NCT04427501|80729957|FG009|Overall Study|Death|0|||
27697952|NCT04427501|80729958|FG010|Overall Study|Death|0|||
27697953|NCT04427501|80729959|FG011|Overall Study|Death|0|||
27697954|NCT04427501|80729948|FG000|Overall Study|Lost to Follow-up|5|||
27697955|NCT04427501|80729949|FG001|Overall Study|Lost to Follow-up|1|||
27697956|NCT04427501|80729950|FG002|Overall Study|Lost to Follow-up|2|||
27697957|NCT04427501|80729951|FG003|Overall Study|Lost to Follow-up|0|||
27828833|NCT00804856|81203059|FG001|Overall Study|Non compliance with protocol|0|||
27828834|NCT00804856|81203060|FG002|Overall Study|Non compliance with protocol|0|||
27828835|NCT00804856|81203061|FG003|Overall Study|Non compliance with protocol|0|||
27828836|NCT00804856|81203062|FG004|Overall Study|Non compliance with protocol|0|||
27828837|NCT00804856|81203063|FG005|Overall Study|Non compliance with protocol|0|||
27828838|NCT00804856|81203064|FG006|Overall Study|Non compliance with protocol|0|||
27828839|NCT00804856|81203065|FG007|Overall Study|Non compliance with protocol|0|||
27828840|NCT00804856|81203066|FG008|Overall Study|Non compliance with protocol|0|||
27828841|NCT00804856|81203067|FG009|Overall Study|Non compliance with protocol|0|||
27828842|NCT00804856|81203068|FG010|Overall Study|Non compliance with protocol|0|||
27828843|NCT00804856|81203069|FG011|Overall Study|Non compliance with protocol|0|||
27828844|NCT00804856|81203070|FG012|Overall Study|Non compliance with protocol|0|||
27828845|NCT00804856|81203071|FG013|Overall Study|Non compliance with protocol|2|||
27828846|NCT00804856|81203072|FG014|Overall Study|Non compliance with protocol|0|||
27828847|NCT00804856|81203058|FG000|Overall Study|Refused to continue medication|0|||
27828848|NCT00804856|81203059|FG001|Overall Study|Refused to continue medication|0|||
27828849|NCT00804856|81203060|FG002|Overall Study|Refused to continue medication|0|||
27884394|NCT02964507|81411806|FG006|Overall Study|Death|0|||
27884395|NCT02964507|81411807|FG007|Overall Study|Death|0|||
27884396|NCT02964507|81411800|FG000|Overall Study|Withdrawal by Subject|1|||
27884397|NCT02964507|81411801|FG001|Overall Study|Withdrawal by Subject|0|||
27884398|NCT02964507|81411802|FG002|Overall Study|Withdrawal by Subject|1|||
27884399|NCT02964507|81411803|FG003|Overall Study|Withdrawal by Subject|1|||
27558325|NCT01603459|80229697|FG000|Overall Study|Predefined discontinuation criteria|3|||
27558326|NCT01603459|80229697|FG000|Overall Study|Non-compliance|1|||
27558327|NCT01603459|80229697|FG000|Overall Study|Administrative reason|1|||
27558328|NCT01928329|80229698|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
27558329|NCT01928329|80229699|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
27558330|NCT01928329|80229698|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
27828850|NCT00804856|81203061|FG003|Overall Study|Refused to continue medication|1|||
27884400|NCT02964507|81411804|FG004|Overall Study|Withdrawal by Subject|0|||
27697958|NCT04427501|80729952|FG004|Overall Study|Lost to Follow-up|2|||
27697959|NCT04427501|80729953|FG005|Overall Study|Lost to Follow-up|11|||
27697960|NCT04427501|80729954|FG006|Overall Study|Lost to Follow-up|10|||
27697961|NCT04427501|80729955|FG007|Overall Study|Lost to Follow-up|10|||
27697962|NCT04427501|80729956|FG008|Overall Study|Lost to Follow-up|2|||
27697963|NCT04427501|80729957|FG009|Overall Study|Lost to Follow-up|5|||
27697964|NCT04427501|80729958|FG010|Overall Study|Lost to Follow-up|2|||
27697965|NCT04427501|80729959|FG011|Overall Study|Lost to Follow-up|0|||
27558331|NCT01928329|80229699|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
27558332|NCT01928329|80229698|FG000|Overall Study|Adverse Event|5|||
27558333|NCT01928329|80229699|FG001|Overall Study|Adverse Event|3|||
27558334|NCT01928329|80229698|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
27558335|NCT01928329|80229699|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
27558336|NCT01928329|80229698|FG000|Overall Study|Withdrawal by Subject|1|||
27697966|NCT04427501|80729948|FG000|Overall Study|Physician Decision|0|||
27697967|NCT04427501|80729949|FG001|Overall Study|Physician Decision|3|||
27697968|NCT04427501|80729950|FG002|Overall Study|Physician Decision|0|||
27697969|NCT04427501|80729951|FG003|Overall Study|Physician Decision|0|||
27697970|NCT04427501|80729952|FG004|Overall Study|Physician Decision|0|||
27697971|NCT04427501|80729953|FG005|Overall Study|Physician Decision|0|||
27697972|NCT04427501|80729954|FG006|Overall Study|Physician Decision|2|||
27697973|NCT04427501|80729955|FG007|Overall Study|Physician Decision|0|||
27697974|NCT04427501|80729956|FG008|Overall Study|Physician Decision|0|||
27697975|NCT04427501|80729957|FG009|Overall Study|Physician Decision|0|||
27697976|NCT04427501|80729958|FG010|Overall Study|Physician Decision|0|||
27697977|NCT04427501|80729959|FG011|Overall Study|Physician Decision|0|||
27697978|NCT04427501|80729948|FG000|Overall Study|Withdrawal by Subject|9|||
27828851|NCT00804856|81203062|FG004|Overall Study|Refused to continue medication|1|||
27828852|NCT00804856|81203063|FG005|Overall Study|Refused to continue medication|0|||
27828853|NCT00804856|81203064|FG006|Overall Study|Refused to continue medication|0|||
27828854|NCT00804856|81203065|FG007|Overall Study|Refused to continue medication|0|||
27828855|NCT00804856|81203066|FG008|Overall Study|Refused to continue medication|0|||
27828856|NCT00804856|81203067|FG009|Overall Study|Refused to continue medication|0|||
27828857|NCT00804856|81203068|FG010|Overall Study|Refused to continue medication|3|||
27828858|NCT00804856|81203069|FG011|Overall Study|Refused to continue medication|0|||
27828859|NCT00804856|81203070|FG012|Overall Study|Refused to continue medication|1|||
27828860|NCT00804856|81203071|FG013|Overall Study|Refused to continue medication|1|||
27828861|NCT00804856|81203072|FG014|Overall Study|Refused to continue medication|5|||
27828862|NCT00804856|81203058|FG000|Overall Study|Other reason than listed above|0|||
27828863|NCT00804856|81203059|FG001|Overall Study|Other reason than listed above|0|||
27828864|NCT00804856|81203060|FG002|Overall Study|Other reason than listed above|0|||
27828865|NCT00804856|81203061|FG003|Overall Study|Other reason than listed above|0|||
27558337|NCT01928329|80229699|FG001|Overall Study|Withdrawal by Subject|5|||
27558338|NCT01928329|80229698|FG000|Overall Study|Physician Decision|1|||
27558339|NCT01928329|80229699|FG001|Overall Study|Physician Decision|1|||
27558340|NCT00391274|80229700|FG000|Overall Study|Death Due to Study Disease|55|||
27697979|NCT04427501|80729949|FG001|Overall Study|Withdrawal by Subject|2|||
27697980|NCT04427501|80729950|FG002|Overall Study|Withdrawal by Subject|2|||
27828866|NCT00804856|81203062|FG004|Overall Study|Other reason than listed above|0|||
27697981|NCT04427501|80729951|FG003|Overall Study|Withdrawal by Subject|3|||
27697982|NCT04427501|80729952|FG004|Overall Study|Withdrawal by Subject|7|||
27697983|NCT04427501|80729953|FG005|Overall Study|Withdrawal by Subject|25|||
27697984|NCT04427501|80729954|FG006|Overall Study|Withdrawal by Subject|15|||
27828867|NCT00804856|81203063|FG005|Overall Study|Other reason than listed above|1|||
27828868|NCT00804856|81203064|FG006|Overall Study|Other reason than listed above|0|||
27828869|NCT00804856|81203065|FG007|Overall Study|Other reason than listed above|0|||
27828870|NCT00804856|81203066|FG008|Overall Study|Other reason than listed above|1|||
27828871|NCT00804856|81203067|FG009|Overall Study|Other reason than listed above|0|||
27828872|NCT00804856|81203068|FG010|Overall Study|Other reason than listed above|3|||
27828873|NCT00804856|81203069|FG011|Overall Study|Other reason than listed above|1|||
27828874|NCT00804856|81203070|FG012|Overall Study|Other reason than listed above|1|||
27828875|NCT00804856|81203071|FG013|Overall Study|Other reason than listed above|10|||
27828876|NCT00804856|81203072|FG014|Overall Study|Other reason than listed above|3|||
27828877|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
27828878|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
27828879|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
27828880|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
27828881|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
27828882|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
27828883|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
27828884|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
27828885|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
27828886|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
27828887|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
27828888|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
27828889|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
27828890|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
27828891|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
27828892|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
27828893|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
27828894|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
27828895|NCT02009163|81203073|FG000|Open-label Period (Non-randomized)|Other|13|||
27828896|NCT02009163|81203074|FG001|Open-label Period (Non-randomized)|Other|0|||
27828897|NCT02009163|81203075|FG002|Open-label Period (Non-randomized)|Other|0|||
27828898|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
27828899|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
27828900|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
27828901|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
27828902|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
27697985|NCT04427501|80729955|FG007|Overall Study|Withdrawal by Subject|7|||
27697986|NCT04427501|80729956|FG008|Overall Study|Withdrawal by Subject|4|||
27828903|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
27828904|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Adverse Event|0|||
27558341|NCT00391274|80229701|FG001|Overall Study|Death Due to Study Disease|45|||
27558342|NCT00391274|80229700|FG000|Overall Study|Lost to Follow-up|0|||
27558343|NCT00391274|80229701|FG001|Overall Study|Lost to Follow-up|3|||
27558344|NCT00391274|80229700|FG000|Overall Study|Physician Decision|4|||
27558345|NCT00391274|80229701|FG001|Overall Study|Physician Decision|2|||
27558346|NCT00391274|80229700|FG000|Overall Study|Withdrawal by Subject|0|||
27558347|NCT00391274|80229701|FG001|Overall Study|Withdrawal by Subject|3|||
27558348|NCT00391274|80229700|FG000|Overall Study|Death Due to Adverse Event|1|||
27558349|NCT00391274|80229701|FG001|Overall Study|Death Due to Adverse Event|3|||
27558350|NCT00391274|80229700|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
27558351|NCT00391274|80229701|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
27558352|NCT00391274|80229700|FG000|Overall Study|Death Not Study Related|0|||
27697987|NCT04427501|80729957|FG009|Overall Study|Withdrawal by Subject|1|||
27697988|NCT04427501|80729958|FG010|Overall Study|Withdrawal by Subject|4|||
27697989|NCT04427501|80729959|FG011|Overall Study|Withdrawal by Subject|0|||
27697990|NCT04427501|80729948|FG000|Overall Study|Other - as reported by the investigator|1|||
27697991|NCT04427501|80729949|FG001|Overall Study|Other - as reported by the investigator|0|||
27697992|NCT04427501|80729950|FG002|Overall Study|Other - as reported by the investigator|0|||
27697993|NCT04427501|80729951|FG003|Overall Study|Other - as reported by the investigator|0|||
27828905|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Adverse Event|0|||
27828906|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Adverse Event|6|||
27558353|NCT00391274|80229701|FG001|Overall Study|Death Not Study Related|1|||
27558354|NCT02153112|80232946|FG000|Overall Study|Adverse Event|0|||
27558355|NCT02153112|80232947|FG001|Overall Study|Adverse Event|0|||
27558356|NCT02153112|80232948|FG002|Overall Study|Adverse Event|1|||
27558357|NCT02153112|80232949|FG003|Overall Study|Adverse Event|0|||
27558358|NCT02153112|80232950|FG004|Overall Study|Adverse Event|0|||
27558359|NCT02153112|80232951|FG005|Overall Study|Adverse Event|0|||
27558360|NCT02153112|80232952|FG006|Overall Study|Adverse Event|0|||
27558361|NCT02153112|80232953|FG007|Overall Study|Adverse Event|0|||
27558362|NCT02153112|80232954|FG008|Overall Study|Adverse Event|0|||
27558363|NCT02153112|80232955|FG009|Overall Study|Adverse Event|0|||
27558364|NCT02153112|80232946|FG000|Overall Study|Lost to Follow-up|1|||
27558365|NCT02153112|80232947|FG001|Overall Study|Lost to Follow-up|1|||
27558366|NCT02153112|80232948|FG002|Overall Study|Lost to Follow-up|0|||
27558367|NCT02153112|80232949|FG003|Overall Study|Lost to Follow-up|0|||
27558368|NCT02153112|80232950|FG004|Overall Study|Lost to Follow-up|2|||
27558369|NCT02153112|80232951|FG005|Overall Study|Lost to Follow-up|1|||
27558370|NCT02153112|80232952|FG006|Overall Study|Lost to Follow-up|1|||
27558371|NCT02153112|80232953|FG007|Overall Study|Lost to Follow-up|0|||
27558372|NCT02153112|80232954|FG008|Overall Study|Lost to Follow-up|1|||
27558373|NCT02153112|80232955|FG009|Overall Study|Lost to Follow-up|1|||
27558374|NCT02153112|80232946|FG000|Overall Study|Withdrawal by Subject|3|||
27558375|NCT02153112|80232947|FG001|Overall Study|Withdrawal by Subject|1|||
27558376|NCT02153112|80232948|FG002|Overall Study|Withdrawal by Subject|2|||
27558377|NCT02153112|80232949|FG003|Overall Study|Withdrawal by Subject|2|||
27697994|NCT04427501|80729952|FG004|Overall Study|Other - as reported by the investigator|0|||
27828907|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
27558378|NCT02153112|80232950|FG004|Overall Study|Withdrawal by Subject|1|||
27558379|NCT02153112|80232951|FG005|Overall Study|Withdrawal by Subject|1|||
27558380|NCT02153112|80232952|FG006|Overall Study|Withdrawal by Subject|7|||
27558381|NCT02153112|80232953|FG007|Overall Study|Withdrawal by Subject|2|||
27558382|NCT02153112|80232954|FG008|Overall Study|Withdrawal by Subject|13|||
27558383|NCT02153112|80232955|FG009|Overall Study|Withdrawal by Subject|12|||
27558384|NCT02153112|80232946|FG000|Overall Study|Reason not Specified|0|||
27697995|NCT04427501|80729953|FG005|Overall Study|Other - as reported by the investigator|6|||
27558385|NCT02153112|80232947|FG001|Overall Study|Reason not Specified|0|||
27558386|NCT02153112|80232948|FG002|Overall Study|Reason not Specified|0|||
27558387|NCT02153112|80232949|FG003|Overall Study|Reason not Specified|0|||
27558388|NCT02153112|80232950|FG004|Overall Study|Reason not Specified|0|||
27558389|NCT02153112|80232951|FG005|Overall Study|Reason not Specified|0|||
27558390|NCT02153112|80232952|FG006|Overall Study|Reason not Specified|0|||
27558391|NCT02153112|80232953|FG007|Overall Study|Reason not Specified|0|||
27558392|NCT02153112|80232954|FG008|Overall Study|Reason not Specified|1|||
27558393|NCT02153112|80232955|FG009|Overall Study|Reason not Specified|1|||
27558394|NCT01349803|80232957|FG000|Overall Study|Adverse Event|0|||
27558395|NCT01349803|80232958|FG001|Overall Study|Adverse Event|0|||
27558396|NCT01349803|80232959|FG002|Overall Study|Adverse Event|0|||
27558397|NCT01349803|80232960|FG003|Overall Study|Adverse Event|2|||
27558398|NCT01349803|80232957|FG000|Overall Study|Withdrawal by Subject|1|||
27558399|NCT01349803|80232958|FG001|Overall Study|Withdrawal by Subject|0|||
27558400|NCT01349803|80232959|FG002|Overall Study|Withdrawal by Subject|0|||
27558401|NCT01349803|80232960|FG003|Overall Study|Withdrawal by Subject|0|||
27558402|NCT01349803|80232957|FG000|Overall Study|Protocol-specified criteria|0|||
27558403|NCT01349803|80232958|FG001|Overall Study|Protocol-specified criteria|1|||
27558404|NCT01349803|80232959|FG002|Overall Study|Protocol-specified criteria|3|||
27558405|NCT01349803|80232960|FG003|Overall Study|Protocol-specified criteria|0|||
27558406|NCT00455429|80232963|FG000|Overall Study|Study Terminated by Sponsor|0|||
27558407|NCT00455429|80232964|FG001|Overall Study|Study Terminated by Sponsor|0|||
27558408|NCT00455429|80232965|FG002|Overall Study|Study Terminated by Sponsor|0|||
27558409|NCT00455429|80232966|FG003|Overall Study|Study Terminated by Sponsor|3|||
27558410|NCT00455429|80232963|FG000|Overall Study|Lost to Follow-up|1|||
27558411|NCT00455429|80232964|FG001|Overall Study|Lost to Follow-up|0|||
27558412|NCT00455429|80232965|FG002|Overall Study|Lost to Follow-up|0|||
27828908|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
27828909|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
27828910|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
27828911|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
27828912|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
27828913|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Pregnancy|0|||
27828914|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Pregnancy|0|||
27828915|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Pregnancy|2|||
27828916|NCT02009163|81203073|FG000|Randomized-withdrawal Period|Other|0|||
27828917|NCT02009163|81203074|FG001|Randomized-withdrawal Period|Other|9|||
27828918|NCT02009163|81203075|FG002|Randomized-withdrawal Period|Other|5|||
27828919|NCT00838279|81203076|FG000|Washout|Protocol Violation|1|||
27828920|NCT00838279|81203077|FG001|Washout|Protocol Violation|0|||
27828921|NCT00838279|81203076|FG000|Washout|Withdrawal by Subject|0|||
27828922|NCT00838279|81203077|FG001|Washout|Withdrawal by Subject|1|||
27828923|NCT00851877|81203078|FG000|Phase I-1|Death|1|||
27828924|NCT00851877|81203079|FG001|Phase I-1|Death|0|||
27828925|NCT00851877|81203080|FG002|Phase I-1|Death|0|||
27828926|NCT00851877|81203078|FG000|Phase II|Withdrawal by Subject|0|||
27828927|NCT00851877|81203079|FG001|Phase II|Withdrawal by Subject|0|||
27828928|NCT00851877|81203080|FG002|Phase II|Withdrawal by Subject|3|||
27828929|NCT00834418|81203083|FG000|Overall Study|Adverse Event|0|||
27828930|NCT00834418|81203084|FG001|Overall Study|Adverse Event|2|||
27828931|NCT00859430|81203087|FG000|First Intervention|Withdrawal by Subject|0|||
27828932|NCT00859430|81203088|FG001|First Intervention|Withdrawal by Subject|1|||
27828933|NCT00418561|81203089|FG000|Overall Study|Participant's (guardian's) decision|0|||
27828934|NCT00418561|81203090|FG001|Overall Study|Participant's (guardian's) decision|1|||
27828935|NCT00418561|81203091|FG002|Overall Study|Participant's (guardian's) decision|0|||
27828936|NCT04594252|81203092|FG000|Overall Study|Adverse Event|0|||
27828937|NCT04594252|81203093|FG001|Overall Study|Adverse Event|2|||
27828938|NCT00461786|81203095|FG000|Overall Study|Entry Criteria Not Met|2|||
27828939|NCT00461786|81203095|FG000|Overall Study|Inevaluable (Never Treated)|1|||
27828940|NCT02286739|81203096|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
27828941|NCT02286739|81203097|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
27828942|NCT02286739|81203096|FG000|Overall Study|No Verasense type documented|0|||
27828943|NCT02286739|81203097|FG001|Overall Study|No Verasense type documented|23|||
27828944|NCT02286739|81203096|FG000|Overall Study|Adverse Event|1|||
27828945|NCT02286739|81203097|FG001|Overall Study|Adverse Event|2|||
27828946|NCT02286739|81203096|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
27828947|NCT02286739|81203097|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
27828948|NCT00123734|81203098|FG000|Overall Study|Death|3|||
27558413|NCT00455429|80232966|FG003|Overall Study|Lost to Follow-up|3|||
27558414|NCT00455429|80232963|FG000|Overall Study|Withdrawal by Subject|0|||
27558415|NCT00455429|80232964|FG001|Overall Study|Withdrawal by Subject|1|||
27558416|NCT00455429|80232965|FG002|Overall Study|Withdrawal by Subject|1|||
27558417|NCT00455429|80232966|FG003|Overall Study|Withdrawal by Subject|0|||
27558418|NCT00455429|80232963|FG000|Overall Study|Lack of Efficacy|0|||
27558419|NCT00455429|80232964|FG001|Overall Study|Lack of Efficacy|1|||
27558420|NCT00455429|80232965|FG002|Overall Study|Lack of Efficacy|0|||
27558421|NCT00455429|80232966|FG003|Overall Study|Lack of Efficacy|1|||
27558422|NCT00455429|80232963|FG000|Overall Study|Adverse Event|0|||
27558423|NCT00455429|80232964|FG001|Overall Study|Adverse Event|1|||
27558424|NCT00455429|80232965|FG002|Overall Study|Adverse Event|0|||
27558425|NCT00455429|80232966|FG003|Overall Study|Adverse Event|3|||
27558426|NCT00455429|80232963|FG000|Overall Study|Randomly assigned but not treated|0|||
27558427|NCT00455429|80232964|FG001|Overall Study|Randomly assigned but not treated|0|||
27558428|NCT00455429|80232965|FG002|Overall Study|Randomly assigned but not treated|0|||
27558429|NCT00455429|80232966|FG003|Overall Study|Randomly assigned but not treated|2|||
27558430|NCT00455429|80232963|FG000|Overall Study|Personal Reason|1|||
27558431|NCT00455429|80232964|FG001|Overall Study|Personal Reason|0|||
27558432|NCT00455429|80232965|FG002|Overall Study|Personal Reason|0|||
27558433|NCT00455429|80232966|FG003|Overall Study|Personal Reason|0|||
27558434|NCT00455429|80232963|FG000|Overall Study|Non-compliance|0|||
27558435|NCT00455429|80232964|FG001|Overall Study|Non-compliance|0|||
27558436|NCT00455429|80232965|FG002|Overall Study|Non-compliance|0|||
27558437|NCT00455429|80232966|FG003|Overall Study|Non-compliance|1|||
27558438|NCT00455429|80232963|FG000|Overall Study|Other|0|||
27558439|NCT00455429|80232964|FG001|Overall Study|Other|2|||
27558440|NCT00455429|80232965|FG002|Overall Study|Other|0|||
27558441|NCT00455429|80232966|FG003|Overall Study|Other|1|||
27558442|NCT02588833|80232967|FG000|Part 1|Withdrawal by Subject|1|||
27558443|NCT02588833|80232968|FG001|Part 1|Withdrawal by Subject|0|||
27558444|NCT02588833|80232967|FG000|Part 2A|Physician Decision|0|||
27558445|NCT02588833|80232968|FG001|Part 2A|Physician Decision|1|||
27558446|NCT02588833|80232967|FG000|Part 2A|Withdrawal by Subject|0|||
27558447|NCT02588833|80232968|FG001|Part 2A|Withdrawal by Subject|1|||
27558448|NCT02588833|80232967|FG000|Part 2B|Adverse Event|0|||
27558449|NCT02588833|80232968|FG001|Part 2B|Adverse Event|1|||
27558450|NCT02588833|80232967|FG000|Part 2C|Adverse Event|0|||
27558451|NCT02588833|80232968|FG001|Part 2C|Adverse Event|1|||
27558452|NCT02588833|80232967|FG000|Part 2C|Withdrawal by Subject|0|||
27558453|NCT02588833|80232968|FG001|Part 2C|Withdrawal by Subject|1|||
27558454|NCT02588833|80232967|FG000|Part 3 (Safety Follow-up)|Other|0|||
27558455|NCT02588833|80232968|FG001|Part 3 (Safety Follow-up)|Other|2|||
27558456|NCT02677922|80232972|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
27558457|NCT02677922|80232973|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
27558458|NCT02677922|80232974|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
27558459|NCT02677922|80232975|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
27558460|NCT02677922|80232976|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
27558461|NCT02677922|80232977|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
27558462|NCT02677922|80232972|FG000|Treatment Period|Adverse Event|0|||
27828949|NCT00123734|81203098|FG000|Overall Study|Lost to Follow-up|3|||
27828950|NCT00123734|81203098|FG000|Overall Study|Dropout|1|||
27828951|NCT00123734|81203098|FG000|Overall Study|Withdrawal by Subject|1|||
27828952|NCT02267187|81205889|FG000|Overall Study|Physician Decision|2|||
27828953|NCT02267187|81205889|FG000|Overall Study|Screen fail|3|||
27828954|NCT03214952|81205890|FG000|Overall Study|Protocol Deviation|45|||
27828955|NCT03214952|81205890|FG000|Overall Study|Case Report Forms Uncollected|13|||
27828956|NCT01200810|81205891|FG000|Overall Study|Physician Decision|1|||
27828957|NCT01200810|81205892|FG001|Overall Study|Physician Decision|0|||
27828958|NCT01200810|81205891|FG000|Overall Study|Withdrawal by Subject|1|||
27828959|NCT01200810|81205892|FG001|Overall Study|Withdrawal by Subject|2|||
27828960|NCT01200810|81205891|FG000|Overall Study|Sponsor stopped making study drug|3|||
27828961|NCT01200810|81205892|FG001|Overall Study|Sponsor stopped making study drug|3|||
27828962|NCT01015625|81205897|FG000|Overall Study|Lost to Follow-up|3|||
27558463|NCT02677922|80232973|FG001|Treatment Period|Adverse Event|0|||
27558464|NCT02677922|80232974|FG002|Treatment Period|Adverse Event|1|||
27558465|NCT02677922|80232975|FG003|Treatment Period|Adverse Event|3|||
27558466|NCT02677922|80232976|FG004|Treatment Period|Adverse Event|5|||
27558467|NCT02677922|80232977|FG005|Treatment Period|Adverse Event|2|||
27558468|NCT02677922|80232972|FG000|Treatment Period|Progressive Disease|1|||
27558469|NCT02677922|80232973|FG001|Treatment Period|Progressive Disease|1|||
27558470|NCT02677922|80232974|FG002|Treatment Period|Progressive Disease|0|||
27558471|NCT02677922|80232975|FG003|Treatment Period|Progressive Disease|0|||
27558472|NCT02677922|80232976|FG004|Treatment Period|Progressive Disease|8|||
27558473|NCT02677922|80232977|FG005|Treatment Period|Progressive Disease|7|||
27558474|NCT02677922|80232972|FG000|Treatment Period|Lack of Efficacy|0|||
27558475|NCT02677922|80232973|FG001|Treatment Period|Lack of Efficacy|0|||
27558476|NCT02677922|80232974|FG002|Treatment Period|Lack of Efficacy|0|||
27558477|NCT02677922|80232975|FG003|Treatment Period|Lack of Efficacy|1|||
27558478|NCT02677922|80232976|FG004|Treatment Period|Lack of Efficacy|1|||
27558479|NCT02677922|80232977|FG005|Treatment Period|Lack of Efficacy|6|||
27828963|NCT01015625|81205898|FG001|Overall Study|Lost to Follow-up|1|||
27828964|NCT01015625|81205897|FG000|Overall Study|Withdrawal by Subject|2|||
27828965|NCT01015625|81205898|FG001|Overall Study|Withdrawal by Subject|3|||
27558480|NCT02677922|80232972|FG000|Treatment Period|Withdrawal by Subject|0|||
27558481|NCT02677922|80232973|FG001|Treatment Period|Withdrawal by Subject|0|||
27558482|NCT02677922|80232974|FG002|Treatment Period|Withdrawal by Subject|1|||
27558483|NCT02677922|80232975|FG003|Treatment Period|Withdrawal by Subject|3|||
27558484|NCT02677922|80232976|FG004|Treatment Period|Withdrawal by Subject|5|||
27558485|NCT02677922|80232977|FG005|Treatment Period|Withdrawal by Subject|5|||
27558486|NCT02677922|80232972|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
27558487|NCT02677922|80232973|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
27558488|NCT02677922|80232974|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
27558489|NCT02677922|80232975|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
27558490|NCT02677922|80232976|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
27558491|NCT02677922|80232977|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
27558492|NCT02677922|80232972|FG000|Treatment Period|Disease Relapse|0|||
27828966|NCT01015625|81205897|FG000|Overall Study|Physician Decision|2|||
27828967|NCT01015625|81205898|FG001|Overall Study|Physician Decision|0|||
27828968|NCT01015625|81205897|FG000|Overall Study|Death|30|||
27828969|NCT01015625|81205898|FG001|Overall Study|Death|22|||
27828970|NCT01948258|81205901|FG000|Overall Study|Pregnancy|41|||
27828971|NCT01948258|81205901|FG000|Overall Study|Did not complete by cut-off date|35|||
27828972|NCT01948258|81205901|FG000|Overall Study|Lost to Follow-up|27|||
27828973|NCT01948258|81205901|FG000|Overall Study|Withdrawal by SPD|8|||
27828974|NCT01948258|81205901|FG000|Overall Study|Withdrawal by Subject|6|||
27828975|NCT01948258|81205901|FG000|Overall Study|Health Care Professional|43|||
27828976|NCT01948258|81205901|FG000|Overall Study|Removed from statistical analysis|2|||
27828977|NCT00418145|81205902|FG000|Overall Study|study terminated|6|||
27828978|NCT00829790|81205903|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
27558493|NCT02677922|80232973|FG001|Treatment Period|Disease Relapse|0|||
27558494|NCT02677922|80232974|FG002|Treatment Period|Disease Relapse|0|||
27828979|NCT00829790|81205904|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
27828980|NCT00859521|81205905|FG000|Washout|Withdrawal by Subject|0|||
27828981|NCT00859521|81205906|FG001|Washout|Withdrawal by Subject|1|||
27828982|NCT01725529|81205907|FG000|Overall Study|Adverse Event|1|||
27828983|NCT01725529|81205908|FG001|Overall Study|Adverse Event|0|||
27828984|NCT01725529|81205909|FG002|Overall Study|Adverse Event|0|||
27828985|NCT01725529|81205907|FG000|Overall Study|Lost to Follow-up|2|||
27828986|NCT01725529|81205908|FG001|Overall Study|Lost to Follow-up|1|||
27828987|NCT01725529|81205909|FG002|Overall Study|Lost to Follow-up|1|||
27558495|NCT02677922|80232975|FG003|Treatment Period|Disease Relapse|3|||
27828988|NCT01725529|81205907|FG000|Overall Study|Protocol Violation|0|||
27558496|NCT02677922|80232976|FG004|Treatment Period|Disease Relapse|6|||
27558497|NCT02677922|80232977|FG005|Treatment Period|Disease Relapse|1|||
27558498|NCT02677922|80232972|FG000|Treatment Period|Allogeneic HSCT|1|||
27828989|NCT01725529|81205908|FG001|Overall Study|Protocol Violation|1|||
27828990|NCT01725529|81205909|FG002|Overall Study|Protocol Violation|1|||
27828991|NCT01725529|81205907|FG000|Overall Study|Withdrawal by Subject|12|||
27828992|NCT01725529|81205908|FG001|Overall Study|Withdrawal by Subject|14|||
27828993|NCT01725529|81205909|FG002|Overall Study|Withdrawal by Subject|8|||
27828994|NCT00583453|81205919|FG000|Overall Study|discontinued intervention|0|||
27828995|NCT00583453|81205920|FG001|Overall Study|discontinued intervention|2|||
27558499|NCT02677922|80232973|FG001|Treatment Period|Allogeneic HSCT|0|||
27558500|NCT02677922|80232974|FG002|Treatment Period|Allogeneic HSCT|0|||
27558501|NCT02677922|80232975|FG003|Treatment Period|Allogeneic HSCT|1|||
27558502|NCT02677922|80232976|FG004|Treatment Period|Allogeneic HSCT|4|||
27828996|NCT00545792|81205923|FG000|Overall Study|Withdrawal by Subject|1|||
27828997|NCT04887415|81205924|FG000|Overall Study|Lost to Follow-up|2|||
27828998|NCT05093205|81205925|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
27828999|NCT05093205|81205926|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
27829000|NCT05093205|81205927|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
27829001|NCT05093205|81205928|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
27829002|NCT05093205|81205929|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
27829003|NCT05093205|81205930|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
27829004|NCT05093205|81205931|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
27829005|NCT05093205|81205932|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
27829006|NCT05093205|81205933|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
27829007|NCT05093205|81205934|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
27829008|NCT05093205|81205935|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
27829009|NCT05093205|81205936|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
27829010|NCT05093205|81205937|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
27829011|NCT05093205|81205925|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829012|NCT05093205|81205926|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829013|NCT05093205|81205927|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
27829014|NCT05093205|81205928|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829015|NCT05093205|81205929|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829016|NCT05093205|81205930|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829017|NCT05093205|81205931|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829018|NCT05093205|81205932|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829019|NCT05093205|81205933|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829020|NCT05093205|81205934|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829021|NCT05093205|81205935|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829022|NCT05093205|81205936|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27558503|NCT02677922|80232977|FG005|Treatment Period|Allogeneic HSCT|1|||
27558504|NCT02677922|80232972|FG000|Treatment Period|Other Reasons|0|||
27558505|NCT02677922|80232973|FG001|Treatment Period|Other Reasons|0|||
27558506|NCT02677922|80232974|FG002|Treatment Period|Other Reasons|0|||
27558507|NCT02677922|80232975|FG003|Treatment Period|Other Reasons|1|||
27558508|NCT02677922|80232976|FG004|Treatment Period|Other Reasons|3|||
27558509|NCT02677922|80232977|FG005|Treatment Period|Other Reasons|5|||
27558510|NCT02677922|80232972|FG000|Treatment Period|Death|0|||
27558511|NCT02677922|80232973|FG001|Treatment Period|Death|0|||
27558512|NCT02677922|80232974|FG002|Treatment Period|Death|0|||
27558513|NCT02677922|80232975|FG003|Treatment Period|Death|0|||
27558514|NCT02677922|80232976|FG004|Treatment Period|Death|12|||
27558515|NCT02677922|80232977|FG005|Treatment Period|Death|1|||
27558516|NCT02677922|80232972|FG000|Treatment Period|Non-compliance with Study Drug|0|||
27558517|NCT02677922|80232973|FG001|Treatment Period|Non-compliance with Study Drug|0|||
27558518|NCT02677922|80232974|FG002|Treatment Period|Non-compliance with Study Drug|0|||
27558519|NCT02677922|80232975|FG003|Treatment Period|Non-compliance with Study Drug|0|||
27697996|NCT04427501|80729954|FG006|Overall Study|Other - as reported by the investigator|6|||
27829023|NCT05093205|81205937|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
27829024|NCT05093205|81205925|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
27829025|NCT05093205|81205926|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
27829026|NCT05093205|81205927|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
27829027|NCT05093205|81205928|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
27829028|NCT05093205|81205929|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
27829029|NCT05093205|81205930|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
27829030|NCT05093205|81205931|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
27829031|NCT05093205|81205932|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
27558520|NCT02677922|80232976|FG004|Treatment Period|Non-compliance with Study Drug|1|||
27558521|NCT02677922|80232977|FG005|Treatment Period|Non-compliance with Study Drug|0|||
27558522|NCT02677922|80232972|FG000|Treatment Period|Physician Decision|0|||
27829032|NCT05093205|81205933|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
27829033|NCT05093205|81205934|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
27558523|NCT02677922|80232973|FG001|Treatment Period|Physician Decision|0|||
27558524|NCT02677922|80232974|FG002|Treatment Period|Physician Decision|0|||
27558525|NCT02677922|80232975|FG003|Treatment Period|Physician Decision|0|||
27558526|NCT02677922|80232976|FG004|Treatment Period|Physician Decision|0|||
27558527|NCT02677922|80232977|FG005|Treatment Period|Physician Decision|1|||
27558528|NCT02677922|80232972|FG000|Treatment Period|Symptomatic Deterioration|0|||
27558529|NCT02677922|80232973|FG001|Treatment Period|Symptomatic Deterioration|0|||
27558530|NCT02677922|80232974|FG002|Treatment Period|Symptomatic Deterioration|0|||
27829034|NCT05093205|81205935|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
27829035|NCT05093205|81205936|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
27829036|NCT05093205|81205937|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
27829037|NCT05093205|81205925|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
27829038|NCT05093205|81205926|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
27829039|NCT05093205|81205927|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
27829040|NCT05093205|81205928|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
27829041|NCT05093205|81205929|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
27829042|NCT05093205|81205930|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
27829043|NCT05093205|81205931|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
27829044|NCT05093205|81205932|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
27829045|NCT05093205|81205933|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
27829046|NCT05093205|81205934|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
27829047|NCT05093205|81205935|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
27558531|NCT02677922|80232975|FG003|Treatment Period|Symptomatic Deterioration|0|||
27829048|NCT05093205|81205936|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
27829049|NCT05093205|81205937|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
27829050|NCT05093205|81205925|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
27829051|NCT05093205|81205926|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
27829052|NCT05093205|81205927|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
27829053|NCT05093205|81205928|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
27829054|NCT05093205|81205929|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
27829055|NCT05093205|81205930|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
27558532|NCT02677922|80232976|FG004|Treatment Period|Symptomatic Deterioration|1|||
27558533|NCT02677922|80232977|FG005|Treatment Period|Symptomatic Deterioration|0|||
27558534|NCT03312933|80232980|FG000|Overall Study|Protocol Violation|15|||
27697997|NCT04427501|80729955|FG007|Overall Study|Other - as reported by the investigator|0|||
27697998|NCT04427501|80729956|FG008|Overall Study|Other - as reported by the investigator|0|||
27697999|NCT04427501|80729957|FG009|Overall Study|Other - as reported by the investigator|0|||
27698000|NCT04427501|80729958|FG010|Overall Study|Other - as reported by the investigator|0|||
27698001|NCT04427501|80729959|FG011|Overall Study|Other - as reported by the investigator|0|||
27698002|NCT04427501|80729948|FG000|Overall Study|Other|0|||
27698003|NCT04427501|80729949|FG001|Overall Study|Other|0|||
27698004|NCT04427501|80729950|FG002|Overall Study|Other|0|||
27698005|NCT04427501|80729951|FG003|Overall Study|Other|0|||
27698006|NCT04427501|80729952|FG004|Overall Study|Other|0|||
27698007|NCT04427501|80729953|FG005|Overall Study|Other|0|||
27698008|NCT04427501|80729954|FG006|Overall Study|Other|0|||
27698009|NCT04427501|80729955|FG007|Overall Study|Other|0|||
27698010|NCT04427501|80729956|FG008|Overall Study|Other|0|||
27698011|NCT04427501|80729957|FG009|Overall Study|Other|0|||
27698012|NCT04427501|80729958|FG010|Overall Study|Other|0|||
27698013|NCT04427501|80729959|FG011|Overall Study|Other|1|||
27698014|NCT02411578|80729960|FG000|Crossover Trial Phase|Pregnancy|0|||
27698015|NCT02411578|80729961|FG001|Crossover Trial Phase|Pregnancy|1|||
27698016|NCT00701220|80729966|FG000|Overall Study|Withdrawal by Subject|0|||
27698017|NCT00701220|80729967|FG001|Overall Study|Withdrawal by Subject|2|||
27698018|NCT00701220|80729966|FG000|Overall Study|Protocol Violation|2|||
27698019|NCT00701220|80729967|FG001|Overall Study|Protocol Violation|0|||
27698020|NCT00601250|80729968|FG000|Overall Study|Adverse Event|3|||
27698021|NCT00601250|80729969|FG001|Overall Study|Adverse Event|9|||
27698022|NCT00601250|80729968|FG000|Overall Study|Protocol Violation|3|||
27698023|NCT00601250|80729969|FG001|Overall Study|Protocol Violation|2|||
27698024|NCT00601250|80729968|FG000|Overall Study|Lost to Follow-up|2|||
27698025|NCT00601250|80729969|FG001|Overall Study|Lost to Follow-up|6|||
27698026|NCT00601250|80729968|FG000|Overall Study|Withdrawal by Subject|4|||
27698027|NCT00601250|80729969|FG001|Overall Study|Withdrawal by Subject|13|||
27698028|NCT00601250|80729968|FG000|Overall Study|Other incl. lack of efficacy|2|||
27698029|NCT00601250|80729969|FG001|Overall Study|Other incl. lack of efficacy|9|||
27698030|NCT03310268|80729970|FG000|Overall Study|(Not specified)|1|||
27698031|NCT03310268|80729971|FG001|Overall Study|(Not specified)|5|||
27698032|NCT03310268|80729972|FG002|Overall Study|(Not specified)|0|||
27698033|NCT04964414|80729973|FG000|Overall Study|Lost to Follow-up|10|||
27698034|NCT04964414|80729974|FG001|Overall Study|Lost to Follow-up|8|||
27698035|NCT04964414|80729973|FG000|Overall Study|Withdrawal by Subject|1|||
27698036|NCT04964414|80729974|FG001|Overall Study|Withdrawal by Subject|1|||
27829056|NCT05093205|81205931|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
27829057|NCT05093205|81205932|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
27829058|NCT05093205|81205933|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
27698037|NCT01390181|80729975|FG000|Overall Study|Lost to Follow-up|1|||
27698038|NCT01390181|80729975|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
27698039|NCT00823901|80729982|FG000|Overall Study|Adverse Event|1|||
27698040|NCT00823901|80729983|FG001|Overall Study|Adverse Event|1|||
27698041|NCT00823901|80729982|FG000|Overall Study|Lack of Efficacy|1|||
27698042|NCT00823901|80729983|FG001|Overall Study|Lack of Efficacy|0|||
27884401|NCT02964507|81411805|FG005|Overall Study|Withdrawal by Subject|1|||
27884402|NCT02964507|81411806|FG006|Overall Study|Withdrawal by Subject|0|||
27884403|NCT02964507|81411807|FG007|Overall Study|Withdrawal by Subject|0|||
27884404|NCT02964507|81411800|FG000|Overall Study|Physician Decision|2|||
27884405|NCT02964507|81411801|FG001|Overall Study|Physician Decision|0|||
27884406|NCT02964507|81411802|FG002|Overall Study|Physician Decision|3|||
27884407|NCT02964507|81411803|FG003|Overall Study|Physician Decision|0|||
27884408|NCT02964507|81411804|FG004|Overall Study|Physician Decision|1|||
27558535|NCT03312933|80232980|FG000|Overall Study|Lost to Follow-up|36|||
27829059|NCT05093205|81205934|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
27829060|NCT05093205|81205935|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
27829061|NCT05093205|81205936|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
27829062|NCT05093205|81205937|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
27829063|NCT05093205|81205925|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
27829064|NCT05093205|81205926|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
27829065|NCT05093205|81205927|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
27829066|NCT05093205|81205928|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
27829067|NCT05093205|81205929|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
27829068|NCT05093205|81205930|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
27829069|NCT05093205|81205931|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
27829070|NCT05093205|81205932|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
27829071|NCT05093205|81205933|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
27829072|NCT05093205|81205934|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
27829073|NCT05093205|81205935|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
27829074|NCT05093205|81205936|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
27829075|NCT05093205|81205937|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
27829076|NCT05093205|81205925|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
27829077|NCT05093205|81205926|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
27829078|NCT05093205|81205927|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
27829079|NCT05093205|81205928|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
27829080|NCT05093205|81205929|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
27829081|NCT05093205|81205930|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
27829082|NCT05093205|81205931|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
27829083|NCT05093205|81205932|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
27829084|NCT05093205|81205933|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
27829085|NCT05093205|81205934|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
27829086|NCT05093205|81205935|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
27829087|NCT05093205|81205936|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
27829088|NCT05093205|81205937|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
27829089|NCT05093205|81205925|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
27829090|NCT05093205|81205926|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
27829091|NCT05093205|81205927|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
27829092|NCT05093205|81205928|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
27829093|NCT05093205|81205929|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
27829094|NCT05093205|81205930|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
27829095|NCT05093205|81205931|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
27829096|NCT05093205|81205932|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
27829097|NCT05093205|81205933|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
27829098|NCT05093205|81205934|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
27829099|NCT05093205|81205935|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
27829100|NCT05093205|81205936|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
27829101|NCT05093205|81205937|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
27829102|NCT05093205|81205925|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829103|NCT05093205|81205926|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829104|NCT05093205|81205927|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829105|NCT05093205|81205928|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829106|NCT05093205|81205929|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27698043|NCT00823901|80729982|FG000|Overall Study|Lost to Follow-up|2|||
27698044|NCT00823901|80729983|FG001|Overall Study|Lost to Follow-up|1|||
27698045|NCT01387230|80729985|FG000|Overall Study|Adverse Event|0|||
27698046|NCT01387230|80729986|FG001|Overall Study|Adverse Event|1|||
27698047|NCT01387230|80729987|FG002|Overall Study|Adverse Event|3|||
27698048|NCT01387230|80729985|FG000|Overall Study|Lack of Efficacy|8|||
27698049|NCT01387230|80729986|FG001|Overall Study|Lack of Efficacy|5|||
27698050|NCT01387230|80729987|FG002|Overall Study|Lack of Efficacy|4|||
27698051|NCT01387230|80729985|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
27698052|NCT01387230|80729986|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
27698053|NCT01387230|80729987|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
27698054|NCT01387230|80729985|FG000|Overall Study|Lost to Follow-up|0|||
27698055|NCT01387230|80729986|FG001|Overall Study|Lost to Follow-up|0|||
27698056|NCT01387230|80729987|FG002|Overall Study|Lost to Follow-up|1|||
27698057|NCT01387230|80729985|FG000|Overall Study|Withdrawal by Subject|4|||
27698058|NCT01387230|80729986|FG001|Overall Study|Withdrawal by Subject|1|||
27698059|NCT01387230|80729987|FG002|Overall Study|Withdrawal by Subject|0|||
27698060|NCT02469896|80729988|FG000|Overall Study|Withdrawal by Subject|2|||
27698061|NCT02469896|80729989|FG001|Overall Study|Withdrawal by Subject|0|||
27698062|NCT01013285|80729998|FG000|Overall Study|Death|48|||
27698063|NCT01013285|80729999|FG001|Overall Study|Death|89|||
27698064|NCT03064035|80730002|FG000|Overall Study|Did not receive allocated intervention|4|||
27698065|NCT03064035|80730003|FG001|Overall Study|Did not receive allocated intervention|2|||
27698066|NCT03064035|80730002|FG000|Overall Study|Lost to Follow-up|1|||
27698067|NCT03064035|80730003|FG001|Overall Study|Lost to Follow-up|1|||
27698068|NCT03097133|80730004|FG000|Overall Study|Lost to Follow-up|3|||
27829107|NCT05093205|81205930|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829108|NCT05093205|81205931|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829109|NCT05093205|81205932|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829110|NCT05093205|81205933|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829111|NCT05093205|81205934|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
27829112|NCT05093205|81205935|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829113|NCT05093205|81205936|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829114|NCT05093205|81205937|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
27829115|NCT05093205|81205925|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
27698069|NCT03097133|80730005|FG001|Overall Study|Lost to Follow-up|2|||
27698070|NCT03097133|80730004|FG000|Overall Study|Withdrawal by Subject|2|||
27698071|NCT03097133|80730005|FG001|Overall Study|Withdrawal by Subject|5|||
27698072|NCT03097133|80730004|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
27698073|NCT03097133|80730005|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
27829116|NCT05093205|81205926|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
27829117|NCT05093205|81205927|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
27558536|NCT03312933|80232980|FG000|Overall Study|Withdrawal by Subject|3|||
27558537|NCT03263442|80232981|FG000|Inpatient Phase|Death|1|||
27698074|NCT03097133|80730004|FG000|Overall Study|Other|3|||
27698075|NCT03097133|80730005|FG001|Overall Study|Other|2|||
27698076|NCT03097133|80730004|FG000|Overall Study|Adverse Event|1|||
27558538|NCT03263442|80232982|FG001|Inpatient Phase|Death|0|||
27558539|NCT03263442|80232981|FG000|Inpatient Phase|Withdrawal by Subject|1|||
27558540|NCT03263442|80232982|FG001|Inpatient Phase|Withdrawal by Subject|0|||
27558541|NCT03263442|80232981|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
27558542|NCT03263442|80232982|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
27558543|NCT03263442|80232981|FG000|1-month Follow-Up|Lost to Follow-up|1|||
27558544|NCT03263442|80232982|FG001|1-month Follow-Up|Lost to Follow-up|0|||
27558545|NCT03263442|80232981|FG000|3-month Follow-Up|Lost to Follow-up|1|||
27558546|NCT03263442|80232982|FG001|3-month Follow-Up|Lost to Follow-up|3|||
27558547|NCT03263442|80232981|FG000|6-month Follow-Up|Lost to Follow-up|2|||
27558548|NCT03263442|80232982|FG001|6-month Follow-Up|Lost to Follow-up|2|||
27558549|NCT00386776|80232983|FG000|Overall Study|Withdrawal by Subject|8|||
27558550|NCT03649711|80232984|FG000|Overall Study|Adverse Event|0|||
27558551|NCT03649711|80232985|FG001|Overall Study|Adverse Event|1|||
27558552|NCT03649711|80232986|FG002|Overall Study|Adverse Event|0|||
27558553|NCT03649711|80232984|FG000|Overall Study|Kidney Transplant|1|||
27558554|NCT03649711|80232985|FG001|Overall Study|Kidney Transplant|0|||
27558555|NCT03649711|80232986|FG002|Overall Study|Kidney Transplant|0|||
27558556|NCT00225251|80232987|FG000|Overall Study|Withdrawal by Subject|1|||
27558557|NCT00225251|80232988|FG001|Overall Study|Withdrawal by Subject|1|||
27558558|NCT01705652|80232989|FG000|Overall Study|Adverse Event|1|||
27558559|NCT01705652|80232990|FG001|Overall Study|Adverse Event|0|||
27558560|NCT01705652|80232989|FG000|Overall Study|Withdrawal by Subject|1|||
27558561|NCT01705652|80232990|FG001|Overall Study|Withdrawal by Subject|2|||
27698077|NCT03097133|80730005|FG001|Overall Study|Adverse Event|0|||
27558562|NCT01705652|80232989|FG000|Overall Study|non-compliance|1|||
27558563|NCT01705652|80232990|FG001|Overall Study|non-compliance|1|||
27558564|NCT00553150|80232993|FG000|Overall Study|Withdrawal by Subject|0|||
27558565|NCT00553150|80232994|FG001|Overall Study|Withdrawal by Subject|0|||
27558566|NCT00553150|80232995|FG002|Overall Study|Withdrawal by Subject|0|||
27558567|NCT00553150|80232996|FG003|Overall Study|Withdrawal by Subject|2|||
27558568|NCT00553150|80232993|FG000|Overall Study|Protocol Violation|0|||
27558569|NCT00553150|80232994|FG001|Overall Study|Protocol Violation|0|||
27558570|NCT00553150|80232995|FG002|Overall Study|Protocol Violation|0|||
27558571|NCT00553150|80232996|FG003|Overall Study|Protocol Violation|1|||
27558572|NCT00553150|80232993|FG000|Overall Study|Ineligible|0|||
27558573|NCT00553150|80232994|FG001|Overall Study|Ineligible|0|||
27558574|NCT00553150|80232995|FG002|Overall Study|Ineligible|0|||
27558575|NCT00553150|80232996|FG003|Overall Study|Ineligible|1|||
27558576|NCT04483011|80232997|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
27698078|NCT03645057|80730009|FG000|Randomization to Baseline|Lost to Follow-up|1|||
27829118|NCT05093205|81205928|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
27558577|NCT04483011|80232998|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
27558578|NCT03480750|80232999|FG000|Overall Study|Withdrawal by Subject|0|||
27558579|NCT03480750|80233000|FG001|Overall Study|Withdrawal by Subject|1|||
27558580|NCT03480750|80233001|FG002|Overall Study|Withdrawal by Subject|0|||
27558581|NCT03480750|80233002|FG003|Overall Study|Withdrawal by Subject|0|||
27558582|NCT03480750|80233003|FG004|Overall Study|Withdrawal by Subject|0|||
27558583|NCT03480750|80233004|FG005|Overall Study|Withdrawal by Subject|0|||
27829119|NCT05093205|81205929|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
27558584|NCT03480750|80232999|FG000|Overall Study|The interruption in Trientine shippment|0|||
27558585|NCT03480750|80233000|FG001|Overall Study|The interruption in Trientine shippment|0|||
27558586|NCT03480750|80233001|FG002|Overall Study|The interruption in Trientine shippment|0|||
27558587|NCT03480750|80233002|FG003|Overall Study|The interruption in Trientine shippment|0|||
27558588|NCT03480750|80233003|FG004|Overall Study|The interruption in Trientine shippment|0|||
27558589|NCT03480750|80233004|FG005|Overall Study|The interruption in Trientine shippment|1|||
27558590|NCT02564042|80233005|FG000|Overall Study|Adverse Event|4|||
27558591|NCT02564042|80233006|FG001|Overall Study|Adverse Event|4|||
27558592|NCT02564042|80233007|FG002|Overall Study|Adverse Event|3|||
27558593|NCT02564042|80233008|FG003|Overall Study|Adverse Event|0|||
27558594|NCT02564042|80233009|FG004|Overall Study|Adverse Event|0|||
27558595|NCT02564042|80233010|FG005|Overall Study|Adverse Event|1|||
27558596|NCT02564042|80233005|FG000|Overall Study|Lost to Follow-up|1|||
27698079|NCT03645057|80730010|FG001|Randomization to Baseline|Lost to Follow-up|0|||
27698080|NCT03645057|80730011|FG002|Randomization to Baseline|Lost to Follow-up|1|||
27698081|NCT03645057|80730012|FG003|Randomization to Baseline|Lost to Follow-up|0|||
27558597|NCT02564042|80233006|FG001|Overall Study|Lost to Follow-up|1|||
27558598|NCT02564042|80233007|FG002|Overall Study|Lost to Follow-up|1|||
27558599|NCT02564042|80233008|FG003|Overall Study|Lost to Follow-up|0|||
27558600|NCT02564042|80233009|FG004|Overall Study|Lost to Follow-up|1|||
27558601|NCT02564042|80233010|FG005|Overall Study|Lost to Follow-up|1|||
27558602|NCT02564042|80233005|FG000|Overall Study|Physician Decision|1|||
27558603|NCT02564042|80233006|FG001|Overall Study|Physician Decision|0|||
27558604|NCT02564042|80233007|FG002|Overall Study|Physician Decision|0|||
27558605|NCT02564042|80233008|FG003|Overall Study|Physician Decision|1|||
27558606|NCT02564042|80233009|FG004|Overall Study|Physician Decision|0|||
27558607|NCT02564042|80233010|FG005|Overall Study|Physician Decision|0|||
27558608|NCT02564042|80233005|FG000|Overall Study|Withdrawal by Subject|5|||
27558609|NCT02564042|80233006|FG001|Overall Study|Withdrawal by Subject|3|||
27558610|NCT02564042|80233007|FG002|Overall Study|Withdrawal by Subject|2|||
27558611|NCT02564042|80233008|FG003|Overall Study|Withdrawal by Subject|2|||
27558612|NCT02564042|80233009|FG004|Overall Study|Withdrawal by Subject|10|||
27558613|NCT02564042|80233010|FG005|Overall Study|Withdrawal by Subject|12|||
27558614|NCT00103142|80233011|FG000|Overall Study|Adverse Event|1|||
27558615|NCT00103142|80233012|FG001|Overall Study|Adverse Event|0|||
27558616|NCT00103142|80233011|FG000|Overall Study|Progression of disease|2|||
27558617|NCT00103142|80233012|FG001|Overall Study|Progression of disease|1|||
27558618|NCT01998633|80233015|FG000|Overall Study|Death|1|||
27558619|NCT01189812|80233016|FG000|Overall Study|Withdrawal by Subject|2|||
27558620|NCT01189812|80233017|FG001|Overall Study|Withdrawal by Subject|3|||
27558621|NCT01189812|80233016|FG000|Overall Study|Adverse Event|1|||
27558622|NCT01189812|80233017|FG001|Overall Study|Adverse Event|0|||
27558623|NCT01189812|80233016|FG000|Overall Study|Out of Window|4|||
27558624|NCT01189812|80233017|FG001|Overall Study|Out of Window|3|||
27558625|NCT01189812|80233016|FG000|Overall Study|Moved out of State|1|||
27698082|NCT03645057|80730009|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
27698083|NCT03645057|80730010|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
27558626|NCT01189812|80233017|FG001|Overall Study|Moved out of State|2|||
27558627|NCT01408030|80233020|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
27558628|NCT01408030|80233021|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
27558629|NCT01408030|80233022|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
27558630|NCT01408030|80233023|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
27558631|NCT01408030|80233020|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
27558632|NCT01408030|80233021|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
27558633|NCT01408030|80233022|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
27884409|NCT02964507|81411805|FG005|Overall Study|Physician Decision|0|||
27558634|NCT01408030|80233023|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
27558635|NCT01408030|80233020|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
27558636|NCT01408030|80233021|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
27558637|NCT01408030|80233022|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
27558638|NCT01408030|80233023|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
27558639|NCT01408030|80233020|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
27558640|NCT01408030|80233021|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
27558641|NCT01408030|80233022|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
27558642|NCT01408030|80233023|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
27558643|NCT01408030|80233020|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
27829120|NCT05093205|81205930|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
27829121|NCT05093205|81205931|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
27829122|NCT05093205|81205932|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
27829123|NCT05093205|81205933|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
27829124|NCT05093205|81205934|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
27558644|NCT01408030|80233021|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
27558645|NCT01408030|80233022|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
27829125|NCT05093205|81205935|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
27829126|NCT05093205|81205936|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
27829127|NCT05093205|81205937|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
27829128|NCT05093205|81205925|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829129|NCT05093205|81205926|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829130|NCT05093205|81205927|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829131|NCT05093205|81205928|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829132|NCT05093205|81205929|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27558646|NCT01408030|80233023|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
27829133|NCT05093205|81205930|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829134|NCT05093205|81205931|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27558647|NCT01408030|80233020|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
27558648|NCT01408030|80233021|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
27558649|NCT01408030|80233022|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
27558650|NCT01408030|80233023|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
27829135|NCT05093205|81205932|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27884410|NCT02964507|81411806|FG006|Overall Study|Physician Decision|0|||
27829136|NCT05093205|81205933|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27698084|NCT03645057|80730011|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
27829137|NCT05093205|81205934|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27558651|NCT01408030|80233020|FG000|Observation Phase (Off Drug)|Other|1|||
27558652|NCT01408030|80233021|FG001|Observation Phase (Off Drug)|Other|1|||
27558653|NCT01408030|80233022|FG002|Observation Phase (Off Drug)|Other|1|||
27558654|NCT01408030|80233023|FG003|Observation Phase (Off Drug)|Other|1|||
27558655|NCT05517382|80233025|FG000|Overall Study|Lost to Follow-up|0|||
27558656|NCT05517382|80233026|FG001|Overall Study|Lost to Follow-up|1|||
27558657|NCT03070392|80233027|FG000|Overall Study|Not Treated|7|||
27558658|NCT03070392|80233028|FG001|Overall Study|Not Treated|0|||
27558659|NCT03070392|80233029|FG002|Overall Study|Not Treated|3|||
27558660|NCT03070392|80233030|FG003|Overall Study|Not Treated|12|||
27558661|NCT03070392|80233027|FG000|Overall Study|Death|3|||
27558662|NCT03070392|80233028|FG001|Overall Study|Death|0|||
27558663|NCT03070392|80233029|FG002|Overall Study|Death|0|||
27558664|NCT03070392|80233030|FG003|Overall Study|Death|1|||
27558665|NCT03070392|80233027|FG000|Overall Study|Withdrawal by Subject|7|||
27558666|NCT03070392|80233028|FG001|Overall Study|Withdrawal by Subject|0|||
27558667|NCT03070392|80233029|FG002|Overall Study|Withdrawal by Subject|0|||
27558668|NCT03070392|80233030|FG003|Overall Study|Withdrawal by Subject|3|||
27558669|NCT03070392|80233027|FG000|Overall Study|Physician Decision|1|||
27558670|NCT03070392|80233028|FG001|Overall Study|Physician Decision|0|||
27558671|NCT03070392|80233029|FG002|Overall Study|Physician Decision|0|||
27558672|NCT03070392|80233030|FG003|Overall Study|Physician Decision|2|||
27558673|NCT03070392|80233027|FG000|Overall Study|Progressive Disease|154|||
27558674|NCT03070392|80233028|FG001|Overall Study|Progressive Disease|6|||
27558675|NCT03070392|80233029|FG002|Overall Study|Progressive Disease|2|||
27558676|NCT03070392|80233030|FG003|Overall Study|Progressive Disease|70|||
27558677|NCT03070392|80233027|FG000|Overall Study|Adverse Event|6|||
27558678|NCT03070392|80233028|FG001|Overall Study|Adverse Event|1|||
27558679|NCT03070392|80233029|FG002|Overall Study|Adverse Event|1|||
27558680|NCT03070392|80233030|FG003|Overall Study|Adverse Event|3|||
27558681|NCT03070392|80233027|FG000|Overall Study|Alternate anticancer treatment|1|||
27558682|NCT03070392|80233028|FG001|Overall Study|Alternate anticancer treatment|0|||
27558683|NCT03070392|80233029|FG002|Overall Study|Alternate anticancer treatment|0|||
27558684|NCT03070392|80233030|FG003|Overall Study|Alternate anticancer treatment|1|||
27558685|NCT03070392|80233027|FG000|Overall Study|Ongoing|73|||
27558686|NCT03070392|80233028|FG001|Overall Study|Ongoing|0|||
27558687|NCT03070392|80233029|FG002|Overall Study|Ongoing|0|||
27829138|NCT05093205|81205935|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
27558688|NCT03070392|80233030|FG003|Overall Study|Ongoing|11|||
27558689|NCT00732615|80233031|FG000|Overall Study|Withdrawal by Subject|3|||
27558690|NCT00732615|80233032|FG001|Overall Study|Withdrawal by Subject|1|||
27558691|NCT00732615|80233031|FG000|Overall Study|Lost to Follow-up|0|||
27558692|NCT00732615|80233032|FG001|Overall Study|Lost to Follow-up|1|||
27558693|NCT00732615|80233031|FG000|Overall Study|Adverse Event|0|||
27558694|NCT00732615|80233032|FG001|Overall Study|Adverse Event|2|||
27829139|NCT05093205|81205936|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829140|NCT05093205|81205937|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
27829141|NCT05093205|81205925|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829142|NCT05093205|81205926|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829143|NCT05093205|81205927|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829144|NCT05093205|81205928|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829145|NCT05093205|81205929|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829146|NCT05093205|81205930|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829147|NCT05093205|81205931|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829148|NCT05093205|81205932|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829149|NCT05093205|81205933|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829150|NCT05093205|81205934|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829151|NCT05093205|81205935|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829152|NCT05093205|81205936|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
27829153|NCT05093205|81205937|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
27829154|NCT05093205|81205925|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
27829155|NCT05093205|81205926|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
27829156|NCT05093205|81205927|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
27829157|NCT05093205|81205928|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
27829158|NCT05093205|81205929|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
27829159|NCT05093205|81205930|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
27829160|NCT05093205|81205931|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
27829161|NCT05093205|81205932|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
27829162|NCT05093205|81205933|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
27829163|NCT05093205|81205934|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
27829164|NCT05093205|81205935|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
27829165|NCT05093205|81205936|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
27829166|NCT05093205|81205937|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
27829167|NCT05093205|81205925|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829168|NCT05093205|81205926|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829169|NCT05093205|81205927|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829170|NCT05093205|81205928|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829171|NCT05093205|81205929|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829172|NCT05093205|81205930|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829173|NCT05093205|81205931|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27558695|NCT00732615|80233031|FG000|Overall Study|Physician Decision|3|||
27558696|NCT00732615|80233032|FG001|Overall Study|Physician Decision|0|||
27558697|NCT00732615|80233031|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
27558698|NCT00732615|80233032|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
27558699|NCT03447990|80233034|FG000|Overall Study|Withdrawal by Subject|0|||
27558700|NCT03447990|80233035|FG001|Overall Study|Withdrawal by Subject|0|||
27558701|NCT03447990|80233036|FG002|Overall Study|Withdrawal by Subject|0|||
27558702|NCT03447990|80233037|FG003|Overall Study|Withdrawal by Subject|0|||
27558703|NCT03447990|80233038|FG004|Overall Study|Withdrawal by Subject|0|||
27558704|NCT03447990|80233039|FG005|Overall Study|Withdrawal by Subject|0|||
27558705|NCT03447990|80233040|FG006|Overall Study|Withdrawal by Subject|1|||
27558706|NCT03909295|80233041|FG000|Overall Study|Adverse Event|2|||
27558707|NCT03909295|80233041|FG000|Overall Study|Study terminated by sponsor|50|||
27558708|NCT00842712|80233050|FG000|Safety Run-in Part|Adverse Event|0|||
27558709|NCT00842712|80233051|FG001|Safety Run-in Part|Adverse Event|1|||
27829174|NCT05093205|81205932|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829175|NCT05093205|81205933|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27558710|NCT00842712|80233052|FG002|Safety Run-in Part|Adverse Event|0|||
27829176|NCT05093205|81205934|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829177|NCT05093205|81205935|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829178|NCT05093205|81205936|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
27829179|NCT05093205|81205937|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
27829180|NCT00477594|81205938|FG000|Year 1 and Year 2|Adverse Event|4|||
27829181|NCT00477594|81205939|FG001|Year 1 and Year 2|Adverse Event|2|||
27829182|NCT00477594|81205938|FG000|Year 1 and Year 2|Physician Decision|2|||
27829183|NCT00477594|81205939|FG001|Year 1 and Year 2|Physician Decision|1|||
27829184|NCT00477594|81205938|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
27829185|NCT00477594|81205939|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
27829186|NCT00477594|81205938|FG000|Year 1 and Year 2|Other|1|||
27884411|NCT02964507|81411807|FG007|Overall Study|Physician Decision|0|||
27558711|NCT00842712|80233053|FG003|Safety Run-in Part|Adverse Event|0|||
27558712|NCT00842712|80233054|FG004|Safety Run-in Part|Adverse Event|0|||
27558713|NCT00842712|80233055|FG005|Safety Run-in Part|Adverse Event|0|||
27558714|NCT00842712|80233056|FG006|Safety Run-in Part|Adverse Event|0|||
27558715|NCT00842712|80233050|FG000|Safety Run-in Part|Progressive disease|3|||
27558716|NCT00842712|80233051|FG001|Safety Run-in Part|Progressive disease|1|||
27558717|NCT00842712|80233052|FG002|Safety Run-in Part|Progressive disease|0|||
27558718|NCT00842712|80233053|FG003|Safety Run-in Part|Progressive disease|1|||
27558719|NCT00842712|80233054|FG004|Safety Run-in Part|Progressive disease|0|||
27558720|NCT00842712|80233055|FG005|Safety Run-in Part|Progressive disease|0|||
27558721|NCT00842712|80233056|FG006|Safety Run-in Part|Progressive disease|0|||
27558722|NCT00842712|80233050|FG000|Randomized Part|Randomized but not treated|0|||
27558723|NCT00842712|80233051|FG001|Randomized Part|Randomized but not treated|0|||
27829187|NCT00477594|81205939|FG001|Year 1 and Year 2|Other|0|||
27829188|NCT00477594|81205938|FG000|Year 3|Adverse Event|1|||
27558724|NCT00842712|80233052|FG002|Randomized Part|Randomized but not treated|0|||
27558725|NCT00842712|80233053|FG003|Randomized Part|Randomized but not treated|0|||
27558726|NCT00842712|80233054|FG004|Randomized Part|Randomized but not treated|0|||
27558727|NCT00842712|80233055|FG005|Randomized Part|Randomized but not treated|1|||
27558728|NCT00842712|80233056|FG006|Randomized Part|Randomized but not treated|4|||
27558729|NCT00842712|80233050|FG000|Randomized Part|Ongoing at cut-off date|0|||
27558730|NCT00842712|80233051|FG001|Randomized Part|Ongoing at cut-off date|0|||
27558731|NCT00842712|80233052|FG002|Randomized Part|Ongoing at cut-off date|0|||
27558732|NCT00842712|80233053|FG003|Randomized Part|Ongoing at cut-off date|0|||
27698085|NCT03645057|80730012|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
27698086|NCT03645057|80730009|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
27698087|NCT03645057|80730010|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
27558733|NCT00842712|80233054|FG004|Randomized Part|Ongoing at cut-off date|0|||
27698088|NCT03645057|80730011|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
27884412|NCT00977314|81411811|FG000|Overall Study|Withdrawal by Subject|1|||
27698089|NCT03645057|80730012|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
27698090|NCT03645057|80730009|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
27698091|NCT03645057|80730010|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
27698092|NCT03645057|80730011|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
27698093|NCT03645057|80730012|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
27829189|NCT00477594|81205939|FG001|Year 3|Adverse Event|0|||
27558734|NCT00842712|80233055|FG005|Randomized Part|Ongoing at cut-off date|0|||
27558735|NCT00842712|80233056|FG006|Randomized Part|Ongoing at cut-off date|2|||
27558736|NCT00202644|80233060|FG000|Overall Study|Adverse Event|12|||
27558737|NCT00202644|80233061|FG001|Overall Study|Adverse Event|13|||
27558738|NCT00202644|80233060|FG000|Overall Study|Withdrawal by Subject|8|||
27558739|NCT00202644|80233061|FG001|Overall Study|Withdrawal by Subject|6|||
27698094|NCT01117857|80730015|FG000|Overall Study|Lost to Follow-up|4|||
27698095|NCT01117857|80730015|FG000|Overall Study|Withdrawal by Subject|4|||
27698096|NCT01117857|80730015|FG000|Overall Study|Physician Decision|1|||
27698097|NCT00001962|80730016|FG000|Overall Study|Lack of Efficacy|18|||
27829190|NCT00477594|81205938|FG000|Year 3|Withdrawal by Subject|1|||
27829191|NCT00477594|81205939|FG001|Year 3|Withdrawal by Subject|0|||
27829192|NCT00477594|81205938|FG000|Follow-up Period|Withdrawal by Subject|2|||
27698098|NCT00001962|80730016|FG000|Overall Study|Lack of Accrual|6|||
27698099|NCT00001962|80730016|FG000|Overall Study|Death|1|||
27698100|NCT00001962|80730016|FG000|Overall Study|Lost to Follow-up|2|||
27698101|NCT00001962|80730016|FG000|Overall Study|Adverse Event|1|||
27698102|NCT00792805|80730017|FG000|Overall Study|Adverse Event|12|||
27698103|NCT00792805|80730018|FG001|Overall Study|Adverse Event|10|||
27698104|NCT00792805|80730019|FG002|Overall Study|Adverse Event|10|||
27698105|NCT00792805|80730017|FG000|Overall Study|Subject withdrew consent|5|||
27698106|NCT00792805|80730018|FG001|Overall Study|Subject withdrew consent|6|||
27698107|NCT00792805|80730019|FG002|Overall Study|Subject withdrew consent|5|||
27698108|NCT00792805|80730017|FG000|Overall Study|Administrative problems|2|||
27698109|NCT00792805|80730018|FG001|Overall Study|Administrative problems|0|||
27698110|NCT00792805|80730019|FG002|Overall Study|Administrative problems|4|||
27698111|NCT00792805|80730017|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27698112|NCT00792805|80730018|FG001|Overall Study|Abnormal test procedure result(s)|2|||
27698113|NCT00792805|80730019|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27698114|NCT00792805|80730017|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27698115|NCT00792805|80730018|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
27698116|NCT00792805|80730019|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
27698117|NCT00792805|80730017|FG000|Overall Study|Lost to Follow-up|1|||
27698118|NCT00792805|80730018|FG001|Overall Study|Lost to Follow-up|1|||
27698119|NCT00792805|80730019|FG002|Overall Study|Lost to Follow-up|6|||
27698120|NCT00792805|80730017|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27698121|NCT00792805|80730018|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27698122|NCT00792805|80730019|FG002|Overall Study|Abnormal laboratory value(s)|1|||
27698123|NCT00792805|80730017|FG000|Overall Study|Protocol deviation|0|||
27698124|NCT00792805|80730018|FG001|Overall Study|Protocol deviation|1|||
27698125|NCT00792805|80730019|FG002|Overall Study|Protocol deviation|1|||
27698126|NCT04824521|80730020|FG000|Overall Study|Lost to Follow-up|1|||
27698127|NCT02178553|80732751|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
27698128|NCT02178553|80732752|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
27698129|NCT02178553|80732751|FG000|Overall Study|Physician Decision|0|||
27698130|NCT02178553|80732752|FG001|Overall Study|Physician Decision|4|||
27558740|NCT00202644|80233060|FG000|Overall Study|Lack of Efficacy|6|||
27558741|NCT00202644|80233061|FG001|Overall Study|Lack of Efficacy|6|||
27558742|NCT00202644|80233060|FG000|Overall Study|Lost to Follow-up|0|||
27558743|NCT00202644|80233061|FG001|Overall Study|Lost to Follow-up|1|||
27558744|NCT00202644|80233060|FG000|Overall Study|Other|9|||
27558745|NCT00202644|80233061|FG001|Overall Study|Other|1|||
27558746|NCT00710710|80233062|FG000|Overall Study|Consent withdrawn|2|||
27558747|NCT00710710|80233063|FG001|Overall Study|Consent withdrawn|2|||
27558748|NCT00710710|80233062|FG000|Overall Study|Protocol Violation|0|||
27558749|NCT00710710|80233063|FG001|Overall Study|Protocol Violation|1|||
27558750|NCT00710710|80233062|FG000|Overall Study|Adverse Event|3|||
27558751|NCT00710710|80233063|FG001|Overall Study|Adverse Event|3|||
27558752|NCT00710710|80233062|FG000|Overall Study|Progressive disease|40|||
27698131|NCT02178553|80732751|FG000|Overall Study|Technical problem with injection|1|||
27698132|NCT02178553|80732752|FG001|Overall Study|Technical problem with injection|3|||
27698133|NCT01940354|80732753|FG000|Overall Study|Withdrawal by Subject|4|||
27698134|NCT01940354|80732754|FG001|Overall Study|Withdrawal by Subject|2|||
27698135|NCT01603082|80732755|FG000|Overall Study|Adverse Event|0|||
27558753|NCT00710710|80233063|FG001|Overall Study|Progressive disease|38|||
27558754|NCT00588848|80233070|FG000|Overall Study|Physician Decision|0|||
27558755|NCT00588848|80233071|FG001|Overall Study|Physician Decision|3|||
27558756|NCT00065507|80233072|FG000|Overall Study|Death|16|||
27558757|NCT00065507|80233073|FG001|Overall Study|Death|17|||
27558758|NCT00065507|80233072|FG000|Overall Study|Adverse Event|4|||
27884413|NCT00977314|81411812|FG001|Overall Study|Withdrawal by Subject|0|||
27884414|NCT00977314|81411811|FG000|Overall Study|Physician Decision|1|||
27884415|NCT00977314|81411812|FG001|Overall Study|Physician Decision|0|||
27884416|NCT01102257|81411813|FG000|Overall Study|Adverse Event|1|||
27884417|NCT01102257|81411814|FG001|Overall Study|Adverse Event|0|||
27884418|NCT01102257|81411813|FG000|Overall Study|Adverse Event|1|||
27884419|NCT01102257|81411814|FG001|Overall Study|Adverse Event|0|||
27884420|NCT01540487|81411824|FG000|Overall Study|Protocol Violation|1|||
27884421|NCT01540487|81411825|FG001|Overall Study|Protocol Violation|0|||
27884422|NCT02418156|81411826|FG000|Overall Study|Lost to Follow-up|12|||
27558759|NCT00065507|80233073|FG001|Overall Study|Adverse Event|3|||
27558760|NCT00065507|80233072|FG000|Overall Study|Lack of Efficacy|0|||
27558761|NCT00065507|80233073|FG001|Overall Study|Lack of Efficacy|6|||
27558762|NCT00065507|80233072|FG000|Overall Study|Poor/Non-compliance|3|||
27558763|NCT00065507|80233073|FG001|Overall Study|Poor/Non-compliance|2|||
27558764|NCT00065507|80233072|FG000|Overall Study|Lost to Follow-up|3|||
27558765|NCT00065507|80233073|FG001|Overall Study|Lost to Follow-up|0|||
27558766|NCT00065507|80233072|FG000|Overall Study|Subject Withdrew Consent|2|||
27884423|NCT02418156|81411826|FG000|Overall Study|Death|2|||
27884424|NCT02418156|81411826|FG000|Overall Study|Physician Decision|1|||
27884425|NCT02418156|81411826|FG000|Overall Study|Withdrawal by Subject|1|||
27558767|NCT00065507|80233073|FG001|Overall Study|Subject Withdrew Consent|1|||
27558768|NCT00065507|80233072|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
27558769|NCT00065507|80233073|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
27558770|NCT01846507|80233074|FG000|Overall Study|Lost to Follow-up|4|||
27558771|NCT01846507|80233074|FG000|Overall Study|Protocol Violation|1|||
27558772|NCT01846507|80233074|FG000|Overall Study|Missing data|2|||
27558773|NCT01996826|80233084|FG000|Overall Study|Lost to Follow-up|6|||
27558774|NCT01996826|80233085|FG001|Overall Study|Lost to Follow-up|2|||
27558775|NCT01996826|80233084|FG000|Overall Study|Physician Decision|1|||
27558776|NCT01996826|80233085|FG001|Overall Study|Physician Decision|1|||
27558777|NCT03566823|80233086|FG000|Overall Study|Lack of Efficacy|0|||
27558778|NCT03566823|80233087|FG001|Overall Study|Lack of Efficacy|1|||
27558779|NCT03566823|80233088|FG002|Overall Study|Lack of Efficacy|0|||
27558780|NCT03566823|80233086|FG000|Overall Study|Withdrawal by Subject|1|||
27558781|NCT03566823|80233087|FG001|Overall Study|Withdrawal by Subject|2|||
27558782|NCT03566823|80233088|FG002|Overall Study|Withdrawal by Subject|0|||
27558783|NCT03566823|80233086|FG000|Overall Study|Adverse Event|1|||
27558784|NCT03566823|80233087|FG001|Overall Study|Adverse Event|0|||
27558785|NCT03566823|80233088|FG002|Overall Study|Adverse Event|2|||
27558786|NCT04517253|80233100|FG000|Overall Study|Adverse Event|1|||
27558787|NCT04517253|80233101|FG001|Overall Study|Adverse Event|0|||
27558788|NCT04517253|80233102|FG002|Overall Study|Adverse Event|0|||
27558789|NCT04517253|80233100|FG000|Overall Study|Death|0|||
27558790|NCT04517253|80233101|FG001|Overall Study|Death|1|||
27558791|NCT04517253|80233102|FG002|Overall Study|Death|0|||
27558792|NCT02233309|80233103|FG000|Overall Study|Physician Decision|5|||
27558793|NCT02069366|80233104|FG000|Overall Study|Lost to Follow-up|0|||
27558794|NCT02069366|80233105|FG001|Overall Study|Lost to Follow-up|0|||
27884426|NCT02418156|81411826|FG000|Overall Study|Subject refused to return|1|||
27884427|NCT02919969|81411829|FG000|Overall Study|Lack of Efficacy|22|||
27884428|NCT02919969|81411829|FG000|Overall Study|Death|4|||
27884429|NCT02919969|81411829|FG000|Overall Study|Physician Decision|3|||
27884430|NCT02919969|81411829|FG000|Overall Study|Withdrawal by Subject|2|||
27558795|NCT02069366|80233106|FG002|Overall Study|Lost to Follow-up|1|||
27829193|NCT00477594|81205939|FG001|Follow-up Period|Withdrawal by Subject|1|||
27829194|NCT00477594|81205938|FG000|Follow-up Period|Other|1|||
27829195|NCT00477594|81205939|FG001|Follow-up Period|Other|0|||
27829196|NCT01218867|81205940|FG000|Overall Study|Death during treatment|0|||
27829197|NCT01218867|81205941|FG001|Overall Study|Death during treatment|0|||
27829198|NCT01218867|81205942|FG002|Overall Study|Death during treatment|0|||
27829199|NCT01218867|81205943|FG003|Overall Study|Death during treatment|0|||
27829200|NCT01218867|81205944|FG004|Overall Study|Death during treatment|0|||
27829201|NCT01218867|81205945|FG005|Overall Study|Death during treatment|0|||
27829202|NCT01218867|81205946|FG006|Overall Study|Death during treatment|1|||
27829203|NCT01218867|81205947|FG007|Overall Study|Death during treatment|0|||
27829204|NCT01218867|81205948|FG008|Overall Study|Death during treatment|0|||
27829205|NCT01218867|81205949|FG009|Overall Study|Death during treatment|0|||
27829206|NCT01218867|81205950|FG010|Overall Study|Death during treatment|0|||
27829207|NCT02300103|81205951|FG000|Overall Study|Lack of Efficacy|3|||
27829208|NCT02300103|81205951|FG000|Overall Study|Protocol Violation|1|||
27829209|NCT02300103|81205951|FG000|Overall Study|Withdrew Consent|2|||
27829210|NCT00838630|81205952|FG000|First Intervention|Adverse Event|1|||
27884431|NCT01222520|81411830|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
27558796|NCT02069366|80233107|FG003|Overall Study|Lost to Follow-up|0|||
27558797|NCT02069366|80233108|FG004|Overall Study|Lost to Follow-up|0|||
27558798|NCT02069366|80233109|FG005|Overall Study|Lost to Follow-up|2|||
27558799|NCT02069366|80233104|FG000|Overall Study|Protocol Violation|0|||
27558800|NCT02069366|80233105|FG001|Overall Study|Protocol Violation|0|||
27558801|NCT02069366|80233106|FG002|Overall Study|Protocol Violation|1|||
27829211|NCT00838630|81205953|FG001|First Intervention|Adverse Event|0|||
27829212|NCT00838630|81205952|FG000|Washout: 7 Days|Protocol Violation|1|||
27829213|NCT00838630|81205953|FG001|Washout: 7 Days|Protocol Violation|0|||
27829214|NCT02576938|81205954|FG000|Overall Study|Adverse Event|5|||
27829215|NCT02576938|81205955|FG001|Overall Study|Adverse Event|3|||
27558802|NCT02069366|80233107|FG003|Overall Study|Protocol Violation|0|||
27558803|NCT02069366|80233108|FG004|Overall Study|Protocol Violation|0|||
27558804|NCT02069366|80233109|FG005|Overall Study|Protocol Violation|0|||
27558805|NCT02069366|80233104|FG000|Overall Study|Withdrawal by Subject|1|||
27558806|NCT02069366|80233105|FG001|Overall Study|Withdrawal by Subject|0|||
27558807|NCT02069366|80233106|FG002|Overall Study|Withdrawal by Subject|1|||
27558808|NCT02069366|80233107|FG003|Overall Study|Withdrawal by Subject|2|||
27558809|NCT02069366|80233108|FG004|Overall Study|Withdrawal by Subject|0|||
27558810|NCT02069366|80233109|FG005|Overall Study|Withdrawal by Subject|0|||
27558811|NCT03303079|80233110|FG000|Overall Study|Adverse Event|0|||
27558812|NCT03303079|80233111|FG001|Overall Study|Adverse Event|1|||
27558813|NCT03303079|80233112|FG002|Overall Study|Adverse Event|3|||
27558814|NCT03303079|80233110|FG000|Overall Study|Protocol Violation|5|||
27558815|NCT03303079|80233111|FG001|Overall Study|Protocol Violation|4|||
27558816|NCT03303079|80233112|FG002|Overall Study|Protocol Violation|7|||
27558817|NCT03303079|80233110|FG000|Overall Study|Withdrawal by Subject|2|||
27558818|NCT03303079|80233111|FG001|Overall Study|Withdrawal by Subject|4|||
27558819|NCT03303079|80233112|FG002|Overall Study|Withdrawal by Subject|2|||
27558820|NCT03303079|80233110|FG000|Overall Study|Other than specified|0|||
27558821|NCT03303079|80233111|FG001|Overall Study|Other than specified|2|||
27884432|NCT01222520|81411831|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
27884433|NCT01222520|81411830|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
27884434|NCT01222520|81411831|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
27884435|NCT01222520|81411830|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
27884436|NCT01222520|81411831|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
27884437|NCT01222520|81411830|FG000|Double-blind Period|Adverse Event|0|||
27884438|NCT01222520|81411831|FG001|Double-blind Period|Adverse Event|1|||
27884439|NCT01222520|81411830|FG000|Double-blind Period|Lack of Efficacy|0|||
27884440|NCT01222520|81411831|FG001|Double-blind Period|Lack of Efficacy|1|||
27884441|NCT01222520|81411830|FG000|Double-blind Period|Study medication stolen|1|||
27884442|NCT01222520|81411831|FG001|Double-blind Period|Study medication stolen|0|||
27558822|NCT03303079|80233112|FG002|Overall Study|Other than specified|0|||
27829216|NCT02576938|81205956|FG002|Overall Study|Adverse Event|6|||
27829217|NCT02576938|81205954|FG000|Overall Study|Protocol Violation|1|||
27829218|NCT02576938|81205955|FG001|Overall Study|Protocol Violation|1|||
27829219|NCT02576938|81205956|FG002|Overall Study|Protocol Violation|1|||
27829220|NCT02576938|81205954|FG000|Overall Study|Withdrawal by Subject|3|||
27829221|NCT02576938|81205955|FG001|Overall Study|Withdrawal by Subject|2|||
27829222|NCT02576938|81205956|FG002|Overall Study|Withdrawal by Subject|4|||
27829223|NCT02576938|81205954|FG000|Overall Study|Lack of Efficacy|9|||
27884443|NCT00596817|81411833|FG000|Open-label Period|Adverse Event|0|||
27884444|NCT00596817|81411834|FG001|Open-label Period|Adverse Event|49|||
27884445|NCT00596817|81411833|FG000|Open-label Period|Lack of Efficacy|0|||
27558823|NCT03518073|80233123|FG000|Overall Study|Adverse Event|2|||
27884446|NCT00596817|81411834|FG001|Open-label Period|Lack of Efficacy|33|||
27558824|NCT03518073|80233124|FG001|Overall Study|Adverse Event|4|||
27829224|NCT02576938|81205955|FG001|Overall Study|Lack of Efficacy|4|||
27829225|NCT02576938|81205956|FG002|Overall Study|Lack of Efficacy|0|||
27829226|NCT02576938|81205954|FG000|Overall Study|Lost to Follow-up|2|||
27884447|NCT00596817|81411833|FG000|Open-label Period|Other Reasons|0|||
27884448|NCT00596817|81411834|FG001|Open-label Period|Other Reasons|65|||
27829227|NCT02576938|81205955|FG001|Overall Study|Lost to Follow-up|0|||
27829228|NCT02576938|81205956|FG002|Overall Study|Lost to Follow-up|1|||
27829229|NCT02576938|81205954|FG000|Overall Study|Physician Decision|0|||
27829230|NCT02576938|81205955|FG001|Overall Study|Physician Decision|1|||
27829231|NCT02576938|81205956|FG002|Overall Study|Physician Decision|0|||
27829232|NCT02576938|81205954|FG000|Overall Study|Met Exclusion Criteria|0|||
27829233|NCT02576938|81205955|FG001|Overall Study|Met Exclusion Criteria|1|||
27829234|NCT02576938|81205956|FG002|Overall Study|Met Exclusion Criteria|0|||
27829235|NCT04238754|81205957|FG000|Washout - 1 Week|Lost to Follow-up|1|||
27829236|NCT04238754|81205958|FG001|Washout - 1 Week|Lost to Follow-up|0|||
27829237|NCT00835666|81205959|FG000|Washout|Protocol Violation|1|||
27829238|NCT00835666|81205960|FG001|Washout|Protocol Violation|0|||
27829239|NCT00835666|81205959|FG000|Washout|Withdrawal by Subject|1|||
27829240|NCT00835666|81205960|FG001|Washout|Withdrawal by Subject|0|||
27829241|NCT02558491|81205966|FG000|First Invention|Withdrawal by Subject|3|||
27829242|NCT02558491|81205967|FG001|First Invention|Withdrawal by Subject|1|||
27829243|NCT02558491|81205966|FG000|First Invention|Data collection issues|1|||
27829244|NCT02558491|81205967|FG001|First Invention|Data collection issues|0|||
27829245|NCT02558491|81205966|FG000|First Invention|Stopping criteria|0|||
27829246|NCT02558491|81205967|FG001|First Invention|Stopping criteria|1|||
27829247|NCT02558491|81205966|FG000|First Invention|Changed parameters during trial|1|||
27829248|NCT02558491|81205967|FG001|First Invention|Changed parameters during trial|0|||
27829249|NCT02558491|81205966|FG000|Second Intervention|Withdrawal by Subject|1|||
27829250|NCT02558491|81205967|FG001|Second Intervention|Withdrawal by Subject|0|||
27829251|NCT02558491|81205966|FG000|Second Intervention|Stopping Criteria|1|||
27829252|NCT02558491|81205967|FG001|Second Intervention|Stopping Criteria|0|||
27829253|NCT03873272|81205970|FG000|Overall Study|Withdrawal by Subject|2|||
27829254|NCT03873272|81205971|FG001|Overall Study|Withdrawal by Subject|0|||
27829255|NCT03873272|81205972|FG002|Overall Study|Withdrawal by Subject|1|||
27829256|NCT03873272|81205970|FG000|Overall Study|Death|0|||
27829257|NCT03873272|81205971|FG001|Overall Study|Death|2|||
27829258|NCT03873272|81205972|FG002|Overall Study|Death|1|||
27829259|NCT00829452|81205977|FG000|First Intervention|Withdrawal by Subject|0|||
27829260|NCT00829452|81205978|FG001|First Intervention|Withdrawal by Subject|1|||
27829261|NCT00829452|81205977|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
27829262|NCT00829452|81205978|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
27829263|NCT00829452|81205977|FG000|Second Intervention|Physician Decision|0|||
27829264|NCT00829452|81205978|FG001|Second Intervention|Physician Decision|1|||
27829265|NCT03158727|81205979|FG000|Overall Study|Withdrawal by Subject|2|||
27829266|NCT03158727|81205980|FG001|Overall Study|Withdrawal by Subject|6|||
27829267|NCT03158727|81205979|FG000|Overall Study|Death|11|||
27829268|NCT03158727|81205980|FG001|Overall Study|Death|12|||
27829269|NCT03158727|81205979|FG000|Overall Study|Lost to Follow-up|1|||
27829270|NCT03158727|81205980|FG001|Overall Study|Lost to Follow-up|0|||
27829271|NCT03158727|81205979|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
27698136|NCT01603082|80732756|FG001|Overall Study|Adverse Event|1|||
27829272|NCT03158727|81205980|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
27829273|NCT03158727|81205979|FG000|Overall Study|Visit 11 not done by mistake|0|||
27829274|NCT03158727|81205980|FG001|Overall Study|Visit 11 not done by mistake|1|||
27829275|NCT03158727|81205979|FG000|Overall Study|Enrolled, not treated|1|||
27829276|NCT03158727|81205980|FG001|Overall Study|Enrolled, not treated|0|||
27829277|NCT00840632|81205984|FG000|First Intervention|Withdrawal by Subject|0|||
27829278|NCT00840632|81205985|FG001|First Intervention|Withdrawal by Subject|1|||
27829279|NCT00840632|81205984|FG000|Washout|Withdrawal by Subject|1|||
27829280|NCT00840632|81205985|FG001|Washout|Withdrawal by Subject|1|||
27829281|NCT01527006|81205987|FG000|Core Study|Adverse Event|0|||
27829282|NCT01527006|81205988|FG001|Core Study|Adverse Event|2|||
27829283|NCT01527006|81205987|FG000|Core Study|Lost to Follow-up|0|||
27829284|NCT01527006|81205988|FG001|Core Study|Lost to Follow-up|1|||
27558825|NCT03518073|80233125|FG002|Overall Study|Adverse Event|2|||
27829285|NCT01527006|81205987|FG000|Core Study|Subject Choice|1|||
27558826|NCT03518073|80233123|FG000|Overall Study|Death|2|||
27558827|NCT03518073|80233124|FG001|Overall Study|Death|1|||
27558828|NCT03518073|80233125|FG002|Overall Study|Death|3|||
27829286|NCT01527006|81205988|FG001|Core Study|Subject Choice|0|||
27829287|NCT01527006|81205987|FG000|Core Study|Inadequate Therapeutic Effect|1|||
27558829|NCT03518073|80233123|FG000|Overall Study|Lost to Follow-up|1|||
27829288|NCT01527006|81205988|FG001|Core Study|Inadequate Therapeutic Effect|0|||
27829289|NCT01527006|81205987|FG000|Core Study|Withdrawal by Subject|0|||
27829290|NCT01527006|81205988|FG001|Core Study|Withdrawal by Subject|1|||
27829291|NCT01527006|81205987|FG000|Core Study|Other|0|||
27829292|NCT01527006|81205988|FG001|Core Study|Other|2|||
27829293|NCT01527006|81205987|FG000|Extension Phase|Adverse Event|4|||
27829294|NCT01527006|81205988|FG001|Extension Phase|Adverse Event|2|||
27829295|NCT01527006|81205987|FG000|Extension Phase|Lost to Follow-up|0|||
27829296|NCT01527006|81205988|FG001|Extension Phase|Lost to Follow-up|1|||
27829297|NCT01527006|81205987|FG000|Extension Phase|Subject Choice|1|||
27829298|NCT01527006|81205988|FG001|Extension Phase|Subject Choice|1|||
27829299|NCT01527006|81205987|FG000|Extension Phase|Inadequate therapeutic effect|1|||
27829300|NCT01527006|81205988|FG001|Extension Phase|Inadequate therapeutic effect|1|||
27829301|NCT01527006|81205987|FG000|Extension Phase|Other|0|||
27829302|NCT01527006|81205988|FG001|Extension Phase|Other|3|||
27829303|NCT02588339|81205989|FG000|Overall Study|Withdrawal by Subject|1|||
27829304|NCT02588339|81205989|FG000|Overall Study|GVHD Progression prior to treatment|2|||
27829305|NCT03769896|81205990|FG000|Open-label Phase|Lack of Efficacy|5|||
27884449|NCT00596817|81411833|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
27884450|NCT00596817|81411834|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
27829306|NCT03769896|81205991|FG001|Open-label Phase|Lack of Efficacy|0|||
27829307|NCT03769896|81205990|FG000|Open-label Phase|Adverse Event|3|||
27698137|NCT01603082|80732755|FG000|Overall Study|Withdrawal by Subject|1|||
27829308|NCT03769896|81205991|FG001|Open-label Phase|Adverse Event|0|||
27829309|NCT03769896|81205990|FG000|Open-label Phase|Withdrawal by Subject|1|||
27829310|NCT03769896|81205991|FG001|Open-label Phase|Withdrawal by Subject|0|||
27829311|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
27829312|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
27829313|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
27829314|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
27829315|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
27829316|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
27829317|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
27829318|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
27829319|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
27558830|NCT03518073|80233124|FG001|Overall Study|Lost to Follow-up|0|||
27558831|NCT03518073|80233125|FG002|Overall Study|Lost to Follow-up|1|||
27558832|NCT03518073|80233123|FG000|Overall Study|Physician Decision|5|||
27558833|NCT03518073|80233124|FG001|Overall Study|Physician Decision|0|||
27558834|NCT03518073|80233125|FG002|Overall Study|Physician Decision|2|||
27558835|NCT03518073|80233123|FG000|Overall Study|Progressive disease|1|||
27558836|NCT03518073|80233124|FG001|Overall Study|Progressive disease|1|||
27558837|NCT03518073|80233125|FG002|Overall Study|Progressive disease|1|||
27558838|NCT03518073|80233123|FG000|Overall Study|Protocol Violation|1|||
27558839|NCT03518073|80233124|FG001|Overall Study|Protocol Violation|0|||
27558840|NCT03518073|80233125|FG002|Overall Study|Protocol Violation|0|||
27558841|NCT03518073|80233123|FG000|Overall Study|Withdrawal by Subject|30|||
27698138|NCT01603082|80732756|FG001|Overall Study|Withdrawal by Subject|0|||
27698139|NCT01603082|80732755|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
27558842|NCT03518073|80233124|FG001|Overall Study|Withdrawal by Subject|34|||
27558843|NCT03518073|80233125|FG002|Overall Study|Withdrawal by Subject|29|||
27558844|NCT03518073|80233123|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
27698140|NCT01603082|80732756|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
27698141|NCT00162032|80732757|FG000|Overall Study|Lost to Follow-up|4|||
27698142|NCT00162032|80732758|FG001|Overall Study|Lost to Follow-up|2|||
27698143|NCT00162032|80732757|FG000|Overall Study|Reason not specified|1|||
27698144|NCT00162032|80732758|FG001|Overall Study|Reason not specified|0|||
27698145|NCT00728481|80732759|FG000|Overall Study|Withdrawal by Subject|0|||
27698146|NCT00728481|80732760|FG001|Overall Study|Withdrawal by Subject|1|||
27698147|NCT00728481|80732759|FG000|Overall Study|Adverse Event|0|||
27698148|NCT00728481|80732760|FG001|Overall Study|Adverse Event|1|||
27698149|NCT00728481|80732759|FG000|Overall Study|Study medication non-compliance|0|||
27698150|NCT00728481|80732760|FG001|Overall Study|Study medication non-compliance|2|||
27698151|NCT00728481|80732759|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
27698152|NCT00728481|80732760|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
27698153|NCT01211197|80732761|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27698154|NCT01211197|80732762|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27698155|NCT01211197|80732763|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27698156|NCT01211197|80732764|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27698157|NCT01211197|80732765|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27698158|NCT01211197|80732766|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27698159|NCT01211197|80732761|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
27698160|NCT01211197|80732762|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
27698161|NCT01211197|80732763|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
27698162|NCT01211197|80732764|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
27698163|NCT01211197|80732765|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
27698164|NCT01211197|80732766|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
27558845|NCT03518073|80233124|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
27558846|NCT03518073|80233125|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
27558847|NCT03518073|80233123|FG000|Overall Study|Covid-19|1|||
27558848|NCT03518073|80233124|FG001|Overall Study|Covid-19|2|||
27698165|NCT01128738|80732767|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
27698166|NCT01128738|80732768|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
27698167|NCT01128738|80732767|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
27698168|NCT01128738|80732768|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
27698169|NCT01128738|80732767|FG000|Second TP|Lost to Follow-up|0|||
27698170|NCT01128738|80732768|FG001|Second TP|Lost to Follow-up|1|||
27698171|NCT01128738|80732767|FG000|Second TP|Withdrawal by Subject|0|||
27698172|NCT01128738|80732768|FG001|Second TP|Withdrawal by Subject|2|||
27698173|NCT01933113|80732769|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
27698174|NCT00760669|80732776|FG000|Overall Study|Not assessed for overall improvement|18|||
27698175|NCT00760669|80732776|FG000|Overall Study|Participants missing efficacy assessment|6|||
27698176|NCT00760669|80732776|FG000|Overall Study|Participants with overlapping cases|1|||
27698177|NCT00760669|80732776|FG000|Overall Study|Took drug before entering in contract|5|||
27698178|NCT02225353|80732777|FG000|Overall Study|Lost to Follow-up|0|||
27698179|NCT02225353|80732778|FG001|Overall Study|Lost to Follow-up|1|||
27698180|NCT02225353|80732779|FG002|Overall Study|Lost to Follow-up|3|||
27698181|NCT02225353|80732777|FG000|Overall Study|Protocol Violation|4|||
27698182|NCT02225353|80732778|FG001|Overall Study|Protocol Violation|5|||
27698183|NCT02225353|80732779|FG002|Overall Study|Protocol Violation|12|||
27698184|NCT04201821|80732783|FG000|Overall Study|Withdrawal by Subject|2|||
27698185|NCT05266586|80732788|FG000|Overall Study|Adverse Event|2|||
27698186|NCT05266586|80732789|FG001|Overall Study|Adverse Event|2|||
27698187|NCT05266586|80732790|FG002|Overall Study|Adverse Event|1|||
27698188|NCT05266586|80732788|FG000|Overall Study|Withdrawal by Subject|1|||
27698189|NCT05266586|80732789|FG001|Overall Study|Withdrawal by Subject|0|||
27698190|NCT05266586|80732790|FG002|Overall Study|Withdrawal by Subject|1|||
27698191|NCT05266586|80732788|FG000|Overall Study|Non-compliance with study drug|0|||
27698192|NCT05266586|80732789|FG001|Overall Study|Non-compliance with study drug|1|||
27698193|NCT05266586|80732790|FG002|Overall Study|Non-compliance with study drug|0|||
27698194|NCT05266586|80732788|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
27698195|NCT05266586|80732789|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
27698196|NCT05266586|80732790|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
27698197|NCT05211739|80732791|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
27698198|NCT05211739|80732792|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
27698199|NCT05211739|80732791|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
27698200|NCT05211739|80732792|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
27698201|NCT05211739|80732791|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
27698202|NCT05211739|80732792|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
27698203|NCT05211739|80732791|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
27558849|NCT03518073|80233125|FG002|Overall Study|Covid-19|1|||
27558850|NCT04577118|80233126|FG000|Overall Study|Withdrawal by Subject|4|||
27698204|NCT05211739|80732792|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
27698205|NCT00567268|80732793|FG000|Overall Study|Protocol Violation|7|||
27698206|NCT00567268|80732793|FG000|Overall Study|Lost to Follow-up|36|||
27698207|NCT00567268|80732793|FG000|Overall Study|No Visit After First Day of Treatment|2|||
27698208|NCT00567268|80732793|FG000|Overall Study|No Drug Administration|4|||
27698209|NCT00567268|80732793|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
27698210|NCT01488487|80732796|FG000|Overall Study|Adverse Event|6|||
27698211|NCT01488487|80732796|FG000|Overall Study|Death|1|||
27698212|NCT01488487|80732796|FG000|Overall Study|Withdrawal by Subject|2|||
27698213|NCT01791803|80732798|FG000|Overall Study|Withdrawal by Subject|0|||
27698214|NCT01791803|80732799|FG001|Overall Study|Withdrawal by Subject|0|||
27698215|NCT01791803|80732800|FG002|Overall Study|Withdrawal by Subject|0|||
27698216|NCT01791803|80732801|FG003|Overall Study|Withdrawal by Subject|2|||
27698217|NCT01791803|80732798|FG000|Overall Study|Physician Decision|0|||
27698218|NCT01791803|80732799|FG001|Overall Study|Physician Decision|2|||
27698219|NCT01791803|80732800|FG002|Overall Study|Physician Decision|0|||
27698220|NCT01791803|80732801|FG003|Overall Study|Physician Decision|1|||
27698221|NCT01791803|80732798|FG000|Overall Study|Death|0|||
27698222|NCT01791803|80732799|FG001|Overall Study|Death|0|||
27698223|NCT01791803|80732800|FG002|Overall Study|Death|2|||
27698224|NCT01791803|80732801|FG003|Overall Study|Death|2|||
27698225|NCT00803270|80732802|FG000|Overall Study|Lost to Follow-up|1|||
27698226|NCT00803270|80732803|FG001|Overall Study|Lost to Follow-up|2|||
27698227|NCT00294554|80732804|FG000|Overall Study|Lack of Efficacy|0|||
27698228|NCT00294554|80732805|FG001|Overall Study|Lack of Efficacy|1|||
27698229|NCT00294554|80732804|FG000|Overall Study|Physician Decision|0|||
27698230|NCT00294554|80732805|FG001|Overall Study|Physician Decision|1|||
27698231|NCT01448213|80732806|FG000|Overall Study|Lost to Follow-up|12|||
27698232|NCT01448213|80732807|FG001|Overall Study|Lost to Follow-up|10|||
27698233|NCT01448213|80732806|FG000|Overall Study|Adverse Event|4|||
27698234|NCT01448213|80732807|FG001|Overall Study|Adverse Event|10|||
27698235|NCT01448213|80732806|FG000|Overall Study|Protocol Violation|1|||
27698236|NCT01448213|80732807|FG001|Overall Study|Protocol Violation|2|||
27698237|NCT01176773|80732808|FG000|Overall Study|Screen Failure|2|||
27698238|NCT01176773|80732808|FG000|Overall Study|Withdrew consent|1|||
27698239|NCT01723774|80732811|FG000|Neoadjuvant|Ki67 > 10%|4|||
27698240|NCT01723774|80732812|FG001|Neoadjuvant|Ki67 > 10%|0|||
27698241|NCT01723774|80732813|FG002|Neoadjuvant|Ki67 > 10%|10|||
27698242|NCT01723774|80732814|FG003|Neoadjuvant|Ki67 > 10%|0|||
27698243|NCT01723774|80732811|FG000|Neoadjuvant|Withdrawal by Subject|3|||
27698244|NCT01723774|80732812|FG001|Neoadjuvant|Withdrawal by Subject|1|||
27698245|NCT01723774|80732813|FG002|Neoadjuvant|Withdrawal by Subject|0|||
27698246|NCT01723774|80732814|FG003|Neoadjuvant|Withdrawal by Subject|0|||
27698247|NCT01723774|80732811|FG000|Neoadjuvant|Disease progression|0|||
27698248|NCT01723774|80732812|FG001|Neoadjuvant|Disease progression|1|||
27698249|NCT01723774|80732813|FG002|Neoadjuvant|Disease progression|1|||
27698250|NCT01723774|80732814|FG003|Neoadjuvant|Disease progression|0|||
27698251|NCT01723774|80732811|FG000|Neoadjuvant|Adverse Event|0|||
27698252|NCT01723774|80732812|FG001|Neoadjuvant|Adverse Event|1|||
27698253|NCT01723774|80732813|FG002|Neoadjuvant|Adverse Event|2|||
27558851|NCT02393547|80233127|FG000|Overall Study|Adverse Event|2|||
27698254|NCT01723774|80732814|FG003|Neoadjuvant|Adverse Event|0|||
27829320|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
27829321|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
27558852|NCT02393547|80233127|FG000|Overall Study|Withdrawal by Subject|3|||
27698255|NCT01723774|80732811|FG000|Neoadjuvant|High estradiol|0|||
27698256|NCT01723774|80732812|FG001|Neoadjuvant|High estradiol|1|||
27698257|NCT01723774|80732813|FG002|Neoadjuvant|High estradiol|0|||
27698258|NCT01723774|80732814|FG003|Neoadjuvant|High estradiol|0|||
27698259|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
27698260|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
27698261|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
27698262|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
27698263|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
27698264|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
27698265|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
27698266|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
27698267|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
27698268|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
27698269|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
27698270|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
27698271|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
27698272|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
27698273|NCT01294683|80732815|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
27698274|NCT01294683|80732816|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
27698275|NCT01294683|80732815|FG000|Post Crossover (Period III)|Adverse Event|6|||
27698276|NCT01294683|80732816|FG001|Post Crossover (Period III)|Adverse Event|6|||
27698277|NCT01294683|80732815|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
27698278|NCT01294683|80732816|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
27698279|NCT01294683|80732815|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
27698280|NCT01294683|80732816|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
27698281|NCT01294683|80732815|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
27698282|NCT01294683|80732816|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
27698283|NCT01862640|80732819|FG000|Overall Study|Adverse Event|4|||
27698284|NCT01862640|80732820|FG001|Overall Study|Adverse Event|10|||
27698285|NCT01862640|80732821|FG002|Overall Study|Adverse Event|6|||
27698286|NCT01862640|80732822|FG003|Overall Study|Adverse Event|8|||
27698287|NCT01862640|80732819|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27829322|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
27829323|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
27829324|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
27829325|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
27829326|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
27829327|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
27829328|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
27829329|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
27829330|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
27829331|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
27829332|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
27829333|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
27829334|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
27829335|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
27829336|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
27698288|NCT01862640|80732820|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
27698289|NCT01862640|80732821|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
27829337|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
27829338|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
27829339|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
27829340|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
27829341|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
27829342|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
27829343|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
27829344|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
27698290|NCT01862640|80732822|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
27698291|NCT01862640|80732819|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
27698292|NCT01862640|80732820|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
27698293|NCT01862640|80732821|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
27698294|NCT01862640|80732822|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
27698295|NCT01862640|80732819|FG000|Overall Study|Withdrawal by Subject|2|||
27829345|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
27698296|NCT01862640|80732820|FG001|Overall Study|Withdrawal by Subject|4|||
27698297|NCT01862640|80732821|FG002|Overall Study|Withdrawal by Subject|8|||
27829346|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
27829347|NCT04194801|81205997|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
27829348|NCT04194801|81205998|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
27829349|NCT04194801|81205999|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
27829350|NCT04194801|81205997|FG000|Part Ib/II End of Study|Death|2|||
27829351|NCT04194801|81205998|FG001|Part Ib/II End of Study|Death|3|||
27829352|NCT04194801|81205999|FG002|Part Ib/II End of Study|Death|3|||
27829353|NCT04194801|81205997|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
27829354|NCT04194801|81205998|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
27829355|NCT04194801|81205999|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
27829356|NCT04194801|81205997|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
27829357|NCT04194801|81205998|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
27829358|NCT04194801|81205999|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
27829359|NCT04194801|81205997|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
27829360|NCT04194801|81205998|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
27829361|NCT04194801|81205999|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
27829362|NCT04194801|81205997|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
27829363|NCT04194801|81205998|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
27829364|NCT04194801|81205999|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
27698298|NCT01862640|80732822|FG003|Overall Study|Withdrawal by Subject|5|||
27698299|NCT01862640|80732819|FG000|Overall Study|Protocol Deviation|0|||
27698300|NCT01862640|80732820|FG001|Overall Study|Protocol Deviation|0|||
27698301|NCT01862640|80732821|FG002|Overall Study|Protocol Deviation|1|||
27829365|NCT02311361|81206004|FG000|Overall Study|Did not receive treatment|0|||
27829366|NCT02311361|81206005|FG001|Overall Study|Did not receive treatment|1|||
27829367|NCT02311361|81206006|FG002|Overall Study|Did not receive treatment|0|||
27829368|NCT02311361|81206007|FG003|Overall Study|Did not receive treatment|1|||
27829369|NCT04551066|81206009|FG000|Overall Study|Death|5|||
27829370|NCT04551066|81206010|FG001|Overall Study|Death|3|||
27829371|NCT04551066|81206009|FG000|Overall Study|Lost to Follow-up|1|||
27829372|NCT04551066|81206010|FG001|Overall Study|Lost to Follow-up|0|||
27884451|NCT00596817|81411833|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
27884452|NCT00596817|81411834|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
27884453|NCT00596817|81411833|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
27884454|NCT00596817|81411834|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
27884455|NCT00596817|81411833|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
27884456|NCT00596817|81411834|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
27884457|NCT00596817|81411833|FG000|Double-blind Period|Adverse Event|5|||
27884458|NCT00596817|81411834|FG001|Double-blind Period|Adverse Event|16|||
27884459|NCT00596817|81411833|FG000|Double-blind Period|Lack of Efficacy|52|||
27884460|NCT00596817|81411834|FG001|Double-blind Period|Lack of Efficacy|28|||
27884461|NCT00596817|81411833|FG000|Double-blind Period|Non-compliance With Study Product|3|||
27884462|NCT00596817|81411834|FG001|Double-blind Period|Non-compliance With Study Product|4|||
27884463|NCT00596817|81411833|FG000|Double-blind Period|Protocol Violation|11|||
27884464|NCT00596817|81411834|FG001|Double-blind Period|Protocol Violation|8|||
27884465|NCT00596817|81411833|FG000|Double-blind Period|Withdrawal of Consent|7|||
27884466|NCT00596817|81411834|FG001|Double-blind Period|Withdrawal of Consent|3|||
27884467|NCT00596817|81411833|FG000|Double-blind Period|Lost to Follow-up|0|||
27884468|NCT00596817|81411834|FG001|Double-blind Period|Lost to Follow-up|2|||
27884469|NCT00596817|81411833|FG000|Double-blind Period|Other Reasons|10|||
27884470|NCT00596817|81411834|FG001|Double-blind Period|Other Reasons|18|||
27884471|NCT00665431|81411835|FG000|Overall Study|Adverse Event|16|||
27884472|NCT00665431|81411836|FG001|Overall Study|Adverse Event|22|||
27884473|NCT00665431|81411837|FG002|Overall Study|Adverse Event|6|||
27884474|NCT00665431|81411835|FG000|Overall Study|Withdrawal by Subject|17|||
27884475|NCT00665431|81411836|FG001|Overall Study|Withdrawal by Subject|25|||
27884476|NCT00665431|81411837|FG002|Overall Study|Withdrawal by Subject|15|||
27884477|NCT00665431|81411835|FG000|Overall Study|Lost to Follow-up|3|||
27884478|NCT00665431|81411836|FG001|Overall Study|Lost to Follow-up|3|||
27884479|NCT00665431|81411837|FG002|Overall Study|Lost to Follow-up|1|||
27884480|NCT00665431|81411835|FG000|Overall Study|Other|4|||
27884481|NCT00665431|81411836|FG001|Overall Study|Other|7|||
27884482|NCT00665431|81411837|FG002|Overall Study|Other|2|||
27884483|NCT00977080|81411849|FG000|Overall Study|Adverse Event|2|||
27884484|NCT00977080|81411850|FG001|Overall Study|Adverse Event|7|||
27829373|NCT04551066|81206009|FG000|Overall Study|Sponsor Decision|103|||
27829374|NCT04551066|81206010|FG001|Overall Study|Sponsor Decision|117|||
27829375|NCT04551066|81206009|FG000|Overall Study|Withdrawal by Subject|8|||
27829376|NCT04551066|81206010|FG001|Overall Study|Withdrawal by Subject|2|||
27884485|NCT00977080|81411851|FG002|Overall Study|Adverse Event|7|||
27884486|NCT00977080|81411852|FG003|Overall Study|Adverse Event|7|||
27884487|NCT00977080|81411849|FG000|Overall Study|Withdrawal by Subject|1|||
27884488|NCT00977080|81411850|FG001|Overall Study|Withdrawal by Subject|5|||
27884489|NCT00977080|81411851|FG002|Overall Study|Withdrawal by Subject|1|||
27884490|NCT00977080|81411852|FG003|Overall Study|Withdrawal by Subject|5|||
27829377|NCT04551066|81206009|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
27884491|NCT00977080|81411849|FG000|Overall Study|Protocol Violation|7|||
27884492|NCT00977080|81411850|FG001|Overall Study|Protocol Violation|3|||
27884493|NCT00977080|81411851|FG002|Overall Study|Protocol Violation|4|||
27884494|NCT00977080|81411852|FG003|Overall Study|Protocol Violation|3|||
27884495|NCT00977080|81411849|FG000|Overall Study|Noncompliance|0|||
27884496|NCT00977080|81411850|FG001|Overall Study|Noncompliance|2|||
27884497|NCT00977080|81411851|FG002|Overall Study|Noncompliance|1|||
27884498|NCT00977080|81411852|FG003|Overall Study|Noncompliance|0|||
27884499|NCT00977080|81411849|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
27884500|NCT00977080|81411850|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
27884501|NCT00977080|81411851|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
27884502|NCT00977080|81411852|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
27884503|NCT00977080|81411849|FG000|Overall Study|Required kidney transplantation|1|||
27884504|NCT00977080|81411850|FG001|Overall Study|Required kidney transplantation|3|||
27884505|NCT00977080|81411851|FG002|Overall Study|Required kidney transplantation|3|||
27884506|NCT00977080|81411852|FG003|Overall Study|Required kidney transplantation|1|||
27884507|NCT00977080|81411849|FG000|Overall Study|Travel for family reasons|1|||
27884508|NCT00977080|81411850|FG001|Overall Study|Travel for family reasons|0|||
27884509|NCT00977080|81411851|FG002|Overall Study|Travel for family reasons|0|||
27884510|NCT00977080|81411852|FG003|Overall Study|Travel for family reasons|0|||
27829378|NCT04551066|81206010|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
27829379|NCT04551066|81206009|FG000|Overall Study|Adverse Event|2|||
27884511|NCT02142959|81411855|FG000|Overall Study|Adverse Event|1|||
27884512|NCT02142959|81411856|FG001|Overall Study|Adverse Event|0|||
27884513|NCT02142959|81411857|FG002|Overall Study|Adverse Event|0|||
27884514|NCT02142959|81411855|FG000|Overall Study|Death|0|||
27884515|NCT02142959|81411856|FG001|Overall Study|Death|1|||
27884516|NCT02142959|81411857|FG002|Overall Study|Death|0|||
27884517|NCT02142959|81411855|FG000|Overall Study|Withdrawal by Subject|3|||
27884518|NCT02142959|81411856|FG001|Overall Study|Withdrawal by Subject|1|||
27884519|NCT02142959|81411857|FG002|Overall Study|Withdrawal by Subject|3|||
27884520|NCT02142959|81411855|FG000|Overall Study|Administrative Reasons|1|||
27829380|NCT04551066|81206010|FG001|Overall Study|Adverse Event|0|||
27829381|NCT04551066|81206009|FG000|Overall Study|Physician Decision|2|||
27829382|NCT04551066|81206010|FG001|Overall Study|Physician Decision|0|||
27829383|NCT04551066|81206009|FG000|Overall Study|Protocol Violation|1|||
27829384|NCT04551066|81206010|FG001|Overall Study|Protocol Violation|0|||
27829385|NCT04551066|81206009|FG000|Overall Study|Lack of Efficacy|0|||
27884521|NCT02142959|81411856|FG001|Overall Study|Administrative Reasons|0|||
27884522|NCT02142959|81411857|FG002|Overall Study|Administrative Reasons|1|||
27884523|NCT02142959|81411855|FG000|Overall Study|Missing|0|||
27884524|NCT02142959|81411856|FG001|Overall Study|Missing|1|||
27884525|NCT02142959|81411857|FG002|Overall Study|Missing|0|||
27829386|NCT04551066|81206010|FG001|Overall Study|Lack of Efficacy|1|||
27829387|NCT04551066|81206009|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
27829388|NCT04551066|81206010|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
27884526|NCT02142959|81411855|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
27884527|NCT02142959|81411856|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
27884528|NCT02142959|81411857|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
27884529|NCT02142959|81411855|FG000|Overall Study|Patient didn't complete end of study visit|0|||
27884530|NCT02142959|81411856|FG001|Overall Study|Patient didn't complete end of study visit|0|||
27829389|NCT06195579|81206011|FG000|Overall Study|Withdrawal by Subject|1|||
27558853|NCT02393547|80233127|FG000|Overall Study|Lost to Follow-up|1|||
27558854|NCT02140567|80233128|FG000|Overall Study|Problems with recording equipment|6|||
27829390|NCT02554877|81206012|FG000|Overall Study|Adverse Event|2|||
27829391|NCT02554877|81206013|FG001|Overall Study|Adverse Event|0|||
27829392|NCT02554877|81206014|FG002|Overall Study|Adverse Event|0|||
27829393|NCT02554877|81206015|FG003|Overall Study|Adverse Event|1|||
27829394|NCT02554877|81206012|FG000|Overall Study|Lost to Follow-up|1|||
27829395|NCT02554877|81206013|FG001|Overall Study|Lost to Follow-up|1|||
27829396|NCT02554877|81206014|FG002|Overall Study|Lost to Follow-up|1|||
27829397|NCT02554877|81206015|FG003|Overall Study|Lost to Follow-up|2|||
27829398|NCT02554877|81206012|FG000|Overall Study|Did not meet entrance criteria|0|||
27829399|NCT02554877|81206013|FG001|Overall Study|Did not meet entrance criteria|0|||
27829400|NCT02554877|81206014|FG002|Overall Study|Did not meet entrance criteria|1|||
27829401|NCT02554877|81206015|FG003|Overall Study|Did not meet entrance criteria|0|||
27829402|NCT02554877|81206012|FG000|Overall Study|No longer met eligibility criteria|1|||
27829403|NCT02554877|81206013|FG001|Overall Study|No longer met eligibility criteria|0|||
27829404|NCT02554877|81206014|FG002|Overall Study|No longer met eligibility criteria|1|||
27829405|NCT02554877|81206015|FG003|Overall Study|No longer met eligibility criteria|1|||
27829406|NCT02554877|81206012|FG000|Overall Study|Protocol Violation|3|||
27829407|NCT02554877|81206013|FG001|Overall Study|Protocol Violation|1|||
27829408|NCT02554877|81206014|FG002|Overall Study|Protocol Violation|1|||
27829409|NCT02554877|81206015|FG003|Overall Study|Protocol Violation|0|||
27829410|NCT02554877|81206012|FG000|Overall Study|Other|1|||
27829411|NCT02554877|81206013|FG001|Overall Study|Other|3|||
27829412|NCT02554877|81206014|FG002|Overall Study|Other|0|||
27829413|NCT02554877|81206015|FG003|Overall Study|Other|3|||
27829414|NCT02554877|81206012|FG000|Overall Study|Insufficient clinical response|4|||
27829415|NCT02554877|81206013|FG001|Overall Study|Insufficient clinical response|0|||
27829416|NCT02554877|81206014|FG002|Overall Study|Insufficient clinical response|0|||
27829417|NCT02554877|81206015|FG003|Overall Study|Insufficient clinical response|0|||
27884531|NCT02142959|81411857|FG002|Overall Study|Patient didn't complete end of study visit|1|||
27884532|NCT01339923|81411870|FG000|Overall Study|Adverse Event|1|||
27884533|NCT01339923|81411871|FG001|Overall Study|Adverse Event|1|||
27829418|NCT02554877|81206012|FG000|Overall Study|No longer willing to participate|0|||
27829419|NCT02554877|81206013|FG001|Overall Study|No longer willing to participate|2|||
27829420|NCT02554877|81206014|FG002|Overall Study|No longer willing to participate|2|||
27829421|NCT02554877|81206015|FG003|Overall Study|No longer willing to participate|0|||
27558855|NCT01846611|80233129|FG000|Overall Study|Lost to Follow-up|4|||
27884534|NCT01339923|81411872|FG002|Overall Study|Adverse Event|1|||
27884535|NCT01339923|81411873|FG003|Overall Study|Adverse Event|0|||
27884536|NCT01339923|81411874|FG004|Overall Study|Adverse Event|0|||
27884537|NCT01339923|81411875|FG005|Overall Study|Adverse Event|0|||
27884538|NCT01339923|81411876|FG006|Overall Study|Adverse Event|1|||
27884539|NCT01339923|81411870|FG000|Overall Study|Inappropriate Enrollment|1|||
27884540|NCT01339923|81411871|FG001|Overall Study|Inappropriate Enrollment|0|||
27884541|NCT01339923|81411872|FG002|Overall Study|Inappropriate Enrollment|0|||
27884542|NCT01339923|81411873|FG003|Overall Study|Inappropriate Enrollment|0|||
27884543|NCT01339923|81411874|FG004|Overall Study|Inappropriate Enrollment|0|||
27884544|NCT01339923|81411875|FG005|Overall Study|Inappropriate Enrollment|1|||
27884545|NCT01339923|81411876|FG006|Overall Study|Inappropriate Enrollment|0|||
27884546|NCT01339923|81411870|FG000|Overall Study|Lost to Follow-up|4|||
27884547|NCT01339923|81411871|FG001|Overall Study|Lost to Follow-up|4|||
27884548|NCT01339923|81411872|FG002|Overall Study|Lost to Follow-up|0|||
27884549|NCT01339923|81411873|FG003|Overall Study|Lost to Follow-up|3|||
27884550|NCT01339923|81411874|FG004|Overall Study|Lost to Follow-up|1|||
27884551|NCT01339923|81411875|FG005|Overall Study|Lost to Follow-up|1|||
27884552|NCT01339923|81411876|FG006|Overall Study|Lost to Follow-up|5|||
27884553|NCT01339923|81411870|FG000|Overall Study|Protocol Violation|0|||
27884554|NCT01339923|81411871|FG001|Overall Study|Protocol Violation|0|||
27884555|NCT01339923|81411872|FG002|Overall Study|Protocol Violation|0|||
27884556|NCT01339923|81411873|FG003|Overall Study|Protocol Violation|0|||
27884557|NCT01339923|81411874|FG004|Overall Study|Protocol Violation|0|||
27884558|NCT01339923|81411875|FG005|Overall Study|Protocol Violation|3|||
27884559|NCT01339923|81411876|FG006|Overall Study|Protocol Violation|1|||
27884560|NCT01339923|81411870|FG000|Overall Study|Unable to Classify|1|||
27829422|NCT00835263|81206016|FG000|Second Intervention|Adverse Event|1|||
27829423|NCT00835263|81206017|FG001|Second Intervention|Adverse Event|0|||
27829424|NCT00455312|81206018|FG000|Overall Study|Death|0|||
27829425|NCT00455312|81206019|FG001|Overall Study|Death|1|||
27829426|NCT00840216|81206020|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27829427|NCT00840216|81206021|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27829428|NCT00840073|81206022|FG000|Second Intervention|Missed 72 hour blood draw|1|||
27829429|NCT00840073|81206023|FG001|Second Intervention|Missed 72 hour blood draw|1|||
27829430|NCT01020474|81206024|FG000|Overall Study|Adverse Event|4|||
27829431|NCT01020474|81206025|FG001|Overall Study|Adverse Event|4|||
27829432|NCT01020474|81206024|FG000|Overall Study|Protocol Violation|0|||
27829433|NCT01020474|81206025|FG001|Overall Study|Protocol Violation|2|||
27829434|NCT01020474|81206024|FG000|Overall Study|Withdrawal by Subject|5|||
27829435|NCT01020474|81206025|FG001|Overall Study|Withdrawal by Subject|7|||
27829436|NCT01020474|81206024|FG000|Overall Study|Other Reasons|1|||
27829437|NCT01020474|81206025|FG001|Overall Study|Other Reasons|1|||
27829438|NCT01020474|81206024|FG000|Overall Study|Insufficient Clinical Response|0|||
27829439|NCT01020474|81206025|FG001|Overall Study|Insufficient Clinical Response|3|||
27884561|NCT01339923|81411871|FG001|Overall Study|Unable to Classify|0|||
27884562|NCT01339923|81411872|FG002|Overall Study|Unable to Classify|1|||
27558856|NCT01846611|80233130|FG001|Overall Study|Lost to Follow-up|6|||
27829440|NCT00875524|81206030|FG000|Overall Study|Serious adverse event|0|||
27829441|NCT00875524|81206031|FG001|Overall Study|Serious adverse event|1|||
27884563|NCT01339923|81411873|FG003|Overall Study|Unable to Classify|0|||
27884564|NCT01339923|81411874|FG004|Overall Study|Unable to Classify|0|||
27884565|NCT01339923|81411875|FG005|Overall Study|Unable to Classify|1|||
27884566|NCT01339923|81411876|FG006|Overall Study|Unable to Classify|5|||
27829442|NCT00875524|81206030|FG000|Overall Study|Protocol Violation|4|||
27829443|NCT00875524|81206031|FG001|Overall Study|Protocol Violation|0|||
27829444|NCT00875524|81206030|FG000|Overall Study|Lost to Follow-up|1|||
27829445|NCT00875524|81206031|FG001|Overall Study|Lost to Follow-up|0|||
27829446|NCT00875524|81206030|FG000|Overall Study|Withdrawal by Subject|3|||
27829447|NCT00875524|81206031|FG001|Overall Study|Withdrawal by Subject|5|||
27829448|NCT00556322|81206034|FG000|Overall Study|Insufficient therapeutic response|158|||
27829449|NCT00556322|81206035|FG001|Overall Study|Insufficient therapeutic response|168|||
27829450|NCT00556322|81206034|FG000|Overall Study|Adverse Event|7|||
27884567|NCT01339923|81411870|FG000|Overall Study|Withdrawal by Subject|7|||
27884568|NCT01339923|81411871|FG001|Overall Study|Withdrawal by Subject|11|||
27884569|NCT01339923|81411872|FG002|Overall Study|Withdrawal by Subject|6|||
27884570|NCT01339923|81411873|FG003|Overall Study|Withdrawal by Subject|1|||
27884571|NCT01339923|81411874|FG004|Overall Study|Withdrawal by Subject|4|||
27884572|NCT01339923|81411875|FG005|Overall Study|Withdrawal by Subject|3|||
27884573|NCT01339923|81411876|FG006|Overall Study|Withdrawal by Subject|2|||
27884574|NCT03363776|81411877|FG000|Overall Study|Progressive disease|2|||
27884575|NCT03363776|81411878|FG001|Overall Study|Progressive disease|3|||
27884576|NCT03363776|81411879|FG002|Overall Study|Progressive disease|1|||
27884577|NCT03363776|81411877|FG000|Overall Study|Study drug toxicity|0|||
27884578|NCT03363776|81411878|FG001|Overall Study|Study drug toxicity|0|||
27884579|NCT03363776|81411879|FG002|Overall Study|Study drug toxicity|1|||
27884580|NCT03363776|81411877|FG000|Overall Study|Death|1|||
27884581|NCT03363776|81411878|FG001|Overall Study|Death|0|||
27884582|NCT03363776|81411879|FG002|Overall Study|Death|0|||
27884583|NCT03508726|81411880|FG000|Overall Study|Withdrawal by Subject|0|||
27884584|NCT03508726|81411881|FG001|Overall Study|Withdrawal by Subject|1|||
27884585|NCT01136356|81411883|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
27884586|NCT01136356|81411884|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
27884587|NCT01136356|81411883|FG000|First 18-day Withdrawal|Physician Decision|1|||
27884588|NCT01136356|81411884|FG001|First 18-day Withdrawal|Physician Decision|0|||
27884589|NCT01136356|81411883|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
27829451|NCT00556322|81206035|FG001|Overall Study|Adverse Event|4|||
27884590|NCT01136356|81411884|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
27829452|NCT00556322|81206034|FG000|Overall Study|Other|4|||
27829453|NCT00556322|81206035|FG001|Overall Study|Other|1|||
27884591|NCT04480424|81411885|FG000|Overall Study|Withdrawal by Subject|0|||
27829454|NCT00556322|81206034|FG000|Overall Study|Lost to Follow-up|5|||
27829455|NCT00556322|81206035|FG001|Overall Study|Lost to Follow-up|3|||
27829456|NCT00556322|81206034|FG000|Overall Study|Withdrawal by Subject|19|||
27829457|NCT00556322|81206035|FG001|Overall Study|Withdrawal by Subject|7|||
27829458|NCT00556322|81206034|FG000|Overall Study|Protocol Violation|5|||
27829459|NCT00556322|81206035|FG001|Overall Study|Protocol Violation|1|||
27829460|NCT00556322|81206034|FG000|Overall Study|Ongoing at data cutoff|3|||
27829461|NCT00556322|81206035|FG001|Overall Study|Ongoing at data cutoff|5|||
27829462|NCT00556322|81206034|FG000|Overall Study|Death|20|||
27829463|NCT00556322|81206035|FG001|Overall Study|Death|14|||
27829464|NCT00574847|81206037|FG000|Overall Study|Adverse Event|2|||
27829465|NCT00574847|81206038|FG001|Overall Study|Adverse Event|0|||
27829466|NCT00574847|81206037|FG000|Overall Study|Death|1|||
27829467|NCT00574847|81206038|FG001|Overall Study|Death|0|||
27829468|NCT00574847|81206037|FG000|Overall Study|Withdrawal by Subject|2|||
27829469|NCT00574847|81206038|FG001|Overall Study|Withdrawal by Subject|2|||
27829470|NCT00574847|81206037|FG000|Overall Study|Physician Decision|1|||
27829471|NCT00574847|81206038|FG001|Overall Study|Physician Decision|0|||
27829472|NCT00574847|81206037|FG000|Overall Study|Did not receive medication (declined)|2|||
27829473|NCT00574847|81206038|FG001|Overall Study|Did not receive medication (declined)|5|||
27829474|NCT00906399|81206039|FG000|Year 1|Randomized But Not Treated|0|||
27829475|NCT00906399|81206040|FG001|Year 1|Randomized But Not Treated|1|||
27829476|NCT00906399|81206041|FG002|Year 1|Randomized But Not Treated|3|||
27829477|NCT00906399|81206042|FG003|Year 1|Randomized But Not Treated|0|||
27829478|NCT00906399|81206043|FG004|Year 1|Randomized But Not Treated|0|||
27829479|NCT00906399|81206044|FG005|Year 1|Randomized But Not Treated|0|||
27829480|NCT00906399|81206045|FG006|Year 1|Randomized But Not Treated|0|||
27829481|NCT00906399|81206039|FG000|Year 1|Adverse Event|4|||
27829482|NCT00906399|81206040|FG001|Year 1|Adverse Event|22|||
27829483|NCT00906399|81206041|FG002|Year 1|Adverse Event|24|||
27829484|NCT00906399|81206042|FG003|Year 1|Adverse Event|0|||
27829485|NCT00906399|81206043|FG004|Year 1|Adverse Event|0|||
27829486|NCT00906399|81206044|FG005|Year 1|Adverse Event|0|||
27829487|NCT00906399|81206045|FG006|Year 1|Adverse Event|0|||
27829488|NCT00906399|81206039|FG000|Year 1|Lost to Follow-up|4|||
27829489|NCT00906399|81206040|FG001|Year 1|Lost to Follow-up|4|||
27829490|NCT00906399|81206041|FG002|Year 1|Lost to Follow-up|2|||
27829491|NCT00906399|81206042|FG003|Year 1|Lost to Follow-up|0|||
27829492|NCT00906399|81206043|FG004|Year 1|Lost to Follow-up|0|||
27829493|NCT00906399|81206044|FG005|Year 1|Lost to Follow-up|0|||
27829494|NCT00906399|81206045|FG006|Year 1|Lost to Follow-up|0|||
27829495|NCT00906399|81206039|FG000|Year 1|Withdrawal by Subject|30|||
27829496|NCT00906399|81206040|FG001|Year 1|Withdrawal by Subject|32|||
27829497|NCT00906399|81206041|FG002|Year 1|Withdrawal by Subject|36|||
27829498|NCT00906399|81206042|FG003|Year 1|Withdrawal by Subject|0|||
27829499|NCT00906399|81206043|FG004|Year 1|Withdrawal by Subject|0|||
27829500|NCT00906399|81206044|FG005|Year 1|Withdrawal by Subject|0|||
27829501|NCT00906399|81206045|FG006|Year 1|Withdrawal by Subject|0|||
27829502|NCT00906399|81206039|FG000|Year 1|Physician Decision|0|||
27829503|NCT00906399|81206040|FG001|Year 1|Physician Decision|1|||
27829504|NCT00906399|81206041|FG002|Year 1|Physician Decision|3|||
27829505|NCT00906399|81206042|FG003|Year 1|Physician Decision|0|||
27829506|NCT00906399|81206043|FG004|Year 1|Physician Decision|0|||
27829507|NCT00906399|81206044|FG005|Year 1|Physician Decision|0|||
27829508|NCT00906399|81206045|FG006|Year 1|Physician Decision|0|||
27829509|NCT00906399|81206039|FG000|Year 1|Death|2|||
27829510|NCT00906399|81206040|FG001|Year 1|Death|1|||
27829511|NCT00906399|81206041|FG002|Year 1|Death|1|||
27829512|NCT00906399|81206042|FG003|Year 1|Death|0|||
27829513|NCT00906399|81206043|FG004|Year 1|Death|0|||
27829514|NCT00906399|81206044|FG005|Year 1|Death|0|||
27829515|NCT00906399|81206045|FG006|Year 1|Death|0|||
27829516|NCT00906399|81206039|FG000|Year 1|Other|4|||
27829517|NCT00906399|81206040|FG001|Year 1|Other|2|||
27829518|NCT00906399|81206041|FG002|Year 1|Other|7|||
27829519|NCT00906399|81206042|FG003|Year 1|Other|0|||
27829520|NCT00906399|81206043|FG004|Year 1|Other|0|||
27558857|NCT01846611|80233129|FG000|Overall Study|Withdrawal by Subject|15|||
27829521|NCT00906399|81206044|FG005|Year 1|Other|0|||
27829522|NCT00906399|81206045|FG006|Year 1|Other|0|||
27829523|NCT00906399|81206039|FG000|Year 2|Adverse Event|0|||
27829524|NCT00906399|81206040|FG001|Year 2|Adverse Event|0|||
27829525|NCT00906399|81206041|FG002|Year 2|Adverse Event|0|||
27829526|NCT00906399|81206042|FG003|Year 2|Adverse Event|9|||
27829527|NCT00906399|81206043|FG004|Year 2|Adverse Event|8|||
27829528|NCT00906399|81206044|FG005|Year 2|Adverse Event|11|||
27829529|NCT00906399|81206045|FG006|Year 2|Adverse Event|6|||
27829530|NCT00906399|81206039|FG000|Year 2|Lost to Follow-up|0|||
27829531|NCT00906399|81206040|FG001|Year 2|Lost to Follow-up|0|||
27829532|NCT00906399|81206041|FG002|Year 2|Lost to Follow-up|0|||
27829533|NCT00906399|81206042|FG003|Year 2|Lost to Follow-up|1|||
27829534|NCT00906399|81206043|FG004|Year 2|Lost to Follow-up|4|||
27829535|NCT00906399|81206044|FG005|Year 2|Lost to Follow-up|2|||
27829536|NCT00906399|81206045|FG006|Year 2|Lost to Follow-up|4|||
27829537|NCT00906399|81206039|FG000|Year 2|Withdrawal by Subject|0|||
27829538|NCT00906399|81206040|FG001|Year 2|Withdrawal by Subject|0|||
27829539|NCT00906399|81206041|FG002|Year 2|Withdrawal by Subject|0|||
27829540|NCT00906399|81206042|FG003|Year 2|Withdrawal by Subject|17|||
27829541|NCT00906399|81206043|FG004|Year 2|Withdrawal by Subject|18|||
27829542|NCT00906399|81206044|FG005|Year 2|Withdrawal by Subject|27|||
27829543|NCT00906399|81206045|FG006|Year 2|Withdrawal by Subject|13|||
27829544|NCT00906399|81206039|FG000|Year 2|Physician Decision|0|||
27829545|NCT00906399|81206040|FG001|Year 2|Physician Decision|0|||
27829546|NCT00906399|81206041|FG002|Year 2|Physician Decision|0|||
27829547|NCT00906399|81206042|FG003|Year 2|Physician Decision|0|||
27829548|NCT00906399|81206043|FG004|Year 2|Physician Decision|2|||
27829549|NCT00906399|81206044|FG005|Year 2|Physician Decision|6|||
27829550|NCT00906399|81206045|FG006|Year 2|Physician Decision|3|||
27829551|NCT00906399|81206039|FG000|Year 2|Death|0|||
27829552|NCT00906399|81206040|FG001|Year 2|Death|0|||
27829553|NCT00906399|81206041|FG002|Year 2|Death|0|||
27829554|NCT00906399|81206042|FG003|Year 2|Death|1|||
27829555|NCT00906399|81206043|FG004|Year 2|Death|0|||
27829556|NCT00906399|81206044|FG005|Year 2|Death|0|||
27829557|NCT00906399|81206045|FG006|Year 2|Death|3|||
27829558|NCT00906399|81206039|FG000|Year 2|Other|0|||
27829559|NCT00906399|81206040|FG001|Year 2|Other|0|||
27829560|NCT00906399|81206041|FG002|Year 2|Other|0|||
27829561|NCT00906399|81206042|FG003|Year 2|Other|2|||
27829562|NCT00906399|81206043|FG004|Year 2|Other|3|||
27829563|NCT00906399|81206044|FG005|Year 2|Other|1|||
27829564|NCT00906399|81206045|FG006|Year 2|Other|0|||
27829565|NCT02566850|81206047|FG000|Overall Study|Protocol Violation|1|||
27829566|NCT02718326|81206048|FG000|Overall Study|Adverse Event|4|||
27829567|NCT02718326|81206049|FG001|Overall Study|Adverse Event|9|||
27829568|NCT02718326|81206050|FG002|Overall Study|Adverse Event|0|||
27829569|NCT02718326|81206048|FG000|Overall Study|Death|8|||
27829570|NCT02718326|81206049|FG001|Overall Study|Death|1|||
27829571|NCT02718326|81206050|FG002|Overall Study|Death|2|||
27829572|NCT02718326|81206048|FG000|Overall Study|Withdrawal by Subject|4|||
27829573|NCT02718326|81206049|FG001|Overall Study|Withdrawal by Subject|9|||
27829574|NCT02718326|81206050|FG002|Overall Study|Withdrawal by Subject|6|||
27829575|NCT02718326|81206048|FG000|Overall Study|Lost to Follow-up|18|||
27558858|NCT01846611|80233130|FG001|Overall Study|Withdrawal by Subject|19|||
27558859|NCT01846611|80233129|FG000|Overall Study|Other|19|||
27558860|NCT01846611|80233130|FG001|Overall Study|Other|18|||
27558861|NCT01881230|80233131|FG000|Overall Study|Death|2|||
27829576|NCT02718326|81206049|FG001|Overall Study|Lost to Follow-up|5|||
27558862|NCT01881230|80233132|FG001|Overall Study|Death|0|||
27829577|NCT02718326|81206050|FG002|Overall Study|Lost to Follow-up|14|||
27829578|NCT02718326|81206048|FG000|Overall Study|Protocol Deviation|1|||
27829579|NCT02718326|81206049|FG001|Overall Study|Protocol Deviation|0|||
27829580|NCT02718326|81206050|FG002|Overall Study|Protocol Deviation|0|||
27829581|NCT02718326|81206048|FG000|Overall Study|Pregnancy|1|||
27829582|NCT02718326|81206049|FG001|Overall Study|Pregnancy|0|||
27884592|NCT04480424|81411886|FG001|Overall Study|Withdrawal by Subject|2|||
27884593|NCT04480424|81411885|FG000|Overall Study|Lost to Follow-up|3|||
27558863|NCT01881230|80233133|FG002|Overall Study|Death|1|||
27829583|NCT02718326|81206050|FG002|Overall Study|Pregnancy|0|||
27558864|NCT01881230|80233131|FG000|Overall Study|Adverse Event|9|||
27558865|NCT01881230|80233132|FG001|Overall Study|Adverse Event|13|||
27558866|NCT01881230|80233133|FG002|Overall Study|Adverse Event|12|||
27829584|NCT02057835|81206054|FG000|Overall Study|Withdrawal by Subject|0|||
27829585|NCT02057835|81206055|FG001|Overall Study|Withdrawal by Subject|2|||
27829586|NCT02057835|81206056|FG002|Overall Study|Withdrawal by Subject|0|||
27829587|NCT02057835|81206057|FG003|Overall Study|Withdrawal by Subject|0|||
27829588|NCT02057835|81206058|FG004|Overall Study|Withdrawal by Subject|0|||
27829589|NCT02057835|81206059|FG005|Overall Study|Withdrawal by Subject|0|||
27829590|NCT02057835|81206060|FG006|Overall Study|Withdrawal by Subject|0|||
27829591|NCT02057835|81206061|FG007|Overall Study|Withdrawal by Subject|0|||
27829592|NCT02057835|81206062|FG008|Overall Study|Withdrawal by Subject|0|||
27829593|NCT02057835|81206063|FG009|Overall Study|Withdrawal by Subject|0|||
27829594|NCT03343535|81206064|FG000|Overall Study|Lost to Follow-up|1|||
27829595|NCT03343535|81206064|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
27829596|NCT03343535|81206064|FG000|Overall Study|Death|12|||
27829597|NCT03719040|81206065|FG000|Overall Study|Withdrawal by Subject|177|||
27829598|NCT03719040|81206065|FG000|Overall Study|Lost to Follow-up|26|||
27829599|NCT01466166|81206068|FG000|Overall Study|Death|1|||
27829600|NCT01466166|81206068|FG000|Overall Study|Lost to Follow-up|7|||
27829601|NCT01466166|81206068|FG000|Overall Study|Infusion Reaction (IR)|27|||
27829602|NCT01466166|81206068|FG000|Overall Study|Adverse Event (Other than IR)|11|||
27829603|NCT01466166|81206068|FG000|Overall Study|Elevated Serum Uric Acid|78|||
27829604|NCT01466166|81206068|FG000|Overall Study|Withdrawal by Subject|13|||
27829605|NCT01466166|81206068|FG000|Overall Study|Sponsor Decision|4|||
27829606|NCT01466166|81206068|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
27829607|NCT01466166|81206068|FG000|Overall Study|Other|20|||
27829608|NCT00679081|81206069|FG000|Overall Study|Lost to Follow-up|1|||
27829609|NCT01249651|81206073|FG000|Overall Study|Withdrawal by Subject|4|||
27829610|NCT01249651|81206073|FG000|Overall Study|Adverse Event|1|||
27829611|NCT01249651|81206073|FG000|Overall Study|Protocol Violation|1|||
27829612|NCT01249651|81206073|FG000|Overall Study|Sponsor Decision|1|||
27829613|NCT03437265|81206074|FG000|Overall Study|Protocol Violation|6|||
27829614|NCT00935012|81206075|FG000|Overall Study|Death|19|||
27829615|NCT00935012|81206075|FG000|Overall Study|Withdrawal by Subject|3|||
27829616|NCT00935012|81206075|FG000|Overall Study|Other|5|||
27829617|NCT00935012|81206075|FG000|Overall Study|Adverse Event|2|||
27829618|NCT01471353|81206082|FG000|Overall Study|remain on study|3|||
27829619|NCT03364192|81206086|FG000|Overall Study|Ineligible|10|||
27829620|NCT03364192|81206086|FG000|Overall Study|Withdrawal by Subject|5|||
27829621|NCT03364192|81206086|FG000|Overall Study|Lost to Follow-up|1|||
27829622|NCT04236596|81206090|FG000|Overall Study|Withdrawal by Subject|1|||
27829623|NCT04236596|81206090|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
27829624|NCT04236596|81206090|FG000|Overall Study|Participants did not receive implant at all|4|||
27829625|NCT03935880|81206091|FG000|Overall Study|Lost to Follow-up|0|||
27829626|NCT03935880|81206092|FG001|Overall Study|Lost to Follow-up|1|||
27829627|NCT03450057|81206093|FG000|Overall Study|Death|17|||
27829628|NCT03450057|81206093|FG000|Overall Study|ICF withdrawal|4|||
27829629|NCT03450057|81206093|FG000|Overall Study|Lost to Follow-up|2|||
27829630|NCT01788423|81206094|FG000|Overall Study|See Comments in Completed (above)|0|||
27829631|NCT01788423|81206095|FG001|Overall Study|See Comments in Completed (above)|4|||
27829632|NCT01788423|81206096|FG002|Overall Study|See Comments in Completed (above)|5|||
27829633|NCT03606174|81206097|FG000|Overall Study|Death|37|||
27829634|NCT03606174|81206098|FG001|Overall Study|Death|15|||
27829635|NCT03606174|81206099|FG002|Overall Study|Death|15|||
27829636|NCT03606174|81206100|FG003|Overall Study|Death|7|||
27829637|NCT03606174|81206101|FG004|Overall Study|Death|35|||
27829638|NCT03606174|81206102|FG005|Overall Study|Death|12|||
27829639|NCT03606174|81206103|FG006|Overall Study|Death|35|||
27829640|NCT03606174|81206104|FG007|Overall Study|Death|8|||
27829641|NCT03606174|81206105|FG008|Overall Study|Death|5|||
27829642|NCT03606174|81206106|FG009|Overall Study|Death|3|||
27829643|NCT03606174|81206107|FG010|Overall Study|Death|0|||
27829644|NCT03606174|81206097|FG000|Overall Study|Lost to Follow-up|0|||
27829645|NCT03606174|81206098|FG001|Overall Study|Lost to Follow-up|0|||
27829646|NCT03606174|81206099|FG002|Overall Study|Lost to Follow-up|0|||
27829647|NCT03606174|81206100|FG003|Overall Study|Lost to Follow-up|0|||
27829648|NCT03606174|81206101|FG004|Overall Study|Lost to Follow-up|1|||
27829649|NCT03606174|81206102|FG005|Overall Study|Lost to Follow-up|1|||
27829650|NCT03606174|81206103|FG006|Overall Study|Lost to Follow-up|0|||
27829651|NCT03606174|81206104|FG007|Overall Study|Lost to Follow-up|0|||
27829652|NCT03606174|81206105|FG008|Overall Study|Lost to Follow-up|0|||
27829653|NCT03606174|81206106|FG009|Overall Study|Lost to Follow-up|0|||
27884594|NCT04480424|81411886|FG001|Overall Study|Lost to Follow-up|3|||
27829654|NCT03606174|81206107|FG010|Overall Study|Lost to Follow-up|0|||
27829655|NCT03606174|81206097|FG000|Overall Study|Withdrawal by Subject|6|||
27829656|NCT03606174|81206098|FG001|Overall Study|Withdrawal by Subject|0|||
27829657|NCT03606174|81206099|FG002|Overall Study|Withdrawal by Subject|0|||
27829658|NCT03606174|81206100|FG003|Overall Study|Withdrawal by Subject|1|||
27829659|NCT03606174|81206101|FG004|Overall Study|Withdrawal by Subject|2|||
27829660|NCT03606174|81206102|FG005|Overall Study|Withdrawal by Subject|1|||
27829661|NCT03606174|81206103|FG006|Overall Study|Withdrawal by Subject|4|||
27829662|NCT03606174|81206104|FG007|Overall Study|Withdrawal by Subject|0|||
27829663|NCT03606174|81206105|FG008|Overall Study|Withdrawal by Subject|0|||
27829664|NCT03606174|81206106|FG009|Overall Study|Withdrawal by Subject|0|||
27829665|NCT03606174|81206107|FG010|Overall Study|Withdrawal by Subject|1|||
27829666|NCT03606174|81206097|FG000|Overall Study|Study Terminated by Sponsor|5|||
27829667|NCT03606174|81206098|FG001|Overall Study|Study Terminated by Sponsor|7|||
27829668|NCT03606174|81206099|FG002|Overall Study|Study Terminated by Sponsor|3|||
27829669|NCT03606174|81206100|FG003|Overall Study|Study Terminated by Sponsor|0|||
27829670|NCT03606174|81206101|FG004|Overall Study|Study Terminated by Sponsor|11|||
27829671|NCT03606174|81206102|FG005|Overall Study|Study Terminated by Sponsor|6|||
27558867|NCT01881230|80233131|FG000|Overall Study|Progressive Disease|31|||
27558868|NCT01881230|80233132|FG001|Overall Study|Progressive Disease|35|||
27558869|NCT01881230|80233133|FG002|Overall Study|Progressive Disease|36|||
27558870|NCT01881230|80233131|FG000|Overall Study|Symptomatic Deterioration|3|||
27558871|NCT01881230|80233132|FG001|Overall Study|Symptomatic Deterioration|3|||
27558872|NCT01881230|80233133|FG002|Overall Study|Symptomatic Deterioration|1|||
27558873|NCT01881230|80233131|FG000|Overall Study|Withdrawal by Subject|6|||
27829672|NCT03606174|81206103|FG006|Overall Study|Study Terminated by Sponsor|12|||
27829673|NCT03606174|81206104|FG007|Overall Study|Study Terminated by Sponsor|1|||
27829674|NCT03606174|81206105|FG008|Overall Study|Study Terminated by Sponsor|3|||
27829675|NCT03606174|81206106|FG009|Overall Study|Study Terminated by Sponsor|1|||
27829676|NCT03606174|81206107|FG010|Overall Study|Study Terminated by Sponsor|2|||
27829677|NCT03606174|81206097|FG000|Overall Study|Miscellaneous|1|||
27829678|NCT03606174|81206098|FG001|Overall Study|Miscellaneous|1|||
27829679|NCT03606174|81206099|FG002|Overall Study|Miscellaneous|0|||
27829680|NCT03606174|81206100|FG003|Overall Study|Miscellaneous|1|||
27829681|NCT03606174|81206101|FG004|Overall Study|Miscellaneous|4|||
27829682|NCT03606174|81206102|FG005|Overall Study|Miscellaneous|7|||
27829683|NCT03606174|81206103|FG006|Overall Study|Miscellaneous|5|||
27829684|NCT03606174|81206104|FG007|Overall Study|Miscellaneous|0|||
27829685|NCT03606174|81206105|FG008|Overall Study|Miscellaneous|0|||
27884595|NCT04480424|81411885|FG000|Overall Study|Death|14|||
27829686|NCT03606174|81206106|FG009|Overall Study|Miscellaneous|0|||
27829687|NCT03606174|81206107|FG010|Overall Study|Miscellaneous|1|||
27884596|NCT04480424|81411886|FG001|Overall Study|Death|16|||
27829688|NCT01547286|81206121|FG000|Overall Study|Did not meet all eligibility criteria|1|||
27829689|NCT01547286|81206121|FG000|Overall Study|Physician Decision|1|||
27829690|NCT00835692|81206122|FG000|First Intervention|Withdrawal by Subject|1|||
27829691|NCT00835692|81206123|FG001|First Intervention|Withdrawal by Subject|0|||
27884597|NCT04480424|81411885|FG000|Overall Study|Reason not Specified|5|||
27558874|NCT01881230|80233132|FG001|Overall Study|Withdrawal by Subject|4|||
27829692|NCT02545283|81206126|FG000|Overall Study|Lost to Follow-up|2|||
27829693|NCT02545283|81206127|FG001|Overall Study|Lost to Follow-up|4|||
27829694|NCT02545283|81206126|FG000|Overall Study|Withdrawal by Subject|5|||
27829695|NCT02545283|81206127|FG001|Overall Study|Withdrawal by Subject|9|||
27829696|NCT02545283|81206126|FG000|Overall Study|Death|109|||
27829697|NCT02545283|81206127|FG001|Overall Study|Death|211|||
27829698|NCT02545283|81206126|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
27829699|NCT02545283|81206127|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
27829700|NCT02545283|81206126|FG000|Overall Study|Study Terminated By Sponsor|33|||
27829701|NCT02545283|81206127|FG001|Overall Study|Study Terminated By Sponsor|71|||
27829702|NCT01701063|81206128|FG000|Overall Study|Lost to Follow-up|0|||
27829703|NCT01701063|81206129|FG001|Overall Study|Lost to Follow-up|1|||
27829704|NCT01701063|81206130|FG002|Overall Study|Lost to Follow-up|0|||
27829705|NCT01701063|81206128|FG000|Overall Study|Withdrawal by Subject|0|||
27829706|NCT01701063|81206129|FG001|Overall Study|Withdrawal by Subject|0|||
27829707|NCT01701063|81206130|FG002|Overall Study|Withdrawal by Subject|1|||
27829708|NCT01701063|81206128|FG000|Overall Study|Other|0|||
27829709|NCT01701063|81206129|FG001|Overall Study|Other|0|||
27829710|NCT01701063|81206130|FG002|Overall Study|Other|1|||
27829711|NCT01895335|81206131|FG000|Overall Study|Adverse Event|106|||
27829712|NCT01895335|81206131|FG000|Overall Study|Lack of Efficacy|53|||
27829713|NCT01895335|81206131|FG000|Overall Study|Poor Compliance to Protocol|11|||
27829714|NCT01895335|81206131|FG000|Overall Study|Included But Not treated|1|||
27829715|NCT01895335|81206131|FG000|Overall Study|Other than Specified Above|44|||
27829716|NCT01124175|81206132|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
27829717|NCT01124175|81206133|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
27829718|NCT01863745|81206137|FG000|Overall Study|Disease Progression|9|||
27829719|NCT01863745|81206137|FG000|Overall Study|Adverse Event|2|||
27829720|NCT01863745|81206137|FG000|Overall Study|Death|1|||
27829721|NCT01863745|81206137|FG000|Overall Study|Withdrawal by Subject|1|||
27829722|NCT00462345|81206139|FG000|Overall Study|Withdrawal by Subject|2|||
27829723|NCT00462345|81206139|FG000|Overall Study|Did not complete second course|1|||
27829724|NCT00829764|81206140|FG000|First Intervention|Adverse Event|1|||
27829725|NCT00829764|81206141|FG001|First Intervention|Adverse Event|0|||
27829726|NCT00829764|81206140|FG000|First Intervention|Withdrawal by Subject|1|||
27829727|NCT00829764|81206141|FG001|First Intervention|Withdrawal by Subject|1|||
27829728|NCT01642277|81206142|FG000|Overall Study|Adverse Event|10|||
27829729|NCT01642277|81206143|FG001|Overall Study|Adverse Event|0|||
27829730|NCT01642277|81206142|FG000|Overall Study|Physician Decision|2|||
27884598|NCT04480424|81411886|FG001|Overall Study|Reason not Specified|5|||
27884599|NCT03625466|81411889|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
27884600|NCT03625466|81411890|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
27558875|NCT01881230|80233133|FG002|Overall Study|Withdrawal by Subject|6|||
27558876|NCT01881230|80233131|FG000|Overall Study|Physician Decision|4|||
27558877|NCT01881230|80233132|FG001|Overall Study|Physician Decision|3|||
27829731|NCT01642277|81206143|FG001|Overall Study|Physician Decision|0|||
27829732|NCT01642277|81206142|FG000|Overall Study|Protocol Violation|1|||
27829733|NCT01642277|81206143|FG001|Overall Study|Protocol Violation|0|||
27829734|NCT01642277|81206142|FG000|Overall Study|Withdrawal by Subject|11|||
27829735|NCT01642277|81206143|FG001|Overall Study|Withdrawal by Subject|0|||
27829736|NCT01528696|81206144|FG000|Overall Study|See detailed description|18|||
27829737|NCT01528696|81206145|FG001|Overall Study|See detailed description|19|||
27829738|NCT00274651|81206148|FG000|Overall Study|Adverse Event|6|||
27698302|NCT01862640|80732822|FG003|Overall Study|Protocol Deviation|0|||
27698303|NCT01256658|80732825|FG000|Period 1|Lost to Follow-up|837|||
27698304|NCT01256658|80732826|FG001|Period 1|Lost to Follow-up|661|||
27698305|NCT01256658|80732825|FG000|Period 1|Withdrawal by Subject|35|||
27698306|NCT01256658|80732826|FG001|Period 1|Withdrawal by Subject|43|||
27698307|NCT01256658|80732825|FG000|Period 1|Death|48|||
27698308|NCT01256658|80732826|FG001|Period 1|Death|44|||
27698309|NCT00833911|80732830|FG000|Titration|Adverse Event|18|||
27829739|NCT00274651|81206149|FG001|Overall Study|Adverse Event|3|||
27829740|NCT00274651|81206148|FG000|Overall Study|Lack of Efficacy|13|||
27829741|NCT00274651|81206149|FG001|Overall Study|Lack of Efficacy|6|||
27829742|NCT00274651|81206148|FG000|Overall Study|Death|1|||
27829743|NCT00274651|81206149|FG001|Overall Study|Death|3|||
27829744|NCT00274651|81206148|FG000|Overall Study|Withdrawal by Subject|0|||
27698310|NCT00833911|80732830|FG000|Titration|Withdrawal by Subject|3|||
27698311|NCT00833911|80732830|FG000|Maintenance Phase I|Adverse Event|73|||
27698312|NCT00833911|80732830|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
27698313|NCT00833911|80732830|FG000|Maintenance Phase I|Physician Decision|10|||
27829745|NCT00274651|81206149|FG001|Overall Study|Withdrawal by Subject|1|||
27829746|NCT00274651|81206148|FG000|Overall Study|Physician Decision|8|||
27829747|NCT00274651|81206149|FG001|Overall Study|Physician Decision|7|||
27829748|NCT02902211|81206150|FG000|First Three Months|Withdrawal by Subject|7|||
27698314|NCT00833911|80732830|FG000|Maintenance Phase I|Lack of Efficacy|4|||
27698315|NCT00833911|80732830|FG000|Maintenance Phase II|Adverse Event|6|||
27698316|NCT00833911|80732830|FG000|Maintenance Phase II|Physician Decision|2|||
27698317|NCT00833911|80732830|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
27698318|NCT00833911|80732830|FG000|Maintenance Phase II|Lack of Efficacy|1|||
27698319|NCT00066742|80732831|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
27698320|NCT00066742|80732831|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
27698321|NCT00066742|80732831|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
27698322|NCT00066742|80732831|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
27698323|NCT00066742|80732831|FG000|Induction Chemoradiotherapy|Ineligible|3|||
27698324|NCT00066742|80732831|FG000|Consolidation Chemotherapy|not protocol specified|1|||
27698325|NCT00066742|80732831|FG000|Consolidation Chemotherapy|Ineligible|2|||
27698326|NCT04448756|80732832|FG000|Overall Study|Adverse Event|0|||
27698327|NCT04448756|80732833|FG001|Overall Study|Adverse Event|1|||
27698328|NCT04448756|80732834|FG002|Overall Study|Adverse Event|0|||
27698329|NCT04448756|80732832|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
27698330|NCT04448756|80732833|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
27698331|NCT04448756|80732834|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
27698332|NCT04448756|80732832|FG000|Overall Study|Withdrawal by Subject|0|||
27698333|NCT04448756|80732833|FG001|Overall Study|Withdrawal by Subject|3|||
27698334|NCT04448756|80732834|FG002|Overall Study|Withdrawal by Subject|1|||
27698335|NCT04448756|80732832|FG000|Overall Study|Death|2|||
27829749|NCT02902211|81206151|FG001|First Three Months|Withdrawal by Subject|3|||
27829750|NCT03256695|81206152|FG000|Overall Study|Adverse Event|8|||
27558878|NCT01881230|80233133|FG002|Overall Study|Physician Decision|6|||
27558879|NCT01881230|80233131|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27558880|NCT01881230|80233132|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27558881|NCT01881230|80233133|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27558882|NCT01881230|80233131|FG000|Overall Study|Given Commercially Available Drug|0|||
27558883|NCT01881230|80233132|FG001|Overall Study|Given Commercially Available Drug|0|||
27558884|NCT01881230|80233133|FG002|Overall Study|Given Commercially Available Drug|2|||
27829751|NCT03256695|81206152|FG000|Overall Study|Death|2|||
27829752|NCT03256695|81206152|FG000|Overall Study|Withdrawal by Subject|14|||
27829753|NCT03256695|81206152|FG000|Overall Study|Non-compliance with study drug|1|||
27829754|NCT03256695|81206152|FG000|Overall Study|Lost to Follow-up|3|||
27829755|NCT03256695|81206152|FG000|Overall Study|Lack of Efficacy|3|||
27829756|NCT03256695|81206152|FG000|Overall Study|Protocol Violation|5|||
27829757|NCT03256695|81206152|FG000|Overall Study|Other than specified|3|||
27829758|NCT00772603|81206153|FG000|Overall Study|Withdrawal by Subject|11|||
27884601|NCT03625466|81411891|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
27884602|NCT03625466|81411889|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
27558885|NCT01881230|80233131|FG000|Overall Study|Protocol Violation|1|||
27558886|NCT01881230|80233132|FG001|Overall Study|Protocol Violation|1|||
27558887|NCT01881230|80233133|FG002|Overall Study|Protocol Violation|0|||
27558888|NCT01881230|80233131|FG000|Overall Study|Miscellaneous|3|||
27558889|NCT01881230|80233132|FG001|Overall Study|Miscellaneous|3|||
27558890|NCT01881230|80233133|FG002|Overall Study|Miscellaneous|0|||
27558891|NCT01881230|80233131|FG000|Overall Study|Untreated: Other|0|||
27558892|NCT01881230|80233132|FG001|Overall Study|Untreated: Other|0|||
27558893|NCT01881230|80233133|FG002|Overall Study|Untreated: Other|1|||
27558894|NCT01881230|80233131|FG000|Overall Study|Untreated: Death|0|||
27558895|NCT01881230|80233132|FG001|Overall Study|Untreated: Death|0|||
27558896|NCT01881230|80233133|FG002|Overall Study|Untreated: Death|1|||
27558897|NCT01881230|80233131|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
27558898|NCT01881230|80233132|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
27558899|NCT01881230|80233133|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
27558900|NCT01034462|80233136|FG000|Overall Study|Adverse Event|7|||
27884603|NCT03625466|81411890|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
27884604|NCT03625466|81411891|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
27884605|NCT03625466|81411889|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
27884606|NCT03625466|81411890|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
27558901|NCT01034462|80233137|FG001|Overall Study|Adverse Event|17|||
27558902|NCT01034462|80233136|FG000|Overall Study|Lack of Efficacy|4|||
27558903|NCT01034462|80233137|FG001|Overall Study|Lack of Efficacy|4|||
27558904|NCT01034462|80233136|FG000|Overall Study|Protocol Violation|10|||
27558905|NCT01034462|80233137|FG001|Overall Study|Protocol Violation|7|||
27558906|NCT01034462|80233136|FG000|Overall Study|Withdrawal by Subject|9|||
27884607|NCT03625466|81411891|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
27884608|NCT01814696|81411892|FG000|Overall Study|Withdrawal by Subject|1|||
27884609|NCT01814696|81411893|FG001|Overall Study|Withdrawal by Subject|0|||
27884610|NCT01814696|81411892|FG000|Overall Study|Randomized to wrong group|1|||
27884611|NCT01814696|81411893|FG001|Overall Study|Randomized to wrong group|0|||
27884612|NCT02649439|81411894|FG000|Overall Study|Switched to alternative treatment|6|||
27884613|NCT02649439|81411895|FG001|Overall Study|Switched to alternative treatment|4|||
27884614|NCT02649439|81411894|FG000|Overall Study|Patient decision|1|||
27884615|NCT02649439|81411895|FG001|Overall Study|Patient decision|0|||
27698336|NCT04448756|80732833|FG001|Overall Study|Death|1|||
27698337|NCT04448756|80732834|FG002|Overall Study|Death|0|||
27698338|NCT01423253|80732835|FG000|Overall Study|Adverse Event|2|||
27698339|NCT01423253|80732835|FG000|Overall Study|Lack of Efficacy|2|||
27884616|NCT02649439|81411894|FG000|Overall Study|Patient going out of country|1|||
27884617|NCT02649439|81411895|FG001|Overall Study|Patient going out of country|0|||
27884618|NCT02649439|81411894|FG000|Overall Study|To start finasteride|1|||
27884619|NCT02649439|81411895|FG001|Overall Study|To start finasteride|0|||
27558907|NCT01034462|80233137|FG001|Overall Study|Withdrawal by Subject|8|||
27558908|NCT01034462|80233136|FG000|Overall Study|Lost to Follow-up|14|||
27558909|NCT01034462|80233137|FG001|Overall Study|Lost to Follow-up|16|||
27558910|NCT01034462|80233136|FG000|Overall Study|Other reasons|1|||
27558911|NCT01034462|80233137|FG001|Overall Study|Other reasons|2|||
27558912|NCT00589914|80233146|FG000|Overall Study|Adverse Event|19|||
27558913|NCT00589914|80233147|FG001|Overall Study|Adverse Event|10|||
27558914|NCT00589914|80233146|FG000|Overall Study|Death|2|||
27558915|NCT00589914|80233147|FG001|Overall Study|Death|0|||
27558916|NCT00589914|80233146|FG000|Overall Study|Lack of Efficacy|40|||
27829759|NCT00772603|81206154|FG001|Overall Study|Withdrawal by Subject|10|||
27829760|NCT00772603|81206155|FG002|Overall Study|Withdrawal by Subject|6|||
27829761|NCT00772603|81206153|FG000|Overall Study|Adverse Event|37|||
27698340|NCT01423253|80732835|FG000|Overall Study|Lost to Follow-up|1|||
27698341|NCT01423253|80732835|FG000|Overall Study|Protocol Violation|2|||
27698342|NCT01423253|80732835|FG000|Overall Study|Withdrawal by Subject|2|||
27698343|NCT01106404|80732838|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
27698344|NCT01106404|80732839|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
27698345|NCT01106404|80732838|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
27698346|NCT01106404|80732839|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
27698347|NCT01106404|80732838|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
27698348|NCT01106404|80732839|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
27698349|NCT01106404|80732838|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
27698350|NCT01106404|80732839|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
27558917|NCT00589914|80233147|FG001|Overall Study|Lack of Efficacy|43|||
27558918|NCT00589914|80233146|FG000|Overall Study|Lost to Follow-up|11|||
27558919|NCT00589914|80233147|FG001|Overall Study|Lost to Follow-up|18|||
27558920|NCT00589914|80233146|FG000|Overall Study|Pregnancy|1|||
27558921|NCT00589914|80233147|FG001|Overall Study|Pregnancy|0|||
27558922|NCT00589914|80233146|FG000|Overall Study|Withdrawal by Subject|55|||
27698351|NCT01975428|80732840|FG000|Overall Study|Lost to Follow-up|17|||
27698352|NCT01975428|80732841|FG001|Overall Study|Lost to Follow-up|4|||
27698353|NCT01975428|80732840|FG000|Overall Study|Withdrawal by Subject|3|||
27698354|NCT01975428|80732841|FG001|Overall Study|Withdrawal by Subject|10|||
27698355|NCT00412971|80732842|FG000|Overall Study|Lost to Follow-up|17|||
27698356|NCT00412971|80732843|FG001|Overall Study|Lost to Follow-up|9|||
27698357|NCT00412971|80732842|FG000|Overall Study|Protocol Violation|13|||
27698358|NCT00412971|80732843|FG001|Overall Study|Protocol Violation|1|||
27558923|NCT00589914|80233147|FG001|Overall Study|Withdrawal by Subject|49|||
27558924|NCT00589914|80233146|FG000|Overall Study|Other|22|||
27558925|NCT00589914|80233147|FG001|Overall Study|Other|17|||
27558926|NCT01770379|80233153|FG000|Overall Study|Technical issues|1|||
27698359|NCT03285178|80732844|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
27698360|NCT03285178|80732845|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
27698361|NCT03285178|80732846|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
27698362|NCT03285178|80732847|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
27698363|NCT03285178|80732848|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
27698364|NCT03285178|80732849|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
27698365|NCT03285178|80732850|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
27558927|NCT01770379|80233154|FG001|Overall Study|Technical issues|0|||
27558928|NCT01770379|80233155|FG002|Overall Study|Technical issues|0|||
27558929|NCT01770379|80233153|FG000|Overall Study|Withdrawal by Subject|7|||
27558930|NCT01770379|80233154|FG001|Overall Study|Withdrawal by Subject|10|||
27698366|NCT03285178|80732844|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
27698367|NCT03285178|80732845|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
27698368|NCT03285178|80732846|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
27698369|NCT03285178|80732847|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
27698370|NCT03285178|80732848|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
27698371|NCT03285178|80732849|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
27698372|NCT03285178|80732850|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
27698373|NCT03285178|80732844|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
27829762|NCT00772603|81206154|FG001|Overall Study|Adverse Event|18|||
27829763|NCT00772603|81206155|FG002|Overall Study|Adverse Event|10|||
27829764|NCT00772603|81206153|FG000|Overall Study|Subject Non-compliance|1|||
27558931|NCT01770379|80233155|FG002|Overall Study|Withdrawal by Subject|7|||
27558932|NCT01770379|80233153|FG000|Overall Study|study terminated by sponsor|22|||
27829765|NCT00772603|81206154|FG001|Overall Study|Subject Non-compliance|6|||
27829766|NCT00772603|81206155|FG002|Overall Study|Subject Non-compliance|4|||
27829767|NCT00772603|81206153|FG000|Overall Study|Protocol Violation|0|||
27829768|NCT00772603|81206154|FG001|Overall Study|Protocol Violation|1|||
27558933|NCT01770379|80233154|FG001|Overall Study|study terminated by sponsor|23|||
27829769|NCT00772603|81206155|FG002|Overall Study|Protocol Violation|1|||
27829770|NCT00772603|81206153|FG000|Overall Study|Lost to Follow-up|1|||
27558934|NCT01770379|80233155|FG002|Overall Study|study terminated by sponsor|22|||
27558935|NCT01770379|80233153|FG000|Overall Study|Protocol Violation|0|||
27558936|NCT01770379|80233154|FG001|Overall Study|Protocol Violation|1|||
27698374|NCT03285178|80732845|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
27698375|NCT03285178|80732846|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
27698376|NCT03285178|80732847|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
27698377|NCT03285178|80732848|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
27698378|NCT03285178|80732849|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
27698379|NCT03285178|80732850|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
27698380|NCT03285178|80732844|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
27698381|NCT03285178|80732845|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
27698382|NCT03285178|80732846|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
27698383|NCT03285178|80732847|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
27698384|NCT03285178|80732848|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
27698385|NCT03285178|80732849|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
27698386|NCT03285178|80732850|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
27698387|NCT03285178|80732844|FG000|Single-Blind Run-In Period|Physician Decision|2|||
27698388|NCT03285178|80732845|FG001|Single-Blind Run-In Period|Physician Decision|0|||
27698389|NCT03285178|80732846|FG002|Single-Blind Run-In Period|Physician Decision|0|||
27698390|NCT03285178|80732847|FG003|Single-Blind Run-In Period|Physician Decision|0|||
27698391|NCT03285178|80732848|FG004|Single-Blind Run-In Period|Physician Decision|0|||
27698392|NCT03285178|80732849|FG005|Single-Blind Run-In Period|Physician Decision|0|||
27698393|NCT03285178|80732850|FG006|Single-Blind Run-In Period|Physician Decision|0|||
27698394|NCT03285178|80732844|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
27698395|NCT03285178|80732845|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
27698396|NCT03285178|80732846|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
27698397|NCT03285178|80732847|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
27698398|NCT03285178|80732848|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
27698399|NCT03285178|80732849|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
27698400|NCT03285178|80732850|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
27698401|NCT03285178|80732844|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27698402|NCT03285178|80732845|FG001|Double-Blind Treatment Period|Adverse Event|0|||
27698403|NCT03285178|80732846|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27698404|NCT03285178|80732847|FG003|Double-Blind Treatment Period|Adverse Event|0|||
27698405|NCT03285178|80732848|FG004|Double-Blind Treatment Period|Adverse Event|0|||
27698406|NCT03285178|80732849|FG005|Double-Blind Treatment Period|Adverse Event|0|||
27698407|NCT03285178|80732850|FG006|Double-Blind Treatment Period|Adverse Event|2|||
27698408|NCT03285178|80732844|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27698409|NCT03285178|80732845|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
27698410|NCT03285178|80732846|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
27698411|NCT03285178|80732847|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
27698412|NCT03285178|80732848|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
27698413|NCT03285178|80732849|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
27698414|NCT03285178|80732850|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
27698415|NCT03285178|80732844|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27698416|NCT03285178|80732845|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27698417|NCT03285178|80732846|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27698418|NCT03285178|80732847|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27698419|NCT03285178|80732848|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27698420|NCT03285178|80732849|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27698421|NCT03285178|80732850|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27698422|NCT03285178|80732844|FG000|Double-Blind Treatment Period|COVID-19|0|||
27698423|NCT03285178|80732845|FG001|Double-Blind Treatment Period|COVID-19|0|||
27698424|NCT03285178|80732846|FG002|Double-Blind Treatment Period|COVID-19|1|||
27698425|NCT03285178|80732847|FG003|Double-Blind Treatment Period|COVID-19|0|||
27698426|NCT03285178|80732848|FG004|Double-Blind Treatment Period|COVID-19|0|||
27698427|NCT03285178|80732849|FG005|Double-Blind Treatment Period|COVID-19|0|||
27698428|NCT03285178|80732850|FG006|Double-Blind Treatment Period|COVID-19|0|||
27698429|NCT01163721|80732851|FG000|Overall Study|Adverse Event|5|||
27698430|NCT01163721|80732852|FG001|Overall Study|Adverse Event|6|||
27698431|NCT01163721|80732851|FG000|Overall Study|Withdrawal by Subject|3|||
27698432|NCT01163721|80732852|FG001|Overall Study|Withdrawal by Subject|4|||
27698433|NCT01163721|80732851|FG000|Overall Study|Lost to Follow-up|0|||
27884620|NCT02649439|81411894|FG000|Overall Study|Physician Decision|1|||
27884621|NCT02649439|81411895|FG001|Overall Study|Physician Decision|0|||
27698434|NCT01163721|80732852|FG001|Overall Study|Lost to Follow-up|1|||
27884622|NCT02649439|81411894|FG000|Overall Study|Disease progression on study|12|||
27698435|NCT01163721|80732851|FG000|Overall Study|Physician Decision|0|||
27698436|NCT01163721|80732852|FG001|Overall Study|Physician Decision|1|||
27698437|NCT04209621|80732853|FG000|Overall Study|Death|1|||
27698438|NCT04209621|80732853|FG000|Overall Study|Study Terminated Early|2|||
27698439|NCT00821431|80732860|FG000|Overall Study|Adverse Event|6|||
27698440|NCT00821431|80732861|FG001|Overall Study|Adverse Event|3|||
27698441|NCT00821431|80732860|FG000|Overall Study|Withdrawal by Subject|5|||
27698442|NCT00821431|80732861|FG001|Overall Study|Withdrawal by Subject|0|||
27698443|NCT00821431|80732860|FG000|Overall Study|Lost to Follow-up|1|||
27698444|NCT00821431|80732861|FG001|Overall Study|Lost to Follow-up|0|||
27698445|NCT00821431|80732860|FG000|Overall Study|Protocol Violation|3|||
27698446|NCT00821431|80732861|FG001|Overall Study|Protocol Violation|1|||
27698447|NCT00821431|80732860|FG000|Overall Study|Physician Decision|0|||
27698448|NCT00821431|80732861|FG001|Overall Study|Physician Decision|1|||
27698449|NCT02187809|80732862|FG000|Overall Study|The study was terminated|3|||
27698450|NCT02336178|80732863|FG000|Overall Study|Lost to Follow-up|1|||
27698451|NCT02336178|80732863|FG000|Overall Study|Protocol Violation|1|||
27698452|NCT02336178|80732863|FG000|Overall Study|Withdrawal by Subject|1|||
27698453|NCT02336178|80732863|FG000|Overall Study|Other|1|||
27698454|NCT02141074|80732864|FG000|Pre-prophylaxis|Adverse Event|3|||
27698455|NCT02141074|80732865|FG001|Pre-prophylaxis|Adverse Event|0|||
27698456|NCT02141074|80732864|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
27698457|NCT02141074|80732865|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
27698458|NCT02141074|80732864|FG000|Prophylaxis|Adverse Event|0|||
27698459|NCT02141074|80732865|FG001|Prophylaxis|Adverse Event|4|||
27698460|NCT02141074|80732864|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
27698461|NCT02141074|80732865|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
27698462|NCT02141074|80732864|FG000|Prophylaxis|Withdrawal by Subject|0|||
27698463|NCT02141074|80732865|FG001|Prophylaxis|Withdrawal by Subject|1|||
27698464|NCT00107120|80732866|FG000|Overall Study|Adverse Event|4|||
27698465|NCT00107120|80732867|FG001|Overall Study|Adverse Event|1|||
27698466|NCT00107120|80732866|FG000|Overall Study|Lack of Efficacy|5|||
27698467|NCT00107120|80732867|FG001|Overall Study|Lack of Efficacy|5|||
27698468|NCT00107120|80732866|FG000|Overall Study|Protocol Violation|3|||
27698469|NCT00107120|80732867|FG001|Overall Study|Protocol Violation|0|||
27698470|NCT00107120|80732866|FG000|Overall Study|Withdrawal by Subject|8|||
27698471|NCT00107120|80732867|FG001|Overall Study|Withdrawal by Subject|9|||
27698472|NCT00107120|80732866|FG000|Overall Study|Lost to Follow-up|8|||
27698473|NCT00107120|80732867|FG001|Overall Study|Lost to Follow-up|6|||
27698474|NCT00107120|80732866|FG000|Overall Study|Pregnancy|0|||
27698475|NCT00107120|80732867|FG001|Overall Study|Pregnancy|1|||
27698476|NCT00107120|80732866|FG000|Overall Study|moving away from site|1|||
27698477|NCT00107120|80732867|FG001|Overall Study|moving away from site|1|||
27558937|NCT01770379|80233155|FG002|Overall Study|Protocol Violation|1|||
27558938|NCT01770379|80233153|FG000|Overall Study|Physician Decision|0|||
27558939|NCT01770379|80233154|FG001|Overall Study|Physician Decision|1|||
27558940|NCT01770379|80233155|FG002|Overall Study|Physician Decision|2|||
27698478|NCT00107120|80732866|FG000|Overall Study|death of parent|0|||
27829771|NCT00772603|81206154|FG001|Overall Study|Lost to Follow-up|5|||
27829772|NCT00772603|81206155|FG002|Overall Study|Lost to Follow-up|2|||
27829773|NCT00772603|81206153|FG000|Overall Study|Physician Decision|0|||
27829774|NCT00772603|81206154|FG001|Overall Study|Physician Decision|0|||
27829775|NCT00772603|81206155|FG002|Overall Study|Physician Decision|1|||
27829776|NCT00772603|81206153|FG000|Overall Study|Other|2|||
27829777|NCT00772603|81206154|FG001|Overall Study|Other|0|||
27829778|NCT00772603|81206155|FG002|Overall Study|Other|2|||
27829779|NCT02554890|81206170|FG000|Double-blind|Adverse Event|45|||
27829780|NCT02554890|81206171|FG001|Double-blind|Adverse Event|51|||
27829781|NCT02554890|81206170|FG000|Double-blind|Death|6|||
27829782|NCT02554890|81206171|FG001|Double-blind|Death|4|||
27829783|NCT02554890|81206170|FG000|Double-blind|Protocol Violation|1|||
27829784|NCT02554890|81206171|FG001|Double-blind|Protocol Violation|1|||
27829785|NCT02554890|81206170|FG000|Double-blind|Physician Decision|4|||
27829786|NCT02554890|81206171|FG001|Double-blind|Physician Decision|3|||
27829787|NCT02554890|81206170|FG000|Double-blind|Subject/Guardian decision|21|||
27829788|NCT02554890|81206171|FG001|Double-blind|Subject/Guardian decision|16|||
27884623|NCT02649439|81411895|FG001|Overall Study|Disease progression on study|13|||
27558941|NCT01770379|80233153|FG000|Overall Study|Lost to Follow-up|0|||
27698479|NCT00107120|80732867|FG001|Overall Study|death of parent|1|||
27698480|NCT00888433|80732870|FG000|Overall Study|Withdrawal by Subject|1|||
27698481|NCT00888433|80732871|FG001|Overall Study|Withdrawal by Subject|2|||
27698482|NCT00888433|80732870|FG000|Overall Study|Missed Visit|2|||
27698483|NCT00888433|80732871|FG001|Overall Study|Missed Visit|1|||
27698484|NCT00195507|80732872|FG000|Overall Study|Adverse Event|24|||
27698485|NCT00195507|80732873|FG001|Overall Study|Adverse Event|13|||
27698486|NCT00195507|80732872|FG000|Overall Study|Death|0|||
27698487|NCT00195507|80732873|FG001|Overall Study|Death|1|||
27698488|NCT00195507|80732872|FG000|Overall Study|Failed to Return|4|||
27829789|NCT02554890|81206170|FG000|Double-blind|Lost to Follow-up|7|||
27829790|NCT02554890|81206171|FG001|Double-blind|Lost to Follow-up|5|||
27829791|NCT02554890|81206170|FG000|Double-blind|Technical problems|1|||
27829792|NCT02554890|81206171|FG001|Double-blind|Technical problems|0|||
27829793|NCT02554890|81206170|FG000|Double-blind|Withdrawal by Subject|5|||
27698489|NCT00195507|80732873|FG001|Overall Study|Failed to Return|3|||
27698490|NCT00195507|80732872|FG000|Overall Study|Physician Decision|1|||
27698491|NCT00195507|80732873|FG001|Overall Study|Physician Decision|2|||
27698492|NCT00195507|80732872|FG000|Overall Study|Lost to Follow-up|3|||
27698493|NCT00195507|80732873|FG001|Overall Study|Lost to Follow-up|2|||
27698494|NCT00195507|80732872|FG000|Overall Study|Protocol Violation|5|||
27698495|NCT00195507|80732873|FG001|Overall Study|Protocol Violation|4|||
27698496|NCT00195507|80732872|FG000|Overall Study|Lack of Efficacy|40|||
27698497|NCT00195507|80732873|FG001|Overall Study|Lack of Efficacy|67|||
27698498|NCT00195507|80732872|FG000|Overall Study|Withdrawal by Subject|16|||
27698499|NCT00195507|80732873|FG001|Overall Study|Withdrawal by Subject|23|||
27698500|NCT00195507|80732872|FG000|Overall Study|Protocol Deviation|6|||
27698501|NCT00195507|80732873|FG001|Overall Study|Protocol Deviation|3|||
27698502|NCT01201343|80732874|FG000|Overall Study|Adverse Event|6|||
27698503|NCT01201343|80732874|FG000|Overall Study|Withdrawal by Subject|5|||
27698504|NCT01201343|80732874|FG000|Overall Study|Lost to Follow-up|2|||
27698505|NCT01201343|80732874|FG000|Overall Study|Lack of Efficacy|2|||
27698506|NCT01201343|80732874|FG000|Overall Study|Participant wrongly included in trial|1|||
27698507|NCT01201343|80732874|FG000|Overall Study|Randomized, not treated|3|||
27698508|NCT02141984|80732875|FG000|Overall Study|Lack of Efficacy|2|||
27698509|NCT01881750|80732876|FG000|Overall Study|Changes in concomitant therapies|2|||
27698510|NCT01881750|80732877|FG001|Overall Study|Changes in concomitant therapies|3|||
27698511|NCT01881750|80732876|FG000|Overall Study|Lost to Follow-up|0|||
27698512|NCT01881750|80732877|FG001|Overall Study|Lost to Follow-up|1|||
27698513|NCT04464265|80732878|FG000|Overall Study|Physician Decision|2|||
27698514|NCT03907410|80732879|FG000|Overall Study|Lost to Follow-up|4|||
27698515|NCT03907410|80732880|FG001|Overall Study|Lost to Follow-up|1|||
27698516|NCT03907410|80732881|FG002|Overall Study|Lost to Follow-up|1|||
27698517|NCT03907410|80732879|FG000|Overall Study|Lost to follow-up and research burden|0|||
27698518|NCT03907410|80732880|FG001|Overall Study|Lost to follow-up and research burden|0|||
27698519|NCT03907410|80732881|FG002|Overall Study|Lost to follow-up and research burden|1|||
27698520|NCT02824263|80732882|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
27698521|NCT02824263|80732883|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
27698522|NCT02824263|80732882|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
27698523|NCT02824263|80732883|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
27698524|NCT03602066|80732884|FG000|Overall Study|Withdrawal by Subject|2|||
27698525|NCT03602066|80732885|FG001|Overall Study|Withdrawal by Subject|0|||
27698526|NCT03602066|80732884|FG000|Overall Study|Physician Decision|1|||
27698527|NCT03602066|80732885|FG001|Overall Study|Physician Decision|0|||
27698528|NCT01067326|80732886|FG000|Overall Study|Adverse Event|0|||
27698529|NCT01067326|80732887|FG001|Overall Study|Adverse Event|2|||
27698530|NCT01067326|80732886|FG000|Overall Study|Withdrawal by Subject|1|||
27698531|NCT01067326|80732887|FG001|Overall Study|Withdrawal by Subject|0|||
27698532|NCT01067326|80732886|FG000|Overall Study|Early Study Termination|1|||
27698533|NCT01067326|80732887|FG001|Overall Study|Early Study Termination|1|||
27698534|NCT00975715|80732889|FG000|Titration Period|Adverse Event|6|||
27698535|NCT00975715|80732890|FG001|Titration Period|Adverse Event|0|||
27698536|NCT00975715|80732889|FG000|Titration Period|Protocol Violation|1|||
27698537|NCT00975715|80732890|FG001|Titration Period|Protocol Violation|0|||
27698538|NCT00975715|80732889|FG000|Maintenance Period|Adverse Event|2|||
27698539|NCT00975715|80732890|FG001|Maintenance Period|Adverse Event|1|||
27698540|NCT03756350|80732891|FG000|Overall Study|Lost to Follow-up|1|||
27698541|NCT03566810|80732895|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
27698542|NCT03566810|80732896|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
27698543|NCT03566810|80732897|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
27698544|NCT03566810|80732898|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
27698545|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
27698546|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
27698547|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
27884624|NCT02649439|81411894|FG000|Overall Study|Refused further treatment|1|||
27884625|NCT02649439|81411895|FG001|Overall Study|Refused further treatment|0|||
27884626|NCT02649439|81411894|FG000|Overall Study|Refused further follow up|2|||
27884627|NCT02649439|81411895|FG001|Overall Study|Refused further follow up|7|||
27884628|NCT02649439|81411894|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
27884629|NCT02649439|81411895|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
27884630|NCT02649439|81411894|FG000|Overall Study|No treatment, per protocol|1|||
27558942|NCT01770379|80233154|FG001|Overall Study|Lost to Follow-up|0|||
27698548|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
27698549|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
27698550|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
27698551|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
27698552|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
27698553|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
27884631|NCT02649439|81411895|FG001|Overall Study|No treatment, per protocol|0|||
27884632|NCT02649439|81411894|FG000|Overall Study|PSA DT makes ineligible|0|||
27884633|NCT02649439|81411895|FG001|Overall Study|PSA DT makes ineligible|1|||
27884634|NCT02649439|81411894|FG000|Overall Study|Rising PSA No Mets|0|||
27884635|NCT02649439|81411895|FG001|Overall Study|Rising PSA No Mets|1|||
27884636|NCT02649439|81411894|FG000|Overall Study|Rising PSA|0|||
27884637|NCT02649439|81411895|FG001|Overall Study|Rising PSA|1|||
27884638|NCT02649439|81411894|FG000|Overall Study|Signed follow up protocol|0|||
27884639|NCT02649439|81411895|FG001|Overall Study|Signed follow up protocol|1|||
27884640|NCT01289639|81411899|FG000|Overall Study|Lost to Follow-up|1|||
27884641|NCT01289639|81411900|FG001|Overall Study|Lost to Follow-up|0|||
27884642|NCT01289639|81411901|FG002|Overall Study|Lost to Follow-up|0|||
27884643|NCT00443079|81411909|FG000|Overall Study|Lost to Follow-up|0|||
27884644|NCT00443079|81411910|FG001|Overall Study|Lost to Follow-up|1|||
27884645|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
27884646|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
27884647|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
27884648|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
27884649|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
27884650|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
27884651|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
27884652|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
27884653|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
27884654|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
27884655|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
27884656|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
27884657|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
27884658|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
27884659|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
27884660|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
27558943|NCT01770379|80233155|FG002|Overall Study|Lost to Follow-up|2|||
27558944|NCT01770379|80233153|FG000|Overall Study|Lack of Efficacy|8|||
27558945|NCT01770379|80233154|FG001|Overall Study|Lack of Efficacy|6|||
27558946|NCT01770379|80233155|FG002|Overall Study|Lack of Efficacy|6|||
27558947|NCT01770379|80233153|FG000|Overall Study|Adverse Event|1|||
27884661|NCT00491556|81411911|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
27884662|NCT00491556|81411912|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
27558948|NCT01770379|80233154|FG001|Overall Study|Adverse Event|3|||
27829794|NCT02554890|81206171|FG001|Double-blind|Withdrawal by Subject|6|||
27829795|NCT02554890|81206170|FG000|Double-blind|Noncompliance with study treatment|6|||
27829796|NCT02554890|81206171|FG001|Double-blind|Noncompliance with study treatment|5|||
27829797|NCT02554890|81206170|FG000|Open-label|Adverse Event|0|||
27829798|NCT02554890|81206171|FG001|Open-label|Adverse Event|30|||
27829799|NCT02554890|81206170|FG000|Open-label|Death|0|||
27829800|NCT02554890|81206171|FG001|Open-label|Death|1|||
27829801|NCT02554890|81206170|FG000|Open-label|Physician Decision|0|||
27829802|NCT02554890|81206171|FG001|Open-label|Physician Decision|1|||
27829803|NCT02554890|81206170|FG000|Open-label|Subject/Guardian decision|0|||
27829804|NCT02554890|81206171|FG001|Open-label|Subject/Guardian decision|11|||
27829805|NCT02554890|81206170|FG000|Open-label|Lost to Follow-up|0|||
27829806|NCT02554890|81206171|FG001|Open-label|Lost to Follow-up|7|||
27829807|NCT02554890|81206170|FG000|Open-label|Technical problems|0|||
27829808|NCT02554890|81206171|FG001|Open-label|Technical problems|1|||
27829809|NCT02554890|81206170|FG000|Open-label|Withdrawal by Subject|0|||
27829810|NCT02554890|81206171|FG001|Open-label|Withdrawal by Subject|1|||
27829811|NCT00829530|81206172|FG000|First Intervention|Adverse Event|0|||
27829812|NCT00829530|81206173|FG001|First Intervention|Adverse Event|1|||
27829813|NCT00829530|81206172|FG000|First Intervention|Intolerance to Venopuncture|0|||
27829814|NCT00829530|81206173|FG001|First Intervention|Intolerance to Venopuncture|1|||
27829815|NCT00829530|81206172|FG000|Second Intervention|Intolerance to Venopuncture|1|||
27829816|NCT00829530|81206173|FG001|Second Intervention|Intolerance to Venopuncture|0|||
27829817|NCT02269657|81206174|FG000|Overall Study|Protocol Violation|3|||
27829818|NCT00835575|81209134|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
27829819|NCT00835575|81209135|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
27829820|NCT04966741|81209143|FG000|Overall Study|Lost to Follow-up|1|||
27558949|NCT01770379|80233155|FG002|Overall Study|Adverse Event|2|||
27558950|NCT03341533|80233156|FG000|Overall Study|Withdrawal by Subject|1|||
27558951|NCT03341533|80233157|FG001|Overall Study|Withdrawal by Subject|1|||
27558952|NCT03341533|80233156|FG000|Overall Study|Not eligible after randomization|2|||
27558953|NCT03341533|80233157|FG001|Overall Study|Not eligible after randomization|1|||
27558954|NCT00909389|80233158|FG000|Overall Study|Adverse Event|6|||
27558955|NCT00909389|80233158|FG000|Overall Study|Death|4|||
27558956|NCT00909389|80233158|FG000|Overall Study|Poor Compliance|16|||
27558957|NCT00909389|80233158|FG000|Overall Study|Lost to Follow-up|4|||
27558958|NCT00909389|80233158|FG000|Overall Study|No Information|103|||
27558959|NCT00541034|80233160|FG000|Overall Study|Non-Compliance|3|||
27558960|NCT00022633|80233161|FG000|Overall Study|Adverse Event|11|||
27558961|NCT00022633|80233162|FG001|Overall Study|Adverse Event|1|||
27558962|NCT00022633|80233161|FG000|Overall Study|Refusal unrelated to adverse event|1|||
27558963|NCT00022633|80233162|FG001|Overall Study|Refusal unrelated to adverse event|0|||
27558964|NCT00022633|80233161|FG000|Overall Study|Progression/relapse|9|||
27558965|NCT00022633|80233162|FG001|Overall Study|Progression/relapse|2|||
27558966|NCT00022633|80233161|FG000|Overall Study|Death|4|||
27558967|NCT00022633|80233162|FG001|Overall Study|Death|0|||
27558968|NCT00022633|80233161|FG000|Overall Study|Other - not protocol specified|3|||
27829821|NCT04966741|81209144|FG001|Overall Study|Lost to Follow-up|0|||
27829822|NCT00712959|81209149|FG000|Overall Study|Protocol Violation|3|||
27558969|NCT00022633|80233162|FG001|Overall Study|Other - not protocol specified|2|||
27558970|NCT00022633|80233161|FG000|Overall Study|Ineligible|4|||
27558971|NCT00022633|80233162|FG001|Overall Study|Ineligible|0|||
27558972|NCT03065244|80233163|FG000|Overall Study|Lost to Follow-up|1|||
27558973|NCT03065244|80233164|FG001|Overall Study|Lost to Follow-up|1|||
27829823|NCT00712959|81209150|FG001|Overall Study|Protocol Violation|1|||
27558974|NCT03065244|80233163|FG000|Overall Study|Diagnosed with a different disease|1|||
27558975|NCT03065244|80233164|FG001|Overall Study|Diagnosed with a different disease|1|||
27829824|NCT00712959|81209149|FG000|Overall Study|Lost to Follow-up|13|||
27829825|NCT00712959|81209150|FG001|Overall Study|Lost to Follow-up|2|||
27829826|NCT00712959|81209149|FG000|Overall Study|Withdrawal by Subject|3|||
27829827|NCT00712959|81209150|FG001|Overall Study|Withdrawal by Subject|0|||
27829828|NCT01340495|81209157|FG000|Overall Study|Withdrawal by Subject|1|||
27829829|NCT00838539|81209158|FG000|Overall Study|Disease Progression|2|||
27558976|NCT03065244|80233163|FG000|Overall Study|Protocol Violation|0|||
27558977|NCT03065244|80233164|FG001|Overall Study|Protocol Violation|1|||
27558978|NCT03065244|80233163|FG000|Overall Study|Withdrawal by Subject|1|||
27558979|NCT03065244|80233164|FG001|Overall Study|Withdrawal by Subject|1|||
27558980|NCT00849381|80233165|FG000|Overall Study|Adverse Event|1|||
27558981|NCT00849381|80233165|FG000|Overall Study|Lost to Follow-up|129|||
27558982|NCT00849381|80233165|FG000|Overall Study|Protocol Violation|5|||
27558983|NCT00849381|80233165|FG000|Overall Study|Withdrawal by Subject|6|||
27558984|NCT00849381|80233165|FG000|Overall Study|Other|4|||
27558985|NCT00224055|80233166|FG000|Overall Study|Adverse Event|9|||
27558986|NCT00224055|80233167|FG001|Overall Study|Adverse Event|3|||
27558987|NCT00224055|80233166|FG000|Overall Study|Lost to Follow-up|1|||
27558988|NCT00224055|80233167|FG001|Overall Study|Lost to Follow-up|2|||
27558989|NCT00224055|80233166|FG000|Overall Study|Protocol Violation|1|||
27558990|NCT00224055|80233167|FG001|Overall Study|Protocol Violation|1|||
27558991|NCT00224055|80233166|FG000|Overall Study|Inclusion Violation|3|||
27558992|NCT00224055|80233167|FG001|Overall Study|Inclusion Violation|6|||
27558993|NCT00224055|80233166|FG000|Overall Study|Withdrawal by Subject|0|||
27558994|NCT00224055|80233167|FG001|Overall Study|Withdrawal by Subject|2|||
27558995|NCT00224055|80233166|FG000|Overall Study|Other|1|||
27558996|NCT00224055|80233167|FG001|Overall Study|Other|0|||
27558997|NCT04166435|80233172|FG000|Overall Study|2 patients ineligible for response|2|||
27558998|NCT00255047|80233173|FG000|Overall Study|Serious Adverse Events|2|||
27558999|NCT00255047|80233174|FG001|Overall Study|Serious Adverse Events|1|||
27559000|NCT00255047|80233175|FG002|Overall Study|Serious Adverse Events|2|||
27559001|NCT00255047|80233176|FG003|Overall Study|Serious Adverse Events|1|||
27559002|NCT00255047|80233173|FG000|Overall Study|Adverse Event|0|||
27559003|NCT00255047|80233174|FG001|Overall Study|Adverse Event|3|||
27559004|NCT00255047|80233175|FG002|Overall Study|Adverse Event|2|||
27559005|NCT00255047|80233176|FG003|Overall Study|Adverse Event|1|||
27559006|NCT00255047|80233173|FG000|Overall Study|Protocol Violation|13|||
27559007|NCT00255047|80233174|FG001|Overall Study|Protocol Violation|13|||
27559008|NCT00255047|80233175|FG002|Overall Study|Protocol Violation|16|||
27559009|NCT00255047|80233176|FG003|Overall Study|Protocol Violation|20|||
27559010|NCT00255047|80233173|FG000|Overall Study|Lost to Follow-up|9|||
27559011|NCT00255047|80233174|FG001|Overall Study|Lost to Follow-up|8|||
27559012|NCT00255047|80233175|FG002|Overall Study|Lost to Follow-up|5|||
27559013|NCT00255047|80233176|FG003|Overall Study|Lost to Follow-up|6|||
27559014|NCT00255047|80233173|FG000|Overall Study|Withdrawal by Subject|24|||
27559015|NCT00255047|80233174|FG001|Overall Study|Withdrawal by Subject|23|||
27559016|NCT00255047|80233175|FG002|Overall Study|Withdrawal by Subject|25|||
27559017|NCT00255047|80233176|FG003|Overall Study|Withdrawal by Subject|18|||
27559018|NCT01686633|80233177|FG000|Overall Study|Lack of Efficacy|33|||
27559019|NCT01686633|80233178|FG001|Overall Study|Lack of Efficacy|13|||
27559020|NCT01686633|80233179|FG002|Overall Study|Lack of Efficacy|11|||
27559021|NCT01686633|80233177|FG000|Overall Study|Withdrawal by Subject|8|||
27559022|NCT01686633|80233178|FG001|Overall Study|Withdrawal by Subject|8|||
27559023|NCT01686633|80233179|FG002|Overall Study|Withdrawal by Subject|5|||
27559024|NCT01686633|80233177|FG000|Overall Study|Physician Decision|3|||
27559025|NCT01686633|80233178|FG001|Overall Study|Physician Decision|4|||
27559026|NCT01686633|80233179|FG002|Overall Study|Physician Decision|4|||
27559027|NCT01686633|80233177|FG000|Overall Study|Adverse Event|4|||
27559028|NCT01686633|80233178|FG001|Overall Study|Adverse Event|3|||
27559029|NCT01686633|80233179|FG002|Overall Study|Adverse Event|3|||
27559030|NCT01686633|80233177|FG000|Overall Study|Protocol Violation|2|||
27559031|NCT01686633|80233178|FG001|Overall Study|Protocol Violation|3|||
27559032|NCT01686633|80233179|FG002|Overall Study|Protocol Violation|0|||
27559033|NCT01686633|80233177|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
27559034|NCT01686633|80233178|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
27559035|NCT01686633|80233179|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
27559036|NCT01686633|80233177|FG000|Overall Study|Lost to Follow-up|0|||
27559037|NCT01686633|80233178|FG001|Overall Study|Lost to Follow-up|1|||
27559038|NCT01686633|80233179|FG002|Overall Study|Lost to Follow-up|1|||
27559039|NCT00656474|80233180|FG000|Overall Study|Other Reason|1|||
27559040|NCT01119131|80233181|FG000|Overall Study|Adverse Event|1|||
27559041|NCT01119131|80233182|FG001|Overall Study|Adverse Event|1|||
27559042|NCT01119131|80233183|FG002|Overall Study|Adverse Event|1|||
27559043|NCT01119131|80233181|FG000|Overall Study|Non-Compliance|1|||
27559044|NCT01119131|80233182|FG001|Overall Study|Non-Compliance|0|||
27559045|NCT01119131|80233183|FG002|Overall Study|Non-Compliance|4|||
27559046|NCT01119131|80233181|FG000|Overall Study|Physician Decision|0|||
27559047|NCT01119131|80233182|FG001|Overall Study|Physician Decision|0|||
27559048|NCT01119131|80233183|FG002|Overall Study|Physician Decision|1|||
27559049|NCT04351087|80233184|FG000|Overall Study|Lost to Follow-up|7|||
27559050|NCT04351087|80233185|FG001|Overall Study|Lost to Follow-up|3|||
27559051|NCT04351087|80233184|FG000|Overall Study|Withdrawal by Subject|3|||
27559052|NCT04351087|80233185|FG001|Overall Study|Withdrawal by Subject|4|||
27559053|NCT04351087|80233184|FG000|Overall Study|Lack of Efficacy|3|||
27559054|NCT04351087|80233185|FG001|Overall Study|Lack of Efficacy|2|||
27559055|NCT03010254|80233186|FG000|Overall Study|Adverse Event|0|||
27559056|NCT03010254|80233187|FG001|Overall Study|Adverse Event|1|||
27559057|NCT03010254|80233186|FG000|Overall Study|Lost to Follow-up|4|||
27559058|NCT03010254|80233187|FG001|Overall Study|Lost to Follow-up|0|||
27559059|NCT03010254|80233186|FG000|Overall Study|Withdrawal by Subject|1|||
27559060|NCT03010254|80233187|FG001|Overall Study|Withdrawal by Subject|1|||
27559061|NCT03010254|80233186|FG000|Overall Study|Other|2|||
27559062|NCT03010254|80233187|FG001|Overall Study|Other|3|||
27559063|NCT03761147|80233188|FG000|Overall Study|Withdrawal by Subject|6|||
27559064|NCT03761147|80233189|FG001|Overall Study|Withdrawal by Subject|1|||
27559065|NCT03761147|80233188|FG000|Overall Study|Adverse Event|1|||
27559066|NCT03761147|80233189|FG001|Overall Study|Adverse Event|3|||
27559067|NCT00567892|80233192|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
27829830|NCT00838539|81209159|FG001|Overall Study|Disease Progression|4|||
27829831|NCT00838539|81209160|FG002|Overall Study|Disease Progression|3|||
27829832|NCT00838539|81209161|FG003|Overall Study|Disease Progression|2|||
27829833|NCT00838539|81209162|FG004|Overall Study|Disease Progression|4|||
27559068|NCT00567892|80233193|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
27559069|NCT00567892|80233194|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
27559070|NCT00567892|80233195|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
27559071|NCT00567892|80233192|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
27559072|NCT00567892|80233193|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
27559073|NCT00567892|80233194|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
27559074|NCT00567892|80233195|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
27559075|NCT04461015|80233196|FG000|Overall Study|IV access lost during the study|0|||
27559076|NCT04461015|80233197|FG001|Overall Study|IV access lost during the study|1|||
27559077|NCT04461015|80233196|FG000|Overall Study|Withdrawal by Subject|0|||
27559078|NCT04461015|80233197|FG001|Overall Study|Withdrawal by Subject|1|||
27829834|NCT00838539|81209163|FG005|Overall Study|Disease Progression|2|||
27829835|NCT00838539|81209164|FG006|Overall Study|Disease Progression|3|||
27829836|NCT00838539|81209165|FG007|Overall Study|Disease Progression|4|||
27559079|NCT00276159|80233198|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
27559080|NCT04200456|80233199|FG000|Overall Study|Physician Decision|0|||
27559081|NCT04200456|80233200|FG001|Overall Study|Physician Decision|1|||
27559082|NCT04200456|80233199|FG000|Overall Study|Withdrawal by Subject|2|||
27829837|NCT00838539|81209166|FG008|Overall Study|Disease Progression|4|||
27829838|NCT00838539|81209167|FG009|Overall Study|Disease Progression|5|||
27829839|NCT00838539|81209168|FG010|Overall Study|Disease Progression|1|||
27829840|NCT00838539|81209169|FG011|Overall Study|Disease Progression|4|||
27829841|NCT00838539|81209158|FG000|Overall Study|Adverse Event|1|||
27829842|NCT00838539|81209159|FG001|Overall Study|Adverse Event|1|||
27829843|NCT00838539|81209160|FG002|Overall Study|Adverse Event|1|||
27829844|NCT00838539|81209161|FG003|Overall Study|Adverse Event|1|||
27829845|NCT00838539|81209162|FG004|Overall Study|Adverse Event|2|||
27829846|NCT00838539|81209163|FG005|Overall Study|Adverse Event|1|||
27829847|NCT00838539|81209164|FG006|Overall Study|Adverse Event|0|||
27829848|NCT00838539|81209165|FG007|Overall Study|Adverse Event|2|||
27829849|NCT00838539|81209166|FG008|Overall Study|Adverse Event|0|||
27829850|NCT00838539|81209167|FG009|Overall Study|Adverse Event|1|||
27829851|NCT00838539|81209168|FG010|Overall Study|Adverse Event|2|||
27829852|NCT00838539|81209169|FG011|Overall Study|Adverse Event|0|||
27829853|NCT00838539|81209158|FG000|Overall Study|Withdrawal by Subject|0|||
27829854|NCT00838539|81209159|FG001|Overall Study|Withdrawal by Subject|1|||
27829855|NCT00838539|81209160|FG002|Overall Study|Withdrawal by Subject|0|||
27698554|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
27698555|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
27829856|NCT00838539|81209161|FG003|Overall Study|Withdrawal by Subject|0|||
27829857|NCT00838539|81209162|FG004|Overall Study|Withdrawal by Subject|0|||
27829858|NCT00838539|81209163|FG005|Overall Study|Withdrawal by Subject|0|||
27829859|NCT00838539|81209164|FG006|Overall Study|Withdrawal by Subject|0|||
27829860|NCT00838539|81209165|FG007|Overall Study|Withdrawal by Subject|0|||
27829861|NCT00838539|81209166|FG008|Overall Study|Withdrawal by Subject|0|||
27829862|NCT00838539|81209167|FG009|Overall Study|Withdrawal by Subject|1|||
27829863|NCT00838539|81209168|FG010|Overall Study|Withdrawal by Subject|2|||
27829864|NCT00838539|81209169|FG011|Overall Study|Withdrawal by Subject|0|||
27829865|NCT00838539|81209158|FG000|Overall Study|Death|0|||
27829866|NCT00838539|81209159|FG001|Overall Study|Death|0|||
27829867|NCT00838539|81209160|FG002|Overall Study|Death|0|||
27829868|NCT00838539|81209161|FG003|Overall Study|Death|0|||
27829869|NCT00838539|81209162|FG004|Overall Study|Death|0|||
27829870|NCT00838539|81209163|FG005|Overall Study|Death|0|||
27829871|NCT00838539|81209164|FG006|Overall Study|Death|1|||
27829872|NCT00838539|81209165|FG007|Overall Study|Death|0|||
27829873|NCT00838539|81209166|FG008|Overall Study|Death|0|||
27829874|NCT00838539|81209167|FG009|Overall Study|Death|0|||
27829875|NCT00838539|81209168|FG010|Overall Study|Death|0|||
27829876|NCT00838539|81209169|FG011|Overall Study|Death|0|||
27829877|NCT00838539|81209158|FG000|Overall Study|Physician Decision|0|||
27829878|NCT00838539|81209159|FG001|Overall Study|Physician Decision|0|||
27829879|NCT00838539|81209160|FG002|Overall Study|Physician Decision|0|||
27829880|NCT00838539|81209161|FG003|Overall Study|Physician Decision|0|||
27829881|NCT00838539|81209162|FG004|Overall Study|Physician Decision|0|||
27829882|NCT00838539|81209163|FG005|Overall Study|Physician Decision|0|||
27829883|NCT00838539|81209164|FG006|Overall Study|Physician Decision|0|||
27829884|NCT00838539|81209165|FG007|Overall Study|Physician Decision|0|||
27829885|NCT00838539|81209166|FG008|Overall Study|Physician Decision|1|||
27829886|NCT00838539|81209167|FG009|Overall Study|Physician Decision|0|||
27829887|NCT00838539|81209168|FG010|Overall Study|Physician Decision|0|||
27829888|NCT00838539|81209169|FG011|Overall Study|Physician Decision|0|||
27829889|NCT00838539|81209158|FG000|Overall Study|Clinical Progression|0|||
27829890|NCT00838539|81209159|FG001|Overall Study|Clinical Progression|0|||
27559083|NCT04200456|80233200|FG001|Overall Study|Withdrawal by Subject|2|||
27559084|NCT04200456|80233199|FG000|Overall Study|Lack of Efficacy|1|||
27559085|NCT04200456|80233200|FG001|Overall Study|Lack of Efficacy|1|||
27559086|NCT04200456|80233199|FG000|Overall Study|Adverse event, non-fatal|0|||
27559087|NCT04200456|80233200|FG001|Overall Study|Adverse event, non-fatal|1|||
27559088|NCT04200456|80233199|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
27559089|NCT04200456|80233200|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
27559090|NCT00535223|80233201|FG000|Overall Study|Withdrawal by Subject|4|||
27559091|NCT00535223|80233202|FG001|Overall Study|Withdrawal by Subject|1|||
27559092|NCT00674661|80233205|FG000|Overall Study|Other|5|||
27559093|NCT00674661|80233206|FG001|Overall Study|Other|7|||
27559094|NCT00674661|80233205|FG000|Overall Study|Lost to Follow-up|6|||
27559095|NCT00674661|80233206|FG001|Overall Study|Lost to Follow-up|3|||
27559096|NCT00674661|80233205|FG000|Overall Study|Withdrawal by Subject|0|||
27559097|NCT00674661|80233206|FG001|Overall Study|Withdrawal by Subject|5|||
27559098|NCT01980875|80233209|FG000|Overall Study|Withdrew Consent|1|||
27559099|NCT01980875|80233210|FG001|Overall Study|Withdrew Consent|1|||
27559100|NCT01980875|80233211|FG002|Overall Study|Withdrew Consent|1|||
27559101|NCT01980875|80233209|FG000|Overall Study|Study Terminated by Sponsor|7|||
27559102|NCT01980875|80233210|FG001|Overall Study|Study Terminated by Sponsor|24|||
27559103|NCT01980875|80233211|FG002|Overall Study|Study Terminated by Sponsor|22|||
27559104|NCT01980875|80233209|FG000|Overall Study|Lost to Follow-up|0|||
27559105|NCT01980875|80233210|FG001|Overall Study|Lost to Follow-up|0|||
27559106|NCT01980875|80233211|FG002|Overall Study|Lost to Follow-up|1|||
27559107|NCT03473808|80233213|FG000|Overall Study|Withdrawal by Subject|1|||
27559108|NCT00498602|80233215|FG000|Overall Study|Death|0|||
27559109|NCT00498602|80233216|FG001|Overall Study|Death|0|||
27559110|NCT00498602|80233217|FG002|Overall Study|Death|0|||
27829891|NCT00838539|81209160|FG002|Overall Study|Clinical Progression|0|||
27829892|NCT00838539|81209161|FG003|Overall Study|Clinical Progression|0|||
27559111|NCT00498602|80233218|FG003|Overall Study|Death|0|||
27559112|NCT00498602|80233219|FG004|Overall Study|Death|0|||
27829893|NCT00838539|81209162|FG004|Overall Study|Clinical Progression|0|||
27829894|NCT00838539|81209163|FG005|Overall Study|Clinical Progression|0|||
27559113|NCT00498602|80233220|FG005|Overall Study|Death|1|||
27559114|NCT00498602|80233221|FG006|Overall Study|Death|0|||
27559115|NCT00498602|80233215|FG000|Overall Study|Lack of Efficacy|1|||
27559116|NCT00498602|80233216|FG001|Overall Study|Lack of Efficacy|0|||
27559117|NCT00498602|80233217|FG002|Overall Study|Lack of Efficacy|0|||
27559118|NCT00498602|80233218|FG003|Overall Study|Lack of Efficacy|0|||
27559119|NCT00498602|80233219|FG004|Overall Study|Lack of Efficacy|0|||
27559120|NCT00498602|80233220|FG005|Overall Study|Lack of Efficacy|0|||
27559121|NCT00498602|80233221|FG006|Overall Study|Lack of Efficacy|0|||
27559122|NCT00498602|80233215|FG000|Overall Study|Lost to Follow-up|0|||
27559123|NCT00498602|80233216|FG001|Overall Study|Lost to Follow-up|2|||
27559124|NCT00498602|80233217|FG002|Overall Study|Lost to Follow-up|0|||
27559125|NCT00498602|80233218|FG003|Overall Study|Lost to Follow-up|2|||
27559126|NCT00498602|80233219|FG004|Overall Study|Lost to Follow-up|0|||
27559127|NCT00498602|80233220|FG005|Overall Study|Lost to Follow-up|0|||
27559128|NCT00498602|80233221|FG006|Overall Study|Lost to Follow-up|0|||
27698556|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
27698557|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
27698558|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
27698559|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
27829895|NCT00838539|81209164|FG006|Overall Study|Clinical Progression|1|||
27829896|NCT00838539|81209165|FG007|Overall Study|Clinical Progression|0|||
27698560|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
27698561|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
27698562|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
27698563|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
27698564|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
27698565|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
27829897|NCT00838539|81209166|FG008|Overall Study|Clinical Progression|0|||
27829898|NCT00838539|81209167|FG009|Overall Study|Clinical Progression|0|||
27829899|NCT00838539|81209168|FG010|Overall Study|Clinical Progression|0|||
27829900|NCT00838539|81209169|FG011|Overall Study|Clinical Progression|0|||
27829901|NCT00838539|81209158|FG000|Overall Study|Symptomatic Deterioration|0|||
27829902|NCT00838539|81209159|FG001|Overall Study|Symptomatic Deterioration|0|||
27829903|NCT00838539|81209160|FG002|Overall Study|Symptomatic Deterioration|1|||
27829904|NCT00838539|81209161|FG003|Overall Study|Symptomatic Deterioration|1|||
27884663|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
27884664|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
27698566|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
27559129|NCT00498602|80233215|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
27559130|NCT00498602|80233216|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
27698567|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
27829905|NCT00838539|81209162|FG004|Overall Study|Symptomatic Deterioration|0|||
27829906|NCT00838539|81209163|FG005|Overall Study|Symptomatic Deterioration|1|||
27698568|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
27829907|NCT00838539|81209164|FG006|Overall Study|Symptomatic Deterioration|0|||
27829908|NCT00838539|81209165|FG007|Overall Study|Symptomatic Deterioration|0|||
27829909|NCT00838539|81209166|FG008|Overall Study|Symptomatic Deterioration|0|||
27829910|NCT00838539|81209167|FG009|Overall Study|Symptomatic Deterioration|1|||
27829911|NCT00838539|81209168|FG010|Overall Study|Symptomatic Deterioration|0|||
27829912|NCT00838539|81209169|FG011|Overall Study|Symptomatic Deterioration|0|||
27829913|NCT02440711|81209170|FG000|Second Intervention|Lost to Follow-up|1|||
27829914|NCT02440711|81209171|FG001|Second Intervention|Lost to Follow-up|0|||
27829915|NCT00443651|81209174|FG000|Overall Study|Death|1|||
27829916|NCT00443651|81209175|FG001|Overall Study|Death|5|||
27829917|NCT00443651|81209174|FG000|Overall Study|Adverse Event|5|||
27829918|NCT00443651|81209175|FG001|Overall Study|Adverse Event|6|||
27829919|NCT00443651|81209174|FG000|Overall Study|Lost to Follow-up|18|||
27829920|NCT00443651|81209175|FG001|Overall Study|Lost to Follow-up|12|||
27829921|NCT00443651|81209174|FG000|Overall Study|Patient's/Guardian's Decision|58|||
27829922|NCT00443651|81209175|FG001|Overall Study|Patient's/Guardian's Decision|30|||
27829923|NCT00443651|81209174|FG000|Overall Study|Physician Decision|13|||
27829924|NCT00443651|81209175|FG001|Overall Study|Physician Decision|4|||
27829925|NCT00443651|81209174|FG000|Overall Study|Pregnancy|0|||
27829926|NCT00443651|81209175|FG001|Overall Study|Pregnancy|1|||
27829927|NCT02149420|81209176|FG000|Core Study|Administrative problems|0|||
27829928|NCT02149420|81209177|FG001|Core Study|Administrative problems|1|||
27829929|NCT02149420|81209178|FG002|Core Study|Administrative problems|2|||
27829930|NCT02149420|81209176|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
27829931|NCT02149420|81209177|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
27829932|NCT02149420|81209178|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
27829933|NCT00942968|81209188|FG000|Overall Study|Adverse Event|60|||
27829934|NCT00942968|81209188|FG000|Overall Study|Death|76|||
27829935|NCT00942968|81209188|FG000|Overall Study|Protocol Violation|9|||
27829936|NCT00942968|81209188|FG000|Overall Study|Lost to Follow-up|4|||
27884665|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
27829937|NCT00942968|81209188|FG000|Overall Study|Withdrawal by Subject|44|||
27829938|NCT00942968|81209188|FG000|Overall Study|Sponsor request|5|||
27884666|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
27884667|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
27884668|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
27884669|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
27884670|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
27884671|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
27884672|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
27884673|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
27884674|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
27884675|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
27884676|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
27884677|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
27884678|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
27884679|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
27884680|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
27884681|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
27884682|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
27884683|NCT00491556|81411911|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
27884684|NCT00491556|81411912|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
27884685|NCT02278939|81411913|FG000|Overall Study|lack of time|1|||
27884686|NCT02278939|81411914|FG001|Overall Study|lack of time|0|||
27829939|NCT00942968|81209188|FG000|Overall Study|Physician Decision|11|||
27829940|NCT00942968|81209188|FG000|Overall Study|Progression of disease|12|||
27884687|NCT02278939|81411913|FG000|Overall Study|Lost to Follow-up|1|||
27884688|NCT02278939|81411914|FG001|Overall Study|Lost to Follow-up|1|||
27884689|NCT02278939|81411913|FG000|Overall Study|death in family|1|||
27884690|NCT02278939|81411914|FG001|Overall Study|death in family|0|||
27884691|NCT02278939|81411913|FG000|Overall Study|family emergency unable to commit|2|||
27884692|NCT02278939|81411914|FG001|Overall Study|family emergency unable to commit|0|||
27884693|NCT02120833|81411915|FG000|Overall Study|Adverse Event|1|||
27884694|NCT02120833|81411916|FG001|Overall Study|Adverse Event|0|||
27884695|NCT02120833|81411915|FG000|Overall Study|Withdrawal by Subject|2|||
27884696|NCT02120833|81411916|FG001|Overall Study|Withdrawal by Subject|0|||
27884697|NCT02120833|81411915|FG000|Overall Study|Lost to Follow-up|1|||
27884698|NCT02120833|81411916|FG001|Overall Study|Lost to Follow-up|1|||
27829941|NCT00942968|81209188|FG000|Overall Study|Inferior vena cava filter placement|4|||
27829942|NCT00942968|81209188|FG000|Overall Study|Pulmonary embolism (PE)|1|||
27829943|NCT00942968|81209188|FG000|Overall Study|Participant required pancreatic biopsy|1|||
27829944|NCT00942968|81209188|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
27884699|NCT02237196|81411917|FG000|Overall Study|Adverse Event|0|||
27884700|NCT02237196|81411918|FG001|Overall Study|Adverse Event|1|||
27884701|NCT02237196|81411919|FG002|Overall Study|Adverse Event|1|||
27884702|NCT02237196|81411920|FG003|Overall Study|Adverse Event|0|||
27884703|NCT02237196|81411917|FG000|Overall Study|Lost to Follow-up|4|||
27884704|NCT02237196|81411918|FG001|Overall Study|Lost to Follow-up|2|||
27829945|NCT00463684|81209189|FG000|Overall Study|Withdrawal by Subject|1|||
27829946|NCT00463684|81209189|FG000|Overall Study|Lost to Follow-up|3|||
27829947|NCT02157974|81209192|FG000|Overall Study|Withdrawal by Subject|0|||
27829948|NCT02157974|81209193|FG001|Overall Study|Withdrawal by Subject|1|||
27829949|NCT02157974|81209194|FG002|Overall Study|Withdrawal by Subject|0|||
27829950|NCT02157974|81209195|FG003|Overall Study|Withdrawal by Subject|0|||
27829951|NCT02157974|81209196|FG004|Overall Study|Withdrawal by Subject|0|||
27884705|NCT02237196|81411919|FG002|Overall Study|Lost to Follow-up|4|||
27884706|NCT02237196|81411920|FG003|Overall Study|Lost to Follow-up|6|||
27884707|NCT02237196|81411917|FG000|Overall Study|Physician Decision|2|||
27829952|NCT02157974|81209192|FG000|Overall Study|Screen Failure|0|||
27829953|NCT02157974|81209193|FG001|Overall Study|Screen Failure|1|||
27884708|NCT02237196|81411918|FG001|Overall Study|Physician Decision|0|||
27884709|NCT02237196|81411919|FG002|Overall Study|Physician Decision|0|||
27884710|NCT02237196|81411920|FG003|Overall Study|Physician Decision|1|||
27884711|NCT02237196|81411917|FG000|Overall Study|Pregnancy|0|||
27884712|NCT02237196|81411918|FG001|Overall Study|Pregnancy|0|||
27884713|NCT02237196|81411919|FG002|Overall Study|Pregnancy|1|||
27884714|NCT02237196|81411920|FG003|Overall Study|Pregnancy|1|||
27884715|NCT02237196|81411917|FG000|Overall Study|Withdrawal by Subject|1|||
27829954|NCT02157974|81209194|FG002|Overall Study|Screen Failure|0|||
27829955|NCT02157974|81209195|FG003|Overall Study|Screen Failure|0|||
27884716|NCT02237196|81411918|FG001|Overall Study|Withdrawal by Subject|1|||
27884717|NCT02237196|81411919|FG002|Overall Study|Withdrawal by Subject|4|||
27884718|NCT02237196|81411920|FG003|Overall Study|Withdrawal by Subject|1|||
27884719|NCT02237196|81411917|FG000|Overall Study|Site Error|1|||
27884720|NCT02237196|81411918|FG001|Overall Study|Site Error|2|||
27884721|NCT02237196|81411919|FG002|Overall Study|Site Error|0|||
27884722|NCT02237196|81411920|FG003|Overall Study|Site Error|2|||
27884723|NCT01177293|81411921|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
27884724|NCT01177293|81411922|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
27884725|NCT01948193|81411925|FG000|Overall Study|Serious event|2|||
27884726|NCT01948193|81411925|FG000|Overall Study|Lost to Follow-up|7|||
27884727|NCT02257489|81411926|FG000|Overall Study|Withdrawal by Subject|0|||
27884728|NCT02257489|81411927|FG001|Overall Study|Withdrawal by Subject|0|||
27884729|NCT02257489|81411928|FG002|Overall Study|Withdrawal by Subject|0|||
27884730|NCT02257489|81411929|FG003|Overall Study|Withdrawal by Subject|1|||
27884731|NCT02257489|81411930|FG004|Overall Study|Withdrawal by Subject|0|||
27884732|NCT02257489|81411931|FG005|Overall Study|Withdrawal by Subject|0|||
27884733|NCT02257489|81411932|FG006|Overall Study|Withdrawal by Subject|0|||
27884734|NCT02257489|81411933|FG007|Overall Study|Withdrawal by Subject|0|||
27884735|NCT02257489|81411934|FG008|Overall Study|Withdrawal by Subject|0|||
27884736|NCT00556933|81411935|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
27884737|NCT00556933|81411936|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
27884738|NCT00556933|81411937|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
27884739|NCT00556933|81411938|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
27829956|NCT02157974|81209196|FG004|Overall Study|Screen Failure|0|||
27829957|NCT02157974|81209192|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
27884740|NCT00556933|81411935|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
27884741|NCT00556933|81411936|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
27884742|NCT00556933|81411937|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
27829958|NCT02157974|81209193|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
27829959|NCT02157974|81209194|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
27829960|NCT02157974|81209195|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
27829961|NCT02157974|81209196|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
27884743|NCT00556933|81411938|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
27884744|NCT00556933|81411935|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
27884745|NCT00556933|81411936|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
27829962|NCT03681470|81209204|FG000|Overall Study|Lack of Efficacy|3|||
27829963|NCT03681470|81209204|FG000|Overall Study|Lost to Follow-up|1|||
27829964|NCT03681470|81209204|FG000|Overall Study|Protocol Violation|3|||
27829965|NCT03681470|81209204|FG000|Overall Study|Withdrawal by Subject|1|||
27829966|NCT03107091|81209205|FG000|Overall Study|Physician Decision|1|||
27829967|NCT00672984|81209206|FG000|First Intervention|Adverse Event|5|||
27829968|NCT00672984|81209207|FG001|First Intervention|Adverse Event|0|||
27829969|NCT00672984|81209208|FG002|First Intervention|Adverse Event|0|||
27829970|NCT00672984|81209206|FG000|First Intervention|Withdrawal by Subject|1|||
27884746|NCT00556933|81411937|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
27884747|NCT00556933|81411938|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
27884748|NCT00556933|81411935|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
27884749|NCT00556933|81411936|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
27884750|NCT00556933|81411937|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
27884751|NCT00556933|81411938|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
27884752|NCT00556933|81411935|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
27884753|NCT00556933|81411936|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
27884754|NCT00556933|81411937|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
27884755|NCT00556933|81411938|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
27884756|NCT00556933|81411935|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
27884757|NCT00556933|81411936|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
27884758|NCT00556933|81411937|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
27884759|NCT00556933|81411938|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
27884760|NCT00556933|81411935|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
27884761|NCT00556933|81411936|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
27884762|NCT00556933|81411937|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
27884763|NCT00556933|81411938|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
27884764|NCT00556933|81411935|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
27884765|NCT00556933|81411936|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
27884766|NCT00556933|81411937|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
27884767|NCT00556933|81411938|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
27884768|NCT00556933|81411935|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
27884769|NCT00556933|81411936|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
27884770|NCT00556933|81411937|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
27884771|NCT00556933|81411938|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
27884772|NCT00556933|81411935|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
27884773|NCT00556933|81411936|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
27884774|NCT00556933|81411937|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
27884775|NCT00556933|81411938|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
27884776|NCT00556933|81411935|FG000|CNI Withdrawal vs. Minimization|Death|0|||
27884777|NCT00556933|81411936|FG001|CNI Withdrawal vs. Minimization|Death|0|||
27884778|NCT00556933|81411937|FG002|CNI Withdrawal vs. Minimization|Death|0|||
27884779|NCT00556933|81411938|FG003|CNI Withdrawal vs. Minimization|Death|1|||
27884780|NCT03887442|81411939|FG000|Overall Study|Adverse Event|1|||
27884781|NCT03887442|81411940|FG001|Overall Study|Adverse Event|0|||
27829971|NCT00672984|81209207|FG001|First Intervention|Withdrawal by Subject|2|||
27829972|NCT00672984|81209208|FG002|First Intervention|Withdrawal by Subject|2|||
27829973|NCT00672984|81209206|FG000|First Intervention|Sponsor decision|3|||
27559131|NCT00498602|80233217|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
27559132|NCT00498602|80233218|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
27559133|NCT00498602|80233219|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
27559134|NCT00498602|80233220|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
27559135|NCT00498602|80233221|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
27559136|NCT00498602|80233215|FG000|Overall Study|AE not related to Study Drug|1|||
27559137|NCT00498602|80233216|FG001|Overall Study|AE not related to Study Drug|3|||
27559138|NCT00498602|80233217|FG002|Overall Study|AE not related to Study Drug|0|||
27559139|NCT00498602|80233218|FG003|Overall Study|AE not related to Study Drug|0|||
27559140|NCT00498602|80233219|FG004|Overall Study|AE not related to Study Drug|2|||
27559141|NCT00498602|80233220|FG005|Overall Study|AE not related to Study Drug|2|||
27559142|NCT00498602|80233221|FG006|Overall Study|AE not related to Study Drug|1|||
27559143|NCT00498602|80233215|FG000|Overall Study|Caregiver Request|2|||
27559144|NCT00498602|80233216|FG001|Overall Study|Caregiver Request|2|||
27559145|NCT00498602|80233217|FG002|Overall Study|Caregiver Request|2|||
27559146|NCT00498602|80233218|FG003|Overall Study|Caregiver Request|0|||
27559147|NCT00498602|80233219|FG004|Overall Study|Caregiver Request|1|||
27559148|NCT00498602|80233220|FG005|Overall Study|Caregiver Request|2|||
27559149|NCT00498602|80233221|FG006|Overall Study|Caregiver Request|0|||
27829974|NCT00672984|81209207|FG001|First Intervention|Sponsor decision|0|||
27559150|NCT00498602|80233215|FG000|Overall Study|Investigator Request|0|||
27559151|NCT00498602|80233216|FG001|Overall Study|Investigator Request|0|||
27559152|NCT00498602|80233217|FG002|Overall Study|Investigator Request|1|||
27559153|NCT00498602|80233218|FG003|Overall Study|Investigator Request|0|||
27559154|NCT00498602|80233219|FG004|Overall Study|Investigator Request|0|||
27559155|NCT00498602|80233220|FG005|Overall Study|Investigator Request|0|||
27559156|NCT00498602|80233221|FG006|Overall Study|Investigator Request|0|||
27559157|NCT00498602|80233215|FG000|Overall Study|Subject Request|3|||
27559158|NCT00498602|80233216|FG001|Overall Study|Subject Request|0|||
27559159|NCT00498602|80233217|FG002|Overall Study|Subject Request|1|||
27559160|NCT00498602|80233218|FG003|Overall Study|Subject Request|1|||
27559161|NCT00498602|80233219|FG004|Overall Study|Subject Request|1|||
27559162|NCT00498602|80233220|FG005|Overall Study|Subject Request|4|||
27559163|NCT00498602|80233221|FG006|Overall Study|Subject Request|1|||
27559164|NCT00498602|80233215|FG000|Overall Study|Other|2|||
27559165|NCT00498602|80233216|FG001|Overall Study|Other|3|||
27559166|NCT00498602|80233217|FG002|Overall Study|Other|1|||
27559167|NCT00498602|80233218|FG003|Overall Study|Other|0|||
27559168|NCT00498602|80233219|FG004|Overall Study|Other|0|||
27559169|NCT00498602|80233220|FG005|Overall Study|Other|3|||
27559170|NCT00498602|80233221|FG006|Overall Study|Other|0|||
27559171|NCT02877082|80233227|FG000|Overall Study|Trial was closed early|5|||
27559172|NCT00561080|80233228|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
27559173|NCT00561080|80233229|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
27559174|NCT00561080|80233230|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
27559175|NCT00561080|80233228|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
27559176|NCT00561080|80233229|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
27698569|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
27829975|NCT00672984|81209208|FG002|First Intervention|Sponsor decision|0|||
27829976|NCT00672984|81209206|FG000|Second Intervention|Non-compliance with facility policies|0|||
27829977|NCT00672984|81209207|FG001|Second Intervention|Non-compliance with facility policies|2|||
27829978|NCT00672984|81209208|FG002|Second Intervention|Non-compliance with facility policies|0|||
27829979|NCT00672984|81209206|FG000|Second Intervention|Withdrawal by Subject|0|||
27829980|NCT00672984|81209207|FG001|Second Intervention|Withdrawal by Subject|3|||
27829981|NCT00672984|81209208|FG002|Second Intervention|Withdrawal by Subject|0|||
27829982|NCT00672984|81209206|FG000|Second Intervention|Protocol Violation|0|||
27829983|NCT00672984|81209207|FG001|Second Intervention|Protocol Violation|1|||
27829984|NCT00672984|81209208|FG002|Second Intervention|Protocol Violation|1|||
27829985|NCT00672984|81209206|FG000|Third Intervention|Adverse Event|1|||
27829986|NCT00672984|81209207|FG001|Third Intervention|Adverse Event|0|||
27829987|NCT00672984|81209208|FG002|Third Intervention|Adverse Event|1|||
27559177|NCT00561080|80233230|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
27559178|NCT00561080|80233228|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
27559179|NCT00561080|80233229|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
27559180|NCT00561080|80233230|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
27559181|NCT00561080|80233228|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
27559182|NCT00561080|80233229|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
27559183|NCT00561080|80233230|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
27559184|NCT00561080|80233228|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
27559185|NCT00561080|80233229|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
27559186|NCT00561080|80233230|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
27829988|NCT01175135|81209210|FG000|Overall Study|Adverse Event|2|||
27829989|NCT01175135|81209211|FG001|Overall Study|Adverse Event|5|||
27559187|NCT00561080|80233228|FG000|Vaccination Period (up to Month 4)|Other|0|||
27559188|NCT00561080|80233229|FG001|Vaccination Period (up to Month 4)|Other|2|||
27829990|NCT01175135|81209212|FG002|Overall Study|Adverse Event|3|||
27829991|NCT01175135|81209213|FG003|Overall Study|Adverse Event|4|||
27559189|NCT00561080|80233230|FG002|Vaccination Period (up to Month 4)|Other|1|||
27559190|NCT00561080|80233228|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
27559191|NCT00561080|80233229|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
27559192|NCT00561080|80233230|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
27559193|NCT00561080|80233228|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
27559194|NCT00561080|80233229|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
27559195|NCT00561080|80233230|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
27559196|NCT00561080|80233228|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
27559197|NCT00561080|80233229|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
27559198|NCT00561080|80233230|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
27829992|NCT01175135|81209210|FG000|Overall Study|Death|1|||
27829993|NCT01175135|81209211|FG001|Overall Study|Death|0|||
27559199|NCT00561080|80233228|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
27559200|NCT00561080|80233229|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
27559201|NCT00561080|80233230|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
27559202|NCT01165554|80233231|FG000|Overall Study|Withdrawal by Subject|23|||
27559203|NCT01013701|80233237|FG000|Overall Study|study prematurely terminated|7|||
27559204|NCT02673489|80233240|FG000|Treatment Period|Lost to Follow-up|3|||
27559205|NCT02673489|80233241|FG001|Treatment Period|Lost to Follow-up|0|||
27559206|NCT02673489|80233240|FG000|Treatment Period|Participant request to discontinue|1|||
27559207|NCT02673489|80233241|FG001|Treatment Period|Participant request to discontinue|1|||
27559208|NCT02673489|80233240|FG000|Treatment Period|Participant moved to another province|1|||
27559209|NCT02673489|80233241|FG001|Treatment Period|Participant moved to another province|0|||
27559210|NCT02673489|80233240|FG000|Treatment Period|Participant was incarcerated|0|||
27559211|NCT02673489|80233241|FG001|Treatment Period|Participant was incarcerated|1|||
27559212|NCT02673489|80233240|FG000|Treatment Period|Adverse Event|0|||
27559213|NCT02673489|80233241|FG001|Treatment Period|Adverse Event|1|||
27559214|NCT02673489|80233240|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
27559215|NCT02673489|80233241|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
27559216|NCT02673489|80233240|FG000|Follow Up Period|Unable to return for follow-up|0|||
27559217|NCT02673489|80233241|FG001|Follow Up Period|Unable to return for follow-up|1|||
27559218|NCT01867021|80233249|FG000|Overall Study|Adverse Event|0|||
27559219|NCT01867021|80233250|FG001|Overall Study|Adverse Event|1|||
27559220|NCT01867021|80233249|FG000|Overall Study|Not Eligible|0|||
27829994|NCT01175135|81209212|FG002|Overall Study|Death|0|||
27829995|NCT01175135|81209213|FG003|Overall Study|Death|0|||
27829996|NCT01175135|81209210|FG000|Overall Study|Lack of Efficacy|4|||
27559221|NCT01867021|80233250|FG001|Overall Study|Not Eligible|1|||
27829997|NCT01175135|81209211|FG001|Overall Study|Lack of Efficacy|5|||
27829998|NCT01175135|81209212|FG002|Overall Study|Lack of Efficacy|0|||
27829999|NCT01175135|81209213|FG003|Overall Study|Lack of Efficacy|5|||
27830000|NCT01175135|81209210|FG000|Overall Study|Lost to Follow-up|1|||
27698570|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
27698571|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
27698572|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
27698573|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
27698574|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
27698575|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Other|10|||
27698576|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Other|7|||
27698577|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Other|8|||
27698578|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Other|8|||
27698579|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Other|0|||
27698580|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
27698581|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
27698582|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
27698583|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
27698584|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
27698585|NCT00615836|80732899|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
27698586|NCT00615836|80732900|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
27698587|NCT00615836|80732901|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
27698588|NCT00615836|80732902|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
27698589|NCT00615836|80732903|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
27698590|NCT00685685|80732904|FG000|Washout Period of 7 Days|Adverse Event|2|||
27698591|NCT00685685|80732905|FG001|Washout Period of 7 Days|Adverse Event|0|||
27698592|NCT00685685|80732904|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27698593|NCT00685685|80732905|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27698594|NCT04223830|80732906|FG000|Overall Study|Lost to Follow-up|9|||
27698595|NCT04223830|80732906|FG000|Overall Study|Adverse Event|1|||
27698596|NCT00056862|80732907|FG000|Overall Study|Protocol Violation|1|||
27698597|NCT00056862|80732908|FG001|Overall Study|Protocol Violation|0|||
27698598|NCT04178967|80732920|FG000|Induction Period|Adverse Event|4|||
27698599|NCT04178967|80732921|FG001|Induction Period|Adverse Event|6|||
27698600|NCT04178967|80732922|FG002|Induction Period|Adverse Event|0|||
27698601|NCT04178967|80732923|FG003|Induction Period|Adverse Event|0|||
27698602|NCT04178967|80732924|FG004|Induction Period|Adverse Event|0|||
27698603|NCT04178967|80732925|FG005|Induction Period|Adverse Event|0|||
27698604|NCT04178967|80732926|FG006|Induction Period|Adverse Event|0|||
27698605|NCT04178967|80732927|FG007|Induction Period|Adverse Event|0|||
27698606|NCT04178967|80732928|FG008|Induction Period|Adverse Event|0|||
27698607|NCT04178967|80732929|FG009|Induction Period|Adverse Event|0|||
27698608|NCT04178967|80732930|FG010|Induction Period|Adverse Event|0|||
27698609|NCT04178967|80732920|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
27698610|NCT04178967|80732921|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
27698611|NCT04178967|80732922|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
27698612|NCT04178967|80732923|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
27698613|NCT04178967|80732924|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
27698614|NCT04178967|80732925|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
27698615|NCT04178967|80732926|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
27698616|NCT04178967|80732927|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
27698617|NCT04178967|80732928|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
27698618|NCT04178967|80732929|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
27698619|NCT04178967|80732930|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
27698620|NCT04178967|80732920|FG000|Induction Period|Lack of Efficacy|4|||
27698621|NCT04178967|80732921|FG001|Induction Period|Lack of Efficacy|1|||
27830001|NCT01175135|81209211|FG001|Overall Study|Lost to Follow-up|2|||
27698622|NCT04178967|80732922|FG002|Induction Period|Lack of Efficacy|0|||
27698623|NCT04178967|80732923|FG003|Induction Period|Lack of Efficacy|0|||
27698624|NCT04178967|80732924|FG004|Induction Period|Lack of Efficacy|0|||
27698625|NCT04178967|80732925|FG005|Induction Period|Lack of Efficacy|0|||
27698626|NCT04178967|80732926|FG006|Induction Period|Lack of Efficacy|0|||
27698627|NCT04178967|80732927|FG007|Induction Period|Lack of Efficacy|0|||
27698628|NCT04178967|80732928|FG008|Induction Period|Lack of Efficacy|0|||
27698629|NCT04178967|80732929|FG009|Induction Period|Lack of Efficacy|0|||
27698630|NCT04178967|80732930|FG010|Induction Period|Lack of Efficacy|0|||
27698631|NCT04178967|80732920|FG000|Induction Period|Protocol Violation|0|||
27830002|NCT01175135|81209212|FG002|Overall Study|Lost to Follow-up|0|||
27698632|NCT04178967|80732921|FG001|Induction Period|Protocol Violation|6|||
27698633|NCT04178967|80732922|FG002|Induction Period|Protocol Violation|0|||
27698634|NCT04178967|80732923|FG003|Induction Period|Protocol Violation|0|||
27698635|NCT04178967|80732924|FG004|Induction Period|Protocol Violation|0|||
27698636|NCT04178967|80732925|FG005|Induction Period|Protocol Violation|0|||
27698637|NCT04178967|80732926|FG006|Induction Period|Protocol Violation|0|||
27698638|NCT04178967|80732927|FG007|Induction Period|Protocol Violation|0|||
27698639|NCT04178967|80732928|FG008|Induction Period|Protocol Violation|0|||
27698640|NCT04178967|80732929|FG009|Induction Period|Protocol Violation|0|||
27698641|NCT04178967|80732930|FG010|Induction Period|Protocol Violation|0|||
27698642|NCT04178967|80732920|FG000|Induction Period|Withdrawal by Subject|6|||
27698643|NCT04178967|80732921|FG001|Induction Period|Withdrawal by Subject|4|||
27698644|NCT04178967|80732922|FG002|Induction Period|Withdrawal by Subject|0|||
27698645|NCT04178967|80732923|FG003|Induction Period|Withdrawal by Subject|0|||
27698646|NCT04178967|80732924|FG004|Induction Period|Withdrawal by Subject|0|||
27698647|NCT04178967|80732925|FG005|Induction Period|Withdrawal by Subject|0|||
27698648|NCT04178967|80732926|FG006|Induction Period|Withdrawal by Subject|0|||
27698649|NCT04178967|80732927|FG007|Induction Period|Withdrawal by Subject|0|||
27698650|NCT04178967|80732928|FG008|Induction Period|Withdrawal by Subject|0|||
27698651|NCT04178967|80732929|FG009|Induction Period|Withdrawal by Subject|0|||
27698652|NCT04178967|80732930|FG010|Induction Period|Withdrawal by Subject|0|||
27698653|NCT04178967|80732920|FG000|Induction Period|Lost to Follow-up|2|||
27698654|NCT04178967|80732921|FG001|Induction Period|Lost to Follow-up|0|||
27698655|NCT04178967|80732922|FG002|Induction Period|Lost to Follow-up|0|||
27698656|NCT04178967|80732923|FG003|Induction Period|Lost to Follow-up|0|||
27698657|NCT04178967|80732924|FG004|Induction Period|Lost to Follow-up|0|||
27698658|NCT04178967|80732925|FG005|Induction Period|Lost to Follow-up|0|||
27698659|NCT04178967|80732926|FG006|Induction Period|Lost to Follow-up|0|||
27698660|NCT04178967|80732927|FG007|Induction Period|Lost to Follow-up|0|||
27698661|NCT04178967|80732928|FG008|Induction Period|Lost to Follow-up|0|||
27698662|NCT04178967|80732929|FG009|Induction Period|Lost to Follow-up|0|||
27698663|NCT04178967|80732930|FG010|Induction Period|Lost to Follow-up|0|||
27698664|NCT04178967|80732920|FG000|Induction Period|Participant Missed Study Visits|0|||
27698665|NCT04178967|80732921|FG001|Induction Period|Participant Missed Study Visits|1|||
27698666|NCT04178967|80732922|FG002|Induction Period|Participant Missed Study Visits|0|||
27698667|NCT04178967|80732923|FG003|Induction Period|Participant Missed Study Visits|0|||
27698668|NCT04178967|80732924|FG004|Induction Period|Participant Missed Study Visits|0|||
27698669|NCT04178967|80732925|FG005|Induction Period|Participant Missed Study Visits|0|||
27698670|NCT04178967|80732926|FG006|Induction Period|Participant Missed Study Visits|0|||
27698671|NCT04178967|80732927|FG007|Induction Period|Participant Missed Study Visits|0|||
27698672|NCT04178967|80732928|FG008|Induction Period|Participant Missed Study Visits|0|||
27830003|NCT01175135|81209213|FG003|Overall Study|Lost to Follow-up|0|||
27830004|NCT01175135|81209210|FG000|Overall Study|Protocol Violation|1|||
27830005|NCT01175135|81209211|FG001|Overall Study|Protocol Violation|1|||
27830006|NCT01175135|81209212|FG002|Overall Study|Protocol Violation|0|||
27830007|NCT01175135|81209213|FG003|Overall Study|Protocol Violation|0|||
27830008|NCT01175135|81209210|FG000|Overall Study|Withdrawal by Subject|4|||
27830009|NCT01175135|81209211|FG001|Overall Study|Withdrawal by Subject|8|||
27830010|NCT01175135|81209212|FG002|Overall Study|Withdrawal by Subject|5|||
27830011|NCT01175135|81209213|FG003|Overall Study|Withdrawal by Subject|5|||
27830012|NCT01175135|81209210|FG000|Overall Study|Other|3|||
27830013|NCT01175135|81209211|FG001|Overall Study|Other|1|||
27830014|NCT01175135|81209212|FG002|Overall Study|Other|3|||
27884782|NCT01194999|81411941|FG000|Overall Study|Lost to Follow-up|17|||
27884783|NCT02049814|81411944|FG000|Overall Study|Reason not Specified|4|||
27698673|NCT04178967|80732929|FG009|Induction Period|Participant Missed Study Visits|0|||
27698674|NCT04178967|80732930|FG010|Induction Period|Participant Missed Study Visits|0|||
27698675|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698676|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698677|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
27830015|NCT01175135|81209213|FG003|Overall Study|Other|0|||
27830016|NCT01175135|81209210|FG000|Overall Study|Randomized But Not Treated|0|||
27830017|NCT01175135|81209211|FG001|Overall Study|Randomized But Not Treated|0|||
27884784|NCT02049814|81411945|FG001|Overall Study|Reason not Specified|3|||
27884785|NCT02049814|81411944|FG000|Overall Study|Pregnancy|1|||
27884786|NCT02049814|81411945|FG001|Overall Study|Pregnancy|0|||
27884787|NCT02049814|81411944|FG000|Overall Study|Lost to Follow-up|2|||
27884788|NCT02049814|81411945|FG001|Overall Study|Lost to Follow-up|3|||
27884789|NCT02049814|81411944|FG000|Overall Study|Serious Protocol Violation|5|||
27884790|NCT02049814|81411945|FG001|Overall Study|Serious Protocol Violation|7|||
27884791|NCT02049814|81411944|FG000|Overall Study|Study Termination|0|||
27884792|NCT02049814|81411945|FG001|Overall Study|Study Termination|1|||
27884793|NCT02049814|81411944|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
27884794|NCT02049814|81411945|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
27884795|NCT02049814|81411944|FG000|Overall Study|Voluntary withdrawal|9|||
27884796|NCT02049814|81411945|FG001|Overall Study|Voluntary withdrawal|8|||
27884797|NCT01163851|81411946|FG000|Overall Study|Site Closure|0|||
27884798|NCT01163851|81411947|FG001|Overall Study|Site Closure|1|||
27884799|NCT01163851|81411946|FG000|Overall Study|Enrolled but not treated|1|||
27884800|NCT01163851|81411947|FG001|Overall Study|Enrolled but not treated|0|||
27884801|NCT00652626|81411954|FG000|Initial Treatment Phase|Adverse Event|0|||
27884802|NCT00652626|81411955|FG001|Initial Treatment Phase|Adverse Event|0|||
27884803|NCT00652626|81411956|FG002|Initial Treatment Phase|Adverse Event|0|||
27884804|NCT00652626|81411957|FG003|Initial Treatment Phase|Adverse Event|0|||
27884805|NCT00652626|81411958|FG004|Initial Treatment Phase|Adverse Event|1|||
27884806|NCT00652626|81411959|FG005|Initial Treatment Phase|Adverse Event|0|||
27884807|NCT00652626|81411960|FG006|Initial Treatment Phase|Adverse Event|0|||
27884808|NCT00652626|81411954|FG000|Initial Treatment Phase|Protocol Violation|0|||
27884809|NCT00652626|81411955|FG001|Initial Treatment Phase|Protocol Violation|0|||
27884810|NCT00652626|81411956|FG002|Initial Treatment Phase|Protocol Violation|0|||
27884811|NCT00652626|81411957|FG003|Initial Treatment Phase|Protocol Violation|1|||
27884812|NCT00652626|81411958|FG004|Initial Treatment Phase|Protocol Violation|0|||
27884813|NCT00652626|81411959|FG005|Initial Treatment Phase|Protocol Violation|0|||
27884814|NCT00652626|81411960|FG006|Initial Treatment Phase|Protocol Violation|0|||
27884815|NCT00652626|81411954|FG000|Initial Treatment Phase|Physician Decision|0|||
27830018|NCT01175135|81209212|FG002|Overall Study|Randomized But Not Treated|1|||
27830019|NCT01175135|81209213|FG003|Overall Study|Randomized But Not Treated|0|||
27830020|NCT01370083|81209217|FG000|Overall Study|Lost to Follow-up|2|||
27830021|NCT01370083|81209218|FG001|Overall Study|Lost to Follow-up|0|||
27830022|NCT01370083|81209217|FG000|Overall Study|Adverse Event|0|||
27830023|NCT01370083|81209218|FG001|Overall Study|Adverse Event|1|||
27830024|NCT00830258|81209219|FG000|First Intervention|Adverse Event|1|||
27830025|NCT00830258|81209220|FG001|First Intervention|Adverse Event|0|||
27830026|NCT00830258|81209219|FG000|Washout: 7 Days|Protocol Violation|1|||
27884816|NCT00652626|81411955|FG001|Initial Treatment Phase|Physician Decision|0|||
27884817|NCT00652626|81411956|FG002|Initial Treatment Phase|Physician Decision|0|||
27884818|NCT00652626|81411957|FG003|Initial Treatment Phase|Physician Decision|0|||
27884819|NCT00652626|81411958|FG004|Initial Treatment Phase|Physician Decision|1|||
27884820|NCT00652626|81411959|FG005|Initial Treatment Phase|Physician Decision|0|||
27884821|NCT00652626|81411960|FG006|Initial Treatment Phase|Physician Decision|0|||
27884822|NCT00652626|81411954|FG000|Initial Treatment Phase|Sponsor Request|0|||
27884823|NCT00652626|81411955|FG001|Initial Treatment Phase|Sponsor Request|0|||
27884824|NCT00652626|81411956|FG002|Initial Treatment Phase|Sponsor Request|1|||
27884825|NCT00652626|81411957|FG003|Initial Treatment Phase|Sponsor Request|0|||
27884826|NCT00652626|81411958|FG004|Initial Treatment Phase|Sponsor Request|0|||
27884827|NCT00652626|81411959|FG005|Initial Treatment Phase|Sponsor Request|0|||
27884828|NCT00652626|81411960|FG006|Initial Treatment Phase|Sponsor Request|0|||
27884829|NCT00652626|81411954|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
27884830|NCT00652626|81411955|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
27884831|NCT00652626|81411956|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
27884832|NCT00652626|81411957|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
27884833|NCT00652626|81411958|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
27884834|NCT00652626|81411959|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
27884835|NCT00652626|81411960|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
27884836|NCT00652626|81411954|FG000|Extension Phase|Withdrawal by Subject|0|||
27884837|NCT00652626|81411955|FG001|Extension Phase|Withdrawal by Subject|0|||
27884838|NCT00652626|81411956|FG002|Extension Phase|Withdrawal by Subject|0|||
27830027|NCT00830258|81209220|FG001|Washout: 7 Days|Protocol Violation|0|||
27830028|NCT00573443|81209224|FG000|Double-Blind Phase|Lost to Follow-up|1|||
27884839|NCT00652626|81411957|FG003|Extension Phase|Withdrawal by Subject|0|||
27884840|NCT00652626|81411958|FG004|Extension Phase|Withdrawal by Subject|0|||
27884841|NCT00652626|81411959|FG005|Extension Phase|Withdrawal by Subject|2|||
27884842|NCT00652626|81411960|FG006|Extension Phase|Withdrawal by Subject|0|||
27884843|NCT00652626|81411954|FG000|Extension Phase|Adverse Event|0|||
27830029|NCT00573443|81209225|FG001|Double-Blind Phase|Lost to Follow-up|3|||
27830030|NCT00573443|81209226|FG002|Double-Blind Phase|Lost to Follow-up|2|||
27830031|NCT00573443|81209224|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
27830032|NCT00573443|81209225|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
27830033|NCT00573443|81209226|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
27830034|NCT00573443|81209224|FG000|Double-Blind Phase|Adverse Event|1|||
27830035|NCT00573443|81209225|FG001|Double-Blind Phase|Adverse Event|5|||
27830036|NCT00573443|81209226|FG002|Double-Blind Phase|Adverse Event|0|||
27830037|NCT00573443|81209224|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
27830038|NCT00573443|81209225|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
27830039|NCT00573443|81209226|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
27830040|NCT00573443|81209224|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
27830041|NCT00573443|81209225|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
27830042|NCT00573443|81209226|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
27830043|NCT00573443|81209224|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
27830044|NCT00573443|81209225|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
27830045|NCT00573443|81209226|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
27830046|NCT00573443|81209224|FG000|Double-Blind Phase|Protocol Violation|0|||
27830047|NCT00573443|81209225|FG001|Double-Blind Phase|Protocol Violation|2|||
27830048|NCT00573443|81209226|FG002|Double-Blind Phase|Protocol Violation|1|||
27830049|NCT00573443|81209224|FG000|Double-Blind Phase|Other|0|||
27830050|NCT00573443|81209225|FG001|Double-Blind Phase|Other|2|||
27830051|NCT00573443|81209226|FG002|Double-Blind Phase|Other|3|||
27830052|NCT00573443|81209224|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
27830053|NCT00573443|81209225|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27830054|NCT00573443|81209226|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27830055|NCT00573443|81209224|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
27830056|NCT00573443|81209225|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
27830057|NCT00573443|81209226|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
27830058|NCT00573443|81209224|FG000|Open-Label Extension Phase|Adverse Event|3|||
27830059|NCT00573443|81209225|FG001|Open-Label Extension Phase|Adverse Event|0|||
27830060|NCT00573443|81209226|FG002|Open-Label Extension Phase|Adverse Event|0|||
27830061|NCT00573443|81209224|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
27830062|NCT00573443|81209225|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
27830063|NCT00573443|81209226|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
27830064|NCT00573443|81209224|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
27830065|NCT00573443|81209225|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
27830066|NCT00573443|81209226|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
27830067|NCT00573443|81209224|FG000|Open-Label Extension Phase|Protocol Violation|2|||
27830068|NCT00573443|81209225|FG001|Open-Label Extension Phase|Protocol Violation|0|||
27830069|NCT00573443|81209226|FG002|Open-Label Extension Phase|Protocol Violation|0|||
27830070|NCT00573443|81209224|FG000|Open-Label Extension Phase|Other|2|||
27830071|NCT00573443|81209225|FG001|Open-Label Extension Phase|Other|0|||
27830072|NCT00573443|81209226|FG002|Open-Label Extension Phase|Other|0|||
27830073|NCT00373256|81209228|FG000|Overall Study|Adverse Event (AE)|1|||
27830074|NCT00373256|81209229|FG001|Overall Study|Adverse Event (AE)|5|||
27830075|NCT00373256|81209228|FG000|Overall Study|Lost to Follow-up|2|||
27830076|NCT00373256|81209229|FG001|Overall Study|Lost to Follow-up|1|||
27830077|NCT00373256|81209228|FG000|Overall Study|Death|9|||
27830078|NCT00373256|81209229|FG001|Overall Study|Death|8|||
27830079|NCT00373256|81209228|FG000|Overall Study|Objective Progression or Relapse|111|||
27830080|NCT00373256|81209229|FG001|Overall Study|Objective Progression or Relapse|104|||
27830081|NCT00373256|81209228|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
27830082|NCT00373256|81209229|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
27830083|NCT00373256|81209228|FG000|Overall Study|Other|73|||
27830084|NCT00373256|81209229|FG001|Overall Study|Other|107|||
27830085|NCT00373256|81209228|FG000|Overall Study|Protocol Violation|0|||
27830086|NCT00373256|81209229|FG001|Overall Study|Protocol Violation|2|||
27830087|NCT00373256|81209228|FG000|Overall Study|Study Terminated by Sponsor|41|||
27830088|NCT00373256|81209229|FG001|Overall Study|Study Terminated by Sponsor|13|||
27830089|NCT02222818|81209230|FG000|Period 1|Eligibility criteria not met|0|||
27830090|NCT02222818|81209231|FG001|Period 1|Eligibility criteria not met|3|||
27884844|NCT00652626|81411955|FG001|Extension Phase|Adverse Event|0|||
27884845|NCT00652626|81411956|FG002|Extension Phase|Adverse Event|0|||
27830091|NCT00107991|81209233|FG000|Eligibility Assessment|Disease not severe enough|7|||
27830092|NCT00107991|81209233|FG000|Eligibility Assessment|Unwilling to participate|7|||
27830093|NCT00107991|81209233|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
27830094|NCT00107991|81209233|FG000|Eligibility Assessment|Abnormal labs|2|||
27830095|NCT00107991|81209233|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
27830096|NCT00107991|81209233|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
27830097|NCT00107991|81209233|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
27884846|NCT00652626|81411957|FG003|Extension Phase|Adverse Event|0|||
27884847|NCT00652626|81411958|FG004|Extension Phase|Adverse Event|0|||
27884848|NCT00652626|81411959|FG005|Extension Phase|Adverse Event|2|||
27884849|NCT00652626|81411960|FG006|Extension Phase|Adverse Event|1|||
27559222|NCT01867021|80233249|FG000|Overall Study|Death|1|||
27559223|NCT01867021|80233250|FG001|Overall Study|Death|0|||
27559224|NCT01867021|80233249|FG000|Overall Study|Lost to Follow-up|0|||
27559225|NCT01867021|80233250|FG001|Overall Study|Lost to Follow-up|2|||
27559226|NCT01867021|80233249|FG000|Overall Study|Withdrawal by Subject|1|||
27559227|NCT01867021|80233250|FG001|Overall Study|Withdrawal by Subject|6|||
27559228|NCT02728895|80233251|FG000|Overall Study|Other|1|||
27559229|NCT02728895|80233252|FG001|Overall Study|Other|2|||
27559230|NCT02728895|80233251|FG000|Overall Study|Withdrawal by Subject|0|||
27559231|NCT02728895|80233252|FG001|Overall Study|Withdrawal by Subject|3|||
27559232|NCT02946047|80233255|FG000|Overall Study|Adverse Event|1|||
27559233|NCT02946047|80233256|FG001|Overall Study|Adverse Event|0|||
27559234|NCT02946047|80233257|FG002|Overall Study|Adverse Event|0|||
27884850|NCT00652626|81411954|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
27884851|NCT00652626|81411955|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
27559235|NCT02946047|80233258|FG003|Overall Study|Adverse Event|0|||
27559236|NCT02617511|80233262|FG000|Overall Study|Withdrawal by Subject|1|||
27559237|NCT02617511|80233263|FG001|Overall Study|Withdrawal by Subject|0|||
27559238|NCT01166763|80233269|FG000|Overall Study|Withdrawal by Subject|3|||
27559239|NCT04814433|80233270|FG000|Overall Study|Survey not returned|4|||
27559240|NCT04814433|80233271|FG001|Overall Study|Survey not returned|8|||
27559241|NCT04814433|80233272|FG002|Overall Study|Survey not returned|4|||
27830098|NCT00107991|81209233|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
27830099|NCT00107991|81209233|FG000|12 Week Treatment Period|Adverse Event|1|||
27830100|NCT00107991|81209233|FG000|12 Week Treatment Period|Protocol Violation|1|||
27830101|NCT00107991|81209233|FG000|12 Week Treatment Period|Incarcerated|1|||
27830102|NCT00107991|81209233|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
27830103|NCT02258074|81209234|FG000|Overall Study|Withdrawal by Subject|1|||
27830104|NCT02258074|81209235|FG001|Overall Study|Withdrawal by Subject|0|||
27830105|NCT02258074|81209236|FG002|Overall Study|Withdrawal by Subject|0|||
27830106|NCT02258074|81209237|FG003|Overall Study|Withdrawal by Subject|0|||
27830107|NCT00830024|81209240|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27830108|NCT00830024|81209241|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27830109|NCT03261167|81209244|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
27830110|NCT03261167|81209245|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
27830111|NCT03261167|81209244|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
27830112|NCT03261167|81209245|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
27830113|NCT03261167|81209244|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
27830114|NCT03261167|81209245|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
27830115|NCT03261167|81209244|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
27559242|NCT04814433|80233273|FG003|Overall Study|Survey not returned|5|||
27698678|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698679|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698680|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
27698681|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
27698682|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
27698683|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698684|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698685|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
27698686|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698687|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698688|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27884852|NCT00652626|81411956|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
27884853|NCT00652626|81411957|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
27884854|NCT00652626|81411958|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
27884855|NCT00652626|81411959|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
27884856|NCT00652626|81411960|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
27884857|NCT00652626|81411954|FG000|Extension Phase|Physician Decision|0|||
27884858|NCT00652626|81411955|FG001|Extension Phase|Physician Decision|0|||
27884859|NCT00652626|81411956|FG002|Extension Phase|Physician Decision|0|||
27884860|NCT00652626|81411957|FG003|Extension Phase|Physician Decision|0|||
27884861|NCT00652626|81411958|FG004|Extension Phase|Physician Decision|0|||
27884862|NCT00652626|81411959|FG005|Extension Phase|Physician Decision|1|||
27884863|NCT00652626|81411960|FG006|Extension Phase|Physician Decision|1|||
27884864|NCT00652626|81411954|FG000|Extension Phase|Death|0|||
27884865|NCT00652626|81411955|FG001|Extension Phase|Death|0|||
27698689|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698690|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698691|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
27559243|NCT01394523|80233274|FG000|Overall Study|Unable to place block|1|||
27559244|NCT01394523|80233275|FG001|Overall Study|Unable to place block|0|||
27559245|NCT01394523|80233276|FG002|Overall Study|Unable to place block|0|||
27559246|NCT03045081|80237574|FG000|Overall Study|Withdrawal by Subject|6|||
27559247|NCT03045081|80237575|FG001|Overall Study|Withdrawal by Subject|11|||
27559248|NCT02355691|80237577|FG000|Overall Study|Loss of Research Personnel|7|||
27559249|NCT02355691|80237578|FG001|Overall Study|Loss of Research Personnel|9|||
27559250|NCT02111850|80237581|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559251|NCT02111850|80237582|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559252|NCT02111850|80237583|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559253|NCT02111850|80237584|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559254|NCT02111850|80237585|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
27559255|NCT02111850|80237586|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559256|NCT02111850|80237587|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559257|NCT02111850|80237588|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559258|NCT02111850|80237589|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559259|NCT02111850|80237590|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559260|NCT02111850|80237591|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
27559261|NCT02221284|80237594|FG000|Overall Study|Case Report Forms Uncollected|56|||
27559262|NCT02221284|80237594|FG000|Overall Study|Protocol Deviation|5|||
27559263|NCT01909479|80237595|FG000|From Baseline to Week 26|Adverse Event|3|||
27559264|NCT01909479|80237596|FG001|From Baseline to Week 26|Adverse Event|2|||
27559265|NCT01909479|80237595|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
27559266|NCT01909479|80237596|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
27559267|NCT01909479|80237595|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
27559268|NCT01909479|80237596|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
27559269|NCT01909479|80237595|FG000|26 - 52 Weeks|Adverse Event|0|||
27559270|NCT01909479|80237596|FG001|26 - 52 Weeks|Adverse Event|1|||
27559271|NCT01909479|80237595|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
27559272|NCT01909479|80237596|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
27559273|NCT01909479|80237595|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
27559274|NCT01909479|80237596|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
27559275|NCT01909479|80237595|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
27559276|NCT01909479|80237596|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
27559277|NCT01909479|80237595|FG000|52 Weeks to End of Study|Adverse Event|2|||
27559278|NCT01909479|80237596|FG001|52 Weeks to End of Study|Adverse Event|1|||
27559279|NCT01909479|80237595|FG000|52 Weeks to End of Study|Death|0|||
27559280|NCT01909479|80237596|FG001|52 Weeks to End of Study|Death|1|||
27559281|NCT01909479|80237595|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
27559282|NCT01909479|80237596|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
27559283|NCT01909479|80237595|FG000|52 Weeks to End of Study|Protocol Violation|1|||
27559284|NCT01909479|80237596|FG001|52 Weeks to End of Study|Protocol Violation|0|||
27559285|NCT01909479|80237595|FG000|52 Weeks to End of Study|Progressive disease|1|||
27559286|NCT01909479|80237596|FG001|52 Weeks to End of Study|Progressive disease|1|||
27559287|NCT01909479|80237595|FG000|52 Weeks to End of Study|Personal reasons|2|||
27559288|NCT01909479|80237596|FG001|52 Weeks to End of Study|Personal reasons|1|||
27559289|NCT01909479|80237595|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
27559290|NCT01909479|80237596|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
27559291|NCT01909479|80237595|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
27884866|NCT00652626|81411956|FG002|Extension Phase|Death|0|||
27884867|NCT00652626|81411957|FG003|Extension Phase|Death|0|||
27884868|NCT00652626|81411958|FG004|Extension Phase|Death|0|||
27884869|NCT00652626|81411959|FG005|Extension Phase|Death|1|||
27884870|NCT00652626|81411960|FG006|Extension Phase|Death|1|||
27884871|NCT01737710|81411961|FG000|Overall Study|Lost to Follow-up|0|||
27884872|NCT01737710|81411962|FG001|Overall Study|Lost to Follow-up|2|||
27884873|NCT01737710|81411963|FG002|Overall Study|Lost to Follow-up|2|||
27884874|NCT01737710|81411964|FG003|Overall Study|Lost to Follow-up|0|||
27884875|NCT01737710|81411965|FG004|Overall Study|Lost to Follow-up|0|||
27884876|NCT01737710|81411961|FG000|Overall Study|Withdrawal by Subject|1|||
27884877|NCT01737710|81411962|FG001|Overall Study|Withdrawal by Subject|1|||
27884878|NCT01737710|81411963|FG002|Overall Study|Withdrawal by Subject|1|||
27884879|NCT01737710|81411964|FG003|Overall Study|Withdrawal by Subject|0|||
27884880|NCT01737710|81411965|FG004|Overall Study|Withdrawal by Subject|0|||
27884881|NCT01737710|81411961|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
27884882|NCT01737710|81411962|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
27884883|NCT01737710|81411963|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
27884884|NCT01737710|81411964|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
27884885|NCT01737710|81411965|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
27884886|NCT00610155|81411966|FG000|Period 1|Withdrawal by Subject|0|||
27559292|NCT01909479|80237596|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
27884887|NCT00610155|81411967|FG001|Period 1|Withdrawal by Subject|0|||
27884888|NCT00610155|81411968|FG002|Period 1|Withdrawal by Subject|1|||
27884889|NCT00610155|81411969|FG003|Period 1|Withdrawal by Subject|0|||
27884890|NCT00610155|81411970|FG004|Period 1|Withdrawal by Subject|0|||
27884891|NCT00610155|81411971|FG005|Period 1|Withdrawal by Subject|0|||
27884892|NCT00610155|81411966|FG000|Period 3|Adverse Event|1|||
27884893|NCT00610155|81411967|FG001|Period 3|Adverse Event|0|||
27559293|NCT01909479|80237595|FG000|52 Weeks to End of Study|Lack of contact|1|||
27559294|NCT01909479|80237596|FG001|52 Weeks to End of Study|Lack of contact|0|||
27884894|NCT00610155|81411968|FG002|Period 3|Adverse Event|0|||
27830116|NCT03261167|81209245|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
27830117|NCT03261167|81209244|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
27830118|NCT03261167|81209245|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
27830119|NCT04547192|81209246|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
27830120|NCT04547192|81209247|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
27830121|NCT04547192|81209248|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
27830122|NCT04547192|81209249|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
27830123|NCT04547192|81209246|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
27830124|NCT04547192|81209247|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
27830125|NCT04547192|81209248|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
27830126|NCT04547192|81209249|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
27830127|NCT04547192|81209246|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
27830128|NCT04547192|81209247|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
27830129|NCT04547192|81209248|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
27830130|NCT04547192|81209249|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
27830131|NCT04547192|81209246|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
27884895|NCT00610155|81411969|FG003|Period 3|Adverse Event|0|||
27884896|NCT00610155|81411970|FG004|Period 3|Adverse Event|0|||
27830132|NCT04547192|81209247|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
27830133|NCT04547192|81209248|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
27830134|NCT04547192|81209249|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
27884897|NCT00610155|81411971|FG005|Period 3|Adverse Event|0|||
27884898|NCT01221272|81411972|FG000|Period 1|Adverse Event|2|||
27884899|NCT01221272|81411973|FG001|Period 1|Adverse Event|0|||
27884900|NCT01221272|81411972|FG000|Period 1|Consent Withdrawal|0|||
27884901|NCT01221272|81411973|FG001|Period 1|Consent Withdrawal|1|||
27884902|NCT01221272|81411972|FG000|Period 1|Significant Dosing Noncompliance|0|||
27884903|NCT01221272|81411973|FG001|Period 1|Significant Dosing Noncompliance|1|||
27884904|NCT01221272|81411972|FG000|Period 2|Adverse Event|0|||
27884905|NCT01221272|81411973|FG001|Period 2|Adverse Event|2|||
27884906|NCT00570687|81411978|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884907|NCT00570687|81411979|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884908|NCT00570687|81411980|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884909|NCT00570687|81411981|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884910|NCT00570687|81411982|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
27884911|NCT00570687|81411983|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
27884912|NCT00570687|81411984|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
27884913|NCT00570687|81411985|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
27884914|NCT00570687|81411986|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
27884915|NCT00570687|81411987|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
27884916|NCT00570687|81411978|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884917|NCT00570687|81411979|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884918|NCT00570687|81411980|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884919|NCT00570687|81411981|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884920|NCT00570687|81411982|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884921|NCT00570687|81411983|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884922|NCT00570687|81411984|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884923|NCT00570687|81411985|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884924|NCT00570687|81411986|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
27884925|NCT00570687|81411987|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884926|NCT00570687|81411978|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884927|NCT00570687|81411979|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884928|NCT00570687|81411980|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884929|NCT00570687|81411981|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884930|NCT00570687|81411982|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884931|NCT00570687|81411983|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27884932|NCT00570687|81411984|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
27884933|NCT00570687|81411985|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27559295|NCT01909479|80237595|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
27559296|NCT01909479|80237596|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
27559297|NCT01909479|80237595|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
27830135|NCT04547192|81209246|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
27830136|NCT04547192|81209247|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
27830137|NCT04547192|81209248|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
27830138|NCT04547192|81209249|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
27830139|NCT00395694|81209250|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
27830140|NCT00395694|81209251|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
27830141|NCT00395694|81209250|FG000|Continuation Phase|Adverse Event|1|||
27830142|NCT00395694|81209251|FG001|Continuation Phase|Adverse Event|0|||
27830143|NCT00395694|81209250|FG000|Continuation Phase|Lack of Efficacy|12|||
27830144|NCT00395694|81209251|FG001|Continuation Phase|Lack of Efficacy|11|||
27830145|NCT00395694|81209250|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
27830146|NCT00395694|81209251|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
27830147|NCT00395694|81209250|FG000|Continuation Phase|Poor Compliance|1|||
27830148|NCT00395694|81209251|FG001|Continuation Phase|Poor Compliance|0|||
27830149|NCT00395694|81209250|FG000|Continuation Phase|Withdrawal by Subject|0|||
27830150|NCT00395694|81209251|FG001|Continuation Phase|Withdrawal by Subject|2|||
27830151|NCT02635750|81209252|FG000|Part 1, Period 2|Adverse Event|1|||
27830152|NCT02635750|81209253|FG001|Part 1, Period 2|Adverse Event|0|||
27830153|NCT02635750|81209254|FG002|Part 1, Period 2|Adverse Event|0|||
27830154|NCT00316277|81209258|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
27830155|NCT00316277|81209259|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
27830156|NCT00316277|81209258|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
27830157|NCT00316277|81209259|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
27830158|NCT00316277|81209258|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
27830159|NCT00316277|81209259|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
27830160|NCT00316277|81209258|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
27830161|NCT00316277|81209259|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
27830162|NCT00316277|81209258|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
27830163|NCT00316277|81209259|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
27830164|NCT03635320|81209260|FG000|Overall Study|not implanted the device|1|||
27830165|NCT03635320|81209261|FG001|Overall Study|not implanted the device|2|||
27830166|NCT03635320|81209260|FG000|Overall Study|Withdrawal by Subject|11|||
27830167|NCT03635320|81209261|FG001|Overall Study|Withdrawal by Subject|6|||
27830168|NCT00418938|81209262|FG000|Overall Study|Reimbursement|1|||
27830169|NCT00418938|81209263|FG001|Overall Study|Reimbursement|0|||
27830170|NCT00418938|81209262|FG000|Overall Study|Administrative decision|3|||
27830171|NCT00418938|81209263|FG001|Overall Study|Administrative decision|3|||
27830172|NCT00418938|81209262|FG000|Overall Study|Withdrawal by Subject|16|||
27830173|NCT00418938|81209263|FG001|Overall Study|Withdrawal by Subject|15|||
27830174|NCT00418938|81209262|FG000|Overall Study|Lost to Follow-up|1|||
27830175|NCT00418938|81209263|FG001|Overall Study|Lost to Follow-up|3|||
27830176|NCT00418938|81209262|FG000|Overall Study|Adverse Event|1|||
27830177|NCT00418938|81209263|FG001|Overall Study|Adverse Event|1|||
27830178|NCT00418938|81209262|FG000|Overall Study|On-going|1|||
27830179|NCT00418938|81209263|FG001|Overall Study|On-going|1|||
27830180|NCT00418938|81209262|FG000|Overall Study|Ineligibility Determined|1|||
27830181|NCT00418938|81209263|FG001|Overall Study|Ineligibility Determined|0|||
27830182|NCT02974621|81209273|FG000|Overall Study|Didn't receive study treatment|1|||
27830183|NCT02974621|81209274|FG001|Overall Study|Didn't receive study treatment|10|||
27830184|NCT01794845|81209275|FG000|Overall Study|Withdrawal by Subject|1|||
27830185|NCT01456221|81209276|FG000|Overall Study|Withdrawal by Subject|56|||
27830186|NCT01456221|81209277|FG001|Overall Study|Withdrawal by Subject|49|||
27559298|NCT01909479|80237596|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
27830187|NCT01456221|81209276|FG000|Overall Study|Lost to Follow-up|1|||
27830188|NCT01456221|81209277|FG001|Overall Study|Lost to Follow-up|4|||
27830189|NCT01456221|81209276|FG000|Overall Study|Received medication|3|||
27830190|NCT01456221|81209277|FG001|Overall Study|Received medication|2|||
27830191|NCT01456221|81209276|FG000|Overall Study|Incomplete data|4|||
27830192|NCT01456221|81209277|FG001|Overall Study|Incomplete data|2|||
27830193|NCT00841698|81209279|FG000|First Intervention|Withdrawal by Subject|1|||
27830194|NCT00841698|81209280|FG001|First Intervention|Withdrawal by Subject|0|||
27830195|NCT01911676|81209284|FG000|Period 1 of Study|Withdrawal by Subject|4|||
27830196|NCT01911676|81209285|FG001|Period 1 of Study|Withdrawal by Subject|2|||
27830197|NCT01911676|81209286|FG002|Period 1 of Study|Withdrawal by Subject|1|||
27830198|NCT01911676|81209287|FG003|Period 1 of Study|Withdrawal by Subject|2|||
27830199|NCT01911676|81209284|FG000|Period 1 of Study|Physician Decision|2|||
27830200|NCT01911676|81209285|FG001|Period 1 of Study|Physician Decision|0|||
27830201|NCT01911676|81209286|FG002|Period 1 of Study|Physician Decision|0|||
27830202|NCT01911676|81209287|FG003|Period 1 of Study|Physician Decision|1|||
27830203|NCT01911676|81209284|FG000|Period 2 of Study|Physician Decision|2|||
27830204|NCT01911676|81209285|FG001|Period 2 of Study|Physician Decision|0|||
27830205|NCT01911676|81209286|FG002|Period 2 of Study|Physician Decision|0|||
27830206|NCT01911676|81209287|FG003|Period 2 of Study|Physician Decision|1|||
27830207|NCT01911676|81209284|FG000|Period 2 of Study|Lost to Follow-up|0|||
27830208|NCT01911676|81209285|FG001|Period 2 of Study|Lost to Follow-up|0|||
27830209|NCT01911676|81209286|FG002|Period 2 of Study|Lost to Follow-up|0|||
27830210|NCT01911676|81209287|FG003|Period 2 of Study|Lost to Follow-up|1|||
27698692|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27830211|NCT01058668|81209288|FG000|Double-blind Treatment Phase|Adverse Event|8|||
27830212|NCT01058668|81209289|FG001|Double-blind Treatment Phase|Adverse Event|15|||
27830213|NCT01058668|81209290|FG002|Double-blind Treatment Phase|Adverse Event|25|||
27830214|NCT01058668|81209288|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
27830215|NCT01058668|81209289|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
27830216|NCT01058668|81209290|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
27830217|NCT01058668|81209288|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
27830218|NCT01058668|81209289|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
27830219|NCT01058668|81209290|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
27830220|NCT01058668|81209288|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
27830221|NCT01058668|81209289|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
27830222|NCT01058668|81209290|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
27830223|NCT01058668|81209288|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27830224|NCT01058668|81209289|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
27830225|NCT01058668|81209290|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
27830226|NCT01058668|81209288|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
27830227|NCT01058668|81209289|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
27830228|NCT01058668|81209290|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
27830229|NCT02842853|81209294|FG000|Overall Study|Non-compliance with the protocol|3|||
27830230|NCT02842853|81209295|FG001|Overall Study|Non-compliance with the protocol|7|||
27830231|NCT02842853|81209296|FG002|Overall Study|Non-compliance with the protocol|2|||
27830232|NCT02842853|81209297|FG003|Overall Study|Non-compliance with the protocol|5|||
27830233|NCT02842853|81209294|FG000|Overall Study|Subject met exclusion criteria|0|||
27830234|NCT02842853|81209295|FG001|Overall Study|Subject met exclusion criteria|1|||
27830235|NCT02842853|81209296|FG002|Overall Study|Subject met exclusion criteria|0|||
27830236|NCT02842853|81209297|FG003|Overall Study|Subject met exclusion criteria|0|||
27830237|NCT02842853|81209294|FG000|Overall Study|Withdrawal by Subject|11|||
27830238|NCT02842853|81209295|FG001|Overall Study|Withdrawal by Subject|13|||
27830239|NCT02842853|81209296|FG002|Overall Study|Withdrawal by Subject|9|||
27830240|NCT02842853|81209297|FG003|Overall Study|Withdrawal by Subject|8|||
27830241|NCT02842853|81209294|FG000|Overall Study|Lost to Follow-up|9|||
27830242|NCT02842853|81209295|FG001|Overall Study|Lost to Follow-up|13|||
27830243|NCT02842853|81209296|FG002|Overall Study|Lost to Follow-up|10|||
27830244|NCT02842853|81209297|FG003|Overall Study|Lost to Follow-up|11|||
27830245|NCT03406156|81209298|FG000|Overall Study|Death|9|||
27830246|NCT03406156|81209299|FG001|Overall Study|Death|3|||
27830247|NCT03406156|81209298|FG000|Overall Study|Withdrawal by Subject|1|||
27830248|NCT03406156|81209299|FG001|Overall Study|Withdrawal by Subject|2|||
27830249|NCT03406156|81209298|FG000|Overall Study|COVID-19 infection|1|||
27830250|NCT03406156|81209299|FG001|Overall Study|COVID-19 infection|0|||
27830251|NCT03406156|81209298|FG000|Overall Study|Non-compliance with study procedures|1|||
27830252|NCT03406156|81209299|FG001|Overall Study|Non-compliance with study procedures|1|||
27830253|NCT03406156|81209298|FG000|Overall Study|Lost to Follow-up|0|||
27830254|NCT03406156|81209299|FG001|Overall Study|Lost to Follow-up|2|||
27830255|NCT03406156|81209298|FG000|Overall Study|Other, not specified|72|||
27830256|NCT03406156|81209299|FG001|Overall Study|Other, not specified|28|||
27830257|NCT03913377|81209302|FG000|Period 1|Test Article no longer available|0|||
27830258|NCT03913377|81209303|FG001|Period 1|Test Article no longer available|1|||
27830259|NCT03913377|81209304|FG002|Period 1|Test Article no longer available|0|||
27830260|NCT03913377|81209302|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
27830261|NCT03913377|81209303|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
27830262|NCT03913377|81209304|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
27830263|NCT00624286|81209305|FG000|Overall Study|Protocol Deviation|7|||
27830264|NCT00624286|81209306|FG001|Overall Study|Protocol Deviation|9|||
27830265|NCT00624286|81209305|FG000|Overall Study|Adverse Event|6|||
27830266|NCT00624286|81209306|FG001|Overall Study|Adverse Event|3|||
27830267|NCT00624286|81209305|FG000|Overall Study|Withdrawal by Subject|5|||
27830268|NCT00624286|81209306|FG001|Overall Study|Withdrawal by Subject|4|||
27830269|NCT00624286|81209305|FG000|Overall Study|Lost to Follow-up|3|||
27830270|NCT00624286|81209306|FG001|Overall Study|Lost to Follow-up|2|||
27830271|NCT00624286|81209305|FG000|Overall Study|Administrative problems|3|||
27830272|NCT00624286|81209306|FG001|Overall Study|Administrative problems|0|||
27830273|NCT00624286|81209305|FG000|Overall Study|Lack of Efficacy|1|||
27830274|NCT00624286|81209306|FG001|Overall Study|Lack of Efficacy|6|||
27830275|NCT00624286|81209305|FG000|Overall Study|Not stated|0|||
27830276|NCT00624286|81209306|FG001|Overall Study|Not stated|1|||
27830277|NCT00624286|81209305|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27830278|NCT00624286|81209306|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27830279|NCT00624286|81209305|FG000|Overall Study|Death|0|||
27830280|NCT00624286|81209306|FG001|Overall Study|Death|1|||
27830281|NCT03679598|81209307|FG000|Overall Study|Adverse Event|2|||
27830282|NCT03679598|81209308|FG001|Overall Study|Adverse Event|0|||
27830283|NCT04173247|81209311|FG000|Overall Study|Withdrawal by Subject|0|||
27830284|NCT04173247|81209312|FG001|Overall Study|Withdrawal by Subject|2|||
27830285|NCT04173247|81209311|FG000|Overall Study|Death|1|||
27830286|NCT04173247|81209312|FG001|Overall Study|Death|0|||
27830287|NCT04173247|81209311|FG000|Overall Study|Physician Decision|1|||
27830288|NCT04173247|81209312|FG001|Overall Study|Physician Decision|0|||
27830289|NCT00903877|81209325|FG000|Overall Study|Did not meet study criteria|33|||
27830290|NCT00903877|81209325|FG000|Overall Study|Withdrawal by Subject|3|||
27830291|NCT00903877|81209325|FG000|Overall Study|Adverse Event|2|||
27830292|NCT00903877|81209325|FG000|Overall Study|Lost to Follow-up|1|||
27830293|NCT00903877|81209325|FG000|Overall Study|Participation put on hold|4|||
27830294|NCT00857454|81209326|FG000|Overall Study|Withdrawal by Subject|2|||
27830295|NCT00857454|81209326|FG000|Overall Study|Lost to Follow-up|1|||
27830296|NCT00857454|81209326|FG000|Overall Study|Adverse Event|2|||
27830297|NCT00857454|81209326|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
27830298|NCT00857454|81209326|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
27830299|NCT00857454|81209326|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
27830300|NCT05616728|81209328|FG000|Overall Study|Lost to Follow-up|0|||
27830301|NCT05616728|81209329|FG001|Overall Study|Lost to Follow-up|0|||
27830302|NCT05616728|81209330|FG002|Overall Study|Lost to Follow-up|1|||
27830303|NCT05616728|81209328|FG000|Overall Study|Withdrawal by Subject|1|||
27830304|NCT05616728|81209329|FG001|Overall Study|Withdrawal by Subject|1|||
27830305|NCT05616728|81209330|FG002|Overall Study|Withdrawal by Subject|0|||
27830306|NCT05616728|81209328|FG000|Overall Study|Physician Decision|1|||
27830307|NCT05616728|81209329|FG001|Overall Study|Physician Decision|1|||
27830308|NCT05616728|81209330|FG002|Overall Study|Physician Decision|1|||
27830309|NCT05616728|81209328|FG000|Overall Study|Other|0|||
27830310|NCT05616728|81209329|FG001|Overall Study|Other|2|||
27830311|NCT05616728|81209330|FG002|Overall Study|Other|0|||
27830312|NCT03874715|81209333|FG000|Overall Study|Adverse Event|2|||
27830313|NCT03874715|81209334|FG001|Overall Study|Adverse Event|0|||
27830314|NCT03874715|81209333|FG000|Overall Study|Poor compliance to protocol|5|||
27830315|NCT03874715|81209334|FG001|Overall Study|Poor compliance to protocol|1|||
27830316|NCT03874715|81209333|FG000|Overall Study|Withdrawal by Subject|1|||
27830317|NCT03874715|81209334|FG001|Overall Study|Withdrawal by Subject|0|||
27830318|NCT03874715|81209333|FG000|Overall Study|Other-unspecified|1|||
27830319|NCT03874715|81209334|FG001|Overall Study|Other-unspecified|0|||
27830320|NCT01983969|81209341|FG000|Overall Study|Disease Progression|0|||
27830321|NCT01983969|81209342|FG001|Overall Study|Disease Progression|1|||
27830322|NCT01983969|81209343|FG002|Overall Study|Disease Progression|0|||
27830323|NCT03106415|81209348|FG000|Phase 1|Withdrawal by Subject|1|||
27830324|NCT03106415|81209349|FG001|Phase 1|Withdrawal by Subject|0|||
27830325|NCT03106415|81209350|FG002|Phase 1|Withdrawal by Subject|0|||
27830326|NCT03106415|81209348|FG000|Phase 1|Adverse Event|1|||
27830327|NCT03106415|81209349|FG001|Phase 1|Adverse Event|1|||
27830328|NCT03106415|81209350|FG002|Phase 1|Adverse Event|0|||
27830329|NCT03106415|81209348|FG000|Phase 1|Protocol Violation|0|||
27830330|NCT03106415|81209349|FG001|Phase 1|Protocol Violation|1|||
27830331|NCT03106415|81209350|FG002|Phase 1|Protocol Violation|0|||
27830332|NCT00841659|81209351|FG000|Washout: 2 Weeks|Protocol Violation|1|||
27830333|NCT00841659|81209352|FG001|Washout: 2 Weeks|Protocol Violation|0|||
27830334|NCT02615249|81209353|FG000|Overall Study|Withdrawal by Subject|1|||
27830335|NCT00571064|81209356|FG000|Overall Study|Adverse Event|13|||
27830336|NCT00571064|81209356|FG000|Overall Study|Protocol Violation|4|||
27830337|NCT00571064|81209356|FG000|Overall Study|Withdrawal by Subject|2|||
27830338|NCT00571064|81209356|FG000|Overall Study|Other|2|||
27830339|NCT01663233|81209357|FG000|Overall Study|Withdrawal by Subject|3|||
27830340|NCT01663233|81209358|FG001|Overall Study|Withdrawal by Subject|2|||
27830341|NCT01663233|81209357|FG000|Overall Study|Protocol Deviation|1|||
27830342|NCT01663233|81209358|FG001|Overall Study|Protocol Deviation|4|||
27830343|NCT01663233|81209357|FG000|Overall Study|Lost to Follow-up|0|||
27830344|NCT01663233|81209358|FG001|Overall Study|Lost to Follow-up|1|||
27830345|NCT03808376|81209360|FG000|Overall Study|Withdrawal by Subject|10|||
27830346|NCT00798603|81209361|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
27830347|NCT00798603|81209361|FG000|Overall Study|Withdrawal by Subject|10|||
27830348|NCT00798603|81209361|FG000|Overall Study|Adverse Event|22|||
27830349|NCT00798603|81209361|FG000|Overall Study|Physician Decision|1|||
27830350|NCT00798603|81209361|FG000|Overall Study|Lack of insurance coverage|1|||
27830351|NCT01484912|81209368|FG000|Overall Study|Withdrawal by Subject|1|||
27830352|NCT01484912|81209369|FG001|Overall Study|Withdrawal by Subject|0|||
27830353|NCT01484912|81209368|FG000|Overall Study|Physician Decision|0|||
27830354|NCT01484912|81209369|FG001|Overall Study|Physician Decision|1|||
27830355|NCT02699463|81209370|FG000|Overall Study|Lost to Follow-up|11|||
27830356|NCT02699463|81209371|FG001|Overall Study|Lost to Follow-up|8|||
27830357|NCT02699463|81209370|FG000|Overall Study|Withdrawal by Subject|4|||
27830358|NCT02699463|81209371|FG001|Overall Study|Withdrawal by Subject|1|||
27830359|NCT01634139|81209378|FG000|Overall Study|Non compliant with protocol|1|||
27830360|NCT01634139|81209379|FG001|Overall Study|Non compliant with protocol|0|||
27830361|NCT01634139|81209380|FG002|Overall Study|Non compliant with protocol|0|||
27830362|NCT01634139|81209378|FG000|Overall Study|Consent withdrawn not due to AE|4|||
27830363|NCT01634139|81209379|FG001|Overall Study|Consent withdrawn not due to AE|3|||
27830364|NCT01634139|81209380|FG002|Overall Study|Consent withdrawn not due to AE|2|||
27830365|NCT01634139|81209378|FG000|Overall Study|Other|4|||
27830366|NCT01634139|81209379|FG001|Overall Study|Other|0|||
27830367|NCT01634139|81209380|FG002|Overall Study|Other|3|||
27830368|NCT01634139|81209378|FG000|Overall Study|Lost to Follow-up|0|||
27830369|NCT01634139|81209379|FG001|Overall Study|Lost to Follow-up|2|||
27830370|NCT01634139|81209380|FG002|Overall Study|Lost to Follow-up|0|||
27830371|NCT01634139|81209378|FG000|Overall Study|Not treated|1|||
27830372|NCT01634139|81209379|FG001|Overall Study|Not treated|1|||
27830373|NCT01634139|81209380|FG002|Overall Study|Not treated|0|||
27830374|NCT03285594|81209383|FG000|Overall Study|At the Participant's Own Request|10|||
27830375|NCT03285594|81209384|FG001|Overall Study|At the Participant's Own Request|5|||
27830376|NCT03285594|81209385|FG002|Overall Study|At the Participant's Own Request|21|||
27830377|NCT03285594|81209383|FG000|Overall Study|Adverse Event|2|||
27830378|NCT03285594|81209384|FG001|Overall Study|Adverse Event|2|||
27830379|NCT03285594|81209385|FG002|Overall Study|Adverse Event|6|||
27830380|NCT03285594|81209383|FG000|Overall Study|Poor Compliance to Protocol|0|||
27884934|NCT00570687|81411986|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27830381|NCT03285594|81209384|FG001|Overall Study|Poor Compliance to Protocol|0|||
27830382|NCT03285594|81209385|FG002|Overall Study|Poor Compliance to Protocol|1|||
27830383|NCT03285594|81209383|FG000|Overall Study|Lost to Follow-up|0|||
27884935|NCT00570687|81411987|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
27830384|NCT03285594|81209384|FG001|Overall Study|Lost to Follow-up|0|||
27830385|NCT03285594|81209385|FG002|Overall Study|Lost to Follow-up|1|||
27830386|NCT03285594|81209383|FG000|Overall Study|Reason Not Specified|3|||
27830387|NCT03285594|81209384|FG001|Overall Study|Reason Not Specified|4|||
27830388|NCT03285594|81209385|FG002|Overall Study|Reason Not Specified|8|||
27884936|NCT03425396|81411988|FG000|Overall Study|Lost to Follow-up|2|||
27884937|NCT03425396|81411989|FG001|Overall Study|Lost to Follow-up|5|||
27884938|NCT03425396|81411990|FG002|Overall Study|Lost to Follow-up|2|||
27884939|NCT03425396|81411991|FG003|Overall Study|Lost to Follow-up|0|||
27884940|NCT03425396|81411992|FG004|Overall Study|Lost to Follow-up|0|||
27884941|NCT03425396|81411988|FG000|Overall Study|Withdrawal by Subject|0|||
27830389|NCT00984022|81209386|FG000|Overall Study|Lost to Follow-up|10|||
27830390|NCT00984022|81209387|FG001|Overall Study|Lost to Follow-up|14|||
27830391|NCT01919112|81209390|FG000|Secondary Analysis-day 30|Death|1|||
27830392|NCT01919112|81209391|FG001|Secondary Analysis-day 30|Death|1|||
27830393|NCT01919112|81209392|FG002|Secondary Analysis-day 30|Death|1|||
27830394|NCT01919112|81209390|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
27698693|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698694|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698695|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698696|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27698697|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698698|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698699|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698700|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
27698701|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698702|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698703|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698704|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698705|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698706|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698707|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27698708|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698709|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698710|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698711|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698712|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698713|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698714|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
27698715|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698716|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698717|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698718|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
27698719|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698720|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698721|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698722|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698723|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
27698724|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
27698725|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698726|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
27698727|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27884942|NCT03425396|81411989|FG001|Overall Study|Withdrawal by Subject|1|||
27884943|NCT03425396|81411990|FG002|Overall Study|Withdrawal by Subject|0|||
27559299|NCT02150954|80237597|FG000|Overall Study|Protocol Violation|1|||
27698728|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698729|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27698730|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27698731|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27698732|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27698733|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27698734|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27698735|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
27698736|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
27698737|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
27698738|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27698739|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27698740|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
27698741|NCT04178967|80732920|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27698742|NCT04178967|80732921|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27698743|NCT04178967|80732922|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27698744|NCT04178967|80732923|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
27884944|NCT03425396|81411991|FG003|Overall Study|Withdrawal by Subject|1|||
27884945|NCT03425396|81411992|FG004|Overall Study|Withdrawal by Subject|0|||
27884946|NCT03425396|81411988|FG000|Overall Study|Other|0|||
27884947|NCT03425396|81411989|FG001|Overall Study|Other|1|||
27884948|NCT03425396|81411990|FG002|Overall Study|Other|1|||
27884949|NCT03425396|81411991|FG003|Overall Study|Other|0|||
27884950|NCT03425396|81411992|FG004|Overall Study|Other|1|||
27884951|NCT00932373|81411993|FG000|Overall Study|Progressive disease|3|||
27884952|NCT00932373|81411994|FG001|Overall Study|Progressive disease|1|||
27884953|NCT00932373|81411995|FG002|Overall Study|Progressive disease|0|||
27884954|NCT00932373|81411996|FG003|Overall Study|Progressive disease|0|||
27884955|NCT00932373|81411997|FG004|Overall Study|Progressive disease|10|||
27884956|NCT00932373|81411998|FG005|Overall Study|Progressive disease|1|||
27884957|NCT00932373|81411999|FG006|Overall Study|Progressive disease|0|||
27884958|NCT00932373|81412000|FG007|Overall Study|Progressive disease|2|||
27884959|NCT00932373|81412001|FG008|Overall Study|Progressive disease|1|||
27884960|NCT00932373|81412002|FG009|Overall Study|Progressive disease|9|||
27884961|NCT00932373|81412003|FG010|Overall Study|Progressive disease|2|||
27884962|NCT00932373|81411993|FG000|Overall Study|Adverse Event|0|||
27884963|NCT00932373|81411994|FG001|Overall Study|Adverse Event|0|||
27884964|NCT00932373|81411995|FG002|Overall Study|Adverse Event|0|||
27884965|NCT00932373|81411996|FG003|Overall Study|Adverse Event|0|||
27884966|NCT00932373|81411997|FG004|Overall Study|Adverse Event|2|||
27559300|NCT02150954|80237598|FG001|Overall Study|Protocol Violation|0|||
27559301|NCT01042236|80237601|FG000|Treatment Period 1|Adverse Event|0|||
27559302|NCT01042236|80237602|FG001|Treatment Period 1|Adverse Event|1|||
27559303|NCT01042236|80237603|FG002|Treatment Period 1|Adverse Event|0|||
27559304|NCT01042236|80237604|FG003|Treatment Period 1|Adverse Event|0|||
27559305|NCT01042236|80237605|FG004|Treatment Period 1|Adverse Event|1|||
27559306|NCT01042236|80237606|FG005|Treatment Period 1|Adverse Event|0|||
27559307|NCT01042236|80237601|FG000|Treatment Period 3|Adverse Event|0|||
27559308|NCT01042236|80237602|FG001|Treatment Period 3|Adverse Event|0|||
27559309|NCT01042236|80237603|FG002|Treatment Period 3|Adverse Event|0|||
27559310|NCT01042236|80237604|FG003|Treatment Period 3|Adverse Event|1|||
27559311|NCT01042236|80237605|FG004|Treatment Period 3|Adverse Event|0|||
27559312|NCT01042236|80237606|FG005|Treatment Period 3|Adverse Event|0|||
27698745|NCT04178967|80732924|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27698746|NCT04178967|80732925|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
27698747|NCT04178967|80732926|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
27698748|NCT04178967|80732927|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
27830395|NCT01919112|81209391|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
27830396|NCT01919112|81209392|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
27830397|NCT03273153|81209393|FG000|Overall Study|Adverse Event|1|||
27830398|NCT03273153|81209394|FG001|Overall Study|Adverse Event|2|||
27830399|NCT03273153|81209393|FG000|Overall Study|Missing|0|||
27830400|NCT03273153|81209394|FG001|Overall Study|Missing|2|||
27830401|NCT03273153|81209393|FG000|Overall Study|Other|3|||
27830402|NCT03273153|81209394|FG001|Overall Study|Other|2|||
27830403|NCT03273153|81209393|FG000|Overall Study|Symptomatic Deterioration|0|||
27830404|NCT03273153|81209394|FG001|Overall Study|Symptomatic Deterioration|1|||
27830405|NCT03273153|81209393|FG000|Overall Study|Progressive Disease|6|||
27830406|NCT03273153|81209394|FG001|Overall Study|Progressive Disease|5|||
27830407|NCT03273153|81209393|FG000|Overall Study|Physician Decision|1|||
27830408|NCT03273153|81209394|FG001|Overall Study|Physician Decision|3|||
27830409|NCT03273153|81209393|FG000|Overall Study|Study Terminated by Sponsor|112|||
27884967|NCT00932373|81411998|FG005|Overall Study|Adverse Event|1|||
27884968|NCT00932373|81411999|FG006|Overall Study|Adverse Event|0|||
27884969|NCT00932373|81412000|FG007|Overall Study|Adverse Event|1|||
27884970|NCT00932373|81412001|FG008|Overall Study|Adverse Event|0|||
27884971|NCT00932373|81412002|FG009|Overall Study|Adverse Event|2|||
27559313|NCT01042236|80237601|FG000|Treatment Period 3|Protocol Violation|0|||
27559314|NCT01042236|80237602|FG001|Treatment Period 3|Protocol Violation|0|||
27559315|NCT01042236|80237603|FG002|Treatment Period 3|Protocol Violation|0|||
27559316|NCT01042236|80237604|FG003|Treatment Period 3|Protocol Violation|1|||
27559317|NCT01042236|80237605|FG004|Treatment Period 3|Protocol Violation|0|||
27559318|NCT01042236|80237606|FG005|Treatment Period 3|Protocol Violation|0|||
27559319|NCT02677987|80237607|FG000|Overall Study|Withdrawal by Subject|3|||
27559320|NCT02677987|80237608|FG001|Overall Study|Withdrawal by Subject|0|||
27559321|NCT02677987|80237607|FG000|Overall Study|Lost to Follow-up|1|||
27559322|NCT02677987|80237608|FG001|Overall Study|Lost to Follow-up|0|||
27559323|NCT02956486|80237609|FG000|Core Phase|Adverse Event|51|||
27559324|NCT02956486|80237610|FG001|Core Phase|Adverse Event|88|||
27559325|NCT02956486|80237611|FG002|Core Phase|Adverse Event|0|||
27559326|NCT02956486|80237609|FG000|Core Phase|Lost to Follow-up|8|||
27559327|NCT02956486|80237610|FG001|Core Phase|Lost to Follow-up|6|||
27559328|NCT02956486|80237611|FG002|Core Phase|Lost to Follow-up|0|||
27698749|NCT04178967|80732928|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27830410|NCT03273153|81209394|FG001|Overall Study|Study Terminated by Sponsor|102|||
27830411|NCT03273153|81209393|FG000|Overall Study|Withdrawal by Subject|26|||
27830412|NCT03273153|81209394|FG001|Overall Study|Withdrawal by Subject|25|||
27830413|NCT03273153|81209393|FG000|Overall Study|Protocol Deviation|3|||
27830414|NCT03273153|81209394|FG001|Overall Study|Protocol Deviation|0|||
27830415|NCT03273153|81209393|FG000|Overall Study|Lost to Follow-up|6|||
27830416|NCT03273153|81209394|FG001|Overall Study|Lost to Follow-up|11|||
27830417|NCT03273153|81209393|FG000|Overall Study|Death|66|||
27830418|NCT03273153|81209394|FG001|Overall Study|Death|69|||
27830419|NCT00627016|81209395|FG000|Overall Study|Adverse Event|1|||
27830420|NCT00627016|81209396|FG001|Overall Study|Adverse Event|1|||
27830421|NCT00627016|81209395|FG000|Overall Study|Protocol Violation|0|||
27830422|NCT00627016|81209396|FG001|Overall Study|Protocol Violation|2|||
27830423|NCT00627016|81209395|FG000|Overall Study|Lost to Follow-up|0|||
27830424|NCT00627016|81209396|FG001|Overall Study|Lost to Follow-up|1|||
27830425|NCT00627016|81209395|FG000|Overall Study|Withdrawal by Subject|2|||
27830426|NCT00627016|81209396|FG001|Overall Study|Withdrawal by Subject|1|||
27830427|NCT00627016|81209395|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
27830428|NCT00627016|81209396|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
27830429|NCT00627016|81209395|FG000|Overall Study|Lack of Efficacy|1|||
27830430|NCT00627016|81209396|FG001|Overall Study|Lack of Efficacy|0|||
27830431|NCT00627016|81209395|FG000|Overall Study|Placed on Excluded Drugs|1|||
27830432|NCT00627016|81209396|FG001|Overall Study|Placed on Excluded Drugs|0|||
27830433|NCT00627016|81209395|FG000|Overall Study|Pregnancy|1|||
27830434|NCT00627016|81209396|FG001|Overall Study|Pregnancy|0|||
27830435|NCT03199963|81209399|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
27830436|NCT03199963|81209400|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
27830437|NCT03199963|81209399|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
27830438|NCT03199963|81209400|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
27830439|NCT03199963|81209399|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
27830440|NCT03199963|81209400|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
27830441|NCT03199963|81209399|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
27830442|NCT03199963|81209400|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
27830443|NCT03199963|81209399|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
27830444|NCT03199963|81209400|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
27830445|NCT03199963|81209399|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
27559329|NCT02956486|80237609|FG000|Core Phase|Inadequate therapeutic effect|4|||
27559330|NCT02956486|80237610|FG001|Core Phase|Inadequate therapeutic effect|5|||
27559331|NCT02956486|80237611|FG002|Core Phase|Inadequate therapeutic effect|0|||
27830446|NCT03199963|81209400|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
27830447|NCT00003470|81209401|FG000|Overall Study|Not evaluable|6|||
27559332|NCT02956486|80237609|FG000|Core Phase|Withdrawal by Subject|101|||
27559333|NCT02956486|80237610|FG001|Core Phase|Withdrawal by Subject|104|||
27559334|NCT02956486|80237611|FG002|Core Phase|Withdrawal by Subject|0|||
27559335|NCT02956486|80237609|FG000|Core Phase|Study terminated by sponsor|888|||
27559336|NCT02956486|80237610|FG001|Core Phase|Study terminated by sponsor|848|||
27830448|NCT00819169|81209402|FG000|Overall Study|Withdrawal by Subject|2|||
27830449|NCT00819169|81209403|FG001|Overall Study|Withdrawal by Subject|0|||
27830450|NCT00819169|81209404|FG002|Overall Study|Withdrawal by Subject|0|||
27830451|NCT00819169|81209405|FG003|Overall Study|Withdrawal by Subject|1|||
27830452|NCT00819169|81209406|FG004|Overall Study|Withdrawal by Subject|1|||
27830453|NCT00819169|81209407|FG005|Overall Study|Withdrawal by Subject|1|||
27830454|NCT00819169|81209408|FG006|Overall Study|Withdrawal by Subject|5|||
27830455|NCT00819169|81209409|FG007|Overall Study|Withdrawal by Subject|1|||
27830456|NCT00819169|81209410|FG008|Overall Study|Withdrawal by Subject|4|||
27830457|NCT00819169|81209402|FG000|Overall Study|Lost to Follow-up|0|||
27830458|NCT00819169|81209403|FG001|Overall Study|Lost to Follow-up|2|||
27830459|NCT00819169|81209404|FG002|Overall Study|Lost to Follow-up|0|||
27830460|NCT00819169|81209405|FG003|Overall Study|Lost to Follow-up|1|||
27830461|NCT00819169|81209406|FG004|Overall Study|Lost to Follow-up|0|||
27830462|NCT00819169|81209407|FG005|Overall Study|Lost to Follow-up|6|||
27830463|NCT00819169|81209408|FG006|Overall Study|Lost to Follow-up|2|||
27830464|NCT00819169|81209409|FG007|Overall Study|Lost to Follow-up|2|||
27830465|NCT00819169|81209410|FG008|Overall Study|Lost to Follow-up|1|||
27830466|NCT00819169|81209402|FG000|Overall Study|Death|1|||
27830467|NCT00819169|81209403|FG001|Overall Study|Death|1|||
27830468|NCT00819169|81209404|FG002|Overall Study|Death|3|||
27830469|NCT00819169|81209405|FG003|Overall Study|Death|8|||
27830470|NCT00819169|81209406|FG004|Overall Study|Death|5|||
27830471|NCT00819169|81209407|FG005|Overall Study|Death|7|||
27830472|NCT00819169|81209408|FG006|Overall Study|Death|9|||
27830473|NCT00819169|81209409|FG007|Overall Study|Death|4|||
27830474|NCT00819169|81209410|FG008|Overall Study|Death|7|||
27830475|NCT00819169|81209402|FG000|Overall Study|Ineligibility determined|0|||
27830476|NCT00819169|81209403|FG001|Overall Study|Ineligibility determined|0|||
27830477|NCT00819169|81209404|FG002|Overall Study|Ineligibility determined|0|||
27830478|NCT00819169|81209405|FG003|Overall Study|Ineligibility determined|2|||
27830479|NCT00819169|81209406|FG004|Overall Study|Ineligibility determined|0|||
27830480|NCT00819169|81209407|FG005|Overall Study|Ineligibility determined|0|||
27830481|NCT00819169|81209408|FG006|Overall Study|Ineligibility determined|0|||
27830482|NCT00819169|81209409|FG007|Overall Study|Ineligibility determined|0|||
27830483|NCT00819169|81209410|FG008|Overall Study|Ineligibility determined|1|||
27830484|NCT00819169|81209402|FG000|Overall Study|Adverse Event|0|||
27830485|NCT00819169|81209403|FG001|Overall Study|Adverse Event|0|||
27830486|NCT00819169|81209404|FG002|Overall Study|Adverse Event|0|||
27830487|NCT00819169|81209405|FG003|Overall Study|Adverse Event|0|||
27830488|NCT00819169|81209406|FG004|Overall Study|Adverse Event|1|||
27830489|NCT00819169|81209407|FG005|Overall Study|Adverse Event|0|||
27830490|NCT00819169|81209408|FG006|Overall Study|Adverse Event|0|||
27830491|NCT00819169|81209409|FG007|Overall Study|Adverse Event|0|||
27830492|NCT00819169|81209410|FG008|Overall Study|Adverse Event|0|||
27830493|NCT00819169|81209402|FG000|Overall Study|Administrative Decision|0|||
27830494|NCT00819169|81209403|FG001|Overall Study|Administrative Decision|0|||
27830495|NCT00819169|81209404|FG002|Overall Study|Administrative Decision|0|||
27830496|NCT00819169|81209405|FG003|Overall Study|Administrative Decision|0|||
27830497|NCT00819169|81209406|FG004|Overall Study|Administrative Decision|1|||
27830498|NCT00819169|81209407|FG005|Overall Study|Administrative Decision|2|||
27830499|NCT00819169|81209408|FG006|Overall Study|Administrative Decision|0|||
27830500|NCT00819169|81209409|FG007|Overall Study|Administrative Decision|2|||
27830501|NCT00819169|81209410|FG008|Overall Study|Administrative Decision|0|||
27830502|NCT01169558|81209415|FG000|Overall Study|Disease progression|98|||
27830503|NCT01169558|81209415|FG000|Overall Study|Adverse Event|25|||
27830504|NCT01169558|81209415|FG000|Overall Study|Withdrawal of Consent|8|||
27830505|NCT01169558|81209415|FG000|Overall Study|Medical Decision|7|||
27830506|NCT01169558|81209415|FG000|Overall Study|Stable Disease|4|||
27830507|NCT01169558|81209415|FG000|Overall Study|Lost to Follow-up|4|||
27830508|NCT01169558|81209415|FG000|Overall Study|Need for Surgery|4|||
27830509|NCT01169558|81209415|FG000|Overall Study|Non-compliance|2|||
27830510|NCT01169558|81209415|FG000|Overall Study|Protocol Violation|2|||
27830511|NCT01169558|81209415|FG000|Overall Study|Partial response|2|||
27830512|NCT04345653|81209416|FG000|Overall Study|Withdrawal by Subject|2|||
27884972|NCT00932373|81412003|FG010|Overall Study|Adverse Event|1|||
27559337|NCT02956486|80237611|FG002|Core Phase|Study terminated by sponsor|0|||
27559338|NCT02956486|80237609|FG000|Core Phase|Other|27|||
27830513|NCT03597256|81209417|FG000|Overall Study|Lost to Follow-up|3|||
27830514|NCT03597256|81209418|FG001|Overall Study|Lost to Follow-up|1|||
27830515|NCT03597256|81209417|FG000|Overall Study|Withdrawal by Subject|0|||
27830516|NCT03597256|81209418|FG001|Overall Study|Withdrawal by Subject|1|||
27830517|NCT03597256|81209417|FG000|Overall Study|Could not return for treatment|0|||
27830518|NCT03597256|81209418|FG001|Overall Study|Could not return for treatment|1|||
27830519|NCT03597256|81209417|FG000|Overall Study|Moved from location|0|||
27884973|NCT00932373|81411993|FG000|Overall Study|Physician Decision|0|||
27884974|NCT00932373|81411994|FG001|Overall Study|Physician Decision|0|||
27884975|NCT00932373|81411995|FG002|Overall Study|Physician Decision|1|||
27884976|NCT00932373|81411996|FG003|Overall Study|Physician Decision|0|||
27884977|NCT00932373|81411997|FG004|Overall Study|Physician Decision|2|||
27884978|NCT00932373|81411998|FG005|Overall Study|Physician Decision|0|||
27884979|NCT00932373|81411999|FG006|Overall Study|Physician Decision|0|||
27884980|NCT00932373|81412000|FG007|Overall Study|Physician Decision|0|||
27884981|NCT00932373|81412001|FG008|Overall Study|Physician Decision|0|||
27884982|NCT00932373|81412002|FG009|Overall Study|Physician Decision|1|||
27884983|NCT00932373|81412003|FG010|Overall Study|Physician Decision|0|||
27884984|NCT00932373|81411993|FG000|Overall Study|Dose limiting toxicity|0|||
27884985|NCT00932373|81411994|FG001|Overall Study|Dose limiting toxicity|0|||
27884986|NCT00932373|81411995|FG002|Overall Study|Dose limiting toxicity|0|||
27884987|NCT00932373|81411996|FG003|Overall Study|Dose limiting toxicity|0|||
27884988|NCT00932373|81411997|FG004|Overall Study|Dose limiting toxicity|0|||
27884989|NCT00932373|81411998|FG005|Overall Study|Dose limiting toxicity|1|||
27884990|NCT00932373|81411999|FG006|Overall Study|Dose limiting toxicity|0|||
27884991|NCT00932373|81412000|FG007|Overall Study|Dose limiting toxicity|0|||
27830520|NCT03597256|81209418|FG001|Overall Study|Moved from location|1|||
27884992|NCT00932373|81412001|FG008|Overall Study|Dose limiting toxicity|0|||
27884993|NCT00932373|81412002|FG009|Overall Study|Dose limiting toxicity|0|||
27884994|NCT00932373|81412003|FG010|Overall Study|Dose limiting toxicity|0|||
27884995|NCT00932373|81411993|FG000|Overall Study|Withdrawal by Subject|0|||
27884996|NCT00932373|81411994|FG001|Overall Study|Withdrawal by Subject|0|||
27884997|NCT00932373|81411995|FG002|Overall Study|Withdrawal by Subject|0|||
27884998|NCT00932373|81411996|FG003|Overall Study|Withdrawal by Subject|0|||
27884999|NCT00932373|81411997|FG004|Overall Study|Withdrawal by Subject|0|||
27885000|NCT00932373|81411998|FG005|Overall Study|Withdrawal by Subject|0|||
27885001|NCT00932373|81411999|FG006|Overall Study|Withdrawal by Subject|0|||
27885002|NCT00932373|81412000|FG007|Overall Study|Withdrawal by Subject|0|||
27885003|NCT00932373|81412001|FG008|Overall Study|Withdrawal by Subject|1|||
27885004|NCT00932373|81412002|FG009|Overall Study|Withdrawal by Subject|0|||
27885005|NCT00932373|81412003|FG010|Overall Study|Withdrawal by Subject|0|||
27698750|NCT04178967|80732929|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27698751|NCT04178967|80732930|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27698752|NCT04178967|80732920|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
27830521|NCT03597256|81209417|FG000|Overall Study|Not accepted the treatment|0|||
27830522|NCT03597256|81209418|FG001|Overall Study|Not accepted the treatment|1|||
27830523|NCT00446966|81209419|FG000|Overall Study|Lost to Follow-up|10|||
27830524|NCT00446966|81209420|FG001|Overall Study|Lost to Follow-up|7|||
27830525|NCT00429416|81209422|FG000|Overall Study|Death|1|||
27830526|NCT05755282|81209423|FG000|Overall Study|Protocol Violation|0|||
27830527|NCT05755282|81209424|FG001|Overall Study|Protocol Violation|1|||
27830528|NCT01811953|81209425|FG000|Overall Study|Adverse Event|0|||
27830529|NCT01811953|81209426|FG001|Overall Study|Adverse Event|0|||
27830530|NCT01811953|81209427|FG002|Overall Study|Adverse Event|0|||
27830531|NCT01811953|81209428|FG003|Overall Study|Adverse Event|1|||
27830532|NCT01811953|81209429|FG004|Overall Study|Adverse Event|0|||
27830533|NCT01811953|81209430|FG005|Overall Study|Adverse Event|1|||
27830534|NCT01811953|81209425|FG000|Overall Study|Protocol Violation|0|||
27830535|NCT01811953|81209426|FG001|Overall Study|Protocol Violation|0|||
27830536|NCT01811953|81209427|FG002|Overall Study|Protocol Violation|0|||
27830537|NCT01811953|81209428|FG003|Overall Study|Protocol Violation|0|||
27830538|NCT01811953|81209429|FG004|Overall Study|Protocol Violation|1|||
27885006|NCT00932373|81411993|FG000|Overall Study|Clinical progression|0|||
27885007|NCT00932373|81411994|FG001|Overall Study|Clinical progression|0|||
27885008|NCT00932373|81411995|FG002|Overall Study|Clinical progression|0|||
27885009|NCT00932373|81411996|FG003|Overall Study|Clinical progression|0|||
27885010|NCT00932373|81411997|FG004|Overall Study|Clinical progression|0|||
27885011|NCT00932373|81411998|FG005|Overall Study|Clinical progression|0|||
27885012|NCT00932373|81411999|FG006|Overall Study|Clinical progression|1|||
27830539|NCT01811953|81209430|FG005|Overall Study|Protocol Violation|0|||
27830540|NCT01440803|81209434|FG000|Overall Study|Met study stopping rule|2|||
27885013|NCT00932373|81412000|FG007|Overall Study|Clinical progression|0|||
27830541|NCT01440803|81209435|FG001|Overall Study|Met study stopping rule|1|||
27830542|NCT01440803|81209434|FG000|Overall Study|Lost to Follow-up|0|||
27830543|NCT01440803|81209435|FG001|Overall Study|Lost to Follow-up|2|||
27830544|NCT01440803|81209434|FG000|Overall Study|Withdrawal by Subject|0|||
27830545|NCT01440803|81209435|FG001|Overall Study|Withdrawal by Subject|1|||
27830546|NCT05239195|81209439|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
27830547|NCT05239195|81209440|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
27830548|NCT02436005|81209441|FG000|Second Intervention|Adverse Event|0|||
27830549|NCT02436005|81209442|FG001|Second Intervention|Adverse Event|1|||
27830550|NCT05387408|81209443|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
27830551|NCT00191815|81209444|FG000|Overall Study|Adverse Event|2|||
27830552|NCT00191815|81209444|FG000|Overall Study|Disease progression or relapse|24|||
27830553|NCT00191815|81209444|FG000|Overall Study|Death|2|||
27830554|NCT00191815|81209444|FG000|Overall Study|Protocol Violation|3|||
27830555|NCT00191815|81209444|FG000|Overall Study|Physician Decision|2|||
27830556|NCT00191815|81209444|FG000|Overall Study|Withdrawal by Subject|7|||
27830557|NCT02905435|81209445|FG000|Overall Study|Death|2|||
27830558|NCT02905435|81209445|FG000|Overall Study|Physician Decision|1|||
27830559|NCT02905435|81209445|FG000|Overall Study|Lost to Follow-up|4|||
27830560|NCT00829309|81209446|FG000|Washout: 7 Days|Protocol Violation|1|||
27830561|NCT00829309|81209447|FG001|Washout: 7 Days|Protocol Violation|0|||
27830562|NCT04112823|81212775|FG000|Overall Study|Lost to Follow-up|2|||
27830563|NCT04112823|81212776|FG001|Overall Study|Lost to Follow-up|3|||
27830564|NCT00152451|81212777|FG000|Overall Study|Adverse Event|4|||
27830565|NCT04183335|81212778|FG000|Overall Study|Adverse Event|1|||
27830566|NCT04183335|81212779|FG001|Overall Study|Adverse Event|0|||
27830567|NCT04183335|81212778|FG000|Overall Study|Withdrawal by Subject|12|||
27830568|NCT04183335|81212779|FG001|Overall Study|Withdrawal by Subject|3|||
27830569|NCT04723693|81212785|FG000|Overall Study|Withdrawal by Subject|2|||
27830570|NCT00840203|81212788|FG000|First Intervention|Protocol Violation|1|||
27830571|NCT00840203|81212789|FG001|First Intervention|Protocol Violation|1|||
27830572|NCT00840203|81212788|FG000|Washout|Protocol Violation|1|||
27830573|NCT00840203|81212789|FG001|Washout|Protocol Violation|0|||
27830574|NCT00377260|81212790|FG000|Overall Study|Lost to Follow-up|0|||
27830575|NCT00377260|81212791|FG001|Overall Study|Lost to Follow-up|1|||
27830576|NCT00377260|81212790|FG000|Overall Study|Withdrawal by Subject|2|||
27830577|NCT00377260|81212791|FG001|Overall Study|Withdrawal by Subject|4|||
27830578|NCT01015703|81212792|FG000|Overall Study|Withdrawal by Subject|0|||
27830579|NCT01015703|81212793|FG001|Overall Study|Withdrawal by Subject|1|||
27830580|NCT01015703|81212794|FG002|Overall Study|Withdrawal by Subject|0|||
27830581|NCT01015703|81212795|FG003|Overall Study|Withdrawal by Subject|0|||
27830582|NCT01015703|81212796|FG004|Overall Study|Withdrawal by Subject|0|||
27830583|NCT01015703|81212792|FG000|Overall Study|Adverse Event|1|||
27830584|NCT01015703|81212793|FG001|Overall Study|Adverse Event|0|||
27830585|NCT01015703|81212794|FG002|Overall Study|Adverse Event|0|||
27830586|NCT01015703|81212795|FG003|Overall Study|Adverse Event|0|||
27559339|NCT02956486|80237610|FG001|Core Phase|Other|18|||
27830587|NCT01015703|81212796|FG004|Overall Study|Adverse Event|0|||
27830588|NCT01015703|81212792|FG000|Overall Study|Protocol Violation|1|||
27830589|NCT01015703|81212793|FG001|Overall Study|Protocol Violation|0|||
27830590|NCT01015703|81212794|FG002|Overall Study|Protocol Violation|0|||
27830591|NCT01015703|81212795|FG003|Overall Study|Protocol Violation|0|||
27830592|NCT01015703|81212796|FG004|Overall Study|Protocol Violation|0|||
27830593|NCT02125461|81212797|FG000|Overall Study|Withdrawal by Subject|30|||
27559340|NCT02956486|80237611|FG002|Core Phase|Other|0|||
27885014|NCT00932373|81412001|FG008|Overall Study|Clinical progression|0|||
27885015|NCT00932373|81412002|FG009|Overall Study|Clinical progression|0|||
27885016|NCT00932373|81412003|FG010|Overall Study|Clinical progression|0|||
27885017|NCT00932373|81411993|FG000|Overall Study|Lack of Efficacy|0|||
27885018|NCT00932373|81411994|FG001|Overall Study|Lack of Efficacy|0|||
27885019|NCT00932373|81411995|FG002|Overall Study|Lack of Efficacy|0|||
27885020|NCT00932373|81411996|FG003|Overall Study|Lack of Efficacy|0|||
27885021|NCT00932373|81411997|FG004|Overall Study|Lack of Efficacy|0|||
27885022|NCT00932373|81411998|FG005|Overall Study|Lack of Efficacy|0|||
27885023|NCT00932373|81411999|FG006|Overall Study|Lack of Efficacy|0|||
27885024|NCT00932373|81412000|FG007|Overall Study|Lack of Efficacy|0|||
27885025|NCT00932373|81412001|FG008|Overall Study|Lack of Efficacy|0|||
27885026|NCT00932373|81412002|FG009|Overall Study|Lack of Efficacy|1|||
27559341|NCT02956486|80237609|FG000|Core Phase|Not treated|0|||
27559342|NCT02956486|80237610|FG001|Core Phase|Not treated|3|||
27885027|NCT00932373|81412003|FG010|Overall Study|Lack of Efficacy|0|||
27885028|NCT01046903|81412007|FG000|Overall Study|Lost to Follow-up|16|||
27885029|NCT01046903|81412007|FG000|Overall Study|Adverse Event|4|||
27885030|NCT01046903|81412007|FG000|Overall Study|Withdrawal by Subject|3|||
27885031|NCT01046903|81412007|FG000|Overall Study|Other|5|||
27885032|NCT00638404|81412008|FG000|Overall Study|Physician Decision|8|||
27885033|NCT00638404|81412009|FG001|Overall Study|Physician Decision|0|||
27885034|NCT01718535|81412015|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
27885035|NCT01718535|81412016|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
27885036|NCT01718535|81412017|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
27885037|NCT01718535|81412018|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
27885038|NCT01718535|81412019|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
27885039|NCT01718535|81412020|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
27559343|NCT02956486|80237611|FG002|Core Phase|Not treated|0|||
27559344|NCT02956486|80237609|FG000|Extension Phase|Adverse Event|0|||
27559345|NCT02956486|80237610|FG001|Extension Phase|Adverse Event|0|||
27559346|NCT02956486|80237611|FG002|Extension Phase|Adverse Event|2|||
27830594|NCT02125461|81212798|FG001|Overall Study|Withdrawal by Subject|16|||
27830595|NCT02125461|81212797|FG000|Overall Study|Lost to Follow-up|8|||
27885040|NCT01718535|81412021|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
27885041|NCT01718535|81412022|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
27885042|NCT01718535|81412023|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
27830596|NCT02125461|81212798|FG001|Overall Study|Lost to Follow-up|3|||
27830597|NCT02125461|81212797|FG000|Overall Study|Death|260|||
27830598|NCT02125461|81212798|FG001|Overall Study|Death|149|||
27830599|NCT02125461|81212797|FG000|Overall Study|Missing Termination Reason|0|||
27830600|NCT02125461|81212798|FG001|Overall Study|Missing Termination Reason|1|||
27830601|NCT03599362|81212799|FG000|Overall Study|Screen Failure|3|||
27830602|NCT00635648|81212800|FG000|Overall Study|Adverse Event|12|||
27830603|NCT00635648|81212800|FG000|Overall Study|Withdrawal by Subject|9|||
27559347|NCT02956486|80237609|FG000|Extension Phase|Study terminated by sponsor|0|||
27559348|NCT02956486|80237610|FG001|Extension Phase|Study terminated by sponsor|0|||
27559349|NCT02956486|80237611|FG002|Extension Phase|Study terminated by sponsor|16|||
27698753|NCT04178967|80732921|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
27698754|NCT04178967|80732922|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
27830604|NCT00635648|81212800|FG000|Overall Study|Physician Decision|4|||
27830605|NCT00635648|81212800|FG000|Overall Study|Rapid progression of baseline disease|4|||
27559350|NCT02956486|80237609|FG000|Extension Phase|Not Treated|0|||
27830606|NCT00635648|81212800|FG000|Overall Study|Use of other antifungal agent needed|1|||
27885043|NCT01718535|81412024|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
27559351|NCT02956486|80237610|FG001|Extension Phase|Not Treated|0|||
27559352|NCT02956486|80237611|FG002|Extension Phase|Not Treated|1|||
27830607|NCT00635648|81212800|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
27830608|NCT00635648|81212800|FG000|Overall Study|Noncompliance with protocol|1|||
27830609|NCT00635648|81212800|FG000|Overall Study|Other reason|2|||
27885044|NCT01680861|81412026|FG000|Early Post-transplant Period|Protocol Violation|1|||
27885045|NCT01680861|81412027|FG001|Early Post-transplant Period|Protocol Violation|1|||
27885046|NCT02316548|81412031|FG000|Overall Study|Protocol Violation|0|||
27559353|NCT01710033|80237612|FG000|Stage 2|Adverse Event|0|||
27559354|NCT01710033|80237613|FG001|Stage 2|Adverse Event|0|||
27559355|NCT01710033|80237614|FG002|Stage 2|Adverse Event|0|||
27559356|NCT01710033|80237615|FG003|Stage 2|Adverse Event|0|||
27559357|NCT01710033|80237616|FG004|Stage 2|Adverse Event|1|||
27559358|NCT00254540|80237617|FG000|Overall Study|Adverse Event|6|||
27559359|NCT00254540|80237618|FG001|Overall Study|Adverse Event|7|||
27559360|NCT00254540|80237617|FG000|Overall Study|Lack of Efficacy|13|||
27559361|NCT00254540|80237618|FG001|Overall Study|Lack of Efficacy|13|||
27559362|NCT00254540|80237617|FG000|Overall Study|Death|0|||
27559363|NCT00254540|80237618|FG001|Overall Study|Death|1|||
27559364|NCT00254540|80237617|FG000|Overall Study|Laboratory Test Abnormality|0|||
27559365|NCT00254540|80237618|FG001|Overall Study|Laboratory Test Abnormality|1|||
27559366|NCT02154581|80237619|FG000|Overall Study|Lost to Follow-up|7|||
27559367|NCT02154581|80237620|FG001|Overall Study|Lost to Follow-up|8|||
27559368|NCT01525550|80237626|FG000|Overall Study|Lost to Follow-up|8|||
27559369|NCT01525550|80237627|FG001|Overall Study|Lost to Follow-up|2|||
27698755|NCT04178967|80732923|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
27698756|NCT04178967|80732924|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
27698757|NCT04178967|80732925|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
27698758|NCT04178967|80732926|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
27698759|NCT04178967|80732927|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
27559370|NCT01525550|80237626|FG000|Overall Study|Death|19|||
27559371|NCT01525550|80237627|FG001|Overall Study|Death|28|||
27559372|NCT01525550|80237626|FG000|Overall Study|Other|0|||
27559373|NCT01525550|80237627|FG001|Overall Study|Other|4|||
27559374|NCT01525550|80237626|FG000|Overall Study|Sponsor's Decision|30|||
27559375|NCT01525550|80237627|FG001|Overall Study|Sponsor's Decision|11|||
27559376|NCT01525550|80237626|FG000|Overall Study|Withdrawal by Subject|4|||
27559377|NCT01525550|80237627|FG001|Overall Study|Withdrawal by Subject|0|||
27559378|NCT02699554|80237628|FG000|Overall Study|Lost to Follow-up|9|||
27559379|NCT02039674|80237629|FG000|Overall Study|Adverse Event|0|||
27559380|NCT02039674|80237630|FG001|Overall Study|Adverse Event|0|||
27559381|NCT02039674|80237631|FG002|Overall Study|Adverse Event|0|||
27698760|NCT04178967|80732928|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
27830610|NCT04035187|81212801|FG000|Overall Study|Withdrawal by Subject|2|||
27830611|NCT04035187|81212802|FG001|Overall Study|Withdrawal by Subject|1|||
27830612|NCT04035187|81212803|FG002|Overall Study|Withdrawal by Subject|0|||
27559382|NCT02039674|80237632|FG003|Overall Study|Adverse Event|1|||
27559383|NCT02039674|80237633|FG004|Overall Study|Adverse Event|0|||
27559384|NCT02039674|80237634|FG005|Overall Study|Adverse Event|0|||
27559385|NCT02039674|80237635|FG006|Overall Study|Adverse Event|0|||
27559386|NCT02039674|80237636|FG007|Overall Study|Adverse Event|0|||
27559387|NCT02039674|80237637|FG008|Overall Study|Adverse Event|2|||
27559388|NCT02039674|80237638|FG009|Overall Study|Adverse Event|1|||
27559389|NCT02039674|80237639|FG010|Overall Study|Adverse Event|0|||
27559390|NCT02039674|80237640|FG011|Overall Study|Adverse Event|2|||
27559391|NCT02039674|80237641|FG012|Overall Study|Adverse Event|3|||
27559392|NCT02039674|80237642|FG013|Overall Study|Adverse Event|1|||
27559393|NCT02039674|80237629|FG000|Overall Study|Death|2|||
27559394|NCT02039674|80237630|FG001|Overall Study|Death|0|||
27559395|NCT02039674|80237631|FG002|Overall Study|Death|2|||
27559396|NCT02039674|80237632|FG003|Overall Study|Death|3|||
27559397|NCT02039674|80237633|FG004|Overall Study|Death|0|||
27559398|NCT02039674|80237634|FG005|Overall Study|Death|0|||
27559399|NCT02039674|80237635|FG006|Overall Study|Death|1|||
27559400|NCT02039674|80237636|FG007|Overall Study|Death|0|||
27559401|NCT02039674|80237637|FG008|Overall Study|Death|2|||
27559402|NCT02039674|80237638|FG009|Overall Study|Death|0|||
27559403|NCT02039674|80237639|FG010|Overall Study|Death|1|||
27559404|NCT02039674|80237640|FG011|Overall Study|Death|3|||
27559405|NCT02039674|80237641|FG012|Overall Study|Death|2|||
27559406|NCT02039674|80237642|FG013|Overall Study|Death|8|||
27559407|NCT02039674|80237629|FG000|Overall Study|Excluded Medication|1|||
27559408|NCT02039674|80237630|FG001|Overall Study|Excluded Medication|1|||
27559409|NCT02039674|80237631|FG002|Overall Study|Excluded Medication|0|||
27559410|NCT02039674|80237632|FG003|Overall Study|Excluded Medication|1|||
27559411|NCT02039674|80237633|FG004|Overall Study|Excluded Medication|0|||
27559412|NCT02039674|80237634|FG005|Overall Study|Excluded Medication|1|||
27830613|NCT04035187|81212804|FG003|Overall Study|Withdrawal by Subject|0|||
27559413|NCT02039674|80237635|FG006|Overall Study|Excluded Medication|0|||
27559414|NCT02039674|80237636|FG007|Overall Study|Excluded Medication|0|||
27559415|NCT02039674|80237637|FG008|Overall Study|Excluded Medication|2|||
27559416|NCT02039674|80237638|FG009|Overall Study|Excluded Medication|3|||
27559417|NCT02039674|80237639|FG010|Overall Study|Excluded Medication|5|||
27559418|NCT02039674|80237640|FG011|Overall Study|Excluded Medication|6|||
27559419|NCT02039674|80237641|FG012|Overall Study|Excluded Medication|8|||
27559420|NCT02039674|80237642|FG013|Overall Study|Excluded Medication|3|||
27559421|NCT02039674|80237629|FG000|Overall Study|Lost to Follow-up|0|||
27830614|NCT04035187|81212801|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
27885047|NCT02316548|81412032|FG001|Overall Study|Protocol Violation|1|||
27559422|NCT02039674|80237630|FG001|Overall Study|Lost to Follow-up|0|||
27698761|NCT04178967|80732929|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
27698762|NCT04178967|80732930|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
27830615|NCT04035187|81212802|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
27830616|NCT04035187|81212803|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
27830617|NCT04035187|81212804|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
27830618|NCT00606281|81212805|FG000|Overall Study|Adverse Event|11|||
27830619|NCT00606281|81212806|FG001|Overall Study|Adverse Event|12|||
27830620|NCT00606281|81212805|FG000|Overall Study|Death|1|||
27830621|NCT00606281|81212806|FG001|Overall Study|Death|0|||
27830622|NCT00606281|81212805|FG000|Overall Study|Lack of Efficacy|28|||
27830623|NCT00606281|81212806|FG001|Overall Study|Lack of Efficacy|35|||
27830624|NCT00606281|81212805|FG000|Overall Study|Physician Decision|0|||
27830625|NCT00606281|81212806|FG001|Overall Study|Physician Decision|1|||
27830626|NCT00606281|81212805|FG000|Overall Study|Protocol Violation|3|||
27830627|NCT00606281|81212806|FG001|Overall Study|Protocol Violation|3|||
27830628|NCT00606281|81212805|FG000|Overall Study|Withdrawal by Subject|11|||
27830629|NCT00606281|81212806|FG001|Overall Study|Withdrawal by Subject|13|||
27830630|NCT00606281|81212805|FG000|Overall Study|Progression to depressive phase|1|||
27830631|NCT00606281|81212806|FG001|Overall Study|Progression to depressive phase|1|||
27830632|NCT00606281|81212805|FG000|Overall Study|Change of residence or other commitments|1|||
27885048|NCT00520533|81412033|FG000|Overall Study|Death|1|||
27885049|NCT00520533|81412033|FG000|Overall Study|Suspension of the study for safety reasons|1|||
27885050|NCT00520533|81412033|FG000|Overall Study|Withdrawal by Subject|1|||
27885051|NCT00520533|81412033|FG000|Overall Study|Physician Decision|1|||
27885052|NCT01355575|81412034|FG000|Overall Study|Withdrawal by Subject|2|||
27885053|NCT00003830|81412041|FG000|Overall Study|No follow up data|3|||
27698763|NCT04178967|80732920|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698764|NCT04178967|80732921|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698765|NCT04178967|80732922|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698766|NCT04178967|80732923|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698767|NCT04178967|80732924|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698768|NCT04178967|80732925|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698769|NCT04178967|80732926|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27885054|NCT00003830|81412042|FG001|Overall Study|No follow up data|0|||
27885055|NCT00003830|81412041|FG000|Overall Study|Sentinel node positive patients|829|||
27885056|NCT00003830|81412042|FG001|Overall Study|Sentinel node positive patients|793|||
27885057|NCT00627445|81412043|FG000|Overall Study|Adverse Event|3|||
27698770|NCT04178967|80732927|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27698771|NCT04178967|80732928|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
27698772|NCT04178967|80732929|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
27698773|NCT04178967|80732930|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
27698774|NCT04178967|80732920|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698775|NCT04178967|80732921|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698776|NCT04178967|80732922|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698777|NCT04178967|80732923|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698778|NCT04178967|80732924|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698779|NCT04178967|80732925|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698780|NCT04178967|80732926|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698781|NCT04178967|80732927|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698782|NCT04178967|80732928|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698783|NCT04178967|80732929|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
27698784|NCT04178967|80732930|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27698785|NCT04178967|80732920|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698786|NCT04178967|80732921|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698787|NCT04178967|80732922|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698788|NCT04178967|80732923|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698789|NCT04178967|80732924|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698790|NCT04178967|80732925|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698791|NCT04178967|80732926|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698792|NCT04178967|80732927|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27698793|NCT04178967|80732928|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
27698794|NCT04178967|80732929|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
27698795|NCT04178967|80732930|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
27698796|NCT04178967|80732920|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698797|NCT04178967|80732921|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698798|NCT04178967|80732922|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698799|NCT04178967|80732923|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27885058|NCT00627445|81412044|FG001|Overall Study|Adverse Event|3|||
27885059|NCT00627445|81412043|FG000|Overall Study|Lack of Efficacy|0|||
27885060|NCT00627445|81412044|FG001|Overall Study|Lack of Efficacy|1|||
27698800|NCT04178967|80732924|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698801|NCT04178967|80732925|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698802|NCT04178967|80732926|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27830633|NCT00606281|81212806|FG001|Overall Study|Change of residence or other commitments|1|||
27830634|NCT00216736|81212807|FG000|Overall Study|Lost to Follow-up|1|||
27830635|NCT00216736|81212808|FG001|Overall Study|Lost to Follow-up|1|||
27830636|NCT04198363|81212809|FG000|Overall Study|Adverse Event|1|||
27830637|NCT04198363|81212810|FG001|Overall Study|Adverse Event|1|||
27830638|NCT04198363|81212809|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
27830639|NCT04198363|81212810|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
27830640|NCT04198363|81212809|FG000|Overall Study|Reason not Specified|1|||
27830641|NCT04198363|81212810|FG001|Overall Study|Reason not Specified|0|||
27885061|NCT00627445|81412043|FG000|Overall Study|Other|6|||
27885062|NCT00627445|81412044|FG001|Overall Study|Other|8|||
27885063|NCT05020665|81412045|FG000|Overall Study|Study terminated by Sponsor|5|||
27885064|NCT05020665|81412046|FG001|Overall Study|Study terminated by Sponsor|4|||
27885065|NCT05020665|81412045|FG000|Overall Study|Death|2|||
27698803|NCT04178967|80732927|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27559423|NCT02039674|80237631|FG002|Overall Study|Lost to Follow-up|0|||
27559424|NCT02039674|80237632|FG003|Overall Study|Lost to Follow-up|0|||
27559425|NCT02039674|80237633|FG004|Overall Study|Lost to Follow-up|1|||
27559426|NCT02039674|80237634|FG005|Overall Study|Lost to Follow-up|1|||
27559427|NCT02039674|80237635|FG006|Overall Study|Lost to Follow-up|0|||
27559428|NCT02039674|80237636|FG007|Overall Study|Lost to Follow-up|0|||
27559429|NCT02039674|80237637|FG008|Overall Study|Lost to Follow-up|0|||
27559430|NCT02039674|80237638|FG009|Overall Study|Lost to Follow-up|0|||
27559431|NCT02039674|80237639|FG010|Overall Study|Lost to Follow-up|0|||
27559432|NCT02039674|80237640|FG011|Overall Study|Lost to Follow-up|2|||
27559433|NCT02039674|80237641|FG012|Overall Study|Lost to Follow-up|2|||
27559434|NCT02039674|80237642|FG013|Overall Study|Lost to Follow-up|1|||
27559435|NCT02039674|80237629|FG000|Overall Study|Physician Decision|0|||
27559436|NCT02039674|80237630|FG001|Overall Study|Physician Decision|0|||
27559437|NCT02039674|80237631|FG002|Overall Study|Physician Decision|0|||
27559438|NCT02039674|80237632|FG003|Overall Study|Physician Decision|0|||
27559439|NCT02039674|80237633|FG004|Overall Study|Physician Decision|0|||
27559440|NCT02039674|80237634|FG005|Overall Study|Physician Decision|0|||
27559441|NCT02039674|80237635|FG006|Overall Study|Physician Decision|0|||
27698804|NCT04178967|80732928|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698805|NCT04178967|80732929|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
27698806|NCT04178967|80732930|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
27698807|NCT04178967|80732920|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698808|NCT04178967|80732921|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698809|NCT04178967|80732922|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698810|NCT04178967|80732923|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698811|NCT04178967|80732924|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698812|NCT04178967|80732925|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698813|NCT04178967|80732926|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698814|NCT04178967|80732927|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698815|NCT04178967|80732928|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698816|NCT04178967|80732929|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
27698817|NCT04178967|80732930|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
27698818|NCT02742766|80732933|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698819|NCT02742766|80732934|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698820|NCT02742766|80732935|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698821|NCT02742766|80732936|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698822|NCT02742766|80732937|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698823|NCT02742766|80732938|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698824|NCT02742766|80732939|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698825|NCT02742766|80732940|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698826|NCT02742766|80732941|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698827|NCT02742766|80732942|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698828|NCT02742766|80732943|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698829|NCT02742766|80732944|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698830|NCT02742766|80732945|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698831|NCT02742766|80732946|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
27698832|NCT02742766|80732947|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698833|NCT02742766|80732948|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698834|NCT02742766|80732949|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698835|NCT02742766|80732950|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698836|NCT02742766|80732951|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
27698837|NCT02742766|80732933|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698838|NCT02742766|80732934|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698839|NCT02742766|80732935|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698840|NCT02742766|80732936|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698841|NCT02742766|80732937|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698842|NCT02742766|80732938|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698843|NCT02742766|80732939|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698844|NCT02742766|80732940|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698845|NCT02742766|80732941|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698846|NCT02742766|80732942|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698847|NCT02742766|80732943|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698848|NCT02742766|80732944|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698849|NCT02742766|80732945|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
27698850|NCT02742766|80732946|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
27698851|NCT02742766|80732947|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698852|NCT02742766|80732948|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
27698853|NCT02742766|80732949|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698854|NCT02742766|80732950|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698855|NCT02742766|80732951|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
27698856|NCT01601847|80732952|FG000|Overall Study|Death|1|||
27698857|NCT01601847|80732953|FG001|Overall Study|Death|0|||
27698858|NCT01601847|80732952|FG000|Overall Study|Withdrawal by Subject|11|||
27698859|NCT01601847|80732953|FG001|Overall Study|Withdrawal by Subject|7|||
27698860|NCT01601847|80732952|FG000|Overall Study|Lost to Follow-up|1|||
27698861|NCT01601847|80732953|FG001|Overall Study|Lost to Follow-up|3|||
27698862|NCT00954421|80732954|FG000|Screening|screen failures|3|||
27698863|NCT00954421|80732954|FG000|6 Months of DBS|Withdrawal by Subject|1|||
27698864|NCT00954421|80732954|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
27698865|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
27698866|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
27698867|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
27698868|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
27698869|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
27698870|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
27698871|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
27698872|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
27698873|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
27698874|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
27698875|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
27559442|NCT02039674|80237636|FG007|Overall Study|Physician Decision|0|||
27559443|NCT02039674|80237637|FG008|Overall Study|Physician Decision|0|||
27559444|NCT02039674|80237638|FG009|Overall Study|Physician Decision|0|||
27559445|NCT02039674|80237639|FG010|Overall Study|Physician Decision|0|||
27559446|NCT02039674|80237640|FG011|Overall Study|Physician Decision|1|||
27559447|NCT02039674|80237641|FG012|Overall Study|Physician Decision|1|||
27559448|NCT02039674|80237642|FG013|Overall Study|Physician Decision|0|||
27559449|NCT02039674|80237629|FG000|Overall Study|Progressive Disease|8|||
27559450|NCT02039674|80237630|FG001|Overall Study|Progressive Disease|8|||
27698876|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
27698877|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Death|3|||
27698878|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Death|1|||
27698879|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
27698880|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
27559451|NCT02039674|80237631|FG002|Overall Study|Progressive Disease|6|||
27559452|NCT02039674|80237632|FG003|Overall Study|Progressive Disease|7|||
27559453|NCT02039674|80237633|FG004|Overall Study|Progressive Disease|9|||
27559454|NCT02039674|80237634|FG005|Overall Study|Progressive Disease|10|||
27559455|NCT02039674|80237635|FG006|Overall Study|Progressive Disease|1|||
27559456|NCT02039674|80237636|FG007|Overall Study|Progressive Disease|3|||
27559457|NCT02039674|80237637|FG008|Overall Study|Progressive Disease|6|||
27559458|NCT02039674|80237638|FG009|Overall Study|Progressive Disease|4|||
27559459|NCT02039674|80237639|FG010|Overall Study|Progressive Disease|0|||
27559460|NCT02039674|80237640|FG011|Overall Study|Progressive Disease|34|||
27559461|NCT02039674|80237641|FG012|Overall Study|Progressive Disease|34|||
27559462|NCT02039674|80237642|FG013|Overall Study|Progressive Disease|18|||
27559463|NCT02039674|80237629|FG000|Overall Study|Withdrawal by Subject|1|||
27559464|NCT02039674|80237630|FG001|Overall Study|Withdrawal by Subject|2|||
27559465|NCT02039674|80237631|FG002|Overall Study|Withdrawal by Subject|3|||
27698881|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Adverse Event|7|||
27559466|NCT02039674|80237632|FG003|Overall Study|Withdrawal by Subject|0|||
27559467|NCT02039674|80237633|FG004|Overall Study|Withdrawal by Subject|1|||
27559468|NCT02039674|80237634|FG005|Overall Study|Withdrawal by Subject|0|||
27559469|NCT02039674|80237635|FG006|Overall Study|Withdrawal by Subject|0|||
27559470|NCT02039674|80237636|FG007|Overall Study|Withdrawal by Subject|0|||
27559471|NCT02039674|80237637|FG008|Overall Study|Withdrawal by Subject|0|||
27559472|NCT02039674|80237638|FG009|Overall Study|Withdrawal by Subject|1|||
27559473|NCT02039674|80237639|FG010|Overall Study|Withdrawal by Subject|1|||
27559474|NCT02039674|80237640|FG011|Overall Study|Withdrawal by Subject|4|||
27559475|NCT02039674|80237641|FG012|Overall Study|Withdrawal by Subject|6|||
27559476|NCT02039674|80237642|FG013|Overall Study|Withdrawal by Subject|2|||
27559477|NCT02039674|80237629|FG000|Overall Study|Clinical Progression|0|||
27559478|NCT02039674|80237630|FG001|Overall Study|Clinical Progression|0|||
27559479|NCT02039674|80237631|FG002|Overall Study|Clinical Progression|0|||
27559480|NCT02039674|80237632|FG003|Overall Study|Clinical Progression|0|||
27559481|NCT02039674|80237633|FG004|Overall Study|Clinical Progression|0|||
27559482|NCT02039674|80237634|FG005|Overall Study|Clinical Progression|0|||
27559483|NCT02039674|80237635|FG006|Overall Study|Clinical Progression|1|||
27559484|NCT02039674|80237636|FG007|Overall Study|Clinical Progression|0|||
27559485|NCT02039674|80237637|FG008|Overall Study|Clinical Progression|0|||
27559486|NCT02039674|80237638|FG009|Overall Study|Clinical Progression|0|||
27559487|NCT02039674|80237639|FG010|Overall Study|Clinical Progression|0|||
27559488|NCT02039674|80237640|FG011|Overall Study|Clinical Progression|0|||
27885066|NCT05020665|81412046|FG001|Overall Study|Death|1|||
27885067|NCT05020665|81412045|FG000|Overall Study|Physician Decision|0|||
27559489|NCT02039674|80237641|FG012|Overall Study|Clinical Progression|1|||
27559490|NCT02039674|80237642|FG013|Overall Study|Clinical Progression|0|||
27559491|NCT02039674|80237629|FG000|Overall Study|Sponsor Decision|1|||
27559492|NCT02039674|80237630|FG001|Overall Study|Sponsor Decision|1|||
27559493|NCT02039674|80237631|FG002|Overall Study|Sponsor Decision|1|||
27559494|NCT02039674|80237632|FG003|Overall Study|Sponsor Decision|1|||
27698882|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Adverse Event|8|||
27698883|NCT03236246|80732956|FG000|24-Week Dose Titration Period|Captured as Other|1|||
27559495|NCT02039674|80237633|FG004|Overall Study|Sponsor Decision|1|||
27559496|NCT02039674|80237634|FG005|Overall Study|Sponsor Decision|0|||
27559497|NCT02039674|80237635|FG006|Overall Study|Sponsor Decision|0|||
27698884|NCT03236246|80732957|FG001|24-Week Dose Titration Period|Captured as Other|2|||
27830682|NCT02272803|81212817|FG000|Overall Study|Disease progression|16|||
27830683|NCT02272803|81212818|FG001|Overall Study|Disease progression|8|||
27830684|NCT02272803|81212817|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
27885068|NCT05020665|81412046|FG001|Overall Study|Physician Decision|1|||
27885069|NCT05020665|81412045|FG000|Overall Study|Withdrawal by Subject|0|||
27885070|NCT05020665|81412046|FG001|Overall Study|Withdrawal by Subject|1|||
27885071|NCT05020665|81412045|FG000|Overall Study|Reason not specified|1|||
27885072|NCT05020665|81412046|FG001|Overall Study|Reason not specified|0|||
27885073|NCT04553471|81412047|FG000|Overall Study|Did not start treatment on protocol|3|||
27885074|NCT04553471|81412047|FG000|Overall Study|Death|1|||
27885075|NCT01011465|81412048|FG000|Overall Study|Withdrawal by Subject|2|||
27885076|NCT01011465|81412049|FG001|Overall Study|Withdrawal by Subject|1|||
27885077|NCT01011465|81412050|FG002|Overall Study|Withdrawal by Subject|0|||
27885078|NCT01011465|81412051|FG003|Overall Study|Withdrawal by Subject|0|||
27885079|NCT01011465|81412052|FG004|Overall Study|Withdrawal by Subject|1|||
27885080|NCT01011465|81412053|FG005|Overall Study|Withdrawal by Subject|0|||
27885081|NCT01011465|81412054|FG006|Overall Study|Withdrawal by Subject|1|||
27885082|NCT01011465|81412055|FG007|Overall Study|Withdrawal by Subject|0|||
27885083|NCT00237458|81412056|FG000|Overall Study|Lack of Efficacy|1|||
27885084|NCT00237458|81412056|FG000|Overall Study|Adverse Event|1|||
27830685|NCT02272803|81212818|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
27830686|NCT02272803|81212817|FG000|Overall Study|Study drug toxicity|4|||
27830687|NCT02272803|81212818|FG001|Overall Study|Study drug toxicity|9|||
27830688|NCT02272803|81212817|FG000|Overall Study|Participant request to discontinue study treatment|3|||
27830689|NCT02272803|81212818|FG001|Overall Study|Participant request to discontinue study treatment|7|||
27830690|NCT02272803|81212817|FG000|Overall Study|Maximum clinical benefit|4|||
27830691|NCT02272803|81212818|FG001|Overall Study|Maximum clinical benefit|2|||
27830692|NCT02272803|81212817|FG000|Overall Study|Poor/non-compliance|2|||
27830693|NCT02272803|81212818|FG001|Overall Study|Poor/non-compliance|2|||
27559498|NCT02039674|80237636|FG007|Overall Study|Sponsor Decision|0|||
27559499|NCT02039674|80237637|FG008|Overall Study|Sponsor Decision|0|||
27559500|NCT02039674|80237638|FG009|Overall Study|Sponsor Decision|3|||
27559501|NCT02039674|80237639|FG010|Overall Study|Sponsor Decision|0|||
27559502|NCT02039674|80237640|FG011|Overall Study|Sponsor Decision|8|||
27698885|NCT03236246|80732956|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
27698886|NCT03236246|80732957|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
27698887|NCT03236246|80732956|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
27830694|NCT02272803|81212817|FG000|Overall Study|Withdrawal by Subject|2|||
27559503|NCT02039674|80237641|FG012|Overall Study|Sponsor Decision|5|||
27559504|NCT02039674|80237642|FG013|Overall Study|Sponsor Decision|0|||
27698888|NCT03236246|80732957|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
27830695|NCT02272803|81212818|FG001|Overall Study|Withdrawal by Subject|1|||
27830696|NCT02272803|81212817|FG000|Overall Study|Death|0|||
27830697|NCT02272803|81212818|FG001|Overall Study|Death|1|||
27830698|NCT02272803|81212817|FG000|Overall Study|Other reasons|1|||
27830699|NCT02272803|81212818|FG001|Overall Study|Other reasons|3|||
27830700|NCT02272803|81212817|FG000|Overall Study|Administrative reason by sponsor|5|||
27559505|NCT02039674|80237629|FG000|Overall Study|Other|0|||
27559506|NCT02039674|80237630|FG001|Overall Study|Other|0|||
27830701|NCT02272803|81212818|FG001|Overall Study|Administrative reason by sponsor|4|||
27830702|NCT05034874|81212819|FG000|Overall Study|Withdrawal by Subject|6|||
27830703|NCT05034874|81212820|FG001|Overall Study|Withdrawal by Subject|6|||
27885085|NCT00237458|81412056|FG000|Overall Study|Withdrawal by Subject|1|||
27885086|NCT00379080|81412057|FG000|Overall Study|Withdrawal by Subject|0|||
27885087|NCT00379080|81412058|FG001|Overall Study|Withdrawal by Subject|4|||
27885088|NCT00379080|81412059|FG002|Overall Study|Withdrawal by Subject|0|||
27885089|NCT03278613|81412060|FG000|Overall Study|Lost to Follow-up|3|||
27885090|NCT03278613|81412061|FG001|Overall Study|Lost to Follow-up|1|||
27830704|NCT05034874|81212819|FG000|Overall Study|Lost to Follow-up|18|||
27830705|NCT05034874|81212820|FG001|Overall Study|Lost to Follow-up|8|||
27830706|NCT05034874|81212819|FG000|Overall Study|Physician Decision|0|||
27830707|NCT05034874|81212820|FG001|Overall Study|Physician Decision|1|||
27830708|NCT05034874|81212819|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
27830709|NCT05034874|81212820|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
27830710|NCT03446768|81212821|FG000|Overall Study|Withdrawal by Subject|0|||
27830711|NCT03446768|81212822|FG001|Overall Study|Withdrawal by Subject|1|||
27830712|NCT00834873|81212823|FG000|First Intervention|Adverse Event|0|||
27830713|NCT00834873|81212824|FG001|First Intervention|Adverse Event|1|||
27830714|NCT02875392|81212825|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
27830715|NCT02875392|81212826|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
27830716|NCT02151981|81212827|FG000|Overall Study|Death|184|||
27885091|NCT00813813|81412062|FG000|Overall Study|Withdrawal by Subject|1|||
27885092|NCT00813813|81412063|FG001|Overall Study|Withdrawal by Subject|1|||
27885093|NCT00813813|81412062|FG000|Overall Study|Lost to Follow-up|2|||
27559507|NCT02039674|80237631|FG002|Overall Study|Other|0|||
27830717|NCT02151981|81212828|FG001|Overall Study|Death|88|||
27830718|NCT02151981|81212827|FG000|Overall Study|Lost to Follow-up|7|||
27885094|NCT00813813|81412063|FG001|Overall Study|Lost to Follow-up|7|||
27885095|NCT00813813|81412062|FG000|Overall Study|Other|0|||
27559508|NCT02039674|80237632|FG003|Overall Study|Other|0|||
27885096|NCT00813813|81412063|FG001|Overall Study|Other|1|||
27885097|NCT02498444|81412066|FG000|Overall Study|Withdrawal by Subject|3|||
27830719|NCT02151981|81212828|FG001|Overall Study|Lost to Follow-up|1|||
27830720|NCT02151981|81212827|FG000|Overall Study|Withdrawal by Subject|27|||
27830721|NCT02151981|81212828|FG001|Overall Study|Withdrawal by Subject|21|||
27830722|NCT02151981|81212827|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
27698889|NCT03236246|80732956|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
27830723|NCT02151981|81212828|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
27830724|NCT02151981|81212827|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27830725|NCT02151981|81212828|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27830726|NCT02151981|81212827|FG000|Overall Study|Patient had no clinical benefit|1|||
27830727|NCT02151981|81212828|FG001|Overall Study|Patient had no clinical benefit|0|||
27830728|NCT02151981|81212827|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
27830729|NCT02151981|81212828|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
27830730|NCT02151981|81212827|FG000|Overall Study|Study terminated|0|||
27885098|NCT02498444|81412067|FG001|Overall Study|Withdrawal by Subject|0|||
27885099|NCT02498444|81412066|FG000|Overall Study|Physician Decision|1|||
27885100|NCT02498444|81412067|FG001|Overall Study|Physician Decision|0|||
27885101|NCT02035202|81412068|FG000|Overall Study|Lost to Follow-up|8|||
27885102|NCT02035202|81412069|FG001|Overall Study|Lost to Follow-up|16|||
27885103|NCT02035202|81412070|FG002|Overall Study|Lost to Follow-up|2|||
27885104|NCT02632409|81412075|FG000|Randomized|AE unrelated to study Drug|0|||
27885105|NCT02632409|81412076|FG001|Randomized|AE unrelated to study Drug|1|||
27885106|NCT02632409|81412075|FG000|Randomized|Participant withdrew consent|2|||
27885107|NCT02632409|81412076|FG001|Randomized|Participant withdrew consent|1|||
27885108|NCT02632409|81412075|FG000|Randomized|No Longer meets study criteria|5|||
27885109|NCT02632409|81412076|FG001|Randomized|No Longer meets study criteria|0|||
27885110|NCT02632409|81412075|FG000|Randomized|other reasons|1|||
27885111|NCT02632409|81412076|FG001|Randomized|other reasons|0|||
27885112|NCT02632409|81412075|FG000|Treatment Period|Ongoing Treatment|20|||
27885113|NCT02632409|81412076|FG001|Treatment Period|Ongoing Treatment|21|||
27885114|NCT02632409|81412075|FG000|Treatment Period|Disease Recurrence|147|||
27885115|NCT02632409|81412076|FG001|Treatment Period|Disease Recurrence|90|||
27885116|NCT02632409|81412075|FG000|Treatment Period|Study Drug Toxicity|8|||
27885117|NCT02632409|81412076|FG001|Treatment Period|Study Drug Toxicity|49|||
27885118|NCT02632409|81412075|FG000|Treatment Period|Death|1|||
27885119|NCT02632409|81412076|FG001|Treatment Period|Death|0|||
27885120|NCT02632409|81412075|FG000|Treatment Period|AE unrelated to study drug|15|||
27885121|NCT02632409|81412076|FG001|Treatment Period|AE unrelated to study drug|16|||
27885122|NCT02632409|81412075|FG000|Treatment Period|Request to discontinue treatment|4|||
27885123|NCT02632409|81412076|FG001|Treatment Period|Request to discontinue treatment|19|||
27885124|NCT02632409|81412075|FG000|Treatment Period|Participant withdrew consent|7|||
27559509|NCT02039674|80237633|FG004|Overall Study|Other|0|||
27698890|NCT03236246|80732957|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
27830731|NCT02151981|81212828|FG001|Overall Study|Study terminated|1|||
27830732|NCT04442503|81212829|FG000|Overall Study|Adverse Event|1|||
27830733|NCT04442503|81212830|FG001|Overall Study|Adverse Event|1|||
27885125|NCT02632409|81412076|FG001|Treatment Period|Participant withdrew consent|5|||
27885126|NCT02632409|81412075|FG000|Treatment Period|Lost to Follow-up|0|||
27885127|NCT02632409|81412076|FG001|Treatment Period|Lost to Follow-up|1|||
27885128|NCT02632409|81412075|FG000|Treatment Period|Maximum clinical benefit|1|||
27885129|NCT02632409|81412076|FG001|Treatment Period|Maximum clinical benefit|0|||
27885130|NCT02632409|81412075|FG000|Treatment Period|No longer meets study criteria|3|||
27885131|NCT02632409|81412076|FG001|Treatment Period|No longer meets study criteria|0|||
27559510|NCT02039674|80237634|FG005|Overall Study|Other|0|||
27830734|NCT04442503|81212829|FG000|Overall Study|Lost to Follow-up|8|||
27830735|NCT04442503|81212830|FG001|Overall Study|Lost to Follow-up|6|||
27830736|NCT04442503|81212829|FG000|Overall Study|Physician Decision|0|||
27830737|NCT04442503|81212830|FG001|Overall Study|Physician Decision|2|||
27830738|NCT04442503|81212829|FG000|Overall Study|Withdrawal by Subject|3|||
27830739|NCT04442503|81212830|FG001|Overall Study|Withdrawal by Subject|4|||
27830740|NCT04442503|81212829|FG000|Overall Study|Reason not Specified|0|||
27830741|NCT04442503|81212830|FG001|Overall Study|Reason not Specified|1|||
27830742|NCT04442503|81212829|FG000|Overall Study|Randomized but not Treated|3|||
27830743|NCT04442503|81212830|FG001|Overall Study|Randomized but not Treated|1|||
27830744|NCT02028715|81212831|FG000|Overall Study|Adverse Event|2|||
27830745|NCT02028715|81212832|FG001|Overall Study|Adverse Event|2|||
27830746|NCT02028715|81212831|FG000|Overall Study|Physician Decision|1|||
27830747|NCT02028715|81212832|FG001|Overall Study|Physician Decision|0|||
27830748|NCT02028715|81212831|FG000|Overall Study|Did not complete satisfaction surveys|2|||
27830749|NCT02028715|81212832|FG001|Overall Study|Did not complete satisfaction surveys|2|||
27830750|NCT02625974|81212833|FG000|Part 1|Lost to Follow-up|9|||
27830751|NCT02625974|81212834|FG001|Part 1|Lost to Follow-up|3|||
27830752|NCT02625974|81212833|FG000|Part 2|Lost to Follow-up|4|||
27830753|NCT02625974|81212834|FG001|Part 2|Lost to Follow-up|6|||
27830754|NCT02625974|81212833|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
27830755|NCT02625974|81212834|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
27830756|NCT02450539|81212835|FG000|Overall Study|Withdrawal by Subject|12|||
27830757|NCT02450539|81212836|FG001|Overall Study|Withdrawal by Subject|6|||
27830758|NCT02450539|81212835|FG000|Overall Study|Lost to Follow-up|4|||
27830759|NCT02450539|81212836|FG001|Overall Study|Lost to Follow-up|1|||
27830760|NCT01116739|81212837|FG000|Overall Study|Child had 2 years of HS|110|||
27830761|NCT01116739|81212838|FG001|Overall Study|Child had 2 years of HS|128|||
27830762|NCT01116739|81212837|FG000|Overall Study|Withdrawal by Subject|6|||
27830763|NCT01116739|81212838|FG001|Overall Study|Withdrawal by Subject|0|||
27830764|NCT01116739|81212837|FG000|Overall Study|child too young|2|||
27830765|NCT01116739|81212838|FG001|Overall Study|child too young|6|||
27830766|NCT01116739|81212837|FG000|Overall Study|child not enrolled in head start|10|||
27830767|NCT01116739|81212838|FG001|Overall Study|child not enrolled in head start|2|||
27830768|NCT01116739|81212837|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
27830769|NCT01116739|81212838|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
27830770|NCT02854800|81212839|FG000|Overall Study|Protocol Violation|16|||
27830771|NCT02854800|81212840|FG001|Overall Study|Protocol Violation|11|||
27830772|NCT02854800|81212841|FG002|Overall Study|Protocol Violation|3|||
27830773|NCT02854800|81212839|FG000|Overall Study|Withdrawal by Subject|4|||
27830774|NCT02854800|81212840|FG001|Overall Study|Withdrawal by Subject|2|||
27830775|NCT02854800|81212841|FG002|Overall Study|Withdrawal by Subject|3|||
27830776|NCT01075516|81212842|FG000|Overall Study|Death|5|||
27830777|NCT01075516|81212843|FG001|Overall Study|Death|9|||
27830778|NCT01075516|81212842|FG000|Overall Study|Lost to Follow-up|10|||
27830779|NCT01075516|81212843|FG001|Overall Study|Lost to Follow-up|2|||
27830780|NCT01075516|81212842|FG000|Overall Study|Withdrawal by Subject|3|||
27830781|NCT01075516|81212843|FG001|Overall Study|Withdrawal by Subject|5|||
27830782|NCT00218257|81212844|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
27830783|NCT00218257|81212845|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
27830784|NCT00834717|81212846|FG000|First Intervention|Adverse Event|1|||
27830785|NCT00834717|81212847|FG001|First Intervention|Adverse Event|0|||
27830786|NCT00834717|81212846|FG000|First Intervention|Withdrawal by Subject|0|||
27830787|NCT00834717|81212847|FG001|First Intervention|Withdrawal by Subject|1|||
27885132|NCT02632409|81412075|FG000|Treatment Period|Administrative Reason by sponsor|0|||
27885133|NCT02632409|81412076|FG001|Treatment Period|Administrative Reason by sponsor|1|||
27830788|NCT00834431|81212848|FG000|First Intervention|Adverse Event|0|||
27830789|NCT00834431|81212849|FG001|First Intervention|Adverse Event|1|||
27830790|NCT00834431|81212848|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
27830791|NCT00834431|81212849|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27885134|NCT02632409|81412075|FG000|Treatment Period|Other Reasons|10|||
27885135|NCT02632409|81412076|FG001|Treatment Period|Other Reasons|6|||
27885136|NCT00596687|81415249|FG000|Overall Study|< 24 hours of insulin treatment|8|||
27885137|NCT00596687|81415250|FG001|Overall Study|< 24 hours of insulin treatment|6|||
27885138|NCT00596687|81415249|FG000|Overall Study|continuous insulin infusion during TPN|2|||
27885139|NCT00596687|81415250|FG001|Overall Study|continuous insulin infusion during TPN|1|||
27885140|NCT00596687|81415249|FG000|Overall Study|Withdrawal by Subject|3|||
27885141|NCT00596687|81415250|FG001|Overall Study|Withdrawal by Subject|1|||
27885142|NCT00596687|81415249|FG000|Overall Study|cancelled surgery|1|||
27885143|NCT00596687|81415250|FG001|Overall Study|cancelled surgery|1|||
27885144|NCT01696929|81415251|FG000|Overall Study|Physician Decision|1|||
27885145|NCT00794040|81415252|FG000|Overall Study|Withdrawal by Subject|3|||
27885146|NCT00794040|81415253|FG001|Overall Study|Withdrawal by Subject|4|||
27885147|NCT00794040|81415252|FG000|Overall Study|Physician Decision|0|||
27830792|NCT01564394|81212852|FG000|Overall Study|Withdrawal by Subject|6|||
27830793|NCT01564394|81212853|FG001|Overall Study|Withdrawal by Subject|10|||
27830794|NCT00840879|81212854|FG000|Second Intervention|Withdrawal by Subject|1|||
27830795|NCT00840879|81212855|FG001|Second Intervention|Withdrawal by Subject|0|||
27830796|NCT03930732|81212856|FG000|Overall Study|Adverse Event|9|||
27830797|NCT03930732|81212857|FG001|Overall Study|Adverse Event|7|||
27830798|NCT03930732|81212856|FG000|Overall Study|Poor compliance to protocol|0|||
27830799|NCT03930732|81212857|FG001|Overall Study|Poor compliance to protocol|1|||
27830800|NCT03930732|81212856|FG000|Overall Study|Withdrawal by Subject|23|||
27830801|NCT03930732|81212857|FG001|Overall Study|Withdrawal by Subject|11|||
27830802|NCT03930732|81212856|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
27830803|NCT03930732|81212857|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
27830804|NCT03930732|81212856|FG000|Overall Study|Other reason not related to COVID-19|5|||
27830805|NCT03930732|81212857|FG001|Overall Study|Other reason not related to COVID-19|8|||
27830806|NCT01010503|81212860|FG000|Overall Study|Adverse Event|1|||
27830807|NCT01010503|81212860|FG000|Overall Study|Death|1|||
27830808|NCT04994535|81212861|FG000|Overall Study|Lost to Follow-up|7|||
27830809|NCT04994535|81212862|FG001|Overall Study|Lost to Follow-up|7|||
27830810|NCT04994535|81212861|FG000|Overall Study|Withdrawal by Subject|10|||
27830811|NCT04994535|81212862|FG001|Overall Study|Withdrawal by Subject|7|||
27830812|NCT04994535|81212861|FG000|Overall Study|Other|1|||
27830813|NCT04994535|81212862|FG001|Overall Study|Other|1|||
27830814|NCT02535923|81212865|FG000|Overall Study|Lost to Follow-up|5|||
27830815|NCT02535923|81212866|FG001|Overall Study|Lost to Follow-up|5|||
27830816|NCT02535923|81212865|FG000|Overall Study|Withdrawal by Subject|4|||
27830817|NCT02535923|81212866|FG001|Overall Study|Withdrawal by Subject|3|||
27830818|NCT00989950|81212867|FG000|Randomized Phase|Protocol Violation|1|||
27885148|NCT00794040|81415253|FG001|Overall Study|Physician Decision|1|||
27885149|NCT00667823|81415257|FG000|Overall Study|Lost to Follow-up|5|||
27559511|NCT02039674|80237635|FG006|Overall Study|Other|0|||
27830819|NCT00989950|81212868|FG001|Randomized Phase|Protocol Violation|0|||
27830820|NCT00989950|81212869|FG002|Randomized Phase|Protocol Violation|0|||
27830821|NCT00989950|81212870|FG003|Randomized Phase|Protocol Violation|0|||
27830822|NCT00989950|81212867|FG000|Randomized Phase|Adverse Event|0|||
27830823|NCT00989950|81212868|FG001|Randomized Phase|Adverse Event|1|||
27830824|NCT00989950|81212869|FG002|Randomized Phase|Adverse Event|0|||
27830825|NCT00989950|81212870|FG003|Randomized Phase|Adverse Event|0|||
27885150|NCT00667823|81415257|FG000|Overall Study|Adverse Event|7|||
27885151|NCT00667823|81415257|FG000|Overall Study|Death|182|||
27559512|NCT02039674|80237636|FG007|Overall Study|Other|0|||
27559513|NCT02039674|80237637|FG008|Overall Study|Other|0|||
27830826|NCT00834444|81212871|FG000|First Intervention|Adverse Event|1|||
27830827|NCT00834444|81212872|FG001|First Intervention|Adverse Event|0|||
27830828|NCT00834444|81212871|FG000|First Intervention|Intolerance to Venopuncture|0|||
27830829|NCT00834444|81212872|FG001|First Intervention|Intolerance to Venopuncture|1|||
27830830|NCT00834444|81212871|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
27830831|NCT00834444|81212872|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27830832|NCT00834444|81212871|FG000|Second Intervention|Adverse Event|1|||
27830833|NCT00834444|81212872|FG001|Second Intervention|Adverse Event|0|||
27830834|NCT04631562|81212873|FG000|Overall Study|Withdrawal by Subject|0|||
27830835|NCT04631562|81212874|FG001|Overall Study|Withdrawal by Subject|0|||
27830836|NCT04631562|81212875|FG002|Overall Study|Withdrawal by Subject|0|||
27830837|NCT04631562|81212876|FG003|Overall Study|Withdrawal by Subject|0|||
27830838|NCT04631562|81212877|FG004|Overall Study|Withdrawal by Subject|0|||
27830839|NCT04631562|81212878|FG005|Overall Study|Withdrawal by Subject|0|||
27830840|NCT04631562|81212879|FG006|Overall Study|Withdrawal by Subject|0|||
27830841|NCT04631562|81212880|FG007|Overall Study|Withdrawal by Subject|1|||
27830842|NCT04631562|81212881|FG008|Overall Study|Withdrawal by Subject|0|||
27830843|NCT04631562|81212873|FG000|Overall Study|Other|0|||
27830844|NCT04631562|81212874|FG001|Overall Study|Other|0|||
27830845|NCT04631562|81212875|FG002|Overall Study|Other|0|||
27830846|NCT04631562|81212876|FG003|Overall Study|Other|0|||
27830847|NCT04631562|81212877|FG004|Overall Study|Other|0|||
27830848|NCT04631562|81212878|FG005|Overall Study|Other|0|||
27830849|NCT04631562|81212879|FG006|Overall Study|Other|0|||
27830850|NCT04631562|81212880|FG007|Overall Study|Other|0|||
27830851|NCT04631562|81212881|FG008|Overall Study|Other|1|||
27830852|NCT04631562|81212873|FG000|Overall Study|Lost to Follow-up|0|||
27830853|NCT04631562|81212874|FG001|Overall Study|Lost to Follow-up|0|||
27830854|NCT04631562|81212875|FG002|Overall Study|Lost to Follow-up|0|||
27885152|NCT00667823|81415257|FG000|Overall Study|Withdrawal by Subject|12|||
27830855|NCT04631562|81212876|FG003|Overall Study|Lost to Follow-up|1|||
27830856|NCT04631562|81212877|FG004|Overall Study|Lost to Follow-up|0|||
27830857|NCT04631562|81212878|FG005|Overall Study|Lost to Follow-up|0|||
27830858|NCT04631562|81212879|FG006|Overall Study|Lost to Follow-up|0|||
27830859|NCT04631562|81212880|FG007|Overall Study|Lost to Follow-up|0|||
27830860|NCT04631562|81212881|FG008|Overall Study|Lost to Follow-up|0|||
27830861|NCT04631562|81212873|FG000|Overall Study|Adverse Event|0|||
27830862|NCT04631562|81212874|FG001|Overall Study|Adverse Event|0|||
27830863|NCT04631562|81212875|FG002|Overall Study|Adverse Event|0|||
27830864|NCT04631562|81212876|FG003|Overall Study|Adverse Event|0|||
27830865|NCT04631562|81212877|FG004|Overall Study|Adverse Event|0|||
27830866|NCT04631562|81212878|FG005|Overall Study|Adverse Event|0|||
27830867|NCT04631562|81212879|FG006|Overall Study|Adverse Event|1|||
27830868|NCT04631562|81212880|FG007|Overall Study|Adverse Event|0|||
27830869|NCT04631562|81212881|FG008|Overall Study|Adverse Event|0|||
27559514|NCT02039674|80237638|FG009|Overall Study|Other|0|||
27830870|NCT05133180|81212882|FG000|Overall Study|Withdrawal of consent|1|||
27830871|NCT05133180|81212883|FG001|Overall Study|Withdrawal of consent|1|||
27830872|NCT05133180|81212882|FG000|Overall Study|Lost to Follow-up|1|||
27830873|NCT05133180|81212883|FG001|Overall Study|Lost to Follow-up|1|||
27830874|NCT05133180|81212882|FG000|Overall Study|Documented disease progression|0|||
27885153|NCT00667823|81415257|FG000|Overall Study|Other|8|||
27885154|NCT00667823|81415257|FG000|Overall Study|Missing (completion page missing)|2|||
27885155|NCT03063086|81415262|FG000|Overall Study|technical problems|1|||
27885156|NCT03063086|81415263|FG001|Overall Study|technical problems|0|||
27885157|NCT03063086|81415264|FG002|Overall Study|technical problems|0|||
27885158|NCT03063086|81415265|FG003|Overall Study|technical problems|0|||
27885159|NCT03063086|81415266|FG004|Overall Study|technical problems|0|||
27885160|NCT03063086|81415267|FG005|Overall Study|technical problems|0|||
27885161|NCT03063086|81415262|FG000|Overall Study|Adverse Event|1|||
27885162|NCT03063086|81415263|FG001|Overall Study|Adverse Event|1|||
27885163|NCT03063086|81415264|FG002|Overall Study|Adverse Event|1|||
27885164|NCT03063086|81415265|FG003|Overall Study|Adverse Event|1|||
27885165|NCT03063086|81415266|FG004|Overall Study|Adverse Event|0|||
27885166|NCT03063086|81415267|FG005|Overall Study|Adverse Event|0|||
27885167|NCT03063086|81415262|FG000|Overall Study|subject/guardian decision|1|||
27885168|NCT03063086|81415263|FG001|Overall Study|subject/guardian decision|0|||
27885169|NCT03063086|81415264|FG002|Overall Study|subject/guardian decision|0|||
27885170|NCT03063086|81415265|FG003|Overall Study|subject/guardian decision|0|||
27885171|NCT03063086|81415266|FG004|Overall Study|subject/guardian decision|0|||
27885172|NCT03063086|81415267|FG005|Overall Study|subject/guardian decision|0|||
27885173|NCT03063086|81415262|FG000|Overall Study|Non-compliance with study treatment|0|||
27885174|NCT03063086|81415263|FG001|Overall Study|Non-compliance with study treatment|0|||
27885175|NCT03063086|81415264|FG002|Overall Study|Non-compliance with study treatment|0|||
27830875|NCT05133180|81212883|FG001|Overall Study|Documented disease progression|1|||
27830876|NCT03049748|81212884|FG000|Overall Study|Lost to Follow-up|1|||
27830877|NCT03049748|81212885|FG001|Overall Study|Lost to Follow-up|0|||
27830878|NCT03049748|81212884|FG000|Overall Study|Death|3|||
27830879|NCT03049748|81212885|FG001|Overall Study|Death|0|||
27830880|NCT03049748|81212884|FG000|Overall Study|Withdrawal by Subject|0|||
27830881|NCT03049748|81212885|FG001|Overall Study|Withdrawal by Subject|3|||
27830882|NCT03049748|81212884|FG000|Overall Study|Protocol Violation|0|||
27830883|NCT03049748|81212885|FG001|Overall Study|Protocol Violation|2|||
27830884|NCT03049748|81212884|FG000|Overall Study|Moved out of state (relocation)|0|||
27830885|NCT03049748|81212885|FG001|Overall Study|Moved out of state (relocation)|1|||
27830886|NCT05740098|81212888|FG000|Overall Study|Lost to Follow-up|26|||
27885176|NCT03063086|81415265|FG003|Overall Study|Non-compliance with study treatment|1|||
27559515|NCT02039674|80237639|FG010|Overall Study|Other|0|||
27830887|NCT05740098|81212889|FG001|Overall Study|Lost to Follow-up|17|||
27830888|NCT05740098|81212890|FG002|Overall Study|Lost to Follow-up|21|||
27830889|NCT04089553|81212895|FG000|Overall Study|Death|1|||
27830890|NCT04089553|81212896|FG001|Overall Study|Death|1|||
27830891|NCT04089553|81212895|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
27885177|NCT03063086|81415266|FG004|Overall Study|Non-compliance with study treatment|0|||
27885178|NCT03063086|81415267|FG005|Overall Study|Non-compliance with study treatment|1|||
27830892|NCT04089553|81212896|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
27830893|NCT04089553|81212895|FG000|Overall Study|Withdrawal by Subject|3|||
27559516|NCT02039674|80237640|FG011|Overall Study|Other|0|||
27885179|NCT03063086|81415262|FG000|Overall Study|Physician Decision|0|||
27885180|NCT03063086|81415263|FG001|Overall Study|Physician Decision|0|||
27885181|NCT03063086|81415264|FG002|Overall Study|Physician Decision|0|||
27885182|NCT03063086|81415265|FG003|Overall Study|Physician Decision|1|||
27885183|NCT03063086|81415266|FG004|Overall Study|Physician Decision|0|||
27885184|NCT03063086|81415267|FG005|Overall Study|Physician Decision|0|||
27885185|NCT02429778|81415268|FG000|Overall Study|Lost to Follow-up|2|||
27885186|NCT02429778|81415269|FG001|Overall Study|Lost to Follow-up|0|||
27885187|NCT02429778|81415268|FG000|Overall Study|Withdrawal by Subject|5|||
27885188|NCT02429778|81415269|FG001|Overall Study|Withdrawal by Subject|0|||
27885189|NCT04105218|81415272|FG000|Overall Study|Withdrawal by Subject|3|||
27885190|NCT04105218|81415273|FG001|Overall Study|Withdrawal by Subject|2|||
27885191|NCT04105218|81415272|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
27885192|NCT04105218|81415273|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
27885193|NCT04105218|81415272|FG000|Overall Study|Failed screening tests|2|||
27885194|NCT04105218|81415273|FG001|Overall Study|Failed screening tests|1|||
27885195|NCT01575834|81415276|FG000|Overall Study|Withdrawal by Subject|352|||
27885196|NCT01575834|81415277|FG001|Overall Study|Withdrawal by Subject|390|||
27885197|NCT01575834|81415276|FG000|Overall Study|Death|81|||
27885198|NCT01575834|81415277|FG001|Overall Study|Death|74|||
27885199|NCT01575834|81415276|FG000|Overall Study|Other|70|||
27885200|NCT01575834|81415277|FG001|Overall Study|Other|70|||
27885201|NCT01575834|81415276|FG000|Overall Study|Adverse Event|63|||
27885202|NCT01575834|81415277|FG001|Overall Study|Adverse Event|61|||
27885203|NCT01575834|81415276|FG000|Overall Study|Lost to Follow-up|55|||
27885204|NCT01575834|81415277|FG001|Overall Study|Lost to Follow-up|68|||
27885205|NCT01575834|81415276|FG000|Overall Study|Noncompliance|52|||
27559517|NCT02039674|80237641|FG012|Overall Study|Other|1|||
27698891|NCT03236246|80732956|FG000|24-Week Dose Maintenance Period|Death|0|||
27885206|NCT01575834|81415277|FG001|Overall Study|Noncompliance|27|||
27885207|NCT01575834|81415276|FG000|Overall Study|Administrative decision|15|||
27885208|NCT01575834|81415277|FG001|Overall Study|Administrative decision|33|||
27885209|NCT01575834|81415276|FG000|Overall Study|Ineligibility Determined|5|||
27885210|NCT01575834|81415277|FG001|Overall Study|Ineligibility Determined|8|||
27885211|NCT01575834|81415276|FG000|Overall Study|Protocol Deviation|4|||
27885212|NCT01575834|81415277|FG001|Overall Study|Protocol Deviation|3|||
27885213|NCT01575834|81415276|FG000|Overall Study|Requirement for Alternative Therapy|2|||
27885214|NCT01575834|81415277|FG001|Overall Study|Requirement for Alternative Therapy|4|||
27885215|NCT01668173|81415278|FG000|Overall Study|Adverse Event|3|||
27885216|NCT01668173|81415278|FG000|Overall Study|Trial suspension|4|||
27698892|NCT03236246|80732957|FG001|24-Week Dose Maintenance Period|Death|1|||
27698893|NCT03236246|80732956|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
27698894|NCT03236246|80732957|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
27698895|NCT01174238|80732958|FG000|Overall Study|Lost to Follow-up|2|||
27698896|NCT01557283|80732959|FG000|Overall Study|Lost to Follow-up|7|||
27698897|NCT01557283|80732959|FG000|Overall Study|Non-responder|19|||
27698898|NCT01557283|80732959|FG000|Overall Study|Adverse Event|7|||
27698899|NCT01557283|80732959|FG000|Overall Study|Lack of Efficacy|1|||
27698900|NCT01557283|80732959|FG000|Overall Study|Non-compliance|1|||
27830894|NCT04089553|81212896|FG001|Overall Study|Withdrawal by Subject|3|||
27830895|NCT04089553|81212895|FG000|Overall Study|Physician Decision|1|||
27830896|NCT04089553|81212896|FG001|Overall Study|Physician Decision|0|||
27830897|NCT04089553|81212895|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
27830898|NCT04089553|81212896|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
27830899|NCT04089553|81212895|FG000|Overall Study|Other|1|||
27830900|NCT04089553|81212896|FG001|Overall Study|Other|0|||
27830901|NCT04089553|81212895|FG000|Overall Study|Adverse Event|1|||
27830902|NCT04089553|81212896|FG001|Overall Study|Adverse Event|1|||
27830903|NCT00841542|81212904|FG000|Period 1|Adverse Event|1|||
27830904|NCT00841542|81212905|FG001|Period 1|Adverse Event|0|||
27830905|NCT01410227|81212909|FG000|Overall Study|Adverse Event|1|||
27830906|NCT01410227|81212910|FG001|Overall Study|Adverse Event|0|||
27830907|NCT01410227|81212911|FG002|Overall Study|Adverse Event|0|||
27830908|NCT01410227|81212912|FG003|Overall Study|Adverse Event|0|||
27830909|NCT01410227|81212909|FG000|Overall Study|Withdrawal by Subject|3|||
27830910|NCT01410227|81212910|FG001|Overall Study|Withdrawal by Subject|0|||
27830911|NCT01410227|81212911|FG002|Overall Study|Withdrawal by Subject|1|||
27830912|NCT01410227|81212912|FG003|Overall Study|Withdrawal by Subject|0|||
27885217|NCT04545567|81415279|FG000|Overall Study|tested positive for SARS-co-V2|1|||
27885218|NCT04545567|81415280|FG001|Overall Study|tested positive for SARS-co-V2|1|||
27885219|NCT04545567|81415279|FG000|Overall Study|Withdrawal by Subject|0|||
27885220|NCT04545567|81415280|FG001|Overall Study|Withdrawal by Subject|1|||
27885221|NCT02126579|81415285|FG000|Overall Study|disease progression|0|||
27885222|NCT02126579|81415286|FG001|Overall Study|disease progression|0|||
27885223|NCT02126579|81415287|FG002|Overall Study|disease progression|0|||
27885224|NCT02126579|81415288|FG003|Overall Study|disease progression|1|||
27885225|NCT02126579|81415289|FG004|Overall Study|disease progression|0|||
27885226|NCT02126579|81415290|FG005|Overall Study|disease progression|0|||
27885227|NCT02126579|81415291|FG006|Overall Study|disease progression|1|||
27885228|NCT03343704|81415294|FG000|Overall Study|Refused to complete follow up|0|||
27885229|NCT03343704|81415295|FG001|Overall Study|Refused to complete follow up|1|||
27885230|NCT03343704|81415294|FG000|Overall Study|Death|0|||
27885231|NCT03343704|81415295|FG001|Overall Study|Death|1|||
27885232|NCT03343704|81415294|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
27885233|NCT03343704|81415295|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
27885234|NCT03070002|81415296|FG000|Follow up for 2 Years|Death|1|||
27885235|NCT01570361|81415302|FG000|Overall Study|Subject discontinued|1|||
27885236|NCT01570361|81415303|FG001|Overall Study|Subject discontinued|2|||
27885237|NCT01570361|81415302|FG000|Overall Study|Sponsor closing the study|51|||
27885238|NCT01570361|81415303|FG001|Overall Study|Sponsor closing the study|50|||
27885239|NCT01570361|81415302|FG000|Overall Study|Subject excluded|5|||
27885240|NCT01570361|81415303|FG001|Overall Study|Subject excluded|3|||
27830913|NCT01410227|81212909|FG000|Overall Study|Pregnancy|0|||
27885241|NCT01570361|81415302|FG000|Overall Study|Subject withdrew consent|14|||
27885242|NCT01570361|81415303|FG001|Overall Study|Subject withdrew consent|9|||
27885243|NCT01570361|81415302|FG000|Overall Study|Adverse Event|2|||
27830914|NCT01410227|81212910|FG001|Overall Study|Pregnancy|0|||
27830915|NCT01410227|81212911|FG002|Overall Study|Pregnancy|0|||
27830916|NCT01410227|81212912|FG003|Overall Study|Pregnancy|1|||
27830917|NCT01410227|81212909|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
27885244|NCT01570361|81415303|FG001|Overall Study|Adverse Event|1|||
27885245|NCT01570361|81415302|FG000|Overall Study|Lost to Follow-up|4|||
27559518|NCT02039674|80237642|FG013|Overall Study|Other|0|||
27698901|NCT01557283|80732959|FG000|Overall Study|Withdrawal by Subject|1|||
27698902|NCT01557283|80732959|FG000|Overall Study|Participant's weight too high for dose|1|||
27698903|NCT01557283|80732959|FG000|Overall Study|Worsening of psoriasis|1|||
27698904|NCT01557283|80732959|FG000|Overall Study|Other|6|||
27698905|NCT02020863|80732960|FG000|Overall Study|Discovery of Metastatic disease|4|||
27698906|NCT02020863|80732960|FG000|Overall Study|Team chose not to place an a line|1|||
27698907|NCT03346057|80732964|FG000|Overall Study|Death|1|||
27698908|NCT03346057|80732965|FG001|Overall Study|Death|2|||
27698909|NCT03346057|80732966|FG002|Overall Study|Death|0|||
27698910|NCT03346057|80732967|FG003|Overall Study|Death|0|||
27698911|NCT03346057|80732964|FG000|Overall Study|Lost to Follow-up|0|||
27698912|NCT03346057|80732965|FG001|Overall Study|Lost to Follow-up|2|||
27698913|NCT03346057|80732966|FG002|Overall Study|Lost to Follow-up|1|||
27698914|NCT03346057|80732967|FG003|Overall Study|Lost to Follow-up|0|||
27698915|NCT03346057|80732964|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
27698916|NCT03346057|80732965|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
27698917|NCT03346057|80732966|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
27698918|NCT03346057|80732967|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
27698919|NCT03346057|80732964|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
27698920|NCT03346057|80732965|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
27698921|NCT03346057|80732966|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
27698922|NCT03346057|80732967|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
27698923|NCT03346057|80732964|FG000|Overall Study|Physician Decision|3|||
27698924|NCT03346057|80732965|FG001|Overall Study|Physician Decision|2|||
27698925|NCT03346057|80732966|FG002|Overall Study|Physician Decision|0|||
27698926|NCT03346057|80732967|FG003|Overall Study|Physician Decision|2|||
27698927|NCT03346057|80732964|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
27698928|NCT03346057|80732965|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
27698929|NCT03346057|80732966|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
27698930|NCT03346057|80732967|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
27698931|NCT03346057|80732964|FG000|Overall Study|Withdrawal by Subject|1|||
27698932|NCT03346057|80732965|FG001|Overall Study|Withdrawal by Subject|0|||
27698933|NCT03346057|80732966|FG002|Overall Study|Withdrawal by Subject|0|||
27698934|NCT03346057|80732967|FG003|Overall Study|Withdrawal by Subject|0|||
27698935|NCT03181451|80732970|FG000|Overall Study|Adverse Event|0|||
27698936|NCT03181451|80732971|FG001|Overall Study|Adverse Event|1|||
27698937|NCT03181451|80732972|FG002|Overall Study|Adverse Event|0|||
27698938|NCT03181451|80732970|FG000|Overall Study|Withdrawal by Subject|0|||
27698939|NCT03181451|80732971|FG001|Overall Study|Withdrawal by Subject|1|||
27698940|NCT03181451|80732972|FG002|Overall Study|Withdrawal by Subject|0|||
27698941|NCT04936841|80732974|FG000|Overall Study|Death|1|||
27698942|NCT00730171|80732975|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
27698943|NCT00730171|80732975|FG000|Overall Study|Adverse Event|193|||
27698944|NCT00730171|80732975|FG000|Overall Study|Protocol Violation|48|||
27698945|NCT00730171|80732975|FG000|Overall Study|Withdrawal by Subject|202|||
27698946|NCT00730171|80732975|FG000|Overall Study|Lost to Follow-up|121|||
27698947|NCT00730171|80732975|FG000|Overall Study|Insufficient Therapeutic Response|141|||
27698948|NCT00730171|80732975|FG000|Overall Study|Other|61|||
27698949|NCT02952001|80732988|FG000|Overall Study|Adverse Event|3|||
27698950|NCT02952001|80732989|FG001|Overall Study|Adverse Event|0|||
27698951|NCT02952001|80732988|FG000|Overall Study|Prohibited therapy|10|||
27698952|NCT02952001|80732989|FG001|Overall Study|Prohibited therapy|3|||
27698953|NCT02952001|80732988|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
27698954|NCT02952001|80732989|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
27698955|NCT01215175|80732994|FG000|Overall Study|Lost to Follow-up|0|||
27698956|NCT01215175|80732995|FG001|Overall Study|Lost to Follow-up|1|||
27698957|NCT01215175|80732996|FG002|Overall Study|Lost to Follow-up|0|||
27698958|NCT01215175|80732997|FG003|Overall Study|Lost to Follow-up|1|||
27698959|NCT01215175|80732998|FG004|Overall Study|Lost to Follow-up|0|||
27698960|NCT01840605|80733000|FG000|Overall Study|Adverse Event|0|||
27698961|NCT01840605|80733001|FG001|Overall Study|Adverse Event|1|||
27698962|NCT01840605|80733000|FG000|Overall Study|Physician Decision|2|||
27830918|NCT01410227|81212910|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
27885246|NCT01570361|81415303|FG001|Overall Study|Lost to Follow-up|4|||
27698963|NCT01840605|80733001|FG001|Overall Study|Physician Decision|1|||
27698964|NCT01290601|80733003|FG000|Overall Study|Adverse Event|0|||
27698965|NCT01290601|80733004|FG001|Overall Study|Adverse Event|2|||
27698966|NCT01290601|80733005|FG002|Overall Study|Adverse Event|0|||
27698967|NCT01290601|80733006|FG003|Overall Study|Adverse Event|0|||
27698968|NCT01290601|80733003|FG000|Overall Study|Lack of Efficacy|2|||
27698969|NCT01290601|80733004|FG001|Overall Study|Lack of Efficacy|1|||
27698970|NCT01290601|80733005|FG002|Overall Study|Lack of Efficacy|0|||
27698971|NCT01290601|80733006|FG003|Overall Study|Lack of Efficacy|0|||
27698972|NCT01290601|80733003|FG000|Overall Study|Lost to Follow-up|7|||
27698973|NCT01290601|80733004|FG001|Overall Study|Lost to Follow-up|2|||
27698974|NCT01290601|80733005|FG002|Overall Study|Lost to Follow-up|0|||
27698975|NCT01290601|80733006|FG003|Overall Study|Lost to Follow-up|0|||
27698976|NCT01290601|80733003|FG000|Overall Study|Other|1|||
27698977|NCT01290601|80733004|FG001|Overall Study|Other|0|||
27698978|NCT01290601|80733005|FG002|Overall Study|Other|0|||
27698979|NCT01290601|80733006|FG003|Overall Study|Other|0|||
27698980|NCT01290601|80733003|FG000|Overall Study|Protocol Violation|1|||
27698981|NCT01290601|80733004|FG001|Overall Study|Protocol Violation|0|||
27698982|NCT01290601|80733005|FG002|Overall Study|Protocol Violation|0|||
27698983|NCT01290601|80733006|FG003|Overall Study|Protocol Violation|0|||
27698984|NCT02593786|80733009|FG000|Overall Study|Disease progression|12|||
27698985|NCT02593786|80733010|FG001|Overall Study|Disease progression|16|||
27698986|NCT02593786|80733011|FG002|Overall Study|Disease progression|10|||
27698987|NCT02593786|80733012|FG003|Overall Study|Disease progression|7|||
27698988|NCT02593786|80733009|FG000|Overall Study|Study drug toxicity|1|||
27698989|NCT02593786|80733010|FG001|Overall Study|Study drug toxicity|0|||
27698990|NCT02593786|80733011|FG002|Overall Study|Study drug toxicity|0|||
27698991|NCT02593786|80733012|FG003|Overall Study|Study drug toxicity|0|||
27698992|NCT02593786|80733009|FG000|Overall Study|Adverse event unrelated to study drug|1|||
27830919|NCT01410227|81212911|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
27830920|NCT01410227|81212912|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
27830921|NCT03138967|81212917|FG000|Overall Study|Death|0|||
27830922|NCT03138967|81212918|FG001|Overall Study|Death|1|||
27830923|NCT03138967|81212917|FG000|Overall Study|Physician Decision|1|||
27830924|NCT03138967|81212918|FG001|Overall Study|Physician Decision|3|||
27830925|NCT03629054|81212919|FG000|Period 2 (4 Days)|Not treated|0|||
27830926|NCT03629054|81212920|FG001|Period 2 (4 Days)|Not treated|1|||
27830927|NCT00665925|81212921|FG000|Overall Study|Lack of Efficacy|10|||
27830928|NCT00665925|81212922|FG001|Overall Study|Lack of Efficacy|8|||
27830929|NCT00665925|81212923|FG002|Overall Study|Lack of Efficacy|9|||
27830930|NCT00665925|81212924|FG003|Overall Study|Lack of Efficacy|8|||
27830931|NCT00665925|81212921|FG000|Overall Study|Lost to Follow-up|1|||
27830932|NCT00665925|81212922|FG001|Overall Study|Lost to Follow-up|2|||
27830933|NCT00665925|81212923|FG002|Overall Study|Lost to Follow-up|2|||
27830934|NCT00665925|81212924|FG003|Overall Study|Lost to Follow-up|2|||
27830935|NCT00665925|81212921|FG000|Overall Study|Withdrawal by Subject|2|||
27830936|NCT00665925|81212922|FG001|Overall Study|Withdrawal by Subject|2|||
27830937|NCT00665925|81212923|FG002|Overall Study|Withdrawal by Subject|3|||
27830938|NCT00665925|81212924|FG003|Overall Study|Withdrawal by Subject|2|||
27830939|NCT00665925|81212921|FG000|Overall Study|Physician Decision|0|||
27885247|NCT01570361|81415302|FG000|Overall Study|Death|5|||
27885248|NCT01570361|81415303|FG001|Overall Study|Death|4|||
27885249|NCT01570361|81415302|FG000|Overall Study|Other|0|||
27885250|NCT01570361|81415303|FG001|Overall Study|Other|2|||
27885251|NCT01387516|81415304|FG000|Overall Study|Lost to Follow-up|4|||
27885252|NCT01387516|81415305|FG001|Overall Study|Lost to Follow-up|4|||
27885253|NCT01387516|81415306|FG002|Overall Study|Lost to Follow-up|2|||
27885254|NCT01387516|81415307|FG003|Overall Study|Lost to Follow-up|3|||
27885255|NCT01387516|81415304|FG000|Overall Study|Withdrawal by Subject|1|||
27885256|NCT01387516|81415305|FG001|Overall Study|Withdrawal by Subject|1|||
27885257|NCT01387516|81415306|FG002|Overall Study|Withdrawal by Subject|2|||
27830940|NCT00665925|81212922|FG001|Overall Study|Physician Decision|0|||
27830941|NCT00665925|81212923|FG002|Overall Study|Physician Decision|1|||
27830942|NCT00665925|81212924|FG003|Overall Study|Physician Decision|2|||
27830943|NCT00665925|81212921|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
27885258|NCT01387516|81415307|FG003|Overall Study|Withdrawal by Subject|0|||
27885259|NCT01387516|81415304|FG000|Overall Study|Death|0|||
27885260|NCT01387516|81415305|FG001|Overall Study|Death|0|||
27885261|NCT01387516|81415306|FG002|Overall Study|Death|0|||
27885262|NCT01387516|81415307|FG003|Overall Study|Death|1|||
27698993|NCT02593786|80733010|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27698994|NCT02593786|80733011|FG002|Overall Study|Adverse event unrelated to study drug|1|||
27698995|NCT02593786|80733012|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27698996|NCT02593786|80733009|FG000|Overall Study|Participant request to discontinue study therapy|0|||
27830944|NCT00665925|81212922|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
27885263|NCT01377922|81415311|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
27885264|NCT01377922|81415312|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
27885265|NCT02477332|81415313|FG000|Overall Study|Adverse Event|0|||
27885266|NCT02477332|81415314|FG001|Overall Study|Adverse Event|1|||
27885267|NCT02477332|81415315|FG002|Overall Study|Adverse Event|1|||
27885268|NCT02477332|81415316|FG003|Overall Study|Adverse Event|2|||
27885269|NCT02477332|81415317|FG004|Overall Study|Adverse Event|1|||
27885270|NCT02477332|81415318|FG005|Overall Study|Adverse Event|2|||
27885271|NCT02477332|81415313|FG000|Overall Study|Lack of Efficacy|1|||
27885272|NCT02477332|81415314|FG001|Overall Study|Lack of Efficacy|2|||
27885273|NCT02477332|81415315|FG002|Overall Study|Lack of Efficacy|1|||
27885274|NCT02477332|81415316|FG003|Overall Study|Lack of Efficacy|2|||
27830945|NCT00665925|81212923|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
27830946|NCT00665925|81212924|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
27830947|NCT00665925|81212921|FG000|Overall Study|Adverse Event|1|||
27830948|NCT00665925|81212922|FG001|Overall Study|Adverse Event|5|||
27830949|NCT00665925|81212923|FG002|Overall Study|Adverse Event|10|||
27830950|NCT00665925|81212924|FG003|Overall Study|Adverse Event|5|||
27830951|NCT00665925|81212921|FG000|Overall Study|Enrolled by mistake|0|||
27830952|NCT00665925|81212922|FG001|Overall Study|Enrolled by mistake|0|||
27830953|NCT00665925|81212923|FG002|Overall Study|Enrolled by mistake|0|||
27830954|NCT00665925|81212924|FG003|Overall Study|Enrolled by mistake|1|||
27830955|NCT00665925|81212921|FG000|Overall Study|Due to exclusion criteria|1|||
27830956|NCT00665925|81212922|FG001|Overall Study|Due to exclusion criteria|0|||
27830957|NCT00665925|81212923|FG002|Overall Study|Due to exclusion criteria|0|||
27830958|NCT00665925|81212924|FG003|Overall Study|Due to exclusion criteria|0|||
27830959|NCT01316055|81212934|FG000|Overall Study|Lost to Follow-up|1|||
27830960|NCT01316055|81212935|FG001|Overall Study|Lost to Follow-up|0|||
27830961|NCT01316055|81212936|FG002|Overall Study|Lost to Follow-up|0|||
27830962|NCT02055547|81212937|FG000|Overall Study|Protocol Violation|0|||
27830963|NCT02055547|81212938|FG001|Overall Study|Protocol Violation|0|||
27830964|NCT02055547|81212939|FG002|Overall Study|Protocol Violation|1|||
27830965|NCT02055547|81212940|FG003|Overall Study|Protocol Violation|0|||
27830966|NCT02055547|81212941|FG004|Overall Study|Protocol Violation|0|||
27830967|NCT02055547|81212942|FG005|Overall Study|Protocol Violation|0|||
27830968|NCT02055547|81212943|FG006|Overall Study|Protocol Violation|1|||
27830969|NCT02055547|81212944|FG007|Overall Study|Protocol Violation|0|||
27830970|NCT02055547|81212945|FG008|Overall Study|Protocol Violation|0|||
27830971|NCT02055547|81212946|FG009|Overall Study|Protocol Violation|0|||
27830972|NCT02055547|81212947|FG010|Overall Study|Protocol Violation|0|||
27830973|NCT02055547|81212948|FG011|Overall Study|Protocol Violation|0|||
27830974|NCT02055547|81212949|FG012|Overall Study|Protocol Violation|0|||
27830975|NCT02055547|81212950|FG013|Overall Study|Protocol Violation|0|||
27830976|NCT02055547|81212951|FG014|Overall Study|Protocol Violation|0|||
27830977|NCT02055547|81212952|FG015|Overall Study|Protocol Violation|0|||
27830978|NCT02055547|81212953|FG016|Overall Study|Protocol Violation|0|||
27830979|NCT02055547|81212954|FG017|Overall Study|Protocol Violation|0|||
27830980|NCT02055547|81212955|FG018|Overall Study|Protocol Violation|0|||
27830981|NCT02055547|81212937|FG000|Overall Study|Physician Decision|0|||
27830982|NCT02055547|81212938|FG001|Overall Study|Physician Decision|1|||
27830983|NCT02055547|81212939|FG002|Overall Study|Physician Decision|1|||
27885275|NCT02477332|81415317|FG004|Overall Study|Lack of Efficacy|1|||
27885276|NCT02477332|81415318|FG005|Overall Study|Lack of Efficacy|1|||
27830984|NCT02055547|81212940|FG003|Overall Study|Physician Decision|0|||
27830985|NCT02055547|81212941|FG004|Overall Study|Physician Decision|1|||
27830986|NCT02055547|81212942|FG005|Overall Study|Physician Decision|0|||
27830987|NCT02055547|81212943|FG006|Overall Study|Physician Decision|0|||
27830988|NCT02055547|81212944|FG007|Overall Study|Physician Decision|0|||
27885277|NCT02477332|81415313|FG000|Overall Study|Non-compliance with study treatment|0|||
27885278|NCT02477332|81415314|FG001|Overall Study|Non-compliance with study treatment|1|||
27698997|NCT02593786|80733010|FG001|Overall Study|Participant request to discontinue study therapy|2|||
27698998|NCT02593786|80733011|FG002|Overall Study|Participant request to discontinue study therapy|0|||
27698999|NCT02593786|80733012|FG003|Overall Study|Participant request to discontinue study therapy|0|||
27699000|NCT02593786|80733009|FG000|Overall Study|Other reasons|1|||
27699001|NCT02593786|80733010|FG001|Overall Study|Other reasons|1|||
27699002|NCT02593786|80733011|FG002|Overall Study|Other reasons|0|||
27699003|NCT02593786|80733012|FG003|Overall Study|Other reasons|5|||
27699004|NCT00874770|80736487|FG000|Overall Study|Lack of Efficacy|2|||
27699005|NCT00874770|80736488|FG001|Overall Study|Lack of Efficacy|0|||
27699006|NCT00874770|80736489|FG002|Overall Study|Lack of Efficacy|0|||
27699007|NCT00874770|80736490|FG003|Overall Study|Lack of Efficacy|2|||
27699008|NCT00874770|80736487|FG000|Overall Study|Adverse Event|1|||
27699009|NCT00874770|80736488|FG001|Overall Study|Adverse Event|1|||
27699010|NCT00874770|80736489|FG002|Overall Study|Adverse Event|4|||
27699011|NCT00874770|80736490|FG003|Overall Study|Adverse Event|2|||
27699012|NCT00874770|80736487|FG000|Overall Study|Lost to Follow-up|1|||
27699013|NCT00874770|80736488|FG001|Overall Study|Lost to Follow-up|0|||
27699014|NCT00874770|80736489|FG002|Overall Study|Lost to Follow-up|0|||
27699015|NCT00874770|80736490|FG003|Overall Study|Lost to Follow-up|1|||
27699016|NCT00874770|80736487|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
27699017|NCT00874770|80736488|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
27699018|NCT00874770|80736489|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
27699019|NCT00874770|80736490|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
27699020|NCT00898443|80736491|FG000|Overall Study|Withdrawal by Subject|1|||
27699021|NCT00898443|80736492|FG001|Overall Study|Withdrawal by Subject|0|||
27699022|NCT01026142|80736493|FG000|Overall Study|Death|136|||
27699023|NCT01026142|80736494|FG001|Overall Study|Death|134|||
27699024|NCT01026142|80736493|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
27699025|NCT01026142|80736494|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
27699026|NCT02745392|80736499|FG000|Overall Study|Lost to Follow-up|0|||
27699027|NCT02745392|80736500|FG001|Overall Study|Lost to Follow-up|1|||
27699028|NCT02745392|80736501|FG002|Overall Study|Lost to Follow-up|0|||
27699029|NCT02745392|80736502|FG003|Overall Study|Lost to Follow-up|0|||
27699030|NCT03359590|80736509|FG000|First Intervention|Withdrawal by Subject|1|||
27699031|NCT03359590|80736510|FG001|First Intervention|Withdrawal by Subject|1|||
27699032|NCT03359590|80736509|FG000|First Intervention|Protocol Violation|0|||
27699033|NCT03359590|80736510|FG001|First Intervention|Protocol Violation|1|||
27699034|NCT00174265|80736516|FG000|Overall Study|Adverse Event|7|||
27699035|NCT00174265|80736517|FG001|Overall Study|Adverse Event|4|||
27885279|NCT02477332|81415315|FG002|Overall Study|Non-compliance with study treatment|2|||
27885280|NCT02477332|81415316|FG003|Overall Study|Non-compliance with study treatment|0|||
27885281|NCT02477332|81415317|FG004|Overall Study|Non-compliance with study treatment|0|||
27885282|NCT02477332|81415318|FG005|Overall Study|Non-compliance with study treatment|0|||
27885283|NCT02477332|81415313|FG000|Overall Study|Pregnancy|0|||
27885284|NCT02477332|81415314|FG001|Overall Study|Pregnancy|0|||
27885285|NCT02477332|81415315|FG002|Overall Study|Pregnancy|0|||
27885286|NCT02477332|81415316|FG003|Overall Study|Pregnancy|1|||
27885287|NCT02477332|81415317|FG004|Overall Study|Pregnancy|0|||
27885288|NCT02477332|81415318|FG005|Overall Study|Pregnancy|0|||
27885289|NCT02477332|81415313|FG000|Overall Study|Protocol Violation|2|||
27885290|NCT02477332|81415314|FG001|Overall Study|Protocol Violation|0|||
27885291|NCT02477332|81415315|FG002|Overall Study|Protocol Violation|3|||
27885292|NCT02477332|81415316|FG003|Overall Study|Protocol Violation|3|||
27699036|NCT00174265|80736516|FG000|Overall Study|Lack of Efficacy|2|||
27699037|NCT00174265|80736517|FG001|Overall Study|Lack of Efficacy|2|||
27699038|NCT00174265|80736516|FG000|Overall Study|Withdrawal by Subject|3|||
27699039|NCT00174265|80736517|FG001|Overall Study|Withdrawal by Subject|5|||
27699040|NCT00174265|80736516|FG000|Overall Study|Lost to Follow-up|1|||
27699041|NCT00174265|80736517|FG001|Overall Study|Lost to Follow-up|0|||
27699042|NCT00174265|80736516|FG000|Overall Study|Other (Not specified)|16|||
27699043|NCT00174265|80736517|FG001|Overall Study|Other (Not specified)|10|||
27885293|NCT02477332|81415317|FG004|Overall Study|Protocol Violation|1|||
27885294|NCT02477332|81415318|FG005|Overall Study|Protocol Violation|1|||
27885295|NCT02477332|81415313|FG000|Overall Study|Technical problems|0|||
27885296|NCT02477332|81415314|FG001|Overall Study|Technical problems|0|||
27885297|NCT02477332|81415315|FG002|Overall Study|Technical problems|1|||
27885298|NCT02477332|81415316|FG003|Overall Study|Technical problems|0|||
27885299|NCT02477332|81415317|FG004|Overall Study|Technical problems|0|||
27885300|NCT02477332|81415318|FG005|Overall Study|Technical problems|0|||
27885301|NCT02477332|81415313|FG000|Overall Study|Lost to Follow-up|0|||
27885302|NCT02477332|81415314|FG001|Overall Study|Lost to Follow-up|0|||
27885303|NCT02477332|81415315|FG002|Overall Study|Lost to Follow-up|2|||
27885304|NCT02477332|81415316|FG003|Overall Study|Lost to Follow-up|0|||
27885305|NCT02477332|81415317|FG004|Overall Study|Lost to Follow-up|0|||
27885306|NCT02477332|81415318|FG005|Overall Study|Lost to Follow-up|0|||
27885307|NCT02477332|81415313|FG000|Overall Study|Physician Decision|0|||
27885308|NCT02477332|81415314|FG001|Overall Study|Physician Decision|0|||
27885309|NCT02477332|81415315|FG002|Overall Study|Physician Decision|1|||
27885310|NCT02477332|81415316|FG003|Overall Study|Physician Decision|3|||
27885311|NCT02477332|81415317|FG004|Overall Study|Physician Decision|0|||
27885312|NCT02477332|81415318|FG005|Overall Study|Physician Decision|1|||
27885313|NCT02477332|81415313|FG000|Overall Study|Withdrawal by Subject|0|||
27885314|NCT02477332|81415314|FG001|Overall Study|Withdrawal by Subject|3|||
27885315|NCT02477332|81415315|FG002|Overall Study|Withdrawal by Subject|1|||
27699044|NCT00462865|80736518|FG000|Overall Study|Adverse Event|1|||
27699045|NCT00628251|80736519|FG000|Randomised Part|Withdrawal by Subject|0|||
27699046|NCT00628251|80736520|FG001|Randomised Part|Withdrawal by Subject|0|||
27699047|NCT00628251|80736521|FG002|Randomised Part|Withdrawal by Subject|1|||
27699048|NCT00628251|80736519|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
27699049|NCT00628251|80736520|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
27699050|NCT00628251|80736521|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
27699051|NCT00628251|80736519|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
27699052|NCT00628251|80736520|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
27699053|NCT00628251|80736521|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
27699054|NCT00628251|80736519|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
27699055|NCT00628251|80736520|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
27699056|NCT00628251|80736521|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
27699057|NCT00628251|80736519|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
27699058|NCT00628251|80736520|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
27699059|NCT00628251|80736521|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
27699060|NCT00628251|80736519|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
27699061|NCT00628251|80736520|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
27699062|NCT00628251|80736521|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
27885316|NCT02477332|81415316|FG003|Overall Study|Withdrawal by Subject|2|||
27885317|NCT02477332|81415317|FG004|Overall Study|Withdrawal by Subject|1|||
27699063|NCT01106027|80736524|FG000|Overall Study|Lost graft early, discontinued|1|||
27699064|NCT03224325|80736529|FG000|Overall Study|Adverse Event|1|||
27885318|NCT02477332|81415318|FG005|Overall Study|Withdrawal by Subject|0|||
27885319|NCT01014988|81415321|FG000|Overall Study|Adverse Event|20|||
27885320|NCT01014988|81415322|FG001|Overall Study|Adverse Event|0|||
27885321|NCT01014988|81415323|FG002|Overall Study|Adverse Event|1|||
27885322|NCT01014988|81415324|FG003|Overall Study|Adverse Event|0|||
27885323|NCT01014988|81415325|FG004|Overall Study|Adverse Event|1|||
27885324|NCT01014988|81415326|FG005|Overall Study|Adverse Event|3|||
27885325|NCT01014988|81415321|FG000|Overall Study|Lost to Follow-up|1|||
27885326|NCT01014988|81415322|FG001|Overall Study|Lost to Follow-up|0|||
27885327|NCT01014988|81415323|FG002|Overall Study|Lost to Follow-up|1|||
27885328|NCT01014988|81415324|FG003|Overall Study|Lost to Follow-up|0|||
27885329|NCT01014988|81415325|FG004|Overall Study|Lost to Follow-up|0|||
27885330|NCT01014988|81415326|FG005|Overall Study|Lost to Follow-up|0|||
27885331|NCT01014988|81415321|FG000|Overall Study|Physician Decision|1|||
27559519|NCT01359449|80237643|FG000|Overall Study|Lost to Follow-up|1|||
27559520|NCT01359449|80237644|FG001|Overall Study|Lost to Follow-up|0|||
27559521|NCT01359449|80237643|FG000|Overall Study|Protocol Violation|0|||
27559522|NCT01359449|80237644|FG001|Overall Study|Protocol Violation|2|||
27559523|NCT01359449|80237643|FG000|Overall Study|Withdrawal by Subject|3|||
27559524|NCT01359449|80237644|FG001|Overall Study|Withdrawal by Subject|2|||
27559525|NCT00665847|80237645|FG000|Overall Study|Adverse Event|8|||
27559526|NCT00665847|80237645|FG000|Overall Study|Withdrawal by Subject|2|||
27559527|NCT00665847|80237645|FG000|Overall Study|Subject non-compliant|8|||
27559528|NCT00665847|80237645|FG000|Overall Study|Subject reached a virologic endpoint|4|||
27559529|NCT00665847|80237645|FG000|Overall Study|Resistance to TMC125|1|||
27699065|NCT03224325|80736530|FG001|Overall Study|Adverse Event|0|||
27885332|NCT01014988|81415322|FG001|Overall Study|Physician Decision|0|||
27885333|NCT01014988|81415323|FG002|Overall Study|Physician Decision|0|||
27885334|NCT01014988|81415324|FG003|Overall Study|Physician Decision|0|||
27885335|NCT01014988|81415325|FG004|Overall Study|Physician Decision|0|||
27885336|NCT01014988|81415326|FG005|Overall Study|Physician Decision|0|||
27885337|NCT01014988|81415321|FG000|Overall Study|Withdrawal by Subject|1|||
27885338|NCT01014988|81415322|FG001|Overall Study|Withdrawal by Subject|0|||
27885339|NCT01014988|81415323|FG002|Overall Study|Withdrawal by Subject|0|||
27885340|NCT01014988|81415324|FG003|Overall Study|Withdrawal by Subject|0|||
27885341|NCT01014988|81415325|FG004|Overall Study|Withdrawal by Subject|0|||
27559530|NCT00665847|80237645|FG000|Overall Study|Subject ineligible to continue the trial|1|||
27559531|NCT00665847|80237645|FG000|Overall Study|Switch to Commercial Medication|1|||
27559532|NCT02810392|80237647|FG000|Overall Study|Subject too ill to continue|1|||
27559533|NCT02810392|80237648|FG001|Overall Study|Subject too ill to continue|0|||
27885342|NCT01014988|81415326|FG005|Overall Study|Withdrawal by Subject|0|||
27885343|NCT01127451|81415327|FG000|Overall Study|Other|2|||
27885344|NCT01127451|81415328|FG001|Overall Study|Other|1|||
27885345|NCT01127451|81415327|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
27885346|NCT01127451|81415328|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
27885347|NCT01127451|81415327|FG000|Overall Study|Death|22|||
27885348|NCT01127451|81415328|FG001|Overall Study|Death|17|||
27885349|NCT01127451|81415327|FG000|Overall Study|Lost to Follow-up|3|||
27885350|NCT01127451|81415328|FG001|Overall Study|Lost to Follow-up|0|||
27885351|NCT01127451|81415327|FG000|Overall Study|Administrative Reason by Sponsor|2|||
27885352|NCT01127451|81415328|FG001|Overall Study|Administrative Reason by Sponsor|2|||
27885353|NCT04967885|81415329|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
27885354|NCT04967885|81415330|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
27885355|NCT04967885|81415329|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
27885356|NCT04967885|81415330|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
27885357|NCT04967885|81415329|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
27885358|NCT04967885|81415330|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
27559534|NCT02810392|80237647|FG000|Overall Study|COVID 19 research restrictions|0|||
27885359|NCT04967885|81415329|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
27885360|NCT04967885|81415330|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
27885361|NCT04967885|81415329|FG000|EMI-II Intervention|Lost to Follow-up|14|||
27885362|NCT04967885|81415330|FG001|EMI-II Intervention|Lost to Follow-up|10|||
27885363|NCT01508130|81415331|FG000|Overall Study|Adverse Event|81|||
27699066|NCT03224325|80736531|FG002|Overall Study|Adverse Event|0|||
27885364|NCT01508130|81415332|FG001|Overall Study|Adverse Event|28|||
27885365|NCT01508130|81415331|FG000|Overall Study|Death|3|||
27885366|NCT01508130|81415332|FG001|Overall Study|Death|1|||
27885367|NCT01508130|81415331|FG000|Overall Study|Protocol Violation|2|||
27885368|NCT01508130|81415332|FG001|Overall Study|Protocol Violation|0|||
27885369|NCT01508130|81415331|FG000|Overall Study|Lost to Follow-up|25|||
27885370|NCT01508130|81415332|FG001|Overall Study|Lost to Follow-up|2|||
27885371|NCT01508130|81415331|FG000|Overall Study|Withdrawal by Subject|3|||
27885372|NCT01508130|81415332|FG001|Overall Study|Withdrawal by Subject|3|||
27885373|NCT01508130|81415331|FG000|Overall Study|Subject's substantial non-compliance|25|||
27885374|NCT01508130|81415332|FG001|Overall Study|Subject's substantial non-compliance|9|||
27885375|NCT01508130|81415331|FG000|Overall Study|Insufficient therapeutic response|74|||
27885376|NCT01508130|81415332|FG001|Overall Study|Insufficient therapeutic response|23|||
27885377|NCT01508130|81415331|FG000|Overall Study|Administrative|14|||
27885378|NCT01508130|81415332|FG001|Overall Study|Administrative|3|||
27559535|NCT02810392|80237648|FG001|Overall Study|COVID 19 research restrictions|1|||
27559536|NCT00410046|80237652|FG000|Overall Study|Adverse Event|3|||
27559537|NCT00410046|80237652|FG000|Overall Study|Withdrawal by Subject|1|||
27699067|NCT03224325|80736532|FG003|Overall Study|Adverse Event|0|||
27885379|NCT02860130|81415333|FG000|Overall Study|Adverse Event|2|||
27885380|NCT02860130|81415334|FG001|Overall Study|Adverse Event|3|||
27885381|NCT02860130|81415333|FG000|Overall Study|Protocol Violation|1|||
27559538|NCT00410046|80237652|FG000|Overall Study|Lost to Follow-up|1|||
27559539|NCT00492115|80237655|FG000|Overall Study|Withdrawal by Subject|3|||
27885382|NCT02860130|81415334|FG001|Overall Study|Protocol Violation|1|||
27885383|NCT02860130|81415333|FG000|Overall Study|Withdrawal by Subject|0|||
27885384|NCT02860130|81415334|FG001|Overall Study|Withdrawal by Subject|2|||
27885385|NCT02860130|81415333|FG000|Overall Study|Physician Decision|2|||
27885386|NCT02860130|81415334|FG001|Overall Study|Physician Decision|2|||
27885387|NCT02860130|81415333|FG000|Overall Study|Other|2|||
27885388|NCT02860130|81415334|FG001|Overall Study|Other|1|||
27885389|NCT00570141|81415335|FG000|Overall Study|Adverse Event|1|||
27885390|NCT00570141|81415335|FG000|Overall Study|Missed visits|1|||
27885391|NCT00570141|81415335|FG000|Overall Study|Lost to Follow-up|1|||
27885392|NCT01857583|81415336|FG000|Overall Study|Adverse Event|0|||
27885393|NCT01857583|81415337|FG001|Overall Study|Adverse Event|0|||
27885394|NCT01857583|81415338|FG002|Overall Study|Adverse Event|1|||
27885395|NCT01857583|81415339|FG003|Overall Study|Adverse Event|1|||
27885396|NCT01857583|81415336|FG000|Overall Study|Death|0|||
27885397|NCT01857583|81415337|FG001|Overall Study|Death|1|||
27885398|NCT01857583|81415338|FG002|Overall Study|Death|1|||
27885399|NCT01857583|81415339|FG003|Overall Study|Death|0|||
27885400|NCT01857583|81415336|FG000|Overall Study|Physician Decision|0|||
27559540|NCT00492115|80237656|FG001|Overall Study|Withdrawal by Subject|4|||
27559541|NCT00894322|80237657|FG000|Overall Study|Withdrawal by Subject|1|||
27559542|NCT00894322|80237658|FG001|Overall Study|Withdrawal by Subject|0|||
27559543|NCT00894322|80237659|FG002|Overall Study|Withdrawal by Subject|0|||
27559544|NCT00469092|80237660|FG000|Overall Study|Adverse Event|5|||
27559545|NCT00469092|80237661|FG001|Overall Study|Adverse Event|4|||
27559546|NCT00469092|80237660|FG000|Overall Study|Lack of Efficacy|1|||
27559547|NCT00469092|80237661|FG001|Overall Study|Lack of Efficacy|0|||
27559548|NCT00469092|80237660|FG000|Overall Study|Lost to Follow-up|1|||
27559549|NCT00469092|80237661|FG001|Overall Study|Lost to Follow-up|2|||
27559550|NCT00469092|80237660|FG000|Overall Study|Protocol Violation|3|||
27559551|NCT00469092|80237661|FG001|Overall Study|Protocol Violation|3|||
27559552|NCT00469092|80237660|FG000|Overall Study|Withdrawal by Subject|4|||
27559553|NCT00469092|80237661|FG001|Overall Study|Withdrawal by Subject|4|||
27559554|NCT00469092|80237660|FG000|Overall Study|Withdrawal Criteria|3|||
27559555|NCT00469092|80237661|FG001|Overall Study|Withdrawal Criteria|4|||
27559556|NCT00469092|80237660|FG000|Overall Study|Incorrectly Randomised|4|||
27559557|NCT00469092|80237661|FG001|Overall Study|Incorrectly Randomised|3|||
27559558|NCT00469092|80237660|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
27885401|NCT01857583|81415337|FG001|Overall Study|Physician Decision|0|||
27885402|NCT01857583|81415338|FG002|Overall Study|Physician Decision|0|||
27559559|NCT00469092|80237661|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
27559560|NCT00469092|80237660|FG000|Overall Study|Use of lipid lowering drug|1|||
27885403|NCT01857583|81415339|FG003|Overall Study|Physician Decision|1|||
27885404|NCT01857583|81415336|FG000|Overall Study|Withdrawal by Subject|1|||
27559561|NCT00469092|80237661|FG001|Overall Study|Use of lipid lowering drug|0|||
27559562|NCT00469092|80237660|FG000|Overall Study|Hypoglycaemic Episodes|1|||
27885405|NCT01857583|81415337|FG001|Overall Study|Withdrawal by Subject|0|||
27885406|NCT01857583|81415338|FG002|Overall Study|Withdrawal by Subject|1|||
27559563|NCT00469092|80237661|FG001|Overall Study|Hypoglycaemic Episodes|1|||
27559564|NCT00469092|80237660|FG000|Overall Study|Abnormal lab value|1|||
27559565|NCT00469092|80237661|FG001|Overall Study|Abnormal lab value|0|||
27559566|NCT00469092|80237660|FG000|Overall Study|Use of Corticosteroid|1|||
27559567|NCT00469092|80237661|FG001|Overall Study|Use of Corticosteroid|0|||
27559568|NCT01082965|80237662|FG000|Overall Study|Protocol Violation|0|||
27559569|NCT01082965|80237663|FG001|Overall Study|Protocol Violation|1|||
27559570|NCT01082965|80237662|FG000|Overall Study|Other|1|||
27559571|NCT01082965|80237663|FG001|Overall Study|Other|1|||
27559572|NCT00460408|80237666|FG000|Overall Study|Adverse Event|1|||
27559573|NCT00460408|80237667|FG001|Overall Study|Adverse Event|0|||
27559574|NCT00460408|80237668|FG002|Overall Study|Adverse Event|0|||
27559575|NCT00460408|80237669|FG003|Overall Study|Adverse Event|0|||
27559576|NCT00460408|80237666|FG000|Overall Study|Death|7|||
27559577|NCT00460408|80237667|FG001|Overall Study|Death|0|||
27559578|NCT00460408|80237668|FG002|Overall Study|Death|0|||
27559579|NCT00460408|80237669|FG003|Overall Study|Death|0|||
27559580|NCT00460408|80237666|FG000|Overall Study|Lost to Follow-up|11|||
27559581|NCT00460408|80237667|FG001|Overall Study|Lost to Follow-up|0|||
27559582|NCT00460408|80237668|FG002|Overall Study|Lost to Follow-up|1|||
27559583|NCT00460408|80237669|FG003|Overall Study|Lost to Follow-up|0|||
27559584|NCT00460408|80237666|FG000|Overall Study|Withdrawal by Subject|31|||
27559585|NCT00460408|80237667|FG001|Overall Study|Withdrawal by Subject|0|||
27559586|NCT00460408|80237668|FG002|Overall Study|Withdrawal by Subject|0|||
27559587|NCT00460408|80237669|FG003|Overall Study|Withdrawal by Subject|0|||
27559588|NCT00460408|80237666|FG000|Overall Study|Insufficient clinical response|5|||
27559589|NCT00460408|80237667|FG001|Overall Study|Insufficient clinical response|1|||
27559590|NCT00460408|80237668|FG002|Overall Study|Insufficient clinical response|5|||
27559591|NCT00460408|80237669|FG003|Overall Study|Insufficient clinical response|0|||
27559592|NCT00460408|80237666|FG000|Overall Study|Other|12|||
27559593|NCT00460408|80237667|FG001|Overall Study|Other|2|||
27559594|NCT00460408|80237668|FG002|Overall Study|Other|0|||
27559595|NCT00460408|80237669|FG003|Overall Study|Other|0|||
27559596|NCT01963403|80237672|FG000|Overall Study|Lost to Follow-up|2|||
27559597|NCT01963403|80237673|FG001|Overall Study|Lost to Follow-up|3|||
27559598|NCT01963403|80237672|FG000|Overall Study|Implant removal|0|||
27559599|NCT01963403|80237673|FG001|Overall Study|Implant removal|1|||
27559600|NCT01675128|80237674|FG000|Overall Study|Disease progression on study|1|||
27559601|NCT01675128|80237675|FG001|Overall Study|Disease progression on study|1|||
27559602|NCT01675128|80237676|FG002|Overall Study|Disease progression on study|1|||
27559603|NCT01675128|80237674|FG000|Overall Study|Refused further treatment|1|||
27559604|NCT01675128|80237675|FG001|Overall Study|Refused further treatment|0|||
27559605|NCT01675128|80237676|FG002|Overall Study|Refused further treatment|0|||
27559606|NCT01675128|80237674|FG000|Overall Study|Pulmonary complication; off study|0|||
27559607|NCT01675128|80237675|FG001|Overall Study|Pulmonary complication; off study|1|||
27559608|NCT01675128|80237676|FG002|Overall Study|Pulmonary complication; off study|0|||
27559609|NCT02335099|80237677|FG000|Treatment|Withdrawal by Subject|1|||
27559610|NCT02335099|80237678|FG001|Treatment|Withdrawal by Subject|3|||
27559611|NCT02335099|80237677|FG000|Treatment|Lost to Follow-up|2|||
27559612|NCT02335099|80237678|FG001|Treatment|Lost to Follow-up|0|||
27559613|NCT02335099|80237677|FG000|Treatment|Death|1|||
27830989|NCT02055547|81212945|FG008|Overall Study|Physician Decision|0|||
27830990|NCT02055547|81212946|FG009|Overall Study|Physician Decision|1|||
27830991|NCT02055547|81212947|FG010|Overall Study|Physician Decision|1|||
27559614|NCT02335099|80237678|FG001|Treatment|Death|0|||
27559615|NCT02335099|80237677|FG000|Treatment|Adverse Event|1|||
27559616|NCT02335099|80237678|FG001|Treatment|Adverse Event|2|||
27559617|NCT02335099|80237677|FG000|Follow-up|Death|0|||
27559618|NCT02335099|80237678|FG001|Follow-up|Death|1|||
27559619|NCT01782664|80237679|FG000|Overall Study|Adverse Event|2|||
27559620|NCT01782664|80237680|FG001|Overall Study|Adverse Event|2|||
27559621|NCT01782664|80237681|FG002|Overall Study|Adverse Event|2|||
27559622|NCT01782664|80237682|FG003|Overall Study|Adverse Event|2|||
27559623|NCT01782664|80237683|FG004|Overall Study|Adverse Event|0|||
27559624|NCT01782664|80237684|FG005|Overall Study|Adverse Event|0|||
27559625|NCT01782664|80237679|FG000|Overall Study|Lack of Efficacy|2|||
27830992|NCT02055547|81212948|FG011|Overall Study|Physician Decision|0|||
27559626|NCT01782664|80237680|FG001|Overall Study|Lack of Efficacy|0|||
27830993|NCT02055547|81212949|FG012|Overall Study|Physician Decision|0|||
27830994|NCT02055547|81212950|FG013|Overall Study|Physician Decision|0|||
27830995|NCT02055547|81212951|FG014|Overall Study|Physician Decision|0|||
27830996|NCT02055547|81212952|FG015|Overall Study|Physician Decision|0|||
27830997|NCT02055547|81212953|FG016|Overall Study|Physician Decision|0|||
27830998|NCT02055547|81212954|FG017|Overall Study|Physician Decision|0|||
27830999|NCT02055547|81212955|FG018|Overall Study|Physician Decision|0|||
27831000|NCT02055547|81212937|FG000|Overall Study|Adverse Event|0|||
27831001|NCT02055547|81212938|FG001|Overall Study|Adverse Event|0|||
27831002|NCT02055547|81212939|FG002|Overall Study|Adverse Event|0|||
27831003|NCT02055547|81212940|FG003|Overall Study|Adverse Event|0|||
27831004|NCT02055547|81212941|FG004|Overall Study|Adverse Event|0|||
27559627|NCT01782664|80237681|FG002|Overall Study|Lack of Efficacy|2|||
27559628|NCT01782664|80237682|FG003|Overall Study|Lack of Efficacy|2|||
27559629|NCT01782664|80237683|FG004|Overall Study|Lack of Efficacy|0|||
27559630|NCT01782664|80237684|FG005|Overall Study|Lack of Efficacy|0|||
27831005|NCT02055547|81212942|FG005|Overall Study|Adverse Event|0|||
27831006|NCT02055547|81212943|FG006|Overall Study|Adverse Event|1|||
27831007|NCT02055547|81212944|FG007|Overall Study|Adverse Event|0|||
27831008|NCT02055547|81212945|FG008|Overall Study|Adverse Event|1|||
27831009|NCT02055547|81212946|FG009|Overall Study|Adverse Event|0|||
27831010|NCT02055547|81212947|FG010|Overall Study|Adverse Event|0|||
27831011|NCT02055547|81212948|FG011|Overall Study|Adverse Event|0|||
27831012|NCT02055547|81212949|FG012|Overall Study|Adverse Event|0|||
27831013|NCT02055547|81212950|FG013|Overall Study|Adverse Event|0|||
27559631|NCT01782664|80237679|FG000|Overall Study|Protocol Violation|0|||
27559632|NCT01782664|80237680|FG001|Overall Study|Protocol Violation|1|||
27559633|NCT01782664|80237681|FG002|Overall Study|Protocol Violation|0|||
27559634|NCT01782664|80237682|FG003|Overall Study|Protocol Violation|1|||
27559635|NCT01782664|80237683|FG004|Overall Study|Protocol Violation|0|||
27559636|NCT01782664|80237684|FG005|Overall Study|Protocol Violation|0|||
27559637|NCT01782664|80237679|FG000|Overall Study|Withdrawal by Subject|2|||
27559638|NCT01782664|80237680|FG001|Overall Study|Withdrawal by Subject|2|||
27559639|NCT01782664|80237681|FG002|Overall Study|Withdrawal by Subject|0|||
27559640|NCT01782664|80237682|FG003|Overall Study|Withdrawal by Subject|0|||
27831014|NCT02055547|81212951|FG014|Overall Study|Adverse Event|0|||
27831015|NCT02055547|81212952|FG015|Overall Study|Adverse Event|0|||
27831016|NCT02055547|81212953|FG016|Overall Study|Adverse Event|0|||
27831017|NCT02055547|81212954|FG017|Overall Study|Adverse Event|0|||
27831018|NCT02055547|81212955|FG018|Overall Study|Adverse Event|0|||
27831019|NCT02055547|81212937|FG000|Overall Study|Withdrawal by Subject|0|||
27831020|NCT02055547|81212938|FG001|Overall Study|Withdrawal by Subject|0|||
27699068|NCT03224325|80736533|FG004|Overall Study|Adverse Event|0|||
27699069|NCT03224325|80736534|FG005|Overall Study|Adverse Event|0|||
27699070|NCT03224325|80736535|FG006|Overall Study|Adverse Event|1|||
27699071|NCT03224325|80736529|FG000|Overall Study|Withdrawal by Subject|0|||
27699072|NCT03224325|80736530|FG001|Overall Study|Withdrawal by Subject|0|||
27699073|NCT03224325|80736531|FG002|Overall Study|Withdrawal by Subject|0|||
27699074|NCT03224325|80736532|FG003|Overall Study|Withdrawal by Subject|1|||
27699075|NCT03224325|80736533|FG004|Overall Study|Withdrawal by Subject|0|||
27699076|NCT03224325|80736534|FG005|Overall Study|Withdrawal by Subject|0|||
27699077|NCT03224325|80736535|FG006|Overall Study|Withdrawal by Subject|0|||
27699078|NCT00293722|80736536|FG000|Overall Study|Other|427|||
27699079|NCT02279862|80736539|FG000|Overall Study|Study drug toxicity|3|||
27699080|NCT02279862|80736540|FG001|Overall Study|Study drug toxicity|6|||
27699081|NCT02279862|80736539|FG000|Overall Study|No longer meets criteria|0|||
27699082|NCT02279862|80736540|FG001|Overall Study|No longer meets criteria|1|||
27699083|NCT02279862|80736539|FG000|Overall Study|Administrative reason by sponsor|0|||
27699084|NCT02279862|80736540|FG001|Overall Study|Administrative reason by sponsor|1|||
27699085|NCT02279862|80736539|FG000|Overall Study|Disease progression|5|||
27699086|NCT02279862|80736540|FG001|Overall Study|Disease progression|2|||
27699087|NCT02279862|80736539|FG000|Overall Study|Study closed by sponsor|16|||
27699088|NCT02279862|80736540|FG001|Overall Study|Study closed by sponsor|13|||
27699089|NCT02279862|80736539|FG000|Overall Study|Other|1|||
27699090|NCT02279862|80736540|FG001|Overall Study|Other|2|||
27699091|NCT02279862|80736539|FG000|Overall Study|Withdrawal by Subject|1|||
27699092|NCT02279862|80736540|FG001|Overall Study|Withdrawal by Subject|0|||
27699093|NCT01251120|80736541|FG000|Overall Study|Lack of Efficacy|0|||
27699094|NCT01251120|80736542|FG001|Overall Study|Lack of Efficacy|1|||
27699095|NCT00300781|80736543|FG000|Overall Study|Disease Progression|55|||
27699096|NCT00300781|80736544|FG001|Overall Study|Disease Progression|52|||
27699097|NCT00300781|80736543|FG000|Overall Study|Adverse Event|5|||
27699098|NCT00300781|80736544|FG001|Overall Study|Adverse Event|6|||
27699099|NCT00300781|80736543|FG000|Overall Study|Withdrawal by Subject|1|||
27699100|NCT00300781|80736544|FG001|Overall Study|Withdrawal by Subject|2|||
27699101|NCT00300781|80736543|FG000|Overall Study|Physician Decision|1|||
27699102|NCT00300781|80736544|FG001|Overall Study|Physician Decision|0|||
27699103|NCT00300781|80736543|FG000|Overall Study|Not Recorded|0|||
27699104|NCT00300781|80736544|FG001|Overall Study|Not Recorded|1|||
27699105|NCT00300781|80736543|FG000|Overall Study|Symptomatic Deterioration|1|||
27699106|NCT00300781|80736544|FG001|Overall Study|Symptomatic Deterioration|0|||
27699107|NCT00300781|80736543|FG000|Overall Study|Lost to Follow-up|0|||
27699108|NCT00300781|80736544|FG001|Overall Study|Lost to Follow-up|1|||
27699109|NCT00775450|80736545|FG000|Overall Study|Serious Adverse Event|2|||
27699110|NCT00775450|80736546|FG001|Overall Study|Serious Adverse Event|0|||
27699111|NCT00775450|80736547|FG002|Overall Study|Serious Adverse Event|0|||
27699112|NCT00775450|80736548|FG003|Overall Study|Serious Adverse Event|0|||
27699113|NCT00775450|80736549|FG004|Overall Study|Serious Adverse Event|0|||
27699114|NCT00775450|80736545|FG000|Overall Study|Protocol Violation|0|||
27699115|NCT00775450|80736546|FG001|Overall Study|Protocol Violation|0|||
27699116|NCT00775450|80736547|FG002|Overall Study|Protocol Violation|0|||
27831021|NCT02055547|81212939|FG002|Overall Study|Withdrawal by Subject|0|||
27831022|NCT02055547|81212940|FG003|Overall Study|Withdrawal by Subject|0|||
27831023|NCT02055547|81212941|FG004|Overall Study|Withdrawal by Subject|0|||
27699117|NCT00775450|80736548|FG003|Overall Study|Protocol Violation|0|||
27699118|NCT00775450|80736549|FG004|Overall Study|Protocol Violation|1|||
27699119|NCT00775450|80736545|FG000|Overall Study|Withdrawal by Subject|1|||
27699120|NCT00775450|80736546|FG001|Overall Study|Withdrawal by Subject|0|||
27699121|NCT00775450|80736547|FG002|Overall Study|Withdrawal by Subject|0|||
27699122|NCT00775450|80736548|FG003|Overall Study|Withdrawal by Subject|0|||
27699123|NCT00775450|80736549|FG004|Overall Study|Withdrawal by Subject|1|||
27699124|NCT01810016|80736550|FG000|Overall Study|Progressive disease|1|||
27699125|NCT01810016|80736551|FG001|Overall Study|Progressive disease|1|||
27699126|NCT01810016|80736552|FG002|Overall Study|Progressive disease|0|||
27831024|NCT02055547|81212942|FG005|Overall Study|Withdrawal by Subject|1|||
27699127|NCT01810016|80736550|FG000|Overall Study|Death|0|||
27699128|NCT01810016|80736551|FG001|Overall Study|Death|0|||
27699129|NCT01810016|80736552|FG002|Overall Study|Death|1|||
27699130|NCT00954174|80736555|FG000|Overall Study|Adverse Event|28|||
27699131|NCT00954174|80736556|FG001|Overall Study|Adverse Event|23|||
27699132|NCT00954174|80736557|FG002|Overall Study|Adverse Event|4|||
27699133|NCT00954174|80736558|FG003|Overall Study|Adverse Event|9|||
27699134|NCT00954174|80736555|FG000|Overall Study|Death|4|||
27699135|NCT00954174|80736556|FG001|Overall Study|Death|2|||
27699136|NCT00954174|80736557|FG002|Overall Study|Death|0|||
27699137|NCT00954174|80736558|FG003|Overall Study|Death|0|||
27699138|NCT00954174|80736555|FG000|Overall Study|Lack of Efficacy|32|||
27699139|NCT00954174|80736556|FG001|Overall Study|Lack of Efficacy|22|||
27699140|NCT00954174|80736557|FG002|Overall Study|Lack of Efficacy|8|||
27699141|NCT00954174|80736558|FG003|Overall Study|Lack of Efficacy|6|||
27699142|NCT00954174|80736555|FG000|Overall Study|Withdrawal by Subject|14|||
27699143|NCT00954174|80736556|FG001|Overall Study|Withdrawal by Subject|10|||
27699144|NCT00954174|80736557|FG002|Overall Study|Withdrawal by Subject|4|||
27699145|NCT00954174|80736558|FG003|Overall Study|Withdrawal by Subject|3|||
27699146|NCT00954174|80736555|FG000|Overall Study|Medical Reason|4|||
27699147|NCT00954174|80736556|FG001|Overall Study|Medical Reason|2|||
27699148|NCT00954174|80736557|FG002|Overall Study|Medical Reason|1|||
27699149|NCT00954174|80736558|FG003|Overall Study|Medical Reason|0|||
27699150|NCT00954174|80736555|FG000|Overall Study|Ineligible|40|||
27699151|NCT00954174|80736556|FG001|Overall Study|Ineligible|47|||
27699152|NCT00954174|80736557|FG002|Overall Study|Ineligible|7|||
27699153|NCT00954174|80736558|FG003|Overall Study|Ineligible|4|||
27699154|NCT00954174|80736555|FG000|Overall Study|Never Treated|4|||
27699155|NCT00954174|80736556|FG001|Overall Study|Never Treated|17|||
27699156|NCT00954174|80736557|FG002|Overall Study|Never Treated|0|||
27699157|NCT00954174|80736558|FG003|Overall Study|Never Treated|3|||
27699158|NCT02864381|80736559|FG000|Overall Study|Death|58|||
27699159|NCT02864381|80736560|FG001|Overall Study|Death|61|||
27699160|NCT02864381|80736559|FG000|Overall Study|Withdrew Consent|5|||
27699161|NCT02864381|80736560|FG001|Overall Study|Withdrew Consent|6|||
27699162|NCT02864381|80736559|FG000|Overall Study|Reason Unknown|7|||
27699163|NCT02864381|80736560|FG001|Overall Study|Reason Unknown|3|||
27699164|NCT02864381|80736559|FG000|Overall Study|Lost to Follow-up|1|||
27699165|NCT02864381|80736560|FG001|Overall Study|Lost to Follow-up|1|||
27699166|NCT02864381|80736559|FG000|Overall Study|Investigator's Discretion|1|||
27699167|NCT02864381|80736560|FG001|Overall Study|Investigator's Discretion|0|||
27699168|NCT02864381|80736559|FG000|Overall Study|Protocol Violation|0|||
27699169|NCT02864381|80736560|FG001|Overall Study|Protocol Violation|1|||
27699170|NCT01423812|80736561|FG000|Overall Study|Lost to Follow-up|2|||
27699171|NCT01423812|80736562|FG001|Overall Study|Lost to Follow-up|2|||
27699172|NCT01423812|80736561|FG000|Overall Study|Withdrawal by Subject|1|||
27699173|NCT01423812|80736562|FG001|Overall Study|Withdrawal by Subject|2|||
27699174|NCT01873495|80736563|FG000|Overall Study|Withdrawal by Subject|1|||
27699175|NCT01873495|80736563|FG000|Overall Study|Physician Decision|3|||
27699176|NCT01873495|80736563|FG000|Overall Study|Adverse Event|1|||
27699177|NCT01873495|80736563|FG000|Overall Study|Removed for Transplantation|1|||
27699178|NCT01873495|80736563|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
27699179|NCT03716050|80736565|FG000|Overall Study|Lost to Follow-up|0|||
27699180|NCT03716050|80736566|FG001|Overall Study|Lost to Follow-up|0|||
27699181|NCT03716050|80736567|FG002|Overall Study|Lost to Follow-up|1|||
27699182|NCT03716050|80736568|FG003|Overall Study|Lost to Follow-up|0|||
27699183|NCT03716050|80736569|FG004|Overall Study|Lost to Follow-up|0|||
27699184|NCT03716050|80736570|FG005|Overall Study|Lost to Follow-up|0|||
27699185|NCT03716050|80736571|FG006|Overall Study|Lost to Follow-up|0|||
27699186|NCT03716050|80736572|FG007|Overall Study|Lost to Follow-up|0|||
27699187|NCT03716050|80736565|FG000|Overall Study|Physician Decision|0|||
27699188|NCT03716050|80736566|FG001|Overall Study|Physician Decision|0|||
27699189|NCT03716050|80736567|FG002|Overall Study|Physician Decision|0|||
27699190|NCT03716050|80736568|FG003|Overall Study|Physician Decision|1|||
27699191|NCT03716050|80736569|FG004|Overall Study|Physician Decision|0|||
27699192|NCT03716050|80736570|FG005|Overall Study|Physician Decision|0|||
27699193|NCT03716050|80736571|FG006|Overall Study|Physician Decision|0|||
27699194|NCT03716050|80736572|FG007|Overall Study|Physician Decision|0|||
27699195|NCT03716050|80736565|FG000|Overall Study|Protocol Violation|0|||
27699196|NCT03716050|80736566|FG001|Overall Study|Protocol Violation|0|||
27699197|NCT03716050|80736567|FG002|Overall Study|Protocol Violation|0|||
27699198|NCT03716050|80736568|FG003|Overall Study|Protocol Violation|1|||
27699199|NCT03716050|80736569|FG004|Overall Study|Protocol Violation|0|||
27699200|NCT03716050|80736570|FG005|Overall Study|Protocol Violation|0|||
27699201|NCT03716050|80736571|FG006|Overall Study|Protocol Violation|0|||
27699202|NCT03716050|80736572|FG007|Overall Study|Protocol Violation|2|||
27699203|NCT01920594|80736573|FG000|Overall Study|Adverse Event|4|||
27699204|NCT01920594|80736574|FG001|Overall Study|Adverse Event|2|||
27699205|NCT01920594|80736573|FG000|Overall Study|Lost to Follow-up|1|||
27699206|NCT01920594|80736574|FG001|Overall Study|Lost to Follow-up|0|||
27699207|NCT01920594|80736573|FG000|Overall Study|Recovery|2|||
27699208|NCT01920594|80736574|FG001|Overall Study|Recovery|0|||
27699209|NCT01920594|80736573|FG000|Overall Study|Investigator discretion|0|||
27699210|NCT01920594|80736574|FG001|Overall Study|Investigator discretion|1|||
27699211|NCT00536809|80736575|FG000|Phase II|Adverse Event|1|||
27699212|NCT00536809|80736575|FG000|Phase II|Referred for surgical resection|1|||
27699213|NCT02547233|80736577|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
27699214|NCT02547233|80736578|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
27699215|NCT02547233|80736577|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
27699216|NCT02547233|80736578|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
27699217|NCT02547233|80736577|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
27699218|NCT02547233|80736578|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
27699219|NCT02547233|80736577|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
27699220|NCT02547233|80736578|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
27699221|NCT02547233|80736577|FG000|12-month Follow-up|Withdrawal by Subject|10|||
27831025|NCT02055547|81212943|FG006|Overall Study|Withdrawal by Subject|0|||
27559641|NCT01782664|80237683|FG004|Overall Study|Withdrawal by Subject|0|||
27699222|NCT02547233|80736578|FG001|12-month Follow-up|Withdrawal by Subject|10|||
27699223|NCT02547233|80736577|FG000|12-month Follow-up|Lost to Follow-up|3|||
27699224|NCT02547233|80736578|FG001|12-month Follow-up|Lost to Follow-up|3|||
27699225|NCT02547233|80736577|FG000|12-month Follow-up|Lack of Efficacy|1|||
27699226|NCT02547233|80736578|FG001|12-month Follow-up|Lack of Efficacy|2|||
27699227|NCT02547233|80736577|FG000|12-month Follow-up|Protocol Violation|0|||
27699228|NCT02547233|80736578|FG001|12-month Follow-up|Protocol Violation|1|||
27699229|NCT02547233|80736577|FG000|12-month Follow-up|Other|0|||
27699230|NCT02547233|80736578|FG001|12-month Follow-up|Other|1|||
27699231|NCT00528866|80736583|FG000|Overall Study|Protocol Violation|6|||
27699232|NCT01096342|80736585|FG000|Overall Study|Protocol Violation|1|||
27699233|NCT01436071|80736590|FG000|Overall Study|Adverse Event|1|||
27699234|NCT01436071|80736591|FG001|Overall Study|Adverse Event|0|||
27699235|NCT01436071|80736590|FG000|Overall Study|Lack of Efficacy|16|||
27699236|NCT01436071|80736591|FG001|Overall Study|Lack of Efficacy|7|||
27699237|NCT01436071|80736590|FG000|Overall Study|Protocol Violation|0|||
27699238|NCT01436071|80736591|FG001|Overall Study|Protocol Violation|1|||
27699239|NCT01436071|80736590|FG000|Overall Study|Lost to Follow-up|3|||
27699240|NCT01436071|80736591|FG001|Overall Study|Lost to Follow-up|1|||
27699241|NCT01436071|80736590|FG000|Overall Study|Physician Decision|1|||
27699242|NCT01436071|80736591|FG001|Overall Study|Physician Decision|0|||
27699243|NCT01436071|80736590|FG000|Overall Study|Withdrawal by Subject|2|||
27699244|NCT01436071|80736591|FG001|Overall Study|Withdrawal by Subject|2|||
27699245|NCT01436071|80736590|FG000|Overall Study|Did Not Receive Trial Medication|3|||
27699246|NCT01436071|80736591|FG001|Overall Study|Did Not Receive Trial Medication|3|||
27699247|NCT00972777|80736592|FG000|Overall Study|Adverse Event|3|||
27699248|NCT00972777|80736593|FG001|Overall Study|Adverse Event|2|||
27699249|NCT00972777|80736592|FG000|Overall Study|Lost to Follow-up|0|||
27699250|NCT00972777|80736593|FG001|Overall Study|Lost to Follow-up|4|||
27699251|NCT00972777|80736592|FG000|Overall Study|Withdrawal by Subject|4|||
27699252|NCT00972777|80736593|FG001|Overall Study|Withdrawal by Subject|5|||
27699253|NCT00972777|80736592|FG000|Overall Study|Physician Decision|4|||
27699254|NCT00972777|80736593|FG001|Overall Study|Physician Decision|0|||
27699255|NCT00972777|80736592|FG000|Overall Study|Protocol Violation|0|||
27699256|NCT00972777|80736593|FG001|Overall Study|Protocol Violation|2|||
27699257|NCT00972777|80736592|FG000|Overall Study|Screening Failure|2|||
27699258|NCT00972777|80736593|FG001|Overall Study|Screening Failure|1|||
27699259|NCT00972777|80736592|FG000|Overall Study|Missed visit|1|||
27699260|NCT00972777|80736593|FG001|Overall Study|Missed visit|0|||
27699261|NCT04620811|80736594|FG000|Overall Study|Withdrawal by Subject|18|||
27699262|NCT04620811|80736595|FG001|Overall Study|Withdrawal by Subject|15|||
27699263|NCT04620811|80736594|FG000|Overall Study|Adverse Event|6|||
27699264|NCT04620811|80736595|FG001|Overall Study|Adverse Event|11|||
27699265|NCT04620811|80736594|FG000|Overall Study|Lost to Follow-up|4|||
27699266|NCT04620811|80736595|FG001|Overall Study|Lost to Follow-up|8|||
27699267|NCT04620811|80736594|FG000|Overall Study|Physician Decision|1|||
27699268|NCT04620811|80736595|FG001|Overall Study|Physician Decision|4|||
27699269|NCT04620811|80736594|FG000|Overall Study|Sponsor Decision|0|||
27699270|NCT04620811|80736595|FG001|Overall Study|Sponsor Decision|1|||
27699271|NCT04620811|80736594|FG000|Overall Study|Elevation of ALT or AST|1|||
27699272|NCT04620811|80736595|FG001|Overall Study|Elevation of ALT or AST|0|||
27699273|NCT04620811|80736594|FG000|Overall Study|Other|3|||
27699274|NCT04620811|80736595|FG001|Overall Study|Other|5|||
27699275|NCT02881957|80736599|FG000|Overall Study|Comfort care|0|||
27699276|NCT02881957|80736600|FG001|Overall Study|Comfort care|1|||
27699277|NCT02881957|80736599|FG000|Overall Study|Concurrent trial enrollment|0|||
27699278|NCT02881957|80736600|FG001|Overall Study|Concurrent trial enrollment|1|||
27699279|NCT02881957|80736599|FG000|Overall Study|Discharged within 48 hours|0|||
27699280|NCT02881957|80736600|FG001|Overall Study|Discharged within 48 hours|1|||
27699281|NCT02881957|80736599|FG000|Overall Study|Withdrawal by Subject|2|||
27699282|NCT02881957|80736600|FG001|Overall Study|Withdrawal by Subject|1|||
27699283|NCT02881957|80736599|FG000|Overall Study|Protocol Violation|1|||
27699284|NCT02881957|80736600|FG001|Overall Study|Protocol Violation|0|||
27699285|NCT00887250|80736601|FG000|Overall Study|Adverse Event|3|||
27885407|NCT01857583|81415339|FG003|Overall Study|Withdrawal by Subject|2|||
27699286|NCT00887250|80736602|FG001|Overall Study|Adverse Event|0|||
27699287|NCT00887250|80736603|FG002|Overall Study|Adverse Event|7|||
27699288|NCT00887250|80736601|FG000|Overall Study|Lack of Efficacy|9|||
27699289|NCT00887250|80736602|FG001|Overall Study|Lack of Efficacy|6|||
27699290|NCT00887250|80736603|FG002|Overall Study|Lack of Efficacy|1|||
27699291|NCT00887250|80736601|FG000|Overall Study|Lost to Follow-up|2|||
27699292|NCT00887250|80736602|FG001|Overall Study|Lost to Follow-up|3|||
27699293|NCT00887250|80736603|FG002|Overall Study|Lost to Follow-up|1|||
27699294|NCT00887250|80736601|FG000|Overall Study|Protocol Violation|2|||
27699295|NCT00887250|80736602|FG001|Overall Study|Protocol Violation|2|||
27699296|NCT00887250|80736603|FG002|Overall Study|Protocol Violation|1|||
27699297|NCT00887250|80736601|FG000|Overall Study|Withdrawal by Subject|2|||
27699298|NCT00887250|80736602|FG001|Overall Study|Withdrawal by Subject|1|||
27699299|NCT00887250|80736603|FG002|Overall Study|Withdrawal by Subject|2|||
27699300|NCT00887250|80736601|FG000|Overall Study|Patient uncooperative|0|||
27699301|NCT00887250|80736602|FG001|Overall Study|Patient uncooperative|0|||
27699302|NCT00887250|80736603|FG002|Overall Study|Patient uncooperative|1|||
27699303|NCT00640016|80736604|FG000|Overall Study|Withdrawal by Subject|0|||
27699304|NCT00640016|80736605|FG001|Overall Study|Withdrawal by Subject|1|||
27699305|NCT00640016|80736606|FG002|Overall Study|Withdrawal by Subject|0|||
27699306|NCT00640016|80736607|FG003|Overall Study|Withdrawal by Subject|0|||
27699307|NCT00640016|80736604|FG000|Overall Study|Study termination|2|||
27699308|NCT00640016|80736605|FG001|Overall Study|Study termination|1|||
27699309|NCT00640016|80736606|FG002|Overall Study|Study termination|3|||
27699310|NCT00640016|80736607|FG003|Overall Study|Study termination|2|||
27699311|NCT00640016|80736604|FG000|Overall Study|Adverse Event|0|||
27699312|NCT00640016|80736605|FG001|Overall Study|Adverse Event|0|||
27699313|NCT00640016|80736606|FG002|Overall Study|Adverse Event|0|||
27699314|NCT00640016|80736607|FG003|Overall Study|Adverse Event|1|||
27699315|NCT03231943|80736612|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699316|NCT03231943|80736613|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
27699317|NCT03231943|80736614|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
27699318|NCT03231943|80736615|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699319|NCT03231943|80736616|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699320|NCT03231943|80736617|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699321|NCT03231943|80736618|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699322|NCT03231943|80736619|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699323|NCT03231943|80736620|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699324|NCT03231943|80736621|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699325|NCT03231943|80736622|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699326|NCT03231943|80736623|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699327|NCT03231943|80736624|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
27699328|NCT03231943|80736612|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699329|NCT03231943|80736613|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
27699330|NCT03231943|80736614|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699331|NCT03231943|80736615|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699332|NCT03231943|80736616|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699333|NCT03231943|80736617|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699334|NCT03231943|80736618|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699335|NCT03231943|80736619|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699336|NCT03231943|80736620|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699337|NCT03231943|80736621|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699338|NCT03231943|80736622|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699339|NCT03231943|80736623|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699340|NCT03231943|80736624|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
27699341|NCT03231943|80736612|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
27699342|NCT03231943|80736613|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699343|NCT03231943|80736614|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699344|NCT03231943|80736615|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699345|NCT03231943|80736616|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699346|NCT03231943|80736617|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699347|NCT03231943|80736618|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699348|NCT03231943|80736619|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699349|NCT03231943|80736620|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699350|NCT03231943|80736621|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699351|NCT03231943|80736622|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699352|NCT03231943|80736623|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699353|NCT03231943|80736624|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
27699354|NCT03231943|80736612|FG000|Part 2|Adverse Event|0|||
27699355|NCT03231943|80736613|FG001|Part 2|Adverse Event|0|||
27699356|NCT03231943|80736614|FG002|Part 2|Adverse Event|0|||
27699357|NCT03231943|80736615|FG003|Part 2|Adverse Event|0|||
27699358|NCT03231943|80736616|FG004|Part 2|Adverse Event|0|||
27699359|NCT03231943|80736617|FG005|Part 2|Adverse Event|0|||
27699360|NCT03231943|80736618|FG006|Part 2|Adverse Event|0|||
27699361|NCT03231943|80736619|FG007|Part 2|Adverse Event|0|||
27699362|NCT03231943|80736620|FG008|Part 2|Adverse Event|0|||
27831026|NCT02055547|81212944|FG007|Overall Study|Withdrawal by Subject|0|||
27831027|NCT02055547|81212945|FG008|Overall Study|Withdrawal by Subject|1|||
27831028|NCT02055547|81212946|FG009|Overall Study|Withdrawal by Subject|0|||
27831029|NCT02055547|81212947|FG010|Overall Study|Withdrawal by Subject|0|||
27831030|NCT02055547|81212948|FG011|Overall Study|Withdrawal by Subject|0|||
27831031|NCT02055547|81212949|FG012|Overall Study|Withdrawal by Subject|0|||
27831032|NCT02055547|81212950|FG013|Overall Study|Withdrawal by Subject|1|||
27831033|NCT02055547|81212951|FG014|Overall Study|Withdrawal by Subject|0|||
27831034|NCT02055547|81212952|FG015|Overall Study|Withdrawal by Subject|1|||
27831035|NCT02055547|81212953|FG016|Overall Study|Withdrawal by Subject|0|||
27831036|NCT02055547|81212954|FG017|Overall Study|Withdrawal by Subject|0|||
27831037|NCT02055547|81212955|FG018|Overall Study|Withdrawal by Subject|0|||
27831038|NCT02055547|81212937|FG000|Overall Study|Lost to Follow-up|0|||
27831039|NCT02055547|81212938|FG001|Overall Study|Lost to Follow-up|0|||
27831040|NCT02055547|81212939|FG002|Overall Study|Lost to Follow-up|1|||
27831041|NCT02055547|81212940|FG003|Overall Study|Lost to Follow-up|0|||
27699363|NCT03231943|80736621|FG009|Part 2|Adverse Event|0|||
27831042|NCT02055547|81212941|FG004|Overall Study|Lost to Follow-up|0|||
27885408|NCT00457002|81415342|FG000|Overall Study|Death|40|||
27831043|NCT02055547|81212942|FG005|Overall Study|Lost to Follow-up|0|||
27699364|NCT03231943|80736622|FG010|Part 2|Adverse Event|1|||
27831044|NCT02055547|81212943|FG006|Overall Study|Lost to Follow-up|0|||
27699365|NCT03231943|80736623|FG011|Part 2|Adverse Event|0|||
27831045|NCT02055547|81212944|FG007|Overall Study|Lost to Follow-up|0|||
27831046|NCT02055547|81212945|FG008|Overall Study|Lost to Follow-up|0|||
27831047|NCT02055547|81212946|FG009|Overall Study|Lost to Follow-up|0|||
27831048|NCT02055547|81212947|FG010|Overall Study|Lost to Follow-up|0|||
27831049|NCT02055547|81212948|FG011|Overall Study|Lost to Follow-up|0|||
27831050|NCT02055547|81212949|FG012|Overall Study|Lost to Follow-up|0|||
27831051|NCT02055547|81212950|FG013|Overall Study|Lost to Follow-up|0|||
27831052|NCT02055547|81212951|FG014|Overall Study|Lost to Follow-up|0|||
27831053|NCT02055547|81212952|FG015|Overall Study|Lost to Follow-up|0|||
27831054|NCT02055547|81212953|FG016|Overall Study|Lost to Follow-up|0|||
27831055|NCT02055547|81212954|FG017|Overall Study|Lost to Follow-up|0|||
27831056|NCT02055547|81212955|FG018|Overall Study|Lost to Follow-up|0|||
27831057|NCT02072096|81212959|FG000|Overall Study|Lack of Efficacy|18|||
27831058|NCT02072096|81212960|FG001|Overall Study|Lack of Efficacy|29|||
27831059|NCT02072096|81212959|FG000|Overall Study|Protocol Violation|7|||
27831060|NCT02072096|81212960|FG001|Overall Study|Protocol Violation|7|||
27831061|NCT02072096|81212959|FG000|Overall Study|Withdrawal by Subject|5|||
27831062|NCT02072096|81212960|FG001|Overall Study|Withdrawal by Subject|7|||
27831063|NCT02072096|81212959|FG000|Overall Study|Adverse Event|5|||
27831064|NCT02072096|81212960|FG001|Overall Study|Adverse Event|2|||
27831065|NCT02072096|81212959|FG000|Overall Study|No Reason Provided|4|||
27831066|NCT02072096|81212960|FG001|Overall Study|No Reason Provided|2|||
27831067|NCT02072096|81212959|FG000|Overall Study|Death|2|||
27831068|NCT02072096|81212960|FG001|Overall Study|Death|0|||
27831069|NCT02072096|81212959|FG000|Overall Study|Physician Decision|0|||
27831070|NCT02072096|81212960|FG001|Overall Study|Physician Decision|1|||
27831071|NCT02072096|81212959|FG000|Overall Study|Study Terminated by Sponsor|43|||
27831072|NCT02072096|81212960|FG001|Overall Study|Study Terminated by Sponsor|30|||
27831073|NCT02072096|81212959|FG000|Overall Study|Lost to Follow-up|1|||
27831074|NCT02072096|81212960|FG001|Overall Study|Lost to Follow-up|0|||
27831075|NCT02334722|81212961|FG000|Overall Study|Lost to Follow-up|4|||
27831076|NCT02334722|81212962|FG001|Overall Study|Lost to Follow-up|0|||
27831077|NCT02334722|81212961|FG000|Overall Study|6 week questionnaire not completed|2|||
27831078|NCT02334722|81212962|FG001|Overall Study|6 week questionnaire not completed|0|||
27831079|NCT02334722|81212961|FG000|Overall Study|Unable to obtain medication|1|||
27831080|NCT02334722|81212962|FG001|Overall Study|Unable to obtain medication|1|||
27831081|NCT02334722|81212961|FG000|Overall Study|Withdrawal by Subject|0|||
27831082|NCT02334722|81212962|FG001|Overall Study|Withdrawal by Subject|3|||
27831083|NCT02334722|81212961|FG000|Overall Study|Adverse Event|0|||
27831084|NCT02334722|81212962|FG001|Overall Study|Adverse Event|2|||
27831085|NCT02334722|81212961|FG000|Overall Study|Physician Decision|0|||
27831086|NCT02334722|81212962|FG001|Overall Study|Physician Decision|1|||
27831087|NCT02316223|81212963|FG000|Overall Study|Lack of Efficacy|0|||
27831088|NCT02316223|81212964|FG001|Overall Study|Lack of Efficacy|1|||
27831089|NCT02316223|81212965|FG002|Overall Study|Lack of Efficacy|1|||
27831090|NCT02316223|81212963|FG000|Overall Study|Lost to Follow-up|27|||
27831091|NCT02316223|81212964|FG001|Overall Study|Lost to Follow-up|34|||
27831092|NCT02316223|81212965|FG002|Overall Study|Lost to Follow-up|36|||
27831093|NCT02316223|81212963|FG000|Overall Study|COPD Diagnosis|3|||
27831094|NCT02316223|81212964|FG001|Overall Study|COPD Diagnosis|2|||
27831095|NCT02316223|81212965|FG002|Overall Study|COPD Diagnosis|3|||
27831096|NCT02316223|81212963|FG000|Overall Study|Reside outside study area|1|||
27831097|NCT02316223|81212964|FG001|Overall Study|Reside outside study area|1|||
27831098|NCT02316223|81212965|FG002|Overall Study|Reside outside study area|1|||
27831099|NCT02316223|81212963|FG000|Overall Study|No asthma|2|||
27831100|NCT02316223|81212964|FG001|Overall Study|No asthma|0|||
27559642|NCT01782664|80237684|FG005|Overall Study|Withdrawal by Subject|0|||
27831101|NCT02316223|81212965|FG002|Overall Study|No asthma|0|||
27831102|NCT02316223|81212963|FG000|Overall Study|Discontinued by PI|11|||
27831103|NCT02316223|81212964|FG001|Overall Study|Discontinued by PI|19|||
27831104|NCT02316223|81212965|FG002|Overall Study|Discontinued by PI|3|||
27831105|NCT02175095|81212968|FG000|Overall Study|Withdrawal by Subject|3|||
27831106|NCT00294047|81212969|FG000|Month 48|Adverse Event|28|||
27831107|NCT00294047|81212970|FG001|Month 48|Adverse Event|13|||
27831108|NCT00294047|81212969|FG000|Month 48|Protocol Violation|4|||
27831109|NCT00294047|81212970|FG001|Month 48|Protocol Violation|4|||
27831110|NCT00294047|81212969|FG000|Month 48|Withdrawal by Subject|111|||
27831111|NCT00294047|81212970|FG001|Month 48|Withdrawal by Subject|115|||
27831112|NCT00294047|81212969|FG000|Month 48|Lost to Follow-up|272|||
27831113|NCT00294047|81212970|FG001|Month 48|Lost to Follow-up|287|||
27831114|NCT00294047|81212969|FG000|Month 48|Other|10|||
27831115|NCT00294047|81212970|FG001|Month 48|Other|14|||
27699366|NCT03231943|80736624|FG012|Part 2|Adverse Event|0|||
27831116|NCT00294047|81212969|FG000|Month 84|Adverse Event|4|||
27831117|NCT00294047|81212970|FG001|Month 84|Adverse Event|2|||
27831118|NCT00294047|81212969|FG000|Month 84|Protocol Violation|1|||
27831119|NCT00294047|81212970|FG001|Month 84|Protocol Violation|1|||
27831120|NCT00294047|81212969|FG000|Month 84|Withdrawal by Subject|33|||
27831121|NCT00294047|81212970|FG001|Month 84|Withdrawal by Subject|31|||
27831122|NCT00294047|81212969|FG000|Month 84|Lost to Follow-up|187|||
27831123|NCT00294047|81212970|FG001|Month 84|Lost to Follow-up|190|||
27831124|NCT00294047|81212969|FG000|Month 84|Absent Cervix|2|||
27831125|NCT00294047|81212970|FG001|Month 84|Absent Cervix|0|||
27831126|NCT00294047|81212969|FG000|Month 84|Work related reasons|4|||
27831127|NCT00294047|81212970|FG001|Month 84|Work related reasons|2|||
27559643|NCT04267133|80237685|FG000|Overall Study|Withdrawal by Subject|1|||
27699367|NCT03231943|80736612|FG000|Part 2|Withdrawal by Subject|0|||
27831128|NCT00294047|81212969|FG000|Month 84|Center closed, subject did not transfer|1|||
27831129|NCT00294047|81212970|FG001|Month 84|Center closed, subject did not transfer|0|||
27831130|NCT00294047|81212969|FG000|Month 84|Family problems|2|||
27699368|NCT03231943|80736613|FG001|Part 2|Withdrawal by Subject|0|||
27559644|NCT04267133|80237685|FG000|Overall Study|Adverse Event|4|||
27559645|NCT01428453|80237686|FG000|Overall Study|Adverse Event|2|||
27559646|NCT01428453|80237687|FG001|Overall Study|Adverse Event|7|||
27559647|NCT01428453|80237686|FG000|Overall Study|Protocol Violation|1|||
27559648|NCT01428453|80237687|FG001|Overall Study|Protocol Violation|0|||
27559649|NCT01428453|80237686|FG000|Overall Study|Lost to Follow-up|0|||
27559650|NCT01428453|80237687|FG001|Overall Study|Lost to Follow-up|1|||
27559651|NCT01428453|80237686|FG000|Overall Study|Withdrawal by Subject|3|||
27559652|NCT01428453|80237687|FG001|Overall Study|Withdrawal by Subject|1|||
27699369|NCT03231943|80736614|FG002|Part 2|Withdrawal by Subject|0|||
27559653|NCT00840294|80237688|FG000|Overall Study|Withdrawal by Subject|2|||
27559654|NCT00840294|80237689|FG001|Overall Study|Withdrawal by Subject|1|||
27559655|NCT00840294|80237688|FG000|Overall Study|Protocol Violation|1|||
27559656|NCT00840294|80237689|FG001|Overall Study|Protocol Violation|3|||
27559657|NCT00840294|80237688|FG000|Overall Study|Illness|0|||
27559658|NCT00840294|80237689|FG001|Overall Study|Illness|1|||
27559659|NCT00075582|80237698|FG000|Overall Study|Adverse Event|3|||
27559660|NCT00075582|80237699|FG001|Overall Study|Adverse Event|1|||
27559661|NCT00075582|80237698|FG000|Overall Study|Lack of Efficacy|4|||
27559662|NCT00075582|80237699|FG001|Overall Study|Lack of Efficacy|8|||
27559663|NCT00075582|80237698|FG000|Overall Study|Physician Decision|5|||
27559664|NCT00075582|80237699|FG001|Overall Study|Physician Decision|8|||
27559665|NCT00075582|80237698|FG000|Overall Study|Withdrawal by Subject|2|||
27559666|NCT00075582|80237699|FG001|Overall Study|Withdrawal by Subject|2|||
27559667|NCT00075582|80237698|FG000|Overall Study|Ineligible for study|36|||
27559668|NCT00075582|80237699|FG001|Overall Study|Ineligible for study|16|||
27559669|NCT04984993|80237702|FG000|Overall Study|Withdrawal by Subject|8|||
27559670|NCT04984993|80237703|FG001|Overall Study|Withdrawal by Subject|2|||
27559671|NCT04984993|80237702|FG000|Overall Study|Lost to Follow-up|2|||
27559672|NCT04984993|80237703|FG001|Overall Study|Lost to Follow-up|2|||
27559673|NCT04984993|80237702|FG000|Overall Study|Both patients moved to another country|4|||
27559674|NCT04984993|80237703|FG001|Overall Study|Both patients moved to another country|0|||
27559675|NCT01372501|80237704|FG000|Overall Study|Adverse Event|4|||
27559676|NCT01372501|80237704|FG000|Overall Study|Device migration|1|||
27559677|NCT01519960|80237705|FG000|Overall Study|Withdrawal from the study|26|||
27559678|NCT01519960|80237706|FG001|Overall Study|Withdrawal from the study|22|||
27559679|NCT01519960|80237707|FG002|Overall Study|Withdrawal from the study|5|||
27559680|NCT01585428|80237708|FG000|Overall Study|Death during treatment|1|||
27559681|NCT01585428|80237709|FG001|Overall Study|Death during treatment|0|||
27559682|NCT02188589|80237710|FG000|Overall Study|Withdrawal by Subject|5|||
27559683|NCT01199289|80237711|FG000|Overall Study|Ineligibility determined|2|||
27559684|NCT01199289|80237712|FG001|Overall Study|Ineligibility determined|1|||
27559685|NCT01199289|80237713|FG002|Overall Study|Ineligibility determined|0|||
27559686|NCT01199289|80237714|FG003|Overall Study|Ineligibility determined|0|||
27559687|NCT01199289|80237711|FG000|Overall Study|Protocol Violation|1|||
27559688|NCT01199289|80237712|FG001|Overall Study|Protocol Violation|0|||
27699370|NCT03231943|80736615|FG003|Part 2|Withdrawal by Subject|0|||
27699371|NCT03231943|80736616|FG004|Part 2|Withdrawal by Subject|0|||
27559689|NCT01199289|80237713|FG002|Overall Study|Protocol Violation|0|||
27559690|NCT01199289|80237714|FG003|Overall Study|Protocol Violation|1|||
27699372|NCT03231943|80736617|FG005|Part 2|Withdrawal by Subject|0|||
27559691|NCT01199289|80237711|FG000|Overall Study|Noncompliance|1|||
27559692|NCT01199289|80237712|FG001|Overall Study|Noncompliance|0|||
27559693|NCT01199289|80237713|FG002|Overall Study|Noncompliance|2|||
27559694|NCT01199289|80237714|FG003|Overall Study|Noncompliance|0|||
27559695|NCT01199289|80237711|FG000|Overall Study|Adverse Event|0|||
27559696|NCT01199289|80237712|FG001|Overall Study|Adverse Event|3|||
27559697|NCT01199289|80237713|FG002|Overall Study|Adverse Event|1|||
27559698|NCT01199289|80237714|FG003|Overall Study|Adverse Event|4|||
27559699|NCT01199289|80237711|FG000|Overall Study|Full consent withdrawn|2|||
27559700|NCT01199289|80237712|FG001|Overall Study|Full consent withdrawn|2|||
27559701|NCT01199289|80237713|FG002|Overall Study|Full consent withdrawn|2|||
27559702|NCT01199289|80237714|FG003|Overall Study|Full consent withdrawn|3|||
27559703|NCT01199289|80237711|FG000|Overall Study|Administrative decision|0|||
27559704|NCT01199289|80237712|FG001|Overall Study|Administrative decision|0|||
27559705|NCT01199289|80237713|FG002|Overall Study|Administrative decision|0|||
27559706|NCT01199289|80237714|FG003|Overall Study|Administrative decision|1|||
27559707|NCT01199289|80237711|FG000|Overall Study|Lost to Follow-up|0|||
27559708|NCT01199289|80237712|FG001|Overall Study|Lost to Follow-up|0|||
27559709|NCT01199289|80237713|FG002|Overall Study|Lost to Follow-up|0|||
27559710|NCT01199289|80237714|FG003|Overall Study|Lost to Follow-up|1|||
27559711|NCT01199289|80237711|FG000|Overall Study|Protocol-specified criteria|3|||
27559712|NCT01199289|80237712|FG001|Overall Study|Protocol-specified criteria|0|||
27559713|NCT01199289|80237713|FG002|Overall Study|Protocol-specified criteria|0|||
27559714|NCT01199289|80237714|FG003|Overall Study|Protocol-specified criteria|1|||
27559715|NCT01199289|80237711|FG000|Overall Study|Pregnancy|0|||
27559716|NCT01199289|80237712|FG001|Overall Study|Pregnancy|1|||
27559717|NCT01199289|80237713|FG002|Overall Study|Pregnancy|0|||
27559718|NCT01199289|80237714|FG003|Overall Study|Pregnancy|1|||
27559719|NCT02484729|80237717|FG000|Overall Study|Failure of IntelliCap Error|0|||
27559720|NCT02484729|80237718|FG001|Overall Study|Failure of IntelliCap Error|0|||
27559721|NCT02484729|80237719|FG002|Overall Study|Failure of IntelliCap Error|0|||
27559722|NCT02484729|80237720|FG003|Overall Study|Failure of IntelliCap Error|0|||
27559723|NCT02484729|80237721|FG004|Overall Study|Failure of IntelliCap Error|0|||
27559724|NCT02484729|80237722|FG005|Overall Study|Failure of IntelliCap Error|0|||
27559725|NCT02484729|80237723|FG006|Overall Study|Failure of IntelliCap Error|0|||
27559726|NCT02484729|80237724|FG007|Overall Study|Failure of IntelliCap Error|0|||
27559727|NCT02484729|80237725|FG008|Overall Study|Failure of IntelliCap Error|0|||
27559728|NCT02484729|80237726|FG009|Overall Study|Failure of IntelliCap Error|1|||
27559729|NCT00487747|80237732|FG000|Overall Study|Adverse Event|1|||
27559730|NCT00487747|80237732|FG000|Overall Study|Lost to Follow-up|9|||
27559731|NCT00487747|80237732|FG000|Overall Study|Lack of Efficacy|1|||
27559732|NCT00597766|80237733|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
27559733|NCT00597766|80237734|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
27559734|NCT00597766|80237735|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
27559735|NCT00597766|80237733|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
27559736|NCT00597766|80237734|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
27559737|NCT00597766|80237735|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
27559738|NCT03103919|80237736|FG000|Overall Study|Adverse Event|2|||
27559739|NCT03103919|80237737|FG001|Overall Study|Adverse Event|2|||
27559740|NCT00730912|80237739|FG000|Overall Study|Discontinued|0|||
27559741|NCT00730912|80237740|FG001|Overall Study|Discontinued|0|||
27559742|NCT00730912|80237741|FG002|Overall Study|Discontinued|1|||
27559743|NCT00156533|80237742|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
27559744|NCT00156533|80237743|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
27559745|NCT00156533|80237744|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
27559746|NCT00156533|80237745|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
27559747|NCT00156533|80237742|FG000|Overall Study|Withdrawal by Subject|1|||
27559748|NCT00156533|80237743|FG001|Overall Study|Withdrawal by Subject|0|||
27559749|NCT00156533|80237744|FG002|Overall Study|Withdrawal by Subject|0|||
27699373|NCT03231943|80736618|FG006|Part 2|Withdrawal by Subject|0|||
27831131|NCT00294047|81212970|FG001|Month 84|Family problems|2|||
27831132|NCT00294047|81212969|FG000|Month 84|Lack of time|3|||
27831133|NCT00294047|81212970|FG001|Month 84|Lack of time|1|||
27559750|NCT00156533|80237745|FG003|Overall Study|Withdrawal by Subject|1|||
27559751|NCT00156533|80237742|FG000|Overall Study|Failed Screening|1|||
27559752|NCT00156533|80237743|FG001|Overall Study|Failed Screening|0|||
27559753|NCT00156533|80237744|FG002|Overall Study|Failed Screening|1|||
27559754|NCT00156533|80237745|FG003|Overall Study|Failed Screening|1|||
27559755|NCT02426892|80237746|FG000|Overall Study|Adverse Event|2|||
27831134|NCT00294047|81212969|FG000|Month 84|Personal reason|2|||
27559756|NCT02426892|80237746|FG000|Overall Study|Lack of Efficacy|17|||
27559757|NCT02426892|80237746|FG000|Overall Study|Withdrawal by Subject|1|||
27559758|NCT04210310|80237748|FG000|Overall Study|Lost to Follow-up|32|||
27699374|NCT03231943|80736619|FG007|Part 2|Withdrawal by Subject|0|||
27559759|NCT04210310|80237749|FG001|Overall Study|Lost to Follow-up|1|||
27559760|NCT00624052|80237750|FG000|Overall Study|Adverse Event|7|||
27559761|NCT00624052|80237751|FG001|Overall Study|Adverse Event|6|||
27699375|NCT03231943|80736620|FG008|Part 2|Withdrawal by Subject|0|||
27831135|NCT00294047|81212970|FG001|Month 84|Personal reason|4|||
27559762|NCT00624052|80237752|FG002|Overall Study|Adverse Event|0|||
27559763|NCT00624052|80237753|FG003|Overall Study|Adverse Event|3|||
27559764|NCT00624052|80237750|FG000|Overall Study|Lack of Efficacy|1|||
27559765|NCT00624052|80237751|FG001|Overall Study|Lack of Efficacy|1|||
27559766|NCT00624052|80237752|FG002|Overall Study|Lack of Efficacy|0|||
27559767|NCT00624052|80237753|FG003|Overall Study|Lack of Efficacy|0|||
27559768|NCT00624052|80237750|FG000|Overall Study|Lost to Follow-up|2|||
27559769|NCT00624052|80237751|FG001|Overall Study|Lost to Follow-up|3|||
27559770|NCT00624052|80237752|FG002|Overall Study|Lost to Follow-up|1|||
27559771|NCT00624052|80237753|FG003|Overall Study|Lost to Follow-up|0|||
27559772|NCT00624052|80237750|FG000|Overall Study|Non compliant with the protocol|2|||
27559773|NCT00624052|80237751|FG001|Overall Study|Non compliant with the protocol|1|||
27559774|NCT00624052|80237752|FG002|Overall Study|Non compliant with the protocol|1|||
27559775|NCT00624052|80237753|FG003|Overall Study|Non compliant with the protocol|1|||
27559776|NCT00624052|80237750|FG000|Overall Study|Consent withdrawn|3|||
27559777|NCT00624052|80237751|FG001|Overall Study|Consent withdrawn|1|||
27559778|NCT00624052|80237752|FG002|Overall Study|Consent withdrawn|1|||
27559779|NCT00624052|80237753|FG003|Overall Study|Consent withdrawn|0|||
27559780|NCT00624052|80237750|FG000|Overall Study|Changed job/ran out if meds|0|||
27559781|NCT00624052|80237751|FG001|Overall Study|Changed job/ran out if meds|2|||
27559782|NCT00624052|80237752|FG002|Overall Study|Changed job/ran out if meds|0|||
27559783|NCT00624052|80237753|FG003|Overall Study|Changed job/ran out if meds|0|||
27559784|NCT04779489|80237754|FG000|Overall Study|Physician Decision|1|||
27559785|NCT00281684|80237755|FG000|Overall Study|Lost to Follow-up|0|||
27559786|NCT00281684|80237756|FG001|Overall Study|Lost to Follow-up|0|||
27559787|NCT00281684|80237757|FG002|Overall Study|Lost to Follow-up|1|||
27559788|NCT00281684|80237758|FG003|Overall Study|Lost to Follow-up|0|||
27559789|NCT00281684|80237755|FG000|Overall Study|Withdrawal by Subject|1|||
27559790|NCT00281684|80237756|FG001|Overall Study|Withdrawal by Subject|0|||
27559791|NCT00281684|80237757|FG002|Overall Study|Withdrawal by Subject|0|||
27559792|NCT00281684|80237758|FG003|Overall Study|Withdrawal by Subject|0|||
27559793|NCT01026792|80237759|FG000|Overall Study|Protocol Violation|1|||
27559794|NCT01287897|80237762|FG000|Overall Study|Adverse Event|5|||
27559795|NCT01287897|80237763|FG001|Overall Study|Adverse Event|3|||
27559796|NCT01287897|80237764|FG002|Overall Study|Adverse Event|6|||
27559797|NCT01287897|80237765|FG003|Overall Study|Adverse Event|4|||
27559798|NCT01287897|80237762|FG000|Overall Study|Lack of Efficacy|2|||
27559799|NCT01287897|80237763|FG001|Overall Study|Lack of Efficacy|0|||
27559800|NCT01287897|80237764|FG002|Overall Study|Lack of Efficacy|0|||
27559801|NCT01287897|80237765|FG003|Overall Study|Lack of Efficacy|0|||
27559802|NCT01287897|80237762|FG000|Overall Study|Protocol Violation|1|||
27559803|NCT01287897|80237763|FG001|Overall Study|Protocol Violation|1|||
27559804|NCT01287897|80237764|FG002|Overall Study|Protocol Violation|0|||
27559805|NCT01287897|80237765|FG003|Overall Study|Protocol Violation|1|||
27559806|NCT01287897|80237762|FG000|Overall Study|Lost to Follow-up|0|||
27559807|NCT01287897|80237763|FG001|Overall Study|Lost to Follow-up|0|||
27559808|NCT01287897|80237764|FG002|Overall Study|Lost to Follow-up|2|||
27559809|NCT01287897|80237765|FG003|Overall Study|Lost to Follow-up|0|||
27559810|NCT01287897|80237762|FG000|Overall Study|Withdrawal by Subject|1|||
27559811|NCT01287897|80237763|FG001|Overall Study|Withdrawal by Subject|5|||
27559812|NCT01287897|80237764|FG002|Overall Study|Withdrawal by Subject|3|||
27559813|NCT01287897|80237765|FG003|Overall Study|Withdrawal by Subject|2|||
27559814|NCT01287897|80237762|FG000|Overall Study|Not consented properly|0|||
27559815|NCT01287897|80237763|FG001|Overall Study|Not consented properly|1|||
27559816|NCT01287897|80237764|FG002|Overall Study|Not consented properly|0|||
27559817|NCT01287897|80237765|FG003|Overall Study|Not consented properly|0|||
27559818|NCT01287897|80237762|FG000|Overall Study|Not meeting entrance criteria|1|||
27559819|NCT01287897|80237763|FG001|Overall Study|Not meeting entrance criteria|1|||
27559820|NCT01287897|80237764|FG002|Overall Study|Not meeting entrance criteria|0|||
27559821|NCT01287897|80237765|FG003|Overall Study|Not meeting entrance criteria|0|||
27559822|NCT01287897|80237762|FG000|Overall Study|Other|1|||
27559823|NCT01287897|80237763|FG001|Overall Study|Other|0|||
27559824|NCT01287897|80237764|FG002|Overall Study|Other|1|||
27559825|NCT01287897|80237765|FG003|Overall Study|Other|0|||
27559826|NCT01156311|80237766|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
27559827|NCT01156311|80237767|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
27559828|NCT01156311|80237768|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
27559829|NCT01156311|80237769|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
27559830|NCT01156311|80237766|FG000|2-Month Monotherapy Period|Physician Decision|0|||
27559831|NCT01156311|80237767|FG001|2-Month Monotherapy Period|Physician Decision|1|||
27559832|NCT01156311|80237768|FG002|2-Month Monotherapy Period|Physician Decision|0|||
27559833|NCT01156311|80237769|FG003|2-Month Monotherapy Period|Physician Decision|0|||
27559834|NCT01156311|80237766|FG000|2-Month Monotherapy Period|Other|1|||
27559835|NCT01156311|80237767|FG001|2-Month Monotherapy Period|Other|0|||
27559836|NCT01156311|80237768|FG002|2-Month Monotherapy Period|Other|0|||
27559837|NCT01156311|80237769|FG003|2-Month Monotherapy Period|Other|0|||
27559838|NCT01156311|80237766|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
27699376|NCT03231943|80736621|FG009|Part 2|Withdrawal by Subject|0|||
27559839|NCT01156311|80237767|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
27559840|NCT01156311|80237768|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
27559841|NCT01156311|80237769|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
27559842|NCT01156311|80237766|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
27559843|NCT01156311|80237767|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
27559844|NCT01156311|80237768|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
27559845|NCT01156311|80237769|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
27559846|NCT01156311|80237766|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
27559847|NCT01156311|80237767|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
27559848|NCT01156311|80237768|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
27559849|NCT01156311|80237769|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
27559850|NCT01156311|80237766|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
27559851|NCT01156311|80237767|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
27559852|NCT01156311|80237768|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
27559853|NCT01156311|80237769|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
27559854|NCT01156311|80237766|FG000|6-month Add-on Therapy Period|Other|0|||
27559855|NCT01156311|80237767|FG001|6-month Add-on Therapy Period|Other|0|||
27559856|NCT01156311|80237768|FG002|6-month Add-on Therapy Period|Other|1|||
27559857|NCT01156311|80237769|FG003|6-month Add-on Therapy Period|Other|2|||
27559858|NCT02068443|80237770|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27699377|NCT03231943|80736622|FG010|Part 2|Withdrawal by Subject|0|||
27831136|NCT00294047|81212969|FG000|Month 84|Subject does not want male physician|1|||
27831137|NCT00294047|81212970|FG001|Month 84|Subject does not want male physician|0|||
27559859|NCT02068443|80237771|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
27831138|NCT00294047|81212969|FG000|Month 84|Transport reimbursement delayed|0|||
27831139|NCT00294047|81212970|FG001|Month 84|Transport reimbursement delayed|1|||
27831140|NCT00294047|81212969|FG000|Month 84|Unable to reach study site|1|||
27831141|NCT00294047|81212970|FG001|Month 84|Unable to reach study site|0|||
27831142|NCT00294047|81212969|FG000|Month 84|Under investigation locally|1|||
27831143|NCT00294047|81212970|FG001|Month 84|Under investigation locally|0|||
27831144|NCT00294047|81212969|FG000|Month 84|Visit missed|0|||
27831145|NCT00294047|81212970|FG001|Month 84|Visit missed|1|||
27699378|NCT03231943|80736623|FG011|Part 2|Withdrawal by Subject|1|||
27831146|NCT00294047|81212969|FG000|Month 84|No consent for Month 84 Follow-up|731|||
27885409|NCT00457002|81415343|FG001|Overall Study|Death|47|||
27699379|NCT03231943|80736624|FG012|Part 2|Withdrawal by Subject|0|||
27559860|NCT02068443|80237772|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
27559861|NCT02068443|80237770|FG000|Overall Study|Voluntary Withdrawal|4|||
27559862|NCT02068443|80237771|FG001|Overall Study|Voluntary Withdrawal|0|||
27559863|NCT02068443|80237772|FG002|Overall Study|Voluntary Withdrawal|1|||
27559864|NCT02068443|80237770|FG000|Overall Study|Lack of Efficacy|2|||
27559865|NCT02068443|80237771|FG001|Overall Study|Lack of Efficacy|1|||
27559866|NCT02068443|80237772|FG002|Overall Study|Lack of Efficacy|0|||
27559867|NCT02068443|80237770|FG000|Overall Study|Other Reason Not Specified|1|||
27885410|NCT00457002|81415342|FG000|Overall Study|Adverse Event|284|||
27885411|NCT00457002|81415343|FG001|Overall Study|Adverse Event|260|||
27885412|NCT00457002|81415342|FG000|Overall Study|Withdrawal by Subject|299|||
27885413|NCT00457002|81415343|FG001|Overall Study|Withdrawal by Subject|271|||
27885414|NCT00457002|81415342|FG000|Overall Study|Lost to Follow-up|72|||
27885415|NCT00457002|81415343|FG001|Overall Study|Lost to Follow-up|71|||
27885416|NCT00457002|81415342|FG000|Overall Study|Poor/Non-compliance|46|||
27885417|NCT00457002|81415343|FG001|Overall Study|Poor/Non-compliance|33|||
27885418|NCT00457002|81415342|FG000|Overall Study|No longer met criteria|41|||
27885419|NCT00457002|81415343|FG001|Overall Study|No longer met criteria|37|||
27885420|NCT00457002|81415342|FG000|Overall Study|Administrative reason by Sponsor|1|||
27885421|NCT00457002|81415343|FG001|Overall Study|Administrative reason by Sponsor|0|||
27885422|NCT00457002|81415342|FG000|Overall Study|non-specified|29|||
27885423|NCT00457002|81415343|FG001|Overall Study|non-specified|38|||
27885424|NCT00457002|81415342|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
27885425|NCT00457002|81415343|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
27885426|NCT01397825|81415344|FG000|Overall Study|Progressive Disease|10|||
27885427|NCT01397825|81415345|FG001|Overall Study|Progressive Disease|3|||
27885428|NCT01397825|81415346|FG002|Overall Study|Progressive Disease|11|||
27885429|NCT01397825|81415347|FG003|Overall Study|Progressive Disease|1|||
27885430|NCT01397825|81415348|FG004|Overall Study|Progressive Disease|0|||
27885431|NCT01397825|81415344|FG000|Overall Study|Symptomatic Deterioration|2|||
27885432|NCT01397825|81415345|FG001|Overall Study|Symptomatic Deterioration|0|||
27885433|NCT01397825|81415346|FG002|Overall Study|Symptomatic Deterioration|4|||
27885434|NCT01397825|81415347|FG003|Overall Study|Symptomatic Deterioration|0|||
27885435|NCT01397825|81415348|FG004|Overall Study|Symptomatic Deterioration|0|||
27885436|NCT01397825|81415344|FG000|Overall Study|Adverse Event|0|||
27885437|NCT01397825|81415345|FG001|Overall Study|Adverse Event|1|||
27885438|NCT01397825|81415346|FG002|Overall Study|Adverse Event|5|||
27885439|NCT01397825|81415347|FG003|Overall Study|Adverse Event|1|||
27885440|NCT01397825|81415348|FG004|Overall Study|Adverse Event|0|||
27885441|NCT01397825|81415344|FG000|Overall Study|Withdrawal by Subject|1|||
27885442|NCT01397825|81415345|FG001|Overall Study|Withdrawal by Subject|0|||
27885443|NCT01397825|81415346|FG002|Overall Study|Withdrawal by Subject|5|||
27699380|NCT00564018|80736625|FG000|Overall Study|Withdrawal by Subject|2|||
27699381|NCT00564018|80736626|FG001|Overall Study|Withdrawal by Subject|3|||
27559868|NCT02068443|80237771|FG001|Overall Study|Other Reason Not Specified|0|||
27699382|NCT00564018|80736627|FG002|Overall Study|Withdrawal by Subject|1|||
27885444|NCT01397825|81415347|FG003|Overall Study|Withdrawal by Subject|1|||
27885445|NCT01397825|81415348|FG004|Overall Study|Withdrawal by Subject|0|||
27885446|NCT00285207|81415350|FG000|Overall Study|Lost to Follow-up|3|||
27885447|NCT00285207|81415351|FG001|Overall Study|Lost to Follow-up|2|||
27885448|NCT00285207|81415350|FG000|Overall Study|Withdrawal by Subject|5|||
27885449|NCT00285207|81415351|FG001|Overall Study|Withdrawal by Subject|2|||
27885450|NCT00285207|81415350|FG000|Overall Study|Pregnancy|1|||
27885451|NCT00285207|81415351|FG001|Overall Study|Pregnancy|1|||
27885452|NCT00285207|81415350|FG000|Overall Study|non-compliance|0|||
27885453|NCT00285207|81415351|FG001|Overall Study|non-compliance|1|||
27885454|NCT00603590|81415356|FG000|Overall Study|Did not attend study clinic|39|||
27885455|NCT00603590|81415357|FG001|Overall Study|Did not attend study clinic|30|||
27885456|NCT00603590|81415356|FG000|Overall Study|Refused blood test|5|||
27885457|NCT00603590|81415357|FG001|Overall Study|Refused blood test|1|||
27885458|NCT00603590|81415356|FG000|Overall Study|Patient discontinued study drug|22|||
27559869|NCT02068443|80237772|FG002|Overall Study|Other Reason Not Specified|0|||
27885459|NCT00603590|81415357|FG001|Overall Study|Patient discontinued study drug|15|||
27559870|NCT04273217|80237773|FG000|Overall Study|Lost to Follow-up|0|||
27559871|NCT04273217|80237774|FG001|Overall Study|Lost to Follow-up|0|||
27559872|NCT04273217|80237775|FG002|Overall Study|Lost to Follow-up|0|||
27559873|NCT04273217|80237776|FG003|Overall Study|Lost to Follow-up|0|||
27559874|NCT04273217|80237777|FG004|Overall Study|Lost to Follow-up|0|||
27559875|NCT04273217|80237778|FG005|Overall Study|Lost to Follow-up|1|||
27559876|NCT04273217|80237773|FG000|Overall Study|Participant non-compliance|0|||
27885460|NCT00603590|81415356|FG000|Overall Study|Adverse Event|2|||
27885461|NCT00603590|81415357|FG001|Overall Study|Adverse Event|0|||
27885462|NCT00603590|81415356|FG000|Overall Study|Lost to Follow-up|8|||
27885463|NCT00603590|81415357|FG001|Overall Study|Lost to Follow-up|4|||
27885464|NCT00603590|81415356|FG000|Overall Study|Cardiovascular event|0|||
27885465|NCT00603590|81415357|FG001|Overall Study|Cardiovascular event|1|||
27885466|NCT02693002|81415358|FG000|Overall Study|Withdrawal by Subject|1|||
27885467|NCT02693002|81415359|FG001|Overall Study|Withdrawal by Subject|0|||
27885468|NCT05140382|81415362|FG000|Overall Study|Death|3|||
27885469|NCT05140382|81415363|FG001|Overall Study|Death|0|||
27885470|NCT05140382|81415364|FG002|Overall Study|Death|0|||
27885471|NCT05140382|81415362|FG000|Overall Study|Investigator decision|1|||
27885472|NCT05140382|81415363|FG001|Overall Study|Investigator decision|0|||
27885473|NCT05140382|81415364|FG002|Overall Study|Investigator decision|0|||
27885474|NCT05140382|81415362|FG000|Overall Study|Other|4|||
27885475|NCT05140382|81415363|FG001|Overall Study|Other|0|||
27885476|NCT05140382|81415364|FG002|Overall Study|Other|1|||
27885477|NCT05140382|81415362|FG000|Overall Study|Progressive disease|20|||
27885478|NCT05140382|81415363|FG001|Overall Study|Progressive disease|1|||
27885479|NCT05140382|81415364|FG002|Overall Study|Progressive disease|12|||
27885480|NCT05140382|81415362|FG000|Overall Study|Subjective disease progression|2|||
27885481|NCT05140382|81415363|FG001|Overall Study|Subjective disease progression|1|||
27885482|NCT05140382|81415364|FG002|Overall Study|Subjective disease progression|0|||
27885483|NCT05140382|81415362|FG000|Overall Study|Unknown at data cut-off|0|||
27885484|NCT05140382|81415363|FG001|Overall Study|Unknown at data cut-off|0|||
27885485|NCT05140382|81415364|FG002|Overall Study|Unknown at data cut-off|1|||
27885486|NCT05140382|81415362|FG000|Overall Study|Withdrawal by Subject|1|||
27885487|NCT05140382|81415363|FG001|Overall Study|Withdrawal by Subject|0|||
27885488|NCT05140382|81415364|FG002|Overall Study|Withdrawal by Subject|4|||
27885489|NCT05140382|81415362|FG000|Overall Study|Withdrawal of consent|0|||
27885490|NCT05140382|81415363|FG001|Overall Study|Withdrawal of consent|0|||
27885491|NCT05140382|81415364|FG002|Overall Study|Withdrawal of consent|1|||
27885492|NCT01609543|81415367|FG000|Overall Study|Disease Progression|28|||
27885493|NCT01609543|81415367|FG000|Overall Study|Adverse Event|5|||
27885494|NCT01609543|81415367|FG000|Overall Study|Withdrawal by Subject|1|||
27885495|NCT01609543|81415367|FG000|Overall Study|Protocol Violation|1|||
27885496|NCT01609543|81415367|FG000|Overall Study|Death|7|||
27885497|NCT01841762|81415368|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
27885498|NCT01841762|81415368|FG000|Treatment Period|Adverse Event|16|||
27885499|NCT01841762|81415368|FG000|Treatment Period|Death|1|||
27885500|NCT01841762|81415368|FG000|Treatment Period|Withdrawal by Subject|7|||
27885501|NCT01841762|81415368|FG000|Treatment Period|Lost to Follow-up|1|||
27885502|NCT01841762|81415368|FG000|Treatment Period|Physician Decision|2|||
27885503|NCT01841762|81415368|FG000|Treatment Period|Other, including non-compliance|5|||
27885504|NCT01841762|81415368|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
27885505|NCT01841762|81415368|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
27885506|NCT01841762|81415368|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
27885507|NCT01841762|81415368|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
27885508|NCT01894100|81415369|FG000|Overall Study|Lost to Follow-up|0|||
27831147|NCT00294047|81212970|FG001|Month 84|No consent for Month 84 Follow-up|754|||
27831148|NCT04466111|81212971|FG000|Prior to Trial Phase|Physician Decision|1|||
27831149|NCT01101022|81212972|FG000|Overall Study|Adverse Event|6|||
27831150|NCT01101022|81212973|FG001|Overall Study|Adverse Event|2|||
27831151|NCT01101022|81212972|FG000|Overall Study|Protocol Violation|4|||
27831152|NCT01101022|81212973|FG001|Overall Study|Protocol Violation|3|||
27831153|NCT01101022|81212972|FG000|Overall Study|Withdrawal by Subject|3|||
27831154|NCT01101022|81212973|FG001|Overall Study|Withdrawal by Subject|8|||
27831155|NCT01101022|81212972|FG000|Overall Study|Lost to Follow-up|1|||
27831156|NCT01101022|81212973|FG001|Overall Study|Lost to Follow-up|4|||
27831157|NCT01101022|81212972|FG000|Overall Study|Lack of Efficacy|0|||
27831158|NCT01101022|81212973|FG001|Overall Study|Lack of Efficacy|7|||
27831159|NCT01101022|81212972|FG000|Overall Study|Sponsor decision|1|||
27831160|NCT01101022|81212973|FG001|Overall Study|Sponsor decision|1|||
27831161|NCT01101022|81212972|FG000|Overall Study|Non-compliance|1|||
27831162|NCT01101022|81212973|FG001|Overall Study|Non-compliance|0|||
27831163|NCT01101022|81212972|FG000|Overall Study|Work schedule|1|||
27831164|NCT01101022|81212973|FG001|Overall Study|Work schedule|1|||
27831165|NCT01101022|81212972|FG000|Overall Study|Vacation|0|||
27831166|NCT01101022|81212973|FG001|Overall Study|Vacation|1|||
27831167|NCT00835705|81212974|FG000|First Intervention|Difficulty with vein|1|||
27699383|NCT03249714|80736630|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
27699384|NCT03249714|80736631|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
27699385|NCT03249714|80736630|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
27699386|NCT03249714|80736631|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
27699387|NCT03249714|80736630|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
27699388|NCT03249714|80736631|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
27699389|NCT03249714|80736630|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
27699390|NCT03249714|80736631|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
27699391|NCT02974088|80736632|FG000|Overall Study|Lost to Follow-up|0|||
27831168|NCT00835705|81212975|FG001|First Intervention|Difficulty with vein|0|||
27831169|NCT00835705|81212974|FG000|Second Intervention|Difficulty with vein|1|||
27831170|NCT00835705|81212975|FG001|Second Intervention|Difficulty with vein|0|||
27831171|NCT01735994|81212981|FG000|Overall Study|Withdrawal by Subject|6|||
27831172|NCT01735994|81212982|FG001|Overall Study|Withdrawal by Subject|4|||
27831173|NCT01735994|81212981|FG000|Overall Study|Injury|2|||
27831174|NCT01735994|81212982|FG001|Overall Study|Injury|0|||
27831175|NCT01735994|81212981|FG000|Overall Study|Kicked off team|5|||
27831176|NCT01735994|81212982|FG001|Overall Study|Kicked off team|0|||
27831177|NCT01735994|81212981|FG000|Overall Study|Lost to Follow-up|50|||
27831178|NCT01735994|81212982|FG001|Overall Study|Lost to Follow-up|62|||
27831179|NCT00881751|81212983|FG000|Overall Study|Physician Decision|0|||
27831180|NCT00881751|81212984|FG001|Overall Study|Physician Decision|1|||
27831181|NCT00881751|81212983|FG000|Overall Study|Adverse Event|0|||
27831182|NCT00881751|81212984|FG001|Overall Study|Adverse Event|2|||
27831183|NCT00881751|81212983|FG000|Overall Study|Withdrawal by Subject|0|||
27831184|NCT00881751|81212984|FG001|Overall Study|Withdrawal by Subject|2|||
27831185|NCT03086460|81212987|FG000|Study Participants|Lost to Follow-up|2|||
27831186|NCT03086460|81212987|FG000|Study Participants|Protocol Violation|1|||
27831187|NCT03086460|81212987|FG000|Study Participants|Withdrawal by Subject|6|||
27831188|NCT03086460|81212987|FG000|Treatment A|Lost to Follow-up|1|||
27831189|NCT03086460|81212987|FG000|Treatment A|Protocol Violation|1|||
27831190|NCT03086460|81212987|FG000|Treatment A|Withdrawal by Subject|2|||
27831191|NCT03086460|81212987|FG000|Treatment C|Withdrawal by Subject|2|||
27831192|NCT03086460|81212987|FG000|Treatment E|Lost to Follow-up|1|||
27885509|NCT01894100|81415370|FG001|Overall Study|Lost to Follow-up|1|||
27885510|NCT01894100|81415369|FG000|Overall Study|Withdrawal by Subject|3|||
27885511|NCT01894100|81415370|FG001|Overall Study|Withdrawal by Subject|0|||
27885512|NCT01672710|81415371|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
27885513|NCT01672710|81415372|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
27885514|NCT01672710|81415371|FG000|3 Month Follow up|Lost to Follow-up|2|||
27699392|NCT02974088|80736633|FG001|Overall Study|Lost to Follow-up|2|||
27699393|NCT02974088|80736632|FG000|Overall Study|Adverse Event|0|||
27699394|NCT02974088|80736633|FG001|Overall Study|Adverse Event|1|||
27699395|NCT00059839|80736634|FG000|Overall Study|Death|1|||
27699396|NCT00059839|80736635|FG001|Overall Study|Death|1|||
27699397|NCT00059839|80736634|FG000|Overall Study|Lack of Efficacy|6|||
27699398|NCT00059839|80736635|FG001|Overall Study|Lack of Efficacy|5|||
27699399|NCT00059839|80736634|FG000|Overall Study|Lost to Follow-up|2|||
27699400|NCT00059839|80736635|FG001|Overall Study|Lost to Follow-up|0|||
27699401|NCT00059839|80736634|FG000|Overall Study|Physician Decision|1|||
27699402|NCT00059839|80736635|FG001|Overall Study|Physician Decision|2|||
27699403|NCT00059839|80736634|FG000|Overall Study|Withdrawal by Subject|1|||
27699404|NCT00059839|80736635|FG001|Overall Study|Withdrawal by Subject|6|||
27699405|NCT00059839|80736634|FG000|Overall Study|Ineligible|1|||
27699406|NCT00059839|80736635|FG001|Overall Study|Ineligible|3|||
27699407|NCT01446016|80736636|FG000|Overall Study|Lost to Follow-up|3|||
27885515|NCT01672710|81415372|FG001|3 Month Follow up|Lost to Follow-up|3|||
27831193|NCT03086460|81212987|FG000|Treatment E|Withdrawal by Subject|3|||
27831194|NCT00836472|81212988|FG000|Washout|Adverse Event|1|||
27831195|NCT00836472|81212989|FG001|Washout|Adverse Event|2|||
27831196|NCT00836472|81212988|FG000|Washout|Withdrawal by Subject|1|||
27831197|NCT00836472|81212989|FG001|Washout|Withdrawal by Subject|1|||
27831198|NCT02358538|81212997|FG000|Through Week 26|Adverse Event|0|||
27831199|NCT02358538|81212998|FG001|Through Week 26|Adverse Event|1|||
27831200|NCT02358538|81212999|FG002|Through Week 26|Adverse Event|1|||
27831201|NCT02358538|81213000|FG003|Through Week 26|Adverse Event|2|||
27831202|NCT02358538|81212997|FG000|Through Week 26|Lack of Efficacy|1|||
27831203|NCT02358538|81212998|FG001|Through Week 26|Lack of Efficacy|1|||
27831204|NCT02358538|81212999|FG002|Through Week 26|Lack of Efficacy|3|||
27831205|NCT02358538|81213000|FG003|Through Week 26|Lack of Efficacy|3|||
27831206|NCT02358538|81212997|FG000|Through Week 26|Withdrawal by Subject|1|||
27831207|NCT02358538|81212998|FG001|Through Week 26|Withdrawal by Subject|0|||
27831208|NCT02358538|81212999|FG002|Through Week 26|Withdrawal by Subject|0|||
27831209|NCT02358538|81213000|FG003|Through Week 26|Withdrawal by Subject|0|||
27885516|NCT01672710|81415371|FG000|3 Month Follow up|follow up due after termination date|4|||
27831210|NCT02358538|81212997|FG000|Through Week 26|Non-Compliance|0|||
27831211|NCT02358538|81212998|FG001|Through Week 26|Non-Compliance|0|||
27831212|NCT02358538|81212999|FG002|Through Week 26|Non-Compliance|1|||
27831213|NCT02358538|81213000|FG003|Through Week 26|Non-Compliance|0|||
27831214|NCT02358538|81212997|FG000|Through Week 26|Family did not see benefit from IP|1|||
27831215|NCT02358538|81212998|FG001|Through Week 26|Family did not see benefit from IP|0|||
27831216|NCT02358538|81212999|FG002|Through Week 26|Family did not see benefit from IP|0|||
27831217|NCT02358538|81213000|FG003|Through Week 26|Family did not see benefit from IP|0|||
27831218|NCT02358538|81212997|FG000|52 Week Extension Period|Lack of Efficacy|0|||
27831219|NCT02358538|81212998|FG001|52 Week Extension Period|Lack of Efficacy|0|||
27831220|NCT02358538|81212999|FG002|52 Week Extension Period|Lack of Efficacy|2|||
27831221|NCT02358538|81213000|FG003|52 Week Extension Period|Lack of Efficacy|4|||
27831222|NCT00115063|81213001|FG000|Overall Study|Lost to Follow-up|98|||
27831223|NCT00115063|81213002|FG001|Overall Study|Lost to Follow-up|104|||
27885517|NCT01672710|81415372|FG001|3 Month Follow up|follow up due after termination date|1|||
27885518|NCT03086967|81415373|FG000|Overall Study|Screen Failure|2|||
27885519|NCT03086967|81415374|FG001|Overall Study|Screen Failure|2|||
27831224|NCT00115063|81213001|FG000|Overall Study|Death|1|||
27831225|NCT00115063|81213002|FG001|Overall Study|Death|0|||
27831226|NCT00828321|81213003|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
27831227|NCT00828321|81213004|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
27831228|NCT00828321|81213003|FG000|Second Intervention|Protocol Violation|0|||
27831229|NCT00828321|81213004|FG001|Second Intervention|Protocol Violation|1|||
27699408|NCT01446016|80736636|FG000|Overall Study|Withdrawal by Subject|1|||
27699409|NCT01446016|80736636|FG000|Overall Study|Toxicity|3|||
27699410|NCT00705432|80736637|FG000|Treatment Period|Adverse Event|45|||
27699411|NCT00705432|80736638|FG001|Treatment Period|Adverse Event|37|||
27699412|NCT00705432|80736639|FG002|Treatment Period|Adverse Event|51|||
27559877|NCT04273217|80237774|FG001|Overall Study|Participant non-compliance|0|||
27559878|NCT04273217|80237775|FG002|Overall Study|Participant non-compliance|0|||
27559879|NCT04273217|80237776|FG003|Overall Study|Participant non-compliance|0|||
27559880|NCT04273217|80237777|FG004|Overall Study|Participant non-compliance|1|||
27559881|NCT04273217|80237778|FG005|Overall Study|Participant non-compliance|0|||
27559882|NCT04273217|80237773|FG000|Overall Study|Positive urine drug screen|1|||
27559883|NCT04273217|80237774|FG001|Overall Study|Positive urine drug screen|0|||
27559884|NCT04273217|80237775|FG002|Overall Study|Positive urine drug screen|1|||
27559885|NCT04273217|80237776|FG003|Overall Study|Positive urine drug screen|0|||
27559886|NCT04273217|80237777|FG004|Overall Study|Positive urine drug screen|0|||
27885520|NCT01568034|81415377|FG000|Overall Study|Withdrawal by Subject|1|||
27885521|NCT01568034|81415378|FG001|Overall Study|Withdrawal by Subject|0|||
27559887|NCT04273217|80237778|FG005|Overall Study|Positive urine drug screen|1|||
27885522|NCT01568034|81415379|FG002|Overall Study|Withdrawal by Subject|0|||
27885523|NCT01568034|81415380|FG003|Overall Study|Withdrawal by Subject|0|||
27885524|NCT01437995|81415381|FG000|Overall Study|Lost to Follow-up|11|||
27559888|NCT03564145|80237779|FG000|Overall Study|Adverse Event|4|||
27559889|NCT03564145|80237779|FG000|Overall Study|Lost to Follow-up|21|||
27559890|NCT03564145|80237779|FG000|Overall Study|Protocol Violation|2|||
27559891|NCT03564145|80237779|FG000|Overall Study|Withdrawal by Subject|48|||
27885525|NCT01437995|81415382|FG001|Overall Study|Lost to Follow-up|18|||
27885526|NCT01437995|81415383|FG002|Overall Study|Lost to Follow-up|20|||
27885527|NCT02609607|81415384|FG000|Overall Study|Lost to Follow-up|0|||
27885528|NCT02609607|81415385|FG001|Overall Study|Lost to Follow-up|1|||
27885529|NCT01077154|81415386|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
27885530|NCT01077154|81415387|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
27885531|NCT01077154|81415386|FG000|Overall Study|Withdrawal by Subject|369|||
27885532|NCT01077154|81415387|FG001|Overall Study|Withdrawal by Subject|385|||
27885533|NCT01077154|81415386|FG000|Overall Study|Death|215|||
27885534|NCT01077154|81415387|FG001|Overall Study|Death|214|||
27885535|NCT01077154|81415386|FG000|Overall Study|Lost to Follow-up|43|||
27885536|NCT01077154|81415387|FG001|Overall Study|Lost to Follow-up|35|||
27885537|NCT01077154|81415386|FG000|Overall Study|Noncompliance|22|||
27885538|NCT01077154|81415387|FG001|Overall Study|Noncompliance|20|||
27559892|NCT03564145|80237779|FG000|Overall Study|Study Terminated by Sponsor|146|||
27559893|NCT03564145|80237779|FG000|Overall Study|Physician Decision|1|||
27559894|NCT03564145|80237779|FG000|Overall Study|Other Than Specified|1|||
27559895|NCT03564145|80237779|FG000|Overall Study|Pregnancy|1|||
27559896|NCT00100815|80237780|FG000|Overall Study|Progression|24|||
27559897|NCT00100815|80237780|FG000|Overall Study|Adverse Event|18|||
27559898|NCT00100815|80237780|FG000|Overall Study|Death|4|||
27559899|NCT00100815|80237780|FG000|Overall Study|Other|3|||
27559900|NCT00728130|80237782|FG000|Overall Study|Withdrawal by Subject|1|||
27559901|NCT00728130|80237782|FG000|Overall Study|Paperwork not completed in time|1|||
27559902|NCT00728130|80237782|FG000|Overall Study|Physician Decision|1|||
27559903|NCT00453544|80237783|FG000|Overall Study|Withdrawal by Subject|1|||
27831230|NCT02704091|81213007|FG000|Overall Study|Adverse Event|4|||
27885539|NCT01077154|81415386|FG000|Overall Study|Disease Progression|18|||
27885540|NCT01077154|81415387|FG001|Overall Study|Disease Progression|20|||
27885541|NCT01077154|81415386|FG000|Overall Study|Ineligibility Determined|10|||
27885542|NCT01077154|81415387|FG001|Overall Study|Ineligibility Determined|14|||
27885543|NCT01077154|81415386|FG000|Overall Study|Other|14|||
27885544|NCT01077154|81415387|FG001|Overall Study|Other|11|||
27885545|NCT01077154|81415386|FG000|Overall Study|Adverse Event|9|||
27885546|NCT01077154|81415387|FG001|Overall Study|Adverse Event|9|||
27885547|NCT01077154|81415386|FG000|Overall Study|Administrative Decision|1|||
27885548|NCT01077154|81415387|FG001|Overall Study|Administrative Decision|6|||
27885549|NCT01077154|81415386|FG000|Overall Study|Protocol Deviation|1|||
27885550|NCT01077154|81415387|FG001|Overall Study|Protocol Deviation|0|||
27885551|NCT00661609|81415388|FG000|Overall Study|Adverse Event|4|||
27885552|NCT00661609|81415388|FG000|Overall Study|Death|20|||
27885553|NCT00661609|81415388|FG000|Overall Study|Withdrawal by Subject|2|||
27885554|NCT00661609|81415388|FG000|Overall Study|PI Decision|1|||
27885555|NCT00661609|81415388|FG000|Overall Study|Survival follow up stage discontinued|11|||
27885556|NCT00661609|81415388|FG000|Overall Study|Disease progression|3|||
27885557|NCT02640677|81415389|FG000|Overall Study|Lost to Follow-up|1|||
27885558|NCT02640677|81415389|FG000|Overall Study|Withdrawal by Subject|1|||
27885559|NCT01972438|81415392|FG000|Baseline-Month 3 Crossover Period|Death|1|||
27885560|NCT01972438|81415393|FG001|Baseline-Month 3 Crossover Period|Death|0|||
27885561|NCT01972438|81415392|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
27885562|NCT01972438|81415393|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
27885563|NCT01972438|81415392|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
27885564|NCT01972438|81415393|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
27885565|NCT01972438|81415392|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
27885566|NCT01972438|81415393|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
27559904|NCT00453544|80237784|FG001|Overall Study|Withdrawal by Subject|0|||
27559905|NCT00453544|80237785|FG002|Overall Study|Withdrawal by Subject|0|||
27831231|NCT02704091|81213008|FG001|Overall Study|Adverse Event|3|||
27831232|NCT02704091|81213007|FG000|Overall Study|Protocol Violation|5|||
27831233|NCT02704091|81213008|FG001|Overall Study|Protocol Violation|3|||
27831234|NCT02704091|81213007|FG000|Overall Study|Consent withdrawn|4|||
27831235|NCT02704091|81213008|FG001|Overall Study|Consent withdrawn|4|||
27831236|NCT02704091|81213007|FG000|Overall Study|Lost to Follow-up|13|||
27831237|NCT02704091|81213008|FG001|Overall Study|Lost to Follow-up|5|||
27831238|NCT02704091|81213007|FG000|Overall Study|Other|2|||
27885567|NCT01972438|81415392|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
27885568|NCT01972438|81415393|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
27885569|NCT01972438|81415392|FG000|Months 6-12 Study Period|Death|1|||
27559906|NCT00453544|80237786|FG003|Overall Study|Withdrawal by Subject|0|||
27559907|NCT00453544|80237783|FG000|Overall Study|Primary outcome measure not completed|1|||
27831239|NCT02704091|81213008|FG001|Overall Study|Other|8|||
27831240|NCT02061280|81213014|FG000|Overall Study|Protocol Violation|12|||
27831241|NCT02061280|81213015|FG001|Overall Study|Protocol Violation|8|||
27831242|NCT02061280|81213014|FG000|Overall Study|moved out of state|0|||
27831243|NCT02061280|81213015|FG001|Overall Study|moved out of state|1|||
27885570|NCT01972438|81415393|FG001|Months 6-12 Study Period|Death|0|||
27885571|NCT01972438|81415392|FG000|Months 6-12 Study Period|Early Study Closure|2|||
27885572|NCT01972438|81415393|FG001|Months 6-12 Study Period|Early Study Closure|2|||
27885573|NCT01972438|81415392|FG000|Post Month 12 Study Period|Early Study Closure|3|||
27885574|NCT01972438|81415393|FG001|Post Month 12 Study Period|Early Study Closure|4|||
27885575|NCT00959374|81415394|FG000|Overall Study|Withdrawal by Subject|2|||
27885576|NCT00959374|81415394|FG000|Overall Study|Lost to Follow-up|14|||
27885577|NCT00959374|81415394|FG000|Overall Study|Death|1|||
27885578|NCT00959374|81415394|FG000|Overall Study|Protocol Violation|1|||
27885579|NCT00959374|81415394|FG000|Overall Study|Implant Removed/Not Replaced|4|||
27885580|NCT00959374|81415394|FG000|Overall Study|Physician Decision|1|||
27885581|NCT00247611|81415400|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
27885582|NCT00247611|81415401|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
27831244|NCT02061280|81213014|FG000|Overall Study|Withdrawal by Subject|1|||
27831245|NCT02061280|81213015|FG001|Overall Study|Withdrawal by Subject|2|||
27831246|NCT02061280|81213014|FG000|Overall Study|Lost to Follow-up|5|||
27831247|NCT02061280|81213015|FG001|Overall Study|Lost to Follow-up|1|||
27831248|NCT02640235|81213016|FG000|Overall Study|Withdrawal by Subject|7|||
27831249|NCT02640235|81213017|FG001|Overall Study|Withdrawal by Subject|6|||
27831250|NCT02640235|81213016|FG000|Overall Study|Lost to Follow-up|4|||
27831251|NCT02640235|81213017|FG001|Overall Study|Lost to Follow-up|3|||
27831252|NCT02640235|81213016|FG000|Overall Study|Death|2|||
27831253|NCT02640235|81213017|FG001|Overall Study|Death|3|||
27831254|NCT02640235|81213016|FG000|Overall Study|Other|1|||
27831255|NCT02640235|81213017|FG001|Overall Study|Other|2|||
27831256|NCT00985439|81213022|FG000|Overall Study|Adverse Event|0|||
27831257|NCT00985439|81213023|FG001|Overall Study|Adverse Event|0|||
27831258|NCT00985439|81213024|FG002|Overall Study|Adverse Event|1|||
27831259|NCT00985439|81213025|FG003|Overall Study|Adverse Event|0|||
27831260|NCT02362464|81213026|FG000|Overall Study|Switched to alternative therapy|1|||
27831261|NCT02362464|81213026|FG000|Overall Study|Refused further treatment|1|||
27831262|NCT02362464|81213026|FG000|Overall Study|Physician Decision|4|||
27831263|NCT05752721|81213028|FG000|Overall Study|Lost to Follow-up|22|||
27831264|NCT05752721|81213029|FG001|Overall Study|Lost to Follow-up|20|||
27831265|NCT05752721|81213028|FG000|Overall Study|Withdrawal by Subject|15|||
27831266|NCT05752721|81213029|FG001|Overall Study|Withdrawal by Subject|12|||
27831267|NCT01034358|81213030|FG000|Overall Study|Withdrawal by Subject|1|||
27831268|NCT01034358|81213030|FG000|Overall Study|Protocol Violation|1|||
27831269|NCT01075282|81213031|FG000|Overall Study|Withdrawal by Subject|11|||
27831270|NCT01075282|81213032|FG001|Overall Study|Withdrawal by Subject|7|||
27831271|NCT01075282|81213033|FG002|Overall Study|Withdrawal by Subject|11|||
27831272|NCT01075282|81213031|FG000|Overall Study|Adverse Event|9|||
27831273|NCT01075282|81213032|FG001|Overall Study|Adverse Event|8|||
27831274|NCT01075282|81213033|FG002|Overall Study|Adverse Event|5|||
27831275|NCT01075282|81213031|FG000|Overall Study|Entry Criteria Not Met|3|||
27699413|NCT00705432|80736640|FG003|Treatment Period|Adverse Event|12|||
27699414|NCT00705432|80736641|FG004|Treatment Period|Adverse Event|8|||
27831276|NCT01075282|81213032|FG001|Overall Study|Entry Criteria Not Met|2|||
27831277|NCT01075282|81213033|FG002|Overall Study|Entry Criteria Not Met|0|||
27831278|NCT01075282|81213031|FG000|Overall Study|Lost to Follow-up|3|||
27831279|NCT01075282|81213032|FG001|Overall Study|Lost to Follow-up|3|||
27831280|NCT01075282|81213033|FG002|Overall Study|Lost to Follow-up|3|||
27831281|NCT01075282|81213031|FG000|Overall Study|Physician Decision|3|||
27831282|NCT01075282|81213032|FG001|Overall Study|Physician Decision|3|||
27831283|NCT01075282|81213033|FG002|Overall Study|Physician Decision|3|||
27831284|NCT01075282|81213031|FG000|Overall Study|Lack of Efficacy|1|||
27831285|NCT01075282|81213032|FG001|Overall Study|Lack of Efficacy|1|||
27831286|NCT01075282|81213033|FG002|Overall Study|Lack of Efficacy|0|||
27885583|NCT00247611|81415400|FG000|Baselined|Completed baseline only|9|||
27885584|NCT00247611|81415401|FG001|Baselined|Completed baseline only|8|||
27699415|NCT00705432|80736642|FG005|Treatment Period|Adverse Event|9|||
27831287|NCT01075282|81213031|FG000|Overall Study|Treatment Non-compliance|1|||
27559908|NCT00453544|80237784|FG001|Overall Study|Primary outcome measure not completed|1|||
27831288|NCT01075282|81213032|FG001|Overall Study|Treatment Non-compliance|2|||
27831289|NCT01075282|81213033|FG002|Overall Study|Treatment Non-compliance|2|||
27831290|NCT01075282|81213031|FG000|Overall Study|Protocol Violation|0|||
27831291|NCT01075282|81213032|FG001|Overall Study|Protocol Violation|2|||
27831292|NCT01075282|81213033|FG002|Overall Study|Protocol Violation|1|||
27831293|NCT01075282|81213031|FG000|Overall Study|Death|0|||
27831294|NCT01075282|81213032|FG001|Overall Study|Death|1|||
27831295|NCT01075282|81213033|FG002|Overall Study|Death|2|||
27831296|NCT01686438|81216036|FG000|Overall Study|Lost to Follow-up|8|||
27831297|NCT01686438|81216037|FG001|Overall Study|Lost to Follow-up|9|||
27831298|NCT01686438|81216038|FG002|Overall Study|Lost to Follow-up|10|||
27831299|NCT01686438|81216036|FG000|Overall Study|Adverse Event|0|||
27831300|NCT01686438|81216037|FG001|Overall Study|Adverse Event|0|||
27831301|NCT01686438|81216038|FG002|Overall Study|Adverse Event|1|||
27831302|NCT01686438|81216036|FG000|Overall Study|Protocol Violation|0|||
27831303|NCT01686438|81216037|FG001|Overall Study|Protocol Violation|0|||
27831304|NCT01686438|81216038|FG002|Overall Study|Protocol Violation|1|||
27559909|NCT00453544|80237785|FG002|Overall Study|Primary outcome measure not completed|0|||
27559910|NCT00453544|80237786|FG003|Overall Study|Primary outcome measure not completed|1|||
27559911|NCT02062879|80237787|FG000|Overall Study|Withdrawal by Subject|4|||
27559912|NCT02062879|80237788|FG001|Overall Study|Withdrawal by Subject|1|||
27831305|NCT01686438|81216036|FG000|Overall Study|Withdrawal by Subject|0|||
27831306|NCT01686438|81216037|FG001|Overall Study|Withdrawal by Subject|0|||
27559913|NCT02169739|80237789|FG000|Overall Study|Lost to Follow-up|0|||
27559914|NCT02169739|80237790|FG001|Overall Study|Lost to Follow-up|4|||
27831307|NCT01686438|81216038|FG002|Overall Study|Withdrawal by Subject|1|||
27831308|NCT02264977|81216039|FG000|Overall Study|Death|3|||
27831309|NCT02264977|81216039|FG000|Overall Study|Physician Decision|1|||
27831310|NCT02264977|81216039|FG000|Overall Study|Refuse to return|1|||
27831311|NCT00506831|81216040|FG000|Overall Study|Death|1|||
27831312|NCT00506831|81216040|FG000|Overall Study|Withdrawal by Subject|1|||
27559915|NCT03261947|80237791|FG000|Overall Study|Death|10|||
27699416|NCT00705432|80736637|FG000|Treatment Period|Treatment failure|92|||
27885585|NCT04468347|81415402|FG000|Overall Study|Withdrawal by Subject|0|||
27699417|NCT00705432|80736638|FG001|Treatment Period|Treatment failure|42|||
27559916|NCT03261947|80237792|FG001|Overall Study|Death|13|||
27559917|NCT03261947|80237793|FG002|Overall Study|Death|17|||
27559918|NCT03261947|80237794|FG003|Overall Study|Death|12|||
27559919|NCT03261947|80237795|FG004|Overall Study|Death|8|||
27831313|NCT00730691|81216043|FG000|Overall Study|Adverse Event|4|||
27831314|NCT00730691|81216044|FG001|Overall Study|Adverse Event|8|||
27831315|NCT00730691|81216045|FG002|Overall Study|Adverse Event|11|||
27831316|NCT00730691|81216046|FG003|Overall Study|Adverse Event|11|||
27559920|NCT03261947|80237791|FG000|Overall Study|Lost to Follow-up|0|||
27831317|NCT00730691|81216047|FG004|Overall Study|Adverse Event|23|||
27831318|NCT00730691|81216043|FG000|Overall Study|Lack of Efficacy|4|||
27559921|NCT03261947|80237792|FG001|Overall Study|Lost to Follow-up|0|||
27831319|NCT00730691|81216044|FG001|Overall Study|Lack of Efficacy|4|||
27831320|NCT00730691|81216045|FG002|Overall Study|Lack of Efficacy|2|||
27831321|NCT00730691|81216046|FG003|Overall Study|Lack of Efficacy|1|||
27831322|NCT00730691|81216047|FG004|Overall Study|Lack of Efficacy|1|||
27831323|NCT00730691|81216043|FG000|Overall Study|Non-compliance with Study Drug|6|||
27831324|NCT00730691|81216044|FG001|Overall Study|Non-compliance with Study Drug|1|||
27831325|NCT00730691|81216045|FG002|Overall Study|Non-compliance with Study Drug|6|||
27831326|NCT00730691|81216046|FG003|Overall Study|Non-compliance with Study Drug|3|||
27831327|NCT00730691|81216047|FG004|Overall Study|Non-compliance with Study Drug|3|||
27559922|NCT03261947|80237793|FG002|Overall Study|Lost to Follow-up|2|||
27699418|NCT00705432|80736639|FG002|Treatment Period|Treatment failure|33|||
27699419|NCT00705432|80736640|FG003|Treatment Period|Treatment failure|25|||
27699420|NCT00705432|80736641|FG004|Treatment Period|Treatment failure|13|||
27831328|NCT00730691|81216043|FG000|Overall Study|Protocol Deviations|3|||
27831329|NCT00730691|81216044|FG001|Overall Study|Protocol Deviations|5|||
27831330|NCT00730691|81216045|FG002|Overall Study|Protocol Deviations|3|||
27831331|NCT00730691|81216046|FG003|Overall Study|Protocol Deviations|7|||
27699421|NCT00705432|80736642|FG005|Treatment Period|Treatment failure|14|||
27831332|NCT00730691|81216047|FG004|Overall Study|Protocol Deviations|5|||
27559923|NCT03261947|80237794|FG003|Overall Study|Lost to Follow-up|1|||
27559924|NCT03261947|80237795|FG004|Overall Study|Lost to Follow-up|0|||
27559925|NCT03261947|80237791|FG000|Overall Study|Withdrawal by Subject|0|||
27559926|NCT03261947|80237792|FG001|Overall Study|Withdrawal by Subject|0|||
27885586|NCT04468347|81415403|FG001|Overall Study|Withdrawal by Subject|1|||
27885587|NCT04468347|81415404|FG002|Overall Study|Withdrawal by Subject|3|||
27885588|NCT04468347|81415405|FG003|Overall Study|Withdrawal by Subject|3|||
27885589|NCT04468347|81415402|FG000|Overall Study|Lost to Follow-up|0|||
27885590|NCT04468347|81415403|FG001|Overall Study|Lost to Follow-up|0|||
27885591|NCT04468347|81415404|FG002|Overall Study|Lost to Follow-up|1|||
27885592|NCT04468347|81415405|FG003|Overall Study|Lost to Follow-up|1|||
27885593|NCT04468347|81415402|FG000|Overall Study|Physician Decision|1|||
27885594|NCT04468347|81415403|FG001|Overall Study|Physician Decision|0|||
27885595|NCT04468347|81415404|FG002|Overall Study|Physician Decision|2|||
27885596|NCT04468347|81415405|FG003|Overall Study|Physician Decision|0|||
27559927|NCT03261947|80237793|FG002|Overall Study|Withdrawal by Subject|3|||
27885597|NCT04468347|81415402|FG000|Overall Study|Protocol Violation|1|||
27885598|NCT04468347|81415403|FG001|Overall Study|Protocol Violation|0|||
27559928|NCT03261947|80237794|FG003|Overall Study|Withdrawal by Subject|0|||
27885599|NCT04468347|81415404|FG002|Overall Study|Protocol Violation|0|||
27559929|NCT03261947|80237795|FG004|Overall Study|Withdrawal by Subject|1|||
27559930|NCT03261947|80237791|FG000|Overall Study|Site Terminated by Sponsor|0|||
27559931|NCT03261947|80237792|FG001|Overall Study|Site Terminated by Sponsor|0|||
27559932|NCT03261947|80237793|FG002|Overall Study|Site Terminated by Sponsor|4|||
27559933|NCT03261947|80237794|FG003|Overall Study|Site Terminated by Sponsor|7|||
27559934|NCT03261947|80237795|FG004|Overall Study|Site Terminated by Sponsor|5|||
27559935|NCT03261947|80237791|FG000|Overall Study|Reason not Specified|2|||
27559936|NCT03261947|80237792|FG001|Overall Study|Reason not Specified|0|||
27559937|NCT03261947|80237793|FG002|Overall Study|Reason not Specified|4|||
27559938|NCT03261947|80237794|FG003|Overall Study|Reason not Specified|1|||
27559939|NCT03261947|80237795|FG004|Overall Study|Reason not Specified|3|||
27559940|NCT00309842|80237796|FG000|Overall Study|Lost to Follow-up|1|||
27559941|NCT01729754|80237797|FG000|Part 1|Adverse Event|2|||
27559942|NCT01729754|80237798|FG001|Part 1|Adverse Event|0|||
27559943|NCT01729754|80237799|FG002|Part 1|Adverse Event|0|||
27559944|NCT01729754|80237800|FG003|Part 1|Adverse Event|1|||
27559945|NCT01729754|80237801|FG004|Part 1|Adverse Event|0|||
27559946|NCT01729754|80237802|FG005|Part 1|Adverse Event|0|||
27559947|NCT01729754|80237803|FG006|Part 1|Adverse Event|2|||
27559948|NCT01729754|80237804|FG007|Part 1|Adverse Event|0|||
27559949|NCT01729754|80237805|FG008|Part 1|Adverse Event|0|||
27559950|NCT01729754|80237806|FG009|Part 1|Adverse Event|5|||
27559951|NCT01729754|80237797|FG000|Part 1|Lack of Efficacy|1|||
27559952|NCT01729754|80237798|FG001|Part 1|Lack of Efficacy|0|||
27559953|NCT01729754|80237799|FG002|Part 1|Lack of Efficacy|0|||
27559954|NCT01729754|80237800|FG003|Part 1|Lack of Efficacy|0|||
27559955|NCT01729754|80237801|FG004|Part 1|Lack of Efficacy|0|||
27559956|NCT01729754|80237802|FG005|Part 1|Lack of Efficacy|0|||
27559957|NCT01729754|80237803|FG006|Part 1|Lack of Efficacy|2|||
27559958|NCT01729754|80237804|FG007|Part 1|Lack of Efficacy|0|||
27559959|NCT01729754|80237805|FG008|Part 1|Lack of Efficacy|0|||
27559960|NCT01729754|80237806|FG009|Part 1|Lack of Efficacy|0|||
27559961|NCT01729754|80237797|FG000|Part 1|Lost to Follow-up|1|||
27559962|NCT01729754|80237798|FG001|Part 1|Lost to Follow-up|0|||
27559963|NCT01729754|80237799|FG002|Part 1|Lost to Follow-up|0|||
27559964|NCT01729754|80237800|FG003|Part 1|Lost to Follow-up|2|||
27559965|NCT01729754|80237801|FG004|Part 1|Lost to Follow-up|0|||
27559966|NCT01729754|80237802|FG005|Part 1|Lost to Follow-up|0|||
27559967|NCT01729754|80237803|FG006|Part 1|Lost to Follow-up|3|||
27559968|NCT01729754|80237804|FG007|Part 1|Lost to Follow-up|0|||
27559969|NCT01729754|80237805|FG008|Part 1|Lost to Follow-up|0|||
27559970|NCT01729754|80237806|FG009|Part 1|Lost to Follow-up|3|||
27559971|NCT01729754|80237797|FG000|Part 1|Non-compliance with Study Drug|1|||
27559972|NCT01729754|80237798|FG001|Part 1|Non-compliance with Study Drug|0|||
27559973|NCT01729754|80237799|FG002|Part 1|Non-compliance with Study Drug|0|||
27559974|NCT01729754|80237800|FG003|Part 1|Non-compliance with Study Drug|0|||
27559975|NCT01729754|80237801|FG004|Part 1|Non-compliance with Study Drug|0|||
27699422|NCT00705432|80736637|FG000|Treatment Period|Non medical reason|26|||
27699423|NCT00705432|80736638|FG001|Treatment Period|Non medical reason|32|||
27699424|NCT00705432|80736639|FG002|Treatment Period|Non medical reason|37|||
27699425|NCT00705432|80736640|FG003|Treatment Period|Non medical reason|4|||
27699426|NCT00705432|80736641|FG004|Treatment Period|Non medical reason|7|||
27699427|NCT00705432|80736642|FG005|Treatment Period|Non medical reason|7|||
27699428|NCT00705432|80736637|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
27559976|NCT01729754|80237802|FG005|Part 1|Non-compliance with Study Drug|0|||
27559977|NCT01729754|80237803|FG006|Part 1|Non-compliance with Study Drug|0|||
27559978|NCT01729754|80237804|FG007|Part 1|Non-compliance with Study Drug|0|||
27559979|NCT01729754|80237805|FG008|Part 1|Non-compliance with Study Drug|0|||
27831333|NCT00730691|81216043|FG000|Overall Study|Withdrawal of Consent|7|||
27831334|NCT00730691|81216044|FG001|Overall Study|Withdrawal of Consent|9|||
27559980|NCT01729754|80237806|FG009|Part 1|Non-compliance with Study Drug|0|||
27559981|NCT01729754|80237797|FG000|Part 1|Physician Decision|0|||
27559982|NCT01729754|80237798|FG001|Part 1|Physician Decision|0|||
27559983|NCT01729754|80237799|FG002|Part 1|Physician Decision|0|||
27559984|NCT01729754|80237800|FG003|Part 1|Physician Decision|0|||
27559985|NCT01729754|80237801|FG004|Part 1|Physician Decision|0|||
27559986|NCT01729754|80237802|FG005|Part 1|Physician Decision|0|||
27559987|NCT01729754|80237803|FG006|Part 1|Physician Decision|0|||
27559988|NCT01729754|80237804|FG007|Part 1|Physician Decision|0|||
27559989|NCT01729754|80237805|FG008|Part 1|Physician Decision|0|||
27699429|NCT00705432|80736638|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
27831335|NCT00730691|81216045|FG002|Overall Study|Withdrawal of Consent|3|||
27831336|NCT00730691|81216046|FG003|Overall Study|Withdrawal of Consent|6|||
27831337|NCT00730691|81216047|FG004|Overall Study|Withdrawal of Consent|3|||
27699430|NCT00705432|80736639|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
27699431|NCT00705432|80736640|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
27699432|NCT00705432|80736641|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
27699433|NCT00705432|80736642|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
27699434|NCT00705432|80736637|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
27699435|NCT00705432|80736638|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
27699436|NCT00705432|80736639|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
27699437|NCT00705432|80736640|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
27831338|NCT00730691|81216043|FG000|Overall Study|Lost to Follow-up|11|||
27831339|NCT00730691|81216044|FG001|Overall Study|Lost to Follow-up|8|||
27831340|NCT00730691|81216045|FG002|Overall Study|Lost to Follow-up|13|||
27831341|NCT00730691|81216046|FG003|Overall Study|Lost to Follow-up|15|||
27831342|NCT00730691|81216047|FG004|Overall Study|Lost to Follow-up|13|||
27559990|NCT01729754|80237806|FG009|Part 1|Physician Decision|4|||
27699438|NCT00705432|80736641|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
27831343|NCT00730691|81216043|FG000|Overall Study|Other|1|||
27831344|NCT00730691|81216044|FG001|Overall Study|Other|1|||
27831345|NCT00730691|81216045|FG002|Overall Study|Other|1|||
27831346|NCT00730691|81216046|FG003|Overall Study|Other|2|||
27559991|NCT01729754|80237797|FG000|Part 1|Pregnancy|0|||
27559992|NCT01729754|80237798|FG001|Part 1|Pregnancy|0|||
27559993|NCT01729754|80237799|FG002|Part 1|Pregnancy|0|||
27559994|NCT01729754|80237800|FG003|Part 1|Pregnancy|1|||
27559995|NCT01729754|80237801|FG004|Part 1|Pregnancy|0|||
27559996|NCT01729754|80237802|FG005|Part 1|Pregnancy|0|||
27559997|NCT01729754|80237803|FG006|Part 1|Pregnancy|0|||
27559998|NCT01729754|80237804|FG007|Part 1|Pregnancy|0|||
27559999|NCT01729754|80237805|FG008|Part 1|Pregnancy|0|||
27560000|NCT01729754|80237806|FG009|Part 1|Pregnancy|1|||
27560001|NCT01729754|80237797|FG000|Part 1|Progressive Disease|0|||
27560002|NCT01729754|80237798|FG001|Part 1|Progressive Disease|0|||
27560003|NCT01729754|80237799|FG002|Part 1|Progressive Disease|0|||
27560004|NCT01729754|80237800|FG003|Part 1|Progressive Disease|0|||
27560005|NCT01729754|80237801|FG004|Part 1|Progressive Disease|0|||
27560006|NCT01729754|80237802|FG005|Part 1|Progressive Disease|0|||
27560007|NCT01729754|80237803|FG006|Part 1|Progressive Disease|0|||
27560008|NCT01729754|80237804|FG007|Part 1|Progressive Disease|0|||
27560009|NCT01729754|80237805|FG008|Part 1|Progressive Disease|0|||
27560010|NCT01729754|80237806|FG009|Part 1|Progressive Disease|1|||
27560011|NCT01729754|80237797|FG000|Part 1|Protocol Violation|2|||
27560012|NCT01729754|80237798|FG001|Part 1|Protocol Violation|0|||
27560013|NCT01729754|80237799|FG002|Part 1|Protocol Violation|0|||
27560014|NCT01729754|80237800|FG003|Part 1|Protocol Violation|1|||
27560015|NCT01729754|80237801|FG004|Part 1|Protocol Violation|0|||
27560016|NCT01729754|80237802|FG005|Part 1|Protocol Violation|0|||
27560017|NCT01729754|80237803|FG006|Part 1|Protocol Violation|1|||
27560018|NCT01729754|80237804|FG007|Part 1|Protocol Violation|0|||
27560019|NCT01729754|80237805|FG008|Part 1|Protocol Violation|0|||
27560020|NCT01729754|80237806|FG009|Part 1|Protocol Violation|0|||
27560021|NCT01729754|80237797|FG000|Part 1|Withdrawal by Subject|5|||
27560022|NCT01729754|80237798|FG001|Part 1|Withdrawal by Subject|0|||
27560023|NCT01729754|80237799|FG002|Part 1|Withdrawal by Subject|0|||
27699439|NCT00705432|80736642|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
27699440|NCT03093350|80736644|FG000|Overall Study|Death|1|||
27831347|NCT00730691|81216047|FG004|Overall Study|Other|2|||
27560024|NCT01729754|80237800|FG003|Part 1|Withdrawal by Subject|7|||
27560025|NCT01729754|80237801|FG004|Part 1|Withdrawal by Subject|0|||
27560026|NCT01729754|80237802|FG005|Part 1|Withdrawal by Subject|0|||
27560027|NCT01729754|80237803|FG006|Part 1|Withdrawal by Subject|5|||
27560028|NCT01729754|80237804|FG007|Part 1|Withdrawal by Subject|0|||
27560029|NCT01729754|80237805|FG008|Part 1|Withdrawal by Subject|0|||
27560030|NCT01729754|80237806|FG009|Part 1|Withdrawal by Subject|6|||
27560031|NCT01729754|80237797|FG000|Part 1|Other Protocol Specified Criteria|2|||
27560032|NCT01729754|80237798|FG001|Part 1|Other Protocol Specified Criteria|0|||
27831348|NCT03499353|81216048|FG000|Treatment|Adverse Event|3|||
27831349|NCT03499353|81216048|FG000|Treatment|Progressive Disease|10|||
27831350|NCT03499353|81216048|FG000|Treatment|Other|1|||
27831351|NCT03499353|81216048|FG000|Treatment|Withdrawal by Subject|2|||
27831352|NCT03499353|81216048|FG000|Long-Term Follow-up|Death|2|||
27831353|NCT03499353|81216048|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
27831354|NCT03499353|81216048|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
27831355|NCT01302548|81216051|FG000|Overall Study|Lost to Follow-up|2|||
27831356|NCT01302548|81216052|FG001|Overall Study|Lost to Follow-up|1|||
27831357|NCT02313558|81216053|FG000|Overall Study|Withdrawal by Subject|2|||
27831358|NCT02313558|81216054|FG001|Overall Study|Withdrawal by Subject|0|||
27831359|NCT02313558|81216053|FG000|Overall Study|Lost to Follow-up|4|||
27831360|NCT02313558|81216054|FG001|Overall Study|Lost to Follow-up|4|||
27831361|NCT04277507|81216055|FG000|Overall Study|Lost to Follow-up|17|||
27831362|NCT04277507|81216055|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
27831363|NCT04277507|81216055|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
27831364|NCT04277507|81216055|FG000|Overall Study|Withdrawal by Subject|3|||
27831365|NCT04277507|81216055|FG000|Overall Study|Death due to COVID-19|1|||
27831366|NCT04277507|81216055|FG000|Overall Study|Data missing for full evaluation|5|||
27831367|NCT01960296|81216056|FG000|Overall Study|Postponed surgery|1|||
27831368|NCT01960296|81216057|FG001|Overall Study|Postponed surgery|0|||
27831369|NCT01960296|81216056|FG000|Overall Study|Received different procedure|1|||
27831370|NCT01960296|81216057|FG001|Overall Study|Received different procedure|3|||
27831371|NCT01660243|81216058|FG000|Overall Study|Adverse Event|1|||
27831372|NCT01660243|81216059|FG001|Overall Study|Adverse Event|0|||
27831373|NCT01660243|81216060|FG002|Overall Study|Adverse Event|1|||
27831374|NCT01660243|81216061|FG003|Overall Study|Adverse Event|0|||
27831375|NCT01660243|81216058|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
27831376|NCT01660243|81216059|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
27831377|NCT01660243|81216060|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
27831378|NCT01660243|81216061|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
27831379|NCT01660243|81216058|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
27831380|NCT01660243|81216059|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
27831381|NCT01660243|81216060|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
27831382|NCT01660243|81216061|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
27831383|NCT01660243|81216058|FG000|Overall Study|Randomization error|0|||
27831384|NCT01660243|81216059|FG001|Overall Study|Randomization error|0|||
27831385|NCT01660243|81216060|FG002|Overall Study|Randomization error|0|||
27831386|NCT01660243|81216061|FG003|Overall Study|Randomization error|1|||
27831387|NCT02336074|81216062|FG000|Overall Study|Adverse Event|0|||
27831388|NCT02336074|81216063|FG001|Overall Study|Adverse Event|2|||
27831389|NCT02441686|81216064|FG000|Induction|Adverse Event|4|||
27831390|NCT02441686|81216064|FG000|Induction|Complicating disease|1|||
27831391|NCT02441686|81216064|FG000|Induction|Physician Decision|1|||
27831392|NCT02441686|81216064|FG000|Induction|Withdrawal by Subject|1|||
27831393|NCT02441686|81216064|FG000|Induction|Did not receive treatment|1|||
27831394|NCT02441686|81216064|FG000|Maintenance|Remaining on Treatment|23|||
27831395|NCT02441686|81216064|FG000|Maintenance|Physician Decision|1|||
27831396|NCT02441686|81216064|FG000|Maintenance|Adverse Event|3|||
27831397|NCT02441686|81216064|FG000|Maintenance|Progressive Disease|10|||
27831398|NCT02441686|81216064|FG000|Maintenance|Withdrawal by Subject|1|||
27831399|NCT00604162|81216065|FG000|Overall Study|Physician Decision|3|||
27831400|NCT00604162|81216065|FG000|Overall Study|Withdrawal by Subject|1|||
27831401|NCT01103713|81216066|FG000|Overall Study|Lost to Follow-up|2|||
27831402|NCT01103713|81216066|FG000|Overall Study|Withdrawal by Subject|8|||
27831403|NCT01103713|81216066|FG000|Overall Study|Study terminated by sponsor|2|||
27831404|NCT01103713|81216066|FG000|Overall Study|Other|1|||
27831405|NCT00663234|81216067|FG000|Overall Study|Not willing to adhere to requirements|1|||
27831406|NCT01647828|81216073|FG000|Overall Study|Death|3|||
27831407|NCT01647828|81216074|FG001|Overall Study|Death|4|||
27831408|NCT01647828|81216075|FG002|Overall Study|Death|4|||
27831409|NCT01647828|81216076|FG003|Overall Study|Death|5|||
27831410|NCT01647828|81216077|FG004|Overall Study|Death|6|||
27831411|NCT01647828|81216078|FG005|Overall Study|Death|3|||
27831412|NCT01647828|81216079|FG006|Overall Study|Death|10|||
27831413|NCT01647828|81216080|FG007|Overall Study|Death|60|||
27831414|NCT01647828|81216081|FG008|Overall Study|Death|71|||
27831415|NCT01647828|81216073|FG000|Overall Study|Withdrawal by Subject|2|||
27831416|NCT01647828|81216074|FG001|Overall Study|Withdrawal by Subject|0|||
27831417|NCT01647828|81216075|FG002|Overall Study|Withdrawal by Subject|0|||
27831418|NCT01647828|81216076|FG003|Overall Study|Withdrawal by Subject|1|||
27831419|NCT01647828|81216077|FG004|Overall Study|Withdrawal by Subject|0|||
27831420|NCT01647828|81216078|FG005|Overall Study|Withdrawal by Subject|0|||
27831421|NCT01647828|81216079|FG006|Overall Study|Withdrawal by Subject|1|||
27831422|NCT01647828|81216080|FG007|Overall Study|Withdrawal by Subject|0|||
27831423|NCT01647828|81216081|FG008|Overall Study|Withdrawal by Subject|2|||
27831424|NCT01647828|81216073|FG000|Overall Study|Study terminated by Sponsor|0|||
27831425|NCT01647828|81216074|FG001|Overall Study|Study terminated by Sponsor|0|||
27831426|NCT01647828|81216075|FG002|Overall Study|Study terminated by Sponsor|0|||
27831427|NCT01647828|81216076|FG003|Overall Study|Study terminated by Sponsor|0|||
27831428|NCT01647828|81216077|FG004|Overall Study|Study terminated by Sponsor|0|||
27831429|NCT01647828|81216078|FG005|Overall Study|Study terminated by Sponsor|0|||
27831430|NCT01647828|81216079|FG006|Overall Study|Study terminated by Sponsor|1|||
27831431|NCT01647828|81216080|FG007|Overall Study|Study terminated by Sponsor|26|||
27831432|NCT01647828|81216081|FG008|Overall Study|Study terminated by Sponsor|16|||
27831433|NCT01647828|81216073|FG000|Overall Study|Lost to Follow-up|0|||
27831434|NCT01647828|81216074|FG001|Overall Study|Lost to Follow-up|0|||
27831435|NCT01647828|81216075|FG002|Overall Study|Lost to Follow-up|0|||
27831436|NCT01647828|81216076|FG003|Overall Study|Lost to Follow-up|0|||
27560033|NCT01729754|80237799|FG002|Part 1|Other Protocol Specified Criteria|0|||
27831437|NCT01647828|81216077|FG004|Overall Study|Lost to Follow-up|0|||
27831438|NCT01647828|81216078|FG005|Overall Study|Lost to Follow-up|0|||
27560034|NCT01729754|80237800|FG003|Part 1|Other Protocol Specified Criteria|0|||
27560035|NCT01729754|80237801|FG004|Part 1|Other Protocol Specified Criteria|0|||
27560036|NCT01729754|80237802|FG005|Part 1|Other Protocol Specified Criteria|0|||
27560037|NCT01729754|80237803|FG006|Part 1|Other Protocol Specified Criteria|1|||
27560038|NCT01729754|80237804|FG007|Part 1|Other Protocol Specified Criteria|0|||
27560039|NCT01729754|80237805|FG008|Part 1|Other Protocol Specified Criteria|0|||
27560040|NCT01729754|80237806|FG009|Part 1|Other Protocol Specified Criteria|4|||
27560041|NCT01729754|80237797|FG000|Part 2|Adverse Event|2|||
27560042|NCT01729754|80237798|FG001|Part 2|Adverse Event|0|||
27560043|NCT01729754|80237799|FG002|Part 2|Adverse Event|0|||
27831439|NCT01647828|81216079|FG006|Overall Study|Lost to Follow-up|0|||
27831440|NCT01647828|81216080|FG007|Overall Study|Lost to Follow-up|2|||
27831441|NCT01647828|81216081|FG008|Overall Study|Lost to Follow-up|0|||
27831442|NCT01906372|81216082|FG000|Overall Study|Withdrawal by Subject|2|||
27831443|NCT00243347|81216086|FG000|Overall Study|Lack of Efficacy|4|||
27831444|NCT00243347|81216086|FG000|Overall Study|Adverse Event|2|||
27831445|NCT00243347|81216086|FG000|Overall Study|Death|1|||
27831446|NCT00243347|81216086|FG000|Overall Study|Withdrawal by Subject|5|||
27831447|NCT00243347|81216086|FG000|Overall Study|Condition worsened|7|||
27831448|NCT00669162|81216087|FG000|Overall Study|Withdrawal by Subject|1|||
27831449|NCT00918645|81216088|FG000|Overall Study|Withdrawal by Subject|1|||
27831450|NCT04633564|81216089|FG000|Period 1|Adverse Event|28|||
27831451|NCT04633564|81216090|FG001|Period 1|Adverse Event|19|||
27831452|NCT04633564|81216089|FG000|Period 1|Death|8|||
27831453|NCT04633564|81216090|FG001|Period 1|Death|7|||
27831454|NCT04633564|81216089|FG000|Period 1|Lost to Follow-up|3|||
27831455|NCT04633564|81216090|FG001|Period 1|Lost to Follow-up|5|||
27831456|NCT04633564|81216089|FG000|Period 1|Physician Decision|4|||
27831457|NCT04633564|81216090|FG001|Period 1|Physician Decision|12|||
27831458|NCT04633564|81216089|FG000|Period 1|Protocol Violation|0|||
27831459|NCT04633564|81216090|FG001|Period 1|Protocol Violation|1|||
27831460|NCT04633564|81216089|FG000|Period 1|Withdrawal by Subject|10|||
27699441|NCT03093350|80736644|FG000|Overall Study|Signed consent, never began treartment|1|||
27699442|NCT02273726|80736645|FG000|Overall Study|Death|70|||
27560044|NCT01729754|80237800|FG003|Part 2|Adverse Event|0|||
27560045|NCT01729754|80237801|FG004|Part 2|Adverse Event|0|||
27560046|NCT01729754|80237802|FG005|Part 2|Adverse Event|0|||
27560047|NCT01729754|80237803|FG006|Part 2|Adverse Event|0|||
27560048|NCT01729754|80237804|FG007|Part 2|Adverse Event|0|||
27560049|NCT01729754|80237805|FG008|Part 2|Adverse Event|1|||
27560050|NCT01729754|80237806|FG009|Part 2|Adverse Event|2|||
27560051|NCT01729754|80237797|FG000|Part 2|Lack of Efficacy|0|||
27699443|NCT02273726|80736646|FG001|Overall Study|Death|62|||
27831461|NCT04633564|81216090|FG001|Period 1|Withdrawal by Subject|8|||
27831462|NCT04633564|81216089|FG000|Period 1|Progressive disease|47|||
27831463|NCT04633564|81216090|FG001|Period 1|Progressive disease|51|||
27831464|NCT04633564|81216089|FG000|Period 1|Terminated by Sponsor|8|||
27831465|NCT04633564|81216090|FG001|Period 1|Terminated by Sponsor|6|||
27831466|NCT04633564|81216089|FG000|Period 2|Adverse Event|3|||
27831467|NCT04633564|81216090|FG001|Period 2|Adverse Event|4|||
27831468|NCT04633564|81216089|FG000|Period 2|Death|0|||
27560052|NCT01729754|80237798|FG001|Part 2|Lack of Efficacy|0|||
27699444|NCT02273726|80736645|FG000|Overall Study|Withdrawal by Subject|41|||
27560053|NCT01729754|80237799|FG002|Part 2|Lack of Efficacy|0|||
27560054|NCT01729754|80237800|FG003|Part 2|Lack of Efficacy|0|||
27560055|NCT01729754|80237801|FG004|Part 2|Lack of Efficacy|0|||
27560056|NCT01729754|80237802|FG005|Part 2|Lack of Efficacy|0|||
27560057|NCT01729754|80237803|FG006|Part 2|Lack of Efficacy|0|||
27560058|NCT01729754|80237804|FG007|Part 2|Lack of Efficacy|0|||
27699445|NCT02273726|80736646|FG001|Overall Study|Withdrawal by Subject|29|||
27699446|NCT02273726|80736645|FG000|Overall Study|Kidney transplant|31|||
27699447|NCT02273726|80736646|FG001|Overall Study|Kidney transplant|39|||
27699448|NCT02273726|80736645|FG000|Overall Study|Physician Decision|30|||
27560059|NCT01729754|80237805|FG008|Part 2|Lack of Efficacy|2|||
27560060|NCT01729754|80237806|FG009|Part 2|Lack of Efficacy|2|||
27560061|NCT01729754|80237797|FG000|Part 2|Lost to Follow-up|0|||
27560062|NCT01729754|80237798|FG001|Part 2|Lost to Follow-up|0|||
27560063|NCT01729754|80237799|FG002|Part 2|Lost to Follow-up|0|||
27560064|NCT01729754|80237800|FG003|Part 2|Lost to Follow-up|2|||
27560065|NCT01729754|80237801|FG004|Part 2|Lost to Follow-up|0|||
27560066|NCT01729754|80237802|FG005|Part 2|Lost to Follow-up|0|||
27560067|NCT01729754|80237803|FG006|Part 2|Lost to Follow-up|0|||
27560068|NCT01729754|80237804|FG007|Part 2|Lost to Follow-up|1|||
27560069|NCT01729754|80237805|FG008|Part 2|Lost to Follow-up|0|||
27560070|NCT01729754|80237806|FG009|Part 2|Lost to Follow-up|2|||
27560071|NCT01729754|80237797|FG000|Part 2|Non-Compliance with Study Drug|0|||
27560072|NCT01729754|80237798|FG001|Part 2|Non-Compliance with Study Drug|0|||
27560073|NCT01729754|80237799|FG002|Part 2|Non-Compliance with Study Drug|0|||
27560074|NCT01729754|80237800|FG003|Part 2|Non-Compliance with Study Drug|0|||
27560075|NCT01729754|80237801|FG004|Part 2|Non-Compliance with Study Drug|0|||
27560076|NCT01729754|80237802|FG005|Part 2|Non-Compliance with Study Drug|0|||
27560077|NCT01729754|80237803|FG006|Part 2|Non-Compliance with Study Drug|0|||
27560078|NCT01729754|80237804|FG007|Part 2|Non-Compliance with Study Drug|0|||
27560079|NCT01729754|80237805|FG008|Part 2|Non-Compliance with Study Drug|0|||
27560080|NCT01729754|80237806|FG009|Part 2|Non-Compliance with Study Drug|1|||
27560081|NCT01729754|80237797|FG000|Part 2|Pregnancy|0|||
27560082|NCT01729754|80237798|FG001|Part 2|Pregnancy|0|||
27699449|NCT02273726|80736646|FG001|Overall Study|Physician Decision|15|||
27699450|NCT02273726|80736645|FG000|Overall Study|Adverse Event|27|||
27699451|NCT02273726|80736646|FG001|Overall Study|Adverse Event|9|||
27699452|NCT02273726|80736645|FG000|Overall Study|Lost to Follow-up|6|||
27699453|NCT02273726|80736646|FG001|Overall Study|Lost to Follow-up|3|||
27699454|NCT02273726|80736645|FG000|Overall Study|Lack of Efficacy|6|||
27699455|NCT02273726|80736646|FG001|Overall Study|Lack of Efficacy|1|||
27699456|NCT02273726|80736645|FG000|Overall Study|Protocol Violation|4|||
27699457|NCT02273726|80736646|FG001|Overall Study|Protocol Violation|0|||
27699458|NCT02273726|80736645|FG000|Overall Study|Other than specified|28|||
27699459|NCT02273726|80736646|FG001|Overall Study|Other than specified|30|||
27560083|NCT01729754|80237799|FG002|Part 2|Pregnancy|0|||
27831469|NCT04633564|81216090|FG001|Period 2|Death|2|||
27831470|NCT04633564|81216089|FG000|Period 2|Lost to Follow-up|0|||
27831471|NCT04633564|81216090|FG001|Period 2|Lost to Follow-up|1|||
27831472|NCT04633564|81216089|FG000|Period 2|Physician Decision|2|||
27831473|NCT04633564|81216090|FG001|Period 2|Physician Decision|4|||
27831474|NCT04633564|81216089|FG000|Period 2|Withdrawal by Subject|5|||
27831475|NCT04633564|81216090|FG001|Period 2|Withdrawal by Subject|1|||
27831476|NCT04633564|81216089|FG000|Period 2|Progressive Disease|74|||
27560084|NCT01729754|80237800|FG003|Part 2|Pregnancy|1|||
27560085|NCT01729754|80237801|FG004|Part 2|Pregnancy|0|||
27560086|NCT01729754|80237802|FG005|Part 2|Pregnancy|0|||
27560087|NCT01729754|80237803|FG006|Part 2|Pregnancy|0|||
27560088|NCT01729754|80237804|FG007|Part 2|Pregnancy|0|||
27560089|NCT01729754|80237805|FG008|Part 2|Pregnancy|0|||
27560090|NCT01729754|80237806|FG009|Part 2|Pregnancy|1|||
27560091|NCT01729754|80237797|FG000|Part 2|Withdrawal by Subject|3|||
27560092|NCT01729754|80237798|FG001|Part 2|Withdrawal by Subject|0|||
27560093|NCT01729754|80237799|FG002|Part 2|Withdrawal by Subject|0|||
27560094|NCT01729754|80237800|FG003|Part 2|Withdrawal by Subject|2|||
27560095|NCT01729754|80237801|FG004|Part 2|Withdrawal by Subject|0|||
27560096|NCT01729754|80237802|FG005|Part 2|Withdrawal by Subject|0|||
27560097|NCT01729754|80237803|FG006|Part 2|Withdrawal by Subject|0|||
27560098|NCT01729754|80237804|FG007|Part 2|Withdrawal by Subject|1|||
27560099|NCT01729754|80237805|FG008|Part 2|Withdrawal by Subject|1|||
27560100|NCT01729754|80237806|FG009|Part 2|Withdrawal by Subject|4|||
27560101|NCT01729754|80237797|FG000|Part 2|Other Protocol Specified Criteria|1|||
27560102|NCT01729754|80237798|FG001|Part 2|Other Protocol Specified Criteria|0|||
27831477|NCT04633564|81216090|FG001|Period 2|Progressive Disease|82|||
27831478|NCT04633564|81216089|FG000|Period 2|Terminated by Sponsor|9|||
27831479|NCT04633564|81216090|FG001|Period 2|Terminated by Sponsor|3|||
27560103|NCT01729754|80237799|FG002|Part 2|Other Protocol Specified Criteria|0|||
27560104|NCT01729754|80237800|FG003|Part 2|Other Protocol Specified Criteria|0|||
27560105|NCT01729754|80237801|FG004|Part 2|Other Protocol Specified Criteria|0|||
27560106|NCT01729754|80237802|FG005|Part 2|Other Protocol Specified Criteria|0|||
27699460|NCT01233869|80736647|FG000|Initial Treatment Period (24 Months)|Death|1|||
27831480|NCT01576705|81216094|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
27831481|NCT01576705|81216095|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
27831482|NCT01576705|81216096|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
27831483|NCT01576705|81216097|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
27831484|NCT01576705|81216094|FG000|Overall Study|invalid ICF|0|||
27831485|NCT01576705|81216095|FG001|Overall Study|invalid ICF|1|||
27831486|NCT01576705|81216096|FG002|Overall Study|invalid ICF|0|||
27831487|NCT01576705|81216097|FG003|Overall Study|invalid ICF|0|||
27831488|NCT03123094|81216098|FG000|Overall Study|Withdrawal by Subject|0|||
27699461|NCT01233869|80736648|FG001|Initial Treatment Period (24 Months)|Death|0|||
27699462|NCT01233869|80736649|FG002|Initial Treatment Period (24 Months)|Death|0|||
27699463|NCT01233869|80736650|FG003|Initial Treatment Period (24 Months)|Death|0|||
27699464|NCT01233869|80736647|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
27699465|NCT01233869|80736648|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
27699466|NCT01233869|80736649|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
27699467|NCT01233869|80736650|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
27699468|NCT01233869|80736647|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
27699469|NCT01233869|80736648|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
27699470|NCT01233869|80736649|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
27831489|NCT03123094|81216099|FG001|Overall Study|Withdrawal by Subject|2|||
27831490|NCT03123094|81216100|FG002|Overall Study|Withdrawal by Subject|1|||
27699471|NCT01233869|80736650|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
27699472|NCT01233869|80736647|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
27699473|NCT01233869|80736648|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
27699474|NCT01233869|80736649|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
27699475|NCT01233869|80736650|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
27699476|NCT01233869|80736647|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
27699477|NCT01233869|80736648|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
27560107|NCT01729754|80237803|FG006|Part 2|Other Protocol Specified Criteria|0|||
27560108|NCT01729754|80237804|FG007|Part 2|Other Protocol Specified Criteria|1|||
27560109|NCT01729754|80237805|FG008|Part 2|Other Protocol Specified Criteria|0|||
27560110|NCT01729754|80237806|FG009|Part 2|Other Protocol Specified Criteria|0|||
27560111|NCT01729754|80237797|FG000|Part 3|Adverse Event|0|||
27560112|NCT01729754|80237798|FG001|Part 3|Adverse Event|0|||
27560113|NCT01729754|80237799|FG002|Part 3|Adverse Event|1|||
27560114|NCT01729754|80237800|FG003|Part 3|Adverse Event|0|||
27560115|NCT01729754|80237801|FG004|Part 3|Adverse Event|0|||
27560116|NCT01729754|80237802|FG005|Part 3|Adverse Event|5|||
27560117|NCT01729754|80237803|FG006|Part 3|Adverse Event|0|||
27885600|NCT04468347|81415405|FG003|Overall Study|Protocol Violation|0|||
27885601|NCT00474045|81415406|FG000|Overall Study|Adverse Event|18|||
27885602|NCT00474045|81415407|FG001|Overall Study|Adverse Event|8|||
27885603|NCT00474045|81415406|FG000|Overall Study|Unclassified|1|||
27885604|NCT00474045|81415407|FG001|Overall Study|Unclassified|3|||
27885605|NCT00474045|81415406|FG000|Overall Study|Lack of Efficacy|0|||
27885606|NCT00474045|81415407|FG001|Overall Study|Lack of Efficacy|9|||
27885607|NCT00474045|81415406|FG000|Overall Study|Lost to Follow-up|1|||
27885608|NCT00474045|81415407|FG001|Overall Study|Lost to Follow-up|1|||
27885609|NCT00474045|81415406|FG000|Overall Study|Protocol Violation|10|||
27885610|NCT00474045|81415407|FG001|Overall Study|Protocol Violation|12|||
27885611|NCT00474045|81415406|FG000|Overall Study|Withdrawal by Subject|16|||
27885612|NCT00474045|81415407|FG001|Overall Study|Withdrawal by Subject|18|||
27885613|NCT00474045|81415406|FG000|Overall Study|Withdrawal criteria|60|||
27885614|NCT00474045|81415407|FG001|Overall Study|Withdrawal criteria|50|||
27885615|NCT02841280|81415411|FG000|Overall Study|Adverse Event|2|||
27885616|NCT02841280|81415412|FG001|Overall Study|Adverse Event|1|||
27560118|NCT01729754|80237804|FG007|Part 3|Adverse Event|0|||
27885617|NCT02841280|81415411|FG000|Overall Study|Death|1|||
27885618|NCT02841280|81415412|FG001|Overall Study|Death|0|||
27885619|NCT02841280|81415411|FG000|Overall Study|Lost to Follow-up|2|||
27885620|NCT02841280|81415412|FG001|Overall Study|Lost to Follow-up|2|||
27885621|NCT02841280|81415411|FG000|Overall Study|Withdrawal by Subject|7|||
27885622|NCT02841280|81415412|FG001|Overall Study|Withdrawal by Subject|3|||
27699478|NCT01233869|80736649|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
27699479|NCT01233869|80736650|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
27699480|NCT01233869|80736647|FG000|Extended Treatment Period (46 Months)|Other|3|||
27699481|NCT01233869|80736648|FG001|Extended Treatment Period (46 Months)|Other|0|||
27699482|NCT01233869|80736649|FG002|Extended Treatment Period (46 Months)|Other|0|||
27699483|NCT01233869|80736650|FG003|Extended Treatment Period (46 Months)|Other|3|||
27699484|NCT01233869|80736647|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
27699485|NCT01233869|80736648|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
27699486|NCT01233869|80736649|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
27699487|NCT01233869|80736650|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
27699488|NCT00352885|80736653|FG000|Overall Study|Withdrawal by Subject|0|||
27699489|NCT00352885|80736654|FG001|Overall Study|Withdrawal by Subject|3|||
27699490|NCT00352885|80736653|FG000|Overall Study|Development of major depression|0|||
27699491|NCT00352885|80736654|FG001|Overall Study|Development of major depression|1|||
27699492|NCT00352885|80736653|FG000|Overall Study|Progression of metastatic melanoma|5|||
27699493|NCT00352885|80736654|FG001|Overall Study|Progression of metastatic melanoma|3|||
27699494|NCT00352885|80736653|FG000|Overall Study|Side effects of IL-2 administration|1|||
27699495|NCT00352885|80736654|FG001|Overall Study|Side effects of IL-2 administration|0|||
27699496|NCT01009554|80736661|FG000|Overall Study|Adverse Event|1|||
27699497|NCT01009554|80736662|FG001|Overall Study|Adverse Event|1|||
27699498|NCT01009554|80736661|FG000|Overall Study|Withdrawal by Subject|1|||
27699499|NCT01009554|80736662|FG001|Overall Study|Withdrawal by Subject|3|||
27699500|NCT01009554|80736661|FG000|Overall Study|Noncompliant with Study Product|0|||
27699501|NCT01009554|80736662|FG001|Overall Study|Noncompliant with Study Product|3|||
27699502|NCT00604279|80736663|FG000|Overall Study|Lack of Efficacy|22|||
27699503|NCT00604279|80736664|FG001|Overall Study|Lack of Efficacy|9|||
27699504|NCT00604279|80736663|FG000|Overall Study|Lost to Follow-up|9|||
27699505|NCT00604279|80736664|FG001|Overall Study|Lost to Follow-up|14|||
27699506|NCT00604279|80736663|FG000|Overall Study|Pregnancy|2|||
27699507|NCT00604279|80736664|FG001|Overall Study|Pregnancy|0|||
27699508|NCT00604279|80736663|FG000|Overall Study|Protocol Violation|3|||
27699509|NCT00604279|80736664|FG001|Overall Study|Protocol Violation|1|||
27699510|NCT00604279|80736663|FG000|Overall Study|Withdrawal by Subject|16|||
27699511|NCT00604279|80736664|FG001|Overall Study|Withdrawal by Subject|5|||
27699512|NCT00604279|80736663|FG000|Overall Study|Adverse Event|4|||
27699513|NCT00604279|80736664|FG001|Overall Study|Adverse Event|5|||
27699514|NCT00604279|80736663|FG000|Overall Study|Other|8|||
27699515|NCT00604279|80736664|FG001|Overall Study|Other|4|||
27699516|NCT04540133|80736665|FG000|Overall Study|Lost to Follow-up|1|||
27699517|NCT04540133|80736666|FG001|Overall Study|Lost to Follow-up|0|||
27699518|NCT00597753|80736667|FG000|Overall Study|Adverse Event|6|||
27699519|NCT00597753|80736668|FG001|Overall Study|Adverse Event|2|||
27699520|NCT00597753|80736667|FG000|Overall Study|Death|55|||
27699521|NCT00597753|80736668|FG001|Overall Study|Death|29|||
27699522|NCT00597753|80736667|FG000|Overall Study|Lack of Efficacy|2|||
27699523|NCT00597753|80736668|FG001|Overall Study|Lack of Efficacy|0|||
27699524|NCT00597753|80736667|FG000|Overall Study|Lost to Follow-up|10|||
27699525|NCT00597753|80736668|FG001|Overall Study|Lost to Follow-up|3|||
27699526|NCT00597753|80736667|FG000|Overall Study|Physician Decision|5|||
27699527|NCT00597753|80736668|FG001|Overall Study|Physician Decision|1|||
27699528|NCT00597753|80736667|FG000|Overall Study|Pregnancy|1|||
27699529|NCT00597753|80736668|FG001|Overall Study|Pregnancy|0|||
27699530|NCT00597753|80736667|FG000|Overall Study|Withdrawal by Subject|35|||
27699531|NCT00597753|80736668|FG001|Overall Study|Withdrawal by Subject|12|||
27699532|NCT00597753|80736667|FG000|Overall Study|Discontinued Dialysis|0|||
27699533|NCT00597753|80736668|FG001|Overall Study|Discontinued Dialysis|1|||
27699534|NCT00597753|80736667|FG000|Overall Study|Never dosed|2|||
27699535|NCT00597753|80736668|FG001|Overall Study|Never dosed|0|||
27699536|NCT00597753|80736667|FG000|Overall Study|Noncompliance|2|||
27699537|NCT00597753|80736668|FG001|Overall Study|Noncompliance|1|||
27699538|NCT00597753|80736667|FG000|Overall Study|Relocation|17|||
27699539|NCT00597753|80736668|FG001|Overall Study|Relocation|6|||
27831491|NCT03123094|81216101|FG003|Overall Study|Withdrawal by Subject|0|||
27831492|NCT03123094|81216102|FG004|Overall Study|Withdrawal by Subject|1|||
27831493|NCT00540423|81216103|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27831494|NCT00540423|81216104|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27699540|NCT00597753|80736667|FG000|Overall Study|Renal transplant|10|||
27699541|NCT00597753|80736668|FG001|Overall Study|Renal transplant|3|||
27699542|NCT00597753|80736667|FG000|Overall Study|Site closed by sponsor|19|||
27699543|NCT00597753|80736668|FG001|Overall Study|Site closed by sponsor|7|||
27699544|NCT00597753|80736667|FG000|Overall Study|Site elected to close|2|||
27699545|NCT00597753|80736668|FG001|Overall Study|Site elected to close|4|||
27699546|NCT01822522|80736673|FG000|Overall Study|Adverse Event|1|||
27699547|NCT01822522|80736674|FG001|Overall Study|Adverse Event|1|||
27831495|NCT00540423|81216105|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27831496|NCT00540423|81216103|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
27699548|NCT01822522|80736675|FG002|Overall Study|Adverse Event|1|||
27699549|NCT01822522|80736676|FG003|Overall Study|Adverse Event|0|||
27699550|NCT01822522|80736677|FG004|Overall Study|Adverse Event|0|||
27699551|NCT01822522|80736678|FG005|Overall Study|Adverse Event|1|||
27699552|NCT01822522|80736673|FG000|Overall Study|Death|3|||
27699553|NCT01822522|80736674|FG001|Overall Study|Death|0|||
27699554|NCT01822522|80736675|FG002|Overall Study|Death|2|||
27699555|NCT01822522|80736676|FG003|Overall Study|Death|0|||
27885623|NCT02841280|81415411|FG000|Overall Study|Stop Point: BP above threshold|2|||
27885624|NCT02841280|81415412|FG001|Overall Study|Stop Point: BP above threshold|0|||
27885625|NCT00900159|81415419|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
27699556|NCT01822522|80736677|FG004|Overall Study|Death|0|||
27699557|NCT01822522|80736678|FG005|Overall Study|Death|0|||
27699558|NCT01822522|80736673|FG000|Overall Study|Lost to Follow-up|0|||
27699559|NCT01822522|80736674|FG001|Overall Study|Lost to Follow-up|0|||
27885626|NCT00900159|81415420|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
27885627|NCT00685399|81415421|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27885628|NCT00685399|81415422|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27699560|NCT01822522|80736675|FG002|Overall Study|Lost to Follow-up|1|||
27699561|NCT01822522|80736676|FG003|Overall Study|Lost to Follow-up|1|||
27699562|NCT01822522|80736677|FG004|Overall Study|Lost to Follow-up|0|||
27699563|NCT01822522|80736678|FG005|Overall Study|Lost to Follow-up|1|||
27699564|NCT01822522|80736673|FG000|Overall Study|Withdrawal by Subject|0|||
27699565|NCT01822522|80736674|FG001|Overall Study|Withdrawal by Subject|0|||
27699566|NCT01822522|80736675|FG002|Overall Study|Withdrawal by Subject|0|||
27699567|NCT01822522|80736676|FG003|Overall Study|Withdrawal by Subject|1|||
27699568|NCT01822522|80736677|FG004|Overall Study|Withdrawal by Subject|0|||
27699569|NCT01822522|80736678|FG005|Overall Study|Withdrawal by Subject|0|||
27699570|NCT01822522|80736673|FG000|Overall Study|Lack of Efficacy|0|||
27699571|NCT01822522|80736674|FG001|Overall Study|Lack of Efficacy|0|||
27699572|NCT01822522|80736675|FG002|Overall Study|Lack of Efficacy|0|||
27699573|NCT01822522|80736676|FG003|Overall Study|Lack of Efficacy|0|||
27699574|NCT01822522|80736677|FG004|Overall Study|Lack of Efficacy|0|||
27699575|NCT01822522|80736678|FG005|Overall Study|Lack of Efficacy|2|||
27699576|NCT04217590|80736679|FG000|Overall Study|Other|1|||
27699577|NCT04217590|80736680|FG001|Overall Study|Other|1|||
27699578|NCT04217590|80736679|FG000|Overall Study|Withdrawal by Subject|3|||
27699579|NCT04217590|80736680|FG001|Overall Study|Withdrawal by Subject|1|||
27699580|NCT04217590|80736679|FG000|Overall Study|Death|0|||
27699581|NCT04217590|80736680|FG001|Overall Study|Death|1|||
27699582|NCT02460497|80736683|FG000|Overall Study|Participant Requested Withdrawal|4|||
27699583|NCT02460497|80736683|FG000|Overall Study|Non-Compliance|1|||
27699584|NCT02460497|80736683|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
27699585|NCT02460497|80736683|FG000|Overall Study|Lost to Follow-up|2|||
27699586|NCT02460497|80736683|FG000|Overall Study|Investigator Decision|1|||
27699587|NCT00795951|80736684|FG000|Overall Study|Lost to Follow-up|1|||
27699588|NCT00795951|80736684|FG000|Overall Study|Withdrawal by Subject|1|||
27699589|NCT01605253|80736685|FG000|Overall Study|Physician Decision|3|||
27699590|NCT01605253|80736686|FG001|Overall Study|Physician Decision|2|||
27699591|NCT01605253|80736685|FG000|Overall Study|Lost to Follow-up|3|||
27699592|NCT01605253|80736686|FG001|Overall Study|Lost to Follow-up|1|||
27699593|NCT03334409|80736687|FG000|Overall Study|Did not meet inclusion criteria|1|||
27699594|NCT03334409|80736688|FG001|Overall Study|Did not meet inclusion criteria|0|||
27699595|NCT00388154|80736689|FG000|Overall Study|Withdrawal by Subject|1|||
27699596|NCT01776424|80736694|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
27699597|NCT01776424|80736695|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
27885629|NCT00685399|81415423|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27885630|NCT00685399|81415424|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27885631|NCT00685399|81415425|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27885632|NCT00685399|81415426|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27885633|NCT00685399|81415427|FG006|Treatment Period 1|Withdrawal by Subject|0|||
27885634|NCT00685399|81415428|FG007|Treatment Period 1|Withdrawal by Subject|0|||
27885635|NCT00685399|81415421|FG000|Treatment Period 1|Protocol Violation|1|||
27885636|NCT00685399|81415422|FG001|Treatment Period 1|Protocol Violation|0|||
27885637|NCT00685399|81415423|FG002|Treatment Period 1|Protocol Violation|0|||
27699598|NCT01776424|80736696|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
27699599|NCT01776424|80736694|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
27885638|NCT00685399|81415424|FG003|Treatment Period 1|Protocol Violation|0|||
27885639|NCT00685399|81415425|FG004|Treatment Period 1|Protocol Violation|0|||
27885640|NCT00685399|81415426|FG005|Treatment Period 1|Protocol Violation|0|||
27699600|NCT01776424|80736695|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
27699601|NCT01776424|80736696|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
27699602|NCT01776424|80736694|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
27699603|NCT01776424|80736695|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
27699604|NCT01776424|80736696|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
27831497|NCT00540423|81216104|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
27831498|NCT00540423|81216105|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
27831499|NCT03644550|81216106|FG000|Overall Study|Withdrawal by Subject|3|||
27831500|NCT03644550|81216106|FG000|Overall Study|Progressive disease|15|||
27831501|NCT03480763|81216107|FG000|Overall Study|Withdrawal by Subject|18|||
27831502|NCT03480763|81216108|FG001|Overall Study|Withdrawal by Subject|10|||
27831503|NCT03480763|81216107|FG000|Overall Study|Lost to Follow-up|4|||
27831504|NCT03480763|81216108|FG001|Overall Study|Lost to Follow-up|7|||
27831505|NCT03480763|81216107|FG000|Overall Study|non-study pneumococcal vaccine|1|||
27831506|NCT03480763|81216108|FG001|Overall Study|non-study pneumococcal vaccine|0|||
27831507|NCT03480763|81216107|FG000|Overall Study|oncological treatment|0|||
27831508|NCT03480763|81216108|FG001|Overall Study|oncological treatment|2|||
27831509|NCT03480763|81216107|FG000|Overall Study|pain with vaccination|1|||
27831510|NCT03480763|81216108|FG001|Overall Study|pain with vaccination|0|||
27831511|NCT04577651|81216109|FG000|Overall Study|Screen Failure|7|||
27831512|NCT04577651|81216109|FG000|Overall Study|Adverse Event|1|||
27831513|NCT04577651|81216109|FG000|Overall Study|Death|1|||
27831514|NCT04577651|81216109|FG000|Overall Study|Physician Decision|1|||
27831515|NCT04577651|81216109|FG000|Overall Study|Withdrawal by Subject|3|||
27831516|NCT00829712|81216110|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
27831517|NCT00829712|81216111|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27831518|NCT03789110|81216112|FG000|Overall Study|Adverse Event|2|||
27831519|NCT03789110|81216112|FG000|Overall Study|Physician Decision|1|||
27831520|NCT03789110|81216112|FG000|Overall Study|Withdrawal by Subject|2|||
27831521|NCT03789110|81216112|FG000|Overall Study|Lack of Efficacy|22|||
27831522|NCT03789110|81216112|FG000|Overall Study|still on treatment|3|||
27831523|NCT00881569|81216113|FG000|Overall Study|Disease progression|1|||
27831524|NCT00881569|81216114|FG001|Overall Study|Disease progression|1|||
27831525|NCT02648438|81216115|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27831526|NCT02648438|81216116|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
27831527|NCT02648438|81216117|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27831528|NCT02648438|81216115|FG000|Overall Study|Protocol Violation|2|||
27831529|NCT02648438|81216116|FG001|Overall Study|Protocol Violation|0|||
27831530|NCT02648438|81216117|FG002|Overall Study|Protocol Violation|0|||
27831531|NCT02648438|81216115|FG000|Overall Study|Withdrawal by Subject|1|||
27831532|NCT02648438|81216116|FG001|Overall Study|Withdrawal by Subject|1|||
27831533|NCT02648438|81216117|FG002|Overall Study|Withdrawal by Subject|0|||
27831534|NCT02611687|81216127|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
27831535|NCT02611687|81216128|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
27831536|NCT03605342|81216132|FG000|Overall Study|Withdrawal by Subject|9|||
27831537|NCT03605342|81216133|FG001|Overall Study|Withdrawal by Subject|7|||
27831538|NCT03605342|81216132|FG000|Overall Study|Lost to Follow-up|1|||
27831539|NCT03605342|81216133|FG001|Overall Study|Lost to Follow-up|1|||
27831540|NCT01709903|81216140|FG000|Overall Study|administrative problems|2|||
27831541|NCT01709903|81216141|FG001|Overall Study|administrative problems|6|||
27831542|NCT01709903|81216140|FG000|Overall Study|Abnormal test procedure results|1|||
27831543|NCT01709903|81216141|FG001|Overall Study|Abnormal test procedure results|0|||
27831544|NCT01709903|81216140|FG000|Overall Study|In ability to use device|1|||
27831545|NCT01709903|81216141|FG001|Overall Study|In ability to use device|1|||
27831546|NCT01709903|81216140|FG000|Overall Study|no longer needed study drug|0|||
27831547|NCT01709903|81216141|FG001|Overall Study|no longer needed study drug|1|||
27831548|NCT01709903|81216140|FG000|Overall Study|Lost to Follow-up|0|||
27831549|NCT01709903|81216141|FG001|Overall Study|Lost to Follow-up|2|||
27831550|NCT01709903|81216140|FG000|Overall Study|Death|2|||
27831551|NCT01709903|81216141|FG001|Overall Study|Death|0|||
27831552|NCT01709903|81216140|FG000|Overall Study|Protocol Violation|3|||
27831553|NCT01709903|81216141|FG001|Overall Study|Protocol Violation|2|||
27831554|NCT01709903|81216140|FG000|Overall Study|Lack of Efficacy|3|||
27831555|NCT01709903|81216141|FG001|Overall Study|Lack of Efficacy|3|||
27831556|NCT01709903|81216140|FG000|Overall Study|Withdrawal by Subject|6|||
27831557|NCT01709903|81216141|FG001|Overall Study|Withdrawal by Subject|6|||
27831558|NCT01709903|81216140|FG000|Overall Study|Adverse Event|11|||
27831559|NCT01709903|81216141|FG001|Overall Study|Adverse Event|18|||
27831560|NCT03669250|81216142|FG000|Overall Study|Adverse Event|0|||
27831561|NCT03669250|81216143|FG001|Overall Study|Adverse Event|0|||
27831562|NCT03669250|81216144|FG002|Overall Study|Adverse Event|0|||
27831563|NCT03669250|81216145|FG003|Overall Study|Adverse Event|0|||
27831564|NCT03669250|81216146|FG004|Overall Study|Adverse Event|1|||
27831565|NCT03669250|81216147|FG005|Overall Study|Adverse Event|0|||
27831566|NCT03669250|81216142|FG000|Overall Study|Withdrawal by Subject|0|||
27831567|NCT03669250|81216143|FG001|Overall Study|Withdrawal by Subject|1|||
27831568|NCT03669250|81216144|FG002|Overall Study|Withdrawal by Subject|0|||
27831569|NCT03669250|81216145|FG003|Overall Study|Withdrawal by Subject|1|||
27831570|NCT03669250|81216146|FG004|Overall Study|Withdrawal by Subject|0|||
27831571|NCT03669250|81216147|FG005|Overall Study|Withdrawal by Subject|0|||
27885641|NCT00685399|81415427|FG006|Treatment Period 1|Protocol Violation|0|||
27885642|NCT00685399|81415428|FG007|Treatment Period 1|Protocol Violation|0|||
27885643|NCT00685399|81415421|FG000|Treatment Period 1|Administrative|2|||
27885644|NCT00685399|81415422|FG001|Treatment Period 1|Administrative|0|||
27885645|NCT00685399|81415423|FG002|Treatment Period 1|Administrative|0|||
27885646|NCT00685399|81415424|FG003|Treatment Period 1|Administrative|0|||
27885647|NCT00685399|81415425|FG004|Treatment Period 1|Administrative|0|||
27885648|NCT00685399|81415426|FG005|Treatment Period 1|Administrative|0|||
27885649|NCT00685399|81415427|FG006|Treatment Period 1|Administrative|0|||
27885650|NCT00685399|81415428|FG007|Treatment Period 1|Administrative|0|||
27885651|NCT00685399|81415421|FG000|Treatment Period 1|Lack of Efficacy|1|||
27885652|NCT00685399|81415422|FG001|Treatment Period 1|Lack of Efficacy|0|||
27885653|NCT00685399|81415423|FG002|Treatment Period 1|Lack of Efficacy|0|||
27885654|NCT00685399|81415424|FG003|Treatment Period 1|Lack of Efficacy|0|||
27885655|NCT00685399|81415425|FG004|Treatment Period 1|Lack of Efficacy|0|||
27885656|NCT00685399|81415426|FG005|Treatment Period 1|Lack of Efficacy|0|||
27885657|NCT00685399|81415427|FG006|Treatment Period 1|Lack of Efficacy|0|||
27885658|NCT00685399|81415428|FG007|Treatment Period 1|Lack of Efficacy|0|||
27885659|NCT00685399|81415421|FG000|Treatment Period 2|Administrative Problems|0|||
27885660|NCT00685399|81415422|FG001|Treatment Period 2|Administrative Problems|2|||
27885661|NCT00685399|81415423|FG002|Treatment Period 2|Administrative Problems|1|||
27885662|NCT00685399|81415424|FG003|Treatment Period 2|Administrative Problems|0|||
27885663|NCT00685399|81415425|FG004|Treatment Period 2|Administrative Problems|0|||
27885664|NCT00685399|81415426|FG005|Treatment Period 2|Administrative Problems|0|||
27885665|NCT00685399|81415427|FG006|Treatment Period 2|Administrative Problems|0|||
27885666|NCT00685399|81415428|FG007|Treatment Period 2|Administrative Problems|0|||
27885667|NCT00685399|81415421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27885668|NCT00685399|81415422|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27885669|NCT00685399|81415423|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27885670|NCT00685399|81415424|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27885671|NCT00685399|81415425|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27885672|NCT00685399|81415426|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27831572|NCT00070291|81216148|FG000|Step 1|Withdrawal by Subject|1|||
27831573|NCT00070291|81216148|FG000|Step 1|Adverse Event|1|||
27831574|NCT00070291|81216148|FG000|Step 2|Adverse Event|1|||
27831575|NCT00371839|81216151|FG000|Overall Study|Death|4|||
27831576|NCT00371839|81216152|FG001|Overall Study|Death|0|||
27831577|NCT00371839|81216153|FG002|Overall Study|Death|0|||
27831578|NCT00371839|81216151|FG000|Overall Study|Withdrawal by Subject|7|||
27831579|NCT00371839|81216152|FG001|Overall Study|Withdrawal by Subject|4|||
27831580|NCT00371839|81216153|FG002|Overall Study|Withdrawal by Subject|0|||
27831581|NCT00371839|81216151|FG000|Overall Study|Lost to Follow-up|6|||
27831582|NCT00371839|81216152|FG001|Overall Study|Lost to Follow-up|3|||
27831583|NCT00371839|81216153|FG002|Overall Study|Lost to Follow-up|2|||
27831584|NCT01597791|81216154|FG000|Overall Study|Physician Decision|2|||
27831585|NCT01597791|81216155|FG001|Overall Study|Physician Decision|1|||
27831586|NCT01597791|81216154|FG000|Overall Study|Cesarean Section|6|||
27831587|NCT01597791|81216155|FG001|Overall Study|Cesarean Section|7|||
27831588|NCT01597791|81216154|FG000|Overall Study|Subject withdrawal|0|||
27831589|NCT01597791|81216155|FG001|Overall Study|Subject withdrawal|1|||
27831590|NCT01597791|81216154|FG000|Overall Study|Protocol Violation|0|||
27831591|NCT01597791|81216155|FG001|Overall Study|Protocol Violation|1|||
27831592|NCT00319696|81216156|FG000|Overall Study|Adverse Event|36|||
27831593|NCT00319696|81216156|FG000|Overall Study|withdrawal of consent|14|||
27831594|NCT00319696|81216156|FG000|Overall Study|administrative|7|||
27831595|NCT00319696|81216156|FG000|Overall Study|Lost to Follow-up|3|||
27831596|NCT01539239|81216157|FG000|Overall Study|Death|5|||
27831597|NCT01539239|81216158|FG001|Overall Study|Death|5|||
27831598|NCT01539239|81216157|FG000|Overall Study|Lost to Follow-up|7|||
27831599|NCT01539239|81216158|FG001|Overall Study|Lost to Follow-up|12|||
27831600|NCT00585286|81216159|FG000|Overall Study|Lost to Follow-up|1|||
27831601|NCT05315713|81216160|FG000|Overall Study|Death|5|||
27831602|NCT05315713|81216160|FG000|Overall Study|Progressive disease|1|||
27831603|NCT05315713|81216160|FG000|Overall Study|Withdrawal by Subject|1|||
27885673|NCT00685399|81415427|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27885674|NCT00685399|81415428|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27885675|NCT00685399|81415421|FG000|Treatment Period 2|Adverse Event|0|||
27560119|NCT01729754|80237805|FG008|Part 3|Adverse Event|0|||
27831604|NCT05315713|81216160|FG000|Overall Study|Study terminated by sponsor|1|||
27831605|NCT03502811|81216162|FG000|Overall Study|Death|157|||
27831606|NCT03502811|81216162|FG000|Overall Study|Withdrawal by Subject|105|||
27885676|NCT00685399|81415422|FG001|Treatment Period 2|Adverse Event|0|||
27885677|NCT00685399|81415423|FG002|Treatment Period 2|Adverse Event|0|||
27885678|NCT00685399|81415424|FG003|Treatment Period 2|Adverse Event|0|||
27885679|NCT00685399|81415425|FG004|Treatment Period 2|Adverse Event|0|||
27831607|NCT03502811|81216162|FG000|Overall Study|Lost to Follow-up|26|||
27831608|NCT03502811|81216162|FG000|Overall Study|No Visits (Missed)|31|||
27831609|NCT03707587|81216163|FG000|Overall Study|Death|0|||
27831610|NCT03707587|81216164|FG001|Overall Study|Death|1|||
27831611|NCT00059332|81216172|FG000|Overall Study|Withdrawal by Subject|2|||
27831612|NCT00059332|81216173|FG001|Overall Study|Withdrawal by Subject|1|||
27885680|NCT00685399|81415426|FG005|Treatment Period 2|Adverse Event|1|||
27885681|NCT00685399|81415427|FG006|Treatment Period 2|Adverse Event|0|||
27885682|NCT00685399|81415428|FG007|Treatment Period 2|Adverse Event|0|||
27885683|NCT00685399|81415421|FG000|Treatment Period 2|Lack of Efficacy|0|||
27885684|NCT00685399|81415422|FG001|Treatment Period 2|Lack of Efficacy|10|||
27885685|NCT00685399|81415423|FG002|Treatment Period 2|Lack of Efficacy|2|||
27885686|NCT00685399|81415424|FG003|Treatment Period 2|Lack of Efficacy|0|||
27831613|NCT00059332|81216172|FG000|Overall Study|Lost to Follow-up|1|||
27831614|NCT00059332|81216173|FG001|Overall Study|Lost to Follow-up|1|||
27831615|NCT02957942|81216182|FG000|Overall Study|Withdrawal by Subject|0|||
27831616|NCT02957942|81216183|FG001|Overall Study|Withdrawal by Subject|1|||
27831617|NCT02957942|81216182|FG000|Overall Study|Practicing experiment protocol|0|||
27831618|NCT02957942|81216183|FG001|Overall Study|Practicing experiment protocol|6|||
27831619|NCT01650194|81216187|FG000|Overall Study|Progressive Disease (PD)|35|||
27831620|NCT01650194|81216187|FG000|Overall Study|Withdrawal by Subject|2|||
27831621|NCT01650194|81216187|FG000|Overall Study|Miscellaneous|10|||
27831622|NCT00795821|81216188|FG000|Acute Treatment Phase|Adverse Event|23|||
27831623|NCT00795821|81216189|FG001|Acute Treatment Phase|Adverse Event|4|||
27831624|NCT00795821|81216188|FG000|Acute Treatment Phase|Death|1|||
27831625|NCT00795821|81216189|FG001|Acute Treatment Phase|Death|0|||
27831626|NCT00795821|81216188|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
27831627|NCT00795821|81216189|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
27831628|NCT00795821|81216188|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
27831629|NCT00795821|81216189|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
27831630|NCT00795821|81216188|FG000|Acute Treatment Phase|Physician Decision|1|||
27831631|NCT00795821|81216189|FG001|Acute Treatment Phase|Physician Decision|1|||
27831632|NCT00795821|81216188|FG000|Acute Treatment Phase|Protocol Violation|1|||
27831633|NCT00795821|81216189|FG001|Acute Treatment Phase|Protocol Violation|2|||
27831634|NCT00795821|81216188|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
27831635|NCT00795821|81216189|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
27831636|NCT00795821|81216188|FG000|Long-term Extension Phase|Adverse Event|25|||
27831637|NCT00795821|81216189|FG001|Long-term Extension Phase|Adverse Event|32|||
27831638|NCT00795821|81216188|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
27831639|NCT00795821|81216189|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
27885687|NCT00685399|81415425|FG004|Treatment Period 2|Lack of Efficacy|0|||
27699605|NCT01776424|80736694|FG000|LTOLE Part (Open Label)|Refused|5|||
27699606|NCT01776424|80736695|FG001|LTOLE Part (Open Label)|Refused|2|||
27699607|NCT01776424|80736696|FG002|LTOLE Part (Open Label)|Refused|11|||
27699608|NCT01776424|80736694|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
27699609|NCT01776424|80736695|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
27699610|NCT01776424|80736696|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
27699611|NCT01479829|80736697|FG000|Overall Study|Withdrawal by Subject|8|||
27699612|NCT01479829|80736698|FG001|Overall Study|Withdrawal by Subject|10|||
27699613|NCT00633061|80736703|FG000|Overall Study|Study closed|86|||
27699614|NCT00633061|80736704|FG001|Overall Study|Study closed|0|||
27699615|NCT01478360|80736705|FG000|Overall Study|Lost to Follow-up|1|||
27699616|NCT01478360|80736706|FG001|Overall Study|Lost to Follow-up|0|||
27699617|NCT01478360|80736705|FG000|Overall Study|Adverse Event|0|||
27699618|NCT01478360|80736706|FG001|Overall Study|Adverse Event|1|||
27699619|NCT01478360|80736705|FG000|Overall Study|Administrative problems|1|||
27699620|NCT01478360|80736706|FG001|Overall Study|Administrative problems|2|||
27699621|NCT00651157|80736707|FG000|Overall Study|Death|1|||
27699622|NCT00651157|80736707|FG000|Overall Study|Protocol Violation|1|||
27699623|NCT01829425|80736708|FG000|Overall Study|Withdrawal by Subject|4|||
27699624|NCT01829425|80736709|FG001|Overall Study|Withdrawal by Subject|3|||
27699625|NCT01829425|80736708|FG000|Overall Study|Lost to Follow-up|2|||
27699626|NCT01829425|80736709|FG001|Overall Study|Lost to Follow-up|1|||
27699627|NCT01009034|80736710|FG000|Overall Study|Lost to Follow-up|2|||
27699628|NCT01009034|80736710|FG000|Overall Study|Withdrawal by Subject|2|||
27699629|NCT01641809|80736711|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
27699630|NCT01641809|80736712|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
27699631|NCT01641809|80736713|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
27699632|NCT01641809|80736714|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
27699633|NCT01641809|80736711|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
27699634|NCT01641809|80736712|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
27560120|NCT01729754|80237806|FG009|Part 3|Adverse Event|3|||
27699635|NCT01641809|80736713|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
27699636|NCT01641809|80736714|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
27699637|NCT01641809|80736711|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
27699638|NCT01641809|80736712|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
27699639|NCT01641809|80736713|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
27699640|NCT01641809|80736714|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
27699641|NCT01641809|80736711|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
27699642|NCT01641809|80736712|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
27831640|NCT00795821|81216188|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
27831641|NCT00795821|81216189|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
27831642|NCT00795821|81216188|FG000|Long-term Extension Phase|Physician Decision|1|||
27831643|NCT00795821|81216189|FG001|Long-term Extension Phase|Physician Decision|2|||
27831644|NCT00795821|81216188|FG000|Long-term Extension Phase|Protocol Violation|3|||
27831645|NCT00795821|81216189|FG001|Long-term Extension Phase|Protocol Violation|5|||
27831646|NCT00795821|81216188|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
27831647|NCT00795821|81216189|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
27831648|NCT00795821|81216188|FG000|Taper Phase|Adverse Event|2|||
27560121|NCT01729754|80237797|FG000|Part 3|Death|0|||
27699643|NCT01641809|80736713|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
27699644|NCT01641809|80736714|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
27699645|NCT01641809|80736711|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
27699646|NCT01641809|80736712|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
27699647|NCT01641809|80736713|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
27699648|NCT01641809|80736714|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
27699649|NCT01641809|80736711|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
27699650|NCT01641809|80736712|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
27699651|NCT01641809|80736713|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
27699652|NCT01641809|80736714|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
27831649|NCT00795821|81216189|FG001|Taper Phase|Adverse Event|0|||
27831650|NCT00795821|81216188|FG000|Taper Phase|Lost to Follow-up|1|||
27831651|NCT00795821|81216189|FG001|Taper Phase|Lost to Follow-up|0|||
27831652|NCT00795821|81216188|FG000|Taper Phase|Physician Decision|2|||
27831653|NCT00795821|81216189|FG001|Taper Phase|Physician Decision|0|||
27831654|NCT00795821|81216188|FG000|Taper Phase|Withdrawal by Subject|4|||
27831655|NCT00795821|81216189|FG001|Taper Phase|Withdrawal by Subject|0|||
27831656|NCT00573313|81216190|FG000|Overall Study|Protocol Violation|5|||
27831657|NCT00573313|81216191|FG001|Overall Study|Protocol Violation|0|||
27831658|NCT00573313|81216192|FG002|Overall Study|Protocol Violation|6|||
27831659|NCT00573313|81216193|FG003|Overall Study|Protocol Violation|0|||
27831660|NCT04223791|81216203|FG000|Overall Study|Lost to Follow-up|0|||
27831661|NCT04223791|81216204|FG001|Overall Study|Lost to Follow-up|4|||
27831662|NCT04223791|81216203|FG000|Overall Study|Physician Decision|5|||
27831663|NCT04223791|81216204|FG001|Overall Study|Physician Decision|1|||
27831664|NCT04223791|81216203|FG000|Overall Study|Protocol Violation|1|||
27831665|NCT04223791|81216204|FG001|Overall Study|Protocol Violation|1|||
27831666|NCT04223791|81216203|FG000|Overall Study|Withdrawal by Subject|10|||
27831667|NCT04223791|81216204|FG001|Overall Study|Withdrawal by Subject|12|||
27831668|NCT04223791|81216203|FG000|Overall Study|Pregnancy|1|||
27831669|NCT04223791|81216204|FG001|Overall Study|Pregnancy|1|||
27831670|NCT04223791|81216203|FG000|Overall Study|Ongoing in Study|305|||
27831671|NCT04223791|81216204|FG001|Overall Study|Ongoing in Study|302|||
27831672|NCT00227370|81216205|FG000|Overall Study|Withdrawal by Subject|1|||
27831673|NCT00227370|81216206|FG001|Overall Study|Withdrawal by Subject|2|||
27699653|NCT01641809|80736711|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
27699654|NCT01641809|80736712|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
27699655|NCT01641809|80736713|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
27699656|NCT01641809|80736714|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
27699657|NCT01641809|80736711|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
27699658|NCT01641809|80736712|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
27699659|NCT01641809|80736713|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
27699660|NCT01641809|80736714|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
27699661|NCT01641809|80736711|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
27699662|NCT01641809|80736712|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
27699663|NCT01641809|80736713|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
27699664|NCT01641809|80736714|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
27831674|NCT00227370|81216205|FG000|Overall Study|Death|3|||
27831675|NCT00227370|81216206|FG001|Overall Study|Death|4|||
27831676|NCT00227370|81216205|FG000|Overall Study|Adverse Event|6|||
27831677|NCT00227370|81216206|FG001|Overall Study|Adverse Event|11|||
27831678|NCT00227370|81216205|FG000|Overall Study|Physician Decision|9|||
27831679|NCT00227370|81216206|FG001|Overall Study|Physician Decision|6|||
27831680|NCT00227370|81216205|FG000|Overall Study|Other reasons|2|||
27831681|NCT00227370|81216206|FG001|Overall Study|Other reasons|1|||
27831682|NCT01874535|81216207|FG000|Overall Study|Lost to Follow-up|10|||
27831683|NCT01874535|81216208|FG001|Overall Study|Lost to Follow-up|9|||
27831684|NCT01874535|81216207|FG000|Overall Study|incomplete symptom resolution|45|||
27831685|NCT01874535|81216208|FG001|Overall Study|incomplete symptom resolution|35|||
27560122|NCT01729754|80237798|FG001|Part 3|Death|0|||
27560123|NCT01729754|80237799|FG002|Part 3|Death|0|||
27560124|NCT01729754|80237800|FG003|Part 3|Death|0|||
27560125|NCT01729754|80237801|FG004|Part 3|Death|0|||
27560126|NCT01729754|80237802|FG005|Part 3|Death|2|||
27560127|NCT01729754|80237803|FG006|Part 3|Death|0|||
27560128|NCT01729754|80237804|FG007|Part 3|Death|0|||
27831686|NCT05169710|81216209|FG000|Overall Study|Adverse Event|1|||
27831687|NCT05169710|81216210|FG001|Overall Study|Adverse Event|2|||
27831688|NCT05169710|81216211|FG002|Overall Study|Adverse Event|2|||
27831689|NCT05169710|81216209|FG000|Overall Study|Lost to Follow-up|0|||
27560129|NCT01729754|80237805|FG008|Part 3|Death|0|||
27560130|NCT01729754|80237806|FG009|Part 3|Death|0|||
27560131|NCT01729754|80237797|FG000|Part 3|Lack of Efficacy|0|||
27560132|NCT01729754|80237798|FG001|Part 3|Lack of Efficacy|0|||
27560133|NCT01729754|80237799|FG002|Part 3|Lack of Efficacy|0|||
27560134|NCT01729754|80237800|FG003|Part 3|Lack of Efficacy|0|||
27560135|NCT01729754|80237801|FG004|Part 3|Lack of Efficacy|2|||
27560136|NCT01729754|80237802|FG005|Part 3|Lack of Efficacy|0|||
27560137|NCT01729754|80237803|FG006|Part 3|Lack of Efficacy|0|||
27560138|NCT01729754|80237804|FG007|Part 3|Lack of Efficacy|0|||
27831690|NCT05169710|81216210|FG001|Overall Study|Lost to Follow-up|0|||
27831691|NCT05169710|81216211|FG002|Overall Study|Lost to Follow-up|1|||
27831692|NCT05169710|81216209|FG000|Overall Study|Withdrawal by Subject|2|||
27831693|NCT05169710|81216210|FG001|Overall Study|Withdrawal by Subject|1|||
27831694|NCT05169710|81216211|FG002|Overall Study|Withdrawal by Subject|0|||
27831695|NCT05169710|81216209|FG000|Overall Study|Other Study Discontinuation Reason|0|||
27831696|NCT05169710|81216210|FG001|Overall Study|Other Study Discontinuation Reason|2|||
27831697|NCT05169710|81216211|FG002|Overall Study|Other Study Discontinuation Reason|0|||
27831698|NCT01196390|81216214|FG000|Overall Study|Protocol Violation|4|||
27831699|NCT01196390|81216215|FG001|Overall Study|Protocol Violation|5|||
27831700|NCT03637764|81216216|FG000|Overall Study|Adverse Event|2|||
27831701|NCT03637764|81216217|FG001|Overall Study|Adverse Event|0|||
27831702|NCT03637764|81216218|FG002|Overall Study|Adverse Event|0|||
27831703|NCT03637764|81216219|FG003|Overall Study|Adverse Event|1|||
27831704|NCT03637764|81216216|FG000|Overall Study|Progressive Disease|23|||
27831705|NCT03637764|81216217|FG001|Overall Study|Progressive Disease|23|||
27831706|NCT03637764|81216218|FG002|Overall Study|Progressive Disease|18|||
27831707|NCT03637764|81216219|FG003|Overall Study|Progressive Disease|31|||
27831708|NCT03637764|81216216|FG000|Overall Study|Withdrawal by Subject|1|||
27699665|NCT01641809|80736711|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
27699666|NCT01641809|80736712|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
27831709|NCT03637764|81216217|FG001|Overall Study|Withdrawal by Subject|3|||
27831710|NCT03637764|81216218|FG002|Overall Study|Withdrawal by Subject|0|||
27831711|NCT03637764|81216219|FG003|Overall Study|Withdrawal by Subject|1|||
27831712|NCT01602380|81216226|FG000|Overall Study|Death|147|||
27560139|NCT01729754|80237805|FG008|Part 3|Lack of Efficacy|0|||
27560140|NCT01729754|80237806|FG009|Part 3|Lack of Efficacy|4|||
27560141|NCT01729754|80237797|FG000|Part 3|Lost to Follow-up|0|||
27560142|NCT01729754|80237798|FG001|Part 3|Lost to Follow-up|1|||
27560143|NCT01729754|80237799|FG002|Part 3|Lost to Follow-up|2|||
27560144|NCT01729754|80237800|FG003|Part 3|Lost to Follow-up|0|||
27560145|NCT01729754|80237801|FG004|Part 3|Lost to Follow-up|0|||
27699667|NCT01641809|80736713|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
27699668|NCT01641809|80736714|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
27560146|NCT01729754|80237802|FG005|Part 3|Lost to Follow-up|3|||
27560147|NCT01729754|80237803|FG006|Part 3|Lost to Follow-up|0|||
27831713|NCT01602380|81216227|FG001|Overall Study|Death|145|||
27831714|NCT01602380|81216226|FG000|Overall Study|Withdrawal by Subject|39|||
27831715|NCT01602380|81216227|FG001|Overall Study|Withdrawal by Subject|41|||
27831716|NCT01602380|81216226|FG000|Overall Study|Lost to Follow-up|15|||
27831717|NCT01602380|81216227|FG001|Overall Study|Lost to Follow-up|12|||
27831718|NCT01602380|81216226|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27831719|NCT01602380|81216227|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
27831720|NCT01602380|81216226|FG000|Overall Study|Other|2|||
27831721|NCT01602380|81216227|FG001|Overall Study|Other|0|||
27831722|NCT01958294|81216228|FG000|Overall Study|Clinical Circumstances|2|||
27885688|NCT00685399|81415426|FG005|Treatment Period 2|Lack of Efficacy|1|||
27885689|NCT00685399|81415427|FG006|Treatment Period 2|Lack of Efficacy|0|||
27885690|NCT00685399|81415428|FG007|Treatment Period 2|Lack of Efficacy|0|||
27885691|NCT00685399|81415421|FG000|Extension|Administrative Issues|0|||
27885692|NCT00685399|81415422|FG001|Extension|Administrative Issues|0|||
27831723|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
27831724|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
27831725|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
27831726|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
27885693|NCT00685399|81415423|FG002|Extension|Administrative Issues|0|||
27885694|NCT00685399|81415424|FG003|Extension|Administrative Issues|1|||
27885695|NCT00685399|81415425|FG004|Extension|Administrative Issues|0|||
27885696|NCT00685399|81415426|FG005|Extension|Administrative Issues|0|||
27885697|NCT00685399|81415427|FG006|Extension|Administrative Issues|0|||
27885698|NCT00685399|81415428|FG007|Extension|Administrative Issues|0|||
27885699|NCT00685399|81415421|FG000|Extension|Withdrawal by Subject|0|||
27885700|NCT00685399|81415422|FG001|Extension|Withdrawal by Subject|0|||
27885701|NCT00685399|81415423|FG002|Extension|Withdrawal by Subject|0|||
27885702|NCT00685399|81415424|FG003|Extension|Withdrawal by Subject|1|||
27885703|NCT00685399|81415425|FG004|Extension|Withdrawal by Subject|0|||
27885704|NCT00685399|81415426|FG005|Extension|Withdrawal by Subject|0|||
27831727|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
27831728|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
27831729|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Death|9|||
27885705|NCT00685399|81415427|FG006|Extension|Withdrawal by Subject|0|||
27885706|NCT00685399|81415428|FG007|Extension|Withdrawal by Subject|0|||
27885707|NCT00685399|81415421|FG000|Extension|Protocol Violation|0|||
27885708|NCT00685399|81415422|FG001|Extension|Protocol Violation|0|||
27831730|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Death|7|||
27831731|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Death|14|||
27831732|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Death|7|||
27885709|NCT00685399|81415423|FG002|Extension|Protocol Violation|0|||
27699669|NCT01641809|80736711|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
27699670|NCT01641809|80736712|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
27699671|NCT01641809|80736713|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
27699672|NCT01641809|80736714|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
27699673|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
27699674|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
27699675|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
27699676|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
27699677|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
27699678|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
27699679|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
27699680|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
27699681|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
27699682|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
27699683|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
27699684|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
27699685|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
27699686|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
27699687|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
27699688|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
27699689|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
27699690|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
27699691|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
27699692|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
27699693|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
27699694|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
27699695|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
27699696|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
27699697|NCT01641809|80736711|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
27699698|NCT01641809|80736712|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
27699699|NCT01641809|80736713|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
27699700|NCT01641809|80736714|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
27699701|NCT03873493|80736716|FG000|Overall Study|Withdrawal by Subject|1|||
27699702|NCT03873493|80736716|FG000|Overall Study|Death|9|||
27699703|NCT03873493|80736716|FG000|Overall Study|Lost to Follow-up|1|||
27699704|NCT03873493|80736716|FG000|Overall Study|Study Terminated by Sponsor|1|||
27699705|NCT03873493|80736716|FG000|Overall Study|Other|2|||
27699706|NCT00993915|80736717|FG000|Overall Study|Insufficient clinical response|3|||
27699707|NCT00993915|80736717|FG000|Overall Study|Withdrawal by Subject|2|||
27699708|NCT00993915|80736717|FG000|Overall Study|Other|1|||
27699709|NCT00993915|80736717|FG000|Overall Study|Ongoing|3|||
27699710|NCT02673619|80736723|FG000|Overall Study|Lost to Follow-up|1|||
27699711|NCT02673619|80736724|FG001|Overall Study|Lost to Follow-up|0|||
27699712|NCT02673619|80736725|FG002|Overall Study|Lost to Follow-up|0|||
27699713|NCT02673619|80736726|FG003|Overall Study|Lost to Follow-up|0|||
27699714|NCT02673619|80736723|FG000|Overall Study|Withdrawal by Subject|1|||
27699715|NCT02673619|80736724|FG001|Overall Study|Withdrawal by Subject|1|||
27699716|NCT02673619|80736725|FG002|Overall Study|Withdrawal by Subject|1|||
27699717|NCT02673619|80736726|FG003|Overall Study|Withdrawal by Subject|0|||
27699718|NCT02673619|80736723|FG000|Overall Study|Adverse Event|0|||
27831733|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Death|0|||
27831734|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Death|0|||
27831735|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
27831736|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
27831737|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
27831738|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
27831739|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
27831740|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
27831741|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Other Event|49|||
27831742|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Other Event|52|||
27831743|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Other Event|41|||
27831744|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Other Event|58|||
27885710|NCT00685399|81415424|FG003|Extension|Protocol Violation|1|||
27885711|NCT00685399|81415425|FG004|Extension|Protocol Violation|0|||
27699719|NCT02673619|80736724|FG001|Overall Study|Adverse Event|0|||
27699720|NCT02673619|80736725|FG002|Overall Study|Adverse Event|1|||
27699721|NCT02673619|80736726|FG003|Overall Study|Adverse Event|0|||
27699722|NCT02673619|80736723|FG000|Overall Study|Lack of Efficacy|0|||
27699723|NCT02673619|80736724|FG001|Overall Study|Lack of Efficacy|0|||
27699724|NCT02673619|80736725|FG002|Overall Study|Lack of Efficacy|1|||
27699725|NCT02673619|80736726|FG003|Overall Study|Lack of Efficacy|0|||
27831745|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Other Event|0|||
27885712|NCT00685399|81415426|FG005|Extension|Protocol Violation|0|||
27560148|NCT01729754|80237804|FG007|Part 3|Lost to Follow-up|0|||
27560149|NCT01729754|80237805|FG008|Part 3|Lost to Follow-up|1|||
27560150|NCT01729754|80237806|FG009|Part 3|Lost to Follow-up|0|||
27560151|NCT01729754|80237797|FG000|Part 3|Physician Decision|0|||
27560152|NCT01729754|80237798|FG001|Part 3|Physician Decision|0|||
27560153|NCT01729754|80237799|FG002|Part 3|Physician Decision|1|||
27560154|NCT01729754|80237800|FG003|Part 3|Physician Decision|0|||
27560155|NCT01729754|80237801|FG004|Part 3|Physician Decision|0|||
27560156|NCT01729754|80237802|FG005|Part 3|Physician Decision|0|||
27560157|NCT01729754|80237803|FG006|Part 3|Physician Decision|0|||
27560158|NCT01729754|80237804|FG007|Part 3|Physician Decision|0|||
27560159|NCT01729754|80237805|FG008|Part 3|Physician Decision|0|||
27560160|NCT01729754|80237806|FG009|Part 3|Physician Decision|0|||
27560161|NCT01729754|80237797|FG000|Part 3|Withdrawal by Subject|0|||
27560162|NCT01729754|80237798|FG001|Part 3|Withdrawal by Subject|4|||
27560163|NCT01729754|80237799|FG002|Part 3|Withdrawal by Subject|1|||
27560164|NCT01729754|80237800|FG003|Part 3|Withdrawal by Subject|0|||
27560165|NCT01729754|80237801|FG004|Part 3|Withdrawal by Subject|2|||
27560166|NCT01729754|80237802|FG005|Part 3|Withdrawal by Subject|1|||
27560167|NCT01729754|80237803|FG006|Part 3|Withdrawal by Subject|0|||
27560168|NCT01729754|80237804|FG007|Part 3|Withdrawal by Subject|2|||
27560169|NCT01729754|80237805|FG008|Part 3|Withdrawal by Subject|0|||
27560170|NCT01729754|80237806|FG009|Part 3|Withdrawal by Subject|0|||
27560171|NCT01729754|80237797|FG000|Part 3|Other Protocol Specified Criteria|0|||
27560172|NCT01729754|80237798|FG001|Part 3|Other Protocol Specified Criteria|0|||
27560173|NCT01729754|80237799|FG002|Part 3|Other Protocol Specified Criteria|0|||
27560174|NCT01729754|80237800|FG003|Part 3|Other Protocol Specified Criteria|0|||
27560175|NCT01729754|80237801|FG004|Part 3|Other Protocol Specified Criteria|0|||
27560176|NCT01729754|80237802|FG005|Part 3|Other Protocol Specified Criteria|2|||
27560177|NCT01729754|80237803|FG006|Part 3|Other Protocol Specified Criteria|0|||
27560178|NCT01729754|80237804|FG007|Part 3|Other Protocol Specified Criteria|1|||
27560179|NCT01729754|80237805|FG008|Part 3|Other Protocol Specified Criteria|0|||
27560180|NCT01729754|80237806|FG009|Part 3|Other Protocol Specified Criteria|0|||
27560181|NCT00744627|80237807|FG000|Overall Study|Adverse Event|6|||
27560182|NCT00744627|80237808|FG001|Overall Study|Adverse Event|9|||
27560183|NCT00744627|80237807|FG000|Overall Study|Lack of Efficacy|7|||
27560184|NCT00744627|80237808|FG001|Overall Study|Lack of Efficacy|3|||
27560185|NCT00744627|80237807|FG000|Overall Study|Noncompliance|0|||
27560186|NCT00744627|80237808|FG001|Overall Study|Noncompliance|1|||
27560187|NCT00744627|80237807|FG000|Overall Study|Protocol Deviations|0|||
27560188|NCT00744627|80237808|FG001|Overall Study|Protocol Deviations|2|||
27560189|NCT00744627|80237807|FG000|Overall Study|Voluntary Withdrawal|9|||
27560190|NCT00744627|80237808|FG001|Overall Study|Voluntary Withdrawal|6|||
27560191|NCT00744627|80237807|FG000|Overall Study|Lost to Follow-up|2|||
27560192|NCT00744627|80237808|FG001|Overall Study|Lost to Follow-up|1|||
27560193|NCT00744627|80237807|FG000|Overall Study|Other|1|||
27560194|NCT00744627|80237808|FG001|Overall Study|Other|0|||
27560195|NCT00616655|80237809|FG000|Overall Study|Adverse Event|10|||
27560196|NCT00616655|80237810|FG001|Overall Study|Adverse Event|7|||
27560197|NCT00616655|80237811|FG002|Overall Study|Adverse Event|12|||
27560198|NCT00616655|80237809|FG000|Overall Study|Lack of Efficacy|5|||
27560199|NCT00616655|80237810|FG001|Overall Study|Lack of Efficacy|5|||
27560200|NCT00616655|80237811|FG002|Overall Study|Lack of Efficacy|5|||
27560201|NCT00616655|80237809|FG000|Overall Study|Lost to Follow-up|3|||
27560202|NCT00616655|80237810|FG001|Overall Study|Lost to Follow-up|12|||
27699726|NCT04399122|80736729|FG000|Overall Study|Lost to Follow-up|2|||
27560203|NCT00616655|80237811|FG002|Overall Study|Lost to Follow-up|10|||
27699727|NCT04399122|80736730|FG001|Overall Study|Lost to Follow-up|0|||
27560204|NCT00616655|80237809|FG000|Overall Study|Protocol Violation|2|||
27560205|NCT00616655|80237810|FG001|Overall Study|Protocol Violation|4|||
27560206|NCT00616655|80237811|FG002|Overall Study|Protocol Violation|3|||
27699728|NCT04399122|80736729|FG000|Overall Study|Withdrawal by Subject|1|||
27560207|NCT00616655|80237809|FG000|Overall Study|Withdrawal by Subject|9|||
27560208|NCT00616655|80237810|FG001|Overall Study|Withdrawal by Subject|7|||
27560209|NCT00616655|80237811|FG002|Overall Study|Withdrawal by Subject|11|||
27560210|NCT00616655|80237809|FG000|Overall Study|Does not meet in/ex criteria|0|||
27560211|NCT00616655|80237810|FG001|Overall Study|Does not meet in/ex criteria|0|||
27560212|NCT00616655|80237811|FG002|Overall Study|Does not meet in/ex criteria|2|||
27560213|NCT00616655|80237809|FG000|Overall Study|Other|6|||
27560214|NCT00616655|80237810|FG001|Overall Study|Other|6|||
27699729|NCT04399122|80736730|FG001|Overall Study|Withdrawal by Subject|0|||
27699730|NCT03037619|80736735|FG000|Overall Study|Lost to Follow-up|0|||
27699731|NCT03037619|80736736|FG001|Overall Study|Lost to Follow-up|1|||
27699732|NCT00928746|80736739|FG000|Overall Study|Adverse Event|2|||
27699733|NCT00928746|80736739|FG000|Overall Study|Protocol Violation|1|||
27699734|NCT00928746|80736739|FG000|Overall Study|Withdrawal by Subject|1|||
27699735|NCT00928746|80736739|FG000|Overall Study|Other|2|||
27699736|NCT00702845|80736740|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
27699737|NCT00702845|80736741|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
27699738|NCT00702845|80736740|FG000|Overall Study|Too high ovarian response|5|||
27699739|NCT00702845|80736741|FG001|Overall Study|Too high ovarian response|1|||
27699740|NCT00702845|80736740|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
27699741|NCT00702845|80736741|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
27699742|NCT00702845|80736740|FG000|Overall Study|Insufficient ovarian response|1|||
27699743|NCT00702845|80736741|FG001|Overall Study|Insufficient ovarian response|0|||
27699744|NCT00702845|80736740|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
27699745|NCT00702845|80736741|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
27699746|NCT00702845|80736740|FG000|Overall Study|No or abnormal fertilization|4|||
27699747|NCT00702845|80736741|FG001|Overall Study|No or abnormal fertilization|2|||
27699748|NCT00702845|80736740|FG000|Overall Study|Patient's decision|2|||
27699749|NCT00702845|80736741|FG001|Overall Study|Patient's decision|1|||
27699750|NCT00702845|80736740|FG000|Overall Study|Not randomized|0|||
27699751|NCT00702845|80736741|FG001|Overall Study|Not randomized|1|||
27699752|NCT00752622|80736742|FG000|Induction Phase|Adverse Event|3|||
27699753|NCT00752622|80736742|FG000|Induction Phase|Other|3|||
27699754|NCT00752622|80736742|FG000|Induction Phase|Non-responder|14|||
27699755|NCT00752622|80736742|FG000|Induction Phase|Withdrawal by Subject|1|||
27699756|NCT00752622|80736742|FG000|Induction Phase|Premature study termination|14|||
27699757|NCT00752622|80736742|FG000|Observational Phase|Premature Study Termination|36|||
27699758|NCT00752622|80736742|FG000|Observational Phase|Non-responder|2|||
27699759|NCT00752622|80736742|FG000|Observational Phase|Withdrawal by Subject|2|||
27699760|NCT00752622|80736742|FG000|Observational Phase|Adverse Event|1|||
27699761|NCT00752622|80736742|FG000|Observational Phase|Other|2|||
27699762|NCT00752622|80736742|FG000|Interventional Phase|Non-responder|2|||
27831746|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Other Event|0|||
27831747|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
27831748|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
27831749|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
27831750|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
27831751|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
27831752|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
27831753|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
27831754|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
27831755|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
27831756|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
27831757|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
27831758|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
27831759|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
27831760|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
27831761|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
27831762|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
27831763|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
27831764|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
27831765|NCT00205777|81216229|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
27885713|NCT00685399|81415427|FG006|Extension|Protocol Violation|0|||
27885714|NCT00685399|81415428|FG007|Extension|Protocol Violation|0|||
27831766|NCT00205777|81216230|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
27831767|NCT00205777|81216231|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
27831768|NCT00205777|81216232|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
27831769|NCT00205777|81216233|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
27831770|NCT00205777|81216234|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
27699763|NCT00752622|80736742|FG000|Interventional Phase|Physician Decision|1|||
27699764|NCT00752622|80736742|FG000|Interventional Phase|Premature Study Termination|5|||
27699765|NCT00364156|80736743|FG000|Overall Study|Withdrawal by Subject|73|||
27699766|NCT00364156|80736744|FG001|Overall Study|Withdrawal by Subject|80|||
27699767|NCT00364156|80736743|FG000|Overall Study|Protocol Violation|6|||
27699768|NCT00364156|80736744|FG001|Overall Study|Protocol Violation|1|||
27699769|NCT00583024|80736746|FG000|Overall Study|Lost to Follow-up|4|||
27699770|NCT01119001|80736747|FG000|Overall Study|Withdrawal by Subject|2|||
27831771|NCT00205777|81216229|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
27831772|NCT00205777|81216230|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
27831773|NCT00205777|81216231|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
27699771|NCT00671554|80736748|FG000|Overall Study|Disease progression|3|||
27831774|NCT00205777|81216232|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
27831775|NCT00205777|81216233|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
27831776|NCT00205777|81216234|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
27831777|NCT00205777|81216229|FG000|Completed Core Study, Entered SE I|Other Event|52|||
27831778|NCT00205777|81216230|FG001|Completed Core Study, Entered SE I|Other Event|46|||
27831779|NCT00205777|81216231|FG002|Completed Core Study, Entered SE I|Other Event|47|||
27831780|NCT00205777|81216232|FG003|Completed Core Study, Entered SE I|Other Event|50|||
27831781|NCT00205777|81216233|FG004|Completed Core Study, Entered SE I|Other Event|0|||
27831782|NCT00205777|81216234|FG005|Completed Core Study, Entered SE I|Other Event|0|||
27831783|NCT00205777|81216229|FG000|Study Extension I|Adverse Event|57|||
27831784|NCT00205777|81216230|FG001|Study Extension I|Adverse Event|0|||
27831785|NCT00205777|81216231|FG002|Study Extension I|Adverse Event|0|||
27831786|NCT00205777|81216232|FG003|Study Extension I|Adverse Event|61|||
27831787|NCT00205777|81216233|FG004|Study Extension I|Adverse Event|58|||
27831788|NCT00205777|81216234|FG005|Study Extension I|Adverse Event|0|||
27831789|NCT00205777|81216229|FG000|Study Extension I|Death|5|||
27831790|NCT00205777|81216230|FG001|Study Extension I|Death|0|||
27831791|NCT00205777|81216231|FG002|Study Extension I|Death|0|||
27831792|NCT00205777|81216232|FG003|Study Extension I|Death|1|||
27831793|NCT00205777|81216233|FG004|Study Extension I|Death|2|||
27831794|NCT00205777|81216234|FG005|Study Extension I|Death|0|||
27831795|NCT00205777|81216229|FG000|Study Extension I|Withdrawal by Subject|99|||
27831796|NCT00205777|81216230|FG001|Study Extension I|Withdrawal by Subject|0|||
27831797|NCT00205777|81216231|FG002|Study Extension I|Withdrawal by Subject|0|||
27831798|NCT00205777|81216232|FG003|Study Extension I|Withdrawal by Subject|106|||
27831799|NCT00205777|81216233|FG004|Study Extension I|Withdrawal by Subject|89|||
27831800|NCT00205777|81216234|FG005|Study Extension I|Withdrawal by Subject|0|||
27831801|NCT00205777|81216229|FG000|Study Extension I|Protocol Violation|4|||
27831802|NCT00205777|81216230|FG001|Study Extension I|Protocol Violation|0|||
27831803|NCT00205777|81216231|FG002|Study Extension I|Protocol Violation|0|||
27831804|NCT00205777|81216232|FG003|Study Extension I|Protocol Violation|8|||
27831805|NCT00205777|81216233|FG004|Study Extension I|Protocol Violation|8|||
27831806|NCT00205777|81216234|FG005|Study Extension I|Protocol Violation|0|||
27831807|NCT00205777|81216229|FG000|Study Extension I|Lack of Efficacy|0|||
27831808|NCT00205777|81216230|FG001|Study Extension I|Lack of Efficacy|0|||
27831809|NCT00205777|81216231|FG002|Study Extension I|Lack of Efficacy|0|||
27831810|NCT00205777|81216232|FG003|Study Extension I|Lack of Efficacy|1|||
27831811|NCT00205777|81216233|FG004|Study Extension I|Lack of Efficacy|2|||
27831812|NCT00205777|81216234|FG005|Study Extension I|Lack of Efficacy|0|||
27831813|NCT00205777|81216229|FG000|Study Extension I|Failed to return|15|||
27831814|NCT00205777|81216230|FG001|Study Extension I|Failed to return|0|||
27831815|NCT00205777|81216231|FG002|Study Extension I|Failed to return|0|||
27831816|NCT00205777|81216232|FG003|Study Extension I|Failed to return|17|||
27831817|NCT00205777|81216233|FG004|Study Extension I|Failed to return|13|||
27831818|NCT00205777|81216234|FG005|Study Extension I|Failed to return|0|||
27831819|NCT00205777|81216229|FG000|Study Extension I|Other Event|34|||
27831820|NCT00205777|81216230|FG001|Study Extension I|Other Event|0|||
27831821|NCT00205777|81216231|FG002|Study Extension I|Other Event|0|||
27831822|NCT00205777|81216232|FG003|Study Extension I|Other Event|34|||
27831823|NCT00205777|81216233|FG004|Study Extension I|Other Event|29|||
27831824|NCT00205777|81216234|FG005|Study Extension I|Other Event|0|||
27831825|NCT00205777|81216229|FG000|Study Extension I|Withdrawn as per protocol|0|||
27831826|NCT00205777|81216230|FG001|Study Extension I|Withdrawn as per protocol|0|||
27831827|NCT00205777|81216231|FG002|Study Extension I|Withdrawn as per protocol|1070|||
27831828|NCT00205777|81216232|FG003|Study Extension I|Withdrawn as per protocol|0|||
27831829|NCT00205777|81216233|FG004|Study Extension I|Withdrawn as per protocol|0|||
27831830|NCT00205777|81216234|FG005|Study Extension I|Withdrawn as per protocol|0|||
27831831|NCT00205777|81216229|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
27831832|NCT00205777|81216230|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
27831833|NCT00205777|81216231|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
27831834|NCT00205777|81216232|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
27831835|NCT00205777|81216233|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
27831836|NCT00205777|81216234|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
27699772|NCT00235326|80736749|FG000|Overall Study|Lost to Follow-up|746|||
27560215|NCT00616655|80237811|FG002|Overall Study|Other|5|||
27560216|NCT02864251|80237812|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
27560217|NCT02864251|80237813|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
27831837|NCT00205777|81216229|FG000|Study Extension II|Adverse Event|0|||
27831838|NCT00205777|81216230|FG001|Study Extension II|Adverse Event|0|||
27831839|NCT00205777|81216231|FG002|Study Extension II|Adverse Event|0|||
27831840|NCT00205777|81216232|FG003|Study Extension II|Adverse Event|14|||
27831841|NCT00205777|81216233|FG004|Study Extension II|Adverse Event|0|||
27831842|NCT00205777|81216234|FG005|Study Extension II|Adverse Event|30|||
27831843|NCT00205777|81216229|FG000|Study Extension II|Death|0|||
27831844|NCT00205777|81216230|FG001|Study Extension II|Death|0|||
27831845|NCT00205777|81216231|FG002|Study Extension II|Death|0|||
27831846|NCT00205777|81216232|FG003|Study Extension II|Death|2|||
27831847|NCT00205777|81216233|FG004|Study Extension II|Death|0|||
27831848|NCT00205777|81216234|FG005|Study Extension II|Death|5|||
27831849|NCT00205777|81216229|FG000|Study Extension II|Withdrawal by Subject|0|||
27831850|NCT00205777|81216230|FG001|Study Extension II|Withdrawal by Subject|0|||
27831851|NCT00205777|81216231|FG002|Study Extension II|Withdrawal by Subject|0|||
27831852|NCT00205777|81216232|FG003|Study Extension II|Withdrawal by Subject|35|||
27560218|NCT02864251|80237814|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
27560219|NCT02864251|80237812|FG000|Pre-Treatment|Withdrawal by Participant|0|||
27560220|NCT02864251|80237813|FG001|Pre-Treatment|Withdrawal by Participant|0|||
27560221|NCT02864251|80237814|FG002|Pre-Treatment|Withdrawal by Participant|4|||
27560222|NCT02864251|80237812|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
27560223|NCT02864251|80237813|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
27560224|NCT02864251|80237814|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
27560225|NCT02864251|80237812|FG000|Pre-Treatment|Other Reasons|0|||
27560226|NCT02864251|80237813|FG001|Pre-Treatment|Other Reasons|1|||
27560227|NCT02864251|80237814|FG002|Pre-Treatment|Other Reasons|1|||
27560228|NCT02864251|80237812|FG000|Treatment|Disease Progression|109|||
27560229|NCT02864251|80237813|FG001|Treatment|Disease Progression|52|||
27560230|NCT02864251|80237814|FG002|Treatment|Disease Progression|101|||
27560231|NCT02864251|80237812|FG000|Treatment|Study Drug Toxicity|9|||
27560232|NCT02864251|80237813|FG001|Treatment|Study Drug Toxicity|4|||
27560233|NCT02864251|80237814|FG002|Treatment|Study Drug Toxicity|10|||
27560234|NCT02864251|80237812|FG000|Treatment|Death|0|||
27560235|NCT02864251|80237813|FG001|Treatment|Death|2|||
27560236|NCT02864251|80237814|FG002|Treatment|Death|3|||
27560237|NCT02864251|80237812|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
27560238|NCT02864251|80237813|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
27560239|NCT02864251|80237814|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
27560240|NCT02864251|80237812|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
27560241|NCT02864251|80237813|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
27560242|NCT02864251|80237814|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
27699773|NCT00235326|80736750|FG001|Overall Study|Lost to Follow-up|1400|||
27831853|NCT00205777|81216233|FG004|Study Extension II|Withdrawal by Subject|0|||
27831854|NCT00205777|81216234|FG005|Study Extension II|Withdrawal by Subject|59|||
27831855|NCT00205777|81216229|FG000|Study Extension II|Protocol Violation|0|||
27831856|NCT00205777|81216230|FG001|Study Extension II|Protocol Violation|0|||
27560243|NCT02864251|80237812|FG000|Treatment|Withdrawal by Participant|8|||
27831857|NCT00205777|81216231|FG002|Study Extension II|Protocol Violation|0|||
27831858|NCT00205777|81216232|FG003|Study Extension II|Protocol Violation|1|||
27560244|NCT02864251|80237813|FG001|Treatment|Withdrawal by Participant|5|||
27560245|NCT02864251|80237814|FG002|Treatment|Withdrawal by Participant|13|||
27560246|NCT02864251|80237812|FG000|Treatment|Maximum Clinical Benefit|1|||
27699774|NCT01303965|80736751|FG000|Overall Study|Adverse Event|1|||
27699775|NCT01303965|80736752|FG001|Overall Study|Adverse Event|1|||
27699776|NCT01303965|80736751|FG000|Overall Study|Death|0|||
27699777|NCT01303965|80736752|FG001|Overall Study|Death|3|||
27699778|NCT01303965|80736751|FG000|Overall Study|Withdrawal by Subject|1|||
27699779|NCT01303965|80736752|FG001|Overall Study|Withdrawal by Subject|0|||
27699780|NCT01303965|80736751|FG000|Overall Study|Disease Progression|1|||
27699781|NCT01303965|80736752|FG001|Overall Study|Disease Progression|6|||
27699782|NCT03434353|80736754|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
27560247|NCT02864251|80237813|FG001|Treatment|Maximum Clinical Benefit|0|||
27560248|NCT02864251|80237814|FG002|Treatment|Maximum Clinical Benefit|1|||
27560249|NCT02864251|80237812|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
27560250|NCT02864251|80237813|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
27560251|NCT02864251|80237814|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
27560252|NCT02864251|80237812|FG000|Treatment|Other Reasons|1|||
27560253|NCT02864251|80237813|FG001|Treatment|Other Reasons|1|||
27560254|NCT02864251|80237814|FG002|Treatment|Other Reasons|4|||
27560255|NCT02864251|80237812|FG000|Treatment|Administrative Reason by Sponsor|1|||
27560256|NCT02864251|80237813|FG001|Treatment|Administrative Reason by Sponsor|0|||
27560257|NCT02864251|80237814|FG002|Treatment|Administrative Reason by Sponsor|0|||
27560258|NCT02631850|80237817|FG000|Treatment Period|Lost to Follow-up|0|||
27560259|NCT02631850|80237818|FG001|Treatment Period|Lost to Follow-up|1|||
27560260|NCT02631850|80237819|FG002|Treatment Period|Lost to Follow-up|0|||
27560261|NCT02631850|80237820|FG003|Treatment Period|Lost to Follow-up|0|||
27560262|NCT02631850|80237817|FG000|Treatment Period|Protocol Violation|1|||
27560263|NCT02631850|80237818|FG001|Treatment Period|Protocol Violation|0|||
27560264|NCT02631850|80237819|FG002|Treatment Period|Protocol Violation|0|||
27560265|NCT02631850|80237820|FG003|Treatment Period|Protocol Violation|0|||
27560266|NCT02631850|80237817|FG000|Treatment Period|Withdrawal by Subject|0|||
27560267|NCT02631850|80237818|FG001|Treatment Period|Withdrawal by Subject|5|||
27560268|NCT02631850|80237819|FG002|Treatment Period|Withdrawal by Subject|2|||
27560269|NCT02631850|80237820|FG003|Treatment Period|Withdrawal by Subject|2|||
27560270|NCT02631850|80237817|FG000|Treatment Period|Adverse Event|1|||
27560271|NCT02631850|80237818|FG001|Treatment Period|Adverse Event|0|||
27560272|NCT02631850|80237819|FG002|Treatment Period|Adverse Event|2|||
27560273|NCT02631850|80237820|FG003|Treatment Period|Adverse Event|3|||
27560274|NCT02631850|80237817|FG000|Treatment Period|Family medical issue|1|||
27560275|NCT02631850|80237818|FG001|Treatment Period|Family medical issue|0|||
27560276|NCT02631850|80237819|FG002|Treatment Period|Family medical issue|0|||
27560277|NCT02631850|80237820|FG003|Treatment Period|Family medical issue|0|||
27560278|NCT02631850|80237817|FG000|6 Month Follow up|Lost to Follow-up|5|||
27560279|NCT02631850|80237818|FG001|6 Month Follow up|Lost to Follow-up|8|||
27560280|NCT02631850|80237819|FG002|6 Month Follow up|Lost to Follow-up|3|||
27560281|NCT02631850|80237820|FG003|6 Month Follow up|Lost to Follow-up|5|||
27560282|NCT02631850|80237817|FG000|6 Month Follow up|Withdrawal by Subject|1|||
27560283|NCT02631850|80237818|FG001|6 Month Follow up|Withdrawal by Subject|0|||
27560284|NCT02631850|80237819|FG002|6 Month Follow up|Withdrawal by Subject|0|||
27560285|NCT02631850|80237820|FG003|6 Month Follow up|Withdrawal by Subject|2|||
27560286|NCT02631850|80237817|FG000|6 Month Follow up|Adverse Event|1|||
27560287|NCT02631850|80237818|FG001|6 Month Follow up|Adverse Event|4|||
27560288|NCT02631850|80237819|FG002|6 Month Follow up|Adverse Event|1|||
27560289|NCT02631850|80237820|FG003|6 Month Follow up|Adverse Event|3|||
27560290|NCT02631850|80237817|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
27560291|NCT02631850|80237818|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
27560292|NCT02631850|80237819|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
27560293|NCT02631850|80237820|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
27560294|NCT03538158|80237823|FG000|Overall Study|Lost to Follow-up|13|||
27560295|NCT03538158|80237824|FG001|Overall Study|Lost to Follow-up|7|||
27560296|NCT03538158|80237823|FG000|Overall Study|Withdrawal by Subject|2|||
27560297|NCT03538158|80237824|FG001|Overall Study|Withdrawal by Subject|1|||
27560298|NCT01462084|80237825|FG000|Overall Study|Withdrawal by Subject|1|||
27560299|NCT01462084|80237826|FG001|Overall Study|Withdrawal by Subject|0|||
27560300|NCT01462084|80237825|FG000|Overall Study|Protocol Violation|1|||
27699783|NCT03434353|80736755|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
27560301|NCT01462084|80237826|FG001|Overall Study|Protocol Violation|1|||
27560302|NCT02743806|80237827|FG000|Overall Study|Adverse Event|9|||
27699784|NCT03434353|80736756|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
27560303|NCT02743806|80237827|FG000|Overall Study|Lost to Follow-up|8|||
27560304|NCT02743806|80237827|FG000|Overall Study|Voluntary Withdrawal|54|||
27560305|NCT02743806|80237827|FG000|Overall Study|Study Termination|65|||
27560306|NCT02743806|80237827|FG000|Overall Study|Pregnancy|6|||
27560307|NCT02743806|80237827|FG000|Overall Study|No Longer Clinically Benefiting|27|||
27699785|NCT03434353|80736757|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
27560308|NCT02743806|80237827|FG000|Overall Study|Reason Not Specified|12|||
27560309|NCT00082355|80237830|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
27560310|NCT00082355|80237830|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
27560311|NCT00082355|80237830|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
27560312|NCT01313767|80237833|FG000|Overall Study|Adverse Event|1|||
27560313|NCT01313767|80237834|FG001|Overall Study|Adverse Event|0|||
27560314|NCT01313767|80237833|FG000|Overall Study|Lost to Follow-up|1|||
27560315|NCT01313767|80237834|FG001|Overall Study|Lost to Follow-up|0|||
27560316|NCT01313767|80237833|FG000|Overall Study|Withdrawal by Subject|2|||
27560317|NCT01313767|80237834|FG001|Overall Study|Withdrawal by Subject|1|||
27560318|NCT01313767|80237833|FG000|Overall Study|Protocol Violation|3|||
27831859|NCT00205777|81216233|FG004|Study Extension II|Protocol Violation|0|||
27831860|NCT00205777|81216234|FG005|Study Extension II|Protocol Violation|10|||
27831861|NCT00205777|81216229|FG000|Study Extension II|Lack of Efficacy|0|||
27831862|NCT00205777|81216230|FG001|Study Extension II|Lack of Efficacy|0|||
27831863|NCT00205777|81216231|FG002|Study Extension II|Lack of Efficacy|0|||
27831864|NCT00205777|81216232|FG003|Study Extension II|Lack of Efficacy|0|||
27831865|NCT00205777|81216233|FG004|Study Extension II|Lack of Efficacy|0|||
27831866|NCT00205777|81216234|FG005|Study Extension II|Lack of Efficacy|1|||
27831867|NCT00205777|81216229|FG000|Study Extension II|Failed to return|0|||
27831868|NCT00205777|81216230|FG001|Study Extension II|Failed to return|0|||
27831869|NCT00205777|81216231|FG002|Study Extension II|Failed to return|0|||
27831870|NCT00205777|81216232|FG003|Study Extension II|Failed to return|14|||
27831871|NCT00205777|81216233|FG004|Study Extension II|Failed to return|0|||
27831872|NCT00205777|81216234|FG005|Study Extension II|Failed to return|26|||
27831873|NCT00205777|81216229|FG000|Study Extension II|Other Event|0|||
27831874|NCT00205777|81216230|FG001|Study Extension II|Other Event|0|||
27831875|NCT00205777|81216231|FG002|Study Extension II|Other Event|0|||
27831876|NCT00205777|81216232|FG003|Study Extension II|Other Event|12|||
27831877|NCT00205777|81216233|FG004|Study Extension II|Other Event|0|||
27831878|NCT00205777|81216234|FG005|Study Extension II|Other Event|20|||
27831879|NCT00205777|81216229|FG000|Study Extension II|Enrolled but not treated|0|||
27831880|NCT00205777|81216230|FG001|Study Extension II|Enrolled but not treated|0|||
27831881|NCT00205777|81216231|FG002|Study Extension II|Enrolled but not treated|0|||
27831882|NCT00205777|81216232|FG003|Study Extension II|Enrolled but not treated|71|||
27831883|NCT00205777|81216233|FG004|Study Extension II|Enrolled but not treated|0|||
27831884|NCT00205777|81216234|FG005|Study Extension II|Enrolled but not treated|131|||
27831885|NCT01117623|81216239|FG000|Overall Study|Adverse Event|0|||
27831886|NCT01117623|81216240|FG001|Overall Study|Adverse Event|2|||
27831887|NCT01117623|81216241|FG002|Overall Study|Adverse Event|4|||
27831888|NCT01117623|81216242|FG003|Overall Study|Adverse Event|0|||
27831889|NCT01117623|81216243|FG004|Overall Study|Adverse Event|2|||
27831890|NCT01117623|81216244|FG005|Overall Study|Adverse Event|0|||
27831891|NCT01117623|81216245|FG006|Overall Study|Adverse Event|0|||
27831892|NCT01117623|81216246|FG007|Overall Study|Adverse Event|2|||
27831893|NCT01117623|81216239|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
27831894|NCT01117623|81216240|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
27831895|NCT01117623|81216241|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
27831896|NCT01117623|81216242|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
27831897|NCT01117623|81216243|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
27560319|NCT01313767|80237834|FG001|Overall Study|Protocol Violation|1|||
27560320|NCT00503308|80237835|FG000|Overall Study|Protocol Violation|2|||
27560321|NCT00503308|80237836|FG001|Overall Study|Protocol Violation|1|||
27831898|NCT01117623|81216244|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
27831899|NCT01117623|81216245|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
27831900|NCT01117623|81216246|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
27831901|NCT01117623|81216239|FG000|Overall Study|Withdrawal by Subject|0|||
27831902|NCT01117623|81216240|FG001|Overall Study|Withdrawal by Subject|0|||
27831903|NCT01117623|81216241|FG002|Overall Study|Withdrawal by Subject|2|||
27560322|NCT01572909|80237837|FG000|Overall Study|Adverse Event|7|||
27560323|NCT01572909|80237838|FG001|Overall Study|Adverse Event|2|||
27560324|NCT01572909|80237837|FG000|Overall Study|Death|3|||
27560325|NCT01572909|80237838|FG001|Overall Study|Death|1|||
27560326|NCT01572909|80237837|FG000|Overall Study|Lost to Follow-up|8|||
27831904|NCT01117623|81216242|FG003|Overall Study|Withdrawal by Subject|0|||
27831905|NCT01117623|81216243|FG004|Overall Study|Withdrawal by Subject|0|||
27560327|NCT01572909|80237838|FG001|Overall Study|Lost to Follow-up|7|||
27560328|NCT01572909|80237837|FG000|Overall Study|Physician Decision|1|||
27831906|NCT01117623|81216244|FG005|Overall Study|Withdrawal by Subject|1|||
27831907|NCT01117623|81216245|FG006|Overall Study|Withdrawal by Subject|1|||
27831908|NCT01117623|81216246|FG007|Overall Study|Withdrawal by Subject|1|||
27831909|NCT01117623|81216239|FG000|Overall Study|Non-compliance with study medication|0|||
27831910|NCT01117623|81216240|FG001|Overall Study|Non-compliance with study medication|0|||
27831911|NCT01117623|81216241|FG002|Overall Study|Non-compliance with study medication|0|||
27831912|NCT01117623|81216242|FG003|Overall Study|Non-compliance with study medication|0|||
27831913|NCT01117623|81216243|FG004|Overall Study|Non-compliance with study medication|0|||
27831914|NCT01117623|81216244|FG005|Overall Study|Non-compliance with study medication|0|||
27831915|NCT01117623|81216245|FG006|Overall Study|Non-compliance with study medication|0|||
27831916|NCT01117623|81216246|FG007|Overall Study|Non-compliance with study medication|1|||
27831917|NCT01117623|81216239|FG000|Overall Study|Invest. text: completed all planned txs|0|||
27831918|NCT01117623|81216240|FG001|Overall Study|Invest. text: completed all planned txs|0|||
27885715|NCT00685399|81415421|FG000|Extension|Lack of Efficacy|0|||
27560329|NCT01572909|80237838|FG001|Overall Study|Physician Decision|1|||
27560330|NCT01572909|80237837|FG000|Overall Study|Technical Issues|1|||
27560331|NCT01572909|80237838|FG001|Overall Study|Technical Issues|0|||
27560332|NCT01572909|80237837|FG000|Overall Study|Withdrawal by Subject|12|||
27560333|NCT01572909|80237838|FG001|Overall Study|Withdrawal by Subject|11|||
27560334|NCT01572909|80237837|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
27560335|NCT01572909|80237838|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
27560336|NCT01541969|80237841|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
27560337|NCT01541969|80237842|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
27560338|NCT01541969|80237841|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
27560339|NCT01541969|80237842|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
27560340|NCT01541969|80237841|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
27560341|NCT01541969|80237842|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
27560342|NCT01541969|80237841|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
27560343|NCT01541969|80237842|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
27560344|NCT01541969|80237841|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
27560345|NCT01541969|80237842|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
27560346|NCT01541969|80237841|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
27560347|NCT01541969|80237842|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
27560348|NCT01541969|80237841|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
27560349|NCT01541969|80237842|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
27560350|NCT01541969|80237841|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
27560351|NCT01541969|80237842|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
27560352|NCT01541969|80237841|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
27560353|NCT01541969|80237842|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
27560354|NCT01541969|80237841|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
27560355|NCT01541969|80237842|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
27560356|NCT03721276|80237843|FG000|Overall Study|Lost to Follow-up|5|||
27560357|NCT03721276|80237844|FG001|Overall Study|Lost to Follow-up|3|||
27560358|NCT03721276|80237843|FG000|Overall Study|Adverse Event|0|||
27560359|NCT03721276|80237844|FG001|Overall Study|Adverse Event|1|||
27560360|NCT03315208|80237845|FG000|Overall Study|Lost to Follow-up|11|||
27699786|NCT03434353|80736758|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
27699787|NCT03434353|80736754|FG000|Overall Study|Withdrew consent|1|||
27699788|NCT03434353|80736755|FG001|Overall Study|Withdrew consent|0|||
27699789|NCT03434353|80736756|FG002|Overall Study|Withdrew consent|3|||
27699790|NCT03434353|80736757|FG003|Overall Study|Withdrew consent|0|||
27699791|NCT03434353|80736758|FG004|Overall Study|Withdrew consent|0|||
27699792|NCT03434353|80736754|FG000|Overall Study|Adverse Event|1|||
27699793|NCT03434353|80736755|FG001|Overall Study|Adverse Event|0|||
27699794|NCT03434353|80736756|FG002|Overall Study|Adverse Event|0|||
27699795|NCT03434353|80736757|FG003|Overall Study|Adverse Event|0|||
27699796|NCT03434353|80736758|FG004|Overall Study|Adverse Event|1|||
27699797|NCT03434353|80736754|FG000|Overall Study|Lost to Follow-up|2|||
27699798|NCT03434353|80736755|FG001|Overall Study|Lost to Follow-up|0|||
27560361|NCT03315208|80237846|FG001|Overall Study|Lost to Follow-up|6|||
27560362|NCT03315208|80237845|FG000|Overall Study|Withdrawal by Subject|2|||
27699799|NCT03434353|80736756|FG002|Overall Study|Lost to Follow-up|0|||
27699800|NCT03434353|80736757|FG003|Overall Study|Lost to Follow-up|0|||
27699801|NCT03434353|80736758|FG004|Overall Study|Lost to Follow-up|0|||
27699802|NCT02003014|80736759|FG000|Overall Study|Case report forms uncollected|9|||
27699803|NCT02003014|80736759|FG000|Overall Study|Treatment started after contract period|1|||
27699804|NCT02003014|80736759|FG000|Overall Study|Patient did not visit the study site|5|||
27699805|NCT02003014|80736759|FG000|Overall Study|Investigator's transfer|4|||
27699806|NCT01289821|80736760|FG000|Treatment Period|Withdrawal by Subject|1|||
27699807|NCT01289821|80736760|FG000|Treatment Period|Physician Decision|3|||
27699808|NCT01289821|80736760|FG000|Treatment Period|Adverse Event|4|||
27699809|NCT01289821|80736760|FG000|Treatment Period|Radiological Progression|43|||
27699810|NCT01289821|80736760|FG000|Treatment Period|Clinical Progression|2|||
27699811|NCT01289821|80736760|FG000|Treatment Period|Therapeutic procedure required|1|||
27699812|NCT01289821|80736760|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
27699813|NCT01289821|80736760|FG000|Safety Follow-up Period|Protocol Violation|3|||
27699814|NCT01289821|80736760|FG000|Safety Follow-up Period|Unspecified reason|1|||
27699815|NCT01289821|80736760|FG000|Survival Follow-up Period|Protocol Violation|1|||
27699816|NCT01289821|80736760|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
27699817|NCT01289821|80736760|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
27699818|NCT00261846|80736764|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
27699819|NCT00261846|80736765|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
27699820|NCT00261846|80736766|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
27699821|NCT00261846|80736767|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699822|NCT00261846|80736768|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699823|NCT00261846|80736769|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699824|NCT00261846|80736770|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699825|NCT00261846|80736771|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699826|NCT00261846|80736772|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699827|NCT00261846|80736773|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699828|NCT00261846|80736774|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699829|NCT00261846|80736775|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
27699830|NCT00261846|80736764|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699831|NCT00261846|80736765|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699832|NCT00261846|80736766|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699833|NCT00261846|80736767|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
27699834|NCT00261846|80736768|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699835|NCT00261846|80736769|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699836|NCT00261846|80736770|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699837|NCT00261846|80736771|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699838|NCT00261846|80736772|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
27699839|NCT00261846|80736773|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699840|NCT00261846|80736774|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699841|NCT00261846|80736775|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
27699842|NCT00261846|80736764|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
27699843|NCT00261846|80736765|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
27699844|NCT00261846|80736766|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
27699845|NCT00261846|80736767|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
27699846|NCT00261846|80736768|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
27699847|NCT00261846|80736769|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
27699848|NCT00261846|80736770|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
27699849|NCT00261846|80736771|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
27699850|NCT00261846|80736772|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
27699851|NCT00261846|80736773|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
27699852|NCT00261846|80736774|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
27699853|NCT00261846|80736775|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
27699854|NCT00261846|80736764|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
27699855|NCT00261846|80736765|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
27699856|NCT00261846|80736766|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
27699857|NCT00261846|80736767|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
27560363|NCT03315208|80237846|FG001|Overall Study|Withdrawal by Subject|0|||
27699858|NCT00261846|80736768|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
27699859|NCT00261846|80736769|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
27885716|NCT00685399|81415422|FG001|Extension|Lack of Efficacy|0|||
27885717|NCT00685399|81415423|FG002|Extension|Lack of Efficacy|0|||
27885718|NCT00685399|81415424|FG003|Extension|Lack of Efficacy|2|||
27885719|NCT00685399|81415425|FG004|Extension|Lack of Efficacy|0|||
27699860|NCT00261846|80736770|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
27699861|NCT00261846|80736771|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
27699862|NCT00261846|80736772|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
27699863|NCT00261846|80736773|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
27699864|NCT00261846|80736774|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
27699865|NCT00261846|80736775|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
27699866|NCT00261846|80736764|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
27699867|NCT00261846|80736765|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
27699868|NCT00261846|80736766|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
27699869|NCT00261846|80736767|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
27699870|NCT00261846|80736768|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
27699871|NCT00261846|80736769|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
27699872|NCT00261846|80736770|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
27699873|NCT00261846|80736771|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
27699874|NCT00261846|80736772|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
27699875|NCT00261846|80736773|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
27699876|NCT00261846|80736774|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
27699877|NCT00261846|80736775|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
27699878|NCT00261846|80736764|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
27699879|NCT00261846|80736765|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
27699880|NCT00261846|80736766|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
27699881|NCT00261846|80736767|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
27699882|NCT00261846|80736768|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
27699883|NCT00261846|80736769|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
27699884|NCT00261846|80736770|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
27699885|NCT00261846|80736771|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
27699886|NCT00261846|80736772|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
27699887|NCT00261846|80736773|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
27699888|NCT00261846|80736774|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
27699889|NCT00261846|80736775|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
27699890|NCT00261846|80736764|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
27699891|NCT00261846|80736765|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
27699892|NCT00261846|80736766|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
27699893|NCT00261846|80736767|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
27699894|NCT00261846|80736768|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
27699895|NCT00261846|80736769|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
27699896|NCT00261846|80736770|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
27699897|NCT00261846|80736771|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
27699898|NCT00261846|80736772|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
27699899|NCT00261846|80736773|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
27885720|NCT00685399|81415426|FG005|Extension|Lack of Efficacy|0|||
27885721|NCT00685399|81415427|FG006|Extension|Lack of Efficacy|0|||
27885722|NCT00685399|81415428|FG007|Extension|Lack of Efficacy|0|||
27885723|NCT00685399|81415421|FG000|Extension|Adverse Event|0|||
27885724|NCT00685399|81415422|FG001|Extension|Adverse Event|0|||
27885725|NCT00685399|81415423|FG002|Extension|Adverse Event|0|||
27885726|NCT00685399|81415424|FG003|Extension|Adverse Event|2|||
27885727|NCT00685399|81415425|FG004|Extension|Adverse Event|0|||
27885728|NCT00685399|81415426|FG005|Extension|Adverse Event|0|||
27885729|NCT00685399|81415427|FG006|Extension|Adverse Event|0|||
27885730|NCT00685399|81415428|FG007|Extension|Adverse Event|0|||
27885731|NCT03865316|81415429|FG000|Overall Study|Procedure Cancelled|4|||
27885732|NCT03865316|81415429|FG000|Overall Study|Equipment failure|4|||
27885733|NCT00887315|81415430|FG000|Overall Study|Study termination|7|||
27885734|NCT00887315|81415431|FG001|Overall Study|Study termination|4|||
27885735|NCT01862250|81415434|FG000|Overall Study|Adverse Event|4|||
27885736|NCT02040857|81415435|FG000|Overall Study|Adverse Event|14|||
27885737|NCT02040857|81415435|FG000|Overall Study|Physician Decision|5|||
27885738|NCT02040857|81415435|FG000|Overall Study|Withdrawal by Subject|31|||
27885739|NCT02040857|81415435|FG000|Overall Study|patient non-compliance|3|||
27885740|NCT02040857|81415435|FG000|Overall Study|Lost to Follow-up|2|||
27885741|NCT02040857|81415435|FG000|Overall Study|recurrence|4|||
27885742|NCT02040857|81415435|FG000|Overall Study|ineligible|1|||
27699900|NCT00261846|80736774|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
27699901|NCT00261846|80736775|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
27831919|NCT01117623|81216241|FG002|Overall Study|Invest. text: completed all planned txs|0|||
27831920|NCT01117623|81216242|FG003|Overall Study|Invest. text: completed all planned txs|0|||
27831921|NCT01117623|81216243|FG004|Overall Study|Invest. text: completed all planned txs|0|||
27831922|NCT01117623|81216244|FG005|Overall Study|Invest. text: completed all planned txs|1|||
27831923|NCT01117623|81216245|FG006|Overall Study|Invest. text: completed all planned txs|0|||
27831924|NCT01117623|81216246|FG007|Overall Study|Invest. text: completed all planned txs|0|||
27831925|NCT00858780|81216249|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
27831926|NCT00858780|81216250|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27831927|NCT00858780|81216251|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27831928|NCT00858780|81216252|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27831929|NCT00858780|81216253|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
27831930|NCT00858780|81216249|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27831931|NCT00858780|81216250|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27831932|NCT00858780|81216251|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
27831933|NCT00858780|81216252|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27831934|NCT00858780|81216253|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
27831935|NCT00858780|81216249|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
27831936|NCT00858780|81216250|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
27831937|NCT00858780|81216251|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
27831938|NCT00858780|81216252|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
27831939|NCT00858780|81216253|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
27831940|NCT00858780|81216249|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27831941|NCT00858780|81216250|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
27831942|NCT00858780|81216251|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27831943|NCT00858780|81216252|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27831944|NCT00858780|81216253|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
27831945|NCT00858780|81216249|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27831946|NCT00858780|81216250|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27831947|NCT00858780|81216251|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27831948|NCT00858780|81216252|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
27831949|NCT00858780|81216253|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
27831950|NCT00858780|81216249|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
27831951|NCT00858780|81216250|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
27831952|NCT00858780|81216251|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
27831953|NCT00858780|81216252|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
27885743|NCT01250873|81415436|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
27885744|NCT01250873|81415436|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
27885745|NCT00857896|81415437|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
27885746|NCT04439214|81415438|FG000|Overall Study|Adverse Event|13|||
27885747|NCT04439214|81415438|FG000|Overall Study|Disease progression|16|||
27885748|NCT04439214|81415438|FG000|Overall Study|Death|1|||
27885749|NCT04439214|81415438|FG000|Overall Study|Withdrawal by Subject|2|||
27885750|NCT04439214|81415438|FG000|Overall Study|Declining health|1|||
27699902|NCT00866697|80736776|FG000|Overall Study|Study closed/terminated|156|||
27885751|NCT04439214|81415438|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
27885752|NCT04439214|81415438|FG000|Overall Study|Ineligible|5|||
27885753|NCT01726270|81415439|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
27831954|NCT00858780|81216253|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
27831955|NCT00402103|81216254|FG000|Overall Study|Adverse Event|60|||
27831956|NCT00402103|81216255|FG001|Overall Study|Adverse Event|7|||
27831957|NCT00402103|81216254|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27831958|NCT00402103|81216255|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27831959|NCT00402103|81216254|FG000|Overall Study|Condition no longer requires study drug|2|||
27831960|NCT00402103|81216255|FG001|Overall Study|Condition no longer requires study drug|0|||
27885754|NCT01726270|81415439|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
27885755|NCT01726270|81415439|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
27885756|NCT01726270|81415439|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
27885757|NCT01726270|81415439|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
27885758|NCT01726270|81415439|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
27885759|NCT01515865|81415445|FG000|Part A (Open-label)|Other|3|||
27885760|NCT01515865|81415446|FG001|Part A (Open-label)|Other|0|||
27885761|NCT01515865|81415447|FG002|Part A (Open-label)|Other|0|||
27885762|NCT01515865|81415445|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
27885763|NCT01515865|81415446|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
27885764|NCT01515865|81415447|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
27885765|NCT01515865|81415445|FG000|Part B (Open-label)|Other|1|||
27831961|NCT00402103|81216254|FG000|Overall Study|Protocol Deviation|8|||
27831962|NCT00402103|81216255|FG001|Overall Study|Protocol Deviation|0|||
27699903|NCT00866697|80736777|FG001|Overall Study|Study closed/terminated|138|||
27699904|NCT00866697|80736776|FG000|Overall Study|Lost to Follow-up|22|||
27699905|NCT00866697|80736777|FG001|Overall Study|Lost to Follow-up|28|||
27699906|NCT00866697|80736776|FG000|Overall Study|Physician Decision|3|||
27699907|NCT00866697|80736777|FG001|Overall Study|Physician Decision|5|||
27699908|NCT00866697|80736776|FG000|Overall Study|Withdrawal by Subject|33|||
27699909|NCT00866697|80736777|FG001|Overall Study|Withdrawal by Subject|57|||
27699910|NCT05395104|80736778|FG000|Overall Study|Met Liver Stopping Criteria|1|||
27699911|NCT05395104|80736778|FG000|Overall Study|Withdrawal by Subject|1|||
27831963|NCT00402103|81216254|FG000|Overall Study|Patient withdrew consent|12|||
27831964|NCT00402103|81216255|FG001|Overall Study|Patient withdrew consent|1|||
27885766|NCT01515865|81415446|FG001|Part B (Open-label)|Other|0|||
27885767|NCT01515865|81415447|FG002|Part B (Open-label)|Other|0|||
27885768|NCT02411448|81415448|FG000|Overall Study|Withdrawal by Subject|1|||
27885769|NCT02411448|81415449|FG001|Overall Study|Withdrawal by Subject|14|||
27885770|NCT02411448|81415450|FG002|Overall Study|Withdrawal by Subject|9|||
27885771|NCT02411448|81415448|FG000|Overall Study|Other|0|||
27885772|NCT02411448|81415449|FG001|Overall Study|Other|2|||
27885773|NCT02411448|81415450|FG002|Overall Study|Other|0|||
27885774|NCT02411448|81415448|FG000|Overall Study|Did not receive study treatment|0|||
27699912|NCT02684279|80736779|FG000|Overall Study|Adverse Event|87|||
27831965|NCT00402103|81216254|FG000|Overall Study|Lost to Follow-up|6|||
27885775|NCT02411448|81415449|FG001|Overall Study|Did not receive study treatment|3|||
27885776|NCT02411448|81415450|FG002|Overall Study|Did not receive study treatment|0|||
27885777|NCT02411448|81415448|FG000|Overall Study|Alive on study treatment|3|||
27885778|NCT02411448|81415449|FG001|Overall Study|Alive on study treatment|64|||
27885779|NCT02411448|81415450|FG002|Overall Study|Alive on study treatment|43|||
27885780|NCT01942486|81415451|FG000|Overall Study|Lost to Follow-up|27|||
27699913|NCT02684279|80736779|FG000|Overall Study|Lack of Efficacy|4|||
27699914|NCT02684279|80736779|FG000|Overall Study|Lost to Follow-up|61|||
27699915|NCT02684279|80736779|FG000|Overall Study|Protocol Violation|6|||
27699916|NCT02684279|80736779|FG000|Overall Study|Pregnancy|8|||
27699917|NCT02684279|80736779|FG000|Overall Study|Withdrawal by Subject|92|||
27699918|NCT02684279|80736779|FG000|Overall Study|non-compliance with study drug|9|||
27885781|NCT03436693|81415452|FG000|Overall Study|Adverse Event|22|||
27885782|NCT03436693|81415453|FG001|Overall Study|Adverse Event|10|||
27885783|NCT03436693|81415452|FG000|Overall Study|Physician Decision|3|||
27831966|NCT00402103|81216255|FG001|Overall Study|Lost to Follow-up|3|||
27831967|NCT00402103|81216254|FG000|Overall Study|Administrative problems|2|||
27831968|NCT00402103|81216255|FG001|Overall Study|Administrative problems|0|||
27831969|NCT00957021|81216258|FG000|Overall Study|Death|5|||
27831970|NCT00957021|81216258|FG000|Overall Study|Lost to Follow-up|8|||
27831971|NCT00957021|81216258|FG000|Overall Study|Withdrawal by Subject|34|||
27831972|NCT00957021|81216258|FG000|Overall Study|No 2 yr ROM data|35|||
27831973|NCT00957021|81216258|FG000|Overall Study|Revised study component by 2 yr visit|8|||
27831974|NCT00957021|81216258|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
27831975|NCT00957021|81216258|FG000|Overall Study|Surgery Cancelled|9|||
27831976|NCT00957021|81216258|FG000|Overall Study|Termination due to language issue|2|||
27831977|NCT01559363|81216260|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
27831978|NCT01559363|81216261|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
27885784|NCT03436693|81415453|FG001|Overall Study|Physician Decision|3|||
27885785|NCT03436693|81415452|FG000|Overall Study|Withdrawal by Subject|4|||
27885786|NCT03436693|81415453|FG001|Overall Study|Withdrawal by Subject|13|||
27885787|NCT03436693|81415452|FG000|Overall Study|Progressive Disease|1|||
27885788|NCT03436693|81415453|FG001|Overall Study|Progressive Disease|1|||
27885789|NCT01263782|81415462|FG000|Overall Study|Death|0|||
27885790|NCT01263782|81415463|FG001|Overall Study|Death|0|||
27885791|NCT01263782|81415464|FG002|Overall Study|Death|1|||
27885792|NCT01263782|81415465|FG003|Overall Study|Death|0|||
27885793|NCT01263782|81415462|FG000|Overall Study|Progressive disease|0|||
27885794|NCT01263782|81415463|FG001|Overall Study|Progressive disease|0|||
27885795|NCT01263782|81415464|FG002|Overall Study|Progressive disease|0|||
27885796|NCT01263782|81415465|FG003|Overall Study|Progressive disease|1|||
27885797|NCT01263782|81415462|FG000|Overall Study|Too early|0|||
27885798|NCT01263782|81415463|FG001|Overall Study|Too early|0|||
27885799|NCT01263782|81415464|FG002|Overall Study|Too early|1|||
27885800|NCT01263782|81415465|FG003|Overall Study|Too early|0|||
27885801|NCT01263782|81415462|FG000|Overall Study|Inevaluable|0|||
27885802|NCT01263782|81415463|FG001|Overall Study|Inevaluable|0|||
27885803|NCT01263782|81415464|FG002|Overall Study|Inevaluable|1|||
27885804|NCT01263782|81415465|FG003|Overall Study|Inevaluable|0|||
27885805|NCT01866111|81415471|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
27885806|NCT01866111|81415472|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
27885807|NCT01866111|81415473|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
27885808|NCT01866111|81415474|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
27885809|NCT01866111|81415471|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
27885810|NCT01866111|81415472|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
27885811|NCT01866111|81415473|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
27885812|NCT01866111|81415474|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
27885813|NCT00280397|81415479|FG000|Overall Study|Adverse Event|1|||
27885814|NCT02907892|81415480|FG000|Overall Study|Lost to Follow-up|27|||
27699919|NCT02684279|80736779|FG000|Overall Study|non compliance with study visits|2|||
27699920|NCT02684279|80736779|FG000|Overall Study|subject to have surgery|1|||
27885815|NCT02907892|81415481|FG001|Overall Study|Lost to Follow-up|40|||
27885816|NCT01322490|81415482|FG000|Treatment Period|Adverse Event|12|||
27885817|NCT01322490|81415483|FG001|Treatment Period|Adverse Event|18|||
27885818|NCT01322490|81415484|FG002|Treatment Period|Adverse Event|15|||
27885819|NCT01322490|81415482|FG000|Treatment Period|Death|5|||
27885820|NCT01322490|81415483|FG001|Treatment Period|Death|7|||
27885821|NCT01322490|81415484|FG002|Treatment Period|Death|3|||
27885822|NCT01322490|81415482|FG000|Treatment Period|Lack of Efficacy|89|||
27885823|NCT01322490|81415483|FG001|Treatment Period|Lack of Efficacy|100|||
27885824|NCT01322490|81415484|FG002|Treatment Period|Lack of Efficacy|112|||
27885825|NCT01322490|81415482|FG000|Treatment Period|Physician Decision|0|||
27699921|NCT02684279|80736779|FG000|Overall Study|family emergency|1|||
27699922|NCT02684279|80736779|FG000|Overall Study|Site closures|7|||
27831979|NCT01559363|81216262|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
27831980|NCT01559363|81216263|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
27885826|NCT01322490|81415483|FG001|Treatment Period|Physician Decision|2|||
27885827|NCT01322490|81415484|FG002|Treatment Period|Physician Decision|1|||
27885828|NCT01322490|81415482|FG000|Treatment Period|Protocol Violation|7|||
27885829|NCT01322490|81415483|FG001|Treatment Period|Protocol Violation|5|||
27885830|NCT01322490|81415484|FG002|Treatment Period|Protocol Violation|4|||
27831981|NCT01559363|81216264|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
27885831|NCT01322490|81415482|FG000|Treatment Period|Withdrawal by Subject|14|||
27885832|NCT01322490|81415483|FG001|Treatment Period|Withdrawal by Subject|16|||
27885833|NCT01322490|81415484|FG002|Treatment Period|Withdrawal by Subject|11|||
27885834|NCT01322490|81415482|FG000|Treatment Period|Non-compliance with study drug|0|||
27885835|NCT01322490|81415483|FG001|Treatment Period|Non-compliance with study drug|0|||
27831982|NCT01559363|81216265|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
27831983|NCT01559363|81216260|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
27831984|NCT01559363|81216261|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
27831985|NCT01559363|81216262|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
27831986|NCT01559363|81216263|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
27831987|NCT01559363|81216264|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
27831988|NCT01559363|81216265|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
27831989|NCT01559363|81216260|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
27831990|NCT01559363|81216261|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
27831991|NCT01559363|81216262|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27831992|NCT01559363|81216263|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27699923|NCT02684279|80736779|FG000|Overall Study|Physician Decision|1|||
27831993|NCT01559363|81216264|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27831994|NCT01559363|81216265|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
27831995|NCT01559363|81216260|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
27831996|NCT01559363|81216261|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27831997|NCT01559363|81216262|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
27831998|NCT01559363|81216263|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27831999|NCT01559363|81216264|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27832000|NCT01559363|81216265|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
27832001|NCT01559363|81216260|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27560364|NCT00249444|80237847|FG000|Overall Study|Lost to Follow-up|2|||
27560365|NCT00249444|80237848|FG001|Overall Study|Lost to Follow-up|2|||
27560366|NCT00249444|80237847|FG000|Overall Study|non-compliant|9|||
27560367|NCT00249444|80237848|FG001|Overall Study|non-compliant|11|||
27560368|NCT00249444|80237847|FG000|Overall Study|Adverse Event|1|||
27560369|NCT00249444|80237848|FG001|Overall Study|Adverse Event|1|||
27560370|NCT00249444|80237847|FG000|Overall Study|life event|0|||
27699924|NCT02401412|80736780|FG000|Overall Study|Lost to Follow-up|1|||
27699925|NCT02401412|80736781|FG001|Overall Study|Lost to Follow-up|0|||
27885836|NCT01322490|81415484|FG002|Treatment Period|Non-compliance with study drug|1|||
27885837|NCT01322490|81415482|FG000|Treatment Period|Other per report|2|||
27885838|NCT01322490|81415483|FG001|Treatment Period|Other per report|2|||
27885839|NCT01322490|81415484|FG002|Treatment Period|Other per report|1|||
27885840|NCT01322490|81415482|FG000|Treatment Period|Randomized but Not Treated|3|||
27885841|NCT01322490|81415483|FG001|Treatment Period|Randomized but Not Treated|3|||
27885842|NCT01322490|81415484|FG002|Treatment Period|Randomized but Not Treated|5|||
27885843|NCT01322490|81415482|FG000|Long Term Follow-up Period|Death|235|||
27885844|NCT01322490|81415483|FG001|Long Term Follow-up Period|Death|239|||
27699926|NCT02401412|80736780|FG000|Overall Study|Discontinued Intervention|15|||
27699927|NCT02401412|80736781|FG001|Overall Study|Discontinued Intervention|21|||
27699928|NCT02401412|80736780|FG000|Overall Study|Withdrawal by Subject|4|||
27885845|NCT01322490|81415484|FG002|Long Term Follow-up Period|Death|236|||
27885846|NCT01322490|81415482|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
27885847|NCT01322490|81415483|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
27885848|NCT01322490|81415484|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
27885849|NCT01322490|81415482|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
27885850|NCT01322490|81415483|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
27885851|NCT01322490|81415484|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
27560371|NCT00249444|80237848|FG001|Overall Study|life event|1|||
27560372|NCT00411645|80237867|FG000|Overall Study|Consent Withdrawn|13|||
27560373|NCT00411645|80237868|FG001|Overall Study|Consent Withdrawn|22|||
27699929|NCT02401412|80736781|FG001|Overall Study|Withdrawal by Subject|4|||
27832002|NCT01559363|81216261|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
27832003|NCT01559363|81216262|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27832004|NCT01559363|81216263|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27832005|NCT01559363|81216264|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27832006|NCT01559363|81216265|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
27832007|NCT01559363|81216260|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27832008|NCT01559363|81216261|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27832009|NCT01559363|81216262|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27832010|NCT01559363|81216263|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
27832011|NCT01559363|81216264|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
27832012|NCT01559363|81216265|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
27832013|NCT01559363|81216260|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27832014|NCT01559363|81216261|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27832015|NCT01559363|81216262|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27832016|NCT01559363|81216263|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
27832017|NCT01559363|81216264|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27832018|NCT01559363|81216265|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
27832019|NCT03218787|81216272|FG000|Overall Study|Lost to Follow-up|12|||
27832020|NCT03218787|81216272|FG000|Overall Study|Withdrawal by Subject|72|||
27832021|NCT03218787|81216272|FG000|Overall Study|Physician Decision|11|||
27832022|NCT03218787|81216272|FG000|Overall Study|Death|111|||
27832023|NCT02654145|81216273|FG000|Overall Study|Lack of Efficacy|1|||
27832024|NCT02654145|81216273|FG000|Overall Study|Protocol Violation|1|||
27832025|NCT02654145|81216273|FG000|Overall Study|Withdrawal by Subject|5|||
27832026|NCT02385708|81216276|FG000|Overall Study|Withdrawal by Subject|0|||
27832027|NCT02385708|81216277|FG001|Overall Study|Withdrawal by Subject|2|||
27832028|NCT02385708|81216276|FG000|Overall Study|Withdrawn - surgery canceled|2|||
27832029|NCT02385708|81216277|FG001|Overall Study|Withdrawn - surgery canceled|5|||
27832030|NCT02385708|81216276|FG000|Overall Study|Investigator decision|5|||
27832031|NCT02385708|81216277|FG001|Overall Study|Investigator decision|7|||
27832032|NCT02385708|81216276|FG000|Overall Study|Protocol Violation|1|||
27832033|NCT02385708|81216277|FG001|Overall Study|Protocol Violation|1|||
27832034|NCT00268203|81216280|FG000|Overall Study|Lost to Follow-up|92|||
27832035|NCT00268203|81216280|FG000|Overall Study|Withdrawal by Subject|9|||
27832036|NCT00268203|81216280|FG000|Overall Study|Received Other NHL Therapy|7|||
27832037|NCT00268203|81216280|FG000|Overall Study|Progressive Disease|359|||
27832038|NCT00268203|81216280|FG000|Overall Study|Death|84|||
27832039|NCT00268203|81216280|FG000|Overall Study|Reason Not Specified|34|||
27832040|NCT00268203|81216280|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
27832041|NCT05068284|81216281|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
27832042|NCT05068284|81216282|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
27832043|NCT05068284|81216283|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
27832044|NCT05068284|81216284|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
27832045|NCT05068284|81216285|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
27832046|NCT05068284|81216286|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
27832047|NCT05068284|81216287|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
27832048|NCT05068284|81216288|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
27832049|NCT05068284|81216281|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832050|NCT05068284|81216282|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832051|NCT05068284|81216283|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
27832052|NCT05068284|81216284|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832053|NCT05068284|81216285|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832054|NCT05068284|81216286|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832055|NCT05068284|81216287|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832056|NCT05068284|81216288|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
27832057|NCT05068284|81216281|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
27832058|NCT05068284|81216282|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
27832059|NCT05068284|81216283|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
27832060|NCT05068284|81216284|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
27885852|NCT01322490|81415482|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
27885853|NCT01322490|81415483|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
27885854|NCT01322490|81415484|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
27885855|NCT01322490|81415482|FG000|Long Term Follow-up Period|Other per report|3|||
27832061|NCT05068284|81216285|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
27832062|NCT05068284|81216286|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
27832063|NCT05068284|81216287|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
27832064|NCT05068284|81216288|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
27832065|NCT05068284|81216281|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
27832066|NCT05068284|81216282|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
27885856|NCT01322490|81415483|FG001|Long Term Follow-up Period|Other per report|2|||
27885857|NCT01322490|81415484|FG002|Long Term Follow-up Period|Other per report|2|||
27885858|NCT01322490|81415482|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
27885859|NCT01322490|81415483|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
27832067|NCT05068284|81216283|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
27832068|NCT05068284|81216284|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
27832069|NCT05068284|81216285|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
27832070|NCT05068284|81216286|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
27832071|NCT05068284|81216287|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
27832072|NCT05068284|81216288|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
27832073|NCT05068284|81216281|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832074|NCT05068284|81216282|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832075|NCT05068284|81216283|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832076|NCT05068284|81216284|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
27832077|NCT05068284|81216285|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832078|NCT05068284|81216286|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832079|NCT05068284|81216287|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832080|NCT05068284|81216288|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
27832081|NCT05068284|81216281|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
27832082|NCT05068284|81216282|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
27832083|NCT05068284|81216283|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
27560374|NCT00411645|80237867|FG000|Overall Study|Death|56|||
27560375|NCT00411645|80237868|FG001|Overall Study|Death|135|||
27560376|NCT00411645|80237867|FG000|Overall Study|Investigator/Sponsor Decision|10|||
27560377|NCT00411645|80237868|FG001|Overall Study|Investigator/Sponsor Decision|7|||
27560378|NCT00411645|80237867|FG000|Overall Study|Lost to Follow-up|2|||
27560379|NCT00411645|80237868|FG001|Overall Study|Lost to Follow-up|0|||
27560380|NCT00695396|80237869|FG000|Overall Study|Study Closed Prematurely|5|||
27560381|NCT00695396|80237870|FG001|Overall Study|Study Closed Prematurely|6|||
27560382|NCT00695396|80237871|FG002|Overall Study|Study Closed Prematurely|8|||
27560383|NCT00695396|80237869|FG000|Overall Study|Withdrawal by Subject|2|||
27560384|NCT00695396|80237870|FG001|Overall Study|Withdrawal by Subject|2|||
27560385|NCT00695396|80237871|FG002|Overall Study|Withdrawal by Subject|0|||
27560386|NCT00475176|80237875|FG000|Overall Study|Adverse Event|2|||
27832084|NCT05068284|81216284|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
27885860|NCT01322490|81415484|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
27885861|NCT00626821|81415485|FG000|Overall Study|Adverse Event|44|||
27885862|NCT00626821|81415485|FG000|Overall Study|Protocol Violation|33|||
27885863|NCT00626821|81415485|FG000|Overall Study|Withdrawal by Subject|10|||
27885864|NCT00626821|81415485|FG000|Overall Study|Physician Decision|9|||
27885865|NCT00626821|81415485|FG000|Overall Study|Product dysfunction|21|||
27885866|NCT00626821|81415485|FG000|Overall Study|other/unknown reason|104|||
27885867|NCT02702388|81415488|FG000|Overall Study|Disease Progression|18|||
27885868|NCT02702388|81415489|FG001|Overall Study|Disease Progression|25|||
27885869|NCT02702388|81415488|FG000|Overall Study|Withdrawal by Subject|9|||
27885870|NCT02702388|81415489|FG001|Overall Study|Withdrawal by Subject|7|||
27885871|NCT02702388|81415488|FG000|Overall Study|Adverse Event|11|||
27885872|NCT02702388|81415489|FG001|Overall Study|Adverse Event|15|||
27885873|NCT02702388|81415488|FG000|Overall Study|Other|2|||
27885874|NCT02702388|81415489|FG001|Overall Study|Other|4|||
27885875|NCT03224598|81415495|FG000|Overall Study|Lost to Follow-up|0|||
27885876|NCT03224598|81415496|FG001|Overall Study|Lost to Follow-up|2|||
27885877|NCT03224598|81415497|FG002|Overall Study|Lost to Follow-up|0|||
27885878|NCT03224598|81415495|FG000|Overall Study|Other|0|||
27885879|NCT03224598|81415496|FG001|Overall Study|Other|1|||
27885880|NCT03224598|81415497|FG002|Overall Study|Other|0|||
27885881|NCT02714595|81415498|FG000|Overall Study|Lost to Follow-up|1|||
27885882|NCT02714595|81415499|FG001|Overall Study|Lost to Follow-up|0|||
27885883|NCT02714595|81415498|FG000|Overall Study|Withdrawal by Subject|1|||
27885884|NCT02714595|81415499|FG001|Overall Study|Withdrawal by Subject|2|||
27885885|NCT02714595|81415498|FG000|Overall Study|Lack of Efficacy|0|||
27885886|NCT02714595|81415499|FG001|Overall Study|Lack of Efficacy|1|||
27885887|NCT02714595|81415498|FG000|Overall Study|Death|30|||
27885888|NCT02714595|81415499|FG001|Overall Study|Death|9|||
27885889|NCT02714595|81415498|FG000|Overall Study|Other-Miscellaneous|0|||
27885890|NCT02714595|81415499|FG001|Overall Study|Other-Miscellaneous|1|||
27885891|NCT04236141|81415500|FG000|Overall Study|Death|18|||
27885892|NCT04236141|81415501|FG001|Overall Study|Death|10|||
27885893|NCT04236141|81415500|FG000|Overall Study|Withdrawal by Participant|1|||
27885894|NCT04236141|81415501|FG001|Overall Study|Withdrawal by Participant|0|||
27885895|NCT04236141|81415500|FG000|Overall Study|Reason not Specified|1|||
27885896|NCT04236141|81415501|FG001|Overall Study|Reason not Specified|0|||
27560387|NCT00475176|80237875|FG000|Overall Study|Withdrawal by Subject|1|||
27560388|NCT00475176|80237875|FG000|Overall Study|Protocol Violation|1|||
27885897|NCT04236141|81415500|FG000|Overall Study|Study terminated by Sponsor|8|||
27832085|NCT05068284|81216285|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
27832086|NCT05068284|81216286|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
27832087|NCT05068284|81216287|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
27832088|NCT05068284|81216288|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
27832089|NCT05068284|81216281|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832090|NCT05068284|81216282|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832091|NCT05068284|81216283|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
27832092|NCT05068284|81216284|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832093|NCT05068284|81216285|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832094|NCT05068284|81216286|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832095|NCT05068284|81216287|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832096|NCT05068284|81216288|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
27832097|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
27832098|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832099|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832100|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832101|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832102|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832103|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832104|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
27832105|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
27832106|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
27832107|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
27832108|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
27832109|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
27832110|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
27832111|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
27832112|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
27832113|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
27832114|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
27832115|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
27832116|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
27832117|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
27832118|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
27832119|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
27832120|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
27832121|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
27832122|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832123|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832124|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832125|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832126|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832127|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832128|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
27832129|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
27832130|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832131|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832132|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832133|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832134|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832135|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832136|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
27832137|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
27560389|NCT02736409|80237876|FG000|Overall Study|Withdrawal by Subject|4|||
27560390|NCT02736409|80237877|FG001|Overall Study|Withdrawal by Subject|2|||
27560391|NCT02736409|80237878|FG002|Overall Study|Withdrawal by Subject|17|||
27560392|NCT02736409|80237879|FG003|Overall Study|Withdrawal by Subject|3|||
27560393|NCT02736409|80237876|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27560394|NCT02736409|80237877|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27832138|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
27832139|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
27832140|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
27832141|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
27832142|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
27832143|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
27832144|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
27832145|NCT05068284|81216281|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
27832146|NCT05068284|81216282|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
27832147|NCT05068284|81216283|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
27832148|NCT05068284|81216284|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
27832149|NCT05068284|81216285|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
27832150|NCT05068284|81216286|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
27885898|NCT04236141|81415501|FG001|Overall Study|Study terminated by Sponsor|4|||
27885899|NCT02111577|81415503|FG000|Overall Study|Protocol Violation|2|||
27560395|NCT02736409|80237878|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27560396|NCT02736409|80237879|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27560397|NCT02736409|80237876|FG000|Overall Study|Adverse Event|0|||
27560398|NCT02736409|80237877|FG001|Overall Study|Adverse Event|1|||
27560399|NCT02736409|80237878|FG002|Overall Study|Adverse Event|5|||
27560400|NCT02736409|80237879|FG003|Overall Study|Adverse Event|4|||
27560401|NCT02736409|80237876|FG000|Overall Study|Other|0|||
27560402|NCT02736409|80237877|FG001|Overall Study|Other|0|||
27885900|NCT02111577|81415504|FG001|Overall Study|Protocol Violation|0|||
27885901|NCT02111577|81415503|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
27885902|NCT02111577|81415504|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
27885903|NCT02111577|81415503|FG000|Overall Study|Failure to produce study treatment|6|||
27885904|NCT02111577|81415504|FG001|Overall Study|Failure to produce study treatment|0|||
27885905|NCT02111577|81415503|FG000|Overall Study|Death|518|||
27885906|NCT02111577|81415504|FG001|Overall Study|Death|254|||
27885907|NCT02111577|81415503|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
27885908|NCT02111577|81415504|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
27885909|NCT02111577|81415503|FG000|Overall Study|Adverse Event|1|||
27885910|NCT02111577|81415504|FG001|Overall Study|Adverse Event|1|||
27832151|NCT05068284|81216287|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
27832152|NCT05068284|81216288|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
27832153|NCT04697173|81216295|FG000|Overall Study|Withdrawal by Subject|34|||
27832154|NCT04697173|81216296|FG001|Overall Study|Withdrawal by Subject|38|||
27832155|NCT04025021|81216297|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
27832156|NCT04025021|81216298|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
27832157|NCT01867658|81216299|FG000|Overall Study|Withdrawal by Subject|6|||
27832158|NCT01867658|81216299|FG000|Overall Study|Death|2|||
27832159|NCT01867658|81216299|FG000|Overall Study|Subject could not be contacted|1|||
27885911|NCT02111577|81415503|FG000|Overall Study|Withdrawal by Subject|51|||
27885912|NCT02111577|81415504|FG001|Overall Study|Withdrawal by Subject|23|||
27885913|NCT02111577|81415503|FG000|Overall Study|Disease progression|0|||
27885914|NCT02111577|81415504|FG001|Overall Study|Disease progression|1|||
27885915|NCT02111577|81415503|FG000|Overall Study|Lost to Follow-up|19|||
27832160|NCT00081653|81216300|FG000|Overall Study|Adverse Event|23|||
27832161|NCT00081653|81216301|FG001|Overall Study|Adverse Event|17|||
27832162|NCT00081653|81216300|FG000|Overall Study|Lost to Follow-up|2|||
27832163|NCT00081653|81216301|FG001|Overall Study|Lost to Follow-up|4|||
27832164|NCT00081653|81216300|FG000|Overall Study|Refused Treatment|18|||
27832165|NCT00081653|81216301|FG001|Overall Study|Refused Treatment|14|||
27832166|NCT00081653|81216300|FG000|Overall Study|Low bone mineral density|1|||
27832167|NCT00081653|81216301|FG001|Overall Study|Low bone mineral density|0|||
27832168|NCT00081653|81216300|FG000|Overall Study|Bone loss|2|||
27832169|NCT00081653|81216301|FG001|Overall Study|Bone loss|0|||
27832170|NCT00081653|81216300|FG000|Overall Study|Participant leaving country|1|||
27832171|NCT00081653|81216301|FG001|Overall Study|Participant leaving country|0|||
27832172|NCT00081653|81216300|FG000|Overall Study|Loss of bone mass|0|||
27832173|NCT00081653|81216301|FG001|Overall Study|Loss of bone mass|2|||
27832174|NCT03889639|81216302|FG000|Overall Study|Withdrawal by Subject|0|||
27832175|NCT03889639|81216303|FG001|Overall Study|Withdrawal by Subject|0|||
27832176|NCT03889639|81216304|FG002|Overall Study|Withdrawal by Subject|0|||
27832177|NCT03889639|81216305|FG003|Overall Study|Withdrawal by Subject|0|||
27832178|NCT03889639|81216306|FG004|Overall Study|Withdrawal by Subject|0|||
27832179|NCT03889639|81216307|FG005|Overall Study|Withdrawal by Subject|0|||
27832180|NCT03889639|81216308|FG006|Overall Study|Withdrawal by Subject|0|||
27832181|NCT03889639|81216309|FG007|Overall Study|Withdrawal by Subject|1|||
27832182|NCT03214588|81216310|FG000|Overall Study|Adverse Event|1|||
27885916|NCT02111577|81415504|FG001|Overall Study|Lost to Follow-up|10|||
27832183|NCT03214588|81216311|FG001|Overall Study|Adverse Event|0|||
27832184|NCT03214588|81216312|FG002|Overall Study|Adverse Event|2|||
27832185|NCT03214588|81216310|FG000|Overall Study|Reason Not Specified|0|||
27832186|NCT03214588|81216311|FG001|Overall Study|Reason Not Specified|1|||
27832187|NCT03214588|81216312|FG002|Overall Study|Reason Not Specified|0|||
27832188|NCT03966911|81216313|FG000|Overall Study|Adverse Event|1|||
27832189|NCT03966911|81216314|FG001|Overall Study|Adverse Event|1|||
27885917|NCT00754234|81415505|FG000|Overall Study|Withdrawal by Subject|3|||
27885918|NCT01738503|81415506|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
27832190|NCT03966911|81216313|FG000|Overall Study|Withdrawal by Subject|8|||
27832191|NCT03966911|81216314|FG001|Overall Study|Withdrawal by Subject|2|||
27885919|NCT01738503|81415507|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
27885920|NCT01738503|81415508|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
27885921|NCT01738503|81415509|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
27885922|NCT01738503|81415510|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
27885923|NCT01738503|81415511|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
27885924|NCT01738503|81415512|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
27885925|NCT01738503|81415506|FG000|Treatment Period|Adverse Event|0|||
27885926|NCT01738503|81415507|FG001|Treatment Period|Adverse Event|1|||
27885927|NCT01738503|81415508|FG002|Treatment Period|Adverse Event|0|||
27885928|NCT01738503|81415509|FG003|Treatment Period|Adverse Event|1|||
27885929|NCT01738503|81415510|FG004|Treatment Period|Adverse Event|2|||
27885930|NCT01738503|81415511|FG005|Treatment Period|Adverse Event|2|||
27885931|NCT01738503|81415512|FG006|Treatment Period|Adverse Event|2|||
27885932|NCT01738503|81415506|FG000|Treatment Period|Lost to Follow-up|0|||
27885933|NCT01738503|81415507|FG001|Treatment Period|Lost to Follow-up|0|||
27885934|NCT01738503|81415508|FG002|Treatment Period|Lost to Follow-up|3|||
27885935|NCT01738503|81415509|FG003|Treatment Period|Lost to Follow-up|4|||
27885936|NCT01738503|81415510|FG004|Treatment Period|Lost to Follow-up|1|||
27885937|NCT01738503|81415511|FG005|Treatment Period|Lost to Follow-up|1|||
27560403|NCT02736409|80237878|FG002|Overall Study|Other|1|||
27560404|NCT02736409|80237879|FG003|Overall Study|Other|1|||
27560405|NCT02736409|80237876|FG000|Overall Study|Pregnancy|0|||
27560406|NCT02736409|80237877|FG001|Overall Study|Pregnancy|0|||
27560407|NCT02736409|80237878|FG002|Overall Study|Pregnancy|1|||
27560408|NCT02736409|80237879|FG003|Overall Study|Pregnancy|0|||
27560409|NCT02736409|80237876|FG000|Overall Study|Lost to Follow-up|0|||
27560410|NCT02736409|80237877|FG001|Overall Study|Lost to Follow-up|0|||
27560411|NCT02736409|80237878|FG002|Overall Study|Lost to Follow-up|2|||
27560412|NCT02736409|80237879|FG003|Overall Study|Lost to Follow-up|1|||
27560413|NCT02736409|80237876|FG000|Overall Study|Physician Decision|0|||
27560414|NCT02736409|80237877|FG001|Overall Study|Physician Decision|0|||
27560415|NCT02736409|80237878|FG002|Overall Study|Physician Decision|0|||
27560416|NCT02736409|80237879|FG003|Overall Study|Physician Decision|2|||
27560417|NCT01111149|80237880|FG000|Overall Study|Protocol Violation|1|||
27560418|NCT01111149|80237881|FG001|Overall Study|Protocol Violation|1|||
27560419|NCT01111149|80237882|FG002|Overall Study|Protocol Violation|2|||
27560420|NCT01111149|80237880|FG000|Overall Study|Withdrawal by Subject|1|||
27885938|NCT01738503|81415512|FG006|Treatment Period|Lost to Follow-up|5|||
27885939|NCT01738503|81415506|FG000|Treatment Period|Withdrawal by Subject|0|||
27885940|NCT01738503|81415507|FG001|Treatment Period|Withdrawal by Subject|1|||
27885941|NCT01738503|81415508|FG002|Treatment Period|Withdrawal by Subject|0|||
27885942|NCT01738503|81415509|FG003|Treatment Period|Withdrawal by Subject|1|||
27885943|NCT01738503|81415510|FG004|Treatment Period|Withdrawal by Subject|1|||
27885944|NCT01738503|81415511|FG005|Treatment Period|Withdrawal by Subject|1|||
27885945|NCT01738503|81415512|FG006|Treatment Period|Withdrawal by Subject|1|||
27885946|NCT01738503|81415506|FG000|Treatment Period|Protocol Violation|0|||
27885947|NCT01738503|81415507|FG001|Treatment Period|Protocol Violation|3|||
27885948|NCT01738503|81415508|FG002|Treatment Period|Protocol Violation|1|||
27885949|NCT01738503|81415509|FG003|Treatment Period|Protocol Violation|0|||
27885950|NCT01738503|81415510|FG004|Treatment Period|Protocol Violation|4|||
27885951|NCT01738503|81415511|FG005|Treatment Period|Protocol Violation|2|||
27885952|NCT01738503|81415512|FG006|Treatment Period|Protocol Violation|0|||
27885953|NCT01738503|81415506|FG000|Treatment Period|Other|0|||
27885954|NCT01738503|81415507|FG001|Treatment Period|Other|0|||
27885955|NCT01738503|81415508|FG002|Treatment Period|Other|1|||
27885956|NCT01738503|81415509|FG003|Treatment Period|Other|0|||
27885957|NCT01738503|81415510|FG004|Treatment Period|Other|0|||
27560421|NCT01111149|80237881|FG001|Overall Study|Withdrawal by Subject|0|||
27885958|NCT01738503|81415511|FG005|Treatment Period|Other|0|||
27885959|NCT01738503|81415512|FG006|Treatment Period|Other|0|||
27885960|NCT01738503|81415506|FG000|PET Imaging Sub-study|Adverse Event|0|||
27885961|NCT01738503|81415507|FG001|PET Imaging Sub-study|Adverse Event|0|||
27885962|NCT01738503|81415508|FG002|PET Imaging Sub-study|Adverse Event|0|||
27560422|NCT01111149|80237882|FG002|Overall Study|Withdrawal by Subject|2|||
27560423|NCT01348347|80237883|FG000|Overall Study|Withdrawal by Subject|1|||
27560424|NCT01348347|80237884|FG001|Overall Study|Withdrawal by Subject|1|||
27560425|NCT01348347|80237885|FG002|Overall Study|Withdrawal by Subject|1|||
27885963|NCT01738503|81415509|FG003|PET Imaging Sub-study|Adverse Event|0|||
27560426|NCT01348347|80237883|FG000|Overall Study|Progressive disease|2|||
27699930|NCT02401412|80736780|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
27699931|NCT02401412|80736781|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
27832192|NCT03966911|81216313|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
27699932|NCT02401412|80736780|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
27699933|NCT02401412|80736781|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
27699934|NCT00892177|80736782|FG000|Phase II|Ineligible|0|||
27699935|NCT00892177|80736783|FG001|Phase II|Ineligible|0|||
27699936|NCT00892177|80736784|FG002|Phase II|Ineligible|0|||
27699937|NCT00892177|80736785|FG003|Phase II|Ineligible|0|||
27699938|NCT00892177|80736786|FG004|Phase II|Ineligible|1|||
27699939|NCT00892177|80736787|FG005|Phase II|Ineligible|1|||
27699940|NCT00892177|80736782|FG000|Phase II|Withdrawal by Subject|0|||
27699941|NCT00892177|80736783|FG001|Phase II|Withdrawal by Subject|0|||
27699942|NCT00892177|80736784|FG002|Phase II|Withdrawal by Subject|0|||
27699943|NCT00892177|80736785|FG003|Phase II|Withdrawal by Subject|0|||
27699944|NCT00892177|80736786|FG004|Phase II|Withdrawal by Subject|4|||
27699945|NCT00892177|80736787|FG005|Phase II|Withdrawal by Subject|1|||
27699946|NCT01310803|80736788|FG000|Overall Study|Subject terminated by Sponsor|1|||
27699947|NCT01310803|80736789|FG001|Overall Study|Subject terminated by Sponsor|0|||
27699948|NCT03606980|80736790|FG000|Overall Study|Lost to Follow-up|3|||
27699949|NCT03606980|80736791|FG001|Overall Study|Lost to Follow-up|2|||
27699950|NCT03606980|80736792|FG002|Overall Study|Lost to Follow-up|3|||
27699951|NCT03606980|80736790|FG000|Overall Study|Withdrawal by Subject|1|||
27699952|NCT03606980|80736791|FG001|Overall Study|Withdrawal by Subject|0|||
27699953|NCT03606980|80736792|FG002|Overall Study|Withdrawal by Subject|4|||
27699954|NCT01979835|80736793|FG000|Primary Outcome SA Measurment|failed insertion|18|||
27699955|NCT01979835|80736793|FG000|Follow-up|Lost to Follow-up|32|||
27699956|NCT04142450|80736794|FG000|Overall Study|Screen Failure|1|||
27699957|NCT04142450|80736794|FG000|Overall Study|Lost to Follow-up|1|||
27699958|NCT02465463|80736799|FG000|Overall Study|Lost to Follow-up|2|||
27699959|NCT02465463|80736800|FG001|Overall Study|Lost to Follow-up|1|||
27699960|NCT02465463|80736799|FG000|Overall Study|Death|1|||
27699961|NCT02465463|80736800|FG001|Overall Study|Death|0|||
27699962|NCT02465463|80736799|FG000|Overall Study|Protocol Violation|1|||
27699963|NCT02465463|80736800|FG001|Overall Study|Protocol Violation|0|||
27699964|NCT01130974|80736801|FG000|Overall Study|Protocol Violation|10|||
27560427|NCT01348347|80237884|FG001|Overall Study|Progressive disease|5|||
27560428|NCT01348347|80237885|FG002|Overall Study|Progressive disease|5|||
27560429|NCT01466348|80237887|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
27560430|NCT01466348|80237888|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
27560431|NCT02278263|80237889|FG000|Overall Study|Protocol Violation|7|||
27560432|NCT02278263|80237890|FG001|Overall Study|Protocol Violation|0|||
27560433|NCT02278263|80237891|FG002|Overall Study|Protocol Violation|9|||
27560434|NCT00736723|80237892|FG000|Overall Study|Withdrawal by Subject|4|||
27560435|NCT00736723|80237893|FG001|Overall Study|Withdrawal by Subject|3|||
27560436|NCT02189473|80237894|FG000|Overall Study|Death|22|||
27560437|NCT02189473|80237895|FG001|Overall Study|Death|23|||
27560438|NCT02189473|80237894|FG000|Overall Study|Lost to Follow-up|1|||
27560439|NCT02189473|80237895|FG001|Overall Study|Lost to Follow-up|2|||
27560440|NCT03089606|80237896|FG000|Overall Study|Progression after Cycle 1|1|||
27560441|NCT02357901|80237897|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
27560442|NCT02357901|80237898|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
27560443|NCT02357901|80237899|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
27560444|NCT02357901|80237900|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
27560445|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
27699965|NCT01130974|80736802|FG001|Overall Study|Protocol Violation|10|||
27699966|NCT01130974|80736801|FG000|Overall Study|Withdrawal by Subject|0|||
27699967|NCT01130974|80736802|FG001|Overall Study|Withdrawal by Subject|1|||
27699968|NCT01130974|80736801|FG000|Overall Study|Ineligibility criteria|5|||
27699969|NCT01130974|80736802|FG001|Overall Study|Ineligibility criteria|2|||
27699970|NCT02249767|80736803|FG000|Overall Study|Did not use medication|8|||
27560446|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
27560447|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
27699971|NCT02249767|80736804|FG001|Overall Study|Did not use medication|9|||
27699972|NCT02249767|80736805|FG002|Overall Study|Did not use medication|8|||
27699973|NCT01050205|80736806|FG000|Overall Study|Lost to Follow-up|7|||
27699974|NCT01050205|80736807|FG001|Overall Study|Lost to Follow-up|1|||
27699975|NCT01050205|80736806|FG000|Overall Study|Withdrawal by Subject|1|||
27699976|NCT01050205|80736807|FG001|Overall Study|Withdrawal by Subject|1|||
27699977|NCT01050205|80736806|FG000|Overall Study|Relocated from area|1|||
27699978|NCT01050205|80736807|FG001|Overall Study|Relocated from area|2|||
27699979|NCT01050205|80736806|FG000|Overall Study|Discontinued Intervention|2|||
27699980|NCT01050205|80736807|FG001|Overall Study|Discontinued Intervention|0|||
27699981|NCT03872453|80736812|FG000|Overall Study|Adverse Event|1|||
27699982|NCT03872453|80736813|FG001|Overall Study|Adverse Event|1|||
27699983|NCT03872453|80736814|FG002|Overall Study|Adverse Event|0|||
27699984|NCT03872453|80736815|FG003|Overall Study|Adverse Event|0|||
27699985|NCT03872453|80736812|FG000|Overall Study|Lost to Follow-up|8|||
27699986|NCT03872453|80736813|FG001|Overall Study|Lost to Follow-up|7|||
27699987|NCT03872453|80736814|FG002|Overall Study|Lost to Follow-up|4|||
27699988|NCT03872453|80736815|FG003|Overall Study|Lost to Follow-up|4|||
27832193|NCT03966911|81216314|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
27832194|NCT03196284|81216315|FG000|Main Part|Withdrawal by Subject|0|||
27832195|NCT03196284|81216316|FG001|Main Part|Withdrawal by Subject|1|||
27832196|NCT03196284|81216317|FG002|Main Part|Withdrawal by Subject|0|||
27832197|NCT03196284|81216315|FG000|Extension Part|Lack of Efficacy|0|||
27832198|NCT03196284|81216316|FG001|Extension Part|Lack of Efficacy|0|||
27832199|NCT03196284|81216317|FG002|Extension Part|Lack of Efficacy|1|||
27832200|NCT03196284|81216315|FG000|Extension Part|Withdrawal by Subject|0|||
27832201|NCT03196284|81216316|FG001|Extension Part|Withdrawal by Subject|0|||
27832202|NCT03196284|81216317|FG002|Extension Part|Withdrawal by Subject|1|||
27832203|NCT03196284|81216315|FG000|Extension Part|Physician Decision|0|||
27832204|NCT03196284|81216316|FG001|Extension Part|Physician Decision|0|||
27832205|NCT03196284|81216317|FG002|Extension Part|Physician Decision|1|||
27560448|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
27560449|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
27560450|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
27560451|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
27560452|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
27832206|NCT02241551|81216324|FG000|Overall Study|Adverse Event|1|||
27885964|NCT01738503|81415510|FG004|PET Imaging Sub-study|Adverse Event|0|||
27885965|NCT01738503|81415511|FG005|PET Imaging Sub-study|Adverse Event|1|||
27832207|NCT02241551|81216325|FG001|Overall Study|Adverse Event|0|||
27832208|NCT02286466|81216329|FG000|Overall Study|Death|1|||
27832209|NCT02286466|81216330|FG001|Overall Study|Death|3|||
27832210|NCT02286466|81216329|FG000|Overall Study|Withdrawal by Subject|5|||
27832211|NCT02286466|81216330|FG001|Overall Study|Withdrawal by Subject|2|||
27832212|NCT02286466|81216329|FG000|Overall Study|Lost to Follow-up|1|||
27832213|NCT02286466|81216330|FG001|Overall Study|Lost to Follow-up|4|||
27832214|NCT02286466|81216329|FG000|Overall Study|Declined Clinician Assessment|0|||
27832215|NCT02286466|81216330|FG001|Overall Study|Declined Clinician Assessment|1|||
27832216|NCT00467597|81219288|FG000|Overall Study|Withdrawal by Subject|2|||
27832217|NCT00467597|81219289|FG001|Overall Study|Withdrawal by Subject|0|||
27832218|NCT03167606|81219290|FG000|Overall Study|Lost to Follow-up|73|||
27832219|NCT03167606|81219291|FG001|Overall Study|Lost to Follow-up|64|||
27832220|NCT03167606|81219290|FG000|Overall Study|Withdrawal by Subject|6|||
27832221|NCT03167606|81219291|FG001|Overall Study|Withdrawal by Subject|5|||
27832222|NCT03167606|81219290|FG000|Overall Study|Withdrawal by Investigator|0|||
27832223|NCT03167606|81219291|FG001|Overall Study|Withdrawal by Investigator|2|||
27832224|NCT01297504|81219294|FG000|Overall Study|Invalid Consent|1|||
27832225|NCT01297504|81219294|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
27832226|NCT01297504|81219294|FG000|Overall Study|No Study Visits|4|||
27885966|NCT01738503|81415512|FG006|PET Imaging Sub-study|Adverse Event|0|||
27560453|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
27560454|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
27560455|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
27560456|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
27699989|NCT03872453|80736812|FG000|Overall Study|Never Treated Migraine|19|||
27699990|NCT03872453|80736813|FG001|Overall Study|Never Treated Migraine|17|||
27699991|NCT03872453|80736814|FG002|Overall Study|Never Treated Migraine|13|||
27832227|NCT01297504|81219294|FG000|Overall Study|Death|3|||
27832228|NCT01297504|81219294|FG000|Overall Study|Lost to Follow-up|43|||
27832229|NCT01297504|81219294|FG000|Overall Study|Withdrawal by Subject|9|||
27832230|NCT01297504|81219294|FG000|Overall Study|Site Closure|3|||
27832231|NCT01297504|81219294|FG000|Overall Study|Protocol Violation|3|||
27832232|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
27832233|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
27832234|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
27832235|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
27832236|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832237|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832238|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832239|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832240|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832241|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832242|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832243|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832244|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832245|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
27832246|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
27832247|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
27832248|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
27832249|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
27832250|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27885967|NCT01738503|81415506|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27885968|NCT01738503|81415507|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27885969|NCT01738503|81415508|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27885970|NCT01738503|81415509|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27885971|NCT01738503|81415510|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
27885972|NCT01738503|81415511|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
27832251|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27832252|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27832253|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27832254|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27885973|NCT01738503|81415512|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
27885974|NCT01684423|81415514|FG000|Overall Study|Withdrawal by Subject|0|||
27885975|NCT01684423|81415515|FG001|Overall Study|Withdrawal by Subject|0|||
27885976|NCT01684423|81415516|FG002|Overall Study|Withdrawal by Subject|1|||
27885977|NCT01684423|81415517|FG003|Overall Study|Withdrawal by Subject|0|||
27885978|NCT01684423|81415518|FG004|Overall Study|Withdrawal by Subject|0|||
27885979|NCT02865499|81415519|FG000|Baseline|Adverse Event|1|||
27885980|NCT02865499|81415519|FG000|Baseline|Withdrawal by Subject|1|||
27885981|NCT04481789|81415521|FG000|Period 1|Withdrawal by Subject|1|||
27885982|NCT04481789|81415522|FG001|Period 1|Withdrawal by Subject|0|||
27832255|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27885983|NCT04481789|81415523|FG002|Period 1|Withdrawal by Subject|0|||
27885984|NCT04481789|81415524|FG003|Period 1|Withdrawal by Subject|0|||
27885985|NCT04481789|81415525|FG004|Period 1|Withdrawal by Subject|0|||
27885986|NCT04481789|81415526|FG005|Period 1|Withdrawal by Subject|0|||
27885987|NCT00930774|81415527|FG000|Overall Study|Withdrawal by Subject|1|||
27885988|NCT00930774|81415528|FG001|Overall Study|Withdrawal by Subject|9|||
27885989|NCT00930774|81415529|FG002|Overall Study|Withdrawal by Subject|2|||
27885990|NCT00930774|81415530|FG003|Overall Study|Withdrawal by Subject|0|||
27885991|NCT02760004|81415531|FG000|Overall Study|Lost to Follow-up|13|||
27885992|NCT02760004|81415532|FG001|Overall Study|Lost to Follow-up|22|||
27885993|NCT00679029|81415533|FG000|Overall Study|Adverse Event|3|||
27885994|NCT00679029|81415533|FG000|Overall Study|Withdrawal by Subject|1|||
27885995|NCT00679029|81415533|FG000|Overall Study|Lost to Follow-up|1|||
27885996|NCT04382755|81415534|FG000|Overall Study|Withdrawal by Subject|1|||
27885997|NCT04382755|81415535|FG001|Overall Study|Withdrawal by Subject|0|||
27885998|NCT04382755|81415534|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
27885999|NCT04382755|81415535|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
27886000|NCT04382755|81415534|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
27886001|NCT04382755|81415535|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
27886002|NCT02107859|81415536|FG000|Overall Study|Withdrawal by Subject|14|||
27886003|NCT02107859|81415536|FG000|Overall Study|Adverse Event|3|||
27832256|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27832257|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27832258|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27832259|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
27886004|NCT02107859|81415536|FG000|Overall Study|Study closure|41|||
27832260|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
27832261|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832262|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
27832263|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832264|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832265|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832266|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832267|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832268|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832269|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832270|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832271|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832272|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832273|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
27832274|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
27832275|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
27832276|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
27832277|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832278|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832279|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832280|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832281|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832282|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832283|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832284|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832285|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832286|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832287|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
27832288|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
27832289|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832290|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
27832291|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832292|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832293|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27886005|NCT02107859|81415536|FG000|Overall Study|Other than specified|3|||
27886006|NCT01122394|81415541|FG000|Overall Study|Withdrawal by Subject|1|||
27886007|NCT01122394|81415542|FG001|Overall Study|Withdrawal by Subject|1|||
27886008|NCT01122394|81415541|FG000|Overall Study|Lost to Follow-up|2|||
27886009|NCT01122394|81415542|FG001|Overall Study|Lost to Follow-up|2|||
27886010|NCT01122394|81415541|FG000|Overall Study|Adverse Event|0|||
27886011|NCT01122394|81415542|FG001|Overall Study|Adverse Event|1|||
27886634|NCT01938430|81418145|FG009|Overall Study|Randomized but Not Treated|0|||
27886635|NCT01938430|81418146|FG010|Overall Study|Randomized but Not Treated|1|||
27832294|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832295|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27560457|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
27560458|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
27560459|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
27832296|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832297|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832298|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832299|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832300|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832301|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
27832302|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27832303|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832304|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
27832305|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832306|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832307|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832308|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832309|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832310|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832311|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832312|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832313|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832314|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832315|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
27832316|NCT01695239|81219295|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
27832317|NCT01695239|81219296|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832318|NCT01695239|81219297|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832319|NCT01695239|81219298|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832320|NCT01695239|81219299|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832321|NCT01695239|81219300|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832322|NCT01695239|81219301|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832323|NCT01695239|81219302|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832324|NCT01695239|81219303|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832325|NCT01695239|81219304|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832326|NCT01695239|81219305|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832327|NCT01695239|81219306|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832328|NCT01695239|81219307|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27886012|NCT00325156|81417915|FG000|Overall Study|Protocol Violation|8|||
27886013|NCT00325156|81417915|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
27560460|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
27560461|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
27560462|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
27560463|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
27560464|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
27560465|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
27560466|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
27560467|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
27832329|NCT01695239|81219308|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
27832330|NCT01695239|81219295|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27560468|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
27560469|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
27560470|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
27560471|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
27560472|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
27560473|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
27886014|NCT00325156|81417915|FG000|Overall Study|Migrated/moved from study area|12|||
27886015|NCT00325156|81417915|FG000|Overall Study|Adverse event, non-fatal|3|||
27886016|NCT00325156|81417915|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
27886017|NCT00325156|81417915|FG000|Overall Study|Other|1|||
27560474|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
27560475|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
27832331|NCT01695239|81219296|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832332|NCT01695239|81219297|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832333|NCT01695239|81219298|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832334|NCT01695239|81219299|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832335|NCT01695239|81219300|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832336|NCT01695239|81219301|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832337|NCT01695239|81219302|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
27832338|NCT01695239|81219303|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832339|NCT01695239|81219304|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832340|NCT01695239|81219305|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832341|NCT01695239|81219306|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832342|NCT01695239|81219307|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832343|NCT01695239|81219308|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
27832344|NCT01695239|81219295|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832345|NCT01695239|81219296|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832346|NCT01695239|81219297|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832347|NCT01695239|81219298|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832348|NCT01695239|81219299|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832349|NCT01695239|81219300|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832350|NCT01695239|81219301|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832351|NCT01695239|81219302|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
27832352|NCT01695239|81219303|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832353|NCT01695239|81219304|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832354|NCT01695239|81219305|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832355|NCT01695239|81219306|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832356|NCT01695239|81219307|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832357|NCT01695239|81219308|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
27832358|NCT01695239|81219295|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832359|NCT01695239|81219296|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832360|NCT01695239|81219297|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832361|NCT01695239|81219298|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832362|NCT01695239|81219299|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832363|NCT01695239|81219300|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832364|NCT01695239|81219301|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832365|NCT01695239|81219302|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
27832366|NCT01695239|81219303|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832367|NCT01695239|81219304|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832368|NCT01695239|81219305|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832369|NCT01695239|81219306|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27886018|NCT00325156|81417915|FG000|Overall Study|Withdrawal by Subject|31|||
27886019|NCT03039621|81417918|FG000|Overall Study|Violation of inclusion criteria|3|||
27886020|NCT03039621|81417919|FG001|Overall Study|Violation of inclusion criteria|2|||
27886021|NCT03039621|81417918|FG000|Overall Study|Non-compliance with protocol requirement|4|||
27886022|NCT03039621|81417919|FG001|Overall Study|Non-compliance with protocol requirement|5|||
27886023|NCT03039621|81417918|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
27886024|NCT03039621|81417919|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
27560476|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
27560477|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
27560478|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
27560479|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
27560480|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
27560481|NCT02357901|80237897|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
27560482|NCT02357901|80237898|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
27560483|NCT02357901|80237899|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
27560484|NCT02357901|80237900|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
27560485|NCT03158051|80237902|FG000|Overall Study|Lost to Follow-up|41|||
27560486|NCT03158051|80237903|FG001|Overall Study|Lost to Follow-up|47|||
27560487|NCT03158051|80237902|FG000|Overall Study|Physician Decision|6|||
27886025|NCT03039621|81417918|FG000|Overall Study|Violation of non-inclusion criteria|1|||
27699992|NCT03872453|80736815|FG003|Overall Study|Never Treated Migraine|12|||
27699993|NCT03872453|80736812|FG000|Overall Study|Pregnancy|1|||
27699994|NCT03872453|80736813|FG001|Overall Study|Pregnancy|0|||
27699995|NCT03872453|80736814|FG002|Overall Study|Pregnancy|0|||
27699996|NCT03872453|80736815|FG003|Overall Study|Pregnancy|0|||
27699997|NCT03872453|80736812|FG000|Overall Study|Protocol Deviation|2|||
27699998|NCT03872453|80736813|FG001|Overall Study|Protocol Deviation|0|||
27699999|NCT03872453|80736814|FG002|Overall Study|Protocol Deviation|0|||
27700000|NCT03872453|80736815|FG003|Overall Study|Protocol Deviation|2|||
27700001|NCT03872453|80736812|FG000|Overall Study|Withdrawal by Subject|0|||
27700002|NCT03872453|80736813|FG001|Overall Study|Withdrawal by Subject|1|||
27700003|NCT03872453|80736814|FG002|Overall Study|Withdrawal by Subject|2|||
27700004|NCT03872453|80736815|FG003|Overall Study|Withdrawal by Subject|0|||
27700005|NCT03872453|80736812|FG000|Overall Study|Other Than Specified|1|||
27700006|NCT03872453|80736813|FG001|Overall Study|Other Than Specified|0|||
27700007|NCT03872453|80736814|FG002|Overall Study|Other Than Specified|0|||
27700008|NCT03872453|80736815|FG003|Overall Study|Other Than Specified|0|||
27700009|NCT01572922|80740963|FG000|Overall Study|Adverse Event|1|||
27700010|NCT01572922|80740963|FG000|Overall Study|Protocol Violation|1|||
27700011|NCT01572922|80740963|FG000|Overall Study|Death|1|||
27700012|NCT01309230|80740975|FG000|Overall Study|Withdrawal by Subject|0|||
27700013|NCT01309230|80740976|FG001|Overall Study|Withdrawal by Subject|2|||
27700014|NCT01309230|80740975|FG000|Overall Study|Observation arm closed|0|||
27700015|NCT01309230|80740976|FG001|Overall Study|Observation arm closed|2|||
27700016|NCT01678209|80740977|FG000|Overall Study|could not scan twice|1|||
27700017|NCT01678209|80740978|FG001|Overall Study|could not scan twice|1|||
27700018|NCT01678209|80740979|FG002|Overall Study|could not scan twice|1|||
27700019|NCT01678209|80740977|FG000|Overall Study|scheduling conflicts|0|||
27700020|NCT01678209|80740978|FG001|Overall Study|scheduling conflicts|0|||
27700021|NCT01678209|80740979|FG002|Overall Study|scheduling conflicts|1|||
27700022|NCT01678209|80740977|FG000|Overall Study|screen fail|16|||
27700023|NCT01678209|80740978|FG001|Overall Study|screen fail|17|||
27700024|NCT01678209|80740979|FG002|Overall Study|screen fail|16|||
27700025|NCT01177722|80740980|FG000|Overall Study|Serious Adverse Event|0|||
27700026|NCT01177722|80740981|FG001|Overall Study|Serious Adverse Event|0|||
27700027|NCT01177722|80740982|FG002|Overall Study|Serious Adverse Event|1|||
27700028|NCT01177722|80740983|FG003|Overall Study|Serious Adverse Event|0|||
27700029|NCT01177722|80740980|FG000|Overall Study|Protocol Violation|0|||
27700030|NCT01177722|80740981|FG001|Overall Study|Protocol Violation|0|||
27700031|NCT01177722|80740982|FG002|Overall Study|Protocol Violation|1|||
27700032|NCT01177722|80740983|FG003|Overall Study|Protocol Violation|0|||
27700033|NCT01177722|80740980|FG000|Overall Study|Lost to Follow-up|3|||
27700034|NCT01177722|80740981|FG001|Overall Study|Lost to Follow-up|4|||
27700035|NCT01177722|80740982|FG002|Overall Study|Lost to Follow-up|3|||
27700036|NCT01177722|80740983|FG003|Overall Study|Lost to Follow-up|1|||
27700037|NCT01177722|80740980|FG000|Overall Study|Withdrawal by Subject|10|||
27700038|NCT01177722|80740981|FG001|Overall Study|Withdrawal by Subject|6|||
27700039|NCT01177722|80740982|FG002|Overall Study|Withdrawal by Subject|4|||
27700040|NCT01177722|80740983|FG003|Overall Study|Withdrawal by Subject|6|||
27700041|NCT01351623|80740984|FG000|Overall Study|Protocol Violation|2|||
27700042|NCT01351623|80740984|FG000|Overall Study|Adverse Event|4|||
27700043|NCT01351623|80740984|FG000|Overall Study|Withdrawal by Subject|1|||
27700044|NCT01351623|80740984|FG000|Overall Study|Death|2|||
27700045|NCT00909792|80740986|FG000|Period 1|Did not meet inclusion criteria|0|||
27700046|NCT00909792|80740987|FG001|Period 1|Did not meet inclusion criteria|1|||
27700047|NCT00909792|80740986|FG000|Period 2|Biomicroscopy|1|||
27700048|NCT00909792|80740987|FG001|Period 2|Biomicroscopy|0|||
27700049|NCT00909792|80740986|FG000|Period 2|Lost to Follow-up|0|||
27832370|NCT01695239|81219307|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27832371|NCT01695239|81219308|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
27700050|NCT00909792|80740987|FG001|Period 2|Lost to Follow-up|1|||
27832372|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27700051|NCT01672788|80740988|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
27700052|NCT01672788|80740989|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
27700053|NCT01672788|80740990|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
27700054|NCT01672788|80740991|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
27700055|NCT02234323|80740992|FG000|All Enrolled|Not Treated: Completed study in database|2|||
27700056|NCT02234323|80740992|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
27700057|NCT02234323|80740992|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
27700058|NCT02234323|80740992|FG000|All Treated|Death|1|||
27832373|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27700059|NCT02234323|80740992|FG000|All Treated|Physician Decision|5|||
27700060|NCT02234323|80740992|FG000|All Treated|Lack of Efficacy|3|||
27700061|NCT02234323|80740992|FG000|All Treated|Exceeded lab value limit|2|||
27700062|NCT02234323|80740992|FG000|All Treated|Other|7|||
27700063|NCT00778622|80740995|FG000|Overall Study|Adverse Event|5|||
27700064|NCT00778622|80740996|FG001|Overall Study|Adverse Event|4|||
27700065|NCT00778622|80740997|FG002|Overall Study|Adverse Event|7|||
27700066|NCT00778622|80740995|FG000|Overall Study|Withdrawal by Subject|4|||
27700067|NCT00778622|80740996|FG001|Overall Study|Withdrawal by Subject|5|||
27700068|NCT00778622|80740997|FG002|Overall Study|Withdrawal by Subject|5|||
27700069|NCT00778622|80740995|FG000|Overall Study|Lost to Follow-up|3|||
27700070|NCT00778622|80740996|FG001|Overall Study|Lost to Follow-up|3|||
27700071|NCT00778622|80740997|FG002|Overall Study|Lost to Follow-up|2|||
27700072|NCT00778622|80740995|FG000|Overall Study|Protocol Violation|0|||
27700073|NCT00778622|80740996|FG001|Overall Study|Protocol Violation|3|||
27700074|NCT00778622|80740997|FG002|Overall Study|Protocol Violation|0|||
27700075|NCT00778622|80740995|FG000|Overall Study|Lack of Efficacy|2|||
27700076|NCT00778622|80740996|FG001|Overall Study|Lack of Efficacy|0|||
27700077|NCT00778622|80740997|FG002|Overall Study|Lack of Efficacy|0|||
27700078|NCT00778622|80740995|FG000|Overall Study|immigration|1|||
27700079|NCT00778622|80740996|FG001|Overall Study|immigration|0|||
27700080|NCT00778622|80740997|FG002|Overall Study|immigration|0|||
27700081|NCT00778622|80740995|FG000|Overall Study|Other|1|||
27700082|NCT00778622|80740996|FG001|Overall Study|Other|0|||
27700083|NCT00778622|80740997|FG002|Overall Study|Other|1|||
27700084|NCT01667107|80740999|FG000|Overall Study|Adverse Event|4|||
27700085|NCT01667107|80741000|FG001|Overall Study|Adverse Event|3|||
27700086|NCT01667107|80740999|FG000|Overall Study|Tolerability issues|0|||
27700087|NCT01667107|80741000|FG001|Overall Study|Tolerability issues|2|||
27700088|NCT01667107|80740999|FG000|Overall Study|Protocol Violation|0|||
27700089|NCT01667107|80741000|FG001|Overall Study|Protocol Violation|1|||
27700090|NCT01667107|80740999|FG000|Overall Study|Lack of Efficacy|0|||
27700091|NCT01667107|80741000|FG001|Overall Study|Lack of Efficacy|1|||
27700092|NCT05085665|80741001|FG000|Overall Study|Physician Decision|2|||
27700093|NCT01955122|80741002|FG000|Overall Study|Physician Decision|5|||
27700094|NCT01955122|80741003|FG001|Overall Study|Physician Decision|5|||
27700095|NCT01287065|80741004|FG000|Treatment Period 1|Adverse Event|0|||
27700096|NCT01287065|80741005|FG001|Treatment Period 1|Adverse Event|0|||
27700097|NCT01287065|80741006|FG002|Treatment Period 1|Adverse Event|0|||
27700098|NCT01287065|80741007|FG003|Treatment Period 1|Adverse Event|0|||
27700099|NCT01287065|80741008|FG004|Treatment Period 1|Adverse Event|1|||
27700100|NCT01287065|80741009|FG005|Treatment Period 1|Adverse Event|0|||
27700101|NCT01287065|80741004|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27700102|NCT01287065|80741005|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27700103|NCT01287065|80741006|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27700104|NCT01287065|80741007|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27700105|NCT01287065|80741008|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27700106|NCT01287065|80741009|FG005|Treatment Period 1|Withdrawal by Subject|1|||
27700107|NCT01330914|80741010|FG000|Overall Study|Withdrawal by Subject|4|||
27700108|NCT01330914|80741010|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
27700109|NCT01357577|80741015|FG000|Overall Study|Lost to Follow-up|20|||
27700110|NCT01357577|80741016|FG001|Overall Study|Lost to Follow-up|16|||
27700111|NCT01357577|80741015|FG000|Overall Study|Withdrawal by Subject|16|||
27700112|NCT01357577|80741016|FG001|Overall Study|Withdrawal by Subject|8|||
27700113|NCT01357577|80741015|FG000|Overall Study|look at data in database?|1|||
27700114|NCT01357577|80741016|FG001|Overall Study|look at data in database?|2|||
27700115|NCT00528567|80741017|FG000|Overall Study|Death|4|||
27700116|NCT00528567|80741018|FG001|Overall Study|Death|5|||
27700117|NCT00528567|80741017|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
27700118|NCT00528567|80741018|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
27700119|NCT00528567|80741017|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
27700120|NCT00528567|80741018|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
27700121|NCT00528567|80741017|FG000|Overall Study|Violation Criteria at Entry|3|||
27700122|NCT00528567|80741018|FG001|Overall Study|Violation Criteria at Entry|17|||
27700123|NCT00528567|80741017|FG000|Overall Study|Withdrew Consent|59|||
27700124|NCT00528567|80741018|FG001|Overall Study|Withdrew Consent|55|||
27700125|NCT00528567|80741017|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
27700126|NCT00528567|80741018|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
27700127|NCT00528567|80741017|FG000|Overall Study|Failure to Return|1|||
27700128|NCT00528567|80741018|FG001|Overall Study|Failure to Return|4|||
27700129|NCT00528567|80741017|FG000|Overall Study|Other Protocol Violation|5|||
27700130|NCT00528567|80741018|FG001|Overall Study|Other Protocol Violation|21|||
27700131|NCT00528567|80741017|FG000|Overall Study|Administrative/Other|22|||
27700132|NCT00528567|80741018|FG001|Overall Study|Administrative/Other|75|||
27560488|NCT03158051|80237903|FG001|Overall Study|Physician Decision|7|||
27832374|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27560489|NCT03158051|80237902|FG000|Overall Study|Withdrawal by Subject|24|||
27560490|NCT03158051|80237903|FG001|Overall Study|Withdrawal by Subject|15|||
27560491|NCT03158051|80237902|FG000|Overall Study|Death|0|||
27560492|NCT03158051|80237903|FG001|Overall Study|Death|1|||
27560493|NCT00483379|80237906|FG000|Treatment Period|Adverse Event|1|||
27560494|NCT00483379|80237907|FG001|Treatment Period|Adverse Event|0|||
27560495|NCT00483379|80237906|FG000|Treatment Period|Withdrawal by Subject|1|||
27560496|NCT00483379|80237907|FG001|Treatment Period|Withdrawal by Subject|0|||
27560497|NCT03178773|80237908|FG000|Overall Study|Death|0|||
27560498|NCT03178773|80237909|FG001|Overall Study|Death|1|||
27560499|NCT03178773|80237908|FG000|Overall Study|Lost to Follow-up|29|||
27560500|NCT03178773|80237909|FG001|Overall Study|Lost to Follow-up|25|||
27560501|NCT03178773|80237908|FG000|Overall Study|Withdrawal by Subject|10|||
27560502|NCT03178773|80237909|FG001|Overall Study|Withdrawal by Subject|14|||
27560503|NCT01581307|80237910|FG000|Overall Study|Withdrawal by Subject|1|||
27560504|NCT00811473|80237918|FG000|Overall Study|Adverse Event|3|||
27560505|NCT00811473|80237919|FG001|Overall Study|Adverse Event|12|||
27560506|NCT00811473|80237918|FG000|Overall Study|Lost to Follow-up|5|||
27560507|NCT00811473|80237919|FG001|Overall Study|Lost to Follow-up|1|||
27560508|NCT00811473|80237918|FG000|Overall Study|Withdrawal by Subject|2|||
27560509|NCT00811473|80237919|FG001|Overall Study|Withdrawal by Subject|4|||
27560510|NCT00811473|80237918|FG000|Overall Study|Severe non-compliance to protocol|2|||
27560511|NCT00811473|80237919|FG001|Overall Study|Severe non-compliance to protocol|4|||
27560512|NCT00811473|80237918|FG000|Overall Study|Lack of therapeutic response|4|||
27560513|NCT00811473|80237919|FG001|Overall Study|Lack of therapeutic response|1|||
27560514|NCT00811473|80237918|FG000|Overall Study|Condition under investigation worsened|1|||
27560515|NCT00811473|80237919|FG001|Overall Study|Condition under investigation worsened|3|||
27560516|NCT00811473|80237918|FG000|Overall Study|Other 2|4|||
27560517|NCT00811473|80237919|FG001|Overall Study|Other 2|1|||
27560518|NCT00811473|80237918|FG000|Overall Study|Incorrect Enrollment|1|||
27560519|NCT00811473|80237919|FG001|Overall Study|Incorrect Enrollment|0|||
27560520|NCT00811473|80237918|FG000|Overall Study|Safety Reasons|1|||
27560521|NCT00811473|80237919|FG001|Overall Study|Safety Reasons|0|||
27560522|NCT00405587|80237920|FG000|Overall Study|Death|0|||
27560523|NCT00405587|80237921|FG001|Overall Study|Death|0|||
27560524|NCT00405587|80237922|FG002|Overall Study|Death|0|||
27560525|NCT00405587|80237923|FG003|Overall Study|Death|1|||
27560526|NCT00405587|80237920|FG000|Overall Study|Disease Progression|22|||
27560527|NCT00405587|80237921|FG001|Overall Study|Disease Progression|23|||
27560528|NCT00405587|80237922|FG002|Overall Study|Disease Progression|21|||
27560529|NCT00405587|80237923|FG003|Overall Study|Disease Progression|17|||
27560530|NCT00405587|80237920|FG000|Overall Study|Physician Decision|3|||
27560531|NCT00405587|80237921|FG001|Overall Study|Physician Decision|2|||
27560532|NCT00405587|80237922|FG002|Overall Study|Physician Decision|0|||
27560533|NCT00405587|80237923|FG003|Overall Study|Physician Decision|0|||
27560534|NCT00405587|80237920|FG000|Overall Study|Adverse Event|1|||
27560535|NCT00405587|80237921|FG001|Overall Study|Adverse Event|0|||
27560536|NCT00405587|80237922|FG002|Overall Study|Adverse Event|0|||
27560537|NCT00405587|80237923|FG003|Overall Study|Adverse Event|0|||
27560538|NCT00405587|80237920|FG000|Overall Study|Lost to Follow-up|0|||
27560539|NCT00405587|80237921|FG001|Overall Study|Lost to Follow-up|1|||
27560540|NCT00405587|80237922|FG002|Overall Study|Lost to Follow-up|1|||
27560541|NCT00405587|80237923|FG003|Overall Study|Lost to Follow-up|0|||
27560542|NCT00405587|80237920|FG000|Overall Study|Radiation induced necrosis|0|||
27560543|NCT00405587|80237921|FG001|Overall Study|Radiation induced necrosis|1|||
27560544|NCT00405587|80237922|FG002|Overall Study|Radiation induced necrosis|0|||
27560545|NCT00405587|80237923|FG003|Overall Study|Radiation induced necrosis|0|||
27560546|NCT00405587|80237920|FG000|Overall Study|Withdrawal by Subject|0|||
27560547|NCT00405587|80237921|FG001|Overall Study|Withdrawal by Subject|0|||
27560548|NCT00405587|80237922|FG002|Overall Study|Withdrawal by Subject|0|||
27560549|NCT00405587|80237923|FG003|Overall Study|Withdrawal by Subject|2|||
27560550|NCT00405587|80237920|FG000|Overall Study|Participant not dosed|0|||
27560551|NCT00405587|80237921|FG001|Overall Study|Participant not dosed|1|||
27560552|NCT00405587|80237922|FG002|Overall Study|Participant not dosed|0|||
27832375|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27832376|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27560553|NCT00405587|80237923|FG003|Overall Study|Participant not dosed|0|||
27560554|NCT00326950|80237924|FG000|Overall Study|Progressive Disease|1|||
27560555|NCT04339296|80237925|FG000|Overall Study|Refuse to participate after allocation|1|||
27560556|NCT04339296|80237926|FG001|Overall Study|Refuse to participate after allocation|1|||
27560557|NCT04339296|80237925|FG000|Overall Study|Withdrew after completion of baseline|2|||
27560558|NCT04339296|80237926|FG001|Overall Study|Withdrew after completion of baseline|1|||
27560559|NCT04339296|80237925|FG000|Overall Study|Lost to Follow-up|0|||
27560560|NCT04339296|80237926|FG001|Overall Study|Lost to Follow-up|4|||
27560561|NCT04339296|80237925|FG000|Overall Study|Discontinued intervention|5|||
27560562|NCT04339296|80237926|FG001|Overall Study|Discontinued intervention|3|||
27832377|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27832378|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27560563|NCT01986855|80237927|FG000|Overall Study|Adverse Event|1|||
27560564|NCT01986855|80237928|FG001|Overall Study|Adverse Event|0|||
27560565|NCT01986855|80237929|FG002|Overall Study|Adverse Event|0|||
27560566|NCT01986855|80237927|FG000|Overall Study|Death|3|||
27560567|NCT01986855|80237928|FG001|Overall Study|Death|4|||
27560568|NCT01986855|80237929|FG002|Overall Study|Death|4|||
27560569|NCT01986855|80237927|FG000|Overall Study|Lost to Follow-up|2|||
27560570|NCT01986855|80237928|FG001|Overall Study|Lost to Follow-up|1|||
27560571|NCT01986855|80237929|FG002|Overall Study|Lost to Follow-up|0|||
27560572|NCT01986855|80237927|FG000|Overall Study|Screen Failure|0|||
27560573|NCT01986855|80237928|FG001|Overall Study|Screen Failure|1|||
27560574|NCT01986855|80237929|FG002|Overall Study|Screen Failure|0|||
27560575|NCT01986855|80237927|FG000|Overall Study|Participant Moved|0|||
27560576|NCT01986855|80237928|FG001|Overall Study|Participant Moved|0|||
27560577|NCT01986855|80237929|FG002|Overall Study|Participant Moved|2|||
27560578|NCT01986855|80237927|FG000|Overall Study|Withdrawal by Subject|7|||
27700133|NCT02202551|80741027|FG000|Overall Study|Adverse Event|8|||
27700134|NCT02202551|80741028|FG001|Overall Study|Adverse Event|19|||
27700135|NCT02202551|80741029|FG002|Overall Study|Adverse Event|5|||
27832379|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27560579|NCT01986855|80237928|FG001|Overall Study|Withdrawal by Subject|8|||
27832380|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
27832381|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
27832382|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27832383|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27560580|NCT01986855|80237929|FG002|Overall Study|Withdrawal by Subject|5|||
27700136|NCT02202551|80741030|FG003|Overall Study|Adverse Event|9|||
27832384|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27832385|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
27832386|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
27832387|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
27832388|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
27832389|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
27832390|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
27832391|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
27832392|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
27832393|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
27832394|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
27832395|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
27832396|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
27832397|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
27832398|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
27832399|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
27832400|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832401|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832402|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27886026|NCT03039621|81417919|FG001|Overall Study|Violation of non-inclusion criteria|2|||
27886027|NCT02423343|81417920|FG000|Overall Study|Withdrawal by Subject|0|||
27886028|NCT02423343|81417921|FG001|Overall Study|Withdrawal by Subject|1|||
27886029|NCT02423343|81417922|FG002|Overall Study|Withdrawal by Subject|0|||
27886030|NCT02423343|81417923|FG003|Overall Study|Withdrawal by Subject|0|||
27886031|NCT02423343|81417924|FG004|Overall Study|Withdrawal by Subject|0|||
27886032|NCT02423343|81417925|FG005|Overall Study|Withdrawal by Subject|0|||
27886033|NCT02423343|81417920|FG000|Overall Study|Progressive Disease|0|||
27886034|NCT02423343|81417921|FG001|Overall Study|Progressive Disease|0|||
27886035|NCT02423343|81417922|FG002|Overall Study|Progressive Disease|0|||
27886036|NCT02423343|81417923|FG003|Overall Study|Progressive Disease|0|||
27886037|NCT02423343|81417924|FG004|Overall Study|Progressive Disease|2|||
27886038|NCT02423343|81417925|FG005|Overall Study|Progressive Disease|0|||
27560581|NCT01349790|80237937|FG000|Overall Study|Investigator Judgement|3|||
27560582|NCT01349790|80237937|FG000|Overall Study|Death|2|||
27560583|NCT01349790|80237937|FG000|Overall Study|Withdrawal by Patient|2|||
27560584|NCT01349790|80237937|FG000|Overall Study|Adverse Event|1|||
27560585|NCT01349790|80237937|FG000|Overall Study|Lost to Follow-up|1|||
27560586|NCT00949325|80237938|FG000|Overall Study|Adverse Event|0|||
27560587|NCT00949325|80237939|FG001|Overall Study|Adverse Event|2|||
27560588|NCT00949325|80237940|FG002|Overall Study|Adverse Event|0|||
27560589|NCT00383149|80241095|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
27560590|NCT00383149|80241095|FG000|Overall Study|Death|2|||
27560591|NCT00383149|80241095|FG000|Overall Study|Disease Progression|38|||
27560592|NCT00383149|80241095|FG000|Overall Study|Lost to Follow-up|1|||
27560593|NCT00383149|80241095|FG000|Overall Study|Other|1|||
27560594|NCT00383149|80241095|FG000|Overall Study|Study Drug Toxicity|4|||
27560595|NCT00383149|80241095|FG000|Overall Study|Request to Discontinue Treatment|4|||
27560596|NCT00383149|80241095|FG000|Overall Study|Participant Withdrew Consent|1|||
27560597|NCT02672423|80241096|FG000|Period 1|Adverse Event|0|||
27700137|NCT02202551|80741027|FG000|Overall Study|Death|3|||
27886039|NCT02423343|81417920|FG000|Overall Study|Adverse Event|0|||
27700138|NCT02202551|80741028|FG001|Overall Study|Death|2|||
27886040|NCT02423343|81417921|FG001|Overall Study|Adverse Event|0|||
27886041|NCT02423343|81417922|FG002|Overall Study|Adverse Event|0|||
27886042|NCT02423343|81417923|FG003|Overall Study|Adverse Event|0|||
27560598|NCT02672423|80241097|FG001|Period 1|Adverse Event|0|||
27886043|NCT02423343|81417924|FG004|Overall Study|Adverse Event|2|||
27560599|NCT02672423|80241098|FG002|Period 1|Adverse Event|0|||
27560600|NCT02672423|80241099|FG003|Period 1|Adverse Event|0|||
27560601|NCT02672423|80241100|FG004|Period 1|Adverse Event|1|||
27886044|NCT02423343|81417925|FG005|Overall Study|Adverse Event|0|||
27700139|NCT02202551|80741029|FG002|Overall Study|Death|1|||
27832403|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832404|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832405|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832406|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832407|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832408|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
27832409|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
27832410|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832411|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832412|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832413|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
27832414|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
27832415|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
27832416|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
27700140|NCT02202551|80741030|FG003|Overall Study|Death|1|||
27700141|NCT02202551|80741027|FG000|Overall Study|Lost to Follow-up|0|||
27560602|NCT02672423|80241101|FG005|Period 1|Adverse Event|0|||
27560603|NCT02672423|80241102|FG006|Period 1|Adverse Event|0|||
27560604|NCT02672423|80241103|FG007|Period 1|Adverse Event|0|||
27832417|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
27832418|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
27832419|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
27832420|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
27832421|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
27886045|NCT02423343|81417920|FG000|Overall Study|Death|0|||
27886046|NCT02423343|81417921|FG001|Overall Study|Death|0|||
27886047|NCT02423343|81417922|FG002|Overall Study|Death|0|||
27886048|NCT02423343|81417923|FG003|Overall Study|Death|0|||
27886049|NCT02423343|81417924|FG004|Overall Study|Death|1|||
27700142|NCT02202551|80741028|FG001|Overall Study|Lost to Follow-up|1|||
27700143|NCT02202551|80741029|FG002|Overall Study|Lost to Follow-up|0|||
27886050|NCT02423343|81417925|FG005|Overall Study|Death|0|||
27886051|NCT01868438|81417933|FG000|First Intervention|Withdrawal by Subject|5|||
27886052|NCT01868438|81417934|FG001|First Intervention|Withdrawal by Subject|1|||
27560605|NCT02672423|80241104|FG008|Period 1|Adverse Event|0|||
27560606|NCT02672423|80241105|FG009|Period 1|Adverse Event|0|||
27560607|NCT02672423|80241096|FG000|Period 2|Withdrawal by Subject|0|||
27560608|NCT02672423|80241097|FG001|Period 2|Withdrawal by Subject|0|||
27560609|NCT02672423|80241098|FG002|Period 2|Withdrawal by Subject|1|||
27560610|NCT02672423|80241099|FG003|Period 2|Withdrawal by Subject|0|||
27560611|NCT02672423|80241100|FG004|Period 2|Withdrawal by Subject|0|||
27560612|NCT02672423|80241101|FG005|Period 2|Withdrawal by Subject|0|||
27560613|NCT02672423|80241102|FG006|Period 2|Withdrawal by Subject|0|||
27560614|NCT02672423|80241103|FG007|Period 2|Withdrawal by Subject|0|||
27560615|NCT02672423|80241104|FG008|Period 2|Withdrawal by Subject|0|||
27560616|NCT02672423|80241105|FG009|Period 2|Withdrawal by Subject|0|||
27560617|NCT02672423|80241096|FG000|Period 3|Withdrawal by Subject|0|||
27560618|NCT02672423|80241097|FG001|Period 3|Withdrawal by Subject|0|||
27560619|NCT02672423|80241098|FG002|Period 3|Withdrawal by Subject|0|||
27560620|NCT02672423|80241099|FG003|Period 3|Withdrawal by Subject|0|||
27560621|NCT02672423|80241100|FG004|Period 3|Withdrawal by Subject|0|||
27560622|NCT02672423|80241101|FG005|Period 3|Withdrawal by Subject|0|||
27560623|NCT02672423|80241102|FG006|Period 3|Withdrawal by Subject|0|||
27560624|NCT02672423|80241103|FG007|Period 3|Withdrawal by Subject|1|||
27560625|NCT02672423|80241104|FG008|Period 3|Withdrawal by Subject|0|||
27560626|NCT02672423|80241105|FG009|Period 3|Withdrawal by Subject|0|||
27560627|NCT02672423|80241096|FG000|Period 3|Physician Decision|0|||
27560628|NCT02672423|80241097|FG001|Period 3|Physician Decision|0|||
27560629|NCT02672423|80241098|FG002|Period 3|Physician Decision|0|||
27560630|NCT02672423|80241099|FG003|Period 3|Physician Decision|0|||
27560631|NCT02672423|80241100|FG004|Period 3|Physician Decision|0|||
27560632|NCT02672423|80241101|FG005|Period 3|Physician Decision|1|||
27560633|NCT02672423|80241102|FG006|Period 3|Physician Decision|0|||
27560634|NCT02672423|80241103|FG007|Period 3|Physician Decision|0|||
27560635|NCT02672423|80241104|FG008|Period 3|Physician Decision|0|||
27560636|NCT02672423|80241105|FG009|Period 3|Physician Decision|0|||
27560637|NCT03054870|80241106|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
27560638|NCT03054870|80241106|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
27560639|NCT01912287|80241108|FG000|Overall Study|Ineligible|1|||
27560640|NCT01912287|80241109|FG001|Overall Study|Ineligible|0|||
27560641|NCT01912287|80241110|FG002|Overall Study|Ineligible|1|||
27560642|NCT01912287|80241108|FG000|Overall Study|No-show|0|||
27560643|NCT01912287|80241109|FG001|Overall Study|No-show|0|||
27560644|NCT01912287|80241110|FG002|Overall Study|No-show|1|||
27560645|NCT01912287|80241108|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
27560646|NCT01912287|80241109|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
27700144|NCT02202551|80741030|FG003|Overall Study|Lost to Follow-up|1|||
27700145|NCT02202551|80741027|FG000|Overall Study|Needed to take excluded medication|0|||
27700146|NCT02202551|80741028|FG001|Overall Study|Needed to take excluded medication|2|||
27700147|NCT02202551|80741029|FG002|Overall Study|Needed to take excluded medication|0|||
27700148|NCT02202551|80741030|FG003|Overall Study|Needed to take excluded medication|1|||
27700149|NCT02202551|80741027|FG000|Overall Study|Subject moved away|0|||
27700150|NCT02202551|80741028|FG001|Overall Study|Subject moved away|1|||
27700151|NCT02202551|80741029|FG002|Overall Study|Subject moved away|0|||
27886053|NCT01868438|81417933|FG000|First Intervention|Lost to Follow-up|2|||
27832422|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
27832423|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
27700152|NCT02202551|80741030|FG003|Overall Study|Subject moved away|0|||
27700153|NCT02202551|80741027|FG000|Overall Study|DBS surgery|3|||
27700154|NCT02202551|80741028|FG001|Overall Study|DBS surgery|0|||
27700155|NCT02202551|80741029|FG002|Overall Study|DBS surgery|0|||
27700156|NCT02202551|80741030|FG003|Overall Study|DBS surgery|0|||
27700157|NCT02202551|80741027|FG000|Overall Study|Dyskinesia upon taper|1|||
27700158|NCT02202551|80741028|FG001|Overall Study|Dyskinesia upon taper|0|||
27700159|NCT02202551|80741029|FG002|Overall Study|Dyskinesia upon taper|0|||
27700160|NCT02202551|80741030|FG003|Overall Study|Dyskinesia upon taper|0|||
27700161|NCT02202551|80741027|FG000|Overall Study|Lack of Efficacy|0|||
27700162|NCT02202551|80741028|FG001|Overall Study|Lack of Efficacy|1|||
27700163|NCT02202551|80741029|FG002|Overall Study|Lack of Efficacy|0|||
27700164|NCT02202551|80741030|FG003|Overall Study|Lack of Efficacy|0|||
27700165|NCT02202551|80741027|FG000|Overall Study|Physician Decision|1|||
27700166|NCT02202551|80741028|FG001|Overall Study|Physician Decision|0|||
27700167|NCT02202551|80741029|FG002|Overall Study|Physician Decision|0|||
27832424|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
27832425|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
27832426|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
27832427|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
27832428|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832429|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27886054|NCT01868438|81417934|FG001|First Intervention|Lost to Follow-up|3|||
27886055|NCT01868438|81417933|FG000|First Intervention|Meeting the non-redosing criteria|0|||
27886056|NCT01868438|81417934|FG001|First Intervention|Meeting the non-redosing criteria|1|||
27886057|NCT01868438|81417933|FG000|Second Intervention|Adverse Event|3|||
27700168|NCT02202551|80741030|FG003|Overall Study|Physician Decision|0|||
27700169|NCT02202551|80741027|FG000|Overall Study|Site closure|3|||
27886058|NCT01868438|81417934|FG001|Second Intervention|Adverse Event|3|||
27886059|NCT03287635|81417938|FG000|Overall Study|Lost to Follow-up|5|||
27700170|NCT02202551|80741028|FG001|Overall Study|Site closure|0|||
27700171|NCT02202551|80741029|FG002|Overall Study|Site closure|0|||
27700172|NCT02202551|80741030|FG003|Overall Study|Site closure|1|||
27700173|NCT02202551|80741027|FG000|Overall Study|Unable to complete visits per protocol|1|||
27700174|NCT02202551|80741028|FG001|Overall Study|Unable to complete visits per protocol|0|||
27700175|NCT02202551|80741029|FG002|Overall Study|Unable to complete visits per protocol|0|||
27700176|NCT02202551|80741030|FG003|Overall Study|Unable to complete visits per protocol|0|||
27700177|NCT02202551|80741027|FG000|Overall Study|Worsening Dyskinesia|0|||
27700178|NCT02202551|80741028|FG001|Overall Study|Worsening Dyskinesia|0|||
27700179|NCT02202551|80741029|FG002|Overall Study|Worsening Dyskinesia|0|||
27700180|NCT02202551|80741030|FG003|Overall Study|Worsening Dyskinesia|1|||
27700181|NCT02202551|80741027|FG000|Overall Study|Protocol Violation|0|||
27700182|NCT02202551|80741028|FG001|Overall Study|Protocol Violation|1|||
27700183|NCT02202551|80741029|FG002|Overall Study|Protocol Violation|0|||
27700184|NCT02202551|80741030|FG003|Overall Study|Protocol Violation|0|||
27700185|NCT02202551|80741027|FG000|Overall Study|Sponsor's decision|2|||
27700186|NCT02202551|80741028|FG001|Overall Study|Sponsor's decision|0|||
27700187|NCT02202551|80741029|FG002|Overall Study|Sponsor's decision|0|||
27700188|NCT02202551|80741030|FG003|Overall Study|Sponsor's decision|0|||
27700189|NCT02202551|80741027|FG000|Overall Study|Subject unwilling to proceed|1|||
27700190|NCT02202551|80741028|FG001|Overall Study|Subject unwilling to proceed|5|||
27700191|NCT02202551|80741029|FG002|Overall Study|Subject unwilling to proceed|3|||
27700192|NCT02202551|80741030|FG003|Overall Study|Subject unwilling to proceed|5|||
27700193|NCT02202551|80741027|FG000|Overall Study|Subject consent withdrawn|0|||
27700194|NCT02202551|80741028|FG001|Overall Study|Subject consent withdrawn|3|||
27700195|NCT02202551|80741029|FG002|Overall Study|Subject consent withdrawn|1|||
27700196|NCT02202551|80741030|FG003|Overall Study|Subject consent withdrawn|2|||
27700197|NCT02202551|80741027|FG000|Overall Study|eGFR<50mL/min/m2|2|||
27700198|NCT02202551|80741028|FG001|Overall Study|eGFR<50mL/min/m2|2|||
27700199|NCT02202551|80741029|FG002|Overall Study|eGFR<50mL/min/m2|0|||
27700200|NCT02202551|80741030|FG003|Overall Study|eGFR<50mL/min/m2|1|||
27700201|NCT00568321|80741031|FG000|Overall Study|Adverse Event|1|||
27700202|NCT00568321|80741032|FG001|Overall Study|Adverse Event|0|||
27700203|NCT00568321|80741033|FG002|Overall Study|Adverse Event|0|||
27700204|NCT00568321|80741031|FG000|Overall Study|Lack of Efficacy|8|||
27700205|NCT00568321|80741032|FG001|Overall Study|Lack of Efficacy|5|||
27700206|NCT00568321|80741033|FG002|Overall Study|Lack of Efficacy|6|||
27700207|NCT00568321|80741031|FG000|Overall Study|Lost to Follow-up|0|||
27700208|NCT00568321|80741032|FG001|Overall Study|Lost to Follow-up|0|||
27700209|NCT00568321|80741033|FG002|Overall Study|Lost to Follow-up|1|||
27700210|NCT00568321|80741031|FG000|Overall Study|Withdrawal by Subject|2|||
27700211|NCT00568321|80741032|FG001|Overall Study|Withdrawal by Subject|0|||
27700212|NCT00568321|80741033|FG002|Overall Study|Withdrawal by Subject|0|||
27700213|NCT00568321|80741031|FG000|Overall Study|Protocol Violation|0|||
27700214|NCT00568321|80741032|FG001|Overall Study|Protocol Violation|0|||
27700215|NCT00568321|80741033|FG002|Overall Study|Protocol Violation|1|||
27700216|NCT00568321|80741031|FG000|Overall Study|Randomized, not treated|2|||
27700217|NCT00568321|80741032|FG001|Overall Study|Randomized, not treated|0|||
27700218|NCT00568321|80741033|FG002|Overall Study|Randomized, not treated|1|||
27700219|NCT00667355|80741034|FG000|Overall Study|Adverse Event|5|||
27700220|NCT00667355|80741034|FG000|Overall Study|Lost to Follow-up|1|||
27700221|NCT00667355|80741034|FG000|Overall Study|Other reason was not specified|5|||
27700222|NCT01184053|80741035|FG000|Overall Study|progression while on treatment|3|||
27700223|NCT00307125|80741038|FG000|Screening Phase|Adverse Event|1|||
27700224|NCT00307125|80741039|FG001|Screening Phase|Adverse Event|0|||
27700225|NCT00307125|80741040|FG002|Screening Phase|Adverse Event|0|||
27700226|NCT00307125|80741038|FG000|Screening Phase|Protocol Violation|27|||
27700227|NCT00307125|80741039|FG001|Screening Phase|Protocol Violation|0|||
27700228|NCT00307125|80741040|FG002|Screening Phase|Protocol Violation|0|||
27700229|NCT00307125|80741038|FG000|Screening Phase|Lost to Follow-up|87|||
27700230|NCT00307125|80741039|FG001|Screening Phase|Lost to Follow-up|0|||
27700231|NCT00307125|80741040|FG002|Screening Phase|Lost to Follow-up|0|||
27700232|NCT00307125|80741038|FG000|Screening Phase|Death|10|||
27700233|NCT00307125|80741039|FG001|Screening Phase|Death|0|||
27700234|NCT00307125|80741040|FG002|Screening Phase|Death|0|||
27700235|NCT00307125|80741038|FG000|Screening Phase|Withdrawal by Subject|77|||
27700236|NCT00307125|80741039|FG001|Screening Phase|Withdrawal by Subject|0|||
27700237|NCT00307125|80741040|FG002|Screening Phase|Withdrawal by Subject|0|||
27700238|NCT00307125|80741038|FG000|Screening Phase|Physician Decision|26|||
27700239|NCT00307125|80741039|FG001|Screening Phase|Physician Decision|0|||
27700240|NCT00307125|80741040|FG002|Screening Phase|Physician Decision|0|||
27700241|NCT00307125|80741038|FG000|Screening Phase|Sponsor Decision|4|||
27700242|NCT00307125|80741039|FG001|Screening Phase|Sponsor Decision|0|||
27700243|NCT00307125|80741040|FG002|Screening Phase|Sponsor Decision|0|||
27700244|NCT00307125|80741038|FG000|Screening Phase|Study Terminated|17|||
27700245|NCT00307125|80741039|FG001|Screening Phase|Study Terminated|0|||
27700246|NCT00307125|80741040|FG002|Screening Phase|Study Terminated|0|||
27700247|NCT00307125|80741038|FG000|Screening Phase|Graft Loss|3|||
27700248|NCT00307125|80741039|FG001|Screening Phase|Graft Loss|0|||
27700249|NCT00307125|80741040|FG002|Screening Phase|Graft Loss|0|||
27700250|NCT00307125|80741038|FG000|Screening Phase|Graft Failure|8|||
27700251|NCT00307125|80741039|FG001|Screening Phase|Graft Failure|0|||
27700252|NCT00307125|80741040|FG002|Screening Phase|Graft Failure|0|||
27700253|NCT00307125|80741038|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
27700254|NCT00307125|80741039|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
27700255|NCT00307125|80741040|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
27700256|NCT00307125|80741038|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
27700257|NCT00307125|80741039|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
27700258|NCT00307125|80741040|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
27700259|NCT00307125|80741038|FG000|Screening Phase|Moved or transferred facilities|34|||
27700260|NCT00307125|80741039|FG001|Screening Phase|Moved or transferred facilities|0|||
27700261|NCT00307125|80741040|FG002|Screening Phase|Moved or transferred facilities|0|||
27700262|NCT00307125|80741038|FG000|Screening Phase|Received Pancreas Transplant|8|||
27700263|NCT00307125|80741039|FG001|Screening Phase|Received Pancreas Transplant|0|||
27700264|NCT00307125|80741040|FG002|Screening Phase|Received Pancreas Transplant|0|||
27700265|NCT00307125|80741038|FG000|Screening Phase|Ineligible for pilot|4|||
27700266|NCT00307125|80741039|FG001|Screening Phase|Ineligible for pilot|0|||
27700267|NCT00307125|80741040|FG002|Screening Phase|Ineligible for pilot|0|||
27700268|NCT00307125|80741038|FG000|Screening Phase|Try to get pregnant|1|||
27700269|NCT00307125|80741039|FG001|Screening Phase|Try to get pregnant|0|||
27700270|NCT00307125|80741040|FG002|Screening Phase|Try to get pregnant|0|||
27700271|NCT00307125|80741038|FG000|Screening Phase|Developed acute leukemia|1|||
27700272|NCT00307125|80741039|FG001|Screening Phase|Developed acute leukemia|0|||
27700273|NCT00307125|80741040|FG002|Screening Phase|Developed acute leukemia|0|||
27700274|NCT00307125|80741038|FG000|Screening Phase|Metastatic colon cancer|1|||
27700275|NCT00307125|80741039|FG001|Screening Phase|Metastatic colon cancer|0|||
27700276|NCT00307125|80741040|FG002|Screening Phase|Metastatic colon cancer|0|||
27700277|NCT00307125|80741038|FG000|Screening Phase|Malignancy|1|||
27700278|NCT00307125|80741039|FG001|Screening Phase|Malignancy|0|||
27700279|NCT00307125|80741040|FG002|Screening Phase|Malignancy|0|||
27700280|NCT00307125|80741038|FG000|Screening Phase|PAK|1|||
27700281|NCT00307125|80741039|FG001|Screening Phase|PAK|0|||
27700282|NCT00307125|80741040|FG002|Screening Phase|PAK|0|||
27832430|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27886060|NCT03287635|81417938|FG000|Overall Study|Withdrawal by Subject|1|||
27886061|NCT03287635|81417938|FG000|Overall Study|Physician Decision|1|||
27886062|NCT02887248|81417940|FG000|Overall Study|Withdrawal by Subject|1|||
27886063|NCT02887248|81417940|FG000|Overall Study|Adverse Event|1|||
27886064|NCT02887248|81417940|FG000|Overall Study|Progressive Disease|1|||
27832431|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832432|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832433|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832434|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832435|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832436|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
27832437|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
27832438|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832439|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832440|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27832441|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
27886065|NCT00427921|81417941|FG000|Overall Study|Adverse Event|26|||
27886066|NCT00427921|81417941|FG000|Overall Study|Withdrawal by Subject|4|||
27886067|NCT00427921|81417941|FG000|Overall Study|Lost to Follow-up|2|||
27886068|NCT00427921|81417941|FG000|Overall Study|Other reason not specified|10|||
27886069|NCT00427921|81417941|FG000|Overall Study|Adverse Event + Hospitalization|1|||
27886070|NCT00427921|81417941|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
27700283|NCT00307125|80741038|FG000|Screening Phase|Ineligible|1|||
27700284|NCT00307125|80741039|FG001|Screening Phase|Ineligible|0|||
27700285|NCT00307125|80741040|FG002|Screening Phase|Ineligible|0|||
27700286|NCT00307125|80741038|FG000|Screening Phase|Screen Error|1|||
27886071|NCT00427921|81417941|FG000|Overall Study|Adverse Event + No Response|1|||
27700287|NCT00307125|80741039|FG001|Screening Phase|Screen Error|0|||
27700288|NCT00307125|80741040|FG002|Screening Phase|Screen Error|0|||
27700289|NCT00307125|80741038|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
27700290|NCT00307125|80741039|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
27700291|NCT00307125|80741040|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
27700292|NCT00307125|80741038|FG000|Screening Phase|AMR and treated with rituximab|1|||
27700293|NCT00307125|80741039|FG001|Screening Phase|AMR and treated with rituximab|0|||
27700294|NCT00307125|80741040|FG002|Screening Phase|AMR and treated with rituximab|0|||
27700295|NCT00307125|80741038|FG000|Screening Phase|Coronary artery bypass|1|||
27700296|NCT00307125|80741039|FG001|Screening Phase|Coronary artery bypass|0|||
27700297|NCT00307125|80741040|FG002|Screening Phase|Coronary artery bypass|0|||
27700298|NCT00307125|80741038|FG000|Pilot Phase|Lost to Follow-up|0|||
27700299|NCT00307125|80741039|FG001|Pilot Phase|Lost to Follow-up|1|||
27700300|NCT00307125|80741040|FG002|Pilot Phase|Lost to Follow-up|0|||
27700301|NCT00307125|80741038|FG000|Pilot Phase|Withdrawal by Subject|0|||
27700302|NCT00307125|80741039|FG001|Pilot Phase|Withdrawal by Subject|1|||
27700303|NCT00307125|80741040|FG002|Pilot Phase|Withdrawal by Subject|1|||
27700304|NCT01008696|80741046|FG000|Overall Study|Participant's evasion of hospital visit|5|||
27700305|NCT01008696|80741047|FG001|Overall Study|Participant's evasion of hospital visit|4|||
27700306|NCT01008696|80741046|FG000|Overall Study|Withdrawal by Subject|2|||
27700307|NCT01008696|80741047|FG001|Overall Study|Withdrawal by Subject|4|||
27700308|NCT01008696|80741046|FG000|Overall Study|Physician Decision|5|||
27700309|NCT01008696|80741047|FG001|Overall Study|Physician Decision|1|||
27700310|NCT01008696|80741046|FG000|Overall Study|Adverse Event|1|||
27700311|NCT01008696|80741047|FG001|Overall Study|Adverse Event|0|||
27700312|NCT01008696|80741046|FG000|Overall Study|Participants' non-cooperation|2|||
27886072|NCT00427921|81417941|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
27886073|NCT00427921|81417941|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
27886074|NCT00427921|81417941|FG000|Overall Study|Adverse Event + Lost Response|1|||
27886075|NCT00427921|81417941|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
27886076|NCT00427921|81417941|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
27886077|NCT02048826|81417945|FG000|Overall Study|Withdrawal by Subject|1|||
27886078|NCT02048826|81417946|FG001|Overall Study|Withdrawal by Subject|0|||
27886079|NCT02880865|81417947|FG000|Overall Study|Adverse Event|1|||
27886080|NCT02880865|81417948|FG001|Overall Study|Adverse Event|0|||
27886081|NCT02880865|81417947|FG000|Overall Study|Withdrawal by Subject|0|||
27886082|NCT02880865|81417948|FG001|Overall Study|Withdrawal by Subject|2|||
27560647|NCT01912287|80241110|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
27700313|NCT01008696|80741047|FG001|Overall Study|Participants' non-cooperation|3|||
27886083|NCT02880865|81417947|FG000|Overall Study|Physician Decision|0|||
27700314|NCT01008696|80741046|FG000|Overall Study|Other|2|||
27886084|NCT02880865|81417948|FG001|Overall Study|Physician Decision|1|||
27886085|NCT01217476|81417951|FG000|Overall Study|Adverse Event|6|||
27886086|NCT01217476|81417952|FG001|Overall Study|Adverse Event|1|||
27886087|NCT01217476|81417951|FG000|Overall Study|Physician Decision|0|||
27700315|NCT01008696|80741047|FG001|Overall Study|Other|3|||
27700316|NCT01008696|80741046|FG000|Overall Study|Other|0|||
27886088|NCT01217476|81417952|FG001|Overall Study|Physician Decision|1|||
27886089|NCT01217476|81417951|FG000|Overall Study|Withdrawal by Subject|3|||
27886090|NCT01217476|81417952|FG001|Overall Study|Withdrawal by Subject|3|||
27886091|NCT01217476|81417951|FG000|Overall Study|Surgery on the Target Limb|0|||
27886092|NCT01217476|81417952|FG001|Overall Study|Surgery on the Target Limb|2|||
27886093|NCT01217476|81417951|FG000|Overall Study|Protocol Deviation|1|||
27886094|NCT01217476|81417952|FG001|Overall Study|Protocol Deviation|0|||
27886095|NCT01217476|81417951|FG000|Overall Study|Other|2|||
27886096|NCT01217476|81417952|FG001|Overall Study|Other|0|||
27886097|NCT02438826|81417953|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
27886098|NCT02438826|81417954|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
27886099|NCT02438826|81417955|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
27560648|NCT01912287|80241108|FG000|Overall Study|Felt treatment no longer needed|0|||
27560649|NCT01912287|80241109|FG001|Overall Study|Felt treatment no longer needed|1|||
27560650|NCT01912287|80241110|FG002|Overall Study|Felt treatment no longer needed|0|||
27886100|NCT02438826|81417956|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27886101|NCT02438826|81417953|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
27886102|NCT02438826|81417954|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27886103|NCT02438826|81417955|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27886104|NCT02438826|81417956|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
27886105|NCT02438826|81417953|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
27886106|NCT02438826|81417954|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
27886107|NCT02438826|81417955|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27560651|NCT01912287|80241108|FG000|Overall Study|Life circumstances|4|||
27560652|NCT01912287|80241109|FG001|Overall Study|Life circumstances|2|||
27560653|NCT01912287|80241110|FG002|Overall Study|Life circumstances|0|||
27560654|NCT01912287|80241108|FG000|Overall Study|Lost Interest|1|||
27700317|NCT01008696|80741047|FG001|Overall Study|Other|2|||
27700318|NCT00120406|80741051|FG000|Overall Study|Death|9|||
27700319|NCT00120406|80741052|FG001|Overall Study|Death|4|||
27700320|NCT00120406|80741051|FG000|Overall Study|Withdrawal by Subject|5|||
27886108|NCT02438826|81417956|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
27886109|NCT02438826|81417953|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
27886110|NCT02438826|81417954|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
27886111|NCT02438826|81417955|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
27886112|NCT02438826|81417956|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
27560655|NCT01912287|80241109|FG001|Overall Study|Lost Interest|0|||
27700321|NCT00120406|80741052|FG001|Overall Study|Withdrawal by Subject|7|||
27560656|NCT01912287|80241110|FG002|Overall Study|Lost Interest|0|||
27560657|NCT01912287|80241108|FG000|Overall Study|Uknown reason - subject drop out|5|||
27886113|NCT02438826|81417953|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
27886114|NCT02438826|81417954|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
27886115|NCT02438826|81417955|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
27886116|NCT02438826|81417956|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
27886117|NCT02438826|81417953|FG000|Open-Label Treatment Phase|Adverse Event|11|||
27886118|NCT02438826|81417954|FG001|Open-Label Treatment Phase|Adverse Event|6|||
27886119|NCT02438826|81417955|FG002|Open-Label Treatment Phase|Adverse Event|0|||
27886120|NCT02438826|81417956|FG003|Open-Label Treatment Phase|Adverse Event|0|||
27886121|NCT02438826|81417953|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
27886122|NCT02438826|81417954|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
27886123|NCT02438826|81417955|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
27886124|NCT02438826|81417956|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
27886125|NCT02438826|81417953|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
27560658|NCT01912287|80241109|FG001|Overall Study|Uknown reason - subject drop out|7|||
27832442|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832443|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832444|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832445|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832446|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832447|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832448|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832449|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832450|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
27832451|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
27832452|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832453|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832454|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832455|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
27832456|NCT01695239|81219295|FG000|Extension Long-Term Extension Periods|Death|0|||
27832457|NCT01695239|81219296|FG001|Extension Long-Term Extension Periods|Death|0|||
27832458|NCT01695239|81219297|FG002|Extension Long-Term Extension Periods|Death|0|||
27832459|NCT01695239|81219298|FG003|Extension Long-Term Extension Periods|Death|0|||
27832460|NCT01695239|81219299|FG004|Extension Long-Term Extension Periods|Death|0|||
27832461|NCT01695239|81219300|FG005|Extension Long-Term Extension Periods|Death|0|||
27832462|NCT01695239|81219301|FG006|Extension Long-Term Extension Periods|Death|0|||
27832463|NCT01695239|81219302|FG007|Extension Long-Term Extension Periods|Death|0|||
27832464|NCT01695239|81219303|FG008|Extension Long-Term Extension Periods|Death|1|||
27832465|NCT01695239|81219304|FG009|Extension Long-Term Extension Periods|Death|0|||
27832466|NCT01695239|81219305|FG010|Extension Long-Term Extension Periods|Death|0|||
27832467|NCT01695239|81219306|FG011|Extension Long-Term Extension Periods|Death|0|||
27832468|NCT01695239|81219307|FG012|Extension Long-Term Extension Periods|Death|0|||
27832469|NCT01695239|81219308|FG013|Extension Long-Term Extension Periods|Death|0|||
27832470|NCT01695239|81219295|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832471|NCT01695239|81219296|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832472|NCT01695239|81219297|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27700322|NCT00120406|80741051|FG000|Overall Study|Lost to Follow-up|5|||
27832473|NCT01695239|81219298|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832474|NCT01695239|81219299|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832475|NCT01695239|81219300|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832476|NCT01695239|81219301|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832477|NCT01695239|81219302|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832478|NCT01695239|81219303|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832479|NCT01695239|81219304|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832480|NCT01695239|81219305|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
27832481|NCT01695239|81219306|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
27832482|NCT01695239|81219307|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
27832483|NCT01695239|81219308|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
27832484|NCT01695239|81219295|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832485|NCT01695239|81219296|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832486|NCT01695239|81219297|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832487|NCT01695239|81219298|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832488|NCT01695239|81219299|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832489|NCT01695239|81219300|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832490|NCT01695239|81219301|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832491|NCT01695239|81219302|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832492|NCT01695239|81219303|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832493|NCT01695239|81219304|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27832494|NCT01695239|81219305|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27886126|NCT02438826|81417954|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
27886127|NCT02438826|81417955|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
27886128|NCT02438826|81417956|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
27886129|NCT02438826|81417953|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
27886130|NCT02438826|81417954|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
27886131|NCT02438826|81417955|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
27886132|NCT02438826|81417956|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
27886133|NCT02438826|81417953|FG000|Post-Treatment Phase|Adverse Event|3|||
27886134|NCT02438826|81417954|FG001|Post-Treatment Phase|Adverse Event|0|||
27886135|NCT02438826|81417955|FG002|Post-Treatment Phase|Adverse Event|0|||
27886136|NCT02438826|81417956|FG003|Post-Treatment Phase|Adverse Event|0|||
27886137|NCT02438826|81417953|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
27886138|NCT02438826|81417954|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
27886139|NCT02438826|81417955|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
27886140|NCT02438826|81417956|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
27886141|NCT02438826|81417953|FG000|Post-Treatment Phase|Physician Decision|1|||
27886142|NCT02438826|81417954|FG001|Post-Treatment Phase|Physician Decision|0|||
27886143|NCT02438826|81417955|FG002|Post-Treatment Phase|Physician Decision|0|||
27886144|NCT02438826|81417956|FG003|Post-Treatment Phase|Physician Decision|0|||
27886145|NCT02438826|81417953|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
27886146|NCT02438826|81417954|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
27886147|NCT02438826|81417955|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
27886148|NCT02438826|81417956|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
27886149|NCT01878149|81417967|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
27886150|NCT01878149|81417968|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
27886151|NCT02282631|81417971|FG000|Overall Study|Lost to Follow-up|2|||
27832495|NCT01695239|81219306|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
27886152|NCT02282631|81417972|FG001|Overall Study|Lost to Follow-up|0|||
27886153|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
27832496|NCT01695239|81219307|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
27832497|NCT01695239|81219308|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
27832498|NCT01695239|81219295|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832499|NCT01695239|81219296|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832500|NCT01695239|81219297|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832501|NCT01695239|81219298|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832502|NCT01695239|81219299|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832503|NCT01695239|81219300|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832504|NCT01695239|81219301|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832505|NCT01695239|81219302|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832506|NCT01695239|81219303|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832507|NCT01695239|81219304|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832508|NCT01695239|81219305|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832509|NCT01695239|81219306|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
27832510|NCT01695239|81219307|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
27832511|NCT01695239|81219308|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
27886154|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
27886155|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
27886156|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
27886157|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
27886158|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
27886159|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
27886160|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
27886161|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
27886162|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
27886163|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
27886164|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
27832512|NCT01695239|81219295|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832513|NCT01695239|81219296|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832514|NCT01695239|81219297|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832515|NCT01695239|81219298|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832516|NCT01695239|81219299|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832517|NCT01695239|81219300|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832518|NCT01695239|81219301|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832519|NCT01695239|81219302|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27886165|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
27886166|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
27886167|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27886168|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27886169|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27832520|NCT01695239|81219303|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832521|NCT01695239|81219304|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832522|NCT01695239|81219305|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832523|NCT01695239|81219306|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832524|NCT01695239|81219307|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
27832525|NCT01695239|81219308|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
27832526|NCT01024855|81219309|FG000|Overall Study|Inclusion/exclusion criteria|1|||
27832527|NCT03259165|81219310|FG000|Overall Study|COVID 19 pandemic|1|||
27832528|NCT03259165|81219311|FG001|Overall Study|COVID 19 pandemic|1|||
27832529|NCT00537095|81219312|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
27832530|NCT00537095|81219313|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
27832531|NCT00537095|81219312|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
27832532|NCT00537095|81219313|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
27832533|NCT00537095|81219312|FG000|Randomized Treatment Period (433 Days)|Death|3|||
27832534|NCT00537095|81219313|FG001|Randomized Treatment Period (433 Days)|Death|1|||
27832535|NCT00537095|81219312|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
27832536|NCT00537095|81219313|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
27832537|NCT00537095|81219312|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
27886170|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
27886171|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
27886172|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
27886173|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
27886174|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
27886175|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
27886176|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
27886177|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
27886178|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
27886179|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
27886180|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
27886181|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
27886182|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
27886183|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
27886184|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
27886185|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27886186|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27886187|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27832538|NCT00537095|81219313|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
27886188|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
27886189|NCT02016105|81417975|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
27886190|NCT02016105|81417976|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
27886191|NCT02016105|81417977|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27886192|NCT02016105|81417978|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27886193|NCT02016105|81417979|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27886194|NCT02016105|81417980|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
27886195|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
27886196|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
27886197|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
27832539|NCT00537095|81219312|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
27832540|NCT00537095|81219313|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
27832541|NCT00537095|81219312|FG000|Open-label Period (590 Days)|Adverse Event|2|||
27832542|NCT00537095|81219313|FG001|Open-label Period (590 Days)|Adverse Event|11|||
27832543|NCT00537095|81219312|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
27832544|NCT00537095|81219313|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
27832545|NCT00537095|81219312|FG000|Open-label Period (590 Days)|Death|2|||
27832546|NCT00537095|81219313|FG001|Open-label Period (590 Days)|Death|2|||
27832547|NCT00537095|81219312|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
27832548|NCT00537095|81219313|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
27832549|NCT00537095|81219312|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
27832550|NCT00537095|81219313|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
27832551|NCT04773600|81219314|FG000|Overall Study|Withdrawal by Subject|15|||
27832552|NCT04773600|81219315|FG001|Overall Study|Withdrawal by Subject|9|||
27832553|NCT04773600|81219314|FG000|Overall Study|Lost to Follow-up|10|||
27832554|NCT04773600|81219315|FG001|Overall Study|Lost to Follow-up|6|||
27832555|NCT04773600|81219314|FG000|Overall Study|Adverse Event|8|||
27832556|NCT04773600|81219315|FG001|Overall Study|Adverse Event|2|||
27832557|NCT04773600|81219314|FG000|Overall Study|Lack of Efficacy|2|||
27832558|NCT04773600|81219315|FG001|Overall Study|Lack of Efficacy|3|||
27832559|NCT04773600|81219314|FG000|Overall Study|Noncompliance|2|||
27560659|NCT01912287|80241110|FG002|Overall Study|Uknown reason - subject drop out|3|||
27560660|NCT01912287|80241108|FG000|Overall Study|Missed Assesment|1|||
27560661|NCT01912287|80241109|FG001|Overall Study|Missed Assesment|1|||
27560662|NCT01912287|80241110|FG002|Overall Study|Missed Assesment|1|||
27560663|NCT01912287|80241108|FG000|Overall Study|Scheduling/change in availability|17|||
27560664|NCT01912287|80241109|FG001|Overall Study|Scheduling/change in availability|10|||
27560665|NCT01912287|80241110|FG002|Overall Study|Scheduling/change in availability|8|||
27560666|NCT01382446|80241116|FG000|Overall Study|Withdrawal by Subject|0|||
27560667|NCT01382446|80241117|FG001|Overall Study|Withdrawal by Subject|1|||
27560668|NCT01382446|80241116|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
27560669|NCT01382446|80241117|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
27560670|NCT01505868|80241118|FG000|Overall Study|Withdrawal by Subject|1|||
27560671|NCT01505868|80241119|FG001|Overall Study|Withdrawal by Subject|0|||
27560672|NCT01505868|80241120|FG002|Overall Study|Withdrawal by Subject|0|||
27560673|NCT01505868|80241121|FG003|Overall Study|Withdrawal by Subject|0|||
27560674|NCT01505868|80241122|FG004|Overall Study|Withdrawal by Subject|0|||
27560675|NCT02081079|80241129|FG000|Overall Study|Lack of Efficacy|3|||
27560676|NCT02081079|80241130|FG001|Overall Study|Lack of Efficacy|2|||
27832560|NCT04773600|81219315|FG001|Overall Study|Noncompliance|0|||
27560677|NCT02081079|80241129|FG000|Overall Study|Lost to Follow-up|1|||
27560678|NCT02081079|80241130|FG001|Overall Study|Lost to Follow-up|0|||
27832561|NCT04773600|81219314|FG000|Overall Study|Protocol Violation|2|||
27560679|NCT00413192|80241132|FG000|Overall Study|Disease progression|26|||
27560680|NCT00413192|80241133|FG001|Overall Study|Disease progression|31|||
27560681|NCT00413192|80241134|FG002|Overall Study|Disease progression|16|||
27832562|NCT04773600|81219315|FG001|Overall Study|Protocol Violation|0|||
27832563|NCT04773600|81219314|FG000|Overall Study|Physician Decision|0|||
27560682|NCT00413192|80241135|FG003|Overall Study|Disease progression|25|||
27560683|NCT00413192|80241132|FG000|Overall Study|Toxicity|3|||
27560684|NCT00413192|80241133|FG001|Overall Study|Toxicity|2|||
27560685|NCT00413192|80241134|FG002|Overall Study|Toxicity|2|||
27560686|NCT00413192|80241135|FG003|Overall Study|Toxicity|2|||
27560687|NCT00413192|80241132|FG000|Overall Study|Withdrawal by Subject|3|||
27560688|NCT00413192|80241133|FG001|Overall Study|Withdrawal by Subject|5|||
27560689|NCT00413192|80241134|FG002|Overall Study|Withdrawal by Subject|0|||
27560690|NCT00413192|80241135|FG003|Overall Study|Withdrawal by Subject|1|||
27700323|NCT00120406|80741052|FG001|Overall Study|Lost to Follow-up|2|||
27560691|NCT00413192|80241132|FG000|Overall Study|Intercurrent illness|0|||
27700324|NCT00120406|80741051|FG000|Overall Study|received non-study stent|0|||
27832564|NCT04773600|81219315|FG001|Overall Study|Physician Decision|1|||
27560692|NCT00413192|80241133|FG001|Overall Study|Intercurrent illness|0|||
27560693|NCT00413192|80241134|FG002|Overall Study|Intercurrent illness|0|||
27560694|NCT00413192|80241135|FG003|Overall Study|Intercurrent illness|1|||
27560695|NCT00413192|80241132|FG000|Overall Study|Intercurrent death|0|||
27832565|NCT04773600|81219314|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
27832566|NCT04773600|81219315|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
27832567|NCT04773600|81219314|FG000|Overall Study|Emergency Travel Out of Country|1|||
27832568|NCT04773600|81219315|FG001|Overall Study|Emergency Travel Out of Country|0|||
27832569|NCT00177164|81219319|FG000|Overall Study|Protocol Violation|0|||
27832570|NCT00177164|81219320|FG001|Overall Study|Protocol Violation|7|||
27832571|NCT00177164|81219319|FG000|Overall Study|Lost to Follow-up|4|||
27832572|NCT00177164|81219320|FG001|Overall Study|Lost to Follow-up|5|||
27832573|NCT00177164|81219319|FG000|Overall Study|increase in alcohol and drug use|1|||
27832574|NCT00177164|81219320|FG001|Overall Study|increase in alcohol and drug use|2|||
27832575|NCT00177164|81219319|FG000|Overall Study|Adverse Event|1|||
27832576|NCT00177164|81219320|FG001|Overall Study|Adverse Event|0|||
27832577|NCT00177164|81219319|FG000|Overall Study|discharge from hospital|1|||
27832578|NCT00177164|81219320|FG001|Overall Study|discharge from hospital|0|||
27832579|NCT00177164|81219319|FG000|Overall Study|Lack of Efficacy|2|||
27832580|NCT00177164|81219320|FG001|Overall Study|Lack of Efficacy|1|||
27832581|NCT00177164|81219319|FG000|Overall Study|Pregnancy|0|||
27832582|NCT00177164|81219320|FG001|Overall Study|Pregnancy|1|||
27832583|NCT03499873|81219323|FG000|Overall Study|Withdrawal by Subject|4|||
27832584|NCT03499873|81219324|FG001|Overall Study|Withdrawal by Subject|6|||
27832585|NCT03499873|81219325|FG002|Overall Study|Withdrawal by Subject|1|||
27832586|NCT03499873|81219323|FG000|Overall Study|Subjects condition worsened|0|||
27832587|NCT03499873|81219324|FG001|Overall Study|Subjects condition worsened|3|||
27832588|NCT03499873|81219325|FG002|Overall Study|Subjects condition worsened|11|||
27832589|NCT03499873|81219323|FG000|Overall Study|Adverse Event|8|||
27832590|NCT03499873|81219324|FG001|Overall Study|Adverse Event|3|||
27832591|NCT03499873|81219325|FG002|Overall Study|Adverse Event|6|||
27832592|NCT03499873|81219323|FG000|Overall Study|Physician Decision|1|||
27832593|NCT03499873|81219324|FG001|Overall Study|Physician Decision|0|||
27832594|NCT03499873|81219325|FG002|Overall Study|Physician Decision|0|||
27832595|NCT03499873|81219323|FG000|Overall Study|Administrative reasons|0|||
27832596|NCT03499873|81219324|FG001|Overall Study|Administrative reasons|1|||
27832597|NCT03499873|81219325|FG002|Overall Study|Administrative reasons|0|||
27832598|NCT03499873|81219323|FG000|Overall Study|Concomitant therapy|5|||
27832599|NCT03499873|81219324|FG001|Overall Study|Concomitant therapy|4|||
27560696|NCT00413192|80241133|FG001|Overall Study|Intercurrent death|1|||
27886198|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
27886199|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
27886200|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
27832600|NCT03499873|81219325|FG002|Overall Study|Concomitant therapy|7|||
27832601|NCT03499873|81219323|FG000|Overall Study|Miscellaneous|1|||
27832602|NCT03499873|81219324|FG001|Overall Study|Miscellaneous|2|||
27700325|NCT00120406|80741052|FG001|Overall Study|received non-study stent|2|||
27700326|NCT00120406|80741051|FG000|Overall Study|patient moved but has not withdrawn|0|||
27700327|NCT00120406|80741052|FG001|Overall Study|patient moved but has not withdrawn|1|||
27700328|NCT02120625|80741053|FG000|Overall Study|Physician Decision|2|||
27700329|NCT00596934|80741054|FG000|Overall Study|Protocol Violation|1|||
27700330|NCT00596934|80741054|FG000|Overall Study|Withdrawal by Subject|1|||
27832603|NCT03499873|81219325|FG002|Overall Study|Miscellaneous|2|||
27832604|NCT03499873|81219323|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
27700331|NCT01729156|80741055|FG000|Overall Study|Withdrawal by Subject|1|||
27700332|NCT01729156|80741056|FG001|Overall Study|Withdrawal by Subject|0|||
27700333|NCT01729156|80741057|FG002|Overall Study|Withdrawal by Subject|0|||
27700334|NCT00517751|80741067|FG000|Overall Study|Death|3|||
27700335|NCT00517751|80741067|FG000|Overall Study|Withdrawal by Subject|37|||
27700336|NCT00517751|80741067|FG000|Overall Study|Lost to Follow-up|4|||
27700337|NCT00517751|80741067|FG000|Overall Study|patient not over due|6|||
27700338|NCT00517751|80741067|FG000|Overall Study|Patient not due for visit|76|||
27700339|NCT00517751|80741067|FG000|Overall Study|Missing|3|||
27700340|NCT01774084|80741068|FG000|Overall Study|Personal reasons|1|||
27700341|NCT01774084|80741069|FG001|Overall Study|Personal reasons|0|||
27700342|NCT01159912|80741070|FG000|Overall Study|Adverse Event|2|||
27700343|NCT01159912|80741071|FG001|Overall Study|Adverse Event|2|||
27700344|NCT01159912|80741072|FG002|Overall Study|Adverse Event|3|||
27700345|NCT01159912|80741070|FG000|Overall Study|Lack of Efficacy|23|||
27700346|NCT01159912|80741071|FG001|Overall Study|Lack of Efficacy|15|||
27700347|NCT01159912|80741072|FG002|Overall Study|Lack of Efficacy|14|||
27700348|NCT01159912|80741070|FG000|Overall Study|Protocol Violation|1|||
27700349|NCT01159912|80741071|FG001|Overall Study|Protocol Violation|2|||
27700350|NCT01159912|80741072|FG002|Overall Study|Protocol Violation|3|||
27700351|NCT01159912|80741070|FG000|Overall Study|Lost to Follow-up|4|||
27700352|NCT01159912|80741071|FG001|Overall Study|Lost to Follow-up|0|||
27832605|NCT03499873|81219324|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
27700353|NCT01159912|80741072|FG002|Overall Study|Lost to Follow-up|0|||
27700354|NCT01159912|80741070|FG000|Overall Study|Physician Decision|0|||
27700355|NCT01159912|80741071|FG001|Overall Study|Physician Decision|0|||
27700356|NCT01159912|80741072|FG002|Overall Study|Physician Decision|3|||
27700357|NCT01159912|80741070|FG000|Overall Study|Withdrawal by Subject|10|||
27700358|NCT01159912|80741071|FG001|Overall Study|Withdrawal by Subject|3|||
27700359|NCT01159912|80741072|FG002|Overall Study|Withdrawal by Subject|3|||
27700360|NCT00129623|80741079|FG000|Overall Study|Adverse Event|3|||
27700361|NCT00129623|80741080|FG001|Overall Study|Adverse Event|7|||
27700362|NCT00129623|80741079|FG000|Overall Study|Refused Treatment|5|||
27700363|NCT00129623|80741080|FG001|Overall Study|Refused Treatment|3|||
27700364|NCT00129623|80741079|FG000|Overall Study|Failure to Return|1|||
27700365|NCT00129623|80741080|FG001|Overall Study|Failure to Return|1|||
27700366|NCT00129623|80741079|FG000|Overall Study|Relocated job out of state|1|||
27700367|NCT00129623|80741080|FG001|Overall Study|Relocated job out of state|0|||
27700368|NCT00129623|80741079|FG000|Overall Study|Uncertainty to return|0|||
27700369|NCT00129623|80741080|FG001|Overall Study|Uncertainty to return|1|||
27700370|NCT01630434|80741081|FG000|Overall Study|Donor lungs turned down|1|||
27700371|NCT01630434|80741082|FG001|Overall Study|Donor lungs turned down|0|||
27700372|NCT01630434|80741081|FG000|Overall Study|Protocol Violation|9|||
27700373|NCT01630434|80741082|FG001|Overall Study|Protocol Violation|4|||
27700374|NCT01630434|80741081|FG000|Overall Study|Death|20|||
27700375|NCT01630434|80741082|FG001|Overall Study|Death|26|||
27700376|NCT01790126|80741089|FG000|Overall Study|PSA Progression|12|||
27700377|NCT01790126|80741090|FG001|Overall Study|PSA Progression|16|||
27700378|NCT01790126|80741091|FG002|Overall Study|PSA Progression|16|||
27700379|NCT01790126|80741089|FG000|Overall Study|Other|5|||
27700380|NCT01790126|80741090|FG001|Overall Study|Other|4|||
27700381|NCT01790126|80741091|FG002|Overall Study|Other|8|||
27700382|NCT01790126|80741089|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
27700383|NCT01790126|80741090|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
27700384|NCT01790126|80741091|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
27700385|NCT01790126|80741089|FG000|Overall Study|Withdrawal by Physician|1|||
27700386|NCT01790126|80741090|FG001|Overall Study|Withdrawal by Physician|1|||
27700387|NCT01790126|80741091|FG002|Overall Study|Withdrawal by Physician|2|||
27700388|NCT01790126|80741089|FG000|Overall Study|Withdrawal by Subject|3|||
27700389|NCT01790126|80741090|FG001|Overall Study|Withdrawal by Subject|1|||
27700390|NCT01790126|80741091|FG002|Overall Study|Withdrawal by Subject|2|||
27700391|NCT01790126|80741089|FG000|Overall Study|Lost to Follow-up|1|||
27700392|NCT01790126|80741090|FG001|Overall Study|Lost to Follow-up|0|||
27700393|NCT01790126|80741091|FG002|Overall Study|Lost to Follow-up|1|||
27700394|NCT01790126|80741089|FG000|Overall Study|Adverse Event|0|||
27700395|NCT01790126|80741090|FG001|Overall Study|Adverse Event|2|||
27700396|NCT01790126|80741091|FG002|Overall Study|Adverse Event|0|||
27700397|NCT01790126|80741089|FG000|Overall Study|Death|2|||
27700398|NCT01790126|80741090|FG001|Overall Study|Death|0|||
27700399|NCT01790126|80741091|FG002|Overall Study|Death|0|||
27700400|NCT01790126|80741089|FG000|Overall Study|Radiographic Progression|3|||
27700401|NCT01790126|80741090|FG001|Overall Study|Radiographic Progression|1|||
27700402|NCT01790126|80741091|FG002|Overall Study|Radiographic Progression|0|||
27700403|NCT03503513|80741092|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
27700404|NCT03503513|80741092|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
27700405|NCT03503513|80741092|FG000|Overall Study|Physician Decision|3|||
27700406|NCT03503513|80741092|FG000|Overall Study|Withdrawal by Subject|2|||
27700407|NCT03503513|80741092|FG000|Overall Study|Lost to Follow-up|1|||
27700408|NCT03189862|80741093|FG000|Overall Study|Withdrawal by Subject|1|||
27700409|NCT03189862|80741094|FG001|Overall Study|Withdrawal by Subject|0|||
27700410|NCT03189862|80741093|FG000|Overall Study|Lost to Follow-up|54|||
27700411|NCT03189862|80741094|FG001|Overall Study|Lost to Follow-up|62|||
27700412|NCT01765179|80741095|FG000|Overall Study|Adverse Event|3|||
27700413|NCT01765179|80741095|FG000|Overall Study|Lost to Follow-up|5|||
27700414|NCT01765179|80741095|FG000|Overall Study|Non-compliance with study drug|2|||
27700415|NCT01765179|80741095|FG000|Overall Study|Protocol Violation|1|||
27700416|NCT01765179|80741095|FG000|Overall Study|Withdrawal by Subject|8|||
27700417|NCT01765179|80741095|FG000|Overall Study|Hematocrit >54%|3|||
27700418|NCT01765179|80741095|FG000|Overall Study|prohibited med|1|||
27700419|NCT01765179|80741095|FG000|Overall Study|Out of country unable to finish study|1|||
27700420|NCT01765179|80741095|FG000|Overall Study|lack of venous access|1|||
27700421|NCT01765179|80741095|FG000|Overall Study|work conflict|1|||
27700422|NCT01765179|80741095|FG000|Overall Study|Ca elevated 10.6|1|||
27700423|NCT02598557|80741096|FG000|Overall Study|Withdrawal by Subject|1|||
27700424|NCT02598557|80741097|FG001|Overall Study|Withdrawal by Subject|0|||
27700425|NCT02598557|80741098|FG002|Overall Study|Withdrawal by Subject|1|||
27700426|NCT02598557|80741096|FG000|Overall Study|Participant did not start treatment|2|||
27700427|NCT02598557|80741097|FG001|Overall Study|Participant did not start treatment|1|||
27700428|NCT02598557|80741098|FG002|Overall Study|Participant did not start treatment|1|||
27700429|NCT02598557|80741096|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
27700430|NCT02598557|80741097|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
27700431|NCT02598557|80741098|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
27700432|NCT02598557|80741096|FG000|Overall Study|Adverse Event|1|||
27700433|NCT02598557|80741097|FG001|Overall Study|Adverse Event|1|||
27700434|NCT02598557|80741098|FG002|Overall Study|Adverse Event|0|||
27700435|NCT00150969|80741100|FG000|24 Month Main Study|Adverse Event|3|||
27700436|NCT00150969|80741101|FG001|24 Month Main Study|Adverse Event|4|||
27700437|NCT00150969|80741100|FG000|24 Month Main Study|Death|1|||
27700438|NCT00150969|80741101|FG001|24 Month Main Study|Death|1|||
27700439|NCT00150969|80741100|FG000|24 Month Main Study|Lack of Efficacy|1|||
27700440|NCT00150969|80741101|FG001|24 Month Main Study|Lack of Efficacy|8|||
27700441|NCT00150969|80741100|FG000|24 Month Main Study|Lost to Follow-up|3|||
27700442|NCT00150969|80741101|FG001|24 Month Main Study|Lost to Follow-up|2|||
27700443|NCT00150969|80741100|FG000|24 Month Main Study|Protocol Violation|4|||
27700444|NCT00150969|80741101|FG001|24 Month Main Study|Protocol Violation|2|||
27700445|NCT00150969|80741100|FG000|24 Month Main Study|Withdrawal by Subject|7|||
27700446|NCT00150969|80741101|FG001|24 Month Main Study|Withdrawal by Subject|4|||
27700447|NCT00150969|80741100|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
27700448|NCT00150969|80741101|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
27700449|NCT00150969|80741100|FG000|24-48 Month Extension|Lack of Efficacy|0|||
27700450|NCT00150969|80741101|FG001|24-48 Month Extension|Lack of Efficacy|1|||
27700451|NCT00150969|80741100|FG000|24-48 Month Extension|Adverse Event|1|||
27700452|NCT00150969|80741101|FG001|24-48 Month Extension|Adverse Event|3|||
27700453|NCT00150969|80741100|FG000|24-48 Month Extension|Other Reason|81|||
27700454|NCT00150969|80741101|FG001|24-48 Month Extension|Other Reason|91|||
27700455|NCT03431857|80741102|FG000|Overall Study|Death|6|||
27700456|NCT03431857|80741102|FG000|Overall Study|Lost to Follow-up|41|||
27700457|NCT03431857|80741102|FG000|Overall Study|Adverse Event|6|||
27700458|NCT03431857|80741102|FG000|Overall Study|Withdrawal by Subject|1|||
27700459|NCT03986866|80741109|FG000|Overall Study|Withdrawal by Subject|0|||
27700460|NCT03986866|80741110|FG001|Overall Study|Withdrawal by Subject|3|||
27700461|NCT03986866|80741109|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
27700462|NCT03986866|80741110|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
27700463|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
27700464|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
27700465|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
27700466|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
27700467|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
27700468|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
27700469|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
27700470|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
27700471|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Death|1|||
27700472|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Death|1|||
27700473|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
27700474|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
27700475|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
27700476|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
27700477|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
27700478|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
27700479|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
27700480|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
27886201|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
27700481|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
27886202|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
27886203|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
27886204|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
27700482|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
27700483|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
27700484|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
27700485|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
27700486|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
27700487|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
27700488|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
27700489|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
27700490|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
27700491|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
27700492|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
27700493|NCT00559585|80741114|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
27700494|NCT00559585|80741115|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
27886205|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
27886206|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
27886207|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
27886208|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
27886209|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
27886210|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
27886211|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
27886212|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
27886213|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Death|0|||
27886214|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Death|0|||
27886215|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Death|0|||
27886216|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Death|0|||
27886217|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Death|0|||
27886218|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Death|1|||
27886219|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
27886220|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
27886221|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
27886222|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
27886223|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
27886224|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
27886225|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
27886226|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
27886227|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
27886228|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
27886229|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
27886230|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
27886231|NCT02016105|81417975|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27700495|NCT00559585|80741114|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
27700496|NCT00559585|80741115|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
27700497|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
27700498|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
27700499|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
27700500|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
27700501|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
27700502|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
27700503|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
27700504|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
27700505|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
27700506|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
27700507|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
27700508|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
27700509|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
27700510|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
27700511|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
27700512|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
27700513|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
27700514|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
27700515|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
27700516|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
27700517|NCT00559585|80741114|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
27886232|NCT02016105|81417976|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27886233|NCT02016105|81417977|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
27886234|NCT02016105|81417978|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27886235|NCT02016105|81417979|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
27886236|NCT02016105|81417980|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
27886237|NCT02016105|81417975|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
27886238|NCT02016105|81417976|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
27700518|NCT00559585|80741115|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
27700519|NCT01526551|80741116|FG000|Overall Study|Lack of returned parental consent form|424|||
27886239|NCT02016105|81417977|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
27886240|NCT02016105|81417978|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
27886241|NCT02016105|81417979|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
27832606|NCT03499873|81219325|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
27832607|NCT02627963|81219326|FG000|Overall Study|Randomized but not treated|2|||
27832608|NCT02627963|81219327|FG001|Overall Study|Randomized but not treated|6|||
27832609|NCT00728754|81219328|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
27832610|NCT00728754|81219329|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
27832611|NCT00728754|81219328|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
27832612|NCT00728754|81219329|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
27832613|NCT00728754|81219328|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
27832614|NCT00728754|81219329|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
27832615|NCT01456962|81219330|FG000|Overall Study|Lost to Follow-up|2|||
27832616|NCT01456962|81219331|FG001|Overall Study|Lost to Follow-up|1|||
27832617|NCT01562613|81219332|FG000|Overall Study|Lost to Follow-up|2|||
27832618|NCT01562613|81219332|FG000|Overall Study|Withdrawal by Subject|2|||
27832619|NCT02488239|81219333|FG000|Overall Study|Death|3|||
27832620|NCT02488239|81219333|FG000|Overall Study|Withdrawal by Subject|3|||
27832621|NCT02488239|81219333|FG000|Overall Study|Physician Decision|2|||
27832622|NCT02488239|81219333|FG000|Overall Study|Consent ineligible|1|||
27832623|NCT02488239|81219333|FG000|Overall Study|Did not undergo implant procedure|1|||
27832624|NCT01205035|81219336|FG000|Overall Study|Withdrawal by Subject|1|||
27832625|NCT01205035|81219337|FG001|Overall Study|Withdrawal by Subject|0|||
27832626|NCT01205035|81219336|FG000|Overall Study|Physician Decision|1|||
27832627|NCT01205035|81219337|FG001|Overall Study|Physician Decision|0|||
27832628|NCT02651987|81219340|FG000|Overall Study|Adverse Event|2|||
27832629|NCT02651987|81219341|FG001|Overall Study|Adverse Event|2|||
27832630|NCT02651987|81219340|FG000|Overall Study|Consent Withdrawn|2|||
27832631|NCT02651987|81219341|FG001|Overall Study|Consent Withdrawn|0|||
27832632|NCT02651987|81219340|FG000|Overall Study|Local PD|0|||
27832633|NCT02651987|81219341|FG001|Overall Study|Local PD|2|||
27832634|NCT02651987|81219340|FG000|Overall Study|Investigator Decision|1|||
27832635|NCT02651987|81219341|FG001|Overall Study|Investigator Decision|1|||
27700520|NCT01055262|80741117|FG000|Overall Study|Adverse Event|5|||
27700521|NCT01055262|80741117|FG000|Overall Study|Protocol Violation|3|||
27700522|NCT01055262|80741117|FG000|Overall Study|Uncooperativeness|1|||
27700523|NCT01118325|80741118|FG000|Overall Study|Adverse Event|1|||
27700524|NCT01118325|80741119|FG001|Overall Study|Adverse Event|0|||
27700525|NCT01118325|80741120|FG002|Overall Study|Adverse Event|1|||
27700526|NCT00992511|80741121|FG000|Overall Study|Migrated/moved from study area|1|||
27700527|NCT00992511|80741122|FG001|Overall Study|Migrated/moved from study area|0|||
27700528|NCT00992511|80741123|FG002|Overall Study|Migrated/moved from study area|1|||
27700529|NCT00992511|80741124|FG003|Overall Study|Migrated/moved from study area|2|||
27700530|NCT00992511|80741121|FG000|Overall Study|Lost to Follow-up|1|||
27700531|NCT00992511|80741122|FG001|Overall Study|Lost to Follow-up|0|||
27700532|NCT00992511|80741123|FG002|Overall Study|Lost to Follow-up|0|||
27700533|NCT00992511|80741124|FG003|Overall Study|Lost to Follow-up|2|||
27700534|NCT00992511|80741121|FG000|Overall Study|Withdrawal by Subject|0|||
27700535|NCT00992511|80741122|FG001|Overall Study|Withdrawal by Subject|0|||
27700536|NCT00992511|80741123|FG002|Overall Study|Withdrawal by Subject|1|||
27700537|NCT00992511|80741124|FG003|Overall Study|Withdrawal by Subject|1|||
27700538|NCT02653300|80741125|FG000|Overall Study|Withdrawal by Subject|2|||
27700539|NCT03049735|80741128|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
27832636|NCT00503867|81219342|FG000|Overall Study|Lost to Follow-up|1|||
27832637|NCT00503867|81219342|FG000|Overall Study|Adverse Event|1|||
27832638|NCT00902538|81219343|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
27832639|NCT00902538|81219344|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27832640|NCT00902538|81219345|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27832641|NCT00902538|81219346|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27832642|NCT00902538|81219347|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27832643|NCT00902538|81219348|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
27832644|NCT00902538|81219343|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
27832645|NCT00902538|81219344|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27832646|NCT00902538|81219345|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27832647|NCT00902538|81219346|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27832648|NCT00902538|81219347|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27832649|NCT00902538|81219348|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
27832650|NCT00902538|81219343|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
27832651|NCT00902538|81219344|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27832652|NCT00902538|81219345|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27832653|NCT00902538|81219346|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27832654|NCT00902538|81219347|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27832655|NCT00902538|81219348|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
27832656|NCT00902538|81219343|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
27832657|NCT00902538|81219344|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27832658|NCT00902538|81219345|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27832659|NCT00902538|81219346|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27832660|NCT00902538|81219347|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27832661|NCT00902538|81219348|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
27832662|NCT00902538|81219343|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
27832663|NCT00902538|81219344|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27832664|NCT00902538|81219345|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27832665|NCT00902538|81219346|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27832666|NCT00902538|81219347|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27832667|NCT00902538|81219348|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
27832668|NCT00902538|81219343|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
27832669|NCT00902538|81219344|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
27700540|NCT03049735|80741129|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
27700541|NCT03049735|80741130|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
27700542|NCT03049735|80741128|FG000|Overall Study|Other|5|||
27700543|NCT03049735|80741129|FG001|Overall Study|Other|3|||
27700544|NCT03049735|80741130|FG002|Overall Study|Other|1|||
27700545|NCT03049735|80741128|FG000|Overall Study|Lack of Efficacy|4|||
27700546|NCT03049735|80741129|FG001|Overall Study|Lack of Efficacy|0|||
27700547|NCT03049735|80741130|FG002|Overall Study|Lack of Efficacy|3|||
27700548|NCT03049735|80741128|FG000|Overall Study|Protocol deviation|1|||
27700549|NCT03049735|80741129|FG001|Overall Study|Protocol deviation|0|||
27700550|NCT03049735|80741130|FG002|Overall Study|Protocol deviation|0|||
27700551|NCT03049735|80741128|FG000|Overall Study|Pregnancy|0|||
27700552|NCT03049735|80741129|FG001|Overall Study|Pregnancy|0|||
27700553|NCT03049735|80741130|FG002|Overall Study|Pregnancy|1|||
27700554|NCT03049735|80741128|FG000|Overall Study|Adverse Event|7|||
27700555|NCT03049735|80741129|FG001|Overall Study|Adverse Event|18|||
27700556|NCT03049735|80741130|FG002|Overall Study|Adverse Event|5|||
27700557|NCT03049735|80741128|FG000|Overall Study|Withdrawal by Subject|10|||
27700558|NCT03049735|80741129|FG001|Overall Study|Withdrawal by Subject|3|||
27700559|NCT03049735|80741130|FG002|Overall Study|Withdrawal by Subject|7|||
27700560|NCT03049735|80741128|FG000|Overall Study|Lost to Follow-up|1|||
27700561|NCT03049735|80741129|FG001|Overall Study|Lost to Follow-up|5|||
27700562|NCT03049735|80741130|FG002|Overall Study|Lost to Follow-up|5|||
27700563|NCT02921269|80741131|FG000|Overall Study|Did not complete DLT period|1|||
27700564|NCT01296035|80741133|FG000|Overall Study|Withdrawal by Subject|1|||
27700565|NCT01215422|80741134|FG000|Overall Study|Relocation|1|||
27700566|NCT01215422|80741135|FG001|Overall Study|Relocation|0|||
27700567|NCT01215422|80741136|FG002|Overall Study|Relocation|0|||
27700568|NCT01215422|80741137|FG003|Overall Study|Relocation|0|||
27700569|NCT01215422|80741134|FG000|Overall Study|Failed intubations|0|||
27700570|NCT01215422|80741135|FG001|Overall Study|Failed intubations|0|||
27700571|NCT01215422|80741136|FG002|Overall Study|Failed intubations|3|||
27700572|NCT01215422|80741137|FG003|Overall Study|Failed intubations|8|||
27700573|NCT01215422|80741134|FG000|Overall Study|Did not complete all intubations|7|||
27700574|NCT01215422|80741135|FG001|Overall Study|Did not complete all intubations|0|||
27700575|NCT01215422|80741136|FG002|Overall Study|Did not complete all intubations|0|||
27700576|NCT01215422|80741137|FG003|Overall Study|Did not complete all intubations|0|||
27700577|NCT04226833|80741138|FG000|Overall Study|Death|0|||
27700578|NCT04226833|80741139|FG001|Overall Study|Death|0|||
27700579|NCT04226833|80741140|FG002|Overall Study|Death|1|||
27700580|NCT04226833|80741141|FG003|Overall Study|Death|0|||
27700581|NCT00999713|80741144|FG000|Overall Study|Physician Decision|2|||
27700582|NCT00999713|80741145|FG001|Overall Study|Physician Decision|0|||
27700583|NCT04880447|80741150|FG000|Overall Study|No vaccination information|1|||
27700584|NCT04880447|80741150|FG000|Overall Study|No adverse event information (missing information)|1|||
27700585|NCT04880447|80741150|FG000|Overall Study|Disease not covered in this study|35|||
27700586|NCT02545322|80741151|FG000|Overall Study|Withdrawal by Subject|3|||
27700587|NCT00719563|80741153|FG000|Overall Study|Adverse Event|16|||
27832670|NCT00902538|81219345|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
27832671|NCT00902538|81219346|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
27832672|NCT00902538|81219347|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
27832673|NCT00902538|81219348|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
27832674|NCT00902538|81219343|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
27832675|NCT00902538|81219344|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
27832676|NCT00902538|81219345|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
27832677|NCT00902538|81219346|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
27832678|NCT00902538|81219347|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
27832679|NCT00902538|81219348|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
27832680|NCT00902538|81219343|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
27832681|NCT00902538|81219344|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27832682|NCT00902538|81219345|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
27832683|NCT00902538|81219346|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27832684|NCT00902538|81219347|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27832685|NCT00902538|81219348|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
27832686|NCT00902538|81219343|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
27832687|NCT00902538|81219344|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
27832688|NCT00902538|81219345|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
27832689|NCT00902538|81219346|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
27832690|NCT00902538|81219347|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
27832691|NCT00902538|81219348|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
27832692|NCT00902538|81219343|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
27832693|NCT00902538|81219344|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
27832694|NCT00902538|81219345|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
27832695|NCT00902538|81219346|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
27832696|NCT00902538|81219347|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
27886242|NCT02016105|81417980|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
27886243|NCT02016105|81417975|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
27886244|NCT02016105|81417976|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
27886245|NCT02016105|81417977|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
27886246|NCT02016105|81417978|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
27886247|NCT02016105|81417979|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
27886248|NCT02016105|81417980|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
27886249|NCT02016105|81417975|FG000|EXTENSION PERIOD|Adverse Event|0|||
27886250|NCT02016105|81417976|FG001|EXTENSION PERIOD|Adverse Event|0|||
27886251|NCT02016105|81417977|FG002|EXTENSION PERIOD|Adverse Event|2|||
27886252|NCT02016105|81417978|FG003|EXTENSION PERIOD|Adverse Event|0|||
27886253|NCT02016105|81417979|FG004|EXTENSION PERIOD|Adverse Event|1|||
27886254|NCT02016105|81417980|FG005|EXTENSION PERIOD|Adverse Event|0|||
27886255|NCT02016105|81417975|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
27886256|NCT02016105|81417976|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
27886257|NCT02016105|81417977|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
27886258|NCT02016105|81417978|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
27886259|NCT02016105|81417979|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
27886260|NCT02016105|81417980|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
27886261|NCT02016105|81417975|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
27886262|NCT02016105|81417976|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
27886263|NCT02016105|81417977|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
27886264|NCT02016105|81417978|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
27886265|NCT02016105|81417979|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
27700588|NCT00719563|80741154|FG001|Overall Study|Adverse Event|13|||
27700589|NCT00719563|80741153|FG000|Overall Study|Medical condition changed|3|||
27886266|NCT02016105|81417980|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
27886267|NCT02016105|81417975|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
27886268|NCT02016105|81417976|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
27886269|NCT02016105|81417977|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
27886270|NCT02016105|81417978|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
27886271|NCT02016105|81417979|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
27886272|NCT02016105|81417980|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
27886273|NCT00803790|81417981|FG000|Period 1|Adverse Event|0|||
27886274|NCT00803790|81417982|FG001|Period 1|Adverse Event|1|||
27886275|NCT00803790|81417983|FG002|Period 1|Adverse Event|0|||
27886276|NCT00803790|81417984|FG003|Period 1|Adverse Event|0|||
27886277|NCT00803790|81417981|FG000|Period 1|Lost to Follow-up|1|||
27886278|NCT00803790|81417982|FG001|Period 1|Lost to Follow-up|2|||
27886279|NCT00803790|81417983|FG002|Period 1|Lost to Follow-up|0|||
27886280|NCT00803790|81417984|FG003|Period 1|Lost to Follow-up|0|||
27886281|NCT00803790|81417981|FG000|Period 1|Withdrawal by Subject|8|||
27886282|NCT00803790|81417982|FG001|Period 1|Withdrawal by Subject|6|||
27886283|NCT00803790|81417983|FG002|Period 1|Withdrawal by Subject|0|||
27886284|NCT00803790|81417984|FG003|Period 1|Withdrawal by Subject|0|||
27886285|NCT00803790|81417981|FG000|Period 1|positive drug screen or personal reasons|0|||
27886286|NCT00803790|81417982|FG001|Period 1|positive drug screen or personal reasons|3|||
27886287|NCT00803790|81417983|FG002|Period 1|positive drug screen or personal reasons|0|||
27886288|NCT00803790|81417984|FG003|Period 1|positive drug screen or personal reasons|4|||
27886289|NCT00803790|81417981|FG000|Period 1|Protocol Violation|0|||
27886290|NCT00803790|81417982|FG001|Period 1|Protocol Violation|0|||
27886291|NCT00803790|81417983|FG002|Period 1|Protocol Violation|1|||
27886292|NCT00803790|81417984|FG003|Period 1|Protocol Violation|0|||
27886293|NCT00803790|81417981|FG000|Period 2|Adverse Event|0|||
27886294|NCT00803790|81417982|FG001|Period 2|Adverse Event|0|||
27886295|NCT00803790|81417983|FG002|Period 2|Adverse Event|1|||
27886296|NCT00803790|81417984|FG003|Period 2|Adverse Event|1|||
27886297|NCT00803790|81417981|FG000|Period 2|Withdrawal by Subject|1|||
27886298|NCT00803790|81417982|FG001|Period 2|Withdrawal by Subject|0|||
27886299|NCT00803790|81417983|FG002|Period 2|Withdrawal by Subject|0|||
27886300|NCT00803790|81417984|FG003|Period 2|Withdrawal by Subject|0|||
27886301|NCT00803790|81417981|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
27886302|NCT00803790|81417982|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
27886303|NCT00803790|81417983|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
27886304|NCT00803790|81417984|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
27886305|NCT01736397|81417986|FG000|Overall Study|Lack of Efficacy|1|||
27886306|NCT01736397|81417987|FG001|Overall Study|Lack of Efficacy|11|||
27886307|NCT01736397|81417986|FG000|Overall Study|Withdrawal by Subject|6|||
27886308|NCT01736397|81417987|FG001|Overall Study|Withdrawal by Subject|5|||
27886309|NCT01736397|81417986|FG000|Overall Study|Lost to Follow-up|0|||
27886310|NCT01736397|81417987|FG001|Overall Study|Lost to Follow-up|1|||
27886311|NCT01736397|81417986|FG000|Overall Study|Adverse Event|6|||
27886312|NCT01736397|81417987|FG001|Overall Study|Adverse Event|3|||
27886313|NCT01736397|81417986|FG000|Overall Study|Not stated|1|||
27886314|NCT01736397|81417987|FG001|Overall Study|Not stated|4|||
27886315|NCT02782923|81417989|FG000|Overall Study|Lost to Follow-up|15|||
27886316|NCT01264081|81417990|FG000|Participants Screened|Screening failures|30|||
27886317|NCT01264081|81417990|FG000|Started Treatment|Withdrawal by Subject|1|||
27886318|NCT01264081|81417990|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
27886319|NCT02101736|81417993|FG000|Overall Study|Protocol Violation|3|||
27886320|NCT02101736|81417994|FG001|Overall Study|Protocol Violation|0|||
27886321|NCT02101736|81417993|FG000|Overall Study|Withdrawal by Subject|1|||
27886322|NCT02101736|81417994|FG001|Overall Study|Withdrawal by Subject|1|||
27886323|NCT02424630|81417998|FG000|Overall Study|No rotator cuff tear|1|||
27886324|NCT02424630|81417999|FG001|Overall Study|No rotator cuff tear|2|||
27886325|NCT02424630|81417998|FG000|Overall Study|Open procedure|0|||
27886326|NCT02424630|81417999|FG001|Overall Study|Open procedure|1|||
27886327|NCT00459290|81418002|FG000|Overall Study|Adverse Event|3|||
27886328|NCT00459290|81418002|FG000|Overall Study|Ineligible|2|||
27886329|NCT01750697|81418004|FG000|Overall Study|Transferred Back to Local Hospital|1|||
27886330|NCT01750697|81418004|FG000|Overall Study|Physician and Family Decision|1|||
27886331|NCT01750697|81418004|FG000|Overall Study|Transferred to Adult Services|5|||
27886332|NCT01750697|81418004|FG000|Overall Study|Physician Decision|1|||
27886333|NCT01750697|81418004|FG000|Overall Study|Withdrawal by Subject|1|||
27886334|NCT04666259|81418011|FG000|Overall Study|ongoing at data cut-off|6|||
27886335|NCT04666259|81418012|FG001|Overall Study|ongoing at data cut-off|14|||
27886336|NCT04666259|81418013|FG002|Overall Study|ongoing at data cut-off|0|||
27886337|NCT04666259|81418011|FG000|Overall Study|Progressive Disease|0|||
27886338|NCT04666259|81418012|FG001|Overall Study|Progressive Disease|1|||
27886339|NCT04666259|81418013|FG002|Overall Study|Progressive Disease|0|||
27886340|NCT04666259|81418011|FG000|Overall Study|Physician Decision|9|||
27886341|NCT04666259|81418012|FG001|Overall Study|Physician Decision|3|||
27886342|NCT04666259|81418013|FG002|Overall Study|Physician Decision|3|||
27886343|NCT04666259|81418011|FG000|Overall Study|Adverse Event|3|||
27886344|NCT04666259|81418012|FG001|Overall Study|Adverse Event|1|||
27886345|NCT04666259|81418013|FG002|Overall Study|Adverse Event|0|||
27886346|NCT04666259|81418011|FG000|Overall Study|Withdrawal by Subject|1|||
27886347|NCT04666259|81418012|FG001|Overall Study|Withdrawal by Subject|2|||
27560697|NCT00413192|80241134|FG002|Overall Study|Intercurrent death|0|||
27560698|NCT00413192|80241135|FG003|Overall Study|Intercurrent death|0|||
27560699|NCT00413192|80241132|FG000|Overall Study|Other|5|||
27560700|NCT00413192|80241133|FG001|Overall Study|Other|1|||
27700590|NCT00719563|80741154|FG001|Overall Study|Medical condition changed|5|||
27700591|NCT00719563|80741153|FG000|Overall Study|Lack of Efficacy|3|||
27700592|NCT00719563|80741154|FG001|Overall Study|Lack of Efficacy|7|||
27700593|NCT00719563|80741153|FG000|Overall Study|Personal reasons|6|||
27700594|NCT00719563|80741154|FG001|Overall Study|Personal reasons|7|||
27700595|NCT00719563|80741153|FG000|Overall Study|Unknown reasons|4|||
27700596|NCT00719563|80741154|FG001|Overall Study|Unknown reasons|6|||
27700597|NCT00719563|80741153|FG000|Overall Study|Noncompliant|1|||
27700598|NCT00719563|80741154|FG001|Overall Study|Noncompliant|1|||
27700599|NCT00719563|80741153|FG000|Overall Study|Lost to Follow-up|5|||
27700600|NCT00719563|80741154|FG001|Overall Study|Lost to Follow-up|3|||
27700601|NCT00928564|80741157|FG000|Overall Study|Lost to Follow-up|6|||
27700602|NCT00928564|80741158|FG001|Overall Study|Lost to Follow-up|0|||
27700603|NCT01854645|80741159|FG000|Overall Study|Protocol-Specified Criteria|13|||
27700604|NCT01854645|80741160|FG001|Overall Study|Protocol-Specified Criteria|10|||
27700605|NCT01854645|80741161|FG002|Overall Study|Protocol-Specified Criteria|8|||
27700606|NCT01854645|80741162|FG003|Overall Study|Protocol-Specified Criteria|5|||
27700607|NCT01854645|80741163|FG004|Overall Study|Protocol-Specified Criteria|7|||
27700608|NCT01854645|80741159|FG000|Overall Study|Administrative Reasons / Missing|0|||
27700609|NCT01854645|80741160|FG001|Overall Study|Administrative Reasons / Missing|0|||
27700610|NCT01854645|80741161|FG002|Overall Study|Administrative Reasons / Missing|0|||
27700611|NCT01854645|80741162|FG003|Overall Study|Administrative Reasons / Missing|1|||
27700612|NCT01854645|80741163|FG004|Overall Study|Administrative Reasons / Missing|1|||
27560701|NCT00413192|80241134|FG002|Overall Study|Other|1|||
27700613|NCT01854645|80741159|FG000|Overall Study|Protocol Violation|3|||
27832697|NCT00902538|81219348|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
27560702|NCT00413192|80241135|FG003|Overall Study|Other|2|||
27560703|NCT00413192|80241132|FG000|Overall Study|Not treated|0|||
27700614|NCT01854645|80741160|FG001|Overall Study|Protocol Violation|0|||
27700615|NCT01854645|80741161|FG002|Overall Study|Protocol Violation|5|||
27832698|NCT00902538|81219343|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
27832699|NCT00902538|81219344|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
27832700|NCT00902538|81219345|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
27832701|NCT00902538|81219346|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
27832702|NCT00902538|81219347|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
27832703|NCT00902538|81219348|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
27560704|NCT00413192|80241133|FG001|Overall Study|Not treated|0|||
27560705|NCT00413192|80241134|FG002|Overall Study|Not treated|0|||
27560706|NCT00413192|80241135|FG003|Overall Study|Not treated|1|||
27560707|NCT01254227|80241136|FG000|Overall Study|Withdrawal by Subject|6|||
27560708|NCT01254227|80241136|FG000|Overall Study|Lost to Follow-up|6|||
27560709|NCT01254227|80241136|FG000|Overall Study|Adverse Event|5|||
27560710|NCT01254227|80241136|FG000|Overall Study|Abnormal test procedure result|5|||
27560711|NCT01254227|80241136|FG000|Overall Study|Administrative problems|2|||
27560712|NCT01254227|80241136|FG000|Overall Study|Death|1|||
27560713|NCT01254227|80241136|FG000|Overall Study|Protocol deviation|1|||
27560714|NCT02882854|80241137|FG000|Overall Study|Lost to Follow-up|1|||
27560715|NCT02882854|80241138|FG001|Overall Study|Lost to Follow-up|2|||
27560716|NCT02882854|80241137|FG000|Overall Study|Physician Decision|0|||
27832704|NCT00902538|81219343|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
27832705|NCT00902538|81219344|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
27560717|NCT02882854|80241138|FG001|Overall Study|Physician Decision|1|||
27560718|NCT01589445|80241139|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
27560719|NCT01589445|80241139|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
27560720|NCT01589445|80241139|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
27560721|NCT01589445|80241139|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
27832706|NCT00902538|81219345|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
27560722|NCT01589445|80241139|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
27560723|NCT01589445|80241139|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
27560724|NCT01589445|80241139|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
27560725|NCT01589445|80241139|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
27560726|NCT01589445|80241139|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
27560727|NCT01589445|80241139|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
27560728|NCT02794103|80241144|FG000|Overall Study|Loss to follow up due to high sedation|3|||
27560729|NCT00333866|80241145|FG000|Overall Study|Adverse Event|23|||
27560730|NCT00333866|80241146|FG001|Overall Study|Adverse Event|37|||
27560731|NCT00333866|80241147|FG002|Overall Study|Adverse Event|38|||
27560732|NCT00333866|80241148|FG003|Overall Study|Adverse Event|47|||
27560733|NCT00333866|80241145|FG000|Overall Study|Other|3|||
27560734|NCT00333866|80241146|FG001|Overall Study|Other|2|||
27560735|NCT00333866|80241147|FG002|Overall Study|Other|2|||
27560736|NCT00333866|80241148|FG003|Overall Study|Other|2|||
27560737|NCT00333866|80241145|FG000|Overall Study|Lack of Efficacy|8|||
27560738|NCT00333866|80241146|FG001|Overall Study|Lack of Efficacy|6|||
27560739|NCT00333866|80241147|FG002|Overall Study|Lack of Efficacy|3|||
27560740|NCT00333866|80241148|FG003|Overall Study|Lack of Efficacy|5|||
27560741|NCT00333866|80241145|FG000|Overall Study|Lost to Follow-up|1|||
27560742|NCT00333866|80241146|FG001|Overall Study|Lost to Follow-up|2|||
27560743|NCT00333866|80241147|FG002|Overall Study|Lost to Follow-up|2|||
27560744|NCT00333866|80241148|FG003|Overall Study|Lost to Follow-up|2|||
27560745|NCT00333866|80241145|FG000|Overall Study|Withdrawal by Subject|8|||
27560746|NCT00333866|80241146|FG001|Overall Study|Withdrawal by Subject|14|||
27560747|NCT00333866|80241147|FG002|Overall Study|Withdrawal by Subject|4|||
27560748|NCT00333866|80241148|FG003|Overall Study|Withdrawal by Subject|9|||
27560749|NCT00333866|80241145|FG000|Overall Study|Randomized but not Treated|5|||
27560750|NCT00333866|80241146|FG001|Overall Study|Randomized but not Treated|3|||
27560751|NCT00333866|80241147|FG002|Overall Study|Randomized but not Treated|2|||
27560752|NCT00333866|80241148|FG003|Overall Study|Randomized but not Treated|1|||
27560753|NCT01996709|80241149|FG000|Overall Study|Withdrawal by Subject|1|||
27560754|NCT01996709|80241150|FG001|Overall Study|Withdrawal by Subject|0|||
27560755|NCT01996709|80241149|FG000|Overall Study|Lost to Follow-up|3|||
27560756|NCT01996709|80241150|FG001|Overall Study|Lost to Follow-up|0|||
27560757|NCT01996709|80241149|FG000|Overall Study|Subject Non-Compliant|1|||
27560758|NCT01996709|80241150|FG001|Overall Study|Subject Non-Compliant|0|||
27700616|NCT01854645|80741162|FG003|Overall Study|Protocol Violation|4|||
27700617|NCT01854645|80741163|FG004|Overall Study|Protocol Violation|1|||
27700618|NCT01854645|80741159|FG000|Overall Study|Lost to Follow-up|10|||
27700619|NCT01854645|80741160|FG001|Overall Study|Lost to Follow-up|7|||
27700620|NCT01854645|80741161|FG002|Overall Study|Lost to Follow-up|8|||
27700621|NCT01854645|80741162|FG003|Overall Study|Lost to Follow-up|5|||
27700622|NCT01854645|80741163|FG004|Overall Study|Lost to Follow-up|0|||
27700623|NCT01854645|80741159|FG000|Overall Study|Physician Decision|1|||
27700624|NCT01854645|80741160|FG001|Overall Study|Physician Decision|5|||
27700625|NCT01854645|80741161|FG002|Overall Study|Physician Decision|3|||
27700626|NCT01854645|80741162|FG003|Overall Study|Physician Decision|3|||
27700627|NCT01854645|80741163|FG004|Overall Study|Physician Decision|7|||
27700628|NCT01854645|80741159|FG000|Overall Study|Withdrawal by Subject|31|||
27700629|NCT01854645|80741160|FG001|Overall Study|Withdrawal by Subject|41|||
27700630|NCT01854645|80741161|FG002|Overall Study|Withdrawal by Subject|30|||
27700631|NCT01854645|80741162|FG003|Overall Study|Withdrawal by Subject|21|||
27700632|NCT01854645|80741163|FG004|Overall Study|Withdrawal by Subject|24|||
27700633|NCT01854645|80741159|FG000|Overall Study|Lack of Efficacy|7|||
27700634|NCT01854645|80741160|FG001|Overall Study|Lack of Efficacy|12|||
27700635|NCT01854645|80741161|FG002|Overall Study|Lack of Efficacy|9|||
27700636|NCT01854645|80741162|FG003|Overall Study|Lack of Efficacy|3|||
27700637|NCT01854645|80741163|FG004|Overall Study|Lack of Efficacy|9|||
27700638|NCT01854645|80741159|FG000|Overall Study|Adverse Event|33|||
27700639|NCT01854645|80741160|FG001|Overall Study|Adverse Event|31|||
27700640|NCT01854645|80741161|FG002|Overall Study|Adverse Event|19|||
27560759|NCT01996709|80241149|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
27560760|NCT01996709|80241150|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
27832707|NCT00902538|81219346|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
27560761|NCT03245008|80241151|FG000|Overall Study|Adverse Event|15|||
27560762|NCT03245008|80241152|FG001|Overall Study|Adverse Event|18|||
27560763|NCT03245008|80241153|FG002|Overall Study|Adverse Event|15|||
27560764|NCT03245008|80241154|FG003|Overall Study|Adverse Event|0|||
27560765|NCT03245008|80241155|FG004|Overall Study|Adverse Event|1|||
27560766|NCT03245008|80241151|FG000|Overall Study|Lack of Efficacy|0|||
27560767|NCT03245008|80241152|FG001|Overall Study|Lack of Efficacy|1|||
27560768|NCT03245008|80241153|FG002|Overall Study|Lack of Efficacy|0|||
27700641|NCT01854645|80741162|FG003|Overall Study|Adverse Event|20|||
27700642|NCT01854645|80741163|FG004|Overall Study|Adverse Event|11|||
27700643|NCT00375219|80741165|FG000|Overall Study|Failure to achieve a response|16|||
27700644|NCT00375219|80741166|FG001|Overall Study|Failure to achieve a response|2|||
27700645|NCT00375219|80741167|FG002|Overall Study|Failure to achieve a response|0|||
27560769|NCT03245008|80241154|FG003|Overall Study|Lack of Efficacy|0|||
27560770|NCT03245008|80241155|FG004|Overall Study|Lack of Efficacy|0|||
27560771|NCT03245008|80241151|FG000|Overall Study|Lost to Follow-up|4|||
27560772|NCT03245008|80241152|FG001|Overall Study|Lost to Follow-up|1|||
27560773|NCT03245008|80241153|FG002|Overall Study|Lost to Follow-up|0|||
27560774|NCT03245008|80241154|FG003|Overall Study|Lost to Follow-up|0|||
27560775|NCT03245008|80241155|FG004|Overall Study|Lost to Follow-up|1|||
27560776|NCT03245008|80241151|FG000|Overall Study|Physician Decision|1|||
27560777|NCT03245008|80241152|FG001|Overall Study|Physician Decision|3|||
27560778|NCT03245008|80241153|FG002|Overall Study|Physician Decision|4|||
27832708|NCT00902538|81219347|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
27832709|NCT00902538|81219348|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
27832710|NCT00902538|81219343|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27832711|NCT00902538|81219344|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
27832712|NCT00902538|81219345|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27832713|NCT00902538|81219346|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27560779|NCT03245008|80241154|FG003|Overall Study|Physician Decision|0|||
27560780|NCT03245008|80241155|FG004|Overall Study|Physician Decision|0|||
27886348|NCT04666259|81418013|FG002|Overall Study|Withdrawal by Subject|0|||
27886349|NCT04666259|81418011|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
27886350|NCT04666259|81418012|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
27886351|NCT04666259|81418013|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
27886352|NCT03706430|81418018|FG000|Overall Study|No A-Line placed|5|||
27886353|NCT03706430|81418018|FG000|Overall Study|Subject had gel nail polish|1|||
27560781|NCT03245008|80241151|FG000|Overall Study|Protocol Violation|0|||
27700646|NCT00375219|80741165|FG000|Overall Study|Adverse Event|8|||
27832714|NCT00902538|81219347|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27832715|NCT00902538|81219348|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
27832716|NCT00902538|81219343|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27832717|NCT00902538|81219344|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
27832718|NCT00902538|81219345|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27832719|NCT00902538|81219346|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27832720|NCT00902538|81219347|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27832721|NCT00902538|81219348|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
27832722|NCT00902538|81219343|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
27832723|NCT00902538|81219344|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
27832724|NCT00902538|81219345|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
27832725|NCT00902538|81219346|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
27832726|NCT00902538|81219347|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
27832727|NCT00902538|81219348|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
27886354|NCT03706430|81418018|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
27886355|NCT03706430|81418018|FG000|Overall Study|Cancelled Case|6|||
27886356|NCT03706430|81418018|FG000|Overall Study|Physician Decision|2|||
27886357|NCT01609010|81418021|FG000|Overall Study|Stable disease (SD)|22|||
27886358|NCT01609010|81418022|FG001|Overall Study|Stable disease (SD)|16|||
27886359|NCT01609010|81418021|FG000|Overall Study|Progressive disease (PD)|8|||
27886360|NCT01609010|81418022|FG001|Overall Study|Progressive disease (PD)|10|||
27886361|NCT01609010|81418021|FG000|Overall Study|Adverse Event|3|||
27886362|NCT01609010|81418022|FG001|Overall Study|Adverse Event|6|||
27886363|NCT01609010|81418021|FG000|Overall Study|Withdrawal by Subject|2|||
27886364|NCT01609010|81418022|FG001|Overall Study|Withdrawal by Subject|2|||
27886365|NCT01609010|81418021|FG000|Overall Study|Other|2|||
27886366|NCT01609010|81418022|FG001|Overall Study|Other|0|||
27886367|NCT01609010|81418021|FG000|Overall Study|Other malignancy|1|||
27886368|NCT01609010|81418022|FG001|Overall Study|Other malignancy|0|||
27832728|NCT00902538|81219343|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27886369|NCT01609010|81418021|FG000|Overall Study|Pathology review|2|||
27886370|NCT01609010|81418022|FG001|Overall Study|Pathology review|1|||
27886371|NCT01609010|81418021|FG000|Overall Study|Protocol Violation|1|||
27832729|NCT00902538|81219344|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27832730|NCT00902538|81219345|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27832731|NCT00902538|81219346|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
27886372|NCT01609010|81418022|FG001|Overall Study|Protocol Violation|1|||
27886373|NCT01609010|81418021|FG000|Overall Study|New cancer|1|||
27886374|NCT01609010|81418022|FG001|Overall Study|New cancer|0|||
27886375|NCT01609010|81418021|FG000|Overall Study|Lost to Follow-up|1|||
27886376|NCT01609010|81418022|FG001|Overall Study|Lost to Follow-up|1|||
27886377|NCT02527434|81418023|FG000|Overall Study|Lost to Follow-up|2|||
27886378|NCT02527434|81418024|FG001|Overall Study|Lost to Follow-up|2|||
27832732|NCT00902538|81219347|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
27832733|NCT00902538|81219348|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
27832734|NCT00902538|81219343|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27832735|NCT00902538|81219344|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27832736|NCT00902538|81219345|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27832737|NCT00902538|81219346|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
27832738|NCT00902538|81219347|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27832739|NCT00902538|81219348|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
27832740|NCT03073798|81219355|FG000|Overall Study|Adverse Event|1|||
27832741|NCT03073798|81219355|FG000|Overall Study|Withdrawal by Subject|1|||
27832742|NCT03025087|81219356|FG000|Overall Study|Physician Decision|3|||
27832743|NCT03025087|81219357|FG001|Overall Study|Physician Decision|3|||
27832744|NCT03025087|81219358|FG002|Overall Study|Physician Decision|0|||
27832745|NCT03025087|81219359|FG003|Overall Study|Physician Decision|0|||
27832746|NCT03025087|81219360|FG004|Overall Study|Physician Decision|0|||
27832747|NCT03025087|81219356|FG000|Overall Study|Withdrawal by Subject|1|||
27832748|NCT03025087|81219357|FG001|Overall Study|Withdrawal by Subject|1|||
27832749|NCT03025087|81219358|FG002|Overall Study|Withdrawal by Subject|0|||
27832750|NCT03025087|81219359|FG003|Overall Study|Withdrawal by Subject|0|||
27832751|NCT03025087|81219360|FG004|Overall Study|Withdrawal by Subject|0|||
27832752|NCT03025087|81219356|FG000|Overall Study|Unable to complete MRI|2|||
27886379|NCT02527434|81418025|FG002|Overall Study|Lost to Follow-up|0|||
27886380|NCT02527434|81418023|FG000|Overall Study|Death|19|||
27886381|NCT02527434|81418024|FG001|Overall Study|Death|6|||
27886382|NCT02527434|81418025|FG002|Overall Study|Death|17|||
27886383|NCT02527434|81418023|FG000|Overall Study|Withdrawal by Subject|5|||
27886384|NCT02527434|81418024|FG001|Overall Study|Withdrawal by Subject|3|||
27886385|NCT02527434|81418025|FG002|Overall Study|Withdrawal by Subject|3|||
27886386|NCT02527434|81418023|FG000|Overall Study|Reason Not Specified|1|||
27886387|NCT02527434|81418024|FG001|Overall Study|Reason Not Specified|0|||
27886388|NCT02527434|81418025|FG002|Overall Study|Reason Not Specified|0|||
27886389|NCT02527434|81418023|FG000|Overall Study|Site closure|1|||
27886390|NCT02527434|81418024|FG001|Overall Study|Site closure|0|||
27886391|NCT02527434|81418025|FG002|Overall Study|Site closure|0|||
27886392|NCT01960907|81418026|FG000|Overall Study|Death|4|||
27886393|NCT01960907|81418027|FG001|Overall Study|Death|3|||
27886394|NCT01960907|81418026|FG000|Overall Study|Withdrawal by Subject|32|||
27886395|NCT01960907|81418027|FG001|Overall Study|Withdrawal by Subject|42|||
27886396|NCT01053663|81418028|FG000|Overall Study|Death|2|||
27886397|NCT01053663|81418028|FG000|Overall Study|Lost to Follow-up|1|||
27886398|NCT01053663|81418028|FG000|Overall Study|Poor IV Access|1|||
27886399|NCT01053663|81418028|FG000|Overall Study|Transferred to Another Hospital|1|||
27886400|NCT01053663|81418028|FG000|Overall Study|Negative Influenza Diagnosis|1|||
27886401|NCT00712543|81418031|FG000|Day 8-14|Lost to Follow-up|0|||
27886402|NCT00712543|81418032|FG001|Day 8-14|Lost to Follow-up|2|||
27886403|NCT02276560|81418033|FG000|Overall Study|Adverse Event|1|||
27886404|NCT02276560|81418034|FG001|Overall Study|Adverse Event|0|||
27886405|NCT02276560|81418035|FG002|Overall Study|Adverse Event|0|||
27886406|NCT02981082|81418039|FG000|Overall Study|Withdrawal by Subject|2|||
27886407|NCT02981082|81418040|FG001|Overall Study|Withdrawal by Subject|0|||
27886408|NCT02981082|81418039|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
27886409|NCT02981082|81418040|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
27886410|NCT02981082|81418039|FG000|Overall Study|Adverse Event|0|||
27886411|NCT02981082|81418040|FG001|Overall Study|Adverse Event|1|||
27886412|NCT03617770|81418042|FG000|Overall Study|Lost to Follow-up|1|||
27886413|NCT03617770|81418043|FG001|Overall Study|Lost to Follow-up|0|||
27886414|NCT02129777|81418056|FG000|Double-Blind Period|Adverse Event|0|||
27886415|NCT02129777|81418057|FG001|Double-Blind Period|Adverse Event|0|||
27886416|NCT02129777|81418058|FG002|Double-Blind Period|Adverse Event|0|||
27886417|NCT02129777|81418059|FG003|Double-Blind Period|Adverse Event|0|||
27886418|NCT02129777|81418060|FG004|Double-Blind Period|Adverse Event|1|||
27886419|NCT02129777|81418061|FG005|Double-Blind Period|Adverse Event|0|||
27886420|NCT02129777|81418062|FG006|Double-Blind Period|Adverse Event|0|||
27886421|NCT02129777|81418056|FG000|Double-Blind Period|Lost to Follow-up|1|||
27886422|NCT02129777|81418057|FG001|Double-Blind Period|Lost to Follow-up|1|||
27886423|NCT02129777|81418058|FG002|Double-Blind Period|Lost to Follow-up|1|||
27886424|NCT02129777|81418059|FG003|Double-Blind Period|Lost to Follow-up|2|||
27886425|NCT02129777|81418060|FG004|Double-Blind Period|Lost to Follow-up|0|||
27886426|NCT02129777|81418061|FG005|Double-Blind Period|Lost to Follow-up|0|||
27886427|NCT02129777|81418062|FG006|Double-Blind Period|Lost to Follow-up|0|||
27886428|NCT02129777|81418056|FG000|Double-Blind Period|Withdrawal by Subject|2|||
27886429|NCT02129777|81418057|FG001|Double-Blind Period|Withdrawal by Subject|4|||
27886430|NCT02129777|81418058|FG002|Double-Blind Period|Withdrawal by Subject|3|||
27886431|NCT02129777|81418059|FG003|Double-Blind Period|Withdrawal by Subject|2|||
27886432|NCT02129777|81418060|FG004|Double-Blind Period|Withdrawal by Subject|3|||
27886433|NCT02129777|81418061|FG005|Double-Blind Period|Withdrawal by Subject|0|||
27886434|NCT02129777|81418062|FG006|Double-Blind Period|Withdrawal by Subject|0|||
27886435|NCT02129777|81418056|FG000|Double-Blind Period|Pregnancy|0|||
27886436|NCT02129777|81418057|FG001|Double-Blind Period|Pregnancy|0|||
27886437|NCT02129777|81418058|FG002|Double-Blind Period|Pregnancy|0|||
27886438|NCT02129777|81418059|FG003|Double-Blind Period|Pregnancy|0|||
27886439|NCT02129777|81418060|FG004|Double-Blind Period|Pregnancy|1|||
27886440|NCT02129777|81418061|FG005|Double-Blind Period|Pregnancy|0|||
27886441|NCT02129777|81418062|FG006|Double-Blind Period|Pregnancy|0|||
27886442|NCT02129777|81418056|FG000|Double-Blind Period|Lack of Efficacy|3|||
27886443|NCT02129777|81418057|FG001|Double-Blind Period|Lack of Efficacy|1|||
27886444|NCT02129777|81418058|FG002|Double-Blind Period|Lack of Efficacy|0|||
27886445|NCT02129777|81418059|FG003|Double-Blind Period|Lack of Efficacy|3|||
27886446|NCT02129777|81418060|FG004|Double-Blind Period|Lack of Efficacy|2|||
27886447|NCT02129777|81418061|FG005|Double-Blind Period|Lack of Efficacy|0|||
27886448|NCT02129777|81418062|FG006|Double-Blind Period|Lack of Efficacy|0|||
27886449|NCT02129777|81418056|FG000|Double-Blind Period|Other|1|||
27886450|NCT02129777|81418057|FG001|Double-Blind Period|Other|2|||
27886451|NCT02129777|81418058|FG002|Double-Blind Period|Other|0|||
27886452|NCT02129777|81418059|FG003|Double-Blind Period|Other|0|||
27886453|NCT02129777|81418060|FG004|Double-Blind Period|Other|0|||
27886454|NCT02129777|81418061|FG005|Double-Blind Period|Other|0|||
27886455|NCT02129777|81418062|FG006|Double-Blind Period|Other|0|||
27886456|NCT02129777|81418056|FG000|Open-Label Period|Lack of Efficacy|0|||
27886457|NCT02129777|81418057|FG001|Open-Label Period|Lack of Efficacy|0|||
27886458|NCT02129777|81418058|FG002|Open-Label Period|Lack of Efficacy|0|||
27886459|NCT02129777|81418059|FG003|Open-Label Period|Lack of Efficacy|0|||
27886460|NCT02129777|81418060|FG004|Open-Label Period|Lack of Efficacy|0|||
27886461|NCT02129777|81418061|FG005|Open-Label Period|Lack of Efficacy|0|||
27886462|NCT02129777|81418062|FG006|Open-Label Period|Lack of Efficacy|5|||
27886463|NCT02129777|81418056|FG000|Open-Label Period|Lost to Follow-up|0|||
27886464|NCT02129777|81418057|FG001|Open-Label Period|Lost to Follow-up|0|||
27886465|NCT02129777|81418058|FG002|Open-Label Period|Lost to Follow-up|0|||
27886466|NCT02129777|81418059|FG003|Open-Label Period|Lost to Follow-up|0|||
27886467|NCT02129777|81418060|FG004|Open-Label Period|Lost to Follow-up|0|||
27832753|NCT03025087|81219357|FG001|Overall Study|Unable to complete MRI|2|||
27832754|NCT03025087|81219358|FG002|Overall Study|Unable to complete MRI|0|||
27832755|NCT03025087|81219359|FG003|Overall Study|Unable to complete MRI|0|||
27832756|NCT03025087|81219360|FG004|Overall Study|Unable to complete MRI|0|||
27832757|NCT01513239|81219361|FG000|Period 1: Main Phase|Adverse Event|1|||
27832758|NCT01513239|81219362|FG001|Period 1: Main Phase|Adverse Event|1|||
27832759|NCT01513239|81219363|FG002|Period 1: Main Phase|Adverse Event|2|||
27832760|NCT01513239|81219364|FG003|Period 1: Main Phase|Adverse Event|0|||
27832761|NCT01513239|81219365|FG004|Period 1: Main Phase|Adverse Event|0|||
27832762|NCT01513239|81219366|FG005|Period 1: Main Phase|Adverse Event|0|||
27832763|NCT01513239|81219361|FG000|Period 1: Main Phase|Death|29|||
27832764|NCT01513239|81219362|FG001|Period 1: Main Phase|Death|22|||
27832765|NCT01513239|81219363|FG002|Period 1: Main Phase|Death|32|||
27832766|NCT01513239|81219364|FG003|Period 1: Main Phase|Death|0|||
27832767|NCT01513239|81219365|FG004|Period 1: Main Phase|Death|0|||
27832768|NCT01513239|81219366|FG005|Period 1: Main Phase|Death|0|||
27832769|NCT01513239|81219361|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
27832770|NCT01513239|81219362|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
27832771|NCT01513239|81219363|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
27832772|NCT01513239|81219364|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
27886468|NCT02129777|81418061|FG005|Open-Label Period|Lost to Follow-up|1|||
27886469|NCT02129777|81418062|FG006|Open-Label Period|Lost to Follow-up|1|||
27886470|NCT02129777|81418056|FG000|Open-Label Period|Withdrawal by Subject|0|||
27886471|NCT02129777|81418057|FG001|Open-Label Period|Withdrawal by Subject|0|||
27886472|NCT02129777|81418058|FG002|Open-Label Period|Withdrawal by Subject|0|||
27886473|NCT02129777|81418059|FG003|Open-Label Period|Withdrawal by Subject|0|||
27886474|NCT02129777|81418060|FG004|Open-Label Period|Withdrawal by Subject|0|||
27886475|NCT02129777|81418061|FG005|Open-Label Period|Withdrawal by Subject|1|||
27886476|NCT02129777|81418062|FG006|Open-Label Period|Withdrawal by Subject|3|||
27700647|NCT00375219|80741166|FG001|Overall Study|Adverse Event|2|||
27700648|NCT00375219|80741167|FG002|Overall Study|Adverse Event|1|||
27700649|NCT00375219|80741165|FG000|Overall Study|Protocol Violation|1|||
27832773|NCT01513239|81219365|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
27832774|NCT01513239|81219366|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
27832775|NCT01513239|81219361|FG000|Period 1: Main Phase|Physician Decision|4|||
27832776|NCT01513239|81219362|FG001|Period 1: Main Phase|Physician Decision|4|||
27832777|NCT01513239|81219363|FG002|Period 1: Main Phase|Physician Decision|4|||
27832778|NCT01513239|81219364|FG003|Period 1: Main Phase|Physician Decision|0|||
27832779|NCT01513239|81219365|FG004|Period 1: Main Phase|Physician Decision|0|||
27832780|NCT01513239|81219366|FG005|Period 1: Main Phase|Physician Decision|0|||
27832781|NCT01513239|81219361|FG000|Period 1: Main Phase|Protocol Violation|2|||
27832782|NCT01513239|81219362|FG001|Period 1: Main Phase|Protocol Violation|2|||
27832783|NCT01513239|81219363|FG002|Period 1: Main Phase|Protocol Violation|2|||
27832784|NCT01513239|81219364|FG003|Period 1: Main Phase|Protocol Violation|0|||
27832785|NCT01513239|81219365|FG004|Period 1: Main Phase|Protocol Violation|0|||
27832786|NCT01513239|81219366|FG005|Period 1: Main Phase|Protocol Violation|0|||
27832787|NCT01513239|81219361|FG000|Period 1: Main Phase|Technical Problems|1|||
27832788|NCT01513239|81219362|FG001|Period 1: Main Phase|Technical Problems|2|||
27832789|NCT01513239|81219363|FG002|Period 1: Main Phase|Technical Problems|0|||
27832790|NCT01513239|81219364|FG003|Period 1: Main Phase|Technical Problems|0|||
27700650|NCT00375219|80741166|FG001|Overall Study|Protocol Violation|0|||
27832791|NCT01513239|81219365|FG004|Period 1: Main Phase|Technical Problems|0|||
27832792|NCT01513239|81219366|FG005|Period 1: Main Phase|Technical Problems|0|||
27832793|NCT01513239|81219361|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
27700651|NCT00375219|80741167|FG002|Overall Study|Protocol Violation|1|||
27886477|NCT02129777|81418056|FG000|Open-Label Period|Study Termination|0|||
27886478|NCT02129777|81418057|FG001|Open-Label Period|Study Termination|0|||
27886479|NCT02129777|81418058|FG002|Open-Label Period|Study Termination|0|||
27886480|NCT02129777|81418059|FG003|Open-Label Period|Study Termination|0|||
27886481|NCT02129777|81418060|FG004|Open-Label Period|Study Termination|0|||
27886482|NCT02129777|81418061|FG005|Open-Label Period|Study Termination|10|||
27886483|NCT02129777|81418062|FG006|Open-Label Period|Study Termination|39|||
27886484|NCT01344824|81418070|FG000|Overall Study|Adverse Event|15|||
27886485|NCT01344824|81418070|FG000|Overall Study|Withdrawal by Subject|6|||
27886486|NCT01344824|81418070|FG000|Overall Study|Other complicating disease|1|||
27886487|NCT01344824|81418070|FG000|Overall Study|Progression|15|||
27886488|NCT03640559|81418071|FG000|Overall Study|Physician Decision|1|||
27700652|NCT00375219|80741165|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
27700653|NCT00375219|80741166|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
27700654|NCT00375219|80741167|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
27700655|NCT00375219|80741165|FG000|Overall Study|Lost to Follow-up|1|||
27700656|NCT00375219|80741166|FG001|Overall Study|Lost to Follow-up|1|||
27700657|NCT00375219|80741167|FG002|Overall Study|Lost to Follow-up|0|||
27700658|NCT00375219|80741165|FG000|Overall Study|Disease progression|18|||
27700659|NCT00375219|80741166|FG001|Overall Study|Disease progression|9|||
27700660|NCT00375219|80741167|FG002|Overall Study|Disease progression|12|||
27700661|NCT00375219|80741165|FG000|Overall Study|Death|4|||
27700662|NCT00375219|80741166|FG001|Overall Study|Death|3|||
27700663|NCT00375219|80741167|FG002|Overall Study|Death|7|||
27700664|NCT00375219|80741165|FG000|Overall Study|Hematologic resistance|1|||
27700665|NCT00375219|80741166|FG001|Overall Study|Hematologic resistance|0|||
27700666|NCT00375219|80741167|FG002|Overall Study|Hematologic resistance|0|||
27700667|NCT00375219|80741165|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
27700668|NCT00375219|80741166|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
27700669|NCT00375219|80741167|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
27700670|NCT00375219|80741165|FG000|Overall Study|Allograft|2|||
27700671|NCT00375219|80741166|FG001|Overall Study|Allograft|0|||
27700672|NCT00375219|80741167|FG002|Overall Study|Allograft|0|||
27832794|NCT01513239|81219362|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
27832795|NCT01513239|81219363|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
27832796|NCT01513239|81219364|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
27832797|NCT01513239|81219365|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
27832798|NCT01513239|81219366|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
27832799|NCT01513239|81219361|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
27832800|NCT01513239|81219362|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
27832801|NCT01513239|81219363|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
27832802|NCT01513239|81219364|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
27832803|NCT01513239|81219365|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
27832804|NCT01513239|81219366|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
27832805|NCT01513239|81219361|FG000|Period 2: 9 Month Extension Phase|Death|0|||
27832806|NCT01513239|81219362|FG001|Period 2: 9 Month Extension Phase|Death|0|||
27832807|NCT01513239|81219363|FG002|Period 2: 9 Month Extension Phase|Death|0|||
27832808|NCT01513239|81219364|FG003|Period 2: 9 Month Extension Phase|Death|2|||
27886489|NCT03640559|81418072|FG001|Overall Study|Physician Decision|1|||
27886490|NCT03640559|81418071|FG000|Overall Study|Withdrawal by Subject|1|||
27886491|NCT03640559|81418072|FG001|Overall Study|Withdrawal by Subject|0|||
27886492|NCT00507728|81418073|FG000|Randomization to Month 3|Lost to Follow-up|15|||
27700673|NCT00375219|80741165|FG000|Overall Study|Cord blood transplantation|1|||
27700674|NCT00375219|80741166|FG001|Overall Study|Cord blood transplantation|0|||
27700675|NCT00375219|80741167|FG002|Overall Study|Cord blood transplantation|0|||
27700676|NCT00375219|80741165|FG000|Overall Study|Withdrawal by Subject|1|||
27700677|NCT00375219|80741166|FG001|Overall Study|Withdrawal by Subject|0|||
27886493|NCT00507728|81418074|FG001|Randomization to Month 3|Lost to Follow-up|14|||
27700678|NCT00375219|80741167|FG002|Overall Study|Withdrawal by Subject|0|||
27700679|NCT01891721|80741168|FG000|Overall Study|Lost to Follow-up|10|||
27700680|NCT01891721|80741169|FG001|Overall Study|Lost to Follow-up|5|||
27700681|NCT01891721|80741170|FG002|Overall Study|Lost to Follow-up|1|||
27700682|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
27700683|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
27700684|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
27700685|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
27700686|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
27700687|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
27700688|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
27700689|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
27700690|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
27700691|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
27700692|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
27700693|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
27700694|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
27700695|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
27700696|NCT03548987|80741173|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
27700697|NCT03548987|80741174|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
27700698|NCT03548987|80741173|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
27700699|NCT03548987|80741174|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
27700700|NCT03548987|80741173|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
27700701|NCT03548987|80741174|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
27700702|NCT03548987|80741173|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
27700703|NCT03548987|80741174|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
27832809|NCT01513239|81219365|FG004|Period 2: 9 Month Extension Phase|Death|5|||
27832810|NCT01513239|81219366|FG005|Period 2: 9 Month Extension Phase|Death|2|||
27832811|NCT01513239|81219361|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27832812|NCT01513239|81219362|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27832813|NCT01513239|81219363|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27832814|NCT01513239|81219364|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
27832815|NCT01513239|81219365|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
27832816|NCT01513239|81219366|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
27832817|NCT01513239|81219361|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27832818|NCT01513239|81219362|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27832819|NCT01513239|81219363|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27832820|NCT01513239|81219364|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
27832821|NCT01513239|81219365|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27832822|NCT01513239|81219366|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
27886494|NCT00507728|81418075|FG002|Randomization to Month 3|Lost to Follow-up|20|||
27886495|NCT00507728|81418073|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
27886496|NCT00507728|81418074|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
27886497|NCT00507728|81418075|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
27700704|NCT03548987|80741173|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
27700705|NCT03548987|80741174|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
27700706|NCT03548987|80741173|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
27700707|NCT03548987|80741174|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
27700708|NCT03548987|80741173|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
27700709|NCT03548987|80741174|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
27700710|NCT01505010|80741175|FG000|Overall Study|Protocol Violation|0|||
27700711|NCT01505010|80741176|FG001|Overall Study|Protocol Violation|1|||
27700712|NCT01505010|80741175|FG000|Overall Study|Lost to Follow-up|0|||
27700713|NCT01505010|80741176|FG001|Overall Study|Lost to Follow-up|1|||
27700714|NCT02717754|80741178|FG000|Overall Study|Incorrect Infusion Duration|0|||
27700715|NCT02717754|80741179|FG001|Overall Study|Incorrect Infusion Duration|0|||
27700716|NCT02717754|80741180|FG002|Overall Study|Incorrect Infusion Duration|0|||
27700717|NCT02717754|80741181|FG003|Overall Study|Incorrect Infusion Duration|10|||
27560782|NCT03245008|80241152|FG001|Overall Study|Protocol Violation|1|||
27700718|NCT02717754|80741182|FG004|Overall Study|Incorrect Infusion Duration|20|||
27700719|NCT02717754|80741183|FG005|Overall Study|Incorrect Infusion Duration|20|||
27700720|NCT01807923|80741185|FG000|Overall Study|Adverse Event|2|||
27700721|NCT01807923|80741186|FG001|Overall Study|Adverse Event|1|||
27700722|NCT01807923|80741187|FG002|Overall Study|Adverse Event|2|||
27700723|NCT01807923|80741185|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
27700724|NCT01807923|80741186|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
27700725|NCT01807923|80741187|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
27700726|NCT01807923|80741185|FG000|Overall Study|Physician Decision|0|||
27700727|NCT01807923|80741186|FG001|Overall Study|Physician Decision|0|||
27700728|NCT01807923|80741187|FG002|Overall Study|Physician Decision|1|||
27700729|NCT01807923|80741185|FG000|Overall Study|Not Eligible (Genotype)|0|||
27700730|NCT01807923|80741186|FG001|Overall Study|Not Eligible (Genotype)|0|||
27560783|NCT03245008|80241153|FG002|Overall Study|Protocol Violation|0|||
27560784|NCT03245008|80241154|FG003|Overall Study|Protocol Violation|0|||
27560785|NCT03245008|80241155|FG004|Overall Study|Protocol Violation|0|||
27560786|NCT03245008|80241151|FG000|Overall Study|Withdrawal by Subject|20|||
27560787|NCT03245008|80241152|FG001|Overall Study|Withdrawal by Subject|19|||
27560788|NCT03245008|80241153|FG002|Overall Study|Withdrawal by Subject|11|||
27560789|NCT03245008|80241154|FG003|Overall Study|Withdrawal by Subject|0|||
27560790|NCT03245008|80241155|FG004|Overall Study|Withdrawal by Subject|0|||
27560791|NCT03245008|80241151|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
27560792|NCT03245008|80241152|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
27560793|NCT03245008|80241153|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
27560794|NCT03245008|80241154|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
27560795|NCT03245008|80241155|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
27560796|NCT03245008|80241151|FG000|Overall Study|Failure to meet randomization criteria|0|||
27886498|NCT01258998|81418079|FG000|Overall Study|Ineligible|1|||
27886499|NCT02211638|81418080|FG000|Overall Study|Case Report Forms Uncollected|291|||
27886500|NCT02211638|81418080|FG000|Overall Study|Protocol Violation|692|||
27886501|NCT03670836|81418083|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
27886502|NCT03670836|81418084|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
27886503|NCT03670836|81418083|FG000|Per Protocol Population (PP)|Physician Decision|9|||
27886504|NCT03670836|81418084|FG001|Per Protocol Population (PP)|Physician Decision|10|||
27886505|NCT03670836|81418083|FG000|Per Protocol Population (PP)|Physician Decision|4|||
27886506|NCT03670836|81418084|FG001|Per Protocol Population (PP)|Physician Decision|6|||
27886507|NCT03670836|81418083|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
27886508|NCT03670836|81418084|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
27886509|NCT02693171|81418089|FG000|Overall Study|Adverse Event|1|||
27886510|NCT02693171|81418089|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
27886511|NCT01075256|81418091|FG000|Overall Study|Withdrawal by Subject|1|||
27886512|NCT01075256|81418092|FG001|Overall Study|Withdrawal by Subject|0|||
27886513|NCT01075256|81418093|FG002|Overall Study|Withdrawal by Subject|0|||
27886514|NCT02217410|81418094|FG000|Overall Study|Graft Loss|0|||
27886515|NCT02217410|81418095|FG001|Overall Study|Graft Loss|0|||
27886516|NCT02217410|81418096|FG002|Overall Study|Graft Loss|2|||
27886517|NCT02217410|81418094|FG000|Overall Study|Withdrawal by Subject|0|||
27886518|NCT02217410|81418095|FG001|Overall Study|Withdrawal by Subject|0|||
27886519|NCT02217410|81418096|FG002|Overall Study|Withdrawal by Subject|2|||
27886520|NCT02217410|81418094|FG000|Overall Study|Lost to Follow-up|0|||
27886521|NCT02217410|81418095|FG001|Overall Study|Lost to Follow-up|0|||
27886522|NCT02217410|81418096|FG002|Overall Study|Lost to Follow-up|1|||
27886523|NCT02217410|81418094|FG000|Overall Study|Lack of Efficacy|0|||
27886524|NCT02217410|81418095|FG001|Overall Study|Lack of Efficacy|1|||
27560797|NCT03245008|80241152|FG001|Overall Study|Failure to meet randomization criteria|1|||
27886525|NCT02217410|81418096|FG002|Overall Study|Lack of Efficacy|0|||
27886526|NCT02217410|81418094|FG000|Overall Study|Physician Decision|1|||
27886527|NCT02217410|81418095|FG001|Overall Study|Physician Decision|3|||
27886528|NCT02217410|81418096|FG002|Overall Study|Physician Decision|0|||
27886529|NCT04470544|81418101|FG000|Overall Study|Withdrawal by Subject|4|||
27832823|NCT01513239|81219361|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27832824|NCT01513239|81219362|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27832825|NCT01513239|81219363|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27832826|NCT01513239|81219364|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
27832827|NCT01513239|81219365|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
27832828|NCT01513239|81219366|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
27832829|NCT02451358|81219367|FG000|Overall Study|Withdrawal by Subject|1|||
27832830|NCT02451358|81219368|FG001|Overall Study|Withdrawal by Subject|1|||
27832831|NCT02451358|81219369|FG002|Overall Study|Withdrawal by Subject|0|||
27832832|NCT02451358|81219370|FG003|Overall Study|Withdrawal by Subject|0|||
27832833|NCT02451358|81219367|FG000|Overall Study|Protocol Violation|0|||
27832834|NCT02451358|81219368|FG001|Overall Study|Protocol Violation|1|||
27832835|NCT02451358|81219369|FG002|Overall Study|Protocol Violation|1|||
27832836|NCT02451358|81219370|FG003|Overall Study|Protocol Violation|0|||
27832837|NCT00367133|81219371|FG000|2 Years|Death|20|||
27700731|NCT01807923|80741187|FG002|Overall Study|Not Eligible (Genotype)|1|||
27700732|NCT01807923|80741185|FG000|Overall Study|Randomized But Not Treated|3|||
27700733|NCT01807923|80741186|FG001|Overall Study|Randomized But Not Treated|2|||
27700734|NCT01807923|80741187|FG002|Overall Study|Randomized But Not Treated|5|||
27560798|NCT03245008|80241153|FG002|Overall Study|Failure to meet randomization criteria|0|||
27560799|NCT03245008|80241154|FG003|Overall Study|Failure to meet randomization criteria|1|||
27560800|NCT03245008|80241155|FG004|Overall Study|Failure to meet randomization criteria|0|||
27560801|NCT01528254|80241156|FG000|Overall Study|Administrative problems|96|||
27560802|NCT01528254|80241157|FG001|Overall Study|Administrative problems|94|||
27560803|NCT01528254|80241156|FG000|Overall Study|Adverse Event|28|||
27700735|NCT00292461|80741188|FG000|Overall Study|Adverse Event|4|||
27700736|NCT00292461|80741189|FG001|Overall Study|Adverse Event|2|||
27700737|NCT00292461|80741188|FG000|Overall Study|Lack of Efficacy|1|||
27700738|NCT00292461|80741189|FG001|Overall Study|Lack of Efficacy|0|||
27700739|NCT00292461|80741188|FG000|Overall Study|Withdrawal by Subject|0|||
27700740|NCT00292461|80741189|FG001|Overall Study|Withdrawal by Subject|1|||
27700741|NCT00292461|80741188|FG000|Overall Study|Protocol Violation|4|||
27700742|NCT00292461|80741189|FG001|Overall Study|Protocol Violation|3|||
27700743|NCT00292461|80741188|FG000|Overall Study|Lost to Follow-up|1|||
27700744|NCT00292461|80741189|FG001|Overall Study|Lost to Follow-up|0|||
27700745|NCT03065023|80741190|FG000|Overall Study|Progressive Disease|0|||
27700746|NCT03065023|80741191|FG001|Overall Study|Progressive Disease|1|||
27700747|NCT03065023|80741192|FG002|Overall Study|Progressive Disease|0|||
27700748|NCT03065023|80741193|FG003|Overall Study|Progressive Disease|0|||
27700749|NCT03065023|80741194|FG004|Overall Study|Progressive Disease|0|||
27700750|NCT03065023|80741190|FG000|Overall Study|Death|2|||
27700751|NCT03065023|80741191|FG001|Overall Study|Death|0|||
27700752|NCT03065023|80741192|FG002|Overall Study|Death|1|||
27700753|NCT03065023|80741193|FG003|Overall Study|Death|1|||
27700754|NCT03065023|80741194|FG004|Overall Study|Death|0|||
27700755|NCT03065023|80741190|FG000|Overall Study|Lost to Follow-up|0|||
27700756|NCT03065023|80741191|FG001|Overall Study|Lost to Follow-up|1|||
27700757|NCT03065023|80741192|FG002|Overall Study|Lost to Follow-up|0|||
27700758|NCT03065023|80741193|FG003|Overall Study|Lost to Follow-up|0|||
27700759|NCT03065023|80741194|FG004|Overall Study|Lost to Follow-up|0|||
27700760|NCT03065023|80741190|FG000|Overall Study|Participant Decision|0|||
27700761|NCT03065023|80741191|FG001|Overall Study|Participant Decision|0|||
27700762|NCT03065023|80741192|FG002|Overall Study|Participant Decision|0|||
27700763|NCT03065023|80741193|FG003|Overall Study|Participant Decision|1|||
27700764|NCT03065023|80741194|FG004|Overall Study|Participant Decision|0|||
27700765|NCT03065023|80741190|FG000|Overall Study|Withdrawal by Subject|0|||
27700766|NCT03065023|80741191|FG001|Overall Study|Withdrawal by Subject|0|||
27700767|NCT03065023|80741192|FG002|Overall Study|Withdrawal by Subject|0|||
27700768|NCT03065023|80741193|FG003|Overall Study|Withdrawal by Subject|1|||
27700769|NCT03065023|80741194|FG004|Overall Study|Withdrawal by Subject|0|||
27700770|NCT01032382|80741197|FG000|Overall Study|Disease dissemination|1|||
27700771|NCT01032382|80741198|FG001|Overall Study|Disease dissemination|1|||
27700772|NCT01032382|80741197|FG000|Overall Study|Treatment failure|3|||
27700773|NCT01032382|80741198|FG001|Overall Study|Treatment failure|1|||
27560804|NCT01528254|80241157|FG001|Overall Study|Adverse Event|44|||
27700774|NCT01032382|80741197|FG000|Overall Study|Index lesion relapse|1|||
27700775|NCT01032382|80741198|FG001|Overall Study|Index lesion relapse|3|||
27700776|NCT00986440|80741199|FG000|Overall Study|Progressive disease|27|||
27700777|NCT00986440|80741200|FG001|Overall Study|Progressive disease|37|||
27700778|NCT00986440|80741199|FG000|Overall Study|Serious adverse event or adverse event|9|||
27700779|NCT00986440|80741200|FG001|Overall Study|Serious adverse event or adverse event|2|||
27700780|NCT00986440|80741199|FG000|Overall Study|Withdrawal by Subject|1|||
27700781|NCT00986440|80741200|FG001|Overall Study|Withdrawal by Subject|2|||
27832838|NCT00367133|81219372|FG001|2 Years|Death|12|||
27700782|NCT00986440|80741199|FG000|Overall Study|Screen failure (not dosed)|4|||
27700783|NCT00986440|80741200|FG001|Overall Study|Screen failure (not dosed)|2|||
27700784|NCT01306890|80741201|FG000|Overall Study|Adverse Event|2|||
27700785|NCT01306890|80741201|FG000|Overall Study|Death|1223|||
27700786|NCT01306890|80741201|FG000|Overall Study|Lost to Follow-up|58|||
27560805|NCT01528254|80241156|FG000|Overall Study|Lost to Follow-up|17|||
27560806|NCT01528254|80241157|FG001|Overall Study|Lost to Follow-up|24|||
27560807|NCT01528254|80241156|FG000|Overall Study|Death|13|||
27560808|NCT01528254|80241157|FG001|Overall Study|Death|9|||
27560809|NCT01528254|80241156|FG000|Overall Study|Protocol deviation|9|||
27560810|NCT01528254|80241157|FG001|Overall Study|Protocol deviation|19|||
27700787|NCT01306890|80741201|FG000|Overall Study|Withdrawal by Subject|88|||
27700788|NCT01306890|80741201|FG000|Overall Study|Unspecified reasons|104|||
27832839|NCT00367133|81219373|FG002|2 Years|Death|12|||
27560811|NCT01528254|80241156|FG000|Overall Study|New therapy for study indication|8|||
27560812|NCT01528254|80241157|FG001|Overall Study|New therapy for study indication|6|||
27700789|NCT01306890|80741201|FG000|Overall Study|Study Termination|3|||
27832840|NCT00367133|81219371|FG000|2 Years|Dropped|34|||
27560813|NCT01528254|80241156|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27560814|NCT01528254|80241157|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
27560815|NCT01528254|80241156|FG000|Overall Study|Withdrawal by Subject|5|||
27832841|NCT00367133|81219372|FG001|2 Years|Dropped|19|||
27700790|NCT01306890|80741201|FG000|Overall Study|No discontinuation documentation|41|||
27700791|NCT01494350|80741202|FG000|Overall Study|Worsening of lesion|1|||
27700792|NCT01521897|80741203|FG000|Overall Study|Protocol Violation|18|||
27700793|NCT01521897|80741203|FG000|Overall Study|Lost to Follow-up|5|||
27700794|NCT01717989|80741204|FG000|Overall Study|Ineligibility determined|6|||
27700795|NCT01717989|80741204|FG000|Overall Study|Protocol deviation|6|||
27700796|NCT01717989|80741204|FG000|Overall Study|Withdrawal by Subject|11|||
27700797|NCT01717989|80741204|FG000|Overall Study|Physician Decision|2|||
27700798|NCT01717989|80741204|FG000|Overall Study|Lost to Follow-up|11|||
27700799|NCT01717989|80741204|FG000|Overall Study|Death|439|||
27700800|NCT01717989|80741204|FG000|Overall Study|Protocol-specified criteria|551|||
27700801|NCT01717989|80741204|FG000|Overall Study|Other|40|||
27700802|NCT02973425|80741205|FG000|Overall Study|Lost to Follow-up|49|||
27700803|NCT02973425|80741206|FG001|Overall Study|Lost to Follow-up|53|||
27700804|NCT02092350|80741211|FG000|Overall Study|Adverse Event|0|||
27700805|NCT02092350|80741212|FG001|Overall Study|Adverse Event|3|||
27700806|NCT02092350|80741211|FG000|Overall Study|Death|2|||
27700807|NCT02092350|80741212|FG001|Overall Study|Death|5|||
27700808|NCT02092350|80741211|FG000|Overall Study|Lost to Follow-up|3|||
27700809|NCT02092350|80741212|FG001|Overall Study|Lost to Follow-up|1|||
27700810|NCT02092350|80741211|FG000|Overall Study|Protocol Violation|1|||
27700811|NCT02092350|80741212|FG001|Overall Study|Protocol Violation|0|||
27700812|NCT02092350|80741211|FG000|Overall Study|Physician Decision|1|||
27700813|NCT02092350|80741212|FG001|Overall Study|Physician Decision|1|||
27700814|NCT02092350|80741211|FG000|Overall Study|Screen Failure|1|||
27700815|NCT02092350|80741212|FG001|Overall Study|Screen Failure|0|||
27700816|NCT02092350|80741211|FG000|Overall Study|Withdrawal by Subject|2|||
27700817|NCT02092350|80741212|FG001|Overall Study|Withdrawal by Subject|2|||
27700818|NCT03836807|80741218|FG000|Overall Study|Physician Decision|1|||
27700819|NCT03836807|80741219|FG001|Overall Study|Physician Decision|0|||
27700820|NCT02941926|80741220|FG000|Core Phase|Progressive disease|1109|||
27700821|NCT02941926|80741220|FG000|Core Phase|Adverse Event|504|||
27700822|NCT02941926|80741220|FG000|Core Phase|Subject/guardian decision|127|||
27700823|NCT02941926|80741220|FG000|Core Phase|Physician Decision|112|||
27700824|NCT02941926|80741220|FG000|Core Phase|Death|46|||
27700825|NCT02941926|80741220|FG000|Core Phase|Protocol deviation|34|||
27700826|NCT02941926|80741220|FG000|Core Phase|Lost to Follow-up|8|||
27700827|NCT02941926|80741220|FG000|Core Phase|Technical problems|5|||
27700828|NCT02941926|80741220|FG000|Extension Phase|Physician Decision|155|||
27700829|NCT02941926|80741220|FG000|Extension Phase|Progressive disease|115|||
27700830|NCT02941926|80741220|FG000|Extension Phase|Adverse Event|13|||
27700831|NCT02941926|80741220|FG000|Extension Phase|Subject/Guardian decision|12|||
27700832|NCT02941926|80741220|FG000|Extension Phase|Death|6|||
27700833|NCT00529451|80741223|FG000|Overall Study|Subject withdrew consent|16|||
27700834|NCT00529451|80741224|FG001|Overall Study|Subject withdrew consent|21|||
27700835|NCT00529451|80741225|FG002|Overall Study|Subject withdrew consent|13|||
27700836|NCT00529451|80741226|FG003|Overall Study|Subject withdrew consent|12|||
27700837|NCT00529451|80741223|FG000|Overall Study|Adverse Event|9|||
27700838|NCT00529451|80741224|FG001|Overall Study|Adverse Event|16|||
27700839|NCT00529451|80741225|FG002|Overall Study|Adverse Event|14|||
27700840|NCT00529451|80741226|FG003|Overall Study|Adverse Event|8|||
27700841|NCT00529451|80741223|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
27700842|NCT00529451|80741224|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
27700843|NCT00529451|80741225|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
27700844|NCT00529451|80741226|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
27700845|NCT00529451|80741223|FG000|Overall Study|Lost to Follow-up|4|||
27700846|NCT00529451|80741224|FG001|Overall Study|Lost to Follow-up|7|||
27700847|NCT00529451|80741225|FG002|Overall Study|Lost to Follow-up|4|||
27700848|NCT00529451|80741226|FG003|Overall Study|Lost to Follow-up|4|||
27700849|NCT00529451|80741223|FG000|Overall Study|Protocol deviation|1|||
27700850|NCT00529451|80741224|FG001|Overall Study|Protocol deviation|1|||
27700851|NCT00529451|80741225|FG002|Overall Study|Protocol deviation|4|||
27832842|NCT00367133|81219373|FG002|2 Years|Dropped|33|||
27832843|NCT00367133|81219371|FG000|2 Years|Missed visit|4|||
27700852|NCT00529451|80741226|FG003|Overall Study|Protocol deviation|1|||
27700853|NCT00529451|80741223|FG000|Overall Study|Administrative problems|1|||
27700854|NCT00529451|80741224|FG001|Overall Study|Administrative problems|1|||
27700855|NCT00529451|80741225|FG002|Overall Study|Administrative problems|0|||
27700856|NCT00529451|80741226|FG003|Overall Study|Administrative problems|2|||
27700857|NCT01128894|80741227|FG000|Overall Study|Adverse Event|31|||
27700858|NCT01128894|80741228|FG001|Overall Study|Adverse Event|41|||
27700859|NCT01128894|80741227|FG000|Overall Study|Protocol Violation|2|||
27700860|NCT01128894|80741228|FG001|Overall Study|Protocol Violation|1|||
27700861|NCT01128894|80741227|FG000|Overall Study|Noncompliance|4|||
27700862|NCT01128894|80741228|FG001|Overall Study|Noncompliance|5|||
27700863|NCT01128894|80741227|FG000|Overall Study|Lost to Follow-up|8|||
27700864|NCT01128894|80741228|FG001|Overall Study|Lost to Follow-up|8|||
27832844|NCT00367133|81219372|FG001|2 Years|Missed visit|5|||
27832845|NCT00367133|81219373|FG002|2 Years|Missed visit|4|||
27832846|NCT00705666|81219375|FG000|Overall Study|No post-treatment questionnaire|279|||
27700865|NCT01128894|80741227|FG000|Overall Study|Withdrawal by Subject|10|||
27700866|NCT01128894|80741228|FG001|Overall Study|Withdrawal by Subject|12|||
27700867|NCT01128894|80741227|FG000|Overall Study|Physician Decision|2|||
27700868|NCT01128894|80741228|FG001|Overall Study|Physician Decision|1|||
27700869|NCT01128894|80741227|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
27700870|NCT01128894|80741228|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
27700871|NCT01019980|80741232|FG000|Overall Study|Drug not available.|2|||
27700872|NCT01019980|80741233|FG001|Overall Study|Drug not available.|0|||
27700873|NCT01431534|80741234|FG000|Treatment Phase|Adverse Event|0|||
27886530|NCT04470544|81418102|FG001|Overall Study|Withdrawal by Subject|6|||
27886531|NCT01683266|81418103|FG000|Overall Study|Adverse Event|5|||
27560816|NCT01528254|80241157|FG001|Overall Study|Withdrawal by Subject|4|||
27560817|NCT01528254|80241156|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27560818|NCT01528254|80241157|FG001|Overall Study|Abnormal laboratory value(s)|7|||
27560819|NCT01528254|80241156|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27560820|NCT01528254|80241157|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27700874|NCT01431534|80741235|FG001|Treatment Phase|Adverse Event|0|||
27700875|NCT01431534|80741236|FG002|Treatment Phase|Adverse Event|1|||
27700876|NCT01431534|80741234|FG000|Treatment Phase|Progressive Disease|4|||
27700877|NCT01431534|80741235|FG001|Treatment Phase|Progressive Disease|3|||
27700878|NCT01431534|80741236|FG002|Treatment Phase|Progressive Disease|10|||
27700879|NCT00887679|80741237|FG000|Overall Study|Withdrawal by Subject|1|||
27700880|NCT00887679|80741237|FG000|Overall Study|Lost to Follow-up|4|||
27700881|NCT00887679|80741237|FG000|Overall Study|Physician Decision|5|||
27700882|NCT01749540|80741240|FG000|Overall Study|Protocol Violation|0|||
27700883|NCT01749540|80741241|FG001|Overall Study|Protocol Violation|0|||
27700884|NCT01749540|80741242|FG002|Overall Study|Protocol Violation|0|||
27700885|NCT01749540|80741243|FG003|Overall Study|Protocol Violation|0|||
27700886|NCT01749540|80741244|FG004|Overall Study|Protocol Violation|0|||
27700887|NCT01749540|80741245|FG005|Overall Study|Protocol Violation|1|||
27700888|NCT01749540|80741246|FG006|Overall Study|Protocol Violation|1|||
27700889|NCT01749540|80741240|FG000|Overall Study|Withdrawal by Subject|0|||
27700890|NCT01749540|80741241|FG001|Overall Study|Withdrawal by Subject|0|||
27700891|NCT01749540|80741242|FG002|Overall Study|Withdrawal by Subject|0|||
27700892|NCT01749540|80741243|FG003|Overall Study|Withdrawal by Subject|1|||
27700893|NCT01749540|80741244|FG004|Overall Study|Withdrawal by Subject|0|||
27700894|NCT01749540|80741245|FG005|Overall Study|Withdrawal by Subject|0|||
27700895|NCT01749540|80741246|FG006|Overall Study|Withdrawal by Subject|0|||
27700896|NCT01749540|80741240|FG000|Overall Study|Initiated into extension study A536-06|0|||
27700897|NCT01749540|80741241|FG001|Overall Study|Initiated into extension study A536-06|0|||
27700898|NCT01749540|80741242|FG002|Overall Study|Initiated into extension study A536-06|0|||
27700899|NCT01749540|80741243|FG003|Overall Study|Initiated into extension study A536-06|0|||
27700900|NCT01749540|80741244|FG004|Overall Study|Initiated into extension study A536-06|0|||
27700901|NCT01749540|80741245|FG005|Overall Study|Initiated into extension study A536-06|2|||
27700902|NCT01749540|80741246|FG006|Overall Study|Initiated into extension study A536-06|24|||
27700903|NCT03952806|80741247|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
27700904|NCT03952806|80741248|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
27700905|NCT03952806|80741247|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
27700906|NCT03952806|80741248|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
27700907|NCT03952806|80741247|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
27700908|NCT03952806|80741248|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
27700909|NCT03952806|80741247|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
27700910|NCT03952806|80741248|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
27700911|NCT03952806|80741247|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
27700912|NCT03952806|80741248|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
27700913|NCT03952806|80741247|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
27700914|NCT03952806|80741248|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
27700915|NCT03952806|80741247|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
27886532|NCT01683266|81418104|FG001|Overall Study|Adverse Event|4|||
27560821|NCT01528254|80241156|FG000|Overall Study|No longer requires study drug|1|||
27560822|NCT01528254|80241157|FG001|Overall Study|No longer requires study drug|1|||
27560823|NCT00378209|80241159|FG000|Overall Study|Progressive disease|11|||
27560824|NCT00378209|80241159|FG000|Overall Study|Adverse Event|3|||
27700916|NCT03952806|80741248|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
27886533|NCT01683266|81418103|FG000|Overall Study|Lack of Efficacy|5|||
27560825|NCT00378209|80241159|FG000|Overall Study|Initiation of non-protocol therapy|3|||
27700917|NCT03952806|80741247|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
27700918|NCT03952806|80741248|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
27700919|NCT03952806|80741247|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
27560826|NCT00378209|80241159|FG000|Overall Study|Physician Decision|3|||
27700920|NCT03952806|80741248|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
27700921|NCT03952806|80741247|FG000|OLE Phase (48 Weeks)|Other|16|||
27886534|NCT01683266|81418104|FG001|Overall Study|Lack of Efficacy|2|||
27700922|NCT03952806|80741248|FG001|OLE Phase (48 Weeks)|Other|13|||
27700923|NCT04029961|80741249|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
27700924|NCT04029961|80741250|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
27886535|NCT01683266|81418103|FG000|Overall Study|Protocol Violation|13|||
27886536|NCT01683266|81418104|FG001|Overall Study|Protocol Violation|6|||
27886537|NCT01683266|81418103|FG000|Overall Study|Personal Reason|17|||
27886538|NCT01683266|81418104|FG001|Overall Study|Personal Reason|25|||
27886539|NCT01683266|81418103|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
27886540|NCT01683266|81418104|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
27886541|NCT01683266|81418103|FG000|Overall Study|Lost to Follow-up|5|||
27886542|NCT01683266|81418104|FG001|Overall Study|Lost to Follow-up|0|||
27886543|NCT01683266|81418103|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
27886544|NCT01683266|81418104|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
27886545|NCT01683266|81418103|FG000|Overall Study|Nonserious Hypoglycemia|0|||
27886546|NCT01683266|81418104|FG001|Overall Study|Nonserious Hypoglycemia|3|||
27886547|NCT01683266|81418103|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27886548|NCT01683266|81418104|FG001|Overall Study|Perceived Lack of Efficacy|1|||
27886549|NCT01683266|81418103|FG000|Overall Study|Possibly Hypoglycemia|1|||
27886550|NCT01683266|81418104|FG001|Overall Study|Possibly Hypoglycemia|0|||
27886551|NCT01683266|81418103|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
27886552|NCT01683266|81418104|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
27886553|NCT02235077|81418105|FG000|Overall Study|Death|5|||
27886554|NCT02235077|81418106|FG001|Overall Study|Death|7|||
27886555|NCT02235077|81418105|FG000|Overall Study|Lost to Follow-up|5|||
27886556|NCT02235077|81418106|FG001|Overall Study|Lost to Follow-up|6|||
27886557|NCT02235077|81418105|FG000|Overall Study|Withdrawal by Subject|8|||
27886558|NCT02235077|81418106|FG001|Overall Study|Withdrawal by Subject|5|||
27886559|NCT02235077|81418105|FG000|Overall Study|Physician Decision|0|||
27886560|NCT02235077|81418106|FG001|Overall Study|Physician Decision|1|||
27886561|NCT00886743|81418110|FG000|Overall Study|Adverse Event|3|||
27886562|NCT00886743|81418110|FG000|Overall Study|Other|1|||
27886563|NCT00582816|81418111|FG000|Overall Study|Engraftment Failure|3|||
27886564|NCT00617890|81418114|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
27886565|NCT00617890|81418115|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
27886566|NCT00617890|81418116|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
27886567|NCT00617890|81418117|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
27886568|NCT00617890|81418114|FG000|Overall Study|Lack of Efficacy|23|||
27886569|NCT00617890|81418115|FG001|Overall Study|Lack of Efficacy|26|||
27886570|NCT00617890|81418116|FG002|Overall Study|Lack of Efficacy|30|||
27886571|NCT00617890|81418117|FG003|Overall Study|Lack of Efficacy|97|||
27886572|NCT00617890|81418114|FG000|Overall Study|Lost to Follow-up|0|||
27886573|NCT00617890|81418115|FG001|Overall Study|Lost to Follow-up|0|||
27886574|NCT00617890|81418116|FG002|Overall Study|Lost to Follow-up|1|||
27700925|NCT04029961|80741249|FG000|Overall Study|Change in Treatment Course|0|||
27700926|NCT04029961|80741250|FG001|Overall Study|Change in Treatment Course|1|||
27700927|NCT03471871|80741251|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
27700928|NCT03471871|80741252|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
27700929|NCT03471871|80741253|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
27700930|NCT03471871|80741254|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
27886575|NCT00617890|81418117|FG003|Overall Study|Lost to Follow-up|2|||
27560827|NCT00378209|80241159|FG000|Overall Study|Death|1|||
27886576|NCT00617890|81418114|FG000|Overall Study|Withdrawal by Subject|4|||
27886577|NCT00617890|81418115|FG001|Overall Study|Withdrawal by Subject|1|||
27886578|NCT00617890|81418116|FG002|Overall Study|Withdrawal by Subject|0|||
27886579|NCT00617890|81418117|FG003|Overall Study|Withdrawal by Subject|2|||
27886580|NCT00617890|81418114|FG000|Overall Study|Protocol Violation|2|||
27886581|NCT00617890|81418115|FG001|Overall Study|Protocol Violation|1|||
27886582|NCT00617890|81418116|FG002|Overall Study|Protocol Violation|0|||
27886583|NCT00617890|81418117|FG003|Overall Study|Protocol Violation|0|||
27886584|NCT00617890|81418114|FG000|Overall Study|Adverse Event|1|||
27886585|NCT00617890|81418115|FG001|Overall Study|Adverse Event|0|||
27886586|NCT00617890|81418116|FG002|Overall Study|Adverse Event|3|||
27886587|NCT00617890|81418117|FG003|Overall Study|Adverse Event|8|||
27886588|NCT00617890|81418114|FG000|Overall Study|Not treated|1|||
27886589|NCT00617890|81418115|FG001|Overall Study|Not treated|0|||
27886590|NCT00617890|81418116|FG002|Overall Study|Not treated|1|||
27560828|NCT00378209|80241159|FG000|Overall Study|Treatment delay|1|||
27886591|NCT00617890|81418117|FG003|Overall Study|Not treated|1|||
27886592|NCT01435018|81418120|FG000|Overall Study|Death|37|||
27886593|NCT01435018|81418121|FG001|Overall Study|Death|18|||
27886594|NCT01435018|81418122|FG002|Overall Study|Death|25|||
27701012|NCT03933397|80741293|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
27701013|NCT03933397|80741294|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
27701014|NCT03933397|80741293|FG000|Overall Study|Withdrawal by Subject|1|||
27701015|NCT03933397|80741294|FG001|Overall Study|Withdrawal by Subject|0|||
27701016|NCT03933397|80741293|FG000|Overall Study|Physician Decision|1|||
27701017|NCT03933397|80741294|FG001|Overall Study|Physician Decision|1|||
27701018|NCT03933397|80741293|FG000|Overall Study|missing pain score|1|||
27701019|NCT03933397|80741294|FG001|Overall Study|missing pain score|1|||
27701020|NCT03933397|80741293|FG000|Overall Study|Confirmed COVID-19|1|||
27701021|NCT03933397|80741294|FG001|Overall Study|Confirmed COVID-19|2|||
27701022|NCT01028222|80741295|FG000|Overall Study|Protocol deviation|1|||
27701023|NCT01028222|80741296|FG001|Overall Study|Protocol deviation|0|||
27701024|NCT01028222|80741295|FG000|Overall Study|Disease progression|33|||
27701025|NCT01028222|80741296|FG001|Overall Study|Disease progression|9|||
27701026|NCT01028222|80741295|FG000|Overall Study|Administrative problems|1|||
27701027|NCT01028222|80741296|FG001|Overall Study|Administrative problems|1|||
27701028|NCT01028222|80741295|FG000|Overall Study|Lost to Follow-up|0|||
27701029|NCT01028222|80741296|FG001|Overall Study|Lost to Follow-up|1|||
27701030|NCT01028222|80741295|FG000|Overall Study|Withdrawal by Subject|1|||
27701031|NCT01028222|80741296|FG001|Overall Study|Withdrawal by Subject|0|||
27701032|NCT01028222|80741295|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
27701033|NCT01028222|80741296|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
27701034|NCT01028222|80741295|FG000|Overall Study|Adverse Event|2|||
27701035|NCT01028222|80741296|FG001|Overall Study|Adverse Event|0|||
27701036|NCT02525861|80741297|FG000|Overall Study|Adverse Event|1|||
27701037|NCT02525861|80741298|FG001|Overall Study|Adverse Event|0|||
27701038|NCT02525861|80741297|FG000|Overall Study|Withdrawal by Subject|0|||
27701039|NCT02525861|80741298|FG001|Overall Study|Withdrawal by Subject|1|||
27701040|NCT02525861|80741297|FG000|Overall Study|Physician Decision|0|||
27701041|NCT02525861|80741298|FG001|Overall Study|Physician Decision|1|||
27701042|NCT00708175|80741299|FG000|Overall Study|Adverse Event|4|||
27701043|NCT00708175|80741300|FG001|Overall Study|Adverse Event|5|||
27701044|NCT00708175|80741299|FG000|Overall Study|Protocol Violation|2|||
27701045|NCT00708175|80741300|FG001|Overall Study|Protocol Violation|3|||
27701046|NCT00708175|80741299|FG000|Overall Study|Lost to Follow-up|5|||
27701047|NCT00708175|80741300|FG001|Overall Study|Lost to Follow-up|3|||
27701048|NCT00708175|80741299|FG000|Overall Study|Withdrawal by Subject|5|||
27701049|NCT00708175|80741300|FG001|Overall Study|Withdrawal by Subject|7|||
27701050|NCT00708175|80741299|FG000|Overall Study|BMD loss >7%|2|||
27701051|NCT00708175|80741300|FG001|Overall Study|BMD loss >7%|3|||
27594403|NCT00955357|80356064|FG001|Titration Phase|Study medication not tolerated|1|||
27594404|NCT00955357|80356063|FG000|Titration Phase|Non compliance to study procedures|0|||
27594405|NCT00955357|80356064|FG001|Titration Phase|Non compliance to study procedures|1|||
27701052|NCT01138007|80741301|FG000|Overall Study|Adverse Event|4|||
27594406|NCT00955357|80356063|FG000|Maintenance Phase|Adverse Event|3|||
27594407|NCT00955357|80356064|FG001|Maintenance Phase|Adverse Event|23|||
27594408|NCT00955357|80356063|FG000|Maintenance Phase|Lack of Efficacy|0|||
27594409|NCT00955357|80356064|FG001|Maintenance Phase|Lack of Efficacy|4|||
27594410|NCT00955357|80356063|FG000|Maintenance Phase|Protocol Violation|2|||
27594411|NCT00955357|80356064|FG001|Maintenance Phase|Protocol Violation|6|||
27594412|NCT00955357|80356063|FG000|Maintenance Phase|Lost to Follow-up|2|||
27594413|NCT00955357|80356064|FG001|Maintenance Phase|Lost to Follow-up|7|||
27594414|NCT00955357|80356063|FG000|Maintenance Phase|Withdrawal by Subject|4|||
27594415|NCT00955357|80356064|FG001|Maintenance Phase|Withdrawal by Subject|4|||
27594416|NCT00955357|80356063|FG000|Maintenance Phase|Patient moving out of area|0|||
27594417|NCT00955357|80356064|FG001|Maintenance Phase|Patient moving out of area|1|||
27594418|NCT00955357|80356063|FG000|Maintenance Phase|Non compliance to study procedures|1|||
27594419|NCT00955357|80356064|FG001|Maintenance Phase|Non compliance to study procedures|0|||
27594420|NCT01422408|80356065|FG000|Overall Study|Adverse Event|1|||
27594421|NCT01422408|80356065|FG000|Overall Study|Withdrawal by Subject|3|||
27594422|NCT02527798|80356067|FG000|Overall Study|Physician Decision|1|||
27594423|NCT02527798|80356068|FG001|Overall Study|Physician Decision|0|||
27594424|NCT02527798|80356069|FG002|Overall Study|Physician Decision|1|||
27594425|NCT02527798|80356070|FG003|Overall Study|Physician Decision|1|||
27594426|NCT02527798|80356071|FG004|Overall Study|Physician Decision|0|||
27594427|NCT02527798|80356072|FG005|Overall Study|Physician Decision|0|||
27594428|NCT02527798|80356067|FG000|Overall Study|Death|0|||
27594429|NCT02527798|80356068|FG001|Overall Study|Death|0|||
27594430|NCT02527798|80356069|FG002|Overall Study|Death|1|||
27594431|NCT02527798|80356070|FG003|Overall Study|Death|0|||
27594432|NCT02527798|80356071|FG004|Overall Study|Death|0|||
27594433|NCT02527798|80356072|FG005|Overall Study|Death|0|||
27594434|NCT02527798|80356067|FG000|Overall Study|Withdrawal by Subject|0|||
27594435|NCT02527798|80356068|FG001|Overall Study|Withdrawal by Subject|1|||
27594436|NCT02527798|80356069|FG002|Overall Study|Withdrawal by Subject|2|||
27594437|NCT02527798|80356070|FG003|Overall Study|Withdrawal by Subject|0|||
27594438|NCT02527798|80356071|FG004|Overall Study|Withdrawal by Subject|0|||
27594439|NCT02527798|80356072|FG005|Overall Study|Withdrawal by Subject|0|||
27594440|NCT02527798|80356067|FG000|Overall Study|Reason undisclosed|1|||
27594441|NCT02527798|80356068|FG001|Overall Study|Reason undisclosed|0|||
27594442|NCT02527798|80356069|FG002|Overall Study|Reason undisclosed|1|||
27594443|NCT02527798|80356070|FG003|Overall Study|Reason undisclosed|0|||
27594444|NCT02527798|80356071|FG004|Overall Study|Reason undisclosed|0|||
27594445|NCT02527798|80356072|FG005|Overall Study|Reason undisclosed|0|||
27594446|NCT02527798|80356067|FG000|Overall Study|Did not receive intervention|1|||
27594447|NCT02527798|80356068|FG001|Overall Study|Did not receive intervention|1|||
27594448|NCT02527798|80356069|FG002|Overall Study|Did not receive intervention|0|||
27594449|NCT02527798|80356070|FG003|Overall Study|Did not receive intervention|0|||
27594450|NCT02527798|80356071|FG004|Overall Study|Did not receive intervention|0|||
27594451|NCT02527798|80356072|FG005|Overall Study|Did not receive intervention|0|||
27594452|NCT02844946|80356077|FG000|Overall Study|Lost to Follow-up|7|||
27594453|NCT02844946|80356078|FG001|Overall Study|Lost to Follow-up|0|||
27594454|NCT03282227|80356079|FG000|Overall Study|Exposure Goals Achieved|60|||
27594455|NCT03282227|80356079|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
27594456|NCT03282227|80356079|FG000|Overall Study|Adverse Event|15|||
27594457|NCT03282227|80356079|FG000|Overall Study|Lost to Follow-up|21|||
27594458|NCT03282227|80356079|FG000|Overall Study|Withdrawal by Subject|20|||
27594459|NCT03282227|80356079|FG000|Overall Study|Lack of Efficacy|12|||
27594460|NCT03282227|80356079|FG000|Overall Study|Sponsor decision|3|||
27594461|NCT03282227|80356079|FG000|Overall Study|Physician Decision|2|||
27594462|NCT03282227|80356079|FG000|Overall Study|Pregnancy|2|||
27594463|NCT03282227|80356079|FG000|Overall Study|Other|1|||
27594464|NCT02099838|80356080|FG000|Overall Study|Death|1|||
27594465|NCT02099838|80356081|FG001|Overall Study|Death|0|||
27594466|NCT02099838|80356080|FG000|Overall Study|Lost to Follow-up|3|||
27594467|NCT02099838|80356081|FG001|Overall Study|Lost to Follow-up|1|||
27594468|NCT02099838|80356080|FG000|Overall Study|Withdrawal by Subject|0|||
27594469|NCT02099838|80356081|FG001|Overall Study|Withdrawal by Subject|1|||
27594470|NCT02349295|80356084|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
27594471|NCT02349295|80356085|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
27594472|NCT02349295|80356086|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
27701053|NCT01138007|80741302|FG001|Overall Study|Adverse Event|12|||
27701054|NCT01138007|80741303|FG002|Overall Study|Adverse Event|9|||
27833150|NCT04281472|81219494|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
27833151|NCT04281472|81219495|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
27594473|NCT02349295|80356087|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594474|NCT02349295|80356088|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594475|NCT02349295|80356089|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594476|NCT02349295|80356090|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594477|NCT02349295|80356091|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594478|NCT02349295|80356092|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594479|NCT02349295|80356093|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594480|NCT02349295|80356094|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27701055|NCT01138007|80741301|FG000|Overall Study|Lack of Efficacy|2|||
27833152|NCT04281472|81219493|FG000|Stage B|Adverse Event|0|||
27833153|NCT04281472|81219494|FG001|Stage B|Adverse Event|3|||
27833154|NCT04281472|81219495|FG002|Stage B|Adverse Event|0|||
27833155|NCT04281472|81219493|FG000|Stage B|Death|0|||
27594481|NCT02349295|80356095|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27833156|NCT04281472|81219494|FG001|Stage B|Death|0|||
27833157|NCT04281472|81219495|FG002|Stage B|Death|1|||
27594482|NCT02349295|80356096|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594483|NCT02349295|80356097|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
27594484|NCT02349295|80356084|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
27594485|NCT02349295|80356085|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
27594486|NCT02349295|80356086|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
27594487|NCT02349295|80356087|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594488|NCT02349295|80356088|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594489|NCT02349295|80356089|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594490|NCT02349295|80356090|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594491|NCT02349295|80356091|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594492|NCT02349295|80356092|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594493|NCT02349295|80356093|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594494|NCT02349295|80356094|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594495|NCT02349295|80356095|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594496|NCT02349295|80356096|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594497|NCT02349295|80356097|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
27594498|NCT02349295|80356084|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
27594499|NCT02349295|80356085|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
27594500|NCT02349295|80356086|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
27594501|NCT02349295|80356087|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594502|NCT02349295|80356088|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594503|NCT02349295|80356089|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594504|NCT02349295|80356090|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594505|NCT02349295|80356091|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594506|NCT02349295|80356092|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594507|NCT02349295|80356093|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594508|NCT02349295|80356094|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594509|NCT02349295|80356095|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594510|NCT02349295|80356096|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594511|NCT02349295|80356097|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
27594512|NCT02349295|80356084|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
27594513|NCT02349295|80356085|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
27594514|NCT02349295|80356086|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
27594515|NCT02349295|80356087|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594516|NCT02349295|80356088|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594517|NCT02349295|80356089|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594518|NCT02349295|80356090|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594519|NCT02349295|80356091|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594520|NCT02349295|80356092|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594521|NCT02349295|80356093|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594522|NCT02349295|80356094|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594523|NCT02349295|80356095|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594524|NCT02349295|80356096|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594525|NCT02349295|80356097|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
27594526|NCT02349295|80356084|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594527|NCT02349295|80356085|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
27594528|NCT02349295|80356086|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
27594529|NCT02349295|80356087|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594530|NCT02349295|80356088|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594531|NCT02349295|80356089|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27701056|NCT01138007|80741302|FG001|Overall Study|Lack of Efficacy|0|||
27701057|NCT01138007|80741303|FG002|Overall Study|Lack of Efficacy|6|||
27701058|NCT01138007|80741301|FG000|Overall Study|Protocol Violation|2|||
27701059|NCT01138007|80741302|FG001|Overall Study|Protocol Violation|3|||
27701060|NCT01138007|80741303|FG002|Overall Study|Protocol Violation|2|||
27701061|NCT01138007|80741301|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
27701062|NCT01138007|80741302|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
27701063|NCT01138007|80741303|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
27701064|NCT01138007|80741301|FG000|Overall Study|Lost to Follow-up|3|||
27701065|NCT01138007|80741302|FG001|Overall Study|Lost to Follow-up|3|||
27701066|NCT01138007|80741303|FG002|Overall Study|Lost to Follow-up|5|||
27701067|NCT01138007|80741301|FG000|Overall Study|Physician Decision|0|||
27701068|NCT01138007|80741302|FG001|Overall Study|Physician Decision|5|||
27701069|NCT01138007|80741303|FG002|Overall Study|Physician Decision|3|||
27701070|NCT01138007|80741301|FG000|Overall Study|Withdrawal by Subject|5|||
27701071|NCT01138007|80741302|FG001|Overall Study|Withdrawal by Subject|6|||
27701072|NCT01138007|80741303|FG002|Overall Study|Withdrawal by Subject|15|||
27701073|NCT00937833|80741308|FG000|Overall Study|Protocol Violation|1|||
27701074|NCT00937833|80741309|FG001|Overall Study|Protocol Violation|2|||
27701075|NCT00937833|80741308|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
27701076|NCT00937833|80741309|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
27701077|NCT00937833|80741308|FG000|Overall Study|Lost to Follow-up|10|||
27701078|NCT00937833|80741309|FG001|Overall Study|Lost to Follow-up|8|||
27701079|NCT00937833|80741308|FG000|Overall Study|Withdrawal by Subject|4|||
27701080|NCT00937833|80741309|FG001|Overall Study|Withdrawal by Subject|6|||
27701081|NCT00448435|80741310|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
27701082|NCT00448435|80741311|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
27701083|NCT00867113|80741312|FG000|Treatment Period|Adverse Event|15|||
27701084|NCT00867113|80741312|FG000|Treatment Period|Death|2|||
27701085|NCT00867113|80741312|FG000|Treatment Period|Withdrawal by Subject|19|||
27701086|NCT00867113|80741312|FG000|Treatment Period|Lost to Follow-up|3|||
27701087|NCT00867113|80741312|FG000|Treatment Period|Administrative problems|1|||
27701088|NCT00867113|80741312|FG000|Treatment Period|Disease progression/relapse|1|||
27701089|NCT00867113|80741312|FG000|Treatment Period|Protocol Violation|4|||
27701090|NCT00867113|80741312|FG000|Post Treatment After Survival Follow-up|Death|1|||
27701091|NCT00867113|80741312|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
27701092|NCT00867113|80741312|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
27701093|NCT00867113|80741312|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
27701094|NCT00325039|80745271|FG000|Overall Study|Lost to Follow-up|18|||
27701095|NCT00325039|80745272|FG001|Overall Study|Lost to Follow-up|14|||
27701096|NCT01170039|80745276|FG000|Overall Study|Withdrawal by Subject|5|||
27701097|NCT01170039|80745277|FG001|Overall Study|Withdrawal by Subject|3|||
27701098|NCT01170039|80745276|FG000|Overall Study|Lack of funding, drug not available|3|||
27701099|NCT01170039|80745277|FG001|Overall Study|Lack of funding, drug not available|3|||
27701100|NCT01130051|80745278|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
27701101|NCT01130051|80745279|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
27701102|NCT01130051|80745278|FG000|Washout Period of 14 Days|Protocol Violation|1|||
27701103|NCT01130051|80745279|FG001|Washout Period of 14 Days|Protocol Violation|1|||
27701104|NCT03044886|80745286|FG000|Overall Study|Lost to Follow-up|15|||
27886636|NCT01938430|81418147|FG011|Overall Study|Randomized but Not Treated|0|||
27594532|NCT02349295|80356090|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594533|NCT02349295|80356091|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27701105|NCT03044886|80745287|FG001|Overall Study|Lost to Follow-up|10|||
27701106|NCT03044886|80745288|FG002|Overall Study|Lost to Follow-up|12|||
27701107|NCT03690141|80745289|FG000|Overall Study|Adverse Event|5|||
27701108|NCT03690141|80745289|FG000|Overall Study|Withdrawal by Subject|3|||
27701109|NCT03690141|80745289|FG000|Overall Study|Physician Decision|4|||
27701110|NCT03690141|80745289|FG000|Overall Study|Disease progression|4|||
27886637|NCT01938430|81418148|FG012|Overall Study|Randomized but Not Treated|0|||
27886638|NCT01938430|81418149|FG013|Overall Study|Randomized but Not Treated|1|||
27886639|NCT01938430|81418136|FG000|Overall Study|Adverse Event|0|||
27886640|NCT01938430|81418137|FG001|Overall Study|Adverse Event|0|||
27886641|NCT01938430|81418138|FG002|Overall Study|Adverse Event|0|||
27886642|NCT01938430|81418139|FG003|Overall Study|Adverse Event|0|||
27886643|NCT01938430|81418140|FG004|Overall Study|Adverse Event|0|||
27886644|NCT01938430|81418141|FG005|Overall Study|Adverse Event|0|||
27886645|NCT01938430|81418142|FG006|Overall Study|Adverse Event|1|||
27886646|NCT01938430|81418143|FG007|Overall Study|Adverse Event|0|||
27886647|NCT01938430|81418144|FG008|Overall Study|Adverse Event|0|||
27886648|NCT01938430|81418145|FG009|Overall Study|Adverse Event|0|||
27886649|NCT01938430|81418146|FG010|Overall Study|Adverse Event|0|||
27701111|NCT00974090|80745290|FG000|Period 1: Double Blind Period|Adverse Event|2|||
27701112|NCT00974090|80745291|FG001|Period 1: Double Blind Period|Adverse Event|1|||
27886650|NCT01938430|81418147|FG011|Overall Study|Adverse Event|0|||
27886651|NCT01938430|81418148|FG012|Overall Study|Adverse Event|0|||
27886652|NCT01938430|81418149|FG013|Overall Study|Adverse Event|0|||
27886653|NCT01938430|81418136|FG000|Overall Study|Death|1|||
27886654|NCT01938430|81418137|FG001|Overall Study|Death|2|||
27886655|NCT01938430|81418138|FG002|Overall Study|Death|2|||
27886656|NCT01938430|81418139|FG003|Overall Study|Death|1|||
27886657|NCT01938430|81418140|FG004|Overall Study|Death|0|||
27886658|NCT01938430|81418141|FG005|Overall Study|Death|0|||
27886659|NCT01938430|81418142|FG006|Overall Study|Death|1|||
27701113|NCT00974090|80745290|FG000|Period 1: Double Blind Period|Physician Decision|1|||
27886660|NCT01938430|81418143|FG007|Overall Study|Death|1|||
27886661|NCT01938430|81418144|FG008|Overall Study|Death|2|||
27886662|NCT01938430|81418145|FG009|Overall Study|Death|3|||
27886663|NCT01938430|81418146|FG010|Overall Study|Death|0|||
27886664|NCT01938430|81418147|FG011|Overall Study|Death|0|||
27701114|NCT00974090|80745291|FG001|Period 1: Double Blind Period|Physician Decision|0|||
27701115|NCT00974090|80745290|FG000|Period 2: Open-label Period|Adverse Event|4|||
27701116|NCT00974090|80745291|FG001|Period 2: Open-label Period|Adverse Event|6|||
27701117|NCT00974090|80745290|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
27701118|NCT00974090|80745291|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
27701119|NCT00974090|80745290|FG000|Period 2: Open-label Period|Physician Decision|0|||
27701120|NCT00974090|80745291|FG001|Period 2: Open-label Period|Physician Decision|3|||
27701121|NCT00974090|80745290|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
27701122|NCT00974090|80745291|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
27701123|NCT00458341|80745292|FG000|Cycle 1|Adverse Event|1|||
27701124|NCT00458341|80745293|FG001|Cycle 1|Adverse Event|0|||
27701125|NCT00576836|80745294|FG000|Overall Study|Death|0|||
27701126|NCT00576836|80745295|FG001|Overall Study|Death|1|||
27701127|NCT00576836|80745294|FG000|Overall Study|Physician Decision|0|||
27701128|NCT00576836|80745295|FG001|Overall Study|Physician Decision|1|||
27701129|NCT01674712|80745298|FG000|Overall Study|Adverse Event|5|||
27701130|NCT01674712|80745299|FG001|Overall Study|Adverse Event|6|||
27701131|NCT01674712|80745300|FG002|Overall Study|Adverse Event|3|||
27701132|NCT01674712|80745301|FG003|Overall Study|Adverse Event|4|||
27701133|NCT01674712|80745302|FG004|Overall Study|Adverse Event|6|||
27701134|NCT01674712|80745298|FG000|Overall Study|Lost to Follow-up|1|||
27701135|NCT01674712|80745299|FG001|Overall Study|Lost to Follow-up|0|||
27701136|NCT01674712|80745300|FG002|Overall Study|Lost to Follow-up|0|||
27701137|NCT01674712|80745301|FG003|Overall Study|Lost to Follow-up|0|||
27701138|NCT01674712|80745302|FG004|Overall Study|Lost to Follow-up|0|||
27701139|NCT01674712|80745298|FG000|Overall Study|Protocol Violation|2|||
27701140|NCT01674712|80745299|FG001|Overall Study|Protocol Violation|0|||
27701141|NCT01674712|80745300|FG002|Overall Study|Protocol Violation|0|||
27701142|NCT01674712|80745301|FG003|Overall Study|Protocol Violation|0|||
27701143|NCT01674712|80745302|FG004|Overall Study|Protocol Violation|0|||
27701144|NCT01674712|80745298|FG000|Overall Study|Withdrawal by Subject|2|||
27701145|NCT01674712|80745299|FG001|Overall Study|Withdrawal by Subject|2|||
27701146|NCT01674712|80745300|FG002|Overall Study|Withdrawal by Subject|5|||
27701147|NCT01674712|80745301|FG003|Overall Study|Withdrawal by Subject|4|||
27701148|NCT01674712|80745302|FG004|Overall Study|Withdrawal by Subject|3|||
27701149|NCT01674712|80745298|FG000|Overall Study|Administrative|0|||
27701150|NCT01674712|80745299|FG001|Overall Study|Administrative|1|||
27701151|NCT01674712|80745300|FG002|Overall Study|Administrative|0|||
27701152|NCT01674712|80745301|FG003|Overall Study|Administrative|0|||
27701153|NCT01674712|80745302|FG004|Overall Study|Administrative|1|||
27701154|NCT01674712|80745298|FG000|Overall Study|Lack of Efficacy|0|||
27701155|NCT01674712|80745299|FG001|Overall Study|Lack of Efficacy|0|||
27701156|NCT01674712|80745300|FG002|Overall Study|Lack of Efficacy|1|||
27701157|NCT01674712|80745301|FG003|Overall Study|Lack of Efficacy|0|||
27701158|NCT01674712|80745302|FG004|Overall Study|Lack of Efficacy|1|||
27701159|NCT02119325|80745304|FG000|Washout Period 1|Adverse Event|0|||
27701160|NCT02119325|80745305|FG001|Washout Period 1|Adverse Event|1|||
27701161|NCT00931944|80745309|FG000|Overall Study|Adverse Event|4|||
27701162|NCT00931944|80745309|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
27701163|NCT00931944|80745309|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
27701164|NCT00931944|80745309|FG000|Overall Study|Death|28|||
27701165|NCT00931944|80745309|FG000|Overall Study|Other|2|||
27701166|NCT02383589|80745315|FG000|Treatment Period|Adverse Event|1|||
27701167|NCT02383589|80745316|FG001|Treatment Period|Adverse Event|3|||
27701168|NCT02383589|80745315|FG000|Treatment Period|Lost to Follow-up|0|||
27701169|NCT02383589|80745316|FG001|Treatment Period|Lost to Follow-up|1|||
27701170|NCT02383589|80745315|FG000|Treatment Period|Withdrawal by Subject|0|||
27701171|NCT02383589|80745316|FG001|Treatment Period|Withdrawal by Subject|5|||
27701172|NCT02383589|80745315|FG000|Treatment Period|Non-compliance with study drug|0|||
27701173|NCT02383589|80745316|FG001|Treatment Period|Non-compliance with study drug|1|||
27701174|NCT02383589|80745315|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
27701175|NCT02383589|80745316|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
27701176|NCT02383589|80745315|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
27701177|NCT02383589|80745316|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
27701178|NCT02383589|80745315|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
27701179|NCT02383589|80745316|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
27701180|NCT01386658|80745317|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
27701181|NCT01386658|80745318|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
27701182|NCT01386658|80745317|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
27701183|NCT01386658|80745318|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
27701184|NCT01176968|80745319|FG000|Overall Study|Adverse Event|10|||
27701185|NCT01176968|80745320|FG001|Overall Study|Adverse Event|11|||
27701186|NCT01176968|80745319|FG000|Overall Study|Death|2|||
27701187|NCT01176968|80745320|FG001|Overall Study|Death|3|||
27701188|NCT01176968|80745319|FG000|Overall Study|Lack of Efficacy|0|||
27701189|NCT01176968|80745320|FG001|Overall Study|Lack of Efficacy|1|||
27701190|NCT01176968|80745319|FG000|Overall Study|Lost to Follow-up|16|||
27701191|NCT01176968|80745320|FG001|Overall Study|Lost to Follow-up|14|||
27701192|NCT01176968|80745319|FG000|Overall Study|Withdrawal by Subject|48|||
27701193|NCT01176968|80745320|FG001|Overall Study|Withdrawal by Subject|48|||
27701194|NCT01176968|80745319|FG000|Overall Study|Protocol Violation|2|||
27701195|NCT01176968|80745320|FG001|Overall Study|Protocol Violation|1|||
27701196|NCT01176968|80745319|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27701197|NCT01176968|80745320|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
27701198|NCT01176968|80745319|FG000|Overall Study|Study terminated by sponsor|0|||
27701199|NCT01176968|80745320|FG001|Overall Study|Study terminated by sponsor|1|||
27701200|NCT01176968|80745319|FG000|Overall Study|Reason not defined|5|||
27701201|NCT01176968|80745320|FG001|Overall Study|Reason not defined|3|||
27701202|NCT01326728|80745325|FG000|Overall Study|Death|13|||
27701203|NCT01326728|80745326|FG001|Overall Study|Death|0|||
27701204|NCT01326728|80745325|FG000|Overall Study|Early closure of study|34|||
27701205|NCT01326728|80745326|FG001|Overall Study|Early closure of study|9|||
27594534|NCT02349295|80356092|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594535|NCT02349295|80356093|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594536|NCT02349295|80356094|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594537|NCT02349295|80356095|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594538|NCT02349295|80356096|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594539|NCT02349295|80356097|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
27594540|NCT02349295|80356084|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
27594541|NCT02349295|80356085|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
27594542|NCT02349295|80356086|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
27594543|NCT02349295|80356087|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
27594544|NCT02349295|80356088|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
27594545|NCT02349295|80356089|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
27594546|NCT02349295|80356090|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
27594547|NCT02349295|80356091|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
27594548|NCT02349295|80356092|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
27594549|NCT02349295|80356093|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
27594550|NCT02349295|80356094|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
27594551|NCT02349295|80356095|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
27594552|NCT02349295|80356096|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
27594553|NCT02349295|80356097|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
27594554|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594555|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594556|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594557|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594558|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594559|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594560|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594561|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
27594562|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
27594563|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
27594564|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
27594565|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594566|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594567|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
27594568|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594569|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594570|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594571|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594572|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594573|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594574|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594575|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
27594576|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
27594577|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
27594578|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
27594579|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594580|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594581|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
27594582|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594583|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594584|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594585|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594586|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594587|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594588|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594589|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
27594590|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27701206|NCT00146328|80745327|FG000|Overall Study|Adverse Event|39|||
27701207|NCT00146328|80745328|FG001|Overall Study|Adverse Event|48|||
27701208|NCT00146328|80745329|FG002|Overall Study|Adverse Event|79|||
27701209|NCT00146328|80745327|FG000|Overall Study|Protocol Violation|11|||
27701210|NCT00146328|80745328|FG001|Overall Study|Protocol Violation|6|||
27701211|NCT00146328|80745329|FG002|Overall Study|Protocol Violation|12|||
27833158|NCT04281472|81219493|FG000|Stage B|Lack of Efficacy|0|||
27833159|NCT04281472|81219494|FG001|Stage B|Lack of Efficacy|0|||
27833160|NCT04281472|81219495|FG002|Stage B|Lack of Efficacy|1|||
27701212|NCT00146328|80745327|FG000|Overall Study|Lost to Follow-up|7|||
27701213|NCT00146328|80745328|FG001|Overall Study|Lost to Follow-up|4|||
27701214|NCT00146328|80745329|FG002|Overall Study|Lost to Follow-up|7|||
27701215|NCT00146328|80745327|FG000|Overall Study|Withdrawal by Subject|16|||
27701216|NCT00146328|80745328|FG001|Overall Study|Withdrawal by Subject|16|||
27701217|NCT00146328|80745329|FG002|Overall Study|Withdrawal by Subject|22|||
27701218|NCT00146328|80745327|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
27701219|NCT00146328|80745328|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
27701220|NCT00146328|80745329|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
27701221|NCT00146328|80745327|FG000|Overall Study|Trial ended/site closed|8|||
27701222|NCT00146328|80745328|FG001|Overall Study|Trial ended/site closed|2|||
27701223|NCT00146328|80745329|FG002|Overall Study|Trial ended/site closed|19|||
27701224|NCT00146328|80745327|FG000|Overall Study|Patient decision to end|0|||
27701225|NCT00146328|80745328|FG001|Overall Study|Patient decision to end|1|||
27701226|NCT00146328|80745329|FG002|Overall Study|Patient decision to end|6|||
27701227|NCT00146328|80745327|FG000|Overall Study|Enroll into other trial|2|||
27701228|NCT00146328|80745328|FG001|Overall Study|Enroll into other trial|4|||
27701229|NCT00146328|80745329|FG002|Overall Study|Enroll into other trial|2|||
27701230|NCT00146328|80745327|FG000|Overall Study|Death|0|||
27701231|NCT00146328|80745328|FG001|Overall Study|Death|1|||
27701232|NCT00146328|80745329|FG002|Overall Study|Death|1|||
27701233|NCT00146328|80745327|FG000|Overall Study|Moved|2|||
27701234|NCT00146328|80745328|FG001|Overall Study|Moved|0|||
27701235|NCT00146328|80745329|FG002|Overall Study|Moved|0|||
27833161|NCT04281472|81219493|FG000|Stage B|Lost to Follow-up|0|||
27833162|NCT04281472|81219494|FG001|Stage B|Lost to Follow-up|0|||
27833163|NCT04281472|81219495|FG002|Stage B|Lost to Follow-up|2|||
27833164|NCT04281472|81219493|FG000|Stage B|Prohibited medications|0|||
27833165|NCT04281472|81219494|FG001|Stage B|Prohibited medications|2|||
27833166|NCT04281472|81219495|FG002|Stage B|Prohibited medications|1|||
27833167|NCT04281472|81219493|FG000|Stage B|Protocol Violation|0|||
27833168|NCT04281472|81219494|FG001|Stage B|Protocol Violation|1|||
27833169|NCT04281472|81219495|FG002|Stage B|Protocol Violation|1|||
27833170|NCT04281472|81219493|FG000|Stage B|Sponsor decision|0|||
27833171|NCT04281472|81219494|FG001|Stage B|Sponsor decision|0|||
27833172|NCT04281472|81219495|FG002|Stage B|Sponsor decision|1|||
27833173|NCT04281472|81219493|FG000|Stage B|Withdrawal by Subject|0|||
27833174|NCT04281472|81219494|FG001|Stage B|Withdrawal by Subject|3|||
27833175|NCT04281472|81219495|FG002|Stage B|Withdrawal by Subject|3|||
27833176|NCT04281472|81219493|FG000|Stage B|Other|0|||
27833177|NCT04281472|81219494|FG001|Stage B|Other|3|||
27833178|NCT04281472|81219495|FG002|Stage B|Other|0|||
27833179|NCT03807440|81219496|FG000|Overall Study|No documentation of index date 2|320|||
27833180|NCT03807440|81219496|FG000|Overall Study|No informed consent for index date 2|117|||
27833181|NCT00387153|81219497|FG000|Overall Study|Adverse Event|1|||
27833182|NCT00387153|81219497|FG000|Overall Study|Disease Progression|3|||
27833183|NCT00387153|81219497|FG000|Overall Study|Lack of Response|4|||
27833184|NCT01859598|81219509|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
27833185|NCT04590027|81219510|FG000|Overall Study|Lost to Follow-up|17|||
27833186|NCT04590027|81219511|FG001|Overall Study|Lost to Follow-up|14|||
27833187|NCT04590027|81219510|FG000|Overall Study|Protocol Violation|0|||
27886665|NCT01938430|81418148|FG012|Overall Study|Death|0|||
27701236|NCT00146328|80745327|FG000|Overall Study|Interaction with other medication|2|||
27701237|NCT00146328|80745328|FG001|Overall Study|Interaction with other medication|0|||
27833188|NCT04590027|81219511|FG001|Overall Study|Protocol Violation|3|||
27833189|NCT03067987|81219512|FG000|Overall Study|Lost to Follow-up|7|||
27833190|NCT03067987|81219513|FG001|Overall Study|Lost to Follow-up|10|||
27833191|NCT03067987|81219512|FG000|Overall Study|Protocol Violation|1|||
27833192|NCT03067987|81219513|FG001|Overall Study|Protocol Violation|2|||
27833193|NCT03067987|81219512|FG000|Overall Study|Withdrawal by Subject|2|||
27833194|NCT03067987|81219513|FG001|Overall Study|Withdrawal by Subject|1|||
27833195|NCT00847535|81219514|FG000|Overall Study|Withdrawal by Subject|2|||
27833196|NCT00847535|81219515|FG001|Overall Study|Withdrawal by Subject|1|||
27833197|NCT00847535|81219516|FG002|Overall Study|Withdrawal by Subject|1|||
27886666|NCT01938430|81418149|FG013|Overall Study|Death|0|||
27833198|NCT00847535|81219514|FG000|Overall Study|Lost to Follow-up|0|||
27594591|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
27594592|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594593|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594594|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594595|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
27594596|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
27594597|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
27594598|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
27594599|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
27594600|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
27594601|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
27594602|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
27594603|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
27594604|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
27594605|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
27594606|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
27594607|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
27594608|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
27594609|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
27594610|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594611|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594612|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594613|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594614|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594615|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594616|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594617|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
27594618|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
27594619|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
27594620|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
27594621|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594622|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594623|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
27594624|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594625|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594626|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594627|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594628|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594629|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594630|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594631|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
27594632|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
27594633|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594634|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594635|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594636|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594637|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
27594638|NCT02349295|80356084|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594639|NCT02349295|80356085|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594640|NCT02349295|80356086|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594641|NCT02349295|80356087|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594642|NCT02349295|80356088|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594643|NCT02349295|80356089|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594644|NCT02349295|80356090|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594645|NCT02349295|80356091|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
27594646|NCT02349295|80356092|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
27594647|NCT02349295|80356093|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594648|NCT02349295|80356094|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594649|NCT02349295|80356095|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594650|NCT02349295|80356096|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594651|NCT02349295|80356097|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
27594652|NCT02349295|80356084|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27833199|NCT00847535|81219515|FG001|Overall Study|Lost to Follow-up|1|||
27833200|NCT00847535|81219516|FG002|Overall Study|Lost to Follow-up|0|||
27701238|NCT00146328|80745329|FG002|Overall Study|Interaction with other medication|1|||
27701239|NCT02289352|80745330|FG000|Overall Study|Withdrawal by Subject|1|||
27701240|NCT02289352|80745331|FG001|Overall Study|Withdrawal by Subject|1|||
27701241|NCT02289352|80745332|FG002|Overall Study|Withdrawal by Subject|0|||
27701242|NCT00932425|80745337|FG000|Overall Study|Lost to Follow-up|0|||
27701243|NCT00932425|80745338|FG001|Overall Study|Lost to Follow-up|1|||
27701244|NCT00932425|80745337|FG000|Overall Study|Withdrawal by Subject|0|||
27701245|NCT00932425|80745338|FG001|Overall Study|Withdrawal by Subject|1|||
27701246|NCT01970488|80745339|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
27701247|NCT01970488|80745340|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
27701248|NCT01970488|80745341|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
27701249|NCT01970488|80745342|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
27701250|NCT01970488|80745343|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
27701251|NCT01970488|80745339|FG000|Part 1: Through Week 16|Protocol Violation|1|||
27701252|NCT01970488|80745340|FG001|Part 1: Through Week 16|Protocol Violation|2|||
27701253|NCT01970488|80745341|FG002|Part 1: Through Week 16|Protocol Violation|0|||
27701254|NCT01970488|80745342|FG003|Part 1: Through Week 16|Protocol Violation|0|||
27701255|NCT01970488|80745343|FG004|Part 1: Through Week 16|Protocol Violation|0|||
27701256|NCT01970488|80745339|FG000|Part 1: Through Week 16|Adverse Event|6|||
27701257|NCT01970488|80745340|FG001|Part 1: Through Week 16|Adverse Event|5|||
27701258|NCT01970488|80745341|FG002|Part 1: Through Week 16|Adverse Event|0|||
27701259|NCT01970488|80745342|FG003|Part 1: Through Week 16|Adverse Event|0|||
27701260|NCT01970488|80745343|FG004|Part 1: Through Week 16|Adverse Event|0|||
27701261|NCT01970488|80745339|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
27701262|NCT01970488|80745340|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
27701263|NCT01970488|80745341|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
27701264|NCT01970488|80745342|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
27701265|NCT01970488|80745343|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
27701266|NCT01970488|80745339|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
27701267|NCT01970488|80745340|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
27701268|NCT01970488|80745341|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
27701269|NCT01970488|80745342|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
27701270|NCT01970488|80745343|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
27701271|NCT01970488|80745339|FG000|Part 2: Post Week 16|Physician Decision|0|||
27701272|NCT01970488|80745340|FG001|Part 2: Post Week 16|Physician Decision|0|||
27701273|NCT01970488|80745341|FG002|Part 2: Post Week 16|Physician Decision|0|||
27701274|NCT01970488|80745342|FG003|Part 2: Post Week 16|Physician Decision|0|||
27701275|NCT01970488|80745343|FG004|Part 2: Post Week 16|Physician Decision|1|||
27701276|NCT01970488|80745339|FG000|Part 2: Post Week 16|Non-compliance|0|||
27701277|NCT01970488|80745340|FG001|Part 2: Post Week 16|Non-compliance|0|||
27701278|NCT01970488|80745341|FG002|Part 2: Post Week 16|Non-compliance|1|||
27701279|NCT01970488|80745342|FG003|Part 2: Post Week 16|Non-compliance|0|||
27701280|NCT01970488|80745343|FG004|Part 2: Post Week 16|Non-compliance|0|||
27701281|NCT01970488|80745339|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
27701282|NCT01970488|80745340|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
27701283|NCT01970488|80745341|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
27701284|NCT01970488|80745342|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
27701285|NCT01970488|80745343|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
27701286|NCT01970488|80745339|FG000|Part 2: Post Week 16|Adverse Event|0|||
27701287|NCT01970488|80745340|FG001|Part 2: Post Week 16|Adverse Event|0|||
27701288|NCT01970488|80745341|FG002|Part 2: Post Week 16|Adverse Event|5|||
27701289|NCT01970488|80745342|FG003|Part 2: Post Week 16|Adverse Event|1|||
27701290|NCT01970488|80745343|FG004|Part 2: Post Week 16|Adverse Event|1|||
27833201|NCT02637141|81219517|FG000|Overall Study|Adverse Event|1|||
27833202|NCT02637141|81219518|FG001|Overall Study|Adverse Event|1|||
27833203|NCT02637141|81219519|FG002|Overall Study|Adverse Event|0|||
27701291|NCT01970488|80745339|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
27701292|NCT01970488|80745340|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
27701293|NCT01970488|80745341|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
27701294|NCT01970488|80745342|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
27701295|NCT01970488|80745343|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
27833204|NCT02637141|81219517|FG000|Overall Study|Withdrawal by Subject|1|||
27833205|NCT02637141|81219518|FG001|Overall Study|Withdrawal by Subject|1|||
27833206|NCT02637141|81219519|FG002|Overall Study|Withdrawal by Subject|1|||
27701296|NCT01970488|80745339|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
27701297|NCT01970488|80745340|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
27701298|NCT01970488|80745341|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
27701299|NCT01970488|80745342|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
27701300|NCT01970488|80745343|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
27701301|NCT04439071|80745346|FG000|Overall Study|Lost to Follow-up|0|||
27701302|NCT04439071|80745347|FG001|Overall Study|Lost to Follow-up|3|||
27701303|NCT04439071|80745346|FG000|Overall Study|Withdrawal by Subject|3|||
27701304|NCT04439071|80745347|FG001|Overall Study|Withdrawal by Subject|8|||
27701305|NCT04439071|80745346|FG000|Overall Study|Death|6|||
27701306|NCT04439071|80745347|FG001|Overall Study|Death|4|||
27701307|NCT04439071|80745346|FG000|Overall Study|Other than specified|3|||
27701308|NCT04439071|80745347|FG001|Overall Study|Other than specified|3|||
27701309|NCT04439071|80745346|FG000|Overall Study|Randomized but not treated|2|||
27701310|NCT04439071|80745347|FG001|Overall Study|Randomized but not treated|0|||
27701311|NCT02608879|80745350|FG000|Overall Study|Lost to Follow-up|1|||
27701312|NCT02608879|80745351|FG001|Overall Study|Lost to Follow-up|0|||
27701313|NCT02608879|80745352|FG002|Overall Study|Lost to Follow-up|0|||
27701314|NCT02608879|80745350|FG000|Overall Study|Did not meet continuation criteria|0|||
27701315|NCT02608879|80745351|FG001|Overall Study|Did not meet continuation criteria|0|||
27701316|NCT02608879|80745352|FG002|Overall Study|Did not meet continuation criteria|3|||
27701317|NCT01557348|80745353|FG000|Overall Study|Adverse Event|6|||
27701318|NCT01557348|80745354|FG001|Overall Study|Adverse Event|16|||
27701319|NCT01557348|80745353|FG000|Overall Study|Infusion reaction event|5|||
27701320|NCT01557348|80745354|FG001|Overall Study|Infusion reaction event|5|||
27701321|NCT01557348|80745353|FG000|Overall Study|Death|7|||
27701322|NCT01557348|80745354|FG001|Overall Study|Death|4|||
27701323|NCT01557348|80745353|FG000|Overall Study|Insufficient Therapeutic Response|13|||
27833207|NCT01266902|81219521|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
27833208|NCT01266902|81219522|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
27833209|NCT01266902|81219523|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
27833210|NCT01266902|81219521|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
27833211|NCT01266902|81219522|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
27833212|NCT01266902|81219523|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
27833213|NCT01266902|81219521|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
27833214|NCT01266902|81219522|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
27833215|NCT01266902|81219523|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
27833216|NCT01266902|81219521|FG000|Period 1 (Main Study)|Adverse Event|3|||
27833217|NCT01266902|81219522|FG001|Period 1 (Main Study)|Adverse Event|11|||
27833218|NCT01266902|81219523|FG002|Period 1 (Main Study)|Adverse Event|0|||
27833219|NCT01266902|81219521|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
27833220|NCT01266902|81219522|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
27833221|NCT01266902|81219523|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
27833222|NCT01266902|81219521|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
27833223|NCT01266902|81219522|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
27833224|NCT01266902|81219523|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
27833225|NCT01266902|81219521|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
27833226|NCT01266902|81219522|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
27833227|NCT01266902|81219523|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
27833228|NCT01266902|81219521|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
27833229|NCT01266902|81219522|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
27833230|NCT01266902|81219523|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
27833231|NCT01266902|81219521|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
27833232|NCT01266902|81219522|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
27833233|NCT01266902|81219523|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
27833234|NCT01266902|81219521|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
27833235|NCT01266902|81219522|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
27833236|NCT01266902|81219523|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
27833237|NCT00796562|81219524|FG000|Overall Study|Death|49|||
27833238|NCT03867760|81219528|FG000|Overall Study|Lost to Follow-up|2|||
27833239|NCT03867760|81219529|FG001|Overall Study|Lost to Follow-up|3|||
27833240|NCT03867760|81219528|FG000|Overall Study|Withdrawal by Subject|1|||
27833241|NCT03867760|81219529|FG001|Overall Study|Withdrawal by Subject|2|||
27833242|NCT03867760|81219528|FG000|Overall Study|subject could not meet study logistics|3|||
27833243|NCT03867760|81219529|FG001|Overall Study|subject could not meet study logistics|3|||
27833244|NCT03497130|81219533|FG000|Overall Study|Lost to Follow-up|1|||
27701324|NCT01557348|80745354|FG001|Overall Study|Insufficient Therapeutic Response|28|||
27701325|NCT01557348|80745353|FG000|Overall Study|Withdrawal by Subject|5|||
27701326|NCT01557348|80745354|FG001|Overall Study|Withdrawal by Subject|4|||
27833245|NCT03497130|81219534|FG001|Overall Study|Lost to Follow-up|1|||
27701327|NCT01557348|80745353|FG000|Overall Study|Lost to Follow-up|26|||
27886667|NCT01938430|81418136|FG000|Overall Study|Investigator's Discretion|0|||
27886668|NCT01938430|81418137|FG001|Overall Study|Investigator's Discretion|0|||
27886669|NCT01938430|81418138|FG002|Overall Study|Investigator's Discretion|1|||
27886670|NCT01938430|81418139|FG003|Overall Study|Investigator's Discretion|0|||
27886671|NCT01938430|81418140|FG004|Overall Study|Investigator's Discretion|0|||
27886672|NCT01938430|81418141|FG005|Overall Study|Investigator's Discretion|0|||
27886673|NCT01938430|81418142|FG006|Overall Study|Investigator's Discretion|0|||
27886674|NCT01938430|81418143|FG007|Overall Study|Investigator's Discretion|0|||
27886675|NCT01938430|81418144|FG008|Overall Study|Investigator's Discretion|0|||
27886676|NCT01938430|81418145|FG009|Overall Study|Investigator's Discretion|0|||
27701328|NCT01557348|80745354|FG001|Overall Study|Lost to Follow-up|22|||
27701329|NCT01557348|80745353|FG000|Overall Study|Administrative|18|||
27701330|NCT01557348|80745354|FG001|Overall Study|Administrative|11|||
27701331|NCT00504153|80745355|FG000|Overall Study|Withdrawal by Subject|1|||
27701332|NCT00504153|80745355|FG000|Overall Study|Adverse Event|4|||
27701333|NCT00504153|80745355|FG000|Overall Study|Death|1|||
27701334|NCT00995007|80745357|FG000|Overall Study|Withdrew consent|1|||
27886677|NCT01938430|81418146|FG010|Overall Study|Investigator's Discretion|0|||
27886678|NCT01938430|81418147|FG011|Overall Study|Investigator's Discretion|0|||
27886679|NCT01938430|81418148|FG012|Overall Study|Investigator's Discretion|0|||
27886680|NCT01938430|81418149|FG013|Overall Study|Investigator's Discretion|0|||
27886681|NCT01938430|81418136|FG000|Overall Study|Lack of Efficacy|3|||
27886682|NCT01938430|81418137|FG001|Overall Study|Lack of Efficacy|1|||
27594653|NCT02349295|80356085|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594654|NCT02349295|80356086|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594655|NCT02349295|80356087|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594656|NCT02349295|80356088|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594657|NCT02349295|80356089|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594658|NCT02349295|80356090|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594659|NCT02349295|80356091|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594660|NCT02349295|80356092|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594661|NCT02349295|80356093|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594662|NCT02349295|80356094|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
27594663|NCT02349295|80356095|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
27594664|NCT02349295|80356096|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
27594665|NCT02349295|80356097|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
27594666|NCT02349295|80356084|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594667|NCT02349295|80356085|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594668|NCT02349295|80356086|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594669|NCT02349295|80356087|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594670|NCT02349295|80356088|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594671|NCT02349295|80356089|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594672|NCT02349295|80356090|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594673|NCT02349295|80356091|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594674|NCT02349295|80356092|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594675|NCT02349295|80356093|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594676|NCT02349295|80356094|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594677|NCT02349295|80356095|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
27594678|NCT02349295|80356096|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
27594679|NCT02349295|80356097|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
27594680|NCT02349295|80356084|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594681|NCT02349295|80356085|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594682|NCT02349295|80356086|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594683|NCT02349295|80356087|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594684|NCT02349295|80356088|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594685|NCT02349295|80356089|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594686|NCT02349295|80356090|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594687|NCT02349295|80356091|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594688|NCT02349295|80356092|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594689|NCT02349295|80356093|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594690|NCT02349295|80356094|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594691|NCT02349295|80356095|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
27594692|NCT02349295|80356096|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
27594693|NCT02349295|80356097|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
27594694|NCT02349295|80356084|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594695|NCT02349295|80356085|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594696|NCT02349295|80356086|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594697|NCT02349295|80356087|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594698|NCT02349295|80356088|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594699|NCT02349295|80356089|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594700|NCT02349295|80356090|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594701|NCT02349295|80356091|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594702|NCT02349295|80356092|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594703|NCT02349295|80356093|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594704|NCT02349295|80356094|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594705|NCT02349295|80356095|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
27594706|NCT02349295|80356096|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594707|NCT02349295|80356097|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
27594708|NCT02349295|80356084|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594709|NCT02349295|80356085|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594710|NCT02349295|80356086|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27833246|NCT02462837|81219535|FG000|Overall Study|pt developed hives|1|||
27833247|NCT02462837|81219536|FG001|Overall Study|pt developed hives|0|||
27833248|NCT02462837|81219535|FG000|Overall Study|Withdrawal by Subject|1|||
27833249|NCT02462837|81219536|FG001|Overall Study|Withdrawal by Subject|0|||
27833250|NCT00874276|81219537|FG000|Overall Study|Withdrawal by Subject|1|||
27594711|NCT02349295|80356087|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594712|NCT02349295|80356088|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594713|NCT02349295|80356089|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594714|NCT02349295|80356090|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594715|NCT02349295|80356091|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594716|NCT02349295|80356092|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594717|NCT02349295|80356093|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594718|NCT02349295|80356094|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594719|NCT02349295|80356095|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
27594720|NCT02349295|80356096|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594721|NCT02349295|80356097|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
27594722|NCT01864564|80356100|FG000|Overall Study|Lost to Follow-up|17|||
27594723|NCT01864564|80356101|FG001|Overall Study|Lost to Follow-up|23|||
27594724|NCT01864564|80356100|FG000|Overall Study|Withdrawal by Subject|20|||
27594725|NCT01864564|80356101|FG001|Overall Study|Withdrawal by Subject|11|||
27594726|NCT01864564|80356100|FG000|Overall Study|Protocol Violation|0|||
27594727|NCT01864564|80356101|FG001|Overall Study|Protocol Violation|27|||
27594728|NCT01864564|80356100|FG000|Overall Study|not reported|0|||
27594729|NCT01864564|80356101|FG001|Overall Study|not reported|34|||
27594730|NCT03031938|80356102|FG000|Overall Study|Death|1|||
27594731|NCT03031938|80356103|FG001|Overall Study|Death|0|||
27594732|NCT04866017|80356112|FG000|Overall Study|Study Terminated by Sponsor|13|||
27594733|NCT04866017|80356113|FG001|Overall Study|Study Terminated by Sponsor|14|||
27594734|NCT04866017|80356114|FG002|Overall Study|Study Terminated by Sponsor|13|||
27594735|NCT04866017|80356112|FG000|Overall Study|Death|8|||
27594736|NCT04866017|80356113|FG001|Overall Study|Death|4|||
27594737|NCT04866017|80356114|FG002|Overall Study|Death|8|||
27594738|NCT04866017|80356112|FG000|Overall Study|Withdrawal by Subject|1|||
27594739|NCT04866017|80356113|FG001|Overall Study|Withdrawal by Subject|0|||
27594740|NCT04866017|80356114|FG002|Overall Study|Withdrawal by Subject|1|||
27594741|NCT04866017|80356112|FG000|Overall Study|Physician Decision|0|||
27594742|NCT04866017|80356113|FG001|Overall Study|Physician Decision|1|||
27594743|NCT04866017|80356114|FG002|Overall Study|Physician Decision|0|||
27594744|NCT03265600|80356116|FG000|Overall Study|Lost to Follow-up|17|||
27594745|NCT03265600|80356117|FG001|Overall Study|Lost to Follow-up|5|||
27594746|NCT03265600|80356116|FG000|Overall Study|Withdrawal by Subject|4|||
27594747|NCT03265600|80356117|FG001|Overall Study|Withdrawal by Subject|2|||
27594748|NCT03265600|80356116|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
27594749|NCT03265600|80356117|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
27594750|NCT02693743|80356118|FG000|Overall Study|Physician Decision|1|||
27594751|NCT02693743|80356119|FG001|Overall Study|Physician Decision|0|||
27594752|NCT00937924|80356120|FG000|Overall Study|Lost to Follow-up|44|||
27594753|NCT00937924|80356121|FG001|Overall Study|Lost to Follow-up|44|||
27594754|NCT00937924|80356122|FG002|Overall Study|Lost to Follow-up|41|||
27594755|NCT00713648|80356123|FG000|Overall Study|Adverse Event|1|||
27594756|NCT00713648|80356123|FG000|Overall Study|Unclassified|2|||
27594757|NCT00713648|80356123|FG000|Overall Study|According to Protocol|2|||
27594758|NCT00713648|80356123|FG000|Overall Study|Development of antibodies|3|||
27594759|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
27594760|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
27594761|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|disease progression|58|||
27594762|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|disease progression|47|||
27594763|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|Death|3|||
27594764|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|Death|6|||
27594765|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
27594766|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
27594767|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
27594768|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
27594769|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
27594770|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
27594771|NCT02472964|80356127|FG000|Part 1 (up to Week 24)|Other|2|||
27594772|NCT02472964|80356128|FG001|Part 1 (up to Week 24)|Other|1|||
27594773|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
27886683|NCT01938430|81418138|FG002|Overall Study|Lack of Efficacy|1|||
27594774|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
27594775|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
27594776|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
27594777|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Death|0|||
27594778|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Death|1|||
27594779|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
27594780|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
27594781|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
27594782|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
27594783|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
27701335|NCT00995007|80745358|FG001|Overall Study|Withdrew consent|0|||
27594784|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
27594785|NCT02472964|80356127|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
27594786|NCT02472964|80356128|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
27594787|NCT02063828|80356129|FG000|Overall Study|Withdrawal by Subject|4|||
27594788|NCT02063828|80356130|FG001|Overall Study|Withdrawal by Subject|6|||
27594789|NCT02063828|80356131|FG002|Overall Study|Withdrawal by Subject|3|||
27594790|NCT02063828|80356129|FG000|Overall Study|Death|0|||
27594791|NCT02063828|80356130|FG001|Overall Study|Death|0|||
27594792|NCT02063828|80356131|FG002|Overall Study|Death|1|||
27594793|NCT00617344|80356132|FG000|Overall Study|Serious adverse event|1|||
27594794|NCT00617344|80356133|FG001|Overall Study|Serious adverse event|0|||
27594795|NCT00617344|80356134|FG002|Overall Study|Serious adverse event|0|||
27594796|NCT00617344|80356132|FG000|Overall Study|Other Adverse Event|1|||
27594797|NCT00617344|80356133|FG001|Overall Study|Other Adverse Event|1|||
27594798|NCT00617344|80356134|FG002|Overall Study|Other Adverse Event|0|||
27594799|NCT00617344|80356132|FG000|Overall Study|Protocol Violation|10|||
27594800|NCT00617344|80356133|FG001|Overall Study|Protocol Violation|8|||
27594801|NCT00617344|80356134|FG002|Overall Study|Protocol Violation|5|||
27594802|NCT00617344|80356132|FG000|Overall Study|Lost to Follow-up|5|||
27594803|NCT00617344|80356133|FG001|Overall Study|Lost to Follow-up|4|||
27594804|NCT00617344|80356134|FG002|Overall Study|Lost to Follow-up|1|||
27594805|NCT00617344|80356132|FG000|Overall Study|Withdrawal by Subject|8|||
27594806|NCT00617344|80356133|FG001|Overall Study|Withdrawal by Subject|9|||
27594807|NCT00617344|80356134|FG002|Overall Study|Withdrawal by Subject|2|||
27594808|NCT03969719|80356135|FG000|Overall Study|Other reasons not specified|1|||
27594809|NCT03969719|80356136|FG001|Overall Study|Other reasons not specified|1|||
27594810|NCT03969719|80356137|FG002|Overall Study|Other reasons not specified|3|||
27594811|NCT03969719|80356135|FG000|Overall Study|Withdrawal by Subject|2|||
27594812|NCT03969719|80356136|FG001|Overall Study|Withdrawal by Subject|3|||
27594813|NCT03969719|80356137|FG002|Overall Study|Withdrawal by Subject|2|||
27594814|NCT03969719|80356135|FG000|Overall Study|Protocol Violation|1|||
27594815|NCT03969719|80356136|FG001|Overall Study|Protocol Violation|2|||
27594816|NCT03969719|80356137|FG002|Overall Study|Protocol Violation|0|||
27594817|NCT03969719|80356135|FG000|Overall Study|Adverse Event|0|||
27594818|NCT03969719|80356136|FG001|Overall Study|Adverse Event|2|||
27594819|NCT03969719|80356137|FG002|Overall Study|Adverse Event|0|||
27594820|NCT03969719|80356135|FG000|Overall Study|Lost to Follow-up|0|||
27594821|NCT03969719|80356136|FG001|Overall Study|Lost to Follow-up|1|||
27594822|NCT03969719|80356137|FG002|Overall Study|Lost to Follow-up|0|||
27594823|NCT01140880|80356138|FG000|Overall Study|Death|0|||
27594824|NCT01140880|80356139|FG001|Overall Study|Death|1|||
27594825|NCT01140880|80356138|FG000|Overall Study|Withdrawal by Subject|6|||
27594826|NCT01140880|80356139|FG001|Overall Study|Withdrawal by Subject|3|||
27594827|NCT01140880|80356138|FG000|Overall Study|Lost to Follow-up|8|||
27594828|NCT01140880|80356139|FG001|Overall Study|Lost to Follow-up|10|||
27594829|NCT01140880|80356138|FG000|Overall Study|Protocol Violation|0|||
27594830|NCT01140880|80356139|FG001|Overall Study|Protocol Violation|30|||
27594831|NCT03657277|80356140|FG000|Overall Study|Physician Decision|2|||
27594832|NCT03657277|80356140|FG000|Overall Study|Lost to Follow-up|1|||
27594833|NCT03657277|80356140|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
27594834|NCT00695669|80356142|FG000|Overall Study|Adverse Event|0|||
27594835|NCT00695669|80356143|FG001|Overall Study|Adverse Event|0|||
27594836|NCT00695669|80356144|FG002|Overall Study|Adverse Event|2|||
27594837|NCT00695669|80356145|FG003|Overall Study|Adverse Event|0|||
27594838|NCT00695669|80356142|FG000|Overall Study|Lost to Follow-up|4|||
27594839|NCT00695669|80356143|FG001|Overall Study|Lost to Follow-up|4|||
27594840|NCT00695669|80356144|FG002|Overall Study|Lost to Follow-up|1|||
27594841|NCT00695669|80356145|FG003|Overall Study|Lost to Follow-up|4|||
27594842|NCT03325712|80356153|FG000|Overall Study|Protocol Violation|0|||
27594843|NCT03325712|80356154|FG001|Overall Study|Protocol Violation|0|||
27594844|NCT03325712|80356155|FG002|Overall Study|Protocol Violation|0|||
27594845|NCT03325712|80356156|FG003|Overall Study|Protocol Violation|0|||
27594846|NCT03325712|80356157|FG004|Overall Study|Protocol Violation|1|||
27833251|NCT00874276|81219538|FG001|Overall Study|Withdrawal by Subject|1|||
27701336|NCT00995007|80745357|FG000|Overall Study|Refused further treatment|8|||
27833252|NCT04768114|81219539|FG000|Overall Study|Lost to Follow-up|5|||
27594847|NCT03325712|80356158|FG005|Overall Study|Protocol Violation|0|||
27594848|NCT03325712|80356159|FG006|Overall Study|Protocol Violation|0|||
27594849|NCT03325712|80356160|FG007|Overall Study|Protocol Violation|0|||
27594850|NCT03325712|80356153|FG000|Overall Study|Adverse Event|0|||
27594851|NCT03325712|80356154|FG001|Overall Study|Adverse Event|0|||
27594852|NCT03325712|80356155|FG002|Overall Study|Adverse Event|0|||
27594853|NCT03325712|80356156|FG003|Overall Study|Adverse Event|0|||
27594854|NCT03325712|80356157|FG004|Overall Study|Adverse Event|1|||
27833253|NCT04768114|81219540|FG001|Overall Study|Lost to Follow-up|10|||
27833254|NCT04768114|81219539|FG000|Overall Study|Withdrawal by Subject|0|||
27833255|NCT04768114|81219540|FG001|Overall Study|Withdrawal by Subject|1|||
27833256|NCT01566435|81219541|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
27594855|NCT03325712|80356158|FG005|Overall Study|Adverse Event|0|||
27594856|NCT03325712|80356159|FG006|Overall Study|Adverse Event|0|||
27594857|NCT03325712|80356160|FG007|Overall Study|Adverse Event|0|||
27594858|NCT02372396|80356161|FG000|Overall Study|Lost to Follow-up|7|||
27594859|NCT02372396|80356162|FG001|Overall Study|Lost to Follow-up|9|||
27594860|NCT01018394|80356163|FG000|Overall Study|Withdrawal by Subject|5|||
27594861|NCT01018394|80356164|FG001|Overall Study|Withdrawal by Subject|5|||
27594862|NCT01018394|80356163|FG000|Overall Study|Lost to Follow-up|4|||
27594863|NCT01018394|80356164|FG001|Overall Study|Lost to Follow-up|3|||
27833257|NCT00438633|81219542|FG000|Overall Study|Withdrawal by Subject|1|||
27833258|NCT00438633|81219543|FG001|Overall Study|Withdrawal by Subject|0|||
27833259|NCT00438633|81219542|FG000|Overall Study|Lost to Follow-up|15|||
27833260|NCT00438633|81219543|FG001|Overall Study|Lost to Follow-up|17|||
27833261|NCT02471807|81219544|FG000|Overall Study|Death|14|||
27833262|NCT02471807|81219544|FG000|Overall Study|Withdrawal by Subject|2|||
27833263|NCT02471807|81219544|FG000|Overall Study|Explant|5|||
27833264|NCT02471807|81219544|FG000|Overall Study|Lost to Follow-up|1|||
27833265|NCT04002648|81219546|FG000|Overall Study|Lost to Follow-up|2|||
27833266|NCT04002648|81219547|FG001|Overall Study|Lost to Follow-up|0|||
27833267|NCT04411680|81219548|FG000|Treatment Period|Adverse Event|3|||
27833268|NCT04411680|81219549|FG001|Treatment Period|Adverse Event|0|||
27833269|NCT04411680|81219548|FG000|Treatment Period|Discharged from hospital|18|||
27833270|NCT04411680|81219549|FG001|Treatment Period|Discharged from hospital|7|||
27833271|NCT04411680|81219548|FG000|Treatment Period|Missed 1 or more doses|8|||
27833272|NCT04411680|81219549|FG001|Treatment Period|Missed 1 or more doses|0|||
27833273|NCT04411680|81219548|FG000|Treatment Period|Transferred to another hospital|0|||
27833274|NCT04411680|81219549|FG001|Treatment Period|Transferred to another hospital|1|||
27833275|NCT04411680|81219548|FG000|Follow up Period|Withdrawal by Subject|2|||
27833276|NCT04411680|81219549|FG001|Follow up Period|Withdrawal by Subject|0|||
27833277|NCT04411680|81219548|FG000|Follow up Period|Lost to Follow-up|5|||
27833278|NCT04411680|81219549|FG001|Follow up Period|Lost to Follow-up|6|||
27833279|NCT04411680|81219548|FG000|Follow up Period|Death|11|||
27833280|NCT04411680|81219549|FG001|Follow up Period|Death|8|||
27833281|NCT01370863|81219553|FG000|Overall Study|Adverse Event|1|||
27833282|NCT01370863|81219554|FG001|Overall Study|Adverse Event|1|||
27833283|NCT01370863|81219553|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
27833284|NCT01370863|81219554|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
27833285|NCT01370863|81219553|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27833286|NCT01370863|81219554|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27833287|NCT03415308|81219555|FG000|Overall Study|Lost to Follow-up|0|||
27833288|NCT03415308|81219556|FG001|Overall Study|Lost to Follow-up|0|||
27594864|NCT00683644|80356165|FG000|Overall Study|Withdrawal by Subject|4|||
27594865|NCT00683644|80356166|FG001|Overall Study|Withdrawal by Subject|2|||
27594866|NCT00683644|80356165|FG000|Overall Study|Lost to Follow-up|1|||
27833289|NCT03415308|81219557|FG002|Overall Study|Lost to Follow-up|1|||
27594867|NCT00683644|80356166|FG001|Overall Study|Lost to Follow-up|4|||
27594868|NCT00683644|80356165|FG000|Overall Study|Adverse Event|1|||
27594869|NCT00683644|80356166|FG001|Overall Study|Adverse Event|2|||
27594870|NCT00683644|80356165|FG000|Overall Study|Low copper, other health problems,|7|||
27594871|NCT00683644|80356166|FG001|Overall Study|Low copper, other health problems,|6|||
27594872|NCT03204279|80356170|FG000|Overall Study|Withdrawal by Subject|0|||
27594873|NCT03204279|80356171|FG001|Overall Study|Withdrawal by Subject|1|||
27594874|NCT01090453|80356172|FG000|Overall Study|Withdrawal by Subject|1|||
27594875|NCT01090453|80356173|FG001|Overall Study|Withdrawal by Subject|2|||
27594876|NCT01090453|80356172|FG000|Overall Study|Lost to Follow-up|7|||
27594877|NCT01090453|80356173|FG001|Overall Study|Lost to Follow-up|7|||
27594878|NCT01090453|80356172|FG000|Overall Study|Non serious AEs|1|||
27594879|NCT01090453|80356173|FG001|Overall Study|Non serious AEs|0|||
27594880|NCT01090453|80356172|FG000|Overall Study|Protocol Violation|2|||
27594881|NCT01090453|80356173|FG001|Overall Study|Protocol Violation|0|||
27594882|NCT01090453|80356172|FG000|Overall Study|Other|2|||
27594883|NCT01090453|80356173|FG001|Overall Study|Other|4|||
27594884|NCT01090453|80356172|FG000|Overall Study|Eligibility Criteria|0|||
27594885|NCT01090453|80356173|FG001|Overall Study|Eligibility Criteria|1|||
27594886|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
27594887|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
27594888|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
27594889|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
27594890|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
27594891|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
27594892|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
27594893|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
27594894|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
27594895|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
27594896|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
27594897|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
27594898|NCT00293267|80356178|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
27594899|NCT00293267|80356179|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
27594900|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
27594901|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
27594902|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
27594903|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
27594904|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
27594905|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
27594906|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
27594907|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
27594908|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Death|3|||
27594909|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Death|0|||
27594910|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
27594911|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
27594912|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
27594913|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
27594914|NCT00293267|80356178|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
27594915|NCT00293267|80356179|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
27594916|NCT00293267|80356178|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
27594917|NCT00293267|80356179|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
27594918|NCT00293267|80356178|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
27594919|NCT00293267|80356179|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
27594920|NCT00293267|80356178|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
27594921|NCT00293267|80356179|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
27594922|NCT00293267|80356178|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
27594923|NCT00293267|80356179|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
27594924|NCT00293267|80356178|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
27594925|NCT00293267|80356179|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
27594926|NCT00293267|80356178|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
27594927|NCT00293267|80356179|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
27594928|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
27594929|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
27594930|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
27594931|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
27594932|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
27594933|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
27594934|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
27594935|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
27594936|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
27594937|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
27594938|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
27594939|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
27594940|NCT00293267|80356178|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
27594941|NCT00293267|80356179|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
27594942|NCT03320070|80356180|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
27594943|NCT03320070|80356181|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
27594944|NCT03320070|80356180|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
27594945|NCT03320070|80356181|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
27594946|NCT03320070|80356180|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
27594947|NCT03320070|80356181|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
27594948|NCT03320070|80356180|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
27594949|NCT03320070|80356181|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
27594950|NCT03320070|80356180|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
27594951|NCT03320070|80356181|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
27594952|NCT03320070|80356180|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
27594953|NCT03320070|80356181|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
27594954|NCT00262821|80356186|FG000|Overall Study|Ineligible - wrong stage|0|||
27594955|NCT00262821|80356187|FG001|Overall Study|Ineligible - wrong stage|3|||
27594956|NCT00262821|80356186|FG000|Overall Study|Ineligible - wrong cell type|2|||
27594957|NCT00262821|80356187|FG001|Overall Study|Ineligible - wrong cell type|2|||
27594958|NCT00262821|80356186|FG000|Overall Study|Ineligible - wrong primary|0|||
27594959|NCT00262821|80356187|FG001|Overall Study|Ineligible - wrong primary|1|||
27594960|NCT00262821|80356186|FG000|Overall Study|Ineligible - inadequate pathology|1|||
27701337|NCT00995007|80745358|FG001|Overall Study|Refused further treatment|2|||
27701338|NCT00995007|80745357|FG000|Overall Study|Toxicity|8|||
27701339|NCT00995007|80745358|FG001|Overall Study|Toxicity|0|||
27886684|NCT01938430|81418139|FG003|Overall Study|Lack of Efficacy|1|||
27886685|NCT01938430|81418140|FG004|Overall Study|Lack of Efficacy|0|||
27886686|NCT01938430|81418141|FG005|Overall Study|Lack of Efficacy|0|||
27594961|NCT00262821|80356187|FG001|Overall Study|Ineligible - inadequate pathology|3|||
27594962|NCT00262821|80356186|FG000|Overall Study|Ineligible - elevated creatinine|0|||
27594963|NCT00262821|80356187|FG001|Overall Study|Ineligible - elevated creatinine|2|||
27594964|NCT00262821|80356186|FG000|Overall Study|Ineligible - required test not done|1|||
27594965|NCT00262821|80356187|FG001|Overall Study|Ineligible - required test not done|4|||
27594966|NCT00262821|80356186|FG000|Overall Study|Inevaluable - inadequate data|0|||
27594967|NCT00262821|80356187|FG001|Overall Study|Inevaluable - inadequate data|4|||
27594968|NCT04205630|80356190|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
27594969|NCT04205630|80356190|FG000|Overall Study|Disease clinical progression|7|||
27594970|NCT04205630|80356190|FG000|Overall Study|Withdrawal by Subject|2|||
27594971|NCT04205630|80356190|FG000|Overall Study|Adverse Event|17|||
27594972|NCT04205630|80356190|FG000|Overall Study|Other|1|||
27594973|NCT01854827|80356191|FG000|Overall Study|Death|1|||
27594974|NCT03581981|80356198|FG000|Overall Study|Withdrawal by Subject|12|||
27594975|NCT03581981|80356199|FG001|Overall Study|Withdrawal by Subject|13|||
27594976|NCT03581981|80356198|FG000|Overall Study|Physician Decision|1|||
27594977|NCT03581981|80356199|FG001|Overall Study|Physician Decision|2|||
27594978|NCT03581981|80356198|FG000|Overall Study|Lost to Follow-up|0|||
27594979|NCT03581981|80356199|FG001|Overall Study|Lost to Follow-up|4|||
27594980|NCT01967732|80356200|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
27594981|NCT01967732|80356201|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
27594982|NCT01967732|80356202|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
27594983|NCT01967732|80356203|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
27594984|NCT01967732|80356200|FG000|First Intervention (Day 1)|Poor venous access|0|||
27594985|NCT01967732|80356201|FG001|First Intervention (Day 1)|Poor venous access|1|||
27594986|NCT01967732|80356202|FG002|First Intervention (Day 1)|Poor venous access|0|||
27594987|NCT01967732|80356203|FG003|First Intervention (Day 1)|Poor venous access|0|||
27594988|NCT01618864|80356206|FG000|Overall Study|Withdrawal by Subject|2|||
27594989|NCT01618864|80356206|FG000|Overall Study|Lost to Follow-up|2|||
27594990|NCT02308748|80356207|FG000|Period 1|Withdrawal by Subject|0|||
27594991|NCT02308748|80356208|FG001|Period 1|Withdrawal by Subject|0|||
27594992|NCT02308748|80356209|FG002|Period 1|Withdrawal by Subject|1|||
27594993|NCT02308748|80356210|FG003|Period 1|Withdrawal by Subject|0|||
27594994|NCT02308748|80356211|FG004|Period 1|Withdrawal by Subject|0|||
27594995|NCT02308748|80356212|FG005|Period 1|Withdrawal by Subject|0|||
27594996|NCT02308748|80356213|FG006|Period 1|Withdrawal by Subject|0|||
27594997|NCT02308748|80356214|FG007|Period 1|Withdrawal by Subject|0|||
27594998|NCT02308748|80356215|FG008|Period 1|Withdrawal by Subject|0|||
27594999|NCT02308748|80356216|FG009|Period 1|Withdrawal by Subject|0|||
27595000|NCT02308748|80356207|FG000|Period 2|Adverse Event|0|||
27595001|NCT02308748|80356208|FG001|Period 2|Adverse Event|0|||
27595002|NCT02308748|80356209|FG002|Period 2|Adverse Event|0|||
27595003|NCT02308748|80356210|FG003|Period 2|Adverse Event|0|||
27595004|NCT02308748|80356211|FG004|Period 2|Adverse Event|0|||
27595005|NCT02308748|80356212|FG005|Period 2|Adverse Event|0|||
27595006|NCT02308748|80356213|FG006|Period 2|Adverse Event|0|||
27595007|NCT02308748|80356214|FG007|Period 2|Adverse Event|1|||
27595008|NCT02308748|80356215|FG008|Period 2|Adverse Event|0|||
27595009|NCT02308748|80356216|FG009|Period 2|Adverse Event|0|||
27595010|NCT02308748|80356207|FG000|Period 3|Protocol Violation|0|||
27595011|NCT02308748|80356208|FG001|Period 3|Protocol Violation|0|||
27595012|NCT02308748|80356209|FG002|Period 3|Protocol Violation|0|||
27595013|NCT02308748|80356210|FG003|Period 3|Protocol Violation|0|||
27595014|NCT02308748|80356211|FG004|Period 3|Protocol Violation|0|||
27595015|NCT02308748|80356212|FG005|Period 3|Protocol Violation|0|||
27595016|NCT02308748|80356213|FG006|Period 3|Protocol Violation|0|||
27833290|NCT03415308|81219555|FG000|Overall Study|Scheduling Conflicts|0|||
27833291|NCT03415308|81219556|FG001|Overall Study|Scheduling Conflicts|0|||
27595017|NCT02308748|80356214|FG007|Period 3|Protocol Violation|0|||
27595018|NCT02308748|80356215|FG008|Period 3|Protocol Violation|0|||
27595019|NCT02308748|80356216|FG009|Period 3|Protocol Violation|1|||
27833292|NCT03415308|81219557|FG002|Overall Study|Scheduling Conflicts|7|||
27595020|NCT02308748|80356207|FG000|Period 5|Adverse Event|1|||
27833293|NCT04750239|81219558|FG000|Overall Study|Withdrawal by Subject|2|||
27595021|NCT02308748|80356208|FG001|Period 5|Adverse Event|0|||
27595022|NCT02308748|80356209|FG002|Period 5|Adverse Event|0|||
27595023|NCT02308748|80356210|FG003|Period 5|Adverse Event|0|||
27595024|NCT02308748|80356211|FG004|Period 5|Adverse Event|0|||
27595025|NCT02308748|80356212|FG005|Period 5|Adverse Event|0|||
27595026|NCT02308748|80356213|FG006|Period 5|Adverse Event|0|||
27595027|NCT02308748|80356214|FG007|Period 5|Adverse Event|0|||
27595028|NCT02308748|80356215|FG008|Period 5|Adverse Event|1|||
27595029|NCT02308748|80356216|FG009|Period 5|Adverse Event|0|||
27595030|NCT01596582|80356217|FG000|Overall Study|Deemed ineligible after study visit|3|||
27595031|NCT01596582|80356218|FG001|Overall Study|Deemed ineligible after study visit|6|||
27595032|NCT01596582|80356217|FG000|Overall Study|Missing all outcome data|1|||
27595033|NCT01596582|80356218|FG001|Overall Study|Missing all outcome data|1|||
27595034|NCT01830127|80356219|FG000|Overall Study|Adverse Event|1|||
27595035|NCT01830127|80356220|FG001|Overall Study|Adverse Event|6|||
27595036|NCT01830127|80356219|FG000|Overall Study|Lack of Efficacy|3|||
27595037|NCT01830127|80356220|FG001|Overall Study|Lack of Efficacy|0|||
27595038|NCT01830127|80356219|FG000|Overall Study|Withdrawal by Subject|1|||
27595039|NCT01830127|80356220|FG001|Overall Study|Withdrawal by Subject|1|||
27595040|NCT01830127|80356219|FG000|Overall Study|Other reason not defined above|0|||
27595041|NCT01830127|80356220|FG001|Overall Study|Other reason not defined above|2|||
27595042|NCT00941330|80356223|FG000|Overall Study|Other|1|||
27595043|NCT00941330|80356224|FG001|Overall Study|Other|0|||
27595044|NCT00941330|80356223|FG000|Overall Study|Physician Decision|0|||
27595045|NCT00941330|80356224|FG001|Overall Study|Physician Decision|2|||
27595046|NCT00335322|80356225|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
27595047|NCT00335322|80356226|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
27595048|NCT00335322|80356227|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
27595049|NCT02570126|80356228|FG000|Overall Study|Lost to Follow-up|2|||
27595050|NCT02570126|80356229|FG001|Overall Study|Lost to Follow-up|0|||
27595051|NCT02570126|80356228|FG000|Overall Study|Unable To Arrange Visit 3|1|||
27595052|NCT02570126|80356229|FG001|Overall Study|Unable To Arrange Visit 3|0|||
27595053|NCT02570126|80356228|FG000|Overall Study|Violation Of Procedures GSK|0|||
27595054|NCT02570126|80356229|FG001|Overall Study|Violation Of Procedures GSK|1|||
27595055|NCT02570126|80356228|FG000|Overall Study|Protocol Violation|0|||
27595056|NCT02570126|80356229|FG001|Overall Study|Protocol Violation|1|||
27595057|NCT02570126|80356228|FG000|Overall Study|Withdrawal by Subject|3|||
27595058|NCT02570126|80356229|FG001|Overall Study|Withdrawal by Subject|7|||
27595059|NCT03762473|80356232|FG000|Overall Study|Death|1|||
27595060|NCT03762473|80356233|FG001|Overall Study|Death|0|||
27595061|NCT04072159|80356235|FG000|Overall Study|Lost to Follow-up|6|||
27595062|NCT04072159|80356236|FG001|Overall Study|Lost to Follow-up|6|||
27595063|NCT04072159|80356235|FG000|Overall Study|Withdrawal by Subject|2|||
27595064|NCT04072159|80356236|FG001|Overall Study|Withdrawal by Subject|0|||
27595065|NCT03364751|80356237|FG000|Overall Study|Withdrawal by Subject|1|||
27595066|NCT03364751|80356238|FG001|Overall Study|Withdrawal by Subject|0|||
27595067|NCT03364751|80356239|FG002|Overall Study|Withdrawal by Subject|0|||
27595068|NCT03364751|80356240|FG003|Overall Study|Withdrawal by Subject|0|||
27595069|NCT03364751|80356237|FG000|Overall Study|Lost to Follow-up|0|||
27595070|NCT03364751|80356238|FG001|Overall Study|Lost to Follow-up|1|||
27595071|NCT03364751|80356239|FG002|Overall Study|Lost to Follow-up|0|||
27595072|NCT03364751|80356240|FG003|Overall Study|Lost to Follow-up|0|||
27595073|NCT00328510|80356242|FG000|Overall Study|Gag disorder, could not use frame|4|||
27595074|NCT00328510|80356243|FG001|Overall Study|Gag disorder, could not use frame|0|||
27595075|NCT00328510|80356242|FG000|Overall Study|Dentition problems, could not use frame|1|||
27595076|NCT00328510|80356243|FG001|Overall Study|Dentition problems, could not use frame|0|||
27595077|NCT00328510|80356242|FG000|Overall Study|Withdrawal by Subject|4|||
27595078|NCT00328510|80356243|FG001|Overall Study|Withdrawal by Subject|2|||
27595079|NCT00328510|80356242|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
27595080|NCT00328510|80356243|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
27595081|NCT00328510|80356242|FG000|Overall Study|Treatment changed to a single fraction|1|||
27595082|NCT00328510|80356243|FG001|Overall Study|Treatment changed to a single fraction|1|||
27595083|NCT01588184|80356244|FG000|Overall Study|Death|1|||
27595084|NCT01588184|80356245|FG001|Overall Study|Death|0|||
27595085|NCT01588184|80356246|FG002|Overall Study|Death|0|||
27595086|NCT01588184|80356247|FG003|Overall Study|Death|1|||
27595087|NCT01588184|80356248|FG004|Overall Study|Death|1|||
27595088|NCT01588184|80356249|FG005|Overall Study|Death|1|||
27595089|NCT01588184|80356244|FG000|Overall Study|Withdrawal by Subject|2|||
27595090|NCT01588184|80356245|FG001|Overall Study|Withdrawal by Subject|4|||
27595091|NCT01588184|80356246|FG002|Overall Study|Withdrawal by Subject|0|||
27595092|NCT01588184|80356247|FG003|Overall Study|Withdrawal by Subject|1|||
27595093|NCT01588184|80356248|FG004|Overall Study|Withdrawal by Subject|0|||
27595094|NCT01588184|80356249|FG005|Overall Study|Withdrawal by Subject|0|||
27595095|NCT01588184|80356244|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
27595096|NCT01588184|80356245|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
27595097|NCT01588184|80356246|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
27595098|NCT01588184|80356247|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
27595099|NCT01588184|80356248|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
27595100|NCT01588184|80356249|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
27595101|NCT01588184|80356244|FG000|Overall Study|multiple reasons|0|||
27595102|NCT01588184|80356245|FG001|Overall Study|multiple reasons|3|||
27595103|NCT01588184|80356246|FG002|Overall Study|multiple reasons|0|||
27595104|NCT01588184|80356247|FG003|Overall Study|multiple reasons|1|||
27595105|NCT01588184|80356248|FG004|Overall Study|multiple reasons|0|||
27595106|NCT01588184|80356249|FG005|Overall Study|multiple reasons|0|||
27595107|NCT01428076|80356250|FG000|Overall Study|Adverse Event|0|||
27595108|NCT01428076|80356251|FG001|Overall Study|Adverse Event|1|||
27595109|NCT02477111|80356252|FG000|Overall Study|Death|28|||
27595110|NCT02477111|80356252|FG000|Overall Study|Withdrawal by Subject|19|||
27595111|NCT02477111|80356252|FG000|Overall Study|Lost to Follow-up|4|||
27595112|NCT04269889|80356253|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
27595113|NCT04269889|80356253|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
27595114|NCT02332590|80356255|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
27595115|NCT02332590|80356256|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
27595116|NCT02332590|80356255|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
27595117|NCT02332590|80356256|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
27595118|NCT02332590|80356255|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
27595119|NCT02332590|80356256|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
27595120|NCT02332590|80356255|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
27595121|NCT02332590|80356256|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
27595122|NCT02332590|80356255|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
27595123|NCT02332590|80356256|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
27595124|NCT02332590|80356255|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
27595125|NCT02332590|80356256|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
27595126|NCT02332590|80356255|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
27595127|NCT02332590|80356256|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
27595128|NCT02332590|80356255|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
27595129|NCT02332590|80356256|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
27595130|NCT02332590|80356255|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
27595131|NCT02332590|80356256|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
27595132|NCT03492281|80356259|FG000|Overall Study|Withdrawal by Subject|21|||
27595133|NCT03492281|80356260|FG001|Overall Study|Withdrawal by Subject|14|||
27595134|NCT03492281|80356261|FG002|Overall Study|Withdrawal by Subject|13|||
27595135|NCT03492281|80356259|FG000|Overall Study|Lost to Follow-up|14|||
27595136|NCT03492281|80356260|FG001|Overall Study|Lost to Follow-up|15|||
27595137|NCT03492281|80356261|FG002|Overall Study|Lost to Follow-up|10|||
27595138|NCT03492281|80356259|FG000|Overall Study|Adverse Event|6|||
27595139|NCT03492281|80356260|FG001|Overall Study|Adverse Event|8|||
27595140|NCT03492281|80356261|FG002|Overall Study|Adverse Event|13|||
27595141|NCT03492281|80356259|FG000|Overall Study|Lack of Efficacy|3|||
27595142|NCT03492281|80356260|FG001|Overall Study|Lack of Efficacy|0|||
27595143|NCT03492281|80356261|FG002|Overall Study|Lack of Efficacy|1|||
27595144|NCT03492281|80356259|FG000|Overall Study|Physician Decision|1|||
27595145|NCT03492281|80356260|FG001|Overall Study|Physician Decision|0|||
27595146|NCT03492281|80356261|FG002|Overall Study|Physician Decision|3|||
27595147|NCT03492281|80356259|FG000|Overall Study|Protocol Violation|0|||
27595148|NCT03492281|80356260|FG001|Overall Study|Protocol Violation|2|||
27595149|NCT03492281|80356261|FG002|Overall Study|Protocol Violation|1|||
27595150|NCT03492281|80356259|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
27595151|NCT03492281|80356260|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
27595152|NCT03492281|80356261|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
27595153|NCT03492281|80356259|FG000|Overall Study|Death|0|||
27595154|NCT03492281|80356260|FG001|Overall Study|Death|0|||
27595155|NCT03492281|80356261|FG002|Overall Study|Death|1|||
27595156|NCT03492281|80356259|FG000|Overall Study|Captured as Other in Database|8|||
27595157|NCT03492281|80356260|FG001|Overall Study|Captured as Other in Database|6|||
27595158|NCT03492281|80356261|FG002|Overall Study|Captured as Other in Database|3|||
27595159|NCT03583554|80356265|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
27595160|NCT03583554|80356266|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
27595161|NCT03583554|80356267|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
27595162|NCT01059175|80356272|FG000|Overall Study|Death|17|||
27701340|NCT00523718|80745359|FG000|Overall Study|Withdrawal by Subject|1|||
27701341|NCT00523718|80745360|FG001|Overall Study|Withdrawal by Subject|0|||
27701342|NCT00523718|80745359|FG000|Overall Study|Protocol Violation|2|||
27595163|NCT01059175|80356273|FG001|Overall Study|Death|17|||
27595164|NCT01059175|80356272|FG000|Overall Study|Adverse Event|4|||
27595165|NCT01059175|80356273|FG001|Overall Study|Adverse Event|2|||
27595166|NCT01059175|80356272|FG000|Overall Study|Lost to Follow-up|0|||
27595167|NCT01059175|80356273|FG001|Overall Study|Lost to Follow-up|1|||
27595168|NCT03213158|80356276|FG000|Overall Study|Withdrawal by Subject|1|||
27701343|NCT00523718|80745360|FG001|Overall Study|Protocol Violation|0|||
27701344|NCT00445068|80745361|FG000|Overall Study|Disease progression|26|||
27701345|NCT00445068|80745361|FG000|Overall Study|Adverse Event|5|||
27701346|NCT00445068|80745361|FG000|Overall Study|Abnormal laboratory value|2|||
27701347|NCT00445068|80745361|FG000|Overall Study|Withdrawal by Subject|2|||
27701348|NCT00445068|80745361|FG000|Overall Study|Death|1|||
27886687|NCT01938430|81418142|FG006|Overall Study|Lack of Efficacy|0|||
27886688|NCT01938430|81418143|FG007|Overall Study|Lack of Efficacy|0|||
27886689|NCT01938430|81418144|FG008|Overall Study|Lack of Efficacy|1|||
27886690|NCT01938430|81418145|FG009|Overall Study|Lack of Efficacy|0|||
27886691|NCT01938430|81418146|FG010|Overall Study|Lack of Efficacy|2|||
27886692|NCT01938430|81418147|FG011|Overall Study|Lack of Efficacy|1|||
27886693|NCT01938430|81418148|FG012|Overall Study|Lack of Efficacy|0|||
27886694|NCT01938430|81418149|FG013|Overall Study|Lack of Efficacy|0|||
27886695|NCT01938430|81418136|FG000|Overall Study|Lost to Follow-up|0|||
27886696|NCT01938430|81418137|FG001|Overall Study|Lost to Follow-up|0|||
27886697|NCT01938430|81418138|FG002|Overall Study|Lost to Follow-up|1|||
27886698|NCT01938430|81418139|FG003|Overall Study|Lost to Follow-up|0|||
27886699|NCT01938430|81418140|FG004|Overall Study|Lost to Follow-up|0|||
27886700|NCT01938430|81418141|FG005|Overall Study|Lost to Follow-up|1|||
27886701|NCT01938430|81418142|FG006|Overall Study|Lost to Follow-up|0|||
27886702|NCT01938430|81418143|FG007|Overall Study|Lost to Follow-up|0|||
27886703|NCT01938430|81418144|FG008|Overall Study|Lost to Follow-up|0|||
27886704|NCT01938430|81418145|FG009|Overall Study|Lost to Follow-up|0|||
27701349|NCT01133379|80745362|FG000|Overall Study|Withdrawal by Subject|0|||
27701350|NCT01133379|80745363|FG001|Overall Study|Withdrawal by Subject|1|||
27833294|NCT04750239|81219558|FG000|Overall Study|Trial terminated by sponsor|1|||
27833295|NCT00608322|81219561|FG000|Overall Study|Death|2|||
27886705|NCT01938430|81418146|FG010|Overall Study|Lost to Follow-up|0|||
27886706|NCT01938430|81418147|FG011|Overall Study|Lost to Follow-up|0|||
27886707|NCT01938430|81418148|FG012|Overall Study|Lost to Follow-up|0|||
27886708|NCT01938430|81418149|FG013|Overall Study|Lost to Follow-up|0|||
27886709|NCT01938430|81418136|FG000|Overall Study|Withdrew Consent|0|||
27886710|NCT01938430|81418137|FG001|Overall Study|Withdrew Consent|0|||
27886711|NCT01938430|81418138|FG002|Overall Study|Withdrew Consent|0|||
27886712|NCT01938430|81418139|FG003|Overall Study|Withdrew Consent|0|||
27886713|NCT01938430|81418140|FG004|Overall Study|Withdrew Consent|0|||
27886714|NCT01938430|81418141|FG005|Overall Study|Withdrew Consent|0|||
27886715|NCT01938430|81418142|FG006|Overall Study|Withdrew Consent|0|||
27886716|NCT01938430|81418143|FG007|Overall Study|Withdrew Consent|0|||
27886717|NCT01938430|81418144|FG008|Overall Study|Withdrew Consent|1|||
27886718|NCT01938430|81418145|FG009|Overall Study|Withdrew Consent|0|||
27886719|NCT01938430|81418146|FG010|Overall Study|Withdrew Consent|0|||
27886720|NCT01938430|81418147|FG011|Overall Study|Withdrew Consent|0|||
27886721|NCT01938430|81418148|FG012|Overall Study|Withdrew Consent|0|||
27886722|NCT01938430|81418149|FG013|Overall Study|Withdrew Consent|0|||
27886723|NCT03489707|81418150|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
27886724|NCT03489707|81418151|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
27833296|NCT00608322|81219562|FG001|Overall Study|Death|1|||
27833297|NCT01186458|81219567|FG000|Overall Study|Adverse Event|1|||
27833298|NCT00239005|81219574|FG000|Overall Study|Adverse Event|6|||
27833299|NCT00239005|81219575|FG001|Overall Study|Adverse Event|6|||
27833300|NCT00239005|81219574|FG000|Overall Study|Withdrawal by Subject|3|||
27833301|NCT00239005|81219575|FG001|Overall Study|Withdrawal by Subject|4|||
27833302|NCT00239005|81219574|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
27833303|NCT00239005|81219575|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
27833304|NCT00239005|81219574|FG000|Overall Study|Protocol Violation|1|||
27833305|NCT00239005|81219575|FG001|Overall Study|Protocol Violation|0|||
27833306|NCT00239005|81219574|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
27833307|NCT00239005|81219575|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
27886725|NCT03489707|81418150|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
27886726|NCT03489707|81418151|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
27886727|NCT03575793|81418154|FG000|Overall Study|Withdrawal by Subject|0|||
27886728|NCT03575793|81418155|FG001|Overall Study|Withdrawal by Subject|1|||
27886729|NCT03575793|81418154|FG000|Overall Study|Never Treated|0|||
27886730|NCT03575793|81418155|FG001|Overall Study|Never Treated|2|||
27886731|NCT02993250|81418159|FG000|Overall Study|Lost to Follow-up|0|||
27886732|NCT02993250|81418160|FG001|Overall Study|Lost to Follow-up|1|||
27886733|NCT00507819|81418162|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
27886734|NCT00507819|81418163|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
27886735|NCT05139303|81419451|FG000|Overall Study|Lost to Follow-up|3|||
27886736|NCT05139303|81419452|FG001|Overall Study|Lost to Follow-up|0|||
27886737|NCT05139303|81419451|FG000|Overall Study|Adverse Event|1|||
27886738|NCT05139303|81419452|FG001|Overall Study|Adverse Event|0|||
27701351|NCT01133379|80745364|FG002|Overall Study|Withdrawal by Subject|1|||
27701352|NCT01133379|80745362|FG000|Overall Study|Lost to Follow-up|1|||
27833308|NCT00239005|81219574|FG000|Overall Study|Lost to Follow-up|0|||
27886739|NCT01744184|81419453|FG000|Overall Study|Adverse Event|1|||
27595169|NCT03213158|80356276|FG000|Overall Study|Physician Decision|2|||
27595170|NCT00773968|80356277|FG000|Overall Study|Adverse Event|2|||
27595171|NCT00773968|80356277|FG000|Overall Study|Death|1|||
27595172|NCT00773968|80356277|FG000|Overall Study|Failure to Return|2|||
27595173|NCT00773968|80356277|FG000|Overall Study|Lack of Efficacy|3|||
27595174|NCT00773968|80356277|FG000|Overall Study|Protocol Violation|1|||
27595175|NCT00773968|80356277|FG000|Overall Study|Withdrawal by Subject|11|||
27595176|NCT00773968|80356277|FG000|Overall Study|Screen Failure|17|||
27595177|NCT00773968|80356277|FG000|Overall Study|Other|8|||
27595178|NCT05045625|80356278|FG000|Overall Study|Lost to Follow-up|3|||
27595179|NCT05374421|80356281|FG000|Overall Study|Withdrawal by Subject|3|||
27595180|NCT05374421|80356282|FG001|Overall Study|Withdrawal by Subject|4|||
27595181|NCT00377234|80356285|FG000|Overall Study|Adverse Event|14|||
27595182|NCT00377234|80356286|FG001|Overall Study|Adverse Event|17|||
27595183|NCT00377234|80356285|FG000|Overall Study|Withdrawal by Subject|11|||
27595184|NCT00377234|80356286|FG001|Overall Study|Withdrawal by Subject|9|||
27595185|NCT00377234|80356285|FG000|Overall Study|Lost to Follow-up|4|||
27595186|NCT00377234|80356286|FG001|Overall Study|Lost to Follow-up|2|||
27595187|NCT00377234|80356285|FG000|Overall Study|Administrative|2|||
27595188|NCT00377234|80356286|FG001|Overall Study|Administrative|1|||
27595189|NCT00377234|80356285|FG000|Overall Study|Not assigned|3|||
27595190|NCT00377234|80356286|FG001|Overall Study|Not assigned|2|||
27595191|NCT01371851|80356287|FG000|Overall Study|Lost to Follow-up|5|||
27595192|NCT01371851|80356288|FG001|Overall Study|Lost to Follow-up|8|||
27595193|NCT01371851|80356287|FG000|Overall Study|was arrested and put in jail|0|||
27595194|NCT01371851|80356288|FG001|Overall Study|was arrested and put in jail|1|||
27595195|NCT01371851|80356287|FG000|Overall Study|non study related adverse event|1|||
27595196|NCT01371851|80356288|FG001|Overall Study|non study related adverse event|0|||
27595197|NCT01371851|80356287|FG000|Overall Study|Blood Pressure outside study parameters|2|||
27595198|NCT01371851|80356288|FG001|Overall Study|Blood Pressure outside study parameters|0|||
27595199|NCT01227889|80356290|FG000|Randomized Phase (RP)|Adverse Event|13|||
27595200|NCT01227889|80356291|FG001|Randomized Phase (RP)|Adverse Event|0|||
27595201|NCT01227889|80356290|FG000|Randomized Phase (RP)|Physician Decision|13|||
27595202|NCT01227889|80356291|FG001|Randomized Phase (RP)|Physician Decision|5|||
27595203|NCT01227889|80356290|FG000|Randomized Phase (RP)|Progressive Disease|135|||
27595204|NCT01227889|80356291|FG001|Randomized Phase (RP)|Progressive Disease|52|||
27595205|NCT01227889|80356290|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
27595206|NCT01227889|80356291|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
27595207|NCT01227889|80356290|FG000|Randomized Phase (RP)|Missing|1|||
27595208|NCT01227889|80356291|FG001|Randomized Phase (RP)|Missing|3|||
27595209|NCT01227889|80356290|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
27595210|NCT01227889|80356291|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
27595211|NCT01227889|80356290|FG000|Crossover Phase|Adverse Event|0|||
27595212|NCT01227889|80356291|FG001|Crossover Phase|Adverse Event|1|||
27595213|NCT01227889|80356290|FG000|Crossover Phase|Physician Decision|0|||
27595214|NCT01227889|80356291|FG001|Crossover Phase|Physician Decision|3|||
27595215|NCT01227889|80356290|FG000|Crossover Phase|Progressive Disease|0|||
27595216|NCT01227889|80356291|FG001|Crossover Phase|Progressive Disease|31|||
27595217|NCT01227889|80356290|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
27595218|NCT01227889|80356291|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
27595219|NCT01227889|80356290|FG000|Crossover Phase|Withdrawal by Subject|0|||
27595220|NCT01227889|80356291|FG001|Crossover Phase|Withdrawal by Subject|1|||
27595221|NCT00092131|80356297|FG000|Treatment Period I|Adverse Event|1|||
27595222|NCT00092131|80356298|FG001|Treatment Period I|Adverse Event|0|||
27595223|NCT00092131|80356297|FG000|Treatment Period II|Adverse Event|0|||
27595224|NCT00092131|80356298|FG001|Treatment Period II|Adverse Event|1|||
27595225|NCT02638948|80356301|FG000|Overall Study|Withdrawal by Subject|4|||
27595226|NCT02638948|80356302|FG001|Overall Study|Withdrawal by Subject|5|||
27595227|NCT02638948|80356303|FG002|Overall Study|Withdrawal by Subject|3|||
27595228|NCT02638948|80356304|FG003|Overall Study|Withdrawal by Subject|1|||
27595229|NCT02638948|80356301|FG000|Overall Study|Administrative Reason by Sponsor|0|||
27595230|NCT02638948|80356302|FG001|Overall Study|Administrative Reason by Sponsor|1|||
27595231|NCT02638948|80356303|FG002|Overall Study|Administrative Reason by Sponsor|0|||
27595232|NCT02638948|80356304|FG003|Overall Study|Administrative Reason by Sponsor|4|||
27595233|NCT02638948|80356301|FG000|Overall Study|Adverse Event|0|||
27595234|NCT02638948|80356302|FG001|Overall Study|Adverse Event|0|||
27595235|NCT02638948|80356303|FG002|Overall Study|Adverse Event|1|||
27595236|NCT02638948|80356304|FG003|Overall Study|Adverse Event|1|||
27595237|NCT02638948|80356301|FG000|Overall Study|Lack of Efficacy|1|||
27595238|NCT02638948|80356302|FG001|Overall Study|Lack of Efficacy|1|||
27595239|NCT02638948|80356303|FG002|Overall Study|Lack of Efficacy|0|||
27701353|NCT01133379|80745363|FG001|Overall Study|Lost to Follow-up|1|||
27701354|NCT01133379|80745364|FG002|Overall Study|Lost to Follow-up|1|||
27595240|NCT02638948|80356304|FG003|Overall Study|Lack of Efficacy|0|||
27595241|NCT02638948|80356301|FG000|Overall Study|Lost to Follow-up|0|||
27595242|NCT02638948|80356302|FG001|Overall Study|Lost to Follow-up|0|||
27595243|NCT02638948|80356303|FG002|Overall Study|Lost to Follow-up|1|||
27595244|NCT02638948|80356304|FG003|Overall Study|Lost to Follow-up|1|||
27595245|NCT02638948|80356301|FG000|Overall Study|Poor/Non-Compliance|0|||
27595246|NCT02638948|80356302|FG001|Overall Study|Poor/Non-Compliance|2|||
27595247|NCT02638948|80356303|FG002|Overall Study|Poor/Non-Compliance|1|||
27595248|NCT02638948|80356304|FG003|Overall Study|Poor/Non-Compliance|0|||
27595249|NCT02638948|80356301|FG000|Overall Study|Participant no longer met study criteria|0|||
27595250|NCT02638948|80356302|FG001|Overall Study|Participant no longer met study criteria|1|||
27595251|NCT02638948|80356303|FG002|Overall Study|Participant no longer met study criteria|0|||
27595252|NCT02638948|80356304|FG003|Overall Study|Participant no longer met study criteria|0|||
27595253|NCT02638948|80356301|FG000|Overall Study|Other than specified above|4|||
27595254|NCT02638948|80356302|FG001|Overall Study|Other than specified above|1|||
27595255|NCT02638948|80356303|FG002|Overall Study|Other than specified above|1|||
27595256|NCT02638948|80356304|FG003|Overall Study|Other than specified above|1|||
27595257|NCT01328080|80356309|FG000|Overall Study|Lost to Follow-up|5|||
27595258|NCT00781391|80356310|FG000|Overall Study|never received study drug|24|||
27595259|NCT00781391|80356311|FG001|Overall Study|never received study drug|23|||
27595260|NCT00781391|80356312|FG002|Overall Study|never received study drug|32|||
27595261|NCT00781391|80356310|FG000|Overall Study|Protocol Violation|19|||
27595262|NCT00781391|80356311|FG001|Overall Study|Protocol Violation|17|||
27595263|NCT00781391|80356312|FG002|Overall Study|Protocol Violation|20|||
27595264|NCT00781391|80356310|FG000|Overall Study|Death|789|||
27595265|NCT00781391|80356311|FG001|Overall Study|Death|730|||
27595266|NCT00781391|80356312|FG002|Overall Study|Death|706|||
27595267|NCT00781391|80356310|FG000|Overall Study|Withdrawal by Subject|47|||
27595268|NCT00781391|80356311|FG001|Overall Study|Withdrawal by Subject|37|||
27595269|NCT00781391|80356312|FG002|Overall Study|Withdrawal by Subject|25|||
27595270|NCT00781391|80356310|FG000|Overall Study|Lost to Follow-up|0|||
27595271|NCT00781391|80356311|FG001|Overall Study|Lost to Follow-up|0|||
27595272|NCT00781391|80356312|FG002|Overall Study|Lost to Follow-up|1|||
27595273|NCT02515279|80356313|FG000|Overall Study|Adverse Event|7|||
27595274|NCT02515279|80356313|FG000|Overall Study|Lack of Efficacy|31|||
27595275|NCT02515279|80356313|FG000|Overall Study|Lost to Follow-up|9|||
27595276|NCT02515279|80356313|FG000|Overall Study|Withdrawal by Subject|18|||
27595277|NCT02515279|80356313|FG000|Overall Study|End-of-treatment visit not attended|17|||
27595278|NCT02515279|80356313|FG000|Overall Study|Other|22|||
27595279|NCT00234052|80356314|FG000|Treatment|Withdrawal by Subject|3|||
27595280|NCT00234052|80356314|FG000|Treatment|Adverse Event|5|||
27595281|NCT00234052|80356314|FG000|Treatment|Death|2|||
27595282|NCT00234052|80356314|FG000|Treatment|Progressive Disease|11|||
27595283|NCT00234052|80356314|FG000|Follow-up for 5 Years|Death|41|||
27595284|NCT00234052|80356314|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
27595285|NCT00234052|80356314|FG000|Follow-up for 5 Years|Other|7|||
27595286|NCT00675766|80356318|FG000|Overall Study|Lost to Follow-up|6|||
27595287|NCT00675766|80356319|FG001|Overall Study|Lost to Follow-up|5|||
27595288|NCT00675766|80356320|FG002|Overall Study|Lost to Follow-up|21|||
27595289|NCT00675766|80356321|FG003|Overall Study|Lost to Follow-up|26|||
27595290|NCT02677116|80356323|FG000|Overall Study|Adverse Event|0|||
27595291|NCT02677116|80356324|FG001|Overall Study|Adverse Event|1|||
27595292|NCT02677116|80356325|FG002|Overall Study|Adverse Event|0|||
27595293|NCT02677116|80356326|FG003|Overall Study|Adverse Event|0|||
27595294|NCT02677116|80356327|FG004|Overall Study|Adverse Event|0|||
27595295|NCT02677116|80356328|FG005|Overall Study|Adverse Event|1|||
27595296|NCT02677116|80356329|FG006|Overall Study|Adverse Event|1|||
27595297|NCT02677116|80356330|FG007|Overall Study|Adverse Event|0|||
27595298|NCT02677116|80356331|FG008|Overall Study|Adverse Event|0|||
27701355|NCT02592018|80745365|FG000|Overall Study|Adverse Event|1|||
27701356|NCT02592018|80745365|FG000|Overall Study|Lost to Follow-up|1|||
27701357|NCT02743819|80745366|FG000|Overall Study|Lack of Efficacy|5|||
27595299|NCT02677116|80356323|FG000|Overall Study|Physician Decision|0|||
27595300|NCT02677116|80356324|FG001|Overall Study|Physician Decision|2|||
27595301|NCT02677116|80356325|FG002|Overall Study|Physician Decision|3|||
27595302|NCT02677116|80356326|FG003|Overall Study|Physician Decision|2|||
27595303|NCT02677116|80356327|FG004|Overall Study|Physician Decision|1|||
27595304|NCT02677116|80356328|FG005|Overall Study|Physician Decision|3|||
27595305|NCT02677116|80356329|FG006|Overall Study|Physician Decision|1|||
27595306|NCT02677116|80356330|FG007|Overall Study|Physician Decision|1|||
27595307|NCT02677116|80356331|FG008|Overall Study|Physician Decision|2|||
27701358|NCT02743819|80745366|FG000|Overall Study|Death|2|||
27595308|NCT02677116|80356323|FG000|Overall Study|Withdrawal by parent or guardian|2|||
27595309|NCT02677116|80356324|FG001|Overall Study|Withdrawal by parent or guardian|1|||
27595310|NCT02677116|80356325|FG002|Overall Study|Withdrawal by parent or guardian|0|||
27595311|NCT02677116|80356326|FG003|Overall Study|Withdrawal by parent or guardian|1|||
27701359|NCT02743819|80745366|FG000|Overall Study|Adverse Event|1|||
27595312|NCT02677116|80356327|FG004|Overall Study|Withdrawal by parent or guardian|0|||
27595313|NCT02677116|80356328|FG005|Overall Study|Withdrawal by parent or guardian|0|||
27595314|NCT02677116|80356329|FG006|Overall Study|Withdrawal by parent or guardian|2|||
27595315|NCT02677116|80356330|FG007|Overall Study|Withdrawal by parent or guardian|1|||
27595316|NCT02677116|80356331|FG008|Overall Study|Withdrawal by parent or guardian|0|||
27595317|NCT02677116|80356323|FG000|Overall Study|Withdrawal by Subject|1|||
27595318|NCT02677116|80356324|FG001|Overall Study|Withdrawal by Subject|0|||
27595319|NCT02677116|80356325|FG002|Overall Study|Withdrawal by Subject|0|||
27595320|NCT02677116|80356326|FG003|Overall Study|Withdrawal by Subject|0|||
27595321|NCT02677116|80356327|FG004|Overall Study|Withdrawal by Subject|0|||
27595322|NCT02677116|80356328|FG005|Overall Study|Withdrawal by Subject|0|||
27595323|NCT02677116|80356329|FG006|Overall Study|Withdrawal by Subject|0|||
27595324|NCT02677116|80356330|FG007|Overall Study|Withdrawal by Subject|0|||
27595325|NCT02677116|80356331|FG008|Overall Study|Withdrawal by Subject|0|||
27595326|NCT02489500|80356334|FG000|Overall Study|Death|1|||
27595327|NCT02489500|80356335|FG001|Overall Study|Death|1|||
27595328|NCT03252587|80356336|FG000|Overall Study|Adverse Event|3|||
27595329|NCT03252587|80356337|FG001|Overall Study|Adverse Event|8|||
27595330|NCT03252587|80356338|FG002|Overall Study|Adverse Event|6|||
27595331|NCT03252587|80356339|FG003|Overall Study|Adverse Event|12|||
27595332|NCT03252587|80356336|FG000|Overall Study|Lack of Efficacy|7|||
27595333|NCT03252587|80356337|FG001|Overall Study|Lack of Efficacy|2|||
27595334|NCT03252587|80356338|FG002|Overall Study|Lack of Efficacy|2|||
27595335|NCT03252587|80356339|FG003|Overall Study|Lack of Efficacy|4|||
27595336|NCT03252587|80356336|FG000|Overall Study|Lost to Follow-up|2|||
27595337|NCT03252587|80356337|FG001|Overall Study|Lost to Follow-up|0|||
27595338|NCT03252587|80356338|FG002|Overall Study|Lost to Follow-up|0|||
27595339|NCT03252587|80356339|FG003|Overall Study|Lost to Follow-up|2|||
27595340|NCT03252587|80356336|FG000|Overall Study|Pregnancy|2|||
27595341|NCT03252587|80356337|FG001|Overall Study|Pregnancy|1|||
27595342|NCT03252587|80356338|FG002|Overall Study|Pregnancy|0|||
27595343|NCT03252587|80356339|FG003|Overall Study|Pregnancy|1|||
27595344|NCT03252587|80356336|FG000|Overall Study|Withdrawal by Subject|8|||
27595345|NCT03252587|80356337|FG001|Overall Study|Withdrawal by Subject|4|||
27595346|NCT03252587|80356338|FG002|Overall Study|Withdrawal by Subject|4|||
27595347|NCT03252587|80356339|FG003|Overall Study|Withdrawal by Subject|4|||
27595348|NCT03252587|80356336|FG000|Overall Study|Other Reasons|2|||
27595349|NCT03252587|80356337|FG001|Overall Study|Other Reasons|5|||
27595350|NCT03252587|80356338|FG002|Overall Study|Other Reasons|5|||
27595351|NCT03252587|80356339|FG003|Overall Study|Other Reasons|4|||
27595352|NCT00862134|80356340|FG000|Overall Study|Death|1|||
27595353|NCT00862134|80356341|FG001|Overall Study|Death|0|||
27595354|NCT00862134|80356340|FG000|Overall Study|Physician Decision|0|||
27595355|NCT00862134|80356341|FG001|Overall Study|Physician Decision|1|||
27595356|NCT00862134|80356340|FG000|Overall Study|Withdrawal by Subject|1|||
27595357|NCT00862134|80356341|FG001|Overall Study|Withdrawal by Subject|2|||
27595358|NCT00862134|80356340|FG000|Overall Study|Sponsor terminated study|5|||
27595359|NCT00862134|80356341|FG001|Overall Study|Sponsor terminated study|7|||
27595360|NCT00862134|80356340|FG000|Overall Study|Adverse Event|2|||
27595361|NCT00862134|80356341|FG001|Overall Study|Adverse Event|2|||
27595362|NCT00862134|80356340|FG000|Overall Study|Withdrew prior to dosing|2|||
27595363|NCT00862134|80356341|FG001|Overall Study|Withdrew prior to dosing|0|||
27595364|NCT03835533|80356344|FG000|Overall Study|Death|5|||
27595365|NCT03835533|80356345|FG001|Overall Study|Death|10|||
27595366|NCT03835533|80356346|FG002|Overall Study|Death|9|||
27595367|NCT03835533|80356344|FG000|Overall Study|Withdrawal by Subject|2|||
27595368|NCT03835533|80356345|FG001|Overall Study|Withdrawal by Subject|2|||
27701360|NCT04585646|80745367|FG000|First Intervention|Physician Decision|1|||
27595369|NCT03835533|80356346|FG002|Overall Study|Withdrawal by Subject|2|||
27595370|NCT03835533|80356344|FG000|Overall Study|Lost to Follow-up|1|||
27595371|NCT03835533|80356345|FG001|Overall Study|Lost to Follow-up|0|||
27595372|NCT03835533|80356346|FG002|Overall Study|Lost to Follow-up|0|||
27595373|NCT00126438|80356347|FG000|Overall Study|Withdrawal due to adverse event|1|||
27595374|NCT00126438|80356348|FG001|Overall Study|Withdrawal due to adverse event|0|||
27595375|NCT00126438|80356347|FG000|Overall Study|Lost to Follow-up|22|||
27595376|NCT00126438|80356348|FG001|Overall Study|Lost to Follow-up|0|||
27595377|NCT00126438|80356347|FG000|Overall Study|Protocol Violation|8|||
27595378|NCT00126438|80356348|FG001|Overall Study|Protocol Violation|8|||
27595379|NCT00126438|80356347|FG000|Overall Study|Withdrawal by Subject|3|||
27595380|NCT00126438|80356348|FG001|Overall Study|Withdrawal by Subject|2|||
27595381|NCT01258608|80356349|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
27595382|NCT01258608|80356350|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
27595383|NCT01258608|80356349|FG000|Overall Study|Clinical progression|1|||
27595384|NCT01258608|80356350|FG001|Overall Study|Clinical progression|0|||
27595385|NCT01258608|80356349|FG000|Overall Study|Sponsor decision|0|||
27595386|NCT01258608|80356350|FG001|Overall Study|Sponsor decision|1|||
27595387|NCT01258608|80356349|FG000|Overall Study|Physician Decision|6|||
27595388|NCT01258608|80356350|FG001|Overall Study|Physician Decision|1|||
27595389|NCT01258608|80356349|FG000|Overall Study|Lost to Follow-up|0|||
27595390|NCT01258608|80356350|FG001|Overall Study|Lost to Follow-up|1|||
27595391|NCT01258608|80356349|FG000|Overall Study|Lack of compliance|1|||
27595392|NCT01258608|80356350|FG001|Overall Study|Lack of compliance|0|||
27595393|NCT01258608|80356349|FG000|Overall Study|Lack of Efficacy|0|||
27595394|NCT01258608|80356350|FG001|Overall Study|Lack of Efficacy|1|||
27595395|NCT01258608|80356349|FG000|Overall Study|Adverse Event|6|||
27595396|NCT01258608|80356350|FG001|Overall Study|Adverse Event|10|||
27595397|NCT01258608|80356349|FG000|Overall Study|Withdrawal by Subject|6|||
27595398|NCT01258608|80356350|FG001|Overall Study|Withdrawal by Subject|5|||
27595399|NCT01003899|80356351|FG000|Overall Study|Other Adverse Event|8|||
27595400|NCT01003899|80356351|FG000|Overall Study|Not entered|4|||
27595401|NCT01003899|80356351|FG000|Overall Study|Not treated|1|||
27595402|NCT01003899|80356351|FG000|Overall Study|Progressive disease|34|||
27595403|NCT03832595|80356356|FG000|Overall Study|Death|142|||
27595404|NCT03832595|80356357|FG001|Overall Study|Death|130|||
27595405|NCT03832595|80356356|FG000|Overall Study|Medical management without dialysis|37|||
27595406|NCT03832595|80356357|FG001|Overall Study|Medical management without dialysis|1|||
27595407|NCT02943408|80356358|FG000|Overall Study|Lost to Follow-up|7|||
27595408|NCT02943408|80356359|FG001|Overall Study|Lost to Follow-up|1|||
27595409|NCT02943408|80356358|FG000|Overall Study|Withdrawal by Subject|0|||
27595410|NCT02943408|80356359|FG001|Overall Study|Withdrawal by Subject|1|||
27595411|NCT01597050|80356362|FG000|Overall Study|Withdrawal by Subject|1|||
27595412|NCT01597050|80356363|FG001|Overall Study|Withdrawal by Subject|0|||
27595413|NCT00594854|80356367|FG000|Overall Study|Study terminated|7|||
27595414|NCT00594854|80356368|FG001|Overall Study|Study terminated|10|||
27595415|NCT02858895|80356369|FG000|Overall Study|Disease progression|31|||
27595416|NCT02858895|80356369|FG000|Overall Study|Death|2|||
27595417|NCT02858895|80356369|FG000|Overall Study|Adverse Event|1|||
27595418|NCT02858895|80356369|FG000|Overall Study|Withdrawal by Subject|3|||
27595419|NCT02858895|80356369|FG000|Overall Study|hospice,|1|||
27595420|NCT02858895|80356369|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
27595421|NCT03519854|80356372|FG000|Overall Study|Technical Error|0|||
27595422|NCT03519854|80356373|FG001|Overall Study|Technical Error|0|||
27595423|NCT03519854|80356374|FG002|Overall Study|Technical Error|1|||
27595424|NCT03519854|80356375|FG003|Overall Study|Technical Error|0|||
27595425|NCT03519854|80356376|FG004|Overall Study|Technical Error|0|||
27595426|NCT03519854|80356377|FG005|Overall Study|Technical Error|0|||
27595427|NCT03519854|80356378|FG006|Overall Study|Technical Error|0|||
27595428|NCT03519854|80356379|FG007|Overall Study|Technical Error|0|||
27595429|NCT03519854|80356380|FG008|Overall Study|Technical Error|0|||
27595430|NCT03519854|80356381|FG009|Overall Study|Technical Error|0|||
27595431|NCT03519854|80356382|FG010|Overall Study|Technical Error|0|||
27595432|NCT03519854|80356383|FG011|Overall Study|Technical Error|0|||
27595433|NCT03519854|80356384|FG012|Overall Study|Technical Error|0|||
27595434|NCT03519854|80356385|FG013|Overall Study|Technical Error|0|||
27595435|NCT03519854|80356386|FG014|Overall Study|Technical Error|0|||
27595436|NCT03519854|80356387|FG015|Overall Study|Technical Error|0|||
27595437|NCT03519854|80356388|FG016|Overall Study|Technical Error|0|||
27595438|NCT03519854|80356389|FG017|Overall Study|Technical Error|0|||
27595439|NCT01654549|80356401|FG000|Overall Study|H.pylori eradication not successful|0|||
27595440|NCT01654549|80356402|FG001|Overall Study|H.pylori eradication not successful|1|||
27595441|NCT03565887|80356403|FG000|Overall Study|Adverse Event|1|||
27595442|NCT03565887|80356404|FG001|Overall Study|Adverse Event|0|||
27595443|NCT03565887|80356403|FG000|Overall Study|Withdrawal by Subject|0|||
27595444|NCT03565887|80356404|FG001|Overall Study|Withdrawal by Subject|2|||
27595445|NCT02030015|80356405|FG000|Overall Study|Withdrawal by Subject|3|||
27595446|NCT02030015|80356405|FG000|Overall Study|Death|13|||
27595447|NCT05072080|80356406|FG000|Overall Study|Death|0|||
27595448|NCT05072080|80356407|FG001|Overall Study|Death|0|||
27595449|NCT05072080|80356408|FG002|Overall Study|Death|1|||
27595450|NCT05072080|80356409|FG003|Overall Study|Death|0|||
27595451|NCT05072080|80356406|FG000|Overall Study|Lost to Follow-up|65|||
27595452|NCT05072080|80356407|FG001|Overall Study|Lost to Follow-up|70|||
27595453|NCT05072080|80356408|FG002|Overall Study|Lost to Follow-up|58|||
27595454|NCT05072080|80356409|FG003|Overall Study|Lost to Follow-up|23|||
27595455|NCT05072080|80356406|FG000|Overall Study|Physician Decision|2|||
27595456|NCT05072080|80356407|FG001|Overall Study|Physician Decision|1|||
27595457|NCT05072080|80356408|FG002|Overall Study|Physician Decision|1|||
27595458|NCT05072080|80356409|FG003|Overall Study|Physician Decision|0|||
27595459|NCT05072080|80356406|FG000|Overall Study|Withdrawal by Subject|45|||
27595460|NCT05072080|80356407|FG001|Overall Study|Withdrawal by Subject|30|||
27595461|NCT05072080|80356408|FG002|Overall Study|Withdrawal by Subject|27|||
27595462|NCT05072080|80356409|FG003|Overall Study|Withdrawal by Subject|7|||
27595463|NCT05072080|80356406|FG000|Overall Study|Sponsor Decision|0|||
27595464|NCT05072080|80356407|FG001|Overall Study|Sponsor Decision|1|||
27595465|NCT05072080|80356408|FG002|Overall Study|Sponsor Decision|0|||
27595466|NCT05072080|80356409|FG003|Overall Study|Sponsor Decision|0|||
27595467|NCT05072080|80356406|FG000|Overall Study|Subject moved|1|||
27595468|NCT05072080|80356407|FG001|Overall Study|Subject moved|3|||
27595469|NCT05072080|80356408|FG002|Overall Study|Subject moved|5|||
27595470|NCT05072080|80356409|FG003|Overall Study|Subject moved|2|||
27595471|NCT05072080|80356406|FG000|Overall Study|Withdrawal by parent|0|||
27595472|NCT05072080|80356407|FG001|Overall Study|Withdrawal by parent|0|||
27595473|NCT05072080|80356408|FG002|Overall Study|Withdrawal by parent|1|||
27595474|NCT05072080|80356409|FG003|Overall Study|Withdrawal by parent|0|||
27595475|NCT05072080|80356406|FG000|Overall Study|Subject was deployed|0|||
27595476|NCT05072080|80356407|FG001|Overall Study|Subject was deployed|1|||
27595477|NCT05072080|80356408|FG002|Overall Study|Subject was deployed|0|||
27595478|NCT05072080|80356409|FG003|Overall Study|Subject was deployed|0|||
27595479|NCT05072080|80356406|FG000|Overall Study|Subject left site without receiving dose|0|||
27595480|NCT05072080|80356407|FG001|Overall Study|Subject left site without receiving dose|1|||
27595481|NCT05072080|80356408|FG002|Overall Study|Subject left site without receiving dose|0|||
27595482|NCT05072080|80356409|FG003|Overall Study|Subject left site without receiving dose|0|||
27595483|NCT05072080|80356406|FG000|Overall Study|Subject incarcerated|0|||
27595484|NCT05072080|80356407|FG001|Overall Study|Subject incarcerated|1|||
27595485|NCT05072080|80356408|FG002|Overall Study|Subject incarcerated|0|||
27595486|NCT05072080|80356409|FG003|Overall Study|Subject incarcerated|1|||
27595487|NCT05072080|80356406|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
27595488|NCT05072080|80356407|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
27595489|NCT05072080|80356408|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
27595490|NCT05072080|80356409|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
27595491|NCT05072080|80356406|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
27595492|NCT05072080|80356407|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
27595493|NCT05072080|80356408|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
27595494|NCT05072080|80356409|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
27595495|NCT00951275|80356410|FG000|Overall Study|Administrative Reason|1|||
27595496|NCT00951275|80356410|FG000|Overall Study|Adverse Event|7|||
27595497|NCT00951275|80356410|FG000|Overall Study|Withdrawal by Subject|4|||
27595498|NCT00951275|80356410|FG000|Overall Study|Protocol Violation|1|||
27595499|NCT00483184|80356412|FG000|Overall Study|Withdrawal by Subject|2|||
27595500|NCT00483184|80356413|FG001|Overall Study|Withdrawal by Subject|2|||
27595501|NCT00483184|80356414|FG002|Overall Study|Withdrawal by Subject|0|||
27595502|NCT00483184|80356412|FG000|Overall Study|Lost to Follow-up|1|||
27595503|NCT00483184|80356413|FG001|Overall Study|Lost to Follow-up|0|||
27595504|NCT00483184|80356414|FG002|Overall Study|Lost to Follow-up|0|||
27595505|NCT00483184|80356412|FG000|Overall Study|Adverse Event|1|||
27595506|NCT00483184|80356413|FG001|Overall Study|Adverse Event|2|||
27595507|NCT00483184|80356414|FG002|Overall Study|Adverse Event|2|||
27595508|NCT00483184|80356412|FG000|Overall Study|Protocol Violation|1|||
27595509|NCT00483184|80356413|FG001|Overall Study|Protocol Violation|0|||
27595510|NCT00483184|80356414|FG002|Overall Study|Protocol Violation|1|||
27595511|NCT04683926|80356415|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
27595512|NCT04683926|80356416|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
27595513|NCT04683926|80356417|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
27595514|NCT04683926|80356418|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
27595515|NCT00951041|80356419|FG000|Overall Study|Withdrawal by Subject|1|||
27701361|NCT04585646|80745368|FG001|First Intervention|Physician Decision|0|||
27701362|NCT04585646|80745367|FG000|First Intervention|Lost to Follow-up|0|||
27701363|NCT04585646|80745368|FG001|First Intervention|Lost to Follow-up|3|||
27701364|NCT04585646|80745367|FG000|First Intervention|Withdrawal by Subject|0|||
27701365|NCT04585646|80745368|FG001|First Intervention|Withdrawal by Subject|1|||
27701366|NCT03239483|80745370|FG000|Overall Study|Lost to Follow-up|1|||
27701367|NCT03239483|80745371|FG001|Overall Study|Lost to Follow-up|0|||
27701368|NCT03239483|80745370|FG000|Overall Study|Withdrawal by Subject|1|||
27701369|NCT03239483|80745371|FG001|Overall Study|Withdrawal by Subject|0|||
27701370|NCT03942406|80745372|FG000|Overall Study|Lost to Follow-up|4|||
27701371|NCT03942406|80745373|FG001|Overall Study|Lost to Follow-up|5|||
27701372|NCT03942406|80745374|FG002|Overall Study|Lost to Follow-up|3|||
27701373|NCT03942406|80745375|FG003|Overall Study|Lost to Follow-up|7|||
27701374|NCT03942406|80745376|FG004|Overall Study|Lost to Follow-up|1|||
27701375|NCT03942406|80745377|FG005|Overall Study|Lost to Follow-up|0|||
27701376|NCT03942406|80745378|FG006|Overall Study|Lost to Follow-up|0|||
27701377|NCT03942406|80745372|FG000|Overall Study|Withdrawal by Subject|3|||
27701378|NCT03942406|80745373|FG001|Overall Study|Withdrawal by Subject|1|||
27701379|NCT03942406|80745374|FG002|Overall Study|Withdrawal by Subject|1|||
27701380|NCT03942406|80745375|FG003|Overall Study|Withdrawal by Subject|3|||
27833309|NCT00239005|81219575|FG001|Overall Study|Lost to Follow-up|1|||
27833310|NCT00472212|81219576|FG000|Overall Study|Lost to Follow-up|6|||
27833311|NCT00472212|81219577|FG001|Overall Study|Lost to Follow-up|4|||
27833312|NCT01751087|81219578|FG000|Overall Study|Withdrawal by Subject|1|||
27833313|NCT01751087|81219579|FG001|Overall Study|Withdrawal by Subject|0|||
27833314|NCT01751087|81219580|FG002|Overall Study|Withdrawal by Subject|0|||
27833315|NCT01751087|81219578|FG000|Overall Study|Physician Decision|0|||
27595516|NCT00951041|80356420|FG001|Overall Study|Withdrawal by Subject|1|||
27595517|NCT00951041|80356419|FG000|Overall Study|Lost to Follow-up|1|||
27595518|NCT00951041|80356420|FG001|Overall Study|Lost to Follow-up|0|||
27595519|NCT00951041|80356419|FG000|Overall Study|Other|3|||
27595520|NCT00951041|80356420|FG001|Overall Study|Other|0|||
27701381|NCT03942406|80745376|FG004|Overall Study|Withdrawal by Subject|0|||
27833316|NCT01751087|81219579|FG001|Overall Study|Physician Decision|0|||
27701382|NCT03942406|80745377|FG005|Overall Study|Withdrawal by Subject|0|||
27701383|NCT03942406|80745378|FG006|Overall Study|Withdrawal by Subject|0|||
27701384|NCT03942406|80745372|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
27833317|NCT01751087|81219580|FG002|Overall Study|Physician Decision|1|||
27701385|NCT03942406|80745373|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
27701386|NCT03942406|80745374|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
27701387|NCT03942406|80745375|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
27701388|NCT03942406|80745376|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
27701389|NCT03942406|80745377|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
27701390|NCT03942406|80745378|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
27701391|NCT03374995|80745379|FG000|Overall Study|Withdrawal by Subject|0|||
27701392|NCT03374995|80745380|FG001|Overall Study|Withdrawal by Subject|1|||
27701393|NCT02678416|80745381|FG000|Part 1|Withdrawal by Subject|1|||
27701394|NCT02678416|80745381|FG000|Part 2|Adverse Event|2|||
27701395|NCT02678416|80745381|FG000|Part 2|Withdrawal by Subject|1|||
27701396|NCT01186939|80745386|FG000|Overall Study|Death|7|||
27701397|NCT01186939|80745386|FG000|Overall Study|Withdrawal by Subject|2|||
27701398|NCT01186939|80745386|FG000|Overall Study|No longer receiving clinical benefit|17|||
27701399|NCT01186939|80745386|FG000|Overall Study|Program closed|5|||
27701400|NCT01186939|80745386|FG000|Overall Study|Sponsor decision|4|||
27701401|NCT01186939|80745386|FG000|Overall Study|Started additional treatment|1|||
27701402|NCT01186939|80745386|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
27701403|NCT01186939|80745386|FG000|Overall Study|Myocardial infarction|1|||
27701404|NCT01186939|80745386|FG000|Overall Study|Bone marrow transplant|1|||
27833318|NCT01252953|81222448|FG000|Overall Study|Withdrawal by Subject|16|||
27886740|NCT01744184|81419454|FG001|Overall Study|Adverse Event|0|||
27595521|NCT04435665|80356421|FG000|Overall Study|Lost to Follow-up|0|||
27595522|NCT04435665|80356422|FG001|Overall Study|Lost to Follow-up|0|||
27595523|NCT04435665|80356423|FG002|Overall Study|Lost to Follow-up|0|||
27595524|NCT04435665|80356424|FG003|Overall Study|Lost to Follow-up|1|||
27595525|NCT03422250|80359431|FG000|Intervention|Adverse Event|0|||
27595526|NCT03422250|80359432|FG001|Intervention|Adverse Event|1|||
27595527|NCT03422250|80359433|FG002|Intervention|Adverse Event|0|||
27595528|NCT03422250|80359434|FG003|Intervention|Adverse Event|1|||
27595529|NCT03422250|80359431|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
27595530|NCT03422250|80359432|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
27701405|NCT01186939|80745386|FG000|Overall Study|Transformation to AML|1|||
27701406|NCT03144804|80745387|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
27701407|NCT01102803|80745388|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
27595531|NCT03422250|80359433|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
27595532|NCT03422250|80359434|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
27595533|NCT03422250|80359431|FG000|Follow-up|Withdrawal by Subject|0|||
27595534|NCT03422250|80359432|FG001|Follow-up|Withdrawal by Subject|0|||
27595535|NCT03422250|80359433|FG002|Follow-up|Withdrawal by Subject|0|||
27595536|NCT03422250|80359434|FG003|Follow-up|Withdrawal by Subject|1|||
27701408|NCT01102803|80745389|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
27701409|NCT01102803|80745388|FG000|Post to Follow-Up|Lost to Follow-up|1|||
27701410|NCT01102803|80745389|FG001|Post to Follow-Up|Lost to Follow-up|3|||
27833319|NCT01252953|81222449|FG001|Overall Study|Withdrawal by Subject|17|||
27886741|NCT01744184|81419453|FG000|Overall Study|Withdrawal by Subject|0|||
27886742|NCT01744184|81419454|FG001|Overall Study|Withdrawal by Subject|1|||
27886743|NCT02782949|81419455|FG000|Overall Study|Protocol Violation|1|||
27886744|NCT02782949|81419456|FG001|Overall Study|Protocol Violation|0|||
27886745|NCT02782949|81419455|FG000|Overall Study|Withdrawal by Subject|0|||
27886746|NCT02782949|81419456|FG001|Overall Study|Withdrawal by Subject|1|||
27886747|NCT01094301|81419461|FG000|Trial Stage|Withdrawal by Subject|1|||
27886748|NCT01094301|81419461|FG000|Implant Stage|Adverse Event|1|||
27886749|NCT01094301|81419461|FG000|Implant Stage|Protocol Violation|1|||
27886750|NCT01094301|81419461|FG000|Implant Stage|Withdrawal by Subject|2|||
27886751|NCT01094301|81419461|FG000|Implant Stage|No return of pain|4|||
27886752|NCT03557931|81419462|FG000|Overall Study|Adverse Event|4|||
27886753|NCT03557931|81419463|FG001|Overall Study|Adverse Event|6|||
27886754|NCT03557931|81419464|FG002|Overall Study|Adverse Event|1|||
27886755|NCT03557931|81419462|FG000|Overall Study|Lost to Follow-up|4|||
27886756|NCT03557931|81419463|FG001|Overall Study|Lost to Follow-up|4|||
27886757|NCT03557931|81419464|FG002|Overall Study|Lost to Follow-up|1|||
27701411|NCT00108069|80745390|FG000|Overall Study|Never rec'd study drug|0|||
27701412|NCT00108069|80745391|FG001|Overall Study|Never rec'd study drug|1|||
27701413|NCT00108069|80745390|FG000|Overall Study|Adverse Event|1|||
27701414|NCT00108069|80745391|FG001|Overall Study|Adverse Event|1|||
27701415|NCT00108069|80745390|FG000|Overall Study|Withdrawal by Subject|1|||
27701416|NCT00108069|80745391|FG001|Overall Study|Withdrawal by Subject|0|||
27701417|NCT00108069|80745390|FG000|Overall Study|Death|1|||
27701418|NCT00108069|80745391|FG001|Overall Study|Death|0|||
27701419|NCT00108069|80745390|FG000|Overall Study|Progessive disease|27|||
27701420|NCT00108069|80745391|FG001|Overall Study|Progessive disease|11|||
27701421|NCT01179672|80745392|FG000|Overall Study|Adverse Event|17|||
27701422|NCT01179672|80745393|FG001|Overall Study|Adverse Event|8|||
27701423|NCT01179672|80745392|FG000|Overall Study|Withdrawal by Subject|10|||
27701424|NCT01179672|80745393|FG001|Overall Study|Withdrawal by Subject|12|||
27701425|NCT01179672|80745392|FG000|Overall Study|Entry Criteria Not Met|0|||
27701426|NCT01179672|80745393|FG001|Overall Study|Entry Criteria Not Met|2|||
27701427|NCT01179672|80745392|FG000|Overall Study|Lost to Follow-up|0|||
27701428|NCT01179672|80745393|FG001|Overall Study|Lost to Follow-up|1|||
27595537|NCT03422250|80359431|FG000|Follow-up|Adverse Event|0|||
27595538|NCT03422250|80359432|FG001|Follow-up|Adverse Event|0|||
27595539|NCT03422250|80359433|FG002|Follow-up|Adverse Event|0|||
27595540|NCT03422250|80359434|FG003|Follow-up|Adverse Event|1|||
27701429|NCT01179672|80745392|FG000|Overall Study|Protocol Violation|2|||
27701430|NCT01179672|80745393|FG001|Overall Study|Protocol Violation|2|||
27701431|NCT01179672|80745392|FG000|Overall Study|Physician Decision|1|||
27701432|NCT01179672|80745393|FG001|Overall Study|Physician Decision|1|||
27701433|NCT01195545|80745394|FG000|Overall Study|Protocol Violation|4|||
27701434|NCT03085758|80745395|FG000|Overall Study|Death|26|||
27595541|NCT03927950|80359435|FG000|Overall Study|Adverse Event|9|||
27595542|NCT03240692|80359436|FG000|Overall Study|Physician Decision|1|||
27701435|NCT03085758|80745396|FG001|Overall Study|Death|24|||
27701436|NCT03085758|80745397|FG002|Overall Study|Death|53|||
27701437|NCT03085758|80745395|FG000|Overall Study|Lost to Follow-up|1|||
27701438|NCT03085758|80745396|FG001|Overall Study|Lost to Follow-up|1|||
27701439|NCT03085758|80745397|FG002|Overall Study|Lost to Follow-up|1|||
27701440|NCT03085758|80745395|FG000|Overall Study|Withdrawal by Subject|2|||
27701441|NCT03085758|80745396|FG001|Overall Study|Withdrawal by Subject|2|||
27595543|NCT03240692|80359436|FG000|Overall Study|Withdrawal by Subject|1|||
27701442|NCT03085758|80745397|FG002|Overall Study|Withdrawal by Subject|1|||
27595544|NCT01112579|80359443|FG000|Overall Study|Missed Visit|1|||
27595545|NCT01112579|80359444|FG001|Overall Study|Missed Visit|1|||
27595546|NCT01112579|80359443|FG000|Overall Study|Death|0|||
27595547|NCT01112579|80359444|FG001|Overall Study|Death|2|||
27595548|NCT02061202|80359445|FG000|Overall Study|Lost to Follow-up|1|||
27595549|NCT02061202|80359446|FG001|Overall Study|Lost to Follow-up|1|||
27595550|NCT02862457|80359447|FG000|Overall Study|Death|1|||
27595551|NCT02862457|80359448|FG001|Overall Study|Death|3|||
27595552|NCT02862457|80359449|FG002|Overall Study|Death|2|||
27595553|NCT02862457|80359450|FG003|Overall Study|Death|3|||
27595554|NCT02862457|80359451|FG004|Overall Study|Death|0|||
27886758|NCT03557931|81419462|FG000|Overall Study|Protocol Violation|1|||
27886759|NCT03557931|81419463|FG001|Overall Study|Protocol Violation|4|||
27886760|NCT03557931|81419464|FG002|Overall Study|Protocol Violation|1|||
27886761|NCT03557931|81419462|FG000|Overall Study|Withdrawal by Subject|14|||
27595555|NCT02862457|80359452|FG005|Overall Study|Death|2|||
27595556|NCT02862457|80359453|FG006|Overall Study|Death|1|||
27595557|NCT02862457|80359447|FG000|Overall Study|Lost to Follow-up|1|||
27595558|NCT02862457|80359448|FG001|Overall Study|Lost to Follow-up|0|||
27595559|NCT02862457|80359449|FG002|Overall Study|Lost to Follow-up|0|||
27595560|NCT02862457|80359450|FG003|Overall Study|Lost to Follow-up|1|||
27595561|NCT02862457|80359451|FG004|Overall Study|Lost to Follow-up|0|||
27595562|NCT02862457|80359452|FG005|Overall Study|Lost to Follow-up|0|||
27595563|NCT02862457|80359453|FG006|Overall Study|Lost to Follow-up|0|||
27595564|NCT02862457|80359447|FG000|Overall Study|Withdrawal by Subject|0|||
27595565|NCT02862457|80359448|FG001|Overall Study|Withdrawal by Subject|0|||
27595566|NCT02862457|80359449|FG002|Overall Study|Withdrawal by Subject|1|||
27595567|NCT02862457|80359450|FG003|Overall Study|Withdrawal by Subject|0|||
27595568|NCT02862457|80359451|FG004|Overall Study|Withdrawal by Subject|0|||
27595569|NCT02862457|80359452|FG005|Overall Study|Withdrawal by Subject|1|||
27595570|NCT02862457|80359453|FG006|Overall Study|Withdrawal by Subject|0|||
27595571|NCT00643916|80359454|FG000|Overall Study|Protocol Violation|0|||
27595572|NCT00643916|80359455|FG001|Overall Study|Protocol Violation|1|||
27595573|NCT00643916|80359456|FG002|Overall Study|Protocol Violation|1|||
27595574|NCT00643916|80359457|FG003|Overall Study|Protocol Violation|1|||
27595575|NCT00643916|80359458|FG004|Overall Study|Protocol Violation|0|||
27595576|NCT00643916|80359459|FG005|Overall Study|Protocol Violation|0|||
27595577|NCT00643916|80359454|FG000|Overall Study|Lost to Follow-up|0|||
27595578|NCT00643916|80359455|FG001|Overall Study|Lost to Follow-up|1|||
27833320|NCT01252953|81222448|FG000|Overall Study|Lost to Follow-up|22|||
27833321|NCT01252953|81222449|FG001|Overall Study|Lost to Follow-up|21|||
27833322|NCT01049581|81222450|FG000|Overall Study|Lost to Follow-up|2|||
27833323|NCT01049581|81222451|FG001|Overall Study|Lost to Follow-up|1|||
27833324|NCT03439085|81222452|FG000|Overall Study|Death|2|||
27833325|NCT03439085|81222452|FG000|Overall Study|Screen Failure|20|||
27833326|NCT00867360|81222453|FG000|Overall Study|Withdrawal by Subject|1|||
27833327|NCT00867360|81222454|FG001|Overall Study|Withdrawal by Subject|0|||
27833328|NCT00867360|81222453|FG000|Overall Study|Physician Decision|0|||
27833329|NCT00867360|81222454|FG001|Overall Study|Physician Decision|1|||
27833330|NCT01131260|81222456|FG000|Overall Study|Randomization error|5|||
27833331|NCT01131260|81222457|FG001|Overall Study|Randomization error|1|||
27833332|NCT01131260|81222456|FG000|Overall Study|Declined to continue participation|8|||
27833333|NCT01131260|81222457|FG001|Overall Study|Declined to continue participation|13|||
27833334|NCT01131260|81222456|FG000|Overall Study|Physician Decision|22|||
27833335|NCT01131260|81222457|FG001|Overall Study|Physician Decision|24|||
27833336|NCT01131260|81222456|FG000|Overall Study|Technical problems|7|||
27833337|NCT01131260|81222457|FG001|Overall Study|Technical problems|6|||
27833338|NCT01131260|81222456|FG000|Overall Study|Staff error|2|||
27833339|NCT01131260|81222457|FG001|Overall Study|Staff error|1|||
27833340|NCT01131260|81222456|FG000|Overall Study|Ineligible|0|||
27595579|NCT00643916|80359456|FG002|Overall Study|Lost to Follow-up|0|||
27595580|NCT00643916|80359457|FG003|Overall Study|Lost to Follow-up|0|||
27595581|NCT00643916|80359458|FG004|Overall Study|Lost to Follow-up|0|||
27595582|NCT00643916|80359459|FG005|Overall Study|Lost to Follow-up|0|||
27833341|NCT01131260|81222457|FG001|Overall Study|Ineligible|2|||
27886762|NCT03557931|81419463|FG001|Overall Study|Withdrawal by Subject|0|||
27595583|NCT00643916|80359454|FG000|Overall Study|Withdrawal by Subject|2|||
27886763|NCT03557931|81419464|FG002|Overall Study|Withdrawal by Subject|7|||
27886764|NCT03557931|81419462|FG000|Overall Study|Miscellaneous|8|||
27886765|NCT03557931|81419463|FG001|Overall Study|Miscellaneous|5|||
27595584|NCT00643916|80359455|FG001|Overall Study|Withdrawal by Subject|2|||
27595585|NCT00643916|80359456|FG002|Overall Study|Withdrawal by Subject|2|||
27595586|NCT00643916|80359457|FG003|Overall Study|Withdrawal by Subject|1|||
27595587|NCT00643916|80359458|FG004|Overall Study|Withdrawal by Subject|0|||
27595588|NCT00643916|80359459|FG005|Overall Study|Withdrawal by Subject|1|||
27833342|NCT00909038|81222458|FG000|Overall Study|Protocol Violation|187|||
27833343|NCT00909038|81222458|FG000|Overall Study|Non-evaluable Subjects|230|||
27833344|NCT03314857|81222461|FG000|Overall Study|Death|4|||
27833345|NCT03314857|81222461|FG000|Overall Study|Physician Decision|1|||
27886766|NCT03557931|81419464|FG002|Overall Study|Miscellaneous|3|||
27959320|NCT02131662|81683271|FG002|Overall Study|Lack of Efficacy|0|||
27595589|NCT00643916|80359454|FG000|Overall Study|Not Vaccinated|2|||
27595590|NCT00643916|80359455|FG001|Overall Study|Not Vaccinated|2|||
27595591|NCT00643916|80359456|FG002|Overall Study|Not Vaccinated|3|||
27595592|NCT00643916|80359457|FG003|Overall Study|Not Vaccinated|0|||
27595593|NCT00643916|80359458|FG004|Overall Study|Not Vaccinated|2|||
27595594|NCT00643916|80359459|FG005|Overall Study|Not Vaccinated|0|||
27595595|NCT00160680|80359460|FG000|Overall Study|Adverse Event|0|||
27595596|NCT00160680|80359461|FG001|Overall Study|Adverse Event|1|||
27595597|NCT00160680|80359460|FG000|Overall Study|Lack of Efficacy|2|||
27595598|NCT00160680|80359461|FG001|Overall Study|Lack of Efficacy|1|||
27595599|NCT00160680|80359460|FG000|Overall Study|Lost to Follow-up|3|||
27595600|NCT00160680|80359461|FG001|Overall Study|Lost to Follow-up|2|||
27595601|NCT00160680|80359460|FG000|Overall Study|Withdrawal by Subject|4|||
27595602|NCT00160680|80359461|FG001|Overall Study|Withdrawal by Subject|9|||
27595603|NCT00419263|80359462|FG000|Overall Study|Lost to Follow-up|2|||
27595604|NCT00419263|80359463|FG001|Overall Study|Lost to Follow-up|1|||
27595605|NCT00419263|80359464|FG002|Overall Study|Lost to Follow-up|1|||
27595606|NCT00419263|80359462|FG000|Overall Study|Randomized in Error, Not Treated|1|||
27595607|NCT00419263|80359463|FG001|Overall Study|Randomized in Error, Not Treated|1|||
27595608|NCT00419263|80359464|FG002|Overall Study|Randomized in Error, Not Treated|0|||
27595609|NCT00419263|80359462|FG000|Overall Study|Adverse Event|0|||
27595610|NCT00419263|80359463|FG001|Overall Study|Adverse Event|0|||
27595611|NCT00419263|80359464|FG002|Overall Study|Adverse Event|1|||
27595612|NCT00419263|80359462|FG000|Overall Study|Withdrawal by Subject|0|||
27595613|NCT00419263|80359463|FG001|Overall Study|Withdrawal by Subject|0|||
27595614|NCT00419263|80359464|FG002|Overall Study|Withdrawal by Subject|1|||
27595615|NCT02366910|80359465|FG000|Overall Study|Withdrawal by Subject|2|||
27595616|NCT02366910|80359465|FG000|Overall Study|Screen Failure|3|||
27595617|NCT01261611|80359467|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
27595618|NCT01261611|80359468|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
27595619|NCT01261611|80359469|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
27595620|NCT01261611|80359467|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
27595621|NCT01261611|80359468|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
27595622|NCT01261611|80359469|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
27595623|NCT01261611|80359467|FG000|Treatment Cycle 1|Adverse Event|0|||
27595624|NCT01261611|80359468|FG001|Treatment Cycle 1|Adverse Event|1|||
27595625|NCT01261611|80359469|FG002|Treatment Cycle 1|Adverse Event|0|||
27595626|NCT01261611|80359467|FG000|Treatment Cycle 1|Protocol Violation|0|||
27595627|NCT01261611|80359468|FG001|Treatment Cycle 1|Protocol Violation|0|||
27595628|NCT01261611|80359469|FG002|Treatment Cycle 1|Protocol Violation|2|||
27595629|NCT01261611|80359467|FG000|Treatment Cycle 2|Completed study|4|||
27595630|NCT01261611|80359468|FG001|Treatment Cycle 2|Completed study|0|||
27595631|NCT01261611|80359469|FG002|Treatment Cycle 2|Completed study|0|||
27886767|NCT01282372|81419466|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
27886768|NCT01282372|81419466|FG000|Overall Study|Lost to Follow-up|23|||
27833346|NCT03306277|81222462|FG000|Overall Study|Death|1|||
27833347|NCT03306277|81222462|FG000|Overall Study|Adverse Event|1|||
27833348|NCT03306277|81222462|FG000|Overall Study|Withdrawal by Subject|1|||
27833349|NCT00101439|81222465|FG000|Period 2|Withdrawal by Subject|0|||
27833350|NCT00101439|81222466|FG001|Period 2|Withdrawal by Subject|2|||
27833351|NCT02255149|81222472|FG000|Overall Study|Lost to Follow-up|2|||
27833352|NCT02255149|81222472|FG000|Overall Study|Withdrawal by Subject|1|||
27595632|NCT01261611|80359467|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
27595633|NCT01261611|80359468|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
27595634|NCT01261611|80359469|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
27595635|NCT01261611|80359467|FG000|Treatment Cycle 2|Adverse Event|1|||
27595636|NCT01261611|80359468|FG001|Treatment Cycle 2|Adverse Event|0|||
27595637|NCT01261611|80359469|FG002|Treatment Cycle 2|Adverse Event|0|||
27595638|NCT01261611|80359467|FG000|Treatment Cycle 2|Protocol Violation|2|||
27595639|NCT01261611|80359468|FG001|Treatment Cycle 2|Protocol Violation|0|||
27595640|NCT01261611|80359469|FG002|Treatment Cycle 2|Protocol Violation|0|||
27886769|NCT01282372|81419466|FG000|Overall Study|Withdrawal by Subject|11|||
27595641|NCT01261611|80359467|FG000|Treatment Cycle 2|Not otherwise specified|2|||
27595642|NCT01261611|80359468|FG001|Treatment Cycle 2|Not otherwise specified|0|||
27886770|NCT01282372|81419466|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
27833353|NCT02255149|81222472|FG000|Overall Study|Withdrawal by PI|1|||
27886771|NCT01282372|81419466|FG000|Overall Study|Death|1|||
27595643|NCT01261611|80359469|FG002|Treatment Cycle 2|Not otherwise specified|0|||
27595644|NCT01261611|80359467|FG000|Treatment Cycle 3|Completed study|24|||
27595645|NCT01261611|80359468|FG001|Treatment Cycle 3|Completed study|0|||
27886772|NCT01282372|81419466|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
27595646|NCT01261611|80359469|FG002|Treatment Cycle 3|Completed study|0|||
27595647|NCT01261611|80359467|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
27595648|NCT01261611|80359468|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
27595649|NCT01261611|80359469|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
27595650|NCT01261611|80359467|FG000|Treatment Cycle 3|Adverse Event|1|||
27595651|NCT01261611|80359468|FG001|Treatment Cycle 3|Adverse Event|0|||
27595652|NCT01261611|80359469|FG002|Treatment Cycle 3|Adverse Event|0|||
27595653|NCT01261611|80359467|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
27595654|NCT01261611|80359468|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
27595655|NCT01261611|80359469|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
27595656|NCT01261611|80359467|FG000|Treatment Cycle 4|Completed study|87|||
27595657|NCT01261611|80359468|FG001|Treatment Cycle 4|Completed study|0|||
27595658|NCT01261611|80359469|FG002|Treatment Cycle 4|Completed study|0|||
27595659|NCT01261611|80359467|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
27595660|NCT01261611|80359468|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
27595661|NCT01261611|80359469|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
27595662|NCT01261611|80359467|FG000|Treatment Cycle 4|Adverse Event|1|||
27701443|NCT03085758|80745395|FG000|Overall Study|Refusal to recall it up to day 90|0|||
27701444|NCT03085758|80745396|FG001|Overall Study|Refusal to recall it up to day 90|0|||
27701445|NCT03085758|80745397|FG002|Overall Study|Refusal to recall it up to day 90|1|||
27701446|NCT03085758|80745395|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
27701447|NCT03085758|80745396|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
27701448|NCT03085758|80745397|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
27701449|NCT01968070|80745398|FG000|Period 1|Withdrawal by Subject|0|||
27701450|NCT01968070|80745399|FG001|Period 1|Withdrawal by Subject|1|||
27701451|NCT01968070|80745400|FG002|Period 1|Withdrawal by Subject|0|||
27701452|NCT01968070|80745401|FG003|Period 1|Withdrawal by Subject|0|||
27701453|NCT01968070|80745402|FG004|Period 1|Withdrawal by Subject|0|||
27595663|NCT01261611|80359468|FG001|Treatment Cycle 4|Adverse Event|0|||
27595664|NCT01261611|80359469|FG002|Treatment Cycle 4|Adverse Event|0|||
27595665|NCT01261611|80359467|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
27701454|NCT01968070|80745403|FG005|Period 1|Withdrawal by Subject|0|||
27701455|NCT01968070|80745404|FG006|Period 1|Withdrawal by Subject|1|||
27701456|NCT01968070|80745405|FG007|Period 1|Withdrawal by Subject|0|||
27701457|NCT01968070|80745406|FG008|Period 1|Withdrawal by Subject|0|||
27833354|NCT02255149|81222472|FG000|Overall Study|Implant Failure|1|||
27595666|NCT01261611|80359468|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
27595667|NCT01261611|80359469|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
27833355|NCT03382041|81222480|FG000|Overall Study|Consent Form Lost|2|||
27595668|NCT01261611|80359467|FG000|Treatment Cycle 4|Not otherwise specified|3|||
27595669|NCT01261611|80359468|FG001|Treatment Cycle 4|Not otherwise specified|0|||
27595670|NCT01261611|80359469|FG002|Treatment Cycle 4|Not otherwise specified|0|||
27595671|NCT01261611|80359467|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
27595672|NCT01261611|80359468|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
27595673|NCT01261611|80359469|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
27595674|NCT01261611|80359467|FG000|Treatment Cycle 5|Adverse Event|1|||
27595675|NCT01261611|80359468|FG001|Treatment Cycle 5|Adverse Event|0|||
27595676|NCT01261611|80359469|FG002|Treatment Cycle 5|Adverse Event|0|||
27595677|NCT01261611|80359467|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
27595678|NCT01261611|80359468|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
27595679|NCT01261611|80359469|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
27595680|NCT00514735|80359470|FG000|Overall Study|Withdrawal by Subject|13|||
27595681|NCT00514735|80359471|FG001|Overall Study|Withdrawal by Subject|5|||
27595682|NCT00514735|80359470|FG000|Overall Study|Death|1|||
27595683|NCT00514735|80359471|FG001|Overall Study|Death|0|||
27595684|NCT00514735|80359470|FG000|Overall Study|Lost to Follow-up|0|||
27595685|NCT00514735|80359471|FG001|Overall Study|Lost to Follow-up|1|||
27595686|NCT00499031|80359472|FG000|Overall Study|Improper pre-protocol treatment|1|||
27595687|NCT00499031|80359472|FG000|Overall Study|Required test not done|1|||
27595688|NCT00499031|80359472|FG000|Overall Study|Never treated|1|||
27595689|NCT00535730|80359475|FG000|Overall Study|Adverse Event|1|||
27595690|NCT00535730|80359476|FG001|Overall Study|Adverse Event|1|||
27595691|NCT00535730|80359475|FG000|Overall Study|Lost to Follow-up|0|||
27595692|NCT00535730|80359476|FG001|Overall Study|Lost to Follow-up|1|||
27595693|NCT00535730|80359475|FG000|Overall Study|Physician Decision|0|||
27595694|NCT00535730|80359476|FG001|Overall Study|Physician Decision|1|||
27595695|NCT00535730|80359475|FG000|Overall Study|Protocol Violation|1|||
27595696|NCT00535730|80359476|FG001|Overall Study|Protocol Violation|0|||
27595697|NCT00535730|80359475|FG000|Overall Study|Withdrawal by Subject|0|||
27595698|NCT00535730|80359476|FG001|Overall Study|Withdrawal by Subject|4|||
27595699|NCT02820623|80359481|FG000|Overall Study|Withdrawal by Subject|1|||
27595700|NCT02820623|80359482|FG001|Overall Study|Withdrawal by Subject|3|||
27595701|NCT02820623|80359483|FG002|Overall Study|Withdrawal by Subject|3|||
27595702|NCT02820623|80359481|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
27595703|NCT02820623|80359482|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
27595704|NCT02820623|80359483|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
27595705|NCT02820623|80359481|FG000|Overall Study|Therapist unable to enroll clients|1|||
27595706|NCT02820623|80359482|FG001|Overall Study|Therapist unable to enroll clients|1|||
27595707|NCT02820623|80359483|FG002|Overall Study|Therapist unable to enroll clients|3|||
27595708|NCT02820623|80359481|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
27595709|NCT02820623|80359482|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
27595710|NCT02820623|80359483|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
27595711|NCT05763628|80359490|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
27595712|NCT05763628|80359491|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
27595713|NCT05763628|80359490|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
27595714|NCT05763628|80359491|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
27595715|NCT05763628|80359490|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
27595716|NCT05763628|80359491|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
27595717|NCT02207816|80359499|FG000|Overall Study|Serious Adverse Event|0|||
27595718|NCT02207816|80359500|FG001|Overall Study|Serious Adverse Event|5|||
27595719|NCT02207816|80359501|FG002|Overall Study|Serious Adverse Event|2|||
27595720|NCT02207816|80359499|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27595721|NCT02207816|80359500|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
27595722|NCT02207816|80359501|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27595723|NCT02207816|80359499|FG000|Overall Study|Withdrawal by Subject|4|||
27595724|NCT02207816|80359500|FG001|Overall Study|Withdrawal by Subject|9|||
27595725|NCT02207816|80359501|FG002|Overall Study|Withdrawal by Subject|7|||
27595726|NCT02207816|80359499|FG000|Overall Study|Migrated/Moved From Study Area|41|||
27595727|NCT02207816|80359500|FG001|Overall Study|Migrated/Moved From Study Area|60|||
27595728|NCT02207816|80359501|FG002|Overall Study|Migrated/Moved From Study Area|51|||
27595729|NCT02207816|80359499|FG000|Overall Study|Lost to Follow-up|3|||
27595730|NCT02207816|80359500|FG001|Overall Study|Lost to Follow-up|9|||
27886773|NCT01282372|81419466|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
27886774|NCT01282372|81419466|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
27886775|NCT01282372|81419466|FG000|Overall Study|Adverse Event|12|||
27886776|NCT02977572|81419469|FG000|Overall Study|Exclusion criterion|2|||
27886777|NCT02977572|81419470|FG001|Overall Study|Exclusion criterion|2|||
27886778|NCT04292912|81419473|FG000|Overall Study|Physician Decision|1|||
27595731|NCT02207816|80359501|FG002|Overall Study|Lost to Follow-up|1|||
27595732|NCT02207816|80359499|FG000|Overall Study|Other|1|||
27595733|NCT02207816|80359500|FG001|Overall Study|Other|2|||
27595734|NCT02207816|80359501|FG002|Overall Study|Other|4|||
27595735|NCT03015402|80359502|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
27886779|NCT04292912|81419473|FG000|Overall Study|Protocol Violation|6|||
27595736|NCT03015402|80359503|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
27595737|NCT03015402|80359502|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
27595738|NCT03015402|80359503|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
27595739|NCT02313428|80359504|FG000|Overall Study|Lost to Follow-up|1|||
27595740|NCT02313428|80359505|FG001|Overall Study|Lost to Follow-up|1|||
27595741|NCT03982186|80359506|FG000|Overall Study|Lost to Follow-up|0|||
27595742|NCT03982186|80359507|FG001|Overall Study|Lost to Follow-up|1|||
27595743|NCT03982186|80359508|FG002|Overall Study|Lost to Follow-up|2|||
27595744|NCT03982186|80359509|FG003|Overall Study|Lost to Follow-up|1|||
27595745|NCT03982186|80359510|FG004|Overall Study|Lost to Follow-up|1|||
27595746|NCT03982186|80359511|FG005|Overall Study|Lost to Follow-up|0|||
27595747|NCT03982186|80359506|FG000|Overall Study|Physician Decision|0|||
27595748|NCT03982186|80359507|FG001|Overall Study|Physician Decision|1|||
27833356|NCT03382041|81222481|FG001|Overall Study|Consent Form Lost|1|||
27595749|NCT03982186|80359508|FG002|Overall Study|Physician Decision|0|||
27595750|NCT03982186|80359509|FG003|Overall Study|Physician Decision|0|||
27595751|NCT03982186|80359510|FG004|Overall Study|Physician Decision|0|||
27595752|NCT03982186|80359511|FG005|Overall Study|Physician Decision|0|||
27595753|NCT03982186|80359506|FG000|Overall Study|Withdrawal by Subject|3|||
27595754|NCT03982186|80359507|FG001|Overall Study|Withdrawal by Subject|4|||
27595755|NCT03982186|80359508|FG002|Overall Study|Withdrawal by Subject|1|||
27595756|NCT03982186|80359509|FG003|Overall Study|Withdrawal by Subject|7|||
27595757|NCT03982186|80359510|FG004|Overall Study|Withdrawal by Subject|2|||
27595758|NCT03982186|80359511|FG005|Overall Study|Withdrawal by Subject|0|||
27595759|NCT03982186|80359506|FG000|Overall Study|Randomized and not treated|0|||
27595760|NCT03982186|80359507|FG001|Overall Study|Randomized and not treated|0|||
27595761|NCT03982186|80359508|FG002|Overall Study|Randomized and not treated|0|||
27595762|NCT03982186|80359509|FG003|Overall Study|Randomized and not treated|1|||
27595763|NCT03982186|80359510|FG004|Overall Study|Randomized and not treated|0|||
27595764|NCT03982186|80359511|FG005|Overall Study|Randomized and not treated|0|||
27595765|NCT00917579|80359512|FG000|Washout >= 2 Weeks|Adverse Event|1|||
27595766|NCT00917579|80359513|FG001|Washout >= 2 Weeks|Adverse Event|0|||
27595767|NCT00917579|80359512|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
27595768|NCT00917579|80359513|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
27595769|NCT03221387|80359514|FG000|Overall Study|Lost to Follow-up|1|||
27595770|NCT03221387|80359514|FG000|Overall Study|Lung transplant|1|||
27886780|NCT03626363|81419474|FG000|Overall Study|Protocol Violation|4|||
27886781|NCT03626363|81419475|FG001|Overall Study|Protocol Violation|0|||
27886782|NCT03626363|81419474|FG000|Overall Study|Lost to Follow-up|5|||
27886783|NCT03626363|81419475|FG001|Overall Study|Lost to Follow-up|7|||
27886784|NCT04445714|81419480|FG000|Overall Study|Discontinuation of the study|14|||
27886785|NCT04445714|81419480|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
27886786|NCT04445714|81419480|FG000|Overall Study|Withdrawal of Informed Consent|8|||
27886787|NCT02125786|81419487|FG000|Overall Study|Still in Follow-up|3|||
27886788|NCT02125786|81419487|FG000|Overall Study|Screen Failure|2|||
27886789|NCT02125786|81419487|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
27886790|NCT02125786|81419487|FG000|Overall Study|Progressive Disease|44|||
27886791|NCT02125786|81419487|FG000|Overall Study|Death|8|||
27886792|NCT02751931|81419488|FG000|Overall Study|Adverse Event|3|||
27886793|NCT02751931|81419489|FG001|Overall Study|Adverse Event|0|||
27886794|NCT02751931|81419488|FG000|Overall Study|Other: Miscelleneous|10|||
27886795|NCT02751931|81419489|FG001|Overall Study|Other: Miscelleneous|8|||
27886796|NCT03379753|81419494|FG000|Overall Study|Withdrawal by Subject|2|||
27886797|NCT03379753|81419495|FG001|Overall Study|Withdrawal by Subject|1|||
27886798|NCT03379753|81419494|FG000|Overall Study|not having correct procedure|1|||
27886799|NCT03379753|81419495|FG001|Overall Study|not having correct procedure|2|||
27886800|NCT03379753|81419494|FG000|Overall Study|No primary outcome|12|||
27886801|NCT03379753|81419495|FG001|Overall Study|No primary outcome|22|||
27595771|NCT00743366|80359515|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
27595772|NCT00743366|80359516|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
27595773|NCT02794285|80359519|FG000|Overall Study|Adverse Event|11|||
27595774|NCT02794285|80359520|FG001|Overall Study|Adverse Event|4|||
27595775|NCT02794285|80359521|FG002|Overall Study|Adverse Event|5|||
27595776|NCT02794285|80359522|FG003|Overall Study|Adverse Event|8|||
27595777|NCT02794285|80359519|FG000|Overall Study|Condition Under Investigation Improved|1|||
27886802|NCT04300309|81419504|FG000|Overall Study|Lost to Follow-up|1|||
27886803|NCT04300309|81419505|FG001|Overall Study|Lost to Follow-up|0|||
27958529|NCT01791517|81680061|FG003|Phase I: Period 2|Lost to Follow-up|0|||
27701458|NCT01968070|80745407|FG009|Period 1|Withdrawal by Subject|0|||
27701459|NCT01968070|80745408|FG010|Period 1|Withdrawal by Subject|0|||
27701460|NCT01968070|80745409|FG011|Period 1|Withdrawal by Subject|0|||
27701461|NCT01968070|80745410|FG012|Period 1|Withdrawal by Subject|0|||
27701462|NCT01968070|80745411|FG013|Period 1|Withdrawal by Subject|0|||
27701463|NCT01968070|80745412|FG014|Period 1|Withdrawal by Subject|0|||
27701464|NCT01968070|80745413|FG015|Period 1|Withdrawal by Subject|1|||
27833357|NCT03382041|81222480|FG000|Overall Study|Withdrawal by Subject|1|||
27595778|NCT02794285|80359520|FG001|Overall Study|Condition Under Investigation Improved|0|||
27595779|NCT02794285|80359521|FG002|Overall Study|Condition Under Investigation Improved|0|||
27595780|NCT02794285|80359522|FG003|Overall Study|Condition Under Investigation Improved|0|||
27595781|NCT02794285|80359519|FG000|Overall Study|Condition Under Investigation Worsened|0|||
27595782|NCT02794285|80359520|FG001|Overall Study|Condition Under Investigation Worsened|2|||
27595783|NCT02794285|80359521|FG002|Overall Study|Condition Under Investigation Worsened|1|||
27595784|NCT02794285|80359522|FG003|Overall Study|Condition Under Investigation Worsened|0|||
27701465|NCT01968070|80745414|FG016|Period 1|Withdrawal by Subject|0|||
27701466|NCT01968070|80745415|FG017|Period 1|Withdrawal by Subject|0|||
27701467|NCT01968070|80745398|FG000|Period 1|Protocol Violation|0|||
27701468|NCT01968070|80745399|FG001|Period 1|Protocol Violation|0|||
27701469|NCT01968070|80745400|FG002|Period 1|Protocol Violation|0|||
27701470|NCT01968070|80745401|FG003|Period 1|Protocol Violation|1|||
27595785|NCT02794285|80359519|FG000|Overall Study|Death|2|||
27595786|NCT02794285|80359520|FG001|Overall Study|Death|1|||
27595787|NCT02794285|80359521|FG002|Overall Study|Death|2|||
27595788|NCT02794285|80359522|FG003|Overall Study|Death|0|||
27595789|NCT02794285|80359519|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
27595790|NCT02794285|80359520|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
27701471|NCT01968070|80745402|FG004|Period 1|Protocol Violation|1|||
27701472|NCT01968070|80745403|FG005|Period 1|Protocol Violation|0|||
27701473|NCT01968070|80745404|FG006|Period 1|Protocol Violation|0|||
27701474|NCT01968070|80745405|FG007|Period 1|Protocol Violation|0|||
27701475|NCT01968070|80745406|FG008|Period 1|Protocol Violation|0|||
27701476|NCT01968070|80745407|FG009|Period 1|Protocol Violation|0|||
27833358|NCT03382041|81222481|FG001|Overall Study|Withdrawal by Subject|4|||
27833359|NCT03382041|81222480|FG000|Overall Study|Lost to Follow-up|1|||
27833360|NCT03382041|81222481|FG001|Overall Study|Lost to Follow-up|4|||
27833361|NCT03504085|81222482|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
27595791|NCT02794285|80359521|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
27701477|NCT01968070|80745408|FG010|Period 1|Protocol Violation|0|||
27701478|NCT01968070|80745409|FG011|Period 1|Protocol Violation|0|||
27833362|NCT03504085|81222483|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
27833363|NCT03504085|81222482|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
27833364|NCT03504085|81222483|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
27833365|NCT05274763|81222485|FG000|Overall Study|Lost to Follow-up|1|||
27833366|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Subject request|8|||
27833367|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Subject request|11|||
27833368|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
27833369|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
27833370|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
27833371|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
27833372|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
27833373|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
27833374|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
27833375|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
27595792|NCT02794285|80359522|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
27701479|NCT01968070|80745410|FG012|Period 1|Protocol Violation|0|||
27701480|NCT01968070|80745411|FG013|Period 1|Protocol Violation|0|||
27833376|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
27833377|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
27701481|NCT01968070|80745412|FG014|Period 1|Protocol Violation|0|||
27701482|NCT01968070|80745413|FG015|Period 1|Protocol Violation|0|||
27701483|NCT01968070|80745414|FG016|Period 1|Protocol Violation|0|||
27701484|NCT01968070|80745415|FG017|Period 1|Protocol Violation|0|||
27701485|NCT01968070|80745398|FG000|Period 1|Lost to Follow-up|0|||
27701486|NCT01968070|80745399|FG001|Period 1|Lost to Follow-up|0|||
27701487|NCT01968070|80745400|FG002|Period 1|Lost to Follow-up|0|||
27701488|NCT01968070|80745401|FG003|Period 1|Lost to Follow-up|1|||
27701489|NCT01968070|80745402|FG004|Period 1|Lost to Follow-up|0|||
27701490|NCT01968070|80745403|FG005|Period 1|Lost to Follow-up|0|||
27701491|NCT01968070|80745404|FG006|Period 1|Lost to Follow-up|0|||
27701492|NCT01968070|80745405|FG007|Period 1|Lost to Follow-up|0|||
27701493|NCT01968070|80745406|FG008|Period 1|Lost to Follow-up|0|||
27701494|NCT01968070|80745407|FG009|Period 1|Lost to Follow-up|0|||
27701495|NCT01968070|80745408|FG010|Period 1|Lost to Follow-up|0|||
27701496|NCT01968070|80745409|FG011|Period 1|Lost to Follow-up|0|||
27701497|NCT01968070|80745410|FG012|Period 1|Lost to Follow-up|0|||
27701498|NCT01968070|80745411|FG013|Period 1|Lost to Follow-up|0|||
27701499|NCT01968070|80745412|FG014|Period 1|Lost to Follow-up|0|||
27701500|NCT01968070|80745413|FG015|Period 1|Lost to Follow-up|0|||
27701501|NCT01968070|80745414|FG016|Period 1|Lost to Follow-up|0|||
27701502|NCT01968070|80745415|FG017|Period 1|Lost to Follow-up|0|||
27701503|NCT01968070|80745398|FG000|Period 1|Adverse Event|0|||
27701504|NCT01968070|80745399|FG001|Period 1|Adverse Event|0|||
27701505|NCT01968070|80745400|FG002|Period 1|Adverse Event|0|||
27701506|NCT01968070|80745401|FG003|Period 1|Adverse Event|0|||
27701507|NCT01968070|80745402|FG004|Period 1|Adverse Event|0|||
27701508|NCT01968070|80745403|FG005|Period 1|Adverse Event|0|||
27701509|NCT01968070|80745404|FG006|Period 1|Adverse Event|1|||
27701510|NCT01968070|80745405|FG007|Period 1|Adverse Event|0|||
27701511|NCT01968070|80745406|FG008|Period 1|Adverse Event|0|||
27701512|NCT01968070|80745407|FG009|Period 1|Adverse Event|0|||
27701513|NCT01968070|80745408|FG010|Period 1|Adverse Event|0|||
27701514|NCT01968070|80745409|FG011|Period 1|Adverse Event|0|||
27701515|NCT01968070|80745410|FG012|Period 1|Adverse Event|0|||
27701516|NCT01968070|80745411|FG013|Period 1|Adverse Event|0|||
27701517|NCT01968070|80745412|FG014|Period 1|Adverse Event|0|||
27701518|NCT01968070|80745413|FG015|Period 1|Adverse Event|0|||
27701519|NCT01968070|80745414|FG016|Period 1|Adverse Event|0|||
27701520|NCT01968070|80745415|FG017|Period 1|Adverse Event|0|||
27701521|NCT01968070|80745398|FG000|Period 1|Physician Decision|0|||
27595793|NCT02794285|80359519|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
27701522|NCT01968070|80745399|FG001|Period 1|Physician Decision|0|||
27701523|NCT01968070|80745400|FG002|Period 1|Physician Decision|0|||
27701524|NCT01968070|80745401|FG003|Period 1|Physician Decision|0|||
27701525|NCT01968070|80745402|FG004|Period 1|Physician Decision|0|||
27701526|NCT01968070|80745403|FG005|Period 1|Physician Decision|0|||
27701527|NCT01968070|80745404|FG006|Period 1|Physician Decision|0|||
27701528|NCT01968070|80745405|FG007|Period 1|Physician Decision|0|||
27701529|NCT01968070|80745406|FG008|Period 1|Physician Decision|0|||
27701530|NCT01968070|80745407|FG009|Period 1|Physician Decision|0|||
27701531|NCT01968070|80745408|FG010|Period 1|Physician Decision|0|||
27701532|NCT01968070|80745409|FG011|Period 1|Physician Decision|1|||
27701533|NCT01968070|80745410|FG012|Period 1|Physician Decision|0|||
27701534|NCT01968070|80745411|FG013|Period 1|Physician Decision|0|||
27701535|NCT01968070|80745412|FG014|Period 1|Physician Decision|0|||
27701536|NCT01968070|80745413|FG015|Period 1|Physician Decision|0|||
27701537|NCT01968070|80745414|FG016|Period 1|Physician Decision|0|||
27701538|NCT01968070|80745415|FG017|Period 1|Physician Decision|0|||
27701539|NCT01968070|80745398|FG000|Period 2|Withdrawal by Subject|0|||
27701540|NCT01968070|80745399|FG001|Period 2|Withdrawal by Subject|0|||
27701541|NCT01968070|80745400|FG002|Period 2|Withdrawal by Subject|0|||
27701542|NCT01968070|80745401|FG003|Period 2|Withdrawal by Subject|0|||
27701543|NCT01968070|80745402|FG004|Period 2|Withdrawal by Subject|1|||
27701544|NCT01968070|80745403|FG005|Period 2|Withdrawal by Subject|0|||
27701545|NCT01968070|80745404|FG006|Period 2|Withdrawal by Subject|0|||
27701546|NCT01968070|80745405|FG007|Period 2|Withdrawal by Subject|0|||
27701547|NCT01968070|80745406|FG008|Period 2|Withdrawal by Subject|0|||
27701548|NCT01968070|80745407|FG009|Period 2|Withdrawal by Subject|0|||
27701549|NCT01968070|80745408|FG010|Period 2|Withdrawal by Subject|0|||
27701550|NCT01968070|80745409|FG011|Period 2|Withdrawal by Subject|0|||
27701551|NCT01968070|80745410|FG012|Period 2|Withdrawal by Subject|0|||
27701552|NCT01968070|80745411|FG013|Period 2|Withdrawal by Subject|0|||
27701553|NCT01968070|80745412|FG014|Period 2|Withdrawal by Subject|0|||
27701554|NCT01968070|80745413|FG015|Period 2|Withdrawal by Subject|0|||
27701555|NCT01968070|80745414|FG016|Period 2|Withdrawal by Subject|0|||
27701556|NCT01968070|80745415|FG017|Period 2|Withdrawal by Subject|0|||
27701557|NCT02366728|80745416|FG000|Overall Study|Death|0|||
27701558|NCT02366728|80745417|FG001|Overall Study|Death|0|||
27701559|NCT02366728|80745418|FG002|Overall Study|Death|1|||
27701560|NCT02366728|80745416|FG000|Overall Study|Adverse Event|1|||
27701561|NCT02366728|80745417|FG001|Overall Study|Adverse Event|0|||
27701562|NCT02366728|80745418|FG002|Overall Study|Adverse Event|0|||
27701563|NCT02366728|80745416|FG000|Overall Study|Screen Failure|2|||
27701564|NCT02366728|80745417|FG001|Overall Study|Screen Failure|1|||
27701565|NCT02366728|80745418|FG002|Overall Study|Screen Failure|0|||
27701566|NCT02366728|80745416|FG000|Overall Study|Only yielded 2 vaccines|1|||
27701567|NCT02366728|80745417|FG001|Overall Study|Only yielded 2 vaccines|0|||
27701568|NCT02366728|80745418|FG002|Overall Study|Only yielded 2 vaccines|0|||
27701569|NCT00617604|80745419|FG000|Overall Study|Death|2|||
27701570|NCT00617604|80745420|FG001|Overall Study|Death|1|||
27701571|NCT00617604|80745419|FG000|Overall Study|Lost to Follow-up|1|||
27701572|NCT00617604|80745420|FG001|Overall Study|Lost to Follow-up|0|||
27701573|NCT00617604|80745419|FG000|Overall Study|Miscellaneous Reasons|8|||
27701574|NCT00617604|80745420|FG001|Overall Study|Miscellaneous Reasons|10|||
27701575|NCT00617604|80745419|FG000|Overall Study|Withdrawal by Subject|4|||
27701576|NCT00617604|80745420|FG001|Overall Study|Withdrawal by Subject|6|||
27701577|NCT00617604|80745419|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
27701578|NCT00617604|80745420|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
27701579|NCT01990534|80745421|FG000|Overall Study|Death|22|||
27701580|NCT01990534|80745421|FG000|Overall Study|Progressive disease|3|||
27701581|NCT01990534|80745421|FG000|Overall Study|Protocol Violation|1|||
27701582|NCT01990534|80745421|FG000|Overall Study|Withdrawal of Informed Consent|2|||
27701583|NCT01990534|80745421|FG000|Overall Study|Symptomatic Deterioration|1|||
27701584|NCT01990534|80745421|FG000|Overall Study|Withdrawal by Subject|3|||
27701585|NCT01990534|80745421|FG000|Overall Study|Reason not Specified|2|||
27701586|NCT01990534|80745421|FG000|Overall Study|Lost to Follow-up|1|||
27701587|NCT01428661|80745422|FG000|Double-Masked Phase|Protocol Violation|9|||
27701588|NCT01428661|80745423|FG001|Double-Masked Phase|Protocol Violation|4|||
27701589|NCT01428661|80745424|FG002|Double-Masked Phase|Protocol Violation|0|||
27701590|NCT01428661|80745422|FG000|Double-Masked Phase|Adverse Event|13|||
27701591|NCT01428661|80745423|FG001|Double-Masked Phase|Adverse Event|4|||
27701592|NCT01428661|80745424|FG002|Double-Masked Phase|Adverse Event|0|||
27701593|NCT01428661|80745422|FG000|Double-Masked Phase|Lost to Follow-up|14|||
27701594|NCT01428661|80745423|FG001|Double-Masked Phase|Lost to Follow-up|14|||
27701595|NCT01428661|80745424|FG002|Double-Masked Phase|Lost to Follow-up|0|||
27701596|NCT01428661|80745422|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
27701597|NCT01428661|80745423|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
27833378|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Death|1|||
27833379|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Death|0|||
27833380|NCT00521586|81222488|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
27701598|NCT01428661|80745424|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
27701599|NCT01428661|80745422|FG000|Double-Masked Phase|Lack of Efficacy|2|||
27701600|NCT01428661|80745423|FG001|Double-Masked Phase|Lack of Efficacy|1|||
27833381|NCT00521586|81222489|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
27833382|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
27833383|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
27833384|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
27833385|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
27833386|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
27833387|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
27833388|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
27833389|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
27701601|NCT01428661|80745424|FG002|Double-Masked Phase|Lack of Efficacy|0|||
27701602|NCT01428661|80745422|FG000|Double-Masked Phase|*Various|1|||
27701603|NCT01428661|80745423|FG001|Double-Masked Phase|*Various|6|||
27701604|NCT01428661|80745424|FG002|Double-Masked Phase|*Various|0|||
27701605|NCT01428661|80745422|FG000|Open Label Extension|Protocol Violation|0|||
27701606|NCT01428661|80745423|FG001|Open Label Extension|Protocol Violation|0|||
27701607|NCT01428661|80745424|FG002|Open Label Extension|Protocol Violation|9|||
27701608|NCT01428661|80745422|FG000|Open Label Extension|Adverse Event|0|||
27701609|NCT01428661|80745423|FG001|Open Label Extension|Adverse Event|0|||
27701610|NCT01428661|80745424|FG002|Open Label Extension|Adverse Event|15|||
27701611|NCT01428661|80745422|FG000|Open Label Extension|Lost to Follow-up|0|||
27701612|NCT01428661|80745423|FG001|Open Label Extension|Lost to Follow-up|0|||
27701613|NCT01428661|80745424|FG002|Open Label Extension|Lost to Follow-up|38|||
27701614|NCT01428661|80745422|FG000|Open Label Extension|Withdrawal by Subject|0|||
27701615|NCT01428661|80745423|FG001|Open Label Extension|Withdrawal by Subject|0|||
27701616|NCT01428661|80745424|FG002|Open Label Extension|Withdrawal by Subject|49|||
27701617|NCT01428661|80745422|FG000|Open Label Extension|Lack of Efficacy|0|||
27701618|NCT01428661|80745423|FG001|Open Label Extension|Lack of Efficacy|0|||
27701619|NCT01428661|80745424|FG002|Open Label Extension|Lack of Efficacy|24|||
27701620|NCT01428661|80745422|FG000|Open Label Extension|**Various|0|||
27701621|NCT01428661|80745423|FG001|Open Label Extension|**Various|0|||
27701622|NCT01428661|80745424|FG002|Open Label Extension|**Various|185|||
27701623|NCT02495233|80745425|FG000|Overall Study|Miscellaneous|0|||
27701624|NCT02495233|80745426|FG001|Overall Study|Miscellaneous|1|||
27701625|NCT03250832|80745427|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
27701626|NCT03250832|80745428|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
27701627|NCT03250832|80745429|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
27701628|NCT03250832|80745430|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
27701629|NCT03250832|80745431|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
27701630|NCT03250832|80745432|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
27701631|NCT03250832|80745433|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
27701632|NCT03250832|80745434|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
27701633|NCT03250832|80745435|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
27701634|NCT03250832|80745436|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
27701635|NCT03250832|80745437|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
27701636|NCT03250832|80745438|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
27701637|NCT03250832|80745427|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
27595794|NCT02794285|80359520|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
27595795|NCT02794285|80359521|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
27595796|NCT02794285|80359522|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
27595797|NCT02794285|80359519|FG000|Overall Study|Lack of Efficacy|10|||
27595798|NCT02794285|80359520|FG001|Overall Study|Lack of Efficacy|6|||
27595799|NCT02794285|80359521|FG002|Overall Study|Lack of Efficacy|3|||
27595800|NCT02794285|80359522|FG003|Overall Study|Lack of Efficacy|3|||
27595801|NCT02794285|80359519|FG000|Overall Study|Lost to Follow-up|5|||
27595802|NCT02794285|80359520|FG001|Overall Study|Lost to Follow-up|6|||
27595803|NCT02794285|80359521|FG002|Overall Study|Lost to Follow-up|3|||
27595804|NCT02794285|80359522|FG003|Overall Study|Lost to Follow-up|1|||
27595805|NCT02794285|80359519|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
27701638|NCT03250832|80745428|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
27886804|NCT04999163|81419506|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
27701639|NCT03250832|80745429|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
27701640|NCT03250832|80745430|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
27886805|NCT04999163|81419507|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
27595806|NCT02794285|80359520|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
27595807|NCT02794285|80359521|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
27595808|NCT02794285|80359522|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
27701641|NCT03250832|80745431|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
27701642|NCT03250832|80745432|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
27701643|NCT03250832|80745433|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
27701644|NCT03250832|80745434|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
27701645|NCT03250832|80745435|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
27701646|NCT03250832|80745436|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
27595809|NCT02794285|80359519|FG000|Overall Study|Withdrawal by Subject|38|||
27595810|NCT02794285|80359520|FG001|Overall Study|Withdrawal by Subject|29|||
27595811|NCT02794285|80359521|FG002|Overall Study|Withdrawal by Subject|20|||
27595812|NCT02794285|80359522|FG003|Overall Study|Withdrawal by Subject|12|||
27595813|NCT02794285|80359519|FG000|Overall Study|Missing|1|||
27595814|NCT02794285|80359520|FG001|Overall Study|Missing|0|||
27595815|NCT02794285|80359521|FG002|Overall Study|Missing|0|||
27595816|NCT02794285|80359522|FG003|Overall Study|Missing|0|||
27595817|NCT02794285|80359519|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
27595818|NCT02794285|80359520|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
27595819|NCT02794285|80359521|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
27595820|NCT02794285|80359522|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
27595821|NCT02794285|80359519|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
27595822|NCT02794285|80359520|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
27595823|NCT02794285|80359521|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
27595824|NCT02794285|80359522|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
27595825|NCT04546581|80359523|FG000|Overall Study|Adverse Event|9|||
27595826|NCT04546581|80359524|FG001|Overall Study|Adverse Event|3|||
27595827|NCT04546581|80359523|FG000|Overall Study|Physician Decision|0|||
27595828|NCT04546581|80359524|FG001|Overall Study|Physician Decision|1|||
27595829|NCT04546581|80359523|FG000|Overall Study|Protocol Violation|1|||
27595830|NCT04546581|80359524|FG001|Overall Study|Protocol Violation|2|||
27595831|NCT04546581|80359523|FG000|Overall Study|Withdrawal by Subject|3|||
27595832|NCT04546581|80359524|FG001|Overall Study|Withdrawal by Subject|7|||
27595833|NCT01292928|80359525|FG000|Overall Study|Death|8|||
27595834|NCT01292928|80359525|FG000|Overall Study|Withdrawal by Subject|8|||
27595835|NCT01292928|80359525|FG000|Overall Study|Lost to Follow-up|6|||
27595836|NCT01292928|80359525|FG000|Overall Study|Physician Decision|2|||
27595837|NCT01970982|80359526|FG000|Overall Study|Withdrawal by Subject|0|||
27595838|NCT01970982|80359527|FG001|Overall Study|Withdrawal by Subject|0|||
27595839|NCT01970982|80359528|FG002|Overall Study|Withdrawal by Subject|2|||
27595840|NCT01332227|80359529|FG000|Overall Study|Adverse Event|4|||
27595841|NCT01332227|80359530|FG001|Overall Study|Adverse Event|1|||
27595842|NCT01332227|80359529|FG000|Overall Study|Withdrawal by Subject|5|||
27595843|NCT01332227|80359530|FG001|Overall Study|Withdrawal by Subject|1|||
27595844|NCT01332227|80359529|FG000|Overall Study|Lost to Follow-up|2|||
27595845|NCT01332227|80359530|FG001|Overall Study|Lost to Follow-up|0|||
27595846|NCT01332227|80359529|FG000|Overall Study|Lack of Efficacy|3|||
27595847|NCT01332227|80359530|FG001|Overall Study|Lack of Efficacy|1|||
27595848|NCT01332227|80359529|FG000|Overall Study|Poor compliance/noncompliance|1|||
27595849|NCT01332227|80359530|FG001|Overall Study|Poor compliance/noncompliance|1|||
27595850|NCT01332227|80359529|FG000|Overall Study|Patient moved from area|1|||
27595851|NCT01332227|80359530|FG001|Overall Study|Patient moved from area|0|||
27595852|NCT01332227|80359529|FG000|Overall Study|Patient began prohibited medication|0|||
27886806|NCT04999163|81419506|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
27886807|NCT04999163|81419507|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
27886808|NCT04999163|81419506|FG000|Overall Study|Withdrawal by Subject|1|||
27886809|NCT04999163|81419507|FG001|Overall Study|Withdrawal by Subject|0|||
27886810|NCT02055365|81419508|FG000|Overall Study|Prematurely Withdrawn|1|||
27886811|NCT00090493|81419509|FG000|Overall Study|Physician Decision|2|||
27886812|NCT00378508|81419510|FG000|Overall Study|Withdrawal by Subject|1|||
27886813|NCT00378508|81419511|FG001|Overall Study|Withdrawal by Subject|3|||
27886814|NCT00378508|81419510|FG000|Overall Study|Lost to Follow-up|1|||
27886815|NCT00378508|81419511|FG001|Overall Study|Lost to Follow-up|0|||
27886816|NCT02366637|81419512|FG000|First Intervention Period|Adverse Event|0|||
27886817|NCT02366637|81419513|FG001|First Intervention Period|Adverse Event|1|||
27886818|NCT02366637|81419512|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
27886819|NCT02366637|81419513|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
27886820|NCT02366637|81419512|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
27886821|NCT02366637|81419513|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
27886822|NCT00526669|81419521|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
27886823|NCT00526669|81419522|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
27886824|NCT00526669|81419521|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
27886825|NCT00526669|81419522|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
27886826|NCT00526669|81419521|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
27886827|NCT00526669|81419522|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
27595853|NCT01332227|80359530|FG001|Overall Study|Patient began prohibited medication|1|||
27595854|NCT00265889|80359533|FG000|Overall Study|Physician Decision|1|||
27595855|NCT00265889|80359533|FG000|Overall Study|Protocol Violation|1|||
27595856|NCT00265889|80359533|FG000|Overall Study|Insurance denied the request|3|||
27595857|NCT00449176|80359535|FG000|Overall Study|Withdrawal by Subject|39|||
27595858|NCT00449176|80359536|FG001|Overall Study|Withdrawal by Subject|43|||
27595859|NCT00449176|80359537|FG002|Overall Study|Withdrawal by Subject|59|||
27595860|NCT00449176|80359535|FG000|Overall Study|Lost to Follow-up|13|||
27595861|NCT00449176|80359536|FG001|Overall Study|Lost to Follow-up|8|||
27595862|NCT00449176|80359537|FG002|Overall Study|Lost to Follow-up|12|||
27595863|NCT00449176|80359535|FG000|Overall Study|Adverse Event|51|||
27595864|NCT00449176|80359536|FG001|Overall Study|Adverse Event|107|||
27595865|NCT00449176|80359537|FG002|Overall Study|Adverse Event|15|||
27595866|NCT00449176|80359535|FG000|Overall Study|Lack of Efficacy|13|||
27595867|NCT00449176|80359536|FG001|Overall Study|Lack of Efficacy|7|||
27595868|NCT00449176|80359537|FG002|Overall Study|Lack of Efficacy|50|||
27595869|NCT00449176|80359535|FG000|Overall Study|Study drug non-compliant|14|||
27595870|NCT00449176|80359536|FG001|Overall Study|Study drug non-compliant|11|||
27595871|NCT00449176|80359537|FG002|Overall Study|Study drug non-compliant|11|||
27595872|NCT00449176|80359535|FG000|Overall Study|all other|22|||
27595873|NCT00449176|80359536|FG001|Overall Study|all other|19|||
27701647|NCT03250832|80745437|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
27595874|NCT00449176|80359537|FG002|Overall Study|all other|20|||
27595875|NCT00760929|80359543|FG000|Overall Study|Adverse Event|2|||
27595876|NCT00760929|80359544|FG001|Overall Study|Adverse Event|0|||
27595877|NCT00760929|80359545|FG002|Overall Study|Adverse Event|6|||
27595878|NCT00760929|80359546|FG003|Overall Study|Adverse Event|10|||
27595879|NCT00760929|80359543|FG000|Overall Study|Lack of Efficacy|0|||
27595880|NCT00760929|80359544|FG001|Overall Study|Lack of Efficacy|2|||
27595881|NCT00760929|80359545|FG002|Overall Study|Lack of Efficacy|1|||
27595882|NCT00760929|80359546|FG003|Overall Study|Lack of Efficacy|0|||
27595883|NCT00760929|80359543|FG000|Overall Study|Withdrawal by Subject|1|||
27595884|NCT00760929|80359544|FG001|Overall Study|Withdrawal by Subject|0|||
27595885|NCT00760929|80359545|FG002|Overall Study|Withdrawal by Subject|9|||
27595886|NCT00760929|80359546|FG003|Overall Study|Withdrawal by Subject|1|||
27595887|NCT00760929|80359543|FG000|Overall Study|Lost to Follow-up|0|||
27595888|NCT00760929|80359544|FG001|Overall Study|Lost to Follow-up|0|||
27595889|NCT00760929|80359545|FG002|Overall Study|Lost to Follow-up|1|||
27595890|NCT00760929|80359546|FG003|Overall Study|Lost to Follow-up|0|||
27595891|NCT00760929|80359543|FG000|Overall Study|Progression of Disease|21|||
27595892|NCT00760929|80359544|FG001|Overall Study|Progression of Disease|26|||
27595893|NCT00760929|80359545|FG002|Overall Study|Progression of Disease|38|||
27595894|NCT00760929|80359546|FG003|Overall Study|Progression of Disease|42|||
27595895|NCT00760929|80359543|FG000|Overall Study|Other|2|||
27595896|NCT00760929|80359544|FG001|Overall Study|Other|0|||
27595897|NCT00760929|80359545|FG002|Overall Study|Other|2|||
27595898|NCT00760929|80359546|FG003|Overall Study|Other|1|||
27595899|NCT00760929|80359543|FG000|Overall Study|Death|0|||
27595900|NCT00760929|80359544|FG001|Overall Study|Death|0|||
27595901|NCT00760929|80359545|FG002|Overall Study|Death|1|||
27595902|NCT00760929|80359546|FG003|Overall Study|Death|0|||
27595903|NCT00760929|80359543|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
27701648|NCT03250832|80745438|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
27701649|NCT03250832|80745427|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701650|NCT03250832|80745428|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27595904|NCT00760929|80359544|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27595905|NCT00760929|80359545|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
27595906|NCT00760929|80359546|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
27701651|NCT03250832|80745429|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
27701652|NCT03250832|80745430|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27833390|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
27833391|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
27833392|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
27833393|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
27833394|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
27833395|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
27833396|NCT00521586|81222488|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
27833397|NCT00521586|81222489|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
27886828|NCT00526669|81419521|FG000|Combined Treatment Phase|Death|0|||
27886829|NCT00526669|81419522|FG001|Combined Treatment Phase|Death|2|||
27886830|NCT01399047|81419523|FG000|Overall Study|Withdrawal by Subject|0|||
27595907|NCT03543254|80359547|FG000|Overall Study|Lost to Follow-up|1|||
27595908|NCT04330638|80359548|FG000|Overall Study|Adverse Event|9|||
27595909|NCT04330638|80359549|FG001|Overall Study|Adverse Event|10|||
27595910|NCT04330638|80359550|FG002|Overall Study|Adverse Event|15|||
27595911|NCT04330638|80359551|FG003|Overall Study|Adverse Event|6|||
27595912|NCT04330638|80359552|FG004|Overall Study|Adverse Event|10|||
27595913|NCT04330638|80359553|FG005|Overall Study|Adverse Event|5|||
27595914|NCT04330638|80359548|FG000|Overall Study|Other|2|||
27595915|NCT04330638|80359549|FG001|Overall Study|Other|2|||
27595916|NCT04330638|80359550|FG002|Overall Study|Other|5|||
27595917|NCT04330638|80359551|FG003|Overall Study|Other|1|||
27595918|NCT04330638|80359552|FG004|Overall Study|Other|3|||
27595919|NCT04330638|80359553|FG005|Overall Study|Other|2|||
27595920|NCT04330638|80359548|FG000|Overall Study|Withdrawal by Subject|4|||
27595921|NCT04330638|80359549|FG001|Overall Study|Withdrawal by Subject|0|||
27595922|NCT04330638|80359550|FG002|Overall Study|Withdrawal by Subject|0|||
27595923|NCT04330638|80359551|FG003|Overall Study|Withdrawal by Subject|0|||
27595924|NCT04330638|80359552|FG004|Overall Study|Withdrawal by Subject|0|||
27595925|NCT04330638|80359553|FG005|Overall Study|Withdrawal by Subject|0|||
27595926|NCT04330638|80359548|FG000|Overall Study|Lost to Follow-up|3|||
27595927|NCT04330638|80359549|FG001|Overall Study|Lost to Follow-up|2|||
27595928|NCT04330638|80359550|FG002|Overall Study|Lost to Follow-up|3|||
27595929|NCT04330638|80359551|FG003|Overall Study|Lost to Follow-up|2|||
27595930|NCT04330638|80359552|FG004|Overall Study|Lost to Follow-up|3|||
27595931|NCT04330638|80359553|FG005|Overall Study|Lost to Follow-up|0|||
27595932|NCT01400503|80359554|FG000|Overall Study|Withdrawal by Subject|1|||
27595933|NCT01400503|80359554|FG000|Overall Study|Study Terminated by Sponsor|58|||
27595934|NCT01400503|80359554|FG000|Overall Study|Other|1|||
27595935|NCT04368429|80359555|FG000|Overall Study|Adverse Event|1|||
27595936|NCT04368429|80359556|FG001|Overall Study|Adverse Event|0|||
27595937|NCT01041638|80359563|FG000|Overall Study|Adverse Event|4|||
27595938|NCT01041638|80359563|FG000|Overall Study|Death|1|||
27595939|NCT01041638|80359563|FG000|Overall Study|Lack of Efficacy|7|||
27595940|NCT01041638|80359563|FG000|Overall Study|Physician Decision|4|||
27595941|NCT01041638|80359563|FG000|Overall Study|Withdrawal by Subject|11|||
27595942|NCT01059565|80359564|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
27595943|NCT01059565|80359565|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
27595944|NCT01059565|80359564|FG000|24-Week Randomized Phase|Adverse Event|5|||
27595945|NCT01059565|80359565|FG001|24-Week Randomized Phase|Adverse Event|0|||
27595946|NCT01059565|80359564|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
27595947|NCT01059565|80359565|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
27595948|NCT01059565|80359564|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
27595949|NCT01059565|80359565|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
27595950|NCT01059565|80359564|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
27595951|NCT01059565|80359565|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
27595952|NCT01059565|80359564|FG000|24-Week Open-Label Phase|Adverse Event|2|||
27595953|NCT01059565|80359565|FG001|24-Week Open-Label Phase|Adverse Event|0|||
27595954|NCT01059565|80359564|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
27595955|NCT01059565|80359565|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
27595956|NCT01059565|80359564|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
27595957|NCT01059565|80359565|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
27595958|NCT01059565|80359564|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
27595959|NCT01059565|80359565|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
27595960|NCT01059565|80359564|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
27595961|NCT01059565|80359565|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
27595962|NCT01059565|80359564|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
27595963|NCT01059565|80359565|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
27595964|NCT01995461|80359566|FG000|Overall Study|Death|1|||
27595965|NCT01995461|80359566|FG000|Overall Study|Lost to Follow-up|2|||
27595966|NCT01995461|80359566|FG000|Overall Study|Withdrawal by Subject|2|||
27595967|NCT01928719|80359567|FG000|Overall Study|Lost to Follow-up|26|||
27595968|NCT01928719|80359568|FG001|Overall Study|Lost to Follow-up|11|||
27595969|NCT01928719|80359567|FG000|Overall Study|Withdrawal by Subject|22|||
27595970|NCT01928719|80359568|FG001|Overall Study|Withdrawal by Subject|7|||
27595971|NCT01928719|80359567|FG000|Overall Study|Protocol Violation|3|||
27595972|NCT01928719|80359568|FG001|Overall Study|Protocol Violation|1|||
27595973|NCT01928719|80359567|FG000|Overall Study|Adverse Event|1|||
27595974|NCT01928719|80359568|FG001|Overall Study|Adverse Event|0|||
27595975|NCT00924287|80359570|FG000|Overall Study|Death|1|||
27595976|NCT00447057|80359571|FG000|Overall Study|Adverse Event|4|||
27595977|NCT00447057|80359572|FG001|Overall Study|Adverse Event|10|||
27595978|NCT00447057|80359573|FG002|Overall Study|Adverse Event|0|||
27595979|NCT00447057|80359574|FG003|Overall Study|Adverse Event|3|||
27595980|NCT00447057|80359571|FG000|Overall Study|Death due to study disease|6|||
27595981|NCT00447057|80359572|FG001|Overall Study|Death due to study disease|4|||
27595982|NCT00447057|80359573|FG002|Overall Study|Death due to study disease|1|||
27595983|NCT00447057|80359574|FG003|Overall Study|Death due to study disease|1|||
27595984|NCT00447057|80359571|FG000|Overall Study|Lost to Follow-up|0|||
27595985|NCT00447057|80359572|FG001|Overall Study|Lost to Follow-up|1|||
27595986|NCT00447057|80359573|FG002|Overall Study|Lost to Follow-up|0|||
27595987|NCT00447057|80359574|FG003|Overall Study|Lost to Follow-up|0|||
27595988|NCT00447057|80359571|FG000|Overall Study|Entry criteria not met|1|||
27595989|NCT00447057|80359572|FG001|Overall Study|Entry criteria not met|1|||
27595990|NCT00447057|80359573|FG002|Overall Study|Entry criteria not met|0|||
27595991|NCT00447057|80359574|FG003|Overall Study|Entry criteria not met|0|||
27595992|NCT00447057|80359571|FG000|Overall Study|Protocol Violation|0|||
27595993|NCT00447057|80359572|FG001|Overall Study|Protocol Violation|1|||
27595994|NCT00447057|80359573|FG002|Overall Study|Protocol Violation|0|||
27595995|NCT00447057|80359574|FG003|Overall Study|Protocol Violation|0|||
27595996|NCT00447057|80359571|FG000|Overall Study|Withdrawal by Subject|4|||
27595997|NCT00447057|80359572|FG001|Overall Study|Withdrawal by Subject|5|||
27595998|NCT00447057|80359573|FG002|Overall Study|Withdrawal by Subject|1|||
27595999|NCT00447057|80359574|FG003|Overall Study|Withdrawal by Subject|1|||
27596000|NCT00447057|80359571|FG000|Overall Study|Physician Decision|9|||
27596001|NCT00447057|80359572|FG001|Overall Study|Physician Decision|6|||
27596002|NCT00447057|80359573|FG002|Overall Study|Physician Decision|3|||
27596003|NCT00447057|80359574|FG003|Overall Study|Physician Decision|1|||
27596004|NCT00447057|80359571|FG000|Overall Study|Sponsor decision|1|||
27596005|NCT00447057|80359572|FG001|Overall Study|Sponsor decision|1|||
27596006|NCT00447057|80359573|FG002|Overall Study|Sponsor decision|0|||
27596007|NCT00447057|80359574|FG003|Overall Study|Sponsor decision|0|||
27596008|NCT00447057|80359571|FG000|Overall Study|Progressive disease|58|||
27596009|NCT00447057|80359572|FG001|Overall Study|Progressive disease|43|||
27596010|NCT00447057|80359573|FG002|Overall Study|Progressive disease|13|||
27596011|NCT00447057|80359574|FG003|Overall Study|Progressive disease|18|||
27596012|NCT00447057|80359571|FG000|Overall Study|Death due to adverse event|0|||
27596013|NCT00447057|80359572|FG001|Overall Study|Death due to adverse event|0|||
27596014|NCT00447057|80359573|FG002|Overall Study|Death due to adverse event|1|||
27596015|NCT00447057|80359574|FG003|Overall Study|Death due to adverse event|2|||
27596016|NCT00447057|80359571|FG000|Overall Study|Death, study drug related|0|||
27596017|NCT00447057|80359572|FG001|Overall Study|Death, study drug related|1|||
27596018|NCT00447057|80359573|FG002|Overall Study|Death, study drug related|0|||
27596019|NCT00447057|80359574|FG003|Overall Study|Death, study drug related|0|||
27596020|NCT04672941|80359575|FG000|Overall Study|Investigator decision|1|||
27596021|NCT04672941|80359575|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
27596022|NCT04672941|80359575|FG000|Overall Study|COVID-19 related but no adverse event|1|||
27596023|NCT04672941|80359575|FG000|Overall Study|Adverse Event|2|||
27886831|NCT01399047|81419524|FG001|Overall Study|Withdrawal by Subject|1|||
27596024|NCT04672941|80359575|FG000|Overall Study|Lost to Follow-up|2|||
27596025|NCT03321396|80359576|FG000|Overall Study|Physician Decision|1|||
27596026|NCT02134587|80359577|FG000|Overall Study|Did not completed all meetings|30|||
27596027|NCT02123108|80359578|FG000|Overall Study|Death|2|||
27596028|NCT02123108|80359579|FG001|Overall Study|Death|3|||
27596029|NCT01860703|80359580|FG000|Overall Study|Adverse Event|1|||
27596030|NCT01860703|80359581|FG001|Overall Study|Adverse Event|4|||
27596031|NCT01860703|80359582|FG002|Overall Study|Adverse Event|0|||
27596032|NCT01860703|80359583|FG003|Overall Study|Adverse Event|2|||
27596033|NCT01860703|80359580|FG000|Overall Study|Withdrawal by Subject|0|||
27596034|NCT01860703|80359581|FG001|Overall Study|Withdrawal by Subject|1|||
27596035|NCT01860703|80359582|FG002|Overall Study|Withdrawal by Subject|0|||
27596036|NCT01860703|80359583|FG003|Overall Study|Withdrawal by Subject|0|||
27596037|NCT01860703|80359580|FG000|Overall Study|Personal reason|1|||
27596038|NCT01860703|80359581|FG001|Overall Study|Personal reason|0|||
27596039|NCT01860703|80359582|FG002|Overall Study|Personal reason|1|||
27596040|NCT01860703|80359583|FG003|Overall Study|Personal reason|0|||
27596041|NCT01483924|80359589|FG000|Overall Study|Withdrawal by Subject|2|||
27596042|NCT01483924|80359590|FG001|Overall Study|Withdrawal by Subject|0|||
27596043|NCT01483924|80359591|FG002|Overall Study|Withdrawal by Subject|0|||
27596044|NCT01483924|80359592|FG003|Overall Study|Withdrawal by Subject|1|||
27596045|NCT01483924|80359593|FG004|Overall Study|Withdrawal by Subject|1|||
27596046|NCT01483924|80359589|FG000|Overall Study|Adverse Event|0|||
27596047|NCT01483924|80359590|FG001|Overall Study|Adverse Event|0|||
27701653|NCT03250832|80745431|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701654|NCT03250832|80745432|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701655|NCT03250832|80745433|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701656|NCT03250832|80745434|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701657|NCT03250832|80745435|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701658|NCT03250832|80745436|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701659|NCT03250832|80745437|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27701660|NCT03250832|80745438|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
27596048|NCT01483924|80359591|FG002|Overall Study|Adverse Event|1|||
27596049|NCT01483924|80359592|FG003|Overall Study|Adverse Event|1|||
27596050|NCT01483924|80359593|FG004|Overall Study|Adverse Event|0|||
27596051|NCT01483924|80359589|FG000|Overall Study|Non-compliance|0|||
27596052|NCT01483924|80359590|FG001|Overall Study|Non-compliance|0|||
27596053|NCT01483924|80359591|FG002|Overall Study|Non-compliance|0|||
27596054|NCT01483924|80359592|FG003|Overall Study|Non-compliance|1|||
27596055|NCT01483924|80359593|FG004|Overall Study|Non-compliance|1|||
27596056|NCT01483924|80359589|FG000|Overall Study|Sponsor concern over ECG result|0|||
27596057|NCT01483924|80359590|FG001|Overall Study|Sponsor concern over ECG result|0|||
27596058|NCT01483924|80359591|FG002|Overall Study|Sponsor concern over ECG result|0|||
27596059|NCT01483924|80359592|FG003|Overall Study|Sponsor concern over ECG result|1|||
27596060|NCT01483924|80359593|FG004|Overall Study|Sponsor concern over ECG result|0|||
27596061|NCT00698646|80359594|FG000|Overall Study|Adverse Event|8|||
27596062|NCT00698646|80359595|FG001|Overall Study|Adverse Event|7|||
27701661|NCT03250832|80745427|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701662|NCT03250832|80745428|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
27886832|NCT01482065|81419526|FG000|Overall Study|Withdrawal by Subject|0|||
27886833|NCT01482065|81419527|FG001|Overall Study|Withdrawal by Subject|1|||
27886834|NCT00814333|81419528|FG000|Enrollment|Lost to Follow-up|1|||
27596063|NCT00698646|80359596|FG002|Overall Study|Adverse Event|8|||
27596064|NCT00698646|80359594|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
27596065|NCT00698646|80359595|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
27596066|NCT00698646|80359596|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
27596067|NCT00698646|80359594|FG000|Overall Study|Protocol Deviation|6|||
27596068|NCT00698646|80359595|FG001|Overall Study|Protocol Deviation|2|||
27596069|NCT00698646|80359596|FG002|Overall Study|Protocol Deviation|3|||
27596070|NCT00698646|80359594|FG000|Overall Study|Withdrawal by Subject|10|||
27596071|NCT00698646|80359595|FG001|Overall Study|Withdrawal by Subject|11|||
27596072|NCT00698646|80359596|FG002|Overall Study|Withdrawal by Subject|8|||
27596073|NCT00698646|80359594|FG000|Overall Study|Lost to Follow-up|0|||
27596074|NCT00698646|80359595|FG001|Overall Study|Lost to Follow-up|0|||
27596075|NCT00698646|80359596|FG002|Overall Study|Lost to Follow-up|2|||
27596076|NCT00698646|80359594|FG000|Overall Study|Administrative problems|1|||
27596077|NCT00698646|80359595|FG001|Overall Study|Administrative problems|0|||
27596078|NCT00698646|80359596|FG002|Overall Study|Administrative problems|1|||
27596079|NCT01292876|80359602|FG000|Overall Study|Physician Decision|4|||
27596080|NCT03152526|80359605|FG000|Overall Study|Withdrawal by Subject|0|||
27596081|NCT03152526|80359606|FG001|Overall Study|Withdrawal by Subject|1|||
27596082|NCT01292239|80359609|FG000|Overall Study|Other|1|||
27596083|NCT01292239|80359610|FG001|Overall Study|Other|1|||
27596084|NCT01292239|80359609|FG000|Overall Study|Withdrawal by Subject|3|||
27596085|NCT01292239|80359610|FG001|Overall Study|Withdrawal by Subject|6|||
27596086|NCT00344461|80359613|FG000|Overall Study|Adverse Event|6|||
27596087|NCT00344461|80359613|FG000|Overall Study|Death|1|||
27596088|NCT00344461|80359613|FG000|Overall Study|Lack of Efficacy|2|||
27596089|NCT00344461|80359613|FG000|Overall Study|Lost to Follow-up|2|||
27596090|NCT00344461|80359613|FG000|Overall Study|Physician Decision|2|||
27596091|NCT00344461|80359613|FG000|Overall Study|Protocol Violation|6|||
27596092|NCT00344461|80359613|FG000|Overall Study|Withdrawal by Subject|2|||
27596093|NCT01994954|80359615|FG000|Overall Study|Death|1|||
27596094|NCT01994954|80359616|FG001|Overall Study|Death|0|||
27596095|NCT01994954|80359615|FG000|Overall Study|Withdrawal by Subject|9|||
27596096|NCT01994954|80359616|FG001|Overall Study|Withdrawal by Subject|14|||
27596097|NCT01994954|80359615|FG000|Overall Study|Physician Decision|2|||
27596098|NCT01994954|80359616|FG001|Overall Study|Physician Decision|2|||
27596099|NCT01994954|80359615|FG000|Overall Study|Lost to Follow-up|8|||
27596100|NCT01994954|80359616|FG001|Overall Study|Lost to Follow-up|10|||
27596101|NCT01994954|80359615|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
27596102|NCT01994954|80359616|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
27596103|NCT04402866|80359617|FG000|Overall Study|Discontinued Prior to Treatment|0|||
27596104|NCT04402866|80359618|FG001|Overall Study|Discontinued Prior to Treatment|0|||
27596105|NCT04402866|80359619|FG002|Overall Study|Discontinued Prior to Treatment|0|||
27596106|NCT04402866|80359620|FG003|Overall Study|Discontinued Prior to Treatment|0|||
27596107|NCT04402866|80359621|FG004|Overall Study|Discontinued Prior to Treatment|2|||
27596108|NCT04402866|80359622|FG005|Overall Study|Discontinued Prior to Treatment|3|||
27596109|NCT04402866|80359617|FG000|Overall Study|Adverse Event|2|||
27596110|NCT04402866|80359618|FG001|Overall Study|Adverse Event|1|||
27596111|NCT04402866|80359619|FG002|Overall Study|Adverse Event|0|||
27596112|NCT04402866|80359620|FG003|Overall Study|Adverse Event|0|||
27596113|NCT04402866|80359621|FG004|Overall Study|Adverse Event|13|||
27596114|NCT04402866|80359622|FG005|Overall Study|Adverse Event|8|||
27596115|NCT04402866|80359617|FG000|Overall Study|Miscellaneous|0|||
27596116|NCT04402866|80359618|FG001|Overall Study|Miscellaneous|0|||
27596117|NCT04402866|80359619|FG002|Overall Study|Miscellaneous|1|||
27596118|NCT04402866|80359620|FG003|Overall Study|Miscellaneous|0|||
27596119|NCT04402866|80359621|FG004|Overall Study|Miscellaneous|0|||
27596120|NCT04402866|80359622|FG005|Overall Study|Miscellaneous|0|||
27596121|NCT04402866|80359617|FG000|Overall Study|Lost to Follow-up|0|||
27596122|NCT04402866|80359618|FG001|Overall Study|Lost to Follow-up|0|||
27596123|NCT04402866|80359619|FG002|Overall Study|Lost to Follow-up|0|||
27596124|NCT04402866|80359620|FG003|Overall Study|Lost to Follow-up|0|||
27596125|NCT04402866|80359621|FG004|Overall Study|Lost to Follow-up|0|||
27596126|NCT04402866|80359622|FG005|Overall Study|Lost to Follow-up|1|||
27596127|NCT04402866|80359617|FG000|Overall Study|Withdrawal by Subject|0|||
27596128|NCT04402866|80359618|FG001|Overall Study|Withdrawal by Subject|0|||
27596129|NCT04402866|80359619|FG002|Overall Study|Withdrawal by Subject|0|||
27596130|NCT04402866|80359620|FG003|Overall Study|Withdrawal by Subject|0|||
27596131|NCT04402866|80359621|FG004|Overall Study|Withdrawal by Subject|0|||
27596132|NCT04402866|80359622|FG005|Overall Study|Withdrawal by Subject|2|||
27596133|NCT02495025|80359627|FG000|Overall Study|Lost to Follow-up|21|||
27596134|NCT02495025|80359628|FG001|Overall Study|Lost to Follow-up|14|||
27596135|NCT02495025|80359627|FG000|Overall Study|Withdrawal by Subject|5|||
27701663|NCT03250832|80745429|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
27596136|NCT02495025|80359628|FG001|Overall Study|Withdrawal by Subject|0|||
27596137|NCT01988779|80359629|FG000|Overall Study|Withdrawal by Subject|2|||
27596138|NCT01988779|80359630|FG001|Overall Study|Withdrawal by Subject|2|||
27596139|NCT01988779|80359629|FG000|Overall Study|Protocol Violation|1|||
27596140|NCT01988779|80359630|FG001|Overall Study|Protocol Violation|0|||
27596141|NCT00686881|80359635|FG000|Overall Study|Withdrawal by Subject|11|||
27596142|NCT00686881|80359636|FG001|Overall Study|Withdrawal by Subject|18|||
27596143|NCT00686881|80359635|FG000|Overall Study|Lost to Follow-up|0|||
27596144|NCT00686881|80359636|FG001|Overall Study|Lost to Follow-up|1|||
27596145|NCT00686881|80359635|FG000|Overall Study|Treatment-related adverse event|10|||
27596146|NCT00686881|80359636|FG001|Overall Study|Treatment-related adverse event|9|||
27886835|NCT00814333|81419529|FG001|Enrollment|Lost to Follow-up|0|||
27886836|NCT00761280|81419537|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
27596147|NCT00686881|80359635|FG000|Overall Study|Met discontinuation criteria|5|||
27596148|NCT00686881|80359636|FG001|Overall Study|Met discontinuation criteria|0|||
27596149|NCT00686881|80359635|FG000|Overall Study|Onset of malignant tumor|11|||
27596150|NCT00686881|80359636|FG001|Overall Study|Onset of malignant tumor|11|||
27596151|NCT00686881|80359635|FG000|Overall Study|Lack of Efficacy|4|||
27596152|NCT00686881|80359636|FG001|Overall Study|Lack of Efficacy|3|||
27596153|NCT00686881|80359635|FG000|Overall Study|Physician Decision|1|||
27596154|NCT00686881|80359636|FG001|Overall Study|Physician Decision|0|||
27596155|NCT00686881|80359635|FG000|Overall Study|Circumstances of site|1|||
27596156|NCT00686881|80359636|FG001|Overall Study|Circumstances of site|1|||
27596157|NCT00686881|80359635|FG000|Overall Study|Did not meet protocol eligibility|1|||
27596158|NCT00686881|80359636|FG001|Overall Study|Did not meet protocol eligibility|0|||
27596159|NCT00686881|80359635|FG000|Overall Study|Irregular visits|1|||
27596160|NCT00686881|80359636|FG001|Overall Study|Irregular visits|0|||
27596161|NCT00686881|80359635|FG000|Overall Study|Study discontinuation|35|||
27596162|NCT00686881|80359636|FG001|Overall Study|Study discontinuation|32|||
27596163|NCT00686881|80359635|FG000|Overall Study|Never received study drug|2|||
27596164|NCT00686881|80359636|FG001|Overall Study|Never received study drug|6|||
27596165|NCT01563536|80359642|FG000|Overall Study|Withdrawal by Subject|0|||
27596166|NCT01563536|80359643|FG001|Overall Study|Withdrawal by Subject|2|||
27596167|NCT01563536|80359642|FG000|Overall Study|Lost to Follow-up|1|||
27596168|NCT01563536|80359643|FG001|Overall Study|Lost to Follow-up|0|||
27596169|NCT00701038|80359644|FG000|Overall Study|study amended pilot group of patients|4|||
27596170|NCT00701038|80359645|FG001|Overall Study|study amended pilot group of patients|4|||
27596171|NCT00528775|80359646|FG000|Overall Study|Other not specified|1|||
27596172|NCT00907153|80359647|FG000|Overall Study|Lost to Follow-up|1|||
27596173|NCT00907153|80359648|FG001|Overall Study|Lost to Follow-up|1|||
27596174|NCT00907153|80359647|FG000|Overall Study|Withdrawal by Subject|1|||
27596175|NCT00907153|80359648|FG001|Overall Study|Withdrawal by Subject|3|||
27596176|NCT02077166|80359649|FG000|Overall Study|Death|6|||
27596177|NCT02077166|80359650|FG001|Overall Study|Death|7|||
27596178|NCT02077166|80359651|FG002|Overall Study|Death|5|||
27596179|NCT02077166|80359652|FG003|Overall Study|Death|6|||
27596180|NCT02077166|80359653|FG004|Overall Study|Death|4|||
27596181|NCT02077166|80359654|FG005|Overall Study|Death|32|||
27596182|NCT02077166|80359655|FG006|Overall Study|Death|22|||
27596183|NCT02077166|80359649|FG000|Overall Study|Study Closure by Sponsor|3|||
27596184|NCT02077166|80359650|FG001|Overall Study|Study Closure by Sponsor|0|||
27596185|NCT02077166|80359651|FG002|Overall Study|Study Closure by Sponsor|2|||
27596186|NCT02077166|80359652|FG003|Overall Study|Study Closure by Sponsor|2|||
27596187|NCT02077166|80359653|FG004|Overall Study|Study Closure by Sponsor|2|||
27596188|NCT02077166|80359654|FG005|Overall Study|Study Closure by Sponsor|12|||
27596189|NCT02077166|80359655|FG006|Overall Study|Study Closure by Sponsor|4|||
27596190|NCT02077166|80359649|FG000|Overall Study|Lost to Follow-up|0|||
27701664|NCT03250832|80745430|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701665|NCT03250832|80745431|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701666|NCT03250832|80745432|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701667|NCT03250832|80745433|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701668|NCT03250832|80745434|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
27701669|NCT03250832|80745435|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701670|NCT03250832|80745436|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701671|NCT03250832|80745437|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701672|NCT03250832|80745438|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
27701673|NCT03250832|80745427|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701674|NCT03250832|80745428|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701675|NCT03250832|80745429|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701676|NCT03250832|80745430|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701677|NCT03250832|80745431|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701678|NCT03250832|80745432|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701679|NCT03250832|80745433|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701680|NCT03250832|80745434|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
27701681|NCT03250832|80745435|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701682|NCT03250832|80745436|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701683|NCT03250832|80745437|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701684|NCT03250832|80745438|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
27701685|NCT03250832|80745427|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701686|NCT03250832|80745428|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701687|NCT03250832|80745429|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701688|NCT03250832|80745430|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27886837|NCT00761280|81419538|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
27596191|NCT02077166|80359650|FG001|Overall Study|Lost to Follow-up|0|||
27596192|NCT02077166|80359651|FG002|Overall Study|Lost to Follow-up|0|||
27596193|NCT02077166|80359652|FG003|Overall Study|Lost to Follow-up|0|||
27596194|NCT02077166|80359653|FG004|Overall Study|Lost to Follow-up|0|||
27596195|NCT02077166|80359654|FG005|Overall Study|Lost to Follow-up|1|||
27596196|NCT02077166|80359655|FG006|Overall Study|Lost to Follow-up|0|||
27596197|NCT02077166|80359649|FG000|Overall Study|Withdrawal by Subject|3|||
27701689|NCT03250832|80745431|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701690|NCT03250832|80745432|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701691|NCT03250832|80745433|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701692|NCT03250832|80745434|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
27701693|NCT03250832|80745435|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701694|NCT03250832|80745436|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701695|NCT03250832|80745437|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27596198|NCT02077166|80359650|FG001|Overall Study|Withdrawal by Subject|0|||
27596199|NCT02077166|80359651|FG002|Overall Study|Withdrawal by Subject|1|||
27959321|NCT02131662|81683272|FG003|Overall Study|Lack of Efficacy|0|||
27596200|NCT02077166|80359652|FG003|Overall Study|Withdrawal by Subject|1|||
27596201|NCT02077166|80359653|FG004|Overall Study|Withdrawal by Subject|1|||
27596202|NCT02077166|80359654|FG005|Overall Study|Withdrawal by Subject|3|||
27596203|NCT02077166|80359655|FG006|Overall Study|Withdrawal by Subject|0|||
27596204|NCT02077166|80359649|FG000|Overall Study|Other, Not Specified|0|||
27596205|NCT02077166|80359650|FG001|Overall Study|Other, Not Specified|0|||
27596206|NCT02077166|80359651|FG002|Overall Study|Other, Not Specified|1|||
27596207|NCT02077166|80359652|FG003|Overall Study|Other, Not Specified|0|||
27596208|NCT02077166|80359653|FG004|Overall Study|Other, Not Specified|1|||
27596209|NCT02077166|80359654|FG005|Overall Study|Other, Not Specified|7|||
27596210|NCT02077166|80359655|FG006|Overall Study|Other, Not Specified|8|||
27596211|NCT02525874|80359663|FG000|Overall Study|Other|1|||
27596212|NCT02525874|80359663|FG000|Overall Study|Investigator Decision|1|||
27596213|NCT02525874|80359663|FG000|Overall Study|Consent withdrawn|22|||
27596214|NCT02525874|80359663|FG000|Overall Study|Non-compliance with study drug|3|||
27596215|NCT02525874|80359663|FG000|Overall Study|Adverse Event|17|||
27596216|NCT02525874|80359663|FG000|Overall Study|Lost to Follow-up|7|||
27596217|NCT02525874|80359663|FG000|Overall Study|Disease progression, defined by protocol|2|||
27596218|NCT02525874|80359663|FG000|Overall Study|Disease relapse|4|||
27596219|NCT02525874|80359663|FG000|Overall Study|Alternative Treatment for MS|2|||
27596220|NCT02525874|80359663|FG000|Overall Study|New lesions in Brain|1|||
27596221|NCT00313820|80359664|FG000|Assigned to Treatment|Other|1|||
27596222|NCT00313820|80359665|FG001|Assigned to Treatment|Other|0|||
27596223|NCT00313820|80359664|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
27701696|NCT03250832|80745438|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
27701697|NCT03250832|80745427|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701698|NCT03250832|80745428|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701699|NCT03250832|80745429|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701700|NCT03250832|80745430|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701701|NCT03250832|80745431|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701702|NCT03250832|80745432|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701703|NCT03250832|80745433|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701704|NCT03250832|80745434|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
27701705|NCT03250832|80745435|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701706|NCT03250832|80745436|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701707|NCT03250832|80745437|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701708|NCT03250832|80745438|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
27701709|NCT03250832|80745427|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701710|NCT03250832|80745428|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701711|NCT03250832|80745429|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701712|NCT03250832|80745430|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701713|NCT03250832|80745431|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701714|NCT03250832|80745432|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701715|NCT03250832|80745433|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701716|NCT03250832|80745434|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
27701717|NCT03250832|80745435|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701718|NCT03250832|80745436|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701719|NCT03250832|80745437|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
27701720|NCT03250832|80745438|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
27596224|NCT00313820|80359665|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
27596225|NCT00313820|80359664|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
27596226|NCT00313820|80359665|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
27596227|NCT00313820|80359664|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
27596228|NCT00313820|80359665|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
27596229|NCT00313820|80359664|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
27596230|NCT00313820|80359665|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
27701721|NCT03250832|80745427|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701722|NCT03250832|80745428|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701723|NCT03250832|80745429|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701724|NCT03250832|80745430|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701725|NCT03250832|80745431|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701726|NCT03250832|80745432|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701727|NCT03250832|80745433|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701728|NCT03250832|80745434|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701729|NCT03250832|80745435|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
27701730|NCT03250832|80745436|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
27701731|NCT03250832|80745437|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701732|NCT03250832|80745438|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
27701733|NCT03250832|80745427|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701734|NCT03250832|80745428|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701735|NCT03250832|80745429|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701736|NCT03250832|80745430|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701737|NCT03250832|80745431|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701738|NCT03250832|80745432|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701739|NCT03250832|80745433|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701740|NCT03250832|80745434|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701741|NCT03250832|80745435|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
27701742|NCT03250832|80745436|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
27701743|NCT03250832|80745437|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701744|NCT03250832|80745438|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
27701745|NCT03250832|80745427|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701746|NCT03250832|80745428|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701747|NCT03250832|80745429|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701748|NCT03250832|80745430|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701749|NCT03250832|80745431|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701750|NCT03250832|80745432|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701751|NCT03250832|80745433|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701752|NCT03250832|80745434|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701753|NCT03250832|80745435|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
27701754|NCT03250832|80745436|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
27701755|NCT03250832|80745437|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701756|NCT03250832|80745438|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
27701757|NCT03250832|80745427|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701758|NCT03250832|80745428|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701759|NCT03250832|80745429|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701760|NCT03250832|80745430|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701761|NCT03250832|80745431|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701762|NCT03250832|80745432|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701763|NCT03250832|80745433|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701764|NCT03250832|80745434|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701765|NCT03250832|80745435|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701766|NCT03250832|80745436|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701767|NCT03250832|80745437|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
27701768|NCT03250832|80745438|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
27701769|NCT02536755|80745439|FG000|Overall Study|Adverse Event|4|||
27701770|NCT01610687|80745440|FG000|Overall Study|Lack of Efficacy|26|||
27701771|NCT01610687|80745440|FG000|Overall Study|Adverse Event|18|||
27701772|NCT01610687|80745440|FG000|Overall Study|Moved out of area|6|||
27701773|NCT01610687|80745440|FG000|Overall Study|Withdrawal by Subject|7|||
27701774|NCT01610687|80745440|FG000|Overall Study|Lost to Follow-up|4|||
27701775|NCT01610687|80745440|FG000|Overall Study|Symptom control without study medication|2|||
27701776|NCT01610687|80745440|FG000|Overall Study|Unable to make journey|1|||
27701777|NCT01610687|80745440|FG000|Overall Study|Death|1|||
27701778|NCT01610687|80745440|FG000|Overall Study|Cannabis affecting job|1|||
27701779|NCT01610687|80745440|FG000|Overall Study|Felt more alter without study medication|1|||
27701782|NCT02072434|80745448|FG000|Overall Study|Protocol Violation|10|||
27701783|NCT02072434|80745449|FG001|Overall Study|Protocol Violation|9|||
27701784|NCT02072434|80745448|FG000|Overall Study|Physician Decision|5|||
27701785|NCT02072434|80745449|FG001|Overall Study|Physician Decision|10|||
27701786|NCT02072434|80745448|FG000|Overall Study|Adverse event, serious fatal|1|||
27701787|NCT02072434|80745449|FG001|Overall Study|Adverse event, serious fatal|6|||
27701788|NCT02072434|80745448|FG000|Overall Study|Adverse Event|7|||
27701789|NCT02072434|80745449|FG001|Overall Study|Adverse Event|6|||
27701790|NCT02072434|80745448|FG000|Overall Study|Withdrawal by Subject|17|||
27701791|NCT02072434|80745449|FG001|Overall Study|Withdrawal by Subject|29|||
27701792|NCT02072434|80745448|FG000|Overall Study|Other|14|||
27701793|NCT02072434|80745449|FG001|Overall Study|Other|29|||
27701794|NCT02072434|80745448|FG000|Overall Study|Lost to Follow-up|0|||
27701795|NCT02072434|80745449|FG001|Overall Study|Lost to Follow-up|1|||
27701796|NCT03123250|80745450|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
27701797|NCT02805725|80745451|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
27701798|NCT02805725|80745452|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
27701799|NCT02805725|80745453|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
27701800|NCT02805725|80745454|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
27701801|NCT02805725|80745455|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
27701802|NCT02805725|80745451|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
27701803|NCT02805725|80745452|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
27701804|NCT02805725|80745453|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
27701805|NCT02805725|80745454|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
27701806|NCT02805725|80745455|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
27701807|NCT02805725|80745451|FG000|Phase II|Protocol Violation|0|||
27701808|NCT02805725|80745452|FG001|Phase II|Protocol Violation|0|||
27701809|NCT02805725|80745453|FG002|Phase II|Protocol Violation|0|||
27701810|NCT02805725|80745454|FG003|Phase II|Protocol Violation|0|||
27701811|NCT02805725|80745455|FG004|Phase II|Protocol Violation|6|||
27701812|NCT01034540|80745457|FG000|Overall Study|Adverse Event|0|||
27701813|NCT01034540|80745458|FG001|Overall Study|Adverse Event|1|||
27701814|NCT00826111|80745459|FG000|Overall Study|Lost to Follow-up|0|||
27701815|NCT00826111|80745460|FG001|Overall Study|Lost to Follow-up|1|||
27701816|NCT00826111|80745459|FG000|Overall Study|Protocol Violation|1|||
27701817|NCT00826111|80745460|FG001|Overall Study|Protocol Violation|0|||
27701818|NCT00826111|80745459|FG000|Overall Study|Withdrawal by Subject|5|||
27701819|NCT00826111|80745460|FG001|Overall Study|Withdrawal by Subject|0|||
27701820|NCT00826111|80745459|FG000|Overall Study|Physician Decision|1|||
27701821|NCT00826111|80745460|FG001|Overall Study|Physician Decision|1|||
27701822|NCT05116046|80745463|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27701823|NCT05116046|80745464|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27701824|NCT05116046|80745465|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27701825|NCT05116046|80745463|FG000|Overall Study|Study terminated by sponsor|14|||
27701826|NCT05116046|80745464|FG001|Overall Study|Study terminated by sponsor|16|||
27701827|NCT05116046|80745465|FG002|Overall Study|Study terminated by sponsor|1|||
27701828|NCT03675776|80745466|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
27701829|NCT03675776|80745467|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
27701830|NCT03675776|80745468|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
27701831|NCT03675776|80745466|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
27701832|NCT03675776|80745467|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27701833|NCT03675776|80745468|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27701834|NCT02456662|80745474|FG000|Overall Study|Lost to Follow-up|2|||
27701835|NCT02456662|80745475|FG001|Overall Study|Lost to Follow-up|1|||
27701836|NCT01103245|80745478|FG000|Overall Study|Withdrawal by Subject|1|||
27701837|NCT01103245|80745479|FG001|Overall Study|Withdrawal by Subject|0|||
27701838|NCT01103245|80745480|FG002|Overall Study|Withdrawal by Subject|3|||
27701839|NCT01103245|80745481|FG003|Overall Study|Withdrawal by Subject|0|||
27701840|NCT01103245|80745478|FG000|Overall Study|Inadequate IV access|1|||
27701841|NCT01103245|80745479|FG001|Overall Study|Inadequate IV access|0|||
27701842|NCT01103245|80745480|FG002|Overall Study|Inadequate IV access|0|||
27701843|NCT01103245|80745481|FG003|Overall Study|Inadequate IV access|0|||
27701844|NCT01103245|80745478|FG000|Overall Study|Adverse Event|0|||
27701845|NCT01103245|80745479|FG001|Overall Study|Adverse Event|2|||
27701846|NCT01103245|80745480|FG002|Overall Study|Adverse Event|1|||
27701847|NCT01103245|80745481|FG003|Overall Study|Adverse Event|0|||
27701848|NCT01103245|80745478|FG000|Overall Study|Physician Decision|1|||
27701849|NCT01103245|80745479|FG001|Overall Study|Physician Decision|0|||
27701850|NCT01103245|80745480|FG002|Overall Study|Physician Decision|0|||
27701851|NCT01103245|80745481|FG003|Overall Study|Physician Decision|0|||
27701852|NCT04556136|80745482|FG000|Overall Study|Lost to Follow-up|6|||
27701853|NCT04556136|80745483|FG001|Overall Study|Lost to Follow-up|6|||
27701854|NCT04556136|80745482|FG000|Overall Study|Physician Decision|2|||
27701855|NCT04556136|80745483|FG001|Overall Study|Physician Decision|1|||
27701856|NCT04556136|80745482|FG000|Overall Study|Withdrawal by Subject|2|||
27701857|NCT04556136|80745483|FG001|Overall Study|Withdrawal by Subject|1|||
27701858|NCT01444651|80745484|FG000|Overall Study|Adverse Event|3|||
27701859|NCT01444651|80745485|FG001|Overall Study|Adverse Event|2|||
27701860|NCT01444651|80745484|FG000|Overall Study|Lost to Follow-up|5|||
27886838|NCT00761280|81419537|FG000|Randomization to First Dose|Sponsor decision|1|||
27886839|NCT00761280|81419538|FG001|Randomization to First Dose|Sponsor decision|0|||
27701861|NCT01444651|80745485|FG001|Overall Study|Lost to Follow-up|5|||
27701862|NCT01444651|80745484|FG000|Overall Study|Non-fasting|2|||
27701863|NCT01444651|80745485|FG001|Overall Study|Non-fasting|1|||
27701864|NCT01444651|80745484|FG000|Overall Study|Missing data|1|||
27886840|NCT00761280|81419537|FG000|Randomization to First Dose|Other|1|||
27701865|NCT01444651|80745485|FG001|Overall Study|Missing data|1|||
27701866|NCT01383161|80745486|FG000|Overall Study|Adverse Event|5|||
27701867|NCT01383161|80745487|FG001|Overall Study|Adverse Event|1|||
27701868|NCT01383161|80745486|FG000|Overall Study|Withdrawal by Subject|0|||
27701869|NCT01383161|80745487|FG001|Overall Study|Withdrawal by Subject|2|||
27701870|NCT01383161|80745486|FG000|Overall Study|Lack of Efficacy|0|||
27701871|NCT01383161|80745487|FG001|Overall Study|Lack of Efficacy|1|||
27701872|NCT03739762|80745488|FG000|Overall Study|Lost to Follow-up|1|||
27701873|NCT03739762|80745489|FG001|Overall Study|Lost to Follow-up|1|||
27701874|NCT03739762|80745488|FG000|Overall Study|Withdrawal by Subject|2|||
27701875|NCT03739762|80745489|FG001|Overall Study|Withdrawal by Subject|6|||
27701876|NCT01294150|80745490|FG000|Overall Study|Physician Decision|2|||
27701877|NCT01294150|80745491|FG001|Overall Study|Physician Decision|2|||
27701878|NCT01717768|80745494|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701879|NCT01717768|80745495|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
27701880|NCT01717768|80745496|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701881|NCT01717768|80745497|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701882|NCT01717768|80745498|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701883|NCT01717768|80745499|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701884|NCT01717768|80745500|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701885|NCT01717768|80745501|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701886|NCT01717768|80745502|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701887|NCT01717768|80745503|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701888|NCT01717768|80745504|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701889|NCT01717768|80745505|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
27701890|NCT01717768|80745494|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701891|NCT01717768|80745495|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701892|NCT01717768|80745496|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701893|NCT01717768|80745497|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701894|NCT01717768|80745498|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701895|NCT01717768|80745499|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701896|NCT01717768|80745500|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701897|NCT01717768|80745501|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701898|NCT01717768|80745502|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27596231|NCT00313820|80359664|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
27596232|NCT00313820|80359665|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
27596233|NCT02085252|80359671|FG000|Overall Study|Withdrawal of Consent|1|||
27596234|NCT02085252|80359672|FG001|Overall Study|Withdrawal of Consent|0|||
27596235|NCT02085252|80359671|FG000|Overall Study|Adverse Event|0|||
27596236|NCT02085252|80359672|FG001|Overall Study|Adverse Event|1|||
27596237|NCT02085252|80359671|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
27596238|NCT02085252|80359672|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
27596239|NCT02085252|80359671|FG000|Overall Study|Reason Not Specified|0|||
27596240|NCT02085252|80359672|FG001|Overall Study|Reason Not Specified|1|||
27596241|NCT02085252|80359671|FG000|Overall Study|Reason Unknown|0|||
27596242|NCT02085252|80359672|FG001|Overall Study|Reason Unknown|1|||
27596243|NCT00810264|80359673|FG000|Overall Study|Lost to Follow-up|191|||
27596244|NCT00810264|80359673|FG000|Overall Study|Withdrawal by subject or physician|721|||
27596245|NCT00810264|80359673|FG000|Overall Study|Death|641|||
27596246|NCT02660827|80359677|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
27596247|NCT02660827|80359677|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
27596248|NCT02660827|80359677|FG000|From Study to End of Continued Access|Adverse Event|3|||
27596249|NCT02660827|80359677|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
27596250|NCT02660827|80359677|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
27596251|NCT02660827|80359677|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
27833398|NCT00521586|81222488|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
27833399|NCT00521586|81222489|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
27596252|NCT02660827|80359677|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
27596253|NCT02660827|80359677|FG000|Period 2: Continued Access Period|Adverse Event|3|||
27596254|NCT01773070|80359680|FG000|Overall Study|Withdrawal by Subject|24|||
27701899|NCT01717768|80745503|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701900|NCT01717768|80745504|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
27701901|NCT01717768|80745505|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
27701902|NCT01717768|80745494|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701903|NCT01717768|80745495|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701904|NCT01717768|80745496|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701905|NCT01717768|80745497|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701906|NCT01717768|80745498|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701907|NCT01717768|80745499|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701908|NCT01717768|80745500|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701909|NCT01717768|80745501|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
27701910|NCT01717768|80745502|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701911|NCT01717768|80745503|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701912|NCT01717768|80745504|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701913|NCT01717768|80745505|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
27701914|NCT01717768|80745494|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701915|NCT01717768|80745495|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701916|NCT01717768|80745496|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701917|NCT01717768|80745497|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701918|NCT01717768|80745498|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701919|NCT01717768|80745499|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701920|NCT01717768|80745500|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701921|NCT01717768|80745501|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701922|NCT01717768|80745502|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701923|NCT01717768|80745503|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
27701924|NCT01717768|80745504|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701925|NCT01717768|80745505|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
27701926|NCT00800683|80745506|FG000|Overall Study|Adverse Event|11|||
27701927|NCT00800683|80745507|FG001|Overall Study|Adverse Event|8|||
27701928|NCT00800683|80745506|FG000|Overall Study|Lost to Follow-up|3|||
27701929|NCT00800683|80745507|FG001|Overall Study|Lost to Follow-up|1|||
27701930|NCT00800683|80745506|FG000|Overall Study|Withdrawal by Subject|1|||
27701931|NCT00800683|80745507|FG001|Overall Study|Withdrawal by Subject|7|||
27701932|NCT00800683|80745506|FG000|Overall Study|Lack of Efficacy|1|||
27701933|NCT00800683|80745507|FG001|Overall Study|Lack of Efficacy|1|||
27701934|NCT00800683|80745506|FG000|Overall Study|Other|1|||
27701935|NCT00800683|80745507|FG001|Overall Study|Other|2|||
27701936|NCT01211535|80745520|FG000|Overall Study|Adverse Event|0|||
27701937|NCT01211535|80745521|FG001|Overall Study|Adverse Event|1|||
27701938|NCT00355056|80745522|FG000|Randomization Period|Early Termination|4|||
27596255|NCT01773070|80359680|FG000|Overall Study|Lost to Follow-up|39|||
27701939|NCT00355056|80745523|FG001|Randomization Period|Early Termination|6|||
27701940|NCT04195581|80745524|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
27701941|NCT04195581|80745524|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
27701942|NCT04195581|80745524|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
27701943|NCT04195581|80745524|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
27701944|NCT04195581|80745524|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
27701945|NCT04195581|80745524|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
27596256|NCT01773070|80359680|FG000|Overall Study|Other|15|||
27701946|NCT03785678|80745528|FG000|Overall Study|Death|44|||
27701947|NCT03785678|80745529|FG001|Overall Study|Death|42|||
27833400|NCT00521586|81222488|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
27833401|NCT00521586|81222489|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
27833402|NCT00521586|81222488|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
27833403|NCT00521586|81222489|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
27833404|NCT01215721|81222490|FG000|Overall Study|Adverse Event|2|||
27833405|NCT00731939|81222493|FG000|Overall Study|Adverse Event|6|||
27833406|NCT00731939|81222493|FG000|Overall Study|Lost to Follow-up|15|||
27833407|NCT00731939|81222493|FG000|Overall Study|Not implanted with study device|9|||
27833408|NCT00731939|81222493|FG000|Overall Study|Withdrawal by Subject|2|||
27833409|NCT00731939|81222493|FG000|Overall Study|Did not meet enrollment criteria|2|||
27833410|NCT00594035|81222494|FG000|Overall Study|Lost to Follow-up|1|||
27833411|NCT00594035|81222495|FG001|Overall Study|Lost to Follow-up|1|||
27833412|NCT00594035|81222494|FG000|Overall Study|Withdrawal by Subject|1|||
27596257|NCT01773070|80359680|FG000|Overall Study|Death (unrelated to study procedures)|3|||
27596258|NCT00234065|80359681|FG000|Overall Study|Adverse Event|268|||
27596259|NCT00234065|80359682|FG001|Overall Study|Adverse Event|166|||
27596260|NCT00234065|80359681|FG000|Overall Study|Withdrawal by Subject|73|||
27596261|NCT00234065|80359682|FG001|Overall Study|Withdrawal by Subject|56|||
27833413|NCT00594035|81222495|FG001|Overall Study|Withdrawal by Subject|0|||
27833414|NCT00594035|81222494|FG000|Overall Study|Subject transferred to nursing home|0|||
27833415|NCT00594035|81222495|FG001|Overall Study|Subject transferred to nursing home|1|||
27833416|NCT00594035|81222494|FG000|Overall Study|Subject couldn't return due to job|0|||
27833417|NCT00594035|81222495|FG001|Overall Study|Subject couldn't return due to job|1|||
27833418|NCT02997176|81222500|FG000|Overall Study|Adverse Event|0|||
27833419|NCT02997176|81222501|FG001|Overall Study|Adverse Event|0|||
27833420|NCT02997176|81222502|FG002|Overall Study|Adverse Event|0|||
27833421|NCT02997176|81222503|FG003|Overall Study|Adverse Event|8|||
27833422|NCT02997176|81222500|FG000|Overall Study|Progressive Disease|1|||
27833423|NCT02997176|81222501|FG001|Overall Study|Progressive Disease|0|||
27833424|NCT02997176|81222502|FG002|Overall Study|Progressive Disease|1|||
27833425|NCT02997176|81222503|FG003|Overall Study|Progressive Disease|1|||
27833426|NCT02997176|81222500|FG000|Overall Study|Death|0|||
27886841|NCT00761280|81419538|FG001|Randomization to First Dose|Other|0|||
27886842|NCT00761280|81419537|FG000|First Dose to End of Study|End of trial|5|||
27886843|NCT00761280|81419538|FG001|First Dose to End of Study|End of trial|5|||
27886844|NCT00761280|81419537|FG000|First Dose to End of Study|Progressive disease|5|||
27886845|NCT00761280|81419538|FG001|First Dose to End of Study|Progressive disease|3|||
27886846|NCT00761280|81419537|FG000|First Dose to End of Study|Sponsor decision|1|||
27886847|NCT00761280|81419538|FG001|First Dose to End of Study|Sponsor decision|2|||
27886848|NCT00761280|81419537|FG000|First Dose to End of Study|Death|1|||
27886849|NCT00761280|81419538|FG001|First Dose to End of Study|Death|0|||
27886850|NCT00761280|81419537|FG000|First Dose to End of Study|Lost to Follow-up|0|||
27886851|NCT00761280|81419538|FG001|First Dose to End of Study|Lost to Follow-up|1|||
27886852|NCT03092674|81419539|FG000|Overall Study|Adverse Event or Side Effects|1|||
27886853|NCT03092674|81419540|FG001|Overall Study|Adverse Event or Side Effects|4|||
27886854|NCT03092674|81419541|FG002|Overall Study|Adverse Event or Side Effects|4|||
27886855|NCT03092674|81419539|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
27886856|NCT03092674|81419540|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
27886857|NCT03092674|81419541|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
27886858|NCT03092674|81419539|FG000|Overall Study|Progression/Relapse|5|||
27886859|NCT03092674|81419540|FG001|Overall Study|Progression/Relapse|4|||
27886860|NCT03092674|81419541|FG002|Overall Study|Progression/Relapse|8|||
27886861|NCT03092674|81419539|FG000|Overall Study|Death|4|||
27886862|NCT03092674|81419540|FG001|Overall Study|Death|8|||
27886863|NCT03092674|81419541|FG002|Overall Study|Death|2|||
27886864|NCT03092674|81419539|FG000|Overall Study|Other - Not Protocol Specified|11|||
27886865|NCT03092674|81419540|FG001|Overall Study|Other - Not Protocol Specified|8|||
27886866|NCT03092674|81419541|FG002|Overall Study|Other - Not Protocol Specified|8|||
27886867|NCT05017103|81419544|FG000|Overall Study|Death|2|||
27886868|NCT05985980|81419545|FG000|Overall Study|Withdrawal by Subject|1|||
27886869|NCT05985980|81419545|FG000|Overall Study|Withdrawal by Subject|1|||
27886870|NCT05985980|81419545|FG000|Overall Study|Withdrawal by Subject|1|||
27886871|NCT05985980|81419545|FG000|Overall Study|Withdrawal by Subject|1|||
27886872|NCT02291601|81419546|FG000|Abdomen|Did not qualify|333|||
27886873|NCT02291601|81419547|FG001|Abdomen|Did not qualify|54|||
27886874|NCT02291601|81419548|FG002|Abdomen|Did not qualify|339|||
27886875|NCT02291601|81419546|FG000|Groin|Did not qualify|183|||
27886876|NCT02291601|81419547|FG001|Groin|Did not qualify|30|||
27886877|NCT02291601|81419548|FG002|Groin|Did not qualify|177|||
27886878|NCT03655470|81419549|FG000|Overall Study|Lost to Follow-up|6|||
27886879|NCT03655470|81419550|FG001|Overall Study|Lost to Follow-up|7|||
27886880|NCT03615144|81419553|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
27886881|NCT03615144|81419554|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
27886882|NCT03233529|81419557|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
27886883|NCT03233529|81419557|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
27886884|NCT00384839|81421989|FG000|Overall Study|Adverse Event|4|||
27886885|NCT00384839|81421989|FG000|Overall Study|Investigator Request|1|||
27886886|NCT00384839|81421989|FG000|Overall Study|Patient Request|1|||
27886887|NCT00384839|81421989|FG000|Overall Study|Ineligible|2|||
27886888|NCT01944839|81421990|FG000|Overall Study|Physician Decision|2|||
27886889|NCT01944839|81421991|FG001|Overall Study|Physician Decision|2|||
27886890|NCT01944839|81421990|FG000|Overall Study|Protocol Violation|0|||
27886891|NCT01944839|81421991|FG001|Overall Study|Protocol Violation|1|||
27886892|NCT01944839|81421990|FG000|Overall Study|Adverse Event|10|||
27596262|NCT00234065|80359681|FG000|Overall Study|Physician Decision|23|||
27596263|NCT00234065|80359682|FG001|Overall Study|Physician Decision|22|||
27596264|NCT00234065|80359681|FG000|Overall Study|Not Classified|111|||
27596265|NCT00234065|80359682|FG001|Overall Study|Not Classified|112|||
27596266|NCT03355326|80359683|FG000|Overall Study|Protocol Violation|3|||
27596267|NCT03355326|80359684|FG001|Overall Study|Protocol Violation|3|||
27596268|NCT00440531|80359689|FG000|Overall Study|Adverse Event|1|||
27596269|NCT00440531|80359690|FG001|Overall Study|Adverse Event|0|||
27596270|NCT00440531|80359691|FG002|Overall Study|Adverse Event|2|||
27833427|NCT02997176|81222501|FG001|Overall Study|Death|0|||
27833428|NCT02997176|81222502|FG002|Overall Study|Death|1|||
27833429|NCT02997176|81222503|FG003|Overall Study|Death|1|||
27833430|NCT02997176|81222500|FG000|Overall Study|Withdrawal by Subject|0|||
27833431|NCT02997176|81222501|FG001|Overall Study|Withdrawal by Subject|2|||
27833432|NCT02997176|81222502|FG002|Overall Study|Withdrawal by Subject|0|||
27833433|NCT02997176|81222503|FG003|Overall Study|Withdrawal by Subject|1|||
27833434|NCT01923740|81222504|FG000|Overall Study|Lost to Follow-up|4|||
27833435|NCT01923740|81222505|FG001|Overall Study|Lost to Follow-up|9|||
27833436|NCT01923740|81222504|FG000|Overall Study|Withdrawal by Subject|2|||
27833437|NCT01923740|81222505|FG001|Overall Study|Withdrawal by Subject|0|||
27833438|NCT05604014|81222506|FG000|Overall Study|Lost to Follow-up|13|||
27833439|NCT02911025|81222507|FG000|Overall Study|Lost to Follow-up|3|||
27833440|NCT01046084|81222508|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
27833441|NCT01046084|81222509|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
27833442|NCT04299087|81222511|FG000|Overall Study|Lost to Follow-up|2|||
27833443|NCT04299087|81222512|FG001|Overall Study|Lost to Follow-up|1|||
27833444|NCT02280863|81222526|FG000|Integrated Platform|Met stopping criteria|0|||
27833445|NCT02280863|81222527|FG001|Integrated Platform|Met stopping criteria|1|||
27833446|NCT01604941|81222534|FG000|Overall Study|Adverse Event|1|||
27886893|NCT01944839|81421991|FG001|Overall Study|Adverse Event|5|||
27886894|NCT01944839|81421990|FG000|Overall Study|Withdrawal by Subject|9|||
27886895|NCT01944839|81421991|FG001|Overall Study|Withdrawal by Subject|17|||
27596271|NCT00440531|80359689|FG000|Overall Study|Withdrawal by Subject|2|||
27886896|NCT01944839|81421990|FG000|Overall Study|Lost to Follow-up|1|||
27596272|NCT00440531|80359690|FG001|Overall Study|Withdrawal by Subject|0|||
27596273|NCT00440531|80359691|FG002|Overall Study|Withdrawal by Subject|0|||
27596274|NCT00440531|80359689|FG000|Overall Study|Protocol Violation|1|||
27596275|NCT00440531|80359690|FG001|Overall Study|Protocol Violation|2|||
27596276|NCT00440531|80359691|FG002|Overall Study|Protocol Violation|0|||
27596277|NCT00440531|80359689|FG000|Overall Study|Lost to Follow-up|4|||
27596278|NCT00440531|80359690|FG001|Overall Study|Lost to Follow-up|3|||
27596279|NCT00440531|80359691|FG002|Overall Study|Lost to Follow-up|5|||
27596280|NCT00440531|80359689|FG000|Overall Study|see pre-assignment details|2|||
27596281|NCT00440531|80359690|FG001|Overall Study|see pre-assignment details|0|||
27596282|NCT00440531|80359691|FG002|Overall Study|see pre-assignment details|0|||
27596283|NCT01800968|80359694|FG000|Overall Study|Death|23|||
27596284|NCT01800968|80359695|FG001|Overall Study|Death|16|||
27596285|NCT01800968|80359694|FG000|Overall Study|Lost to Follow-up|5|||
27596286|NCT01800968|80359695|FG001|Overall Study|Lost to Follow-up|7|||
27596287|NCT01800968|80359694|FG000|Overall Study|Withdrawal by Subject|7|||
27596288|NCT01800968|80359695|FG001|Overall Study|Withdrawal by Subject|9|||
27833447|NCT01604941|81222535|FG001|Overall Study|Adverse Event|2|||
27833448|NCT01604941|81222536|FG002|Overall Study|Adverse Event|0|||
27886897|NCT01944839|81421991|FG001|Overall Study|Lost to Follow-up|0|||
27886898|NCT01944839|81421990|FG000|Overall Study|Subject non-compliance|0|||
27886899|NCT01944839|81421991|FG001|Overall Study|Subject non-compliance|3|||
27886900|NCT03260244|81421992|FG000|Overall Study|Death|19|||
27886901|NCT03260244|81421992|FG000|Overall Study|Lost to Follow-up|60|||
27886902|NCT03260244|81421992|FG000|Overall Study|Withdrawal by Subject|48|||
27886903|NCT03260244|81421992|FG000|Overall Study|Procedure Not Performed|21|||
27596289|NCT01800968|80359694|FG000|Overall Study|Physician Decision|1|||
27596290|NCT01800968|80359695|FG001|Overall Study|Physician Decision|0|||
27596291|NCT00951483|80359696|FG000|Overall Study|Physician Decision|4|||
27596292|NCT00951483|80359697|FG001|Overall Study|Physician Decision|0|||
27833449|NCT01604941|81222537|FG003|Overall Study|Adverse Event|0|||
27833450|NCT01604941|81222538|FG004|Overall Study|Adverse Event|1|||
27886904|NCT03260244|81421992|FG000|Overall Study|Enrollment Criteria Not Met|31|||
27886905|NCT03260244|81421992|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
27596293|NCT00951483|80359696|FG000|Overall Study|Withdrawal by Subject|15|||
27596294|NCT00951483|80359697|FG001|Overall Study|Withdrawal by Subject|0|||
27833451|NCT01604941|81222539|FG005|Overall Study|Adverse Event|5|||
27596295|NCT00651664|80359698|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
27596296|NCT00651664|80359699|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
27596297|NCT00651664|80359700|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
27596298|NCT00651664|80359701|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
27596299|NCT00651664|80359702|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
27596300|NCT00651664|80359703|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
27596301|NCT00651664|80359704|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
27596302|NCT00651664|80359705|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
27596303|NCT00651664|80359706|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
27596304|NCT00651664|80359707|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
27596305|NCT00651664|80359698|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
27596306|NCT00651664|80359699|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
27596307|NCT00651664|80359700|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27596308|NCT00651664|80359701|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
27596309|NCT00651664|80359702|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
27596310|NCT00651664|80359703|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
27596311|NCT00651664|80359704|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
27596312|NCT00651664|80359705|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
27596313|NCT00651664|80359706|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
27596314|NCT00651664|80359707|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
27596315|NCT00651664|80359698|FG000|Overall Study|Progressive Disease|3|||
27596316|NCT00651664|80359699|FG001|Overall Study|Progressive Disease|3|||
27596317|NCT00651664|80359700|FG002|Overall Study|Progressive Disease|3|||
27596318|NCT00651664|80359701|FG003|Overall Study|Progressive Disease|12|||
27596319|NCT00651664|80359702|FG004|Overall Study|Progressive Disease|4|||
27596320|NCT00651664|80359703|FG005|Overall Study|Progressive Disease|1|||
27596321|NCT00651664|80359704|FG006|Overall Study|Progressive Disease|3|||
27596322|NCT00651664|80359705|FG007|Overall Study|Progressive Disease|6|||
27596323|NCT00651664|80359706|FG008|Overall Study|Progressive Disease|5|||
27596324|NCT00651664|80359707|FG009|Overall Study|Progressive Disease|5|||
27596325|NCT00651664|80359698|FG000|Overall Study|Patient Declined Further Treatment|0|||
27596326|NCT00651664|80359699|FG001|Overall Study|Patient Declined Further Treatment|0|||
27596327|NCT00651664|80359700|FG002|Overall Study|Patient Declined Further Treatment|0|||
27596328|NCT00651664|80359701|FG003|Overall Study|Patient Declined Further Treatment|1|||
27596329|NCT00651664|80359702|FG004|Overall Study|Patient Declined Further Treatment|1|||
27596330|NCT00651664|80359703|FG005|Overall Study|Patient Declined Further Treatment|1|||
27596331|NCT00651664|80359704|FG006|Overall Study|Patient Declined Further Treatment|0|||
27596332|NCT00651664|80359705|FG007|Overall Study|Patient Declined Further Treatment|0|||
27596333|NCT00651664|80359706|FG008|Overall Study|Patient Declined Further Treatment|0|||
27596334|NCT00651664|80359707|FG009|Overall Study|Patient Declined Further Treatment|1|||
27596335|NCT00651664|80359698|FG000|Overall Study|Symptomatic Deterioration|0|||
27596336|NCT00651664|80359699|FG001|Overall Study|Symptomatic Deterioration|0|||
27596337|NCT00651664|80359700|FG002|Overall Study|Symptomatic Deterioration|0|||
27596338|NCT00651664|80359701|FG003|Overall Study|Symptomatic Deterioration|1|||
27596339|NCT00651664|80359702|FG004|Overall Study|Symptomatic Deterioration|0|||
27596340|NCT00651664|80359703|FG005|Overall Study|Symptomatic Deterioration|0|||
27596341|NCT00651664|80359704|FG006|Overall Study|Symptomatic Deterioration|1|||
27596342|NCT00651664|80359705|FG007|Overall Study|Symptomatic Deterioration|0|||
27596343|NCT00651664|80359706|FG008|Overall Study|Symptomatic Deterioration|1|||
27596344|NCT00651664|80359707|FG009|Overall Study|Symptomatic Deterioration|0|||
27596345|NCT00651664|80359698|FG000|Overall Study|Reason not Specified|0|||
27596346|NCT00651664|80359699|FG001|Overall Study|Reason not Specified|0|||
27596347|NCT00651664|80359700|FG002|Overall Study|Reason not Specified|0|||
27596348|NCT00651664|80359701|FG003|Overall Study|Reason not Specified|0|||
27596349|NCT00651664|80359702|FG004|Overall Study|Reason not Specified|0|||
27833452|NCT01604941|81222534|FG000|Overall Study|Non-compliance|1|||
27701948|NCT03785678|80745528|FG000|Overall Study|Lost to Follow-up|4|||
27701949|NCT03785678|80745529|FG001|Overall Study|Lost to Follow-up|2|||
27701950|NCT03785678|80745528|FG000|Overall Study|Physician Decision|0|||
27701951|NCT03785678|80745529|FG001|Overall Study|Physician Decision|2|||
27701952|NCT03785678|80745528|FG000|Overall Study|Withdrawal by Subject|5|||
27701953|NCT03785678|80745529|FG001|Overall Study|Withdrawal by Subject|3|||
27833453|NCT01604941|81222535|FG001|Overall Study|Non-compliance|0|||
27833454|NCT01604941|81222536|FG002|Overall Study|Non-compliance|0|||
27833455|NCT01604941|81222537|FG003|Overall Study|Non-compliance|0|||
27596350|NCT00651664|80359703|FG005|Overall Study|Reason not Specified|0|||
27596351|NCT00651664|80359704|FG006|Overall Study|Reason not Specified|1|||
27701954|NCT00907257|80745530|FG000|Overall Study|Adverse Event|0|||
27701955|NCT00907257|80745531|FG001|Overall Study|Adverse Event|4|||
27701956|NCT00907257|80745530|FG000|Overall Study|Protocol Violation|1|||
27701957|NCT00907257|80745531|FG001|Overall Study|Protocol Violation|2|||
27701958|NCT00907257|80745530|FG000|Overall Study|Lost to Follow-up|3|||
27701959|NCT00907257|80745531|FG001|Overall Study|Lost to Follow-up|3|||
27701960|NCT00907257|80745530|FG000|Overall Study|Withdrawal by Subject|1|||
27701961|NCT00907257|80745531|FG001|Overall Study|Withdrawal by Subject|2|||
27701962|NCT00907257|80745530|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
27701963|NCT00907257|80745531|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
27701964|NCT00907257|80745530|FG000|Overall Study|Moved|1|||
27701965|NCT00907257|80745531|FG001|Overall Study|Moved|0|||
27701966|NCT00907257|80745530|FG000|Overall Study|Personal Reasons|6|||
27701967|NCT00907257|80745531|FG001|Overall Study|Personal Reasons|1|||
27701968|NCT00216203|80745537|FG000|Overall Study|Withdrawal by Subject|2|||
27701969|NCT02540538|80745538|FG000|Overall Study|Pregnancy|0|||
27701970|NCT02540538|80745539|FG001|Overall Study|Pregnancy|1|||
27701971|NCT02540538|80745540|FG002|Overall Study|Pregnancy|0|||
27701972|NCT00659529|80745541|FG000|Overall Study|Withdrawal by Subject|4|||
27701973|NCT00659529|80745541|FG000|Overall Study|Protocol Violation|3|||
27701974|NCT00659529|80745541|FG000|Overall Study|Screen failure|9|||
27701975|NCT02544217|80745542|FG000|Overall Study|Withdrawal by Subject|1|||
27701976|NCT02544217|80745543|FG001|Overall Study|Withdrawal by Subject|1|||
27701977|NCT02544217|80745544|FG002|Overall Study|Withdrawal by Subject|0|||
27701978|NCT02544217|80745545|FG003|Overall Study|Withdrawal by Subject|0|||
27701979|NCT02544217|80745546|FG004|Overall Study|Withdrawal by Subject|0|||
27701980|NCT02544217|80745547|FG005|Overall Study|Withdrawal by Subject|0|||
27701981|NCT01109173|80745548|FG000|Overall Study|Adverse Event|15|||
27701982|NCT01109173|80745549|FG001|Overall Study|Adverse Event|17|||
27701983|NCT01109173|80745550|FG002|Overall Study|Adverse Event|9|||
27701984|NCT01109173|80745551|FG003|Overall Study|Adverse Event|6|||
27701985|NCT01109173|80745548|FG000|Overall Study|Lost to Follow-up|0|||
27701986|NCT01109173|80745549|FG001|Overall Study|Lost to Follow-up|1|||
27701987|NCT01109173|80745550|FG002|Overall Study|Lost to Follow-up|0|||
27701988|NCT01109173|80745551|FG003|Overall Study|Lost to Follow-up|0|||
27701989|NCT01109173|80745548|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
27701990|NCT01109173|80745549|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
27833456|NCT01604941|81222538|FG004|Overall Study|Non-compliance|0|||
27701991|NCT01109173|80745550|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
27833457|NCT01604941|81222539|FG005|Overall Study|Non-compliance|0|||
27833458|NCT01604941|81222534|FG000|Overall Study|Participant Decision|0|||
27833459|NCT01604941|81222535|FG001|Overall Study|Participant Decision|0|||
27833460|NCT01604941|81222536|FG002|Overall Study|Participant Decision|0|||
27833461|NCT01604941|81222537|FG003|Overall Study|Participant Decision|0|||
27833462|NCT01604941|81222538|FG004|Overall Study|Participant Decision|0|||
27833463|NCT01604941|81222539|FG005|Overall Study|Participant Decision|2|||
27833464|NCT01604941|81222534|FG000|Overall Study|Early Study Termination|9|||
27833465|NCT01604941|81222535|FG001|Overall Study|Early Study Termination|2|||
27833466|NCT01604941|81222536|FG002|Overall Study|Early Study Termination|3|||
27833467|NCT01604941|81222537|FG003|Overall Study|Early Study Termination|3|||
27833468|NCT01604941|81222538|FG004|Overall Study|Early Study Termination|0|||
27833469|NCT01604941|81222539|FG005|Overall Study|Early Study Termination|0|||
27833470|NCT00714051|81222540|FG000|Overall Study|Withdrawal by Subject|1|||
27701992|NCT01109173|80745551|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
27701993|NCT01109173|80745548|FG000|Overall Study|Noncompliance|0|||
27701994|NCT01109173|80745549|FG001|Overall Study|Noncompliance|1|||
27701995|NCT01109173|80745550|FG002|Overall Study|Noncompliance|0|||
27833471|NCT00714051|81222541|FG001|Overall Study|Withdrawal by Subject|0|||
27833472|NCT00714051|81222540|FG000|Overall Study|Death|0|||
27833473|NCT00714051|81222541|FG001|Overall Study|Death|1|||
27701996|NCT01109173|80745551|FG003|Overall Study|Noncompliance|0|||
27701997|NCT01109173|80745548|FG000|Overall Study|Treatment Failure|25|||
27701998|NCT01109173|80745549|FG001|Overall Study|Treatment Failure|32|||
27701999|NCT01109173|80745550|FG002|Overall Study|Treatment Failure|69|||
27702000|NCT01109173|80745551|FG003|Overall Study|Treatment Failure|64|||
27702001|NCT01109173|80745548|FG000|Overall Study|Protocol Violation|4|||
27702002|NCT01109173|80745549|FG001|Overall Study|Protocol Violation|5|||
27702003|NCT01109173|80745550|FG002|Overall Study|Protocol Violation|1|||
27702004|NCT01109173|80745551|FG003|Overall Study|Protocol Violation|2|||
27702005|NCT01109173|80745548|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
27702006|NCT01109173|80745549|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
27702007|NCT01109173|80745550|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
27702008|NCT01109173|80745551|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
27702009|NCT01109173|80745548|FG000|Overall Study|Not Specifiied|5|||
27702010|NCT01109173|80745549|FG001|Overall Study|Not Specifiied|4|||
27702011|NCT01109173|80745550|FG002|Overall Study|Not Specifiied|9|||
27702012|NCT01109173|80745551|FG003|Overall Study|Not Specifiied|14|||
27702013|NCT02060383|80745552|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
27702014|NCT02060383|80745553|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
27702015|NCT02060383|80745554|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
27702016|NCT02060383|80745555|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
27702017|NCT02060383|80745556|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
27702018|NCT02060383|80745552|FG000|Core Phase|Adverse Event|2|||
27702019|NCT02060383|80745553|FG001|Core Phase|Adverse Event|0|||
27702020|NCT02060383|80745554|FG002|Core Phase|Adverse Event|0|||
27702021|NCT02060383|80745555|FG003|Core Phase|Adverse Event|2|||
27702022|NCT02060383|80745556|FG004|Core Phase|Adverse Event|6|||
27702023|NCT02060383|80745552|FG000|Core Phase|Administrative problems|0|||
27702024|NCT02060383|80745553|FG001|Core Phase|Administrative problems|1|||
27702025|NCT02060383|80745554|FG002|Core Phase|Administrative problems|0|||
27702026|NCT02060383|80745555|FG003|Core Phase|Administrative problems|0|||
27702027|NCT02060383|80745556|FG004|Core Phase|Administrative problems|0|||
27702028|NCT02060383|80745552|FG000|Core Phase|Protocol Violation|0|||
27702029|NCT02060383|80745553|FG001|Core Phase|Protocol Violation|0|||
27833474|NCT03827395|81222544|FG000|Overall Study|Lost to Follow-up|1|||
27833475|NCT03827395|81222545|FG001|Overall Study|Lost to Follow-up|0|||
27702030|NCT02060383|80745554|FG002|Core Phase|Protocol Violation|0|||
27702031|NCT02060383|80745555|FG003|Core Phase|Protocol Violation|1|||
27702032|NCT02060383|80745556|FG004|Core Phase|Protocol Violation|0|||
27702033|NCT02060383|80745552|FG000|Core Phase|Withdrawal by Subject|0|||
27702034|NCT02060383|80745553|FG001|Core Phase|Withdrawal by Subject|0|||
27702035|NCT02060383|80745554|FG002|Core Phase|Withdrawal by Subject|0|||
27702036|NCT02060383|80745555|FG003|Core Phase|Withdrawal by Subject|4|||
27702037|NCT02060383|80745556|FG004|Core Phase|Withdrawal by Subject|2|||
27702038|NCT02060383|80745552|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
27833476|NCT03827395|81222544|FG000|Overall Study|Protocol Violation|1|||
27833477|NCT03827395|81222545|FG001|Overall Study|Protocol Violation|0|||
27702039|NCT02060383|80745553|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
27702040|NCT02060383|80745554|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
27833478|NCT03827395|81222544|FG000|Overall Study|Became ineligible after enrollment|1|||
27702041|NCT02060383|80745555|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
27702042|NCT02060383|80745556|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
27702043|NCT02060383|80745552|FG000|Extension Phase|Adverse Event|1|||
27702044|NCT02060383|80745553|FG001|Extension Phase|Adverse Event|1|||
27702045|NCT02060383|80745554|FG002|Extension Phase|Adverse Event|2|||
27702046|NCT02060383|80745555|FG003|Extension Phase|Adverse Event|0|||
27702047|NCT02060383|80745556|FG004|Extension Phase|Adverse Event|1|||
27702048|NCT02060383|80745552|FG000|Extension Phase|Withdrawal by Subject|0|||
27702049|NCT02060383|80745553|FG001|Extension Phase|Withdrawal by Subject|1|||
27702050|NCT02060383|80745554|FG002|Extension Phase|Withdrawal by Subject|0|||
27702051|NCT02060383|80745555|FG003|Extension Phase|Withdrawal by Subject|0|||
27702052|NCT02060383|80745556|FG004|Extension Phase|Withdrawal by Subject|2|||
27702053|NCT02060383|80745552|FG000|Extension Phase|Administrative problems|1|||
27702054|NCT02060383|80745553|FG001|Extension Phase|Administrative problems|0|||
27702055|NCT02060383|80745554|FG002|Extension Phase|Administrative problems|0|||
27702056|NCT02060383|80745555|FG003|Extension Phase|Administrative problems|0|||
27596352|NCT00651664|80359705|FG007|Overall Study|Reason not Specified|0|||
27596353|NCT00651664|80359706|FG008|Overall Study|Reason not Specified|0|||
27596354|NCT00651664|80359707|FG009|Overall Study|Reason not Specified|0|||
27596355|NCT03822533|80359708|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
27596356|NCT03822533|80359709|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
27596357|NCT03822533|80359708|FG000|3 Month Follow-up|Lost to Follow-up|2|||
27596358|NCT03822533|80359709|FG001|3 Month Follow-up|Lost to Follow-up|2|||
27596359|NCT03822533|80359708|FG000|6 Month Follow-up|Lost to Follow-up|3|||
27596360|NCT03822533|80359709|FG001|6 Month Follow-up|Lost to Follow-up|0|||
27596361|NCT03822533|80359708|FG000|12 Month Follow-up|Lost to Follow-up|2|||
27596362|NCT03822533|80359709|FG001|12 Month Follow-up|Lost to Follow-up|3|||
27596363|NCT03822533|80359708|FG000|12 Month Follow-up|Pregnancy|0|||
27596364|NCT03822533|80359709|FG001|12 Month Follow-up|Pregnancy|1|||
27596365|NCT03822533|80359708|FG000|12 Month Follow-up|Surgery|2|||
27596366|NCT03822533|80359709|FG001|12 Month Follow-up|Surgery|0|||
27596367|NCT03822533|80359708|FG000|12 Month Follow-up|Wrong address|1|||
27596368|NCT03822533|80359709|FG001|12 Month Follow-up|Wrong address|0|||
27596369|NCT03822533|80359708|FG000|12 Month Follow-up|No symptoms|1|||
27596370|NCT03822533|80359709|FG001|12 Month Follow-up|No symptoms|0|||
27596371|NCT03822533|80359708|FG000|12 Month Follow-up|Changed primary care center|0|||
27596372|NCT03822533|80359709|FG001|12 Month Follow-up|Changed primary care center|1|||
27596373|NCT01749982|80359710|FG000|Overall Study|Physician Decision|0|||
27596374|NCT01749982|80359711|FG001|Overall Study|Physician Decision|0|||
27596375|NCT01749982|80359712|FG002|Overall Study|Physician Decision|0|||
27596376|NCT01749982|80359713|FG003|Overall Study|Physician Decision|1|||
27702057|NCT02060383|80745556|FG004|Extension Phase|Administrative problems|0|||
27702058|NCT02060383|80745552|FG000|Extension Phase|Death|0|||
27702059|NCT02060383|80745553|FG001|Extension Phase|Death|0|||
27702060|NCT02060383|80745554|FG002|Extension Phase|Death|1|||
27596377|NCT01749982|80359710|FG000|Overall Study|Lost to Follow-up|0|||
27596378|NCT01749982|80359711|FG001|Overall Study|Lost to Follow-up|0|||
27596379|NCT01749982|80359712|FG002|Overall Study|Lost to Follow-up|0|||
27596380|NCT01749982|80359713|FG003|Overall Study|Lost to Follow-up|1|||
27596381|NCT01749982|80359710|FG000|Overall Study|Withdrawal by Subject|0|||
27702061|NCT02060383|80745555|FG003|Extension Phase|Death|0|||
27702062|NCT02060383|80745556|FG004|Extension Phase|Death|1|||
27702063|NCT02060383|80745552|FG000|Extension Phase|Protocol Violation|0|||
27702064|NCT02060383|80745553|FG001|Extension Phase|Protocol Violation|0|||
27833479|NCT03827395|81222545|FG001|Overall Study|Became ineligible after enrollment|2|||
27833480|NCT00087529|81222547|FG000|Overall Study|Death|1|||
27833481|NCT00087529|81222548|FG001|Overall Study|Death|0|||
27833482|NCT00087529|81222547|FG000|Overall Study|Adverse Event|0|||
27833483|NCT00087529|81222548|FG001|Overall Study|Adverse Event|8|||
27833484|NCT00087529|81222547|FG000|Overall Study|Pregnancy|0|||
27833485|NCT00087529|81222548|FG001|Overall Study|Pregnancy|1|||
27833486|NCT00087529|81222547|FG000|Overall Study|Lost to Follow-up|2|||
27833487|NCT00087529|81222548|FG001|Overall Study|Lost to Follow-up|3|||
27886906|NCT03260244|81421992|FG000|Overall Study|Subject Noncompliance|6|||
27886907|NCT03260244|81421992|FG000|Overall Study|No inducible Arrhythmia|2|||
27702065|NCT02060383|80745554|FG002|Extension Phase|Protocol Violation|0|||
27702066|NCT02060383|80745555|FG003|Extension Phase|Protocol Violation|0|||
27702067|NCT02060383|80745556|FG004|Extension Phase|Protocol Violation|1|||
27702068|NCT03027557|80745559|FG000|Overall Study|Adverse Event|1|||
27886908|NCT03260244|81421992|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
27886909|NCT03260244|81421992|FG000|Overall Study|Screen Failure|2|||
27886910|NCT03260244|81421992|FG000|Overall Study|Treated Off Label|69|||
27886911|NCT03260244|81421992|FG000|Overall Study|No Radiofrequency Ablation|14|||
27833488|NCT00087529|81222547|FG000|Overall Study|Participant Decision|14|||
27833489|NCT00087529|81222548|FG001|Overall Study|Participant Decision|37|||
27833490|NCT00087529|81222547|FG000|Overall Study|Physician Decision|4|||
27833491|NCT00087529|81222548|FG001|Overall Study|Physician Decision|8|||
27833492|NCT00087529|81222547|FG000|Overall Study|Initiation of Excluded Therapy|0|||
27886912|NCT03339726|81421993|FG000|Overall Study|Withdrawal by Subject|1|||
27886913|NCT03339726|81421994|FG001|Overall Study|Withdrawal by Subject|0|||
27886914|NCT03339726|81421995|FG002|Overall Study|Withdrawal by Subject|0|||
27886915|NCT03339726|81421993|FG000|Overall Study|Lost to Follow-up|0|||
27886916|NCT03339726|81421994|FG001|Overall Study|Lost to Follow-up|1|||
27886917|NCT03339726|81421995|FG002|Overall Study|Lost to Follow-up|0|||
27886918|NCT00869999|81421996|FG000|Overall Study|Withdrawal by Subject|1|||
27886919|NCT00869999|81421996|FG000|Overall Study|removed prior to starting therapy|1|||
27886920|NCT03681678|81421997|FG000|Overall Study|Lost to Follow-up|20|||
27886921|NCT01085630|81421999|FG000|Overall Study|Insufficient data|1|||
27886922|NCT01085630|81422000|FG001|Overall Study|Insufficient data|0|||
27702069|NCT03027557|80745560|FG001|Overall Study|Adverse Event|0|||
27886923|NCT01085630|81421999|FG000|Overall Study|Ineligible|3|||
27886924|NCT01085630|81422000|FG001|Overall Study|Ineligible|0|||
27702070|NCT03027557|80745561|FG002|Overall Study|Adverse Event|0|||
27702071|NCT03370471|80745565|FG000|Overall Study|Withdrawal by Subject|6|||
27702072|NCT03370471|80745566|FG001|Overall Study|Withdrawal by Subject|1|||
27833493|NCT00087529|81222548|FG001|Overall Study|Initiation of Excluded Therapy|1|||
27886925|NCT03852264|81422001|FG000|Third Research Visit|Lost to Follow-up|1|||
27886926|NCT03852264|81422002|FG001|Third Research Visit|Lost to Follow-up|0|||
27886927|NCT04815031|81422006|FG000|Overall Study|No adverse event information (missing information)|33|||
27886928|NCT03103321|81422007|FG000|Overall Study|Protocol Violation|1|||
27702073|NCT03370471|80745565|FG000|Overall Study|Unable to access veins for blood draw|0|||
27833494|NCT00087529|81222547|FG000|Overall Study|Participant Noncompliance|0|||
27886929|NCT03103321|81422008|FG001|Overall Study|Protocol Violation|1|||
27833495|NCT00087529|81222548|FG001|Overall Study|Participant Noncompliance|1|||
27833496|NCT00087529|81222547|FG000|Overall Study|Disease Progression|5|||
27833497|NCT00087529|81222548|FG001|Overall Study|Disease Progression|4|||
27702074|NCT03370471|80745566|FG001|Overall Study|Unable to access veins for blood draw|1|||
27886930|NCT03103321|81422009|FG002|Overall Study|Protocol Violation|1|||
27886931|NCT03103321|81422010|FG003|Overall Study|Protocol Violation|0|||
27886932|NCT02792192|81422017|FG000|Overall Study|Death|1|||
27886933|NCT02792192|81422018|FG001|Overall Study|Death|0|||
27886934|NCT02792192|81422019|FG002|Overall Study|Death|0|||
27886935|NCT02792192|81422020|FG003|Overall Study|Death|0|||
27886936|NCT02792192|81422017|FG000|Overall Study|Informed Consent Withdrawn|4|||
27886937|NCT02792192|81422018|FG001|Overall Study|Informed Consent Withdrawn|0|||
27886938|NCT02792192|81422019|FG002|Overall Study|Informed Consent Withdrawn|0|||
27886939|NCT02792192|81422020|FG003|Overall Study|Informed Consent Withdrawn|0|||
27886940|NCT02792192|81422017|FG000|Overall Study|Physician Decision|1|||
27886941|NCT02792192|81422018|FG001|Overall Study|Physician Decision|0|||
27886942|NCT02792192|81422019|FG002|Overall Study|Physician Decision|0|||
27886943|NCT02792192|81422020|FG003|Overall Study|Physician Decision|0|||
27886944|NCT02792192|81422017|FG000|Overall Study|Progressive Disease|0|||
27886945|NCT02792192|81422018|FG001|Overall Study|Progressive Disease|1|||
27886946|NCT02792192|81422019|FG002|Overall Study|Progressive Disease|0|||
27596382|NCT01749982|80359711|FG001|Overall Study|Withdrawal by Subject|0|||
27886947|NCT02792192|81422020|FG003|Overall Study|Progressive Disease|0|||
27886948|NCT02792192|81422017|FG000|Overall Study|Study Terminated By Sponsor|6|||
27886949|NCT02792192|81422018|FG001|Overall Study|Study Terminated By Sponsor|10|||
27886950|NCT02792192|81422019|FG002|Overall Study|Study Terminated By Sponsor|0|||
27886951|NCT02792192|81422020|FG003|Overall Study|Study Terminated By Sponsor|0|||
27886952|NCT00680901|81422021|FG000|Overall Study|Lost to Follow-up|8|||
27886953|NCT00680901|81422022|FG001|Overall Study|Lost to Follow-up|8|||
27886954|NCT00680901|81422021|FG000|Overall Study|Withdrawal by Subject|4|||
27886955|NCT00680901|81422022|FG001|Overall Study|Withdrawal by Subject|13|||
27886956|NCT00680901|81422021|FG000|Overall Study|Physician Decision|0|||
27886957|NCT00680901|81422022|FG001|Overall Study|Physician Decision|1|||
27886958|NCT00680901|81422021|FG000|Overall Study|Ongoing: On Study Treatment|16|||
27886959|NCT00680901|81422022|FG001|Overall Study|Ongoing: On Study Treatment|13|||
27886960|NCT00680901|81422021|FG000|Overall Study|Ongoing: In Follow Up|45|||
27886961|NCT00680901|81422022|FG001|Overall Study|Ongoing: In Follow Up|41|||
27886962|NCT02453334|81422024|FG000|Overall Study|Death|15|||
27886963|NCT02453334|81422025|FG001|Overall Study|Death|13|||
27886964|NCT02453334|81422024|FG000|Overall Study|Adverse Event|2|||
27886965|NCT02453334|81422025|FG001|Overall Study|Adverse Event|1|||
27886966|NCT02453334|81422024|FG000|Overall Study|Lost to Follow-up|5|||
27886967|NCT02453334|81422025|FG001|Overall Study|Lost to Follow-up|9|||
27886968|NCT02453334|81422024|FG000|Overall Study|Physician Decision|1|||
27886969|NCT02453334|81422025|FG001|Overall Study|Physician Decision|0|||
27886970|NCT02453334|81422024|FG000|Overall Study|Withdrawal by Subject|17|||
27886971|NCT02453334|81422025|FG001|Overall Study|Withdrawal by Subject|13|||
27886972|NCT02453334|81422024|FG000|Overall Study|Other reason|1|||
27886973|NCT02453334|81422025|FG001|Overall Study|Other reason|4|||
27886974|NCT05653427|81422026|FG000|Overall Study|Study Terminated by Sponsor|13|||
27886975|NCT04590586|81422031|FG000|Overall Study|Death|7|||
27886976|NCT04590586|81422032|FG001|Overall Study|Death|1|||
27886977|NCT04590586|81422033|FG002|Overall Study|Death|37|||
27886978|NCT04590586|81422034|FG003|Overall Study|Death|34|||
27886979|NCT04590586|81422035|FG004|Overall Study|Death|19|||
27886980|NCT04590586|81422036|FG005|Overall Study|Death|3|||
27886981|NCT04590586|81422031|FG000|Overall Study|Lost to Follow-up|3|||
27886982|NCT04590586|81422032|FG001|Overall Study|Lost to Follow-up|0|||
27886983|NCT04590586|81422033|FG002|Overall Study|Lost to Follow-up|11|||
27886984|NCT04590586|81422034|FG003|Overall Study|Lost to Follow-up|11|||
27702075|NCT03370471|80745565|FG000|Overall Study|Screen fail|1|||
27886985|NCT04590586|81422035|FG004|Overall Study|Lost to Follow-up|6|||
27886986|NCT04590586|81422036|FG005|Overall Study|Lost to Follow-up|0|||
27886987|NCT04590586|81422031|FG000|Overall Study|Withdrawal by Subject|0|||
27886988|NCT04590586|81422032|FG001|Overall Study|Withdrawal by Subject|0|||
27886989|NCT04590586|81422033|FG002|Overall Study|Withdrawal by Subject|6|||
27886990|NCT04590586|81422034|FG003|Overall Study|Withdrawal by Subject|0|||
27886991|NCT04590586|81422035|FG004|Overall Study|Withdrawal by Subject|3|||
27886992|NCT04590586|81422036|FG005|Overall Study|Withdrawal by Subject|0|||
27702076|NCT03370471|80745566|FG001|Overall Study|Screen fail|0|||
27702077|NCT05097716|80745572|FG000|Period 1|Adverse Event|1|||
27702078|NCT05097716|80745572|FG000|Period 1|Close contact with highly-transmissible infection|1|||
27702079|NCT02566577|80745573|FG000|Overall Study|Withdrawal by Subject|1|||
27702080|NCT02566577|80745574|FG001|Overall Study|Withdrawal by Subject|1|||
27702081|NCT02566577|80745573|FG000|Overall Study|Equipment failure|1|||
27702082|NCT02566577|80745574|FG001|Overall Study|Equipment failure|1|||
27702083|NCT02566577|80745573|FG000|Overall Study|Physical limitation|1|||
27702084|NCT02566577|80745574|FG001|Overall Study|Physical limitation|0|||
27702085|NCT00757003|80745575|FG000|Overall Study|Death|33|||
27886993|NCT04590586|81422031|FG000|Overall Study|Other|3|||
27886994|NCT04590586|81422032|FG001|Overall Study|Other|0|||
27886995|NCT04590586|81422033|FG002|Overall Study|Other|1|||
27886996|NCT04590586|81422034|FG003|Overall Study|Other|1|||
27886997|NCT04590586|81422035|FG004|Overall Study|Other|2|||
27886998|NCT04590586|81422036|FG005|Overall Study|Other|1|||
27886999|NCT02309411|81422037|FG000|Overall Study|Physician Decision|1|||
27887000|NCT02309411|81422038|FG001|Overall Study|Physician Decision|0|||
27887001|NCT02309411|81422039|FG002|Overall Study|Physician Decision|0|||
27887002|NCT02309411|81422037|FG000|Overall Study|Withdrawal by Subject|1|||
27887003|NCT02309411|81422038|FG001|Overall Study|Withdrawal by Subject|1|||
27887004|NCT02309411|81422039|FG002|Overall Study|Withdrawal by Subject|0|||
27887005|NCT02993146|81422040|FG000|Overall Study|Withdrawal by Subject|0|||
27887006|NCT02993146|81422041|FG001|Overall Study|Withdrawal by Subject|0|||
27702086|NCT00757003|80745575|FG000|Overall Study|Lost to Follow-up|9|||
27702087|NCT00757003|80745575|FG000|Overall Study|Withdrawal by Subject|4|||
27702088|NCT00757003|80745575|FG000|Overall Study|Surgically explanted|2|||
27702089|NCT00757003|80745575|FG000|Overall Study|Not implanted|1|||
27702090|NCT01284062|80745578|FG000|Overall Study|Adverse Event|4|||
27702091|NCT01284062|80745579|FG001|Overall Study|Adverse Event|5|||
27702092|NCT01284062|80745580|FG002|Overall Study|Adverse Event|0|||
27702093|NCT01284062|80745581|FG003|Overall Study|Adverse Event|5|||
27702094|NCT01284062|80745578|FG000|Overall Study|Lack of Efficacy|3|||
27702095|NCT01284062|80745579|FG001|Overall Study|Lack of Efficacy|2|||
27702096|NCT01284062|80745580|FG002|Overall Study|Lack of Efficacy|2|||
27702097|NCT01284062|80745581|FG003|Overall Study|Lack of Efficacy|1|||
27702098|NCT01284062|80745578|FG000|Overall Study|Medication error without adverse event|0|||
27702099|NCT01284062|80745579|FG001|Overall Study|Medication error without adverse event|0|||
27702100|NCT01284062|80745580|FG002|Overall Study|Medication error without adverse event|1|||
27702101|NCT01284062|80745581|FG003|Overall Study|Medication error without adverse event|0|||
27702102|NCT01284062|80745578|FG000|Overall Study|Protocol Violation|1|||
27702103|NCT01284062|80745579|FG001|Overall Study|Protocol Violation|0|||
27702104|NCT01284062|80745580|FG002|Overall Study|Protocol Violation|0|||
27702105|NCT01284062|80745581|FG003|Overall Study|Protocol Violation|2|||
27702106|NCT01284062|80745578|FG000|Overall Study|Withdrawal by Subject|3|||
27702107|NCT01284062|80745579|FG001|Overall Study|Withdrawal by Subject|1|||
27702108|NCT01284062|80745580|FG002|Overall Study|Withdrawal by Subject|2|||
27702109|NCT01284062|80745581|FG003|Overall Study|Withdrawal by Subject|5|||
27702110|NCT01284062|80745578|FG000|Overall Study|Other|0|||
27702111|NCT01284062|80745579|FG001|Overall Study|Other|0|||
27702112|NCT01284062|80745580|FG002|Overall Study|Other|0|||
27702113|NCT01284062|80745581|FG003|Overall Study|Other|1|||
27702114|NCT01284062|80745578|FG000|Overall Study|Site Closed|0|||
27702115|NCT01284062|80745579|FG001|Overall Study|Site Closed|0|||
27702116|NCT01284062|80745580|FG002|Overall Study|Site Closed|1|||
27702117|NCT01284062|80745581|FG003|Overall Study|Site Closed|0|||
27702118|NCT02876835|80745582|FG000|Treatment Period (51.1 Month)|Other|1|||
27702119|NCT02876835|80745583|FG001|Treatment Period (51.1 Month)|Other|0|||
27887007|NCT02993146|81422042|FG002|Overall Study|Withdrawal by Subject|1|||
27887008|NCT02993146|81422043|FG003|Overall Study|Withdrawal by Subject|1|||
27702120|NCT02876835|80745582|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
27702121|NCT02876835|80745583|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
27702122|NCT02876835|80745582|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
27702123|NCT02876835|80745583|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
27702124|NCT02876835|80745582|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
27702125|NCT02876835|80745583|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
27702126|NCT02615470|80748171|FG000|Overall Study|Lost to Follow-up|21|||
27702127|NCT02615470|80748172|FG001|Overall Study|Lost to Follow-up|32|||
27702128|NCT02877927|80748174|FG000|Overall Study|Adverse Event|1|||
27887009|NCT02805660|81422045|FG000|Overall Study|Death|5|||
27596383|NCT01749982|80359712|FG002|Overall Study|Withdrawal by Subject|0|||
27596384|NCT01749982|80359713|FG003|Overall Study|Withdrawal by Subject|1|||
27596385|NCT04528069|80359717|FG000|Overall Study|Adverse Event|1|||
27596386|NCT04528069|80359717|FG000|Overall Study|Lost to Follow-up|1|||
27596387|NCT04528069|80359717|FG000|Overall Study|Patient Unable to Come|1|||
27596388|NCT04528069|80359717|FG000|Overall Study|Patient Unable to Attend|1|||
27596389|NCT00074282|80359718|FG000|Step 1|Adverse Event|32|||
27596390|NCT00074282|80359719|FG001|Step 1|Adverse Event|0|||
27596391|NCT00074282|80359720|FG002|Step 1|Adverse Event|0|||
27833498|NCT00087529|81222547|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
27887010|NCT02805660|81422046|FG001|Overall Study|Death|2|||
27887011|NCT02805660|81422047|FG002|Overall Study|Death|9|||
27887012|NCT02805660|81422048|FG003|Overall Study|Death|5|||
27887013|NCT02805660|81422049|FG004|Overall Study|Death|0|||
27833499|NCT00087529|81222548|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
27833500|NCT03961204|81222550|FG000|Overall Study|Withdrawal by Subject|2|||
27833501|NCT03961204|81222550|FG000|Overall Study|Lost to Follow-up|3|||
27833502|NCT03961204|81222550|FG000|Overall Study|Other|1|||
27833503|NCT03961204|81222550|FG000|Overall Study|Missing|1|||
27833504|NCT03694197|81222551|FG000|Overall Study|Adverse Event|9|||
27833505|NCT03694197|81222551|FG000|Overall Study|Protocol became inconvenient to participate|1|||
27833506|NCT03694197|81222551|FG000|Overall Study|Physician Decision|4|||
27887014|NCT02805660|81422050|FG005|Overall Study|Death|14|||
27833507|NCT03694197|81222551|FG000|Overall Study|Study terminated by sponsor|1350|||
27596392|NCT00074282|80359718|FG000|Step 1|Death|6|||
27596393|NCT00074282|80359719|FG001|Step 1|Death|0|||
27833508|NCT03694197|81222551|FG000|Overall Study|Participant moved|5|||
27596394|NCT00074282|80359720|FG002|Step 1|Death|0|||
27596395|NCT00074282|80359718|FG000|Step 1|Withdrawal by Subject|7|||
27887015|NCT02805660|81422051|FG006|Overall Study|Death|12|||
27833509|NCT03694197|81222551|FG000|Overall Study|Participant withdrew consent|10|||
27833510|NCT03694197|81222551|FG000|Overall Study|Related to IMP administration|1|||
27833511|NCT03694197|81222551|FG000|Overall Study|Not disclosed|5|||
27596396|NCT00074282|80359719|FG001|Step 1|Withdrawal by Subject|0|||
27596397|NCT00074282|80359720|FG002|Step 1|Withdrawal by Subject|0|||
27596398|NCT00074282|80359718|FG000|Step 1|Disease progression|2|||
27596399|NCT00074282|80359719|FG001|Step 1|Disease progression|0|||
27596400|NCT00074282|80359720|FG002|Step 1|Disease progression|0|||
27596401|NCT00074282|80359718|FG000|Step 1|Alternative therapy|2|||
27596402|NCT00074282|80359719|FG001|Step 1|Alternative therapy|0|||
27596403|NCT00074282|80359720|FG002|Step 1|Alternative therapy|0|||
27596404|NCT00074282|80359718|FG000|Step 1|Other complicating disease|2|||
27596405|NCT00074282|80359719|FG001|Step 1|Other complicating disease|0|||
27596406|NCT00074282|80359720|FG002|Step 1|Other complicating disease|0|||
27596407|NCT00074282|80359718|FG000|Step 1|Physician Decision|1|||
27596408|NCT00074282|80359719|FG001|Step 1|Physician Decision|0|||
27596409|NCT00074282|80359720|FG002|Step 1|Physician Decision|0|||
27596410|NCT00074282|80359718|FG000|Step 1|Ineligible|4|||
27596411|NCT00074282|80359719|FG001|Step 1|Ineligible|0|||
27596412|NCT00074282|80359720|FG002|Step 1|Ineligible|0|||
27596413|NCT00074282|80359718|FG000|Step 1|Never started treatment|2|||
27596414|NCT00074282|80359719|FG001|Step 1|Never started treatment|0|||
27596415|NCT00074282|80359720|FG002|Step 1|Never started treatment|0|||
27596416|NCT00074282|80359718|FG000|Step 2|Adverse Event|0|||
27596417|NCT00074282|80359719|FG001|Step 2|Adverse Event|2|||
27596418|NCT00074282|80359720|FG002|Step 2|Adverse Event|12|||
27596419|NCT00074282|80359718|FG000|Step 2|Disease progression|0|||
27596420|NCT00074282|80359719|FG001|Step 2|Disease progression|0|||
27596421|NCT00074282|80359720|FG002|Step 2|Disease progression|5|||
27596422|NCT00074282|80359718|FG000|Step 2|Death|0|||
27596423|NCT00074282|80359719|FG001|Step 2|Death|0|||
27596424|NCT00074282|80359720|FG002|Step 2|Death|3|||
27596425|NCT00074282|80359718|FG000|Step 2|Withdrawal by Subject|0|||
27596426|NCT00074282|80359719|FG001|Step 2|Withdrawal by Subject|0|||
27596427|NCT00074282|80359720|FG002|Step 2|Withdrawal by Subject|2|||
27596428|NCT00074282|80359718|FG000|Step 2|Physician Decision|0|||
27596429|NCT00074282|80359719|FG001|Step 2|Physician Decision|0|||
27596430|NCT00074282|80359720|FG002|Step 2|Physician Decision|1|||
27596431|NCT00074282|80359718|FG000|Step 2|Ineligible|0|||
27596432|NCT00074282|80359719|FG001|Step 2|Ineligible|0|||
27596433|NCT00074282|80359720|FG002|Step 2|Ineligible|1|||
27596434|NCT01152580|80359722|FG000|Overall Study|Withdrawal by Subject|0|||
27596435|NCT01152580|80359723|FG001|Overall Study|Withdrawal by Subject|1|||
27596436|NCT03593655|80359724|FG000|First Product Use Period|Withdrawal by Subject|1|||
27596437|NCT03593655|80359725|FG001|First Product Use Period|Withdrawal by Subject|1|||
27596438|NCT03593655|80359724|FG000|First Product Use Period|Lost to Follow-up|1|||
27596439|NCT03593655|80359725|FG001|First Product Use Period|Lost to Follow-up|3|||
27596440|NCT03593655|80359724|FG000|Second Product Use Period|Withdrawal by Subject|1|||
27596441|NCT03593655|80359725|FG001|Second Product Use Period|Withdrawal by Subject|1|||
27596442|NCT03593655|80359724|FG000|Second Product Use Period|Lost to Follow-up|1|||
27596443|NCT03593655|80359725|FG001|Second Product Use Period|Lost to Follow-up|0|||
27596444|NCT03593655|80359724|FG000|Third Product Use Period|Lost to Follow-up|1|||
27596445|NCT03593655|80359725|FG001|Third Product Use Period|Lost to Follow-up|2|||
27596446|NCT03593655|80359724|FG000|Third Product Use Period|Physician Decision|0|||
27596447|NCT03593655|80359725|FG001|Third Product Use Period|Physician Decision|1|||
27596448|NCT03593655|80359724|FG000|Third Product Use Period|Withdrawal by Subject|0|||
27596449|NCT03593655|80359725|FG001|Third Product Use Period|Withdrawal by Subject|1|||
27702129|NCT02877927|80748175|FG001|Overall Study|Adverse Event|0|||
27702130|NCT02877927|80748174|FG000|Overall Study|Lost to Follow-up|37|||
27702131|NCT02877927|80748175|FG001|Overall Study|Lost to Follow-up|38|||
27702132|NCT02877927|80748174|FG000|Overall Study|Withdrawal by Subject|11|||
27702133|NCT02877927|80748175|FG001|Overall Study|Withdrawal by Subject|12|||
27702134|NCT02877927|80748174|FG000|Overall Study|Physician Decision|0|||
27702135|NCT02877927|80748175|FG001|Overall Study|Physician Decision|1|||
27596450|NCT03141359|80359728|FG000|Overall Study|Death|32|||
27596451|NCT03141359|80359728|FG000|Overall Study|Still On Study (in follow up)|29|||
27702136|NCT02877927|80748174|FG000|Overall Study|Missed EOT/PTE Visit|5|||
27702137|NCT02877927|80748175|FG001|Overall Study|Missed EOT/PTE Visit|6|||
27702138|NCT00387764|80748176|FG000|Overall Study|Adverse Event|12|||
27702139|NCT00387764|80748176|FG000|Overall Study|Withdrawal by Subject|8|||
27702140|NCT00387764|80748176|FG000|Overall Study|Sponsor Terminated Study|1|||
27702141|NCT00387764|80748176|FG000|Overall Study|Physician Decision|1|||
27702142|NCT00387764|80748176|FG000|Overall Study|Other|2|||
27702143|NCT00387764|80748176|FG000|Overall Study|Death|7|||
27596452|NCT00827918|80359729|FG000|Overall Study|Adverse Event|4|||
27596453|NCT00827918|80359730|FG001|Overall Study|Adverse Event|0|||
27596454|NCT00827918|80359731|FG002|Overall Study|Adverse Event|0|||
27596455|NCT00827918|80359729|FG000|Overall Study|Lack of Efficacy|16|||
27596456|NCT00827918|80359730|FG001|Overall Study|Lack of Efficacy|4|||
27702144|NCT02606461|80748177|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
27596457|NCT00827918|80359731|FG002|Overall Study|Lack of Efficacy|15|||
27596458|NCT00827918|80359729|FG000|Overall Study|Physician Decision|1|||
27596459|NCT00827918|80359730|FG001|Overall Study|Physician Decision|0|||
27702145|NCT02606461|80748178|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
27702146|NCT02606461|80748179|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
27596460|NCT00827918|80359731|FG002|Overall Study|Physician Decision|0|||
27596461|NCT00827918|80359729|FG000|Overall Study|Pregnancy|0|||
27596462|NCT00827918|80359730|FG001|Overall Study|Pregnancy|1|||
27596463|NCT00827918|80359731|FG002|Overall Study|Pregnancy|0|||
27596464|NCT00827918|80359729|FG000|Overall Study|Progressive Disease|1|||
27596465|NCT00827918|80359730|FG001|Overall Study|Progressive Disease|1|||
27596466|NCT00827918|80359731|FG002|Overall Study|Progressive Disease|0|||
27596467|NCT00827918|80359729|FG000|Overall Study|Protocol Violation|0|||
27596468|NCT00827918|80359730|FG001|Overall Study|Protocol Violation|1|||
27596469|NCT00827918|80359731|FG002|Overall Study|Protocol Violation|0|||
27596470|NCT00827918|80359729|FG000|Overall Study|Withdrawal by Subject|6|||
27596471|NCT00827918|80359730|FG001|Overall Study|Withdrawal by Subject|2|||
27596472|NCT00827918|80359731|FG002|Overall Study|Withdrawal by Subject|6|||
27596473|NCT03923933|80363145|FG000|Overall Study|Lost to Follow-up|1|||
27596474|NCT03923933|80363146|FG001|Overall Study|Lost to Follow-up|0|||
27596475|NCT03923933|80363145|FG000|Overall Study|Withdrawal by Subject|0|||
27596476|NCT03923933|80363146|FG001|Overall Study|Withdrawal by Subject|1|||
27596477|NCT02251990|80363149|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
27596478|NCT02251990|80363150|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
27596479|NCT02251990|80363149|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
27596480|NCT02251990|80363150|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
27596481|NCT02251990|80363149|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
27596482|NCT02251990|80363150|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
27596483|NCT02251990|80363149|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
27596484|NCT02251990|80363150|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
27596485|NCT02251990|80363149|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
27596486|NCT02251990|80363150|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
27596487|NCT02251990|80363149|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
27596488|NCT02251990|80363150|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
27596489|NCT01791725|80363154|FG000|Overall Study|Withdrawal by Subject|0|||
27596490|NCT01791725|80363155|FG001|Overall Study|Withdrawal by Subject|1|||
27596491|NCT01791725|80363156|FG002|Overall Study|Withdrawal by Subject|0|||
27596492|NCT04089865|80363157|FG000|Overall Study|Withdrawal by Subject|2|||
27596493|NCT04089865|80363158|FG001|Overall Study|Withdrawal by Subject|2|||
27596494|NCT04089865|80363159|FG002|Overall Study|Withdrawal by Subject|7|||
27596495|NCT04089865|80363160|FG003|Overall Study|Withdrawal by Subject|2|||
27596496|NCT02618967|80363161|FG000|Overall Study|Lost to Follow-up|0|||
27596497|NCT02618967|80363162|FG001|Overall Study|Lost to Follow-up|0|||
27596498|NCT02618967|80363163|FG002|Overall Study|Lost to Follow-up|1|||
27596499|NCT02618967|80363164|FG003|Overall Study|Lost to Follow-up|0|||
27596500|NCT02618967|80363165|FG004|Overall Study|Lost to Follow-up|2|||
27596501|NCT02618967|80363166|FG005|Overall Study|Lost to Follow-up|0|||
27596502|NCT02618967|80363167|FG006|Overall Study|Lost to Follow-up|0|||
27596503|NCT02618967|80363168|FG007|Overall Study|Lost to Follow-up|0|||
27596504|NCT02618967|80363161|FG000|Overall Study|Withdrawal by Subject|1|||
27596505|NCT02618967|80363162|FG001|Overall Study|Withdrawal by Subject|0|||
27596506|NCT02618967|80363163|FG002|Overall Study|Withdrawal by Subject|0|||
27596507|NCT02618967|80363164|FG003|Overall Study|Withdrawal by Subject|0|||
27596508|NCT02618967|80363165|FG004|Overall Study|Withdrawal by Subject|0|||
27596509|NCT02618967|80363166|FG005|Overall Study|Withdrawal by Subject|0|||
27596510|NCT02618967|80363167|FG006|Overall Study|Withdrawal by Subject|0|||
27596511|NCT02618967|80363168|FG007|Overall Study|Withdrawal by Subject|0|||
27596512|NCT00626028|80363169|FG000|Overall Study|Adverse Event|1|||
27596513|NCT00626028|80363170|FG001|Overall Study|Adverse Event|1|||
27596514|NCT00626028|80363169|FG000|Overall Study|Device Failure|0|||
27596515|NCT00626028|80363170|FG001|Overall Study|Device Failure|1|||
27596516|NCT00626028|80363169|FG000|Overall Study|Physician Decision|2|||
27596517|NCT00626028|80363170|FG001|Overall Study|Physician Decision|1|||
27596518|NCT00626028|80363169|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
27596519|NCT00626028|80363170|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
27596520|NCT02778100|80363173|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
27596521|NCT02778100|80363174|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
27596522|NCT01368965|80363175|FG000|Overall Study|Lost to Follow-up|12|||
27596523|NCT03086330|80363176|FG000|Overall Study|Withdrawal by Subject|3|||
27596524|NCT03086330|80363177|FG001|Overall Study|Withdrawal by Subject|2|||
27596525|NCT03086330|80363176|FG000|Overall Study|Lost to Follow-up|1|||
27596526|NCT03086330|80363177|FG001|Overall Study|Lost to Follow-up|2|||
27596527|NCT04004611|80363178|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596528|NCT04004611|80363179|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596529|NCT04004611|80363180|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596530|NCT04004611|80363181|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27702147|NCT02606461|80748180|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
27702148|NCT02606461|80748181|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
27596531|NCT04004611|80363182|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596532|NCT04004611|80363183|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596533|NCT04004611|80363184|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596534|NCT04004611|80363185|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
27596535|NCT04004611|80363186|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
27596536|NCT04004611|80363178|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
27596537|NCT04004611|80363179|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
27596538|NCT04004611|80363180|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
27596539|NCT04004611|80363181|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
27596540|NCT04004611|80363182|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
27596541|NCT04004611|80363183|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
27596542|NCT04004611|80363184|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
27596543|NCT04004611|80363185|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
27596544|NCT04004611|80363186|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
27596545|NCT04004611|80363178|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596546|NCT04004611|80363179|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596547|NCT04004611|80363180|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596548|NCT04004611|80363181|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596549|NCT04004611|80363182|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
27596550|NCT04004611|80363183|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596551|NCT04004611|80363184|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596552|NCT04004611|80363185|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596553|NCT04004611|80363186|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
27596554|NCT04004611|80363178|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
27596555|NCT04004611|80363179|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
27596556|NCT04004611|80363180|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
27596557|NCT04004611|80363181|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
27596558|NCT04004611|80363182|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
27596559|NCT04004611|80363183|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
27596560|NCT04004611|80363184|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
27596561|NCT04004611|80363185|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
27596562|NCT04004611|80363186|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
27596563|NCT04004611|80363178|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
27596564|NCT04004611|80363179|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596565|NCT04004611|80363180|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
27596566|NCT04004611|80363181|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596567|NCT04004611|80363182|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596568|NCT04004611|80363183|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596569|NCT04004611|80363184|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596570|NCT04004611|80363185|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596571|NCT04004611|80363186|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
27596572|NCT04004611|80363178|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596573|NCT04004611|80363179|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
27596574|NCT04004611|80363180|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596575|NCT04004611|80363181|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596576|NCT04004611|80363182|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596577|NCT04004611|80363183|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596578|NCT04004611|80363184|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596579|NCT04004611|80363185|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596580|NCT04004611|80363186|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
27596581|NCT02732938|80363190|FG000|Overall Study|Death|0|||
27596582|NCT02732938|80363191|FG001|Overall Study|Death|11|||
27596583|NCT02732938|80363192|FG002|Overall Study|Death|0|||
27596584|NCT02732938|80363190|FG000|Overall Study|Randomized but did not receive treatment|0|||
27596585|NCT02732938|80363191|FG001|Overall Study|Randomized but did not receive treatment|1|||
27596586|NCT02732938|80363192|FG002|Overall Study|Randomized but did not receive treatment|0|||
27596587|NCT02732938|80363190|FG000|Overall Study|Refused further follow-up|1|||
27596588|NCT02732938|80363191|FG001|Overall Study|Refused further follow-up|0|||
27596589|NCT02732938|80363192|FG002|Overall Study|Refused further follow-up|0|||
27596590|NCT02732938|80363190|FG000|Overall Study|Study terminated by sponsor|3|||
27596591|NCT02732938|80363191|FG001|Overall Study|Study terminated by sponsor|6|||
27596592|NCT02732938|80363192|FG002|Overall Study|Study terminated by sponsor|0|||
27596593|NCT01218126|80363193|FG000|Overall Study|Adverse Event|8|||
27596594|NCT01218126|80363194|FG001|Overall Study|Adverse Event|10|||
27596595|NCT01218126|80363195|FG002|Overall Study|Adverse Event|12|||
27596596|NCT01218126|80363196|FG003|Overall Study|Adverse Event|16|||
27596597|NCT01218126|80363193|FG000|Overall Study|Lack of Efficacy|7|||
27596598|NCT01218126|80363194|FG001|Overall Study|Lack of Efficacy|2|||
27596599|NCT01218126|80363195|FG002|Overall Study|Lack of Efficacy|2|||
27596600|NCT01218126|80363196|FG003|Overall Study|Lack of Efficacy|6|||
27596601|NCT01218126|80363193|FG000|Overall Study|Protocol Violation|5|||
27596602|NCT01218126|80363194|FG001|Overall Study|Protocol Violation|2|||
27596603|NCT01218126|80363195|FG002|Overall Study|Protocol Violation|2|||
27596604|NCT01218126|80363196|FG003|Overall Study|Protocol Violation|3|||
27596605|NCT01218126|80363193|FG000|Overall Study|Protocol-defined stopping criteria|1|||
27596606|NCT01218126|80363194|FG001|Overall Study|Protocol-defined stopping criteria|1|||
27596607|NCT01218126|80363195|FG002|Overall Study|Protocol-defined stopping criteria|0|||
27596608|NCT01218126|80363196|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27596609|NCT01218126|80363193|FG000|Overall Study|Lost to Follow-up|0|||
27596610|NCT01218126|80363194|FG001|Overall Study|Lost to Follow-up|0|||
27596611|NCT01218126|80363195|FG002|Overall Study|Lost to Follow-up|0|||
27596612|NCT01218126|80363196|FG003|Overall Study|Lost to Follow-up|2|||
27596613|NCT01218126|80363193|FG000|Overall Study|Physician Decision|1|||
27596614|NCT01218126|80363194|FG001|Overall Study|Physician Decision|2|||
27596615|NCT01218126|80363195|FG002|Overall Study|Physician Decision|4|||
27596616|NCT01218126|80363196|FG003|Overall Study|Physician Decision|2|||
27596617|NCT01218126|80363193|FG000|Overall Study|Withdrawal by Subject|2|||
27596618|NCT01218126|80363194|FG001|Overall Study|Withdrawal by Subject|5|||
27596619|NCT01218126|80363195|FG002|Overall Study|Withdrawal by Subject|4|||
27596620|NCT01218126|80363196|FG003|Overall Study|Withdrawal by Subject|6|||
27596621|NCT01812655|80363197|FG000|Overall Study|Protocol Violation|1|||
27596622|NCT01812655|80363198|FG001|Overall Study|Protocol Violation|1|||
27596623|NCT01812655|80363199|FG002|Overall Study|Protocol Violation|0|||
27596624|NCT00803452|80363201|FG000|Overall Study|Adverse Event|0|||
27596625|NCT00803452|80363202|FG001|Overall Study|Adverse Event|2|||
27596626|NCT00803452|80363201|FG000|Overall Study|Lost to Follow-up|0|||
27596627|NCT00803452|80363202|FG001|Overall Study|Lost to Follow-up|3|||
27596628|NCT00602667|80363205|FG000|Overall Study|Still on Therapy|0|||
27596629|NCT00602667|80363206|FG001|Overall Study|Still on Therapy|2|||
27596630|NCT00602667|80363207|FG002|Overall Study|Still on Therapy|2|||
27596631|NCT00602667|80363205|FG000|Overall Study|Death|0|||
27596632|NCT00602667|80363206|FG001|Overall Study|Death|1|||
27596633|NCT00602667|80363207|FG002|Overall Study|Death|1|||
27596634|NCT00602667|80363205|FG000|Overall Study|Family request|3|||
27596635|NCT00602667|80363206|FG001|Overall Study|Family request|25|||
27596636|NCT00602667|80363207|FG002|Overall Study|Family request|6|||
27596637|NCT00602667|80363205|FG000|Overall Study|Excessive toxicity|1|||
27596638|NCT00602667|80363206|FG001|Overall Study|Excessive toxicity|1|||
27596639|NCT00602667|80363207|FG002|Overall Study|Excessive toxicity|0|||
27596640|NCT00602667|80363205|FG000|Overall Study|Second malignancy|0|||
27596641|NCT00602667|80363206|FG001|Overall Study|Second malignancy|1|||
27596642|NCT00602667|80363207|FG002|Overall Study|Second malignancy|0|||
27596643|NCT00602667|80363205|FG000|Overall Study|Physician Decision|2|||
27596644|NCT00602667|80363206|FG001|Overall Study|Physician Decision|3|||
27596645|NCT00602667|80363207|FG002|Overall Study|Physician Decision|8|||
27596646|NCT00602667|80363205|FG000|Overall Study|Progressive disease|13|||
27833512|NCT03888235|81222552|FG000|Overall Study|Lost to Follow-up|1|||
27833513|NCT03888235|81222553|FG001|Overall Study|Lost to Follow-up|1|||
27833514|NCT03888235|81222554|FG002|Overall Study|Lost to Follow-up|0|||
27833515|NCT03552484|81222555|FG000|Overall Study|Death|6|||
27833516|NCT03552484|81222556|FG001|Overall Study|Death|4|||
27833517|NCT03552484|81222555|FG000|Overall Study|Lost to Follow-up|0|||
27833518|NCT03552484|81222556|FG001|Overall Study|Lost to Follow-up|16|||
27833519|NCT04692155|81222557|FG000|Overall Study|Death|1|||
27833520|NCT00654186|81222558|FG000|Overall Study|Withdrawal by Subject|5|||
27833521|NCT00529763|81222559|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
27833522|NCT00529763|81222560|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
27833523|NCT00529763|81222561|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27887016|NCT02805660|81422045|FG000|Overall Study|Lost to Follow-up|0|||
27887017|NCT02805660|81422046|FG001|Overall Study|Lost to Follow-up|1|||
27596647|NCT00602667|80363206|FG001|Overall Study|Progressive disease|48|||
27596648|NCT00602667|80363207|FG002|Overall Study|Progressive disease|45|||
27833524|NCT00529763|81222559|FG000|Overall Study|Death|1|||
27596649|NCT00602667|80363205|FG000|Overall Study|Progressive disease prior to therapy|0|||
27596650|NCT00602667|80363206|FG001|Overall Study|Progressive disease prior to therapy|0|||
27596651|NCT00602667|80363207|FG002|Overall Study|Progressive disease prior to therapy|1|||
27596652|NCT01515748|80363211|FG000|Overall Study|Withdrawal by Subject|32|||
27596653|NCT01515748|80363212|FG001|Overall Study|Withdrawal by Subject|41|||
27596654|NCT01515748|80363211|FG000|Overall Study|Lost to Follow-up|2|||
27596655|NCT01515748|80363212|FG001|Overall Study|Lost to Follow-up|4|||
27596656|NCT01515748|80363211|FG000|Overall Study|Other than specified above|5|||
27833525|NCT00529763|81222560|FG001|Overall Study|Death|1|||
27833526|NCT00529763|81222561|FG002|Overall Study|Death|1|||
27833527|NCT00529763|81222559|FG000|Overall Study|Disease Progression|10|||
27596657|NCT01515748|80363212|FG001|Overall Study|Other than specified above|10|||
27596658|NCT00130533|80363213|FG000|Overall Study|Withdrawal by Subject|33|||
27833528|NCT00529763|81222560|FG001|Overall Study|Disease Progression|16|||
27833529|NCT00529763|81222561|FG002|Overall Study|Disease Progression|11|||
27833530|NCT00529763|81222559|FG000|Overall Study|Lost to Follow-up|1|||
27833531|NCT00529763|81222560|FG001|Overall Study|Lost to Follow-up|2|||
27833532|NCT00529763|81222561|FG002|Overall Study|Lost to Follow-up|3|||
27833533|NCT00529763|81222559|FG000|Overall Study|Stem Cell Transplant|0|||
27833534|NCT00529763|81222560|FG001|Overall Study|Stem Cell Transplant|3|||
27833535|NCT00529763|81222561|FG002|Overall Study|Stem Cell Transplant|1|||
27833536|NCT00529763|81222559|FG000|Overall Study|Study Drug Toxicity|3|||
27833537|NCT00529763|81222560|FG001|Overall Study|Study Drug Toxicity|6|||
27833538|NCT00529763|81222561|FG002|Overall Study|Study Drug Toxicity|4|||
27833539|NCT00529763|81222559|FG000|Overall Study|Participant Withdrew Consent|2|||
27833540|NCT00529763|81222560|FG001|Overall Study|Participant Withdrew Consent|3|||
27833541|NCT00529763|81222561|FG002|Overall Study|Participant Withdrew Consent|4|||
27833542|NCT00529763|81222559|FG000|Overall Study|Other reasons|2|||
27833543|NCT00529763|81222560|FG001|Overall Study|Other reasons|0|||
27833544|NCT00529763|81222561|FG002|Overall Study|Other reasons|2|||
27833545|NCT00529763|81222559|FG000|Overall Study|Participant request to discontinue treatment|1|||
27833546|NCT00529763|81222560|FG001|Overall Study|Participant request to discontinue treatment|1|||
27833547|NCT00529763|81222561|FG002|Overall Study|Participant request to discontinue treatment|3|||
27833548|NCT00840658|81222562|FG000|Overall Study|Death|2|||
27833549|NCT00840658|81222563|FG001|Overall Study|Death|2|||
27833550|NCT00840658|81222564|FG002|Overall Study|Death|3|||
27833551|NCT00840658|81222565|FG003|Overall Study|Death|3|||
27833552|NCT00840658|81222562|FG000|Overall Study|Lost to Follow-up|3|||
27833553|NCT00840658|81222563|FG001|Overall Study|Lost to Follow-up|1|||
27833554|NCT00840658|81222564|FG002|Overall Study|Lost to Follow-up|2|||
27833555|NCT00840658|81222565|FG003|Overall Study|Lost to Follow-up|1|||
27833556|NCT00406393|81222566|FG000|Overall Study|Did not undergo transplantation|2|||
27833557|NCT00406393|81222567|FG001|Overall Study|Did not undergo transplantation|1|||
27833558|NCT00421304|81222568|FG000|Overall Study|Lost to Follow-up|5|||
27833559|NCT00421304|81222569|FG001|Overall Study|Lost to Follow-up|2|||
27833560|NCT00421304|81222570|FG002|Overall Study|Lost to Follow-up|5|||
27833561|NCT00421304|81222568|FG000|Overall Study|Withdrawal by Subject|2|||
27833562|NCT00421304|81222569|FG001|Overall Study|Withdrawal by Subject|2|||
27833563|NCT00421304|81222570|FG002|Overall Study|Withdrawal by Subject|2|||
27833564|NCT00421304|81222568|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
27833565|NCT00421304|81222569|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
27887018|NCT02805660|81422047|FG002|Overall Study|Lost to Follow-up|1|||
27887019|NCT02805660|81422048|FG003|Overall Study|Lost to Follow-up|2|||
27887020|NCT02805660|81422049|FG004|Overall Study|Lost to Follow-up|0|||
27887021|NCT02805660|81422050|FG005|Overall Study|Lost to Follow-up|0|||
27887022|NCT02805660|81422051|FG006|Overall Study|Lost to Follow-up|0|||
27887023|NCT02805660|81422045|FG000|Overall Study|Withdrawal by Subject|0|||
27887024|NCT02805660|81422046|FG001|Overall Study|Withdrawal by Subject|0|||
27887025|NCT02805660|81422047|FG002|Overall Study|Withdrawal by Subject|0|||
27887026|NCT02805660|81422048|FG003|Overall Study|Withdrawal by Subject|3|||
27887027|NCT02805660|81422049|FG004|Overall Study|Withdrawal by Subject|1|||
27887028|NCT02805660|81422050|FG005|Overall Study|Withdrawal by Subject|0|||
27887029|NCT02805660|81422051|FG006|Overall Study|Withdrawal by Subject|2|||
27887030|NCT02805660|81422045|FG000|Overall Study|Study terminated by Sponsor|0|||
27887031|NCT02805660|81422046|FG001|Overall Study|Study terminated by Sponsor|0|||
27887032|NCT02805660|81422047|FG002|Overall Study|Study terminated by Sponsor|1|||
27887033|NCT02805660|81422048|FG003|Overall Study|Study terminated by Sponsor|4|||
27887034|NCT02805660|81422049|FG004|Overall Study|Study terminated by Sponsor|2|||
27887035|NCT02805660|81422050|FG005|Overall Study|Study terminated by Sponsor|3|||
27887036|NCT02805660|81422051|FG006|Overall Study|Study terminated by Sponsor|1|||
27887037|NCT02805660|81422045|FG000|Overall Study|Miscellaneous|0|||
27887038|NCT02805660|81422046|FG001|Overall Study|Miscellaneous|1|||
27887039|NCT02805660|81422047|FG002|Overall Study|Miscellaneous|0|||
27887040|NCT02805660|81422048|FG003|Overall Study|Miscellaneous|4|||
27887041|NCT02805660|81422049|FG004|Overall Study|Miscellaneous|0|||
27887042|NCT02805660|81422050|FG005|Overall Study|Miscellaneous|6|||
27887043|NCT02805660|81422051|FG006|Overall Study|Miscellaneous|4|||
27887044|NCT04964544|81422052|FG000|Overall Study|Screen failure or other uncategorised|10|||
27887045|NCT04964544|81422052|FG000|Overall Study|Physician Decision|4|||
27887046|NCT04964544|81422052|FG000|Overall Study|Lost to Follow-up|9|||
27833566|NCT00421304|81222570|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
27833567|NCT00421304|81222568|FG000|Overall Study|Did not attend Day 360 visit|0|||
27833568|NCT00421304|81222569|FG001|Overall Study|Did not attend Day 360 visit|0|||
27887047|NCT04964544|81422052|FG000|Overall Study|Withdrawal by Subject|18|||
27887048|NCT04964544|81422052|FG000|Overall Study|Death|1|||
27887049|NCT02135107|81422054|FG000|Treatment Period|Withdrawal by Subject|11|||
27887050|NCT02135107|81422055|FG001|Treatment Period|Withdrawal by Subject|0|||
27887051|NCT02135107|81422056|FG002|Treatment Period|Withdrawal by Subject|0|||
27887052|NCT02135107|81422057|FG003|Treatment Period|Withdrawal by Subject|0|||
27596659|NCT00130533|80363214|FG001|Overall Study|Withdrawal by Subject|6|||
27596660|NCT00130533|80363213|FG000|Overall Study|Adverse Event|34|||
27596661|NCT00130533|80363214|FG001|Overall Study|Adverse Event|1|||
27596662|NCT00130533|80363213|FG000|Overall Study|Disease relapse|9|||
27596663|NCT00130533|80363214|FG001|Overall Study|Disease relapse|13|||
27596664|NCT00130533|80363213|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
27596665|NCT00130533|80363214|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
27596666|NCT00130533|80363213|FG000|Overall Study|Death|4|||
27596667|NCT00130533|80363214|FG001|Overall Study|Death|2|||
27596668|NCT00130533|80363213|FG000|Overall Study|Protocol Violation|5|||
27596669|NCT00130533|80363214|FG001|Overall Study|Protocol Violation|1|||
27596670|NCT00130533|80363213|FG000|Overall Study|Lost to Follow-up|1|||
27596671|NCT00130533|80363214|FG001|Overall Study|Lost to Follow-up|1|||
27596672|NCT00130533|80363213|FG000|Overall Study|Sponsor´s decision|2|||
27596673|NCT00130533|80363214|FG001|Overall Study|Sponsor´s decision|0|||
27596674|NCT00130533|80363213|FG000|Overall Study|Second Primary Malignancy|0|||
27596675|NCT00130533|80363214|FG001|Overall Study|Second Primary Malignancy|1|||
27596676|NCT00130533|80363213|FG000|Overall Study|Other|12|||
27596677|NCT00130533|80363214|FG001|Overall Study|Other|5|||
27596678|NCT04570436|80363215|FG000|Overall Study|Adverse Event|0|||
27596679|NCT04570436|80363216|FG001|Overall Study|Adverse Event|0|||
27596680|NCT04570436|80363217|FG002|Overall Study|Adverse Event|1|||
27596681|NCT04570436|80363218|FG003|Overall Study|Adverse Event|0|||
27596682|NCT04570436|80363219|FG004|Overall Study|Adverse Event|0|||
27596683|NCT04570436|80363220|FG005|Overall Study|Adverse Event|0|||
27596684|NCT04570436|80363221|FG006|Overall Study|Adverse Event|0|||
27596685|NCT04570436|80363222|FG007|Overall Study|Adverse Event|0|||
27596686|NCT04570436|80363223|FG008|Overall Study|Adverse Event|0|||
27596687|NCT04570436|80363224|FG009|Overall Study|Adverse Event|0|||
27596688|NCT04570436|80363215|FG000|Overall Study|Physician Decision|1|||
27596689|NCT04570436|80363216|FG001|Overall Study|Physician Decision|0|||
27596690|NCT04570436|80363217|FG002|Overall Study|Physician Decision|0|||
27596691|NCT04570436|80363218|FG003|Overall Study|Physician Decision|0|||
27596692|NCT04570436|80363219|FG004|Overall Study|Physician Decision|0|||
27596693|NCT04570436|80363220|FG005|Overall Study|Physician Decision|0|||
27596694|NCT04570436|80363221|FG006|Overall Study|Physician Decision|0|||
27596695|NCT04570436|80363222|FG007|Overall Study|Physician Decision|0|||
27596696|NCT04570436|80363223|FG008|Overall Study|Physician Decision|0|||
27596697|NCT04570436|80363224|FG009|Overall Study|Physician Decision|0|||
27596698|NCT00045110|80363225|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
27596699|NCT00045110|80363226|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
27596700|NCT00045110|80363227|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
27596701|NCT00045110|80363225|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
27596702|NCT00045110|80363226|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
27596703|NCT00045110|80363227|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
27596704|NCT00045110|80363225|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
27596705|NCT00045110|80363226|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
27596706|NCT00045110|80363227|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
27596707|NCT02131272|80363231|FG000|Overall Study|Withdrawal by parent|0|||
27596708|NCT02131272|80363232|FG001|Overall Study|Withdrawal by parent|1|||
27596709|NCT02131272|80363231|FG000|Overall Study|Withdrawal by Subject|0|||
27596710|NCT02131272|80363232|FG001|Overall Study|Withdrawal by Subject|1|||
27596711|NCT02131272|80363231|FG000|Overall Study|Withdrawal Criteria|1|||
27596712|NCT02131272|80363232|FG001|Overall Study|Withdrawal Criteria|0|||
27596713|NCT01692782|80363241|FG000|Overall Study|Adverse Event|12|||
27596714|NCT01692782|80363242|FG001|Overall Study|Adverse Event|32|||
27596715|NCT01692782|80363243|FG002|Overall Study|Adverse Event|2|||
27833569|NCT00421304|81222570|FG002|Overall Study|Did not attend Day 360 visit|1|||
27833570|NCT04060251|81222573|FG000|Overall Study|Study terminated due to low enrollment.|7|||
27596716|NCT01692782|80363241|FG000|Overall Study|Lack of Efficacy|1|||
27596717|NCT01692782|80363242|FG001|Overall Study|Lack of Efficacy|2|||
27596718|NCT01692782|80363243|FG002|Overall Study|Lack of Efficacy|0|||
27596719|NCT01692782|80363241|FG000|Overall Study|Lost to Follow-up|2|||
27596720|NCT01692782|80363242|FG001|Overall Study|Lost to Follow-up|7|||
27596721|NCT01692782|80363243|FG002|Overall Study|Lost to Follow-up|1|||
27596722|NCT01692782|80363241|FG000|Overall Study|Pregnancy|1|||
27596723|NCT01692782|80363242|FG001|Overall Study|Pregnancy|0|||
27596724|NCT01692782|80363243|FG002|Overall Study|Pregnancy|0|||
27596725|NCT01692782|80363241|FG000|Overall Study|Protocol Violation|1|||
27596726|NCT01692782|80363242|FG001|Overall Study|Protocol Violation|0|||
27596727|NCT01692782|80363243|FG002|Overall Study|Protocol Violation|2|||
27596728|NCT01692782|80363241|FG000|Overall Study|Non-complance with study drug|0|||
27596729|NCT01692782|80363242|FG001|Overall Study|Non-complance with study drug|4|||
27596730|NCT01692782|80363243|FG002|Overall Study|Non-complance with study drug|1|||
27596731|NCT01692782|80363241|FG000|Overall Study|Non-compliant with study visits|0|||
27596732|NCT01692782|80363242|FG001|Overall Study|Non-compliant with study visits|0|||
27596733|NCT01692782|80363243|FG002|Overall Study|Non-compliant with study visits|1|||
27596734|NCT01692782|80363241|FG000|Overall Study|SAE not related to study drug|0|||
27596735|NCT01692782|80363242|FG001|Overall Study|SAE not related to study drug|1|||
27596736|NCT01692782|80363243|FG002|Overall Study|SAE not related to study drug|0|||
27596737|NCT01692782|80363241|FG000|Overall Study|Withdrawal by Subject|3|||
27596738|NCT01692782|80363242|FG001|Overall Study|Withdrawal by Subject|10|||
27596739|NCT01692782|80363243|FG002|Overall Study|Withdrawal by Subject|3|||
27596740|NCT03365882|80363246|FG000|Randomization|Still Receiving Protocol Treatment|2|||
27596741|NCT03365882|80363247|FG001|Randomization|Still Receiving Protocol Treatment|0|||
27596742|NCT03365882|80363246|FG000|Randomization|Adverse Event|1|||
27596743|NCT03365882|80363247|FG001|Randomization|Adverse Event|2|||
27596744|NCT03365882|80363246|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
27596745|NCT03365882|80363247|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
27596746|NCT03365882|80363246|FG000|Randomization|Progression/Relapse|21|||
27596747|NCT03365882|80363247|FG001|Randomization|Progression/Relapse|3|||
27596748|NCT03365882|80363246|FG000|Randomization|Death|1|||
27596749|NCT03365882|80363247|FG001|Randomization|Death|0|||
27596750|NCT03365882|80363246|FG000|Randomization|Other - Not Protocol Specified|1|||
27596751|NCT03365882|80363247|FG001|Randomization|Other - Not Protocol Specified|1|||
27596752|NCT03365882|80363246|FG000|Randomization|Major Protocol Deviation|0|||
27596753|NCT03365882|80363247|FG001|Randomization|Major Protocol Deviation|1|||
27596754|NCT03365882|80363246|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
27596755|NCT03365882|80363247|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
27596756|NCT03365882|80363246|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
27596757|NCT03365882|80363247|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
27596758|NCT03365882|80363246|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
27596759|NCT03365882|80363247|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
27596760|NCT03365882|80363246|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
27596761|NCT03365882|80363247|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
27596762|NCT02633137|80363248|FG000|Overall Study|Adverse Event|1|||
27596763|NCT02633137|80363248|FG000|Overall Study|Lack of Efficacy|2|||
27596764|NCT02633137|80363248|FG000|Overall Study|Withdrawal by Subject|1|||
27596765|NCT00736645|80363252|FG000|Overall Study|Adverse Event|0|||
27596766|NCT00736645|80363253|FG001|Overall Study|Adverse Event|2|||
27596767|NCT00736645|80363254|FG002|Overall Study|Adverse Event|0|||
27596768|NCT00736645|80363255|FG003|Overall Study|Adverse Event|0|||
27596769|NCT02747238|80363262|FG000|Overall Study|Lack of Efficacy|0|||
27596770|NCT02747238|80363263|FG001|Overall Study|Lack of Efficacy|1|||
27596771|NCT02747238|80363262|FG000|Overall Study|Data lost|3|||
27596772|NCT02747238|80363263|FG001|Overall Study|Data lost|5|||
27596773|NCT01477853|80363264|FG000|Phase A|Adverse Event|1|||
27596774|NCT01477853|80363265|FG001|Phase A|Adverse Event|2|||
27596775|NCT01477853|80363266|FG002|Phase A|Adverse Event|2|||
27596776|NCT01477853|80363264|FG000|Phase A|Lost to Follow-up|4|||
27596777|NCT01477853|80363265|FG001|Phase A|Lost to Follow-up|3|||
27596778|NCT01477853|80363266|FG002|Phase A|Lost to Follow-up|2|||
27596779|NCT01477853|80363264|FG000|Phase A|Physician Decision|1|||
27596780|NCT01477853|80363265|FG001|Phase A|Physician Decision|0|||
27596781|NCT01477853|80363266|FG002|Phase A|Physician Decision|1|||
27596782|NCT01477853|80363264|FG000|Phase A|Study terminated by sponsor|37|||
27596783|NCT01477853|80363265|FG001|Phase A|Study terminated by sponsor|40|||
27596784|NCT01477853|80363266|FG002|Phase A|Study terminated by sponsor|39|||
27596785|NCT01477853|80363264|FG000|Phase B|Lost to Follow-up|0|||
27596786|NCT01477853|80363265|FG001|Phase B|Lost to Follow-up|1|||
27596787|NCT01477853|80363266|FG002|Phase B|Lost to Follow-up|0|||
27596788|NCT01477853|80363264|FG000|Phase B|Study terminated by sponsor|12|||
27596789|NCT01477853|80363265|FG001|Phase B|Study terminated by sponsor|10|||
27596790|NCT01477853|80363266|FG002|Phase B|Study terminated by sponsor|11|||
27596791|NCT03162224|80363268|FG000|Overall Study|Death|4|||
27596792|NCT03162224|80363269|FG001|Overall Study|Death|5|||
27596793|NCT03162224|80363270|FG002|Overall Study|Death|8|||
27833571|NCT04060251|81222574|FG001|Overall Study|Study terminated due to low enrollment.|5|||
27833572|NCT04060251|81222575|FG002|Overall Study|Study terminated due to low enrollment.|7|||
27596794|NCT03162224|80363268|FG000|Overall Study|Withdrawal by Subject|1|||
27596795|NCT03162224|80363269|FG001|Overall Study|Withdrawal by Subject|0|||
27833573|NCT04060251|81222573|FG000|Overall Study|Adverse Event|1|||
27833574|NCT04060251|81222574|FG001|Overall Study|Adverse Event|1|||
27596796|NCT03162224|80363270|FG002|Overall Study|Withdrawal by Subject|1|||
27596797|NCT03162224|80363268|FG000|Overall Study|Lost to Follow-up|0|||
27596798|NCT03162224|80363269|FG001|Overall Study|Lost to Follow-up|1|||
27596799|NCT03162224|80363270|FG002|Overall Study|Lost to Follow-up|0|||
27596800|NCT03162224|80363268|FG000|Overall Study|Other|6|||
27596801|NCT03162224|80363269|FG001|Overall Study|Other|2|||
27596802|NCT03162224|80363270|FG002|Overall Study|Other|1|||
27833575|NCT04060251|81222575|FG002|Overall Study|Adverse Event|0|||
27596803|NCT02182973|80363273|FG000|Overall Study|Withdrawal by Subject|3|||
27596804|NCT02182973|80363274|FG001|Overall Study|Withdrawal by Subject|0|||
27596805|NCT02195986|80363275|FG000|Overall Study|Adverse Event|3|||
27596806|NCT02195986|80363276|FG001|Overall Study|Adverse Event|0|||
27596807|NCT02195986|80363277|FG002|Overall Study|Adverse Event|0|||
27596808|NCT02195986|80363275|FG000|Overall Study|Withdrawal by Subject|0|||
27596809|NCT02195986|80363276|FG001|Overall Study|Withdrawal by Subject|3|||
27596810|NCT02195986|80363277|FG002|Overall Study|Withdrawal by Subject|0|||
27596811|NCT02195986|80363275|FG000|Overall Study|Family Emergency|0|||
27596812|NCT02195986|80363276|FG001|Overall Study|Family Emergency|0|||
27596813|NCT02195986|80363277|FG002|Overall Study|Family Emergency|1|||
27596814|NCT02195986|80363275|FG000|Overall Study|Protocol Violation|0|||
27596815|NCT02195986|80363276|FG001|Overall Study|Protocol Violation|1|||
27596816|NCT02195986|80363277|FG002|Overall Study|Protocol Violation|1|||
27596817|NCT02195986|80363275|FG000|Overall Study|Non-compliance|0|||
27596818|NCT02195986|80363276|FG001|Overall Study|Non-compliance|1|||
27596819|NCT02195986|80363277|FG002|Overall Study|Non-compliance|0|||
27596820|NCT03393000|80363280|FG000|Overall Study|Death|11|||
27596821|NCT03393000|80363280|FG000|Overall Study|Withdrawal by Subject|2|||
27596822|NCT03393000|80363280|FG000|Overall Study|Physician Decision|1|||
27596823|NCT02633800|80363281|FG000|Overall Study|Death|3|||
27596824|NCT02633800|80363282|FG001|Overall Study|Death|3|||
27596825|NCT02633800|80363281|FG000|Overall Study|Reason not provided|1|||
27596826|NCT02633800|80363282|FG001|Overall Study|Reason not provided|0|||
27596827|NCT02633800|80363281|FG000|Overall Study|Radiologic(al) progression|23|||
27596828|NCT02633800|80363282|FG001|Overall Study|Radiologic(al) progression|23|||
27596829|NCT02633800|80363281|FG000|Overall Study|Clinical progression|3|||
27596830|NCT02633800|80363282|FG001|Overall Study|Clinical progression|6|||
27596831|NCT02633800|80363281|FG000|Overall Study|Study terminated by sponsor|6|||
27596832|NCT02633800|80363282|FG001|Overall Study|Study terminated by sponsor|5|||
27596833|NCT02633800|80363281|FG000|Overall Study|Adverse event, non-fatal|7|||
27596834|NCT02633800|80363282|FG001|Overall Study|Adverse event, non-fatal|2|||
27596835|NCT02633800|80363281|FG000|Overall Study|Withdrawal by Subject|0|||
27596836|NCT02633800|80363282|FG001|Overall Study|Withdrawal by Subject|3|||
27596837|NCT02633800|80363281|FG000|Overall Study|Patient Request|1|||
27596838|NCT02633800|80363282|FG001|Overall Study|Patient Request|1|||
27596839|NCT00530855|80363286|FG000|Overall Study|Lack of Efficacy|20|||
27596840|NCT00530855|80363286|FG000|Overall Study|Withdrawal by Subject|30|||
27596841|NCT00530855|80363286|FG000|Overall Study|Fatal Serious AE|3|||
27596842|NCT00530855|80363286|FG000|Overall Study|Non Fatal Serious AE|7|||
27596843|NCT00530855|80363286|FG000|Overall Study|Non Fatal Non Serious AE|12|||
27596844|NCT00530855|80363286|FG000|Overall Study|Protocol Violation|3|||
27596845|NCT00530855|80363286|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
27596846|NCT00530855|80363286|FG000|Overall Study|Lost to Follow-up|9|||
27596847|NCT00530855|80363286|FG000|Overall Study|Other reason for premature termination|17|||
27596848|NCT00724152|80363291|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
27596849|NCT00724152|80363292|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
27702149|NCT02606461|80748182|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
27702150|NCT00929656|80748184|FG000|Overall Study|Lost to Follow-up|0|||
27702151|NCT00929656|80748185|FG001|Overall Study|Lost to Follow-up|1|||
27702152|NCT03715153|80748186|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
27702153|NCT03715153|80748187|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
27702154|NCT03715153|80748186|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
27702155|NCT03715153|80748187|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
27702156|NCT03715153|80748186|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
27702157|NCT03715153|80748187|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
27702158|NCT03715153|80748186|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
27702159|NCT03715153|80748187|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
27702160|NCT03715153|80748186|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
27702161|NCT03715153|80748187|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
27702162|NCT03715153|80748186|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
27702163|NCT03715153|80748187|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
27596850|NCT00724152|80363293|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
27596851|NCT00724152|80363291|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
27596852|NCT00724152|80363292|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
27596853|NCT00724152|80363293|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
27596854|NCT02436330|80363294|FG000|Cohort 1|Lost to Follow-up|5|||
27596855|NCT02436330|80363295|FG001|Cohort 1|Lost to Follow-up|2|||
27596856|NCT02436330|80363294|FG000|Cohort 1|Withdrawal by Subject|0|||
27596857|NCT02436330|80363295|FG001|Cohort 1|Withdrawal by Subject|1|||
27596858|NCT02436330|80363294|FG000|Cohort 2|Lost to Follow-up|2|||
27702164|NCT01770912|80748192|FG000|Overall Study|Lost to Follow-up|2|||
27702165|NCT01770912|80748193|FG001|Overall Study|Lost to Follow-up|0|||
27596859|NCT02436330|80363295|FG001|Cohort 2|Lost to Follow-up|0|||
27596860|NCT02436330|80363294|FG000|Cohort 2|Withdrawal by Subject|2|||
27596861|NCT02436330|80363295|FG001|Cohort 2|Withdrawal by Subject|3|||
27596862|NCT02436330|80363294|FG000|Cohort 3|Lost to Follow-up|1|||
27596863|NCT02436330|80363295|FG001|Cohort 3|Lost to Follow-up|0|||
27596864|NCT02436330|80363294|FG000|Cohort 3|Withdrawal by Subject|4|||
27596865|NCT02436330|80363295|FG001|Cohort 3|Withdrawal by Subject|0|||
27596866|NCT02436330|80363294|FG000|Cohort 4|Lost to Follow-up|1|||
27596867|NCT02436330|80363295|FG001|Cohort 4|Lost to Follow-up|0|||
27596868|NCT02436330|80363294|FG000|Cohort 4|Withdrawal by Subject|1|||
27596869|NCT02436330|80363295|FG001|Cohort 4|Withdrawal by Subject|0|||
27596870|NCT02436330|80363294|FG000|Cohort 5|Lost to Follow-up|3|||
27596871|NCT02436330|80363295|FG001|Cohort 5|Lost to Follow-up|2|||
27596872|NCT02436330|80363294|FG000|Cohort 5|Withdrawal by Subject|3|||
27596873|NCT02436330|80363295|FG001|Cohort 5|Withdrawal by Subject|2|||
27596874|NCT02436330|80363294|FG000|Cohort 6|Lost to Follow-up|2|||
27596875|NCT02436330|80363295|FG001|Cohort 6|Lost to Follow-up|0|||
27596876|NCT02436330|80363294|FG000|Cohort 6|Withdrawal by Subject|1|||
27596877|NCT02436330|80363295|FG001|Cohort 6|Withdrawal by Subject|1|||
27596878|NCT03804710|80363296|FG000|Overall Study|Adverse Event|0|||
27596879|NCT03804710|80363297|FG001|Overall Study|Adverse Event|3|||
27596880|NCT03804710|80363296|FG000|Overall Study|Withdrawal by Subject|2|||
27596881|NCT03804710|80363297|FG001|Overall Study|Withdrawal by Subject|1|||
27596882|NCT03804710|80363296|FG000|Overall Study|Other|0|||
27596883|NCT03804710|80363297|FG001|Overall Study|Other|1|||
27596884|NCT01256411|80363299|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
27596885|NCT01256411|80363300|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
27596886|NCT01256411|80363301|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
27702166|NCT00369785|80748194|FG000|Overall Study|Physician Decision|3|||
27702167|NCT00369785|80748195|FG001|Overall Study|Physician Decision|2|||
27702168|NCT00369785|80748194|FG000|Overall Study|Death|1|||
27596887|NCT01256411|80363302|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
27596888|NCT01256411|80363303|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
27596889|NCT01256411|80363304|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
27596890|NCT01256411|80363299|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
27596891|NCT01256411|80363300|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
27596892|NCT01256411|80363301|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
27596893|NCT01256411|80363302|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
27596894|NCT01256411|80363303|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
27596895|NCT01256411|80363304|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
27596896|NCT01256411|80363299|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
27596897|NCT01256411|80363300|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
27596898|NCT01256411|80363301|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
27596899|NCT01256411|80363302|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
27596900|NCT01256411|80363303|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
27596901|NCT01256411|80363304|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
27596902|NCT01256411|80363299|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
27596903|NCT01256411|80363300|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
27596904|NCT01256411|80363301|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
27596905|NCT01256411|80363302|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
27596906|NCT01256411|80363303|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
27596907|NCT01256411|80363304|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
27596908|NCT01256411|80363299|FG000|Extension by Maximum Treatment|Adverse Event|4|||
27596909|NCT01256411|80363300|FG001|Extension by Maximum Treatment|Adverse Event|2|||
27596910|NCT01256411|80363301|FG002|Extension by Maximum Treatment|Adverse Event|1|||
27596911|NCT01256411|80363302|FG003|Extension by Maximum Treatment|Adverse Event|0|||
27596912|NCT01256411|80363303|FG004|Extension by Maximum Treatment|Adverse Event|0|||
27596913|NCT01256411|80363304|FG005|Extension by Maximum Treatment|Adverse Event|0|||
27596914|NCT01256411|80363299|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
27596915|NCT01256411|80363300|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
27596916|NCT01256411|80363301|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
27596917|NCT01256411|80363302|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
27596918|NCT01256411|80363303|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
27596919|NCT01256411|80363304|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
27596920|NCT01256411|80363299|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27596921|NCT01256411|80363300|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27596922|NCT01256411|80363301|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27596923|NCT01256411|80363302|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27596924|NCT01256411|80363303|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
27596925|NCT01256411|80363304|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
27596926|NCT01256411|80363299|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27596927|NCT01256411|80363300|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27596928|NCT01256411|80363301|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27596929|NCT01256411|80363302|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27596930|NCT01256411|80363303|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
27596931|NCT01256411|80363304|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
27596932|NCT01256411|80363299|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27596933|NCT01256411|80363300|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27596934|NCT01256411|80363301|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27596935|NCT01256411|80363302|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
27596936|NCT01256411|80363303|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
27596937|NCT01256411|80363304|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
27596938|NCT01256411|80363299|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27596939|NCT01256411|80363300|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27596940|NCT01256411|80363301|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27596941|NCT01256411|80363302|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
27702169|NCT00369785|80748195|FG001|Overall Study|Death|2|||
27702170|NCT00369785|80748194|FG000|Overall Study|Withdrawal by Subject|7|||
27702171|NCT00369785|80748195|FG001|Overall Study|Withdrawal by Subject|6|||
27702172|NCT00369785|80748194|FG000|Overall Study|Toxicity|6|||
27596942|NCT01256411|80363303|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
27596943|NCT01256411|80363304|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
27596944|NCT00815295|80363305|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
27596945|NCT00815295|80363306|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
27596946|NCT00815295|80363307|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
27596947|NCT04198805|80363310|FG000|Overall Study|Death|0|||
27596948|NCT04198805|80363311|FG001|Overall Study|Death|0|||
27596949|NCT04198805|80363312|FG002|Overall Study|Death|0|||
27702173|NCT00369785|80748195|FG001|Overall Study|Toxicity|4|||
27596950|NCT04198805|80363313|FG003|Overall Study|Death|1|||
27596951|NCT04198805|80363310|FG000|Overall Study|Early Termination|8|||
27596952|NCT04198805|80363311|FG001|Overall Study|Early Termination|4|||
27596953|NCT04198805|80363312|FG002|Overall Study|Early Termination|6|||
27596954|NCT04198805|80363313|FG003|Overall Study|Early Termination|9|||
27596955|NCT00765388|80363315|FG000|Period 1|Lack of Efficacy|1|||
27596956|NCT00765388|80363316|FG001|Period 1|Lack of Efficacy|2|||
27596957|NCT00765388|80363315|FG000|Period 1|Lost to Follow-up|0|||
27596958|NCT00765388|80363316|FG001|Period 1|Lost to Follow-up|1|||
27596959|NCT00765388|80363315|FG000|Period 1|Herpes Zoster|0|||
27702174|NCT00369785|80748194|FG000|Overall Study|Never started|0|||
27702175|NCT00369785|80748195|FG001|Overall Study|Never started|2|||
27702176|NCT00369785|80748194|FG000|Overall Study|Progression|4|||
27702177|NCT00369785|80748195|FG001|Overall Study|Progression|4|||
27702178|NCT00369785|80748194|FG000|Overall Study|Multiple reasons|6|||
27702179|NCT00369785|80748195|FG001|Overall Study|Multiple reasons|5|||
27702180|NCT00935272|80748199|FG000|Overall Study|Lost to Follow-up|10|||
27702181|NCT00935272|80748200|FG001|Overall Study|Lost to Follow-up|3|||
27702182|NCT00935272|80748199|FG000|Overall Study|Withdrawal by Subject|8|||
27702183|NCT00935272|80748200|FG001|Overall Study|Withdrawal by Subject|2|||
27702184|NCT00935272|80748199|FG000|Overall Study|Physician Decision|1|||
27702185|NCT00935272|80748200|FG001|Overall Study|Physician Decision|0|||
27702186|NCT00935272|80748199|FG000|Overall Study|Protocol Violation|0|||
27702187|NCT00935272|80748200|FG001|Overall Study|Protocol Violation|1|||
27702188|NCT04906616|80748201|FG000|Overall Study|Divorce|3|||
27702189|NCT04906616|80748202|FG001|Overall Study|Divorce|2|||
27702190|NCT01681628|80748207|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
27702191|NCT01681628|80748208|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
27702192|NCT01681628|80748207|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
27702193|NCT01681628|80748208|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
27702194|NCT01681628|80748207|FG000|19 Months Follow-up|Death|1|||
27702195|NCT01681628|80748208|FG001|19 Months Follow-up|Death|0|||
27702196|NCT01681628|80748207|FG000|19 Months Follow-up|Lost to Follow-up|61|||
27833576|NCT01808651|81222580|FG000|Study Period 1|Lost to Follow-up|1|||
27833577|NCT01808651|81222581|FG001|Study Period 1|Lost to Follow-up|3|||
27833578|NCT01808651|81222582|FG002|Study Period 1|Lost to Follow-up|0|||
27887053|NCT02135107|81422054|FG000|Treatment Period|Adverse Event|5|||
27702197|NCT01681628|80748208|FG001|19 Months Follow-up|Lost to Follow-up|43|||
27702198|NCT00210184|80748209|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
27702199|NCT02511678|80748210|FG000|Overall Study|Withdrawal by Subject|2|||
27702200|NCT02511678|80748210|FG000|Overall Study|Lost to Follow-up|4|||
27702201|NCT02511678|80748210|FG000|Overall Study|Death|19|||
27833579|NCT01808651|81222580|FG000|Study Period 1|Protocol Violation|1|||
27833580|NCT01808651|81222581|FG001|Study Period 1|Protocol Violation|0|||
27596960|NCT00765388|80363316|FG001|Period 1|Herpes Zoster|1|||
27596961|NCT00765388|80363315|FG000|Period 1|Hip operation|0|||
27596962|NCT00765388|80363316|FG001|Period 1|Hip operation|1|||
27833581|NCT01808651|81222582|FG002|Study Period 1|Protocol Violation|1|||
27833582|NCT01808651|81222580|FG000|Study Period 1|Physician Decision|3|||
27833583|NCT01808651|81222581|FG001|Study Period 1|Physician Decision|2|||
27833584|NCT01808651|81222582|FG002|Study Period 1|Physician Decision|0|||
27833585|NCT01808651|81222580|FG000|Study Period 1|Lack of Efficacy|2|||
27833586|NCT01808651|81222581|FG001|Study Period 1|Lack of Efficacy|1|||
27833587|NCT01808651|81222582|FG002|Study Period 1|Lack of Efficacy|0|||
27702202|NCT02511678|80748210|FG000|Overall Study|Adverse Event|1|||
27702203|NCT02511678|80748210|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
27702204|NCT02511678|80748210|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
27702205|NCT02511678|80748210|FG000|Overall Study|Required Radiofrequency Ablation|1|||
27702206|NCT02511678|80748210|FG000|Overall Study|Biopsy was Negative|1|||
27702207|NCT02511678|80748210|FG000|Overall Study|Protocol Violation|1|||
27702208|NCT02511678|80748210|FG000|Overall Study|Received Radiation Treatment|1|||
27702209|NCT00860951|80748211|FG000|Overall Study|Withdrawal by Subject|2|||
27702210|NCT00860951|80748211|FG000|Overall Study|Lost to Follow-up|5|||
27702211|NCT02811549|80748212|FG000|Overall Study|Lost to Follow-up|1|||
27702212|NCT02811549|80748212|FG000|Overall Study|Withdrawal by Subject|3|||
27702213|NCT02811549|80748212|FG000|Overall Study|Subject screen failed|4|||
27702214|NCT02811549|80748212|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
27702215|NCT02308007|80748216|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
27702216|NCT02308007|80748217|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
27702217|NCT02308007|80748218|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
27702218|NCT02308007|80748216|FG000|Overall Study|Positive for STD at Baseline|7|||
27702219|NCT02308007|80748217|FG001|Overall Study|Positive for STD at Baseline|11|||
27702220|NCT02308007|80748218|FG002|Overall Study|Positive for STD at Baseline|7|||
27702221|NCT02308007|80748216|FG000|Overall Study|Lost to Follow-up|3|||
27702222|NCT02308007|80748217|FG001|Overall Study|Lost to Follow-up|0|||
27702223|NCT02308007|80748218|FG002|Overall Study|Lost to Follow-up|1|||
27702224|NCT01754857|80748224|FG000|Overall Study|Adverse Event|7|||
27702225|NCT01754857|80748224|FG000|Overall Study|Disease progression|3|||
27702226|NCT01754857|80748224|FG000|Overall Study|Physician Decision|2|||
27702227|NCT01754857|80748224|FG000|Overall Study|Withdrawal by Subject|3|||
27702228|NCT01754857|80748224|FG000|Overall Study|other complicating disease|1|||
27702229|NCT01754857|80748224|FG000|Overall Study|ineligible to continue onto maintenance|1|||
27702230|NCT01754857|80748224|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
27702231|NCT01754857|80748224|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
27702232|NCT02019420|80748225|FG000|Overall Study|Did not receive study drug|2|||
27702233|NCT02019420|80748226|FG001|Overall Study|Did not receive study drug|2|||
27702234|NCT02019420|80748225|FG000|Overall Study|Withdrawal by Subject|1|||
27702235|NCT02019420|80748226|FG001|Overall Study|Withdrawal by Subject|3|||
27702236|NCT02019420|80748225|FG000|Overall Study|At request of sponsor or investigator|0|||
27702237|NCT02019420|80748226|FG001|Overall Study|At request of sponsor or investigator|1|||
27702238|NCT02019420|80748225|FG000|Overall Study|Death|104|||
27702239|NCT02019420|80748226|FG001|Overall Study|Death|99|||
27702240|NCT02019420|80748225|FG000|Overall Study|Transferred to other care facility|1|||
27702241|NCT02019420|80748226|FG001|Overall Study|Transferred to other care facility|1|||
27702242|NCT00890929|80748227|FG000|Overall Study|Death before treatment|2|||
27702243|NCT00890929|80748227|FG000|Overall Study|Withdrawal by Subject|3|||
27702244|NCT00890929|80748227|FG000|Overall Study|Physician Decision|1|||
27702245|NCT00698451|80748228|FG000|Overall Study|Adverse Event|22|||
27702246|NCT00698451|80748228|FG000|Overall Study|Physician Decision|2|||
27702247|NCT00698451|80748228|FG000|Overall Study|Protocol Violation|6|||
27702248|NCT00698451|80748228|FG000|Overall Study|Withdrawal by Subject|6|||
27702249|NCT00698451|80748228|FG000|Overall Study|Disease progression|3|||
27702250|NCT00068588|80748229|FG000|Overall Study|Adverse Event|0|||
27702251|NCT00068588|80748230|FG001|Overall Study|Adverse Event|0|||
27702252|NCT00068588|80748231|FG002|Overall Study|Adverse Event|2|||
27702253|NCT00068588|80748229|FG000|Overall Study|Withdrawal by Subject|0|||
27702254|NCT00068588|80748230|FG001|Overall Study|Withdrawal by Subject|0|||
27702255|NCT00068588|80748231|FG002|Overall Study|Withdrawal by Subject|1|||
27702256|NCT00068588|80748229|FG000|Overall Study|Poor KPS|0|||
27702257|NCT00068588|80748230|FG001|Overall Study|Poor KPS|0|||
27702258|NCT00068588|80748231|FG002|Overall Study|Poor KPS|1|||
27702259|NCT01886313|80748232|FG000|Overall Study|Adverse Event|1|||
27702260|NCT01886313|80748233|FG001|Overall Study|Adverse Event|1|||
27702261|NCT01230554|80748234|FG000|Overall Study|Lost to Follow-up|2|||
27702262|NCT01230554|80748234|FG000|Overall Study|Inability to maintain visit schedule|1|||
27702263|NCT05513625|80748235|FG000|Overall Study|Withdrawal by Subject|1|||
27702264|NCT03047551|80748236|FG000|Overall Study|Did not receive TAS|1|||
27833588|NCT01808651|81222580|FG000|Study Period 1|Adverse Event|10|||
27833589|NCT01808651|81222581|FG001|Study Period 1|Adverse Event|4|||
27833590|NCT01808651|81222582|FG002|Study Period 1|Adverse Event|1|||
27833591|NCT01808651|81222580|FG000|Study Period 1|Participant Decision|9|||
27833592|NCT01808651|81222581|FG001|Study Period 1|Participant Decision|7|||
27833593|NCT01808651|81222582|FG002|Study Period 1|Participant Decision|3|||
27833594|NCT04474405|81222583|FG000|Overall Study|Withdrawal by Subject|0|||
27833595|NCT04474405|81222584|FG001|Overall Study|Withdrawal by Subject|0|||
27833596|NCT04474405|81222585|FG002|Overall Study|Withdrawal by Subject|1|||
27833597|NCT04474405|81222586|FG003|Overall Study|Withdrawal by Subject|0|||
27833598|NCT04474405|81222587|FG004|Overall Study|Withdrawal by Subject|1|||
27833599|NCT04474405|81222588|FG005|Overall Study|Withdrawal by Subject|0|||
27833600|NCT04474405|81222583|FG000|Overall Study|Other|0|||
27833601|NCT04474405|81222584|FG001|Overall Study|Other|0|||
27833602|NCT04474405|81222585|FG002|Overall Study|Other|0|||
27833603|NCT04474405|81222586|FG003|Overall Study|Other|0|||
27833604|NCT04474405|81222587|FG004|Overall Study|Other|3|||
27833605|NCT04474405|81222588|FG005|Overall Study|Other|0|||
27833606|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
27833607|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
27833608|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
27833609|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
27833610|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
27833611|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
27833612|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
27833613|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
27833614|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
27833615|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
27833616|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
27833617|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
27833618|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
27833619|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
27833620|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
27833621|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
27833622|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
27833623|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
27833624|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
27833625|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
27833626|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
27833627|NCT02227238|81222589|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
27833628|NCT02227238|81222590|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
27833629|NCT02227238|81222591|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
27833630|NCT02227238|81222589|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
27833631|NCT02227238|81222590|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
27833632|NCT02227238|81222591|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
27833633|NCT02227238|81222589|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
27833634|NCT02227238|81222590|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
27833635|NCT02227238|81222591|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
27833636|NCT02227238|81222589|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
27833637|NCT02227238|81222590|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
27833638|NCT02227238|81222591|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
27833639|NCT02227238|81222589|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
27833640|NCT02227238|81222590|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
27833641|NCT02227238|81222591|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
27833642|NCT02227238|81222589|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
27833643|NCT02227238|81222590|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
27833644|NCT02227238|81222591|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
27702265|NCT03047551|80748237|FG001|Overall Study|Did not receive TAS|0|||
27702266|NCT03047551|80748236|FG000|Overall Study|Physician Decision|1|||
27702267|NCT03047551|80748237|FG001|Overall Study|Physician Decision|0|||
27833645|NCT02227238|81222589|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
27702268|NCT03047551|80748236|FG000|Overall Study|Withdrawal by Subject|0|||
27702269|NCT03047551|80748237|FG001|Overall Study|Withdrawal by Subject|1|||
27702270|NCT03047551|80748236|FG000|Overall Study|Probe malfunction|0|||
27702271|NCT03047551|80748237|FG001|Overall Study|Probe malfunction|1|||
27702272|NCT03047551|80748236|FG000|Overall Study|Ineligible|0|||
27702273|NCT03047551|80748237|FG001|Overall Study|Ineligible|1|||
27702274|NCT04004429|80748238|FG000|Overall Study|Protocol Violation|1|||
27702275|NCT04004429|80748239|FG001|Overall Study|Protocol Violation|0|||
27702276|NCT04004429|80748240|FG002|Overall Study|Protocol Violation|0|||
27702277|NCT04004429|80748238|FG000|Overall Study|Physician Decision|0|||
27702278|NCT04004429|80748239|FG001|Overall Study|Physician Decision|1|||
27702279|NCT04004429|80748240|FG002|Overall Study|Physician Decision|1|||
27596963|NCT00686166|80363317|FG000|Overall Study|Adverse Event|7|||
27702280|NCT04004429|80748238|FG000|Overall Study|Withdrawal by Subject|1|||
27702281|NCT04004429|80748239|FG001|Overall Study|Withdrawal by Subject|1|||
27833646|NCT02227238|81222590|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
27833647|NCT02227238|81222591|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
27833648|NCT01139762|81222592|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
27833649|NCT01139762|81222593|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
27833650|NCT01139762|81222594|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
27833651|NCT01139762|81222592|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
27833652|NCT01139762|81222593|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
27833653|NCT01139762|81222594|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
27833654|NCT01139762|81222592|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
27833655|NCT01139762|81222593|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
27833656|NCT01139762|81222594|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
27833657|NCT01139762|81222592|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
27833658|NCT01139762|81222593|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
27833659|NCT01139762|81222594|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
27833660|NCT01139762|81222592|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
27833661|NCT01139762|81222593|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
27833662|NCT01139762|81222594|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
27833663|NCT01139762|81222592|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
27833664|NCT01139762|81222593|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
27833665|NCT01139762|81222594|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
27833666|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
27833667|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
27833668|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
27833669|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Death|0|||
27833670|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Death|1|||
27596964|NCT00686166|80363317|FG000|Overall Study|Withdrawal by Subject|1|||
27702282|NCT04004429|80748240|FG002|Overall Study|Withdrawal by Subject|1|||
27702283|NCT03876171|80748241|FG000|Overall Study|Withdrawal by Subject|3|||
27887054|NCT02135107|81422055|FG001|Treatment Period|Adverse Event|2|||
27887055|NCT02135107|81422056|FG002|Treatment Period|Adverse Event|0|||
27887056|NCT02135107|81422057|FG003|Treatment Period|Adverse Event|0|||
27887057|NCT02135107|81422054|FG000|Treatment Period|Pregnancy|1|||
27887058|NCT02135107|81422055|FG001|Treatment Period|Pregnancy|0|||
27887059|NCT02135107|81422056|FG002|Treatment Period|Pregnancy|0|||
27887060|NCT02135107|81422057|FG003|Treatment Period|Pregnancy|0|||
27887061|NCT02135107|81422054|FG000|Treatment Period|Other|115|||
27887062|NCT02135107|81422055|FG001|Treatment Period|Other|24|||
27887063|NCT02135107|81422056|FG002|Treatment Period|Other|0|||
27887064|NCT02135107|81422057|FG003|Treatment Period|Other|0|||
27887065|NCT02135107|81422054|FG000|Maintenance Therapy Period|Adverse Event|0|||
27887066|NCT02135107|81422055|FG001|Maintenance Therapy Period|Adverse Event|0|||
27887067|NCT02135107|81422056|FG002|Maintenance Therapy Period|Adverse Event|3|||
27887068|NCT02135107|81422057|FG003|Maintenance Therapy Period|Adverse Event|7|||
27887069|NCT02135107|81422054|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
27887070|NCT02135107|81422055|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
27887071|NCT02135107|81422056|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
27887072|NCT02135107|81422057|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
27887073|NCT02135107|81422054|FG000|Maintenance Therapy Period|Pregnancy|0|||
27887074|NCT02135107|81422055|FG001|Maintenance Therapy Period|Pregnancy|0|||
27887075|NCT02135107|81422056|FG002|Maintenance Therapy Period|Pregnancy|0|||
27887076|NCT02135107|81422057|FG003|Maintenance Therapy Period|Pregnancy|1|||
27887077|NCT02135107|81422054|FG000|Maintenance Therapy Period|Other|0|||
27887078|NCT02135107|81422055|FG001|Maintenance Therapy Period|Other|0|||
27887079|NCT02135107|81422056|FG002|Maintenance Therapy Period|Other|7|||
27887080|NCT02135107|81422057|FG003|Maintenance Therapy Period|Other|8|||
27887081|NCT01940887|81422064|FG000|Year 1|Protocol Violation|0|||
27887082|NCT01940887|81422065|FG001|Year 1|Protocol Violation|1|||
27887083|NCT01940887|81422064|FG000|Year 1|Physician Decision|7|||
27887084|NCT01940887|81422065|FG001|Year 1|Physician Decision|3|||
27887085|NCT01940887|81422064|FG000|Year 1|Death|5|||
27887086|NCT01940887|81422065|FG001|Year 1|Death|3|||
27887087|NCT01940887|81422064|FG000|Year 1|Adverse Event|7|||
27887088|NCT01940887|81422065|FG001|Year 1|Adverse Event|6|||
27887089|NCT01940887|81422064|FG000|Year 1|Withdrawal by Subject|18|||
27887090|NCT01940887|81422065|FG001|Year 1|Withdrawal by Subject|9|||
27887091|NCT01940887|81422064|FG000|Year 1|Lost to Follow-up|2|||
27887092|NCT01940887|81422065|FG001|Year 1|Lost to Follow-up|1|||
27887093|NCT01940887|81422064|FG000|Year 2|Physician Decision|8|||
27887094|NCT01940887|81422065|FG001|Year 2|Physician Decision|1|||
27887095|NCT01940887|81422064|FG000|Year 2|Death|0|||
27887096|NCT01940887|81422065|FG001|Year 2|Death|2|||
27887097|NCT01940887|81422064|FG000|Year 2|Sponsor Decision, early termination|192|||
27887098|NCT01940887|81422065|FG001|Year 2|Sponsor Decision, early termination|203|||
27887099|NCT01940887|81422064|FG000|Year 2|Adverse Event|8|||
27887100|NCT01940887|81422065|FG001|Year 2|Adverse Event|2|||
27887101|NCT01940887|81422064|FG000|Year 2|Withdrawal by Subject|8|||
27887102|NCT01940887|81422065|FG001|Year 2|Withdrawal by Subject|8|||
27887103|NCT01940887|81422064|FG000|Year 2|Lost to Follow-up|1|||
27887104|NCT01940887|81422065|FG001|Year 2|Lost to Follow-up|6|||
27887105|NCT02387957|81422066|FG000|Overall Study|The study was discontinued|21|||
27887106|NCT02387957|81422067|FG001|Overall Study|The study was discontinued|21|||
27887107|NCT02387957|81422068|FG002|Overall Study|The study was discontinued|20|||
27887108|NCT00002931|81422069|FG000|Overall Study|rapidly progressing disease during|2|||
27887109|NCT02582242|81422070|FG000|Overall Study|Adverse Event|4|||
27887110|NCT02582242|81422071|FG001|Overall Study|Adverse Event|3|||
27887111|NCT02582242|81422070|FG000|Overall Study|Protocol Violation|3|||
27887112|NCT02582242|81422071|FG001|Overall Study|Protocol Violation|1|||
27887113|NCT02582242|81422070|FG000|Overall Study|Lost to Follow-up|0|||
27887114|NCT02582242|81422071|FG001|Overall Study|Lost to Follow-up|1|||
27887115|NCT02582242|81422070|FG000|Overall Study|Withdrawal by Subject|11|||
27596965|NCT00686166|80363317|FG000|Overall Study|Progression/Relapse|1|||
27887116|NCT02582242|81422071|FG001|Overall Study|Withdrawal by Subject|11|||
27887117|NCT02582242|81422070|FG000|Overall Study|Unclassified|2|||
27887118|NCT02582242|81422071|FG001|Overall Study|Unclassified|1|||
27887119|NCT05338502|81422072|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
27887120|NCT05338502|81422073|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
27887121|NCT05338502|81422074|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
27887122|NCT05338502|81422072|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
27887123|NCT05338502|81422073|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
27887124|NCT05338502|81422074|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
27887125|NCT01015131|81422075|FG000|Overall Study|Physician Decision|1|||
27887126|NCT01015131|81422075|FG000|Overall Study|Protocol Violation|1|||
27887127|NCT01015131|81422075|FG000|Overall Study|Withdrawal by Subject|2|||
27887128|NCT01015131|81422075|FG000|Overall Study|Other Protocol Specified Criteria|4|||
27887129|NCT00812981|81422076|FG000|Overall Study|Other|0|||
27887130|NCT00812981|81422077|FG001|Overall Study|Other|1|||
27887131|NCT03973918|81422078|FG000|Overall Study|Adverse Event|0|||
27887132|NCT03973918|81422079|FG001|Overall Study|Adverse Event|0|||
27887133|NCT03973918|81422080|FG002|Overall Study|Adverse Event|0|||
27887134|NCT03973918|81422081|FG003|Overall Study|Adverse Event|1|||
27887135|NCT03973918|81422078|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
27887136|NCT03973918|81422079|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
27887137|NCT03973918|81422080|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
27887138|NCT03973918|81422081|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
27596966|NCT00686166|80363317|FG000|Overall Study|Death|1|||
27596967|NCT00686166|80363317|FG000|Overall Study|Not Protocol Specified|1|||
27887139|NCT04075266|81422086|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
27702284|NCT03876171|80748242|FG001|Overall Study|Withdrawal by Subject|3|||
27887140|NCT04075266|81422087|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
27596968|NCT00686166|80363317|FG000|Overall Study|Ineligible|5|||
27596969|NCT00686166|80363317|FG000|Overall Study|Did not begin protocol therapy|4|||
27596970|NCT00952367|80363318|FG000|Overall Study|Withdrawal by Subject|2|||
27596971|NCT00952367|80363318|FG000|Overall Study|Noncoordination|1|||
27596972|NCT00952367|80363318|FG000|Overall Study|Protocol Violation|3|||
27596973|NCT00911534|80363319|FG000|Overall Study|Adverse Event|4|||
27596974|NCT00911534|80363320|FG001|Overall Study|Adverse Event|4|||
27596975|NCT00911534|80363319|FG000|Overall Study|Lost to Follow-up|2|||
27596976|NCT00911534|80363320|FG001|Overall Study|Lost to Follow-up|4|||
27596977|NCT00911534|80363319|FG000|Overall Study|Withdrawal by Subject|2|||
27596978|NCT00911534|80363320|FG001|Overall Study|Withdrawal by Subject|1|||
27596979|NCT00911534|80363319|FG000|Overall Study|Lack of Efficacy|4|||
27596980|NCT00911534|80363320|FG001|Overall Study|Lack of Efficacy|1|||
27596981|NCT00911534|80363319|FG000|Overall Study|Withdrawal of consent|1|||
27596982|NCT00911534|80363320|FG001|Overall Study|Withdrawal of consent|4|||
27596983|NCT00911534|80363319|FG000|Overall Study|Other|2|||
27596984|NCT00911534|80363320|FG001|Overall Study|Other|2|||
27596985|NCT05338333|80363321|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
27596986|NCT05338333|80363322|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
27596987|NCT00677352|80363324|FG000|Treatment Phase|Adverse Event|14|||
27596988|NCT00677352|80363325|FG001|Treatment Phase|Adverse Event|22|||
27596989|NCT00677352|80363324|FG000|Treatment Phase|Lack of Efficacy|2|||
27596990|NCT00677352|80363325|FG001|Treatment Phase|Lack of Efficacy|3|||
27596991|NCT00677352|80363324|FG000|Treatment Phase|Lost to Follow-up|0|||
27596992|NCT00677352|80363325|FG001|Treatment Phase|Lost to Follow-up|1|||
27596993|NCT00677352|80363324|FG000|Treatment Phase|Withdrawal by Subject|7|||
27596994|NCT00677352|80363325|FG001|Treatment Phase|Withdrawal by Subject|7|||
27596995|NCT00677352|80363324|FG000|Treatment Phase|Physician Decision|1|||
27596996|NCT00677352|80363325|FG001|Treatment Phase|Physician Decision|0|||
27596997|NCT00677352|80363324|FG000|Treatment Phase|Pregnancy|0|||
27596998|NCT00677352|80363325|FG001|Treatment Phase|Pregnancy|1|||
27596999|NCT00677352|80363324|FG000|Treatment Phase|Protocol Violation|1|||
27597000|NCT00677352|80363325|FG001|Treatment Phase|Protocol Violation|1|||
27597001|NCT00677352|80363324|FG000|Treatment Phase|Transference or work related matter|0|||
27597002|NCT00677352|80363325|FG001|Treatment Phase|Transference or work related matter|5|||
27597003|NCT00677352|80363324|FG000|Treatment Phase|Not treated|0|||
27597004|NCT00677352|80363325|FG001|Treatment Phase|Not treated|2|||
27597005|NCT00677352|80363324|FG000|Tapering Phase|Adverse Event|1|||
27597006|NCT00677352|80363325|FG001|Tapering Phase|Adverse Event|5|||
27597007|NCT00677352|80363324|FG000|Tapering Phase|Withdrawal by Subject|5|||
27597008|NCT00677352|80363325|FG001|Tapering Phase|Withdrawal by Subject|3|||
27702285|NCT03876171|80748241|FG000|Overall Study|Re-arrest|0|||
27702286|NCT03876171|80748242|FG001|Overall Study|Re-arrest|4|||
27702287|NCT00403754|80748243|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
27702288|NCT00403754|80748244|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
27833671|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Death|1|||
27833672|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
27833673|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
27833674|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
27833675|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
27833676|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
27833677|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
27833678|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
27833679|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
27887141|NCT04075266|81422086|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
27597009|NCT00677352|80363324|FG000|Tapering Phase|Pregnancy|0|||
27597010|NCT00677352|80363325|FG001|Tapering Phase|Pregnancy|1|||
27597011|NCT00677352|80363324|FG000|Tapering Phase|Job transfer|0|||
27597012|NCT00677352|80363325|FG001|Tapering Phase|Job transfer|1|||
27597013|NCT02395042|80363328|FG000|Treatment 1 Period|Adverse Event|1|||
27597014|NCT02395042|80363329|FG001|Treatment 1 Period|Adverse Event|3|||
27597015|NCT02395042|80363330|FG002|Treatment 1 Period|Adverse Event|1|||
27597016|NCT02395042|80363328|FG000|Treatment 1 Period|Lack of Efficacy|1|||
27597017|NCT02395042|80363329|FG001|Treatment 1 Period|Lack of Efficacy|1|||
27702289|NCT00403754|80748245|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
27702290|NCT00403754|80748246|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
27702291|NCT00403754|80748243|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
27702292|NCT00403754|80748244|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
27702293|NCT00403754|80748245|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
27702294|NCT00403754|80748246|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
27702295|NCT01207596|80748247|FG000|Overall Study|Physician Decision|4|||
27702296|NCT01207596|80748247|FG000|Overall Study|Lack of Efficacy|1|||
27702297|NCT01207596|80748247|FG000|Overall Study|Adverse Event|3|||
27702298|NCT01207596|80748247|FG000|Overall Study|Withdrawal by Subject|1|||
27702299|NCT01287364|80748250|FG000|Overall Study|Adverse Event|0|||
27702300|NCT01287364|80748251|FG001|Overall Study|Adverse Event|3|||
27702301|NCT01287364|80748250|FG000|Overall Study|Protocol Violation|5|||
27702302|NCT01287364|80748251|FG001|Overall Study|Protocol Violation|5|||
27702303|NCT01287364|80748250|FG000|Overall Study|Other Reason|4|||
27702304|NCT01287364|80748251|FG001|Overall Study|Other Reason|2|||
27702305|NCT01650285|80748255|FG000|Overall Study|Adverse Event|1|||
27702306|NCT02464228|80748262|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
27702307|NCT02464228|80748263|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
27702308|NCT02464228|80748264|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
27702309|NCT02464228|80748265|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
27702310|NCT02464228|80748262|FG000|Overall Study|Physician Decision|2|||
27702311|NCT02464228|80748263|FG001|Overall Study|Physician Decision|0|||
27702312|NCT02464228|80748264|FG002|Overall Study|Physician Decision|1|||
27702313|NCT02464228|80748265|FG003|Overall Study|Physician Decision|0|||
27702314|NCT02464228|80748262|FG000|Overall Study|Miscellaneous|1|||
27702315|NCT02464228|80748263|FG001|Overall Study|Miscellaneous|0|||
27702316|NCT02464228|80748264|FG002|Overall Study|Miscellaneous|1|||
27702317|NCT02464228|80748265|FG003|Overall Study|Miscellaneous|0|||
27887142|NCT04075266|81422087|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
27887143|NCT02783729|81422088|FG000|Overall Study|Lack of Efficacy|1|||
27887144|NCT02783729|81422089|FG001|Overall Study|Lack of Efficacy|0|||
27887145|NCT02783729|81422090|FG002|Overall Study|Lack of Efficacy|0|||
27887146|NCT02783729|81422091|FG003|Overall Study|Lack of Efficacy|0|||
27887147|NCT02783729|81422088|FG000|Overall Study|Adverse Event|2|||
27887148|NCT02783729|81422089|FG001|Overall Study|Adverse Event|6|||
27887149|NCT02783729|81422090|FG002|Overall Study|Adverse Event|2|||
27887150|NCT02783729|81422091|FG003|Overall Study|Adverse Event|3|||
27887151|NCT02783729|81422088|FG000|Overall Study|Other|1|||
27887152|NCT02783729|81422089|FG001|Overall Study|Other|6|||
27887153|NCT02783729|81422090|FG002|Overall Study|Other|2|||
27887154|NCT02783729|81422091|FG003|Overall Study|Other|3|||
27887155|NCT02783729|81422088|FG000|Overall Study|Withdrawal by Subject|2|||
27887156|NCT02783729|81422089|FG001|Overall Study|Withdrawal by Subject|3|||
27887157|NCT02783729|81422090|FG002|Overall Study|Withdrawal by Subject|1|||
27887158|NCT02783729|81422091|FG003|Overall Study|Withdrawal by Subject|2|||
27887159|NCT02783729|81422088|FG000|Overall Study|Participant's choice|2|||
27887160|NCT02783729|81422089|FG001|Overall Study|Participant's choice|1|||
27887161|NCT02783729|81422090|FG002|Overall Study|Participant's choice|2|||
27887162|NCT02783729|81422091|FG003|Overall Study|Participant's choice|1|||
27887163|NCT02783729|81422088|FG000|Overall Study|Lost to Follow-up|2|||
27887164|NCT02783729|81422089|FG001|Overall Study|Lost to Follow-up|1|||
27887165|NCT02783729|81422090|FG002|Overall Study|Lost to Follow-up|1|||
27887166|NCT02783729|81422091|FG003|Overall Study|Lost to Follow-up|0|||
27887167|NCT04871711|81422093|FG000|Overall Study|Withdrawal by Subject|11|||
27887168|NCT04871711|81422094|FG001|Overall Study|Withdrawal by Subject|5|||
27887169|NCT04871711|81422093|FG000|Overall Study|Lack of Efficacy|5|||
27887170|NCT04871711|81422094|FG001|Overall Study|Lack of Efficacy|7|||
27887171|NCT04871711|81422093|FG000|Overall Study|Adverse Event|2|||
27702318|NCT02464228|80748262|FG000|Overall Study|Adverse Event|9|||
27702319|NCT02464228|80748263|FG001|Overall Study|Adverse Event|0|||
27702320|NCT02464228|80748264|FG002|Overall Study|Adverse Event|3|||
27702321|NCT02464228|80748265|FG003|Overall Study|Adverse Event|0|||
27702322|NCT02464228|80748262|FG000|Overall Study|Withdrawal by Subject|1|||
27887172|NCT04871711|81422094|FG001|Overall Study|Adverse Event|6|||
27887173|NCT04871711|81422093|FG000|Overall Study|Various reasons|2|||
27887174|NCT04871711|81422094|FG001|Overall Study|Various reasons|1|||
27887175|NCT04871711|81422093|FG000|Overall Study|Lost to Follow-up|0|||
27887176|NCT04871711|81422094|FG001|Overall Study|Lost to Follow-up|2|||
27887177|NCT02797080|81422097|FG000|Overall Study|Lost to Follow-up|1|||
27887178|NCT02797080|81422097|FG000|Overall Study|Withdrawal by Subject|1|||
27887179|NCT00565851|81422108|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
27702323|NCT02464228|80748263|FG001|Overall Study|Withdrawal by Subject|1|||
27702324|NCT02464228|80748264|FG002|Overall Study|Withdrawal by Subject|1|||
27702325|NCT02464228|80748265|FG003|Overall Study|Withdrawal by Subject|0|||
27887180|NCT00565851|81422109|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
27702326|NCT02464228|80748262|FG000|Overall Study|Disease Progression|22|||
27887181|NCT00565851|81422110|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
27833680|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
27833681|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
27833682|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
27833683|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
27833684|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
27833685|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
27833686|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
27833687|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
27833688|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
27833689|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
27833690|NCT01139762|81222592|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
27833691|NCT01139762|81222593|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
27833692|NCT01139762|81222594|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
27833693|NCT01018862|81222595|FG000|Overall Study|Adverse Event|2|||
27833694|NCT01018862|81222596|FG001|Overall Study|Adverse Event|0|||
27833695|NCT01018862|81222597|FG002|Overall Study|Adverse Event|6|||
27833696|NCT01018862|81222595|FG000|Overall Study|Lack of Efficacy|1|||
27833697|NCT01018862|81222596|FG001|Overall Study|Lack of Efficacy|0|||
27833698|NCT01018862|81222597|FG002|Overall Study|Lack of Efficacy|2|||
27597018|NCT02395042|80363330|FG002|Treatment 1 Period|Lack of Efficacy|0|||
27597019|NCT02395042|80363328|FG000|Treatment 1 Period|Lost to Follow-up|1|||
27597020|NCT02395042|80363329|FG001|Treatment 1 Period|Lost to Follow-up|0|||
27597021|NCT02395042|80363330|FG002|Treatment 1 Period|Lost to Follow-up|0|||
27597022|NCT02395042|80363328|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
27597023|NCT02395042|80363329|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
27597024|NCT02395042|80363330|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
27597025|NCT02395042|80363328|FG000|Treatment 2 Period|Lack of Efficacy|1|||
27597026|NCT02395042|80363329|FG001|Treatment 2 Period|Lack of Efficacy|1|||
27597027|NCT02395042|80363330|FG002|Treatment 2 Period|Lack of Efficacy|0|||
27597028|NCT04058353|80363331|FG000|Overall Study|Adverse Event|2|||
27597029|NCT04058353|80363332|FG001|Overall Study|Adverse Event|1|||
27597030|NCT04058353|80363331|FG000|Overall Study|Physician Decision|1|||
27597031|NCT04058353|80363332|FG001|Overall Study|Physician Decision|0|||
27597032|NCT04058353|80363331|FG000|Overall Study|Other|1|||
27597033|NCT04058353|80363332|FG001|Overall Study|Other|0|||
27597034|NCT02453685|80363333|FG000|Overall Study|Adverse Event|0|||
27597035|NCT02453685|80363334|FG001|Overall Study|Adverse Event|1|||
27597036|NCT02453685|80363333|FG000|Overall Study|Protocol Violation|7|||
27597037|NCT02453685|80363334|FG001|Overall Study|Protocol Violation|4|||
27597038|NCT02453685|80363333|FG000|Overall Study|Lost to Follow-up|0|||
27597039|NCT02453685|80363334|FG001|Overall Study|Lost to Follow-up|1|||
27597040|NCT02453685|80363333|FG000|Overall Study|Withdrawal by Subject|8|||
27597041|NCT02453685|80363334|FG001|Overall Study|Withdrawal by Subject|4|||
27597042|NCT02453685|80363333|FG000|Overall Study|Unclassified|4|||
27597043|NCT02453685|80363334|FG001|Overall Study|Unclassified|2|||
27597044|NCT02178566|80363339|FG000|Overall Study|patient did not complete due to noncompliance|0|||
27597045|NCT02178566|80363340|FG001|Overall Study|patient did not complete due to noncompliance|1|||
27597046|NCT02181803|80363341|FG000|Overall Study|Withdrawal by Subject|0|||
27597047|NCT02181803|80363342|FG001|Overall Study|Withdrawal by Subject|2|||
27597048|NCT02181803|80363343|FG002|Overall Study|Withdrawal by Subject|0|||
27597049|NCT02181803|80363344|FG003|Overall Study|Withdrawal by Subject|0|||
27597050|NCT02181803|80363345|FG004|Overall Study|Withdrawal by Subject|0|||
27597051|NCT02181803|80363346|FG005|Overall Study|Withdrawal by Subject|0|||
27597052|NCT02181803|80363347|FG006|Overall Study|Withdrawal by Subject|0|||
27597053|NCT02181803|80363348|FG007|Overall Study|Withdrawal by Subject|0|||
27597054|NCT02181803|80363349|FG008|Overall Study|Withdrawal by Subject|0|||
27597055|NCT02181803|80363341|FG000|Overall Study|Physician Decision|0|||
27597056|NCT02181803|80363342|FG001|Overall Study|Physician Decision|0|||
27597057|NCT02181803|80363343|FG002|Overall Study|Physician Decision|0|||
27597058|NCT02181803|80363344|FG003|Overall Study|Physician Decision|1|||
27597059|NCT02181803|80363345|FG004|Overall Study|Physician Decision|0|||
27597060|NCT02181803|80363346|FG005|Overall Study|Physician Decision|0|||
27597061|NCT02181803|80363347|FG006|Overall Study|Physician Decision|0|||
27597062|NCT02181803|80363348|FG007|Overall Study|Physician Decision|1|||
27597063|NCT02181803|80363349|FG008|Overall Study|Physician Decision|0|||
27597064|NCT02181803|80363341|FG000|Overall Study|Adverse Event|0|||
27597065|NCT02181803|80363342|FG001|Overall Study|Adverse Event|2|||
27597066|NCT02181803|80363343|FG002|Overall Study|Adverse Event|0|||
27597067|NCT02181803|80363344|FG003|Overall Study|Adverse Event|1|||
27597068|NCT02181803|80363345|FG004|Overall Study|Adverse Event|0|||
27597069|NCT02181803|80363346|FG005|Overall Study|Adverse Event|0|||
27597070|NCT02181803|80363347|FG006|Overall Study|Adverse Event|1|||
27597071|NCT02181803|80363348|FG007|Overall Study|Adverse Event|0|||
27597072|NCT02181803|80363349|FG008|Overall Study|Adverse Event|0|||
27702327|NCT02464228|80748263|FG001|Overall Study|Disease Progression|12|||
27702328|NCT02464228|80748264|FG002|Overall Study|Disease Progression|5|||
27702329|NCT02464228|80748265|FG003|Overall Study|Disease Progression|2|||
27702330|NCT01555151|80748267|FG000|Overall Study|Withdrawal by Subject|6|||
27702331|NCT01555151|80748268|FG001|Overall Study|Withdrawal by Subject|2|||
27702332|NCT01555151|80748269|FG002|Overall Study|Withdrawal by Subject|0|||
27702333|NCT01555151|80748270|FG003|Overall Study|Withdrawal by Subject|2|||
27887182|NCT00565851|81422111|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
27597073|NCT02626780|80363350|FG000|Overall Study|Withdrawal by Subject|3|||
27597074|NCT04050865|80363356|FG000|Overall Study|Adverse Event|1|||
27597075|NCT04050865|80363357|FG001|Overall Study|Adverse Event|0|||
27597076|NCT04050865|80363356|FG000|Overall Study|no insert|1|||
27597077|NCT04050865|80363357|FG001|Overall Study|no insert|0|||
27597078|NCT04050865|80363356|FG000|Overall Study|Only 1 insert|2|||
27597079|NCT04050865|80363357|FG001|Overall Study|Only 1 insert|3|||
27597080|NCT04050865|80363356|FG000|Overall Study|Physician Decision|0|||
27597081|NCT04050865|80363357|FG001|Overall Study|Physician Decision|1|||
27597082|NCT04050865|80363356|FG000|Overall Study|Withdrawal by Subject|0|||
27597083|NCT04050865|80363357|FG001|Overall Study|Withdrawal by Subject|1|||
27597084|NCT04120233|80363361|FG000|Overall Study|Adverse Event|0|||
27597085|NCT04120233|80363362|FG001|Overall Study|Adverse Event|0|||
27597086|NCT04120233|80363363|FG002|Overall Study|Adverse Event|0|||
27597087|NCT04120233|80363364|FG003|Overall Study|Adverse Event|0|||
27597088|NCT04120233|80363365|FG004|Overall Study|Adverse Event|1|||
27597089|NCT04120233|80363366|FG005|Overall Study|Adverse Event|0|||
27597090|NCT00584727|80363367|FG000|First Intervention|Discontinuation|0|||
27597091|NCT00584727|80363368|FG001|First Intervention|Discontinuation|0|||
27597092|NCT00584727|80363369|FG002|First Intervention|Discontinuation|1|||
27597093|NCT00584727|80363370|FG003|First Intervention|Discontinuation|0|||
27597094|NCT00584727|80363371|FG004|First Intervention|Discontinuation|0|||
27597095|NCT00584727|80363372|FG005|First Intervention|Discontinuation|0|||
27597096|NCT00584727|80363367|FG000|Third Intervention|Protocol Violation|0|||
27597097|NCT00584727|80363368|FG001|Third Intervention|Protocol Violation|0|||
27597098|NCT00584727|80363369|FG002|Third Intervention|Protocol Violation|1|||
27597099|NCT00584727|80363370|FG003|Third Intervention|Protocol Violation|0|||
27597100|NCT00584727|80363371|FG004|Third Intervention|Protocol Violation|4|||
27597101|NCT00584727|80363372|FG005|Third Intervention|Protocol Violation|2|||
27597102|NCT03311373|80363373|FG000|Overall Study|Adverse Event|1|||
27702334|NCT01555151|80748267|FG000|Overall Study|Administrative|3|||
27702335|NCT01555151|80748268|FG001|Overall Study|Administrative|1|||
27702336|NCT01555151|80748269|FG002|Overall Study|Administrative|2|||
27702337|NCT01555151|80748270|FG003|Overall Study|Administrative|0|||
27702338|NCT01555151|80748267|FG000|Overall Study|Protocol Violation|3|||
27702339|NCT01555151|80748268|FG001|Overall Study|Protocol Violation|3|||
27702340|NCT01555151|80748269|FG002|Overall Study|Protocol Violation|3|||
27702341|NCT01555151|80748270|FG003|Overall Study|Protocol Violation|5|||
27702342|NCT01555151|80748267|FG000|Overall Study|Adverse Event|1|||
27702343|NCT01555151|80748268|FG001|Overall Study|Adverse Event|2|||
27702344|NCT01555151|80748269|FG002|Overall Study|Adverse Event|1|||
27702345|NCT01555151|80748270|FG003|Overall Study|Adverse Event|2|||
27702346|NCT01555151|80748267|FG000|Overall Study|Lost to Follow-up|0|||
27702347|NCT01555151|80748268|FG001|Overall Study|Lost to Follow-up|0|||
27959322|NCT02131662|81683273|FG004|Overall Study|Lack of Efficacy|1|||
27597103|NCT03311373|80363373|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
27597104|NCT03311373|80363373|FG000|Overall Study|Lost to Follow-up|1|||
27597105|NCT03311373|80363373|FG000|Overall Study|Physician Decision|1|||
27597106|NCT03311373|80363373|FG000|Overall Study|Withdrawal by Subject|3|||
27597107|NCT01239030|80363381|FG000|Double Blind|Adverse Event|0|||
27597108|NCT01239030|80363382|FG001|Double Blind|Adverse Event|1|||
27702348|NCT01555151|80748269|FG002|Overall Study|Lost to Follow-up|0|||
27702349|NCT01555151|80748270|FG003|Overall Study|Lost to Follow-up|1|||
27702350|NCT04275297|80748271|FG000|Overall Study|Lost to Follow-up|1|||
27597109|NCT01239030|80363383|FG002|Double Blind|Adverse Event|0|||
27597110|NCT01239030|80363384|FG003|Double Blind|Adverse Event|2|||
27702351|NCT04275297|80748272|FG001|Overall Study|Lost to Follow-up|1|||
27702352|NCT05093322|80748276|FG000|Overall Study|Death|6|||
27702353|NCT05093322|80748277|FG001|Overall Study|Death|2|||
27702354|NCT05093322|80748276|FG000|Overall Study|Other|4|||
27702355|NCT05093322|80748277|FG001|Overall Study|Other|1|||
27702356|NCT00607880|80748278|FG000|Overall Study|Unable to place port due to occlusion|1|||
27702357|NCT00607880|80748279|FG001|Overall Study|Unable to place port due to occlusion|0|||
27702358|NCT02966223|80748280|FG000|Overall Study|Physician Decision|3|||
27702359|NCT02966223|80748280|FG000|Overall Study|Withdrawal by Subject|11|||
27702360|NCT02966223|80748280|FG000|Overall Study|Lost to Follow-up|1|||
27702361|NCT02303704|80748283|FG000|Overall Study|Protocol Violation|5|||
27702362|NCT02303704|80748284|FG001|Overall Study|Protocol Violation|9|||
27702363|NCT01524133|80748285|FG000|Treatment Phase|Withdrawal by Subject|13|||
27702364|NCT01524133|80748286|FG001|Treatment Phase|Withdrawal by Subject|28|||
27702365|NCT01524133|80748287|FG002|Treatment Phase|Withdrawal by Subject|31|||
27702366|NCT01524133|80748285|FG000|Treatment Phase|Physician Decision|6|||
27702367|NCT01524133|80748286|FG001|Treatment Phase|Physician Decision|3|||
27702368|NCT01524133|80748287|FG002|Treatment Phase|Physician Decision|3|||
27702369|NCT01524133|80748285|FG000|Treatment Phase|Lost to Follow-up|0|||
27702370|NCT01524133|80748286|FG001|Treatment Phase|Lost to Follow-up|1|||
27702371|NCT01524133|80748287|FG002|Treatment Phase|Lost to Follow-up|2|||
27702372|NCT01524133|80748285|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
27702373|NCT01524133|80748286|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
27597111|NCT01239030|80363385|FG004|Double Blind|Adverse Event|0|||
27887183|NCT00565851|81422112|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
27597112|NCT01239030|80363381|FG000|Double Blind|Withdrawal by Subject|0|||
27702374|NCT01524133|80748287|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
27702375|NCT01524133|80748285|FG000|Overall Study 52 Weeks|Physician Decision|1|||
27702376|NCT01524133|80748286|FG001|Overall Study 52 Weeks|Physician Decision|0|||
27597113|NCT01239030|80363382|FG001|Double Blind|Withdrawal by Subject|1|||
27597114|NCT01239030|80363383|FG002|Double Blind|Withdrawal by Subject|1|||
27597115|NCT01239030|80363384|FG003|Double Blind|Withdrawal by Subject|0|||
27597116|NCT01239030|80363385|FG004|Double Blind|Withdrawal by Subject|1|||
27597117|NCT01239030|80363381|FG000|Double Blind|Lost to Follow-up|1|||
27597118|NCT01239030|80363382|FG001|Double Blind|Lost to Follow-up|1|||
27597119|NCT01239030|80363383|FG002|Double Blind|Lost to Follow-up|0|||
27597120|NCT01239030|80363384|FG003|Double Blind|Lost to Follow-up|0|||
27597121|NCT01239030|80363385|FG004|Double Blind|Lost to Follow-up|0|||
27597122|NCT01239030|80363381|FG000|Double Blind|Physician Decision|0|||
27597123|NCT01239030|80363382|FG001|Double Blind|Physician Decision|1|||
27597124|NCT01239030|80363383|FG002|Double Blind|Physician Decision|0|||
27597125|NCT01239030|80363384|FG003|Double Blind|Physician Decision|0|||
27597126|NCT01239030|80363385|FG004|Double Blind|Physician Decision|0|||
27597127|NCT01239030|80363381|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
27597128|NCT01239030|80363382|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
27597129|NCT01239030|80363383|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
27597130|NCT01239030|80363384|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
27597131|NCT01239030|80363385|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
27597132|NCT01239030|80363381|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
27597133|NCT01239030|80363382|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
27597134|NCT01239030|80363383|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
27597135|NCT01239030|80363384|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
27597136|NCT01239030|80363385|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
27597137|NCT01239030|80363381|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
27597138|NCT01239030|80363382|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
27597139|NCT01239030|80363383|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
27597140|NCT01239030|80363384|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
27597141|NCT01239030|80363385|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
27597142|NCT01239030|80363381|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
27597143|NCT01239030|80363382|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
27597144|NCT01239030|80363383|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
27597145|NCT01239030|80363384|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
27597146|NCT01239030|80363385|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
27597147|NCT01506193|80363386|FG000|Overall Study|Protocol Violation|1|||
27597148|NCT01506193|80363387|FG001|Overall Study|Protocol Violation|0|||
27597149|NCT01506193|80363388|FG002|Overall Study|Protocol Violation|1|||
27597150|NCT01506193|80363386|FG000|Overall Study|Migrated/moved from study area|0|||
27597151|NCT01506193|80363387|FG001|Overall Study|Migrated/moved from study area|0|||
27597152|NCT01506193|80363388|FG002|Overall Study|Migrated/moved from study area|1|||
27597153|NCT01506193|80363386|FG000|Overall Study|Adverse event, non-fatal|0|||
27597154|NCT01506193|80363387|FG001|Overall Study|Adverse event, non-fatal|0|||
27597155|NCT01506193|80363388|FG002|Overall Study|Adverse event, non-fatal|1|||
27702377|NCT01524133|80748287|FG002|Overall Study 52 Weeks|Physician Decision|2|||
27597156|NCT01506193|80363386|FG000|Overall Study|Withdrawal by Subject|5|||
27702378|NCT01524133|80748285|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
27702379|NCT01524133|80748286|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
27702380|NCT01524133|80748287|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
27702381|NCT02322229|80748290|FG000|Overall Study|Physician Decision|2|||
27702382|NCT01829360|80748295|FG000|Overall Study|Protocol Violation|0|||
27702383|NCT01829360|80748296|FG001|Overall Study|Protocol Violation|0|||
27702384|NCT01829360|80748297|FG002|Overall Study|Protocol Violation|1|||
27702385|NCT01829360|80748298|FG003|Overall Study|Protocol Violation|0|||
27702386|NCT00616434|80748299|FG000|Overall Study|Adverse Event|5|||
27702387|NCT00616434|80748300|FG001|Overall Study|Adverse Event|2|||
27702388|NCT00616434|80748299|FG000|Overall Study|Physician Decision|0|||
27702389|NCT00616434|80748300|FG001|Overall Study|Physician Decision|4|||
27702390|NCT00616434|80748299|FG000|Overall Study|Withdrawal by Subject|1|||
27702391|NCT00616434|80748300|FG001|Overall Study|Withdrawal by Subject|1|||
27702392|NCT00616434|80748299|FG000|Overall Study|Protocol deviation|0|||
27702393|NCT00616434|80748300|FG001|Overall Study|Protocol deviation|1|||
27702394|NCT00024167|80748305|FG000|Overall Study|Death|53|||
27597157|NCT01506193|80363387|FG001|Overall Study|Withdrawal by Subject|1|||
27597158|NCT01506193|80363388|FG002|Overall Study|Withdrawal by Subject|8|||
27597159|NCT01506193|80363386|FG000|Overall Study|Lost to Follow-up|8|||
27702395|NCT00024167|80748306|FG001|Overall Study|Death|47|||
27597160|NCT01506193|80363387|FG001|Overall Study|Lost to Follow-up|3|||
27597161|NCT01506193|80363388|FG002|Overall Study|Lost to Follow-up|3|||
27597162|NCT02192502|80363392|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
27597163|NCT02192502|80363393|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
27597164|NCT02192502|80363392|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
27702396|NCT01098812|80748309|FG000|Overall Study|Death|2|||
27702397|NCT01098812|80748310|FG001|Overall Study|Death|0|||
27702398|NCT01098812|80748311|FG002|Overall Study|Death|1|||
27887184|NCT00565851|81422113|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
27702399|NCT01098812|80748309|FG000|Overall Study|Lost to Follow-up|0|||
27702400|NCT01098812|80748310|FG001|Overall Study|Lost to Follow-up|1|||
27702401|NCT01098812|80748311|FG002|Overall Study|Lost to Follow-up|0|||
27702402|NCT03492554|80748312|FG000|Overall Study|Protocol Violation|0|||
27702403|NCT03492554|80748313|FG001|Overall Study|Protocol Violation|14|||
27702404|NCT01210690|80748314|FG000|Overall Study|Adverse Event|7|||
27702405|NCT01210690|80748314|FG000|Overall Study|Lack of Efficacy|12|||
27702406|NCT01210690|80748314|FG000|Overall Study|Lost to Follow-up|3|||
27702407|NCT01210690|80748314|FG000|Overall Study|Disease Remission|1|||
27702408|NCT01210690|80748314|FG000|Overall Study|Withdrawal by Subject|1|||
27702409|NCT01210690|80748314|FG000|Overall Study|Patient refused to swallow|1|||
27702410|NCT01210690|80748314|FG000|Overall Study|Patient could not take glucose|1|||
27702411|NCT00146757|80748315|FG000|Overall Study|Death|1|||
27833699|NCT01018862|81222595|FG000|Overall Study|Lost to Follow-up|3|||
27597165|NCT02192502|80363393|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
27597166|NCT02192502|80363392|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
27597167|NCT02192502|80363393|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
27597168|NCT00929162|80363398|FG000|Overall Study|Adverse Event|8|||
27597169|NCT00929162|80363399|FG001|Overall Study|Adverse Event|5|||
27597170|NCT00929162|80363398|FG000|Overall Study|Withdrawal by Subject|3|||
27597171|NCT00929162|80363399|FG001|Overall Study|Withdrawal by Subject|1|||
27702412|NCT00146757|80748316|FG001|Overall Study|Death|0|||
27702413|NCT00146757|80748315|FG000|Overall Study|Adverse Event|1|||
27833700|NCT01018862|81222596|FG001|Overall Study|Lost to Follow-up|1|||
27702414|NCT00146757|80748316|FG001|Overall Study|Adverse Event|0|||
27702415|NCT01910116|80748317|FG000|Overall Study|Adverse Event|0|||
27702416|NCT01910116|80748318|FG001|Overall Study|Adverse Event|3|||
27702417|NCT01910116|80748317|FG000|Overall Study|Lack of Efficacy|3|||
27702418|NCT01910116|80748318|FG001|Overall Study|Lack of Efficacy|4|||
27702419|NCT01910116|80748317|FG000|Overall Study|Lost to Follow-up|1|||
27702420|NCT01910116|80748318|FG001|Overall Study|Lost to Follow-up|0|||
27702421|NCT01910116|80748317|FG000|Overall Study|Protocol Violation|1|||
27702422|NCT01910116|80748318|FG001|Overall Study|Protocol Violation|2|||
27702423|NCT01910116|80748317|FG000|Overall Study|Withdrawal by Subject|8|||
27702424|NCT01910116|80748318|FG001|Overall Study|Withdrawal by Subject|3|||
27702425|NCT01910116|80748317|FG000|Overall Study|uncertain allocation|1|||
27702426|NCT01910116|80748318|FG001|Overall Study|uncertain allocation|3|||
27702427|NCT01910116|80748317|FG000|Overall Study|incomplete data|0|||
27702428|NCT01910116|80748318|FG001|Overall Study|incomplete data|1|||
27702429|NCT01704287|80748330|FG000|Initial Treatment Period|Death|139|||
27702430|NCT01704287|80748331|FG001|Initial Treatment Period|Death|129|||
27702431|NCT01704287|80748332|FG002|Initial Treatment Period|Death|71|||
27702432|NCT01704287|80748333|FG003|Initial Treatment Period|Death|0|||
27702433|NCT01704287|80748334|FG004|Initial Treatment Period|Death|0|||
27702434|NCT01704287|80748330|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
27702435|NCT01704287|80748331|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
27702436|NCT01704287|80748332|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
27702437|NCT01704287|80748333|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
27702438|NCT01704287|80748334|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
27702439|NCT01704287|80748330|FG000|Initial Treatment Period|Lost to Follow-up|5|||
27702440|NCT01704287|80748331|FG001|Initial Treatment Period|Lost to Follow-up|3|||
27702441|NCT01704287|80748332|FG002|Initial Treatment Period|Lost to Follow-up|0|||
27702442|NCT01704287|80748333|FG003|Initial Treatment Period|Lost to Follow-up|0|||
27702443|NCT01704287|80748334|FG004|Initial Treatment Period|Lost to Follow-up|0|||
27702444|NCT01704287|80748330|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
27702445|NCT01704287|80748331|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
27702446|NCT01704287|80748332|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
27702447|NCT01704287|80748333|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
27702448|NCT01704287|80748334|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
27702449|NCT01704287|80748330|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
27702450|NCT01704287|80748331|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
27702451|NCT01704287|80748332|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
27702452|NCT01704287|80748333|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
27702453|NCT01704287|80748334|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
27702454|NCT01704287|80748330|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
27702455|NCT01704287|80748331|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
27702456|NCT01704287|80748332|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
27702457|NCT01704287|80748333|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
27702458|NCT01704287|80748334|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
27702459|NCT01704287|80748330|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27702460|NCT01704287|80748331|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27702461|NCT01704287|80748332|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27702462|NCT01704287|80748333|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
27702463|NCT01704287|80748334|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
27702464|NCT04695392|80748335|FG000|Overall Study|Withdrawn by parent/guardian|0|||
27702465|NCT04695392|80748336|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27702466|NCT04695392|80748335|FG000|Overall Study|Withdrawn by physician|0|||
27702467|NCT04695392|80748336|FG001|Overall Study|Withdrawn by physician|1|||
27702468|NCT01301456|80748337|FG000|Stage 1|Withdrawal by Subject|0|||
27702469|NCT01301456|80748338|FG001|Stage 1|Withdrawal by Subject|0|||
27702470|NCT01301456|80748339|FG002|Stage 1|Withdrawal by Subject|1|||
27702471|NCT01301456|80748340|FG003|Stage 1|Withdrawal by Subject|0|||
27702472|NCT01301456|80748341|FG004|Stage 1|Withdrawal by Subject|1|||
27702473|NCT01301456|80748342|FG005|Stage 1|Withdrawal by Subject|0|||
27702474|NCT01301456|80748343|FG006|Stage 1|Withdrawal by Subject|0|||
27702475|NCT01301456|80748344|FG007|Stage 1|Withdrawal by Subject|0|||
27702476|NCT01301456|80748345|FG008|Stage 1|Withdrawal by Subject|0|||
27702477|NCT01301456|80748346|FG009|Stage 1|Withdrawal by Subject|0|||
27702478|NCT01301456|80748347|FG010|Stage 1|Withdrawal by Subject|0|||
27702479|NCT01301456|80748348|FG011|Stage 1|Withdrawal by Subject|0|||
27702480|NCT01301456|80748337|FG000|Stage 1|Randomized but not treated|0|||
27702481|NCT01301456|80748338|FG001|Stage 1|Randomized but not treated|0|||
27702482|NCT01301456|80748339|FG002|Stage 1|Randomized but not treated|0|||
27702483|NCT01301456|80748340|FG003|Stage 1|Randomized but not treated|0|||
27702484|NCT01301456|80748341|FG004|Stage 1|Randomized but not treated|0|||
27702485|NCT01301456|80748342|FG005|Stage 1|Randomized but not treated|0|||
27702486|NCT01301456|80748343|FG006|Stage 1|Randomized but not treated|1|||
27702487|NCT01301456|80748344|FG007|Stage 1|Randomized but not treated|0|||
27702488|NCT01301456|80748345|FG008|Stage 1|Randomized but not treated|0|||
27702489|NCT01301456|80748346|FG009|Stage 1|Randomized but not treated|0|||
27702490|NCT01301456|80748347|FG010|Stage 1|Randomized but not treated|0|||
27702491|NCT01301456|80748348|FG011|Stage 1|Randomized but not treated|0|||
27702492|NCT01301456|80748337|FG000|Stage 2|Adverse Event|0|||
27702493|NCT01301456|80748338|FG001|Stage 2|Adverse Event|0|||
27702494|NCT01301456|80748339|FG002|Stage 2|Adverse Event|0|||
27702495|NCT01301456|80748340|FG003|Stage 2|Adverse Event|0|||
27702496|NCT01301456|80748341|FG004|Stage 2|Adverse Event|0|||
27702497|NCT01301456|80748342|FG005|Stage 2|Adverse Event|0|||
27702498|NCT01301456|80748343|FG006|Stage 2|Adverse Event|0|||
27702499|NCT01301456|80748344|FG007|Stage 2|Adverse Event|0|||
27702500|NCT01301456|80748345|FG008|Stage 2|Adverse Event|0|||
27702501|NCT01301456|80748346|FG009|Stage 2|Adverse Event|0|||
27702502|NCT01301456|80748347|FG010|Stage 2|Adverse Event|1|||
27702503|NCT01301456|80748348|FG011|Stage 2|Adverse Event|0|||
27702504|NCT00727649|80748353|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
27702505|NCT00727649|80748354|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
27702506|NCT00727649|80748353|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
27702507|NCT00727649|80748354|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
27702508|NCT00727649|80748353|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
27702509|NCT00727649|80748354|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
27702510|NCT00727649|80748353|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
27702511|NCT00727649|80748354|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
27702512|NCT00727649|80748353|FG000|Second Intervention (4-weeks)|Death|1|||
27702513|NCT00727649|80748354|FG001|Second Intervention (4-weeks)|Death|0|||
27702514|NCT00727649|80748353|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
27702515|NCT00727649|80748354|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
27702516|NCT00727649|80748353|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
27702517|NCT00727649|80748354|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
27833701|NCT01018862|81222597|FG002|Overall Study|Lost to Follow-up|0|||
27833702|NCT01018862|81222595|FG000|Overall Study|Protocol Violation|1|||
27833703|NCT01018862|81222596|FG001|Overall Study|Protocol Violation|3|||
27833704|NCT01018862|81222597|FG002|Overall Study|Protocol Violation|3|||
27833705|NCT01018862|81222595|FG000|Overall Study|Withdrawal by Subject|1|||
27702518|NCT01205438|80748356|FG000|Overall Study|Adverse Event|19|||
27702519|NCT01205438|80748357|FG001|Overall Study|Adverse Event|17|||
27702520|NCT01205438|80748358|FG002|Overall Study|Adverse Event|24|||
27702521|NCT01205438|80748356|FG000|Overall Study|Death|1|||
27702522|NCT01205438|80748357|FG001|Overall Study|Death|1|||
27702523|NCT01205438|80748358|FG002|Overall Study|Death|3|||
27702524|NCT01205438|80748356|FG000|Overall Study|Entry Criteria Not Met|16|||
27702525|NCT01205438|80748357|FG001|Overall Study|Entry Criteria Not Met|15|||
27702526|NCT01205438|80748358|FG002|Overall Study|Entry Criteria Not Met|13|||
27702527|NCT01205438|80748356|FG000|Overall Study|Lack of Efficacy|14|||
27702528|NCT01205438|80748357|FG001|Overall Study|Lack of Efficacy|11|||
27702529|NCT01205438|80748358|FG002|Overall Study|Lack of Efficacy|14|||
27702530|NCT01205438|80748356|FG000|Overall Study|Lost to Follow-up|6|||
27702531|NCT01205438|80748357|FG001|Overall Study|Lost to Follow-up|7|||
27702532|NCT01205438|80748358|FG002|Overall Study|Lost to Follow-up|8|||
27702533|NCT01205438|80748356|FG000|Overall Study|Withdrawal by Subject|19|||
27702534|NCT01205438|80748357|FG001|Overall Study|Withdrawal by Subject|25|||
27702535|NCT01205438|80748358|FG002|Overall Study|Withdrawal by Subject|19|||
27702536|NCT01205438|80748356|FG000|Overall Study|Physician Decision|0|||
27702537|NCT01205438|80748357|FG001|Overall Study|Physician Decision|3|||
27702538|NCT01205438|80748358|FG002|Overall Study|Physician Decision|2|||
27702539|NCT01205438|80748356|FG000|Overall Study|Protocol Violation|2|||
27702540|NCT01205438|80748357|FG001|Overall Study|Protocol Violation|7|||
27702541|NCT01205438|80748358|FG002|Overall Study|Protocol Violation|4|||
27702542|NCT01205438|80748356|FG000|Overall Study|Sponsor Decision|0|||
27702543|NCT01205438|80748357|FG001|Overall Study|Sponsor Decision|1|||
27702544|NCT01205438|80748358|FG002|Overall Study|Sponsor Decision|1|||
27702545|NCT01708291|80748363|FG000|Overall Study|fighting|2|||
27702546|NCT01708291|80748364|FG001|Overall Study|fighting|1|||
27702547|NCT00239226|80748365|FG000|Overall Study|permAF during stabilization period|0|||
27702548|NCT00239226|80748366|FG001|Overall Study|permAF during stabilization period|0|||
27702549|NCT00239226|80748367|FG002|Overall Study|permAF during stabilization period|0|||
27702550|NCT00239226|80748368|FG003|Overall Study|permAF during stabilization period|3|||
27702551|NCT00239226|80748365|FG000|Overall Study|Lost to Follow-up|1|||
27702552|NCT00239226|80748366|FG001|Overall Study|Lost to Follow-up|0|||
27702553|NCT00239226|80748367|FG002|Overall Study|Lost to Follow-up|1|||
27702554|NCT00239226|80748368|FG003|Overall Study|Lost to Follow-up|0|||
27702555|NCT02818920|80748369|FG000|Overall Study|Unresectable|4|||
27702556|NCT02818920|80748369|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
27702557|NCT02818920|80748369|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
27702558|NCT02818920|80748369|FG000|Overall Study|Adverse Event|3|||
27702559|NCT02818920|80748369|FG000|Overall Study|Developed Other Disease|1|||
27702560|NCT02818920|80748369|FG000|Overall Study|Refused Further Treatment|1|||
27702561|NCT01235793|80748370|FG000|Overall Study|Death|6|||
27702562|NCT04166383|80748378|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
27702563|NCT04166383|80748378|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
27702564|NCT04166383|80748378|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
27702565|NCT00233363|80748389|FG000|Overall Study|Adverse Event|1|||
27702566|NCT00233363|80748390|FG001|Overall Study|Adverse Event|2|||
27702567|NCT00233363|80748389|FG000|Overall Study|Lack of Efficacy|0|||
27702568|NCT00233363|80748390|FG001|Overall Study|Lack of Efficacy|2|||
27702569|NCT00233363|80748389|FG000|Overall Study|Withdrawal by Subject|1|||
27702570|NCT00233363|80748390|FG001|Overall Study|Withdrawal by Subject|1|||
27702571|NCT00233363|80748389|FG000|Overall Study|Aggravation of complication|1|||
27702572|NCT00233363|80748390|FG001|Overall Study|Aggravation of complication|0|||
27702573|NCT00521053|80748391|FG000|Observation Phase|Disease Progression|55|||
27702574|NCT00521053|80748391|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
27702575|NCT00521053|80748391|FG000|Observation Phase|Death|2|||
27702576|NCT00521053|80748391|FG000|Observation Phase|Adverse Event|1|||
27702577|NCT00521053|80748391|FG000|Observation Phase|Other non-study melanoma treatment|1|||
27702578|NCT00521053|80748391|FG000|Observation Phase|Physician Decision|1|||
27702579|NCT00832117|80748392|FG000|Overall Study|Death|1|||
27702580|NCT00832117|80748392|FG000|Overall Study|Disease Progression|11|||
27702581|NCT00773136|80748400|FG000|Overall Study|Physician Decision|2|||
27702582|NCT00234494|80748408|FG000|Overall Study|Protocol Violation|2|||
27702583|NCT00865904|80748409|FG000|Overall Study|Randomized but not Treated|2|||
27702584|NCT00865904|80748410|FG001|Overall Study|Randomized but not Treated|0|||
27702585|NCT00865904|80748411|FG002|Overall Study|Randomized but not Treated|0|||
27702586|NCT00865904|80748412|FG003|Overall Study|Randomized but not Treated|1|||
27702587|NCT00865904|80748413|FG004|Overall Study|Randomized but not Treated|1|||
27702588|NCT01252810|80748414|FG000|Overall Study|Withdrawal by Subject|4|||
27702589|NCT01252810|80748415|FG001|Overall Study|Withdrawal by Subject|1|||
27702590|NCT01252810|80748414|FG000|Overall Study|Lost to Follow-up|0|||
27702591|NCT01252810|80748415|FG001|Overall Study|Lost to Follow-up|1|||
27702592|NCT01252810|80748414|FG000|Overall Study|Physician Decision|2|||
27702593|NCT01252810|80748415|FG001|Overall Study|Physician Decision|1|||
27702594|NCT01252810|80748414|FG000|Overall Study|Various reasons|8|||
27702595|NCT01252810|80748415|FG001|Overall Study|Various reasons|0|||
27702596|NCT01323621|80748416|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
27702597|NCT01323621|80748417|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
27702598|NCT01323621|80748418|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
27702599|NCT01323621|80748416|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
27702600|NCT01323621|80748417|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
27702601|NCT01323621|80748418|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
27702602|NCT01323621|80748416|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
27702603|NCT01323621|80748417|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
27702604|NCT01323621|80748418|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
27702605|NCT01323621|80748416|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
27702606|NCT01323621|80748417|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
27702607|NCT01323621|80748418|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
27702608|NCT01323621|80748416|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
27702609|NCT01323621|80748417|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
27702610|NCT01323621|80748418|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
27702611|NCT01323621|80748416|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
27702612|NCT01323621|80748417|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
27702613|NCT01323621|80748418|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
27702614|NCT01323621|80748416|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
27702615|NCT01323621|80748417|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
27702616|NCT01323621|80748418|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
27702617|NCT01323621|80748416|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27702618|NCT01323621|80748417|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
27702619|NCT01323621|80748418|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
27702620|NCT01323621|80748416|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
27702621|NCT01323621|80748417|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
27702622|NCT01323621|80748418|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
27702623|NCT01323621|80748416|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27702624|NCT01323621|80748417|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27702625|NCT01323621|80748418|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27702626|NCT01323621|80748416|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
27702627|NCT01323621|80748417|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
27702628|NCT01323621|80748418|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
27702629|NCT01323621|80748416|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27702630|NCT01323621|80748417|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
27702631|NCT01323621|80748418|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
27702632|NCT02113579|80748419|FG000|Overall Study|Adverse Event|1|||
27702633|NCT02113579|80748420|FG001|Overall Study|Adverse Event|0|||
27702634|NCT02113579|80748419|FG000|Overall Study|Withdrawal by Subject|3|||
27702635|NCT02113579|80748420|FG001|Overall Study|Withdrawal by Subject|2|||
27702636|NCT02113579|80748419|FG000|Overall Study|Lost to Follow-up|6|||
27702637|NCT02113579|80748420|FG001|Overall Study|Lost to Follow-up|2|||
27702638|NCT00726622|80748421|FG000|Overall Study|Withdrawal by Subject|16|||
27702639|NCT00726622|80748422|FG001|Overall Study|Withdrawal by Subject|2|||
27702640|NCT00726622|80748421|FG000|Overall Study|Physician Decision|0|||
27702641|NCT00726622|80748422|FG001|Overall Study|Physician Decision|1|||
27702642|NCT00726622|80748421|FG000|Overall Study|Metastasis|2|||
27702643|NCT00726622|80748422|FG001|Overall Study|Metastasis|0|||
27702644|NCT00908583|80748423|FG000|Phase 1|Withdrawal by Subject|1|||
27702645|NCT00908583|80748423|FG000|Phase 1|Adverse Event|4|||
27702646|NCT00908583|80748423|FG000|Phase 2|Physician Decision|1|||
27702647|NCT00908583|80748423|FG000|Phase 2|Adverse Event|1|||
27702648|NCT00908583|80748423|FG000|Phase 3|Adverse Event|2|||
27702649|NCT00908583|80748423|FG000|Phase 4|Adverse Event|1|||
27702650|NCT00908583|80748423|FG000|Phase 4|Physician Decision|1|||
27702651|NCT00908583|80748423|FG000|Phase 5|Adverse Event|3|||
27702652|NCT01472380|80748426|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
27702653|NCT01472380|80748426|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
27702654|NCT00385203|80748430|FG000|Overall Study|Adverse Event|5|||
27702655|NCT00385203|80748431|FG001|Overall Study|Adverse Event|4|||
27702656|NCT00385203|80748430|FG000|Overall Study|Death|1|||
27702657|NCT00385203|80748431|FG001|Overall Study|Death|0|||
27702658|NCT00385203|80748430|FG000|Overall Study|Condition under investigation worsened|18|||
27702659|NCT00385203|80748431|FG001|Overall Study|Condition under investigation worsened|3|||
27702660|NCT00385203|80748430|FG000|Overall Study|Incorrect enrollment|2|||
27702661|NCT00385203|80748431|FG001|Overall Study|Incorrect enrollment|0|||
27702662|NCT00404066|80748434|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
27702663|NCT00404066|80748434|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
27702664|NCT00088907|80748435|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
27887185|NCT00565851|81422114|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
27702665|NCT00088907|80748436|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
27702666|NCT00088907|80748435|FG000|Randomized Study (Step 1)|Adverse Event|14|||
27702667|NCT00088907|80748436|FG001|Randomized Study (Step 1)|Adverse Event|19|||
27702668|NCT00088907|80748435|FG000|Randomized Study (Step 1)|Death|11|||
27702669|NCT00088907|80748436|FG001|Randomized Study (Step 1)|Death|12|||
27702670|NCT00088907|80748435|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
27702671|NCT00088907|80748436|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
27702672|NCT00088907|80748435|FG000|Randomized Study (Step 1)|complicating disease|3|||
27702673|NCT00088907|80748436|FG001|Randomized Study (Step 1)|complicating disease|1|||
27702674|NCT00088907|80748435|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
27702675|NCT00088907|80748436|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
27702676|NCT00088907|80748435|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
27702677|NCT00088907|80748436|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
27702678|NCT00088907|80748435|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
27702679|NCT00088907|80748436|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
27702680|NCT00088907|80748435|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
27702681|NCT00088907|80748436|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
27702682|NCT00088907|80748435|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
27702683|NCT00088907|80748436|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
27702684|NCT00088907|80748435|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
27702685|NCT00088907|80748436|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
27702686|NCT01177384|80748437|FG000|Overall Study|Adverse Event|6|||
27702687|NCT01177384|80748438|FG001|Overall Study|Adverse Event|4|||
27702688|NCT01177384|80748437|FG000|Overall Study|Lack of Efficacy|0|||
27702689|NCT01177384|80748438|FG001|Overall Study|Lack of Efficacy|1|||
27702690|NCT01177384|80748437|FG000|Overall Study|Lost to Follow-up|3|||
27702691|NCT01177384|80748438|FG001|Overall Study|Lost to Follow-up|4|||
27702692|NCT01177384|80748437|FG000|Overall Study|Physician Decision|0|||
27702693|NCT01177384|80748438|FG001|Overall Study|Physician Decision|3|||
27702694|NCT01177384|80748437|FG000|Overall Study|Protocol Violation|0|||
27702695|NCT01177384|80748438|FG001|Overall Study|Protocol Violation|2|||
27702696|NCT01177384|80748437|FG000|Overall Study|Withdrawal by Subject|5|||
27702697|NCT01177384|80748438|FG001|Overall Study|Withdrawal by Subject|12|||
27702698|NCT00545402|80751452|FG000|Overall Study|Discontinuation of treatment|17|||
27702699|NCT00545402|80751453|FG001|Overall Study|Discontinuation of treatment|9|||
27702700|NCT00545402|80751452|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
27702701|NCT00545402|80751453|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
27702702|NCT00545402|80751452|FG000|Overall Study|Death|5|||
27702703|NCT00545402|80751453|FG001|Overall Study|Death|7|||
27702704|NCT00545402|80751452|FG000|Overall Study|Graft loss|2|||
27702705|NCT00545402|80751453|FG001|Overall Study|Graft loss|4|||
27702706|NCT00545402|80751452|FG000|Overall Study|Withdrawal by Subject|0|||
27702707|NCT00545402|80751453|FG001|Overall Study|Withdrawal by Subject|1|||
27702708|NCT00545402|80751452|FG000|Overall Study|Protocol Violation|1|||
27702709|NCT00545402|80751453|FG001|Overall Study|Protocol Violation|0|||
27702710|NCT00545402|80751452|FG000|Overall Study|Reason not specified|1|||
27702711|NCT00545402|80751453|FG001|Overall Study|Reason not specified|1|||
27702712|NCT01849497|80751456|FG000|Overall Study|Withdrawal by Subject|1|||
27702713|NCT01849497|80751457|FG001|Overall Study|Withdrawal by Subject|2|||
27702714|NCT01849497|80751456|FG000|Overall Study|Sponsor Decision|0|||
27702715|NCT01849497|80751457|FG001|Overall Study|Sponsor Decision|1|||
27702716|NCT01849497|80751456|FG000|Overall Study|Lost to Follow-up|0|||
27702717|NCT01849497|80751457|FG001|Overall Study|Lost to Follow-up|1|||
27702718|NCT03829241|80751462|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
27702719|NCT03829241|80751463|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
27702720|NCT03829241|80751462|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
27702721|NCT03829241|80751463|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
27702722|NCT03829241|80751462|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
27702723|NCT03829241|80751463|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
27702724|NCT03829241|80751462|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
27702725|NCT03829241|80751463|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
27702726|NCT03829241|80751462|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
27702727|NCT03829241|80751463|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
27702728|NCT03829241|80751462|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
27702729|NCT03829241|80751463|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
27702730|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
27702731|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
27702732|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
27702733|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
27702734|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
27702735|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
27833706|NCT01018862|81222596|FG001|Overall Study|Withdrawal by Subject|2|||
27833707|NCT01018862|81222597|FG002|Overall Study|Withdrawal by Subject|1|||
27702736|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
27702737|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
27702738|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
27833708|NCT01018862|81222595|FG000|Overall Study|administrative problems|5|||
27702739|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
27702740|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
27702741|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
27702742|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
27702743|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
27702744|NCT03829241|80751462|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
27702745|NCT03829241|80751463|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
27702746|NCT02378220|80751464|FG000|Overall Study|Death|6|||
27702747|NCT02378220|80751465|FG001|Overall Study|Death|1|||
27702748|NCT02689284|80751466|FG000|Overall Study|Adverse Event|1|||
27702749|NCT02689284|80751467|FG001|Overall Study|Adverse Event|8|||
27702750|NCT02689284|80751466|FG000|Overall Study|Death|0|||
27702751|NCT02689284|80751467|FG001|Overall Study|Death|1|||
27702752|NCT02689284|80751466|FG000|Overall Study|Physician Decision|1|||
27702753|NCT02689284|80751467|FG001|Overall Study|Physician Decision|2|||
27702754|NCT02689284|80751466|FG000|Overall Study|Withdrawal by Subject|0|||
27702755|NCT02689284|80751467|FG001|Overall Study|Withdrawal by Subject|1|||
27702756|NCT02689284|80751466|FG000|Overall Study|progression of cancer|1|||
27702757|NCT02689284|80751467|FG001|Overall Study|progression of cancer|72|||
27702758|NCT02689284|80751466|FG000|Overall Study|decreased heart function|0|||
27702759|NCT02689284|80751467|FG001|Overall Study|decreased heart function|1|||
27702760|NCT02689284|80751466|FG000|Overall Study|concern for anemia|0|||
27702761|NCT02689284|80751467|FG001|Overall Study|concern for anemia|1|||
27702762|NCT02689284|80751466|FG000|Overall Study|no measurable cancer for evaluation|0|||
27702763|NCT02689284|80751467|FG001|Overall Study|no measurable cancer for evaluation|1|||
27702764|NCT03426787|80751468|FG000|Overall Study|Withdrawal by Subject|6|||
27702765|NCT03426787|80751468|FG000|Overall Study|Lost to Follow-up|7|||
27887186|NCT00565851|81422115|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
27702766|NCT03426787|80751468|FG000|Overall Study|Unrelated to intervention death|1|||
27702767|NCT01105091|80751469|FG000|Overall Study|Death|2|||
27702768|NCT01105091|80751470|FG001|Overall Study|Death|0|||
27702769|NCT00911625|80751471|FG000|Overall Study|Lost to Follow-up|7|||
27702770|NCT00911625|80751472|FG001|Overall Study|Lost to Follow-up|0|||
27887187|NCT00565851|81422108|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
27702771|NCT00381563|80751476|FG000|Overall Study|Withdrawal by Subject|5|||
27702772|NCT00381563|80751477|FG001|Overall Study|Withdrawal by Subject|5|||
27597172|NCT00929162|80363398|FG000|Overall Study|Protocol Violation|32|||
27597173|NCT00929162|80363399|FG001|Overall Study|Protocol Violation|30|||
27702773|NCT00381563|80751476|FG000|Overall Study|Lost to Follow-up|2|||
27702774|NCT00381563|80751477|FG001|Overall Study|Lost to Follow-up|0|||
27702775|NCT00381563|80751476|FG000|Overall Study|Protocol Violation|0|||
27702776|NCT00381563|80751477|FG001|Overall Study|Protocol Violation|1|||
27702777|NCT04784897|80751479|FG000|Overall Study|Death|4|||
27702778|NCT04784897|80751480|FG001|Overall Study|Death|2|||
27702779|NCT04784897|80751481|FG002|Overall Study|Death|1|||
27702780|NCT04784897|80751479|FG000|Overall Study|Withdrawal by Subject|0|||
27702781|NCT04784897|80751480|FG001|Overall Study|Withdrawal by Subject|0|||
27702782|NCT04784897|80751481|FG002|Overall Study|Withdrawal by Subject|1|||
27702783|NCT02247960|80751486|FG000|Patient Consent and Randomization|Physician Decision|2|||
27702784|NCT02247960|80751487|FG001|Patient Consent and Randomization|Physician Decision|2|||
27702785|NCT02247960|80751486|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
27702786|NCT02247960|80751487|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
27702787|NCT02247960|80751486|FG000|Catheter Removed|Lost to Follow-up|7|||
27702788|NCT02247960|80751487|FG001|Catheter Removed|Lost to Follow-up|10|||
27702789|NCT01237340|80751488|FG000|Overall Study|Adverse Event|3|||
27702790|NCT01237340|80751488|FG000|Overall Study|Withdrawal by Subject|1|||
27702791|NCT01237340|80751488|FG000|Overall Study|Early termination of the trial|36|||
27702792|NCT01122576|80751493|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
27702793|NCT01122576|80751494|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
27702794|NCT01122576|80751495|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
27702795|NCT01122576|80751493|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
27702796|NCT01122576|80751494|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
27702797|NCT01122576|80751495|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
27702798|NCT01122576|80751493|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
27702799|NCT01122576|80751494|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
27702800|NCT01122576|80751495|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
27702801|NCT00041080|80751496|FG000|Overall Study|Adverse Event|21|||
27702802|NCT00041080|80751497|FG001|Overall Study|Adverse Event|1|||
27702803|NCT00041080|80751496|FG000|Overall Study|Withdrawal by Subject|6|||
27702804|NCT00041080|80751497|FG001|Overall Study|Withdrawal by Subject|6|||
27702805|NCT00041080|80751496|FG000|Overall Study|Concommitant Illness/Other|1|||
27702806|NCT00041080|80751497|FG001|Overall Study|Concommitant Illness/Other|2|||
27702807|NCT00041080|80751496|FG000|Overall Study|Did not start therapy|1|||
27702808|NCT00041080|80751497|FG001|Overall Study|Did not start therapy|1|||
27702809|NCT00041080|80751496|FG000|Overall Study|Ineligible|1|||
27702810|NCT00041080|80751497|FG001|Overall Study|Ineligible|0|||
27702811|NCT00894686|80751498|FG000|Overall Study|Withdrawal by Subject|50|||
27702812|NCT00894686|80751498|FG000|Overall Study|Physician Decision|1|||
27702813|NCT00894686|80751498|FG000|Overall Study|Other|5|||
27702814|NCT04042740|80751499|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
27702815|NCT04042740|80751499|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
27702816|NCT01117454|80751500|FG000|Overall Study|Pregnancy|0|||
27702817|NCT01117454|80751501|FG001|Overall Study|Pregnancy|1|||
27702818|NCT02973087|80751502|FG000|Overall Study|Withdrawal by Subject|2|||
27702819|NCT02973087|80751503|FG001|Overall Study|Withdrawal by Subject|1|||
27702820|NCT02973087|80751502|FG000|Overall Study|Adverse Event|1|||
27702821|NCT02973087|80751503|FG001|Overall Study|Adverse Event|0|||
27702822|NCT02973087|80751502|FG000|Overall Study|other|1|||
27702823|NCT02973087|80751503|FG001|Overall Study|other|1|||
27702824|NCT01438151|80751504|FG000|Overall Study|study terminated|8|||
27702825|NCT02224599|80751509|FG000|Overall Study|Physician Decision|1|||
27702826|NCT02224599|80751509|FG000|Overall Study|Progression of Disease|1|||
27702827|NCT01794520|80751510|FG000|Overall Study|Adverse events- related to progression|0|||
27702828|NCT01794520|80751511|FG001|Overall Study|Adverse events- related to progression|0|||
27702829|NCT01794520|80751512|FG002|Overall Study|Adverse events- related to progression|1|||
27702830|NCT01794520|80751513|FG003|Overall Study|Adverse events- related to progression|2|||
27702831|NCT01794520|80751514|FG004|Overall Study|Adverse events- related to progression|0|||
27702832|NCT01794520|80751515|FG005|Overall Study|Adverse events- related to progression|1|||
27702833|NCT01794520|80751516|FG006|Overall Study|Adverse events- related to progression|0|||
27702834|NCT01794520|80751510|FG000|Overall Study|Adverse event- not related to progression|1|||
27702835|NCT01794520|80751511|FG001|Overall Study|Adverse event- not related to progression|1|||
27702836|NCT01794520|80751512|FG002|Overall Study|Adverse event- not related to progression|0|||
27702837|NCT01794520|80751513|FG003|Overall Study|Adverse event- not related to progression|0|||
27702838|NCT01794520|80751514|FG004|Overall Study|Adverse event- not related to progression|2|||
27702839|NCT01794520|80751515|FG005|Overall Study|Adverse event- not related to progression|0|||
27702840|NCT01794520|80751516|FG006|Overall Study|Adverse event- not related to progression|0|||
27702841|NCT01794520|80751510|FG000|Overall Study|Progressive disease|5|||
27702842|NCT01794520|80751511|FG001|Overall Study|Progressive disease|6|||
27597174|NCT00929162|80363398|FG000|Overall Study|Other termination reason|5|||
27887188|NCT00565851|81422109|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
27887189|NCT00565851|81422110|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
27887190|NCT00565851|81422111|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
27887191|NCT00565851|81422112|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
27887192|NCT00565851|81422113|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
27887193|NCT00565851|81422114|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
27887194|NCT00565851|81422115|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
27887195|NCT02137850|81422126|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
27887196|NCT02137850|81422127|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
27887197|NCT02137850|81422128|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
27887198|NCT02137850|81422126|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
27887199|NCT02137850|81422127|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
27887200|NCT02137850|81422128|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
27887201|NCT02137850|81422126|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
27887202|NCT02137850|81422127|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
27887203|NCT02137850|81422128|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
27887204|NCT02137850|81422126|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
27887205|NCT02137850|81422127|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
27887206|NCT02137850|81422128|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
27887207|NCT02137850|81422126|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
27887208|NCT02137850|81422127|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
27887209|NCT02137850|81422128|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
27887210|NCT02137850|81422126|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
27887211|NCT02137850|81422127|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
27887212|NCT02137850|81422128|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
27887213|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
27887214|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
27887215|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
27887216|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
27887217|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
27887218|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
27887219|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
27887220|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
27887221|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
27887222|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
27702843|NCT01794520|80751512|FG002|Overall Study|Progressive disease|2|||
27702844|NCT01794520|80751513|FG003|Overall Study|Progressive disease|5|||
27702845|NCT01794520|80751514|FG004|Overall Study|Progressive disease|27|||
27702846|NCT01794520|80751515|FG005|Overall Study|Progressive disease|18|||
27702847|NCT01794520|80751516|FG006|Overall Study|Progressive disease|0|||
27702848|NCT01794520|80751510|FG000|Overall Study|Withdrew consent|0|||
27702849|NCT01794520|80751511|FG001|Overall Study|Withdrew consent|0|||
27702850|NCT01794520|80751512|FG002|Overall Study|Withdrew consent|1|||
27702851|NCT01794520|80751513|FG003|Overall Study|Withdrew consent|1|||
27702852|NCT01794520|80751514|FG004|Overall Study|Withdrew consent|0|||
27702853|NCT01794520|80751515|FG005|Overall Study|Withdrew consent|0|||
27702854|NCT01794520|80751516|FG006|Overall Study|Withdrew consent|0|||
27702855|NCT01794520|80751510|FG000|Overall Study|Lost to Follow-up|0|||
27702856|NCT01794520|80751511|FG001|Overall Study|Lost to Follow-up|0|||
27702857|NCT01794520|80751512|FG002|Overall Study|Lost to Follow-up|0|||
27702858|NCT01794520|80751513|FG003|Overall Study|Lost to Follow-up|0|||
27702859|NCT01794520|80751514|FG004|Overall Study|Lost to Follow-up|1|||
27702860|NCT01794520|80751515|FG005|Overall Study|Lost to Follow-up|0|||
27702861|NCT01794520|80751516|FG006|Overall Study|Lost to Follow-up|0|||
27702862|NCT01794520|80751510|FG000|Overall Study|Toxicity|0|||
27702863|NCT01794520|80751511|FG001|Overall Study|Toxicity|2|||
27702864|NCT01794520|80751512|FG002|Overall Study|Toxicity|0|||
27702865|NCT01794520|80751513|FG003|Overall Study|Toxicity|0|||
27702866|NCT01794520|80751514|FG004|Overall Study|Toxicity|0|||
27702867|NCT01794520|80751515|FG005|Overall Study|Toxicity|0|||
27702868|NCT01794520|80751516|FG006|Overall Study|Toxicity|0|||
27702869|NCT01794520|80751510|FG000|Overall Study|Study terminated by sponsor|0|||
27702870|NCT01794520|80751511|FG001|Overall Study|Study terminated by sponsor|0|||
27702871|NCT01794520|80751512|FG002|Overall Study|Study terminated by sponsor|1|||
27702872|NCT01794520|80751513|FG003|Overall Study|Study terminated by sponsor|0|||
27702873|NCT01794520|80751514|FG004|Overall Study|Study terminated by sponsor|1|||
27887223|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
27887224|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
27887225|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Other|0|||
27887226|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Other|1|||
27702874|NCT01794520|80751515|FG005|Overall Study|Study terminated by sponsor|0|||
27702875|NCT01794520|80751516|FG006|Overall Study|Study terminated by sponsor|7|||
27702876|NCT01794520|80751510|FG000|Overall Study|Death|0|||
27702877|NCT01794520|80751511|FG001|Overall Study|Death|0|||
27702878|NCT01794520|80751512|FG002|Overall Study|Death|0|||
27702879|NCT01794520|80751513|FG003|Overall Study|Death|0|||
27702880|NCT01794520|80751514|FG004|Overall Study|Death|1|||
27702881|NCT01794520|80751515|FG005|Overall Study|Death|0|||
27702882|NCT01794520|80751516|FG006|Overall Study|Death|22|||
27702883|NCT01794520|80751510|FG000|Overall Study|Other, not specified|0|||
27702884|NCT01794520|80751511|FG001|Overall Study|Other, not specified|0|||
27702885|NCT01794520|80751512|FG002|Overall Study|Other, not specified|1|||
27702886|NCT01794520|80751513|FG003|Overall Study|Other, not specified|1|||
27702887|NCT01794520|80751514|FG004|Overall Study|Other, not specified|4|||
27702888|NCT01794520|80751515|FG005|Overall Study|Other, not specified|1|||
27702889|NCT01794520|80751516|FG006|Overall Study|Other, not specified|2|||
27702890|NCT00709111|80751517|FG000|Overall Study|Withdrawal by Subject|1|||
27702891|NCT00709111|80751517|FG000|Overall Study|Unable to attend clinic visits|1|||
27833709|NCT01018862|81222596|FG001|Overall Study|administrative problems|4|||
27833710|NCT01018862|81222597|FG002|Overall Study|administrative problems|4|||
27833711|NCT00487695|81222598|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
27597175|NCT00929162|80363399|FG001|Overall Study|Other termination reason|6|||
27702892|NCT01383096|80751518|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
27833712|NCT00487695|81222599|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
27833713|NCT00487695|81222598|FG000|First Procedure|active wheezing (did not have procedure)|1|||
27833714|NCT00487695|81222599|FG001|First Procedure|active wheezing (did not have procedure)|0|||
27597176|NCT00763958|80363400|FG000|Overall Study|did not meet final criteria|4|||
27597177|NCT00763958|80363401|FG001|Overall Study|did not meet final criteria|4|||
27702893|NCT01383096|80751519|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
27833715|NCT00487695|81222598|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
27597178|NCT00763958|80363400|FG000|Overall Study|Lost to Follow-up|10|||
27597179|NCT00763958|80363401|FG001|Overall Study|Lost to Follow-up|2|||
27597180|NCT00763958|80363400|FG000|Overall Study|Believed they were receiving placebo|0|||
27597181|NCT00763958|80363401|FG001|Overall Study|Believed they were receiving placebo|5|||
27597182|NCT03318523|80363402|FG000|PC Period: Up to Year 1|Adverse Event|1|||
27597183|NCT03318523|80363403|FG001|PC Period: Up to Year 1|Adverse Event|0|||
27597184|NCT03318523|80363404|FG002|PC Period: Up to Year 1|Adverse Event|2|||
27597185|NCT03318523|80363405|FG003|PC Period: Up to Year 1|Adverse Event|0|||
27597186|NCT03318523|80363406|FG004|PC Period: Up to Year 1|Adverse Event|0|||
27597187|NCT03318523|80363407|FG005|PC Period: Up to Year 1|Adverse Event|0|||
27597188|NCT03318523|80363408|FG006|PC Period: Up to Year 1|Adverse Event|0|||
27597189|NCT03318523|80363409|FG007|PC Period: Up to Year 1|Adverse Event|0|||
27597190|NCT03318523|80363410|FG008|PC Period: Up to Year 1|Adverse Event|0|||
27597191|NCT03318523|80363411|FG009|PC Period: Up to Year 1|Adverse Event|0|||
27597192|NCT03318523|80363402|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
27702894|NCT01383096|80751520|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
27702895|NCT01383096|80751518|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
27702896|NCT01383096|80751519|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
27833716|NCT00487695|81222599|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
27833717|NCT00487695|81222598|FG000|Second Procedure|active wheezing|0|||
27833718|NCT00487695|81222599|FG001|Second Procedure|active wheezing|1|||
27833719|NCT00487695|81222598|FG000|Second Procedure|Withdrawal by Subject|1|||
27833720|NCT00487695|81222599|FG001|Second Procedure|Withdrawal by Subject|2|||
27833721|NCT01426854|81222600|FG000|Overall Study|Adverse Event|1|||
27833722|NCT01426854|81222601|FG001|Overall Study|Adverse Event|5|||
27833723|NCT01426854|81222600|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
27833724|NCT01426854|81222601|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
27833725|NCT01426854|81222600|FG000|Overall Study|Lost to Follow-up|3|||
27833726|NCT01426854|81222601|FG001|Overall Study|Lost to Follow-up|0|||
27833727|NCT01426854|81222600|FG000|Overall Study|Noncompliance|0|||
27833728|NCT01426854|81222601|FG001|Overall Study|Noncompliance|1|||
27833729|NCT01426854|81222600|FG000|Overall Study|Treatment Failure|0|||
27833730|NCT01426854|81222601|FG001|Overall Study|Treatment Failure|16|||
27833731|NCT01426854|81222600|FG000|Overall Study|Protocol Deviation|0|||
27833732|NCT01426854|81222601|FG001|Overall Study|Protocol Deviation|1|||
27833733|NCT01426854|81222600|FG000|Overall Study|Other|3|||
27833734|NCT01426854|81222601|FG001|Overall Study|Other|2|||
27833735|NCT00420095|81222604|FG000|Overall Study|Adverse Event|1|||
27833736|NCT00420095|81222605|FG001|Overall Study|Adverse Event|0|||
27833737|NCT00420095|81222604|FG000|Overall Study|Protocol Violation|1|||
27833738|NCT00420095|81222605|FG001|Overall Study|Protocol Violation|1|||
27833739|NCT00420095|81222604|FG000|Overall Study|Lost to Follow-up|1|||
27833740|NCT00420095|81222605|FG001|Overall Study|Lost to Follow-up|0|||
27833741|NCT01442376|81222608|FG000|Overall Study|Adverse Event|0|||
27833742|NCT01442376|81222609|FG001|Overall Study|Adverse Event|3|||
27833743|NCT01442376|81222610|FG002|Overall Study|Adverse Event|2|||
27833744|NCT01442376|81222608|FG000|Overall Study|Death|0|||
27833745|NCT01442376|81222609|FG001|Overall Study|Death|1|||
27833746|NCT01442376|81222610|FG002|Overall Study|Death|1|||
27833747|NCT01442376|81222608|FG000|Overall Study|Withdrawal of consent|0|||
27597193|NCT03318523|80363403|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
27597194|NCT03318523|80363404|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597195|NCT03318523|80363405|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
27833748|NCT01442376|81222609|FG001|Overall Study|Withdrawal of consent|0|||
27597196|NCT03318523|80363406|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597197|NCT03318523|80363407|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597198|NCT03318523|80363408|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597199|NCT03318523|80363409|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597200|NCT03318523|80363410|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597201|NCT03318523|80363411|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
27597202|NCT03318523|80363402|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27597203|NCT03318523|80363403|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27597204|NCT03318523|80363404|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27597205|NCT03318523|80363405|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27833749|NCT01442376|81222610|FG002|Overall Study|Withdrawal of consent|1|||
27833750|NCT01442376|81222608|FG000|Overall Study|Patients not treated|2|||
27597206|NCT03318523|80363406|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
27833751|NCT01442376|81222609|FG001|Overall Study|Patients not treated|3|||
27597207|NCT03318523|80363407|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27597208|NCT03318523|80363408|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27597209|NCT03318523|80363409|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
27597210|NCT03318523|80363410|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
27597211|NCT03318523|80363411|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
27597212|NCT03318523|80363402|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27597213|NCT03318523|80363403|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27597214|NCT03318523|80363404|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27597215|NCT03318523|80363405|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27597216|NCT03318523|80363406|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
27597217|NCT03318523|80363407|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27597218|NCT03318523|80363408|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
27597219|NCT03318523|80363409|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
27597220|NCT03318523|80363410|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
27597221|NCT03318523|80363411|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
27597222|NCT03318523|80363402|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597223|NCT03318523|80363403|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597224|NCT03318523|80363404|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597225|NCT03318523|80363405|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597226|NCT03318523|80363406|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597227|NCT03318523|80363407|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
27597228|NCT03318523|80363408|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597229|NCT03318523|80363409|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597230|NCT03318523|80363410|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27702897|NCT01383096|80751520|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
27702898|NCT01383096|80751518|FG000|Third Intervention (8 Days)|Elevated AST|0|||
27702899|NCT01383096|80751519|FG001|Third Intervention (8 Days)|Elevated AST|1|||
27597231|NCT03318523|80363411|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
27597232|NCT03318523|80363402|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597233|NCT03318523|80363403|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597234|NCT03318523|80363404|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597235|NCT03318523|80363405|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597236|NCT03318523|80363406|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597237|NCT03318523|80363407|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597238|NCT03318523|80363408|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597239|NCT03318523|80363409|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597240|NCT03318523|80363410|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
27597241|NCT03318523|80363411|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
27597242|NCT03318523|80363402|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27597243|NCT03318523|80363403|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27597244|NCT03318523|80363404|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27597245|NCT03318523|80363405|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
27597246|NCT03318523|80363406|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
27597247|NCT03318523|80363407|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
27597248|NCT03318523|80363408|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
27597249|NCT03318523|80363409|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
27597250|NCT03318523|80363410|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
27597251|NCT03318523|80363411|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
27597252|NCT03318523|80363402|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27597253|NCT03318523|80363403|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27702900|NCT01383096|80751520|FG002|Third Intervention (8 Days)|Elevated AST|0|||
27597254|NCT03318523|80363404|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27754802|NCT01104558|80929587|FG000|Overall Study|Missing of genetic analysis results|1|||
27597255|NCT03318523|80363405|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27597256|NCT03318523|80363406|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
27597257|NCT03318523|80363407|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27597258|NCT03318523|80363408|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27597259|NCT03318523|80363409|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
27597260|NCT03318523|80363410|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
27597261|NCT03318523|80363411|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
27597262|NCT00279201|80363412|FG000|Initiation|Death|1|||
27597263|NCT00279201|80363413|FG001|Initiation|Death|5|||
27597264|NCT00279201|80363414|FG002|Initiation|Death|0|||
27597265|NCT00279201|80363415|FG003|Initiation|Death|0|||
27597266|NCT00279201|80363416|FG004|Initiation|Death|0|||
27597267|NCT00279201|80363417|FG005|Initiation|Death|0|||
27597268|NCT00279201|80363412|FG000|Initiation|Adverse Event|6|||
27597269|NCT00279201|80363413|FG001|Initiation|Adverse Event|15|||
27597270|NCT00279201|80363414|FG002|Initiation|Adverse Event|0|||
27597271|NCT00279201|80363415|FG003|Initiation|Adverse Event|0|||
27597272|NCT00279201|80363416|FG004|Initiation|Adverse Event|0|||
27597273|NCT00279201|80363417|FG005|Initiation|Adverse Event|0|||
27597274|NCT00279201|80363412|FG000|Initiation|Lost to Follow-up|42|||
27597275|NCT00279201|80363413|FG001|Initiation|Lost to Follow-up|41|||
27597276|NCT00279201|80363414|FG002|Initiation|Lost to Follow-up|0|||
27597277|NCT00279201|80363415|FG003|Initiation|Lost to Follow-up|0|||
27597278|NCT00279201|80363416|FG004|Initiation|Lost to Follow-up|0|||
27597279|NCT00279201|80363417|FG005|Initiation|Lost to Follow-up|0|||
27597280|NCT00279201|80363412|FG000|Initiation|Entry Criteria Exclusion|7|||
27597281|NCT00279201|80363413|FG001|Initiation|Entry Criteria Exclusion|9|||
27597282|NCT00279201|80363414|FG002|Initiation|Entry Criteria Exclusion|0|||
27597283|NCT00279201|80363415|FG003|Initiation|Entry Criteria Exclusion|0|||
27597284|NCT00279201|80363416|FG004|Initiation|Entry Criteria Exclusion|0|||
27597285|NCT00279201|80363417|FG005|Initiation|Entry Criteria Exclusion|0|||
27597286|NCT00279201|80363412|FG000|Initiation|Protocol Violation|9|||
27597287|NCT00279201|80363413|FG001|Initiation|Protocol Violation|10|||
27597288|NCT00279201|80363414|FG002|Initiation|Protocol Violation|0|||
27597289|NCT00279201|80363415|FG003|Initiation|Protocol Violation|0|||
27597290|NCT00279201|80363416|FG004|Initiation|Protocol Violation|0|||
27597291|NCT00279201|80363417|FG005|Initiation|Protocol Violation|0|||
27597292|NCT00279201|80363412|FG000|Initiation|Withdrawal by Subject|35|||
27597293|NCT00279201|80363413|FG001|Initiation|Withdrawal by Subject|41|||
27597294|NCT00279201|80363414|FG002|Initiation|Withdrawal by Subject|0|||
27597295|NCT00279201|80363415|FG003|Initiation|Withdrawal by Subject|0|||
27597296|NCT00279201|80363416|FG004|Initiation|Withdrawal by Subject|0|||
27597297|NCT00279201|80363417|FG005|Initiation|Withdrawal by Subject|0|||
27597298|NCT00279201|80363412|FG000|Initiation|Physician Decision|15|||
27597299|NCT00279201|80363413|FG001|Initiation|Physician Decision|18|||
27597300|NCT00279201|80363414|FG002|Initiation|Physician Decision|0|||
27597301|NCT00279201|80363415|FG003|Initiation|Physician Decision|0|||
27597302|NCT00279201|80363416|FG004|Initiation|Physician Decision|0|||
27597303|NCT00279201|80363417|FG005|Initiation|Physician Decision|0|||
27597304|NCT00279201|80363412|FG000|Initiation|Sponsor Decision|13|||
27597305|NCT00279201|80363413|FG001|Initiation|Sponsor Decision|5|||
27597306|NCT00279201|80363414|FG002|Initiation|Sponsor Decision|0|||
27597307|NCT00279201|80363415|FG003|Initiation|Sponsor Decision|0|||
27597308|NCT00279201|80363416|FG004|Initiation|Sponsor Decision|0|||
27597309|NCT00279201|80363417|FG005|Initiation|Sponsor Decision|0|||
27597310|NCT00279201|80363412|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
27597311|NCT00279201|80363413|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
27597312|NCT00279201|80363414|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
27597313|NCT00279201|80363415|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
27597314|NCT00279201|80363416|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
27597315|NCT00279201|80363417|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
27597316|NCT00279201|80363412|FG000|Maintenance|Lack of Efficacy|32|||
27597317|NCT00279201|80363413|FG001|Maintenance|Lack of Efficacy|30|||
27597318|NCT00279201|80363414|FG002|Maintenance|Lack of Efficacy|0|||
27597319|NCT00279201|80363415|FG003|Maintenance|Lack of Efficacy|0|||
27597320|NCT00279201|80363416|FG004|Maintenance|Lack of Efficacy|0|||
27597321|NCT00279201|80363417|FG005|Maintenance|Lack of Efficacy|0|||
27597322|NCT00279201|80363412|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
27597323|NCT00279201|80363413|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
27597324|NCT00279201|80363414|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
27597325|NCT00279201|80363415|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
27597326|NCT00279201|80363416|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
27597327|NCT00279201|80363417|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
27597328|NCT00279201|80363412|FG000|Maintenance|Adverse Event|4|||
27597329|NCT00279201|80363413|FG001|Maintenance|Adverse Event|4|||
27597330|NCT00279201|80363414|FG002|Maintenance|Adverse Event|0|||
27597331|NCT00279201|80363415|FG003|Maintenance|Adverse Event|0|||
27597332|NCT00279201|80363416|FG004|Maintenance|Adverse Event|0|||
27597333|NCT00279201|80363417|FG005|Maintenance|Adverse Event|0|||
27887227|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Other|0|||
27887228|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
27887229|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
27887230|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
27887231|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Early site closure|0|||
27702901|NCT01383096|80751518|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
27702902|NCT01383096|80751519|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
27702903|NCT01383096|80751520|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
27702904|NCT01383096|80751518|FG000|Third Intervention (8 Days)|Adverse Event|1|||
27702905|NCT01383096|80751519|FG001|Third Intervention (8 Days)|Adverse Event|0|||
27702906|NCT01383096|80751520|FG002|Third Intervention (8 Days)|Adverse Event|0|||
27702907|NCT01383096|80751518|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
27702908|NCT01383096|80751519|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
27702909|NCT01383096|80751520|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
27702910|NCT01383096|80751518|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
27702911|NCT01383096|80751519|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27702912|NCT01383096|80751520|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27702913|NCT01383096|80751518|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
27702914|NCT01383096|80751519|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
27702915|NCT01383096|80751520|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
27702916|NCT01383096|80751518|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
27702917|NCT01383096|80751519|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27702918|NCT01383096|80751520|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
27702919|NCT01383096|80751518|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
27702920|NCT01383096|80751519|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
27702921|NCT01383096|80751520|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
27702922|NCT01383096|80751518|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
27702923|NCT01383096|80751519|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
27702924|NCT01383096|80751520|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
27702925|NCT01358760|80751522|FG000|Overall Study|Adverse Event|3|||
27702926|NCT01358760|80751523|FG001|Overall Study|Adverse Event|4|||
27702927|NCT01358760|80751524|FG002|Overall Study|Adverse Event|3|||
27702928|NCT01358760|80751522|FG000|Overall Study|Lost to Follow-up|1|||
27702929|NCT01358760|80751523|FG001|Overall Study|Lost to Follow-up|1|||
27702930|NCT01358760|80751524|FG002|Overall Study|Lost to Follow-up|3|||
27702931|NCT01358760|80751522|FG000|Overall Study|Withdrawal by Subject|5|||
27702932|NCT01358760|80751523|FG001|Overall Study|Withdrawal by Subject|3|||
27702933|NCT01358760|80751524|FG002|Overall Study|Withdrawal by Subject|2|||
27702934|NCT01358760|80751522|FG000|Overall Study|Physician Decision|1|||
27702935|NCT01358760|80751523|FG001|Overall Study|Physician Decision|0|||
27702936|NCT01358760|80751524|FG002|Overall Study|Physician Decision|1|||
27702937|NCT01358760|80751522|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
27702938|NCT01358760|80751523|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
27702939|NCT01358760|80751524|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
27702940|NCT00882310|80751525|FG000|Overall Study|Screen Failure|10|||
27702941|NCT00882310|80751525|FG000|Overall Study|Never received treatment|1|||
27702942|NCT00882310|80751525|FG000|Overall Study|Death|6|||
27702943|NCT00882310|80751525|FG000|Overall Study|Progression of disease|4|||
27702944|NCT00882310|80751525|FG000|Overall Study|Adverse Event|1|||
27702945|NCT01458366|80751526|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
27702946|NCT01458366|80751527|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
27702947|NCT01458366|80751528|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
27702948|NCT01458366|80751529|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
27702949|NCT01458366|80751530|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
27702950|NCT01458366|80751526|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27702951|NCT01458366|80751527|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27702952|NCT01458366|80751528|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27702953|NCT01458366|80751529|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
27702954|NCT01458366|80751530|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
27887232|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Early site closure|2|||
27702955|NCT01162239|80751537|FG000|Treatment Phase|Withdrawal by Subject|1|||
27702956|NCT01162239|80751538|FG001|Treatment Phase|Withdrawal by Subject|3|||
27702957|NCT01162239|80751539|FG002|Treatment Phase|Withdrawal by Subject|2|||
27702958|NCT01162239|80751540|FG003|Treatment Phase|Withdrawal by Subject|3|||
27702959|NCT01162239|80751537|FG000|Treatment Phase|Death|0|||
27702960|NCT01162239|80751538|FG001|Treatment Phase|Death|0|||
27702961|NCT01162239|80751539|FG002|Treatment Phase|Death|0|||
27702962|NCT01162239|80751540|FG003|Treatment Phase|Death|1|||
27702963|NCT01162239|80751537|FG000|Treatment Phase|Lost to Follow-up|5|||
27702964|NCT01162239|80751538|FG001|Treatment Phase|Lost to Follow-up|4|||
27702965|NCT01162239|80751539|FG002|Treatment Phase|Lost to Follow-up|2|||
27702966|NCT01162239|80751540|FG003|Treatment Phase|Lost to Follow-up|1|||
27702967|NCT01162239|80751537|FG000|Extended Follow-up|Lost to Follow-up|8|||
27702968|NCT01162239|80751538|FG001|Extended Follow-up|Lost to Follow-up|13|||
27702969|NCT01162239|80751539|FG002|Extended Follow-up|Lost to Follow-up|8|||
27702970|NCT01162239|80751540|FG003|Extended Follow-up|Lost to Follow-up|6|||
27702971|NCT00430482|80751541|FG000|Completed Treatment|Insufficient Treatment|7|||
27702972|NCT00430482|80751542|FG001|Completed Treatment|Insufficient Treatment|11|||
27702973|NCT00578136|80751545|FG000|Overall Study|Not given intervention|1|||
27702974|NCT00578136|80751546|FG001|Overall Study|Not given intervention|1|||
27702975|NCT01536951|80751558|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702976|NCT01536951|80751559|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702977|NCT01536951|80751560|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
27597334|NCT00279201|80363412|FG000|Maintenance|Death|4|||
27702978|NCT01536951|80751561|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27754803|NCT00495495|80929588|FG000|Overall Study|Protocol Violation|99|||
27597335|NCT00279201|80363413|FG001|Maintenance|Death|4|||
27597336|NCT00279201|80363414|FG002|Maintenance|Death|0|||
27597337|NCT00279201|80363415|FG003|Maintenance|Death|0|||
27597338|NCT00279201|80363416|FG004|Maintenance|Death|0|||
27597339|NCT00279201|80363417|FG005|Maintenance|Death|0|||
27702979|NCT01536951|80751562|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702980|NCT01536951|80751563|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702981|NCT01536951|80751564|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702982|NCT01536951|80751565|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702983|NCT01536951|80751566|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
27702984|NCT01536951|80751558|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
27702985|NCT01536951|80751559|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
27702986|NCT01536951|80751560|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
27702987|NCT01536951|80751561|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
27702988|NCT01536951|80751562|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
27702989|NCT01536951|80751563|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
27702990|NCT01536951|80751564|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
27702991|NCT01536951|80751565|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
27702992|NCT01536951|80751566|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
27702993|NCT02043548|80751569|FG000|Overall Study|Lack of Efficacy|1|||
27597340|NCT00279201|80363412|FG000|Maintenance|Lost to Follow-up|17|||
27597341|NCT00279201|80363413|FG001|Maintenance|Lost to Follow-up|13|||
27597342|NCT00279201|80363414|FG002|Maintenance|Lost to Follow-up|0|||
27597343|NCT00279201|80363415|FG003|Maintenance|Lost to Follow-up|0|||
27597344|NCT00279201|80363416|FG004|Maintenance|Lost to Follow-up|0|||
27702994|NCT02043548|80751570|FG001|Overall Study|Lack of Efficacy|0|||
27833752|NCT01442376|81222610|FG002|Overall Study|Patients not treated|1|||
27833753|NCT01442376|81222608|FG000|Overall Study|Not eligible for subsequent cycles|1|||
27833754|NCT01442376|81222609|FG001|Overall Study|Not eligible for subsequent cycles|2|||
27833755|NCT01442376|81222610|FG002|Overall Study|Not eligible for subsequent cycles|0|||
27833756|NCT00009945|81222611|FG000|Overall Study|no follow up data|7|||
27833757|NCT00009945|81222612|FG001|Overall Study|no follow up data|5|||
27833758|NCT00834613|81222613|FG000|First Intervention|Protocol Violation|1|||
27833759|NCT00834613|81222614|FG001|First Intervention|Protocol Violation|0|||
27833760|NCT03801707|81222615|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
27833761|NCT01943435|81222617|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
27833762|NCT01943435|81222618|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
27833763|NCT01943435|81222619|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
27833764|NCT01943435|81222617|FG000|Intervention Period|Withdrawal by Subject|3|||
27833765|NCT01943435|81222618|FG001|Intervention Period|Withdrawal by Subject|3|||
27833766|NCT01943435|81222619|FG002|Intervention Period|Withdrawal by Subject|4|||
27833767|NCT01943435|81222617|FG000|2 Month Follow up|Lost to Follow-up|2|||
27833768|NCT01943435|81222618|FG001|2 Month Follow up|Lost to Follow-up|3|||
27833769|NCT01943435|81222619|FG002|2 Month Follow up|Lost to Follow-up|0|||
27833770|NCT01943435|81222617|FG000|6 Month Follow up|Lost to Follow-up|12|||
27833771|NCT01943435|81222618|FG001|6 Month Follow up|Lost to Follow-up|7|||
27833772|NCT01943435|81222619|FG002|6 Month Follow up|Lost to Follow-up|15|||
27833773|NCT00466167|81222620|FG000|Overall Study|Adverse Event|8|||
27833774|NCT00466167|81222621|FG001|Overall Study|Adverse Event|8|||
27833775|NCT00466167|81222622|FG002|Overall Study|Adverse Event|7|||
27833776|NCT00466167|81222620|FG000|Overall Study|Lack of Efficacy|2|||
27833777|NCT00466167|81222621|FG001|Overall Study|Lack of Efficacy|0|||
27833778|NCT00466167|81222622|FG002|Overall Study|Lack of Efficacy|3|||
27833779|NCT00466167|81222620|FG000|Overall Study|Protocol Violation|1|||
27833780|NCT00466167|81222621|FG001|Overall Study|Protocol Violation|1|||
27833781|NCT00466167|81222622|FG002|Overall Study|Protocol Violation|2|||
27833782|NCT00466167|81222620|FG000|Overall Study|Lost to Follow-up|3|||
27833783|NCT00466167|81222621|FG001|Overall Study|Lost to Follow-up|2|||
27833784|NCT00466167|81222622|FG002|Overall Study|Lost to Follow-up|2|||
27833785|NCT00466167|81222620|FG000|Overall Study|Withdrawal by Subject|4|||
27833786|NCT00466167|81222621|FG001|Overall Study|Withdrawal by Subject|1|||
27833787|NCT00466167|81222622|FG002|Overall Study|Withdrawal by Subject|6|||
27833788|NCT00466167|81222620|FG000|Overall Study|patient did not meet inclusion criteria|1|||
27833789|NCT00466167|81222621|FG001|Overall Study|patient did not meet inclusion criteria|0|||
27833790|NCT00466167|81222622|FG002|Overall Study|patient did not meet inclusion criteria|1|||
27833791|NCT00466167|81222620|FG000|Overall Study|Not treated|1|||
27833792|NCT00466167|81222621|FG001|Overall Study|Not treated|0|||
27833793|NCT00466167|81222622|FG002|Overall Study|Not treated|0|||
27833794|NCT00295490|81222623|FG000|Overall Study|Protocol Violation|0|||
27833795|NCT00295490|81222624|FG001|Overall Study|Protocol Violation|0|||
27833796|NCT00295490|81222625|FG002|Overall Study|Protocol Violation|3|||
27833797|NCT00295490|81222626|FG003|Overall Study|Protocol Violation|3|||
27833798|NCT00295490|81222623|FG000|Overall Study|Withdrawal by Subject|0|||
27833799|NCT00295490|81222624|FG001|Overall Study|Withdrawal by Subject|2|||
27833800|NCT00295490|81222625|FG002|Overall Study|Withdrawal by Subject|0|||
27833801|NCT00295490|81222626|FG003|Overall Study|Withdrawal by Subject|1|||
27833802|NCT00295490|81222623|FG000|Overall Study|Lost to Follow-up|0|||
27833803|NCT00295490|81222624|FG001|Overall Study|Lost to Follow-up|0|||
27833804|NCT00295490|81222625|FG002|Overall Study|Lost to Follow-up|1|||
27833805|NCT00295490|81222626|FG003|Overall Study|Lost to Follow-up|0|||
27833806|NCT00295490|81222623|FG000|Overall Study|Adverse Event|1|||
27833807|NCT00295490|81222624|FG001|Overall Study|Adverse Event|0|||
27833808|NCT00295490|81222625|FG002|Overall Study|Adverse Event|0|||
27833809|NCT00295490|81222626|FG003|Overall Study|Adverse Event|0|||
27833810|NCT00295490|81222623|FG000|Overall Study|Other|0|||
27833811|NCT00295490|81222624|FG001|Overall Study|Other|2|||
27833812|NCT00295490|81222625|FG002|Overall Study|Other|0|||
27833813|NCT00295490|81222626|FG003|Overall Study|Other|1|||
27833814|NCT00425308|81222629|FG000|Overall Study|Adverse Event|2|||
27597345|NCT00279201|80363417|FG005|Maintenance|Lost to Follow-up|0|||
27702995|NCT02043548|80751569|FG000|Overall Study|Adverse Event|0|||
27702996|NCT02043548|80751570|FG001|Overall Study|Adverse Event|1|||
27702997|NCT02030405|80751573|FG000|Overall Study|Withdrawal by Subject|1|||
27833815|NCT00425308|81222630|FG001|Overall Study|Adverse Event|1|||
27833816|NCT00425308|81222629|FG000|Overall Study|Withdrawal by Subject|1|||
27833817|NCT00425308|81222630|FG001|Overall Study|Withdrawal by Subject|0|||
27833818|NCT00425308|81222629|FG000|Overall Study|Death|1|||
27833819|NCT00425308|81222630|FG001|Overall Study|Death|0|||
27702998|NCT02030405|80751573|FG000|Overall Study|Lost to Follow-up|1|||
27702999|NCT02982239|80751577|FG000|Overall Study|Lost to Follow-up|3|||
27703000|NCT02982239|80751578|FG001|Overall Study|Lost to Follow-up|2|||
27703001|NCT00818389|80751588|FG000|Overall Study|Death|1|||
27833820|NCT00414726|81222631|FG000|Overall Study|Withdrawal by Subject|0|||
27597346|NCT00279201|80363412|FG000|Maintenance|Entry Criteria Exclusion|1|||
27597347|NCT00279201|80363413|FG001|Maintenance|Entry Criteria Exclusion|4|||
27597348|NCT00279201|80363414|FG002|Maintenance|Entry Criteria Exclusion|0|||
27597349|NCT00279201|80363415|FG003|Maintenance|Entry Criteria Exclusion|0|||
27597350|NCT00279201|80363416|FG004|Maintenance|Entry Criteria Exclusion|0|||
27597351|NCT00279201|80363417|FG005|Maintenance|Entry Criteria Exclusion|0|||
27597352|NCT00279201|80363412|FG000|Maintenance|Protocol Violation|16|||
27597353|NCT00279201|80363413|FG001|Maintenance|Protocol Violation|24|||
27597354|NCT00279201|80363414|FG002|Maintenance|Protocol Violation|0|||
27597355|NCT00279201|80363415|FG003|Maintenance|Protocol Violation|0|||
27597356|NCT00279201|80363416|FG004|Maintenance|Protocol Violation|0|||
27597357|NCT00279201|80363417|FG005|Maintenance|Protocol Violation|0|||
27597358|NCT00279201|80363412|FG000|Maintenance|Withdrawal by Subject|18|||
27597359|NCT00279201|80363413|FG001|Maintenance|Withdrawal by Subject|18|||
27597360|NCT00279201|80363414|FG002|Maintenance|Withdrawal by Subject|0|||
27597361|NCT00279201|80363415|FG003|Maintenance|Withdrawal by Subject|0|||
27597362|NCT00279201|80363416|FG004|Maintenance|Withdrawal by Subject|0|||
27597363|NCT00279201|80363417|FG005|Maintenance|Withdrawal by Subject|0|||
27597364|NCT00279201|80363412|FG000|Maintenance|Physician Decision|9|||
27597365|NCT00279201|80363413|FG001|Maintenance|Physician Decision|9|||
27597366|NCT00279201|80363414|FG002|Maintenance|Physician Decision|0|||
27597367|NCT00279201|80363415|FG003|Maintenance|Physician Decision|0|||
27597368|NCT00279201|80363416|FG004|Maintenance|Physician Decision|0|||
27597369|NCT00279201|80363417|FG005|Maintenance|Physician Decision|0|||
27597370|NCT00279201|80363412|FG000|Maintenance|Sponsor Decision|4|||
27597371|NCT00279201|80363413|FG001|Maintenance|Sponsor Decision|0|||
27597372|NCT00279201|80363414|FG002|Maintenance|Sponsor Decision|0|||
27597373|NCT00279201|80363415|FG003|Maintenance|Sponsor Decision|0|||
27597374|NCT00279201|80363416|FG004|Maintenance|Sponsor Decision|0|||
27597375|NCT00279201|80363417|FG005|Maintenance|Sponsor Decision|0|||
27597376|NCT00279201|80363412|FG000|Maintenance|HbA1c>7.5%|123|||
27597377|NCT00279201|80363413|FG001|Maintenance|HbA1c>7.5%|126|||
27597378|NCT00279201|80363414|FG002|Maintenance|HbA1c>7.5%|0|||
27597379|NCT00279201|80363415|FG003|Maintenance|HbA1c>7.5%|0|||
27597380|NCT00279201|80363416|FG004|Maintenance|HbA1c>7.5%|0|||
27597381|NCT00279201|80363417|FG005|Maintenance|HbA1c>7.5%|0|||
27597382|NCT00279201|80363412|FG000|Intensification Addendum|Withdrawal by Subject|0|||
27597383|NCT00279201|80363413|FG001|Intensification Addendum|Withdrawal by Subject|0|||
27597384|NCT00279201|80363414|FG002|Intensification Addendum|Withdrawal by Subject|12|||
27597385|NCT00279201|80363415|FG003|Intensification Addendum|Withdrawal by Subject|14|||
27597386|NCT00279201|80363416|FG004|Intensification Addendum|Withdrawal by Subject|9|||
27597387|NCT00279201|80363417|FG005|Intensification Addendum|Withdrawal by Subject|18|||
27597388|NCT00279201|80363412|FG000|Intensification Addendum|Lost to Follow-up|0|||
27597389|NCT00279201|80363413|FG001|Intensification Addendum|Lost to Follow-up|0|||
27597390|NCT00279201|80363414|FG002|Intensification Addendum|Lost to Follow-up|4|||
27597391|NCT00279201|80363415|FG003|Intensification Addendum|Lost to Follow-up|6|||
27597392|NCT00279201|80363416|FG004|Intensification Addendum|Lost to Follow-up|7|||
27597393|NCT00279201|80363417|FG005|Intensification Addendum|Lost to Follow-up|7|||
27597394|NCT00279201|80363412|FG000|Intensification Addendum|Protocol Violation|0|||
27597395|NCT00279201|80363413|FG001|Intensification Addendum|Protocol Violation|0|||
27597396|NCT00279201|80363414|FG002|Intensification Addendum|Protocol Violation|2|||
27597397|NCT00279201|80363415|FG003|Intensification Addendum|Protocol Violation|2|||
27703002|NCT00818389|80751589|FG001|Overall Study|Death|3|||
27703003|NCT00818389|80751588|FG000|Overall Study|ALS Disease Progression|1|||
27597398|NCT00279201|80363416|FG004|Intensification Addendum|Protocol Violation|6|||
27597399|NCT00279201|80363417|FG005|Intensification Addendum|Protocol Violation|6|||
27597400|NCT00279201|80363412|FG000|Intensification Addendum|Adverse Event|0|||
27597401|NCT00279201|80363413|FG001|Intensification Addendum|Adverse Event|0|||
27597402|NCT00279201|80363414|FG002|Intensification Addendum|Adverse Event|0|||
27597403|NCT00279201|80363415|FG003|Intensification Addendum|Adverse Event|4|||
27597404|NCT00279201|80363416|FG004|Intensification Addendum|Adverse Event|1|||
27597405|NCT00279201|80363417|FG005|Intensification Addendum|Adverse Event|3|||
27597406|NCT00279201|80363412|FG000|Intensification Addendum|Physician Decision|0|||
27597407|NCT00279201|80363413|FG001|Intensification Addendum|Physician Decision|0|||
27597408|NCT00279201|80363414|FG002|Intensification Addendum|Physician Decision|4|||
27597409|NCT00279201|80363415|FG003|Intensification Addendum|Physician Decision|1|||
27597410|NCT00279201|80363416|FG004|Intensification Addendum|Physician Decision|3|||
27597411|NCT00279201|80363417|FG005|Intensification Addendum|Physician Decision|2|||
27597412|NCT00279201|80363412|FG000|Intensification Addendum|Sponsor Decision|0|||
27597413|NCT00279201|80363413|FG001|Intensification Addendum|Sponsor Decision|0|||
27597414|NCT00279201|80363414|FG002|Intensification Addendum|Sponsor Decision|0|||
27597415|NCT00279201|80363415|FG003|Intensification Addendum|Sponsor Decision|0|||
27597416|NCT00279201|80363416|FG004|Intensification Addendum|Sponsor Decision|1|||
27597417|NCT00279201|80363417|FG005|Intensification Addendum|Sponsor Decision|1|||
27597418|NCT00279201|80363412|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
27597419|NCT00279201|80363413|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
27597420|NCT00279201|80363414|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
27597421|NCT00279201|80363415|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
27597422|NCT00279201|80363416|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
27597423|NCT00279201|80363417|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
27597424|NCT00279201|80363412|FG000|Intensification Addendum|Lack of Efficacy|0|||
27597425|NCT00279201|80363413|FG001|Intensification Addendum|Lack of Efficacy|0|||
27597426|NCT00279201|80363414|FG002|Intensification Addendum|Lack of Efficacy|0|||
27597427|NCT00279201|80363415|FG003|Intensification Addendum|Lack of Efficacy|1|||
27597428|NCT00279201|80363416|FG004|Intensification Addendum|Lack of Efficacy|1|||
27597429|NCT00279201|80363417|FG005|Intensification Addendum|Lack of Efficacy|0|||
27597430|NCT00279201|80363412|FG000|Intensification Addendum|Death|0|||
27597431|NCT00279201|80363413|FG001|Intensification Addendum|Death|0|||
27597432|NCT00279201|80363414|FG002|Intensification Addendum|Death|0|||
27597433|NCT00279201|80363415|FG003|Intensification Addendum|Death|0|||
27597434|NCT00279201|80363416|FG004|Intensification Addendum|Death|1|||
27597435|NCT00279201|80363417|FG005|Intensification Addendum|Death|0|||
27597436|NCT00645164|80363429|FG000|Overall Study|Lost to Follow-up|2|||
27597437|NCT00645164|80363429|FG000|Overall Study|Withdrawal by Subject|4|||
27597438|NCT00645164|80363429|FG000|Overall Study|Protocol Violation|1|||
27597439|NCT00377403|80363432|FG000|Overall Study|Unable to contact for telephone intervie|4|||
27597440|NCT00377403|80363433|FG001|Overall Study|Unable to contact for telephone intervie|7|||
27597441|NCT01441102|80363439|FG000|Overall Study|Adverse Event|1|||
27703004|NCT00818389|80751589|FG001|Overall Study|ALS Disease Progression|0|||
27703005|NCT00818389|80751588|FG000|Overall Study|Withdrawal by Subject|2|||
27703006|NCT00818389|80751589|FG001|Overall Study|Withdrawal by Subject|2|||
27703007|NCT00818389|80751588|FG000|Overall Study|Adverse Event|0|||
27597442|NCT01441102|80363439|FG000|Overall Study|Withdrawal by Subject|2|||
27597443|NCT02199028|80363442|FG000|Week 1|Adverse Event|1|||
27703008|NCT00818389|80751589|FG001|Overall Study|Adverse Event|1|||
27703009|NCT02409290|80751592|FG000|Overall Study|Protocol Violation|3|||
27703010|NCT02409290|80751593|FG001|Overall Study|Protocol Violation|6|||
27703011|NCT02409290|80751594|FG002|Overall Study|Protocol Violation|9|||
27703012|NCT02409290|80751595|FG003|Overall Study|Protocol Violation|4|||
27703013|NCT02409290|80751592|FG000|Overall Study|No positive culture/no baseline sample|3|||
27703014|NCT02409290|80751593|FG001|Overall Study|No positive culture/no baseline sample|9|||
27703015|NCT02409290|80751594|FG002|Overall Study|No positive culture/no baseline sample|6|||
27703016|NCT02409290|80751595|FG003|Overall Study|No positive culture/no baseline sample|5|||
27703017|NCT02409290|80751592|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
27703018|NCT02409290|80751593|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
27703019|NCT02409290|80751594|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
27703020|NCT02409290|80751595|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
27703021|NCT02710136|80751599|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
27703022|NCT02710136|80751600|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
27703023|NCT03805750|80751601|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
27703024|NCT03805750|80751602|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
27703025|NCT02708095|80751603|FG000|Overall Study|Adverse Event|4|||
27703026|NCT02708095|80751604|FG001|Overall Study|Adverse Event|10|||
27703027|NCT02708095|80751605|FG002|Overall Study|Adverse Event|11|||
27703028|NCT02708095|80751603|FG000|Overall Study|Lack of Efficacy|9|||
27703029|NCT02708095|80751604|FG001|Overall Study|Lack of Efficacy|3|||
27703030|NCT02708095|80751605|FG002|Overall Study|Lack of Efficacy|0|||
27703031|NCT02708095|80751603|FG000|Overall Study|Lost to Follow-up|2|||
27703032|NCT02708095|80751604|FG001|Overall Study|Lost to Follow-up|0|||
27703033|NCT02708095|80751605|FG002|Overall Study|Lost to Follow-up|0|||
27703034|NCT02708095|80751603|FG000|Overall Study|Physician Decision|2|||
27703035|NCT02708095|80751604|FG001|Overall Study|Physician Decision|3|||
27703036|NCT02708095|80751605|FG002|Overall Study|Physician Decision|2|||
27703037|NCT02708095|80751603|FG000|Overall Study|Protocol Violation|0|||
27703038|NCT02708095|80751604|FG001|Overall Study|Protocol Violation|0|||
27703039|NCT02708095|80751605|FG002|Overall Study|Protocol Violation|1|||
27703040|NCT02708095|80751603|FG000|Overall Study|Withdrawal by Subject|5|||
27703041|NCT02708095|80751604|FG001|Overall Study|Withdrawal by Subject|3|||
27887233|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Early site closure|0|||
27887234|NCT02137850|81422126|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
27703042|NCT02708095|80751605|FG002|Overall Study|Withdrawal by Subject|4|||
27703043|NCT01660451|80751606|FG000|Overall Study|Protocol Violation|0|||
27703044|NCT01660451|80751607|FG001|Overall Study|Protocol Violation|1|||
27703045|NCT01660451|80751608|FG002|Overall Study|Protocol Violation|1|||
27703046|NCT01660451|80751606|FG000|Overall Study|AE not associated with clinical disease progression|13|||
27703047|NCT01660451|80751607|FG001|Overall Study|AE not associated with clinical disease progression|10|||
27703048|NCT01660451|80751608|FG002|Overall Study|AE not associated with clinical disease progression|40|||
27703049|NCT01660451|80751606|FG000|Overall Study|AE associated with clinical disease progression|1|||
27703050|NCT01660451|80751607|FG001|Overall Study|AE associated with clinical disease progression|3|||
27703051|NCT01660451|80751608|FG002|Overall Study|AE associated with clinical disease progression|11|||
27703052|NCT01660451|80751606|FG000|Overall Study|Sponsor Decision|0|||
27703053|NCT01660451|80751607|FG001|Overall Study|Sponsor Decision|0|||
27703054|NCT01660451|80751608|FG002|Overall Study|Sponsor Decision|1|||
27703055|NCT01660451|80751606|FG000|Overall Study|Protocol Deviation|0|||
27703056|NCT01660451|80751607|FG001|Overall Study|Protocol Deviation|0|||
27703057|NCT01660451|80751608|FG002|Overall Study|Protocol Deviation|1|||
27703058|NCT01660451|80751606|FG000|Overall Study|Physician Decision|1|||
27703059|NCT01660451|80751607|FG001|Overall Study|Physician Decision|2|||
27597444|NCT02199028|80363443|FG001|Week 1|Adverse Event|0|||
27703060|NCT01660451|80751608|FG002|Overall Study|Physician Decision|5|||
27703061|NCT01660451|80751606|FG000|Overall Study|Withdrawal by Subject|1|||
27703062|NCT01660451|80751607|FG001|Overall Study|Withdrawal by Subject|1|||
27703063|NCT01660451|80751608|FG002|Overall Study|Withdrawal by Subject|20|||
27703064|NCT01660451|80751606|FG000|Overall Study|Trial closure.|0|||
27833821|NCT00414726|81222632|FG001|Overall Study|Withdrawal by Subject|1|||
27833822|NCT00863330|81222633|FG000|Overall Study|study terminated early due to administra|6|||
27833823|NCT01401062|81222637|FG000|Overall Study|Death|9|||
27833824|NCT01401062|81222638|FG001|Overall Study|Death|7|||
27833825|NCT01401062|81222637|FG000|Overall Study|Physician Decision|1|||
27833826|NCT01401062|81222638|FG001|Overall Study|Physician Decision|0|||
27833827|NCT01401062|81222637|FG000|Overall Study|Withdrawal by Subject|1|||
27833828|NCT01401062|81222638|FG001|Overall Study|Withdrawal by Subject|1|||
27833829|NCT01087502|81222642|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
27833830|NCT01087502|81222643|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
27833831|NCT01087502|81222642|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
27833832|NCT01087502|81222643|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
27833833|NCT01087502|81222642|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
27833834|NCT01087502|81222643|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
27833835|NCT01087502|81222642|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
27833836|NCT01087502|81222643|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
27833837|NCT01087502|81222642|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
27833838|NCT01087502|81222643|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
27833839|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
27833840|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
27833841|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
27887235|NCT02137850|81422127|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
27887236|NCT02137850|81422128|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
27703065|NCT01660451|80751607|FG001|Overall Study|Trial closure.|0|||
27703066|NCT01660451|80751608|FG002|Overall Study|Trial closure.|1|||
27703067|NCT01660451|80751606|FG000|Overall Study|Switching to other therapy|0|||
27703068|NCT01660451|80751607|FG001|Overall Study|Switching to other therapy|1|||
27703069|NCT01660451|80751608|FG002|Overall Study|Switching to other therapy|1|||
27703070|NCT01660451|80751606|FG000|Overall Study|Progressive disease - clinical progression|4|||
27703071|NCT01660451|80751607|FG001|Overall Study|Progressive disease - clinical progression|10|||
27887237|NCT02137850|81422126|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
27754804|NCT02546674|80929604|FG000|Overall Study|Adverse Event|19|||
27833842|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
27703072|NCT01660451|80751608|FG002|Overall Study|Progressive disease - clinical progression|9|||
27703073|NCT01660451|80751606|FG000|Overall Study|Progressive disease - radiological progression|12|||
27703074|NCT01660451|80751607|FG001|Overall Study|Progressive disease - radiological progression|23|||
27703075|NCT01660451|80751608|FG002|Overall Study|Progressive disease - radiological progression|50|||
27703076|NCT01660451|80751606|FG000|Overall Study|Death|1|||
27703077|NCT01660451|80751607|FG001|Overall Study|Death|0|||
27703078|NCT01660451|80751608|FG002|Overall Study|Death|1|||
27703079|NCT01660451|80751606|FG000|Overall Study|Other|0|||
27703080|NCT01660451|80751607|FG001|Overall Study|Other|0|||
27703081|NCT01660451|80751608|FG002|Overall Study|Other|1|||
27703082|NCT02459769|80751609|FG000|Overall Study|Withdrawal by Subject|7|||
27703083|NCT02459769|80751610|FG001|Overall Study|Withdrawal by Subject|4|||
27703084|NCT02459769|80751611|FG002|Overall Study|Withdrawal by Subject|8|||
27703085|NCT02459769|80751612|FG003|Overall Study|Withdrawal by Subject|5|||
27703086|NCT02459769|80751609|FG000|Overall Study|Lost to Follow-up|1|||
27703087|NCT02459769|80751610|FG001|Overall Study|Lost to Follow-up|0|||
27703088|NCT02459769|80751611|FG002|Overall Study|Lost to Follow-up|1|||
27703089|NCT02459769|80751612|FG003|Overall Study|Lost to Follow-up|0|||
27703090|NCT02108964|80751613|FG000|Overall Study|Progressive disease|12|||
27703091|NCT02108964|80751614|FG001|Overall Study|Progressive disease|25|||
27703092|NCT02108964|80751615|FG002|Overall Study|Progressive disease|50|||
27703093|NCT02108964|80751616|FG003|Overall Study|Progressive disease|6|||
27703094|NCT02108964|80751617|FG004|Overall Study|Progressive disease|18|||
27703095|NCT02108964|80751618|FG005|Overall Study|Progressive disease|5|||
27703096|NCT02108964|80751619|FG006|Overall Study|Progressive disease|7|||
27703097|NCT02108964|80751620|FG007|Overall Study|Progressive disease|9|||
27703098|NCT02108964|80751613|FG000|Overall Study|Physician Decision|1|||
27703099|NCT02108964|80751614|FG001|Overall Study|Physician Decision|5|||
27703100|NCT02108964|80751615|FG002|Overall Study|Physician Decision|6|||
27703101|NCT02108964|80751616|FG003|Overall Study|Physician Decision|0|||
27703102|NCT02108964|80751617|FG004|Overall Study|Physician Decision|1|||
27703103|NCT02108964|80751618|FG005|Overall Study|Physician Decision|0|||
27703104|NCT02108964|80751619|FG006|Overall Study|Physician Decision|0|||
27703105|NCT02108964|80751620|FG007|Overall Study|Physician Decision|0|||
27703106|NCT02108964|80751613|FG000|Overall Study|Adverse Event|0|||
27703107|NCT02108964|80751614|FG001|Overall Study|Adverse Event|0|||
27703108|NCT02108964|80751615|FG002|Overall Study|Adverse Event|4|||
27703109|NCT02108964|80751616|FG003|Overall Study|Adverse Event|0|||
27703110|NCT02108964|80751617|FG004|Overall Study|Adverse Event|1|||
27703111|NCT02108964|80751618|FG005|Overall Study|Adverse Event|0|||
27703112|NCT02108964|80751619|FG006|Overall Study|Adverse Event|3|||
27703113|NCT02108964|80751620|FG007|Overall Study|Adverse Event|1|||
27703114|NCT02108964|80751613|FG000|Overall Study|Death|1|||
27703115|NCT02108964|80751614|FG001|Overall Study|Death|1|||
27703116|NCT02108964|80751615|FG002|Overall Study|Death|2|||
27703117|NCT02108964|80751616|FG003|Overall Study|Death|0|||
27703118|NCT02108964|80751617|FG004|Overall Study|Death|3|||
27703119|NCT02108964|80751618|FG005|Overall Study|Death|0|||
27703120|NCT02108964|80751619|FG006|Overall Study|Death|0|||
27703121|NCT02108964|80751620|FG007|Overall Study|Death|1|||
27703122|NCT02108964|80751613|FG000|Overall Study|Subject/Guardian decision|0|||
27703123|NCT02108964|80751614|FG001|Overall Study|Subject/Guardian decision|1|||
27703124|NCT02108964|80751615|FG002|Overall Study|Subject/Guardian decision|3|||
27703125|NCT02108964|80751616|FG003|Overall Study|Subject/Guardian decision|0|||
27703126|NCT02108964|80751617|FG004|Overall Study|Subject/Guardian decision|2|||
27703127|NCT02108964|80751618|FG005|Overall Study|Subject/Guardian decision|0|||
27703128|NCT02108964|80751619|FG006|Overall Study|Subject/Guardian decision|1|||
27703129|NCT02108964|80751620|FG007|Overall Study|Subject/Guardian decision|1|||
27703130|NCT04060563|80751621|FG000|Overall Study|Lost to Follow-up|1|||
27703131|NCT04060563|80751622|FG001|Overall Study|Lost to Follow-up|1|||
27703132|NCT04060563|80751621|FG000|Overall Study|Physician Decision|0|||
27703133|NCT04060563|80751622|FG001|Overall Study|Physician Decision|1|||
27703134|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
27703135|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
27703136|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
27703137|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
27703138|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
27703139|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
27703140|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
27703141|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
27703142|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
27703143|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
27703144|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
27703145|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
27703146|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
27703147|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
27703148|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
27703149|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
27887238|NCT02137850|81422127|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
27887239|NCT02137850|81422128|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
27887240|NCT02137850|81422126|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
27887241|NCT02137850|81422127|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
27887242|NCT02137850|81422128|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
27887243|NCT02137850|81422126|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
27703150|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
27833843|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
27833844|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
27833845|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
27833846|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
27833847|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
27703151|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
27703152|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Early termination|0|||
27703153|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Early termination|0|||
27833848|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
27833849|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
27703154|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Early termination|34|||
27703155|NCT01493557|80751623|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
27703156|NCT01493557|80751624|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
27703157|NCT01493557|80751625|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
27703158|NCT01493557|80751623|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
27703159|NCT01493557|80751624|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
27703160|NCT01493557|80751625|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
27703161|NCT01493557|80751623|FG000|Randomized to Management Strategies|Other adverse event|8|||
27703162|NCT01493557|80751624|FG001|Randomized to Management Strategies|Other adverse event|5|||
27703163|NCT01493557|80751625|FG002|Randomized to Management Strategies|Other adverse event|0|||
27703164|NCT01493557|80751623|FG000|Randomized to Management Strategies|Protocol Violation|3|||
27703165|NCT01493557|80751624|FG001|Randomized to Management Strategies|Protocol Violation|0|||
27703166|NCT01493557|80751625|FG002|Randomized to Management Strategies|Protocol Violation|0|||
27703167|NCT01493557|80751623|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
27703168|NCT01493557|80751624|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
27703169|NCT01493557|80751625|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
27703170|NCT01493557|80751623|FG000|Randomized to Management Strategies|Other than stated above|1|||
27703171|NCT01493557|80751624|FG001|Randomized to Management Strategies|Other than stated above|3|||
27703172|NCT01493557|80751625|FG002|Randomized to Management Strategies|Other than stated above|0|||
27703173|NCT01493557|80751623|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
27703174|NCT01493557|80751624|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
27703175|NCT01493557|80751625|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
27703176|NCT01493557|80751623|FG000|Adding the Second Strategy|Other adverse event|1|||
27703177|NCT01493557|80751624|FG001|Adding the Second Strategy|Other adverse event|2|||
27703178|NCT01493557|80751625|FG002|Adding the Second Strategy|Other adverse event|0|||
27703179|NCT01493557|80751623|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
27703180|NCT01493557|80751624|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
27703181|NCT01493557|80751625|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
27597445|NCT02199028|80363442|FG000|Week 3|Adverse Event|1|||
27597446|NCT02199028|80363443|FG001|Week 3|Adverse Event|0|||
27703182|NCT01069172|80751626|FG000|Overall Study|Withdrawal by Subject|1|||
27703183|NCT01069172|80751627|FG001|Overall Study|Withdrawal by Subject|0|||
27833850|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
27703184|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
27833851|NCT01087502|81222642|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
27833852|NCT01087502|81222643|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
27833853|NCT01558635|81222644|FG000|Overall Study|Death|1|||
27833854|NCT01558635|81222644|FG000|Overall Study|Withdrawal by Subject|2|||
27833855|NCT01558635|81222644|FG000|Overall Study|Physician Decision|1|||
27833856|NCT01558635|81222644|FG000|Overall Study|Subject received other treatment|1|||
27833857|NCT01558635|81222644|FG000|Overall Study|Reveal XT was explanted|1|||
27833858|NCT00301964|81222645|FG000|Overall Study|Second primary|2|||
27833859|NCT00301964|81222645|FG000|Overall Study|Wrong primary|1|||
27833860|NCT00301964|81222645|FG000|Overall Study|Inadequate pathology|1|||
27833861|NCT02426918|81222650|FG000|Overall Study|Adverse Event|2|||
27833862|NCT02426918|81222651|FG001|Overall Study|Adverse Event|2|||
27833863|NCT02426918|81222652|FG002|Overall Study|Adverse Event|0|||
27833864|NCT02426918|81222650|FG000|Overall Study|Physician Decision|1|||
27833865|NCT02426918|81222651|FG001|Overall Study|Physician Decision|1|||
27833866|NCT02426918|81222652|FG002|Overall Study|Physician Decision|1|||
27833867|NCT02426918|81222650|FG000|Overall Study|Withdrawal by Subject|5|||
27833868|NCT02426918|81222651|FG001|Overall Study|Withdrawal by Subject|5|||
27833869|NCT02426918|81222652|FG002|Overall Study|Withdrawal by Subject|4|||
27833870|NCT02426918|81222650|FG000|Overall Study|Other|9|||
27833871|NCT02426918|81222651|FG001|Overall Study|Other|11|||
27833872|NCT02426918|81222652|FG002|Overall Study|Other|9|||
27833873|NCT04388787|81222663|FG000|Blinded Period|Patient could not follow instructions|1|||
27833874|NCT04388787|81222663|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
27833875|NCT01378962|81222664|FG000|Overall Study|Death|14|||
27833876|NCT01378962|81222664|FG000|Overall Study|Lost to Follow-up|1|||
27833877|NCT01378962|81222664|FG000|Overall Study|Other|2|||
27703185|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
27703186|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
27703187|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
27703188|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
27703189|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
27703190|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
27703191|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
27703192|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
27703193|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
27703194|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
27703195|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
27703196|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
27703197|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
27703198|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
27703199|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
27703200|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
27703201|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
27703202|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
27703203|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
27703204|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
27703205|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
27703206|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
27703207|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
27703208|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
27703209|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
27703210|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
27703211|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
27703212|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
27703213|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
27703214|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
27703215|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
27703216|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
27703217|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
27703218|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
27703219|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
27703220|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
27703221|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
27887244|NCT02137850|81422127|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
27887245|NCT02137850|81422128|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
27887246|NCT02137850|81422126|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
27833878|NCT00645853|81222667|FG000|Overall Study|Adverse Event|18|||
27833879|NCT00645853|81222668|FG001|Overall Study|Adverse Event|7|||
27833880|NCT00645853|81222667|FG000|Overall Study|AZ study closure in Hungary|60|||
27833881|NCT00645853|81222668|FG001|Overall Study|AZ study closure in Hungary|40|||
27833882|NCT00645853|81222667|FG000|Overall Study|Withdrawal by Subject|5|||
27833883|NCT00645853|81222668|FG001|Overall Study|Withdrawal by Subject|2|||
27833884|NCT00645853|81222667|FG000|Overall Study|Protocol Violation|0|||
27833885|NCT00645853|81222668|FG001|Overall Study|Protocol Violation|2|||
27833886|NCT00645853|81222667|FG000|Overall Study|Discontinuation criteria|2|||
27887247|NCT02137850|81422127|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
27887248|NCT02137850|81422128|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
27887249|NCT02137850|81422126|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
27887250|NCT02137850|81422127|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
27887251|NCT02137850|81422128|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
27703222|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
27703223|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
27887252|NCT02137850|81422126|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
27887253|NCT02137850|81422127|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
27887254|NCT02137850|81422128|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
27887255|NCT02137850|81422126|FG000|Extension Phase: Prophylaxis|Other|0|||
27887256|NCT02137850|81422127|FG001|Extension Phase: Prophylaxis|Other|1|||
27887257|NCT02137850|81422128|FG002|Extension Phase: Prophylaxis|Other|0|||
27887258|NCT02137850|81422126|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
27887259|NCT02137850|81422127|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
27887260|NCT02137850|81422128|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
27887261|NCT03514485|81422129|FG000|Overall Study|Lost to Follow-up|5|||
27887262|NCT03514485|81422130|FG001|Overall Study|Lost to Follow-up|3|||
27887263|NCT03514485|81422131|FG002|Overall Study|Lost to Follow-up|2|||
27887264|NCT03514485|81422132|FG003|Overall Study|Lost to Follow-up|0|||
27887265|NCT03514485|81422133|FG004|Overall Study|Lost to Follow-up|1|||
27887266|NCT03514485|81422134|FG005|Overall Study|Lost to Follow-up|4|||
27887267|NCT03514485|81422129|FG000|Overall Study|Withdrawal by Subject|0|||
27887268|NCT03514485|81422130|FG001|Overall Study|Withdrawal by Subject|1|||
27887269|NCT03514485|81422131|FG002|Overall Study|Withdrawal by Subject|3|||
27887270|NCT03514485|81422132|FG003|Overall Study|Withdrawal by Subject|1|||
27887271|NCT03514485|81422133|FG004|Overall Study|Withdrawal by Subject|2|||
27887272|NCT03514485|81422134|FG005|Overall Study|Withdrawal by Subject|1|||
27887273|NCT01340027|81422135|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
27887274|NCT01340027|81422136|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
27887275|NCT01340027|81422137|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
27887276|NCT01340027|81422138|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
27887277|NCT01340027|81422139|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
27887278|NCT01340027|81422140|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
27887279|NCT01340027|81422141|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
27887280|NCT01340027|81422142|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
27887281|NCT01340027|81422143|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
27887282|NCT01340027|81422144|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
27887283|NCT01340027|81422145|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
27887284|NCT01340027|81422146|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
27887285|NCT01340027|81422135|FG000|Overall Study|Adverse Event|0|||
27887286|NCT01340027|81422136|FG001|Overall Study|Adverse Event|1|||
27887287|NCT01340027|81422137|FG002|Overall Study|Adverse Event|2|||
27887288|NCT01340027|81422138|FG003|Overall Study|Adverse Event|0|||
27887289|NCT01340027|81422139|FG004|Overall Study|Adverse Event|1|||
27887290|NCT01340027|81422140|FG005|Overall Study|Adverse Event|2|||
27887291|NCT01340027|81422141|FG006|Overall Study|Adverse Event|2|||
27887292|NCT01340027|81422142|FG007|Overall Study|Adverse Event|1|||
27887293|NCT01340027|81422143|FG008|Overall Study|Adverse Event|4|||
27887294|NCT01340027|81422144|FG009|Overall Study|Adverse Event|1|||
27887295|NCT01340027|81422145|FG010|Overall Study|Adverse Event|1|||
27887296|NCT01340027|81422146|FG011|Overall Study|Adverse Event|3|||
27887297|NCT01340027|81422135|FG000|Overall Study|Lack of Efficacy|0|||
27703224|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
27833887|NCT00645853|81222668|FG001|Overall Study|Discontinuation criteria|2|||
27887298|NCT01340027|81422136|FG001|Overall Study|Lack of Efficacy|0|||
27887299|NCT01340027|81422137|FG002|Overall Study|Lack of Efficacy|0|||
27887300|NCT01340027|81422138|FG003|Overall Study|Lack of Efficacy|0|||
27887301|NCT01340027|81422139|FG004|Overall Study|Lack of Efficacy|0|||
27887302|NCT01340027|81422140|FG005|Overall Study|Lack of Efficacy|0|||
27887303|NCT01340027|81422141|FG006|Overall Study|Lack of Efficacy|1|||
27887304|NCT01340027|81422142|FG007|Overall Study|Lack of Efficacy|1|||
27887305|NCT01340027|81422143|FG008|Overall Study|Lack of Efficacy|1|||
27887306|NCT01340027|81422144|FG009|Overall Study|Lack of Efficacy|0|||
27833888|NCT00645853|81222667|FG000|Overall Study|recall of ICF, planned operation, death|7|||
27833889|NCT00645853|81222668|FG001|Overall Study|recall of ICF, planned operation, death|4|||
27833890|NCT00660660|81222670|FG000|Overall Study|Adverse Event|1|||
27833891|NCT00660660|81222671|FG001|Overall Study|Adverse Event|0|||
27833892|NCT00660660|81222670|FG000|Overall Study|Lost to Follow-up|0|||
27833893|NCT00660660|81222671|FG001|Overall Study|Lost to Follow-up|6|||
27833894|NCT00660660|81222670|FG000|Overall Study|Lack of Efficacy|0|||
27833895|NCT00660660|81222671|FG001|Overall Study|Lack of Efficacy|2|||
27833896|NCT00660660|81222670|FG000|Overall Study|Withdrawal by Subject|3|||
27833897|NCT00660660|81222671|FG001|Overall Study|Withdrawal by Subject|0|||
27833898|NCT00660660|81222670|FG000|Overall Study|Incorrect enrollment and other|0|||
27833899|NCT00660660|81222671|FG001|Overall Study|Incorrect enrollment and other|1|||
27833900|NCT00660660|81222670|FG000|Overall Study|New medication after randomization|1|||
27833901|NCT00660660|81222671|FG001|Overall Study|New medication after randomization|0|||
27833902|NCT00736190|81222673|FG000|Overall Study|Pregnancy|1|||
27833903|NCT00736190|81222673|FG000|Overall Study|Withdrawal by Subject|1|||
27833904|NCT00736190|81222673|FG000|Overall Study|Adverse Event|1|||
27833905|NCT01698554|81222674|FG000|Overall Study|Adverse Event|2|||
27833906|NCT01698554|81222675|FG001|Overall Study|Adverse Event|5|||
27833907|NCT01698554|81222676|FG002|Overall Study|Adverse Event|0|||
27833908|NCT01698554|81222677|FG003|Overall Study|Adverse Event|1|||
27833909|NCT01698554|81222674|FG000|Overall Study|Lost to Follow-up|1|||
27833910|NCT01698554|81222675|FG001|Overall Study|Lost to Follow-up|0|||
27833911|NCT01698554|81222676|FG002|Overall Study|Lost to Follow-up|0|||
27833912|NCT01698554|81222677|FG003|Overall Study|Lost to Follow-up|0|||
27833913|NCT01698554|81222674|FG000|Overall Study|Personal Reasons|0|||
27833914|NCT01698554|81222675|FG001|Overall Study|Personal Reasons|5|||
27833915|NCT01698554|81222676|FG002|Overall Study|Personal Reasons|1|||
27833916|NCT01698554|81222677|FG003|Overall Study|Personal Reasons|1|||
27833917|NCT01698554|81222674|FG000|Overall Study|Protocol Violation|2|||
27833918|NCT01698554|81222675|FG001|Overall Study|Protocol Violation|0|||
27833919|NCT01698554|81222676|FG002|Overall Study|Protocol Violation|1|||
27833920|NCT01698554|81222677|FG003|Overall Study|Protocol Violation|0|||
27833921|NCT01698554|81222674|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27833922|NCT01698554|81222675|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27833923|NCT01698554|81222676|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27833924|NCT01698554|81222677|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27833925|NCT01120028|81222678|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
27833926|NCT01120028|81222679|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
27833927|NCT01120028|81222680|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
27833928|NCT01120028|81222681|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
27833929|NCT01120028|81222678|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
27833930|NCT01120028|81222679|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
27887307|NCT01340027|81422145|FG010|Overall Study|Lack of Efficacy|0|||
27887308|NCT01340027|81422146|FG011|Overall Study|Lack of Efficacy|0|||
27887309|NCT01340027|81422135|FG000|Overall Study|Lost to Follow-up|0|||
27887310|NCT01340027|81422136|FG001|Overall Study|Lost to Follow-up|1|||
27887311|NCT01340027|81422137|FG002|Overall Study|Lost to Follow-up|0|||
27887312|NCT01340027|81422138|FG003|Overall Study|Lost to Follow-up|0|||
27833931|NCT01120028|81222680|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
27833932|NCT01120028|81222681|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
27833933|NCT03980522|81222682|FG000|Treatment Period|Adverse Event|1|||
27833934|NCT03980522|81222683|FG001|Treatment Period|Adverse Event|0|||
27833935|NCT03980522|81222684|FG002|Treatment Period|Adverse Event|0|||
27833936|NCT03980522|81222685|FG003|Treatment Period|Adverse Event|0|||
27833937|NCT03980522|81222686|FG004|Treatment Period|Adverse Event|0|||
27833938|NCT02003391|81222687|FG000|Overall Study|Withdrawal by Subject|2|||
27703225|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
27703226|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
27703227|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
27703228|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
27703229|NCT03627767|80751630|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
27703230|NCT03627767|80751631|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
27703231|NCT03627767|80751632|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
27703232|NCT03627767|80751633|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
27703233|NCT03627767|80751634|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
27703234|NCT03627767|80751630|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
27597447|NCT01970462|80363445|FG000|Overall Study|Lost to Follow-up|0|||
27597448|NCT01970462|80363446|FG001|Overall Study|Lost to Follow-up|2|||
27597449|NCT01843374|80363447|FG000|Overall Study|Death|155|||
27597450|NCT01843374|80363448|FG001|Overall Study|Death|313|||
27597451|NCT01843374|80363447|FG000|Overall Study|Withdrawal by Subject|14|||
27597452|NCT01843374|80363448|FG001|Overall Study|Withdrawal by Subject|20|||
27597453|NCT01843374|80363447|FG000|Overall Study|Withdrawing due to Other reason|20|||
27597454|NCT01843374|80363448|FG001|Overall Study|Withdrawing due to Other reason|46|||
27597455|NCT01064297|80363449|FG000|Overall Study|Lost to Follow-up|791|||
27597456|NCT01064297|80363450|FG001|Overall Study|Lost to Follow-up|48|||
27597457|NCT01064297|80363451|FG002|Overall Study|Lost to Follow-up|133|||
27597458|NCT00765674|80363452|FG000|Overall Study|Adverse Event|7|||
27597459|NCT00765674|80363453|FG001|Overall Study|Adverse Event|2|||
27597460|NCT00765674|80363454|FG002|Overall Study|Adverse Event|8|||
27597461|NCT00765674|80363455|FG003|Overall Study|Adverse Event|11|||
27597462|NCT00765674|80363452|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
27597463|NCT00765674|80363453|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
27597464|NCT00765674|80363454|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
27597465|NCT00765674|80363455|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
27597466|NCT00765674|80363452|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
27597467|NCT00765674|80363453|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
27597468|NCT00765674|80363454|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
27703235|NCT03627767|80751631|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
27833939|NCT02003391|81222688|FG001|Overall Study|Withdrawal by Subject|1|||
27597469|NCT00765674|80363455|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
27597470|NCT00765674|80363452|FG000|Overall Study|Lack of Efficacy|2|||
27597471|NCT00765674|80363453|FG001|Overall Study|Lack of Efficacy|3|||
27703236|NCT03627767|80751632|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
27833940|NCT02003391|81222687|FG000|Overall Study|Protocol Violation|0|||
27597472|NCT00765674|80363454|FG002|Overall Study|Lack of Efficacy|1|||
27597473|NCT00765674|80363455|FG003|Overall Study|Lack of Efficacy|2|||
27597474|NCT00765674|80363452|FG000|Overall Study|Protocol Violation|2|||
27597475|NCT00765674|80363453|FG001|Overall Study|Protocol Violation|0|||
27597476|NCT00765674|80363454|FG002|Overall Study|Protocol Violation|1|||
27597477|NCT00765674|80363455|FG003|Overall Study|Protocol Violation|0|||
27597478|NCT00765674|80363452|FG000|Overall Study|Withdrawal by Subject|5|||
27597479|NCT00765674|80363453|FG001|Overall Study|Withdrawal by Subject|7|||
27597480|NCT00765674|80363454|FG002|Overall Study|Withdrawal by Subject|3|||
27597481|NCT00765674|80363455|FG003|Overall Study|Withdrawal by Subject|8|||
27597482|NCT00765674|80363452|FG000|Overall Study|Lost to Follow-up|4|||
27597483|NCT00765674|80363453|FG001|Overall Study|Lost to Follow-up|6|||
27597484|NCT00765674|80363454|FG002|Overall Study|Lost to Follow-up|2|||
27597485|NCT00765674|80363455|FG003|Overall Study|Lost to Follow-up|1|||
27597486|NCT00765674|80363452|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
27597487|NCT00765674|80363453|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
27597488|NCT00765674|80363454|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
27597489|NCT00765674|80363455|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
27597490|NCT00224874|80363456|FG000|Overall Study|Withdrawal by Subject|0|||
27597491|NCT00224874|80363457|FG001|Overall Study|Withdrawal by Subject|0|||
27597492|NCT00224874|80363458|FG002|Overall Study|Withdrawal by Subject|1|||
27597493|NCT00224874|80363459|FG003|Overall Study|Withdrawal by Subject|0|||
27597494|NCT00540124|80363468|FG000|Overall Study|Adverse Event|0|||
27597495|NCT00540124|80363469|FG001|Overall Study|Adverse Event|2|||
27597496|NCT00540124|80363470|FG002|Overall Study|Adverse Event|1|||
27597497|NCT00540124|80363468|FG000|Overall Study|Entry Criteria Not Met|2|||
27597498|NCT00540124|80363469|FG001|Overall Study|Entry Criteria Not Met|0|||
27597499|NCT00540124|80363470|FG002|Overall Study|Entry Criteria Not Met|0|||
27597500|NCT00540124|80363468|FG000|Overall Study|Lack of Efficacy|1|||
27597501|NCT00540124|80363469|FG001|Overall Study|Lack of Efficacy|0|||
27597502|NCT00540124|80363470|FG002|Overall Study|Lack of Efficacy|0|||
27597503|NCT00540124|80363468|FG000|Overall Study|Withdrawal by Subject|1|||
27597504|NCT00540124|80363469|FG001|Overall Study|Withdrawal by Subject|1|||
27597505|NCT00540124|80363470|FG002|Overall Study|Withdrawal by Subject|0|||
27597506|NCT01338025|80366475|FG000|Overall Study|Unexpected closure of study|10|||
27597507|NCT01338025|80366476|FG001|Overall Study|Unexpected closure of study|9|||
27597508|NCT01338025|80366475|FG000|Overall Study|Withdrawal by Subject|0|||
27597509|NCT01338025|80366476|FG001|Overall Study|Withdrawal by Subject|2|||
27597510|NCT01338025|80366475|FG000|Overall Study|Found ineligible after starting|1|||
27597511|NCT01338025|80366476|FG001|Overall Study|Found ineligible after starting|0|||
27597512|NCT02816138|80366477|FG000|Overall Study|Adverse Event|1|||
27597513|NCT03685591|80366478|FG000|Overall Study|Global Deterioration of Health Status|0|||
27703237|NCT03627767|80751633|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
27703238|NCT03627767|80751634|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
27703239|NCT03627767|80751630|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27703240|NCT03627767|80751631|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27703241|NCT03627767|80751632|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
27703242|NCT03627767|80751633|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
27597514|NCT03685591|80366479|FG001|Overall Study|Global Deterioration of Health Status|0|||
27597515|NCT03685591|80366480|FG002|Overall Study|Global Deterioration of Health Status|0|||
27597516|NCT03685591|80366481|FG003|Overall Study|Global Deterioration of Health Status|1|||
27597517|NCT03685591|80366482|FG004|Overall Study|Global Deterioration of Health Status|2|||
27597518|NCT03685591|80366483|FG005|Overall Study|Global Deterioration of Health Status|4|||
27597519|NCT03685591|80366484|FG006|Overall Study|Global Deterioration of Health Status|1|||
27754805|NCT02546674|80929604|FG000|Overall Study|Death|1|||
27597520|NCT03685591|80366485|FG007|Overall Study|Global Deterioration of Health Status|1|||
27597521|NCT03685591|80366486|FG008|Overall Study|Global Deterioration of Health Status|0|||
27597522|NCT03685591|80366478|FG000|Overall Study|Progressive Disease|1|||
27597523|NCT03685591|80366479|FG001|Overall Study|Progressive Disease|1|||
27597524|NCT03685591|80366480|FG002|Overall Study|Progressive Disease|0|||
27597525|NCT03685591|80366481|FG003|Overall Study|Progressive Disease|3|||
27597526|NCT03685591|80366482|FG004|Overall Study|Progressive Disease|5|||
27597527|NCT03685591|80366483|FG005|Overall Study|Progressive Disease|4|||
27597528|NCT03685591|80366484|FG006|Overall Study|Progressive Disease|3|||
27597529|NCT03685591|80366485|FG007|Overall Study|Progressive Disease|2|||
27597530|NCT03685591|80366486|FG008|Overall Study|Progressive Disease|1|||
27597531|NCT03685591|80366478|FG000|Overall Study|Other|0|||
27597532|NCT03685591|80366479|FG001|Overall Study|Other|0|||
27597533|NCT03685591|80366480|FG002|Overall Study|Other|1|||
27597534|NCT03685591|80366481|FG003|Overall Study|Other|0|||
27597535|NCT03685591|80366482|FG004|Overall Study|Other|2|||
27597536|NCT03685591|80366483|FG005|Overall Study|Other|3|||
27597537|NCT03685591|80366484|FG006|Overall Study|Other|0|||
27597538|NCT03685591|80366485|FG007|Overall Study|Other|0|||
27597539|NCT03685591|80366486|FG008|Overall Study|Other|0|||
27597540|NCT03685591|80366478|FG000|Overall Study|Withdrawal by Subject|0|||
27597541|NCT03685591|80366479|FG001|Overall Study|Withdrawal by Subject|0|||
27597542|NCT03685591|80366480|FG002|Overall Study|Withdrawal by Subject|0|||
27597543|NCT03685591|80366481|FG003|Overall Study|Withdrawal by Subject|0|||
27597544|NCT03685591|80366482|FG004|Overall Study|Withdrawal by Subject|3|||
27597545|NCT03685591|80366483|FG005|Overall Study|Withdrawal by Subject|2|||
27597546|NCT03685591|80366484|FG006|Overall Study|Withdrawal by Subject|0|||
27597547|NCT03685591|80366485|FG007|Overall Study|Withdrawal by Subject|0|||
27597548|NCT03685591|80366486|FG008|Overall Study|Withdrawal by Subject|1|||
27597549|NCT03685591|80366478|FG000|Overall Study|Adverse Event|0|||
27597550|NCT03685591|80366479|FG001|Overall Study|Adverse Event|0|||
27597551|NCT03685591|80366480|FG002|Overall Study|Adverse Event|0|||
27887313|NCT01340027|81422139|FG004|Overall Study|Lost to Follow-up|0|||
27887314|NCT01340027|81422140|FG005|Overall Study|Lost to Follow-up|0|||
27887315|NCT01340027|81422141|FG006|Overall Study|Lost to Follow-up|1|||
27887316|NCT01340027|81422142|FG007|Overall Study|Lost to Follow-up|0|||
27887317|NCT01340027|81422143|FG008|Overall Study|Lost to Follow-up|0|||
27887318|NCT01340027|81422144|FG009|Overall Study|Lost to Follow-up|1|||
27887319|NCT01340027|81422145|FG010|Overall Study|Lost to Follow-up|0|||
27887320|NCT01340027|81422146|FG011|Overall Study|Lost to Follow-up|0|||
27887321|NCT01340027|81422135|FG000|Overall Study|Protocol Violation|1|||
27597552|NCT03685591|80366481|FG003|Overall Study|Adverse Event|1|||
27597553|NCT03685591|80366482|FG004|Overall Study|Adverse Event|1|||
27597554|NCT03685591|80366483|FG005|Overall Study|Adverse Event|4|||
27597555|NCT03685591|80366484|FG006|Overall Study|Adverse Event|0|||
27887322|NCT01340027|81422136|FG001|Overall Study|Protocol Violation|2|||
27887323|NCT01340027|81422137|FG002|Overall Study|Protocol Violation|0|||
27597556|NCT03685591|80366485|FG007|Overall Study|Adverse Event|1|||
27597557|NCT03685591|80366486|FG008|Overall Study|Adverse Event|1|||
27597558|NCT02355002|80366491|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
27597559|NCT02355002|80366492|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
27597560|NCT02355002|80366491|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
27597561|NCT02355002|80366492|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
27597562|NCT02355002|80366491|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
27597563|NCT02355002|80366492|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
27597564|NCT02355002|80366491|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
27597565|NCT02355002|80366492|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
27597566|NCT02355002|80366491|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
27597567|NCT02355002|80366492|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
27597568|NCT02355002|80366491|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
27597569|NCT02355002|80366492|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
27597570|NCT02355002|80366491|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
27597571|NCT02355002|80366492|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
27597572|NCT00734630|80366494|FG000|Overall Study|Lack of Efficacy|4|||
27597573|NCT00734630|80366495|FG001|Overall Study|Lack of Efficacy|4|||
27887324|NCT01340027|81422138|FG003|Overall Study|Protocol Violation|0|||
27597574|NCT00734630|80366494|FG000|Overall Study|Withdrawal by Subject|7|||
27597575|NCT00734630|80366495|FG001|Overall Study|Withdrawal by Subject|9|||
27597576|NCT00734630|80366494|FG000|Overall Study|Lost to Follow-up|13|||
27597577|NCT00734630|80366495|FG001|Overall Study|Lost to Follow-up|7|||
27597578|NCT00734630|80366494|FG000|Overall Study|Protocol Violation|0|||
27597579|NCT00734630|80366495|FG001|Overall Study|Protocol Violation|3|||
27597580|NCT00734630|80366494|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
27597581|NCT00734630|80366495|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
27597582|NCT00734630|80366494|FG000|Overall Study|Adverse Event|3|||
27597583|NCT00734630|80366495|FG001|Overall Study|Adverse Event|6|||
27597584|NCT00734630|80366494|FG000|Overall Study|Randomized in Error|0|||
27597585|NCT00734630|80366495|FG001|Overall Study|Randomized in Error|1|||
27597586|NCT00734630|80366494|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
27597587|NCT00734630|80366495|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
27597588|NCT00734630|80366494|FG000|Overall Study|Poor Compliance|1|||
27597589|NCT00734630|80366495|FG001|Overall Study|Poor Compliance|1|||
27597590|NCT02454101|80366496|FG000|Overall Study|Adverse Event|2|||
27597591|NCT02454101|80366497|FG001|Overall Study|Adverse Event|3|||
27597592|NCT02454101|80366496|FG000|Overall Study|Lost to Follow-up|3|||
27597593|NCT02454101|80366497|FG001|Overall Study|Lost to Follow-up|4|||
27597594|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
27597595|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
27597596|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
27597597|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
27597598|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Other|13|||
27597599|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
27597600|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
27597601|NCT02497287|80366498|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
27597602|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
27703243|NCT03627767|80751634|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27703244|NCT03627767|80751630|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
27703245|NCT03627767|80751631|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
27703246|NCT03627767|80751632|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
27703247|NCT03627767|80751633|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
27703248|NCT03627767|80751634|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
27703249|NCT03627767|80751630|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27703250|NCT03627767|80751631|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
27703251|NCT03627767|80751632|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
27703252|NCT03627767|80751633|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
27703253|NCT03627767|80751634|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27703254|NCT03627767|80751630|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
27703255|NCT03627767|80751631|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
27703256|NCT03627767|80751632|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
27703257|NCT03627767|80751633|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
27887325|NCT01340027|81422139|FG004|Overall Study|Protocol Violation|6|||
27887326|NCT01340027|81422140|FG005|Overall Study|Protocol Violation|0|||
27887327|NCT01340027|81422141|FG006|Overall Study|Protocol Violation|0|||
27887328|NCT01340027|81422142|FG007|Overall Study|Protocol Violation|1|||
27597603|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
27597604|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
27597605|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
27597606|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
27597607|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
27597608|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
27597609|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
27597610|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
27597611|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
27597612|NCT02497287|80366498|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
27597613|NCT02497287|80366498|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
27597614|NCT02497287|80366498|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
27597615|NCT02497287|80366498|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
27597616|NCT02497287|80366498|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
27597617|NCT02497287|80366498|FG000|Follow-up Phase (4 Week)|Other|1|||
27597618|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
27597619|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
27597620|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
27597621|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
27597622|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
27597623|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
27597624|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
27597625|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
27597626|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Other|18|||
27597627|NCT02565914|80366503|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
27597628|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
27597629|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Other|1|||
27597630|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
27597631|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
27597632|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
27597633|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
27597634|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
27887329|NCT01340027|81422143|FG008|Overall Study|Protocol Violation|2|||
27597635|NCT02565914|80366503|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
27597636|NCT02565914|80366503|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
27597637|NCT02565914|80366503|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
27597638|NCT02565914|80366503|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
27833941|NCT02003391|81222688|FG001|Overall Study|Protocol Violation|1|||
27597639|NCT02565914|80366503|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
27597640|NCT02565914|80366503|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
27597641|NCT02565914|80366503|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
27597642|NCT00289887|80366506|FG000|Overall Study|Adverse Event|3|||
27597643|NCT00289887|80366507|FG001|Overall Study|Adverse Event|3|||
27597644|NCT00289887|80366506|FG000|Overall Study|Lack of Efficacy|3|||
27597645|NCT00289887|80366507|FG001|Overall Study|Lack of Efficacy|11|||
27597646|NCT00289887|80366506|FG000|Overall Study|Lost to Follow-up|3|||
27597647|NCT00289887|80366507|FG001|Overall Study|Lost to Follow-up|3|||
27597648|NCT00289887|80366506|FG000|Overall Study|Protocol Violation|3|||
27597649|NCT00289887|80366507|FG001|Overall Study|Protocol Violation|1|||
27597650|NCT00289887|80366506|FG000|Overall Study|Withdrawal by Subject|3|||
27597651|NCT00289887|80366507|FG001|Overall Study|Withdrawal by Subject|8|||
27597652|NCT00289887|80366506|FG000|Overall Study|Other|7|||
27597653|NCT00289887|80366507|FG001|Overall Study|Other|3|||
27597654|NCT03263429|80366509|FG000|Overall Study|Withdrawal by Subject|0|||
27597655|NCT03263429|80366510|FG001|Overall Study|Withdrawal by Subject|1|||
27597656|NCT03263429|80366511|FG002|Overall Study|Withdrawal by Subject|0|||
27597657|NCT03263429|80366509|FG000|Overall Study|Follow-Up Period Completed|0|||
27833942|NCT02003391|81222687|FG000|Overall Study|Adverse Event|1|||
27833943|NCT02003391|81222688|FG001|Overall Study|Adverse Event|0|||
27833944|NCT01598896|81222689|FG000|Overall Study|Withdrawal by Subject|0|||
27597658|NCT03263429|80366510|FG001|Overall Study|Follow-Up Period Completed|2|||
27597659|NCT03263429|80366511|FG002|Overall Study|Follow-Up Period Completed|0|||
27597660|NCT03263429|80366509|FG000|Overall Study|Death|3|||
27597661|NCT03263429|80366510|FG001|Overall Study|Death|5|||
27597662|NCT03263429|80366511|FG002|Overall Study|Death|16|||
27597663|NCT03263429|80366509|FG000|Overall Study|Participant unable to return|0|||
27597664|NCT03263429|80366510|FG001|Overall Study|Participant unable to return|0|||
27597665|NCT03263429|80366511|FG002|Overall Study|Participant unable to return|1|||
27597666|NCT03263429|80366509|FG000|Overall Study|Study Closed|0|||
27597667|NCT03263429|80366510|FG001|Overall Study|Study Closed|0|||
27597668|NCT03263429|80366511|FG002|Overall Study|Study Closed|1|||
27597669|NCT00857207|80366513|FG000|Overall Study|Withdrawal by Subject|13|||
27597670|NCT00857207|80366514|FG001|Overall Study|Withdrawal by Subject|0|||
27597671|NCT00857207|80366513|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
27597672|NCT00857207|80366514|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
27597673|NCT00857207|80366513|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
27597674|NCT00857207|80366514|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
27597675|NCT01274182|80366518|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27597676|NCT01274182|80366519|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27597677|NCT01274182|80366520|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
27597678|NCT01274182|80366518|FG000|Overall Study|Adverse Event|4|||
27597679|NCT01274182|80366519|FG001|Overall Study|Adverse Event|5|||
27597680|NCT01274182|80366520|FG002|Overall Study|Adverse Event|3|||
27597681|NCT01274182|80366518|FG000|Overall Study|Withdrawal by Subject|5|||
27597682|NCT01274182|80366519|FG001|Overall Study|Withdrawal by Subject|5|||
27597683|NCT01274182|80366520|FG002|Overall Study|Withdrawal by Subject|3|||
27597684|NCT01274182|80366518|FG000|Overall Study|Lost to Follow-up|2|||
27597685|NCT01274182|80366519|FG001|Overall Study|Lost to Follow-up|3|||
27597686|NCT01274182|80366520|FG002|Overall Study|Lost to Follow-up|1|||
27597687|NCT01274182|80366518|FG000|Overall Study|Protocol Violation|3|||
27597688|NCT01274182|80366519|FG001|Overall Study|Protocol Violation|2|||
27597689|NCT01274182|80366520|FG002|Overall Study|Protocol Violation|0|||
27597690|NCT01274182|80366518|FG000|Overall Study|Death|1|||
27597691|NCT01274182|80366519|FG001|Overall Study|Death|0|||
27597692|NCT01274182|80366520|FG002|Overall Study|Death|1|||
27597693|NCT00082173|80366521|FG000|Overall Study|Withdrawal by Subject|3|||
27597694|NCT00082173|80366522|FG001|Overall Study|Withdrawal by Subject|5|||
27597695|NCT00082173|80366521|FG000|Overall Study|Lost to Follow-up|1|||
27597696|NCT00082173|80366522|FG001|Overall Study|Lost to Follow-up|0|||
27597697|NCT00082173|80366521|FG000|Overall Study|Adverse Event|1|||
27597698|NCT00082173|80366522|FG001|Overall Study|Adverse Event|0|||
27597699|NCT00082173|80366521|FG000|Overall Study|Culture negative or resistant at baselin|5|||
27597700|NCT00082173|80366522|FG001|Overall Study|Culture negative or resistant at baselin|6|||
27597701|NCT02782169|80366524|FG000|Overall Study|Lost to Follow-up|1|||
27597702|NCT02782169|80366525|FG001|Overall Study|Lost to Follow-up|2|||
27597703|NCT02883062|80366526|FG000|Overall Study|Withdrawal by Subject|6|||
27597704|NCT02883062|80366527|FG001|Overall Study|Withdrawal by Subject|0|||
27597705|NCT02355743|80366528|FG000|Overall Study|Withdrawal by Subject|1|||
27597706|NCT02355743|80366528|FG000|Overall Study|Lost to Follow-up|1|||
27597707|NCT02013622|80366531|FG000|Overall Study|Lost to Follow-up|10|||
27597708|NCT02013622|80366531|FG000|Overall Study|Adverse Event|3|||
27597709|NCT02013622|80366531|FG000|Overall Study|Met Withdrawal Criteria|3|||
27597710|NCT02013622|80366531|FG000|Overall Study|Withdrawal by Subject|6|||
27597711|NCT02013622|80366531|FG000|Overall Study|Protocol Deviation|1|||
27597712|NCT02013622|80366531|FG000|Overall Study|Lack of Efficacy|1|||
27703258|NCT03627767|80751634|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
27754806|NCT02546674|80929604|FG000|Overall Study|Lost to Follow-up|1|||
27887330|NCT01340027|81422144|FG009|Overall Study|Protocol Violation|2|||
27703259|NCT03627767|80751630|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
27703260|NCT03627767|80751631|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
27703261|NCT03627767|80751632|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
27703262|NCT03627767|80751633|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
27703263|NCT03627767|80751634|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
27703264|NCT03627767|80751630|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
27703265|NCT03627767|80751631|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
27703266|NCT03627767|80751632|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
27703267|NCT03627767|80751633|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
27703268|NCT03627767|80751634|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
27703269|NCT03627767|80751630|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
27703270|NCT03627767|80751631|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
27703271|NCT03627767|80751632|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
27703272|NCT03627767|80751633|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
27703273|NCT03627767|80751634|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
27703274|NCT03627767|80751630|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
27703275|NCT03627767|80751631|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
27703276|NCT03627767|80751632|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
27703277|NCT03627767|80751633|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
27703278|NCT03627767|80751634|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
27703279|NCT03627767|80751630|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
27703280|NCT03627767|80751631|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
27703281|NCT03627767|80751632|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
27703282|NCT03627767|80751633|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
27703283|NCT03627767|80751634|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
27703284|NCT04490395|80751635|FG000|Overall Study|Lost to Follow-up|0|||
27703285|NCT04490395|80751636|FG001|Overall Study|Lost to Follow-up|1|||
27703286|NCT01145495|80751637|FG000|Overall Study|Adverse Event|6|||
27703287|NCT01145495|80751637|FG000|Overall Study|Withdrawal by Subject|6|||
27703288|NCT01145495|80751637|FG000|Overall Study|Disease progression after respone|2|||
27703289|NCT00509067|80751641|FG000|Overall Study|Lost to Follow-up|1|||
27703290|NCT00509067|80751642|FG001|Overall Study|Lost to Follow-up|1|||
27703291|NCT00509067|80751641|FG000|Overall Study|Adverse Event|3|||
27703292|NCT00509067|80751642|FG001|Overall Study|Adverse Event|1|||
27703293|NCT00509067|80751641|FG000|Overall Study|Protocol Violation|0|||
27703294|NCT00509067|80751642|FG001|Overall Study|Protocol Violation|3|||
27703295|NCT00332839|80751643|FG000|Core (Months 0 - 12)|Administrative problems|1|||
27703296|NCT00332839|80751644|FG001|Core (Months 0 - 12)|Administrative problems|1|||
27703297|NCT00332839|80751643|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
27703298|NCT00332839|80751644|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
27703299|NCT00332839|80751643|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
27703300|NCT00332839|80751644|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
27703301|NCT00332839|80751643|FG000|Core (Months 0 - 12)|Adverse Event|5|||
27703302|NCT00332839|80751644|FG001|Core (Months 0 - 12)|Adverse Event|15|||
27703303|NCT00332839|80751643|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
27703304|NCT00332839|80751644|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
27703305|NCT00332839|80751643|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
27703306|NCT00332839|80751644|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
27703307|NCT00332839|80751643|FG000|Follow-up (Months 12 - 60)|Death|1|||
27703308|NCT00332839|80751644|FG001|Follow-up (Months 12 - 60)|Death|1|||
27703309|NCT00631189|80751645|FG000|Initial Phase|Protocol Violation|347|||
27703310|NCT00631189|80751646|FG001|Initial Phase|Protocol Violation|0|||
27703311|NCT00631189|80751647|FG002|Initial Phase|Protocol Violation|0|||
27703312|NCT00631189|80751648|FG003|Initial Phase|Protocol Violation|0|||
27703313|NCT00631189|80751645|FG000|Initial Phase|Withdrawal by Subject|4|||
27703314|NCT00631189|80751646|FG001|Initial Phase|Withdrawal by Subject|0|||
27703315|NCT00631189|80751647|FG002|Initial Phase|Withdrawal by Subject|0|||
27703316|NCT00631189|80751648|FG003|Initial Phase|Withdrawal by Subject|0|||
27703317|NCT00631189|80751645|FG000|Treatment Phase|Withdrawal by Subject|0|||
27703318|NCT00631189|80751646|FG001|Treatment Phase|Withdrawal by Subject|2|||
27703319|NCT00631189|80751647|FG002|Treatment Phase|Withdrawal by Subject|1|||
27703320|NCT00631189|80751648|FG003|Treatment Phase|Withdrawal by Subject|1|||
27703321|NCT00631189|80751645|FG000|Treatment Phase|Protocol Violation|0|||
27703322|NCT00631189|80751646|FG001|Treatment Phase|Protocol Violation|1|||
27703323|NCT00631189|80751647|FG002|Treatment Phase|Protocol Violation|6|||
27703324|NCT00631189|80751648|FG003|Treatment Phase|Protocol Violation|2|||
27703325|NCT00631189|80751645|FG000|Treatment Phase|Adverse Event|0|||
27703326|NCT00631189|80751646|FG001|Treatment Phase|Adverse Event|3|||
27703327|NCT00631189|80751647|FG002|Treatment Phase|Adverse Event|2|||
27703328|NCT00631189|80751648|FG003|Treatment Phase|Adverse Event|4|||
27703329|NCT00631189|80751645|FG000|Treatment Phase|Lost to Follow-up|0|||
27703330|NCT00631189|80751646|FG001|Treatment Phase|Lost to Follow-up|1|||
27703331|NCT00631189|80751647|FG002|Treatment Phase|Lost to Follow-up|0|||
27703332|NCT00631189|80751648|FG003|Treatment Phase|Lost to Follow-up|0|||
27703333|NCT00631189|80751645|FG000|Treatment Phase|Pregnancy|0|||
27703334|NCT00631189|80751646|FG001|Treatment Phase|Pregnancy|0|||
27703335|NCT00631189|80751647|FG002|Treatment Phase|Pregnancy|1|||
27703336|NCT00631189|80751648|FG003|Treatment Phase|Pregnancy|0|||
27703337|NCT00631189|80751645|FG000|Treatment Phase|patient did not take pravastatin|0|||
27703338|NCT00631189|80751646|FG001|Treatment Phase|patient did not take pravastatin|0|||
27703339|NCT00631189|80751647|FG002|Treatment Phase|patient did not take pravastatin|1|||
27703340|NCT00631189|80751648|FG003|Treatment Phase|patient did not take pravastatin|0|||
27703341|NCT01221727|80751649|FG000|Overall Study|Physician Decision|2|||
27703342|NCT01221727|80751650|FG001|Overall Study|Physician Decision|0|||
27703343|NCT01221727|80751649|FG000|Overall Study|Withdrawal by Subject|1|||
27703344|NCT01221727|80751650|FG001|Overall Study|Withdrawal by Subject|1|||
27703345|NCT01200238|80751651|FG000|Overall Study|Adverse Event|2|||
27703346|NCT01200238|80751652|FG001|Overall Study|Adverse Event|1|||
27703347|NCT01200238|80751651|FG000|Overall Study|Progressive Disease|5|||
27703348|NCT01200238|80751652|FG001|Overall Study|Progressive Disease|8|||
27703349|NCT01200238|80751651|FG000|Overall Study|Withdrawal by Subject|0|||
27703350|NCT01200238|80751652|FG001|Overall Study|Withdrawal by Subject|1|||
27703351|NCT00732251|80751653|FG000|Overall Study|Lost to Follow-up|3|||
27703352|NCT00732251|80751653|FG000|Overall Study|Withdrawal by Subject|3|||
27703353|NCT00732251|80751653|FG000|Overall Study|Early Term due to Site Closure|1|||
27703354|NCT01843972|80751654|FG000|Overall Study|Withdrawal by Subject|0|||
27703355|NCT01843972|80751655|FG001|Overall Study|Withdrawal by Subject|0|||
27703356|NCT01843972|80751656|FG002|Overall Study|Withdrawal by Subject|0|||
27703357|NCT01843972|80751657|FG003|Overall Study|Withdrawal by Subject|0|||
27703358|NCT01843972|80751658|FG004|Overall Study|Withdrawal by Subject|1|||
27703359|NCT01843972|80751659|FG005|Overall Study|Withdrawal by Subject|0|||
27703360|NCT01843972|80751660|FG006|Overall Study|Withdrawal by Subject|0|||
27703361|NCT01843972|80751661|FG007|Overall Study|Withdrawal by Subject|0|||
27887331|NCT01340027|81422145|FG010|Overall Study|Protocol Violation|0|||
27887332|NCT01340027|81422146|FG011|Overall Study|Protocol Violation|0|||
27887333|NCT01340027|81422135|FG000|Overall Study|Withdrawal by Subject|4|||
27887334|NCT01340027|81422136|FG001|Overall Study|Withdrawal by Subject|3|||
27887335|NCT01340027|81422137|FG002|Overall Study|Withdrawal by Subject|1|||
27597713|NCT00504426|80366532|FG000|Overall Study|Adverse Event|0|||
27597714|NCT00504426|80366533|FG001|Overall Study|Adverse Event|0|||
27597715|NCT00504426|80366534|FG002|Overall Study|Adverse Event|2|||
27597716|NCT00504426|80366535|FG003|Overall Study|Adverse Event|0|||
27597717|NCT00504426|80366532|FG000|Overall Study|Protocol Violation|1|||
27597718|NCT00504426|80366533|FG001|Overall Study|Protocol Violation|1|||
27833945|NCT01598896|81222690|FG001|Overall Study|Withdrawal by Subject|1|||
27597719|NCT00504426|80366534|FG002|Overall Study|Protocol Violation|2|||
27597720|NCT00504426|80366535|FG003|Overall Study|Protocol Violation|0|||
27597721|NCT00504426|80366532|FG000|Overall Study|Withdrawal by Subject|2|||
27703362|NCT01843972|80751662|FG008|Overall Study|Withdrawal by Subject|0|||
27703363|NCT01843972|80751663|FG009|Overall Study|Withdrawal by Subject|0|||
27833946|NCT01598896|81222689|FG000|Overall Study|Lack of Efficacy|0|||
27833947|NCT01598896|81222690|FG001|Overall Study|Lack of Efficacy|1|||
27833948|NCT00396162|81222691|FG000|Overall Study|Withdrawal by Subject|2|||
27833949|NCT00396162|81222692|FG001|Overall Study|Withdrawal by Subject|3|||
27833950|NCT00702507|81222693|FG000|Initial Treatment Phase|Adverse Event|2|||
27833951|NCT00702507|81222693|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
27833952|NCT00702507|81222693|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
27833953|NCT00702507|81222693|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
27833954|NCT00702507|81222693|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
27833955|NCT00702507|81222693|FG000|Follow-up Phase|Protocol Violation|2|||
27833956|NCT00702507|81222693|FG000|Follow-up Phase|Lost to Follow-up|23|||
27833957|NCT00702507|81222693|FG000|Follow-up Phase|Late Enrollment|1|||
27833958|NCT03255733|81222694|FG000|Overall Study|Lost to Follow-up|4|||
27833959|NCT00474058|81222695|FG000|Overall Study|Adverse Event|11|||
27833960|NCT00474058|81222696|FG001|Overall Study|Adverse Event|6|||
27833961|NCT00474058|81222695|FG000|Overall Study|Lack of Efficacy|0|||
27833962|NCT00474058|81222696|FG001|Overall Study|Lack of Efficacy|4|||
27833963|NCT00474058|81222695|FG000|Overall Study|Withdrawal by Subject|11|||
27833964|NCT00474058|81222696|FG001|Overall Study|Withdrawal by Subject|7|||
27833965|NCT00474058|81222695|FG000|Overall Study|Other|2|||
27833966|NCT00474058|81222696|FG001|Overall Study|Other|0|||
27833967|NCT02050321|81222697|FG000|Overall Study|Withdrawal by Subject|1|||
27833968|NCT02050321|81222697|FG000|Overall Study|Adverse Event|1|||
27833969|NCT03224624|81222702|FG000|Overall Study|Lost to Follow-up|9|||
27833970|NCT03224624|81222703|FG001|Overall Study|Lost to Follow-up|4|||
27833971|NCT03224624|81222702|FG000|Overall Study|Death|1|||
27833972|NCT03224624|81222703|FG001|Overall Study|Death|0|||
27833973|NCT01670097|81222704|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
27833974|NCT01670097|81222705|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
27833975|NCT01670097|81222704|FG000|Overall Study|Study burden|1|||
27833976|NCT01670097|81222705|FG001|Overall Study|Study burden|0|||
27833977|NCT01670097|81222704|FG000|Overall Study|COPD exacerbation|0|||
27833978|NCT01670097|81222705|FG001|Overall Study|COPD exacerbation|1|||
27833979|NCT01670097|81222704|FG000|Overall Study|Neutropenia|0|||
27833980|NCT01670097|81222705|FG001|Overall Study|Neutropenia|1|||
27833981|NCT01670097|81222704|FG000|Overall Study|Clinical deterioration|0|||
27703364|NCT02012296|80751673|FG000|Overall Study|Lack of Efficacy|0|||
27887336|NCT01340027|81422138|FG003|Overall Study|Withdrawal by Subject|3|||
27833982|NCT01670097|81222705|FG001|Overall Study|Clinical deterioration|1|||
27833983|NCT01670097|81222704|FG000|Overall Study|Disease progression|0|||
27833984|NCT01670097|81222705|FG001|Overall Study|Disease progression|1|||
27833985|NCT00715676|81222708|FG000|Overall Study|Adverse Event|3|||
27703365|NCT02012296|80751674|FG001|Overall Study|Lack of Efficacy|0|||
27703366|NCT02012296|80751675|FG002|Overall Study|Lack of Efficacy|15|||
27703367|NCT02012296|80751673|FG000|Overall Study|Adverse Event|0|||
27703368|NCT02012296|80751674|FG001|Overall Study|Adverse Event|0|||
27887337|NCT01340027|81422139|FG004|Overall Study|Withdrawal by Subject|3|||
27887338|NCT01340027|81422140|FG005|Overall Study|Withdrawal by Subject|2|||
27703369|NCT02012296|80751675|FG002|Overall Study|Adverse Event|2|||
27703370|NCT02012296|80751673|FG000|Overall Study|Early study closure|0|||
27703371|NCT02012296|80751674|FG001|Overall Study|Early study closure|0|||
27703372|NCT02012296|80751675|FG002|Overall Study|Early study closure|5|||
27703373|NCT02012296|80751673|FG000|Overall Study|Protocol Violation|0|||
27703374|NCT02012296|80751674|FG001|Overall Study|Protocol Violation|1|||
27703375|NCT02012296|80751675|FG002|Overall Study|Protocol Violation|0|||
27703376|NCT00993954|80751679|FG000|Overall Study|Protocol Violation|21|||
27703377|NCT00993954|80751680|FG001|Overall Study|Protocol Violation|2|||
27703378|NCT01022502|80751681|FG000|Overall Study|Adverse Event|1|||
27703379|NCT01022502|80751681|FG000|Overall Study|employment related reasons|1|||
27703380|NCT01022502|80751681|FG000|Overall Study|Withdrawal by Subject|1|||
27703381|NCT00493220|80751682|FG000|Third Intervention|Withdrawal by Subject|1|||
27703382|NCT00493220|80751683|FG001|Third Intervention|Withdrawal by Subject|0|||
27703383|NCT00493220|80751684|FG002|Third Intervention|Withdrawal by Subject|0|||
27703384|NCT00493220|80751685|FG003|Third Intervention|Withdrawal by Subject|0|||
27703385|NCT00493220|80751686|FG004|Third Intervention|Withdrawal by Subject|0|||
27833986|NCT00715676|81222709|FG001|Overall Study|Adverse Event|5|||
27833987|NCT00715676|81222710|FG002|Overall Study|Adverse Event|21|||
27833988|NCT00715676|81222708|FG000|Overall Study|Withdrawal by Subject|1|||
27833989|NCT00715676|81222709|FG001|Overall Study|Withdrawal by Subject|3|||
27833990|NCT00715676|81222710|FG002|Overall Study|Withdrawal by Subject|8|||
27833991|NCT00715676|81222708|FG000|Overall Study|Lost to Follow-up|1|||
27833992|NCT00715676|81222709|FG001|Overall Study|Lost to Follow-up|2|||
27833993|NCT00715676|81222710|FG002|Overall Study|Lost to Follow-up|1|||
27833994|NCT00715676|81222708|FG000|Overall Study|Terminated by Sponsor|1|||
27833995|NCT00715676|81222709|FG001|Overall Study|Terminated by Sponsor|0|||
27833996|NCT00715676|81222710|FG002|Overall Study|Terminated by Sponsor|0|||
27833997|NCT00715676|81222708|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
27833998|NCT00715676|81222709|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
27833999|NCT00715676|81222710|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
27834000|NCT00715676|81222708|FG000|Overall Study|Use of Exclusionary Medication|0|||
27834001|NCT00715676|81222709|FG001|Overall Study|Use of Exclusionary Medication|0|||
27834002|NCT00715676|81222710|FG002|Overall Study|Use of Exclusionary Medication|1|||
27834003|NCT00715676|81222708|FG000|Overall Study|Elevated Blood Glucose|0|||
27834004|NCT00715676|81222709|FG001|Overall Study|Elevated Blood Glucose|1|||
27834005|NCT00715676|81222710|FG002|Overall Study|Elevated Blood Glucose|0|||
27834006|NCT02653664|81222716|FG000|Post-Treatment|Withdrawal by Subject|6|||
27834007|NCT02653664|81222717|FG001|Post-Treatment|Withdrawal by Subject|5|||
27834008|NCT02653664|81222718|FG002|Post-Treatment|Withdrawal by Subject|7|||
27834009|NCT02653664|81222716|FG000|Post-Treatment|Lost to Follow-up|8|||
27834010|NCT02653664|81222717|FG001|Post-Treatment|Lost to Follow-up|1|||
27834011|NCT02653664|81222718|FG002|Post-Treatment|Lost to Follow-up|7|||
27834012|NCT02653664|81222716|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
27834013|NCT02653664|81222717|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
27834014|NCT02653664|81222718|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
27834015|NCT02653664|81222716|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
27834016|NCT02653664|81222717|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
27834017|NCT02653664|81222718|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
27834018|NCT02653664|81222716|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
27834019|NCT02653664|81222717|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
27834020|NCT02653664|81222718|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
27834021|NCT02653664|81222716|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
27834022|NCT02653664|81222717|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
27834023|NCT02653664|81222718|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
27834024|NCT02653664|81222716|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
27834025|NCT02653664|81222717|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
27834026|NCT02653664|81222718|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
27834027|NCT02653664|81222716|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
27834028|NCT02653664|81222717|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
27834029|NCT02653664|81222718|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
27834030|NCT02653664|81222716|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
27834031|NCT02653664|81222717|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
27834032|NCT02653664|81222718|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
27887339|NCT01340027|81422141|FG006|Overall Study|Withdrawal by Subject|3|||
27887340|NCT01340027|81422142|FG007|Overall Study|Withdrawal by Subject|4|||
27887341|NCT01340027|81422143|FG008|Overall Study|Withdrawal by Subject|1|||
27703386|NCT00493220|80751687|FG005|Third Intervention|Withdrawal by Subject|0|||
27703387|NCT02243865|80751692|FG000|Overall Study|Protocol Violation|1|||
27703388|NCT02243865|80751693|FG001|Overall Study|Protocol Violation|3|||
27703389|NCT02243865|80751692|FG000|Overall Study|Lost to Follow-up|1|||
27703390|NCT02243865|80751693|FG001|Overall Study|Lost to Follow-up|1|||
27703391|NCT02243865|80751692|FG000|Overall Study|Withdrawal by Subject|1|||
27834033|NCT02653664|81222716|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
27834034|NCT02653664|81222717|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
27834035|NCT02653664|81222718|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
27834036|NCT02679729|81222719|FG000|Overall Study|Lost to Follow-up|0|||
27834037|NCT02679729|81222720|FG001|Overall Study|Lost to Follow-up|1|||
27834038|NCT02679729|81222721|FG002|Overall Study|Lost to Follow-up|0|||
27834039|NCT02679729|81222722|FG003|Overall Study|Lost to Follow-up|0|||
27834040|NCT02679729|81222723|FG004|Overall Study|Lost to Follow-up|1|||
27834041|NCT02679729|81222724|FG005|Overall Study|Lost to Follow-up|0|||
27834042|NCT02679729|81222725|FG006|Overall Study|Lost to Follow-up|0|||
27834043|NCT02679729|81222726|FG007|Overall Study|Lost to Follow-up|0|||
27834044|NCT02679729|81222727|FG008|Overall Study|Lost to Follow-up|0|||
27887342|NCT01340027|81422144|FG009|Overall Study|Withdrawal by Subject|2|||
27887343|NCT01340027|81422145|FG010|Overall Study|Withdrawal by Subject|0|||
27703392|NCT02243865|80751693|FG001|Overall Study|Withdrawal by Subject|0|||
27703393|NCT02243865|80751692|FG000|Overall Study|Adverse Event|1|||
27834045|NCT02679729|81222719|FG000|Overall Study|Participant decision|0|||
27834046|NCT02679729|81222720|FG001|Overall Study|Participant decision|1|||
27703394|NCT02243865|80751693|FG001|Overall Study|Adverse Event|1|||
27834047|NCT02679729|81222721|FG002|Overall Study|Participant decision|0|||
27834048|NCT02679729|81222722|FG003|Overall Study|Participant decision|0|||
27834049|NCT02679729|81222723|FG004|Overall Study|Participant decision|0|||
27834050|NCT02679729|81222724|FG005|Overall Study|Participant decision|0|||
27834051|NCT02679729|81222725|FG006|Overall Study|Participant decision|1|||
27834052|NCT02679729|81222726|FG007|Overall Study|Participant decision|0|||
27834053|NCT02679729|81222727|FG008|Overall Study|Participant decision|0|||
27834054|NCT04133311|81222728|FG000|Period 1 Double Masked Treatment Period|Death|1|||
27834055|NCT04133311|81222729|FG001|Period 1 Double Masked Treatment Period|Death|0|||
27834056|NCT04133311|81222730|FG002|Period 1 Double Masked Treatment Period|Death|0|||
27834057|NCT04133311|81222731|FG003|Period 1 Double Masked Treatment Period|Death|0|||
27834058|NCT04133311|81222728|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
27834059|NCT04133311|81222729|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
27834060|NCT04133311|81222730|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
27834061|NCT04133311|81222731|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
27834062|NCT04133311|81222728|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
27834063|NCT04133311|81222729|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
27834064|NCT04133311|81222730|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
27834065|NCT04133311|81222731|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
27834066|NCT04133311|81222728|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
27834067|NCT04133311|81222729|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
27834068|NCT04133311|81222730|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
27834069|NCT04133311|81222731|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
27834070|NCT04133311|81222728|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
27834071|NCT04133311|81222729|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
27834072|NCT04133311|81222730|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
27834073|NCT04133311|81222731|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
27834074|NCT04133311|81222728|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
27834075|NCT04133311|81222729|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
27834076|NCT04133311|81222730|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
27834077|NCT04133311|81222731|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
27834078|NCT04133311|81222728|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
27834079|NCT04133311|81222729|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
27834080|NCT04133311|81222730|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
27834081|NCT04133311|81222731|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
27834082|NCT04133311|81222728|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
27834083|NCT04133311|81222729|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
27834084|NCT04133311|81222730|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
27834085|NCT04133311|81222731|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
27834086|NCT03684928|81222734|FG000|First Intervention|Lost to Follow-up|0|||
27834087|NCT03684928|81222735|FG001|First Intervention|Lost to Follow-up|1|||
27834088|NCT03684928|81222734|FG000|First Intervention|Withdrawal by Subject|0|||
27834089|NCT03684928|81222735|FG001|First Intervention|Withdrawal by Subject|2|||
27834090|NCT03684928|81222734|FG000|Second Intervention|Soft Tissue Injury|1|||
27834091|NCT03684928|81222735|FG001|Second Intervention|Soft Tissue Injury|0|||
27834092|NCT01174186|81222739|FG000|Overall Study|Lost to Follow-up|0|||
27834093|NCT01174186|81222740|FG001|Overall Study|Lost to Follow-up|1|||
27834094|NCT01174186|81222739|FG000|Overall Study|Withdrawal by Subject|0|||
27834095|NCT01174186|81222740|FG001|Overall Study|Withdrawal by Subject|2|||
27834096|NCT03500094|81222743|FG000|Overall Study|Withdrawal by Subject|1|||
27834097|NCT03500094|81222743|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
27834098|NCT03500094|81222743|FG000|Overall Study|Lost to Follow-up|1|||
27887344|NCT01340027|81422146|FG011|Overall Study|Withdrawal by Subject|1|||
27887345|NCT01340027|81422135|FG000|Overall Study|Miscellaneous|0|||
27887346|NCT01340027|81422136|FG001|Overall Study|Miscellaneous|0|||
27887347|NCT01340027|81422137|FG002|Overall Study|Miscellaneous|0|||
27887348|NCT01340027|81422138|FG003|Overall Study|Miscellaneous|1|||
27887349|NCT01340027|81422139|FG004|Overall Study|Miscellaneous|0|||
27887350|NCT01340027|81422140|FG005|Overall Study|Miscellaneous|0|||
27887351|NCT01340027|81422141|FG006|Overall Study|Miscellaneous|0|||
27887352|NCT01340027|81422142|FG007|Overall Study|Miscellaneous|0|||
27887353|NCT01340027|81422143|FG008|Overall Study|Miscellaneous|0|||
27887354|NCT01340027|81422144|FG009|Overall Study|Miscellaneous|0|||
27887355|NCT01340027|81422145|FG010|Overall Study|Miscellaneous|1|||
27887356|NCT01340027|81422146|FG011|Overall Study|Miscellaneous|0|||
27887357|NCT03728426|81422151|FG000|Overall Study|Death|3|||
27887358|NCT03502070|81422152|FG000|Overall Study|Withdrawal by Subject|1|||
27887359|NCT03502070|81422152|FG000|Overall Study|Screen Failure|1|||
27887360|NCT03089697|81422153|FG000|Overall Study|Adverse Event|1|||
27597722|NCT00504426|80366533|FG001|Overall Study|Withdrawal by Subject|0|||
27887361|NCT03089697|81422154|FG001|Overall Study|Adverse Event|2|||
27834099|NCT00660387|81225962|FG000|Overall Study|Adverse Event|1|||
27834100|NCT00660387|81225963|FG001|Overall Study|Adverse Event|2|||
27834101|NCT00660387|81225962|FG000|Overall Study|Lack of Efficacy|0|||
27834102|NCT00660387|81225963|FG001|Overall Study|Lack of Efficacy|1|||
27834103|NCT00660387|81225962|FG000|Overall Study|Protocol Violation|1|||
27834104|NCT00660387|81225963|FG001|Overall Study|Protocol Violation|0|||
27834105|NCT01675596|81225965|FG000|Overall Study|Death|6|||
27834106|NCT01675596|81225965|FG000|Overall Study|Exit with other reason|1|||
27834107|NCT01675596|81225965|FG000|Overall Study|Missed Visit|1|||
27834108|NCT01547728|81225967|FG000|Overall Study|Change in procedure and equipment|1|||
27834109|NCT01547728|81225967|FG000|Overall Study|Drug not ready for subject|1|||
27834110|NCT01547728|81225967|FG000|Overall Study|Screen failure|39|||
27834111|NCT02888756|81225968|FG000|Analytical Treatment Interruption|Physician Decision|10|||
27834112|NCT02888756|81225969|FG001|Analytical Treatment Interruption|Physician Decision|6|||
27834113|NCT02888756|81225970|FG002|Analytical Treatment Interruption|Physician Decision|5|||
27834114|NCT03008005|81225971|FG000|Overall Study|Physician Decision|1|||
27834115|NCT03008005|81225972|FG001|Overall Study|Physician Decision|0|||
27834116|NCT03008005|81225973|FG002|Overall Study|Physician Decision|0|||
27834117|NCT03008005|81225971|FG000|Overall Study|Withdrawal by Subject|1|||
27834118|NCT03008005|81225972|FG001|Overall Study|Withdrawal by Subject|0|||
27834119|NCT03008005|81225973|FG002|Overall Study|Withdrawal by Subject|0|||
27834120|NCT03008005|81225971|FG000|Overall Study|Ineligible|0|||
27834121|NCT03008005|81225972|FG001|Overall Study|Ineligible|1|||
27834122|NCT03008005|81225973|FG002|Overall Study|Ineligible|0|||
27834123|NCT04203667|81225974|FG000|Overall Study|Withdrawal by Subject|1|||
27834124|NCT04203667|81225974|FG000|Overall Study|Lost to Follow-up|1|||
27834125|NCT04203667|81225974|FG000|Overall Study|Death|1|||
27834126|NCT04203667|81225974|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
27834127|NCT03101358|81225975|FG000|Overall Study|Non-compliance with study schedule|1|||
27834128|NCT03101358|81225976|FG001|Overall Study|Non-compliance with study schedule|0|||
27834129|NCT03101358|81225977|FG002|Overall Study|Non-compliance with study schedule|0|||
27834130|NCT03101358|81225978|FG003|Overall Study|Non-compliance with study schedule|1|||
27834131|NCT03101358|81225975|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
27834132|NCT03101358|81225976|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
27834133|NCT03101358|81225977|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
27834134|NCT03101358|81225978|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
27834135|NCT03101358|81225975|FG000|Overall Study|Physician Decision|1|||
27834136|NCT03101358|81225976|FG001|Overall Study|Physician Decision|0|||
27834137|NCT03101358|81225977|FG002|Overall Study|Physician Decision|0|||
27834138|NCT03101358|81225978|FG003|Overall Study|Physician Decision|3|||
27834139|NCT03101358|81225975|FG000|Overall Study|Adverse Event|0|||
27834140|NCT03101358|81225976|FG001|Overall Study|Adverse Event|0|||
27834141|NCT03101358|81225977|FG002|Overall Study|Adverse Event|1|||
27834142|NCT03101358|81225978|FG003|Overall Study|Adverse Event|0|||
27834143|NCT03101358|81225975|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
27834144|NCT03101358|81225976|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
27834145|NCT03101358|81225977|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
27834146|NCT03101358|81225978|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
27834147|NCT03101358|81225975|FG000|Overall Study|Lost to Follow-up|1|||
27834148|NCT03101358|81225976|FG001|Overall Study|Lost to Follow-up|0|||
27834149|NCT03101358|81225977|FG002|Overall Study|Lost to Follow-up|0|||
27834150|NCT03101358|81225978|FG003|Overall Study|Lost to Follow-up|1|||
27834151|NCT03555695|81225979|FG000|Overall Study|Withdrawal by Subject|1|||
27834152|NCT03555695|81225979|FG000|Overall Study|Lost to Follow-up|1|||
27834153|NCT03555695|81225979|FG000|Overall Study|appendicitis (unrelated)|1|||
27834154|NCT03555695|81225979|FG000|Overall Study|pre-existing sciatica|1|||
27834155|NCT01590563|81225984|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
27834156|NCT00198133|81225985|FG000|Overall Study|Disease progression|2|||
27887362|NCT03089697|81422153|FG000|Overall Study|Withdrawal by Subject|1|||
27887363|NCT03089697|81422154|FG001|Overall Study|Withdrawal by Subject|0|||
27887364|NCT01334918|81422155|FG000|Overall Study|Did not receive study drug|6|||
27887365|NCT01334918|81422156|FG001|Overall Study|Did not receive study drug|0|||
27887366|NCT01334918|81422155|FG000|Overall Study|Adverse Event|2|||
27834157|NCT00198133|81225986|FG001|Overall Study|Disease progression|5|||
27834158|NCT00198133|81225985|FG000|Overall Study|Adverse Event|1|||
27834159|NCT00198133|81225986|FG001|Overall Study|Adverse Event|3|||
27834160|NCT00198133|81225985|FG000|Overall Study|Withdrawal by Subject|1|||
27834161|NCT00198133|81225986|FG001|Overall Study|Withdrawal by Subject|0|||
27834162|NCT00198133|81225985|FG000|Overall Study|Physician Decision|1|||
27887367|NCT01334918|81422156|FG001|Overall Study|Adverse Event|0|||
27887368|NCT01334918|81422155|FG000|Overall Study|Withdrawal by Subject|0|||
27834163|NCT00198133|81225986|FG001|Overall Study|Physician Decision|0|||
27834164|NCT00876265|81225991|FG000|Overall Study|Miscellaneous reasons|4|||
27834165|NCT00876265|81225991|FG000|Overall Study|Lost to Follow-up|6|||
27834166|NCT00876265|81225991|FG000|Overall Study|Withdrawal by Subject|2|||
27887369|NCT01334918|81422156|FG001|Overall Study|Withdrawal by Subject|1|||
27887370|NCT04484142|81422157|FG000|Overall Study|Adverse Event|13|||
27887371|NCT04484142|81422157|FG000|Overall Study|Progressive Disease|87|||
27887372|NCT04484142|81422157|FG000|Overall Study|Clinical Progression|10|||
27834167|NCT02694536|81225996|FG000|Overall Study|Progressive Disease|40|||
27834168|NCT02694536|81225996|FG000|Overall Study|Lost to Follow-up|1|||
27887373|NCT04484142|81422157|FG000|Overall Study|Withdrawal by Subject|6|||
27887374|NCT04484142|81422157|FG000|Overall Study|Physician Decision|1|||
27887375|NCT03362190|81422158|FG000|Overall Study|Adverse Event|0|||
27887376|NCT03362190|81422159|FG001|Overall Study|Adverse Event|0|||
27887377|NCT03362190|81422160|FG002|Overall Study|Adverse Event|0|||
27887378|NCT03362190|81422161|FG003|Overall Study|Adverse Event|1|||
27887379|NCT03362190|81422158|FG000|Overall Study|Withdrawal by Subject|0|||
27887380|NCT03362190|81422159|FG001|Overall Study|Withdrawal by Subject|0|||
27887381|NCT03362190|81422160|FG002|Overall Study|Withdrawal by Subject|0|||
27887382|NCT03362190|81422161|FG003|Overall Study|Withdrawal by Subject|1|||
27887383|NCT01908829|81422164|FG000|Overall Study|Adverse Event|13|||
27887384|NCT01908829|81422165|FG001|Overall Study|Adverse Event|11|||
27887385|NCT01908829|81422166|FG002|Overall Study|Adverse Event|13|||
27887386|NCT01908829|81422164|FG000|Overall Study|Lost to Follow-up|4|||
27887387|NCT01908829|81422165|FG001|Overall Study|Lost to Follow-up|2|||
27887388|NCT01908829|81422166|FG002|Overall Study|Lost to Follow-up|1|||
27597723|NCT00504426|80366534|FG002|Overall Study|Withdrawal by Subject|0|||
27597724|NCT00504426|80366535|FG003|Overall Study|Withdrawal by Subject|0|||
27834169|NCT02694536|81225996|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
27834170|NCT02694536|81225996|FG000|Overall Study|Withdrawal by Subject|8|||
27834171|NCT02694536|81225996|FG000|Overall Study|Death|8|||
27834172|NCT02694536|81225996|FG000|Overall Study|Other|22|||
27834173|NCT02858037|81225997|FG000|Overall Study|Death|1|||
27834174|NCT02858037|81225997|FG000|Overall Study|Withdrawal by Subject|18|||
27834175|NCT02858037|81225997|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
27834176|NCT02858037|81225997|FG000|Overall Study|Lost to Follow-up|3|||
27834177|NCT02858037|81225997|FG000|Overall Study|Other|4|||
27834178|NCT00486434|81225998|FG000|Overall Study|Withdrawal by Subject|34|||
27834179|NCT00486434|81225999|FG001|Overall Study|Withdrawal by Subject|39|||
27834180|NCT00486434|81225998|FG000|Overall Study|Adverse Event|118|||
27834181|NCT00486434|81225999|FG001|Overall Study|Adverse Event|44|||
27834182|NCT00486434|81225998|FG000|Overall Study|Protocol Violation|22|||
27834183|NCT00486434|81225999|FG001|Overall Study|Protocol Violation|21|||
27834184|NCT00486434|81225998|FG000|Overall Study|Lack of Efficacy|12|||
27834185|NCT00486434|81225999|FG001|Overall Study|Lack of Efficacy|19|||
27834186|NCT00486434|81225998|FG000|Overall Study|Lost to Follow-up|2|||
27834187|NCT00486434|81225999|FG001|Overall Study|Lost to Follow-up|3|||
27834188|NCT00486434|81225998|FG000|Overall Study|Death|1|||
27834189|NCT00486434|81225999|FG001|Overall Study|Death|2|||
27834190|NCT00486434|81225998|FG000|Overall Study|Personal reasons|5|||
27834191|NCT00486434|81225999|FG001|Overall Study|Personal reasons|6|||
27834192|NCT02372006|81226001|FG000|Overall Study|Progressive disease|8|||
27834193|NCT02372006|81226002|FG001|Overall Study|Progressive disease|7|||
27834194|NCT02372006|81226003|FG002|Overall Study|Progressive disease|34|||
27834195|NCT02372006|81226001|FG000|Overall Study|Dose limiting toxicity|0|||
27834196|NCT02372006|81226002|FG001|Overall Study|Dose limiting toxicity|1|||
27834197|NCT02372006|81226003|FG002|Overall Study|Dose limiting toxicity|0|||
27834198|NCT02372006|81226001|FG000|Overall Study|Adverse Event|0|||
27834199|NCT02372006|81226002|FG001|Overall Study|Adverse Event|0|||
27834200|NCT02372006|81226003|FG002|Overall Study|Adverse Event|3|||
27834201|NCT02372006|81226001|FG000|Overall Study|Withdrawal by Subject|0|||
27834202|NCT02372006|81226002|FG001|Overall Study|Withdrawal by Subject|1|||
27834203|NCT02372006|81226003|FG002|Overall Study|Withdrawal by Subject|1|||
27834204|NCT02372006|81226001|FG000|Overall Study|Other reason for not completing|0|||
27834205|NCT02372006|81226002|FG001|Overall Study|Other reason for not completing|0|||
27834206|NCT02372006|81226003|FG002|Overall Study|Other reason for not completing|1|||
27834207|NCT01051349|81226004|FG000|Overall Study|Adverse Event|88|||
27887389|NCT01908829|81422164|FG000|Overall Study|Randomized no double-blind drug received|1|||
27887390|NCT01908829|81422165|FG001|Overall Study|Randomized no double-blind drug received|0|||
27834208|NCT01051349|81226004|FG000|Overall Study|Consent Withdrawn|54|||
27887391|NCT01908829|81422166|FG002|Overall Study|Randomized no double-blind drug received|1|||
27887392|NCT01908829|81422164|FG000|Overall Study|Discontinued (no EoT page)|2|||
27887393|NCT01908829|81422165|FG001|Overall Study|Discontinued (no EoT page)|0|||
27834209|NCT01051349|81226004|FG000|Overall Study|Investigator Decision|6|||
27834210|NCT01051349|81226004|FG000|Overall Study|Lost to Follow-up|6|||
27834211|NCT01051349|81226004|FG000|Overall Study|Subject non-compliance|7|||
27834212|NCT01051349|81226004|FG000|Overall Study|Reason not Specified|12|||
27834213|NCT02957331|81226007|FG000|Overall Study|Protocol Violation|1|||
27834214|NCT02957331|81226008|FG001|Overall Study|Protocol Violation|0|||
27834215|NCT02387762|81226010|FG000|Overall Study|Withdrawal by Subject|1|||
27834216|NCT02387762|81226011|FG001|Overall Study|Withdrawal by Subject|0|||
27834217|NCT02611362|81226014|FG000|Overall Study|Withdrawal by Subject|7|||
27834218|NCT02611362|81226015|FG001|Overall Study|Withdrawal by Subject|2|||
27834219|NCT02611362|81226014|FG000|Overall Study|Lost to Follow-up|2|||
27834220|NCT02611362|81226015|FG001|Overall Study|Lost to Follow-up|4|||
27834221|NCT00999687|81226017|FG000|First Intervention|Withdrawal by Subject|1|||
27834222|NCT00999687|81226017|FG000|Second Intervention|Withdrawal by Subject|2|||
27834223|NCT00999687|81226017|FG000|Second Intervention|Lack of Efficacy|1|||
27834224|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Refused|1|||
27834225|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Refused|3|||
27834226|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Medical|0|||
27834227|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Medical|1|||
27834228|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
27834229|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
27834230|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
27834231|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
27834232|NCT02054715|81226018|FG000|Baseline/Follow-up 1|No Reason|0|||
27834233|NCT02054715|81226019|FG001|Baseline/Follow-up 1|No Reason|1|||
27834234|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
27834235|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
27834236|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Ineligible|3|||
27834237|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Ineligible|0|||
27834238|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Hospitalization|1|||
27597725|NCT01298999|80366536|FG000|Overall Study|Physician Decision|0|||
27834239|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Hospitalization|0|||
27834240|NCT02054715|81226018|FG000|Baseline/Follow-up 1|Changed Mind|1|||
27834241|NCT02054715|81226019|FG001|Baseline/Follow-up 1|Changed Mind|0|||
27834242|NCT02054715|81226018|FG000|Follow-up 2|Lost to Followup|3|||
27834243|NCT02054715|81226019|FG001|Follow-up 2|Lost to Followup|1|||
27834244|NCT02054715|81226018|FG000|Follow-up 2|Refused|3|||
27834245|NCT02054715|81226019|FG001|Follow-up 2|Refused|2|||
27834246|NCT02054715|81226018|FG000|Follow-up 2|Followup Not Completed|3|||
27834247|NCT02054715|81226019|FG001|Follow-up 2|Followup Not Completed|4|||
27834248|NCT02054715|81226018|FG000|Follow-up 2|Ineligible|4|||
27834249|NCT02054715|81226019|FG001|Follow-up 2|Ineligible|5|||
27834250|NCT02054715|81226018|FG000|Follow-up 2|Death|3|||
27834251|NCT02054715|81226019|FG001|Follow-up 2|Death|3|||
27834252|NCT02054715|81226018|FG000|Follow-up 2|Hospitalization|0|||
27834253|NCT02054715|81226019|FG001|Follow-up 2|Hospitalization|2|||
27834254|NCT02054715|81226018|FG000|Follow-up 2|Changed MD/Facility|0|||
27834255|NCT02054715|81226019|FG001|Follow-up 2|Changed MD/Facility|1|||
27834256|NCT02054715|81226018|FG000|Follow-up 2|Changed Mind|0|||
27834257|NCT02054715|81226019|FG001|Follow-up 2|Changed Mind|1|||
27834258|NCT02054715|81226018|FG000|Follow-up 2|No Reason|2|||
27834259|NCT02054715|81226019|FG001|Follow-up 2|No Reason|0|||
27834260|NCT02054715|81226018|FG000|Follow-up 2|Treatment Change or Delay|1|||
27834261|NCT02054715|81226019|FG001|Follow-up 2|Treatment Change or Delay|0|||
27834262|NCT03669861|81226020|FG000|Overall Study|Disease Flare|5|||
27834263|NCT03669861|81226020|FG000|Overall Study|Lack of Efficacy|2|||
27834264|NCT02179190|81226021|FG000|Enrollment|Exit Prior to Device Attempt|11|||
27834265|NCT02179190|81226021|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
27834266|NCT02179190|81226021|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
27834267|NCT02179190|81226021|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
27834268|NCT02179190|81226021|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
27834269|NCT02179190|81226021|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
27834270|NCT00556673|81226024|FG000|Overall Study|Protocol deviation|3|||
27834271|NCT00556673|81226025|FG001|Overall Study|Protocol deviation|2|||
27834272|NCT01968551|81226028|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
27834273|NCT01968551|81226029|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
27834274|NCT01968551|81226030|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
27834275|NCT01968551|81226028|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
27834276|NCT01968551|81226029|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
27597726|NCT01298999|80366537|FG001|Overall Study|Physician Decision|1|||
27703395|NCT03496012|80751696|FG000|Overall Study|Withdrawal by Subject|2|||
27834277|NCT01968551|81226030|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
27834278|NCT01968551|81226028|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
27834279|NCT01968551|81226029|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
27834280|NCT01968551|81226030|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
27834281|NCT01968551|81226028|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
27834282|NCT01968551|81226029|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
27834283|NCT01968551|81226030|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
27834284|NCT01968551|81226028|FG000|Extension Phase|Adverse Event|0|||
27834285|NCT01968551|81226029|FG001|Extension Phase|Adverse Event|0|||
27834286|NCT01968551|81226030|FG002|Extension Phase|Adverse Event|2|||
27834287|NCT01968551|81226028|FG000|Extension Phase|Death|0|||
27834288|NCT01968551|81226029|FG001|Extension Phase|Death|1|||
27834289|NCT01968551|81226030|FG002|Extension Phase|Death|0|||
27834290|NCT01968551|81226028|FG000|Extension Phase|Withdrew Consent|0|||
27834291|NCT01968551|81226029|FG001|Extension Phase|Withdrew Consent|0|||
27834292|NCT01968551|81226030|FG002|Extension Phase|Withdrew Consent|1|||
27834293|NCT01968551|81226028|FG000|Extension Phase|Lost to Follow-up|1|||
27834294|NCT01968551|81226029|FG001|Extension Phase|Lost to Follow-up|0|||
27834295|NCT01968551|81226030|FG002|Extension Phase|Lost to Follow-up|1|||
27834296|NCT04968925|81226031|FG000|Phase I- Period 1|COVID-19 related|0|||
27834297|NCT04968925|81226032|FG001|Phase I- Period 1|COVID-19 related|1|||
27834298|NCT04968925|81226033|FG002|Phase I- Period 1|COVID-19 related|0|||
27834299|NCT04968925|81226034|FG003|Phase I- Period 1|COVID-19 related|0|||
27834300|NCT04968925|81226031|FG000|Phase I- Period 1|Subject enrolled in error|1|||
27834301|NCT04968925|81226032|FG001|Phase I- Period 1|Subject enrolled in error|1|||
27834302|NCT04968925|81226033|FG002|Phase I- Period 1|Subject enrolled in error|0|||
27834303|NCT04968925|81226034|FG003|Phase I- Period 1|Subject enrolled in error|0|||
27834304|NCT04968925|81226031|FG000|Phase II- Period 1|COVID-19 Related|0|||
27597727|NCT01298999|80366536|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
27597728|NCT01298999|80366537|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
27597729|NCT03574597|80366541|FG000|Overall Study|Withdrawal by Subject|67|||
27597730|NCT03574597|80366542|FG001|Overall Study|Withdrawal by Subject|96|||
27597731|NCT03574597|80366541|FG000|Overall Study|Lost to Follow-up|192|||
27597732|NCT03574597|80366542|FG001|Overall Study|Lost to Follow-up|188|||
27597733|NCT03489304|80366543|FG000|Overall Study|Lost to Follow-up|4|||
27597734|NCT00981084|80366544|FG000|Post Intervention (Data Analysis)|poor effort|1|||
27597735|NCT00981084|80366545|FG001|Post Intervention (Data Analysis)|poor effort|1|||
27597736|NCT00981084|80366544|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
27597737|NCT00981084|80366545|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
27597738|NCT04385368|80366546|FG000|Overall Study|Death|5|||
27597739|NCT04385368|80366547|FG001|Overall Study|Death|5|||
27597740|NCT04385368|80366546|FG000|Overall Study|Physician Decision|3|||
27597741|NCT04385368|80366547|FG001|Overall Study|Physician Decision|0|||
27597742|NCT04385368|80366546|FG000|Overall Study|Withdrawal by Subject|4|||
27597743|NCT04385368|80366547|FG001|Overall Study|Withdrawal by Subject|3|||
27703396|NCT03496012|80751697|FG001|Overall Study|Withdrawal by Subject|0|||
27834305|NCT04968925|81226032|FG001|Phase II- Period 1|COVID-19 Related|0|||
27834306|NCT04968925|81226033|FG002|Phase II- Period 1|COVID-19 Related|6|||
27834307|NCT04968925|81226034|FG003|Phase II- Period 1|COVID-19 Related|6|||
27834308|NCT04968925|81226031|FG000|Phase II- Period 1|Subject enrolled in error|0|||
27834309|NCT04968925|81226032|FG001|Phase II- Period 1|Subject enrolled in error|0|||
27834310|NCT04968925|81226033|FG002|Phase II- Period 1|Subject enrolled in error|1|||
27834311|NCT04968925|81226034|FG003|Phase II- Period 1|Subject enrolled in error|0|||
27834312|NCT04968925|81226031|FG000|Phase II -Period 2|COVID-19 related|0|||
27834313|NCT04968925|81226032|FG001|Phase II -Period 2|COVID-19 related|0|||
27834314|NCT04968925|81226033|FG002|Phase II -Period 2|COVID-19 related|4|||
27834315|NCT04968925|81226034|FG003|Phase II -Period 2|COVID-19 related|3|||
27834316|NCT04968925|81226031|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
27834317|NCT04968925|81226032|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
27834318|NCT04968925|81226033|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
27834319|NCT04968925|81226034|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
27834320|NCT04435782|81226035|FG000|Overall Study|Study terminated by sponsor|4|||
27834321|NCT02761915|81226036|FG000|Overall Study|Death|3|||
27834322|NCT02761915|81226037|FG001|Overall Study|Death|1|||
27834323|NCT02761915|81226038|FG002|Overall Study|Death|1|||
27834324|NCT02761915|81226039|FG003|Overall Study|Death|1|||
27597744|NCT04495179|80366548|FG000|Overall Study|Lost to Follow-up|0|||
27597745|NCT04495179|80366549|FG001|Overall Study|Lost to Follow-up|1|||
27597746|NCT04495179|80366548|FG000|Overall Study|Withdrawal by Subject|2|||
27834325|NCT02761915|81226040|FG004|Overall Study|Death|0|||
27834326|NCT02761915|81226041|FG005|Overall Study|Death|1|||
27834327|NCT02761915|81226036|FG000|Overall Study|Withdrawal by Subject|1|||
27834328|NCT02761915|81226037|FG001|Overall Study|Withdrawal by Subject|0|||
27834329|NCT02761915|81226038|FG002|Overall Study|Withdrawal by Subject|0|||
27834330|NCT02761915|81226039|FG003|Overall Study|Withdrawal by Subject|0|||
27834331|NCT02761915|81226040|FG004|Overall Study|Withdrawal by Subject|1|||
27834332|NCT02761915|81226041|FG005|Overall Study|Withdrawal by Subject|2|||
27834333|NCT02761915|81226036|FG000|Overall Study|Disease Progression|0|||
27834334|NCT02761915|81226037|FG001|Overall Study|Disease Progression|0|||
27834335|NCT02761915|81226038|FG002|Overall Study|Disease Progression|0|||
27597747|NCT04495179|80366549|FG001|Overall Study|Withdrawal by Subject|4|||
27754807|NCT02546674|80929604|FG000|Overall Study|Physician Decision|13|||
27887394|NCT01908829|81422166|FG002|Overall Study|Discontinued (no EoT page)|0|||
27887395|NCT01908829|81422164|FG000|Overall Study|Miscellaneous|0|||
27887396|NCT01908829|81422165|FG001|Overall Study|Miscellaneous|2|||
27887397|NCT01908829|81422166|FG002|Overall Study|Miscellaneous|0|||
27887398|NCT01908829|81422164|FG000|Overall Study|Protocol Violation|2|||
27887399|NCT01908829|81422165|FG001|Overall Study|Protocol Violation|2|||
27887400|NCT01908829|81422166|FG002|Overall Study|Protocol Violation|0|||
27887401|NCT01908829|81422164|FG000|Overall Study|Lack of Efficacy|1|||
27887402|NCT01908829|81422165|FG001|Overall Study|Lack of Efficacy|3|||
27887403|NCT01908829|81422166|FG002|Overall Study|Lack of Efficacy|2|||
27887404|NCT01908829|81422164|FG000|Overall Study|Withdrawal by Subject|26|||
27887405|NCT01908829|81422165|FG001|Overall Study|Withdrawal by Subject|29|||
27887406|NCT01908829|81422166|FG002|Overall Study|Withdrawal by Subject|22|||
27887407|NCT03589326|81422169|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
27887408|NCT03589326|81422170|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
27887409|NCT03589326|81422169|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
27887410|NCT03589326|81422170|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
27887411|NCT03589326|81422169|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
27887412|NCT03589326|81422170|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
27887413|NCT03589326|81422169|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
27887414|NCT03589326|81422170|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
27887415|NCT03589326|81422169|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
27887416|NCT03589326|81422170|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
27887417|NCT01637922|81422171|FG000|Overall Study|Adverse Event|0|||
27887418|NCT01637922|81422172|FG001|Overall Study|Adverse Event|1|||
27887419|NCT01637922|81422171|FG000|Overall Study|Protocol Violation|0|||
27887420|NCT01637922|81422172|FG001|Overall Study|Protocol Violation|1|||
27834336|NCT02761915|81226039|FG003|Overall Study|Disease Progression|2|||
27834337|NCT02761915|81226040|FG004|Overall Study|Disease Progression|2|||
27834338|NCT02761915|81226041|FG005|Overall Study|Disease Progression|2|||
27834339|NCT00860262|81226042|FG000|Overall Study|Adverse Event|9|||
27834340|NCT00860262|81226043|FG001|Overall Study|Adverse Event|6|||
27834341|NCT00860262|81226044|FG002|Overall Study|Adverse Event|7|||
27834342|NCT00860262|81226042|FG000|Overall Study|Protocol Violation|0|||
27834343|NCT00860262|81226043|FG001|Overall Study|Protocol Violation|1|||
27834344|NCT00860262|81226044|FG002|Overall Study|Protocol Violation|0|||
27834345|NCT00860262|81226042|FG000|Overall Study|Lost to Follow-up|2|||
27834346|NCT00860262|81226043|FG001|Overall Study|Lost to Follow-up|0|||
27834347|NCT00860262|81226044|FG002|Overall Study|Lost to Follow-up|1|||
27834348|NCT00860262|81226042|FG000|Overall Study|Withdrawal by Subject|4|||
27834349|NCT00860262|81226043|FG001|Overall Study|Withdrawal by Subject|8|||
27834350|NCT00860262|81226044|FG002|Overall Study|Withdrawal by Subject|6|||
27834351|NCT00860262|81226042|FG000|Overall Study|Lack of Efficacy|0|||
27834352|NCT00860262|81226043|FG001|Overall Study|Lack of Efficacy|4|||
27834353|NCT00860262|81226044|FG002|Overall Study|Lack of Efficacy|3|||
27834354|NCT00860262|81226042|FG000|Overall Study|Other|5|||
27834355|NCT00860262|81226043|FG001|Overall Study|Other|3|||
27834356|NCT00860262|81226044|FG002|Overall Study|Other|1|||
27834357|NCT04892147|81226047|FG000|Overall Study|Withdrawal by Subject|2|||
27834358|NCT04892147|81226048|FG001|Overall Study|Withdrawal by Subject|0|||
27834359|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
27834360|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
27834361|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
27834362|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
27834363|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
27834364|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
27834365|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
27834366|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
27834367|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
27834368|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
27834369|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
27834370|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
27834371|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
27834372|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
27834373|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
27834374|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
27834375|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
27597748|NCT04495179|80366548|FG000|Overall Study|Study terminated by sponsor|0|||
27597749|NCT04495179|80366549|FG001|Overall Study|Study terminated by sponsor|18|||
27597750|NCT04495179|80366548|FG000|Overall Study|Death|0|||
27597751|NCT04495179|80366549|FG001|Overall Study|Death|4|||
27597752|NCT04495179|80366548|FG000|Overall Study|Adverse Event|0|||
27597753|NCT04495179|80366549|FG001|Overall Study|Adverse Event|1|||
27597754|NCT01685138|80366550|FG000|Overall Study|Lost to Follow-up|1|||
27597755|NCT01685138|80366550|FG000|Overall Study|Protocol Violation|1|||
27597756|NCT01685138|80366550|FG000|Overall Study|No longer requires treatment|1|||
27597757|NCT01685138|80366550|FG000|Overall Study|Subject/guardian decision|2|||
27597758|NCT01685138|80366550|FG000|Overall Study|Physician Decision|6|||
27597759|NCT01685138|80366550|FG000|Overall Study|Death|10|||
27597760|NCT01685138|80366550|FG000|Overall Study|Adverse Event|18|||
27597761|NCT01685138|80366550|FG000|Overall Study|Progressive disease|53|||
27597762|NCT02723864|80366551|FG000|Overall Study|Refused further treatment|1|||
27597763|NCT02723864|80366552|FG001|Overall Study|Refused further treatment|0|||
27597764|NCT02723864|80366553|FG002|Overall Study|Refused further treatment|0|||
27597765|NCT02723864|80366554|FG003|Overall Study|Refused further treatment|0|||
27597766|NCT02723864|80366555|FG004|Overall Study|Refused further treatment|1|||
27597767|NCT02723864|80366556|FG005|Overall Study|Refused further treatment|2|||
27597768|NCT02723864|80366557|FG006|Overall Study|Refused further treatment|0|||
27597769|NCT02723864|80366551|FG000|Overall Study|Exceed treatment hold time|0|||
27597770|NCT02723864|80366552|FG001|Overall Study|Exceed treatment hold time|1|||
27597771|NCT02723864|80366553|FG002|Overall Study|Exceed treatment hold time|0|||
27597772|NCT02723864|80366554|FG003|Overall Study|Exceed treatment hold time|0|||
27597773|NCT02723864|80366555|FG004|Overall Study|Exceed treatment hold time|0|||
27597774|NCT02723864|80366556|FG005|Overall Study|Exceed treatment hold time|0|||
27597775|NCT02723864|80366557|FG006|Overall Study|Exceed treatment hold time|0|||
27597776|NCT02723864|80366551|FG000|Overall Study|Clinical progression|0|||
27597777|NCT02723864|80366552|FG001|Overall Study|Clinical progression|0|||
27597778|NCT02723864|80366553|FG002|Overall Study|Clinical progression|1|||
27597779|NCT02723864|80366554|FG003|Overall Study|Clinical progression|0|||
27597780|NCT02723864|80366555|FG004|Overall Study|Clinical progression|0|||
27597781|NCT02723864|80366556|FG005|Overall Study|Clinical progression|3|||
27597782|NCT02723864|80366557|FG006|Overall Study|Clinical progression|1|||
27597783|NCT02723864|80366551|FG000|Overall Study|Physician Decision|0|||
27597784|NCT02723864|80366552|FG001|Overall Study|Physician Decision|0|||
27597785|NCT02723864|80366553|FG002|Overall Study|Physician Decision|0|||
27597786|NCT02723864|80366554|FG003|Overall Study|Physician Decision|0|||
27597787|NCT02723864|80366555|FG004|Overall Study|Physician Decision|0|||
27597788|NCT02723864|80366556|FG005|Overall Study|Physician Decision|0|||
27597789|NCT02723864|80366557|FG006|Overall Study|Physician Decision|1|||
27597790|NCT02723864|80366551|FG000|Overall Study|Changes in patient condition|0|||
27597791|NCT02723864|80366552|FG001|Overall Study|Changes in patient condition|0|||
27597792|NCT02723864|80366553|FG002|Overall Study|Changes in patient condition|0|||
27597793|NCT02723864|80366554|FG003|Overall Study|Changes in patient condition|0|||
27597794|NCT02723864|80366555|FG004|Overall Study|Changes in patient condition|0|||
27597795|NCT02723864|80366556|FG005|Overall Study|Changes in patient condition|1|||
27597796|NCT02723864|80366557|FG006|Overall Study|Changes in patient condition|0|||
27597797|NCT02723864|80366551|FG000|Overall Study|Patient choice|0|||
27597798|NCT02723864|80366552|FG001|Overall Study|Patient choice|0|||
27597799|NCT02723864|80366553|FG002|Overall Study|Patient choice|0|||
27597800|NCT02723864|80366554|FG003|Overall Study|Patient choice|0|||
27597801|NCT02723864|80366555|FG004|Overall Study|Patient choice|0|||
27597802|NCT02723864|80366556|FG005|Overall Study|Patient choice|1|||
27597803|NCT02723864|80366557|FG006|Overall Study|Patient choice|0|||
27597804|NCT02723864|80366551|FG000|Overall Study|Adverse Event|0|||
27597805|NCT02723864|80366552|FG001|Overall Study|Adverse Event|0|||
27597806|NCT02723864|80366553|FG002|Overall Study|Adverse Event|0|||
27597807|NCT02723864|80366554|FG003|Overall Study|Adverse Event|0|||
27597808|NCT02723864|80366555|FG004|Overall Study|Adverse Event|0|||
27597809|NCT02723864|80366556|FG005|Overall Study|Adverse Event|1|||
27597810|NCT02723864|80366557|FG006|Overall Study|Adverse Event|0|||
27597811|NCT02723864|80366551|FG000|Overall Study|Started new treatment|0|||
27597812|NCT02723864|80366552|FG001|Overall Study|Started new treatment|0|||
27597813|NCT02723864|80366553|FG002|Overall Study|Started new treatment|0|||
27597814|NCT02723864|80366554|FG003|Overall Study|Started new treatment|0|||
27754808|NCT02546674|80929604|FG000|Overall Study|Pregnancy|1|||
27597815|NCT02723864|80366555|FG004|Overall Study|Started new treatment|0|||
27597816|NCT02723864|80366556|FG005|Overall Study|Started new treatment|1|||
27597817|NCT02723864|80366557|FG006|Overall Study|Started new treatment|0|||
27597818|NCT02723864|80366551|FG000|Overall Study|Switched to alternative treatment|0|||
27597819|NCT02723864|80366552|FG001|Overall Study|Switched to alternative treatment|0|||
27597820|NCT02723864|80366553|FG002|Overall Study|Switched to alternative treatment|0|||
27597821|NCT02723864|80366554|FG003|Overall Study|Switched to alternative treatment|0|||
27597822|NCT02723864|80366555|FG004|Overall Study|Switched to alternative treatment|0|||
27597823|NCT02723864|80366556|FG005|Overall Study|Switched to alternative treatment|1|||
27597824|NCT02723864|80366557|FG006|Overall Study|Switched to alternative treatment|0|||
27703397|NCT03496012|80751698|FG002|Overall Study|Withdrawal by Subject|2|||
27703398|NCT03496012|80751696|FG000|Overall Study|Adverse Event|0|||
27703399|NCT03496012|80751697|FG001|Overall Study|Adverse Event|0|||
27703400|NCT03496012|80751698|FG002|Overall Study|Adverse Event|1|||
27703401|NCT03496012|80751696|FG000|Overall Study|Reason Not Specified|2|||
27703402|NCT03496012|80751697|FG001|Overall Study|Reason Not Specified|0|||
27703403|NCT03496012|80751698|FG002|Overall Study|Reason Not Specified|1|||
27703404|NCT00851682|80751701|FG000|Overall Study|screen failure|5|||
27703405|NCT00851682|80751702|FG001|Overall Study|screen failure|0|||
27703406|NCT02014740|80751705|FG000|Overall Study|Lost to Follow-up|4|||
27703407|NCT02014740|80751706|FG001|Overall Study|Lost to Follow-up|4|||
27703408|NCT02014740|80751705|FG000|Overall Study|Withdrawal by Subject|2|||
27703409|NCT02014740|80751706|FG001|Overall Study|Withdrawal by Subject|1|||
27703410|NCT00805025|80751717|FG000|Overall Study|Screened but not enrolled/treated|42|||
27703411|NCT00805025|80751717|FG000|Overall Study|Adverse Event|4|||
27703412|NCT00805025|80751717|FG000|Overall Study|Withdrawal by Subject|2|||
27703413|NCT00805025|80751717|FG000|Overall Study|Physician Decision|1|||
27703414|NCT03427125|80751718|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
27703415|NCT03427125|80751719|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
27703416|NCT03427125|80751720|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
27703417|NCT04376060|80751725|FG000|Overall Study|Physician Decision|1|||
27703418|NCT01335009|80751726|FG000|Overall Study|Too ill to travel to study sites|1|||
27703419|NCT01335009|80751727|FG001|Overall Study|Too ill to travel to study sites|0|||
27597825|NCT02723864|80366551|FG000|Overall Study|Late determination of ineligibility|0|||
27597826|NCT02723864|80366552|FG001|Overall Study|Late determination of ineligibility|0|||
27597827|NCT02723864|80366553|FG002|Overall Study|Late determination of ineligibility|0|||
27597828|NCT02723864|80366554|FG003|Overall Study|Late determination of ineligibility|0|||
27597829|NCT02723864|80366555|FG004|Overall Study|Late determination of ineligibility|0|||
27597830|NCT02723864|80366556|FG005|Overall Study|Late determination of ineligibility|1|||
27597831|NCT02723864|80366557|FG006|Overall Study|Late determination of ineligibility|0|||
27597832|NCT01024608|80366558|FG000|Overall Study|Adverse Event|1|||
27597833|NCT01024608|80366559|FG001|Overall Study|Adverse Event|0|||
27597834|NCT01024608|80366558|FG000|Overall Study|Withdrawal by Subject|1|||
27597835|NCT01024608|80366559|FG001|Overall Study|Withdrawal by Subject|0|||
27597836|NCT01024608|80366558|FG000|Overall Study|Lost to Follow-up|0|||
27597837|NCT01024608|80366559|FG001|Overall Study|Lost to Follow-up|1|||
27597838|NCT01024608|80366558|FG000|Overall Study|Protocol Violation|0|||
27597839|NCT01024608|80366559|FG001|Overall Study|Protocol Violation|3|||
27597840|NCT01024608|80366558|FG000|Overall Study|Never received study treatment|2|||
27597841|NCT01024608|80366559|FG001|Overall Study|Never received study treatment|0|||
27597842|NCT03185481|80366560|FG000|Overall Study|Adverse Event|1|||
27597843|NCT03185481|80366560|FG000|Overall Study|Study Terminated by Sponsor|4|||
27597844|NCT01844284|80366562|FG000|Overall Study|Lost to Follow-up|12|||
27597845|NCT01844284|80366563|FG001|Overall Study|Lost to Follow-up|7|||
27597846|NCT04535947|80366564|FG000|Overall Study|Adverse Event|1|||
27597847|NCT04535947|80366565|FG001|Overall Study|Adverse Event|4|||
27597848|NCT04535947|80366564|FG000|Overall Study|Other reasons not specified|2|||
27597849|NCT04535947|80366565|FG001|Overall Study|Other reasons not specified|0|||
27597850|NCT04535947|80366564|FG000|Overall Study|Withdrawal by Subject|1|||
27597851|NCT04535947|80366565|FG001|Overall Study|Withdrawal by Subject|1|||
27597852|NCT03151005|80366574|FG000|Overall Study|Lost to Follow-up|5|||
27597853|NCT03151005|80366575|FG001|Overall Study|Lost to Follow-up|5|||
27597854|NCT05711641|80366590|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
27597855|NCT05711641|80366591|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
27597856|NCT05711641|80366590|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
27597857|NCT05711641|80366591|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
27597858|NCT02690974|80366592|FG000|Overall Study|Adverse Event|16|||
27597859|NCT02690974|80366592|FG000|Overall Study|Death|9|||
27597860|NCT02690974|80366592|FG000|Overall Study|Subject/guardian decision|4|||
27597861|NCT02690974|80366592|FG000|Overall Study|Lost to Follow-up|3|||
27597862|NCT02690974|80366592|FG000|Overall Study|Withdrawal of Informed Consent|3|||
27597863|NCT02690974|80366592|FG000|Overall Study|Physician Decision|2|||
27597864|NCT02690974|80366592|FG000|Overall Study|Non-compliance with study treatment|1|||
27597865|NCT02690974|80366592|FG000|Overall Study|Protocol-defined stopping criteria|1|||
27597866|NCT02690974|80366592|FG000|Overall Study|Protocol Deviation|1|||
27597867|NCT01687257|80366593|FG000|Overall Study|Efficacy Failure|6|||
27597868|NCT01687257|80366594|FG001|Overall Study|Efficacy Failure|0|||
27597869|NCT01687257|80366595|FG002|Overall Study|Efficacy Failure|5|||
27597870|NCT01687257|80366593|FG000|Overall Study|Subject Withdrew Consent|1|||
27597871|NCT01687257|80366594|FG001|Overall Study|Subject Withdrew Consent|1|||
27597872|NCT01687257|80366595|FG002|Overall Study|Subject Withdrew Consent|1|||
27597873|NCT01687257|80366593|FG000|Overall Study|Adverse Event|1|||
27597874|NCT01687257|80366594|FG001|Overall Study|Adverse Event|0|||
27597875|NCT01687257|80366595|FG002|Overall Study|Adverse Event|0|||
27597876|NCT01687257|80366593|FG000|Overall Study|Investigator's Discretion|0|||
27597877|NCT01687257|80366594|FG001|Overall Study|Investigator's Discretion|3|||
27597878|NCT01687257|80366595|FG002|Overall Study|Investigator's Discretion|0|||
27703420|NCT01335009|80751726|FG000|Overall Study|Death|28|||
27597879|NCT01207102|80366596|FG000|Overall Study|Withdrawal by Subject|5|||
27597880|NCT01207102|80366596|FG000|Overall Study|Adverse Event|2|||
27597881|NCT01207102|80366596|FG000|Overall Study|progression|2|||
27597882|NCT01207102|80366596|FG000|Overall Study|Withdrawal by Treating Physician|1|||
27597883|NCT01813474|80366597|FG000|Overall Study|Withdrawal by Subject|0|||
27597884|NCT01813474|80366598|FG001|Overall Study|Withdrawal by Subject|0|||
27597885|NCT01813474|80366599|FG002|Overall Study|Withdrawal by Subject|1|||
27703421|NCT01335009|80751727|FG001|Overall Study|Death|32|||
27703422|NCT01335009|80751726|FG000|Overall Study|Withdrawal by Subject|1|||
27597886|NCT01813474|80366597|FG000|Overall Study|Adverse Event|1|||
27834376|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
27597887|NCT01813474|80366598|FG001|Overall Study|Adverse Event|1|||
27597888|NCT01813474|80366599|FG002|Overall Study|Adverse Event|0|||
27597889|NCT01813474|80366597|FG000|Overall Study|Lack of Efficacy|2|||
27597890|NCT01813474|80366598|FG001|Overall Study|Lack of Efficacy|6|||
27597891|NCT01813474|80366599|FG002|Overall Study|Lack of Efficacy|9|||
27597892|NCT01813474|80366597|FG000|Overall Study|Death|0|||
27597893|NCT01813474|80366598|FG001|Overall Study|Death|0|||
27597894|NCT01813474|80366599|FG002|Overall Study|Death|1|||
27597895|NCT03945188|80366600|FG000|Overall Study|Protocol Violation|1|||
27597896|NCT03945188|80366601|FG001|Overall Study|Protocol Violation|0|||
27597897|NCT03945188|80366600|FG000|Overall Study|Disease worsening|79|||
27597898|NCT03945188|80366601|FG001|Overall Study|Disease worsening|73|||
27597899|NCT03945188|80366600|FG000|Overall Study|Physician Decision|2|||
27597900|NCT03945188|80366601|FG001|Overall Study|Physician Decision|2|||
27597901|NCT03945188|80366600|FG000|Overall Study|Lack of Efficacy|7|||
27703423|NCT01335009|80751727|FG001|Overall Study|Withdrawal by Subject|1|||
27703424|NCT01335009|80751726|FG000|Overall Study|Lost to Follow-up|1|||
27703425|NCT01335009|80751727|FG001|Overall Study|Lost to Follow-up|0|||
27703426|NCT00786565|80751728|FG000|Enrollment Prior to Surgery|Site Closed|3|||
27703427|NCT00786565|80751728|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
27703428|NCT00786565|80751728|FG000|Post Surgery|Abnormal macular pucker|1|||
27887421|NCT01637922|81422171|FG000|Overall Study|Withdrawal by Subject|0|||
27887422|NCT01637922|81422172|FG001|Overall Study|Withdrawal by Subject|3|||
27887423|NCT01637922|81422171|FG000|Overall Study|Lost to Follow-up|2|||
27887424|NCT01637922|81422172|FG001|Overall Study|Lost to Follow-up|0|||
27887425|NCT04435366|81422173|FG000|Year 1 (12 Months)|Adverse Event|3|||
27887426|NCT04435366|81422174|FG001|Year 1 (12 Months)|Adverse Event|0|||
27887427|NCT04435366|81422175|FG002|Year 1 (12 Months)|Adverse Event|2|||
27887428|NCT04435366|81422173|FG000|Year 1 (12 Months)|Death|2|||
27887429|NCT04435366|81422174|FG001|Year 1 (12 Months)|Death|0|||
27887430|NCT04435366|81422175|FG002|Year 1 (12 Months)|Death|1|||
27887431|NCT04435366|81422173|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
27887432|NCT04435366|81422174|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
27887433|NCT04435366|81422175|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
27703429|NCT00786565|80751728|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
27703430|NCT02906787|80751733|FG000|Overall Study|Withdrawal by Subject|12|||
27703431|NCT02906787|80751734|FG001|Overall Study|Withdrawal by Subject|10|||
27703432|NCT02906787|80751733|FG000|Overall Study|Missed|24|||
27703433|NCT02906787|80751734|FG001|Overall Study|Missed|22|||
27703434|NCT04411628|80751740|FG000|Overall Study|Withdrawal by Subject|1|||
27703435|NCT04411628|80751741|FG001|Overall Study|Withdrawal by Subject|1|||
27703436|NCT04411628|80751742|FG002|Overall Study|Withdrawal by Subject|2|||
27703437|NCT04411628|80751743|FG003|Overall Study|Withdrawal by Subject|0|||
27703438|NCT04411628|80751740|FG000|Overall Study|Lost to Follow-up|0|||
27703439|NCT04411628|80751741|FG001|Overall Study|Lost to Follow-up|1|||
27703440|NCT04411628|80751742|FG002|Overall Study|Lost to Follow-up|0|||
27703441|NCT04411628|80751743|FG003|Overall Study|Lost to Follow-up|0|||
27703442|NCT00102960|80751744|FG000|Overall Study|Death|23|||
27703443|NCT00102960|80751745|FG001|Overall Study|Death|11|||
27703444|NCT00102960|80751746|FG002|Overall Study|Death|11|||
27703445|NCT00102960|80751744|FG000|Overall Study|Lost to Follow-up|6|||
27703446|NCT00102960|80751745|FG001|Overall Study|Lost to Follow-up|12|||
27703447|NCT00102960|80751746|FG002|Overall Study|Lost to Follow-up|16|||
27703448|NCT00102960|80751744|FG000|Overall Study|Withdrawal by Subject|1|||
27703449|NCT00102960|80751745|FG001|Overall Study|Withdrawal by Subject|0|||
27703450|NCT00102960|80751746|FG002|Overall Study|Withdrawal by Subject|1|||
27703451|NCT01949155|80751747|FG000|Overall Study|Lost to Follow-up|1|||
27703452|NCT01949155|80751748|FG001|Overall Study|Lost to Follow-up|0|||
27703453|NCT01949155|80751747|FG000|Overall Study|Protocol Violation|1|||
27703454|NCT01949155|80751748|FG001|Overall Study|Protocol Violation|0|||
27703455|NCT00938717|80751749|FG000|Overall Study|Adverse Event|10|||
27703456|NCT00938717|80751750|FG001|Overall Study|Adverse Event|41|||
27703457|NCT00938717|80751749|FG000|Overall Study|Protocol Violation|11|||
27887434|NCT04435366|81422173|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
27887435|NCT04435366|81422174|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
27887436|NCT04435366|81422175|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
27887437|NCT04435366|81422173|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
27597902|NCT03945188|80366601|FG001|Overall Study|Lack of Efficacy|4|||
27703458|NCT00938717|80751750|FG001|Overall Study|Protocol Violation|8|||
27703459|NCT00938717|80751749|FG000|Overall Study|Withdrawal by Subject|26|||
27703460|NCT00938717|80751750|FG001|Overall Study|Withdrawal by Subject|24|||
27703461|NCT00938717|80751749|FG000|Overall Study|Lost to Follow-up|13|||
27703462|NCT00938717|80751750|FG001|Overall Study|Lost to Follow-up|18|||
27703463|NCT00938717|80751749|FG000|Overall Study|Lack of Efficacy|33|||
27703464|NCT00938717|80751750|FG001|Overall Study|Lack of Efficacy|15|||
27597903|NCT03945188|80366600|FG000|Overall Study|Pregnancy|2|||
27597904|NCT03945188|80366601|FG001|Overall Study|Pregnancy|0|||
27597905|NCT03945188|80366600|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
27887438|NCT04435366|81422174|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
27597906|NCT03945188|80366601|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
27597907|NCT03945188|80366600|FG000|Overall Study|Adverse Event|10|||
27597908|NCT03945188|80366601|FG001|Overall Study|Adverse Event|5|||
27597909|NCT03945188|80366600|FG000|Overall Study|Other|2|||
27597910|NCT03945188|80366601|FG001|Overall Study|Other|2|||
27597911|NCT03945188|80366600|FG000|Overall Study|Lost to Follow-up|1|||
27597912|NCT03945188|80366601|FG001|Overall Study|Lost to Follow-up|2|||
27887439|NCT04435366|81422175|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
27887440|NCT04435366|81422173|FG000|Year 1 (12 Months)|Not treated|0|||
27887441|NCT04435366|81422174|FG001|Year 1 (12 Months)|Not treated|0|||
27887442|NCT04435366|81422175|FG002|Year 1 (12 Months)|Not treated|1|||
27887443|NCT04435366|81422173|FG000|Year 2 (12 Months)|Death|1|||
27887444|NCT04435366|81422174|FG001|Year 2 (12 Months)|Death|4|||
27887445|NCT04435366|81422175|FG002|Year 2 (12 Months)|Death|6|||
27887446|NCT04435366|81422173|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
27887447|NCT04435366|81422174|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
27887448|NCT04435366|81422175|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
27887449|NCT04435366|81422173|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
27597913|NCT03076970|80366602|FG000|Washout Period 2|Adverse Event|0|||
27597914|NCT03076970|80366603|FG001|Washout Period 2|Adverse Event|0|||
27834377|NCT00950300|81226049|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
27834378|NCT00950300|81226050|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
27834379|NCT00950300|81226049|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
27834380|NCT00950300|81226050|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
27834381|NCT00950300|81226049|FG000|TFFU Period|Death|4|||
27834382|NCT00950300|81226050|FG001|TFFU Period|Death|1|||
27834383|NCT00950300|81226049|FG000|TFFU Period|Refused Treatment|10|||
27834384|NCT00950300|81226050|FG001|TFFU Period|Refused Treatment|11|||
27834385|NCT00950300|81226049|FG000|TFFU Period|Failure to Return|16|||
27834386|NCT00950300|81226050|FG001|TFFU Period|Failure to Return|16|||
27834387|NCT00950300|81226049|FG000|TFFU Period|Recurrence of Disease|63|||
27834388|NCT00950300|81226050|FG001|TFFU Period|Recurrence of Disease|72|||
27834389|NCT00950300|81226049|FG000|TFFU Period|Other|4|||
27834390|NCT00950300|81226050|FG001|TFFU Period|Other|3|||
27834391|NCT00950300|81226049|FG000|SFU Period|Death|44|||
27834392|NCT00950300|81226050|FG001|SFU Period|Death|42|||
27834393|NCT00950300|81226049|FG000|SFU Period|Lost to Follow-up|30|||
27834394|NCT00950300|81226050|FG001|SFU Period|Lost to Follow-up|28|||
27834395|NCT00950300|81226049|FG000|SFU Period|Withdrawal by Subject|4|||
27887450|NCT04435366|81422174|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
27887451|NCT04435366|81422175|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
27887452|NCT04435366|81422173|FG000|Year 2 (12 Months)|Adverse Event|2|||
27834396|NCT00950300|81226050|FG001|SFU Period|Withdrawal by Subject|8|||
27887453|NCT04435366|81422174|FG001|Year 2 (12 Months)|Adverse Event|1|||
27887454|NCT04435366|81422175|FG002|Year 2 (12 Months)|Adverse Event|6|||
27887455|NCT05217641|81422176|FG000|Overall Study|Lost to Follow-up|1|||
27887456|NCT05217641|81422177|FG001|Overall Study|Lost to Follow-up|1|||
27887457|NCT05217641|81422178|FG002|Overall Study|Lost to Follow-up|0|||
27887458|NCT05217641|81422179|FG003|Overall Study|Lost to Follow-up|1|||
27887459|NCT05217641|81422180|FG004|Overall Study|Lost to Follow-up|1|||
27887460|NCT05217641|81422181|FG005|Overall Study|Lost to Follow-up|0|||
27887461|NCT05217641|81422176|FG000|Overall Study|Withdrawal by Subject|0|||
27887462|NCT05217641|81422177|FG001|Overall Study|Withdrawal by Subject|0|||
27887463|NCT05217641|81422178|FG002|Overall Study|Withdrawal by Subject|0|||
27887464|NCT05217641|81422179|FG003|Overall Study|Withdrawal by Subject|3|||
27887465|NCT05217641|81422180|FG004|Overall Study|Withdrawal by Subject|1|||
27834397|NCT00484679|81226053|FG000|Overall Study|Withdrawal by Subject|3|||
27834398|NCT01986647|81226054|FG000|Overall Study|Lost to Follow-up|4|||
27834399|NCT01986647|81226055|FG001|Overall Study|Lost to Follow-up|1|||
27834400|NCT01986647|81226056|FG002|Overall Study|Lost to Follow-up|4|||
27834401|NCT01986647|81226057|FG003|Overall Study|Lost to Follow-up|4|||
27834402|NCT01986647|81226054|FG000|Overall Study|Withdrawal by Subject|1|||
27834403|NCT01986647|81226055|FG001|Overall Study|Withdrawal by Subject|3|||
27834404|NCT01986647|81226056|FG002|Overall Study|Withdrawal by Subject|2|||
27834405|NCT01986647|81226057|FG003|Overall Study|Withdrawal by Subject|3|||
27834406|NCT01986647|81226054|FG000|Overall Study|Health|5|||
27834407|NCT01986647|81226055|FG001|Overall Study|Health|3|||
27834408|NCT01986647|81226056|FG002|Overall Study|Health|6|||
27834409|NCT01986647|81226057|FG003|Overall Study|Health|4|||
27834410|NCT03419403|81226058|FG000|Overall Study|Withdrawal by Subject|5|||
27834411|NCT03419403|81226059|FG001|Overall Study|Withdrawal by Subject|2|||
27834412|NCT03419403|81226060|FG002|Overall Study|Withdrawal by Subject|5|||
27834413|NCT03419403|81226061|FG003|Overall Study|Withdrawal by Subject|1|||
27834414|NCT03419403|81226058|FG000|Overall Study|Progressive disease (per protocol)|0|||
27834415|NCT03419403|81226059|FG001|Overall Study|Progressive disease (per protocol)|2|||
27834416|NCT03419403|81226060|FG002|Overall Study|Progressive disease (per protocol)|2|||
27834417|NCT03419403|81226061|FG003|Overall Study|Progressive disease (per protocol)|0|||
27834418|NCT03419403|81226058|FG000|Overall Study|Other, not specified|6|||
27834419|NCT03419403|81226059|FG001|Overall Study|Other, not specified|4|||
27834420|NCT03419403|81226060|FG002|Overall Study|Other, not specified|5|||
27834421|NCT03419403|81226061|FG003|Overall Study|Other, not specified|1|||
27834422|NCT03419403|81226058|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
27834423|NCT03419403|81226059|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
27834424|NCT03419403|81226060|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
27834425|NCT03419403|81226061|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
27834426|NCT00697827|81226066|FG000|Overall Study|enrolled but not treated|2|||
27834427|NCT00697827|81226067|FG001|Overall Study|enrolled but not treated|1|||
27834428|NCT00633022|81226068|FG000|Overall Study|Adverse Event|1|||
27834429|NCT00633022|81226069|FG001|Overall Study|Adverse Event|0|||
27834430|NCT00633022|81226070|FG002|Overall Study|Adverse Event|5|||
27887466|NCT05217641|81422181|FG005|Overall Study|Withdrawal by Subject|0|||
27887467|NCT05217641|81422176|FG000|Overall Study|Other: participant did not specify reason|0|||
27834431|NCT00633022|81226068|FG000|Overall Study|Physician Decision|0|||
27834432|NCT00633022|81226069|FG001|Overall Study|Physician Decision|1|||
27887468|NCT05217641|81422177|FG001|Overall Study|Other: participant did not specify reason|0|||
27887469|NCT05217641|81422178|FG002|Overall Study|Other: participant did not specify reason|0|||
27887470|NCT05217641|81422179|FG003|Overall Study|Other: participant did not specify reason|0|||
27887471|NCT05217641|81422180|FG004|Overall Study|Other: participant did not specify reason|1|||
27887472|NCT05217641|81422181|FG005|Overall Study|Other: participant did not specify reason|0|||
27887473|NCT05217641|81422176|FG000|Overall Study|Extended Follow up|1|||
27887474|NCT05217641|81422177|FG001|Overall Study|Extended Follow up|1|||
27887475|NCT05217641|81422178|FG002|Overall Study|Extended Follow up|0|||
27887476|NCT05217641|81422179|FG003|Overall Study|Extended Follow up|0|||
27887477|NCT05217641|81422180|FG004|Overall Study|Extended Follow up|1|||
27887478|NCT05217641|81422181|FG005|Overall Study|Extended Follow up|0|||
27887479|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
27887480|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
27887481|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
27887482|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
27887483|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
27887484|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
27887485|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
27887486|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
27887487|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
27887488|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
27887489|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
27887490|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
27887491|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
27887492|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
27887493|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
27887494|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
27887495|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
27887496|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
27887497|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
27887498|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
27887499|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
27887500|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
27887501|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
27887502|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
27887503|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
27887504|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
27887505|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
27887506|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
27887507|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
27887508|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
27887509|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
27887510|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
27887511|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
27887512|NCT00839527|81422182|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
27887513|NCT00839527|81422183|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
27887514|NCT00839527|81422184|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
27887515|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
27887516|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
27887517|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
27887518|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
27887519|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
27887520|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
27703465|NCT00938717|80751749|FG000|Overall Study|Other reason|5|||
27703466|NCT00938717|80751750|FG001|Overall Study|Other reason|2|||
27703467|NCT00791258|80751751|FG000|Overall Study|Adverse Event|87|||
27703468|NCT00791258|80751751|FG000|Overall Study|Lost to Follow-up|18|||
27703469|NCT00791258|80751751|FG000|Overall Study|Protocol Violation|109|||
27703470|NCT00791258|80751751|FG000|Overall Study|Withdrawal by Subject|40|||
27703471|NCT00791258|80751751|FG000|Overall Study|Did not take medication for >3 days|1|||
27703472|NCT00791258|80751751|FG000|Overall Study|subject left area|2|||
27703473|NCT00791258|80751751|FG000|Overall Study|non-compliance|3|||
27703474|NCT00791258|80751751|FG000|Overall Study|Subject incarcerated|1|||
27703475|NCT00791258|80751751|FG000|Overall Study|Subject required restricted medication|1|||
27703476|NCT00791258|80751751|FG000|Overall Study|Lack of Efficacy|1|||
27703477|NCT00701090|80751754|FG000|Overall Study|Adverse Event|11|||
27703478|NCT00701090|80751755|FG001|Overall Study|Adverse Event|2|||
27703479|NCT00701090|80751754|FG000|Overall Study|Death|0|||
27703480|NCT00701090|80751755|FG001|Overall Study|Death|1|||
27703481|NCT00701090|80751754|FG000|Overall Study|Lack of Efficacy|5|||
27703482|NCT00701090|80751755|FG001|Overall Study|Lack of Efficacy|4|||
27703483|NCT00701090|80751754|FG000|Overall Study|Lost to Follow-up|9|||
27703484|NCT00701090|80751755|FG001|Overall Study|Lost to Follow-up|9|||
27703485|NCT00701090|80751754|FG000|Overall Study|Physician Decision|3|||
27703486|NCT00701090|80751755|FG001|Overall Study|Physician Decision|4|||
27703487|NCT00701090|80751754|FG000|Overall Study|Protocol Violation|2|||
27834433|NCT00633022|81226070|FG002|Overall Study|Physician Decision|0|||
27834434|NCT02167594|81226077|FG000|Overall Study|Withdrawal by Subject|2|||
27834435|NCT02167594|81226078|FG001|Overall Study|Withdrawal by Subject|0|||
27834436|NCT02167594|81226079|FG002|Overall Study|Withdrawal by Subject|0|||
27834437|NCT02167594|81226077|FG000|Overall Study|Death|0|||
27834438|NCT02167594|81226078|FG001|Overall Study|Death|1|||
27834439|NCT02167594|81226079|FG002|Overall Study|Death|0|||
27834440|NCT02964039|81226080|FG000|Overall Study|Medical reason unrelated to study participation|1|||
27834441|NCT02964039|81226081|FG001|Overall Study|Medical reason unrelated to study participation|0|||
27703488|NCT00701090|80751755|FG001|Overall Study|Protocol Violation|3|||
27703489|NCT00701090|80751754|FG000|Overall Study|Withdrawal by Subject|11|||
27703490|NCT00701090|80751755|FG001|Overall Study|Withdrawal by Subject|16|||
27887521|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
27887522|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
27887523|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
27887524|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
27887525|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
27887526|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
27887527|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
27887528|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
27887529|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
27887530|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
27887531|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
27887532|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
27887533|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
27887534|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
27887535|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
27887536|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
27887537|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
27887538|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
27887539|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
27887540|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
27887541|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
27887542|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
27887543|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
27887544|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
27887545|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
27887546|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
27887547|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
27887548|NCT00839527|81422182|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
27887549|NCT00839527|81422183|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
27887550|NCT00839527|81422184|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
27887551|NCT04310397|81422191|FG000|Overall Study|Lack of Efficacy|3|||
27887552|NCT04310397|81422191|FG000|Overall Study|Withdrawal by Subject|1|||
27887553|NCT02361346|81422192|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887554|NCT02361346|81422193|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887555|NCT02361346|81422194|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887556|NCT02361346|81422195|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
27887557|NCT02361346|81422196|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887558|NCT02361346|81422197|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887559|NCT02361346|81422198|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887560|NCT02361346|81422199|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887561|NCT02361346|81422200|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
27887562|NCT02361346|81422192|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27597915|NCT03076970|80366604|FG002|Washout Period 2|Adverse Event|0|||
27597916|NCT03076970|80366605|FG003|Washout Period 2|Adverse Event|0|||
27597917|NCT03076970|80366606|FG004|Washout Period 2|Adverse Event|1|||
27597918|NCT03076970|80366607|FG005|Washout Period 2|Adverse Event|0|||
27597919|NCT03076970|80366602|FG000|Period 3|Withdrawal by Subject|0|||
27597920|NCT03076970|80366603|FG001|Period 3|Withdrawal by Subject|0|||
27597921|NCT03076970|80366604|FG002|Period 3|Withdrawal by Subject|0|||
27597922|NCT03076970|80366605|FG003|Period 3|Withdrawal by Subject|0|||
27597923|NCT03076970|80366606|FG004|Period 3|Withdrawal by Subject|0|||
27597924|NCT03076970|80366607|FG005|Period 3|Withdrawal by Subject|1|||
27597925|NCT03076970|80366602|FG000|Period 3|Failure to meet I/E criteria|0|||
27597926|NCT03076970|80366603|FG001|Period 3|Failure to meet I/E criteria|0|||
27597927|NCT03076970|80366604|FG002|Period 3|Failure to meet I/E criteria|0|||
27597928|NCT03076970|80366605|FG003|Period 3|Failure to meet I/E criteria|0|||
27597929|NCT03076970|80366606|FG004|Period 3|Failure to meet I/E criteria|1|||
27597930|NCT03076970|80366607|FG005|Period 3|Failure to meet I/E criteria|0|||
27597931|NCT02163733|80366608|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
27597932|NCT02163733|80366609|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
27597933|NCT02163733|80366610|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
27597934|NCT02163733|80366608|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
27597935|NCT02163733|80366609|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
27597936|NCT02163733|80366610|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
27597937|NCT03280121|80366611|FG000|Overall Study|Physician Decision|1|||
27597938|NCT03280121|80366611|FG000|Overall Study|Lost to Follow-up|1|||
27597939|NCT03280121|80366611|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
27597940|NCT02618616|80366614|FG000|Overall Study|Lack of Efficacy|4|||
27597941|NCT02618616|80366615|FG001|Overall Study|Lack of Efficacy|0|||
27597942|NCT02618616|80366614|FG000|Overall Study|Pregnancy|0|||
27597943|NCT02618616|80366615|FG001|Overall Study|Pregnancy|1|||
27597944|NCT02618616|80366614|FG000|Overall Study|Adverse Event|8|||
27597945|NCT02618616|80366615|FG001|Overall Study|Adverse Event|0|||
27597946|NCT02618616|80366614|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
27597947|NCT02618616|80366615|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
27597948|NCT02618616|80366614|FG000|Overall Study|Consent withdrawn by subject|8|||
27597949|NCT02618616|80366615|FG001|Overall Study|Consent withdrawn by subject|5|||
27597950|NCT02618616|80366614|FG000|Overall Study|Lost to Follow-up|0|||
27597951|NCT02618616|80366615|FG001|Overall Study|Lost to Follow-up|1|||
27597952|NCT02450331|80366616|FG000|Overall Study|Death|162|||
27597953|NCT02450331|80366617|FG001|Overall Study|Death|171|||
27597954|NCT02450331|80366616|FG000|Overall Study|Lost to Follow-up|14|||
27597955|NCT02450331|80366617|FG001|Overall Study|Lost to Follow-up|12|||
27597956|NCT02450331|80366616|FG000|Overall Study|Withdrawal by Subject|55|||
27597957|NCT02450331|80366617|FG001|Overall Study|Withdrawal by Subject|44|||
27597958|NCT02450331|80366616|FG000|Overall Study|Non-specified other|1|||
27597959|NCT02450331|80366617|FG001|Overall Study|Non-specified other|1|||
27597960|NCT00569582|80366618|FG000|Overall Study|Withdrawal by Subject|5|||
27597961|NCT00569582|80366618|FG000|Overall Study|Death|2|||
27597962|NCT00569582|80366618|FG000|Overall Study|Adverse Event|7|||
27597963|NCT00569582|80366618|FG000|Overall Study|Subject was too ill to travel.|1|||
27597964|NCT00569582|80366618|FG000|Overall Study|Subject was non-compliant.|1|||
27597965|NCT00677833|80366622|FG000|Overall Study|Withdrawal by Subject|4|||
27597966|NCT00677833|80366623|FG001|Overall Study|Withdrawal by Subject|0|||
27597967|NCT00677833|80366624|FG002|Overall Study|Withdrawal by Subject|1|||
27597968|NCT00677833|80366625|FG003|Overall Study|Withdrawal by Subject|3|||
27597969|NCT00677833|80366622|FG000|Overall Study|Lost to Follow-up|0|||
27597970|NCT00677833|80366623|FG001|Overall Study|Lost to Follow-up|0|||
27597971|NCT00677833|80366624|FG002|Overall Study|Lost to Follow-up|1|||
27597972|NCT00677833|80366625|FG003|Overall Study|Lost to Follow-up|0|||
27597973|NCT00156065|80366629|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
27597974|NCT00156065|80366630|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
27597975|NCT00156065|80366631|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
27597976|NCT00156065|80366629|FG000|Overall Study|Adverse Event|8|||
27597977|NCT00156065|80366630|FG001|Overall Study|Adverse Event|11|||
27597978|NCT00156065|80366631|FG002|Overall Study|Adverse Event|4|||
27597979|NCT00156065|80366629|FG000|Overall Study|Lack of Efficacy|2|||
27597980|NCT00156065|80366630|FG001|Overall Study|Lack of Efficacy|9|||
27597981|NCT00156065|80366631|FG002|Overall Study|Lack of Efficacy|3|||
27597982|NCT00156065|80366629|FG000|Overall Study|Withdrawal by Subject|13|||
27597983|NCT00156065|80366630|FG001|Overall Study|Withdrawal by Subject|26|||
27597984|NCT00156065|80366631|FG002|Overall Study|Withdrawal by Subject|16|||
27597985|NCT00156065|80366629|FG000|Overall Study|Lost to Follow-up|5|||
27597986|NCT00156065|80366630|FG001|Overall Study|Lost to Follow-up|7|||
27597987|NCT00156065|80366631|FG002|Overall Study|Lost to Follow-up|1|||
27597988|NCT00156065|80366629|FG000|Overall Study|Other|2|||
27597989|NCT00156065|80366630|FG001|Overall Study|Other|9|||
27597990|NCT00156065|80366631|FG002|Overall Study|Other|3|||
27597991|NCT00828984|80366632|FG000|Overall Study|Adverse Event|2|||
27597992|NCT00828984|80366633|FG001|Overall Study|Adverse Event|3|||
27597993|NCT00828984|80366634|FG002|Overall Study|Adverse Event|0|||
27597994|NCT00828984|80366632|FG000|Overall Study|Lost to Follow-up|5|||
27597995|NCT00828984|80366633|FG001|Overall Study|Lost to Follow-up|3|||
27597996|NCT00828984|80366634|FG002|Overall Study|Lost to Follow-up|1|||
27597997|NCT00828984|80366632|FG000|Overall Study|Withdrawal by Subject|4|||
27597998|NCT00828984|80366633|FG001|Overall Study|Withdrawal by Subject|4|||
27597999|NCT00828984|80366634|FG002|Overall Study|Withdrawal by Subject|4|||
27598000|NCT00828984|80366632|FG000|Overall Study|Ineligable|1|||
27598001|NCT00828984|80366633|FG001|Overall Study|Ineligable|2|||
27598002|NCT00828984|80366634|FG002|Overall Study|Ineligable|0|||
27598003|NCT00828984|80366632|FG000|Overall Study|Medical Contraindication|0|||
27598004|NCT00828984|80366633|FG001|Overall Study|Medical Contraindication|1|||
27598005|NCT00828984|80366634|FG002|Overall Study|Medical Contraindication|0|||
27598006|NCT00828984|80366632|FG000|Overall Study|Noncompliant|1|||
27598007|NCT00828984|80366633|FG001|Overall Study|Noncompliant|2|||
27598008|NCT00828984|80366634|FG002|Overall Study|Noncompliant|3|||
27598009|NCT00828984|80366632|FG000|Overall Study|ConMed|1|||
27598010|NCT00828984|80366633|FG001|Overall Study|ConMed|1|||
27598011|NCT00828984|80366634|FG002|Overall Study|ConMed|1|||
27598012|NCT02822222|80366635|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
27598013|NCT02822222|80366636|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
27598014|NCT03371940|80366637|FG000|Overall Study|Withdrawal by Subject|8|||
27598015|NCT03371940|80366638|FG001|Overall Study|Withdrawal by Subject|1|||
27598016|NCT03371940|80366639|FG002|Overall Study|Withdrawal by Subject|3|||
27598017|NCT03371940|80366640|FG003|Overall Study|Withdrawal by Subject|4|||
27598018|NCT00746590|80366644|FG000|Overall Study|Death|1|||
27598019|NCT04052204|80366647|FG000|Overall Study|Death|1|||
27598020|NCT04052204|80366648|FG001|Overall Study|Death|0|||
27598021|NCT04052204|80366649|FG002|Overall Study|Death|0|||
27598022|NCT04052204|80366647|FG000|Overall Study|Progressive disease|1|||
27703491|NCT00701090|80751754|FG000|Overall Study|Other|7|||
27703492|NCT00701090|80751755|FG001|Overall Study|Other|12|||
27703493|NCT03519867|80751756|FG000|Overall Study|Adverse Event|1|||
27598023|NCT04052204|80366648|FG001|Overall Study|Progressive disease|0|||
27598024|NCT04052204|80366649|FG002|Overall Study|Progressive disease|0|||
27598025|NCT04052204|80366647|FG000|Overall Study|Other|1|||
27598026|NCT04052204|80366648|FG001|Overall Study|Other|0|||
27598027|NCT04052204|80366649|FG002|Overall Study|Other|0|||
27598028|NCT02332720|80366652|FG000|Part A and Part B|Lost to Follow-up|1|||
27598029|NCT02332720|80366653|FG001|Part A and Part B|Lost to Follow-up|0|||
27598030|NCT02332720|80366654|FG002|Part A and Part B|Lost to Follow-up|0|||
27598031|NCT02332720|80366655|FG003|Part A and Part B|Lost to Follow-up|0|||
27598032|NCT02332720|80366656|FG004|Part A and Part B|Lost to Follow-up|0|||
27598033|NCT02332720|80366657|FG005|Part A and Part B|Lost to Follow-up|2|||
27598034|NCT02332720|80366658|FG006|Part A and Part B|Lost to Follow-up|1|||
27703494|NCT03519867|80751757|FG001|Overall Study|Adverse Event|1|||
27598035|NCT02332720|80366659|FG007|Part A and Part B|Lost to Follow-up|1|||
27598036|NCT02332720|80366660|FG008|Part A and Part B|Lost to Follow-up|0|||
27598037|NCT02332720|80366661|FG009|Part A and Part B|Lost to Follow-up|0|||
27598038|NCT02332720|80366662|FG010|Part A and Part B|Lost to Follow-up|0|||
27598039|NCT02332720|80366663|FG011|Part A and Part B|Lost to Follow-up|0|||
27598040|NCT02332720|80366664|FG012|Part A and Part B|Lost to Follow-up|0|||
27598041|NCT02332720|80366665|FG013|Part A and Part B|Lost to Follow-up|0|||
27598042|NCT02332720|80366666|FG014|Part A and Part B|Lost to Follow-up|0|||
27598043|NCT02332720|80366667|FG015|Part A and Part B|Lost to Follow-up|1|||
27598044|NCT02332720|80366668|FG016|Part A and Part B|Lost to Follow-up|0|||
27598045|NCT02332720|80366669|FG017|Part A and Part B|Lost to Follow-up|0|||
27598046|NCT02332720|80366670|FG018|Part A and Part B|Lost to Follow-up|0|||
27598047|NCT02332720|80366671|FG019|Part A and Part B|Lost to Follow-up|0|||
27598048|NCT02332720|80366672|FG020|Part A and Part B|Lost to Follow-up|0|||
27598049|NCT02332720|80366673|FG021|Part A and Part B|Lost to Follow-up|0|||
27598050|NCT02332720|80366674|FG022|Part A and Part B|Lost to Follow-up|0|||
27598051|NCT02332720|80366652|FG000|Part A and Part B|Adverse Event|0|||
27598052|NCT02332720|80366653|FG001|Part A and Part B|Adverse Event|0|||
27598053|NCT02332720|80366654|FG002|Part A and Part B|Adverse Event|0|||
27598054|NCT02332720|80366655|FG003|Part A and Part B|Adverse Event|0|||
27703495|NCT03519867|80751758|FG002|Overall Study|Adverse Event|0|||
27703496|NCT03519867|80751759|FG003|Overall Study|Adverse Event|0|||
27703497|NCT03519867|80751760|FG004|Overall Study|Adverse Event|0|||
27703498|NCT03519867|80751761|FG005|Overall Study|Adverse Event|0|||
27703499|NCT03519867|80751762|FG006|Overall Study|Adverse Event|0|||
27887563|NCT02361346|81422193|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27598055|NCT02332720|80366656|FG004|Part A and Part B|Adverse Event|0|||
27598056|NCT02332720|80366657|FG005|Part A and Part B|Adverse Event|0|||
27598057|NCT02332720|80366658|FG006|Part A and Part B|Adverse Event|0|||
27598058|NCT02332720|80366659|FG007|Part A and Part B|Adverse Event|0|||
27598059|NCT02332720|80366660|FG008|Part A and Part B|Adverse Event|0|||
27703500|NCT03519867|80751763|FG007|Overall Study|Adverse Event|0|||
27598060|NCT02332720|80366661|FG009|Part A and Part B|Adverse Event|0|||
27598061|NCT02332720|80366662|FG010|Part A and Part B|Adverse Event|0|||
27598062|NCT02332720|80366663|FG011|Part A and Part B|Adverse Event|0|||
27834442|NCT02964039|81226082|FG002|Overall Study|Medical reason unrelated to study participation|3|||
27598063|NCT02332720|80366664|FG012|Part A and Part B|Adverse Event|0|||
27598064|NCT02332720|80366665|FG013|Part A and Part B|Adverse Event|0|||
27598065|NCT02332720|80366666|FG014|Part A and Part B|Adverse Event|0|||
27598066|NCT02332720|80366667|FG015|Part A and Part B|Adverse Event|0|||
27598067|NCT02332720|80366668|FG016|Part A and Part B|Adverse Event|0|||
27703501|NCT03519867|80751764|FG008|Overall Study|Adverse Event|0|||
27598068|NCT02332720|80366669|FG017|Part A and Part B|Adverse Event|1|||
27598069|NCT02332720|80366670|FG018|Part A and Part B|Adverse Event|0|||
27598070|NCT02332720|80366671|FG019|Part A and Part B|Adverse Event|0|||
27598071|NCT02332720|80366672|FG020|Part A and Part B|Adverse Event|0|||
27598072|NCT02332720|80366673|FG021|Part A and Part B|Adverse Event|0|||
27598073|NCT02332720|80366674|FG022|Part A and Part B|Adverse Event|0|||
27598074|NCT02332720|80366652|FG000|Part A and Part B|Physician Decision|0|||
27598075|NCT02332720|80366653|FG001|Part A and Part B|Physician Decision|0|||
27598076|NCT02332720|80366654|FG002|Part A and Part B|Physician Decision|0|||
27598077|NCT02332720|80366655|FG003|Part A and Part B|Physician Decision|0|||
27703502|NCT03519867|80751765|FG009|Overall Study|Adverse Event|0|||
27703503|NCT03519867|80751756|FG000|Overall Study|Protocol Violation|0|||
27703504|NCT03519867|80751757|FG001|Overall Study|Protocol Violation|0|||
27703505|NCT03519867|80751758|FG002|Overall Study|Protocol Violation|0|||
27703506|NCT03519867|80751759|FG003|Overall Study|Protocol Violation|0|||
27703507|NCT03519867|80751760|FG004|Overall Study|Protocol Violation|0|||
27703508|NCT03519867|80751761|FG005|Overall Study|Protocol Violation|1|||
27703509|NCT03519867|80751762|FG006|Overall Study|Protocol Violation|0|||
27703510|NCT03519867|80751763|FG007|Overall Study|Protocol Violation|0|||
27703511|NCT03519867|80751764|FG008|Overall Study|Protocol Violation|0|||
27703512|NCT03519867|80751765|FG009|Overall Study|Protocol Violation|0|||
27703513|NCT03519867|80751756|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703514|NCT03519867|80751757|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703515|NCT03519867|80751758|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703516|NCT03519867|80751759|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703517|NCT03519867|80751760|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703518|NCT03519867|80751761|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27598078|NCT02332720|80366656|FG004|Part A and Part B|Physician Decision|0|||
27598079|NCT02332720|80366657|FG005|Part A and Part B|Physician Decision|0|||
27703519|NCT03519867|80751762|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
27703520|NCT03519867|80751763|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27754809|NCT02546674|80929604|FG000|Overall Study|Progressive Disease|2|||
27703521|NCT03519867|80751764|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703522|NCT03519867|80751765|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
27703523|NCT03519867|80751756|FG000|Overall Study|Admin. of other reversal agent|1|||
27703524|NCT03519867|80751757|FG001|Overall Study|Admin. of other reversal agent|1|||
27703525|NCT03519867|80751758|FG002|Overall Study|Admin. of other reversal agent|0|||
27703526|NCT03519867|80751759|FG003|Overall Study|Admin. of other reversal agent|0|||
27703527|NCT03519867|80751760|FG004|Overall Study|Admin. of other reversal agent|0|||
27703528|NCT03519867|80751761|FG005|Overall Study|Admin. of other reversal agent|1|||
27703529|NCT03519867|80751762|FG006|Overall Study|Admin. of other reversal agent|0|||
27703530|NCT03519867|80751763|FG007|Overall Study|Admin. of other reversal agent|0|||
27703531|NCT03519867|80751764|FG008|Overall Study|Admin. of other reversal agent|0|||
27703532|NCT03519867|80751765|FG009|Overall Study|Admin. of other reversal agent|0|||
27703533|NCT03519867|80751756|FG000|Overall Study|Reason not provided|1|||
27703534|NCT03519867|80751757|FG001|Overall Study|Reason not provided|1|||
27703535|NCT03519867|80751758|FG002|Overall Study|Reason not provided|1|||
27703536|NCT03519867|80751759|FG003|Overall Study|Reason not provided|1|||
27703537|NCT03519867|80751760|FG004|Overall Study|Reason not provided|0|||
27703538|NCT03519867|80751761|FG005|Overall Study|Reason not provided|1|||
27703539|NCT03519867|80751762|FG006|Overall Study|Reason not provided|0|||
27703540|NCT03519867|80751763|FG007|Overall Study|Reason not provided|1|||
27703541|NCT03519867|80751764|FG008|Overall Study|Reason not provided|1|||
27703542|NCT03519867|80751765|FG009|Overall Study|Reason not provided|0|||
27703543|NCT00418665|80751766|FG000|Treatment Period|Ineligibility determined|1|||
27703544|NCT00418665|80751767|FG001|Treatment Period|Ineligibility determined|1|||
27703545|NCT00418665|80751768|FG002|Treatment Period|Ineligibility determined|0|||
27703546|NCT00418665|80751766|FG000|Treatment Period|Adverse Event|2|||
27703547|NCT00418665|80751767|FG001|Treatment Period|Adverse Event|2|||
27703548|NCT00418665|80751768|FG002|Treatment Period|Adverse Event|0|||
27703549|NCT00418665|80751766|FG000|Treatment Period|Withdrawal by Subject|0|||
27703550|NCT00418665|80751767|FG001|Treatment Period|Withdrawal by Subject|3|||
27703551|NCT00418665|80751768|FG002|Treatment Period|Withdrawal by Subject|1|||
27703552|NCT00418665|80751766|FG000|Treatment Period|Requirement for alternative therapy|1|||
27887564|NCT02361346|81422194|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27887565|NCT02361346|81422195|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27887566|NCT02361346|81422196|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
27887567|NCT02361346|81422197|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27887568|NCT02361346|81422198|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27887569|NCT02361346|81422199|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27887570|NCT02361346|81422200|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
27887571|NCT02361346|81422192|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
27887572|NCT02361346|81422193|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
27887573|NCT02361346|81422194|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
27887574|NCT02361346|81422195|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
27887575|NCT02361346|81422196|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
27887576|NCT02361346|81422197|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
27887577|NCT02361346|81422198|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
27887578|NCT02361346|81422199|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
27887579|NCT02361346|81422200|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
27887580|NCT02361346|81422192|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887581|NCT02361346|81422193|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887582|NCT02361346|81422194|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887583|NCT02361346|81422195|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887584|NCT02361346|81422196|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887585|NCT02361346|81422197|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887586|NCT02361346|81422198|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887587|NCT02361346|81422199|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
27887588|NCT02361346|81422200|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
27887589|NCT02361346|81422192|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27887590|NCT02361346|81422193|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27887591|NCT02361346|81422194|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27887592|NCT02361346|81422195|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27887593|NCT02361346|81422196|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27887594|NCT02361346|81422197|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27598080|NCT02332720|80366658|FG006|Part A and Part B|Physician Decision|0|||
27598081|NCT02332720|80366659|FG007|Part A and Part B|Physician Decision|0|||
27598082|NCT02332720|80366660|FG008|Part A and Part B|Physician Decision|0|||
27598083|NCT02332720|80366661|FG009|Part A and Part B|Physician Decision|0|||
27598084|NCT02332720|80366662|FG010|Part A and Part B|Physician Decision|0|||
27598085|NCT02332720|80366663|FG011|Part A and Part B|Physician Decision|0|||
27598086|NCT02332720|80366664|FG012|Part A and Part B|Physician Decision|0|||
27598087|NCT02332720|80366665|FG013|Part A and Part B|Physician Decision|0|||
27598088|NCT02332720|80366666|FG014|Part A and Part B|Physician Decision|0|||
27598089|NCT02332720|80366667|FG015|Part A and Part B|Physician Decision|0|||
27598090|NCT02332720|80366668|FG016|Part A and Part B|Physician Decision|0|||
27598091|NCT02332720|80366669|FG017|Part A and Part B|Physician Decision|0|||
27598092|NCT02332720|80366670|FG018|Part A and Part B|Physician Decision|1|||
27598093|NCT02332720|80366671|FG019|Part A and Part B|Physician Decision|0|||
27598094|NCT02332720|80366672|FG020|Part A and Part B|Physician Decision|0|||
27598095|NCT02332720|80366673|FG021|Part A and Part B|Physician Decision|0|||
27598096|NCT02332720|80366674|FG022|Part A and Part B|Physician Decision|0|||
27598097|NCT02332720|80366652|FG000|Part A and Part B|Withdrawal by Subject|0|||
27598098|NCT02332720|80366653|FG001|Part A and Part B|Withdrawal by Subject|0|||
27598099|NCT02332720|80366654|FG002|Part A and Part B|Withdrawal by Subject|0|||
27598100|NCT02332720|80366655|FG003|Part A and Part B|Withdrawal by Subject|0|||
27598101|NCT02332720|80366656|FG004|Part A and Part B|Withdrawal by Subject|0|||
27598102|NCT02332720|80366657|FG005|Part A and Part B|Withdrawal by Subject|1|||
27887595|NCT02361346|81422198|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27598103|NCT02332720|80366658|FG006|Part A and Part B|Withdrawal by Subject|0|||
27598104|NCT02332720|80366659|FG007|Part A and Part B|Withdrawal by Subject|0|||
27598105|NCT02332720|80366660|FG008|Part A and Part B|Withdrawal by Subject|0|||
27598106|NCT02332720|80366661|FG009|Part A and Part B|Withdrawal by Subject|0|||
27598107|NCT02332720|80366662|FG010|Part A and Part B|Withdrawal by Subject|0|||
27598108|NCT02332720|80366663|FG011|Part A and Part B|Withdrawal by Subject|0|||
27703553|NCT00418665|80751767|FG001|Treatment Period|Requirement for alternative therapy|0|||
27887596|NCT02361346|81422199|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
27887597|NCT02361346|81422200|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
27887598|NCT02361346|81422192|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887599|NCT02361346|81422193|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887600|NCT02361346|81422194|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887601|NCT02361346|81422195|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887602|NCT02361346|81422196|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887603|NCT02361346|81422197|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887604|NCT02361346|81422198|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887605|NCT02361346|81422199|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
27887606|NCT02361346|81422200|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
27887607|NCT06303167|81422201|FG000|Overall Study|Ineligible|1|||
27887608|NCT06303167|81422201|FG000|Overall Study|Never start protocol therapy|2|||
27887609|NCT06303167|81422201|FG000|Overall Study|Disease progression|16|||
27887610|NCT02640404|81422202|FG000|Overall Study|Protocol Violation|1|||
27887611|NCT02640404|81422203|FG001|Overall Study|Protocol Violation|0|||
27887612|NCT02640404|81422202|FG000|Overall Study|Withdrawal by Subject|1|||
27887613|NCT02640404|81422203|FG001|Overall Study|Withdrawal by Subject|0|||
27887614|NCT00601172|81422205|FG000|Overall Study|Adverse Event|43|||
27887615|NCT00601172|81422206|FG001|Overall Study|Adverse Event|32|||
27887616|NCT00601172|81422205|FG000|Overall Study|Lack of Efficacy|11|||
27887617|NCT00601172|81422206|FG001|Overall Study|Lack of Efficacy|12|||
27598109|NCT02332720|80366664|FG012|Part A and Part B|Withdrawal by Subject|0|||
27598110|NCT02332720|80366665|FG013|Part A and Part B|Withdrawal by Subject|0|||
27598111|NCT02332720|80366666|FG014|Part A and Part B|Withdrawal by Subject|0|||
27598112|NCT02332720|80366667|FG015|Part A and Part B|Withdrawal by Subject|0|||
27598113|NCT02332720|80366668|FG016|Part A and Part B|Withdrawal by Subject|0|||
27598114|NCT02332720|80366669|FG017|Part A and Part B|Withdrawal by Subject|0|||
27598115|NCT02332720|80366670|FG018|Part A and Part B|Withdrawal by Subject|0|||
27598116|NCT02332720|80366671|FG019|Part A and Part B|Withdrawal by Subject|1|||
27598117|NCT02332720|80366672|FG020|Part A and Part B|Withdrawal by Subject|0|||
27598118|NCT02332720|80366673|FG021|Part A and Part B|Withdrawal by Subject|0|||
27598119|NCT02332720|80366674|FG022|Part A and Part B|Withdrawal by Subject|0|||
27598120|NCT01822587|80366679|FG000|Overall Study|Lost to Follow-up|7|||
27598121|NCT01822587|80366680|FG001|Overall Study|Lost to Follow-up|9|||
27703554|NCT00418665|80751768|FG002|Treatment Period|Requirement for alternative therapy|0|||
27598122|NCT01822587|80366681|FG002|Overall Study|Lost to Follow-up|12|||
27598123|NCT01822587|80366679|FG000|Overall Study|Physician Decision|9|||
27598124|NCT01822587|80366680|FG001|Overall Study|Physician Decision|6|||
27598125|NCT01822587|80366681|FG002|Overall Study|Physician Decision|6|||
27598126|NCT00689221|80366682|FG000|Overall Study|Ongoing at cut-off date|39|||
27703555|NCT00418665|80751766|FG000|Treatment Period|Physician Decision|1|||
27598127|NCT00689221|80366683|FG001|Overall Study|Ongoing at cut-off date|36|||
27598128|NCT00831779|80366684|FG000|Overall Study|Lost to Follow-up|1|||
27598129|NCT00831779|80366685|FG001|Overall Study|Lost to Follow-up|0|||
27598130|NCT00831779|80366684|FG000|Overall Study|No longer met criteria|0|||
27598131|NCT00831779|80366685|FG001|Overall Study|No longer met criteria|1|||
27598132|NCT04252742|80366688|FG000|Overall Study|Decision by sponsor|0|||
27598133|NCT04252742|80366689|FG001|Overall Study|Decision by sponsor|2|||
27598134|NCT04252742|80366688|FG000|Overall Study|Withdrawal by Subject|15|||
27598135|NCT04252742|80366689|FG001|Overall Study|Withdrawal by Subject|9|||
27598136|NCT04252742|80366688|FG000|Overall Study|Lost to Follow-up|0|||
27598137|NCT04252742|80366689|FG001|Overall Study|Lost to Follow-up|1|||
27598138|NCT02008890|80366694|FG000|Period 1|Withdrawal by Subject|7|||
27598139|NCT02008890|80366695|FG001|Period 1|Withdrawal by Subject|7|||
27598140|NCT02008890|80366696|FG002|Period 1|Withdrawal by Subject|5|||
27598141|NCT02008890|80366697|FG003|Period 1|Withdrawal by Subject|0|||
27598142|NCT02008890|80366698|FG004|Period 1|Withdrawal by Subject|0|||
27598143|NCT02008890|80366694|FG000|Period 1|Pregnancy|1|||
27598144|NCT02008890|80366695|FG001|Period 1|Pregnancy|0|||
27598145|NCT02008890|80366696|FG002|Period 1|Pregnancy|0|||
27598146|NCT02008890|80366697|FG003|Period 1|Pregnancy|0|||
27598147|NCT02008890|80366698|FG004|Period 1|Pregnancy|0|||
27598148|NCT02008890|80366694|FG000|Period 1|Physician Decision|1|||
27598149|NCT02008890|80366695|FG001|Period 1|Physician Decision|0|||
27598150|NCT02008890|80366696|FG002|Period 1|Physician Decision|1|||
27598151|NCT02008890|80366697|FG003|Period 1|Physician Decision|0|||
27598152|NCT02008890|80366698|FG004|Period 1|Physician Decision|0|||
27598153|NCT02008890|80366694|FG000|Period 1|Adverse Event|6|||
27598154|NCT02008890|80366695|FG001|Period 1|Adverse Event|8|||
27887618|NCT00601172|81422205|FG000|Overall Study|Protocol Violation|2|||
27887619|NCT00601172|81422206|FG001|Overall Study|Protocol Violation|5|||
27887620|NCT00601172|81422205|FG000|Overall Study|Lost to Follow-up|4|||
27598155|NCT02008890|80366696|FG002|Period 1|Adverse Event|6|||
27598156|NCT02008890|80366697|FG003|Period 1|Adverse Event|0|||
27598157|NCT02008890|80366698|FG004|Period 1|Adverse Event|0|||
27598158|NCT02008890|80366694|FG000|Period 2|Adverse Event|12|||
27598159|NCT02008890|80366695|FG001|Period 2|Adverse Event|7|||
27598160|NCT02008890|80366696|FG002|Period 2|Adverse Event|0|||
27598161|NCT02008890|80366697|FG003|Period 2|Adverse Event|5|||
27598162|NCT02008890|80366698|FG004|Period 2|Adverse Event|5|||
27598163|NCT02008890|80366694|FG000|Period 2|Withdrawal by Subject|11|||
27598164|NCT02008890|80366695|FG001|Period 2|Withdrawal by Subject|8|||
27598165|NCT02008890|80366696|FG002|Period 2|Withdrawal by Subject|0|||
27598166|NCT02008890|80366697|FG003|Period 2|Withdrawal by Subject|7|||
27598167|NCT02008890|80366698|FG004|Period 2|Withdrawal by Subject|2|||
27598168|NCT02008890|80366694|FG000|Period 2|Physician Decision|4|||
27598169|NCT02008890|80366695|FG001|Period 2|Physician Decision|0|||
27598170|NCT02008890|80366696|FG002|Period 2|Physician Decision|0|||
27598171|NCT02008890|80366697|FG003|Period 2|Physician Decision|2|||
27598172|NCT02008890|80366698|FG004|Period 2|Physician Decision|1|||
27598173|NCT02008890|80366694|FG000|Period 2|Lost to Follow-up|0|||
27887621|NCT00601172|81422206|FG001|Overall Study|Lost to Follow-up|3|||
27887622|NCT00601172|81422205|FG000|Overall Study|Physician Decision|27|||
27887623|NCT00601172|81422206|FG001|Overall Study|Physician Decision|28|||
27598174|NCT02008890|80366695|FG001|Period 2|Lost to Follow-up|0|||
27598175|NCT02008890|80366696|FG002|Period 2|Lost to Follow-up|1|||
27598176|NCT02008890|80366697|FG003|Period 2|Lost to Follow-up|0|||
27598177|NCT02008890|80366698|FG004|Period 2|Lost to Follow-up|0|||
27598178|NCT02008890|80366694|FG000|Extension Period|Withdrawal by Subject|3|||
27887624|NCT00601172|81422205|FG000|Overall Study|Withdrawal by Subject|35|||
27887625|NCT00601172|81422206|FG001|Overall Study|Withdrawal by Subject|27|||
27887626|NCT00601172|81422205|FG000|Overall Study|Did not meet continuation criteria|19|||
27598179|NCT02008890|80366695|FG001|Extension Period|Withdrawal by Subject|2|||
27598180|NCT02008890|80366696|FG002|Extension Period|Withdrawal by Subject|0|||
27598181|NCT02008890|80366697|FG003|Extension Period|Withdrawal by Subject|4|||
27598182|NCT02008890|80366698|FG004|Extension Period|Withdrawal by Subject|2|||
27598183|NCT02008890|80366694|FG000|Extension Period|Lost to Follow-up|1|||
27598184|NCT02008890|80366695|FG001|Extension Period|Lost to Follow-up|0|||
27598185|NCT02008890|80366696|FG002|Extension Period|Lost to Follow-up|0|||
27598186|NCT02008890|80366697|FG003|Extension Period|Lost to Follow-up|0|||
27598187|NCT02008890|80366698|FG004|Extension Period|Lost to Follow-up|0|||
27598188|NCT02008890|80366694|FG000|Extension Period|Adverse Event|1|||
27598189|NCT02008890|80366695|FG001|Extension Period|Adverse Event|3|||
27598190|NCT02008890|80366696|FG002|Extension Period|Adverse Event|0|||
27598191|NCT02008890|80366697|FG003|Extension Period|Adverse Event|0|||
27598192|NCT02008890|80366698|FG004|Extension Period|Adverse Event|2|||
27598193|NCT01925950|80366703|FG000|Part 2|Withdrawal by Subject|1|||
27598194|NCT01925950|80366704|FG001|Part 2|Withdrawal by Subject|0|||
27598195|NCT01939548|80366705|FG000|Overall Study|Non compliance|0|||
27598196|NCT01939548|80366706|FG001|Overall Study|Non compliance|2|||
27598197|NCT01939548|80366707|FG002|Overall Study|Non compliance|0|||
27598198|NCT01939548|80366705|FG000|Overall Study|Study Terminated by Sponsor|17|||
27598199|NCT01939548|80366706|FG001|Overall Study|Study Terminated by Sponsor|19|||
27598200|NCT01939548|80366707|FG002|Overall Study|Study Terminated by Sponsor|12|||
27598201|NCT01939548|80366705|FG000|Overall Study|Insufficient Clinical Response|1|||
27598202|NCT01939548|80366706|FG001|Overall Study|Insufficient Clinical Response|0|||
27598203|NCT01939548|80366707|FG002|Overall Study|Insufficient Clinical Response|0|||
27598204|NCT01939548|80366705|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27834443|NCT02964039|81226080|FG000|Overall Study|Research shutdown due to pandemic|2|||
27834444|NCT02964039|81226081|FG001|Overall Study|Research shutdown due to pandemic|0|||
27834445|NCT02964039|81226082|FG002|Overall Study|Research shutdown due to pandemic|1|||
27598205|NCT01939548|80366706|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
27598206|NCT01939548|80366707|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
27598207|NCT01939548|80366705|FG000|Overall Study|Withdrawal by Subject|4|||
27703556|NCT00418665|80751767|FG001|Treatment Period|Physician Decision|0|||
27703557|NCT00418665|80751768|FG002|Treatment Period|Physician Decision|3|||
27703558|NCT00418665|80751766|FG000|Treatment Extension|Adverse Event|1|||
27703559|NCT00418665|80751767|FG001|Treatment Extension|Adverse Event|0|||
27703560|NCT00418665|80751768|FG002|Treatment Extension|Adverse Event|0|||
27703561|NCT00418665|80751766|FG000|Treatment Extension|Withdrawal by Subject|1|||
27703562|NCT00418665|80751767|FG001|Treatment Extension|Withdrawal by Subject|0|||
27703563|NCT00418665|80751768|FG002|Treatment Extension|Withdrawal by Subject|0|||
27703564|NCT00418665|80751766|FG000|Treatment Extension|Requirement for alternative therapy|2|||
27703565|NCT00418665|80751767|FG001|Treatment Extension|Requirement for alternative therapy|2|||
27703566|NCT00418665|80751768|FG002|Treatment Extension|Requirement for alternative therapy|0|||
27703567|NCT00418665|80751766|FG000|Treatment Extension|Physician Decision|2|||
27703568|NCT00418665|80751767|FG001|Treatment Extension|Physician Decision|2|||
27703569|NCT00418665|80751768|FG002|Treatment Extension|Physician Decision|1|||
27703570|NCT00418665|80751766|FG000|Treatment Extension|Death|0|||
27703571|NCT00418665|80751767|FG001|Treatment Extension|Death|0|||
27703572|NCT00418665|80751768|FG002|Treatment Extension|Death|1|||
27703573|NCT01514136|80751771|FG000|Test Period 1; Test A|Protocol Violation|1|||
27703574|NCT01514136|80751772|FG001|Test Period 1; Test A|Protocol Violation|0|||
27703575|NCT01514136|80751773|FG002|Test Period 1; Test A|Protocol Violation|0|||
27703576|NCT01514136|80751774|FG003|Test Period 1; Test A|Protocol Violation|0|||
27703577|NCT01514136|80751775|FG004|Test Period 1; Test A|Protocol Violation|0|||
27703578|NCT01514136|80751776|FG005|Test Period 1; Test A|Protocol Violation|0|||
27703579|NCT01514136|80751777|FG006|Test Period 1; Test A|Protocol Violation|0|||
27703580|NCT01514136|80751778|FG007|Test Period 1; Test A|Protocol Violation|0|||
27703581|NCT01514136|80751771|FG000|Test Period 1; Test A|Break from study holiday|2|||
27703582|NCT01514136|80751772|FG001|Test Period 1; Test A|Break from study holiday|0|||
27887627|NCT00601172|81422206|FG001|Overall Study|Did not meet continuation criteria|20|||
27887628|NCT01116648|81422207|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
27887629|NCT01116648|81422208|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
27887630|NCT01116648|81422209|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
27887631|NCT01116648|81422210|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
27887632|NCT01116648|81422211|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
27887633|NCT01116648|81422212|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
27887634|NCT01116648|81422213|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
27703583|NCT01514136|80751773|FG002|Test Period 1; Test A|Break from study holiday|0|||
27703584|NCT01514136|80751774|FG003|Test Period 1; Test A|Break from study holiday|0|||
27703585|NCT01514136|80751775|FG004|Test Period 1; Test A|Break from study holiday|0|||
27703586|NCT01514136|80751776|FG005|Test Period 1; Test A|Break from study holiday|0|||
27703587|NCT01514136|80751777|FG006|Test Period 1; Test A|Break from study holiday|0|||
27703588|NCT01514136|80751778|FG007|Test Period 1; Test A|Break from study holiday|0|||
27703589|NCT01514136|80751771|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
27703590|NCT01514136|80751772|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
27703591|NCT01514136|80751773|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
27703592|NCT01514136|80751774|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
27703593|NCT01514136|80751775|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
27703594|NCT01514136|80751776|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
27703595|NCT01514136|80751777|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
27703596|NCT01514136|80751778|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
27703597|NCT01514136|80751771|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
27703598|NCT01514136|80751772|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
27703599|NCT01514136|80751773|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
27703600|NCT01514136|80751774|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
27703601|NCT01514136|80751775|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
27703602|NCT01514136|80751776|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
27703603|NCT01514136|80751777|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
27703604|NCT01514136|80751778|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
27887635|NCT01116648|81422214|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
27703605|NCT01514136|80751771|FG000|Test Period 2; Test A*|Adverse Event|0|||
27703606|NCT01514136|80751772|FG001|Test Period 2; Test A*|Adverse Event|0|||
27887636|NCT01116648|81422215|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
27887637|NCT01116648|81422216|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
27887638|NCT01116648|81422217|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
27887639|NCT01116648|81422218|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
27703607|NCT01514136|80751773|FG002|Test Period 2; Test A*|Adverse Event|0|||
27703608|NCT01514136|80751774|FG003|Test Period 2; Test A*|Adverse Event|0|||
27887640|NCT01116648|81422219|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
27598208|NCT01939548|80366706|FG001|Overall Study|Withdrawal by Subject|4|||
27598209|NCT01939548|80366707|FG002|Overall Study|Withdrawal by Subject|1|||
27598210|NCT01939548|80366705|FG000|Overall Study|Protocol Violation|7|||
27598211|NCT01939548|80366706|FG001|Overall Study|Protocol Violation|6|||
27598212|NCT01939548|80366707|FG002|Overall Study|Protocol Violation|5|||
27598213|NCT01939548|80366705|FG000|Overall Study|Lost to Follow-up|5|||
27598214|NCT01939548|80366706|FG001|Overall Study|Lost to Follow-up|5|||
27598215|NCT01939548|80366707|FG002|Overall Study|Lost to Follow-up|3|||
27598216|NCT01939548|80366705|FG000|Overall Study|Adverse Event|2|||
27598217|NCT01939548|80366706|FG001|Overall Study|Adverse Event|9|||
27598218|NCT01939548|80366707|FG002|Overall Study|Adverse Event|7|||
27598219|NCT01939548|80366705|FG000|Overall Study|Death|0|||
27598220|NCT01939548|80366706|FG001|Overall Study|Death|0|||
27598221|NCT01939548|80366707|FG002|Overall Study|Death|1|||
27598222|NCT01939548|80366705|FG000|Overall Study|Participant dropped|0|||
27598223|NCT01939548|80366706|FG001|Overall Study|Participant dropped|0|||
27703609|NCT01514136|80751775|FG004|Test Period 2; Test A*|Adverse Event|1|||
27703610|NCT01514136|80751776|FG005|Test Period 2; Test A*|Adverse Event|0|||
27887641|NCT01116648|81422220|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
27598224|NCT01939548|80366707|FG002|Overall Study|Participant dropped|1|||
27598225|NCT01939548|80366705|FG000|Overall Study|Participant unwilling to continue|0|||
27598226|NCT01939548|80366706|FG001|Overall Study|Participant unwilling to continue|1|||
27703611|NCT01514136|80751777|FG006|Test Period 2; Test A*|Adverse Event|0|||
27703612|NCT01514136|80751778|FG007|Test Period 2; Test A*|Adverse Event|0|||
27703613|NCT01514136|80751771|FG000|Test Period 2; Test A*|Holiday|0|||
27703614|NCT01514136|80751772|FG001|Test Period 2; Test A*|Holiday|0|||
27703615|NCT01514136|80751773|FG002|Test Period 2; Test A*|Holiday|0|||
27703616|NCT01514136|80751774|FG003|Test Period 2; Test A*|Holiday|0|||
27703617|NCT01514136|80751775|FG004|Test Period 2; Test A*|Holiday|1|||
27703618|NCT01514136|80751776|FG005|Test Period 2; Test A*|Holiday|0|||
27703619|NCT01514136|80751777|FG006|Test Period 2; Test A*|Holiday|0|||
27703620|NCT01514136|80751778|FG007|Test Period 2; Test A*|Holiday|0|||
27703621|NCT01514136|80751771|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703622|NCT01514136|80751772|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703623|NCT01514136|80751773|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703624|NCT01514136|80751774|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703625|NCT01514136|80751775|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703626|NCT01514136|80751776|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
27703627|NCT01514136|80751777|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703628|NCT01514136|80751778|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
27703629|NCT01514136|80751771|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703630|NCT01514136|80751772|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703631|NCT01514136|80751773|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703632|NCT01514136|80751774|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703633|NCT01514136|80751775|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703634|NCT01514136|80751776|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703635|NCT01514136|80751777|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
27703636|NCT01514136|80751778|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
27703637|NCT01514136|80751771|FG000|Test Period 2; Test C*|holiday|0|||
27703638|NCT01514136|80751772|FG001|Test Period 2; Test C*|holiday|0|||
27703639|NCT01514136|80751773|FG002|Test Period 2; Test C*|holiday|0|||
27703640|NCT01514136|80751774|FG003|Test Period 2; Test C*|holiday|0|||
27703641|NCT01514136|80751775|FG004|Test Period 2; Test C*|holiday|0|||
27703642|NCT01514136|80751776|FG005|Test Period 2; Test C*|holiday|0|||
27703643|NCT01514136|80751777|FG006|Test Period 2; Test C*|holiday|1|||
27703644|NCT01514136|80751778|FG007|Test Period 2; Test C*|holiday|0|||
27703645|NCT01514136|80751771|FG000|Test Period 2; Test C*|Protocol Violation|0|||
27703646|NCT01514136|80751772|FG001|Test Period 2; Test C*|Protocol Violation|0|||
27703647|NCT01514136|80751773|FG002|Test Period 2; Test C*|Protocol Violation|0|||
27703648|NCT01514136|80751774|FG003|Test Period 2; Test C*|Protocol Violation|0|||
27703649|NCT01514136|80751775|FG004|Test Period 2; Test C*|Protocol Violation|0|||
27703650|NCT01514136|80751776|FG005|Test Period 2; Test C*|Protocol Violation|0|||
27703651|NCT01514136|80751777|FG006|Test Period 2; Test C*|Protocol Violation|1|||
27703652|NCT01514136|80751778|FG007|Test Period 2; Test C*|Protocol Violation|0|||
27703653|NCT00888381|80751786|FG000|Overall Study|Lost to Follow-up|0|||
27703654|NCT00888381|80751787|FG001|Overall Study|Lost to Follow-up|1|||
27703655|NCT03684642|80751788|FG000|Overall Study|Adverse Event|6|||
27703656|NCT03684642|80751789|FG001|Overall Study|Adverse Event|15|||
27703657|NCT03684642|80751790|FG002|Overall Study|Adverse Event|11|||
27703658|NCT03684642|80751788|FG000|Overall Study|Withdrawal by Subject|35|||
27703659|NCT03684642|80751789|FG001|Overall Study|Withdrawal by Subject|53|||
27703660|NCT03684642|80751790|FG002|Overall Study|Withdrawal by Subject|23|||
27703661|NCT03684642|80751788|FG000|Overall Study|Lack of Efficacy|0|||
27703662|NCT03684642|80751789|FG001|Overall Study|Lack of Efficacy|0|||
27703663|NCT03684642|80751790|FG002|Overall Study|Lack of Efficacy|1|||
27703664|NCT03684642|80751788|FG000|Overall Study|Poor compliance to protocol|0|||
27703665|NCT03684642|80751789|FG001|Overall Study|Poor compliance to protocol|4|||
27703666|NCT03684642|80751790|FG002|Overall Study|Poor compliance to protocol|1|||
27703667|NCT03684642|80751788|FG000|Overall Study|Other than specified|62|||
27703668|NCT03684642|80751789|FG001|Overall Study|Other than specified|60|||
27703669|NCT03684642|80751790|FG002|Overall Study|Other than specified|67|||
27703670|NCT03684642|80751788|FG000|Overall Study|Randomized and not treated|0|||
27703671|NCT03684642|80751789|FG001|Overall Study|Randomized and not treated|0|||
27703672|NCT03684642|80751790|FG002|Overall Study|Randomized and not treated|1|||
27703673|NCT03684642|80751788|FG000|Overall Study|Missing completion status but alive at last contact|0|||
27703674|NCT03684642|80751789|FG001|Overall Study|Missing completion status but alive at last contact|1|||
27703675|NCT03684642|80751790|FG002|Overall Study|Missing completion status but alive at last contact|2|||
27703676|NCT02445755|80751793|FG000|Overall Study|Withdrawal by Subject|2|||
27703677|NCT02445755|80751793|FG000|Overall Study|Protocol Violation|6|||
27703678|NCT02445755|80751793|FG000|Overall Study|Screen Failure|5|||
27703679|NCT04422990|80751797|FG000|Overall Study|Withdrawal by Subject|0|||
27703680|NCT04422990|80751798|FG001|Overall Study|Withdrawal by Subject|1|||
27703681|NCT04422990|80751797|FG000|Overall Study|Travel|3|||
27703682|NCT04422990|80751798|FG001|Overall Study|Travel|0|||
27703683|NCT00702325|80751801|FG000|Overall Study|Adverse Event|1|||
27703684|NCT00702325|80751802|FG001|Overall Study|Adverse Event|0|||
27703685|NCT00702325|80751801|FG000|Overall Study|Withdrawal by Subject|7|||
27703686|NCT00702325|80751802|FG001|Overall Study|Withdrawal by Subject|7|||
27703687|NCT00702325|80751801|FG000|Overall Study|Lost to Follow-up|3|||
27703688|NCT00702325|80751802|FG001|Overall Study|Lost to Follow-up|4|||
27703689|NCT00702325|80751801|FG000|Overall Study|Incorrect enrollment|5|||
27703690|NCT00702325|80751802|FG001|Overall Study|Incorrect enrollment|7|||
27703691|NCT00702325|80751801|FG000|Overall Study|Developed study discontinuation criteria|18|||
27703692|NCT00702325|80751802|FG001|Overall Study|Developed study discontinuation criteria|28|||
27703693|NCT00702325|80751801|FG000|Overall Study|Severe noncompliance to protocol|3|||
27703694|NCT00702325|80751802|FG001|Overall Study|Severe noncompliance to protocol|3|||
27703695|NCT00702325|80751801|FG000|Overall Study|Termination due to lab results|1|||
27703696|NCT00702325|80751802|FG001|Overall Study|Termination due to lab results|0|||
27703697|NCT00702325|80751801|FG000|Overall Study|Didn't follow study medication dosage|0|||
27703698|NCT00702325|80751802|FG001|Overall Study|Didn't follow study medication dosage|2|||
27703699|NCT00702325|80751801|FG000|Overall Study|Withdrew consent|0|||
27703700|NCT00702325|80751802|FG001|Overall Study|Withdrew consent|1|||
27703701|NCT00702325|80751801|FG000|Overall Study|Incorrectly Discontinued|0|||
27703702|NCT00702325|80751802|FG001|Overall Study|Incorrectly Discontinued|1|||
27703703|NCT01132612|80755277|FG000|Overall Study|Death|0|||
27703704|NCT01132612|80755278|FG001|Overall Study|Death|0|||
27703705|NCT01132612|80755279|FG002|Overall Study|Death|1|||
27703706|NCT01132612|80755277|FG000|Overall Study|Protocol deviation|0|||
27703707|NCT01132612|80755278|FG001|Overall Study|Protocol deviation|0|||
27703708|NCT01132612|80755279|FG002|Overall Study|Protocol deviation|3|||
27703709|NCT01132612|80755277|FG000|Overall Study|Lost to Follow-up|2|||
27703710|NCT01132612|80755278|FG001|Overall Study|Lost to Follow-up|2|||
27703711|NCT01132612|80755279|FG002|Overall Study|Lost to Follow-up|7|||
27703712|NCT01132612|80755277|FG000|Overall Study|Adverse Event|5|||
27703713|NCT01132612|80755278|FG001|Overall Study|Adverse Event|2|||
27703714|NCT01132612|80755279|FG002|Overall Study|Adverse Event|15|||
27703715|NCT01132612|80755277|FG000|Overall Study|Withdrawal by Subject|5|||
27703716|NCT01132612|80755278|FG001|Overall Study|Withdrawal by Subject|8|||
27834446|NCT02964039|81226080|FG000|Overall Study|Withdrawal by Subject|0|||
27834447|NCT02964039|81226081|FG001|Overall Study|Withdrawal by Subject|1|||
27834448|NCT02964039|81226082|FG002|Overall Study|Withdrawal by Subject|0|||
27834449|NCT02964039|81226080|FG000|Overall Study|Lost to Follow-up|1|||
27834450|NCT02964039|81226081|FG001|Overall Study|Lost to Follow-up|0|||
27834451|NCT02964039|81226082|FG002|Overall Study|Lost to Follow-up|1|||
27834452|NCT02670551|81226083|FG000|Overall Study|Adverse Event|4|||
27834453|NCT02670551|81226084|FG001|Overall Study|Adverse Event|7|||
27834454|NCT02670551|81226085|FG002|Overall Study|Adverse Event|9|||
27834455|NCT02670551|81226083|FG000|Overall Study|Lack of Efficacy|2|||
27703717|NCT01132612|80755279|FG002|Overall Study|Withdrawal by Subject|19|||
27703718|NCT01132612|80755277|FG000|Overall Study|Administrative problems|5|||
27703719|NCT01132612|80755278|FG001|Overall Study|Administrative problems|1|||
27703720|NCT01132612|80755279|FG002|Overall Study|Administrative problems|52|||
27703721|NCT01132612|80755277|FG000|Overall Study|Lack of Efficacy|23|||
27703722|NCT01132612|80755278|FG001|Overall Study|Lack of Efficacy|22|||
27703723|NCT01132612|80755279|FG002|Overall Study|Lack of Efficacy|73|||
27703724|NCT03842163|80755285|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
27703725|NCT03842163|80755285|FG000|Overall Study|Scintigraphy was not performed|44|||
27703726|NCT00916149|80755290|FG000|Overall Study|Lost to Follow-up|3|||
27703727|NCT00916149|80755291|FG001|Overall Study|Lost to Follow-up|2|||
27703728|NCT00916149|80755292|FG002|Overall Study|Lost to Follow-up|0|||
27703729|NCT00916149|80755290|FG000|Overall Study|Unable to place scalp EEG leads|1|||
27703730|NCT00916149|80755291|FG001|Overall Study|Unable to place scalp EEG leads|0|||
27703731|NCT00916149|80755292|FG002|Overall Study|Unable to place scalp EEG leads|0|||
27703732|NCT01087957|80755293|FG000|Overall Study|Death|2|||
27703733|NCT01087957|80755294|FG001|Overall Study|Death|2|||
27703734|NCT01087957|80755293|FG000|Overall Study|Lost to Follow-up|3|||
27703735|NCT01087957|80755294|FG001|Overall Study|Lost to Follow-up|4|||
27703736|NCT01087957|80755293|FG000|Overall Study|Protocol Violation|13|||
27703737|NCT01087957|80755294|FG001|Overall Study|Protocol Violation|25|||
27703738|NCT01087957|80755293|FG000|Overall Study|Withdrawal by Subject|18|||
27703739|NCT01087957|80755294|FG001|Overall Study|Withdrawal by Subject|15|||
27703740|NCT01087957|80755293|FG000|Overall Study|Physician Decision|5|||
27703741|NCT01087957|80755294|FG001|Overall Study|Physician Decision|9|||
27703742|NCT02700997|80755295|FG000|Overall Study|Did not undergo CT imaging|1|||
27703743|NCT02700997|80755295|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
27703744|NCT03472924|80755300|FG000|Overall Study|Adverse Event|1|||
27703745|NCT03472924|80755301|FG001|Overall Study|Adverse Event|0|||
27703746|NCT00132496|80755302|FG000|Overall Study|Withdrawal by Subject|1|||
27703747|NCT00132496|80755303|FG001|Overall Study|Withdrawal by Subject|2|||
27703748|NCT00132496|80755302|FG000|Overall Study|Physician Decision|1|||
27703749|NCT00132496|80755303|FG001|Overall Study|Physician Decision|0|||
27703750|NCT00880555|80755306|FG000|Overall Study|Physician Decision|0|||
27703751|NCT00880555|80755307|FG001|Overall Study|Physician Decision|8|||
27703752|NCT00880555|80755308|FG002|Overall Study|Physician Decision|0|||
27834456|NCT02670551|81226084|FG001|Overall Study|Lack of Efficacy|0|||
27834457|NCT02670551|81226085|FG002|Overall Study|Lack of Efficacy|3|||
27887642|NCT01116648|81422221|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
27834458|NCT02670551|81226083|FG000|Overall Study|Withdrawal of Consent|6|||
27703753|NCT00880555|80755309|FG003|Overall Study|Physician Decision|2|||
27703754|NCT00880555|80755310|FG004|Overall Study|Physician Decision|1|||
27703755|NCT00880555|80755311|FG005|Overall Study|Physician Decision|0|||
27703756|NCT00880555|80755306|FG000|Overall Study|Withdrawal by Subject|1|||
27703757|NCT00880555|80755307|FG001|Overall Study|Withdrawal by Subject|1|||
27703758|NCT00880555|80755308|FG002|Overall Study|Withdrawal by Subject|0|||
27703759|NCT00880555|80755309|FG003|Overall Study|Withdrawal by Subject|0|||
27887643|NCT02475265|81422222|FG000|Overall Study|Physician Decision|1|||
27703760|NCT00880555|80755310|FG004|Overall Study|Withdrawal by Subject|0|||
27887644|NCT02475265|81422222|FG000|Overall Study|Withdrawal by Subject|2|||
27703761|NCT00880555|80755311|FG005|Overall Study|Withdrawal by Subject|0|||
27703762|NCT00880555|80755306|FG000|Overall Study|Lack of resources (hired rater)|9|||
27703763|NCT00880555|80755307|FG001|Overall Study|Lack of resources (hired rater)|7|||
27703764|NCT00880555|80755308|FG002|Overall Study|Lack of resources (hired rater)|5|||
27703765|NCT00880555|80755309|FG003|Overall Study|Lack of resources (hired rater)|0|||
27703766|NCT00880555|80755310|FG004|Overall Study|Lack of resources (hired rater)|0|||
27703767|NCT00880555|80755311|FG005|Overall Study|Lack of resources (hired rater)|0|||
27887645|NCT03485495|81425119|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
27887646|NCT03485495|81425120|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
27887647|NCT00957268|81425121|FG000|Overall Study|Voluntary Withdrawal|0|||
27887648|NCT00957268|81425122|FG001|Overall Study|Voluntary Withdrawal|0|||
27887649|NCT00957268|81425123|FG002|Overall Study|Voluntary Withdrawal|1|||
27834459|NCT02670551|81226084|FG001|Overall Study|Withdrawal of Consent|3|||
27834460|NCT02670551|81226085|FG002|Overall Study|Withdrawal of Consent|8|||
27834461|NCT02670551|81226083|FG000|Overall Study|Lost to Follow-up|5|||
27834462|NCT02670551|81226084|FG001|Overall Study|Lost to Follow-up|7|||
27834463|NCT02670551|81226085|FG002|Overall Study|Lost to Follow-up|6|||
27834464|NCT02670551|81226083|FG000|Overall Study|Protocol Violation|1|||
27834465|NCT02670551|81226084|FG001|Overall Study|Protocol Violation|0|||
27834466|NCT02670551|81226085|FG002|Overall Study|Protocol Violation|0|||
27834467|NCT02670551|81226083|FG000|Overall Study|Noncompliance with study drug|3|||
27834468|NCT02670551|81226084|FG001|Overall Study|Noncompliance with study drug|3|||
27834469|NCT02670551|81226085|FG002|Overall Study|Noncompliance with study drug|2|||
27834470|NCT02670551|81226083|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27834471|NCT02670551|81226084|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27834472|NCT02670551|81226085|FG002|Overall Study|Other Miscellaneous Reasons|3|||
27834473|NCT02670551|81226083|FG000|Overall Study|Did Not Receive Treatment|5|||
27834474|NCT02670551|81226084|FG001|Overall Study|Did Not Receive Treatment|3|||
27598227|NCT01939548|80366707|FG002|Overall Study|Participant unwilling to continue|0|||
27598228|NCT01939548|80366705|FG000|Overall Study|Participant withdrew consent|0|||
27598229|NCT01939548|80366706|FG001|Overall Study|Participant withdrew consent|2|||
27598230|NCT01939548|80366707|FG002|Overall Study|Participant withdrew consent|0|||
27598231|NCT01939548|80366705|FG000|Overall Study|Did not complete follow-up|0|||
27598232|NCT01939548|80366706|FG001|Overall Study|Did not complete follow-up|1|||
27598233|NCT01939548|80366707|FG002|Overall Study|Did not complete follow-up|0|||
27598234|NCT03538951|80366710|FG000|Overall Study|Withdrawal by Subject|1|||
27598235|NCT03538951|80366711|FG001|Overall Study|Withdrawal by Subject|2|||
27598236|NCT00238433|80366714|FG000|Overall Study|Screen failure|1|||
27598237|NCT00238433|80366714|FG000|Overall Study|Lost to Follow-up|1|||
27598238|NCT00238433|80366714|FG000|Overall Study|Death|1|||
27598239|NCT01666951|80366719|FG000|Overall Study|Not dosed|1|||
27598240|NCT01666951|80366720|FG001|Overall Study|Not dosed|1|||
27598241|NCT04020341|80366721|FG000|Overall Study|Adverse Event|8|||
27598242|NCT04020341|80366722|FG001|Overall Study|Adverse Event|6|||
27598243|NCT04020341|80366721|FG000|Overall Study|Lost to Follow-up|8|||
27598244|NCT04020341|80366722|FG001|Overall Study|Lost to Follow-up|2|||
27598245|NCT04020341|80366721|FG000|Overall Study|Withdrawal by Subject|16|||
27598246|NCT04020341|80366722|FG001|Overall Study|Withdrawal by Subject|16|||
27598247|NCT04020341|80366721|FG000|Overall Study|Participant not able to swallow the tablet|1|||
27598248|NCT04020341|80366722|FG001|Overall Study|Participant not able to swallow the tablet|0|||
27598249|NCT04020341|80366721|FG000|Overall Study|Physician Decision|0|||
27598250|NCT04020341|80366722|FG001|Overall Study|Physician Decision|2|||
27598251|NCT04020341|80366721|FG000|Overall Study|Protocol Deviation|0|||
27598252|NCT04020341|80366722|FG001|Overall Study|Protocol Deviation|2|||
27598253|NCT03284788|80366723|FG000|Overall Study|Withdrawal by Subject|2|||
27598254|NCT00522626|80366724|FG000|Overall Study|Lost to Follow-up|7|||
27598255|NCT02291679|80366728|FG000|Overall Study|Adverse Event|2|||
27598256|NCT02291679|80366729|FG001|Overall Study|Adverse Event|12|||
27598257|NCT02291679|80366730|FG002|Overall Study|Adverse Event|19|||
27598258|NCT02291679|80366728|FG000|Overall Study|Protocol Violation|5|||
27598259|NCT02291679|80366729|FG001|Overall Study|Protocol Violation|1|||
27598260|NCT02291679|80366730|FG002|Overall Study|Protocol Violation|7|||
27598261|NCT02291679|80366728|FG000|Overall Study|Withdrew Consent|18|||
27703768|NCT00880555|80755306|FG000|Overall Study|Death|0|||
27703769|NCT00880555|80755307|FG001|Overall Study|Death|0|||
27834475|NCT02670551|81226085|FG002|Overall Study|Did Not Receive Treatment|0|||
27598262|NCT02291679|80366729|FG001|Overall Study|Withdrew Consent|10|||
27703770|NCT00880555|80755308|FG002|Overall Study|Death|0|||
27834476|NCT02252016|81226086|FG000|Overall Study|Lost to Follow-up|2|||
27887650|NCT00957268|81425124|FG003|Overall Study|Voluntary Withdrawal|0|||
27834477|NCT02252016|81226087|FG001|Overall Study|Lost to Follow-up|1|||
27834478|NCT02252016|81226086|FG000|Overall Study|Physician Decision|1|||
27887651|NCT00957268|81425125|FG004|Overall Study|Voluntary Withdrawal|0|||
27887652|NCT02496091|81425132|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27598263|NCT02291679|80366730|FG002|Overall Study|Withdrew Consent|15|||
27598264|NCT02291679|80366728|FG000|Overall Study|Lost to Follow-up|12|||
27598265|NCT02291679|80366729|FG001|Overall Study|Lost to Follow-up|10|||
27703771|NCT00880555|80755309|FG003|Overall Study|Death|0|||
27703772|NCT00880555|80755310|FG004|Overall Study|Death|0|||
27703773|NCT00880555|80755311|FG005|Overall Study|Death|1|||
27703774|NCT00880555|80755306|FG000|Overall Study|Lost to Follow-up|0|||
27598266|NCT02291679|80366730|FG002|Overall Study|Lost to Follow-up|9|||
27703775|NCT00880555|80755307|FG001|Overall Study|Lost to Follow-up|1|||
27703776|NCT00880555|80755308|FG002|Overall Study|Lost to Follow-up|0|||
27703777|NCT00880555|80755309|FG003|Overall Study|Lost to Follow-up|0|||
27703778|NCT00880555|80755310|FG004|Overall Study|Lost to Follow-up|0|||
27703779|NCT00880555|80755311|FG005|Overall Study|Lost to Follow-up|0|||
27703780|NCT01101438|80755313|FG000|Overall Study|Withdrawal by Subject|8|||
27703781|NCT01101438|80755314|FG001|Overall Study|Withdrawal by Subject|9|||
27703782|NCT03808688|80755319|FG000|Overall Study|Adverse Event|13|||
27703783|NCT03808688|80755320|FG001|Overall Study|Adverse Event|17|||
27703784|NCT03808688|80755319|FG000|Overall Study|Lack of Efficacy|2|||
27703785|NCT03808688|80755320|FG001|Overall Study|Lack of Efficacy|0|||
27703786|NCT03808688|80755319|FG000|Overall Study|Lost to Follow-up|0|||
27703787|NCT03808688|80755320|FG001|Overall Study|Lost to Follow-up|2|||
27703788|NCT03808688|80755319|FG000|Overall Study|Withdrawal by Subject|1|||
27703789|NCT03808688|80755320|FG001|Overall Study|Withdrawal by Subject|0|||
27703790|NCT03808688|80755319|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
27703791|NCT03808688|80755320|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
27703792|NCT03808688|80755319|FG000|Overall Study|IOP Too High|1|||
27703793|NCT03808688|80755320|FG001|Overall Study|IOP Too High|1|||
27703794|NCT03808688|80755319|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
27703795|NCT03808688|80755320|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
27703796|NCT03808688|80755319|FG000|Overall Study|Visit Out of Window|0|||
27703797|NCT03808688|80755320|FG001|Overall Study|Visit Out of Window|1|||
27703798|NCT03808688|80755319|FG000|Overall Study|Medication Non-Compliance|0|||
27703799|NCT03808688|80755320|FG001|Overall Study|Medication Non-Compliance|1|||
27703800|NCT02321930|80755321|FG000|Overall Study|Lost to Follow-up|1|||
27703801|NCT03974334|80755322|FG000|Overall Study|Lost to Follow-up|1|||
27703802|NCT00283049|80755323|FG000|Overall Study|Adverse Event|6|||
27703803|NCT00283049|80755324|FG001|Overall Study|Adverse Event|1|||
27703804|NCT00283049|80755325|FG002|Overall Study|Adverse Event|4|||
27703805|NCT00283049|80755323|FG000|Overall Study|Protocol Violation|3|||
27703806|NCT00283049|80755324|FG001|Overall Study|Protocol Violation|0|||
27703807|NCT00283049|80755325|FG002|Overall Study|Protocol Violation|3|||
27703808|NCT00283049|80755323|FG000|Overall Study|Death|1|||
27703809|NCT00283049|80755324|FG001|Overall Study|Death|1|||
27703810|NCT00283049|80755325|FG002|Overall Study|Death|1|||
27703811|NCT00283049|80755323|FG000|Overall Study|Lack of Efficacy|0|||
27703812|NCT00283049|80755324|FG001|Overall Study|Lack of Efficacy|1|||
27703813|NCT00283049|80755325|FG002|Overall Study|Lack of Efficacy|1|||
27703814|NCT00283049|80755323|FG000|Overall Study|Lost to Follow-up|4|||
27703815|NCT00283049|80755324|FG001|Overall Study|Lost to Follow-up|2|||
27703816|NCT00283049|80755325|FG002|Overall Study|Lost to Follow-up|5|||
27703817|NCT00283049|80755323|FG000|Overall Study|Withdrawal by Subject|26|||
27834479|NCT02252016|81226087|FG001|Overall Study|Physician Decision|0|||
27834480|NCT02252016|81226086|FG000|Overall Study|Withdrawal by Subject|0|||
27834481|NCT02252016|81226087|FG001|Overall Study|Withdrawal by Subject|2|||
27834482|NCT00516295|81226090|FG000|Overall Study|Lack of Efficacy|2|||
27834483|NCT00516295|81226091|FG001|Overall Study|Lack of Efficacy|0|||
27834484|NCT00516295|81226092|FG002|Overall Study|Lack of Efficacy|0|||
27834485|NCT00516295|81226090|FG000|Overall Study|Ineligible|1|||
27834486|NCT00516295|81226091|FG001|Overall Study|Ineligible|0|||
27834487|NCT00516295|81226092|FG002|Overall Study|Ineligible|0|||
27834488|NCT02005276|81226093|FG000|Overall Study|No longer interested|5|||
27887653|NCT02778074|81425135|FG000|Overall Study|Lost to Follow-up|7|||
27598267|NCT02291679|80366728|FG000|Overall Study|Insufficient Therapeutic Response|5|||
27598268|NCT02291679|80366729|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27598269|NCT02291679|80366730|FG002|Overall Study|Insufficient Therapeutic Response|7|||
27598270|NCT02291679|80366728|FG000|Overall Study|Other|2|||
27598271|NCT02291679|80366729|FG001|Overall Study|Other|4|||
27598272|NCT02291679|80366730|FG002|Overall Study|Other|2|||
27703818|NCT00283049|80755324|FG001|Overall Study|Withdrawal by Subject|24|||
27703819|NCT00283049|80755325|FG002|Overall Study|Withdrawal by Subject|19|||
27703820|NCT00283049|80755323|FG000|Overall Study|Discontinuation of Study|18|||
27703821|NCT00283049|80755324|FG001|Overall Study|Discontinuation of Study|16|||
27703822|NCT00283049|80755325|FG002|Overall Study|Discontinuation of Study|20|||
27703823|NCT00283049|80755323|FG000|Overall Study|No longer requires study treatment|0|||
27703824|NCT00283049|80755324|FG001|Overall Study|No longer requires study treatment|0|||
27834489|NCT02005276|81226094|FG001|Overall Study|No longer interested|2|||
27834490|NCT02005276|81226095|FG002|Overall Study|No longer interested|3|||
27887654|NCT02778074|81425136|FG001|Overall Study|Lost to Follow-up|10|||
27887655|NCT01931956|81425139|FG000|Overall Study|Death|42|||
27598273|NCT03750006|80366731|FG000|Overall Study|Withdrawal by Subject|8|||
27598274|NCT03750006|80366731|FG000|Overall Study|COVID PANDEMIC|11|||
27703825|NCT00283049|80755325|FG002|Overall Study|No longer requires study treatment|1|||
27703826|NCT00454857|80755329|FG000|Overall Study|Withdrawal by Subject|15|||
27703827|NCT00454857|80755329|FG000|Overall Study|Lost to Follow-up|16|||
27703828|NCT00454857|80755329|FG000|Overall Study|Noncompliance|6|||
27703829|NCT00454857|80755329|FG000|Overall Study|Death|5|||
27703830|NCT00454857|80755329|FG000|Overall Study|Other|11|||
27703831|NCT00454857|80755329|FG000|Overall Study|Reason unknown|1|||
27703832|NCT02170779|80755337|FG000|Overall Study|Withdrawal by Subject|1|||
27703833|NCT02170779|80755338|FG001|Overall Study|Withdrawal by Subject|0|||
27703834|NCT02170779|80755337|FG000|Overall Study|Lost to Follow-up|0|||
27703835|NCT02170779|80755338|FG001|Overall Study|Lost to Follow-up|1|||
27703836|NCT01848353|80755339|FG000|Phase 1|Withdrawal by Subject|3|||
27703837|NCT01848353|80755340|FG001|Phase 1|Withdrawal by Subject|1|||
27703838|NCT01848353|80755341|FG002|Phase 1|Withdrawal by Subject|0|||
27703839|NCT01848353|80755342|FG003|Phase 1|Withdrawal by Subject|0|||
27834491|NCT02005276|81226096|FG003|Overall Study|No longer interested|3|||
27834492|NCT01344018|81226097|FG000|Overall Study|Death|22|||
27834493|NCT01344018|81226098|FG001|Overall Study|Death|25|||
27834494|NCT01344018|81226097|FG000|Overall Study|Lost to Follow-up|4|||
27834495|NCT01344018|81226098|FG001|Overall Study|Lost to Follow-up|7|||
27834496|NCT05776901|81226100|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
27834497|NCT03828539|81226101|FG000|Overall Study|Adverse Event|3|||
27834498|NCT03828539|81226102|FG001|Overall Study|Adverse Event|12|||
27834499|NCT03828539|81226101|FG000|Overall Study|Patient's/guardian's decision|3|||
27834500|NCT03828539|81226102|FG001|Overall Study|Patient's/guardian's decision|5|||
27834501|NCT03828539|81226101|FG000|Overall Study|Lost to Follow-up|4|||
27834502|NCT03828539|81226102|FG001|Overall Study|Lost to Follow-up|2|||
27834503|NCT03828539|81226101|FG000|Overall Study|Protocol Violation|3|||
27834504|NCT03828539|81226102|FG001|Overall Study|Protocol Violation|2|||
27834505|NCT03828539|81226101|FG000|Overall Study|Withdrawal of informed consent|2|||
27834506|NCT03828539|81226102|FG001|Overall Study|Withdrawal of informed consent|1|||
27703840|NCT01848353|80755339|FG000|Phase 2|Withdrawal by Subject|3|||
27703841|NCT01848353|80755340|FG001|Phase 2|Withdrawal by Subject|2|||
27703842|NCT01848353|80755341|FG002|Phase 2|Withdrawal by Subject|0|||
27703843|NCT01848353|80755342|FG003|Phase 2|Withdrawal by Subject|0|||
27703844|NCT01848353|80755339|FG000|Phase 3|Withdrawal by Subject|1|||
27703845|NCT01848353|80755340|FG001|Phase 3|Withdrawal by Subject|1|||
27703846|NCT01848353|80755341|FG002|Phase 3|Withdrawal by Subject|0|||
27703847|NCT01848353|80755342|FG003|Phase 3|Withdrawal by Subject|0|||
27703848|NCT00122681|80755343|FG000|Overall Study|Adverse Event|20|||
27703849|NCT00122681|80755344|FG001|Overall Study|Adverse Event|16|||
27703850|NCT00122681|80755343|FG000|Overall Study|Lost to Follow-up|1080|||
27703851|NCT00122681|80755344|FG001|Overall Study|Lost to Follow-up|1097|||
27703852|NCT00122681|80755343|FG000|Overall Study|Protocol Violation|7|||
27703853|NCT00122681|80755344|FG001|Overall Study|Protocol Violation|10|||
27703854|NCT00122681|80755343|FG000|Overall Study|Withdrawal by Subject|257|||
27703855|NCT00122681|80755344|FG001|Overall Study|Withdrawal by Subject|251|||
27703856|NCT00122681|80755343|FG000|Overall Study|Personal reasons|150|||
27703857|NCT00122681|80755344|FG001|Overall Study|Personal reasons|147|||
27703858|NCT00798135|80755347|FG000|Overall Study|Disease progression, relapse|11|||
27703859|NCT00798135|80755347|FG000|Overall Study|Disease progression, refractory|1|||
27703860|NCT00798135|80755347|FG000|Overall Study|Physician Decision|1|||
27703861|NCT04498169|80755348|FG000|Study Completion|Adverse Event|1|||
27703862|NCT04498169|80755349|FG001|Study Completion|Adverse Event|1|||
27703863|NCT01093625|80755350|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
27703864|NCT01093625|80755351|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
27703865|NCT01093625|80755350|FG000|2-Week Visit|Withdrawal by Subject|1|||
27703866|NCT01093625|80755351|FG001|2-Week Visit|Withdrawal by Subject|0|||
27703867|NCT01093625|80755350|FG000|1-Month Visit|Lost to Follow-up|2|||
27703868|NCT01093625|80755351|FG001|1-Month Visit|Lost to Follow-up|0|||
27703869|NCT01093625|80755350|FG000|3-Month Visit|Lost to Follow-up|2|||
27703870|NCT01093625|80755351|FG001|3-Month Visit|Lost to Follow-up|0|||
27703871|NCT01093625|80755350|FG000|6-Month Visit|Withdrawal by Subject|6|||
27703872|NCT01093625|80755351|FG001|6-Month Visit|Withdrawal by Subject|7|||
27703873|NCT01093625|80755350|FG000|6-Month Visit|Lost to Follow-up|2|||
27703874|NCT01093625|80755351|FG001|6-Month Visit|Lost to Follow-up|2|||
27703875|NCT01093625|80755350|FG000|1-Year Visit|Lost to Follow-up|5|||
27703876|NCT01093625|80755351|FG001|1-Year Visit|Lost to Follow-up|3|||
27703877|NCT00884325|80755352|FG000|Overall Study|Lost to Follow-up|1|||
27703878|NCT00884325|80755353|FG001|Overall Study|Lost to Follow-up|2|||
27703879|NCT00884325|80755352|FG000|Overall Study|Lack of Efficacy|0|||
27703880|NCT00884325|80755353|FG001|Overall Study|Lack of Efficacy|1|||
27703881|NCT00884325|80755352|FG000|Overall Study|Withdrawal by Subject|1|||
27703882|NCT00884325|80755353|FG001|Overall Study|Withdrawal by Subject|1|||
27703883|NCT00884325|80755352|FG000|Overall Study|Not provided|1|||
27703884|NCT00884325|80755353|FG001|Overall Study|Not provided|0|||
27703885|NCT03422172|80755354|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
27703886|NCT03422172|80755354|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
27703887|NCT03422172|80755354|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
27703888|NCT01129921|80755355|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
27703889|NCT01129921|80755356|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
27703890|NCT01129921|80755355|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
27703891|NCT01129921|80755356|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
27703892|NCT01129921|80755355|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
27703893|NCT01129921|80755356|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
27703894|NCT01129921|80755355|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
27703895|NCT01129921|80755356|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
27703896|NCT02194062|80755357|FG000|Overall Study|Lost to Follow-up|2|||
27703897|NCT02194062|80755358|FG001|Overall Study|Lost to Follow-up|2|||
27703898|NCT02194062|80755359|FG002|Overall Study|Lost to Follow-up|5|||
27703899|NCT01576172|80755367|FG000|Overall Study|Ineligible|2|||
27703900|NCT01576172|80755368|FG001|Overall Study|Ineligible|1|||
27703901|NCT01576172|80755367|FG000|Overall Study|Withdrawal by Subject|2|||
27703902|NCT01576172|80755368|FG001|Overall Study|Withdrawal by Subject|0|||
27703903|NCT01576172|80755367|FG000|Overall Study|Insurance issue|1|||
27703904|NCT01576172|80755368|FG001|Overall Study|Insurance issue|0|||
27703905|NCT01353508|80755369|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
27703906|NCT01353508|80755370|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
27703907|NCT01353508|80755371|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
27703908|NCT01353508|80755372|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
27703909|NCT01353508|80755369|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
27703910|NCT01353508|80755370|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
27703911|NCT01353508|80755371|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
27703912|NCT01353508|80755372|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
27703913|NCT01717287|80755373|FG000|Overall Study|Lost to Follow-up|0|||
27703914|NCT01717287|80755374|FG001|Overall Study|Lost to Follow-up|2|||
27834507|NCT03828539|81226101|FG000|Overall Study|New therapy for study indication|1|||
27703915|NCT01717287|80755373|FG000|Overall Study|Protocol Violation|0|||
27703916|NCT01717287|80755374|FG001|Overall Study|Protocol Violation|1|||
27703917|NCT03520959|80755375|FG000|Overall Study|Study terminated by Sponsor|0|||
27703918|NCT03520959|80755376|FG001|Overall Study|Study terminated by Sponsor|1|||
27703919|NCT01641237|80755377|FG000|Period II|Withdrawal by Subject|1|||
27834508|NCT03828539|81226102|FG001|Overall Study|New therapy for study indication|0|||
27703920|NCT01641237|80755378|FG001|Period II|Withdrawal by Subject|0|||
27703921|NCT01641237|80755379|FG002|Period II|Withdrawal by Subject|0|||
27703922|NCT01641237|80755380|FG003|Period II|Withdrawal by Subject|0|||
27703923|NCT01641237|80755377|FG000|Period III|Lost to Follow-up|1|||
27703924|NCT01641237|80755378|FG001|Period III|Lost to Follow-up|0|||
27703925|NCT01641237|80755379|FG002|Period III|Lost to Follow-up|0|||
27703926|NCT01641237|80755380|FG003|Period III|Lost to Follow-up|0|||
27703927|NCT02357134|80755381|FG000|Overall Study|Lost to Follow-up|1|||
27703928|NCT02357134|80755382|FG001|Overall Study|Lost to Follow-up|0|||
27703929|NCT02357134|80755383|FG002|Overall Study|Lost to Follow-up|0|||
27703930|NCT02357134|80755384|FG003|Overall Study|Lost to Follow-up|0|||
27703931|NCT00078325|80755385|FG000|Overall Study|Adverse Event|15|||
27703932|NCT00078325|80755386|FG001|Overall Study|Adverse Event|10|||
27703933|NCT00078325|80755387|FG002|Overall Study|Adverse Event|5|||
27703934|NCT00078325|80755385|FG000|Overall Study|Protocol Violation|2|||
27703935|NCT00078325|80755386|FG001|Overall Study|Protocol Violation|2|||
27703936|NCT00078325|80755387|FG002|Overall Study|Protocol Violation|0|||
27703937|NCT00078325|80755385|FG000|Overall Study|Withdrawal by Subject|1|||
27703938|NCT00078325|80755386|FG001|Overall Study|Withdrawal by Subject|5|||
27703939|NCT00078325|80755387|FG002|Overall Study|Withdrawal by Subject|3|||
27703940|NCT00078325|80755385|FG000|Overall Study|Lost to Follow-up|0|||
27703941|NCT00078325|80755386|FG001|Overall Study|Lost to Follow-up|1|||
27703942|NCT00078325|80755387|FG002|Overall Study|Lost to Follow-up|1|||
27703943|NCT00078325|80755385|FG000|Overall Study|Physician Decision|2|||
27703944|NCT00078325|80755386|FG001|Overall Study|Physician Decision|0|||
27703945|NCT00078325|80755387|FG002|Overall Study|Physician Decision|1|||
27703946|NCT00078325|80755385|FG000|Overall Study|Miscellaneous|1|||
27703947|NCT00078325|80755386|FG001|Overall Study|Miscellaneous|1|||
27703948|NCT00078325|80755387|FG002|Overall Study|Miscellaneous|1|||
27703949|NCT00478933|80755388|FG000|Overall Study|Protocol Violation|22|||
27703950|NCT00478933|80755388|FG000|Overall Study|Informed consent not verified|3|||
27703951|NCT00478933|80755388|FG000|Overall Study|Inadequate data available|53|||
27703952|NCT01509079|80755389|FG000|Overall Study|Lack of Efficacy|0|||
27703953|NCT01509079|80755390|FG001|Overall Study|Lack of Efficacy|2|||
27703954|NCT01509079|80755389|FG000|Overall Study|started an excluded medication|0|||
27703955|NCT01509079|80755390|FG001|Overall Study|started an excluded medication|1|||
27703956|NCT02281357|80755402|FG000|Overall Study|Adverse Event|2|||
27703957|NCT02281357|80755403|FG001|Overall Study|Adverse Event|1|||
27703958|NCT02281357|80755402|FG000|Overall Study|Lost to Follow-up|1|||
27703959|NCT02281357|80755403|FG001|Overall Study|Lost to Follow-up|0|||
27703960|NCT02281357|80755402|FG000|Overall Study|Withdrawal by Subject|4|||
27703961|NCT02281357|80755403|FG001|Overall Study|Withdrawal by Subject|3|||
27703962|NCT01809132|80755404|FG000|Overall Study|Withdrawal by Subject|0|||
27703963|NCT01809132|80755405|FG001|Overall Study|Withdrawal by Subject|0|||
27703964|NCT01809132|80755406|FG002|Overall Study|Withdrawal by Subject|1|||
27703965|NCT01817751|80755407|FG000|Overall Study|Physician Decision|1|||
27703966|NCT00356889|80755410|FG000|Overall Study|Protocol Violation|2|||
27703967|NCT00356889|80755410|FG000|Overall Study|Adverse Event|1|||
27703968|NCT00578786|80755411|FG000|Overall Study|Adverse Event|27|||
27703969|NCT00578786|80755412|FG001|Overall Study|Adverse Event|37|||
27703970|NCT00578786|80755413|FG002|Overall Study|Adverse Event|17|||
27703971|NCT00578786|80755411|FG000|Overall Study|Lack of Efficacy|2|||
27703972|NCT00578786|80755412|FG001|Overall Study|Lack of Efficacy|5|||
27703973|NCT00578786|80755413|FG002|Overall Study|Lack of Efficacy|2|||
27703974|NCT00578786|80755411|FG000|Overall Study|Early Escape from Prior Study|2|||
27703975|NCT00578786|80755412|FG001|Overall Study|Early Escape from Prior Study|1|||
27703976|NCT00578786|80755413|FG002|Overall Study|Early Escape from Prior Study|2|||
27703977|NCT00578786|80755411|FG000|Overall Study|Withdrawal by Subject|7|||
27703978|NCT00578786|80755412|FG001|Overall Study|Withdrawal by Subject|8|||
27703979|NCT00578786|80755413|FG002|Overall Study|Withdrawal by Subject|5|||
27703980|NCT00578786|80755411|FG000|Overall Study|Protocol Violation|0|||
27703981|NCT00578786|80755412|FG001|Overall Study|Protocol Violation|3|||
27703982|NCT00578786|80755413|FG002|Overall Study|Protocol Violation|1|||
27703983|NCT00578786|80755411|FG000|Overall Study|Physician Decision|1|||
27703984|NCT00578786|80755412|FG001|Overall Study|Physician Decision|0|||
27703985|NCT00578786|80755413|FG002|Overall Study|Physician Decision|1|||
27703986|NCT00578786|80755411|FG000|Overall Study|Sponsor Decision|0|||
27703987|NCT00578786|80755412|FG001|Overall Study|Sponsor Decision|0|||
27703988|NCT00578786|80755413|FG002|Overall Study|Sponsor Decision|1|||
27703989|NCT00578786|80755411|FG000|Overall Study|Lost to Follow-up|0|||
27703990|NCT00578786|80755412|FG001|Overall Study|Lost to Follow-up|4|||
27703991|NCT00578786|80755413|FG002|Overall Study|Lost to Follow-up|0|||
27703992|NCT00578786|80755411|FG000|Overall Study|Pregnancy|0|||
27703993|NCT00578786|80755412|FG001|Overall Study|Pregnancy|1|||
27703994|NCT00578786|80755413|FG002|Overall Study|Pregnancy|0|||
27754810|NCT02546674|80929604|FG000|Overall Study|Protocol Deviation|2|||
27703995|NCT00578786|80755411|FG000|Overall Study|Not Otherwise Specified|0|||
27703996|NCT00578786|80755412|FG001|Overall Study|Not Otherwise Specified|4|||
27703997|NCT00578786|80755413|FG002|Overall Study|Not Otherwise Specified|1|||
27703998|NCT00578786|80755411|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
27703999|NCT00578786|80755412|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
27704000|NCT00578786|80755413|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
27704001|NCT01506960|80755416|FG000|Overall Study|Did not meet angiographic criteria|47|||
27704002|NCT00698204|80755417|FG000|Overall Study|Withdrawal by Subject|1|||
27704003|NCT00698204|80755418|FG001|Overall Study|Withdrawal by Subject|0|||
27704004|NCT01010633|80755420|FG000|Overall Study|Adverse Event|1|||
27704005|NCT01010633|80755421|FG001|Overall Study|Adverse Event|1|||
27704006|NCT01010633|80755420|FG000|Overall Study|Protocol Violation|1|||
27704007|NCT01010633|80755421|FG001|Overall Study|Protocol Violation|2|||
27704008|NCT01010633|80755420|FG000|Overall Study|Withdrawal by Subject|2|||
27704009|NCT01010633|80755421|FG001|Overall Study|Withdrawal by Subject|1|||
27704010|NCT01010633|80755420|FG000|Overall Study|Investigator decision|0|||
27704011|NCT01010633|80755421|FG001|Overall Study|Investigator decision|1|||
27704012|NCT00733304|80755422|FG000|Overall Study|Adverse Event|3|||
27704013|NCT00733304|80755423|FG001|Overall Study|Adverse Event|0|||
27704014|NCT00733304|80755424|FG002|Overall Study|Adverse Event|0|||
27704015|NCT00733304|80755422|FG000|Overall Study|Lack of Efficacy|0|||
27704016|NCT00733304|80755423|FG001|Overall Study|Lack of Efficacy|0|||
27704017|NCT00733304|80755424|FG002|Overall Study|Lack of Efficacy|2|||
27704018|NCT00733304|80755422|FG000|Overall Study|Lost to Follow-up|0|||
27704019|NCT00733304|80755423|FG001|Overall Study|Lost to Follow-up|1|||
27704020|NCT00733304|80755424|FG002|Overall Study|Lost to Follow-up|0|||
27704021|NCT00733304|80755422|FG000|Overall Study|Physician Decision|3|||
27704022|NCT00733304|80755423|FG001|Overall Study|Physician Decision|1|||
27704023|NCT00733304|80755424|FG002|Overall Study|Physician Decision|3|||
27704024|NCT00733304|80755422|FG000|Overall Study|Withdrawal by Subject|1|||
27704025|NCT00733304|80755423|FG001|Overall Study|Withdrawal by Subject|1|||
27704026|NCT00733304|80755424|FG002|Overall Study|Withdrawal by Subject|0|||
27598275|NCT01281644|80366734|FG000|Overall Study|Lost to Follow-up|3|||
27704027|NCT04246801|80755425|FG000|Overall Study|Adverse Event|1|||
27704028|NCT04246801|80755426|FG001|Overall Study|Adverse Event|1|||
27704029|NCT04246801|80755425|FG000|Overall Study|Protocol Violation|1|||
27704030|NCT04246801|80755426|FG001|Overall Study|Protocol Violation|1|||
27704031|NCT04246801|80755425|FG000|Overall Study|Lack of Efficacy|0|||
27704032|NCT04246801|80755426|FG001|Overall Study|Lack of Efficacy|2|||
27704033|NCT04246801|80755425|FG000|Overall Study|Lost to Follow-up|1|||
27704034|NCT04246801|80755426|FG001|Overall Study|Lost to Follow-up|1|||
27704035|NCT04246801|80755425|FG000|Overall Study|Withdrawal by Subject|2|||
27704036|NCT04246801|80755426|FG001|Overall Study|Withdrawal by Subject|1|||
27704037|NCT02146599|80755430|FG000|Overall Study|Failed to meet inclusion criteria|5|||
27704038|NCT02090413|80755431|FG000|Overall Study|Adverse Event|11|||
27704039|NCT02090413|80755432|FG001|Overall Study|Adverse Event|15|||
27704040|NCT02090413|80755433|FG002|Overall Study|Adverse Event|20|||
27704041|NCT02090413|80755431|FG000|Overall Study|Flushing event|2|||
27704042|NCT02090413|80755432|FG001|Overall Study|Flushing event|0|||
27704043|NCT02090413|80755433|FG002|Overall Study|Flushing event|1|||
27704044|NCT02090413|80755431|FG000|Overall Study|Withdrawal by Subject|2|||
27704045|NCT02090413|80755432|FG001|Overall Study|Withdrawal by Subject|2|||
27704046|NCT02090413|80755433|FG002|Overall Study|Withdrawal by Subject|2|||
27704047|NCT02090413|80755431|FG000|Overall Study|Investigator Decision|1|||
27704048|NCT02090413|80755432|FG001|Overall Study|Investigator Decision|1|||
27704049|NCT02090413|80755433|FG002|Overall Study|Investigator Decision|0|||
27704050|NCT02090413|80755431|FG000|Overall Study|Other|2|||
27704051|NCT02090413|80755432|FG001|Overall Study|Other|1|||
27704052|NCT02090413|80755433|FG002|Overall Study|Other|0|||
27704053|NCT02090413|80755431|FG000|Overall Study|Lost to Follow-up|1|||
27704054|NCT02090413|80755432|FG001|Overall Study|Lost to Follow-up|1|||
27704055|NCT02090413|80755433|FG002|Overall Study|Lost to Follow-up|0|||
27704056|NCT01431274|80755434|FG000|Overall Study|Adverse Event|51|||
27704057|NCT01431274|80755435|FG001|Overall Study|Adverse Event|37|||
27704058|NCT01431274|80755436|FG002|Overall Study|Adverse Event|43|||
27704059|NCT01431274|80755437|FG003|Overall Study|Adverse Event|30|||
27704060|NCT01431274|80755438|FG004|Overall Study|Adverse Event|37|||
27704061|NCT01431274|80755434|FG000|Overall Study|Consent withdrawn not due to AE|29|||
27704062|NCT01431274|80755435|FG001|Overall Study|Consent withdrawn not due to AE|20|||
27704063|NCT01431274|80755436|FG002|Overall Study|Consent withdrawn not due to AE|17|||
27704064|NCT01431274|80755437|FG003|Overall Study|Consent withdrawn not due to AE|20|||
27704065|NCT01431274|80755438|FG004|Overall Study|Consent withdrawn not due to AE|11|||
27704066|NCT01431274|80755434|FG000|Overall Study|Non compliant with protocol|5|||
27704067|NCT01431274|80755435|FG001|Overall Study|Non compliant with protocol|8|||
27704068|NCT01431274|80755436|FG002|Overall Study|Non compliant with protocol|4|||
27704069|NCT01431274|80755437|FG003|Overall Study|Non compliant with protocol|4|||
27704070|NCT01431274|80755438|FG004|Overall Study|Non compliant with protocol|4|||
27598276|NCT01281644|80366734|FG000|Overall Study|Withdrawal by Subject|2|||
27598277|NCT00515502|80366744|FG000|Treatment Period 1|Adverse Event|0|||
27598278|NCT00515502|80366745|FG001|Treatment Period 1|Adverse Event|0|||
27598279|NCT00515502|80366746|FG002|Treatment Period 1|Adverse Event|0|||
27598280|NCT00515502|80366747|FG003|Treatment Period 1|Adverse Event|0|||
27598281|NCT00515502|80366748|FG004|Treatment Period 1|Adverse Event|0|||
27598282|NCT00515502|80366749|FG005|Treatment Period 1|Adverse Event|0|||
27598283|NCT00515502|80366750|FG006|Treatment Period 1|Adverse Event|1|||
27598284|NCT00515502|80366751|FG007|Treatment Period 1|Adverse Event|0|||
27598285|NCT00515502|80366752|FG008|Treatment Period 1|Adverse Event|1|||
27598286|NCT00515502|80366753|FG009|Treatment Period 1|Adverse Event|0|||
27598287|NCT00515502|80366754|FG010|Treatment Period 1|Adverse Event|0|||
27598288|NCT00515502|80366755|FG011|Treatment Period 1|Adverse Event|1|||
27598289|NCT00515502|80366744|FG000|Treatment Period 2|Adverse Event|0|||
27598290|NCT00515502|80366745|FG001|Treatment Period 2|Adverse Event|1|||
27598291|NCT00515502|80366746|FG002|Treatment Period 2|Adverse Event|0|||
27598292|NCT00515502|80366747|FG003|Treatment Period 2|Adverse Event|0|||
27598293|NCT00515502|80366748|FG004|Treatment Period 2|Adverse Event|0|||
27598294|NCT00515502|80366749|FG005|Treatment Period 2|Adverse Event|0|||
27598295|NCT00515502|80366750|FG006|Treatment Period 2|Adverse Event|0|||
27598296|NCT00515502|80366751|FG007|Treatment Period 2|Adverse Event|0|||
27598297|NCT00515502|80366752|FG008|Treatment Period 2|Adverse Event|0|||
27704071|NCT01431274|80755434|FG000|Overall Study|Lost to Follow-up|6|||
27704072|NCT01431274|80755435|FG001|Overall Study|Lost to Follow-up|7|||
27704073|NCT01431274|80755436|FG002|Overall Study|Lost to Follow-up|1|||
27704074|NCT01431274|80755437|FG003|Overall Study|Lost to Follow-up|4|||
27704075|NCT01431274|80755438|FG004|Overall Study|Lost to Follow-up|0|||
27704076|NCT01431274|80755434|FG000|Overall Study|Other reason not stated above|6|||
27704077|NCT01431274|80755435|FG001|Overall Study|Other reason not stated above|5|||
27704078|NCT01431274|80755436|FG002|Overall Study|Other reason not stated above|7|||
27704079|NCT01431274|80755437|FG003|Overall Study|Other reason not stated above|2|||
27704080|NCT01431274|80755438|FG004|Overall Study|Other reason not stated above|4|||
27704081|NCT00646906|80755441|FG000|Crossover Period 1|Withdrawal by Subject|1|||
27704082|NCT00646906|80755442|FG001|Crossover Period 1|Withdrawal by Subject|0|||
27704083|NCT00646906|80755443|FG002|Crossover Period 1|Withdrawal by Subject|0|||
27704084|NCT00646906|80755444|FG003|Crossover Period 1|Withdrawal by Subject|0|||
27704085|NCT00646906|80755445|FG004|Crossover Period 1|Withdrawal by Subject|0|||
27704086|NCT00646906|80755446|FG005|Crossover Period 1|Withdrawal by Subject|1|||
27704087|NCT00646906|80755447|FG006|Crossover Period 1|Withdrawal by Subject|0|||
27704088|NCT00646906|80755441|FG000|Crossover Period 2|Withdrawal by Subject|0|||
27704089|NCT00646906|80755442|FG001|Crossover Period 2|Withdrawal by Subject|1|||
27704090|NCT00646906|80755443|FG002|Crossover Period 2|Withdrawal by Subject|2|||
27704091|NCT00646906|80755444|FG003|Crossover Period 2|Withdrawal by Subject|1|||
27704092|NCT00646906|80755445|FG004|Crossover Period 2|Withdrawal by Subject|0|||
27704093|NCT00646906|80755446|FG005|Crossover Period 2|Withdrawal by Subject|0|||
27704094|NCT00646906|80755447|FG006|Crossover Period 2|Withdrawal by Subject|0|||
27704095|NCT00646906|80755441|FG000|Crossover Period 2|Physician Decision|0|||
27704096|NCT00646906|80755442|FG001|Crossover Period 2|Physician Decision|0|||
27704097|NCT00646906|80755443|FG002|Crossover Period 2|Physician Decision|0|||
27704098|NCT00646906|80755444|FG003|Crossover Period 2|Physician Decision|0|||
27704099|NCT00646906|80755445|FG004|Crossover Period 2|Physician Decision|0|||
27704100|NCT00646906|80755446|FG005|Crossover Period 2|Physician Decision|0|||
27704101|NCT00646906|80755447|FG006|Crossover Period 2|Physician Decision|1|||
27704102|NCT00419120|80755448|FG000|Long Term Follow up Period|study ongoing|10|||
27704103|NCT02129205|80755449|FG000|Overall Study|Withdrawal by Subject|0|||
27704104|NCT02129205|80755450|FG001|Overall Study|Withdrawal by Subject|0|||
27704105|NCT02129205|80755451|FG002|Overall Study|Withdrawal by Subject|0|||
27704106|NCT02129205|80755452|FG003|Overall Study|Withdrawal by Subject|0|||
27704107|NCT02129205|80755453|FG004|Overall Study|Withdrawal by Subject|1|||
27704108|NCT02129205|80755454|FG005|Overall Study|Withdrawal by Subject|1|||
27704109|NCT02129205|80755455|FG006|Overall Study|Withdrawal by Subject|1|||
27704110|NCT02129205|80755456|FG007|Overall Study|Withdrawal by Subject|0|||
27704111|NCT02129205|80755457|FG008|Overall Study|Withdrawal by Subject|1|||
27704112|NCT02129205|80755458|FG009|Overall Study|Withdrawal by Subject|0|||
27834509|NCT01528735|81226103|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
27834510|NCT01528735|81226104|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
27598298|NCT00515502|80366753|FG009|Treatment Period 2|Adverse Event|0|||
27598299|NCT00515502|80366754|FG010|Treatment Period 2|Adverse Event|0|||
27598300|NCT00515502|80366755|FG011|Treatment Period 2|Adverse Event|0|||
27598301|NCT02970318|80366761|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
27704113|NCT02129205|80755449|FG000|Overall Study|Other|1|||
27704114|NCT02129205|80755450|FG001|Overall Study|Other|0|||
27704115|NCT02129205|80755451|FG002|Overall Study|Other|0|||
27704116|NCT02129205|80755452|FG003|Overall Study|Other|0|||
27704117|NCT02129205|80755453|FG004|Overall Study|Other|2|||
27704118|NCT02129205|80755454|FG005|Overall Study|Other|3|||
27704119|NCT02129205|80755455|FG006|Overall Study|Other|3|||
27704120|NCT02129205|80755456|FG007|Overall Study|Other|2|||
27704121|NCT02129205|80755457|FG008|Overall Study|Other|1|||
27704122|NCT02129205|80755458|FG009|Overall Study|Other|0|||
27704123|NCT00590044|80755459|FG000|Overall Study|Withdrawal by Subject|2|||
27704124|NCT00590044|80755460|FG001|Overall Study|Withdrawal by Subject|2|||
27704125|NCT00590044|80755459|FG000|Overall Study|wrong insulin arm assigned|1|||
27704126|NCT00590044|80755460|FG001|Overall Study|wrong insulin arm assigned|0|||
27704127|NCT00590044|80755459|FG000|Overall Study|Protocol Violation|1|||
27704128|NCT00590044|80755460|FG001|Overall Study|Protocol Violation|0|||
27704129|NCT01538628|80755461|FG000|Overall Study|Withdrawal by Subject|1|||
27704130|NCT01538628|80755462|FG001|Overall Study|Withdrawal by Subject|1|||
27704131|NCT01538628|80755461|FG000|Overall Study|Lost to Follow-up|0|||
27704132|NCT01538628|80755462|FG001|Overall Study|Lost to Follow-up|1|||
27704133|NCT01519934|80755467|FG000|Overall Study|Lost to Follow-up|3|||
27704134|NCT00388505|80755468|FG000|Overall Study|Adverse Event or Death|43|||
27704135|NCT00388505|80755469|FG001|Overall Study|Adverse Event or Death|17|||
27704136|NCT00388505|80755468|FG000|Overall Study|Withdrawal by Subject|24|||
27704137|NCT00388505|80755469|FG001|Overall Study|Withdrawal by Subject|9|||
27704138|NCT00388505|80755468|FG000|Overall Study|Lost to Follow-up|5|||
27704139|NCT00388505|80755469|FG001|Overall Study|Lost to Follow-up|3|||
27704140|NCT00388505|80755468|FG000|Overall Study|Inappropriate Enrollment|0|||
27704141|NCT00388505|80755469|FG001|Overall Study|Inappropriate Enrollment|1|||
27704142|NCT00388505|80755468|FG000|Overall Study|Administrative Reason|1|||
27704143|NCT00388505|80755469|FG001|Overall Study|Administrative Reason|0|||
27704144|NCT00388505|80755468|FG000|Overall Study|Protocol Violation|6|||
27704145|NCT00388505|80755469|FG001|Overall Study|Protocol Violation|5|||
27704146|NCT00388505|80755468|FG000|Overall Study|Unable to classify|4|||
27704147|NCT00388505|80755469|FG001|Overall Study|Unable to classify|3|||
27704148|NCT03308942|80755470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
27704149|NCT03308942|80755471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
27704150|NCT03308942|80755472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
27704151|NCT03308942|80755473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
27704152|NCT03308942|80755474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
27704153|NCT03308942|80755470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
27704154|NCT03308942|80755471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
27704155|NCT03308942|80755472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
27704156|NCT03308942|80755473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
27704157|NCT03308942|80755474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
27704158|NCT03308942|80755470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
27704159|NCT03308942|80755471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
27704160|NCT03308942|80755472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
27704161|NCT03308942|80755473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
27704162|NCT03308942|80755474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
27704163|NCT03308942|80755470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
27704164|NCT03308942|80755471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
27704165|NCT03308942|80755472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
27704166|NCT03308942|80755473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
27704167|NCT03308942|80755474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
27704168|NCT03308942|80755470|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
27704169|NCT03308942|80755471|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
27704170|NCT03308942|80755472|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
27704171|NCT03308942|80755473|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
27704172|NCT03308942|80755474|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
27704173|NCT03308942|80755470|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
27704174|NCT03308942|80755471|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
27704175|NCT03308942|80755472|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
27704176|NCT03308942|80755473|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
27704177|NCT03308942|80755474|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
27704178|NCT03308942|80755470|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
27704179|NCT03308942|80755471|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
27704180|NCT03308942|80755472|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
27704181|NCT03308942|80755473|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
27704182|NCT03308942|80755474|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
27704183|NCT03945591|80755475|FG000|Overall Study|Participant not transplanted|1|||
27704184|NCT03945591|80755475|FG000|Overall Study|Change in treatment plan|3|||
27704185|NCT03945591|80755475|FG000|Overall Study|Adverse Event|1|||
27704186|NCT01368536|80755480|FG000|Overall Study|Adverse Event|5|||
27704187|NCT01368536|80755481|FG001|Overall Study|Adverse Event|6|||
27704188|NCT01368536|80755482|FG002|Overall Study|Adverse Event|8|||
27704189|NCT01368536|80755480|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27704190|NCT01368536|80755481|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27704191|NCT01368536|80755482|FG002|Overall Study|Abnormal laboratory value(s)|2|||
27704192|NCT01368536|80755480|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27704193|NCT01368536|80755481|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27704194|NCT01368536|80755482|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27704195|NCT01368536|80755480|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
27704196|NCT01368536|80755481|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27704197|NCT01368536|80755482|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27704198|NCT01368536|80755480|FG000|Overall Study|No longer required study medication|0|||
27704199|NCT01368536|80755481|FG001|Overall Study|No longer required study medication|0|||
27704200|NCT01368536|80755482|FG002|Overall Study|No longer required study medication|1|||
27704201|NCT01368536|80755480|FG000|Overall Study|Withdrawal by Subject|2|||
27704202|NCT01368536|80755481|FG001|Overall Study|Withdrawal by Subject|5|||
27704203|NCT01368536|80755482|FG002|Overall Study|Withdrawal by Subject|4|||
27704204|NCT01368536|80755480|FG000|Overall Study|Lost to Follow-up|3|||
27704205|NCT01368536|80755481|FG001|Overall Study|Lost to Follow-up|3|||
27704206|NCT01368536|80755482|FG002|Overall Study|Lost to Follow-up|5|||
27704207|NCT01368536|80755480|FG000|Overall Study|Administrative problems|34|||
27704208|NCT01368536|80755481|FG001|Overall Study|Administrative problems|39|||
27704209|NCT01368536|80755482|FG002|Overall Study|Administrative problems|35|||
27704210|NCT01368536|80755480|FG000|Overall Study|Protocol deviation|0|||
27704211|NCT01368536|80755481|FG001|Overall Study|Protocol deviation|3|||
27704212|NCT01368536|80755482|FG002|Overall Study|Protocol deviation|1|||
27704213|NCT02739620|80755483|FG000|Overall Study|Lost to Follow-up|3|||
27704214|NCT02739620|80755484|FG001|Overall Study|Lost to Follow-up|1|||
27704215|NCT02739620|80755483|FG000|Overall Study|Adverse Event|0|||
27704216|NCT02739620|80755484|FG001|Overall Study|Adverse Event|1|||
27704217|NCT00736034|80755489|FG000|Overall Study|Adverse Event|2|||
27704218|NCT00943579|80755490|FG000|Overall Study|Adverse Event|4|||
27704219|NCT00943579|80755491|FG001|Overall Study|Adverse Event|3|||
27704220|NCT00943579|80755490|FG000|Overall Study|Lack of Efficacy|2|||
27704221|NCT00943579|80755491|FG001|Overall Study|Lack of Efficacy|2|||
27704222|NCT04340557|80755492|FG000|Overall Study|Transferred to ICU and/or death|1|||
27704223|NCT04340557|80755493|FG001|Overall Study|Transferred to ICU and/or death|2|||
27704224|NCT01279850|80755494|FG000|Overall Study|Protocol Violation|50|||
27704225|NCT01279850|80755494|FG000|Overall Study|No Drug Administration Information|7|||
27704226|NCT01279850|80755494|FG000|Overall Study|No Visit After Treatment|34|||
27704227|NCT01265615|80755495|FG000|Overall Study|Protocol Violation|2|||
27704228|NCT01265615|80755496|FG001|Overall Study|Protocol Violation|2|||
27704229|NCT01265615|80755497|FG002|Overall Study|Protocol Violation|4|||
27704230|NCT01265615|80755498|FG003|Overall Study|Protocol Violation|3|||
27704231|NCT00909181|80755510|FG000|Overall Study|Lost to Follow-up|39|||
27704232|NCT00909181|80755511|FG001|Overall Study|Lost to Follow-up|18|||
27704233|NCT00909181|80755512|FG002|Overall Study|Lost to Follow-up|33|||
27704234|NCT01519765|80755513|FG000|Overall Study|Adverse Event|0|||
27704235|NCT01519765|80755514|FG001|Overall Study|Adverse Event|1|||
27704236|NCT01519765|80755513|FG000|Overall Study|Lack of Efficacy|2|||
27704237|NCT01519765|80755514|FG001|Overall Study|Lack of Efficacy|0|||
27704238|NCT01519765|80755513|FG000|Overall Study|Protocol Violation|1|||
27704239|NCT01519765|80755514|FG001|Overall Study|Protocol Violation|0|||
27704240|NCT01519765|80755513|FG000|Overall Study|Withdrawal by Subject|0|||
27704241|NCT01519765|80755514|FG001|Overall Study|Withdrawal by Subject|1|||
27704242|NCT03710486|80755517|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
27704243|NCT03710486|80755518|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
27704244|NCT03710486|80755517|FG000|Overall Study|Missing|0|||
27598302|NCT02970318|80366762|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
27598303|NCT02970318|80366763|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
27598304|NCT02970318|80366764|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
27704245|NCT03710486|80755518|FG001|Overall Study|Missing|2|||
27704246|NCT00228566|80755519|FG000|Overall Study|Adverse Event|31|||
27704247|NCT00228566|80755519|FG000|Overall Study|Lack of Efficacy|14|||
27704248|NCT00228566|80755519|FG000|Overall Study|Lost to Follow-up|16|||
27704249|NCT00228566|80755519|FG000|Overall Study|Physician Decision|5|||
27704250|NCT00228566|80755519|FG000|Overall Study|Withdrawal by Subject|4|||
27704251|NCT00228566|80755519|FG000|Overall Study|Miscellaneous|1|||
27704252|NCT00682448|80755521|FG000|Overall Study|Adverse Event|1|||
27704253|NCT00682448|80755522|FG001|Overall Study|Adverse Event|2|||
27704254|NCT00682448|80755521|FG000|Overall Study|Lack of Efficacy|1|||
27704255|NCT00682448|80755522|FG001|Overall Study|Lack of Efficacy|0|||
27704256|NCT00682448|80755521|FG000|Overall Study|Lost to Follow-up|1|||
27704257|NCT00682448|80755522|FG001|Overall Study|Lost to Follow-up|3|||
27704258|NCT00682448|80755521|FG000|Overall Study|Pregnancy|0|||
27704259|NCT00682448|80755522|FG001|Overall Study|Pregnancy|1|||
27704260|NCT00682448|80755521|FG000|Overall Study|Withdrawal by Subject|2|||
27704261|NCT00682448|80755522|FG001|Overall Study|Withdrawal by Subject|0|||
27704262|NCT02252536|80755523|FG000|Overall Study|Lost to Follow-up|5|||
27704263|NCT02252536|80755524|FG001|Overall Study|Lost to Follow-up|3|||
27704264|NCT00594516|80755525|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
27704265|NCT00594516|80755526|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
27704266|NCT00594516|80755527|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
27704267|NCT00594516|80755525|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
27704268|NCT00594516|80755526|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
27704269|NCT00594516|80755527|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
27704270|NCT00594516|80755525|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
27704271|NCT00594516|80755526|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
27704272|NCT00594516|80755527|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
27704273|NCT00594516|80755525|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
27704274|NCT00594516|80755526|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
27704275|NCT00594516|80755527|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
27704276|NCT00594516|80755525|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
27704277|NCT00594516|80755526|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
27704278|NCT00594516|80755527|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
27704279|NCT00594516|80755525|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
27704280|NCT00594516|80755526|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
27704281|NCT00594516|80755527|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
27704282|NCT00594516|80755525|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
27704283|NCT00594516|80755526|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
27704284|NCT00594516|80755527|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
27704285|NCT00594516|80755525|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
27704286|NCT00594516|80755526|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
27704287|NCT00594516|80755527|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
27704288|NCT00594516|80755525|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
27704289|NCT00594516|80755526|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
27704290|NCT00594516|80755527|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
27704291|NCT00711425|80755528|FG000|Overall Study|Protocol Violation|1|||
27834511|NCT01528735|81226103|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
27704292|NCT00711425|80755528|FG000|Overall Study|Death|2|||
27704293|NCT00711425|80755528|FG000|Overall Study|Lost to Follow-up|1|||
27834512|NCT01528735|81226104|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
27704294|NCT02463071|80755529|FG000|Overall Study|Adverse Event|3|||
27834513|NCT02436200|81226110|FG000|Overall Study|Significant outlier|1|||
27834514|NCT02030535|81226117|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
27834515|NCT00292227|81226118|FG000|Patch Period|Adverse Event|1|||
27834516|NCT00292227|81226119|FG001|Patch Period|Adverse Event|0|||
27834517|NCT00292227|81226120|FG002|Patch Period|Adverse Event|2|||
27834518|NCT00292227|81226118|FG000|Patch Period|Withdrawal by Subject|0|||
27834519|NCT00292227|81226119|FG001|Patch Period|Withdrawal by Subject|0|||
27834520|NCT00292227|81226120|FG002|Patch Period|Withdrawal by Subject|1|||
27834521|NCT03248128|81226125|FG000|Overall Study|Lost to Follow-up|1|||
27704295|NCT02463071|80755530|FG001|Overall Study|Adverse Event|5|||
27598305|NCT02970318|80366761|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
27704296|NCT02463071|80755531|FG002|Overall Study|Adverse Event|1|||
27704297|NCT02463071|80755529|FG000|Overall Study|Death|1|||
27704298|NCT02463071|80755530|FG001|Overall Study|Death|0|||
27704299|NCT02463071|80755531|FG002|Overall Study|Death|0|||
27704300|NCT02463071|80755529|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
27704301|NCT02463071|80755530|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27704302|NCT02463071|80755531|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27704303|NCT02463071|80755529|FG000|Overall Study|Reason not specified|7|||
27704304|NCT02463071|80755530|FG001|Overall Study|Reason not specified|9|||
27704305|NCT02463071|80755531|FG002|Overall Study|Reason not specified|4|||
27704306|NCT02463071|80755529|FG000|Overall Study|Protocol Violation|0|||
27704307|NCT02463071|80755530|FG001|Overall Study|Protocol Violation|2|||
27704308|NCT02463071|80755531|FG002|Overall Study|Protocol Violation|0|||
27704309|NCT02463071|80755529|FG000|Overall Study|Lost to Follow-up|0|||
27704310|NCT02463071|80755530|FG001|Overall Study|Lost to Follow-up|0|||
27704311|NCT02463071|80755531|FG002|Overall Study|Lost to Follow-up|1|||
27704312|NCT00763971|80755533|FG000|Overall Study|Adverse Event|5|||
27704313|NCT00763971|80755534|FG001|Overall Study|Adverse Event|2|||
27704314|NCT00763971|80755535|FG002|Overall Study|Adverse Event|4|||
27704315|NCT00763971|80755533|FG000|Overall Study|Protocol Violation|3|||
27704316|NCT00763971|80755534|FG001|Overall Study|Protocol Violation|3|||
27704317|NCT00763971|80755535|FG002|Overall Study|Protocol Violation|2|||
27704318|NCT00763971|80755533|FG000|Overall Study|Withdrawal by Subject|4|||
27704319|NCT00763971|80755534|FG001|Overall Study|Withdrawal by Subject|5|||
27704320|NCT00763971|80755535|FG002|Overall Study|Withdrawal by Subject|5|||
27704321|NCT00763971|80755533|FG000|Overall Study|Lost to Follow-up|0|||
27704322|NCT00763971|80755534|FG001|Overall Study|Lost to Follow-up|1|||
27704323|NCT00763971|80755535|FG002|Overall Study|Lost to Follow-up|0|||
27704324|NCT00763971|80755533|FG000|Overall Study|Lack of Efficacy|11|||
27704325|NCT00763971|80755534|FG001|Overall Study|Lack of Efficacy|22|||
27704326|NCT00763971|80755535|FG002|Overall Study|Lack of Efficacy|54|||
27704327|NCT00763971|80755533|FG000|Overall Study|Unable to swallow capsule|2|||
27704328|NCT00763971|80755534|FG001|Overall Study|Unable to swallow capsule|1|||
27704329|NCT00763971|80755535|FG002|Overall Study|Unable to swallow capsule|1|||
27834522|NCT03248128|81226126|FG001|Overall Study|Lost to Follow-up|0|||
27598306|NCT02970318|80366762|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
27704330|NCT00763971|80755533|FG000|Overall Study|Personal reason|3|||
27704331|NCT00763971|80755534|FG001|Overall Study|Personal reason|0|||
27704332|NCT00763971|80755535|FG002|Overall Study|Personal reason|0|||
27704333|NCT00763971|80755533|FG000|Overall Study|Exclusion criteria met|1|||
27704334|NCT00763971|80755534|FG001|Overall Study|Exclusion criteria met|0|||
27704335|NCT00763971|80755535|FG002|Overall Study|Exclusion criteria met|0|||
27704336|NCT00763971|80755533|FG000|Overall Study|Sponsor decision|1|||
27704337|NCT00763971|80755534|FG001|Overall Study|Sponsor decision|0|||
27704338|NCT00763971|80755535|FG002|Overall Study|Sponsor decision|0|||
27704339|NCT00763971|80755533|FG000|Overall Study|Due to holiday season|2|||
27834523|NCT03248128|81226125|FG000|Overall Study|Withdrawal by Subject|16|||
27834524|NCT03248128|81226126|FG001|Overall Study|Withdrawal by Subject|14|||
27834525|NCT03248128|81226125|FG000|Overall Study|Site Closed|4|||
27834526|NCT03248128|81226126|FG001|Overall Study|Site Closed|3|||
27834527|NCT03248128|81226125|FG000|Overall Study|Randomized, but did not receive treatment|1|||
27834528|NCT03248128|81226126|FG001|Overall Study|Randomized, but did not receive treatment|3|||
27834529|NCT00985751|81226137|FG000|Overall Study|Adverse Event|0|||
27834530|NCT00985751|81226138|FG001|Overall Study|Adverse Event|0|||
27834531|NCT00985751|81226139|FG002|Overall Study|Adverse Event|0|||
27834532|NCT00985751|81226140|FG003|Overall Study|Adverse Event|0|||
27834533|NCT00985751|81226141|FG004|Overall Study|Adverse Event|1|||
27834534|NCT00533507|81226142|FG000|Overall Study|Withdrawal by Subject|1|||
27704340|NCT00763971|80755534|FG001|Overall Study|Due to holiday season|0|||
27704341|NCT00763971|80755535|FG002|Overall Study|Due to holiday season|1|||
27704342|NCT00763971|80755533|FG000|Overall Study|Randomization error|0|||
27704343|NCT00763971|80755534|FG001|Overall Study|Randomization error|0|||
27704344|NCT00763971|80755535|FG002|Overall Study|Randomization error|1|||
27704345|NCT00763971|80755533|FG000|Overall Study|Medical monitor decision|0|||
27704346|NCT00763971|80755534|FG001|Overall Study|Medical monitor decision|0|||
27704347|NCT00763971|80755535|FG002|Overall Study|Medical monitor decision|1|||
27704348|NCT00763971|80755533|FG000|Overall Study|Moved to another country|0|||
27704349|NCT00763971|80755534|FG001|Overall Study|Moved to another country|1|||
27704350|NCT00763971|80755535|FG002|Overall Study|Moved to another country|0|||
27704351|NCT00763971|80755533|FG000|Overall Study|Subject wanted dose reduction|0|||
27704352|NCT00763971|80755534|FG001|Overall Study|Subject wanted dose reduction|1|||
27704353|NCT00763971|80755535|FG002|Overall Study|Subject wanted dose reduction|0|||
27704354|NCT00763971|80755533|FG000|Overall Study|Lack of availability|0|||
27704355|NCT00763971|80755534|FG001|Overall Study|Lack of availability|1|||
27704356|NCT00763971|80755535|FG002|Overall Study|Lack of availability|0|||
27704357|NCT00763971|80755533|FG000|Overall Study|Performed final visit on phone|0|||
27704358|NCT00763971|80755534|FG001|Overall Study|Performed final visit on phone|1|||
27834535|NCT01717313|81226143|FG000|Phase A (Weeks 0 to 24)|Death|0|||
27704359|NCT00763971|80755535|FG002|Overall Study|Performed final visit on phone|0|||
27598307|NCT02970318|80366763|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
27598308|NCT02970318|80366764|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
27598309|NCT02970318|80366761|FG000|Overall for Arm A & Main for Arm B|Death|41|||
27598310|NCT02970318|80366762|FG001|Overall for Arm A & Main for Arm B|Death|33|||
27598311|NCT02970318|80366763|FG002|Overall for Arm A & Main for Arm B|Death|0|||
27598312|NCT02970318|80366764|FG003|Overall for Arm A & Main for Arm B|Death|0|||
27598313|NCT02970318|80366761|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
27598314|NCT02970318|80366762|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
27598315|NCT02970318|80366763|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
27598316|NCT02970318|80366764|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
27598317|NCT02970318|80366761|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
27598318|NCT02970318|80366762|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
27598319|NCT02970318|80366763|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
27598320|NCT02970318|80366764|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
27598321|NCT02970318|80366761|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
27598322|NCT02970318|80366762|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
27598323|NCT02970318|80366763|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
27598324|NCT02970318|80366764|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
27598325|NCT02970318|80366761|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
27598326|NCT02970318|80366762|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
27598327|NCT02970318|80366763|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
27598328|NCT02970318|80366764|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
27834536|NCT01717313|81226144|FG001|Phase A (Weeks 0 to 24)|Death|1|||
27834537|NCT01717313|81226143|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
27834538|NCT01717313|81226144|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
27834539|NCT01717313|81226143|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
27834540|NCT01717313|81226144|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
27598329|NCT01877408|80366765|FG000|Overall Study|Lost to Follow-up|0|||
27598330|NCT01877408|80366766|FG001|Overall Study|Lost to Follow-up|2|||
27598331|NCT02184611|80366767|FG000|Overall Study|Lack of Efficacy|11|||
27598332|NCT02184611|80366768|FG001|Overall Study|Lack of Efficacy|15|||
27598333|NCT02184611|80366767|FG000|Overall Study|Withdrawal by Subject|5|||
27598334|NCT02184611|80366768|FG001|Overall Study|Withdrawal by Subject|6|||
27598335|NCT02184611|80366767|FG000|Overall Study|Adverse Event|4|||
27598336|NCT02184611|80366768|FG001|Overall Study|Adverse Event|5|||
27598337|NCT02184611|80366767|FG000|Overall Study|Protocol Violation|1|||
27598338|NCT02184611|80366768|FG001|Overall Study|Protocol Violation|1|||
27598339|NCT02184611|80366767|FG000|Overall Study|Protocol defined stopping criteria|0|||
27598340|NCT02184611|80366768|FG001|Overall Study|Protocol defined stopping criteria|1|||
27598341|NCT01533493|80366769|FG000|Overall Study|Adverse Event|2|||
27598342|NCT01533493|80366770|FG001|Overall Study|Adverse Event|1|||
27598343|NCT01533493|80366769|FG000|Overall Study|Withdrawal by Subject|1|||
27598344|NCT01533493|80366770|FG001|Overall Study|Withdrawal by Subject|2|||
27598345|NCT01533493|80366769|FG000|Overall Study|Lost to Follow-up|2|||
27598346|NCT01533493|80366770|FG001|Overall Study|Lost to Follow-up|0|||
27598347|NCT01297959|80366771|FG000|Overall Study|Adverse Event|0|||
27598348|NCT01297959|80366772|FG001|Overall Study|Adverse Event|1|||
27598349|NCT01297959|80366771|FG000|Overall Study|Protocol Violation|2|||
27598350|NCT01297959|80366772|FG001|Overall Study|Protocol Violation|1|||
27598351|NCT01297959|80366771|FG000|Overall Study|Withdrawal by Subject|5|||
27598352|NCT01297959|80366772|FG001|Overall Study|Withdrawal by Subject|4|||
27598353|NCT01297959|80366771|FG000|Overall Study|Physician Decision|0|||
27598354|NCT01297959|80366772|FG001|Overall Study|Physician Decision|1|||
27598355|NCT01297959|80366771|FG000|Overall Study|Unrelated medical illness / complication|0|||
27598356|NCT01297959|80366772|FG001|Overall Study|Unrelated medical illness / complication|2|||
27598357|NCT01297959|80366771|FG000|Overall Study|Other|13|||
27598358|NCT01297959|80366772|FG001|Overall Study|Other|7|||
27598359|NCT02279043|80366773|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
27598360|NCT02279043|80366774|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
27598361|NCT02279043|80366775|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
27598362|NCT02279043|80366773|FG000|Overall Study|Lost to Follow-up|46|||
27598363|NCT02279043|80366774|FG001|Overall Study|Lost to Follow-up|88|||
27598364|NCT02279043|80366775|FG002|Overall Study|Lost to Follow-up|0|||
27598365|NCT00316082|80366776|FG000|Overall Study|Lack of Efficacy|2|||
27598366|NCT00316082|80366777|FG001|Overall Study|Lack of Efficacy|3|||
27598367|NCT00316082|80366778|FG002|Overall Study|Lack of Efficacy|3|||
27598368|NCT00316082|80366779|FG003|Overall Study|Lack of Efficacy|4|||
27598369|NCT00316082|80366780|FG004|Overall Study|Lack of Efficacy|6|||
27598370|NCT00316082|80366776|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
27598371|NCT00316082|80366777|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
27598372|NCT00316082|80366778|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
27598373|NCT00316082|80366779|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
27598374|NCT00316082|80366780|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
27598375|NCT00316082|80366776|FG000|Overall Study|Lost to Follow-up|7|||
27598376|NCT00316082|80366777|FG001|Overall Study|Lost to Follow-up|6|||
27598377|NCT00316082|80366778|FG002|Overall Study|Lost to Follow-up|7|||
27598378|NCT00316082|80366779|FG003|Overall Study|Lost to Follow-up|8|||
27598379|NCT00316082|80366780|FG004|Overall Study|Lost to Follow-up|6|||
27598380|NCT00316082|80366776|FG000|Overall Study|Poor/noncompliance|6|||
27598381|NCT00316082|80366777|FG001|Overall Study|Poor/noncompliance|1|||
27598382|NCT00316082|80366778|FG002|Overall Study|Poor/noncompliance|4|||
27598383|NCT00316082|80366779|FG003|Overall Study|Poor/noncompliance|1|||
27598384|NCT00316082|80366780|FG004|Overall Study|Poor/noncompliance|4|||
27598385|NCT00316082|80366776|FG000|Overall Study|Adverse Event|4|||
27598386|NCT00316082|80366777|FG001|Overall Study|Adverse Event|2|||
27598387|NCT00316082|80366778|FG002|Overall Study|Adverse Event|5|||
27598388|NCT00316082|80366779|FG003|Overall Study|Adverse Event|1|||
27598389|NCT00316082|80366780|FG004|Overall Study|Adverse Event|3|||
27598390|NCT00316082|80366776|FG000|Overall Study|Subject no longer meets study criteria|3|||
27598391|NCT00316082|80366777|FG001|Overall Study|Subject no longer meets study criteria|1|||
27598392|NCT00316082|80366778|FG002|Overall Study|Subject no longer meets study criteria|2|||
27598393|NCT00316082|80366779|FG003|Overall Study|Subject no longer meets study criteria|2|||
27598394|NCT00316082|80366780|FG004|Overall Study|Subject no longer meets study criteria|1|||
27598395|NCT00316082|80366776|FG000|Overall Study|Physician Decision|1|||
27598396|NCT00316082|80366777|FG001|Overall Study|Physician Decision|1|||
27598397|NCT00316082|80366778|FG002|Overall Study|Physician Decision|2|||
27598398|NCT00316082|80366779|FG003|Overall Study|Physician Decision|1|||
27598399|NCT00316082|80366780|FG004|Overall Study|Physician Decision|1|||
27598400|NCT00316082|80366776|FG000|Overall Study|Death|0|||
27704360|NCT00763971|80755533|FG000|Overall Study|Participation in 489-326 required|1|||
27598401|NCT00316082|80366777|FG001|Overall Study|Death|0|||
27598402|NCT00316082|80366778|FG002|Overall Study|Death|1|||
27598403|NCT00316082|80366779|FG003|Overall Study|Death|0|||
27598404|NCT00316082|80366780|FG004|Overall Study|Death|0|||
27598405|NCT00316082|80366776|FG000|Overall Study|Administrative reason by sponsor|0|||
27598406|NCT00316082|80366777|FG001|Overall Study|Administrative reason by sponsor|0|||
27598407|NCT00316082|80366778|FG002|Overall Study|Administrative reason by sponsor|1|||
27598408|NCT00316082|80366779|FG003|Overall Study|Administrative reason by sponsor|0|||
27598409|NCT00316082|80366780|FG004|Overall Study|Administrative reason by sponsor|0|||
27598410|NCT01050816|80370727|FG000|Overall Study|Lost to Follow-up|2|||
27598411|NCT01050816|80370727|FG000|Overall Study|patient's refusal|2|||
27598412|NCT00500903|80370728|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
27598413|NCT00500903|80370729|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
27598414|NCT00500903|80370730|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
27598415|NCT00500903|80370728|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
27598416|NCT00500903|80370729|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
27598417|NCT00500903|80370730|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27598418|NCT00500903|80370728|FG000|Overall Study|Progressive Disease|41|||
27598419|NCT00500903|80370729|FG001|Overall Study|Progressive Disease|2|||
27598420|NCT00500903|80370730|FG002|Overall Study|Progressive Disease|15|||
27598421|NCT00500903|80370728|FG000|Overall Study|Patient Declined Further Treatment|0|||
27598422|NCT00500903|80370729|FG001|Overall Study|Patient Declined Further Treatment|0|||
27598423|NCT00500903|80370730|FG002|Overall Study|Patient Declined Further Treatment|3|||
27598424|NCT00500903|80370728|FG000|Overall Study|Symptomatic Deterioration|2|||
27598425|NCT00500903|80370729|FG001|Overall Study|Symptomatic Deterioration|0|||
27598426|NCT00500903|80370730|FG002|Overall Study|Symptomatic Deterioration|0|||
27598427|NCT00500903|80370728|FG000|Overall Study|Reason Not Specified|10|||
27598428|NCT00500903|80370729|FG001|Overall Study|Reason Not Specified|0|||
27598429|NCT00500903|80370730|FG002|Overall Study|Reason Not Specified|2|||
27598430|NCT01559844|80370731|FG000|Overall Study|Consent Withdrawn|7|||
27598431|NCT01559844|80370731|FG000|Overall Study|Death|5|||
27598432|NCT01559844|80370731|FG000|Overall Study|Efficacy Failure|10|||
27598433|NCT01559844|80370731|FG000|Overall Study|No Longer A Transplant Candidate|3|||
27598434|NCT02548455|80370732|FG000|Overall Study|Withdrawal by Subject|27|||
27598435|NCT02548455|80370732|FG000|Overall Study|Death|26|||
27598436|NCT02548455|80370732|FG000|Overall Study|Lost to Follow-up|14|||
27598437|NCT02548455|80370732|FG000|Overall Study|Visit not completed|173|||
27598438|NCT01569438|80370735|FG000|Overall Study|Lack of Efficacy|1|||
27598439|NCT01569438|80370736|FG001|Overall Study|Lack of Efficacy|2|||
27887656|NCT01931956|81425140|FG001|Overall Study|Death|7|||
27598440|NCT01569438|80370735|FG000|Overall Study|Withdrawal by Subject|0|||
27598441|NCT01569438|80370736|FG001|Overall Study|Withdrawal by Subject|3|||
27598442|NCT01569438|80370735|FG000|Overall Study|Adverse Event|2|||
27598443|NCT01569438|80370736|FG001|Overall Study|Adverse Event|15|||
27598444|NCT01569438|80370735|FG000|Overall Study|Protocol Violation|2|||
27598445|NCT01569438|80370736|FG001|Overall Study|Protocol Violation|0|||
27598446|NCT01569438|80370735|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
27598447|NCT01569438|80370736|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
27598448|NCT01569438|80370735|FG000|Overall Study|Sponsor/Physician decision|1|||
27598449|NCT01569438|80370736|FG001|Overall Study|Sponsor/Physician decision|1|||
27598450|NCT01569438|80370735|FG000|Overall Study|Unable to adhere to study schedule|0|||
27598451|NCT01569438|80370736|FG001|Overall Study|Unable to adhere to study schedule|1|||
27598452|NCT01735201|80370743|FG000|Overall Study|Adverse Event|1|||
27598453|NCT01735201|80370744|FG001|Overall Study|Adverse Event|1|||
27598454|NCT01735201|80370745|FG002|Overall Study|Adverse Event|0|||
27598455|NCT01735201|80370746|FG003|Overall Study|Adverse Event|1|||
27598456|NCT01735201|80370747|FG004|Overall Study|Adverse Event|1|||
27598457|NCT01735201|80370748|FG005|Overall Study|Adverse Event|3|||
27598458|NCT01735201|80370749|FG006|Overall Study|Adverse Event|2|||
27598459|NCT01735201|80370750|FG007|Overall Study|Adverse Event|1|||
27598460|NCT01735201|80370743|FG000|Overall Study|Personal Reasons|1|||
27598461|NCT01735201|80370744|FG001|Overall Study|Personal Reasons|0|||
27598462|NCT01735201|80370745|FG002|Overall Study|Personal Reasons|0|||
27598463|NCT01735201|80370746|FG003|Overall Study|Personal Reasons|0|||
27598464|NCT01735201|80370747|FG004|Overall Study|Personal Reasons|0|||
27598465|NCT01735201|80370748|FG005|Overall Study|Personal Reasons|0|||
27598466|NCT01735201|80370749|FG006|Overall Study|Personal Reasons|0|||
27598467|NCT01735201|80370750|FG007|Overall Study|Personal Reasons|0|||
27704361|NCT00763971|80755534|FG001|Overall Study|Participation in 489-326 required|0|||
27887657|NCT01931956|81425141|FG002|Overall Study|Death|379|||
27598468|NCT01735201|80370743|FG000|Overall Study|Protocol Violation|1|||
27598469|NCT01735201|80370744|FG001|Overall Study|Protocol Violation|0|||
27598470|NCT01735201|80370745|FG002|Overall Study|Protocol Violation|0|||
27598471|NCT01735201|80370746|FG003|Overall Study|Protocol Violation|0|||
27598472|NCT01735201|80370747|FG004|Overall Study|Protocol Violation|0|||
27598473|NCT01735201|80370748|FG005|Overall Study|Protocol Violation|0|||
27598474|NCT01735201|80370749|FG006|Overall Study|Protocol Violation|0|||
27598475|NCT01735201|80370750|FG007|Overall Study|Protocol Violation|0|||
27598476|NCT01735201|80370743|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27598477|NCT01735201|80370744|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27598478|NCT01735201|80370745|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27598479|NCT01735201|80370746|FG003|Overall Study|Other Miscellaneous Reasons|1|||
27598480|NCT01735201|80370747|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27598481|NCT01735201|80370748|FG005|Overall Study|Other Miscellaneous Reasons|2|||
27598482|NCT01735201|80370749|FG006|Overall Study|Other Miscellaneous Reasons|1|||
27598483|NCT01735201|80370750|FG007|Overall Study|Other Miscellaneous Reasons|1|||
27598484|NCT04512066|80370751|FG000|Double-blind Treatment Period|Adverse Event|6|||
27598485|NCT04512066|80370752|FG001|Double-blind Treatment Period|Adverse Event|4|||
27598486|NCT04512066|80370753|FG002|Double-blind Treatment Period|Adverse Event|5|||
27598487|NCT04512066|80370754|FG003|Double-blind Treatment Period|Adverse Event|1|||
27598488|NCT04512066|80370755|FG004|Double-blind Treatment Period|Adverse Event|0|||
27598489|NCT04512066|80370756|FG005|Double-blind Treatment Period|Adverse Event|0|||
27598490|NCT04512066|80370751|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
27598491|NCT04512066|80370752|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
27598492|NCT04512066|80370753|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
27598493|NCT04512066|80370754|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
27598494|NCT04512066|80370755|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
27598495|NCT04512066|80370756|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
27598496|NCT04512066|80370751|FG000|Double-blind Treatment Period|Physician Decision|1|||
27598497|NCT04512066|80370752|FG001|Double-blind Treatment Period|Physician Decision|0|||
27598498|NCT04512066|80370753|FG002|Double-blind Treatment Period|Physician Decision|1|||
27598499|NCT04512066|80370754|FG003|Double-blind Treatment Period|Physician Decision|0|||
27598500|NCT04512066|80370755|FG004|Double-blind Treatment Period|Physician Decision|0|||
27598501|NCT04512066|80370756|FG005|Double-blind Treatment Period|Physician Decision|0|||
27598502|NCT04512066|80370751|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
27598503|NCT04512066|80370752|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
27704362|NCT00763971|80755535|FG002|Overall Study|Participation in 489-326 required|0|||
27598504|NCT04512066|80370753|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
27598505|NCT04512066|80370754|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
27598506|NCT04512066|80370755|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
27598507|NCT04512066|80370756|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
27598508|NCT04512066|80370751|FG000|Extension Period|Adverse Event|0|||
27704363|NCT00455013|80755536|FG000|Short Term Period|Adverse Event|2|||
27598509|NCT04512066|80370752|FG001|Extension Period|Adverse Event|1|||
27598510|NCT04512066|80370753|FG002|Extension Period|Adverse Event|4|||
27598511|NCT04512066|80370754|FG003|Extension Period|Adverse Event|3|||
27598512|NCT04512066|80370755|FG004|Extension Period|Adverse Event|1|||
27598513|NCT04512066|80370756|FG005|Extension Period|Adverse Event|3|||
27598514|NCT04512066|80370751|FG000|Extension Period|Death|0|||
27598515|NCT04512066|80370752|FG001|Extension Period|Death|0|||
27598516|NCT04512066|80370753|FG002|Extension Period|Death|0|||
27598517|NCT04512066|80370754|FG003|Extension Period|Death|0|||
27598518|NCT04512066|80370755|FG004|Extension Period|Death|0|||
27598519|NCT04512066|80370756|FG005|Extension Period|Death|1|||
27598520|NCT04512066|80370751|FG000|Extension Period|Lack of Efficacy|0|||
27598521|NCT04512066|80370752|FG001|Extension Period|Lack of Efficacy|4|||
27598522|NCT04512066|80370753|FG002|Extension Period|Lack of Efficacy|4|||
27598523|NCT04512066|80370754|FG003|Extension Period|Lack of Efficacy|1|||
27598524|NCT04512066|80370755|FG004|Extension Period|Lack of Efficacy|3|||
27598525|NCT04512066|80370756|FG005|Extension Period|Lack of Efficacy|3|||
27598526|NCT04512066|80370751|FG000|Extension Period|Lost to Follow-up|0|||
27598527|NCT04512066|80370752|FG001|Extension Period|Lost to Follow-up|1|||
27598528|NCT04512066|80370753|FG002|Extension Period|Lost to Follow-up|5|||
27598529|NCT04512066|80370754|FG003|Extension Period|Lost to Follow-up|2|||
27598530|NCT04512066|80370755|FG004|Extension Period|Lost to Follow-up|3|||
27598531|NCT04512066|80370756|FG005|Extension Period|Lost to Follow-up|2|||
27598532|NCT04512066|80370751|FG000|Extension Period|Non-compliance with study drug|0|||
27598533|NCT04512066|80370752|FG001|Extension Period|Non-compliance with study drug|1|||
27598534|NCT04512066|80370753|FG002|Extension Period|Non-compliance with study drug|0|||
27834541|NCT01717313|81226143|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
27834542|NCT01717313|81226144|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
27834543|NCT01717313|81226143|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
27834544|NCT01717313|81226144|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
27834545|NCT01717313|81226143|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
27887658|NCT01931956|81425142|FG003|Overall Study|Death|96|||
27598535|NCT04512066|80370754|FG003|Extension Period|Non-compliance with study drug|0|||
27598536|NCT04512066|80370755|FG004|Extension Period|Non-compliance with study drug|0|||
27598537|NCT04512066|80370756|FG005|Extension Period|Non-compliance with study drug|1|||
27704364|NCT00455013|80755537|FG001|Short Term Period|Adverse Event|5|||
27704365|NCT00455013|80755538|FG002|Short Term Period|Adverse Event|0|||
27704366|NCT00455013|80755536|FG000|Short Term Period|Withdrawal by Subject|0|||
27704367|NCT00455013|80755537|FG001|Short Term Period|Withdrawal by Subject|0|||
27704368|NCT00455013|80755538|FG002|Short Term Period|Withdrawal by Subject|1|||
27704369|NCT00455013|80755536|FG000|Short Term Period|Lack of Efficacy|4|||
27704370|NCT00455013|80755537|FG001|Short Term Period|Lack of Efficacy|0|||
27704371|NCT00455013|80755538|FG002|Short Term Period|Lack of Efficacy|0|||
27704372|NCT00455013|80755536|FG000|Short Term Period|Other|0|||
27704373|NCT00455013|80755537|FG001|Short Term Period|Other|0|||
27704374|NCT00455013|80755538|FG002|Short Term Period|Other|1|||
27704375|NCT00455013|80755536|FG000|Long Term Extension (LTE)|Adverse Event|0|||
27704376|NCT00455013|80755537|FG001|Long Term Extension (LTE)|Adverse Event|1|||
27704377|NCT00455013|80755538|FG002|Long Term Extension (LTE)|Adverse Event|1|||
27704378|NCT00455013|80755536|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
27704379|NCT00455013|80755537|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
27704380|NCT00455013|80755538|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
27704381|NCT00455013|80755536|FG000|Long Term Extension (LTE)|Death|1|||
27704382|NCT00455013|80755537|FG001|Long Term Extension (LTE)|Death|1|||
27704383|NCT00455013|80755538|FG002|Long Term Extension (LTE)|Death|0|||
27704384|NCT00455013|80755536|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
27704385|NCT00455013|80755537|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
27704386|NCT00455013|80755538|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
27704387|NCT00455013|80755536|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
27704388|NCT00455013|80755537|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
27704389|NCT00455013|80755538|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
27704390|NCT00455013|80755536|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
27704391|NCT00455013|80755537|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
27704392|NCT00455013|80755538|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
27704393|NCT00455013|80755536|FG000|Long Term Extension (LTE)|non-specified|0|||
27704394|NCT00455013|80755537|FG001|Long Term Extension (LTE)|non-specified|0|||
27704395|NCT00455013|80755538|FG002|Long Term Extension (LTE)|non-specified|1|||
27704396|NCT01873417|80755540|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
27704397|NCT01873417|80755540|FG000|Overall Study|Adverse Event|24|||
27704398|NCT01873417|80755540|FG000|Overall Study|Lost to Follow-up|2|||
27704399|NCT01873417|80755540|FG000|Overall Study|Withdrawal by Subject|2|||
27704400|NCT01873417|80755540|FG000|Overall Study|Physician Decision|3|||
27704401|NCT04343248|80755541|FG000|Overall Study|Withdrawal by Subject|5|||
27704402|NCT04343248|80755542|FG001|Overall Study|Withdrawal by Subject|6|||
27704403|NCT04343248|80755541|FG000|Overall Study|Death|1|||
27704404|NCT04343248|80755542|FG001|Overall Study|Death|2|||
27704405|NCT04343248|80755541|FG000|Overall Study|Lost to Follow-up|9|||
27704406|NCT04343248|80755542|FG001|Overall Study|Lost to Follow-up|6|||
27704407|NCT04343248|80755541|FG000|Overall Study|Physician Decision|0|||
27704408|NCT04343248|80755542|FG001|Overall Study|Physician Decision|1|||
27598538|NCT04512066|80370751|FG000|Extension Period|Other|0|||
27598539|NCT04512066|80370752|FG001|Extension Period|Other|2|||
27598540|NCT04512066|80370753|FG002|Extension Period|Other|0|||
27598541|NCT04512066|80370754|FG003|Extension Period|Other|0|||
27598542|NCT04512066|80370755|FG004|Extension Period|Other|0|||
27598543|NCT04512066|80370756|FG005|Extension Period|Other|0|||
27598544|NCT04512066|80370751|FG000|Extension Period|Physician Decision|0|||
27598545|NCT04512066|80370752|FG001|Extension Period|Physician Decision|2|||
27598546|NCT04512066|80370753|FG002|Extension Period|Physician Decision|0|||
27598547|NCT04512066|80370754|FG003|Extension Period|Physician Decision|1|||
27598548|NCT04512066|80370755|FG004|Extension Period|Physician Decision|1|||
27598549|NCT04512066|80370756|FG005|Extension Period|Physician Decision|0|||
27598550|NCT04512066|80370751|FG000|Extension Period|Withdrawal by Subject|0|||
27704409|NCT04343248|80755541|FG000|Overall Study|Adverse Event|1|||
27598551|NCT04512066|80370752|FG001|Extension Period|Withdrawal by Subject|3|||
27598552|NCT04512066|80370753|FG002|Extension Period|Withdrawal by Subject|7|||
27598553|NCT04512066|80370754|FG003|Extension Period|Withdrawal by Subject|11|||
27704410|NCT04343248|80755542|FG001|Overall Study|Adverse Event|0|||
27704411|NCT04029116|80755545|FG000|Overall Study|Adverse Event|0|||
27704412|NCT04029116|80755546|FG001|Overall Study|Adverse Event|2|||
27704413|NCT04029116|80755545|FG000|Overall Study|Lost to Follow-up|3|||
27704414|NCT04029116|80755546|FG001|Overall Study|Lost to Follow-up|5|||
27704415|NCT04029116|80755545|FG000|Overall Study|Physician Decision|2|||
27704416|NCT04029116|80755546|FG001|Overall Study|Physician Decision|0|||
27704417|NCT04029116|80755545|FG000|Overall Study|Pregnancy|1|||
27704418|NCT04029116|80755546|FG001|Overall Study|Pregnancy|2|||
27704419|NCT04029116|80755545|FG000|Overall Study|Withdrawal by Subject|4|||
27704420|NCT04029116|80755546|FG001|Overall Study|Withdrawal by Subject|6|||
27704421|NCT04029116|80755545|FG000|Overall Study|Other|2|||
27704422|NCT04029116|80755546|FG001|Overall Study|Other|1|||
27598554|NCT04512066|80370755|FG004|Extension Period|Withdrawal by Subject|8|||
27704423|NCT03583450|80755547|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
27704424|NCT03583450|80755548|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
27704425|NCT00962390|80755549|FG000|Overall Study|Adverse Event|0|||
27704426|NCT00962390|80755550|FG001|Overall Study|Adverse Event|0|||
27704427|NCT00962390|80755551|FG002|Overall Study|Adverse Event|3|||
27704428|NCT00962390|80755552|FG003|Overall Study|Adverse Event|1|||
27704429|NCT00962390|80755549|FG000|Overall Study|Lost to Follow-up|2|||
27704430|NCT00962390|80755550|FG001|Overall Study|Lost to Follow-up|2|||
27704431|NCT00962390|80755551|FG002|Overall Study|Lost to Follow-up|0|||
27704432|NCT00962390|80755552|FG003|Overall Study|Lost to Follow-up|0|||
27704433|NCT00962390|80755549|FG000|Overall Study|Protocol Violation|1|||
27704434|NCT00962390|80755550|FG001|Overall Study|Protocol Violation|0|||
27704435|NCT00962390|80755551|FG002|Overall Study|Protocol Violation|0|||
27704436|NCT00962390|80755552|FG003|Overall Study|Protocol Violation|0|||
27704437|NCT00962390|80755549|FG000|Overall Study|Withdrawal by Subject|1|||
27704438|NCT00962390|80755550|FG001|Overall Study|Withdrawal by Subject|1|||
27704439|NCT00962390|80755551|FG002|Overall Study|Withdrawal by Subject|1|||
27704440|NCT00962390|80755552|FG003|Overall Study|Withdrawal by Subject|0|||
27704441|NCT01942148|80755559|FG000|Overall Study|Adverse Event|4|||
27704442|NCT01942148|80755559|FG000|Overall Study|Lack of Efficacy|2|||
27704443|NCT01942148|80755559|FG000|Overall Study|Physician Decision|11|||
27704444|NCT01942148|80755559|FG000|Overall Study|Protocol Violation|1|||
27704445|NCT01942148|80755559|FG000|Overall Study|Withdrawal by Subject|8|||
27704446|NCT01942148|80755559|FG000|Overall Study|Use of the prohibition medicine|1|||
27887659|NCT01931956|81425139|FG000|Overall Study|Withdrawal by Subject|5|||
27887660|NCT01931956|81425140|FG001|Overall Study|Withdrawal by Subject|0|||
27887661|NCT01931956|81425141|FG002|Overall Study|Withdrawal by Subject|70|||
27887662|NCT01931956|81425142|FG003|Overall Study|Withdrawal by Subject|30|||
27704447|NCT02767323|80755560|FG000|Overall Study|Withdrawal by Subject|17|||
27704448|NCT02767323|80755561|FG001|Overall Study|Withdrawal by Subject|5|||
27704449|NCT02767323|80755562|FG002|Overall Study|Withdrawal by Subject|13|||
27704450|NCT02767323|80755563|FG003|Overall Study|Withdrawal by Subject|0|||
27704451|NCT02767323|80755560|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
27704452|NCT02767323|80755561|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
27704453|NCT02767323|80755562|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
27704454|NCT02767323|80755563|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
27704455|NCT00307333|80755564|FG000|Overall Study|Lost to Follow-up|11|||
27704456|NCT00307333|80755565|FG001|Overall Study|Lost to Follow-up|3|||
27704457|NCT01444742|80755566|FG000|Overall Study|Death|1|||
27704458|NCT03794583|80755567|FG000|Overall Study|Death|8|||
27704459|NCT03794583|80755567|FG000|Overall Study|Study Terminated by Sponsor|24|||
27704460|NCT03794583|80755567|FG000|Overall Study|Withdrawal by Subject|9|||
27704461|NCT02632721|80755568|FG000|Overall Study|Adverse Event|0|||
27834546|NCT01717313|81226144|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
27834547|NCT01717313|81226143|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
27834548|NCT01717313|81226144|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
27834549|NCT01717313|81226143|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
27834550|NCT01717313|81226144|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
27834551|NCT01717313|81226143|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
27834552|NCT01717313|81226144|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
27834553|NCT01519947|81226147|FG000|Overall Study|Death|0|||
27834554|NCT01519947|81226148|FG001|Overall Study|Death|0|||
27834555|NCT01519947|81226149|FG002|Overall Study|Death|0|||
27834556|NCT01519947|81226150|FG003|Overall Study|Death|1|||
27834557|NCT01519947|81226147|FG000|Overall Study|Protocol Violation|0|||
27834558|NCT01519947|81226148|FG001|Overall Study|Protocol Violation|0|||
27834559|NCT01519947|81226149|FG002|Overall Study|Protocol Violation|2|||
27834560|NCT01519947|81226150|FG003|Overall Study|Protocol Violation|1|||
27834561|NCT01519947|81226147|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
27834562|NCT01519947|81226148|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
27834563|NCT01519947|81226149|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
27834564|NCT01519947|81226150|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
27834565|NCT01519947|81226147|FG000|Overall Study|Development of Anemia|0|||
27834566|NCT01519947|81226148|FG001|Overall Study|Development of Anemia|1|||
27834567|NCT01519947|81226149|FG002|Overall Study|Development of Anemia|0|||
27834568|NCT01519947|81226150|FG003|Overall Study|Development of Anemia|1|||
27834569|NCT01519947|81226147|FG000|Overall Study|Blood Transfusion|0|||
27834570|NCT01519947|81226148|FG001|Overall Study|Blood Transfusion|1|||
27834571|NCT01519947|81226149|FG002|Overall Study|Blood Transfusion|1|||
27834572|NCT01519947|81226150|FG003|Overall Study|Blood Transfusion|0|||
27834573|NCT01519947|81226147|FG000|Overall Study|Withdrawal by Subject|0|||
27834574|NCT01519947|81226148|FG001|Overall Study|Withdrawal by Subject|1|||
27887663|NCT01931956|81425139|FG000|Overall Study|Lost to Follow-up|2|||
27834575|NCT01519947|81226149|FG002|Overall Study|Withdrawal by Subject|0|||
27834576|NCT01519947|81226150|FG003|Overall Study|Withdrawal by Subject|1|||
27704462|NCT02632721|80755569|FG001|Overall Study|Adverse Event|0|||
27704463|NCT02632721|80755570|FG002|Overall Study|Adverse Event|2|||
27704464|NCT02632721|80755571|FG003|Overall Study|Adverse Event|5|||
27704465|NCT02632721|80755572|FG004|Overall Study|Adverse Event|3|||
27704466|NCT02632721|80755568|FG000|Overall Study|Dose limiting toxicity|0|||
27704467|NCT02632721|80755569|FG001|Overall Study|Dose limiting toxicity|0|||
27704468|NCT02632721|80755570|FG002|Overall Study|Dose limiting toxicity|0|||
27704469|NCT02632721|80755571|FG003|Overall Study|Dose limiting toxicity|1|||
27704470|NCT02632721|80755572|FG004|Overall Study|Dose limiting toxicity|0|||
27704471|NCT02632721|80755568|FG000|Overall Study|Progressive disease|3|||
27704472|NCT02632721|80755569|FG001|Overall Study|Progressive disease|0|||
27704473|NCT02632721|80755570|FG002|Overall Study|Progressive disease|4|||
27704474|NCT02632721|80755571|FG003|Overall Study|Progressive disease|6|||
27704475|NCT02632721|80755572|FG004|Overall Study|Progressive disease|5|||
27704476|NCT02632721|80755568|FG000|Overall Study|Refused to continue taking trial medication|0|||
27598555|NCT04512066|80370756|FG005|Extension Period|Withdrawal by Subject|4|||
27598556|NCT00765843|80370757|FG000|Overall Study|Lost to Follow-up|1|||
27598557|NCT00765843|80370758|FG001|Overall Study|Lost to Follow-up|3|||
27598558|NCT00765843|80370759|FG002|Overall Study|Lost to Follow-up|2|||
27598559|NCT00765843|80370757|FG000|Overall Study|did not return to receive intervention|0|||
27598560|NCT00765843|80370758|FG001|Overall Study|did not return to receive intervention|1|||
27598561|NCT00765843|80370759|FG002|Overall Study|did not return to receive intervention|0|||
27598562|NCT00765843|80370757|FG000|Overall Study|Adverse Event|0|||
27598563|NCT00765843|80370758|FG001|Overall Study|Adverse Event|0|||
27598564|NCT00765843|80370759|FG002|Overall Study|Adverse Event|1|||
27598565|NCT00553696|80370760|FG000|Overall Study|Adverse Event|2|||
27598566|NCT00553696|80370761|FG001|Overall Study|Adverse Event|4|||
27598567|NCT00553696|80370762|FG002|Overall Study|Adverse Event|0|||
27598568|NCT00553696|80370763|FG003|Overall Study|Adverse Event|1|||
27598569|NCT00553696|80370760|FG000|Overall Study|Global deterioration of health status|0|||
27598570|NCT00553696|80370761|FG001|Overall Study|Global deterioration of health status|2|||
27598571|NCT00553696|80370762|FG002|Overall Study|Global deterioration of health status|0|||
27598572|NCT00553696|80370763|FG003|Overall Study|Global deterioration of health status|0|||
27598573|NCT00553696|80370760|FG000|Overall Study|Objective progression or relapse|2|||
27598574|NCT00553696|80370761|FG001|Overall Study|Objective progression or relapse|9|||
27598575|NCT00553696|80370762|FG002|Overall Study|Objective progression or relapse|6|||
27598576|NCT00553696|80370763|FG003|Overall Study|Objective progression or relapse|0|||
27598577|NCT00553696|80370760|FG000|Overall Study|Withdrawal by Subject|0|||
27598578|NCT00553696|80370761|FG001|Overall Study|Withdrawal by Subject|1|||
27598579|NCT00553696|80370762|FG002|Overall Study|Withdrawal by Subject|0|||
27598580|NCT00553696|80370763|FG003|Overall Study|Withdrawal by Subject|0|||
27598581|NCT03238300|80370764|FG000|Baseline (Before Intervention)|Physician Decision|0|||
27598582|NCT03238300|80370765|FG001|Baseline (Before Intervention)|Physician Decision|1|||
27598583|NCT03238300|80370764|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
27598584|NCT03238300|80370765|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
27598585|NCT03238300|80370764|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
27598586|NCT03238300|80370765|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
27598587|NCT03238300|80370764|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
27598588|NCT03238300|80370765|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
27598589|NCT00833560|80370771|FG000|Overall Study|Toxicity|13|||
27598590|NCT00833560|80370771|FG000|Overall Study|Adverse Event|11|||
27598591|NCT00833560|80370771|FG000|Overall Study|Protocol Violation|6|||
27598592|NCT00833560|80370771|FG000|Overall Study|Lack of Efficacy|4|||
27598593|NCT00833560|80370771|FG000|Overall Study|Death|2|||
27598594|NCT00833560|80370771|FG000|Overall Study|Pregression of other disease|1|||
27598595|NCT00833560|80370771|FG000|Overall Study|Other|5|||
27598596|NCT01688466|80370773|FG000|Overall Study|Withdrawal by Subject|2|||
27598597|NCT01688466|80370774|FG001|Overall Study|Withdrawal by Subject|1|||
27598598|NCT01688466|80370773|FG000|Overall Study|Death|0|||
27598599|NCT01688466|80370774|FG001|Overall Study|Death|1|||
27887664|NCT01931956|81425140|FG001|Overall Study|Lost to Follow-up|0|||
27598600|NCT01688466|80370773|FG000|Overall Study|Adverse Event|0|||
27598601|NCT01688466|80370774|FG001|Overall Study|Adverse Event|4|||
27598602|NCT01688466|80370773|FG000|Overall Study|Not evaluable|0|||
27598603|NCT01688466|80370774|FG001|Overall Study|Not evaluable|1|||
27598604|NCT01936857|80370775|FG000|Overall Study|Sent to prison or 06 center|11|||
27598605|NCT01936857|80370776|FG001|Overall Study|Sent to prison or 06 center|12|||
27598606|NCT01936857|80370775|FG000|Overall Study|Lost to Follow-up|10|||
27598607|NCT01936857|80370776|FG001|Overall Study|Lost to Follow-up|7|||
27598608|NCT01936857|80370775|FG000|Overall Study|Death|7|||
27598609|NCT01936857|80370776|FG001|Overall Study|Death|3|||
27704477|NCT02632721|80755569|FG001|Overall Study|Refused to continue taking trial medication|1|||
27704478|NCT02632721|80755570|FG002|Overall Study|Refused to continue taking trial medication|1|||
27704479|NCT02632721|80755571|FG003|Overall Study|Refused to continue taking trial medication|1|||
27887665|NCT01931956|81425141|FG002|Overall Study|Lost to Follow-up|11|||
27598610|NCT01936857|80370775|FG000|Overall Study|Moved|2|||
27704480|NCT02632721|80755572|FG004|Overall Study|Refused to continue taking trial medication|2|||
27704481|NCT02632721|80755568|FG000|Overall Study|Inadequate clinical condition|0|||
27704482|NCT02632721|80755569|FG001|Overall Study|Inadequate clinical condition|0|||
27704483|NCT02632721|80755570|FG002|Overall Study|Inadequate clinical condition|0|||
27887666|NCT01931956|81425142|FG003|Overall Study|Lost to Follow-up|7|||
27887667|NCT01931956|81425139|FG000|Overall Study|Expected|2|||
27887668|NCT01931956|81425140|FG001|Overall Study|Expected|0|||
27598611|NCT01936857|80370776|FG001|Overall Study|Moved|1|||
27704484|NCT02632721|80755571|FG003|Overall Study|Inadequate clinical condition|0|||
27704485|NCT02632721|80755572|FG004|Overall Study|Inadequate clinical condition|1|||
27704486|NCT02632721|80755568|FG000|Overall Study|No meet eligibility|0|||
27704487|NCT02632721|80755569|FG001|Overall Study|No meet eligibility|0|||
27704488|NCT02632721|80755570|FG002|Overall Study|No meet eligibility|0|||
27704489|NCT02632721|80755571|FG003|Overall Study|No meet eligibility|0|||
27704490|NCT02632721|80755572|FG004|Overall Study|No meet eligibility|1|||
27704491|NCT02632721|80755568|FG000|Overall Study|Allergic reaction|0|||
27704492|NCT02632721|80755569|FG001|Overall Study|Allergic reaction|0|||
27704493|NCT02632721|80755570|FG002|Overall Study|Allergic reaction|0|||
27704494|NCT02632721|80755571|FG003|Overall Study|Allergic reaction|1|||
27704495|NCT02632721|80755572|FG004|Overall Study|Allergic reaction|0|||
27704496|NCT02632721|80755568|FG000|Overall Study|Receiving Decitabine locally|0|||
27704497|NCT02632721|80755569|FG001|Overall Study|Receiving Decitabine locally|0|||
27704498|NCT02632721|80755570|FG002|Overall Study|Receiving Decitabine locally|1|||
27704499|NCT02632721|80755571|FG003|Overall Study|Receiving Decitabine locally|0|||
27704500|NCT02632721|80755572|FG004|Overall Study|Receiving Decitabine locally|0|||
27704501|NCT02632721|80755568|FG000|Overall Study|No benefit from study treatment|1|||
27704502|NCT02632721|80755569|FG001|Overall Study|No benefit from study treatment|1|||
27704503|NCT02632721|80755570|FG002|Overall Study|No benefit from study treatment|0|||
27704504|NCT02632721|80755571|FG003|Overall Study|No benefit from study treatment|0|||
27704505|NCT02632721|80755572|FG004|Overall Study|No benefit from study treatment|1|||
27704506|NCT02632721|80755568|FG000|Overall Study|Patient wish for other treatment|0|||
27704507|NCT02632721|80755569|FG001|Overall Study|Patient wish for other treatment|1|||
27704508|NCT02632721|80755570|FG002|Overall Study|Patient wish for other treatment|0|||
27704509|NCT02632721|80755571|FG003|Overall Study|Patient wish for other treatment|0|||
27704510|NCT02632721|80755572|FG004|Overall Study|Patient wish for other treatment|0|||
27704511|NCT02632721|80755568|FG000|Overall Study|Relapsed Pneumonia|0|||
27704512|NCT02632721|80755569|FG001|Overall Study|Relapsed Pneumonia|0|||
27704513|NCT02632721|80755570|FG002|Overall Study|Relapsed Pneumonia|0|||
27704514|NCT02632721|80755571|FG003|Overall Study|Relapsed Pneumonia|0|||
27704515|NCT02632721|80755572|FG004|Overall Study|Relapsed Pneumonia|1|||
27704516|NCT02632721|80755568|FG000|Overall Study|Therapy refractory AML|0|||
27704517|NCT02632721|80755569|FG001|Overall Study|Therapy refractory AML|0|||
27704518|NCT02632721|80755570|FG002|Overall Study|Therapy refractory AML|0|||
27704519|NCT02632721|80755571|FG003|Overall Study|Therapy refractory AML|0|||
27704520|NCT02632721|80755572|FG004|Overall Study|Therapy refractory AML|1|||
27704521|NCT02632721|80755568|FG000|Overall Study|Increase of white blood cell count|0|||
27704522|NCT02632721|80755569|FG001|Overall Study|Increase of white blood cell count|0|||
27704523|NCT02632721|80755570|FG002|Overall Study|Increase of white blood cell count|0|||
27704524|NCT02632721|80755571|FG003|Overall Study|Increase of white blood cell count|0|||
27704525|NCT02632721|80755572|FG004|Overall Study|Increase of white blood cell count|1|||
27704526|NCT02632721|80755568|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
27704527|NCT02632721|80755569|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
27704528|NCT02632721|80755570|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
27704529|NCT02632721|80755571|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
27704530|NCT02632721|80755572|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
27704531|NCT03227471|80755577|FG000|Overall Study|Withdrawal by Subject|0|||
27704532|NCT03227471|80755578|FG001|Overall Study|Withdrawal by Subject|0|||
27704533|NCT03227471|80755579|FG002|Overall Study|Withdrawal by Subject|0|||
27704534|NCT03227471|80755580|FG003|Overall Study|Withdrawal by Subject|0|||
27704535|NCT03227471|80755581|FG004|Overall Study|Withdrawal by Subject|1|||
27704536|NCT03227471|80755582|FG005|Overall Study|Withdrawal by Subject|0|||
27704537|NCT03227471|80755583|FG006|Overall Study|Withdrawal by Subject|0|||
27704538|NCT03227471|80755584|FG007|Overall Study|Withdrawal by Subject|0|||
27704539|NCT03227471|80755585|FG008|Overall Study|Withdrawal by Subject|0|||
27887669|NCT01931956|81425141|FG002|Overall Study|Expected|6|||
27704540|NCT03227471|80755586|FG009|Overall Study|Withdrawal by Subject|0|||
27887670|NCT01931956|81425142|FG003|Overall Study|Expected|0|||
27598612|NCT01936857|80370775|FG000|Overall Study|Withdrawal by Subject|1|||
27704541|NCT03227471|80755587|FG010|Overall Study|Withdrawal by Subject|0|||
27704542|NCT03227471|80755588|FG011|Overall Study|Withdrawal by Subject|0|||
27704543|NCT03227471|80755589|FG012|Overall Study|Withdrawal by Subject|1|||
27704544|NCT03227471|80755590|FG013|Overall Study|Withdrawal by Subject|0|||
27704545|NCT03227471|80755591|FG014|Overall Study|Withdrawal by Subject|0|||
27887671|NCT01931956|81425139|FG000|Overall Study|Not due|0|||
27704546|NCT03227471|80755577|FG000|Overall Study|Randomized, Never Dosed|0|||
27704547|NCT03227471|80755578|FG001|Overall Study|Randomized, Never Dosed|0|||
27704548|NCT03227471|80755579|FG002|Overall Study|Randomized, Never Dosed|0|||
27704549|NCT03227471|80755580|FG003|Overall Study|Randomized, Never Dosed|0|||
27704550|NCT03227471|80755581|FG004|Overall Study|Randomized, Never Dosed|0|||
27704551|NCT03227471|80755582|FG005|Overall Study|Randomized, Never Dosed|0|||
27704552|NCT03227471|80755583|FG006|Overall Study|Randomized, Never Dosed|0|||
27704553|NCT03227471|80755584|FG007|Overall Study|Randomized, Never Dosed|0|||
27704554|NCT03227471|80755585|FG008|Overall Study|Randomized, Never Dosed|0|||
27704555|NCT03227471|80755586|FG009|Overall Study|Randomized, Never Dosed|0|||
27704556|NCT03227471|80755587|FG010|Overall Study|Randomized, Never Dosed|0|||
27704557|NCT03227471|80755588|FG011|Overall Study|Randomized, Never Dosed|0|||
27704558|NCT03227471|80755589|FG012|Overall Study|Randomized, Never Dosed|0|||
27704559|NCT03227471|80755590|FG013|Overall Study|Randomized, Never Dosed|0|||
27704560|NCT03227471|80755591|FG014|Overall Study|Randomized, Never Dosed|1|||
27704561|NCT02790138|80755592|FG000|Overall Study|Adverse Event|5|||
27704562|NCT02790138|80755593|FG001|Overall Study|Adverse Event|2|||
27704563|NCT02790138|80755592|FG000|Overall Study|Significant Protocol Deviation|0|||
27704564|NCT02790138|80755593|FG001|Overall Study|Significant Protocol Deviation|1|||
27704565|NCT02790138|80755592|FG000|Overall Study|Lost to Follow-up|1|||
27704566|NCT02790138|80755593|FG001|Overall Study|Lost to Follow-up|0|||
27598613|NCT01936857|80370776|FG001|Overall Study|Withdrawal by Subject|0|||
27598614|NCT01936857|80370775|FG000|Overall Study|Side effect of medication|1|||
27598615|NCT01936857|80370776|FG001|Overall Study|Side effect of medication|0|||
27704567|NCT02790138|80755592|FG000|Overall Study|Voluntary Withdrawal|8|||
27704568|NCT02790138|80755593|FG001|Overall Study|Voluntary Withdrawal|9|||
27704569|NCT02790138|80755592|FG000|Overall Study|Lack of Efficacy|6|||
27704570|NCT02790138|80755593|FG001|Overall Study|Lack of Efficacy|7|||
27887672|NCT01931956|81425140|FG001|Overall Study|Not due|0|||
27887673|NCT01931956|81425141|FG002|Overall Study|Not due|21|||
27887674|NCT01931956|81425142|FG003|Overall Study|Not due|0|||
27887675|NCT01866657|81425143|FG000|Overall Study|Surgery canceled|2|||
27887676|NCT01866657|81425144|FG001|Overall Study|Surgery canceled|0|||
27887677|NCT00915876|81425147|FG000|Overall Study|Adverse Event|0|||
27704571|NCT02790138|80755592|FG000|Overall Study|Reason not Specified|1|||
27704572|NCT02790138|80755593|FG001|Overall Study|Reason not Specified|0|||
27704573|NCT01187550|80755594|FG000|Overall Study|Protocol Violation|3|||
27704574|NCT01187550|80755595|FG001|Overall Study|Protocol Violation|1|||
27704575|NCT01187550|80755594|FG000|Overall Study|Other|3|||
27704576|NCT01187550|80755595|FG001|Overall Study|Other|0|||
27704577|NCT01187550|80755594|FG000|Overall Study|Randomized but not treated|8|||
27887678|NCT00915876|81425148|FG001|Overall Study|Adverse Event|1|||
27887679|NCT01475851|81425149|FG000|Overall Study|Protocol defined stopping criteria|1|||
27704578|NCT01187550|80755595|FG001|Overall Study|Randomized but not treated|0|||
27704579|NCT00290290|80755596|FG000|Overall Study|Death|3|||
27704580|NCT00290290|80755597|FG001|Overall Study|Death|4|||
27704581|NCT00290290|80755596|FG000|Overall Study|Withdrawal by Subject|2|||
27704582|NCT00290290|80755597|FG001|Overall Study|Withdrawal by Subject|2|||
27704583|NCT00290290|80755596|FG000|Overall Study|Underwent clean surgical procedure|13|||
27704584|NCT00290290|80755597|FG001|Overall Study|Underwent clean surgical procedure|12|||
27704585|NCT02294682|80755598|FG000|Overall Study|Could not swallow pills|1|||
27704586|NCT02294682|80755599|FG001|Overall Study|Could not swallow pills|0|||
27704587|NCT00525044|80755600|FG000|Overall Study|Lost to Follow-up|0|||
27704588|NCT00525044|80755601|FG001|Overall Study|Lost to Follow-up|1|||
27704589|NCT01131351|80758410|FG000|Overall Study|Adverse Event|0|||
27704590|NCT01131351|80758411|FG001|Overall Study|Adverse Event|2|||
27704591|NCT01131351|80758410|FG000|Overall Study|Protocol Deviation|0|||
27704592|NCT01131351|80758411|FG001|Overall Study|Protocol Deviation|1|||
27704593|NCT01621542|80758413|FG000|Overall Study|Adverse Event|0|||
27704594|NCT01621542|80758414|FG001|Overall Study|Adverse Event|0|||
27704595|NCT01621542|80758415|FG002|Overall Study|Adverse Event|1|||
27704596|NCT01621542|80758416|FG003|Overall Study|Adverse Event|3|||
27704597|NCT01621542|80758417|FG004|Overall Study|Adverse Event|0|||
27704598|NCT01621542|80758418|FG005|Overall Study|Adverse Event|0|||
27704599|NCT01621542|80758413|FG000|Overall Study|Death|0|||
27887680|NCT01475851|81425150|FG001|Overall Study|Protocol defined stopping criteria|0|||
27598616|NCT01936857|80370775|FG000|Overall Study|Other|2|||
27598617|NCT01936857|80370776|FG001|Overall Study|Other|2|||
27704600|NCT01621542|80758414|FG001|Overall Study|Death|1|||
27704601|NCT01621542|80758415|FG002|Overall Study|Death|0|||
27704602|NCT01621542|80758416|FG003|Overall Study|Death|0|||
27704603|NCT01621542|80758417|FG004|Overall Study|Death|0|||
27704604|NCT01621542|80758418|FG005|Overall Study|Death|0|||
27704605|NCT01621542|80758413|FG000|Overall Study|Physician Decision|1|||
27704606|NCT01621542|80758414|FG001|Overall Study|Physician Decision|0|||
27704607|NCT01621542|80758415|FG002|Overall Study|Physician Decision|1|||
27704608|NCT01621542|80758416|FG003|Overall Study|Physician Decision|13|||
27704609|NCT01621542|80758417|FG004|Overall Study|Physician Decision|3|||
27704610|NCT01621542|80758418|FG005|Overall Study|Physician Decision|1|||
27704611|NCT01621542|80758413|FG000|Overall Study|Withdrawal by Subject|2|||
27704612|NCT01621542|80758414|FG001|Overall Study|Withdrawal by Subject|0|||
27704613|NCT01621542|80758415|FG002|Overall Study|Withdrawal by Subject|1|||
27704614|NCT01621542|80758416|FG003|Overall Study|Withdrawal by Subject|3|||
27704615|NCT01621542|80758417|FG004|Overall Study|Withdrawal by Subject|3|||
27704616|NCT01621542|80758418|FG005|Overall Study|Withdrawal by Subject|3|||
27704617|NCT01621542|80758413|FG000|Overall Study|progression/treatment failure|2|||
27704618|NCT01621542|80758414|FG001|Overall Study|progression/treatment failure|4|||
27887681|NCT02294396|81425151|FG000|Overall Study|Adverse Event|26|||
27887682|NCT02294396|81425152|FG001|Overall Study|Adverse Event|25|||
27704619|NCT01621542|80758415|FG002|Overall Study|progression/treatment failure|3|||
27834577|NCT01519947|81226147|FG000|Overall Study|Lost to Follow-up|0|||
27834578|NCT01519947|81226148|FG001|Overall Study|Lost to Follow-up|0|||
27834579|NCT01519947|81226149|FG002|Overall Study|Lost to Follow-up|3|||
27834580|NCT01519947|81226150|FG003|Overall Study|Lost to Follow-up|2|||
27834581|NCT01519947|81226147|FG000|Overall Study|Poor Response|1|||
27834582|NCT01519947|81226148|FG001|Overall Study|Poor Response|0|||
27834583|NCT01519947|81226149|FG002|Overall Study|Poor Response|0|||
27834584|NCT01519947|81226150|FG003|Overall Study|Poor Response|1|||
27834585|NCT01519947|81226147|FG000|Overall Study|Adverse Event|1|||
27834586|NCT01519947|81226148|FG001|Overall Study|Adverse Event|0|||
27834587|NCT01519947|81226149|FG002|Overall Study|Adverse Event|1|||
27834588|NCT01519947|81226150|FG003|Overall Study|Adverse Event|1|||
27834589|NCT01499043|81226151|FG000|Overall Study|Progressive disease (radiographic)|2|||
27834590|NCT01499043|81226151|FG000|Overall Study|Progressive disease (clinical)|1|||
27834591|NCT01499043|81226151|FG000|Overall Study|Withdrawal by Subject|2|||
27834592|NCT01499043|81226151|FG000|Overall Study|Adverse Event|1|||
27834593|NCT00673660|81226152|FG000|Overall Study|Lost to Follow-up|107|||
27834594|NCT02663349|81226153|FG000|Overall Study|Withdrawal by Subject|6|||
27834595|NCT04608448|81226154|FG000|Overall Study|Withdrawal by Subject|1|||
27834596|NCT04608448|81226154|FG000|Overall Study|Adverse Event|1|||
27834597|NCT01143337|81226155|FG000|Overall Study|Adverse Event|3|||
27834598|NCT01143337|81226156|FG001|Overall Study|Adverse Event|9|||
27834599|NCT01143337|81226157|FG002|Overall Study|Adverse Event|5|||
27834600|NCT01143337|81226155|FG000|Overall Study|Lack of Efficacy|6|||
27834601|NCT01143337|81226156|FG001|Overall Study|Lack of Efficacy|2|||
27834602|NCT01143337|81226157|FG002|Overall Study|Lack of Efficacy|1|||
27834603|NCT01143337|81226155|FG000|Overall Study|Protocol Violation|1|||
27834604|NCT01143337|81226156|FG001|Overall Study|Protocol Violation|0|||
27834605|NCT01143337|81226157|FG002|Overall Study|Protocol Violation|0|||
27834606|NCT01143337|81226155|FG000|Overall Study|Withdrawal by Subject|0|||
27887683|NCT02294396|81425153|FG002|Overall Study|Adverse Event|21|||
27704620|NCT01621542|80758416|FG003|Overall Study|progression/treatment failure|7|||
27834607|NCT01143337|81226156|FG001|Overall Study|Withdrawal by Subject|0|||
27834608|NCT01143337|81226157|FG002|Overall Study|Withdrawal by Subject|1|||
27887684|NCT02294396|81425154|FG003|Overall Study|Adverse Event|24|||
27704621|NCT01621542|80758417|FG004|Overall Study|progression/treatment failure|3|||
27704622|NCT01621542|80758418|FG005|Overall Study|progression/treatment failure|5|||
27704623|NCT01621542|80758413|FG000|Overall Study|Protocol Violation|0|||
27834609|NCT01143337|81226155|FG000|Overall Study|Other reason|0|||
27834610|NCT01143337|81226156|FG001|Overall Study|Other reason|0|||
27834611|NCT01143337|81226157|FG002|Overall Study|Other reason|5|||
27834612|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
27834613|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
27704624|NCT01621542|80758414|FG001|Overall Study|Protocol Violation|0|||
27704625|NCT01621542|80758415|FG002|Overall Study|Protocol Violation|0|||
27834614|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
27887685|NCT02294396|81425151|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
27887686|NCT02294396|81425152|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
27887687|NCT02294396|81425153|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
27887688|NCT02294396|81425154|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
27887689|NCT02294396|81425151|FG000|Overall Study|Withdrawal by Subject|8|||
27887690|NCT02294396|81425152|FG001|Overall Study|Withdrawal by Subject|6|||
27887691|NCT02294396|81425153|FG002|Overall Study|Withdrawal by Subject|6|||
27887692|NCT02294396|81425154|FG003|Overall Study|Withdrawal by Subject|8|||
27887693|NCT02294396|81425151|FG000|Overall Study|Lost to Follow-up|0|||
27887694|NCT02294396|81425152|FG001|Overall Study|Lost to Follow-up|0|||
27887695|NCT02294396|81425153|FG002|Overall Study|Lost to Follow-up|1|||
27887696|NCT02294396|81425154|FG003|Overall Study|Lost to Follow-up|1|||
27834615|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
27834616|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
27834617|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834618|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
27887697|NCT02294396|81425151|FG000|Overall Study|Protocol Deviation|3|||
27887698|NCT02294396|81425152|FG001|Overall Study|Protocol Deviation|2|||
27887699|NCT02294396|81425153|FG002|Overall Study|Protocol Deviation|2|||
27887700|NCT02294396|81425154|FG003|Overall Study|Protocol Deviation|1|||
27887701|NCT02294396|81425151|FG000|Overall Study|Miscellaneous|2|||
27834619|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834620|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834621|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834622|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834623|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834624|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834625|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834626|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834627|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834628|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834629|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834630|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834631|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834632|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834633|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834634|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834635|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834636|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834637|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
27834638|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834639|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
27834640|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834641|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27598618|NCT00386022|80370777|FG000|Plus Estrogen|Lost to Follow-up|2|||
27834642|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27887702|NCT02294396|81425152|FG001|Overall Study|Miscellaneous|0|||
27887703|NCT02294396|81425153|FG002|Overall Study|Miscellaneous|5|||
27598619|NCT00386022|80370778|FG001|Plus Estrogen|Lost to Follow-up|0|||
27598620|NCT00386022|80370777|FG000|Plus Estrogen|Adverse Event|0|||
27704626|NCT01621542|80758416|FG003|Overall Study|Protocol Violation|1|||
27834643|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27887704|NCT02294396|81425154|FG003|Overall Study|Miscellaneous|2|||
27887705|NCT00095238|81425157|FG000|Overall Study|Lack of Efficacy|9|||
27598621|NCT00386022|80370778|FG001|Plus Estrogen|Adverse Event|1|||
27598622|NCT03494166|80370779|FG000|Overall Study|Death|0|||
27598623|NCT03494166|80370780|FG001|Overall Study|Death|0|||
27598624|NCT03494166|80370781|FG002|Overall Study|Death|0|||
27598625|NCT03494166|80370782|FG003|Overall Study|Death|1|||
27598626|NCT03494166|80370783|FG004|Overall Study|Death|3|||
27598627|NCT03494166|80370784|FG005|Overall Study|Death|0|||
27598628|NCT03494166|80370779|FG000|Overall Study|Lost to Follow-up|2|||
27598629|NCT03494166|80370780|FG001|Overall Study|Lost to Follow-up|2|||
27598630|NCT03494166|80370781|FG002|Overall Study|Lost to Follow-up|2|||
27598631|NCT03494166|80370782|FG003|Overall Study|Lost to Follow-up|2|||
27598632|NCT03494166|80370783|FG004|Overall Study|Lost to Follow-up|14|||
27598633|NCT03494166|80370784|FG005|Overall Study|Lost to Follow-up|0|||
27598634|NCT03494166|80370779|FG000|Overall Study|Withdrawal by Subject|10|||
27704627|NCT01621542|80758417|FG004|Overall Study|Protocol Violation|0|||
27704628|NCT01621542|80758418|FG005|Overall Study|Protocol Violation|0|||
27704629|NCT01621542|80758413|FG000|Overall Study|study stopped by sponsor|0|||
27704630|NCT01621542|80758414|FG001|Overall Study|study stopped by sponsor|0|||
27834644|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834645|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834646|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834647|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834648|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834649|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834650|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834651|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834652|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834653|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834654|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27598635|NCT03494166|80370780|FG001|Overall Study|Withdrawal by Subject|7|||
27704631|NCT01621542|80758415|FG002|Overall Study|study stopped by sponsor|0|||
27834655|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834656|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834657|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834658|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834659|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834660|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834661|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27834662|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27598636|NCT03494166|80370781|FG002|Overall Study|Withdrawal by Subject|0|||
27598637|NCT03494166|80370782|FG003|Overall Study|Withdrawal by Subject|5|||
27598638|NCT03494166|80370783|FG004|Overall Study|Withdrawal by Subject|3|||
27598639|NCT03494166|80370784|FG005|Overall Study|Withdrawal by Subject|17|||
27598640|NCT03494166|80370779|FG000|Overall Study|Screen failure|1|||
27598641|NCT03494166|80370780|FG001|Overall Study|Screen failure|0|||
27598642|NCT03494166|80370781|FG002|Overall Study|Screen failure|0|||
27598643|NCT03494166|80370782|FG003|Overall Study|Screen failure|0|||
27598644|NCT03494166|80370783|FG004|Overall Study|Screen failure|1|||
27598645|NCT03494166|80370784|FG005|Overall Study|Screen failure|0|||
27887706|NCT00095238|81425158|FG001|Overall Study|Lack of Efficacy|9|||
27887707|NCT00095238|81425157|FG000|Overall Study|Adverse Event|331|||
27598646|NCT02543658|80370785|FG000|Overall Study|Lack of Efficacy|0|||
27598647|NCT02543658|80370786|FG001|Overall Study|Lack of Efficacy|4|||
27598648|NCT01433354|80370788|FG000|Overall Study|Adverse Event|6|||
27598649|NCT01433354|80370788|FG000|Overall Study|Lost to Follow-up|1|||
27598650|NCT01433354|80370788|FG000|Overall Study|Administrative problems|90|||
27598651|NCT01433354|80370788|FG000|Overall Study|Protocol Violation|2|||
27598652|NCT01433354|80370788|FG000|Overall Study|Lack of Efficacy|17|||
27598653|NCT01433354|80370788|FG000|Overall Study|Subject Withdrew Consent|3|||
27598654|NCT00522301|80370789|FG000|Overall Study|Withdrawal by Subject|1|||
27598655|NCT00522301|80370789|FG000|Overall Study|Adverse Event|5|||
27598656|NCT00168038|80370790|FG000|Overall Study|Adverse Event|1|||
27598657|NCT00168038|80370790|FG000|Overall Study|Therapy failure|1|||
27598658|NCT01471054|80370791|FG000|Overall Study|Study terminated prematurely|4|||
27598659|NCT01471054|80370792|FG001|Overall Study|Study terminated prematurely|0|||
27598660|NCT02925676|80370793|FG000|Overall Study|Withdrawal by Subject|1|||
27598661|NCT04398537|80370794|FG000|Overall Study|Physician Decision|10|||
27598662|NCT04398537|80370795|FG001|Overall Study|Physician Decision|15|||
27598663|NCT00136955|80370796|FG000|Overall Study|Adverse Event|8|||
27598664|NCT00136955|80370796|FG000|Overall Study|Lost to Follow-up|1|||
27598665|NCT00136955|80370796|FG000|Overall Study|Withdrawal by Subject|2|||
27598666|NCT00136955|80370796|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
27598667|NCT01040260|80370799|FG000|Overall Study|Withdrawal by Subject|12|||
27598668|NCT01040260|80370800|FG001|Overall Study|Withdrawal by Subject|6|||
27598669|NCT01040260|80370799|FG000|Overall Study|Lost to Follow-up|3|||
27598670|NCT01040260|80370800|FG001|Overall Study|Lost to Follow-up|5|||
27598671|NCT00708916|80370802|FG000|Overall Study|Subject Noncompliance|2|||
27598672|NCT00708916|80370802|FG000|Overall Study|Adverse Event|2|||
27598673|NCT03338894|80370803|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
27598674|NCT04259450|80370804|FG000|Overall Study|Adverse event/ Toxicity|0|||
27598675|NCT04259450|80370805|FG001|Overall Study|Adverse event/ Toxicity|3|||
27598676|NCT04259450|80370806|FG002|Overall Study|Adverse event/ Toxicity|0|||
27598677|NCT04259450|80370807|FG003|Overall Study|Adverse event/ Toxicity|1|||
27598678|NCT04259450|80370808|FG004|Overall Study|Adverse event/ Toxicity|0|||
27598679|NCT04259450|80370809|FG005|Overall Study|Adverse event/ Toxicity|0|||
27598680|NCT04259450|80370810|FG006|Overall Study|Adverse event/ Toxicity|0|||
27598681|NCT04259450|80370811|FG007|Overall Study|Adverse event/ Toxicity|1|||
27598682|NCT04259450|80370812|FG008|Overall Study|Adverse event/ Toxicity|0|||
27598683|NCT04259450|80370813|FG009|Overall Study|Adverse event/ Toxicity|3|||
27598684|NCT04259450|80370804|FG000|Overall Study|Disease progression|2|||
27598685|NCT04259450|80370805|FG001|Overall Study|Disease progression|3|||
27598686|NCT04259450|80370806|FG002|Overall Study|Disease progression|4|||
27598687|NCT04259450|80370807|FG003|Overall Study|Disease progression|4|||
27598688|NCT04259450|80370808|FG004|Overall Study|Disease progression|6|||
27598689|NCT04259450|80370809|FG005|Overall Study|Disease progression|6|||
27598690|NCT04259450|80370810|FG006|Overall Study|Disease progression|5|||
27598691|NCT04259450|80370811|FG007|Overall Study|Disease progression|15|||
27887708|NCT00095238|81425158|FG001|Overall Study|Adverse Event|287|||
27598692|NCT04259450|80370812|FG008|Overall Study|Disease progression|6|||
27598693|NCT04259450|80370813|FG009|Overall Study|Disease progression|17|||
27598694|NCT04259450|80370804|FG000|Overall Study|Death|0|||
27598695|NCT04259450|80370805|FG001|Overall Study|Death|0|||
27598696|NCT04259450|80370806|FG002|Overall Study|Death|0|||
27598697|NCT04259450|80370807|FG003|Overall Study|Death|0|||
27598698|NCT04259450|80370808|FG004|Overall Study|Death|0|||
27598699|NCT04259450|80370809|FG005|Overall Study|Death|0|||
27598700|NCT04259450|80370810|FG006|Overall Study|Death|0|||
27598701|NCT04259450|80370811|FG007|Overall Study|Death|1|||
27598702|NCT04259450|80370812|FG008|Overall Study|Death|1|||
27598703|NCT04259450|80370813|FG009|Overall Study|Death|0|||
27598704|NCT04259450|80370804|FG000|Overall Study|Withdrawal by Subject|0|||
27598705|NCT04259450|80370805|FG001|Overall Study|Withdrawal by Subject|0|||
27598706|NCT04259450|80370806|FG002|Overall Study|Withdrawal by Subject|0|||
27598707|NCT04259450|80370807|FG003|Overall Study|Withdrawal by Subject|0|||
27598708|NCT04259450|80370808|FG004|Overall Study|Withdrawal by Subject|0|||
27598709|NCT04259450|80370809|FG005|Overall Study|Withdrawal by Subject|0|||
27598710|NCT04259450|80370810|FG006|Overall Study|Withdrawal by Subject|0|||
27598711|NCT04259450|80370811|FG007|Overall Study|Withdrawal by Subject|1|||
27598712|NCT04259450|80370812|FG008|Overall Study|Withdrawal by Subject|0|||
27598713|NCT04259450|80370813|FG009|Overall Study|Withdrawal by Subject|0|||
27598714|NCT04259450|80370804|FG000|Overall Study|Long Term Adverse Event|0|||
27598715|NCT04259450|80370805|FG001|Overall Study|Long Term Adverse Event|0|||
27598716|NCT04259450|80370806|FG002|Overall Study|Long Term Adverse Event|0|||
27598717|NCT04259450|80370807|FG003|Overall Study|Long Term Adverse Event|0|||
27598718|NCT04259450|80370808|FG004|Overall Study|Long Term Adverse Event|0|||
27598719|NCT04259450|80370809|FG005|Overall Study|Long Term Adverse Event|0|||
27598720|NCT04259450|80370810|FG006|Overall Study|Long Term Adverse Event|0|||
27598721|NCT04259450|80370811|FG007|Overall Study|Long Term Adverse Event|0|||
27598722|NCT04259450|80370812|FG008|Overall Study|Long Term Adverse Event|0|||
27598723|NCT04259450|80370813|FG009|Overall Study|Long Term Adverse Event|1|||
27598724|NCT03432364|80370814|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
27598725|NCT03014674|80370818|FG000|Overall Study|Withdrawal by Subject|1|||
27598726|NCT03014674|80370819|FG001|Overall Study|Withdrawal by Subject|0|||
27598727|NCT03014674|80370820|FG002|Overall Study|Withdrawal by Subject|0|||
27598728|NCT01592370|80370821|FG000|Overall Study|Disease Progression|62|||
27598729|NCT01592370|80370822|FG001|Overall Study|Disease Progression|16|||
27598730|NCT01592370|80370823|FG002|Overall Study|Disease Progression|52|||
27598731|NCT01592370|80370824|FG003|Overall Study|Disease Progression|3|||
27598732|NCT01592370|80370825|FG004|Overall Study|Disease Progression|3|||
27598733|NCT01592370|80370826|FG005|Overall Study|Disease Progression|31|||
27598734|NCT01592370|80370827|FG006|Overall Study|Disease Progression|14|||
27598735|NCT01592370|80370821|FG000|Overall Study|Study Drug Toxicity|14|||
27598736|NCT01592370|80370822|FG001|Overall Study|Study Drug Toxicity|3|||
27598737|NCT01592370|80370823|FG002|Overall Study|Study Drug Toxicity|0|||
27598738|NCT01592370|80370824|FG003|Overall Study|Study Drug Toxicity|0|||
27598739|NCT01592370|80370825|FG004|Overall Study|Study Drug Toxicity|0|||
27598740|NCT01592370|80370826|FG005|Overall Study|Study Drug Toxicity|0|||
27598741|NCT01592370|80370827|FG006|Overall Study|Study Drug Toxicity|1|||
27598742|NCT01592370|80370821|FG000|Overall Study|AE unrelated to study drug|4|||
27598743|NCT01592370|80370822|FG001|Overall Study|AE unrelated to study drug|3|||
27598744|NCT01592370|80370823|FG002|Overall Study|AE unrelated to study drug|0|||
27598745|NCT01592370|80370824|FG003|Overall Study|AE unrelated to study drug|0|||
27598746|NCT01592370|80370825|FG004|Overall Study|AE unrelated to study drug|0|||
27598747|NCT01592370|80370826|FG005|Overall Study|AE unrelated to study drug|0|||
27598748|NCT01592370|80370827|FG006|Overall Study|AE unrelated to study drug|1|||
27598749|NCT01592370|80370821|FG000|Overall Study|Request to discontinue study treatment|5|||
27598750|NCT01592370|80370822|FG001|Overall Study|Request to discontinue study treatment|0|||
27598751|NCT01592370|80370823|FG002|Overall Study|Request to discontinue study treatment|2|||
27598752|NCT01592370|80370824|FG003|Overall Study|Request to discontinue study treatment|0|||
27598753|NCT01592370|80370825|FG004|Overall Study|Request to discontinue study treatment|1|||
27598754|NCT01592370|80370826|FG005|Overall Study|Request to discontinue study treatment|2|||
27598755|NCT01592370|80370827|FG006|Overall Study|Request to discontinue study treatment|0|||
27598756|NCT01592370|80370821|FG000|Overall Study|Withdrew consent|1|||
27598757|NCT01592370|80370822|FG001|Overall Study|Withdrew consent|2|||
27598758|NCT01592370|80370823|FG002|Overall Study|Withdrew consent|1|||
27598759|NCT01592370|80370824|FG003|Overall Study|Withdrew consent|1|||
27598760|NCT01592370|80370825|FG004|Overall Study|Withdrew consent|0|||
27598761|NCT01592370|80370826|FG005|Overall Study|Withdrew consent|0|||
27598762|NCT01592370|80370827|FG006|Overall Study|Withdrew consent|0|||
27598763|NCT01592370|80370821|FG000|Overall Study|Maximum clinical benefit|11|||
27598764|NCT01592370|80370822|FG001|Overall Study|Maximum clinical benefit|1|||
27598765|NCT01592370|80370823|FG002|Overall Study|Maximum clinical benefit|7|||
27598766|NCT01592370|80370824|FG003|Overall Study|Maximum clinical benefit|1|||
27598767|NCT01592370|80370825|FG004|Overall Study|Maximum clinical benefit|0|||
27598768|NCT01592370|80370826|FG005|Overall Study|Maximum clinical benefit|0|||
27598769|NCT01592370|80370827|FG006|Overall Study|Maximum clinical benefit|0|||
27598770|NCT01592370|80370821|FG000|Overall Study|No longer meets study criteria|1|||
27598771|NCT01592370|80370822|FG001|Overall Study|No longer meets study criteria|0|||
27598772|NCT01592370|80370823|FG002|Overall Study|No longer meets study criteria|0|||
27598773|NCT01592370|80370824|FG003|Overall Study|No longer meets study criteria|0|||
27598774|NCT01592370|80370825|FG004|Overall Study|No longer meets study criteria|0|||
27598775|NCT01592370|80370826|FG005|Overall Study|No longer meets study criteria|0|||
27598776|NCT01592370|80370827|FG006|Overall Study|No longer meets study criteria|0|||
27598777|NCT01592370|80370821|FG000|Overall Study|Other Reasons|6|||
27598778|NCT01592370|80370822|FG001|Overall Study|Other Reasons|0|||
27598779|NCT01592370|80370823|FG002|Overall Study|Other Reasons|10|||
27598780|NCT01592370|80370824|FG003|Overall Study|Other Reasons|0|||
27598781|NCT01592370|80370825|FG004|Overall Study|Other Reasons|0|||
27598782|NCT01592370|80370826|FG005|Overall Study|Other Reasons|1|||
27598783|NCT01592370|80370827|FG006|Overall Study|Other Reasons|0|||
27598784|NCT02151266|80370828|FG000|Overall Study|Lost to Follow-up|1|||
27598785|NCT02151266|80370829|FG001|Overall Study|Lost to Follow-up|4|||
27598786|NCT02151266|80370830|FG002|Overall Study|Lost to Follow-up|1|||
27598787|NCT02151266|80370828|FG000|Overall Study|Did NOT receive intervention|3|||
27598788|NCT02151266|80370829|FG001|Overall Study|Did NOT receive intervention|6|||
27598789|NCT02151266|80370830|FG002|Overall Study|Did NOT receive intervention|2|||
27598790|NCT02151266|80370828|FG000|Overall Study|Not able to exercise|4|||
27598791|NCT02151266|80370829|FG001|Overall Study|Not able to exercise|5|||
27598792|NCT02151266|80370830|FG002|Overall Study|Not able to exercise|4|||
27598793|NCT04791761|80370831|FG000|Overall Study|Lost to Follow-up|8|||
27598794|NCT04791761|80370832|FG001|Overall Study|Lost to Follow-up|6|||
27598795|NCT04791761|80370833|FG002|Overall Study|Lost to Follow-up|10|||
27598796|NCT04791761|80370831|FG000|Overall Study|Withdrawal by Subject|0|||
27598797|NCT04791761|80370832|FG001|Overall Study|Withdrawal by Subject|1|||
27598798|NCT04791761|80370833|FG002|Overall Study|Withdrawal by Subject|1|||
27598799|NCT04791761|80370831|FG000|Overall Study|Protocol Violation|0|||
27598800|NCT04791761|80370832|FG001|Overall Study|Protocol Violation|1|||
27598801|NCT04791761|80370833|FG002|Overall Study|Protocol Violation|1|||
27598802|NCT04026165|80370834|FG000|Run-in Placebo Period|Enrollment Error|13|||
27598803|NCT04026165|80370835|FG001|Run-in Placebo Period|Enrollment Error|0|||
27598804|NCT04026165|80370836|FG002|Run-in Placebo Period|Enrollment Error|0|||
27598805|NCT04026165|80370837|FG003|Run-in Placebo Period|Enrollment Error|0|||
27598806|NCT04026165|80370834|FG000|Run-in Placebo Period|Run-in Failure|4|||
27598807|NCT04026165|80370835|FG001|Run-in Placebo Period|Run-in Failure|0|||
27598808|NCT04026165|80370836|FG002|Run-in Placebo Period|Run-in Failure|0|||
27598809|NCT04026165|80370837|FG003|Run-in Placebo Period|Run-in Failure|0|||
27598810|NCT04026165|80370834|FG000|Run-in Placebo Period|Protocol Violation|2|||
27704632|NCT01621542|80758416|FG003|Overall Study|study stopped by sponsor|1|||
27834663|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
27598811|NCT04026165|80370835|FG001|Run-in Placebo Period|Protocol Violation|0|||
27598812|NCT04026165|80370836|FG002|Run-in Placebo Period|Protocol Violation|0|||
27834664|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834665|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
27834666|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27598813|NCT04026165|80370837|FG003|Run-in Placebo Period|Protocol Violation|0|||
27598814|NCT04026165|80370834|FG000|Run-in Placebo Period|Withdrew Consent|2|||
27598815|NCT04026165|80370835|FG001|Run-in Placebo Period|Withdrew Consent|0|||
27887709|NCT00095238|81425157|FG000|Overall Study|Subject Withdrew Consent|208|||
27887710|NCT00095238|81425158|FG001|Overall Study|Subject Withdrew Consent|223|||
27887711|NCT00095238|81425157|FG000|Overall Study|Death|154|||
27598816|NCT04026165|80370836|FG002|Run-in Placebo Period|Withdrew Consent|0|||
27598817|NCT04026165|80370837|FG003|Run-in Placebo Period|Withdrew Consent|0|||
27598818|NCT04026165|80370834|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
27598819|NCT04026165|80370835|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
27598820|NCT04026165|80370836|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
27598821|NCT04026165|80370837|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
27598822|NCT04026165|80370834|FG000|Run-in SEL Period|Run-in Failure|0|||
27598823|NCT04026165|80370835|FG001|Run-in SEL Period|Run-in Failure|26|||
27598824|NCT04026165|80370836|FG002|Run-in SEL Period|Run-in Failure|0|||
27598825|NCT04026165|80370837|FG003|Run-in SEL Period|Run-in Failure|0|||
27598826|NCT04026165|80370834|FG000|Run-in SEL Period|Withdrew Consent|0|||
27598827|NCT04026165|80370835|FG001|Run-in SEL Period|Withdrew Consent|10|||
27598828|NCT04026165|80370836|FG002|Run-in SEL Period|Withdrew Consent|0|||
27598829|NCT04026165|80370837|FG003|Run-in SEL Period|Withdrew Consent|0|||
27598830|NCT04026165|80370834|FG000|Run-in SEL Period|Enrollment Error|0|||
27598831|NCT04026165|80370835|FG001|Run-in SEL Period|Enrollment Error|4|||
27598832|NCT04026165|80370836|FG002|Run-in SEL Period|Enrollment Error|0|||
27598833|NCT04026165|80370837|FG003|Run-in SEL Period|Enrollment Error|0|||
27598834|NCT04026165|80370834|FG000|Run-in SEL Period|Protocol Violation|0|||
27598835|NCT04026165|80370835|FG001|Run-in SEL Period|Protocol Violation|3|||
27598836|NCT04026165|80370836|FG002|Run-in SEL Period|Protocol Violation|0|||
27598837|NCT04026165|80370837|FG003|Run-in SEL Period|Protocol Violation|0|||
27598838|NCT04026165|80370834|FG000|Run-in SEL Period|Investigator's Discretion|0|||
27598839|NCT04026165|80370835|FG001|Run-in SEL Period|Investigator's Discretion|2|||
27598840|NCT04026165|80370836|FG002|Run-in SEL Period|Investigator's Discretion|0|||
27598841|NCT04026165|80370837|FG003|Run-in SEL Period|Investigator's Discretion|0|||
27598842|NCT04026165|80370834|FG000|Run-in SEL Period|Death|0|||
27704633|NCT01621542|80758417|FG004|Overall Study|study stopped by sponsor|0|||
27704634|NCT01621542|80758418|FG005|Overall Study|study stopped by sponsor|0|||
27704635|NCT02576444|80758420|FG000|Overall Study|Death|1|||
27598843|NCT04026165|80370835|FG001|Run-in SEL Period|Death|1|||
27704636|NCT02576444|80758421|FG001|Overall Study|Death|1|||
27704637|NCT02576444|80758422|FG002|Overall Study|Death|0|||
27704638|NCT02576444|80758423|FG003|Overall Study|Death|0|||
27598844|NCT04026165|80370836|FG002|Run-in SEL Period|Death|0|||
27598845|NCT04026165|80370837|FG003|Run-in SEL Period|Death|0|||
27598846|NCT04026165|80370834|FG000|Randomized Period|Withdrew Consent|0|||
27598847|NCT04026165|80370835|FG001|Randomized Period|Withdrew Consent|0|||
27598848|NCT04026165|80370836|FG002|Randomized Period|Withdrew Consent|5|||
27704639|NCT02576444|80758420|FG000|Overall Study|Withdrawal by Subject|0|||
27887712|NCT00095238|81425158|FG001|Overall Study|Death|170|||
27887713|NCT00095238|81425157|FG000|Overall Study|Lost to Follow-up|19|||
27834667|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834668|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834669|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834670|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834671|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834672|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834673|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834674|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834675|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834676|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834677|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834678|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834679|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834680|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834681|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834682|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834683|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834684|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834685|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834686|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834687|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834688|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834689|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
27834690|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
27834691|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834692|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
27834693|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
27834694|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
27834695|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834696|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27887714|NCT00095238|81425158|FG001|Overall Study|Lost to Follow-up|24|||
27887715|NCT00095238|81425157|FG000|Overall Study|Noncompliance|44|||
27887716|NCT00095238|81425158|FG001|Overall Study|Noncompliance|45|||
27887717|NCT00095238|81425157|FG000|Overall Study|No longer met study criteria|4|||
27598849|NCT04026165|80370837|FG003|Randomized Period|Withdrew Consent|8|||
27598850|NCT04026165|80370834|FG000|Randomized Period|Death|0|||
27598851|NCT04026165|80370835|FG001|Randomized Period|Death|0|||
27598852|NCT04026165|80370836|FG002|Randomized Period|Death|5|||
27598853|NCT04026165|80370837|FG003|Randomized Period|Death|7|||
27598854|NCT04026165|80370834|FG000|Randomized Period|Investigator's Discretion|0|||
27598855|NCT04026165|80370835|FG001|Randomized Period|Investigator's Discretion|0|||
27598856|NCT04026165|80370836|FG002|Randomized Period|Investigator's Discretion|2|||
27598857|NCT04026165|80370837|FG003|Randomized Period|Investigator's Discretion|2|||
27598858|NCT04026165|80370834|FG000|Randomized Period|Lost to Follow-up|0|||
27598859|NCT04026165|80370835|FG001|Randomized Period|Lost to Follow-up|0|||
27598860|NCT04026165|80370836|FG002|Randomized Period|Lost to Follow-up|2|||
27598861|NCT04026165|80370837|FG003|Randomized Period|Lost to Follow-up|2|||
27598862|NCT01410474|80370838|FG000|Overall Study|Withdrawal by Subject|0|||
27598863|NCT01410474|80370839|FG001|Overall Study|Withdrawal by Subject|1|||
27598864|NCT01896869|80370840|FG000|Overall Study|Withdrawal by Subject|0|||
27598865|NCT01896869|80370841|FG001|Overall Study|Withdrawal by Subject|6|||
27598866|NCT01896869|80370840|FG000|Overall Study|Lost to Follow-up|1|||
27598867|NCT01896869|80370841|FG001|Overall Study|Lost to Follow-up|0|||
27598868|NCT01814748|80370843|FG000|Overall Study|Lost to Follow-up|1|||
27598869|NCT01814748|80370844|FG001|Overall Study|Lost to Follow-up|2|||
27598870|NCT01814748|80370843|FG000|Overall Study|Study site terminated by sponsor|1|||
27598871|NCT01814748|80370844|FG001|Overall Study|Study site terminated by sponsor|1|||
27598872|NCT01814748|80370843|FG000|Overall Study|Withdrawal by Subject|6|||
27598873|NCT01814748|80370844|FG001|Overall Study|Withdrawal by Subject|4|||
27598874|NCT04987762|80370847|FG000|Overall Study|Study was Terminated by Sponsor|103|||
27598875|NCT01972529|80370856|FG000|Overall Study|Adverse Event|0|||
27598876|NCT01972529|80370857|FG001|Overall Study|Adverse Event|1|||
27598877|NCT01972529|80370858|FG002|Overall Study|Adverse Event|0|||
27887718|NCT00095238|81425158|FG001|Overall Study|No longer met study criteria|5|||
27887719|NCT00095238|81425157|FG000|Overall Study|Study terminated by sponsor|0|||
27598878|NCT01972529|80370859|FG003|Overall Study|Adverse Event|0|||
27598879|NCT01972529|80370856|FG000|Overall Study|Lost to Follow-up|1|||
27598880|NCT01972529|80370857|FG001|Overall Study|Lost to Follow-up|0|||
27598881|NCT01972529|80370858|FG002|Overall Study|Lost to Follow-up|0|||
27598882|NCT01972529|80370859|FG003|Overall Study|Lost to Follow-up|0|||
27887720|NCT00095238|81425158|FG001|Overall Study|Study terminated by sponsor|1|||
27598883|NCT01972529|80370856|FG000|Overall Study|Participant Choice|0|||
27598884|NCT01972529|80370857|FG001|Overall Study|Participant Choice|1|||
27598885|NCT01972529|80370858|FG002|Overall Study|Participant Choice|0|||
27598886|NCT01972529|80370859|FG003|Overall Study|Participant Choice|0|||
27598887|NCT01972529|80370856|FG000|Overall Study|Withdrawl of Consent|1|||
27598888|NCT01972529|80370857|FG001|Overall Study|Withdrawl of Consent|2|||
27598889|NCT01972529|80370858|FG002|Overall Study|Withdrawl of Consent|0|||
27598890|NCT01972529|80370859|FG003|Overall Study|Withdrawl of Consent|1|||
27598891|NCT01972529|80370856|FG000|Overall Study|Other|0|||
27598892|NCT01972529|80370857|FG001|Overall Study|Other|0|||
27598893|NCT01972529|80370858|FG002|Overall Study|Other|0|||
27598894|NCT01972529|80370859|FG003|Overall Study|Other|2|||
27598895|NCT01972529|80370856|FG000|Overall Study|Not treated|0|||
27598896|NCT01972529|80370857|FG001|Overall Study|Not treated|1|||
27598897|NCT01972529|80370858|FG002|Overall Study|Not treated|2|||
27598898|NCT01972529|80370859|FG003|Overall Study|Not treated|1|||
27598899|NCT03260868|80370860|FG000|Overall Study|Poor Compliance to Protocol|0|||
27598900|NCT03260868|80370861|FG001|Overall Study|Poor Compliance to Protocol|2|||
27598901|NCT03260868|80370860|FG000|Overall Study|Study Terminated By Sponsor|2|||
27598902|NCT03260868|80370861|FG001|Overall Study|Study Terminated By Sponsor|1|||
27598903|NCT03260868|80370860|FG000|Overall Study|Other than specified above|1|||
27598904|NCT03260868|80370861|FG001|Overall Study|Other than specified above|0|||
27598905|NCT01922076|80370862|FG000|Overall Study|Adverse Event|0|||
27598906|NCT01922076|80370863|FG001|Overall Study|Adverse Event|0|||
27598907|NCT01922076|80370864|FG002|Overall Study|Adverse Event|0|||
27598908|NCT01922076|80370865|FG003|Overall Study|Adverse Event|0|||
27598909|NCT01922076|80370866|FG004|Overall Study|Adverse Event|1|||
27598910|NCT01922076|80370867|FG005|Overall Study|Adverse Event|0|||
27598911|NCT01922076|80370868|FG006|Overall Study|Adverse Event|0|||
27598912|NCT01922076|80370862|FG000|Overall Study|Physician Decision|0|||
27598913|NCT01922076|80370863|FG001|Overall Study|Physician Decision|0|||
27598914|NCT01922076|80370864|FG002|Overall Study|Physician Decision|1|||
27598915|NCT01922076|80370865|FG003|Overall Study|Physician Decision|0|||
27598916|NCT01922076|80370866|FG004|Overall Study|Physician Decision|0|||
27598917|NCT01922076|80370867|FG005|Overall Study|Physician Decision|0|||
27598918|NCT01922076|80370868|FG006|Overall Study|Physician Decision|0|||
27598919|NCT01922076|80370862|FG000|Overall Study|Withdrawal by Subject|0|||
27598920|NCT01922076|80370863|FG001|Overall Study|Withdrawal by Subject|0|||
27598921|NCT01922076|80370864|FG002|Overall Study|Withdrawal by Subject|0|||
27704640|NCT02576444|80758421|FG001|Overall Study|Withdrawal by Subject|0|||
27704641|NCT02576444|80758422|FG002|Overall Study|Withdrawal by Subject|2|||
27704642|NCT02576444|80758423|FG003|Overall Study|Withdrawal by Subject|0|||
27704643|NCT02576444|80758420|FG000|Overall Study|Adverse Event|0|||
27704644|NCT02576444|80758421|FG001|Overall Study|Adverse Event|0|||
27704645|NCT02576444|80758422|FG002|Overall Study|Adverse Event|1|||
27704646|NCT02576444|80758423|FG003|Overall Study|Adverse Event|0|||
27704647|NCT02576444|80758420|FG000|Overall Study|Physician Decision|0|||
27704648|NCT02576444|80758421|FG001|Overall Study|Physician Decision|0|||
27704649|NCT02576444|80758422|FG002|Overall Study|Physician Decision|1|||
27704650|NCT02576444|80758423|FG003|Overall Study|Physician Decision|0|||
27704651|NCT01628107|80758424|FG000|Overall Study|Withdrawal by Subject|17|||
27704652|NCT01628107|80758424|FG000|Overall Study|Lost to Follow-up|4|||
27704653|NCT01628107|80758424|FG000|Overall Study|Adverse Event|33|||
27704654|NCT01628107|80758424|FG000|Overall Study|Physician Decision|2|||
27704655|NCT01628107|80758424|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
27704656|NCT01628107|80758424|FG000|Overall Study|Non-compliant with Study Procedures|10|||
27704657|NCT01628107|80758424|FG000|Overall Study|Not Treated|8|||
27834697|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834698|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27598922|NCT01922076|80370865|FG003|Overall Study|Withdrawal by Subject|1|||
27598923|NCT01922076|80370866|FG004|Overall Study|Withdrawal by Subject|0|||
27598924|NCT01922076|80370867|FG005|Overall Study|Withdrawal by Subject|1|||
27598925|NCT01922076|80370868|FG006|Overall Study|Withdrawal by Subject|1|||
27598926|NCT05159622|80370869|FG000|Overall Study|Lost to Follow-up|4|||
27598927|NCT05159622|80370870|FG001|Overall Study|Lost to Follow-up|5|||
27704658|NCT01628107|80758424|FG000|Overall Study|Sponsor Decision|11|||
27704659|NCT01628107|80758424|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
27704660|NCT01628107|80758424|FG000|Overall Study|Relocated|8|||
27598928|NCT02487810|80370871|FG000|Overall Study|Withdrawal by Subject|1|||
27598929|NCT02487810|80370872|FG001|Overall Study|Withdrawal by Subject|0|||
27598930|NCT00558064|80370873|FG000|Overall Study|Adverse Event|3|||
27598931|NCT00558064|80370874|FG001|Overall Study|Adverse Event|2|||
27598932|NCT00558064|80370873|FG000|Overall Study|Lack of Efficacy|0|||
27598933|NCT00558064|80370874|FG001|Overall Study|Lack of Efficacy|1|||
27598934|NCT00558064|80370873|FG000|Overall Study|Protocol Violation|1|||
27598935|NCT00558064|80370874|FG001|Overall Study|Protocol Violation|0|||
27704661|NCT01628107|80758424|FG000|Overall Study|Kidney Transplant|9|||
27704662|NCT01628107|80758424|FG000|Overall Study|Use of Standard of Care|9|||
27704663|NCT00074581|80758425|FG000|Overall Study|Death|15|||
27598936|NCT00558064|80370873|FG000|Overall Study|Lost to Follow-up|0|||
27598937|NCT00558064|80370874|FG001|Overall Study|Lost to Follow-up|1|||
27598938|NCT00558064|80370873|FG000|Overall Study|Withdrawal by Subject|0|||
27598939|NCT00558064|80370874|FG001|Overall Study|Withdrawal by Subject|1|||
27598940|NCT00558064|80370873|FG000|Overall Study|No visit within allowance period|1|||
27598941|NCT00558064|80370874|FG001|Overall Study|No visit within allowance period|0|||
27598942|NCT03232983|80370875|FG000|Period 1|Physician Decision|0|||
27704664|NCT00074581|80758426|FG001|Overall Study|Death|16|||
27704665|NCT00074581|80758425|FG000|Overall Study|Withdrawal by Subject|50|||
27704666|NCT00074581|80758426|FG001|Overall Study|Withdrawal by Subject|49|||
27704667|NCT00074581|80758425|FG000|Overall Study|Unable to adhere to visit schedule|13|||
27704668|NCT00074581|80758426|FG001|Overall Study|Unable to adhere to visit schedule|14|||
27704669|NCT00074581|80758425|FG000|Overall Study|Relocated|14|||
27704670|NCT00074581|80758426|FG001|Overall Study|Relocated|9|||
27704671|NCT00074581|80758425|FG000|Overall Study|Were withdrawn by investigator|5|||
27704672|NCT00074581|80758426|FG001|Overall Study|Were withdrawn by investigator|2|||
27704673|NCT00074581|80758425|FG000|Overall Study|Lost to Follow-up|16|||
27704674|NCT00074581|80758426|FG001|Overall Study|Lost to Follow-up|11|||
27704675|NCT00074581|80758425|FG000|Overall Study|Ended relationship w. index participant|117|||
27704676|NCT00074581|80758426|FG001|Overall Study|Ended relationship w. index participant|106|||
27704677|NCT00074581|80758425|FG000|Overall Study|Other|14|||
27704678|NCT00074581|80758426|FG001|Overall Study|Other|19|||
27704679|NCT01877915|80758429|FG000|Overall Study|Lost to Follow-up|10|||
27704680|NCT01877915|80758430|FG001|Overall Study|Lost to Follow-up|9|||
27704681|NCT01877915|80758429|FG000|Overall Study|Withdrawal by Subject|42|||
27704682|NCT01877915|80758430|FG001|Overall Study|Withdrawal by Subject|55|||
27704683|NCT01877915|80758429|FG000|Overall Study|Other|2|||
27704684|NCT01877915|80758430|FG001|Overall Study|Other|4|||
27704685|NCT00404820|80758431|FG000|Overall Study|Adverse Event|4|||
27704686|NCT00404820|80758432|FG001|Overall Study|Adverse Event|16|||
27704687|NCT00404820|80758431|FG000|Overall Study|Withdrawal by Subject|5|||
27704688|NCT00404820|80758432|FG001|Overall Study|Withdrawal by Subject|3|||
27704689|NCT00404820|80758431|FG000|Overall Study|Lost to Follow-up|7|||
27704690|NCT00404820|80758432|FG001|Overall Study|Lost to Follow-up|3|||
27704691|NCT00404820|80758431|FG000|Overall Study|Administrative problems|2|||
27704692|NCT00404820|80758432|FG001|Overall Study|Administrative problems|0|||
27704693|NCT00404820|80758431|FG000|Overall Study|Death|1|||
27704694|NCT00404820|80758432|FG001|Overall Study|Death|0|||
27704695|NCT00404820|80758431|FG000|Overall Study|Other|0|||
27704696|NCT00404820|80758432|FG001|Overall Study|Other|2|||
27704697|NCT02228720|80758433|FG000|Open Label - Day 30|Lost to Follow-up|1|||
27704698|NCT02000427|80758435|FG000|Overall Study|Death|22|||
27704699|NCT01086410|80758437|FG000|Overall Study|Adverse Event|1|||
27704700|NCT01086410|80758438|FG001|Overall Study|Adverse Event|0|||
27704701|NCT01086410|80758439|FG002|Overall Study|Adverse Event|0|||
27704702|NCT01086410|80758440|FG003|Overall Study|Adverse Event|2|||
27704703|NCT01086410|80758437|FG000|Overall Study|Lack of Efficacy|1|||
27704704|NCT01086410|80758438|FG001|Overall Study|Lack of Efficacy|1|||
27704705|NCT01086410|80758439|FG002|Overall Study|Lack of Efficacy|0|||
27704706|NCT01086410|80758440|FG003|Overall Study|Lack of Efficacy|0|||
27704707|NCT01086410|80758437|FG000|Overall Study|Protocol Violation|1|||
27704708|NCT01086410|80758438|FG001|Overall Study|Protocol Violation|1|||
27704709|NCT01086410|80758439|FG002|Overall Study|Protocol Violation|0|||
27704710|NCT01086410|80758440|FG003|Overall Study|Protocol Violation|0|||
27704711|NCT01086410|80758437|FG000|Overall Study|Lost to Follow-up|0|||
27704712|NCT01086410|80758438|FG001|Overall Study|Lost to Follow-up|0|||
27704713|NCT01086410|80758439|FG002|Overall Study|Lost to Follow-up|1|||
27704714|NCT01086410|80758440|FG003|Overall Study|Lost to Follow-up|0|||
27704715|NCT01987960|80758445|FG000|Period 1|Adverse Event|24|||
27704716|NCT01987960|80758446|FG001|Period 1|Adverse Event|0|||
27598943|NCT03232983|80370876|FG001|Period 1|Physician Decision|0|||
27704717|NCT01987960|80758447|FG002|Period 1|Adverse Event|0|||
27704718|NCT01987960|80758448|FG003|Period 1|Adverse Event|0|||
27704719|NCT01987960|80758445|FG000|Period 1|Lack of Efficacy|4|||
27704720|NCT01987960|80758446|FG001|Period 1|Lack of Efficacy|0|||
27704721|NCT01987960|80758447|FG002|Period 1|Lack of Efficacy|0|||
27704722|NCT01987960|80758448|FG003|Period 1|Lack of Efficacy|0|||
27704723|NCT01987960|80758445|FG000|Period 1|Non-compliance with IMP|6|||
27704724|NCT01987960|80758446|FG001|Period 1|Non-compliance with IMP|0|||
27704725|NCT01987960|80758447|FG002|Period 1|Non-compliance with IMP|0|||
27704726|NCT01987960|80758448|FG003|Period 1|Non-compliance with IMP|0|||
27704727|NCT01987960|80758445|FG000|Period 1|Protocol Violation|12|||
27704728|NCT01987960|80758446|FG001|Period 1|Protocol Violation|0|||
27704729|NCT01987960|80758447|FG002|Period 1|Protocol Violation|0|||
27704730|NCT01987960|80758448|FG003|Period 1|Protocol Violation|0|||
27704731|NCT01987960|80758445|FG000|Period 1|Withdrawal by Subject|21|||
27704732|NCT01987960|80758446|FG001|Period 1|Withdrawal by Subject|0|||
27598944|NCT03232983|80370877|FG002|Period 1|Physician Decision|1|||
27598945|NCT03232983|80370878|FG003|Period 1|Physician Decision|0|||
27598946|NCT03232983|80370875|FG000|Washout Period 2|Physician Decision|0|||
27598947|NCT03232983|80370876|FG001|Washout Period 2|Physician Decision|0|||
27598948|NCT03232983|80370877|FG002|Washout Period 2|Physician Decision|1|||
27598949|NCT03232983|80370878|FG003|Washout Period 2|Physician Decision|0|||
27598950|NCT03232983|80370875|FG000|Washout Period 2|Withdrawal by Subject|0|||
27598951|NCT03232983|80370876|FG001|Washout Period 2|Withdrawal by Subject|0|||
27598952|NCT03232983|80370877|FG002|Washout Period 2|Withdrawal by Subject|0|||
27598953|NCT03232983|80370878|FG003|Washout Period 2|Withdrawal by Subject|1|||
27598954|NCT03232983|80370875|FG000|Period 4|Withdrawal by Subject|1|||
27598955|NCT03232983|80370876|FG001|Period 4|Withdrawal by Subject|0|||
27598956|NCT03232983|80370877|FG002|Period 4|Withdrawal by Subject|0|||
27598957|NCT03232983|80370878|FG003|Period 4|Withdrawal by Subject|0|||
27598958|NCT02985866|80370882|FG000|Overall Study|Poor CGM data|1|||
27598959|NCT02985866|80370883|FG001|Overall Study|Poor CGM data|1|||
27598960|NCT01783418|80370884|FG000|Overall Study|Withdrawal by Subject|1|||
27598961|NCT01783418|80370885|FG001|Overall Study|Withdrawal by Subject|0|||
27598962|NCT00952822|80370886|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
27598963|NCT00952822|80370887|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
27598964|NCT00952822|80370888|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
27598965|NCT00952822|80370889|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
27598966|NCT00952822|80370886|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
27598967|NCT00952822|80370887|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
27598968|NCT00952822|80370888|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
27598969|NCT00952822|80370889|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
27598970|NCT03599349|80370891|FG000|Overall Study|Lost to Follow-up|1|||
27887721|NCT00095238|81425157|FG000|Overall Study|Missing|1|||
27887722|NCT00095238|81425158|FG001|Overall Study|Missing|0|||
27887723|NCT00095238|81425157|FG000|Overall Study|Other Reasons|87|||
27887724|NCT00095238|81425158|FG001|Overall Study|Other Reasons|88|||
27887725|NCT03503370|81425159|FG000|Overall Study|Death|3|||
27887726|NCT03503370|81425160|FG001|Overall Study|Death|1|||
27887727|NCT02640950|81425161|FG000|Overall Study|Adverse Event|1|||
27887728|NCT02640950|81425161|FG000|Overall Study|Withdrawal by Subject|1|||
27887729|NCT02208362|81425163|FG000|Overall Study|Participant did not complete treatment|0|||
27887730|NCT02208362|81425164|FG001|Overall Study|Participant did not complete treatment|1|||
27887731|NCT02208362|81425165|FG002|Overall Study|Participant did not complete treatment|0|||
27887732|NCT02208362|81425166|FG003|Overall Study|Participant did not complete treatment|0|||
27887733|NCT02208362|81425167|FG004|Overall Study|Participant did not complete treatment|0|||
27887734|NCT02208362|81425168|FG005|Overall Study|Participant did not complete treatment|0|||
27887735|NCT02208362|81425169|FG006|Overall Study|Participant did not complete treatment|1|||
27887736|NCT02208362|81425170|FG007|Overall Study|Participant did not complete treatment|1|||
27887737|NCT02208362|81425171|FG008|Overall Study|Participant did not complete treatment|2|||
27887738|NCT02208362|81425172|FG009|Overall Study|Participant did not complete treatment|0|||
27887739|NCT02208362|81425173|FG010|Overall Study|Participant did not complete treatment|1|||
27887740|NCT02208362|81425174|FG011|Overall Study|Participant did not complete treatment|0|||
27887741|NCT02208362|81425163|FG000|Overall Study|Participant received disallowed treatment|0|||
27598971|NCT02753595|80370893|FG000|Overall Study|Sponsor termination|2|||
27598972|NCT02753595|80370894|FG001|Overall Study|Sponsor termination|2|||
27598973|NCT01169675|80370899|FG000|Overall Study|Progressive disease|13|||
27598974|NCT01169675|80370900|FG001|Overall Study|Progressive disease|2|||
27598975|NCT01169675|80370901|FG002|Overall Study|Progressive disease|5|||
27598976|NCT01169675|80370902|FG003|Overall Study|Progressive disease|15|||
27887742|NCT02208362|81425164|FG001|Overall Study|Participant received disallowed treatment|0|||
27887743|NCT02208362|81425165|FG002|Overall Study|Participant received disallowed treatment|0|||
27887744|NCT02208362|81425166|FG003|Overall Study|Participant received disallowed treatment|0|||
27704733|NCT01987960|80758447|FG002|Period 1|Withdrawal by Subject|0|||
27598977|NCT01169675|80370903|FG004|Overall Study|Progressive disease|1|||
27598978|NCT01169675|80370899|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27598979|NCT01169675|80370900|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27598980|NCT01169675|80370901|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27598981|NCT01169675|80370902|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27598982|NCT01169675|80370903|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27598983|NCT01169675|80370899|FG000|Overall Study|Adverse Event|5|||
27598984|NCT01169675|80370900|FG001|Overall Study|Adverse Event|1|||
27598985|NCT01169675|80370901|FG002|Overall Study|Adverse Event|2|||
27598986|NCT01169675|80370902|FG003|Overall Study|Adverse Event|0|||
27598987|NCT01169675|80370903|FG004|Overall Study|Adverse Event|0|||
27598988|NCT01169675|80370899|FG000|Overall Study|Withdrawal by Subject|1|||
27598989|NCT01169675|80370900|FG001|Overall Study|Withdrawal by Subject|0|||
27598990|NCT01169675|80370901|FG002|Overall Study|Withdrawal by Subject|0|||
27598991|NCT01169675|80370902|FG003|Overall Study|Withdrawal by Subject|1|||
27598992|NCT01169675|80370903|FG004|Overall Study|Withdrawal by Subject|2|||
27598993|NCT01169675|80370899|FG000|Overall Study|Other Reason Not Defined Above|0|||
27598994|NCT01169675|80370900|FG001|Overall Study|Other Reason Not Defined Above|0|||
27598995|NCT01169675|80370901|FG002|Overall Study|Other Reason Not Defined Above|0|||
27598996|NCT01169675|80370902|FG003|Overall Study|Other Reason Not Defined Above|1|||
27598997|NCT01169675|80370903|FG004|Overall Study|Other Reason Not Defined Above|1|||
27598998|NCT01514448|80370908|FG000|Overall Study|Death|7|||
27598999|NCT01514448|80370909|FG001|Overall Study|Death|8|||
27599000|NCT01514448|80370908|FG000|Overall Study|Withdrawal by Subject|2|||
27599001|NCT01514448|80370909|FG001|Overall Study|Withdrawal by Subject|0|||
27599002|NCT01514448|80370908|FG000|Overall Study|Lost to Follow-up|2|||
27599003|NCT01514448|80370909|FG001|Overall Study|Lost to Follow-up|0|||
27599004|NCT01514448|80370908|FG000|Overall Study|New Cancer Therapy|1|||
27599005|NCT01514448|80370909|FG001|Overall Study|New Cancer Therapy|0|||
27599006|NCT03382782|80370917|FG000|Cohort 1|Withdrawal by Subject|11|||
27599007|NCT03382782|80370918|FG001|Cohort 1|Withdrawal by Subject|5|||
27599008|NCT03382782|80370919|FG002|Cohort 1|Withdrawal by Subject|0|||
27599009|NCT03382782|80370917|FG000|Cohort 2|Withdrawal by Subject|1|||
27599010|NCT03382782|80370918|FG001|Cohort 2|Withdrawal by Subject|1|||
27599011|NCT03382782|80370919|FG002|Cohort 2|Withdrawal by Subject|0|||
27599012|NCT03382782|80370917|FG000|Cohort 3|Withdrawal by Subject|1|||
27599013|NCT03382782|80370918|FG001|Cohort 3|Withdrawal by Subject|2|||
27599014|NCT03382782|80370919|FG002|Cohort 3|Withdrawal by Subject|0|||
27599015|NCT02080871|80370920|FG000|Overall Study|Death|1|||
27599016|NCT02080871|80370920|FG000|Overall Study|Lost to Follow-up|1|||
27599017|NCT02219048|80370921|FG000|Overall Study|Adverse Event|2|||
27599018|NCT02219048|80370922|FG001|Overall Study|Adverse Event|5|||
27599019|NCT02219048|80370921|FG000|Overall Study|No longer meets eligibility criteria|1|||
27599020|NCT02219048|80370922|FG001|Overall Study|No longer meets eligibility criteria|0|||
27599021|NCT02219048|80370921|FG000|Overall Study|Study terminated by sponsor|16|||
27599022|NCT02219048|80370922|FG001|Overall Study|Study terminated by sponsor|15|||
27599023|NCT02219048|80370921|FG000|Overall Study|Withdrawal by Subject|2|||
27599024|NCT02219048|80370922|FG001|Overall Study|Withdrawal by Subject|0|||
27599025|NCT02219048|80370921|FG000|Overall Study|Other|0|||
27599026|NCT02219048|80370922|FG001|Overall Study|Other|1|||
27599027|NCT01313286|80370926|FG000|Period 1|Withdrawal by Subject|2|||
27599028|NCT01313286|80370927|FG001|Period 1|Withdrawal by Subject|0|||
27599029|NCT00338884|80370928|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
27599030|NCT00338884|80370928|FG000|Overall Study|Adverse Event|14|||
27599031|NCT00338884|80370928|FG000|Overall Study|Death|8|||
27599032|NCT00338884|80370928|FG000|Overall Study|Other|4|||
27599033|NCT00338884|80370928|FG000|Overall Study|Global Deterioration of Health Status|3|||
27599034|NCT00338884|80370928|FG000|Overall Study|Withdrawal by Subject|3|||
27599035|NCT00338884|80370928|FG000|Overall Study|Lost to Follow-up|1|||
27599036|NCT00338884|80370928|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
27599037|NCT01362439|80370929|FG000|Overall Study|Adverse Event|1|||
27599038|NCT01362439|80370929|FG000|Overall Study|Lack of Efficacy|3|||
27599039|NCT01362439|80370929|FG000|Overall Study|Lost to Follow-up|2|||
27599040|NCT01362439|80370929|FG000|Overall Study|Study medication non-compliant|1|||
27599041|NCT01362439|80370929|FG000|Overall Study|Participant who withdrew consent|8|||
27599042|NCT04870710|80370930|FG000|Overall Study|Lost to Follow-up|3|||
27599043|NCT01266850|80370931|FG000|Overall Study|Lost to Follow-up|19|||
27599044|NCT01266850|80370932|FG001|Overall Study|Lost to Follow-up|19|||
27599045|NCT01266850|80370933|FG002|Overall Study|Lost to Follow-up|13|||
27599046|NCT01266850|80370934|FG003|Overall Study|Lost to Follow-up|13|||
27834699|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834700|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834701|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27599047|NCT01266850|80370935|FG004|Overall Study|Lost to Follow-up|12|||
27599048|NCT01266850|80370931|FG000|Overall Study|Withdrawal by Subject|8|||
27599049|NCT01266850|80370932|FG001|Overall Study|Withdrawal by Subject|9|||
27599050|NCT01266850|80370933|FG002|Overall Study|Withdrawal by Subject|6|||
27599051|NCT01266850|80370934|FG003|Overall Study|Withdrawal by Subject|9|||
27599052|NCT01266850|80370935|FG004|Overall Study|Withdrawal by Subject|12|||
27599053|NCT01266850|80370931|FG000|Overall Study|Physician Decision|3|||
27599054|NCT01266850|80370932|FG001|Overall Study|Physician Decision|6|||
27599055|NCT01266850|80370933|FG002|Overall Study|Physician Decision|4|||
27599056|NCT01266850|80370934|FG003|Overall Study|Physician Decision|4|||
27599057|NCT01266850|80370935|FG004|Overall Study|Physician Decision|3|||
27599058|NCT01266850|80370931|FG000|Overall Study|Protocol Violation|0|||
27599059|NCT01266850|80370932|FG001|Overall Study|Protocol Violation|1|||
27599060|NCT01266850|80370933|FG002|Overall Study|Protocol Violation|0|||
27599061|NCT01266850|80370934|FG003|Overall Study|Protocol Violation|1|||
27599062|NCT01266850|80370935|FG004|Overall Study|Protocol Violation|2|||
27599063|NCT01266850|80370931|FG000|Overall Study|Adverse Event|0|||
27599064|NCT01266850|80370932|FG001|Overall Study|Adverse Event|0|||
27599065|NCT01266850|80370933|FG002|Overall Study|Adverse Event|0|||
27599066|NCT01266850|80370934|FG003|Overall Study|Adverse Event|0|||
27599067|NCT01266850|80370935|FG004|Overall Study|Adverse Event|1|||
27599068|NCT01266850|80370931|FG000|Overall Study|Site Closure|0|||
27599069|NCT01266850|80370932|FG001|Overall Study|Site Closure|1|||
27599070|NCT01266850|80370933|FG002|Overall Study|Site Closure|1|||
27599071|NCT01266850|80370934|FG003|Overall Study|Site Closure|1|||
27599072|NCT01266850|80370935|FG004|Overall Study|Site Closure|0|||
27599073|NCT00166296|80370936|FG000|Overall Study|Withdrawal by Subject|1|||
27599074|NCT00166296|80370937|FG001|Overall Study|Withdrawal by Subject|3|||
27599075|NCT00166296|80370936|FG000|Overall Study|Adverse Event|2|||
27599076|NCT00166296|80370937|FG001|Overall Study|Adverse Event|4|||
27599077|NCT00166296|80370936|FG000|Overall Study|Lost to Follow-up|4|||
27599078|NCT00166296|80370937|FG001|Overall Study|Lost to Follow-up|2|||
27599079|NCT00445679|80370939|FG000|Overall Study|Adverse Event|22|||
27599080|NCT00445679|80370940|FG001|Overall Study|Adverse Event|12|||
27599081|NCT00445679|80370941|FG002|Overall Study|Adverse Event|30|||
27599082|NCT00445679|80370942|FG003|Overall Study|Adverse Event|19|||
27599083|NCT00445679|80370939|FG000|Overall Study|Failed to return|1|||
27599084|NCT00445679|80370940|FG001|Overall Study|Failed to return|3|||
27599085|NCT00445679|80370941|FG002|Overall Study|Failed to return|2|||
27599086|NCT00445679|80370942|FG003|Overall Study|Failed to return|2|||
27599087|NCT00445679|80370939|FG000|Overall Study|Physician Decision|0|||
27599088|NCT00445679|80370940|FG001|Overall Study|Physician Decision|0|||
27599089|NCT00445679|80370941|FG002|Overall Study|Physician Decision|1|||
27599090|NCT00445679|80370942|FG003|Overall Study|Physician Decision|0|||
27704734|NCT01987960|80758448|FG003|Period 1|Withdrawal by Subject|0|||
27704735|NCT01987960|80758445|FG000|Period 1|Lost to Follow-up|40|||
27704736|NCT01987960|80758446|FG001|Period 1|Lost to Follow-up|0|||
27704737|NCT01987960|80758447|FG002|Period 1|Lost to Follow-up|0|||
27704738|NCT01987960|80758448|FG003|Period 1|Lost to Follow-up|0|||
27704739|NCT01987960|80758445|FG000|Period 1|administrative or other reason|75|||
27704740|NCT01987960|80758446|FG001|Period 1|administrative or other reason|0|||
27704741|NCT01987960|80758447|FG002|Period 1|administrative or other reason|0|||
27704742|NCT01987960|80758448|FG003|Period 1|administrative or other reason|0|||
27704743|NCT01987960|80758445|FG000|Period 1|Withdrawal of consent before treatment|4|||
27704744|NCT01987960|80758446|FG001|Period 1|Withdrawal of consent before treatment|0|||
27704745|NCT01987960|80758447|FG002|Period 1|Withdrawal of consent before treatment|0|||
27704746|NCT01987960|80758448|FG003|Period 1|Withdrawal of consent before treatment|0|||
27704747|NCT01987960|80758445|FG000|Period 2|Adverse Event|0|||
27704748|NCT01987960|80758446|FG001|Period 2|Adverse Event|0|||
27704749|NCT01987960|80758447|FG002|Period 2|Adverse Event|1|||
27704750|NCT01987960|80758448|FG003|Period 2|Adverse Event|0|||
27704751|NCT01987960|80758445|FG000|Period 2|Withdrawal by Subject|0|||
27704752|NCT01987960|80758446|FG001|Period 2|Withdrawal by Subject|0|||
27704753|NCT01987960|80758447|FG002|Period 2|Withdrawal by Subject|1|||
27704754|NCT01987960|80758448|FG003|Period 2|Withdrawal by Subject|0|||
27704755|NCT01987960|80758445|FG000|Period 2|Administrative or other reason|0|||
27704756|NCT01987960|80758446|FG001|Period 2|Administrative or other reason|5|||
27704757|NCT01987960|80758447|FG002|Period 2|Administrative or other reason|7|||
27704758|NCT01987960|80758448|FG003|Period 2|Administrative or other reason|0|||
27704759|NCT01987960|80758445|FG000|Period 3|Adverse Event|0|||
27704760|NCT01987960|80758446|FG001|Period 3|Adverse Event|0|||
27704761|NCT01987960|80758447|FG002|Period 3|Adverse Event|0|||
27704762|NCT01987960|80758448|FG003|Period 3|Adverse Event|7|||
27704763|NCT01987960|80758445|FG000|Period 3|Non-compliance with IMP|0|||
27704764|NCT01987960|80758446|FG001|Period 3|Non-compliance with IMP|0|||
27704765|NCT01987960|80758447|FG002|Period 3|Non-compliance with IMP|0|||
27704766|NCT01987960|80758448|FG003|Period 3|Non-compliance with IMP|1|||
27704767|NCT01987960|80758445|FG000|Period 3|Protocol Violation|0|||
27704768|NCT01987960|80758446|FG001|Period 3|Protocol Violation|0|||
27704769|NCT01987960|80758447|FG002|Period 3|Protocol Violation|0|||
27704770|NCT01987960|80758448|FG003|Period 3|Protocol Violation|6|||
27704771|NCT01987960|80758445|FG000|Period 3|Withdrawal by Subject|0|||
27704772|NCT01987960|80758446|FG001|Period 3|Withdrawal by Subject|0|||
27704773|NCT01987960|80758447|FG002|Period 3|Withdrawal by Subject|0|||
27704774|NCT01987960|80758448|FG003|Period 3|Withdrawal by Subject|9|||
27704775|NCT01987960|80758445|FG000|Period 3|Lost to Follow-up|0|||
27704776|NCT01987960|80758446|FG001|Period 3|Lost to Follow-up|0|||
27704777|NCT01987960|80758447|FG002|Period 3|Lost to Follow-up|0|||
27704778|NCT01987960|80758448|FG003|Period 3|Lost to Follow-up|5|||
27704779|NCT01987960|80758445|FG000|Period 3|Administrative or other reason|0|||
27704780|NCT01987960|80758446|FG001|Period 3|Administrative or other reason|0|||
27704781|NCT01987960|80758447|FG002|Period 3|Administrative or other reason|0|||
27704782|NCT01987960|80758448|FG003|Period 3|Administrative or other reason|43|||
27704783|NCT03768505|80758449|FG000|Overall Study|sponsor decision|76|||
27704784|NCT03768505|80758449|FG000|Overall Study|Death|35|||
27704785|NCT03768505|80758449|FG000|Overall Study|Other -Various|30|||
27599091|NCT00445679|80370939|FG000|Overall Study|Lost to Follow-up|10|||
27599092|NCT00445679|80370940|FG001|Overall Study|Lost to Follow-up|6|||
27704786|NCT03768505|80758449|FG000|Overall Study|Withdrawal by Subject|22|||
27704787|NCT03768505|80758449|FG000|Overall Study|Lost to Follow-up|6|||
27704788|NCT01293968|80758450|FG000|Overall Study|non-cooperation|3|||
27704789|NCT01293968|80758451|FG001|Overall Study|non-cooperation|3|||
27704790|NCT01379573|80758452|FG000|Overall Study|Lost to Follow-up|1|||
27704791|NCT01379573|80758452|FG000|Overall Study|Screen Failure|10|||
27704792|NCT00290342|80758453|FG000|Overall Study|Other|0|||
27704793|NCT00290342|80758454|FG001|Overall Study|Other|1|||
27704794|NCT00290342|80758453|FG000|Overall Study|Withdrawal by Subject|6|||
27704795|NCT00290342|80758454|FG001|Overall Study|Withdrawal by Subject|4|||
27704796|NCT00290342|80758453|FG000|Overall Study|Lost to Follow-up|1|||
27704797|NCT00290342|80758454|FG001|Overall Study|Lost to Follow-up|0|||
27704798|NCT00436618|80758460|FG000|Overall Study|Withdrawal by Subject|5|||
27704799|NCT00436618|80758461|FG001|Overall Study|Withdrawal by Subject|8|||
27704800|NCT00436618|80758462|FG002|Overall Study|Withdrawal by Subject|11|||
27704801|NCT00436618|80758460|FG000|Overall Study|Adverse Event|8|||
27887745|NCT02208362|81425167|FG004|Overall Study|Participant received disallowed treatment|0|||
27887746|NCT02208362|81425168|FG005|Overall Study|Participant received disallowed treatment|0|||
27887747|NCT02208362|81425169|FG006|Overall Study|Participant received disallowed treatment|0|||
27887748|NCT02208362|81425170|FG007|Overall Study|Participant received disallowed treatment|0|||
27887749|NCT02208362|81425171|FG008|Overall Study|Participant received disallowed treatment|1|||
27887750|NCT02208362|81425172|FG009|Overall Study|Participant received disallowed treatment|0|||
27887751|NCT02208362|81425173|FG010|Overall Study|Participant received disallowed treatment|0|||
27887752|NCT02208362|81425174|FG011|Overall Study|Participant received disallowed treatment|0|||
27887753|NCT05483686|81425175|FG000|Overall Study|Lost to Follow-up|5|||
27887754|NCT05483686|81425176|FG001|Overall Study|Lost to Follow-up|7|||
27887755|NCT02231879|81425177|FG000|Overall Study|Adverse Event|2|||
27887756|NCT02231879|81425178|FG001|Overall Study|Adverse Event|1|||
27887757|NCT02231879|81425177|FG000|Overall Study|Lack of Efficacy|0|||
27887758|NCT02231879|81425178|FG001|Overall Study|Lack of Efficacy|1|||
27887759|NCT03881696|81425179|FG000|Overall Study|Adverse Event|2|||
27887760|NCT03881696|81425180|FG001|Overall Study|Adverse Event|0|||
27887761|NCT03881696|81425179|FG000|Overall Study|Withdrawal by Subject|2|||
27887762|NCT03881696|81425180|FG001|Overall Study|Withdrawal by Subject|0|||
27887763|NCT03881696|81425179|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
27599093|NCT00445679|80370941|FG002|Overall Study|Lost to Follow-up|6|||
27887764|NCT03881696|81425180|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
27887765|NCT03881696|81425179|FG000|Overall Study|Failure to meet continuation criteria|1|||
27834702|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834703|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834704|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834705|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834706|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834707|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834708|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834709|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834710|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834711|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834712|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834713|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834714|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834715|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
27834716|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
27834717|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
27834718|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
27834719|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
27834720|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
27834721|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834722|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834723|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834724|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834725|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834726|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834727|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834728|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834729|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834730|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834731|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834732|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834733|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834734|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834735|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834736|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834737|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834738|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834739|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834740|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834741|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
27834742|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|moved|0|||
27834743|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|moved|1|||
27834744|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|moved|1|||
27834745|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|moved|0|||
27834746|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|moved|0|||
27834747|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|moved|0|||
27834748|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|moved|0|||
27834749|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|moved|0|||
27834750|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|moved|0|||
27834751|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|moved|0|||
27834752|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|moved|0|||
27834753|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|moved|0|||
27834754|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|moved|0|||
27834755|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|moved|0|||
27834756|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|moved|0|||
27834757|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|moved|0|||
27834758|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|moved|0|||
27599094|NCT00445679|80370942|FG003|Overall Study|Lost to Follow-up|5|||
27599095|NCT00445679|80370939|FG000|Overall Study|Compliance|3|||
27599096|NCT00445679|80370940|FG001|Overall Study|Compliance|2|||
27599097|NCT00445679|80370941|FG002|Overall Study|Compliance|1|||
27599098|NCT00445679|80370942|FG003|Overall Study|Compliance|2|||
27599099|NCT00445679|80370939|FG000|Overall Study|Withdrawal of Informed Consent|0|||
27599100|NCT00445679|80370940|FG001|Overall Study|Withdrawal of Informed Consent|0|||
27599101|NCT00445679|80370941|FG002|Overall Study|Withdrawal of Informed Consent|1|||
27599102|NCT00445679|80370942|FG003|Overall Study|Withdrawal of Informed Consent|0|||
27599103|NCT00445679|80370939|FG000|Overall Study|Protocol Violation|2|||
27599104|NCT00445679|80370940|FG001|Overall Study|Protocol Violation|3|||
27599105|NCT00445679|80370941|FG002|Overall Study|Protocol Violation|3|||
27599106|NCT00445679|80370942|FG003|Overall Study|Protocol Violation|1|||
27599107|NCT00445679|80370939|FG000|Overall Study|Withdrawal by Subject|8|||
27599108|NCT00445679|80370940|FG001|Overall Study|Withdrawal by Subject|14|||
27599109|NCT00445679|80370941|FG002|Overall Study|Withdrawal by Subject|20|||
27599110|NCT00445679|80370942|FG003|Overall Study|Withdrawal by Subject|18|||
27599111|NCT00445679|80370939|FG000|Overall Study|Lack of Efficacy|2|||
27599112|NCT00445679|80370940|FG001|Overall Study|Lack of Efficacy|6|||
27599113|NCT00445679|80370941|FG002|Overall Study|Lack of Efficacy|2|||
27599114|NCT00445679|80370942|FG003|Overall Study|Lack of Efficacy|0|||
27599115|NCT03848403|80370943|FG000|Period 2 (Day 8)|Adverse Event|1|||
27599116|NCT03848403|80370944|FG001|Period 2 (Day 8)|Adverse Event|2|||
27599117|NCT03848403|80370945|FG002|Period 2 (Day 8)|Adverse Event|2|||
27599118|NCT03848403|80370943|FG000|Period 2 (Day 8)|Physician Decision|0|||
27599119|NCT03848403|80370944|FG001|Period 2 (Day 8)|Physician Decision|1|||
27599120|NCT03848403|80370945|FG002|Period 2 (Day 8)|Physician Decision|0|||
27599121|NCT03848403|80370943|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
27599122|NCT03848403|80370944|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
27599123|NCT03848403|80370945|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
27599124|NCT00886340|80370949|FG000|Overall Study|Withdrawal by Subject|0|||
27599125|NCT00886340|80370950|FG001|Overall Study|Withdrawal by Subject|7|||
27599126|NCT03802123|80370953|FG000|Overall Study|Withdrawal by Subject|3|||
27599127|NCT03802123|80370953|FG000|Overall Study|Physician Decision|1|||
27599128|NCT03802123|80370953|FG000|Overall Study|Subject moved to hospice care|1|||
27599129|NCT03802123|80370953|FG000|Overall Study|technician error|1|||
27599130|NCT03802123|80370953|FG000|Overall Study|Death|3|||
27834759|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|moved|0|||
27834760|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|moved|0|||
27834761|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|moved|0|||
27834762|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|moved|0|||
27834763|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|moved|0|||
27834764|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|moved|0|||
27834765|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|moved|0|||
27834766|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|moved|0|||
27834767|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|moved|0|||
27834768|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834769|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834770|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834771|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
27834772|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834773|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27599131|NCT02657031|80370954|FG000|Overall Study|Adverse Event|1|||
27599132|NCT02657031|80370955|FG001|Overall Study|Adverse Event|2|||
27599133|NCT00689026|80370956|FG000|Overall Study|Withdrawal by Subject|13|||
27599134|NCT00689026|80370957|FG001|Overall Study|Withdrawal by Subject|6|||
27599135|NCT00999466|80370958|FG000|Main Part|Withdrawal by Subject|0|||
27599136|NCT00999466|80370959|FG001|Main Part|Withdrawal by Subject|0|||
27599137|NCT00999466|80370960|FG002|Main Part|Withdrawal by Subject|2|||
27599138|NCT00999466|80370958|FG000|Main Part|Adverse Event|0|||
27599139|NCT00999466|80370959|FG001|Main Part|Adverse Event|4|||
27599140|NCT00999466|80370960|FG002|Main Part|Adverse Event|2|||
27599141|NCT01738984|80370961|FG000|Overall Study|Pregnancy|4|||
27599142|NCT01738984|80370962|FG001|Overall Study|Pregnancy|0|||
27599143|NCT01738984|80370961|FG000|Overall Study|Withdrawal by Subject|1|||
27599144|NCT01738984|80370962|FG001|Overall Study|Withdrawal by Subject|0|||
27599145|NCT01738984|80370961|FG000|Overall Study|Lost to Follow-up|59|||
27599146|NCT01738984|80370962|FG001|Overall Study|Lost to Follow-up|39|||
27599147|NCT02173548|80370964|FG000|Overall Study|Lost to Follow-up|0|||
27887766|NCT03881696|81425180|FG001|Overall Study|Failure to meet continuation criteria|0|||
27887767|NCT00877071|81425181|FG000|Overall Study|disease progression|2|||
27887768|NCT00986921|81425182|FG000|Overall Study|Physician Decision|1|||
27887769|NCT00986921|81425183|FG001|Overall Study|Physician Decision|0|||
27599148|NCT02173548|80370965|FG001|Overall Study|Lost to Follow-up|2|||
27599149|NCT02173548|80370964|FG000|Overall Study|Withdrawal by Subject|1|||
27599150|NCT02173548|80370965|FG001|Overall Study|Withdrawal by Subject|0|||
27599151|NCT01235546|80370966|FG000|Overall Study|Staff error, medication not administered|1|||
27599152|NCT01235546|80370967|FG001|Overall Study|Staff error, medication not administered|0|||
27599153|NCT01235546|80370966|FG000|Overall Study|Protocol Violation|1|||
27704802|NCT00436618|80758461|FG001|Overall Study|Adverse Event|8|||
27704803|NCT00436618|80758462|FG002|Overall Study|Adverse Event|9|||
27704804|NCT00436618|80758460|FG000|Overall Study|Alternate Treatment|3|||
27704805|NCT00436618|80758461|FG001|Overall Study|Alternate Treatment|4|||
27704806|NCT00436618|80758462|FG002|Overall Study|Alternate Treatment|12|||
27704807|NCT00436618|80758460|FG000|Overall Study|Other Medical Problems|3|||
27704808|NCT00436618|80758461|FG001|Overall Study|Other Medical Problems|1|||
27704809|NCT00436618|80758462|FG002|Overall Study|Other Medical Problems|7|||
27704810|NCT00436618|80758460|FG000|Overall Study|Death|4|||
27704811|NCT00436618|80758461|FG001|Overall Study|Death|2|||
27704812|NCT00436618|80758462|FG002|Overall Study|Death|3|||
27704813|NCT00436618|80758460|FG000|Overall Study|New Primary or Other Reasons|6|||
27704814|NCT00436618|80758461|FG001|Overall Study|New Primary or Other Reasons|2|||
27704815|NCT00436618|80758462|FG002|Overall Study|New Primary or Other Reasons|12|||
27704816|NCT00436618|80758460|FG000|Overall Study|Still on treatment|1|||
27704817|NCT00436618|80758461|FG001|Overall Study|Still on treatment|2|||
27704818|NCT00436618|80758462|FG002|Overall Study|Still on treatment|7|||
27704819|NCT02716675|80758464|FG000|Overall Study|Death|2|||
27704820|NCT02716675|80758465|FG001|Overall Study|Death|3|||
27704821|NCT02716675|80758466|FG002|Overall Study|Death|0|||
27704822|NCT02716675|80758464|FG000|Overall Study|Physician Decision|2|||
27704823|NCT02716675|80758465|FG001|Overall Study|Physician Decision|1|||
27704824|NCT02716675|80758466|FG002|Overall Study|Physician Decision|1|||
27704825|NCT02716675|80758464|FG000|Overall Study|Lost to Follow-up|100|||
27704826|NCT02716675|80758465|FG001|Overall Study|Lost to Follow-up|87|||
27704827|NCT02716675|80758466|FG002|Overall Study|Lost to Follow-up|99|||
27704828|NCT02716675|80758464|FG000|Overall Study|Withdrawal by Subject|22|||
27704829|NCT02716675|80758465|FG001|Overall Study|Withdrawal by Subject|25|||
27704830|NCT02716675|80758466|FG002|Overall Study|Withdrawal by Subject|20|||
27704831|NCT02716675|80758464|FG000|Overall Study|Protocol Violation|0|||
27704832|NCT02716675|80758465|FG001|Overall Study|Protocol Violation|3|||
27704833|NCT02716675|80758466|FG002|Overall Study|Protocol Violation|1|||
27704834|NCT02716675|80758464|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
27704835|NCT02716675|80758465|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
27704836|NCT02716675|80758466|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
27704837|NCT02716675|80758464|FG000|Overall Study|Other|38|||
27704838|NCT02716675|80758465|FG001|Overall Study|Other|47|||
27704839|NCT02716675|80758466|FG002|Overall Study|Other|48|||
27704840|NCT04344301|80758473|FG000|Overall Study|Withdrawal by Subject|1|||
27704841|NCT04344301|80758474|FG001|Overall Study|Withdrawal by Subject|0|||
27704842|NCT04344301|80758473|FG000|Overall Study|Death|0|||
27704843|NCT04344301|80758474|FG001|Overall Study|Death|1|||
27704844|NCT01846624|80758475|FG000|Overall Study|Died during induction, no midostaurin|1|||
27704845|NCT00873366|80758477|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
27887770|NCT01769508|81425184|FG000|Overall Study|Death|3|||
27704846|NCT00873366|80758477|FG000|Overall Study|Off tamoxifen due to side effects|2|||
27704847|NCT00873366|80758477|FG000|Overall Study|Refused to continue DM-BT testing|3|||
27704848|NCT00853749|80758480|FG000|Overall Study|Lost to Follow-up|0|||
27704849|NCT00853749|80758481|FG001|Overall Study|Lost to Follow-up|1|||
27887771|NCT01769508|81425184|FG000|Overall Study|Withdrawal by Subject|1|||
27704850|NCT02729740|80758484|FG000|Overall Study|Early Termination|130|||
27599154|NCT01235546|80370967|FG001|Overall Study|Protocol Violation|1|||
27599155|NCT01693068|80370968|FG000|Randomization Period|On-study|2|||
27599156|NCT01693068|80370969|FG001|Randomization Period|On-study|5|||
27599157|NCT01693068|80370970|FG002|Randomization Period|On-study|0|||
27599158|NCT01693068|80370968|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
27599159|NCT01693068|80370969|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
27599160|NCT01693068|80370970|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
27599161|NCT00511875|80370971|FG000|Overall Study|Lost to Follow-up|4|||
27599162|NCT00511875|80370972|FG001|Overall Study|Lost to Follow-up|0|||
27599163|NCT00511875|80370971|FG000|Overall Study|Missing variables|1|||
27599164|NCT00511875|80370972|FG001|Overall Study|Missing variables|0|||
27599165|NCT00117676|80370981|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
27599166|NCT00117676|80370982|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
27599167|NCT00117676|80370981|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
27599168|NCT00117676|80370982|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
27599169|NCT00117676|80370981|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
27599170|NCT00117676|80370982|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
27599171|NCT00117676|80370981|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
27599172|NCT00117676|80370982|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
27599173|NCT00117676|80370981|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
27599174|NCT00117676|80370982|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
27599175|NCT00117676|80370981|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
27599176|NCT00117676|80370982|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
27599177|NCT00117676|80370981|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
27599178|NCT00117676|80370982|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
27599179|NCT00117676|80370981|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
27599180|NCT00117676|80370982|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
27599181|NCT00117676|80370981|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
27599182|NCT00117676|80370982|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
27599183|NCT00117676|80370981|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
27599184|NCT00117676|80370982|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
27599185|NCT00117676|80370981|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
27599186|NCT00117676|80370982|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
27599187|NCT00117676|80370981|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
27599188|NCT00117676|80370982|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
27599189|NCT00117676|80370981|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
27599190|NCT00117676|80370982|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
27599191|NCT00117676|80370981|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
27704851|NCT02729740|80758484|FG000|Overall Study|Other|1|||
27704852|NCT02546765|80758485|FG000|Overall Study|Withdrawal by Subject|0|||
27887772|NCT01769508|81425184|FG000|Overall Study|Adverse Event|1|||
27887773|NCT01769508|81425184|FG000|Overall Study|Lost to Follow-up|1|||
27887774|NCT03190915|81425185|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
27887775|NCT03190915|81425185|FG000|Overall Study|Progressive Disease|3|||
27887776|NCT01860040|81425190|FG000|Overall Study|Withdrawal by Subject|1|||
27887777|NCT01860040|81425191|FG001|Overall Study|Withdrawal by Subject|0|||
27887778|NCT01270464|81425199|FG000|Overall Study|Protocol Violation|4|||
27887779|NCT01270464|81425200|FG001|Overall Study|Protocol Violation|3|||
27887780|NCT01270464|81425201|FG002|Overall Study|Protocol Violation|2|||
27887781|NCT01270464|81425199|FG000|Overall Study|Lack of Efficacy|2|||
27887782|NCT01270464|81425200|FG001|Overall Study|Lack of Efficacy|3|||
27887783|NCT01270464|81425201|FG002|Overall Study|Lack of Efficacy|1|||
27887784|NCT01270464|81425199|FG000|Overall Study|Adverse Event|9|||
27887785|NCT01270464|81425200|FG001|Overall Study|Adverse Event|1|||
27887786|NCT01270464|81425201|FG002|Overall Study|Adverse Event|7|||
27887787|NCT01270464|81425199|FG000|Overall Study|Withdrawal by Subject|2|||
27887788|NCT01270464|81425200|FG001|Overall Study|Withdrawal by Subject|1|||
27887789|NCT01270464|81425201|FG002|Overall Study|Withdrawal by Subject|4|||
27887790|NCT01270464|81425199|FG000|Overall Study|Lost to Follow-up|2|||
27887791|NCT01270464|81425200|FG001|Overall Study|Lost to Follow-up|3|||
27887792|NCT01270464|81425201|FG002|Overall Study|Lost to Follow-up|1|||
27887793|NCT01270464|81425199|FG000|Overall Study|Other|1|||
27887794|NCT01270464|81425200|FG001|Overall Study|Other|1|||
27887795|NCT01270464|81425201|FG002|Overall Study|Other|3|||
27887796|NCT03854370|81425202|FG000|Overall Study|samples not collected|1|||
27887797|NCT03854370|81425203|FG001|Overall Study|samples not collected|1|||
27887798|NCT03854370|81425204|FG002|Overall Study|samples not collected|1|||
27887799|NCT03854370|81425205|FG003|Overall Study|samples not collected|1|||
27887800|NCT00533702|81425211|FG000|Overall Study|Withdrawal by Subject|3|||
27887801|NCT00533702|81425212|FG001|Overall Study|Withdrawal by Subject|1|||
27887802|NCT00533702|81425211|FG000|Overall Study|Found ineligible after randomization|2|||
27887803|NCT00533702|81425212|FG001|Overall Study|Found ineligible after randomization|1|||
27887804|NCT02727777|81425217|FG000|Overall Study|Screen Failure|2|||
27887805|NCT02727777|81425218|FG001|Overall Study|Screen Failure|0|||
27887806|NCT02727777|81425219|FG002|Overall Study|Screen Failure|0|||
27887807|NCT02727777|81425217|FG000|Overall Study|Progressive disease|2|||
27887808|NCT02727777|81425218|FG001|Overall Study|Progressive disease|0|||
27887809|NCT02727777|81425219|FG002|Overall Study|Progressive disease|0|||
27887810|NCT03169881|81425223|FG000|Overall Study|Incomplete Follow-up|10|||
27887811|NCT03169881|81425224|FG001|Overall Study|Incomplete Follow-up|15|||
27887812|NCT03169881|81425223|FG000|Overall Study|Lost to Follow-up|18|||
27887813|NCT03169881|81425224|FG001|Overall Study|Lost to Follow-up|20|||
27887814|NCT03169881|81425223|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
27887815|NCT03169881|81425224|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
27887816|NCT00330343|81425225|FG000|Overall Study|Lost to Follow-up|5|||
27887817|NCT02295020|81425226|FG000|Overall Study|Adverse Event|0|||
27887818|NCT02295020|81425227|FG001|Overall Study|Adverse Event|1|||
27887819|NCT02295020|81425226|FG000|Overall Study|Withdrawal by Subject|3|||
27887820|NCT02295020|81425227|FG001|Overall Study|Withdrawal by Subject|2|||
27887821|NCT04432831|81425228|FG000|Overall Study|Withdrawal by Subject|24|||
27887822|NCT04432831|81425229|FG001|Overall Study|Withdrawal by Subject|28|||
27887823|NCT04432831|81425230|FG002|Overall Study|Withdrawal by Subject|21|||
27887824|NCT04432831|81425228|FG000|Overall Study|Death|23|||
27887825|NCT04432831|81425229|FG001|Overall Study|Death|23|||
27887826|NCT04432831|81425230|FG002|Overall Study|Death|17|||
27599192|NCT00117676|80370982|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
27599193|NCT00117676|80370981|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
27599194|NCT00117676|80370982|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
27599195|NCT00117676|80370981|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
27599196|NCT00117676|80370982|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
27599197|NCT00117676|80370981|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
27887827|NCT04432831|81425228|FG000|Overall Study|Lost to Follow-up|15|||
27599198|NCT00117676|80370982|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
27599199|NCT00117676|80370981|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
27599200|NCT00117676|80370982|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
27599201|NCT00117676|80370981|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
27599202|NCT00117676|80370982|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
27599203|NCT00117676|80370981|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
27599204|NCT00117676|80370982|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
27599205|NCT00117676|80370981|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
27599206|NCT00117676|80370982|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
27599207|NCT00117676|80370981|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
27887828|NCT04432831|81425229|FG001|Overall Study|Lost to Follow-up|15|||
27599208|NCT00117676|80370982|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
27599209|NCT00117676|80370981|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
27599210|NCT00117676|80370982|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
27599211|NCT00117676|80370981|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
27599212|NCT00117676|80370982|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
27599213|NCT00117676|80370981|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
27599214|NCT00117676|80370982|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
27599215|NCT00117676|80370981|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
27599216|NCT00117676|80370982|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
27599217|NCT00117676|80370981|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
27887829|NCT04432831|81425230|FG002|Overall Study|Lost to Follow-up|12|||
27887830|NCT04432831|81425228|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
27887831|NCT04432831|81425229|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
27887832|NCT04432831|81425230|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
27887833|NCT04432831|81425228|FG000|Overall Study|Reason Not Specified|7|||
27887834|NCT04432831|81425229|FG001|Overall Study|Reason Not Specified|11|||
27599218|NCT00117676|80370982|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
27599219|NCT00117676|80370981|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
27599220|NCT00117676|80370982|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
27599221|NCT00117676|80370981|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
27599222|NCT00117676|80370982|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
27599223|NCT00117676|80370981|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
27599224|NCT00117676|80370982|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
27599225|NCT00117676|80370981|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
27599226|NCT00117676|80370982|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
27599227|NCT00117676|80370981|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
27599228|NCT00117676|80370982|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
27599229|NCT00117676|80370981|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
27599230|NCT00117676|80370982|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
27599231|NCT00117676|80370981|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
27599232|NCT00117676|80370982|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
27599233|NCT00117676|80370981|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
27599234|NCT00117676|80370982|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
27599235|NCT02027402|80370983|FG000|Overall Study|Withdrawal by Subject|4|||
27599236|NCT02027402|80370984|FG001|Overall Study|Withdrawal by Subject|1|||
27599237|NCT02390531|80370985|FG000|Overall Study|Death|0|||
27599238|NCT02390531|80370986|FG001|Overall Study|Death|2|||
27599239|NCT02390531|80370987|FG002|Overall Study|Death|0|||
27599240|NCT02390531|80370988|FG003|Overall Study|Death|1|||
27599241|NCT02390531|80370989|FG004|Overall Study|Death|0|||
27599242|NCT02390531|80370990|FG005|Overall Study|Death|0|||
27599243|NCT02390531|80370991|FG006|Overall Study|Death|0|||
27599244|NCT02390531|80370992|FG007|Overall Study|Death|1|||
27599245|NCT02390531|80370985|FG000|Overall Study|Protocol Violation|0|||
27599246|NCT02390531|80370986|FG001|Overall Study|Protocol Violation|0|||
27599247|NCT02390531|80370987|FG002|Overall Study|Protocol Violation|0|||
27599248|NCT02390531|80370988|FG003|Overall Study|Protocol Violation|0|||
27599249|NCT02390531|80370989|FG004|Overall Study|Protocol Violation|1|||
27599250|NCT02390531|80370990|FG005|Overall Study|Protocol Violation|0|||
27599251|NCT02390531|80370991|FG006|Overall Study|Protocol Violation|2|||
27599252|NCT02390531|80370992|FG007|Overall Study|Protocol Violation|0|||
27599253|NCT01756352|80371003|FG000|Overall Study|moved away and lost to followup|1|||
27599254|NCT01345630|80371005|FG000|Overall Study|Adverse Event|22|||
27599255|NCT01345630|80371006|FG001|Overall Study|Adverse Event|23|||
27599256|NCT01345630|80371005|FG000|Overall Study|Lost to Follow-up|17|||
27599257|NCT01345630|80371006|FG001|Overall Study|Lost to Follow-up|16|||
27599258|NCT01345630|80371005|FG000|Overall Study|Protocol Violation|4|||
27599259|NCT01345630|80371006|FG001|Overall Study|Protocol Violation|1|||
27599260|NCT01345630|80371005|FG000|Overall Study|Medication error without associated AE|0|||
27599261|NCT01345630|80371006|FG001|Overall Study|Medication error without associated AE|1|||
27599262|NCT01345630|80371005|FG000|Overall Study|Study terminated by sponsor|254|||
27599263|NCT01345630|80371006|FG001|Overall Study|Study terminated by sponsor|285|||
27599264|NCT01345630|80371005|FG000|Overall Study|Other reasons|6|||
27599265|NCT01345630|80371006|FG001|Overall Study|Other reasons|8|||
27599266|NCT01345630|80371005|FG000|Overall Study|Withdrawn due to pregnancy|1|||
27599267|NCT01345630|80371006|FG001|Overall Study|Withdrawn due to pregnancy|2|||
27599268|NCT01345630|80371005|FG000|Overall Study|No longer willing to participate|9|||
27599269|NCT01345630|80371006|FG001|Overall Study|No longer willing to participate|12|||
27599270|NCT01345630|80371005|FG000|Overall Study|Insufficient clinical response|48|||
27599271|NCT01345630|80371006|FG001|Overall Study|Insufficient clinical response|11|||
27599272|NCT02047045|80371009|FG000|Baseline|Withdrawal by Subject|3|||
27599273|NCT02047045|80371010|FG001|Baseline|Withdrawal by Subject|2|||
27599274|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
27599275|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
27599276|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
27599277|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
27599278|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
27599279|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
27599280|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
27599281|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
27599282|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
27599283|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
27599284|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
27599285|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
27599286|NCT02047045|80371009|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
27599287|NCT02047045|80371010|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
27599288|NCT02047045|80371009|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
27599289|NCT02047045|80371010|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
27599290|NCT01615328|80371011|FG000|Overall Study|Lost to Follow-up|3|||
27599291|NCT01615328|80371012|FG001|Overall Study|Lost to Follow-up|5|||
27599292|NCT00330174|80371013|FG000|Overall Study|Withdrawal by Subject|7|||
27599293|NCT00330174|80371014|FG001|Overall Study|Withdrawal by Subject|7|||
27599294|NCT00330174|80371013|FG000|Overall Study|Lost to Follow-up|4|||
27599295|NCT00330174|80371014|FG001|Overall Study|Lost to Follow-up|1|||
27599296|NCT00330174|80371013|FG000|Overall Study|Clinical deterioration|1|||
27599297|NCT00330174|80371014|FG001|Overall Study|Clinical deterioration|2|||
27599298|NCT00330174|80371013|FG000|Overall Study|Excessive missed visits|3|||
27599299|NCT00330174|80371014|FG001|Overall Study|Excessive missed visits|8|||
27599300|NCT00330174|80371013|FG000|Overall Study|Miscellaneous reasons|7|||
27599301|NCT00330174|80371014|FG001|Overall Study|Miscellaneous reasons|1|||
27599302|NCT02114151|80371023|FG000|Overall Study|Death|1|||
27599303|NCT02114151|80371023|FG000|Overall Study|Lost to Follow-up|1|||
27599304|NCT02114151|80371023|FG000|Overall Study|Withdrawal by Subject|5|||
27599305|NCT01944631|80371024|FG000|Overall Study|Adverse Event|1|||
27599306|NCT01944631|80371025|FG001|Overall Study|Adverse Event|0|||
27599307|NCT01944631|80371024|FG000|Overall Study|Lost to Follow-up|3|||
27599308|NCT01944631|80371025|FG001|Overall Study|Lost to Follow-up|1|||
27599309|NCT01944631|80371024|FG000|Overall Study|Withdrawal by Subject|0|||
27599310|NCT01944631|80371025|FG001|Overall Study|Withdrawal by Subject|1|||
27599311|NCT01505387|80371028|FG000|Overall Study|Protocol Violation|1|||
27599312|NCT01505387|80371029|FG001|Overall Study|Protocol Violation|0|||
27599313|NCT01505387|80371028|FG000|Overall Study|Withdrawal by Subject|1|||
27599314|NCT01505387|80371029|FG001|Overall Study|Withdrawal by Subject|1|||
27599315|NCT01951625|80371030|FG000|Treatment Period|Protocol Violation|2|||
27599316|NCT01951625|80371031|FG001|Treatment Period|Protocol Violation|0|||
27599317|NCT01951625|80371032|FG002|Treatment Period|Protocol Violation|1|||
27599318|NCT01951625|80371033|FG003|Treatment Period|Protocol Violation|3|||
27599319|NCT01951625|80371034|FG004|Treatment Period|Protocol Violation|2|||
27599320|NCT01951625|80371030|FG000|Treatment Period|Physician Decision|0|||
27599321|NCT01951625|80371031|FG001|Treatment Period|Physician Decision|0|||
27599322|NCT01951625|80371032|FG002|Treatment Period|Physician Decision|0|||
27599323|NCT01951625|80371033|FG003|Treatment Period|Physician Decision|0|||
27599324|NCT01951625|80371034|FG004|Treatment Period|Physician Decision|1|||
27599325|NCT01951625|80371030|FG000|Treatment Period|Protocol driven decision point|0|||
27599326|NCT01951625|80371031|FG001|Treatment Period|Protocol driven decision point|5|||
27599327|NCT01951625|80371032|FG002|Treatment Period|Protocol driven decision point|0|||
27599328|NCT01951625|80371033|FG003|Treatment Period|Protocol driven decision point|2|||
27599329|NCT01951625|80371034|FG004|Treatment Period|Protocol driven decision point|1|||
27599330|NCT01951625|80371030|FG000|Treatment Period|Non compliance with study drug|1|||
27599331|NCT01951625|80371031|FG001|Treatment Period|Non compliance with study drug|2|||
27599332|NCT01951625|80371032|FG002|Treatment Period|Non compliance with study drug|2|||
27599333|NCT01951625|80371033|FG003|Treatment Period|Non compliance with study drug|0|||
27599334|NCT01951625|80371034|FG004|Treatment Period|Non compliance with study drug|0|||
27599335|NCT01951625|80371030|FG000|Treatment Period|Death|3|||
27599336|NCT01951625|80371031|FG001|Treatment Period|Death|2|||
27599337|NCT01951625|80371032|FG002|Treatment Period|Death|2|||
27599338|NCT01951625|80371033|FG003|Treatment Period|Death|1|||
27599339|NCT01951625|80371034|FG004|Treatment Period|Death|2|||
27599340|NCT01951625|80371030|FG000|Treatment Period|Adverse Event|7|||
27599341|NCT01951625|80371031|FG001|Treatment Period|Adverse Event|10|||
27599342|NCT01951625|80371032|FG002|Treatment Period|Adverse Event|9|||
27599343|NCT01951625|80371033|FG003|Treatment Period|Adverse Event|8|||
27599344|NCT01951625|80371034|FG004|Treatment Period|Adverse Event|8|||
27599345|NCT01951625|80371030|FG000|Treatment Period|Withdrawal by Subject|5|||
27599346|NCT01951625|80371031|FG001|Treatment Period|Withdrawal by Subject|2|||
27599347|NCT01951625|80371032|FG002|Treatment Period|Withdrawal by Subject|1|||
27599348|NCT01951625|80371033|FG003|Treatment Period|Withdrawal by Subject|7|||
27599349|NCT01951625|80371034|FG004|Treatment Period|Withdrawal by Subject|3|||
27599350|NCT01951625|80371030|FG000|Treatment Period|Lost to Follow-up|1|||
27599351|NCT01951625|80371031|FG001|Treatment Period|Lost to Follow-up|0|||
27599352|NCT01951625|80371032|FG002|Treatment Period|Lost to Follow-up|0|||
27599353|NCT01951625|80371033|FG003|Treatment Period|Lost to Follow-up|1|||
27599354|NCT01951625|80371034|FG004|Treatment Period|Lost to Follow-up|0|||
27599355|NCT01951625|80371030|FG000|Follow Up Period|Non-compliance with study drug|1|||
27599356|NCT01951625|80371031|FG001|Follow Up Period|Non-compliance with study drug|0|||
27599357|NCT01951625|80371032|FG002|Follow Up Period|Non-compliance with study drug|0|||
27887835|NCT04432831|81425230|FG002|Overall Study|Reason Not Specified|9|||
27704853|NCT02546765|80758486|FG001|Overall Study|Withdrawal by Subject|1|||
27704854|NCT02546765|80758487|FG002|Overall Study|Withdrawal by Subject|0|||
27704855|NCT02546765|80758488|FG003|Overall Study|Withdrawal by Subject|0|||
27704856|NCT02462928|80758489|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27704857|NCT02462928|80758490|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27887836|NCT04432831|81425228|FG000|Overall Study|Adverse Event|7|||
27704858|NCT02462928|80758491|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
27704859|NCT02462928|80758489|FG000|Overall Study|Adverse Event|47|||
27704860|NCT02462928|80758490|FG001|Overall Study|Adverse Event|51|||
27704861|NCT02462928|80758491|FG002|Overall Study|Adverse Event|25|||
27704862|NCT02462928|80758489|FG000|Overall Study|Lack of Efficacy|3|||
27704863|NCT02462928|80758490|FG001|Overall Study|Lack of Efficacy|8|||
27704864|NCT02462928|80758491|FG002|Overall Study|Lack of Efficacy|3|||
27704865|NCT02462928|80758489|FG000|Overall Study|Lost to Follow-up|4|||
27704866|NCT02462928|80758490|FG001|Overall Study|Lost to Follow-up|4|||
27704867|NCT02462928|80758491|FG002|Overall Study|Lost to Follow-up|1|||
27704868|NCT02462928|80758489|FG000|Overall Study|Withdrawal by Patient|31|||
27704869|NCT02462928|80758490|FG001|Overall Study|Withdrawal by Patient|21|||
27704870|NCT02462928|80758491|FG002|Overall Study|Withdrawal by Patient|21|||
27887837|NCT04432831|81425229|FG001|Overall Study|Adverse Event|7|||
27887838|NCT04432831|81425230|FG002|Overall Study|Adverse Event|7|||
27887839|NCT04432831|81425228|FG000|Overall Study|Physician Decision|1|||
27887840|NCT04432831|81425229|FG001|Overall Study|Physician Decision|3|||
27887841|NCT04432831|81425230|FG002|Overall Study|Physician Decision|6|||
27887842|NCT04432831|81425228|FG000|Overall Study|Protocol Violation|1|||
27887843|NCT04432831|81425229|FG001|Overall Study|Protocol Violation|0|||
27887844|NCT04432831|81425230|FG002|Overall Study|Protocol Violation|2|||
27887845|NCT04432831|81425228|FG000|Overall Study|Pregnancy|0|||
27887846|NCT04432831|81425229|FG001|Overall Study|Pregnancy|1|||
27887847|NCT04432831|81425230|FG002|Overall Study|Pregnancy|0|||
27887848|NCT04432831|81425228|FG000|Overall Study|Lack of Efficacy|0|||
27704871|NCT02462928|80758489|FG000|Overall Study|Protocol Violation|0|||
27704872|NCT02462928|80758490|FG001|Overall Study|Protocol Violation|1|||
27704873|NCT02462928|80758491|FG002|Overall Study|Protocol Violation|0|||
27887849|NCT04432831|81425229|FG001|Overall Study|Lack of Efficacy|0|||
27887850|NCT04432831|81425230|FG002|Overall Study|Lack of Efficacy|2|||
27887851|NCT02980341|81425234|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
27704874|NCT02462928|80758489|FG000|Overall Study|Reason not Specified|4|||
27704875|NCT02462928|80758490|FG001|Overall Study|Reason not Specified|6|||
27704876|NCT02462928|80758491|FG002|Overall Study|Reason not Specified|5|||
27704877|NCT00729378|80758494|FG000|Baseline|Did not complete study measurements|72|||
27704878|NCT00729378|80758495|FG001|Baseline|Did not complete study measurements|33|||
27704879|NCT00729378|80758494|FG000|Baseline|Withdrawal by Subject|66|||
27704880|NCT00729378|80758495|FG001|Baseline|Withdrawal by Subject|59|||
27704881|NCT00729378|80758494|FG000|12-months|Lost to Follow-up|100|||
27704882|NCT00729378|80758495|FG001|12-months|Lost to Follow-up|65|||
27704883|NCT00729378|80758494|FG000|24-months|Lost to Follow-up|72|||
27704884|NCT00729378|80758495|FG001|24-months|Lost to Follow-up|51|||
27704885|NCT00729378|80758494|FG000|36-months|Lost to Follow-up|15|||
27704886|NCT00729378|80758495|FG001|36-months|Lost to Follow-up|6|||
27704887|NCT03713034|80758496|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
27704888|NCT03713034|80758497|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
27704889|NCT00718549|80758498|FG000|Induction Phase|Disease Progression|1|||
27704890|NCT00718549|80758499|FG001|Induction Phase|Disease Progression|0|||
27704891|NCT00718549|80758500|FG002|Induction Phase|Disease Progression|0|||
27704892|NCT00718549|80758498|FG000|Induction Phase|Eligibility Criteria Violation|2|||
27704893|NCT00718549|80758499|FG001|Induction Phase|Eligibility Criteria Violation|0|||
27704894|NCT00718549|80758500|FG002|Induction Phase|Eligibility Criteria Violation|0|||
27704895|NCT00718549|80758498|FG000|Induction Phase|Early Termination - No Additional Info|59|||
27704896|NCT00718549|80758499|FG001|Induction Phase|Early Termination - No Additional Info|0|||
27704897|NCT00718549|80758500|FG002|Induction Phase|Early Termination - No Additional Info|0|||
27704898|NCT00718549|80758498|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
27704899|NCT00718549|80758499|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
27704900|NCT00718549|80758500|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
27704901|NCT00718549|80758498|FG000|Maintenance/ Observation Phase|Death|0|||
27704902|NCT00718549|80758499|FG001|Maintenance/ Observation Phase|Death|1|||
27704903|NCT00718549|80758500|FG002|Maintenance/ Observation Phase|Death|2|||
27704904|NCT00718549|80758498|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
27704905|NCT00718549|80758499|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
27704906|NCT00718549|80758500|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
27704907|NCT00718549|80758498|FG000|Maintenance/ Observation Phase|Progression|0|||
27704908|NCT00718549|80758499|FG001|Maintenance/ Observation Phase|Progression|5|||
27704909|NCT00718549|80758500|FG002|Maintenance/ Observation Phase|Progression|14|||
27704910|NCT00718549|80758498|FG000|Maintenance/ Observation Phase|Relapse|0|||
27704911|NCT00718549|80758499|FG001|Maintenance/ Observation Phase|Relapse|3|||
27704912|NCT00718549|80758500|FG002|Maintenance/ Observation Phase|Relapse|2|||
27704913|NCT00932360|80758502|FG000|Washout (One Week)|Withdrawal by Subject|0|||
27704914|NCT00932360|80758503|FG001|Washout (One Week)|Withdrawal by Subject|0|||
27704915|NCT00932360|80758504|FG002|Washout (One Week)|Withdrawal by Subject|0|||
27704916|NCT00932360|80758505|FG003|Washout (One Week)|Withdrawal by Subject|0|||
27704917|NCT00932360|80758506|FG004|Washout (One Week)|Withdrawal by Subject|2|||
27704918|NCT00932360|80758507|FG005|Washout (One Week)|Withdrawal by Subject|0|||
27704919|NCT00073528|80758508|FG000|Overall Study|Death|488|||
27704920|NCT00073528|80758509|FG001|Overall Study|Death|473|||
27704921|NCT00073528|80758508|FG000|Overall Study|Lost to Follow-up|52|||
27704922|NCT00073528|80758509|FG001|Overall Study|Lost to Follow-up|45|||
27704923|NCT00073528|80758508|FG000|Overall Study|Withdrawal by Subject|50|||
27599358|NCT01951625|80371033|FG003|Follow Up Period|Non-compliance with study drug|0|||
27599359|NCT01951625|80371034|FG004|Follow Up Period|Non-compliance with study drug|0|||
27599360|NCT01951625|80371030|FG000|Follow Up Period|Death|1|||
27599361|NCT01951625|80371031|FG001|Follow Up Period|Death|3|||
27599362|NCT01951625|80371032|FG002|Follow Up Period|Death|2|||
27704924|NCT00073528|80758509|FG001|Overall Study|Withdrawal by Subject|45|||
27704925|NCT00073528|80758508|FG000|Overall Study|Study terminated by Sponsor|10|||
27704926|NCT00073528|80758509|FG001|Overall Study|Study terminated by Sponsor|29|||
27704927|NCT00073528|80758508|FG000|Overall Study|Other|18|||
27704928|NCT00073528|80758509|FG001|Overall Study|Other|19|||
27704929|NCT00073528|80758508|FG000|Overall Study|Other|9|||
27704930|NCT00073528|80758509|FG001|Overall Study|Other|12|||
27704931|NCT00073528|80758508|FG000|Overall Study|Protocol Violation|3|||
27704932|NCT00073528|80758509|FG001|Overall Study|Protocol Violation|5|||
27704933|NCT02486653|80758514|FG000|Overall Study|Withdrawal by Subject|1|||
27704934|NCT02486653|80758515|FG001|Overall Study|Withdrawal by Subject|3|||
27704935|NCT02486653|80758514|FG000|Overall Study|Protocol Violation|1|||
27704936|NCT02486653|80758515|FG001|Overall Study|Protocol Violation|0|||
27704937|NCT02486653|80758514|FG000|Overall Study|surgery cancelled|4|||
27704938|NCT02486653|80758515|FG001|Overall Study|surgery cancelled|1|||
27704939|NCT02873936|80758516|FG000|Overall Study|Withdrew Consent|4|||
27704940|NCT02873936|80758517|FG001|Overall Study|Withdrew Consent|11|||
27704941|NCT02873936|80758518|FG002|Overall Study|Withdrew Consent|20|||
27704942|NCT02873936|80758516|FG000|Overall Study|Investigator's Discretion|3|||
27704943|NCT02873936|80758517|FG001|Overall Study|Investigator's Discretion|5|||
27704944|NCT02873936|80758518|FG002|Overall Study|Investigator's Discretion|4|||
27704945|NCT02873936|80758516|FG000|Overall Study|Adverse Event|3|||
27704946|NCT02873936|80758517|FG001|Overall Study|Adverse Event|5|||
27704947|NCT02873936|80758518|FG002|Overall Study|Adverse Event|3|||
27704948|NCT02873936|80758516|FG000|Overall Study|Protocol Violation|0|||
27704949|NCT02873936|80758517|FG001|Overall Study|Protocol Violation|1|||
27704950|NCT02873936|80758518|FG002|Overall Study|Protocol Violation|3|||
27704951|NCT02873936|80758516|FG000|Overall Study|Lost to Follow-up|1|||
27704952|NCT02873936|80758517|FG001|Overall Study|Lost to Follow-up|1|||
27704953|NCT02873936|80758518|FG002|Overall Study|Lost to Follow-up|1|||
27704954|NCT02873936|80758516|FG000|Overall Study|Non-compliance With Study Drug|1|||
27704955|NCT02873936|80758517|FG001|Overall Study|Non-compliance With Study Drug|0|||
27704956|NCT02873936|80758518|FG002|Overall Study|Non-compliance With Study Drug|1|||
27704957|NCT02873936|80758516|FG000|Overall Study|Randomized but not Dosed|1|||
27704958|NCT02873936|80758517|FG001|Overall Study|Randomized but not Dosed|0|||
27704959|NCT02873936|80758518|FG002|Overall Study|Randomized but not Dosed|0|||
27704960|NCT00495820|80758519|FG000|Overall Study|Adverse Event|1|||
27704961|NCT00495820|80758520|FG001|Overall Study|Adverse Event|1|||
27704962|NCT01378104|80758521|FG000|Overall Study|Adverse Event|8|||
27704963|NCT01378104|80758522|FG001|Overall Study|Adverse Event|8|||
27704964|NCT01378104|80758521|FG000|Overall Study|Lack of Efficacy|7|||
27704965|NCT01378104|80758522|FG001|Overall Study|Lack of Efficacy|5|||
27704966|NCT01378104|80758521|FG000|Overall Study|Withdrawal by Subject|12|||
27704967|NCT01378104|80758522|FG001|Overall Study|Withdrawal by Subject|13|||
27599363|NCT01951625|80371033|FG003|Follow Up Period|Death|2|||
27599364|NCT01951625|80371034|FG004|Follow Up Period|Death|1|||
27599365|NCT01951625|80371030|FG000|Follow Up Period|Logistical difficulties|1|||
27599366|NCT01951625|80371031|FG001|Follow Up Period|Logistical difficulties|2|||
27704968|NCT01092143|80758524|FG000|Overall Study|Adverse Event|10|||
27704969|NCT01092143|80758525|FG001|Overall Study|Adverse Event|5|||
27704970|NCT01092143|80758526|FG002|Overall Study|Adverse Event|1|||
27599367|NCT01951625|80371032|FG002|Follow Up Period|Logistical difficulties|0|||
27599368|NCT01951625|80371033|FG003|Follow Up Period|Logistical difficulties|0|||
27599369|NCT01951625|80371034|FG004|Follow Up Period|Logistical difficulties|0|||
27704971|NCT01092143|80758527|FG003|Overall Study|Adverse Event|4|||
27704972|NCT01092143|80758528|FG004|Overall Study|Adverse Event|3|||
27704973|NCT01092143|80758524|FG000|Overall Study|Lost to Follow-up|1|||
27704974|NCT01092143|80758525|FG001|Overall Study|Lost to Follow-up|0|||
27704975|NCT01092143|80758526|FG002|Overall Study|Lost to Follow-up|1|||
27704976|NCT01092143|80758527|FG003|Overall Study|Lost to Follow-up|0|||
27704977|NCT01092143|80758528|FG004|Overall Study|Lost to Follow-up|0|||
27704978|NCT01092143|80758524|FG000|Overall Study|Consent withdrawn|2|||
27704979|NCT01092143|80758525|FG001|Overall Study|Consent withdrawn|1|||
27704980|NCT01092143|80758526|FG002|Overall Study|Consent withdrawn|0|||
27704981|NCT01092143|80758527|FG003|Overall Study|Consent withdrawn|1|||
27704982|NCT01092143|80758528|FG004|Overall Study|Consent withdrawn|3|||
27704983|NCT01092143|80758524|FG000|Overall Study|Not treated|0|||
27704984|NCT01092143|80758525|FG001|Overall Study|Not treated|0|||
27704985|NCT01092143|80758526|FG002|Overall Study|Not treated|1|||
27704986|NCT01092143|80758527|FG003|Overall Study|Not treated|0|||
27704987|NCT01092143|80758528|FG004|Overall Study|Not treated|0|||
27704988|NCT01092143|80758524|FG000|Overall Study|did not reversibility criteria|0|||
27704989|NCT01092143|80758525|FG001|Overall Study|did not reversibility criteria|0|||
27704990|NCT01092143|80758526|FG002|Overall Study|did not reversibility criteria|1|||
27704991|NCT01092143|80758527|FG003|Overall Study|did not reversibility criteria|0|||
27704992|NCT01092143|80758528|FG004|Overall Study|did not reversibility criteria|0|||
27704993|NCT01092143|80758524|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
27704994|NCT01092143|80758525|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
27704995|NCT01092143|80758526|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
27704996|NCT01092143|80758527|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
27704997|NCT01092143|80758528|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
27704998|NCT01092143|80758524|FG000|Overall Study|Ineligible patient|1|||
27704999|NCT01092143|80758525|FG001|Overall Study|Ineligible patient|0|||
27705000|NCT01092143|80758526|FG002|Overall Study|Ineligible patient|0|||
27705001|NCT01092143|80758527|FG003|Overall Study|Ineligible patient|0|||
27705002|NCT01092143|80758528|FG004|Overall Study|Ineligible patient|0|||
27705003|NCT01092143|80758524|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
27705004|NCT01092143|80758525|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
27705005|NCT01092143|80758526|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
27705006|NCT01092143|80758527|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
27705007|NCT01092143|80758528|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
27705008|NCT01092143|80758524|FG000|Overall Study|Patient travel|0|||
27705009|NCT01092143|80758525|FG001|Overall Study|Patient travel|0|||
27705010|NCT01092143|80758526|FG002|Overall Study|Patient travel|0|||
27705011|NCT01092143|80758527|FG003|Overall Study|Patient travel|0|||
27705012|NCT01092143|80758528|FG004|Overall Study|Patient travel|1|||
27705013|NCT01092143|80758524|FG000|Overall Study|Non compliance with study medication|0|||
27705014|NCT01092143|80758525|FG001|Overall Study|Non compliance with study medication|0|||
27705015|NCT01092143|80758526|FG002|Overall Study|Non compliance with study medication|0|||
27705016|NCT01092143|80758527|FG003|Overall Study|Non compliance with study medication|0|||
27705017|NCT01092143|80758528|FG004|Overall Study|Non compliance with study medication|1|||
27705018|NCT01092143|80758524|FG000|Overall Study|Randomized by mistake|0|||
27705019|NCT01092143|80758525|FG001|Overall Study|Randomized by mistake|0|||
27705020|NCT01092143|80758526|FG002|Overall Study|Randomized by mistake|0|||
27705021|NCT01092143|80758527|FG003|Overall Study|Randomized by mistake|1|||
27705022|NCT01092143|80758528|FG004|Overall Study|Randomized by mistake|0|||
27705023|NCT01092143|80758524|FG000|Overall Study|Pregnancy|0|||
27705024|NCT01092143|80758525|FG001|Overall Study|Pregnancy|0|||
27705025|NCT01092143|80758526|FG002|Overall Study|Pregnancy|0|||
27705026|NCT01092143|80758527|FG003|Overall Study|Pregnancy|1|||
27705027|NCT01092143|80758528|FG004|Overall Study|Pregnancy|0|||
27705028|NCT03337542|80758529|FG000|Overall Study|Withdrew Consent|17|||
27705029|NCT03337542|80758529|FG000|Overall Study|Allergic Adverse Event|1|||
27705030|NCT03337542|80758529|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
27705031|NCT03337542|80758529|FG000|Overall Study|Lost to Follow-up|1|||
27705032|NCT03337542|80758529|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
27705033|NCT01045798|80758530|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
27705034|NCT01045798|80758531|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
27705035|NCT01045798|80758530|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
27599370|NCT01951625|80371030|FG000|Follow Up Period|Adverse Event|0|||
27599371|NCT01951625|80371031|FG001|Follow Up Period|Adverse Event|3|||
27599372|NCT01951625|80371032|FG002|Follow Up Period|Adverse Event|2|||
27705036|NCT01045798|80758531|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
27705037|NCT01045798|80758530|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
27705038|NCT01045798|80758531|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
27705039|NCT01045798|80758530|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
27705040|NCT01045798|80758531|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
27599373|NCT01951625|80371033|FG003|Follow Up Period|Adverse Event|3|||
27599374|NCT01951625|80371034|FG004|Follow Up Period|Adverse Event|5|||
27705041|NCT02046096|80758534|FG000|Overall Study|Death|28|||
27705042|NCT02046096|80758535|FG001|Overall Study|Death|45|||
27705043|NCT02046096|80758534|FG000|Overall Study|Lost to Follow-up|9|||
27705044|NCT02046096|80758535|FG001|Overall Study|Lost to Follow-up|20|||
27705045|NCT02046096|80758534|FG000|Overall Study|Withdrawal by Subject|5|||
27705046|NCT02046096|80758535|FG001|Overall Study|Withdrawal by Subject|17|||
27705047|NCT02046096|80758534|FG000|Overall Study|Other endpoint|2|||
27705048|NCT02046096|80758535|FG001|Overall Study|Other endpoint|19|||
27705049|NCT02568475|80758536|FG000|Overall Study|Lost to Follow-up|40|||
27705050|NCT02568475|80758537|FG001|Overall Study|Lost to Follow-up|39|||
27705051|NCT02568475|80758536|FG000|Overall Study|Withdrawal by Subject|2|||
27705052|NCT02568475|80758537|FG001|Overall Study|Withdrawal by Subject|0|||
27705053|NCT02568475|80758536|FG000|Overall Study|Discharged home|4|||
27705054|NCT02568475|80758537|FG001|Overall Study|Discharged home|4|||
27705055|NCT02568475|80758536|FG000|Overall Study|Short-term: Discharge location unknown|4|||
27705056|NCT02568475|80758537|FG001|Overall Study|Short-term: Discharge location unknown|0|||
27705057|NCT02568475|80758536|FG000|Overall Study|Transferred to another facility|1|||
27705058|NCT02568475|80758537|FG001|Overall Study|Transferred to another facility|0|||
27705059|NCT04233164|80758538|FG000|Overall Study|Unable to obtain specimen|0|||
27705060|NCT04233164|80758539|FG001|Overall Study|Unable to obtain specimen|1|||
27705061|NCT00290186|80758540|FG000|Overall Study|Adverse Event|1|||
27705062|NCT00290186|80758541|FG001|Overall Study|Adverse Event|1|||
27834774|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834775|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834776|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834777|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834778|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834779|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834780|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834781|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834782|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834783|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834784|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834785|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834786|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834787|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834788|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834789|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834790|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834791|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834792|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834793|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
27834794|NCT00112437|81226158|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834795|NCT00112437|81226159|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834796|NCT00112437|81226160|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27599375|NCT01951625|80371030|FG000|Follow Up Period|Withdrawal by Subject|4|||
27599376|NCT01951625|80371031|FG001|Follow Up Period|Withdrawal by Subject|1|||
27705063|NCT00290186|80758540|FG000|Overall Study|Lost to Follow-up|3|||
27705064|NCT00290186|80758541|FG001|Overall Study|Lost to Follow-up|2|||
27705065|NCT00290186|80758540|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
27599377|NCT01951625|80371032|FG002|Follow Up Period|Withdrawal by Subject|0|||
27887852|NCT02980341|81425235|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
27887853|NCT02980341|81425236|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
27887854|NCT02980341|81425237|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
27887855|NCT02980341|81425238|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
27887856|NCT02980341|81425239|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
27887857|NCT02980341|81425240|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
27887858|NCT02980341|81425241|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
27887859|NCT02980341|81425242|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
27887860|NCT02980341|81425243|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
27887861|NCT02980341|81425244|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
27887862|NCT02980341|81425234|FG000|Dose Escalation|Clinical progression|0|||
27887863|NCT02980341|81425235|FG001|Dose Escalation|Clinical progression|0|||
27887864|NCT02980341|81425236|FG002|Dose Escalation|Clinical progression|2|||
27887865|NCT02980341|81425237|FG003|Dose Escalation|Clinical progression|1|||
27887866|NCT02980341|81425238|FG004|Dose Escalation|Clinical progression|0|||
27887867|NCT02980341|81425239|FG005|Dose Escalation|Clinical progression|0|||
27887868|NCT02980341|81425240|FG006|Dose Escalation|Clinical progression|0|||
27887869|NCT02980341|81425241|FG007|Dose Escalation|Clinical progression|0|||
27887870|NCT02980341|81425242|FG008|Dose Escalation|Clinical progression|0|||
27887871|NCT02980341|81425243|FG009|Dose Escalation|Clinical progression|0|||
27887872|NCT02980341|81425244|FG010|Dose Escalation|Clinical progression|0|||
27887873|NCT02980341|81425234|FG000|Dose Escalation|Adverse Event|0|||
27887874|NCT02980341|81425235|FG001|Dose Escalation|Adverse Event|0|||
27887875|NCT02980341|81425236|FG002|Dose Escalation|Adverse Event|1|||
27887876|NCT02980341|81425237|FG003|Dose Escalation|Adverse Event|2|||
27887877|NCT02980341|81425238|FG004|Dose Escalation|Adverse Event|2|||
27887878|NCT02980341|81425239|FG005|Dose Escalation|Adverse Event|0|||
27887879|NCT02980341|81425240|FG006|Dose Escalation|Adverse Event|0|||
27887880|NCT02980341|81425241|FG007|Dose Escalation|Adverse Event|0|||
27887881|NCT02980341|81425242|FG008|Dose Escalation|Adverse Event|0|||
27887882|NCT02980341|81425243|FG009|Dose Escalation|Adverse Event|0|||
27887883|NCT02980341|81425244|FG010|Dose Escalation|Adverse Event|0|||
27887884|NCT02980341|81425234|FG000|Dose Escalation|Withdrawal by Subject|0|||
27887885|NCT02980341|81425235|FG001|Dose Escalation|Withdrawal by Subject|0|||
27887886|NCT02980341|81425236|FG002|Dose Escalation|Withdrawal by Subject|1|||
27887887|NCT02980341|81425237|FG003|Dose Escalation|Withdrawal by Subject|0|||
27887888|NCT02980341|81425238|FG004|Dose Escalation|Withdrawal by Subject|0|||
27887889|NCT02980341|81425239|FG005|Dose Escalation|Withdrawal by Subject|0|||
27887890|NCT02980341|81425240|FG006|Dose Escalation|Withdrawal by Subject|0|||
27887891|NCT02980341|81425241|FG007|Dose Escalation|Withdrawal by Subject|0|||
27887892|NCT02980341|81425242|FG008|Dose Escalation|Withdrawal by Subject|0|||
27887893|NCT02980341|81425243|FG009|Dose Escalation|Withdrawal by Subject|0|||
27887894|NCT02980341|81425244|FG010|Dose Escalation|Withdrawal by Subject|0|||
27887895|NCT02980341|81425234|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887896|NCT02980341|81425235|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887897|NCT02980341|81425236|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887898|NCT02980341|81425237|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
27887899|NCT02980341|81425238|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887900|NCT02980341|81425239|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887901|NCT02980341|81425240|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887902|NCT02980341|81425241|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887903|NCT02980341|81425242|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887904|NCT02980341|81425243|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887905|NCT02980341|81425244|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
27887906|NCT02980341|81425234|FG000|Dose Escalation|Due to investigator's decision|0|||
27599378|NCT01951625|80371033|FG003|Follow Up Period|Withdrawal by Subject|5|||
27705066|NCT00290186|80758541|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
27705067|NCT00290186|80758540|FG000|Overall Study|Withdrawal by Subject|0|||
27705068|NCT00290186|80758541|FG001|Overall Study|Withdrawal by Subject|1|||
27887907|NCT02980341|81425235|FG001|Dose Escalation|Due to investigator's decision|0|||
27887908|NCT02980341|81425236|FG002|Dose Escalation|Due to investigator's decision|0|||
27887909|NCT02980341|81425237|FG003|Dose Escalation|Due to investigator's decision|0|||
27887910|NCT02980341|81425238|FG004|Dose Escalation|Due to investigator's decision|1|||
27705069|NCT02023242|80758542|FG000|Overall Study|Lost to Follow-up|3|||
27705070|NCT02023242|80758543|FG001|Overall Study|Lost to Follow-up|1|||
27705071|NCT02023242|80758542|FG000|Overall Study|Death|0|||
27705072|NCT02023242|80758543|FG001|Overall Study|Death|1|||
27705073|NCT01202279|80758544|FG000|Overall Study|Adverse Event|8|||
27705074|NCT01202279|80758545|FG001|Overall Study|Adverse Event|6|||
27599379|NCT01951625|80371034|FG004|Follow Up Period|Withdrawal by Subject|3|||
27599380|NCT01951625|80371030|FG000|Follow Up Period|Lost to Follow-up|1|||
27599381|NCT01951625|80371031|FG001|Follow Up Period|Lost to Follow-up|0|||
27599382|NCT01951625|80371032|FG002|Follow Up Period|Lost to Follow-up|0|||
27599383|NCT01951625|80371033|FG003|Follow Up Period|Lost to Follow-up|1|||
27599384|NCT01951625|80371034|FG004|Follow Up Period|Lost to Follow-up|1|||
27599385|NCT04530448|80371040|FG000|Overall Study|Physician Decision|3|||
27599386|NCT04530448|80371041|FG001|Overall Study|Physician Decision|0|||
27599387|NCT02481310|80371046|FG000|Follow up|Still in follow up|0|||
27599388|NCT02481310|80371047|FG001|Follow up|Still in follow up|3|||
27599389|NCT02481310|80371048|FG002|Follow up|Still in follow up|0|||
27599390|NCT02191267|80371049|FG000|Overall Study|Withdrawal by Subject|1|||
27599391|NCT02191267|80371050|FG001|Overall Study|Withdrawal by Subject|0|||
27599392|NCT02191267|80371051|FG002|Overall Study|Withdrawal by Subject|0|||
27599393|NCT02110901|80371068|FG000|Overall Study|Death|6|||
27599394|NCT02110901|80371069|FG001|Overall Study|Death|3|||
27599395|NCT02110901|80371068|FG000|Overall Study|Lost to Follow-up|12|||
27599396|NCT02110901|80371069|FG001|Overall Study|Lost to Follow-up|8|||
27599397|NCT02110901|80371068|FG000|Overall Study|Withdrawal by Subject|7|||
27599398|NCT02110901|80371069|FG001|Overall Study|Withdrawal by Subject|3|||
27599399|NCT02110901|80371068|FG000|Overall Study|received a kidney transplant|5|||
27599400|NCT02110901|80371069|FG001|Overall Study|received a kidney transplant|0|||
27599401|NCT00441701|80371070|FG000|Overall Study|Adverse Event|3|||
27599402|NCT00441701|80371071|FG001|Overall Study|Adverse Event|2|||
27599403|NCT00441701|80371072|FG002|Overall Study|Adverse Event|1|||
27599404|NCT00441701|80371073|FG003|Overall Study|Adverse Event|0|||
27599405|NCT00441701|80371074|FG004|Overall Study|Adverse Event|2|||
27599406|NCT00441701|80371075|FG005|Overall Study|Adverse Event|2|||
27599407|NCT00441701|80371076|FG006|Overall Study|Adverse Event|0|||
27599408|NCT00441701|80371077|FG007|Overall Study|Adverse Event|0|||
27599409|NCT00441701|80371078|FG008|Overall Study|Adverse Event|0|||
27599410|NCT00441701|80371079|FG009|Overall Study|Adverse Event|0|||
27887911|NCT02980341|81425239|FG005|Dose Escalation|Due to investigator's decision|0|||
27887912|NCT02980341|81425240|FG006|Dose Escalation|Due to investigator's decision|0|||
27599411|NCT00441701|80371070|FG000|Overall Study|Lack of Efficacy|2|||
27599412|NCT00441701|80371071|FG001|Overall Study|Lack of Efficacy|0|||
27599413|NCT00441701|80371072|FG002|Overall Study|Lack of Efficacy|2|||
27599414|NCT00441701|80371073|FG003|Overall Study|Lack of Efficacy|2|||
27834797|NCT00112437|81226161|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834798|NCT00112437|81226162|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
27834799|NCT00112437|81226163|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834800|NCT00112437|81226164|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834801|NCT00112437|81226165|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834802|NCT00112437|81226166|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834803|NCT00112437|81226167|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834804|NCT00112437|81226168|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834805|NCT00112437|81226169|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834806|NCT00112437|81226170|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27705075|NCT01202279|80758544|FG000|Overall Study|Withdrawal by Subject|13|||
27705076|NCT01202279|80758545|FG001|Overall Study|Withdrawal by Subject|10|||
27705077|NCT01202279|80758544|FG000|Overall Study|Physician Decision|0|||
27705078|NCT01202279|80758545|FG001|Overall Study|Physician Decision|1|||
27705079|NCT01202279|80758544|FG000|Overall Study|Lost to Follow-up|10|||
27705080|NCT01202279|80758545|FG001|Overall Study|Lost to Follow-up|7|||
27705081|NCT01202279|80758544|FG000|Overall Study|Protocol Violation|1|||
27705082|NCT01202279|80758545|FG001|Overall Study|Protocol Violation|1|||
27887913|NCT02980341|81425241|FG007|Dose Escalation|Due to investigator's decision|0|||
27887914|NCT02980341|81425242|FG008|Dose Escalation|Due to investigator's decision|0|||
27887915|NCT02980341|81425243|FG009|Dose Escalation|Due to investigator's decision|0|||
27887916|NCT02980341|81425244|FG010|Dose Escalation|Due to investigator's decision|0|||
27887917|NCT02980341|81425234|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887918|NCT02980341|81425235|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887919|NCT02980341|81425236|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887920|NCT02980341|81425237|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887921|NCT02980341|81425238|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887922|NCT02980341|81425239|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
27887923|NCT02980341|81425240|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
27887924|NCT02980341|81425241|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887925|NCT02980341|81425242|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887926|NCT02980341|81425243|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887927|NCT02980341|81425244|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
27887928|NCT02980341|81425234|FG000|Dose Finding|Adverse Event|0|||
27887929|NCT02980341|81425235|FG001|Dose Finding|Adverse Event|0|||
27887930|NCT02980341|81425236|FG002|Dose Finding|Adverse Event|0|||
27887931|NCT02980341|81425237|FG003|Dose Finding|Adverse Event|0|||
27887932|NCT02980341|81425238|FG004|Dose Finding|Adverse Event|0|||
27887933|NCT02980341|81425239|FG005|Dose Finding|Adverse Event|3|||
27887934|NCT02980341|81425240|FG006|Dose Finding|Adverse Event|0|||
27887935|NCT02980341|81425241|FG007|Dose Finding|Adverse Event|0|||
27887936|NCT02980341|81425242|FG008|Dose Finding|Adverse Event|0|||
27887937|NCT02980341|81425243|FG009|Dose Finding|Adverse Event|0|||
27887938|NCT02980341|81425244|FG010|Dose Finding|Adverse Event|0|||
27887939|NCT02980341|81425234|FG000|Dose Finding|Withdrawal by Subject|0|||
27887940|NCT02980341|81425235|FG001|Dose Finding|Withdrawal by Subject|0|||
27887941|NCT02980341|81425236|FG002|Dose Finding|Withdrawal by Subject|0|||
27887942|NCT02980341|81425237|FG003|Dose Finding|Withdrawal by Subject|0|||
27887943|NCT02980341|81425238|FG004|Dose Finding|Withdrawal by Subject|0|||
27887944|NCT02980341|81425239|FG005|Dose Finding|Withdrawal by Subject|1|||
27887945|NCT02980341|81425240|FG006|Dose Finding|Withdrawal by Subject|1|||
27887946|NCT02980341|81425241|FG007|Dose Finding|Withdrawal by Subject|0|||
27887947|NCT02980341|81425242|FG008|Dose Finding|Withdrawal by Subject|0|||
27887948|NCT02980341|81425243|FG009|Dose Finding|Withdrawal by Subject|0|||
27887949|NCT02980341|81425244|FG010|Dose Finding|Withdrawal by Subject|0|||
27599415|NCT00441701|80371074|FG004|Overall Study|Lack of Efficacy|0|||
27705083|NCT01202279|80758544|FG000|Overall Study|study compliance|5|||
27705084|NCT01202279|80758545|FG001|Overall Study|study compliance|2|||
27705085|NCT00058552|80758548|FG000|Overall Study|Died prior to receiving treatment|4|||
27705086|NCT00058552|80758549|FG001|Overall Study|Died prior to receiving treatment|2|||
27705087|NCT00058552|80758548|FG000|Overall Study|Disease progression|52|||
27887950|NCT02980341|81425234|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27887951|NCT02980341|81425235|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27887952|NCT02980341|81425236|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27887953|NCT02980341|81425237|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27887954|NCT02980341|81425238|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27887955|NCT02980341|81425239|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27834807|NCT00112437|81226171|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27887956|NCT02980341|81425240|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
27887957|NCT02980341|81425241|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
27887958|NCT02980341|81425242|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
27887959|NCT02980341|81425243|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
27887960|NCT02980341|81425244|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
27887961|NCT02980341|81425234|FG000|Dose Expansion|Clinical progression|0|||
27887962|NCT02980341|81425235|FG001|Dose Expansion|Clinical progression|0|||
27887963|NCT02980341|81425236|FG002|Dose Expansion|Clinical progression|0|||
27887964|NCT02980341|81425237|FG003|Dose Expansion|Clinical progression|0|||
27887965|NCT02980341|81425238|FG004|Dose Expansion|Clinical progression|0|||
27887966|NCT02980341|81425239|FG005|Dose Expansion|Clinical progression|0|||
27887967|NCT02980341|81425240|FG006|Dose Expansion|Clinical progression|0|||
27887968|NCT02980341|81425241|FG007|Dose Expansion|Clinical progression|4|||
27887969|NCT02980341|81425242|FG008|Dose Expansion|Clinical progression|3|||
27887970|NCT02980341|81425243|FG009|Dose Expansion|Clinical progression|1|||
27887971|NCT02980341|81425244|FG010|Dose Expansion|Clinical progression|4|||
27887972|NCT02980341|81425234|FG000|Dose Expansion|Adverse Event|0|||
27887973|NCT02980341|81425235|FG001|Dose Expansion|Adverse Event|0|||
27887974|NCT02980341|81425236|FG002|Dose Expansion|Adverse Event|0|||
27887975|NCT02980341|81425237|FG003|Dose Expansion|Adverse Event|0|||
27887976|NCT02980341|81425238|FG004|Dose Expansion|Adverse Event|0|||
27887977|NCT02980341|81425239|FG005|Dose Expansion|Adverse Event|0|||
27887978|NCT02980341|81425240|FG006|Dose Expansion|Adverse Event|0|||
27887979|NCT02980341|81425241|FG007|Dose Expansion|Adverse Event|3|||
27887980|NCT02980341|81425242|FG008|Dose Expansion|Adverse Event|0|||
27887981|NCT02980341|81425243|FG009|Dose Expansion|Adverse Event|1|||
27887982|NCT02980341|81425244|FG010|Dose Expansion|Adverse Event|3|||
27887983|NCT02980341|81425234|FG000|Dose Expansion|Death|0|||
27887984|NCT02980341|81425235|FG001|Dose Expansion|Death|0|||
27887985|NCT02980341|81425236|FG002|Dose Expansion|Death|0|||
27887986|NCT02980341|81425237|FG003|Dose Expansion|Death|0|||
27887987|NCT02980341|81425238|FG004|Dose Expansion|Death|0|||
27887988|NCT02980341|81425239|FG005|Dose Expansion|Death|0|||
27887989|NCT02980341|81425240|FG006|Dose Expansion|Death|0|||
27887990|NCT02980341|81425241|FG007|Dose Expansion|Death|0|||
27705088|NCT00058552|80758549|FG001|Overall Study|Disease progression|44|||
27887991|NCT02980341|81425242|FG008|Dose Expansion|Death|2|||
27887992|NCT02980341|81425243|FG009|Dose Expansion|Death|1|||
27887993|NCT02980341|81425244|FG010|Dose Expansion|Death|0|||
27887994|NCT02980341|81425234|FG000|Dose Expansion|Withdrawal by Subject|0|||
27887995|NCT02980341|81425235|FG001|Dose Expansion|Withdrawal by Subject|0|||
27887996|NCT02980341|81425236|FG002|Dose Expansion|Withdrawal by Subject|0|||
27887997|NCT02980341|81425237|FG003|Dose Expansion|Withdrawal by Subject|0|||
27887998|NCT02980341|81425238|FG004|Dose Expansion|Withdrawal by Subject|0|||
27887999|NCT02980341|81425239|FG005|Dose Expansion|Withdrawal by Subject|0|||
27888000|NCT02980341|81425240|FG006|Dose Expansion|Withdrawal by Subject|0|||
27888001|NCT02980341|81425241|FG007|Dose Expansion|Withdrawal by Subject|2|||
27888002|NCT02980341|81425242|FG008|Dose Expansion|Withdrawal by Subject|0|||
27888003|NCT02980341|81425243|FG009|Dose Expansion|Withdrawal by Subject|1|||
27888004|NCT02980341|81425244|FG010|Dose Expansion|Withdrawal by Subject|0|||
27888005|NCT02980341|81425234|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888006|NCT02980341|81425235|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888007|NCT02980341|81425236|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888008|NCT02980341|81425237|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888009|NCT02980341|81425238|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888010|NCT02980341|81425239|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888011|NCT02980341|81425240|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888012|NCT02980341|81425241|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
27888013|NCT02980341|81425242|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888014|NCT02980341|81425243|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27599416|NCT00441701|80371075|FG005|Overall Study|Lack of Efficacy|1|||
27599417|NCT00441701|80371076|FG006|Overall Study|Lack of Efficacy|0|||
27599418|NCT00441701|80371077|FG007|Overall Study|Lack of Efficacy|0|||
27599419|NCT00441701|80371078|FG008|Overall Study|Lack of Efficacy|0|||
27888015|NCT02980341|81425244|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
27888016|NCT02980341|81425234|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888017|NCT02980341|81425235|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888018|NCT02980341|81425236|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888019|NCT02980341|81425237|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27599420|NCT00441701|80371079|FG009|Overall Study|Lack of Efficacy|0|||
27599421|NCT00441701|80371070|FG000|Overall Study|Withdrawal by Subject|0|||
27599422|NCT00441701|80371071|FG001|Overall Study|Withdrawal by Subject|2|||
27599423|NCT00441701|80371072|FG002|Overall Study|Withdrawal by Subject|1|||
27599424|NCT00441701|80371073|FG003|Overall Study|Withdrawal by Subject|1|||
27599425|NCT00441701|80371074|FG004|Overall Study|Withdrawal by Subject|0|||
27599426|NCT00441701|80371075|FG005|Overall Study|Withdrawal by Subject|0|||
27599427|NCT00441701|80371076|FG006|Overall Study|Withdrawal by Subject|0|||
27599428|NCT00441701|80371077|FG007|Overall Study|Withdrawal by Subject|0|||
27599429|NCT00441701|80371078|FG008|Overall Study|Withdrawal by Subject|0|||
27599430|NCT00441701|80371079|FG009|Overall Study|Withdrawal by Subject|0|||
27599431|NCT00696384|80371082|FG000|Open Label Phase|Adverse Event|27|||
27599432|NCT00696384|80371083|FG001|Open Label Phase|Adverse Event|0|||
27599433|NCT00696384|80371084|FG002|Open Label Phase|Adverse Event|0|||
27599434|NCT00696384|80371082|FG000|Open Label Phase|Protocol Violation|18|||
27599435|NCT00696384|80371083|FG001|Open Label Phase|Protocol Violation|0|||
27599436|NCT00696384|80371084|FG002|Open Label Phase|Protocol Violation|0|||
27599437|NCT00696384|80371082|FG000|Open Label Phase|Lost to Follow-up|24|||
27599438|NCT00696384|80371083|FG001|Open Label Phase|Lost to Follow-up|0|||
27599439|NCT00696384|80371084|FG002|Open Label Phase|Lost to Follow-up|0|||
27599440|NCT00696384|80371082|FG000|Open Label Phase|Withdrawal by Subject|37|||
27599441|NCT00696384|80371083|FG001|Open Label Phase|Withdrawal by Subject|0|||
27599442|NCT00696384|80371084|FG002|Open Label Phase|Withdrawal by Subject|0|||
27599443|NCT00696384|80371082|FG000|Open Label Phase|Other|6|||
27705089|NCT00058552|80758548|FG000|Overall Study|Adverse Event|4|||
27599444|NCT00696384|80371083|FG001|Open Label Phase|Other|0|||
27599445|NCT00696384|80371084|FG002|Open Label Phase|Other|0|||
27599446|NCT00696384|80371082|FG000|Open Label Phase|Lack of Efficacy|3|||
27599447|NCT00696384|80371083|FG001|Open Label Phase|Lack of Efficacy|0|||
27599448|NCT00696384|80371084|FG002|Open Label Phase|Lack of Efficacy|0|||
27599449|NCT00696384|80371082|FG000|Open Label Phase|Physician Decision|4|||
27705090|NCT00058552|80758549|FG001|Overall Study|Adverse Event|2|||
27705091|NCT00058552|80758548|FG000|Overall Study|Withdrawal by Subject|3|||
27599450|NCT00696384|80371083|FG001|Open Label Phase|Physician Decision|0|||
27599451|NCT00696384|80371084|FG002|Open Label Phase|Physician Decision|0|||
27599452|NCT00696384|80371082|FG000|Double Blind Phase|Adverse Event|0|||
27599453|NCT00696384|80371083|FG001|Double Blind Phase|Adverse Event|2|||
27599454|NCT00696384|80371084|FG002|Double Blind Phase|Adverse Event|2|||
27599455|NCT00696384|80371082|FG000|Double Blind Phase|Lost to Follow-up|0|||
27599456|NCT00696384|80371083|FG001|Double Blind Phase|Lost to Follow-up|2|||
27599457|NCT00696384|80371084|FG002|Double Blind Phase|Lost to Follow-up|1|||
27599458|NCT00696384|80371082|FG000|Double Blind Phase|Withdrawal by Subject|0|||
27599459|NCT00696384|80371083|FG001|Double Blind Phase|Withdrawal by Subject|4|||
27599460|NCT00696384|80371084|FG002|Double Blind Phase|Withdrawal by Subject|3|||
27599461|NCT00696384|80371082|FG000|Double Blind Phase|Lack of Efficacy|0|||
27599462|NCT00696384|80371083|FG001|Double Blind Phase|Lack of Efficacy|1|||
27599463|NCT00696384|80371084|FG002|Double Blind Phase|Lack of Efficacy|0|||
27599464|NCT00696384|80371082|FG000|Double Blind Phase|Physician Decision|0|||
27599465|NCT00696384|80371083|FG001|Double Blind Phase|Physician Decision|2|||
27599466|NCT00696384|80371084|FG002|Double Blind Phase|Physician Decision|0|||
27599467|NCT00003508|80371085|FG000|Overall Study|Not evaluable|5|||
27599468|NCT01181726|80374305|FG000|First Intervention|Adverse Event|1|||
27599469|NCT01181726|80374306|FG001|First Intervention|Adverse Event|0|||
27599470|NCT01833143|80374311|FG000|Overall Study|Not Treated|1|||
27599471|NCT05099926|80374312|FG000|Overall Study|Lost to Follow-up|1|||
27599472|NCT00428090|80374313|FG000|Overall Study|Adverse Event|10|||
27599473|NCT00428090|80374314|FG001|Overall Study|Adverse Event|8|||
27599474|NCT00428090|80374315|FG002|Overall Study|Adverse Event|10|||
27599475|NCT00428090|80374316|FG003|Overall Study|Adverse Event|11|||
27599476|NCT00428090|80374313|FG000|Overall Study|Lost to Follow-up|3|||
27599477|NCT00428090|80374314|FG001|Overall Study|Lost to Follow-up|6|||
27599478|NCT00428090|80374315|FG002|Overall Study|Lost to Follow-up|1|||
27599479|NCT00428090|80374316|FG003|Overall Study|Lost to Follow-up|4|||
27599480|NCT00428090|80374313|FG000|Overall Study|Protocol Violation|3|||
27599481|NCT00428090|80374314|FG001|Overall Study|Protocol Violation|1|||
27599482|NCT00428090|80374315|FG002|Overall Study|Protocol Violation|3|||
27599483|NCT00428090|80374316|FG003|Overall Study|Protocol Violation|3|||
27599484|NCT00428090|80374313|FG000|Overall Study|Withdrawal by Subject|10|||
27599485|NCT00428090|80374314|FG001|Overall Study|Withdrawal by Subject|12|||
27599486|NCT00428090|80374315|FG002|Overall Study|Withdrawal by Subject|15|||
27599487|NCT00428090|80374316|FG003|Overall Study|Withdrawal by Subject|5|||
27599488|NCT00428090|80374313|FG000|Overall Study|Sponsor terminated study|0|||
27599489|NCT00428090|80374314|FG001|Overall Study|Sponsor terminated study|1|||
27599490|NCT00428090|80374315|FG002|Overall Study|Sponsor terminated study|0|||
27599491|NCT00428090|80374316|FG003|Overall Study|Sponsor terminated study|0|||
27599492|NCT00428090|80374313|FG000|Overall Study|Non-compliance|4|||
27599493|NCT00428090|80374314|FG001|Overall Study|Non-compliance|0|||
27599494|NCT00428090|80374315|FG002|Overall Study|Non-compliance|1|||
27599495|NCT00428090|80374316|FG003|Overall Study|Non-compliance|3|||
27599496|NCT00428090|80374313|FG000|Overall Study|Par. did not returned to visit|1|||
27599497|NCT00428090|80374314|FG001|Overall Study|Par. did not returned to visit|0|||
27599498|NCT00428090|80374315|FG002|Overall Study|Par. did not returned to visit|0|||
27599499|NCT00428090|80374316|FG003|Overall Study|Par. did not returned to visit|1|||
27599500|NCT00428090|80374313|FG000|Overall Study|Follow-Up visit not possible|1|||
27599501|NCT00428090|80374314|FG001|Overall Study|Follow-Up visit not possible|0|||
27599502|NCT00428090|80374315|FG002|Overall Study|Follow-Up visit not possible|0|||
27599503|NCT00428090|80374316|FG003|Overall Study|Follow-Up visit not possible|0|||
27599504|NCT00428090|80374313|FG000|Overall Study|Prohibited medication used for SAE|1|||
27599505|NCT00428090|80374314|FG001|Overall Study|Prohibited medication used for SAE|0|||
27705092|NCT00058552|80758549|FG001|Overall Study|Withdrawal by Subject|5|||
27705093|NCT00058552|80758548|FG000|Overall Study|Physician Decision|2|||
27705094|NCT00058552|80758549|FG001|Overall Study|Physician Decision|5|||
27705095|NCT00058552|80758548|FG000|Overall Study|Clinical disease progression|0|||
27705096|NCT00058552|80758549|FG001|Overall Study|Clinical disease progression|4|||
27599506|NCT00428090|80374315|FG002|Overall Study|Prohibited medication used for SAE|0|||
27599507|NCT00428090|80374316|FG003|Overall Study|Prohibited medication used for SAE|0|||
27599508|NCT00428090|80374313|FG000|Overall Study|Death of par.|1|||
27599509|NCT00428090|80374314|FG001|Overall Study|Death of par.|0|||
27599510|NCT00428090|80374315|FG002|Overall Study|Death of par.|1|||
27705097|NCT00574145|80758550|FG000|Overall Study|Withdrawal by Subject|2|||
27705098|NCT00574145|80758551|FG001|Overall Study|Withdrawal by Subject|1|||
27705099|NCT02217436|80758552|FG000|Overall Study|Protocol Violation|1|||
27705100|NCT02217436|80758553|FG001|Overall Study|Protocol Violation|1|||
27599511|NCT00428090|80374316|FG003|Overall Study|Death of par.|0|||
27599512|NCT00428090|80374313|FG000|Overall Study|Visit 7 exceed the visit window|0|||
27599513|NCT00428090|80374314|FG001|Overall Study|Visit 7 exceed the visit window|1|||
27599514|NCT00428090|80374315|FG002|Overall Study|Visit 7 exceed the visit window|0|||
27599515|NCT00428090|80374316|FG003|Overall Study|Visit 7 exceed the visit window|0|||
27599516|NCT00428090|80374313|FG000|Overall Study|Medical monitor terminated par.|0|||
27599517|NCT00428090|80374314|FG001|Overall Study|Medical monitor terminated par.|1|||
27599518|NCT00428090|80374315|FG002|Overall Study|Medical monitor terminated par.|0|||
27599519|NCT00428090|80374316|FG003|Overall Study|Medical monitor terminated par.|0|||
27599520|NCT00428090|80374313|FG000|Overall Study|Mental status of par. was|0|||
27599521|NCT00428090|80374314|FG001|Overall Study|Mental status of par. was|1|||
27599522|NCT00428090|80374315|FG002|Overall Study|Mental status of par. was|0|||
27599523|NCT00428090|80374316|FG003|Overall Study|Mental status of par. was|0|||
27599524|NCT00428090|80374313|FG000|Overall Study|Worsening of AD|0|||
27599525|NCT00428090|80374314|FG001|Overall Study|Worsening of AD|0|||
27599526|NCT00428090|80374315|FG002|Overall Study|Worsening of AD|1|||
27599527|NCT00428090|80374316|FG003|Overall Study|Worsening of AD|0|||
27599528|NCT00428090|80374313|FG000|Overall Study|Excluded for concerning QTc value|0|||
27599529|NCT00428090|80374314|FG001|Overall Study|Excluded for concerning QTc value|0|||
27599530|NCT00428090|80374315|FG002|Overall Study|Excluded for concerning QTc value|1|||
27599531|NCT00428090|80374316|FG003|Overall Study|Excluded for concerning QTc value|0|||
27599532|NCT00428090|80374313|FG000|Overall Study|Insufficient AD documentation|0|||
27599533|NCT00428090|80374314|FG001|Overall Study|Insufficient AD documentation|0|||
27599534|NCT00428090|80374315|FG002|Overall Study|Insufficient AD documentation|1|||
27599535|NCT00428090|80374316|FG003|Overall Study|Insufficient AD documentation|0|||
27599536|NCT00428090|80374313|FG000|Overall Study|High MMSE scores|0|||
27599537|NCT00428090|80374314|FG001|Overall Study|High MMSE scores|0|||
27599538|NCT00428090|80374315|FG002|Overall Study|High MMSE scores|1|||
27599539|NCT00428090|80374316|FG003|Overall Study|High MMSE scores|0|||
27599540|NCT00428090|80374313|FG000|Overall Study|Deterioration of cognitive status|0|||
27599541|NCT00428090|80374314|FG001|Overall Study|Deterioration of cognitive status|0|||
27599542|NCT00428090|80374315|FG002|Overall Study|Deterioration of cognitive status|1|||
27599543|NCT00428090|80374316|FG003|Overall Study|Deterioration of cognitive status|0|||
27599544|NCT00428090|80374313|FG000|Overall Study|Serious adverse event|0|||
27599545|NCT00428090|80374314|FG001|Overall Study|Serious adverse event|0|||
27599546|NCT00428090|80374315|FG002|Overall Study|Serious adverse event|1|||
27599547|NCT00428090|80374316|FG003|Overall Study|Serious adverse event|0|||
27599548|NCT00428090|80374313|FG000|Overall Study|Excluded for heart insufficiency|0|||
27599549|NCT00428090|80374314|FG001|Overall Study|Excluded for heart insufficiency|0|||
27599550|NCT00428090|80374315|FG002|Overall Study|Excluded for heart insufficiency|1|||
27599551|NCT00428090|80374316|FG003|Overall Study|Excluded for heart insufficiency|0|||
27599552|NCT00428090|80374313|FG000|Overall Study|Raised Creatinine Value|0|||
27705101|NCT02217436|80758552|FG000|Overall Study|Incomplete data|0|||
27705102|NCT02217436|80758553|FG001|Overall Study|Incomplete data|1|||
27705103|NCT02101021|80758555|FG000|Overall Study|Death|4|||
27705104|NCT02101021|80758556|FG001|Overall Study|Death|3|||
27705105|NCT02101021|80758557|FG002|Overall Study|Death|6|||
27705106|NCT02101021|80758558|FG003|Overall Study|Death|0|||
27705107|NCT02101021|80758559|FG004|Overall Study|Death|3|||
27705108|NCT02101021|80758555|FG000|Overall Study|Withdrew Consent from study|1|||
27705109|NCT02101021|80758556|FG001|Overall Study|Withdrew Consent from study|1|||
27705110|NCT02101021|80758557|FG002|Overall Study|Withdrew Consent from study|0|||
27705111|NCT02101021|80758558|FG003|Overall Study|Withdrew Consent from study|2|||
27705112|NCT02101021|80758559|FG004|Overall Study|Withdrew Consent from study|0|||
27705113|NCT02101021|80758555|FG000|Overall Study|Lost to Follow-up|1|||
27705114|NCT02101021|80758556|FG001|Overall Study|Lost to Follow-up|0|||
27705115|NCT02101021|80758557|FG002|Overall Study|Lost to Follow-up|0|||
27705116|NCT02101021|80758558|FG003|Overall Study|Lost to Follow-up|0|||
27705117|NCT02101021|80758559|FG004|Overall Study|Lost to Follow-up|0|||
27705118|NCT02101021|80758555|FG000|Overall Study|Study Terminated by Sponsor|1|||
27705119|NCT02101021|80758556|FG001|Overall Study|Study Terminated by Sponsor|0|||
27705120|NCT02101021|80758557|FG002|Overall Study|Study Terminated by Sponsor|1|||
27705121|NCT02101021|80758558|FG003|Overall Study|Study Terminated by Sponsor|1|||
27705122|NCT02101021|80758559|FG004|Overall Study|Study Terminated by Sponsor|1|||
27705123|NCT01721876|80758563|FG000|Overall Study|Not treated|1|||
27705124|NCT01721876|80758564|FG001|Overall Study|Not treated|4|||
27705125|NCT01721876|80758563|FG000|Overall Study|Disease progression / relapse|123|||
27705126|NCT01721876|80758564|FG001|Overall Study|Disease progression / relapse|156|||
27705127|NCT01721876|80758563|FG000|Overall Study|Death|6|||
27705128|NCT01721876|80758564|FG001|Overall Study|Death|13|||
27705129|NCT01721876|80758563|FG000|Overall Study|Adverse Event|41|||
27705130|NCT01721876|80758564|FG001|Overall Study|Adverse Event|165|||
27705131|NCT01721876|80758563|FG000|Overall Study|Protocol Violation|2|||
27705132|NCT01721876|80758564|FG001|Overall Study|Protocol Violation|1|||
27705133|NCT01721876|80758563|FG000|Overall Study|Withdrawal by Subject|15|||
27705134|NCT01721876|80758564|FG001|Overall Study|Withdrawal by Subject|38|||
27705135|NCT01721876|80758563|FG000|Overall Study|Reason not listed|34|||
27705136|NCT01721876|80758564|FG001|Overall Study|Reason not listed|63|||
27705137|NCT01721876|80758563|FG000|Overall Study|Sponsor terminated trial|0|||
27705138|NCT01721876|80758564|FG001|Overall Study|Sponsor terminated trial|4|||
27705139|NCT02448225|80758565|FG000|Overall Study|Withdrawal by Subject|1|||
27705140|NCT02448225|80758565|FG000|Overall Study|Did not get FSPG scan|18|||
27705141|NCT02448225|80758565|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
27705142|NCT01195090|80758566|FG000|Overall Study|Adverse Event|1|||
27705143|NCT01195090|80758567|FG001|Overall Study|Adverse Event|2|||
27705144|NCT01195090|80758566|FG000|Overall Study|Lost to Follow-up|2|||
27705145|NCT01195090|80758567|FG001|Overall Study|Lost to Follow-up|2|||
27705146|NCT01195090|80758566|FG000|Overall Study|Protocol Violation|3|||
27705147|NCT01195090|80758567|FG001|Overall Study|Protocol Violation|4|||
27705148|NCT05082376|80758568|FG000|Overall Study|Lost to Follow-up|2|||
27705149|NCT03155373|80758569|FG000|Overall Study|No longer required surgery|1|||
27705150|NCT03155373|80758569|FG000|Overall Study|Protocol Violation|1|||
27705151|NCT03155373|80758569|FG000|Overall Study|Death|2|||
27705152|NCT03155373|80758569|FG000|Overall Study|Withdrawal by Subject|3|||
27705153|NCT04163900|80758570|FG000|Overall Study|Radiological disease progression|112|||
27834808|NCT00112437|81226172|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834809|NCT00112437|81226173|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834810|NCT00112437|81226174|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834811|NCT00112437|81226175|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834812|NCT00112437|81226176|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834813|NCT00112437|81226177|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834814|NCT00112437|81226178|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834815|NCT00112437|81226179|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834816|NCT00112437|81226180|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834817|NCT00112437|81226181|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834818|NCT00112437|81226182|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27705154|NCT04163900|80758571|FG001|Overall Study|Radiological disease progression|127|||
27705155|NCT04163900|80758570|FG000|Overall Study|Study closure|98|||
27705156|NCT04163900|80758571|FG001|Overall Study|Study closure|133|||
27705157|NCT04163900|80758570|FG000|Overall Study|Adverse Event|78|||
27705158|NCT04163900|80758571|FG001|Overall Study|Adverse Event|32|||
27705159|NCT04163900|80758570|FG000|Overall Study|Withdrawal by Subject|37|||
27705160|NCT04163900|80758571|FG001|Overall Study|Withdrawal by Subject|34|||
27705161|NCT04163900|80758570|FG000|Overall Study|Death|29|||
27705162|NCT04163900|80758571|FG001|Overall Study|Death|16|||
27705163|NCT04163900|80758570|FG000|Overall Study|Physician Decision|17|||
27705164|NCT04163900|80758571|FG001|Overall Study|Physician Decision|25|||
27705165|NCT04163900|80758570|FG000|Overall Study|Clinical disease progression|14|||
27705166|NCT04163900|80758571|FG001|Overall Study|Clinical disease progression|13|||
27705167|NCT04163900|80758570|FG000|Overall Study|Protocol Violation|3|||
27705168|NCT04163900|80758571|FG001|Overall Study|Protocol Violation|4|||
27705169|NCT04163900|80758570|FG000|Overall Study|Lost to Follow-up|0|||
27705170|NCT04163900|80758571|FG001|Overall Study|Lost to Follow-up|1|||
27705171|NCT04353596|80758572|FG000|Overall Study|Protocol Violation|4|||
27705172|NCT04353596|80758573|FG001|Overall Study|Protocol Violation|4|||
27705173|NCT04353596|80758572|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
27705174|NCT04353596|80758573|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
27705175|NCT01667081|80758574|FG000|Overall Study|Death|43|||
27705176|NCT01667081|80758575|FG001|Overall Study|Death|3|||
27705177|NCT01667081|80758574|FG000|Overall Study|Lost to Follow-up|99|||
27705178|NCT01667081|80758575|FG001|Overall Study|Lost to Follow-up|48|||
27705179|NCT01667081|80758574|FG000|Overall Study|Physician Decision|16|||
27705180|NCT01667081|80758575|FG001|Overall Study|Physician Decision|2|||
27705181|NCT01667081|80758574|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
27705182|NCT01667081|80758575|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
27705183|NCT01667081|80758574|FG000|Overall Study|Withdrawal by Subject|90|||
27705184|NCT01667081|80758575|FG001|Overall Study|Withdrawal by Subject|35|||
27705185|NCT01069120|80758577|FG000|Overall Study|Study prematurely terminated|27|||
27705186|NCT02319668|80758581|FG000|Overall Study|Other (Not specified)|0|||
27705187|NCT02319668|80758582|FG001|Overall Study|Other (Not specified)|2|||
27705188|NCT03083847|80758583|FG000|Main|Physician Decision|0|||
27705189|NCT03083847|80758584|FG001|Main|Physician Decision|0|||
27705190|NCT03083847|80758585|FG002|Main|Physician Decision|0|||
27705191|NCT03083847|80758586|FG003|Main|Physician Decision|0|||
27705192|NCT03083847|80758587|FG004|Main|Physician Decision|0|||
27705193|NCT03083847|80758588|FG005|Main|Physician Decision|1|||
27705194|NCT03083847|80758589|FG006|Main|Physician Decision|0|||
27705195|NCT03083847|80758590|FG007|Main|Physician Decision|0|||
27705196|NCT03083847|80758591|FG008|Main|Physician Decision|0|||
27705197|NCT03083847|80758592|FG009|Main|Physician Decision|0|||
27705198|NCT03083847|80758583|FG000|Main|Pregnancy|0|||
27705199|NCT03083847|80758584|FG001|Main|Pregnancy|0|||
27705200|NCT03083847|80758585|FG002|Main|Pregnancy|0|||
27705201|NCT03083847|80758586|FG003|Main|Pregnancy|0|||
27705202|NCT03083847|80758587|FG004|Main|Pregnancy|0|||
27705203|NCT03083847|80758588|FG005|Main|Pregnancy|0|||
27705204|NCT03083847|80758589|FG006|Main|Pregnancy|0|||
27705205|NCT03083847|80758590|FG007|Main|Pregnancy|1|||
27705206|NCT03083847|80758591|FG008|Main|Pregnancy|0|||
27705207|NCT03083847|80758592|FG009|Main|Pregnancy|0|||
27705208|NCT03083847|80758583|FG000|Main|Adverse Event|0|||
27705209|NCT03083847|80758584|FG001|Main|Adverse Event|0|||
27705210|NCT03083847|80758585|FG002|Main|Adverse Event|0|||
27705211|NCT03083847|80758586|FG003|Main|Adverse Event|0|||
27705212|NCT03083847|80758587|FG004|Main|Adverse Event|0|||
27705213|NCT03083847|80758588|FG005|Main|Adverse Event|0|||
27705214|NCT03083847|80758589|FG006|Main|Adverse Event|0|||
27705215|NCT03083847|80758590|FG007|Main|Adverse Event|2|||
27705216|NCT03083847|80758591|FG008|Main|Adverse Event|0|||
27705217|NCT03083847|80758592|FG009|Main|Adverse Event|0|||
27705218|NCT03083847|80758583|FG000|Main|Withdrawal by Subject|0|||
27705219|NCT03083847|80758584|FG001|Main|Withdrawal by Subject|0|||
27705220|NCT03083847|80758585|FG002|Main|Withdrawal by Subject|0|||
27705221|NCT03083847|80758586|FG003|Main|Withdrawal by Subject|0|||
27705222|NCT03083847|80758587|FG004|Main|Withdrawal by Subject|0|||
27705223|NCT03083847|80758588|FG005|Main|Withdrawal by Subject|0|||
27705224|NCT03083847|80758589|FG006|Main|Withdrawal by Subject|1|||
27705225|NCT03083847|80758590|FG007|Main|Withdrawal by Subject|1|||
27705226|NCT03083847|80758591|FG008|Main|Withdrawal by Subject|0|||
27705227|NCT03083847|80758592|FG009|Main|Withdrawal by Subject|0|||
27705228|NCT01007032|80758593|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
27958530|NCT01791517|81680062|FG004|Phase I: Period 2|Lost to Follow-up|0|||
27705229|NCT01007032|80758594|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
27705230|NCT01007032|80758595|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
27705231|NCT01007032|80758596|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
27705232|NCT01007032|80758593|FG000|Overall Study|Withdrawal by Subject|0|||
27705233|NCT01007032|80758594|FG001|Overall Study|Withdrawal by Subject|0|||
27705234|NCT01007032|80758595|FG002|Overall Study|Withdrawal by Subject|0|||
27705235|NCT01007032|80758596|FG003|Overall Study|Withdrawal by Subject|1|||
27705236|NCT01401842|80758599|FG000|Overall Study|Withdrawal by Subject|3|||
27705237|NCT01401842|80758600|FG001|Overall Study|Withdrawal by Subject|2|||
27705238|NCT01401842|80758599|FG000|Overall Study|academic reason|4|||
27705239|NCT01401842|80758600|FG001|Overall Study|academic reason|1|||
27705240|NCT01401842|80758599|FG000|Overall Study|changed companies|20|||
27705241|NCT01401842|80758600|FG001|Overall Study|changed companies|34|||
27599553|NCT00428090|80374314|FG001|Overall Study|Raised Creatinine Value|0|||
27599554|NCT00428090|80374315|FG002|Overall Study|Raised Creatinine Value|0|||
27599555|NCT00428090|80374316|FG003|Overall Study|Raised Creatinine Value|1|||
27599556|NCT00453986|80374317|FG000|Overall Study|Lost to Follow-up|6|||
27599557|NCT00453986|80374318|FG001|Overall Study|Lost to Follow-up|5|||
27599558|NCT00453986|80374319|FG002|Overall Study|Lost to Follow-up|6|||
27599559|NCT00453986|80374320|FG003|Overall Study|Lost to Follow-up|2|||
27599560|NCT00453986|80374321|FG004|Overall Study|Lost to Follow-up|0|||
27599561|NCT01951638|80374329|FG000|Treatment Period|Protocol Violation|0|||
27599562|NCT01951638|80374330|FG001|Treatment Period|Protocol Violation|0|||
27599563|NCT01951638|80374331|FG002|Treatment Period|Protocol Violation|0|||
27599564|NCT01951638|80374332|FG003|Treatment Period|Protocol Violation|2|||
27599565|NCT01951638|80374333|FG004|Treatment Period|Protocol Violation|0|||
27599566|NCT01951638|80374329|FG000|Treatment Period|Protocol-driven decision point|1|||
27599567|NCT01951638|80374330|FG001|Treatment Period|Protocol-driven decision point|3|||
27599568|NCT01951638|80374331|FG002|Treatment Period|Protocol-driven decision point|0|||
27599569|NCT01951638|80374332|FG003|Treatment Period|Protocol-driven decision point|0|||
27599570|NCT01951638|80374333|FG004|Treatment Period|Protocol-driven decision point|0|||
27599571|NCT01951638|80374329|FG000|Treatment Period|Logistical difficulties|0|||
27599572|NCT01951638|80374330|FG001|Treatment Period|Logistical difficulties|1|||
27599573|NCT01951638|80374331|FG002|Treatment Period|Logistical difficulties|1|||
27599574|NCT01951638|80374332|FG003|Treatment Period|Logistical difficulties|0|||
27599575|NCT01951638|80374333|FG004|Treatment Period|Logistical difficulties|0|||
27599576|NCT01951638|80374329|FG000|Treatment Period|Withdrawal by Subject|9|||
27599577|NCT01951638|80374330|FG001|Treatment Period|Withdrawal by Subject|6|||
27599578|NCT01951638|80374331|FG002|Treatment Period|Withdrawal by Subject|4|||
27599579|NCT01951638|80374332|FG003|Treatment Period|Withdrawal by Subject|5|||
27599580|NCT01951638|80374333|FG004|Treatment Period|Withdrawal by Subject|4|||
27599581|NCT01951638|80374329|FG000|Treatment Period|Death|0|||
27599582|NCT01951638|80374330|FG001|Treatment Period|Death|0|||
27599583|NCT01951638|80374331|FG002|Treatment Period|Death|0|||
27599584|NCT01951638|80374332|FG003|Treatment Period|Death|3|||
27599585|NCT01951638|80374333|FG004|Treatment Period|Death|1|||
27599586|NCT01951638|80374329|FG000|Treatment Period|Adverse Event|3|||
27599587|NCT01951638|80374330|FG001|Treatment Period|Adverse Event|4|||
27599588|NCT01951638|80374331|FG002|Treatment Period|Adverse Event|8|||
27599589|NCT01951638|80374332|FG003|Treatment Period|Adverse Event|6|||
27599590|NCT01951638|80374333|FG004|Treatment Period|Adverse Event|5|||
27599591|NCT01951638|80374329|FG000|Follow-up Period|Protocol Violation|0|||
27599592|NCT01951638|80374330|FG001|Follow-up Period|Protocol Violation|0|||
27599593|NCT01951638|80374331|FG002|Follow-up Period|Protocol Violation|0|||
27599594|NCT01951638|80374332|FG003|Follow-up Period|Protocol Violation|1|||
27705242|NCT01401842|80758599|FG000|Overall Study|discharged from US Army|3|||
27705243|NCT01401842|80758600|FG001|Overall Study|discharged from US Army|4|||
27705244|NCT01401842|80758599|FG000|Overall Study|invalid follow-up strength data|1|||
27705245|NCT01401842|80758600|FG001|Overall Study|invalid follow-up strength data|4|||
27705246|NCT01401842|80758599|FG000|Overall Study|on profile|9|||
27834819|NCT00112437|81226183|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
27834820|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
27834821|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
27834822|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
27834823|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
27834824|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
27834825|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
27705247|NCT01401842|80758600|FG001|Overall Study|on profile|5|||
27705248|NCT01401842|80758599|FG000|Overall Study|other/unknown|28|||
27705249|NCT01401842|80758600|FG001|Overall Study|other/unknown|17|||
27834826|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
27834827|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
27834828|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
27834829|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
27834830|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
27834831|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
27834832|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
27705250|NCT00766090|80758601|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705251|NCT00766090|80758602|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705252|NCT00766090|80758603|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705253|NCT00766090|80758604|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705254|NCT00766090|80758605|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705255|NCT00766090|80758606|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705256|NCT00766090|80758607|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705257|NCT00766090|80758608|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705258|NCT00766090|80758609|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
27705259|NCT00766090|80758610|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705260|NCT00766090|80758611|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705261|NCT00766090|80758612|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27705262|NCT00766090|80758601|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
27705263|NCT00766090|80758602|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705264|NCT00766090|80758603|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705265|NCT00766090|80758604|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705266|NCT00766090|80758605|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705267|NCT00766090|80758606|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705268|NCT00766090|80758607|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705269|NCT00766090|80758608|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705270|NCT00766090|80758609|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705271|NCT00766090|80758610|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705272|NCT00766090|80758611|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705273|NCT00766090|80758612|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
27705274|NCT00766090|80758601|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27705275|NCT00766090|80758602|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705276|NCT00766090|80758603|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705277|NCT00766090|80758604|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27705278|NCT00766090|80758605|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705279|NCT00766090|80758606|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705280|NCT00766090|80758607|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705281|NCT00766090|80758608|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705282|NCT00766090|80758609|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705283|NCT00766090|80758610|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705284|NCT00766090|80758611|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705285|NCT00766090|80758612|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27705286|NCT00766090|80758601|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705287|NCT00766090|80758602|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705288|NCT00766090|80758603|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
27705289|NCT00766090|80758604|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705290|NCT00766090|80758605|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705291|NCT00766090|80758606|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705292|NCT00766090|80758607|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705293|NCT00766090|80758608|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705294|NCT00766090|80758609|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
27599595|NCT01951638|80374333|FG004|Follow-up Period|Protocol Violation|0|||
27599596|NCT01951638|80374329|FG000|Follow-up Period|Logistical difficulties|0|||
27599597|NCT01951638|80374330|FG001|Follow-up Period|Logistical difficulties|2|||
27599598|NCT01951638|80374331|FG002|Follow-up Period|Logistical difficulties|0|||
27599599|NCT01951638|80374332|FG003|Follow-up Period|Logistical difficulties|0|||
27599600|NCT01951638|80374333|FG004|Follow-up Period|Logistical difficulties|1|||
27705295|NCT00766090|80758610|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705296|NCT00766090|80758611|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
27599601|NCT01951638|80374329|FG000|Follow-up Period|Withdrawal by Subject|1|||
27599602|NCT01951638|80374330|FG001|Follow-up Period|Withdrawal by Subject|5|||
27599603|NCT01951638|80374331|FG002|Follow-up Period|Withdrawal by Subject|2|||
27599604|NCT01951638|80374332|FG003|Follow-up Period|Withdrawal by Subject|1|||
27599605|NCT01951638|80374333|FG004|Follow-up Period|Withdrawal by Subject|2|||
27599606|NCT01951638|80374329|FG000|Follow-up Period|Lost to Follow-up|0|||
27599607|NCT01951638|80374330|FG001|Follow-up Period|Lost to Follow-up|1|||
27599608|NCT01951638|80374331|FG002|Follow-up Period|Lost to Follow-up|0|||
27599609|NCT01951638|80374332|FG003|Follow-up Period|Lost to Follow-up|1|||
27599610|NCT01951638|80374333|FG004|Follow-up Period|Lost to Follow-up|0|||
27599611|NCT01951638|80374329|FG000|Follow-up Period|Death|1|||
27599612|NCT01951638|80374330|FG001|Follow-up Period|Death|0|||
27599613|NCT01951638|80374331|FG002|Follow-up Period|Death|1|||
27599614|NCT01951638|80374332|FG003|Follow-up Period|Death|4|||
27599615|NCT01951638|80374333|FG004|Follow-up Period|Death|1|||
27599616|NCT01951638|80374329|FG000|Follow-up Period|Adverse Event|0|||
27599617|NCT01951638|80374330|FG001|Follow-up Period|Adverse Event|1|||
27599618|NCT01951638|80374331|FG002|Follow-up Period|Adverse Event|2|||
27599619|NCT01951638|80374332|FG003|Follow-up Period|Adverse Event|1|||
27599620|NCT01951638|80374333|FG004|Follow-up Period|Adverse Event|1|||
27599621|NCT03266770|80374334|FG000|Overall Study|Physician Decision|3|||
27599622|NCT03266770|80374334|FG000|Overall Study|Insufficient study supplies|1|||
27599623|NCT03266770|80374334|FG000|Overall Study|Adverse Event|1|||
27599624|NCT04040751|80374337|FG000|Overall Study|Withdrawal by Subject|2|||
27705297|NCT00766090|80758612|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
27705298|NCT00766090|80758601|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27599625|NCT04040751|80374338|FG001|Overall Study|Withdrawal by Subject|0|||
27599626|NCT04040751|80374339|FG002|Overall Study|Withdrawal by Subject|2|||
27599627|NCT04040751|80374340|FG003|Overall Study|Withdrawal by Subject|0|||
27599628|NCT01059630|80374343|FG000|Overall Study|Death|100|||
27599629|NCT01059630|80374344|FG001|Overall Study|Death|84|||
27599630|NCT01059630|80374343|FG000|Overall Study|Lost to Follow-up|4|||
27599631|NCT01059630|80374344|FG001|Overall Study|Lost to Follow-up|1|||
27599632|NCT01059630|80374343|FG000|Overall Study|Physician Decision|2|||
27599633|NCT01059630|80374344|FG001|Overall Study|Physician Decision|4|||
27599634|NCT01059630|80374343|FG000|Overall Study|Withdrawal by Subject|21|||
27599635|NCT01059630|80374344|FG001|Overall Study|Withdrawal by Subject|14|||
27599636|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
27599637|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
27599638|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
27599639|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
27599640|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
27599641|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
27599642|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
27599643|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
27599644|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
27599645|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
27599646|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
27599647|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
27599648|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27599649|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27599650|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
27599651|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
27599652|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
27599653|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27599654|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27599655|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
27599656|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Death|2|||
27599657|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Death|2|||
27705299|NCT00766090|80758602|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705300|NCT00766090|80758603|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27599658|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Death|0|||
27599659|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Death|0|||
27599660|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Death|0|||
27705301|NCT00766090|80758604|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705302|NCT00766090|80758605|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
27599661|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
27599662|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
27599663|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
27599664|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
27888020|NCT02980341|81425238|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888021|NCT02980341|81425239|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27599665|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
27599666|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27599667|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
27599668|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27599669|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27599670|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
27599671|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
27599672|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
27599673|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
27599674|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
27599675|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
27599676|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
27599677|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27599678|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27599679|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27599680|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
27599681|NCT03420781|80374345|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
27599682|NCT03420781|80374346|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27599683|NCT03420781|80374347|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27599684|NCT03420781|80374348|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27599685|NCT03420781|80374349|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
27599686|NCT03420781|80374345|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27599687|NCT03420781|80374346|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27599688|NCT03420781|80374347|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27599689|NCT03420781|80374348|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
27599690|NCT03420781|80374349|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
27599691|NCT03420781|80374345|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27599692|NCT03420781|80374346|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27599693|NCT03420781|80374347|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27599694|NCT03420781|80374348|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
27599695|NCT03420781|80374349|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
27599696|NCT03420781|80374345|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
27599697|NCT03420781|80374346|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
27599698|NCT03420781|80374347|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
27599699|NCT03420781|80374348|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
27599700|NCT03420781|80374349|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
27599701|NCT00526630|80374350|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
27599702|NCT00526630|80374351|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
27599703|NCT00526630|80374350|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
27599704|NCT00526630|80374351|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
27599705|NCT00119405|80374352|FG000|Overall Study|Withdrawal by Subject|1|||
27599706|NCT04839965|80374354|FG000|Overall Study|Death|6|||
27599707|NCT04839965|80374355|FG001|Overall Study|Death|6|||
27599708|NCT04839965|80374354|FG000|Overall Study|Lost to Follow-up|1|||
27599709|NCT04839965|80374355|FG001|Overall Study|Lost to Follow-up|0|||
27599710|NCT01649232|80374357|FG000|Overall Study|Physician Decision|2|||
27599711|NCT01649232|80374358|FG001|Overall Study|Physician Decision|0|||
27599712|NCT02034708|80374359|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
27599713|NCT02034708|80374360|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
27599714|NCT02034708|80374359|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
27599715|NCT02034708|80374360|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
27599716|NCT02034708|80374359|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
27599717|NCT02034708|80374360|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
27599718|NCT02034708|80374359|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
27599719|NCT02034708|80374360|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
27599720|NCT00541450|80374363|FG000|Phase A|Adverse Event|3|||
27599721|NCT00541450|80374364|FG001|Phase A|Adverse Event|0|||
27599722|NCT00541450|80374363|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
27599723|NCT00541450|80374364|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
27599724|NCT00541450|80374363|FG000|Phase A|Hyperglycemia|0|||
27599725|NCT00541450|80374364|FG001|Phase A|Hyperglycemia|1|||
27599726|NCT00541450|80374363|FG000|Phase A|Lost to Follow-up|6|||
27599727|NCT00541450|80374364|FG001|Phase A|Lost to Follow-up|4|||
27599728|NCT00541450|80374363|FG000|Phase A|Physician Decision|2|||
27599729|NCT00541450|80374364|FG001|Phase A|Physician Decision|0|||
27599730|NCT00541450|80374363|FG000|Phase A|Protocol Violation|2|||
27599731|NCT00541450|80374364|FG001|Phase A|Protocol Violation|3|||
27599732|NCT00541450|80374363|FG000|Phase A|Withdrawal by Subject|7|||
27599733|NCT00541450|80374364|FG001|Phase A|Withdrawal by Subject|7|||
27599734|NCT00541450|80374363|FG000|Phase B|Adverse Event|6|||
27599735|NCT00541450|80374364|FG001|Phase B|Adverse Event|6|||
27599736|NCT00541450|80374363|FG000|Phase B|Hyperglycemia|10|||
27599737|NCT00541450|80374364|FG001|Phase B|Hyperglycemia|9|||
27599738|NCT00541450|80374363|FG000|Phase B|Lost to Follow-up|6|||
27599739|NCT00541450|80374364|FG001|Phase B|Lost to Follow-up|4|||
27599740|NCT00541450|80374363|FG000|Phase B|Physician Decision|4|||
27599741|NCT00541450|80374364|FG001|Phase B|Physician Decision|2|||
27599742|NCT00541450|80374363|FG000|Phase B|Pregnancy|0|||
27599743|NCT00541450|80374364|FG001|Phase B|Pregnancy|1|||
27599744|NCT00541450|80374363|FG000|Phase B|Protocol Violation|3|||
27599745|NCT00541450|80374364|FG001|Phase B|Protocol Violation|3|||
27599746|NCT00541450|80374363|FG000|Phase B|Withdrawal by Subject|8|||
27599747|NCT00541450|80374364|FG001|Phase B|Withdrawal by Subject|6|||
27599748|NCT02709005|80374367|FG000|Overall Study|Lost to Follow-up|1|||
27599749|NCT02709005|80374368|FG001|Overall Study|Lost to Follow-up|1|||
27599750|NCT02709005|80374367|FG000|Overall Study|Withdrawal by Subject|3|||
27599751|NCT02709005|80374368|FG001|Overall Study|Withdrawal by Subject|0|||
27599752|NCT04279314|80374369|FG000|Overall Study|Adverse Event|55|||
27599753|NCT04279314|80374369|FG000|Overall Study|Withdrawal by Subject|5|||
27599754|NCT04279314|80374369|FG000|Overall Study|Lack of Efficacy|5|||
27599755|NCT04279314|80374369|FG000|Overall Study|Protocol Violation|3|||
27599756|NCT04279314|80374369|FG000|Overall Study|Other (not COVID-19 related)|2|||
27599757|NCT02220894|80374370|FG000|Overall Study|Adverse Event|127|||
27599758|NCT02220894|80374371|FG001|Overall Study|Adverse Event|74|||
27599759|NCT02220894|80374370|FG000|Overall Study|Death|418|||
27599760|NCT02220894|80374371|FG001|Overall Study|Death|508|||
27599761|NCT02220894|80374370|FG000|Overall Study|Lost to Follow-up|0|||
27599762|NCT02220894|80374371|FG001|Overall Study|Lost to Follow-up|4|||
27599763|NCT02220894|80374370|FG000|Overall Study|Site Terminated by Sponsor|2|||
27599764|NCT02220894|80374371|FG001|Overall Study|Site Terminated by Sponsor|0|||
27599765|NCT02220894|80374370|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
27599766|NCT02220894|80374371|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
27599767|NCT02220894|80374370|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27599768|NCT02220894|80374371|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27599769|NCT02220894|80374370|FG000|Overall Study|Withdrawal by Subject|10|||
27599770|NCT02220894|80374371|FG001|Overall Study|Withdrawal by Subject|9|||
27599771|NCT01843192|80374372|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
27599772|NCT01843192|80374373|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
27599773|NCT01843192|80374374|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
27599774|NCT00316173|80374375|FG000|Run-in Phase|Adverse Event|1|||
27599775|NCT00316173|80374376|FG001|Run-in Phase|Adverse Event|0|||
27599776|NCT00316173|80374375|FG000|Run-in Phase|Protocol Violation|1|||
27599777|NCT00316173|80374376|FG001|Run-in Phase|Protocol Violation|0|||
27599778|NCT00316173|80374375|FG000|Run-in Phase|Study Follow-up Stopped|5|||
27599779|NCT00316173|80374376|FG001|Run-in Phase|Study Follow-up Stopped|0|||
27599780|NCT00316173|80374375|FG000|Treatment Phase|Adverse Event|0|||
27599781|NCT00316173|80374376|FG001|Treatment Phase|Adverse Event|1|||
27599782|NCT00316173|80374375|FG000|Treatment Phase|Lack of Efficacy|0|||
27599783|NCT00316173|80374376|FG001|Treatment Phase|Lack of Efficacy|3|||
27599784|NCT00316173|80374375|FG000|Treatment Phase|Lost to Follow-up|0|||
27599785|NCT00316173|80374376|FG001|Treatment Phase|Lost to Follow-up|3|||
27599786|NCT00316173|80374375|FG000|Treatment Phase|Withdrawal by Subject|0|||
27599787|NCT00316173|80374376|FG001|Treatment Phase|Withdrawal by Subject|1|||
27599788|NCT00316173|80374375|FG000|Treatment Phase|Study Follow-up Stopped|0|||
27599789|NCT00316173|80374376|FG001|Treatment Phase|Study Follow-up Stopped|34|||
27599790|NCT02314624|80374381|FG000|Overall Study|No participating patient|16|||
27599791|NCT02314624|80374382|FG001|Overall Study|No participating patient|13|||
27599792|NCT02314624|80374381|FG000|Overall Study|Participant withdrew|7|||
27599793|NCT02314624|80374382|FG001|Overall Study|Participant withdrew|2|||
27599794|NCT02314624|80374381|FG000|Overall Study|Lost to Follow-up|2|||
27599795|NCT02314624|80374382|FG001|Overall Study|Lost to Follow-up|5|||
27599796|NCT02314624|80374381|FG000|Overall Study|Dropped/Excluded by PI|6|||
27599797|NCT02314624|80374382|FG001|Overall Study|Dropped/Excluded by PI|6|||
27599798|NCT05899686|80374392|FG000|Overall Study|Protocol Violation|1|||
27599799|NCT02586025|80374401|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
27599800|NCT02586025|80374402|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
27599801|NCT02586025|80374401|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
27599802|NCT02586025|80374402|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
27599803|NCT02586025|80374401|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
27599804|NCT02586025|80374402|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
27599805|NCT02586025|80374401|FG000|Neoadjuvant Treatment|Death|1|||
27599806|NCT02586025|80374402|FG001|Neoadjuvant Treatment|Death|0|||
27599807|NCT02586025|80374401|FG000|Neoadjuvant Treatment|Adverse Event|1|||
27599808|NCT02586025|80374402|FG001|Neoadjuvant Treatment|Adverse Event|0|||
27599809|NCT02586025|80374401|FG000|Neoadjuvant Treatment|Physician Decision|2|||
27599810|NCT02586025|80374402|FG001|Neoadjuvant Treatment|Physician Decision|1|||
27599811|NCT02586025|80374401|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
27599812|NCT02586025|80374402|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
27599813|NCT02586025|80374401|FG000|Adjuvant Treatment|Recurrent Disease|4|||
27599814|NCT02586025|80374402|FG001|Adjuvant Treatment|Recurrent Disease|5|||
27599815|NCT02586025|80374401|FG000|Adjuvant Treatment|Physician Decision|0|||
27599816|NCT02586025|80374402|FG001|Adjuvant Treatment|Physician Decision|1|||
27599817|NCT02586025|80374401|FG000|Adjuvant Treatment|Pregnancy|1|||
27599818|NCT02586025|80374402|FG001|Adjuvant Treatment|Pregnancy|0|||
27599819|NCT02586025|80374401|FG000|Treatment-Free Follow-Up|Death|11|||
27599820|NCT02586025|80374402|FG001|Treatment-Free Follow-Up|Death|11|||
27599821|NCT02586025|80374401|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
27599822|NCT02586025|80374402|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
27599823|NCT02586025|80374401|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
27599824|NCT02586025|80374402|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
27599825|NCT02586025|80374401|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
27599826|NCT02586025|80374402|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
27599827|NCT02586025|80374401|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
27599828|NCT02586025|80374402|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
27599829|NCT04162769|80374403|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
27599830|NCT04162769|80374404|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
27599831|NCT04162769|80374405|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
27599832|NCT04162769|80374406|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
27599833|NCT04162769|80374403|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
27599834|NCT04162769|80374404|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
27599835|NCT04162769|80374405|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
27599836|NCT04162769|80374406|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
27599837|NCT04162769|80374403|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
27599838|NCT04162769|80374404|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
27599839|NCT04162769|80374405|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
27599840|NCT04162769|80374406|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
27599841|NCT04162769|80374403|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
27599842|NCT04162769|80374404|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
27599843|NCT04162769|80374405|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
27599844|NCT04162769|80374406|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
27599845|NCT04162769|80374403|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
27705303|NCT00766090|80758606|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27599846|NCT04162769|80374404|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
27599847|NCT04162769|80374405|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
27599848|NCT04162769|80374406|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
27599849|NCT04162769|80374403|FG000|Double-blind Treatment (12-Week)|Other|0|||
27599850|NCT04162769|80374404|FG001|Double-blind Treatment (12-Week)|Other|1|||
27599851|NCT04162769|80374405|FG002|Double-blind Treatment (12-Week)|Other|1|||
27599852|NCT04162769|80374406|FG003|Double-blind Treatment (12-Week)|Other|0|||
27599853|NCT04162769|80374403|FG000|OLE Period (52-Week)|Adverse Event|0|||
27599854|NCT04162769|80374404|FG001|OLE Period (52-Week)|Adverse Event|0|||
27599855|NCT04162769|80374405|FG002|OLE Period (52-Week)|Adverse Event|0|||
27599856|NCT04162769|80374406|FG003|OLE Period (52-Week)|Adverse Event|5|||
27599857|NCT04162769|80374403|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
27599858|NCT04162769|80374404|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
27599859|NCT04162769|80374405|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
27599860|NCT04162769|80374406|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
27599861|NCT04162769|80374403|FG000|OLE Period (52-Week)|Physician Decision|0|||
27599862|NCT04162769|80374404|FG001|OLE Period (52-Week)|Physician Decision|0|||
27599863|NCT04162769|80374405|FG002|OLE Period (52-Week)|Physician Decision|0|||
27599864|NCT04162769|80374406|FG003|OLE Period (52-Week)|Physician Decision|1|||
27599865|NCT04162769|80374403|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
27599866|NCT04162769|80374404|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
27599867|NCT04162769|80374405|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
27599868|NCT04162769|80374406|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
27599869|NCT04162769|80374403|FG000|OLE Period (52-Week)|Protocol deviation|0|||
27599870|NCT04162769|80374404|FG001|OLE Period (52-Week)|Protocol deviation|0|||
27599871|NCT04162769|80374405|FG002|OLE Period (52-Week)|Protocol deviation|0|||
27599872|NCT04162769|80374406|FG003|OLE Period (52-Week)|Protocol deviation|2|||
27599873|NCT02969525|80374407|FG000|Double-Blind Period|Adverse Event|0|||
27599874|NCT02969525|80374408|FG001|Double-Blind Period|Adverse Event|0|||
27599875|NCT02969525|80374409|FG002|Double-Blind Period|Adverse Event|1|||
27599876|NCT02969525|80374410|FG003|Double-Blind Period|Adverse Event|1|||
27599877|NCT02969525|80374411|FG004|Double-Blind Period|Adverse Event|0|||
27599878|NCT02969525|80374412|FG005|Double-Blind Period|Adverse Event|0|||
27599879|NCT02969525|80374413|FG006|Double-Blind Period|Adverse Event|0|||
27599880|NCT02969525|80374414|FG007|Double-Blind Period|Adverse Event|0|||
27599881|NCT02969525|80374415|FG008|Double-Blind Period|Adverse Event|0|||
27599882|NCT02969525|80374416|FG009|Double-Blind Period|Adverse Event|0|||
27599883|NCT02969525|80374417|FG010|Double-Blind Period|Adverse Event|0|||
27599884|NCT02969525|80374418|FG011|Double-Blind Period|Adverse Event|0|||
27599885|NCT02969525|80374407|FG000|Double-Blind Period|LOW EGFR|0|||
27599886|NCT02969525|80374408|FG001|Double-Blind Period|LOW EGFR|0|||
27599887|NCT02969525|80374409|FG002|Double-Blind Period|LOW EGFR|0|||
27599888|NCT02969525|80374410|FG003|Double-Blind Period|LOW EGFR|1|||
27599889|NCT02969525|80374411|FG004|Double-Blind Period|LOW EGFR|0|||
27599890|NCT02969525|80374412|FG005|Double-Blind Period|LOW EGFR|0|||
27599891|NCT02969525|80374413|FG006|Double-Blind Period|LOW EGFR|0|||
27599892|NCT02969525|80374414|FG007|Double-Blind Period|LOW EGFR|0|||
27705304|NCT00766090|80758607|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27599893|NCT02969525|80374415|FG008|Double-Blind Period|LOW EGFR|0|||
27599894|NCT02969525|80374416|FG009|Double-Blind Period|LOW EGFR|0|||
27599895|NCT02969525|80374417|FG010|Double-Blind Period|LOW EGFR|0|||
27599896|NCT02969525|80374418|FG011|Double-Blind Period|LOW EGFR|0|||
27599897|NCT02969525|80374407|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
27599898|NCT02969525|80374408|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599899|NCT02969525|80374409|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599900|NCT02969525|80374410|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
27599901|NCT02969525|80374411|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599902|NCT02969525|80374412|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599903|NCT02969525|80374413|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599904|NCT02969525|80374414|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599905|NCT02969525|80374415|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599906|NCT02969525|80374416|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599907|NCT02969525|80374417|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599908|NCT02969525|80374418|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
27599909|NCT02969525|80374407|FG000|Dose-Blind Period|Adverse Event|0|||
27599910|NCT02969525|80374408|FG001|Dose-Blind Period|Adverse Event|0|||
27599911|NCT02969525|80374409|FG002|Dose-Blind Period|Adverse Event|0|||
27599912|NCT02969525|80374410|FG003|Dose-Blind Period|Adverse Event|0|||
27599913|NCT02969525|80374411|FG004|Dose-Blind Period|Adverse Event|0|||
27599914|NCT02969525|80374412|FG005|Dose-Blind Period|Adverse Event|0|||
27599915|NCT02969525|80374413|FG006|Dose-Blind Period|Adverse Event|0|||
27599916|NCT02969525|80374414|FG007|Dose-Blind Period|Adverse Event|0|||
27705305|NCT00766090|80758608|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705306|NCT00766090|80758609|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705307|NCT00766090|80758610|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705308|NCT00766090|80758611|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705309|NCT00766090|80758612|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
27705310|NCT00766090|80758601|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27599917|NCT02969525|80374415|FG008|Dose-Blind Period|Adverse Event|0|||
27599918|NCT02969525|80374416|FG009|Dose-Blind Period|Adverse Event|1|||
27599919|NCT02969525|80374417|FG010|Dose-Blind Period|Adverse Event|1|||
27599920|NCT02969525|80374418|FG011|Dose-Blind Period|Adverse Event|1|||
27599921|NCT02969525|80374407|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
27599922|NCT02969525|80374408|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
27599923|NCT02969525|80374409|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
27599924|NCT02969525|80374410|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
27599925|NCT02969525|80374411|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
27599926|NCT02969525|80374412|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
27705311|NCT00766090|80758602|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27599927|NCT02969525|80374413|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
27599928|NCT02969525|80374414|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
27599929|NCT02969525|80374415|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
27599930|NCT02969525|80374416|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
27599931|NCT02969525|80374417|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
27705312|NCT00766090|80758603|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
27705313|NCT00766090|80758604|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27599932|NCT02969525|80374418|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
27599933|NCT02969525|80374407|FG000|Dose-Blind Period|Non-cooperating patient|0|||
27599934|NCT02969525|80374408|FG001|Dose-Blind Period|Non-cooperating patient|0|||
27599935|NCT02969525|80374409|FG002|Dose-Blind Period|Non-cooperating patient|0|||
27599936|NCT02969525|80374410|FG003|Dose-Blind Period|Non-cooperating patient|0|||
27599937|NCT02969525|80374411|FG004|Dose-Blind Period|Non-cooperating patient|0|||
27599938|NCT02969525|80374412|FG005|Dose-Blind Period|Non-cooperating patient|0|||
27599939|NCT02969525|80374413|FG006|Dose-Blind Period|Non-cooperating patient|0|||
27599940|NCT02969525|80374414|FG007|Dose-Blind Period|Non-cooperating patient|0|||
27599941|NCT02969525|80374415|FG008|Dose-Blind Period|Non-cooperating patient|0|||
27705314|NCT00766090|80758605|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705315|NCT00766090|80758606|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705316|NCT00766090|80758607|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705317|NCT00766090|80758608|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705318|NCT00766090|80758609|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705319|NCT00766090|80758610|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705320|NCT00766090|80758611|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705321|NCT00766090|80758612|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
27705322|NCT00766090|80758601|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
27705323|NCT00766090|80758602|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
27705324|NCT00766090|80758603|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
27705325|NCT00766090|80758604|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
27705326|NCT00766090|80758605|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
27705327|NCT00766090|80758606|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
27705328|NCT00766090|80758607|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
27705329|NCT00766090|80758608|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
27705330|NCT00766090|80758609|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
27705331|NCT00766090|80758610|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
27705332|NCT00766090|80758611|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
27705333|NCT00766090|80758612|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
27705334|NCT00766090|80758601|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705335|NCT00766090|80758602|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705336|NCT00766090|80758603|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705337|NCT00766090|80758604|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705338|NCT00766090|80758605|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705339|NCT00766090|80758606|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
27705340|NCT00766090|80758607|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705341|NCT00766090|80758608|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705342|NCT00766090|80758609|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705343|NCT00766090|80758610|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705344|NCT00766090|80758611|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705345|NCT00766090|80758612|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
27705346|NCT00766090|80758601|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705347|NCT00766090|80758602|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
27705348|NCT00766090|80758603|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27599942|NCT02969525|80374416|FG009|Dose-Blind Period|Non-cooperating patient|0|||
27599943|NCT02969525|80374417|FG010|Dose-Blind Period|Non-cooperating patient|0|||
27705349|NCT00766090|80758604|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
27705350|NCT00766090|80758605|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705351|NCT00766090|80758606|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705352|NCT00766090|80758607|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705353|NCT00766090|80758608|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705354|NCT00766090|80758609|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27599944|NCT02969525|80374418|FG011|Dose-Blind Period|Non-cooperating patient|1|||
27599945|NCT02969525|80374407|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599946|NCT02969525|80374408|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599947|NCT02969525|80374409|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599948|NCT02969525|80374410|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599949|NCT02969525|80374411|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599950|NCT02969525|80374412|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27705355|NCT00766090|80758610|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705356|NCT00766090|80758611|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
27705357|NCT00766090|80758612|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
27705358|NCT00766090|80758601|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705359|NCT00766090|80758602|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27834833|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
27834834|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
27888022|NCT02980341|81425240|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27599951|NCT02969525|80374413|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599952|NCT02969525|80374414|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599953|NCT02969525|80374415|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599954|NCT02969525|80374416|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27599955|NCT02969525|80374417|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
27599956|NCT02969525|80374418|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
27705360|NCT00766090|80758603|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27834835|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
27888023|NCT02980341|81425241|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888024|NCT02980341|81425242|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
27888025|NCT02980341|81425243|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888026|NCT02980341|81425244|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
27888027|NCT02980341|81425234|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888028|NCT02980341|81425235|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888029|NCT02980341|81425236|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888030|NCT02980341|81425237|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888031|NCT02980341|81425238|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888032|NCT02980341|81425239|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888033|NCT02980341|81425240|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888034|NCT02980341|81425241|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27888035|NCT02980341|81425242|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
27888036|NCT02980341|81425243|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27834836|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
27834837|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
27834838|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
27834839|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
27834840|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
27834841|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
27834842|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
27834843|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
27834844|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
27599957|NCT00855062|80374419|FG000|Step1|Early Study Closure|5|||
27599958|NCT00855062|80374420|FG001|Step1|Early Study Closure|7|||
27599959|NCT00855062|80374419|FG000|Step1|Adverse Event|1|||
27599960|NCT00855062|80374420|FG001|Step1|Adverse Event|1|||
27599961|NCT00855062|80374419|FG000|Step1|Protocol Violation|1|||
27599962|NCT00855062|80374420|FG001|Step1|Protocol Violation|0|||
27599963|NCT00855062|80374419|FG000|Step1|Pregnancy|1|||
27599964|NCT00855062|80374420|FG001|Step1|Pregnancy|0|||
27599965|NCT00855062|80374419|FG000|Step1|Withdrawal by Subject|2|||
27599966|NCT00855062|80374420|FG001|Step1|Withdrawal by Subject|3|||
27599967|NCT00855062|80374419|FG000|Step2|Early Study Closure|6|||
27599968|NCT00855062|80374420|FG001|Step2|Early Study Closure|2|||
27599969|NCT00855062|80374419|FG000|Step2|Adverse Event|0|||
27599970|NCT00855062|80374420|FG001|Step2|Adverse Event|3|||
27599971|NCT00855062|80374419|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
27599972|NCT00855062|80374420|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
27599973|NCT02612064|80374426|FG000|Overall Study|Withdrawal by Subject|1|||
27599974|NCT02612064|80374427|FG001|Overall Study|Withdrawal by Subject|1|||
27599975|NCT02612064|80374426|FG000|Overall Study|Other|0|||
27599976|NCT02612064|80374427|FG001|Overall Study|Other|2|||
27599977|NCT02701985|80374428|FG000|Overall Study|Withdrawal by Subject|1|||
27599978|NCT02701985|80374429|FG001|Overall Study|Withdrawal by Subject|1|||
27599979|NCT02701985|80374428|FG000|Overall Study|Lost to Follow-up|1|||
27599980|NCT02701985|80374429|FG001|Overall Study|Lost to Follow-up|0|||
27599981|NCT02701985|80374428|FG000|Overall Study|Death|1|||
27599982|NCT02701985|80374429|FG001|Overall Study|Death|0|||
27599983|NCT02701985|80374428|FG000|Overall Study|Adverse Event|0|||
27599984|NCT02701985|80374429|FG001|Overall Study|Adverse Event|5|||
27599985|NCT04843930|80374433|FG000|Randomization|Withdrawal by Subject|6|||
27599986|NCT04843930|80374434|FG001|Randomization|Withdrawal by Subject|6|||
27599987|NCT04843930|80374435|FG002|Randomization|Withdrawal by Subject|0|||
27599988|NCT04843930|80374436|FG003|Randomization|Withdrawal by Subject|0|||
27599989|NCT04843930|80374433|FG000|Week 6 Assessment|Adverse Event|3|||
27599990|NCT04843930|80374434|FG001|Week 6 Assessment|Adverse Event|0|||
27599991|NCT04843930|80374435|FG002|Week 6 Assessment|Adverse Event|0|||
27599992|NCT04843930|80374436|FG003|Week 6 Assessment|Adverse Event|0|||
27599993|NCT04843930|80374433|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
27599994|NCT04843930|80374434|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
27599995|NCT04843930|80374435|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
27599996|NCT04843930|80374436|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
27599997|NCT04843930|80374433|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
27599998|NCT04843930|80374434|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
27599999|NCT04843930|80374435|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
27600000|NCT04843930|80374436|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
27600001|NCT01949311|80374441|FG000|Overall Study|Lost to Follow-up|73|||
27600002|NCT01949311|80374441|FG000|Overall Study|Terminated by Sponsor|708|||
27600003|NCT01949311|80374441|FG000|Overall Study|Withdrawal by Subject|375|||
27600004|NCT01949311|80374441|FG000|Overall Study|Lack of Efficacy|50|||
27600005|NCT01949311|80374441|FG000|Overall Study|Protocol Deviation|34|||
27958531|NCT01791517|81680063|FG005|Phase I: Period 2|Lost to Follow-up|0|||
27600006|NCT01949311|80374441|FG000|Overall Study|Pregnancy|20|||
27600007|NCT01949311|80374441|FG000|Overall Study|Physician Decision|9|||
27600008|NCT01949311|80374441|FG000|Overall Study|Other|4|||
27600009|NCT01949311|80374441|FG000|Overall Study|Adverse Event|107|||
27600010|NCT00785291|80374446|FG000|Overall Study|Never began treatment|8|||
27600011|NCT00785291|80374447|FG001|Overall Study|Never began treatment|4|||
27600012|NCT00785291|80374448|FG002|Overall Study|Never began treatment|4|||
27600013|NCT00785291|80374446|FG000|Overall Study|Adverse Event|39|||
27600014|NCT00785291|80374447|FG001|Overall Study|Adverse Event|70|||
27600015|NCT00785291|80374448|FG002|Overall Study|Adverse Event|56|||
27600016|NCT00785291|80374446|FG000|Overall Study|Death|7|||
27600017|NCT00785291|80374447|FG001|Overall Study|Death|4|||
27705361|NCT00766090|80758604|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705362|NCT00766090|80758605|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
27705363|NCT00766090|80758606|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705364|NCT00766090|80758607|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27834845|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
27834846|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834847|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834848|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834849|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834850|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834851|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
27888037|NCT02980341|81425244|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
27600018|NCT00785291|80374448|FG002|Overall Study|Death|3|||
27600019|NCT00785291|80374446|FG000|Overall Study|Withdrawal by Subject|35|||
27600020|NCT00785291|80374447|FG001|Overall Study|Withdrawal by Subject|36|||
27600021|NCT00785291|80374448|FG002|Overall Study|Withdrawal by Subject|17|||
27600022|NCT00785291|80374446|FG000|Overall Study|Alternative Therapy|12|||
27600023|NCT00785291|80374447|FG001|Overall Study|Alternative Therapy|6|||
27600024|NCT00785291|80374448|FG002|Overall Study|Alternative Therapy|7|||
27600025|NCT00785291|80374446|FG000|Overall Study|Complicating illness|6|||
27600026|NCT00785291|80374447|FG001|Overall Study|Complicating illness|4|||
27600027|NCT00785291|80374448|FG002|Overall Study|Complicating illness|4|||
27600028|NCT00785291|80374446|FG000|Overall Study|Other Medical Reasons|29|||
27600029|NCT00785291|80374447|FG001|Overall Study|Other Medical Reasons|25|||
27600030|NCT00785291|80374448|FG002|Overall Study|Other Medical Reasons|15|||
27600031|NCT02255357|80374449|FG000|Overall Study|Physician Decision|10|||
27600032|NCT02255357|80374450|FG001|Overall Study|Physician Decision|24|||
27600033|NCT00716092|80374451|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
27600034|NCT00716092|80374452|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
27600035|NCT00716092|80374453|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
27600036|NCT02807636|80374458|FG000|Overall Study|Lost to Follow-up|9|||
27600037|NCT02807636|80374459|FG001|Overall Study|Lost to Follow-up|12|||
27600038|NCT02807636|80374460|FG002|Overall Study|Lost to Follow-up|6|||
27600039|NCT02807636|80374458|FG000|Overall Study|Protocol Deviation|2|||
27600040|NCT02807636|80374459|FG001|Overall Study|Protocol Deviation|0|||
27600041|NCT02807636|80374460|FG002|Overall Study|Protocol Deviation|0|||
27834852|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
27834853|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834854|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834855|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
27834856|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834857|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834858|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834859|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834860|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27600042|NCT02807636|80374458|FG000|Overall Study|Symptomatic Deterioration|0|||
27600043|NCT02807636|80374459|FG001|Overall Study|Symptomatic Deterioration|1|||
27600044|NCT02807636|80374460|FG002|Overall Study|Symptomatic Deterioration|0|||
27600045|NCT02807636|80374458|FG000|Overall Study|Withdrawal by Subject|39|||
27600046|NCT02807636|80374459|FG001|Overall Study|Withdrawal by Subject|27|||
27600047|NCT02807636|80374460|FG002|Overall Study|Withdrawal by Subject|23|||
27600048|NCT02807636|80374458|FG000|Overall Study|Death|298|||
27600049|NCT02807636|80374459|FG001|Overall Study|Death|327|||
27834861|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834862|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27600050|NCT02807636|80374460|FG002|Overall Study|Death|266|||
27600051|NCT02807636|80374458|FG000|Overall Study|Ongoing in Study|52|||
27600052|NCT02807636|80374459|FG001|Overall Study|Ongoing in Study|84|||
27600053|NCT02807636|80374460|FG002|Overall Study|Ongoing in Study|67|||
27600054|NCT01132326|80374461|FG000|Overall Study|Lack of Efficacy|25|||
27600055|NCT01132326|80374461|FG000|Overall Study|Adverse Event|37|||
27888038|NCT02980341|81425234|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888039|NCT02980341|81425235|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888040|NCT02980341|81425236|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888041|NCT02980341|81425237|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888042|NCT02980341|81425238|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888043|NCT02980341|81425239|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888044|NCT02980341|81425240|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888045|NCT02980341|81425241|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888046|NCT02980341|81425242|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888047|NCT02980341|81425243|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
27888048|NCT02980341|81425244|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
27888049|NCT01252563|81425248|FG000|Overall Study|Contract Deviation|41|||
27888050|NCT01252563|81425248|FG000|Overall Study|Centralized Registration Deviation|30|||
27888051|NCT01252563|81425248|FG000|Overall Study|Lost to Follow-up|161|||
27888052|NCT01252563|81425248|FG000|Overall Study|No visit after first day of treatment|194|||
27888053|NCT01252563|81425248|FG000|Overall Study|No drug administration|6|||
27888054|NCT04687072|81425251|FG000|Overall Study|Adverse Event|2|||
27888055|NCT04687072|81425252|FG001|Overall Study|Adverse Event|0|||
27888056|NCT04687072|81425251|FG000|Overall Study|Death|1|||
27888057|NCT04687072|81425252|FG001|Overall Study|Death|0|||
27888058|NCT04687072|81425251|FG000|Overall Study|Lack of Efficacy|2|||
27888059|NCT04687072|81425252|FG001|Overall Study|Lack of Efficacy|1|||
27888060|NCT04687072|81425251|FG000|Overall Study|Physician Decision|1|||
27888061|NCT04687072|81425252|FG001|Overall Study|Physician Decision|0|||
27888062|NCT04687072|81425251|FG000|Overall Study|Pregnancy|1|||
27888063|NCT04687072|81425252|FG001|Overall Study|Pregnancy|0|||
27888064|NCT04687072|81425251|FG000|Overall Study|Requires Prohibited Medication|2|||
27888065|NCT04687072|81425252|FG001|Overall Study|Requires Prohibited Medication|0|||
27888066|NCT04687072|81425251|FG000|Overall Study|Withdrawal of Consent|11|||
27888067|NCT04687072|81425252|FG001|Overall Study|Withdrawal of Consent|6|||
27888068|NCT04687072|81425251|FG000|Overall Study|Miscellaneous|4|||
27888069|NCT04687072|81425252|FG001|Overall Study|Miscellaneous|1|||
27888070|NCT01780038|81425255|FG000|Overall Study|Lost to Follow-up|4|||
27888071|NCT01780038|81425256|FG001|Overall Study|Lost to Follow-up|1|||
27888072|NCT02730377|81425260|FG000|Overall Study|Other|5|||
27888073|NCT02730377|81425261|FG001|Overall Study|Other|4|||
27888074|NCT02730377|81425260|FG000|Overall Study|Death|1|||
27888075|NCT02730377|81425261|FG001|Overall Study|Death|8|||
27888076|NCT02730377|81425260|FG000|Overall Study|Inadequate glycaemic control|368|||
27888077|NCT02730377|81425261|FG001|Overall Study|Inadequate glycaemic control|473|||
27888078|NCT02730377|81425260|FG000|Overall Study|Adverse Event|79|||
27888079|NCT02730377|81425261|FG001|Overall Study|Adverse Event|41|||
27600056|NCT01132326|80374461|FG000|Overall Study|Protocol Violation|1|||
27888080|NCT02730377|81425260|FG000|Overall Study|Protocol Violation|23|||
27600057|NCT01132326|80374461|FG000|Overall Study|Lost to Follow-up|16|||
27600058|NCT01132326|80374461|FG000|Overall Study|Withdrawal by Subject|40|||
27600059|NCT01132326|80374461|FG000|Overall Study|Physician Decision|10|||
27600060|NCT01132326|80374461|FG000|Overall Study|Study Termination|80|||
27888081|NCT02730377|81425261|FG001|Overall Study|Protocol Violation|30|||
27888082|NCT02730377|81425260|FG000|Overall Study|Lack of Efficacy|4|||
27888083|NCT02730377|81425261|FG001|Overall Study|Lack of Efficacy|13|||
27888084|NCT02730377|81425260|FG000|Overall Study|Pregnancy|0|||
27888085|NCT02730377|81425261|FG001|Overall Study|Pregnancy|1|||
27888086|NCT02730377|81425260|FG000|Overall Study|Withdrawal by Subject|45|||
27888087|NCT02730377|81425261|FG001|Overall Study|Withdrawal by Subject|42|||
27888088|NCT02730377|81425260|FG000|Overall Study|Lost to Follow-up|25|||
27705365|NCT00766090|80758608|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705366|NCT00766090|80758609|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705367|NCT00766090|80758610|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705368|NCT00766090|80758611|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705369|NCT00766090|80758612|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
27705370|NCT01732796|80758613|FG000|Overall Study|Adverse Event|16|||
27705371|NCT01732796|80758614|FG001|Overall Study|Adverse Event|16|||
27705372|NCT01732796|80758615|FG002|Overall Study|Adverse Event|4|||
27705373|NCT01732796|80758613|FG000|Overall Study|Lack of Efficacy|21|||
27834863|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834864|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834865|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27888089|NCT02730377|81425261|FG001|Overall Study|Lost to Follow-up|21|||
27888090|NCT03124407|81425271|FG000|Overall Study|Lost to Follow-up|1|||
27888091|NCT03124407|81425272|FG001|Overall Study|Lost to Follow-up|0|||
27888092|NCT03124407|81425273|FG002|Overall Study|Lost to Follow-up|0|||
27888093|NCT03124407|81425274|FG003|Overall Study|Lost to Follow-up|0|||
27888094|NCT03124407|81425271|FG000|Overall Study|Adverse Event|0|||
27888095|NCT03124407|81425272|FG001|Overall Study|Adverse Event|0|||
27888096|NCT03124407|81425273|FG002|Overall Study|Adverse Event|1|||
27888097|NCT03124407|81425274|FG003|Overall Study|Adverse Event|0|||
27888098|NCT00089778|81425275|FG000|Overall Study|Protocol Violation|0|||
27888099|NCT00089778|81425276|FG001|Overall Study|Protocol Violation|0|||
27888100|NCT00089778|81425277|FG002|Overall Study|Protocol Violation|1|||
27834866|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834867|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27888101|NCT03005327|81425285|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
27888102|NCT03005327|81425286|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
27888103|NCT03005327|81425287|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
27834868|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834869|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834870|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834871|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
27834872|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834873|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27888104|NCT03005327|81425288|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
27888105|NCT03005327|81425285|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27888106|NCT03005327|81425286|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
27888107|NCT03005327|81425287|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27888108|NCT03005327|81425288|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27888109|NCT05367973|81425289|FG000|Overall Study|Adverse Event|0|||
27600061|NCT01132326|80374461|FG000|Overall Study|Declining Health|1|||
27600062|NCT01132326|80374461|FG000|Overall Study|Pregnancy|1|||
27600063|NCT01132326|80374461|FG000|Overall Study|Caregiver Withdrew Consent|1|||
27705374|NCT01732796|80758614|FG001|Overall Study|Lack of Efficacy|18|||
27705375|NCT01732796|80758615|FG002|Overall Study|Lack of Efficacy|5|||
27705376|NCT01732796|80758613|FG000|Overall Study|Lost to Follow-up|2|||
27705377|NCT01732796|80758614|FG001|Overall Study|Lost to Follow-up|0|||
27705378|NCT01732796|80758615|FG002|Overall Study|Lost to Follow-up|0|||
27705379|NCT01732796|80758613|FG000|Overall Study|Withdrawal by Subject|6|||
27705380|NCT01732796|80758614|FG001|Overall Study|Withdrawal by Subject|8|||
27600064|NCT01132326|80374461|FG000|Overall Study|Death|5|||
27600065|NCT01132326|80374461|FG000|Overall Study|Subject Unable to Come To Visits|1|||
27600066|NCT00567190|80374463|FG000|Overall Study|Death|235|||
27600067|NCT00567190|80374464|FG001|Overall Study|Death|280|||
27600068|NCT00567190|80374463|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
27600069|NCT00567190|80374464|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
27600070|NCT02044848|80374465|FG000|Overall Study|Administrative Problems|2|||
27705381|NCT01732796|80758615|FG002|Overall Study|Withdrawal by Subject|2|||
27705382|NCT01732796|80758613|FG000|Overall Study|Other reason not defined above|1|||
27705383|NCT01732796|80758614|FG001|Overall Study|Other reason not defined above|0|||
27705384|NCT01732796|80758615|FG002|Overall Study|Other reason not defined above|2|||
27705385|NCT00516048|80758633|FG000|Overall Study|Death|0|||
27705386|NCT00516048|80758634|FG001|Overall Study|Death|0|||
27705387|NCT00516048|80758635|FG002|Overall Study|Death|1|||
27705388|NCT00516048|80758633|FG000|Overall Study|Subject Decision|0|||
27705389|NCT00516048|80758634|FG001|Overall Study|Subject Decision|2|||
27705390|NCT00516048|80758635|FG002|Overall Study|Subject Decision|0|||
27705391|NCT01977820|80758636|FG000|Overall Study|Sponsor terminated the study|1|||
27705392|NCT01977820|80758637|FG001|Overall Study|Sponsor terminated the study|1|||
27705393|NCT04126083|80758640|FG000|Overall Study|Withdrawal by Subject|1|||
27888110|NCT05367973|81425290|FG001|Overall Study|Adverse Event|2|||
27888111|NCT01062113|81425293|FG000|Overall Study|Adverse Event|1|||
27705394|NCT01721057|80758642|FG000|Treatment Period|Withdrawal by Subject|11|||
27705395|NCT01721057|80758643|FG001|Treatment Period|Withdrawal by Subject|5|||
27705396|NCT01721057|80758644|FG002|Treatment Period|Withdrawal by Subject|8|||
27705397|NCT01721057|80758645|FG003|Treatment Period|Withdrawal by Subject|0|||
27705398|NCT01721057|80758646|FG004|Treatment Period|Withdrawal by Subject|0|||
27888112|NCT01062113|81425294|FG001|Overall Study|Adverse Event|0|||
27600071|NCT02044848|80374466|FG001|Overall Study|Administrative Problems|3|||
27600072|NCT01123382|80374467|FG000|Overall Study|Withdrawal by Subject|1|||
27705399|NCT01721057|80758647|FG005|Treatment Period|Withdrawal by Subject|0|||
27705400|NCT01721057|80758648|FG006|Treatment Period|Withdrawal by Subject|0|||
27705401|NCT01721057|80758642|FG000|Treatment Period|Adverse Event|7|||
27705402|NCT01721057|80758643|FG001|Treatment Period|Adverse Event|10|||
27705403|NCT01721057|80758644|FG002|Treatment Period|Adverse Event|12|||
27705404|NCT01721057|80758645|FG003|Treatment Period|Adverse Event|0|||
27705405|NCT01721057|80758646|FG004|Treatment Period|Adverse Event|0|||
27705406|NCT01721057|80758647|FG005|Treatment Period|Adverse Event|0|||
27705407|NCT01721057|80758648|FG006|Treatment Period|Adverse Event|0|||
27705408|NCT01721057|80758642|FG000|Treatment Period|Lack of Efficacy|7|||
27705409|NCT01721057|80758643|FG001|Treatment Period|Lack of Efficacy|3|||
27705410|NCT01721057|80758644|FG002|Treatment Period|Lack of Efficacy|0|||
27705411|NCT01721057|80758645|FG003|Treatment Period|Lack of Efficacy|0|||
27705412|NCT01721057|80758646|FG004|Treatment Period|Lack of Efficacy|0|||
27705413|NCT01721057|80758647|FG005|Treatment Period|Lack of Efficacy|0|||
27705414|NCT01721057|80758648|FG006|Treatment Period|Lack of Efficacy|0|||
27705415|NCT01721057|80758642|FG000|Treatment Period|Lost to Follow-up|1|||
27705416|NCT01721057|80758643|FG001|Treatment Period|Lost to Follow-up|0|||
27705417|NCT01721057|80758644|FG002|Treatment Period|Lost to Follow-up|0|||
27705418|NCT01721057|80758645|FG003|Treatment Period|Lost to Follow-up|0|||
27705419|NCT01721057|80758646|FG004|Treatment Period|Lost to Follow-up|0|||
27705420|NCT01721057|80758647|FG005|Treatment Period|Lost to Follow-up|0|||
27705421|NCT01721057|80758648|FG006|Treatment Period|Lost to Follow-up|0|||
27705422|NCT01721057|80758642|FG000|Treatment Period|Physician Decision|0|||
27705423|NCT01721057|80758643|FG001|Treatment Period|Physician Decision|1|||
27705424|NCT01721057|80758644|FG002|Treatment Period|Physician Decision|3|||
27705425|NCT01721057|80758645|FG003|Treatment Period|Physician Decision|0|||
27705426|NCT01721057|80758646|FG004|Treatment Period|Physician Decision|0|||
27705427|NCT01721057|80758647|FG005|Treatment Period|Physician Decision|0|||
27705428|NCT01721057|80758648|FG006|Treatment Period|Physician Decision|0|||
27705429|NCT01721057|80758642|FG000|Treatment Period|Death|2|||
27705430|NCT01721057|80758643|FG001|Treatment Period|Death|0|||
27705431|NCT01721057|80758644|FG002|Treatment Period|Death|0|||
27705432|NCT01721057|80758645|FG003|Treatment Period|Death|0|||
27705433|NCT01721057|80758646|FG004|Treatment Period|Death|0|||
27705434|NCT01721057|80758647|FG005|Treatment Period|Death|0|||
27705435|NCT01721057|80758648|FG006|Treatment Period|Death|0|||
27705436|NCT01721057|80758642|FG000|Rescue Period|Adverse Event|0|||
27705437|NCT01721057|80758643|FG001|Rescue Period|Adverse Event|0|||
27705438|NCT01721057|80758644|FG002|Rescue Period|Adverse Event|0|||
27705439|NCT01721057|80758645|FG003|Rescue Period|Adverse Event|1|||
27705440|NCT01721057|80758646|FG004|Rescue Period|Adverse Event|0|||
27888113|NCT01062113|81425295|FG002|Overall Study|Adverse Event|0|||
27888114|NCT01062113|81425293|FG000|Overall Study|Lack of Efficacy|38|||
27888115|NCT01062113|81425294|FG001|Overall Study|Lack of Efficacy|22|||
27888116|NCT01062113|81425295|FG002|Overall Study|Lack of Efficacy|31|||
27888117|NCT01062113|81425293|FG000|Overall Study|Withdrawal by Subject|1|||
27888118|NCT01062113|81425294|FG001|Overall Study|Withdrawal by Subject|0|||
27705441|NCT01721057|80758647|FG005|Rescue Period|Adverse Event|0|||
27705442|NCT01721057|80758648|FG006|Rescue Period|Adverse Event|0|||
27705443|NCT01721057|80758642|FG000|Rescue Period|Lack of Efficacy|0|||
27705444|NCT01721057|80758643|FG001|Rescue Period|Lack of Efficacy|0|||
27705445|NCT01721057|80758644|FG002|Rescue Period|Lack of Efficacy|0|||
27834874|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834875|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834876|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834877|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834878|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834879|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834880|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
27834881|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27705446|NCT01721057|80758645|FG003|Rescue Period|Lack of Efficacy|2|||
27705447|NCT01721057|80758646|FG004|Rescue Period|Lack of Efficacy|0|||
27705448|NCT01721057|80758647|FG005|Rescue Period|Lack of Efficacy|0|||
27705449|NCT01721057|80758648|FG006|Rescue Period|Lack of Efficacy|0|||
27600073|NCT01123382|80374468|FG001|Overall Study|Withdrawal by Subject|4|||
27600074|NCT01123382|80374467|FG000|Overall Study|Lost to Follow-up|1|||
27600075|NCT01123382|80374468|FG001|Overall Study|Lost to Follow-up|2|||
27600076|NCT02459262|80374469|FG000|Overall Study|Withdrawal by Subject|0|||
27600077|NCT02459262|80374470|FG001|Overall Study|Withdrawal by Subject|0|||
27600078|NCT02459262|80374471|FG002|Overall Study|Withdrawal by Subject|0|||
27600079|NCT02459262|80374472|FG003|Overall Study|Withdrawal by Subject|0|||
27600080|NCT02459262|80374473|FG004|Overall Study|Withdrawal by Subject|0|||
27600081|NCT02459262|80374474|FG005|Overall Study|Withdrawal by Subject|0|||
27600082|NCT02459262|80374475|FG006|Overall Study|Withdrawal by Subject|0|||
27600083|NCT02459262|80374476|FG007|Overall Study|Withdrawal by Subject|0|||
27600084|NCT02459262|80374477|FG008|Overall Study|Withdrawal by Subject|0|||
27600085|NCT02459262|80374478|FG009|Overall Study|Withdrawal by Subject|1|||
27600086|NCT02459262|80374479|FG010|Overall Study|Withdrawal by Subject|0|||
27600087|NCT04493931|80374480|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
27600088|NCT04493931|80374481|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
27600089|NCT04493931|80374482|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
27600090|NCT04493931|80374483|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
27600091|NCT04493931|80374484|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
27600092|NCT04493931|80374485|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
27600093|NCT04493931|80374486|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
27600094|NCT04493931|80374480|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
27600095|NCT04493931|80374481|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
27600096|NCT04493931|80374482|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
27600097|NCT04493931|80374483|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
27600098|NCT04493931|80374484|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
27600099|NCT04493931|80374485|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
27600100|NCT04493931|80374486|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
27600101|NCT04493931|80374480|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
27600102|NCT04493931|80374481|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
27600103|NCT04493931|80374482|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
27600104|NCT04493931|80374483|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
27600105|NCT04493931|80374484|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
27600106|NCT04493931|80374485|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
27600107|NCT04493931|80374486|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
27600108|NCT04493931|80374480|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
27600109|NCT04493931|80374481|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
27600110|NCT04493931|80374482|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
27600111|NCT04493931|80374483|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
27600112|NCT04493931|80374484|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
27600113|NCT04493931|80374485|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
27600114|NCT04493931|80374486|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
27600115|NCT03466086|80374487|FG000|Period 1|Sponsor decision due to study timeline|1|||
27600116|NCT03466086|80374488|FG001|Period 1|Sponsor decision due to study timeline|0|||
27600117|NCT03466086|80374487|FG000|Period 1|Withdrawal by Subject|1|||
27600118|NCT03466086|80374488|FG001|Period 1|Withdrawal by Subject|0|||
27600119|NCT03248375|80374491|FG000|Overall Study|Lost to Follow-up|5|||
27600120|NCT02657317|80374494|FG000|Overall Study|Withdrawal by Subject|2|||
27600121|NCT02657317|80374495|FG001|Overall Study|Withdrawal by Subject|0|||
27600122|NCT02657317|80374494|FG000|Overall Study|Lost to Follow-up|3|||
27600123|NCT02657317|80374495|FG001|Overall Study|Lost to Follow-up|3|||
27600124|NCT00590902|80374496|FG000|Overall Study|Death|1|||
27600125|NCT01559454|80374501|FG000|Overall Study|Lost to Follow-up|3|||
27600126|NCT01559454|80374502|FG001|Overall Study|Lost to Follow-up|2|||
27600127|NCT01559454|80374501|FG000|Overall Study|Withdrawal by Subject|0|||
27600128|NCT01559454|80374502|FG001|Overall Study|Withdrawal by Subject|1|||
27600129|NCT01559454|80374501|FG000|Overall Study|Physician Decision|0|||
27600130|NCT01559454|80374502|FG001|Overall Study|Physician Decision|1|||
27600131|NCT01559454|80374501|FG000|Overall Study|Protocol Violation|0|||
27600132|NCT01559454|80374502|FG001|Overall Study|Protocol Violation|1|||
27600133|NCT01559454|80374501|FG000|Overall Study|Lack of Efficacy|0|||
27600134|NCT01559454|80374502|FG001|Overall Study|Lack of Efficacy|1|||
27600135|NCT04102579|80374509|FG000|Overall Study|Withdrawal by Subject|3|||
27600136|NCT04102579|80374510|FG001|Overall Study|Withdrawal by Subject|4|||
27705450|NCT00789880|80758655|FG000|Overall Study|Adverse Event|0|||
27705451|NCT00789880|80758656|FG001|Overall Study|Adverse Event|0|||
27705452|NCT00789880|80758657|FG002|Overall Study|Adverse Event|0|||
27705453|NCT00789880|80758658|FG003|Overall Study|Adverse Event|0|||
27705454|NCT00789880|80758659|FG004|Overall Study|Adverse Event|1|||
27705455|NCT00789880|80758660|FG005|Overall Study|Adverse Event|0|||
27705456|NCT00789880|80758655|FG000|Overall Study|Protocol Violation|0|||
27705457|NCT00789880|80758656|FG001|Overall Study|Protocol Violation|1|||
27705458|NCT00789880|80758657|FG002|Overall Study|Protocol Violation|0|||
27705459|NCT00789880|80758658|FG003|Overall Study|Protocol Violation|1|||
27705460|NCT00789880|80758659|FG004|Overall Study|Protocol Violation|0|||
27705461|NCT00789880|80758660|FG005|Overall Study|Protocol Violation|0|||
27705462|NCT00789880|80758655|FG000|Overall Study|Withdrawal by Subject|1|||
27705463|NCT00789880|80758656|FG001|Overall Study|Withdrawal by Subject|0|||
27705464|NCT00789880|80758657|FG002|Overall Study|Withdrawal by Subject|0|||
27705465|NCT00789880|80758658|FG003|Overall Study|Withdrawal by Subject|0|||
27705466|NCT00789880|80758659|FG004|Overall Study|Withdrawal by Subject|2|||
27705467|NCT00789880|80758660|FG005|Overall Study|Withdrawal by Subject|0|||
27705468|NCT01168973|80758661|FG000|Overall Study|Progressive Disease|341|||
27705469|NCT01168973|80758662|FG001|Overall Study|Progressive Disease|429|||
27705470|NCT01168973|80758661|FG000|Overall Study|Adverse Event|94|||
27705471|NCT01168973|80758662|FG001|Overall Study|Adverse Event|55|||
27705472|NCT01168973|80758661|FG000|Overall Study|Withdrawal by Subject|90|||
27705473|NCT01168973|80758662|FG001|Overall Study|Withdrawal by Subject|53|||
27705474|NCT01168973|80758661|FG000|Overall Study|Death|42|||
27705475|NCT01168973|80758662|FG001|Overall Study|Death|45|||
27705476|NCT01168973|80758661|FG000|Overall Study|Physician Decision|37|||
27705477|NCT01168973|80758662|FG001|Overall Study|Physician Decision|19|||
27705478|NCT01168973|80758661|FG000|Overall Study|Sponsor Decision|2|||
27705479|NCT01168973|80758662|FG001|Overall Study|Sponsor Decision|1|||
27705480|NCT01168973|80758661|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
27705481|NCT01168973|80758662|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
27705482|NCT00591214|80758669|FG000|Overall Study|Physician Decision|7|||
27705483|NCT00591214|80758669|FG000|Overall Study|Withdrawal by Subject|1|||
27705484|NCT00915772|80758670|FG000|Overall Study|Adverse Event|12|||
27705485|NCT00915772|80758671|FG001|Overall Study|Adverse Event|13|||
27705486|NCT00915772|80758672|FG002|Overall Study|Adverse Event|11|||
27705487|NCT00915772|80758670|FG000|Overall Study|Protocol Violation|4|||
27705488|NCT00915772|80758671|FG001|Overall Study|Protocol Violation|1|||
27705489|NCT00915772|80758672|FG002|Overall Study|Protocol Violation|2|||
27705490|NCT00915772|80758670|FG000|Overall Study|Lost to Follow-up|1|||
27705491|NCT00915772|80758671|FG001|Overall Study|Lost to Follow-up|2|||
27705492|NCT00915772|80758672|FG002|Overall Study|Lost to Follow-up|2|||
27705493|NCT00915772|80758670|FG000|Overall Study|Lack of Efficacy|9|||
27705494|NCT00915772|80758671|FG001|Overall Study|Lack of Efficacy|15|||
27705495|NCT00915772|80758672|FG002|Overall Study|Lack of Efficacy|3|||
27705496|NCT00915772|80758670|FG000|Overall Study|Refused to continue trial medication|6|||
27705497|NCT00915772|80758671|FG001|Overall Study|Refused to continue trial medication|8|||
27705498|NCT00915772|80758672|FG002|Overall Study|Refused to continue trial medication|4|||
27705499|NCT00915772|80758670|FG000|Overall Study|Any other reason|4|||
27705500|NCT00915772|80758671|FG001|Overall Study|Any other reason|7|||
27705501|NCT00915772|80758672|FG002|Overall Study|Any other reason|7|||
27705502|NCT00295633|80758673|FG000|Overall Study|Lack of Efficacy|19|||
27705503|NCT00295633|80758674|FG001|Overall Study|Lack of Efficacy|7|||
27705504|NCT00295633|80758675|FG002|Overall Study|Lack of Efficacy|16|||
27705505|NCT00295633|80758673|FG000|Overall Study|Withdrawal of consent by subject|16|||
27705506|NCT00295633|80758674|FG001|Overall Study|Withdrawal of consent by subject|16|||
27705507|NCT00295633|80758675|FG002|Overall Study|Withdrawal of consent by subject|26|||
27705508|NCT00295633|80758673|FG000|Overall Study|Adverse Event|9|||
27705509|NCT00295633|80758674|FG001|Overall Study|Adverse Event|17|||
27705510|NCT00295633|80758675|FG002|Overall Study|Adverse Event|9|||
27705511|NCT00295633|80758673|FG000|Overall Study|Lost to Follow-up|6|||
27705512|NCT00295633|80758674|FG001|Overall Study|Lost to Follow-up|11|||
27705513|NCT00295633|80758675|FG002|Overall Study|Lost to Follow-up|7|||
27705514|NCT00295633|80758673|FG000|Overall Study|Physician Decision|9|||
27705515|NCT00295633|80758674|FG001|Overall Study|Physician Decision|10|||
27705516|NCT00295633|80758675|FG002|Overall Study|Physician Decision|8|||
27705517|NCT00295633|80758673|FG000|Overall Study|Poor/Noncompliance|2|||
27705518|NCT00295633|80758674|FG001|Overall Study|Poor/Noncompliance|2|||
27705519|NCT00295633|80758675|FG002|Overall Study|Poor/Noncompliance|6|||
27705520|NCT00295633|80758673|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
27705521|NCT00295633|80758674|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
27705522|NCT00295633|80758675|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
27705523|NCT00295633|80758673|FG000|Overall Study|Death|1|||
27705524|NCT00295633|80758674|FG001|Overall Study|Death|1|||
27834882|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27705525|NCT00295633|80758675|FG002|Overall Study|Death|0|||
27705526|NCT00295633|80758673|FG000|Overall Study|Administrative reason by sponsor|0|||
27705527|NCT00295633|80758674|FG001|Overall Study|Administrative reason by sponsor|0|||
27705528|NCT00295633|80758675|FG002|Overall Study|Administrative reason by sponsor|1|||
27705529|NCT02181816|80758689|FG000|Overall Study|Case Report Forms Uncollected|38|||
27705530|NCT02181816|80758689|FG000|Overall Study|Protocol Deviation|21|||
27705531|NCT00955279|80758692|FG000|Overall Study|Other|0|||
27705532|NCT00955279|80758693|FG001|Overall Study|Other|0|||
27705533|NCT00955279|80758694|FG002|Overall Study|Other|3|||
27705534|NCT00955279|80758692|FG000|Overall Study|Death|1|||
27705535|NCT00955279|80758693|FG001|Overall Study|Death|1|||
27705536|NCT00955279|80758694|FG002|Overall Study|Death|1|||
27705537|NCT00955279|80758692|FG000|Overall Study|Lost to Follow-up|0|||
27705538|NCT00955279|80758693|FG001|Overall Study|Lost to Follow-up|3|||
27705539|NCT00955279|80758694|FG002|Overall Study|Lost to Follow-up|1|||
27705540|NCT00955279|80758692|FG000|Overall Study|Withdrawal by Subject|2|||
27705541|NCT00955279|80758693|FG001|Overall Study|Withdrawal by Subject|0|||
27705542|NCT00955279|80758694|FG002|Overall Study|Withdrawal by Subject|3|||
27705543|NCT00930722|80758695|FG000|Overall Study|Lost to Follow-up|16|||
27705544|NCT00930722|80758695|FG000|Overall Study|No longer willing to participate|9|||
27705545|NCT00930722|80758695|FG000|Overall Study|Study terminated by sponsor|2|||
27705546|NCT03034460|80758699|FG000|Overall Study|Adverse Event|0|||
27705547|NCT03034460|80758700|FG001|Overall Study|Adverse Event|1|||
27705548|NCT03034460|80758699|FG000|Overall Study|Withdrawal by Subject|2|||
27705549|NCT03034460|80758700|FG001|Overall Study|Withdrawal by Subject|2|||
27705550|NCT03034460|80758699|FG000|Overall Study|Personal Reasons|1|||
27705551|NCT03034460|80758700|FG001|Overall Study|Personal Reasons|0|||
27705552|NCT01553188|80758701|FG000|Overall Study|Patient choice|1|||
27705553|NCT01553188|80758702|FG001|Overall Study|Patient choice|0|||
27705554|NCT01553188|80758703|FG002|Overall Study|Patient choice|0|||
27705555|NCT01553188|80758704|FG003|Overall Study|Patient choice|0|||
27705556|NCT01553188|80758701|FG000|Overall Study|Intercurrent illness and adverse event|0|||
27705557|NCT01553188|80758702|FG001|Overall Study|Intercurrent illness and adverse event|1|||
27705558|NCT01553188|80758703|FG002|Overall Study|Intercurrent illness and adverse event|2|||
27705559|NCT01553188|80758704|FG003|Overall Study|Intercurrent illness and adverse event|0|||
27705560|NCT00314249|80758705|FG000|Overall Study|Adverse Event|73|||
27705561|NCT00314249|80758706|FG001|Overall Study|Adverse Event|94|||
27705562|NCT00314249|80758705|FG000|Overall Study|Lack of Efficacy|33|||
27705563|NCT00314249|80758706|FG001|Overall Study|Lack of Efficacy|24|||
27705564|NCT00314249|80758705|FG000|Overall Study|Withdrawal by Subject|21|||
27705565|NCT00314249|80758706|FG001|Overall Study|Withdrawal by Subject|28|||
27705566|NCT00314249|80758705|FG000|Overall Study|Lost to Follow-up|15|||
27705567|NCT00314249|80758706|FG001|Overall Study|Lost to Follow-up|9|||
27705568|NCT00314249|80758705|FG000|Overall Study|Physician Decision|1|||
27705569|NCT00314249|80758706|FG001|Overall Study|Physician Decision|1|||
27705570|NCT00314249|80758705|FG000|Overall Study|Withdrawn for other reasons|4|||
27705571|NCT00314249|80758706|FG001|Overall Study|Withdrawn for other reasons|1|||
27705572|NCT00314249|80758705|FG000|Overall Study|Non-Compliant|5|||
27705573|NCT00314249|80758706|FG001|Overall Study|Non-Compliant|6|||
27705574|NCT00054704|80758707|FG000|Overall Study|Lack of Efficacy|2|||
27705575|NCT00054704|80758708|FG001|Overall Study|Lack of Efficacy|3|||
27705576|NCT00054704|80758707|FG000|Overall Study|Adverse Event|3|||
27705577|NCT00054704|80758708|FG001|Overall Study|Adverse Event|1|||
27705578|NCT00054704|80758707|FG000|Overall Study|Lost to Follow-up|0|||
27705579|NCT00054704|80758708|FG001|Overall Study|Lost to Follow-up|1|||
27705580|NCT01128361|80758718|FG000|Overall Study|Lost to Follow-up|0|||
27705581|NCT01128361|80758719|FG001|Overall Study|Lost to Follow-up|1|||
27888119|NCT01062113|81425295|FG002|Overall Study|Withdrawal by Subject|0|||
27888120|NCT03218826|81425296|FG000|Overall Study|Non-compliance with protocol|1|||
27600137|NCT04102579|80374509|FG000|Overall Study|Lost to Follow-up|0|||
27705582|NCT01128361|80758718|FG000|Overall Study|Withdrawal by Subject|5|||
27705583|NCT01128361|80758719|FG001|Overall Study|Withdrawal by Subject|2|||
27705584|NCT03838198|80758722|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
27705585|NCT03838198|80758723|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
27705586|NCT03838198|80758724|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
27705587|NCT03838198|80758725|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
27705588|NCT03838198|80758722|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
27705589|NCT03838198|80758723|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
27705590|NCT03838198|80758724|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
27705591|NCT03838198|80758725|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
27600138|NCT04102579|80374510|FG001|Overall Study|Lost to Follow-up|1|||
27600139|NCT04102579|80374509|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
27600140|NCT04102579|80374510|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
27600141|NCT04102579|80374509|FG000|Overall Study|Other than Specified|1|||
27600142|NCT04102579|80374510|FG001|Overall Study|Other than Specified|0|||
27600143|NCT04102579|80374509|FG000|Overall Study|Not Dosed with Study Drug|0|||
27600144|NCT04102579|80374510|FG001|Overall Study|Not Dosed with Study Drug|1|||
27600145|NCT01111123|80374511|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
27600146|NCT01111123|80374512|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
27600147|NCT01111123|80374511|FG000|Maintenance Phase|Lost to Follow-up|0|||
27600148|NCT01111123|80374512|FG001|Maintenance Phase|Lost to Follow-up|2|||
27600149|NCT00542880|80374513|FG000|Period 1|Eligibility criteria not fulfilled|2|||
27600150|NCT00542880|80374514|FG001|Period 1|Eligibility criteria not fulfilled|6|||
27600151|NCT00542880|80374513|FG000|Period 1|Adverse Event|2|||
27600152|NCT00542880|80374514|FG001|Period 1|Adverse Event|2|||
27600153|NCT00542880|80374513|FG000|Period 1|Development of study-specific criteria|1|||
27600154|NCT00542880|80374514|FG001|Period 1|Development of study-specific criteria|2|||
27600155|NCT00542880|80374513|FG000|Period 1|Withdrawal by Subject|1|||
27600156|NCT00542880|80374514|FG001|Period 1|Withdrawal by Subject|1|||
27600157|NCT00542880|80374513|FG000|Period 1|Protocol Violation|0|||
27600158|NCT00542880|80374514|FG001|Period 1|Protocol Violation|1|||
27705592|NCT00698997|80758726|FG000|Overall Study|Lost to Follow-up|3|||
27705593|NCT00698997|80758727|FG001|Overall Study|Lost to Follow-up|0|||
27705594|NCT00698997|80758726|FG000|Overall Study|Withdrawal by Subject|7|||
27705595|NCT00698997|80758727|FG001|Overall Study|Withdrawal by Subject|27|||
27705596|NCT00621751|80758728|FG000|Overall Study|Adverse Event|0|||
27705597|NCT00621751|80758729|FG001|Overall Study|Adverse Event|1|||
27754811|NCT02546674|80929604|FG000|Overall Study|Subject/Guardian Decision|6|||
27754812|NCT02546674|80929604|FG000|Overall Study|Withdrawal of Informed Consent|3|||
27754813|NCT00585923|80929612|FG000|Overall Study|Physician decided not to continue|31|||
27754814|NCT00585923|80929613|FG001|Overall Study|Physician decided not to continue|33|||
27754815|NCT00953043|80929614|FG000|Overall Study|Withdrawal by Subject|4|||
27754816|NCT00953043|80929615|FG001|Overall Study|Withdrawal by Subject|0|||
27754817|NCT00953043|80929614|FG000|Overall Study|Physician Decision|0|||
27754818|NCT00953043|80929615|FG001|Overall Study|Physician Decision|2|||
27754819|NCT00471536|80929616|FG000|Overall Study|Withdrawal by Subject|1|||
27754820|NCT00406783|80929617|FG000|Overall Study|Adverse Event|4|||
27754821|NCT00406783|80929618|FG001|Overall Study|Adverse Event|4|||
27754822|NCT00406783|80929617|FG000|Overall Study|Treatment Failure|2|||
27754823|NCT00406783|80929618|FG001|Overall Study|Treatment Failure|3|||
27754824|NCT00406783|80929617|FG000|Overall Study|Lost to Follow-up|3|||
27754825|NCT00406783|80929618|FG001|Overall Study|Lost to Follow-up|0|||
27754826|NCT00406783|80929617|FG000|Overall Study|Withdrawal by Subject|1|||
27754827|NCT00406783|80929618|FG001|Overall Study|Withdrawal by Subject|4|||
27754828|NCT00406783|80929617|FG000|Overall Study|Protocol Violation|4|||
27754829|NCT00406783|80929618|FG001|Overall Study|Protocol Violation|4|||
27754830|NCT04191967|80929621|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
27754831|NCT04191967|80929621|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
27754832|NCT00446446|80929622|FG000|Overall Study|Death|10|||
27754833|NCT00446446|80929622|FG000|Overall Study|Withdrawal by Subject|6|||
27754834|NCT00446446|80929622|FG000|Overall Study|Other|4|||
27754835|NCT00446446|80929622|FG000|Overall Study|Disease Progession|2|||
27754836|NCT00446446|80929622|FG000|Overall Study|Adverse Event|1|||
27754837|NCT00446446|80929622|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
27754838|NCT00622869|80929623|FG000|Overall Study|Subject Withdrew Consent|13|||
27754839|NCT00622869|80929624|FG001|Overall Study|Subject Withdrew Consent|17|||
27754840|NCT00622869|80929625|FG002|Overall Study|Subject Withdrew Consent|11|||
27754841|NCT00622869|80929623|FG000|Overall Study|Administrative Problems|11|||
27754842|NCT00622869|80929624|FG001|Overall Study|Administrative Problems|17|||
27754843|NCT00622869|80929625|FG002|Overall Study|Administrative Problems|13|||
27754844|NCT00622869|80929623|FG000|Overall Study|Death|12|||
27754845|NCT00622869|80929624|FG001|Overall Study|Death|15|||
27754846|NCT00622869|80929625|FG002|Overall Study|Death|10|||
27754847|NCT00622869|80929623|FG000|Overall Study|Lost to Follow-up|2|||
27754848|NCT00622869|80929624|FG001|Overall Study|Lost to Follow-up|4|||
27754849|NCT00622869|80929625|FG002|Overall Study|Lost to Follow-up|2|||
27754850|NCT00622869|80929623|FG000|Overall Study|Graft Loss|5|||
27754851|NCT00622869|80929624|FG001|Overall Study|Graft Loss|3|||
27754852|NCT00622869|80929625|FG002|Overall Study|Graft Loss|2|||
27754853|NCT00622869|80929623|FG000|Overall Study|Missing|0|||
27754854|NCT00622869|80929624|FG001|Overall Study|Missing|1|||
27754855|NCT00622869|80929625|FG002|Overall Study|Missing|1|||
27754856|NCT01067508|80929626|FG000|Overall Study|Physician Decision|0|||
27754857|NCT01067508|80929627|FG001|Overall Study|Physician Decision|1|||
27705598|NCT01011439|80762038|FG000|Overall Study|Death|37|||
27705599|NCT01011439|80762038|FG000|Overall Study|Lost to Follow-up|4|||
27705600|NCT01011439|80762038|FG000|Overall Study|Withdrawal by Subject|1|||
27705601|NCT01011439|80762038|FG000|Overall Study|Sponsor's decision|15|||
27705602|NCT02361944|80762041|FG000|Overall Study|surgery cancellation|0|||
27705603|NCT02361944|80762042|FG001|Overall Study|surgery cancellation|1|||
27705604|NCT02495844|80762044|FG000|Overall Study|Lack of Efficacy|1|||
27705605|NCT02495844|80762045|FG001|Overall Study|Lack of Efficacy|2|||
27705606|NCT02495844|80762044|FG000|Overall Study|AE, non-fatal|0|||
27705607|NCT02495844|80762045|FG001|Overall Study|AE, non-fatal|1|||
27705608|NCT02495844|80762044|FG000|Overall Study|Hepatitis Positivity|0|||
27705609|NCT02495844|80762045|FG001|Overall Study|Hepatitis Positivity|1|||
27705610|NCT01022996|80762046|FG000|Overall Study|Adverse Event|14|||
27705611|NCT01022996|80762046|FG000|Overall Study|Withdrawal by Subject|3|||
27705612|NCT01022996|80762046|FG000|Overall Study|Lost to Follow-up|1|||
27705613|NCT01022996|80762046|FG000|Overall Study|Administrative problems|6|||
27705614|NCT01022996|80762046|FG000|Overall Study|Disease Progression|32|||
27705615|NCT01022996|80762046|FG000|Overall Study|Protocol Violation|1|||
27705616|NCT00117507|80762047|FG000|Overall Study|Adverse Event|4|||
27705617|NCT00117507|80762047|FG000|Overall Study|Abnormal laboratory values|3|||
27705618|NCT00117507|80762047|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27705619|NCT00117507|80762047|FG000|Overall Study|Patient withdrew consent|4|||
27705620|NCT00117507|80762047|FG000|Overall Study|Death|3|||
27705621|NCT03086057|80762048|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
27705622|NCT03086057|80762049|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
27705623|NCT03086057|80762050|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
27705624|NCT03086057|80762051|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
27705625|NCT03086057|80762048|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
27705626|NCT03086057|80762049|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
27705627|NCT03086057|80762050|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
27705628|NCT03086057|80762051|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
27705629|NCT03086057|80762048|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
27705630|NCT03086057|80762049|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
27705631|NCT03086057|80762050|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
27705632|NCT03086057|80762051|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
27705633|NCT03086057|80762048|FG000|Stage 1: PrEP Uptake|Death|1|||
27705634|NCT03086057|80762049|FG001|Stage 1: PrEP Uptake|Death|0|||
27705635|NCT03086057|80762050|FG002|Stage 1: PrEP Uptake|Death|0|||
27705636|NCT03086057|80762051|FG003|Stage 1: PrEP Uptake|Death|0|||
27705637|NCT03086057|80762048|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
27705638|NCT03086057|80762049|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
27888121|NCT03218826|81425297|FG001|Overall Study|Non-compliance with protocol|0|||
27705639|NCT03086057|80762050|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
27705640|NCT03086057|80762051|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
27705641|NCT03086057|80762048|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
27705642|NCT03086057|80762049|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
27705643|NCT03086057|80762050|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
27705644|NCT03086057|80762051|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
27705645|NCT03086057|80762048|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
27705646|NCT03086057|80762049|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
27705647|NCT03086057|80762050|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
27705648|NCT03086057|80762051|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
27705649|NCT01984164|80762053|FG000|Overall Study|Withdrawal by Subject|4|||
27705650|NCT01984164|80762054|FG001|Overall Study|Withdrawal by Subject|3|||
27705651|NCT01984164|80762053|FG000|Overall Study|Adverse Event|5|||
27705652|NCT01984164|80762054|FG001|Overall Study|Adverse Event|19|||
27705653|NCT01984164|80762053|FG000|Overall Study|Lost to Follow-up|1|||
27705654|NCT01984164|80762054|FG001|Overall Study|Lost to Follow-up|3|||
27705655|NCT03625687|80762057|FG000|Overall Study|Death|1|||
27705656|NCT00397033|80762058|FG000|Overall Study|Adverse Event|7|||
27705657|NCT00397033|80762059|FG001|Overall Study|Adverse Event|10|||
27600159|NCT00542880|80374513|FG000|Period 2|Adverse Event|5|||
27600160|NCT00542880|80374514|FG001|Period 2|Adverse Event|7|||
27600161|NCT00542880|80374513|FG000|Period 2|Eligibility not fulfilled|0|||
27600162|NCT00542880|80374514|FG001|Period 2|Eligibility not fulfilled|1|||
27600163|NCT00542880|80374513|FG000|Period 2|Discontinuation criteria|2|||
27600164|NCT00542880|80374514|FG001|Period 2|Discontinuation criteria|0|||
27600165|NCT00542880|80374513|FG000|Period 2|Severe non-compliance|0|||
27600166|NCT00542880|80374514|FG001|Period 2|Severe non-compliance|1|||
27600167|NCT00542880|80374513|FG000|Period 2|Other|0|||
27705658|NCT00397033|80762060|FG002|Overall Study|Adverse Event|4|||
27705659|NCT00397033|80762058|FG000|Overall Study|Lack of Efficacy|22|||
27705660|NCT00397033|80762059|FG001|Overall Study|Lack of Efficacy|12|||
27600168|NCT00542880|80374514|FG001|Period 2|Other|1|||
27600169|NCT00542880|80374513|FG000|Period 3|Adverse Event|0|||
27705661|NCT00397033|80762060|FG002|Overall Study|Lack of Efficacy|9|||
27888122|NCT03218826|81425298|FG002|Overall Study|Non-compliance with protocol|2|||
27888123|NCT03218826|81425299|FG003|Overall Study|Non-compliance with protocol|1|||
27888124|NCT03218826|81425300|FG004|Overall Study|Non-compliance with protocol|1|||
27888125|NCT04720911|81425305|FG000|Overall Study|Withdrawal by Subject|0|||
27888126|NCT04720911|81425306|FG001|Overall Study|Withdrawal by Subject|1|||
27888127|NCT04720911|81425307|FG002|Overall Study|Withdrawal by Subject|0|||
27705662|NCT00397033|80762058|FG000|Overall Study|Lost to Follow-up|3|||
27834883|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834884|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834885|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834886|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834887|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834888|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834889|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834890|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834891|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834892|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834893|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834894|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834895|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834896|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834897|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
27834898|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834899|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834900|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834901|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834902|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834903|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834904|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834905|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834906|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
27834907|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834908|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834909|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834910|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834911|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834912|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
27600170|NCT00542880|80374514|FG001|Period 3|Adverse Event|2|||
27600171|NCT02342886|80374516|FG000|Overall Study|Treatment non-compliance|1|||
27600172|NCT02342886|80374517|FG001|Overall Study|Treatment non-compliance|0|||
27600173|NCT02342886|80374518|FG002|Overall Study|Treatment non-compliance|0|||
27600174|NCT02342886|80374519|FG003|Overall Study|Treatment non-compliance|1|||
27600175|NCT02342886|80374520|FG004|Overall Study|Treatment non-compliance|0|||
27600176|NCT02342886|80374516|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
27705663|NCT00397033|80762059|FG001|Overall Study|Lost to Follow-up|3|||
27705664|NCT00397033|80762060|FG002|Overall Study|Lost to Follow-up|3|||
27705665|NCT00397033|80762058|FG000|Overall Study|Withdrawal by Subject|12|||
27705666|NCT00397033|80762059|FG001|Overall Study|Withdrawal by Subject|7|||
27705667|NCT00397033|80762060|FG002|Overall Study|Withdrawal by Subject|5|||
27705668|NCT00397033|80762058|FG000|Overall Study|Other|0|||
27705669|NCT00397033|80762059|FG001|Overall Study|Other|5|||
27705670|NCT00397033|80762060|FG002|Overall Study|Other|2|||
27888128|NCT00833482|81425308|FG000|Days 11-20|Adverse Event|0|||
27888129|NCT00833482|81425309|FG001|Days 11-20|Adverse Event|2|||
27888130|NCT00833482|81425310|FG002|Days 11-20|Adverse Event|0|||
27888131|NCT00833482|81425311|FG003|Days 11-20|Adverse Event|0|||
27888132|NCT00833482|81425312|FG004|Days 11-20|Adverse Event|0|||
27888133|NCT00833482|81425313|FG005|Days 11-20|Adverse Event|0|||
27888134|NCT00833482|81425308|FG000|Days 11-20|Withdrawal by Subject|0|||
27888135|NCT00833482|81425309|FG001|Days 11-20|Withdrawal by Subject|1|||
27888136|NCT00833482|81425310|FG002|Days 11-20|Withdrawal by Subject|0|||
27888137|NCT00833482|81425311|FG003|Days 11-20|Withdrawal by Subject|0|||
27888138|NCT00833482|81425312|FG004|Days 11-20|Withdrawal by Subject|0|||
27888139|NCT00833482|81425313|FG005|Days 11-20|Withdrawal by Subject|0|||
27888140|NCT00833482|81425308|FG000|Days 21-30|Adverse Event|0|||
27888141|NCT00833482|81425309|FG001|Days 21-30|Adverse Event|0|||
27888142|NCT00833482|81425310|FG002|Days 21-30|Adverse Event|1|||
27888143|NCT00833482|81425311|FG003|Days 21-30|Adverse Event|0|||
27888144|NCT00833482|81425312|FG004|Days 21-30|Adverse Event|0|||
27888145|NCT00833482|81425313|FG005|Days 21-30|Adverse Event|0|||
27888146|NCT00833482|81425308|FG000|Days 21-30|Withdrawal by Subject|0|||
27888147|NCT00833482|81425309|FG001|Days 21-30|Withdrawal by Subject|0|||
27888148|NCT00833482|81425310|FG002|Days 21-30|Withdrawal by Subject|0|||
27888149|NCT00833482|81425311|FG003|Days 21-30|Withdrawal by Subject|0|||
27888150|NCT00833482|81425312|FG004|Days 21-30|Withdrawal by Subject|1|||
27888151|NCT00833482|81425313|FG005|Days 21-30|Withdrawal by Subject|0|||
27888152|NCT00750139|81425316|FG000|Overall Study|Adverse Event|1|||
27705671|NCT00482703|80762061|FG000|Overall Study|Poor compliance|1|||
27705672|NCT00482703|80762062|FG001|Overall Study|Poor compliance|0|||
27888153|NCT00750139|81425317|FG001|Overall Study|Adverse Event|2|||
27705673|NCT00733954|80762063|FG000|Overall Study|Lost to Follow-up|5|||
27888154|NCT00750139|81425318|FG002|Overall Study|Adverse Event|0|||
27888155|NCT00750139|81425319|FG003|Overall Study|Adverse Event|1|||
27888156|NCT00750139|81425316|FG000|Overall Study|Lost to Follow-up|17|||
27888157|NCT00750139|81425317|FG001|Overall Study|Lost to Follow-up|12|||
27705674|NCT00733954|80762064|FG001|Overall Study|Lost to Follow-up|2|||
27705675|NCT00733954|80762063|FG000|Overall Study|Protocol Violation|1|||
27705676|NCT00733954|80762064|FG001|Overall Study|Protocol Violation|0|||
27705677|NCT00733954|80762063|FG000|Overall Study|Withdrawal by Subject|2|||
27705678|NCT00733954|80762064|FG001|Overall Study|Withdrawal by Subject|0|||
27705679|NCT00922480|80762070|FG000|Main Study|Protocol Violation|3|||
27705680|NCT00922480|80762071|FG001|Main Study|Protocol Violation|6|||
27705681|NCT00922480|80762070|FG000|Main Study|Adverse Event|6|||
27705682|NCT00922480|80762071|FG001|Main Study|Adverse Event|7|||
27705683|NCT00922480|80762070|FG000|Main Study|Lack of Efficacy|3|||
27705684|NCT00922480|80762071|FG001|Main Study|Lack of Efficacy|0|||
27705685|NCT00922480|80762070|FG000|Main Study|Withdrawal by Subject|20|||
27705686|NCT00922480|80762071|FG001|Main Study|Withdrawal by Subject|15|||
27705687|NCT00922480|80762070|FG000|Main Study|Lost to Follow-up|5|||
27705688|NCT00922480|80762071|FG001|Main Study|Lost to Follow-up|0|||
27705689|NCT00922480|80762070|FG000|Main Study|Physician Decision|0|||
27705690|NCT00922480|80762071|FG001|Main Study|Physician Decision|1|||
27705691|NCT00922480|80762070|FG000|Extension Study|Protocol Violation|3|||
27888158|NCT00750139|81425318|FG002|Overall Study|Lost to Follow-up|15|||
27888159|NCT00750139|81425319|FG003|Overall Study|Lost to Follow-up|6|||
27888160|NCT00750139|81425316|FG000|Overall Study|Withdrawal by Subject|3|||
27888161|NCT00750139|81425317|FG001|Overall Study|Withdrawal by Subject|2|||
27888162|NCT00750139|81425318|FG002|Overall Study|Withdrawal by Subject|6|||
27888163|NCT00750139|81425319|FG003|Overall Study|Withdrawal by Subject|2|||
27888164|NCT00750139|81425316|FG000|Overall Study|Physician Decision|1|||
27888165|NCT00750139|81425317|FG001|Overall Study|Physician Decision|1|||
27888166|NCT00750139|81425318|FG002|Overall Study|Physician Decision|0|||
27888167|NCT00750139|81425319|FG003|Overall Study|Physician Decision|0|||
27888168|NCT00750139|81425316|FG000|Overall Study|Non-compliance|1|||
27888169|NCT00750139|81425317|FG001|Overall Study|Non-compliance|0|||
27600177|NCT02342886|80374517|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
27600178|NCT02342886|80374518|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
27600179|NCT02342886|80374519|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
27600180|NCT02342886|80374520|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
27600181|NCT02342886|80374516|FG000|Overall Study|Adverse event/specific toxicity|4|||
27600182|NCT02342886|80374517|FG001|Overall Study|Adverse event/specific toxicity|3|||
27600183|NCT02342886|80374518|FG002|Overall Study|Adverse event/specific toxicity|11|||
27600184|NCT02342886|80374519|FG003|Overall Study|Adverse event/specific toxicity|2|||
27600185|NCT02342886|80374520|FG004|Overall Study|Adverse event/specific toxicity|1|||
27600186|NCT02342886|80374516|FG000|Overall Study|Lost to Follow-up|1|||
27600187|NCT02342886|80374517|FG001|Overall Study|Lost to Follow-up|0|||
27600188|NCT02342886|80374518|FG002|Overall Study|Lost to Follow-up|0|||
27600189|NCT02342886|80374519|FG003|Overall Study|Lost to Follow-up|0|||
27600190|NCT02342886|80374520|FG004|Overall Study|Lost to Follow-up|0|||
27600191|NCT02342886|80374516|FG000|Overall Study|Death|1|||
27600192|NCT02342886|80374517|FG001|Overall Study|Death|2|||
27600193|NCT02342886|80374518|FG002|Overall Study|Death|1|||
27600194|NCT02342886|80374519|FG003|Overall Study|Death|0|||
27600195|NCT02342886|80374520|FG004|Overall Study|Death|1|||
27600196|NCT02342886|80374516|FG000|Overall Study|Withdrawal by Subject|0|||
27600197|NCT02342886|80374517|FG001|Overall Study|Withdrawal by Subject|1|||
27600198|NCT02342886|80374518|FG002|Overall Study|Withdrawal by Subject|0|||
27600199|NCT02342886|80374519|FG003|Overall Study|Withdrawal by Subject|1|||
27600200|NCT02342886|80374520|FG004|Overall Study|Withdrawal by Subject|0|||
27600201|NCT02342886|80374516|FG000|Overall Study|Investigator/sponsor decision|0|||
27600202|NCT02342886|80374517|FG001|Overall Study|Investigator/sponsor decision|2|||
27705692|NCT00922480|80762071|FG001|Extension Study|Protocol Violation|0|||
27705693|NCT00922480|80762070|FG000|Extension Study|Adverse Event|1|||
27888170|NCT00750139|81425318|FG002|Overall Study|Non-compliance|1|||
27888171|NCT00750139|81425319|FG003|Overall Study|Non-compliance|3|||
27600203|NCT02342886|80374518|FG002|Overall Study|Investigator/sponsor decision|0|||
27600204|NCT02342886|80374519|FG003|Overall Study|Investigator/sponsor decision|3|||
27600205|NCT02342886|80374520|FG004|Overall Study|Investigator/sponsor decision|1|||
27600206|NCT02342886|80374516|FG000|Overall Study|Pregnancy|0|||
27600207|NCT02342886|80374517|FG001|Overall Study|Pregnancy|0|||
27600208|NCT02342886|80374518|FG002|Overall Study|Pregnancy|2|||
27705694|NCT00922480|80762071|FG001|Extension Study|Adverse Event|1|||
27888172|NCT00750139|81425316|FG000|Overall Study|Termination by sponsor|4|||
27600209|NCT02342886|80374519|FG003|Overall Study|Pregnancy|0|||
27705695|NCT00922480|80762070|FG000|Extension Study|Withdrawal by Subject|1|||
27888173|NCT00750139|81425317|FG001|Overall Study|Termination by sponsor|0|||
27600210|NCT02342886|80374520|FG004|Overall Study|Pregnancy|0|||
27600211|NCT02342886|80374516|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27600212|NCT02342886|80374517|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27705696|NCT00922480|80762071|FG001|Extension Study|Withdrawal by Subject|1|||
27705697|NCT00922480|80762070|FG000|Extension Study|Others|0|||
27600213|NCT02342886|80374518|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
27600214|NCT02342886|80374519|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27600215|NCT02342886|80374520|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
27600216|NCT02342886|80374516|FG000|Overall Study|Protocol Violation|0|||
27600217|NCT02342886|80374517|FG001|Overall Study|Protocol Violation|0|||
27600218|NCT02342886|80374518|FG002|Overall Study|Protocol Violation|0|||
27600219|NCT02342886|80374519|FG003|Overall Study|Protocol Violation|2|||
27600220|NCT02342886|80374520|FG004|Overall Study|Protocol Violation|0|||
27600221|NCT04721925|80374521|FG000|2-Month Assessment|Lost to Follow-up|5|||
27600222|NCT04721925|80374522|FG001|2-Month Assessment|Lost to Follow-up|3|||
27600223|NCT04721925|80374521|FG000|4-Month Assessment|Lost to Follow-up|3|||
27600224|NCT04721925|80374522|FG001|4-Month Assessment|Lost to Follow-up|6|||
27600225|NCT02432105|80374523|FG000|Overall Study|Lost to Follow-up|1|||
27600226|NCT02432105|80374524|FG001|Overall Study|Lost to Follow-up|1|||
27600227|NCT02432105|80374525|FG002|Overall Study|Lost to Follow-up|0|||
27600228|NCT02432105|80374523|FG000|Overall Study|Withdrawal by Subject|1|||
27600229|NCT02432105|80374524|FG001|Overall Study|Withdrawal by Subject|0|||
27600230|NCT02432105|80374525|FG002|Overall Study|Withdrawal by Subject|1|||
27600231|NCT02432105|80374523|FG000|Overall Study|Culture positive for yeast|0|||
27600232|NCT02432105|80374524|FG001|Overall Study|Culture positive for yeast|1|||
27600233|NCT02432105|80374525|FG002|Overall Study|Culture positive for yeast|0|||
27600234|NCT02432105|80374523|FG000|Overall Study|Randomized in error|0|||
27600235|NCT02432105|80374524|FG001|Overall Study|Randomized in error|0|||
27600236|NCT02432105|80374525|FG002|Overall Study|Randomized in error|2|||
27600237|NCT02384759|80374527|FG000|Overall Study|Patients not treated|3|||
27600238|NCT02384759|80374528|FG001|Overall Study|Patients not treated|2|||
27600239|NCT00671931|80374531|FG000|Overall Study|Physician Decision|1|||
27600240|NCT00671931|80374532|FG001|Overall Study|Physician Decision|0|||
27600241|NCT00671931|80374533|FG002|Overall Study|Physician Decision|0|||
27600242|NCT00671931|80374534|FG003|Overall Study|Physician Decision|2|||
27705698|NCT00922480|80762071|FG001|Extension Study|Others|1|||
27705699|NCT03349775|80762072|FG000|Overall Study|Side Effects|1|||
27705700|NCT03349775|80762073|FG001|Overall Study|Side Effects|2|||
27705701|NCT03349775|80762072|FG000|Overall Study|Withdrawal by Subject|1|||
27705702|NCT03349775|80762073|FG001|Overall Study|Withdrawal by Subject|1|||
27705703|NCT03349775|80762072|FG000|Overall Study|No primary outcome measurements|0|||
27705704|NCT03349775|80762073|FG001|Overall Study|No primary outcome measurements|1|||
27705705|NCT00097773|80762075|FG000|Overall Study|Lost to Follow-up|2|||
27705706|NCT00097773|80762076|FG001|Overall Study|Lost to Follow-up|2|||
27705707|NCT00097773|80762077|FG002|Overall Study|Lost to Follow-up|0|||
27888174|NCT00750139|81425318|FG002|Overall Study|Termination by sponsor|0|||
27888175|NCT00750139|81425319|FG003|Overall Study|Termination by sponsor|1|||
27705708|NCT00097773|80762078|FG003|Overall Study|Lost to Follow-up|1|||
27705709|NCT00097773|80762075|FG000|Overall Study|Physician Decision|2|||
27705710|NCT00097773|80762076|FG001|Overall Study|Physician Decision|2|||
27600243|NCT00671931|80374535|FG004|Overall Study|Physician Decision|1|||
27600244|NCT02275065|80374536|FG000|Overall Study|Randomized but not treated|1|||
27600245|NCT02275065|80374537|FG001|Overall Study|Randomized but not treated|0|||
27705711|NCT00097773|80762077|FG002|Overall Study|Physician Decision|3|||
27705712|NCT00097773|80762078|FG003|Overall Study|Physician Decision|1|||
27705713|NCT00097773|80762075|FG000|Overall Study|Withdrawal by Subject|3|||
27600246|NCT02275065|80374538|FG002|Overall Study|Randomized but not treated|1|||
27600247|NCT02275065|80374539|FG003|Overall Study|Randomized but not treated|1|||
27600248|NCT02275065|80374540|FG004|Overall Study|Randomized but not treated|0|||
27600249|NCT00045305|80374541|FG000|Overall Study|Lack of Efficacy|6|||
27600250|NCT00045305|80374541|FG000|Overall Study|Adverse Event|3|||
27600251|NCT00045305|80374541|FG000|Overall Study|Death|3|||
27600252|NCT00045305|80374541|FG000|Overall Study|site error|2|||
27600253|NCT00633464|80374542|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
27600254|NCT00633464|80374543|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
27705714|NCT00097773|80762076|FG001|Overall Study|Withdrawal by Subject|3|||
27600255|NCT00633464|80374542|FG000|Overall Study|Never Treated (Randomized in error)|0|||
27600256|NCT00633464|80374543|FG001|Overall Study|Never Treated (Randomized in error)|1|||
27600257|NCT00977665|80374544|FG000|Overall Study|Withdrawal by Subject|1|||
27600258|NCT00977665|80374545|FG001|Overall Study|Withdrawal by Subject|3|||
27600259|NCT00977665|80374544|FG000|Overall Study|Physician Decision|2|||
27600260|NCT00977665|80374545|FG001|Overall Study|Physician Decision|1|||
27600261|NCT00977665|80374544|FG000|Overall Study|Sponsor requested withdrawal|0|||
27600262|NCT00977665|80374545|FG001|Overall Study|Sponsor requested withdrawal|1|||
27600263|NCT00977665|80374544|FG000|Overall Study|Lost to Follow-up|1|||
27600264|NCT00977665|80374545|FG001|Overall Study|Lost to Follow-up|0|||
27600265|NCT00977665|80374544|FG000|Overall Study|Death|3|||
27600266|NCT00977665|80374545|FG001|Overall Study|Death|2|||
27600267|NCT00977665|80374544|FG000|Overall Study|Adverse Event|14|||
27600268|NCT00977665|80374545|FG001|Overall Study|Adverse Event|7|||
27600269|NCT00977665|80374544|FG000|Overall Study|Treatment failure|0|||
27600270|NCT00977665|80374545|FG001|Overall Study|Treatment failure|1|||
27600271|NCT00710606|80374555|FG000|Overall Study|Adverse Event|0|||
27600272|NCT00710606|80374556|FG001|Overall Study|Adverse Event|2|||
27600273|NCT00989092|80374557|FG000|Overall Study|Physician Decision|9|||
27600274|NCT00989092|80374558|FG001|Overall Study|Physician Decision|6|||
27600275|NCT00989092|80374557|FG000|Overall Study|Adverse Event|20|||
27600276|NCT00989092|80374558|FG001|Overall Study|Adverse Event|1|||
27600277|NCT00989092|80374557|FG000|Overall Study|Chemotherapy initiated|12|||
27600278|NCT00989092|80374558|FG001|Overall Study|Chemotherapy initiated|4|||
27600279|NCT00989092|80374557|FG000|Overall Study|Withdrawal by Subject|17|||
27600280|NCT00989092|80374558|FG001|Overall Study|Withdrawal by Subject|9|||
27600281|NCT00989092|80374557|FG000|Overall Study|Death|14|||
27600282|NCT00989092|80374558|FG001|Overall Study|Death|2|||
27600283|NCT00989092|80374557|FG000|Overall Study|Ineligibility determined|3|||
27600284|NCT00989092|80374558|FG001|Overall Study|Ineligibility determined|3|||
27600285|NCT00989092|80374557|FG000|Overall Study|Lost to Follow-up|6|||
27600286|NCT00989092|80374558|FG001|Overall Study|Lost to Follow-up|2|||
27600287|NCT00989092|80374557|FG000|Overall Study|Other|3|||
27600288|NCT00989092|80374558|FG001|Overall Study|Other|1|||
27600289|NCT00989092|80374557|FG000|Overall Study|Protocol deviation|2|||
27600290|NCT00989092|80374558|FG001|Overall Study|Protocol deviation|0|||
27600291|NCT00989092|80374557|FG000|Overall Study|Erythropoietin therapy initiated|2|||
27834913|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834914|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
27888176|NCT00750139|81425316|FG000|Overall Study|Non-specific|62|||
27888177|NCT00750139|81425317|FG001|Overall Study|Non-specific|42|||
27888178|NCT00750139|81425318|FG002|Overall Study|Non-specific|79|||
27888179|NCT00750139|81425319|FG003|Overall Study|Non-specific|33|||
27888180|NCT04531462|81425320|FG000|Overall Study|Withdrawal by Subject|3|||
27888181|NCT04531462|81425321|FG001|Overall Study|Withdrawal by Subject|1|||
27888182|NCT04531462|81425320|FG000|Overall Study|Adverse Event|3|||
27888183|NCT04531462|81425321|FG001|Overall Study|Adverse Event|3|||
27834915|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834916|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834917|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834918|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834919|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834920|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834921|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834922|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834923|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
27834924|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834925|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834926|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834927|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834928|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27888184|NCT01878084|81425322|FG000|Overall Study|Physician Decision|2|||
27888185|NCT02572076|81425333|FG000|Overall Study|Protocol Violation|1|||
27888186|NCT01758731|81425334|FG000|Overall Study|Physician Decision|1|||
27888187|NCT01023256|81425337|FG000|Overall Study|Protocol Violation|2|||
27600292|NCT00989092|80374558|FG001|Overall Study|Erythropoietin therapy initiated|0|||
27600293|NCT00989092|80374557|FG000|Overall Study|Did not receive study drug|2|||
27600294|NCT00989092|80374558|FG001|Overall Study|Did not receive study drug|0|||
27600295|NCT00512148|80374562|FG000|Primay Study Period|Withdrawal by Subject|1|||
27600296|NCT01971723|80374563|FG000|Overall Study|Withdrawal by Subject|1|||
27600297|NCT01971723|80374564|FG001|Overall Study|Withdrawal by Subject|1|||
27600298|NCT01971723|80374563|FG000|Overall Study|Protocol Violation|1|||
27600299|NCT01971723|80374564|FG001|Overall Study|Protocol Violation|2|||
27600300|NCT01089374|80374565|FG000|Overall Study|Lost to Follow-up|3|||
27600301|NCT01089374|80374566|FG001|Overall Study|Lost to Follow-up|0|||
27888188|NCT01023256|81425338|FG001|Overall Study|Protocol Violation|3|||
27888189|NCT01023256|81425339|FG002|Overall Study|Protocol Violation|0|||
27888190|NCT01023256|81425340|FG003|Overall Study|Protocol Violation|0|||
27888191|NCT01023256|81425337|FG000|Overall Study|Randomized but not treated|1|||
27888192|NCT01023256|81425338|FG001|Overall Study|Randomized but not treated|0|||
27888193|NCT01023256|81425339|FG002|Overall Study|Randomized but not treated|1|||
27888194|NCT01023256|81425340|FG003|Overall Study|Randomized but not treated|0|||
27888195|NCT01023256|81425337|FG000|Overall Study|Other|1|||
27888196|NCT01023256|81425338|FG001|Overall Study|Other|0|||
27888197|NCT01023256|81425339|FG002|Overall Study|Other|0|||
27888198|NCT01023256|81425340|FG003|Overall Study|Other|2|||
27600302|NCT01089374|80374565|FG000|Overall Study|Withdrawal by Subject|1|||
27600303|NCT01089374|80374566|FG001|Overall Study|Withdrawal by Subject|0|||
27600304|NCT01089374|80374565|FG000|Overall Study|Study closed early - low accrual|6|||
27600305|NCT01089374|80374566|FG001|Overall Study|Study closed early - low accrual|0|||
27600306|NCT00587964|80374567|FG000|Overall Study|Withdrawal by Subject|1|||
27600307|NCT00587964|80374567|FG000|Overall Study|Lost to Follow-up|1|||
27600308|NCT00587964|80374567|FG000|Overall Study|Patient found to be ineligible|1|||
27600309|NCT00587964|80374567|FG000|Overall Study|Patient did not receive intervention|5|||
27600310|NCT00587964|80374567|FG000|Overall Study|Progression of Disease|4|||
27600311|NCT00621543|80374574|FG000|Overall Study|Lost to Follow-up|23|||
27600312|NCT01235403|80374575|FG000|Overall Study|Adverse Event|14|||
27600313|NCT01235403|80374575|FG000|Overall Study|Lost to Follow-up|2|||
27600314|NCT01235403|80374575|FG000|Overall Study|Withdrawal by Subject|4|||
27600315|NCT01235403|80374575|FG000|Overall Study|Lack of Efficacy|2|||
27600316|NCT01235403|80374575|FG000|Overall Study|Other reasons for premature termination|4|||
27600317|NCT00725452|80374579|FG000|Overall Study|Adverse Event|3|||
27600318|NCT00725452|80374579|FG000|Overall Study|Lack of Efficacy|2|||
27600319|NCT00725452|80374579|FG000|Overall Study|Reason not specified|1|||
27600320|NCT00725452|80374579|FG000|Overall Study|Physician Decision|1|||
27600321|NCT00725452|80374579|FG000|Overall Study|Withdrawal by Subject|3|||
27600322|NCT00725452|80374579|FG000|Overall Study|Lost to Follow-up|1|||
27834929|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
27834930|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
27834931|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
27834932|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
27834933|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
27834934|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834935|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834936|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834937|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834938|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834939|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834940|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834941|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27888199|NCT01023256|81425337|FG000|Overall Study|Adverse Event|0|||
27888200|NCT01023256|81425338|FG001|Overall Study|Adverse Event|0|||
27834942|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27600323|NCT03298451|80374580|FG000|Overall Study|Death|275|||
27600324|NCT03298451|80374581|FG001|Overall Study|Death|260|||
27600325|NCT03298451|80374582|FG002|Overall Study|Death|122|||
27600326|NCT03298451|80374583|FG003|Overall Study|Death|280|||
27600327|NCT03298451|80374580|FG000|Overall Study|Lost to Follow-up|1|||
27600328|NCT03298451|80374581|FG001|Overall Study|Lost to Follow-up|1|||
27888201|NCT01023256|81425339|FG002|Overall Study|Adverse Event|0|||
27888202|NCT01023256|81425340|FG003|Overall Study|Adverse Event|1|||
27600329|NCT03298451|80374582|FG002|Overall Study|Lost to Follow-up|0|||
27600330|NCT03298451|80374583|FG003|Overall Study|Lost to Follow-up|7|||
27600331|NCT03298451|80374580|FG000|Overall Study|Withdrawal by Subject|9|||
27600332|NCT03298451|80374581|FG001|Overall Study|Withdrawal by Subject|7|||
27600333|NCT03298451|80374582|FG002|Overall Study|Withdrawal by Subject|1|||
27834943|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834944|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834945|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834946|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834947|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834948|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834949|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
27834950|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834951|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834952|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834953|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834954|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834955|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834956|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834957|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834958|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27888203|NCT01023256|81425337|FG000|Overall Study|Withdrawal by Subject|0|||
27888204|NCT01023256|81425338|FG001|Overall Study|Withdrawal by Subject|0|||
27834959|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
27834960|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834961|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834962|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834963|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27888205|NCT01023256|81425339|FG002|Overall Study|Withdrawal by Subject|0|||
27888206|NCT01023256|81425340|FG003|Overall Study|Withdrawal by Subject|2|||
27888207|NCT01082211|81425345|FG000|Overall Study|Protocol Violation|4|||
27888208|NCT01082211|81425345|FG000|Overall Study|No protocol treatment received|3|||
27888209|NCT05088603|81425351|FG000|Overall Study|Protocol Violation|6|||
27888210|NCT05088603|81425352|FG001|Overall Study|Protocol Violation|1|||
27888211|NCT05413369|81425353|FG000|Overall Study|Adverse Event|1|||
27888212|NCT05413369|81425354|FG001|Overall Study|Adverse Event|1|||
27600334|NCT03298451|80374583|FG003|Overall Study|Withdrawal by Subject|20|||
27600335|NCT03703466|80374584|FG000|Overall Study|Death|2|||
27600336|NCT03703466|80374585|FG001|Overall Study|Death|1|||
27600337|NCT03703466|80374586|FG002|Overall Study|Death|0|||
27600338|NCT03703466|80374584|FG000|Overall Study|Withdrawal by Subject|0|||
27600339|NCT03703466|80374585|FG001|Overall Study|Withdrawal by Subject|3|||
27600340|NCT03703466|80374586|FG002|Overall Study|Withdrawal by Subject|0|||
27600341|NCT03703466|80374584|FG000|Overall Study|Completed < 3 Cycles|2|||
27600342|NCT03703466|80374585|FG001|Overall Study|Completed < 3 Cycles|2|||
27600343|NCT03703466|80374586|FG002|Overall Study|Completed < 3 Cycles|2|||
27600344|NCT00335452|80374587|FG000|Overall Study|Death|156|||
27600345|NCT00335452|80374588|FG001|Overall Study|Death|144|||
27600346|NCT00335452|80374589|FG002|Overall Study|Death|158|||
27705715|NCT00097773|80762077|FG002|Overall Study|Withdrawal by Subject|3|||
27705716|NCT00097773|80762078|FG003|Overall Study|Withdrawal by Subject|1|||
27705717|NCT00097773|80762075|FG000|Overall Study|Adverse Event|0|||
27705718|NCT00097773|80762076|FG001|Overall Study|Adverse Event|1|||
27705719|NCT00097773|80762077|FG002|Overall Study|Adverse Event|0|||
27705720|NCT00097773|80762078|FG003|Overall Study|Adverse Event|0|||
27834964|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834965|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834966|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834967|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834968|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834969|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834970|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834971|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834972|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834973|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27888213|NCT05413369|81425353|FG000|Overall Study|Withdrawal by Subject|13|||
27888214|NCT05413369|81425354|FG001|Overall Study|Withdrawal by Subject|4|||
27888215|NCT05413369|81425353|FG000|Overall Study|Non-compliance with study schedule|2|||
27888216|NCT05413369|81425354|FG001|Overall Study|Non-compliance with study schedule|1|||
27888217|NCT05413369|81425353|FG000|Overall Study|Other|1|||
27888218|NCT05413369|81425354|FG001|Overall Study|Other|1|||
27888219|NCT03261674|81425361|FG000|Overall Study|Lost to Follow-up|6|||
27888220|NCT03261674|81425362|FG001|Overall Study|Lost to Follow-up|7|||
27888221|NCT03261674|81425361|FG000|Overall Study|Protocol Violation|1|||
27888222|NCT03261674|81425362|FG001|Overall Study|Protocol Violation|4|||
27888223|NCT03261674|81425361|FG000|Overall Study|Withdrawal by Subject|1|||
27888224|NCT03261674|81425362|FG001|Overall Study|Withdrawal by Subject|4|||
27888225|NCT03261674|81425361|FG000|Overall Study|Physician Decision|1|||
27888226|NCT03261674|81425362|FG001|Overall Study|Physician Decision|0|||
27888227|NCT02587598|81425363|FG000|Overall Study|Death|4|||
27888228|NCT02587598|81425364|FG001|Overall Study|Death|8|||
27888229|NCT02587598|81425365|FG002|Overall Study|Death|4|||
27888230|NCT02587598|81425366|FG003|Overall Study|Death|16|||
27888231|NCT02587598|81425367|FG004|Overall Study|Death|9|||
27888232|NCT02587598|81425368|FG005|Overall Study|Death|4|||
27600347|NCT00335452|80374590|FG003|Overall Study|Death|129|||
27705721|NCT00097773|80762075|FG000|Overall Study|Other|1|||
27888233|NCT02587598|81425369|FG006|Overall Study|Death|6|||
27888234|NCT02587598|81425370|FG007|Overall Study|Death|7|||
27888235|NCT02587598|81425371|FG008|Overall Study|Death|9|||
27888236|NCT02587598|81425372|FG009|Overall Study|Death|1|||
27600348|NCT00335452|80374587|FG000|Overall Study|Lost to Follow-up|2|||
27600349|NCT00335452|80374588|FG001|Overall Study|Lost to Follow-up|3|||
27888237|NCT02587598|81425373|FG010|Overall Study|Death|3|||
27600350|NCT00335452|80374589|FG002|Overall Study|Lost to Follow-up|1|||
27600351|NCT00335452|80374590|FG003|Overall Study|Lost to Follow-up|2|||
27705722|NCT00097773|80762076|FG001|Overall Study|Other|0|||
27600352|NCT01572389|80374593|FG000|Overall Study|Death|1|||
27888238|NCT02587598|81425363|FG000|Overall Study|Study Terminated by the Sponsor|0|||
27600353|NCT01572389|80374594|FG001|Overall Study|Death|3|||
27600354|NCT01572389|80374593|FG000|Overall Study|Withdrawal by Subject|14|||
27600355|NCT01572389|80374594|FG001|Overall Study|Withdrawal by Subject|2|||
27600356|NCT01572389|80374593|FG000|Overall Study|Lost to Follow-up|25|||
27600357|NCT01572389|80374594|FG001|Overall Study|Lost to Follow-up|14|||
27600358|NCT01572389|80374593|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
27600359|NCT01572389|80374594|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
27600360|NCT04027348|80374601|FG000|Overall Study|Adverse Event|2|||
27600361|NCT04225988|80374604|FG000|Overall Study|Withdrawal by Subject|2|||
27600362|NCT04225988|80374605|FG001|Overall Study|Withdrawal by Subject|0|||
27600363|NCT02338154|80374606|FG000|Overall Study|Death|46|||
27600364|NCT02338154|80374606|FG000|Overall Study|Valve Implant Failure|17|||
27600365|NCT02338154|80374606|FG000|Overall Study|Valve Explant|11|||
27600366|NCT02338154|80374606|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
27600367|NCT02338154|80374606|FG000|Overall Study|Lost to Follow-up|8|||
27600368|NCT02338154|80374606|FG000|Overall Study|Other Reason|3|||
27600369|NCT02338154|80374606|FG000|Overall Study|Patients Without Exit Form|47|||
27600370|NCT02338154|80374606|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
27600371|NCT02054806|80374607|FG000|Overall Study|Sponsor Decision|31|||
27600372|NCT02054806|80374607|FG000|Overall Study|Withdrawal by Subject|43|||
27600373|NCT02054806|80374607|FG000|Overall Study|Protocol Violation|2|||
27600374|NCT02054806|80374607|FG000|Overall Study|Lost to Follow-up|10|||
27600375|NCT02054806|80374607|FG000|Overall Study|Death|391|||
27600376|NCT00674570|80378122|FG000|Overall Study|Withdrawal by Subject|0|||
27600377|NCT00674570|80378123|FG001|Overall Study|Withdrawal by Subject|2|||
27600378|NCT00674570|80378124|FG002|Overall Study|Withdrawal by Subject|0|||
27600379|NCT02272725|80378125|FG000|Overall Study|equipment malfunction|2|||
27600380|NCT02272725|80378126|FG001|Overall Study|equipment malfunction|0|||
27600381|NCT03751631|80378127|FG000|Overall Study|Withdrawal by Subject|0|||
27600382|NCT03751631|80378128|FG001|Overall Study|Withdrawal by Subject|0|||
27600383|NCT03751631|80378129|FG002|Overall Study|Withdrawal by Subject|1|||
27600384|NCT03751631|80378130|FG003|Overall Study|Withdrawal by Subject|1|||
27600385|NCT03751631|80378131|FG004|Overall Study|Withdrawal by Subject|0|||
27600386|NCT03751631|80378132|FG005|Overall Study|Withdrawal by Subject|0|||
27600387|NCT01357616|80378133|FG000|Overall Study|Adverse Event|1|||
27600388|NCT01357616|80378134|FG001|Overall Study|Adverse Event|1|||
27600389|NCT01357616|80378133|FG000|Overall Study|Lost to Follow-up|4|||
27600390|NCT01357616|80378134|FG001|Overall Study|Lost to Follow-up|3|||
27600391|NCT01357616|80378133|FG000|Overall Study|Protocol Violation|0|||
27888239|NCT02587598|81425364|FG001|Overall Study|Study Terminated by the Sponsor|1|||
27888240|NCT02587598|81425365|FG002|Overall Study|Study Terminated by the Sponsor|0|||
27888241|NCT02587598|81425366|FG003|Overall Study|Study Terminated by the Sponsor|3|||
27888242|NCT02587598|81425367|FG004|Overall Study|Study Terminated by the Sponsor|0|||
27888243|NCT02587598|81425368|FG005|Overall Study|Study Terminated by the Sponsor|1|||
27600392|NCT01357616|80378134|FG001|Overall Study|Protocol Violation|2|||
27600393|NCT01357616|80378133|FG000|Overall Study|Inadequate Control of IOP|1|||
27600394|NCT01357616|80378134|FG001|Overall Study|Inadequate Control of IOP|2|||
27600395|NCT01357616|80378133|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
27600396|NCT01357616|80378134|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
27705723|NCT00097773|80762077|FG002|Overall Study|Other|2|||
27600397|NCT01357616|80378133|FG000|Overall Study|Withdrawal by Subject|1|||
27705724|NCT00097773|80762078|FG003|Overall Study|Other|0|||
27705725|NCT02554903|80762087|FG000|Overall Study|Death|1|||
27705726|NCT02554903|80762088|FG001|Overall Study|Death|1|||
27705727|NCT02554903|80762087|FG000|Overall Study|Physician Decision|2|||
27705728|NCT02554903|80762088|FG001|Overall Study|Physician Decision|2|||
27705729|NCT02554903|80762087|FG000|Overall Study|Heart Transplant|1|||
27705730|NCT02554903|80762088|FG001|Overall Study|Heart Transplant|2|||
27705731|NCT02536313|80762089|FG000|Overall Study|Lack of Efficacy|0|||
27705732|NCT02536313|80762090|FG001|Overall Study|Lack of Efficacy|1|||
27705733|NCT03007979|80762097|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
27705734|NCT03021499|80762098|FG000|Overall Study|Adverse Event|1|||
27705735|NCT03021499|80762099|FG001|Overall Study|Adverse Event|0|||
27705736|NCT03021499|80762098|FG000|Overall Study|Death|1|||
27705737|NCT03021499|80762099|FG001|Overall Study|Death|5|||
27705738|NCT03021499|80762098|FG000|Overall Study|Lack of Efficacy|0|||
27705739|NCT03021499|80762099|FG001|Overall Study|Lack of Efficacy|1|||
27705740|NCT03021499|80762098|FG000|Overall Study|Lost to Follow-up|1|||
27705741|NCT03021499|80762099|FG001|Overall Study|Lost to Follow-up|3|||
27705742|NCT03021499|80762098|FG000|Overall Study|Physician Decision|2|||
27705743|NCT03021499|80762099|FG001|Overall Study|Physician Decision|3|||
27705744|NCT03021499|80762098|FG000|Overall Study|Pregnancy|1|||
27705745|NCT03021499|80762099|FG001|Overall Study|Pregnancy|0|||
27600398|NCT01357616|80378134|FG001|Overall Study|Withdrawal by Subject|0|||
27600399|NCT02719990|80378135|FG000|Overall Study|Physician Decision|2|||
27600400|NCT02719990|80378135|FG000|Overall Study|Withdrawal by Subject|2|||
27600401|NCT02719990|80378135|FG000|Overall Study|Study Terminated By Sponsor|32|||
27600402|NCT00572195|80378136|FG000|Overall Study|Withdrawal by Subject|50|||
27600403|NCT00572195|80378136|FG000|Overall Study|Death|9|||
27600404|NCT00572195|80378136|FG000|Overall Study|Adverse Event|4|||
27600405|NCT00572195|80378136|FG000|Overall Study|Lost to Follow-up|5|||
27600406|NCT03017079|80378137|FG000|Overall Study|Physician Decision|1|||
27600407|NCT03017079|80378138|FG001|Overall Study|Physician Decision|1|||
27600408|NCT03017079|80378137|FG000|Overall Study|Death|3|||
27600409|NCT03017079|80378138|FG001|Overall Study|Death|2|||
27705746|NCT03021499|80762098|FG000|Overall Study|Withdrawal by Subject|7|||
27705747|NCT03021499|80762099|FG001|Overall Study|Withdrawal by Subject|14|||
27705748|NCT03021499|80762098|FG000|Overall Study|Prohibited medication required|1|||
27705749|NCT03021499|80762099|FG001|Overall Study|Prohibited medication required|0|||
27705750|NCT03021499|80762098|FG000|Overall Study|Protocol non-compliance|1|||
27705751|NCT03021499|80762099|FG001|Overall Study|Protocol non-compliance|1|||
27705752|NCT03021499|80762098|FG000|Overall Study|None of the above|0|||
27705753|NCT03021499|80762099|FG001|Overall Study|None of the above|4|||
27705754|NCT03021499|80762098|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
27705755|NCT03021499|80762099|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
27705756|NCT00770770|80762100|FG000|Overall Study|Lost to Follow-up|1|||
27705757|NCT00770770|80762101|FG001|Overall Study|Lost to Follow-up|0|||
27705758|NCT00770770|80762100|FG000|Overall Study|Withdrawal by Subject|1|||
27705759|NCT00770770|80762101|FG001|Overall Study|Withdrawal by Subject|0|||
27705760|NCT00770770|80762100|FG000|Overall Study|Death|0|||
27705761|NCT00770770|80762101|FG001|Overall Study|Death|1|||
27705762|NCT00770770|80762100|FG000|Overall Study|Study Terminated|8|||
27705763|NCT00770770|80762101|FG001|Overall Study|Study Terminated|0|||
27705764|NCT00362414|80762105|FG000|Overall Study|Death|2|||
27705765|NCT00362414|80762105|FG000|Overall Study|Adverse Event|1|||
27705766|NCT00243386|80762107|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
27705767|NCT00243386|80762108|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
27705768|NCT00243386|80762109|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
27705769|NCT00243386|80762107|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
27705770|NCT00243386|80762108|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
27705771|NCT00243386|80762109|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
27705772|NCT00243386|80762107|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
27705773|NCT00243386|80762108|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
27705774|NCT00243386|80762109|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
27705775|NCT00243386|80762107|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
27705776|NCT00243386|80762108|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
27705777|NCT00243386|80762109|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
27705778|NCT00243386|80762107|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
27705779|NCT00243386|80762108|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
27705780|NCT00243386|80762109|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
27705781|NCT00243386|80762107|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
27705782|NCT00243386|80762108|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
27600410|NCT03017079|80378137|FG000|Overall Study|Lack of Efficacy|2|||
27705783|NCT00243386|80762109|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
27600411|NCT03017079|80378138|FG001|Overall Study|Lack of Efficacy|2|||
27600412|NCT03017079|80378137|FG000|Overall Study|Protocol Violation|0|||
27705784|NCT00243386|80762107|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
27705785|NCT00243386|80762108|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
27705786|NCT00243386|80762109|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
27705787|NCT00243386|80762107|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
27705788|NCT00243386|80762108|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
27705789|NCT00243386|80762109|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
27705790|NCT00555477|80762120|FG000|Overall Study|Adverse Event|0|||
27705791|NCT00555477|80762121|FG001|Overall Study|Adverse Event|9|||
27705792|NCT00555477|80762120|FG000|Overall Study|Withdrawal by Subject|1|||
27705793|NCT00555477|80762121|FG001|Overall Study|Withdrawal by Subject|2|||
27705794|NCT00555477|80762120|FG000|Overall Study|Physician Decision|1|||
27705795|NCT00555477|80762121|FG001|Overall Study|Physician Decision|2|||
27705796|NCT01624259|80762122|FG000|Overall Study|Adverse Event|18|||
27705797|NCT01624259|80762123|FG001|Overall Study|Adverse Event|18|||
27705798|NCT01624259|80762122|FG000|Overall Study|Protocol Violation|1|||
27705799|NCT01624259|80762123|FG001|Overall Study|Protocol Violation|2|||
27705800|NCT01624259|80762122|FG000|Overall Study|Withdrawal by Subject|5|||
27705801|NCT01624259|80762123|FG001|Overall Study|Withdrawal by Subject|7|||
27705802|NCT01624259|80762122|FG000|Overall Study|Physician Decision|1|||
27705803|NCT01624259|80762123|FG001|Overall Study|Physician Decision|1|||
27705804|NCT01624259|80762122|FG000|Overall Study|Lost to Follow-up|2|||
27705805|NCT01624259|80762123|FG001|Overall Study|Lost to Follow-up|3|||
27705806|NCT01624259|80762122|FG000|Overall Study|Abnormal laboratory measure|3|||
27705807|NCT01624259|80762123|FG001|Overall Study|Abnormal laboratory measure|0|||
27705808|NCT00253643|80762124|FG000|Overall Study|Withdrawal by Subject|0|||
27705809|NCT00253643|80762125|FG001|Overall Study|Withdrawal by Subject|0|||
27705810|NCT00253643|80762126|FG002|Overall Study|Withdrawal by Subject|1|||
27705811|NCT00253643|80762127|FG003|Overall Study|Withdrawal by Subject|1|||
27705812|NCT00253643|80762124|FG000|Overall Study|Non-Compliance|0|||
27705813|NCT00253643|80762125|FG001|Overall Study|Non-Compliance|0|||
27705814|NCT00253643|80762126|FG002|Overall Study|Non-Compliance|0|||
27705815|NCT00253643|80762127|FG003|Overall Study|Non-Compliance|2|||
27705816|NCT01830855|80762132|FG000|Overall Study|Other|7|||
27705817|NCT01830855|80762133|FG001|Overall Study|Other|1|||
27705818|NCT01830855|80762134|FG002|Overall Study|Other|4|||
27705819|NCT01830855|80762135|FG003|Overall Study|Other|4|||
27705820|NCT01830855|80762132|FG000|Overall Study|Medication error without associated AE|1|||
27705821|NCT01830855|80762133|FG001|Overall Study|Medication error without associated AE|0|||
27705822|NCT01830855|80762134|FG002|Overall Study|Medication error without associated AE|0|||
27705823|NCT01830855|80762135|FG003|Overall Study|Medication error without associated AE|1|||
27705824|NCT01830855|80762132|FG000|Overall Study|Pregnancy|3|||
27705825|NCT01830855|80762133|FG001|Overall Study|Pregnancy|1|||
27705826|NCT01830855|80762134|FG002|Overall Study|Pregnancy|2|||
27705827|NCT01830855|80762135|FG003|Overall Study|Pregnancy|1|||
27705828|NCT01830855|80762132|FG000|Overall Study|No longer meets eligibility criteria|11|||
27705829|NCT01830855|80762133|FG001|Overall Study|No longer meets eligibility criteria|2|||
27888244|NCT02587598|81425369|FG006|Overall Study|Study Terminated by the Sponsor|0|||
27705830|NCT01830855|80762134|FG002|Overall Study|No longer meets eligibility criteria|3|||
27705831|NCT01830855|80762135|FG003|Overall Study|No longer meets eligibility criteria|5|||
27705832|NCT01830855|80762132|FG000|Overall Study|Adverse Event|11|||
27705833|NCT01830855|80762133|FG001|Overall Study|Adverse Event|5|||
27705834|NCT01830855|80762134|FG002|Overall Study|Adverse Event|6|||
27705835|NCT01830855|80762135|FG003|Overall Study|Adverse Event|3|||
27705836|NCT01830855|80762132|FG000|Overall Study|Protocol deviation|10|||
27705837|NCT01830855|80762133|FG001|Overall Study|Protocol deviation|5|||
27705838|NCT01830855|80762134|FG002|Overall Study|Protocol deviation|6|||
27705839|NCT01830855|80762135|FG003|Overall Study|Protocol deviation|6|||
27705840|NCT01830855|80762132|FG000|Overall Study|Withdrawal by Subject|33|||
27705841|NCT01830855|80762133|FG001|Overall Study|Withdrawal by Subject|14|||
27705842|NCT01830855|80762134|FG002|Overall Study|Withdrawal by Subject|10|||
27705843|NCT01830855|80762135|FG003|Overall Study|Withdrawal by Subject|12|||
27705844|NCT01830855|80762132|FG000|Overall Study|No longer willing to participate|32|||
27705845|NCT01830855|80762133|FG001|Overall Study|No longer willing to participate|13|||
27705846|NCT01830855|80762134|FG002|Overall Study|No longer willing to participate|12|||
27705847|NCT01830855|80762135|FG003|Overall Study|No longer willing to participate|17|||
27705848|NCT01830855|80762132|FG000|Overall Study|Lost to Follow-up|47|||
27705849|NCT01830855|80762133|FG001|Overall Study|Lost to Follow-up|20|||
27834974|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834975|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
27834976|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834977|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834978|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834979|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834980|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834981|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834982|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
27705850|NCT01830855|80762134|FG002|Overall Study|Lost to Follow-up|23|||
27705851|NCT01830855|80762135|FG003|Overall Study|Lost to Follow-up|33|||
27834983|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834984|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
27705852|NCT01299376|80762140|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
27705853|NCT01299376|80762141|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
27705854|NCT01299376|80762140|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
27834985|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
27600413|NCT03017079|80378138|FG001|Overall Study|Protocol Violation|1|||
27600414|NCT01287611|80378147|FG000|Overall Study|Lost to Follow-up|29|||
27600415|NCT01287611|80378148|FG001|Overall Study|Lost to Follow-up|16|||
27600416|NCT01287611|80378147|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
27600417|NCT01287611|80378148|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
27600418|NCT03419364|80378155|FG000|Overall Study|Delivery due to maternal condition|2|||
27600419|NCT03419364|80378156|FG001|Overall Study|Delivery due to maternal condition|0|||
27600420|NCT03419364|80378157|FG002|Overall Study|Delivery due to maternal condition|0|||
27600421|NCT03403426|80378166|FG000|Overall Study|Death|1|||
27600422|NCT03403426|80378166|FG000|Overall Study|Lost to Follow-up|2|||
27600423|NCT00654901|80378169|FG000|Overall Study|Lost to Follow-up|1|||
27600424|NCT00654901|80378170|FG001|Overall Study|Lost to Follow-up|0|||
27600425|NCT00654901|80378171|FG002|Overall Study|Lost to Follow-up|1|||
27600426|NCT00654901|80378172|FG003|Overall Study|Lost to Follow-up|0|||
27600427|NCT00654901|80378169|FG000|Overall Study|Withdrawal by Subject|3|||
27600428|NCT00654901|80378170|FG001|Overall Study|Withdrawal by Subject|0|||
27600429|NCT00654901|80378171|FG002|Overall Study|Withdrawal by Subject|1|||
27600430|NCT00654901|80378172|FG003|Overall Study|Withdrawal by Subject|0|||
27600431|NCT02954354|80378173|FG000|Overall Study|Adverse Event|2|||
27600432|NCT02954354|80378174|FG001|Overall Study|Adverse Event|2|||
27600433|NCT02954354|80378175|FG002|Overall Study|Adverse Event|4|||
27600434|NCT02954354|80378173|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
27600435|NCT02954354|80378174|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
27600436|NCT02954354|80378175|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
27600437|NCT02954354|80378173|FG000|Overall Study|Lack of Efficacy|0|||
27600438|NCT02954354|80378174|FG001|Overall Study|Lack of Efficacy|2|||
27600439|NCT02954354|80378175|FG002|Overall Study|Lack of Efficacy|0|||
27600440|NCT02954354|80378173|FG000|Overall Study|Withdrawal by Subject|17|||
27600441|NCT02954354|80378174|FG001|Overall Study|Withdrawal by Subject|9|||
27600442|NCT02954354|80378175|FG002|Overall Study|Withdrawal by Subject|11|||
27600443|NCT02954354|80378173|FG000|Overall Study|Lost to Follow-up|12|||
27600444|NCT02954354|80378174|FG001|Overall Study|Lost to Follow-up|5|||
27600445|NCT02954354|80378175|FG002|Overall Study|Lost to Follow-up|0|||
27600446|NCT02954354|80378173|FG000|Overall Study|Miscellaneous|2|||
27600447|NCT02954354|80378174|FG001|Overall Study|Miscellaneous|2|||
27600448|NCT02954354|80378175|FG002|Overall Study|Miscellaneous|1|||
27600449|NCT02856113|80378176|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27600450|NCT02856113|80378177|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27600451|NCT02856113|80378176|FG000|Overall Study|Significant Protocol Deviation|1|||
27600452|NCT02856113|80378177|FG001|Overall Study|Significant Protocol Deviation|0|||
27600453|NCT02856113|80378176|FG000|Overall Study|Lost to Follow-up|3|||
27600454|NCT02856113|80378177|FG001|Overall Study|Lost to Follow-up|5|||
27600455|NCT02856113|80378176|FG000|Overall Study|Voluntary Withdrawal|3|||
27600456|NCT02856113|80378177|FG001|Overall Study|Voluntary Withdrawal|5|||
27600457|NCT02856113|80378176|FG000|Overall Study|Pregnancy|0|||
27600458|NCT02856113|80378177|FG001|Overall Study|Pregnancy|1|||
27600459|NCT02856113|80378176|FG000|Overall Study|Principal Investigator Discretion|2|||
27600460|NCT02856113|80378177|FG001|Overall Study|Principal Investigator Discretion|1|||
27600461|NCT02856113|80378176|FG000|Overall Study|Randomized but not Treated|1|||
27600462|NCT02856113|80378177|FG001|Overall Study|Randomized but not Treated|0|||
27600463|NCT02856113|80378176|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
27600464|NCT02856113|80378177|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
27600465|NCT02831257|80378178|FG000|Overall Study|Lack of Efficacy|3|||
27600466|NCT02831257|80378178|FG000|Overall Study|Adverse Event|2|||
27600467|NCT02831257|80378178|FG000|Overall Study|Physician Decision|1|||
27600468|NCT02831257|80378178|FG000|Overall Study|Withdrawal by Subject|6|||
27600469|NCT00696410|80378179|FG000|Overall Study|Lost to Follow-up|2|||
27600470|NCT00696410|80378180|FG001|Overall Study|Lost to Follow-up|0|||
27600471|NCT00696410|80378179|FG000|Overall Study|Withdrawal by Subject|8|||
27600472|NCT00696410|80378180|FG001|Overall Study|Withdrawal by Subject|0|||
27705855|NCT01299376|80762141|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
27705856|NCT01299376|80762140|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
27705857|NCT01299376|80762141|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
27888245|NCT02587598|81425370|FG007|Overall Study|Study Terminated by the Sponsor|0|||
27600473|NCT00696410|80378179|FG000|Overall Study|Physician Decision|3|||
27705858|NCT01299376|80762140|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
27600474|NCT00696410|80378180|FG001|Overall Study|Physician Decision|0|||
27600475|NCT03879408|80378181|FG000|Overall Study|Lost to Follow-up|0|||
27600476|NCT03879408|80378182|FG001|Overall Study|Lost to Follow-up|3|||
27600477|NCT03879408|80378183|FG002|Overall Study|Lost to Follow-up|2|||
27600478|NCT03879408|80378184|FG003|Overall Study|Lost to Follow-up|1|||
27600479|NCT03879408|80378185|FG004|Overall Study|Lost to Follow-up|0|||
27600480|NCT03879408|80378181|FG000|Overall Study|Withdrawal by Subject|2|||
27600481|NCT03879408|80378182|FG001|Overall Study|Withdrawal by Subject|1|||
27600482|NCT03879408|80378183|FG002|Overall Study|Withdrawal by Subject|1|||
27600483|NCT03879408|80378184|FG003|Overall Study|Withdrawal by Subject|0|||
27600484|NCT03879408|80378185|FG004|Overall Study|Withdrawal by Subject|1|||
27600485|NCT04123067|80378187|FG000|Overall Study|Lost to Follow-up|0|||
27600486|NCT04123067|80378188|FG001|Overall Study|Lost to Follow-up|1|||
27600487|NCT01552954|80378189|FG000|Overall Study|Adverse Event|1|||
27600488|NCT01552954|80378190|FG001|Overall Study|Adverse Event|2|||
27600489|NCT01552954|80378189|FG000|Overall Study|Lost to Follow-up|1|||
27600490|NCT01552954|80378190|FG001|Overall Study|Lost to Follow-up|1|||
27600491|NCT01552954|80378189|FG000|Overall Study|Withdrawal by Subject|1|||
27600492|NCT01552954|80378190|FG001|Overall Study|Withdrawal by Subject|1|||
27600493|NCT01552954|80378189|FG000|Overall Study|Protocol Violation|1|||
27600494|NCT01552954|80378190|FG001|Overall Study|Protocol Violation|2|||
27600495|NCT01552954|80378189|FG000|Overall Study|diagnosed DM|1|||
27600496|NCT01552954|80378190|FG001|Overall Study|diagnosed DM|0|||
27600497|NCT00508261|80378191|FG000|Overall Study|Other|0|||
27600498|NCT00508261|80378192|FG001|Overall Study|Other|1|||
27600499|NCT00508261|80378193|FG002|Overall Study|Other|1|||
27600500|NCT00508261|80378194|FG003|Overall Study|Other|0|||
27600501|NCT00508261|80378191|FG000|Overall Study|Serious Adverse Event|0|||
27600502|NCT00508261|80378192|FG001|Overall Study|Serious Adverse Event|1|||
27600503|NCT00508261|80378193|FG002|Overall Study|Serious Adverse Event|0|||
27600504|NCT00508261|80378194|FG003|Overall Study|Serious Adverse Event|0|||
27600505|NCT00508261|80378191|FG000|Overall Study|Withdrawal by Subject|3|||
27600506|NCT00508261|80378192|FG001|Overall Study|Withdrawal by Subject|4|||
27600507|NCT00508261|80378193|FG002|Overall Study|Withdrawal by Subject|4|||
27600508|NCT00508261|80378194|FG003|Overall Study|Withdrawal by Subject|0|||
27600509|NCT00508261|80378191|FG000|Overall Study|Migrated/ moved from study area|0|||
27600510|NCT00508261|80378192|FG001|Overall Study|Migrated/ moved from study area|1|||
27600511|NCT00508261|80378193|FG002|Overall Study|Migrated/ moved from study area|0|||
27600512|NCT00508261|80378194|FG003|Overall Study|Migrated/ moved from study area|0|||
27600513|NCT00508261|80378191|FG000|Overall Study|Lost to Follow-up|0|||
27600514|NCT00508261|80378192|FG001|Overall Study|Lost to Follow-up|1|||
27600515|NCT00508261|80378193|FG002|Overall Study|Lost to Follow-up|1|||
27600516|NCT00508261|80378194|FG003|Overall Study|Lost to Follow-up|1|||
27600517|NCT04241094|80378197|FG000|Overall Study|Dropped out of treatment|4|||
27600518|NCT04241094|80378197|FG000|Overall Study|Ineligible after clinical assessment|2|||
27600519|NCT04241094|80378197|FG000|Overall Study|Lost to Follow-up|2|||
27600520|NCT02157779|80378205|FG000|Overall Study|Logistical|9|||
27600521|NCT02157779|80378206|FG001|Overall Study|Logistical|3|||
27600522|NCT02157779|80378205|FG000|Overall Study|Stopped attending, reason unknown|11|||
27600523|NCT02157779|80378206|FG001|Overall Study|Stopped attending, reason unknown|7|||
27600524|NCT02157779|80378205|FG000|Overall Study|No response to outreach after Baseline|1|||
27600525|NCT02157779|80378206|FG001|Overall Study|No response to outreach after Baseline|1|||
27600526|NCT02157779|80378205|FG000|Overall Study|Moved|1|||
27600527|NCT02157779|80378206|FG001|Overall Study|Moved|0|||
27600528|NCT02157779|80378205|FG000|Overall Study|Medical|1|||
27600529|NCT02157779|80378206|FG001|Overall Study|Medical|0|||
27600530|NCT02157779|80378205|FG000|Overall Study|Legal issue|1|||
27600531|NCT02157779|80378206|FG001|Overall Study|Legal issue|0|||
27600532|NCT03496662|80378207|FG000|Overall Study|Adverse Event|1|||
27600533|NCT03496662|80378208|FG001|Overall Study|Adverse Event|0|||
27600534|NCT03496662|80378209|FG002|Overall Study|Adverse Event|1|||
27600535|NCT03496662|80378207|FG000|Overall Study|Physician Decision|1|||
27600536|NCT03496662|80378208|FG001|Overall Study|Physician Decision|0|||
27600537|NCT03496662|80378209|FG002|Overall Study|Physician Decision|3|||
27600538|NCT03496662|80378207|FG000|Overall Study|Withdrawal by Subject|0|||
27600539|NCT03496662|80378208|FG001|Overall Study|Withdrawal by Subject|0|||
27600540|NCT03496662|80378209|FG002|Overall Study|Withdrawal by Subject|2|||
27600541|NCT03496662|80378207|FG000|Overall Study|Death|0|||
27600542|NCT03496662|80378208|FG001|Overall Study|Death|0|||
27600543|NCT03496662|80378209|FG002|Overall Study|Death|2|||
27600544|NCT03496662|80378207|FG000|Overall Study|Noncompliance|0|||
27600545|NCT03496662|80378208|FG001|Overall Study|Noncompliance|0|||
27600546|NCT03496662|80378209|FG002|Overall Study|Noncompliance|1|||
27600547|NCT04465357|80378210|FG000|Overall Study|Adverse Event|2|||
27600548|NCT04465357|80378210|FG000|Overall Study|Lack of Efficacy|1|||
27600549|NCT04465357|80378210|FG000|Overall Study|Lost to Follow-up|2|||
27600550|NCT04465357|80378210|FG000|Overall Study|Withdrawal by Subject|6|||
27600551|NCT04465357|80378210|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
27600552|NCT03395405|80378211|FG000|Overall Study|Death|0|||
27600553|NCT03395405|80378212|FG001|Overall Study|Death|2|||
27600554|NCT03395405|80378211|FG000|Overall Study|Lost to Follow-up|0|||
27600555|NCT03395405|80378212|FG001|Overall Study|Lost to Follow-up|1|||
27600556|NCT03395405|80378211|FG000|Overall Study|Protocol Violation|0|||
27600557|NCT03395405|80378212|FG001|Overall Study|Protocol Violation|1|||
27600558|NCT03395405|80378211|FG000|Overall Study|Withdrawal by Subject|3|||
27600559|NCT03395405|80378212|FG001|Overall Study|Withdrawal by Subject|1|||
27600560|NCT03395405|80378211|FG000|Overall Study|COVID-19 Pandemic|1|||
27600561|NCT03395405|80378212|FG001|Overall Study|COVID-19 Pandemic|0|||
27600562|NCT00415610|80378214|FG000|Overall Study|Death|3|||
27600563|NCT00415610|80378215|FG001|Overall Study|Death|2|||
27600564|NCT00415610|80378216|FG002|Overall Study|Death|5|||
27600565|NCT01119898|80378217|FG000|Overall Study|Adverse Event|4|||
27600566|NCT01119898|80378218|FG001|Overall Study|Adverse Event|5|||
27600567|NCT01119898|80378217|FG000|Overall Study|Withdrawal by Subject|1|||
27600568|NCT01119898|80378218|FG001|Overall Study|Withdrawal by Subject|4|||
27600569|NCT01119898|80378217|FG000|Overall Study|Lack of Efficacy|0|||
27600570|NCT01119898|80378218|FG001|Overall Study|Lack of Efficacy|2|||
27600571|NCT01119898|80378217|FG000|Overall Study|Protocol Violation|1|||
27600572|NCT01119898|80378218|FG001|Overall Study|Protocol Violation|1|||
27600573|NCT01119898|80378217|FG000|Overall Study|Medical procedure|1|||
27600574|NCT01119898|80378218|FG001|Overall Study|Medical procedure|0|||
27600575|NCT01119898|80378217|FG000|Overall Study|Randomized in error did not participate|1|||
27600576|NCT01119898|80378218|FG001|Overall Study|Randomized in error did not participate|0|||
27600577|NCT02569710|80378220|FG000|Overall Study|Adverse Event|1|||
27600578|NCT02569710|80378221|FG001|Overall Study|Adverse Event|0|||
27600579|NCT02569710|80378222|FG002|Overall Study|Adverse Event|0|||
27600580|NCT02569710|80378223|FG003|Overall Study|Adverse Event|0|||
27600581|NCT02569710|80378224|FG004|Overall Study|Adverse Event|0|||
27600582|NCT02569710|80378225|FG005|Overall Study|Adverse Event|0|||
27600583|NCT02569710|80378226|FG006|Overall Study|Adverse Event|0|||
27600584|NCT02569710|80378227|FG007|Overall Study|Adverse Event|0|||
27600585|NCT02569710|80378228|FG008|Overall Study|Adverse Event|0|||
27600586|NCT02569710|80378229|FG009|Overall Study|Adverse Event|0|||
27600587|NCT02569710|80378220|FG000|Overall Study|Lost to Follow-up|0|||
27600588|NCT02569710|80378221|FG001|Overall Study|Lost to Follow-up|0|||
27600589|NCT02569710|80378222|FG002|Overall Study|Lost to Follow-up|0|||
27600590|NCT02569710|80378223|FG003|Overall Study|Lost to Follow-up|0|||
27600591|NCT02569710|80378224|FG004|Overall Study|Lost to Follow-up|0|||
27600592|NCT02569710|80378225|FG005|Overall Study|Lost to Follow-up|0|||
27600593|NCT02569710|80378226|FG006|Overall Study|Lost to Follow-up|1|||
27600594|NCT02569710|80378227|FG007|Overall Study|Lost to Follow-up|0|||
27600595|NCT02569710|80378228|FG008|Overall Study|Lost to Follow-up|1|||
27600596|NCT02569710|80378229|FG009|Overall Study|Lost to Follow-up|0|||
27600597|NCT02569710|80378220|FG000|Overall Study|Virologic failure|0|||
27600598|NCT02569710|80378221|FG001|Overall Study|Virologic failure|0|||
27600599|NCT02569710|80378222|FG002|Overall Study|Virologic failure|0|||
27600600|NCT02569710|80378223|FG003|Overall Study|Virologic failure|0|||
27600601|NCT02569710|80378224|FG004|Overall Study|Virologic failure|1|||
27600602|NCT02569710|80378225|FG005|Overall Study|Virologic failure|0|||
27600603|NCT02569710|80378226|FG006|Overall Study|Virologic failure|1|||
27600604|NCT02569710|80378227|FG007|Overall Study|Virologic failure|0|||
27600605|NCT02569710|80378228|FG008|Overall Study|Virologic failure|0|||
27600606|NCT02569710|80378229|FG009|Overall Study|Virologic failure|0|||
27600607|NCT02569710|80378220|FG000|Overall Study|Withdrawal by Subject|0|||
27600608|NCT02569710|80378221|FG001|Overall Study|Withdrawal by Subject|0|||
27600609|NCT02569710|80378222|FG002|Overall Study|Withdrawal by Subject|0|||
27600610|NCT02569710|80378223|FG003|Overall Study|Withdrawal by Subject|0|||
27600611|NCT02569710|80378224|FG004|Overall Study|Withdrawal by Subject|0|||
27600612|NCT02569710|80378225|FG005|Overall Study|Withdrawal by Subject|1|||
27600613|NCT02569710|80378226|FG006|Overall Study|Withdrawal by Subject|0|||
27600614|NCT02569710|80378227|FG007|Overall Study|Withdrawal by Subject|0|||
27600615|NCT02569710|80378228|FG008|Overall Study|Withdrawal by Subject|0|||
27600616|NCT02569710|80378229|FG009|Overall Study|Withdrawal by Subject|0|||
27600617|NCT00779779|80378230|FG000|Overall Study|Adverse Event|1|||
27600618|NCT00779779|80378230|FG000|Overall Study|Protocol Violation|14|||
27600619|NCT00779779|80378230|FG000|Overall Study|Withdrawal by Subject|4|||
27600620|NCT00779779|80378230|FG000|Overall Study|Lost to Follow-up|5|||
27600621|NCT00077064|80378231|FG000|Overall Study|Adverse Event|0|||
27600622|NCT00077064|80378232|FG001|Overall Study|Adverse Event|4|||
27600623|NCT00077064|80378231|FG000|Overall Study|Patient refusal|0|||
27600624|NCT00077064|80378232|FG001|Overall Study|Patient refusal|2|||
27600625|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
27600626|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
27600627|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
27600628|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
27600629|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
27600630|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
27600631|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
27600632|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
27600633|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
27600634|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
27600635|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
27600636|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
27600637|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
27600638|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
27600639|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
27600640|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
27600641|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
27600642|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
27600643|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
27600644|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
27600645|NCT00549757|80378235|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
27600646|NCT00549757|80378236|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
27600647|NCT00549757|80378235|FG000|Extension Period (in Average 9 Months)|Death|143|||
27600648|NCT00549757|80378236|FG001|Extension Period (in Average 9 Months)|Death|136|||
27705859|NCT01299376|80762141|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
27705860|NCT01299376|80762140|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
27705861|NCT01299376|80762141|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
27705862|NCT01299376|80762140|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
27705863|NCT01299376|80762141|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
27705864|NCT01299376|80762140|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
27705865|NCT01299376|80762141|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
27705866|NCT01299376|80762140|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
27705867|NCT01299376|80762141|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
27600649|NCT00549757|80378235|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
27600650|NCT00549757|80378236|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
27600651|NCT00549757|80378235|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
27600652|NCT00549757|80378236|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
27705868|NCT01299376|80762140|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
27834986|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834987|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834988|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834989|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834990|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834991|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834992|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834993|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834994|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834995|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834996|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834997|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834998|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
27834999|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
27835000|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
27835001|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
27835002|NCT00112437|81226158|FG000|Year 2 (12-Month Extension)|Moved|0|||
27835003|NCT00112437|81226159|FG001|Year 2 (12-Month Extension)|Moved|0|||
27835004|NCT00112437|81226160|FG002|Year 2 (12-Month Extension)|Moved|0|||
27835005|NCT00112437|81226161|FG003|Year 2 (12-Month Extension)|Moved|0|||
27835006|NCT00112437|81226162|FG004|Year 2 (12-Month Extension)|Moved|0|||
27835007|NCT00112437|81226163|FG005|Year 2 (12-Month Extension)|Moved|0|||
27835008|NCT00112437|81226164|FG006|Year 2 (12-Month Extension)|Moved|0|||
27835009|NCT00112437|81226165|FG007|Year 2 (12-Month Extension)|Moved|0|||
27888246|NCT02587598|81425371|FG008|Overall Study|Study Terminated by the Sponsor|0|||
27888247|NCT02587598|81425372|FG009|Overall Study|Study Terminated by the Sponsor|1|||
27888248|NCT02587598|81425373|FG010|Overall Study|Study Terminated by the Sponsor|6|||
27888249|NCT02587598|81425363|FG000|Overall Study|Reason for study withdrawal not specified|0|||
27888250|NCT02587598|81425364|FG001|Overall Study|Reason for study withdrawal not specified|1|||
27888251|NCT02587598|81425365|FG002|Overall Study|Reason for study withdrawal not specified|0|||
27888252|NCT02587598|81425366|FG003|Overall Study|Reason for study withdrawal not specified|0|||
27888253|NCT02587598|81425367|FG004|Overall Study|Reason for study withdrawal not specified|0|||
27888254|NCT02587598|81425368|FG005|Overall Study|Reason for study withdrawal not specified|0|||
27600653|NCT00549757|80378235|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
27600654|NCT00549757|80378236|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
27600655|NCT04082884|80378237|FG000|Overall Study|Withdrawal by Subject|1|||
27888255|NCT02587598|81425369|FG006|Overall Study|Reason for study withdrawal not specified|0|||
27888256|NCT02587598|81425370|FG007|Overall Study|Reason for study withdrawal not specified|0|||
27888257|NCT02587598|81425371|FG008|Overall Study|Reason for study withdrawal not specified|0|||
27888258|NCT02587598|81425372|FG009|Overall Study|Reason for study withdrawal not specified|0|||
27705869|NCT01299376|80762141|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
27705870|NCT01299376|80762140|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
27600656|NCT01060553|80378241|FG000|Overall Study|Lost to Follow-up|3|||
27600657|NCT01060553|80378242|FG001|Overall Study|Lost to Follow-up|5|||
27600658|NCT01060553|80378241|FG000|Overall Study|Withdrawal by Subject|5|||
27600659|NCT01060553|80378242|FG001|Overall Study|Withdrawal by Subject|5|||
27600660|NCT01060553|80378241|FG000|Overall Study|Lack of Efficacy|1|||
27705871|NCT01299376|80762141|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
27705872|NCT01299376|80762140|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
27705873|NCT01299376|80762141|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
27705874|NCT00187096|80762142|FG000|Overall Study|unacceptable toxicity|0|||
27705875|NCT00187096|80762143|FG001|Overall Study|unacceptable toxicity|0|||
27705876|NCT00187096|80762144|FG002|Overall Study|unacceptable toxicity|1|||
27705877|NCT01484977|80762145|FG000|Overall Study|Adverse Event|8|||
27705878|NCT01484977|80762145|FG000|Overall Study|Lack of Efficacy|4|||
27600661|NCT01060553|80378242|FG001|Overall Study|Lack of Efficacy|0|||
27705879|NCT01484977|80762145|FG000|Overall Study|Protocol Violation|6|||
27888259|NCT02587598|81425373|FG010|Overall Study|Reason for study withdrawal not specified|0|||
27705880|NCT01484977|80762145|FG000|Overall Study|Lost to Follow-up|1|||
27705881|NCT01484977|80762145|FG000|Overall Study|Withdrawal by Subject|4|||
27705882|NCT01484977|80762145|FG000|Overall Study|Subject Protocol Non-compliant|1|||
27705883|NCT01484977|80762145|FG000|Overall Study|Moving Overseas|1|||
27705884|NCT01484977|80762145|FG000|Overall Study|Low White Blood Cell Count|1|||
27705885|NCT01484977|80762145|FG000|Overall Study|Lack of Compliance|1|||
27705886|NCT03441334|80762146|FG000|Overall Study|Withdrawal by Subject|1|||
27705887|NCT03441334|80762147|FG001|Overall Study|Withdrawal by Subject|0|||
27705888|NCT02163187|80762161|FG000|Overall Study|Device removed|1|||
27705889|NCT02163187|80762162|FG001|Overall Study|Device removed|0|||
27705890|NCT02163187|80762161|FG000|Overall Study|Progressive disease|1|||
27705891|NCT02163187|80762162|FG001|Overall Study|Progressive disease|0|||
27705892|NCT02490475|80762163|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
27705893|NCT02490475|80762164|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
27705894|NCT02490475|80762165|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
27705895|NCT02490475|80762166|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
27705896|NCT02490475|80762163|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
27705897|NCT02490475|80762164|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
27705898|NCT02490475|80762165|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
27705899|NCT02490475|80762166|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
27705900|NCT02490475|80762163|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
27705901|NCT02490475|80762164|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
27705902|NCT02490475|80762165|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
27705903|NCT02490475|80762166|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
27705904|NCT02490475|80762163|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
27705905|NCT02490475|80762164|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
27705906|NCT02490475|80762165|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
27705907|NCT02490475|80762166|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
27705908|NCT02490475|80762163|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
27705909|NCT02490475|80762164|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
27705910|NCT02490475|80762165|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
27705911|NCT02490475|80762166|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
27705912|NCT02490475|80762163|FG000|Period 2: Extension Phase|Refused Treatment|0|||
27705913|NCT02490475|80762164|FG001|Period 2: Extension Phase|Refused Treatment|0|||
27705914|NCT02490475|80762165|FG002|Period 2: Extension Phase|Refused Treatment|0|||
27705915|NCT02490475|80762166|FG003|Period 2: Extension Phase|Refused Treatment|1|||
27705916|NCT02490475|80762163|FG000|Period 2: Extension Phase|Adverse Event|0|||
27705917|NCT02490475|80762164|FG001|Period 2: Extension Phase|Adverse Event|0|||
27705918|NCT02490475|80762165|FG002|Period 2: Extension Phase|Adverse Event|1|||
27705919|NCT02490475|80762166|FG003|Period 2: Extension Phase|Adverse Event|0|||
27705920|NCT02109562|80762167|FG000|Overall Study|Insufficient clinical response|2|||
27705921|NCT02109562|80762168|FG001|Overall Study|Insufficient clinical response|0|||
27705922|NCT02109562|80762169|FG002|Overall Study|Insufficient clinical response|4|||
27705923|NCT02109562|80762167|FG000|Overall Study|Adverse Event|0|||
27705924|NCT02109562|80762168|FG001|Overall Study|Adverse Event|2|||
27705925|NCT02109562|80762169|FG002|Overall Study|Adverse Event|3|||
27705926|NCT02109562|80762167|FG000|Overall Study|Lost to Follow-up|1|||
27705927|NCT02109562|80762168|FG001|Overall Study|Lost to Follow-up|0|||
27705928|NCT02109562|80762169|FG002|Overall Study|Lost to Follow-up|1|||
27705929|NCT02109562|80762167|FG000|Overall Study|Protocol Violation|0|||
27705930|NCT02109562|80762168|FG001|Overall Study|Protocol Violation|3|||
27705931|NCT02109562|80762169|FG002|Overall Study|Protocol Violation|1|||
27705932|NCT02109562|80762167|FG000|Overall Study|Withdrawal by Subject|20|||
27705933|NCT02109562|80762168|FG001|Overall Study|Withdrawal by Subject|25|||
27705934|NCT02109562|80762169|FG002|Overall Study|Withdrawal by Subject|21|||
27705935|NCT02109562|80762167|FG000|Overall Study|Physician Decision|3|||
27705936|NCT02109562|80762168|FG001|Overall Study|Physician Decision|4|||
27705937|NCT02109562|80762169|FG002|Overall Study|Physician Decision|5|||
27705938|NCT03511053|80762173|FG000|Overall Study|Withdrawal by Subject|1|||
27888260|NCT02587598|81425363|FG000|Overall Study|Withdrawal by Subject|0|||
27888261|NCT02587598|81425364|FG001|Overall Study|Withdrawal by Subject|1|||
27705939|NCT01735279|80762174|FG000|Overall Study|Lost to Follow-up|11|||
27705940|NCT01735279|80762175|FG001|Overall Study|Lost to Follow-up|8|||
27705941|NCT00449670|80762178|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
27705942|NCT00449670|80762179|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
27705943|NCT00449670|80762178|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
27705944|NCT00449670|80762179|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
27705945|NCT00449670|80762178|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
27705946|NCT00449670|80762179|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
27705947|NCT00449670|80762178|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
27705948|NCT00449670|80762179|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
27835010|NCT00112437|81226166|FG008|Year 2 (12-Month Extension)|Moved|0|||
27835011|NCT00112437|81226167|FG009|Year 2 (12-Month Extension)|Moved|1|||
27835012|NCT00112437|81226168|FG010|Year 2 (12-Month Extension)|Moved|0|||
27835013|NCT00112437|81226169|FG011|Year 2 (12-Month Extension)|Moved|0|||
27835014|NCT00112437|81226170|FG012|Year 2 (12-Month Extension)|Moved|0|||
27705949|NCT00449670|80762178|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
27705950|NCT00449670|80762179|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
27705951|NCT00449670|80762178|FG000|Booster Phase (Study no.109873)|Other|0|||
27705952|NCT00449670|80762179|FG001|Booster Phase (Study no.109873)|Other|2|||
27705953|NCT05092919|80762185|FG000|Overall Study|Lost to Follow-up|7|||
27705954|NCT05092919|80762185|FG000|Overall Study|Withdrawal by Subject|2|||
27705955|NCT00804570|80762186|FG000|Overall Study|Adverse Event|14|||
27705956|NCT00804570|80762187|FG001|Overall Study|Adverse Event|7|||
27705957|NCT00804570|80762186|FG000|Overall Study|Lack of Efficacy|0|||
27705958|NCT00804570|80762187|FG001|Overall Study|Lack of Efficacy|1|||
27705959|NCT00804570|80762186|FG000|Overall Study|Lost to Follow-up|18|||
27705960|NCT00804570|80762187|FG001|Overall Study|Lost to Follow-up|21|||
27705961|NCT00804570|80762186|FG000|Overall Study|Entry criteria not met|5|||
27705962|NCT00804570|80762187|FG001|Overall Study|Entry criteria not met|5|||
27705963|NCT00804570|80762186|FG000|Overall Study|Protocol Violation|12|||
27705964|NCT00804570|80762187|FG001|Overall Study|Protocol Violation|16|||
27705965|NCT00804570|80762186|FG000|Overall Study|Physician Decision|1|||
27705966|NCT00804570|80762187|FG001|Overall Study|Physician Decision|2|||
27705967|NCT00804570|80762186|FG000|Overall Study|Sponsor decision|1|||
27705968|NCT00804570|80762187|FG001|Overall Study|Sponsor decision|4|||
27705969|NCT00804570|80762186|FG000|Overall Study|Withdrawal by Subject|21|||
27705970|NCT00804570|80762187|FG001|Overall Study|Withdrawal by Subject|38|||
27705971|NCT03302975|80762188|FG000|Overall Study|Lost to Follow-up|4|||
27705972|NCT03668600|80762189|FG000|Overall Study|Study Terminated by the Sponsor|157|||
27705973|NCT03668600|80762189|FG000|Overall Study|Protocol Violation|1|||
27705974|NCT03668600|80762189|FG000|Overall Study|Pregnancy|1|||
27705975|NCT03668600|80762189|FG000|Overall Study|Lost to Follow-up|7|||
27705976|NCT03668600|80762189|FG000|Overall Study|Withdrawal by Subject|56|||
27705977|NCT03668600|80762189|FG000|Overall Study|Lack of Efficacy|7|||
27705978|NCT03668600|80762189|FG000|Overall Study|Adverse Event|1|||
27705979|NCT00382018|80762192|FG000|Overall Study|Progression|0|||
27705980|NCT00382018|80762193|FG001|Overall Study|Progression|136|||
27705981|NCT00382018|80762194|FG002|Overall Study|Progression|51|||
27705982|NCT00382018|80762195|FG003|Overall Study|Progression|43|||
27705983|NCT00382018|80762192|FG000|Overall Study|Death|0|||
27705984|NCT00382018|80762193|FG001|Overall Study|Death|9|||
27705985|NCT00382018|80762194|FG002|Overall Study|Death|7|||
27705986|NCT00382018|80762195|FG003|Overall Study|Death|11|||
27705987|NCT00382018|80762192|FG000|Overall Study|Withdrawal by Subject|0|||
27705988|NCT00382018|80762193|FG001|Overall Study|Withdrawal by Subject|4|||
27705989|NCT00382018|80762194|FG002|Overall Study|Withdrawal by Subject|3|||
27705990|NCT00382018|80762195|FG003|Overall Study|Withdrawal by Subject|4|||
27705991|NCT00382018|80762192|FG000|Overall Study|Other, not protocol specified|0|||
27705992|NCT00382018|80762193|FG001|Overall Study|Other, not protocol specified|16|||
27705993|NCT00382018|80762194|FG002|Overall Study|Other, not protocol specified|3|||
27705994|NCT00382018|80762195|FG003|Overall Study|Other, not protocol specified|1|||
27705995|NCT00395863|80762200|FG000|Overall Study|Patients did not complete both exams|2|||
27705996|NCT00395863|80762201|FG001|Overall Study|Patients did not complete both exams|3|||
27705997|NCT03275285|80762202|FG000|Overall Study|Ongoing|45|||
27705998|NCT03275285|80762203|FG001|Overall Study|Ongoing|69|||
27705999|NCT00475722|80762204|FG000|Overall Study|Withdrawal by Subject|12|||
27706000|NCT00475722|80762205|FG001|Overall Study|Withdrawal by Subject|12|||
27706001|NCT00475722|80762204|FG000|Overall Study|Protocol Violation|3|||
27706002|NCT00475722|80762205|FG001|Overall Study|Protocol Violation|0|||
27706003|NCT00698932|80762206|FG000|Overall Study|Adverse Event|0|||
27706004|NCT00698932|80762207|FG001|Overall Study|Adverse Event|2|||
27706005|NCT00698932|80762206|FG000|Overall Study|Incorrect enrollment|0|||
27835015|NCT00112437|81226171|FG013|Year 2 (12-Month Extension)|Moved|0|||
27835016|NCT00112437|81226172|FG014|Year 2 (12-Month Extension)|Moved|0|||
27835017|NCT00112437|81226173|FG015|Year 2 (12-Month Extension)|Moved|0|||
27600662|NCT00337272|80378247|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
27600663|NCT00337272|80378248|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
27706006|NCT00698932|80762207|FG001|Overall Study|Incorrect enrollment|2|||
27706007|NCT00698932|80762206|FG000|Overall Study|Study specific discontinuation criteria|3|||
27706008|NCT00698932|80762207|FG001|Overall Study|Study specific discontinuation criteria|4|||
27835018|NCT00112437|81226174|FG016|Year 2 (12-Month Extension)|Moved|0|||
27835019|NCT00112437|81226175|FG017|Year 2 (12-Month Extension)|Moved|0|||
27835020|NCT00112437|81226176|FG018|Year 2 (12-Month Extension)|Moved|0|||
27835021|NCT00112437|81226177|FG019|Year 2 (12-Month Extension)|Moved|0|||
27706009|NCT00698932|80762206|FG000|Overall Study|Withdrawal by Subject|11|||
27706010|NCT00698932|80762207|FG001|Overall Study|Withdrawal by Subject|23|||
27706011|NCT00698932|80762206|FG000|Overall Study|Lost to Follow-up|6|||
27835022|NCT00112437|81226178|FG020|Year 2 (12-Month Extension)|Moved|0|||
27706012|NCT00698932|80762207|FG001|Overall Study|Lost to Follow-up|1|||
27706013|NCT00698932|80762206|FG000|Overall Study|Severe non-compliance to protocol|1|||
27706014|NCT00698932|80762207|FG001|Overall Study|Severe non-compliance to protocol|2|||
27706015|NCT00698932|80762206|FG000|Overall Study|Safety reasons|0|||
27706016|NCT00698932|80762207|FG001|Overall Study|Safety reasons|2|||
27706017|NCT00698932|80762206|FG000|Overall Study|Death|1|||
27706018|NCT00698932|80762207|FG001|Overall Study|Death|0|||
27706019|NCT00310804|80762213|FG000|Overall Study|Lost to Follow-up|2|||
27706020|NCT00310804|80762214|FG001|Overall Study|Lost to Follow-up|0|||
27706021|NCT00310804|80762213|FG000|Overall Study|Withdrawal by Subject|3|||
27706022|NCT00310804|80762214|FG001|Overall Study|Withdrawal by Subject|0|||
27706023|NCT01177683|80762215|FG000|Study Treatment|Disease Progressions during treatment|2|||
27706024|NCT01177683|80762216|FG001|Study Treatment|Disease Progressions during treatment|0|||
27706025|NCT01177683|80762217|FG002|Study Treatment|Disease Progressions during treatment|3|||
27706026|NCT01177683|80762215|FG000|Study Treatment|Adverse Event|0|||
27706027|NCT01177683|80762216|FG001|Study Treatment|Adverse Event|1|||
27706028|NCT01177683|80762217|FG002|Study Treatment|Adverse Event|12|||
27706029|NCT01177683|80762215|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
27706030|NCT01177683|80762216|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
27706031|NCT01177683|80762217|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
27706032|NCT01177683|80762215|FG000|Study Treatment|Alternative therapy|0|||
27706033|NCT01177683|80762216|FG001|Study Treatment|Alternative therapy|0|||
27706034|NCT01177683|80762217|FG002|Study Treatment|Alternative therapy|4|||
27706035|NCT01177683|80762215|FG000|Study Treatment|Physician Decision|1|||
27706036|NCT01177683|80762216|FG001|Study Treatment|Physician Decision|0|||
27706037|NCT01177683|80762217|FG002|Study Treatment|Physician Decision|1|||
27706038|NCT01177683|80762215|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
27706039|NCT01177683|80762216|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
27706040|NCT01177683|80762217|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
27706041|NCT01177683|80762215|FG000|Study Treatment|Symptomatic Deterioration|0|||
27706042|NCT01177683|80762216|FG001|Study Treatment|Symptomatic Deterioration|0|||
27706043|NCT01177683|80762217|FG002|Study Treatment|Symptomatic Deterioration|1|||
27706044|NCT01177683|80762215|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
27706045|NCT01177683|80762216|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
27706046|NCT01177683|80762217|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
27706047|NCT01177683|80762215|FG000|Follow up|Patient lost to follow up|0|||
27706048|NCT01177683|80762216|FG001|Follow up|Patient lost to follow up|0|||
27706049|NCT01177683|80762217|FG002|Follow up|Patient lost to follow up|2|||
27706050|NCT01177683|80762215|FG000|Follow up|Death|2|||
27706051|NCT01177683|80762216|FG001|Follow up|Death|1|||
27706052|NCT01177683|80762217|FG002|Follow up|Death|7|||
27706053|NCT01177683|80762215|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
27706054|NCT01177683|80762216|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
27706055|NCT01177683|80762217|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
27706056|NCT00747643|80762221|FG000|Overall Study|Withdrawal by Subject|36|||
27706057|NCT00747643|80762222|FG001|Overall Study|Withdrawal by Subject|27|||
27706058|NCT02269787|80762223|FG000|Overall Study|Lost to Follow-up|20|||
27706059|NCT02269787|80762224|FG001|Overall Study|Lost to Follow-up|6|||
27706060|NCT02269787|80762223|FG000|Overall Study|Death|2|||
27706061|NCT02269787|80762224|FG001|Overall Study|Death|3|||
27706062|NCT02269787|80762223|FG000|Overall Study|Incapacitated|0|||
27706063|NCT02269787|80762224|FG001|Overall Study|Incapacitated|1|||
27706064|NCT01473563|80762226|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
27706065|NCT00544648|80762232|FG000|Overall Study|Withdrawal by Subject|1|||
27706066|NCT00544648|80762233|FG001|Overall Study|Withdrawal by Subject|0|||
27706067|NCT00544648|80762232|FG000|Overall Study|Adverse Event|1|||
27706068|NCT00544648|80762233|FG001|Overall Study|Adverse Event|1|||
27706069|NCT00544648|80762232|FG000|Overall Study|progression of disease|1|||
27706070|NCT00544648|80762233|FG001|Overall Study|progression of disease|0|||
27706071|NCT03677596|80762234|FG000|Overall Study|Adverse Event|0|||
27706072|NCT03677596|80762235|FG001|Overall Study|Adverse Event|1|||
27706073|NCT03677596|80762234|FG000|Overall Study|Death|10|||
27706074|NCT03677596|80762235|FG001|Overall Study|Death|6|||
27706075|NCT03677596|80762234|FG000|Overall Study|Lost to Follow-up|0|||
27706076|NCT03677596|80762235|FG001|Overall Study|Lost to Follow-up|1|||
27706077|NCT03677596|80762234|FG000|Overall Study|Progressive Disease|8|||
27706078|NCT03677596|80762235|FG001|Overall Study|Progressive Disease|8|||
27706079|NCT03677596|80762234|FG000|Overall Study|Withdrawal by Subject|3|||
27706080|NCT03677596|80762235|FG001|Overall Study|Withdrawal by Subject|0|||
27706081|NCT03677596|80762234|FG000|Overall Study|Disease Relapse|2|||
27706082|NCT03677596|80762235|FG001|Overall Study|Disease Relapse|2|||
27706083|NCT03677596|80762234|FG000|Overall Study|Other|0|||
27706084|NCT03677596|80762235|FG001|Overall Study|Other|1|||
27706085|NCT03654976|80762236|FG000|Overall Study|Withdrawal by Subject|12|||
27706086|NCT03654976|80762237|FG001|Overall Study|Withdrawal by Subject|11|||
27706087|NCT03654976|80762236|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
27706088|NCT03654976|80762237|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
27706089|NCT03654976|80762236|FG000|Overall Study|Adverse Event|5|||
27706090|NCT03654976|80762237|FG001|Overall Study|Adverse Event|0|||
27706091|NCT03654976|80762236|FG000|Overall Study|Lost to Follow-up|2|||
27706092|NCT03654976|80762237|FG001|Overall Study|Lost to Follow-up|0|||
27706093|NCT03654976|80762236|FG000|Overall Study|Lack of Efficacy|0|||
27706094|NCT03654976|80762237|FG001|Overall Study|Lack of Efficacy|1|||
27706095|NCT02246582|80762239|FG000|Overall Study|Withdrawal by Subject|3|||
27706096|NCT02246582|80762240|FG001|Overall Study|Withdrawal by Subject|4|||
27706097|NCT02248259|80762245|FG000|Treatment Period 1|Adverse Event|0|||
27706098|NCT02248259|80762246|FG001|Treatment Period 1|Adverse Event|0|||
27706099|NCT02248259|80762247|FG002|Treatment Period 1|Adverse Event|1|||
27835023|NCT00112437|81226179|FG021|Year 2 (12-Month Extension)|Moved|0|||
27835024|NCT00112437|81226180|FG022|Year 2 (12-Month Extension)|Moved|0|||
27835025|NCT00112437|81226181|FG023|Year 2 (12-Month Extension)|Moved|0|||
27835026|NCT00112437|81226182|FG024|Year 2 (12-Month Extension)|Moved|0|||
27835027|NCT00112437|81226183|FG025|Year 2 (12-Month Extension)|Moved|0|||
27835028|NCT00112437|81226158|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
27835029|NCT00112437|81226159|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
27835030|NCT00112437|81226160|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
27835031|NCT00112437|81226161|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
27835032|NCT00112437|81226162|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
27835033|NCT00112437|81226163|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
27835034|NCT00112437|81226164|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
27835035|NCT00112437|81226165|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
27835036|NCT00112437|81226166|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
27835037|NCT00112437|81226167|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
27835038|NCT00112437|81226168|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
27835039|NCT00112437|81226169|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
27835040|NCT00112437|81226170|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
27835041|NCT00112437|81226171|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
27835042|NCT00112437|81226172|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
27835043|NCT00112437|81226173|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
27835044|NCT00112437|81226174|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
27835045|NCT00112437|81226175|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
27835046|NCT00112437|81226176|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
27835047|NCT00112437|81226177|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
27835048|NCT00112437|81226178|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
27835049|NCT00112437|81226179|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
27835050|NCT00112437|81226180|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
27835051|NCT00112437|81226181|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
27835052|NCT00112437|81226182|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
27835053|NCT00112437|81226183|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
27835054|NCT00112437|81226158|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835055|NCT00112437|81226159|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835056|NCT00112437|81226160|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835057|NCT00112437|81226161|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835058|NCT00112437|81226162|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835059|NCT00112437|81226163|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27888262|NCT02587598|81425365|FG002|Overall Study|Withdrawal by Subject|0|||
27888263|NCT02587598|81425366|FG003|Overall Study|Withdrawal by Subject|2|||
27888264|NCT02587598|81425367|FG004|Overall Study|Withdrawal by Subject|3|||
27888265|NCT02587598|81425368|FG005|Overall Study|Withdrawal by Subject|1|||
27888266|NCT02587598|81425369|FG006|Overall Study|Withdrawal by Subject|0|||
27888267|NCT02587598|81425370|FG007|Overall Study|Withdrawal by Subject|0|||
27888268|NCT02587598|81425371|FG008|Overall Study|Withdrawal by Subject|0|||
27888269|NCT02587598|81425372|FG009|Overall Study|Withdrawal by Subject|1|||
27888270|NCT02587598|81425373|FG010|Overall Study|Withdrawal by Subject|2|||
27888271|NCT02587598|81425363|FG000|Overall Study|Physician Decision|0|||
27888272|NCT02587598|81425364|FG001|Overall Study|Physician Decision|0|||
27888273|NCT02587598|81425365|FG002|Overall Study|Physician Decision|0|||
27888274|NCT02587598|81425366|FG003|Overall Study|Physician Decision|0|||
27888275|NCT02587598|81425367|FG004|Overall Study|Physician Decision|0|||
27888276|NCT02587598|81425368|FG005|Overall Study|Physician Decision|0|||
27888277|NCT02587598|81425369|FG006|Overall Study|Physician Decision|0|||
27835060|NCT00112437|81226164|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27888278|NCT02587598|81425370|FG007|Overall Study|Physician Decision|0|||
27888279|NCT02587598|81425371|FG008|Overall Study|Physician Decision|0|||
27835061|NCT00112437|81226165|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835062|NCT00112437|81226166|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27888280|NCT02587598|81425372|FG009|Overall Study|Physician Decision|0|||
27888281|NCT02587598|81425373|FG010|Overall Study|Physician Decision|3|||
27888282|NCT01953601|81425376|FG000|Part 1 (Base Study)|Adverse Event|24|||
27706100|NCT02248259|80762248|FG003|Treatment Period 1|Adverse Event|0|||
27706101|NCT01372150|80762249|FG000|Overall Study|Lack of Efficacy|3|||
27706102|NCT01372150|80762250|FG001|Overall Study|Lack of Efficacy|0|||
27706103|NCT01372150|80762251|FG002|Overall Study|Lack of Efficacy|1|||
27888283|NCT01953601|81425377|FG001|Part 1 (Base Study)|Adverse Event|37|||
27706104|NCT01372150|80762249|FG000|Overall Study|Lost to Follow-up|4|||
27706105|NCT01372150|80762250|FG001|Overall Study|Lost to Follow-up|5|||
27706106|NCT01372150|80762251|FG002|Overall Study|Lost to Follow-up|6|||
27706107|NCT01372150|80762249|FG000|Overall Study|Protocol Violation|1|||
27706108|NCT01372150|80762250|FG001|Overall Study|Protocol Violation|0|||
27706109|NCT01372150|80762251|FG002|Overall Study|Protocol Violation|3|||
27706110|NCT01372150|80762249|FG000|Overall Study|Withdrawal by Subject|2|||
27706111|NCT01372150|80762250|FG001|Overall Study|Withdrawal by Subject|7|||
27835063|NCT00112437|81226167|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835064|NCT00112437|81226168|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835065|NCT00112437|81226169|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
27835066|NCT00112437|81226170|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835067|NCT00112437|81226171|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
27835068|NCT00112437|81226172|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835069|NCT00112437|81226173|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
27835070|NCT00112437|81226174|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835071|NCT00112437|81226175|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835072|NCT00112437|81226176|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
27835073|NCT00112437|81226177|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835074|NCT00112437|81226178|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835075|NCT00112437|81226179|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835076|NCT00112437|81226180|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835077|NCT00112437|81226181|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835078|NCT00112437|81226182|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835079|NCT00112437|81226183|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
27835080|NCT00112437|81226158|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835081|NCT00112437|81226159|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835082|NCT00112437|81226160|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835083|NCT00112437|81226161|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835084|NCT00112437|81226162|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835085|NCT00112437|81226163|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835086|NCT00112437|81226164|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835087|NCT00112437|81226165|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27888284|NCT01953601|81425378|FG002|Part 1 (Base Study)|Adverse Event|15|||
27888285|NCT01953601|81425376|FG000|Part 1 (Base Study)|Death|2|||
27888286|NCT01953601|81425377|FG001|Part 1 (Base Study)|Death|0|||
27706112|NCT01372150|80762251|FG002|Overall Study|Withdrawal by Subject|2|||
27835088|NCT00112437|81226166|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835089|NCT00112437|81226167|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835090|NCT00112437|81226168|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835091|NCT00112437|81226169|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27888287|NCT01953601|81425378|FG002|Part 1 (Base Study)|Death|3|||
27706113|NCT01372150|80762249|FG000|Overall Study|Other|1|||
27600664|NCT00337272|80378247|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
27706114|NCT01372150|80762250|FG001|Overall Study|Other|0|||
27706115|NCT01372150|80762251|FG002|Overall Study|Other|2|||
27835092|NCT00112437|81226170|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835093|NCT00112437|81226171|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835094|NCT00112437|81226172|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835095|NCT00112437|81226173|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
27835096|NCT00112437|81226174|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835097|NCT00112437|81226175|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835098|NCT00112437|81226176|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835099|NCT00112437|81226177|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835100|NCT00112437|81226178|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835101|NCT00112437|81226179|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27888288|NCT01953601|81425376|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
27706116|NCT01372150|80762249|FG000|Overall Study|Adverse Event|2|||
27706117|NCT01372150|80762250|FG001|Overall Study|Adverse Event|1|||
27706118|NCT01372150|80762251|FG002|Overall Study|Adverse Event|2|||
27706119|NCT01372150|80762249|FG000|Overall Study|Randomized but not treated|0|||
27706120|NCT01372150|80762250|FG001|Overall Study|Randomized but not treated|1|||
27706121|NCT01372150|80762251|FG002|Overall Study|Randomized but not treated|0|||
27706122|NCT02161575|80762257|FG000|Overall Study|Protocol Violation|8|||
27706123|NCT02161575|80762257|FG000|Overall Study|Lack of Efficacy|1|||
27706124|NCT02161575|80762257|FG000|Overall Study|Adverse Event|2|||
27706125|NCT01147744|80762258|FG000|Overall Study|Protocol Violation|1|||
27706126|NCT01147744|80762259|FG001|Overall Study|Protocol Violation|0|||
27706127|NCT01147744|80762260|FG002|Overall Study|Protocol Violation|1|||
27706128|NCT01147744|80762261|FG003|Overall Study|Protocol Violation|0|||
27706129|NCT01147744|80762262|FG004|Overall Study|Protocol Violation|1|||
27706130|NCT01147744|80762263|FG005|Overall Study|Protocol Violation|3|||
27706131|NCT01147744|80762264|FG006|Overall Study|Protocol Violation|1|||
27706132|NCT01147744|80762258|FG000|Overall Study|Physician Decision|0|||
27706133|NCT01147744|80762259|FG001|Overall Study|Physician Decision|1|||
27706134|NCT01147744|80762260|FG002|Overall Study|Physician Decision|1|||
27706135|NCT01147744|80762261|FG003|Overall Study|Physician Decision|0|||
27706136|NCT01147744|80762262|FG004|Overall Study|Physician Decision|0|||
27706137|NCT01147744|80762263|FG005|Overall Study|Physician Decision|0|||
27706138|NCT01147744|80762264|FG006|Overall Study|Physician Decision|1|||
27706139|NCT01147744|80762258|FG000|Overall Study|Lack of Efficacy|11|||
27835102|NCT00112437|81226180|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835103|NCT00112437|81226181|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835104|NCT00112437|81226182|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835105|NCT00112437|81226183|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
27835106|NCT00112437|81226158|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
27706140|NCT01147744|80762259|FG001|Overall Study|Lack of Efficacy|11|||
27706141|NCT01147744|80762260|FG002|Overall Study|Lack of Efficacy|9|||
27706142|NCT01147744|80762261|FG003|Overall Study|Lack of Efficacy|11|||
27706143|NCT01147744|80762262|FG004|Overall Study|Lack of Efficacy|13|||
27706144|NCT01147744|80762263|FG005|Overall Study|Lack of Efficacy|8|||
27706145|NCT01147744|80762264|FG006|Overall Study|Lack of Efficacy|7|||
27706146|NCT01147744|80762258|FG000|Overall Study|Adverse Event|1|||
27706147|NCT01147744|80762259|FG001|Overall Study|Adverse Event|2|||
27706148|NCT01147744|80762260|FG002|Overall Study|Adverse Event|3|||
27706149|NCT01147744|80762261|FG003|Overall Study|Adverse Event|0|||
27706150|NCT01147744|80762262|FG004|Overall Study|Adverse Event|2|||
27706151|NCT01147744|80762263|FG005|Overall Study|Adverse Event|1|||
27706152|NCT01147744|80762264|FG006|Overall Study|Adverse Event|2|||
27706153|NCT01147744|80762258|FG000|Overall Study|Withdrawal by Subject|8|||
27706154|NCT01147744|80762259|FG001|Overall Study|Withdrawal by Subject|4|||
27706155|NCT01147744|80762260|FG002|Overall Study|Withdrawal by Subject|2|||
27706156|NCT01147744|80762261|FG003|Overall Study|Withdrawal by Subject|2|||
27706157|NCT01147744|80762262|FG004|Overall Study|Withdrawal by Subject|2|||
27706158|NCT01147744|80762263|FG005|Overall Study|Withdrawal by Subject|5|||
27706159|NCT01147744|80762264|FG006|Overall Study|Withdrawal by Subject|2|||
27706160|NCT01147744|80762258|FG000|Overall Study|Lost to Follow-up|0|||
27600665|NCT00337272|80378248|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
27600666|NCT00337272|80378247|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
27600667|NCT00337272|80378248|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
27600668|NCT00337272|80378247|FG000|Treatment Period|Non-compliance|1|||
27600669|NCT00337272|80378248|FG001|Treatment Period|Non-compliance|1|||
27600670|NCT00337272|80378247|FG000|Treatment Period|Withdrawal by Subject|0|||
27600671|NCT00337272|80378248|FG001|Treatment Period|Withdrawal by Subject|1|||
27600672|NCT00337272|80378247|FG000|Withdrawal Period|Non-compliance|0|||
27835107|NCT00112437|81226159|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835108|NCT00112437|81226160|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835109|NCT00112437|81226161|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835110|NCT00112437|81226162|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835111|NCT00112437|81226163|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
27706161|NCT01147744|80762259|FG001|Overall Study|Lost to Follow-up|1|||
27706162|NCT01147744|80762260|FG002|Overall Study|Lost to Follow-up|0|||
27706163|NCT01147744|80762261|FG003|Overall Study|Lost to Follow-up|0|||
27706164|NCT01147744|80762262|FG004|Overall Study|Lost to Follow-up|0|||
27706165|NCT01147744|80762263|FG005|Overall Study|Lost to Follow-up|0|||
27706166|NCT01147744|80762264|FG006|Overall Study|Lost to Follow-up|0|||
27706167|NCT01147744|80762258|FG000|Overall Study|Sponsor decision to amend protocol|7|||
27706168|NCT01147744|80762259|FG001|Overall Study|Sponsor decision to amend protocol|4|||
27706169|NCT01147744|80762260|FG002|Overall Study|Sponsor decision to amend protocol|2|||
27706170|NCT01147744|80762261|FG003|Overall Study|Sponsor decision to amend protocol|5|||
27706171|NCT01147744|80762262|FG004|Overall Study|Sponsor decision to amend protocol|7|||
27706172|NCT01147744|80762263|FG005|Overall Study|Sponsor decision to amend protocol|2|||
27706173|NCT01147744|80762264|FG006|Overall Study|Sponsor decision to amend protocol|6|||
27706174|NCT01147744|80762258|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27706175|NCT01147744|80762259|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27706176|NCT01147744|80762260|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27600673|NCT00337272|80378248|FG001|Withdrawal Period|Non-compliance|1|||
27600674|NCT01984697|80378255|FG000|Overall Study|Adverse Event|0|||
27600675|NCT01984697|80378256|FG001|Overall Study|Adverse Event|0|||
27600676|NCT01984697|80378257|FG002|Overall Study|Adverse Event|2|||
27706177|NCT01147744|80762261|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27706178|NCT01147744|80762262|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27706179|NCT01147744|80762263|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27706180|NCT01147744|80762264|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27835112|NCT00112437|81226164|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
27706181|NCT03349099|80762265|FG000|Overall Study|Physician Decision|3|||
27706182|NCT03349099|80762266|FG001|Overall Study|Physician Decision|4|||
27706183|NCT03349099|80762265|FG000|Overall Study|Stone migrated from the kidney|1|||
27706184|NCT03349099|80762266|FG001|Overall Study|Stone migrated from the kidney|0|||
27706185|NCT02613884|80762267|FG000|Overall Study|Death|1|||
27706186|NCT02613884|80762267|FG000|Overall Study|Lost to Follow-up|1|||
27835113|NCT00112437|81226165|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835114|NCT00112437|81226166|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835115|NCT00112437|81226167|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
27600677|NCT01984697|80378258|FG003|Overall Study|Adverse Event|0|||
27835116|NCT00112437|81226168|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835117|NCT00112437|81226169|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835118|NCT00112437|81226170|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835119|NCT00112437|81226171|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
27600678|NCT01984697|80378259|FG004|Overall Study|Adverse Event|0|||
27600679|NCT01984697|80378255|FG000|Overall Study|Lost to Follow-up|14|||
27600680|NCT01984697|80378256|FG001|Overall Study|Lost to Follow-up|5|||
27600681|NCT01984697|80378257|FG002|Overall Study|Lost to Follow-up|10|||
27600682|NCT01984697|80378258|FG003|Overall Study|Lost to Follow-up|6|||
27600683|NCT01984697|80378259|FG004|Overall Study|Lost to Follow-up|21|||
27600684|NCT01984697|80378255|FG000|Overall Study|Physician Decision|3|||
27600685|NCT01984697|80378256|FG001|Overall Study|Physician Decision|0|||
27835120|NCT00112437|81226172|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835121|NCT00112437|81226173|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
27835122|NCT00112437|81226174|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835123|NCT00112437|81226175|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835124|NCT00112437|81226176|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835125|NCT00112437|81226177|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835126|NCT00112437|81226178|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835127|NCT00112437|81226179|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835128|NCT00112437|81226180|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835129|NCT00112437|81226181|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835130|NCT00112437|81226182|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835131|NCT00112437|81226183|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
27835132|NCT00112437|81226158|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835133|NCT00112437|81226159|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835134|NCT00112437|81226160|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835135|NCT00112437|81226161|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835136|NCT00112437|81226162|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835137|NCT00112437|81226163|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835138|NCT00112437|81226164|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835139|NCT00112437|81226165|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835140|NCT00112437|81226166|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835141|NCT00112437|81226167|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835142|NCT00112437|81226168|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835143|NCT00112437|81226169|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
27835144|NCT00112437|81226170|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835145|NCT00112437|81226171|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27600686|NCT01984697|80378257|FG002|Overall Study|Physician Decision|0|||
27600687|NCT01984697|80378258|FG003|Overall Study|Physician Decision|1|||
27600688|NCT01984697|80378259|FG004|Overall Study|Physician Decision|0|||
27835146|NCT00112437|81226172|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
27835147|NCT00112437|81226173|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835148|NCT00112437|81226174|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835149|NCT00112437|81226175|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835150|NCT00112437|81226176|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835151|NCT00112437|81226177|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835152|NCT00112437|81226178|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835153|NCT00112437|81226179|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835154|NCT00112437|81226180|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835155|NCT00112437|81226181|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27600689|NCT01984697|80378255|FG000|Overall Study|Protocol Violation|8|||
27600690|NCT01984697|80378256|FG001|Overall Study|Protocol Violation|5|||
27600691|NCT01984697|80378257|FG002|Overall Study|Protocol Violation|3|||
27600692|NCT01984697|80378258|FG003|Overall Study|Protocol Violation|2|||
27600693|NCT01984697|80378259|FG004|Overall Study|Protocol Violation|0|||
27706187|NCT02663271|80762268|FG000|Overall Study|Withdrawal by Subject|5|||
27706188|NCT02663271|80762268|FG000|Overall Study|Lack of Efficacy|1|||
27706189|NCT00687440|80762271|FG000|Overall Study|Adverse Event|3|||
27706190|NCT00687440|80762271|FG000|Overall Study|Lost to Follow-up|3|||
27835156|NCT00112437|81226182|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27835157|NCT00112437|81226183|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
27888289|NCT01953601|81425377|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
27888290|NCT01953601|81425378|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
27888291|NCT01953601|81425376|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
27888292|NCT01953601|81425377|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
27835158|NCT00112437|81226158|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835159|NCT00112437|81226159|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835160|NCT00112437|81226160|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835161|NCT00112437|81226161|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835162|NCT00112437|81226162|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835163|NCT00112437|81226163|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835164|NCT00112437|81226164|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835165|NCT00112437|81226165|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835166|NCT00112437|81226166|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835167|NCT00112437|81226167|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835168|NCT00112437|81226168|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
27835169|NCT00112437|81226169|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
27835170|NCT00112437|81226170|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835171|NCT00112437|81226171|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835172|NCT00112437|81226172|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835173|NCT00112437|81226173|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835174|NCT00112437|81226174|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835175|NCT00112437|81226175|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835176|NCT00112437|81226176|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835177|NCT00112437|81226177|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835178|NCT00112437|81226178|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835179|NCT00112437|81226179|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835180|NCT00112437|81226180|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835181|NCT00112437|81226181|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835182|NCT00112437|81226182|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835183|NCT00112437|81226183|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
27835184|NCT00112437|81226158|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835185|NCT00112437|81226159|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835186|NCT00112437|81226160|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835187|NCT00112437|81226161|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835188|NCT00112437|81226162|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835189|NCT00112437|81226163|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835190|NCT00112437|81226164|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835191|NCT00112437|81226165|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835192|NCT00112437|81226166|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835193|NCT00112437|81226167|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835194|NCT00112437|81226168|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835195|NCT00112437|81226169|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835196|NCT00112437|81226170|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835197|NCT00112437|81226171|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27888293|NCT01953601|81425378|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
27888294|NCT01953601|81425376|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
27600694|NCT01984697|80378255|FG000|Overall Study|Withdrawal by Subject|15|||
27835198|NCT00112437|81226172|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835199|NCT00112437|81226173|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835200|NCT00112437|81226174|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835201|NCT00112437|81226175|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835202|NCT00112437|81226176|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835203|NCT00112437|81226177|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835204|NCT00112437|81226178|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
27600695|NCT01984697|80378256|FG001|Overall Study|Withdrawal by Subject|21|||
27600696|NCT01984697|80378257|FG002|Overall Study|Withdrawal by Subject|13|||
27835205|NCT00112437|81226179|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
27835206|NCT00112437|81226180|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835207|NCT00112437|81226181|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835208|NCT00112437|81226182|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835209|NCT00112437|81226183|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
27835210|NCT00112437|81226158|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835211|NCT00112437|81226159|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835212|NCT00112437|81226160|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835213|NCT00112437|81226161|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835214|NCT00112437|81226162|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835215|NCT00112437|81226163|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27888295|NCT01953601|81425377|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
27888296|NCT01953601|81425378|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
27888297|NCT01953601|81425376|FG000|Part 1 (Base Study)|Physician Decision|3|||
27600697|NCT01984697|80378258|FG003|Overall Study|Withdrawal by Subject|11|||
27600698|NCT01984697|80378259|FG004|Overall Study|Withdrawal by Subject|13|||
27600699|NCT01984697|80378255|FG000|Overall Study|Missed last follow-up visit|1|||
27600700|NCT01984697|80378256|FG001|Overall Study|Missed last follow-up visit|0|||
27600701|NCT01984697|80378257|FG002|Overall Study|Missed last follow-up visit|0|||
27600702|NCT01984697|80378258|FG003|Overall Study|Missed last follow-up visit|0|||
27600703|NCT01984697|80378259|FG004|Overall Study|Missed last follow-up visit|0|||
27600704|NCT01984697|80378255|FG000|Overall Study|Death|0|||
27600705|NCT01984697|80378256|FG001|Overall Study|Death|0|||
27600706|NCT01984697|80378257|FG002|Overall Study|Death|0|||
27600707|NCT01984697|80378258|FG003|Overall Study|Death|1|||
27600708|NCT01984697|80378259|FG004|Overall Study|Death|0|||
27600709|NCT01984697|80378255|FG000|Overall Study|Pregnancy|2|||
27600710|NCT01984697|80378256|FG001|Overall Study|Pregnancy|0|||
27600711|NCT01984697|80378257|FG002|Overall Study|Pregnancy|1|||
27706191|NCT00687440|80762271|FG000|Overall Study|Lack of Efficacy|2|||
27888298|NCT01953601|81425377|FG001|Part 1 (Base Study)|Physician Decision|7|||
27600712|NCT01984697|80378258|FG003|Overall Study|Pregnancy|0|||
27600713|NCT01984697|80378259|FG004|Overall Study|Pregnancy|1|||
27600714|NCT00539279|80378260|FG000|Treatment|Withdrawal by Subject|10|||
27888299|NCT01953601|81425378|FG002|Part 1 (Base Study)|Physician Decision|4|||
27600715|NCT00539279|80378261|FG001|Treatment|Withdrawal by Subject|8|||
27600716|NCT00539279|80378260|FG000|Treatment|Death|1|||
27600717|NCT00539279|80378261|FG001|Treatment|Death|0|||
27600718|NCT00539279|80378260|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
27835216|NCT00112437|81226164|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835217|NCT00112437|81226165|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27600719|NCT00539279|80378261|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
27600720|NCT00539279|80378260|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
27600721|NCT00539279|80378261|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
27600722|NCT02172625|80378262|FG000|Overall Study|Adverse Event|0|||
27600723|NCT02172625|80378263|FG001|Overall Study|Adverse Event|1|||
27600724|NCT02172625|80378262|FG000|Overall Study|Pregnancy|0|||
27600725|NCT02172625|80378263|FG001|Overall Study|Pregnancy|1|||
27600726|NCT02172625|80378262|FG000|Overall Study|car accident|0|||
27600727|NCT02172625|80378263|FG001|Overall Study|car accident|1|||
27600728|NCT00538590|80378264|FG000|Overall Study|Death|1|||
27600729|NCT00538590|80378265|FG001|Overall Study|Death|0|||
27600730|NCT00464815|80378266|FG000|Overall Study|Withdrawal by Subject|6|||
27706192|NCT00687440|80762271|FG000|Overall Study|Death|2|||
27835218|NCT00112437|81226166|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835219|NCT00112437|81226167|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835220|NCT00112437|81226168|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27600731|NCT00464815|80378267|FG001|Overall Study|Withdrawal by Subject|3|||
27600732|NCT02355028|80378270|FG000|Overall Study|Adverse Event|2|||
27835221|NCT00112437|81226169|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27706193|NCT00687440|80762271|FG000|Overall Study|Other|1|||
27706194|NCT00687440|80762271|FG000|Overall Study|Missing|1|||
27706195|NCT01245387|80762276|FG000|Overall Study|Lost to Follow-up|106|||
27706196|NCT01245387|80762276|FG000|Overall Study|Lack of Efficacy|195|||
27706197|NCT01245387|80762276|FG000|Overall Study|Adverse Event|9|||
27706198|NCT01245387|80762276|FG000|Overall Study|Death|3|||
27706199|NCT01245387|80762276|FG000|Overall Study|Other|131|||
27706200|NCT01245387|80762276|FG000|Overall Study|Missing discontinuation status|369|||
27706201|NCT03975920|80762278|FG000|Overall Study|Lost to Follow-up|1|||
27835222|NCT00112437|81226170|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27706202|NCT03975920|80762279|FG001|Overall Study|Lost to Follow-up|2|||
27706203|NCT03975920|80762278|FG000|Overall Study|Protocol Violation|1|||
27706204|NCT03975920|80762279|FG001|Overall Study|Protocol Violation|1|||
27706205|NCT03975920|80762278|FG000|Overall Study|Did not complete survey|2|||
27706206|NCT03975920|80762279|FG001|Overall Study|Did not complete survey|1|||
27706207|NCT01368042|80762280|FG000|Overall Study|Death|14|||
27706208|NCT01368042|80762280|FG000|Overall Study|Protocol Violation|11|||
27706209|NCT01368042|80762280|FG000|Overall Study|Lost to Follow-up|4|||
27706210|NCT01368042|80762280|FG000|Overall Study|Transplanted|1|||
27706211|NCT02844920|80762283|FG000|Overall Study|Lost to Follow-up|2|||
27706212|NCT01342484|80762284|FG000|Overall Study|Other Reasons|1|||
27706213|NCT01342484|80762285|FG001|Overall Study|Other Reasons|0|||
27706214|NCT01342484|80762286|FG002|Overall Study|Other Reasons|0|||
27706215|NCT01342484|80762284|FG000|Overall Study|Protocol Violation|0|||
27706216|NCT01342484|80762285|FG001|Overall Study|Protocol Violation|0|||
27706217|NCT01342484|80762286|FG002|Overall Study|Protocol Violation|1|||
27706218|NCT01342484|80762284|FG000|Overall Study|Withdrawal by Subject|1|||
27706219|NCT01342484|80762285|FG001|Overall Study|Withdrawal by Subject|0|||
27600733|NCT02355028|80378271|FG001|Overall Study|Adverse Event|0|||
27706220|NCT01342484|80762286|FG002|Overall Study|Withdrawal by Subject|0|||
27706221|NCT00113074|80762288|FG000|Overall Study|Lost to Follow-up|10|||
27706222|NCT00113074|80762289|FG001|Overall Study|Lost to Follow-up|10|||
27706223|NCT00113074|80762290|FG002|Overall Study|Lost to Follow-up|14|||
27706224|NCT01186796|80762291|FG000|Overall Study|Adverse Event|3|||
27706225|NCT01186796|80762292|FG001|Overall Study|Adverse Event|0|||
27706226|NCT01186796|80762291|FG000|Overall Study|Withdrawal by Subject|1|||
27706227|NCT01186796|80762292|FG001|Overall Study|Withdrawal by Subject|1|||
27706228|NCT01186796|80762291|FG000|Overall Study|Protocol Violation|0|||
27706229|NCT01186796|80762292|FG001|Overall Study|Protocol Violation|1|||
27706230|NCT04206020|80762293|FG000|Overall Study|Adverse Event|1|||
27706231|NCT04206020|80762294|FG001|Overall Study|Adverse Event|4|||
27706232|NCT04206020|80762293|FG000|Overall Study|Protocol Violation|2|||
27706233|NCT04206020|80762294|FG001|Overall Study|Protocol Violation|0|||
27706234|NCT04206020|80762293|FG000|Overall Study|Withdrawal by Subject|2|||
27706235|NCT04206020|80762294|FG001|Overall Study|Withdrawal by Subject|0|||
27706236|NCT04206020|80762293|FG000|Overall Study|Lost to Follow-up|2|||
27706237|NCT04206020|80762294|FG001|Overall Study|Lost to Follow-up|0|||
27706238|NCT04206020|80762293|FG000|Overall Study|Pregnancy|0|||
27706239|NCT04206020|80762294|FG001|Overall Study|Pregnancy|1|||
27706240|NCT04206020|80762293|FG000|Overall Study|Unable to attend visits|1|||
27706241|NCT04206020|80762294|FG001|Overall Study|Unable to attend visits|2|||
27706242|NCT00467779|80762295|FG000|Stage 1|Adverse Event|1|||
27706243|NCT00467779|80762296|FG001|Stage 1|Adverse Event|0|||
27706244|NCT00467779|80762297|FG002|Stage 1|Adverse Event|0|||
27706245|NCT00467779|80762298|FG003|Stage 1|Adverse Event|0|||
27706246|NCT00467779|80762299|FG004|Stage 1|Adverse Event|0|||
27706247|NCT00467779|80762300|FG005|Stage 1|Adverse Event|1|||
27706248|NCT00467779|80762301|FG006|Stage 1|Adverse Event|2|||
27706249|NCT00467779|80762302|FG007|Stage 1|Adverse Event|1|||
27706250|NCT00467779|80762303|FG008|Stage 1|Adverse Event|0|||
27706251|NCT00467779|80762304|FG009|Stage 1|Adverse Event|0|||
27706252|NCT00467779|80762305|FG010|Stage 1|Adverse Event|0|||
27706253|NCT00467779|80762306|FG011|Stage 1|Adverse Event|0|||
27706254|NCT00467779|80762307|FG012|Stage 1|Adverse Event|0|||
27706255|NCT00467779|80762308|FG013|Stage 1|Adverse Event|0|||
27706256|NCT00467779|80762309|FG014|Stage 1|Adverse Event|0|||
27600734|NCT02355028|80378270|FG000|Overall Study|Withdrawal by Subject|1|||
27706257|NCT00467779|80762295|FG000|Stage 1|Disease Progression|2|||
27706258|NCT00467779|80762296|FG001|Stage 1|Disease Progression|2|||
27706259|NCT00467779|80762297|FG002|Stage 1|Disease Progression|2|||
27706260|NCT00467779|80762298|FG003|Stage 1|Disease Progression|3|||
27706261|NCT00467779|80762299|FG004|Stage 1|Disease Progression|2|||
27706262|NCT00467779|80762300|FG005|Stage 1|Disease Progression|2|||
27706263|NCT00467779|80762301|FG006|Stage 1|Disease Progression|4|||
27706264|NCT00467779|80762302|FG007|Stage 1|Disease Progression|5|||
27706265|NCT00467779|80762303|FG008|Stage 1|Disease Progression|0|||
27706266|NCT00467779|80762304|FG009|Stage 1|Disease Progression|0|||
27706267|NCT00467779|80762305|FG010|Stage 1|Disease Progression|0|||
27706268|NCT00467779|80762306|FG011|Stage 1|Disease Progression|0|||
27706269|NCT00467779|80762307|FG012|Stage 1|Disease Progression|0|||
27706270|NCT00467779|80762308|FG013|Stage 1|Disease Progression|0|||
27706271|NCT00467779|80762309|FG014|Stage 1|Disease Progression|0|||
27706272|NCT00467779|80762295|FG000|Stage 1|Unspecified Reason|1|||
27706273|NCT00467779|80762296|FG001|Stage 1|Unspecified Reason|0|||
27706274|NCT00467779|80762297|FG002|Stage 1|Unspecified Reason|1|||
27706275|NCT00467779|80762298|FG003|Stage 1|Unspecified Reason|0|||
27706276|NCT00467779|80762299|FG004|Stage 1|Unspecified Reason|1|||
27706277|NCT00467779|80762300|FG005|Stage 1|Unspecified Reason|2|||
27706278|NCT00467779|80762301|FG006|Stage 1|Unspecified Reason|0|||
27706279|NCT00467779|80762302|FG007|Stage 1|Unspecified Reason|0|||
27706280|NCT00467779|80762303|FG008|Stage 1|Unspecified Reason|0|||
27706281|NCT00467779|80762304|FG009|Stage 1|Unspecified Reason|0|||
27706282|NCT00467779|80762305|FG010|Stage 1|Unspecified Reason|0|||
27706283|NCT00467779|80762306|FG011|Stage 1|Unspecified Reason|0|||
27706284|NCT00467779|80762307|FG012|Stage 1|Unspecified Reason|0|||
27706285|NCT00467779|80762308|FG013|Stage 1|Unspecified Reason|0|||
27706286|NCT00467779|80762309|FG014|Stage 1|Unspecified Reason|0|||
27706287|NCT00467779|80762295|FG000|Stage 1|Physician Decision|0|||
27706288|NCT00467779|80762296|FG001|Stage 1|Physician Decision|1|||
27706289|NCT00467779|80762297|FG002|Stage 1|Physician Decision|0|||
27706290|NCT00467779|80762298|FG003|Stage 1|Physician Decision|0|||
27706291|NCT00467779|80762299|FG004|Stage 1|Physician Decision|0|||
27706292|NCT00467779|80762300|FG005|Stage 1|Physician Decision|0|||
27706293|NCT00467779|80762301|FG006|Stage 1|Physician Decision|0|||
27706294|NCT00467779|80762302|FG007|Stage 1|Physician Decision|0|||
27706295|NCT00467779|80762303|FG008|Stage 1|Physician Decision|0|||
27706296|NCT00467779|80762304|FG009|Stage 1|Physician Decision|0|||
27706297|NCT00467779|80762305|FG010|Stage 1|Physician Decision|0|||
27706298|NCT00467779|80762306|FG011|Stage 1|Physician Decision|0|||
27706299|NCT00467779|80762307|FG012|Stage 1|Physician Decision|0|||
27706300|NCT00467779|80762308|FG013|Stage 1|Physician Decision|0|||
27706301|NCT00467779|80762309|FG014|Stage 1|Physician Decision|0|||
27706302|NCT00467779|80762295|FG000|Stage 1|Withdrawal by Subject|0|||
27706303|NCT00467779|80762296|FG001|Stage 1|Withdrawal by Subject|0|||
27706304|NCT00467779|80762297|FG002|Stage 1|Withdrawal by Subject|0|||
27706305|NCT00467779|80762298|FG003|Stage 1|Withdrawal by Subject|0|||
27706306|NCT00467779|80762299|FG004|Stage 1|Withdrawal by Subject|0|||
27706307|NCT00467779|80762300|FG005|Stage 1|Withdrawal by Subject|0|||
27888300|NCT01953601|81425376|FG000|Part 1 (Base Study)|Screen failure|1|||
27888301|NCT01953601|81425377|FG001|Part 1 (Base Study)|Screen failure|0|||
27706308|NCT00467779|80762301|FG006|Stage 1|Withdrawal by Subject|1|||
27888302|NCT01953601|81425378|FG002|Part 1 (Base Study)|Screen failure|1|||
27706309|NCT00467779|80762302|FG007|Stage 1|Withdrawal by Subject|1|||
27706310|NCT00467779|80762303|FG008|Stage 1|Withdrawal by Subject|0|||
27706311|NCT00467779|80762304|FG009|Stage 1|Withdrawal by Subject|0|||
27706312|NCT00467779|80762305|FG010|Stage 1|Withdrawal by Subject|0|||
27888303|NCT01953601|81425376|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
27706313|NCT00467779|80762306|FG011|Stage 1|Withdrawal by Subject|0|||
27706314|NCT00467779|80762307|FG012|Stage 1|Withdrawal by Subject|0|||
27706315|NCT00467779|80762308|FG013|Stage 1|Withdrawal by Subject|0|||
27706316|NCT00467779|80762309|FG014|Stage 1|Withdrawal by Subject|0|||
27706317|NCT00467779|80762295|FG000|Stage 1A|Adverse Event|0|||
27706318|NCT00467779|80762296|FG001|Stage 1A|Adverse Event|0|||
27706319|NCT00467779|80762297|FG002|Stage 1A|Adverse Event|0|||
27706320|NCT00467779|80762298|FG003|Stage 1A|Adverse Event|0|||
27706321|NCT00467779|80762299|FG004|Stage 1A|Adverse Event|0|||
27706322|NCT00467779|80762300|FG005|Stage 1A|Adverse Event|0|||
27706323|NCT00467779|80762301|FG006|Stage 1A|Adverse Event|0|||
27706324|NCT00467779|80762302|FG007|Stage 1A|Adverse Event|0|||
27706325|NCT00467779|80762303|FG008|Stage 1A|Adverse Event|0|||
27706326|NCT00467779|80762304|FG009|Stage 1A|Adverse Event|0|||
27706327|NCT00467779|80762305|FG010|Stage 1A|Adverse Event|0|||
27706328|NCT00467779|80762306|FG011|Stage 1A|Adverse Event|0|||
27706329|NCT00467779|80762307|FG012|Stage 1A|Adverse Event|1|||
27706330|NCT00467779|80762308|FG013|Stage 1A|Adverse Event|0|||
27706331|NCT00467779|80762309|FG014|Stage 1A|Adverse Event|0|||
27706332|NCT00467779|80762295|FG000|Stage 1A|Death|0|||
27706333|NCT00467779|80762296|FG001|Stage 1A|Death|0|||
27706334|NCT00467779|80762297|FG002|Stage 1A|Death|0|||
27706335|NCT00467779|80762298|FG003|Stage 1A|Death|0|||
27706336|NCT00467779|80762299|FG004|Stage 1A|Death|0|||
27706337|NCT00467779|80762300|FG005|Stage 1A|Death|0|||
27706338|NCT00467779|80762301|FG006|Stage 1A|Death|0|||
27706339|NCT00467779|80762302|FG007|Stage 1A|Death|0|||
27706340|NCT00467779|80762303|FG008|Stage 1A|Death|0|||
27706341|NCT00467779|80762304|FG009|Stage 1A|Death|0|||
27706342|NCT00467779|80762305|FG010|Stage 1A|Death|0|||
27706343|NCT00467779|80762306|FG011|Stage 1A|Death|1|||
27706344|NCT00467779|80762307|FG012|Stage 1A|Death|1|||
27706345|NCT00467779|80762308|FG013|Stage 1A|Death|0|||
27706346|NCT00467779|80762309|FG014|Stage 1A|Death|0|||
27706347|NCT00467779|80762295|FG000|Stage 1A|Disease Progression|0|||
27706348|NCT00467779|80762296|FG001|Stage 1A|Disease Progression|0|||
27706349|NCT00467779|80762297|FG002|Stage 1A|Disease Progression|0|||
27706350|NCT00467779|80762298|FG003|Stage 1A|Disease Progression|0|||
27706351|NCT00467779|80762299|FG004|Stage 1A|Disease Progression|0|||
27706352|NCT00467779|80762300|FG005|Stage 1A|Disease Progression|0|||
27706353|NCT00467779|80762301|FG006|Stage 1A|Disease Progression|0|||
27706354|NCT00467779|80762302|FG007|Stage 1A|Disease Progression|0|||
27706355|NCT00467779|80762303|FG008|Stage 1A|Disease Progression|0|||
27706356|NCT00467779|80762304|FG009|Stage 1A|Disease Progression|2|||
27706357|NCT00467779|80762305|FG010|Stage 1A|Disease Progression|2|||
27706358|NCT00467779|80762306|FG011|Stage 1A|Disease Progression|5|||
27706359|NCT00467779|80762307|FG012|Stage 1A|Disease Progression|2|||
27706360|NCT00467779|80762308|FG013|Stage 1A|Disease Progression|0|||
27706361|NCT00467779|80762309|FG014|Stage 1A|Disease Progression|0|||
27706362|NCT00467779|80762295|FG000|Stage 1A|Physician Decision|0|||
27706363|NCT00467779|80762296|FG001|Stage 1A|Physician Decision|0|||
27706364|NCT00467779|80762297|FG002|Stage 1A|Physician Decision|0|||
27706365|NCT00467779|80762298|FG003|Stage 1A|Physician Decision|0|||
27706366|NCT00467779|80762299|FG004|Stage 1A|Physician Decision|0|||
27706367|NCT00467779|80762300|FG005|Stage 1A|Physician Decision|0|||
27706368|NCT00467779|80762301|FG006|Stage 1A|Physician Decision|0|||
27706369|NCT00467779|80762302|FG007|Stage 1A|Physician Decision|0|||
27706370|NCT00467779|80762303|FG008|Stage 1A|Physician Decision|0|||
27706371|NCT00467779|80762304|FG009|Stage 1A|Physician Decision|1|||
27706372|NCT00467779|80762305|FG010|Stage 1A|Physician Decision|0|||
27706373|NCT00467779|80762306|FG011|Stage 1A|Physician Decision|0|||
27706374|NCT00467779|80762307|FG012|Stage 1A|Physician Decision|0|||
27706375|NCT00467779|80762308|FG013|Stage 1A|Physician Decision|0|||
27706376|NCT00467779|80762309|FG014|Stage 1A|Physician Decision|0|||
27706377|NCT00467779|80762295|FG000|Stage 1A|Withdrawal by Subject|0|||
27706378|NCT00467779|80762296|FG001|Stage 1A|Withdrawal by Subject|0|||
27706379|NCT00467779|80762297|FG002|Stage 1A|Withdrawal by Subject|0|||
27706380|NCT00467779|80762298|FG003|Stage 1A|Withdrawal by Subject|0|||
27706381|NCT00467779|80762299|FG004|Stage 1A|Withdrawal by Subject|0|||
27706382|NCT00467779|80762300|FG005|Stage 1A|Withdrawal by Subject|0|||
27706383|NCT00467779|80762301|FG006|Stage 1A|Withdrawal by Subject|0|||
27706384|NCT00467779|80762302|FG007|Stage 1A|Withdrawal by Subject|0|||
27706385|NCT00467779|80762303|FG008|Stage 1A|Withdrawal by Subject|0|||
27706386|NCT00467779|80762304|FG009|Stage 1A|Withdrawal by Subject|0|||
27706387|NCT00467779|80762305|FG010|Stage 1A|Withdrawal by Subject|1|||
27706388|NCT00467779|80762306|FG011|Stage 1A|Withdrawal by Subject|1|||
27706389|NCT00467779|80762307|FG012|Stage 1A|Withdrawal by Subject|1|||
27706390|NCT00467779|80762308|FG013|Stage 1A|Withdrawal by Subject|0|||
27706391|NCT00467779|80762309|FG014|Stage 1A|Withdrawal by Subject|0|||
27706392|NCT00467779|80762295|FG000|Stage 1A|Unspecified Reason|0|||
27706393|NCT00467779|80762296|FG001|Stage 1A|Unspecified Reason|0|||
27600735|NCT02355028|80378271|FG001|Overall Study|Withdrawal by Subject|1|||
27600736|NCT02355028|80378270|FG000|Overall Study|Deemed ineligible after randomization|8|||
27600737|NCT02355028|80378271|FG001|Overall Study|Deemed ineligible after randomization|4|||
27600738|NCT01113502|80378272|FG000|Overall Study|Withdrawal by Subject|1|||
27600739|NCT01113502|80378273|FG001|Overall Study|Withdrawal by Subject|0|||
27600740|NCT01113502|80378274|FG002|Overall Study|Withdrawal by Subject|1|||
27600741|NCT01113502|80378275|FG003|Overall Study|Withdrawal by Subject|1|||
27600742|NCT01113502|80378276|FG004|Overall Study|Withdrawal by Subject|0|||
27600743|NCT01113502|80378272|FG000|Overall Study|Adverse Event|0|||
27600744|NCT01113502|80378273|FG001|Overall Study|Adverse Event|0|||
27600745|NCT01113502|80378274|FG002|Overall Study|Adverse Event|3|||
27600746|NCT01113502|80378275|FG003|Overall Study|Adverse Event|2|||
27600747|NCT01113502|80378276|FG004|Overall Study|Adverse Event|0|||
27600748|NCT02216773|80378279|FG000|Overall Study|Disease progression|4|||
27600749|NCT02216773|80378280|FG001|Overall Study|Disease progression|2|||
27600750|NCT02216773|80378279|FG000|Overall Study|Insufficient FLRV|4|||
27600751|NCT02216773|80378280|FG001|Overall Study|Insufficient FLRV|0|||
27600752|NCT02216773|80378279|FG000|Overall Study|Abandoned|4|||
27600753|NCT02216773|80378280|FG001|Overall Study|Abandoned|3|||
27600754|NCT00620750|80378287|FG000|Overall Study|Lost to Follow-up|25|||
27706394|NCT00467779|80762297|FG002|Stage 1A|Unspecified Reason|0|||
27706395|NCT00467779|80762298|FG003|Stage 1A|Unspecified Reason|0|||
27706396|NCT00467779|80762299|FG004|Stage 1A|Unspecified Reason|0|||
27706397|NCT00467779|80762300|FG005|Stage 1A|Unspecified Reason|0|||
27835223|NCT00112437|81226171|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835224|NCT00112437|81226172|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835225|NCT00112437|81226173|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835226|NCT00112437|81226174|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835227|NCT00112437|81226175|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835228|NCT00112437|81226176|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835229|NCT00112437|81226177|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835230|NCT00112437|81226178|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
27835231|NCT00112437|81226179|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835232|NCT00112437|81226180|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835233|NCT00112437|81226181|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835234|NCT00112437|81226182|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835235|NCT00112437|81226183|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
27835236|NCT00112437|81226158|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835237|NCT00112437|81226159|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835238|NCT00112437|81226160|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835239|NCT00112437|81226161|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835240|NCT00112437|81226162|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835241|NCT00112437|81226163|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835242|NCT00112437|81226164|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27706398|NCT00467779|80762301|FG006|Stage 1A|Unspecified Reason|0|||
27706399|NCT00467779|80762302|FG007|Stage 1A|Unspecified Reason|0|||
27706400|NCT00467779|80762303|FG008|Stage 1A|Unspecified Reason|0|||
27706401|NCT00467779|80762304|FG009|Stage 1A|Unspecified Reason|0|||
27706402|NCT00467779|80762305|FG010|Stage 1A|Unspecified Reason|0|||
27706403|NCT00467779|80762306|FG011|Stage 1A|Unspecified Reason|1|||
27706404|NCT00467779|80762307|FG012|Stage 1A|Unspecified Reason|1|||
27706405|NCT00467779|80762308|FG013|Stage 1A|Unspecified Reason|0|||
27706406|NCT00467779|80762309|FG014|Stage 1A|Unspecified Reason|0|||
27706407|NCT00467779|80762295|FG000|Stage 2|Adverse Event|0|||
27706408|NCT00467779|80762296|FG001|Stage 2|Adverse Event|0|||
27706409|NCT00467779|80762297|FG002|Stage 2|Adverse Event|0|||
27706410|NCT00467779|80762298|FG003|Stage 2|Adverse Event|0|||
27706411|NCT00467779|80762299|FG004|Stage 2|Adverse Event|0|||
27706412|NCT00467779|80762300|FG005|Stage 2|Adverse Event|0|||
27706413|NCT00467779|80762301|FG006|Stage 2|Adverse Event|0|||
27706414|NCT00467779|80762302|FG007|Stage 2|Adverse Event|0|||
27706415|NCT00467779|80762303|FG008|Stage 2|Adverse Event|1|||
27706416|NCT00467779|80762304|FG009|Stage 2|Adverse Event|0|||
27706417|NCT00467779|80762305|FG010|Stage 2|Adverse Event|0|||
27706418|NCT00467779|80762306|FG011|Stage 2|Adverse Event|0|||
27706419|NCT00467779|80762307|FG012|Stage 2|Adverse Event|0|||
27706420|NCT00467779|80762308|FG013|Stage 2|Adverse Event|0|||
27706421|NCT00467779|80762309|FG014|Stage 2|Adverse Event|0|||
27706422|NCT00467779|80762295|FG000|Stage 2|Death|0|||
27706423|NCT00467779|80762296|FG001|Stage 2|Death|0|||
27706424|NCT00467779|80762297|FG002|Stage 2|Death|0|||
27706425|NCT00467779|80762298|FG003|Stage 2|Death|0|||
27706426|NCT00467779|80762299|FG004|Stage 2|Death|0|||
27706427|NCT00467779|80762300|FG005|Stage 2|Death|0|||
27706428|NCT00467779|80762301|FG006|Stage 2|Death|0|||
27706429|NCT00467779|80762302|FG007|Stage 2|Death|0|||
27706430|NCT00467779|80762303|FG008|Stage 2|Death|1|||
27706431|NCT00467779|80762304|FG009|Stage 2|Death|0|||
27706432|NCT00467779|80762305|FG010|Stage 2|Death|0|||
27706433|NCT00467779|80762306|FG011|Stage 2|Death|0|||
27706434|NCT00467779|80762307|FG012|Stage 2|Death|0|||
27706435|NCT00467779|80762308|FG013|Stage 2|Death|0|||
27706436|NCT00467779|80762309|FG014|Stage 2|Death|0|||
27706437|NCT00467779|80762295|FG000|Stage 2|Disease Progression|0|||
27706438|NCT00467779|80762296|FG001|Stage 2|Disease Progression|0|||
27706439|NCT00467779|80762297|FG002|Stage 2|Disease Progression|0|||
27706440|NCT00467779|80762298|FG003|Stage 2|Disease Progression|0|||
27706441|NCT00467779|80762299|FG004|Stage 2|Disease Progression|0|||
27706442|NCT00467779|80762300|FG005|Stage 2|Disease Progression|0|||
27706443|NCT00467779|80762301|FG006|Stage 2|Disease Progression|0|||
27706444|NCT00467779|80762302|FG007|Stage 2|Disease Progression|0|||
27706445|NCT00467779|80762303|FG008|Stage 2|Disease Progression|16|||
27706446|NCT00467779|80762304|FG009|Stage 2|Disease Progression|0|||
27706447|NCT00467779|80762305|FG010|Stage 2|Disease Progression|0|||
27706448|NCT00467779|80762306|FG011|Stage 2|Disease Progression|0|||
27706449|NCT00467779|80762307|FG012|Stage 2|Disease Progression|0|||
27706450|NCT00467779|80762308|FG013|Stage 2|Disease Progression|0|||
27706451|NCT00467779|80762309|FG014|Stage 2|Disease Progression|0|||
27706452|NCT00467779|80762295|FG000|Stage 2|Unspecified Reason|0|||
27706453|NCT00467779|80762296|FG001|Stage 2|Unspecified Reason|0|||
27706454|NCT00467779|80762297|FG002|Stage 2|Unspecified Reason|0|||
27706455|NCT00467779|80762298|FG003|Stage 2|Unspecified Reason|0|||
27600755|NCT01281202|80378289|FG000|Overall Study|Adverse Event|2|||
27706456|NCT00467779|80762299|FG004|Stage 2|Unspecified Reason|0|||
27600756|NCT01281202|80378290|FG001|Overall Study|Adverse Event|0|||
27706457|NCT00467779|80762300|FG005|Stage 2|Unspecified Reason|0|||
27706458|NCT00467779|80762301|FG006|Stage 2|Unspecified Reason|0|||
27706459|NCT00467779|80762302|FG007|Stage 2|Unspecified Reason|0|||
27706460|NCT00467779|80762303|FG008|Stage 2|Unspecified Reason|3|||
27706461|NCT00467779|80762304|FG009|Stage 2|Unspecified Reason|0|||
27706462|NCT00467779|80762305|FG010|Stage 2|Unspecified Reason|0|||
27706463|NCT00467779|80762306|FG011|Stage 2|Unspecified Reason|0|||
27706464|NCT00467779|80762307|FG012|Stage 2|Unspecified Reason|0|||
27706465|NCT00467779|80762308|FG013|Stage 2|Unspecified Reason|0|||
27706466|NCT00467779|80762309|FG014|Stage 2|Unspecified Reason|0|||
27706467|NCT00467779|80762295|FG000|Stage 2A|Adverse Event|0|||
27706468|NCT00467779|80762296|FG001|Stage 2A|Adverse Event|0|||
27706469|NCT00467779|80762297|FG002|Stage 2A|Adverse Event|0|||
27706470|NCT00467779|80762298|FG003|Stage 2A|Adverse Event|0|||
27706471|NCT00467779|80762299|FG004|Stage 2A|Adverse Event|0|||
27706472|NCT00467779|80762300|FG005|Stage 2A|Adverse Event|0|||
27706473|NCT00467779|80762301|FG006|Stage 2A|Adverse Event|0|||
27706474|NCT00467779|80762302|FG007|Stage 2A|Adverse Event|0|||
27706475|NCT00467779|80762303|FG008|Stage 2A|Adverse Event|0|||
27706476|NCT00467779|80762304|FG009|Stage 2A|Adverse Event|0|||
27706477|NCT00467779|80762305|FG010|Stage 2A|Adverse Event|0|||
27706478|NCT00467779|80762306|FG011|Stage 2A|Adverse Event|0|||
27706479|NCT00467779|80762307|FG012|Stage 2A|Adverse Event|0|||
27706480|NCT00467779|80762308|FG013|Stage 2A|Adverse Event|2|||
27706481|NCT00467779|80762309|FG014|Stage 2A|Adverse Event|0|||
27706482|NCT00467779|80762295|FG000|Stage 2A|Death|0|||
27706483|NCT00467779|80762296|FG001|Stage 2A|Death|0|||
27706484|NCT00467779|80762297|FG002|Stage 2A|Death|0|||
27706485|NCT00467779|80762298|FG003|Stage 2A|Death|0|||
27706486|NCT00467779|80762299|FG004|Stage 2A|Death|0|||
27706487|NCT00467779|80762300|FG005|Stage 2A|Death|0|||
27706488|NCT00467779|80762301|FG006|Stage 2A|Death|0|||
27706489|NCT00467779|80762302|FG007|Stage 2A|Death|0|||
27706490|NCT00467779|80762303|FG008|Stage 2A|Death|0|||
27706491|NCT00467779|80762304|FG009|Stage 2A|Death|0|||
27706492|NCT00467779|80762305|FG010|Stage 2A|Death|0|||
27706493|NCT00467779|80762306|FG011|Stage 2A|Death|0|||
27706494|NCT00467779|80762307|FG012|Stage 2A|Death|0|||
27600757|NCT01281202|80378289|FG000|Overall Study|Withdrawal by Subject|2|||
27706495|NCT00467779|80762308|FG013|Stage 2A|Death|1|||
27706496|NCT00467779|80762309|FG014|Stage 2A|Death|0|||
27706497|NCT00467779|80762295|FG000|Stage 2A|Disease Progression|0|||
27706498|NCT00467779|80762296|FG001|Stage 2A|Disease Progression|0|||
27706499|NCT00467779|80762297|FG002|Stage 2A|Disease Progression|0|||
27706500|NCT00467779|80762298|FG003|Stage 2A|Disease Progression|0|||
27835243|NCT00112437|81226165|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835244|NCT00112437|81226166|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835245|NCT00112437|81226167|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27600758|NCT01281202|80378290|FG001|Overall Study|Withdrawal by Subject|2|||
27706501|NCT00467779|80762299|FG004|Stage 2A|Disease Progression|0|||
27706502|NCT00467779|80762300|FG005|Stage 2A|Disease Progression|0|||
27706503|NCT00467779|80762301|FG006|Stage 2A|Disease Progression|0|||
27706504|NCT00467779|80762302|FG007|Stage 2A|Disease Progression|0|||
27706505|NCT00467779|80762303|FG008|Stage 2A|Disease Progression|0|||
27706506|NCT00467779|80762304|FG009|Stage 2A|Disease Progression|0|||
27706507|NCT00467779|80762305|FG010|Stage 2A|Disease Progression|0|||
27706508|NCT00467779|80762306|FG011|Stage 2A|Disease Progression|0|||
27706509|NCT00467779|80762307|FG012|Stage 2A|Disease Progression|0|||
27706510|NCT00467779|80762308|FG013|Stage 2A|Disease Progression|10|||
27706511|NCT00467779|80762309|FG014|Stage 2A|Disease Progression|0|||
27706512|NCT00467779|80762295|FG000|Stage 2A|Unspecified Reason|0|||
27706513|NCT00467779|80762296|FG001|Stage 2A|Unspecified Reason|0|||
27706514|NCT00467779|80762297|FG002|Stage 2A|Unspecified Reason|0|||
27706515|NCT00467779|80762298|FG003|Stage 2A|Unspecified Reason|0|||
27706516|NCT00467779|80762299|FG004|Stage 2A|Unspecified Reason|0|||
27706517|NCT00467779|80762300|FG005|Stage 2A|Unspecified Reason|0|||
27706518|NCT00467779|80762301|FG006|Stage 2A|Unspecified Reason|0|||
27706519|NCT00467779|80762302|FG007|Stage 2A|Unspecified Reason|0|||
27706520|NCT00467779|80762303|FG008|Stage 2A|Unspecified Reason|0|||
27706521|NCT00467779|80762304|FG009|Stage 2A|Unspecified Reason|0|||
27706522|NCT00467779|80762305|FG010|Stage 2A|Unspecified Reason|0|||
27706523|NCT00467779|80762306|FG011|Stage 2A|Unspecified Reason|0|||
27706524|NCT00467779|80762307|FG012|Stage 2A|Unspecified Reason|0|||
27706525|NCT00467779|80762308|FG013|Stage 2A|Unspecified Reason|7|||
27706526|NCT00467779|80762309|FG014|Stage 2A|Unspecified Reason|0|||
27706527|NCT00467779|80762295|FG000|Stage 2A|Withdrawal by Subject|0|||
27706528|NCT00467779|80762296|FG001|Stage 2A|Withdrawal by Subject|0|||
27706529|NCT00467779|80762297|FG002|Stage 2A|Withdrawal by Subject|0|||
27706530|NCT00467779|80762298|FG003|Stage 2A|Withdrawal by Subject|0|||
27706531|NCT00467779|80762299|FG004|Stage 2A|Withdrawal by Subject|0|||
27706532|NCT00467779|80762300|FG005|Stage 2A|Withdrawal by Subject|0|||
27706533|NCT00467779|80762301|FG006|Stage 2A|Withdrawal by Subject|0|||
27706534|NCT00467779|80762302|FG007|Stage 2A|Withdrawal by Subject|0|||
27706535|NCT00467779|80762303|FG008|Stage 2A|Withdrawal by Subject|0|||
27706536|NCT00467779|80762304|FG009|Stage 2A|Withdrawal by Subject|0|||
27706537|NCT00467779|80762305|FG010|Stage 2A|Withdrawal by Subject|0|||
27706538|NCT00467779|80762306|FG011|Stage 2A|Withdrawal by Subject|0|||
27706539|NCT00467779|80762307|FG012|Stage 2A|Withdrawal by Subject|0|||
27706540|NCT00467779|80762308|FG013|Stage 2A|Withdrawal by Subject|1|||
27706541|NCT00467779|80762309|FG014|Stage 2A|Withdrawal by Subject|0|||
27706542|NCT00467779|80762295|FG000|Stage 3|Adverse Event|0|||
27706543|NCT00467779|80762296|FG001|Stage 3|Adverse Event|0|||
27706544|NCT00467779|80762297|FG002|Stage 3|Adverse Event|0|||
27706545|NCT00467779|80762298|FG003|Stage 3|Adverse Event|0|||
27706546|NCT00467779|80762299|FG004|Stage 3|Adverse Event|0|||
27706547|NCT00467779|80762300|FG005|Stage 3|Adverse Event|0|||
27706548|NCT00467779|80762301|FG006|Stage 3|Adverse Event|0|||
27706549|NCT00467779|80762302|FG007|Stage 3|Adverse Event|0|||
27706550|NCT00467779|80762303|FG008|Stage 3|Adverse Event|0|||
27706551|NCT00467779|80762304|FG009|Stage 3|Adverse Event|0|||
27706552|NCT00467779|80762305|FG010|Stage 3|Adverse Event|0|||
27706553|NCT00467779|80762306|FG011|Stage 3|Adverse Event|0|||
27706554|NCT00467779|80762307|FG012|Stage 3|Adverse Event|0|||
27706555|NCT00467779|80762308|FG013|Stage 3|Adverse Event|0|||
27706556|NCT00467779|80762309|FG014|Stage 3|Adverse Event|2|||
27706557|NCT00467779|80762295|FG000|Stage 3|Death|0|||
27706558|NCT00467779|80762296|FG001|Stage 3|Death|0|||
27706559|NCT00467779|80762297|FG002|Stage 3|Death|0|||
27706560|NCT00467779|80762298|FG003|Stage 3|Death|0|||
27706561|NCT00467779|80762299|FG004|Stage 3|Death|0|||
27706562|NCT00467779|80762300|FG005|Stage 3|Death|0|||
27706563|NCT00467779|80762301|FG006|Stage 3|Death|0|||
27706564|NCT00467779|80762302|FG007|Stage 3|Death|0|||
27706565|NCT00467779|80762303|FG008|Stage 3|Death|0|||
27706566|NCT00467779|80762304|FG009|Stage 3|Death|0|||
27706567|NCT00467779|80762305|FG010|Stage 3|Death|0|||
27706568|NCT00467779|80762306|FG011|Stage 3|Death|0|||
27706569|NCT00467779|80762307|FG012|Stage 3|Death|0|||
27706570|NCT00467779|80762308|FG013|Stage 3|Death|0|||
27706571|NCT00467779|80762309|FG014|Stage 3|Death|1|||
27706572|NCT00467779|80762295|FG000|Stage 3|Disease Progression|0|||
27706573|NCT00467779|80762296|FG001|Stage 3|Disease Progression|0|||
27706574|NCT00467779|80762297|FG002|Stage 3|Disease Progression|0|||
27706575|NCT00467779|80762298|FG003|Stage 3|Disease Progression|0|||
27706576|NCT00467779|80762299|FG004|Stage 3|Disease Progression|0|||
27706577|NCT00467779|80762300|FG005|Stage 3|Disease Progression|0|||
27706578|NCT00467779|80762301|FG006|Stage 3|Disease Progression|0|||
27706579|NCT00467779|80762302|FG007|Stage 3|Disease Progression|0|||
27706580|NCT00467779|80762303|FG008|Stage 3|Disease Progression|0|||
27706581|NCT00467779|80762304|FG009|Stage 3|Disease Progression|0|||
27706582|NCT00467779|80762305|FG010|Stage 3|Disease Progression|0|||
27706583|NCT00467779|80762306|FG011|Stage 3|Disease Progression|0|||
27706584|NCT00467779|80762307|FG012|Stage 3|Disease Progression|0|||
27706585|NCT00467779|80762308|FG013|Stage 3|Disease Progression|0|||
27706586|NCT00467779|80762309|FG014|Stage 3|Disease Progression|9|||
27706587|NCT00467779|80762295|FG000|Stage 3|Unspecified Reason|0|||
27706588|NCT00467779|80762296|FG001|Stage 3|Unspecified Reason|0|||
27706589|NCT00467779|80762297|FG002|Stage 3|Unspecified Reason|0|||
27706590|NCT00467779|80762298|FG003|Stage 3|Unspecified Reason|0|||
27706591|NCT00467779|80762299|FG004|Stage 3|Unspecified Reason|0|||
27706592|NCT00467779|80762300|FG005|Stage 3|Unspecified Reason|0|||
27706593|NCT00467779|80762301|FG006|Stage 3|Unspecified Reason|0|||
27706594|NCT00467779|80762302|FG007|Stage 3|Unspecified Reason|0|||
27706595|NCT00467779|80762303|FG008|Stage 3|Unspecified Reason|0|||
27706596|NCT00467779|80762304|FG009|Stage 3|Unspecified Reason|0|||
27706597|NCT00467779|80762305|FG010|Stage 3|Unspecified Reason|0|||
27706598|NCT00467779|80762306|FG011|Stage 3|Unspecified Reason|0|||
27706599|NCT00467779|80762307|FG012|Stage 3|Unspecified Reason|0|||
27706600|NCT00467779|80762308|FG013|Stage 3|Unspecified Reason|0|||
27706601|NCT00467779|80762309|FG014|Stage 3|Unspecified Reason|5|||
27706602|NCT02865018|80762310|FG000|Overall Study|Withdrawal by Subject|1|||
27706603|NCT03574753|80762315|FG000|Overall Study|Adverse Event|3|||
27706604|NCT03574753|80762315|FG000|Overall Study|Progression/relapse|19|||
27706605|NCT03574753|80762315|FG000|Overall Study|Death|1|||
27706606|NCT00257166|80762316|FG000|Overall Study|Adverse Event|18|||
27706607|NCT00257166|80762317|FG001|Overall Study|Adverse Event|13|||
27706608|NCT00257166|80762316|FG000|Overall Study|Laboratory abnormality|1|||
27706609|NCT00257166|80762317|FG001|Overall Study|Laboratory abnormality|0|||
27706610|NCT00257166|80762316|FG000|Overall Study|Lost to Follow-up|8|||
27706611|NCT00257166|80762317|FG001|Overall Study|Lost to Follow-up|1|||
27706612|NCT00257166|80762316|FG000|Overall Study|Withdrawal by Subject|9|||
27706613|NCT00257166|80762317|FG001|Overall Study|Withdrawal by Subject|2|||
27706614|NCT00257166|80762316|FG000|Overall Study|Other|16|||
27706615|NCT00257166|80762317|FG001|Overall Study|Other|21|||
27706616|NCT00257166|80762316|FG000|Overall Study|Randomized, but not treated|1|||
27706617|NCT00257166|80762317|FG001|Overall Study|Randomized, but not treated|0|||
27706618|NCT01876251|80762320|FG000|Overall Study|Clinical progression|1|||
27706619|NCT01876251|80762321|FG001|Overall Study|Clinical progression|0|||
27706620|NCT01876251|80762322|FG002|Overall Study|Clinical progression|0|||
27706621|NCT01876251|80762320|FG000|Overall Study|Death|2|||
27706622|NCT01876251|80762321|FG001|Overall Study|Death|0|||
27706623|NCT01876251|80762322|FG002|Overall Study|Death|1|||
27835246|NCT00112437|81226168|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835247|NCT00112437|81226169|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835248|NCT00112437|81226170|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835249|NCT00112437|81226171|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835250|NCT00112437|81226172|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835251|NCT00112437|81226173|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835252|NCT00112437|81226174|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835253|NCT00112437|81226175|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835254|NCT00112437|81226176|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835255|NCT00112437|81226177|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835256|NCT00112437|81226178|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835257|NCT00112437|81226179|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
27835258|NCT00112437|81226180|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835259|NCT00112437|81226181|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835260|NCT00112437|81226182|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835261|NCT00112437|81226183|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
27835262|NCT00112437|81226158|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835263|NCT00112437|81226159|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835264|NCT00112437|81226160|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835265|NCT00112437|81226161|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835266|NCT00112437|81226162|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835267|NCT00112437|81226163|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835268|NCT00112437|81226164|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835269|NCT00112437|81226165|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835270|NCT00112437|81226166|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835271|NCT00112437|81226167|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835272|NCT00112437|81226168|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835273|NCT00112437|81226169|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835274|NCT00112437|81226170|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835275|NCT00112437|81226171|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835276|NCT00112437|81226172|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835277|NCT00112437|81226173|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835278|NCT00112437|81226174|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835279|NCT00112437|81226175|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
27706624|NCT01876251|80762320|FG000|Overall Study|Participant started new treatment|1|||
27706625|NCT01876251|80762321|FG001|Overall Study|Participant started new treatment|0|||
27706626|NCT01876251|80762322|FG002|Overall Study|Participant started new treatment|1|||
27706627|NCT01876251|80762320|FG000|Overall Study|Participant refused further follow-up|0|||
27706628|NCT01876251|80762321|FG001|Overall Study|Participant refused further follow-up|0|||
27706629|NCT01876251|80762322|FG002|Overall Study|Participant refused further follow-up|1|||
27706630|NCT01876251|80762320|FG000|Overall Study|Study terminated|1|||
27706631|NCT01876251|80762321|FG001|Overall Study|Study terminated|0|||
27706632|NCT01876251|80762322|FG002|Overall Study|Study terminated|0|||
27706633|NCT01876251|80762320|FG000|Overall Study|Objective progression or relapse|10|||
27706634|NCT01876251|80762321|FG001|Overall Study|Objective progression or relapse|3|||
27706635|NCT01876251|80762322|FG002|Overall Study|Objective progression or relapse|8|||
27706636|NCT00785044|80762329|FG000|Overall Study|Dosed at non-participating sites|152|||
27706637|NCT00785044|80762329|FG000|Overall Study|Death|77|||
27706638|NCT00785044|80762329|FG000|Overall Study|Lost to Follow-up|266|||
27706639|NCT00785044|80762329|FG000|Overall Study|Withdrawal by Subject|1|||
27706640|NCT02230254|80762337|FG000|Overall Study|Lost to Follow-up|3|||
27706641|NCT02375724|80762338|FG000|Overall Study|Lack of Efficacy|1|||
27706642|NCT02375724|80762339|FG001|Overall Study|Lack of Efficacy|1|||
27706643|NCT02375724|80762338|FG000|Overall Study|Withdrawal by Subject|1|||
27835280|NCT00112437|81226176|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
27888304|NCT01953601|81425377|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
27888305|NCT01953601|81425378|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
27888306|NCT01953601|81425376|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
27888307|NCT01953601|81425377|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
27888308|NCT01953601|81425378|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
27888309|NCT01953601|81425376|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
27888310|NCT01953601|81425377|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
27888311|NCT01953601|81425378|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
27888312|NCT01953601|81425376|FG000|Part 1 (Base Study)|Subject moved|2|||
27888313|NCT01953601|81425377|FG001|Part 1 (Base Study)|Subject moved|2|||
27888314|NCT01953601|81425378|FG002|Part 1 (Base Study)|Subject moved|1|||
27888315|NCT01953601|81425376|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
27888316|NCT01953601|81425377|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
27888317|NCT01953601|81425378|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
27888318|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Adverse Event|1|||
27888319|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Adverse Event|1|||
27888320|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Adverse Event|10|||
27888321|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Death|0|||
27706644|NCT02375724|80762339|FG001|Overall Study|Withdrawal by Subject|1|||
27835281|NCT00112437|81226177|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835282|NCT00112437|81226178|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835283|NCT00112437|81226179|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
27835284|NCT00112437|81226180|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835285|NCT00112437|81226181|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835286|NCT00112437|81226182|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835287|NCT00112437|81226183|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
27835288|NCT00112437|81226158|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835289|NCT00112437|81226159|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835290|NCT00112437|81226160|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835291|NCT00112437|81226161|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835292|NCT00112437|81226162|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835293|NCT00112437|81226163|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835294|NCT00112437|81226164|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835295|NCT00112437|81226165|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835296|NCT00112437|81226166|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27888322|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Death|3|||
27888323|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Death|0|||
27888324|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
27835297|NCT00112437|81226167|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835298|NCT00112437|81226168|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27888325|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
27706645|NCT02375724|80762338|FG000|Overall Study|Lost to Follow-up|1|||
27888326|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
27706646|NCT02375724|80762339|FG001|Overall Study|Lost to Follow-up|0|||
27706647|NCT02375724|80762338|FG000|Overall Study|Protocol Violation|1|||
27600759|NCT01281202|80378289|FG000|Overall Study|Protocol Violation|11|||
27600760|NCT01281202|80378290|FG001|Overall Study|Protocol Violation|10|||
27600761|NCT01281202|80378289|FG000|Overall Study|Administrative|2|||
27600762|NCT01281202|80378290|FG001|Overall Study|Administrative|8|||
27600763|NCT01281202|80378289|FG000|Overall Study|Lost to Follow-up|11|||
27600764|NCT01281202|80378290|FG001|Overall Study|Lost to Follow-up|13|||
27600765|NCT01281202|80378289|FG000|Overall Study|Incarceration|0|||
27600766|NCT01281202|80378290|FG001|Overall Study|Incarceration|3|||
27600767|NCT02048072|80378291|FG000|Overall Study|Adverse Event|3|||
27600768|NCT02048072|80378291|FG000|Overall Study|Lost to Follow-up|1|||
27600769|NCT02623322|80378294|FG000|Overall Study|Lost to Follow-up|2|||
27600770|NCT02623322|80378295|FG001|Overall Study|Lost to Follow-up|1|||
27600771|NCT02623322|80378296|FG002|Overall Study|Lost to Follow-up|0|||
27600772|NCT00031486|80378299|FG000|Overall Study|Adverse Event|1|||
27600773|NCT00031486|80378300|FG001|Overall Study|Adverse Event|0|||
27600774|NCT00031486|80378299|FG000|Overall Study|Lost to Follow-up|0|||
27600775|NCT00031486|80378300|FG001|Overall Study|Lost to Follow-up|1|||
27600776|NCT00031486|80378299|FG000|Overall Study|Withdrawal by Subject|3|||
27600777|NCT00031486|80378300|FG001|Overall Study|Withdrawal by Subject|2|||
27600778|NCT00031486|80378299|FG000|Overall Study|Death|0|||
27888327|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
27888328|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
27600779|NCT00031486|80378300|FG001|Overall Study|Death|3|||
27600780|NCT00031486|80378299|FG000|Overall Study|Non-compliant|0|||
27600781|NCT00031486|80378300|FG001|Overall Study|Non-compliant|4|||
27888329|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
27888330|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Physician Decision|2|||
27600782|NCT00031486|80378299|FG000|Overall Study|Did not meet eligibility requirement|2|||
27888331|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Physician Decision|0|||
27835299|NCT00112437|81226169|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835300|NCT00112437|81226170|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835301|NCT00112437|81226171|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835302|NCT00112437|81226172|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835303|NCT00112437|81226173|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835304|NCT00112437|81226174|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835305|NCT00112437|81226175|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835306|NCT00112437|81226176|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835307|NCT00112437|81226177|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835308|NCT00112437|81226178|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
27835309|NCT00112437|81226179|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
27835310|NCT00112437|81226180|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835311|NCT00112437|81226181|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835312|NCT00112437|81226182|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835313|NCT00112437|81226183|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
27835314|NCT00112437|81226158|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835315|NCT00112437|81226159|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27600783|NCT00031486|80378300|FG001|Overall Study|Did not meet eligibility requirement|1|||
27600784|NCT00031486|80378299|FG000|Overall Study|Other|1|||
27600785|NCT00031486|80378300|FG001|Overall Study|Other|1|||
27600786|NCT00766675|80378306|FG000|Overall Study|Adverse Event|16|||
27600787|NCT00766675|80378306|FG000|Overall Study|Lost to Follow-up|2|||
27600788|NCT00766675|80378306|FG000|Overall Study|Withdrawal by Subject|11|||
27600789|NCT00766675|80378306|FG000|Overall Study|Protocol Violation|8|||
27600790|NCT00766675|80378306|FG000|Overall Study|Participant took prohibited medication|1|||
27835316|NCT00112437|81226160|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835317|NCT00112437|81226161|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835318|NCT00112437|81226162|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835319|NCT00112437|81226163|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835320|NCT00112437|81226164|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835321|NCT00112437|81226165|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27600791|NCT00766675|80378306|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
27600792|NCT00766675|80378306|FG000|Overall Study|Insufficient therapy|1|||
27600793|NCT02089230|80378309|FG000|Overall Study|Death|0|||
27600794|NCT02089230|80378310|FG001|Overall Study|Death|0|||
27600795|NCT02089230|80378311|FG002|Overall Study|Death|2|||
27600796|NCT02089230|80378309|FG000|Overall Study|Seeking Alternative Therapy|0|||
27600797|NCT02089230|80378310|FG001|Overall Study|Seeking Alternative Therapy|0|||
27600798|NCT02089230|80378311|FG002|Overall Study|Seeking Alternative Therapy|4|||
27600799|NCT02889133|80378313|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
27600800|NCT02889133|80378314|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
27600801|NCT02889133|80378313|FG000|Completed Primary Outcome|Manufacturing error|3|||
27600802|NCT02889133|80378314|FG001|Completed Primary Outcome|Manufacturing error|8|||
27600803|NCT02889133|80378313|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
27600804|NCT02889133|80378314|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
27600805|NCT02889133|80378313|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
27600806|NCT02889133|80378314|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
27600807|NCT02889133|80378313|FG000|Completed Primary Outcome|Protocol Violation|1|||
27600808|NCT02889133|80378314|FG001|Completed Primary Outcome|Protocol Violation|0|||
27600809|NCT02889133|80378313|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
27600810|NCT02889133|80378314|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
27600811|NCT02889133|80378313|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
27600812|NCT02889133|80378314|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
27600813|NCT02889133|80378313|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
27600814|NCT02889133|80378314|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
27600815|NCT02889133|80378313|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
27835322|NCT00112437|81226166|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835323|NCT00112437|81226167|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835324|NCT00112437|81226168|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835325|NCT00112437|81226169|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27600816|NCT02889133|80378314|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
27835326|NCT00112437|81226170|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835327|NCT00112437|81226171|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27600817|NCT02889133|80378313|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
27835328|NCT00112437|81226172|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27706648|NCT02375724|80762339|FG001|Overall Study|Protocol Violation|0|||
27600818|NCT02889133|80378314|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
27600819|NCT02365519|80378315|FG000|Randomized and Treated|Adverse Event|0|||
27600820|NCT02365519|80378316|FG001|Randomized and Treated|Adverse Event|1|||
27600821|NCT02365519|80378317|FG002|Randomized and Treated|Adverse Event|0|||
27600822|NCT02365519|80378315|FG000|Randomized and Treated|Withdrawal by Subject|0|||
27600823|NCT02365519|80378316|FG001|Randomized and Treated|Withdrawal by Subject|1|||
27600824|NCT02365519|80378317|FG002|Randomized and Treated|Withdrawal by Subject|1|||
27600825|NCT02057874|80378318|FG000|Overall Study|participant did not return for scan|1|||
27600826|NCT01221948|80378323|FG000|Overall Study|Physician Decision|5|||
27600827|NCT01221948|80378323|FG000|Overall Study|Withdrawal by Subject|2|||
27600828|NCT01221948|80378323|FG000|Overall Study|not disclosed|2|||
27600829|NCT01221948|80378323|FG000|Overall Study|Death|1|||
27600830|NCT01221948|80378323|FG000|Overall Study|Protocol Violation|4|||
27600831|NCT01120249|80378324|FG000|Overall Study|No protocol treatment received|21|||
27600832|NCT01120249|80378325|FG001|Overall Study|No protocol treatment received|15|||
27600833|NCT01120249|80378324|FG000|Overall Study|Disease recurrence|107|||
27600834|NCT01120249|80378325|FG001|Overall Study|Disease recurrence|57|||
27600835|NCT01120249|80378324|FG000|Overall Study|Death|1|||
27600836|NCT01120249|80378325|FG001|Overall Study|Death|0|||
27600837|NCT01120249|80378324|FG000|Overall Study|Adverse Event|40|||
27600838|NCT01120249|80378325|FG001|Overall Study|Adverse Event|276|||
27706649|NCT02375724|80762338|FG000|Overall Study|Adverse Event|2|||
27706650|NCT02375724|80762339|FG001|Overall Study|Adverse Event|4|||
27706651|NCT01436084|80762348|FG000|Overall Study|Disease Progression|2|||
27706652|NCT01436084|80762348|FG000|Overall Study|Withdrawal by Subject|1|||
27835329|NCT00112437|81226173|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835330|NCT00112437|81226174|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835331|NCT00112437|81226175|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27706653|NCT01436084|80762348|FG000|Overall Study|Early Closure of Study|1|||
27706654|NCT00601705|80762349|FG000|Overall Study|Withdrawal by Subject|1|||
27706655|NCT02285998|80765182|FG000|Overall Study|Adverse Event|9|||
27706656|NCT02285998|80765183|FG001|Overall Study|Adverse Event|8|||
27706657|NCT02285998|80765182|FG000|Overall Study|Physician Decision|1|||
27706658|NCT02285998|80765183|FG001|Overall Study|Physician Decision|2|||
27706659|NCT02285998|80765182|FG000|Overall Study|Lost to Follow-up|176|||
27706660|NCT02285998|80765183|FG001|Overall Study|Lost to Follow-up|172|||
27706661|NCT02285998|80765182|FG000|Overall Study|Withdrawal by Subject|53|||
27706662|NCT02285998|80765183|FG001|Overall Study|Withdrawal by Subject|61|||
27706663|NCT02285998|80765182|FG000|Overall Study|Other Reasons|7|||
27706664|NCT02285998|80765183|FG001|Overall Study|Other Reasons|10|||
27706665|NCT02285920|80765184|FG000|Overall Study|Kidney transplantation|2|||
27706666|NCT02285920|80765185|FG001|Overall Study|Kidney transplantation|2|||
27706667|NCT02285920|80765186|FG002|Overall Study|Kidney transplantation|2|||
27835332|NCT00112437|81226176|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835333|NCT00112437|81226177|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835334|NCT00112437|81226178|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835335|NCT00112437|81226179|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27835336|NCT00112437|81226180|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
27888332|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Physician Decision|2|||
27888333|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
27835337|NCT00112437|81226181|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
27600839|NCT01120249|80378324|FG000|Overall Study|Participant refusal|34|||
27600840|NCT01120249|80378325|FG001|Overall Study|Participant refusal|42|||
27600841|NCT01120249|80378324|FG000|Overall Study|Other reasons, not protocol specified|29|||
27600842|NCT01120249|80378325|FG001|Overall Study|Other reasons, not protocol specified|22|||
27706668|NCT02285920|80765187|FG003|Overall Study|Kidney transplantation|0|||
27706669|NCT02285920|80765184|FG000|Overall Study|Change to peritoneal dialysis|0|||
27706670|NCT02285920|80765185|FG001|Overall Study|Change to peritoneal dialysis|0|||
27706671|NCT02285920|80765186|FG002|Overall Study|Change to peritoneal dialysis|1|||
27706672|NCT02285920|80765187|FG003|Overall Study|Change to peritoneal dialysis|0|||
27835338|NCT00112437|81226182|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
27706673|NCT02285920|80765184|FG000|Overall Study|Transfer to non-participating unit|0|||
27706674|NCT02285920|80765185|FG001|Overall Study|Transfer to non-participating unit|1|||
27706675|NCT02285920|80765186|FG002|Overall Study|Transfer to non-participating unit|0|||
27706676|NCT02285920|80765187|FG003|Overall Study|Transfer to non-participating unit|0|||
27706677|NCT02285920|80765184|FG000|Overall Study|Dialysis discontinuation|0|||
27706678|NCT02285920|80765185|FG001|Overall Study|Dialysis discontinuation|1|||
27706679|NCT02285920|80765186|FG002|Overall Study|Dialysis discontinuation|0|||
27706680|NCT02285920|80765187|FG003|Overall Study|Dialysis discontinuation|0|||
27706681|NCT02285920|80765184|FG000|Overall Study|Death|2|||
27706682|NCT02285920|80765185|FG001|Overall Study|Death|0|||
27706683|NCT02285920|80765186|FG002|Overall Study|Death|2|||
27706684|NCT02285920|80765187|FG003|Overall Study|Death|1|||
27706685|NCT00121108|80765188|FG000|Overall Study|Lost to Follow-up|10|||
27706686|NCT00121108|80765189|FG001|Overall Study|Lost to Follow-up|22|||
27706687|NCT00121108|80765188|FG000|Overall Study|Withdrawal by Subject|106|||
27706688|NCT00121108|80765189|FG001|Overall Study|Withdrawal by Subject|195|||
27706689|NCT00121108|80765188|FG000|Overall Study|Death|5|||
27706690|NCT00121108|80765189|FG001|Overall Study|Death|8|||
27706691|NCT00942175|80765191|FG000|Overall Study|Adverse Event|2|||
27706692|NCT00942175|80765192|FG001|Overall Study|Adverse Event|1|||
27706693|NCT00942175|80765193|FG002|Overall Study|Adverse Event|0|||
27706694|NCT00942175|80765194|FG003|Overall Study|Adverse Event|0|||
27706695|NCT00942175|80765191|FG000|Overall Study|Protocol Violation|0|||
27706696|NCT00942175|80765192|FG001|Overall Study|Protocol Violation|1|||
27706697|NCT00942175|80765193|FG002|Overall Study|Protocol Violation|2|||
27706698|NCT00942175|80765194|FG003|Overall Study|Protocol Violation|0|||
27706699|NCT00942175|80765191|FG000|Overall Study|Pregnancy|0|||
27706700|NCT00942175|80765192|FG001|Overall Study|Pregnancy|0|||
27706701|NCT00942175|80765193|FG002|Overall Study|Pregnancy|0|||
27706702|NCT00942175|80765194|FG003|Overall Study|Pregnancy|1|||
27706703|NCT00942175|80765191|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
27706704|NCT00942175|80765192|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
27706705|NCT00942175|80765193|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
27600843|NCT00089141|80378326|FG000|Overall Study|Termination of trial|18|||
27600844|NCT00089141|80378327|FG001|Overall Study|Termination of trial|24|||
27600845|NCT01137474|80378332|FG000|Overall Study|Adverse Event|3|||
27600846|NCT01137474|80378333|FG001|Overall Study|Adverse Event|5|||
27600847|NCT01137474|80378334|FG002|Overall Study|Adverse Event|1|||
27600848|NCT01137474|80378335|FG003|Overall Study|Adverse Event|3|||
27600849|NCT01137474|80378332|FG000|Overall Study|Withdrawal by Subject|7|||
27600850|NCT01137474|80378333|FG001|Overall Study|Withdrawal by Subject|2|||
27600851|NCT01137474|80378334|FG002|Overall Study|Withdrawal by Subject|6|||
27600852|NCT01137474|80378335|FG003|Overall Study|Withdrawal by Subject|9|||
27600853|NCT01137474|80378332|FG000|Overall Study|No longer met study criteria|6|||
27600854|NCT01137474|80378333|FG001|Overall Study|No longer met study criteria|1|||
27600855|NCT01137474|80378334|FG002|Overall Study|No longer met study criteria|0|||
27600856|NCT01137474|80378335|FG003|Overall Study|No longer met study criteria|5|||
27600857|NCT01137474|80378332|FG000|Overall Study|Lost to Follow-up|5|||
27600858|NCT01137474|80378333|FG001|Overall Study|Lost to Follow-up|1|||
27706706|NCT00942175|80765194|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
27706707|NCT00942175|80765191|FG000|Overall Study|Low Platelet Count|0|||
27600859|NCT01137474|80378334|FG002|Overall Study|Lost to Follow-up|0|||
27706708|NCT00942175|80765192|FG001|Overall Study|Low Platelet Count|2|||
27706709|NCT00942175|80765193|FG002|Overall Study|Low Platelet Count|0|||
27706710|NCT00942175|80765194|FG003|Overall Study|Low Platelet Count|0|||
27600860|NCT01137474|80378335|FG003|Overall Study|Lost to Follow-up|2|||
27600861|NCT01137474|80378332|FG000|Overall Study|Lack of Efficacy|0|||
27706711|NCT04607148|80765197|FG000|Overall Study|Withdrawal by Subject|0|||
27706712|NCT04607148|80765198|FG001|Overall Study|Withdrawal by Subject|4|||
27706713|NCT04607148|80765199|FG002|Overall Study|Withdrawal by Subject|2|||
27706714|NCT04607148|80765200|FG003|Overall Study|Withdrawal by Subject|8|||
27706715|NCT04607148|80765197|FG000|Overall Study|Study Terminated by Sponsor|14|||
27706716|NCT04607148|80765198|FG001|Overall Study|Study Terminated by Sponsor|59|||
27706717|NCT04607148|80765199|FG002|Overall Study|Study Terminated by Sponsor|9|||
27706718|NCT04607148|80765200|FG003|Overall Study|Study Terminated by Sponsor|39|||
27706719|NCT04607148|80765197|FG000|Overall Study|Sponsor Decision|0|||
27706720|NCT04607148|80765198|FG001|Overall Study|Sponsor Decision|0|||
27706721|NCT04607148|80765199|FG002|Overall Study|Sponsor Decision|1|||
27706722|NCT04607148|80765200|FG003|Overall Study|Sponsor Decision|0|||
27706723|NCT04607148|80765197|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27706724|NCT04607148|80765198|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27706725|NCT04607148|80765199|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27706726|NCT04607148|80765200|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27706727|NCT04607148|80765197|FG000|Overall Study|Lost to Follow-up|0|||
27706728|NCT04607148|80765198|FG001|Overall Study|Lost to Follow-up|2|||
27706729|NCT04607148|80765199|FG002|Overall Study|Lost to Follow-up|0|||
27706730|NCT04607148|80765200|FG003|Overall Study|Lost to Follow-up|0|||
27706731|NCT04607148|80765197|FG000|Overall Study|Death|0|||
27706732|NCT04607148|80765198|FG001|Overall Study|Death|3|||
27706733|NCT04607148|80765199|FG002|Overall Study|Death|0|||
27706734|NCT04607148|80765200|FG003|Overall Study|Death|1|||
27706735|NCT04607148|80765197|FG000|Overall Study|Adverse Event|0|||
27706736|NCT04607148|80765198|FG001|Overall Study|Adverse Event|1|||
27600862|NCT01137474|80378333|FG001|Overall Study|Lack of Efficacy|0|||
27706737|NCT04607148|80765199|FG002|Overall Study|Adverse Event|0|||
27706738|NCT04607148|80765200|FG003|Overall Study|Adverse Event|0|||
27706739|NCT00006392|80765203|FG000|Overall Study|Ineligible|11|||
27706740|NCT00006392|80765204|FG001|Overall Study|Ineligible|3|||
27706741|NCT00006392|80765205|FG002|Overall Study|Ineligible|5|||
27706742|NCT00006392|80765206|FG003|Overall Study|Ineligible|5|||
27706743|NCT00006392|80765203|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
27706744|NCT00006392|80765204|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
27706745|NCT00006392|80765205|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
27706746|NCT00006392|80765206|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
27706747|NCT02819635|80765210|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
27706748|NCT02819635|80765211|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
27706749|NCT02819635|80765212|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
27706750|NCT02819635|80765213|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
27706751|NCT02819635|80765214|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
27706752|NCT02819635|80765215|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
27706753|NCT02819635|80765216|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
27706754|NCT02819635|80765217|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27706755|NCT02819635|80765218|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27706756|NCT02819635|80765219|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27706757|NCT02819635|80765220|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27706758|NCT02819635|80765221|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
27706759|NCT02819635|80765210|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706760|NCT02819635|80765211|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706761|NCT02819635|80765212|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706762|NCT02819635|80765213|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706763|NCT02819635|80765214|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
27835339|NCT00112437|81226183|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
27835340|NCT00112437|81226158|FG000|Years 6-10 (60-Month Extension)|Death|0|||
27835341|NCT00112437|81226159|FG001|Years 6-10 (60-Month Extension)|Death|0|||
27835342|NCT00112437|81226160|FG002|Years 6-10 (60-Month Extension)|Death|0|||
27835343|NCT00112437|81226161|FG003|Years 6-10 (60-Month Extension)|Death|0|||
27835344|NCT00112437|81226162|FG004|Years 6-10 (60-Month Extension)|Death|0|||
27835345|NCT00112437|81226163|FG005|Years 6-10 (60-Month Extension)|Death|0|||
27835346|NCT00112437|81226164|FG006|Years 6-10 (60-Month Extension)|Death|0|||
27835347|NCT00112437|81226165|FG007|Years 6-10 (60-Month Extension)|Death|0|||
27835348|NCT00112437|81226166|FG008|Years 6-10 (60-Month Extension)|Death|0|||
27835349|NCT00112437|81226167|FG009|Years 6-10 (60-Month Extension)|Death|0|||
27835350|NCT00112437|81226168|FG010|Years 6-10 (60-Month Extension)|Death|0|||
27835351|NCT00112437|81226169|FG011|Years 6-10 (60-Month Extension)|Death|0|||
27835352|NCT00112437|81226170|FG012|Years 6-10 (60-Month Extension)|Death|0|||
27835353|NCT00112437|81226171|FG013|Years 6-10 (60-Month Extension)|Death|0|||
27888334|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
27888335|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
27888336|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
27888337|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
27888338|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
27888339|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
27888340|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
27600863|NCT01137474|80378334|FG002|Overall Study|Lack of Efficacy|0|||
27600864|NCT01137474|80378335|FG003|Overall Study|Lack of Efficacy|2|||
27835354|NCT00112437|81226172|FG014|Years 6-10 (60-Month Extension)|Death|0|||
27835355|NCT00112437|81226173|FG015|Years 6-10 (60-Month Extension)|Death|0|||
27835356|NCT00112437|81226174|FG016|Years 6-10 (60-Month Extension)|Death|0|||
27835357|NCT00112437|81226175|FG017|Years 6-10 (60-Month Extension)|Death|0|||
27835358|NCT00112437|81226176|FG018|Years 6-10 (60-Month Extension)|Death|0|||
27835359|NCT00112437|81226177|FG019|Years 6-10 (60-Month Extension)|Death|0|||
27835360|NCT00112437|81226178|FG020|Years 6-10 (60-Month Extension)|Death|0|||
27835361|NCT00112437|81226179|FG021|Years 6-10 (60-Month Extension)|Death|0|||
27835362|NCT00112437|81226180|FG022|Years 6-10 (60-Month Extension)|Death|0|||
27835363|NCT00112437|81226181|FG023|Years 6-10 (60-Month Extension)|Death|2|||
27835364|NCT00112437|81226182|FG024|Years 6-10 (60-Month Extension)|Death|0|||
27835365|NCT00112437|81226183|FG025|Years 6-10 (60-Month Extension)|Death|0|||
27835366|NCT00112437|81226158|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835367|NCT00112437|81226159|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835368|NCT00112437|81226160|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835369|NCT00112437|81226161|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835370|NCT00112437|81226162|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835371|NCT00112437|81226163|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835372|NCT00112437|81226164|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835373|NCT00112437|81226165|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835374|NCT00112437|81226166|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835375|NCT00112437|81226167|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835376|NCT00112437|81226168|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835377|NCT00112437|81226169|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835378|NCT00112437|81226170|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835379|NCT00112437|81226171|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27888341|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
27888342|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Subject moved|0|||
27888343|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Subject moved|0|||
27888344|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Subject moved|1|||
27888345|NCT01953601|81425376|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
27888346|NCT01953601|81425377|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
27888347|NCT01953601|81425378|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
27888348|NCT01981954|81425379|FG000|Titration Period|Protocol Deviation|1|||
27888349|NCT01981954|81425379|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
27888350|NCT03875482|81425382|FG000|Overall Study|Adverse Event|0|||
27888351|NCT03875482|81425383|FG001|Overall Study|Adverse Event|1|||
27888352|NCT03875482|81425382|FG000|Overall Study|Withdrew consent|5|||
27888353|NCT03875482|81425383|FG001|Overall Study|Withdrew consent|6|||
27888354|NCT03875482|81425382|FG000|Overall Study|Lost to Follow-up|8|||
27888355|NCT03875482|81425383|FG001|Overall Study|Lost to Follow-up|2|||
27888356|NCT03875482|81425382|FG000|Overall Study|Lack of Efficacy|0|||
27888357|NCT03875482|81425383|FG001|Overall Study|Lack of Efficacy|11|||
27888358|NCT02720744|81425388|FG000|Overall Study|Protocol Violation|0|||
27888359|NCT02720744|81425389|FG001|Overall Study|Protocol Violation|2|||
27888360|NCT02720744|81425388|FG000|Overall Study|Pregnancy|2|||
27888361|NCT02720744|81425389|FG001|Overall Study|Pregnancy|0|||
27888362|NCT02720744|81425388|FG000|Overall Study|Lack of Efficacy|2|||
27888363|NCT02720744|81425389|FG001|Overall Study|Lack of Efficacy|8|||
27888364|NCT02720744|81425388|FG000|Overall Study|Adverse Event|21|||
27888365|NCT02720744|81425389|FG001|Overall Study|Adverse Event|3|||
27888366|NCT02720744|81425388|FG000|Overall Study|Withdrawal by Subject|11|||
27888367|NCT02720744|81425389|FG001|Overall Study|Withdrawal by Subject|11|||
27888368|NCT02720744|81425388|FG000|Overall Study|Lost to follow up|2|||
27888369|NCT02720744|81425389|FG001|Overall Study|Lost to follow up|0|||
27888370|NCT02720744|81425388|FG000|Overall Study|Non Compliance with Investigational Product|0|||
27888371|NCT02720744|81425389|FG001|Overall Study|Non Compliance with Investigational Product|1|||
27600865|NCT01137474|80378332|FG000|Overall Study|Other|3|||
27600866|NCT01137474|80378333|FG001|Overall Study|Other|1|||
27600867|NCT01137474|80378334|FG002|Overall Study|Other|0|||
27600868|NCT01137474|80378335|FG003|Overall Study|Other|0|||
27600869|NCT01137474|80378332|FG000|Overall Study|Pregnancy|0|||
27600870|NCT01137474|80378333|FG001|Overall Study|Pregnancy|1|||
27888372|NCT02720744|81425388|FG000|Overall Study|Excluded Concomitant Medication|0|||
27888373|NCT02720744|81425389|FG001|Overall Study|Excluded Concomitant Medication|1|||
27888374|NCT03521115|81425390|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
27888375|NCT03521115|81425391|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
27888376|NCT03521115|81425390|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
27888377|NCT03521115|81425391|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
27888378|NCT01031836|81427978|FG000|Stage I|Adverse Event|1|||
27888379|NCT01031836|81427979|FG001|Stage I|Adverse Event|1|||
27888380|NCT01031836|81427980|FG002|Stage I|Adverse Event|0|||
27600871|NCT01137474|80378334|FG002|Overall Study|Pregnancy|0|||
27600872|NCT01137474|80378335|FG003|Overall Study|Pregnancy|0|||
27600873|NCT01137474|80378332|FG000|Overall Study|Administrative reason by sponsor|0|||
27600874|NCT01137474|80378333|FG001|Overall Study|Administrative reason by sponsor|1|||
27600875|NCT01137474|80378334|FG002|Overall Study|Administrative reason by sponsor|0|||
27600876|NCT01137474|80378335|FG003|Overall Study|Administrative reason by sponsor|0|||
27600877|NCT01323530|80378336|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
27600878|NCT01323530|80378337|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27600879|NCT01323530|80378338|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27600880|NCT01323530|80378339|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27600881|NCT01323530|80378340|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27600882|NCT01323530|80378341|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
27600883|NCT01323530|80378342|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27600884|NCT01323530|80378336|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27600885|NCT01323530|80378337|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27600886|NCT01323530|80378338|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27600887|NCT01323530|80378339|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27600888|NCT01323530|80378340|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
27600889|NCT01323530|80378341|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27600890|NCT01323530|80378342|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27600891|NCT01323530|80378336|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27600892|NCT01323530|80378337|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
27600893|NCT01323530|80378338|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27600894|NCT01323530|80378339|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27600895|NCT01323530|80378340|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
27600896|NCT01323530|80378341|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
27600897|NCT01323530|80378342|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
27600898|NCT01323530|80378336|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27706764|NCT02819635|80765215|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
27888381|NCT01031836|81427981|FG003|Stage I|Adverse Event|0|||
27706765|NCT02819635|80765216|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
27888382|NCT01031836|81427982|FG004|Stage I|Adverse Event|0|||
27888383|NCT01031836|81427983|FG005|Stage I|Adverse Event|0|||
27600899|NCT01323530|80378337|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27600900|NCT01323530|80378338|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27600901|NCT01323530|80378339|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27600902|NCT01323530|80378340|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27600903|NCT01323530|80378341|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
27600904|NCT01323530|80378342|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
27600905|NCT01323530|80378336|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27600906|NCT01323530|80378337|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27600907|NCT01323530|80378338|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27600908|NCT01323530|80378339|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27600909|NCT01323530|80378340|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27600910|NCT01323530|80378341|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
27600911|NCT01323530|80378342|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
27600912|NCT01323530|80378336|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27600913|NCT01323530|80378337|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27600914|NCT01323530|80378338|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27600915|NCT01323530|80378339|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27600916|NCT01323530|80378340|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27600917|NCT01323530|80378341|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
27600918|NCT01323530|80378342|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
27600919|NCT01323530|80378336|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27600920|NCT01323530|80378337|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27600921|NCT01323530|80378338|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27600922|NCT01323530|80378339|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27600923|NCT01323530|80378340|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27600924|NCT01323530|80378341|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
27600925|NCT01323530|80378342|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
27600926|NCT01323530|80378336|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27600927|NCT01323530|80378337|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27600928|NCT01323530|80378338|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27600929|NCT01323530|80378339|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27600930|NCT01323530|80378340|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27600931|NCT01323530|80378341|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
27600932|NCT01323530|80378342|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
27600933|NCT01696981|80378345|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
27600934|NCT01696981|80378346|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
27600935|NCT01696981|80378345|FG000|Overall Study|Died Before Randomization|3|||
27600936|NCT01696981|80378346|FG001|Overall Study|Died Before Randomization|8|||
27600937|NCT01696981|80378345|FG000|Overall Study|Died Before ASU (Control)|278|||
27600938|NCT01696981|80378346|FG001|Overall Study|Died Before ASU (Control)|0|||
27600939|NCT01696981|80378345|FG000|Overall Study|Refused ASU (Control)|920|||
27600940|NCT01696981|80378346|FG001|Overall Study|Refused ASU (Control)|0|||
27600941|NCT01696981|80378345|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
27600942|NCT01696981|80378346|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
27600943|NCT02055157|80378349|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
27600944|NCT02055157|80378350|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
27600945|NCT02055157|80378351|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
27600946|NCT02055157|80378352|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
27600947|NCT02055157|80378349|FG000|Initial 6 Months|Adverse Event|0|||
27600948|NCT02055157|80378350|FG001|Initial 6 Months|Adverse Event|0|||
27600949|NCT02055157|80378351|FG002|Initial 6 Months|Adverse Event|0|||
27600950|NCT02055157|80378352|FG003|Initial 6 Months|Adverse Event|1|||
27600951|NCT02055157|80378349|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
27600952|NCT02055157|80378350|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
27600953|NCT02055157|80378351|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
27600954|NCT02055157|80378352|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
27600955|NCT02055157|80378349|FG000|18-month Extension|Investigator decision|0|||
27600956|NCT02055157|80378350|FG001|18-month Extension|Investigator decision|1|||
27600957|NCT02055157|80378351|FG002|18-month Extension|Investigator decision|0|||
27600958|NCT02055157|80378352|FG003|18-month Extension|Investigator decision|0|||
27600959|NCT02055157|80378349|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
27600960|NCT02055157|80378350|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
27600961|NCT02055157|80378351|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
27600962|NCT02055157|80378352|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
27600963|NCT00948974|80378353|FG000|Overall Study|Lost to Follow-up|23|||
27600964|NCT00948974|80378354|FG001|Overall Study|Lost to Follow-up|20|||
27600965|NCT01875185|80378355|FG000|Overall Study|study was terminated|52|||
27600966|NCT01875185|80378356|FG001|Overall Study|study was terminated|48|||
27600967|NCT01065350|80378362|FG000|Overall Study|Received incorrect drug allocation|0|||
27600968|NCT01065350|80378363|FG001|Overall Study|Received incorrect drug allocation|1|||
27600969|NCT00985725|80378364|FG000|Overall Study|Adverse Event|4|||
27600970|NCT00985725|80378365|FG001|Overall Study|Adverse Event|1|||
27600971|NCT00985725|80378364|FG000|Overall Study|Protocol Violation|1|||
27600972|NCT00985725|80378365|FG001|Overall Study|Protocol Violation|3|||
27600973|NCT00985725|80378364|FG000|Overall Study|Withdrawal by Subject|4|||
27600974|NCT00985725|80378365|FG001|Overall Study|Withdrawal by Subject|4|||
27600975|NCT00985725|80378364|FG000|Overall Study|Lost to Follow-up|1|||
27600976|NCT00985725|80378365|FG001|Overall Study|Lost to Follow-up|1|||
27600977|NCT00985725|80378364|FG000|Overall Study|Lack of Efficacy|0|||
27600978|NCT00985725|80378365|FG001|Overall Study|Lack of Efficacy|1|||
27600979|NCT00985725|80378364|FG000|Overall Study|Non-compliance|1|||
27600980|NCT00985725|80378365|FG001|Overall Study|Non-compliance|2|||
27600981|NCT00985725|80378364|FG000|Overall Study|Out-of-window visits|0|||
27600982|NCT00985725|80378365|FG001|Overall Study|Out-of-window visits|1|||
27600983|NCT00733499|80378368|FG000|Pre-operative|Protocol Violation|0|||
27600984|NCT00733499|80378369|FG001|Pre-operative|Protocol Violation|1|||
27600985|NCT00733499|80378368|FG000|3 Months Follow-up|Death|1|||
27600986|NCT00733499|80378369|FG001|3 Months Follow-up|Death|2|||
27600987|NCT00733499|80378368|FG000|6 Months Follow-up|Death|0|||
27600988|NCT00733499|80378369|FG001|6 Months Follow-up|Death|2|||
27706766|NCT02819635|80765217|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706767|NCT02819635|80765218|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706768|NCT02819635|80765219|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27835380|NCT00112437|81226172|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27888384|NCT01031836|81427978|FG000|Stage I|Other|0|||
27888385|NCT01031836|81427979|FG001|Stage I|Other|1|||
27888386|NCT01031836|81427980|FG002|Stage I|Other|0|||
27888387|NCT01031836|81427981|FG003|Stage I|Other|0|||
27888388|NCT01031836|81427982|FG004|Stage I|Other|0|||
27888389|NCT01031836|81427983|FG005|Stage I|Other|1|||
27600989|NCT00733499|80378368|FG000|6 Months Follow-up|Adverse Event|0|||
27600990|NCT00733499|80378369|FG001|6 Months Follow-up|Adverse Event|1|||
27600991|NCT00733499|80378368|FG000|12 Months Follow-up|Death|2|||
27600992|NCT00733499|80378369|FG001|12 Months Follow-up|Death|1|||
27600993|NCT00733499|80378368|FG000|24 Months Follow-up|Death|0|||
27835381|NCT00112437|81226173|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835382|NCT00112437|81226174|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835383|NCT00112437|81226175|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835384|NCT00112437|81226176|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835385|NCT00112437|81226177|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835386|NCT00112437|81226178|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835387|NCT00112437|81226179|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835388|NCT00112437|81226180|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835389|NCT00112437|81226181|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27835390|NCT00112437|81226182|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
27888390|NCT01031836|81427978|FG000|Stage II|Adverse Event|0|||
27600994|NCT00733499|80378369|FG001|24 Months Follow-up|Death|1|||
27600995|NCT00733499|80378368|FG000|5 Year Followup|Adverse Event|2|||
27600996|NCT00733499|80378369|FG001|5 Year Followup|Adverse Event|2|||
27600997|NCT00733499|80378368|FG000|5 Year Followup|Non device related AE|0|||
27706769|NCT02819635|80765220|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706770|NCT02819635|80765221|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
27706771|NCT02819635|80765210|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706772|NCT02819635|80765211|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706773|NCT02819635|80765212|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706774|NCT02819635|80765213|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706775|NCT02819635|80765214|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706776|NCT02819635|80765215|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
27706777|NCT02819635|80765216|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
27706778|NCT02819635|80765217|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706779|NCT02819635|80765218|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706780|NCT02819635|80765219|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706781|NCT02819635|80765220|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706782|NCT02819635|80765221|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
27706783|NCT02819635|80765210|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27835391|NCT00112437|81226183|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
27600998|NCT00733499|80378369|FG001|5 Year Followup|Non device related AE|1|||
27600999|NCT00733499|80378368|FG000|5 Year Followup|Revision of Study Implant|0|||
27601000|NCT00733499|80378369|FG001|5 Year Followup|Revision of Study Implant|1|||
27601001|NCT00733499|80378368|FG000|5 Year Followup|Lost to Follow-up|2|||
27601002|NCT00733499|80378369|FG001|5 Year Followup|Lost to Follow-up|0|||
27601003|NCT00733499|80378368|FG000|5 Year Followup|Death|13|||
27601004|NCT00733499|80378369|FG001|5 Year Followup|Death|19|||
27601005|NCT00733499|80378368|FG000|5 Year Followup|missing, unable to locate|0|||
27601006|NCT00733499|80378369|FG001|5 Year Followup|missing, unable to locate|1|||
27601007|NCT00733499|80378368|FG000|5 Year Followup|Withdrawal by Subject|4|||
27601008|NCT00733499|80378369|FG001|5 Year Followup|Withdrawal by Subject|1|||
27601009|NCT00733499|80378368|FG000|10 Year Followup|Death|9|||
27835392|NCT00112437|81226158|FG000|Years 6-10 (60-Month Extension)|Other|0|||
27835393|NCT00112437|81226159|FG001|Years 6-10 (60-Month Extension)|Other|0|||
27835394|NCT00112437|81226160|FG002|Years 6-10 (60-Month Extension)|Other|0|||
27835395|NCT00112437|81226161|FG003|Years 6-10 (60-Month Extension)|Other|0|||
27835396|NCT00112437|81226162|FG004|Years 6-10 (60-Month Extension)|Other|0|||
27835397|NCT00112437|81226163|FG005|Years 6-10 (60-Month Extension)|Other|0|||
27835398|NCT00112437|81226164|FG006|Years 6-10 (60-Month Extension)|Other|0|||
27835399|NCT00112437|81226165|FG007|Years 6-10 (60-Month Extension)|Other|0|||
27835400|NCT00112437|81226166|FG008|Years 6-10 (60-Month Extension)|Other|0|||
27835401|NCT00112437|81226167|FG009|Years 6-10 (60-Month Extension)|Other|0|||
27835402|NCT00112437|81226168|FG010|Years 6-10 (60-Month Extension)|Other|0|||
27835403|NCT00112437|81226169|FG011|Years 6-10 (60-Month Extension)|Other|0|||
27835404|NCT00112437|81226170|FG012|Years 6-10 (60-Month Extension)|Other|0|||
27835405|NCT00112437|81226171|FG013|Years 6-10 (60-Month Extension)|Other|0|||
27601010|NCT00733499|80378369|FG001|10 Year Followup|Death|7|||
27601011|NCT00733499|80378368|FG000|10 Year Followup|Adverse Event|3|||
27601012|NCT00733499|80378369|FG001|10 Year Followup|Adverse Event|3|||
27835406|NCT00112437|81226172|FG014|Years 6-10 (60-Month Extension)|Other|0|||
27835407|NCT00112437|81226173|FG015|Years 6-10 (60-Month Extension)|Other|0|||
27835408|NCT00112437|81226174|FG016|Years 6-10 (60-Month Extension)|Other|0|||
27601013|NCT00733499|80378368|FG000|10 Year Followup|Lost to Follow-up|3|||
27601014|NCT00733499|80378369|FG001|10 Year Followup|Lost to Follow-up|2|||
27601015|NCT00733499|80378368|FG000|10 Year Followup|Withdrawal by Subject|5|||
27601016|NCT00733499|80378369|FG001|10 Year Followup|Withdrawal by Subject|5|||
27601017|NCT00733499|80378368|FG000|10 Year Followup|missing, unable to locate|0|||
27706784|NCT02819635|80765211|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706785|NCT02819635|80765212|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706786|NCT02819635|80765213|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706787|NCT02819635|80765214|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706788|NCT02819635|80765215|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706789|NCT02819635|80765216|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
27601018|NCT00733499|80378369|FG001|10 Year Followup|missing, unable to locate|2|||
27601019|NCT00789815|80378370|FG000|Overall Study|Protocol Violation|6|||
27601020|NCT00789815|80378371|FG001|Overall Study|Protocol Violation|1|||
27601021|NCT00789815|80378370|FG000|Overall Study|Intubation due to massive bleeding|1|||
27601022|NCT00789815|80378371|FG001|Overall Study|Intubation due to massive bleeding|0|||
27601023|NCT00387894|80378372|FG000|Overall Study|Withdrawal by Subject|1|||
27601024|NCT04517864|80378373|FG000|Placebo-Controlled Phase|Adverse Event|1|||
27601025|NCT04517864|80378374|FG001|Placebo-Controlled Phase|Adverse Event|0|||
27601026|NCT04517864|80378373|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
27601027|NCT04517864|80378374|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
27601028|NCT04517864|80378373|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
27601029|NCT04517864|80378374|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
27601030|NCT04517864|80378373|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
27601031|NCT04517864|80378374|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
27601032|NCT04517864|80378373|FG000|Active Therapy Extension Phase|Adverse Event|1|||
27601033|NCT04517864|80378374|FG001|Active Therapy Extension Phase|Adverse Event|0|||
27601034|NCT04517864|80378373|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
27601035|NCT04517864|80378374|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
27601036|NCT04517864|80378373|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
27601037|NCT04517864|80378374|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
27601038|NCT04517864|80378373|FG000|Active Therapy Extension Phase|Physician Decision|1|||
27601039|NCT04517864|80378374|FG001|Active Therapy Extension Phase|Physician Decision|0|||
27601040|NCT04517864|80378373|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
27601041|NCT04517864|80378374|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
27601042|NCT04517864|80378373|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
27601043|NCT04517864|80378374|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
27601044|NCT01648348|80378376|FG000|Overall Study|Cancel|1|||
27601045|NCT01648348|80378377|FG001|Overall Study|Cancel|0|||
27601046|NCT01648348|80378378|FG002|Overall Study|Cancel|0|||
27601047|NCT01648348|80378379|FG003|Overall Study|Cancel|0|||
27601048|NCT01648348|80378380|FG004|Overall Study|Cancel|3|||
27601049|NCT01648348|80378381|FG005|Overall Study|Cancel|6|||
27601050|NCT01648348|80378376|FG000|Overall Study|Replaced for MTD analysis|1|||
27601051|NCT01648348|80378377|FG001|Overall Study|Replaced for MTD analysis|0|||
27601052|NCT01648348|80378378|FG002|Overall Study|Replaced for MTD analysis|1|||
27601053|NCT01648348|80378379|FG003|Overall Study|Replaced for MTD analysis|0|||
27706790|NCT02819635|80765217|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706791|NCT02819635|80765218|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27835409|NCT00112437|81226175|FG017|Years 6-10 (60-Month Extension)|Other|0|||
27601054|NCT01648348|80378380|FG004|Overall Study|Replaced for MTD analysis|0|||
27601055|NCT01648348|80378381|FG005|Overall Study|Replaced for MTD analysis|0|||
27601056|NCT01324271|80378384|FG000|Overall Study|Lost to Follow-up|3|||
27601057|NCT01324271|80378385|FG001|Overall Study|Lost to Follow-up|0|||
27601058|NCT01324271|80378384|FG000|Overall Study|Physician Decision|1|||
27601059|NCT01324271|80378385|FG001|Overall Study|Physician Decision|0|||
27601060|NCT01693692|80378386|FG000|Overall Study|Withdrawal by Subject|12|||
27601061|NCT01693692|80378387|FG001|Overall Study|Withdrawal by Subject|10|||
27601062|NCT01693692|80378388|FG002|Overall Study|Withdrawal by Subject|11|||
27601063|NCT01693692|80378386|FG000|Overall Study|Adverse Event|7|||
27601064|NCT01693692|80378387|FG001|Overall Study|Adverse Event|14|||
27835410|NCT00112437|81226176|FG018|Years 6-10 (60-Month Extension)|Other|0|||
27835411|NCT00112437|81226177|FG019|Years 6-10 (60-Month Extension)|Other|0|||
27601065|NCT01693692|80378388|FG002|Overall Study|Adverse Event|9|||
27601066|NCT01693692|80378386|FG000|Overall Study|Physician Decision|0|||
27601067|NCT01693692|80378387|FG001|Overall Study|Physician Decision|0|||
27601068|NCT01693692|80378388|FG002|Overall Study|Physician Decision|1|||
27601069|NCT01693692|80378386|FG000|Overall Study|Protocol Violation|5|||
27601070|NCT01693692|80378387|FG001|Overall Study|Protocol Violation|4|||
27601071|NCT01693692|80378388|FG002|Overall Study|Protocol Violation|6|||
27601072|NCT01693692|80378386|FG000|Overall Study|Lost to Follow-up|2|||
27601073|NCT01693692|80378387|FG001|Overall Study|Lost to Follow-up|2|||
27601074|NCT01693692|80378388|FG002|Overall Study|Lost to Follow-up|3|||
27601075|NCT01693692|80378386|FG000|Overall Study|Other|4|||
27601076|NCT01693692|80378387|FG001|Overall Study|Other|4|||
27601077|NCT01693692|80378388|FG002|Overall Study|Other|6|||
27601078|NCT02274857|80378395|FG000|Overall Study|Adverse Event|1|||
27601079|NCT02274857|80378396|FG001|Overall Study|Adverse Event|0|||
27601080|NCT02274857|80378395|FG000|Overall Study|Death|1|||
27601081|NCT02274857|80378396|FG001|Overall Study|Death|2|||
27601082|NCT02274857|80378395|FG000|Overall Study|Lost to Follow-up|3|||
27601083|NCT02274857|80378396|FG001|Overall Study|Lost to Follow-up|0|||
27601084|NCT02274857|80378395|FG000|Overall Study|Physician Decision|2|||
27601085|NCT02274857|80378396|FG001|Overall Study|Physician Decision|0|||
27601086|NCT02274857|80378395|FG000|Overall Study|Trial screen failure|0|||
27601087|NCT02274857|80378396|FG001|Overall Study|Trial screen failure|2|||
27601088|NCT02274857|80378395|FG000|Overall Study|Withdrawal by Subject|11|||
27601089|NCT02274857|80378396|FG001|Overall Study|Withdrawal by Subject|2|||
27601090|NCT02274857|80378395|FG000|Overall Study|Other|2|||
27601091|NCT02274857|80378396|FG001|Overall Study|Other|0|||
27601092|NCT02068495|80378399|FG000|Overall Study|Case Report Forms Uncollected|60|||
27601093|NCT02068495|80378399|FG000|Overall Study|Protocol Deviation|49|||
27601094|NCT02243280|80378400|FG000|Treated|Adverse Event|1|||
27601095|NCT02243280|80378401|FG001|Treated|Adverse Event|0|||
27601096|NCT02243280|80378402|FG002|Treated|Adverse Event|0|||
27601097|NCT02243280|80378403|FG003|Treated|Adverse Event|0|||
27601098|NCT02243280|80378404|FG004|Treated|Adverse Event|0|||
27601099|NCT02243280|80378405|FG005|Treated|Adverse Event|0|||
27601100|NCT02243280|80378406|FG006|Treated|Adverse Event|0|||
27601101|NCT02243280|80378407|FG007|Treated|Adverse Event|0|||
27601102|NCT02243280|80378408|FG008|Treated|Adverse Event|0|||
27601103|NCT02243280|80378409|FG009|Treated|Adverse Event|0|||
27601104|NCT02243280|80378410|FG010|Treated|Adverse Event|1|||
27601105|NCT02243280|80378400|FG000|Treated|Lost to Follow-up|0|||
27601106|NCT02243280|80378401|FG001|Treated|Lost to Follow-up|0|||
27601107|NCT02243280|80378402|FG002|Treated|Lost to Follow-up|0|||
27601108|NCT02243280|80378403|FG003|Treated|Lost to Follow-up|0|||
27601109|NCT02243280|80378404|FG004|Treated|Lost to Follow-up|0|||
27601110|NCT02243280|80378405|FG005|Treated|Lost to Follow-up|0|||
27601111|NCT02243280|80378406|FG006|Treated|Lost to Follow-up|0|||
27706792|NCT02819635|80765219|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706793|NCT02819635|80765220|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706794|NCT02819635|80765221|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
27706795|NCT02819635|80765210|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
27706796|NCT02819635|80765211|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
27706797|NCT02819635|80765212|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
27706798|NCT02819635|80765213|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
27706799|NCT02819635|80765214|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
27706800|NCT02819635|80765215|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
27706801|NCT02819635|80765216|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
27888391|NCT01031836|81427979|FG001|Stage II|Adverse Event|0|||
27888392|NCT01031836|81427980|FG002|Stage II|Adverse Event|2|||
27888393|NCT01031836|81427981|FG003|Stage II|Adverse Event|2|||
27888394|NCT01031836|81427982|FG004|Stage II|Adverse Event|1|||
27601112|NCT02243280|80378407|FG007|Treated|Lost to Follow-up|0|||
27601113|NCT02243280|80378408|FG008|Treated|Lost to Follow-up|1|||
27601114|NCT02243280|80378409|FG009|Treated|Lost to Follow-up|0|||
27601115|NCT02243280|80378410|FG010|Treated|Lost to Follow-up|2|||
27601116|NCT02403180|80378411|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
27601117|NCT02403180|80378412|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
27601118|NCT02403180|80378411|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
27601119|NCT02403180|80378412|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
27601120|NCT02276222|80378413|FG000|Overall Study|Adverse Event|62|||
27601121|NCT02276222|80378414|FG001|Overall Study|Adverse Event|11|||
27601122|NCT02276222|80378413|FG000|Overall Study|Death|3|||
27888395|NCT01031836|81427983|FG005|Stage II|Adverse Event|1|||
27888396|NCT01031836|81427978|FG000|Stage II|Other|2|||
27601123|NCT02276222|80378414|FG001|Overall Study|Death|4|||
27601124|NCT02276222|80378413|FG000|Overall Study|Lack of Efficacy|13|||
27601125|NCT02276222|80378414|FG001|Overall Study|Lack of Efficacy|3|||
27888397|NCT01031836|81427979|FG001|Stage II|Other|0|||
27601126|NCT02276222|80378413|FG000|Overall Study|Protocol Violation|3|||
27601127|NCT02276222|80378414|FG001|Overall Study|Protocol Violation|2|||
27601128|NCT02276222|80378413|FG000|Overall Study|Withdrawal by Subject|79|||
27706802|NCT02819635|80765217|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27706803|NCT02819635|80765218|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27706804|NCT02819635|80765219|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27706805|NCT02819635|80765220|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27706806|NCT02819635|80765221|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
27706807|NCT02819635|80765210|FG000|Substudy 2, Part 2|Adverse Event|0|||
27706808|NCT02819635|80765211|FG001|Substudy 2, Part 2|Adverse Event|0|||
27706809|NCT02819635|80765212|FG002|Substudy 2, Part 2|Adverse Event|0|||
27706810|NCT02819635|80765213|FG003|Substudy 2, Part 2|Adverse Event|0|||
27706811|NCT02819635|80765214|FG004|Substudy 2, Part 2|Adverse Event|0|||
27706812|NCT02819635|80765215|FG005|Substudy 2, Part 2|Adverse Event|4|||
27706813|NCT02819635|80765216|FG006|Substudy 2, Part 2|Adverse Event|0|||
27706814|NCT02819635|80765217|FG007|Substudy 2, Part 2|Adverse Event|0|||
27706815|NCT02819635|80765218|FG008|Substudy 2, Part 2|Adverse Event|0|||
27706816|NCT02819635|80765219|FG009|Substudy 2, Part 2|Adverse Event|0|||
27706817|NCT02819635|80765220|FG010|Substudy 2, Part 2|Adverse Event|0|||
27706818|NCT02819635|80765221|FG011|Substudy 2, Part 2|Adverse Event|0|||
27706819|NCT02819635|80765210|FG000|Substudy 2, Part 2|Withdrew consent|0|||
27706820|NCT02819635|80765211|FG001|Substudy 2, Part 2|Withdrew consent|0|||
27706821|NCT02819635|80765212|FG002|Substudy 2, Part 2|Withdrew consent|0|||
27706822|NCT02819635|80765213|FG003|Substudy 2, Part 2|Withdrew consent|0|||
27706823|NCT02819635|80765214|FG004|Substudy 2, Part 2|Withdrew consent|0|||
27706824|NCT02819635|80765215|FG005|Substudy 2, Part 2|Withdrew consent|3|||
27706825|NCT02819635|80765216|FG006|Substudy 2, Part 2|Withdrew consent|1|||
27706826|NCT02819635|80765217|FG007|Substudy 2, Part 2|Withdrew consent|0|||
27706827|NCT02819635|80765218|FG008|Substudy 2, Part 2|Withdrew consent|0|||
27706828|NCT02819635|80765219|FG009|Substudy 2, Part 2|Withdrew consent|0|||
27706829|NCT02819635|80765220|FG010|Substudy 2, Part 2|Withdrew consent|0|||
27706830|NCT02819635|80765221|FG011|Substudy 2, Part 2|Withdrew consent|0|||
27706831|NCT02819635|80765210|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
27706832|NCT02819635|80765211|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
27706833|NCT02819635|80765212|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
27706834|NCT02819635|80765213|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
27706835|NCT02819635|80765214|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
27706836|NCT02819635|80765215|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
27706837|NCT02819635|80765216|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
27706838|NCT02819635|80765217|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
27706839|NCT02819635|80765218|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
27706840|NCT02819635|80765219|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
27706841|NCT02819635|80765220|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
27706842|NCT02819635|80765221|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
27706843|NCT02819635|80765210|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706844|NCT02819635|80765211|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706845|NCT02819635|80765212|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706846|NCT02819635|80765213|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706847|NCT02819635|80765214|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706848|NCT02819635|80765215|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706849|NCT02819635|80765216|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
27706850|NCT02819635|80765217|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706851|NCT02819635|80765218|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706852|NCT02819635|80765219|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706853|NCT02819635|80765220|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706854|NCT02819635|80765221|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
27706855|NCT02819635|80765210|FG000|Substudy 2, Part 2|Other, not specified|0|||
27706856|NCT02819635|80765211|FG001|Substudy 2, Part 2|Other, not specified|0|||
27706857|NCT02819635|80765212|FG002|Substudy 2, Part 2|Other, not specified|0|||
27706858|NCT02819635|80765213|FG003|Substudy 2, Part 2|Other, not specified|0|||
27706859|NCT02819635|80765214|FG004|Substudy 2, Part 2|Other, not specified|0|||
27706860|NCT02819635|80765215|FG005|Substudy 2, Part 2|Other, not specified|4|||
27706861|NCT02819635|80765216|FG006|Substudy 2, Part 2|Other, not specified|8|||
27706862|NCT02819635|80765217|FG007|Substudy 2, Part 2|Other, not specified|0|||
27706863|NCT02819635|80765218|FG008|Substudy 2, Part 2|Other, not specified|0|||
27706864|NCT02819635|80765219|FG009|Substudy 2, Part 2|Other, not specified|0|||
27706865|NCT02819635|80765220|FG010|Substudy 2, Part 2|Other, not specified|0|||
27706866|NCT02819635|80765221|FG011|Substudy 2, Part 2|Other, not specified|0|||
27706867|NCT02819635|80765210|FG000|Substudy 3|Adverse Event|0|||
27706868|NCT02819635|80765211|FG001|Substudy 3|Adverse Event|0|||
27706869|NCT02819635|80765212|FG002|Substudy 3|Adverse Event|0|||
27706870|NCT02819635|80765213|FG003|Substudy 3|Adverse Event|0|||
27706871|NCT02819635|80765214|FG004|Substudy 3|Adverse Event|0|||
27706872|NCT02819635|80765215|FG005|Substudy 3|Adverse Event|0|||
27706873|NCT02819635|80765216|FG006|Substudy 3|Adverse Event|0|||
27706874|NCT02819635|80765217|FG007|Substudy 3|Adverse Event|0|||
27706875|NCT02819635|80765218|FG008|Substudy 3|Adverse Event|32|||
27706876|NCT02819635|80765219|FG009|Substudy 3|Adverse Event|3|||
27706877|NCT02819635|80765220|FG010|Substudy 3|Adverse Event|12|||
27706878|NCT02819635|80765221|FG011|Substudy 3|Adverse Event|18|||
27706879|NCT02819635|80765210|FG000|Substudy 3|Withdrew consent|0|||
27706880|NCT02819635|80765211|FG001|Substudy 3|Withdrew consent|0|||
27706881|NCT02819635|80765212|FG002|Substudy 3|Withdrew consent|0|||
27706882|NCT02819635|80765213|FG003|Substudy 3|Withdrew consent|0|||
27706883|NCT02819635|80765214|FG004|Substudy 3|Withdrew consent|0|||
27706884|NCT02819635|80765215|FG005|Substudy 3|Withdrew consent|0|||
27706885|NCT02819635|80765216|FG006|Substudy 3|Withdrew consent|0|||
27706886|NCT02819635|80765217|FG007|Substudy 3|Withdrew consent|0|||
27706887|NCT02819635|80765218|FG008|Substudy 3|Withdrew consent|11|||
27706888|NCT02819635|80765219|FG009|Substudy 3|Withdrew consent|1|||
27706889|NCT02819635|80765220|FG010|Substudy 3|Withdrew consent|4|||
27706890|NCT02819635|80765221|FG011|Substudy 3|Withdrew consent|9|||
27706891|NCT02819635|80765210|FG000|Substudy 3|Lost to Follow-up|0|||
27706892|NCT02819635|80765211|FG001|Substudy 3|Lost to Follow-up|0|||
27706893|NCT02819635|80765212|FG002|Substudy 3|Lost to Follow-up|0|||
27706894|NCT02819635|80765213|FG003|Substudy 3|Lost to Follow-up|0|||
27706895|NCT02819635|80765214|FG004|Substudy 3|Lost to Follow-up|0|||
27706896|NCT02819635|80765215|FG005|Substudy 3|Lost to Follow-up|0|||
27706897|NCT02819635|80765216|FG006|Substudy 3|Lost to Follow-up|0|||
27706898|NCT02819635|80765217|FG007|Substudy 3|Lost to Follow-up|0|||
27706899|NCT02819635|80765218|FG008|Substudy 3|Lost to Follow-up|1|||
27706900|NCT02819635|80765219|FG009|Substudy 3|Lost to Follow-up|0|||
27706901|NCT02819635|80765220|FG010|Substudy 3|Lost to Follow-up|1|||
27706902|NCT02819635|80765221|FG011|Substudy 3|Lost to Follow-up|1|||
27706903|NCT02819635|80765210|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706904|NCT02819635|80765211|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706905|NCT02819635|80765212|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706906|NCT02819635|80765213|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706907|NCT02819635|80765214|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706908|NCT02819635|80765215|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706909|NCT02819635|80765216|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706910|NCT02819635|80765217|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706911|NCT02819635|80765218|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706912|NCT02819635|80765219|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
27601129|NCT02276222|80378414|FG001|Overall Study|Withdrawal by Subject|33|||
27706913|NCT02819635|80765220|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
27706914|NCT02819635|80765221|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
27706915|NCT02819635|80765210|FG000|Substudy 3|Other, not specified|0|||
27706916|NCT02819635|80765211|FG001|Substudy 3|Other, not specified|0|||
27706917|NCT02819635|80765212|FG002|Substudy 3|Other, not specified|0|||
27706918|NCT02819635|80765213|FG003|Substudy 3|Other, not specified|0|||
27706919|NCT02819635|80765214|FG004|Substudy 3|Other, not specified|0|||
27706920|NCT02819635|80765215|FG005|Substudy 3|Other, not specified|0|||
27706921|NCT02819635|80765216|FG006|Substudy 3|Other, not specified|0|||
27706922|NCT02819635|80765217|FG007|Substudy 3|Other, not specified|0|||
27706923|NCT02819635|80765218|FG008|Substudy 3|Other, not specified|202|||
27706924|NCT02819635|80765219|FG009|Substudy 3|Other, not specified|5|||
27706925|NCT02819635|80765220|FG010|Substudy 3|Other, not specified|89|||
27706926|NCT02819635|80765221|FG011|Substudy 3|Other, not specified|39|||
27706927|NCT01015768|80765222|FG000|Overall Study|Some subject data unuseable|4|||
27706928|NCT01015768|80765223|FG001|Overall Study|Some subject data unuseable|4|||
27706929|NCT04196803|80765224|FG000|Overall Study|Withdrawal by Subject|1|||
27706930|NCT04196803|80765225|FG001|Overall Study|Withdrawal by Subject|3|||
27706931|NCT04196803|80765224|FG000|Overall Study|Adverse Event|4|||
27706932|NCT04196803|80765225|FG001|Overall Study|Adverse Event|2|||
27706933|NCT04196803|80765224|FG000|Overall Study|Lost to Follow-up|0|||
27706934|NCT04196803|80765225|FG001|Overall Study|Lost to Follow-up|1|||
27706935|NCT04641299|80765226|FG000|Overall Study|Adverse Event|0|||
27706936|NCT04641299|80765227|FG001|Overall Study|Adverse Event|0|||
27706937|NCT04641299|80765228|FG002|Overall Study|Adverse Event|2|||
27706938|NCT04641299|80765229|FG003|Overall Study|Adverse Event|0|||
27706939|NCT04641299|80765226|FG000|Overall Study|Lost to Follow-up|0|||
27706940|NCT04641299|80765227|FG001|Overall Study|Lost to Follow-up|1|||
27706941|NCT04641299|80765228|FG002|Overall Study|Lost to Follow-up|0|||
27706942|NCT04641299|80765229|FG003|Overall Study|Lost to Follow-up|0|||
27706943|NCT04641299|80765226|FG000|Overall Study|Withdrawal by Subject|1|||
27706944|NCT04641299|80765227|FG001|Overall Study|Withdrawal by Subject|0|||
27706945|NCT04641299|80765228|FG002|Overall Study|Withdrawal by Subject|0|||
27706946|NCT04641299|80765229|FG003|Overall Study|Withdrawal by Subject|0|||
27706947|NCT04641299|80765226|FG000|Overall Study|Reason not given|1|||
27706948|NCT04641299|80765227|FG001|Overall Study|Reason not given|0|||
27706949|NCT04641299|80765228|FG002|Overall Study|Reason not given|0|||
27706950|NCT04641299|80765229|FG003|Overall Study|Reason not given|0|||
27706951|NCT00820950|80765232|FG000|Overall Study|Scheduling Conflict|0|||
27706952|NCT00820950|80765233|FG001|Overall Study|Scheduling Conflict|0|||
27706953|NCT00820950|80765234|FG002|Overall Study|Scheduling Conflict|0|||
27706954|NCT00820950|80765235|FG003|Overall Study|Scheduling Conflict|0|||
27706955|NCT00820950|80765236|FG004|Overall Study|Scheduling Conflict|0|||
27706956|NCT00820950|80765237|FG005|Overall Study|Scheduling Conflict|0|||
27706957|NCT00820950|80765238|FG006|Overall Study|Scheduling Conflict|1|||
27706958|NCT00820950|80765239|FG007|Overall Study|Scheduling Conflict|1|||
27706959|NCT00820950|80765240|FG008|Overall Study|Scheduling Conflict|0|||
27706960|NCT00820950|80765241|FG009|Overall Study|Scheduling Conflict|0|||
27706961|NCT00820950|80765232|FG000|Overall Study|Protocol Violation|1|||
27706962|NCT00820950|80765233|FG001|Overall Study|Protocol Violation|1|||
27706963|NCT00820950|80765234|FG002|Overall Study|Protocol Violation|0|||
27706964|NCT00820950|80765235|FG003|Overall Study|Protocol Violation|0|||
27706965|NCT00820950|80765236|FG004|Overall Study|Protocol Violation|0|||
27706966|NCT00820950|80765237|FG005|Overall Study|Protocol Violation|0|||
27706967|NCT00820950|80765238|FG006|Overall Study|Protocol Violation|0|||
27706968|NCT00820950|80765239|FG007|Overall Study|Protocol Violation|0|||
27706969|NCT00820950|80765240|FG008|Overall Study|Protocol Violation|0|||
27706970|NCT00820950|80765241|FG009|Overall Study|Protocol Violation|0|||
27706971|NCT03451084|80765242|FG000|Overall Study|Withdrawal by Subject|2|||
27706972|NCT03451084|80765243|FG001|Overall Study|Withdrawal by Subject|1|||
27706973|NCT03451084|80765244|FG002|Overall Study|Withdrawal by Subject|2|||
27706974|NCT03451084|80765245|FG003|Overall Study|Withdrawal by Subject|1|||
27706975|NCT03451084|80765242|FG000|Overall Study|Disease recurrence|0|||
27706976|NCT03451084|80765243|FG001|Overall Study|Disease recurrence|2|||
27706977|NCT03451084|80765244|FG002|Overall Study|Disease recurrence|0|||
27706978|NCT03451084|80765245|FG003|Overall Study|Disease recurrence|0|||
27706979|NCT03451084|80765242|FG000|Overall Study|Lack of Efficacy|0|||
27706980|NCT03451084|80765243|FG001|Overall Study|Lack of Efficacy|3|||
27706981|NCT03451084|80765244|FG002|Overall Study|Lack of Efficacy|0|||
27706982|NCT03451084|80765245|FG003|Overall Study|Lack of Efficacy|1|||
27706983|NCT03451084|80765242|FG000|Overall Study|Death|1|||
27706984|NCT03451084|80765243|FG001|Overall Study|Death|0|||
27706985|NCT03451084|80765244|FG002|Overall Study|Death|2|||
27706986|NCT03451084|80765245|FG003|Overall Study|Death|0|||
27706987|NCT03451084|80765242|FG000|Overall Study|Physician Decision|0|||
27706988|NCT03451084|80765243|FG001|Overall Study|Physician Decision|0|||
27706989|NCT03451084|80765244|FG002|Overall Study|Physician Decision|2|||
27706990|NCT03451084|80765245|FG003|Overall Study|Physician Decision|2|||
27706991|NCT03451084|80765242|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
27706992|NCT03451084|80765243|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
27706993|NCT03451084|80765244|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
27706994|NCT03451084|80765245|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
27706995|NCT02066311|80765251|FG000|Overall Study|Adverse Event|4|||
27706996|NCT02066311|80765251|FG000|Overall Study|Withdrawal by Subject|1|||
27601130|NCT02276222|80378413|FG000|Overall Study|non compliance with study medication|6|||
27601131|NCT02276222|80378414|FG001|Overall Study|non compliance with study medication|2|||
27601132|NCT02276222|80378413|FG000|Overall Study|sponsor decision|0|||
27601133|NCT02276222|80378414|FG001|Overall Study|sponsor decision|3|||
27601134|NCT02276222|80378413|FG000|Overall Study|Lost to Follow-up|15|||
27601135|NCT02276222|80378414|FG001|Overall Study|Lost to Follow-up|5|||
27601136|NCT02276222|80378413|FG000|Overall Study|Physician Decision|2|||
27601137|NCT02276222|80378414|FG001|Overall Study|Physician Decision|1|||
27601138|NCT02276222|80378413|FG000|Overall Study|sheduling conflict|1|||
27601139|NCT02276222|80378414|FG001|Overall Study|sheduling conflict|0|||
27601140|NCT02276222|80378413|FG000|Overall Study|subject withdrew after randomization|1|||
27601141|NCT02276222|80378414|FG001|Overall Study|subject withdrew after randomization|0|||
27601142|NCT02120027|80378416|FG000|Overall Study|Adverse Event|4|||
27601143|NCT02120027|80378417|FG001|Overall Study|Adverse Event|5|||
27601144|NCT02120027|80378416|FG000|Overall Study|Lack of Efficacy|3|||
27601145|NCT02120027|80378417|FG001|Overall Study|Lack of Efficacy|5|||
27601146|NCT02120027|80378416|FG000|Overall Study|Lost to Follow-up|5|||
27601147|NCT02120027|80378417|FG001|Overall Study|Lost to Follow-up|13|||
27706997|NCT00424749|80765252|FG000|Overall Study|Withdrawal by Subject|1|||
27706998|NCT03104075|80765253|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
27706999|NCT03104075|80765254|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
27707000|NCT04667377|80765255|FG000|Dose Escalation Period|Other not specified below|3|||
27601148|NCT02120027|80378416|FG000|Overall Study|Other|4|||
27707001|NCT04667377|80765256|FG001|Dose Escalation Period|Other not specified below|3|||
27707002|NCT04667377|80765257|FG002|Dose Escalation Period|Other not specified below|2|||
27707003|NCT04667377|80765258|FG003|Dose Escalation Period|Other not specified below|1|||
27835412|NCT00112437|81226178|FG020|Years 6-10 (60-Month Extension)|Other|0|||
27835413|NCT00112437|81226179|FG021|Years 6-10 (60-Month Extension)|Other|0|||
27835414|NCT00112437|81226180|FG022|Years 6-10 (60-Month Extension)|Other|0|||
27835415|NCT00112437|81226181|FG023|Years 6-10 (60-Month Extension)|Other|0|||
27835416|NCT00112437|81226182|FG024|Years 6-10 (60-Month Extension)|Other|1|||
27835417|NCT00112437|81226183|FG025|Years 6-10 (60-Month Extension)|Other|0|||
27835418|NCT00112437|81226158|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835419|NCT00112437|81226159|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835420|NCT00112437|81226160|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835421|NCT00112437|81226161|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835422|NCT00112437|81226162|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835423|NCT00112437|81226163|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835424|NCT00112437|81226164|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835425|NCT00112437|81226165|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835426|NCT00112437|81226166|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835427|NCT00112437|81226167|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835428|NCT00112437|81226168|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835429|NCT00112437|81226169|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835430|NCT00112437|81226170|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835431|NCT00112437|81226171|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835432|NCT00112437|81226172|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835433|NCT00112437|81226173|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835434|NCT00112437|81226174|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835435|NCT00112437|81226175|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835436|NCT00112437|81226176|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835437|NCT00112437|81226177|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835438|NCT00112437|81226178|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835439|NCT00112437|81226179|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27601149|NCT02120027|80378417|FG001|Overall Study|Other|0|||
27601150|NCT02120027|80378416|FG000|Overall Study|Physician Decision|4|||
27601151|NCT02120027|80378417|FG001|Overall Study|Physician Decision|3|||
27601152|NCT02120027|80378416|FG000|Overall Study|Protocol Violation|18|||
27601153|NCT02120027|80378417|FG001|Overall Study|Protocol Violation|21|||
27601154|NCT02120027|80378416|FG000|Overall Study|Study terminated by Sponsor|45|||
27601155|NCT02120027|80378417|FG001|Overall Study|Study terminated by Sponsor|47|||
27601156|NCT02120027|80378416|FG000|Overall Study|Withdrawal by Subject|33|||
27601157|NCT02120027|80378417|FG001|Overall Study|Withdrawal by Subject|25|||
27601158|NCT00430248|80378420|FG000|Overall Study|Adverse Event|49|||
27601159|NCT00430248|80378421|FG001|Overall Study|Adverse Event|61|||
27601160|NCT00430248|80378422|FG002|Overall Study|Adverse Event|64|||
27601161|NCT00430248|80378420|FG000|Overall Study|Protocol Violation|10|||
27835440|NCT00112437|81226180|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835441|NCT00112437|81226181|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
27888398|NCT01031836|81427980|FG002|Stage II|Other|0|||
27888399|NCT01031836|81427981|FG003|Stage II|Other|1|||
27888400|NCT01031836|81427982|FG004|Stage II|Other|1|||
27888401|NCT01031836|81427983|FG005|Stage II|Other|0|||
27835442|NCT00112437|81226182|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835443|NCT00112437|81226183|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
27835444|NCT00112437|81226158|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835445|NCT00112437|81226159|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835446|NCT00112437|81226160|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835447|NCT00112437|81226161|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835448|NCT00112437|81226162|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835449|NCT00112437|81226163|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835450|NCT00112437|81226164|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835451|NCT00112437|81226165|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835452|NCT00112437|81226166|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835453|NCT00112437|81226167|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835454|NCT00112437|81226168|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835455|NCT00112437|81226169|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27888402|NCT01925131|81427984|FG000|Overall Study|Death|0|||
27888403|NCT01925131|81427985|FG001|Overall Study|Death|0|||
27888404|NCT01925131|81427986|FG002|Overall Study|Death|1|||
27888405|NCT01925131|81427987|FG003|Overall Study|Death|0|||
27888406|NCT01925131|81427988|FG004|Overall Study|Death|0|||
27888407|NCT01925131|81427989|FG005|Overall Study|Death|0|||
27888408|NCT01925131|81427984|FG000|Overall Study|Progression/Relapse|1|||
27888409|NCT01925131|81427985|FG001|Overall Study|Progression/Relapse|1|||
27888410|NCT01925131|81427986|FG002|Overall Study|Progression/Relapse|4|||
27888411|NCT01925131|81427987|FG003|Overall Study|Progression/Relapse|0|||
27888412|NCT01925131|81427988|FG004|Overall Study|Progression/Relapse|0|||
27888413|NCT01925131|81427989|FG005|Overall Study|Progression/Relapse|1|||
27888414|NCT01925131|81427984|FG000|Overall Study|Patient Refusal|1|||
27888415|NCT01925131|81427985|FG001|Overall Study|Patient Refusal|0|||
27888416|NCT01925131|81427986|FG002|Overall Study|Patient Refusal|0|||
27601162|NCT00430248|80378421|FG001|Overall Study|Protocol Violation|2|||
27601163|NCT00430248|80378422|FG002|Overall Study|Protocol Violation|4|||
27835456|NCT00112437|81226170|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27888417|NCT01925131|81427987|FG003|Overall Study|Patient Refusal|0|||
27888418|NCT01925131|81427988|FG004|Overall Study|Patient Refusal|0|||
27888419|NCT01925131|81427989|FG005|Overall Study|Patient Refusal|0|||
27888420|NCT01925131|81427984|FG000|Overall Study|Adverse Event|0|||
27888421|NCT01925131|81427985|FG001|Overall Study|Adverse Event|0|||
27888422|NCT01925131|81427986|FG002|Overall Study|Adverse Event|2|||
27888423|NCT01925131|81427987|FG003|Overall Study|Adverse Event|0|||
27888424|NCT01925131|81427988|FG004|Overall Study|Adverse Event|1|||
27888425|NCT01925131|81427989|FG005|Overall Study|Adverse Event|3|||
27888426|NCT01925131|81427984|FG000|Overall Study|Other - Not Protocol Specified|3|||
27888427|NCT01925131|81427985|FG001|Overall Study|Other - Not Protocol Specified|1|||
27888428|NCT01925131|81427986|FG002|Overall Study|Other - Not Protocol Specified|2|||
27707004|NCT04667377|80765259|FG004|Dose Escalation Period|Other not specified below|3|||
27707005|NCT04667377|80765255|FG000|Dose Escalation Period|Protocol Violation|2|||
27707006|NCT04667377|80765256|FG001|Dose Escalation Period|Protocol Violation|2|||
27707007|NCT04667377|80765257|FG002|Dose Escalation Period|Protocol Violation|0|||
27707008|NCT04667377|80765258|FG003|Dose Escalation Period|Protocol Violation|2|||
27707009|NCT04667377|80765259|FG004|Dose Escalation Period|Protocol Violation|1|||
27707010|NCT04667377|80765255|FG000|Dose Escalation Period|Burden of study procedures|2|||
27601164|NCT00430248|80378420|FG000|Overall Study|Personal Reasons|12|||
27601165|NCT00430248|80378421|FG001|Overall Study|Personal Reasons|24|||
27601166|NCT00430248|80378422|FG002|Overall Study|Personal Reasons|9|||
27707011|NCT04667377|80765256|FG001|Dose Escalation Period|Burden of study procedures|1|||
27707012|NCT04667377|80765257|FG002|Dose Escalation Period|Burden of study procedures|1|||
27707013|NCT04667377|80765258|FG003|Dose Escalation Period|Burden of study procedures|1|||
27601167|NCT00430248|80378420|FG000|Overall Study|Lost to Follow-up|28|||
27601168|NCT00430248|80378421|FG001|Overall Study|Lost to Follow-up|33|||
27835457|NCT00112437|81226171|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835458|NCT00112437|81226172|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835459|NCT00112437|81226173|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835460|NCT00112437|81226174|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835461|NCT00112437|81226175|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835462|NCT00112437|81226176|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835463|NCT00112437|81226177|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835464|NCT00112437|81226178|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835465|NCT00112437|81226179|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835466|NCT00112437|81226180|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
27835467|NCT00112437|81226181|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
27888429|NCT01925131|81427987|FG003|Overall Study|Other - Not Protocol Specified|5|||
27601169|NCT00430248|80378422|FG002|Overall Study|Lost to Follow-up|28|||
27601170|NCT00430248|80378420|FG000|Overall Study|Therapeutic Failure|1|||
27601171|NCT00430248|80378421|FG001|Overall Study|Therapeutic Failure|1|||
27601172|NCT00430248|80378422|FG002|Overall Study|Therapeutic Failure|1|||
27601173|NCT00430248|80378420|FG000|Overall Study|Withdrawal by Subject|14|||
27601174|NCT00430248|80378421|FG001|Overall Study|Withdrawal by Subject|20|||
27601175|NCT00430248|80378422|FG002|Overall Study|Withdrawal by Subject|16|||
27601176|NCT00430248|80378420|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27601177|NCT00430248|80378421|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
27601178|NCT00430248|80378422|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27601179|NCT00430248|80378420|FG000|Overall Study|Gout Flare|3|||
27601180|NCT00430248|80378421|FG001|Overall Study|Gout Flare|7|||
27601181|NCT00430248|80378422|FG002|Overall Study|Gout Flare|2|||
27601182|NCT00430248|80378420|FG000|Overall Study|Reason Not Specified|8|||
27601183|NCT00430248|80378421|FG001|Overall Study|Reason Not Specified|8|||
27601184|NCT00430248|80378422|FG002|Overall Study|Reason Not Specified|11|||
27601185|NCT04349280|80378423|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
27601186|NCT04349280|80378424|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
27601187|NCT04349280|80378423|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
27601188|NCT04349280|80378424|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
27601189|NCT04349280|80378423|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
27601190|NCT04349280|80378424|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
27601191|NCT02119260|80378427|FG000|Overall Study|Adverse Event|1|||
27601192|NCT02119260|80378428|FG001|Overall Study|Adverse Event|0|||
27601193|NCT02119260|80378429|FG002|Overall Study|Adverse Event|0|||
27601194|NCT02119260|80378430|FG003|Overall Study|Adverse Event|0|||
27601195|NCT02119260|80378431|FG004|Overall Study|Adverse Event|0|||
27601196|NCT02119260|80378432|FG005|Overall Study|Adverse Event|0|||
27601197|NCT02119260|80378433|FG006|Overall Study|Adverse Event|0|||
27601198|NCT02119260|80378427|FG000|Overall Study|Withdrew consent|0|||
27601199|NCT02119260|80378428|FG001|Overall Study|Withdrew consent|1|||
27601200|NCT02119260|80378429|FG002|Overall Study|Withdrew consent|1|||
27835468|NCT00112437|81226182|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
27835469|NCT00112437|81226183|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
27835470|NCT01438060|81226185|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
27835471|NCT01438060|81226186|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
27835472|NCT01438060|81226185|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
27835473|NCT01438060|81226186|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
27888430|NCT01925131|81427988|FG004|Overall Study|Other - Not Protocol Specified|10|||
27888431|NCT01925131|81427989|FG005|Overall Study|Other - Not Protocol Specified|6|||
27888432|NCT00562302|81427993|FG000|Overall Study|Lost to Follow-up|3|||
27888433|NCT00562302|81427994|FG001|Overall Study|Lost to Follow-up|3|||
27601201|NCT02119260|80378430|FG003|Overall Study|Withdrew consent|0|||
27601202|NCT02119260|80378431|FG004|Overall Study|Withdrew consent|0|||
27601203|NCT02119260|80378432|FG005|Overall Study|Withdrew consent|0|||
27601204|NCT02119260|80378433|FG006|Overall Study|Withdrew consent|0|||
27601205|NCT03508843|80378434|FG000|Overall Study|Withdrawal by Subject|1|||
27601206|NCT03508843|80378434|FG000|Overall Study|technical difficulties|2|||
27835474|NCT01438060|81226185|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
27888434|NCT00562302|81427993|FG000|Overall Study|Adverse Event|0|||
27601207|NCT01194570|80378439|FG000|Overall Study|Adverse Event|22|||
27601208|NCT01194570|80378440|FG001|Overall Study|Adverse Event|40|||
27601209|NCT01194570|80378439|FG000|Overall Study|Death|6|||
27601210|NCT01194570|80378440|FG001|Overall Study|Death|20|||
27601211|NCT01194570|80378439|FG000|Overall Study|Lack of Efficacy|32|||
27888435|NCT00562302|81427994|FG001|Overall Study|Adverse Event|6|||
27601212|NCT01194570|80378440|FG001|Overall Study|Lack of Efficacy|33|||
27601213|NCT01194570|80378439|FG000|Overall Study|Lost to Follow-up|4|||
27601214|NCT01194570|80378440|FG001|Overall Study|Lost to Follow-up|15|||
27601215|NCT01194570|80378439|FG000|Overall Study|Non-Compliance|2|||
27601216|NCT01194570|80378440|FG001|Overall Study|Non-Compliance|2|||
27601217|NCT01194570|80378439|FG000|Overall Study|Non-Compliance With Study Drug|2|||
27601218|NCT01194570|80378440|FG001|Overall Study|Non-Compliance With Study Drug|2|||
27601219|NCT01194570|80378439|FG000|Overall Study|Other|18|||
27601220|NCT01194570|80378440|FG001|Overall Study|Other|47|||
27601221|NCT01194570|80378439|FG000|Overall Study|Physician Decision|10|||
27601222|NCT01194570|80378440|FG001|Overall Study|Physician Decision|25|||
27601223|NCT01194570|80378439|FG000|Overall Study|Protocol Violation|1|||
27601224|NCT01194570|80378440|FG001|Overall Study|Protocol Violation|2|||
27601225|NCT01194570|80378439|FG000|Overall Study|Study Terminated By Sponsor|0|||
27601226|NCT01194570|80378440|FG001|Overall Study|Study Terminated By Sponsor|1|||
27601227|NCT01194570|80378439|FG000|Overall Study|Withdrawal by Subject|57|||
27601228|NCT01194570|80378440|FG001|Overall Study|Withdrawal by Subject|82|||
27601229|NCT01194570|80378439|FG000|Overall Study|Pregnancy|1|||
27601230|NCT01194570|80378440|FG001|Overall Study|Pregnancy|1|||
27601231|NCT01445652|80378457|FG000|Overall Study|Not comfortable in lenses|5|||
27601232|NCT01445652|80378458|FG001|Overall Study|Not comfortable in lenses|0|||
27601233|NCT01445652|80378457|FG000|Overall Study|Failed to attend scheduled visit|2|||
27601234|NCT01445652|80378458|FG001|Overall Study|Failed to attend scheduled visit|3|||
27601235|NCT01445652|80378457|FG000|Overall Study|Failed teach session|2|||
27601236|NCT01445652|80378458|FG001|Overall Study|Failed teach session|0|||
27601237|NCT01445652|80378457|FG000|Overall Study|Adverse Event|1|||
27601238|NCT01445652|80378458|FG001|Overall Study|Adverse Event|0|||
27601239|NCT02636270|80378460|FG000|Overall Study|Adverse Event|1|||
27601240|NCT02636270|80378461|FG001|Overall Study|Adverse Event|0|||
27601241|NCT02636270|80378462|FG002|Overall Study|Adverse Event|0|||
27601242|NCT02636270|80378460|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
27601243|NCT02636270|80378461|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
27601244|NCT02636270|80378462|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
27601245|NCT02090634|80378463|FG000|Overall Study|Lost to Follow-up|0|||
27601246|NCT02090634|80378464|FG001|Overall Study|Lost to Follow-up|1|||
27601247|NCT02090634|80378463|FG000|Overall Study|Death|0|||
27601248|NCT02090634|80378464|FG001|Overall Study|Death|1|||
27601249|NCT02090634|80378463|FG000|Overall Study|Protocol Violation|3|||
27601250|NCT02090634|80378464|FG001|Overall Study|Protocol Violation|1|||
27601251|NCT02090634|80378463|FG000|Overall Study|Adverse Event|2|||
27601252|NCT02090634|80378464|FG001|Overall Study|Adverse Event|0|||
27601253|NCT02230956|80378465|FG000|Overall Study|Adverse Event|1|||
27601254|NCT02230956|80378466|FG001|Overall Study|Adverse Event|1|||
27601255|NCT02230956|80378467|FG002|Overall Study|Adverse Event|0|||
27601256|NCT02230956|80378465|FG000|Overall Study|Lack of Efficacy|1|||
27601257|NCT02230956|80378466|FG001|Overall Study|Lack of Efficacy|1|||
27707014|NCT04667377|80765259|FG004|Dose Escalation Period|Burden of study procedures|5|||
27707015|NCT04667377|80765255|FG000|Dose Escalation Period|Change of residence|0|||
27707016|NCT04667377|80765256|FG001|Dose Escalation Period|Change of residence|0|||
27707017|NCT04667377|80765257|FG002|Dose Escalation Period|Change of residence|1|||
27707018|NCT04667377|80765258|FG003|Dose Escalation Period|Change of residence|0|||
27707019|NCT04667377|80765259|FG004|Dose Escalation Period|Change of residence|0|||
27707020|NCT04667377|80765255|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
27707021|NCT04667377|80765256|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
27707022|NCT04667377|80765257|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
27707023|NCT04667377|80765258|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
27707024|NCT04667377|80765259|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
27707025|NCT04667377|80765255|FG000|Dose Escalation Period|Adverse Event|9|||
27707026|NCT04667377|80765256|FG001|Dose Escalation Period|Adverse Event|10|||
27601258|NCT02230956|80378467|FG002|Overall Study|Lack of Efficacy|1|||
27601259|NCT02230956|80378465|FG000|Overall Study|Lost to Follow-up|1|||
27601260|NCT02230956|80378466|FG001|Overall Study|Lost to Follow-up|1|||
27601261|NCT02230956|80378467|FG002|Overall Study|Lost to Follow-up|2|||
27835475|NCT01438060|81226186|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
27601262|NCT02230956|80378465|FG000|Overall Study|Personal Reasons|2|||
27601263|NCT02230956|80378466|FG001|Overall Study|Personal Reasons|1|||
27601264|NCT02230956|80378467|FG002|Overall Study|Personal Reasons|1|||
27601265|NCT02230956|80378465|FG000|Overall Study|Protocol Violation|0|||
27601266|NCT02230956|80378466|FG001|Overall Study|Protocol Violation|1|||
27601267|NCT02230956|80378467|FG002|Overall Study|Protocol Violation|1|||
27601268|NCT02230956|80378465|FG000|Overall Study|Other Miscellaneous Reason|0|||
27601269|NCT02230956|80378466|FG001|Overall Study|Other Miscellaneous Reason|1|||
27601270|NCT02230956|80378467|FG002|Overall Study|Other Miscellaneous Reason|2|||
27601271|NCT01733732|80378473|FG000|Overall Study|Adverse Event|1|||
27707027|NCT04667377|80765257|FG002|Dose Escalation Period|Adverse Event|12|||
27707028|NCT04667377|80765258|FG003|Dose Escalation Period|Adverse Event|17|||
27601272|NCT01733732|80378474|FG001|Overall Study|Adverse Event|0|||
27601273|NCT01733732|80378473|FG000|Overall Study|Did not attend all study visits|1|||
27601274|NCT01733732|80378474|FG001|Overall Study|Did not attend all study visits|0|||
27601275|NCT02740049|80381489|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
27601276|NCT01984684|80381490|FG000|Overall Study|Lost to Follow-up|25|||
27601277|NCT01984684|80381491|FG001|Overall Study|Lost to Follow-up|24|||
27601278|NCT01984684|80381490|FG000|Overall Study|Adverse Event|8|||
27601279|NCT01984684|80381491|FG001|Overall Study|Adverse Event|12|||
27601280|NCT01984684|80381490|FG000|Overall Study|Withdrawal by Subject|9|||
27601281|NCT01984684|80381491|FG001|Overall Study|Withdrawal by Subject|9|||
27601282|NCT01984684|80381490|FG000|Overall Study|Lack of Efficacy|3|||
27601283|NCT01984684|80381491|FG001|Overall Study|Lack of Efficacy|6|||
27601284|NCT01984684|80381490|FG000|Overall Study|Physician Decision|4|||
27601285|NCT01984684|80381491|FG001|Overall Study|Physician Decision|2|||
27601286|NCT01984684|80381490|FG000|Overall Study|Protocol Violation|4|||
27601287|NCT01984684|80381491|FG001|Overall Study|Protocol Violation|2|||
27601288|NCT01984684|80381490|FG000|Overall Study|Death|0|||
27601289|NCT01984684|80381491|FG001|Overall Study|Death|1|||
27601290|NCT01984684|80381490|FG000|Overall Study|Noncompliance with study drug|2|||
27601291|NCT01984684|80381491|FG001|Overall Study|Noncompliance with study drug|1|||
27601292|NCT01984684|80381490|FG000|Overall Study|Subject incarcerated|1|||
27601293|NCT01984684|80381491|FG001|Overall Study|Subject incarcerated|0|||
27601294|NCT01984684|80381490|FG000|Overall Study|Study drug not available at site|1|||
27601295|NCT01984684|80381491|FG001|Overall Study|Study drug not available at site|1|||
27601296|NCT01984684|80381490|FG000|Overall Study|Subject had inadequate IV access|0|||
27601297|NCT01984684|80381491|FG001|Overall Study|Subject had inadequate IV access|1|||
27601298|NCT03764072|80381494|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27601299|NCT03764072|80381495|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27601300|NCT03764072|80381496|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
27601301|NCT03764072|80381497|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27601302|NCT03764072|80381498|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27601303|NCT03764072|80381499|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
27601304|NCT03764072|80381494|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
27601305|NCT03764072|80381495|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
27601306|NCT03764072|80381496|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
27601307|NCT03764072|80381497|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
27601308|NCT03764072|80381498|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
27601309|NCT03764072|80381499|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
27601310|NCT03764072|80381494|FG000|Overall Study|Lost to Follow-up|0|||
27601311|NCT03764072|80381495|FG001|Overall Study|Lost to Follow-up|0|||
27601312|NCT03764072|80381496|FG002|Overall Study|Lost to Follow-up|0|||
27601313|NCT03764072|80381497|FG003|Overall Study|Lost to Follow-up|0|||
27601314|NCT03764072|80381498|FG004|Overall Study|Lost to Follow-up|1|||
27601315|NCT03764072|80381499|FG005|Overall Study|Lost to Follow-up|0|||
27601316|NCT02192970|80381505|FG000|Overall Study|Lost to Follow-up|6|||
27601317|NCT02192970|80381506|FG001|Overall Study|Lost to Follow-up|0|||
27601318|NCT05168579|80381509|FG000|Overall Study|Lack of Consent|1|||
27601319|NCT05168579|80381510|FG001|Overall Study|Lack of Consent|0|||
27601320|NCT05168579|80381509|FG000|Overall Study|Conflicts with time|2|||
27601321|NCT05168579|80381510|FG001|Overall Study|Conflicts with time|0|||
27601322|NCT05168579|80381509|FG000|Overall Study|Time slots were full|3|||
27601323|NCT05168579|80381510|FG001|Overall Study|Time slots were full|0|||
27601324|NCT05168579|80381509|FG000|Overall Study|Lost to Follow-up|0|||
27601325|NCT05168579|80381510|FG001|Overall Study|Lost to Follow-up|15|||
27601326|NCT02953938|80381513|FG000|Overall Study|Adverse Event|0|||
27601327|NCT02953938|80381514|FG001|Overall Study|Adverse Event|1|||
27707029|NCT04667377|80765259|FG004|Dose Escalation Period|Adverse Event|3|||
27707030|NCT04667377|80765255|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
27707031|NCT04667377|80765256|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
27601328|NCT02953938|80381513|FG000|Overall Study|Withdrawal by Subject|1|||
27601329|NCT02953938|80381514|FG001|Overall Study|Withdrawal by Subject|1|||
27601330|NCT04918784|80381519|FG000|Overall Study|Amputation - no longer eligible|1|||
27707032|NCT04667377|80765257|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
27707033|NCT04667377|80765258|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
27707034|NCT04667377|80765259|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
27601331|NCT04918784|80381520|FG001|Overall Study|Amputation - no longer eligible|2|||
27601332|NCT04918784|80381519|FG000|Overall Study|Death|1|||
27601333|NCT04918784|80381520|FG001|Overall Study|Death|0|||
27601334|NCT04918784|80381519|FG000|Overall Study|patient non-compliance|3|||
27601335|NCT04918784|80381520|FG001|Overall Study|patient non-compliance|1|||
27601336|NCT04918784|80381519|FG000|Overall Study|Adverse Event|1|||
27601337|NCT04918784|80381520|FG001|Overall Study|Adverse Event|0|||
27601338|NCT03286751|80381521|FG000|Washout Period 1|Withdrawal by Subject|0|||
27601339|NCT03286751|80381522|FG001|Washout Period 1|Withdrawal by Subject|0|||
27601340|NCT03286751|80381523|FG002|Washout Period 1|Withdrawal by Subject|0|||
27601341|NCT03286751|80381524|FG003|Washout Period 1|Withdrawal by Subject|0|||
27601342|NCT03286751|80381525|FG004|Washout Period 1|Withdrawal by Subject|1|||
27601343|NCT03286751|80381526|FG005|Washout Period 1|Withdrawal by Subject|0|||
27601344|NCT03286751|80381521|FG000|Washout Period 2|Personal Reasons|0|||
27601345|NCT03286751|80381522|FG001|Washout Period 2|Personal Reasons|1|||
27601346|NCT03286751|80381523|FG002|Washout Period 2|Personal Reasons|0|||
27601347|NCT03286751|80381524|FG003|Washout Period 2|Personal Reasons|0|||
27601348|NCT03286751|80381525|FG004|Washout Period 2|Personal Reasons|0|||
27601349|NCT03286751|80381526|FG005|Washout Period 2|Personal Reasons|0|||
27601350|NCT03286751|80381521|FG000|Washout Period 5|Adverse Event|0|||
27601351|NCT03286751|80381522|FG001|Washout Period 5|Adverse Event|0|||
27601352|NCT03286751|80381523|FG002|Washout Period 5|Adverse Event|0|||
27601353|NCT03286751|80381524|FG003|Washout Period 5|Adverse Event|0|||
27601354|NCT03286751|80381525|FG004|Washout Period 5|Adverse Event|1|||
27601355|NCT03286751|80381526|FG005|Washout Period 5|Adverse Event|0|||
27601356|NCT00409682|80381527|FG000|Open-label Induction Period|Adverse Event|1|||
27601357|NCT00409682|80381528|FG001|Open-label Induction Period|Adverse Event|0|||
27601358|NCT00409682|80381529|FG002|Open-label Induction Period|Adverse Event|0|||
27601359|NCT00409682|80381527|FG000|Open-label Induction Period|Lack of Efficacy|1|||
27601360|NCT00409682|80381528|FG001|Open-label Induction Period|Lack of Efficacy|0|||
27601361|NCT00409682|80381529|FG002|Open-label Induction Period|Lack of Efficacy|0|||
27601362|NCT00409682|80381527|FG000|Open-label Induction Period|Protocol Violation|1|||
27601363|NCT00409682|80381528|FG001|Open-label Induction Period|Protocol Violation|0|||
27601364|NCT00409682|80381529|FG002|Open-label Induction Period|Protocol Violation|0|||
27601365|NCT00409682|80381527|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
27601366|NCT00409682|80381528|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
27601367|NCT00409682|80381529|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
27601368|NCT00409682|80381527|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
27601369|NCT00409682|80381528|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
27601370|NCT00409682|80381529|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
27601371|NCT00409682|80381527|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
27601372|NCT00409682|80381528|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
27601373|NCT00409682|80381529|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
27601374|NCT00409682|80381527|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
27601375|NCT00409682|80381528|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
27601376|NCT00409682|80381529|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
27601377|NCT00409682|80381527|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
27601378|NCT00409682|80381528|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
27601379|NCT00409682|80381529|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
27601380|NCT00409682|80381527|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
27601381|NCT00409682|80381528|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
27601382|NCT00409682|80381529|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
27601383|NCT00409682|80381527|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
27601384|NCT00409682|80381528|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
27601385|NCT00409682|80381529|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
27601386|NCT02979639|80381530|FG000|Overall Study|Withdrawal based on medical judgement|1|||
27601387|NCT02979639|80381530|FG000|Overall Study|Lost to Follow-up|8|||
27601388|NCT02979639|80381530|FG000|Overall Study|Withdrawal by Subject|3|||
27601389|NCT02979639|80381530|FG000|Overall Study|Adverse Event|2|||
27601390|NCT00490282|80381532|FG000|Overall Study|Withdrawal by Subject|3|||
27601391|NCT02001194|80381534|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
27601392|NCT02001194|80381535|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
27601393|NCT02001194|80381536|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
27601394|NCT02001194|80381537|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
27601395|NCT02001194|80381534|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
27707035|NCT04667377|80765255|FG000|Dose Escalation Period|Not treated|1|||
27835476|NCT01438060|81226185|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
27707036|NCT04667377|80765256|FG001|Dose Escalation Period|Not treated|0|||
27707037|NCT04667377|80765257|FG002|Dose Escalation Period|Not treated|0|||
27707038|NCT04667377|80765258|FG003|Dose Escalation Period|Not treated|0|||
27707039|NCT04667377|80765259|FG004|Dose Escalation Period|Not treated|0|||
27707040|NCT04667377|80765255|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
27707041|NCT04667377|80765256|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
27707042|NCT04667377|80765257|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
27707043|NCT04667377|80765258|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
27707044|NCT04667377|80765259|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
27707045|NCT04667377|80765255|FG000|Dose Escalation Period|Lost to Follow-up|0|||
27707046|NCT04667377|80765256|FG001|Dose Escalation Period|Lost to Follow-up|1|||
27707047|NCT04667377|80765257|FG002|Dose Escalation Period|Lost to Follow-up|0|||
27707048|NCT04667377|80765258|FG003|Dose Escalation Period|Lost to Follow-up|0|||
27707049|NCT04667377|80765259|FG004|Dose Escalation Period|Lost to Follow-up|0|||
27707050|NCT04667377|80765255|FG000|Maintenance Period|Perceived lack of efficacy|0|||
27707051|NCT04667377|80765256|FG001|Maintenance Period|Perceived lack of efficacy|2|||
27707052|NCT04667377|80765257|FG002|Maintenance Period|Perceived lack of efficacy|1|||
27707053|NCT04667377|80765258|FG003|Maintenance Period|Perceived lack of efficacy|0|||
27707054|NCT04667377|80765259|FG004|Maintenance Period|Perceived lack of efficacy|1|||
27707055|NCT04667377|80765255|FG000|Maintenance Period|Adverse Event|2|||
27707056|NCT04667377|80765256|FG001|Maintenance Period|Adverse Event|8|||
27707057|NCT04667377|80765257|FG002|Maintenance Period|Adverse Event|5|||
27707058|NCT04667377|80765258|FG003|Maintenance Period|Adverse Event|4|||
27707059|NCT04667377|80765259|FG004|Maintenance Period|Adverse Event|1|||
27707060|NCT04667377|80765255|FG000|Maintenance Period|Adverse event: COVID infection|0|||
27707061|NCT04667377|80765256|FG001|Maintenance Period|Adverse event: COVID infection|1|||
27707062|NCT04667377|80765257|FG002|Maintenance Period|Adverse event: COVID infection|0|||
27707063|NCT04667377|80765258|FG003|Maintenance Period|Adverse event: COVID infection|0|||
27707064|NCT04667377|80765259|FG004|Maintenance Period|Adverse event: COVID infection|0|||
27707065|NCT04667377|80765255|FG000|Maintenance Period|COVID-related|0|||
27707066|NCT04667377|80765256|FG001|Maintenance Period|COVID-related|0|||
27707067|NCT04667377|80765257|FG002|Maintenance Period|COVID-related|1|||
27707068|NCT04667377|80765258|FG003|Maintenance Period|COVID-related|1|||
27707069|NCT04667377|80765259|FG004|Maintenance Period|COVID-related|0|||
27707070|NCT04667377|80765255|FG000|Maintenance Period|Protocol Violation|1|||
27707071|NCT04667377|80765256|FG001|Maintenance Period|Protocol Violation|0|||
27707072|NCT04667377|80765257|FG002|Maintenance Period|Protocol Violation|0|||
27707073|NCT04667377|80765258|FG003|Maintenance Period|Protocol Violation|0|||
27707074|NCT04667377|80765259|FG004|Maintenance Period|Protocol Violation|1|||
27707075|NCT04667377|80765255|FG000|Maintenance Period|Burden of study procedures|1|||
27707076|NCT04667377|80765256|FG001|Maintenance Period|Burden of study procedures|2|||
27707077|NCT04667377|80765257|FG002|Maintenance Period|Burden of study procedures|0|||
27707078|NCT04667377|80765258|FG003|Maintenance Period|Burden of study procedures|1|||
27707079|NCT04667377|80765259|FG004|Maintenance Period|Burden of study procedures|0|||
27707080|NCT04667377|80765255|FG000|Maintenance Period|Change of residence|0|||
27707081|NCT04667377|80765256|FG001|Maintenance Period|Change of residence|1|||
27707082|NCT04667377|80765257|FG002|Maintenance Period|Change of residence|0|||
27707083|NCT04667377|80765258|FG003|Maintenance Period|Change of residence|0|||
27707084|NCT04667377|80765259|FG004|Maintenance Period|Change of residence|1|||
27707085|NCT04667377|80765255|FG000|Maintenance Period|Missing|1|||
27707086|NCT04667377|80765256|FG001|Maintenance Period|Missing|0|||
27707087|NCT04667377|80765257|FG002|Maintenance Period|Missing|0|||
27707088|NCT04667377|80765258|FG003|Maintenance Period|Missing|0|||
27707089|NCT04667377|80765259|FG004|Maintenance Period|Missing|0|||
27707090|NCT04667377|80765255|FG000|Maintenance Period|Other than listed above|2|||
27707091|NCT04667377|80765256|FG001|Maintenance Period|Other than listed above|0|||
27707092|NCT04667377|80765257|FG002|Maintenance Period|Other than listed above|3|||
27707093|NCT04667377|80765258|FG003|Maintenance Period|Other than listed above|2|||
27707094|NCT04667377|80765259|FG004|Maintenance Period|Other than listed above|6|||
27707095|NCT04667377|80765255|FG000|Maintenance Period|Withdrawal by Subject|0|||
27707096|NCT04667377|80765256|FG001|Maintenance Period|Withdrawal by Subject|1|||
27707097|NCT04667377|80765257|FG002|Maintenance Period|Withdrawal by Subject|0|||
27707098|NCT04667377|80765258|FG003|Maintenance Period|Withdrawal by Subject|0|||
27707099|NCT04667377|80765259|FG004|Maintenance Period|Withdrawal by Subject|0|||
27707100|NCT04667377|80765255|FG000|Maintenance Period|Lost to Follow-up|1|||
27707101|NCT04667377|80765256|FG001|Maintenance Period|Lost to Follow-up|0|||
27707102|NCT04667377|80765257|FG002|Maintenance Period|Lost to Follow-up|1|||
27707103|NCT04667377|80765258|FG003|Maintenance Period|Lost to Follow-up|0|||
27707104|NCT04667377|80765259|FG004|Maintenance Period|Lost to Follow-up|1|||
27707105|NCT01131520|80765260|FG000|Overall Study|Computer problem|1|||
27707106|NCT01131520|80765261|FG001|Overall Study|Computer problem|0|||
27707107|NCT01131520|80765260|FG000|Overall Study|Counselor not available|0|||
27707108|NCT01131520|80765261|FG001|Overall Study|Counselor not available|3|||
27707109|NCT01131520|80765260|FG000|Overall Study|Subject changed history after enrollment|0|||
27707110|NCT01131520|80765261|FG001|Overall Study|Subject changed history after enrollment|1|||
27707111|NCT04353284|80765267|FG000|Overall Study|Adverse Event|1|||
27707112|NCT04353284|80765268|FG001|Overall Study|Adverse Event|1|||
27707113|NCT04353284|80765267|FG000|Overall Study|Lost to Follow-up|1|||
27707114|NCT04353284|80765268|FG001|Overall Study|Lost to Follow-up|0|||
27707115|NCT02428855|80765278|FG000|Overall Study|Withdrawal by Subject|2|||
27707116|NCT04857996|80765281|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
27707117|NCT04857996|80765282|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
27707118|NCT04857996|80765281|FG000|Overall Study|Lost to Follow-up|1|||
27707119|NCT04857996|80765282|FG001|Overall Study|Lost to Follow-up|3|||
27707120|NCT04857996|80765281|FG000|Overall Study|Site Closure|1|||
27707121|NCT04857996|80765282|FG001|Overall Study|Site Closure|0|||
27707122|NCT04857996|80765281|FG000|Overall Study|Withdrawal by Subject|1|||
27707123|NCT04857996|80765282|FG001|Overall Study|Withdrawal by Subject|0|||
27707124|NCT04534491|80765283|FG000|Overall Study|Not completed end-of-study interview|24|||
27707125|NCT04534491|80765283|FG000|Overall Study|Non-users|70|||
27707126|NCT04534491|80765283|FG000|Overall Study|Non-verifiable users|58|||
27707127|NCT01429584|80765284|FG000|Overall Study|Withdrawal by Subject|1|||
27707128|NCT01429584|80765285|FG001|Overall Study|Withdrawal by Subject|0|||
27707129|NCT01429584|80765284|FG000|Overall Study|Protocol Violation|0|||
27707130|NCT01429584|80765285|FG001|Overall Study|Protocol Violation|1|||
27707131|NCT00750698|80765287|FG000|Overall Study|Withdrawal by Subject|1|||
27707132|NCT00750698|80765288|FG001|Overall Study|Withdrawal by Subject|0|||
27707133|NCT00750698|80765287|FG000|Overall Study|Progressive disease|5|||
27707134|NCT00750698|80765288|FG001|Overall Study|Progressive disease|2|||
27707135|NCT00754793|80765289|FG000|Overall Study|voluntary withdrawn from study|0|||
27707136|NCT00754793|80765290|FG001|Overall Study|voluntary withdrawn from study|1|||
27707137|NCT01543828|80765291|FG000|Treatment 2|Lost to Follow-up|1|||
27707138|NCT01543828|80765292|FG001|Treatment 2|Lost to Follow-up|0|||
27707139|NCT01816061|80765293|FG000|Overall Study|Lost to Follow-up|13|||
27707140|NCT01816061|80765294|FG001|Overall Study|Lost to Follow-up|24|||
27707141|NCT03000179|80765295|FG000|Overall Study|Lost to Follow-up|2|||
27707142|NCT02535715|80765298|FG000|Overall Study|Withdrawal by Subject|0|||
27707143|NCT02535715|80765299|FG001|Overall Study|Withdrawal by Subject|0|||
27707144|NCT02535715|80765300|FG002|Overall Study|Withdrawal by Subject|1|||
27707145|NCT05418673|80765302|FG000|Overall Study|Study Terminated by Sponsor|2|||
27707146|NCT05418673|80765303|FG001|Overall Study|Study Terminated by Sponsor|4|||
27707147|NCT05418673|80765302|FG000|Overall Study|Lost to Follow-up|1|||
27707148|NCT05418673|80765303|FG001|Overall Study|Lost to Follow-up|0|||
27707149|NCT01994382|80765307|FG000|Overall Study|Informed consent withdrawn|0|||
27707150|NCT01994382|80765308|FG001|Overall Study|Informed consent withdrawn|0|||
27707151|NCT01994382|80765309|FG002|Overall Study|Informed consent withdrawn|0|||
27707152|NCT01994382|80765310|FG003|Overall Study|Informed consent withdrawn|0|||
27707153|NCT01994382|80765311|FG004|Overall Study|Informed consent withdrawn|0|||
27707154|NCT01994382|80765312|FG005|Overall Study|Informed consent withdrawn|0|||
27707155|NCT01994382|80765313|FG006|Overall Study|Informed consent withdrawn|1|||
27707156|NCT01994382|80765314|FG007|Overall Study|Informed consent withdrawn|0|||
27707157|NCT01994382|80765315|FG008|Overall Study|Informed consent withdrawn|0|||
27707158|NCT01994382|80765316|FG009|Overall Study|Informed consent withdrawn|0|||
27707159|NCT01994382|80765317|FG010|Overall Study|Informed consent withdrawn|0|||
27707160|NCT01994382|80765318|FG011|Overall Study|Informed consent withdrawn|0|||
27707161|NCT01994382|80765319|FG012|Overall Study|Informed consent withdrawn|0|||
27707162|NCT01994382|80765320|FG013|Overall Study|Informed consent withdrawn|0|||
27707163|NCT01994382|80765321|FG014|Overall Study|Informed consent withdrawn|0|||
27707164|NCT01994382|80765322|FG015|Overall Study|Informed consent withdrawn|0|||
27707165|NCT01994382|80765323|FG016|Overall Study|Informed consent withdrawn|0|||
27707166|NCT01994382|80765307|FG000|Overall Study|Progressive disease|3|||
27707167|NCT01994382|80765308|FG001|Overall Study|Progressive disease|4|||
27707168|NCT01994382|80765309|FG002|Overall Study|Progressive disease|4|||
27707169|NCT01994382|80765310|FG003|Overall Study|Progressive disease|3|||
27707170|NCT01994382|80765311|FG004|Overall Study|Progressive disease|2|||
27707171|NCT01994382|80765312|FG005|Overall Study|Progressive disease|3|||
27707172|NCT01994382|80765313|FG006|Overall Study|Progressive disease|3|||
27707173|NCT01994382|80765314|FG007|Overall Study|Progressive disease|6|||
27707174|NCT01994382|80765315|FG008|Overall Study|Progressive disease|2|||
27707175|NCT01994382|80765316|FG009|Overall Study|Progressive disease|2|||
27707176|NCT01994382|80765317|FG010|Overall Study|Progressive disease|13|||
27707177|NCT01994382|80765318|FG011|Overall Study|Progressive disease|8|||
27707178|NCT01994382|80765319|FG012|Overall Study|Progressive disease|7|||
27707179|NCT01994382|80765320|FG013|Overall Study|Progressive disease|3|||
27707180|NCT01994382|80765321|FG014|Overall Study|Progressive disease|6|||
27707181|NCT01994382|80765322|FG015|Overall Study|Progressive disease|44|||
27707182|NCT01994382|80765323|FG016|Overall Study|Progressive disease|28|||
27707183|NCT01994382|80765307|FG000|Overall Study|Physician Decision|0|||
27707184|NCT01994382|80765308|FG001|Overall Study|Physician Decision|1|||
27707185|NCT01994382|80765309|FG002|Overall Study|Physician Decision|0|||
27707186|NCT01994382|80765310|FG003|Overall Study|Physician Decision|0|||
27707187|NCT01994382|80765311|FG004|Overall Study|Physician Decision|0|||
27707188|NCT01994382|80765312|FG005|Overall Study|Physician Decision|0|||
27707189|NCT01994382|80765313|FG006|Overall Study|Physician Decision|0|||
27707190|NCT01994382|80765314|FG007|Overall Study|Physician Decision|0|||
27707191|NCT01994382|80765315|FG008|Overall Study|Physician Decision|0|||
27707192|NCT01994382|80765316|FG009|Overall Study|Physician Decision|0|||
27707193|NCT01994382|80765317|FG010|Overall Study|Physician Decision|3|||
27707194|NCT01994382|80765318|FG011|Overall Study|Physician Decision|1|||
27707195|NCT01994382|80765319|FG012|Overall Study|Physician Decision|1|||
27707196|NCT01994382|80765320|FG013|Overall Study|Physician Decision|0|||
27707197|NCT01994382|80765321|FG014|Overall Study|Physician Decision|1|||
27707198|NCT01994382|80765322|FG015|Overall Study|Physician Decision|4|||
27707199|NCT01994382|80765323|FG016|Overall Study|Physician Decision|2|||
27707200|NCT01994382|80765307|FG000|Overall Study|Death|0|||
27707201|NCT01994382|80765308|FG001|Overall Study|Death|0|||
27707202|NCT01994382|80765309|FG002|Overall Study|Death|0|||
27707203|NCT01994382|80765310|FG003|Overall Study|Death|0|||
27707204|NCT01994382|80765311|FG004|Overall Study|Death|1|||
27707205|NCT01994382|80765312|FG005|Overall Study|Death|0|||
27707206|NCT01994382|80765313|FG006|Overall Study|Death|0|||
27707207|NCT01994382|80765314|FG007|Overall Study|Death|0|||
27707208|NCT01994382|80765315|FG008|Overall Study|Death|1|||
27707209|NCT01994382|80765316|FG009|Overall Study|Death|1|||
27707210|NCT01994382|80765317|FG010|Overall Study|Death|0|||
27707211|NCT01994382|80765318|FG011|Overall Study|Death|0|||
27707212|NCT01994382|80765319|FG012|Overall Study|Death|0|||
27707213|NCT01994382|80765320|FG013|Overall Study|Death|0|||
27707214|NCT01994382|80765321|FG014|Overall Study|Death|0|||
27707215|NCT01994382|80765322|FG015|Overall Study|Death|1|||
27707216|NCT01994382|80765323|FG016|Overall Study|Death|0|||
27707217|NCT01994382|80765307|FG000|Overall Study|Adverse Event|0|||
27707218|NCT01994382|80765308|FG001|Overall Study|Adverse Event|1|||
27707219|NCT01994382|80765309|FG002|Overall Study|Adverse Event|2|||
27707220|NCT01994382|80765310|FG003|Overall Study|Adverse Event|0|||
27707221|NCT01994382|80765311|FG004|Overall Study|Adverse Event|0|||
27707222|NCT01994382|80765312|FG005|Overall Study|Adverse Event|0|||
27707223|NCT01994382|80765313|FG006|Overall Study|Adverse Event|0|||
27707224|NCT01994382|80765314|FG007|Overall Study|Adverse Event|0|||
27707225|NCT01994382|80765315|FG008|Overall Study|Adverse Event|0|||
27707226|NCT01994382|80765316|FG009|Overall Study|Adverse Event|0|||
27707227|NCT01994382|80765317|FG010|Overall Study|Adverse Event|15|||
27707228|NCT01994382|80765318|FG011|Overall Study|Adverse Event|2|||
27707229|NCT01994382|80765319|FG012|Overall Study|Adverse Event|7|||
27707230|NCT01994382|80765320|FG013|Overall Study|Adverse Event|3|||
27707231|NCT01994382|80765321|FG014|Overall Study|Adverse Event|17|||
27707232|NCT01994382|80765322|FG015|Overall Study|Adverse Event|6|||
27707233|NCT01994382|80765323|FG016|Overall Study|Adverse Event|3|||
27707234|NCT01994382|80765307|FG000|Overall Study|Other than specified|0|||
27707235|NCT01994382|80765308|FG001|Overall Study|Other than specified|0|||
27707236|NCT01994382|80765309|FG002|Overall Study|Other than specified|0|||
27707237|NCT01994382|80765310|FG003|Overall Study|Other than specified|0|||
27707238|NCT01994382|80765311|FG004|Overall Study|Other than specified|0|||
27707239|NCT01994382|80765312|FG005|Overall Study|Other than specified|0|||
27707240|NCT01994382|80765313|FG006|Overall Study|Other than specified|0|||
27707241|NCT01994382|80765314|FG007|Overall Study|Other than specified|0|||
27707242|NCT01994382|80765315|FG008|Overall Study|Other than specified|0|||
27707243|NCT01994382|80765316|FG009|Overall Study|Other than specified|0|||
27707244|NCT01994382|80765317|FG010|Overall Study|Other than specified|2|||
27707245|NCT01994382|80765318|FG011|Overall Study|Other than specified|0|||
27707246|NCT01994382|80765319|FG012|Overall Study|Other than specified|2|||
27707247|NCT01994382|80765320|FG013|Overall Study|Other than specified|0|||
27707248|NCT01994382|80765321|FG014|Overall Study|Other than specified|0|||
27707249|NCT01994382|80765322|FG015|Overall Study|Other than specified|4|||
27707250|NCT01994382|80765323|FG016|Overall Study|Other than specified|4|||
27707251|NCT01994382|80765307|FG000|Overall Study|Withdrawal by Subject|0|||
27707252|NCT01994382|80765308|FG001|Overall Study|Withdrawal by Subject|0|||
27707253|NCT01994382|80765309|FG002|Overall Study|Withdrawal by Subject|0|||
27707254|NCT01994382|80765310|FG003|Overall Study|Withdrawal by Subject|0|||
27707255|NCT01994382|80765311|FG004|Overall Study|Withdrawal by Subject|0|||
27707256|NCT01994382|80765312|FG005|Overall Study|Withdrawal by Subject|0|||
27707257|NCT01994382|80765313|FG006|Overall Study|Withdrawal by Subject|0|||
27707258|NCT01994382|80765314|FG007|Overall Study|Withdrawal by Subject|0|||
27707259|NCT01994382|80765315|FG008|Overall Study|Withdrawal by Subject|0|||
27707260|NCT01994382|80765316|FG009|Overall Study|Withdrawal by Subject|0|||
27707261|NCT01994382|80765317|FG010|Overall Study|Withdrawal by Subject|6|||
27707262|NCT01994382|80765318|FG011|Overall Study|Withdrawal by Subject|0|||
27707263|NCT01994382|80765319|FG012|Overall Study|Withdrawal by Subject|2|||
27707264|NCT01994382|80765320|FG013|Overall Study|Withdrawal by Subject|0|||
27707265|NCT01994382|80765321|FG014|Overall Study|Withdrawal by Subject|4|||
27707266|NCT01994382|80765322|FG015|Overall Study|Withdrawal by Subject|3|||
27707267|NCT01994382|80765323|FG016|Overall Study|Withdrawal by Subject|0|||
27707268|NCT01994382|80765307|FG000|Overall Study|Lost to Follow-up|0|||
27707269|NCT01994382|80765308|FG001|Overall Study|Lost to Follow-up|0|||
27707270|NCT01994382|80765309|FG002|Overall Study|Lost to Follow-up|0|||
27707271|NCT01994382|80765310|FG003|Overall Study|Lost to Follow-up|0|||
27707272|NCT01994382|80765311|FG004|Overall Study|Lost to Follow-up|0|||
27707273|NCT01994382|80765312|FG005|Overall Study|Lost to Follow-up|0|||
27707274|NCT01994382|80765313|FG006|Overall Study|Lost to Follow-up|0|||
27707275|NCT01994382|80765314|FG007|Overall Study|Lost to Follow-up|0|||
27707276|NCT01994382|80765315|FG008|Overall Study|Lost to Follow-up|0|||
27707277|NCT01994382|80765316|FG009|Overall Study|Lost to Follow-up|0|||
27707278|NCT01994382|80765317|FG010|Overall Study|Lost to Follow-up|1|||
27707279|NCT01994382|80765318|FG011|Overall Study|Lost to Follow-up|0|||
27707280|NCT01994382|80765319|FG012|Overall Study|Lost to Follow-up|0|||
27707281|NCT01994382|80765320|FG013|Overall Study|Lost to Follow-up|0|||
27707282|NCT01994382|80765321|FG014|Overall Study|Lost to Follow-up|0|||
27707283|NCT01994382|80765322|FG015|Overall Study|Lost to Follow-up|0|||
27707284|NCT01994382|80765323|FG016|Overall Study|Lost to Follow-up|0|||
27707285|NCT01994382|80765307|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707286|NCT01994382|80765308|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707287|NCT01994382|80765309|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707288|NCT01994382|80765310|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707289|NCT01994382|80765311|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707290|NCT01994382|80765312|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707291|NCT01994382|80765313|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707292|NCT01994382|80765314|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707293|NCT01994382|80765315|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707294|NCT01994382|80765316|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707295|NCT01994382|80765317|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
27707296|NCT01994382|80765318|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707297|NCT01994382|80765319|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
27707298|NCT01994382|80765320|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707299|NCT01994382|80765321|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
27707300|NCT01994382|80765322|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
27707301|NCT01994382|80765323|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
27707302|NCT01994382|80765307|FG000|Overall Study|Protocol violation/noncompliance|0|||
27707303|NCT01994382|80765308|FG001|Overall Study|Protocol violation/noncompliance|0|||
27707304|NCT01994382|80765309|FG002|Overall Study|Protocol violation/noncompliance|0|||
27707305|NCT01994382|80765310|FG003|Overall Study|Protocol violation/noncompliance|0|||
27707306|NCT01994382|80765311|FG004|Overall Study|Protocol violation/noncompliance|0|||
27707307|NCT01994382|80765312|FG005|Overall Study|Protocol violation/noncompliance|0|||
27707308|NCT01994382|80765313|FG006|Overall Study|Protocol violation/noncompliance|0|||
27707309|NCT01994382|80765314|FG007|Overall Study|Protocol violation/noncompliance|0|||
27707310|NCT01994382|80765315|FG008|Overall Study|Protocol violation/noncompliance|0|||
27707311|NCT01994382|80765316|FG009|Overall Study|Protocol violation/noncompliance|0|||
27707312|NCT01994382|80765317|FG010|Overall Study|Protocol violation/noncompliance|0|||
27707313|NCT01994382|80765318|FG011|Overall Study|Protocol violation/noncompliance|1|||
27707314|NCT01994382|80765319|FG012|Overall Study|Protocol violation/noncompliance|0|||
27707315|NCT01994382|80765320|FG013|Overall Study|Protocol violation/noncompliance|0|||
27707316|NCT01994382|80765321|FG014|Overall Study|Protocol violation/noncompliance|0|||
27707317|NCT01994382|80765322|FG015|Overall Study|Protocol violation/noncompliance|0|||
27707318|NCT01994382|80765323|FG016|Overall Study|Protocol violation/noncompliance|2|||
27707319|NCT01994382|80765307|FG000|Overall Study|Rolled over to Phase 2a|0|||
27707320|NCT01994382|80765308|FG001|Overall Study|Rolled over to Phase 2a|0|||
27707321|NCT01994382|80765309|FG002|Overall Study|Rolled over to Phase 2a|1|||
27707322|NCT01994382|80765310|FG003|Overall Study|Rolled over to Phase 2a|0|||
27707323|NCT01994382|80765311|FG004|Overall Study|Rolled over to Phase 2a|0|||
27707324|NCT01994382|80765312|FG005|Overall Study|Rolled over to Phase 2a|0|||
27707325|NCT01994382|80765313|FG006|Overall Study|Rolled over to Phase 2a|0|||
27707326|NCT01994382|80765314|FG007|Overall Study|Rolled over to Phase 2a|0|||
27707327|NCT01994382|80765315|FG008|Overall Study|Rolled over to Phase 2a|0|||
27707328|NCT01994382|80765316|FG009|Overall Study|Rolled over to Phase 2a|2|||
27707329|NCT01994382|80765317|FG010|Overall Study|Rolled over to Phase 2a|0|||
27707330|NCT01994382|80765318|FG011|Overall Study|Rolled over to Phase 2a|0|||
27707331|NCT01994382|80765319|FG012|Overall Study|Rolled over to Phase 2a|0|||
27707332|NCT01994382|80765320|FG013|Overall Study|Rolled over to Phase 2a|0|||
27707333|NCT01994382|80765321|FG014|Overall Study|Rolled over to Phase 2a|0|||
27707334|NCT01994382|80765322|FG015|Overall Study|Rolled over to Phase 2a|0|||
27707335|NCT01994382|80765323|FG016|Overall Study|Rolled over to Phase 2a|0|||
27707336|NCT02592551|80765329|FG000|Overall Study|Not evaluable|1|||
27707337|NCT02592551|80765330|FG001|Overall Study|Not evaluable|3|||
27707338|NCT02592551|80765331|FG002|Overall Study|Not evaluable|0|||
27707339|NCT00382720|80765336|FG000|Overall Study|Adverse Event|21|||
27707340|NCT00382720|80765337|FG001|Overall Study|Adverse Event|23|||
27707341|NCT00382720|80765338|FG002|Overall Study|Adverse Event|15|||
27707342|NCT00382720|80765336|FG000|Overall Study|Protocol Violation|2|||
27707343|NCT00382720|80765337|FG001|Overall Study|Protocol Violation|5|||
27707344|NCT00382720|80765338|FG002|Overall Study|Protocol Violation|1|||
27707345|NCT00382720|80765336|FG000|Overall Study|Death|0|||
27707346|NCT00382720|80765337|FG001|Overall Study|Death|1|||
27707347|NCT00382720|80765338|FG002|Overall Study|Death|2|||
27707348|NCT00382720|80765336|FG000|Overall Study|Progressive disease|37|||
27707349|NCT00382720|80765337|FG001|Overall Study|Progressive disease|28|||
27835477|NCT01438060|81226186|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
27835478|NCT01438060|81226185|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
27835479|NCT01438060|81226186|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
27835480|NCT01438060|81226185|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
27707350|NCT00382720|80765338|FG002|Overall Study|Progressive disease|38|||
27707351|NCT00382720|80765336|FG000|Overall Study|Withdrew consent|1|||
27707352|NCT00382720|80765337|FG001|Overall Study|Withdrew consent|1|||
27707353|NCT00382720|80765338|FG002|Overall Study|Withdrew consent|2|||
27707354|NCT00382720|80765336|FG000|Overall Study|Withdrawal by Subject|11|||
27707355|NCT00382720|80765337|FG001|Overall Study|Withdrawal by Subject|20|||
27888436|NCT00562302|81427993|FG000|Overall Study|Non-compliance|1|||
27707356|NCT00382720|80765338|FG002|Overall Study|Withdrawal by Subject|12|||
27707357|NCT00382720|80765336|FG000|Overall Study|Surgery|1|||
27707358|NCT00382720|80765337|FG001|Overall Study|Surgery|1|||
27707359|NCT00382720|80765338|FG002|Overall Study|Surgery|4|||
27707360|NCT00382720|80765336|FG000|Overall Study|Patient did not receive study medication|1|||
27707361|NCT00382720|80765337|FG001|Overall Study|Patient did not receive study medication|1|||
27707362|NCT00382720|80765338|FG002|Overall Study|Patient did not receive study medication|4|||
27707363|NCT00382720|80765336|FG000|Overall Study|Clinically progressive disease|0|||
27707364|NCT00382720|80765337|FG001|Overall Study|Clinically progressive disease|1|||
27707365|NCT00382720|80765338|FG002|Overall Study|Clinically progressive disease|0|||
27707366|NCT00382720|80765336|FG000|Overall Study|Good prognosis|0|||
27707367|NCT00382720|80765337|FG001|Overall Study|Good prognosis|1|||
27707368|NCT00382720|80765338|FG002|Overall Study|Good prognosis|0|||
27707369|NCT00382720|80765336|FG000|Overall Study|Investigator/Clinical decision|5|||
27707370|NCT00382720|80765337|FG001|Overall Study|Investigator/Clinical decision|6|||
27707371|NCT00382720|80765338|FG002|Overall Study|Investigator/Clinical decision|6|||
27707372|NCT00382720|80765336|FG000|Overall Study|Discontinued at end of study|0|||
27707373|NCT00382720|80765337|FG001|Overall Study|Discontinued at end of study|1|||
27707374|NCT00382720|80765338|FG002|Overall Study|Discontinued at end of study|2|||
27707375|NCT01490814|80765341|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
27707376|NCT01490814|80765342|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
27707377|NCT01490814|80765341|FG000|Overall Study|Physician Decision|1|||
27707378|NCT01490814|80765342|FG001|Overall Study|Physician Decision|0|||
27707379|NCT01490814|80765341|FG000|Overall Study|Withdrawal by Subject|0|||
27707380|NCT01490814|80765342|FG001|Overall Study|Withdrawal by Subject|5|||
27707381|NCT00282295|80765343|FG000|Overall Study|Adverse Event|0|||
27707382|NCT00282295|80765344|FG001|Overall Study|Adverse Event|1|||
27707383|NCT00282295|80765345|FG002|Overall Study|Adverse Event|0|||
27707384|NCT00282295|80765343|FG000|Overall Study|Serious Adverse Events|0|||
27707385|NCT00282295|80765344|FG001|Overall Study|Serious Adverse Events|0|||
27707386|NCT00282295|80765345|FG002|Overall Study|Serious Adverse Events|1|||
27707387|NCT00282295|80765343|FG000|Overall Study|Protocol Violation|0|||
27707388|NCT00282295|80765344|FG001|Overall Study|Protocol Violation|2|||
27888437|NCT00562302|81427994|FG001|Overall Study|Non-compliance|2|||
27888438|NCT00562302|81427993|FG000|Overall Study|Withdrawal by Subject|7|||
27888439|NCT00562302|81427994|FG001|Overall Study|Withdrawal by Subject|8|||
27888440|NCT00562302|81427993|FG000|Overall Study|Death|1|||
27888441|NCT00562302|81427994|FG001|Overall Study|Death|2|||
27888442|NCT00562302|81427993|FG000|Overall Study|Lung resection prior to study completion|7|||
27888443|NCT00562302|81427994|FG001|Overall Study|Lung resection prior to study completion|7|||
27888444|NCT00562302|81427993|FG000|Overall Study|Not stated|1|||
27888445|NCT00562302|81427994|FG001|Overall Study|Not stated|4|||
27888446|NCT00160706|81427995|FG000|Overall Study|Adverse Event|53|||
27888447|NCT00160706|81427995|FG000|Overall Study|Adverse Event and Other Reason|105|||
27888448|NCT00160706|81427995|FG000|Overall Study|Protocol Violation|3|||
27888449|NCT00160706|81427995|FG000|Overall Study|Withdrawal by Subject|41|||
27888450|NCT00160706|81427995|FG000|Overall Study|Withdrawal by Subject and Other|12|||
27888451|NCT00160706|81427995|FG000|Overall Study|Physician Decision|10|||
27888452|NCT00160706|81427995|FG000|Overall Study|Physician Decision and Other|3|||
27888453|NCT00160706|81427995|FG000|Overall Study|Lost to Follow-up|4|||
27707389|NCT00282295|80765345|FG002|Overall Study|Protocol Violation|1|||
27707390|NCT00282295|80765343|FG000|Overall Study|Withdrawal by Subject|2|||
27707391|NCT00282295|80765344|FG001|Overall Study|Withdrawal by Subject|6|||
27888454|NCT00160706|81427995|FG000|Overall Study|Lost to Follow-up and Other|1|||
27707392|NCT00282295|80765345|FG002|Overall Study|Withdrawal by Subject|4|||
27707393|NCT00282295|80765343|FG000|Overall Study|Lost to Follow-up|1|||
27707394|NCT00282295|80765344|FG001|Overall Study|Lost to Follow-up|7|||
27707395|NCT00282295|80765345|FG002|Overall Study|Lost to Follow-up|2|||
27888455|NCT00160706|81427995|FG000|Overall Study|Lack of Efficacy|42|||
27888456|NCT00160706|81427995|FG000|Overall Study|Lack of Efficacy and Other|1|||
27707396|NCT00282295|80765343|FG000|Overall Study|Other|0|||
27707397|NCT00282295|80765344|FG001|Overall Study|Other|1|||
27707398|NCT00282295|80765345|FG002|Overall Study|Other|0|||
27888457|NCT00160706|81427995|FG000|Overall Study|Other Reason|11|||
27888458|NCT04429555|81427996|FG000|Overall Study|Death|0|||
27888459|NCT04429555|81427997|FG001|Overall Study|Death|2|||
27888460|NCT04429555|81427996|FG000|Overall Study|Other|2|||
27707399|NCT03281668|80765346|FG000|Overall Study|Physician Decision|1|||
27888461|NCT04429555|81427997|FG001|Overall Study|Other|0|||
27888462|NCT05481125|81427998|FG000|Overall Study|Adverse Event|1|||
27707400|NCT03281668|80765346|FG000|Overall Study|scheduling conflict, family circumstance|2|||
27888463|NCT05481125|81427999|FG001|Overall Study|Adverse Event|0|||
27888464|NCT05481125|81427998|FG000|Overall Study|Lost to Follow-up|0|||
27888465|NCT05481125|81427999|FG001|Overall Study|Lost to Follow-up|1|||
27835481|NCT01438060|81226186|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
27601396|NCT02001194|80381535|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
27601397|NCT02001194|80381536|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
27601398|NCT02001194|80381537|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
27601399|NCT01368900|80381538|FG000|Overall Study|Lost to Follow-up|7|||
27835482|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
27835483|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
27835484|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
27835485|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
27835486|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
27835487|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
27835488|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
27835489|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
27835490|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
27888466|NCT05481125|81427998|FG000|Overall Study|Withdrawal by Subject|0|||
27888467|NCT05481125|81427999|FG001|Overall Study|Withdrawal by Subject|1|||
27888468|NCT03033602|81428000|FG000|Overall Study|Withdrawal by Subject|11|||
27601400|NCT01964326|80381539|FG000|Overall Study|Adverse Event|48|||
27601401|NCT01964326|80381539|FG000|Overall Study|Death|2|||
27601402|NCT01964326|80381539|FG000|Overall Study|Protocol Violation|4|||
27601403|NCT01964326|80381539|FG000|Overall Study|Lost to Follow-up|88|||
27601404|NCT01964326|80381539|FG000|Overall Study|Withdrawal by Subject|87|||
27601405|NCT01964326|80381539|FG000|Overall Study|Pregnancy|1|||
27601406|NCT01964326|80381539|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
27601407|NCT01964326|80381539|FG000|Overall Study|Physician Decision|55|||
27601408|NCT01964326|80381539|FG000|Overall Study|Investigator Discretion|1|||
27601409|NCT01964326|80381539|FG000|Overall Study|Other|9|||
27601410|NCT01964326|80381539|FG000|Overall Study|Did not meet eligibility criteria|1|||
27601411|NCT03315143|80381540|FG000|Overall Study|Death|240|||
27601412|NCT03315143|80381541|FG001|Overall Study|Death|246|||
27601413|NCT03315143|80381540|FG000|Overall Study|Withdrawal by Subject|57|||
27835491|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
27835492|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
27601414|NCT03315143|80381541|FG001|Overall Study|Withdrawal by Subject|68|||
27601415|NCT03315143|80381540|FG000|Overall Study|Site Terminated by Sponsor|256|||
27601416|NCT03315143|80381541|FG001|Overall Study|Site Terminated by Sponsor|282|||
27601417|NCT03315143|80381540|FG000|Overall Study|Study Terminated by Sponsor|4723|||
27601418|NCT03315143|80381541|FG001|Overall Study|Study Terminated by Sponsor|4664|||
27601419|NCT03315143|80381540|FG000|Overall Study|Reason not Specified|16|||
27601420|NCT03315143|80381541|FG001|Overall Study|Reason not Specified|32|||
27601421|NCT04477187|80381542|FG000|Overall Study|Lost to Follow-up|2|||
27601422|NCT03988166|80381545|FG000|Overall Study|Lost to Follow-up|2|||
27601423|NCT03988166|80381545|FG000|Overall Study|Death|1|||
27601424|NCT01621126|80381546|FG000|Overall Study|Physician Decision|6|||
27601425|NCT00827541|80381547|FG000|Overall Study|Exitus|1|||
27601426|NCT00827541|80381548|FG001|Overall Study|Exitus|8|||
27601427|NCT00827541|80381547|FG000|Overall Study|Other|1|||
27601428|NCT00827541|80381548|FG001|Overall Study|Other|3|||
27601429|NCT00827541|80381547|FG000|Overall Study|Pathogen not susceptible|1|||
27601430|NCT00827541|80381548|FG001|Overall Study|Pathogen not susceptible|0|||
27601431|NCT00827541|80381547|FG000|Overall Study|Lack of effectiveness|1|||
27601432|NCT00827541|80381548|FG001|Overall Study|Lack of effectiveness|0|||
27601433|NCT04179721|80381550|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
27601434|NCT04179721|80381551|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
27601435|NCT04179721|80381550|FG000|Overall Study|Lost to Follow-up|0|||
27601436|NCT04179721|80381551|FG001|Overall Study|Lost to Follow-up|1|||
27601437|NCT01412801|80381553|FG000|Overall Study|Death|0|||
27601438|NCT01412801|80381554|FG001|Overall Study|Death|1|||
27601439|NCT01412801|80381555|FG002|Overall Study|Death|0|||
27888469|NCT03033602|81428001|FG001|Overall Study|Withdrawal by Subject|21|||
27888470|NCT03033602|81428000|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
27888471|NCT03033602|81428001|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
27888472|NCT02045862|81428002|FG000|Overall Study|Death|0|||
27888473|NCT02045862|81428003|FG001|Overall Study|Death|0|||
27888474|NCT02045862|81428004|FG002|Overall Study|Death|1|||
27888475|NCT02045862|81428002|FG000|Overall Study|Miscellaneous|5|||
27888476|NCT02045862|81428003|FG001|Overall Study|Miscellaneous|0|||
27888477|NCT02045862|81428004|FG002|Overall Study|Miscellaneous|8|||
27888478|NCT02045862|81428002|FG000|Overall Study|Withdrawal by Patient|18|||
27601440|NCT01412801|80381556|FG003|Overall Study|Death|4|||
27888479|NCT02045862|81428003|FG001|Overall Study|Withdrawal by Patient|27|||
27888480|NCT02045862|81428004|FG002|Overall Study|Withdrawal by Patient|57|||
27888481|NCT02045862|81428002|FG000|Overall Study|Protocol Violation|0|||
27601441|NCT01412801|80381557|FG004|Overall Study|Death|2|||
27601442|NCT01412801|80381558|FG005|Overall Study|Death|2|||
27601443|NCT01412801|80381553|FG000|Overall Study|Lost to Follow-up|1|||
27888482|NCT02045862|81428003|FG001|Overall Study|Protocol Violation|0|||
27888483|NCT02045862|81428004|FG002|Overall Study|Protocol Violation|6|||
27888484|NCT02045862|81428002|FG000|Overall Study|Lack of Efficacy|8|||
27888485|NCT02045862|81428003|FG001|Overall Study|Lack of Efficacy|4|||
27888486|NCT02045862|81428004|FG002|Overall Study|Lack of Efficacy|13|||
27888487|NCT02045862|81428002|FG000|Overall Study|Randomized but not Received Study Drug|0|||
27888488|NCT02045862|81428003|FG001|Overall Study|Randomized but not Received Study Drug|2|||
27888489|NCT02045862|81428004|FG002|Overall Study|Randomized but not Received Study Drug|8|||
27888490|NCT02045862|81428002|FG000|Overall Study|Adverse Event|7|||
27888491|NCT02045862|81428003|FG001|Overall Study|Adverse Event|5|||
27888492|NCT02045862|81428004|FG002|Overall Study|Adverse Event|27|||
27888493|NCT02045862|81428002|FG000|Overall Study|Lost to Follow-up|1|||
27888494|NCT02045862|81428003|FG001|Overall Study|Lost to Follow-up|2|||
27888495|NCT02045862|81428004|FG002|Overall Study|Lost to Follow-up|6|||
27888496|NCT00729157|81428005|FG000|Overall Study|Withdrawal by Subject|1|||
27888497|NCT00594100|81428008|FG000|Procedure|Technical Failure|9|||
27888498|NCT00594100|81428008|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
27888499|NCT00594100|81428008|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
27888500|NCT00594100|81428008|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
27888501|NCT00960986|81428009|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
27888502|NCT00960986|81428010|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
27888503|NCT00960986|81428011|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
27888504|NCT00960986|81428012|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
27888505|NCT00960986|81428009|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
27601444|NCT01412801|80381554|FG001|Overall Study|Lost to Follow-up|2|||
27601445|NCT01412801|80381555|FG002|Overall Study|Lost to Follow-up|4|||
27601446|NCT01412801|80381556|FG003|Overall Study|Lost to Follow-up|0|||
27888506|NCT00960986|81428010|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
27888507|NCT00960986|81428011|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
27601447|NCT01412801|80381557|FG004|Overall Study|Lost to Follow-up|1|||
27601448|NCT01412801|80381558|FG005|Overall Study|Lost to Follow-up|1|||
27601449|NCT01412801|80381553|FG000|Overall Study|Withdrawal by Subject|3|||
27601450|NCT01412801|80381554|FG001|Overall Study|Withdrawal by Subject|2|||
27601451|NCT01412801|80381555|FG002|Overall Study|Withdrawal by Subject|1|||
27601452|NCT01412801|80381556|FG003|Overall Study|Withdrawal by Subject|0|||
27601453|NCT01412801|80381557|FG004|Overall Study|Withdrawal by Subject|0|||
27601454|NCT01412801|80381558|FG005|Overall Study|Withdrawal by Subject|0|||
27601455|NCT01412801|80381553|FG000|Overall Study|Relocated to another area|0|||
27601456|NCT01412801|80381554|FG001|Overall Study|Relocated to another area|0|||
27601457|NCT01412801|80381555|FG002|Overall Study|Relocated to another area|2|||
27601458|NCT01412801|80381556|FG003|Overall Study|Relocated to another area|0|||
27601459|NCT01412801|80381557|FG004|Overall Study|Relocated to another area|0|||
27601460|NCT01412801|80381558|FG005|Overall Study|Relocated to another area|0|||
27601461|NCT03172702|80381565|FG000|Overall Study|Adverse Event|9|||
27601462|NCT03172702|80381565|FG000|Overall Study|Death|2|||
27601463|NCT03172702|80381565|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
27601464|NCT03172702|80381565|FG000|Overall Study|Withdrawal by Subject|5|||
27601465|NCT03172702|80381565|FG000|Overall Study|Other|2|||
27601466|NCT00331344|80381566|FG000|Phase I|Adverse Event|0|||
27601467|NCT00331344|80381567|FG001|Phase I|Adverse Event|0|||
27601468|NCT00331344|80381568|FG002|Phase I|Adverse Event|0|||
27601469|NCT00331344|80381569|FG003|Phase I|Adverse Event|1|||
27601470|NCT00331344|80381570|FG004|Phase I|Adverse Event|2|||
27601471|NCT00331344|80381571|FG005|Phase I|Adverse Event|2|||
27601472|NCT00331344|80381572|FG006|Phase I|Adverse Event|0|||
27601473|NCT00331344|80381573|FG007|Phase I|Adverse Event|1|||
27601474|NCT00331344|80381574|FG008|Phase I|Adverse Event|0|||
27601475|NCT00331344|80381566|FG000|Phase II|Death|0|||
27601476|NCT00331344|80381567|FG001|Phase II|Death|0|||
27601477|NCT00331344|80381568|FG002|Phase II|Death|0|||
27601478|NCT00331344|80381569|FG003|Phase II|Death|0|||
27601479|NCT00331344|80381570|FG004|Phase II|Death|0|||
27601480|NCT00331344|80381571|FG005|Phase II|Death|0|||
27601481|NCT00331344|80381572|FG006|Phase II|Death|0|||
27601482|NCT00331344|80381573|FG007|Phase II|Death|0|||
27601483|NCT00331344|80381574|FG008|Phase II|Death|4|||
27601484|NCT01111838|80381577|FG000|Overall Study|Patient Ineligible|2|||
27601485|NCT01111838|80381577|FG000|Overall Study|Not Treated|3|||
27601486|NCT01111838|80381577|FG000|Overall Study|Clinical deterioration|1|||
27601487|NCT01111838|80381577|FG000|Overall Study|Other Complicating Disease|1|||
27601488|NCT04274894|80381580|FG000|Overall Study|Adverse Event|7|||
27601489|NCT04274894|80381580|FG000|Overall Study|Withdrew consent|5|||
27601490|NCT04274894|80381580|FG000|Overall Study|Lost to Follow-up|9|||
27601491|NCT04274894|80381580|FG000|Overall Study|COVID-19 infection|1|||
27601492|NCT04274894|80381580|FG000|Overall Study|Other, not specified|20|||
27601493|NCT02070484|80381583|FG000|Overall Study|Withdrawal by Subject|1|||
27601494|NCT02070484|80381584|FG001|Overall Study|Withdrawal by Subject|0|||
27601495|NCT00118898|80381585|FG000|Overall Study|Death|6|||
27601496|NCT00118898|80381586|FG001|Overall Study|Death|11|||
27601497|NCT00118898|80381587|FG002|Overall Study|Death|6|||
27601498|NCT00118898|80381588|FG003|Overall Study|Death|8|||
27601499|NCT00118898|80381585|FG000|Overall Study|Lost to Follow-up|26|||
27601500|NCT00118898|80381586|FG001|Overall Study|Lost to Follow-up|34|||
27601501|NCT00118898|80381587|FG002|Overall Study|Lost to Follow-up|33|||
27601502|NCT00118898|80381588|FG003|Overall Study|Lost to Follow-up|33|||
27601503|NCT00118898|80381585|FG000|Overall Study|Withdrawal by Subject|10|||
27601504|NCT00118898|80381586|FG001|Overall Study|Withdrawal by Subject|5|||
27601505|NCT00118898|80381587|FG002|Overall Study|Withdrawal by Subject|8|||
27601506|NCT00118898|80381588|FG003|Overall Study|Withdrawal by Subject|8|||
27601507|NCT00118898|80381585|FG000|Overall Study|Site Closure|33|||
27601508|NCT00118898|80381586|FG001|Overall Study|Site Closure|31|||
27601509|NCT00118898|80381587|FG002|Overall Study|Site Closure|28|||
27601510|NCT00118898|80381588|FG003|Overall Study|Site Closure|37|||
27601511|NCT00118898|80381585|FG000|Overall Study|Severe debilitation|1|||
27601512|NCT00118898|80381586|FG001|Overall Study|Severe debilitation|4|||
27888508|NCT00960986|81428012|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
27601513|NCT00118898|80381587|FG002|Overall Study|Severe debilitation|6|||
27888509|NCT00960986|81428009|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
27601514|NCT00118898|80381588|FG003|Overall Study|Severe debilitation|4|||
27601515|NCT00118898|80381585|FG000|Overall Study|Not compliant with requirements|11|||
27601516|NCT00118898|80381586|FG001|Overall Study|Not compliant with requirements|13|||
27601517|NCT00118898|80381587|FG002|Overall Study|Not compliant with requirements|11|||
27601518|NCT00118898|80381588|FG003|Overall Study|Not compliant with requirements|11|||
27601519|NCT00118898|80381585|FG000|Overall Study|Not able to get to clinic|34|||
27601520|NCT00118898|80381586|FG001|Overall Study|Not able to get to clinic|43|||
27601521|NCT00118898|80381587|FG002|Overall Study|Not able to get to clinic|31|||
27601522|NCT00118898|80381588|FG003|Overall Study|Not able to get to clinic|40|||
27601523|NCT04124926|80381589|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
27601524|NCT04124926|80381590|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
27601525|NCT04124926|80381591|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
27601526|NCT04124926|80381592|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
27601527|NCT04124926|80381593|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
27601528|NCT04124926|80381589|FG000|Healing Phase|Protocol Violation|0|||
27601529|NCT04124926|80381590|FG001|Healing Phase|Protocol Violation|1|||
27601530|NCT04124926|80381591|FG002|Healing Phase|Protocol Violation|0|||
27601531|NCT04124926|80381592|FG003|Healing Phase|Protocol Violation|0|||
27601532|NCT04124926|80381593|FG004|Healing Phase|Protocol Violation|0|||
27601533|NCT04124926|80381589|FG000|Healing Phase|Lost to Follow-up|5|||
27601534|NCT04124926|80381590|FG001|Healing Phase|Lost to Follow-up|4|||
27601535|NCT04124926|80381591|FG002|Healing Phase|Lost to Follow-up|0|||
27601536|NCT04124926|80381592|FG003|Healing Phase|Lost to Follow-up|0|||
27601537|NCT04124926|80381593|FG004|Healing Phase|Lost to Follow-up|0|||
27601538|NCT04124926|80381589|FG000|Healing Phase|Voluntary Withdrawal|10|||
27601539|NCT04124926|80381590|FG001|Healing Phase|Voluntary Withdrawal|7|||
27601540|NCT04124926|80381591|FG002|Healing Phase|Voluntary Withdrawal|0|||
27601541|NCT04124926|80381592|FG003|Healing Phase|Voluntary Withdrawal|0|||
27601542|NCT04124926|80381593|FG004|Healing Phase|Voluntary Withdrawal|0|||
27601543|NCT04124926|80381589|FG000|Healing Phase|Withdrawal of Consent|5|||
27601544|NCT04124926|80381590|FG001|Healing Phase|Withdrawal of Consent|3|||
27601545|NCT04124926|80381591|FG002|Healing Phase|Withdrawal of Consent|0|||
27601546|NCT04124926|80381592|FG003|Healing Phase|Withdrawal of Consent|0|||
27601547|NCT04124926|80381593|FG004|Healing Phase|Withdrawal of Consent|0|||
27601548|NCT04124926|80381589|FG000|Healing Phase|Miscellaneous|8|||
27601549|NCT04124926|80381590|FG001|Healing Phase|Miscellaneous|7|||
27601550|NCT04124926|80381591|FG002|Healing Phase|Miscellaneous|0|||
27601551|NCT04124926|80381592|FG003|Healing Phase|Miscellaneous|0|||
27601552|NCT04124926|80381593|FG004|Healing Phase|Miscellaneous|0|||
27601553|NCT04124926|80381589|FG000|Healing Phase|Randomized but not Treated|0|||
27601554|NCT04124926|80381590|FG001|Healing Phase|Randomized but not Treated|3|||
27601555|NCT04124926|80381591|FG002|Healing Phase|Randomized but not Treated|0|||
27601556|NCT04124926|80381592|FG003|Healing Phase|Randomized but not Treated|0|||
27601557|NCT04124926|80381593|FG004|Healing Phase|Randomized but not Treated|0|||
27601558|NCT04124926|80381589|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
27601559|NCT04124926|80381590|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
27601560|NCT04124926|80381591|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
27601561|NCT04124926|80381592|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
27601562|NCT04124926|80381593|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
27601563|NCT04124926|80381589|FG000|Maintenance Phase|Protocol Violation|0|||
27601564|NCT04124926|80381590|FG001|Maintenance Phase|Protocol Violation|0|||
27601565|NCT04124926|80381591|FG002|Maintenance Phase|Protocol Violation|3|||
27601566|NCT04124926|80381592|FG003|Maintenance Phase|Protocol Violation|0|||
27601567|NCT04124926|80381593|FG004|Maintenance Phase|Protocol Violation|0|||
27601568|NCT04124926|80381589|FG000|Maintenance Phase|Lost to Follow-up|0|||
27835493|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
27888510|NCT00960986|81428010|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
27601569|NCT04124926|80381590|FG001|Maintenance Phase|Lost to Follow-up|0|||
27601570|NCT04124926|80381591|FG002|Maintenance Phase|Lost to Follow-up|7|||
27601571|NCT04124926|80381592|FG003|Maintenance Phase|Lost to Follow-up|8|||
27601572|NCT04124926|80381593|FG004|Maintenance Phase|Lost to Follow-up|9|||
27601573|NCT04124926|80381589|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
27601574|NCT04124926|80381590|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
27601575|NCT04124926|80381591|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
27835494|NCT01438060|81226185|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
27835495|NCT01438060|81226186|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
27835496|NCT01438060|81226185|FG000|On Study Beyond Week 140|Adverse Event|0|||
27835497|NCT01438060|81226186|FG001|On Study Beyond Week 140|Adverse Event|2|||
27835498|NCT01438060|81226185|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
27835499|NCT01438060|81226186|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
27835500|NCT01438060|81226185|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
27835501|NCT01438060|81226186|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
27835502|NCT01438060|81226185|FG000|On Study Beyond Week 140|Death|0|||
27888511|NCT00960986|81428011|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
27601576|NCT04124926|80381592|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
27601577|NCT04124926|80381593|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
27601578|NCT04124926|80381589|FG000|Maintenance Phase|Pregnancy|0|||
27601579|NCT04124926|80381590|FG001|Maintenance Phase|Pregnancy|0|||
27601580|NCT04124926|80381591|FG002|Maintenance Phase|Pregnancy|0|||
27601581|NCT04124926|80381592|FG003|Maintenance Phase|Pregnancy|1|||
27601582|NCT04124926|80381593|FG004|Maintenance Phase|Pregnancy|0|||
27601583|NCT04124926|80381589|FG000|Maintenance Phase|Lack of Efficacy|0|||
27601584|NCT04124926|80381590|FG001|Maintenance Phase|Lack of Efficacy|0|||
27601585|NCT04124926|80381591|FG002|Maintenance Phase|Lack of Efficacy|0|||
27601586|NCT04124926|80381592|FG003|Maintenance Phase|Lack of Efficacy|0|||
27601587|NCT04124926|80381593|FG004|Maintenance Phase|Lack of Efficacy|1|||
27601588|NCT04124926|80381589|FG000|Maintenance Phase|Withdrawal of Consent|0|||
27601589|NCT04124926|80381590|FG001|Maintenance Phase|Withdrawal of Consent|0|||
27601590|NCT04124926|80381591|FG002|Maintenance Phase|Withdrawal of Consent|5|||
27601591|NCT04124926|80381592|FG003|Maintenance Phase|Withdrawal of Consent|5|||
27601592|NCT04124926|80381593|FG004|Maintenance Phase|Withdrawal of Consent|5|||
27601593|NCT04124926|80381589|FG000|Maintenance Phase|Miscellaneous|0|||
27601594|NCT04124926|80381590|FG001|Maintenance Phase|Miscellaneous|0|||
27601595|NCT04124926|80381591|FG002|Maintenance Phase|Miscellaneous|1|||
27601596|NCT04124926|80381592|FG003|Maintenance Phase|Miscellaneous|2|||
27601597|NCT04124926|80381593|FG004|Maintenance Phase|Miscellaneous|4|||
27601598|NCT04124926|80381589|FG000|Maintenance Phase|Randomized but not Treated|0|||
27601599|NCT04124926|80381590|FG001|Maintenance Phase|Randomized but not Treated|0|||
27601600|NCT04124926|80381591|FG002|Maintenance Phase|Randomized but not Treated|2|||
27601601|NCT04124926|80381592|FG003|Maintenance Phase|Randomized but not Treated|2|||
27601602|NCT04124926|80381593|FG004|Maintenance Phase|Randomized but not Treated|0|||
27601603|NCT01982435|80381596|FG000|Overall Study|Adverse Event|1|||
27601604|NCT01982435|80381597|FG001|Overall Study|Adverse Event|0|||
27601605|NCT01256567|80381607|FG000|Overall Study|Withdrawal by Subject|1|||
27601606|NCT01806584|80381623|FG000|Overall Study|Adverse Event|2|||
27601607|NCT01806584|80381624|FG001|Overall Study|Adverse Event|1|||
27601608|NCT01806584|80381623|FG000|Overall Study|Death|1|||
27707401|NCT03281668|80765346|FG000|Overall Study|Withdrawal by Subject|4|||
27707402|NCT03281668|80765346|FG000|Overall Study|Lost to Follow-up|1|||
27707403|NCT01961349|80765347|FG000|Overall Study|Withdrawal by Subject|1|||
27707404|NCT01961349|80765348|FG001|Overall Study|Withdrawal by Subject|4|||
27707405|NCT01961349|80765349|FG002|Overall Study|Withdrawal by Subject|0|||
27707406|NCT01961349|80765347|FG000|Overall Study|Adverse Event|0|||
27707407|NCT01961349|80765348|FG001|Overall Study|Adverse Event|0|||
27707408|NCT01961349|80765349|FG002|Overall Study|Adverse Event|1|||
27707409|NCT01961349|80765347|FG000|Overall Study|registration error, personal reason etc|2|||
27707410|NCT01961349|80765348|FG001|Overall Study|registration error, personal reason etc|2|||
27707411|NCT01961349|80765349|FG002|Overall Study|registration error, personal reason etc|1|||
27707412|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
27707413|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
27707414|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Death|0|||
27707415|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Death|1|||
27707416|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
27707417|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
27707418|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
27707419|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
27707420|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
27707421|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
27707422|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
27707423|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
27707424|NCT00843518|80765350|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
27707425|NCT00843518|80765351|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
27707426|NCT04202679|80765352|FG000|Overall Study|Adverse Event|2|||
27707427|NCT04202679|80765353|FG001|Overall Study|Adverse Event|0|||
27707428|NCT04202679|80765352|FG000|Overall Study|Poor compliance to protocol|1|||
27707429|NCT04202679|80765353|FG001|Overall Study|Poor compliance to protocol|0|||
27835503|NCT01438060|81226186|FG001|On Study Beyond Week 140|Death|1|||
27835504|NCT01438060|81226185|FG000|On Study Beyond Week 140|Other Reason|0|||
27835505|NCT01438060|81226186|FG001|On Study Beyond Week 140|Other Reason|3|||
27835506|NCT04408924|81226187|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
27835507|NCT04408924|81226187|FG000|Overall Study|Lost to Follow-up|3|||
27835508|NCT04408924|81226187|FG000|Overall Study|Withdrawal by Subject|5|||
27835509|NCT04408924|81226187|FG000|Overall Study|Sponsor Decision|2|||
27835510|NCT01596127|81226188|FG000|Overall Study|Patient Ineligible|1|||
27835511|NCT00642993|81226189|FG000|Overall Study|Adverse Event|85|||
27835512|NCT00642993|81226190|FG001|Overall Study|Adverse Event|4|||
27835513|NCT00642993|81226189|FG000|Overall Study|Lost to Follow-up|8|||
27835514|NCT00642993|81226190|FG001|Overall Study|Lost to Follow-up|4|||
27888512|NCT00960986|81428012|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
27707430|NCT04202679|80765352|FG000|Overall Study|Withdrawal by Subject|23|||
27707431|NCT04202679|80765353|FG001|Overall Study|Withdrawal by Subject|6|||
27707432|NCT02064920|80765359|FG000|Overall Study|Adverse Event|0|||
27707433|NCT02064920|80765360|FG001|Overall Study|Adverse Event|4|||
27707434|NCT02064920|80765359|FG000|Overall Study|Physician Decision|0|||
27835515|NCT00642993|81226189|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
27888513|NCT00960986|81428009|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
27707435|NCT02064920|80765360|FG001|Overall Study|Physician Decision|1|||
27707436|NCT02064920|80765359|FG000|Overall Study|Technical Problems|0|||
27707437|NCT02064920|80765360|FG001|Overall Study|Technical Problems|1|||
27707438|NCT02064920|80765359|FG000|Overall Study|Withdrawal by Subject|1|||
27707439|NCT02064920|80765360|FG001|Overall Study|Withdrawal by Subject|3|||
27707440|NCT00577642|80765361|FG000|Overall Study|Clinical Disease Progression|1|||
27707441|NCT00474708|80765362|FG000|Overall Study|Lack of Efficacy|11|||
27707442|NCT00474708|80765363|FG001|Overall Study|Lack of Efficacy|5|||
27707443|NCT00474708|80765362|FG000|Overall Study|Suicide ideation/behavior|0|||
27707444|NCT00474708|80765363|FG001|Overall Study|Suicide ideation/behavior|1|||
27707445|NCT00474708|80765362|FG000|Overall Study|Withdrawal by Subject|7|||
27707446|NCT00474708|80765363|FG001|Overall Study|Withdrawal by Subject|0|||
27707447|NCT00474708|80765362|FG000|Overall Study|Lack of compliance|12|||
27707448|NCT00474708|80765363|FG001|Overall Study|Lack of compliance|4|||
27707449|NCT00474708|80765362|FG000|Overall Study|Lost to Follow-up|18|||
27707450|NCT00474708|80765363|FG001|Overall Study|Lost to Follow-up|9|||
27707451|NCT00474708|80765362|FG000|Overall Study|Physician Decision|9|||
27707452|NCT00474708|80765363|FG001|Overall Study|Physician Decision|6|||
27707453|NCT02982590|80765364|FG000|Overall Study|Lost to Follow-up|0|||
27707454|NCT02982590|80765365|FG001|Overall Study|Lost to Follow-up|1|||
27707455|NCT02982590|80765364|FG000|Overall Study|Death|4|||
27707456|NCT02982590|80765365|FG001|Overall Study|Death|0|||
27707457|NCT04416555|80765366|FG000|Overall Study|Withdrawal by Subject|0|||
27707458|NCT04416555|80765367|FG001|Overall Study|Withdrawal by Subject|3|||
27707459|NCT00312221|80765368|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
27707460|NCT00312221|80765369|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
27707461|NCT00312221|80765370|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
27707462|NCT00312221|80765371|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
27707463|NCT00312221|80765368|FG000|Open-label Run-in Period|Adverse Event|74|||
27707464|NCT00312221|80765369|FG001|Open-label Run-in Period|Adverse Event|0|||
27707465|NCT00312221|80765370|FG002|Open-label Run-in Period|Adverse Event|0|||
27707466|NCT00312221|80765371|FG003|Open-label Run-in Period|Adverse Event|0|||
27707467|NCT00312221|80765368|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
27707468|NCT00312221|80765369|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
27707469|NCT00312221|80765370|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
27707470|NCT00312221|80765371|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
27707471|NCT00312221|80765368|FG000|Open-label Run-in Period|Administrative|42|||
27707472|NCT00312221|80765369|FG001|Open-label Run-in Period|Administrative|0|||
27707473|NCT00312221|80765370|FG002|Open-label Run-in Period|Administrative|0|||
27707474|NCT00312221|80765371|FG003|Open-label Run-in Period|Administrative|0|||
27707475|NCT00312221|80765368|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
27707476|NCT00312221|80765369|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
27707477|NCT00312221|80765370|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
27707478|NCT00312221|80765371|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
27707479|NCT00312221|80765368|FG000|Open-label Run-in Period|Did not qualify|5|||
27707480|NCT00312221|80765369|FG001|Open-label Run-in Period|Did not qualify|0|||
27707481|NCT00312221|80765370|FG002|Open-label Run-in Period|Did not qualify|0|||
27707482|NCT00312221|80765371|FG003|Open-label Run-in Period|Did not qualify|0|||
27707483|NCT00312221|80765368|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27707484|NCT00312221|80765369|FG001|Double-blind Phase|Withdrawal by Subject|6|||
27707485|NCT00312221|80765370|FG002|Double-blind Phase|Withdrawal by Subject|8|||
27707486|NCT00312221|80765371|FG003|Double-blind Phase|Withdrawal by Subject|7|||
27707487|NCT00312221|80765368|FG000|Double-blind Phase|Adverse Event|0|||
27707488|NCT00312221|80765369|FG001|Double-blind Phase|Adverse Event|10|||
27707489|NCT00312221|80765370|FG002|Double-blind Phase|Adverse Event|19|||
27707490|NCT00312221|80765371|FG003|Double-blind Phase|Adverse Event|18|||
27707491|NCT00312221|80765368|FG000|Double-blind Phase|Lost to Follow-up|0|||
27707492|NCT00312221|80765369|FG001|Double-blind Phase|Lost to Follow-up|0|||
27707493|NCT00312221|80765370|FG002|Double-blind Phase|Lost to Follow-up|2|||
27707494|NCT00312221|80765371|FG003|Double-blind Phase|Lost to Follow-up|2|||
27707495|NCT00312221|80765368|FG000|Double-blind Phase|Administrative|0|||
27707496|NCT00312221|80765369|FG001|Double-blind Phase|Administrative|26|||
27707497|NCT00312221|80765370|FG002|Double-blind Phase|Administrative|37|||
27707498|NCT00312221|80765371|FG003|Double-blind Phase|Administrative|33|||
27707499|NCT00312221|80765368|FG000|Double-blind Phase|Lack of Efficacy|0|||
27707500|NCT00312221|80765369|FG001|Double-blind Phase|Lack of Efficacy|17|||
27707501|NCT00312221|80765370|FG002|Double-blind Phase|Lack of Efficacy|6|||
27707502|NCT00312221|80765371|FG003|Double-blind Phase|Lack of Efficacy|10|||
27707503|NCT01423851|80765372|FG000|Whole Study|Disease progression|2|||
27707504|NCT01423851|80765373|FG001|Whole Study|Disease progression|1|||
27707505|NCT01423851|80765374|FG002|Whole Study|Disease progression|1|||
27707506|NCT01423851|80765375|FG003|Whole Study|Disease progression|4|||
27707507|NCT01423851|80765376|FG004|Whole Study|Disease progression|1|||
27707508|NCT01423851|80765377|FG005|Whole Study|Disease progression|3|||
27707509|NCT01423851|80765378|FG006|Whole Study|Disease progression|1|||
27707510|NCT01423851|80765379|FG007|Whole Study|Disease progression|4|||
27707511|NCT01423851|80765380|FG008|Whole Study|Disease progression|0|||
27707512|NCT01423851|80765381|FG009|Whole Study|Disease progression|2|||
27601609|NCT01806584|80381624|FG001|Overall Study|Death|0|||
27601610|NCT01806584|80381623|FG000|Overall Study|Lost to Follow-up|0|||
27601611|NCT01806584|80381624|FG001|Overall Study|Lost to Follow-up|2|||
27601612|NCT01806584|80381623|FG000|Overall Study|Study terminated by sponsor|9|||
27601613|NCT01806584|80381624|FG001|Overall Study|Study terminated by sponsor|14|||
27601614|NCT01806584|80381623|FG000|Overall Study|Withdrawal by Subject|1|||
27707513|NCT01423851|80765382|FG010|Whole Study|Disease progression|10|||
27707514|NCT01423851|80765372|FG000|Whole Study|Physician Decision|0|||
27707515|NCT01423851|80765373|FG001|Whole Study|Physician Decision|1|||
27707516|NCT01423851|80765374|FG002|Whole Study|Physician Decision|2|||
27707517|NCT01423851|80765375|FG003|Whole Study|Physician Decision|0|||
27707518|NCT01423851|80765376|FG004|Whole Study|Physician Decision|2|||
27707519|NCT01423851|80765377|FG005|Whole Study|Physician Decision|0|||
27707520|NCT01423851|80765378|FG006|Whole Study|Physician Decision|2|||
27707521|NCT01423851|80765379|FG007|Whole Study|Physician Decision|1|||
27707522|NCT01423851|80765380|FG008|Whole Study|Physician Decision|3|||
27707523|NCT01423851|80765381|FG009|Whole Study|Physician Decision|4|||
27707524|NCT01423851|80765382|FG010|Whole Study|Physician Decision|12|||
27707525|NCT01423851|80765372|FG000|Whole Study|Withdrawal by Subject|1|||
27707526|NCT01423851|80765373|FG001|Whole Study|Withdrawal by Subject|1|||
27707527|NCT01423851|80765374|FG002|Whole Study|Withdrawal by Subject|0|||
27707528|NCT01423851|80765375|FG003|Whole Study|Withdrawal by Subject|0|||
27707529|NCT01423851|80765376|FG004|Whole Study|Withdrawal by Subject|0|||
27707530|NCT01423851|80765377|FG005|Whole Study|Withdrawal by Subject|0|||
27707531|NCT01423851|80765378|FG006|Whole Study|Withdrawal by Subject|0|||
27707532|NCT01423851|80765379|FG007|Whole Study|Withdrawal by Subject|0|||
27707533|NCT01423851|80765380|FG008|Whole Study|Withdrawal by Subject|2|||
27707534|NCT01423851|80765381|FG009|Whole Study|Withdrawal by Subject|0|||
27707535|NCT01423851|80765382|FG010|Whole Study|Withdrawal by Subject|4|||
27707536|NCT01423851|80765372|FG000|Whole Study|Adverse Event|0|||
27707537|NCT01423851|80765373|FG001|Whole Study|Adverse Event|0|||
27707538|NCT01423851|80765374|FG002|Whole Study|Adverse Event|0|||
27707539|NCT01423851|80765375|FG003|Whole Study|Adverse Event|2|||
27707540|NCT01423851|80765376|FG004|Whole Study|Adverse Event|0|||
27707541|NCT01423851|80765377|FG005|Whole Study|Adverse Event|0|||
27707542|NCT01423851|80765378|FG006|Whole Study|Adverse Event|0|||
27707543|NCT01423851|80765379|FG007|Whole Study|Adverse Event|3|||
27707544|NCT01423851|80765380|FG008|Whole Study|Adverse Event|3|||
27707545|NCT01423851|80765381|FG009|Whole Study|Adverse Event|2|||
27707546|NCT01423851|80765382|FG010|Whole Study|Adverse Event|3|||
27707547|NCT03329196|80765386|FG000|Overall Study|Adverse Event|10|||
27707548|NCT03329196|80765387|FG001|Overall Study|Adverse Event|5|||
27707549|NCT03329196|80765386|FG000|Overall Study|Physician Decision|2|||
27707550|NCT03329196|80765387|FG001|Overall Study|Physician Decision|2|||
27707551|NCT03329196|80765386|FG000|Overall Study|Withdrawal by Subject|11|||
27707552|NCT03329196|80765387|FG001|Overall Study|Withdrawal by Subject|3|||
27707553|NCT03329196|80765386|FG000|Overall Study|Hepatic function abnormalities|0|||
27707554|NCT03329196|80765387|FG001|Overall Study|Hepatic function abnormalities|1|||
27707555|NCT03329196|80765386|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
27707556|NCT03329196|80765387|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
27707557|NCT03329196|80765386|FG000|Overall Study|Difficult to control Hb|2|||
27707558|NCT03329196|80765387|FG001|Overall Study|Difficult to control Hb|3|||
27707559|NCT03329196|80765386|FG000|Overall Study|Dialysis or renal transplant|13|||
27707560|NCT03329196|80765387|FG001|Overall Study|Dialysis or renal transplant|15|||
27707561|NCT03184077|80765388|FG000|Overall Study|Lost to Follow-up|21|||
27707562|NCT03184077|80765389|FG001|Overall Study|Lost to Follow-up|21|||
27707563|NCT03179891|80765395|FG000|First Intervention|Withdrawal by Subject|1|||
27707564|NCT03179891|80765396|FG001|First Intervention|Withdrawal by Subject|1|||
27707565|NCT03179891|80765395|FG000|First Intervention|Unspecified reason|1|||
27707566|NCT03179891|80765396|FG001|First Intervention|Unspecified reason|0|||
27707567|NCT03179891|80765395|FG000|First Intervention|Protocol Violation|0|||
27707568|NCT03179891|80765396|FG001|First Intervention|Protocol Violation|1|||
27707569|NCT01572675|80765399|FG000|Overall Study|End of prescribed treatment|140|||
27707570|NCT01572675|80765400|FG001|Overall Study|End of prescribed treatment|118|||
27707571|NCT01572675|80765399|FG000|Overall Study|Recovery|16|||
27707572|NCT01572675|80765400|FG001|Overall Study|Recovery|23|||
27707573|NCT01572675|80765399|FG000|Overall Study|Lack of Efficacy|31|||
27707574|NCT01572675|80765400|FG001|Overall Study|Lack of Efficacy|31|||
27707575|NCT01572675|80765399|FG000|Overall Study|Intolerance|6|||
27707576|NCT01572675|80765400|FG001|Overall Study|Intolerance|5|||
27707577|NCT01572675|80765399|FG000|Overall Study|Improved symptoms|8|||
27707578|NCT01572675|80765400|FG001|Overall Study|Improved symptoms|2|||
27707579|NCT01572675|80765399|FG000|Overall Study|Surgical intervention|3|||
27601615|NCT01806584|80381624|FG001|Overall Study|Withdrawal by Subject|1|||
27601616|NCT01806584|80381623|FG000|Overall Study|Other unspecified|1|||
27601617|NCT01806584|80381624|FG001|Overall Study|Other unspecified|0|||
27707580|NCT01572675|80765400|FG001|Overall Study|Surgical intervention|6|||
27707581|NCT01572675|80765399|FG000|Overall Study|Withdrawal by Subject|5|||
27707582|NCT01572675|80765400|FG001|Overall Study|Withdrawal by Subject|1|||
27601618|NCT01330316|80381637|FG000|Overall Study|Adverse Event|2|||
27601619|NCT01330316|80381638|FG001|Overall Study|Adverse Event|2|||
27601620|NCT01330316|80381637|FG000|Overall Study|Lack of Efficacy|0|||
27601621|NCT01330316|80381638|FG001|Overall Study|Lack of Efficacy|10|||
27601622|NCT01330316|80381637|FG000|Overall Study|Lost to Follow-up|0|||
27601623|NCT01330316|80381638|FG001|Overall Study|Lost to Follow-up|1|||
27601624|NCT01330316|80381637|FG000|Overall Study|Withdrawal by Subject|0|||
27601625|NCT01330316|80381638|FG001|Overall Study|Withdrawal by Subject|1|||
27707583|NCT01572675|80765399|FG000|Overall Study|Physician Decision|2|||
27707584|NCT01572675|80765400|FG001|Overall Study|Physician Decision|2|||
27888514|NCT00960986|81428010|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
27888515|NCT00960986|81428011|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
27888516|NCT00960986|81428012|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
27888517|NCT00960986|81428009|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
27888518|NCT00960986|81428010|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
27888519|NCT00960986|81428011|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
27888520|NCT00960986|81428012|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
27888521|NCT00960986|81428009|FG000|Period 3 (7-week Therapy Period)|Death|0|||
27888522|NCT00960986|81428010|FG001|Period 3 (7-week Therapy Period)|Death|0|||
27888523|NCT00960986|81428011|FG002|Period 3 (7-week Therapy Period)|Death|1|||
27888524|NCT00960986|81428012|FG003|Period 3 (7-week Therapy Period)|Death|0|||
27888525|NCT00960986|81428009|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
27888526|NCT00960986|81428010|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
27888527|NCT00960986|81428011|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
27707585|NCT01572675|80765399|FG000|Overall Study|Death unrelated to coxibs|1|||
27707586|NCT01572675|80765400|FG001|Overall Study|Death unrelated to coxibs|1|||
27707587|NCT01572675|80765399|FG000|Overall Study|Other disease detected|1|||
27707588|NCT01572675|80765400|FG001|Overall Study|Other disease detected|1|||
27707589|NCT01572675|80765399|FG000|Overall Study|Unknown reason|1|||
27707590|NCT01572675|80765400|FG001|Overall Study|Unknown reason|1|||
27707591|NCT01572675|80765399|FG000|Overall Study|Rheumatologist new evaluation|0|||
27707592|NCT01572675|80765400|FG001|Overall Study|Rheumatologist new evaluation|1|||
27707593|NCT01572675|80765399|FG000|Overall Study|Missing data|1|||
27707594|NCT01572675|80765400|FG001|Overall Study|Missing data|4|||
27707595|NCT01572675|80765399|FG000|Overall Study|Lost to Follow-up|22|||
27707596|NCT01572675|80765400|FG001|Overall Study|Lost to Follow-up|27|||
27707597|NCT02354222|80765403|FG000|Overall Study|Adverse Event|0|||
27707598|NCT02354222|80765404|FG001|Overall Study|Adverse Event|3|||
27707599|NCT02354222|80765403|FG000|Overall Study|Physician Decision|1|||
27707600|NCT02354222|80765404|FG001|Overall Study|Physician Decision|1|||
27707601|NCT02354222|80765403|FG000|Overall Study|Pregnancy|1|||
27707602|NCT02354222|80765404|FG001|Overall Study|Pregnancy|0|||
27707603|NCT02354222|80765403|FG000|Overall Study|Withdrawal by Subject|2|||
27707604|NCT02354222|80765404|FG001|Overall Study|Withdrawal by Subject|3|||
27707605|NCT02354222|80765403|FG000|Overall Study|Conflict with the stopping criteria|0|||
27707606|NCT02354222|80765404|FG001|Overall Study|Conflict with the stopping criteria|4|||
27707607|NCT03199040|80765405|FG000|Overall Study|Lack of Efficacy|2|||
27707608|NCT03199040|80765406|FG001|Overall Study|Lack of Efficacy|0|||
27707609|NCT03199040|80765405|FG000|Overall Study|Withdrawal by Subject|2|||
27707610|NCT03199040|80765406|FG001|Overall Study|Withdrawal by Subject|0|||
27707611|NCT03199040|80765405|FG000|Overall Study|Adverse Event|0|||
27707612|NCT03199040|80765406|FG001|Overall Study|Adverse Event|1|||
27707613|NCT03199040|80765405|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
27707614|NCT03199040|80765406|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
27707615|NCT00262522|80765407|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
27707616|NCT00262522|80765408|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
27707617|NCT00262522|80765409|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
27707618|NCT00262522|80765410|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
27707619|NCT00262522|80765407|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
27707620|NCT00262522|80765408|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
27707621|NCT00262522|80765409|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
27707622|NCT00262522|80765410|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
27707623|NCT00262522|80765407|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
27707624|NCT00262522|80765408|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
27707625|NCT00262522|80765409|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
27707626|NCT00262522|80765410|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
27707627|NCT00262522|80765407|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
27707628|NCT00262522|80765408|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
27707629|NCT00262522|80765409|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
27707630|NCT00262522|80765410|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
27888528|NCT00960986|81428012|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
27888529|NCT00960986|81428009|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
27888530|NCT00960986|81428010|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
27888531|NCT00960986|81428011|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
27707631|NCT00262522|80765407|FG000|Study Start Through 8 Weeks|Death|1|||
27707632|NCT00262522|80765408|FG001|Study Start Through 8 Weeks|Death|0|||
27707633|NCT00262522|80765409|FG002|Study Start Through 8 Weeks|Death|0|||
27707634|NCT00262522|80765410|FG003|Study Start Through 8 Weeks|Death|0|||
27707635|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
27707636|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
27707637|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
27707638|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
27707639|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
27707640|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
27707641|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
27835516|NCT00642993|81226190|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
27835517|NCT00642993|81226189|FG000|Overall Study|Protocol Violation|1|||
27835518|NCT00642993|81226190|FG001|Overall Study|Protocol Violation|4|||
27835519|NCT00642993|81226189|FG000|Overall Study|Did not meet protocol eligibility|0|||
27835520|NCT00642993|81226190|FG001|Overall Study|Did not meet protocol eligibility|1|||
27835521|NCT00642993|81226189|FG000|Overall Study|Administrative|1|||
27835522|NCT00642993|81226190|FG001|Overall Study|Administrative|0|||
27835523|NCT02664415|81226194|FG000|Overall Study|Adverse Event|1|||
27835524|NCT02664415|81226195|FG001|Overall Study|Adverse Event|0|||
27835525|NCT01460628|81226204|FG000|Overall Study|Adverse Event|3|||
27601626|NCT01330316|80381637|FG000|Overall Study|other than above|0|||
27888532|NCT00960986|81428012|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
27835526|NCT01460628|81226204|FG000|Overall Study|Withdrawal by Subject|2|||
27888533|NCT00960986|81428009|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
27888534|NCT00960986|81428010|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
27888535|NCT00960986|81428011|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
27888536|NCT00960986|81428012|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
27888537|NCT00960986|81428009|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
27888538|NCT00960986|81428010|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
27888539|NCT00960986|81428011|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
27888540|NCT00960986|81428012|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
27888541|NCT00631410|81428019|FG000|Overall Study|Adverse Event|1|||
27888542|NCT00631410|81428020|FG001|Overall Study|Adverse Event|3|||
27888543|NCT00631410|81428019|FG000|Overall Study|Objective Progression or Relapse|4|||
27888544|NCT00631410|81428020|FG001|Overall Study|Objective Progression or Relapse|3|||
27888545|NCT00631410|81428019|FG000|Overall Study|Surgery|1|||
27888546|NCT00631410|81428020|FG001|Overall Study|Surgery|0|||
27888547|NCT02244463|81428021|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
27888548|NCT02244463|81428022|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
27888549|NCT02244463|81428023|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
27888550|NCT02244463|81428024|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
27888551|NCT02244463|81428025|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
27888552|NCT02244463|81428026|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
27888553|NCT02244463|81428021|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
27888554|NCT02244463|81428022|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
27601627|NCT01330316|80381638|FG001|Overall Study|other than above|1|||
27601628|NCT00404495|80381639|FG000|Overall Study|Death|37|||
27601629|NCT00404495|80381640|FG001|Overall Study|Death|11|||
27601630|NCT00404495|80381639|FG000|Overall Study|Lost to Follow-up|5|||
27601631|NCT00404495|80381640|FG001|Overall Study|Lost to Follow-up|0|||
27601632|NCT00404495|80381639|FG000|Overall Study|Other|1|||
27888555|NCT02244463|81428023|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
27888556|NCT02244463|81428024|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
27601633|NCT00404495|80381640|FG001|Overall Study|Other|0|||
27601634|NCT00404495|80381639|FG000|Overall Study|Withdrawal by Subject|1|||
27601635|NCT00404495|80381640|FG001|Overall Study|Withdrawal by Subject|0|||
27601636|NCT00295022|80381641|FG000|Overall Study|Adverse Event|1|||
27888557|NCT02244463|81428025|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
27888558|NCT02244463|81428026|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
27888559|NCT02244463|81428021|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
27888560|NCT02244463|81428022|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
27888561|NCT02244463|81428023|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
27601637|NCT00295022|80381642|FG001|Overall Study|Adverse Event|1|||
27601638|NCT00295022|80381643|FG002|Overall Study|Adverse Event|2|||
27601639|NCT00295022|80381641|FG000|Overall Study|Lost to Follow-up|0|||
27601640|NCT00295022|80381642|FG001|Overall Study|Lost to Follow-up|0|||
27601641|NCT00295022|80381643|FG002|Overall Study|Lost to Follow-up|1|||
27601642|NCT00295022|80381641|FG000|Overall Study|Withdrawal by Subject|0|||
27601643|NCT00295022|80381642|FG001|Overall Study|Withdrawal by Subject|0|||
27601644|NCT00295022|80381643|FG002|Overall Study|Withdrawal by Subject|2|||
27601645|NCT01353222|80381644|FG000|Overall Study|Death|30|||
27601646|NCT01353222|80381645|FG001|Overall Study|Death|30|||
27707642|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
27707643|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
27835527|NCT00918684|81226205|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
27835528|NCT00918684|81226205|FG000|Treatment Phase|Lack of Efficacy|6|||
27835529|NCT00918684|81226205|FG000|Treatment Phase|Lost to Follow-up|2|||
27835530|NCT00918684|81226205|FG000|Treatment Phase|Physician Decision|8|||
27835531|NCT00918684|81226205|FG000|Treatment Phase|Protocol Violation|1|||
27601647|NCT01353222|80381644|FG000|Overall Study|Withdrawal by Subject|8|||
27601648|NCT01353222|80381645|FG001|Overall Study|Withdrawal by Subject|5|||
27601649|NCT01353222|80381644|FG000|Overall Study|Study Terminated|31|||
27601650|NCT01353222|80381645|FG001|Overall Study|Study Terminated|37|||
27601651|NCT01353222|80381644|FG000|Overall Study|Site closed research department|1|||
27601652|NCT01353222|80381645|FG001|Overall Study|Site closed research department|0|||
27601653|NCT02658630|80381646|FG000|Overall Study|Withdrawal by Subject|4|||
27601654|NCT01197508|80381647|FG000|Overall Study|Withdrawal by Subject|8|||
27601655|NCT01197508|80381648|FG001|Overall Study|Withdrawal by Subject|7|||
27601656|NCT01197508|80381649|FG002|Overall Study|Withdrawal by Subject|15|||
27601657|NCT01197508|80381650|FG003|Overall Study|Withdrawal by Subject|4|||
27601658|NCT01197508|80381647|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
27601659|NCT01197508|80381648|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
27601660|NCT01197508|80381649|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
27601661|NCT01197508|80381650|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
27601662|NCT01197508|80381647|FG000|Overall Study|Adverse Event|10|||
27601663|NCT01197508|80381648|FG001|Overall Study|Adverse Event|13|||
27601664|NCT01197508|80381649|FG002|Overall Study|Adverse Event|23|||
27601665|NCT01197508|80381650|FG003|Overall Study|Adverse Event|3|||
27601666|NCT01197508|80381647|FG000|Overall Study|Severe non-compliance to protocol|0|||
27888562|NCT02244463|81428024|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
27888563|NCT02244463|81428025|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
27888564|NCT02244463|81428026|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
27888565|NCT02244463|81428021|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
27888566|NCT02244463|81428022|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
27888567|NCT02244463|81428023|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
27888568|NCT02244463|81428024|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
27888569|NCT02244463|81428025|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
27888570|NCT02244463|81428026|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
27888571|NCT02244463|81428021|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
27888572|NCT02244463|81428022|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
27888573|NCT02244463|81428023|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
27888574|NCT02244463|81428024|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
27888575|NCT02244463|81428025|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
27888576|NCT02244463|81428026|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
27888577|NCT02244463|81428021|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
27888578|NCT02244463|81428022|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
27888579|NCT02244463|81428023|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
27888580|NCT02244463|81428024|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
27888581|NCT02244463|81428025|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
27888582|NCT02244463|81428026|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
27888583|NCT02244463|81428021|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
27888584|NCT02244463|81428022|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
27888585|NCT02244463|81428023|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
27888586|NCT02244463|81428024|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
27888587|NCT02244463|81428025|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
27888588|NCT02244463|81428026|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
27888589|NCT02244463|81428021|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
27888590|NCT02244463|81428022|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
27888591|NCT02244463|81428023|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
27888592|NCT02244463|81428024|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
27888593|NCT02244463|81428025|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
27888594|NCT02244463|81428026|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
27888595|NCT02244463|81428021|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
27888596|NCT02244463|81428022|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
27888597|NCT02244463|81428023|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
27888598|NCT02244463|81428024|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
27888599|NCT02244463|81428025|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
27888600|NCT02244463|81428026|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
27888601|NCT02244463|81428021|FG000|Period 5: Phase II|Disease Progression|0|||
27888602|NCT02244463|81428022|FG001|Period 5: Phase II|Disease Progression|0|||
27888603|NCT02244463|81428023|FG002|Period 5: Phase II|Disease Progression|0|||
27888604|NCT02244463|81428024|FG003|Period 5: Phase II|Disease Progression|0|||
27888605|NCT02244463|81428025|FG004|Period 5: Phase II|Disease Progression|10|||
27601667|NCT01197508|80381648|FG001|Overall Study|Severe non-compliance to protocol|3|||
27601668|NCT01197508|80381649|FG002|Overall Study|Severe non-compliance to protocol|1|||
27601669|NCT01197508|80381650|FG003|Overall Study|Severe non-compliance to protocol|3|||
27601670|NCT01197508|80381647|FG000|Overall Study|Condition under investigation worsened|1|||
27601671|NCT01197508|80381648|FG001|Overall Study|Condition under investigation worsened|1|||
27888606|NCT02244463|81428026|FG005|Period 5: Phase II|Disease Progression|11|||
27888607|NCT02244463|81428021|FG000|Period 5: Phase II|Physician Decision|0|||
27601672|NCT01197508|80381649|FG002|Overall Study|Condition under investigation worsened|1|||
27888608|NCT02244463|81428022|FG001|Period 5: Phase II|Physician Decision|0|||
27888609|NCT02244463|81428023|FG002|Period 5: Phase II|Physician Decision|0|||
27888610|NCT02244463|81428024|FG003|Period 5: Phase II|Physician Decision|0|||
27888611|NCT02244463|81428025|FG004|Period 5: Phase II|Physician Decision|3|||
27888612|NCT02244463|81428026|FG005|Period 5: Phase II|Physician Decision|2|||
27888613|NCT02244463|81428021|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
27888614|NCT02244463|81428022|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
27888615|NCT02244463|81428023|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
27888616|NCT02244463|81428024|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
27888617|NCT02244463|81428025|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
27888618|NCT02244463|81428026|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
27888619|NCT02244463|81428021|FG000|Period 5: Phase II|Intercurrent Illness|0|||
27888620|NCT02244463|81428022|FG001|Period 5: Phase II|Intercurrent Illness|0|||
27888621|NCT02244463|81428023|FG002|Period 5: Phase II|Intercurrent Illness|0|||
27888622|NCT02244463|81428024|FG003|Period 5: Phase II|Intercurrent Illness|0|||
27888623|NCT02244463|81428025|FG004|Period 5: Phase II|Intercurrent Illness|2|||
27888624|NCT02244463|81428026|FG005|Period 5: Phase II|Intercurrent Illness|0|||
27888625|NCT02244463|81428021|FG000|Period 5: Phase II|Adverse Event|0|||
27888626|NCT02244463|81428022|FG001|Period 5: Phase II|Adverse Event|0|||
27888627|NCT02244463|81428023|FG002|Period 5: Phase II|Adverse Event|0|||
27888628|NCT02244463|81428024|FG003|Period 5: Phase II|Adverse Event|0|||
27888629|NCT02244463|81428025|FG004|Period 5: Phase II|Adverse Event|0|||
27888630|NCT02244463|81428026|FG005|Period 5: Phase II|Adverse Event|2|||
27888631|NCT02244463|81428021|FG000|Period 5: Phase II|Still On treatment|0|||
27888632|NCT02244463|81428022|FG001|Period 5: Phase II|Still On treatment|0|||
27888633|NCT02244463|81428023|FG002|Period 5: Phase II|Still On treatment|0|||
27888634|NCT02244463|81428024|FG003|Period 5: Phase II|Still On treatment|0|||
27888635|NCT02244463|81428025|FG004|Period 5: Phase II|Still On treatment|0|||
27888636|NCT02244463|81428026|FG005|Period 5: Phase II|Still On treatment|3|||
27888637|NCT03483961|81428034|FG000|Overall Study|Lost to Follow-up|7|||
27888638|NCT03483961|81428035|FG001|Overall Study|Lost to Follow-up|6|||
27888639|NCT03483961|81428036|FG002|Overall Study|Lost to Follow-up|6|||
27888640|NCT03483961|81428037|FG003|Overall Study|Lost to Follow-up|6|||
27888641|NCT03483961|81428038|FG004|Overall Study|Lost to Follow-up|6|||
27888642|NCT03483961|81428039|FG005|Overall Study|Lost to Follow-up|4|||
27888643|NCT03483961|81428040|FG006|Overall Study|Lost to Follow-up|4|||
27888644|NCT03483961|81428041|FG007|Overall Study|Lost to Follow-up|11|||
27888645|NCT03483961|81428042|FG008|Overall Study|Lost to Follow-up|1|||
27888646|NCT03483961|81428043|FG009|Overall Study|Lost to Follow-up|0|||
27888647|NCT03483961|81428034|FG000|Overall Study|Withdrawal by Subject|3|||
27888648|NCT03483961|81428035|FG001|Overall Study|Withdrawal by Subject|4|||
27888649|NCT03483961|81428036|FG002|Overall Study|Withdrawal by Subject|5|||
27888650|NCT03483961|81428037|FG003|Overall Study|Withdrawal by Subject|3|||
27888651|NCT03483961|81428038|FG004|Overall Study|Withdrawal by Subject|4|||
27888652|NCT03483961|81428039|FG005|Overall Study|Withdrawal by Subject|2|||
27888653|NCT03483961|81428040|FG006|Overall Study|Withdrawal by Subject|1|||
27888654|NCT03483961|81428041|FG007|Overall Study|Withdrawal by Subject|2|||
27888655|NCT03483961|81428042|FG008|Overall Study|Withdrawal by Subject|1|||
27835532|NCT00918684|81226205|FG000|Treatment Phase|Withdrawal by Subject|8|||
27835533|NCT00252564|81226206|FG000|Overall Study|Adverse Event|17|||
27835534|NCT00252564|81226207|FG001|Overall Study|Adverse Event|13|||
27835535|NCT00252564|81226206|FG000|Overall Study|Unrelated Complication|2|||
27835536|NCT00252564|81226207|FG001|Overall Study|Unrelated Complication|1|||
27835537|NCT00252564|81226206|FG000|Overall Study|Disease Progression|14|||
27835538|NCT00252564|81226207|FG001|Overall Study|Disease Progression|20|||
27835539|NCT00252564|81226206|FG000|Overall Study|Death|0|||
27835540|NCT00252564|81226207|FG001|Overall Study|Death|3|||
27835541|NCT00252564|81226206|FG000|Overall Study|Physician Decision|1|||
27835542|NCT00252564|81226207|FG001|Overall Study|Physician Decision|0|||
27888656|NCT03483961|81428043|FG009|Overall Study|Withdrawal by Subject|0|||
27888657|NCT03483961|81428034|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
27888658|NCT03483961|81428035|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888659|NCT03483961|81428036|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27835543|NCT00252564|81226206|FG000|Overall Study|Lost to Follow-up|1|||
27835544|NCT00252564|81226207|FG001|Overall Study|Lost to Follow-up|0|||
27835545|NCT00252564|81226206|FG000|Overall Study|Patient Request|4|||
27835546|NCT00252564|81226207|FG001|Overall Study|Patient Request|5|||
27888660|NCT03483961|81428037|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888661|NCT03483961|81428038|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27835547|NCT00252564|81226206|FG000|Overall Study|Withdrawal by Subject|0|||
27835548|NCT00252564|81226207|FG001|Overall Study|Withdrawal by Subject|2|||
27835549|NCT04010227|81226210|FG000|Overall Study|Death|1|||
27835550|NCT04010227|81226211|FG001|Overall Study|Death|2|||
27835551|NCT04010227|81226210|FG000|Overall Study|Medical Reasons|4|||
27835552|NCT04010227|81226211|FG001|Overall Study|Medical Reasons|3|||
27835553|NCT04010227|81226210|FG000|Overall Study|Withdrawal by Subject|2|||
27835554|NCT04010227|81226211|FG001|Overall Study|Withdrawal by Subject|0|||
27835555|NCT04010227|81226210|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
27888662|NCT03483961|81428039|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888663|NCT03483961|81428040|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888664|NCT03483961|81428041|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888665|NCT03483961|81428042|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888666|NCT03483961|81428043|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
27888667|NCT03483961|81428034|FG000|Overall Study|Adverse Event|0|||
27888668|NCT03483961|81428035|FG001|Overall Study|Adverse Event|0|||
27888669|NCT03483961|81428036|FG002|Overall Study|Adverse Event|1|||
27888670|NCT03483961|81428037|FG003|Overall Study|Adverse Event|0|||
27888671|NCT03483961|81428038|FG004|Overall Study|Adverse Event|0|||
27888672|NCT03483961|81428039|FG005|Overall Study|Adverse Event|0|||
27888673|NCT03483961|81428040|FG006|Overall Study|Adverse Event|0|||
27888674|NCT03483961|81428041|FG007|Overall Study|Adverse Event|0|||
27888675|NCT03483961|81428042|FG008|Overall Study|Adverse Event|0|||
27888676|NCT03483961|81428043|FG009|Overall Study|Adverse Event|0|||
27888677|NCT00623935|81428046|FG000|Overall Study|Death|1|||
27888678|NCT00623935|81428046|FG000|Overall Study|Patient Declined Transplant|1|||
27888679|NCT05238025|81428048|FG000|Overall Study|Adverse Event|2|||
27888680|NCT05238025|81428049|FG001|Overall Study|Adverse Event|2|||
27888681|NCT05238025|81428048|FG000|Overall Study|Lost to Follow-up|334|||
27888682|NCT05238025|81428049|FG001|Overall Study|Lost to Follow-up|339|||
27888683|NCT05238025|81428048|FG000|Overall Study|Withdrawal by Subject|203|||
27888684|NCT05238025|81428049|FG001|Overall Study|Withdrawal by Subject|222|||
27888685|NCT05238025|81428048|FG000|Overall Study|Physician Decision|20|||
27888686|NCT05238025|81428049|FG001|Overall Study|Physician Decision|8|||
27888687|NCT05238025|81428048|FG000|Overall Study|Protocol Violation|6|||
27888688|NCT05238025|81428049|FG001|Overall Study|Protocol Violation|2|||
27888689|NCT05238025|81428048|FG000|Overall Study|Death|38|||
27888690|NCT05238025|81428049|FG001|Overall Study|Death|32|||
27888691|NCT05238025|81428048|FG000|Overall Study|Study terminated by Sponsor|6358|||
27888692|NCT05238025|81428049|FG001|Overall Study|Study terminated by Sponsor|6358|||
27888693|NCT05238025|81428048|FG000|Overall Study|Other Reason|669|||
27888694|NCT05238025|81428049|FG001|Overall Study|Other Reason|690|||
27888695|NCT03348930|81428053|FG000|Washout (1 Week)|Lost to Follow-up|1|||
27888696|NCT03348930|81428054|FG001|Washout (1 Week)|Lost to Follow-up|1|||
27888697|NCT00355147|81428059|FG000|Overall Study|Lost to Follow-up|10|||
27888698|NCT00355147|81428060|FG001|Overall Study|Lost to Follow-up|8|||
27888699|NCT00355147|81428059|FG000|Overall Study|Withdrawal by Subject|8|||
27888700|NCT00355147|81428060|FG001|Overall Study|Withdrawal by Subject|12|||
27888701|NCT02759055|81428061|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
27888702|NCT02759055|81428062|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
27888703|NCT00675428|81428065|FG000|Overall Study|Disease Progression|2|||
27888704|NCT00675428|81428066|FG001|Overall Study|Disease Progression|2|||
27888705|NCT00675428|81428065|FG000|Overall Study|No Disease Response After Cycle 6|0|||
27888706|NCT00675428|81428066|FG001|Overall Study|No Disease Response After Cycle 6|1|||
27707644|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
27888707|NCT00675428|81428065|FG000|Overall Study|Physician Decision|1|||
27888708|NCT00675428|81428066|FG001|Overall Study|Physician Decision|0|||
27888709|NCT03301844|81428067|FG000|Overall Study|suspected colon cancer|1|||
27888710|NCT03301844|81428068|FG001|Overall Study|suspected colon cancer|1|||
27888711|NCT03528369|81428069|FG000|Overall Study|Withdrawal by Subject|2|||
27888712|NCT03528369|81428070|FG001|Overall Study|Withdrawal by Subject|0|||
27888713|NCT03528369|81428071|FG002|Overall Study|Withdrawal by Subject|0|||
27888714|NCT03528369|81428069|FG000|Overall Study|Lost to Follow-up|1|||
27707645|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
27888715|NCT03528369|81428070|FG001|Overall Study|Lost to Follow-up|0|||
27888716|NCT03528369|81428071|FG002|Overall Study|Lost to Follow-up|0|||
27888717|NCT03528369|81428069|FG000|Overall Study|Adverse Event|0|||
27888718|NCT03528369|81428070|FG001|Overall Study|Adverse Event|1|||
27835556|NCT04010227|81226211|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
27601673|NCT01197508|80381650|FG003|Overall Study|Condition under investigation worsened|1|||
27601674|NCT01197508|80381647|FG000|Overall Study|Lack of Efficacy|1|||
27601675|NCT01197508|80381648|FG001|Overall Study|Lack of Efficacy|2|||
27601676|NCT01197508|80381649|FG002|Overall Study|Lack of Efficacy|2|||
27601677|NCT01197508|80381650|FG003|Overall Study|Lack of Efficacy|1|||
27601678|NCT01197508|80381647|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27601679|NCT01197508|80381648|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27601680|NCT01197508|80381649|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27601681|NCT01197508|80381650|FG003|Overall Study|Study-specific withdrawal criteria|2|||
27601682|NCT01197508|80381647|FG000|Overall Study|Lost to Follow-up|1|||
27601683|NCT01197508|80381648|FG001|Overall Study|Lost to Follow-up|1|||
27601684|NCT01197508|80381649|FG002|Overall Study|Lost to Follow-up|2|||
27601685|NCT01197508|80381650|FG003|Overall Study|Lost to Follow-up|0|||
27601686|NCT01197508|80381647|FG000|Overall Study|Other|2|||
27888719|NCT03528369|81428071|FG002|Overall Study|Adverse Event|0|||
27601687|NCT01197508|80381648|FG001|Overall Study|Other|3|||
27601688|NCT01197508|80381649|FG002|Overall Study|Other|2|||
27601689|NCT01197508|80381650|FG003|Overall Study|Other|2|||
27601690|NCT02686034|80381651|FG000|Run-In Period 1|Eligibility|12|||
27601691|NCT02686034|80381652|FG001|Run-In Period 1|Eligibility|10|||
27601692|NCT02686034|80381651|FG000|Run-In Period 1|Withdrawal by Subject|4|||
27601693|NCT02686034|80381652|FG001|Run-In Period 1|Withdrawal by Subject|3|||
27601694|NCT02686034|80381651|FG000|Run-In Period 1|Lost to Follow-up|4|||
27601695|NCT02686034|80381652|FG001|Run-In Period 1|Lost to Follow-up|4|||
27601696|NCT02686034|80381651|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
27601697|NCT02686034|80381652|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
27601698|NCT02686034|80381651|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
27601699|NCT02686034|80381652|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
27601700|NCT02686034|80381651|FG000|Randomized Controlled Period 2|Adverse Event|0|||
27601701|NCT02686034|80381652|FG001|Randomized Controlled Period 2|Adverse Event|2|||
27601702|NCT02686034|80381651|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
27601703|NCT02686034|80381652|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
27601704|NCT02686034|80381651|FG000|Open Label Period 3|Lost to Follow-up|0|||
27601705|NCT02686034|80381652|FG001|Open Label Period 3|Lost to Follow-up|1|||
27601706|NCT03021668|80381654|FG000|Overall Study|Physician Decision|0|||
27601707|NCT03021668|80381655|FG001|Overall Study|Physician Decision|1|||
27601708|NCT03409666|80381656|FG000|Overall Study|Physician Decision|0|||
27601709|NCT03409666|80381657|FG001|Overall Study|Physician Decision|1|||
27601710|NCT03409666|80381656|FG000|Overall Study|Protocol Violation|0|||
27601711|NCT03409666|80381657|FG001|Overall Study|Protocol Violation|3|||
27601712|NCT00441090|80381661|FG000|Overall Study|Adverse Event|0|||
27601713|NCT00441090|80381662|FG001|Overall Study|Adverse Event|1|||
27601714|NCT00441090|80381663|FG002|Overall Study|Adverse Event|1|||
27601715|NCT00441090|80381664|FG003|Overall Study|Adverse Event|0|||
27601716|NCT00441090|80381665|FG004|Overall Study|Adverse Event|0|||
27601717|NCT00441090|80381661|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
27601718|NCT00441090|80381662|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
27601719|NCT00441090|80381663|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
27601720|NCT00441090|80381664|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
27601721|NCT00441090|80381665|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
27601722|NCT00441090|80381661|FG000|Overall Study|Withdrawal by Subject|1|||
27601723|NCT00441090|80381662|FG001|Overall Study|Withdrawal by Subject|0|||
27601724|NCT00441090|80381663|FG002|Overall Study|Withdrawal by Subject|1|||
27601725|NCT00441090|80381664|FG003|Overall Study|Withdrawal by Subject|0|||
27707646|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
27707647|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
27601726|NCT00441090|80381665|FG004|Overall Study|Withdrawal by Subject|0|||
27601727|NCT00441090|80381661|FG000|Overall Study|Lack of Efficacy|1|||
27601728|NCT00441090|80381662|FG001|Overall Study|Lack of Efficacy|0|||
27601729|NCT00441090|80381663|FG002|Overall Study|Lack of Efficacy|0|||
27601730|NCT00441090|80381664|FG003|Overall Study|Lack of Efficacy|0|||
27835557|NCT02676973|81226212|FG000|Overall Study|Withdrawal by Subject|9|||
27835558|NCT02676973|81226213|FG001|Overall Study|Withdrawal by Subject|8|||
27835559|NCT02676973|81226214|FG002|Overall Study|Withdrawal by Subject|11|||
27835560|NCT02676973|81226212|FG000|Overall Study|Lost to Follow-up|8|||
27835561|NCT02676973|81226213|FG001|Overall Study|Lost to Follow-up|12|||
27835562|NCT02676973|81226214|FG002|Overall Study|Lost to Follow-up|8|||
27835563|NCT02676973|81226212|FG000|Overall Study|Death|2|||
27835564|NCT02676973|81226213|FG001|Overall Study|Death|1|||
27835565|NCT02676973|81226214|FG002|Overall Study|Death|5|||
27835566|NCT02420353|81226215|FG000|Overall Study|Withdrawal by Subject|0|||
27835567|NCT02420353|81226216|FG001|Overall Study|Withdrawal by Subject|1|||
27835568|NCT02623218|81226217|FG000|Overall Study|Lost to Follow-up|0|||
27835569|NCT02623218|81226218|FG001|Overall Study|Lost to Follow-up|1|||
27835570|NCT02623218|81226219|FG002|Overall Study|Lost to Follow-up|0|||
27835571|NCT02623218|81226220|FG003|Overall Study|Lost to Follow-up|0|||
27835572|NCT02623218|81226221|FG004|Overall Study|Lost to Follow-up|0|||
27835573|NCT01488448|81226222|FG000|Overall Study|Withdrawal by Subject|3|||
27835574|NCT01488448|81226223|FG001|Overall Study|Withdrawal by Subject|1|||
27835575|NCT01488448|81226222|FG000|Overall Study|Adverse Event|9|||
27835576|NCT01488448|81226223|FG001|Overall Study|Adverse Event|4|||
27835577|NCT01488448|81226222|FG000|Overall Study|Physician Decision|4|||
27835578|NCT01488448|81226223|FG001|Overall Study|Physician Decision|9|||
27835579|NCT01488448|81226222|FG000|Overall Study|Protocol Violation|4|||
27835580|NCT01488448|81226223|FG001|Overall Study|Protocol Violation|3|||
27835581|NCT00735696|81226224|FG000|Overall Study|Withdrawal by Subject|1|||
27835582|NCT00735696|81226224|FG000|Overall Study|Enrolled but never Treated|1|||
27835583|NCT04878211|81226226|FG000|Overall Study|Lost to Follow-up|0|||
27835584|NCT04878211|81226227|FG001|Overall Study|Lost to Follow-up|0|||
27835585|NCT04878211|81226228|FG002|Overall Study|Lost to Follow-up|0|||
27835586|NCT04878211|81226229|FG003|Overall Study|Lost to Follow-up|1|||
27835587|NCT04878211|81226230|FG004|Overall Study|Lost to Follow-up|0|||
27835588|NCT04878211|81226231|FG005|Overall Study|Lost to Follow-up|1|||
27835589|NCT04878211|81226226|FG000|Overall Study|Protocol deviation|1|||
27835590|NCT04878211|81226227|FG001|Overall Study|Protocol deviation|0|||
27835591|NCT04878211|81226228|FG002|Overall Study|Protocol deviation|0|||
27835592|NCT04878211|81226229|FG003|Overall Study|Protocol deviation|0|||
27835593|NCT04878211|81226230|FG004|Overall Study|Protocol deviation|0|||
27835594|NCT04878211|81226231|FG005|Overall Study|Protocol deviation|0|||
27835595|NCT04878211|81226226|FG000|Overall Study|Study terminated by sponsor|0|||
27835596|NCT04878211|81226227|FG001|Overall Study|Study terminated by sponsor|0|||
27835597|NCT04878211|81226228|FG002|Overall Study|Study terminated by sponsor|0|||
27835598|NCT04878211|81226229|FG003|Overall Study|Study terminated by sponsor|0|||
27835599|NCT04878211|81226230|FG004|Overall Study|Study terminated by sponsor|9|||
27835600|NCT04878211|81226231|FG005|Overall Study|Study terminated by sponsor|4|||
27835601|NCT04878211|81226226|FG000|Overall Study|Subject decision|0|||
27835602|NCT04878211|81226227|FG001|Overall Study|Subject decision|0|||
27835603|NCT04878211|81226228|FG002|Overall Study|Subject decision|0|||
27835604|NCT04878211|81226229|FG003|Overall Study|Subject decision|0|||
27835605|NCT04878211|81226230|FG004|Overall Study|Subject decision|1|||
27835606|NCT04878211|81226231|FG005|Overall Study|Subject decision|0|||
27835607|NCT01320722|81226236|FG000|Overall Study|Did not Receive Intervention|3|||
27835608|NCT01320722|81226237|FG001|Overall Study|Did not Receive Intervention|2|||
27835609|NCT01320722|81226238|FG002|Overall Study|Did not Receive Intervention|1|||
27835610|NCT01320722|81226239|FG003|Overall Study|Did not Receive Intervention|1|||
27835611|NCT01320722|81226240|FG004|Overall Study|Did not Receive Intervention|2|||
27835612|NCT01320722|81226236|FG000|Overall Study|Lost to Follow-up|0|||
27835613|NCT01320722|81226237|FG001|Overall Study|Lost to Follow-up|1|||
27835614|NCT01320722|81226238|FG002|Overall Study|Lost to Follow-up|0|||
27835615|NCT01320722|81226239|FG003|Overall Study|Lost to Follow-up|1|||
27835616|NCT01320722|81226240|FG004|Overall Study|Lost to Follow-up|3|||
27601731|NCT00441090|80381665|FG004|Overall Study|Lack of Efficacy|0|||
27601732|NCT03224182|80381666|FG000|Overall Study|Study Drug Not Instilled|6|||
27601733|NCT03224182|80381667|FG001|Overall Study|Study Drug Not Instilled|1|||
27601734|NCT03224182|80381666|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
27601735|NCT03224182|80381667|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
27601736|NCT03224182|80381666|FG000|Overall Study|Withdrew of Consent|4|||
27601737|NCT03224182|80381667|FG001|Overall Study|Withdrew of Consent|2|||
27835617|NCT01320722|81226236|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
27835618|NCT01320722|81226237|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
27835619|NCT01320722|81226238|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
27835620|NCT01320722|81226239|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
27601738|NCT03224182|80381666|FG000|Overall Study|Investigator Decision|3|||
27601739|NCT03224182|80381667|FG001|Overall Study|Investigator Decision|1|||
27601740|NCT03224182|80381666|FG000|Overall Study|Sponsor Decision|26|||
27601741|NCT03224182|80381667|FG001|Overall Study|Sponsor Decision|12|||
27601742|NCT03224182|80381666|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
27601743|NCT03224182|80381667|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
27601744|NCT03224182|80381666|FG000|Overall Study|Lost to Follow-up|1|||
27601745|NCT03224182|80381667|FG001|Overall Study|Lost to Follow-up|0|||
27601746|NCT03224182|80381666|FG000|Overall Study|Participant Had Recurrence|11|||
27601747|NCT03224182|80381667|FG001|Overall Study|Participant Had Recurrence|5|||
27601748|NCT03224182|80381666|FG000|Overall Study|Death|0|||
27601749|NCT03224182|80381667|FG001|Overall Study|Death|1|||
27601750|NCT03224182|80381666|FG000|Overall Study|Reason not Specified|3|||
27601751|NCT03224182|80381667|FG001|Overall Study|Reason not Specified|3|||
27601752|NCT03224182|80381666|FG000|Overall Study|Other|1|||
27601753|NCT03224182|80381667|FG001|Overall Study|Other|0|||
27601754|NCT00266825|80381670|FG000|Completed Follow-Up|Lost to Follow-up|14|||
27601755|NCT00266825|80381671|FG001|Completed Follow-Up|Lost to Follow-up|19|||
27601756|NCT00266825|80381670|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
27601757|NCT00266825|80381671|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
27601758|NCT03255824|80381678|FG000|Overall Study|Under-sedation|2|||
27601759|NCT03255824|80381679|FG001|Overall Study|Under-sedation|1|||
27601760|NCT02641392|80381682|FG000|Overall Study|Lost to Follow-up|0|||
27601761|NCT02641392|80381683|FG001|Overall Study|Lost to Follow-up|0|||
27601762|NCT02641392|80381684|FG002|Overall Study|Lost to Follow-up|2|||
27601763|NCT02641392|80381682|FG000|Overall Study|Withdrawal by Subject|0|||
27601764|NCT02641392|80381683|FG001|Overall Study|Withdrawal by Subject|0|||
27601765|NCT02641392|80381684|FG002|Overall Study|Withdrawal by Subject|17|||
27601766|NCT02641392|80381682|FG000|Overall Study|Adverse Event|0|||
27601767|NCT02641392|80381683|FG001|Overall Study|Adverse Event|1|||
27601768|NCT02641392|80381684|FG002|Overall Study|Adverse Event|25|||
27601769|NCT02641392|80381682|FG000|Overall Study|Study Terminated by Sponsor|4|||
27707648|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
27707649|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
27707650|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
27707651|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Death|2|||
27707652|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Death|0|||
27707653|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Death|1|||
27707654|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Death|0|||
27707655|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
27707656|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
27707657|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
27707658|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
27707659|NCT00262522|80765407|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
27707660|NCT00262522|80765408|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
27707661|NCT00262522|80765409|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
27707662|NCT00262522|80765410|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
27707663|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
27707664|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
27707665|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
27835621|NCT01320722|81226240|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
27835622|NCT01320722|81226236|FG000|Overall Study|Participant Developed a Rash|0|||
27835623|NCT01320722|81226237|FG001|Overall Study|Participant Developed a Rash|0|||
27835624|NCT01320722|81226238|FG002|Overall Study|Participant Developed a Rash|2|||
27835625|NCT01320722|81226239|FG003|Overall Study|Participant Developed a Rash|1|||
27835626|NCT01320722|81226240|FG004|Overall Study|Participant Developed a Rash|1|||
27835627|NCT01320722|81226236|FG000|Overall Study|Non-compliant with Medication|0|||
27835628|NCT01320722|81226237|FG001|Overall Study|Non-compliant with Medication|0|||
27835629|NCT01320722|81226238|FG002|Overall Study|Non-compliant with Medication|1|||
27835630|NCT01320722|81226239|FG003|Overall Study|Non-compliant with Medication|0|||
27835631|NCT01320722|81226240|FG004|Overall Study|Non-compliant with Medication|0|||
27835632|NCT01320722|81226236|FG000|Overall Study|Adverse Event|0|||
27835633|NCT01320722|81226237|FG001|Overall Study|Adverse Event|0|||
27835634|NCT01320722|81226238|FG002|Overall Study|Adverse Event|3|||
27835635|NCT01320722|81226239|FG003|Overall Study|Adverse Event|6|||
27835636|NCT01320722|81226240|FG004|Overall Study|Adverse Event|0|||
27835637|NCT01320722|81226236|FG000|Overall Study|Not Compliant with Study Procedures|0|||
27835638|NCT01320722|81226237|FG001|Overall Study|Not Compliant with Study Procedures|0|||
27835639|NCT01320722|81226238|FG002|Overall Study|Not Compliant with Study Procedures|0|||
27707666|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
27707667|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
27835640|NCT01320722|81226239|FG003|Overall Study|Not Compliant with Study Procedures|4|||
27888720|NCT00435487|81428077|FG000|Overall Study|Death|3|||
27835641|NCT01320722|81226240|FG004|Overall Study|Not Compliant with Study Procedures|0|||
27835642|NCT01320722|81226236|FG000|Overall Study|Pregnancy|0|||
27835643|NCT01320722|81226237|FG001|Overall Study|Pregnancy|0|||
27888721|NCT00435487|81428078|FG001|Overall Study|Death|4|||
27707668|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
27707669|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
27707670|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
27707671|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
27707672|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
27707673|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
27707674|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
27707675|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
27707676|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
27707677|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
27707678|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
27707679|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Death|2|||
27707680|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Death|0|||
27707681|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Death|2|||
27707682|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Death|0|||
27707683|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
27707684|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
27707685|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
27601770|NCT02641392|80381683|FG001|Overall Study|Study Terminated by Sponsor|12|||
27601771|NCT02641392|80381684|FG002|Overall Study|Study Terminated by Sponsor|144|||
27601772|NCT02641392|80381682|FG000|Overall Study|Lack of Efficacy|0|||
27601773|NCT02641392|80381683|FG001|Overall Study|Lack of Efficacy|0|||
27601774|NCT02641392|80381684|FG002|Overall Study|Lack of Efficacy|101|||
27601775|NCT02641392|80381682|FG000|Overall Study|Miscellaneous|0|||
27601776|NCT02641392|80381683|FG001|Overall Study|Miscellaneous|0|||
27601777|NCT02641392|80381684|FG002|Overall Study|Miscellaneous|3|||
27601778|NCT02641392|80381682|FG000|Overall Study|Death|0|||
27601779|NCT02641392|80381683|FG001|Overall Study|Death|0|||
27601780|NCT02641392|80381684|FG002|Overall Study|Death|1|||
27601781|NCT01078155|80381685|FG000|Overall Study|Adverse Event|7|||
27601782|NCT01078155|80381685|FG000|Overall Study|Lack of Efficacy|16|||
27601783|NCT01078155|80381685|FG000|Overall Study|Participant's Decision|6|||
27601784|NCT01078155|80381685|FG000|Overall Study|Lost to Follow-up|15|||
27601785|NCT02240108|80381686|FG000|Overall Study|Other than specified|8|||
27601786|NCT02240108|80381687|FG001|Overall Study|Other than specified|6|||
27601787|NCT02240108|80381686|FG000|Overall Study|Adverse Event|1|||
27601788|NCT02240108|80381687|FG001|Overall Study|Adverse Event|9|||
27601789|NCT02240108|80381686|FG000|Overall Study|Pregnancy|1|||
27601790|NCT02240108|80381687|FG001|Overall Study|Pregnancy|0|||
27601791|NCT02240108|80381686|FG000|Overall Study|Withdrawal by Subject|4|||
27601792|NCT02240108|80381687|FG001|Overall Study|Withdrawal by Subject|9|||
27601793|NCT02240108|80381686|FG000|Overall Study|StudyTerminated by Sponsor|0|||
27601794|NCT02240108|80381687|FG001|Overall Study|StudyTerminated by Sponsor|1|||
27601795|NCT01435655|80381688|FG000|Overall Study|Death|2|||
27601796|NCT01435655|80381688|FG000|Overall Study|Other|1|||
27601797|NCT00844857|80381689|FG000|Overall Study|Adverse Event|24|||
27601798|NCT00844857|80381690|FG001|Overall Study|Adverse Event|5|||
27601799|NCT00844857|80381689|FG000|Overall Study|Sponsor Decision|1|||
27601800|NCT00844857|80381690|FG001|Overall Study|Sponsor Decision|1|||
27601801|NCT00844857|80381689|FG000|Overall Study|Physician Decision|2|||
27601802|NCT00844857|80381690|FG001|Overall Study|Physician Decision|0|||
27601803|NCT00844857|80381689|FG000|Overall Study|Parent/Caregiver Decision|6|||
27601804|NCT00844857|80381690|FG001|Overall Study|Parent/Caregiver Decision|2|||
27601805|NCT00844857|80381689|FG000|Overall Study|Withdrawal by Subject|8|||
27707686|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
27707687|NCT00262522|80765407|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
27707688|NCT00262522|80765408|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
27601806|NCT00844857|80381690|FG001|Overall Study|Withdrawal by Subject|7|||
27601807|NCT00844857|80381689|FG000|Overall Study|Protocol Violation|6|||
27601808|NCT00844857|80381690|FG001|Overall Study|Protocol Violation|0|||
27601809|NCT00844857|80381689|FG000|Overall Study|Lack of Efficacy|5|||
27707689|NCT00262522|80765409|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
27707690|NCT00262522|80765410|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
27707691|NCT02664272|80765413|FG000|Overall Study|Fluoroscopic images not made available|2|||
27707692|NCT00761306|80765426|FG000|Overall Study|Adverse Event|5|||
27707693|NCT00761306|80765426|FG000|Overall Study|Lack of Efficacy|4|||
27707694|NCT00761306|80765426|FG000|Overall Study|Protocol Violation|2|||
27707695|NCT00761306|80765426|FG000|Overall Study|Withdrawal of Consent|3|||
27707696|NCT00761306|80765426|FG000|Overall Study|Lost to Follow-up|1|||
27707697|NCT00761306|80765426|FG000|Overall Study|Administrative or Other Reasons|5|||
27707698|NCT00636675|80765429|FG000|Overall Study|Lost to Follow-up|121|||
27707699|NCT00636675|80765430|FG001|Overall Study|Lost to Follow-up|31|||
27707700|NCT00636675|80765429|FG000|Overall Study|Withdrawal by Subject|19|||
27707701|NCT00636675|80765430|FG001|Overall Study|Withdrawal by Subject|10|||
27707702|NCT03150862|80765431|FG000|Overall Study|Death|2|||
27707703|NCT03150862|80765432|FG001|Overall Study|Death|7|||
27707704|NCT03150862|80765433|FG002|Overall Study|Death|8|||
27707705|NCT03150862|80765434|FG003|Overall Study|Death|27|||
27707706|NCT03150862|80765435|FG004|Overall Study|Death|4|||
27707707|NCT03150862|80765436|FG005|Overall Study|Death|8|||
27707708|NCT03150862|80765437|FG006|Overall Study|Death|6|||
27707709|NCT03150862|80765438|FG007|Overall Study|Death|21|||
27707710|NCT03150862|80765431|FG000|Overall Study|Withdrawal by Subject|1|||
27707711|NCT03150862|80765432|FG001|Overall Study|Withdrawal by Subject|1|||
27707712|NCT03150862|80765433|FG002|Overall Study|Withdrawal by Subject|0|||
27707713|NCT03150862|80765434|FG003|Overall Study|Withdrawal by Subject|3|||
27707714|NCT03150862|80765435|FG004|Overall Study|Withdrawal by Subject|1|||
27707715|NCT03150862|80765436|FG005|Overall Study|Withdrawal by Subject|1|||
27707716|NCT03150862|80765437|FG006|Overall Study|Withdrawal by Subject|1|||
27707717|NCT03150862|80765438|FG007|Overall Study|Withdrawal by Subject|3|||
27707718|NCT03150862|80765431|FG000|Overall Study|Lost to Follow-up|0|||
27707719|NCT03150862|80765432|FG001|Overall Study|Lost to Follow-up|0|||
27707720|NCT03150862|80765433|FG002|Overall Study|Lost to Follow-up|1|||
27707721|NCT03150862|80765434|FG003|Overall Study|Lost to Follow-up|0|||
27707722|NCT03150862|80765435|FG004|Overall Study|Lost to Follow-up|0|||
27707723|NCT03150862|80765436|FG005|Overall Study|Lost to Follow-up|0|||
27707724|NCT03150862|80765437|FG006|Overall Study|Lost to Follow-up|0|||
27707725|NCT03150862|80765438|FG007|Overall Study|Lost to Follow-up|2|||
27707726|NCT03150862|80765431|FG000|Overall Study|Sponsor's decision|0|||
27707727|NCT03150862|80765432|FG001|Overall Study|Sponsor's decision|0|||
27707728|NCT03150862|80765433|FG002|Overall Study|Sponsor's decision|0|||
27707729|NCT03150862|80765434|FG003|Overall Study|Sponsor's decision|10|||
27707730|NCT03150862|80765435|FG004|Overall Study|Sponsor's decision|3|||
27707731|NCT03150862|80765436|FG005|Overall Study|Sponsor's decision|0|||
27707732|NCT03150862|80765437|FG006|Overall Study|Sponsor's decision|1|||
27707733|NCT03150862|80765438|FG007|Overall Study|Sponsor's decision|1|||
27707734|NCT03150862|80765431|FG000|Overall Study|Change in Methylation status|0|||
27707735|NCT03150862|80765432|FG001|Overall Study|Change in Methylation status|0|||
27707736|NCT03150862|80765433|FG002|Overall Study|Change in Methylation status|0|||
27707737|NCT03150862|80765434|FG003|Overall Study|Change in Methylation status|0|||
27707738|NCT03150862|80765435|FG004|Overall Study|Change in Methylation status|1|||
27707739|NCT03150862|80765436|FG005|Overall Study|Change in Methylation status|0|||
27707740|NCT03150862|80765437|FG006|Overall Study|Change in Methylation status|0|||
27707741|NCT03150862|80765438|FG007|Overall Study|Change in Methylation status|0|||
27707742|NCT03150862|80765431|FG000|Overall Study|Roll over in to Long Term Extension|0|||
27707743|NCT03150862|80765432|FG001|Overall Study|Roll over in to Long Term Extension|0|||
27707744|NCT03150862|80765433|FG002|Overall Study|Roll over in to Long Term Extension|0|||
27707745|NCT03150862|80765434|FG003|Overall Study|Roll over in to Long Term Extension|0|||
27707746|NCT03150862|80765435|FG004|Overall Study|Roll over in to Long Term Extension|0|||
27707747|NCT03150862|80765436|FG005|Overall Study|Roll over in to Long Term Extension|0|||
27707748|NCT03150862|80765437|FG006|Overall Study|Roll over in to Long Term Extension|0|||
27707749|NCT03150862|80765438|FG007|Overall Study|Roll over in to Long Term Extension|1|||
27707750|NCT03150862|80765431|FG000|Overall Study|Progressive Disease|0|||
27707751|NCT03150862|80765432|FG001|Overall Study|Progressive Disease|0|||
27707752|NCT03150862|80765433|FG002|Overall Study|Progressive Disease|0|||
27707753|NCT03150862|80765434|FG003|Overall Study|Progressive Disease|0|||
27707754|NCT03150862|80765435|FG004|Overall Study|Progressive Disease|0|||
27707755|NCT03150862|80765436|FG005|Overall Study|Progressive Disease|0|||
27707756|NCT03150862|80765437|FG006|Overall Study|Progressive Disease|0|||
27707757|NCT03150862|80765438|FG007|Overall Study|Progressive Disease|2|||
27707758|NCT04206605|80765439|FG000|Overall Study|Adverse Event|0|||
27707759|NCT04206605|80765440|FG001|Overall Study|Adverse Event|1|||
27707760|NCT04206605|80765439|FG000|Overall Study|Withdrawal by Subject|1|||
27707761|NCT04206605|80765440|FG001|Overall Study|Withdrawal by Subject|0|||
27707762|NCT02596620|80765442|FG000|Overall Study|Lost to Follow-up|1|||
27707763|NCT02596620|80765443|FG001|Overall Study|Lost to Follow-up|1|||
27707764|NCT00829179|80765444|FG000|Overall Study|Withdrawal by Subject|1|||
27707765|NCT00003895|80765445|FG000|Overall Study|Adverse Event|4|||
27707766|NCT00003895|80765446|FG001|Overall Study|Adverse Event|0|||
27707767|NCT00003895|80765445|FG000|Overall Study|Lack of Efficacy|1|||
27707768|NCT00003895|80765446|FG001|Overall Study|Lack of Efficacy|1|||
27707769|NCT00003895|80765445|FG000|Overall Study|Patient Vacation|2|||
27707770|NCT00003895|80765446|FG001|Overall Study|Patient Vacation|0|||
27707771|NCT00003895|80765445|FG000|Overall Study|Withdrawal by Subject|0|||
27707772|NCT00003895|80765446|FG001|Overall Study|Withdrawal by Subject|3|||
27707773|NCT01553136|80765449|FG000|Overall Study|Adverse Event|3|||
27707774|NCT01553136|80765450|FG001|Overall Study|Adverse Event|2|||
27707775|NCT01553136|80765449|FG000|Overall Study|Withdrawal by Subject|2|||
27707776|NCT01553136|80765450|FG001|Overall Study|Withdrawal by Subject|3|||
27707777|NCT01553136|80765449|FG000|Overall Study|Lost to Follow-up|4|||
27835644|NCT01320722|81226238|FG002|Overall Study|Pregnancy|0|||
27835645|NCT01320722|81226239|FG003|Overall Study|Pregnancy|1|||
27835646|NCT01320722|81226240|FG004|Overall Study|Pregnancy|0|||
27835647|NCT01320722|81226236|FG000|Overall Study|Started an Exclusionary Medication|0|||
27835648|NCT01320722|81226237|FG001|Overall Study|Started an Exclusionary Medication|0|||
27835649|NCT01320722|81226238|FG002|Overall Study|Started an Exclusionary Medication|0|||
27835650|NCT01320722|81226239|FG003|Overall Study|Started an Exclusionary Medication|0|||
27835651|NCT01320722|81226240|FG004|Overall Study|Started an Exclusionary Medication|1|||
27888722|NCT00435487|81428077|FG000|Overall Study|Adverse Event|0|||
27888723|NCT00435487|81428078|FG001|Overall Study|Adverse Event|3|||
27601810|NCT00844857|80381690|FG001|Overall Study|Lack of Efficacy|5|||
27707778|NCT01553136|80765450|FG001|Overall Study|Lost to Follow-up|10|||
27707779|NCT01553136|80765449|FG000|Overall Study|Physician Decision|2|||
27707780|NCT01553136|80765450|FG001|Overall Study|Physician Decision|3|||
27707781|NCT01553136|80765449|FG000|Overall Study|Scheduling Difficulties|5|||
27707782|NCT01553136|80765450|FG001|Overall Study|Scheduling Difficulties|4|||
27707783|NCT01161043|80765451|FG000|Overall Study|Withdrawal by Subject|3|||
27707784|NCT03823404|80765455|FG000|Overall Study|Lost to Follow-up|1|||
27707785|NCT03823404|80765456|FG001|Overall Study|Lost to Follow-up|2|||
27835652|NCT01320722|81226236|FG000|Overall Study|Withdrew due to Health Condition|0|||
27888724|NCT00435487|81428077|FG000|Overall Study|Lost to Follow-up|2|||
27601811|NCT00844857|80381689|FG000|Overall Study|Clinical Relapse|0|||
27601812|NCT00844857|80381690|FG001|Overall Study|Clinical Relapse|1|||
27601813|NCT00844857|80381689|FG000|Overall Study|Entry Criteria Not Met|0|||
27601814|NCT00844857|80381690|FG001|Overall Study|Entry Criteria Not Met|1|||
27601815|NCT00844857|80381689|FG000|Overall Study|Lost to Follow-up|2|||
27601816|NCT00844857|80381690|FG001|Overall Study|Lost to Follow-up|3|||
27601817|NCT00844857|80381689|FG000|Overall Study|Did Not Take Study Drug|3|||
27601818|NCT00844857|80381690|FG001|Overall Study|Did Not Take Study Drug|1|||
27601819|NCT00844857|80381689|FG000|Overall Study|Good Clinical Practice Violations|21|||
27601820|NCT00844857|80381690|FG001|Overall Study|Good Clinical Practice Violations|11|||
27601821|NCT01499082|80381691|FG000|Overall Study|Randomized but not Treated|0|||
27601822|NCT01499082|80381692|FG001|Overall Study|Randomized but not Treated|1|||
27601823|NCT01499082|80381691|FG000|Overall Study|Adverse Event|12|||
27601824|NCT01499082|80381692|FG001|Overall Study|Adverse Event|16|||
27888725|NCT00435487|81428078|FG001|Overall Study|Lost to Follow-up|2|||
27888726|NCT00435487|81428077|FG000|Overall Study|Other|5|||
27888727|NCT00435487|81428078|FG001|Overall Study|Other|2|||
27888728|NCT00435487|81428077|FG000|Overall Study|Withdrawal by Subject|2|||
27888729|NCT00435487|81428078|FG001|Overall Study|Withdrawal by Subject|1|||
27888730|NCT00435487|81428077|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
27888731|NCT00435487|81428078|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
27888732|NCT00435487|81428077|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
27888733|NCT00435487|81428078|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
27601825|NCT01499082|80381691|FG000|Overall Study|Lack of Efficacy|1|||
27601826|NCT01499082|80381692|FG001|Overall Study|Lack of Efficacy|1|||
27601827|NCT01499082|80381691|FG000|Overall Study|Protocol Violation|6|||
27601828|NCT01499082|80381692|FG001|Overall Study|Protocol Violation|8|||
27601829|NCT01499082|80381691|FG000|Overall Study|Diverse Reasons|18|||
27601830|NCT01499082|80381692|FG001|Overall Study|Diverse Reasons|14|||
27601831|NCT01499082|80381691|FG000|Overall Study|Site Closure for Noncompliance|5|||
27888734|NCT01489254|81428079|FG000|Double-blind Part|Adverse Event|7|||
27707786|NCT03823404|80765457|FG002|Overall Study|Lost to Follow-up|3|||
27707787|NCT03823404|80765455|FG000|Overall Study|Protocol Violation|2|||
27888735|NCT01489254|81428080|FG001|Double-blind Part|Adverse Event|2|||
27888736|NCT01489254|81428081|FG002|Double-blind Part|Adverse Event|2|||
27888737|NCT01489254|81428082|FG003|Double-blind Part|Adverse Event|0|||
27888738|NCT01489254|81428079|FG000|Double-blind Part|Pregnancy|1|||
27888739|NCT01489254|81428080|FG001|Double-blind Part|Pregnancy|3|||
27888740|NCT01489254|81428081|FG002|Double-blind Part|Pregnancy|0|||
27888741|NCT01489254|81428082|FG003|Double-blind Part|Pregnancy|0|||
27707788|NCT03823404|80765456|FG001|Overall Study|Protocol Violation|0|||
27707789|NCT03823404|80765457|FG002|Overall Study|Protocol Violation|2|||
27888742|NCT01489254|81428079|FG000|Double-blind Part|Withdrawal by Subject|12|||
27888743|NCT01489254|81428080|FG001|Double-blind Part|Withdrawal by Subject|20|||
27707790|NCT03823404|80765455|FG000|Overall Study|Adverse Event|35|||
27601832|NCT01499082|80381692|FG001|Overall Study|Site Closure for Noncompliance|2|||
27601833|NCT01499082|80381691|FG000|Overall Study|Hypoglycemia|2|||
27601834|NCT01499082|80381692|FG001|Overall Study|Hypoglycemia|3|||
27601835|NCT01499082|80381691|FG000|Overall Study|Lost to Follow-up|1|||
27601836|NCT01499082|80381692|FG001|Overall Study|Lost to Follow-up|3|||
27601837|NCT01678131|80381698|FG000|Overall Study|Adverse Event|0|||
27601838|NCT01678131|80381699|FG001|Overall Study|Adverse Event|1|||
27601839|NCT01678131|80381700|FG002|Overall Study|Adverse Event|0|||
27601840|NCT01678131|80381698|FG000|Overall Study|Withdrawal by Subject|0|||
27601841|NCT01678131|80381699|FG001|Overall Study|Withdrawal by Subject|0|||
27601842|NCT01678131|80381700|FG002|Overall Study|Withdrawal by Subject|2|||
27601843|NCT00742079|80381701|FG000|Overall Study|Lost to Follow-up|0|||
27601844|NCT00742079|80381702|FG001|Overall Study|Lost to Follow-up|1|||
27601845|NCT03214367|80381703|FG000|Lead-in Period|Withdrawal by Subject|50|||
27601846|NCT03214367|80381704|FG001|Lead-in Period|Withdrawal by Subject|0|||
27601847|NCT03214367|80381705|FG002|Lead-in Period|Withdrawal by Subject|0|||
27601848|NCT03214367|80381706|FG003|Lead-in Period|Withdrawal by Subject|0|||
27601849|NCT03214367|80381707|FG004|Lead-in Period|Withdrawal by Subject|2|||
27601850|NCT03214367|80381708|FG005|Lead-in Period|Withdrawal by Subject|0|||
27601851|NCT03214367|80381709|FG006|Lead-in Period|Withdrawal by Subject|0|||
27601852|NCT03214367|80381710|FG007|Lead-in Period|Withdrawal by Subject|0|||
27601853|NCT03214367|80381703|FG000|Lead-in Period|Adverse Event|3|||
27601854|NCT03214367|80381704|FG001|Lead-in Period|Adverse Event|0|||
27601855|NCT03214367|80381705|FG002|Lead-in Period|Adverse Event|0|||
27601856|NCT03214367|80381706|FG003|Lead-in Period|Adverse Event|0|||
27601857|NCT03214367|80381707|FG004|Lead-in Period|Adverse Event|0|||
27601858|NCT03214367|80381708|FG005|Lead-in Period|Adverse Event|0|||
27601859|NCT03214367|80381709|FG006|Lead-in Period|Adverse Event|0|||
27601860|NCT03214367|80381710|FG007|Lead-in Period|Adverse Event|0|||
27601861|NCT03214367|80381703|FG000|Lead-in Period|Lost to Follow-up|12|||
27601862|NCT03214367|80381704|FG001|Lead-in Period|Lost to Follow-up|0|||
27601863|NCT03214367|80381705|FG002|Lead-in Period|Lost to Follow-up|0|||
27601864|NCT03214367|80381706|FG003|Lead-in Period|Lost to Follow-up|0|||
27601865|NCT03214367|80381707|FG004|Lead-in Period|Lost to Follow-up|0|||
27601866|NCT03214367|80381708|FG005|Lead-in Period|Lost to Follow-up|0|||
27601867|NCT03214367|80381709|FG006|Lead-in Period|Lost to Follow-up|0|||
27601868|NCT03214367|80381710|FG007|Lead-in Period|Lost to Follow-up|0|||
27601869|NCT03214367|80381703|FG000|Lead-in Period|Sponsor Decision|11|||
27601870|NCT03214367|80381704|FG001|Lead-in Period|Sponsor Decision|0|||
27601871|NCT03214367|80381705|FG002|Lead-in Period|Sponsor Decision|0|||
27601872|NCT03214367|80381706|FG003|Lead-in Period|Sponsor Decision|0|||
27601873|NCT03214367|80381707|FG004|Lead-in Period|Sponsor Decision|0|||
27601874|NCT03214367|80381708|FG005|Lead-in Period|Sponsor Decision|0|||
27601875|NCT03214367|80381709|FG006|Lead-in Period|Sponsor Decision|0|||
27601876|NCT03214367|80381710|FG007|Lead-in Period|Sponsor Decision|0|||
27601877|NCT03214367|80381703|FG000|Lead-in Period|Physician Decision|12|||
27601878|NCT03214367|80381704|FG001|Lead-in Period|Physician Decision|0|||
27601879|NCT03214367|80381705|FG002|Lead-in Period|Physician Decision|0|||
27601880|NCT03214367|80381706|FG003|Lead-in Period|Physician Decision|0|||
27601881|NCT03214367|80381707|FG004|Lead-in Period|Physician Decision|0|||
27601882|NCT03214367|80381708|FG005|Lead-in Period|Physician Decision|0|||
27601883|NCT03214367|80381709|FG006|Lead-in Period|Physician Decision|0|||
27601884|NCT03214367|80381710|FG007|Lead-in Period|Physician Decision|0|||
27601885|NCT03214367|80381703|FG000|Lead-in Period|Protocol Violation|5|||
27601886|NCT03214367|80381704|FG001|Lead-in Period|Protocol Violation|0|||
27601887|NCT03214367|80381705|FG002|Lead-in Period|Protocol Violation|0|||
27601888|NCT03214367|80381706|FG003|Lead-in Period|Protocol Violation|0|||
27601889|NCT03214367|80381707|FG004|Lead-in Period|Protocol Violation|0|||
27601890|NCT03214367|80381708|FG005|Lead-in Period|Protocol Violation|0|||
27601891|NCT03214367|80381709|FG006|Lead-in Period|Protocol Violation|0|||
27601892|NCT03214367|80381710|FG007|Lead-in Period|Protocol Violation|0|||
27601893|NCT03214367|80381703|FG000|Lead-in Period|Treatment Interruption|1|||
27601894|NCT03214367|80381704|FG001|Lead-in Period|Treatment Interruption|0|||
27707791|NCT03823404|80765456|FG001|Overall Study|Adverse Event|38|||
27835653|NCT01320722|81226237|FG001|Overall Study|Withdrew due to Health Condition|0|||
27835654|NCT01320722|81226238|FG002|Overall Study|Withdrew due to Health Condition|0|||
27835655|NCT01320722|81226239|FG003|Overall Study|Withdrew due to Health Condition|0|||
27835656|NCT01320722|81226240|FG004|Overall Study|Withdrew due to Health Condition|1|||
27835657|NCT03498560|81226241|FG000|Overall Study|Found Ineligible|2|||
27835658|NCT03498560|81226241|FG000|Overall Study|Withdrawal by Subject|14|||
27835659|NCT03498560|81226241|FG000|Overall Study|Lost to Follow-up|4|||
27835660|NCT03498560|81226241|FG000|Overall Study|Death|1|||
27835661|NCT01572662|81226242|FG000|Overall Study|Withdrawal by Subject|1|||
27601895|NCT03214367|80381705|FG002|Lead-in Period|Treatment Interruption|0|||
27601896|NCT03214367|80381706|FG003|Lead-in Period|Treatment Interruption|0|||
27601897|NCT03214367|80381707|FG004|Lead-in Period|Treatment Interruption|0|||
27601898|NCT03214367|80381708|FG005|Lead-in Period|Treatment Interruption|0|||
27601899|NCT03214367|80381709|FG006|Lead-in Period|Treatment Interruption|0|||
27601900|NCT03214367|80381710|FG007|Lead-in Period|Treatment Interruption|0|||
27601901|NCT03214367|80381703|FG000|Treatment Period|Adverse Event|0|||
27601902|NCT03214367|80381704|FG001|Treatment Period|Adverse Event|1|||
27601903|NCT03214367|80381705|FG002|Treatment Period|Adverse Event|4|||
27601904|NCT03214367|80381706|FG003|Treatment Period|Adverse Event|2|||
27601905|NCT03214367|80381707|FG004|Treatment Period|Adverse Event|0|||
27601906|NCT03214367|80381708|FG005|Treatment Period|Adverse Event|0|||
27601907|NCT03214367|80381709|FG006|Treatment Period|Adverse Event|0|||
27601908|NCT03214367|80381710|FG007|Treatment Period|Adverse Event|0|||
27601909|NCT03214367|80381703|FG000|Treatment Period|Death|0|||
27601910|NCT03214367|80381704|FG001|Treatment Period|Death|1|||
27835662|NCT01572662|81226243|FG001|Overall Study|Withdrawal by Subject|0|||
27601911|NCT03214367|80381705|FG002|Treatment Period|Death|1|||
27601912|NCT03214367|80381706|FG003|Treatment Period|Death|1|||
27601913|NCT03214367|80381707|FG004|Treatment Period|Death|0|||
27601914|NCT03214367|80381708|FG005|Treatment Period|Death|0|||
27601915|NCT03214367|80381709|FG006|Treatment Period|Death|0|||
27601916|NCT03214367|80381710|FG007|Treatment Period|Death|0|||
27601917|NCT03214367|80381703|FG000|Treatment Period|Lost to Follow-up|0|||
27601918|NCT03214367|80381704|FG001|Treatment Period|Lost to Follow-up|5|||
27601919|NCT03214367|80381705|FG002|Treatment Period|Lost to Follow-up|3|||
27601920|NCT03214367|80381706|FG003|Treatment Period|Lost to Follow-up|2|||
27601921|NCT03214367|80381707|FG004|Treatment Period|Lost to Follow-up|0|||
27601922|NCT03214367|80381708|FG005|Treatment Period|Lost to Follow-up|2|||
27601923|NCT03214367|80381709|FG006|Treatment Period|Lost to Follow-up|1|||
27601924|NCT03214367|80381710|FG007|Treatment Period|Lost to Follow-up|0|||
27601925|NCT03214367|80381703|FG000|Treatment Period|Sponsor Decision|0|||
27601926|NCT03214367|80381704|FG001|Treatment Period|Sponsor Decision|3|||
27601927|NCT03214367|80381705|FG002|Treatment Period|Sponsor Decision|0|||
27601928|NCT03214367|80381706|FG003|Treatment Period|Sponsor Decision|0|||
27601929|NCT03214367|80381707|FG004|Treatment Period|Sponsor Decision|0|||
27601930|NCT03214367|80381708|FG005|Treatment Period|Sponsor Decision|0|||
27601931|NCT03214367|80381709|FG006|Treatment Period|Sponsor Decision|0|||
27601932|NCT03214367|80381710|FG007|Treatment Period|Sponsor Decision|0|||
27601933|NCT03214367|80381703|FG000|Treatment Period|Physician Decision|0|||
27601934|NCT03214367|80381704|FG001|Treatment Period|Physician Decision|1|||
27601935|NCT03214367|80381705|FG002|Treatment Period|Physician Decision|2|||
27601936|NCT03214367|80381706|FG003|Treatment Period|Physician Decision|0|||
27601937|NCT03214367|80381707|FG004|Treatment Period|Physician Decision|0|||
27601938|NCT03214367|80381708|FG005|Treatment Period|Physician Decision|0|||
27601939|NCT03214367|80381709|FG006|Treatment Period|Physician Decision|0|||
27601940|NCT03214367|80381710|FG007|Treatment Period|Physician Decision|0|||
27601941|NCT03214367|80381703|FG000|Treatment Period|Protocol Violation|0|||
27601942|NCT03214367|80381704|FG001|Treatment Period|Protocol Violation|3|||
27601943|NCT03214367|80381705|FG002|Treatment Period|Protocol Violation|0|||
27601944|NCT03214367|80381706|FG003|Treatment Period|Protocol Violation|0|||
27601945|NCT03214367|80381707|FG004|Treatment Period|Protocol Violation|0|||
27601946|NCT03214367|80381708|FG005|Treatment Period|Protocol Violation|0|||
27601947|NCT03214367|80381709|FG006|Treatment Period|Protocol Violation|0|||
27601948|NCT03214367|80381710|FG007|Treatment Period|Protocol Violation|0|||
27601949|NCT03214367|80381703|FG000|Treatment Period|Withdrawal by Subject|0|||
27601950|NCT03214367|80381704|FG001|Treatment Period|Withdrawal by Subject|20|||
27601951|NCT03214367|80381705|FG002|Treatment Period|Withdrawal by Subject|23|||
27601952|NCT03214367|80381706|FG003|Treatment Period|Withdrawal by Subject|14|||
27601953|NCT03214367|80381707|FG004|Treatment Period|Withdrawal by Subject|0|||
27601954|NCT03214367|80381708|FG005|Treatment Period|Withdrawal by Subject|1|||
27601955|NCT03214367|80381709|FG006|Treatment Period|Withdrawal by Subject|1|||
27601956|NCT03214367|80381710|FG007|Treatment Period|Withdrawal by Subject|1|||
27601957|NCT02839343|80381711|FG000|Overall Study|Withdrawal by Subject|3|||
27601958|NCT02839343|80381712|FG001|Overall Study|Withdrawal by Subject|1|||
27601959|NCT02839343|80381711|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
27707792|NCT03823404|80765457|FG002|Overall Study|Adverse Event|8|||
27707793|NCT03823404|80765455|FG000|Overall Study|Withdrawal by Subject|38|||
27707794|NCT03823404|80765456|FG001|Overall Study|Withdrawal by Subject|40|||
27601960|NCT02839343|80381712|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
27601961|NCT02839343|80381711|FG000|Overall Study|Adverse Event|1|||
27601962|NCT02839343|80381712|FG001|Overall Study|Adverse Event|0|||
27601963|NCT00116844|80381714|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
27601964|NCT00116844|80381715|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
27707795|NCT03823404|80765457|FG002|Overall Study|Withdrawal by Subject|35|||
27601965|NCT00116844|80381714|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
27601966|NCT00116844|80381715|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
27601967|NCT00116844|80381714|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
27601968|NCT00116844|80381715|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
27601969|NCT00116844|80381714|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
27601970|NCT00116844|80381715|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
27601971|NCT00116844|80381714|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
27601972|NCT00116844|80381715|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
27601973|NCT00116844|80381714|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
27601974|NCT00116844|80381715|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
27601975|NCT00116844|80381714|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
27601976|NCT00116844|80381715|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
27601977|NCT00116844|80381714|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
27601978|NCT00116844|80381715|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
27601979|NCT00116844|80381714|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
27601980|NCT00116844|80381715|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
27601981|NCT02007434|80381716|FG000|Overall Study|Lost to Follow-up|0|||
27601982|NCT02007434|80381717|FG001|Overall Study|Lost to Follow-up|1|||
27601983|NCT02007434|80381718|FG002|Overall Study|Lost to Follow-up|0|||
27601984|NCT02007434|80381719|FG003|Overall Study|Lost to Follow-up|0|||
27601985|NCT02007434|80381720|FG004|Overall Study|Lost to Follow-up|0|||
27601986|NCT02007434|80381721|FG005|Overall Study|Lost to Follow-up|0|||
27601987|NCT02007434|80381722|FG006|Overall Study|Lost to Follow-up|0|||
27601988|NCT02007434|80381723|FG007|Overall Study|Lost to Follow-up|0|||
27601989|NCT02007434|80381716|FG000|Overall Study|Non-compliance|1|||
27601990|NCT02007434|80381717|FG001|Overall Study|Non-compliance|0|||
27601991|NCT02007434|80381718|FG002|Overall Study|Non-compliance|1|||
27601992|NCT02007434|80381719|FG003|Overall Study|Non-compliance|0|||
27601993|NCT02007434|80381720|FG004|Overall Study|Non-compliance|0|||
27601994|NCT02007434|80381721|FG005|Overall Study|Non-compliance|0|||
27601995|NCT02007434|80381722|FG006|Overall Study|Non-compliance|0|||
27601996|NCT02007434|80381723|FG007|Overall Study|Non-compliance|0|||
27601997|NCT00790452|80381729|FG000|Overall Study|Drug supply issue|1|||
27707796|NCT03823404|80765455|FG000|Overall Study|Death|4|||
27707797|NCT03823404|80765456|FG001|Overall Study|Death|0|||
27707798|NCT03823404|80765457|FG002|Overall Study|Death|0|||
27707799|NCT03823404|80765455|FG000|Overall Study|Other: Various reasons provided|5|||
27601998|NCT00790452|80381730|FG001|Overall Study|Drug supply issue|0|||
27601999|NCT02487472|80381731|FG000|Overall Study|Did not complete telephonic interviews|9|||
27602000|NCT02487472|80381731|FG000|Overall Study|Other|2|||
27707800|NCT03823404|80765456|FG001|Overall Study|Other: Various reasons provided|5|||
27602001|NCT01648270|80381733|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
27835663|NCT01572662|81226242|FG000|Overall Study|Physician Decision|0|||
27602002|NCT03595332|80381734|FG000|Overall Study|Lost to Follow-up|16|||
27602003|NCT03595332|80381735|FG001|Overall Study|Lost to Follow-up|22|||
27602004|NCT03595332|80381734|FG000|Overall Study|Unable to retrieve ID from school|0|||
27602005|NCT03595332|80381735|FG001|Overall Study|Unable to retrieve ID from school|2|||
27602006|NCT04247282|80381737|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
27602007|NCT04247282|80381738|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
27602008|NCT04247282|80381739|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
27602009|NCT04247282|80381740|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
27602010|NCT04247282|80381737|FG000|Overall Study|Refused further treatment|0|||
27602011|NCT04247282|80381738|FG001|Overall Study|Refused further treatment|1|||
27602012|NCT04247282|80381739|FG002|Overall Study|Refused further treatment|0|||
27602013|NCT04247282|80381740|FG003|Overall Study|Refused further treatment|0|||
27602014|NCT00611858|80381741|FG000|Overall Study|Adverse Event|2|||
27602015|NCT00611858|80381741|FG000|Overall Study|Withdrawal by Subject|2|||
27602016|NCT00002558|80381743|FG000|Overall Study|Withdrawal by Subject|0|||
27602017|NCT00002558|80381744|FG001|Overall Study|Withdrawal by Subject|1|||
27602018|NCT03645759|80381745|FG000|Overall Study|Lost to Follow-up|3|||
27602019|NCT03645759|80381746|FG001|Overall Study|Lost to Follow-up|2|||
27602020|NCT01224158|80381750|FG000|Overall Study|Withdrawal by Subject|1|||
27602021|NCT01224158|80381751|FG001|Overall Study|Withdrawal by Subject|0|||
27602022|NCT04098406|80381752|FG000|Overall Study|Adverse Event|2|||
27602023|NCT04098406|80381753|FG001|Overall Study|Adverse Event|1|||
27602024|NCT04098406|80381752|FG000|Overall Study|Withdrawal by Subject|1|||
27602025|NCT04098406|80381753|FG001|Overall Study|Withdrawal by Subject|0|||
27602026|NCT02052310|80381754|FG000|Overall Study|Death|64|||
27602027|NCT02052310|80381755|FG001|Overall Study|Death|54|||
27602028|NCT02052310|80381754|FG000|Overall Study|Withdrawal by Subject|37|||
27602029|NCT02052310|80381755|FG001|Overall Study|Withdrawal by Subject|49|||
27602030|NCT02052310|80381754|FG000|Overall Study|Other than specified|32|||
27602031|NCT02052310|80381755|FG001|Overall Study|Other than specified|29|||
27602032|NCT02052310|80381754|FG000|Overall Study|Adverse Event|29|||
27602033|NCT02052310|80381755|FG001|Overall Study|Adverse Event|22|||
27602034|NCT02052310|80381754|FG000|Overall Study|Kidney Transplant|23|||
27602035|NCT02052310|80381755|FG001|Overall Study|Kidney Transplant|29|||
27602036|NCT02052310|80381754|FG000|Overall Study|Physician Decision|14|||
27602037|NCT02052310|80381755|FG001|Overall Study|Physician Decision|7|||
27602038|NCT02052310|80381754|FG000|Overall Study|Lack of Efficacy|6|||
27602039|NCT02052310|80381755|FG001|Overall Study|Lack of Efficacy|1|||
27602040|NCT02052310|80381754|FG000|Overall Study|Site Terminated by Sponsor|5|||
27602041|NCT02052310|80381755|FG001|Overall Study|Site Terminated by Sponsor|13|||
27602042|NCT02052310|80381754|FG000|Overall Study|Lost to Follow-up|4|||
27602043|NCT02052310|80381755|FG001|Overall Study|Lost to Follow-up|2|||
27602044|NCT02052310|80381754|FG000|Overall Study|Protocol Violation|1|||
27602045|NCT02052310|80381755|FG001|Overall Study|Protocol Violation|6|||
27602046|NCT03308825|80381756|FG000|Overall Study|Lost to Follow-up|2|||
27602047|NCT03308825|80381757|FG001|Overall Study|Lost to Follow-up|2|||
27602048|NCT03308825|80381758|FG002|Overall Study|Lost to Follow-up|1|||
27602049|NCT03308825|80381759|FG003|Overall Study|Lost to Follow-up|0|||
27602050|NCT03308825|80381756|FG000|Overall Study|Protocol Violation|0|||
27602051|NCT03308825|80381757|FG001|Overall Study|Protocol Violation|2|||
27602052|NCT03308825|80381758|FG002|Overall Study|Protocol Violation|0|||
27602053|NCT03308825|80381759|FG003|Overall Study|Protocol Violation|0|||
27602054|NCT00754338|80381766|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
27602055|NCT00754338|80381767|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
27602056|NCT00754338|80381768|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
27602057|NCT00754338|80381769|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
27602058|NCT00754338|80381766|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
27602059|NCT00754338|80381767|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
27602060|NCT00754338|80381768|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
27602061|NCT00754338|80381769|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
27602062|NCT02436811|80381780|FG000|Overall Study|Lost to Follow-up|2|||
27707801|NCT03823404|80765457|FG002|Overall Study|Other: Various reasons provided|6|||
27602063|NCT02436811|80381781|FG001|Overall Study|Lost to Follow-up|9|||
27602064|NCT02436811|80381782|FG002|Overall Study|Lost to Follow-up|7|||
27602065|NCT01494584|80381783|FG000|Overall Study|Study Closed/Terminated|1|||
27602066|NCT00118716|80381784|FG000|Overall Study|Adverse Event|2|||
27602067|NCT00118716|80381785|FG001|Overall Study|Adverse Event|7|||
27602068|NCT00118716|80381784|FG000|Overall Study|Protocol Violation|5|||
27602069|NCT00118716|80381785|FG001|Overall Study|Protocol Violation|4|||
27707802|NCT00923130|80765461|FG000|Overall Study|Stopped treatment due to progression|17|||
27707803|NCT00923130|80765461|FG000|Overall Study|Death|1|||
27707804|NCT00923130|80765461|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
27707805|NCT00923130|80765461|FG000|Overall Study|Switched to alternative treatment|2|||
27707806|NCT00923130|80765461|FG000|Overall Study|Refused further treatment|2|||
27707807|NCT01843842|80765464|FG000|Overall Study|Do not meet inclusion criteria|1|||
27707808|NCT01843842|80765465|FG001|Overall Study|Do not meet inclusion criteria|1|||
27707809|NCT01537198|80765466|FG000|Overall Study|RSV infection|2|||
27707810|NCT01537198|80765466|FG000|Overall Study|Adverse Event|4|||
27707811|NCT01537198|80765466|FG000|Overall Study|No Further Visits to the Clinic|37|||
27707812|NCT01537198|80765466|FG000|Overall Study|Other|111|||
27707813|NCT01793142|80765467|FG000|Overall Study|Randomized not treated|7|||
27707814|NCT01073267|80765468|FG000|Overall Study|Disease Progression|3|||
27707815|NCT01392677|80765469|FG000|Overall Study|Adverse Event|3|||
27707816|NCT01392677|80765470|FG001|Overall Study|Adverse Event|1|||
27707817|NCT01392677|80765469|FG000|Overall Study|Withdrawal by Subject|0|||
27707818|NCT01392677|80765470|FG001|Overall Study|Withdrawal by Subject|2|||
27707819|NCT01392677|80765469|FG000|Overall Study|Incorrect enrollment|2|||
27707820|NCT01392677|80765470|FG001|Overall Study|Incorrect enrollment|3|||
27707821|NCT01392677|80765469|FG000|Overall Study|Other reason|3|||
27707822|NCT01392677|80765470|FG001|Overall Study|Other reason|2|||
27707823|NCT04037748|80765475|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27707824|NCT04037748|80765476|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27707825|NCT04037748|80765475|FG000|Treatment Period 1|Adverse Event|1|||
27707826|NCT04037748|80765476|FG001|Treatment Period 1|Adverse Event|1|||
27707827|NCT04037748|80765475|FG000|Treatment Period 1|Protocol Violation|4|||
27707828|NCT04037748|80765476|FG001|Treatment Period 1|Protocol Violation|5|||
27707829|NCT04037748|80765475|FG000|Treatment Period 2|Adverse Event|0|||
27707830|NCT04037748|80765476|FG001|Treatment Period 2|Adverse Event|1|||
27707831|NCT04037748|80765475|FG000|Treatment Period 2|Protocol Violation|2|||
27707832|NCT04037748|80765476|FG001|Treatment Period 2|Protocol Violation|0|||
27707833|NCT00552175|80765477|FG000|Overall Study|Lack of Efficacy|2|||
27707834|NCT00552175|80765478|FG001|Overall Study|Lack of Efficacy|0|||
27707835|NCT00552175|80765479|FG002|Overall Study|Lack of Efficacy|1|||
27707836|NCT00552175|80765477|FG000|Overall Study|Adverse Event|9|||
27707837|NCT00552175|80765478|FG001|Overall Study|Adverse Event|9|||
27707838|NCT00552175|80765479|FG002|Overall Study|Adverse Event|10|||
27707839|NCT00552175|80765477|FG000|Overall Study|Withdrawal by Subject|2|||
27602070|NCT00118716|80381784|FG000|Overall Study|Withdrawal by Subject|0|||
27707840|NCT00552175|80765478|FG001|Overall Study|Withdrawal by Subject|2|||
27707841|NCT00552175|80765479|FG002|Overall Study|Withdrawal by Subject|1|||
27707842|NCT00552175|80765477|FG000|Overall Study|Lost to Follow-up|0|||
27707843|NCT00552175|80765478|FG001|Overall Study|Lost to Follow-up|0|||
27707844|NCT00552175|80765479|FG002|Overall Study|Lost to Follow-up|1|||
27707845|NCT00552175|80765477|FG000|Overall Study|Entry Criteria Not Met|1|||
27707846|NCT00552175|80765478|FG001|Overall Study|Entry Criteria Not Met|1|||
27707847|NCT00552175|80765479|FG002|Overall Study|Entry Criteria Not Met|0|||
27707848|NCT00552175|80765477|FG000|Overall Study|Reason Not Specified|3|||
27707849|NCT00552175|80765478|FG001|Overall Study|Reason Not Specified|1|||
27707850|NCT00552175|80765479|FG002|Overall Study|Reason Not Specified|1|||
27707851|NCT00916279|80765480|FG000|Overall Study|Death|2|||
27707852|NCT00916279|80765480|FG000|Overall Study|Lost to Follow-up|2|||
27707853|NCT02616614|80765483|FG000|Overall Study|Withdrawal by Subject|10|||
27707854|NCT02616614|80765484|FG001|Overall Study|Withdrawal by Subject|5|||
27707855|NCT02616614|80765485|FG002|Overall Study|Withdrawal by Subject|6|||
27707856|NCT02616614|80765483|FG000|Overall Study|Physician Decision|2|||
27707857|NCT02616614|80765484|FG001|Overall Study|Physician Decision|1|||
27707858|NCT02616614|80765485|FG002|Overall Study|Physician Decision|0|||
27707859|NCT02616614|80765483|FG000|Overall Study|Adverse Event|1|||
27707860|NCT02616614|80765484|FG001|Overall Study|Adverse Event|4|||
27707861|NCT02616614|80765485|FG002|Overall Study|Adverse Event|1|||
27707862|NCT02616614|80765483|FG000|Overall Study|Protocol Violation|0|||
27707863|NCT02616614|80765484|FG001|Overall Study|Protocol Violation|3|||
27707864|NCT02616614|80765485|FG002|Overall Study|Protocol Violation|1|||
27707865|NCT02616614|80765483|FG000|Overall Study|Prohibited Medication|12|||
27707866|NCT02616614|80765484|FG001|Overall Study|Prohibited Medication|9|||
27707867|NCT02616614|80765485|FG002|Overall Study|Prohibited Medication|5|||
27707868|NCT02616614|80765483|FG000|Overall Study|More than 3 applications missed|6|||
27707869|NCT02616614|80765484|FG001|Overall Study|More than 3 applications missed|8|||
27707870|NCT02616614|80765485|FG002|Overall Study|More than 3 applications missed|1|||
27707871|NCT02616614|80765483|FG000|Overall Study|Lost to Follow-up|31|||
27707872|NCT02616614|80765484|FG001|Overall Study|Lost to Follow-up|28|||
27707873|NCT02616614|80765485|FG002|Overall Study|Lost to Follow-up|13|||
27707874|NCT02616614|80765483|FG000|Overall Study|Pregnancy|2|||
27707875|NCT02616614|80765484|FG001|Overall Study|Pregnancy|0|||
27707876|NCT02616614|80765485|FG002|Overall Study|Pregnancy|1|||
27707877|NCT02616614|80765483|FG000|Overall Study|Other|1|||
27707878|NCT02616614|80765484|FG001|Overall Study|Other|2|||
27707879|NCT02616614|80765485|FG002|Overall Study|Other|1|||
27707880|NCT03016325|80765486|FG000|Treatment Period|Participant withdrew consent|0|||
27707881|NCT03016325|80765487|FG001|Treatment Period|Participant withdrew consent|1|||
27707882|NCT03016325|80765488|FG002|Treatment Period|Participant withdrew consent|0|||
27707883|NCT03016325|80765489|FG003|Treatment Period|Participant withdrew consent|0|||
27707884|NCT03016325|80765490|FG004|Treatment Period|Participant withdrew consent|0|||
27707885|NCT03016325|80765491|FG005|Treatment Period|Participant withdrew consent|0|||
27707886|NCT03016325|80765492|FG006|Treatment Period|Participant withdrew consent|0|||
27707887|NCT03016325|80765493|FG007|Treatment Period|Participant withdrew consent|0|||
27707888|NCT03016325|80765486|FG000|Treatment Period|Death|0|||
27707889|NCT03016325|80765487|FG001|Treatment Period|Death|0|||
27707890|NCT03016325|80765488|FG002|Treatment Period|Death|0|||
27707891|NCT03016325|80765489|FG003|Treatment Period|Death|0|||
27707892|NCT03016325|80765490|FG004|Treatment Period|Death|2|||
27707893|NCT03016325|80765491|FG005|Treatment Period|Death|0|||
27707894|NCT03016325|80765492|FG006|Treatment Period|Death|0|||
27707895|NCT03016325|80765493|FG007|Treatment Period|Death|0|||
27707896|NCT03016325|80765486|FG000|Treatment Period|Participant refuses assessments|0|||
27707897|NCT03016325|80765487|FG001|Treatment Period|Participant refuses assessments|0|||
27707898|NCT03016325|80765488|FG002|Treatment Period|Participant refuses assessments|1|||
27707899|NCT03016325|80765489|FG003|Treatment Period|Participant refuses assessments|0|||
27707900|NCT03016325|80765490|FG004|Treatment Period|Participant refuses assessments|0|||
27707901|NCT03016325|80765491|FG005|Treatment Period|Participant refuses assessments|0|||
27707902|NCT03016325|80765492|FG006|Treatment Period|Participant refuses assessments|0|||
27707903|NCT03016325|80765493|FG007|Treatment Period|Participant refuses assessments|0|||
27707904|NCT03016325|80765486|FG000|32-Day Follow-Up Period|Death|2|||
27707905|NCT03016325|80765487|FG001|32-Day Follow-Up Period|Death|0|||
27707906|NCT03016325|80765488|FG002|32-Day Follow-Up Period|Death|5|||
27707907|NCT03016325|80765489|FG003|32-Day Follow-Up Period|Death|6|||
27707908|NCT03016325|80765490|FG004|32-Day Follow-Up Period|Death|3|||
27707909|NCT03016325|80765491|FG005|32-Day Follow-Up Period|Death|0|||
27707910|NCT03016325|80765492|FG006|32-Day Follow-Up Period|Death|0|||
27707911|NCT03016325|80765493|FG007|32-Day Follow-Up Period|Death|0|||
27707912|NCT03016325|80765486|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
27707913|NCT03016325|80765487|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
27707914|NCT03016325|80765488|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
27707915|NCT03016325|80765489|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
27707916|NCT03016325|80765490|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
27707917|NCT03016325|80765491|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
27707918|NCT03016325|80765492|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
27707919|NCT03016325|80765493|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
27707920|NCT03016325|80765486|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
27707921|NCT03016325|80765487|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
27707922|NCT03016325|80765488|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
27707923|NCT03016325|80765489|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
27707924|NCT03016325|80765490|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
27707925|NCT03016325|80765491|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
27707926|NCT03016325|80765492|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
27707927|NCT03016325|80765493|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
27707928|NCT03016325|80765486|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
27707929|NCT03016325|80765487|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
27707930|NCT03016325|80765488|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
27707931|NCT03016325|80765489|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
27707932|NCT03016325|80765490|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
27707933|NCT03016325|80765491|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
27707934|NCT03016325|80765492|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
27707935|NCT03016325|80765493|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
27707936|NCT03016325|80765486|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
27707937|NCT03016325|80765487|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
27707938|NCT03016325|80765488|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
27707939|NCT03016325|80765489|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
27707940|NCT03016325|80765490|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
27707941|NCT03016325|80765491|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
27707942|NCT03016325|80765492|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
27707943|NCT03016325|80765493|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
27707944|NCT03016325|80765486|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707945|NCT03016325|80765487|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707946|NCT03016325|80765488|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
27707947|NCT03016325|80765489|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707948|NCT03016325|80765490|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707949|NCT03016325|80765491|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707950|NCT03016325|80765492|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707951|NCT03016325|80765493|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
27707952|NCT03016325|80765486|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707953|NCT03016325|80765487|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
27707954|NCT03016325|80765488|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707955|NCT03016325|80765489|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707956|NCT03016325|80765490|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707957|NCT03016325|80765491|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707958|NCT03016325|80765492|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707959|NCT03016325|80765493|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
27707960|NCT03016325|80765486|FG000|182-Day Follow-Up Period|Death|3|||
27707961|NCT03016325|80765487|FG001|182-Day Follow-Up Period|Death|3|||
27707962|NCT03016325|80765488|FG002|182-Day Follow-Up Period|Death|11|||
27707963|NCT03016325|80765489|FG003|182-Day Follow-Up Period|Death|12|||
27707964|NCT03016325|80765490|FG004|182-Day Follow-Up Period|Death|9|||
27707965|NCT03016325|80765491|FG005|182-Day Follow-Up Period|Death|0|||
27707966|NCT03016325|80765492|FG006|182-Day Follow-Up Period|Death|0|||
27707967|NCT03016325|80765493|FG007|182-Day Follow-Up Period|Death|1|||
27707968|NCT03016325|80765486|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
27707969|NCT03016325|80765487|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27707970|NCT03016325|80765488|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27707971|NCT03016325|80765489|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27707972|NCT03016325|80765490|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27707973|NCT03016325|80765491|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27707974|NCT03016325|80765492|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27707975|NCT03016325|80765493|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
27835664|NCT01572662|81226243|FG001|Overall Study|Physician Decision|1|||
27835665|NCT00835796|81229013|FG000|First Intervention|Withdrawal by Subject|0|||
27707976|NCT03016325|80765486|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
27707977|NCT03016325|80765487|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
27707978|NCT03016325|80765488|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
27707979|NCT03016325|80765489|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
27707980|NCT03016325|80765490|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
27707981|NCT03016325|80765491|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
27707982|NCT03016325|80765492|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
27707983|NCT03016325|80765493|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
27707984|NCT03016325|80765486|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707985|NCT03016325|80765487|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707986|NCT03016325|80765488|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707987|NCT03016325|80765489|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707988|NCT03016325|80765490|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
27707989|NCT03016325|80765491|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707990|NCT03016325|80765492|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707991|NCT03016325|80765493|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
27707992|NCT03016325|80765486|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
27707993|NCT03016325|80765487|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
27707994|NCT03016325|80765488|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
27707995|NCT03016325|80765489|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
27707996|NCT03016325|80765490|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
27707997|NCT03016325|80765491|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
27707998|NCT03016325|80765492|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
27707999|NCT03016325|80765493|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
27708000|NCT03016325|80765486|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708001|NCT03016325|80765487|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708002|NCT03016325|80765488|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708003|NCT03016325|80765489|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
27708004|NCT03016325|80765490|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708005|NCT03016325|80765491|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708006|NCT03016325|80765492|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708007|NCT03016325|80765493|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
27708008|NCT03016325|80765486|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708009|NCT03016325|80765487|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
27708010|NCT03016325|80765488|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708011|NCT03016325|80765489|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708012|NCT03016325|80765490|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708013|NCT03016325|80765491|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708014|NCT03016325|80765492|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708015|NCT03016325|80765493|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
27708016|NCT03016325|80765486|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
27708017|NCT03016325|80765487|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
27708018|NCT03016325|80765488|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
27708019|NCT03016325|80765489|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
27708020|NCT03016325|80765490|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
27708021|NCT03016325|80765491|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
27708022|NCT03016325|80765492|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
27708023|NCT03016325|80765493|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
27708024|NCT00383084|80765494|FG000|Overall Study|Withdrawal by Subject|12|||
27708025|NCT00383084|80765495|FG001|Overall Study|Withdrawal by Subject|10|||
27708026|NCT00618410|80765496|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
27708027|NCT00618410|80765497|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
27708028|NCT00993265|80765498|FG000|Overall Study|Adverse Event|1|||
27708029|NCT00993265|80765499|FG001|Overall Study|Adverse Event|0|||
27708030|NCT00993265|80765498|FG000|Overall Study|Changed dose of concomitant drug|2|||
27708031|NCT00993265|80765499|FG001|Overall Study|Changed dose of concomitant drug|0|||
27708032|NCT00993265|80765498|FG000|Overall Study|Non-compliant with study medication|1|||
27708033|NCT00993265|80765499|FG001|Overall Study|Non-compliant with study medication|0|||
27708034|NCT00003702|80768527|FG000|Overall Study|Ineligible cell types|2|||
27708035|NCT00003702|80768528|FG001|Overall Study|Ineligible cell types|2|||
27708036|NCT00003702|80768527|FG000|Overall Study|Did not meet criteria for persistence|8|||
27708037|NCT00003702|80768528|FG001|Overall Study|Did not meet criteria for persistence|5|||
27708038|NCT00003702|80768527|FG000|Overall Study|WHO score > 6|2|||
27708039|NCT00003702|80768528|FG001|Overall Study|WHO score > 6|1|||
27708040|NCT00003702|80768527|FG000|Overall Study|Inadequate documentation of disease|1|||
27835666|NCT00835796|81229014|FG001|First Intervention|Withdrawal by Subject|1|||
27835667|NCT01253564|81229015|FG000|Overall Study|Disease Progression|22|||
27708041|NCT00003702|80768528|FG001|Overall Study|Inadequate documentation of disease|3|||
27835668|NCT01253564|81229015|FG000|Overall Study|Withdrawal by Subject|1|||
27708042|NCT03069352|80768529|FG000|Overall Study|Ongoing|12|||
27708043|NCT03069352|80768530|FG001|Overall Study|Ongoing|40|||
27708044|NCT01786603|80768531|FG000|Overall Study|Death|5|||
27708045|NCT01786603|80768532|FG001|Overall Study|Death|1|||
27708046|NCT01786603|80768531|FG000|Overall Study|Adverse Event|6|||
27708047|NCT01786603|80768532|FG001|Overall Study|Adverse Event|2|||
27708048|NCT01786603|80768531|FG000|Overall Study|Physician decision to withdraw|6|||
27708049|NCT01786603|80768532|FG001|Overall Study|Physician decision to withdraw|7|||
27708050|NCT01786603|80768531|FG000|Overall Study|Lost to Follow-up|1|||
27708051|NCT01786603|80768532|FG001|Overall Study|Lost to Follow-up|2|||
27708052|NCT00359021|80768533|FG000|Overall Study|Adverse Event|26|||
27708053|NCT00359021|80768534|FG001|Overall Study|Adverse Event|8|||
27708054|NCT00359021|80768533|FG000|Overall Study|Subject Non-Compliant|1|||
27708055|NCT00359021|80768534|FG001|Overall Study|Subject Non-Compliant|2|||
27708056|NCT00359021|80768533|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
27708057|NCT00359021|80768534|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
27708058|NCT00359021|80768533|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
27708059|NCT00359021|80768534|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
27708060|NCT00359021|80768533|FG000|Overall Study|Withdrawal by Subject|2|||
27708061|NCT00359021|80768534|FG001|Overall Study|Withdrawal by Subject|9|||
27708062|NCT00359021|80768533|FG000|Overall Study|Lost to Follow-up|1|||
27835669|NCT01253564|81229015|FG000|Overall Study|Serious Adverse Event|1|||
27835670|NCT04561115|81229016|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
27708063|NCT00359021|80768534|FG001|Overall Study|Lost to Follow-up|0|||
27708064|NCT00359021|80768533|FG000|Overall Study|Other|4|||
27708065|NCT00359021|80768534|FG001|Overall Study|Other|1|||
27708066|NCT00359021|80768533|FG000|Overall Study|Pregnancy|1|||
27708067|NCT00359021|80768534|FG001|Overall Study|Pregnancy|0|||
27708068|NCT04425720|80768535|FG000|Overall Study|Withdrawal by Subject|0|||
27708069|NCT04425720|80768536|FG001|Overall Study|Withdrawal by Subject|20|||
27708070|NCT03901079|80768537|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
27708071|NCT01380379|80768540|FG000|Overall Study|Pregnancy|1|||
27708072|NCT05289570|80768541|FG000|Overall Study|Physician Decision|1|||
27708073|NCT03962738|80768542|FG000|Overall Study|Protocol Deviation|3|||
27708074|NCT03962738|80768543|FG001|Overall Study|Protocol Deviation|0|||
27708075|NCT03962738|80768544|FG002|Overall Study|Protocol Deviation|1|||
27708076|NCT03962738|80768545|FG003|Overall Study|Protocol Deviation|1|||
27708077|NCT03962738|80768542|FG000|Overall Study|Withdrawal by Subject|4|||
27708078|NCT03962738|80768543|FG001|Overall Study|Withdrawal by Subject|0|||
27708079|NCT03962738|80768544|FG002|Overall Study|Withdrawal by Subject|0|||
27708080|NCT03962738|80768545|FG003|Overall Study|Withdrawal by Subject|0|||
27708081|NCT03962738|80768542|FG000|Overall Study|Lost to Follow-up|0|||
27708082|NCT03962738|80768543|FG001|Overall Study|Lost to Follow-up|0|||
27708083|NCT03962738|80768544|FG002|Overall Study|Lost to Follow-up|1|||
27708084|NCT03962738|80768545|FG003|Overall Study|Lost to Follow-up|0|||
27708085|NCT00545298|80768546|FG000|Overall Study|Issues with Standard of Care|2|||
27708086|NCT00545298|80768547|FG001|Overall Study|Issues with Standard of Care|0|||
27708087|NCT00545298|80768548|FG002|Overall Study|Issues with Standard of Care|1|||
27708088|NCT01671111|80768551|FG000|Overall Study|Adverse Event|2|||
27708089|NCT01671111|80768551|FG000|Overall Study|Lack of Efficacy|1|||
27708090|NCT01671111|80768551|FG000|Overall Study|Withdrawal by Subject|2|||
27708091|NCT01671111|80768551|FG000|Overall Study|Physician Decision|1|||
27708092|NCT01671111|80768551|FG000|Overall Study|Other|24|||
27708093|NCT02437864|80768552|FG000|Overall Study|Protocol Violation|4|||
27708094|NCT02437864|80768553|FG001|Overall Study|Protocol Violation|0|||
27708095|NCT03215771|80768554|FG000|Overall Study|Withdrawal by Subject|2|||
27708096|NCT03215771|80768554|FG000|Overall Study|Physician Decision|1|||
27708097|NCT01301950|80768558|FG000|Overall Study|Surgery was cancelled by patient|0|||
27708098|NCT01301950|80768559|FG001|Overall Study|Surgery was cancelled by patient|1|||
27708099|NCT02047253|80768560|FG000|Overall Study|Lost to Follow-up|8|||
27708100|NCT04251910|80768569|FG000|Overall Study|Covid 19 lockdown|0|||
27708101|NCT04251910|80768570|FG001|Overall Study|Covid 19 lockdown|5|||
27708102|NCT04251910|80768571|FG002|Overall Study|Covid 19 lockdown|0|||
27708103|NCT04251910|80768572|FG003|Overall Study|Covid 19 lockdown|4|||
27708104|NCT04251910|80768573|FG004|Overall Study|Covid 19 lockdown|0|||
27708105|NCT04251910|80768574|FG005|Overall Study|Covid 19 lockdown|0|||
27708106|NCT04251910|80768569|FG000|Overall Study|Assisted living facility was closed|0|||
27708107|NCT04251910|80768570|FG001|Overall Study|Assisted living facility was closed|0|||
27708108|NCT04251910|80768571|FG002|Overall Study|Assisted living facility was closed|0|||
27708109|NCT04251910|80768572|FG003|Overall Study|Assisted living facility was closed|0|||
27708110|NCT04251910|80768573|FG004|Overall Study|Assisted living facility was closed|1|||
27708111|NCT04251910|80768574|FG005|Overall Study|Assisted living facility was closed|0|||
27708112|NCT00096785|80768576|FG000|Overall Study|Lost to Follow-up|1|||
27708113|NCT00096785|80768577|FG001|Overall Study|Lost to Follow-up|0|||
27708114|NCT00096785|80768576|FG000|Overall Study|Withdrawal by Subject|0|||
27708115|NCT00096785|80768577|FG001|Overall Study|Withdrawal by Subject|1|||
27708116|NCT00096785|80768576|FG000|Overall Study|Relocated|1|||
27708117|NCT00096785|80768577|FG001|Overall Study|Relocated|0|||
27708118|NCT01225731|80768579|FG000|Part 1|Did not meet eligibility criteria|1|||
27708119|NCT01225731|80768580|FG001|Part 1|Did not meet eligibility criteria|0|||
27708120|NCT01225731|80768581|FG002|Part 1|Did not meet eligibility criteria|0|||
27708121|NCT01225731|80768582|FG003|Part 1|Did not meet eligibility criteria|0|||
27708122|NCT01225731|80768583|FG004|Part 1|Did not meet eligibility criteria|1|||
27708123|NCT01225731|80768584|FG005|Part 1|Did not meet eligibility criteria|0|||
27708124|NCT01225731|80768585|FG006|Part 1|Did not meet eligibility criteria|0|||
27708125|NCT01225731|80768586|FG007|Part 1|Did not meet eligibility criteria|0|||
27708126|NCT01225731|80768587|FG008|Part 1|Did not meet eligibility criteria|0|||
27708127|NCT01225731|80768588|FG009|Part 1|Did not meet eligibility criteria|0|||
27708128|NCT01225731|80768589|FG010|Part 1|Did not meet eligibility criteria|0|||
27708129|NCT01225731|80768590|FG011|Part 1|Did not meet eligibility criteria|0|||
27708130|NCT01225731|80768591|FG012|Part 1|Did not meet eligibility criteria|0|||
27708131|NCT01225731|80768579|FG000|Part 1|Adverse Event|1|||
27708132|NCT01225731|80768580|FG001|Part 1|Adverse Event|2|||
27708133|NCT01225731|80768581|FG002|Part 1|Adverse Event|1|||
27708134|NCT01225731|80768582|FG003|Part 1|Adverse Event|1|||
27708135|NCT01225731|80768583|FG004|Part 1|Adverse Event|1|||
27708136|NCT01225731|80768584|FG005|Part 1|Adverse Event|0|||
27708137|NCT01225731|80768585|FG006|Part 1|Adverse Event|0|||
27835671|NCT04561115|81229017|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
27835672|NCT04561115|81229016|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
27602071|NCT00118716|80381785|FG001|Overall Study|Withdrawal by Subject|1|||
27602072|NCT00118716|80381784|FG000|Overall Study|Exacerbation|2|||
27835673|NCT04561115|81229017|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
27835674|NCT04561115|81229016|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
27835675|NCT04561115|81229017|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
27835676|NCT02911701|81229020|FG000|Overall Study|Withdrawal by Subject|2|||
27835677|NCT02911701|81229021|FG001|Overall Study|Withdrawal by Subject|4|||
27835678|NCT02911701|81229020|FG000|Overall Study|Adverse Event|1|||
27835679|NCT02911701|81229021|FG001|Overall Study|Adverse Event|0|||
27835680|NCT00868998|81229022|FG000|Overall Study|Screen Failure|1|||
27835681|NCT00868998|81229022|FG000|Overall Study|Withdrawal by Subject|1|||
27835682|NCT00868998|81229022|FG000|Overall Study|Progression of disease|2|||
27835683|NCT00868998|81229022|FG000|Overall Study|Death|1|||
27835684|NCT00057941|81229025|FG000|Overall Study|Death|1|||
27835685|NCT00057941|81229026|FG001|Overall Study|Death|2|||
27835686|NCT00057941|81229025|FG000|Overall Study|Adverse Event|7|||
27835687|NCT00057941|81229026|FG001|Overall Study|Adverse Event|9|||
27835688|NCT00057941|81229025|FG000|Overall Study|Lack of Efficacy|54|||
27835689|NCT00057941|81229026|FG001|Overall Study|Lack of Efficacy|53|||
27835690|NCT00057941|81229025|FG000|Overall Study|Withdrawal by Subject|6|||
27602073|NCT00118716|80381785|FG001|Overall Study|Exacerbation|2|||
27602074|NCT00118716|80381784|FG000|Overall Study|Discontinued by sponsor|1|||
27708138|NCT01225731|80768586|FG007|Part 1|Adverse Event|0|||
27602075|NCT00118716|80381785|FG001|Overall Study|Discontinued by sponsor|1|||
27602076|NCT00118716|80381784|FG000|Overall Study|Non-compliance|1|||
27602077|NCT00118716|80381785|FG001|Overall Study|Non-compliance|3|||
27602078|NCT00118716|80381784|FG000|Overall Study|misrandomized|1|||
27602079|NCT00118716|80381785|FG001|Overall Study|misrandomized|1|||
27602080|NCT00118716|80381784|FG000|Overall Study|Expired drug use|1|||
27602081|NCT00118716|80381785|FG001|Overall Study|Expired drug use|2|||
27602082|NCT00118716|80381784|FG000|Overall Study|Investigator discretion|0|||
27602083|NCT00118716|80381785|FG001|Overall Study|Investigator discretion|1|||
27602084|NCT01959425|80381788|FG000|Overall Study|Withdrawal by Subject|5|||
27602085|NCT01959425|80381789|FG001|Overall Study|Withdrawal by Subject|4|||
27835691|NCT00057941|81229026|FG001|Overall Study|Withdrawal by Subject|1|||
27835692|NCT00057941|81229025|FG000|Overall Study|still on treatment|3|||
27835693|NCT00057941|81229026|FG001|Overall Study|still on treatment|1|||
27835694|NCT00057941|81229025|FG000|Overall Study|insurance, symptomatic deterioration|1|||
27835695|NCT00057941|81229026|FG001|Overall Study|insurance, symptomatic deterioration|3|||
27835696|NCT00057941|81229025|FG000|Overall Study|Ineligible|2|||
27835697|NCT00057941|81229026|FG001|Overall Study|Ineligible|5|||
27835698|NCT00884390|81229027|FG000|Overall Study|Adverse Event|0|||
27835699|NCT00884390|81229028|FG001|Overall Study|Adverse Event|1|||
27835700|NCT00884390|81229027|FG000|Overall Study|Lost to Follow-up|0|||
27835701|NCT00884390|81229028|FG001|Overall Study|Lost to Follow-up|1|||
27835702|NCT00884390|81229027|FG000|Overall Study|Physician Decision|2|||
27835703|NCT00884390|81229028|FG001|Overall Study|Physician Decision|1|||
27835704|NCT00884390|81229027|FG000|Overall Study|Protocol Violation|4|||
27835705|NCT00884390|81229028|FG001|Overall Study|Protocol Violation|1|||
27602086|NCT01959425|80381788|FG000|Overall Study|Lost to Follow-up|1|||
27602087|NCT01959425|80381789|FG001|Overall Study|Lost to Follow-up|0|||
27602088|NCT01959425|80381788|FG000|Overall Study|Discontinued Subjects|6|||
27835706|NCT00884390|81229027|FG000|Overall Study|Withdrawal by Subject|4|||
27835707|NCT00884390|81229028|FG001|Overall Study|Withdrawal by Subject|1|||
27835708|NCT00884390|81229027|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
27835709|NCT00884390|81229028|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
27835710|NCT00884390|81229027|FG000|Overall Study|Other|11|||
27602089|NCT01959425|80381789|FG001|Overall Study|Discontinued Subjects|4|||
27602090|NCT03576768|80381797|FG000|Overall Study|Lost to Follow-up|3|||
27602091|NCT03576768|80381798|FG001|Overall Study|Lost to Follow-up|3|||
27602092|NCT03576768|80381799|FG002|Overall Study|Lost to Follow-up|0|||
27602093|NCT03576768|80381800|FG003|Overall Study|Lost to Follow-up|0|||
27602094|NCT03295318|80381801|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
27602095|NCT03295318|80381802|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
27602096|NCT03295318|80381803|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
27602097|NCT03295318|80381801|FG000|Overall Study|Death|1|||
27602098|NCT03295318|80381802|FG001|Overall Study|Death|1|||
27602099|NCT03295318|80381803|FG002|Overall Study|Death|1|||
27835711|NCT00884390|81229028|FG001|Overall Study|Other|1|||
27835712|NCT02483416|81229029|FG000|Overall Study|Other reason|0|||
27835713|NCT02483416|81229030|FG001|Overall Study|Other reason|1|||
27835714|NCT02483416|81229029|FG000|Overall Study|Treatment stop|3|||
27835715|NCT02483416|81229030|FG001|Overall Study|Treatment stop|0|||
27835716|NCT00757172|81229031|FG000|Overall Study|Withdrawal by Subject|4|||
27835717|NCT00757172|81229031|FG000|Overall Study|Physician Decision|3|||
27835718|NCT00757172|81229031|FG000|Overall Study|Progression|4|||
27835719|NCT04194008|81229033|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
27835720|NCT04194008|81229033|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
27835721|NCT04194008|81229033|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
27835722|NCT04194008|81229033|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
27835723|NCT04194008|81229033|FG000|Treatment Phase With Nerivio|Missing data|4|||
27835724|NCT04194008|81229033|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
27835725|NCT00515216|81229035|FG000|Overall Study|Withdrawal by Subject|1|||
27835726|NCT03257254|81229039|FG000|Overall Study|Withdrawal by Subject|7|||
27835727|NCT03257254|81229039|FG000|Overall Study|Lost to Follow-up|9|||
27835728|NCT03257254|81229039|FG000|Overall Study|Study discontinued by sponsor|5|||
27835729|NCT02046122|81229044|FG000|Overall Study|Physician Decision|8|||
27835730|NCT02046122|81229044|FG000|Overall Study|Withdrawal by Subject|1|||
27835731|NCT00787605|81229047|FG000|Overall Study|Administrative Problems|3|||
27835732|NCT00787605|81229048|FG001|Overall Study|Administrative Problems|0|||
27835733|NCT00787605|81229047|FG000|Overall Study|Adverse Event|14|||
27835734|NCT00787605|81229048|FG001|Overall Study|Adverse Event|25|||
27835735|NCT00787605|81229047|FG000|Overall Study|Lost to Follow-up|3|||
27835736|NCT00787605|81229048|FG001|Overall Study|Lost to Follow-up|6|||
27835737|NCT00787605|81229047|FG000|Overall Study|Protocol Violation|7|||
27835738|NCT00787605|81229048|FG001|Overall Study|Protocol Violation|3|||
27835739|NCT00787605|81229047|FG000|Overall Study|Withdrawal by Subject|6|||
27835740|NCT00787605|81229048|FG001|Overall Study|Withdrawal by Subject|13|||
27835741|NCT00787605|81229047|FG000|Overall Study|Lack of Efficacy|13|||
27835742|NCT00787605|81229048|FG001|Overall Study|Lack of Efficacy|9|||
27835743|NCT05004649|81229051|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
27835744|NCT05004649|81229051|FG000|Overall Study|Lost to Follow-up|1|||
27835745|NCT05004649|81229051|FG000|Overall Study|Withdrawal by Subject|2|||
27835746|NCT05004649|81229051|FG000|Overall Study|COVID-19|1|||
27835747|NCT01685008|81229052|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
27835748|NCT01685008|81229053|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
27835749|NCT01685008|81229054|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
27835750|NCT01685008|81229055|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
27835751|NCT01685008|81229052|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
27835752|NCT01685008|81229053|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
27835753|NCT01685008|81229054|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
27835754|NCT01685008|81229055|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
27835755|NCT01685008|81229052|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
27835756|NCT01685008|81229053|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
27835757|NCT01685008|81229054|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
27602100|NCT03295318|80381801|FG000|Overall Study|Protocol Violation|4|||
27602101|NCT03295318|80381802|FG001|Overall Study|Protocol Violation|3|||
27602102|NCT03295318|80381803|FG002|Overall Study|Protocol Violation|3|||
27835758|NCT01685008|81229055|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
27835759|NCT01685008|81229052|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
27835760|NCT01685008|81229053|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
27835761|NCT01685008|81229054|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
27888744|NCT01489254|81428081|FG002|Double-blind Part|Withdrawal by Subject|1|||
27888745|NCT01489254|81428082|FG003|Double-blind Part|Withdrawal by Subject|0|||
27888746|NCT01489254|81428079|FG000|Double-blind Part|Lost to Follow-up|1|||
27888747|NCT01489254|81428080|FG001|Double-blind Part|Lost to Follow-up|2|||
27888748|NCT01489254|81428081|FG002|Double-blind Part|Lost to Follow-up|0|||
27888749|NCT01489254|81428082|FG003|Double-blind Part|Lost to Follow-up|0|||
27888750|NCT01489254|81428079|FG000|Double-blind Part|Other reasons for not completing study|4|||
27888751|NCT01489254|81428080|FG001|Double-blind Part|Other reasons for not completing study|6|||
27888752|NCT01489254|81428081|FG002|Double-blind Part|Other reasons for not completing study|0|||
27888753|NCT01489254|81428082|FG003|Double-blind Part|Other reasons for not completing study|0|||
27888754|NCT01489254|81428079|FG000|Open-label Extension Part|Adverse Event|0|||
27602103|NCT03295318|80381801|FG000|Overall Study|Withdrawal by Subject|0|||
27602104|NCT03295318|80381802|FG001|Overall Study|Withdrawal by Subject|0|||
27888755|NCT01489254|81428080|FG001|Open-label Extension Part|Adverse Event|0|||
27602105|NCT03295318|80381803|FG002|Overall Study|Withdrawal by Subject|1|||
27708139|NCT01225731|80768587|FG008|Part 1|Adverse Event|0|||
27708140|NCT01225731|80768588|FG009|Part 1|Adverse Event|0|||
27888756|NCT01489254|81428081|FG002|Open-label Extension Part|Adverse Event|0|||
27888757|NCT01489254|81428082|FG003|Open-label Extension Part|Adverse Event|10|||
27888758|NCT01489254|81428079|FG000|Open-label Extension Part|Pregnancy|0|||
27602106|NCT03295318|80381801|FG000|Overall Study|Subject discontinued due to travel|0|||
27602107|NCT03295318|80381802|FG001|Overall Study|Subject discontinued due to travel|1|||
27602108|NCT03295318|80381803|FG002|Overall Study|Subject discontinued due to travel|0|||
27708141|NCT01225731|80768589|FG010|Part 1|Adverse Event|0|||
27708142|NCT01225731|80768590|FG011|Part 1|Adverse Event|0|||
27708143|NCT01225731|80768591|FG012|Part 1|Adverse Event|0|||
27708144|NCT01225731|80768579|FG000|Part 1|Withdrawal by Subject|0|||
27708145|NCT01225731|80768580|FG001|Part 1|Withdrawal by Subject|3|||
27708146|NCT01225731|80768581|FG002|Part 1|Withdrawal by Subject|0|||
27708147|NCT01225731|80768582|FG003|Part 1|Withdrawal by Subject|0|||
27708148|NCT01225731|80768583|FG004|Part 1|Withdrawal by Subject|4|||
27602109|NCT04510675|80381804|FG000|Overall Study|Withdrawal by Subject|5|||
27602110|NCT02170025|80381805|FG000|Overall Study|Adverse Event|2|||
27602111|NCT02170025|80381806|FG001|Overall Study|Adverse Event|0|||
27602112|NCT02606279|80381807|FG000|Overall Study|Lost to Follow-up|0|||
27602113|NCT02606279|80381808|FG001|Overall Study|Lost to Follow-up|1|||
27602114|NCT00733980|80381813|FG000|Overall Study|Adverse Event|5|||
27602115|NCT00733980|80381814|FG001|Overall Study|Adverse Event|2|||
27602116|NCT00733980|80381813|FG000|Overall Study|Lack of Efficacy|0|||
27602117|NCT00733980|80381814|FG001|Overall Study|Lack of Efficacy|1|||
27602118|NCT00733980|80381813|FG000|Overall Study|Protocol Violation|2|||
27602119|NCT00733980|80381814|FG001|Overall Study|Protocol Violation|1|||
27602120|NCT00733980|80381813|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
27602121|NCT00733980|80381814|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
27602122|NCT00733980|80381813|FG000|Overall Study|Lost to Follow-up|6|||
27602123|NCT00733980|80381814|FG001|Overall Study|Lost to Follow-up|11|||
27602124|NCT00733980|80381813|FG000|Overall Study|Physician Decision|2|||
27602125|NCT00733980|80381814|FG001|Overall Study|Physician Decision|3|||
27602126|NCT00733980|80381813|FG000|Overall Study|Withdrawal by Subject|6|||
27602127|NCT00733980|80381814|FG001|Overall Study|Withdrawal by Subject|2|||
27602128|NCT01966003|80381820|FG000|Overall Study|Death|43|||
27602129|NCT01966003|80381821|FG001|Overall Study|Death|36|||
27602130|NCT01966003|80381820|FG000|Overall Study|Protocol Violation|6|||
27602131|NCT01966003|80381821|FG001|Overall Study|Protocol Violation|4|||
27602132|NCT01966003|80381820|FG000|Overall Study|Lost to Follow-up|4|||
27602133|NCT01966003|80381821|FG001|Overall Study|Lost to Follow-up|3|||
27602134|NCT01966003|80381820|FG000|Overall Study|Physician Decision|12|||
27602135|NCT01966003|80381821|FG001|Overall Study|Physician Decision|13|||
27602136|NCT01966003|80381820|FG000|Overall Study|Withdrawal by Subject|29|||
27602137|NCT01966003|80381821|FG001|Overall Study|Withdrawal by Subject|19|||
27602138|NCT01966003|80381820|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
27602139|NCT01966003|80381821|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
27602140|NCT01966003|80381820|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
27602141|NCT01966003|80381821|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
27602142|NCT01966003|80381820|FG000|Overall Study|Other|1|||
27602143|NCT01966003|80381821|FG001|Overall Study|Other|1|||
27602144|NCT01654601|80381822|FG000|1st Administration|Withdrawal by Subject|2|||
27602145|NCT01654601|80381823|FG001|1st Administration|Withdrawal by Subject|0|||
27602146|NCT01654601|80381822|FG000|1st Administration|Protocol Violation|0|||
27602147|NCT01654601|80381823|FG001|1st Administration|Protocol Violation|2|||
27602148|NCT01654601|80381822|FG000|2nd Administration|Adverse Event|1|||
27602149|NCT01654601|80381823|FG001|2nd Administration|Adverse Event|0|||
27602150|NCT01654601|80381822|FG000|2nd Administration|Protocol Violation|0|||
27602151|NCT01654601|80381823|FG001|2nd Administration|Protocol Violation|1|||
27602152|NCT00593567|80381824|FG000|Overall Study|Adverse Event|2|||
27602153|NCT00593567|80381825|FG001|Overall Study|Adverse Event|0|||
27602154|NCT00593567|80381824|FG000|Overall Study|Physician Decision|2|||
27602155|NCT00593567|80381825|FG001|Overall Study|Physician Decision|0|||
27602156|NCT00593567|80381824|FG000|Overall Study|Protocol Violation|13|||
27602157|NCT00593567|80381825|FG001|Overall Study|Protocol Violation|7|||
27602158|NCT00593567|80381824|FG000|Overall Study|Lack of Efficacy|2|||
27602159|NCT00593567|80381825|FG001|Overall Study|Lack of Efficacy|1|||
27602160|NCT00593567|80381824|FG000|Overall Study|Withdrawal by Subject|1|||
27602161|NCT00593567|80381825|FG001|Overall Study|Withdrawal by Subject|2|||
27602162|NCT04425902|80385296|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
27708149|NCT01225731|80768584|FG005|Part 1|Withdrawal by Subject|0|||
27708150|NCT01225731|80768585|FG006|Part 1|Withdrawal by Subject|0|||
27708151|NCT01225731|80768586|FG007|Part 1|Withdrawal by Subject|0|||
27602163|NCT02158884|80385311|FG000|Baseline Assessment|Missed performance assessment|3|||
27602164|NCT02158884|80385311|FG000|Baseline Assessment|Missed SMFA|1|||
27602165|NCT02158884|80385311|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
27602166|NCT02158884|80385311|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
27602167|NCT02158884|80385311|FG000|6 Month Assessment|Missed SMFA|20|||
27602168|NCT02158884|80385311|FG000|12 Month Assessment|Missed SMFA|17|||
27602169|NCT02901626|80385315|FG000|Overall Study|Lost to Follow-up|1|||
27602170|NCT02901626|80385316|FG001|Overall Study|Lost to Follow-up|1|||
27602171|NCT01830595|80385317|FG000|First Period|Withdrawal by Subject|1|||
27602172|NCT01830595|80385318|FG001|First Period|Withdrawal by Subject|3|||
27602173|NCT01830595|80385317|FG000|Washout|Withdrawal by Subject|2|||
27602174|NCT01830595|80385318|FG001|Washout|Withdrawal by Subject|2|||
27708152|NCT01225731|80768587|FG008|Part 1|Withdrawal by Subject|0|||
27708153|NCT01225731|80768588|FG009|Part 1|Withdrawal by Subject|0|||
27602175|NCT00261495|80385319|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
27602176|NCT00261495|80385320|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
27602177|NCT00261495|80385319|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
27602178|NCT00261495|80385320|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
27602179|NCT00261495|80385319|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
27602180|NCT00261495|80385320|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
27602181|NCT00261495|80385319|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
27602182|NCT00261495|80385320|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
27602183|NCT00261495|80385319|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
27602184|NCT00261495|80385320|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
27602185|NCT00261495|80385319|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
27602186|NCT00261495|80385320|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
27602187|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
27602188|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
27602189|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
27602190|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
27602191|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
27602192|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
27602193|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
27602194|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
27602195|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
27602196|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
27602197|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
27602198|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
27602199|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
27602200|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
27602201|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
27602202|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
27602203|NCT00261495|80385319|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
27602204|NCT00261495|80385320|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
27602205|NCT00261495|80385319|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
27708154|NCT01225731|80768589|FG010|Part 1|Withdrawal by Subject|0|||
27888759|NCT01489254|81428080|FG001|Open-label Extension Part|Pregnancy|0|||
27602206|NCT00261495|80385320|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
27602207|NCT00261495|80385319|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
27888760|NCT01489254|81428081|FG002|Open-label Extension Part|Pregnancy|0|||
27888761|NCT01489254|81428082|FG003|Open-label Extension Part|Pregnancy|3|||
27708155|NCT01225731|80768590|FG011|Part 1|Withdrawal by Subject|0|||
27602208|NCT00261495|80385320|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27602209|NCT00261495|80385319|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
27602210|NCT00261495|80385320|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
27602211|NCT00261495|80385319|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27602212|NCT00261495|80385320|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
27602213|NCT00261495|80385319|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
27602214|NCT00261495|80385320|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
27602215|NCT00261495|80385319|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
27602216|NCT00261495|80385320|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27602217|NCT01242748|80385321|FG000|Overall Study|Adverse Event|10|||
27602218|NCT01242748|80385322|FG001|Overall Study|Adverse Event|5|||
27602219|NCT01242748|80385321|FG000|Overall Study|Lost to Follow-up|6|||
27602220|NCT01242748|80385322|FG001|Overall Study|Lost to Follow-up|2|||
27602221|NCT01242748|80385321|FG000|Overall Study|Physician Decision|3|||
27602222|NCT01242748|80385322|FG001|Overall Study|Physician Decision|2|||
27602223|NCT01242748|80385321|FG000|Overall Study|Protocol Violation|1|||
27602224|NCT01242748|80385322|FG001|Overall Study|Protocol Violation|0|||
27602225|NCT01242748|80385321|FG000|Overall Study|Withdrawal by Subject|10|||
27602226|NCT01242748|80385322|FG001|Overall Study|Withdrawal by Subject|2|||
27602227|NCT01242748|80385321|FG000|Overall Study|Miscellaneous reasons|8|||
27602228|NCT01242748|80385322|FG001|Overall Study|Miscellaneous reasons|3|||
27602229|NCT02428296|80385334|FG000|Overall Study|Adverse Event|7|||
27602230|NCT02428296|80385334|FG000|Overall Study|Withdrawal by Subject|2|||
27602231|NCT02395133|80385335|FG000|Overall Study|Adverse Event|4|||
27602232|NCT02395133|80385336|FG001|Overall Study|Adverse Event|1|||
27835762|NCT01685008|81229055|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
27835763|NCT01685008|81229052|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
27835764|NCT01685008|81229053|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
27835765|NCT01685008|81229054|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
27835766|NCT01685008|81229055|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
27835767|NCT02096705|81229058|FG000|Treatment|Adverse Event|6|||
27835768|NCT02096705|81229059|FG001|Treatment|Adverse Event|3|||
27835769|NCT02096705|81229058|FG000|Treatment|Subject request to discontinue treatment|1|||
27835770|NCT02096705|81229059|FG001|Treatment|Subject request to discontinue treatment|1|||
27835771|NCT02096705|81229058|FG000|Treatment|Withdrawal by Subject|1|||
27835772|NCT02096705|81229059|FG001|Treatment|Withdrawal by Subject|0|||
27835773|NCT02096705|81229058|FG000|Treatment|Other|1|||
27835774|NCT02096705|81229059|FG001|Treatment|Other|1|||
27835775|NCT02096705|81229058|FG000|Follow-up|Withdrawal by Subject|1|||
27835776|NCT02096705|81229059|FG001|Follow-up|Withdrawal by Subject|0|||
27835777|NCT02096705|81229058|FG000|Follow-up|Adverse Event|2|||
27835778|NCT02096705|81229059|FG001|Follow-up|Adverse Event|2|||
27835779|NCT02096705|81229058|FG000|Follow-up|Subjects not reporting status|1|||
27835780|NCT02096705|81229059|FG001|Follow-up|Subjects not reporting status|2|||
27835781|NCT04364763|81229060|FG000|Overall Study|Death|1|||
27835782|NCT04364763|81229061|FG001|Overall Study|Death|2|||
27835783|NCT04364763|81229060|FG000|Overall Study|Lost to Follow-up|1|||
27835784|NCT04364763|81229061|FG001|Overall Study|Lost to Follow-up|0|||
27835785|NCT02845336|81229062|FG000|Overall Study|Lost to Follow-up|3|||
27835786|NCT02845336|81229063|FG001|Overall Study|Lost to Follow-up|1|||
27835787|NCT02845336|81229062|FG000|Overall Study|Inability to get medication|2|||
27835788|NCT02845336|81229063|FG001|Overall Study|Inability to get medication|0|||
27835789|NCT01277510|81229064|FG000|Double-blind Phase|Non-compliance|0|||
27602233|NCT02395133|80385337|FG002|Overall Study|Adverse Event|3|||
27602234|NCT02395133|80385338|FG003|Overall Study|Adverse Event|0|||
27602235|NCT02395133|80385335|FG000|Overall Study|Lack of Efficacy|1|||
27835790|NCT01277510|81229065|FG001|Double-blind Phase|Non-compliance|1|||
27835791|NCT01277510|81229064|FG000|Double-blind Phase|Adverse Event|1|||
27835792|NCT01277510|81229065|FG001|Double-blind Phase|Adverse Event|0|||
27835793|NCT01277510|81229064|FG000|Double-blind Phase|Withdrawal by Subject|2|||
27835794|NCT01277510|81229065|FG001|Double-blind Phase|Withdrawal by Subject|0|||
27835795|NCT01277510|81229064|FG000|Double-blind Phase|Administrative decision|7|||
27602236|NCT02395133|80385336|FG001|Overall Study|Lack of Efficacy|0|||
27602237|NCT02395133|80385337|FG002|Overall Study|Lack of Efficacy|1|||
27602238|NCT02395133|80385338|FG003|Overall Study|Lack of Efficacy|1|||
27602239|NCT02395133|80385335|FG000|Overall Study|Protocol Violation|1|||
27602240|NCT02395133|80385336|FG001|Overall Study|Protocol Violation|1|||
27602241|NCT02395133|80385337|FG002|Overall Study|Protocol Violation|0|||
27602242|NCT02395133|80385338|FG003|Overall Study|Protocol Violation|3|||
27602243|NCT02395133|80385335|FG000|Overall Study|Lost to Follow-up|0|||
27602244|NCT02395133|80385336|FG001|Overall Study|Lost to Follow-up|1|||
27602245|NCT02395133|80385337|FG002|Overall Study|Lost to Follow-up|1|||
27602246|NCT02395133|80385338|FG003|Overall Study|Lost to Follow-up|0|||
27602247|NCT02395133|80385335|FG000|Overall Study|Pregnancy|0|||
27602248|NCT02395133|80385336|FG001|Overall Study|Pregnancy|0|||
27602249|NCT02395133|80385337|FG002|Overall Study|Pregnancy|3|||
27602250|NCT02395133|80385338|FG003|Overall Study|Pregnancy|0|||
27602251|NCT02395133|80385335|FG000|Overall Study|Consent withdrawn with no reason given|1|||
27602252|NCT02395133|80385336|FG001|Overall Study|Consent withdrawn with no reason given|3|||
27602253|NCT02395133|80385337|FG002|Overall Study|Consent withdrawn with no reason given|0|||
27602254|NCT02395133|80385338|FG003|Overall Study|Consent withdrawn with no reason given|2|||
27602255|NCT02395133|80385335|FG000|Overall Study|Consent withdrawn with personal reason|0|||
27708156|NCT01225731|80768591|FG012|Part 1|Withdrawal by Subject|0|||
27708157|NCT01225731|80768579|FG000|Part 1|Protocol Violation|0|||
27888762|NCT01489254|81428079|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
27888763|NCT01489254|81428080|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
27888764|NCT01489254|81428081|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
27888765|NCT01489254|81428082|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
27602256|NCT02395133|80385336|FG001|Overall Study|Consent withdrawn with personal reason|1|||
27602257|NCT02395133|80385337|FG002|Overall Study|Consent withdrawn with personal reason|0|||
27602258|NCT02395133|80385338|FG003|Overall Study|Consent withdrawn with personal reason|3|||
27602259|NCT02395133|80385335|FG000|Overall Study|Sponsor decision|2|||
27708158|NCT01225731|80768580|FG001|Part 1|Protocol Violation|0|||
27708159|NCT01225731|80768581|FG002|Part 1|Protocol Violation|0|||
27708160|NCT01225731|80768582|FG003|Part 1|Protocol Violation|1|||
27708161|NCT01225731|80768583|FG004|Part 1|Protocol Violation|0|||
27708162|NCT01225731|80768584|FG005|Part 1|Protocol Violation|0|||
27708163|NCT01225731|80768585|FG006|Part 1|Protocol Violation|0|||
27708164|NCT01225731|80768586|FG007|Part 1|Protocol Violation|0|||
27708165|NCT01225731|80768587|FG008|Part 1|Protocol Violation|0|||
27708166|NCT01225731|80768588|FG009|Part 1|Protocol Violation|0|||
27708167|NCT01225731|80768589|FG010|Part 1|Protocol Violation|0|||
27602260|NCT02395133|80385336|FG001|Overall Study|Sponsor decision|0|||
27602261|NCT02395133|80385337|FG002|Overall Study|Sponsor decision|0|||
27602262|NCT02395133|80385338|FG003|Overall Study|Sponsor decision|1|||
27602263|NCT02395133|80385335|FG000|Overall Study|Other than specified above|5|||
27602264|NCT02395133|80385336|FG001|Overall Study|Other than specified above|2|||
27602265|NCT02395133|80385337|FG002|Overall Study|Other than specified above|2|||
27708168|NCT01225731|80768590|FG011|Part 1|Protocol Violation|0|||
27708169|NCT01225731|80768591|FG012|Part 1|Protocol Violation|0|||
27835796|NCT01277510|81229065|FG001|Double-blind Phase|Administrative decision|9|||
27835797|NCT01277510|81229064|FG000|Double-blind Phase|Death|0|||
27708170|NCT01225731|80768579|FG000|Part 2|Protocol Violation|0|||
27602266|NCT02395133|80385338|FG003|Overall Study|Other than specified above|4|||
27602267|NCT02634788|80385339|FG000|Overall Study|Adverse Event|0|||
27602268|NCT02634788|80385340|FG001|Overall Study|Adverse Event|8|||
27602269|NCT02634788|80385341|FG002|Overall Study|Adverse Event|3|||
27602270|NCT02634788|80385342|FG003|Overall Study|Adverse Event|1|||
27602271|NCT02634788|80385339|FG000|Overall Study|Lack of Efficacy|4|||
27602272|NCT02634788|80385340|FG001|Overall Study|Lack of Efficacy|0|||
27602273|NCT02634788|80385341|FG002|Overall Study|Lack of Efficacy|1|||
27602274|NCT02634788|80385342|FG003|Overall Study|Lack of Efficacy|4|||
27602275|NCT02634788|80385339|FG000|Overall Study|Lost to Follow-up|0|||
27602276|NCT02634788|80385340|FG001|Overall Study|Lost to Follow-up|1|||
27602277|NCT02634788|80385341|FG002|Overall Study|Lost to Follow-up|0|||
27602278|NCT02634788|80385342|FG003|Overall Study|Lost to Follow-up|0|||
27602279|NCT02634788|80385339|FG000|Overall Study|Withdrawal by Subject|0|||
27602280|NCT02634788|80385340|FG001|Overall Study|Withdrawal by Subject|1|||
27602281|NCT02634788|80385341|FG002|Overall Study|Withdrawal by Subject|1|||
27602282|NCT02634788|80385342|FG003|Overall Study|Withdrawal by Subject|0|||
27602283|NCT02238379|80385343|FG000|Overall Study|Lost to Follow-up|1|||
27602284|NCT02238379|80385344|FG001|Overall Study|Lost to Follow-up|0|||
27602285|NCT00641719|80385345|FG000|Overall Study|Lack of Efficacy|1|||
27602286|NCT00641719|80385346|FG001|Overall Study|Lack of Efficacy|2|||
27602287|NCT00641719|80385345|FG000|Overall Study|Adverse Event|24|||
27602288|NCT00641719|80385346|FG001|Overall Study|Adverse Event|29|||
27602289|NCT00641719|80385345|FG000|Overall Study|Withdrawal by Subject|4|||
27602290|NCT00641719|80385346|FG001|Overall Study|Withdrawal by Subject|4|||
27602291|NCT00641719|80385345|FG000|Overall Study|Reason Not Specified|1|||
27602292|NCT00641719|80385346|FG001|Overall Study|Reason Not Specified|2|||
27708171|NCT01225731|80768580|FG001|Part 2|Protocol Violation|0|||
27602293|NCT04524598|80385349|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
27602294|NCT04524598|80385350|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
27602295|NCT04524598|80385351|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
27602296|NCT04524598|80385352|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
27602297|NCT04524598|80385353|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
27708172|NCT01225731|80768581|FG002|Part 2|Protocol Violation|0|||
27708173|NCT01225731|80768582|FG003|Part 2|Protocol Violation|0|||
27602298|NCT04524598|80385349|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
27602299|NCT04524598|80385350|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
27602300|NCT04524598|80385351|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602301|NCT04524598|80385352|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602302|NCT04524598|80385353|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602303|NCT04524598|80385349|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
27602304|NCT04524598|80385350|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
27602305|NCT04524598|80385351|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
27602306|NCT04524598|80385352|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
27602307|NCT04524598|80385353|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
27602308|NCT04524598|80385349|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
27602309|NCT04524598|80385350|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
27602310|NCT04524598|80385351|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
27602311|NCT04524598|80385352|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
27602312|NCT04524598|80385353|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
27602313|NCT04524598|80385349|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602314|NCT04524598|80385350|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602315|NCT04524598|80385351|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
27602316|NCT04524598|80385352|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
27602317|NCT04524598|80385353|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602318|NCT04524598|80385349|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
27602319|NCT04524598|80385350|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
27602320|NCT04524598|80385351|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
27602321|NCT04524598|80385352|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
27602322|NCT04524598|80385353|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
27602323|NCT04524598|80385349|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602324|NCT04524598|80385350|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602325|NCT04524598|80385351|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602326|NCT04524598|80385352|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
27602327|NCT04524598|80385353|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
27602328|NCT03585296|80385363|FG000|Overall Study|Adverse Event|1|||
27602329|NCT03585296|80385363|FG000|Overall Study|Lost to Follow-up|2|||
27602330|NCT03585296|80385363|FG000|Overall Study|Withdrawal by Subject|2|||
27602331|NCT04044456|80385364|FG000|Overall Study|Lost to Follow-up|4|||
27602332|NCT04044456|80385365|FG001|Overall Study|Lost to Follow-up|1|||
27602333|NCT04044456|80385364|FG000|Overall Study|Withdrawal by Subject|1|||
27602334|NCT04044456|80385365|FG001|Overall Study|Withdrawal by Subject|0|||
27602335|NCT01373931|80385366|FG000|Lead-in Period|Adverse Event|2|||
27602336|NCT01373931|80385367|FG001|Lead-in Period|Adverse Event|0|||
27602337|NCT01373931|80385366|FG000|Period 1|Adverse Event|2|||
27602338|NCT01373931|80385367|FG001|Period 1|Adverse Event|0|||
27602339|NCT01373931|80385366|FG000|Period 1|Withdrawal by Subject|0|||
27602340|NCT01373931|80385367|FG001|Period 1|Withdrawal by Subject|2|||
27602341|NCT00429663|80385368|FG000|Overall Study|Lost to Follow-up|24|||
27602342|NCT00429663|80385369|FG001|Overall Study|Lost to Follow-up|31|||
27602343|NCT00429663|80385368|FG000|Overall Study|Physician Decision|6|||
27602344|NCT00429663|80385369|FG001|Overall Study|Physician Decision|3|||
27602345|NCT00429663|80385368|FG000|Overall Study|Withdrawal by Subject|2|||
27602346|NCT00429663|80385369|FG001|Overall Study|Withdrawal by Subject|5|||
27602347|NCT00429663|80385368|FG000|Overall Study|Death|4|||
27602348|NCT00429663|80385369|FG001|Overall Study|Death|0|||
27602349|NCT00658567|80385370|FG000|Overall Study|Adverse Event|5|||
27602350|NCT00658567|80385371|FG001|Overall Study|Adverse Event|2|||
27602351|NCT00658567|80385372|FG002|Overall Study|Adverse Event|3|||
27602352|NCT00658567|80385370|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
27602353|NCT00658567|80385371|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
27602354|NCT00658567|80385372|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
27602355|NCT00658567|80385370|FG000|Overall Study|Physician Decision|0|||
27602356|NCT00658567|80385371|FG001|Overall Study|Physician Decision|1|||
27602357|NCT00658567|80385372|FG002|Overall Study|Physician Decision|0|||
27602358|NCT00658567|80385370|FG000|Overall Study|At Discretion of Sponsor|1|||
27602359|NCT00658567|80385371|FG001|Overall Study|At Discretion of Sponsor|1|||
27602360|NCT00658567|80385372|FG002|Overall Study|At Discretion of Sponsor|1|||
27602361|NCT00736489|80385378|FG000|Period 1|Lost to Follow-up|1|||
27602362|NCT00736489|80385379|FG001|Period 1|Lost to Follow-up|0|||
27602363|NCT00736489|80385380|FG002|Period 1|Lost to Follow-up|0|||
27602364|NCT00736489|80385381|FG003|Period 1|Lost to Follow-up|0|||
27602365|NCT00736489|80385382|FG004|Period 1|Lost to Follow-up|0|||
27602366|NCT00736489|80385383|FG005|Period 1|Lost to Follow-up|0|||
27602367|NCT00736489|80385378|FG000|Period 1|Withdrawal by Subject|0|||
27602368|NCT00736489|80385379|FG001|Period 1|Withdrawal by Subject|0|||
27602369|NCT00736489|80385380|FG002|Period 1|Withdrawal by Subject|0|||
27602370|NCT00736489|80385381|FG003|Period 1|Withdrawal by Subject|0|||
27602371|NCT00736489|80385382|FG004|Period 1|Withdrawal by Subject|0|||
27602372|NCT00736489|80385383|FG005|Period 1|Withdrawal by Subject|1|||
27602373|NCT01058304|80385384|FG000|Overall Study|Withdrawal by Subject|8|||
27602374|NCT01058304|80385385|FG001|Overall Study|Withdrawal by Subject|5|||
27602375|NCT01058304|80385384|FG000|Overall Study|Lost to Follow-up|13|||
27602376|NCT01058304|80385385|FG001|Overall Study|Lost to Follow-up|16|||
27602377|NCT01058304|80385384|FG000|Overall Study|Developed exclusion criterion|6|||
27602378|NCT01058304|80385385|FG001|Overall Study|Developed exclusion criterion|12|||
27602379|NCT00676130|80385388|FG000|Overall Study|Lost to Follow-up|0|||
27602380|NCT00676130|80385389|FG001|Overall Study|Lost to Follow-up|1|||
27602381|NCT00676130|80385388|FG000|Overall Study|Found ineligible|3|||
27602382|NCT00676130|80385389|FG001|Overall Study|Found ineligible|2|||
27602383|NCT00676130|80385388|FG000|Overall Study|Withdrawal by Subject|0|||
27602384|NCT00676130|80385389|FG001|Overall Study|Withdrawal by Subject|1|||
27602385|NCT00662857|80385397|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
27602386|NCT00662857|80385398|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
27602387|NCT00662857|80385397|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
27602388|NCT00662857|80385398|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
27602389|NCT00662857|80385397|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
27602390|NCT00662857|80385398|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
27602391|NCT01122381|80385401|FG000|Overall Study|study terminated early|0|||
27602392|NCT01122381|80385402|FG001|Overall Study|study terminated early|1|||
27602393|NCT00939484|80385406|FG000|Overall Study|Progression/Relapse|8|||
27602394|NCT00939484|80385407|FG001|Overall Study|Progression/Relapse|20|||
27602395|NCT00939484|80385408|FG002|Overall Study|Progression/Relapse|3|||
27602396|NCT00595504|80385412|FG000|Overall Study|Withdrawal by Subject|1|||
27602397|NCT00595504|80385413|FG001|Overall Study|Withdrawal by Subject|3|||
27602398|NCT00595504|80385412|FG000|Overall Study|Physician Decision|1|||
27602399|NCT00595504|80385413|FG001|Overall Study|Physician Decision|0|||
27602400|NCT03445065|80385414|FG000|Overall Study|Withdrawal by Subject|3|||
27602401|NCT03445065|80385415|FG001|Overall Study|Withdrawal by Subject|6|||
27602402|NCT03445065|80385416|FG002|Overall Study|Withdrawal by Subject|2|||
27602403|NCT03445065|80385417|FG003|Overall Study|Withdrawal by Subject|2|||
27602404|NCT03445065|80385414|FG000|Overall Study|Other|4|||
27602405|NCT03445065|80385415|FG001|Overall Study|Other|3|||
27602406|NCT03445065|80385416|FG002|Overall Study|Other|3|||
27602407|NCT03445065|80385417|FG003|Overall Study|Other|1|||
27602408|NCT01337674|80385418|FG000|Treatment Period 1|Adverse Event|0|||
27602409|NCT01337674|80385419|FG001|Treatment Period 1|Adverse Event|1|||
27602410|NCT01337674|80385420|FG002|Treatment Period 1|Adverse Event|0|||
27602411|NCT01337674|80385421|FG003|Treatment Period 1|Adverse Event|0|||
27602412|NCT01337674|80385418|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
27602413|NCT01337674|80385419|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
27602414|NCT01337674|80385420|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
27602415|NCT01337674|80385421|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
27602416|NCT01337674|80385418|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27602417|NCT01337674|80385419|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27708174|NCT01225731|80768583|FG004|Part 2|Protocol Violation|0|||
27708175|NCT01225731|80768584|FG005|Part 2|Protocol Violation|1|||
27835798|NCT01277510|81229065|FG001|Double-blind Phase|Death|1|||
27835799|NCT01277510|81229064|FG000|Double-blind Phase|Protocol-specified criteria|2|||
27602418|NCT01337674|80385420|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27602419|NCT01337674|80385421|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27602420|NCT00991341|80385424|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
27602421|NCT00991341|80385425|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
27708176|NCT01225731|80768585|FG006|Part 2|Protocol Violation|0|||
27602422|NCT00991341|80385424|FG000|Overall Study|Death|3|||
27602423|NCT00991341|80385425|FG001|Overall Study|Death|0|||
27602424|NCT00991341|80385424|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
27602425|NCT00991341|80385425|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
27602426|NCT00991341|80385424|FG000|Overall Study|Physician Decision|1|||
27708177|NCT01225731|80768586|FG007|Part 2|Protocol Violation|0|||
27708178|NCT01225731|80768587|FG008|Part 2|Protocol Violation|1|||
27602427|NCT00991341|80385425|FG001|Overall Study|Physician Decision|2|||
27602428|NCT00991341|80385424|FG000|Overall Study|Withdrawal by Subject|3|||
27602429|NCT00991341|80385425|FG001|Overall Study|Withdrawal by Subject|4|||
27602430|NCT01490125|80385428|FG000|Period I|Adverse Event|4|||
27602431|NCT01490125|80385429|FG001|Period I|Adverse Event|1|||
27602432|NCT01490125|80385430|FG002|Period I|Adverse Event|1|||
27602433|NCT01490125|80385431|FG003|Period I|Adverse Event|3|||
27602434|NCT01490125|80385432|FG004|Period I|Adverse Event|2|||
27602435|NCT01490125|80385433|FG005|Period I|Adverse Event|4|||
27602436|NCT01490125|80385428|FG000|Period I|Protocol Violation|1|||
27602437|NCT01490125|80385429|FG001|Period I|Protocol Violation|1|||
27602438|NCT01490125|80385430|FG002|Period I|Protocol Violation|1|||
27602439|NCT01490125|80385431|FG003|Period I|Protocol Violation|1|||
27602440|NCT01490125|80385432|FG004|Period I|Protocol Violation|0|||
27602441|NCT01490125|80385433|FG005|Period I|Protocol Violation|0|||
27602442|NCT01490125|80385428|FG000|Period I|Withdrawal by Subject|1|||
27602443|NCT01490125|80385429|FG001|Period I|Withdrawal by Subject|3|||
27835800|NCT01277510|81229065|FG001|Double-blind Phase|Protocol-specified criteria|6|||
27602444|NCT01490125|80385430|FG002|Period I|Withdrawal by Subject|2|||
27602445|NCT01490125|80385431|FG003|Period I|Withdrawal by Subject|1|||
27602446|NCT01490125|80385432|FG004|Period I|Withdrawal by Subject|2|||
27602447|NCT01490125|80385433|FG005|Period I|Withdrawal by Subject|1|||
27602448|NCT01490125|80385428|FG000|Period II|Adverse Event|2|||
27602449|NCT01490125|80385429|FG001|Period II|Adverse Event|3|||
27602450|NCT01490125|80385430|FG002|Period II|Adverse Event|2|||
27602451|NCT01490125|80385431|FG003|Period II|Adverse Event|2|||
27602452|NCT01490125|80385432|FG004|Period II|Adverse Event|4|||
27602453|NCT01490125|80385433|FG005|Period II|Adverse Event|2|||
27602454|NCT01490125|80385428|FG000|Period II|Protocol Violation|0|||
27602455|NCT01490125|80385429|FG001|Period II|Protocol Violation|0|||
27602456|NCT01490125|80385430|FG002|Period II|Protocol Violation|1|||
27602457|NCT01490125|80385431|FG003|Period II|Protocol Violation|1|||
27602458|NCT01490125|80385432|FG004|Period II|Protocol Violation|0|||
27602459|NCT01490125|80385433|FG005|Period II|Protocol Violation|0|||
27602460|NCT01490125|80385428|FG000|Period II|Lost to Follow-up|0|||
27602461|NCT01490125|80385429|FG001|Period II|Lost to Follow-up|1|||
27602462|NCT01490125|80385430|FG002|Period II|Lost to Follow-up|0|||
27602463|NCT01490125|80385431|FG003|Period II|Lost to Follow-up|0|||
27602464|NCT01490125|80385432|FG004|Period II|Lost to Follow-up|0|||
27602465|NCT01490125|80385433|FG005|Period II|Lost to Follow-up|0|||
27602466|NCT01490125|80385428|FG000|Period II|Withdrawal by Subject|1|||
27602467|NCT01490125|80385429|FG001|Period II|Withdrawal by Subject|0|||
27602468|NCT01490125|80385430|FG002|Period II|Withdrawal by Subject|0|||
27602469|NCT01490125|80385431|FG003|Period II|Withdrawal by Subject|0|||
27602470|NCT01490125|80385432|FG004|Period II|Withdrawal by Subject|0|||
27602471|NCT01490125|80385433|FG005|Period II|Withdrawal by Subject|0|||
27602472|NCT01490125|80385428|FG000|Period III|Adverse Event|3|||
27602473|NCT01490125|80385429|FG001|Period III|Adverse Event|1|||
27602474|NCT01490125|80385430|FG002|Period III|Adverse Event|0|||
27602475|NCT01490125|80385431|FG003|Period III|Adverse Event|1|||
27602476|NCT01490125|80385432|FG004|Period III|Adverse Event|0|||
27602477|NCT01490125|80385433|FG005|Period III|Adverse Event|0|||
27602478|NCT01490125|80385428|FG000|Period III|Death|0|||
27602479|NCT01490125|80385429|FG001|Period III|Death|0|||
27602480|NCT01490125|80385430|FG002|Period III|Death|0|||
27708179|NCT01225731|80768588|FG009|Part 2|Protocol Violation|0|||
27708180|NCT01225731|80768589|FG010|Part 2|Protocol Violation|0|||
27602481|NCT01490125|80385431|FG003|Period III|Death|1|||
27602482|NCT01490125|80385432|FG004|Period III|Death|0|||
27602483|NCT01490125|80385433|FG005|Period III|Death|0|||
27602484|NCT01490125|80385428|FG000|Period III|Lack of Efficacy|0|||
27602485|NCT01490125|80385429|FG001|Period III|Lack of Efficacy|0|||
27602486|NCT01490125|80385430|FG002|Period III|Lack of Efficacy|0|||
27602487|NCT01490125|80385431|FG003|Period III|Lack of Efficacy|0|||
27602488|NCT01490125|80385432|FG004|Period III|Lack of Efficacy|1|||
27602489|NCT01490125|80385433|FG005|Period III|Lack of Efficacy|0|||
27602490|NCT03649230|80385435|FG000|Overall Study|Adverse Event|12|||
27602491|NCT03649230|80385435|FG000|Overall Study|Death|8|||
27602492|NCT03649230|80385435|FG000|Overall Study|Withdrawal by Subject|6|||
27602493|NCT03649230|80385435|FG000|Overall Study|Physician Decision|5|||
27708181|NCT01225731|80768590|FG011|Part 2|Protocol Violation|0|||
27602494|NCT03649230|80385435|FG000|Overall Study|Disease progression|5|||
27602495|NCT03649230|80385435|FG000|Overall Study|Switched to non-HEC|5|||
27708182|NCT01225731|80768591|FG012|Part 2|Protocol Violation|0|||
27602496|NCT03649230|80385435|FG000|Overall Study|Chemotherapy discontinued|4|||
27602497|NCT03649230|80385435|FG000|Overall Study|Received only 3 HEC cycles|4|||
27602498|NCT03649230|80385435|FG000|Overall Study|Screen Failure|3|||
27602499|NCT03649230|80385435|FG000|Overall Study|Patient stopped treatment|2|||
27602500|NCT03649230|80385435|FG000|Overall Study|Protocol Violation|1|||
27602501|NCT03649230|80385435|FG000|Overall Study|Non-compliance|1|||
27602502|NCT03649230|80385435|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
27602503|NCT04605978|80385438|FG000|Overall Study|Adverse Event|2|||
27602504|NCT04605978|80385439|FG001|Overall Study|Adverse Event|1|||
27602505|NCT04605978|80385438|FG000|Overall Study|Withdrawal nonmedical reason|1|||
27602506|NCT04605978|80385439|FG001|Overall Study|Withdrawal nonmedical reason|1|||
27602507|NCT02130284|80385443|FG000|Overall Study|Withdrawal by Subject|3|||
27602508|NCT02130284|80385443|FG000|Overall Study|Subject Withdrew Consent|1|||
27602509|NCT02130284|80385443|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
27602510|NCT02130284|80385443|FG000|Overall Study|Subject was screened as backup for study|3|||
27602511|NCT02130284|80385443|FG000|Overall Study|Screen Failure|1|||
27602512|NCT00941798|80385444|FG000|Overall Study|Withdrawal by Subject|72|||
27602513|NCT00941798|80385445|FG001|Overall Study|Withdrawal by Subject|74|||
27602514|NCT00941798|80385444|FG000|Overall Study|Adverse Event|43|||
27602515|NCT00941798|80385445|FG001|Overall Study|Adverse Event|23|||
27602516|NCT00941798|80385444|FG000|Overall Study|Lost to Follow-up|29|||
27602517|NCT00941798|80385445|FG001|Overall Study|Lost to Follow-up|23|||
27602518|NCT00941798|80385444|FG000|Overall Study|Protocol Violation|17|||
27602519|NCT00941798|80385445|FG001|Overall Study|Protocol Violation|20|||
27602520|NCT00941798|80385444|FG000|Overall Study|Administrative problems|13|||
27602521|NCT00941798|80385445|FG001|Overall Study|Administrative problems|23|||
27602522|NCT00941798|80385444|FG000|Overall Study|Lack of Efficacy|10|||
27602523|NCT00941798|80385445|FG001|Overall Study|Lack of Efficacy|17|||
27602524|NCT00941798|80385444|FG000|Overall Study|Patient's inability to use device|6|||
27835801|NCT01277510|81229064|FG000|Double-blind Phase|Other|1|||
27835802|NCT01277510|81229065|FG001|Double-blind Phase|Other|1|||
27602525|NCT00941798|80385445|FG001|Overall Study|Patient's inability to use device|1|||
27602526|NCT00941798|80385444|FG000|Overall Study|Abnormal test procedure results|3|||
27602527|NCT00941798|80385445|FG001|Overall Study|Abnormal test procedure results|1|||
27602528|NCT00941798|80385444|FG000|Overall Study|Abnormal laboratory values|1|||
27835803|NCT01277510|81229064|FG000|Open-label Phase|Administrative decision|4|||
27602529|NCT00941798|80385445|FG001|Overall Study|Abnormal laboratory values|2|||
27602530|NCT00941798|80385444|FG000|Overall Study|Death|0|||
27602531|NCT00941798|80385445|FG001|Overall Study|Death|1|||
27602532|NCT03520400|80385448|FG000|Overall Study|Physician Decision|15|||
27602533|NCT03520400|80385449|FG001|Overall Study|Physician Decision|7|||
27602534|NCT00552084|80385460|FG000|Overall Study|Adverse Event|2|||
27602535|NCT00552084|80385461|FG001|Overall Study|Adverse Event|3|||
27602536|NCT00552084|80385460|FG000|Overall Study|Withdrawal by Subject|4|||
27602537|NCT00552084|80385461|FG001|Overall Study|Withdrawal by Subject|5|||
27602538|NCT00552084|80385460|FG000|Overall Study|Protocol Violation|1|||
27602539|NCT00552084|80385461|FG001|Overall Study|Protocol Violation|0|||
27602540|NCT00552084|80385460|FG000|Overall Study|change in anti-arrythmic drug|1|||
27602541|NCT00552084|80385461|FG001|Overall Study|change in anti-arrythmic drug|1|||
27602542|NCT00394355|80385462|FG000|Overall Study|Adverse Event|10|||
27602543|NCT00394355|80385463|FG001|Overall Study|Adverse Event|6|||
27602544|NCT00394355|80385464|FG002|Overall Study|Adverse Event|7|||
27602545|NCT00394355|80385465|FG003|Overall Study|Adverse Event|8|||
27602546|NCT00394355|80385462|FG000|Overall Study|Did not meet protocol eligibility|1|||
27602547|NCT00394355|80385463|FG001|Overall Study|Did not meet protocol eligibility|5|||
27602548|NCT00394355|80385464|FG002|Overall Study|Did not meet protocol eligibility|4|||
27602549|NCT00394355|80385465|FG003|Overall Study|Did not meet protocol eligibility|2|||
27708183|NCT01225731|80768579|FG000|Part 2|Adverse Event|0|||
27602550|NCT00394355|80385462|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
27602551|NCT00394355|80385463|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
27602552|NCT00394355|80385464|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
27602553|NCT00394355|80385465|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
27602554|NCT00394355|80385462|FG000|Overall Study|Subject withdrawal - related to drug|1|||
27602555|NCT00394355|80385463|FG001|Overall Study|Subject withdrawal - related to drug|0|||
27602556|NCT00394355|80385464|FG002|Overall Study|Subject withdrawal - related to drug|0|||
27708184|NCT01225731|80768580|FG001|Part 2|Adverse Event|0|||
27708185|NCT01225731|80768581|FG002|Part 2|Adverse Event|0|||
27708186|NCT01225731|80768582|FG003|Part 2|Adverse Event|0|||
27708187|NCT01225731|80768583|FG004|Part 2|Adverse Event|0|||
27708188|NCT01225731|80768584|FG005|Part 2|Adverse Event|0|||
27708189|NCT01225731|80768585|FG006|Part 2|Adverse Event|4|||
27708190|NCT01225731|80768586|FG007|Part 2|Adverse Event|4|||
27708191|NCT01225731|80768587|FG008|Part 2|Adverse Event|2|||
27708192|NCT01225731|80768588|FG009|Part 2|Adverse Event|0|||
27708193|NCT01225731|80768589|FG010|Part 2|Adverse Event|0|||
27708194|NCT01225731|80768590|FG011|Part 2|Adverse Event|0|||
27708195|NCT01225731|80768591|FG012|Part 2|Adverse Event|0|||
27708196|NCT01225731|80768579|FG000|Part 2|Lack of Efficacy|0|||
27708197|NCT01225731|80768580|FG001|Part 2|Lack of Efficacy|0|||
27708198|NCT01225731|80768581|FG002|Part 2|Lack of Efficacy|0|||
27708199|NCT01225731|80768582|FG003|Part 2|Lack of Efficacy|0|||
27602557|NCT00394355|80385465|FG003|Overall Study|Subject withdrawal - related to drug|0|||
27602558|NCT00394355|80385462|FG000|Overall Study|Lost to Follow-up|7|||
27602559|NCT00394355|80385463|FG001|Overall Study|Lost to Follow-up|5|||
27602560|NCT00394355|80385464|FG002|Overall Study|Lost to Follow-up|4|||
27602561|NCT00394355|80385465|FG003|Overall Study|Lost to Follow-up|3|||
27602562|NCT00394355|80385462|FG000|Overall Study|Noncompliance with protocol|4|||
27602563|NCT00394355|80385463|FG001|Overall Study|Noncompliance with protocol|3|||
27602564|NCT00394355|80385464|FG002|Overall Study|Noncompliance with protocol|10|||
27602565|NCT00394355|80385465|FG003|Overall Study|Noncompliance with protocol|8|||
27602566|NCT00394355|80385462|FG000|Overall Study|Administrative|0|||
27602567|NCT00394355|80385463|FG001|Overall Study|Administrative|1|||
27602568|NCT00394355|80385464|FG002|Overall Study|Administrative|1|||
27602569|NCT00394355|80385465|FG003|Overall Study|Administrative|1|||
27602570|NCT00394355|80385462|FG000|Overall Study|Lack of Efficacy|0|||
27602571|NCT00394355|80385463|FG001|Overall Study|Lack of Efficacy|0|||
27602572|NCT00394355|80385464|FG002|Overall Study|Lack of Efficacy|2|||
27602573|NCT00394355|80385465|FG003|Overall Study|Lack of Efficacy|3|||
27602574|NCT01750879|80385485|FG000|Overall Study|Adverse Event|8|||
27602575|NCT01750879|80385486|FG001|Overall Study|Adverse Event|0|||
27708200|NCT01225731|80768583|FG004|Part 2|Lack of Efficacy|0|||
27708201|NCT01225731|80768584|FG005|Part 2|Lack of Efficacy|1|||
27708202|NCT01225731|80768585|FG006|Part 2|Lack of Efficacy|0|||
27708203|NCT01225731|80768586|FG007|Part 2|Lack of Efficacy|12|||
27708204|NCT01225731|80768587|FG008|Part 2|Lack of Efficacy|3|||
27708205|NCT01225731|80768588|FG009|Part 2|Lack of Efficacy|0|||
27708206|NCT01225731|80768589|FG010|Part 2|Lack of Efficacy|0|||
27708207|NCT01225731|80768590|FG011|Part 2|Lack of Efficacy|0|||
27708208|NCT01225731|80768591|FG012|Part 2|Lack of Efficacy|0|||
27708209|NCT01225731|80768579|FG000|Part 2|Pregnancy|0|||
27708210|NCT01225731|80768580|FG001|Part 2|Pregnancy|0|||
27708211|NCT01225731|80768581|FG002|Part 2|Pregnancy|0|||
27708212|NCT01225731|80768582|FG003|Part 2|Pregnancy|0|||
27708213|NCT01225731|80768583|FG004|Part 2|Pregnancy|0|||
27708214|NCT01225731|80768584|FG005|Part 2|Pregnancy|0|||
27708215|NCT01225731|80768585|FG006|Part 2|Pregnancy|1|||
27708216|NCT01225731|80768586|FG007|Part 2|Pregnancy|0|||
27708217|NCT01225731|80768587|FG008|Part 2|Pregnancy|1|||
27708218|NCT01225731|80768588|FG009|Part 2|Pregnancy|0|||
27708219|NCT01225731|80768589|FG010|Part 2|Pregnancy|0|||
27708220|NCT01225731|80768590|FG011|Part 2|Pregnancy|0|||
27708221|NCT01225731|80768591|FG012|Part 2|Pregnancy|0|||
27708222|NCT01225731|80768579|FG000|Part 2|Lost to Follow-up|0|||
27708223|NCT01225731|80768580|FG001|Part 2|Lost to Follow-up|0|||
27602576|NCT01750879|80385485|FG000|Overall Study|Lack of Efficacy|1|||
27602577|NCT01750879|80385486|FG001|Overall Study|Lack of Efficacy|0|||
27602578|NCT01750879|80385485|FG000|Overall Study|Withdrawal by Subject|1|||
27835804|NCT01277510|81229065|FG001|Open-label Phase|Administrative decision|3|||
27708224|NCT01225731|80768581|FG002|Part 2|Lost to Follow-up|0|||
27708225|NCT01225731|80768582|FG003|Part 2|Lost to Follow-up|0|||
27708226|NCT01225731|80768583|FG004|Part 2|Lost to Follow-up|0|||
27708227|NCT01225731|80768584|FG005|Part 2|Lost to Follow-up|0|||
27708228|NCT01225731|80768585|FG006|Part 2|Lost to Follow-up|0|||
27708229|NCT01225731|80768586|FG007|Part 2|Lost to Follow-up|3|||
27708230|NCT01225731|80768587|FG008|Part 2|Lost to Follow-up|1|||
27708231|NCT01225731|80768588|FG009|Part 2|Lost to Follow-up|0|||
27708232|NCT01225731|80768589|FG010|Part 2|Lost to Follow-up|0|||
27835805|NCT01277510|81229064|FG000|Open-label Phase|Protocol-specified criteria|1|||
27835806|NCT01277510|81229065|FG001|Open-label Phase|Protocol-specified criteria|0|||
27602579|NCT01750879|80385486|FG001|Overall Study|Withdrawal by Subject|0|||
27602580|NCT01750879|80385485|FG000|Overall Study|Did not complete per protocol|0|||
27602581|NCT01750879|80385486|FG001|Overall Study|Did not complete per protocol|3|||
27708233|NCT01225731|80768590|FG011|Part 2|Lost to Follow-up|0|||
27708234|NCT01225731|80768591|FG012|Part 2|Lost to Follow-up|0|||
27708235|NCT01225731|80768579|FG000|Part 2|Physician Decision|0|||
27708236|NCT01225731|80768580|FG001|Part 2|Physician Decision|0|||
27708237|NCT01225731|80768581|FG002|Part 2|Physician Decision|0|||
27708238|NCT01225731|80768582|FG003|Part 2|Physician Decision|0|||
27708239|NCT01225731|80768583|FG004|Part 2|Physician Decision|0|||
27708240|NCT01225731|80768584|FG005|Part 2|Physician Decision|0|||
27708241|NCT01225731|80768585|FG006|Part 2|Physician Decision|0|||
27708242|NCT01225731|80768586|FG007|Part 2|Physician Decision|2|||
27708243|NCT01225731|80768587|FG008|Part 2|Physician Decision|2|||
27708244|NCT01225731|80768588|FG009|Part 2|Physician Decision|0|||
27708245|NCT01225731|80768589|FG010|Part 2|Physician Decision|0|||
27708246|NCT01225731|80768590|FG011|Part 2|Physician Decision|0|||
27708247|NCT01225731|80768591|FG012|Part 2|Physician Decision|0|||
27708248|NCT01225731|80768579|FG000|Part 2|Withdrawal by Subject|0|||
27708249|NCT01225731|80768580|FG001|Part 2|Withdrawal by Subject|0|||
27708250|NCT01225731|80768581|FG002|Part 2|Withdrawal by Subject|0|||
27708251|NCT01225731|80768582|FG003|Part 2|Withdrawal by Subject|0|||
27708252|NCT01225731|80768583|FG004|Part 2|Withdrawal by Subject|0|||
27708253|NCT01225731|80768584|FG005|Part 2|Withdrawal by Subject|1|||
27708254|NCT01225731|80768585|FG006|Part 2|Withdrawal by Subject|3|||
27708255|NCT01225731|80768586|FG007|Part 2|Withdrawal by Subject|4|||
27708256|NCT01225731|80768587|FG008|Part 2|Withdrawal by Subject|1|||
27708257|NCT01225731|80768588|FG009|Part 2|Withdrawal by Subject|0|||
27708258|NCT01225731|80768589|FG010|Part 2|Withdrawal by Subject|0|||
27708259|NCT01225731|80768590|FG011|Part 2|Withdrawal by Subject|0|||
27708260|NCT01225731|80768591|FG012|Part 2|Withdrawal by Subject|0|||
27708261|NCT01225731|80768579|FG000|Part 3|Adverse Event|0|||
27708262|NCT01225731|80768580|FG001|Part 3|Adverse Event|0|||
27708263|NCT01225731|80768581|FG002|Part 3|Adverse Event|0|||
27708264|NCT01225731|80768582|FG003|Part 3|Adverse Event|0|||
27708265|NCT01225731|80768583|FG004|Part 3|Adverse Event|0|||
27708266|NCT01225731|80768584|FG005|Part 3|Adverse Event|0|||
27708267|NCT01225731|80768585|FG006|Part 3|Adverse Event|0|||
27708268|NCT01225731|80768586|FG007|Part 3|Adverse Event|0|||
27708269|NCT01225731|80768587|FG008|Part 3|Adverse Event|0|||
27708270|NCT01225731|80768588|FG009|Part 3|Adverse Event|0|||
27708271|NCT01225731|80768589|FG010|Part 3|Adverse Event|1|||
27708272|NCT01225731|80768590|FG011|Part 3|Adverse Event|1|||
27708273|NCT01225731|80768591|FG012|Part 3|Adverse Event|0|||
27708274|NCT01225731|80768579|FG000|Part 3|Lost to Follow-up|0|||
27708275|NCT01225731|80768580|FG001|Part 3|Lost to Follow-up|0|||
27708276|NCT01225731|80768581|FG002|Part 3|Lost to Follow-up|0|||
27708277|NCT01225731|80768582|FG003|Part 3|Lost to Follow-up|0|||
27708278|NCT01225731|80768583|FG004|Part 3|Lost to Follow-up|0|||
27708279|NCT01225731|80768584|FG005|Part 3|Lost to Follow-up|0|||
27708280|NCT01225731|80768585|FG006|Part 3|Lost to Follow-up|0|||
27708281|NCT01225731|80768586|FG007|Part 3|Lost to Follow-up|0|||
27708282|NCT01225731|80768587|FG008|Part 3|Lost to Follow-up|0|||
27708283|NCT01225731|80768588|FG009|Part 3|Lost to Follow-up|0|||
27708284|NCT01225731|80768589|FG010|Part 3|Lost to Follow-up|1|||
27708285|NCT01225731|80768590|FG011|Part 3|Lost to Follow-up|2|||
27708286|NCT01225731|80768591|FG012|Part 3|Lost to Follow-up|1|||
27708287|NCT01225731|80768579|FG000|Part 3|Physician Decision|0|||
27708288|NCT01225731|80768580|FG001|Part 3|Physician Decision|0|||
27708289|NCT01225731|80768581|FG002|Part 3|Physician Decision|0|||
27708290|NCT01225731|80768582|FG003|Part 3|Physician Decision|0|||
27888766|NCT01489254|81428079|FG000|Open-label Extension Part|Protocol Violation|0|||
27888767|NCT01489254|81428080|FG001|Open-label Extension Part|Protocol Violation|0|||
27708291|NCT01225731|80768583|FG004|Part 3|Physician Decision|0|||
27708292|NCT01225731|80768584|FG005|Part 3|Physician Decision|0|||
27708293|NCT01225731|80768585|FG006|Part 3|Physician Decision|0|||
27708294|NCT01225731|80768586|FG007|Part 3|Physician Decision|0|||
27708295|NCT01225731|80768587|FG008|Part 3|Physician Decision|0|||
27708296|NCT01225731|80768588|FG009|Part 3|Physician Decision|0|||
27708297|NCT01225731|80768589|FG010|Part 3|Physician Decision|0|||
27708298|NCT01225731|80768590|FG011|Part 3|Physician Decision|1|||
27708299|NCT01225731|80768591|FG012|Part 3|Physician Decision|2|||
27708300|NCT01225731|80768579|FG000|Part 3|Withdrawal by Subject|0|||
27708301|NCT01225731|80768580|FG001|Part 3|Withdrawal by Subject|0|||
27708302|NCT01225731|80768581|FG002|Part 3|Withdrawal by Subject|0|||
27708303|NCT01225731|80768582|FG003|Part 3|Withdrawal by Subject|0|||
27708304|NCT01225731|80768583|FG004|Part 3|Withdrawal by Subject|0|||
27708305|NCT01225731|80768584|FG005|Part 3|Withdrawal by Subject|0|||
27708306|NCT01225731|80768585|FG006|Part 3|Withdrawal by Subject|0|||
27708307|NCT01225731|80768586|FG007|Part 3|Withdrawal by Subject|0|||
27708308|NCT01225731|80768587|FG008|Part 3|Withdrawal by Subject|0|||
27708309|NCT01225731|80768588|FG009|Part 3|Withdrawal by Subject|0|||
27708310|NCT01225731|80768589|FG010|Part 3|Withdrawal by Subject|4|||
27708311|NCT01225731|80768590|FG011|Part 3|Withdrawal by Subject|6|||
27708312|NCT01225731|80768591|FG012|Part 3|Withdrawal by Subject|4|||
27708313|NCT00268437|80768594|FG000|Overall Study|Ineligible|1|||
27708314|NCT04640272|80768597|FG000|Overall Study|Subject moved out of area|1|||
27708315|NCT00974675|80768601|FG000|Overall Study|Adverse Event|2|||
27708316|NCT00974675|80768602|FG001|Overall Study|Adverse Event|1|||
27708317|NCT00974675|80768603|FG002|Overall Study|Adverse Event|1|||
27708318|NCT00974675|80768604|FG003|Overall Study|Adverse Event|1|||
27708319|NCT00974675|80768601|FG000|Overall Study|Physician Decision|0|||
27708320|NCT00974675|80768602|FG001|Overall Study|Physician Decision|0|||
27708321|NCT00974675|80768603|FG002|Overall Study|Physician Decision|1|||
27708322|NCT00974675|80768604|FG003|Overall Study|Physician Decision|0|||
27708323|NCT00974675|80768601|FG000|Overall Study|Participant on holiday; unable to attend|0|||
27708324|NCT00974675|80768602|FG001|Overall Study|Participant on holiday; unable to attend|0|||
27708325|NCT00974675|80768603|FG002|Overall Study|Participant on holiday; unable to attend|0|||
27708326|NCT00974675|80768604|FG003|Overall Study|Participant on holiday; unable to attend|1|||
27708327|NCT00806195|80768607|FG000|Overall Study|Death|6|||
27708328|NCT00806195|80768608|FG001|Overall Study|Death|0|||
27708329|NCT00806195|80768609|FG002|Overall Study|Death|1|||
27708330|NCT00806195|80768610|FG003|Overall Study|Death|0|||
27708331|NCT00806195|80768607|FG000|Overall Study|Adverse Event|25|||
27708332|NCT00806195|80768608|FG001|Overall Study|Adverse Event|5|||
27708333|NCT00806195|80768609|FG002|Overall Study|Adverse Event|11|||
27708334|NCT00806195|80768610|FG003|Overall Study|Adverse Event|2|||
27708335|NCT00806195|80768607|FG000|Overall Study|Withdrawal by Subject|119|||
27708336|NCT00806195|80768608|FG001|Overall Study|Withdrawal by Subject|31|||
27708337|NCT00806195|80768609|FG002|Overall Study|Withdrawal by Subject|76|||
27708338|NCT00806195|80768610|FG003|Overall Study|Withdrawal by Subject|35|||
27708339|NCT00806195|80768607|FG000|Overall Study|Lost to Follow-up|217|||
27708340|NCT00806195|80768608|FG001|Overall Study|Lost to Follow-up|66|||
27708341|NCT00806195|80768609|FG002|Overall Study|Lost to Follow-up|90|||
27708342|NCT00806195|80768610|FG003|Overall Study|Lost to Follow-up|34|||
27708343|NCT00806195|80768607|FG000|Overall Study|Inappropriate Enrollment|0|||
27708344|NCT00806195|80768608|FG001|Overall Study|Inappropriate Enrollment|1|||
27708345|NCT00806195|80768609|FG002|Overall Study|Inappropriate Enrollment|0|||
27708346|NCT00806195|80768610|FG003|Overall Study|Inappropriate Enrollment|0|||
27708347|NCT00806195|80768607|FG000|Overall Study|Administrative Reason|113|||
27708348|NCT00806195|80768608|FG001|Overall Study|Administrative Reason|35|||
27708349|NCT00806195|80768609|FG002|Overall Study|Administrative Reason|66|||
27708350|NCT00806195|80768610|FG003|Overall Study|Administrative Reason|26|||
27708351|NCT00806195|80768607|FG000|Overall Study|Protocol Violation|34|||
27708352|NCT00806195|80768608|FG001|Overall Study|Protocol Violation|24|||
27708353|NCT00806195|80768609|FG002|Overall Study|Protocol Violation|26|||
27708354|NCT00806195|80768610|FG003|Overall Study|Protocol Violation|9|||
27708355|NCT00445224|80768615|FG000|Specific Exercises|Withdrawal by Subject|3|||
27708356|NCT00445224|80768616|FG001|Specific Exercises|Withdrawal by Subject|3|||
27708357|NCT00445224|80768615|FG000|Specific Exercises|Withdrawal by Subject|1|||
27708358|NCT00445224|80768616|FG001|Specific Exercises|Withdrawal by Subject|0|||
27708359|NCT01979536|80768622|FG000|Overall Study|Physician Decision|2|||
27708360|NCT01979536|80768623|FG001|Overall Study|Physician Decision|3|||
27708361|NCT01979536|80768622|FG000|Overall Study|Withdrawal by Subject|0|||
27708362|NCT01979536|80768623|FG001|Overall Study|Withdrawal by Subject|1|||
27708363|NCT01979536|80768622|FG000|Overall Study|Refusal|0|||
27708364|NCT01979536|80768623|FG001|Overall Study|Refusal|1|||
27708365|NCT01979536|80768622|FG000|Overall Study|Relapse|0|||
27708366|NCT01979536|80768623|FG001|Overall Study|Relapse|1|||
27708367|NCT01979536|80768622|FG000|Overall Study|Study terminated by Sponsor|0|||
27708368|NCT01979536|80768623|FG001|Overall Study|Study terminated by Sponsor|1|||
27708369|NCT01979536|80768622|FG000|Overall Study|Did not start treatment|0|||
27708370|NCT01979536|80768623|FG001|Overall Study|Did not start treatment|1|||
27708371|NCT01205230|80768624|FG000|Overall Study|Adverse Event|4|||
27708372|NCT01205230|80768625|FG001|Overall Study|Adverse Event|0|||
27708373|NCT01205230|80768624|FG000|Overall Study|Physician Decision|1|||
27708374|NCT01205230|80768625|FG001|Overall Study|Physician Decision|0|||
27888768|NCT01489254|81428081|FG002|Open-label Extension Part|Protocol Violation|0|||
27888769|NCT01489254|81428082|FG003|Open-label Extension Part|Protocol Violation|1|||
27888770|NCT01489254|81428079|FG000|Open-label Extension Part|Lost to Follow-up|0|||
27888771|NCT01489254|81428080|FG001|Open-label Extension Part|Lost to Follow-up|0|||
27888772|NCT01489254|81428081|FG002|Open-label Extension Part|Lost to Follow-up|0|||
27888773|NCT01489254|81428082|FG003|Open-label Extension Part|Lost to Follow-up|9|||
27888774|NCT01489254|81428079|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
27835807|NCT01277510|81229064|FG000|Open-label Phase|Never received investigational product|2|||
27835808|NCT01277510|81229065|FG001|Open-label Phase|Never received investigational product|0|||
27835809|NCT00045162|81229073|FG000|Overall Study|Ineligible|12|||
27835810|NCT00045162|81229074|FG001|Overall Study|Ineligible|8|||
27835811|NCT00045162|81229073|FG000|Overall Study|Not treated|7|||
27835812|NCT00045162|81229074|FG001|Overall Study|Not treated|2|||
27835813|NCT00045162|81229073|FG000|Overall Study|Adverse Event|55|||
27835814|NCT00045162|81229074|FG001|Overall Study|Adverse Event|50|||
27835815|NCT00045162|81229073|FG000|Overall Study|Lack of Efficacy|32|||
27835816|NCT00045162|81229074|FG001|Overall Study|Lack of Efficacy|29|||
27835817|NCT00045162|81229073|FG000|Overall Study|Death|10|||
27888775|NCT01489254|81428080|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
27888776|NCT01489254|81428081|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
27888777|NCT01489254|81428082|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
27888778|NCT01108341|81428085|FG000|Overall Study|Death|2|||
27888779|NCT01108341|81428085|FG000|Overall Study|Withdrawal by Subject|1|||
27888780|NCT01108341|81428085|FG000|Overall Study|Lost to Follow-up|1|||
27888781|NCT01108341|81428085|FG000|Overall Study|Other|1|||
27888782|NCT03180684|81428089|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
27888783|NCT03180684|81428090|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
27888784|NCT03180684|81428089|FG000|Overall Study|Physician Decision|1|||
27888785|NCT03180684|81428090|FG001|Overall Study|Physician Decision|0|||
27888786|NCT03180684|81428089|FG000|Overall Study|Lost to Follow-up|1|||
27888787|NCT03180684|81428090|FG001|Overall Study|Lost to Follow-up|0|||
27888788|NCT03180684|81428089|FG000|Overall Study|Progressive Disease|1|||
27888789|NCT03180684|81428090|FG001|Overall Study|Progressive Disease|0|||
27888790|NCT03395184|81428091|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
27888791|NCT03395184|81428092|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
27888792|NCT03395184|81428093|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
27888793|NCT03395184|81428094|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
27888794|NCT03395184|81428095|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
27888795|NCT03395184|81428096|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
27888796|NCT03395184|81428097|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
27888797|NCT03395184|81428091|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
27888798|NCT03395184|81428092|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
27888799|NCT03395184|81428093|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
27888800|NCT03395184|81428094|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
27888801|NCT03395184|81428095|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
27888802|NCT03395184|81428096|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
27888803|NCT03395184|81428097|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
27888804|NCT03395184|81428091|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
27835818|NCT00045162|81229074|FG001|Overall Study|Death|10|||
27835819|NCT00045162|81229073|FG000|Overall Study|Withdrawal by Subject|5|||
27835820|NCT00045162|81229074|FG001|Overall Study|Withdrawal by Subject|3|||
27835821|NCT00045162|81229073|FG000|Overall Study|Other|21|||
27835822|NCT00045162|81229074|FG001|Overall Study|Other|16|||
27835823|NCT03255980|81229075|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
27835824|NCT03255980|81229076|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
27835825|NCT03255980|81229077|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
27835826|NCT03255980|81229078|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
27835827|NCT03255980|81229075|FG000|Overall Study|Adverse Event|1|||
27835828|NCT03255980|81229076|FG001|Overall Study|Adverse Event|1|||
27835829|NCT03255980|81229077|FG002|Overall Study|Adverse Event|0|||
27835830|NCT03255980|81229078|FG003|Overall Study|Adverse Event|1|||
27835831|NCT03255980|81229075|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
27835832|NCT03255980|81229076|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
27835833|NCT03255980|81229077|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
27835834|NCT03255980|81229078|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
27835835|NCT03255980|81229075|FG000|Overall Study|Lost to Follow-up|1|||
27835836|NCT03255980|81229076|FG001|Overall Study|Lost to Follow-up|1|||
27835837|NCT03255980|81229077|FG002|Overall Study|Lost to Follow-up|0|||
27835838|NCT03255980|81229078|FG003|Overall Study|Lost to Follow-up|3|||
27888805|NCT03395184|81428092|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
27835839|NCT03255980|81229075|FG000|Overall Study|Withdrawal by Subject|0|||
27835840|NCT03255980|81229076|FG001|Overall Study|Withdrawal by Subject|1|||
27835841|NCT03255980|81229077|FG002|Overall Study|Withdrawal by Subject|0|||
27835842|NCT03255980|81229078|FG003|Overall Study|Withdrawal by Subject|3|||
27888806|NCT03395184|81428093|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
27888807|NCT03395184|81428094|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
27888808|NCT03395184|81428095|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
27888809|NCT03395184|81428096|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
27888810|NCT03395184|81428097|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
27888811|NCT03395184|81428091|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
27888812|NCT03395184|81428092|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
27888813|NCT03395184|81428093|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
27888814|NCT03395184|81428094|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
27888815|NCT03395184|81428095|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
27888816|NCT03395184|81428096|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
27888817|NCT03395184|81428097|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
27888818|NCT03395184|81428091|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
27888819|NCT03395184|81428092|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27888820|NCT03395184|81428093|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
27888821|NCT03395184|81428094|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27888822|NCT03395184|81428095|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27888823|NCT03395184|81428096|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27888824|NCT03395184|81428097|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27888825|NCT03395184|81428091|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
27888826|NCT03395184|81428092|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
27888827|NCT03395184|81428093|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
27708375|NCT00589420|80768626|FG000|Overall Study|screen failure|1|||
27708376|NCT00609986|80768627|FG000|Overall Study|Did not receive transplant or treatment|8|||
27708377|NCT00609986|80768628|FG001|Overall Study|Did not receive transplant or treatment|3|||
27835843|NCT01456949|81229079|FG000|Enrollment|PI death- incomplete data|6|||
27835844|NCT01456949|81229079|FG000|Enrollment|Death|1|||
27835845|NCT01456949|81229079|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
27888828|NCT03395184|81428094|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
27888829|NCT03395184|81428095|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
27888830|NCT03395184|81428096|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
27888831|NCT03395184|81428097|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
27888832|NCT03395184|81428091|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
27888833|NCT03395184|81428092|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
27888834|NCT03395184|81428093|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
27888835|NCT03395184|81428094|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
27835846|NCT01456949|81229079|FG000|Enrollment|Physician Decision|10|||
27835847|NCT01456949|81229079|FG000|Enrollment|Withdrawal by Subject|7|||
27835848|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
27835849|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
27835850|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
27835851|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
27835852|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
27835853|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
27835854|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
27835855|NCT01456949|81229079|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
27835856|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Adverse Event|8|||
27835857|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Adverse Event|5|||
27835858|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Adverse Event|9|||
27835859|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Adverse Event|0|||
27835860|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Adverse Event|0|||
27835861|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Adverse Event|0|||
27835862|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
27835863|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
27835864|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
27835865|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
27835866|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
27835867|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
27835868|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
27835869|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
27835870|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
27835871|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
27888836|NCT03395184|81428095|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
27888837|NCT03395184|81428096|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
27888838|NCT03395184|81428097|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
27888839|NCT03395184|81428091|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
27888840|NCT03395184|81428092|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
27708378|NCT05162027|80768629|FG000|Overall Study|Adverse Event|1|||
27888841|NCT03395184|81428093|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
27888842|NCT03395184|81428094|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
27888843|NCT03395184|81428095|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
27888844|NCT03395184|81428096|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
27888845|NCT03395184|81428097|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
27888846|NCT03395184|81428091|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
27888847|NCT03395184|81428092|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
27888848|NCT03395184|81428093|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
27888849|NCT03395184|81428094|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
27888850|NCT03395184|81428095|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
27888851|NCT03395184|81428096|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
27888852|NCT03395184|81428097|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
27888853|NCT03395184|81428091|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
27888854|NCT03395184|81428092|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
27888855|NCT03395184|81428093|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
27888856|NCT03395184|81428094|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
27888857|NCT03395184|81428095|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
27888858|NCT03395184|81428096|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
27888859|NCT03395184|81428097|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
27888860|NCT03395184|81428091|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
27888861|NCT03395184|81428092|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
27888862|NCT03395184|81428093|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
27888863|NCT03395184|81428094|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
27888864|NCT03395184|81428095|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
27888865|NCT03395184|81428096|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
27888866|NCT03395184|81428097|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
27888867|NCT03395184|81428091|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
27888868|NCT03395184|81428092|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
27602582|NCT00682643|80385487|FG000|Overall Study|Adverse Event|12|||
27602583|NCT00682643|80385488|FG001|Overall Study|Adverse Event|23|||
27602584|NCT00682643|80385487|FG000|Overall Study|Lack of Efficacy|2|||
27602585|NCT00682643|80385488|FG001|Overall Study|Lack of Efficacy|0|||
27835872|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
27835873|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
27835874|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Physician Decision|4|||
27835875|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Physician Decision|0|||
27835876|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Physician Decision|2|||
27835877|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Physician Decision|0|||
27835878|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Physician Decision|0|||
27835879|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Physician Decision|0|||
27835880|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Pregnancy|1|||
27835881|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Pregnancy|2|||
27835882|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Pregnancy|0|||
27835883|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Pregnancy|0|||
27835884|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Pregnancy|0|||
27835885|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Pregnancy|0|||
27835886|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
27835887|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
27835888|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
27835889|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
27835890|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
27835891|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
27835892|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
27835893|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
27835894|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
27835895|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
27835896|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
27835897|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
27835898|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
27835899|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
27835900|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
27835901|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
27835902|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
27835903|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
27835904|NCT02614196|81229080|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
27835905|NCT02614196|81229081|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
27835906|NCT02614196|81229082|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
27888869|NCT03395184|81428093|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
27888870|NCT03395184|81428094|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
27888871|NCT03395184|81428095|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
27602586|NCT00682643|80385487|FG000|Overall Study|Protocol Violation|38|||
27602587|NCT00682643|80385488|FG001|Overall Study|Protocol Violation|76|||
27888872|NCT03395184|81428096|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
27888873|NCT03395184|81428097|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
27602588|NCT00682643|80385487|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
27602589|NCT00682643|80385488|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
27602590|NCT00682643|80385487|FG000|Overall Study|Lost to Follow-up|1|||
27602591|NCT00682643|80385488|FG001|Overall Study|Lost to Follow-up|6|||
27602592|NCT00682643|80385487|FG000|Overall Study|Physician Decision|2|||
27602593|NCT00682643|80385488|FG001|Overall Study|Physician Decision|6|||
27602594|NCT00682643|80385487|FG000|Overall Study|Withdrawal by Subject|19|||
27602595|NCT00682643|80385488|FG001|Overall Study|Withdrawal by Subject|53|||
27602596|NCT00682643|80385487|FG000|Overall Study|Did Not Receive Study Drug|1|||
27602597|NCT00682643|80385488|FG001|Overall Study|Did Not Receive Study Drug|1|||
27602598|NCT01699022|80385490|FG000|Overall Study|Early discontinuation from the study|3|||
27602599|NCT03002610|80385497|FG000|Overall Study|Withdrawal by Subject|6|||
27602600|NCT03002610|80385498|FG001|Overall Study|Withdrawal by Subject|25|||
27888874|NCT02225366|81428101|FG000|Overall Study|Lack of Efficacy|1|||
27888875|NCT02225366|81428102|FG001|Overall Study|Lack of Efficacy|0|||
27888876|NCT00721279|81428103|FG000|Overall Study|Lack of Efficacy|6|||
27888877|NCT00721279|81428104|FG001|Overall Study|Lack of Efficacy|3|||
27888878|NCT00721279|81428103|FG000|Overall Study|Tolerability insufficient|5|||
27888879|NCT00721279|81428104|FG001|Overall Study|Tolerability insufficient|2|||
27888880|NCT00721279|81428103|FG000|Overall Study|Withdrawal by Subject|13|||
27888881|NCT00721279|81428104|FG001|Overall Study|Withdrawal by Subject|3|||
27888882|NCT00721279|81428103|FG000|Overall Study|Other|12|||
27888883|NCT00721279|81428104|FG001|Overall Study|Other|16|||
27888884|NCT03800836|81428105|FG000|Overall Study|Other|2|||
27888885|NCT03800836|81428106|FG001|Overall Study|Other|1|||
27888886|NCT03800836|81428107|FG002|Overall Study|Other|0|||
27888887|NCT03800836|81428108|FG003|Overall Study|Other|2|||
27888888|NCT03800836|81428109|FG004|Overall Study|Other|0|||
27888889|NCT03800836|81428110|FG005|Overall Study|Other|1|||
27888890|NCT03800836|81428105|FG000|Overall Study|Lost to Follow-up|2|||
27888891|NCT03800836|81428106|FG001|Overall Study|Lost to Follow-up|0|||
27888892|NCT03800836|81428107|FG002|Overall Study|Lost to Follow-up|1|||
27888893|NCT03800836|81428108|FG003|Overall Study|Lost to Follow-up|1|||
27888894|NCT03800836|81428109|FG004|Overall Study|Lost to Follow-up|3|||
27888895|NCT03800836|81428110|FG005|Overall Study|Lost to Follow-up|0|||
27888896|NCT03800836|81428105|FG000|Overall Study|Withdrawal by Subject|1|||
27888897|NCT03800836|81428106|FG001|Overall Study|Withdrawal by Subject|0|||
27888898|NCT03800836|81428107|FG002|Overall Study|Withdrawal by Subject|0|||
27888899|NCT03800836|81428108|FG003|Overall Study|Withdrawal by Subject|0|||
27888900|NCT03800836|81428109|FG004|Overall Study|Withdrawal by Subject|0|||
27888901|NCT03800836|81428110|FG005|Overall Study|Withdrawal by Subject|0|||
27888902|NCT03800836|81428105|FG000|Overall Study|Physician Decision|31|||
27888903|NCT03800836|81428106|FG001|Overall Study|Physician Decision|3|||
27888904|NCT03800836|81428107|FG002|Overall Study|Physician Decision|6|||
27888905|NCT03800836|81428108|FG003|Overall Study|Physician Decision|4|||
27888906|NCT03800836|81428109|FG004|Overall Study|Physician Decision|4|||
27602601|NCT03002610|80385499|FG002|Overall Study|Withdrawal by Subject|13|||
27602602|NCT03587142|80385500|FG000|Overall Study|Lost to Follow-up|5|||
27602603|NCT03587142|80385501|FG001|Overall Study|Lost to Follow-up|3|||
27602604|NCT03587142|80385500|FG000|Overall Study|Did not complete the f4 visit|3|||
27602605|NCT03587142|80385501|FG001|Overall Study|Did not complete the f4 visit|7|||
27888907|NCT03800836|81428110|FG005|Overall Study|Physician Decision|5|||
27888908|NCT03800836|81428105|FG000|Overall Study|Death|34|||
27888909|NCT03800836|81428106|FG001|Overall Study|Death|16|||
27888910|NCT03800836|81428107|FG002|Overall Study|Death|5|||
27888911|NCT03800836|81428108|FG003|Overall Study|Death|5|||
27888912|NCT03800836|81428109|FG004|Overall Study|Death|10|||
27602606|NCT02583425|80385502|FG000|Screening|Did not meet entry criteria|12|||
27602607|NCT02583425|80385502|FG000|Baseline|Did not meet continued criteria|5|||
27888913|NCT03800836|81428110|FG005|Overall Study|Death|0|||
27888914|NCT03800836|81428105|FG000|Overall Study|Symptomatic Deterioration|1|||
27888915|NCT03800836|81428106|FG001|Overall Study|Symptomatic Deterioration|0|||
27888916|NCT03800836|81428107|FG002|Overall Study|Symptomatic Deterioration|1|||
27888917|NCT03800836|81428108|FG003|Overall Study|Symptomatic Deterioration|0|||
27888918|NCT03800836|81428109|FG004|Overall Study|Symptomatic Deterioration|0|||
27888919|NCT03800836|81428110|FG005|Overall Study|Symptomatic Deterioration|0|||
27888920|NCT01940900|81428111|FG000|Overall Study|Physician Decision|4|||
27888921|NCT01940900|81428112|FG001|Overall Study|Physician Decision|0|||
27888922|NCT01940900|81428111|FG000|Overall Study|Adverse Event|10|||
27602608|NCT02583425|80385502|FG000|Treatment Period|Adverse Event|1|||
27888923|NCT01940900|81428112|FG001|Overall Study|Adverse Event|15|||
27888924|NCT01940900|81428111|FG000|Overall Study|Withdrawal by Subject|11|||
27888925|NCT01940900|81428112|FG001|Overall Study|Withdrawal by Subject|15|||
27888926|NCT01940900|81428111|FG000|Overall Study|Lost to Follow-up|1|||
27888927|NCT01940900|81428112|FG001|Overall Study|Lost to Follow-up|0|||
27888928|NCT01940900|81428111|FG000|Overall Study|Sponsor Decision|1|||
27888929|NCT01940900|81428112|FG001|Overall Study|Sponsor Decision|0|||
27888930|NCT01940900|81428111|FG000|Overall Study|subject non-compliance|1|||
27888931|NCT01940900|81428112|FG001|Overall Study|subject non-compliance|1|||
27888932|NCT01940900|81428111|FG000|Overall Study|other|1|||
27888933|NCT01940900|81428112|FG001|Overall Study|other|0|||
27888934|NCT02009397|81428114|FG000|Overall Study|Protocol Violation|6|||
27888935|NCT02009397|81428114|FG000|Overall Study|Death|8|||
27888936|NCT02009397|81428114|FG000|Overall Study|Lost to Follow-up|6|||
27888937|NCT01290679|81428115|FG000|Overall Study|Adverse Event|2|||
27888938|NCT01290679|81428116|FG001|Overall Study|Adverse Event|0|||
27888939|NCT01290679|81428115|FG000|Overall Study|Lost to Follow-up|8|||
27888940|NCT01290679|81428116|FG001|Overall Study|Lost to Follow-up|10|||
27888941|NCT01290679|81428115|FG000|Overall Study|Protocol Violation|0|||
27888942|NCT01290679|81428116|FG001|Overall Study|Protocol Violation|1|||
27888943|NCT01290679|81428115|FG000|Overall Study|Withdrawal by Subject|6|||
27888944|NCT01290679|81428116|FG001|Overall Study|Withdrawal by Subject|5|||
27888945|NCT01290679|81428115|FG000|Overall Study|Subject Entered Another Trial|0|||
27888946|NCT01290679|81428116|FG001|Overall Study|Subject Entered Another Trial|5|||
27888947|NCT00793624|81428117|FG000|Overall Study|Adverse Event|18|||
27888948|NCT00793624|81428118|FG001|Overall Study|Adverse Event|16|||
27888949|NCT00793624|81428119|FG002|Overall Study|Adverse Event|15|||
27888950|NCT00793624|81428120|FG003|Overall Study|Adverse Event|20|||
27888951|NCT00793624|81428117|FG000|Overall Study|Lost to Follow-up|2|||
27888952|NCT00793624|81428118|FG001|Overall Study|Lost to Follow-up|2|||
27888953|NCT00793624|81428119|FG002|Overall Study|Lost to Follow-up|4|||
27888954|NCT00793624|81428120|FG003|Overall Study|Lost to Follow-up|0|||
27888955|NCT00793624|81428117|FG000|Overall Study|Withdrawal by Subject|20|||
27888956|NCT00793624|81428118|FG001|Overall Study|Withdrawal by Subject|9|||
27888957|NCT00793624|81428119|FG002|Overall Study|Withdrawal by Subject|11|||
27888958|NCT00793624|81428120|FG003|Overall Study|Withdrawal by Subject|14|||
27888959|NCT00793624|81428117|FG000|Overall Study|Lack of Efficacy|9|||
27888960|NCT00793624|81428118|FG001|Overall Study|Lack of Efficacy|2|||
27888961|NCT00793624|81428119|FG002|Overall Study|Lack of Efficacy|1|||
27888962|NCT00793624|81428120|FG003|Overall Study|Lack of Efficacy|3|||
27888963|NCT00793624|81428117|FG000|Overall Study|Non compliance with protocol|2|||
27888964|NCT00793624|81428118|FG001|Overall Study|Non compliance with protocol|3|||
27888965|NCT00793624|81428119|FG002|Overall Study|Non compliance with protocol|2|||
27888966|NCT00793624|81428120|FG003|Overall Study|Non compliance with protocol|3|||
27888967|NCT00793624|81428117|FG000|Overall Study|Other reason not described above|6|||
27888968|NCT00793624|81428118|FG001|Overall Study|Other reason not described above|4|||
27888969|NCT00793624|81428119|FG002|Overall Study|Other reason not described above|6|||
27835907|NCT02614196|81229083|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
27835908|NCT02614196|81229084|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
27835909|NCT02614196|81229085|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
27835910|NCT02614196|81229080|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
27835911|NCT02614196|81229081|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
27835912|NCT02614196|81229082|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
27835913|NCT02614196|81229083|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
27835914|NCT02614196|81229084|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
27835915|NCT02614196|81229085|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
27835916|NCT02614196|81229080|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
27835917|NCT02614196|81229081|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
27835918|NCT02614196|81229082|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
27835919|NCT02614196|81229083|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
27835920|NCT02614196|81229084|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
27835921|NCT02614196|81229085|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
27835922|NCT02614196|81229080|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
27835923|NCT02614196|81229081|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
27835924|NCT02614196|81229082|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
27835925|NCT02614196|81229083|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
27835926|NCT02614196|81229084|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
27602609|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
27602610|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
27602611|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
27602612|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
27602613|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
27602614|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
27602615|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
27602616|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
27602617|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
27602618|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
27602619|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
27602620|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
27602621|NCT01493687|80385503|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
27602622|NCT01493687|80385504|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
27602623|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
27602624|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
27602625|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
27602626|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
27602627|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
27602628|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
27602629|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
27602630|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
27602631|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
27602632|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
27602633|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
27602634|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
27602635|NCT01493687|80385503|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
27602636|NCT01493687|80385504|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
27602637|NCT01493687|80385503|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
27602638|NCT01493687|80385504|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
27602639|NCT02946918|80385505|FG000|Overall Study|Patient unblinded himself|1|||
27602640|NCT02946918|80385506|FG001|Overall Study|Patient unblinded himself|0|||
27602641|NCT02946918|80385505|FG000|Overall Study|Physician Decision|0|||
27602642|NCT02946918|80385506|FG001|Overall Study|Physician Decision|2|||
27602643|NCT02946918|80385505|FG000|Overall Study|Ran out of study medication|0|||
27602644|NCT02946918|80385506|FG001|Overall Study|Ran out of study medication|1|||
27602645|NCT04209725|80385507|FG000|Overall Study|Adverse Event|1|||
27602646|NCT03995784|80385511|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
27835927|NCT02614196|81229085|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
27835928|NCT02614196|81229080|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
27835929|NCT02614196|81229081|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
27835930|NCT02614196|81229082|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
27835931|NCT02614196|81229083|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
27835932|NCT02614196|81229084|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
27835933|NCT02614196|81229085|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
27835934|NCT00695110|81229086|FG000|Treatment Period 1|Adverse Event|1|||
27602647|NCT00943306|80385512|FG000|Overall Study|Physician Decision|1|||
27602648|NCT00943306|80385512|FG000|Overall Study|Death|1|||
27602649|NCT00943306|80385512|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
27602650|NCT01666808|80385513|FG000|Overall Study|Lost to Follow-up|9|||
27602651|NCT01666808|80385514|FG001|Overall Study|Lost to Follow-up|15|||
27602652|NCT01666808|80385513|FG000|Overall Study|Withdrawal by Subject|3|||
27602653|NCT01666808|80385514|FG001|Overall Study|Withdrawal by Subject|1|||
27708379|NCT05162027|80768630|FG001|Overall Study|Adverse Event|0|||
27602654|NCT01666808|80385513|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
27602655|NCT01666808|80385514|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
27602656|NCT03745222|80385515|FG000|Overall Study|Withdrawal by Subject|0|||
27602657|NCT03745222|80385516|FG001|Overall Study|Withdrawal by Subject|1|||
27602658|NCT03745222|80385517|FG002|Overall Study|Withdrawal by Subject|0|||
27602659|NCT03078816|80385518|FG000|Overall Study|Withdrawal by Subject|1|||
27602660|NCT03124199|80385524|FG000|Overall Study|Lost to Follow-up|4|||
27602661|NCT00454571|80385525|FG000|Overall Study|Adverse Event|2|||
27602662|NCT00454571|80385526|FG001|Overall Study|Adverse Event|0|||
27602663|NCT00454571|80385525|FG000|Overall Study|Physician Decision|0|||
27602664|NCT00454571|80385526|FG001|Overall Study|Physician Decision|1|||
27602665|NCT00454571|80385525|FG000|Overall Study|Protocol Violation|1|||
27602666|NCT00454571|80385526|FG001|Overall Study|Protocol Violation|0|||
27602667|NCT00454571|80385525|FG000|Overall Study|Withdrawal by Subject|10|||
27602668|NCT00454571|80385526|FG001|Overall Study|Withdrawal by Subject|5|||
27602669|NCT05158296|80385531|FG000|Overall Study|Sponsor Decision|2|||
27602670|NCT05158296|80385532|FG001|Overall Study|Sponsor Decision|3|||
27602671|NCT05158296|80385533|FG002|Overall Study|Sponsor Decision|2|||
27602672|NCT01301391|80385534|FG000|Overall Study|Death|13|||
27602673|NCT01301391|80385534|FG000|Overall Study|Lost to Follow-up|3|||
27602674|NCT01301391|80385534|FG000|Overall Study|Physician Decision|2|||
27602675|NCT01301391|80385534|FG000|Overall Study|Sponsor's decision|8|||
27602676|NCT02417064|80385535|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
27602677|NCT02417064|80385536|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
27602678|NCT02417064|80385537|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
27602679|NCT02417064|80385535|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
27602680|NCT02417064|80385536|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
27602681|NCT02417064|80385537|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
27602682|NCT02417064|80385535|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
27602683|NCT02417064|80385536|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
27602684|NCT02417064|80385537|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
27602685|NCT02417064|80385535|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
27602686|NCT02417064|80385536|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
27602687|NCT02417064|80385537|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
27602688|NCT02417064|80385535|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
27602689|NCT02417064|80385536|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
27602690|NCT02417064|80385537|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
27602691|NCT02417064|80385535|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
27602692|NCT02417064|80385536|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
27602693|NCT02417064|80385537|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
27602694|NCT02417064|80385535|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
27602695|NCT02417064|80385536|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
27602696|NCT02417064|80385537|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
27602697|NCT02417064|80385535|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
27602698|NCT02417064|80385536|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
27602699|NCT02417064|80385537|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
27602700|NCT02417064|80385535|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
27602701|NCT02417064|80385536|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
27602702|NCT02417064|80385537|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
27602703|NCT02417064|80385535|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
27602704|NCT02417064|80385536|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
27602705|NCT02417064|80385537|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
27602706|NCT02417064|80385535|FG000|Follow-up Phase (24 Weeks)|Other|2|||
27602707|NCT02417064|80385536|FG001|Follow-up Phase (24 Weeks)|Other|2|||
27602708|NCT02417064|80385537|FG002|Follow-up Phase (24 Weeks)|Other|3|||
27602709|NCT01191840|80385542|FG000|Overall Study|withdrew consent|2|||
27602710|NCT01191840|80385543|FG001|Overall Study|withdrew consent|1|||
27602711|NCT01191840|80385542|FG000|Overall Study|Subject discontinued treatment|1|||
27602712|NCT01191840|80385543|FG001|Overall Study|Subject discontinued treatment|2|||
27602713|NCT01191840|80385542|FG000|Overall Study|Lost to Follow-up|4|||
27602714|NCT01191840|80385543|FG001|Overall Study|Lost to Follow-up|6|||
27602715|NCT01191840|80385542|FG000|Overall Study|Non Staph Infection|4|||
27602716|NCT01191840|80385543|FG001|Overall Study|Non Staph Infection|3|||
27708380|NCT01376778|80768635|FG000|Overall Study|Lost to Follow-up|3|||
27708381|NCT01376778|80768636|FG001|Overall Study|Lost to Follow-up|2|||
27602717|NCT01191840|80385542|FG000|Overall Study|ineligible at enrollment|1|||
27602718|NCT01191840|80385543|FG001|Overall Study|ineligible at enrollment|0|||
27602719|NCT01191840|80385542|FG000|Overall Study|IRB approval lapse|0|||
27602720|NCT01191840|80385543|FG001|Overall Study|IRB approval lapse|2|||
27602721|NCT01191840|80385542|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
27708382|NCT00596947|80768637|FG000|Overall Study|study halted due to low enrollment|5|||
27708383|NCT00596947|80768638|FG001|Overall Study|study halted due to low enrollment|3|||
27708384|NCT00596947|80768637|FG000|Overall Study|Lost to Follow-up|1|||
27708385|NCT00596947|80768638|FG001|Overall Study|Lost to Follow-up|0|||
27708386|NCT01670539|80768641|FG000|Overall Study|Death|3|||
27708387|NCT01670539|80768642|FG001|Overall Study|Death|5|||
27708388|NCT01670539|80768641|FG000|Overall Study|Withdrawal by Subject|3|||
27708389|NCT01670539|80768642|FG001|Overall Study|Withdrawal by Subject|0|||
27708390|NCT01226459|80768643|FG000|Overall Study|Adverse Event|2|||
27708391|NCT01226459|80768644|FG001|Overall Study|Adverse Event|8|||
27708392|NCT01226459|80768643|FG000|Overall Study|Protocol Violation|4|||
27708393|NCT01226459|80768644|FG001|Overall Study|Protocol Violation|3|||
27708394|NCT01226459|80768643|FG000|Overall Study|Withdrawal by Subject|10|||
27708395|NCT01226459|80768644|FG001|Overall Study|Withdrawal by Subject|13|||
27708396|NCT01226459|80768643|FG000|Overall Study|Lost to Follow-up|4|||
27708397|NCT01226459|80768644|FG001|Overall Study|Lost to Follow-up|8|||
27708398|NCT01226459|80768643|FG000|Overall Study|Pregnancy|1|||
27708399|NCT01226459|80768644|FG001|Overall Study|Pregnancy|0|||
27708400|NCT00470054|80768653|FG000|Overall Study|Ineligible|1|||
27708401|NCT00928889|80768654|FG000|Overall Study|Lost to Follow-up|3|||
27708402|NCT00928889|80768655|FG001|Overall Study|Lost to Follow-up|1|||
27708403|NCT00928889|80768654|FG000|Overall Study|Protocol Violation|0|||
27708404|NCT00928889|80768655|FG001|Overall Study|Protocol Violation|1|||
27708405|NCT00928889|80768654|FG000|Overall Study|Adverse Event|1|||
27708406|NCT00928889|80768655|FG001|Overall Study|Adverse Event|0|||
27708407|NCT00928889|80768654|FG000|Overall Study|Other|1|||
27708408|NCT00928889|80768655|FG001|Overall Study|Other|0|||
27708409|NCT03807349|80768656|FG000|Overall Study|Early Study Termination|9|||
27708410|NCT00847145|80768657|FG000|Overall Study|AE or Death|0|||
27708411|NCT00847145|80768658|FG001|Overall Study|AE or Death|1|||
27708412|NCT00847145|80768659|FG002|Overall Study|AE or Death|1|||
27708413|NCT00847145|80768660|FG003|Overall Study|AE or Death|0|||
27708414|NCT00847145|80768661|FG004|Overall Study|AE or Death|0|||
27708415|NCT00847145|80768662|FG005|Overall Study|AE or Death|0|||
27708416|NCT00847145|80768663|FG006|Overall Study|AE or Death|0|||
27708417|NCT00847145|80768664|FG007|Overall Study|AE or Death|0|||
27708418|NCT00847145|80768657|FG000|Overall Study|Withdrawal by Subject|3|||
27708419|NCT00847145|80768658|FG001|Overall Study|Withdrawal by Subject|4|||
27708420|NCT00847145|80768659|FG002|Overall Study|Withdrawal by Subject|6|||
27708421|NCT00847145|80768660|FG003|Overall Study|Withdrawal by Subject|1|||
27708422|NCT00847145|80768661|FG004|Overall Study|Withdrawal by Subject|0|||
27708423|NCT00847145|80768662|FG005|Overall Study|Withdrawal by Subject|0|||
27708424|NCT00847145|80768663|FG006|Overall Study|Withdrawal by Subject|1|||
27708425|NCT00847145|80768664|FG007|Overall Study|Withdrawal by Subject|1|||
27708426|NCT00847145|80768657|FG000|Overall Study|Lost to Follow-up|3|||
27708427|NCT00847145|80768658|FG001|Overall Study|Lost to Follow-up|1|||
27708428|NCT00847145|80768659|FG002|Overall Study|Lost to Follow-up|1|||
27708429|NCT00847145|80768660|FG003|Overall Study|Lost to Follow-up|0|||
27708430|NCT00847145|80768661|FG004|Overall Study|Lost to Follow-up|4|||
27708431|NCT00847145|80768662|FG005|Overall Study|Lost to Follow-up|4|||
27708432|NCT00847145|80768663|FG006|Overall Study|Lost to Follow-up|8|||
27708433|NCT00847145|80768664|FG007|Overall Study|Lost to Follow-up|2|||
27708434|NCT00847145|80768657|FG000|Overall Study|Inappropriate enrollment|0|||
27708435|NCT00847145|80768658|FG001|Overall Study|Inappropriate enrollment|0|||
27708436|NCT00847145|80768659|FG002|Overall Study|Inappropriate enrollment|0|||
27708437|NCT00847145|80768660|FG003|Overall Study|Inappropriate enrollment|0|||
27708438|NCT00847145|80768661|FG004|Overall Study|Inappropriate enrollment|1|||
27708439|NCT00847145|80768662|FG005|Overall Study|Inappropriate enrollment|0|||
27708440|NCT00847145|80768663|FG006|Overall Study|Inappropriate enrollment|0|||
27888970|NCT00793624|81428120|FG003|Overall Study|Other reason not described above|3|||
27708441|NCT00847145|80768664|FG007|Overall Study|Inappropriate enrollment|0|||
27708442|NCT00847145|80768657|FG000|Overall Study|Protocol Violation|0|||
27708443|NCT00847145|80768658|FG001|Overall Study|Protocol Violation|0|||
27708444|NCT00847145|80768659|FG002|Overall Study|Protocol Violation|3|||
27708445|NCT00847145|80768660|FG003|Overall Study|Protocol Violation|0|||
27708446|NCT00847145|80768661|FG004|Overall Study|Protocol Violation|1|||
27708447|NCT00847145|80768662|FG005|Overall Study|Protocol Violation|0|||
27708448|NCT00847145|80768663|FG006|Overall Study|Protocol Violation|0|||
27708449|NCT00847145|80768664|FG007|Overall Study|Protocol Violation|1|||
27708450|NCT00841568|80768665|FG000|Overall Study|Adverse Event|1|||
27708451|NCT00841568|80768665|FG000|Overall Study|Death|1|||
27602722|NCT01191840|80385543|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
27602723|NCT01191840|80385542|FG000|Overall Study|Withdrawal by Subject|2|||
27602724|NCT01191840|80385543|FG001|Overall Study|Withdrawal by Subject|0|||
27708452|NCT00841568|80768665|FG000|Overall Study|Withdrawal by Subject|2|||
27708453|NCT00841568|80768665|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
27708454|NCT01490450|80768667|FG000|Period 1|Lack of Efficacy|2|||
27708455|NCT01490450|80768668|FG001|Period 1|Lack of Efficacy|0|||
27708456|NCT01490450|80768669|FG002|Period 1|Lack of Efficacy|3|||
27708457|NCT01490450|80768670|FG003|Period 1|Lack of Efficacy|0|||
27708458|NCT01490450|80768667|FG000|Period 1|Adverse Event|0|||
27708459|NCT01490450|80768668|FG001|Period 1|Adverse Event|0|||
27708460|NCT01490450|80768669|FG002|Period 1|Adverse Event|0|||
27708461|NCT01490450|80768670|FG003|Period 1|Adverse Event|5|||
27602725|NCT00180479|80385544|FG000|Overall Study|Death|4|||
27602726|NCT00180479|80385545|FG001|Overall Study|Death|2|||
27602727|NCT00180479|80385544|FG000|Overall Study|Lost to Follow-up|9|||
27602728|NCT00180479|80385545|FG001|Overall Study|Lost to Follow-up|7|||
27708462|NCT01490450|80768667|FG000|Period 1|Request to discontinue treatment|1|||
27708463|NCT01490450|80768668|FG001|Period 1|Request to discontinue treatment|0|||
27708464|NCT01490450|80768669|FG002|Period 1|Request to discontinue treatment|0|||
27708465|NCT01490450|80768670|FG003|Period 1|Request to discontinue treatment|0|||
27835935|NCT00695110|81229086|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27835936|NCT00695110|81229086|FG000|Treatment Period 3|Withdrawal by Subject|1|||
27835937|NCT00695110|81229086|FG000|Treatment Period 4|Adverse Event|1|||
27602729|NCT00180479|80385544|FG000|Overall Study|Withdrawal by Subject|3|||
27602730|NCT00180479|80385545|FG001|Overall Study|Withdrawal by Subject|3|||
27835938|NCT01944722|81229087|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
27835939|NCT01944722|81229087|FG000|Overall Study|Specimen Shipping Issues|34|||
27708466|NCT01490450|80768667|FG000|Period 1|Withdrawal by Subject|0|||
27708467|NCT01490450|80768668|FG001|Period 1|Withdrawal by Subject|0|||
27708468|NCT01490450|80768669|FG002|Period 1|Withdrawal by Subject|0|||
27708469|NCT01490450|80768670|FG003|Period 1|Withdrawal by Subject|3|||
27835940|NCT01944722|81229087|FG000|Overall Study|Improper Storage/Transport|5|||
27835941|NCT01944722|81229087|FG000|Overall Study|Insufficient Volume for Test|1|||
27888971|NCT00319592|81428121|FG000|Overall Study|Protocol Violation|1|||
27888972|NCT00319592|81428122|FG001|Overall Study|Protocol Violation|0|||
27888973|NCT00319592|81428121|FG000|Overall Study|Physician Decision|0|||
27888974|NCT00319592|81428122|FG001|Overall Study|Physician Decision|1|||
27888975|NCT06586788|81428125|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
27888976|NCT02651155|81428126|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27888977|NCT02651155|81428127|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27835942|NCT01944722|81229087|FG000|Overall Study|Missing Specimens|3|||
27835943|NCT01944722|81229087|FG000|Overall Study|Specimens Mislabeled|2|||
27835944|NCT01944722|81229087|FG000|Overall Study|Withdrawal by Subject|8|||
27835945|NCT01944722|81229087|FG000|Overall Study|NILM Subjects <30 years old|8106|||
27835946|NCT01944722|81229087|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
27602731|NCT00180479|80385544|FG000|Overall Study|Informed consent not signed|0|||
27602732|NCT00180479|80385545|FG001|Overall Study|Informed consent not signed|1|||
27888978|NCT02651155|81428126|FG000|Overall Study|Voluntary Withdrawal|5|||
27888979|NCT02651155|81428127|FG001|Overall Study|Voluntary Withdrawal|0|||
27888980|NCT01613222|81428128|FG000|Overall Study|Physician Decision|1|||
27888981|NCT01613222|81428128|FG000|Overall Study|Unable to place arterial line|1|||
27888982|NCT01613222|81428128|FG000|Overall Study|Reused disposable sensors|10|||
27888983|NCT01893281|81428133|FG000|Overall Study|Adverse Event|1|||
27888984|NCT01893281|81428133|FG000|Overall Study|Protocol Violation|1|||
27888985|NCT01893281|81428133|FG000|Overall Study|Withdrawal by Subject|1|||
27888986|NCT02751450|81428134|FG000|Overall Study|Adverse Event|1|||
27888987|NCT02751450|81428135|FG001|Overall Study|Adverse Event|0|||
27888988|NCT01880086|81428136|FG000|Overall Study|Lost to Follow-up|1|||
27888989|NCT01880086|81428137|FG001|Overall Study|Lost to Follow-up|1|||
27888990|NCT01421225|81428138|FG000|Overall Study|Withdrawal by Subject|0|||
27888991|NCT01421225|81428139|FG001|Overall Study|Withdrawal by Subject|1|||
27888992|NCT01089608|81428140|FG000|Overall Study|Adverse Event|0|||
27708470|NCT01490450|80768667|FG000|Period 1|No longer met study criteria|0|||
27708471|NCT01490450|80768668|FG001|Period 1|No longer met study criteria|1|||
27835947|NCT01944722|81229087|FG000|Overall Study|>ASCUS Cytology|1122|||
27888993|NCT01089608|81428141|FG001|Overall Study|Adverse Event|4|||
27888994|NCT01089608|81428140|FG000|Overall Study|Lost to Follow-up|0|||
27602733|NCT02710292|80385546|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
27602734|NCT02710292|80385547|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
27602735|NCT02710292|80385546|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
27602736|NCT02710292|80385547|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
27602737|NCT00514683|80385548|FG000|Overall Study|Not treated|2|||
27602738|NCT00514683|80385549|FG001|Overall Study|Not treated|1|||
27602739|NCT00514683|80385550|FG002|Overall Study|Not treated|0|||
27602740|NCT00514683|80385551|FG003|Overall Study|Not treated|0|||
27602741|NCT00514683|80385552|FG004|Overall Study|Not treated|1|||
27602742|NCT00514683|80385548|FG000|Overall Study|Adverse Event|21|||
27602743|NCT00514683|80385549|FG001|Overall Study|Adverse Event|20|||
27602744|NCT00514683|80385550|FG002|Overall Study|Adverse Event|15|||
27602745|NCT00514683|80385551|FG003|Overall Study|Adverse Event|13|||
27602746|NCT00514683|80385552|FG004|Overall Study|Adverse Event|27|||
27602747|NCT00514683|80385548|FG000|Overall Study|Protocol Violation|1|||
27602748|NCT00514683|80385549|FG001|Overall Study|Protocol Violation|1|||
27602749|NCT00514683|80385550|FG002|Overall Study|Protocol Violation|0|||
27602750|NCT00514683|80385551|FG003|Overall Study|Protocol Violation|1|||
27602751|NCT00514683|80385552|FG004|Overall Study|Protocol Violation|0|||
27602752|NCT00514683|80385548|FG000|Overall Study|Withdrawal by Subject|2|||
27602753|NCT00514683|80385549|FG001|Overall Study|Withdrawal by Subject|2|||
27602754|NCT00514683|80385550|FG002|Overall Study|Withdrawal by Subject|1|||
27602755|NCT00514683|80385551|FG003|Overall Study|Withdrawal by Subject|0|||
27602756|NCT00514683|80385552|FG004|Overall Study|Withdrawal by Subject|4|||
27602757|NCT00514683|80385548|FG000|Overall Study|Reason other than listed above|0|||
27602758|NCT00514683|80385549|FG001|Overall Study|Reason other than listed above|1|||
27602759|NCT00514683|80385550|FG002|Overall Study|Reason other than listed above|2|||
27602760|NCT00514683|80385551|FG003|Overall Study|Reason other than listed above|0|||
27602761|NCT00514683|80385552|FG004|Overall Study|Reason other than listed above|1|||
27602762|NCT01995539|80385553|FG000|Overall Study|Screening Failure|1|||
27602763|NCT01995539|80385553|FG000|Overall Study|Withdrawal by Investigator|15|||
27602764|NCT01995539|80385553|FG000|Overall Study|Withdrawal by Subject|11|||
27888995|NCT01089608|81428141|FG001|Overall Study|Lost to Follow-up|2|||
27888996|NCT05033262|81428144|FG000|Overall Study|Lost to Follow-up|1|||
27888997|NCT05033262|81428145|FG001|Overall Study|Lost to Follow-up|0|||
27888998|NCT05033262|81428146|FG002|Overall Study|Lost to Follow-up|0|||
27888999|NCT05033262|81428147|FG003|Overall Study|Lost to Follow-up|1|||
27889000|NCT01163318|81428148|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
27889001|NCT01163318|81428148|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
27889002|NCT01163318|81428148|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
27889003|NCT01163318|81428148|FG000|Overall Study|Participants Without Case Report Form|7|||
27889004|NCT01163318|81428148|FG000|Overall Study|Multiple Reasons Per Participant|224|||
27889005|NCT02277444|81428149|FG000|Overall Study|Adverse Event|10|||
27889006|NCT02277444|81428149|FG000|Overall Study|Withdrawal by Subject|3|||
27889007|NCT02277444|81428149|FG000|Overall Study|Other|1|||
27889008|NCT02277444|81428149|FG000|Overall Study|Enrolled and not Treated|3|||
27889009|NCT02277444|81428149|FG000|Overall Study|Ongoing|113|||
27889010|NCT02693106|81428150|FG000|Overall Study|No time|3|||
27889011|NCT01343277|81428151|FG000|Overall Study|Other|3|||
27889012|NCT01343277|81428152|FG001|Overall Study|Other|3|||
27602765|NCT01995539|80385553|FG000|Overall Study|Lost to Follow-up|5|||
27889013|NCT01343277|81428151|FG000|Overall Study|Withdrawal by Subject|18|||
27889014|NCT01343277|81428152|FG001|Overall Study|Withdrawal by Subject|13|||
27602766|NCT01995539|80385553|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
27602767|NCT00615264|80385554|FG000|Overall Study|Withdrawal by Subject|17|||
27602768|NCT00615264|80385555|FG001|Overall Study|Withdrawal by Subject|19|||
27602769|NCT00615264|80385554|FG000|Overall Study|Lost to Follow-up|6|||
27602770|NCT00615264|80385555|FG001|Overall Study|Lost to Follow-up|13|||
27708472|NCT01490450|80768669|FG002|Period 1|No longer met study criteria|1|||
27889015|NCT01343277|81428151|FG000|Overall Study|Physician Decision|1|||
27889016|NCT01343277|81428152|FG001|Overall Study|Physician Decision|2|||
27889017|NCT01343277|81428151|FG000|Overall Study|Death|10|||
27602771|NCT00615264|80385554|FG000|Overall Study|Adverse Event|8|||
27602772|NCT00615264|80385555|FG001|Overall Study|Adverse Event|5|||
27602773|NCT00615264|80385554|FG000|Overall Study|Death|1|||
27602774|NCT00615264|80385555|FG001|Overall Study|Death|1|||
27889018|NCT01343277|81428152|FG001|Overall Study|Death|1|||
27889019|NCT01343277|81428151|FG000|Overall Study|Adverse Event|67|||
27889020|NCT01343277|81428152|FG001|Overall Study|Adverse Event|13|||
27708473|NCT01490450|80768670|FG003|Period 1|No longer met study criteria|0|||
27708474|NCT01490450|80768667|FG000|Period 2|Lack of Efficacy|0|||
27708475|NCT01490450|80768668|FG001|Period 2|Lack of Efficacy|0|||
27708476|NCT01490450|80768669|FG002|Period 2|Lack of Efficacy|0|||
27708477|NCT01490450|80768670|FG003|Period 2|Lack of Efficacy|1|||
27835948|NCT02418754|81229088|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
27835949|NCT02418754|81229089|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
27835950|NCT02418754|81229090|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
27835951|NCT02418754|81229091|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
27835952|NCT02418754|81229092|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
27835953|NCT02418754|81229088|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
27835954|NCT02418754|81229089|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
27835955|NCT02418754|81229090|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
27835956|NCT02418754|81229091|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
27835957|NCT02418754|81229092|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
27835958|NCT02418754|81229088|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
27835959|NCT02418754|81229089|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
27835960|NCT02418754|81229090|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
27835961|NCT02418754|81229091|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
27835962|NCT02418754|81229092|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
27835963|NCT02418754|81229088|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
27835964|NCT02418754|81229089|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
27835965|NCT02418754|81229090|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
27835966|NCT02418754|81229091|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
27835967|NCT02418754|81229092|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
27835968|NCT02418754|81229088|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
27835969|NCT02418754|81229089|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
27835970|NCT02418754|81229090|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
27835971|NCT02418754|81229091|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
27835972|NCT02418754|81229092|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
27835973|NCT02418754|81229088|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
27835974|NCT02418754|81229089|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
27835975|NCT02418754|81229090|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
27835976|NCT02418754|81229091|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
27835977|NCT02418754|81229092|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
27835978|NCT02418754|81229088|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
27835979|NCT02418754|81229089|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
27835980|NCT02418754|81229090|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
27835981|NCT02418754|81229091|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
27835982|NCT02418754|81229092|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
27835983|NCT02418754|81229088|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
27835984|NCT02418754|81229089|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
27835985|NCT02418754|81229090|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
27835986|NCT02418754|81229091|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
27835987|NCT02418754|81229092|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
27835988|NCT02418754|81229088|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
27835989|NCT02418754|81229089|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
27835990|NCT02418754|81229090|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
27835991|NCT02418754|81229091|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
27835992|NCT02418754|81229092|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
27835993|NCT02418754|81229088|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
27835994|NCT02418754|81229089|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
27835995|NCT02418754|81229090|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
27835996|NCT02418754|81229091|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
27708478|NCT01490450|80768667|FG000|Period 2|Adverse Event|1|||
27708479|NCT01490450|80768668|FG001|Period 2|Adverse Event|1|||
27708480|NCT01490450|80768669|FG002|Period 2|Adverse Event|0|||
27835997|NCT02418754|81229092|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
27835998|NCT02418754|81229088|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
27835999|NCT02418754|81229089|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
27836000|NCT02418754|81229090|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
27836001|NCT02418754|81229091|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
27889021|NCT01343277|81428151|FG000|Overall Study|Disease progression|270|||
27602775|NCT00615264|80385554|FG000|Overall Study|Protocol Violation|11|||
27602776|NCT00615264|80385555|FG001|Overall Study|Protocol Violation|7|||
27602777|NCT00615264|80385554|FG000|Overall Study|Not defined|7|||
27602778|NCT00615264|80385555|FG001|Overall Study|Not defined|4|||
27602779|NCT00615264|80385554|FG000|Overall Study|Dermal Hypersensitivity|0|||
27602780|NCT00615264|80385555|FG001|Overall Study|Dermal Hypersensitivity|3|||
27602781|NCT00571701|80385556|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
27602782|NCT00571701|80385557|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
27602783|NCT00571701|80385556|FG000|First Intervention 12 Months|Death|1|||
27602784|NCT00571701|80385557|FG001|First Intervention 12 Months|Death|0|||
27602785|NCT00571701|80385556|FG000|Second Intervention 12 Months|Adverse Event|0|||
27602786|NCT00571701|80385557|FG001|Second Intervention 12 Months|Adverse Event|1|||
27602787|NCT00571701|80385556|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
27602788|NCT00571701|80385557|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
27602789|NCT00863655|80385558|FG000|Overall Study|Protocol Violation|4|||
27602790|NCT00863655|80385559|FG001|Overall Study|Protocol Violation|0|||
27602791|NCT00863655|80385558|FG000|Overall Study|Adverse Event|52|||
27602792|NCT00863655|80385559|FG001|Overall Study|Adverse Event|8|||
27602793|NCT00863655|80385558|FG000|Overall Study|Withdrawal by Subject|47|||
27602794|NCT00863655|80385559|FG001|Overall Study|Withdrawal by Subject|7|||
27602795|NCT00863655|80385558|FG000|Overall Study|Administrative problems|1|||
27602796|NCT00863655|80385559|FG001|Overall Study|Administrative problems|0|||
27602797|NCT00863655|80385558|FG000|Overall Study|Death|7|||
27602798|NCT00863655|80385559|FG001|Overall Study|Death|1|||
27602799|NCT00863655|80385558|FG000|Overall Study|New cancer therapy|5|||
27602800|NCT00863655|80385559|FG001|Overall Study|New cancer therapy|1|||
27602801|NCT00863655|80385558|FG000|Overall Study|Disease progression|364|||
27602802|NCT00863655|80385559|FG001|Overall Study|Disease progression|221|||
27602803|NCT00863655|80385558|FG000|Overall Study|Treatment completed as per protocol|5|||
27602804|NCT00863655|80385559|FG001|Overall Study|Treatment completed as per protocol|1|||
27602805|NCT00152464|80385562|FG000|Overall Study|Adverse Event|3|||
27602806|NCT00152464|80385563|FG001|Overall Study|Adverse Event|6|||
27602807|NCT00152464|80385562|FG000|Overall Study|Lost to Follow-up|8|||
27602808|NCT00152464|80385563|FG001|Overall Study|Lost to Follow-up|4|||
27602809|NCT00152464|80385562|FG000|Overall Study|Protocol Violation|3|||
27602810|NCT00152464|80385563|FG001|Overall Study|Protocol Violation|1|||
27602811|NCT00152464|80385562|FG000|Overall Study|Withdrawal by Subject|21|||
27602812|NCT00152464|80385563|FG001|Overall Study|Withdrawal by Subject|22|||
27602813|NCT00152464|80385562|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
27602814|NCT00152464|80385563|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
27602815|NCT00152464|80385562|FG000|Overall Study|Eczema deterioration|0|||
27602816|NCT00152464|80385563|FG001|Overall Study|Eczema deterioration|1|||
27602817|NCT00152464|80385562|FG000|Overall Study|Parent decision|1|||
27602818|NCT00152464|80385563|FG001|Overall Study|Parent decision|1|||
27602819|NCT00152464|80385562|FG000|Overall Study|Investigator decision|1|||
27602820|NCT00152464|80385563|FG001|Overall Study|Investigator decision|0|||
27602821|NCT00152464|80385562|FG000|Overall Study|Lack of Efficacy|1|||
27602822|NCT00152464|80385563|FG001|Overall Study|Lack of Efficacy|0|||
27602823|NCT00152464|80385562|FG000|Overall Study|Eczema poorly controlled|1|||
27602824|NCT00152464|80385563|FG001|Overall Study|Eczema poorly controlled|0|||
27836002|NCT02418754|81229092|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
27836003|NCT02473393|81229098|FG000|Overall Study|Adverse Event|0|||
27836004|NCT02473393|81229099|FG001|Overall Study|Adverse Event|0|||
27836005|NCT02473393|81229100|FG002|Overall Study|Adverse Event|1|||
27836006|NCT02473393|81229101|FG003|Overall Study|Adverse Event|0|||
27836007|NCT02473393|81229098|FG000|Overall Study|Withdrawal by Subject|0|||
27836008|NCT02473393|81229099|FG001|Overall Study|Withdrawal by Subject|0|||
27836009|NCT02473393|81229100|FG002|Overall Study|Withdrawal by Subject|1|||
27836010|NCT02473393|81229101|FG003|Overall Study|Withdrawal by Subject|1|||
27836011|NCT01841060|81229104|FG000|Overall Study|Protocol Violation|10|||
27836012|NCT00508651|81229107|FG000|Overall Study|Lost to Follow-up|3|||
27836013|NCT00508651|81229108|FG001|Overall Study|Lost to Follow-up|1|||
27836014|NCT00508651|81229107|FG000|Overall Study|Withdrawal by Subject|1|||
27836015|NCT00508651|81229108|FG001|Overall Study|Withdrawal by Subject|1|||
27836016|NCT00288704|81229109|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
27836017|NCT00288704|81229110|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
27836018|NCT00288704|81229111|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
27836019|NCT00288704|81229109|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
27836020|NCT00288704|81229110|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
27836021|NCT00288704|81229111|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
27836022|NCT00288704|81229109|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
27836023|NCT00288704|81229110|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
27836024|NCT00288704|81229111|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
27836025|NCT00288704|81229109|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
27836026|NCT00288704|81229110|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
27836027|NCT00288704|81229111|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
27836028|NCT00288704|81229109|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
27889022|NCT01343277|81428152|FG001|Overall Study|Disease progression|138|||
27889023|NCT01343277|81428151|FG000|Overall Study|Randomized not treated|6|||
27889024|NCT01343277|81428152|FG001|Overall Study|Randomized not treated|21|||
27889025|NCT01343277|81428151|FG000|Overall Study|Treatment ongoing|8|||
27889026|NCT01343277|81428152|FG001|Overall Study|Treatment ongoing|2|||
27889027|NCT01343277|81428151|FG000|Overall Study|Subsequent anticancer therapy|1|||
27889028|NCT01343277|81428152|FG001|Overall Study|Subsequent anticancer therapy|0|||
27889029|NCT02656290|81428160|FG000|Overall Study|Lost to Follow-up|1|||
27708481|NCT01490450|80768670|FG003|Period 2|Adverse Event|1|||
27836029|NCT00288704|81229110|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
27836030|NCT00288704|81229111|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
27889030|NCT02656290|81428160|FG000|Overall Study|Reintervention|3|||
27602825|NCT00152464|80385562|FG000|Overall Study|Patient relocated|1|||
27602826|NCT00152464|80385563|FG001|Overall Study|Patient relocated|0|||
27602827|NCT02296190|80385564|FG000|Overall Study|Lost to Follow-up|0|||
27602828|NCT02296190|80385565|FG001|Overall Study|Lost to Follow-up|0|||
27602829|NCT02296190|80385566|FG002|Overall Study|Lost to Follow-up|0|||
27602830|NCT02296190|80385567|FG003|Overall Study|Lost to Follow-up|0|||
27602831|NCT02296190|80385568|FG004|Overall Study|Lost to Follow-up|1|||
27602832|NCT02296190|80385569|FG005|Overall Study|Lost to Follow-up|0|||
27602833|NCT02296190|80385564|FG000|Overall Study|Failure to induce PSVT|6|||
27602834|NCT02296190|80385565|FG001|Overall Study|Failure to induce PSVT|10|||
27602835|NCT02296190|80385566|FG002|Overall Study|Failure to induce PSVT|5|||
27602836|NCT02296190|80385567|FG003|Overall Study|Failure to induce PSVT|13|||
27708482|NCT01490450|80768667|FG000|Period 2|Withdrawal by Subject|1|||
27602837|NCT02296190|80385568|FG004|Overall Study|Failure to induce PSVT|8|||
27602838|NCT02296190|80385569|FG005|Overall Study|Failure to induce PSVT|0|||
27602839|NCT02296190|80385564|FG000|Overall Study|Physician Decision|1|||
27602840|NCT02296190|80385565|FG001|Overall Study|Physician Decision|1|||
27602841|NCT02296190|80385566|FG002|Overall Study|Physician Decision|0|||
27602842|NCT02296190|80385567|FG003|Overall Study|Physician Decision|1|||
27602843|NCT02296190|80385568|FG004|Overall Study|Physician Decision|2|||
27602844|NCT02296190|80385569|FG005|Overall Study|Physician Decision|0|||
27602845|NCT02296190|80385564|FG000|Overall Study|Withdrawal by Subject|0|||
27602846|NCT02296190|80385565|FG001|Overall Study|Withdrawal by Subject|1|||
27602847|NCT02296190|80385566|FG002|Overall Study|Withdrawal by Subject|0|||
27602848|NCT02296190|80385567|FG003|Overall Study|Withdrawal by Subject|0|||
27602849|NCT02296190|80385568|FG004|Overall Study|Withdrawal by Subject|0|||
27602850|NCT02296190|80385569|FG005|Overall Study|Withdrawal by Subject|0|||
27602851|NCT02296190|80385564|FG000|Overall Study|PSVT < 5 minutes|5|||
27602852|NCT02296190|80385565|FG001|Overall Study|PSVT < 5 minutes|6|||
27602853|NCT02296190|80385566|FG002|Overall Study|PSVT < 5 minutes|6|||
27602854|NCT02296190|80385567|FG003|Overall Study|PSVT < 5 minutes|6|||
27602855|NCT02296190|80385568|FG004|Overall Study|PSVT < 5 minutes|5|||
27602856|NCT02296190|80385569|FG005|Overall Study|PSVT < 5 minutes|0|||
27602857|NCT02296190|80385564|FG000|Overall Study|Patient was given Propofol|0|||
27602858|NCT02296190|80385565|FG001|Overall Study|Patient was given Propofol|1|||
27602859|NCT02296190|80385566|FG002|Overall Study|Patient was given Propofol|0|||
27602860|NCT02296190|80385567|FG003|Overall Study|Patient was given Propofol|1|||
27602861|NCT02296190|80385568|FG004|Overall Study|Patient was given Propofol|0|||
27602862|NCT02296190|80385569|FG005|Overall Study|Patient was given Propofol|0|||
27602863|NCT02296190|80385564|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
27602864|NCT02296190|80385565|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
27602865|NCT02296190|80385566|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
27602866|NCT02296190|80385567|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
27602867|NCT02296190|80385568|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
27602868|NCT02296190|80385569|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
27602869|NCT02296190|80385564|FG000|Overall Study|Blood pressure <100 after sedation|0|||
27602870|NCT02296190|80385565|FG001|Overall Study|Blood pressure <100 after sedation|0|||
27602871|NCT02296190|80385566|FG002|Overall Study|Blood pressure <100 after sedation|0|||
27602872|NCT02296190|80385567|FG003|Overall Study|Blood pressure <100 after sedation|1|||
27602873|NCT02296190|80385568|FG004|Overall Study|Blood pressure <100 after sedation|0|||
27602874|NCT02296190|80385569|FG005|Overall Study|Blood pressure <100 after sedation|0|||
27602875|NCT02296190|80385564|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27708483|NCT01490450|80768668|FG001|Period 2|Withdrawal by Subject|0|||
27602876|NCT02296190|80385565|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
27602877|NCT02296190|80385566|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
27602878|NCT02296190|80385567|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27602879|NCT02296190|80385568|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27602880|NCT02296190|80385569|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
27602881|NCT02296190|80385564|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
27602882|NCT02296190|80385565|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
27602883|NCT02296190|80385566|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
27602884|NCT02296190|80385567|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
27602885|NCT02296190|80385568|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
27602886|NCT02296190|80385569|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
27602887|NCT02296190|80385564|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27602888|NCT02296190|80385565|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
27602889|NCT02296190|80385566|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27602890|NCT02296190|80385567|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27708484|NCT01490450|80768669|FG002|Period 2|Withdrawal by Subject|0|||
27602891|NCT02296190|80385568|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27602892|NCT02296190|80385569|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
27602893|NCT02296190|80385564|FG000|Overall Study|Lab result not available in time|1|||
27602894|NCT02296190|80385565|FG001|Overall Study|Lab result not available in time|0|||
27602895|NCT02296190|80385566|FG002|Overall Study|Lab result not available in time|0|||
27602896|NCT02296190|80385567|FG003|Overall Study|Lab result not available in time|0|||
27602897|NCT02296190|80385568|FG004|Overall Study|Lab result not available in time|0|||
27602898|NCT02296190|80385569|FG005|Overall Study|Lab result not available in time|0|||
27602899|NCT00677235|80385570|FG000|Overall Study|Withdrawal by Subject|1|||
27602900|NCT00677235|80385571|FG001|Overall Study|Withdrawal by Subject|1|||
27602901|NCT00677235|80385570|FG000|Overall Study|Lost to Follow-up|2|||
27602902|NCT00677235|80385571|FG001|Overall Study|Lost to Follow-up|1|||
27602903|NCT00677235|80385570|FG000|Overall Study|Death|37|||
27602904|NCT00677235|80385571|FG001|Overall Study|Death|36|||
27708485|NCT01490450|80768670|FG003|Period 2|Withdrawal by Subject|0|||
27708486|NCT01490450|80768667|FG000|Period 2|Lost to Follow-up|0|||
27708487|NCT01490450|80768668|FG001|Period 2|Lost to Follow-up|0|||
27708488|NCT01490450|80768669|FG002|Period 2|Lost to Follow-up|0|||
27708489|NCT01490450|80768670|FG003|Period 2|Lost to Follow-up|2|||
27708490|NCT03029143|80768671|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
27708491|NCT03029143|80768672|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
27708492|NCT03029143|80768673|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
27708493|NCT03029143|80768671|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
27708494|NCT03029143|80768672|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
27708495|NCT03029143|80768673|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
27708496|NCT03029143|80768671|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
27708497|NCT03029143|80768672|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
27708498|NCT03029143|80768673|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
27836031|NCT00288704|81229109|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
27836032|NCT00288704|81229110|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
27836033|NCT00288704|81229111|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
27836034|NCT00288704|81229109|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
27836035|NCT00288704|81229110|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
27836036|NCT00288704|81229111|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
27836037|NCT01942135|81229112|FG000|Overall Study|Adverse Event|21|||
27836038|NCT01942135|81229113|FG001|Overall Study|Adverse Event|7|||
27836039|NCT01942135|81229112|FG000|Overall Study|Global Deterioration of Health Status|9|||
27836040|NCT01942135|81229113|FG001|Overall Study|Global Deterioration of Health Status|6|||
27836041|NCT01942135|81229112|FG000|Overall Study|Randomized Not Treated|2|||
27836042|NCT01942135|81229113|FG001|Overall Study|Randomized Not Treated|2|||
27836043|NCT01942135|81229112|FG000|Overall Study|Death|2|||
27836044|NCT01942135|81229113|FG001|Overall Study|Death|1|||
27836045|NCT01942135|81229112|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
27836046|NCT01942135|81229113|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
27836047|NCT01942135|81229112|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
27836048|NCT01942135|81229113|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
27836049|NCT01942135|81229112|FG000|Overall Study|Withdrawal by Subject|4|||
27836050|NCT01942135|81229113|FG001|Overall Study|Withdrawal by Subject|3|||
27836051|NCT01942135|81229112|FG000|Overall Study|Protocol Violation|1|||
27602905|NCT00677235|80385570|FG000|Overall Study|Adverse Experience|1|||
27708499|NCT03029143|80768671|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
27708500|NCT03029143|80768672|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
27836052|NCT01942135|81229113|FG001|Overall Study|Protocol Violation|0|||
27836053|NCT01942135|81229112|FG000|Overall Study|Other|19|||
27602906|NCT00677235|80385571|FG001|Overall Study|Adverse Experience|0|||
27708501|NCT03029143|80768673|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
27708502|NCT03029143|80768671|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
27708503|NCT03029143|80768672|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
27708504|NCT03029143|80768673|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
27708505|NCT03029143|80768671|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
27708506|NCT03029143|80768672|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
27708507|NCT03029143|80768673|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
27708508|NCT03029143|80768671|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
27708509|NCT03029143|80768672|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
27708510|NCT03029143|80768673|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
27708511|NCT03029143|80768671|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27708512|NCT03029143|80768672|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27708513|NCT03029143|80768673|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
27708514|NCT03029143|80768671|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
27708515|NCT03029143|80768672|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
27708516|NCT03029143|80768673|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
27708517|NCT03029143|80768671|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27708518|NCT03029143|80768672|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
27708519|NCT03029143|80768673|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
27708520|NCT03029143|80768671|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
27708521|NCT03029143|80768672|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
27708522|NCT03029143|80768673|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
27708523|NCT02830776|80768674|FG000|Overall Study|Lost to Follow-up|1|||
27708524|NCT02349048|80768677|FG000|Overall Study|Withdrawal by Subject|4|||
27708525|NCT02349048|80768678|FG001|Overall Study|Withdrawal by Subject|0|||
27708526|NCT02349048|80768677|FG000|Overall Study|Lost to Follow-up|1|||
27708527|NCT02349048|80768678|FG001|Overall Study|Lost to Follow-up|0|||
27708528|NCT05038020|80768679|FG000|Overall Study|Early Termination|3|||
27708529|NCT05038020|80768680|FG001|Overall Study|Early Termination|0|||
27708530|NCT00710879|80768681|FG000|Overall Study|Lost to Follow-up|2|||
27708531|NCT00710879|80768682|FG001|Overall Study|Lost to Follow-up|1|||
27708532|NCT00710879|80768681|FG000|Overall Study|Protocol Violation|0|||
27708533|NCT00710879|80768682|FG001|Overall Study|Protocol Violation|3|||
27708534|NCT02285777|80768683|FG000|Overall Study|Withdrawal by Subject|1|||
27708535|NCT02285777|80768684|FG001|Overall Study|Withdrawal by Subject|1|||
27708536|NCT02285777|80768683|FG000|Overall Study|Lost to Follow-up|4|||
27708537|NCT02285777|80768684|FG001|Overall Study|Lost to Follow-up|2|||
27708538|NCT00432042|80768689|FG000|Overall Study|Protocol Violation|2|||
27708539|NCT00432042|80768690|FG001|Overall Study|Protocol Violation|0|||
27708540|NCT00432042|80768691|FG002|Overall Study|Protocol Violation|0|||
27708541|NCT00432042|80768689|FG000|Overall Study|Withdrawal by Subject|0|||
27708542|NCT00432042|80768690|FG001|Overall Study|Withdrawal by Subject|0|||
27708543|NCT00432042|80768691|FG002|Overall Study|Withdrawal by Subject|2|||
27708544|NCT00432042|80768689|FG000|Overall Study|Lost to Follow-up|5|||
27708545|NCT00432042|80768690|FG001|Overall Study|Lost to Follow-up|1|||
27708546|NCT00432042|80768691|FG002|Overall Study|Lost to Follow-up|0|||
27708547|NCT01648790|80768692|FG000|Treatment 3|Withdrawal by Subject|0|||
27708548|NCT01648790|80768693|FG001|Treatment 3|Withdrawal by Subject|0|||
27708549|NCT01648790|80768694|FG002|Treatment 3|Withdrawal by Subject|0|||
27708550|NCT01648790|80768695|FG003|Treatment 3|Withdrawal by Subject|1|||
27708551|NCT01648790|80768696|FG004|Treatment 3|Withdrawal by Subject|0|||
27708552|NCT02716987|80768697|FG000|Overall Study|Ligand synthesis failure|0|||
27708553|NCT02716987|80768698|FG001|Overall Study|Ligand synthesis failure|0|||
27708554|NCT02716987|80768699|FG002|Overall Study|Ligand synthesis failure|1|||
27708555|NCT02716987|80768700|FG003|Overall Study|Ligand synthesis failure|0|||
27708556|NCT02716987|80768701|FG004|Overall Study|Ligand synthesis failure|0|||
27708557|NCT02716987|80768702|FG005|Overall Study|Ligand synthesis failure|0|||
27708558|NCT02716987|80768697|FG000|Overall Study|Withdrawal by Subject|0|||
27602907|NCT02277743|80385574|FG000|Overall Study|Protocol Violation|1|||
27602908|NCT02277743|80385575|FG001|Overall Study|Protocol Violation|1|||
27602909|NCT02277743|80385576|FG002|Overall Study|Protocol Violation|1|||
27602910|NCT02277743|80385574|FG000|Overall Study|Adverse Event|10|||
27602911|NCT02277743|80385575|FG001|Overall Study|Adverse Event|6|||
27602912|NCT02277743|80385576|FG002|Overall Study|Adverse Event|6|||
27602913|NCT02277743|80385574|FG000|Overall Study|Lack of Efficacy|11|||
27602914|NCT02277743|80385575|FG001|Overall Study|Lack of Efficacy|4|||
27602915|NCT02277743|80385576|FG002|Overall Study|Lack of Efficacy|3|||
27602916|NCT02277743|80385574|FG000|Overall Study|Other than specified above|18|||
27708559|NCT02716987|80768698|FG001|Overall Study|Withdrawal by Subject|0|||
27602917|NCT02277743|80385575|FG001|Overall Study|Other than specified above|5|||
27708560|NCT02716987|80768699|FG002|Overall Study|Withdrawal by Subject|0|||
27836054|NCT01942135|81229113|FG001|Overall Study|Other|4|||
27602918|NCT02277743|80385576|FG002|Overall Study|Other than specified above|16|||
27602919|NCT00118092|80388435|FG000|Overall Study|Withdrawal by Subject|1|||
27602920|NCT00118092|80388435|FG000|Overall Study|Protocol Violation|1|||
27708561|NCT02716987|80768700|FG003|Overall Study|Withdrawal by Subject|0|||
27708562|NCT02716987|80768701|FG004|Overall Study|Withdrawal by Subject|1|||
27708563|NCT02716987|80768702|FG005|Overall Study|Withdrawal by Subject|1|||
27708564|NCT04305275|80768703|FG000|Overall Study|Adverse Event|4|||
27708565|NCT04305275|80768704|FG001|Overall Study|Adverse Event|0|||
27708566|NCT04305275|80768703|FG000|Overall Study|Lost to Follow-up|1|||
27708567|NCT04305275|80768704|FG001|Overall Study|Lost to Follow-up|1|||
27708568|NCT04305275|80768703|FG000|Overall Study|Withdrawal by Participant|8|||
27708569|NCT04305275|80768704|FG001|Overall Study|Withdrawal by Participant|1|||
27708570|NCT03077685|80768705|FG000|Overall Study|Lost to Follow-up|0|||
27708571|NCT03077685|80768706|FG001|Overall Study|Lost to Follow-up|0|||
27708572|NCT03077685|80768707|FG002|Overall Study|Lost to Follow-up|0|||
27708573|NCT03077685|80768708|FG003|Overall Study|Lost to Follow-up|0|||
27708574|NCT03077685|80768709|FG004|Overall Study|Lost to Follow-up|1|||
27708575|NCT03077685|80768705|FG000|Overall Study|Death|0|||
27708576|NCT03077685|80768706|FG001|Overall Study|Death|0|||
27708577|NCT03077685|80768707|FG002|Overall Study|Death|1|||
27708578|NCT03077685|80768708|FG003|Overall Study|Death|1|||
27708579|NCT03077685|80768709|FG004|Overall Study|Death|3|||
27708580|NCT03077685|80768705|FG000|Overall Study|Withdrawal by Subject|0|||
27708581|NCT03077685|80768706|FG001|Overall Study|Withdrawal by Subject|0|||
27708582|NCT03077685|80768707|FG002|Overall Study|Withdrawal by Subject|0|||
27708583|NCT03077685|80768708|FG003|Overall Study|Withdrawal by Subject|2|||
27708584|NCT03077685|80768709|FG004|Overall Study|Withdrawal by Subject|1|||
27708585|NCT03077685|80768705|FG000|Overall Study|Physician Decision|0|||
27708586|NCT03077685|80768706|FG001|Overall Study|Physician Decision|0|||
27708587|NCT03077685|80768707|FG002|Overall Study|Physician Decision|1|||
27708588|NCT03077685|80768708|FG003|Overall Study|Physician Decision|0|||
27708589|NCT03077685|80768709|FG004|Overall Study|Physician Decision|3|||
27708590|NCT03077685|80768705|FG000|Overall Study|Disease Progression|1|||
27708591|NCT03077685|80768706|FG001|Overall Study|Disease Progression|0|||
27708592|NCT03077685|80768707|FG002|Overall Study|Disease Progression|0|||
27708593|NCT03077685|80768708|FG003|Overall Study|Disease Progression|2|||
27708594|NCT03077685|80768709|FG004|Overall Study|Disease Progression|1|||
27708595|NCT03077685|80768705|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
27708596|NCT03077685|80768706|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
27708597|NCT03077685|80768707|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
27708598|NCT03077685|80768708|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
27708599|NCT03077685|80768709|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
27708600|NCT03077685|80768705|FG000|Overall Study|Subject entered hospice care|0|||
27708601|NCT03077685|80768706|FG001|Overall Study|Subject entered hospice care|0|||
27708602|NCT03077685|80768707|FG002|Overall Study|Subject entered hospice care|0|||
27708603|NCT03077685|80768708|FG003|Overall Study|Subject entered hospice care|0|||
27708604|NCT03077685|80768709|FG004|Overall Study|Subject entered hospice care|1|||
27708605|NCT00677820|80768710|FG000|Overall Study|Lost to Follow-up|1|||
27708606|NCT00677820|80768711|FG001|Overall Study|Lost to Follow-up|0|||
27708607|NCT01066585|80768712|FG000|Overall Study|Protocol Violation|1|||
27708608|NCT01066585|80768713|FG001|Overall Study|Protocol Violation|0|||
27708609|NCT01066585|80768712|FG000|Overall Study|Withdrawal by Subject|0|||
27708610|NCT01066585|80768713|FG001|Overall Study|Withdrawal by Subject|3|||
27708611|NCT00496730|80768714|FG000|Overall Study|Lost to Follow-up|4|||
27708612|NCT00496730|80768715|FG001|Overall Study|Lost to Follow-up|3|||
27708613|NCT00496730|80768714|FG000|Overall Study|Withdrawal by Subject|2|||
27708614|NCT00496730|80768715|FG001|Overall Study|Withdrawal by Subject|2|||
27708615|NCT03697720|80768719|FG000|Overall Study|Lost to Follow-up|7|||
27708616|NCT01469182|80768724|FG000|Overall Study|Adverse Event|21|||
27708617|NCT01469182|80768725|FG001|Overall Study|Adverse Event|3|||
27708618|NCT01469182|80768724|FG000|Overall Study|Lost to Follow-up|3|||
27708619|NCT01469182|80768725|FG001|Overall Study|Lost to Follow-up|0|||
27708620|NCT01469182|80768724|FG000|Overall Study|Withdrawal by Subject|4|||
27708621|NCT01469182|80768725|FG001|Overall Study|Withdrawal by Subject|1|||
27708622|NCT01469182|80768724|FG000|Overall Study|Protocol Violation|4|||
27708623|NCT01469182|80768725|FG001|Overall Study|Protocol Violation|2|||
27708624|NCT01469182|80768724|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
27708625|NCT01469182|80768725|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
27708626|NCT00808236|80768726|FG000|Overall Study|Was not resuscitated|50|||
27708627|NCT00808236|80768727|FG001|Overall Study|Was not resuscitated|56|||
27708628|NCT00808236|80768726|FG000|Overall Study|Pre-defined exclusion|13|||
27602921|NCT01965938|80388441|FG000|Overall Study|Withdrawal by Subject|1|||
27602922|NCT01965938|80388442|FG001|Overall Study|Withdrawal by Subject|0|||
27602923|NCT01682213|80388443|FG000|Overall Study|Withdrawal by Subject|2|||
27602924|NCT00758459|80388444|FG000|Overall Study|Adverse Event|3|||
27602925|NCT00758459|80388445|FG001|Overall Study|Adverse Event|2|||
27602926|NCT00758459|80388444|FG000|Overall Study|Protocol Violation|0|||
27602927|NCT00758459|80388445|FG001|Overall Study|Protocol Violation|1|||
27602928|NCT00758459|80388444|FG000|Overall Study|Withdrawal by Subject|0|||
27602929|NCT00758459|80388445|FG001|Overall Study|Withdrawal by Subject|1|||
27602930|NCT02217280|80388448|FG000|Overall Study|Withdrawal by Subject|2|||
27602931|NCT02217280|80388448|FG000|Overall Study|Post-consent sceen fail|2|||
27602932|NCT01538472|80388449|FG000|Overall Study|Disease Progression|3|||
27602933|NCT01538472|80388449|FG000|Overall Study|Death|1|||
27602934|NCT03205371|80388450|FG000|Overall Study|Withdrawal by Subject|4|||
27602935|NCT03205371|80388451|FG001|Overall Study|Withdrawal by Subject|1|||
27602936|NCT03205371|80388452|FG002|Overall Study|Withdrawal by Subject|0|||
27602937|NCT03205371|80388453|FG003|Overall Study|Withdrawal by Subject|0|||
27602938|NCT03205371|80388454|FG004|Overall Study|Withdrawal by Subject|0|||
27602939|NCT03205371|80388455|FG005|Overall Study|Withdrawal by Subject|0|||
27602940|NCT03205371|80388456|FG006|Overall Study|Withdrawal by Subject|4|||
27602941|NCT03205371|80388457|FG007|Overall Study|Withdrawal by Subject|0|||
27602942|NCT03205371|80388458|FG008|Overall Study|Withdrawal by Subject|2|||
27602943|NCT03205371|80388459|FG009|Overall Study|Withdrawal by Subject|0|||
27602944|NCT03205371|80388460|FG010|Overall Study|Withdrawal by Subject|0|||
27602945|NCT03205371|80388461|FG011|Overall Study|Withdrawal by Subject|1|||
27602946|NCT03205371|80388450|FG000|Overall Study|Lost to Follow-up|0|||
27602947|NCT03205371|80388451|FG001|Overall Study|Lost to Follow-up|0|||
27602948|NCT03205371|80388452|FG002|Overall Study|Lost to Follow-up|0|||
27602949|NCT03205371|80388453|FG003|Overall Study|Lost to Follow-up|0|||
27602950|NCT03205371|80388454|FG004|Overall Study|Lost to Follow-up|0|||
27602951|NCT03205371|80388455|FG005|Overall Study|Lost to Follow-up|0|||
27836055|NCT01963260|81229114|FG000|Overall Study|Withdrawal by Subject|2|||
27836056|NCT01963260|81229115|FG001|Overall Study|Withdrawal by Subject|0|||
27836057|NCT01963260|81229116|FG002|Overall Study|Withdrawal by Subject|0|||
27836058|NCT01963260|81229117|FG003|Overall Study|Withdrawal by Subject|1|||
27836059|NCT01963260|81229118|FG004|Overall Study|Withdrawal by Subject|2|||
27836060|NCT01963260|81229119|FG005|Overall Study|Withdrawal by Subject|0|||
27836061|NCT01963260|81229120|FG006|Overall Study|Withdrawal by Subject|0|||
27836062|NCT01963260|81229121|FG007|Overall Study|Withdrawal by Subject|0|||
27836063|NCT01963260|81229122|FG008|Overall Study|Withdrawal by Subject|0|||
27836064|NCT01963260|81229123|FG009|Overall Study|Withdrawal by Subject|0|||
27836065|NCT00487435|81229126|FG000|Overall Study|Adverse Event|146|||
27836066|NCT00487435|81229126|FG000|Overall Study|Death|2|||
27836067|NCT00487435|81229126|FG000|Overall Study|Lack of Efficacy|33|||
27836068|NCT00487435|81229126|FG000|Overall Study|Lost to Follow-up|54|||
27836069|NCT00487435|81229126|FG000|Overall Study|Pregnancy|2|||
27836070|NCT00487435|81229126|FG000|Overall Study|Withdrawal by Subject|132|||
27836071|NCT00487435|81229126|FG000|Overall Study|Resolution Of Pain|1|||
27836072|NCT00487435|81229126|FG000|Overall Study|Study Medication Non-Compliant|32|||
27708629|NCT00808236|80768727|FG001|Overall Study|Pre-defined exclusion|3|||
27708630|NCT00808236|80768726|FG000|Overall Study|Lost to Follow-up|1|||
27708631|NCT00808236|80768727|FG001|Overall Study|Lost to Follow-up|1|||
27708632|NCT00808236|80768726|FG000|Overall Study|Physician Decision|0|||
27708633|NCT00808236|80768727|FG001|Overall Study|Physician Decision|1|||
27708634|NCT00808236|80768726|FG000|Overall Study|Death|18|||
27708635|NCT00808236|80768727|FG001|Overall Study|Death|30|||
27708636|NCT04912245|80768731|FG000|Overall Study|Withdrawal by Subject|21|||
27708637|NCT04912245|80768732|FG001|Overall Study|Withdrawal by Subject|4|||
27708638|NCT04912245|80768731|FG000|Overall Study|Lost to Follow-up|5|||
27708639|NCT04912245|80768732|FG001|Overall Study|Lost to Follow-up|11|||
27708640|NCT00766038|80768734|FG000|Overall Study|Lost to Follow-up|15|||
27708641|NCT00766038|80768735|FG001|Overall Study|Lost to Follow-up|14|||
27708642|NCT02187172|80768736|FG000|Overall Study|Lost to Follow-up|1|||
27708643|NCT02187172|80768737|FG001|Overall Study|Lost to Follow-up|2|||
27708644|NCT02187172|80768736|FG000|Overall Study|Lack of Efficacy|1|||
27708645|NCT02187172|80768737|FG001|Overall Study|Lack of Efficacy|2|||
27708646|NCT02187172|80768736|FG000|Overall Study|Adverse Event|0|||
27708647|NCT02187172|80768737|FG001|Overall Study|Adverse Event|1|||
27708648|NCT02187172|80768736|FG000|Overall Study|Physician Decision|1|||
27708649|NCT02187172|80768737|FG001|Overall Study|Physician Decision|1|||
27708650|NCT00402649|80768739|FG000|Overall Study|Lost to Follow-up|1|||
27708651|NCT00402649|80768739|FG000|Overall Study|Withdrawal by Subject|1|||
27708652|NCT00688155|80768741|FG000|Overall Study|Withdrawal by Subject|2|||
27836073|NCT00487435|81229126|FG000|Overall Study|Other|83|||
27708653|NCT00688155|80768742|FG001|Overall Study|Withdrawal by Subject|2|||
27708654|NCT00688155|80768743|FG002|Overall Study|Withdrawal by Subject|1|||
27836074|NCT00452348|81229127|FG000|Overall Study|Adverse Event|6|||
27602952|NCT03205371|80388456|FG006|Overall Study|Lost to Follow-up|5|||
27602953|NCT03205371|80388457|FG007|Overall Study|Lost to Follow-up|2|||
27602954|NCT03205371|80388458|FG008|Overall Study|Lost to Follow-up|3|||
27602955|NCT03205371|80388459|FG009|Overall Study|Lost to Follow-up|0|||
27602956|NCT03205371|80388460|FG010|Overall Study|Lost to Follow-up|0|||
27602957|NCT03205371|80388461|FG011|Overall Study|Lost to Follow-up|0|||
27602958|NCT03205371|80388450|FG000|Overall Study|Protocol Violation|0|||
27602959|NCT03205371|80388451|FG001|Overall Study|Protocol Violation|0|||
27602960|NCT03205371|80388452|FG002|Overall Study|Protocol Violation|0|||
27602961|NCT03205371|80388453|FG003|Overall Study|Protocol Violation|0|||
27602962|NCT03205371|80388454|FG004|Overall Study|Protocol Violation|0|||
27602963|NCT03205371|80388455|FG005|Overall Study|Protocol Violation|0|||
27602964|NCT03205371|80388456|FG006|Overall Study|Protocol Violation|1|||
27602965|NCT03205371|80388457|FG007|Overall Study|Protocol Violation|0|||
27602966|NCT03205371|80388458|FG008|Overall Study|Protocol Violation|0|||
27602967|NCT03205371|80388459|FG009|Overall Study|Protocol Violation|0|||
27602968|NCT03205371|80388460|FG010|Overall Study|Protocol Violation|0|||
27602969|NCT03205371|80388461|FG011|Overall Study|Protocol Violation|0|||
27602970|NCT03205371|80388450|FG000|Overall Study|Adverse Event|0|||
27602971|NCT03205371|80388451|FG001|Overall Study|Adverse Event|0|||
27602972|NCT03205371|80388452|FG002|Overall Study|Adverse Event|0|||
27602973|NCT03205371|80388453|FG003|Overall Study|Adverse Event|0|||
27602974|NCT03205371|80388454|FG004|Overall Study|Adverse Event|0|||
27602975|NCT03205371|80388455|FG005|Overall Study|Adverse Event|0|||
27602976|NCT03205371|80388456|FG006|Overall Study|Adverse Event|0|||
27602977|NCT03205371|80388457|FG007|Overall Study|Adverse Event|1|||
27708655|NCT00688155|80768744|FG003|Overall Study|Withdrawal by Subject|1|||
27708656|NCT02116777|80768745|FG000|Overall Study|Adverse Event|0|||
27708657|NCT02116777|80768746|FG001|Overall Study|Adverse Event|0|||
27708658|NCT02116777|80768747|FG002|Overall Study|Adverse Event|0|||
27708659|NCT02116777|80768748|FG003|Overall Study|Adverse Event|0|||
27708660|NCT02116777|80768749|FG004|Overall Study|Adverse Event|2|||
27708661|NCT02116777|80768750|FG005|Overall Study|Adverse Event|2|||
27708662|NCT02116777|80768751|FG006|Overall Study|Adverse Event|0|||
27708663|NCT02116777|80768745|FG000|Overall Study|Death|0|||
27708664|NCT02116777|80768746|FG001|Overall Study|Death|0|||
27708665|NCT02116777|80768747|FG002|Overall Study|Death|0|||
27708666|NCT02116777|80768748|FG003|Overall Study|Death|1|||
27708667|NCT02116777|80768749|FG004|Overall Study|Death|0|||
27708668|NCT02116777|80768750|FG005|Overall Study|Death|0|||
27708669|NCT02116777|80768751|FG006|Overall Study|Death|0|||
27708670|NCT02116777|80768745|FG000|Overall Study|Lack of Efficacy|3|||
27708671|NCT02116777|80768746|FG001|Overall Study|Lack of Efficacy|3|||
27708672|NCT02116777|80768747|FG002|Overall Study|Lack of Efficacy|3|||
27708673|NCT02116777|80768748|FG003|Overall Study|Lack of Efficacy|8|||
27708674|NCT02116777|80768749|FG004|Overall Study|Lack of Efficacy|4|||
27708675|NCT02116777|80768750|FG005|Overall Study|Lack of Efficacy|1|||
27708676|NCT02116777|80768751|FG006|Overall Study|Lack of Efficacy|9|||
27708677|NCT02116777|80768745|FG000|Overall Study|Physician Decision|0|||
27708678|NCT02116777|80768746|FG001|Overall Study|Physician Decision|0|||
27708679|NCT02116777|80768747|FG002|Overall Study|Physician Decision|0|||
27708680|NCT02116777|80768748|FG003|Overall Study|Physician Decision|2|||
27708681|NCT02116777|80768749|FG004|Overall Study|Physician Decision|0|||
27708682|NCT02116777|80768750|FG005|Overall Study|Physician Decision|0|||
27708683|NCT02116777|80768751|FG006|Overall Study|Physician Decision|0|||
27708684|NCT02116777|80768745|FG000|Overall Study|Protocol Violation|0|||
27708685|NCT02116777|80768746|FG001|Overall Study|Protocol Violation|0|||
27708686|NCT02116777|80768747|FG002|Overall Study|Protocol Violation|0|||
27708687|NCT02116777|80768748|FG003|Overall Study|Protocol Violation|1|||
27708688|NCT02116777|80768749|FG004|Overall Study|Protocol Violation|0|||
27708689|NCT02116777|80768750|FG005|Overall Study|Protocol Violation|0|||
27708690|NCT02116777|80768751|FG006|Overall Study|Protocol Violation|0|||
27708691|NCT02116777|80768745|FG000|Overall Study|Withdrawal by Subject|0|||
27708692|NCT02116777|80768746|FG001|Overall Study|Withdrawal by Subject|0|||
27708693|NCT02116777|80768747|FG002|Overall Study|Withdrawal by Subject|0|||
27708694|NCT02116777|80768748|FG003|Overall Study|Withdrawal by Subject|1|||
27708695|NCT02116777|80768749|FG004|Overall Study|Withdrawal by Subject|0|||
27708696|NCT02116777|80768750|FG005|Overall Study|Withdrawal by Subject|0|||
27708697|NCT02116777|80768751|FG006|Overall Study|Withdrawal by Subject|0|||
27708698|NCT01210807|80768752|FG000|Overall Study|Lost to Follow-up|1|||
27708699|NCT01210807|80768753|FG001|Overall Study|Lost to Follow-up|2|||
27708700|NCT01210807|80768752|FG000|Overall Study|Not implanted bilaterally|2|||
27708701|NCT01210807|80768753|FG001|Overall Study|Not implanted bilaterally|1|||
27708702|NCT02230384|80768756|FG000|Phase 1|Lost to Follow-up|1|||
27708703|NCT02230384|80768757|FG001|Phase 1|Lost to Follow-up|0|||
27708704|NCT02230384|80768756|FG000|Phase 1|Physician Decision|0|||
27708705|NCT02230384|80768757|FG001|Phase 1|Physician Decision|1|||
27708706|NCT02230384|80768756|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
27708707|NCT02230384|80768757|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
27708708|NCT02230384|80768756|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
27708709|NCT02230384|80768757|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
27708710|NCT02230384|80768756|FG000|Phase 2 - Switch|Adverse Event|2|||
27708711|NCT02230384|80768757|FG001|Phase 2 - Switch|Adverse Event|0|||
27708712|NCT02114268|80768758|FG000|Overall Study|Lost to Follow-up|4|||
27708713|NCT02114268|80768759|FG001|Overall Study|Lost to Follow-up|1|||
27708714|NCT02114268|80768760|FG002|Overall Study|Lost to Follow-up|1|||
27708715|NCT02114268|80768761|FG003|Overall Study|Lost to Follow-up|0|||
27708716|NCT02114268|80768762|FG004|Overall Study|Lost to Follow-up|0|||
27708717|NCT02114268|80768763|FG005|Overall Study|Lost to Follow-up|2|||
27708718|NCT02114268|80768758|FG000|Overall Study|Withdrawal by Subject|1|||
27708719|NCT02114268|80768759|FG001|Overall Study|Withdrawal by Subject|0|||
27708720|NCT02114268|80768760|FG002|Overall Study|Withdrawal by Subject|0|||
27708721|NCT02114268|80768761|FG003|Overall Study|Withdrawal by Subject|0|||
27708722|NCT02114268|80768762|FG004|Overall Study|Withdrawal by Subject|0|||
27708723|NCT02114268|80768763|FG005|Overall Study|Withdrawal by Subject|1|||
27708724|NCT02114268|80768758|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
27708725|NCT02114268|80768759|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
27708726|NCT02114268|80768760|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
27708727|NCT02114268|80768761|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
27708728|NCT02114268|80768762|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
27708729|NCT02114268|80768763|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
27708730|NCT03829657|80768764|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
27708731|NCT03829657|80768765|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
27708732|NCT03829657|80768766|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
27708733|NCT03829657|80768767|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
27708734|NCT03829657|80768768|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
27708735|NCT03829657|80768764|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
27708736|NCT03829657|80768765|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
27708737|NCT03829657|80768766|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
27708738|NCT03829657|80768767|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
27708739|NCT03829657|80768768|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
27708740|NCT03829657|80768764|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
27708741|NCT03829657|80768765|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
27708742|NCT03829657|80768766|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
27708743|NCT03829657|80768767|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
27708744|NCT03829657|80768768|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
27708745|NCT03829657|80768764|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
27708746|NCT03829657|80768765|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
27708747|NCT03829657|80768766|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
27708748|NCT03829657|80768767|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
27708749|NCT03829657|80768768|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
27708750|NCT03829657|80768764|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
27708751|NCT03829657|80768765|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
27708752|NCT03829657|80768766|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
27708753|NCT03829657|80768767|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
27708754|NCT03829657|80768768|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
27708755|NCT03829657|80768764|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
27708756|NCT03829657|80768765|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
27708757|NCT03829657|80768766|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
27708758|NCT03829657|80768767|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
27708759|NCT03829657|80768768|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
27708760|NCT03829657|80768764|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
27708761|NCT03829657|80768765|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
27708762|NCT03829657|80768766|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
27708763|NCT03829657|80768767|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
27708764|NCT03829657|80768768|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
27708765|NCT03829657|80768764|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
27708766|NCT03829657|80768765|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
27708767|NCT03829657|80768766|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
27708768|NCT03829657|80768767|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
27708769|NCT03829657|80768768|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
27708770|NCT03829657|80768764|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
27708771|NCT03829657|80768765|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
27708772|NCT03829657|80768766|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
27708773|NCT03829657|80768767|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
27708774|NCT03829657|80768768|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
27708775|NCT03829657|80768764|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
27708776|NCT03829657|80768765|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
27708777|NCT03829657|80768766|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
27708778|NCT03829657|80768767|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
27708779|NCT03829657|80768768|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
27708780|NCT00906087|80768769|FG000|Initial Washout|Withdrawal by Subject|1|||
27708781|NCT00906087|80768769|FG000|Initial Washout|Physician Decision|1|||
27836075|NCT00452348|81229128|FG001|Overall Study|Adverse Event|9|||
27708782|NCT01892163|80768774|FG000|Overall Study|Death|1|||
27708783|NCT01892163|80768775|FG001|Overall Study|Death|1|||
27708784|NCT01892163|80768774|FG000|Overall Study|Lost to Follow-up|1|||
27708785|NCT01892163|80768775|FG001|Overall Study|Lost to Follow-up|0|||
27708786|NCT04854434|80768776|FG000|Overall Study|Death|1|||
27708787|NCT04854434|80768777|FG001|Overall Study|Death|3|||
27708788|NCT04854434|80768778|FG002|Overall Study|Death|4|||
27708789|NCT04854434|80768776|FG000|Overall Study|Study Terminated by Sponsor|2|||
27708790|NCT04854434|80768777|FG001|Overall Study|Study Terminated by Sponsor|0|||
27708791|NCT04854434|80768778|FG002|Overall Study|Study Terminated by Sponsor|0|||
27836076|NCT00452348|81229127|FG000|Overall Study|Lack of Efficacy|10|||
27602978|NCT03205371|80388458|FG008|Overall Study|Adverse Event|0|||
27602979|NCT03205371|80388459|FG009|Overall Study|Adverse Event|0|||
27602980|NCT03205371|80388460|FG010|Overall Study|Adverse Event|0|||
27602981|NCT03205371|80388461|FG011|Overall Study|Adverse Event|0|||
27602982|NCT03320018|80388462|FG000|Treatment Period|Withdrawal by Subject|1|||
27602983|NCT03320018|80388463|FG001|Treatment Period|Withdrawal by Subject|0|||
27602984|NCT03320018|80388462|FG000|Day 90 Follow up|Death|0|||
27602985|NCT03320018|80388463|FG001|Day 90 Follow up|Death|1|||
27602986|NCT05096208|80388466|FG000|Overall Study|Lost to Follow-up|3|||
27602987|NCT05096208|80388467|FG001|Overall Study|Lost to Follow-up|5|||
27602988|NCT05096208|80388468|FG002|Overall Study|Lost to Follow-up|5|||
27602989|NCT05096208|80388469|FG003|Overall Study|Lost to Follow-up|2|||
27602990|NCT05096208|80388466|FG000|Overall Study|Withdrawal by Subject|0|||
27602991|NCT05096208|80388467|FG001|Overall Study|Withdrawal by Subject|1|||
27602992|NCT05096208|80388468|FG002|Overall Study|Withdrawal by Subject|2|||
27602993|NCT05096208|80388469|FG003|Overall Study|Withdrawal by Subject|3|||
27602994|NCT05096208|80388466|FG000|Overall Study|No longer met eligibility criteria|1|||
27602995|NCT05096208|80388467|FG001|Overall Study|No longer met eligibility criteria|0|||
27602996|NCT05096208|80388468|FG002|Overall Study|No longer met eligibility criteria|0|||
27602997|NCT05096208|80388469|FG003|Overall Study|No longer met eligibility criteria|0|||
27602998|NCT05096208|80388466|FG000|Overall Study|Other|0|||
27602999|NCT05096208|80388467|FG001|Overall Study|Other|0|||
27603000|NCT05096208|80388468|FG002|Overall Study|Other|1|||
27603001|NCT05096208|80388469|FG003|Overall Study|Other|0|||
27603002|NCT00069784|80388470|FG000|Overall Study|Adverse Event|105|||
27603003|NCT00069784|80388471|FG001|Overall Study|Adverse Event|0|||
27603004|NCT00069784|80388470|FG000|Overall Study|Withdrawal by Subject|1090|||
27603005|NCT00069784|80388471|FG001|Overall Study|Withdrawal by Subject|0|||
27603006|NCT00069784|80388470|FG000|Overall Study|Other|17|||
27603007|NCT00069784|80388471|FG001|Overall Study|Other|0|||
27603008|NCT00685945|80388472|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
27603009|NCT01337986|80388473|FG000|Overall Study|Adverse Event|2|||
27603010|NCT01337986|80388474|FG001|Overall Study|Adverse Event|2|||
27603011|NCT01337986|80388473|FG000|Overall Study|Lost to Follow-up|1|||
27603012|NCT01337986|80388474|FG001|Overall Study|Lost to Follow-up|0|||
27603013|NCT01337986|80388473|FG000|Overall Study|Protocol Violation|0|||
27603014|NCT01337986|80388474|FG001|Overall Study|Protocol Violation|3|||
27603015|NCT03988634|80388487|FG000|Double-Blind|Adverse Event|4|||
27603016|NCT03988634|80388488|FG001|Double-Blind|Adverse Event|0|||
27603017|NCT03988634|80388489|FG002|Double-Blind|Adverse Event|0|||
27603018|NCT03988634|80388487|FG000|Double-Blind|Death|18|||
27603019|NCT03988634|80388488|FG001|Double-Blind|Death|26|||
27603020|NCT03988634|80388489|FG002|Double-Blind|Death|0|||
27603021|NCT03988634|80388487|FG000|Double-Blind|Lost to Follow-up|6|||
27603022|NCT03988634|80388488|FG001|Double-Blind|Lost to Follow-up|7|||
27603023|NCT03988634|80388489|FG002|Double-Blind|Lost to Follow-up|0|||
27708792|NCT04854434|80768776|FG000|Overall Study|Other|1|||
27708793|NCT04854434|80768777|FG001|Overall Study|Other|1|||
27836077|NCT00452348|81229128|FG001|Overall Study|Lack of Efficacy|9|||
27603024|NCT03988634|80388487|FG000|Double-Blind|Physician Decision|9|||
27603025|NCT03988634|80388488|FG001|Double-Blind|Physician Decision|5|||
27708794|NCT04854434|80768778|FG002|Overall Study|Other|0|||
27603026|NCT03988634|80388489|FG002|Double-Blind|Physician Decision|0|||
27603027|NCT03988634|80388487|FG000|Double-Blind|Subject decision|24|||
27603028|NCT03988634|80388488|FG001|Double-Blind|Subject decision|13|||
27603029|NCT03988634|80388489|FG002|Double-Blind|Subject decision|0|||
27603030|NCT03988634|80388487|FG000|Open-Label|Adverse Event|0|||
27603031|NCT03988634|80388488|FG001|Open-Label|Adverse Event|0|||
27603032|NCT03988634|80388489|FG002|Open-Label|Adverse Event|7|||
27708795|NCT01357655|80768783|FG000|Overall Study|Administrative Reason by Sponsor|45|||
27708796|NCT01357655|80768784|FG001|Overall Study|Administrative Reason by Sponsor|0|||
27708797|NCT01357655|80768783|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27708798|NCT01357655|80768784|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27708799|NCT01357655|80768783|FG000|Overall Study|Disease Progression|1|||
27708800|NCT01357655|80768784|FG001|Overall Study|Disease Progression|0|||
27708801|NCT01357655|80768783|FG000|Overall Study|Lost to Follow-up|2|||
27708802|NCT01357655|80768784|FG001|Overall Study|Lost to Follow-up|0|||
27708803|NCT01357655|80768783|FG000|Overall Study|Maximum Clinical Benefit|2|||
27708804|NCT01357655|80768784|FG001|Overall Study|Maximum Clinical Benefit|0|||
27708805|NCT01357655|80768783|FG000|Overall Study|Reason Unspecified|1|||
27708806|NCT01357655|80768784|FG001|Overall Study|Reason Unspecified|0|||
27708807|NCT01357655|80768783|FG000|Overall Study|Study Drug Toxicity|11|||
27708808|NCT01357655|80768784|FG001|Overall Study|Study Drug Toxicity|0|||
27708809|NCT01357655|80768783|FG000|Overall Study|Subject Withdrew Consent|1|||
27708810|NCT01357655|80768784|FG001|Overall Study|Subject Withdrew Consent|0|||
27708811|NCT01422915|80768785|FG000|Overall Study|Adverse Event|1|||
27708812|NCT01517893|80768788|FG000|Overall Study|Withdrawal by Subject|3|||
27708813|NCT01517893|80768789|FG001|Overall Study|Withdrawal by Subject|0|||
27708814|NCT01378858|80768790|FG000|Overall Study|Withdrawal by Subject|4|||
27708815|NCT01378858|80768791|FG001|Overall Study|Withdrawal by Subject|4|||
27708816|NCT01476475|80768792|FG000|Overall Study|Adverse Event|6|||
27708817|NCT01476475|80768793|FG001|Overall Study|Adverse Event|0|||
27708818|NCT01476475|80768792|FG000|Overall Study|Poor compliance to protocol|1|||
27708819|NCT01476475|80768793|FG001|Overall Study|Poor compliance to protocol|1|||
27708820|NCT01476475|80768792|FG000|Overall Study|Other reasons|4|||
27708821|NCT01476475|80768793|FG001|Overall Study|Other reasons|2|||
27708822|NCT02700412|80768798|FG000|Overall Study|Adverse Event|6|||
27708823|NCT02700412|80768798|FG000|Overall Study|Death|1|||
27708824|NCT02700412|80768798|FG000|Overall Study|Lack of Efficacy|19|||
27708825|NCT02700412|80768798|FG000|Overall Study|Protocol Violation|5|||
27708826|NCT02700412|80768798|FG000|Overall Study|Withdrawal by Subject|2|||
27836078|NCT00452348|81229127|FG000|Overall Study|Lost to Follow-up|14|||
27708827|NCT03996876|80768799|FG000|Overall Study|Incomplete Data|2|||
27603033|NCT03988634|80388487|FG000|Open-Label|Physician Decision|0|||
27708828|NCT03996876|80768800|FG001|Overall Study|Incomplete Data|4|||
27708829|NCT00880399|80768801|FG000|Overall Study|Adverse Event|4|||
27603034|NCT03988634|80388488|FG001|Open-Label|Physician Decision|0|||
27708830|NCT00880399|80768802|FG001|Overall Study|Adverse Event|6|||
27708831|NCT00880399|80768803|FG002|Overall Study|Adverse Event|5|||
27708832|NCT00880399|80768801|FG000|Overall Study|Lack of Efficacy|1|||
27603035|NCT03988634|80388489|FG002|Open-Label|Physician Decision|1|||
27603036|NCT03988634|80388487|FG000|Open-Label|Technical problems|0|||
27603037|NCT03988634|80388488|FG001|Open-Label|Technical problems|0|||
27603038|NCT03988634|80388489|FG002|Open-Label|Technical problems|1|||
27603039|NCT00886639|80388492|FG000|Overall Study|acute exacerbation|14|||
27603040|NCT00886639|80388492|FG000|Overall Study|non-compliance|2|||
27603041|NCT05050578|80388493|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
27603042|NCT05050578|80388494|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
27603043|NCT05050578|80388493|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
27603044|NCT05050578|80388494|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
27603045|NCT05050578|80388493|FG000|Period 2, 30 Days|Protocol Violation|0|||
27603046|NCT05050578|80388494|FG001|Period 2, 30 Days|Protocol Violation|1|||
27603047|NCT01553318|80388502|FG000|Overall Study|Protocol Violation|3|||
27603048|NCT01553318|80388503|FG001|Overall Study|Protocol Violation|2|||
27603049|NCT00570674|80388504|FG000|Overall Study|Withdrawal by Subject|0|||
27603050|NCT00570674|80388505|FG001|Overall Study|Withdrawal by Subject|0|||
27603051|NCT00570674|80388506|FG002|Overall Study|Withdrawal by Subject|1|||
27603052|NCT00570674|80388507|FG003|Overall Study|Withdrawal by Subject|0|||
27603053|NCT00570674|80388508|FG004|Overall Study|Withdrawal by Subject|0|||
27603054|NCT00570674|80388509|FG005|Overall Study|Withdrawal by Subject|0|||
27603055|NCT00570674|80388510|FG006|Overall Study|Withdrawal by Subject|0|||
27603056|NCT02316769|80388511|FG000|Overall Study|Physician Decision|1|||
27603057|NCT02316769|80388512|FG001|Overall Study|Physician Decision|0|||
27603058|NCT02316769|80388511|FG000|Overall Study|Withdrawal by Subject|1|||
27603059|NCT02316769|80388512|FG001|Overall Study|Withdrawal by Subject|0|||
27603060|NCT04108000|80388516|FG000|Overall Study|Death of patient|1|||
27603061|NCT04108000|80388517|FG001|Overall Study|Death of patient|0|||
27603062|NCT04108000|80388518|FG002|Overall Study|Death of patient|1|||
27603063|NCT04108000|80388519|FG003|Overall Study|Death of patient|0|||
27603064|NCT04108000|80388516|FG000|Overall Study|Withdrawal by Subject|2|||
27603065|NCT04108000|80388517|FG001|Overall Study|Withdrawal by Subject|2|||
27603066|NCT04108000|80388518|FG002|Overall Study|Withdrawal by Subject|0|||
27603067|NCT04108000|80388519|FG003|Overall Study|Withdrawal by Subject|0|||
27603068|NCT04108000|80388516|FG000|Overall Study|Death of surrogate partner|0|||
27603069|NCT04108000|80388517|FG001|Overall Study|Death of surrogate partner|1|||
27603070|NCT04108000|80388518|FG002|Overall Study|Death of surrogate partner|0|||
27603071|NCT04108000|80388519|FG003|Overall Study|Death of surrogate partner|1|||
27603072|NCT05056870|80388520|FG000|Period 1|Site COVID-19 Related|3|||
27603073|NCT05056870|80388521|FG001|Period 1|Site COVID-19 Related|3|||
27603074|NCT05056870|80388520|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
27603075|NCT05056870|80388521|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
27603076|NCT05056870|80388520|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
27603077|NCT05056870|80388521|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
27603078|NCT05056870|80388520|FG000|Period 2|COVID-19 Related|1|||
27603079|NCT05056870|80388521|FG001|Period 2|COVID-19 Related|0|||
27603080|NCT05056870|80388520|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
27603081|NCT05056870|80388521|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
27603082|NCT02347657|80388522|FG000|Overall Study|Physician Decision|0|||
27603083|NCT02347657|80388523|FG001|Overall Study|Physician Decision|1|||
27603084|NCT02347657|80388522|FG000|Overall Study|Adverse Event|8|||
27603085|NCT02347657|80388523|FG001|Overall Study|Adverse Event|4|||
27603086|NCT02347657|80388522|FG000|Overall Study|Withdrawal by Subject|6|||
27603087|NCT02347657|80388523|FG001|Overall Study|Withdrawal by Subject|7|||
27603088|NCT02347657|80388522|FG000|Overall Study|Randomized but not treated|1|||
27603089|NCT02347657|80388523|FG001|Overall Study|Randomized but not treated|0|||
27603090|NCT02347657|80388522|FG000|Overall Study|Other|3|||
27603091|NCT02347657|80388523|FG001|Overall Study|Other|3|||
27603092|NCT02940574|80388524|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
27603093|NCT02940574|80388525|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
27603094|NCT02940574|80388524|FG000|1-year Follow-up|Lost to Follow-up|3|||
27603095|NCT02940574|80388525|FG001|1-year Follow-up|Lost to Follow-up|4|||
27836079|NCT00452348|81229128|FG001|Overall Study|Lost to Follow-up|8|||
27836080|NCT00452348|81229127|FG000|Overall Study|Protocol Violation|22|||
27836081|NCT00452348|81229128|FG001|Overall Study|Protocol Violation|28|||
27836082|NCT00452348|81229127|FG000|Overall Study|Withdrawal by Subject|18|||
27836083|NCT00452348|81229128|FG001|Overall Study|Withdrawal by Subject|21|||
27836084|NCT00452348|81229127|FG000|Overall Study|Other|9|||
27836085|NCT00452348|81229128|FG001|Overall Study|Other|9|||
27836086|NCT01395017|81229131|FG000|Overall Study|Lost to Follow-up|1|||
27889031|NCT04696354|81428161|FG000|Overall Study|Study termination|6|||
27889032|NCT04696354|81428162|FG001|Overall Study|Study termination|6|||
27889033|NCT03843541|81428163|FG000|Overall Study|Adverse Event|4|||
27889034|NCT03843541|81428164|FG001|Overall Study|Adverse Event|2|||
27889035|NCT03843541|81428165|FG002|Overall Study|Adverse Event|3|||
27889036|NCT03843541|81428163|FG000|Overall Study|Death|1|||
27889037|NCT03843541|81428164|FG001|Overall Study|Death|0|||
27603096|NCT01690130|80388526|FG000|Overall Study|Subject have cancelled visit.|1|||
27836087|NCT01395017|81229132|FG001|Overall Study|Lost to Follow-up|0|||
27836088|NCT01395017|81229131|FG000|Overall Study|Adverse Event|26|||
27889038|NCT03843541|81428165|FG002|Overall Study|Death|0|||
27603097|NCT01690130|80388527|FG001|Overall Study|Subject have cancelled visit.|0|||
27603098|NCT01125722|80388528|FG000|Overall Study|Withdrawal by Subject|2|||
27603099|NCT01125722|80388529|FG001|Overall Study|Withdrawal by Subject|1|||
27603100|NCT01125722|80388528|FG000|Overall Study|Lost to Follow-up|1|||
27603101|NCT01125722|80388529|FG001|Overall Study|Lost to Follow-up|0|||
27603102|NCT00949715|80388531|FG000|Overall Study|Physician Decision|1|||
27603103|NCT00949715|80388532|FG001|Overall Study|Physician Decision|0|||
27603104|NCT00949715|80388531|FG000|Overall Study|Lost to Follow-up|1|||
27603105|NCT00949715|80388532|FG001|Overall Study|Lost to Follow-up|0|||
27603106|NCT00949715|80388531|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
27603107|NCT00949715|80388532|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
27603108|NCT00105235|80388533|FG000|Overall Study|Death|4|||
27603109|NCT00105235|80388533|FG000|Overall Study|Physician Decision|1|||
27603110|NCT00105235|80388533|FG000|Overall Study|Withdrawal by Subject|2|||
27603111|NCT03040713|80388534|FG000|Overall Study|Positive amyloid scan|3|||
27603112|NCT01800201|80388535|FG000|Overall Study|Withdrawal by Subject|2|||
27603113|NCT01800201|80388536|FG001|Overall Study|Withdrawal by Subject|0|||
27603114|NCT01800201|80388535|FG000|Overall Study|patient privacy concerns|1|||
27603115|NCT01800201|80388536|FG001|Overall Study|patient privacy concerns|1|||
27603116|NCT01800201|80388535|FG000|Overall Study|did not want to use device|0|||
27603117|NCT01800201|80388536|FG001|Overall Study|did not want to use device|1|||
27708833|NCT00880399|80768802|FG001|Overall Study|Lack of Efficacy|4|||
27708834|NCT00880399|80768803|FG002|Overall Study|Lack of Efficacy|2|||
27708835|NCT00880399|80768801|FG000|Overall Study|Protocol Violation|4|||
27603118|NCT01800201|80388535|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
27603119|NCT01800201|80388536|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
27603120|NCT00840801|80388537|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
27708836|NCT00880399|80768802|FG001|Overall Study|Protocol Violation|4|||
27889039|NCT03843541|81428163|FG000|Overall Study|Lack of adherence to study medication|0|||
27889040|NCT03843541|81428164|FG001|Overall Study|Lack of adherence to study medication|0|||
27889041|NCT03843541|81428165|FG002|Overall Study|Lack of adherence to study medication|1|||
27889042|NCT03843541|81428163|FG000|Overall Study|Physician Decision|1|||
27889043|NCT03843541|81428164|FG001|Overall Study|Physician Decision|2|||
27889044|NCT03843541|81428165|FG002|Overall Study|Physician Decision|2|||
27889045|NCT03843541|81428163|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
27889046|NCT03843541|81428164|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
27889047|NCT03843541|81428165|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
27889048|NCT03843541|81428163|FG000|Overall Study|Withdrawal by Subject|6|||
27889049|NCT03843541|81428164|FG001|Overall Study|Withdrawal by Subject|9|||
27889050|NCT03843541|81428165|FG002|Overall Study|Withdrawal by Subject|7|||
27889051|NCT03843541|81428163|FG000|Overall Study|Administration of rescue mucolytic|0|||
27889052|NCT03843541|81428164|FG001|Overall Study|Administration of rescue mucolytic|0|||
27889053|NCT03843541|81428165|FG002|Overall Study|Administration of rescue mucolytic|1|||
27889054|NCT03843541|81428163|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
27889055|NCT03843541|81428164|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
27889056|NCT03843541|81428165|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
27889057|NCT02320058|81428166|FG000|Overall Study|Death|25|||
27889058|NCT02320058|81428167|FG001|Overall Study|Death|10|||
27889059|NCT02320058|81428166|FG000|Overall Study|Lost to Follow-up|4|||
27889060|NCT02320058|81428167|FG001|Overall Study|Lost to Follow-up|0|||
27889061|NCT02320058|81428166|FG000|Overall Study|Other reasons|4|||
27889062|NCT02320058|81428167|FG001|Overall Study|Other reasons|1|||
27836089|NCT01395017|81229132|FG001|Overall Study|Adverse Event|12|||
27836090|NCT01395017|81229131|FG000|Overall Study|Physician Decision|11|||
27836091|NCT01395017|81229132|FG001|Overall Study|Physician Decision|15|||
27836092|NCT01395017|81229131|FG000|Overall Study|Withdrawal by Subject|14|||
27836093|NCT01395017|81229132|FG001|Overall Study|Withdrawal by Subject|8|||
27836094|NCT01395017|81229131|FG000|Overall Study|Protocol deviation|1|||
27836095|NCT01395017|81229132|FG001|Overall Study|Protocol deviation|2|||
27836096|NCT01395017|81229131|FG000|Overall Study|Death|4|||
27836097|NCT01395017|81229132|FG001|Overall Study|Death|3|||
27836098|NCT01395017|81229131|FG000|Overall Study|Disease progression|42|||
27836099|NCT01395017|81229132|FG001|Overall Study|Disease progression|58|||
27836100|NCT01395017|81229131|FG000|Overall Study|Sponsor discontinued study|1|||
27836101|NCT01395017|81229132|FG001|Overall Study|Sponsor discontinued study|4|||
27836102|NCT02218216|81229138|FG000|Overall Study|Study terminated before completed|6|||
27836103|NCT02218216|81229139|FG001|Overall Study|Study terminated before completed|0|||
27836104|NCT02218216|81229140|FG002|Overall Study|Study terminated before completed|0|||
27889063|NCT02320058|81428166|FG000|Overall Study|Withdrawal by Subject|8|||
27889064|NCT02320058|81428167|FG001|Overall Study|Withdrawal by Subject|2|||
27708837|NCT00880399|80768803|FG002|Overall Study|Protocol Violation|6|||
27836105|NCT01374451|81229147|FG000|Overall Study|Administrative problems|1|||
27836106|NCT01374451|81229148|FG001|Overall Study|Administrative problems|0|||
27836107|NCT01726803|81229149|FG000|Overall Study|Lost to Follow-up|6|||
27889065|NCT02320058|81428166|FG000|Overall Study|Not reported|1|||
27889066|NCT02320058|81428167|FG001|Overall Study|Not reported|0|||
27889067|NCT03613649|81428168|FG000|Second Treatment|Lost to Follow-up|0|||
27889068|NCT03613649|81428169|FG001|Second Treatment|Lost to Follow-up|0|||
27889069|NCT03613649|81428170|FG002|Second Treatment|Lost to Follow-up|1|||
27889070|NCT03613649|81428171|FG003|Second Treatment|Lost to Follow-up|0|||
27889071|NCT03613649|81428172|FG004|Second Treatment|Lost to Follow-up|0|||
27889072|NCT03613649|81428173|FG005|Second Treatment|Lost to Follow-up|0|||
27889073|NCT03613649|81428174|FG006|Second Treatment|Lost to Follow-up|0|||
27889074|NCT03613649|81428175|FG007|Second Treatment|Lost to Follow-up|0|||
27889075|NCT03613649|81428176|FG008|Second Treatment|Lost to Follow-up|0|||
27889076|NCT03613649|81428177|FG009|Second Treatment|Lost to Follow-up|0|||
27889077|NCT03613649|81428178|FG010|Second Treatment|Lost to Follow-up|0|||
27889078|NCT03613649|81428179|FG011|Second Treatment|Lost to Follow-up|0|||
27889079|NCT03613649|81428168|FG000|Second Treatment|Withdrawal by Subject|0|||
27889080|NCT03613649|81428169|FG001|Second Treatment|Withdrawal by Subject|0|||
27603121|NCT00840801|80388538|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
27708838|NCT00880399|80768801|FG000|Overall Study|Study closed/terminated|3|||
27889081|NCT03613649|81428170|FG002|Second Treatment|Withdrawal by Subject|0|||
27889082|NCT03613649|81428171|FG003|Second Treatment|Withdrawal by Subject|0|||
27603122|NCT00840801|80388539|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
27603123|NCT00840801|80388537|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
27603124|NCT00840801|80388538|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
27603125|NCT00840801|80388539|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
27603126|NCT00840801|80388537|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
27708839|NCT00880399|80768802|FG001|Overall Study|Study closed/terminated|7|||
27708840|NCT00880399|80768803|FG002|Overall Study|Study closed/terminated|4|||
27708841|NCT00880399|80768801|FG000|Overall Study|Lost to Follow-up|8|||
27708842|NCT00880399|80768802|FG001|Overall Study|Lost to Follow-up|5|||
27708843|NCT00880399|80768803|FG002|Overall Study|Lost to Follow-up|3|||
27708844|NCT00880399|80768801|FG000|Overall Study|Physician Decision|5|||
27708845|NCT00880399|80768802|FG001|Overall Study|Physician Decision|0|||
27708846|NCT00880399|80768803|FG002|Overall Study|Physician Decision|3|||
27708847|NCT00880399|80768801|FG000|Overall Study|Withdrawal by Subject|6|||
27708848|NCT00880399|80768802|FG001|Overall Study|Withdrawal by Subject|3|||
27708849|NCT00880399|80768803|FG002|Overall Study|Withdrawal by Subject|3|||
27708850|NCT04544475|80768804|FG000|Overall Study|Withdrawal by Subject|1|||
27708851|NCT04544475|80768805|FG001|Overall Study|Withdrawal by Subject|3|||
27708852|NCT03370120|80768806|FG000|Overall Study|Adverse event, non-fatal|24|||
27708853|NCT03370120|80768806|FG000|Overall Study|Withdrawal by Subject|6|||
27708854|NCT03370120|80768806|FG000|Overall Study|Lost to Follow-up|1|||
27708855|NCT03370120|80768806|FG000|Overall Study|Lack of Efficacy|37|||
27708856|NCT03370120|80768806|FG000|Overall Study|Per sponsor's instructions|1|||
27708857|NCT03370120|80768806|FG000|Overall Study|Study was terminated by parent company UCB|2|||
27708858|NCT03370120|80768806|FG000|Overall Study|The study was ended by the promoter|3|||
27708859|NCT03370120|80768806|FG000|Overall Study|Discontinuation of drug development|3|||
27708860|NCT03370120|80768806|FG000|Overall Study|End of project|2|||
27708861|NCT03370120|80768806|FG000|Overall Study|Premature study closure|2|||
27708862|NCT03370120|80768806|FG000|Overall Study|Premature program termination|1|||
27708863|NCT03370120|80768806|FG000|Overall Study|Premature study termination|7|||
27708864|NCT03370120|80768806|FG000|Overall Study|Trial terminated by sponsor|2|||
27708865|NCT03370120|80768806|FG000|Overall Study|Trial discontinued by sponsor|2|||
27708866|NCT03370120|80768806|FG000|Overall Study|Study ended|15|||
27708867|NCT03370120|80768806|FG000|Overall Study|Clinical trial has been cancelled|1|||
27708868|NCT03370120|80768806|FG000|Overall Study|End of study per sponsor decision|2|||
27708869|NCT03370120|80768806|FG000|Overall Study|Promoter's decision|2|||
27708870|NCT03370120|80768806|FG000|Overall Study|The trial has been suspended|3|||
27708871|NCT03370120|80768806|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
27708872|NCT03370120|80768806|FG000|Overall Study|Early termination by order of sponsor|2|||
27708873|NCT03370120|80768806|FG000|Overall Study|Discontinuation of the study|5|||
27708874|NCT03370120|80768806|FG000|Overall Study|End of clinical trial discontinuation|1|||
27708875|NCT03370120|80768806|FG000|Overall Study|Because the clinical trial ended halfway|4|||
27708876|NCT03370120|80768806|FG000|Overall Study|Development discontinued|5|||
27708877|NCT03370120|80768806|FG000|Overall Study|Padsenovil program closed|3|||
27708878|NCT03370120|80768806|FG000|Overall Study|End of project|2|||
27708879|NCT03370120|80768806|FG000|Overall Study|Termination of project|1|||
27708880|NCT03370120|80768806|FG000|Overall Study|The study was interrupted by sponsor|4|||
27708881|NCT03370120|80768806|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
27708882|NCT03370120|80768806|FG000|Overall Study|End of sponsor decision|1|||
27708883|NCT03370120|80768806|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
27708884|NCT03370120|80768806|FG000|Overall Study|Early termination of studies|5|||
27708885|NCT03370120|80768806|FG000|Overall Study|This study is ended early|1|||
27708886|NCT03370120|80768806|FG000|Overall Study|End of padsevonil program|2|||
27708887|NCT03370120|80768806|FG000|Overall Study|Decision of sponsor|6|||
27708888|NCT03370120|80768806|FG000|Overall Study|Asked by the sponsor|3|||
27708889|NCT03370120|80768806|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
27836108|NCT01726803|81229150|FG001|Overall Study|Lost to Follow-up|1|||
27836109|NCT01726803|81229149|FG000|Overall Study|Withdrawal by Subject|1|||
27603127|NCT00840801|80388538|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
27708890|NCT03370120|80768806|FG000|Overall Study|PI decision poor compliance from participant|1|||
27708891|NCT03370120|80768806|FG000|Overall Study|Promoter ended the study|3|||
27708892|NCT03370120|80768806|FG000|Overall Study|Premature study close by sponsor's decision|4|||
27708893|NCT03370120|80768806|FG000|Overall Study|Study terminated by sponsor|33|||
27708894|NCT03370120|80768806|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
27708895|NCT03370120|80768806|FG000|Overall Study|Sponsor decision to terminate study|63|||
27708896|NCT03370120|80768806|FG000|Overall Study|Program closure|3|||
27708897|NCT03370120|80768806|FG000|Overall Study|Study ended prematurely|1|||
27708898|NCT03370120|80768806|FG000|Overall Study|Study stopped by sponsor|2|||
27708899|NCT03370120|80768806|FG000|Overall Study|Program termination|55|||
27708900|NCT03370120|80768806|FG000|Overall Study|Sponsor decision|62|||
27708901|NCT03370120|80768806|FG000|Overall Study|Sponsor study closure|10|||
27708902|NCT00528021|80768808|FG000|Overall Study|Lack of Efficacy|17|||
27708903|NCT00528021|80768809|FG001|Overall Study|Lack of Efficacy|13|||
27708904|NCT00528021|80768810|FG002|Overall Study|Lack of Efficacy|7|||
27708905|NCT00528021|80768811|FG003|Overall Study|Lack of Efficacy|9|||
27708906|NCT00199836|80768812|FG000|Overall Study|Progressive Disease|5|||
27708907|NCT00199836|80768812|FG000|Overall Study|Death|1|||
27708908|NCT02663453|80768816|FG000|Overall Study|Death|4|||
27889083|NCT03613649|81428172|FG004|Second Treatment|Withdrawal by Subject|1|||
27889084|NCT03613649|81428173|FG005|Second Treatment|Withdrawal by Subject|0|||
27889085|NCT03613649|81428174|FG006|Second Treatment|Withdrawal by Subject|0|||
27889086|NCT03613649|81428175|FG007|Second Treatment|Withdrawal by Subject|0|||
27889087|NCT03613649|81428176|FG008|Second Treatment|Withdrawal by Subject|0|||
27889088|NCT03613649|81428177|FG009|Second Treatment|Withdrawal by Subject|0|||
27889089|NCT03613649|81428178|FG010|Second Treatment|Withdrawal by Subject|0|||
27889090|NCT03613649|81428179|FG011|Second Treatment|Withdrawal by Subject|0|||
27889091|NCT03613649|81428168|FG000|Third Treatment|Lost to Follow-up|0|||
27889092|NCT03613649|81428169|FG001|Third Treatment|Lost to Follow-up|0|||
27889093|NCT03613649|81428170|FG002|Third Treatment|Lost to Follow-up|0|||
27889094|NCT03613649|81428171|FG003|Third Treatment|Lost to Follow-up|0|||
27889095|NCT03613649|81428172|FG004|Third Treatment|Lost to Follow-up|1|||
27889096|NCT03613649|81428173|FG005|Third Treatment|Lost to Follow-up|0|||
27889097|NCT03613649|81428174|FG006|Third Treatment|Lost to Follow-up|0|||
27889098|NCT03613649|81428175|FG007|Third Treatment|Lost to Follow-up|0|||
27889099|NCT03613649|81428176|FG008|Third Treatment|Lost to Follow-up|0|||
27889100|NCT03613649|81428177|FG009|Third Treatment|Lost to Follow-up|0|||
27889101|NCT03613649|81428178|FG010|Third Treatment|Lost to Follow-up|0|||
27889102|NCT03613649|81428179|FG011|Third Treatment|Lost to Follow-up|1|||
27889103|NCT03613649|81428168|FG000|Third Treatment|Protocol Violation|0|||
27889104|NCT03613649|81428169|FG001|Third Treatment|Protocol Violation|0|||
27889105|NCT03613649|81428170|FG002|Third Treatment|Protocol Violation|0|||
27889106|NCT03613649|81428171|FG003|Third Treatment|Protocol Violation|0|||
27889107|NCT03613649|81428172|FG004|Third Treatment|Protocol Violation|0|||
27889108|NCT03613649|81428173|FG005|Third Treatment|Protocol Violation|0|||
27889109|NCT03613649|81428174|FG006|Third Treatment|Protocol Violation|1|||
27889110|NCT03613649|81428175|FG007|Third Treatment|Protocol Violation|0|||
27889111|NCT03613649|81428176|FG008|Third Treatment|Protocol Violation|0|||
27889112|NCT03613649|81428177|FG009|Third Treatment|Protocol Violation|0|||
27889113|NCT03613649|81428178|FG010|Third Treatment|Protocol Violation|0|||
27889114|NCT03613649|81428179|FG011|Third Treatment|Protocol Violation|1|||
27889115|NCT03613649|81428168|FG000|Fourth Treatment|Protocol Violation|1|||
27889116|NCT03613649|81428169|FG001|Fourth Treatment|Protocol Violation|0|||
27889117|NCT03613649|81428170|FG002|Fourth Treatment|Protocol Violation|0|||
27889118|NCT03613649|81428171|FG003|Fourth Treatment|Protocol Violation|0|||
27889119|NCT03613649|81428172|FG004|Fourth Treatment|Protocol Violation|1|||
27889120|NCT03613649|81428173|FG005|Fourth Treatment|Protocol Violation|0|||
27889121|NCT03613649|81428174|FG006|Fourth Treatment|Protocol Violation|0|||
27889122|NCT03613649|81428175|FG007|Fourth Treatment|Protocol Violation|0|||
27889123|NCT03613649|81428176|FG008|Fourth Treatment|Protocol Violation|0|||
27889124|NCT03613649|81428177|FG009|Fourth Treatment|Protocol Violation|0|||
27889125|NCT03613649|81428178|FG010|Fourth Treatment|Protocol Violation|0|||
27889126|NCT03613649|81428179|FG011|Fourth Treatment|Protocol Violation|0|||
27889127|NCT03613649|81428168|FG000|Fourth Treatment|Physician Decision|0|||
27889128|NCT03613649|81428169|FG001|Fourth Treatment|Physician Decision|0|||
27889129|NCT03613649|81428170|FG002|Fourth Treatment|Physician Decision|0|||
27889130|NCT03613649|81428171|FG003|Fourth Treatment|Physician Decision|0|||
27708909|NCT02663453|80768817|FG001|Overall Study|Death|4|||
27708910|NCT02663453|80768816|FG000|Overall Study|Withdrawal by Subject|1|||
27708911|NCT02663453|80768817|FG001|Overall Study|Withdrawal by Subject|0|||
27708912|NCT01003210|80768818|FG000|Overall Study|Lost to Follow-up|1|||
27708913|NCT01003210|80768819|FG001|Overall Study|Lost to Follow-up|3|||
27708914|NCT00219284|80768820|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
27889131|NCT03613649|81428172|FG004|Fourth Treatment|Physician Decision|0|||
27889132|NCT03613649|81428173|FG005|Fourth Treatment|Physician Decision|0|||
27889133|NCT03613649|81428174|FG006|Fourth Treatment|Physician Decision|1|||
27889134|NCT03613649|81428175|FG007|Fourth Treatment|Physician Decision|0|||
27889135|NCT03613649|81428176|FG008|Fourth Treatment|Physician Decision|0|||
27889136|NCT03613649|81428177|FG009|Fourth Treatment|Physician Decision|0|||
27889137|NCT03613649|81428178|FG010|Fourth Treatment|Physician Decision|0|||
27708915|NCT00219284|80768821|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
27708916|NCT00219284|80768820|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
27708917|NCT00219284|80768821|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
27708918|NCT00219284|80768820|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
27708919|NCT00219284|80768821|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
27708920|NCT00219284|80768820|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
27708921|NCT00219284|80768821|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
27708922|NCT00219284|80768820|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
27708923|NCT00219284|80768821|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
27708924|NCT00219284|80768820|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
27708925|NCT00219284|80768821|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
27708926|NCT00219284|80768820|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
27708927|NCT00219284|80768821|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
27708928|NCT00219284|80768820|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
27708929|NCT00219284|80768821|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
27708930|NCT00219284|80768820|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
27708931|NCT00219284|80768821|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
27708932|NCT01840579|80768822|FG000|Overall Study|Status not recorded|0|||
27708933|NCT01840579|80768823|FG001|Overall Study|Status not recorded|0|||
27708934|NCT01840579|80768824|FG002|Overall Study|Status not recorded|2|||
27708935|NCT01840579|80768825|FG003|Overall Study|Status not recorded|3|||
27708936|NCT01840579|80768826|FG004|Overall Study|Status not recorded|4|||
27708937|NCT01840579|80768827|FG005|Overall Study|Status not recorded|3|||
27708938|NCT01840579|80768828|FG006|Overall Study|Status not recorded|0|||
27708939|NCT01840579|80768829|FG007|Overall Study|Status not recorded|3|||
27708940|NCT01840579|80768830|FG008|Overall Study|Status not recorded|3|||
27708941|NCT01840579|80768831|FG009|Overall Study|Status not recorded|3|||
27708942|NCT01840579|80768822|FG000|Overall Study|Progressive disease|3|||
27708943|NCT01840579|80768823|FG001|Overall Study|Progressive disease|5|||
27708944|NCT01840579|80768824|FG002|Overall Study|Progressive disease|0|||
27708945|NCT01840579|80768825|FG003|Overall Study|Progressive disease|0|||
27708946|NCT01840579|80768826|FG004|Overall Study|Progressive disease|0|||
27708947|NCT01840579|80768827|FG005|Overall Study|Progressive disease|0|||
27708948|NCT01840579|80768828|FG006|Overall Study|Progressive disease|0|||
27708949|NCT01840579|80768829|FG007|Overall Study|Progressive disease|0|||
27708950|NCT01840579|80768830|FG008|Overall Study|Progressive disease|0|||
27708951|NCT01840579|80768831|FG009|Overall Study|Progressive disease|0|||
27708952|NCT01840579|80768822|FG000|Overall Study|Ongoing in study|0|||
27708953|NCT01840579|80768823|FG001|Overall Study|Ongoing in study|1|||
27708954|NCT01840579|80768824|FG002|Overall Study|Ongoing in study|0|||
27708955|NCT01840579|80768825|FG003|Overall Study|Ongoing in study|0|||
27708956|NCT01840579|80768826|FG004|Overall Study|Ongoing in study|0|||
27708957|NCT01840579|80768827|FG005|Overall Study|Ongoing in study|0|||
27708958|NCT01840579|80768828|FG006|Overall Study|Ongoing in study|0|||
27708959|NCT01840579|80768829|FG007|Overall Study|Ongoing in study|0|||
27708960|NCT01840579|80768830|FG008|Overall Study|Ongoing in study|0|||
27708961|NCT01840579|80768831|FG009|Overall Study|Ongoing in study|0|||
27708962|NCT01840579|80768822|FG000|Overall Study|Death|0|||
27708963|NCT01840579|80768823|FG001|Overall Study|Death|0|||
27708964|NCT01840579|80768824|FG002|Overall Study|Death|0|||
27708965|NCT01840579|80768825|FG003|Overall Study|Death|0|||
27708966|NCT01840579|80768826|FG004|Overall Study|Death|0|||
27708967|NCT01840579|80768827|FG005|Overall Study|Death|1|||
27708968|NCT01840579|80768828|FG006|Overall Study|Death|0|||
27708969|NCT01840579|80768829|FG007|Overall Study|Death|0|||
27708970|NCT01840579|80768830|FG008|Overall Study|Death|0|||
27836110|NCT01726803|81229150|FG001|Overall Study|Withdrawal by Subject|0|||
27708971|NCT01840579|80768831|FG009|Overall Study|Death|0|||
27708972|NCT01840579|80768822|FG000|Overall Study|Adverse Event|0|||
27708973|NCT01840579|80768823|FG001|Overall Study|Adverse Event|1|||
27708974|NCT01840579|80768824|FG002|Overall Study|Adverse Event|0|||
27708975|NCT01840579|80768825|FG003|Overall Study|Adverse Event|0|||
27708976|NCT01840579|80768826|FG004|Overall Study|Adverse Event|0|||
27836111|NCT03541252|81229151|FG000|Overall Study|Withdrawal by Subject|1|||
27708977|NCT01840579|80768827|FG005|Overall Study|Adverse Event|0|||
27708978|NCT01840579|80768828|FG006|Overall Study|Adverse Event|0|||
27708979|NCT01840579|80768829|FG007|Overall Study|Adverse Event|0|||
27708980|NCT01840579|80768830|FG008|Overall Study|Adverse Event|0|||
27708981|NCT01840579|80768831|FG009|Overall Study|Adverse Event|0|||
27708982|NCT01840579|80768822|FG000|Overall Study|Follow-up ended by Sponsor|0|||
27708983|NCT01840579|80768823|FG001|Overall Study|Follow-up ended by Sponsor|0|||
27708984|NCT01840579|80768824|FG002|Overall Study|Follow-up ended by Sponsor|0|||
27708985|NCT01840579|80768825|FG003|Overall Study|Follow-up ended by Sponsor|0|||
27708986|NCT01840579|80768826|FG004|Overall Study|Follow-up ended by Sponsor|0|||
27708987|NCT01840579|80768827|FG005|Overall Study|Follow-up ended by Sponsor|0|||
27708988|NCT01840579|80768828|FG006|Overall Study|Follow-up ended by Sponsor|2|||
27708989|NCT01840579|80768829|FG007|Overall Study|Follow-up ended by Sponsor|0|||
27708990|NCT01840579|80768830|FG008|Overall Study|Follow-up ended by Sponsor|0|||
27889138|NCT03613649|81428179|FG011|Fourth Treatment|Physician Decision|0|||
27889139|NCT00102531|81428182|FG000|Overall Study|Adverse Event|0|||
27889140|NCT00102531|81428183|FG001|Overall Study|Adverse Event|1|||
27708991|NCT01840579|80768831|FG009|Overall Study|Follow-up ended by Sponsor|0|||
27708992|NCT05376215|80768832|FG000|Overall Study|Withdrawal by Subject|2|||
27708993|NCT05376215|80768833|FG001|Overall Study|Withdrawal by Subject|1|||
27708994|NCT05376215|80768832|FG000|Overall Study|Lost to Follow-up|0|||
27708995|NCT05376215|80768833|FG001|Overall Study|Lost to Follow-up|1|||
27708996|NCT01056510|80771453|FG000|Overall Study|Dropout Before Start of Treatment|1|||
27708997|NCT01056510|80771454|FG001|Overall Study|Dropout Before Start of Treatment|1|||
27708998|NCT01056510|80771453|FG000|Overall Study|Withdrawal by Subject|4|||
27708999|NCT01056510|80771454|FG001|Overall Study|Withdrawal by Subject|2|||
27709000|NCT01056510|80771453|FG000|Overall Study|Death|29|||
27709001|NCT01056510|80771454|FG001|Overall Study|Death|34|||
27709002|NCT01056510|80771453|FG000|Overall Study|Noncompliance|1|||
27709003|NCT01056510|80771454|FG001|Overall Study|Noncompliance|3|||
27709004|NCT01056510|80771453|FG000|Overall Study|Physician Decision|4|||
27709005|NCT01056510|80771454|FG001|Overall Study|Physician Decision|5|||
27709006|NCT01056510|80771453|FG000|Overall Study|Lost to Follow-up|5|||
27709007|NCT01056510|80771454|FG001|Overall Study|Lost to Follow-up|6|||
27709008|NCT01056510|80771453|FG000|Overall Study|Other|10|||
27709009|NCT01056510|80771454|FG001|Overall Study|Other|12|||
27709010|NCT01056510|80771453|FG000|Overall Study|Missing|0|||
27709011|NCT01056510|80771454|FG001|Overall Study|Missing|1|||
27709012|NCT01543152|80771459|FG000|Overall Study|Withdrawal by Subject|0|||
27709013|NCT01543152|80771460|FG001|Overall Study|Withdrawal by Subject|2|||
27709014|NCT01543152|80771461|FG002|Overall Study|Withdrawal by Subject|0|||
27709015|NCT01543152|80771462|FG003|Overall Study|Withdrawal by Subject|0|||
27709016|NCT01543152|80771463|FG004|Overall Study|Withdrawal by Subject|0|||
27709017|NCT02665052|80771464|FG000|Overall Study|Lost to Follow-up|1|||
27709018|NCT02665052|80771465|FG001|Overall Study|Lost to Follow-up|0|||
27709019|NCT02665052|80771466|FG002|Overall Study|Lost to Follow-up|0|||
27709020|NCT02665052|80771467|FG003|Overall Study|Lost to Follow-up|0|||
27709021|NCT02665052|80771464|FG000|Overall Study|Withdrawal by Subject|1|||
27709022|NCT02665052|80771465|FG001|Overall Study|Withdrawal by Subject|1|||
27709023|NCT02665052|80771466|FG002|Overall Study|Withdrawal by Subject|0|||
27709024|NCT02665052|80771467|FG003|Overall Study|Withdrawal by Subject|5|||
27709025|NCT02665052|80771464|FG000|Overall Study|Adverse Event|1|||
27709026|NCT02665052|80771465|FG001|Overall Study|Adverse Event|1|||
27709027|NCT02665052|80771466|FG002|Overall Study|Adverse Event|0|||
27709028|NCT02665052|80771467|FG003|Overall Study|Adverse Event|0|||
27709029|NCT02142738|80771468|FG000|Overall Study|Adverse Event|13|||
27709030|NCT02142738|80771469|FG001|Overall Study|Adverse Event|9|||
27709031|NCT02142738|80771468|FG000|Overall Study|Death|92|||
27709032|NCT02142738|80771469|FG001|Overall Study|Death|112|||
27709033|NCT02142738|80771468|FG000|Overall Study|Lost to Follow-up|0|||
27709034|NCT02142738|80771469|FG001|Overall Study|Lost to Follow-up|3|||
27709035|NCT02142738|80771468|FG000|Overall Study|Withdrawal by Subject|6|||
27709036|NCT02142738|80771469|FG001|Overall Study|Withdrawal by Subject|7|||
27709037|NCT02142738|80771468|FG000|Overall Study|Follow up ended by sponsor|43|||
27709038|NCT02142738|80771469|FG001|Overall Study|Follow up ended by sponsor|20|||
27709039|NCT01858532|80771470|FG000|Overall Study|Adverse Event|58|||
27709040|NCT01858532|80771471|FG001|Overall Study|Adverse Event|50|||
27709041|NCT01858532|80771472|FG002|Overall Study|Adverse Event|23|||
27709042|NCT01858532|80771473|FG003|Overall Study|Adverse Event|28|||
27709043|NCT01858532|80771470|FG000|Overall Study|Withdrew consent|71|||
27709044|NCT01858532|80771471|FG001|Overall Study|Withdrew consent|93|||
27709045|NCT01858532|80771472|FG002|Overall Study|Withdrew consent|46|||
27709046|NCT01858532|80771473|FG003|Overall Study|Withdrew consent|27|||
27889141|NCT00102531|81428182|FG000|Overall Study|Disease Progression|5|||
27889142|NCT00102531|81428183|FG001|Overall Study|Disease Progression|9|||
27889143|NCT00102531|81428182|FG000|Overall Study|Physician Decision|0|||
27889144|NCT00102531|81428183|FG001|Overall Study|Physician Decision|1|||
27709047|NCT01858532|80771470|FG000|Overall Study|Lost to Follow-up|17|||
27709048|NCT01858532|80771471|FG001|Overall Study|Lost to Follow-up|26|||
27709049|NCT01858532|80771472|FG002|Overall Study|Lost to Follow-up|11|||
27709050|NCT01858532|80771473|FG003|Overall Study|Lost to Follow-up|14|||
27709051|NCT01858532|80771470|FG000|Overall Study|Deterioration of medical status|3|||
27709052|NCT01858532|80771471|FG001|Overall Study|Deterioration of medical status|4|||
27709053|NCT01858532|80771472|FG002|Overall Study|Deterioration of medical status|3|||
27709054|NCT01858532|80771473|FG003|Overall Study|Deterioration of medical status|7|||
27709055|NCT01858532|80771470|FG000|Overall Study|Investigator request|3|||
27709056|NCT01858532|80771471|FG001|Overall Study|Investigator request|4|||
27709057|NCT01858532|80771472|FG002|Overall Study|Investigator request|2|||
27709058|NCT01858532|80771473|FG003|Overall Study|Investigator request|6|||
27709059|NCT01858532|80771470|FG000|Overall Study|Other, not specified|29|||
27709060|NCT01858532|80771471|FG001|Overall Study|Other, not specified|15|||
27709061|NCT01858532|80771472|FG002|Overall Study|Other, not specified|13|||
27709062|NCT01858532|80771473|FG003|Overall Study|Other, not specified|11|||
27709063|NCT01365039|80771476|FG000|Overall Study|Study related symptoms and complaints|1|||
27709064|NCT01365039|80771477|FG001|Overall Study|Study related symptoms and complaints|0|||
27709065|NCT00427349|80771478|FG000|Overall Study|Lack of Efficacy|23|||
27709066|NCT00427349|80771478|FG000|Overall Study|Adverse Event|14|||
27709067|NCT00427349|80771478|FG000|Overall Study|Death|1|||
27709068|NCT00427349|80771478|FG000|Overall Study|Withdrawal by Subject|3|||
27709069|NCT00427349|80771478|FG000|Overall Study|Alternative therapy|1|||
27709070|NCT00427349|80771478|FG000|Overall Study|Other|2|||
27709071|NCT00427349|80771478|FG000|Overall Study|Ineligible|1|||
27709072|NCT00427349|80771478|FG000|Overall Study|Never started therapy|1|||
27709073|NCT03198520|80771479|FG000|Overall Study|Physician Decision|2|||
27709074|NCT03198520|80771479|FG000|Overall Study|Protocol Violation|2|||
27709075|NCT03198520|80771479|FG000|Overall Study|Withdrawal by Subject|1|||
27709076|NCT03198520|80771479|FG000|Overall Study|Study Ended|1|||
27709077|NCT03700320|80771480|FG000|Overall Study|Adverse Event|5|||
27709078|NCT03700320|80771481|FG001|Overall Study|Adverse Event|31|||
27709079|NCT03700320|80771480|FG000|Overall Study|Lack of Efficacy|2|||
27709080|NCT03700320|80771481|FG001|Overall Study|Lack of Efficacy|5|||
27709081|NCT03700320|80771480|FG000|Overall Study|Withdrawal by Subject|29|||
27709082|NCT03700320|80771481|FG001|Overall Study|Withdrawal by Subject|75|||
27709083|NCT03700320|80771480|FG000|Overall Study|Lost to Follow-up|16|||
27709084|NCT03700320|80771481|FG001|Overall Study|Lost to Follow-up|23|||
27709085|NCT03700320|80771480|FG000|Overall Study|Pregnancy|2|||
27709086|NCT03700320|80771481|FG001|Overall Study|Pregnancy|4|||
27709087|NCT03700320|80771480|FG000|Overall Study|Protocol Deviation|7|||
27709088|NCT03700320|80771481|FG001|Overall Study|Protocol Deviation|31|||
27709089|NCT03700320|80771480|FG000|Overall Study|Non-compliance with Study Drug|1|||
27709090|NCT03700320|80771481|FG001|Overall Study|Non-compliance with Study Drug|3|||
27709091|NCT03700320|80771480|FG000|Overall Study|Reason not Specified|0|||
27709092|NCT03700320|80771481|FG001|Overall Study|Reason not Specified|1|||
27709093|NCT01924182|80771486|FG000|Overall Study|Withdrawal by Subject|1|||
27709094|NCT01924182|80771487|FG001|Overall Study|Withdrawal by Subject|0|||
27709095|NCT04194528|80771491|FG000|Overall Study|Adverse Event|1|||
27709096|NCT04770389|80771492|FG000|Overall Study|Adverse Event|1|||
27709097|NCT04770389|80771493|FG001|Overall Study|Adverse Event|2|||
27709098|NCT04770389|80771494|FG002|Overall Study|Adverse Event|0|||
27709099|NCT04770389|80771495|FG003|Overall Study|Adverse Event|1|||
27709100|NCT04770389|80771492|FG000|Overall Study|Withdrawal by Subject|0|||
27709101|NCT04770389|80771493|FG001|Overall Study|Withdrawal by Subject|2|||
27709102|NCT04770389|80771494|FG002|Overall Study|Withdrawal by Subject|1|||
27709103|NCT04770389|80771495|FG003|Overall Study|Withdrawal by Subject|0|||
27709104|NCT04770389|80771492|FG000|Overall Study|Failed attempt to draw blood|1|||
27709105|NCT04770389|80771493|FG001|Overall Study|Failed attempt to draw blood|0|||
27709106|NCT04770389|80771494|FG002|Overall Study|Failed attempt to draw blood|0|||
27709107|NCT04770389|80771495|FG003|Overall Study|Failed attempt to draw blood|0|||
27709108|NCT04770389|80771492|FG000|Overall Study|Left the country|0|||
27709109|NCT04770389|80771493|FG001|Overall Study|Left the country|0|||
27709110|NCT04770389|80771494|FG002|Overall Study|Left the country|1|||
27709111|NCT04770389|80771495|FG003|Overall Study|Left the country|2|||
27709112|NCT04770389|80771492|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
27709113|NCT04770389|80771493|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
27709114|NCT04770389|80771494|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
27709115|NCT04770389|80771495|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
27709116|NCT04770389|80771492|FG000|Overall Study|Lost to Follow-up|0|||
27709117|NCT04770389|80771493|FG001|Overall Study|Lost to Follow-up|0|||
27709118|NCT04770389|80771494|FG002|Overall Study|Lost to Follow-up|0|||
27709119|NCT04770389|80771495|FG003|Overall Study|Lost to Follow-up|1|||
27709120|NCT04770389|80771492|FG000|Overall Study|Moved away from study site|0|||
27709121|NCT04770389|80771493|FG001|Overall Study|Moved away from study site|1|||
27709122|NCT04770389|80771494|FG002|Overall Study|Moved away from study site|0|||
27709123|NCT04770389|80771495|FG003|Overall Study|Moved away from study site|0|||
27709124|NCT00715026|80771500|FG000|Overall Study|Withdrawal by Subject|5|||
27709125|NCT00715026|80771500|FG000|Overall Study|Lost to Follow-up|3|||
27709126|NCT00715026|80771500|FG000|Overall Study|Protocol Violation|1|||
27709127|NCT00715026|80771500|FG000|Overall Study|Surgery done on non-study consented hip|1|||
27709128|NCT03061175|80771501|FG000|Baseline|Participant was deemed ineligible|1|||
27709129|NCT03061175|80771502|FG001|Baseline|Participant was deemed ineligible|0|||
27709130|NCT03061175|80771501|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
27709131|NCT03061175|80771502|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
27709132|NCT03061175|80771501|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
27709133|NCT03061175|80771502|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
27709134|NCT03061175|80771501|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
27709135|NCT03061175|80771502|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
27709136|NCT04143009|80771503|FG000|Pilot Trial|Lost to Follow-up|0|||
27709137|NCT04143009|80771504|FG001|Pilot Trial|Lost to Follow-up|1|||
27709138|NCT04143009|80771505|FG002|Pilot Trial|Lost to Follow-up|1|||
27709139|NCT02953639|80771506|FG000|Overall Study|Adverse Event|2|||
27709140|NCT02953639|80771507|FG001|Overall Study|Adverse Event|0|||
27709141|NCT02953639|80771508|FG002|Overall Study|Adverse Event|1|||
27709142|NCT02953639|80771506|FG000|Overall Study|Lost to Follow-up|8|||
27709143|NCT02953639|80771507|FG001|Overall Study|Lost to Follow-up|4|||
27709144|NCT02953639|80771508|FG002|Overall Study|Lost to Follow-up|3|||
27709145|NCT02953639|80771506|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27709146|NCT02953639|80771507|FG001|Overall Study|Non-Compliance With Study Drug|2|||
27709147|NCT02953639|80771508|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27709148|NCT02953639|80771506|FG000|Overall Study|Multiple Reasons|1|||
27709149|NCT02953639|80771507|FG001|Overall Study|Multiple Reasons|0|||
27709150|NCT02953639|80771508|FG002|Overall Study|Multiple Reasons|1|||
27709151|NCT02953639|80771506|FG000|Overall Study|Physician Decision|1|||
27709152|NCT02953639|80771507|FG001|Overall Study|Physician Decision|0|||
27709153|NCT02953639|80771508|FG002|Overall Study|Physician Decision|0|||
27709154|NCT02953639|80771506|FG000|Overall Study|Withdrawal by Subject|7|||
27709155|NCT02953639|80771507|FG001|Overall Study|Withdrawal by Subject|8|||
27709156|NCT02953639|80771508|FG002|Overall Study|Withdrawal by Subject|10|||
27709157|NCT02953639|80771506|FG000|Overall Study|Completed or Discontinued information is missing|1|||
27709158|NCT02953639|80771507|FG001|Overall Study|Completed or Discontinued information is missing|0|||
27709159|NCT02953639|80771508|FG002|Overall Study|Completed or Discontinued information is missing|0|||
27709160|NCT03631784|80771509|FG000|Overall Study|Death|48|||
27709161|NCT03631784|80771510|FG001|Overall Study|Death|28|||
27709162|NCT03631784|80771509|FG000|Overall Study|Lost to Follow-up|1|||
27709163|NCT03631784|80771510|FG001|Overall Study|Lost to Follow-up|0|||
27709164|NCT03631784|80771509|FG000|Overall Study|Withdrawal by Subject|0|||
27709165|NCT03631784|80771510|FG001|Overall Study|Withdrawal by Subject|3|||
27709166|NCT03631784|80771509|FG000|Overall Study|Participants Ongoing|63|||
27709167|NCT03631784|80771510|FG001|Overall Study|Participants Ongoing|71|||
27709168|NCT02969187|80771511|FG000|Overall Study|Physician Decision|12|||
27709169|NCT02969187|80771512|FG001|Overall Study|Physician Decision|13|||
27709170|NCT01967628|80771513|FG000|Overall Study|Withdrawal by Subject|2|||
27709171|NCT01967628|80771514|FG001|Overall Study|Withdrawal by Subject|0|||
27709172|NCT01967628|80771513|FG000|Overall Study|Unable to complete bronchoscopy|4|||
27709173|NCT01967628|80771514|FG001|Overall Study|Unable to complete bronchoscopy|6|||
27709174|NCT01967628|80771513|FG000|Overall Study|Lost to Follow-up|1|||
27709175|NCT01967628|80771514|FG001|Overall Study|Lost to Follow-up|0|||
27709176|NCT01967628|80771513|FG000|Overall Study|Low protein concentration in sample|20|||
27709177|NCT01967628|80771514|FG001|Overall Study|Low protein concentration in sample|25|||
27709178|NCT02625233|80771515|FG000|Overall Study|Adverse Event|2|||
27709179|NCT02625233|80771516|FG001|Overall Study|Adverse Event|0|||
27709180|NCT01087775|80771517|FG000|Overall Study|failed inclusion criteria|2|||
27709181|NCT00645593|80771518|FG000|Overall Study|Later found to be ineligible|1|||
27709182|NCT00645593|80771519|FG001|Overall Study|Later found to be ineligible|0|||
27709183|NCT00912028|80771520|FG000|Overall Study|Lost to Follow-up|2|||
27709184|NCT00912028|80771521|FG001|Overall Study|Lost to Follow-up|3|||
27709185|NCT00912028|80771522|FG002|Overall Study|Lost to Follow-up|0|||
27709186|NCT00912028|80771523|FG003|Overall Study|Lost to Follow-up|1|||
27709187|NCT00912028|80771524|FG004|Overall Study|Lost to Follow-up|3|||
27836112|NCT03366792|81229155|FG000|Overall Study|Withdrawal by Subject|7|||
27836113|NCT03366792|81229155|FG000|Overall Study|Lost to Follow-up|2|||
27836114|NCT03366792|81229155|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
27709188|NCT00912028|80771520|FG000|Overall Study|Withdrawal by Subject|3|||
27709189|NCT00912028|80771521|FG001|Overall Study|Withdrawal by Subject|0|||
27709190|NCT00912028|80771522|FG002|Overall Study|Withdrawal by Subject|0|||
27709191|NCT00912028|80771523|FG003|Overall Study|Withdrawal by Subject|0|||
27709192|NCT00912028|80771524|FG004|Overall Study|Withdrawal by Subject|0|||
27709193|NCT03891264|80771526|FG000|Overall Study|Adverse Event|1|||
27836115|NCT03366792|81229155|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
27709194|NCT03891264|80771526|FG000|Overall Study|Withdrawal by Subject|2|||
27709195|NCT03891264|80771526|FG000|Overall Study|Physician Decision|2|||
27709196|NCT01617070|80771531|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
27709197|NCT04869345|80771535|FG000|Overall Study|Lost to Follow-up|8|||
27709198|NCT04869345|80771536|FG001|Overall Study|Lost to Follow-up|3|||
27709199|NCT01471015|80771541|FG000|Overall Study|Death|0|||
27709200|NCT01471015|80771542|FG001|Overall Study|Death|1|||
27709201|NCT01471015|80771543|FG002|Overall Study|Death|1|||
27709202|NCT02737852|80771544|FG000|Overall Study|Withdrawal by Subject|2|||
27709203|NCT03719690|80771545|FG000|Overall Study|Withdrawal by Subject|5|||
27709204|NCT03719690|80771546|FG001|Overall Study|Withdrawal by Subject|10|||
27709205|NCT03719690|80771545|FG000|Overall Study|Death|40|||
27709206|NCT03719690|80771546|FG001|Overall Study|Death|149|||
27709207|NCT03719690|80771545|FG000|Overall Study|Miscellaneous|12|||
27709208|NCT03719690|80771546|FG001|Overall Study|Miscellaneous|56|||
27709209|NCT03719690|80771545|FG000|Overall Study|Lost to Follow-up|2|||
27709210|NCT03719690|80771546|FG001|Overall Study|Lost to Follow-up|18|||
27709211|NCT03719690|80771545|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
27709212|NCT03719690|80771546|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
27709213|NCT02687542|80771547|FG000|Overall Study|Medication error without associated AEs|0|||
27709214|NCT02687542|80771548|FG001|Overall Study|Medication error without associated AEs|0|||
27709215|NCT02687542|80771549|FG002|Overall Study|Medication error without associated AEs|0|||
27709216|NCT02687542|80771550|FG003|Overall Study|Medication error without associated AEs|0|||
27709217|NCT02687542|80771551|FG004|Overall Study|Medication error without associated AEs|1|||
27709218|NCT02687542|80771547|FG000|Overall Study|Lost to Follow-up|0|||
27709219|NCT02687542|80771548|FG001|Overall Study|Lost to Follow-up|0|||
27709220|NCT02687542|80771549|FG002|Overall Study|Lost to Follow-up|0|||
27709221|NCT02687542|80771550|FG003|Overall Study|Lost to Follow-up|0|||
27709222|NCT02687542|80771551|FG004|Overall Study|Lost to Follow-up|1|||
27709223|NCT02687542|80771547|FG000|Overall Study|Protocol Violation|0|||
27709224|NCT02687542|80771548|FG001|Overall Study|Protocol Violation|1|||
27709225|NCT02687542|80771549|FG002|Overall Study|Protocol Violation|0|||
27709226|NCT02687542|80771550|FG003|Overall Study|Protocol Violation|0|||
27709227|NCT02687542|80771551|FG004|Overall Study|Protocol Violation|0|||
27709228|NCT02687542|80771547|FG000|Overall Study|Other|5|||
27709229|NCT02687542|80771548|FG001|Overall Study|Other|9|||
27709230|NCT02687542|80771549|FG002|Overall Study|Other|10|||
27709231|NCT02687542|80771550|FG003|Overall Study|Other|6|||
27709232|NCT02687542|80771551|FG004|Overall Study|Other|5|||
27709233|NCT02687542|80771547|FG000|Overall Study|Adverse Event|3|||
27709234|NCT02687542|80771548|FG001|Overall Study|Adverse Event|1|||
27709235|NCT02687542|80771549|FG002|Overall Study|Adverse Event|3|||
27709236|NCT02687542|80771550|FG003|Overall Study|Adverse Event|2|||
27709237|NCT02687542|80771551|FG004|Overall Study|Adverse Event|9|||
27709238|NCT02687542|80771547|FG000|Overall Study|Withdrawal by Subject|0|||
27709239|NCT02687542|80771548|FG001|Overall Study|Withdrawal by Subject|1|||
27709240|NCT02687542|80771549|FG002|Overall Study|Withdrawal by Subject|1|||
27709241|NCT02687542|80771550|FG003|Overall Study|Withdrawal by Subject|2|||
27709242|NCT02687542|80771551|FG004|Overall Study|Withdrawal by Subject|4|||
27709243|NCT01075412|80771552|FG000|Overall Study|Withdrawal by Subject|0|||
27709244|NCT01075412|80771553|FG001|Overall Study|Withdrawal by Subject|1|||
27709245|NCT01054144|80771554|FG000|Overall Study|Death|2|||
27709246|NCT01274715|80771555|FG000|Overall Study|Lost to Follow-up|1|||
27709247|NCT01274715|80771555|FG000|Overall Study|After consent, met exclusion criteria.|1|||
27709248|NCT01274715|80771555|FG000|Overall Study|After consent, met exclusion criteria.|1|||
27709249|NCT01274715|80771555|FG000|Overall Study|After consent, met exclusion criteria.|1|||
27709250|NCT01430455|80771556|FG000|Overall Study|Withdrawal by Subject|1|||
27709251|NCT01430455|80771556|FG000|Overall Study|Switched to follow-up phase|1|||
27709252|NCT04329702|80771557|FG000|Overall Study|illness|3|||
27709253|NCT04329702|80771558|FG001|Overall Study|illness|4|||
27709254|NCT04329702|80771559|FG002|Overall Study|illness|0|||
27709255|NCT04329702|80771557|FG000|Overall Study|Lost to Follow-up|0|||
27709256|NCT04329702|80771558|FG001|Overall Study|Lost to Follow-up|0|||
27709257|NCT04329702|80771559|FG002|Overall Study|Lost to Follow-up|2|||
27709258|NCT04329702|80771557|FG000|Overall Study|Death|0|||
27709259|NCT04329702|80771558|FG001|Overall Study|Death|2|||
27709260|NCT04329702|80771559|FG002|Overall Study|Death|0|||
27709261|NCT02347098|80771564|FG000|Overall Study|Death|1|||
27709262|NCT02347098|80771565|FG001|Overall Study|Death|0|||
27709263|NCT02347098|80771564|FG000|Overall Study|Withdrawal by Subject|1|||
27709264|NCT02347098|80771565|FG001|Overall Study|Withdrawal by Subject|0|||
27709265|NCT02347098|80771564|FG000|Overall Study|Lost to Follow-up|2|||
27709266|NCT02347098|80771565|FG001|Overall Study|Lost to Follow-up|2|||
27709267|NCT02347098|80771564|FG000|Overall Study|Refuse Follow-up Visit|1|||
27709268|NCT02347098|80771565|FG001|Overall Study|Refuse Follow-up Visit|5|||
27709269|NCT02347098|80771564|FG000|Overall Study|no visit due to illness|2|||
27709270|NCT02347098|80771565|FG001|Overall Study|no visit due to illness|1|||
27709271|NCT01835015|80771566|FG000|Overall Study|Adverse Event|0|||
27709272|NCT01835015|80771567|FG001|Overall Study|Adverse Event|0|||
27709273|NCT01835015|80771568|FG002|Overall Study|Adverse Event|1|||
27709274|NCT01835015|80771569|FG003|Overall Study|Adverse Event|0|||
27709275|NCT01835015|80771570|FG004|Overall Study|Adverse Event|0|||
27709276|NCT02234284|80771571|FG000|Overall Study|Death|4|||
27709277|NCT02234284|80771572|FG001|Overall Study|Death|2|||
27709278|NCT02234284|80771571|FG000|Overall Study|Withdrawal by Subject|1|||
27709279|NCT02234284|80771572|FG001|Overall Study|Withdrawal by Subject|0|||
27709280|NCT02234284|80771571|FG000|Overall Study|Lost to Follow-up|20|||
27709281|NCT02234284|80771572|FG001|Overall Study|Lost to Follow-up|7|||
27709282|NCT02374099|80771579|FG000|Overall Study|Adverse Event|1|||
27709283|NCT02374099|80771580|FG001|Overall Study|Adverse Event|0|||
27709284|NCT02374099|80771579|FG000|Overall Study|Progressive Disease|35|||
27709285|NCT02374099|80771580|FG001|Overall Study|Progressive Disease|40|||
27709286|NCT02374099|80771579|FG000|Overall Study|Withdrawal by Subject|5|||
27709287|NCT02374099|80771580|FG001|Overall Study|Withdrawal by Subject|1|||
27709288|NCT02374099|80771579|FG000|Overall Study|Miscellaneous|2|||
27709289|NCT02374099|80771580|FG001|Overall Study|Miscellaneous|3|||
27709290|NCT02374099|80771579|FG000|Overall Study|Randomized, but not treated|2|||
27709291|NCT02374099|80771580|FG001|Overall Study|Randomized, but not treated|1|||
27709292|NCT02374099|80771579|FG000|Overall Study|Study Terminated by Sponsor|3|||
27709293|NCT02374099|80771580|FG001|Overall Study|Study Terminated by Sponsor|4|||
27709294|NCT03610724|80771584|FG000|Overall Study|Death|17|||
27709295|NCT03610724|80771584|FG000|Overall Study|Lost to Follow-up|1|||
27709296|NCT03610724|80771584|FG000|Overall Study|Physician Decision|1|||
27709297|NCT03610724|80771584|FG000|Overall Study|Died prior to infusion|1|||
27709298|NCT00800436|80771585|FG000|Overall Study|Withdrawal by Subject|0|||
27709299|NCT00800436|80771586|FG001|Overall Study|Withdrawal by Subject|0|||
27709300|NCT00800436|80771587|FG002|Overall Study|Withdrawal by Subject|1|||
27709301|NCT00800436|80771588|FG003|Overall Study|Withdrawal by Subject|1|||
27709302|NCT00800436|80771589|FG004|Overall Study|Withdrawal by Subject|0|||
27709303|NCT00800436|80771590|FG005|Overall Study|Withdrawal by Subject|0|||
27709304|NCT00800436|80771591|FG006|Overall Study|Withdrawal by Subject|0|||
27709305|NCT02713542|80771592|FG000|Overall Study|Use of prohibited medication|14|||
27709306|NCT02713542|80771593|FG001|Overall Study|Use of prohibited medication|5|||
27709307|NCT02713542|80771592|FG000|Overall Study|Withdrawal by Subject|4|||
27709308|NCT02713542|80771593|FG001|Overall Study|Withdrawal by Subject|1|||
27836116|NCT01490190|81229156|FG000|Overall Study|Withdrawal by Subject|9|||
27709309|NCT03593850|80771594|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
27709310|NCT03593850|80771595|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
27709311|NCT03418129|80771596|FG000|Overall Study|Lost to Follow-up|11|||
27709312|NCT03418129|80771597|FG001|Overall Study|Lost to Follow-up|20|||
27709313|NCT03418129|80771598|FG002|Overall Study|Lost to Follow-up|15|||
27836117|NCT01490190|81229156|FG000|Overall Study|Adverse Event|17|||
27836118|NCT01490190|81229156|FG000|Overall Study|Protocol Violation|5|||
27836119|NCT01490190|81229156|FG000|Overall Study|Lost to Follow-up|13|||
27836120|NCT01490190|81229156|FG000|Overall Study|Relocation|1|||
27709314|NCT03418129|80771596|FG000|Overall Study|Withdrawal by Subject|3|||
27709315|NCT03418129|80771597|FG001|Overall Study|Withdrawal by Subject|6|||
27709316|NCT03418129|80771598|FG002|Overall Study|Withdrawal by Subject|4|||
27709317|NCT03335163|80771601|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
27709318|NCT03335163|80771601|FG000|Overall Study|Withdrawal by Subject|18|||
27709319|NCT00652366|80771621|FG000|Overall Study|Adverse Event|8|||
27709320|NCT00652366|80771622|FG001|Overall Study|Adverse Event|4|||
27709321|NCT00652366|80771623|FG002|Overall Study|Adverse Event|7|||
27889145|NCT02549287|81428186|FG000|Overall Study|Lost to Follow-up|65|||
27889146|NCT02549287|81428187|FG001|Overall Study|Lost to Follow-up|26|||
27889147|NCT02549287|81428186|FG000|Overall Study|Withdrawal by Subject|15|||
27889148|NCT02549287|81428187|FG001|Overall Study|Withdrawal by Subject|6|||
27709322|NCT00652366|80771624|FG003|Overall Study|Adverse Event|17|||
27709323|NCT00652366|80771625|FG004|Overall Study|Adverse Event|13|||
27709324|NCT00652366|80771621|FG000|Overall Study|Death|5|||
27709325|NCT00652366|80771622|FG001|Overall Study|Death|4|||
27709326|NCT00652366|80771623|FG002|Overall Study|Death|1|||
27709327|NCT00652366|80771624|FG003|Overall Study|Death|8|||
27709328|NCT00652366|80771625|FG004|Overall Study|Death|5|||
27709329|NCT00652366|80771621|FG000|Overall Study|Lack of Efficacy|84|||
27709330|NCT00652366|80771622|FG001|Overall Study|Lack of Efficacy|58|||
27709331|NCT00652366|80771623|FG002|Overall Study|Lack of Efficacy|53|||
27709332|NCT00652366|80771624|FG003|Overall Study|Lack of Efficacy|133|||
27709333|NCT00652366|80771625|FG004|Overall Study|Lack of Efficacy|13|||
27709334|NCT00652366|80771621|FG000|Overall Study|Violation of Selection Criteria|0|||
27709335|NCT00652366|80771622|FG001|Overall Study|Violation of Selection Criteria|0|||
27709336|NCT00652366|80771623|FG002|Overall Study|Violation of Selection Criteria|1|||
27709337|NCT00652366|80771624|FG003|Overall Study|Violation of Selection Criteria|0|||
27709338|NCT00652366|80771625|FG004|Overall Study|Violation of Selection Criteria|0|||
27709339|NCT00652366|80771621|FG000|Overall Study|Protocol Violation|1|||
27709340|NCT00652366|80771622|FG001|Overall Study|Protocol Violation|0|||
27709341|NCT00652366|80771623|FG002|Overall Study|Protocol Violation|0|||
27709342|NCT00652366|80771624|FG003|Overall Study|Protocol Violation|0|||
27709343|NCT00652366|80771625|FG004|Overall Study|Protocol Violation|0|||
27709344|NCT00652366|80771621|FG000|Overall Study|Refused treatment|3|||
27709345|NCT00652366|80771622|FG001|Overall Study|Refused treatment|7|||
27709346|NCT00652366|80771623|FG002|Overall Study|Refused treatment|6|||
27709347|NCT00652366|80771624|FG003|Overall Study|Refused treatment|17|||
27709348|NCT00652366|80771625|FG004|Overall Study|Refused treatment|5|||
27709349|NCT00652366|80771621|FG000|Overall Study|Other|5|||
27709350|NCT00652366|80771622|FG001|Overall Study|Other|2|||
27709351|NCT00652366|80771623|FG002|Overall Study|Other|3|||
27709352|NCT00652366|80771624|FG003|Overall Study|Other|4|||
27709353|NCT00652366|80771625|FG004|Overall Study|Other|0|||
27709354|NCT03882970|80771626|FG000|Overall Study|Adverse Event|5|||
27709355|NCT03882970|80771627|FG001|Overall Study|Adverse Event|7|||
27709356|NCT03882970|80771628|FG002|Overall Study|Adverse Event|3|||
27709357|NCT03882970|80771629|FG003|Overall Study|Adverse Event|1|||
27709358|NCT03882970|80771626|FG000|Overall Study|Death|1|||
27709359|NCT03882970|80771627|FG001|Overall Study|Death|2|||
27709360|NCT03882970|80771628|FG002|Overall Study|Death|1|||
27709361|NCT03882970|80771629|FG003|Overall Study|Death|1|||
27709362|NCT03882970|80771626|FG000|Overall Study|Lost to Follow-up|8|||
27709363|NCT03882970|80771627|FG001|Overall Study|Lost to Follow-up|9|||
27709364|NCT03882970|80771628|FG002|Overall Study|Lost to Follow-up|5|||
27889149|NCT03689374|81428188|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
27889150|NCT03689374|81428189|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
27603128|NCT00840801|80388539|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
27709365|NCT03882970|80771629|FG003|Overall Study|Lost to Follow-up|5|||
27709366|NCT03882970|80771626|FG000|Overall Study|Physician Decision|0|||
27709367|NCT03882970|80771627|FG001|Overall Study|Physician Decision|2|||
27709368|NCT03882970|80771628|FG002|Overall Study|Physician Decision|2|||
27709369|NCT03882970|80771629|FG003|Overall Study|Physician Decision|2|||
27709370|NCT03882970|80771626|FG000|Overall Study|Protocol Violation|2|||
27709371|NCT03882970|80771627|FG001|Overall Study|Protocol Violation|0|||
27709372|NCT03882970|80771628|FG002|Overall Study|Protocol Violation|0|||
27709373|NCT03882970|80771629|FG003|Overall Study|Protocol Violation|0|||
27709374|NCT03882970|80771626|FG000|Overall Study|Withdrawal by Subject|8|||
27889151|NCT03689374|81428190|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
27709375|NCT03882970|80771627|FG001|Overall Study|Withdrawal by Subject|17|||
27709376|NCT03882970|80771628|FG002|Overall Study|Withdrawal by Subject|7|||
27889152|NCT03689374|81428188|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
27709377|NCT03882970|80771629|FG003|Overall Study|Withdrawal by Subject|22|||
27709378|NCT03882970|80771626|FG000|Overall Study|Personal Reason|2|||
27709379|NCT03882970|80771627|FG001|Overall Study|Personal Reason|3|||
27709380|NCT03882970|80771628|FG002|Overall Study|Personal Reason|1|||
27709381|NCT03882970|80771629|FG003|Overall Study|Personal Reason|3|||
27709382|NCT02634151|80771630|FG000|Overall Study|Withdrawal by Subject|1|||
27709383|NCT02634151|80771631|FG001|Overall Study|Withdrawal by Subject|0|||
27709384|NCT02634151|80771630|FG000|Overall Study|Non-Compliance|0|||
27709385|NCT02634151|80771631|FG001|Overall Study|Non-Compliance|1|||
27709386|NCT02634151|80771630|FG000|Overall Study|Other|0|||
27709387|NCT02634151|80771631|FG001|Overall Study|Other|1|||
27709388|NCT02113436|80771632|FG000|Period 1: 8 Weeks|Adverse Event|1|||
27709389|NCT02113436|80771633|FG001|Period 1: 8 Weeks|Adverse Event|0|||
27709390|NCT02113436|80771634|FG002|Period 1: 8 Weeks|Adverse Event|0|||
27709391|NCT02113436|80771635|FG003|Period 1: 8 Weeks|Adverse Event|0|||
27709392|NCT02113436|80771632|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
27709393|NCT02113436|80771633|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
27709394|NCT02113436|80771634|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
27709395|NCT02113436|80771635|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
27709396|NCT02113436|80771632|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
27709397|NCT02113436|80771633|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
27836121|NCT01490190|81229156|FG000|Overall Study|Inconvenience|1|||
27836122|NCT01490190|81229156|FG000|Overall Study|Ring expulsion|2|||
27836123|NCT01158118|81229157|FG000|Overall Study|Screen failure|1|||
27836124|NCT01158118|81229158|FG001|Overall Study|Screen failure|0|||
27836125|NCT01158118|81229157|FG000|Overall Study|Donor match was a screen failure|0|||
27836126|NCT01158118|81229158|FG001|Overall Study|Donor match was a screen failure|1|||
27836127|NCT01158118|81229157|FG000|Overall Study|Suffered stroke prior to transplant|0|||
27836128|NCT01158118|81229158|FG001|Overall Study|Suffered stroke prior to transplant|1|||
27836129|NCT01158118|81229157|FG000|Overall Study|Death|0|||
27836130|NCT01158118|81229158|FG001|Overall Study|Death|1|||
27836131|NCT00685334|81229159|FG000|Overall Study|Withdrawal by Subject|5|||
27836132|NCT00685334|81229160|FG001|Overall Study|Withdrawal by Subject|6|||
27836133|NCT00685334|81229159|FG000|Overall Study|Lost to Follow-up|4|||
27836134|NCT00685334|81229160|FG001|Overall Study|Lost to Follow-up|0|||
27836135|NCT00685334|81229159|FG000|Overall Study|Chose to enter hospital|1|||
27836136|NCT00685334|81229160|FG001|Overall Study|Chose to enter hospital|1|||
27836137|NCT03366428|81229161|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
27836138|NCT03366428|81229161|FG000|Overall Study|Adverse Event|12|||
27836139|NCT03366428|81229161|FG000|Overall Study|Clinical progression|2|||
27836140|NCT03366428|81229161|FG000|Overall Study|Withdrawal by Subject|4|||
27836141|NCT00965757|81229169|FG000|Double-blind Phase|Progression of concomitant disease|1|||
27836142|NCT00965757|81229170|FG001|Double-blind Phase|Progression of concomitant disease|2|||
27836143|NCT00965757|81229171|FG002|Double-blind Phase|Progression of concomitant disease|0|||
27836144|NCT00965757|81229172|FG003|Double-blind Phase|Progression of concomitant disease|0|||
27836145|NCT00965757|81229169|FG000|Double-blind Phase|Adverse drug reaction|2|||
27836146|NCT00965757|81229170|FG001|Double-blind Phase|Adverse drug reaction|1|||
27836147|NCT00965757|81229171|FG002|Double-blind Phase|Adverse drug reaction|0|||
27836148|NCT00965757|81229172|FG003|Double-blind Phase|Adverse drug reaction|0|||
27836149|NCT00965757|81229169|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
27836150|NCT00965757|81229170|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
27836151|NCT00965757|81229171|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
27836152|NCT00965757|81229172|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
27836153|NCT00965757|81229169|FG000|Double-blind Phase|Lack of Efficacy|7|||
27836154|NCT00965757|81229170|FG001|Double-blind Phase|Lack of Efficacy|11|||
27836155|NCT00965757|81229171|FG002|Double-blind Phase|Lack of Efficacy|0|||
27836156|NCT00965757|81229172|FG003|Double-blind Phase|Lack of Efficacy|0|||
27836157|NCT00965757|81229169|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
27836158|NCT00965757|81229170|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
27709398|NCT02113436|80771634|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
27709399|NCT02113436|80771635|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
27709400|NCT02113436|80771632|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
27709401|NCT02113436|80771633|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
27836159|NCT00965757|81229171|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
27836160|NCT00965757|81229172|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
27836161|NCT00965757|81229169|FG000|Double-blind Phase|Lost to Follow-up|0|||
27836162|NCT00965757|81229170|FG001|Double-blind Phase|Lost to Follow-up|1|||
27836163|NCT00965757|81229171|FG002|Double-blind Phase|Lost to Follow-up|0|||
27889153|NCT03689374|81428189|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
27889154|NCT03689374|81428190|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
27889155|NCT03689374|81428188|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
27889156|NCT03689374|81428189|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
27889157|NCT03689374|81428190|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
27836164|NCT00965757|81229172|FG003|Double-blind Phase|Lost to Follow-up|0|||
27836165|NCT00965757|81229169|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
27836166|NCT00965757|81229170|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
27836167|NCT00965757|81229171|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
27836168|NCT00965757|81229172|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
27836169|NCT00965757|81229169|FG000|Double-blind Phase|Other|1|||
27836170|NCT00965757|81229170|FG001|Double-blind Phase|Other|0|||
27836171|NCT00965757|81229171|FG002|Double-blind Phase|Other|0|||
27836172|NCT00965757|81229172|FG003|Double-blind Phase|Other|0|||
27836173|NCT00965757|81229169|FG000|Extension Phase|Progression of concomitant disease|0|||
27836174|NCT00965757|81229170|FG001|Extension Phase|Progression of concomitant disease|0|||
27836175|NCT00965757|81229171|FG002|Extension Phase|Progression of concomitant disease|4|||
27836176|NCT00965757|81229172|FG003|Extension Phase|Progression of concomitant disease|2|||
27836177|NCT00965757|81229169|FG000|Extension Phase|Adverse drug reaction|0|||
27836178|NCT00965757|81229170|FG001|Extension Phase|Adverse drug reaction|0|||
27836179|NCT00965757|81229171|FG002|Extension Phase|Adverse drug reaction|6|||
27836180|NCT00965757|81229172|FG003|Extension Phase|Adverse drug reaction|3|||
27836181|NCT00965757|81229169|FG000|Extension Phase|Abnormal Laboratory Value|0|||
27836182|NCT00965757|81229170|FG001|Extension Phase|Abnormal Laboratory Value|0|||
27836183|NCT00965757|81229171|FG002|Extension Phase|Abnormal Laboratory Value|6|||
27836184|NCT00965757|81229172|FG003|Extension Phase|Abnormal Laboratory Value|1|||
27836185|NCT00965757|81229169|FG000|Extension Phase|Lack of Efficacy|0|||
27836186|NCT00965757|81229170|FG001|Extension Phase|Lack of Efficacy|0|||
27836187|NCT00965757|81229171|FG002|Extension Phase|Lack of Efficacy|8|||
27836188|NCT00965757|81229172|FG003|Extension Phase|Lack of Efficacy|12|||
27836189|NCT00965757|81229169|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
27889158|NCT03689374|81428188|FG000|Treatment Period (Week 0 to 52)|Death|0|||
27889159|NCT03689374|81428189|FG001|Treatment Period (Week 0 to 52)|Death|11|||
27836190|NCT00965757|81229170|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
27836191|NCT00965757|81229171|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
27836192|NCT00965757|81229172|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
27836193|NCT00965757|81229169|FG000|Extension Phase|Lost to Follow-up|0|||
27836194|NCT00965757|81229170|FG001|Extension Phase|Lost to Follow-up|0|||
27836195|NCT00965757|81229171|FG002|Extension Phase|Lost to Follow-up|0|||
27836196|NCT00965757|81229172|FG003|Extension Phase|Lost to Follow-up|1|||
27836197|NCT00965757|81229169|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
27836198|NCT00965757|81229170|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
27836199|NCT00965757|81229171|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
27836200|NCT00965757|81229172|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
27836201|NCT00965757|81229169|FG000|Extension Phase|Protocol Violation|0|||
27836202|NCT00965757|81229170|FG001|Extension Phase|Protocol Violation|0|||
27836203|NCT00965757|81229171|FG002|Extension Phase|Protocol Violation|0|||
27836204|NCT00965757|81229172|FG003|Extension Phase|Protocol Violation|1|||
27836205|NCT00965757|81229169|FG000|Extension Phase|Other|0|||
27836206|NCT00965757|81229170|FG001|Extension Phase|Other|0|||
27836207|NCT00965757|81229171|FG002|Extension Phase|Other|2|||
27836208|NCT00965757|81229172|FG003|Extension Phase|Other|1|||
27836209|NCT03428750|81229173|FG000|Overall Study|Withdrawal by Subject|11|||
27836210|NCT03428750|81229174|FG001|Overall Study|Withdrawal by Subject|10|||
27836211|NCT03428750|81229173|FG000|Overall Study|Lost to Follow-up|3|||
27836212|NCT03428750|81229174|FG001|Overall Study|Lost to Follow-up|9|||
27836213|NCT03428750|81229173|FG000|Overall Study|Adverse Event|9|||
27836214|NCT03428750|81229174|FG001|Overall Study|Adverse Event|1|||
27836215|NCT03428750|81229173|FG000|Overall Study|Protocol Violation|1|||
27836216|NCT03428750|81229174|FG001|Overall Study|Protocol Violation|0|||
27836217|NCT03428750|81229173|FG000|Overall Study|Administrative|0|||
27836218|NCT03428750|81229174|FG001|Overall Study|Administrative|1|||
27836219|NCT01592240|81229175|FG000|Overall Study|Adverse Event|1|||
27836220|NCT01592240|81229176|FG001|Overall Study|Adverse Event|0|||
27836221|NCT01592240|81229177|FG002|Overall Study|Adverse Event|0|||
27836222|NCT01592240|81229178|FG003|Overall Study|Adverse Event|1|||
27836223|NCT01592240|81229179|FG004|Overall Study|Adverse Event|1|||
27889160|NCT03689374|81428190|FG002|Treatment Period (Week 0 to 52)|Death|1|||
27889161|NCT02833844|81428191|FG000|Double-Blind Period|Withdrawal by Subject|2|||
27889162|NCT02833844|81428192|FG001|Double-Blind Period|Withdrawal by Subject|3|||
27889163|NCT02833844|81428191|FG000|Double-Blind Period|Protocol Violation|0|||
27889164|NCT02833844|81428192|FG001|Double-Blind Period|Protocol Violation|4|||
27889165|NCT02833844|81428191|FG000|Open-Label Period|Death|0|||
27889166|NCT02833844|81428192|FG001|Open-Label Period|Death|2|||
27889167|NCT02833844|81428191|FG000|Open-Label Period|Lost to Follow-up|1|||
27889168|NCT02833844|81428192|FG001|Open-Label Period|Lost to Follow-up|0|||
27889169|NCT02833844|81428191|FG000|Open-Label Period|Withdrawal by Subject|1|||
27889170|NCT02833844|81428192|FG001|Open-Label Period|Withdrawal by Subject|0|||
27889171|NCT01704651|81428195|FG000|Overall Study|Pre-op withdrawal by subject|1|||
27889172|NCT01704651|81428196|FG001|Overall Study|Pre-op withdrawal by subject|1|||
27889173|NCT01704651|81428195|FG000|Overall Study|Pre-op change in treatment plan|1|||
27889174|NCT01704651|81428196|FG001|Overall Study|Pre-op change in treatment plan|4|||
27889175|NCT01704651|81428195|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
27889176|NCT01704651|81428196|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
27889177|NCT01704651|81428195|FG000|Overall Study|Post-op did not have laparotomy|2|||
27889178|NCT01704651|81428196|FG001|Overall Study|Post-op did not have laparotomy|1|||
27889179|NCT00968981|81428207|FG000|Overall Study|Adverse Event|2|||
27889180|NCT00968981|81428208|FG001|Overall Study|Adverse Event|0|||
27889181|NCT00968981|81428209|FG002|Overall Study|Adverse Event|0|||
27889182|NCT00968981|81428207|FG000|Overall Study|Disease Progression|14|||
27889183|NCT00968981|81428208|FG001|Overall Study|Disease Progression|16|||
27889184|NCT00968981|81428209|FG002|Overall Study|Disease Progression|13|||
27889185|NCT00968981|81428207|FG000|Overall Study|Lost to Follow-up|0|||
27889186|NCT00968981|81428208|FG001|Overall Study|Lost to Follow-up|0|||
27889187|NCT00968981|81428209|FG002|Overall Study|Lost to Follow-up|1|||
27889188|NCT00968981|81428207|FG000|Overall Study|Physician Decision|5|||
27836224|NCT01592240|81229180|FG005|Overall Study|Adverse Event|0|||
27889189|NCT00968981|81428208|FG001|Overall Study|Physician Decision|3|||
27836225|NCT01592240|81229181|FG006|Overall Study|Adverse Event|0|||
27836226|NCT01592240|81229175|FG000|Overall Study|Death|0|||
27836227|NCT01592240|81229176|FG001|Overall Study|Death|1|||
27889190|NCT00968981|81428209|FG002|Overall Study|Physician Decision|5|||
27889191|NCT00968981|81428207|FG000|Overall Study|Withdrawal by Subject|1|||
27889192|NCT00968981|81428208|FG001|Overall Study|Withdrawal by Subject|3|||
27889193|NCT00968981|81428209|FG002|Overall Study|Withdrawal by Subject|3|||
27889194|NCT00941863|81428210|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
27889195|NCT00941863|81428211|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
27889196|NCT00941863|81428212|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
27889197|NCT00941863|81428213|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
27889198|NCT00941863|81428214|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
27889199|NCT00941863|81428210|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
27889200|NCT00941863|81428211|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
27889201|NCT00941863|81428212|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
27889202|NCT00941863|81428213|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
27889203|NCT00941863|81428214|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
27889204|NCT00941863|81428210|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
27889205|NCT00941863|81428211|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
27889206|NCT00941863|81428212|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
27889207|NCT00941863|81428213|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
27889208|NCT00941863|81428214|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
27889209|NCT00941863|81428210|FG000|Until Primary Completion Date (PCD)|Death|0|||
27889210|NCT00941863|81428211|FG001|Until Primary Completion Date (PCD)|Death|0|||
27889211|NCT00941863|81428212|FG002|Until Primary Completion Date (PCD)|Death|1|||
27889212|NCT00941863|81428213|FG003|Until Primary Completion Date (PCD)|Death|2|||
27889213|NCT00941863|81428214|FG004|Until Primary Completion Date (PCD)|Death|7|||
27889214|NCT00941863|81428210|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
27889215|NCT00941863|81428211|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
27889216|NCT00941863|81428212|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
27889217|NCT00941863|81428213|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
27889218|NCT00941863|81428214|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
27889219|NCT00941863|81428210|FG000|Continued After PCD|Withdrawal by Subject|0|||
27889220|NCT00941863|81428211|FG001|Continued After PCD|Withdrawal by Subject|0|||
27889221|NCT00941863|81428212|FG002|Continued After PCD|Withdrawal by Subject|0|||
27889222|NCT00941863|81428213|FG003|Continued After PCD|Withdrawal by Subject|0|||
27889223|NCT00941863|81428214|FG004|Continued After PCD|Withdrawal by Subject|1|||
27889224|NCT00941863|81428210|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
27889225|NCT00941863|81428211|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
27889226|NCT00941863|81428212|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
27889227|NCT00941863|81428213|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
27889228|NCT00941863|81428214|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
27889229|NCT01817582|81428215|FG000|Overall Study|Withdrawal by Subject|0|||
27889230|NCT01817582|81428216|FG001|Overall Study|Withdrawal by Subject|1|||
27889231|NCT01817582|81428217|FG002|Overall Study|Withdrawal by Subject|0|||
27889232|NCT01817582|81428215|FG000|Overall Study|Participant revealed masked treatment|1|||
27889233|NCT01817582|81428216|FG001|Overall Study|Participant revealed masked treatment|0|||
27889234|NCT01817582|81428217|FG002|Overall Study|Participant revealed masked treatment|0|||
27889235|NCT01817582|81428215|FG000|Overall Study|Randomized but exclusion criteria met|1|||
27889236|NCT01817582|81428216|FG001|Overall Study|Randomized but exclusion criteria met|0|||
27889237|NCT01817582|81428217|FG002|Overall Study|Randomized but exclusion criteria met|0|||
27889238|NCT03919695|81430759|FG000|3-month Follow-up|Death|1|||
27889239|NCT03919695|81430760|FG001|3-month Follow-up|Death|1|||
27889240|NCT03919695|81430759|FG000|3-month Follow-up|unable to contact|0|||
27889241|NCT03919695|81430760|FG001|3-month Follow-up|unable to contact|3|||
27836228|NCT01592240|81229177|FG002|Overall Study|Death|0|||
27836229|NCT01592240|81229178|FG003|Overall Study|Death|0|||
27836230|NCT01592240|81229179|FG004|Overall Study|Death|0|||
27836231|NCT01592240|81229180|FG005|Overall Study|Death|0|||
27836232|NCT01592240|81229181|FG006|Overall Study|Death|0|||
27836233|NCT01592240|81229175|FG000|Overall Study|Lost to Follow-up|1|||
27836234|NCT01592240|81229176|FG001|Overall Study|Lost to Follow-up|3|||
27836235|NCT01592240|81229177|FG002|Overall Study|Lost to Follow-up|1|||
27836236|NCT01592240|81229178|FG003|Overall Study|Lost to Follow-up|0|||
27836237|NCT01592240|81229179|FG004|Overall Study|Lost to Follow-up|3|||
27836238|NCT01592240|81229180|FG005|Overall Study|Lost to Follow-up|2|||
27836239|NCT01592240|81229181|FG006|Overall Study|Lost to Follow-up|0|||
27836240|NCT01592240|81229175|FG000|Overall Study|Protocol Violation|0|||
27889242|NCT03919695|81430759|FG000|3-month Follow-up|in prison|0|||
27889243|NCT03919695|81430760|FG001|3-month Follow-up|in prison|1|||
27889244|NCT03919695|81430759|FG000|6-month Follow-up|Death|0|||
27836241|NCT01592240|81229176|FG001|Overall Study|Protocol Violation|0|||
27836242|NCT01592240|81229177|FG002|Overall Study|Protocol Violation|0|||
27836243|NCT01592240|81229178|FG003|Overall Study|Protocol Violation|0|||
27836244|NCT01592240|81229179|FG004|Overall Study|Protocol Violation|0|||
27836245|NCT01592240|81229180|FG005|Overall Study|Protocol Violation|1|||
27889245|NCT03919695|81430760|FG001|6-month Follow-up|Death|1|||
27889246|NCT03919695|81430759|FG000|6-month Follow-up|Lost to Follow-up|1|||
27889247|NCT03919695|81430760|FG001|6-month Follow-up|Lost to Follow-up|2|||
27889248|NCT03919695|81430759|FG000|6-month Follow-up|in prison|0|||
27889249|NCT03919695|81430760|FG001|6-month Follow-up|in prison|2|||
27889250|NCT03919695|81430759|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
27889251|NCT03919695|81430760|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
27889252|NCT03919695|81430759|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
27889253|NCT03919695|81430760|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
27889254|NCT00090220|81430761|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
27889255|NCT00090220|81430762|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
27889256|NCT00090220|81430763|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27889257|NCT00090220|81430764|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27889258|NCT00090220|81430765|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27889259|NCT00090220|81430766|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
27889260|NCT00090220|81430761|FG000|Base Study Vaccination Period|Adverse Event|6|||
27889261|NCT00090220|81430762|FG001|Base Study Vaccination Period|Adverse Event|1|||
27889262|NCT00090220|81430763|FG002|Base Study Vaccination Period|Adverse Event|0|||
27889263|NCT00090220|81430764|FG003|Base Study Vaccination Period|Adverse Event|0|||
27889264|NCT00090220|81430765|FG004|Base Study Vaccination Period|Adverse Event|0|||
27603129|NCT00840801|80388537|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
27603130|NCT00840801|80388538|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
27603131|NCT00840801|80388539|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
27603132|NCT04382924|80388540|FG000|Overall Study|Death|2|||
27603133|NCT04382924|80388541|FG001|Overall Study|Death|5|||
27603134|NCT04382924|80388542|FG002|Overall Study|Death|4|||
27603135|NCT04382924|80388540|FG000|Overall Study|Protocol Violation|0|||
27603136|NCT04382924|80388541|FG001|Overall Study|Protocol Violation|1|||
27603137|NCT04382924|80388542|FG002|Overall Study|Protocol Violation|1|||
27603138|NCT04382924|80388540|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
27836246|NCT01592240|81229181|FG006|Overall Study|Protocol Violation|0|||
27836247|NCT01592240|81229175|FG000|Overall Study|Withdrawal by Subject|0|||
27836248|NCT01592240|81229176|FG001|Overall Study|Withdrawal by Subject|4|||
27836249|NCT01592240|81229177|FG002|Overall Study|Withdrawal by Subject|4|||
27836250|NCT01592240|81229178|FG003|Overall Study|Withdrawal by Subject|1|||
27836251|NCT01592240|81229179|FG004|Overall Study|Withdrawal by Subject|3|||
27836252|NCT01592240|81229180|FG005|Overall Study|Withdrawal by Subject|0|||
27836253|NCT01592240|81229181|FG006|Overall Study|Withdrawal by Subject|2|||
27836254|NCT01592240|81229175|FG000|Overall Study|Other|0|||
27836255|NCT01592240|81229176|FG001|Overall Study|Other|3|||
27836256|NCT01592240|81229177|FG002|Overall Study|Other|1|||
27836257|NCT01592240|81229178|FG003|Overall Study|Other|1|||
27836258|NCT01592240|81229179|FG004|Overall Study|Other|0|||
27889265|NCT00090220|81430766|FG005|Base Study Vaccination Period|Adverse Event|0|||
27889266|NCT00090220|81430761|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
27889267|NCT00090220|81430762|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
27889268|NCT00090220|81430763|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
27709402|NCT02113436|80771634|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
27836259|NCT01592240|81229180|FG005|Overall Study|Other|0|||
27836260|NCT01592240|81229181|FG006|Overall Study|Other|1|||
27836261|NCT01592240|81229175|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27836262|NCT01592240|81229176|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
27603139|NCT04382924|80388541|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
27603140|NCT04382924|80388542|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
27603141|NCT04382924|80388540|FG000|Overall Study|Withdrawal by Subject|6|||
27603142|NCT04382924|80388541|FG001|Overall Study|Withdrawal by Subject|3|||
27603143|NCT04382924|80388542|FG002|Overall Study|Withdrawal by Subject|6|||
27603144|NCT01712009|80388543|FG000|Overall Study|Withdrawal by Subject|24|||
27603145|NCT01712009|80388544|FG001|Overall Study|Withdrawal by Subject|15|||
27603146|NCT01712009|80388545|FG002|Overall Study|Withdrawal by Subject|8|||
27603147|NCT01712009|80388543|FG000|Overall Study|Lost to Follow-up|2|||
27603148|NCT01712009|80388544|FG001|Overall Study|Lost to Follow-up|0|||
27603149|NCT01712009|80388545|FG002|Overall Study|Lost to Follow-up|1|||
27603150|NCT01712009|80388543|FG000|Overall Study|Decision by Sponsor|12|||
27603151|NCT01712009|80388544|FG001|Overall Study|Decision by Sponsor|14|||
27603152|NCT01712009|80388545|FG002|Overall Study|Decision by Sponsor|12|||
27603153|NCT02124265|80388546|FG000|Overall Study|Adverse Event|1|||
27603154|NCT05232864|80388547|FG000|Overall Study|Adverse Event|0|||
27603155|NCT05232864|80388548|FG001|Overall Study|Adverse Event|1|||
27603156|NCT05232864|80388547|FG000|Overall Study|Study terminated by sponsor|16|||
27603157|NCT05232864|80388548|FG001|Overall Study|Study terminated by sponsor|14|||
27603158|NCT00045708|80388549|FG000|Phase 1|early progressive disease|0|||
27603159|NCT00045708|80388550|FG001|Phase 1|early progressive disease|1|||
27603160|NCT00045708|80388551|FG002|Phase 1|early progressive disease|0|||
27603161|NCT01591382|80388552|FG000|Overall Study|Discharged Prior to Study Completion|2|||
27603162|NCT01591382|80388553|FG001|Overall Study|Discharged Prior to Study Completion|1|||
27603163|NCT01591382|80388552|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
27603164|NCT01591382|80388553|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
27603165|NCT04493216|80388554|FG000|Overall Study|Study terminated by sponsor|30|||
27603166|NCT04493216|80388555|FG001|Overall Study|Study terminated by sponsor|33|||
27603167|NCT04493216|80388556|FG002|Overall Study|Study terminated by sponsor|28|||
27603168|NCT04493216|80388557|FG003|Overall Study|Study terminated by sponsor|27|||
27603169|NCT04493216|80388554|FG000|Overall Study|Withdrawal by Subject|2|||
27603170|NCT04493216|80388555|FG001|Overall Study|Withdrawal by Subject|1|||
27603171|NCT04493216|80388556|FG002|Overall Study|Withdrawal by Subject|1|||
27603172|NCT04493216|80388557|FG003|Overall Study|Withdrawal by Subject|2|||
27603173|NCT04493216|80388554|FG000|Overall Study|Protocol Violation|1|||
27603174|NCT04493216|80388555|FG001|Overall Study|Protocol Violation|2|||
27603175|NCT04493216|80388556|FG002|Overall Study|Protocol Violation|0|||
27603176|NCT04493216|80388557|FG003|Overall Study|Protocol Violation|2|||
27603177|NCT04493216|80388554|FG000|Overall Study|Physician Decision|0|||
27603178|NCT04493216|80388555|FG001|Overall Study|Physician Decision|0|||
27603179|NCT04493216|80388556|FG002|Overall Study|Physician Decision|1|||
27603180|NCT04493216|80388557|FG003|Overall Study|Physician Decision|0|||
27603181|NCT04493216|80388554|FG000|Overall Study|Lost to Follow-up|2|||
27603182|NCT04493216|80388555|FG001|Overall Study|Lost to Follow-up|1|||
27603183|NCT04493216|80388556|FG002|Overall Study|Lost to Follow-up|0|||
27603184|NCT04493216|80388557|FG003|Overall Study|Lost to Follow-up|1|||
27603185|NCT04493216|80388554|FG000|Overall Study|Adverse Event|1|||
27603186|NCT04493216|80388555|FG001|Overall Study|Adverse Event|4|||
27603187|NCT04493216|80388556|FG002|Overall Study|Adverse Event|5|||
27603188|NCT04493216|80388557|FG003|Overall Study|Adverse Event|2|||
27836263|NCT01592240|81229177|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
27836264|NCT01592240|81229178|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
27836265|NCT01592240|81229179|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
27709403|NCT02113436|80771635|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
27709404|NCT02113436|80771632|FG000|Period 2: 16 Weeks|Adverse Event|0|||
27709405|NCT02113436|80771633|FG001|Period 2: 16 Weeks|Adverse Event|0|||
27709406|NCT02113436|80771634|FG002|Period 2: 16 Weeks|Adverse Event|4|||
27709407|NCT02113436|80771635|FG003|Period 2: 16 Weeks|Adverse Event|5|||
27709408|NCT02113436|80771632|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
27709409|NCT02113436|80771633|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
27709410|NCT02113436|80771634|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
27709411|NCT02113436|80771635|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
27709412|NCT02113436|80771632|FG000|Period 2: 16 Weeks|Physician Decision|0|||
27709413|NCT02113436|80771633|FG001|Period 2: 16 Weeks|Physician Decision|0|||
27709414|NCT02113436|80771634|FG002|Period 2: 16 Weeks|Physician Decision|2|||
27709415|NCT02113436|80771635|FG003|Period 2: 16 Weeks|Physician Decision|0|||
27709416|NCT02113436|80771632|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
27709417|NCT02113436|80771633|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
27709418|NCT02113436|80771634|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
27709419|NCT02113436|80771635|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
27709420|NCT00433914|80771636|FG000|Overall Study|Withdrawal by Subject|0|||
27709421|NCT00433914|80771637|FG001|Overall Study|Withdrawal by Subject|2|||
27709422|NCT00433914|80771636|FG000|Overall Study|Lost to Follow-up|0|||
27709423|NCT00433914|80771637|FG001|Overall Study|Lost to Follow-up|1|||
27709424|NCT01033825|80771643|FG000|Overall Study|Withdrawal by Subject|2|||
27709425|NCT01033825|80771644|FG001|Overall Study|Withdrawal by Subject|3|||
27709426|NCT01033825|80771645|FG002|Overall Study|Withdrawal by Subject|2|||
27709427|NCT01033825|80771646|FG003|Overall Study|Withdrawal by Subject|1|||
27709428|NCT01033825|80771647|FG004|Overall Study|Withdrawal by Subject|1|||
27709429|NCT01033825|80771648|FG005|Overall Study|Withdrawal by Subject|0|||
27709430|NCT01033825|80771649|FG006|Overall Study|Withdrawal by Subject|0|||
27709431|NCT01033825|80771643|FG000|Overall Study|Adverse Event|0|||
27709432|NCT01033825|80771644|FG001|Overall Study|Adverse Event|0|||
27709433|NCT01033825|80771645|FG002|Overall Study|Adverse Event|0|||
27709434|NCT01033825|80771646|FG003|Overall Study|Adverse Event|1|||
27709435|NCT01033825|80771647|FG004|Overall Study|Adverse Event|0|||
27709436|NCT01033825|80771648|FG005|Overall Study|Adverse Event|0|||
27836266|NCT01592240|81229180|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
27836267|NCT01592240|81229181|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
27836268|NCT03246503|81229182|FG000|Overall Study|Lost to Follow-up|23|||
27836269|NCT03246503|81229182|FG000|Overall Study|Withdrawal by Subject|20|||
27709437|NCT01033825|80771649|FG006|Overall Study|Adverse Event|0|||
27709438|NCT01033825|80771643|FG000|Overall Study|Protocol Violation|1|||
27709439|NCT01033825|80771644|FG001|Overall Study|Protocol Violation|0|||
27709440|NCT01033825|80771645|FG002|Overall Study|Protocol Violation|0|||
27709441|NCT01033825|80771646|FG003|Overall Study|Protocol Violation|0|||
27709442|NCT01033825|80771647|FG004|Overall Study|Protocol Violation|0|||
27709443|NCT01033825|80771648|FG005|Overall Study|Protocol Violation|0|||
27709444|NCT01033825|80771649|FG006|Overall Study|Protocol Violation|0|||
27709445|NCT01033825|80771643|FG000|Overall Study|Other|0|||
27709446|NCT01033825|80771644|FG001|Overall Study|Other|0|||
27709447|NCT01033825|80771645|FG002|Overall Study|Other|0|||
27709448|NCT01033825|80771646|FG003|Overall Study|Other|0|||
27709449|NCT01033825|80771647|FG004|Overall Study|Other|1|||
27709450|NCT01033825|80771648|FG005|Overall Study|Other|0|||
27709451|NCT01033825|80771649|FG006|Overall Study|Other|0|||
27709452|NCT03159091|80771650|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
27709453|NCT03159091|80771651|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
27709454|NCT03159091|80771650|FG000|Overall Study|Patient has taken no dose of study drug|0|||
27709455|NCT03159091|80771651|FG001|Overall Study|Patient has taken no dose of study drug|1|||
27709456|NCT00133991|80771658|FG000|Overall Study|Death|4|||
27709457|NCT00708123|80771661|FG000|Period 1|Protocol Violation|0|||
27709458|NCT00708123|80771662|FG001|Period 1|Protocol Violation|1|||
27709459|NCT00708123|80771663|FG002|Period 1|Protocol Violation|0|||
27709460|NCT00708123|80771664|FG003|Period 1|Protocol Violation|1|||
27709461|NCT00708123|80771665|FG004|Period 1|Protocol Violation|0|||
27709462|NCT00708123|80771661|FG000|Period 1|Adverse Event|0|||
27709463|NCT00708123|80771662|FG001|Period 1|Adverse Event|0|||
27709464|NCT00708123|80771663|FG002|Period 1|Adverse Event|1|||
27709465|NCT00708123|80771664|FG003|Period 1|Adverse Event|0|||
27709466|NCT00708123|80771665|FG004|Period 1|Adverse Event|0|||
27709467|NCT00708123|80771661|FG000|Period 2|Protocol Violation|0|||
27709468|NCT00708123|80771662|FG001|Period 2|Protocol Violation|0|||
27709469|NCT00708123|80771663|FG002|Period 2|Protocol Violation|0|||
27709470|NCT00708123|80771664|FG003|Period 2|Protocol Violation|1|||
27709471|NCT00708123|80771665|FG004|Period 2|Protocol Violation|0|||
27709472|NCT00708123|80771661|FG000|Period 2|Other Reason|1|||
27709473|NCT00708123|80771662|FG001|Period 2|Other Reason|0|||
27709474|NCT00708123|80771663|FG002|Period 2|Other Reason|0|||
27709475|NCT00708123|80771664|FG003|Period 2|Other Reason|0|||
27709476|NCT00708123|80771665|FG004|Period 2|Other Reason|0|||
27709477|NCT00708123|80771661|FG000|Period 3|Lost to Follow-up|0|||
27709478|NCT00708123|80771662|FG001|Period 3|Lost to Follow-up|0|||
27709479|NCT00708123|80771663|FG002|Period 3|Lost to Follow-up|1|||
27709480|NCT00708123|80771664|FG003|Period 3|Lost to Follow-up|1|||
27709481|NCT00708123|80771665|FG004|Period 3|Lost to Follow-up|0|||
27709482|NCT00708123|80771661|FG000|Period 4|Protocol Violation|0|||
27709483|NCT00708123|80771662|FG001|Period 4|Protocol Violation|1|||
27709484|NCT00708123|80771663|FG002|Period 4|Protocol Violation|0|||
27709485|NCT00708123|80771664|FG003|Period 4|Protocol Violation|0|||
27709486|NCT00708123|80771665|FG004|Period 4|Protocol Violation|0|||
27709487|NCT00388973|80771668|FG000|Overall Study|Adverse Event|16|||
27709488|NCT00388973|80771669|FG001|Overall Study|Adverse Event|6|||
27709489|NCT00388973|80771668|FG000|Overall Study|Lack of Efficacy|1|||
27709490|NCT00388973|80771669|FG001|Overall Study|Lack of Efficacy|12|||
27709491|NCT00388973|80771668|FG000|Overall Study|Protocol Violation|3|||
27709492|NCT00388973|80771669|FG001|Overall Study|Protocol Violation|0|||
27709493|NCT00388973|80771668|FG000|Overall Study|Withdrawal by Subject|14|||
27709494|NCT00388973|80771669|FG001|Overall Study|Withdrawal by Subject|17|||
27709495|NCT00388973|80771668|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
27709496|NCT00388973|80771669|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
27709497|NCT00388973|80771668|FG000|Overall Study|Did not complete 61 days of treatment|5|||
27709498|NCT00388973|80771669|FG001|Overall Study|Did not complete 61 days of treatment|4|||
27836270|NCT03246503|81229182|FG000|Overall Study|Physician Decision|5|||
27836271|NCT03246503|81229182|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
27836272|NCT04535986|81229184|FG000|Overall Study|Death|4|||
27836273|NCT04535986|81229185|FG001|Overall Study|Death|5|||
27836274|NCT04535986|81229184|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
27836275|NCT04535986|81229185|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
27836276|NCT04535986|81229184|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
27836277|NCT04535986|81229185|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
27709499|NCT00388973|80771668|FG000|Overall Study|Left region|0|||
27836278|NCT04535986|81229184|FG000|Overall Study|Adverse Event|10|||
27836279|NCT04535986|81229185|FG001|Overall Study|Adverse Event|1|||
27836280|NCT04535986|81229184|FG000|Overall Study|Lack of Efficacy|3|||
27836281|NCT04535986|81229185|FG001|Overall Study|Lack of Efficacy|2|||
27709500|NCT00388973|80771669|FG001|Overall Study|Left region|1|||
27709501|NCT00388973|80771668|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
27709502|NCT00388973|80771669|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
27709503|NCT04050670|80771672|FG000|Period 3|Physician Decision|0|||
27709504|NCT04050670|80771673|FG001|Period 3|Physician Decision|1|||
27709505|NCT04050670|80771674|FG002|Period 3|Physician Decision|0|||
27709506|NCT01986920|80771684|FG000|A- 101 25%|Withdrawal by Subject|1|||
27709507|NCT01986920|80771685|FG001|A- 101 25%|Withdrawal by Subject|0|||
27709508|NCT01986920|80771686|FG002|A- 101 25%|Withdrawal by Subject|0|||
27709509|NCT01986920|80771687|FG003|A- 101 25%|Withdrawal by Subject|0|||
27709510|NCT01986920|80771684|FG000|A-101 32.5%|Withdrawal by Subject|0|||
27709511|NCT01986920|80771685|FG001|A-101 32.5%|Withdrawal by Subject|1|||
27709512|NCT01986920|80771686|FG002|A-101 32.5%|Withdrawal by Subject|0|||
27709513|NCT01986920|80771687|FG003|A-101 32.5%|Withdrawal by Subject|0|||
27709514|NCT01986920|80771684|FG000|A-101 40%|Withdrawal by Subject|0|||
27709515|NCT01986920|80771685|FG001|A-101 40%|Withdrawal by Subject|0|||
27709516|NCT01986920|80771686|FG002|A-101 40%|Withdrawal by Subject|1|||
27709517|NCT01986920|80771687|FG003|A-101 40%|Withdrawal by Subject|0|||
27709518|NCT01986920|80771684|FG000|Placebo|Withdrawal by Subject|0|||
27709519|NCT01986920|80771685|FG001|Placebo|Withdrawal by Subject|0|||
27709520|NCT01986920|80771686|FG002|Placebo|Withdrawal by Subject|0|||
27709521|NCT01986920|80771687|FG003|Placebo|Withdrawal by Subject|1|||
27709522|NCT02943564|80771694|FG000|Overall Study|Miscellaneous Reasons|0|||
27709523|NCT02943564|80771695|FG001|Overall Study|Miscellaneous Reasons|0|||
27709524|NCT02943564|80771696|FG002|Overall Study|Miscellaneous Reasons|3|||
27709525|NCT02943564|80771694|FG000|Overall Study|Site terminated by sponsor|0|||
27709526|NCT02943564|80771695|FG001|Overall Study|Site terminated by sponsor|1|||
27709527|NCT02943564|80771696|FG002|Overall Study|Site terminated by sponsor|0|||
27709528|NCT02943564|80771694|FG000|Overall Study|Non-compliance with study drug|0|||
27709529|NCT02943564|80771695|FG001|Overall Study|Non-compliance with study drug|1|||
27709530|NCT02943564|80771696|FG002|Overall Study|Non-compliance with study drug|0|||
27709531|NCT02943564|80771694|FG000|Overall Study|Pregnancy|0|||
27709532|NCT02943564|80771695|FG001|Overall Study|Pregnancy|1|||
27709533|NCT02943564|80771696|FG002|Overall Study|Pregnancy|1|||
27709534|NCT02943564|80771694|FG000|Overall Study|Protocol Violation|2|||
27709535|NCT02943564|80771695|FG001|Overall Study|Protocol Violation|2|||
27709536|NCT02943564|80771696|FG002|Overall Study|Protocol Violation|2|||
27709537|NCT02943564|80771694|FG000|Overall Study|Lost to Follow-up|1|||
27709538|NCT02943564|80771695|FG001|Overall Study|Lost to Follow-up|0|||
27709539|NCT02943564|80771696|FG002|Overall Study|Lost to Follow-up|0|||
27709540|NCT02943564|80771694|FG000|Overall Study|Withdrawal by Subject|6|||
27709541|NCT02943564|80771695|FG001|Overall Study|Withdrawal by Subject|5|||
27709542|NCT02943564|80771696|FG002|Overall Study|Withdrawal by Subject|2|||
27709543|NCT02943564|80771694|FG000|Overall Study|Adverse Event|1|||
27709544|NCT02943564|80771695|FG001|Overall Study|Adverse Event|2|||
27709545|NCT02943564|80771696|FG002|Overall Study|Adverse Event|1|||
27709546|NCT02943564|80771694|FG000|Overall Study|Lack of Efficacy|0|||
27709547|NCT02943564|80771695|FG001|Overall Study|Lack of Efficacy|1|||
27709548|NCT02943564|80771696|FG002|Overall Study|Lack of Efficacy|0|||
27709549|NCT01040351|80771702|FG000|Overall Study|poor ovarian response|1|||
27709550|NCT01040351|80771703|FG001|Overall Study|poor ovarian response|2|||
27709551|NCT01524198|80771707|FG000|Overall Study|Protocol Violation|8|||
27709552|NCT01524198|80771708|FG001|Overall Study|Protocol Violation|6|||
27709553|NCT01524198|80771707|FG000|Overall Study|Withdrawal by Subject|15|||
27709554|NCT01524198|80771708|FG001|Overall Study|Withdrawal by Subject|10|||
27709555|NCT03134599|80771711|FG000|Week 1|Lost to Follow-up|0|||
27709556|NCT03134599|80771712|FG001|Week 1|Lost to Follow-up|0|||
27709557|NCT03134599|80771713|FG002|Week 1|Lost to Follow-up|0|||
27709558|NCT03134599|80771714|FG003|Week 1|Lost to Follow-up|0|||
27709559|NCT03134599|80771715|FG004|Week 1|Lost to Follow-up|1|||
27709560|NCT03134599|80771716|FG005|Week 1|Lost to Follow-up|0|||
27709561|NCT03134599|80771711|FG000|Week 2|Lost to Follow-up|1|||
27709562|NCT03134599|80771712|FG001|Week 2|Lost to Follow-up|0|||
27709563|NCT03134599|80771713|FG002|Week 2|Lost to Follow-up|0|||
27709564|NCT03134599|80771714|FG003|Week 2|Lost to Follow-up|1|||
27709565|NCT03134599|80771715|FG004|Week 2|Lost to Follow-up|1|||
27709566|NCT03134599|80771716|FG005|Week 2|Lost to Follow-up|0|||
27709567|NCT03134599|80771711|FG000|Week 3|Lost to Follow-up|0|||
27709568|NCT03134599|80771712|FG001|Week 3|Lost to Follow-up|0|||
27709569|NCT03134599|80771713|FG002|Week 3|Lost to Follow-up|0|||
27709570|NCT03134599|80771714|FG003|Week 3|Lost to Follow-up|1|||
27709571|NCT03134599|80771715|FG004|Week 3|Lost to Follow-up|0|||
27709572|NCT03134599|80771716|FG005|Week 3|Lost to Follow-up|1|||
27709573|NCT02054897|80771718|FG000|Overall Study|Withdrawal by Subject|2|||
27709574|NCT02054897|80771719|FG001|Overall Study|Withdrawal by Subject|0|||
27836282|NCT04535986|81229184|FG000|Overall Study|Investigator discretion|3|||
27836283|NCT04535986|81229185|FG001|Overall Study|Investigator discretion|0|||
27709575|NCT02054897|80771720|FG002|Overall Study|Withdrawal by Subject|2|||
27709576|NCT02054897|80771718|FG000|Overall Study|Missing follow-up information|3|||
27709577|NCT02054897|80771719|FG001|Overall Study|Missing follow-up information|5|||
27709578|NCT02054897|80771720|FG002|Overall Study|Missing follow-up information|3|||
27709579|NCT02054897|80771718|FG000|Overall Study|Lost to Follow-up|4|||
27709580|NCT02054897|80771719|FG001|Overall Study|Lost to Follow-up|2|||
27709581|NCT02054897|80771720|FG002|Overall Study|Lost to Follow-up|7|||
27709582|NCT02054897|80771718|FG000|Overall Study|Randomized but not exposed|1|||
27709583|NCT02054897|80771719|FG001|Overall Study|Randomized but not exposed|0|||
27709584|NCT02054897|80771720|FG002|Overall Study|Randomized but not exposed|0|||
27709585|NCT02667275|80771721|FG000|Overall Study|Protocol Violation|11|||
27709586|NCT02667275|80771722|FG001|Overall Study|Protocol Violation|7|||
27709587|NCT02667275|80771721|FG000|Overall Study|Lost to Follow-up|0|||
27709588|NCT02667275|80771722|FG001|Overall Study|Lost to Follow-up|2|||
27709589|NCT02667275|80771721|FG000|Overall Study|Withdrawal by Subject|0|||
27709590|NCT02667275|80771722|FG001|Overall Study|Withdrawal by Subject|5|||
27709591|NCT02667275|80771721|FG000|Overall Study|Discontinued early without completing|0|||
27709592|NCT02667275|80771722|FG001|Overall Study|Discontinued early without completing|1|||
27709593|NCT01877187|80771726|FG000|Overall Study|Death|2|||
27709594|NCT01877187|80771726|FG000|Overall Study|Withdrawal by Subject|4|||
27709595|NCT01877187|80771726|FG000|Overall Study|Lost to Follow-up|3|||
27709596|NCT01877187|80771726|FG000|Overall Study|Declining clinical status|11|||
27709597|NCT01877187|80771726|FG000|Overall Study|Liver transplant|2|||
27709598|NCT00282334|80771738|FG000|Overall Study|Withdrawal by Subject|8|||
27709599|NCT00282334|80771739|FG001|Overall Study|Withdrawal by Subject|5|||
27709600|NCT03693625|80771743|FG000|Overall Study|Adverse Event|2|||
27709601|NCT03693625|80771744|FG001|Overall Study|Adverse Event|0|||
27709602|NCT03693625|80771743|FG000|Overall Study|Study Terminated By Sponsor|20|||
27709603|NCT03693625|80771744|FG001|Overall Study|Study Terminated By Sponsor|7|||
27709604|NCT03693625|80771743|FG000|Overall Study|Withdrawal by Subject|1|||
27709605|NCT03693625|80771744|FG001|Overall Study|Withdrawal by Subject|1|||
27709606|NCT00254501|80771745|FG000|Overall Study|Lost to Follow-up|1|||
27709607|NCT00254501|80771746|FG001|Overall Study|Lost to Follow-up|1|||
27709608|NCT01439555|80771751|FG000|Overall Study|Protocol Violation|1|||
27709609|NCT02016820|80771754|FG000|Overall Study|Lost to Follow-up|2|||
27709610|NCT02016820|80771755|FG001|Overall Study|Lost to Follow-up|4|||
27709611|NCT00631020|80771758|FG000|Overall Study|Lost to Follow-up|7|||
27709612|NCT00631020|80771758|FG000|Overall Study|Incarcerated|1|||
27709613|NCT00530894|80774922|FG000|Overall Study|Death|84|||
27709614|NCT00530894|80774923|FG001|Overall Study|Death|89|||
27709615|NCT00530894|80774924|FG002|Overall Study|Death|55|||
27709616|NCT00530894|80774925|FG003|Overall Study|Death|89|||
27709617|NCT00530894|80774922|FG000|Overall Study|Lost to Follow-up|1|||
27709618|NCT00530894|80774923|FG001|Overall Study|Lost to Follow-up|3|||
27709619|NCT00530894|80774924|FG002|Overall Study|Lost to Follow-up|0|||
27709620|NCT00530894|80774925|FG003|Overall Study|Lost to Follow-up|0|||
27709621|NCT00530894|80774922|FG000|Overall Study|Withdrawal by Subject|1|||
27709622|NCT00530894|80774923|FG001|Overall Study|Withdrawal by Subject|23|||
27709623|NCT00530894|80774924|FG002|Overall Study|Withdrawal by Subject|0|||
27709624|NCT00530894|80774925|FG003|Overall Study|Withdrawal by Subject|5|||
27709625|NCT00530894|80774922|FG000|Overall Study|Alive and censored prior to 1 year|2|||
27709626|NCT00530894|80774923|FG001|Overall Study|Alive and censored prior to 1 year|0|||
27709627|NCT00530894|80774924|FG002|Overall Study|Alive and censored prior to 1 year|0|||
27709628|NCT00530894|80774925|FG003|Overall Study|Alive and censored prior to 1 year|0|||
27709629|NCT01349465|80774926|FG000|Overall Study|Adverse Event|1|||
27709630|NCT01349465|80774927|FG001|Overall Study|Adverse Event|0|||
27709631|NCT01349465|80774926|FG000|Overall Study|Death|3|||
27709632|NCT01349465|80774927|FG001|Overall Study|Death|0|||
27709633|NCT01349465|80774926|FG000|Overall Study|Lost to Follow-up|10|||
27709634|NCT01349465|80774927|FG001|Overall Study|Lost to Follow-up|1|||
27709635|NCT01349465|80774926|FG000|Overall Study|Withdrawal by Subject|4|||
27709636|NCT01349465|80774927|FG001|Overall Study|Withdrawal by Subject|2|||
27709637|NCT01349465|80774926|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
27709638|NCT01349465|80774927|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
27709639|NCT00405067|80774929|FG000|Overall Study|Adverse Event|4|||
27709640|NCT00405067|80774930|FG001|Overall Study|Adverse Event|9|||
27709641|NCT00405067|80774931|FG002|Overall Study|Adverse Event|4|||
27709642|NCT00405067|80774929|FG000|Overall Study|Lost to Follow-up|0|||
27709643|NCT00405067|80774930|FG001|Overall Study|Lost to Follow-up|0|||
27709644|NCT00405067|80774931|FG002|Overall Study|Lost to Follow-up|1|||
27709645|NCT01485627|80774943|FG000|Overall Study|Patient withdrew|6|||
27709646|NCT01485627|80774944|FG001|Overall Study|Patient withdrew|5|||
27709647|NCT01485627|80774943|FG000|Overall Study|Patient died|3|||
27709648|NCT01485627|80774944|FG001|Overall Study|Patient died|1|||
27709649|NCT01485627|80774943|FG000|Overall Study|Patient lost to followup|0|||
27709650|NCT01485627|80774944|FG001|Overall Study|Patient lost to followup|1|||
27709651|NCT01485627|80774943|FG000|Overall Study|Caregiver withdrew|3|||
27709652|NCT01485627|80774944|FG001|Overall Study|Caregiver withdrew|3|||
27709653|NCT01485627|80774943|FG000|Overall Study|Caregiver lost to follow up|11|||
27709654|NCT01485627|80774944|FG001|Overall Study|Caregiver lost to follow up|12|||
27709655|NCT01485627|80774943|FG000|Overall Study|Caregiver died|1|||
27709656|NCT01485627|80774944|FG001|Overall Study|Caregiver died|0|||
27709657|NCT01485627|80774943|FG000|Overall Study|caregiver was not bereaved|42|||
27709658|NCT01485627|80774944|FG001|Overall Study|caregiver was not bereaved|35|||
27709659|NCT02053168|80774947|FG000|Overall Study|Withdrawal by Subject|1|||
27709660|NCT02053168|80774947|FG000|Overall Study|Physician Decision|1|||
27709661|NCT02053168|80774947|FG000|Overall Study|Lost to Follow-up|1|||
27709662|NCT02953340|80774950|FG000|Overall Study|Death|0|||
27709663|NCT02953340|80774951|FG001|Overall Study|Death|1|||
27709664|NCT02953340|80774950|FG000|Overall Study|Investigator Decision|3|||
27709665|NCT02953340|80774951|FG001|Overall Study|Investigator Decision|3|||
27709666|NCT02953340|80774950|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
27709667|NCT02953340|80774951|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
27709668|NCT02953340|80774950|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
27709669|NCT02953340|80774951|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
27709670|NCT02953340|80774950|FG000|Overall Study|Withdrawal by Subject|9|||
27709671|NCT02953340|80774951|FG001|Overall Study|Withdrawal by Subject|9|||
27709672|NCT02953340|80774950|FG000|Overall Study|Sponsor decision|0|||
27709673|NCT02953340|80774951|FG001|Overall Study|Sponsor decision|2|||
27709674|NCT02953340|80774950|FG000|Overall Study|Lost to Follow-up|3|||
27709675|NCT02953340|80774951|FG001|Overall Study|Lost to Follow-up|2|||
27709676|NCT02953340|80774950|FG000|Overall Study|Reason not specified|2|||
27709677|NCT02953340|80774951|FG001|Overall Study|Reason not specified|2|||
27709678|NCT02159729|80774954|FG000|Overall Study|Adverse Event|0|||
27709679|NCT02159729|80774955|FG001|Overall Study|Adverse Event|1|||
27709680|NCT02159729|80774954|FG000|Overall Study|Subject's Request|13|||
27709681|NCT02159729|80774955|FG001|Overall Study|Subject's Request|10|||
27709682|NCT02159729|80774954|FG000|Overall Study|Lost to Follow-up|24|||
27709683|NCT02159729|80774955|FG001|Overall Study|Lost to Follow-up|9|||
27709684|NCT02159729|80774954|FG000|Overall Study|Non compliance|2|||
27709685|NCT02159729|80774955|FG001|Overall Study|Non compliance|0|||
27709686|NCT02159729|80774954|FG000|Overall Study|Other Unspecified|3|||
27709687|NCT02159729|80774955|FG001|Overall Study|Other Unspecified|1|||
27709688|NCT01923285|80774962|FG000|Overall Study|Withdrawal by Subject|7|||
27709689|NCT01923285|80774963|FG001|Overall Study|Withdrawal by Subject|6|||
27709690|NCT03462576|80774967|FG000|Overall Study|Protocol Violation|5|||
27709691|NCT03462576|80774968|FG001|Overall Study|Protocol Violation|11|||
27709692|NCT03462576|80774969|FG002|Overall Study|Protocol Violation|7|||
27709693|NCT03462576|80774967|FG000|Overall Study|Device Malfunction|0|||
27709694|NCT03462576|80774968|FG001|Overall Study|Device Malfunction|0|||
27709695|NCT03462576|80774969|FG002|Overall Study|Device Malfunction|1|||
27709696|NCT00550680|80774970|FG000|Overall Study|Administrative Reasons|1|||
27709697|NCT00550680|80774970|FG000|Overall Study|Adverse Event|5|||
27709698|NCT00550680|80774970|FG000|Overall Study|Death|3|||
27709699|NCT00550680|80774970|FG000|Overall Study|Early Improvement|1|||
27709700|NCT00550680|80774970|FG000|Overall Study|Lost to Follow-up|3|||
27709701|NCT00550680|80774970|FG000|Overall Study|Lack of Efficacy|1|||
27709702|NCT00550680|80774970|FG000|Overall Study|Other|10|||
27709703|NCT00550680|80774970|FG000|Overall Study|Protocol Violation|7|||
27709704|NCT00550680|80774970|FG000|Overall Study|Refused Treatment|19|||
27709705|NCT00550680|80774970|FG000|Overall Study|Screen Failure|6|||
27709706|NCT01379274|80774971|FG000|Overall Study|funding withdrawn|1|||
27836284|NCT04535986|81229184|FG000|Overall Study|Withdrawal by Subject|32|||
27709707|NCT01438489|80774974|FG000|Overall Study|Lost to Follow-up|4|||
27709708|NCT01438489|80774975|FG001|Overall Study|Lost to Follow-up|2|||
27709709|NCT01438489|80774976|FG002|Overall Study|Lost to Follow-up|2|||
27709710|NCT01438489|80774974|FG000|Overall Study|Withdrawal by Subject|11|||
27709711|NCT01438489|80774975|FG001|Overall Study|Withdrawal by Subject|3|||
27709712|NCT01438489|80774976|FG002|Overall Study|Withdrawal by Subject|8|||
27709713|NCT01438489|80774974|FG000|Overall Study|Death|0|||
27709714|NCT01438489|80774975|FG001|Overall Study|Death|0|||
27709715|NCT01438489|80774976|FG002|Overall Study|Death|1|||
27709716|NCT01438489|80774974|FG000|Overall Study|Sponsor decision|4|||
27709717|NCT01438489|80774975|FG001|Overall Study|Sponsor decision|1|||
27709718|NCT01438489|80774976|FG002|Overall Study|Sponsor decision|4|||
27709719|NCT01438489|80774974|FG000|Overall Study|Subject choice/Subject moved|2|||
27709720|NCT01438489|80774975|FG001|Overall Study|Subject choice/Subject moved|1|||
27709721|NCT01438489|80774976|FG002|Overall Study|Subject choice/Subject moved|1|||
27709722|NCT01438489|80774974|FG000|Overall Study|Investigator decision|0|||
27709723|NCT01438489|80774975|FG001|Overall Study|Investigator decision|1|||
27709724|NCT01438489|80774976|FG002|Overall Study|Investigator decision|0|||
27709725|NCT01438489|80774974|FG000|Overall Study|AE/SAEs|2|||
27709726|NCT01438489|80774975|FG001|Overall Study|AE/SAEs|1|||
27709727|NCT01438489|80774976|FG002|Overall Study|AE/SAEs|1|||
27709728|NCT01438489|80774974|FG000|Overall Study|Received prohibited medication|1|||
27709729|NCT01438489|80774975|FG001|Overall Study|Received prohibited medication|0|||
27709730|NCT01438489|80774976|FG002|Overall Study|Received prohibited medication|0|||
27709731|NCT01438489|80774974|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
27709732|NCT01438489|80774975|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
27709733|NCT01438489|80774976|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
27709734|NCT01438489|80774974|FG000|Overall Study|Inadequate venous access|0|||
27709735|NCT01438489|80774975|FG001|Overall Study|Inadequate venous access|2|||
27709736|NCT01438489|80774976|FG002|Overall Study|Inadequate venous access|0|||
27709737|NCT00814892|80774980|FG000|Overall Study|Disease Progression|1|||
27709738|NCT00814892|80774980|FG000|Overall Study|Study Termination|1|||
27709739|NCT02369848|80774981|FG000|Overall Study|Death|1|||
27709740|NCT02369848|80774981|FG000|Overall Study|Withdrawal by Subject|2|||
27709741|NCT02369848|80774981|FG000|Overall Study|Lost to Follow-up|1|||
27709742|NCT00632099|80774983|FG000|Overall Study|Lost to Follow-up|3|||
27709743|NCT00632099|80774984|FG001|Overall Study|Lost to Follow-up|3|||
27709744|NCT01999465|80774987|FG000|Overall Study|Lost to Follow-up|0|||
27709745|NCT01999465|80774988|FG001|Overall Study|Lost to Follow-up|2|||
27709746|NCT01999465|80774987|FG000|Overall Study|Protocol Violation|0|||
27709747|NCT01999465|80774988|FG001|Overall Study|Protocol Violation|1|||
27709748|NCT02231164|80774989|FG000|Overall Study|Adverse Event|1|||
27709749|NCT02231164|80774990|FG001|Overall Study|Adverse Event|1|||
27709750|NCT02231164|80774989|FG000|Overall Study|Lack of Efficacy|4|||
27709751|NCT02231164|80774990|FG001|Overall Study|Lack of Efficacy|3|||
27709752|NCT02231164|80774989|FG000|Overall Study|Withdrawal by Subject|1|||
27709753|NCT02231164|80774990|FG001|Overall Study|Withdrawal by Subject|2|||
27709754|NCT02004262|80774993|FG000|Overall Study|Death|67|||
27709755|NCT02004262|80774994|FG001|Overall Study|Death|64|||
27709756|NCT02004262|80774995|FG002|Overall Study|Death|66|||
27709757|NCT02004262|80774996|FG003|Overall Study|Death|28|||
27709758|NCT02004262|80774997|FG004|Overall Study|Death|29|||
27709759|NCT02004262|80774998|FG005|Overall Study|Death|22|||
27709760|NCT02004262|80774993|FG000|Overall Study|Withdrawal by Subject|1|||
27709761|NCT02004262|80774994|FG001|Overall Study|Withdrawal by Subject|0|||
27709762|NCT02004262|80774995|FG002|Overall Study|Withdrawal by Subject|4|||
27709763|NCT02004262|80774996|FG003|Overall Study|Withdrawal by Subject|0|||
27709764|NCT02004262|80774997|FG004|Overall Study|Withdrawal by Subject|1|||
27709765|NCT02004262|80774998|FG005|Overall Study|Withdrawal by Subject|3|||
27709766|NCT02004262|80774993|FG000|Overall Study|Lost to Follow-up|1|||
27709767|NCT02004262|80774994|FG001|Overall Study|Lost to Follow-up|1|||
27709768|NCT02004262|80774995|FG002|Overall Study|Lost to Follow-up|0|||
27709769|NCT02004262|80774996|FG003|Overall Study|Lost to Follow-up|0|||
27709770|NCT02004262|80774997|FG004|Overall Study|Lost to Follow-up|0|||
27709771|NCT02004262|80774998|FG005|Overall Study|Lost to Follow-up|0|||
27709772|NCT02004262|80774993|FG000|Overall Study|Study Terminated by Sponsor|4|||
27709773|NCT02004262|80774994|FG001|Overall Study|Study Terminated by Sponsor|3|||
27709774|NCT02004262|80774995|FG002|Overall Study|Study Terminated by Sponsor|2|||
27709775|NCT02004262|80774996|FG003|Overall Study|Study Terminated by Sponsor|1|||
27709776|NCT02004262|80774997|FG004|Overall Study|Study Terminated by Sponsor|1|||
27709777|NCT02004262|80774998|FG005|Overall Study|Study Terminated by Sponsor|5|||
27709778|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Adverse Event|2|||
27603189|NCT04493216|80388554|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
27603190|NCT04493216|80388555|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
27709779|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Adverse Event|2|||
27709780|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Adverse Event|4|||
27709781|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Adverse Event|0|||
27709782|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Adverse Event|0|||
27709783|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Progressive disease|0|||
27603191|NCT04493216|80388556|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
27709784|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Progressive disease|0|||
27709785|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Progressive disease|1|||
27709786|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Progressive disease|0|||
27709787|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Progressive disease|0|||
27709788|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
27709789|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
27709790|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
27709791|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
27709792|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
27709793|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
27709794|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
27709795|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
27709796|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
27709797|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
27709798|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
27709799|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
27709800|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
27709801|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
27709802|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
27709803|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
27709804|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
27709805|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
27709806|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
27709807|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
27709808|NCT03523728|80775001|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
27709809|NCT03523728|80775002|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
27709810|NCT03523728|80775003|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
27709811|NCT03523728|80775004|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
27709812|NCT03523728|80775005|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
27709813|NCT03523728|80775001|FG000|Stage 2 (24 Months)|Adverse Event|0|||
27709814|NCT03523728|80775002|FG001|Stage 2 (24 Months)|Adverse Event|0|||
27709815|NCT03523728|80775003|FG002|Stage 2 (24 Months)|Adverse Event|0|||
27709816|NCT03523728|80775004|FG003|Stage 2 (24 Months)|Adverse Event|1|||
27709817|NCT03523728|80775005|FG004|Stage 2 (24 Months)|Adverse Event|2|||
27709818|NCT03523728|80775001|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
27709819|NCT03523728|80775002|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
27709820|NCT03523728|80775003|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
27709821|NCT03523728|80775004|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
27709822|NCT03523728|80775005|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
27709823|NCT03523728|80775001|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
27709824|NCT03523728|80775002|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
27709825|NCT03523728|80775003|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
27709826|NCT03523728|80775004|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
27709827|NCT03523728|80775005|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
27709828|NCT03523728|80775001|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
27709829|NCT03523728|80775002|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
27709830|NCT03523728|80775003|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
27709831|NCT03523728|80775004|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
27709832|NCT03523728|80775005|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
27709833|NCT03523728|80775001|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
27709834|NCT03523728|80775002|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
27709835|NCT03523728|80775003|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
27709836|NCT03523728|80775004|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
27709837|NCT03523728|80775005|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
27709838|NCT05003622|80775006|FG000|Overall Study|Progressive disease|2|||
27709839|NCT05003622|80775006|FG000|Overall Study|Withdrawal by Subject|1|||
27709840|NCT03200366|80775010|FG000|Patient Navigation Intervention Given|Death|0|||
27709841|NCT03200366|80775011|FG001|Patient Navigation Intervention Given|Death|2|||
27709842|NCT03200366|80775012|FG002|Patient Navigation Intervention Given|Death|0|||
27709843|NCT03200366|80775010|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
27709844|NCT03200366|80775011|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
27709845|NCT03200366|80775012|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
27709846|NCT03200366|80775010|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
27709847|NCT03200366|80775011|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
27709848|NCT03200366|80775012|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
27709849|NCT03200366|80775010|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
27709850|NCT03200366|80775011|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
27709851|NCT03200366|80775012|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
27709852|NCT03200366|80775010|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
27709853|NCT03200366|80775011|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
27709854|NCT03200366|80775012|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
27709855|NCT03200366|80775010|FG000|6 Month Post-Baseline Interview|Death|1|||
27709856|NCT03200366|80775011|FG001|6 Month Post-Baseline Interview|Death|1|||
27709857|NCT03200366|80775012|FG002|6 Month Post-Baseline Interview|Death|1|||
27709858|NCT03200366|80775010|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
27709859|NCT03200366|80775011|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
27709860|NCT03200366|80775012|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
27709861|NCT03200366|80775010|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
27709862|NCT03200366|80775011|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
27709863|NCT03200366|80775012|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
27709864|NCT03200366|80775010|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
27709865|NCT03200366|80775011|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
27709866|NCT03200366|80775012|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
27709867|NCT03200366|80775010|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
27709868|NCT03200366|80775011|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
27709869|NCT03200366|80775012|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
27709870|NCT03200366|80775010|FG000|9 Month Post-Baseline Interview|Death|1|||
27709871|NCT03200366|80775011|FG001|9 Month Post-Baseline Interview|Death|1|||
27709872|NCT03200366|80775012|FG002|9 Month Post-Baseline Interview|Death|1|||
27709873|NCT03200366|80775010|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
27709874|NCT03200366|80775011|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
27709875|NCT03200366|80775012|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
27709876|NCT03200366|80775010|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
27709877|NCT03200366|80775011|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
27709878|NCT03200366|80775012|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
27709879|NCT03200366|80775010|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
27709880|NCT03200366|80775011|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
27709881|NCT03200366|80775012|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
27709882|NCT00441974|80775016|FG000|Overall Study|Adverse Event|6|||
27709883|NCT00441974|80775016|FG000|Overall Study|Consent Withdrawn|35|||
27709884|NCT00441974|80775016|FG000|Overall Study|Lost to Follow-up|80|||
27709885|NCT00441974|80775016|FG000|Overall Study|Protocol Violation|7|||
27709886|NCT01756040|80775024|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
27709887|NCT01756040|80775024|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
27709888|NCT01756040|80775024|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
27709889|NCT00917150|80775025|FG000|Overall Study|Adverse Event|12|||
27709890|NCT00917150|80775026|FG001|Overall Study|Adverse Event|7|||
27709891|NCT00917150|80775027|FG002|Overall Study|Adverse Event|12|||
27709892|NCT00917150|80775028|FG003|Overall Study|Adverse Event|11|||
27709893|NCT00917150|80775025|FG000|Overall Study|Death|1|||
27709894|NCT00917150|80775026|FG001|Overall Study|Death|4|||
27709895|NCT00917150|80775027|FG002|Overall Study|Death|3|||
27709896|NCT00917150|80775028|FG003|Overall Study|Death|2|||
27709897|NCT00917150|80775025|FG000|Overall Study|Lost to Follow-up|1|||
27709898|NCT00917150|80775026|FG001|Overall Study|Lost to Follow-up|0|||
27709899|NCT00917150|80775027|FG002|Overall Study|Lost to Follow-up|4|||
27709900|NCT00917150|80775028|FG003|Overall Study|Lost to Follow-up|2|||
27709901|NCT00917150|80775025|FG000|Overall Study|Physician Decision|0|||
27709902|NCT00917150|80775026|FG001|Overall Study|Physician Decision|2|||
27709903|NCT00917150|80775027|FG002|Overall Study|Physician Decision|0|||
27709904|NCT00917150|80775028|FG003|Overall Study|Physician Decision|1|||
27709905|NCT00917150|80775025|FG000|Overall Study|Protocol Violation|5|||
27709906|NCT00917150|80775026|FG001|Overall Study|Protocol Violation|5|||
27709907|NCT00917150|80775027|FG002|Overall Study|Protocol Violation|3|||
27709908|NCT00917150|80775028|FG003|Overall Study|Protocol Violation|5|||
27709909|NCT00917150|80775025|FG000|Overall Study|Withdrawal by Subject|15|||
27709910|NCT00917150|80775026|FG001|Overall Study|Withdrawal by Subject|16|||
27709911|NCT00917150|80775027|FG002|Overall Study|Withdrawal by Subject|18|||
27709912|NCT00917150|80775028|FG003|Overall Study|Withdrawal by Subject|11|||
27709913|NCT00917150|80775025|FG000|Overall Study|Other than specified|3|||
27709914|NCT00917150|80775026|FG001|Overall Study|Other than specified|3|||
27709915|NCT00917150|80775027|FG002|Overall Study|Other than specified|2|||
27709916|NCT00917150|80775028|FG003|Overall Study|Other than specified|2|||
27709917|NCT00827606|80775029|FG000|Overall Study|Protocol Violation|4|||
27709918|NCT00827606|80775030|FG001|Overall Study|Protocol Violation|3|||
27709919|NCT00827606|80775029|FG000|Overall Study|Lost to Follow-up|3|||
27709920|NCT00827606|80775030|FG001|Overall Study|Lost to Follow-up|1|||
27709921|NCT00827606|80775029|FG000|Overall Study|Withdrawal by Subject|7|||
27709922|NCT00827606|80775030|FG001|Overall Study|Withdrawal by Subject|6|||
27709923|NCT00827606|80775029|FG000|Overall Study|Pregnancy|0|||
27709924|NCT00827606|80775030|FG001|Overall Study|Pregnancy|1|||
27709925|NCT00827606|80775029|FG000|Overall Study|Other|5|||
27709926|NCT00827606|80775030|FG001|Overall Study|Other|13|||
27709927|NCT00827606|80775029|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
27709928|NCT00827606|80775030|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
27709929|NCT00827606|80775029|FG000|Overall Study|Adverse Event|4|||
27709930|NCT00827606|80775030|FG001|Overall Study|Adverse Event|2|||
27709931|NCT03680911|80775031|FG000|At Home Treatment|Study Termination|3|||
27709932|NCT03680911|80775032|FG001|At Home Treatment|Study Termination|0|||
27709933|NCT03680911|80775031|FG000|At Home Treatment|Lost to Follow-up|0|||
27709934|NCT03680911|80775032|FG001|At Home Treatment|Lost to Follow-up|1|||
27709935|NCT03680911|80775031|FG000|At Home Treatment|Withdrawal by Subject|0|||
27709936|NCT03680911|80775032|FG001|At Home Treatment|Withdrawal by Subject|2|||
27709937|NCT03680911|80775031|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
27709938|NCT03680911|80775032|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
27709939|NCT04013529|80775033|FG000|Overall Study|Withdrawal by Subject|1|||
27709940|NCT04013529|80775034|FG001|Overall Study|Withdrawal by Subject|1|||
27709941|NCT02871778|80775037|FG000|Part A: Treatment Period 1|Adverse Event|1|||
27709942|NCT02871778|80775038|FG001|Part A: Treatment Period 1|Adverse Event|1|||
27709943|NCT02871778|80775039|FG002|Part A: Treatment Period 1|Adverse Event|1|||
27709944|NCT02871778|80775040|FG003|Part A: Treatment Period 1|Adverse Event|0|||
27709945|NCT02871778|80775041|FG004|Part A: Treatment Period 1|Adverse Event|0|||
27709946|NCT02871778|80775042|FG005|Part A: Treatment Period 1|Adverse Event|0|||
27709947|NCT02871778|80775043|FG006|Part A: Treatment Period 1|Adverse Event|0|||
27709948|NCT02871778|80775044|FG007|Part A: Treatment Period 1|Adverse Event|0|||
27709949|NCT02871778|80775037|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
27709950|NCT02871778|80775038|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
27709951|NCT02871778|80775039|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
27709952|NCT02871778|80775040|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
27709953|NCT02871778|80775041|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
27709954|NCT02871778|80775042|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
27709955|NCT02871778|80775043|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
27709956|NCT02871778|80775044|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
27709957|NCT02871778|80775037|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709958|NCT02871778|80775038|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709959|NCT02871778|80775039|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
27709960|NCT02871778|80775040|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709961|NCT02871778|80775041|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709962|NCT02871778|80775042|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709963|NCT02871778|80775043|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709964|NCT02871778|80775044|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
27709965|NCT02871778|80775037|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709966|NCT02871778|80775038|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709967|NCT02871778|80775039|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
27709968|NCT02871778|80775040|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709969|NCT02871778|80775041|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709970|NCT02871778|80775042|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709971|NCT02871778|80775043|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709972|NCT02871778|80775044|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
27709973|NCT02871778|80775037|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709974|NCT02871778|80775038|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
27709975|NCT02871778|80775039|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709976|NCT02871778|80775040|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709977|NCT02871778|80775041|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709978|NCT02871778|80775042|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709979|NCT02871778|80775043|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709980|NCT02871778|80775044|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
27709981|NCT02871778|80775037|FG000|Part A: Treatment Period 2|Adverse Event|2|||
27709982|NCT02871778|80775038|FG001|Part A: Treatment Period 2|Adverse Event|2|||
27709983|NCT02871778|80775039|FG002|Part A: Treatment Period 2|Adverse Event|0|||
27709984|NCT02871778|80775040|FG003|Part A: Treatment Period 2|Adverse Event|0|||
27709985|NCT02871778|80775041|FG004|Part A: Treatment Period 2|Adverse Event|0|||
27709986|NCT02871778|80775042|FG005|Part A: Treatment Period 2|Adverse Event|0|||
27709987|NCT02871778|80775043|FG006|Part A: Treatment Period 2|Adverse Event|0|||
27709988|NCT02871778|80775044|FG007|Part A: Treatment Period 2|Adverse Event|0|||
27709989|NCT02871778|80775037|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
27709990|NCT02871778|80775038|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
27709991|NCT02871778|80775039|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
27709992|NCT02871778|80775040|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
27709993|NCT02871778|80775041|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
27889269|NCT00090220|81430764|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
27889270|NCT00090220|81430765|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
27889271|NCT00090220|81430766|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
27889272|NCT00090220|81430761|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
27889273|NCT00090220|81430762|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
27889274|NCT00090220|81430763|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
27889275|NCT00090220|81430764|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
27889276|NCT00090220|81430765|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
27889277|NCT00090220|81430766|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
27889278|NCT00090220|81430761|FG000|Base Study Vaccination Period|Patient Moved|6|||
27889279|NCT00090220|81430762|FG001|Base Study Vaccination Period|Patient Moved|2|||
27889280|NCT00090220|81430763|FG002|Base Study Vaccination Period|Patient Moved|0|||
27889281|NCT00090220|81430764|FG003|Base Study Vaccination Period|Patient Moved|0|||
27889282|NCT00090220|81430765|FG004|Base Study Vaccination Period|Patient Moved|0|||
27889283|NCT00090220|81430766|FG005|Base Study Vaccination Period|Patient Moved|0|||
27889284|NCT00090220|81430761|FG000|Base Study Vaccination Period|Other|4|||
27889285|NCT00090220|81430762|FG001|Base Study Vaccination Period|Other|4|||
27889286|NCT00090220|81430763|FG002|Base Study Vaccination Period|Other|0|||
27889287|NCT00090220|81430764|FG003|Base Study Vaccination Period|Other|0|||
27889288|NCT00090220|81430765|FG004|Base Study Vaccination Period|Other|0|||
27889289|NCT00090220|81430766|FG005|Base Study Vaccination Period|Other|0|||
27889290|NCT00090220|81430761|FG000|Base Study Follow-up Period|Adverse Event|6|||
27889291|NCT00090220|81430762|FG001|Base Study Follow-up Period|Adverse Event|1|||
27889292|NCT00090220|81430763|FG002|Base Study Follow-up Period|Adverse Event|0|||
27889293|NCT00090220|81430764|FG003|Base Study Follow-up Period|Adverse Event|0|||
27889294|NCT00090220|81430765|FG004|Base Study Follow-up Period|Adverse Event|0|||
27889295|NCT00090220|81430766|FG005|Base Study Follow-up Period|Adverse Event|0|||
27889296|NCT00090220|81430761|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
27709994|NCT02871778|80775042|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
27889297|NCT00090220|81430762|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
27889298|NCT00090220|81430763|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
27889299|NCT00090220|81430764|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
27889300|NCT00090220|81430765|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
27709995|NCT02871778|80775043|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
27709996|NCT02871778|80775044|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
27889301|NCT00090220|81430766|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
27603192|NCT04493216|80388557|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
27603193|NCT01564368|80388564|FG000|Overall Study|Ineligible|18|||
27603194|NCT01564368|80388564|FG000|Overall Study|Not Randomized in Parent study|116|||
27603195|NCT01564368|80388564|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
27889302|NCT00090220|81430761|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
27603196|NCT01564368|80388564|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
27603197|NCT02173054|80388565|FG000|Overall Study|lack of compliance|1|||
27603198|NCT02173054|80388566|FG001|Overall Study|lack of compliance|0|||
27603199|NCT02173054|80388567|FG002|Overall Study|lack of compliance|0|||
27603200|NCT02173054|80388565|FG000|Overall Study|Withdrawal by Subject|0|||
27603201|NCT02173054|80388566|FG001|Overall Study|Withdrawal by Subject|0|||
27836285|NCT04535986|81229185|FG001|Overall Study|Withdrawal by Subject|14|||
27836286|NCT04535986|81229184|FG000|Overall Study|Lost to Follow-up|5|||
27836287|NCT04535986|81229185|FG001|Overall Study|Lost to Follow-up|3|||
27836288|NCT04535986|81229184|FG000|Overall Study|Other|7|||
27836289|NCT04535986|81229185|FG001|Overall Study|Other|3|||
27836290|NCT02786953|81229186|FG000|Overall Study|Withdrawal by Subject|3|||
27836291|NCT02786953|81229187|FG001|Overall Study|Withdrawal by Subject|0|||
27836292|NCT02786953|81229186|FG000|Overall Study|Physician Decision|0|||
27836293|NCT02786953|81229187|FG001|Overall Study|Physician Decision|1|||
27836294|NCT01891357|81229190|FG000|Overall Study|Protocol Violation|3|||
27836295|NCT00826241|81229191|FG000|Overall Study|Withdrawal from Follow-up|1|||
27836296|NCT00826241|81229191|FG000|Overall Study|Withdrew consent|2|||
27836297|NCT00826241|81229191|FG000|Overall Study|Death|4|||
27836298|NCT00826241|81229191|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
27836299|NCT00826241|81229191|FG000|Overall Study|Non-compliance|1|||
27603202|NCT02173054|80388567|FG002|Overall Study|Withdrawal by Subject|1|||
27836300|NCT00826241|81229191|FG000|Overall Study|Progression of disease|1|||
27603203|NCT02160314|80388568|FG000|Overall Study|Adverse Event|0|||
27889303|NCT00090220|81430762|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
27889304|NCT00090220|81430763|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
27889305|NCT00090220|81430764|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
27889306|NCT00090220|81430765|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
27889307|NCT00090220|81430766|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
27889308|NCT00090220|81430761|FG000|Base Study Follow-up Period|Patient Moved|20|||
27889309|NCT00090220|81430762|FG001|Base Study Follow-up Period|Patient Moved|28|||
27889310|NCT00090220|81430763|FG002|Base Study Follow-up Period|Patient Moved|0|||
27889311|NCT00090220|81430764|FG003|Base Study Follow-up Period|Patient Moved|0|||
27889312|NCT00090220|81430765|FG004|Base Study Follow-up Period|Patient Moved|0|||
27889313|NCT00090220|81430766|FG005|Base Study Follow-up Period|Patient Moved|0|||
27889314|NCT00090220|81430761|FG000|Base Study Follow-up Period|Other|19|||
27889315|NCT00090220|81430762|FG001|Base Study Follow-up Period|Other|21|||
27889316|NCT00090220|81430763|FG002|Base Study Follow-up Period|Other|0|||
27889317|NCT00090220|81430764|FG003|Base Study Follow-up Period|Other|0|||
27889318|NCT00090220|81430765|FG004|Base Study Follow-up Period|Other|0|||
27889319|NCT00090220|81430766|FG005|Base Study Follow-up Period|Other|0|||
27889320|NCT00090220|81430761|FG000|Extension 1 (EXT1)|Adverse Event|0|||
27889321|NCT00090220|81430762|FG001|Extension 1 (EXT1)|Adverse Event|0|||
27889322|NCT00090220|81430763|FG002|Extension 1 (EXT1)|Adverse Event|4|||
27889323|NCT00090220|81430764|FG003|Extension 1 (EXT1)|Adverse Event|0|||
27889324|NCT00090220|81430765|FG004|Extension 1 (EXT1)|Adverse Event|0|||
27889325|NCT00090220|81430766|FG005|Extension 1 (EXT1)|Adverse Event|0|||
27889326|NCT00090220|81430761|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
27889327|NCT00090220|81430762|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
27889328|NCT00090220|81430763|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
27889329|NCT00090220|81430764|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
27889330|NCT00090220|81430765|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
27889331|NCT00090220|81430766|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
27889332|NCT00090220|81430761|FG000|Extension 1 (EXT1)|Moved|0|||
27889333|NCT00090220|81430762|FG001|Extension 1 (EXT1)|Moved|0|||
27889334|NCT00090220|81430763|FG002|Extension 1 (EXT1)|Moved|2|||
27889335|NCT00090220|81430764|FG003|Extension 1 (EXT1)|Moved|1|||
27889336|NCT00090220|81430765|FG004|Extension 1 (EXT1)|Moved|0|||
27889337|NCT00090220|81430766|FG005|Extension 1 (EXT1)|Moved|0|||
27889338|NCT00090220|81430761|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
27889339|NCT00090220|81430762|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
27889340|NCT00090220|81430763|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
27603204|NCT02160314|80388569|FG001|Overall Study|Adverse Event|6|||
27603205|NCT02160314|80388568|FG000|Overall Study|Protocol Violation|0|||
27603206|NCT02160314|80388569|FG001|Overall Study|Protocol Violation|4|||
27603207|NCT02160314|80388568|FG000|Overall Study|Withdrawal by Subject|1|||
27603208|NCT02160314|80388569|FG001|Overall Study|Withdrawal by Subject|2|||
27603209|NCT02160314|80388568|FG000|Overall Study|Lost to Follow-up|0|||
27603210|NCT02160314|80388569|FG001|Overall Study|Lost to Follow-up|1|||
27889341|NCT00090220|81430764|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
27889342|NCT00090220|81430765|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
27889343|NCT00090220|81430766|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
27889344|NCT00090220|81430761|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
27603211|NCT00909428|80388570|FG000|Overall Study|Lost to Follow-up|13|||
27603212|NCT00909428|80388571|FG001|Overall Study|Lost to Follow-up|10|||
27603213|NCT00909428|80388572|FG002|Overall Study|Lost to Follow-up|9|||
27889345|NCT00090220|81430762|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
27889346|NCT00090220|81430763|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
27889347|NCT00090220|81430764|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
27889348|NCT00090220|81430765|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
27889349|NCT00090220|81430766|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
27889350|NCT00090220|81430761|FG000|Extension 1 (EXT1)|Other reason|0|||
27889351|NCT00090220|81430762|FG001|Extension 1 (EXT1)|Other reason|0|||
27889352|NCT00090220|81430763|FG002|Extension 1 (EXT1)|Other reason|2|||
27889353|NCT00090220|81430764|FG003|Extension 1 (EXT1)|Other reason|0|||
27889354|NCT00090220|81430765|FG004|Extension 1 (EXT1)|Other reason|0|||
27889355|NCT00090220|81430766|FG005|Extension 1 (EXT1)|Other reason|0|||
27889356|NCT00090220|81430761|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27836301|NCT00826241|81229191|FG000|Overall Study|Patient refused follow-up|3|||
27836302|NCT00826241|81229191|FG000|Overall Study|Lost to Follow-up|9|||
27836303|NCT00826241|81229191|FG000|Overall Study|Could not obtain records|1|||
27836304|NCT00826241|81229191|FG000|Overall Study|Screen failure|2|||
27836305|NCT00826241|81229191|FG000|Overall Study|Pt unable to proceed to registration|1|||
27836306|NCT00826241|81229191|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
27836307|NCT04567329|81229192|FG000|Overall Study|Withdrawal by Subject|5|||
27836308|NCT04567329|81229193|FG001|Overall Study|Withdrawal by Subject|6|||
27889357|NCT00090220|81430762|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27889358|NCT00090220|81430763|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27889359|NCT00090220|81430764|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27889360|NCT00090220|81430765|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
27889361|NCT00090220|81430766|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
27889362|NCT00090220|81430761|FG000|Long-term Follow-up (EXT2)|Death|0|||
27889363|NCT00090220|81430762|FG001|Long-term Follow-up (EXT2)|Death|0|||
27889364|NCT00090220|81430763|FG002|Long-term Follow-up (EXT2)|Death|0|||
27889365|NCT00090220|81430764|FG003|Long-term Follow-up (EXT2)|Death|0|||
27889366|NCT00090220|81430765|FG004|Long-term Follow-up (EXT2)|Death|1|||
27889367|NCT00090220|81430766|FG005|Long-term Follow-up (EXT2)|Death|1|||
27889368|NCT00090220|81430761|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27889369|NCT00090220|81430762|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27889370|NCT00090220|81430763|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27889371|NCT00090220|81430764|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27889372|NCT00090220|81430765|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
27889373|NCT00090220|81430766|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
27889374|NCT00090220|81430761|FG000|Long-term Follow-up (EXT2)|Other|0|||
27889375|NCT00090220|81430762|FG001|Long-term Follow-up (EXT2)|Other|0|||
27889376|NCT00090220|81430763|FG002|Long-term Follow-up (EXT2)|Other|0|||
27889377|NCT00090220|81430764|FG003|Long-term Follow-up (EXT2)|Other|0|||
27889378|NCT00090220|81430765|FG004|Long-term Follow-up (EXT2)|Other|1|||
27889379|NCT00090220|81430766|FG005|Long-term Follow-up (EXT2)|Other|0|||
27889380|NCT00688701|81430775|FG000|Overall Study|Adverse Event|1|||
27889381|NCT00688701|81430776|FG001|Overall Study|Adverse Event|0|||
27889382|NCT00688701|81430777|FG002|Overall Study|Adverse Event|5|||
27889383|NCT00688701|81430778|FG003|Overall Study|Adverse Event|3|||
27889384|NCT00688701|81430775|FG000|Overall Study|Lack of Efficacy|0|||
27889385|NCT00688701|81430776|FG001|Overall Study|Lack of Efficacy|1|||
27889386|NCT00688701|81430777|FG002|Overall Study|Lack of Efficacy|0|||
27889387|NCT00688701|81430778|FG003|Overall Study|Lack of Efficacy|0|||
27889388|NCT00688701|81430775|FG000|Overall Study|Withdrawal by Subject|3|||
27889389|NCT00688701|81430776|FG001|Overall Study|Withdrawal by Subject|3|||
27889390|NCT00688701|81430777|FG002|Overall Study|Withdrawal by Subject|4|||
27889391|NCT00688701|81430778|FG003|Overall Study|Withdrawal by Subject|8|||
27889392|NCT00688701|81430775|FG000|Overall Study|Poor compliance to protocol|0|||
27889393|NCT00688701|81430776|FG001|Overall Study|Poor compliance to protocol|1|||
27889394|NCT00688701|81430777|FG002|Overall Study|Poor compliance to protocol|1|||
27889395|NCT00688701|81430778|FG003|Overall Study|Poor compliance to protocol|0|||
27889396|NCT01275755|81430779|FG000|Double-blind Treatment Period|Adverse Event|0|||
27889397|NCT01275755|81430780|FG001|Double-blind Treatment Period|Adverse Event|2|||
27889398|NCT01275755|81430779|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
27889399|NCT01275755|81430780|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27889400|NCT01275755|81430779|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27889401|NCT01275755|81430780|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27889402|NCT01275755|81430779|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
27889403|NCT01275755|81430780|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
27889404|NCT02548351|81430786|FG000|Overall Study|Withdrawal by Subject|149|||
27709997|NCT02871778|80775037|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
27836309|NCT04567329|81229192|FG000|Overall Study|Protocol Violation|2|||
27889405|NCT02548351|81430787|FG001|Overall Study|Withdrawal by Subject|154|||
27889406|NCT02548351|81430788|FG002|Overall Study|Withdrawal by Subject|152|||
27889407|NCT02548351|81430786|FG000|Overall Study|Death|11|||
27889408|NCT02548351|81430787|FG001|Overall Study|Death|15|||
27889409|NCT02548351|81430788|FG002|Overall Study|Death|12|||
27889410|NCT02548351|81430786|FG000|Overall Study|Adverse Event|22|||
27889411|NCT02548351|81430787|FG001|Overall Study|Adverse Event|56|||
27889412|NCT02548351|81430788|FG002|Overall Study|Adverse Event|36|||
27709998|NCT02871778|80775038|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
27709999|NCT02871778|80775039|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
27710000|NCT02871778|80775040|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
27710001|NCT02871778|80775041|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
27710002|NCT02871778|80775042|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
27710003|NCT02871778|80775043|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
27710004|NCT02871778|80775044|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
27710005|NCT02871778|80775037|FG000|Part B: Treatment Period 3|Adverse Event|0|||
27710006|NCT02871778|80775038|FG001|Part B: Treatment Period 3|Adverse Event|0|||
27710007|NCT02871778|80775039|FG002|Part B: Treatment Period 3|Adverse Event|0|||
27710008|NCT02871778|80775040|FG003|Part B: Treatment Period 3|Adverse Event|0|||
27836310|NCT04567329|81229193|FG001|Overall Study|Protocol Violation|3|||
27836311|NCT04567329|81229192|FG000|Overall Study|Discontinued|2|||
27836312|NCT04567329|81229193|FG001|Overall Study|Discontinued|2|||
27836313|NCT04567329|81229192|FG000|Overall Study|Lost to Follow-up|0|||
27836314|NCT04567329|81229193|FG001|Overall Study|Lost to Follow-up|1|||
27836315|NCT04567329|81229192|FG000|Overall Study|Lack of Efficacy|0|||
27710009|NCT02871778|80775041|FG004|Part B: Treatment Period 3|Adverse Event|1|||
27710010|NCT02871778|80775042|FG005|Part B: Treatment Period 3|Adverse Event|1|||
27836316|NCT04567329|81229193|FG001|Overall Study|Lack of Efficacy|1|||
27836317|NCT03247686|81229198|FG000|Overall Study|Withdrawal by Subject|1|||
27836318|NCT03247686|81229199|FG001|Overall Study|Withdrawal by Subject|2|||
27836319|NCT04476277|81229204|FG000|Overall Study|Withdrawal by Subject|0|||
27836320|NCT04476277|81229205|FG001|Overall Study|Withdrawal by Subject|0|||
27836321|NCT04476277|81229206|FG002|Overall Study|Withdrawal by Subject|1|||
27836322|NCT04476277|81229207|FG003|Overall Study|Withdrawal by Subject|0|||
27836323|NCT01971645|81229208|FG000|Overall Study|Adverse Event|1|||
27836324|NCT01971645|81229209|FG001|Overall Study|Adverse Event|0|||
27836325|NCT01971645|81229210|FG002|Overall Study|Adverse Event|0|||
27836326|NCT01971645|81229208|FG000|Overall Study|Lost to Follow-up|1|||
27836327|NCT01971645|81229209|FG001|Overall Study|Lost to Follow-up|0|||
27836328|NCT01971645|81229210|FG002|Overall Study|Lost to Follow-up|1|||
27836329|NCT01971645|81229208|FG000|Overall Study|Protocol Violation|0|||
27836330|NCT01971645|81229209|FG001|Overall Study|Protocol Violation|0|||
27836331|NCT01971645|81229210|FG002|Overall Study|Protocol Violation|1|||
27603214|NCT00755222|80388573|FG000|Overall Study|Withdrawal by Subject|4|||
27710011|NCT02871778|80775043|FG006|Part B: Treatment Period 3|Adverse Event|1|||
27710012|NCT02871778|80775044|FG007|Part B: Treatment Period 3|Adverse Event|0|||
27836332|NCT03141151|81229211|FG000|Overall Study|Lost to Follow-up|3|||
27836333|NCT03141151|81229212|FG001|Overall Study|Lost to Follow-up|2|||
27836334|NCT03141151|81229211|FG000|Overall Study|Withdrawal by Subject|3|||
27889413|NCT02548351|81430786|FG000|Overall Study|Study Terminated by Sponsor|549|||
27889414|NCT02548351|81430787|FG001|Overall Study|Study Terminated by Sponsor|509|||
27836335|NCT03141151|81229212|FG001|Overall Study|Withdrawal by Subject|2|||
27836336|NCT01151280|81229213|FG000|Overall Study|Adverse Event|1|||
27889415|NCT02548351|81430788|FG002|Overall Study|Study Terminated by Sponsor|528|||
27603215|NCT00755222|80388574|FG001|Overall Study|Withdrawal by Subject|2|||
27889416|NCT02548351|81430786|FG000|Overall Study|Site Closure|14|||
27889417|NCT02548351|81430787|FG001|Overall Study|Site Closure|5|||
27889418|NCT02548351|81430788|FG002|Overall Study|Site Closure|7|||
27889419|NCT02548351|81430786|FG000|Overall Study|Non-compliance with Study Drug|4|||
27889420|NCT02548351|81430787|FG001|Overall Study|Non-compliance with Study Drug|2|||
27889421|NCT02548351|81430788|FG002|Overall Study|Non-compliance with Study Drug|0|||
27889422|NCT02548351|81430786|FG000|Overall Study|Protocol Violation|2|||
27889423|NCT02548351|81430787|FG001|Overall Study|Protocol Violation|1|||
27889424|NCT02548351|81430788|FG002|Overall Study|Protocol Violation|2|||
27603216|NCT00755222|80388573|FG000|Overall Study|Adverse Event|2|||
27603217|NCT00755222|80388574|FG001|Overall Study|Adverse Event|0|||
27603218|NCT00755222|80388573|FG000|Overall Study|Protocol Violation|2|||
27603219|NCT00755222|80388574|FG001|Overall Study|Protocol Violation|0|||
27603220|NCT03642938|80388577|FG000|Overall Study|Withdrawal by Subject|0|||
27603221|NCT03642938|80388578|FG001|Overall Study|Withdrawal by Subject|0|||
27603222|NCT03642938|80388579|FG002|Overall Study|Withdrawal by Subject|0|||
27603223|NCT03642938|80388580|FG003|Overall Study|Withdrawal by Subject|1|||
27603224|NCT01114204|80388581|FG000|Overall Study|Adverse Event|3|||
27603225|NCT01114204|80388582|FG001|Overall Study|Adverse Event|2|||
27603226|NCT01114204|80388581|FG000|Overall Study|Lost to Follow-up|1|||
27603227|NCT01114204|80388582|FG001|Overall Study|Lost to Follow-up|0|||
27603228|NCT01114204|80388581|FG000|Overall Study|Withdrawal by Subject|10|||
27603229|NCT01114204|80388582|FG001|Overall Study|Withdrawal by Subject|6|||
27603230|NCT01114204|80388581|FG000|Overall Study|Death|1|||
27603231|NCT01114204|80388582|FG001|Overall Study|Death|0|||
27603232|NCT01114204|80388581|FG000|Overall Study|Other-Personal reasons|2|||
27603233|NCT01114204|80388582|FG001|Overall Study|Other-Personal reasons|0|||
27603234|NCT01114204|80388581|FG000|Overall Study|Other-Medical monitor request|1|||
27603235|NCT01114204|80388582|FG001|Overall Study|Other-Medical monitor request|0|||
27603236|NCT01114204|80388581|FG000|Overall Study|Other-Participant request|2|||
27603237|NCT01114204|80388582|FG001|Overall Study|Other-Participant request|0|||
27603238|NCT01114204|80388581|FG000|Overall Study|Other-Protocol Violation|1|||
27603239|NCT01114204|80388582|FG001|Overall Study|Other-Protocol Violation|0|||
27603240|NCT00420199|80388583|FG000|Overall Study|Participant no longer met study criteria|1|||
27603241|NCT00420199|80388584|FG001|Overall Study|Participant no longer met study criteria|0|||
27603242|NCT00691938|80388587|FG000|Overall Study|QTc prolongation|1|||
27603243|NCT00691938|80388588|FG001|Overall Study|QTc prolongation|0|||
27603244|NCT00691938|80388589|FG002|Overall Study|QTc prolongation|0|||
27603245|NCT00691938|80388590|FG003|Overall Study|QTc prolongation|0|||
27603246|NCT00691938|80388591|FG004|Overall Study|QTc prolongation|0|||
27603247|NCT00691938|80388592|FG005|Overall Study|QTc prolongation|0|||
27603248|NCT00691938|80388593|FG006|Overall Study|QTc prolongation|0|||
27710013|NCT01516970|80775045|FG000|Overall Study|Lost to Follow-up|7|||
27710014|NCT01516970|80775046|FG001|Overall Study|Lost to Follow-up|8|||
27710015|NCT01516970|80775045|FG000|Overall Study|Adverse Event|1|||
27710016|NCT01516970|80775046|FG001|Overall Study|Adverse Event|5|||
27710017|NCT01516970|80775045|FG000|Overall Study|Withdrawal by Subject|1|||
27710018|NCT01516970|80775046|FG001|Overall Study|Withdrawal by Subject|1|||
27710019|NCT01516970|80775045|FG000|Overall Study|Other|9|||
27710020|NCT01516970|80775046|FG001|Overall Study|Other|7|||
27710021|NCT00434421|80775047|FG000|Overall Study|Withdrawal by Subject|1|||
27710022|NCT00434421|80775047|FG000|Overall Study|Non-compliance with study treatment|1|||
27710023|NCT00950664|80775049|FG000|First Intervention|Lost to Follow-up|1|||
27710024|NCT00950664|80775050|FG001|First Intervention|Lost to Follow-up|3|||
27710025|NCT00950664|80775049|FG000|First Intervention|Withdrawal by Subject|2|||
27710026|NCT00950664|80775050|FG001|First Intervention|Withdrawal by Subject|2|||
27710027|NCT00176605|80775051|FG000|Overall Study|Withdrawal by Subject|2|||
27603249|NCT04080752|80388594|FG000|Overall Study|Adverse Event|2|||
27603250|NCT04080752|80388595|FG001|Overall Study|Adverse Event|3|||
27603251|NCT04080752|80388594|FG000|Overall Study|Lack of Efficacy|1|||
27603252|NCT04080752|80388595|FG001|Overall Study|Lack of Efficacy|0|||
27603253|NCT04080752|80388594|FG000|Overall Study|Lost to Follow-up|1|||
27603254|NCT04080752|80388595|FG001|Overall Study|Lost to Follow-up|0|||
27603255|NCT04080752|80388594|FG000|Overall Study|Pregnancy|0|||
27603256|NCT04080752|80388595|FG001|Overall Study|Pregnancy|1|||
27603257|NCT04080752|80388594|FG000|Overall Study|Withdrawal by Subject|7|||
27603258|NCT04080752|80388595|FG001|Overall Study|Withdrawal by Subject|0|||
27603259|NCT04080752|80388594|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27603260|NCT04080752|80388595|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27710028|NCT02311153|80775065|FG000|Overall Study|Lost to Follow-up|5|||
27710029|NCT02311153|80775066|FG001|Overall Study|Lost to Follow-up|7|||
27710030|NCT02322125|80775067|FG000|Overall Study|Withdrawal by Subject|2|||
27710031|NCT03703102|80775069|FG000|Overall Study|Adverse Event|4|||
27710032|NCT03703102|80775070|FG001|Overall Study|Adverse Event|3|||
27710033|NCT03703102|80775071|FG002|Overall Study|Adverse Event|7|||
27710034|NCT03703102|80775072|FG003|Overall Study|Adverse Event|3|||
27710035|NCT03703102|80775073|FG004|Overall Study|Adverse Event|13|||
27710036|NCT03703102|80775069|FG000|Overall Study|Lack of Efficacy|4|||
27710037|NCT03703102|80775070|FG001|Overall Study|Lack of Efficacy|0|||
27710038|NCT03703102|80775071|FG002|Overall Study|Lack of Efficacy|1|||
27710039|NCT03703102|80775072|FG003|Overall Study|Lack of Efficacy|4|||
27710040|NCT03703102|80775073|FG004|Overall Study|Lack of Efficacy|1|||
27710041|NCT03703102|80775069|FG000|Overall Study|Lost to Follow-up|0|||
27603261|NCT04080752|80388594|FG000|Overall Study|Other|2|||
27603262|NCT04080752|80388595|FG001|Overall Study|Other|1|||
27603263|NCT03145766|80388600|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
27603264|NCT03145766|80388601|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
27603265|NCT03145766|80388602|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
27603266|NCT03145766|80388603|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
27603267|NCT03145766|80388604|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
27710042|NCT03703102|80775070|FG001|Overall Study|Lost to Follow-up|0|||
27710043|NCT03703102|80775071|FG002|Overall Study|Lost to Follow-up|1|||
27710044|NCT03703102|80775072|FG003|Overall Study|Lost to Follow-up|2|||
27836337|NCT01151280|81229213|FG000|Overall Study|Lack of Efficacy|3|||
27836338|NCT01492439|81229217|FG000|Overall Study|Withdrew from RTE|4|||
27836339|NCT01492439|81229218|FG001|Overall Study|Withdrew from RTE|9|||
27836340|NCT02817828|81229224|FG000|Overall Study|Lost to Follow-up|41|||
27836341|NCT02817828|81229224|FG000|Overall Study|Adverse event not related to bleeding|104|||
27836342|NCT02817828|81229224|FG000|Overall Study|Adverse event related to bleeding|53|||
27710045|NCT03703102|80775073|FG004|Overall Study|Lost to Follow-up|2|||
27710046|NCT03703102|80775069|FG000|Overall Study|Physician Decision|2|||
27710047|NCT03703102|80775070|FG001|Overall Study|Physician Decision|2|||
27836343|NCT02817828|81229224|FG000|Overall Study|Protocol Violation|11|||
27836344|NCT02817828|81229224|FG000|Overall Study|Pregnancy|7|||
27836345|NCT02817828|81229224|FG000|Overall Study|Pregnancy wish|15|||
27836346|NCT02817828|81229224|FG000|Overall Study|Withdrawal by Subject|78|||
27710048|NCT03703102|80775071|FG002|Overall Study|Physician Decision|2|||
27710049|NCT03703102|80775072|FG003|Overall Study|Physician Decision|2|||
27710050|NCT03703102|80775073|FG004|Overall Study|Physician Decision|4|||
27710051|NCT03703102|80775069|FG000|Overall Study|Withdrawal by Subject|7|||
27710052|NCT03703102|80775070|FG001|Overall Study|Withdrawal by Subject|5|||
27710053|NCT03703102|80775071|FG002|Overall Study|Withdrawal by Subject|5|||
27710054|NCT03703102|80775072|FG003|Overall Study|Withdrawal by Subject|5|||
27710055|NCT03703102|80775073|FG004|Overall Study|Withdrawal by Subject|9|||
27710056|NCT03703102|80775069|FG000|Overall Study|Ineligibility|0|||
27710057|NCT03703102|80775070|FG001|Overall Study|Ineligibility|0|||
27710058|NCT03703102|80775071|FG002|Overall Study|Ineligibility|1|||
27710059|NCT03703102|80775072|FG003|Overall Study|Ineligibility|0|||
27710060|NCT03703102|80775073|FG004|Overall Study|Ineligibility|0|||
27710061|NCT03703102|80775069|FG000|Overall Study|Protocol Deviation|4|||
27710062|NCT03703102|80775070|FG001|Overall Study|Protocol Deviation|4|||
27710063|NCT03703102|80775071|FG002|Overall Study|Protocol Deviation|3|||
27710064|NCT03703102|80775072|FG003|Overall Study|Protocol Deviation|0|||
27710065|NCT03703102|80775073|FG004|Overall Study|Protocol Deviation|0|||
27710066|NCT03703102|80775069|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27836347|NCT02817828|81229224|FG000|Overall Study|Other|26|||
27836348|NCT01229150|81229225|FG000|Overall Study|Toxicity|2|||
27889425|NCT02548351|81430786|FG000|Overall Study|Physician Decision|11|||
27889426|NCT02548351|81430787|FG001|Overall Study|Physician Decision|18|||
27710067|NCT03703102|80775070|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27710068|NCT03703102|80775071|FG002|Overall Study|Non-Compliance with Study Drug|2|||
27710069|NCT03703102|80775072|FG003|Overall Study|Non-Compliance with Study Drug|1|||
27710070|NCT03703102|80775073|FG004|Overall Study|Non-Compliance with Study Drug|4|||
27710071|NCT02257372|80775074|FG000|Overall Study|Adverse Event|3|||
27710072|NCT02257372|80775075|FG001|Overall Study|Adverse Event|7|||
27710073|NCT02257372|80775074|FG000|Overall Study|Lack of Efficacy|2|||
27836349|NCT01229150|81229226|FG001|Overall Study|Toxicity|2|||
27836350|NCT01229150|81229227|FG002|Overall Study|Toxicity|0|||
27836351|NCT01229150|81229228|FG003|Overall Study|Toxicity|0|||
27889427|NCT02548351|81430788|FG002|Overall Study|Physician Decision|11|||
27603268|NCT03145766|80388600|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
27710074|NCT02257372|80775075|FG001|Overall Study|Lack of Efficacy|1|||
27710075|NCT02257372|80775074|FG000|Overall Study|Protocol Violation|1|||
27710076|NCT02257372|80775075|FG001|Overall Study|Protocol Violation|1|||
27710077|NCT02257372|80775074|FG000|Overall Study|Lost to Follow-up|0|||
27710078|NCT02257372|80775075|FG001|Overall Study|Lost to Follow-up|1|||
27710079|NCT02257372|80775074|FG000|Overall Study|Withdrew consent|1|||
27710080|NCT02257372|80775075|FG001|Overall Study|Withdrew consent|0|||
27603269|NCT03145766|80388601|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
27710081|NCT02263079|80775078|FG000|Overall Study|Physician Decision|1|||
27710082|NCT02263079|80775079|FG001|Overall Study|Physician Decision|0|||
27710083|NCT02263079|80775080|FG002|Overall Study|Physician Decision|0|||
27710084|NCT02263079|80775078|FG000|Overall Study|Withdrawal by Subject|2|||
27710085|NCT02263079|80775079|FG001|Overall Study|Withdrawal by Subject|8|||
27710086|NCT02263079|80775080|FG002|Overall Study|Withdrawal by Subject|0|||
27710087|NCT00957528|80775081|FG000|Overall Study|Protocol Violation|0|||
27710088|NCT00957528|80775082|FG001|Overall Study|Protocol Violation|1|||
27710089|NCT00957528|80775083|FG002|Overall Study|Protocol Violation|0|||
27710090|NCT00957528|80775081|FG000|Overall Study|Withdrawal by Subject|0|||
27710091|NCT00957528|80775082|FG001|Overall Study|Withdrawal by Subject|0|||
27710092|NCT00957528|80775083|FG002|Overall Study|Withdrawal by Subject|1|||
27710093|NCT00175877|80775084|FG000|Overall Study|Adverse Event|136|||
27710094|NCT00175877|80775084|FG000|Overall Study|Withdrawal by Subject|141|||
27710095|NCT00175877|80775084|FG000|Overall Study|Lost to Follow-up|9|||
27710096|NCT00175877|80775084|FG000|Overall Study|Lack of Efficacy|26|||
27710097|NCT00175877|80775084|FG000|Overall Study|Protocol Violation|15|||
27710098|NCT00175877|80775084|FG000|Overall Study|Other Reason|20|||
27710099|NCT00175877|80775084|FG000|Overall Study|AE & Other|1|||
27710100|NCT00175877|80775084|FG000|Overall Study|Withdrawal by subject & Other|1|||
27710101|NCT02614859|80775085|FG000|Overall Study|Physician Decision|0|||
27710102|NCT02614859|80775086|FG001|Overall Study|Physician Decision|1|||
27710103|NCT00549939|80775087|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
27710104|NCT00549939|80775088|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
27710105|NCT00549939|80775089|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
27710106|NCT00549939|80775087|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
27836352|NCT03201003|81229229|FG000|Overall Study|Adverse Event|14|||
27836353|NCT03201003|81229230|FG001|Overall Study|Adverse Event|1|||
27836354|NCT03201003|81229229|FG000|Overall Study|Other reasons|5|||
27836355|NCT03201003|81229230|FG001|Overall Study|Other reasons|1|||
27836356|NCT03201003|81229229|FG000|Overall Study|Withdrawal by Subject|4|||
27836357|NCT03201003|81229230|FG001|Overall Study|Withdrawal by Subject|1|||
27836358|NCT03201003|81229229|FG000|Overall Study|Lost to Follow-up|2|||
27836359|NCT03201003|81229230|FG001|Overall Study|Lost to Follow-up|0|||
27836360|NCT03201003|81229229|FG000|Overall Study|Protocol Violation|1|||
27836361|NCT03201003|81229230|FG001|Overall Study|Protocol Violation|0|||
27836362|NCT01824498|81229233|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
27836363|NCT01824498|81229234|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
27836364|NCT01824498|81229235|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
27603270|NCT03145766|80388602|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
27710107|NCT00549939|80775088|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
27710108|NCT00549939|80775089|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
27836365|NCT01824498|81229236|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
27836366|NCT01824498|81229237|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
27836367|NCT01824498|81229238|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
27710109|NCT00549939|80775087|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
27836368|NCT00958724|81229239|FG000|Overall Study|Disease Progression|6|||
27710110|NCT00549939|80775088|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
27710111|NCT00549939|80775089|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
27710112|NCT00549939|80775087|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
27710113|NCT00549939|80775088|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
27710114|NCT00549939|80775089|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
27710115|NCT00549939|80775087|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
27710116|NCT00549939|80775088|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
27710117|NCT00549939|80775089|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
27710118|NCT00549939|80775087|FG000|40-week Open Label Treatment Period|Other|0|||
27710119|NCT00549939|80775088|FG001|40-week Open Label Treatment Period|Other|1|||
27710120|NCT00549939|80775089|FG002|40-week Open Label Treatment Period|Other|4|||
27710121|NCT04649255|80775090|FG000|Overall Study|Death|9|||
27710122|NCT04649255|80775090|FG000|Overall Study|Withdrawal by Subject|1|||
27710123|NCT01505634|80775091|FG000|Overall Study|Withdrawal by Subject|2|||
27710124|NCT01505634|80775092|FG001|Overall Study|Withdrawal by Subject|5|||
27710125|NCT01505634|80775093|FG002|Overall Study|Withdrawal by Subject|1|||
27710126|NCT01505634|80775091|FG000|Overall Study|Physician Decision|1|||
27710127|NCT01505634|80775092|FG001|Overall Study|Physician Decision|1|||
27710128|NCT01505634|80775093|FG002|Overall Study|Physician Decision|0|||
27710129|NCT01505634|80775091|FG000|Overall Study|Adverse Event|1|||
27710130|NCT01505634|80775092|FG001|Overall Study|Adverse Event|0|||
27710131|NCT01505634|80775093|FG002|Overall Study|Adverse Event|0|||
27710132|NCT01505634|80775091|FG000|Overall Study|Insufficient supply of drug at site|1|||
27710133|NCT01505634|80775092|FG001|Overall Study|Insufficient supply of drug at site|0|||
27710134|NCT01505634|80775093|FG002|Overall Study|Insufficient supply of drug at site|0|||
27710135|NCT01505634|80775091|FG000|Overall Study|Protocol Violation|2|||
27710136|NCT01505634|80775092|FG001|Overall Study|Protocol Violation|0|||
27710137|NCT01505634|80775093|FG002|Overall Study|Protocol Violation|0|||
27710138|NCT01505634|80775091|FG000|Overall Study|Lost to Follow-up|1|||
27710139|NCT01505634|80775092|FG001|Overall Study|Lost to Follow-up|4|||
27710140|NCT01505634|80775093|FG002|Overall Study|Lost to Follow-up|4|||
27710141|NCT01505634|80775091|FG000|Overall Study|Death|1|||
27710142|NCT01505634|80775092|FG001|Overall Study|Death|0|||
27710143|NCT01505634|80775093|FG002|Overall Study|Death|0|||
27710144|NCT01505634|80775091|FG000|Overall Study|In a conflict zone|0|||
27710145|NCT01505634|80775092|FG001|Overall Study|In a conflict zone|0|||
27710146|NCT01505634|80775093|FG002|Overall Study|In a conflict zone|1|||
27710147|NCT02164929|80775097|FG000|Overall Study|Converted to open procedure|1|||
27710148|NCT02164929|80775098|FG001|Overall Study|Converted to open procedure|0|||
27710149|NCT02164929|80775099|FG002|Overall Study|Converted to open procedure|0|||
27710150|NCT02164929|80775100|FG003|Overall Study|Converted to open procedure|2|||
27710151|NCT02164929|80775097|FG000|Overall Study|Failed regional block|0|||
27710152|NCT02164929|80775098|FG001|Overall Study|Failed regional block|0|||
27710153|NCT02164929|80775099|FG002|Overall Study|Failed regional block|1|||
27710154|NCT02164929|80775100|FG003|Overall Study|Failed regional block|0|||
27710155|NCT01838616|80775101|FG000|Titration Period|Adverse Event|18|||
27710156|NCT01838616|80775102|FG001|Titration Period|Adverse Event|48|||
27710157|NCT01838616|80775101|FG000|Titration Period|Lack of Efficacy|5|||
27710158|NCT01838616|80775102|FG001|Titration Period|Lack of Efficacy|12|||
27710159|NCT01838616|80775101|FG000|Titration Period|Withdrawal by Subject|5|||
27710160|NCT01838616|80775102|FG001|Titration Period|Withdrawal by Subject|5|||
27710161|NCT01838616|80775101|FG000|Titration Period|Technical problems|1|||
27710162|NCT01838616|80775102|FG001|Titration Period|Technical problems|0|||
27710163|NCT01838616|80775101|FG000|Titration Period|Other|1|||
27710164|NCT01838616|80775102|FG001|Titration Period|Other|0|||
27710165|NCT01838616|80775101|FG000|Titration Period|Protocol Violation|0|||
27710166|NCT01838616|80775102|FG001|Titration Period|Protocol Violation|1|||
27710167|NCT01838616|80775101|FG000|Continuation Period|Lack of Efficacy|3|||
27603271|NCT03145766|80388603|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
27603272|NCT03145766|80388604|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
27603273|NCT03145766|80388600|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
27603274|NCT03145766|80388601|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
27603275|NCT03145766|80388602|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
27603276|NCT03145766|80388603|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
27603277|NCT03145766|80388604|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
27603278|NCT03145766|80388600|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
27889428|NCT02548351|81430786|FG000|Overall Study|Lost to Follow-up|43|||
27889429|NCT02548351|81430787|FG001|Overall Study|Lost to Follow-up|50|||
27889430|NCT02548351|81430788|FG002|Overall Study|Lost to Follow-up|57|||
27889431|NCT02548351|81430786|FG000|Overall Study|Other|19|||
27889432|NCT02548351|81430787|FG001|Overall Study|Other|16|||
27889433|NCT02548351|81430788|FG002|Overall Study|Other|20|||
27889434|NCT02548351|81430786|FG000|Overall Study|Missing|1|||
27889435|NCT02548351|81430787|FG001|Overall Study|Missing|1|||
27889436|NCT02548351|81430788|FG002|Overall Study|Missing|0|||
27889437|NCT00471718|81430790|FG000|Overall Study|Adverse Event|3|||
27889438|NCT00471718|81430790|FG000|Overall Study|other complicating disease|1|||
27889439|NCT00471718|81430790|FG000|Overall Study|disease progression|22|||
27889440|NCT00471718|81430790|FG000|Overall Study|Withdrawal by Subject|1|||
27889441|NCT02163447|81430791|FG000|Overall Study|Withdrawal by Subject|2|||
27889442|NCT02163447|81430792|FG001|Overall Study|Withdrawal by Subject|0|||
27889443|NCT02163447|81430793|FG002|Overall Study|Withdrawal by Subject|1|||
27603279|NCT03145766|80388601|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
27603280|NCT03145766|80388602|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
27603281|NCT03145766|80388603|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
27603282|NCT03145766|80388604|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
27603283|NCT03145766|80388600|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
27710168|NCT01838616|80775102|FG001|Continuation Period|Lack of Efficacy|5|||
27710169|NCT01838616|80775101|FG000|Continuation Period|Adverse Event|8|||
27889444|NCT02163447|81430791|FG000|Overall Study|Lost to Follow-up|1|||
27889445|NCT02163447|81430792|FG001|Overall Study|Lost to Follow-up|3|||
27889446|NCT02163447|81430793|FG002|Overall Study|Lost to Follow-up|0|||
27889447|NCT02163447|81430791|FG000|Overall Study|Moved out of study area|2|||
27710170|NCT01838616|80775102|FG001|Continuation Period|Adverse Event|4|||
27710171|NCT01838616|80775101|FG000|Continuation Period|Protocol Violation|2|||
27710172|NCT01838616|80775102|FG001|Continuation Period|Protocol Violation|0|||
27710173|NCT01838616|80775101|FG000|Continuation Period|Lost to Follow-up|1|||
27710174|NCT01838616|80775102|FG001|Continuation Period|Lost to Follow-up|0|||
27710175|NCT01838616|80775101|FG000|Continuation Period|Withdrawal by Subject|0|||
27710176|NCT01838616|80775102|FG001|Continuation Period|Withdrawal by Subject|4|||
27710177|NCT01838616|80775101|FG000|Continuation Period|Technical problems|0|||
27710178|NCT01838616|80775102|FG001|Continuation Period|Technical problems|1|||
27710179|NCT01838616|80775101|FG000|Pick-up Arm|Lack of Efficacy|4|||
27710180|NCT01838616|80775102|FG001|Pick-up Arm|Lack of Efficacy|0|||
27710181|NCT01838616|80775101|FG000|Pick-up Arm|Adverse Event|9|||
27710182|NCT01838616|80775102|FG001|Pick-up Arm|Adverse Event|0|||
27710183|NCT01838616|80775101|FG000|Pick-up Arm|Withdrawal by Subject|1|||
27710184|NCT01838616|80775102|FG001|Pick-up Arm|Withdrawal by Subject|0|||
27710185|NCT01838616|80775101|FG000|Pick-up Arm|Technical problems|1|||
27710186|NCT01838616|80775102|FG001|Pick-up Arm|Technical problems|0|||
27710187|NCT01785160|80775105|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
27710188|NCT01785160|80775105|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
27710189|NCT03332498|80775106|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
27710190|NCT03332498|80775107|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
27710191|NCT03332498|80775108|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
27710192|NCT01328951|80775111|FG000|Overall Study|Disease Progression|17|||
27836369|NCT04148287|81229240|FG000|Overall Study|Death|2|||
27836370|NCT00160524|81229251|FG000|Overall Study|Adverse Event|119|||
27836371|NCT00160524|81229251|FG000|Overall Study|Adverse Event and Other|94|||
27836372|NCT00160524|81229251|FG000|Overall Study|Protocol Violation|16|||
27836373|NCT00160524|81229251|FG000|Overall Study|Protocol Violation and Other|2|||
27836374|NCT00160524|81229251|FG000|Overall Study|Withdrawal by Subject|141|||
27836375|NCT00160524|81229251|FG000|Overall Study|Withdrawal by Subject and Other|17|||
27836376|NCT00160524|81229251|FG000|Overall Study|Physician Decision|27|||
27836377|NCT00160524|81229251|FG000|Overall Study|Physician Decision and Other|6|||
27836378|NCT00160524|81229251|FG000|Overall Study|Lost to Follow-up|13|||
27836379|NCT00160524|81229251|FG000|Overall Study|Lost to Follow-up and Other|1|||
27836380|NCT00160524|81229251|FG000|Overall Study|Lack of Efficacy|21|||
27836381|NCT00160524|81229251|FG000|Overall Study|Lack of Efficacy and Other|1|||
27836382|NCT00160524|81229251|FG000|Overall Study|Other|20|||
27836383|NCT02119936|81229252|FG000|Overall Study|Lost to Follow-up|10|||
27836384|NCT02661022|81229258|FG000|Overall Study|Withdrawal by Subject|3|||
27836385|NCT02661022|81229259|FG001|Overall Study|Withdrawal by Subject|0|||
27836386|NCT02661022|81229258|FG000|Overall Study|Adverse Event|1|||
27836387|NCT02661022|81229259|FG001|Overall Study|Adverse Event|1|||
27836388|NCT02661022|81229258|FG000|Overall Study|Physician Decision|1|||
27836389|NCT02661022|81229259|FG001|Overall Study|Physician Decision|0|||
27836390|NCT02661022|81229258|FG000|Overall Study|Progressive Disease|2|||
27836391|NCT02661022|81229259|FG001|Overall Study|Progressive Disease|1|||
27836392|NCT02472639|81229266|FG000|Overall Study|Physician Decision|4|||
27836393|NCT02472639|81229267|FG001|Overall Study|Physician Decision|3|||
27836394|NCT00494013|81229272|FG000|Overall Study|Adverse Event|0|||
27836395|NCT00494013|81229273|FG001|Overall Study|Adverse Event|1|||
27836396|NCT00494013|81229272|FG000|Overall Study|Entry Criteria Not Met|1|||
27836397|NCT00494013|81229273|FG001|Overall Study|Entry Criteria Not Met|4|||
27836398|NCT00494013|81229272|FG000|Overall Study|Lost to Follow-up|5|||
27836399|NCT00494013|81229273|FG001|Overall Study|Lost to Follow-up|6|||
27836400|NCT00494013|81229272|FG000|Overall Study|Physician Decision|3|||
27836401|NCT00494013|81229273|FG001|Overall Study|Physician Decision|5|||
27836402|NCT00494013|81229272|FG000|Overall Study|Protocol Violation|8|||
27836403|NCT00494013|81229273|FG001|Overall Study|Protocol Violation|5|||
27710193|NCT01328951|80775112|FG001|Overall Study|Disease Progression|14|||
27836404|NCT00494013|81229272|FG000|Overall Study|Withdrawal by Subject|13|||
27836405|NCT00494013|81229273|FG001|Overall Study|Withdrawal by Subject|14|||
27836406|NCT00494013|81229272|FG000|Overall Study|Sponsor Decision|0|||
27836407|NCT00494013|81229273|FG001|Overall Study|Sponsor Decision|1|||
27710194|NCT01328951|80775111|FG000|Overall Study|Adverse Event|2|||
27710195|NCT01328951|80775112|FG001|Overall Study|Adverse Event|0|||
27710196|NCT01328951|80775111|FG000|Overall Study|Death|243|||
27710197|NCT01328951|80775112|FG001|Overall Study|Death|258|||
27710198|NCT01328951|80775111|FG000|Overall Study|Lost to Follow-up|6|||
27710199|NCT01328951|80775112|FG001|Overall Study|Lost to Follow-up|7|||
27710200|NCT01328951|80775111|FG000|Overall Study|Withdrawal by Subject|6|||
27710201|NCT01328951|80775112|FG001|Overall Study|Withdrawal by Subject|6|||
27710202|NCT01328951|80775111|FG000|Overall Study|Study Closed by the Sponsor|36|||
27710203|NCT01328951|80775112|FG001|Overall Study|Study Closed by the Sponsor|31|||
27710204|NCT01328951|80775111|FG000|Overall Study|Other|11|||
27710205|NCT01328951|80775112|FG001|Overall Study|Other|6|||
27710206|NCT01251653|80775113|FG000|Overall Study|Progressive Disease|1|||
27710207|NCT01251653|80775114|FG001|Overall Study|Progressive Disease|7|||
27710208|NCT01251653|80775115|FG002|Overall Study|Progressive Disease|16|||
27710209|NCT01251653|80775116|FG003|Overall Study|Progressive Disease|4|||
27603284|NCT03145766|80388601|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
27603285|NCT03145766|80388602|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
27603286|NCT03145766|80388603|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
27603287|NCT03145766|80388604|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
27603288|NCT03145766|80388600|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
27603289|NCT03145766|80388601|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
27710210|NCT01251653|80775117|FG004|Overall Study|Progressive Disease|0|||
27710211|NCT01251653|80775118|FG005|Overall Study|Progressive Disease|17|||
27710212|NCT01251653|80775119|FG006|Overall Study|Progressive Disease|14|||
27710213|NCT01251653|80775120|FG007|Overall Study|Progressive Disease|7|||
27710214|NCT01251653|80775121|FG008|Overall Study|Progressive Disease|5|||
27710215|NCT01251653|80775113|FG000|Overall Study|Dose-limiting toxicity|0|||
27710216|NCT01251653|80775114|FG001|Overall Study|Dose-limiting toxicity|1|||
27710217|NCT01251653|80775115|FG002|Overall Study|Dose-limiting toxicity|1|||
27710218|NCT01251653|80775116|FG003|Overall Study|Dose-limiting toxicity|1|||
27710219|NCT01251653|80775117|FG004|Overall Study|Dose-limiting toxicity|0|||
27710220|NCT01251653|80775118|FG005|Overall Study|Dose-limiting toxicity|0|||
27710221|NCT01251653|80775119|FG006|Overall Study|Dose-limiting toxicity|2|||
27710222|NCT01251653|80775120|FG007|Overall Study|Dose-limiting toxicity|0|||
27710223|NCT01251653|80775121|FG008|Overall Study|Dose-limiting toxicity|0|||
27710224|NCT01251653|80775113|FG000|Overall Study|Adverse Event|1|||
27710225|NCT01251653|80775114|FG001|Overall Study|Adverse Event|0|||
27710226|NCT01251653|80775115|FG002|Overall Study|Adverse Event|2|||
27710227|NCT01251653|80775116|FG003|Overall Study|Adverse Event|1|||
27710228|NCT01251653|80775117|FG004|Overall Study|Adverse Event|1|||
27710229|NCT01251653|80775118|FG005|Overall Study|Adverse Event|0|||
27710230|NCT01251653|80775119|FG006|Overall Study|Adverse Event|2|||
27710231|NCT01251653|80775120|FG007|Overall Study|Adverse Event|2|||
27710232|NCT01251653|80775121|FG008|Overall Study|Adverse Event|1|||
27710233|NCT01251653|80775113|FG000|Overall Study|Withdrawal by Subject|1|||
27710234|NCT01251653|80775114|FG001|Overall Study|Withdrawal by Subject|0|||
27710235|NCT01251653|80775115|FG002|Overall Study|Withdrawal by Subject|1|||
27710236|NCT01251653|80775116|FG003|Overall Study|Withdrawal by Subject|0|||
27710237|NCT01251653|80775117|FG004|Overall Study|Withdrawal by Subject|1|||
27710238|NCT01251653|80775118|FG005|Overall Study|Withdrawal by Subject|1|||
27710239|NCT01251653|80775119|FG006|Overall Study|Withdrawal by Subject|0|||
27710240|NCT01251653|80775120|FG007|Overall Study|Withdrawal by Subject|1|||
27710241|NCT01251653|80775121|FG008|Overall Study|Withdrawal by Subject|0|||
27710242|NCT01251653|80775113|FG000|Overall Study|Other reason not mentioned above|0|||
27836408|NCT05562011|81229275|FG000|Overall Study|Withdrawal by Subject|3|||
27836409|NCT05562011|81229275|FG000|Overall Study|Lost to Follow-up|1|||
27836410|NCT05562011|81229275|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
27836411|NCT05562011|81229275|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
27603290|NCT03145766|80388602|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
27603291|NCT03145766|80388603|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
27710243|NCT01251653|80775114|FG001|Overall Study|Other reason not mentioned above|0|||
27710244|NCT01251653|80775115|FG002|Overall Study|Other reason not mentioned above|0|||
27710245|NCT01251653|80775116|FG003|Overall Study|Other reason not mentioned above|0|||
27710246|NCT01251653|80775117|FG004|Overall Study|Other reason not mentioned above|0|||
27710247|NCT01251653|80775118|FG005|Overall Study|Other reason not mentioned above|0|||
27710248|NCT01251653|80775119|FG006|Overall Study|Other reason not mentioned above|0|||
27710249|NCT01251653|80775120|FG007|Overall Study|Other reason not mentioned above|2|||
27710250|NCT01251653|80775121|FG008|Overall Study|Other reason not mentioned above|0|||
27710251|NCT04518462|80775126|FG000|Overall Study|Withdrawal by Subject|0|||
27710252|NCT04518462|80775127|FG001|Overall Study|Withdrawal by Subject|0|||
27603292|NCT03145766|80388604|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
27710253|NCT04518462|80775128|FG002|Overall Study|Withdrawal by Subject|1|||
27710254|NCT04518462|80775126|FG000|Overall Study|Physician Decision|1|||
27710255|NCT04518462|80775127|FG001|Overall Study|Physician Decision|1|||
27710256|NCT04518462|80775128|FG002|Overall Study|Physician Decision|0|||
27710257|NCT03221751|80775129|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
27710258|NCT03221751|80775130|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
27710259|NCT04744207|80775131|FG000|Treatment|Withdrawal by Subject|2|||
27710260|NCT04744207|80775132|FG001|Treatment|Withdrawal by Subject|0|||
27710261|NCT04744207|80775131|FG000|Treatment|Adverse Event|1|||
27710262|NCT04744207|80775132|FG001|Treatment|Adverse Event|2|||
27710263|NCT01265797|80775133|FG000|Run-in Month|Withdrawal by Subject|0|||
27710264|NCT01265797|80775134|FG001|Run-in Month|Withdrawal by Subject|4|||
27710265|NCT01265797|80775133|FG000|Run-in Month|1st seizure during run-in month|0|||
27710266|NCT01265797|80775134|FG001|Run-in Month|1st seizure during run-in month|1|||
27710267|NCT01265797|80775133|FG000|Blinded Month|Lack of Efficacy|5|||
27710268|NCT01265797|80775134|FG001|Blinded Month|Lack of Efficacy|0|||
27710269|NCT01265797|80775133|FG000|Blinded Month|Lost to Follow-up|1|||
27710270|NCT01265797|80775134|FG001|Blinded Month|Lost to Follow-up|0|||
27710271|NCT01265797|80775133|FG000|Blinded Month|Protocol Violation|2|||
27710272|NCT01265797|80775134|FG001|Blinded Month|Protocol Violation|1|||
27710273|NCT01265797|80775133|FG000|Blinded Month|Adverse Event|2|||
27710274|NCT01265797|80775134|FG001|Blinded Month|Adverse Event|0|||
27603293|NCT03145766|80388600|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
27603294|NCT03145766|80388601|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
27603295|NCT03145766|80388602|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
27603296|NCT03145766|80388603|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
27603297|NCT03145766|80388604|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
27603298|NCT00903786|80388613|FG000|Overall Study|Physician Decision|6|||
27603299|NCT00903786|80388613|FG000|Overall Study|Lack of Efficacy|5|||
27603300|NCT00903786|80388613|FG000|Overall Study|Reason other than lack of efficacy|4|||
27603301|NCT00499863|80388614|FG000|Overall Study|Lack of Efficacy|21|||
27710275|NCT01265797|80775133|FG000|Blinded Month|Diary data incomplete|0|||
27710276|NCT01265797|80775134|FG001|Blinded Month|Diary data incomplete|1|||
27710277|NCT01265797|80775133|FG000|Open Label Month|Lost to Follow-up|0|||
27710278|NCT01265797|80775134|FG001|Open Label Month|Lost to Follow-up|1|||
27710279|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
27710280|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
27710281|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
27710282|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
27836412|NCT05562011|81229275|FG000|Overall Study|Device malfunction|13|||
27836413|NCT01624233|81229276|FG000|Period 2 - Induction|Adverse Event|1|||
27836414|NCT01624233|81229276|FG000|Period 3 - Maintenance|Adverse Event|2|||
27836415|NCT01624233|81229276|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
27836416|NCT01624233|81229276|FG000|Period 3 - Maintenance|Physician Decision|2|||
27836417|NCT01624233|81229276|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
27836418|NCT01624233|81229276|FG000|Period 4 - Drug Free Period|Relapsed|61|||
27836419|NCT01624233|81229276|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
27836420|NCT01624233|81229276|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
27836421|NCT01624233|81229276|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
27603302|NCT00499863|80388615|FG001|Overall Study|Lack of Efficacy|27|||
27603303|NCT00499863|80388614|FG000|Overall Study|Protocol Violation|12|||
27603304|NCT00499863|80388615|FG001|Overall Study|Protocol Violation|7|||
27603305|NCT00499863|80388614|FG000|Overall Study|Withdrawal by Subject|6|||
27603306|NCT00499863|80388615|FG001|Overall Study|Withdrawal by Subject|4|||
27603307|NCT00499863|80388614|FG000|Overall Study|Adverse Event|8|||
27603308|NCT00499863|80388615|FG001|Overall Study|Adverse Event|2|||
27603309|NCT00499863|80388614|FG000|Overall Study|Sponsor decision|2|||
27603310|NCT00499863|80388615|FG001|Overall Study|Sponsor decision|2|||
27603311|NCT00499863|80388614|FG000|Overall Study|Lost to Follow-up|1|||
27603312|NCT00499863|80388615|FG001|Overall Study|Lost to Follow-up|1|||
27603313|NCT01960725|80388618|FG000|Overall Study|Lost to Follow-up|4|||
27603314|NCT01960725|80388619|FG001|Overall Study|Lost to Follow-up|3|||
27603315|NCT01960725|80388618|FG000|Overall Study|Withdrawal by Subject|1|||
27603316|NCT01960725|80388619|FG001|Overall Study|Withdrawal by Subject|0|||
27603317|NCT01960725|80388618|FG000|Overall Study|unable to obtain blood sample|1|||
27603318|NCT01960725|80388619|FG001|Overall Study|unable to obtain blood sample|2|||
27603319|NCT00652938|80388622|FG000|Overall Study|Adverse Event|1|||
27603320|NCT00652938|80388623|FG001|Overall Study|Adverse Event|0|||
27603321|NCT00652938|80388624|FG002|Overall Study|Adverse Event|2|||
27603322|NCT00652938|80388622|FG000|Overall Study|Withdrawal by Subject|0|||
27710283|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
27710284|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
27710285|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
27710286|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
27710287|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
27603323|NCT00652938|80388623|FG001|Overall Study|Withdrawal by Subject|6|||
27603324|NCT00652938|80388624|FG002|Overall Study|Withdrawal by Subject|1|||
27603325|NCT00652938|80388622|FG000|Overall Study|Lost to Follow-up|0|||
27710288|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
27710289|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
27710290|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
27710291|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
27710292|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
27710293|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
27710294|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
27710295|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
27710296|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
27710297|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
27710298|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
27710299|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
27710300|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
27710301|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
27710302|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
27710303|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Death|2|||
27710304|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Death|1|||
27710305|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Death|0|||
27710306|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Death|0|||
27710307|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
27710308|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
27710309|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
27710310|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
27710311|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
27710312|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
27710313|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
27710314|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
27710315|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
27603326|NCT00652938|80388623|FG001|Overall Study|Lost to Follow-up|0|||
27710316|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
27710317|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
27710318|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
27710319|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
27889448|NCT02163447|81430792|FG001|Overall Study|Moved out of study area|3|||
27889449|NCT02163447|81430793|FG002|Overall Study|Moved out of study area|2|||
27889450|NCT02163447|81430791|FG000|Overall Study|Became HIV infected at time of delivery|1|||
27889451|NCT02163447|81430792|FG001|Overall Study|Became HIV infected at time of delivery|0|||
27889452|NCT02163447|81430793|FG002|Overall Study|Became HIV infected at time of delivery|0|||
27889453|NCT02659514|81430794|FG000|Overall Study|Adverse Event|3|||
27889454|NCT02659514|81430795|FG001|Overall Study|Adverse Event|12|||
27889455|NCT02659514|81430794|FG000|Overall Study|Disease Progression|23|||
27889456|NCT02659514|81430795|FG001|Overall Study|Disease Progression|13|||
27889457|NCT02659514|81430794|FG000|Overall Study|Withdrawal by Subject|0|||
27889458|NCT02659514|81430795|FG001|Overall Study|Withdrawal by Subject|4|||
27889459|NCT02659514|81430794|FG000|Overall Study|Lost to Follow-up|0|||
27889460|NCT02659514|81430795|FG001|Overall Study|Lost to Follow-up|1|||
27889461|NCT02659514|81430794|FG000|Overall Study|Death|6|||
27889462|NCT02659514|81430795|FG001|Overall Study|Death|1|||
27603327|NCT00652938|80388624|FG002|Overall Study|Lost to Follow-up|2|||
27603328|NCT00652938|80388622|FG000|Overall Study|fear of blood sampling|0|||
27603329|NCT00652938|80388623|FG001|Overall Study|fear of blood sampling|1|||
27603330|NCT00652938|80388624|FG002|Overall Study|fear of blood sampling|0|||
27603331|NCT00524030|80388628|FG000|Overall Study|Lack of Efficacy|10|||
27603332|NCT00524030|80388629|FG001|Overall Study|Lack of Efficacy|24|||
27603333|NCT00524030|80388628|FG000|Overall Study|Lost to Follow-up|0|||
27603334|NCT00524030|80388629|FG001|Overall Study|Lost to Follow-up|2|||
27603335|NCT00524030|80388628|FG000|Overall Study|Withdrawal by Subject|3|||
27603336|NCT00524030|80388629|FG001|Overall Study|Withdrawal by Subject|8|||
27603337|NCT00524030|80388628|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
27603338|NCT00524030|80388629|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
27603339|NCT00524030|80388628|FG000|Overall Study|Protocol Violation|0|||
27603340|NCT00524030|80388629|FG001|Overall Study|Protocol Violation|1|||
27603341|NCT00524030|80388628|FG000|Overall Study|Pregnancy|1|||
27603342|NCT00524030|80388629|FG001|Overall Study|Pregnancy|0|||
27603343|NCT00524030|80388628|FG000|Overall Study|Adverse Event|3|||
27603344|NCT00524030|80388629|FG001|Overall Study|Adverse Event|21|||
27603345|NCT00524030|80388628|FG000|Overall Study|Death|0|||
27603346|NCT00524030|80388629|FG001|Overall Study|Death|1|||
27603347|NCT02857426|80388632|FG000|Overall Study|Disease progression|34|||
27603348|NCT02857426|80388633|FG001|Overall Study|Disease progression|13|||
27603349|NCT02857426|80388632|FG000|Overall Study|Study drug toxicity|4|||
27603350|NCT02857426|80388633|FG001|Overall Study|Study drug toxicity|1|||
27603351|NCT02857426|80388632|FG000|Overall Study|Death|1|||
27603352|NCT02857426|80388633|FG001|Overall Study|Death|0|||
27603353|NCT02857426|80388632|FG000|Overall Study|Adverse event unrelated to study drug|6|||
27603354|NCT02857426|80388633|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27603355|NCT02857426|80388632|FG000|Overall Study|Participant withdrew consent|1|||
27603356|NCT02857426|80388633|FG001|Overall Study|Participant withdrew consent|1|||
27603357|NCT02857426|80388632|FG000|Overall Study|Maximum clinical benefit|1|||
27603358|NCT02857426|80388633|FG001|Overall Study|Maximum clinical benefit|0|||
27603359|NCT02857426|80388632|FG000|Overall Study|Completed treatment|0|||
27603360|NCT02857426|80388633|FG001|Overall Study|Completed treatment|2|||
27603361|NCT00985985|80388634|FG000|Overall Study|Adverse Event|4|||
27603362|NCT00985985|80388635|FG001|Overall Study|Adverse Event|2|||
27889463|NCT02659514|81430794|FG000|Overall Study|Reason Unspecified|0|||
27603363|NCT00985985|80388636|FG002|Overall Study|Adverse Event|2|||
27603364|NCT00985985|80388637|FG003|Overall Study|Adverse Event|2|||
27603365|NCT00985985|80388634|FG000|Overall Study|Lost to Follow-up|4|||
27603366|NCT00985985|80388635|FG001|Overall Study|Lost to Follow-up|11|||
27603367|NCT00985985|80388636|FG002|Overall Study|Lost to Follow-up|2|||
27603368|NCT00985985|80388637|FG003|Overall Study|Lost to Follow-up|3|||
27603369|NCT00985985|80388634|FG000|Overall Study|Protocol Violation|1|||
27603370|NCT00985985|80388635|FG001|Overall Study|Protocol Violation|2|||
27603371|NCT00985985|80388636|FG002|Overall Study|Protocol Violation|0|||
27603372|NCT00985985|80388637|FG003|Overall Study|Protocol Violation|1|||
27603373|NCT00985985|80388634|FG000|Overall Study|Lack of Efficacy|5|||
27603374|NCT00985985|80388635|FG001|Overall Study|Lack of Efficacy|6|||
27603375|NCT00985985|80388636|FG002|Overall Study|Lack of Efficacy|1|||
27603376|NCT00985985|80388637|FG003|Overall Study|Lack of Efficacy|3|||
27603377|NCT00985985|80388634|FG000|Overall Study|Withdrawal by Subject|4|||
27603378|NCT00985985|80388635|FG001|Overall Study|Withdrawal by Subject|2|||
27603379|NCT00985985|80388636|FG002|Overall Study|Withdrawal by Subject|2|||
27603380|NCT00985985|80388637|FG003|Overall Study|Withdrawal by Subject|2|||
27603381|NCT00985985|80388634|FG000|Overall Study|Other Reason|6|||
27710320|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
27710321|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
27710322|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
27710323|NCT01940471|80775135|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
27710324|NCT01940471|80775136|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
27710325|NCT01940471|80775137|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
27710326|NCT01940471|80775138|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
27710327|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
27710328|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
27710329|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
27710330|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
27710331|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
27710332|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
27710333|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
27710334|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
27710335|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
27710336|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
27710337|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
27710338|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
27710339|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
27710340|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
27710341|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
27710342|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
27710343|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
27710344|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
27710345|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
27710346|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
27710347|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
27710348|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
27710349|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
27710350|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
27710351|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
27710352|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
27710353|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
27710354|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
27710355|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
27710356|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
27710357|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
27710358|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
27710359|NCT01940471|80775135|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
27710360|NCT01940471|80775136|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
27710361|NCT01940471|80775137|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
27710362|NCT01940471|80775138|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
27710363|NCT00939783|80775139|FG000|Overall Study|Death|6|||
27710364|NCT00939783|80775139|FG000|Overall Study|Adverse Event|39|||
27710365|NCT00939783|80775139|FG000|Overall Study|Study Terminated by Sponsor|498|||
27710366|NCT00939783|80775139|FG000|Overall Study|Withdrawal by Subject|78|||
27710367|NCT00939783|80775139|FG000|Overall Study|Other|16|||
27710368|NCT00939783|80775139|FG000|Overall Study|Lost to Follow-up|8|||
27710369|NCT00939783|80775139|FG000|Overall Study|Protocol Violation|3|||
27710370|NCT00939783|80775139|FG000|Overall Study|Enrolled but not treated|1|||
27710371|NCT00833053|80775140|FG000|Overall Study|Adverse Event|4|||
27710372|NCT00833053|80775141|FG001|Overall Study|Adverse Event|0|||
27710373|NCT00833053|80775140|FG000|Overall Study|Treatment Failure|3|||
27603382|NCT00985985|80388635|FG001|Overall Study|Other Reason|1|||
27603383|NCT00985985|80388636|FG002|Overall Study|Other Reason|4|||
27603384|NCT00985985|80388637|FG003|Overall Study|Other Reason|2|||
27710374|NCT00833053|80775141|FG001|Overall Study|Treatment Failure|1|||
27710375|NCT00833053|80775140|FG000|Overall Study|Withdrawal by Subject|0|||
27710376|NCT00833053|80775141|FG001|Overall Study|Withdrawal by Subject|1|||
27710377|NCT00833053|80775140|FG000|Overall Study|Protocol Violation|2|||
27603385|NCT00659490|80388644|FG000|Overall Study|Lost to Follow-up|2|||
27710378|NCT00833053|80775141|FG001|Overall Study|Protocol Violation|1|||
27710379|NCT03803059|80775142|FG000|Overall Study|Protocol Violation|2|||
27710380|NCT03803059|80775142|FG000|Overall Study|Lost to Follow-up|1|||
27710381|NCT01471782|80775143|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
27710382|NCT01471782|80775144|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
27710383|NCT01471782|80775145|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
27710384|NCT01471782|80775146|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
27710385|NCT01471782|80775147|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
27710386|NCT01471782|80775148|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
27710387|NCT01471782|80775143|FG000|Overall Study|Lack of Efficacy|1|||
27710388|NCT01471782|80775144|FG001|Overall Study|Lack of Efficacy|2|||
27710389|NCT01471782|80775145|FG002|Overall Study|Lack of Efficacy|1|||
27710390|NCT01471782|80775146|FG003|Overall Study|Lack of Efficacy|1|||
27710391|NCT01471782|80775147|FG004|Overall Study|Lack of Efficacy|5|||
27710392|NCT01471782|80775148|FG005|Overall Study|Lack of Efficacy|18|||
27710393|NCT01471782|80775143|FG000|Overall Study|Adverse Event|1|||
27710394|NCT01471782|80775144|FG001|Overall Study|Adverse Event|1|||
27710395|NCT01471782|80775145|FG002|Overall Study|Adverse Event|2|||
27710396|NCT01471782|80775146|FG003|Overall Study|Adverse Event|2|||
27710397|NCT01471782|80775147|FG004|Overall Study|Adverse Event|3|||
27710398|NCT01471782|80775148|FG005|Overall Study|Adverse Event|1|||
27710399|NCT01471782|80775143|FG000|Overall Study|Other|0|||
27710400|NCT01471782|80775144|FG001|Overall Study|Other|0|||
27710401|NCT01471782|80775145|FG002|Overall Study|Other|1|||
27710402|NCT01471782|80775146|FG003|Overall Study|Other|1|||
27710403|NCT01471782|80775147|FG004|Overall Study|Other|6|||
27710404|NCT01471782|80775148|FG005|Overall Study|Other|5|||
27710405|NCT01471782|80775143|FG000|Overall Study|Change of Chemotherapy|1|||
27710406|NCT01471782|80775144|FG001|Overall Study|Change of Chemotherapy|1|||
27710407|NCT01471782|80775145|FG002|Overall Study|Change of Chemotherapy|0|||
27710408|NCT01471782|80775146|FG003|Overall Study|Change of Chemotherapy|0|||
27710409|NCT01471782|80775147|FG004|Overall Study|Change of Chemotherapy|1|||
27710410|NCT01471782|80775148|FG005|Overall Study|Change of Chemotherapy|4|||
27710411|NCT01471782|80775143|FG000|Overall Study|Disease Relapse|0|||
27710412|NCT01471782|80775144|FG001|Overall Study|Disease Relapse|0|||
27710413|NCT01471782|80775145|FG002|Overall Study|Disease Relapse|0|||
27710414|NCT01471782|80775146|FG003|Overall Study|Disease Relapse|1|||
27710415|NCT01471782|80775147|FG004|Overall Study|Disease Relapse|2|||
27710416|NCT01471782|80775148|FG005|Overall Study|Disease Relapse|1|||
27710417|NCT01471782|80775143|FG000|Overall Study|Physician Decision|0|||
27710418|NCT01471782|80775144|FG001|Overall Study|Physician Decision|0|||
27710419|NCT01471782|80775145|FG002|Overall Study|Physician Decision|0|||
27710420|NCT01471782|80775146|FG003|Overall Study|Physician Decision|0|||
27710421|NCT01471782|80775147|FG004|Overall Study|Physician Decision|3|||
27710422|NCT01471782|80775148|FG005|Overall Study|Physician Decision|8|||
27710423|NCT01471782|80775143|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27710424|NCT01471782|80775144|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27710425|NCT01471782|80775145|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27710426|NCT01471782|80775146|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27710427|NCT01471782|80775147|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
27710428|NCT01471782|80775148|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27710429|NCT01471782|80775143|FG000|Overall Study|Death|0|||
27710430|NCT01471782|80775144|FG001|Overall Study|Death|0|||
27710431|NCT01471782|80775145|FG002|Overall Study|Death|0|||
27710432|NCT01471782|80775146|FG003|Overall Study|Death|0|||
27710433|NCT01471782|80775147|FG004|Overall Study|Death|0|||
27710434|NCT01471782|80775148|FG005|Overall Study|Death|1|||
27710435|NCT00492752|80775149|FG000|Double Blind Treatment|Death|13|||
27710436|NCT00492752|80775150|FG001|Double Blind Treatment|Death|0|||
27710437|NCT00492752|80775151|FG002|Double Blind Treatment|Death|2|||
27710438|NCT00492752|80775152|FG003|Double Blind Treatment|Death|0|||
27710439|NCT00492752|80775149|FG000|Double Blind Treatment|Adverse Event|1|||
27710440|NCT00492752|80775150|FG001|Double Blind Treatment|Adverse Event|0|||
27836422|NCT01624233|81229276|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
27836423|NCT01624233|81229276|FG000|Period 6: Follow-up|Adverse Event|3|||
27710441|NCT00492752|80775151|FG002|Double Blind Treatment|Adverse Event|0|||
27710442|NCT00492752|80775152|FG003|Double Blind Treatment|Adverse Event|0|||
27836424|NCT01624233|81229276|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
27710443|NCT00492752|80775149|FG000|Double Blind Treatment|Protocol Violation|0|||
27710444|NCT00492752|80775150|FG001|Double Blind Treatment|Protocol Violation|0|||
27710445|NCT00492752|80775151|FG002|Double Blind Treatment|Protocol Violation|1|||
27710446|NCT00492752|80775152|FG003|Double Blind Treatment|Protocol Violation|0|||
27710447|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
27710448|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
27710449|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
27836425|NCT01624233|81229276|FG000|Period 6: Follow-up|Physician Decision|1|||
27710450|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
27603386|NCT00659490|80388645|FG001|Overall Study|Lost to Follow-up|0|||
27603387|NCT00659490|80388646|FG002|Overall Study|Lost to Follow-up|1|||
27603388|NCT00321048|80388647|FG000|Overall Study|Withdrawal by Subject|6|||
27603389|NCT00321048|80388648|FG001|Overall Study|Withdrawal by Subject|8|||
27603390|NCT04062448|80388649|FG000|Overall Study|Lost to Follow-up|1|||
27603391|NCT04062448|80388649|FG000|Overall Study|Withdrawal by Subject|2|||
27603392|NCT02227875|80388651|FG000|Overall Study|Protocol Violation|10|||
27603393|NCT02227875|80388652|FG001|Overall Study|Protocol Violation|7|||
27603394|NCT02227875|80388651|FG000|Overall Study|Other|1|||
27603395|NCT02227875|80388652|FG001|Overall Study|Other|3|||
27603396|NCT02227875|80388651|FG000|Overall Study|Physician Decision|1|||
27603397|NCT02227875|80388652|FG001|Overall Study|Physician Decision|0|||
27603398|NCT02227875|80388651|FG000|Overall Study|Adverse Event|3|||
27603399|NCT02227875|80388652|FG001|Overall Study|Adverse Event|0|||
27603400|NCT02227875|80388651|FG000|Overall Study|Withdrawal by Subject|12|||
27603401|NCT02227875|80388652|FG001|Overall Study|Withdrawal by Subject|13|||
27603402|NCT02227875|80388651|FG000|Overall Study|Lost to Follow-up|10|||
27603403|NCT02227875|80388652|FG001|Overall Study|Lost to Follow-up|10|||
27603404|NCT00982930|80388653|FG000|Overall Study|Adverse Event|1|||
27603405|NCT00982930|80388653|FG000|Overall Study|Withdrawal by Subject|1|||
27603406|NCT00982930|80388653|FG000|Overall Study|Administrative Problems|2|||
27603407|NCT02991482|80388658|FG000|Overall Study|Disease progression|56|||
27603408|NCT02991482|80388659|FG001|Overall Study|Disease progression|47|||
27603409|NCT02991482|80388658|FG000|Overall Study|Death|4|||
27603410|NCT02991482|80388659|FG001|Overall Study|Death|4|||
27603411|NCT02991482|80388658|FG000|Overall Study|Adverse Event|1|||
27603412|NCT02991482|80388659|FG001|Overall Study|Adverse Event|6|||
27603413|NCT02991482|80388658|FG000|Overall Study|Patient decision|1|||
27603414|NCT02991482|80388659|FG001|Overall Study|Patient decision|1|||
27603415|NCT02991482|80388658|FG000|Overall Study|Physician Decision|0|||
27603416|NCT02991482|80388659|FG001|Overall Study|Physician Decision|6|||
27603417|NCT02991482|80388658|FG000|Overall Study|Clinical deterioration|1|||
27603418|NCT02991482|80388659|FG001|Overall Study|Clinical deterioration|0|||
27603419|NCT02991482|80388658|FG000|Overall Study|Patient feeling too unwell|1|||
27603420|NCT02991482|80388659|FG001|Overall Study|Patient feeling too unwell|0|||
27603421|NCT02991482|80388658|FG000|Overall Study|Worsening of performance status|0|||
27603422|NCT02991482|80388659|FG001|Overall Study|Worsening of performance status|1|||
27603423|NCT02991482|80388658|FG000|Overall Study|Death prior to study drug initiation|1|||
27603424|NCT02991482|80388659|FG001|Overall Study|Death prior to study drug initiation|0|||
27603425|NCT02991482|80388658|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
27603426|NCT02991482|80388659|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
27603427|NCT01407354|80388668|FG000|First Intervention|Withdrawal by Subject|0|||
27603428|NCT01407354|80388669|FG001|First Intervention|Withdrawal by Subject|2|||
27603429|NCT01407354|80388668|FG000|First Intervention|Adverse Event|1|||
27603430|NCT01407354|80388669|FG001|First Intervention|Adverse Event|0|||
27603431|NCT01407354|80388668|FG000|First Intervention|Physician Decision|1|||
27603432|NCT01407354|80388669|FG001|First Intervention|Physician Decision|0|||
27603433|NCT02036645|80388670|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603434|NCT02036645|80388671|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603435|NCT02036645|80388672|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603436|NCT02036645|80388673|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603437|NCT02036645|80388674|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603438|NCT02036645|80388675|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603439|NCT02036645|80388676|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
27603440|NCT02036645|80388677|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603441|NCT02036645|80388678|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603442|NCT02036645|80388679|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603443|NCT02036645|80388680|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27603444|NCT02036645|80388681|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
27710451|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
27710452|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
27889464|NCT02659514|81430795|FG001|Overall Study|Reason Unspecified|3|||
27603445|NCT02036645|80388670|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603446|NCT02036645|80388671|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603447|NCT02036645|80388672|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603448|NCT02036645|80388673|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
27603449|NCT02036645|80388674|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603450|NCT02036645|80388675|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603451|NCT02036645|80388676|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603452|NCT02036645|80388677|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603453|NCT02036645|80388678|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603454|NCT02036645|80388679|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603455|NCT02036645|80388680|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603456|NCT02036645|80388681|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
27603457|NCT00224770|80388682|FG000|Overall Study|Lost to Follow-up|4|||
27710453|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
27710454|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
27710455|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
27710456|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
27710457|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
27710458|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
27710459|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
27710460|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
27710461|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
27710462|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
27710463|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
27710464|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
27710465|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
27710466|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
27710467|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
27710468|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
27710469|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
27710470|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
27710471|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
27710472|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
27710473|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
27710474|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
27710475|NCT00492752|80775149|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
27710476|NCT00492752|80775150|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
27710477|NCT00492752|80775151|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
27710478|NCT00492752|80775152|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
27710479|NCT02234479|80775157|FG000|Overall Study|Withdrawal by Subject|1|||
27710480|NCT02234479|80775158|FG001|Overall Study|Withdrawal by Subject|3|||
27710481|NCT03921424|80775159|FG000|Overall Study|Lost to Follow-up|0|||
27710482|NCT03921424|80775160|FG001|Overall Study|Lost to Follow-up|1|||
27710483|NCT03921424|80775159|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27710484|NCT03921424|80775160|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
27710485|NCT01585272|80775161|FG000|Overall Study|Adverse Event|22|||
27710486|NCT01585272|80775161|FG000|Overall Study|Protocol Violation|7|||
27710487|NCT01585272|80775161|FG000|Overall Study|Withdrawal by Subject|10|||
27710488|NCT00257725|80775162|FG000|Overall Study|Adverse Event|3|||
27710489|NCT00139776|80775165|FG000|Period I|Did not enter Period II|575|||
27710490|NCT00139776|80775166|FG001|Period I|Did not enter Period II|0|||
27710491|NCT00139776|80775167|FG002|Period I|Did not enter Period II|0|||
27710492|NCT00139776|80775168|FG003|Period I|Did not enter Period II|0|||
27710493|NCT00139776|80775165|FG000|Period II|Not Randomized into Period III|0|||
27710494|NCT00139776|80775166|FG001|Period II|Not Randomized into Period III|322|||
27710495|NCT00139776|80775167|FG002|Period II|Not Randomized into Period III|0|||
27710496|NCT00139776|80775168|FG003|Period II|Not Randomized into Period III|0|||
27710497|NCT00139776|80775165|FG000|Period III|Adverse Event|0|||
27710498|NCT00139776|80775166|FG001|Period III|Adverse Event|0|||
27710499|NCT00139776|80775167|FG002|Period III|Adverse Event|22|||
27710500|NCT00139776|80775168|FG003|Period III|Adverse Event|23|||
27710501|NCT00139776|80775165|FG000|Period III|Other|0|||
27710502|NCT00139776|80775166|FG001|Period III|Other|0|||
27710503|NCT00139776|80775167|FG002|Period III|Other|23|||
27710504|NCT00139776|80775168|FG003|Period III|Other|34|||
27836426|NCT01624233|81229276|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
27836427|NCT03234608|81229277|FG000|Overall Study|Lost to Follow-up|23|||
27836428|NCT03234608|81229278|FG001|Overall Study|Lost to Follow-up|21|||
27836429|NCT04428645|81229279|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
27836430|NCT00796328|81229280|FG000|Overall Study|experienced hypotension requiring tx|6|||
27836431|NCT00413049|81229284|FG000|Overall Study|Adverse Event|10|||
27836432|NCT00413049|81229285|FG001|Overall Study|Adverse Event|8|||
27836433|NCT00413049|81229284|FG000|Overall Study|Withdrawal by Subject|7|||
27836434|NCT00413049|81229285|FG001|Overall Study|Withdrawal by Subject|5|||
27836435|NCT00413049|81229284|FG000|Overall Study|Lost to Follow-up|2|||
27836436|NCT00413049|81229285|FG001|Overall Study|Lost to Follow-up|3|||
27836437|NCT00413049|81229284|FG000|Overall Study|Protocol Violation|3|||
27836438|NCT00413049|81229285|FG001|Overall Study|Protocol Violation|1|||
27889465|NCT02111785|81430796|FG000|Overall Study|Death|0|||
27710505|NCT00139776|80775165|FG000|Period III|Lack of Efficacy|0|||
27710506|NCT00139776|80775166|FG001|Period III|Lack of Efficacy|0|||
27710507|NCT00139776|80775167|FG002|Period III|Lack of Efficacy|10|||
27710508|NCT00139776|80775168|FG003|Period III|Lack of Efficacy|24|||
27889466|NCT02111785|81430797|FG001|Overall Study|Death|1|||
27710509|NCT00139776|80775165|FG000|Period III|Lost to Follow-up|0|||
27710510|NCT00139776|80775166|FG001|Period III|Lost to Follow-up|0|||
27710511|NCT00139776|80775167|FG002|Period III|Lost to Follow-up|5|||
27710512|NCT00139776|80775168|FG003|Period III|Lost to Follow-up|4|||
27710513|NCT00139776|80775165|FG000|Period III|Withdrawal by Subject|0|||
27710514|NCT00139776|80775166|FG001|Period III|Withdrawal by Subject|0|||
27710515|NCT00139776|80775167|FG002|Period III|Withdrawal by Subject|16|||
27710516|NCT00139776|80775168|FG003|Period III|Withdrawal by Subject|21|||
27710517|NCT02577146|80775169|FG000|Overall Study|Lost to Follow-up|8|||
27710518|NCT02577146|80775169|FG000|Overall Study|Physician Decision|3|||
27710519|NCT02577146|80775169|FG000|Overall Study|Screen Failure|17|||
27710520|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
27710521|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
27710522|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
27710523|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
27710524|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
27710525|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
27710526|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
27710527|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
27710528|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
27710529|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
27710530|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
27710531|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
27710532|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
27710533|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
27710534|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
27710535|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
27710536|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
27836439|NCT00413049|81229284|FG000|Overall Study|Subject no longer requires study drug|0|||
27836440|NCT00413049|81229285|FG001|Overall Study|Subject no longer requires study drug|1|||
27836441|NCT00413049|81229284|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27836442|NCT00413049|81229285|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27836443|NCT00413049|81229284|FG000|Overall Study|Lack of Efficacy|1|||
27836444|NCT00413049|81229285|FG001|Overall Study|Lack of Efficacy|0|||
27836445|NCT02760433|81229286|FG000|Overall Study|Lost to Follow-up|1|||
27836446|NCT02760433|81229287|FG001|Overall Study|Lost to Follow-up|0|||
27836447|NCT02760433|81229288|FG002|Overall Study|Lost to Follow-up|1|||
27836448|NCT02760433|81229289|FG003|Overall Study|Lost to Follow-up|0|||
27836449|NCT02760433|81229290|FG004|Overall Study|Lost to Follow-up|0|||
27889467|NCT02111785|81430798|FG002|Overall Study|Death|0|||
27836450|NCT02760433|81229286|FG000|Overall Study|Withdrawal by Subject|23|||
27836451|NCT02760433|81229287|FG001|Overall Study|Withdrawal by Subject|9|||
27836452|NCT02760433|81229288|FG002|Overall Study|Withdrawal by Subject|0|||
27836453|NCT02760433|81229289|FG003|Overall Study|Withdrawal by Subject|2|||
27836454|NCT02760433|81229290|FG004|Overall Study|Withdrawal by Subject|9|||
27836455|NCT02760433|81229286|FG000|Overall Study|Lack of Response At Week 14|0|||
27836456|NCT02760433|81229287|FG001|Overall Study|Lack of Response At Week 14|0|||
27836457|NCT02760433|81229288|FG002|Overall Study|Lack of Response At Week 14|0|||
27836458|NCT02760433|81229289|FG003|Overall Study|Lack of Response At Week 14|0|||
27836459|NCT02760433|81229290|FG004|Overall Study|Lack of Response At Week 14|1|||
27836460|NCT02760433|81229286|FG000|Overall Study|Subject refused to continue the study|1|||
27836461|NCT02760433|81229287|FG001|Overall Study|Subject refused to continue the study|0|||
27836462|NCT02760433|81229288|FG002|Overall Study|Subject refused to continue the study|0|||
27836463|NCT02760433|81229289|FG003|Overall Study|Subject refused to continue the study|0|||
27836464|NCT02760433|81229290|FG004|Overall Study|Subject refused to continue the study|0|||
27836465|NCT02760433|81229286|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
27836466|NCT02760433|81229287|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27836467|NCT02760433|81229288|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27603458|NCT00224770|80388683|FG001|Overall Study|Lost to Follow-up|2|||
27836468|NCT02760433|81229289|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27603459|NCT00224770|80388684|FG002|Overall Study|Lost to Follow-up|0|||
27603460|NCT04710927|80388695|FG000|Overall Study|Lost to Follow-up|7|||
27603461|NCT04710927|80388696|FG001|Overall Study|Lost to Follow-up|6|||
27603462|NCT04710927|80388697|FG002|Overall Study|Lost to Follow-up|5|||
27603463|NCT01436201|80388701|FG000|Overall Study|Adverse Event|2|||
27603464|NCT01436201|80388701|FG000|Overall Study|Withdrawal by Subject|1|||
27603465|NCT01436201|80388701|FG000|Overall Study|Protocol Violation|1|||
27603466|NCT00946296|80388704|FG000|Overall Study|Physician Decision|3|||
27603467|NCT00946296|80388705|FG001|Overall Study|Physician Decision|0|||
27603468|NCT01525602|80388710|FG000|Overall Study|Adverse Event|1|||
27603469|NCT01525602|80388711|FG001|Overall Study|Adverse Event|0|||
27603470|NCT01525602|80388712|FG002|Overall Study|Adverse Event|1|||
27603471|NCT01525602|80388713|FG003|Overall Study|Adverse Event|1|||
27603472|NCT01525602|80388714|FG004|Overall Study|Adverse Event|3|||
27603473|NCT01525602|80388715|FG005|Overall Study|Adverse Event|3|||
27603474|NCT01525602|80388716|FG006|Overall Study|Adverse Event|0|||
27603475|NCT01525602|80388717|FG007|Overall Study|Adverse Event|1|||
27603476|NCT01525602|80388710|FG000|Overall Study|Disease progression|6|||
27603477|NCT01525602|80388711|FG001|Overall Study|Disease progression|3|||
27603478|NCT01525602|80388712|FG002|Overall Study|Disease progression|2|||
27603479|NCT01525602|80388713|FG003|Overall Study|Disease progression|5|||
27603480|NCT01525602|80388714|FG004|Overall Study|Disease progression|22|||
27603481|NCT01525602|80388715|FG005|Overall Study|Disease progression|2|||
27603482|NCT01525602|80388716|FG006|Overall Study|Disease progression|3|||
27603483|NCT01525602|80388717|FG007|Overall Study|Disease progression|3|||
27603484|NCT01525602|80388710|FG000|Overall Study|Clinical progression|2|||
27603485|NCT01525602|80388711|FG001|Overall Study|Clinical progression|0|||
27603486|NCT01525602|80388712|FG002|Overall Study|Clinical progression|0|||
27603487|NCT01525602|80388713|FG003|Overall Study|Clinical progression|0|||
27603488|NCT01525602|80388714|FG004|Overall Study|Clinical progression|0|||
27603489|NCT01525602|80388715|FG005|Overall Study|Clinical progression|0|||
27603490|NCT01525602|80388716|FG006|Overall Study|Clinical progression|1|||
27603491|NCT01525602|80388717|FG007|Overall Study|Clinical progression|1|||
27603492|NCT01525602|80388710|FG000|Overall Study|Non-compliance|0|||
27836469|NCT02760433|81229290|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
27603493|NCT01525602|80388711|FG001|Overall Study|Non-compliance|0|||
27603494|NCT01525602|80388712|FG002|Overall Study|Non-compliance|0|||
27603495|NCT01525602|80388713|FG003|Overall Study|Non-compliance|0|||
27603496|NCT01525602|80388714|FG004|Overall Study|Non-compliance|1|||
27603497|NCT01525602|80388715|FG005|Overall Study|Non-compliance|0|||
27603498|NCT01525602|80388716|FG006|Overall Study|Non-compliance|0|||
27603499|NCT01525602|80388717|FG007|Overall Study|Non-compliance|0|||
27603500|NCT01525602|80388710|FG000|Overall Study|Withdrawal by Subject|0|||
27603501|NCT01525602|80388711|FG001|Overall Study|Withdrawal by Subject|0|||
27710537|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
27710538|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
27710539|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
27710540|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
27710541|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
27710542|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
27710543|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
27836470|NCT02760433|81229286|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27710544|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
27710545|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
27710546|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
27710547|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
27710548|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
27710549|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
27710550|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710551|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
27710552|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
27710553|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
27710554|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710555|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
27710556|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
27710557|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
27710558|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
27710559|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
27710560|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
27710561|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
27710562|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
27710563|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
27710564|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
27710565|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
27710566|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
27710567|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
27710568|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
27710569|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
27710570|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
27710571|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
27710572|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
27710573|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
27710574|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
27710575|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
27710576|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
27710577|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
27710578|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
27710579|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
27710580|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
27710581|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
27710582|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
27710583|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
27710584|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
27710585|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
27710586|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
27710587|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
27710588|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
27710589|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
27710590|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
27710591|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
27710592|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
27710593|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
27710594|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
27710595|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
27710596|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
27710597|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
27710598|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
27710599|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
27710600|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
27710601|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
27710602|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
27710603|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
27710604|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
27710605|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
27710606|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
27710607|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
27710608|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
27710609|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
27710610|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27710611|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27710612|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27710613|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27710614|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
27710615|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
27710616|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27710617|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27710618|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27710619|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27710620|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
27710621|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
27710622|NCT00111800|80775172|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
27710623|NCT00111800|80775173|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
27710624|NCT00111800|80775174|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
27710625|NCT00111800|80775175|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
27710626|NCT00111800|80775176|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
27710627|NCT00111800|80775177|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
27710628|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
27710629|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
27710630|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
27710631|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
27710632|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
27710633|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
27710634|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
27710635|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
27710636|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
27710637|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
27710638|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
27710639|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
27710640|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
27710641|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
27710642|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
27710643|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
27710644|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
27710645|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
27710646|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
27710647|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
27710648|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
27710649|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
27710650|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
27710651|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
27710652|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710653|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710654|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
27710655|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710656|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710657|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
27710658|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
27710659|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
27710660|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
27836471|NCT02760433|81229287|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
27710661|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
27710662|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
27710663|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
27710664|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27710665|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27710666|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
27710667|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27710668|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27710669|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
27710670|NCT00111800|80775172|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
27710671|NCT00111800|80775173|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
27710672|NCT00111800|80775174|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
27710673|NCT00111800|80775175|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
27710674|NCT00111800|80775176|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
27710675|NCT00111800|80775177|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
27710676|NCT00530270|80775178|FG000|Overall Study|Protocol Violation|1|||
27710677|NCT00530270|80775179|FG001|Overall Study|Protocol Violation|0|||
27710678|NCT02915523|80775180|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
27710679|NCT02915523|80775181|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
27710680|NCT02915523|80775182|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
27710681|NCT02915523|80775183|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
27710682|NCT02915523|80775180|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
27710683|NCT02915523|80775181|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
27710684|NCT02915523|80775182|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
27710685|NCT02915523|80775183|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
27710686|NCT02915523|80775180|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
27710687|NCT02915523|80775181|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
27710688|NCT02915523|80775182|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
27710689|NCT02915523|80775183|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
27710690|NCT02915523|80775180|FG000|Expansion Phase (Phase 2)|Death|0|||
27710691|NCT02915523|80775181|FG001|Expansion Phase (Phase 2)|Death|0|||
27710692|NCT02915523|80775182|FG002|Expansion Phase (Phase 2)|Death|26|||
27710693|NCT02915523|80775183|FG003|Expansion Phase (Phase 2)|Death|53|||
27710694|NCT02915523|80775180|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
27710695|NCT02915523|80775181|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
27710696|NCT02915523|80775182|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
27710697|NCT02915523|80775183|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
27710698|NCT02915523|80775180|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
27710699|NCT02915523|80775181|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
27710700|NCT02915523|80775182|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
27710701|NCT02915523|80775183|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
27710702|NCT02915523|80775180|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
27836472|NCT02760433|81229288|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27710703|NCT02915523|80775181|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
27710704|NCT02915523|80775182|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
27710705|NCT02915523|80775183|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
27710706|NCT01500278|80775184|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
27710707|NCT01500278|80775185|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
27710708|NCT01500278|80775184|FG000|Week 0 - Week 12|Protocol Violation|10|||
27710709|NCT01500278|80775185|FG001|Week 0 - Week 12|Protocol Violation|16|||
27710710|NCT01500278|80775184|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
27710711|NCT01500278|80775185|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
27710712|NCT01500278|80775184|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
27710713|NCT01500278|80775185|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
27710714|NCT01500278|80775184|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
27710715|NCT01500278|80775185|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
27710716|NCT01500278|80775184|FG000|Week 0 - Week 12|Patient decision|1|||
27710717|NCT01500278|80775185|FG001|Week 0 - Week 12|Patient decision|0|||
27710718|NCT01500278|80775184|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
27710719|NCT01500278|80775185|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
27710720|NCT01500278|80775184|FG000|Week 0 - Week 12|Investigator decision|1|||
27710721|NCT01500278|80775185|FG001|Week 0 - Week 12|Investigator decision|0|||
27710722|NCT01500278|80775184|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
27889468|NCT02111785|81430799|FG003|Overall Study|Death|0|||
27889469|NCT01680159|81430804|FG000|Screening Period|Not meet criteria for dose-up period|7|||
27603502|NCT01525602|80388712|FG002|Overall Study|Withdrawal by Subject|0|||
27603503|NCT01525602|80388713|FG003|Overall Study|Withdrawal by Subject|0|||
27603504|NCT01525602|80388714|FG004|Overall Study|Withdrawal by Subject|3|||
27603505|NCT01525602|80388715|FG005|Overall Study|Withdrawal by Subject|1|||
27603506|NCT01525602|80388716|FG006|Overall Study|Withdrawal by Subject|0|||
27603507|NCT01525602|80388717|FG007|Overall Study|Withdrawal by Subject|1|||
27603508|NCT01525602|80388710|FG000|Overall Study|Physician Decision|0|||
27603509|NCT01525602|80388711|FG001|Overall Study|Physician Decision|0|||
27603510|NCT01525602|80388712|FG002|Overall Study|Physician Decision|0|||
27603511|NCT01525602|80388713|FG003|Overall Study|Physician Decision|0|||
27603512|NCT01525602|80388714|FG004|Overall Study|Physician Decision|3|||
27603513|NCT01525602|80388715|FG005|Overall Study|Physician Decision|0|||
27603514|NCT01525602|80388716|FG006|Overall Study|Physician Decision|1|||
27603515|NCT01525602|80388717|FG007|Overall Study|Physician Decision|0|||
27603516|NCT01525602|80388710|FG000|Overall Study|Death|0|||
27603517|NCT01525602|80388711|FG001|Overall Study|Death|0|||
27603518|NCT01525602|80388712|FG002|Overall Study|Death|0|||
27603519|NCT01525602|80388713|FG003|Overall Study|Death|0|||
27603520|NCT01525602|80388714|FG004|Overall Study|Death|1|||
27603521|NCT01525602|80388715|FG005|Overall Study|Death|1|||
27603522|NCT01525602|80388716|FG006|Overall Study|Death|0|||
27603523|NCT01525602|80388717|FG007|Overall Study|Death|0|||
27710723|NCT01500278|80775185|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
27603524|NCT01525602|80388710|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
27603525|NCT01525602|80388711|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
27710724|NCT01500278|80775184|FG000|Week 0 - Week 12|Sponsor decision|1|||
27710725|NCT01500278|80775185|FG001|Week 0 - Week 12|Sponsor decision|0|||
27603526|NCT01525602|80388712|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
27603527|NCT01525602|80388713|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
27603528|NCT01525602|80388714|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
27603529|NCT01525602|80388715|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
27603530|NCT01525602|80388716|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
27603531|NCT01525602|80388717|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
27603532|NCT01644734|80388718|FG000|Overall Study|Adverse Event|4|||
27603533|NCT01644734|80388718|FG000|Overall Study|Lost to Follow-up|17|||
27603534|NCT01644734|80388718|FG000|Overall Study|Reasons other than stated above|7|||
27603535|NCT01644734|80388718|FG000|Overall Study|Missing documentation|238|||
27603536|NCT02287584|80388730|FG000|the Double-blind Phase|Adverse Event|17|||
27603537|NCT02287584|80388731|FG001|the Double-blind Phase|Adverse Event|17|||
27603538|NCT02287584|80388732|FG002|the Double-blind Phase|Adverse Event|12|||
27603539|NCT02287584|80388733|FG003|the Double-blind Phase|Adverse Event|0|||
27603540|NCT02287584|80388734|FG004|the Double-blind Phase|Adverse Event|0|||
27603541|NCT02287584|80388735|FG005|the Double-blind Phase|Adverse Event|0|||
27603542|NCT02287584|80388730|FG000|the Double-blind Phase|Lack of Efficacy|18|||
27603543|NCT02287584|80388731|FG001|the Double-blind Phase|Lack of Efficacy|8|||
27603544|NCT02287584|80388732|FG002|the Double-blind Phase|Lack of Efficacy|8|||
27603545|NCT02287584|80388733|FG003|the Double-blind Phase|Lack of Efficacy|0|||
27603546|NCT02287584|80388734|FG004|the Double-blind Phase|Lack of Efficacy|0|||
27603547|NCT02287584|80388735|FG005|the Double-blind Phase|Lack of Efficacy|0|||
27603548|NCT02287584|80388730|FG000|the Double-blind Phase|Lost to Follow-up|0|||
27603549|NCT02287584|80388731|FG001|the Double-blind Phase|Lost to Follow-up|1|||
27603550|NCT02287584|80388732|FG002|the Double-blind Phase|Lost to Follow-up|1|||
27603551|NCT02287584|80388733|FG003|the Double-blind Phase|Lost to Follow-up|0|||
27603552|NCT02287584|80388734|FG004|the Double-blind Phase|Lost to Follow-up|0|||
27603553|NCT02287584|80388735|FG005|the Double-blind Phase|Lost to Follow-up|0|||
27603554|NCT02287584|80388730|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
27603555|NCT02287584|80388731|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
27603556|NCT02287584|80388732|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
27603557|NCT02287584|80388733|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
27603558|NCT02287584|80388734|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
27603559|NCT02287584|80388735|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
27603560|NCT02287584|80388730|FG000|the Double-blind Phase|Pregnancy|0|||
27603561|NCT02287584|80388731|FG001|the Double-blind Phase|Pregnancy|1|||
27603562|NCT02287584|80388732|FG002|the Double-blind Phase|Pregnancy|0|||
27603563|NCT02287584|80388733|FG003|the Double-blind Phase|Pregnancy|0|||
27603564|NCT02287584|80388734|FG004|the Double-blind Phase|Pregnancy|0|||
27603565|NCT02287584|80388735|FG005|the Double-blind Phase|Pregnancy|0|||
27603566|NCT02287584|80388730|FG000|the Double-blind Phase|Protocol Violation|0|||
27603567|NCT02287584|80388731|FG001|the Double-blind Phase|Protocol Violation|3|||
27603568|NCT02287584|80388732|FG002|the Double-blind Phase|Protocol Violation|0|||
27603569|NCT02287584|80388733|FG003|the Double-blind Phase|Protocol Violation|0|||
27603570|NCT02287584|80388734|FG004|the Double-blind Phase|Protocol Violation|0|||
27603571|NCT02287584|80388735|FG005|the Double-blind Phase|Protocol Violation|0|||
27603572|NCT02287584|80388730|FG000|the Double-blind Phase|other reasons|0|||
27603573|NCT02287584|80388731|FG001|the Double-blind Phase|other reasons|0|||
27603574|NCT02287584|80388732|FG002|the Double-blind Phase|other reasons|1|||
27603575|NCT02287584|80388733|FG003|the Double-blind Phase|other reasons|0|||
27603576|NCT02287584|80388734|FG004|the Double-blind Phase|other reasons|0|||
27603577|NCT02287584|80388735|FG005|the Double-blind Phase|other reasons|0|||
27603578|NCT02287584|80388730|FG000|the Open-label Phase|Did not receive drug|0|||
27603579|NCT02287584|80388731|FG001|the Open-label Phase|Did not receive drug|0|||
27603580|NCT02287584|80388732|FG002|the Open-label Phase|Did not receive drug|0|||
27603581|NCT02287584|80388733|FG003|the Open-label Phase|Did not receive drug|7|||
27603582|NCT02287584|80388734|FG004|the Open-label Phase|Did not receive drug|6|||
27603583|NCT02287584|80388735|FG005|the Open-label Phase|Did not receive drug|4|||
27603584|NCT02287584|80388730|FG000|the Open-label Phase|Adverse Event|0|||
27603585|NCT02287584|80388731|FG001|the Open-label Phase|Adverse Event|0|||
27603586|NCT02287584|80388732|FG002|the Open-label Phase|Adverse Event|0|||
27603587|NCT02287584|80388733|FG003|the Open-label Phase|Adverse Event|15|||
27603588|NCT02287584|80388734|FG004|the Open-label Phase|Adverse Event|12|||
27603589|NCT02287584|80388735|FG005|the Open-label Phase|Adverse Event|16|||
27603590|NCT02287584|80388730|FG000|the Open-label Phase|Lack of Efficacy|0|||
27603591|NCT02287584|80388731|FG001|the Open-label Phase|Lack of Efficacy|0|||
27603592|NCT02287584|80388732|FG002|the Open-label Phase|Lack of Efficacy|0|||
27603593|NCT02287584|80388733|FG003|the Open-label Phase|Lack of Efficacy|8|||
27603594|NCT02287584|80388734|FG004|the Open-label Phase|Lack of Efficacy|3|||
27603595|NCT02287584|80388735|FG005|the Open-label Phase|Lack of Efficacy|7|||
27603596|NCT02287584|80388730|FG000|the Open-label Phase|Lost to Follow-up|0|||
27603597|NCT02287584|80388731|FG001|the Open-label Phase|Lost to Follow-up|0|||
27603598|NCT02287584|80388732|FG002|the Open-label Phase|Lost to Follow-up|0|||
27603599|NCT02287584|80388733|FG003|the Open-label Phase|Lost to Follow-up|4|||
27603600|NCT02287584|80388734|FG004|the Open-label Phase|Lost to Follow-up|1|||
27603601|NCT02287584|80388735|FG005|the Open-label Phase|Lost to Follow-up|2|||
27603602|NCT02287584|80388730|FG000|the Open-label Phase|Withdrawal by Subject|0|||
27603603|NCT02287584|80388731|FG001|the Open-label Phase|Withdrawal by Subject|0|||
27603604|NCT02287584|80388732|FG002|the Open-label Phase|Withdrawal by Subject|0|||
27603605|NCT02287584|80388733|FG003|the Open-label Phase|Withdrawal by Subject|18|||
27603606|NCT02287584|80388734|FG004|the Open-label Phase|Withdrawal by Subject|29|||
27603607|NCT02287584|80388735|FG005|the Open-label Phase|Withdrawal by Subject|21|||
27603608|NCT02287584|80388730|FG000|the Open-label Phase|non-compliance|0|||
27603609|NCT02287584|80388731|FG001|the Open-label Phase|non-compliance|0|||
27603610|NCT02287584|80388732|FG002|the Open-label Phase|non-compliance|0|||
27603611|NCT02287584|80388733|FG003|the Open-label Phase|non-compliance|2|||
27603612|NCT02287584|80388734|FG004|the Open-label Phase|non-compliance|5|||
27603613|NCT02287584|80388735|FG005|the Open-label Phase|non-compliance|1|||
27603614|NCT02287584|80388730|FG000|the Open-label Phase|other reasons|0|||
27603615|NCT02287584|80388731|FG001|the Open-label Phase|other reasons|0|||
27603616|NCT02287584|80388732|FG002|the Open-label Phase|other reasons|0|||
27603617|NCT02287584|80388733|FG003|the Open-label Phase|other reasons|3|||
27603618|NCT02287584|80388734|FG004|the Open-label Phase|other reasons|6|||
27603619|NCT02287584|80388735|FG005|the Open-label Phase|other reasons|6|||
27603620|NCT02472652|80388737|FG000|Overall Study|Lost to Follow-up|1|||
27603621|NCT03813238|80388739|FG000|Overall Study|Adverse Event|0|||
27603622|NCT03813238|80388740|FG001|Overall Study|Adverse Event|6|||
27603623|NCT03813238|80388739|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27603624|NCT03813238|80388740|FG001|Overall Study|Withdrawal by parent/guardian|2|||
27603625|NCT03813238|80388739|FG000|Overall Study|Lost to Follow-up|0|||
27603626|NCT03813238|80388740|FG001|Overall Study|Lost to Follow-up|1|||
27603627|NCT03813238|80388739|FG000|Overall Study|Other than specified|1|||
27603628|NCT03813238|80388740|FG001|Overall Study|Other than specified|2|||
27603629|NCT00112580|80388742|FG000|Overall Study|Adverse Event|1|||
27603630|NCT00112580|80388743|FG001|Overall Study|Adverse Event|2|||
27603631|NCT00112580|80388742|FG000|Overall Study|Disease progression|5|||
27603632|NCT00112580|80388743|FG001|Overall Study|Disease progression|16|||
27603633|NCT00112580|80388742|FG000|Overall Study|Participant withdrew consent|2|||
27603634|NCT00112580|80388743|FG001|Overall Study|Participant withdrew consent|1|||
27603635|NCT03954743|80388744|FG000|Overall Study|Adverse Event|1|||
27603636|NCT03954743|80388745|FG001|Overall Study|Adverse Event|0|||
27603637|NCT03954743|80388744|FG000|Overall Study|Lost to Follow-up|6|||
27603638|NCT03954743|80388745|FG001|Overall Study|Lost to Follow-up|4|||
27603639|NCT03954743|80388744|FG000|Overall Study|Protocol Violation|1|||
27603640|NCT03954743|80388745|FG001|Overall Study|Protocol Violation|0|||
27603641|NCT03954743|80388744|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
27603642|NCT03954743|80388745|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
27603643|NCT03954743|80388744|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
27603644|NCT03954743|80388745|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27603645|NCT02978443|80388746|FG000|Overall Study|Withdrawal by Subject|1|||
27603646|NCT02978443|80388746|FG000|Overall Study|Adverse Event|3|||
27603647|NCT02978443|80388746|FG000|Overall Study|Disease Progression on study|6|||
27603648|NCT02978443|80388746|FG000|Overall Study|Death|1|||
27603649|NCT02978443|80388746|FG000|Overall Study|Physician Decision|1|||
27603650|NCT02978443|80388746|FG000|Overall Study|Switch to alternative therapy|1|||
27603651|NCT02978443|80388746|FG000|Overall Study|Refused further treatment|1|||
27603652|NCT00800202|80388748|FG000|Overall Study|Adverse Event|7|||
27603653|NCT00800202|80388749|FG001|Overall Study|Adverse Event|6|||
27710726|NCT01500278|80775184|FG000|Week 0 - Week 12|Personal reason|0|||
27710727|NCT01500278|80775185|FG001|Week 0 - Week 12|Personal reason|1|||
27710728|NCT01500278|80775184|FG000|Week 0 - Week 12|Other serious disease|0|||
27710729|NCT01500278|80775185|FG001|Week 0 - Week 12|Other serious disease|1|||
27710730|NCT01500278|80775184|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
27710731|NCT01500278|80775185|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
27710732|NCT01500278|80775184|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
27710733|NCT01500278|80775185|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
27710734|NCT01500278|80775184|FG000|Week 13 - Week 104|Protocol Violation|6|||
27710735|NCT01500278|80775185|FG001|Week 13 - Week 104|Protocol Violation|6|||
27710736|NCT01500278|80775184|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
27710737|NCT01500278|80775185|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
27710738|NCT01500278|80775184|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
27710739|NCT01500278|80775185|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
27710740|NCT01500278|80775184|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
27710741|NCT01500278|80775185|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
27710742|NCT01500278|80775184|FG000|Week 13 - Week 104|Non/bad compliance|7|||
27710743|NCT01500278|80775185|FG001|Week 13 - Week 104|Non/bad compliance|5|||
27710744|NCT01500278|80775184|FG000|Week 13 - Week 104|Recurrent infections|1|||
27710745|NCT01500278|80775185|FG001|Week 13 - Week 104|Recurrent infections|0|||
27710746|NCT01500278|80775184|FG000|Week 13 - Week 104|False positive test|1|||
27710747|NCT01500278|80775185|FG001|Week 13 - Week 104|False positive test|2|||
27710748|NCT01500278|80775184|FG000|Week 13 - Week 104|Sponsor request|4|||
27710749|NCT01500278|80775185|FG001|Week 13 - Week 104|Sponsor request|0|||
27710750|NCT01500278|80775184|FG000|Week 13 - Week 104|Withdrawn in error|1|||
27710751|NCT01500278|80775185|FG001|Week 13 - Week 104|Withdrawn in error|0|||
27710752|NCT01500278|80775184|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
27710753|NCT01500278|80775185|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
27710754|NCT01500278|80775184|FG000|Week 13 - Week 104|Protocol deviation|1|||
27710755|NCT01500278|80775185|FG001|Week 13 - Week 104|Protocol deviation|0|||
27710756|NCT01500278|80775184|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
27710757|NCT01500278|80775185|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
27710758|NCT01500278|80775184|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
27603654|NCT00800202|80388748|FG000|Overall Study|Death|1|||
27603655|NCT00800202|80388749|FG001|Overall Study|Death|0|||
27710759|NCT01500278|80775185|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
27603656|NCT00800202|80388748|FG000|Overall Study|Other|5|||
27603657|NCT00800202|80388749|FG001|Overall Study|Other|0|||
27603658|NCT00800202|80388748|FG000|Overall Study|Disease Progression|54|||
27603659|NCT00800202|80388749|FG001|Overall Study|Disease Progression|18|||
27603660|NCT01279343|80388750|FG000|Overall Study|Did not receive treatment|2|||
27603661|NCT01279343|80388751|FG001|Overall Study|Did not receive treatment|6|||
27603662|NCT00106184|80388752|FG000|Overall Study|Withdrawal by Subject|3|||
27603663|NCT00106184|80388753|FG001|Overall Study|Withdrawal by Subject|2|||
27603664|NCT01061333|80388754|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
27603665|NCT01061333|80388755|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
27710760|NCT01500278|80775184|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
27710761|NCT01500278|80775185|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
27710762|NCT01500278|80775184|FG000|Week 13 - Week 104|Relocation|0|||
27710763|NCT01500278|80775185|FG001|Week 13 - Week 104|Relocation|1|||
27710764|NCT01500278|80775184|FG000|Week 13 - Week 104|Sponsor decision|0|||
27710765|NCT01500278|80775185|FG001|Week 13 - Week 104|Sponsor decision|2|||
27710766|NCT01500278|80775184|FG000|Week 13 - Week 104|Medical monitor decision|0|||
27710767|NCT01500278|80775185|FG001|Week 13 - Week 104|Medical monitor decision|2|||
27710768|NCT01500278|80775184|FG000|Week 13 - Week 104|Personal reason|0|||
27710769|NCT01500278|80775185|FG001|Week 13 - Week 104|Personal reason|1|||
27710770|NCT01500278|80775184|FG000|Week 13 - Week 104|Not completed|0|||
27710771|NCT01500278|80775185|FG001|Week 13 - Week 104|Not completed|1|||
27710772|NCT01500278|80775184|FG000|Week 13 - Week 104|Death|2|||
27710773|NCT01500278|80775185|FG001|Week 13 - Week 104|Death|4|||
27710774|NCT01500278|80775184|FG000|Week 13 - Week 104|Adverse Event|54|||
27710775|NCT01500278|80775185|FG001|Week 13 - Week 104|Adverse Event|54|||
27710776|NCT01449461|80775186|FG000|Overall Study|Adverse Event|0|||
27710777|NCT01449461|80775187|FG001|Overall Study|Adverse Event|3|||
27710778|NCT01449461|80775188|FG002|Overall Study|Adverse Event|2|||
27710779|NCT01449461|80775189|FG003|Overall Study|Adverse Event|3|||
27710780|NCT01449461|80775190|FG004|Overall Study|Adverse Event|4|||
27710781|NCT01449461|80775191|FG005|Overall Study|Adverse Event|4|||
27710782|NCT01449461|80775186|FG000|Overall Study|Death|0|||
27710783|NCT01449461|80775187|FG001|Overall Study|Death|2|||
27710784|NCT01449461|80775188|FG002|Overall Study|Death|0|||
27710785|NCT01449461|80775189|FG003|Overall Study|Death|0|||
27710786|NCT01449461|80775190|FG004|Overall Study|Death|7|||
27710787|NCT01449461|80775191|FG005|Overall Study|Death|1|||
27710788|NCT01449461|80775186|FG000|Overall Study|Physician Decision|0|||
27710789|NCT01449461|80775187|FG001|Overall Study|Physician Decision|1|||
27710790|NCT01449461|80775188|FG002|Overall Study|Physician Decision|0|||
27710791|NCT01449461|80775189|FG003|Overall Study|Physician Decision|4|||
27710792|NCT01449461|80775190|FG004|Overall Study|Physician Decision|1|||
27710793|NCT01449461|80775191|FG005|Overall Study|Physician Decision|0|||
27710794|NCT01449461|80775186|FG000|Overall Study|Documented Progressive Disease|4|||
27710795|NCT01449461|80775187|FG001|Overall Study|Documented Progressive Disease|7|||
27710796|NCT01449461|80775188|FG002|Overall Study|Documented Progressive Disease|14|||
27710797|NCT01449461|80775189|FG003|Overall Study|Documented Progressive Disease|15|||
27710798|NCT01449461|80775190|FG004|Overall Study|Documented Progressive Disease|24|||
27710799|NCT01449461|80775191|FG005|Overall Study|Documented Progressive Disease|5|||
27710800|NCT01449461|80775186|FG000|Overall Study|Clinical Progressive Disease|2|||
27710801|NCT01449461|80775187|FG001|Overall Study|Clinical Progressive Disease|2|||
27710802|NCT01449461|80775188|FG002|Overall Study|Clinical Progressive Disease|0|||
27710803|NCT01449461|80775189|FG003|Overall Study|Clinical Progressive Disease|3|||
27710804|NCT01449461|80775190|FG004|Overall Study|Clinical Progressive Disease|4|||
27710805|NCT01449461|80775191|FG005|Overall Study|Clinical Progressive Disease|2|||
27710806|NCT01449461|80775186|FG000|Overall Study|Protocol Violation|0|||
27710807|NCT01449461|80775187|FG001|Overall Study|Protocol Violation|0|||
27710808|NCT01449461|80775188|FG002|Overall Study|Protocol Violation|0|||
27710809|NCT01449461|80775189|FG003|Overall Study|Protocol Violation|1|||
27710810|NCT01449461|80775190|FG004|Overall Study|Protocol Violation|0|||
27710811|NCT01449461|80775191|FG005|Overall Study|Protocol Violation|0|||
27710812|NCT01449461|80775186|FG000|Overall Study|Site Terminated by Sponsor|0|||
27710813|NCT01449461|80775187|FG001|Overall Study|Site Terminated by Sponsor|1|||
27710814|NCT01449461|80775188|FG002|Overall Study|Site Terminated by Sponsor|2|||
27710815|NCT01449461|80775189|FG003|Overall Study|Site Terminated by Sponsor|3|||
27710816|NCT01449461|80775190|FG004|Overall Study|Site Terminated by Sponsor|4|||
27710817|NCT01449461|80775191|FG005|Overall Study|Site Terminated by Sponsor|1|||
27710818|NCT01449461|80775186|FG000|Overall Study|Withdrawal by Subject|0|||
27710819|NCT01449461|80775187|FG001|Overall Study|Withdrawal by Subject|1|||
27710820|NCT01449461|80775188|FG002|Overall Study|Withdrawal by Subject|0|||
27710821|NCT01449461|80775189|FG003|Overall Study|Withdrawal by Subject|0|||
27710822|NCT01449461|80775190|FG004|Overall Study|Withdrawal by Subject|2|||
27710823|NCT01449461|80775191|FG005|Overall Study|Withdrawal by Subject|1|||
27710824|NCT01449461|80775186|FG000|Overall Study|Reason not Specified|0|||
27710825|NCT01449461|80775187|FG001|Overall Study|Reason not Specified|1|||
27710826|NCT01449461|80775188|FG002|Overall Study|Reason not Specified|0|||
27710827|NCT01449461|80775189|FG003|Overall Study|Reason not Specified|3|||
27710828|NCT01449461|80775190|FG004|Overall Study|Reason not Specified|2|||
27710829|NCT01449461|80775191|FG005|Overall Study|Reason not Specified|1|||
27710830|NCT02250274|80775194|FG000|Overall Study|Insufficient blood draw amount|7|||
27710831|NCT02250274|80775195|FG001|Overall Study|Insufficient blood draw amount|6|||
27710832|NCT03785925|80775200|FG000|Overall Study|Withdrawal by Subject|15|||
27710833|NCT03785925|80775200|FG000|Overall Study|Lost to Follow-up|1|||
27710834|NCT00501007|80775201|FG000|Overall Study|Inclusion criteria not met.|29|||
27710835|NCT00501007|80775202|FG001|Overall Study|Inclusion criteria not met.|25|||
27710836|NCT04688775|80775203|FG000|Placebo-controlled Period|Randomized, not treated|1|||
27710837|NCT04688775|80775204|FG001|Placebo-controlled Period|Randomized, not treated|1|||
27710838|NCT04688775|80775205|FG002|Placebo-controlled Period|Randomized, not treated|0|||
27710839|NCT04688775|80775206|FG003|Placebo-controlled Period|Randomized, not treated|0|||
27710840|NCT04688775|80775203|FG000|Placebo-controlled Period|Adverse Event|2|||
27710841|NCT04688775|80775204|FG001|Placebo-controlled Period|Adverse Event|0|||
27710842|NCT04688775|80775205|FG002|Placebo-controlled Period|Adverse Event|0|||
27710843|NCT04688775|80775206|FG003|Placebo-controlled Period|Adverse Event|0|||
27710844|NCT04688775|80775203|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
27710845|NCT04688775|80775204|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
27710846|NCT04688775|80775205|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
27710847|NCT04688775|80775206|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
27710848|NCT04688775|80775203|FG000|Placebo-controlled Period|Protocol Violation|0|||
27710849|NCT04688775|80775204|FG001|Placebo-controlled Period|Protocol Violation|1|||
27710850|NCT04688775|80775205|FG002|Placebo-controlled Period|Protocol Violation|0|||
27710851|NCT04688775|80775206|FG003|Placebo-controlled Period|Protocol Violation|0|||
27710852|NCT04688775|80775203|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
27710853|NCT04688775|80775204|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
27710854|NCT04688775|80775205|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
27710855|NCT04688775|80775206|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
27710856|NCT04688775|80775203|FG000|Placebo-controlled Period|Other reasons|0|||
27710857|NCT04688775|80775204|FG001|Placebo-controlled Period|Other reasons|1|||
27710858|NCT04688775|80775205|FG002|Placebo-controlled Period|Other reasons|0|||
27710859|NCT04688775|80775206|FG003|Placebo-controlled Period|Other reasons|0|||
27710860|NCT04688775|80775203|FG000|Delayed Start Period|Adverse Event|0|||
27710861|NCT04688775|80775204|FG001|Delayed Start Period|Adverse Event|0|||
27710862|NCT04688775|80775205|FG002|Delayed Start Period|Adverse Event|1|||
27710863|NCT04688775|80775206|FG003|Delayed Start Period|Adverse Event|0|||
27710864|NCT04688775|80775203|FG000|Delayed Start Period|Lack of Efficacy|0|||
27710865|NCT04688775|80775204|FG001|Delayed Start Period|Lack of Efficacy|0|||
27710866|NCT04688775|80775205|FG002|Delayed Start Period|Lack of Efficacy|0|||
27710867|NCT04688775|80775206|FG003|Delayed Start Period|Lack of Efficacy|3|||
27710868|NCT04688775|80775203|FG000|Delayed Start Period|Withdrawal by Subject|0|||
27710869|NCT04688775|80775204|FG001|Delayed Start Period|Withdrawal by Subject|0|||
27710870|NCT04688775|80775205|FG002|Delayed Start Period|Withdrawal by Subject|2|||
27710871|NCT04688775|80775206|FG003|Delayed Start Period|Withdrawal by Subject|4|||
27710872|NCT04688775|80775203|FG000|Delayed Start Period|Lost to Follow-up|0|||
27710873|NCT04688775|80775204|FG001|Delayed Start Period|Lost to Follow-up|0|||
27710874|NCT04688775|80775205|FG002|Delayed Start Period|Lost to Follow-up|2|||
27710875|NCT04688775|80775206|FG003|Delayed Start Period|Lost to Follow-up|1|||
27710876|NCT04688775|80775203|FG000|Delayed Start Period|other reasons|0|||
27710877|NCT04688775|80775204|FG001|Delayed Start Period|other reasons|0|||
27710878|NCT04688775|80775205|FG002|Delayed Start Period|other reasons|1|||
27710879|NCT04688775|80775206|FG003|Delayed Start Period|other reasons|0|||
27710880|NCT01439204|80775207|FG000|Overall Study|Withdrawal by Subject|0|||
27710881|NCT01439204|80775208|FG001|Overall Study|Withdrawal by Subject|1|||
27710882|NCT01439204|80775207|FG000|Overall Study|Lost to Follow-up|0|||
27710883|NCT01439204|80775208|FG001|Overall Study|Lost to Follow-up|2|||
27710884|NCT01439204|80775207|FG000|Overall Study|No longer meets study criteria|1|||
27710885|NCT01439204|80775208|FG001|Overall Study|No longer meets study criteria|0|||
27710886|NCT01439204|80775207|FG000|Overall Study|poor/non-compliance|3|||
27603666|NCT01641926|80391217|FG000|Overall Study|Adverse Event|5|||
27710887|NCT01439204|80775208|FG001|Overall Study|poor/non-compliance|0|||
27603667|NCT01641926|80391218|FG001|Overall Study|Adverse Event|2|||
27710888|NCT02121262|80775209|FG000|Overall Study|Adverse Event|6|||
27710889|NCT02121262|80775210|FG001|Overall Study|Adverse Event|3|||
27710890|NCT02121262|80775209|FG000|Overall Study|Lack of Efficacy|3|||
27710891|NCT02121262|80775210|FG001|Overall Study|Lack of Efficacy|0|||
27710892|NCT02121262|80775209|FG000|Overall Study|Personal Reasons|19|||
27710893|NCT02121262|80775210|FG001|Overall Study|Personal Reasons|5|||
27710894|NCT02121262|80775209|FG000|Overall Study|Protocol Violation|1|||
27710895|NCT02121262|80775210|FG001|Overall Study|Protocol Violation|1|||
27710896|NCT02121262|80775209|FG000|Overall Study|Participant Dropped-out|0|||
27710897|NCT02121262|80775210|FG001|Overall Study|Participant Dropped-out|1|||
27710898|NCT02121262|80775209|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
27710899|NCT02121262|80775210|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
27710900|NCT02121262|80775209|FG000|Overall Study|Consent Withdrawn|1|||
27710901|NCT02121262|80775210|FG001|Overall Study|Consent Withdrawn|0|||
27710902|NCT01380730|80775211|FG000|Overall Study|Death|0|||
27710903|NCT01380730|80775212|FG001|Overall Study|Death|0|||
27710904|NCT01380730|80775213|FG002|Overall Study|Death|0|||
27710905|NCT01380730|80775214|FG003|Overall Study|Death|0|||
27710906|NCT01380730|80775215|FG004|Overall Study|Death|1|||
27710907|NCT01380730|80775216|FG005|Overall Study|Death|0|||
27710908|NCT01380730|80775217|FG006|Overall Study|Death|0|||
27710909|NCT01380730|80775218|FG007|Overall Study|Death|0|||
27710910|NCT00143312|80778797|FG000|Overall Study|Death|11|||
27710911|NCT00143312|80778797|FG000|Overall Study|Adverse Event|2|||
27710912|NCT00143312|80778797|FG000|Overall Study|Lost to Follow-up|1|||
27710913|NCT00143312|80778797|FG000|Overall Study|Other|1|||
27710914|NCT00143312|80778797|FG000|Overall Study|Withdrawal by Subject|1|||
27710915|NCT00531752|80778798|FG000|First Double-blind Intervention Period|Adverse Event|2|||
27710916|NCT00531752|80778799|FG001|First Double-blind Intervention Period|Adverse Event|0|||
27710917|NCT00531752|80778800|FG002|First Double-blind Intervention Period|Adverse Event|1|||
27710918|NCT00531752|80778801|FG003|First Double-blind Intervention Period|Adverse Event|1|||
27710919|NCT00531752|80778798|FG000|First Double-blind Intervention Period|Other|1|||
27710920|NCT00531752|80778799|FG001|First Double-blind Intervention Period|Other|4|||
27710921|NCT00531752|80778800|FG002|First Double-blind Intervention Period|Other|4|||
27710922|NCT00531752|80778801|FG003|First Double-blind Intervention Period|Other|0|||
27710923|NCT00531752|80778798|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
27710924|NCT00531752|80778799|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
27710925|NCT00531752|80778800|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
27710926|NCT00531752|80778801|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
27710927|NCT00531752|80778798|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
27710928|NCT00531752|80778799|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
27710929|NCT00531752|80778800|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
27710930|NCT00531752|80778801|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
27710931|NCT00531752|80778798|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
27710932|NCT00531752|80778799|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
27710933|NCT00531752|80778800|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
27710934|NCT00531752|80778801|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
27710935|NCT00531752|80778798|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
27710936|NCT00531752|80778799|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
27710937|NCT00531752|80778800|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
27710938|NCT00531752|80778801|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
27710939|NCT00531752|80778798|FG000|Second Double-blind Intervention Period|Other|1|||
27710940|NCT00531752|80778799|FG001|Second Double-blind Intervention Period|Other|1|||
27710941|NCT00531752|80778800|FG002|Second Double-blind Intervention Period|Other|0|||
27710942|NCT00531752|80778801|FG003|Second Double-blind Intervention Period|Other|0|||
27710943|NCT00531752|80778798|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
27710944|NCT00531752|80778799|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
27710945|NCT00531752|80778800|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
27710946|NCT00531752|80778801|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
27603668|NCT01641926|80391219|FG002|Overall Study|Adverse Event|3|||
27603669|NCT01641926|80391220|FG003|Overall Study|Adverse Event|1|||
27603670|NCT01641926|80391217|FG000|Overall Study|Lost to Follow-up|2|||
27603671|NCT01641926|80391218|FG001|Overall Study|Lost to Follow-up|2|||
27603672|NCT01641926|80391219|FG002|Overall Study|Lost to Follow-up|1|||
27603673|NCT01641926|80391220|FG003|Overall Study|Lost to Follow-up|0|||
27603674|NCT01641926|80391217|FG000|Overall Study|Physician Decision|6|||
27603675|NCT01641926|80391218|FG001|Overall Study|Physician Decision|5|||
27603676|NCT01641926|80391219|FG002|Overall Study|Physician Decision|0|||
27603677|NCT01641926|80391220|FG003|Overall Study|Physician Decision|1|||
27603678|NCT01641926|80391217|FG000|Overall Study|Protocol Violation|1|||
27603679|NCT01641926|80391218|FG001|Overall Study|Protocol Violation|0|||
27603680|NCT01641926|80391219|FG002|Overall Study|Protocol Violation|0|||
27603681|NCT01641926|80391220|FG003|Overall Study|Protocol Violation|1|||
27603682|NCT01641926|80391217|FG000|Overall Study|Withdrawal by Subject|13|||
27603683|NCT01641926|80391218|FG001|Overall Study|Withdrawal by Subject|5|||
27603684|NCT01641926|80391219|FG002|Overall Study|Withdrawal by Subject|6|||
27603685|NCT01641926|80391220|FG003|Overall Study|Withdrawal by Subject|1|||
27603686|NCT01641926|80391217|FG000|Overall Study|Not Treated|1|||
27603687|NCT01641926|80391218|FG001|Overall Study|Not Treated|1|||
27603688|NCT01641926|80391219|FG002|Overall Study|Not Treated|1|||
27603689|NCT01641926|80391220|FG003|Overall Study|Not Treated|0|||
27603690|NCT02259517|80391221|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
27603691|NCT02259517|80391222|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
27710947|NCT00531752|80778798|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
27603692|NCT02259517|80391223|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
27603693|NCT02259517|80391221|FG000|Overall Study|Withdrawal by Subject|0|||
27603694|NCT02259517|80391222|FG001|Overall Study|Withdrawal by Subject|0|||
27603695|NCT02259517|80391223|FG002|Overall Study|Withdrawal by Subject|3|||
27603696|NCT02552238|80391224|FG000|Overall Study|Withdrawal by Subject|2|||
27710948|NCT00531752|80778799|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
27603697|NCT02552238|80391224|FG000|Overall Study|Adverse Event|2|||
27603698|NCT05292534|80391232|FG000|Overall Study|Protocol Violation|3|||
27603699|NCT05292534|80391233|FG001|Overall Study|Protocol Violation|4|||
27603700|NCT05292534|80391232|FG000|Overall Study|Withdrawal by Subject|0|||
27710949|NCT00531752|80778800|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
27710950|NCT00531752|80778801|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
27710951|NCT02703311|80778807|FG000|Overall Study|Death|5|||
27710952|NCT02703311|80778807|FG000|Overall Study|Withdrawal by Subject|3|||
27710953|NCT03861936|80778812|FG000|Overall Study|Withdrawal by Subject|4|||
27710954|NCT03861936|80778813|FG001|Overall Study|Withdrawal by Subject|1|||
27710955|NCT03861936|80778814|FG002|Overall Study|Withdrawal by Subject|3|||
27710956|NCT03861936|80778812|FG000|Overall Study|Lost to Follow-up|5|||
27710957|NCT03861936|80778813|FG001|Overall Study|Lost to Follow-up|3|||
27710958|NCT03861936|80778814|FG002|Overall Study|Lost to Follow-up|3|||
27710959|NCT03861936|80778812|FG000|Overall Study|Physician Decision|0|||
27710960|NCT03861936|80778813|FG001|Overall Study|Physician Decision|1|||
27710961|NCT03861936|80778814|FG002|Overall Study|Physician Decision|0|||
27710962|NCT03861936|80778812|FG000|Overall Study|Protocol Deviation|0|||
27710963|NCT03861936|80778813|FG001|Overall Study|Protocol Deviation|0|||
27710964|NCT03861936|80778814|FG002|Overall Study|Protocol Deviation|1|||
27710965|NCT03861936|80778812|FG000|Overall Study|Reason not Specified|5|||
27710966|NCT03861936|80778813|FG001|Overall Study|Reason not Specified|5|||
27710967|NCT03861936|80778814|FG002|Overall Study|Reason not Specified|3|||
27710968|NCT01197521|80778815|FG000|Overall Study|Not reported|24|||
27836473|NCT02760433|81229289|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27836474|NCT02760433|81229290|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
27710969|NCT01197521|80778816|FG001|Overall Study|Not reported|25|||
27710970|NCT01197521|80778817|FG002|Overall Study|Not reported|21|||
27710971|NCT01197521|80778815|FG000|Overall Study|Enrolment in long term extension|42|||
27710972|NCT01197521|80778816|FG001|Overall Study|Enrolment in long term extension|36|||
27710973|NCT01197521|80778817|FG002|Overall Study|Enrolment in long term extension|87|||
27710974|NCT01197521|80778815|FG000|Overall Study|Severe non-compliance to protocol|1|||
27710975|NCT01197521|80778816|FG001|Overall Study|Severe non-compliance to protocol|3|||
27710976|NCT01197521|80778817|FG002|Overall Study|Severe non-compliance to protocol|3|||
27710977|NCT01197521|80778815|FG000|Overall Study|Lack of therapeutic response|2|||
27710978|NCT01197521|80778816|FG001|Overall Study|Lack of therapeutic response|3|||
27710979|NCT01197521|80778817|FG002|Overall Study|Lack of therapeutic response|4|||
27710980|NCT01197521|80778815|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
27710981|NCT01197521|80778816|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
27710982|NCT01197521|80778817|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
27710983|NCT01197521|80778815|FG000|Overall Study|Lost to Follow-up|3|||
27710984|NCT01197521|80778816|FG001|Overall Study|Lost to Follow-up|2|||
27710985|NCT01197521|80778817|FG002|Overall Study|Lost to Follow-up|2|||
27710986|NCT01197521|80778815|FG000|Overall Study|Adverse Event|25|||
27710987|NCT01197521|80778816|FG001|Overall Study|Adverse Event|28|||
27710988|NCT01197521|80778817|FG002|Overall Study|Adverse Event|24|||
27710989|NCT00889265|80778824|FG000|Overall Study|Adverse Event|1|||
27710990|NCT00889265|80778824|FG000|Overall Study|Lost to Follow-up|5|||
27710991|NCT00889265|80778824|FG000|Overall Study|Protocol Violation|1|||
27710992|NCT04419610|80778825|FG000|Overall Study|Withdrawal by Subject|3|||
27710993|NCT04419610|80778826|FG001|Overall Study|Withdrawal by Subject|1|||
27710994|NCT04419610|80778825|FG000|Overall Study|Adverse Event|1|||
27710995|NCT04419610|80778826|FG001|Overall Study|Adverse Event|0|||
27836475|NCT01971554|81229291|FG000|Overall Study|Lost to Follow-up|1|||
27836476|NCT01971554|81229292|FG001|Overall Study|Lost to Follow-up|0|||
27836477|NCT01971554|81229293|FG002|Overall Study|Lost to Follow-up|0|||
27836478|NCT01971554|81229294|FG003|Overall Study|Lost to Follow-up|0|||
27836479|NCT04974580|81229295|FG000|Overall Study|Lost to Follow-up|33|||
27836480|NCT04974580|81229296|FG001|Overall Study|Lost to Follow-up|39|||
27836481|NCT04974580|81229297|FG002|Overall Study|Lost to Follow-up|30|||
27836482|NCT04974580|81229298|FG003|Overall Study|Lost to Follow-up|29|||
27836483|NCT02311894|81229299|FG000|Overall Study|Discontinued in error|1|||
27836484|NCT02311894|81229299|FG000|Overall Study|Lost to Follow-up|1|||
27836485|NCT02311894|81229299|FG000|Overall Study|Adverse Event|1|||
27836486|NCT02311894|81229299|FG000|Overall Study|Withdrawal by Subject|1|||
27836487|NCT01055886|81232787|FG000|Overall Study|Withdrawal by Subject|4|||
27836488|NCT01055886|81232788|FG001|Overall Study|Withdrawal by Subject|9|||
27836489|NCT01055886|81232787|FG000|Overall Study|Lost to Follow-up|1|||
27836490|NCT01055886|81232788|FG001|Overall Study|Lost to Follow-up|1|||
27836491|NCT01055886|81232787|FG000|Overall Study|Withdrawal by PI|0|||
27836492|NCT01055886|81232788|FG001|Overall Study|Withdrawal by PI|1|||
27836493|NCT01993940|81232789|FG000|Overall Study|Adverse Event|16|||
27836494|NCT01993940|81232790|FG001|Overall Study|Adverse Event|11|||
27836495|NCT01993940|81232789|FG000|Overall Study|Withdrawal by Subject|15|||
27836496|NCT01993940|81232790|FG001|Overall Study|Withdrawal by Subject|19|||
27836497|NCT01993940|81232789|FG000|Overall Study|Lost to Follow-up|2|||
27836498|NCT01993940|81232790|FG001|Overall Study|Lost to Follow-up|5|||
27836499|NCT01993940|81232789|FG000|Overall Study|Protocol Violation|5|||
27836500|NCT01993940|81232790|FG001|Overall Study|Protocol Violation|8|||
27836501|NCT01993940|81232789|FG000|Overall Study|Death|1|||
27836502|NCT01993940|81232790|FG001|Overall Study|Death|0|||
27836503|NCT01993940|81232789|FG000|Overall Study|Other - Miscellaneous|1|||
27836504|NCT01993940|81232790|FG001|Overall Study|Other - Miscellaneous|1|||
27710996|NCT04419610|80778825|FG000|Overall Study|discharged early|1|||
27836505|NCT03614728|81232793|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
27836506|NCT03614728|81232794|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
27836507|NCT03614728|81232795|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
27836508|NCT03614728|81232796|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
27836509|NCT03614728|81232793|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
27710997|NCT04419610|80778826|FG001|Overall Study|discharged early|1|||
27710998|NCT01462435|80778827|FG000|Overall Study|Lack of Efficacy|1|||
27710999|NCT01462435|80778828|FG001|Overall Study|Lack of Efficacy|0|||
27711000|NCT01462435|80778829|FG002|Overall Study|Lack of Efficacy|0|||
27711001|NCT01462435|80778830|FG003|Overall Study|Lack of Efficacy|3|||
27711002|NCT01462435|80778827|FG000|Overall Study|Physician Decision|0|||
27711003|NCT01462435|80778828|FG001|Overall Study|Physician Decision|0|||
27711004|NCT01462435|80778829|FG002|Overall Study|Physician Decision|1|||
27711005|NCT01462435|80778830|FG003|Overall Study|Physician Decision|0|||
27711006|NCT01462435|80778827|FG000|Overall Study|Withdrawal by Subject|0|||
27711007|NCT01462435|80778828|FG001|Overall Study|Withdrawal by Subject|0|||
27711008|NCT01462435|80778829|FG002|Overall Study|Withdrawal by Subject|0|||
27711009|NCT01462435|80778830|FG003|Overall Study|Withdrawal by Subject|1|||
27711010|NCT01462435|80778827|FG000|Overall Study|Lost to Follow-up|0|||
27711011|NCT01462435|80778828|FG001|Overall Study|Lost to Follow-up|0|||
27711012|NCT01462435|80778829|FG002|Overall Study|Lost to Follow-up|0|||
27711013|NCT01462435|80778830|FG003|Overall Study|Lost to Follow-up|1|||
27711014|NCT01231659|80778834|FG000|Overall Study|Adverse Event|9|||
27711015|NCT01231659|80778834|FG000|Overall Study|Disease Progression|48|||
27711016|NCT01231659|80778834|FG000|Overall Study|Death|2|||
27711017|NCT01231659|80778834|FG000|Overall Study|Patient refused to complete study visit|1|||
27711018|NCT01231659|80778834|FG000|Overall Study|Other protocol defined criteria|12|||
27711019|NCT01236573|80778835|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711020|NCT01236573|80778836|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711021|NCT01236573|80778837|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711022|NCT01236573|80778838|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711023|NCT01236573|80778839|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711024|NCT01236573|80778840|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711025|NCT01236573|80778841|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
27711026|NCT01236573|80778842|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711027|NCT01236573|80778843|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
27711028|NCT01236573|80778844|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
27711029|NCT01236573|80778845|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
27711030|NCT01236573|80778835|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711031|NCT01236573|80778836|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711032|NCT01236573|80778837|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711033|NCT01236573|80778838|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711034|NCT01236573|80778839|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711035|NCT01236573|80778840|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711036|NCT01236573|80778841|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711037|NCT01236573|80778842|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711038|NCT01236573|80778843|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
27711039|NCT01236573|80778844|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711040|NCT01236573|80778845|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
27711041|NCT01236573|80778835|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711042|NCT01236573|80778836|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711043|NCT01236573|80778837|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711044|NCT01236573|80778838|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711045|NCT01236573|80778839|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711046|NCT01236573|80778840|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711047|NCT01236573|80778841|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711048|NCT01236573|80778842|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711049|NCT01236573|80778843|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711050|NCT01236573|80778844|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
27711051|NCT01236573|80778845|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
27711052|NCT01502709|80778846|FG000|Overall Study|Lost to Follow-up|4|||
27711053|NCT01502709|80778847|FG001|Overall Study|Lost to Follow-up|0|||
27711054|NCT03357731|80778848|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
27711055|NCT03357731|80778849|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
27711056|NCT03357731|80778850|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
27711057|NCT03357731|80778851|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
27711058|NCT03357731|80778852|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
27711059|NCT03357731|80778853|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
27711060|NCT03357731|80778848|FG000|Overall Study|Acute bradycardia and hypotension|0|||
27711061|NCT03357731|80778849|FG001|Overall Study|Acute bradycardia and hypotension|0|||
27711062|NCT03357731|80778850|FG002|Overall Study|Acute bradycardia and hypotension|0|||
27711063|NCT03357731|80778851|FG003|Overall Study|Acute bradycardia and hypotension|1|||
27711064|NCT03357731|80778852|FG004|Overall Study|Acute bradycardia and hypotension|0|||
27711065|NCT03357731|80778853|FG005|Overall Study|Acute bradycardia and hypotension|0|||
27711066|NCT03357731|80778848|FG000|Overall Study|Adverse Event|0|||
27711067|NCT03357731|80778849|FG001|Overall Study|Adverse Event|0|||
27711068|NCT03357731|80778850|FG002|Overall Study|Adverse Event|0|||
27711069|NCT03357731|80778851|FG003|Overall Study|Adverse Event|0|||
27711070|NCT03357731|80778852|FG004|Overall Study|Adverse Event|0|||
27711071|NCT03357731|80778853|FG005|Overall Study|Adverse Event|1|||
27711072|NCT03357731|80778848|FG000|Overall Study|Hypotension|0|||
27711073|NCT03357731|80778849|FG001|Overall Study|Hypotension|0|||
27711074|NCT03357731|80778850|FG002|Overall Study|Hypotension|1|||
27711075|NCT03357731|80778851|FG003|Overall Study|Hypotension|1|||
27711076|NCT03357731|80778852|FG004|Overall Study|Hypotension|0|||
27711077|NCT03357731|80778853|FG005|Overall Study|Hypotension|0|||
27711078|NCT03357731|80778848|FG000|Overall Study|Lost to Follow-up|0|||
27711079|NCT03357731|80778849|FG001|Overall Study|Lost to Follow-up|0|||
27711080|NCT03357731|80778850|FG002|Overall Study|Lost to Follow-up|0|||
27711081|NCT03357731|80778851|FG003|Overall Study|Lost to Follow-up|1|||
27711082|NCT03357731|80778852|FG004|Overall Study|Lost to Follow-up|0|||
27711083|NCT03357731|80778853|FG005|Overall Study|Lost to Follow-up|0|||
27711084|NCT00766532|80778854|FG000|Overall Study|Protocol Violation|2|||
27711085|NCT01230242|80778855|FG000|Overall Study|Physician Decision|2|||
27711086|NCT01230242|80778855|FG000|Overall Study|Withdrawal by Subject|1|||
27711087|NCT03317795|80778857|FG000|Overall Study|IUD Expulsion|1|||
27711088|NCT03317795|80778858|FG001|Overall Study|IUD Expulsion|0|||
27711089|NCT03317795|80778857|FG000|Overall Study|Lost to Follow-up|1|||
27711090|NCT03317795|80778858|FG001|Overall Study|Lost to Follow-up|3|||
27711091|NCT03317795|80778857|FG000|Overall Study|Treatment change|0|||
27711092|NCT03317795|80778858|FG001|Overall Study|Treatment change|3|||
27711093|NCT03317795|80778857|FG000|Overall Study|Intolerance of medication|0|||
27711094|NCT03317795|80778858|FG001|Overall Study|Intolerance of medication|1|||
27711095|NCT00562354|80778861|FG000|Overall Study|Physician Decision|0|||
27711096|NCT00562354|80778862|FG001|Overall Study|Physician Decision|1|||
27711097|NCT00562354|80778861|FG000|Overall Study|Lost to Follow-up|0|||
27711098|NCT00562354|80778862|FG001|Overall Study|Lost to Follow-up|1|||
27711099|NCT00894556|80778863|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
27711100|NCT00894556|80778864|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
27711101|NCT00894556|80778865|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
27711102|NCT00894556|80778866|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
27711103|NCT00894556|80778863|FG000|Treatment Phase|Lost to Follow-up|2|||
27711104|NCT00894556|80778864|FG001|Treatment Phase|Lost to Follow-up|3|||
27711105|NCT00894556|80778865|FG002|Treatment Phase|Lost to Follow-up|1|||
27711106|NCT00894556|80778866|FG003|Treatment Phase|Lost to Follow-up|0|||
27711107|NCT00894556|80778863|FG000|Treatment Phase|Lack of Qualifying Event|2|||
27711108|NCT00894556|80778864|FG001|Treatment Phase|Lack of Qualifying Event|1|||
27711109|NCT00894556|80778865|FG002|Treatment Phase|Lack of Qualifying Event|0|||
27711110|NCT00894556|80778866|FG003|Treatment Phase|Lack of Qualifying Event|0|||
27711111|NCT00961220|80778867|FG000|Overall Study|Adverse Event|3|||
27711112|NCT00961220|80778867|FG000|Overall Study|Lack of Efficacy|1|||
27711113|NCT00961220|80778867|FG000|Overall Study|No IV access for O6BG|1|||
27711114|NCT00961220|80778867|FG000|Overall Study|O6BG no longer supplied|1|||
27711115|NCT00961220|80778867|FG000|Overall Study|Complete Response prior to 12 courses|1|||
27711116|NCT02839265|80778868|FG000|Overall Study|Screen Failure|2|||
27711117|NCT02839265|80778868|FG000|Overall Study|Death|1|||
27711118|NCT02839265|80778868|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
27711119|NCT01911442|80778869|FG000|Overall Study|Adverse Event|2|||
27711120|NCT01911442|80778870|FG001|Overall Study|Adverse Event|2|||
27711121|NCT01911442|80778871|FG002|Overall Study|Adverse Event|4|||
27711122|NCT01911442|80778869|FG000|Overall Study|Lack of Efficacy|1|||
27711123|NCT01911442|80778870|FG001|Overall Study|Lack of Efficacy|1|||
27711124|NCT01911442|80778871|FG002|Overall Study|Lack of Efficacy|1|||
27711125|NCT01911442|80778869|FG000|Overall Study|Lost to Follow-up|2|||
27711126|NCT01911442|80778870|FG001|Overall Study|Lost to Follow-up|0|||
27711127|NCT01911442|80778871|FG002|Overall Study|Lost to Follow-up|1|||
27711128|NCT01911442|80778869|FG000|Overall Study|Withdrawal by Subject|1|||
27711129|NCT01911442|80778870|FG001|Overall Study|Withdrawal by Subject|0|||
27711130|NCT01911442|80778871|FG002|Overall Study|Withdrawal by Subject|6|||
27711131|NCT01911442|80778869|FG000|Overall Study|Mother's Work Schedule|0|||
27711132|NCT01911442|80778870|FG001|Overall Study|Mother's Work Schedule|1|||
27711133|NCT01911442|80778871|FG002|Overall Study|Mother's Work Schedule|0|||
27711134|NCT00361270|80778878|FG000|Overall Study|Death|0|||
27711135|NCT00361270|80778879|FG001|Overall Study|Death|0|||
27711136|NCT00361270|80778880|FG002|Overall Study|Death|0|||
27711137|NCT00361270|80778881|FG003|Overall Study|Death|2|||
27711138|NCT00361270|80778878|FG000|Overall Study|Lost to Follow-up|4|||
27711139|NCT00361270|80778879|FG001|Overall Study|Lost to Follow-up|1|||
27711140|NCT00361270|80778880|FG002|Overall Study|Lost to Follow-up|0|||
27711141|NCT00361270|80778881|FG003|Overall Study|Lost to Follow-up|0|||
27711142|NCT00361270|80778878|FG000|Overall Study|Physician Decision|0|||
27711143|NCT00361270|80778879|FG001|Overall Study|Physician Decision|0|||
27711144|NCT00361270|80778880|FG002|Overall Study|Physician Decision|1|||
27711145|NCT00361270|80778881|FG003|Overall Study|Physician Decision|0|||
27711146|NCT00361270|80778878|FG000|Overall Study|Protocol Violation|9|||
27711147|NCT00361270|80778879|FG001|Overall Study|Protocol Violation|4|||
27711148|NCT00361270|80778880|FG002|Overall Study|Protocol Violation|5|||
27711149|NCT00361270|80778881|FG003|Overall Study|Protocol Violation|4|||
27711150|NCT00361270|80778878|FG000|Overall Study|Withdrawal by Subject|6|||
27711151|NCT00361270|80778879|FG001|Overall Study|Withdrawal by Subject|6|||
27711152|NCT00361270|80778880|FG002|Overall Study|Withdrawal by Subject|3|||
27711153|NCT00361270|80778881|FG003|Overall Study|Withdrawal by Subject|7|||
27711154|NCT00361270|80778878|FG000|Overall Study|Afraid of Hypnosis|1|||
27711155|NCT00361270|80778879|FG001|Overall Study|Afraid of Hypnosis|2|||
27711156|NCT00361270|80778880|FG002|Overall Study|Afraid of Hypnosis|0|||
27711157|NCT00361270|80778881|FG003|Overall Study|Afraid of Hypnosis|0|||
27711158|NCT00361270|80778878|FG000|Overall Study|Problems with Transportation|4|||
27711159|NCT00361270|80778879|FG001|Overall Study|Problems with Transportation|0|||
27711160|NCT00361270|80778880|FG002|Overall Study|Problems with Transportation|0|||
27711161|NCT00361270|80778881|FG003|Overall Study|Problems with Transportation|0|||
27711162|NCT00361270|80778878|FG000|Overall Study|Adverse Event|0|||
27711163|NCT00361270|80778879|FG001|Overall Study|Adverse Event|1|||
27711164|NCT00361270|80778880|FG002|Overall Study|Adverse Event|1|||
27711165|NCT00361270|80778881|FG003|Overall Study|Adverse Event|0|||
27711166|NCT02039375|80778882|FG000|Overall Study|Lost to Follow-up|2|||
27711167|NCT03127384|80778885|FG000|Overall Study|Lost to Follow-up|4|||
27711168|NCT03127384|80778885|FG000|Overall Study|Subject request|2|||
27711169|NCT03028870|80778886|FG000|Overall Study|Adverse Event|7|||
27711170|NCT03028870|80778887|FG001|Overall Study|Adverse Event|4|||
27711171|NCT03028870|80778888|FG002|Overall Study|Adverse Event|3|||
27711172|NCT03028870|80778889|FG003|Overall Study|Adverse Event|3|||
27711173|NCT03028870|80778886|FG000|Overall Study|Withdrawal by Subject|1|||
27711174|NCT03028870|80778887|FG001|Overall Study|Withdrawal by Subject|1|||
27711175|NCT03028870|80778888|FG002|Overall Study|Withdrawal by Subject|1|||
27711176|NCT03028870|80778889|FG003|Overall Study|Withdrawal by Subject|2|||
27603701|NCT05292534|80391233|FG001|Overall Study|Withdrawal by Subject|1|||
27711177|NCT03028870|80778886|FG000|Overall Study|Lost to Follow-up|1|||
27711178|NCT03028870|80778887|FG001|Overall Study|Lost to Follow-up|0|||
27711179|NCT03028870|80778888|FG002|Overall Study|Lost to Follow-up|0|||
27711180|NCT03028870|80778889|FG003|Overall Study|Lost to Follow-up|0|||
27711181|NCT03028870|80778886|FG000|Overall Study|Lack of Efficacy|3|||
27711182|NCT03028870|80778887|FG001|Overall Study|Lack of Efficacy|0|||
27711183|NCT03028870|80778888|FG002|Overall Study|Lack of Efficacy|0|||
27711184|NCT03028870|80778889|FG003|Overall Study|Lack of Efficacy|0|||
27711185|NCT03028870|80778886|FG000|Overall Study|Administrative|5|||
27711186|NCT03028870|80778887|FG001|Overall Study|Administrative|5|||
27711187|NCT03028870|80778888|FG002|Overall Study|Administrative|12|||
27711188|NCT03028870|80778889|FG003|Overall Study|Administrative|4|||
27711189|NCT00960843|80778890|FG000|Overall Study|Lost to Follow-up|2|||
27711190|NCT00960843|80778891|FG001|Overall Study|Lost to Follow-up|0|||
27711191|NCT00960843|80778890|FG000|Overall Study|Protocol Violation|0|||
27711192|NCT00960843|80778891|FG001|Overall Study|Protocol Violation|4|||
27711193|NCT00960843|80778890|FG000|Overall Study|Repeated needle dislodgment|0|||
27711194|NCT00960843|80778891|FG001|Overall Study|Repeated needle dislodgment|1|||
27711195|NCT00677014|80778892|FG000|Overall Study|Lost to Follow-up|20|||
27711196|NCT00677014|80778893|FG001|Overall Study|Lost to Follow-up|12|||
27711197|NCT00677014|80778894|FG002|Overall Study|Lost to Follow-up|24|||
27711198|NCT00677014|80778892|FG000|Overall Study|Death|6|||
27711199|NCT00677014|80778893|FG001|Overall Study|Death|15|||
27711200|NCT00677014|80778894|FG002|Overall Study|Death|7|||
27711201|NCT00677014|80778892|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
27711202|NCT00677014|80778893|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
27711203|NCT00677014|80778894|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
27711204|NCT02316340|80778895|FG000|First Progression|Clinical progression|2|||
27711205|NCT02316340|80778896|FG001|First Progression|Clinical progression|1|||
27711206|NCT02316340|80778895|FG000|First Progression|Withdrawal by Subject|1|||
27711207|NCT02316340|80778896|FG001|First Progression|Withdrawal by Subject|0|||
27711208|NCT02025907|80778897|FG000|Overall Study|Lack of Efficacy|1|||
27711209|NCT02025907|80778898|FG001|Overall Study|Lack of Efficacy|0|||
27711210|NCT02025907|80778897|FG000|Overall Study|Withdrawal by Subject|15|||
27711211|NCT02025907|80778898|FG001|Overall Study|Withdrawal by Subject|8|||
27711212|NCT02025907|80778897|FG000|Overall Study|Protocol Violation|2|||
27711213|NCT02025907|80778898|FG001|Overall Study|Protocol Violation|0|||
27711214|NCT02025907|80778897|FG000|Overall Study|Physician Decision|2|||
27711215|NCT02025907|80778898|FG001|Overall Study|Physician Decision|0|||
27711216|NCT02025907|80778897|FG000|Overall Study|Lost to Follow-up|2|||
27711217|NCT02025907|80778898|FG001|Overall Study|Lost to Follow-up|2|||
27711218|NCT02025907|80778897|FG000|Overall Study|Adverse Event|3|||
27711219|NCT02025907|80778898|FG001|Overall Study|Adverse Event|1|||
27711220|NCT02025907|80778897|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
27603702|NCT02228967|80391234|FG000|Overall Study|Lost to Follow-up|146|||
27603703|NCT02228967|80391235|FG001|Overall Study|Lost to Follow-up|142|||
27603704|NCT02228967|80391234|FG000|Overall Study|Withdrawal by Subject|13|||
27603705|NCT02228967|80391235|FG001|Overall Study|Withdrawal by Subject|18|||
27603706|NCT02178059|80391236|FG000|Washout|Physician Decision|1|||
27603707|NCT02178059|80391237|FG001|Washout|Physician Decision|0|||
27603708|NCT02739347|80391241|FG000|Overall Study|Adverse Event|3|||
27603709|NCT02739347|80391242|FG001|Overall Study|Adverse Event|0|||
27603710|NCT02739347|80391241|FG000|Overall Study|Protocol Violation|0|||
27603711|NCT02739347|80391242|FG001|Overall Study|Protocol Violation|1|||
27603712|NCT02739347|80391241|FG000|Overall Study|Lost to Follow-up|0|||
27603713|NCT02739347|80391242|FG001|Overall Study|Lost to Follow-up|2|||
27603714|NCT02691182|80391243|FG000|Overall Study|Withdrawal by Subject|4|||
27603715|NCT02691182|80391244|FG001|Overall Study|Withdrawal by Subject|7|||
27603716|NCT02691182|80391245|FG002|Overall Study|Withdrawal by Subject|6|||
27603717|NCT02691182|80391246|FG003|Overall Study|Withdrawal by Subject|8|||
27603718|NCT02691182|80391243|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
27603719|NCT02691182|80391244|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
27603720|NCT02691182|80391245|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
27603721|NCT02691182|80391246|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
27603722|NCT02691182|80391243|FG000|Overall Study|Lost to Follow-up|8|||
27603723|NCT02691182|80391244|FG001|Overall Study|Lost to Follow-up|33|||
27603724|NCT02691182|80391245|FG002|Overall Study|Lost to Follow-up|19|||
27603725|NCT02691182|80391246|FG003|Overall Study|Lost to Follow-up|22|||
27603726|NCT02691182|80391243|FG000|Overall Study|Adverse Event|3|||
27603727|NCT02691182|80391244|FG001|Overall Study|Adverse Event|10|||
27711221|NCT02025907|80778898|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
27603728|NCT02691182|80391245|FG002|Overall Study|Adverse Event|10|||
27711222|NCT04053868|80778899|FG000|Overall Study|Withdrawal by Subject|1|||
27603729|NCT02691182|80391246|FG003|Overall Study|Adverse Event|11|||
27603730|NCT02691182|80391243|FG000|Overall Study|Physician Decision|3|||
27603731|NCT02691182|80391244|FG001|Overall Study|Physician Decision|7|||
27603732|NCT02691182|80391245|FG002|Overall Study|Physician Decision|14|||
27603733|NCT02691182|80391246|FG003|Overall Study|Physician Decision|8|||
27603734|NCT02691182|80391243|FG000|Overall Study|Lack of Efficacy|0|||
27603735|NCT02691182|80391244|FG001|Overall Study|Lack of Efficacy|0|||
27711223|NCT04053868|80778900|FG001|Overall Study|Withdrawal by Subject|0|||
27711224|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
27711225|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
27711226|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
27711227|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27711228|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
27711229|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
27711230|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Death|2|||
27711231|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Death|0|||
27711232|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
27711233|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
27711234|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
27711235|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
27711236|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
27711237|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
27711238|NCT02603120|80778901|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
27711239|NCT02603120|80778902|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
27711240|NCT02603120|80778901|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
27603736|NCT02691182|80391245|FG002|Overall Study|Lack of Efficacy|0|||
27603737|NCT02691182|80391246|FG003|Overall Study|Lack of Efficacy|4|||
27711241|NCT02603120|80778902|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
27711242|NCT02603120|80778901|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
27711243|NCT02603120|80778902|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
27711244|NCT02603120|80778901|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
27711245|NCT02603120|80778902|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
27711246|NCT02603120|80778901|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
27711247|NCT02603120|80778902|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
27711248|NCT02603120|80778901|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
27711249|NCT02603120|80778902|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
27711250|NCT02603120|80778901|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
27711251|NCT02603120|80778902|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
27711252|NCT01294579|80778903|FG000|Overall Study|Disease progression|12|||
27711253|NCT01294579|80778903|FG000|Overall Study|Adverse Event|11|||
27711254|NCT01294579|80778903|FG000|Overall Study|Study closed/terminated|3|||
27711255|NCT01294579|80778903|FG000|Overall Study|Lost to Follow-up|1|||
27711256|NCT01294579|80778903|FG000|Overall Study|Physician Decision|3|||
27711257|NCT01294579|80778903|FG000|Overall Study|Withdrawal by Subject|5|||
27711258|NCT00607386|80778904|FG000|Overall Study|Physician Decision|1|||
27711259|NCT01199042|80778909|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
27711260|NCT01199042|80778909|FG000|At Home (3 Months)|Lost to Follow-up|1|||
27711261|NCT02055820|80778912|FG000|Phase I: Dose-Finding|Death|1|||
27711262|NCT02055820|80778913|FG001|Phase I: Dose-Finding|Death|0|||
27711263|NCT02055820|80778914|FG002|Phase I: Dose-Finding|Death|1|||
27711264|NCT02055820|80778915|FG003|Phase I: Dose-Finding|Death|2|||
27711265|NCT02055820|80778916|FG004|Phase I: Dose-Finding|Death|0|||
27711266|NCT02055820|80778917|FG005|Phase I: Dose-Finding|Death|1|||
27711267|NCT02055820|80778918|FG006|Phase I: Dose-Finding|Death|1|||
27711268|NCT02055820|80778919|FG007|Phase I: Dose-Finding|Death|0|||
27711269|NCT02055820|80778920|FG008|Phase I: Dose-Finding|Death|0|||
27711270|NCT02055820|80778921|FG009|Phase I: Dose-Finding|Death|0|||
27711271|NCT02055820|80778912|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711272|NCT02055820|80778913|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711273|NCT02055820|80778914|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711274|NCT02055820|80778915|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711275|NCT02055820|80778916|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27603738|NCT02691182|80391243|FG000|Overall Study|Protocol Violation|2|||
27711276|NCT02055820|80778917|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
27711277|NCT02055820|80778918|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711278|NCT02055820|80778919|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711279|NCT02055820|80778920|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711280|NCT02055820|80778921|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
27711281|NCT02055820|80778912|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711282|NCT02055820|80778913|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711283|NCT02055820|80778914|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711284|NCT02055820|80778915|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
27711285|NCT02055820|80778916|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711286|NCT02055820|80778917|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711287|NCT02055820|80778918|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
27711288|NCT02055820|80778919|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711289|NCT02055820|80778920|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711290|NCT02055820|80778921|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
27711291|NCT02055820|80778912|FG000|Phase II: Expansion|Death|0|||
27711292|NCT02055820|80778913|FG001|Phase II: Expansion|Death|0|||
27711293|NCT02055820|80778914|FG002|Phase II: Expansion|Death|0|||
27711294|NCT02055820|80778915|FG003|Phase II: Expansion|Death|0|||
27711295|NCT02055820|80778916|FG004|Phase II: Expansion|Death|33|||
27711296|NCT02055820|80778917|FG005|Phase II: Expansion|Death|0|||
27711297|NCT02055820|80778918|FG006|Phase II: Expansion|Death|0|||
27711298|NCT02055820|80778919|FG007|Phase II: Expansion|Death|0|||
27711299|NCT02055820|80778920|FG008|Phase II: Expansion|Death|0|||
27711300|NCT02055820|80778921|FG009|Phase II: Expansion|Death|0|||
27711301|NCT02055820|80778912|FG000|Phase II: Expansion|Lost to Follow-up|0|||
27711302|NCT02055820|80778913|FG001|Phase II: Expansion|Lost to Follow-up|0|||
27711303|NCT02055820|80778914|FG002|Phase II: Expansion|Lost to Follow-up|0|||
27711304|NCT02055820|80778915|FG003|Phase II: Expansion|Lost to Follow-up|0|||
27711305|NCT02055820|80778916|FG004|Phase II: Expansion|Lost to Follow-up|4|||
27711306|NCT02055820|80778917|FG005|Phase II: Expansion|Lost to Follow-up|0|||
27836510|NCT03614728|81232794|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
27836511|NCT03614728|81232795|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
27836512|NCT03614728|81232796|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
27603739|NCT02691182|80391244|FG001|Overall Study|Protocol Violation|6|||
27603740|NCT02691182|80391245|FG002|Overall Study|Protocol Violation|6|||
27603741|NCT02691182|80391246|FG003|Overall Study|Protocol Violation|8|||
27603742|NCT02691182|80391243|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
27603743|NCT02691182|80391244|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
27603744|NCT02691182|80391245|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
27603745|NCT02691182|80391246|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
27603746|NCT02691182|80391243|FG000|Overall Study|Missing|0|||
27603747|NCT02691182|80391244|FG001|Overall Study|Missing|5|||
27603748|NCT02691182|80391245|FG002|Overall Study|Missing|1|||
27603749|NCT02691182|80391246|FG003|Overall Study|Missing|5|||
27603750|NCT01127646|80391249|FG000|Overall Study|Entry Criteria Not Met|1|||
27603751|NCT01127646|80391250|FG001|Overall Study|Entry Criteria Not Met|0|||
27603752|NCT01127646|80391249|FG000|Overall Study|Protocol Violation|0|||
27603753|NCT01127646|80391250|FG001|Overall Study|Protocol Violation|1|||
27603754|NCT02835339|80391251|FG000|Overall Study|Did not receive allocated intervention|13|||
27711307|NCT02055820|80778918|FG006|Phase II: Expansion|Lost to Follow-up|0|||
27711308|NCT02055820|80778919|FG007|Phase II: Expansion|Lost to Follow-up|0|||
27836513|NCT00674128|81232799|FG000|Overall Study|Withdrawal by Subject|25|||
27711309|NCT02055820|80778920|FG008|Phase II: Expansion|Lost to Follow-up|0|||
27711310|NCT02055820|80778921|FG009|Phase II: Expansion|Lost to Follow-up|0|||
27711311|NCT02055820|80778912|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
27836514|NCT00674128|81232800|FG001|Overall Study|Withdrawal by Subject|23|||
27711312|NCT02055820|80778913|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
27711313|NCT02055820|80778914|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
27711314|NCT02055820|80778915|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
27711315|NCT02055820|80778916|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
27711316|NCT02055820|80778917|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
27711317|NCT02055820|80778918|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
27711318|NCT02055820|80778919|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
27711319|NCT02055820|80778920|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
27711320|NCT02055820|80778921|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
27711321|NCT01834274|80778927|FG000|Overall Study|Study Termination|41|||
27711322|NCT01834274|80778928|FG001|Overall Study|Study Termination|38|||
27711323|NCT01834274|80778927|FG000|Overall Study|Withdrawal by Subject|1|||
27711324|NCT01834274|80778928|FG001|Overall Study|Withdrawal by Subject|1|||
27711325|NCT01834274|80778927|FG000|Overall Study|Lost to Follow-up|3|||
27711326|NCT01834274|80778928|FG001|Overall Study|Lost to Follow-up|1|||
27711327|NCT01834274|80778927|FG000|Overall Study|Other|2|||
27711328|NCT01834274|80778928|FG001|Overall Study|Other|1|||
27711329|NCT00736255|80778929|FG000|Overall Study|Adverse Event|1|||
27711330|NCT00736255|80778930|FG001|Overall Study|Adverse Event|0|||
27711331|NCT00736255|80778929|FG000|Overall Study|Physician Decision|1|||
27711332|NCT00736255|80778930|FG001|Overall Study|Physician Decision|0|||
27711333|NCT00736255|80778929|FG000|Overall Study|Non-compliance|1|||
27711334|NCT00736255|80778930|FG001|Overall Study|Non-compliance|1|||
27711335|NCT01848288|80778931|FG000|Overall Study|Death|1|||
27711336|NCT01848288|80778931|FG000|Overall Study|Protocol Violation|1|||
27711337|NCT01848288|80778931|FG000|Overall Study|Withdrawal by Subject|1|||
27711338|NCT01358864|80778936|FG000|Overall Study|Adverse Event|0|||
27711339|NCT01358864|80778937|FG001|Overall Study|Adverse Event|6|||
27711340|NCT01358864|80778938|FG002|Overall Study|Adverse Event|9|||
27711341|NCT01358864|80778939|FG003|Overall Study|Adverse Event|0|||
27711342|NCT01358864|80778940|FG004|Overall Study|Adverse Event|4|||
27711343|NCT01358864|80778941|FG005|Overall Study|Adverse Event|8|||
27836515|NCT01206439|81232801|FG000|Overall Study|subject did not meet inclusion criteria|1|||
27836516|NCT03250117|81232804|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
27711344|NCT01358864|80778942|FG006|Overall Study|Adverse Event|12|||
27711345|NCT01358864|80778943|FG007|Overall Study|Adverse Event|7|||
27711346|NCT01358864|80778936|FG000|Overall Study|Lack of Efficacy|26|||
27711347|NCT01358864|80778937|FG001|Overall Study|Lack of Efficacy|3|||
27711348|NCT01358864|80778938|FG002|Overall Study|Lack of Efficacy|4|||
27711349|NCT01358864|80778939|FG003|Overall Study|Lack of Efficacy|19|||
27711350|NCT01358864|80778940|FG004|Overall Study|Lack of Efficacy|7|||
27711351|NCT01358864|80778941|FG005|Overall Study|Lack of Efficacy|4|||
27711352|NCT01358864|80778942|FG006|Overall Study|Lack of Efficacy|49|||
27711353|NCT01358864|80778943|FG007|Overall Study|Lack of Efficacy|44|||
27711354|NCT01358864|80778936|FG000|Overall Study|Lost to Follow-up|0|||
27711355|NCT01358864|80778937|FG001|Overall Study|Lost to Follow-up|0|||
27711356|NCT01358864|80778938|FG002|Overall Study|Lost to Follow-up|1|||
27711357|NCT01358864|80778939|FG003|Overall Study|Lost to Follow-up|0|||
27711358|NCT01358864|80778940|FG004|Overall Study|Lost to Follow-up|0|||
27711359|NCT01358864|80778941|FG005|Overall Study|Lost to Follow-up|0|||
27711360|NCT01358864|80778942|FG006|Overall Study|Lost to Follow-up|0|||
27711361|NCT01358864|80778943|FG007|Overall Study|Lost to Follow-up|1|||
27711362|NCT01358864|80778936|FG000|Overall Study|Withdrawal by Subject|3|||
27711363|NCT01358864|80778937|FG001|Overall Study|Withdrawal by Subject|4|||
27711364|NCT01358864|80778938|FG002|Overall Study|Withdrawal by Subject|2|||
27711365|NCT01358864|80778939|FG003|Overall Study|Withdrawal by Subject|0|||
27711366|NCT01358864|80778940|FG004|Overall Study|Withdrawal by Subject|0|||
27711367|NCT01358864|80778941|FG005|Overall Study|Withdrawal by Subject|1|||
27711368|NCT01358864|80778942|FG006|Overall Study|Withdrawal by Subject|1|||
27711369|NCT01358864|80778943|FG007|Overall Study|Withdrawal by Subject|3|||
27711370|NCT01358864|80778936|FG000|Overall Study|Other reason not defined above|2|||
27711371|NCT01358864|80778937|FG001|Overall Study|Other reason not defined above|0|||
27711372|NCT01358864|80778938|FG002|Overall Study|Other reason not defined above|0|||
27711373|NCT01358864|80778939|FG003|Overall Study|Other reason not defined above|0|||
27711374|NCT01358864|80778940|FG004|Overall Study|Other reason not defined above|0|||
27711375|NCT01358864|80778941|FG005|Overall Study|Other reason not defined above|0|||
27711376|NCT01358864|80778942|FG006|Overall Study|Other reason not defined above|2|||
27711377|NCT01358864|80778943|FG007|Overall Study|Other reason not defined above|0|||
27711378|NCT01358864|80778936|FG000|Overall Study|Not treated|0|||
27711379|NCT01358864|80778937|FG001|Overall Study|Not treated|0|||
27711380|NCT01358864|80778938|FG002|Overall Study|Not treated|0|||
27711381|NCT01358864|80778939|FG003|Overall Study|Not treated|0|||
27711382|NCT01358864|80778940|FG004|Overall Study|Not treated|0|||
27711383|NCT01358864|80778941|FG005|Overall Study|Not treated|0|||
27711384|NCT01358864|80778942|FG006|Overall Study|Not treated|1|||
27711385|NCT01358864|80778943|FG007|Overall Study|Not treated|0|||
27711386|NCT01087905|80778944|FG000|Overall Study|Lost to Follow-up|24|||
27711387|NCT01087905|80778945|FG001|Overall Study|Lost to Follow-up|28|||
27711388|NCT01087905|80778946|FG002|Overall Study|Lost to Follow-up|18|||
27711389|NCT01087905|80778947|FG003|Overall Study|Lost to Follow-up|31|||
27711390|NCT01087905|80778948|FG004|Overall Study|Lost to Follow-up|27|||
27711391|NCT01087905|80778949|FG005|Overall Study|Lost to Follow-up|25|||
27711392|NCT01087905|80778950|FG006|Overall Study|Lost to Follow-up|20|||
27711393|NCT01087905|80778951|FG007|Overall Study|Lost to Follow-up|24|||
27711394|NCT01087905|80778944|FG000|Overall Study|Withdrawal by Subject|5|||
27711395|NCT01087905|80778945|FG001|Overall Study|Withdrawal by Subject|4|||
27711396|NCT01087905|80778946|FG002|Overall Study|Withdrawal by Subject|4|||
27711397|NCT01087905|80778947|FG003|Overall Study|Withdrawal by Subject|5|||
27711398|NCT01087905|80778948|FG004|Overall Study|Withdrawal by Subject|4|||
27711399|NCT01087905|80778949|FG005|Overall Study|Withdrawal by Subject|3|||
27711400|NCT01087905|80778950|FG006|Overall Study|Withdrawal by Subject|3|||
27836517|NCT03250117|81232805|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
27711401|NCT01087905|80778951|FG007|Overall Study|Withdrawal by Subject|5|||
27711402|NCT00117598|80778952|FG000|Prior to Treatment Cross Over|Death|40|||
27711403|NCT00117598|80778953|FG001|Prior to Treatment Cross Over|Death|41|||
27836518|NCT03250117|81232806|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
27711404|NCT00117598|80778954|FG002|Prior to Treatment Cross Over|Death|37|||
27711405|NCT00117598|80778955|FG003|Prior to Treatment Cross Over|Death|0|||
27711406|NCT00117598|80778956|FG004|Prior to Treatment Cross Over|Death|0|||
27711407|NCT00117598|80778952|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
27711408|NCT00117598|80778953|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
27711409|NCT00117598|80778954|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
27711410|NCT00117598|80778955|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
27711411|NCT00117598|80778956|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
27711412|NCT00117598|80778952|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
27711413|NCT00117598|80778953|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
27711414|NCT00117598|80778954|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
27711415|NCT00117598|80778955|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
27711416|NCT00117598|80778956|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
27711417|NCT00117598|80778952|FG000|Prior to Treatment Cross Over|Other|15|||
27711418|NCT00117598|80778953|FG001|Prior to Treatment Cross Over|Other|9|||
27711419|NCT00117598|80778954|FG002|Prior to Treatment Cross Over|Other|9|||
27711420|NCT00117598|80778955|FG003|Prior to Treatment Cross Over|Other|0|||
27711421|NCT00117598|80778956|FG004|Prior to Treatment Cross Over|Other|0|||
27711422|NCT00117598|80778952|FG000|After Treament Cross Over|Death|0|||
27711423|NCT00117598|80778953|FG001|After Treament Cross Over|Death|0|||
27711424|NCT00117598|80778954|FG002|After Treament Cross Over|Death|0|||
27711425|NCT00117598|80778955|FG003|After Treament Cross Over|Death|1|||
27711426|NCT00117598|80778956|FG004|After Treament Cross Over|Death|2|||
27711427|NCT00117598|80778952|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
27711428|NCT00117598|80778953|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
27711429|NCT00117598|80778954|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
27711430|NCT00117598|80778955|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
27711431|NCT00117598|80778956|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
27711432|NCT00117598|80778952|FG000|After Treament Cross Over|Other|0|||
27711433|NCT00117598|80778953|FG001|After Treament Cross Over|Other|0|||
27711434|NCT00117598|80778954|FG002|After Treament Cross Over|Other|0|||
27711435|NCT00117598|80778955|FG003|After Treament Cross Over|Other|1|||
27711436|NCT00117598|80778956|FG004|After Treament Cross Over|Other|2|||
27711437|NCT02829138|80778957|FG000|Overall Study|Withdrawal by Subject|1|||
27711438|NCT02829138|80778958|FG001|Overall Study|Withdrawal by Subject|0|||
27711439|NCT01549275|80778961|FG000|Overall Study|Lost to Follow-up|1|||
27711440|NCT01549275|80778962|FG001|Overall Study|Lost to Follow-up|0|||
27836519|NCT03250117|81232807|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
27711441|NCT00365456|80778963|FG000|Trial Period I (12 Months)|Adverse Event|84|||
27711442|NCT00365456|80778964|FG001|Trial Period I (12 Months)|Adverse Event|0|||
27711443|NCT00365456|80778963|FG000|Trial Period I (12 Months)|Non-compliance|3|||
27711444|NCT00365456|80778964|FG001|Trial Period I (12 Months)|Non-compliance|0|||
27711445|NCT00365456|80778963|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
27711446|NCT00365456|80778964|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
27711447|NCT00365456|80778963|FG000|Trial Period I (12 Months)|Other|11|||
27711448|NCT00365456|80778964|FG001|Trial Period I (12 Months)|Other|0|||
27711449|NCT00365456|80778963|FG000|Trial Period II (12 Months)|Adverse Event|0|||
27711450|NCT00365456|80778964|FG001|Trial Period II (12 Months)|Adverse Event|6|||
27711451|NCT00365456|80778963|FG000|Trial Period II (12 Months)|Non-compliance|0|||
27711452|NCT00365456|80778964|FG001|Trial Period II (12 Months)|Non-compliance|2|||
27711453|NCT00365456|80778963|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
27711454|NCT00365456|80778964|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
27711455|NCT00365456|80778963|FG000|Trial Period II (12 Months)|Other|0|||
27711456|NCT00365456|80778964|FG001|Trial Period II (12 Months)|Other|1|||
27711457|NCT00365456|80778963|FG000|Trial Period III (12 Months)|Adverse Event|13|||
27711458|NCT00365456|80778964|FG001|Trial Period III (12 Months)|Adverse Event|3|||
27711459|NCT00365456|80778963|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
27711460|NCT00365456|80778964|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
27711461|NCT00365456|80778963|FG000|Trial Period III (12 Months)|Other|1|||
27711462|NCT00365456|80778964|FG001|Trial Period III (12 Months)|Other|1|||
27711463|NCT01111851|80778967|FG000|Overall Study|All planned PET scans were not obtained.|2|||
27711464|NCT01111851|80778968|FG001|Overall Study|All planned PET scans were not obtained.|0|||
27711465|NCT01081912|80778969|FG000|Conversion/Titration|Adverse Event|47|||
27711466|NCT01081912|80778970|FG001|Conversion/Titration|Adverse Event|0|||
27711467|NCT01081912|80778971|FG002|Conversion/Titration|Adverse Event|0|||
27711468|NCT01081912|80778969|FG000|Conversion/Titration|Lack of Efficacy|17|||
27711469|NCT01081912|80778970|FG001|Conversion/Titration|Lack of Efficacy|0|||
27711470|NCT01081912|80778971|FG002|Conversion/Titration|Lack of Efficacy|0|||
27711471|NCT01081912|80778969|FG000|Conversion/Titration|Lost to Follow-up|5|||
27711472|NCT01081912|80778970|FG001|Conversion/Titration|Lost to Follow-up|0|||
27711473|NCT01081912|80778971|FG002|Conversion/Titration|Lost to Follow-up|0|||
27711474|NCT01081912|80778969|FG000|Conversion/Titration|Physician Decision|2|||
27711475|NCT01081912|80778970|FG001|Conversion/Titration|Physician Decision|0|||
27711476|NCT01081912|80778971|FG002|Conversion/Titration|Physician Decision|0|||
27711477|NCT01081912|80778969|FG000|Conversion/Titration|Protocol Violation|67|||
27711478|NCT01081912|80778970|FG001|Conversion/Titration|Protocol Violation|0|||
27711479|NCT01081912|80778971|FG002|Conversion/Titration|Protocol Violation|0|||
27711480|NCT01081912|80778969|FG000|Conversion/Titration|Withdrawal by Subject|23|||
27711481|NCT01081912|80778970|FG001|Conversion/Titration|Withdrawal by Subject|0|||
27711482|NCT01081912|80778971|FG002|Conversion/Titration|Withdrawal by Subject|0|||
27711483|NCT01081912|80778969|FG000|Conversion/Titration|Non-Compliance|47|||
27711484|NCT01081912|80778970|FG001|Conversion/Titration|Non-Compliance|0|||
27711485|NCT01081912|80778971|FG002|Conversion/Titration|Non-Compliance|0|||
27711486|NCT01081912|80778969|FG000|Maintenance Treatment|Adverse Event|0|||
27711487|NCT01081912|80778970|FG001|Maintenance Treatment|Adverse Event|2|||
27711488|NCT01081912|80778971|FG002|Maintenance Treatment|Adverse Event|12|||
27711489|NCT01081912|80778969|FG000|Maintenance Treatment|Lack of Efficacy|0|||
27711490|NCT01081912|80778970|FG001|Maintenance Treatment|Lack of Efficacy|14|||
27711491|NCT01081912|80778971|FG002|Maintenance Treatment|Lack of Efficacy|64|||
27711492|NCT01081912|80778969|FG000|Maintenance Treatment|Lost to Follow-up|0|||
27711493|NCT01081912|80778970|FG001|Maintenance Treatment|Lost to Follow-up|1|||
27711494|NCT01081912|80778971|FG002|Maintenance Treatment|Lost to Follow-up|0|||
27711495|NCT01081912|80778969|FG000|Maintenance Treatment|Physician Decision|0|||
27711496|NCT01081912|80778970|FG001|Maintenance Treatment|Physician Decision|0|||
27711497|NCT01081912|80778971|FG002|Maintenance Treatment|Physician Decision|1|||
27711498|NCT01081912|80778969|FG000|Maintenance Treatment|Protocol Violation|0|||
27711499|NCT01081912|80778970|FG001|Maintenance Treatment|Protocol Violation|1|||
27711500|NCT01081912|80778971|FG002|Maintenance Treatment|Protocol Violation|2|||
27711501|NCT01081912|80778969|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
27711502|NCT01081912|80778970|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
27711503|NCT01081912|80778971|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
27711504|NCT01081912|80778969|FG000|Maintenance Treatment|Non-Compliance|0|||
27711505|NCT01081912|80778970|FG001|Maintenance Treatment|Non-Compliance|4|||
27711506|NCT01081912|80778971|FG002|Maintenance Treatment|Non-Compliance|7|||
27711507|NCT01081912|80778969|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
27603755|NCT02835339|80391252|FG001|Overall Study|Did not receive allocated intervention|16|||
27603756|NCT00508404|80391253|FG000|Overall Study|Ongoing at Data Cut-off|12|||
27711508|NCT01081912|80778970|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
27711509|NCT01081912|80778971|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
27711510|NCT00823823|80778972|FG000|Overall Study|Lost to Follow-up|3|||
27711511|NCT00823823|80778973|FG001|Overall Study|Lost to Follow-up|1|||
27711512|NCT00823823|80778972|FG000|Overall Study|Protocol Violation|5|||
27711513|NCT00823823|80778973|FG001|Overall Study|Protocol Violation|5|||
27603757|NCT00508404|80391253|FG000|Overall Study|Adverse Event|2|||
27603758|NCT00508404|80391253|FG000|Overall Study|Death|16|||
27603759|NCT00508404|80391253|FG000|Overall Study|Physician Decision|2|||
27603760|NCT00508404|80391253|FG000|Overall Study|Withdrawal by Subject|3|||
27603761|NCT00508404|80391253|FG000|Overall Study|Protocol-specified Criteria|2|||
27603762|NCT00508404|80391253|FG000|Overall Study|Lost to Follow-up|2|||
27603763|NCT00508404|80391253|FG000|Overall Study|Other - Not Specified|3|||
27603764|NCT02073097|80391257|FG000|Overall Study|Adverse Event|0|||
27603765|NCT02073097|80391258|FG001|Overall Study|Adverse Event|0|||
27603766|NCT02073097|80391259|FG002|Overall Study|Adverse Event|0|||
27603767|NCT02073097|80391260|FG003|Overall Study|Adverse Event|0|||
27603768|NCT02073097|80391261|FG004|Overall Study|Adverse Event|0|||
27603769|NCT02073097|80391262|FG005|Overall Study|Adverse Event|0|||
27603770|NCT02073097|80391263|FG006|Overall Study|Adverse Event|0|||
27603771|NCT02073097|80391264|FG007|Overall Study|Adverse Event|2|||
27603772|NCT02073097|80391257|FG000|Overall Study|Withdrawal by Subject|0|||
27603773|NCT02073097|80391258|FG001|Overall Study|Withdrawal by Subject|0|||
27603774|NCT02073097|80391259|FG002|Overall Study|Withdrawal by Subject|0|||
27603775|NCT02073097|80391260|FG003|Overall Study|Withdrawal by Subject|0|||
27836520|NCT02151149|81232808|FG000|Treatment Period|Death|2|||
27603776|NCT02073097|80391261|FG004|Overall Study|Withdrawal by Subject|0|||
27603777|NCT02073097|80391262|FG005|Overall Study|Withdrawal by Subject|0|||
27603778|NCT02073097|80391263|FG006|Overall Study|Withdrawal by Subject|0|||
27603779|NCT02073097|80391264|FG007|Overall Study|Withdrawal by Subject|2|||
27836521|NCT02151149|81232809|FG001|Treatment Period|Death|3|||
27603780|NCT02073097|80391257|FG000|Overall Study|Death|0|||
27836522|NCT02151149|81232808|FG000|Treatment Period|Adverse Event|17|||
27603781|NCT02073097|80391258|FG001|Overall Study|Death|0|||
27603782|NCT02073097|80391259|FG002|Overall Study|Death|0|||
27603783|NCT02073097|80391260|FG003|Overall Study|Death|0|||
27603784|NCT02073097|80391261|FG004|Overall Study|Death|0|||
27711514|NCT00440947|80778986|FG000|36-Week Induction Phase|Adverse Event|16|||
27711515|NCT00440947|80778987|FG001|36-Week Induction Phase|Adverse Event|0|||
27711516|NCT00440947|80778988|FG002|36-Week Induction Phase|Adverse Event|0|||
27711517|NCT00440947|80778989|FG003|36-Week Induction Phase|Adverse Event|0|||
27711518|NCT00440947|80778990|FG004|36-Week Induction Phase|Adverse Event|0|||
27711519|NCT00440947|80778986|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
27711520|NCT00440947|80778987|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
27711521|NCT00440947|80778988|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
27711522|NCT00440947|80778989|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
27711523|NCT00440947|80778990|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
27836523|NCT02151149|81232809|FG001|Treatment Period|Adverse Event|14|||
27836524|NCT02151149|81232808|FG000|Treatment Period|Progressive Disease|25|||
27836525|NCT02151149|81232809|FG001|Treatment Period|Progressive Disease|24|||
27836526|NCT02151149|81232808|FG000|Treatment Period|Symptomatic Deterioration|2|||
27836527|NCT02151149|81232809|FG001|Treatment Period|Symptomatic Deterioration|10|||
27836528|NCT02151149|81232808|FG000|Treatment Period|Withdrawal by Subject|13|||
27836529|NCT02151149|81232809|FG001|Treatment Period|Withdrawal by Subject|11|||
27836530|NCT02151149|81232808|FG000|Treatment Period|Miscellaneous|8|||
27836531|NCT02151149|81232809|FG001|Treatment Period|Miscellaneous|7|||
27836532|NCT02151149|81232808|FG000|Treatment Period|Participants randomized but not treated|3|||
27836533|NCT02151149|81232809|FG001|Treatment Period|Participants randomized but not treated|2|||
27836534|NCT02151149|81232808|FG000|Follow-Up Period|Lost to Follow-up|2|||
27836535|NCT02151149|81232809|FG001|Follow-Up Period|Lost to Follow-up|3|||
27836536|NCT02151149|81232808|FG000|Follow-Up Period|Death|37|||
27836537|NCT02151149|81232809|FG001|Follow-Up Period|Death|34|||
27836538|NCT05065619|81232810|FG000|Up to Day 42|Lost to Follow-up|1|||
27836539|NCT05065619|81232811|FG001|Up to Day 42|Lost to Follow-up|0|||
27836540|NCT05065619|81232810|FG000|Up to Day 42|Withdrawal by Subject|1|||
27836541|NCT05065619|81232811|FG001|Up to Day 42|Withdrawal by Subject|0|||
27836542|NCT05065619|81232810|FG000|After Day 43|Lost to Follow-up|1|||
27836543|NCT05065619|81232811|FG001|After Day 43|Lost to Follow-up|0|||
27836544|NCT05065619|81232810|FG000|After Day 43|Physician Decision|3|||
27836545|NCT05065619|81232811|FG001|After Day 43|Physician Decision|0|||
27836546|NCT05065619|81232810|FG000|After Day 43|Withdrawal by Subject|1|||
27836547|NCT05065619|81232811|FG001|After Day 43|Withdrawal by Subject|2|||
27836548|NCT05065619|81232810|FG000|After Day 43|Public vaccination|6|||
27836549|NCT05065619|81232811|FG001|After Day 43|Public vaccination|8|||
27836550|NCT05065619|81232810|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
27836551|NCT05065619|81232811|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
27603785|NCT02073097|80391262|FG005|Overall Study|Death|0|||
27603786|NCT02073097|80391263|FG006|Overall Study|Death|0|||
27836552|NCT05065619|81232810|FG000|After Day 43|Study Terminated by Sponsor|88|||
27836553|NCT05065619|81232811|FG001|After Day 43|Study Terminated by Sponsor|16|||
27836554|NCT04049097|81232814|FG000|Overall Study|Adverse Event|18|||
27836555|NCT04049097|81232814|FG000|Overall Study|Death|2|||
27836556|NCT04049097|81232814|FG000|Overall Study|Lost to Follow-up|1|||
27836557|NCT04049097|81232814|FG000|Overall Study|Physician Decision|2|||
27836558|NCT04049097|81232814|FG000|Overall Study|Withdrawal by Subject|9|||
27836559|NCT04049097|81232814|FG000|Overall Study|Protocol Violation|2|||
27603787|NCT02073097|80391264|FG007|Overall Study|Death|1|||
27603788|NCT02073097|80391257|FG000|Overall Study|Physician Decision|0|||
27603789|NCT02073097|80391258|FG001|Overall Study|Physician Decision|0|||
27603790|NCT02073097|80391259|FG002|Overall Study|Physician Decision|0|||
27603791|NCT02073097|80391260|FG003|Overall Study|Physician Decision|0|||
27603792|NCT02073097|80391261|FG004|Overall Study|Physician Decision|0|||
27603793|NCT02073097|80391262|FG005|Overall Study|Physician Decision|0|||
27603794|NCT02073097|80391263|FG006|Overall Study|Physician Decision|0|||
27603795|NCT02073097|80391264|FG007|Overall Study|Physician Decision|1|||
27603796|NCT00509236|80391265|FG000|Overall Study|Adverse Event|7|||
27603797|NCT00509236|80391266|FG001|Overall Study|Adverse Event|9|||
27603798|NCT00509236|80391265|FG000|Overall Study|Withdrawal by Subject|5|||
27603799|NCT00509236|80391266|FG001|Overall Study|Withdrawal by Subject|10|||
27603800|NCT00509236|80391265|FG000|Overall Study|Protocol Violation|3|||
27711524|NCT00440947|80778986|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
27711525|NCT00440947|80778987|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
27711526|NCT00440947|80778988|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
27711527|NCT00440947|80778989|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
27711528|NCT00440947|80778990|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
27711529|NCT00440947|80778986|FG000|36-Week Induction Phase|Non-compliance|10|||
27711530|NCT00440947|80778987|FG001|36-Week Induction Phase|Non-compliance|0|||
27836560|NCT04049097|81232814|FG000|Overall Study|Other|1|||
27711531|NCT00440947|80778988|FG002|36-Week Induction Phase|Non-compliance|0|||
27603801|NCT00509236|80391266|FG001|Overall Study|Protocol Violation|0|||
27603802|NCT00509236|80391265|FG000|Overall Study|Excluded Medication|1|||
27603803|NCT00509236|80391266|FG001|Overall Study|Excluded Medication|1|||
27603804|NCT00509236|80391265|FG000|Overall Study|Scheduled Kidney Transplant|1|||
27603805|NCT00509236|80391266|FG001|Overall Study|Scheduled Kidney Transplant|0|||
27603806|NCT01520402|80391269|FG000|Overall Study|Withdrawal by Subject|2|||
27603807|NCT01520402|80391269|FG000|Overall Study|Physician Decision|3|||
27603808|NCT02487498|80391270|FG000|Period: Period 1|Adverse Event|2|||
27603809|NCT02487498|80391271|FG001|Period: Period 1|Adverse Event|4|||
27603810|NCT02487498|80391270|FG000|Period: Period 1|Subject/guardian decision|2|||
27603811|NCT02487498|80391271|FG001|Period: Period 1|Subject/guardian decision|4|||
27603812|NCT02487498|80391270|FG000|Period: Period 1|Lost to Follow-up|0|||
27603813|NCT02487498|80391271|FG001|Period: Period 1|Lost to Follow-up|2|||
27603814|NCT02487498|80391270|FG000|Period: Period 1|Lack of Efficacy|1|||
27603815|NCT02487498|80391271|FG001|Period: Period 1|Lack of Efficacy|0|||
27603816|NCT02487498|80391270|FG000|Period: Period 1|Physician Decision|0|||
27603817|NCT02487498|80391271|FG001|Period: Period 1|Physician Decision|1|||
27603818|NCT02487498|80391270|FG000|Period: Period 1|Protocol deviation|1|||
27603819|NCT02487498|80391271|FG001|Period: Period 1|Protocol deviation|0|||
27603820|NCT02487498|80391270|FG000|Period: Washout|Subject/guardian decision|0|||
27603821|NCT02487498|80391271|FG001|Period: Washout|Subject/guardian decision|5|||
27603822|NCT02487498|80391270|FG000|Period: Washout|Lack of Efficacy|1|||
27603823|NCT02487498|80391271|FG001|Period: Washout|Lack of Efficacy|1|||
27603824|NCT02487498|80391270|FG000|Period: Washout|Physician Decision|1|||
27603825|NCT02487498|80391271|FG001|Period: Washout|Physician Decision|0|||
27603826|NCT02487498|80391270|FG000|Period: Washout|Non-compliance with study treatment|0|||
27603827|NCT02487498|80391271|FG001|Period: Washout|Non-compliance with study treatment|1|||
27603828|NCT02487498|80391270|FG000|Period: Period 2|Adverse Event|2|||
27603829|NCT02487498|80391271|FG001|Period: Period 2|Adverse Event|2|||
27603830|NCT02487498|80391270|FG000|Period: Period 2|Subject/guardian decision|2|||
27603831|NCT02487498|80391271|FG001|Period: Period 2|Subject/guardian decision|1|||
27711532|NCT00440947|80778989|FG003|36-Week Induction Phase|Non-compliance|0|||
27711533|NCT00440947|80778990|FG004|36-Week Induction Phase|Non-compliance|0|||
27711534|NCT00440947|80778986|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
27711535|NCT00440947|80778987|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
27711536|NCT00440947|80778988|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
27711537|NCT00440947|80778989|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
27711538|NCT00440947|80778990|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
27711539|NCT00440947|80778986|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
27711540|NCT00440947|80778987|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
27711541|NCT00440947|80778988|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
27711542|NCT00440947|80778989|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
27711543|NCT00440947|80778990|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
27711544|NCT00440947|80778986|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
27711545|NCT00440947|80778987|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
27711546|NCT00440947|80778988|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
27711547|NCT00440947|80778989|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
27711548|NCT00440947|80778990|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
27711549|NCT00440947|80778986|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
27836561|NCT04049097|81232814|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
27836562|NCT03922750|81232819|FG000|Overall Study|Unclassified|0|||
27603832|NCT02487498|80391270|FG000|Period: Period 2|Lost to Follow-up|1|||
27603833|NCT02487498|80391271|FG001|Period: Period 2|Lost to Follow-up|1|||
27603834|NCT02487498|80391270|FG000|Period: Period 2|Death|0|||
27603835|NCT02487498|80391271|FG001|Period: Period 2|Death|1|||
27836563|NCT03922750|81232820|FG001|Overall Study|Unclassified|0|||
27603836|NCT02487498|80391270|FG000|Period: Period 2|Physician Decision|1|||
27603837|NCT02487498|80391271|FG001|Period: Period 2|Physician Decision|0|||
27603838|NCT01424930|80391272|FG000|Overall Study|Adverse Event|0|||
27603839|NCT01424930|80391273|FG001|Overall Study|Adverse Event|1|||
27603840|NCT01424930|80391272|FG000|Overall Study|Death|1|||
27603841|NCT01424930|80391273|FG001|Overall Study|Death|0|||
27603842|NCT01424930|80391272|FG000|Overall Study|Progressive Disease|3|||
27603843|NCT01424930|80391273|FG001|Overall Study|Progressive Disease|6|||
27603844|NCT01424930|80391272|FG000|Overall Study|Screen Failure|0|||
27603845|NCT01424930|80391273|FG001|Overall Study|Screen Failure|1|||
27603846|NCT01424930|80391272|FG000|Overall Study|Reason not specified|0|||
27603847|NCT01424930|80391273|FG001|Overall Study|Reason not specified|6|||
27603848|NCT02010632|80391274|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
27603849|NCT02010632|80391275|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
27603850|NCT03633929|80391276|FG000|Overall Study|Lost to Follow-up|1|||
27603851|NCT03633929|80391276|FG000|Overall Study|Did not login to software. Did not participate|3|||
27603852|NCT00895622|80391280|FG000|Overall Study|Protocol Violation|5|||
27603853|NCT00895622|80391281|FG001|Overall Study|Protocol Violation|4|||
27603854|NCT00895622|80391282|FG002|Overall Study|Protocol Violation|4|||
27603855|NCT02234063|80391283|FG000|Overall Study|Lost to Follow-up|235|||
27603856|NCT02234063|80391284|FG001|Overall Study|Lost to Follow-up|42|||
27603857|NCT02234063|80391283|FG000|Overall Study|Withdrawal by Subject|20|||
27603858|NCT02234063|80391284|FG001|Overall Study|Withdrawal by Subject|1|||
27603859|NCT01657266|80391285|FG000|Overall Study|Lost to Follow-up|2|||
27603860|NCT01657266|80391286|FG001|Overall Study|Lost to Follow-up|2|||
27603861|NCT01657266|80391285|FG000|Overall Study|Adverse Event|2|||
27603862|NCT01657266|80391286|FG001|Overall Study|Adverse Event|3|||
27603863|NCT01807650|80391287|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
27711550|NCT00440947|80778987|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
27603864|NCT01807650|80391287|FG000|Overall Study|Adverse Event|5|||
27711551|NCT00440947|80778988|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
27603865|NCT01807650|80391287|FG000|Overall Study|Other|2|||
27603866|NCT05597722|80391288|FG000|Overall Study|Study was terminated|6|||
27603867|NCT05597722|80391289|FG001|Overall Study|Study was terminated|1|||
27836564|NCT03922750|81232821|FG002|Overall Study|Unclassified|1|||
27603868|NCT03929562|80391290|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
27603869|NCT03929562|80391291|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
27603870|NCT03929562|80391290|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
27603871|NCT03929562|80391291|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
27603872|NCT03929562|80391290|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
27603873|NCT03929562|80391291|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
27603874|NCT01226511|80391293|FG000|Acute Treatment Period|Adverse Event|7|||
27603875|NCT01226511|80391294|FG001|Acute Treatment Period|Adverse Event|6|||
27603876|NCT01226511|80391293|FG000|Acute Treatment Period|Lack of Efficacy|2|||
27603877|NCT01226511|80391294|FG001|Acute Treatment Period|Lack of Efficacy|1|||
27603878|NCT01226511|80391293|FG000|Acute Treatment Period|Lost to Follow-up|3|||
27603879|NCT01226511|80391294|FG001|Acute Treatment Period|Lost to Follow-up|6|||
27603880|NCT01226511|80391293|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
27836565|NCT03922750|81232819|FG000|Overall Study|Adverse Event|0|||
27711552|NCT00440947|80778989|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
27711553|NCT00440947|80778990|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
27711554|NCT00440947|80778986|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
27711555|NCT00440947|80778987|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
27711556|NCT00440947|80778988|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
27711557|NCT00440947|80778989|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
27711558|NCT00440947|80778990|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
27711559|NCT00440947|80778986|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
27711560|NCT00440947|80778987|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
27711561|NCT00440947|80778988|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
27711562|NCT00440947|80778989|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
27711563|NCT00440947|80778990|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
27711564|NCT00440947|80778986|FG000|36-Week Induction Phase|Incarceration|3|||
27711565|NCT00440947|80778987|FG001|36-Week Induction Phase|Incarceration|0|||
27711566|NCT00440947|80778988|FG002|36-Week Induction Phase|Incarceration|0|||
27711567|NCT00440947|80778989|FG003|36-Week Induction Phase|Incarceration|0|||
27711568|NCT00440947|80778990|FG004|36-Week Induction Phase|Incarceration|0|||
27711569|NCT00440947|80778986|FG000|36-Week Induction Phase|Pregnancy|1|||
27711570|NCT00440947|80778987|FG001|36-Week Induction Phase|Pregnancy|0|||
27711571|NCT00440947|80778988|FG002|36-Week Induction Phase|Pregnancy|0|||
27711572|NCT00440947|80778989|FG003|36-Week Induction Phase|Pregnancy|0|||
27711573|NCT00440947|80778990|FG004|36-Week Induction Phase|Pregnancy|0|||
27711574|NCT00440947|80778986|FG000|48-Week Randomization Phase|Adverse Event|0|||
27711575|NCT00440947|80778987|FG001|48-Week Randomization Phase|Adverse Event|2|||
27711576|NCT00440947|80778988|FG002|48-Week Randomization Phase|Adverse Event|5|||
27711577|NCT00440947|80778989|FG003|48-Week Randomization Phase|Adverse Event|0|||
27711578|NCT00440947|80778990|FG004|48-Week Randomization Phase|Adverse Event|0|||
27711579|NCT00440947|80778986|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
27711580|NCT00440947|80778987|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
27711581|NCT00440947|80778988|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
27711582|NCT00440947|80778989|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
27603881|NCT01226511|80391294|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
27603882|NCT01226511|80391293|FG000|Acute Treatment Period|Protocol Violation|5|||
27603883|NCT01226511|80391294|FG001|Acute Treatment Period|Protocol Violation|5|||
27603884|NCT01226511|80391293|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
27603885|NCT01226511|80391294|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
27603886|NCT01226511|80391293|FG000|Extension Treatment Period|Adverse Event|8|||
27603887|NCT01226511|80391294|FG001|Extension Treatment Period|Adverse Event|8|||
27603888|NCT01226511|80391293|FG000|Extension Treatment Period|Lack of Efficacy|3|||
27603889|NCT01226511|80391294|FG001|Extension Treatment Period|Lack of Efficacy|2|||
27603890|NCT01226511|80391293|FG000|Extension Treatment Period|Lost to Follow-up|4|||
27603891|NCT01226511|80391294|FG001|Extension Treatment Period|Lost to Follow-up|3|||
27603892|NCT01226511|80391293|FG000|Extension Treatment Period|Protocol Violation|2|||
27603893|NCT01226511|80391294|FG001|Extension Treatment Period|Protocol Violation|2|||
27603894|NCT01226511|80391293|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
27603895|NCT01226511|80391294|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
27603896|NCT01226511|80391293|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
27603897|NCT01226511|80391294|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
27603898|NCT01226511|80391293|FG000|Extension Treatment Period|Sponsor Decision|1|||
27603899|NCT01226511|80391294|FG001|Extension Treatment Period|Sponsor Decision|1|||
27603900|NCT01226511|80391293|FG000|Taper Period|Adverse Event|1|||
27603901|NCT01226511|80391294|FG001|Taper Period|Adverse Event|0|||
27603902|NCT01226511|80391293|FG000|Taper Period|Lost to Follow-up|2|||
27603903|NCT01226511|80391294|FG001|Taper Period|Lost to Follow-up|2|||
27603904|NCT01226511|80391293|FG000|Taper Period|Protocol Violation|1|||
27603905|NCT01226511|80391294|FG001|Taper Period|Protocol Violation|0|||
27603906|NCT01226511|80391293|FG000|Taper Period|Parent/Caregiver Decision|1|||
27603907|NCT01226511|80391294|FG001|Taper Period|Parent/Caregiver Decision|1|||
27603908|NCT01059643|80391296|FG000|Overall Study|Adverse Event|3|||
27603909|NCT01059643|80391296|FG000|Overall Study|Withdrawal by Subject|2|||
27603910|NCT01059643|80391296|FG000|Overall Study|Physician Decision|1|||
27603911|NCT01820559|80391297|FG000|Overall Study|Adverse Event|4|||
27603912|NCT01820559|80391298|FG001|Overall Study|Adverse Event|6|||
27603913|NCT01820559|80391299|FG002|Overall Study|Adverse Event|13|||
27603914|NCT01820559|80391297|FG000|Overall Study|Withdrawal by Subject|1|||
27603915|NCT01820559|80391298|FG001|Overall Study|Withdrawal by Subject|2|||
27603916|NCT01820559|80391299|FG002|Overall Study|Withdrawal by Subject|5|||
27603917|NCT01820559|80391297|FG000|Overall Study|Protocol Violation|2|||
27603918|NCT01820559|80391298|FG001|Overall Study|Protocol Violation|1|||
27603919|NCT01820559|80391299|FG002|Overall Study|Protocol Violation|3|||
27603920|NCT01820559|80391297|FG000|Overall Study|Subject's non-compliance|1|||
27603921|NCT01820559|80391298|FG001|Overall Study|Subject's non-compliance|0|||
27603922|NCT01820559|80391299|FG002|Overall Study|Subject's non-compliance|2|||
27603923|NCT01820559|80391297|FG000|Overall Study|Lost to Follow-up|3|||
27603924|NCT01820559|80391298|FG001|Overall Study|Lost to Follow-up|2|||
27603925|NCT01820559|80391299|FG002|Overall Study|Lost to Follow-up|2|||
27603926|NCT01820559|80391297|FG000|Overall Study|At sponsor request|0|||
27603927|NCT01820559|80391298|FG001|Overall Study|At sponsor request|0|||
27603928|NCT01820559|80391299|FG002|Overall Study|At sponsor request|1|||
27603929|NCT01820559|80391297|FG000|Overall Study|Lack of Efficacy|3|||
27603930|NCT01820559|80391298|FG001|Overall Study|Lack of Efficacy|2|||
27603931|NCT01820559|80391299|FG002|Overall Study|Lack of Efficacy|3|||
27603932|NCT01320943|80391300|FG000|Overall Study|Lost to Follow-up|1|||
27603933|NCT01320943|80391301|FG001|Overall Study|Lost to Follow-up|0|||
27603934|NCT01320943|80391300|FG000|Overall Study|Physician Decision|0|||
27603935|NCT01320943|80391301|FG001|Overall Study|Physician Decision|1|||
27603936|NCT01320943|80391300|FG000|Overall Study|Randomized but not Treated|0|||
27603937|NCT01320943|80391301|FG001|Overall Study|Randomized but not Treated|1|||
27603938|NCT01786330|80391302|FG000|Overall Study|Withdrawal by Subject|0|||
27603939|NCT01786330|80391303|FG001|Overall Study|Withdrawal by Subject|1|||
27603940|NCT01786330|80391302|FG000|Overall Study|Lost to Follow-up|0|||
27603941|NCT01786330|80391303|FG001|Overall Study|Lost to Follow-up|1|||
27603942|NCT01786330|80391302|FG000|Overall Study|Excluded intraoperatively|0|||
27603943|NCT01786330|80391303|FG001|Overall Study|Excluded intraoperatively|1|||
27603944|NCT01786330|80391302|FG000|Overall Study|Protocol Violation|1|||
27603945|NCT01786330|80391303|FG001|Overall Study|Protocol Violation|0|||
27603946|NCT01949870|80391306|FG000|Overall Study|Lack of Efficacy|2|||
27603947|NCT01949870|80391306|FG000|Overall Study|Adverse Event|1|||
27603948|NCT01949870|80391306|FG000|Overall Study|Study termination|1|||
27603949|NCT01949870|80391306|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
27603950|NCT03243422|80391307|FG000|Overall Study|Death|20|||
27603951|NCT03243422|80391308|FG001|Overall Study|Death|21|||
27603952|NCT03243422|80391307|FG000|Overall Study|Lost to Follow-up|9|||
27603953|NCT03243422|80391308|FG001|Overall Study|Lost to Follow-up|21|||
27603954|NCT03243422|80391307|FG000|Overall Study|Withdrawal by Subject|22|||
27603955|NCT03243422|80391308|FG001|Overall Study|Withdrawal by Subject|8|||
27603956|NCT01987817|80391309|FG000|Overall Study|Adverse Event|4|||
27603957|NCT01987817|80391310|FG001|Overall Study|Adverse Event|0|||
27603958|NCT01987817|80391309|FG000|Overall Study|Withdrawal by Subject|1|||
27603959|NCT01987817|80391310|FG001|Overall Study|Withdrawal by Subject|1|||
27603960|NCT01987817|80391309|FG000|Overall Study|Physician Decision|1|||
27603961|NCT01987817|80391310|FG001|Overall Study|Physician Decision|0|||
27603962|NCT00085202|80391313|FG000|Overall Study|Still on therapy|2|||
27603963|NCT00085202|80391314|FG001|Overall Study|Still on therapy|0|||
27603964|NCT00085202|80391313|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
27603965|NCT00085202|80391314|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
27603966|NCT00085202|80391313|FG000|Overall Study|Excessive toxicity|6|||
27603967|NCT00085202|80391314|FG001|Overall Study|Excessive toxicity|5|||
27603968|NCT00085202|80391313|FG000|Overall Study|Non-specified|3|||
27603969|NCT00085202|80391314|FG001|Overall Study|Non-specified|5|||
27603970|NCT00085202|80391313|FG000|Overall Study|Withdrawal by Subject|2|||
27603971|NCT00085202|80391314|FG001|Overall Study|Withdrawal by Subject|1|||
27603972|NCT00085202|80391313|FG000|Overall Study|Physician Decision|4|||
27603973|NCT00085202|80391314|FG001|Overall Study|Physician Decision|1|||
27603974|NCT00085202|80391313|FG000|Overall Study|Progressive disease|1|||
27603975|NCT00085202|80391314|FG001|Overall Study|Progressive disease|11|||
27603976|NCT03300570|80391324|FG000|Overall Study|Adverse Event|0|||
27603977|NCT03300570|80391325|FG001|Overall Study|Adverse Event|1|||
27603978|NCT03300570|80391324|FG000|Overall Study|Withdrawal by Subject|1|||
27603979|NCT03300570|80391325|FG001|Overall Study|Withdrawal by Subject|0|||
27603980|NCT03300570|80391324|FG000|Overall Study|Inadequate bowel prep|1|||
27603981|NCT03300570|80391325|FG001|Overall Study|Inadequate bowel prep|0|||
27603982|NCT01778556|80391329|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
27603983|NCT01778556|80391330|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
27603984|NCT01778556|80391329|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
27603985|NCT01778556|80391330|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
27603986|NCT01778556|80391329|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
27603987|NCT01778556|80391330|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
27603988|NCT01778556|80391329|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
27603989|NCT01778556|80391330|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
27603990|NCT04043962|80391331|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
27603991|NCT04043962|80391331|FG000|Post-Treatment|Withdrawal by Subject|5|||
27603992|NCT04043962|80391331|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
27836566|NCT03922750|81232820|FG001|Overall Study|Adverse Event|1|||
27836567|NCT03922750|81232821|FG002|Overall Study|Adverse Event|0|||
27603993|NCT01453348|80391332|FG000|Overall Study|Death|0|||
27603994|NCT01453348|80391333|FG001|Overall Study|Death|0|||
27836568|NCT00323258|81232822|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
27603995|NCT01453348|80391334|FG002|Overall Study|Death|1|||
27603996|NCT01453348|80391332|FG000|Overall Study|Withdrawal by Subject|0|||
27603997|NCT01453348|80391333|FG001|Overall Study|Withdrawal by Subject|1|||
27711583|NCT00440947|80778990|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
27711584|NCT00440947|80778986|FG000|48-Week Randomization Phase|Non-compliance|0|||
27711585|NCT00440947|80778987|FG001|48-Week Randomization Phase|Non-compliance|3|||
27711586|NCT00440947|80778988|FG002|48-Week Randomization Phase|Non-compliance|4|||
27711587|NCT00440947|80778989|FG003|48-Week Randomization Phase|Non-compliance|0|||
27711588|NCT00440947|80778990|FG004|48-Week Randomization Phase|Non-compliance|0|||
27711589|NCT00440947|80778986|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
27711590|NCT00440947|80778987|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
27711591|NCT00440947|80778988|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
27711592|NCT00440947|80778989|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
27711593|NCT00440947|80778990|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
27711594|NCT00440947|80778986|FG000|48-Week Randomization Phase|Protocol Violation|0|||
27711595|NCT00440947|80778987|FG001|48-Week Randomization Phase|Protocol Violation|0|||
27711596|NCT00440947|80778988|FG002|48-Week Randomization Phase|Protocol Violation|1|||
27711597|NCT00440947|80778989|FG003|48-Week Randomization Phase|Protocol Violation|0|||
27711598|NCT00440947|80778990|FG004|48-Week Randomization Phase|Protocol Violation|0|||
27711599|NCT00440947|80778986|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
27711600|NCT00440947|80778987|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
27711601|NCT00440947|80778988|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
27711602|NCT00440947|80778989|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
27711603|NCT00440947|80778990|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
27711604|NCT00440947|80778986|FG000|48-Week Randomization Phase|Pregnancy|0|||
27711605|NCT00440947|80778987|FG001|48-Week Randomization Phase|Pregnancy|0|||
27711606|NCT00440947|80778988|FG002|48-Week Randomization Phase|Pregnancy|1|||
27711607|NCT00440947|80778989|FG003|48-Week Randomization Phase|Pregnancy|0|||
27711608|NCT00440947|80778990|FG004|48-Week Randomization Phase|Pregnancy|0|||
27711609|NCT00440947|80778986|FG000|48-Week Randomization Phase|Incarceration|0|||
27711610|NCT00440947|80778987|FG001|48-Week Randomization Phase|Incarceration|3|||
27711611|NCT00440947|80778988|FG002|48-Week Randomization Phase|Incarceration|0|||
27711612|NCT00440947|80778989|FG003|48-Week Randomization Phase|Incarceration|0|||
27711613|NCT00440947|80778990|FG004|48-Week Randomization Phase|Incarceration|0|||
27711614|NCT00440947|80778986|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
27711615|NCT00440947|80778987|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
27711616|NCT00440947|80778988|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
27711617|NCT00440947|80778989|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
27711618|NCT00440947|80778990|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
27711619|NCT00440947|80778986|FG000|48-Week Randomization Phase|Physician Decision|0|||
27711620|NCT00440947|80778987|FG001|48-Week Randomization Phase|Physician Decision|2|||
27711621|NCT00440947|80778988|FG002|48-Week Randomization Phase|Physician Decision|0|||
27711622|NCT00440947|80778989|FG003|48-Week Randomization Phase|Physician Decision|0|||
27711623|NCT00440947|80778990|FG004|48-Week Randomization Phase|Physician Decision|0|||
27711624|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
27711625|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
27711626|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
27711627|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
27711628|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
27711629|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
27711630|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
27711631|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
27711632|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
27711633|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
27711634|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
27711635|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
27711636|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
27711637|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
27711638|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
27711639|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
27711640|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
27711641|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
27711642|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
27711643|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
27711644|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
27711645|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
27711646|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
27711647|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
27711648|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
27711649|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
27711650|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
27711651|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
27711652|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
27711653|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
27711654|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
27711655|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
27711656|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
27711657|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
27711658|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
27711659|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
27711660|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
27711661|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
27711662|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
27711663|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
27711664|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
27711665|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
27711666|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
27711667|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
27711668|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
27711669|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
27711670|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
27711671|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
27711672|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
27711673|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
27711674|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
27711675|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
27711676|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
27711677|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
27711678|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
27711679|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Other|0|||
27711680|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Other|0|||
27711681|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Other|0|||
27711682|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Other|1|||
27711683|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Other|0|||
27711684|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
27711685|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
27711686|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
27711687|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
27711688|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
27711689|NCT00440947|80778986|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
27711690|NCT00440947|80778987|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
27711691|NCT00440947|80778988|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
27711692|NCT00440947|80778989|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
27711693|NCT00440947|80778990|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
27711694|NCT03688880|80778994|FG000|Overall Study|Withdrawal by Subject|0|||
27711695|NCT03688880|80778995|FG001|Overall Study|Withdrawal by Subject|2|||
27711696|NCT03688880|80778994|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
27711697|NCT03688880|80778995|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
27711698|NCT03688880|80778994|FG000|Overall Study|Lost to Follow-up|4|||
27711699|NCT03688880|80778995|FG001|Overall Study|Lost to Follow-up|7|||
27711700|NCT03688880|80778994|FG000|Overall Study|Adverse Event|0|||
27711701|NCT03688880|80778995|FG001|Overall Study|Adverse Event|2|||
27711702|NCT03688880|80778994|FG000|Overall Study|Device deficiencies|0|||
27711703|NCT03688880|80778995|FG001|Overall Study|Device deficiencies|2|||
27711704|NCT03688880|80778994|FG000|Overall Study|Other|10|||
27711705|NCT03688880|80778995|FG001|Overall Study|Other|16|||
27711706|NCT00876187|80778996|FG000|Overall Study|Adverse Event|14|||
27711707|NCT00876187|80778997|FG001|Overall Study|Adverse Event|12|||
27711708|NCT00876187|80778998|FG002|Overall Study|Adverse Event|19|||
27711709|NCT00876187|80778999|FG003|Overall Study|Adverse Event|29|||
27711710|NCT00876187|80779000|FG004|Overall Study|Adverse Event|10|||
27711711|NCT00876187|80778996|FG000|Overall Study|Lack of Efficacy|59|||
27711712|NCT00876187|80778997|FG001|Overall Study|Lack of Efficacy|34|||
27711713|NCT00876187|80778998|FG002|Overall Study|Lack of Efficacy|45|||
27711714|NCT00876187|80778999|FG003|Overall Study|Lack of Efficacy|34|||
27711715|NCT00876187|80779000|FG004|Overall Study|Lack of Efficacy|59|||
27711716|NCT00876187|80778996|FG000|Overall Study|Lost to Follow-up|9|||
27711717|NCT00876187|80778997|FG001|Overall Study|Lost to Follow-up|10|||
27711718|NCT00876187|80778998|FG002|Overall Study|Lost to Follow-up|8|||
27711719|NCT00876187|80778999|FG003|Overall Study|Lost to Follow-up|8|||
27711720|NCT00876187|80779000|FG004|Overall Study|Lost to Follow-up|11|||
27711721|NCT00876187|80778996|FG000|Overall Study|Protocol Violation|6|||
27711722|NCT00876187|80778997|FG001|Overall Study|Protocol Violation|7|||
27711723|NCT00876187|80778998|FG002|Overall Study|Protocol Violation|7|||
27711724|NCT00876187|80778999|FG003|Overall Study|Protocol Violation|6|||
27711725|NCT00876187|80779000|FG004|Overall Study|Protocol Violation|3|||
27711726|NCT00876187|80778996|FG000|Overall Study|Withdrawal by Subject|16|||
27711727|NCT00876187|80778997|FG001|Overall Study|Withdrawal by Subject|26|||
27711728|NCT00876187|80778998|FG002|Overall Study|Withdrawal by Subject|32|||
27711729|NCT00876187|80778999|FG003|Overall Study|Withdrawal by Subject|38|||
27711730|NCT00876187|80779000|FG004|Overall Study|Withdrawal by Subject|37|||
27711731|NCT00876187|80778996|FG000|Overall Study|Entered extension study|101|||
27711732|NCT00876187|80778997|FG001|Overall Study|Entered extension study|120|||
27711733|NCT00876187|80778998|FG002|Overall Study|Entered extension study|156|||
27711734|NCT00876187|80778999|FG003|Overall Study|Entered extension study|151|||
27711735|NCT00876187|80779000|FG004|Overall Study|Entered extension study|144|||
27711736|NCT00876187|80778996|FG000|Overall Study|Randomized but not treated|3|||
27711737|NCT00876187|80778997|FG001|Overall Study|Randomized but not treated|1|||
27711738|NCT00876187|80778998|FG002|Overall Study|Randomized but not treated|3|||
27711739|NCT00876187|80778999|FG003|Overall Study|Randomized but not treated|2|||
27711740|NCT00876187|80779000|FG004|Overall Study|Randomized but not treated|3|||
27711741|NCT00876187|80778996|FG000|Overall Study|Other|2|||
27711742|NCT00876187|80778997|FG001|Overall Study|Other|5|||
27711743|NCT00876187|80778998|FG002|Overall Study|Other|9|||
27711744|NCT00876187|80778999|FG003|Overall Study|Other|7|||
27711745|NCT00876187|80779000|FG004|Overall Study|Other|4|||
27711746|NCT00781911|80779003|FG000|Overall Study|Adverse Event|4|||
27711747|NCT00781911|80779004|FG001|Overall Study|Adverse Event|4|||
27711748|NCT00781911|80779003|FG000|Overall Study|Withdrawal by Subject|1|||
27711749|NCT00781911|80779004|FG001|Overall Study|Withdrawal by Subject|2|||
27711750|NCT00781911|80779003|FG000|Overall Study|Physician Decision|0|||
27711751|NCT00781911|80779004|FG001|Overall Study|Physician Decision|2|||
27711752|NCT00781911|80779003|FG000|Overall Study|Sponsor Decision|1|||
27711753|NCT00781911|80779004|FG001|Overall Study|Sponsor Decision|0|||
27711754|NCT03962101|80779005|FG000|Overall Study|Adverse Event|1|||
27711755|NCT03962101|80779005|FG000|Overall Study|Physician Decision|2|||
27711756|NCT03962101|80779005|FG000|Overall Study|Not related to medical events|1|||
27711757|NCT00777101|80779006|FG000|Overall Study|Death|48|||
27711758|NCT00777101|80779007|FG001|Overall Study|Death|43|||
27711759|NCT00777101|80779006|FG000|Overall Study|Withdrawal by Subject|11|||
27711760|NCT00777101|80779007|FG001|Overall Study|Withdrawal by Subject|6|||
27711761|NCT00777101|80779006|FG000|Overall Study|Lost to Follow-up|2|||
27711762|NCT00777101|80779007|FG001|Overall Study|Lost to Follow-up|1|||
27711763|NCT00777101|80779006|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
27711764|NCT00777101|80779007|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27711765|NCT00777101|80779006|FG000|Overall Study|Failed to Return|0|||
27711766|NCT00777101|80779007|FG001|Overall Study|Failed to Return|1|||
27711767|NCT04096274|80779008|FG000|Phase I|Lost to Follow-up|5|||
27711768|NCT04096274|80779009|FG001|Phase I|Lost to Follow-up|5|||
27711769|NCT04096274|80779008|FG000|Phase II|Lost to Follow-up|11|||
27711770|NCT04096274|80779009|FG001|Phase II|Lost to Follow-up|11|||
27603998|NCT01453348|80391334|FG002|Overall Study|Withdrawal by Subject|0|||
27603999|NCT01453348|80391332|FG000|Overall Study|Protocol Violation|1|||
27604000|NCT01453348|80391333|FG001|Overall Study|Protocol Violation|0|||
27604001|NCT01453348|80391334|FG002|Overall Study|Protocol Violation|0|||
27604002|NCT00457639|80391337|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
27604003|NCT00457639|80391338|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
27604004|NCT00457639|80391337|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
27604005|NCT00457639|80391338|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
27604006|NCT00457639|80391337|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
27604007|NCT00457639|80391338|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
27604008|NCT00094328|80391341|FG000|Overall Study|Lost to Follow-up|1|||
27604009|NCT02799784|80391342|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
27604010|NCT02799784|80391343|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
27604011|NCT02799784|80391342|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
27604012|NCT02799784|80391343|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
27604013|NCT02799784|80391342|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
27604014|NCT02799784|80391343|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
27604015|NCT02799784|80391342|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
27604016|NCT02799784|80391343|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
27604017|NCT02799784|80391342|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
27604018|NCT02799784|80391343|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
27604019|NCT02799784|80391342|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
27604020|NCT02799784|80391343|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
27604021|NCT00246337|80391344|FG000|Overall Study|Lost to Follow-up|3|||
27604022|NCT00246337|80391345|FG001|Overall Study|Lost to Follow-up|0|||
27604023|NCT00246337|80391346|FG002|Overall Study|Lost to Follow-up|0|||
27604024|NCT00246337|80391347|FG003|Overall Study|Lost to Follow-up|0|||
27604025|NCT00246337|80391348|FG004|Overall Study|Lost to Follow-up|2|||
27604026|NCT00246337|80391349|FG005|Overall Study|Lost to Follow-up|2|||
27604027|NCT00246337|80391350|FG006|Overall Study|Lost to Follow-up|1|||
27604028|NCT00246337|80391351|FG007|Overall Study|Lost to Follow-up|2|||
27604029|NCT00246337|80391352|FG008|Overall Study|Lost to Follow-up|0|||
27604030|NCT00246337|80391344|FG000|Overall Study|Protocol Violation|1|||
27604031|NCT00246337|80391345|FG001|Overall Study|Protocol Violation|0|||
27604032|NCT00246337|80391346|FG002|Overall Study|Protocol Violation|0|||
27604033|NCT00246337|80391347|FG003|Overall Study|Protocol Violation|0|||
27604034|NCT00246337|80391348|FG004|Overall Study|Protocol Violation|1|||
27604035|NCT00246337|80391349|FG005|Overall Study|Protocol Violation|0|||
27604036|NCT00246337|80391350|FG006|Overall Study|Protocol Violation|1|||
27604037|NCT00246337|80391351|FG007|Overall Study|Protocol Violation|1|||
27604038|NCT00246337|80391352|FG008|Overall Study|Protocol Violation|0|||
27604039|NCT00246337|80391344|FG000|Overall Study|Withdrawal by Subject|2|||
27604040|NCT00246337|80391345|FG001|Overall Study|Withdrawal by Subject|0|||
27604041|NCT00246337|80391346|FG002|Overall Study|Withdrawal by Subject|0|||
27604042|NCT00246337|80391347|FG003|Overall Study|Withdrawal by Subject|0|||
27604043|NCT00246337|80391348|FG004|Overall Study|Withdrawal by Subject|0|||
27604044|NCT00246337|80391349|FG005|Overall Study|Withdrawal by Subject|0|||
27604045|NCT00246337|80391350|FG006|Overall Study|Withdrawal by Subject|1|||
27604046|NCT00246337|80391351|FG007|Overall Study|Withdrawal by Subject|1|||
27604047|NCT00246337|80391352|FG008|Overall Study|Withdrawal by Subject|0|||
27604048|NCT00246337|80391344|FG000|Overall Study|Lack of Qualifying Event|8|||
27604049|NCT00246337|80391345|FG001|Overall Study|Lack of Qualifying Event|2|||
27604050|NCT00246337|80391346|FG002|Overall Study|Lack of Qualifying Event|1|||
27604051|NCT00246337|80391347|FG003|Overall Study|Lack of Qualifying Event|1|||
27604052|NCT00246337|80391348|FG004|Overall Study|Lack of Qualifying Event|1|||
27604053|NCT00246337|80391349|FG005|Overall Study|Lack of Qualifying Event|3|||
27604054|NCT00246337|80391350|FG006|Overall Study|Lack of Qualifying Event|3|||
27604055|NCT00246337|80391351|FG007|Overall Study|Lack of Qualifying Event|2|||
27604056|NCT00246337|80391352|FG008|Overall Study|Lack of Qualifying Event|5|||
27604057|NCT00246337|80391344|FG000|Overall Study|Site Terminated|10|||
27604058|NCT00246337|80391345|FG001|Overall Study|Site Terminated|0|||
27604059|NCT00246337|80391346|FG002|Overall Study|Site Terminated|0|||
27604060|NCT00246337|80391347|FG003|Overall Study|Site Terminated|0|||
27604061|NCT00246337|80391348|FG004|Overall Study|Site Terminated|0|||
27604062|NCT00246337|80391349|FG005|Overall Study|Site Terminated|7|||
27604063|NCT00246337|80391350|FG006|Overall Study|Site Terminated|1|||
27604064|NCT00246337|80391351|FG007|Overall Study|Site Terminated|6|||
27604065|NCT00246337|80391352|FG008|Overall Study|Site Terminated|2|||
27711771|NCT02287623|80779010|FG000|Overall Study|Protocol Violation|0|||
27711772|NCT02287623|80779011|FG001|Overall Study|Protocol Violation|1|||
27711773|NCT00714285|80779012|FG000|Overall Study|Lost to Follow-up|0|||
27711774|NCT00714285|80779013|FG001|Overall Study|Lost to Follow-up|2|||
27711775|NCT00714285|80779014|FG002|Overall Study|Lost to Follow-up|0|||
27711776|NCT00714285|80779015|FG003|Overall Study|Lost to Follow-up|1|||
27711777|NCT00714285|80779012|FG000|Overall Study|Migrated/moved from study area|0|||
27711778|NCT00714285|80779013|FG001|Overall Study|Migrated/moved from study area|1|||
27711779|NCT00714285|80779014|FG002|Overall Study|Migrated/moved from study area|0|||
27711780|NCT00714285|80779015|FG003|Overall Study|Migrated/moved from study area|0|||
27711781|NCT01627899|80779016|FG000|Overall Study|Study terminated early by sponsor.|5|||
27711782|NCT02184195|80779019|FG000|Overall Study|Patient decision|5|||
27711783|NCT02184195|80779020|FG001|Overall Study|Patient decision|2|||
27711784|NCT02184195|80779019|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27711785|NCT02184195|80779020|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27711786|NCT02184195|80779019|FG000|Overall Study|Death|67|||
27711787|NCT02184195|80779020|FG001|Overall Study|Death|44|||
27711788|NCT02184195|80779019|FG000|Overall Study|Lost to Follow-up|1|||
27711789|NCT02184195|80779020|FG001|Overall Study|Lost to Follow-up|5|||
27711790|NCT02184195|80779019|FG000|Overall Study|Other|0|||
27711791|NCT02184195|80779020|FG001|Overall Study|Other|3|||
27711792|NCT02573870|80779021|FG000|Overall Study|Adverse Event|0|||
27711793|NCT02573870|80779022|FG001|Overall Study|Adverse Event|2|||
27711794|NCT02573870|80779021|FG000|Overall Study|Lack of Efficacy|0|||
27711795|NCT02573870|80779022|FG001|Overall Study|Lack of Efficacy|1|||
27711796|NCT02573870|80779021|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
27711797|NCT02573870|80779022|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
27711798|NCT02573870|80779021|FG000|Overall Study|Lost to Follow-up|0|||
27711799|NCT02573870|80779022|FG001|Overall Study|Lost to Follow-up|1|||
27711800|NCT02573870|80779021|FG000|Overall Study|Other: Fail to Meet Visit|0|||
27711801|NCT02573870|80779022|FG001|Overall Study|Other: Fail to Meet Visit|2|||
27711802|NCT03152019|80779023|FG000|Overall Study|Adverse Event|0|||
27711803|NCT03152019|80779024|FG001|Overall Study|Adverse Event|1|||
27711804|NCT00003535|80779029|FG000|Overall Study|Not evaluable|5|||
27711805|NCT02553265|80779030|FG000|Enrollment|Death|0|||
27711806|NCT02553265|80779031|FG001|Enrollment|Death|0|||
27711807|NCT02553265|80779032|FG002|Enrollment|Death|1|||
27711808|NCT02553265|80779030|FG000|First Intervention (28 Days)|Adverse Event|1|||
27711809|NCT02553265|80779031|FG001|First Intervention (28 Days)|Adverse Event|0|||
27711810|NCT02553265|80779032|FG002|First Intervention (28 Days)|Adverse Event|0|||
27711811|NCT02553265|80779030|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
27711812|NCT02553265|80779031|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
27711813|NCT02553265|80779032|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
27711814|NCT02553265|80779030|FG000|Second Intervention (28 Days)|Adverse Event|1|||
27711815|NCT02553265|80779031|FG001|Second Intervention (28 Days)|Adverse Event|0|||
27711816|NCT02553265|80779032|FG002|Second Intervention (28 Days)|Adverse Event|0|||
27711817|NCT02553265|80779030|FG000|Third Intervention (28 Days)|Adverse Event|1|||
27711818|NCT02553265|80779031|FG001|Third Intervention (28 Days)|Adverse Event|0|||
27711819|NCT02553265|80779032|FG002|Third Intervention (28 Days)|Adverse Event|0|||
27711820|NCT02553265|80779030|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
27711821|NCT02553265|80779031|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
27711822|NCT02553265|80779032|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
27711823|NCT00788372|80779034|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
27711824|NCT00788372|80779034|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
27711825|NCT00788372|80779034|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
27711826|NCT00788372|80779034|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
27711827|NCT00788372|80779034|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
27711828|NCT00788372|80779034|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
27711829|NCT00788372|80779034|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
27711830|NCT02581202|80779035|FG000|Overall Study|Lack of Efficacy|2|||
27711831|NCT02581202|80779035|FG000|Overall Study|Withdrawal by Subject|4|||
27711832|NCT02581202|80779035|FG000|Overall Study|Lost to Follow-up|5|||
27711833|NCT02581202|80779035|FG000|Overall Study|Pregnancy|3|||
27711834|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
27711835|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
27711836|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
27711837|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
27711838|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
27711839|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
27711840|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
27711841|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
27711842|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
27711843|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
27711844|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
27711845|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
27711846|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
27711847|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
27711848|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
27711849|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
27711850|NCT00094770|80779036|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
27711851|NCT00094770|80779037|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
27711852|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
27711853|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
27711854|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
27711855|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
27711856|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
27711857|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
27711858|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
27711859|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
27711860|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
27711861|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
27711862|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
27711863|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
27711864|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
27711865|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
27711866|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
27711867|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
27711868|NCT00094770|80779036|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
27711869|NCT00094770|80779037|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
27711870|NCT00346073|80779042|FG000|Overall Study|Serious Adverse Event|2|||
27711871|NCT00346073|80779043|FG001|Overall Study|Serious Adverse Event|0|||
27711872|NCT00346073|80779042|FG000|Overall Study|Lost to Follow-up|39|||
27711873|NCT00346073|80779043|FG001|Overall Study|Lost to Follow-up|24|||
27711874|NCT03440814|80779045|FG000|Overall Study|Adverse Event|2|||
27711875|NCT03440814|80779046|FG001|Overall Study|Adverse Event|1|||
27711876|NCT03440814|80779045|FG000|Overall Study|Lost to Follow-up|2|||
27711877|NCT03440814|80779046|FG001|Overall Study|Lost to Follow-up|0|||
27711878|NCT03440814|80779045|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
27711879|NCT03440814|80779046|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
27711880|NCT00844753|80779049|FG000|Overall Study|Lack of Efficacy|1|||
27711881|NCT00844753|80779050|FG001|Overall Study|Lack of Efficacy|0|||
27711882|NCT00844753|80779051|FG002|Overall Study|Lack of Efficacy|2|||
27711883|NCT00844753|80779052|FG003|Overall Study|Lack of Efficacy|2|||
27836569|NCT00323258|81232823|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
27836570|NCT00323258|81232822|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
27836571|NCT00323258|81232823|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
27836572|NCT00323258|81232822|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
27836573|NCT00323258|81232823|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
27836574|NCT00323258|81232822|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
27836575|NCT00323258|81232823|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
27836576|NCT00323258|81232822|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
27836577|NCT00323258|81232823|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
27836578|NCT00323258|81232822|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
27836579|NCT00323258|81232823|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
27836580|NCT00323258|81232822|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
27836581|NCT00323258|81232823|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
27836582|NCT02028455|81232825|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27836583|NCT02028455|81232826|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27836584|NCT02028455|81232827|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27836585|NCT02028455|81232828|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27836586|NCT02028455|81232829|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27889470|NCT01680159|81430804|FG000|Increased Dose Period|Adverse Event|6|||
27889471|NCT01680159|81430804|FG000|Increased Dose Period|Withdrawal by Subject|2|||
27889472|NCT02752165|81430805|FG000|Overall Study|Withdrawal by Subject|6|||
27711884|NCT00844753|80779049|FG000|Overall Study|Adverse Event|3|||
27711885|NCT00844753|80779050|FG001|Overall Study|Adverse Event|2|||
27711886|NCT00844753|80779051|FG002|Overall Study|Adverse Event|5|||
27711887|NCT00844753|80779052|FG003|Overall Study|Adverse Event|5|||
27711888|NCT00844753|80779049|FG000|Overall Study|Lost to Follow-up|1|||
27711889|NCT00844753|80779050|FG001|Overall Study|Lost to Follow-up|1|||
27711890|NCT00844753|80779051|FG002|Overall Study|Lost to Follow-up|0|||
27836587|NCT02028455|81232830|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
27836588|NCT02028455|81232831|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
27836589|NCT02028455|81232832|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
27836590|NCT02028455|81232825|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
27836591|NCT02028455|81232826|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
27836592|NCT02028455|81232827|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
27836593|NCT02028455|81232828|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
27836594|NCT02028455|81232829|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
27836595|NCT02028455|81232830|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
27836596|NCT02028455|81232831|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
27836597|NCT02028455|81232832|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
27836598|NCT02028455|81232825|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27836599|NCT02028455|81232826|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27836600|NCT02028455|81232827|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27836601|NCT02028455|81232828|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27836602|NCT02028455|81232829|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27836603|NCT02028455|81232830|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
27836604|NCT02028455|81232831|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
27836605|NCT02028455|81232832|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
27836606|NCT02028455|81232825|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27836607|NCT02028455|81232826|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27604066|NCT00246337|80391344|FG000|Overall Study|Abnormal baseline lab values|7|||
27604067|NCT00246337|80391345|FG001|Overall Study|Abnormal baseline lab values|0|||
27604068|NCT00246337|80391346|FG002|Overall Study|Abnormal baseline lab values|2|||
27836608|NCT02028455|81232827|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
27836609|NCT02028455|81232828|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
27836610|NCT02028455|81232829|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27836611|NCT02028455|81232830|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
27836612|NCT02028455|81232831|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
27604069|NCT00246337|80391347|FG003|Overall Study|Abnormal baseline lab values|0|||
27836613|NCT02028455|81232832|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
27836614|NCT00210639|81232833|FG000|Overall Study|Lost to Follow-up|37|||
27836615|NCT00210639|81232834|FG001|Overall Study|Lost to Follow-up|29|||
27836616|NCT00210639|81232833|FG000|Overall Study|Withdrawal by Subject|8|||
27836617|NCT00210639|81232834|FG001|Overall Study|Withdrawal by Subject|1|||
27836618|NCT00210639|81232833|FG000|Overall Study|Other|18|||
27836619|NCT00210639|81232834|FG001|Overall Study|Other|12|||
27836620|NCT00874822|81232835|FG000|Overall Study|excluded by criteria|8|||
27836621|NCT00874549|81232836|FG000|Overall Study|Adverse Event|0|||
27836622|NCT00874549|81232837|FG001|Overall Study|Adverse Event|0|||
27836623|NCT00874549|81232838|FG002|Overall Study|Adverse Event|1|||
27836624|NCT00874549|81232839|FG003|Overall Study|Adverse Event|0|||
27836625|NCT00874549|81232836|FG000|Overall Study|Protocol Violation|1|||
27836626|NCT00874549|81232837|FG001|Overall Study|Protocol Violation|0|||
27836627|NCT00874549|81232838|FG002|Overall Study|Protocol Violation|2|||
27836628|NCT00874549|81232839|FG003|Overall Study|Protocol Violation|1|||
27836629|NCT00874549|81232836|FG000|Overall Study|Lost to Follow-up|0|||
27836630|NCT00874549|81232837|FG001|Overall Study|Lost to Follow-up|0|||
27836631|NCT00874549|81232838|FG002|Overall Study|Lost to Follow-up|1|||
27836632|NCT00874549|81232839|FG003|Overall Study|Lost to Follow-up|0|||
27836633|NCT00874549|81232836|FG000|Overall Study|Withdrawal by Subject|0|||
27836634|NCT00874549|81232837|FG001|Overall Study|Withdrawal by Subject|1|||
27836635|NCT00874549|81232838|FG002|Overall Study|Withdrawal by Subject|0|||
27836636|NCT00874549|81232839|FG003|Overall Study|Withdrawal by Subject|1|||
27836637|NCT01559116|81232840|FG000|Overall Study|Adverse Event|10|||
27836638|NCT01559116|81232840|FG000|Overall Study|Lack of Efficacy|1|||
27836639|NCT01559116|81232840|FG000|Overall Study|Lost to Follow-up|1|||
27836640|NCT01559116|81232840|FG000|Overall Study|Protocol Violation|1|||
27836641|NCT01559116|81232840|FG000|Overall Study|Withdrawal by Subject|4|||
27836642|NCT01559116|81232840|FG000|Overall Study|other than stated above|9|||
27836643|NCT02490800|81232845|FG000|Overall Study|Adverse Event|0|||
27836644|NCT02490800|81232846|FG001|Overall Study|Adverse Event|0|||
27836645|NCT02490800|81232847|FG002|Overall Study|Adverse Event|0|||
27836646|NCT02490800|81232848|FG003|Overall Study|Adverse Event|2|||
27604070|NCT00246337|80391348|FG004|Overall Study|Abnormal baseline lab values|0|||
27604071|NCT00246337|80391349|FG005|Overall Study|Abnormal baseline lab values|2|||
27604072|NCT00246337|80391350|FG006|Overall Study|Abnormal baseline lab values|2|||
27711891|NCT00844753|80779052|FG003|Overall Study|Lost to Follow-up|1|||
27836647|NCT02490800|81232849|FG004|Overall Study|Adverse Event|3|||
27836648|NCT02490800|81232850|FG005|Overall Study|Adverse Event|2|||
27836649|NCT02490800|81232851|FG006|Overall Study|Adverse Event|0|||
27836650|NCT02490800|81232852|FG007|Overall Study|Adverse Event|0|||
27836651|NCT02490800|81232853|FG008|Overall Study|Adverse Event|0|||
27836652|NCT02490800|81232854|FG009|Overall Study|Adverse Event|0|||
27836653|NCT02490800|81232855|FG010|Overall Study|Adverse Event|0|||
27836654|NCT02490800|81232856|FG011|Overall Study|Adverse Event|2|||
27711892|NCT00844753|80779049|FG000|Overall Study|could not swallow medication|2|||
27711893|NCT00844753|80779050|FG001|Overall Study|could not swallow medication|0|||
27711894|NCT00844753|80779051|FG002|Overall Study|could not swallow medication|0|||
27836655|NCT02490800|81232857|FG012|Overall Study|Adverse Event|2|||
27836656|NCT02490800|81232845|FG000|Overall Study|Withdrawal by Subject|0|||
27836657|NCT02490800|81232846|FG001|Overall Study|Withdrawal by Subject|0|||
27836658|NCT02490800|81232847|FG002|Overall Study|Withdrawal by Subject|0|||
27836659|NCT02490800|81232848|FG003|Overall Study|Withdrawal by Subject|1|||
27836660|NCT02490800|81232849|FG004|Overall Study|Withdrawal by Subject|0|||
27836661|NCT02490800|81232850|FG005|Overall Study|Withdrawal by Subject|0|||
27836662|NCT02490800|81232851|FG006|Overall Study|Withdrawal by Subject|0|||
27836663|NCT02490800|81232852|FG007|Overall Study|Withdrawal by Subject|0|||
27836664|NCT02490800|81232853|FG008|Overall Study|Withdrawal by Subject|1|||
27836665|NCT02490800|81232854|FG009|Overall Study|Withdrawal by Subject|0|||
27836666|NCT02490800|81232855|FG010|Overall Study|Withdrawal by Subject|0|||
27836667|NCT02490800|81232856|FG011|Overall Study|Withdrawal by Subject|0|||
27836668|NCT02490800|81232857|FG012|Overall Study|Withdrawal by Subject|0|||
27836669|NCT02490800|81232845|FG000|Overall Study|Progressive disease|3|||
27836670|NCT02490800|81232846|FG001|Overall Study|Progressive disease|3|||
27836671|NCT02490800|81232847|FG002|Overall Study|Progressive disease|3|||
27836672|NCT02490800|81232848|FG003|Overall Study|Progressive disease|4|||
27836673|NCT02490800|81232849|FG004|Overall Study|Progressive disease|4|||
27836674|NCT02490800|81232850|FG005|Overall Study|Progressive disease|1|||
27836675|NCT02490800|81232851|FG006|Overall Study|Progressive disease|4|||
27836676|NCT02490800|81232852|FG007|Overall Study|Progressive disease|3|||
27836677|NCT02490800|81232853|FG008|Overall Study|Progressive disease|6|||
27836678|NCT02490800|81232854|FG009|Overall Study|Progressive disease|2|||
27836679|NCT02490800|81232855|FG010|Overall Study|Progressive disease|7|||
27836680|NCT02490800|81232856|FG011|Overall Study|Progressive disease|1|||
27836681|NCT02490800|81232857|FG012|Overall Study|Progressive disease|10|||
27836682|NCT02490800|81232845|FG000|Overall Study|Patient enrolled in post-trial access|0|||
27836683|NCT02490800|81232846|FG001|Overall Study|Patient enrolled in post-trial access|0|||
27836684|NCT02490800|81232847|FG002|Overall Study|Patient enrolled in post-trial access|0|||
27836685|NCT02490800|81232848|FG003|Overall Study|Patient enrolled in post-trial access|0|||
27836686|NCT02490800|81232849|FG004|Overall Study|Patient enrolled in post-trial access|0|||
27604073|NCT00246337|80391351|FG007|Overall Study|Abnormal baseline lab values|0|||
27836687|NCT02490800|81232850|FG005|Overall Study|Patient enrolled in post-trial access|0|||
27836688|NCT02490800|81232851|FG006|Overall Study|Patient enrolled in post-trial access|0|||
27836689|NCT02490800|81232852|FG007|Overall Study|Patient enrolled in post-trial access|0|||
27836690|NCT02490800|81232853|FG008|Overall Study|Patient enrolled in post-trial access|0|||
27836691|NCT02490800|81232854|FG009|Overall Study|Patient enrolled in post-trial access|1|||
27836692|NCT02490800|81232855|FG010|Overall Study|Patient enrolled in post-trial access|1|||
27836693|NCT02490800|81232856|FG011|Overall Study|Patient enrolled in post-trial access|0|||
27836694|NCT02490800|81232857|FG012|Overall Study|Patient enrolled in post-trial access|6|||
27711895|NCT00844753|80779052|FG003|Overall Study|could not swallow medication|0|||
27711896|NCT00844753|80779049|FG000|Overall Study|Withdrawal by Subject|1|||
27604074|NCT00246337|80391352|FG008|Overall Study|Abnormal baseline lab values|4|||
27604075|NCT00246337|80391344|FG000|Overall Study|Overwhelmed|0|||
27604076|NCT00246337|80391345|FG001|Overall Study|Overwhelmed|0|||
27711897|NCT00844753|80779050|FG001|Overall Study|Withdrawal by Subject|0|||
27711898|NCT00844753|80779051|FG002|Overall Study|Withdrawal by Subject|0|||
27711899|NCT00844753|80779052|FG003|Overall Study|Withdrawal by Subject|3|||
27711900|NCT00807742|80779053|FG000|Overall Study|Death|9|||
27711901|NCT00807742|80779054|FG001|Overall Study|Death|2|||
27711902|NCT00807742|80779053|FG000|Overall Study|Withdrawal by Subject|2|||
27836695|NCT00398073|81232860|FG000|Overall Study|Withdrawal by Subject|1|||
27836696|NCT00398073|81232861|FG001|Overall Study|Withdrawal by Subject|0|||
27889473|NCT02752165|81430806|FG001|Overall Study|Withdrawal by Subject|6|||
27889474|NCT02752165|81430805|FG000|Overall Study|Protocol Violation|6|||
27889475|NCT02752165|81430806|FG001|Overall Study|Protocol Violation|5|||
27889476|NCT02752165|81430805|FG000|Overall Study|Lost to Follow-up|33|||
27889477|NCT02752165|81430806|FG001|Overall Study|Lost to Follow-up|38|||
27889478|NCT02029989|81430809|FG000|Overall Study|Withdrawal by Subject|1|||
27889479|NCT02029989|81430810|FG001|Overall Study|Withdrawal by Subject|0|||
27889480|NCT02029989|81430809|FG000|Overall Study|Withdrawal: Fear of needles|1|||
27889481|NCT02029989|81430810|FG001|Overall Study|Withdrawal: Fear of needles|0|||
27889482|NCT02029989|81430809|FG000|Overall Study|Change of location|2|||
27889483|NCT02029989|81430810|FG001|Overall Study|Change of location|3|||
27889484|NCT02029989|81430809|FG000|Overall Study|Physician Decision|2|||
27889485|NCT02029989|81430810|FG001|Overall Study|Physician Decision|0|||
27889486|NCT02029989|81430809|FG000|Overall Study|Lost to Follow-up|9|||
27889487|NCT02029989|81430810|FG001|Overall Study|Lost to Follow-up|7|||
27889488|NCT02029989|81430809|FG000|Overall Study|Death|0|||
27889489|NCT02029989|81430810|FG001|Overall Study|Death|1|||
27889490|NCT02029989|81430809|FG000|Overall Study|Protocol Violation|1|||
27889491|NCT02029989|81430810|FG001|Overall Study|Protocol Violation|0|||
27889492|NCT02537431|81430811|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
27889493|NCT01895270|81430817|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
27889494|NCT01895270|81430818|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
27889495|NCT01895270|81430817|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
27836697|NCT01912807|81232866|FG000|Overall Study|Did not meet elegibility criteria|6|||
27836698|NCT01912807|81232867|FG001|Overall Study|Did not meet elegibility criteria|4|||
27836699|NCT01912807|81232866|FG000|Overall Study|Lost to Follow-up|36|||
27836700|NCT01912807|81232867|FG001|Overall Study|Lost to Follow-up|37|||
27836701|NCT03185741|81232872|FG000|Baseline|Withdrawal by Subject|1|||
27836702|NCT03185741|81232873|FG001|Baseline|Withdrawal by Subject|3|||
27836703|NCT03185741|81232874|FG002|Baseline|Withdrawal by Subject|2|||
27836704|NCT03185741|81232872|FG000|Baseline|Lost to Follow-up|1|||
27836705|NCT03185741|81232873|FG001|Baseline|Lost to Follow-up|2|||
27836706|NCT03185741|81232874|FG002|Baseline|Lost to Follow-up|3|||
27836707|NCT03185741|81232872|FG000|3Month|Death|1|||
27836708|NCT03185741|81232873|FG001|3Month|Death|1|||
27836709|NCT03185741|81232874|FG002|3Month|Death|2|||
27836710|NCT03185741|81232872|FG000|3Month|Withdrawal by Subject|1|||
27836711|NCT03185741|81232873|FG001|3Month|Withdrawal by Subject|5|||
27836712|NCT03185741|81232874|FG002|3Month|Withdrawal by Subject|1|||
27836713|NCT03185741|81232872|FG000|3Month|Lost to Follow-up|7|||
27836714|NCT03185741|81232873|FG001|3Month|Lost to Follow-up|9|||
27836715|NCT03185741|81232874|FG002|3Month|Lost to Follow-up|8|||
27836716|NCT03185741|81232872|FG000|3Month|Unavailable for 3Month|11|||
27836717|NCT03185741|81232873|FG001|3Month|Unavailable for 3Month|10|||
27836718|NCT03185741|81232874|FG002|3Month|Unavailable for 3Month|11|||
27836719|NCT03185741|81232872|FG000|3Month|Protocol Violation|0|||
27604077|NCT00246337|80391346|FG002|Overall Study|Overwhelmed|0|||
27711903|NCT00807742|80779054|FG001|Overall Study|Withdrawal by Subject|1|||
27836720|NCT03185741|81232873|FG001|3Month|Protocol Violation|0|||
27836721|NCT03185741|81232874|FG002|3Month|Protocol Violation|3|||
27836722|NCT03185741|81232872|FG000|6Month|Death|1|||
27836723|NCT03185741|81232873|FG001|6Month|Death|1|||
27889496|NCT01895270|81430818|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
27889497|NCT01895270|81430817|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
27889498|NCT01895270|81430818|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
27889499|NCT01895270|81430817|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
27836724|NCT03185741|81232874|FG002|6Month|Death|2|||
27836725|NCT03185741|81232872|FG000|6Month|Withdrawal by Subject|2|||
27836726|NCT03185741|81232873|FG001|6Month|Withdrawal by Subject|3|||
27836727|NCT03185741|81232874|FG002|6Month|Withdrawal by Subject|1|||
27836728|NCT03185741|81232872|FG000|6Month|Lost to Follow-up|16|||
27836729|NCT03185741|81232873|FG001|6Month|Lost to Follow-up|15|||
27836730|NCT03185741|81232874|FG002|6Month|Lost to Follow-up|16|||
27836731|NCT03488108|81232875|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
27836732|NCT03488108|81232876|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27836733|NCT03488108|81232875|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
27836734|NCT03488108|81232876|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
27836735|NCT02369458|81232877|FG000|Overall Study|Determined to be not eligible|1|||
27836736|NCT02369458|81232878|FG001|Overall Study|Determined to be not eligible|0|||
27836737|NCT04142658|81232882|FG000|Overall Study|Death|2|||
27836738|NCT04142658|81232883|FG001|Overall Study|Death|1|||
27836739|NCT04142658|81232882|FG000|Overall Study|Lost to Follow-up|4|||
27836740|NCT04142658|81232883|FG001|Overall Study|Lost to Follow-up|13|||
27836741|NCT04142658|81232882|FG000|Overall Study|Withdrawal by Subject|9|||
27836742|NCT04142658|81232883|FG001|Overall Study|Withdrawal by Subject|16|||
27836743|NCT00274625|81232884|FG000|Overall Study|Lost to Follow-up|46|||
27836744|NCT00274625|81232885|FG001|Overall Study|Lost to Follow-up|54|||
27836745|NCT00274625|81232884|FG000|Overall Study|Excluded from analysis|14|||
27836746|NCT00274625|81232885|FG001|Overall Study|Excluded from analysis|8|||
27836747|NCT00757705|81232886|FG000|Overall Study|Adverse Event|19|||
27836748|NCT00757705|81232886|FG000|Overall Study|Lost to Follow-up|16|||
27836749|NCT00757705|81232886|FG000|Overall Study|Withdrawal by Subject|25|||
27836750|NCT00757705|81232886|FG000|Overall Study|Insufficient Response|26|||
27836751|NCT00757705|81232886|FG000|Overall Study|Ineligible to continue|8|||
27836752|NCT00757705|81232886|FG000|Overall Study|Non-compliant|9|||
27836753|NCT00757705|81232886|FG000|Overall Study|Other|18|||
27836754|NCT00105157|81232891|FG000|Double-Blind (DB)|Never Treated|1|||
27836755|NCT00105157|81232892|FG001|Double-Blind (DB)|Never Treated|0|||
27836756|NCT00105157|81232893|FG002|Double-Blind (DB)|Never Treated|0|||
27836757|NCT00105157|81232894|FG003|Double-Blind (DB)|Never Treated|0|||
27836758|NCT00105157|81232891|FG000|Double-Blind (DB)|Adverse Event|2|||
27836759|NCT00105157|81232892|FG001|Double-Blind (DB)|Adverse Event|0|||
27836760|NCT00105157|81232893|FG002|Double-Blind (DB)|Adverse Event|1|||
27836761|NCT00105157|81232894|FG003|Double-Blind (DB)|Adverse Event|1|||
27836762|NCT00105157|81232891|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
27836763|NCT00105157|81232892|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
27836764|NCT00105157|81232893|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
27836765|NCT00105157|81232894|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
27889500|NCT01895270|81430818|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
27604078|NCT00246337|80391347|FG003|Overall Study|Overwhelmed|0|||
27836766|NCT00105157|81232891|FG000|Open-Label Continuation of DB|Adverse Event|3|||
27836767|NCT00105157|81232892|FG001|Open-Label Continuation of DB|Adverse Event|1|||
27836768|NCT00105157|81232893|FG002|Open-Label Continuation of DB|Adverse Event|0|||
27836769|NCT00105157|81232894|FG003|Open-Label Continuation of DB|Adverse Event|0|||
27889501|NCT01895270|81430817|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
27836770|NCT00105157|81232891|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
27836771|NCT00105157|81232892|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
27836772|NCT00105157|81232893|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
27836773|NCT00105157|81232894|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
27836774|NCT00105157|81232891|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
27836775|NCT00105157|81232892|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
27836776|NCT00105157|81232893|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
27836777|NCT00105157|81232894|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
27836778|NCT00105157|81232891|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
27604079|NCT00246337|80391348|FG004|Overall Study|Overwhelmed|0|||
27604080|NCT00246337|80391349|FG005|Overall Study|Overwhelmed|1|||
27604081|NCT00246337|80391350|FG006|Overall Study|Overwhelmed|0|||
27604082|NCT00246337|80391351|FG007|Overall Study|Overwhelmed|0|||
27604083|NCT00246337|80391352|FG008|Overall Study|Overwhelmed|0|||
27604084|NCT00246337|80391344|FG000|Overall Study|Protocol Violator|1|||
27604085|NCT00246337|80391345|FG001|Overall Study|Protocol Violator|0|||
27604086|NCT00246337|80391346|FG002|Overall Study|Protocol Violator|0|||
27604087|NCT00246337|80391347|FG003|Overall Study|Protocol Violator|0|||
27604088|NCT00246337|80391348|FG004|Overall Study|Protocol Violator|0|||
27604089|NCT00246337|80391349|FG005|Overall Study|Protocol Violator|0|||
27604090|NCT00246337|80391350|FG006|Overall Study|Protocol Violator|0|||
27604091|NCT00246337|80391351|FG007|Overall Study|Protocol Violator|0|||
27604092|NCT00246337|80391352|FG008|Overall Study|Protocol Violator|0|||
27604093|NCT00246337|80391344|FG000|Overall Study|Reported as completing trial in error|0|||
27604094|NCT00246337|80391345|FG001|Overall Study|Reported as completing trial in error|0|||
27604095|NCT00246337|80391346|FG002|Overall Study|Reported as completing trial in error|0|||
27604096|NCT00246337|80391347|FG003|Overall Study|Reported as completing trial in error|0|||
27604097|NCT00246337|80391348|FG004|Overall Study|Reported as completing trial in error|0|||
27604098|NCT00246337|80391349|FG005|Overall Study|Reported as completing trial in error|0|||
27604099|NCT00246337|80391350|FG006|Overall Study|Reported as completing trial in error|0|||
27604100|NCT00246337|80391351|FG007|Overall Study|Reported as completing trial in error|1|||
27604101|NCT00246337|80391352|FG008|Overall Study|Reported as completing trial in error|0|||
27604102|NCT03324880|80391353|FG000|Overall Study|Adverse Event|0|||
27604103|NCT03324880|80391354|FG001|Overall Study|Adverse Event|2|||
27604104|NCT03324880|80391353|FG000|Overall Study|Withdrawal by Subject|2|||
27604105|NCT03324880|80391354|FG001|Overall Study|Withdrawal by Subject|2|||
27604106|NCT03324880|80391353|FG000|Overall Study|Lost to Follow-up|0|||
27604107|NCT03324880|80391354|FG001|Overall Study|Lost to Follow-up|1|||
27604108|NCT03324880|80391353|FG000|Overall Study|Product Recall|0|||
27604109|NCT03324880|80391354|FG001|Overall Study|Product Recall|1|||
27604110|NCT04176939|80391359|FG000|Overall Study|Adverse Event|7|||
27604111|NCT04176939|80391359|FG000|Overall Study|Unspecified reason|2|||
27604112|NCT04176939|80391359|FG000|Overall Study|Migrated/Moved from the study area|1|||
27604113|NCT04176939|80391359|FG000|Overall Study|Withdrawal by Subject|4|||
27604114|NCT04176939|80391359|FG000|Overall Study|In follow-up|54|||
27604115|NCT02801669|80391362|FG000|Overall Study|Death|66|||
27604116|NCT02801669|80391363|FG001|Overall Study|Death|69|||
27604117|NCT02801669|80391362|FG000|Overall Study|Withdrawal by Subject|81|||
27836779|NCT00105157|81232892|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
27836780|NCT00105157|81232893|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
27836781|NCT00105157|81232894|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
27711904|NCT00807742|80779053|FG000|Overall Study|Lost to Follow-up|35|||
27711905|NCT00807742|80779054|FG001|Overall Study|Lost to Follow-up|51|||
27711906|NCT02431702|80779060|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
27711907|NCT02431702|80779061|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
27711908|NCT02431702|80779062|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
27711909|NCT02431702|80779063|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
27711910|NCT02431702|80779064|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
27711911|NCT02431702|80779065|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
27711912|NCT02431702|80779066|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
27711913|NCT02431702|80779060|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
27711914|NCT02431702|80779061|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
27711915|NCT02431702|80779062|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
27836782|NCT00105157|81232891|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
27836783|NCT00105157|81232892|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
27836784|NCT00105157|81232893|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
27836785|NCT00105157|81232894|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
27836786|NCT00105157|81232891|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
27836787|NCT00105157|81232892|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
27836788|NCT00105157|81232893|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
27836789|NCT00105157|81232894|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
27836790|NCT00105157|81232891|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
27836791|NCT00105157|81232892|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
27836792|NCT00105157|81232893|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
27889502|NCT01895270|81430818|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
27711916|NCT02431702|80779063|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
27711917|NCT02431702|80779064|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
27711918|NCT02431702|80779065|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
27711919|NCT02431702|80779066|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
27711920|NCT02431702|80779060|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
27711921|NCT02431702|80779061|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
27711922|NCT02431702|80779062|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
27711923|NCT02431702|80779063|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
27711924|NCT02431702|80779064|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
27711925|NCT02431702|80779065|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
27711926|NCT02431702|80779066|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
27711927|NCT02431702|80779060|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
27711928|NCT02431702|80779061|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
27711929|NCT02431702|80779062|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
27711930|NCT02431702|80779063|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
27711931|NCT02431702|80779064|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
27711932|NCT02431702|80779065|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
27711933|NCT02431702|80779066|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
27711934|NCT02431702|80779060|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
27711935|NCT02431702|80779061|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
27711936|NCT02431702|80779062|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
27711937|NCT02431702|80779063|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
27711938|NCT02431702|80779064|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
27711939|NCT02431702|80779065|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
27604118|NCT02801669|80391363|FG001|Overall Study|Withdrawal by Subject|77|||
27711940|NCT02431702|80779066|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
27711941|NCT02431702|80779060|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
27711942|NCT02431702|80779061|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
27711943|NCT02431702|80779062|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
27711944|NCT02431702|80779063|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
27711945|NCT02431702|80779064|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
27711946|NCT02431702|80779065|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
27711947|NCT02431702|80779066|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
27711948|NCT02431702|80779060|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
27711949|NCT02431702|80779061|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
27711950|NCT02431702|80779062|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
27711951|NCT02431702|80779063|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
27711952|NCT02431702|80779064|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
27711953|NCT02431702|80779065|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
27711954|NCT02431702|80779066|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
27711955|NCT02431702|80779060|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
27711956|NCT02431702|80779061|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
27711957|NCT02431702|80779062|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
27711958|NCT02431702|80779063|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
27711959|NCT02431702|80779064|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
27836793|NCT00105157|81232894|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
27836794|NCT00105157|81232891|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
27604119|NCT02801669|80391362|FG000|Overall Study|Other|4|||
27711960|NCT02431702|80779065|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
27711961|NCT02431702|80779066|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
27711962|NCT02431702|80779060|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
27711963|NCT02431702|80779061|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
27711964|NCT02431702|80779062|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
27711965|NCT02431702|80779063|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
27711966|NCT02431702|80779064|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
27711967|NCT02431702|80779065|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
27711968|NCT02431702|80779066|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
27711969|NCT02431702|80779060|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
27711970|NCT02431702|80779061|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
27711971|NCT02431702|80779062|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
27711972|NCT02431702|80779063|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
27711973|NCT02431702|80779064|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
27711974|NCT02431702|80779065|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
27711975|NCT02431702|80779066|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
27711976|NCT02431702|80779060|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
27711977|NCT02431702|80779061|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
27711978|NCT02431702|80779062|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
27711979|NCT02431702|80779063|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
27711980|NCT02431702|80779064|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
27711981|NCT02431702|80779065|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
27711982|NCT02431702|80779066|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
27711983|NCT02431702|80779060|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
27711984|NCT02431702|80779061|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
27711985|NCT02431702|80779062|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
27711986|NCT02431702|80779063|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
27711987|NCT02431702|80779064|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
27711988|NCT02431702|80779065|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
27711989|NCT02431702|80779066|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
27711990|NCT02431702|80779060|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
27711991|NCT02431702|80779061|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
27711992|NCT02431702|80779062|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
27711993|NCT02431702|80779063|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
27711994|NCT02431702|80779064|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
27711995|NCT02431702|80779065|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
27711996|NCT02431702|80779066|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
27711997|NCT02431702|80779060|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
27711998|NCT02431702|80779061|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
27711999|NCT02431702|80779062|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
27712000|NCT02431702|80779063|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
27712001|NCT02431702|80779064|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
27712002|NCT02431702|80779065|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
27712003|NCT02431702|80779066|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
27712004|NCT02431702|80779060|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
27712005|NCT02431702|80779061|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
27712006|NCT02431702|80779062|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
27712007|NCT02431702|80779063|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
27712008|NCT02431702|80779064|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
27712009|NCT02431702|80779065|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
27712010|NCT02431702|80779066|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
27712011|NCT03594227|80779069|FG000|Overall Study|Adverse Event|2|||
27712012|NCT03594227|80779070|FG001|Overall Study|Adverse Event|1|||
27712013|NCT03594227|80779071|FG002|Overall Study|Adverse Event|0|||
27712014|NCT03594227|80779072|FG003|Overall Study|Adverse Event|2|||
27712015|NCT03594227|80779069|FG000|Overall Study|Lost to Follow-up|1|||
27712016|NCT03594227|80779070|FG001|Overall Study|Lost to Follow-up|1|||
27712017|NCT03594227|80779071|FG002|Overall Study|Lost to Follow-up|1|||
27712018|NCT03594227|80779072|FG003|Overall Study|Lost to Follow-up|0|||
27712019|NCT03594227|80779069|FG000|Overall Study|Withdrawal by Subject|1|||
27712020|NCT03594227|80779070|FG001|Overall Study|Withdrawal by Subject|1|||
27712021|NCT03594227|80779071|FG002|Overall Study|Withdrawal by Subject|1|||
27836795|NCT00105157|81232892|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
27712022|NCT03594227|80779072|FG003|Overall Study|Withdrawal by Subject|1|||
27712023|NCT03594227|80779069|FG000|Overall Study|Pregnancy|0|||
27712024|NCT03594227|80779070|FG001|Overall Study|Pregnancy|1|||
27712025|NCT03594227|80779071|FG002|Overall Study|Pregnancy|0|||
27712026|NCT03594227|80779072|FG003|Overall Study|Pregnancy|0|||
27712027|NCT03594227|80779069|FG000|Overall Study|Sponsor Decision|0|||
27712028|NCT03594227|80779070|FG001|Overall Study|Sponsor Decision|0|||
27836796|NCT00105157|81232893|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
27836797|NCT00105157|81232894|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
27836798|NCT00105157|81232891|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
27836799|NCT00105157|81232892|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
27836800|NCT00105157|81232893|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
27836801|NCT00105157|81232894|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
27836802|NCT00105157|81232891|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
27836803|NCT00105157|81232892|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
27836804|NCT00105157|81232893|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
27836805|NCT00105157|81232894|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
27836806|NCT00105157|81232891|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
27836807|NCT00105157|81232892|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
27836808|NCT00105157|81232893|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
27836809|NCT00105157|81232894|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
27836810|NCT00640341|81232896|FG000|Overall Study|Adverse Event|0|||
27836811|NCT00640341|81232897|FG001|Overall Study|Adverse Event|0|||
27836812|NCT00640341|81232898|FG002|Overall Study|Adverse Event|1|||
27836813|NCT00640341|81232896|FG000|Overall Study|Positive Slit Lamp Findings|0|||
27836814|NCT00640341|81232897|FG001|Overall Study|Positive Slit Lamp Findings|0|||
27836815|NCT00640341|81232898|FG002|Overall Study|Positive Slit Lamp Findings|1|||
27836816|NCT00640341|81232896|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
27836817|NCT00640341|81232897|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
27836818|NCT00640341|81232898|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
27836819|NCT00640341|81232896|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
27836820|NCT00640341|81232897|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
27836821|NCT00640341|81232898|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
27836822|NCT00640341|81232896|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
27836823|NCT00640341|81232897|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
27836824|NCT00640341|81232898|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
27836825|NCT00640341|81232896|FG000|Overall Study|Lost to Follow-up|2|||
27836826|NCT00640341|81232897|FG001|Overall Study|Lost to Follow-up|0|||
27836827|NCT00640341|81232898|FG002|Overall Study|Lost to Follow-up|0|||
27836828|NCT00640341|81232896|FG000|Overall Study|Withdrawal by Subject|4|||
27836829|NCT00640341|81232897|FG001|Overall Study|Withdrawal by Subject|0|||
27836830|NCT00640341|81232898|FG002|Overall Study|Withdrawal by Subject|1|||
27836831|NCT00640341|81232896|FG000|Overall Study|Unacceptable Lens Movement|1|||
27836832|NCT00640341|81232897|FG001|Overall Study|Unacceptable Lens Movement|0|||
27836833|NCT00640341|81232898|FG002|Overall Study|Unacceptable Lens Movement|0|||
27836834|NCT00640341|81232896|FG000|Overall Study|Poor fit/Uncomfortable|4|||
27712029|NCT03594227|80779071|FG002|Overall Study|Sponsor Decision|0|||
27836835|NCT00640341|81232897|FG001|Overall Study|Poor fit/Uncomfortable|0|||
27836836|NCT00640341|81232898|FG002|Overall Study|Poor fit/Uncomfortable|0|||
27836837|NCT00640341|81232896|FG000|Overall Study|Ineligable at Baseline|5|||
27836838|NCT00640341|81232897|FG001|Overall Study|Ineligable at Baseline|3|||
27836839|NCT00640341|81232898|FG002|Overall Study|Ineligable at Baseline|2|||
27836840|NCT00640341|81232896|FG000|Overall Study|Adverse event and positive slit lamp|1|||
27836841|NCT00640341|81232897|FG001|Overall Study|Adverse event and positive slit lamp|0|||
27836842|NCT00640341|81232898|FG002|Overall Study|Adverse event and positive slit lamp|0|||
27712030|NCT03594227|80779072|FG003|Overall Study|Sponsor Decision|1|||
27712031|NCT03594227|80779069|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
27712032|NCT03594227|80779070|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
27712033|NCT03594227|80779071|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
27712034|NCT03594227|80779072|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
27712035|NCT01246583|80779083|FG000|Overall Study|Lost to Follow-up|0|||
27712036|NCT01246583|80779084|FG001|Overall Study|Lost to Follow-up|0|||
27712037|NCT01246583|80779085|FG002|Overall Study|Lost to Follow-up|0|||
27712038|NCT01246583|80779086|FG003|Overall Study|Lost to Follow-up|1|||
27712039|NCT01246583|80779083|FG000|Overall Study|Protocol Violation|0|||
27712040|NCT01246583|80779084|FG001|Overall Study|Protocol Violation|0|||
27712041|NCT01246583|80779085|FG002|Overall Study|Protocol Violation|1|||
27712042|NCT01246583|80779086|FG003|Overall Study|Protocol Violation|0|||
27712043|NCT01246583|80779083|FG000|Overall Study|Withdrawal by Subject|1|||
27712044|NCT01246583|80779084|FG001|Overall Study|Withdrawal by Subject|0|||
27712045|NCT01246583|80779085|FG002|Overall Study|Withdrawal by Subject|0|||
27712046|NCT01246583|80779086|FG003|Overall Study|Withdrawal by Subject|0|||
27712047|NCT00129766|80779087|FG000|Overall Study|Death|3|||
27712048|NCT00129766|80779088|FG001|Overall Study|Death|8|||
27712049|NCT00129766|80779087|FG000|Overall Study|Withdrawal of consent|31|||
27712050|NCT00129766|80779088|FG001|Overall Study|Withdrawal of consent|30|||
27712051|NCT00129766|80779087|FG000|Overall Study|Lost to Follow-up|26|||
27712052|NCT00129766|80779088|FG001|Overall Study|Lost to Follow-up|21|||
27712053|NCT03044249|80779089|FG000|Overall Study|Adverse Event|4|||
27712054|NCT03044249|80779090|FG001|Overall Study|Adverse Event|9|||
27712055|NCT03044249|80779089|FG000|Overall Study|Lost to Follow-up|1|||
27712056|NCT03044249|80779090|FG001|Overall Study|Lost to Follow-up|0|||
27712057|NCT03044249|80779089|FG000|Overall Study|Non-compliance with Study Drug|1|||
27712058|NCT03044249|80779090|FG001|Overall Study|Non-compliance with Study Drug|0|||
27712059|NCT03044249|80779089|FG000|Overall Study|Study Terminated by Sponsor|2|||
27712060|NCT03044249|80779090|FG001|Overall Study|Study Terminated by Sponsor|0|||
27712061|NCT03044249|80779089|FG000|Overall Study|Withdrawal by Subject|2|||
27712062|NCT03044249|80779090|FG001|Overall Study|Withdrawal by Subject|5|||
27712063|NCT01230307|80779092|FG000|Overall Study|LVAD Placement|0|||
27712064|NCT01230307|80779093|FG001|Overall Study|LVAD Placement|2|||
27712065|NCT01549002|80779094|FG000|Overall Study|Excessive pain|0|||
27712066|NCT01549002|80779095|FG001|Overall Study|Excessive pain|2|||
27712067|NCT01549002|80779094|FG000|Overall Study|Moderate sedation required|0|||
27712068|NCT01549002|80779095|FG001|Overall Study|Moderate sedation required|2|||
27712069|NCT02290873|80779096|FG000|Overall Study|Withdrawal by Subject|0|||
27712070|NCT02290873|80779097|FG001|Overall Study|Withdrawal by Subject|1|||
27712071|NCT02290873|80779098|FG002|Overall Study|Withdrawal by Subject|1|||
27712072|NCT02290873|80779096|FG000|Overall Study|Nellcor device error|1|||
27712073|NCT02290873|80779097|FG001|Overall Study|Nellcor device error|0|||
27712074|NCT02290873|80779098|FG002|Overall Study|Nellcor device error|0|||
27712075|NCT02290873|80779096|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
27712076|NCT02290873|80779097|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
27712077|NCT02290873|80779098|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
27712078|NCT02290873|80779096|FG000|Overall Study|Protocol Violation|0|||
27712079|NCT02290873|80779097|FG001|Overall Study|Protocol Violation|0|||
27712080|NCT02290873|80779098|FG002|Overall Study|Protocol Violation|1|||
27712081|NCT03765138|80779102|FG000|Overall Study|Lost to Follow-up|1|||
27712082|NCT01263483|80779108|FG000|Overall Study|Adverse Event|4|||
27712083|NCT01263483|80779109|FG001|Overall Study|Adverse Event|0|||
27712084|NCT01263483|80779110|FG002|Overall Study|Adverse Event|3|||
27712085|NCT01263483|80779108|FG000|Overall Study|Withdrawal by Subject|1|||
27712086|NCT01263483|80779109|FG001|Overall Study|Withdrawal by Subject|0|||
27712087|NCT01263483|80779110|FG002|Overall Study|Withdrawal by Subject|0|||
27712088|NCT01263483|80779108|FG000|Overall Study|Lack of Efficacy|2|||
27712089|NCT01263483|80779109|FG001|Overall Study|Lack of Efficacy|0|||
27712090|NCT01263483|80779110|FG002|Overall Study|Lack of Efficacy|0|||
27712091|NCT01263483|80779108|FG000|Overall Study|Protocol Violation|0|||
27712092|NCT01263483|80779109|FG001|Overall Study|Protocol Violation|1|||
27712093|NCT01263483|80779110|FG002|Overall Study|Protocol Violation|1|||
27712094|NCT01263483|80779108|FG000|Overall Study|Participant Unavailability|0|||
27712095|NCT01263483|80779109|FG001|Overall Study|Participant Unavailability|1|||
27712096|NCT01263483|80779110|FG002|Overall Study|Participant Unavailability|1|||
27712097|NCT02255409|80779111|FG000|Overall Study|Administrative Reason|3|||
27712098|NCT02255409|80779112|FG001|Overall Study|Administrative Reason|7|||
27712099|NCT02255409|80779111|FG000|Overall Study|Withdrawal by Subject|1|||
27712100|NCT02255409|80779112|FG001|Overall Study|Withdrawal by Subject|5|||
27712101|NCT02255409|80779111|FG000|Overall Study|Lost to Follow-up|10|||
27836843|NCT03419962|81232903|FG000|Overall Study|Change to other medication|1|||
27836844|NCT03419962|81232903|FG000|Overall Study|Refusal of continuing with trial drug|1|||
27836845|NCT03419962|81232903|FG000|Overall Study|Lost to Follow-up|3|||
27836846|NCT03419962|81232903|FG000|Overall Study|Difficulty in inhaling the doses|1|||
27836847|NCT03419962|81232903|FG000|Overall Study|Missing completion data|31|||
27836848|NCT03750695|81232904|FG000|Overall Study|Lost to Follow-up|0|||
27712102|NCT02255409|80779112|FG001|Overall Study|Lost to Follow-up|19|||
27836849|NCT03750695|81232905|FG001|Overall Study|Lost to Follow-up|1|||
27836850|NCT01119625|81232906|FG000|Overall Study|Lost to Follow-up|1|||
27836851|NCT01119625|81232907|FG001|Overall Study|Lost to Follow-up|2|||
27836852|NCT01119625|81232906|FG000|Overall Study|Withdrawal by Subject|2|||
27836853|NCT01119625|81232907|FG001|Overall Study|Withdrawal by Subject|1|||
27836854|NCT01119625|81232906|FG000|Overall Study|Other|0|||
27836855|NCT01119625|81232907|FG001|Overall Study|Other|1|||
27836856|NCT03950674|81232908|FG000|Overall Study|Death|16|||
27836857|NCT03950674|81232909|FG001|Overall Study|Death|15|||
27836858|NCT03950674|81232908|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
27836859|NCT03950674|81232909|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
27836860|NCT00396630|81232910|FG000|Overall Study|Lost to Follow-up|1|||
27836861|NCT00396630|81232911|FG001|Overall Study|Lost to Follow-up|1|||
27836862|NCT00396630|81232910|FG000|Overall Study|Withdrawal by Subject|1|||
27836863|NCT00396630|81232911|FG001|Overall Study|Withdrawal by Subject|1|||
27836864|NCT00396630|81232910|FG000|Overall Study|Not vaccinated at Visit 3|3|||
27836865|NCT00396630|81232911|FG001|Overall Study|Not vaccinated at Visit 3|3|||
27836866|NCT00858403|81232914|FG000|Overall Study|Withdrawal by Subject|1|||
27836867|NCT00858403|81232914|FG000|Overall Study|Death|3|||
27836868|NCT00858403|81232914|FG000|Overall Study|Disease Progression|1|||
27836869|NCT03885934|81232915|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
27836870|NCT03885934|81232916|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
27836871|NCT03885934|81232917|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
27836872|NCT03885934|81232918|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
27836873|NCT03885934|81232919|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
27836874|NCT03885934|81232920|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
27836875|NCT03387462|81232923|FG000|Overall Study|Lost to Follow-up|1|||
27836876|NCT01451541|81232924|FG000|Overall Study|Adverse Event|4|||
27836877|NCT01451541|81232925|FG001|Overall Study|Adverse Event|3|||
27836878|NCT01451541|81232926|FG002|Overall Study|Adverse Event|6|||
27712103|NCT01439282|80779113|FG000|Overall Study|Adverse Event|5|||
27712104|NCT01439282|80779114|FG001|Overall Study|Adverse Event|0|||
27712105|NCT01439282|80779113|FG000|Overall Study|Withdrawal by Subject|2|||
27712106|NCT01439282|80779114|FG001|Overall Study|Withdrawal by Subject|0|||
27712107|NCT01439282|80779113|FG000|Overall Study|Other|1|||
27712108|NCT01439282|80779114|FG001|Overall Study|Other|1|||
27712109|NCT01140451|80779121|FG000|Overall Study|Withdrawal by Subject|26|||
27712110|NCT01140451|80779122|FG001|Overall Study|Withdrawal by Subject|33|||
27712111|NCT01140451|80779121|FG000|Overall Study|Adverse Event|2|||
27712112|NCT01140451|80779122|FG001|Overall Study|Adverse Event|6|||
27712113|NCT01140451|80779121|FG000|Overall Study|Physician Decision|5|||
27712114|NCT01140451|80779122|FG001|Overall Study|Physician Decision|3|||
27712115|NCT01140451|80779121|FG000|Overall Study|Lost to Follow-up|2|||
27712116|NCT01140451|80779122|FG001|Overall Study|Lost to Follow-up|0|||
27836879|NCT01451541|81232924|FG000|Overall Study|Lack of Efficacy|2|||
27836880|NCT01451541|81232925|FG001|Overall Study|Lack of Efficacy|0|||
27836881|NCT01451541|81232926|FG002|Overall Study|Lack of Efficacy|0|||
27836882|NCT01451541|81232924|FG000|Overall Study|Lost to Follow-up|4|||
27836883|NCT01451541|81232925|FG001|Overall Study|Lost to Follow-up|4|||
27889503|NCT01895270|81430817|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
27712117|NCT01140451|80779121|FG000|Overall Study|Participants Planning Pregnancy|3|||
27712118|NCT01140451|80779122|FG001|Overall Study|Participants Planning Pregnancy|0|||
27712119|NCT00514514|80779126|FG000|Pre-phase|Death|10|||
27712120|NCT00514514|80779127|FG001|Pre-phase|Death|0|||
27712121|NCT00514514|80779128|FG002|Pre-phase|Death|0|||
27712122|NCT00514514|80779126|FG000|Pre-phase|administrative problems|2|||
27712123|NCT00514514|80779127|FG001|Pre-phase|administrative problems|0|||
27712124|NCT00514514|80779128|FG002|Pre-phase|administrative problems|0|||
27836884|NCT01451541|81232926|FG002|Overall Study|Lost to Follow-up|7|||
27836885|NCT01451541|81232924|FG000|Overall Study|Withdrawal by Subject|15|||
27712125|NCT00514514|80779126|FG000|Pre-phase|Protocol Violation|6|||
27712126|NCT00514514|80779127|FG001|Pre-phase|Protocol Violation|0|||
27712127|NCT00514514|80779128|FG002|Pre-phase|Protocol Violation|0|||
27712128|NCT00514514|80779126|FG000|Pre-phase|condition no longer requires study drug|7|||
27712129|NCT00514514|80779127|FG001|Pre-phase|condition no longer requires study drug|0|||
27712130|NCT00514514|80779128|FG002|Pre-phase|condition no longer requires study drug|0|||
27712131|NCT00514514|80779126|FG000|Pre-phase|abnormal test procedure results|15|||
27712132|NCT00514514|80779127|FG001|Pre-phase|abnormal test procedure results|0|||
27712133|NCT00514514|80779128|FG002|Pre-phase|abnormal test procedure results|0|||
27712134|NCT00514514|80779126|FG000|Pre-phase|Lost to Follow-up|2|||
27712135|NCT00514514|80779127|FG001|Pre-phase|Lost to Follow-up|0|||
27712136|NCT00514514|80779128|FG002|Pre-phase|Lost to Follow-up|0|||
27712137|NCT00514514|80779126|FG000|Pre-phase|abnormal lab values|23|||
27712138|NCT00514514|80779127|FG001|Pre-phase|abnormal lab values|0|||
27712139|NCT00514514|80779128|FG002|Pre-phase|abnormal lab values|0|||
27712140|NCT00514514|80779126|FG000|Pre-phase|Lack of Efficacy|35|||
27712141|NCT00514514|80779127|FG001|Pre-phase|Lack of Efficacy|0|||
27712142|NCT00514514|80779128|FG002|Pre-phase|Lack of Efficacy|0|||
27712143|NCT00514514|80779126|FG000|Pre-phase|Adverse Event|137|||
27712144|NCT00514514|80779127|FG001|Pre-phase|Adverse Event|0|||
27712145|NCT00514514|80779128|FG002|Pre-phase|Adverse Event|0|||
27712146|NCT00514514|80779126|FG000|Pre-phase|Withdrawal by Subject|66|||
27712147|NCT00514514|80779127|FG001|Pre-phase|Withdrawal by Subject|0|||
27712148|NCT00514514|80779128|FG002|Pre-phase|Withdrawal by Subject|0|||
27712149|NCT00514514|80779126|FG000|Randomized - 9 Month|Death|3|||
27712150|NCT00514514|80779127|FG001|Randomized - 9 Month|Death|2|||
27712151|NCT00514514|80779128|FG002|Randomized - 9 Month|Death|2|||
27712152|NCT00514514|80779126|FG000|Randomized - 9 Month|Administrative problems|1|||
27712153|NCT00514514|80779127|FG001|Randomized - 9 Month|Administrative problems|1|||
27712154|NCT00514514|80779128|FG002|Randomized - 9 Month|Administrative problems|2|||
27712155|NCT00514514|80779126|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
27712156|NCT00514514|80779127|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
27712157|NCT00514514|80779128|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
27712158|NCT00514514|80779126|FG000|Randomized - 9 Month|Protocol Violation|1|||
27712159|NCT00514514|80779127|FG001|Randomized - 9 Month|Protocol Violation|1|||
27712160|NCT00514514|80779128|FG002|Randomized - 9 Month|Protocol Violation|0|||
27712161|NCT00514514|80779126|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
27712162|NCT00514514|80779127|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
27712163|NCT00514514|80779128|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
27712164|NCT00514514|80779126|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
27712165|NCT00514514|80779127|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
27712166|NCT00514514|80779128|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
27712167|NCT00514514|80779126|FG000|Randomized - 9 Month|Adverse Event|25|||
27712168|NCT00514514|80779127|FG001|Randomized - 9 Month|Adverse Event|44|||
27712169|NCT00514514|80779128|FG002|Randomized - 9 Month|Adverse Event|27|||
27712170|NCT00514514|80779126|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
27712171|NCT00514514|80779127|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
27712172|NCT00514514|80779128|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
27712173|NCT00514514|80779126|FG000|Extension - 4 Years|Lost to Follow-up|12|||
27712174|NCT00514514|80779127|FG001|Extension - 4 Years|Lost to Follow-up|10|||
27712175|NCT00514514|80779128|FG002|Extension - 4 Years|Lost to Follow-up|9|||
27712176|NCT00514514|80779126|FG000|Extension - 4 Years|Administrative problems|3|||
27712177|NCT00514514|80779127|FG001|Extension - 4 Years|Administrative problems|1|||
27712178|NCT00514514|80779128|FG002|Extension - 4 Years|Administrative problems|1|||
27712179|NCT00514514|80779126|FG000|Extension - 4 Years|Death|8|||
27712180|NCT00514514|80779127|FG001|Extension - 4 Years|Death|3|||
27712181|NCT00514514|80779128|FG002|Extension - 4 Years|Death|6|||
27712182|NCT00514514|80779126|FG000|Extension - 4 Years|Adverse Event|9|||
27712183|NCT00514514|80779127|FG001|Extension - 4 Years|Adverse Event|6|||
27712184|NCT00514514|80779128|FG002|Extension - 4 Years|Adverse Event|3|||
27712185|NCT00840086|80779134|FG000|Overall Study|Adverse Event|1|||
27712186|NCT00840086|80779134|FG000|Overall Study|Protocol Violation|2|||
27712187|NCT00840086|80779134|FG000|Overall Study|Lost to Follow-up|1|||
27712188|NCT02807480|80779144|FG000|Overall Study|Withdrawal by Subject|14|||
27712189|NCT02807480|80779145|FG001|Overall Study|Withdrawal by Subject|10|||
27712190|NCT00393887|80779146|FG000|Overall Study|Physician Decision|5|||
27712191|NCT00393887|80779147|FG001|Overall Study|Physician Decision|0|||
27712192|NCT00393887|80779146|FG000|Overall Study|Lost to Follow-up|11|||
27712193|NCT00393887|80779147|FG001|Overall Study|Lost to Follow-up|9|||
27836886|NCT01451541|81232925|FG001|Overall Study|Withdrawal by Subject|8|||
27836887|NCT01451541|81232926|FG002|Overall Study|Withdrawal by Subject|6|||
27836888|NCT01451541|81232924|FG000|Overall Study|randomization error, noncompliance|11|||
27836889|NCT01451541|81232925|FG001|Overall Study|randomization error, noncompliance|10|||
27712194|NCT03073980|80779148|FG000|Overall Study|Lost to Follow-up|10|||
27604120|NCT02801669|80391363|FG001|Overall Study|Other|6|||
27604121|NCT01555164|80391364|FG000|Overall Study|Adverse Event|5|||
27604122|NCT01555164|80391365|FG001|Overall Study|Adverse Event|7|||
27604123|NCT01555164|80391364|FG000|Overall Study|Hyperglycemia|0|||
27712195|NCT03073980|80779149|FG001|Overall Study|Lost to Follow-up|2|||
27712196|NCT03073980|80779150|FG002|Overall Study|Lost to Follow-up|9|||
27712197|NCT03073980|80779148|FG000|Overall Study|No post-procedure data|0|||
27712198|NCT03073980|80779149|FG001|Overall Study|No post-procedure data|0|||
27889504|NCT01895270|81430818|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
27604124|NCT01555164|80391365|FG001|Overall Study|Hyperglycemia|1|||
27712199|NCT03073980|80779150|FG002|Overall Study|No post-procedure data|2|||
27712200|NCT01692275|80779153|FG000|Overall Study|Lost to Follow-up|57|||
27604125|NCT01555164|80391364|FG000|Overall Study|Investigator's Discretion|2|||
27604126|NCT01555164|80391365|FG001|Overall Study|Investigator's Discretion|2|||
27604127|NCT01555164|80391364|FG000|Overall Study|Lost to Follow-up|4|||
27604128|NCT01555164|80391365|FG001|Overall Study|Lost to Follow-up|3|||
27604129|NCT01555164|80391364|FG000|Overall Study|Protocol Violation|9|||
27604130|NCT01555164|80391365|FG001|Overall Study|Protocol Violation|5|||
27604131|NCT01555164|80391364|FG000|Overall Study|Subject Non-compliance|14|||
27604132|NCT01555164|80391365|FG001|Overall Study|Subject Non-compliance|6|||
27604133|NCT01555164|80391364|FG000|Overall Study|Subject Withdrew Consent|6|||
27604134|NCT01555164|80391365|FG001|Overall Study|Subject Withdrew Consent|11|||
27604135|NCT01621880|80391366|FG000|Overall Study|Adverse Event|5|||
27604136|NCT01621880|80391367|FG001|Overall Study|Adverse Event|1|||
27604137|NCT01621880|80391366|FG000|Overall Study|Withdrawal by Subject|5|||
27604138|NCT01621880|80391367|FG001|Overall Study|Withdrawal by Subject|4|||
27604139|NCT00058422|80391368|FG000|Overall Study|Not treated|2|||
27604140|NCT04934722|80391372|FG000|Overall Study|Death|4|||
27604141|NCT04934722|80391373|FG001|Overall Study|Death|3|||
27604142|NCT04934722|80391372|FG000|Overall Study|Participants Ongoing|88|||
27604143|NCT04934722|80391373|FG001|Overall Study|Participants Ongoing|91|||
27604144|NCT03010462|80391376|FG000|Overall Study|Withdrawal by Subject|3|||
27604145|NCT03010462|80391377|FG001|Overall Study|Withdrawal by Subject|1|||
27604146|NCT03386032|80391378|FG000|Overall Study|Lack of Efficacy|6|||
27604147|NCT03386032|80391379|FG001|Overall Study|Lack of Efficacy|2|||
27604148|NCT03386032|80391380|FG002|Overall Study|Lack of Efficacy|0|||
27604149|NCT03386032|80391378|FG000|Overall Study|Adverse Event|2|||
27604150|NCT03386032|80391379|FG001|Overall Study|Adverse Event|2|||
27604151|NCT03386032|80391380|FG002|Overall Study|Adverse Event|0|||
27604152|NCT03386032|80391378|FG000|Overall Study|Withdrawal by Subject|1|||
27604153|NCT03386032|80391379|FG001|Overall Study|Withdrawal by Subject|0|||
27604154|NCT03386032|80391380|FG002|Overall Study|Withdrawal by Subject|0|||
27604155|NCT03386032|80391378|FG000|Overall Study|Lost to Follow-up|9|||
27604156|NCT03386032|80391379|FG001|Overall Study|Lost to Follow-up|3|||
27604157|NCT03386032|80391380|FG002|Overall Study|Lost to Follow-up|0|||
27604158|NCT00437645|80391382|FG000|Overall Study|Adverse Event|15|||
27889505|NCT01895270|81430817|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
27889506|NCT01895270|81430818|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
27889507|NCT01273623|81430819|FG000|Overall Study|did not meet IVUS criteria|29|||
27604159|NCT00437645|80391383|FG001|Overall Study|Adverse Event|84|||
27604160|NCT00437645|80391382|FG000|Overall Study|Withdrawal by Subject|10|||
27604161|NCT00437645|80391383|FG001|Overall Study|Withdrawal by Subject|22|||
27604162|NCT00437645|80391382|FG000|Overall Study|Protocol Violation|3|||
27604163|NCT00437645|80391383|FG001|Overall Study|Protocol Violation|3|||
27604164|NCT00437645|80391382|FG000|Overall Study|Lost to Follow-up|2|||
27889508|NCT01931995|81430820|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
27604165|NCT00437645|80391383|FG001|Overall Study|Lost to Follow-up|3|||
27604166|NCT00437645|80391382|FG000|Overall Study|Administrative problems|2|||
27604167|NCT00437645|80391383|FG001|Overall Study|Administrative problems|1|||
27604168|NCT00437645|80391382|FG000|Overall Study|Lack of Efficacy|2|||
27604169|NCT00437645|80391383|FG001|Overall Study|Lack of Efficacy|1|||
27604170|NCT00437645|80391382|FG000|Overall Study|Condition no longer requires study drug|1|||
27604171|NCT00437645|80391383|FG001|Overall Study|Condition no longer requires study drug|1|||
27604172|NCT03928028|80391384|FG000|Overall Study|Physician Decision|9|||
27604173|NCT03928028|80391385|FG001|Overall Study|Physician Decision|6|||
27604174|NCT03928028|80391386|FG002|Overall Study|Physician Decision|3|||
27604175|NCT03928028|80391384|FG000|Overall Study|Withdrawal by Subject|12|||
27604176|NCT03928028|80391385|FG001|Overall Study|Withdrawal by Subject|3|||
27604177|NCT03928028|80391386|FG002|Overall Study|Withdrawal by Subject|3|||
27604178|NCT04810221|80391392|FG000|Overall Study|Physician Decision|3|||
27604179|NCT01201811|80391393|FG000|Overall Study|Adverse Event|6|||
27604180|NCT01201811|80391393|FG000|Overall Study|Disease progression|3|||
27604181|NCT01201811|80391393|FG000|Overall Study|Withdrawal by Subject|3|||
27604182|NCT01201811|80391393|FG000|Overall Study|Death|4|||
27604183|NCT01201811|80391393|FG000|Overall Study|Treatment Failure|2|||
27712201|NCT01692275|80779154|FG001|Overall Study|Lost to Follow-up|48|||
27712202|NCT01692275|80779153|FG000|Overall Study|Withdrawal by Subject|9|||
27712203|NCT01692275|80779154|FG001|Overall Study|Withdrawal by Subject|11|||
27604184|NCT01201811|80391393|FG000|Overall Study|Physician Decision|1|||
27712204|NCT00825162|80779157|FG000|Overall Study|Withdrawal by Subject|11|||
27712205|NCT00825162|80779158|FG001|Overall Study|Withdrawal by Subject|13|||
27604185|NCT03757234|80391394|FG000|Overall Study|Adverse Event|0|||
27604186|NCT03757234|80391395|FG001|Overall Study|Adverse Event|0|||
27604187|NCT03757234|80391396|FG002|Overall Study|Adverse Event|0|||
27604188|NCT03757234|80391397|FG003|Overall Study|Adverse Event|0|||
27604189|NCT03757234|80391398|FG004|Overall Study|Adverse Event|1|||
27604190|NCT03757234|80391394|FG000|Overall Study|Lost to Follow-up|1|||
27712206|NCT00825162|80779159|FG002|Overall Study|Withdrawal by Subject|3|||
27712207|NCT00825162|80779157|FG000|Overall Study|Lost to Follow-up|9|||
27604191|NCT03757234|80391395|FG001|Overall Study|Lost to Follow-up|0|||
27604192|NCT03757234|80391396|FG002|Overall Study|Lost to Follow-up|0|||
27604193|NCT03757234|80391397|FG003|Overall Study|Lost to Follow-up|0|||
27712208|NCT00825162|80779158|FG001|Overall Study|Lost to Follow-up|6|||
27712209|NCT00825162|80779159|FG002|Overall Study|Lost to Follow-up|3|||
27712210|NCT00825162|80779157|FG000|Overall Study|Physician Decision|2|||
27712211|NCT00825162|80779158|FG001|Overall Study|Physician Decision|0|||
27712212|NCT00825162|80779159|FG002|Overall Study|Physician Decision|0|||
27712213|NCT00825162|80779157|FG000|Overall Study|Move away from the study area|1|||
27712214|NCT00825162|80779158|FG001|Overall Study|Move away from the study area|0|||
27712215|NCT00825162|80779159|FG002|Overall Study|Move away from the study area|0|||
27712216|NCT00825162|80779157|FG000|Overall Study|Unable to attend the study visit|5|||
27712217|NCT00825162|80779158|FG001|Overall Study|Unable to attend the study visit|2|||
27712218|NCT00825162|80779159|FG002|Overall Study|Unable to attend the study visit|0|||
27712219|NCT04360551|80779160|FG000|Overall Study|Withdrawal by Subject|1|||
27712220|NCT04360551|80779161|FG001|Overall Study|Withdrawal by Subject|0|||
27712221|NCT04050982|80779162|FG000|Overall Study|Did not meet eligibility criteria|0|||
27712222|NCT04050982|80779163|FG001|Overall Study|Did not meet eligibility criteria|1|||
27712223|NCT04050982|80779164|FG002|Overall Study|Did not meet eligibility criteria|0|||
27712224|NCT04050982|80779162|FG000|Overall Study|Withdrawal by Subject|1|||
27712225|NCT04050982|80779163|FG001|Overall Study|Withdrawal by Subject|0|||
27712226|NCT04050982|80779164|FG002|Overall Study|Withdrawal by Subject|0|||
27712227|NCT04050982|80779162|FG000|Overall Study|Unable to enroll on platform|1|||
27712228|NCT04050982|80779163|FG001|Overall Study|Unable to enroll on platform|0|||
27712229|NCT04050982|80779164|FG002|Overall Study|Unable to enroll on platform|0|||
27712230|NCT00137111|80781813|FG000|Total Therapy|Death|35|||
27712231|NCT00137111|80781814|FG001|Total Therapy|Death|0|||
27712232|NCT00137111|80781815|FG002|Total Therapy|Death|0|||
27712233|NCT00137111|80781816|FG003|Total Therapy|Death|0|||
27712234|NCT00137111|80781813|FG000|Total Therapy|Non Compliance|5|||
27604194|NCT03757234|80391398|FG004|Overall Study|Lost to Follow-up|1|||
27604195|NCT03757234|80391394|FG000|Overall Study|Withdrawal by Subject|1|||
27604196|NCT03757234|80391395|FG001|Overall Study|Withdrawal by Subject|1|||
27604197|NCT03757234|80391396|FG002|Overall Study|Withdrawal by Subject|0|||
27604198|NCT03757234|80391397|FG003|Overall Study|Withdrawal by Subject|1|||
27604199|NCT03757234|80391398|FG004|Overall Study|Withdrawal by Subject|2|||
27604200|NCT03757234|80391394|FG000|Overall Study|Other|1|||
27712235|NCT00137111|80781814|FG001|Total Therapy|Non Compliance|0|||
27712236|NCT00137111|80781815|FG002|Total Therapy|Non Compliance|0|||
27712237|NCT00137111|80781816|FG003|Total Therapy|Non Compliance|0|||
27712238|NCT00573430|80781817|FG000|Overall Study|Incorrect enrollment of randomization|0|||
27712239|NCT00573430|80781818|FG001|Overall Study|Incorrect enrollment of randomization|4|||
27712240|NCT00573430|80781819|FG002|Overall Study|Incorrect enrollment of randomization|3|||
27712241|NCT00573430|80781817|FG000|Overall Study|Adverse Event|0|||
27712242|NCT00573430|80781818|FG001|Overall Study|Adverse Event|0|||
27712243|NCT00573430|80781819|FG002|Overall Study|Adverse Event|2|||
27712244|NCT00573430|80781817|FG000|Overall Study|Withdrawal by Subject|1|||
27712245|NCT00573430|80781818|FG001|Overall Study|Withdrawal by Subject|0|||
27712246|NCT00573430|80781819|FG002|Overall Study|Withdrawal by Subject|1|||
27712247|NCT00573430|80781817|FG000|Overall Study|Protocol Violation|0|||
27712248|NCT00573430|80781818|FG001|Overall Study|Protocol Violation|1|||
27712249|NCT00573430|80781819|FG002|Overall Study|Protocol Violation|1|||
27712250|NCT00573430|80781817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27712251|NCT00573430|80781818|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27712252|NCT00573430|80781819|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
27712253|NCT00473343|80781822|FG000|Overall Study|Adverse Event|9|||
27889509|NCT01931995|81430821|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
27889510|NCT01931995|81430820|FG000|First Intervention (1 Day)|Physician Decision|1|||
27712254|NCT00473343|80781822|FG000|Overall Study|Lost to Follow-up|8|||
27604201|NCT03757234|80391395|FG001|Overall Study|Other|1|||
27604202|NCT03757234|80391396|FG002|Overall Study|Other|0|||
27712255|NCT00473343|80781822|FG000|Overall Study|Treatment failure|27|||
27712256|NCT00473343|80781822|FG000|Overall Study|Withdrew consent|3|||
27712257|NCT00473343|80781822|FG000|Overall Study|Other un-specified reason|3|||
27604203|NCT03757234|80391397|FG003|Overall Study|Other|0|||
27712258|NCT04995055|80781829|FG000|Period 1|COVID-19 Related|1|||
27712259|NCT04995055|80781830|FG001|Period 1|COVID-19 Related|0|||
27712260|NCT04995055|80781829|FG000|Period 1|Withdrawal by Subject|0|||
27712261|NCT04995055|80781830|FG001|Period 1|Withdrawal by Subject|1|||
27712262|NCT04995055|80781829|FG000|Period 1|Subject discontinued due to timing|4|||
27712263|NCT04995055|80781830|FG001|Period 1|Subject discontinued due to timing|4|||
27712264|NCT03782376|80781831|FG000|Overall Study|Lost to Follow-up|2|||
27712265|NCT03782376|80781832|FG001|Overall Study|Lost to Follow-up|2|||
27712266|NCT03782376|80781831|FG000|Overall Study|Withdrawal by Subject|7|||
27712267|NCT03782376|80781832|FG001|Overall Study|Withdrawal by Subject|11|||
27712268|NCT03782376|80781831|FG000|Overall Study|Death|1|||
27712269|NCT03782376|80781832|FG001|Overall Study|Death|0|||
27712270|NCT03782376|80781831|FG000|Overall Study|Other|16|||
27712271|NCT03782376|80781832|FG001|Overall Study|Other|17|||
27712272|NCT05054114|80781838|FG000|Overall Study|Protocol Violation|13|||
27712273|NCT05054114|80781839|FG001|Overall Study|Protocol Violation|1|||
27712274|NCT05054114|80781838|FG000|Overall Study|Pregnancy|0|||
27712275|NCT05054114|80781839|FG001|Overall Study|Pregnancy|1|||
27712276|NCT00971178|80781840|FG000|Overall Study|Lost to Follow-up|2|||
27712277|NCT00971178|80781841|FG001|Overall Study|Lost to Follow-up|2|||
27712278|NCT00971178|80781842|FG002|Overall Study|Lost to Follow-up|2|||
27712279|NCT01761292|80781843|FG000|Part 1|Adverse Event|1|||
27712280|NCT01761292|80781843|FG000|Part 1|not receiving treatment in Part 1|1|||
27712281|NCT01761292|80781843|FG000|Extension 1|Withdrawal by Subject|1|||
27712282|NCT01250379|80781844|FG000|Overall Study|Death|141|||
27712283|NCT01250379|80781845|FG001|Overall Study|Death|148|||
27712284|NCT01250379|80781844|FG000|Overall Study|Withdrawal by Subject|32|||
27712285|NCT01250379|80781845|FG001|Overall Study|Withdrawal by Subject|20|||
27712286|NCT01250379|80781844|FG000|Overall Study|Physician Decision|11|||
27712287|NCT01250379|80781845|FG001|Overall Study|Physician Decision|3|||
27712288|NCT01250379|80781844|FG000|Overall Study|Protocol Violation|2|||
27712289|NCT01250379|80781845|FG001|Overall Study|Protocol Violation|8|||
27712290|NCT01250379|80781844|FG000|Overall Study|Lost to Follow-up|9|||
27712291|NCT01250379|80781845|FG001|Overall Study|Lost to Follow-up|6|||
27712292|NCT01250379|80781844|FG000|Overall Study|Adverse Event|5|||
27712293|NCT01250379|80781845|FG001|Overall Study|Adverse Event|4|||
27712294|NCT01250379|80781844|FG000|Overall Study|Other|0|||
27712295|NCT01250379|80781845|FG001|Overall Study|Other|4|||
27712296|NCT01250379|80781844|FG000|Overall Study|Participant noncompliance|2|||
27712297|NCT01250379|80781845|FG001|Overall Study|Participant noncompliance|0|||
27712298|NCT00562588|80781846|FG000|Overall Study|Adverse Event|40|||
27712299|NCT00562588|80781847|FG001|Overall Study|Adverse Event|58|||
27712300|NCT00562588|80781846|FG000|Overall Study|Protocol Violation|30|||
27712301|NCT00562588|80781847|FG001|Overall Study|Protocol Violation|26|||
27712302|NCT00562588|80781846|FG000|Overall Study|Lost to Follow-up|12|||
27712303|NCT00562588|80781847|FG001|Overall Study|Lost to Follow-up|4|||
27712304|NCT00562588|80781846|FG000|Overall Study|Withdrawal by Subject|10|||
27712305|NCT00562588|80781847|FG001|Overall Study|Withdrawal by Subject|9|||
27712306|NCT00562588|80781846|FG000|Overall Study|Other|0|||
27712307|NCT00562588|80781847|FG001|Overall Study|Other|2|||
27712308|NCT03703882|80781848|FG000|Overall Study|Adverse Event|1|||
27712309|NCT03703882|80781849|FG001|Overall Study|Adverse Event|0|||
27712310|NCT03703882|80781848|FG000|Overall Study|Lost to Follow-up|0|||
27712311|NCT03703882|80781849|FG001|Overall Study|Lost to Follow-up|2|||
27712312|NCT03703882|80781848|FG000|Overall Study|Non-compliance with study drug|0|||
27712313|NCT03703882|80781849|FG001|Overall Study|Non-compliance with study drug|1|||
27712314|NCT03703882|80781848|FG000|Overall Study|Physician Decision|0|||
27604204|NCT03757234|80391398|FG004|Overall Study|Other|0|||
27712315|NCT03703882|80781849|FG001|Overall Study|Physician Decision|1|||
27712316|NCT03703882|80781848|FG000|Overall Study|Progressive disease|1|||
27712317|NCT03703882|80781849|FG001|Overall Study|Progressive disease|0|||
27604205|NCT00746096|80391399|FG000|Overall Study|Adverse Event|1|||
27604206|NCT00746096|80391400|FG001|Overall Study|Adverse Event|0|||
27712318|NCT03703882|80781848|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27712319|NCT03703882|80781849|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27712320|NCT03703882|80781848|FG000|Overall Study|Starting another treatment|0|||
27712321|NCT03703882|80781849|FG001|Overall Study|Starting another treatment|1|||
27712322|NCT03703882|80781848|FG000|Overall Study|noncompliance with study procedures|0|||
27712323|NCT03703882|80781849|FG001|Overall Study|noncompliance with study procedures|1|||
27712324|NCT03363321|80781850|FG000|Overall Study|Withdrawal by Subject|0|||
27712325|NCT03363321|80781851|FG001|Overall Study|Withdrawal by Subject|1|||
27712326|NCT03363321|80781852|FG002|Overall Study|Withdrawal by Subject|0|||
27604207|NCT00746096|80391399|FG000|Overall Study|Withdrawal by Subject|5|||
27712327|NCT03363321|80781853|FG003|Overall Study|Withdrawal by Subject|1|||
27712328|NCT03363321|80781854|FG004|Overall Study|Withdrawal by Subject|0|||
27712329|NCT02411539|80781857|FG000|Overall Study|Lost to Follow-up|2|||
27712330|NCT02411539|80781858|FG001|Overall Study|Lost to Follow-up|0|||
27712331|NCT02411539|80781857|FG000|Overall Study|Confounding medical condition|0|||
27712332|NCT02411539|80781858|FG001|Overall Study|Confounding medical condition|1|||
27712333|NCT00885703|80781863|FG000|Overall Study|Death|9|||
27712334|NCT00885703|80781864|FG001|Overall Study|Death|7|||
27712335|NCT00885703|80781865|FG002|Overall Study|Death|8|||
27712336|NCT00885703|80781866|FG003|Overall Study|Death|7|||
27604208|NCT00746096|80391400|FG001|Overall Study|Withdrawal by Subject|1|||
27604209|NCT00746096|80391399|FG000|Overall Study|Lost to Follow-up|2|||
27604210|NCT00746096|80391400|FG001|Overall Study|Lost to Follow-up|1|||
27604211|NCT00746096|80391399|FG000|Overall Study|Protocol Violation|1|||
27604212|NCT00746096|80391400|FG001|Overall Study|Protocol Violation|0|||
27604213|NCT00746096|80391399|FG000|Overall Study|No study drug treatment|1|||
27604214|NCT00746096|80391400|FG001|Overall Study|No study drug treatment|1|||
27604215|NCT03108157|80391401|FG000|Overall Study|Protocol Violation|15|||
27604216|NCT03108157|80391402|FG001|Overall Study|Protocol Violation|4|||
27604217|NCT02404389|80391407|FG000|Overall Study|Adverse Event|1|||
27604218|NCT02404389|80391408|FG001|Overall Study|Adverse Event|0|||
27604219|NCT02404389|80391409|FG002|Overall Study|Adverse Event|1|||
27604220|NCT02404389|80391410|FG003|Overall Study|Adverse Event|0|||
27604221|NCT02404389|80391411|FG004|Overall Study|Adverse Event|2|||
27604222|NCT02404389|80391407|FG000|Overall Study|Subject/guardian decision|1|||
27604223|NCT02404389|80391408|FG001|Overall Study|Subject/guardian decision|0|||
27604224|NCT02404389|80391409|FG002|Overall Study|Subject/guardian decision|0|||
27604225|NCT02404389|80391410|FG003|Overall Study|Subject/guardian decision|1|||
27604226|NCT02404389|80391411|FG004|Overall Study|Subject/guardian decision|1|||
27604227|NCT00110890|80391412|FG000|Overall Study|Adverse Event|30|||
27604228|NCT00110890|80391413|FG001|Overall Study|Adverse Event|7|||
27604229|NCT00110890|80391412|FG000|Overall Study|Death|16|||
27604230|NCT00110890|80391413|FG001|Overall Study|Death|9|||
27604231|NCT00110890|80391412|FG000|Overall Study|Lost to Follow-up|3|||
27604232|NCT00110890|80391413|FG001|Overall Study|Lost to Follow-up|1|||
27604233|NCT00110890|80391412|FG000|Overall Study|Physician Decision|4|||
27604234|NCT00110890|80391413|FG001|Overall Study|Physician Decision|5|||
27604235|NCT00110890|80391412|FG000|Overall Study|Withdrawal by Subject|17|||
27604236|NCT00110890|80391413|FG001|Overall Study|Withdrawal by Subject|5|||
27604237|NCT00110890|80391412|FG000|Overall Study|Protocol Deviation|1|||
27604238|NCT00110890|80391413|FG001|Overall Study|Protocol Deviation|0|||
27604239|NCT00110890|80391412|FG000|Overall Study|Noncompliance|10|||
27604240|NCT00110890|80391413|FG001|Overall Study|Noncompliance|0|||
27604241|NCT00110890|80391412|FG000|Overall Study|Kidney Transplant|16|||
27604242|NCT00110890|80391413|FG001|Overall Study|Kidney Transplant|12|||
27604243|NCT00110890|80391412|FG000|Overall Study|Invest. Product Commercially Available|217|||
27604244|NCT00110890|80391413|FG001|Overall Study|Invest. Product Commercially Available|110|||
27604245|NCT00110890|80391412|FG000|Overall Study|Other|34|||
27712337|NCT00885703|80781867|FG004|Overall Study|Death|7|||
27712338|NCT00885703|80781868|FG005|Overall Study|Death|8|||
27712339|NCT00885703|80781869|FG006|Overall Study|Death|4|||
27712340|NCT00885703|80781863|FG000|Overall Study|Lost to Follow-up|0|||
27604246|NCT00110890|80391413|FG001|Overall Study|Other|23|||
27604247|NCT00110890|80391412|FG000|Overall Study|Ineligibility determined|3|||
27604248|NCT00110890|80391413|FG001|Overall Study|Ineligibility determined|0|||
27604249|NCT00110890|80391412|FG000|Overall Study|Requirement for alternative therapy|0|||
27604250|NCT00110890|80391413|FG001|Overall Study|Requirement for alternative therapy|1|||
27712341|NCT00885703|80781864|FG001|Overall Study|Lost to Follow-up|0|||
27604251|NCT00110890|80391412|FG000|Overall Study|Disease progression|0|||
27604252|NCT00110890|80391413|FG001|Overall Study|Disease progression|1|||
27604253|NCT00110890|80391412|FG000|Overall Study|Parathyroidectomy|0|||
27604254|NCT00110890|80391413|FG001|Overall Study|Parathyroidectomy|1|||
27604255|NCT00110890|80391412|FG000|Overall Study|Did not enter follow-up phase|10|||
27712342|NCT00885703|80781865|FG002|Overall Study|Lost to Follow-up|1|||
27712343|NCT00885703|80781866|FG003|Overall Study|Lost to Follow-up|0|||
27712344|NCT00885703|80781867|FG004|Overall Study|Lost to Follow-up|0|||
27712345|NCT00885703|80781868|FG005|Overall Study|Lost to Follow-up|1|||
27712346|NCT00885703|80781869|FG006|Overall Study|Lost to Follow-up|0|||
27712347|NCT00885703|80781863|FG000|Overall Study|Withdrawal by Subject|0|||
27712348|NCT00885703|80781864|FG001|Overall Study|Withdrawal by Subject|0|||
27712349|NCT00885703|80781865|FG002|Overall Study|Withdrawal by Subject|0|||
27712350|NCT00885703|80781866|FG003|Overall Study|Withdrawal by Subject|1|||
27712351|NCT00885703|80781867|FG004|Overall Study|Withdrawal by Subject|3|||
27712352|NCT00885703|80781868|FG005|Overall Study|Withdrawal by Subject|1|||
27712353|NCT00885703|80781869|FG006|Overall Study|Withdrawal by Subject|1|||
27712354|NCT00885703|80781863|FG000|Overall Study|Ineligible (no CM)|1|||
27712355|NCT00885703|80781864|FG001|Overall Study|Ineligible (no CM)|3|||
27712356|NCT00885703|80781865|FG002|Overall Study|Ineligible (no CM)|2|||
27712357|NCT00885703|80781866|FG003|Overall Study|Ineligible (no CM)|1|||
27712358|NCT00885703|80781867|FG004|Overall Study|Ineligible (no CM)|2|||
27712359|NCT00885703|80781868|FG005|Overall Study|Ineligible (no CM)|3|||
27712360|NCT00885703|80781869|FG006|Overall Study|Ineligible (no CM)|1|||
27712361|NCT00886600|80781870|FG000|Double-blind Monotherapy|Adverse Event|1|||
27712362|NCT00886600|80781871|FG001|Double-blind Monotherapy|Adverse Event|1|||
27712363|NCT00886600|80781872|FG002|Double-blind Monotherapy|Adverse Event|1|||
27712364|NCT00886600|80781873|FG003|Double-blind Monotherapy|Adverse Event|1|||
27712365|NCT00886600|80781870|FG000|Double-blind Monotherapy|Protocol Violation|0|||
27712366|NCT00886600|80781871|FG001|Double-blind Monotherapy|Protocol Violation|0|||
27712367|NCT00886600|80781872|FG002|Double-blind Monotherapy|Protocol Violation|0|||
27712368|NCT00886600|80781873|FG003|Double-blind Monotherapy|Protocol Violation|1|||
27712369|NCT00886600|80781870|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
27712370|NCT00886600|80781871|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
27712371|NCT00886600|80781872|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
27712372|NCT00886600|80781873|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
27712373|NCT00886600|80781870|FG000|Combination Therapy Period|Adverse Event|0|||
27712374|NCT00886600|80781871|FG001|Combination Therapy Period|Adverse Event|0|||
27712375|NCT00886600|80781872|FG002|Combination Therapy Period|Adverse Event|1|||
27712376|NCT00886600|80781873|FG003|Combination Therapy Period|Adverse Event|0|||
27712377|NCT00886600|80781870|FG000|Combination Therapy Period|Protocol Violation|0|||
27712378|NCT00886600|80781871|FG001|Combination Therapy Period|Protocol Violation|0|||
27712379|NCT00886600|80781872|FG002|Combination Therapy Period|Protocol Violation|1|||
27712380|NCT00886600|80781873|FG003|Combination Therapy Period|Protocol Violation|0|||
27712381|NCT01347554|80781874|FG000|Overall Study|Lack of Efficacy|7|||
27712382|NCT01347554|80781875|FG001|Overall Study|Lack of Efficacy|11|||
27712383|NCT00563186|80781882|FG000|Overall Study|LOS<48 hours|97|||
27712384|NCT00563186|80781883|FG001|Overall Study|LOS<48 hours|74|||
27889511|NCT01931995|81430821|FG001|First Intervention (1 Day)|Physician Decision|1|||
27712385|NCT00563186|80781882|FG000|Overall Study|Incomplete data|1|||
27712386|NCT00563186|80781883|FG001|Overall Study|Incomplete data|1|||
27712387|NCT03681119|80781884|FG000|Overall Study|No specific reason|4|||
27712388|NCT03681119|80781885|FG001|Overall Study|No specific reason|0|||
27712389|NCT03681119|80781884|FG000|Overall Study|Sickness|2|||
27712390|NCT03681119|80781885|FG001|Overall Study|Sickness|0|||
27712391|NCT01097746|80781886|FG000|Overall Study|Adverse Event|4|||
27712392|NCT01097746|80781886|FG000|Overall Study|taken off study before any treatment given|1|||
27712393|NCT01970501|80781890|FG000|Overall Study|Discontinuation of study by sponsor|16|||
27712394|NCT01970501|80781891|FG001|Overall Study|Discontinuation of study by sponsor|14|||
27712395|NCT01970501|80781890|FG000|Overall Study|Withdrawal by Subject|6|||
27712396|NCT01970501|80781891|FG001|Overall Study|Withdrawal by Subject|7|||
27712397|NCT01970501|80781890|FG000|Overall Study|Adverse Event|2|||
27712398|NCT01970501|80781891|FG001|Overall Study|Adverse Event|4|||
27712399|NCT01970501|80781890|FG000|Overall Study|Death|1|||
27712400|NCT01970501|80781891|FG001|Overall Study|Death|3|||
27712401|NCT01970501|80781890|FG000|Overall Study|Physician Decision|2|||
27712402|NCT01970501|80781891|FG001|Overall Study|Physician Decision|0|||
27712403|NCT02898259|80781893|FG000|Overall Study|Adverse Event|0|||
27712404|NCT02898259|80781894|FG001|Overall Study|Adverse Event|0|||
27712405|NCT02898259|80781895|FG002|Overall Study|Adverse Event|1|||
27712406|NCT02898259|80781896|FG003|Overall Study|Adverse Event|0|||
27712407|NCT02898259|80781897|FG004|Overall Study|Adverse Event|0|||
27712408|NCT02898259|80781893|FG000|Overall Study|Lack of Efficacy|1|||
27604256|NCT00110890|80391413|FG001|Overall Study|Did not enter follow-up phase|4|||
27604257|NCT01931735|80391414|FG000|Randomized Phase|Lost to Follow-up|2|||
27604258|NCT01931735|80391415|FG001|Randomized Phase|Lost to Follow-up|2|||
27712409|NCT02898259|80781894|FG001|Overall Study|Lack of Efficacy|1|||
27712410|NCT02898259|80781895|FG002|Overall Study|Lack of Efficacy|3|||
27712411|NCT02898259|80781896|FG003|Overall Study|Lack of Efficacy|0|||
27712412|NCT02898259|80781897|FG004|Overall Study|Lack of Efficacy|0|||
27712413|NCT02898259|80781893|FG000|Overall Study|Lost to Follow-up|0|||
27712414|NCT02898259|80781894|FG001|Overall Study|Lost to Follow-up|0|||
27712415|NCT02898259|80781895|FG002|Overall Study|Lost to Follow-up|1|||
27712416|NCT02898259|80781896|FG003|Overall Study|Lost to Follow-up|0|||
27712417|NCT02898259|80781897|FG004|Overall Study|Lost to Follow-up|0|||
27712418|NCT02898259|80781893|FG000|Overall Study|Transformation before study began|0|||
27604259|NCT01931735|80391416|FG002|Randomized Phase|Lost to Follow-up|5|||
27712419|NCT02898259|80781894|FG001|Overall Study|Transformation before study began|0|||
27712420|NCT02898259|80781895|FG002|Overall Study|Transformation before study began|0|||
27712421|NCT02898259|80781896|FG003|Overall Study|Transformation before study began|1|||
27712422|NCT02898259|80781897|FG004|Overall Study|Transformation before study began|0|||
27712423|NCT01417195|80781898|FG000|Overall Study|Stimulation failure|1|||
27712424|NCT01417195|80781899|FG001|Overall Study|Stimulation failure|0|||
27712425|NCT01417195|80781898|FG000|Overall Study|No embryos for transfer|0|||
27712426|NCT01417195|80781899|FG001|Overall Study|No embryos for transfer|1|||
27712427|NCT01417195|80781898|FG000|Overall Study|No transfer due to risk of OHSS|1|||
27712428|NCT01417195|80781899|FG001|Overall Study|No transfer due to risk of OHSS|0|||
27712429|NCT01417195|80781898|FG000|Overall Study|No transfer due to elevated progesterone|1|||
27712430|NCT01417195|80781899|FG001|Overall Study|No transfer due to elevated progesterone|0|||
27712431|NCT01765920|80781907|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
27712432|NCT01765920|80781908|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
27712433|NCT01765920|80781907|FG000|Overall Study|Patient code disclosure|0|||
27712434|NCT01765920|80781908|FG001|Overall Study|Patient code disclosure|1|||
27712435|NCT02199080|80781909|FG000|Overall Study|Protocol Violation|12|||
27712436|NCT01181011|80781910|FG000|Overall Study|Adverse Event|2|||
27712437|NCT01181011|80781910|FG000|Overall Study|Lost to Follow-up|1|||
27712438|NCT00545064|80781913|FG000|Overall Study|Lost to Follow-up|3|||
27712439|NCT00545064|80781913|FG000|Overall Study|Withdrawal by Subject|2|||
27712440|NCT00545064|80781913|FG000|Overall Study|did not complete course of treatment|1|||
27712441|NCT00545064|80781913|FG000|Overall Study|cancel all appointments, no rebooking|1|||
27712442|NCT00545064|80781913|FG000|Overall Study|inclement weather|1|||
27712443|NCT00794677|80781914|FG000|First Intervention|Withdrawal by Subject|2|||
27712444|NCT00794677|80781915|FG001|First Intervention|Withdrawal by Subject|0|||
27712445|NCT02813694|80781922|FG000|Overall Study|Physician Decision|0|||
27712446|NCT02813694|80781923|FG001|Overall Study|Physician Decision|1|||
27712447|NCT02813694|80781922|FG000|Overall Study|Withdrawal by Subject|10|||
27712448|NCT02813694|80781923|FG001|Overall Study|Withdrawal by Subject|9|||
27712449|NCT02813694|80781922|FG000|Overall Study|Lost to Follow-up|1|||
27712450|NCT02813694|80781923|FG001|Overall Study|Lost to Follow-up|1|||
27712451|NCT02813694|80781922|FG000|Overall Study|Death|3|||
27712452|NCT02813694|80781923|FG001|Overall Study|Death|3|||
27712453|NCT02813694|80781922|FG000|Overall Study|Randomized- did not receive study drug|2|||
27712454|NCT02813694|80781923|FG001|Overall Study|Randomized- did not receive study drug|0|||
27712455|NCT02813694|80781922|FG000|Overall Study|Patient hospitalized|1|||
27604260|NCT01931735|80391417|FG003|Randomized Phase|Lost to Follow-up|0|||
27604261|NCT01931735|80391414|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
27604262|NCT01931735|80391415|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
27604263|NCT01931735|80391416|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
27604264|NCT01931735|80391417|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
27604265|NCT01931735|80391414|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
27604266|NCT01931735|80391415|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
27604267|NCT01931735|80391416|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
27604268|NCT01931735|80391417|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
27604269|NCT01892345|80391418|FG000|Overall Study|Adverse Event|0|||
27604270|NCT01892345|80391419|FG001|Overall Study|Adverse Event|2|||
27604271|NCT01892345|80391418|FG000|Overall Study|Death|1|||
27604272|NCT01892345|80391419|FG001|Overall Study|Death|0|||
27604273|NCT01892345|80391418|FG000|Overall Study|Lost to Follow-up|3|||
27604274|NCT01892345|80391419|FG001|Overall Study|Lost to Follow-up|0|||
27604275|NCT01892345|80391418|FG000|Overall Study|Withdrawal by Subject|12|||
27604276|NCT01892345|80391419|FG001|Overall Study|Withdrawal by Subject|1|||
27604277|NCT05178121|80391422|FG000|Overall Study|Other|4|||
27604278|NCT05178121|80391422|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
27604279|NCT00384059|80391429|FG000|Infant Series|Not consented|2|||
27604280|NCT00384059|80391430|FG001|Infant Series|Not consented|6|||
27712456|NCT02813694|80781923|FG001|Overall Study|Patient hospitalized|0|||
27712457|NCT02256540|80781924|FG000|Overall Study|Withdrawal by Subject|0|||
27712458|NCT02256540|80781925|FG001|Overall Study|Withdrawal by Subject|1|||
27712459|NCT02256540|80781926|FG002|Overall Study|Withdrawal by Subject|1|||
27712460|NCT02256540|80781924|FG000|Overall Study|Back pain preventing exercise|0|||
27712461|NCT02256540|80781925|FG001|Overall Study|Back pain preventing exercise|0|||
27712462|NCT02256540|80781926|FG002|Overall Study|Back pain preventing exercise|1|||
27712463|NCT01278745|80781927|FG000|Overall Study|Death|2|||
27712464|NCT01278745|80781928|FG001|Overall Study|Death|5|||
27712465|NCT01278745|80781929|FG002|Overall Study|Death|7|||
27712466|NCT01278745|80781930|FG003|Overall Study|Death|0|||
27712467|NCT01278745|80781927|FG000|Overall Study|Physician Decision|1|||
27712468|NCT01278745|80781928|FG001|Overall Study|Physician Decision|0|||
27604281|NCT00384059|80391429|FG000|Infant Series|Withdrawal by Subject|2|||
27604282|NCT00384059|80391430|FG001|Infant Series|Withdrawal by Subject|2|||
27604283|NCT00384059|80391429|FG000|Infant Series|Adverse Event|1|||
27604284|NCT00384059|80391430|FG001|Infant Series|Adverse Event|2|||
27712469|NCT01278745|80781929|FG002|Overall Study|Physician Decision|0|||
27712470|NCT01278745|80781930|FG003|Overall Study|Physician Decision|9|||
27712471|NCT01278745|80781927|FG000|Overall Study|Withdrawal by Subject|1|||
27712472|NCT01278745|80781928|FG001|Overall Study|Withdrawal by Subject|1|||
27712473|NCT01278745|80781929|FG002|Overall Study|Withdrawal by Subject|5|||
27604285|NCT00384059|80391429|FG000|Infant Series|Protocol Violation|1|||
27712474|NCT01278745|80781930|FG003|Overall Study|Withdrawal by Subject|1|||
27712475|NCT01278745|80781927|FG000|Overall Study|Sponsor Decision|1|||
27712476|NCT01278745|80781928|FG001|Overall Study|Sponsor Decision|0|||
27712477|NCT01278745|80781929|FG002|Overall Study|Sponsor Decision|62|||
27712478|NCT01278745|80781930|FG003|Overall Study|Sponsor Decision|6|||
27712479|NCT01278745|80781927|FG000|Overall Study|Ineligible|0|||
27604286|NCT00384059|80391430|FG001|Infant Series|Protocol Violation|2|||
27604287|NCT00384059|80391429|FG000|Infant Series|Lost to Follow-up|0|||
27712480|NCT01278745|80781928|FG001|Overall Study|Ineligible|0|||
27712481|NCT01278745|80781929|FG002|Overall Study|Ineligible|42|||
27712482|NCT01278745|80781930|FG003|Overall Study|Ineligible|61|||
27836890|NCT01451541|81232926|FG002|Overall Study|randomization error, noncompliance|8|||
27604288|NCT00384059|80391430|FG001|Infant Series|Lost to Follow-up|1|||
27836891|NCT01929681|81232927|FG000|Overall Study|Withdrawal by Subject|1|||
27836892|NCT01929681|81232928|FG001|Overall Study|Withdrawal by Subject|0|||
27604289|NCT00384059|80391429|FG000|After Infant Series|Protocol Violation|2|||
27604290|NCT00384059|80391430|FG001|After Infant Series|Protocol Violation|3|||
27604291|NCT00384059|80391429|FG000|After Infant Series|Withdrawal by Subject|2|||
27604292|NCT00384059|80391430|FG001|After Infant Series|Withdrawal by Subject|2|||
27604293|NCT00384059|80391429|FG000|After Infant Series|Failed to Return|0|||
27604294|NCT00384059|80391430|FG001|After Infant Series|Failed to Return|2|||
27604295|NCT00384059|80391429|FG000|After Infant Series|Adverse Event|0|||
27604296|NCT00384059|80391430|FG001|After Infant Series|Adverse Event|1|||
27604297|NCT00384059|80391429|FG000|After Infant Series|Physician Decision|0|||
27836893|NCT01929681|81232927|FG000|Overall Study|Physician Decision|1|||
27836894|NCT01929681|81232928|FG001|Overall Study|Physician Decision|1|||
27836895|NCT01896934|81232931|FG000|Overall Study|Adverse Event|1|||
27604298|NCT00384059|80391430|FG001|After Infant Series|Physician Decision|1|||
27604299|NCT00384059|80391429|FG000|After Infant Series|Lost to Follow-up|0|||
27836896|NCT01896934|81232931|FG000|Overall Study|Withdrawal by Subject|1|||
27836897|NCT01567527|81232932|FG000|Conversion Phase.|Protocol deviation|3|||
27604300|NCT00384059|80391430|FG001|After Infant Series|Lost to Follow-up|1|||
27836898|NCT01567527|81232933|FG001|Conversion Phase.|Protocol deviation|0|||
27836899|NCT01567527|81232934|FG002|Conversion Phase.|Protocol deviation|0|||
27836900|NCT01567527|81232935|FG003|Conversion Phase.|Protocol deviation|0|||
27836901|NCT01567527|81232936|FG004|Conversion Phase.|Protocol deviation|0|||
27836902|NCT01567527|81232932|FG000|Conversion Phase.|Met withdrawal criteria|10|||
27836903|NCT01567527|81232933|FG001|Conversion Phase.|Met withdrawal criteria|0|||
27836904|NCT01567527|81232934|FG002|Conversion Phase.|Met withdrawal criteria|0|||
27836905|NCT01567527|81232935|FG003|Conversion Phase.|Met withdrawal criteria|0|||
27836906|NCT01567527|81232936|FG004|Conversion Phase.|Met withdrawal criteria|0|||
27836907|NCT01567527|81232932|FG000|Conversion Phase.|Withdrawal by Subject|32|||
27836908|NCT01567527|81232933|FG001|Conversion Phase.|Withdrawal by Subject|0|||
27836909|NCT01567527|81232934|FG002|Conversion Phase.|Withdrawal by Subject|0|||
27712483|NCT01278745|80781927|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
27836910|NCT01567527|81232935|FG003|Conversion Phase.|Withdrawal by Subject|0|||
27712484|NCT01278745|80781928|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
27712485|NCT01278745|80781929|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
27712486|NCT01278745|80781930|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
27712487|NCT02300298|80781933|FG000|Disposition for Nintedanib|Progressive disease|10|||
27712488|NCT02300298|80781934|FG001|Disposition for Nintedanib|Progressive disease|0|||
27712489|NCT02300298|80781933|FG000|Disposition for Docetaxel|Progressive disease|0|||
27712490|NCT02300298|80781934|FG001|Disposition for Docetaxel|Progressive disease|6|||
27712491|NCT02300298|80781933|FG000|Disposition for Docetaxel|other adverse event|0|||
27712492|NCT02300298|80781934|FG001|Disposition for Docetaxel|other adverse event|4|||
27712493|NCT00066703|80781935|FG000|Overall Study|Adverse Event|80|||
27712494|NCT00066703|80781936|FG001|Overall Study|Adverse Event|111|||
27712495|NCT00066703|80781935|FG000|Overall Study|Death|3|||
27712496|NCT00066703|80781936|FG001|Overall Study|Death|0|||
27712497|NCT00066703|80781935|FG000|Overall Study|Lack of Efficacy|114|||
27712498|NCT00066703|80781936|FG001|Overall Study|Lack of Efficacy|69|||
27712499|NCT00066703|80781935|FG000|Overall Study|Lost to Follow-up|31|||
27712500|NCT00066703|80781936|FG001|Overall Study|Lost to Follow-up|28|||
27712501|NCT00066703|80781935|FG000|Overall Study|Withdrawal by Subject|38|||
27712502|NCT00066703|80781936|FG001|Overall Study|Withdrawal by Subject|63|||
27712503|NCT00066703|80781935|FG000|Overall Study|Treatment ongoing|346|||
27712504|NCT00066703|80781936|FG001|Overall Study|Treatment ongoing|311|||
27712505|NCT03201458|80781937|FG000|Overall Study|No longer eligible|2|||
27712506|NCT03201458|80781938|FG001|Overall Study|No longer eligible|5|||
27836911|NCT01567527|81232936|FG004|Conversion Phase.|Withdrawal by Subject|0|||
27836912|NCT01567527|81232932|FG000|Conversion Phase.|Lost to Follow-up|16|||
27836913|NCT01567527|81232933|FG001|Conversion Phase.|Lost to Follow-up|0|||
27712507|NCT03201458|80781937|FG000|Overall Study|Health event before starting|1|||
27712508|NCT03201458|80781938|FG001|Overall Study|Health event before starting|0|||
27712509|NCT03201458|80781937|FG000|Overall Study|Physician Decision|1|||
27712510|NCT03201458|80781938|FG001|Overall Study|Physician Decision|0|||
27712511|NCT00271817|80781939|FG000|Part 1|Adverse Event|68|||
27712512|NCT00271817|80781940|FG001|Part 1|Adverse Event|25|||
27712513|NCT00271817|80781941|FG002|Part 1|Adverse Event|156|||
27712514|NCT00271817|80781939|FG000|Part 1|Lost to Follow-up|6|||
27712515|NCT00271817|80781940|FG001|Part 1|Lost to Follow-up|8|||
27712516|NCT00271817|80781941|FG002|Part 1|Lost to Follow-up|24|||
27712517|NCT00271817|80781939|FG000|Part 1|Protocol Violation|5|||
27712518|NCT00271817|80781940|FG001|Part 1|Protocol Violation|4|||
27712519|NCT00271817|80781941|FG002|Part 1|Protocol Violation|7|||
27712520|NCT00271817|80781939|FG000|Part 1|Patient Moved|3|||
27712521|NCT00271817|80781940|FG001|Part 1|Patient Moved|1|||
27712522|NCT00271817|80781941|FG002|Part 1|Patient Moved|5|||
27604301|NCT00384059|80391429|FG000|Toddler Dose|Lost to Follow-up|1|||
27712523|NCT00271817|80781939|FG000|Part 1|Withdrawal by Subject|23|||
27712524|NCT00271817|80781940|FG001|Part 1|Withdrawal by Subject|17|||
27712525|NCT00271817|80781941|FG002|Part 1|Withdrawal by Subject|45|||
27712526|NCT00271817|80781939|FG000|Part 1|LDL < 50 mg/dL|1|||
27712527|NCT00271817|80781940|FG001|Part 1|LDL < 50 mg/dL|4|||
27712528|NCT00271817|80781941|FG002|Part 1|LDL < 50 mg/dL|48|||
27712529|NCT00271817|80781939|FG000|Part 2|Adverse Event|0|||
27712530|NCT00271817|80781940|FG001|Part 2|Adverse Event|17|||
27712531|NCT00271817|80781941|FG002|Part 2|Adverse Event|33|||
27712532|NCT00271817|80781939|FG000|Part 2|Lack of Efficacy|0|||
27604302|NCT00384059|80391430|FG001|Toddler Dose|Lost to Follow-up|1|||
27604303|NCT00384059|80391429|FG000|Toddler Dose|Failed to return|0|||
27712533|NCT00271817|80781940|FG001|Part 2|Lack of Efficacy|1|||
27712534|NCT00271817|80781941|FG002|Part 2|Lack of Efficacy|6|||
27712535|NCT00271817|80781939|FG000|Part 2|Lost to Follow-up|0|||
27712536|NCT00271817|80781940|FG001|Part 2|Lost to Follow-up|6|||
27712537|NCT00271817|80781941|FG002|Part 2|Lost to Follow-up|18|||
27712538|NCT00271817|80781939|FG000|Part 2|Protocol Violation|0|||
27712539|NCT00271817|80781940|FG001|Part 2|Protocol Violation|3|||
27712540|NCT00271817|80781941|FG002|Part 2|Protocol Violation|5|||
27712541|NCT00271817|80781939|FG000|Part 2|Patient Moved|0|||
27712542|NCT00271817|80781940|FG001|Part 2|Patient Moved|0|||
27712543|NCT00271817|80781941|FG002|Part 2|Patient Moved|5|||
27712544|NCT00271817|80781939|FG000|Part 2|Withdrawal by Subject|0|||
27712545|NCT00271817|80781940|FG001|Part 2|Withdrawal by Subject|2|||
27712546|NCT00271817|80781941|FG002|Part 2|Withdrawal by Subject|13|||
27712547|NCT00271817|80781939|FG000|Part 2|LDL < 50 mg/dL|0|||
27712548|NCT00271817|80781940|FG001|Part 2|LDL < 50 mg/dL|3|||
27712549|NCT00271817|80781941|FG002|Part 2|LDL < 50 mg/dL|4|||
27604304|NCT00384059|80391430|FG001|Toddler Dose|Failed to return|1|||
27712550|NCT00794157|80781944|FG000|Overall Study|Adverse Event|4|||
27604305|NCT00838682|80391436|FG000|Overall Study|Lost to Follow-up|21|||
27712551|NCT00794157|80781945|FG001|Overall Study|Adverse Event|1|||
27712552|NCT00794157|80781946|FG002|Overall Study|Adverse Event|8|||
27712553|NCT00794157|80781944|FG000|Overall Study|Subject withdrew consent|2|||
27712554|NCT00794157|80781945|FG001|Overall Study|Subject withdrew consent|0|||
27712555|NCT00794157|80781946|FG002|Overall Study|Subject withdrew consent|3|||
27712556|NCT00794157|80781944|FG000|Overall Study|Lost to Follow-up|2|||
27712557|NCT00794157|80781945|FG001|Overall Study|Lost to Follow-up|0|||
27712558|NCT00794157|80781946|FG002|Overall Study|Lost to Follow-up|1|||
27604306|NCT00838682|80391437|FG001|Overall Study|Lost to Follow-up|14|||
27712559|NCT00794157|80781944|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27712560|NCT00794157|80781945|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27712561|NCT00794157|80781946|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27712562|NCT00794157|80781944|FG000|Overall Study|Administrative problems|1|||
27712563|NCT00794157|80781945|FG001|Overall Study|Administrative problems|7|||
27712564|NCT00794157|80781946|FG002|Overall Study|Administrative problems|4|||
27712565|NCT00794157|80781944|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27712566|NCT00794157|80781945|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27712567|NCT00794157|80781946|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27712568|NCT00794157|80781944|FG000|Overall Study|Protocol deviation|0|||
27712569|NCT00794157|80781945|FG001|Overall Study|Protocol deviation|1|||
27712570|NCT00794157|80781946|FG002|Overall Study|Protocol deviation|1|||
27712571|NCT00574288|80781947|FG000|Overall Study|Adverse Event|2|||
27712572|NCT00574288|80781948|FG001|Overall Study|Adverse Event|0|||
27712573|NCT00574288|80781949|FG002|Overall Study|Adverse Event|0|||
27712574|NCT00574288|80781950|FG003|Overall Study|Adverse Event|0|||
27712575|NCT00574288|80781951|FG004|Overall Study|Adverse Event|1|||
27712576|NCT00574288|80781952|FG005|Overall Study|Adverse Event|0|||
27889512|NCT01931995|81430820|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
27712577|NCT00574288|80781953|FG006|Overall Study|Adverse Event|0|||
27712578|NCT00574288|80781947|FG000|Overall Study|Death|0|||
27712579|NCT00574288|80781948|FG001|Overall Study|Death|0|||
27836914|NCT01567527|81232934|FG002|Conversion Phase.|Lost to Follow-up|0|||
27836915|NCT01567527|81232935|FG003|Conversion Phase.|Lost to Follow-up|0|||
27836916|NCT01567527|81232936|FG004|Conversion Phase.|Lost to Follow-up|0|||
27836917|NCT01567527|81232932|FG000|Conversion Phase.|Lack of Efficacy|2|||
27836918|NCT01567527|81232933|FG001|Conversion Phase.|Lack of Efficacy|0|||
27836919|NCT01567527|81232934|FG002|Conversion Phase.|Lack of Efficacy|0|||
27712580|NCT00574288|80781949|FG002|Overall Study|Death|0|||
27712581|NCT00574288|80781950|FG003|Overall Study|Death|0|||
27712582|NCT00574288|80781951|FG004|Overall Study|Death|0|||
27712583|NCT00574288|80781952|FG005|Overall Study|Death|25|||
27712584|NCT00574288|80781953|FG006|Overall Study|Death|21|||
27712585|NCT00574288|80781947|FG000|Overall Study|Lost to Follow-up|0|||
27712586|NCT00574288|80781948|FG001|Overall Study|Lost to Follow-up|0|||
27712587|NCT00574288|80781949|FG002|Overall Study|Lost to Follow-up|0|||
27712588|NCT00574288|80781950|FG003|Overall Study|Lost to Follow-up|0|||
27712589|NCT00574288|80781951|FG004|Overall Study|Lost to Follow-up|0|||
27712590|NCT00574288|80781952|FG005|Overall Study|Lost to Follow-up|1|||
27836920|NCT01567527|81232935|FG003|Conversion Phase.|Lack of Efficacy|0|||
27836921|NCT01567527|81232936|FG004|Conversion Phase.|Lack of Efficacy|0|||
27836922|NCT01567527|81232932|FG000|Conversion Phase.|Adverse Event|33|||
27836923|NCT01567527|81232933|FG001|Conversion Phase.|Adverse Event|0|||
27712591|NCT00574288|80781953|FG006|Overall Study|Lost to Follow-up|2|||
27712592|NCT00574288|80781947|FG000|Overall Study|Study Terminated By Sponsor|0|||
27836924|NCT01567527|81232934|FG002|Conversion Phase.|Adverse Event|0|||
27836925|NCT01567527|81232935|FG003|Conversion Phase.|Adverse Event|0|||
27836926|NCT01567527|81232936|FG004|Conversion Phase.|Adverse Event|0|||
27836927|NCT01567527|81232932|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
27836928|NCT01567527|81232933|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
27836929|NCT01567527|81232934|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
27836930|NCT01567527|81232935|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
27836931|NCT01567527|81232936|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
27836932|NCT01567527|81232932|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27836933|NCT01567527|81232933|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
27836934|NCT01567527|81232934|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27836935|NCT01567527|81232935|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27604307|NCT00838682|80391436|FG000|Overall Study|detection of exclusion criteria|4|||
27604308|NCT00838682|80391437|FG001|Overall Study|detection of exclusion criteria|3|||
27604309|NCT00838682|80391436|FG000|Overall Study|Protocol Violation|0|||
27604310|NCT00838682|80391437|FG001|Overall Study|Protocol Violation|1|||
27604311|NCT00838682|80391436|FG000|Overall Study|Withdrawal by Subject|0|||
27604312|NCT00838682|80391437|FG001|Overall Study|Withdrawal by Subject|1|||
27604313|NCT01521884|80391438|FG000|Overall Study|Non Responders|10|||
27604314|NCT01521884|80391438|FG000|Overall Study|Adverse Event|5|||
27604315|NCT01521884|80391438|FG000|Overall Study|Pregnancy|1|||
27604316|NCT01521884|80391438|FG000|Overall Study|Withdrawal by Subject|1|||
27604317|NCT01521884|80391438|FG000|Overall Study|Physician Decision|2|||
27604318|NCT01521884|80391438|FG000|Overall Study|Protocol Violation|3|||
27604319|NCT01521884|80391438|FG000|Overall Study|Participant non-eligible|1|||
27604320|NCT01521884|80391438|FG000|Overall Study|Lost to Follow-up|4|||
27604321|NCT04539821|80391439|FG000|Overall Study|Withdrawal by Subject|2|||
27712593|NCT00574288|80781948|FG001|Overall Study|Study Terminated By Sponsor|0|||
27712594|NCT00574288|80781949|FG002|Overall Study|Study Terminated By Sponsor|0|||
27712595|NCT00574288|80781950|FG003|Overall Study|Study Terminated By Sponsor|0|||
27712596|NCT00574288|80781951|FG004|Overall Study|Study Terminated By Sponsor|0|||
27712597|NCT00574288|80781952|FG005|Overall Study|Study Terminated By Sponsor|0|||
27712598|NCT00574288|80781953|FG006|Overall Study|Study Terminated By Sponsor|5|||
27712599|NCT00574288|80781947|FG000|Overall Study|Progressive Disease|17|||
27712600|NCT00574288|80781948|FG001|Overall Study|Progressive Disease|2|||
27712601|NCT00574288|80781949|FG002|Overall Study|Progressive Disease|3|||
27712602|NCT00574288|80781950|FG003|Overall Study|Progressive Disease|2|||
27712603|NCT00574288|80781951|FG004|Overall Study|Progressive Disease|1|||
27712604|NCT00574288|80781952|FG005|Overall Study|Progressive Disease|0|||
27712605|NCT00574288|80781953|FG006|Overall Study|Progressive Disease|0|||
27712606|NCT00574288|80781947|FG000|Overall Study|Other|1|||
27712607|NCT00574288|80781948|FG001|Overall Study|Other|1|||
27712608|NCT00574288|80781949|FG002|Overall Study|Other|0|||
27712609|NCT00574288|80781950|FG003|Overall Study|Other|0|||
27712610|NCT00574288|80781951|FG004|Overall Study|Other|0|||
27604322|NCT04539821|80391439|FG000|Overall Study|continued care with their physician|20|||
27604323|NCT04539821|80391439|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
27604324|NCT03682705|80391440|FG000|Overall Study|Adverse Event|1|||
27604325|NCT03682705|80391441|FG001|Overall Study|Adverse Event|1|||
27712611|NCT00574288|80781952|FG005|Overall Study|Other|0|||
27712612|NCT00574288|80781953|FG006|Overall Study|Other|0|||
27712613|NCT02833974|80781954|FG000|Overall Study|Lost to Follow-up|1|||
27712614|NCT02833974|80781955|FG001|Overall Study|Lost to Follow-up|0|||
27712615|NCT02833974|80781954|FG000|Overall Study|Adverse Event|0|||
27712616|NCT02833974|80781955|FG001|Overall Study|Adverse Event|3|||
27712617|NCT00769184|80781956|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
27712618|NCT00769184|80781957|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
27836936|NCT01567527|81232936|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
27836937|NCT01567527|81232932|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27712619|NCT00769184|80781956|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
27712620|NCT00769184|80781957|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
27712621|NCT00769184|80781956|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
27712622|NCT00769184|80781957|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
27712623|NCT02457637|80781959|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
27712624|NCT02728830|80781960|FG000|Overall Study|Exclusionary Surgery|9|||
27712625|NCT02728830|80781960|FG000|Overall Study|Exclusionary Pathology|6|||
27712626|NCT02728830|80781960|FG000|Overall Study|Physician Decision|3|||
27712627|NCT02728830|80781960|FG000|Overall Study|Withdrawal by Subject|2|||
27712628|NCT02728830|80781960|FG000|Overall Study|Lost to Follow-up|1|||
27712629|NCT02728830|80781960|FG000|Overall Study|Exclusionary Lab Values|1|||
27712630|NCT02728830|80781960|FG000|Overall Study|Contraindicated Illness|1|||
27712631|NCT02728830|80781960|FG000|Overall Study|Language Barrier|1|||
27712632|NCT00131469|80781975|FG000|Overall Study|Withdrawal by Subject|3|||
27712633|NCT00131469|80781976|FG001|Overall Study|Withdrawal by Subject|4|||
27712634|NCT00131469|80781975|FG000|Overall Study|Protocol Violation|3|||
27712635|NCT00131469|80781976|FG001|Overall Study|Protocol Violation|1|||
27712636|NCT00131469|80781975|FG000|Overall Study|Death|0|||
27712637|NCT00131469|80781976|FG001|Overall Study|Death|1|||
27712638|NCT00131469|80781975|FG000|Overall Study|Lost to Follow-up|0|||
27836938|NCT01567527|81232933|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
27836939|NCT01567527|81232934|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27712639|NCT00131469|80781976|FG001|Overall Study|Lost to Follow-up|1|||
27712640|NCT00131469|80781975|FG000|Overall Study|scan not analyzable|3|||
27712641|NCT00131469|80781976|FG001|Overall Study|scan not analyzable|6|||
27712642|NCT02037295|80781977|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
27712643|NCT02037295|80781978|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
27712644|NCT02037295|80781979|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
27712645|NCT02037295|80781980|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
27712646|NCT02255422|80781981|FG000|Overall Study|Withdrawal by Subject|0|||
27712647|NCT02255422|80781982|FG001|Overall Study|Withdrawal by Subject|0|||
27604326|NCT03682705|80391442|FG002|Overall Study|Adverse Event|1|||
27712648|NCT02255422|80781983|FG002|Overall Study|Withdrawal by Subject|0|||
27712649|NCT02255422|80781984|FG003|Overall Study|Withdrawal by Subject|0|||
27836940|NCT01567527|81232935|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27712650|NCT02255422|80781985|FG004|Overall Study|Withdrawal by Subject|0|||
27712651|NCT02255422|80781986|FG005|Overall Study|Withdrawal by Subject|0|||
27712652|NCT02255422|80781987|FG006|Overall Study|Withdrawal by Subject|2|||
27712653|NCT02255422|80781981|FG000|Overall Study|Lost to Follow-up|0|||
27712654|NCT02255422|80781982|FG001|Overall Study|Lost to Follow-up|0|||
27712655|NCT02255422|80781983|FG002|Overall Study|Lost to Follow-up|1|||
27712656|NCT02255422|80781984|FG003|Overall Study|Lost to Follow-up|0|||
27712657|NCT02255422|80781985|FG004|Overall Study|Lost to Follow-up|0|||
27712658|NCT02255422|80781986|FG005|Overall Study|Lost to Follow-up|0|||
27712659|NCT02255422|80781987|FG006|Overall Study|Lost to Follow-up|0|||
27712660|NCT01394627|80781989|FG000|First Intervention (1 Day)|poor intravenous access|0|||
27712661|NCT01394627|80781990|FG001|First Intervention (1 Day)|poor intravenous access|1|||
27712662|NCT01394627|80781989|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
27712663|NCT01394627|80781990|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
27712664|NCT00925015|80781992|FG000|Overall Study|Adverse Event|1|||
27712665|NCT00925015|80781993|FG001|Overall Study|Adverse Event|2|||
27712666|NCT00925015|80781994|FG002|Overall Study|Adverse Event|1|||
27712667|NCT00925015|80781992|FG000|Overall Study|Physician Decision|0|||
27712668|NCT00925015|80781993|FG001|Overall Study|Physician Decision|1|||
27712669|NCT00925015|80781994|FG002|Overall Study|Physician Decision|0|||
27712670|NCT00925015|80781992|FG000|Overall Study|Progressive Disease|7|||
27712671|NCT00925015|80781993|FG001|Overall Study|Progressive Disease|3|||
27712672|NCT00925015|80781994|FG002|Overall Study|Progressive Disease|4|||
27712673|NCT00925015|80781992|FG000|Overall Study|Withdrawal by Subject|0|||
27712674|NCT00925015|80781993|FG001|Overall Study|Withdrawal by Subject|0|||
27712675|NCT00925015|80781994|FG002|Overall Study|Withdrawal by Subject|1|||
27712676|NCT00094055|80781995|FG000|Overall Study|Adverse Event|11|||
27712677|NCT00094055|80781995|FG000|Overall Study|Death|4|||
27712678|NCT00094055|80781995|FG000|Overall Study|Lack of Efficacy|17|||
27712679|NCT00094055|80781995|FG000|Overall Study|Lost to Follow-up|2|||
27712680|NCT00094055|80781995|FG000|Overall Study|progressive disease|2|||
27712681|NCT00094055|80781995|FG000|Overall Study|clinical progression|1|||
27712682|NCT00094055|80781995|FG000|Overall Study|roll-over to another study|14|||
27712683|NCT00094055|80781995|FG000|Overall Study|Withdrawal by Subject|9|||
27712684|NCT00326209|80781996|FG000|Overall Study|Adverse Event|28|||
27712685|NCT00326209|80781996|FG000|Overall Study|Withdrawal by Subject|22|||
27712686|NCT00326209|80781996|FG000|Overall Study|Lack of Efficacy|31|||
27712687|NCT00326209|80781996|FG000|Overall Study|Lost to Follow-up|18|||
27712688|NCT00326209|80781996|FG000|Overall Study|Participant non-compliant|6|||
27712689|NCT00326209|80781996|FG000|Overall Study|Sponsor closed study|173|||
27712690|NCT00326209|80781996|FG000|Overall Study|Prohibited medication use|1|||
27712691|NCT00326209|80781996|FG000|Overall Study|Violation of entry criteria|1|||
27712692|NCT00326209|80781996|FG000|Overall Study|Withdrawn in error|1|||
27712693|NCT00326209|80781996|FG000|Overall Study|Pregnancy|1|||
27604327|NCT03682705|80391443|FG003|Overall Study|Adverse Event|0|||
27712694|NCT00644787|80781997|FG000|Period 1: Titration Phase|Adverse Event|11|||
27712695|NCT00644787|80781998|FG001|Period 1: Titration Phase|Adverse Event|0|||
27712696|NCT00644787|80781999|FG002|Period 1: Titration Phase|Adverse Event|0|||
27712697|NCT00644787|80781997|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
27712698|NCT00644787|80781998|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
27712699|NCT00644787|80781999|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
27836941|NCT01567527|81232936|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
27712700|NCT00644787|80781997|FG000|Period 1: Titration Phase|Physician Decision|1|||
27712701|NCT00644787|80781998|FG001|Period 1: Titration Phase|Physician Decision|0|||
27604328|NCT03682705|80391444|FG004|Overall Study|Adverse Event|1|||
27604329|NCT03682705|80391445|FG005|Overall Study|Adverse Event|1|||
27604330|NCT03682705|80391440|FG000|Overall Study|Withdrawal by Subject|1|||
27889513|NCT01931995|81430821|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
27889514|NCT05318092|81430822|FG000|Overall Study|Lost to Follow-up|3|||
27889515|NCT05318092|81430822|FG000|Overall Study|Withdrawal by Subject|1|||
27712702|NCT00644787|80781999|FG002|Period 1: Titration Phase|Physician Decision|0|||
27712703|NCT00644787|80781997|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
27712704|NCT00644787|80781998|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
27712705|NCT00644787|80781999|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
27712706|NCT00644787|80781997|FG000|Period 1: Titration Phase|Worsening of complications|1|||
27712707|NCT00644787|80781998|FG001|Period 1: Titration Phase|Worsening of complications|0|||
27712708|NCT00644787|80781999|FG002|Period 1: Titration Phase|Worsening of complications|0|||
27712709|NCT00644787|80781997|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
27712710|NCT00644787|80781998|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
27712711|NCT00644787|80781999|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
27712712|NCT00644787|80781997|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
27712713|NCT00644787|80781998|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
27712714|NCT00644787|80781999|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
27712715|NCT00644787|80781997|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
27712716|NCT00644787|80781998|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
27712717|NCT00644787|80781999|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
27712718|NCT00644787|80781997|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
27712719|NCT00644787|80781998|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
27712720|NCT00644787|80781999|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
27712721|NCT00644787|80781997|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
27712722|NCT00644787|80781998|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
27712723|NCT00644787|80781999|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
27712724|NCT00644787|80781997|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
27712725|NCT00644787|80781998|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
27712726|NCT00644787|80781999|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
27712727|NCT00644787|80781997|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
27712728|NCT00644787|80781998|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
27712729|NCT00644787|80781999|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
27712730|NCT00845650|80782005|FG000|Overall Study|Withdrawal by Subject|0|||
27712731|NCT00845650|80782006|FG001|Overall Study|Withdrawal by Subject|0|||
27712732|NCT00845650|80782007|FG002|Overall Study|Withdrawal by Subject|0|||
27712733|NCT00845650|80782008|FG003|Overall Study|Withdrawal by Subject|0|||
27712734|NCT00845650|80782009|FG004|Overall Study|Withdrawal by Subject|2|||
27712735|NCT00845650|80782010|FG005|Overall Study|Withdrawal by Subject|0|||
27712736|NCT00845650|80782005|FG000|Overall Study|Lost to Follow-up|0|||
27712737|NCT00845650|80782006|FG001|Overall Study|Lost to Follow-up|0|||
27712738|NCT00845650|80782007|FG002|Overall Study|Lost to Follow-up|3|||
27712739|NCT00845650|80782008|FG003|Overall Study|Lost to Follow-up|1|||
27712740|NCT00845650|80782009|FG004|Overall Study|Lost to Follow-up|0|||
27712741|NCT00845650|80782010|FG005|Overall Study|Lost to Follow-up|1|||
27712742|NCT00845650|80782005|FG000|Overall Study|Sponsor hold on dosing|0|||
27712743|NCT00845650|80782006|FG001|Overall Study|Sponsor hold on dosing|0|||
27712744|NCT00845650|80782007|FG002|Overall Study|Sponsor hold on dosing|0|||
27712745|NCT00845650|80782008|FG003|Overall Study|Sponsor hold on dosing|0|||
27712746|NCT00845650|80782009|FG004|Overall Study|Sponsor hold on dosing|1|||
27712747|NCT00845650|80782010|FG005|Overall Study|Sponsor hold on dosing|1|||
27712748|NCT00845650|80782005|FG000|Overall Study|Unable to access IV line|1|||
27712749|NCT00845650|80782006|FG001|Overall Study|Unable to access IV line|0|||
27712750|NCT00845650|80782007|FG002|Overall Study|Unable to access IV line|0|||
27712751|NCT00845650|80782008|FG003|Overall Study|Unable to access IV line|0|||
27712752|NCT00845650|80782009|FG004|Overall Study|Unable to access IV line|0|||
27712753|NCT00845650|80782010|FG005|Overall Study|Unable to access IV line|0|||
27712754|NCT01014689|80782011|FG000|Overall Study|Lack of Efficacy|0|||
27712755|NCT01014689|80782012|FG001|Overall Study|Lack of Efficacy|1|||
27712756|NCT01014689|80782011|FG000|Overall Study|Adverse Event|3|||
27712757|NCT01014689|80782012|FG001|Overall Study|Adverse Event|0|||
27712758|NCT01014689|80782011|FG000|Overall Study|Withdrawal by Subject|5|||
27712759|NCT01014689|80782012|FG001|Overall Study|Withdrawal by Subject|4|||
27712760|NCT01014689|80782011|FG000|Overall Study|Protocol Violation|1|||
27712761|NCT01014689|80782012|FG001|Overall Study|Protocol Violation|1|||
27712762|NCT01014689|80782011|FG000|Overall Study|Lost to Follow-up|3|||
27712763|NCT01014689|80782012|FG001|Overall Study|Lost to Follow-up|7|||
27889516|NCT01430403|81430823|FG000|Overall Study|Lost to Follow-up|5|||
27889517|NCT01430403|81430824|FG001|Overall Study|Lost to Follow-up|5|||
27889518|NCT01430403|81430825|FG002|Overall Study|Lost to Follow-up|3|||
27889519|NCT01430403|81430823|FG000|Overall Study|Physician Decision|1|||
27712764|NCT01014689|80782011|FG000|Overall Study|Pregnancy|1|||
27712765|NCT01014689|80782012|FG001|Overall Study|Pregnancy|0|||
27712766|NCT02554019|80782019|FG000|Overall Study|Withdrawal by Subject|1|||
27712767|NCT02554019|80782020|FG001|Overall Study|Withdrawal by Subject|0|||
27712768|NCT02554019|80782021|FG002|Overall Study|Withdrawal by Subject|2|||
27889520|NCT01430403|81430824|FG001|Overall Study|Physician Decision|0|||
27712769|NCT02554019|80782019|FG000|Overall Study|Adverse Event|1|||
27712770|NCT02554019|80782020|FG001|Overall Study|Adverse Event|0|||
27712771|NCT02554019|80782021|FG002|Overall Study|Adverse Event|0|||
27712772|NCT01321710|80782022|FG000|Overall Study|Lost to Follow-up|4|||
27712773|NCT01321710|80782023|FG001|Overall Study|Lost to Follow-up|5|||
27712774|NCT01321710|80782024|FG002|Overall Study|Lost to Follow-up|0|||
27712775|NCT04247061|80782028|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
27712776|NCT04247061|80782028|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
27712777|NCT04247061|80782028|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
27712778|NCT00490451|80782029|FG000|Overall Study|Adverse Event|3|||
27712779|NCT00490451|80782030|FG001|Overall Study|Adverse Event|3|||
27712780|NCT00490451|80782029|FG000|Overall Study|Death|3|||
27712781|NCT00490451|80782030|FG001|Overall Study|Death|1|||
27712782|NCT00490451|80782029|FG000|Overall Study|Withdrawal by Subject|2|||
27712783|NCT00490451|80782030|FG001|Overall Study|Withdrawal by Subject|0|||
27712784|NCT00490451|80782029|FG000|Overall Study|Investigator Decision|1|||
27712785|NCT00490451|80782030|FG001|Overall Study|Investigator Decision|0|||
27712786|NCT00490451|80782029|FG000|Overall Study|Protocol Violation|1|||
27712787|NCT00490451|80782030|FG001|Overall Study|Protocol Violation|0|||
27712788|NCT00490451|80782029|FG000|Overall Study|Progressive Disease|53|||
27712789|NCT00490451|80782030|FG001|Overall Study|Progressive Disease|34|||
27712790|NCT00357500|80782031|FG000|Overall Study|Adverse Event|3|||
27712791|NCT00357500|80782031|FG000|Overall Study|Withdrawal by Subject|5|||
27889521|NCT01430403|81430825|FG002|Overall Study|Physician Decision|0|||
27889522|NCT01430403|81430823|FG000|Overall Study|Protocol Violation|2|||
27889523|NCT01430403|81430824|FG001|Overall Study|Protocol Violation|3|||
27889524|NCT01430403|81430825|FG002|Overall Study|Protocol Violation|2|||
27889525|NCT01430403|81430823|FG000|Overall Study|Withdrawal by Subject|9|||
27889526|NCT01430403|81430824|FG001|Overall Study|Withdrawal by Subject|1|||
27889527|NCT01430403|81430825|FG002|Overall Study|Withdrawal by Subject|3|||
27889528|NCT00150800|81430826|FG000|Overall Study|Adverse Event|89|||
27889529|NCT00150800|81430826|FG000|Overall Study|Death|18|||
27889530|NCT00150800|81430826|FG000|Overall Study|Lack of Efficacy|166|||
27889531|NCT00150800|81430826|FG000|Overall Study|Lost to Follow-up|58|||
27712792|NCT00357500|80782031|FG000|Overall Study|Progressive Disease|65|||
27889532|NCT00150800|81430826|FG000|Overall Study|Subject's choice|90|||
27889533|NCT00150800|81430826|FG000|Overall Study|No compliance|18|||
27889534|NCT00150800|81430826|FG000|Overall Study|IP misshandling|1|||
27889535|NCT00150800|81430826|FG000|Overall Study|Site closure|24|||
27889536|NCT00150800|81430826|FG000|Overall Study|Protocol non-adherence|2|||
27889537|NCT00150800|81430826|FG000|Overall Study|Nobody to accompany patient|1|||
27889538|NCT00150800|81430826|FG000|Overall Study|Distance too long for patient|1|||
27889539|NCT00150800|81430826|FG000|Overall Study|Neurosurgery|2|||
27889540|NCT00150800|81430826|FG000|Overall Study|BRV monotherapy|1|||
27889541|NCT00150800|81430826|FG000|Overall Study|Visit refusal|3|||
27712793|NCT00357500|80782031|FG000|Overall Study|Not Started Protocol Therapy|4|||
27712794|NCT01131676|80782032|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
27712795|NCT01131676|80782033|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
27712796|NCT01131676|80782034|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
27712797|NCT01131676|80782032|FG000|Discontinuation From Treatment|Not treated|4|||
27712798|NCT01131676|80782033|FG001|Discontinuation From Treatment|Not treated|2|||
27712799|NCT01131676|80782034|FG002|Discontinuation From Treatment|Not treated|2|||
27712800|NCT01131676|80782032|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
27712801|NCT01131676|80782033|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
27712802|NCT01131676|80782034|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
27712803|NCT01131676|80782032|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
27712804|NCT01131676|80782033|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
27712805|NCT01131676|80782034|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
27712806|NCT01131676|80782032|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
27712807|NCT01131676|80782033|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
27712808|NCT01131676|80782034|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
27712809|NCT01131676|80782032|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
27712810|NCT01131676|80782033|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
27712811|NCT01131676|80782034|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
27712812|NCT01131676|80782032|FG000|Discontinuation From Treatment|Other than those specified|162|||
27712813|NCT01131676|80782033|FG001|Discontinuation From Treatment|Other than those specified|142|||
27836942|NCT01567527|81232932|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27836943|NCT01567527|81232933|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
27836944|NCT01567527|81232934|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27836945|NCT01567527|81232935|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27836946|NCT01567527|81232936|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
27836947|NCT01567527|81232932|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27604331|NCT03682705|80391441|FG001|Overall Study|Withdrawal by Subject|3|||
27604332|NCT03682705|80391442|FG002|Overall Study|Withdrawal by Subject|2|||
27604333|NCT03682705|80391443|FG003|Overall Study|Withdrawal by Subject|4|||
27604334|NCT03682705|80391444|FG004|Overall Study|Withdrawal by Subject|0|||
27604335|NCT03682705|80391445|FG005|Overall Study|Withdrawal by Subject|1|||
27604336|NCT03682705|80391440|FG000|Overall Study|Other, not specified|0|||
27604337|NCT03682705|80391441|FG001|Overall Study|Other, not specified|0|||
27604338|NCT03682705|80391442|FG002|Overall Study|Other, not specified|0|||
27604339|NCT03682705|80391443|FG003|Overall Study|Other, not specified|1|||
27604340|NCT03682705|80391444|FG004|Overall Study|Other, not specified|2|||
27604341|NCT03682705|80391445|FG005|Overall Study|Other, not specified|0|||
27604342|NCT03682705|80391440|FG000|Overall Study|Lost to Follow-up|0|||
27604343|NCT03682705|80391441|FG001|Overall Study|Lost to Follow-up|0|||
27604344|NCT03682705|80391442|FG002|Overall Study|Lost to Follow-up|0|||
27604345|NCT03682705|80391443|FG003|Overall Study|Lost to Follow-up|0|||
27604346|NCT03682705|80391444|FG004|Overall Study|Lost to Follow-up|3|||
27604347|NCT03682705|80391445|FG005|Overall Study|Lost to Follow-up|0|||
27604348|NCT03391765|80391450|FG000|Overall Study|Adverse Event|2|||
27604349|NCT03391765|80391451|FG001|Overall Study|Adverse Event|0|||
27604350|NCT03391765|80391452|FG002|Overall Study|Adverse Event|0|||
27604351|NCT03391765|80391453|FG003|Overall Study|Adverse Event|2|||
27604352|NCT03391765|80391450|FG000|Overall Study|Withdrew consent|5|||
27604353|NCT03391765|80391451|FG001|Overall Study|Withdrew consent|7|||
27604354|NCT03391765|80391452|FG002|Overall Study|Withdrew consent|2|||
27604355|NCT03391765|80391453|FG003|Overall Study|Withdrew consent|5|||
27604356|NCT03391765|80391450|FG000|Overall Study|Other, not specified|44|||
27604357|NCT03391765|80391451|FG001|Overall Study|Other, not specified|38|||
27604358|NCT03391765|80391452|FG002|Overall Study|Other, not specified|21|||
27604359|NCT03391765|80391453|FG003|Overall Study|Other, not specified|16|||
27604360|NCT01460160|80391454|FG000|Treatment Phase|Lack of Efficacy|3|||
27836948|NCT01567527|81232933|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
27836949|NCT01567527|81232934|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27836950|NCT01567527|81232935|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27836951|NCT01567527|81232936|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
27836952|NCT01567527|81232932|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27836953|NCT01567527|81232933|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
27836954|NCT01567527|81232934|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27836955|NCT01567527|81232935|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27836956|NCT01567527|81232936|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
27836957|NCT01567527|81232932|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27836958|NCT01567527|81232933|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
27889542|NCT00150800|81430826|FG000|Overall Study|Sponsor's request|2|||
27712814|NCT01131676|80782034|FG002|Discontinuation From Treatment|Other than those specified|125|||
27712815|NCT01131676|80782032|FG000|Discontinuation From Treatment|Adverse Event|303|||
27712816|NCT01131676|80782033|FG001|Discontinuation From Treatment|Adverse Event|267|||
27712817|NCT01131676|80782034|FG002|Discontinuation From Treatment|Adverse Event|273|||
27712818|NCT01131676|80782032|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
27712819|NCT01131676|80782033|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
27712820|NCT01131676|80782034|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
27712821|NCT01131676|80782032|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
27712822|NCT01131676|80782033|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
27712823|NCT01131676|80782034|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
27712824|NCT01131676|80782032|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
27712825|NCT01131676|80782033|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
27712826|NCT01131676|80782034|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
27712827|NCT01131676|80782032|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
27712828|NCT01131676|80782033|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
27712829|NCT01131676|80782034|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
27712830|NCT01131676|80782032|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
27712831|NCT01131676|80782033|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
27712832|NCT01131676|80782034|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
27712833|NCT01131676|80782032|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
27712834|NCT01131676|80782033|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
27712835|NCT01131676|80782034|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
27712836|NCT01827670|80782035|FG000|Overall Study|Withdrawal of Consent|3|||
27712837|NCT01827670|80782036|FG001|Overall Study|Withdrawal of Consent|2|||
27712838|NCT01827670|80782035|FG000|Overall Study|Lost to Follow-up|0|||
27712839|NCT01827670|80782036|FG001|Overall Study|Lost to Follow-up|1|||
27712840|NCT02289950|80782048|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
27712841|NCT02289950|80782049|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
27712842|NCT02289950|80782048|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
27712843|NCT02289950|80782049|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
27712844|NCT02289950|80782048|FG000|Overall Study|Lost to Follow-up|1|||
27712845|NCT02289950|80782049|FG001|Overall Study|Lost to Follow-up|0|||
27889543|NCT00150800|81430826|FG000|Overall Study|Generalized Epilepsy|1|||
27604361|NCT01460160|80391454|FG000|Treatment Phase|Study Drug Toxicity|2|||
27836959|NCT01567527|81232934|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27836960|NCT01567527|81232935|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27836961|NCT01567527|81232936|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
27712846|NCT02289950|80782048|FG000|Overall Study|Physician Decision|9|||
27712847|NCT02289950|80782049|FG001|Overall Study|Physician Decision|3|||
27712848|NCT02289950|80782048|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
27712849|NCT02289950|80782049|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
27712850|NCT02289950|80782048|FG000|Overall Study|Withdrawal by Subject|1|||
27712851|NCT02289950|80782049|FG001|Overall Study|Withdrawal by Subject|3|||
27712852|NCT02289950|80782048|FG000|Overall Study|Test article held for greater than 28 days|0|||
27712853|NCT02289950|80782049|FG001|Overall Study|Test article held for greater than 28 days|1|||
27712854|NCT02289950|80782048|FG000|Overall Study|Adverse Event|11|||
27712855|NCT02289950|80782049|FG001|Overall Study|Adverse Event|3|||
27712856|NCT02289950|80782048|FG000|Overall Study|Death|1|||
27712857|NCT02289950|80782049|FG001|Overall Study|Death|1|||
27712858|NCT02289950|80782048|FG000|Overall Study|Other|5|||
27712859|NCT02289950|80782049|FG001|Overall Study|Other|2|||
27712860|NCT02289950|80782048|FG000|Overall Study|Not Treated|2|||
27712861|NCT02289950|80782049|FG001|Overall Study|Not Treated|1|||
27712862|NCT01918007|80782053|FG000|Overall Study|Baseline oximetry not acceptable|11|||
27712863|NCT01918007|80782054|FG001|Overall Study|Baseline oximetry not acceptable|7|||
27712864|NCT01918007|80782053|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
27712865|NCT01918007|80782054|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
27712866|NCT01918007|80782053|FG000|Overall Study|Lost to Follow-up|4|||
27712867|NCT01918007|80782054|FG001|Overall Study|Lost to Follow-up|7|||
27712868|NCT01560780|80782055|FG000|Overall Study|Death|2|||
27712869|NCT01560780|80782056|FG001|Overall Study|Death|1|||
27836962|NCT01567527|81232932|FG000|IM Depot Stabilization.|Protocol deviation|0|||
27836963|NCT01567527|81232933|FG001|IM Depot Stabilization.|Protocol deviation|0|||
27836964|NCT01567527|81232934|FG002|IM Depot Stabilization.|Protocol deviation|5|||
27836965|NCT01567527|81232935|FG003|IM Depot Stabilization.|Protocol deviation|0|||
27836966|NCT01567527|81232936|FG004|IM Depot Stabilization.|Protocol deviation|0|||
27836967|NCT01567527|81232932|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
27836968|NCT01567527|81232933|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
27836969|NCT01567527|81232934|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
27836970|NCT01567527|81232935|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
27836971|NCT01567527|81232936|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
27836972|NCT01567527|81232932|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
27836973|NCT01567527|81232933|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
27836974|NCT01567527|81232934|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
27836975|NCT01567527|81232935|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
27836976|NCT01567527|81232936|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
27836977|NCT01567527|81232932|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
27836978|NCT01567527|81232933|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
27712870|NCT01560780|80782055|FG000|Overall Study|Patient Preference|11|||
27836979|NCT01567527|81232934|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
27712871|NCT01560780|80782056|FG001|Overall Study|Patient Preference|11|||
27712872|NCT04066491|80782057|FG000|Overall Study|Randomized, not treated|0|||
27712873|NCT04066491|80782058|FG001|Overall Study|Randomized, not treated|0|||
27712874|NCT04066491|80782059|FG002|Overall Study|Randomized, not treated|2|||
27712875|NCT01577186|80782060|FG000|Overall Study|Adverse Event|23|||
27712876|NCT01577186|80782060|FG000|Overall Study|Death|1|||
27712877|NCT01577186|80782060|FG000|Overall Study|Lost to Follow-up|28|||
27712878|NCT01577186|80782060|FG000|Overall Study|Withdrawal by Subject|35|||
27712879|NCT01577186|80782060|FG000|Overall Study|Insufficient Response|18|||
27604362|NCT01460160|80391454|FG000|Treatment Phase|Adverse Event|8|||
27712880|NCT01577186|80782060|FG000|Overall Study|Ineligible to Continue|15|||
27712881|NCT01577186|80782060|FG000|Overall Study|Non-Compliant|8|||
27712882|NCT01577186|80782060|FG000|Overall Study|Other|2|||
27889544|NCT00150800|81430826|FG000|Overall Study|Moved from area/country|8|||
27889545|NCT00150800|81430826|FG000|Overall Study|PI retiring|2|||
27889546|NCT00150800|81430826|FG000|Overall Study|PI leaving site|2|||
27604363|NCT01460160|80391454|FG000|Treatment Phase|Withdrawal by Subject|4|||
27604364|NCT01460160|80391454|FG000|Treatment Phase|Death|2|||
27604365|NCT01460160|80391454|FG000|Treatment Phase|Other reasons|9|||
27604366|NCT01460160|80391454|FG000|Follow-up Phase|Withdrawal by Subject|4|||
27604367|NCT01460160|80391454|FG000|Follow-up Phase|Death|14|||
27604368|NCT01460160|80391454|FG000|Follow-up Phase|Lost to Follow-up|7|||
27604369|NCT01460160|80391454|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
27604370|NCT01460160|80391454|FG000|Follow-up Phase|Other and not reported reasons|5|||
27604371|NCT01392300|80391457|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
27604372|NCT01392300|80391458|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
27604373|NCT01392300|80391459|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
27604374|NCT01392300|80391457|FG000|Main Period (MP)|Withdrawal by Subject|5|||
27604375|NCT01392300|80391458|FG001|Main Period (MP)|Withdrawal by Subject|1|||
27604376|NCT01392300|80391459|FG002|Main Period (MP)|Withdrawal by Subject|0|||
27712883|NCT02081534|80782061|FG000|Overall Study|Adverse Event|5|||
27712884|NCT02081534|80782062|FG001|Overall Study|Adverse Event|4|||
27712885|NCT02081534|80782063|FG002|Overall Study|Adverse Event|3|||
27889547|NCT00150800|81430826|FG000|Overall Study|Patient insurance|1|||
27889548|NCT00150800|81430826|FG000|Overall Study|Surgical intervention|4|||
27889549|NCT00150800|81430826|FG000|Overall Study|Pregnancy planned|1|||
27889550|NCT00150800|81430826|FG000|Overall Study|PI discontinuation request|1|||
27889551|NCT00073983|81430827|FG000|Overall Study|not evaluable|1|||
27889552|NCT02278120|81430829|FG000|Treatment Period|Progressive disease|234|||
27889553|NCT02278120|81430830|FG001|Treatment Period|Progressive disease|260|||
27889554|NCT02278120|81430829|FG000|Treatment Period|Subject/guardian decision|23|||
27889555|NCT02278120|81430830|FG001|Treatment Period|Subject/guardian decision|20|||
27889556|NCT02278120|81430829|FG000|Treatment Period|Adverse Event|16|||
27889557|NCT02278120|81430830|FG001|Treatment Period|Adverse Event|14|||
27889558|NCT02278120|81430829|FG000|Treatment Period|Physician Decision|14|||
27889559|NCT02278120|81430830|FG001|Treatment Period|Physician Decision|27|||
27604377|NCT01392300|80391457|FG000|Main Period (MP)|Lost to Follow-up|3|||
27712886|NCT02081534|80782064|FG003|Overall Study|Adverse Event|10|||
27712887|NCT02081534|80782065|FG004|Overall Study|Adverse Event|2|||
27889560|NCT02278120|81430829|FG000|Treatment Period|Death|3|||
27712888|NCT02081534|80782066|FG005|Overall Study|Adverse Event|8|||
27889561|NCT02278120|81430830|FG001|Treatment Period|Death|3|||
27889562|NCT02278120|81430829|FG000|Treatment Period|Lost to Follow-up|2|||
27889563|NCT02278120|81430830|FG001|Treatment Period|Lost to Follow-up|0|||
27712889|NCT02081534|80782067|FG006|Overall Study|Adverse Event|2|||
27712890|NCT02081534|80782061|FG000|Overall Study|Withdrawal by Subject|0|||
27712891|NCT02081534|80782062|FG001|Overall Study|Withdrawal by Subject|1|||
27712892|NCT02081534|80782063|FG002|Overall Study|Withdrawal by Subject|1|||
27712893|NCT02081534|80782064|FG003|Overall Study|Withdrawal by Subject|1|||
27712894|NCT02081534|80782065|FG004|Overall Study|Withdrawal by Subject|1|||
27712895|NCT02081534|80782066|FG005|Overall Study|Withdrawal by Subject|0|||
27712896|NCT02081534|80782067|FG006|Overall Study|Withdrawal by Subject|1|||
27712897|NCT02081534|80782061|FG000|Overall Study|Protocol Violation|0|||
27712898|NCT02081534|80782062|FG001|Overall Study|Protocol Violation|3|||
27712899|NCT02081534|80782063|FG002|Overall Study|Protocol Violation|0|||
27712900|NCT02081534|80782064|FG003|Overall Study|Protocol Violation|0|||
27712901|NCT02081534|80782065|FG004|Overall Study|Protocol Violation|0|||
27712902|NCT02081534|80782066|FG005|Overall Study|Protocol Violation|0|||
27712903|NCT02081534|80782067|FG006|Overall Study|Protocol Violation|1|||
27712904|NCT02081534|80782061|FG000|Overall Study|Lost to Follow-up|0|||
27712905|NCT02081534|80782062|FG001|Overall Study|Lost to Follow-up|0|||
27712906|NCT02081534|80782063|FG002|Overall Study|Lost to Follow-up|0|||
27712907|NCT02081534|80782064|FG003|Overall Study|Lost to Follow-up|2|||
27712908|NCT02081534|80782065|FG004|Overall Study|Lost to Follow-up|1|||
27712909|NCT02081534|80782066|FG005|Overall Study|Lost to Follow-up|1|||
27712910|NCT02081534|80782067|FG006|Overall Study|Lost to Follow-up|0|||
27712911|NCT03024970|80782068|FG000|First Intervention|Adverse Event|1|||
27712912|NCT03024970|80782069|FG001|First Intervention|Adverse Event|0|||
27712913|NCT03024970|80782068|FG000|Second Intervention|Lost to Follow-up|1|||
27712914|NCT03024970|80782069|FG001|Second Intervention|Lost to Follow-up|0|||
27712915|NCT03923426|80782071|FG000|Overall Study|Other|19|||
27712916|NCT03923426|80782071|FG000|Overall Study|Lost to Follow-up|16|||
27712917|NCT03923426|80782071|FG000|Overall Study|Death|107|||
27712918|NCT03923426|80782071|FG000|Overall Study|Incomplete response to question|13|||
27712919|NCT04712110|80782077|FG000|Overall Study|Lost to Follow-up|0|||
27712920|NCT04712110|80782078|FG001|Overall Study|Lost to Follow-up|1|||
27712921|NCT04712110|80782077|FG000|Overall Study|Withdrawal by Subject|0|||
27712922|NCT04712110|80782078|FG001|Overall Study|Withdrawal by Subject|4|||
27712923|NCT04712110|80782077|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
27712924|NCT04712110|80782078|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
27712925|NCT02424253|80782079|FG000|Overall Study|Other, unspecified|1|||
27712926|NCT02424253|80782080|FG001|Overall Study|Other, unspecified|0|||
27712927|NCT02424253|80782079|FG000|Overall Study|Compliance problems|1|||
27712928|NCT02424253|80782080|FG001|Overall Study|Compliance problems|0|||
27712929|NCT02424253|80782079|FG000|Overall Study|Physician Decision|2|||
27712930|NCT02424253|80782080|FG001|Overall Study|Physician Decision|0|||
27712931|NCT02424253|80782079|FG000|Overall Study|Lack of Efficacy|0|||
27712932|NCT02424253|80782080|FG001|Overall Study|Lack of Efficacy|7|||
27712933|NCT02424253|80782079|FG000|Overall Study|Adverse Event|2|||
27712934|NCT02424253|80782080|FG001|Overall Study|Adverse Event|0|||
27712935|NCT02424253|80782079|FG000|Overall Study|Consent withdrawn by subject|4|||
27712936|NCT02424253|80782080|FG001|Overall Study|Consent withdrawn by subject|1|||
27712937|NCT02424253|80782079|FG000|Overall Study|Lost to Follow-up|1|||
27712938|NCT02424253|80782080|FG001|Overall Study|Lost to Follow-up|1|||
27712939|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
27712940|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
27712941|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
27712942|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
27712943|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
27712944|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
27712945|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
27712946|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
27712947|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
27712948|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
27712949|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
27712950|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
27712951|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
27712952|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
27712953|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
27712954|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
27889564|NCT02278120|81430829|FG000|Treatment Period|Protocol deviation|0|||
27889565|NCT02278120|81430830|FG001|Treatment Period|Protocol deviation|2|||
27889566|NCT02278120|81430829|FG000|Treatment Period|Study terminated as per protocol|43|||
27889567|NCT02278120|81430830|FG001|Treatment Period|Study terminated as per protocol|11|||
27889568|NCT02278120|81430829|FG000|Post-treatment Efficacy Follow-up|Death|0|||
27889569|NCT02278120|81430830|FG001|Post-treatment Efficacy Follow-up|Death|1|||
27889570|NCT02278120|81430829|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
27889571|NCT02278120|81430830|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
27889572|NCT02278120|81430829|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
27889573|NCT02278120|81430830|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
27889574|NCT02278120|81430829|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
27889575|NCT02278120|81430830|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
27889576|NCT02278120|81430829|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27889577|NCT02278120|81430830|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27889578|NCT01190410|81430834|FG000|Overall Study|Adverse Event|0|||
27889579|NCT01190410|81430835|FG001|Overall Study|Adverse Event|3|||
27889580|NCT01190410|81430834|FG000|Overall Study|Lack of Efficacy|0|||
27889581|NCT01190410|81430835|FG001|Overall Study|Lack of Efficacy|2|||
27889582|NCT01190410|81430834|FG000|Overall Study|Withdrawal by Subject|0|||
27889583|NCT01190410|81430835|FG001|Overall Study|Withdrawal by Subject|2|||
27889584|NCT01190410|81430834|FG000|Overall Study|Administrative decision|1|||
27889585|NCT01190410|81430835|FG001|Overall Study|Administrative decision|0|||
27889586|NCT01190410|81430834|FG000|Overall Study|PI discretion|0|||
27889587|NCT01190410|81430835|FG001|Overall Study|PI discretion|2|||
27889588|NCT05129137|81430843|FG000|Second Period|Adverse Event|1|||
27889589|NCT05129137|81430844|FG001|Second Period|Adverse Event|0|||
27889590|NCT05129137|81430845|FG002|Second Period|Adverse Event|0|||
27889591|NCT05129137|81430846|FG003|Second Period|Adverse Event|0|||
27889592|NCT05129137|81430843|FG000|Second Period|Protocol Violation|0|||
27889593|NCT05129137|81430844|FG001|Second Period|Protocol Violation|0|||
27889594|NCT05129137|81430845|FG002|Second Period|Protocol Violation|0|||
27889595|NCT05129137|81430846|FG003|Second Period|Protocol Violation|1|||
27889596|NCT05129137|81430843|FG000|Third Period|Protocol Violation|0|||
27889597|NCT05129137|81430844|FG001|Third Period|Protocol Violation|0|||
27889598|NCT05129137|81430845|FG002|Third Period|Protocol Violation|0|||
27889599|NCT05129137|81430846|FG003|Third Period|Protocol Violation|1|||
27889600|NCT05129137|81430843|FG000|Forth Period|Protocol Violation|0|||
27889601|NCT05129137|81430844|FG001|Forth Period|Protocol Violation|1|||
27889602|NCT05129137|81430845|FG002|Forth Period|Protocol Violation|0|||
27889603|NCT05129137|81430846|FG003|Forth Period|Protocol Violation|0|||
27889604|NCT05129137|81430843|FG000|Forth Period|Withdrawal by Subject|0|||
27889605|NCT05129137|81430844|FG001|Forth Period|Withdrawal by Subject|0|||
27889606|NCT05129137|81430845|FG002|Forth Period|Withdrawal by Subject|1|||
27889607|NCT05129137|81430846|FG003|Forth Period|Withdrawal by Subject|0|||
27604378|NCT01392300|80391458|FG001|Main Period (MP)|Lost to Follow-up|3|||
27604379|NCT01392300|80391459|FG002|Main Period (MP)|Lost to Follow-up|0|||
27712955|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
27889608|NCT02448537|81430849|FG000|Overall Study|Withdrawal by Subject|1|||
27889609|NCT02448537|81430850|FG001|Overall Study|Withdrawal by Subject|1|||
27889610|NCT02448537|81430851|FG002|Overall Study|Withdrawal by Subject|1|||
27712956|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
27712957|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
27712958|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
27712959|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
27712960|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
27712961|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
27712962|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
27712963|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
27712964|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
27712965|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
27712966|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
27712967|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
27712968|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
27712969|NCT00784654|80785131|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
27712970|NCT00784654|80785132|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
27712971|NCT00784654|80785133|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
27712972|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
27712973|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
27712974|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
27712975|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
27712976|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
27712977|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
27712978|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27712979|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
27712980|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
27712981|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
27712982|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
27712983|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
27712984|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Adverse Event|0|||
27712985|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Adverse Event|1|||
27712986|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Adverse Event|1|||
27712987|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
27712988|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
27712989|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
27712990|NCT00784654|80785131|FG000|Randomized Withdrawal Period|Family reasons|0|||
27712991|NCT00784654|80785132|FG001|Randomized Withdrawal Period|Family reasons|0|||
27712992|NCT00784654|80785133|FG002|Randomized Withdrawal Period|Family reasons|1|||
27712993|NCT02980224|80785139|FG000|Overall Study|Adverse Event|4|||
27712994|NCT02980224|80785140|FG001|Overall Study|Adverse Event|1|||
27712995|NCT02980224|80785139|FG000|Overall Study|Withdrawal by Subject|0|||
27712996|NCT02980224|80785140|FG001|Overall Study|Withdrawal by Subject|2|||
27712997|NCT01356407|80785143|FG000|Overall Study|Lost to Follow-up|2|||
27712998|NCT01356407|80785144|FG001|Overall Study|Lost to Follow-up|0|||
27712999|NCT01356407|80785143|FG000|Overall Study|Patient Withdrew Consent|2|||
27713000|NCT01356407|80785144|FG001|Overall Study|Patient Withdrew Consent|1|||
27836980|NCT01567527|81232935|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
27836981|NCT01567527|81232936|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
27836982|NCT01567527|81232932|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
27836983|NCT01567527|81232933|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
27836984|NCT01567527|81232934|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
27836985|NCT01567527|81232935|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
27836986|NCT01567527|81232936|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
27836987|NCT01567527|81232932|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
27836988|NCT01567527|81232933|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
27836989|NCT01567527|81232934|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
27836990|NCT01567527|81232935|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
27836991|NCT01567527|81232936|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
27836992|NCT01567527|81232932|FG000|IM Depot Stabilization.|Adverse Event|0|||
27836993|NCT01567527|81232933|FG001|IM Depot Stabilization.|Adverse Event|0|||
27836994|NCT01567527|81232934|FG002|IM Depot Stabilization.|Adverse Event|37|||
27836995|NCT01567527|81232935|FG003|IM Depot Stabilization.|Adverse Event|0|||
27836996|NCT01567527|81232936|FG004|IM Depot Stabilization.|Adverse Event|0|||
27889611|NCT01867710|81430852|FG000|Overall Study|Death|25|||
27889612|NCT01867710|81430853|FG001|Overall Study|Death|15|||
27889613|NCT01867710|81430854|FG002|Overall Study|Death|27|||
27889614|NCT01867710|81430855|FG003|Overall Study|Death|20|||
27889615|NCT01867710|81430852|FG000|Overall Study|Lost to Follow-up|3|||
27889616|NCT01867710|81430853|FG001|Overall Study|Lost to Follow-up|4|||
27889617|NCT01867710|81430854|FG002|Overall Study|Lost to Follow-up|3|||
27889618|NCT01867710|81430855|FG003|Overall Study|Lost to Follow-up|2|||
27889619|NCT01867710|81430852|FG000|Overall Study|Withdrawal of consent|2|||
27889620|NCT01867710|81430853|FG001|Overall Study|Withdrawal of consent|5|||
27713001|NCT01356407|80785143|FG000|Overall Study|Could not afford IMP administration|0|||
27713002|NCT01356407|80785144|FG001|Overall Study|Could not afford IMP administration|1|||
27713003|NCT01356407|80785143|FG000|Overall Study|Not complete Endoscopy|2|||
27713004|NCT01356407|80785144|FG001|Overall Study|Not complete Endoscopy|2|||
27889621|NCT01867710|81430854|FG002|Overall Study|Withdrawal of consent|1|||
27889622|NCT01867710|81430855|FG003|Overall Study|Withdrawal of consent|2|||
27713005|NCT00401375|80785145|FG000|Overall Study|Protocol Violation|2|||
27713006|NCT00401375|80785146|FG001|Overall Study|Protocol Violation|2|||
27713007|NCT00401375|80785147|FG002|Overall Study|Protocol Violation|1|||
27713008|NCT00401375|80785145|FG000|Overall Study|Adverse Event|6|||
27713009|NCT00401375|80785146|FG001|Overall Study|Adverse Event|11|||
27713010|NCT00401375|80785147|FG002|Overall Study|Adverse Event|10|||
27713011|NCT00401375|80785145|FG000|Overall Study|Withdrawal by Subject|9|||
27713012|NCT00401375|80785146|FG001|Overall Study|Withdrawal by Subject|7|||
27713013|NCT00401375|80785147|FG002|Overall Study|Withdrawal by Subject|7|||
27713014|NCT00401375|80785145|FG000|Overall Study|Lost to Follow-up|0|||
27713015|NCT00401375|80785146|FG001|Overall Study|Lost to Follow-up|1|||
27713016|NCT00401375|80785147|FG002|Overall Study|Lost to Follow-up|1|||
27713017|NCT00401375|80785145|FG000|Overall Study|Other than specified|2|||
27713018|NCT00401375|80785146|FG001|Overall Study|Other than specified|1|||
27713019|NCT00401375|80785147|FG002|Overall Study|Other than specified|3|||
27713020|NCT00401375|80785145|FG000|Overall Study|Randomized but not treated|3|||
27713021|NCT00401375|80785146|FG001|Overall Study|Randomized but not treated|3|||
27713022|NCT00401375|80785147|FG002|Overall Study|Randomized but not treated|3|||
27713023|NCT01508702|80785148|FG000|Overall Study|Adverse Event|7|||
27713024|NCT01508702|80785149|FG001|Overall Study|Adverse Event|3|||
27713025|NCT01508702|80785148|FG000|Overall Study|Gout flare|2|||
27713026|NCT01508702|80785149|FG001|Overall Study|Gout flare|0|||
27713027|NCT01508702|80785148|FG000|Overall Study|Protocol Violation|2|||
27604380|NCT01392300|80391457|FG000|Main Period (MP)|Non-compliance|1|||
27604381|NCT01392300|80391458|FG001|Main Period (MP)|Non-compliance|0|||
27604382|NCT01392300|80391459|FG002|Main Period (MP)|Non-compliance|0|||
27604383|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
27604384|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
27604385|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
27604386|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
27604387|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
27713028|NCT01508702|80785149|FG001|Overall Study|Protocol Violation|1|||
27713029|NCT01508702|80785148|FG000|Overall Study|Lost to Follow-up|1|||
27889623|NCT01867710|81430852|FG000|Overall Study|Study Terminated by Sponsor|9|||
27604388|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
27604389|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
27604390|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
27713030|NCT01508702|80785149|FG001|Overall Study|Lost to Follow-up|2|||
27713031|NCT01508702|80785148|FG000|Overall Study|Withdrawal by Subject|11|||
27889624|NCT01867710|81430853|FG001|Overall Study|Study Terminated by Sponsor|13|||
27889625|NCT01867710|81430854|FG002|Overall Study|Study Terminated by Sponsor|8|||
27889626|NCT01867710|81430855|FG003|Overall Study|Study Terminated by Sponsor|16|||
27889627|NCT01867710|81430852|FG000|Overall Study|Biochemical progression|0|||
27713032|NCT01508702|80785149|FG001|Overall Study|Withdrawal by Subject|7|||
27713033|NCT00193063|80785151|FG000|Overall Study|Lack of Efficacy|3|||
27713034|NCT00193063|80785151|FG000|Overall Study|Adverse Event|1|||
27713035|NCT00408694|80785152|FG000|Overall Study|Ineligible|1|||
27713036|NCT00408694|80785152|FG000|Overall Study|No protocol treatment|1|||
27713037|NCT03631732|80785153|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
27713038|NCT03631732|80785154|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
27713039|NCT03631732|80785153|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
27713040|NCT03631732|80785154|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
27713041|NCT03631732|80785153|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
27713042|NCT03631732|80785154|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
27713043|NCT03631732|80785153|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
27713044|NCT03631732|80785154|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
27713045|NCT03631732|80785153|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
27713046|NCT03631732|80785154|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
27713047|NCT03631732|80785153|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
27713048|NCT03631732|80785154|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
27713049|NCT03631732|80785153|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
27713050|NCT03631732|80785154|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
27713051|NCT03631732|80785153|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
27713052|NCT03631732|80785154|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
27713053|NCT03631732|80785153|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
27713054|NCT03631732|80785154|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
27713055|NCT03631732|80785153|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
27713056|NCT03631732|80785154|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
27713057|NCT01136655|80785155|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
27713058|NCT01136655|80785155|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
27713059|NCT01136655|80785155|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
27713060|NCT01136655|80785155|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
27713061|NCT01318109|80785156|FG000|Overall Study|Adverse Event|0|||
27713062|NCT01318109|80785157|FG001|Overall Study|Adverse Event|2|||
27713063|NCT01318109|80785158|FG002|Overall Study|Adverse Event|0|||
27713064|NCT01318109|80785156|FG000|Overall Study|Withdrawal by Subject|1|||
27713065|NCT01318109|80785157|FG001|Overall Study|Withdrawal by Subject|0|||
27713066|NCT01318109|80785158|FG002|Overall Study|Withdrawal by Subject|0|||
27713067|NCT01318109|80785156|FG000|Overall Study|Schedule Conflict|0|||
27713068|NCT01318109|80785157|FG001|Overall Study|Schedule Conflict|1|||
27713069|NCT01318109|80785158|FG002|Overall Study|Schedule Conflict|0|||
27713070|NCT04169373|80785164|FG000|Week 1 to Week 14|Adverse Event|1|||
27713071|NCT04169373|80785165|FG001|Week 1 to Week 14|Adverse Event|0|||
27713072|NCT04169373|80785166|FG002|Week 1 to Week 14|Adverse Event|1|||
27713073|NCT04169373|80785167|FG003|Week 1 to Week 14|Adverse Event|2|||
27713074|NCT04169373|80785164|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
27713075|NCT04169373|80785165|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
27713076|NCT04169373|80785166|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
27713077|NCT04169373|80785167|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
27713078|NCT04169373|80785164|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
27713079|NCT04169373|80785165|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
27713080|NCT04169373|80785166|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
27713081|NCT04169373|80785167|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
27713082|NCT04169373|80785164|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
27713083|NCT04169373|80785165|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
27713084|NCT04169373|80785166|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
27713085|NCT04169373|80785167|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
27713086|NCT04169373|80785164|FG000|Week 1 to Week 14|Other|1|||
27713087|NCT04169373|80785165|FG001|Week 1 to Week 14|Other|3|||
27713088|NCT04169373|80785166|FG002|Week 1 to Week 14|Other|3|||
27713089|NCT04169373|80785167|FG003|Week 1 to Week 14|Other|5|||
27713090|NCT04169373|80785164|FG000|Week 14 to Week 52|Adverse Event|1|||
27713091|NCT04169373|80785165|FG001|Week 14 to Week 52|Adverse Event|0|||
27713092|NCT04169373|80785166|FG002|Week 14 to Week 52|Adverse Event|0|||
27713093|NCT04169373|80785167|FG003|Week 14 to Week 52|Adverse Event|1|||
27713094|NCT04169373|80785164|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
27713095|NCT04169373|80785165|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
27713096|NCT04169373|80785166|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
27713097|NCT04169373|80785167|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
27713098|NCT04169373|80785164|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
27713099|NCT04169373|80785165|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
27713100|NCT04169373|80785166|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
27713101|NCT04169373|80785167|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
27713102|NCT04169373|80785164|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
27713103|NCT04169373|80785165|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
27713104|NCT04169373|80785166|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
27713105|NCT04169373|80785167|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
27713106|NCT04169373|80785164|FG000|Week 14 to Week 52|Other|4|||
27713107|NCT04169373|80785165|FG001|Week 14 to Week 52|Other|5|||
27713108|NCT04169373|80785166|FG002|Week 14 to Week 52|Other|4|||
27713109|NCT04169373|80785167|FG003|Week 14 to Week 52|Other|5|||
27713110|NCT04169373|80785164|FG000|Week 14 to Week 52|Ongoing|0|||
27713111|NCT04169373|80785165|FG001|Week 14 to Week 52|Ongoing|1|||
27713112|NCT04169373|80785166|FG002|Week 14 to Week 52|Ongoing|0|||
27713113|NCT04169373|80785167|FG003|Week 14 to Week 52|Ongoing|0|||
27713114|NCT04179734|80785168|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
27713115|NCT04179734|80785169|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
27713116|NCT04179734|80785168|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
27713117|NCT04179734|80785169|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
27713118|NCT01967537|80785172|FG000|Overall Study|Withdrawal by Subject|52|||
27713119|NCT01967537|80785172|FG000|Overall Study|Refuse treatment|2|||
27713120|NCT01967537|80785172|FG000|Overall Study|Lost to Follow-up|6|||
27713121|NCT01032915|80785173|FG000|Overall Study|Adverse Event|2|||
27889628|NCT01867710|81430853|FG001|Overall Study|Biochemical progression|1|||
27604391|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
27604392|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Death|0|||
27713122|NCT01032915|80785174|FG001|Overall Study|Adverse Event|2|||
27713123|NCT01032915|80785175|FG002|Overall Study|Adverse Event|1|||
27713124|NCT01032915|80785176|FG003|Overall Study|Adverse Event|1|||
27713125|NCT01032915|80785173|FG000|Overall Study|Abnormal test procedure result|0|||
27713126|NCT01032915|80785174|FG001|Overall Study|Abnormal test procedure result|0|||
27713127|NCT01032915|80785175|FG002|Overall Study|Abnormal test procedure result|1|||
27713128|NCT01032915|80785176|FG003|Overall Study|Abnormal test procedure result|0|||
27713129|NCT01032915|80785173|FG000|Overall Study|Withdrawal by Subject|0|||
27713130|NCT01032915|80785174|FG001|Overall Study|Withdrawal by Subject|3|||
27713131|NCT01032915|80785175|FG002|Overall Study|Withdrawal by Subject|1|||
27713132|NCT01032915|80785176|FG003|Overall Study|Withdrawal by Subject|1|||
27713133|NCT01032915|80785173|FG000|Overall Study|Administrative reasons|5|||
27713134|NCT01032915|80785174|FG001|Overall Study|Administrative reasons|6|||
27713135|NCT01032915|80785175|FG002|Overall Study|Administrative reasons|4|||
27713136|NCT01032915|80785176|FG003|Overall Study|Administrative reasons|4|||
27713137|NCT01032915|80785173|FG000|Overall Study|Protocol Violation|1|||
27713138|NCT01032915|80785174|FG001|Overall Study|Protocol Violation|0|||
27713139|NCT01032915|80785175|FG002|Overall Study|Protocol Violation|0|||
27713140|NCT01032915|80785176|FG003|Overall Study|Protocol Violation|1|||
27713141|NCT02500121|80785177|FG000|Overall Study|Lost to Follow-up|0|||
27713142|NCT02500121|80785178|FG001|Overall Study|Lost to Follow-up|1|||
27713143|NCT02500121|80785177|FG000|Overall Study|Withdrawal by Subject|1|||
27713144|NCT02500121|80785178|FG001|Overall Study|Withdrawal by Subject|1|||
27713145|NCT02500121|80785177|FG000|Overall Study|Death|26|||
27713146|NCT02500121|80785178|FG001|Overall Study|Death|24|||
27713147|NCT04288154|80785179|FG000|Overall Study|Withdrawal by Subject|9|||
27713148|NCT04288154|80785180|FG001|Overall Study|Withdrawal by Subject|9|||
27713149|NCT00317109|80785181|FG000|Overall Study|Withdrawal by Subject|2|||
27713150|NCT00317109|80785182|FG001|Overall Study|Withdrawal by Subject|0|||
27713151|NCT00317109|80785181|FG000|Overall Study|Migated/moved from study area|1|||
27713152|NCT00317109|80785182|FG001|Overall Study|Migated/moved from study area|0|||
27713153|NCT02846532|80785183|FG000|Overall Study|Lost to Follow-up|0|||
27713154|NCT02846532|80785184|FG001|Overall Study|Lost to Follow-up|1|||
27713155|NCT02846532|80785185|FG002|Overall Study|Lost to Follow-up|1|||
27713156|NCT02846532|80785183|FG000|Overall Study|Withdrawal by Subject|1|||
27713157|NCT02846532|80785184|FG001|Overall Study|Withdrawal by Subject|2|||
27713158|NCT02846532|80785185|FG002|Overall Study|Withdrawal by Subject|0|||
27713159|NCT00930761|80785186|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
27713160|NCT00930761|80785187|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
27713161|NCT00930761|80785186|FG000|Overall Study|less than 3 music therapy sessions|0|||
27713162|NCT00930761|80785187|FG001|Overall Study|less than 3 music therapy sessions|3|||
27713163|NCT01486927|80785190|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
27713164|NCT01486927|80785190|FG000|Overall Study|Physician Decision|1|||
27713165|NCT01486927|80785190|FG000|Overall Study|50 Exposure days not reached|2|||
27713166|NCT01486927|80785190|FG000|Overall Study|Withdrawal by Subject|8|||
27713167|NCT01486927|80785190|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
27713168|NCT01277549|80785191|FG000|Overall Study|Failed to meet eligibility criteria|13|||
27713169|NCT01277549|80785192|FG001|Overall Study|Failed to meet eligibility criteria|9|||
27713170|NCT01277549|80785191|FG000|Overall Study|Withdrawal by Subject|1|||
27713171|NCT01277549|80785192|FG001|Overall Study|Withdrawal by Subject|3|||
27713172|NCT01277549|80785191|FG000|Overall Study|Protocol Violation|10|||
27713173|NCT01277549|80785192|FG001|Overall Study|Protocol Violation|1|||
27713174|NCT01277549|80785191|FG000|Overall Study|Physician Decision|2|||
27713175|NCT01277549|80785192|FG001|Overall Study|Physician Decision|1|||
27713176|NCT03116698|80785197|FG000|Overall Study|Adverse Event|1|||
27713177|NCT03116698|80785198|FG001|Overall Study|Adverse Event|1|||
27713178|NCT03116698|80785199|FG002|Overall Study|Adverse Event|1|||
27713179|NCT03116698|80785200|FG003|Overall Study|Adverse Event|0|||
27713180|NCT03116698|80785197|FG000|Overall Study|Withdrawal by Subject|1|||
27713181|NCT03116698|80785198|FG001|Overall Study|Withdrawal by Subject|4|||
27713182|NCT03116698|80785199|FG002|Overall Study|Withdrawal by Subject|5|||
27713183|NCT03116698|80785200|FG003|Overall Study|Withdrawal by Subject|2|||
27713184|NCT03116698|80785197|FG000|Overall Study|Lost to Follow-up|2|||
27713185|NCT03116698|80785198|FG001|Overall Study|Lost to Follow-up|0|||
27713186|NCT03116698|80785199|FG002|Overall Study|Lost to Follow-up|0|||
27713187|NCT03116698|80785200|FG003|Overall Study|Lost to Follow-up|0|||
27604393|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Death|0|||
27604394|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Death|4|||
27604395|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
27604396|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
27604397|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
27604398|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
27604399|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
27604400|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
27604401|NCT01392300|80391457|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
27604402|NCT01392300|80391458|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
27604403|NCT01392300|80391459|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
27604404|NCT02569437|80391460|FG000|Overall Study|Lost to Follow-up|12|||
27604405|NCT02569437|80391461|FG001|Overall Study|Lost to Follow-up|14|||
27604406|NCT01669798|80391462|FG000|Overall Study|Physician Decision|5|||
27604407|NCT01480596|80391467|FG000|Overall Study|Adverse Event|3|||
27604408|NCT01480596|80391468|FG001|Overall Study|Adverse Event|0|||
27713188|NCT03116698|80785197|FG000|Overall Study|Physician Decision|1|||
27713189|NCT03116698|80785198|FG001|Overall Study|Physician Decision|1|||
27713190|NCT03116698|80785199|FG002|Overall Study|Physician Decision|0|||
27713191|NCT03116698|80785200|FG003|Overall Study|Physician Decision|0|||
27713192|NCT03116698|80785197|FG000|Overall Study|Protocol Violation|1|||
27713193|NCT03116698|80785198|FG001|Overall Study|Protocol Violation|0|||
27713194|NCT03116698|80785199|FG002|Overall Study|Protocol Violation|0|||
27713195|NCT03116698|80785200|FG003|Overall Study|Protocol Violation|0|||
27713196|NCT03116698|80785197|FG000|Overall Study|Death|0|||
27713197|NCT03116698|80785198|FG001|Overall Study|Death|0|||
27713198|NCT03116698|80785199|FG002|Overall Study|Death|2|||
27713199|NCT03116698|80785200|FG003|Overall Study|Death|0|||
27713200|NCT00761514|80785202|FG000|Overall Study|Adverse Event|1|||
27713201|NCT00761514|80785202|FG000|Overall Study|Withdrawal by Subject|2|||
27713202|NCT00761514|80785202|FG000|Overall Study|Lost to Follow-up|1|||
27713203|NCT00761514|80785202|FG000|Overall Study|Health insurance didn't cover study drug|1|||
27713204|NCT00761514|80785202|FG000|Overall Study|Problem complying with study visit|1|||
27713205|NCT00761514|80785202|FG000|Overall Study|Unable to pay for medications|1|||
27604409|NCT01480596|80391467|FG000|Overall Study|MG exacerbation or change in medication|2|||
27604410|NCT01480596|80391468|FG001|Overall Study|MG exacerbation or change in medication|2|||
27604411|NCT03474549|80391469|FG000|Overall Study|Death|31|||
27713206|NCT03374189|80785205|FG000|Overall Study|Lost to Follow-up|1|||
27713207|NCT03374189|80785206|FG001|Overall Study|Lost to Follow-up|0|||
27713208|NCT01744665|80785213|FG000|Monitoring Phase|Adverse Event|4|||
27713209|NCT01744665|80785213|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
27836997|NCT01567527|81232932|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27836998|NCT01567527|81232933|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27836999|NCT01567527|81232934|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
27837000|NCT01567527|81232935|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27837001|NCT01567527|81232936|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
27837002|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
27837003|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
27889629|NCT01867710|81430854|FG002|Overall Study|Biochemical progression|0|||
27889630|NCT01867710|81430855|FG003|Overall Study|Biochemical progression|0|||
27604412|NCT03474549|80391469|FG000|Overall Study|Lost to Follow-up|4|||
27713210|NCT01744665|80785213|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
27713211|NCT01744665|80785213|FG000|Monitoring Phase|Withdrawal by Subject|5|||
27837004|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
27837005|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
27837006|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
27837007|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
27837008|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
27837009|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
27837010|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
27837011|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
27889631|NCT01867710|81430852|FG000|Overall Study|Clinical progression|0|||
27713212|NCT01744665|80785213|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
27713213|NCT01744665|80785213|FG000|Consolidation Phase|Adverse Event|2|||
27713214|NCT01744665|80785213|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
27713215|NCT01744665|80785213|FG000|Consolidation Phase|Withdrawal by Subject|4|||
27713216|NCT01744665|80785213|FG000|Consolidation Phase|Administrative problems|9|||
27713217|NCT01744665|80785213|FG000|Re-initiation Phase|Administrative problems|10|||
27713218|NCT01744665|80785213|FG000|Re-initiation Phase|Adverse Event|1|||
27713219|NCT01744665|80785213|FG000|Re-initiation Phase|No longer required treatment|1|||
27604413|NCT03474549|80391469|FG000|Overall Study|Withdrawal by Subject|2|||
27604414|NCT00717314|80391470|FG000|Overall Study|Adverse Event|3|||
27604415|NCT00717314|80391471|FG001|Overall Study|Adverse Event|2|||
27604416|NCT00717314|80391470|FG000|Overall Study|Protocol Violation|1|||
27713220|NCT01744665|80785213|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
27604417|NCT00717314|80391471|FG001|Overall Study|Protocol Violation|0|||
27604418|NCT00717314|80391470|FG000|Overall Study|Lost to Follow-up|1|||
27604419|NCT00717314|80391471|FG001|Overall Study|Lost to Follow-up|5|||
27604420|NCT00717314|80391470|FG000|Overall Study|Withdrawal by Subject|1|||
27604421|NCT00717314|80391471|FG001|Overall Study|Withdrawal by Subject|3|||
27604422|NCT02755597|80391478|FG000|Overall Study|Withdrew consent|27|||
27604423|NCT02755597|80391479|FG001|Overall Study|Withdrew consent|11|||
27604424|NCT02755597|80391478|FG000|Overall Study|Lost to Follow-up|1|||
27713221|NCT03505021|80785214|FG000|Overall Study|Protocol Violation|1|||
27713222|NCT03505021|80785215|FG001|Overall Study|Protocol Violation|0|||
27713223|NCT03505021|80785214|FG000|Overall Study|Death|9|||
27713224|NCT03505021|80785215|FG001|Overall Study|Death|8|||
27713225|NCT03505021|80785214|FG000|Overall Study|Consent withdrawn by subject|6|||
27713226|NCT03505021|80785215|FG001|Overall Study|Consent withdrawn by subject|1|||
27713227|NCT03505021|80785214|FG000|Overall Study|Lost to Follow-up|5|||
27713228|NCT03505021|80785215|FG001|Overall Study|Lost to Follow-up|3|||
27713229|NCT03505021|80785214|FG000|Overall Study|Adverse Event|26|||
27713230|NCT03505021|80785215|FG001|Overall Study|Adverse Event|9|||
27713231|NCT03505021|80785214|FG000|Overall Study|Disease progression|33|||
27713232|NCT03505021|80785215|FG001|Overall Study|Disease progression|17|||
27889632|NCT01867710|81430853|FG001|Overall Study|Clinical progression|0|||
27889633|NCT01867710|81430854|FG002|Overall Study|Clinical progression|1|||
27889634|NCT01867710|81430855|FG003|Overall Study|Clinical progression|0|||
27889635|NCT01867710|81430852|FG000|Overall Study|Disease progression|1|||
27889636|NCT01867710|81430853|FG001|Overall Study|Disease progression|0|||
27889637|NCT01867710|81430854|FG002|Overall Study|Disease progression|0|||
27713233|NCT03505021|80785214|FG000|Overall Study|Other|11|||
27713234|NCT03505021|80785215|FG001|Overall Study|Other|5|||
27713235|NCT03505021|80785214|FG000|Overall Study|Personal reason|21|||
27713236|NCT03505021|80785215|FG001|Overall Study|Personal reason|12|||
27713237|NCT01239342|80785216|FG000|Overall Study|Adverse Event|1|||
27713238|NCT01239342|80785217|FG001|Overall Study|Adverse Event|0|||
27713239|NCT01239342|80785216|FG000|Overall Study|Withdrawal by Subject|1|||
27713240|NCT01239342|80785217|FG001|Overall Study|Withdrawal by Subject|5|||
27889638|NCT01867710|81430855|FG003|Overall Study|Disease progression|0|||
27889639|NCT01867710|81430852|FG000|Overall Study|Patient decision|0|||
27889640|NCT01867710|81430853|FG001|Overall Study|Patient decision|0|||
27889641|NCT01867710|81430854|FG002|Overall Study|Patient decision|0|||
27889642|NCT01867710|81430855|FG003|Overall Study|Patient decision|1|||
27889643|NCT01867710|81430852|FG000|Overall Study|Patient to follow subsequent treatment|0|||
27889644|NCT01867710|81430853|FG001|Overall Study|Patient to follow subsequent treatment|1|||
27889645|NCT01867710|81430854|FG002|Overall Study|Patient to follow subsequent treatment|0|||
27889646|NCT01867710|81430855|FG003|Overall Study|Patient to follow subsequent treatment|0|||
27889647|NCT01867710|81430852|FG000|Overall Study|Progressive disease|1|||
27889648|NCT01867710|81430853|FG001|Overall Study|Progressive disease|0|||
27889649|NCT01867710|81430854|FG002|Overall Study|Progressive disease|0|||
27889650|NCT01867710|81430855|FG003|Overall Study|Progressive disease|0|||
27889651|NCT01867710|81430852|FG000|Overall Study|Protocol Violation|0|||
27889652|NCT01867710|81430853|FG001|Overall Study|Protocol Violation|0|||
27889653|NCT01867710|81430854|FG002|Overall Study|Protocol Violation|0|||
27889654|NCT01867710|81430855|FG003|Overall Study|Protocol Violation|1|||
27889655|NCT01867710|81430852|FG000|Overall Study|PSA-progression|0|||
27889656|NCT01867710|81430853|FG001|Overall Study|PSA-progression|1|||
27889657|NCT01867710|81430854|FG002|Overall Study|PSA-progression|0|||
27604425|NCT02755597|80391479|FG001|Overall Study|Lost to Follow-up|0|||
27713241|NCT01239342|80785216|FG000|Overall Study|Reason Unknown|1|||
27889658|NCT01867710|81430855|FG003|Overall Study|PSA-progression|0|||
27889659|NCT01867710|81430852|FG000|Overall Study|Study medication no longer effective|0|||
27889660|NCT01867710|81430853|FG001|Overall Study|Study medication no longer effective|1|||
27713242|NCT01239342|80785217|FG001|Overall Study|Reason Unknown|1|||
27713243|NCT03084536|80785218|FG000|Overall Study|Determined to be ineligible|0|||
27713244|NCT03084536|80785219|FG001|Overall Study|Determined to be ineligible|0|||
27889661|NCT01867710|81430854|FG002|Overall Study|Study medication no longer effective|0|||
27889662|NCT01867710|81430855|FG003|Overall Study|Study medication no longer effective|0|||
27889663|NCT04533412|81430857|FG000|Overall Study|Withdrawal by Subject|1|||
27889664|NCT04533412|81430858|FG001|Overall Study|Withdrawal by Subject|1|||
27889665|NCT04533412|81430857|FG000|Overall Study|Lost to Follow-up|1|||
27889666|NCT04533412|81430858|FG001|Overall Study|Lost to Follow-up|4|||
27889667|NCT05723328|81430869|FG000|Overall Study|Investigator's Decision|5|||
27889668|NCT05723328|81430870|FG001|Overall Study|Investigator's Decision|2|||
27889669|NCT01493284|81430871|FG000|Overall Study|Death|29|||
27889670|NCT01493284|81430871|FG000|Overall Study|Withdrawal by Subject|32|||
27889671|NCT00890084|81430873|FG000|Overall Study|Adverse Event|16|||
27889672|NCT00890084|81430873|FG000|Overall Study|Lost to Follow-up|126|||
27889673|NCT00747474|81430874|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889674|NCT00747474|81430875|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889675|NCT00747474|81430876|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27713245|NCT03084536|80785220|FG002|Overall Study|Determined to be ineligible|16|||
27713246|NCT03084536|80785218|FG000|Overall Study|Withdrawal by Subject|0|||
27713247|NCT03084536|80785219|FG001|Overall Study|Withdrawal by Subject|0|||
27713248|NCT03084536|80785220|FG002|Overall Study|Withdrawal by Subject|4|||
27713249|NCT03084536|80785218|FG000|Overall Study|Physician Decision|0|||
27713250|NCT03084536|80785219|FG001|Overall Study|Physician Decision|0|||
27713251|NCT03084536|80785220|FG002|Overall Study|Physician Decision|3|||
27713252|NCT03084536|80785218|FG000|Overall Study|Death|0|||
27713253|NCT03084536|80785219|FG001|Overall Study|Death|0|||
27713254|NCT03084536|80785220|FG002|Overall Study|Death|1|||
27713255|NCT03084536|80785218|FG000|Overall Study|Lost to Follow-up|0|||
27713256|NCT03084536|80785219|FG001|Overall Study|Lost to Follow-up|0|||
27713257|NCT03084536|80785220|FG002|Overall Study|Lost to Follow-up|1|||
27889676|NCT00747474|81430877|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889677|NCT00747474|81430878|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889678|NCT00747474|81430879|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889679|NCT00747474|81430880|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27604426|NCT02755597|80391478|FG000|Overall Study|Death|78|||
27604427|NCT02755597|80391479|FG001|Overall Study|Death|36|||
27604428|NCT02755597|80391478|FG000|Overall Study|Study terminated by Sponsor|67|||
27604429|NCT02755597|80391479|FG001|Overall Study|Study terminated by Sponsor|47|||
27604430|NCT02755597|80391478|FG000|Overall Study|Other, not specified|20|||
27604431|NCT02755597|80391479|FG001|Overall Study|Other, not specified|3|||
27604432|NCT02755597|80391478|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
27604433|NCT02755597|80391479|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
27604434|NCT01077544|80391482|FG000|Overall Study|New Cancer Therapy|3|||
27604435|NCT01077544|80391483|FG001|Overall Study|New Cancer Therapy|3|||
27889680|NCT00747474|81430881|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
27889681|NCT00747474|81430882|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889682|NCT00747474|81430883|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889683|NCT00747474|81430884|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889684|NCT00747474|81430885|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
27889685|NCT03505593|81430886|FG000|Overall Study|Withdrawal by Subject|1|||
27889686|NCT03505593|81430886|FG000|Overall Study|Died before procedure|1|||
27889687|NCT03505593|81430886|FG000|Overall Study|Anatomical abnormality|1|||
27889688|NCT03505593|81430886|FG000|Overall Study|Unable to pass through esophagus|1|||
27889689|NCT03505593|81430886|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
27889690|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
27889691|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
27889692|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
27889693|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
27889694|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Death|0|||
27889695|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Death|0|||
27889696|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Death|1|||
27889697|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Death|0|||
27889698|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
27889699|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
27889700|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
27889701|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
27889702|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
27889703|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
27889704|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
27889705|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
27889706|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
27889707|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
27889708|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
27713258|NCT03084536|80785218|FG000|Overall Study|Protocol Violation|0|||
27713259|NCT03084536|80785219|FG001|Overall Study|Protocol Violation|0|||
27713260|NCT03084536|80785220|FG002|Overall Study|Protocol Violation|1|||
27713261|NCT03084536|80785218|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
27713262|NCT03084536|80785219|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
27889709|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
27889710|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
27889711|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
27889712|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
27889713|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
27889714|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
27889715|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
27889716|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
27889717|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
27889718|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
27889719|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
27889720|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
27889721|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
27889722|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27889723|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
27889724|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27889725|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27604436|NCT01077544|80391482|FG000|Overall Study|Adverse Event|0|||
27713263|NCT03084536|80785220|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
27713264|NCT02443883|80785221|FG000|Overall Study|Adverse Event|0|||
27713265|NCT02443883|80785222|FG001|Overall Study|Adverse Event|1|||
27713266|NCT02443883|80785223|FG002|Overall Study|Adverse Event|0|||
27713267|NCT02443883|80785224|FG003|Overall Study|Adverse Event|0|||
27713268|NCT02443883|80785221|FG000|Overall Study|Lost to Follow-up|3|||
27713269|NCT02443883|80785222|FG001|Overall Study|Lost to Follow-up|2|||
27713270|NCT02443883|80785223|FG002|Overall Study|Lost to Follow-up|1|||
27713271|NCT02443883|80785224|FG003|Overall Study|Lost to Follow-up|0|||
27889726|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
27889727|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
27889728|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
27604437|NCT01077544|80391483|FG001|Overall Study|Adverse Event|1|||
27889729|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
27889730|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
27889731|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
27889732|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
27889733|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
27889734|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Other|8|||
27889735|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Other|14|||
27604438|NCT01077544|80391482|FG000|Overall Study|Disease Progression|0|||
27604439|NCT01077544|80391483|FG001|Overall Study|Disease Progression|1|||
27604440|NCT02668016|80391484|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
27604441|NCT02668016|80391484|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
27604442|NCT02668016|80391484|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
27604443|NCT02668016|80391484|FG000|Month 4|Withdrawal due to severe symptoms|1|||
27604444|NCT02668016|80391484|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
27604445|NCT02668016|80391484|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
27604446|NCT02668016|80391484|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
27604447|NCT02668016|80391484|FG000|Month 6|Withdrawal due to severe symptoms|2|||
27604448|NCT02668016|80391484|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
27604449|NCT02668016|80391484|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
27604450|NCT02668016|80391484|FG000|Month 8|Withdrawal due to severe symptoms|1|||
27604451|NCT02668016|80391484|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
27604452|NCT02668016|80391484|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
27604453|NCT02668016|80391484|FG000|Month 10|Withdrawal due to severe symptoms|1|||
27604454|NCT02668016|80391484|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
27604455|NCT00768430|80391485|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
27604456|NCT00768430|80391486|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
27604457|NCT03214081|80395140|FG000|Overall Study|Case Report Forms Uncollected|9|||
27604458|NCT03214081|80395140|FG000|Overall Study|Protocol Deviation|54|||
27604459|NCT01919970|80395141|FG000|Overall Study|Withdrawal by Subject|3|||
27604460|NCT01919970|80395142|FG001|Overall Study|Withdrawal by Subject|0|||
27604461|NCT04899245|80395146|FG000|Overall Study|Withdrawal by Subject|3|||
27604462|NCT04899245|80395147|FG001|Overall Study|Withdrawal by Subject|5|||
27604463|NCT04899245|80395148|FG002|Overall Study|Withdrawal by Subject|2|||
27604464|NCT04899245|80395146|FG000|Overall Study|No longer eligible - Left staff position|0|||
27604465|NCT04899245|80395147|FG001|Overall Study|No longer eligible - Left staff position|0|||
27604466|NCT04899245|80395148|FG002|Overall Study|No longer eligible - Left staff position|1|||
27604467|NCT04899245|80395146|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
27604468|NCT04899245|80395147|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
27604469|NCT04899245|80395148|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
27604470|NCT04899245|80395146|FG000|Overall Study|No longer eligible - Moved away from area|2|||
27604471|NCT04899245|80395147|FG001|Overall Study|No longer eligible - Moved away from area|2|||
27604472|NCT04899245|80395148|FG002|Overall Study|No longer eligible - Moved away from area|0|||
27604473|NCT01330433|80395149|FG000|Overall Study|Death|1|||
27604474|NCT01330433|80395150|FG001|Overall Study|Death|3|||
27604475|NCT01330433|80395149|FG000|Overall Study|Lost to Follow-up|1|||
27604476|NCT01330433|80395150|FG001|Overall Study|Lost to Follow-up|0|||
27604477|NCT03315130|80395151|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
27604478|NCT03315130|80395152|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
27713272|NCT02443883|80785221|FG000|Overall Study|Physician Decision|1|||
27713273|NCT02443883|80785222|FG001|Overall Study|Physician Decision|1|||
27713274|NCT02443883|80785223|FG002|Overall Study|Physician Decision|0|||
27713275|NCT02443883|80785224|FG003|Overall Study|Physician Decision|3|||
27837012|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
27837013|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
27837014|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
27837015|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
27837016|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
27837017|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
27837018|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
27837019|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
27837020|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
27837021|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
27837022|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27837023|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27837024|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27713276|NCT02443883|80785221|FG000|Overall Study|Withdrawal by Subject|1|||
27713277|NCT02443883|80785222|FG001|Overall Study|Withdrawal by Subject|0|||
27713278|NCT02443883|80785223|FG002|Overall Study|Withdrawal by Subject|0|||
27713279|NCT02443883|80785224|FG003|Overall Study|Withdrawal by Subject|2|||
27713280|NCT02443883|80785221|FG000|Overall Study|Randomized, but never treated|1|||
27713281|NCT02443883|80785222|FG001|Overall Study|Randomized, but never treated|0|||
27713282|NCT02443883|80785223|FG002|Overall Study|Randomized, but never treated|0|||
27604479|NCT03315130|80395153|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
27604480|NCT03315130|80395154|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
27604481|NCT03315130|80395151|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
27604482|NCT03315130|80395152|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
27604483|NCT03315130|80395153|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
27713283|NCT02443883|80785224|FG003|Overall Study|Randomized, but never treated|0|||
27713284|NCT02232802|80785225|FG000|Period 1|Sponsor request|1|||
27713285|NCT02232802|80785226|FG001|Period 1|Sponsor request|0|||
27713286|NCT02232802|80785225|FG000|Period 1|Adverse Event|1|||
27713287|NCT02232802|80785226|FG001|Period 1|Adverse Event|1|||
27713288|NCT01152021|80785230|FG000|Overall Study|Adverse Event|4|||
27713289|NCT01152021|80785231|FG001|Overall Study|Adverse Event|4|||
27713290|NCT01152021|80785230|FG000|Overall Study|Study drug had expired|1|||
27713291|NCT01152021|80785231|FG001|Overall Study|Study drug had expired|0|||
27713292|NCT01152021|80785230|FG000|Overall Study|Physician Decision|1|||
27713293|NCT01152021|80785231|FG001|Overall Study|Physician Decision|1|||
27713294|NCT01152021|80785230|FG000|Overall Study|No access to study drug in Pharmacy|0|||
27713295|NCT01152021|80785231|FG001|Overall Study|No access to study drug in Pharmacy|1|||
27713296|NCT01187953|80785236|FG000|Overall Study|Death|11|||
27713297|NCT01187953|80785237|FG001|Overall Study|Death|13|||
27604484|NCT03315130|80395154|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
27889736|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Other|8|||
27889737|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Other|23|||
27889738|NCT01106677|81430887|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
27889739|NCT01106677|81430888|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
27889740|NCT01106677|81430889|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
27889741|NCT01106677|81430890|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
27889742|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27889743|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27889744|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
27889745|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
27889746|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Death|0|||
27889747|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Death|0|||
27889748|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Death|0|||
27889749|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Death|1|||
27889750|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
27889751|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
27889752|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
27604485|NCT03315130|80395151|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
27604486|NCT03315130|80395152|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
27604487|NCT03315130|80395153|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
27604488|NCT03315130|80395154|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
27604489|NCT03315130|80395151|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
27604490|NCT03315130|80395152|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
27604491|NCT03315130|80395153|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
27604492|NCT03315130|80395154|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
27604493|NCT03315130|80395151|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
27604494|NCT03315130|80395152|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
27713298|NCT01187953|80785236|FG000|Overall Study|Adverse Event|1|||
27889753|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
27889754|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27889755|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27889756|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27889757|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
27889758|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27889759|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
27889760|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27889761|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
27889762|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27889763|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27889764|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27889765|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
27889766|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27889767|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
27889768|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
27889769|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27889770|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
27889771|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
27889772|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
27889773|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
27713299|NCT01187953|80785237|FG001|Overall Study|Adverse Event|2|||
27837025|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
27837026|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
27837027|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
27837028|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
27837029|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
27837030|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
27837031|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
27837032|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
27713300|NCT01187953|80785236|FG000|Overall Study|Lost to Follow-up|0|||
27837033|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
27837034|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
27713301|NCT01187953|80785237|FG001|Overall Study|Lost to Follow-up|3|||
27889774|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27889775|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27889776|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27889777|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27713302|NCT01187953|80785236|FG000|Overall Study|Withdrawal by Subject|3|||
27713303|NCT01187953|80785237|FG001|Overall Study|Withdrawal by Subject|3|||
27713304|NCT03287219|80785238|FG000|Overall Study|Protocol Violation|0|||
27713305|NCT03287219|80785239|FG001|Overall Study|Protocol Violation|2|||
27713306|NCT00294060|80785240|FG000|Overall Study|Death|225|||
27713307|NCT00294060|80785240|FG000|Overall Study|Other|59|||
27713308|NCT00294060|80785240|FG000|Overall Study|Lost to Follow-up|55|||
27713309|NCT00294060|80785240|FG000|Overall Study|Withdrawal by Subject|11|||
27713310|NCT00294060|80785240|FG000|Overall Study|Physician Decision|797|||
27713311|NCT00294060|80785240|FG000|Overall Study|Medical condition|3|||
27713312|NCT00294060|80785240|FG000|Overall Study|Device explanted/not replaced|23|||
27713313|NCT01970995|80785244|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27713314|NCT01970995|80785245|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27713315|NCT01970995|80785246|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
27713316|NCT01970995|80785244|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
27713317|NCT01970995|80785245|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
27713318|NCT01970995|80785246|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
27713319|NCT04839380|80785247|FG000|Overall Study|Withdrawal by Subject|2|||
27713320|NCT04839380|80785247|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
27713321|NCT00258674|80785248|FG000|Overall Study|Death|32|||
27713322|NCT00258674|80785249|FG001|Overall Study|Death|53|||
27713323|NCT00258674|80785250|FG002|Overall Study|Death|34|||
27713324|NCT00606320|80785254|FG000|Overall Study|Adverse Event|3|||
27713325|NCT00606320|80785254|FG000|Overall Study|Lack of Efficacy|5|||
27713326|NCT00606320|80785254|FG000|Overall Study|Physician Decision|7|||
27713327|NCT00606320|80785254|FG000|Overall Study|Protocol Violation|8|||
27713328|NCT00606320|80785254|FG000|Overall Study|Withdrawal by Subject|10|||
27713329|NCT00606320|80785254|FG000|Overall Study|Progression to depressive phase|4|||
27713330|NCT00446511|80785264|FG000|Overall Study|Adverse Event|7|||
27713331|NCT00446511|80785265|FG001|Overall Study|Adverse Event|2|||
27889778|NCT01106677|81430887|FG000|Extension Period: Week 26 to Week 52|Other|6|||
27889779|NCT01106677|81430888|FG001|Extension Period: Week 26 to Week 52|Other|5|||
27889780|NCT01106677|81430889|FG002|Extension Period: Week 26 to Week 52|Other|8|||
27713332|NCT00446511|80785266|FG002|Overall Study|Adverse Event|3|||
27713333|NCT00446511|80785267|FG003|Overall Study|Adverse Event|1|||
27713334|NCT00446511|80785264|FG000|Overall Study|Protocol Violation|0|||
27713335|NCT00446511|80785265|FG001|Overall Study|Protocol Violation|0|||
27713336|NCT00446511|80785266|FG002|Overall Study|Protocol Violation|0|||
27713337|NCT00446511|80785267|FG003|Overall Study|Protocol Violation|1|||
27713338|NCT00446511|80785264|FG000|Overall Study|Withdrawal by Subject|0|||
27713339|NCT00446511|80785265|FG001|Overall Study|Withdrawal by Subject|0|||
27713340|NCT00446511|80785266|FG002|Overall Study|Withdrawal by Subject|0|||
27713341|NCT00446511|80785267|FG003|Overall Study|Withdrawal by Subject|3|||
27713342|NCT00446511|80785264|FG000|Overall Study|Administrative Problems|3|||
27713343|NCT00446511|80785265|FG001|Overall Study|Administrative Problems|0|||
27713344|NCT00446511|80785266|FG002|Overall Study|Administrative Problems|4|||
27713345|NCT00446511|80785267|FG003|Overall Study|Administrative Problems|1|||
27713346|NCT02343159|80785274|FG000|Overall Study|Early Study Termination|16|||
27713347|NCT02343159|80785275|FG001|Overall Study|Early Study Termination|19|||
27713348|NCT02343159|80785276|FG002|Overall Study|Early Study Termination|23|||
27713349|NCT02343159|80785274|FG000|Overall Study|Physician Decision|2|||
27713350|NCT02343159|80785275|FG001|Overall Study|Physician Decision|0|||
27713351|NCT02343159|80785276|FG002|Overall Study|Physician Decision|1|||
27713352|NCT02343159|80785274|FG000|Overall Study|Withdrawal by Subject|3|||
27713353|NCT02343159|80785275|FG001|Overall Study|Withdrawal by Subject|0|||
27713354|NCT02343159|80785276|FG002|Overall Study|Withdrawal by Subject|2|||
27713355|NCT02343159|80785274|FG000|Overall Study|Lost to Follow-up|0|||
27713356|NCT02343159|80785275|FG001|Overall Study|Lost to Follow-up|2|||
27713357|NCT02343159|80785276|FG002|Overall Study|Lost to Follow-up|2|||
27713358|NCT02343159|80785274|FG000|Overall Study|Adverse Event|4|||
27713359|NCT02343159|80785275|FG001|Overall Study|Adverse Event|4|||
27713360|NCT02343159|80785276|FG002|Overall Study|Adverse Event|2|||
27713361|NCT02343159|80785274|FG000|Overall Study|Sponsor Decision|0|||
27713362|NCT02343159|80785275|FG001|Overall Study|Sponsor Decision|1|||
27713363|NCT02343159|80785276|FG002|Overall Study|Sponsor Decision|0|||
27713364|NCT02343159|80785274|FG000|Overall Study|Enrollment Error|1|||
27713365|NCT02343159|80785275|FG001|Overall Study|Enrollment Error|0|||
27713366|NCT02343159|80785276|FG002|Overall Study|Enrollment Error|0|||
27713367|NCT00081159|80785277|FG000|Overall Study|Withdrawal by Subject|0|||
27713368|NCT00081159|80785278|FG001|Overall Study|Withdrawal by Subject|3|||
27713369|NCT00081159|80785277|FG000|Overall Study|Myelosuppression prior to treatment|0|||
27713370|NCT00081159|80785278|FG001|Overall Study|Myelosuppression prior to treatment|1|||
27713371|NCT00081159|80785277|FG000|Overall Study|Lost to Follow-up|2|||
27713372|NCT00081159|80785278|FG001|Overall Study|Lost to Follow-up|1|||
27713373|NCT02941627|80785279|FG000|Overall Study|Death|1|||
27713374|NCT02941627|80785279|FG000|Overall Study|Surgical failure|1|||
27713375|NCT02941627|80785279|FG000|Overall Study|cholesteatoma prevented implantation|1|||
27713376|NCT02124564|80785288|FG000|Treatment Period|Adverse Event|2|||
27713377|NCT02124564|80785288|FG000|Treatment Period|Lack of Efficacy|3|||
27713378|NCT02124564|80785288|FG000|Treatment Period|Withdrawal by Subject|2|||
27713379|NCT00535132|80785289|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
27713380|NCT00535132|80785290|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
27713381|NCT00535132|80785289|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
27713382|NCT00535132|80785290|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
27713383|NCT02270242|80785291|FG000|Overall Study|Withdrawal by Subject|18|||
27713384|NCT02270242|80785292|FG001|Overall Study|Withdrawal by Subject|25|||
27713385|NCT02270242|80785291|FG000|Overall Study|Lost to Follow-up|41|||
27713386|NCT02270242|80785292|FG001|Overall Study|Lost to Follow-up|27|||
27713387|NCT02270242|80785291|FG000|Overall Study|Physician Decision|0|||
27713388|NCT02270242|80785292|FG001|Overall Study|Physician Decision|1|||
27713389|NCT01372384|80785301|FG000|Overall Study|Progression of disease|3|||
27713390|NCT01227187|80785302|FG000|Overall Study|Physician Decision|0|||
27713391|NCT01227187|80785303|FG001|Overall Study|Physician Decision|0|||
27713392|NCT01227187|80785304|FG002|Overall Study|Physician Decision|0|||
27713393|NCT01227187|80785305|FG003|Overall Study|Physician Decision|1|||
27713394|NCT03461757|80785306|FG000|Overall Study|Adverse Event|1|||
27713395|NCT03461757|80785307|FG001|Overall Study|Adverse Event|0|||
27713396|NCT03461757|80785306|FG000|Overall Study|Lost to Follow-up|13|||
27713397|NCT03461757|80785307|FG001|Overall Study|Lost to Follow-up|7|||
27713398|NCT03461757|80785306|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
27713399|NCT03461757|80785307|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
27713400|NCT03461757|80785306|FG000|Overall Study|Non-compliance with study treatment|0|||
27713401|NCT03461757|80785307|FG001|Overall Study|Non-compliance with study treatment|1|||
27713402|NCT03461757|80785306|FG000|Overall Study|Pregnancy|2|||
27713403|NCT03461757|80785307|FG001|Overall Study|Pregnancy|0|||
27713404|NCT03461757|80785306|FG000|Overall Study|Protocol Violation|1|||
27713405|NCT03461757|80785307|FG001|Overall Study|Protocol Violation|1|||
27713406|NCT03461757|80785306|FG000|Overall Study|Withdrawal by Subject|7|||
27713407|NCT03461757|80785307|FG001|Overall Study|Withdrawal by Subject|7|||
27713408|NCT03461757|80785306|FG000|Overall Study|Other Reasons|1|||
27713409|NCT03461757|80785307|FG001|Overall Study|Other Reasons|4|||
27713410|NCT00763815|80785308|FG000|Overall Study|Adverse Event|14|||
27713411|NCT00763815|80785309|FG001|Overall Study|Adverse Event|29|||
27713412|NCT00763815|80785308|FG000|Overall Study|Lack of Efficacy|10|||
27713413|NCT00763815|80785309|FG001|Overall Study|Lack of Efficacy|11|||
27713414|NCT00763815|80785308|FG000|Overall Study|Poor Compliance to Protocol|6|||
27713415|NCT00763815|80785309|FG001|Overall Study|Poor Compliance to Protocol|6|||
27713416|NCT00763815|80785308|FG000|Overall Study|Lost to Follow-up|2|||
27713417|NCT00763815|80785309|FG001|Overall Study|Lost to Follow-up|4|||
27713418|NCT00763815|80785308|FG000|Overall Study|Early Termination|1|||
27713419|NCT00763815|80785309|FG001|Overall Study|Early Termination|0|||
27713420|NCT00763815|80785308|FG000|Overall Study|Familial and Personal Reasons|9|||
27713421|NCT00763815|80785309|FG001|Overall Study|Familial and Personal Reasons|16|||
27713422|NCT00763815|80785308|FG000|Overall Study|Physician Decision|1|||
27713423|NCT00763815|80785309|FG001|Overall Study|Physician Decision|0|||
27713424|NCT00763815|80785308|FG000|Overall Study|Withdrawal by Subject|7|||
27713425|NCT00763815|80785309|FG001|Overall Study|Withdrawal by Subject|12|||
27713426|NCT00763815|80785308|FG000|Overall Study|Protocol Violation|2|||
27713427|NCT00763815|80785309|FG001|Overall Study|Protocol Violation|5|||
27713428|NCT00763815|80785308|FG000|Overall Study|Sponsor's Decision|0|||
27713429|NCT00763815|80785309|FG001|Overall Study|Sponsor's Decision|1|||
27713430|NCT00343889|80785315|FG000|Overall Study|Lost to Follow-up|2|||
27713431|NCT00343889|80785316|FG001|Overall Study|Lost to Follow-up|0|||
27713432|NCT00343889|80785315|FG000|Overall Study|Withdrawal by Subject|0|||
27713433|NCT00343889|80785316|FG001|Overall Study|Withdrawal by Subject|1|||
27713434|NCT00343889|80785315|FG000|Overall Study|Protocol Violation|1|||
27713435|NCT00343889|80785316|FG001|Overall Study|Protocol Violation|0|||
27713436|NCT01624662|80785317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
27713437|NCT01624662|80785318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
27713438|NCT01624662|80785319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
27713439|NCT01624662|80785320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
27713440|NCT01624662|80785317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
27713441|NCT01624662|80785318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
27713442|NCT01624662|80785319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
27713443|NCT01624662|80785320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
27713444|NCT01624662|80785317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27713445|NCT01624662|80785318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
27837035|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
27837036|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
27713446|NCT01624662|80785319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27713447|NCT01624662|80785320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27713448|NCT01624662|80785317|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
27713449|NCT01624662|80785318|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
27713450|NCT01624662|80785319|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
27713451|NCT01624662|80785320|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
27713452|NCT01624662|80785317|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27713453|NCT01624662|80785318|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27713454|NCT01624662|80785319|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
27713455|NCT01624662|80785320|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27713456|NCT01624662|80785317|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27713457|NCT01624662|80785318|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
27713458|NCT01624662|80785319|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27713459|NCT01624662|80785320|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27713460|NCT01624662|80785317|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27713461|NCT01624662|80785318|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27713462|NCT01624662|80785319|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
27713463|NCT01624662|80785320|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27713464|NCT02236520|80785326|FG000|Overall Study|Physician Decision|0|||
27713465|NCT02236520|80785327|FG001|Overall Study|Physician Decision|5|||
27713466|NCT02236520|80785328|FG002|Overall Study|Physician Decision|0|||
27713467|NCT02236520|80785329|FG003|Overall Study|Physician Decision|0|||
27713468|NCT02236520|80785326|FG000|Overall Study|Withdrawal by Subject|1|||
27713469|NCT02236520|80785327|FG001|Overall Study|Withdrawal by Subject|0|||
27713470|NCT02236520|80785328|FG002|Overall Study|Withdrawal by Subject|0|||
27713471|NCT02236520|80785329|FG003|Overall Study|Withdrawal by Subject|1|||
27713472|NCT02236520|80785326|FG000|Overall Study|Pregnancy|1|||
27713473|NCT02236520|80785327|FG001|Overall Study|Pregnancy|0|||
27713474|NCT02236520|80785328|FG002|Overall Study|Pregnancy|0|||
27713475|NCT02236520|80785329|FG003|Overall Study|Pregnancy|0|||
27713476|NCT01146873|80785330|FG000|Overall Study|Transfer out|0|||
27713477|NCT01146873|80785331|FG001|Overall Study|Transfer out|6|||
27713478|NCT02289742|80785332|FG000|First Wear Period|Adverse event prior to treatment|0|||
27713479|NCT02289742|80785333|FG001|First Wear Period|Adverse event prior to treatment|1|||
27713480|NCT02289742|80785334|FG002|First Wear Period|Adverse event prior to treatment|0|||
27713481|NCT02289742|80785335|FG003|First Wear Period|Adverse event prior to treatment|0|||
27713482|NCT02289742|80785332|FG000|First Wear Period|Adverse Event|0|||
27713483|NCT02289742|80785333|FG001|First Wear Period|Adverse Event|0|||
27713484|NCT02289742|80785334|FG002|First Wear Period|Adverse Event|1|||
27713485|NCT02289742|80785335|FG003|First Wear Period|Adverse Event|0|||
27713486|NCT02289742|80785332|FG000|First Wear Period|Other prior to treatment|0|||
27713487|NCT02289742|80785333|FG001|First Wear Period|Other prior to treatment|0|||
27713488|NCT02289742|80785334|FG002|First Wear Period|Other prior to treatment|0|||
27713489|NCT02289742|80785335|FG003|First Wear Period|Other prior to treatment|1|||
27713490|NCT02289742|80785332|FG000|Third Wear Period|Adverse Event|0|||
27713491|NCT02289742|80785333|FG001|Third Wear Period|Adverse Event|1|||
27713492|NCT02289742|80785334|FG002|Third Wear Period|Adverse Event|0|||
27713493|NCT02289742|80785335|FG003|Third Wear Period|Adverse Event|0|||
27713494|NCT02289742|80785332|FG000|Third Wear Period|Reason not given|0|||
27713495|NCT02289742|80785333|FG001|Third Wear Period|Reason not given|0|||
27713496|NCT02289742|80785334|FG002|Third Wear Period|Reason not given|0|||
27713497|NCT02289742|80785335|FG003|Third Wear Period|Reason not given|1|||
27713498|NCT01611974|80785336|FG000|Overall Study|Death|10|||
27713499|NCT01611974|80785337|FG001|Overall Study|Death|12|||
27713500|NCT01611974|80785338|FG002|Overall Study|Death|10|||
27713501|NCT01611974|80785336|FG000|Overall Study|Lost to Follow-up|0|||
27713502|NCT01611974|80785337|FG001|Overall Study|Lost to Follow-up|1|||
27713503|NCT01611974|80785338|FG002|Overall Study|Lost to Follow-up|0|||
27713504|NCT01611974|80785336|FG000|Overall Study|Physician Decision|5|||
27713505|NCT01611974|80785337|FG001|Overall Study|Physician Decision|1|||
27713506|NCT01611974|80785338|FG002|Overall Study|Physician Decision|2|||
27713507|NCT01611974|80785336|FG000|Overall Study|Withdrawal by Subject|0|||
27713508|NCT01611974|80785337|FG001|Overall Study|Withdrawal by Subject|1|||
27713509|NCT01611974|80785338|FG002|Overall Study|Withdrawal by Subject|4|||
27713510|NCT01883635|80785351|FG000|Overall Study|Withdrawal by Subject|4|||
27713511|NCT01883635|80785352|FG001|Overall Study|Withdrawal by Subject|0|||
27713512|NCT00964743|80785356|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
27713513|NCT01360554|80785358|FG000|Overall Study|Death|359|||
27713514|NCT01360554|80785359|FG001|Overall Study|Death|371|||
27713515|NCT01360554|80785358|FG000|Overall Study|Lost to Follow-up|4|||
27713516|NCT01360554|80785359|FG001|Overall Study|Lost to Follow-up|4|||
27713517|NCT01360554|80785358|FG000|Overall Study|Withdrawal by Subject|23|||
27713518|NCT01360554|80785359|FG001|Overall Study|Withdrawal by Subject|24|||
27713519|NCT01360554|80785358|FG000|Overall Study|Study terminated by sponsor|49|||
27713520|NCT01360554|80785359|FG001|Overall Study|Study terminated by sponsor|37|||
27713521|NCT01360554|80785358|FG000|Overall Study|Other, not specified|1|||
27713522|NCT01360554|80785359|FG001|Overall Study|Other, not specified|0|||
27713523|NCT01360554|80785358|FG000|Overall Study|Randomized but not treated.|3|||
27713524|NCT01360554|80785359|FG001|Overall Study|Randomized but not treated.|3|||
27713525|NCT03917823|80785360|FG000|Overall Study|Lost to Follow-up|1|||
27713526|NCT03917823|80785361|FG001|Overall Study|Lost to Follow-up|1|||
27713527|NCT03917823|80785360|FG000|Overall Study|Withdrawal by Subject|0|||
27713528|NCT03917823|80785361|FG001|Overall Study|Withdrawal by Subject|1|||
27713529|NCT02463409|80785362|FG000|Overall Study|Withdrawal by Subject|1|||
27713530|NCT02463409|80785362|FG000|Overall Study|Screen failure|1|||
27713531|NCT03577730|80785363|FG000|Overall Study|Physician Decision|3|||
27713532|NCT03577730|80785364|FG001|Overall Study|Physician Decision|1|||
27713533|NCT03577730|80785363|FG000|Overall Study|Did not receive allocated intervention|1|||
27713534|NCT03577730|80785364|FG001|Overall Study|Did not receive allocated intervention|0|||
27713535|NCT01399788|80785365|FG000|First Intervention Period|Adverse Event|1|||
27713536|NCT01399788|80785366|FG001|First Intervention Period|Adverse Event|0|||
27713537|NCT00750737|80785376|FG000|Overall Study|Withdrawal by Subject|3|||
27713538|NCT00750737|80785377|FG001|Overall Study|Withdrawal by Subject|3|||
27713539|NCT00385255|80785378|FG000|Overall Study|Serious Adverse Event|1|||
27713540|NCT00385255|80785379|FG001|Overall Study|Serious Adverse Event|2|||
27713541|NCT00385255|80785378|FG000|Overall Study|Protocol Violation|0|||
27713542|NCT00385255|80785379|FG001|Overall Study|Protocol Violation|4|||
27713543|NCT00385255|80785378|FG000|Overall Study|Withdrawal by Subject|0|||
27713544|NCT00385255|80785379|FG001|Overall Study|Withdrawal by Subject|8|||
27713545|NCT00385255|80785378|FG000|Overall Study|Migrated/moved from study area|0|||
27713546|NCT00385255|80785379|FG001|Overall Study|Migrated/moved from study area|1|||
27713547|NCT00385255|80785378|FG000|Overall Study|Lost to Follow-up|20|||
27713548|NCT00385255|80785379|FG001|Overall Study|Lost to Follow-up|58|||
27713549|NCT01183143|80785380|FG000|Overall Study|Protocol Violation|115|||
27713550|NCT01183143|80785380|FG000|Overall Study|Withdrawal by Subject|19|||
27713551|NCT01183143|80785380|FG000|Overall Study|Subject Questionnaires not returned|5|||
27713552|NCT01183143|80785380|FG000|Overall Study|Subjects enrolled, but not treated|11|||
27713553|NCT00143455|80785381|FG000|Cohort 1|Adverse Event|8|||
27713554|NCT00143455|80785382|FG001|Cohort 1|Adverse Event|4|||
27713555|NCT00143455|80785383|FG002|Cohort 1|Adverse Event|0|||
27713556|NCT00143455|80785384|FG003|Cohort 1|Adverse Event|0|||
27713557|NCT00143455|80785381|FG000|Cohort 1|Death|5|||
27713558|NCT00143455|80785382|FG001|Cohort 1|Death|2|||
27713559|NCT00143455|80785383|FG002|Cohort 1|Death|0|||
27713560|NCT00143455|80785384|FG003|Cohort 1|Death|0|||
27713561|NCT00143455|80785381|FG000|Cohort 1|Progressive Disease|0|||
27713562|NCT00143455|80785382|FG001|Cohort 1|Progressive Disease|6|||
27713563|NCT00143455|80785383|FG002|Cohort 1|Progressive Disease|0|||
27713564|NCT00143455|80785384|FG003|Cohort 1|Progressive Disease|0|||
27713565|NCT00143455|80785381|FG000|Cohort 1|Withdrawal by Subject|1|||
27713566|NCT00143455|80785382|FG001|Cohort 1|Withdrawal by Subject|4|||
27713567|NCT00143455|80785383|FG002|Cohort 1|Withdrawal by Subject|0|||
27713568|NCT00143455|80785384|FG003|Cohort 1|Withdrawal by Subject|0|||
27713569|NCT00143455|80785381|FG000|Cohort 1|Randomized But Not Treated|0|||
27713570|NCT00143455|80785382|FG001|Cohort 1|Randomized But Not Treated|1|||
27713571|NCT00143455|80785383|FG002|Cohort 1|Randomized But Not Treated|0|||
27713572|NCT00143455|80785384|FG003|Cohort 1|Randomized But Not Treated|0|||
27713573|NCT00143455|80785381|FG000|Cohort 2|Adverse Event|0|||
27889781|NCT01106677|81430890|FG003|Extension Period: Week 26 to Week 52|Other|5|||
27889782|NCT02163226|81430891|FG000|Overall Study|Death|2|||
27889783|NCT02163226|81430892|FG001|Overall Study|Death|1|||
27889784|NCT02163226|81430891|FG000|Overall Study|Withdrawal by Subject|5|||
27713574|NCT00143455|80785382|FG001|Cohort 2|Adverse Event|0|||
27713575|NCT00143455|80785383|FG002|Cohort 2|Adverse Event|42|||
27713576|NCT00143455|80785384|FG003|Cohort 2|Adverse Event|30|||
27713577|NCT00143455|80785381|FG000|Cohort 2|No Longer Required Study Treatment|0|||
27713578|NCT00143455|80785382|FG001|Cohort 2|No Longer Required Study Treatment|0|||
27713579|NCT00143455|80785383|FG002|Cohort 2|No Longer Required Study Treatment|1|||
27713580|NCT00143455|80785384|FG003|Cohort 2|No Longer Required Study Treatment|0|||
27713581|NCT00143455|80785381|FG000|Cohort 2|Protocol Violation|0|||
27713582|NCT00143455|80785382|FG001|Cohort 2|Protocol Violation|0|||
27713583|NCT00143455|80785383|FG002|Cohort 2|Protocol Violation|1|||
27713584|NCT00143455|80785384|FG003|Cohort 2|Protocol Violation|1|||
27713585|NCT00143455|80785381|FG000|Cohort 2|Lost to Follow-up|0|||
27713586|NCT00143455|80785382|FG001|Cohort 2|Lost to Follow-up|0|||
27713587|NCT00143455|80785383|FG002|Cohort 2|Lost to Follow-up|1|||
27713588|NCT00143455|80785384|FG003|Cohort 2|Lost to Follow-up|4|||
27713589|NCT00143455|80785381|FG000|Cohort 2|Death|0|||
27713590|NCT00143455|80785382|FG001|Cohort 2|Death|0|||
27713591|NCT00143455|80785383|FG002|Cohort 2|Death|20|||
27713592|NCT00143455|80785384|FG003|Cohort 2|Death|12|||
27713593|NCT00143455|80785381|FG000|Cohort 2|Progressive Disease|0|||
27713594|NCT00143455|80785382|FG001|Cohort 2|Progressive Disease|0|||
27713595|NCT00143455|80785383|FG002|Cohort 2|Progressive Disease|20|||
27713596|NCT00143455|80785384|FG003|Cohort 2|Progressive Disease|27|||
27713597|NCT00143455|80785381|FG000|Cohort 2|Withdrawal by Subject|0|||
27713598|NCT00143455|80785382|FG001|Cohort 2|Withdrawal by Subject|0|||
27713599|NCT00143455|80785383|FG002|Cohort 2|Withdrawal by Subject|13|||
27713600|NCT00143455|80785384|FG003|Cohort 2|Withdrawal by Subject|12|||
27713601|NCT00143455|80785381|FG000|Cohort 2|Other|0|||
27713602|NCT00143455|80785382|FG001|Cohort 2|Other|0|||
27713603|NCT00143455|80785383|FG002|Cohort 2|Other|7|||
27713604|NCT00143455|80785384|FG003|Cohort 2|Other|6|||
27713605|NCT00143455|80785381|FG000|Cohort 2|Randomized But Not Treated|0|||
27713606|NCT00143455|80785382|FG001|Cohort 2|Randomized But Not Treated|0|||
27713607|NCT00143455|80785383|FG002|Cohort 2|Randomized But Not Treated|1|||
27713608|NCT00143455|80785384|FG003|Cohort 2|Randomized But Not Treated|1|||
27713609|NCT05121480|80785387|FG000|Overall Study|Lack of Efficacy|2|||
27713610|NCT05121480|80785388|FG001|Overall Study|Lack of Efficacy|2|||
27713611|NCT05121480|80785389|FG002|Overall Study|Lack of Efficacy|1|||
27713612|NCT05121480|80785390|FG003|Overall Study|Lack of Efficacy|4|||
27713613|NCT05121480|80785391|FG004|Overall Study|Lack of Efficacy|0|||
27713614|NCT05121480|80785392|FG005|Overall Study|Lack of Efficacy|1|||
27713615|NCT05121480|80785393|FG006|Overall Study|Lack of Efficacy|0|||
27713616|NCT05121480|80785394|FG007|Overall Study|Lack of Efficacy|2|||
27713617|NCT05121480|80785387|FG000|Overall Study|Treatment Failure|0|||
27604495|NCT03315130|80395153|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
27604496|NCT03315130|80395154|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
27604497|NCT03315130|80395151|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
27604498|NCT03315130|80395152|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
27604499|NCT03315130|80395153|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
27604500|NCT03315130|80395154|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
27604501|NCT03092375|80395155|FG000|Overall Study|Lack of Efficacy|0|||
27604502|NCT03092375|80395156|FG001|Overall Study|Lack of Efficacy|1|||
27604503|NCT03092375|80395157|FG002|Overall Study|Lack of Efficacy|1|||
27713618|NCT05121480|80785388|FG001|Overall Study|Treatment Failure|2|||
27713619|NCT05121480|80785389|FG002|Overall Study|Treatment Failure|0|||
27713620|NCT05121480|80785390|FG003|Overall Study|Treatment Failure|1|||
27713621|NCT05121480|80785391|FG004|Overall Study|Treatment Failure|0|||
27713622|NCT05121480|80785392|FG005|Overall Study|Treatment Failure|0|||
27604504|NCT03092375|80395158|FG003|Overall Study|Lack of Efficacy|0|||
27604505|NCT00847405|80395159|FG000|First Intervention|Adverse Event|0|||
27713623|NCT05121480|80785393|FG006|Overall Study|Treatment Failure|0|||
27713624|NCT05121480|80785394|FG007|Overall Study|Treatment Failure|0|||
27713625|NCT05121480|80785387|FG000|Overall Study|Adverse Event|0|||
27713626|NCT05121480|80785388|FG001|Overall Study|Adverse Event|1|||
27713627|NCT05121480|80785389|FG002|Overall Study|Adverse Event|0|||
27713628|NCT05121480|80785390|FG003|Overall Study|Adverse Event|5|||
27713629|NCT05121480|80785391|FG004|Overall Study|Adverse Event|3|||
27713630|NCT05121480|80785392|FG005|Overall Study|Adverse Event|2|||
27713631|NCT05121480|80785393|FG006|Overall Study|Adverse Event|0|||
27713632|NCT05121480|80785394|FG007|Overall Study|Adverse Event|4|||
27713633|NCT05121480|80785387|FG000|Overall Study|Withdrawal by Subject|4|||
27713634|NCT05121480|80785388|FG001|Overall Study|Withdrawal by Subject|9|||
27713635|NCT05121480|80785389|FG002|Overall Study|Withdrawal by Subject|1|||
27713636|NCT05121480|80785390|FG003|Overall Study|Withdrawal by Subject|8|||
27713637|NCT05121480|80785391|FG004|Overall Study|Withdrawal by Subject|0|||
27713638|NCT05121480|80785392|FG005|Overall Study|Withdrawal by Subject|9|||
27713639|NCT05121480|80785393|FG006|Overall Study|Withdrawal by Subject|0|||
27713640|NCT05121480|80785394|FG007|Overall Study|Withdrawal by Subject|4|||
27713641|NCT05121480|80785387|FG000|Overall Study|Non-compliance with the protocol|0|||
27713642|NCT05121480|80785388|FG001|Overall Study|Non-compliance with the protocol|0|||
27713643|NCT05121480|80785389|FG002|Overall Study|Non-compliance with the protocol|0|||
27713644|NCT05121480|80785390|FG003|Overall Study|Non-compliance with the protocol|0|||
27713645|NCT05121480|80785391|FG004|Overall Study|Non-compliance with the protocol|1|||
27713646|NCT05121480|80785392|FG005|Overall Study|Non-compliance with the protocol|6|||
27713647|NCT05121480|80785393|FG006|Overall Study|Non-compliance with the protocol|0|||
27889785|NCT02163226|81430892|FG001|Overall Study|Withdrawal by Subject|2|||
27889786|NCT02163226|81430891|FG000|Overall Study|Returned home, local radiotherapy|3|||
27889787|NCT02163226|81430892|FG001|Overall Study|Returned home, local radiotherapy|0|||
27713648|NCT05121480|80785394|FG007|Overall Study|Non-compliance with the protocol|1|||
27713649|NCT05121480|80785387|FG000|Overall Study|Lost to Follow-up|0|||
27713650|NCT05121480|80785388|FG001|Overall Study|Lost to Follow-up|4|||
27713651|NCT05121480|80785389|FG002|Overall Study|Lost to Follow-up|1|||
27713652|NCT05121480|80785390|FG003|Overall Study|Lost to Follow-up|3|||
27713653|NCT05121480|80785391|FG004|Overall Study|Lost to Follow-up|1|||
27713654|NCT05121480|80785392|FG005|Overall Study|Lost to Follow-up|1|||
27713655|NCT05121480|80785393|FG006|Overall Study|Lost to Follow-up|1|||
27713656|NCT05121480|80785394|FG007|Overall Study|Lost to Follow-up|4|||
27713657|NCT05121480|80785387|FG000|Overall Study|Physician Decision|0|||
27713658|NCT05121480|80785388|FG001|Overall Study|Physician Decision|0|||
27713659|NCT05121480|80785389|FG002|Overall Study|Physician Decision|0|||
27713660|NCT05121480|80785390|FG003|Overall Study|Physician Decision|0|||
27713661|NCT05121480|80785391|FG004|Overall Study|Physician Decision|0|||
27713662|NCT05121480|80785392|FG005|Overall Study|Physician Decision|1|||
27713663|NCT05121480|80785393|FG006|Overall Study|Physician Decision|0|||
27713664|NCT05121480|80785394|FG007|Overall Study|Physician Decision|1|||
27713665|NCT05121480|80785387|FG000|Overall Study|Other Reason|0|||
27713666|NCT05121480|80785388|FG001|Overall Study|Other Reason|0|||
27713667|NCT05121480|80785389|FG002|Overall Study|Other Reason|0|||
27713668|NCT05121480|80785390|FG003|Overall Study|Other Reason|0|||
27713669|NCT05121480|80785391|FG004|Overall Study|Other Reason|0|||
27713670|NCT05121480|80785392|FG005|Overall Study|Other Reason|1|||
27713671|NCT05121480|80785393|FG006|Overall Study|Other Reason|1|||
27713672|NCT05121480|80785394|FG007|Overall Study|Other Reason|1|||
27713673|NCT00075400|80785400|FG000|Overall Study|Ineligible: wrong primary|1|||
27713674|NCT00075400|80785400|FG000|Overall Study|Never treated|2|||
27713675|NCT01820364|80785402|FG000|Part I: LGX818|Death|1|||
27713676|NCT01820364|80785403|FG001|Part I: LGX818|Death|0|||
27713677|NCT01820364|80785402|FG000|Part I: LGX818|Administrative Problems|3|||
27713678|NCT01820364|80785403|FG001|Part I: LGX818|Administrative Problems|0|||
27713679|NCT01820364|80785402|FG000|Part I: LGX818|Adverse Event|6|||
27713680|NCT01820364|80785403|FG001|Part I: LGX818|Adverse Event|0|||
27713681|NCT01820364|80785402|FG000|Part I: LGX818|Disease Progression|4|||
27713682|NCT01820364|80785403|FG001|Part I: LGX818|Disease Progression|0|||
27713683|NCT01820364|80785402|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
27713684|NCT01820364|80785403|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
27713685|NCT01157364|80785404|FG000|Overall Study|Other Reasons|1|||
27713686|NCT01157364|80785405|FG001|Overall Study|Other Reasons|1|||
27713687|NCT01157364|80785406|FG002|Overall Study|Other Reasons|2|||
27713688|NCT01157364|80785407|FG003|Overall Study|Other Reasons|1|||
27713689|NCT01157364|80785408|FG004|Overall Study|Other Reasons|0|||
27713690|NCT01157364|80785409|FG005|Overall Study|Other Reasons|0|||
27713691|NCT01157364|80785404|FG000|Overall Study|Personal Reasons|0|||
27713692|NCT01157364|80785405|FG001|Overall Study|Personal Reasons|2|||
27713693|NCT01157364|80785406|FG002|Overall Study|Personal Reasons|0|||
27713694|NCT01157364|80785407|FG003|Overall Study|Personal Reasons|0|||
27713695|NCT01157364|80785408|FG004|Overall Study|Personal Reasons|1|||
27713696|NCT01157364|80785409|FG005|Overall Study|Personal Reasons|1|||
27713697|NCT01157364|80785404|FG000|Overall Study|Lost to Follow-up|1|||
27713698|NCT01157364|80785405|FG001|Overall Study|Lost to Follow-up|0|||
27713699|NCT01157364|80785406|FG002|Overall Study|Lost to Follow-up|1|||
27713700|NCT01157364|80785407|FG003|Overall Study|Lost to Follow-up|0|||
27713701|NCT01157364|80785408|FG004|Overall Study|Lost to Follow-up|0|||
27713702|NCT01157364|80785409|FG005|Overall Study|Lost to Follow-up|0|||
27713703|NCT01157364|80785404|FG000|Overall Study|Lack of Efficacy|0|||
27713704|NCT01157364|80785405|FG001|Overall Study|Lack of Efficacy|0|||
27713705|NCT01157364|80785406|FG002|Overall Study|Lack of Efficacy|0|||
27713706|NCT01157364|80785407|FG003|Overall Study|Lack of Efficacy|1|||
27713707|NCT01157364|80785408|FG004|Overall Study|Lack of Efficacy|0|||
27713708|NCT01157364|80785409|FG005|Overall Study|Lack of Efficacy|0|||
27713709|NCT01157364|80785404|FG000|Overall Study|Adverse Event|0|||
27713710|NCT01157364|80785405|FG001|Overall Study|Adverse Event|1|||
27713711|NCT01157364|80785406|FG002|Overall Study|Adverse Event|1|||
27713712|NCT01157364|80785407|FG003|Overall Study|Adverse Event|0|||
27713713|NCT01157364|80785408|FG004|Overall Study|Adverse Event|1|||
27713714|NCT01157364|80785409|FG005|Overall Study|Adverse Event|0|||
27713715|NCT00914927|80785411|FG000|Overall Study|Adverse Event|0|||
27713716|NCT00914927|80785412|FG001|Overall Study|Adverse Event|0|||
27713717|NCT00914927|80785413|FG002|Overall Study|Adverse Event|0|||
27713718|NCT00914927|80785414|FG003|Overall Study|Adverse Event|0|||
27713719|NCT00914927|80785415|FG004|Overall Study|Adverse Event|1|||
27713720|NCT00914927|80785416|FG005|Overall Study|Adverse Event|0|||
27713721|NCT00914927|80785417|FG006|Overall Study|Adverse Event|0|||
27713722|NCT00914927|80785411|FG000|Overall Study|Withdrawal by Subject|0|||
27713723|NCT00914927|80785412|FG001|Overall Study|Withdrawal by Subject|1|||
27713724|NCT00914927|80785413|FG002|Overall Study|Withdrawal by Subject|0|||
27713725|NCT00914927|80785414|FG003|Overall Study|Withdrawal by Subject|1|||
27713726|NCT00914927|80785415|FG004|Overall Study|Withdrawal by Subject|0|||
27713727|NCT00914927|80785416|FG005|Overall Study|Withdrawal by Subject|0|||
27713728|NCT00914927|80785417|FG006|Overall Study|Withdrawal by Subject|0|||
27713729|NCT00914927|80785411|FG000|Overall Study|Lost to Follow-up|0|||
27713730|NCT00914927|80785412|FG001|Overall Study|Lost to Follow-up|0|||
27713731|NCT00914927|80785413|FG002|Overall Study|Lost to Follow-up|0|||
27713732|NCT00914927|80785414|FG003|Overall Study|Lost to Follow-up|1|||
27713733|NCT00914927|80785415|FG004|Overall Study|Lost to Follow-up|0|||
27713734|NCT00914927|80785416|FG005|Overall Study|Lost to Follow-up|0|||
27713735|NCT00914927|80785417|FG006|Overall Study|Lost to Follow-up|0|||
27713736|NCT00914927|80785411|FG000|Overall Study|Administrative/Other|2|||
27713737|NCT00914927|80785412|FG001|Overall Study|Administrative/Other|1|||
27713738|NCT00914927|80785413|FG002|Overall Study|Administrative/Other|0|||
27713739|NCT00914927|80785414|FG003|Overall Study|Administrative/Other|0|||
27713740|NCT00914927|80785415|FG004|Overall Study|Administrative/Other|1|||
27713741|NCT00914927|80785416|FG005|Overall Study|Administrative/Other|0|||
27713742|NCT00914927|80785417|FG006|Overall Study|Administrative/Other|0|||
27713743|NCT02193074|80785418|FG000|Overall Study|Withdrawal by Subject|1|||
27713744|NCT02193074|80785419|FG001|Overall Study|Withdrawal by Subject|2|||
27713745|NCT02193074|80785418|FG000|Overall Study|Adverse Event|16|||
27713746|NCT02193074|80785419|FG001|Overall Study|Adverse Event|13|||
27713747|NCT01118351|80785420|FG000|Overall Study|Adverse Event|3|||
27713748|NCT01118351|80785420|FG000|Overall Study|Withdrawal by Subject|1|||
27713749|NCT00542269|80785424|FG000|Overall Study|Adverse Event|10|||
27713750|NCT00542269|80785425|FG001|Overall Study|Adverse Event|4|||
27713751|NCT00542269|80785426|FG002|Overall Study|Adverse Event|5|||
27713752|NCT00542269|80785424|FG000|Overall Study|Protocol Violation|1|||
27713753|NCT00542269|80785425|FG001|Overall Study|Protocol Violation|1|||
27713754|NCT00542269|80785426|FG002|Overall Study|Protocol Violation|0|||
27713755|NCT00542269|80785424|FG000|Overall Study|Withdrawal by Subject|1|||
27713756|NCT00542269|80785425|FG001|Overall Study|Withdrawal by Subject|0|||
27713757|NCT00542269|80785426|FG002|Overall Study|Withdrawal by Subject|0|||
27713758|NCT00542269|80785424|FG000|Overall Study|Administrative problems|1|||
27713759|NCT00542269|80785425|FG001|Overall Study|Administrative problems|1|||
27889788|NCT02163226|81430891|FG000|Overall Study|Repeat imaging showed no disease|2|||
27889789|NCT02163226|81430892|FG001|Overall Study|Repeat imaging showed no disease|0|||
27889790|NCT02163226|81430891|FG000|Overall Study|Incomplete radiotherapy|3|||
27889791|NCT02163226|81430892|FG001|Overall Study|Incomplete radiotherapy|0|||
27713760|NCT00542269|80785426|FG002|Overall Study|Administrative problems|1|||
27713761|NCT01709149|80785427|FG000|Open-label Lead-in Phase|Adverse Event|109|||
27713762|NCT01709149|80785428|FG001|Open-label Lead-in Phase|Adverse Event|0|||
27889792|NCT02163226|81430891|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
27889793|NCT02163226|81430892|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
27889794|NCT02163226|81430891|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
27889795|NCT02163226|81430892|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
27889796|NCT02163226|81430891|FG000|Overall Study|ineligible|0|||
27889797|NCT02163226|81430892|FG001|Overall Study|ineligible|3|||
27889798|NCT05113979|81430894|FG000|Overall Study|Death|2|||
27889799|NCT05113979|81430894|FG000|Overall Study|Lost to Follow-up|1|||
27889800|NCT02279745|81430899|FG000|Overall Study|Adverse Event|7|||
27889801|NCT02279745|81430899|FG000|Overall Study|Death|6|||
27889802|NCT02279745|81430899|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
27889803|NCT02279745|81430899|FG000|Overall Study|Withdrawal by Subject|2|||
27889804|NCT02279745|81430899|FG000|Overall Study|Pregnancy|1|||
27713763|NCT01709149|80785429|FG002|Open-label Lead-in Phase|Adverse Event|0|||
27713764|NCT01709149|80785427|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
27713765|NCT01709149|80785428|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
27713766|NCT01709149|80785429|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
27713767|NCT01709149|80785427|FG000|Open-label Lead-in Phase|Death|1|||
27713768|NCT01709149|80785428|FG001|Open-label Lead-in Phase|Death|0|||
27713769|NCT01709149|80785429|FG002|Open-label Lead-in Phase|Death|0|||
27713770|NCT01709149|80785427|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
27713771|NCT01709149|80785428|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
27713772|NCT01709149|80785429|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
27713773|NCT01709149|80785427|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27889805|NCT02279745|81430899|FG000|Overall Study|Study Non-compliance|1|||
27889806|NCT02279745|81430899|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
27889807|NCT01385176|81430904|FG000|Randomization Phase|Death|1|||
27889808|NCT01385176|81430905|FG001|Randomization Phase|Death|2|||
27889809|NCT01385176|81430904|FG000|6-18 Month All VNS Active|Death|1|||
27889810|NCT01385176|81430905|FG001|6-18 Month All VNS Active|Death|2|||
27889811|NCT01385176|81430904|FG000|6-18 Month All VNS Active|Physician Decision|0|||
27889812|NCT01385176|81430905|FG001|6-18 Month All VNS Active|Physician Decision|1|||
27713774|NCT01709149|80785428|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
27713775|NCT01709149|80785429|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
27713776|NCT01709149|80785427|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27713777|NCT01709149|80785428|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
27713778|NCT01709149|80785429|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
27713779|NCT01709149|80785427|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27713780|NCT01709149|80785428|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
27713781|NCT01709149|80785429|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
27713782|NCT01709149|80785427|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
27713783|NCT01709149|80785428|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
27713784|NCT01709149|80785429|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
27713785|NCT01709149|80785427|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
27713786|NCT01709149|80785428|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
27713787|NCT01709149|80785429|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
27713788|NCT01709149|80785427|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27713789|NCT01709149|80785428|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
27713790|NCT01709149|80785429|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27889813|NCT01385176|81430904|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
27889814|NCT01385176|81430905|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
27604506|NCT00847405|80395160|FG001|First Intervention|Adverse Event|1|||
27604507|NCT00847405|80395159|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27604508|NCT00847405|80395160|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27604509|NCT03518125|80395161|FG000|Overall Study|Lost to Follow-up|0|||
27604510|NCT03518125|80395162|FG001|Overall Study|Lost to Follow-up|2|||
27604511|NCT03518125|80395163|FG002|Overall Study|Lost to Follow-up|0|||
27604512|NCT03518125|80395164|FG003|Overall Study|Lost to Follow-up|0|||
27713791|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
27713792|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
27754858|NCT01067508|80929626|FG000|Overall Study|Withdrawal by Subject|0|||
27604513|NCT03518125|80395165|FG004|Overall Study|Lost to Follow-up|3|||
27889815|NCT01385176|81430904|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
27604514|NCT03518125|80395166|FG005|Overall Study|Lost to Follow-up|5|||
27604515|NCT03518125|80395161|FG000|Overall Study|Physician Decision|0|||
27604516|NCT03518125|80395162|FG001|Overall Study|Physician Decision|1|||
27889816|NCT01385176|81430905|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
27889817|NCT00809471|81430906|FG000|Overall Study|Protocol non-compliance|15|||
27889818|NCT00809471|81430907|FG001|Overall Study|Protocol non-compliance|15|||
27889819|NCT00809471|81430908|FG002|Overall Study|Protocol non-compliance|6|||
27889820|NCT00809471|81430906|FG000|Overall Study|Lost to Follow-up|4|||
27889821|NCT00809471|81430907|FG001|Overall Study|Lost to Follow-up|2|||
27889822|NCT00809471|81430908|FG002|Overall Study|Lost to Follow-up|9|||
27889823|NCT00809471|81430906|FG000|Overall Study|Adverse Event|0|||
27889824|NCT00809471|81430907|FG001|Overall Study|Adverse Event|2|||
27889825|NCT00809471|81430908|FG002|Overall Study|Adverse Event|2|||
27889826|NCT00809471|81430906|FG000|Overall Study|Requirement for restricted medication|1|||
27889827|NCT00809471|81430907|FG001|Overall Study|Requirement for restricted medication|1|||
27889828|NCT00809471|81430908|FG002|Overall Study|Requirement for restricted medication|0|||
27889829|NCT04672252|81430909|FG000|Overall Study|Protocol Violation|1|||
27889830|NCT04672252|81430910|FG001|Overall Study|Protocol Violation|0|||
27889831|NCT02989649|81430911|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
27889832|NCT02989649|81430911|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
27889833|NCT02989649|81430911|FG000|Overall Study|Lost For Observation During Study|3|||
27889834|NCT02989649|81430911|FG000|Overall Study|Reason Not Specified|13|||
27889835|NCT04713592|81430917|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
27889836|NCT04713592|81430918|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
27889837|NCT04713592|81430919|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
27889838|NCT04713592|81430920|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
27889839|NCT04713592|81430917|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
27889840|NCT04713592|81430918|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
27889841|NCT04713592|81430919|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
27889842|NCT04713592|81430920|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
27889843|NCT04713592|81430917|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
27889844|NCT04713592|81430918|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
27604517|NCT03518125|80395163|FG002|Overall Study|Physician Decision|0|||
27604518|NCT03518125|80395164|FG003|Overall Study|Physician Decision|0|||
27604519|NCT03518125|80395165|FG004|Overall Study|Physician Decision|0|||
27604520|NCT03518125|80395166|FG005|Overall Study|Physician Decision|0|||
27604521|NCT03518125|80395161|FG000|Overall Study|Withdrawal by Subject|1|||
27604522|NCT03518125|80395162|FG001|Overall Study|Withdrawal by Subject|1|||
27713793|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
27713794|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
27889845|NCT04713592|81430919|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
27889846|NCT04713592|81430920|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
27889847|NCT04713592|81430917|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27713795|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
27713796|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
27604523|NCT03518125|80395163|FG002|Overall Study|Withdrawal by Subject|0|||
27713797|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
27713798|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
27604524|NCT03518125|80395164|FG003|Overall Study|Withdrawal by Subject|1|||
27604525|NCT03518125|80395165|FG004|Overall Study|Withdrawal by Subject|1|||
27604526|NCT03518125|80395166|FG005|Overall Study|Withdrawal by Subject|3|||
27604527|NCT03518125|80395161|FG000|Overall Study|Missed Day 394 Visit|1|||
27604528|NCT03518125|80395162|FG001|Overall Study|Missed Day 394 Visit|0|||
27604529|NCT03518125|80395163|FG002|Overall Study|Missed Day 394 Visit|0|||
27604530|NCT03518125|80395164|FG003|Overall Study|Missed Day 394 Visit|0|||
27604531|NCT03518125|80395165|FG004|Overall Study|Missed Day 394 Visit|0|||
27604532|NCT03518125|80395166|FG005|Overall Study|Missed Day 394 Visit|0|||
27604533|NCT01224925|80395168|FG000|Overall Study|Lost to Follow-up|3|||
27604534|NCT01224925|80395169|FG001|Overall Study|Lost to Follow-up|2|||
27604535|NCT02535364|80395172|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
27604536|NCT02535364|80395172|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
27604537|NCT02535364|80395172|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
27604538|NCT02535364|80395172|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
27604539|NCT02535364|80395172|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
27604540|NCT02535364|80395172|FG000|Part B Screening|Death|2|||
27604541|NCT02535364|80395172|FG000|Part B Screening|Physician Decision|1|||
27604542|NCT02535364|80395172|FG000|Part B Screening|Withdrawal by Subject|1|||
27604543|NCT02535364|80395172|FG000|Part B Screening|Adverse Event|1|||
27713799|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to death|4|||
27713800|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to death|3|||
27713801|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
27713802|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
27713803|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
27713804|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
27713805|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
27713806|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
27713807|NCT02258451|80785430|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
27713808|NCT02258451|80785431|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
27713809|NCT02258451|80785430|FG000|Overall Study|Other reason|1|||
27713810|NCT02258451|80785431|FG001|Overall Study|Other reason|1|||
27604544|NCT02535364|80395172|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
27604545|NCT02535364|80395172|FG000|Study Treatment|Death|1|||
27713811|NCT02258451|80785430|FG000|Overall Study|Never treated|2|||
27604546|NCT02535364|80395172|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
27604547|NCT02535364|80395172|FG000|12-Month Follow-up Period|Disease progression|22|||
27604548|NCT02535364|80395172|FG000|12-Month Follow-up Period|Death|5|||
27713812|NCT02258451|80785431|FG001|Overall Study|Never treated|3|||
27713813|NCT03723707|80785432|FG000|Overall Study|Death|32|||
27713814|NCT03723707|80785433|FG001|Overall Study|Death|32|||
27713815|NCT03723707|80785432|FG000|Overall Study|Admitted to long term care|12|||
27713816|NCT03723707|80785433|FG001|Overall Study|Admitted to long term care|12|||
27713817|NCT03723707|80785432|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
27713818|NCT03723707|80785433|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
27713819|NCT03723707|80785432|FG000|Overall Study|Lost to Follow-up|40|||
27713820|NCT03723707|80785433|FG001|Overall Study|Lost to Follow-up|22|||
27713821|NCT03723707|80785432|FG000|Overall Study|Discontinued after study closure|24|||
27713822|NCT03723707|80785433|FG001|Overall Study|Discontinued after study closure|12|||
27713823|NCT00975156|80785434|FG000|Overall Study|Protocol Violation|0|||
27713824|NCT00975156|80785435|FG001|Overall Study|Protocol Violation|1|||
27713825|NCT01773109|80785436|FG000|Overall Study|Symptomatic Progression|2|||
27713826|NCT01773109|80785436|FG000|Overall Study|Death|1|||
27713827|NCT04342871|80785437|FG000|Overall Study|Death|4|||
27713828|NCT04342871|80785437|FG000|Overall Study|Clinical deterioration/illness progression|2|||
27604549|NCT02535364|80395172|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
27604550|NCT02535364|80395172|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
27604551|NCT02535364|80395172|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
27604552|NCT01364922|80395173|FG000|Open-label (OL) Period|Adverse Event|7|||
27604553|NCT01364922|80395174|FG001|Open-label (OL) Period|Adverse Event|0|||
27604554|NCT01364922|80395175|FG002|Open-label (OL) Period|Adverse Event|0|||
27604555|NCT01364922|80395173|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
27604556|NCT01364922|80395174|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
27713829|NCT04342871|80785437|FG000|Overall Study|Did not complete baseline assessments|5|||
27837037|NCT01567527|81232932|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27837038|NCT01567527|81232933|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27837039|NCT01567527|81232934|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27837040|NCT01567527|81232935|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
27837041|NCT01567527|81232936|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
27837042|NCT03234907|81232937|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
27837043|NCT03234907|81232938|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
27837044|NCT03234907|81232939|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27837045|NCT03234907|81232940|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27837046|NCT03234907|81232941|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27837047|NCT03234907|81232942|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
27837048|NCT03234907|81232937|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
27837049|NCT03234907|81232938|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
27837050|NCT03234907|81232939|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27837051|NCT03234907|81232940|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27837052|NCT03234907|81232941|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27837053|NCT03234907|81232942|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
27604557|NCT01364922|80395175|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
27604558|NCT01364922|80395173|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
27837054|NCT03234907|81232937|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
27837055|NCT03234907|81232938|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27837056|NCT03234907|81232939|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27837057|NCT03234907|81232940|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27713830|NCT04342871|80785437|FG000|Overall Study|Lost to Follow-up|13|||
27713831|NCT00053417|80785439|FG000|Overall Study|Adverse Event|1|||
27713832|NCT00053417|80785440|FG001|Overall Study|Adverse Event|0|||
27837058|NCT03234907|81232941|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27604559|NCT01364922|80395174|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
27604560|NCT01364922|80395175|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
27713833|NCT00053417|80785441|FG002|Overall Study|Adverse Event|1|||
27713834|NCT00053417|80785442|FG003|Overall Study|Adverse Event|5|||
27604561|NCT01364922|80395173|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
27604562|NCT01364922|80395174|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
27713835|NCT00053417|80785439|FG000|Overall Study|Non-Compliance|0|||
27713836|NCT00053417|80785440|FG001|Overall Study|Non-Compliance|0|||
27713837|NCT00053417|80785441|FG002|Overall Study|Non-Compliance|0|||
27713838|NCT00053417|80785442|FG003|Overall Study|Non-Compliance|1|||
27713839|NCT00053417|80785439|FG000|Overall Study|Withdrawal by Subject|0|||
27713840|NCT00053417|80785440|FG001|Overall Study|Withdrawal by Subject|1|||
27713841|NCT00053417|80785441|FG002|Overall Study|Withdrawal by Subject|0|||
27713842|NCT00053417|80785442|FG003|Overall Study|Withdrawal by Subject|0|||
27713843|NCT00053417|80785439|FG000|Overall Study|Lost to Follow-up|1|||
27713844|NCT00053417|80785440|FG001|Overall Study|Lost to Follow-up|1|||
27713845|NCT00053417|80785441|FG002|Overall Study|Lost to Follow-up|0|||
27713846|NCT00053417|80785442|FG003|Overall Study|Lost to Follow-up|0|||
27713847|NCT01982292|80788773|FG000|Overall Study|Adverse Event|2|||
27713848|NCT01982292|80788774|FG001|Overall Study|Adverse Event|0|||
27713849|NCT01982292|80788773|FG000|Overall Study|Death|1|||
27713850|NCT01982292|80788774|FG001|Overall Study|Death|0|||
27713851|NCT01982292|80788773|FG000|Overall Study|Lost to Follow-up|2|||
27713852|NCT01982292|80788774|FG001|Overall Study|Lost to Follow-up|0|||
27713853|NCT01982292|80788773|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
27713854|NCT01982292|80788774|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
27713855|NCT01982292|80788773|FG000|Overall Study|Protocol Deviation|1|||
27713856|NCT01982292|80788774|FG001|Overall Study|Protocol Deviation|0|||
27713857|NCT01982292|80788773|FG000|Overall Study|Patient/Guardian Decision|3|||
27713858|NCT01982292|80788774|FG001|Overall Study|Patient/Guardian Decision|1|||
27713859|NCT01982292|80788773|FG000|Overall Study|Technical Problems|2|||
27713860|NCT01982292|80788774|FG001|Overall Study|Technical Problems|0|||
27713861|NCT01650636|80788775|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
27713862|NCT01650636|80788776|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
27713863|NCT01650636|80788775|FG000|Washout up to 5 Months|Physician Decision|2|||
27713864|NCT01650636|80788776|FG001|Washout up to 5 Months|Physician Decision|2|||
27713865|NCT01650636|80788775|FG000|Washout up to 5 Months|Death|1|||
27713866|NCT01650636|80788776|FG001|Washout up to 5 Months|Death|0|||
27713867|NCT01650636|80788775|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
27713868|NCT01650636|80788776|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
27713869|NCT01650636|80788775|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
27713870|NCT01650636|80788776|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
27713871|NCT01650636|80788775|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
27604563|NCT01364922|80395175|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
27604564|NCT01364922|80395173|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
27604565|NCT01364922|80395174|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
27604566|NCT01364922|80395175|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
27604567|NCT01364922|80395173|FG000|Open-label (OL) Period|Other, Unspecified|1|||
27604568|NCT01364922|80395174|FG001|Open-label (OL) Period|Other, Unspecified|0|||
27604569|NCT01364922|80395175|FG002|Open-label (OL) Period|Other, Unspecified|0|||
27889848|NCT04713592|81430918|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27604570|NCT01364922|80395173|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
27604571|NCT01364922|80395174|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
27604572|NCT01364922|80395175|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
27604573|NCT01364922|80395173|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
27604574|NCT01364922|80395174|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
27604575|NCT01364922|80395175|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
27604576|NCT01364922|80395173|FG000|Double-Blind (DB) Period|Adverse Event|0|||
27713872|NCT01650636|80788776|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
27713873|NCT00498173|80788777|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
27713874|NCT00498173|80788778|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
27713875|NCT00498173|80788779|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
27713876|NCT04623242|80788780|FG000|Overall Study|Withdrawal by Subject|7|||
27713877|NCT04623242|80788781|FG001|Overall Study|Withdrawal by Subject|12|||
27889849|NCT04713592|81430919|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
27713878|NCT04623242|80788782|FG002|Overall Study|Withdrawal by Subject|5|||
27604577|NCT01364922|80395174|FG001|Double-Blind (DB) Period|Adverse Event|0|||
27889850|NCT04713592|81430920|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
27889851|NCT04713592|81430917|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
27604578|NCT01364922|80395175|FG002|Double-Blind (DB) Period|Adverse Event|1|||
27604579|NCT01364922|80395173|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
27604580|NCT01364922|80395174|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
27604581|NCT01364922|80395175|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
27713879|NCT04623242|80788783|FG003|Overall Study|Withdrawal by Subject|7|||
27713880|NCT04623242|80788784|FG004|Overall Study|Withdrawal by Subject|0|||
27713881|NCT04623242|80788780|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
27713882|NCT04623242|80788781|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
27713883|NCT04623242|80788782|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
27713884|NCT04623242|80788783|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
27713885|NCT04623242|80788784|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
27713886|NCT04623242|80788780|FG000|Overall Study|Subject unblinded to mutation status|0|||
27713887|NCT04623242|80788781|FG001|Overall Study|Subject unblinded to mutation status|0|||
27713888|NCT04623242|80788782|FG002|Overall Study|Subject unblinded to mutation status|0|||
27713889|NCT04623242|80788783|FG003|Overall Study|Subject unblinded to mutation status|13|||
27713890|NCT04623242|80788784|FG004|Overall Study|Subject unblinded to mutation status|0|||
27713891|NCT04486950|80788786|FG000|Overall Study|Lost to Follow-up|0|||
27713892|NCT04486950|80788787|FG001|Overall Study|Lost to Follow-up|0|||
27837059|NCT03234907|81232942|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
27837060|NCT03234907|81232937|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
27837061|NCT03234907|81232938|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
27837062|NCT03234907|81232939|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27837063|NCT03234907|81232940|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27837064|NCT03234907|81232941|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27713893|NCT04486950|80788788|FG002|Overall Study|Lost to Follow-up|0|||
27713894|NCT04486950|80788789|FG003|Overall Study|Lost to Follow-up|0|||
27713895|NCT04486950|80788790|FG004|Overall Study|Lost to Follow-up|0|||
27713896|NCT04486950|80788791|FG005|Overall Study|Lost to Follow-up|1|||
27713897|NCT04486950|80788792|FG006|Overall Study|Lost to Follow-up|0|||
27713898|NCT03368170|80788796|FG000|Overall Study|Adverse Event|2|||
27837065|NCT03234907|81232942|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
27713899|NCT03368170|80788797|FG001|Overall Study|Adverse Event|1|||
27713900|NCT01652885|80788800|FG000|Overall Study|Adverse Event|1|||
27713901|NCT04317274|80788801|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
27713902|NCT04317274|80788802|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
27713903|NCT04317274|80788803|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
27713904|NCT04317274|80788804|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
27713905|NCT02069899|80788805|FG000|Overall Study|Adverse Event|6|||
27713906|NCT02069899|80788806|FG001|Overall Study|Adverse Event|0|||
27713907|NCT02069899|80788807|FG002|Overall Study|Adverse Event|1|||
27713908|NCT02069899|80788805|FG000|Overall Study|Withdrawal by Participant|2|||
27713909|NCT02069899|80788806|FG001|Overall Study|Withdrawal by Participant|0|||
27713910|NCT02069899|80788807|FG002|Overall Study|Withdrawal by Participant|0|||
27713911|NCT02069899|80788805|FG000|Overall Study|Lost to Follow-up|1|||
27713912|NCT02069899|80788806|FG001|Overall Study|Lost to Follow-up|0|||
27713913|NCT02069899|80788807|FG002|Overall Study|Lost to Follow-up|1|||
27713914|NCT02069899|80788805|FG000|Overall Study|Other|4|||
27713915|NCT02069899|80788806|FG001|Overall Study|Other|0|||
27713916|NCT02069899|80788807|FG002|Overall Study|Other|0|||
27713917|NCT02069899|80788805|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
27713918|NCT02069899|80788806|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
27713919|NCT02069899|80788807|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
27713920|NCT02069899|80788805|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
27713921|NCT02069899|80788806|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
27713922|NCT02069899|80788807|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
27713923|NCT01576549|80788811|FG000|Overall Study|Sponsor Decision|2|||
27713924|NCT02192827|80788812|FG000|Overall Study|Lost to Follow-up|25|||
27713925|NCT02192827|80788813|FG001|Overall Study|Lost to Follow-up|27|||
27713926|NCT02192827|80788812|FG000|Overall Study|Given additional steroids with admission|13|||
27604582|NCT04067401|80395176|FG000|Overall Study|Withdrawal by Subject|7|||
27713927|NCT02192827|80788813|FG001|Overall Study|Given additional steroids with admission|11|||
27604583|NCT04067401|80395177|FG001|Overall Study|Withdrawal by Subject|0|||
27713928|NCT01326546|80788814|FG000|Overall Study|Lost to Follow-up|8|||
27713929|NCT01326546|80788815|FG001|Overall Study|Lost to Follow-up|7|||
27837066|NCT03234907|81232937|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
27837067|NCT03234907|81232938|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
27837068|NCT03234907|81232939|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
27837069|NCT03234907|81232940|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
27837070|NCT03234907|81232941|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
27837071|NCT03234907|81232942|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
27837072|NCT03234907|81232937|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
27837073|NCT03234907|81232938|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
27837074|NCT03234907|81232939|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
27604584|NCT04067401|80395176|FG000|Overall Study|no data provided|1|||
27604585|NCT04067401|80395177|FG001|Overall Study|no data provided|0|||
27604586|NCT01489189|80395178|FG000|Overall Study|Withdrawal by Subject|20|||
27604587|NCT01489189|80395179|FG001|Overall Study|Withdrawal by Subject|23|||
27604588|NCT01489189|80395178|FG000|Overall Study|Death|10|||
27713930|NCT01326546|80788814|FG000|Overall Study|Protocol Violation|3|||
27713931|NCT01326546|80788815|FG001|Overall Study|Protocol Violation|4|||
27713932|NCT01326546|80788814|FG000|Overall Study|Pregnancy|0|||
27713933|NCT01326546|80788815|FG001|Overall Study|Pregnancy|1|||
27713934|NCT01326546|80788814|FG000|Overall Study|Adverse Event|1|||
27713935|NCT01326546|80788815|FG001|Overall Study|Adverse Event|0|||
27713936|NCT01326546|80788814|FG000|Overall Study|Withdrawal by Subject|5|||
27713937|NCT01326546|80788815|FG001|Overall Study|Withdrawal by Subject|1|||
27713938|NCT02770547|80788816|FG000|Overall Study|Patient non-compliant|1|||
27713939|NCT02770547|80788817|FG001|Overall Study|Patient non-compliant|0|||
27713940|NCT02770547|80788816|FG000|Overall Study|Adverse Event|0|||
27713941|NCT02770547|80788817|FG001|Overall Study|Adverse Event|1|||
27713942|NCT00271596|80788818|FG000|Overall Study|Protocol Violation|1|||
27604589|NCT01489189|80395179|FG001|Overall Study|Death|8|||
27713943|NCT00271596|80788819|FG001|Overall Study|Protocol Violation|0|||
27713944|NCT00271596|80788818|FG000|Overall Study|Withdrawal by Subject|0|||
27713945|NCT00271596|80788819|FG001|Overall Study|Withdrawal by Subject|1|||
27713946|NCT03652662|80788825|FG000|Overall Study|Withdrawal by Subject|2|||
27713947|NCT03652662|80788826|FG001|Overall Study|Withdrawal by Subject|1|||
27713948|NCT03652662|80788825|FG000|Overall Study|Lost to Follow-up|1|||
27713949|NCT03652662|80788826|FG001|Overall Study|Lost to Follow-up|0|||
27713950|NCT04153188|80788829|FG000|Overall Study|Lost to Follow-up|1|||
27713951|NCT04153188|80788830|FG001|Overall Study|Lost to Follow-up|1|||
27713952|NCT04153188|80788829|FG000|Overall Study|Withdrawal by Subject|2|||
27713953|NCT04153188|80788830|FG001|Overall Study|Withdrawal by Subject|0|||
27713954|NCT04153188|80788829|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
27713955|NCT04153188|80788830|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
27713956|NCT00879645|80788831|FG000|Overall Study|Adverse Event|1|||
27713957|NCT00879645|80788832|FG001|Overall Study|Adverse Event|0|||
27713958|NCT00879645|80788833|FG002|Overall Study|Adverse Event|0|||
27713959|NCT00879645|80788834|FG003|Overall Study|Adverse Event|0|||
27713960|NCT02590588|80788837|FG000|Overall Study|Adverse Event|1|||
27889852|NCT04713592|81430918|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
27604590|NCT01489189|80395178|FG000|Overall Study|Missed Visit|1|||
27713961|NCT04418076|80788838|FG000|Overall Study|Death|1|||
27713962|NCT04418076|80788839|FG001|Overall Study|Death|0|||
27713963|NCT04418076|80788840|FG002|Overall Study|Death|0|||
27713964|NCT04418076|80788841|FG003|Overall Study|Death|0|||
27713965|NCT04418076|80788838|FG000|Overall Study|Lost to Follow-up|2|||
27837075|NCT03234907|81232940|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
27837076|NCT03234907|81232941|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
27604591|NCT01489189|80395179|FG001|Overall Study|Missed Visit|4|||
27713966|NCT04418076|80788839|FG001|Overall Study|Lost to Follow-up|5|||
27713967|NCT04418076|80788840|FG002|Overall Study|Lost to Follow-up|1|||
27713968|NCT04418076|80788841|FG003|Overall Study|Lost to Follow-up|2|||
27713969|NCT04418076|80788838|FG000|Overall Study|Withdrawal by Subject|1|||
27713970|NCT04418076|80788839|FG001|Overall Study|Withdrawal by Subject|0|||
27713971|NCT04418076|80788840|FG002|Overall Study|Withdrawal by Subject|1|||
27713972|NCT04418076|80788841|FG003|Overall Study|Withdrawal by Subject|1|||
27713973|NCT04418076|80788838|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
27713974|NCT04418076|80788839|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
27713975|NCT04418076|80788840|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
27713976|NCT04418076|80788841|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
27713977|NCT03548935|80788849|FG000|Overall Study|Withdrawal by Subject|26|||
27713978|NCT03548935|80788850|FG001|Overall Study|Withdrawal by Subject|17|||
27713979|NCT03548935|80788849|FG000|Overall Study|Lost to Follow-up|39|||
27713980|NCT03548935|80788850|FG001|Overall Study|Lost to Follow-up|28|||
27713981|NCT03548935|80788849|FG000|Overall Study|Death|1|||
27713982|NCT03548935|80788850|FG001|Overall Study|Death|1|||
27713983|NCT01309659|80788855|FG000|Overall Study|Protocol Violation|0|||
27713984|NCT01309659|80788856|FG001|Overall Study|Protocol Violation|1|||
27713985|NCT00082888|80788859|FG000|Overall Study|Ineligible|1|||
27713986|NCT00082888|80788860|FG001|Overall Study|Ineligible|0|||
27713987|NCT00082888|80788861|FG002|Overall Study|Ineligible|0|||
27713988|NCT01135498|80788865|FG000|Overall Study|Adverse Event|20|||
27713989|NCT01135498|80788865|FG000|Overall Study|Progressive disease|38|||
27713990|NCT01135498|80788865|FG000|Overall Study|Investigator judgement|25|||
27713991|NCT01135498|80788865|FG000|Overall Study|Withdrawal by Subject|4|||
27713992|NCT01135498|80788865|FG000|Overall Study|Death|1|||
27713993|NCT01135498|80788865|FG000|Overall Study|Ongoing at time of analysis|2|||
27713994|NCT02187471|80788868|FG000|Overall Study|Protocol Violation|4|||
27713995|NCT02187471|80788869|FG001|Overall Study|Protocol Violation|5|||
27713996|NCT02187471|80788870|FG002|Overall Study|Protocol Violation|4|||
27713997|NCT02187471|80788871|FG003|Overall Study|Protocol Violation|4|||
27713998|NCT02187471|80788868|FG000|Overall Study|Missing|0|||
27713999|NCT02187471|80788869|FG001|Overall Study|Missing|0|||
27714000|NCT02187471|80788870|FG002|Overall Study|Missing|0|||
27714001|NCT02187471|80788871|FG003|Overall Study|Missing|1|||
27714002|NCT02187471|80788868|FG000|Overall Study|Lack of Efficacy|18|||
27714003|NCT02187471|80788869|FG001|Overall Study|Lack of Efficacy|9|||
27714004|NCT02187471|80788870|FG002|Overall Study|Lack of Efficacy|13|||
27714005|NCT02187471|80788871|FG003|Overall Study|Lack of Efficacy|11|||
27714006|NCT02187471|80788868|FG000|Overall Study|Adverse Event|24|||
27714007|NCT02187471|80788869|FG001|Overall Study|Adverse Event|34|||
27714008|NCT02187471|80788870|FG002|Overall Study|Adverse Event|44|||
27714009|NCT02187471|80788871|FG003|Overall Study|Adverse Event|36|||
27714010|NCT02187471|80788868|FG000|Overall Study|Withdrawal by Subject|23|||
27714011|NCT02187471|80788869|FG001|Overall Study|Withdrawal by Subject|29|||
27714012|NCT02187471|80788870|FG002|Overall Study|Withdrawal by Subject|22|||
27714013|NCT02187471|80788871|FG003|Overall Study|Withdrawal by Subject|24|||
27714014|NCT02187471|80788868|FG000|Overall Study|Other|7|||
27714015|NCT02187471|80788869|FG001|Overall Study|Other|5|||
27714016|NCT02187471|80788870|FG002|Overall Study|Other|3|||
27714017|NCT02187471|80788871|FG003|Overall Study|Other|4|||
27714018|NCT01308008|80788872|FG000|4 Weeks|Illness, disinterest, time|9|||
27714019|NCT01308008|80788873|FG001|4 Weeks|Illness, disinterest, time|2|||
27837077|NCT03234907|81232942|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
27837078|NCT03234907|81232937|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
27837079|NCT03234907|81232938|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
27837080|NCT03234907|81232939|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
27837081|NCT03234907|81232940|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
27714020|NCT01709435|80788875|FG000|Overall Study|Adverse Event|1|||
27714021|NCT01709435|80788876|FG001|Overall Study|Adverse Event|1|||
27714022|NCT01709435|80788877|FG002|Overall Study|Adverse Event|1|||
27714023|NCT01709435|80788878|FG003|Overall Study|Adverse Event|0|||
27714024|NCT01709435|80788879|FG004|Overall Study|Adverse Event|0|||
27714025|NCT01709435|80788880|FG005|Overall Study|Adverse Event|1|||
27714026|NCT01709435|80788875|FG000|Overall Study|Lack of Efficacy|5|||
27714027|NCT01709435|80788876|FG001|Overall Study|Lack of Efficacy|7|||
27714028|NCT01709435|80788877|FG002|Overall Study|Lack of Efficacy|2|||
27714029|NCT01709435|80788878|FG003|Overall Study|Lack of Efficacy|2|||
27714030|NCT01709435|80788879|FG004|Overall Study|Lack of Efficacy|6|||
27714031|NCT01709435|80788880|FG005|Overall Study|Lack of Efficacy|3|||
27714032|NCT01709435|80788875|FG000|Overall Study|Physician Decision|0|||
27714033|NCT01709435|80788876|FG001|Overall Study|Physician Decision|1|||
27714034|NCT01709435|80788877|FG002|Overall Study|Physician Decision|0|||
27714035|NCT01709435|80788878|FG003|Overall Study|Physician Decision|1|||
27714036|NCT01709435|80788879|FG004|Overall Study|Physician Decision|2|||
27714037|NCT01709435|80788880|FG005|Overall Study|Physician Decision|0|||
27714038|NCT01709435|80788875|FG000|Overall Study|Withdrawal by Subject|0|||
27714039|NCT01709435|80788876|FG001|Overall Study|Withdrawal by Subject|0|||
27714040|NCT01709435|80788877|FG002|Overall Study|Withdrawal by Subject|3|||
27714041|NCT01709435|80788878|FG003|Overall Study|Withdrawal by Subject|0|||
27714042|NCT01709435|80788879|FG004|Overall Study|Withdrawal by Subject|2|||
27714043|NCT01709435|80788880|FG005|Overall Study|Withdrawal by Subject|2|||
27714044|NCT01265550|80788881|FG000|Pre Randomization|Withdrawal by Subject|0|||
27714045|NCT01265550|80788882|FG001|Pre Randomization|Withdrawal by Subject|0|||
27714046|NCT01265550|80788883|FG002|Pre Randomization|Withdrawal by Subject|0|||
27714047|NCT01265550|80788884|FG003|Pre Randomization|Withdrawal by Subject|70|||
27714048|NCT01265550|80788881|FG000|Pre Randomization|Technical Exclusions|0|||
27714049|NCT01265550|80788882|FG001|Pre Randomization|Technical Exclusions|0|||
27714050|NCT01265550|80788883|FG002|Pre Randomization|Technical Exclusions|0|||
27714051|NCT01265550|80788884|FG003|Pre Randomization|Technical Exclusions|54|||
27714052|NCT01265550|80788881|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
27714053|NCT01265550|80788882|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
27714054|NCT01265550|80788883|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
27714055|NCT01265550|80788884|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
27714056|NCT01265550|80788881|FG000|Pre Randomization|Non-GERD organic disorders|0|||
27714057|NCT01265550|80788882|FG001|Pre Randomization|Non-GERD organic disorders|0|||
27714058|NCT01265550|80788883|FG002|Pre Randomization|Non-GERD organic disorders|0|||
27714059|NCT01265550|80788884|FG003|Pre Randomization|Non-GERD organic disorders|23|||
27714060|NCT01265550|80788881|FG000|Pre Randomization|Functional heartburn|0|||
27714061|NCT01265550|80788882|FG001|Pre Randomization|Functional heartburn|0|||
27714062|NCT01265550|80788883|FG002|Pre Randomization|Functional heartburn|0|||
27714063|NCT01265550|80788884|FG003|Pre Randomization|Functional heartburn|99|||
27714064|NCT02595723|80788885|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
27714065|NCT02595723|80788886|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
27714066|NCT02595723|80788887|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
27714067|NCT02595723|80788885|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
27714068|NCT02595723|80788886|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
27714069|NCT02595723|80788887|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
27714070|NCT01180660|80788892|FG000|Overall Study|Changed to open surgery|1|||
27714071|NCT01180660|80788893|FG001|Overall Study|Changed to open surgery|0|||
27714072|NCT01425008|80788894|FG000|Dose Escalation Phase|Progressive Disease|2|||
27714073|NCT01425008|80788895|FG001|Dose Escalation Phase|Progressive Disease|3|||
27714074|NCT01425008|80788896|FG002|Dose Escalation Phase|Progressive Disease|2|||
27714075|NCT01425008|80788897|FG003|Dose Escalation Phase|Progressive Disease|3|||
27714076|NCT01425008|80788898|FG004|Dose Escalation Phase|Progressive Disease|5|||
27714077|NCT01425008|80788899|FG005|Dose Escalation Phase|Progressive Disease|4|||
27714078|NCT01425008|80788900|FG006|Dose Escalation Phase|Progressive Disease|0|||
27714079|NCT01425008|80788901|FG007|Dose Escalation Phase|Progressive Disease|2|||
27714080|NCT01425008|80788902|FG008|Dose Escalation Phase|Progressive Disease|6|||
27714081|NCT01425008|80788903|FG009|Dose Escalation Phase|Progressive Disease|2|||
27714082|NCT01425008|80788904|FG010|Dose Escalation Phase|Progressive Disease|0|||
27714083|NCT01425008|80788905|FG011|Dose Escalation Phase|Progressive Disease|0|||
27714084|NCT01425008|80788906|FG012|Dose Escalation Phase|Progressive Disease|0|||
27714085|NCT01425008|80788907|FG013|Dose Escalation Phase|Progressive Disease|0|||
27714086|NCT01425008|80788908|FG014|Dose Escalation Phase|Progressive Disease|0|||
27714087|NCT01425008|80788909|FG015|Dose Escalation Phase|Progressive Disease|0|||
27714088|NCT01425008|80788910|FG016|Dose Escalation Phase|Progressive Disease|0|||
27714089|NCT01425008|80788911|FG017|Dose Escalation Phase|Progressive Disease|0|||
27714090|NCT01425008|80788912|FG018|Dose Escalation Phase|Progressive Disease|0|||
27714091|NCT01425008|80788894|FG000|Dose Escalation Phase|Adverse Event|2|||
27714092|NCT01425008|80788895|FG001|Dose Escalation Phase|Adverse Event|0|||
27714093|NCT01425008|80788896|FG002|Dose Escalation Phase|Adverse Event|0|||
27714094|NCT01425008|80788897|FG003|Dose Escalation Phase|Adverse Event|0|||
27714095|NCT01425008|80788898|FG004|Dose Escalation Phase|Adverse Event|0|||
27714096|NCT01425008|80788899|FG005|Dose Escalation Phase|Adverse Event|2|||
27714097|NCT01425008|80788900|FG006|Dose Escalation Phase|Adverse Event|0|||
27714098|NCT01425008|80788901|FG007|Dose Escalation Phase|Adverse Event|0|||
27714099|NCT01425008|80788902|FG008|Dose Escalation Phase|Adverse Event|2|||
27714100|NCT01425008|80788903|FG009|Dose Escalation Phase|Adverse Event|0|||
27714101|NCT01425008|80788904|FG010|Dose Escalation Phase|Adverse Event|0|||
27714102|NCT01425008|80788905|FG011|Dose Escalation Phase|Adverse Event|0|||
27837082|NCT03234907|81232941|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
27604592|NCT00738101|80395180|FG000|Overall Study|Physician Decision|5|||
27604593|NCT00738101|80395180|FG000|Overall Study|Death|1|||
27714103|NCT01425008|80788906|FG012|Dose Escalation Phase|Adverse Event|0|||
27714104|NCT01425008|80788907|FG013|Dose Escalation Phase|Adverse Event|0|||
27714105|NCT01425008|80788908|FG014|Dose Escalation Phase|Adverse Event|0|||
27714106|NCT01425008|80788909|FG015|Dose Escalation Phase|Adverse Event|0|||
27714107|NCT01425008|80788910|FG016|Dose Escalation Phase|Adverse Event|0|||
27714108|NCT01425008|80788911|FG017|Dose Escalation Phase|Adverse Event|0|||
27714109|NCT01425008|80788912|FG018|Dose Escalation Phase|Adverse Event|0|||
27714110|NCT01425008|80788894|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714111|NCT01425008|80788895|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714112|NCT01425008|80788896|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714113|NCT01425008|80788897|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714114|NCT01425008|80788898|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27714115|NCT01425008|80788899|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714116|NCT01425008|80788900|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
27714117|NCT01425008|80788901|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27714118|NCT01425008|80788902|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
27714119|NCT01425008|80788903|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714120|NCT01425008|80788904|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714121|NCT01425008|80788905|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714122|NCT01425008|80788906|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714123|NCT01425008|80788907|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714124|NCT01425008|80788908|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714125|NCT01425008|80788909|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714126|NCT01425008|80788910|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714127|NCT01425008|80788911|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714128|NCT01425008|80788912|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
27714129|NCT01425008|80788894|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27714130|NCT01425008|80788895|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27714131|NCT01425008|80788896|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27714132|NCT01425008|80788897|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27714133|NCT01425008|80788898|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
27714134|NCT01425008|80788899|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
27714135|NCT01425008|80788900|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
27714136|NCT01425008|80788901|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
27714137|NCT01425008|80788902|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
27714138|NCT01425008|80788903|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
27714139|NCT01425008|80788904|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
27714140|NCT01425008|80788905|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
27714141|NCT01425008|80788906|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
27714142|NCT01425008|80788907|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
27714143|NCT01425008|80788908|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
27714144|NCT01425008|80788909|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
27714145|NCT01425008|80788910|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
27714146|NCT01425008|80788911|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
27714147|NCT01425008|80788912|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
27714148|NCT01425008|80788894|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714149|NCT01425008|80788895|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714150|NCT01425008|80788896|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
27714151|NCT01425008|80788897|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714152|NCT01425008|80788898|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714153|NCT01425008|80788899|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714154|NCT01425008|80788900|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714155|NCT01425008|80788901|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714156|NCT01425008|80788902|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
27714157|NCT01425008|80788903|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
27714158|NCT01425008|80788904|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714159|NCT01425008|80788905|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714160|NCT01425008|80788906|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714161|NCT01425008|80788907|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714162|NCT01425008|80788908|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714163|NCT01425008|80788909|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714164|NCT01425008|80788910|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714165|NCT01425008|80788911|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714166|NCT01425008|80788912|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
27714167|NCT01425008|80788894|FG000|Dose Escalation Phase|Other|0|||
27714168|NCT01425008|80788895|FG001|Dose Escalation Phase|Other|0|||
27714169|NCT01425008|80788896|FG002|Dose Escalation Phase|Other|0|||
27714170|NCT01425008|80788897|FG003|Dose Escalation Phase|Other|0|||
27714171|NCT01425008|80788898|FG004|Dose Escalation Phase|Other|0|||
27714172|NCT01425008|80788899|FG005|Dose Escalation Phase|Other|0|||
27714173|NCT01425008|80788900|FG006|Dose Escalation Phase|Other|0|||
27714174|NCT01425008|80788901|FG007|Dose Escalation Phase|Other|0|||
27714175|NCT01425008|80788902|FG008|Dose Escalation Phase|Other|1|||
27714176|NCT01425008|80788903|FG009|Dose Escalation Phase|Other|0|||
27714177|NCT01425008|80788904|FG010|Dose Escalation Phase|Other|0|||
27714178|NCT01425008|80788905|FG011|Dose Escalation Phase|Other|0|||
27714179|NCT01425008|80788906|FG012|Dose Escalation Phase|Other|0|||
27714180|NCT01425008|80788907|FG013|Dose Escalation Phase|Other|0|||
27714181|NCT01425008|80788908|FG014|Dose Escalation Phase|Other|0|||
27714182|NCT01425008|80788909|FG015|Dose Escalation Phase|Other|0|||
27714183|NCT01425008|80788910|FG016|Dose Escalation Phase|Other|0|||
27714184|NCT01425008|80788911|FG017|Dose Escalation Phase|Other|0|||
27714185|NCT01425008|80788912|FG018|Dose Escalation Phase|Other|0|||
27714186|NCT01425008|80788894|FG000|Dose Expansion Phase|Progressive Disease|0|||
27714187|NCT01425008|80788895|FG001|Dose Expansion Phase|Progressive Disease|0|||
27714188|NCT01425008|80788896|FG002|Dose Expansion Phase|Progressive Disease|0|||
27714189|NCT01425008|80788897|FG003|Dose Expansion Phase|Progressive Disease|0|||
27714190|NCT01425008|80788898|FG004|Dose Expansion Phase|Progressive Disease|0|||
27714191|NCT01425008|80788899|FG005|Dose Expansion Phase|Progressive Disease|0|||
27714192|NCT01425008|80788900|FG006|Dose Expansion Phase|Progressive Disease|0|||
27714193|NCT01425008|80788901|FG007|Dose Expansion Phase|Progressive Disease|0|||
27714194|NCT01425008|80788902|FG008|Dose Expansion Phase|Progressive Disease|0|||
27714195|NCT01425008|80788903|FG009|Dose Expansion Phase|Progressive Disease|0|||
27714196|NCT01425008|80788904|FG010|Dose Expansion Phase|Progressive Disease|10|||
27714197|NCT01425008|80788905|FG011|Dose Expansion Phase|Progressive Disease|4|||
27714198|NCT01425008|80788906|FG012|Dose Expansion Phase|Progressive Disease|12|||
27714199|NCT01425008|80788907|FG013|Dose Expansion Phase|Progressive Disease|1|||
27714200|NCT01425008|80788908|FG014|Dose Expansion Phase|Progressive Disease|5|||
27714201|NCT01425008|80788909|FG015|Dose Expansion Phase|Progressive Disease|8|||
27714202|NCT01425008|80788910|FG016|Dose Expansion Phase|Progressive Disease|9|||
27714203|NCT01425008|80788911|FG017|Dose Expansion Phase|Progressive Disease|2|||
27714204|NCT01425008|80788912|FG018|Dose Expansion Phase|Progressive Disease|10|||
27714205|NCT01425008|80788894|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
27714206|NCT01425008|80788895|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
27714207|NCT01425008|80788896|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
27889853|NCT04713592|81430919|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
27889854|NCT04713592|81430920|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
27604594|NCT00738101|80395180|FG000|Overall Study|Repeat enrollment|1|||
27604595|NCT00215540|80395181|FG000|Overall Study|Withdrew from study medication|1|||
27604596|NCT00215540|80395182|FG001|Overall Study|Withdrew from study medication|0|||
27604597|NCT00215540|80395183|FG002|Overall Study|Withdrew from study medication|0|||
27604598|NCT02532179|80395184|FG000|Overall Study|Lost to Follow-up|1|||
27604599|NCT02532179|80395184|FG000|Overall Study|Pregnancy|1|||
27604600|NCT02532179|80395184|FG000|Overall Study|Subject received depot steroid injection|1|||
27604601|NCT02127372|80395185|FG000|Overall Study|Withdrawal by Subject|1|||
27604602|NCT02127372|80395186|FG001|Overall Study|Withdrawal by Subject|0|||
27604603|NCT01959347|80395190|FG000|Overall Study|Protocol Violation|9|||
27604604|NCT01959347|80395191|FG001|Overall Study|Protocol Violation|7|||
27604605|NCT01370525|80395197|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
27604606|NCT01370525|80395198|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
27604607|NCT01370525|80395197|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27604608|NCT01370525|80395198|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27604609|NCT01370525|80395197|FG000|Overall Study|Adverse Event|0|||
27604610|NCT01370525|80395198|FG001|Overall Study|Adverse Event|1|||
27604611|NCT01370525|80395197|FG000|Overall Study|Protocol Violation|2|||
27604612|NCT01370525|80395198|FG001|Overall Study|Protocol Violation|1|||
27604613|NCT01370525|80395197|FG000|Overall Study|Lost to follow up|2|||
27604614|NCT01370525|80395198|FG001|Overall Study|Lost to follow up|6|||
27604615|NCT03122119|80395199|FG000|Overall Study|Did not meet eligibility critria|1|||
27604616|NCT01301274|80395201|FG000|Overall Study|Physician Decision|2|||
27604617|NCT01301274|80395202|FG001|Overall Study|Physician Decision|1|||
27604618|NCT02110732|80395206|FG000|Overall Study|Physician Decision|5|||
27604619|NCT02110732|80395207|FG001|Overall Study|Physician Decision|2|||
27604620|NCT02110732|80395206|FG000|Overall Study|Lost to Follow-up|1|||
27604621|NCT02110732|80395207|FG001|Overall Study|Lost to Follow-up|1|||
27604622|NCT01395823|80395212|FG000|Overall Study|Death|4|||
27604623|NCT01395823|80395213|FG001|Overall Study|Death|4|||
27604624|NCT01395823|80395212|FG000|Overall Study|Physician Decision|3|||
27604625|NCT01395823|80395213|FG001|Overall Study|Physician Decision|1|||
27604626|NCT01395823|80395212|FG000|Overall Study|Lost to Follow-up|1|||
27604627|NCT01395823|80395213|FG001|Overall Study|Lost to Follow-up|0|||
27604628|NCT01395823|80395212|FG000|Overall Study|Transplant|1|||
27604629|NCT01395823|80395213|FG001|Overall Study|Transplant|0|||
27604630|NCT01395823|80395212|FG000|Overall Study|GI symptoms|1|||
27604631|NCT01395823|80395213|FG001|Overall Study|GI symptoms|0|||
27604632|NCT01395823|80395212|FG000|Overall Study|Withdrawal by Subject|5|||
27604633|NCT01395823|80395213|FG001|Overall Study|Withdrawal by Subject|4|||
27604634|NCT02237508|80395214|FG000|Overall Study|Withdrawal by Subject|0|||
27604635|NCT02237508|80395215|FG001|Overall Study|Withdrawal by Subject|2|||
27604636|NCT02237508|80395216|FG002|Overall Study|Withdrawal by Subject|0|||
27604637|NCT02237508|80395217|FG003|Overall Study|Withdrawal by Subject|1|||
27604638|NCT02237508|80395218|FG004|Overall Study|Withdrawal by Subject|0|||
27604639|NCT02237508|80395219|FG005|Overall Study|Withdrawal by Subject|1|||
27604640|NCT02237508|80395220|FG006|Overall Study|Withdrawal by Subject|1|||
27604641|NCT02237508|80395221|FG007|Overall Study|Withdrawal by Subject|0|||
27604642|NCT02237508|80395222|FG008|Overall Study|Withdrawal by Subject|1|||
27604643|NCT02237508|80395223|FG009|Overall Study|Withdrawal by Subject|0|||
27604644|NCT02237508|80395214|FG000|Overall Study|Physician Decision|0|||
27604645|NCT02237508|80395215|FG001|Overall Study|Physician Decision|1|||
27604646|NCT02237508|80395216|FG002|Overall Study|Physician Decision|0|||
27604647|NCT02237508|80395217|FG003|Overall Study|Physician Decision|0|||
27604648|NCT02237508|80395218|FG004|Overall Study|Physician Decision|0|||
27604649|NCT02237508|80395219|FG005|Overall Study|Physician Decision|0|||
27604650|NCT02237508|80395220|FG006|Overall Study|Physician Decision|0|||
27604651|NCT02237508|80395221|FG007|Overall Study|Physician Decision|0|||
27604652|NCT02237508|80395222|FG008|Overall Study|Physician Decision|0|||
27604653|NCT02237508|80395223|FG009|Overall Study|Physician Decision|0|||
27604654|NCT02237508|80395214|FG000|Overall Study|Protocol Violation|0|||
27604655|NCT02237508|80395215|FG001|Overall Study|Protocol Violation|0|||
27604656|NCT02237508|80395216|FG002|Overall Study|Protocol Violation|1|||
27604657|NCT02237508|80395217|FG003|Overall Study|Protocol Violation|0|||
27604658|NCT02237508|80395218|FG004|Overall Study|Protocol Violation|0|||
27604659|NCT02237508|80395219|FG005|Overall Study|Protocol Violation|0|||
27604660|NCT02237508|80395220|FG006|Overall Study|Protocol Violation|0|||
27604661|NCT02237508|80395221|FG007|Overall Study|Protocol Violation|0|||
27604662|NCT02237508|80395222|FG008|Overall Study|Protocol Violation|0|||
27604663|NCT02237508|80395223|FG009|Overall Study|Protocol Violation|0|||
27604664|NCT00909480|80395226|FG000|Overall Study|Adverse Event|5|||
27604665|NCT00909480|80395227|FG001|Overall Study|Adverse Event|3|||
27604666|NCT00909480|80395226|FG000|Overall Study|Protocol Violation|6|||
27604667|NCT00909480|80395227|FG001|Overall Study|Protocol Violation|8|||
27604668|NCT00909480|80395226|FG000|Overall Study|Withdrawal criteria|9|||
27604669|NCT00909480|80395227|FG001|Overall Study|Withdrawal criteria|11|||
27604670|NCT00909480|80395226|FG000|Overall Study|Unclassified|18|||
27604671|NCT00909480|80395227|FG001|Overall Study|Unclassified|19|||
27604672|NCT04766086|80395230|FG000|Overall Study|Lost to Follow-up|3|||
27604673|NCT04766086|80395231|FG001|Overall Study|Lost to Follow-up|5|||
27604674|NCT04766086|80395232|FG002|Overall Study|Lost to Follow-up|3|||
27604675|NCT04766086|80395230|FG000|Overall Study|Withdrawal by Subject|1|||
27604676|NCT04766086|80395231|FG001|Overall Study|Withdrawal by Subject|1|||
27604677|NCT04766086|80395232|FG002|Overall Study|Withdrawal by Subject|2|||
27604678|NCT04766086|80395230|FG000|Overall Study|Other|0|||
27604679|NCT04766086|80395231|FG001|Overall Study|Other|0|||
27604680|NCT04766086|80395232|FG002|Overall Study|Other|1|||
27604681|NCT05044325|80395234|FG000|Part A:Treatment Period 1|Adverse Event|0|||
27604682|NCT05044325|80395235|FG001|Part A:Treatment Period 1|Adverse Event|0|||
27604683|NCT05044325|80395236|FG002|Part A:Treatment Period 1|Adverse Event|0|||
27604684|NCT05044325|80395237|FG003|Part A:Treatment Period 1|Adverse Event|0|||
27714208|NCT01425008|80788897|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
27714209|NCT01425008|80788898|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
27714210|NCT01425008|80788899|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
27714211|NCT01425008|80788900|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
27714212|NCT01425008|80788901|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
27714213|NCT01425008|80788902|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
27714214|NCT01425008|80788903|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
27714215|NCT01425008|80788904|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
27714216|NCT01425008|80788905|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
27714217|NCT01425008|80788906|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
27714218|NCT01425008|80788907|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
27714219|NCT01425008|80788908|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
27714220|NCT01425008|80788909|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
27714221|NCT01425008|80788910|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
27714222|NCT01425008|80788911|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
27604685|NCT05044325|80395238|FG004|Part A:Treatment Period 1|Adverse Event|0|||
27604686|NCT05044325|80395239|FG005|Part A:Treatment Period 1|Adverse Event|1|||
27604687|NCT05044325|80395240|FG006|Part A:Treatment Period 1|Adverse Event|0|||
27604688|NCT05044325|80395241|FG007|Part A:Treatment Period 1|Adverse Event|1|||
27604689|NCT05044325|80395242|FG008|Part A:Treatment Period 1|Adverse Event|0|||
27604690|NCT05044325|80395243|FG009|Part A:Treatment Period 1|Adverse Event|0|||
27604691|NCT05044325|80395234|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604692|NCT05044325|80395235|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604693|NCT05044325|80395236|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604694|NCT05044325|80395237|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
27714223|NCT01425008|80788912|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
27714224|NCT01425008|80788894|FG000|Dose Expansion Phase|Other|0|||
27714225|NCT01425008|80788895|FG001|Dose Expansion Phase|Other|0|||
27714226|NCT01425008|80788896|FG002|Dose Expansion Phase|Other|0|||
27714227|NCT01425008|80788897|FG003|Dose Expansion Phase|Other|0|||
27714228|NCT01425008|80788898|FG004|Dose Expansion Phase|Other|0|||
27714229|NCT01425008|80788899|FG005|Dose Expansion Phase|Other|0|||
27714230|NCT01425008|80788900|FG006|Dose Expansion Phase|Other|0|||
27714231|NCT01425008|80788901|FG007|Dose Expansion Phase|Other|0|||
27714232|NCT01425008|80788902|FG008|Dose Expansion Phase|Other|0|||
27714233|NCT01425008|80788903|FG009|Dose Expansion Phase|Other|0|||
27714234|NCT01425008|80788904|FG010|Dose Expansion Phase|Other|0|||
27714235|NCT01425008|80788905|FG011|Dose Expansion Phase|Other|0|||
27714236|NCT01425008|80788906|FG012|Dose Expansion Phase|Other|1|||
27714237|NCT01425008|80788907|FG013|Dose Expansion Phase|Other|0|||
27714238|NCT01425008|80788908|FG014|Dose Expansion Phase|Other|0|||
27714239|NCT01425008|80788909|FG015|Dose Expansion Phase|Other|0|||
27714240|NCT01425008|80788910|FG016|Dose Expansion Phase|Other|2|||
27837083|NCT03234907|81232942|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
27714241|NCT01425008|80788911|FG017|Dose Expansion Phase|Other|0|||
27714242|NCT01425008|80788912|FG018|Dose Expansion Phase|Other|4|||
27714243|NCT01425008|80788894|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
27837084|NCT00372996|81232944|FG000|Overall Study|Death|11|||
27837085|NCT00372996|81232945|FG001|Overall Study|Death|4|||
27837086|NCT00372996|81232946|FG002|Overall Study|Death|8|||
27837087|NCT00372996|81232947|FG003|Overall Study|Death|7|||
27604695|NCT05044325|80395238|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
27604696|NCT05044325|80395239|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
27604697|NCT05044325|80395240|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604698|NCT05044325|80395241|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604699|NCT05044325|80395242|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604700|NCT05044325|80395243|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
27604701|NCT05044325|80395234|FG000|Part A:Treatment Period 1|Physician Decision|0|||
27604702|NCT05044325|80395235|FG001|Part A:Treatment Period 1|Physician Decision|0|||
27604703|NCT05044325|80395236|FG002|Part A:Treatment Period 1|Physician Decision|0|||
27604704|NCT05044325|80395237|FG003|Part A:Treatment Period 1|Physician Decision|0|||
27604705|NCT05044325|80395238|FG004|Part A:Treatment Period 1|Physician Decision|0|||
27604706|NCT05044325|80395239|FG005|Part A:Treatment Period 1|Physician Decision|0|||
27604707|NCT05044325|80395240|FG006|Part A:Treatment Period 1|Physician Decision|1|||
27604708|NCT05044325|80395241|FG007|Part A:Treatment Period 1|Physician Decision|0|||
27604709|NCT05044325|80395242|FG008|Part A:Treatment Period 1|Physician Decision|0|||
27604710|NCT05044325|80395243|FG009|Part A:Treatment Period 1|Physician Decision|0|||
27604711|NCT05044325|80395234|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604712|NCT05044325|80395235|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604713|NCT05044325|80395236|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
27604714|NCT05044325|80395237|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604715|NCT05044325|80395238|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604716|NCT05044325|80395239|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604717|NCT05044325|80395240|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604718|NCT05044325|80395241|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604719|NCT05044325|80395242|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604720|NCT05044325|80395243|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
27604721|NCT05044325|80395234|FG000|Part A:Treatment Period 2|Adverse Event|0|||
27604722|NCT05044325|80395235|FG001|Part A:Treatment Period 2|Adverse Event|1|||
27604723|NCT05044325|80395236|FG002|Part A:Treatment Period 2|Adverse Event|0|||
27604724|NCT05044325|80395237|FG003|Part A:Treatment Period 2|Adverse Event|0|||
27604725|NCT05044325|80395238|FG004|Part A:Treatment Period 2|Adverse Event|1|||
27604726|NCT05044325|80395239|FG005|Part A:Treatment Period 2|Adverse Event|1|||
27604727|NCT05044325|80395240|FG006|Part A:Treatment Period 2|Adverse Event|0|||
27604728|NCT05044325|80395241|FG007|Part A:Treatment Period 2|Adverse Event|0|||
27604729|NCT05044325|80395242|FG008|Part A:Treatment Period 2|Adverse Event|0|||
27604730|NCT05044325|80395243|FG009|Part A:Treatment Period 2|Adverse Event|0|||
27604731|NCT05044325|80395234|FG000|Part A:Treatment Period 2|Physician Decision|0|||
27604732|NCT05044325|80395235|FG001|Part A:Treatment Period 2|Physician Decision|0|||
27604733|NCT05044325|80395236|FG002|Part A:Treatment Period 2|Physician Decision|0|||
27604734|NCT05044325|80395237|FG003|Part A:Treatment Period 2|Physician Decision|0|||
27604735|NCT05044325|80395238|FG004|Part A:Treatment Period 2|Physician Decision|0|||
27604736|NCT05044325|80395239|FG005|Part A:Treatment Period 2|Physician Decision|1|||
27604737|NCT05044325|80395240|FG006|Part A:Treatment Period 2|Physician Decision|0|||
27604738|NCT05044325|80395241|FG007|Part A:Treatment Period 2|Physician Decision|0|||
27604739|NCT05044325|80395242|FG008|Part A:Treatment Period 2|Physician Decision|0|||
27604740|NCT05044325|80395243|FG009|Part A:Treatment Period 2|Physician Decision|0|||
27604741|NCT05044325|80395234|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604742|NCT05044325|80395235|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604743|NCT05044325|80395236|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604744|NCT05044325|80395237|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
27604745|NCT05044325|80395238|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
27714244|NCT01425008|80788895|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714245|NCT01425008|80788896|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714246|NCT01425008|80788897|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714247|NCT01425008|80788898|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714248|NCT01425008|80788899|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714249|NCT01425008|80788900|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714250|NCT01425008|80788901|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714251|NCT01425008|80788902|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
27889855|NCT04713592|81430917|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27889856|NCT04713592|81430918|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27604746|NCT05044325|80395239|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604747|NCT05044325|80395240|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604748|NCT05044325|80395241|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604749|NCT05044325|80395242|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604750|NCT05044325|80395243|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
27604751|NCT02736825|80395247|FG000|Overall Study|Lost to Follow-up|10|||
27604752|NCT02736825|80395248|FG001|Overall Study|Lost to Follow-up|11|||
27604753|NCT02736825|80395247|FG000|Overall Study|Early Termination|0|||
27604754|NCT02736825|80395248|FG001|Overall Study|Early Termination|1|||
27604755|NCT02277990|80395250|FG000|Overall Study|Death|170|||
27604756|NCT02277990|80395251|FG001|Overall Study|Death|188|||
27604757|NCT02277990|80395250|FG000|Overall Study|Withdrawal by Subject|64|||
27604758|NCT02277990|80395251|FG001|Overall Study|Withdrawal by Subject|53|||
27604759|NCT02277990|80395250|FG000|Overall Study|Physician Decision|40|||
27604760|NCT02277990|80395251|FG001|Overall Study|Physician Decision|34|||
27604761|NCT02277990|80395250|FG000|Overall Study|Lost to Follow-up|66|||
27604762|NCT02277990|80395251|FG001|Overall Study|Lost to Follow-up|69|||
27604763|NCT02277990|80395250|FG000|Overall Study|Had other reason|26|||
27604764|NCT02277990|80395251|FG001|Overall Study|Had other reason|32|||
27604765|NCT05076149|80395252|FG000|Overall Study|Adverse Event|3|||
27604766|NCT05076149|80395253|FG001|Overall Study|Adverse Event|9|||
27604767|NCT05076149|80395252|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
27604768|NCT05076149|80395253|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
27604769|NCT05076149|80395252|FG000|Overall Study|Lost to Follow-up|0|||
27604770|NCT05076149|80395253|FG001|Overall Study|Lost to Follow-up|1|||
27604771|NCT05076149|80395252|FG000|Overall Study|Commercial drug is available for participant|0|||
27604772|NCT05076149|80395253|FG001|Overall Study|Commercial drug is available for participant|1|||
27604773|NCT05076149|80395252|FG000|Overall Study|Other non compliance|1|||
27604774|NCT05076149|80395253|FG001|Overall Study|Other non compliance|1|||
27604775|NCT05076149|80395252|FG000|Overall Study|Physician Decision|0|||
27604776|NCT05076149|80395253|FG001|Overall Study|Physician Decision|1|||
27604777|NCT05076149|80395252|FG000|Overall Study|Other|5|||
27604778|NCT05076149|80395253|FG001|Overall Study|Other|4|||
27604779|NCT01376323|80395254|FG000|Overall Study|Adverse Event|1|||
27604780|NCT01376323|80395255|FG001|Overall Study|Adverse Event|0|||
27604781|NCT01376323|80395256|FG002|Overall Study|Adverse Event|0|||
27604782|NCT01376323|80395257|FG003|Overall Study|Adverse Event|2|||
27604783|NCT01376323|80395258|FG004|Overall Study|Adverse Event|0|||
27604784|NCT01376323|80395254|FG000|Overall Study|Lost to Follow-up|0|||
27604785|NCT01376323|80395255|FG001|Overall Study|Lost to Follow-up|0|||
27604786|NCT01376323|80395256|FG002|Overall Study|Lost to Follow-up|0|||
27604787|NCT01376323|80395257|FG003|Overall Study|Lost to Follow-up|2|||
27604788|NCT01376323|80395258|FG004|Overall Study|Lost to Follow-up|0|||
27604789|NCT01376323|80395254|FG000|Overall Study|Physician Decision|1|||
27604790|NCT01376323|80395255|FG001|Overall Study|Physician Decision|0|||
27604791|NCT01376323|80395256|FG002|Overall Study|Physician Decision|2|||
27604792|NCT01376323|80395257|FG003|Overall Study|Physician Decision|1|||
27604793|NCT01376323|80395258|FG004|Overall Study|Physician Decision|1|||
27604794|NCT01376323|80395254|FG000|Overall Study|Withdrawal by Subject|0|||
27604795|NCT01376323|80395255|FG001|Overall Study|Withdrawal by Subject|1|||
27604796|NCT01376323|80395256|FG002|Overall Study|Withdrawal by Subject|1|||
27604797|NCT01376323|80395257|FG003|Overall Study|Withdrawal by Subject|0|||
27604798|NCT01376323|80395258|FG004|Overall Study|Withdrawal by Subject|0|||
27604799|NCT03287414|80395259|FG000|Treatment Epoch|Adverse Event|0|||
27604800|NCT03287414|80395260|FG001|Treatment Epoch|Adverse Event|1|||
27604801|NCT03287414|80395259|FG000|Treatment Epoch|Study terminated by sponsor|2|||
27604802|NCT03287414|80395260|FG001|Treatment Epoch|Study terminated by sponsor|2|||
27604803|NCT03287414|80395259|FG000|Treatment Epoch|Subject/Guardian decision|4|||
27604804|NCT03287414|80395260|FG001|Treatment Epoch|Subject/Guardian decision|0|||
27604805|NCT03287414|80395259|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
27604806|NCT03287414|80395260|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
27604807|NCT03287414|80395259|FG000|Treatment Epoch|Withdrawal by Subject|1|||
27604808|NCT03287414|80395260|FG001|Treatment Epoch|Withdrawal by Subject|0|||
27604809|NCT03287414|80395259|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
27604810|NCT03287414|80395260|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
27604811|NCT03287414|80395259|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
27604812|NCT03287414|80395260|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
27604813|NCT04006925|80395261|FG000|Overall Study|Side effects|2|||
27604814|NCT04006925|80395262|FG001|Overall Study|Side effects|0|||
27604815|NCT00643123|80395263|FG000|Overall Study|Lost to Follow-up|4|||
27604816|NCT00643123|80395264|FG001|Overall Study|Lost to Follow-up|0|||
27604817|NCT00643123|80395263|FG000|Overall Study|Withdrawal by Subject|1|||
27604818|NCT00643123|80395264|FG001|Overall Study|Withdrawal by Subject|1|||
27604819|NCT01807156|80395265|FG000|Overall Study|Physician Decision|1|||
27604820|NCT00521144|80395267|FG000|Overall Study|Not Treated|0|||
27604821|NCT00521144|80395268|FG001|Overall Study|Not Treated|0|||
27604822|NCT00521144|80395269|FG002|Overall Study|Not Treated|0|||
27604823|NCT00521144|80395270|FG003|Overall Study|Not Treated|1|||
27604824|NCT00521144|80395271|FG004|Overall Study|Not Treated|0|||
27604825|NCT00521144|80395267|FG000|Overall Study|Adverse Event|0|||
27604826|NCT00521144|80395268|FG001|Overall Study|Adverse Event|1|||
27604827|NCT00521144|80395269|FG002|Overall Study|Adverse Event|0|||
27604828|NCT00521144|80395270|FG003|Overall Study|Adverse Event|0|||
27604829|NCT00521144|80395271|FG004|Overall Study|Adverse Event|1|||
27604830|NCT00521144|80395267|FG000|Overall Study|Progressive Disease|4|||
27604831|NCT00521144|80395268|FG001|Overall Study|Progressive Disease|2|||
27604832|NCT00521144|80395269|FG002|Overall Study|Progressive Disease|2|||
27604833|NCT00521144|80395270|FG003|Overall Study|Progressive Disease|0|||
27604834|NCT00521144|80395271|FG004|Overall Study|Progressive Disease|6|||
27604835|NCT00855595|80395272|FG000|Overall Study|Withdrawal by Subject|1|||
27604836|NCT00855595|80395273|FG001|Overall Study|Withdrawal by Subject|2|||
27714252|NCT01425008|80788903|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714253|NCT01425008|80788904|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
27714254|NCT01425008|80788905|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
27714255|NCT01425008|80788906|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
27604837|NCT00855595|80395272|FG000|Overall Study|Lost to Follow-up|3|||
27604838|NCT00855595|80395273|FG001|Overall Study|Lost to Follow-up|3|||
27604839|NCT00855595|80395272|FG000|Overall Study|Adverse Event|1|||
27604840|NCT00855595|80395273|FG001|Overall Study|Adverse Event|1|||
27604841|NCT00855595|80395272|FG000|Overall Study|patient moved out of state|1|||
27604842|NCT00855595|80395273|FG001|Overall Study|patient moved out of state|0|||
27604843|NCT00855595|80395272|FG000|Overall Study|patient left country|0|||
27604844|NCT00855595|80395273|FG001|Overall Study|patient left country|1|||
27604845|NCT00116272|80395274|FG000|Overall Study|Lost to Follow-up|11|||
27604846|NCT00116272|80395275|FG001|Overall Study|Lost to Follow-up|6|||
27604847|NCT01013792|80395276|FG000|Overall Study|Study suspended|2|||
27604848|NCT01013792|80395277|FG001|Overall Study|Study suspended|1|||
27604849|NCT01013792|80395276|FG000|Overall Study|Adverse Event|0|||
27604850|NCT01013792|80395277|FG001|Overall Study|Adverse Event|3|||
27604851|NCT01013792|80395276|FG000|Overall Study|Lost to Follow-up|0|||
27604852|NCT01013792|80395277|FG001|Overall Study|Lost to Follow-up|1|||
27604853|NCT00576732|80395279|FG000|DOUBLE BLIND|Adverse Event|0|||
27604854|NCT00576732|80395280|FG001|DOUBLE BLIND|Adverse Event|0|||
27714256|NCT01425008|80788907|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714257|NCT01425008|80788908|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714258|NCT01425008|80788909|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
27714259|NCT01425008|80788910|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
27714260|NCT01425008|80788911|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
27714261|NCT01425008|80788912|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
27714262|NCT01425008|80788894|FG000|Dose Expansion Phase|Adverse Event|0|||
27714263|NCT01425008|80788895|FG001|Dose Expansion Phase|Adverse Event|0|||
27714264|NCT01425008|80788896|FG002|Dose Expansion Phase|Adverse Event|0|||
27714265|NCT01425008|80788897|FG003|Dose Expansion Phase|Adverse Event|0|||
27714266|NCT01425008|80788898|FG004|Dose Expansion Phase|Adverse Event|0|||
27714267|NCT01425008|80788899|FG005|Dose Expansion Phase|Adverse Event|0|||
27604855|NCT00576732|80395281|FG002|DOUBLE BLIND|Adverse Event|1|||
27604856|NCT00576732|80395282|FG003|DOUBLE BLIND|Adverse Event|0|||
27604857|NCT00576732|80395283|FG004|DOUBLE BLIND|Adverse Event|0|||
27604858|NCT00576732|80395284|FG005|DOUBLE BLIND|Adverse Event|0|||
27604859|NCT00576732|80395279|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
27604860|NCT00576732|80395280|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
27837088|NCT00372996|81232944|FG000|Overall Study|Lost to Follow-up|0|||
27604861|NCT00576732|80395281|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
27604862|NCT00576732|80395282|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
27604863|NCT00576732|80395283|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
27604864|NCT00576732|80395284|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
27604865|NCT00576732|80395279|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
27604866|NCT00576732|80395280|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
27714268|NCT01425008|80788900|FG006|Dose Expansion Phase|Adverse Event|0|||
27714269|NCT01425008|80788901|FG007|Dose Expansion Phase|Adverse Event|0|||
27714270|NCT01425008|80788902|FG008|Dose Expansion Phase|Adverse Event|0|||
27714271|NCT01425008|80788903|FG009|Dose Expansion Phase|Adverse Event|0|||
27714272|NCT01425008|80788904|FG010|Dose Expansion Phase|Adverse Event|2|||
27714273|NCT01425008|80788905|FG011|Dose Expansion Phase|Adverse Event|3|||
27714274|NCT01425008|80788906|FG012|Dose Expansion Phase|Adverse Event|3|||
27714275|NCT01425008|80788907|FG013|Dose Expansion Phase|Adverse Event|0|||
27714276|NCT01425008|80788908|FG014|Dose Expansion Phase|Adverse Event|1|||
27714277|NCT01425008|80788909|FG015|Dose Expansion Phase|Adverse Event|1|||
27714278|NCT01425008|80788910|FG016|Dose Expansion Phase|Adverse Event|5|||
27714279|NCT01425008|80788911|FG017|Dose Expansion Phase|Adverse Event|0|||
27714280|NCT01425008|80788912|FG018|Dose Expansion Phase|Adverse Event|3|||
27714281|NCT01425008|80788894|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
27714282|NCT01425008|80788895|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
27714283|NCT01425008|80788896|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
27714284|NCT01425008|80788897|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
27837089|NCT00372996|81232945|FG001|Overall Study|Lost to Follow-up|2|||
27604867|NCT00576732|80395281|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
27604868|NCT00576732|80395282|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
27604869|NCT00576732|80395283|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
27604870|NCT00576732|80395284|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
27604871|NCT00576732|80395279|FG000|DOUBLE BLIND|OTHER|0|||
27604872|NCT00576732|80395280|FG001|DOUBLE BLIND|OTHER|2|||
27604873|NCT00576732|80395281|FG002|DOUBLE BLIND|OTHER|1|||
27604874|NCT00576732|80395282|FG003|DOUBLE BLIND|OTHER|0|||
27604875|NCT00576732|80395283|FG004|DOUBLE BLIND|OTHER|0|||
27604876|NCT00576732|80395284|FG005|DOUBLE BLIND|OTHER|0|||
27604877|NCT00576732|80395279|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
27604878|NCT00576732|80395280|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
27604879|NCT00576732|80395281|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
27604880|NCT00576732|80395282|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
27604881|NCT00576732|80395283|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
27604882|NCT00576732|80395284|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
27604883|NCT00576732|80395279|FG000|DOUBLE BLIND|Protocol Violation|1|||
27604884|NCT00576732|80395280|FG001|DOUBLE BLIND|Protocol Violation|0|||
27604885|NCT00576732|80395281|FG002|DOUBLE BLIND|Protocol Violation|0|||
27604886|NCT00576732|80395282|FG003|DOUBLE BLIND|Protocol Violation|0|||
27714285|NCT01425008|80788898|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
27714286|NCT01425008|80788899|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
27837090|NCT00372996|81232946|FG002|Overall Study|Lost to Follow-up|0|||
27837091|NCT00372996|81232947|FG003|Overall Study|Lost to Follow-up|1|||
27837092|NCT00372996|81232944|FG000|Overall Study|Withdrawal by Subject|12|||
27837093|NCT00372996|81232945|FG001|Overall Study|Withdrawal by Subject|6|||
27837094|NCT00372996|81232946|FG002|Overall Study|Withdrawal by Subject|9|||
27837095|NCT00372996|81232947|FG003|Overall Study|Withdrawal by Subject|5|||
27837096|NCT00372996|81232944|FG000|Overall Study|Study Terminated by Sponsor|4|||
27837097|NCT00372996|81232945|FG001|Overall Study|Study Terminated by Sponsor|0|||
27837098|NCT00372996|81232946|FG002|Overall Study|Study Terminated by Sponsor|4|||
27714287|NCT01425008|80788900|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
27714288|NCT01425008|80788901|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
27837099|NCT00372996|81232947|FG003|Overall Study|Study Terminated by Sponsor|0|||
27604887|NCT00576732|80395283|FG004|DOUBLE BLIND|Protocol Violation|0|||
27604888|NCT00576732|80395284|FG005|DOUBLE BLIND|Protocol Violation|0|||
27604889|NCT00576732|80395279|FG000|OPEN LABEL|Adverse Event|0|||
27604890|NCT00576732|80395280|FG001|OPEN LABEL|Adverse Event|0|||
27604891|NCT00576732|80395281|FG002|OPEN LABEL|Adverse Event|0|||
27604892|NCT00576732|80395282|FG003|OPEN LABEL|Adverse Event|4|||
27604893|NCT00576732|80395283|FG004|OPEN LABEL|Adverse Event|0|||
27837100|NCT00372996|81232944|FG000|Overall Study|Other|10|||
27837101|NCT00372996|81232945|FG001|Overall Study|Other|2|||
27837102|NCT00372996|81232946|FG002|Overall Study|Other|7|||
27837103|NCT00372996|81232947|FG003|Overall Study|Other|7|||
27714289|NCT01425008|80788902|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
27714290|NCT01425008|80788903|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
27714291|NCT01425008|80788904|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
27714292|NCT01425008|80788905|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
27837104|NCT01183884|81232949|FG000|Overall Study|Progressive Disease|26|||
27837105|NCT01183884|81232949|FG000|Overall Study|Adverse Event|3|||
27837106|NCT01183884|81232949|FG000|Overall Study|Withdrawal by Subject|1|||
27837107|NCT01183884|81232949|FG000|Overall Study|Other Complicating Disease|3|||
27837108|NCT01183884|81232949|FG000|Overall Study|Not Treated|1|||
27714293|NCT01425008|80788906|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
27714294|NCT01425008|80788907|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
27714295|NCT01425008|80788908|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
27714296|NCT01425008|80788909|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
27714297|NCT01425008|80788910|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
27714298|NCT01425008|80788911|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
27714299|NCT01425008|80788912|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
27714300|NCT01425008|80788894|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714301|NCT01425008|80788895|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714302|NCT01425008|80788896|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714303|NCT01425008|80788897|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714304|NCT01425008|80788898|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714305|NCT01425008|80788899|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714306|NCT01425008|80788900|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714307|NCT01425008|80788901|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714308|NCT01425008|80788902|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714309|NCT01425008|80788903|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714310|NCT01425008|80788904|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714311|NCT01425008|80788905|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714312|NCT01425008|80788906|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714313|NCT01425008|80788907|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714314|NCT01425008|80788908|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714315|NCT01425008|80788909|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714316|NCT01425008|80788910|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714317|NCT01425008|80788911|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
27714318|NCT01425008|80788912|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
27714319|NCT01033734|80788913|FG000|Overall Study|Withdrawal by Subject|1|||
27714320|NCT01251367|80788916|FG000|Overall Study|Protocol Violation|1|||
27714321|NCT01251367|80788916|FG000|Overall Study|Lack of Efficacy|2|||
27714322|NCT01251367|80788916|FG000|Overall Study|Adverse Event|19|||
27837109|NCT01183884|81232949|FG000|Overall Study|Other|4|||
27714323|NCT01251367|80788916|FG000|Overall Study|Withdrawal by Subject|36|||
27889857|NCT04713592|81430919|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
27714324|NCT01251367|80788916|FG000|Overall Study|Lost to Follow-up|5|||
27714325|NCT01251367|80788916|FG000|Overall Study|Subject Required Alternative Treatment|7|||
27714326|NCT01251367|80788916|FG000|Overall Study|No Study Drug Available|1|||
27714327|NCT01251367|80788916|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
27714328|NCT01251367|80788916|FG000|Overall Study|End of Study Visit Performed in Error|1|||
27714329|NCT02484911|80788917|FG000|Overall Study|Withdrawal by Subject|2|||
27714330|NCT02484911|80788918|FG001|Overall Study|Withdrawal by Subject|1|||
27714331|NCT02484911|80788917|FG000|Overall Study|Protocol Violation|2|||
27714332|NCT02484911|80788918|FG001|Overall Study|Protocol Violation|1|||
27837110|NCT04230876|81232950|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
27714333|NCT04718974|80788920|FG000|Overall Study|Death|0|||
27714334|NCT04718974|80788921|FG001|Overall Study|Death|2|||
27714335|NCT04718974|80788920|FG000|Overall Study|Lost to Follow-up|10|||
27714336|NCT04718974|80788921|FG001|Overall Study|Lost to Follow-up|20|||
27714337|NCT04718974|80788920|FG000|Overall Study|Transferred out|2|||
27714338|NCT04718974|80788921|FG001|Overall Study|Transferred out|4|||
27714339|NCT00811135|80788922|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
27714340|NCT00811135|80788922|FG000|Overall Study|Death|3|||
27714341|NCT00811135|80788922|FG000|Overall Study|Protocol Violation|2|||
27714342|NCT00811135|80788922|FG000|Overall Study|Violation of Selection Criteria|1|||
27714343|NCT00811135|80788922|FG000|Overall Study|Refused Treatment|1|||
27714344|NCT00811135|80788922|FG000|Overall Study|Withdrawal by Subject|3|||
27714345|NCT00811135|80788922|FG000|Overall Study|Administrative/Other Unspecified|11|||
27714346|NCT00811135|80788922|FG000|Overall Study|Ongoing|59|||
27714347|NCT04191382|80788923|FG000|Overall Study|Withdrawal by Subject|1|||
27714348|NCT04191382|80788924|FG001|Overall Study|Withdrawal by Subject|0|||
27714349|NCT04191382|80788925|FG002|Overall Study|Withdrawal by Subject|0|||
27714350|NCT01081249|80788927|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
27714351|NCT01081249|80788928|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
27714352|NCT01227044|80788929|FG000|Overall Study|Lost to Follow-up|5|||
27714353|NCT01227044|80788930|FG001|Overall Study|Lost to Follow-up|7|||
27714354|NCT01227044|80788929|FG000|Overall Study|Discontinued Intervention|1|||
27714355|NCT01227044|80788930|FG001|Overall Study|Discontinued Intervention|2|||
27714356|NCT02318667|80788931|FG000|Overall Study|Adverse Event|1|||
27714357|NCT02318667|80788931|FG000|Overall Study|Lack of Efficacy|6|||
27714358|NCT02318667|80788931|FG000|Overall Study|Protocol Violation|2|||
27714359|NCT02969707|80788945|FG000|Overall Study|Adverse Event|1|||
27714360|NCT02969707|80788946|FG001|Overall Study|Adverse Event|2|||
27714361|NCT02969707|80788945|FG000|Overall Study|Lost to Follow-up|3|||
27714362|NCT02969707|80788946|FG001|Overall Study|Lost to Follow-up|0|||
27714363|NCT02969707|80788945|FG000|Overall Study|Physician Decision|0|||
27837111|NCT04230876|81232951|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
27837112|NCT02218541|81232956|FG000|Overall Study|Lost to Follow-up|2|||
27837113|NCT02218541|81232957|FG001|Overall Study|Lost to Follow-up|1|||
27714364|NCT02969707|80788946|FG001|Overall Study|Physician Decision|1|||
27714365|NCT02969707|80788945|FG000|Overall Study|Protocol Violation|1|||
27714366|NCT02969707|80788946|FG001|Overall Study|Protocol Violation|1|||
27714367|NCT02969707|80788945|FG000|Overall Study|Withdrawal by Subject|3|||
27714368|NCT02969707|80788946|FG001|Overall Study|Withdrawal by Subject|4|||
27714369|NCT00960661|80788947|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
27714370|NCT00960661|80788948|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
27714371|NCT00960661|80788949|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
27714372|NCT00960661|80788947|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
27714373|NCT00960661|80788948|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
27714374|NCT00960661|80788949|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
27714375|NCT00960661|80788947|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
27714376|NCT00960661|80788948|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
27714377|NCT00960661|80788949|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
27714378|NCT00960661|80788947|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
27714379|NCT00960661|80788948|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
27714380|NCT00960661|80788949|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
27714381|NCT00960661|80788947|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
27714382|NCT00960661|80788948|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
27714383|NCT00960661|80788949|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
27714384|NCT00960661|80788947|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
27714385|NCT00960661|80788948|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
27714386|NCT00960661|80788949|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
27714387|NCT00960661|80788947|FG000|Interventional Phase|Adverse Event|0|||
27714388|NCT00960661|80788948|FG001|Interventional Phase|Adverse Event|17|||
27714389|NCT00960661|80788949|FG002|Interventional Phase|Adverse Event|8|||
27714390|NCT00960661|80788947|FG000|Interventional Phase|Death|0|||
27714391|NCT00960661|80788948|FG001|Interventional Phase|Death|1|||
27889858|NCT04713592|81430920|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
27889859|NCT04713592|81430917|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
27889860|NCT04713592|81430918|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
27889861|NCT04713592|81430919|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
27889862|NCT04713592|81430920|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
27889863|NCT02691013|81430921|FG000|Overall Study|Withdrawal by Subject|3|||
27889864|NCT02691013|81430922|FG001|Overall Study|Withdrawal by Subject|0|||
27604894|NCT00576732|80395284|FG005|OPEN LABEL|Adverse Event|1|||
27604895|NCT00576732|80395279|FG000|OPEN LABEL|Lost to Follow-up|0|||
27604896|NCT00576732|80395280|FG001|OPEN LABEL|Lost to Follow-up|0|||
27604897|NCT00576732|80395281|FG002|OPEN LABEL|Lost to Follow-up|0|||
27604898|NCT00576732|80395282|FG003|OPEN LABEL|Lost to Follow-up|2|||
27604899|NCT00576732|80395283|FG004|OPEN LABEL|Lost to Follow-up|1|||
27604900|NCT00576732|80395284|FG005|OPEN LABEL|Lost to Follow-up|1|||
27604901|NCT00576732|80395279|FG000|OPEN LABEL|Withdrawal by Subject|0|||
27604902|NCT00576732|80395280|FG001|OPEN LABEL|Withdrawal by Subject|0|||
27604903|NCT00576732|80395281|FG002|OPEN LABEL|Withdrawal by Subject|0|||
27604904|NCT00576732|80395282|FG003|OPEN LABEL|Withdrawal by Subject|1|||
27604905|NCT00576732|80395283|FG004|OPEN LABEL|Withdrawal by Subject|0|||
27604906|NCT00576732|80395284|FG005|OPEN LABEL|Withdrawal by Subject|1|||
27604907|NCT00576732|80395279|FG000|OPEN LABEL|OTHER|0|||
27604908|NCT00576732|80395280|FG001|OPEN LABEL|OTHER|0|||
27604909|NCT00576732|80395281|FG002|OPEN LABEL|OTHER|0|||
27604910|NCT00576732|80395282|FG003|OPEN LABEL|OTHER|0|||
27604911|NCT00576732|80395283|FG004|OPEN LABEL|OTHER|0|||
27604912|NCT00576732|80395284|FG005|OPEN LABEL|OTHER|2|||
27604913|NCT00576732|80395279|FG000|OPEN LABEL|Lack of Efficacy|0|||
27604914|NCT00576732|80395280|FG001|OPEN LABEL|Lack of Efficacy|0|||
27604915|NCT00576732|80395281|FG002|OPEN LABEL|Lack of Efficacy|0|||
27604916|NCT00576732|80395282|FG003|OPEN LABEL|Lack of Efficacy|2|||
27604917|NCT00576732|80395283|FG004|OPEN LABEL|Lack of Efficacy|2|||
27604918|NCT00576732|80395284|FG005|OPEN LABEL|Lack of Efficacy|3|||
27604919|NCT00576732|80395279|FG000|OPEN LABEL|Protocol Violation|0|||
27604920|NCT00576732|80395280|FG001|OPEN LABEL|Protocol Violation|0|||
27604921|NCT00576732|80395281|FG002|OPEN LABEL|Protocol Violation|0|||
27604922|NCT00576732|80395282|FG003|OPEN LABEL|Protocol Violation|2|||
27604923|NCT00576732|80395283|FG004|OPEN LABEL|Protocol Violation|1|||
27604924|NCT00576732|80395284|FG005|OPEN LABEL|Protocol Violation|0|||
27604925|NCT00612534|80395288|FG000|Overall Study|Adverse Event|0|||
27604926|NCT00612534|80395289|FG001|Overall Study|Adverse Event|4|||
27604927|NCT00612534|80395290|FG002|Overall Study|Adverse Event|2|||
27604928|NCT00612534|80395291|FG003|Overall Study|Adverse Event|1|||
27604929|NCT00612534|80395288|FG000|Overall Study|Lack of Efficacy|13|||
27604930|NCT00612534|80395289|FG001|Overall Study|Lack of Efficacy|12|||
27604931|NCT00612534|80395290|FG002|Overall Study|Lack of Efficacy|5|||
27604932|NCT00612534|80395291|FG003|Overall Study|Lack of Efficacy|16|||
27604933|NCT00612534|80395288|FG000|Overall Study|Other Reason|0|||
27604934|NCT00612534|80395289|FG001|Overall Study|Other Reason|1|||
27604935|NCT00612534|80395290|FG002|Overall Study|Other Reason|0|||
27604936|NCT00612534|80395291|FG003|Overall Study|Other Reason|0|||
27604937|NCT00312702|80395292|FG000|Immunization Phase|Lost to Follow-up|0|||
27604938|NCT00312702|80395293|FG001|Immunization Phase|Lost to Follow-up|1|||
27604939|NCT00312702|80395294|FG002|Immunization Phase|Lost to Follow-up|0|||
27604940|NCT01352585|80395296|FG000|Overall Study|Adverse Event|2|||
27604941|NCT01352585|80395297|FG001|Overall Study|Adverse Event|1|||
27604942|NCT01352585|80395296|FG000|Overall Study|Lost to Follow-up|1|||
27604943|NCT01352585|80395297|FG001|Overall Study|Lost to Follow-up|0|||
27604944|NCT01352585|80395296|FG000|Overall Study|Other|5|||
27604945|NCT01352585|80395297|FG001|Overall Study|Other|2|||
27714392|NCT00960661|80788949|FG002|Interventional Phase|Death|0|||
27714393|NCT00960661|80788947|FG000|Interventional Phase|Lost to Follow-up|0|||
27714394|NCT00960661|80788948|FG001|Interventional Phase|Lost to Follow-up|0|||
27714395|NCT00960661|80788949|FG002|Interventional Phase|Lost to Follow-up|2|||
27604946|NCT04860518|80395298|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
27604947|NCT04860518|80395299|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
27604948|NCT00642902|80395300|FG000|Overall Study|Adverse Event|0|||
27604949|NCT00642902|80395301|FG001|Overall Study|Adverse Event|1|||
27604950|NCT00642902|80395302|FG002|Overall Study|Adverse Event|3|||
27604951|NCT00642902|80395303|FG003|Overall Study|Adverse Event|1|||
27604952|NCT00642902|80395300|FG000|Overall Study|Lost to Follow-up|1|||
27604953|NCT00642902|80395301|FG001|Overall Study|Lost to Follow-up|1|||
27604954|NCT00642902|80395302|FG002|Overall Study|Lost to Follow-up|0|||
27604955|NCT00642902|80395303|FG003|Overall Study|Lost to Follow-up|0|||
27604956|NCT00642902|80395300|FG000|Overall Study|Lack of Efficacy|0|||
27604957|NCT00642902|80395301|FG001|Overall Study|Lack of Efficacy|3|||
27604958|NCT00642902|80395302|FG002|Overall Study|Lack of Efficacy|3|||
27604959|NCT00642902|80395303|FG003|Overall Study|Lack of Efficacy|0|||
27604960|NCT00642902|80395300|FG000|Overall Study|Death|1|||
27604961|NCT00642902|80395301|FG001|Overall Study|Death|0|||
27604962|NCT00642902|80395302|FG002|Overall Study|Death|0|||
27604963|NCT00642902|80395303|FG003|Overall Study|Death|0|||
27604964|NCT00642902|80395300|FG000|Overall Study|Premature termination of clinical trial|37|||
27604965|NCT00642902|80395301|FG001|Overall Study|Premature termination of clinical trial|32|||
27604966|NCT00642902|80395302|FG002|Overall Study|Premature termination of clinical trial|35|||
27604967|NCT00642902|80395303|FG003|Overall Study|Premature termination of clinical trial|35|||
27604968|NCT00642902|80395300|FG000|Overall Study|Randomized, but not treated|0|||
27604969|NCT00642902|80395301|FG001|Overall Study|Randomized, but not treated|0|||
27714396|NCT00960661|80788947|FG000|Interventional Phase|entry criteria not met|0|||
27714397|NCT00960661|80788948|FG001|Interventional Phase|entry criteria not met|3|||
27714398|NCT00960661|80788949|FG002|Interventional Phase|entry criteria not met|0|||
27714399|NCT00960661|80788947|FG000|Interventional Phase|Protocol Violation|0|||
27714400|NCT00960661|80788948|FG001|Interventional Phase|Protocol Violation|7|||
27714401|NCT00960661|80788949|FG002|Interventional Phase|Protocol Violation|2|||
27714402|NCT00960661|80788947|FG000|Interventional Phase|Withdrawal by Subject|0|||
27714403|NCT00960661|80788948|FG001|Interventional Phase|Withdrawal by Subject|18|||
27714404|NCT00960661|80788949|FG002|Interventional Phase|Withdrawal by Subject|29|||
27714405|NCT00960661|80788947|FG000|Interventional Phase|Physician Decision|0|||
27714406|NCT00960661|80788948|FG001|Interventional Phase|Physician Decision|3|||
27714407|NCT00960661|80788949|FG002|Interventional Phase|Physician Decision|5|||
27714408|NCT00960661|80788947|FG000|Interventional Phase|sponsor decision|0|||
27714409|NCT00960661|80788948|FG001|Interventional Phase|sponsor decision|1|||
27714410|NCT00960661|80788949|FG002|Interventional Phase|sponsor decision|0|||
27714411|NCT00960661|80788947|FG000|Interventional Phase|Lack of Efficacy|0|||
27714412|NCT00960661|80788948|FG001|Interventional Phase|Lack of Efficacy|2|||
27714413|NCT00960661|80788949|FG002|Interventional Phase|Lack of Efficacy|0|||
27714414|NCT01934556|80788954|FG000|Overall Study|Withdrawal by Subject|0|||
27714415|NCT01934556|80788955|FG001|Overall Study|Withdrawal by Subject|1|||
27714416|NCT01934556|80788956|FG002|Overall Study|Withdrawal by Subject|1|||
27714417|NCT01934556|80788954|FG000|Overall Study|Lost to Follow-up|4|||
27714418|NCT01934556|80788955|FG001|Overall Study|Lost to Follow-up|10|||
27714419|NCT01934556|80788956|FG002|Overall Study|Lost to Follow-up|7|||
27714420|NCT01934556|80788954|FG000|Overall Study|Death|1|||
27714421|NCT01934556|80788955|FG001|Overall Study|Death|5|||
27714422|NCT01934556|80788956|FG002|Overall Study|Death|2|||
27714423|NCT02321436|80788957|FG000|Overall Study|Withdrawal by Subject|1|||
27714424|NCT02321436|80788958|FG001|Overall Study|Withdrawal by Subject|0|||
27714425|NCT02321436|80788957|FG000|Overall Study|Lost to Follow-up|0|||
27714426|NCT02321436|80788958|FG001|Overall Study|Lost to Follow-up|1|||
27714427|NCT04707157|80788959|FG000|Overall Study|Adverse Event|12|||
27714428|NCT04707157|80788960|FG001|Overall Study|Adverse Event|3|||
27714429|NCT04707157|80788959|FG000|Overall Study|Lost to Follow-up|2|||
27714430|NCT04707157|80788960|FG001|Overall Study|Lost to Follow-up|0|||
27714431|NCT04707157|80788959|FG000|Overall Study|Sponsor's decision|1|||
27714432|NCT04707157|80788960|FG001|Overall Study|Sponsor's decision|0|||
27714433|NCT04707157|80788959|FG000|Overall Study|Physician Decision|8|||
27714434|NCT04707157|80788960|FG001|Overall Study|Physician Decision|5|||
27714435|NCT04707157|80788959|FG000|Overall Study|Protocol Deviation|1|||
27714436|NCT04707157|80788960|FG001|Overall Study|Protocol Deviation|0|||
27714437|NCT04707157|80788959|FG000|Overall Study|Withdrawal by Subject|1|||
27714438|NCT04707157|80788960|FG001|Overall Study|Withdrawal by Subject|1|||
27714439|NCT02937818|80788963|FG000|Overall Study|Participants decision|2|||
27714440|NCT02937818|80788964|FG001|Overall Study|Participants decision|1|||
27714441|NCT02937818|80788965|FG002|Overall Study|Participants decision|1|||
27714442|NCT02937818|80788966|FG003|Overall Study|Participants decision|1|||
27604970|NCT00642902|80395302|FG002|Overall Study|Randomized, but not treated|1|||
27604971|NCT00642902|80395303|FG003|Overall Study|Randomized, but not treated|0|||
27604972|NCT00642902|80395300|FG000|Overall Study|Other|1|||
27604973|NCT00642902|80395301|FG001|Overall Study|Other|5|||
27714443|NCT02937818|80788963|FG000|Overall Study|Adverse Event|2|||
27714444|NCT02937818|80788964|FG001|Overall Study|Adverse Event|4|||
27714445|NCT02937818|80788965|FG002|Overall Study|Adverse Event|1|||
27714446|NCT02937818|80788966|FG003|Overall Study|Adverse Event|1|||
27714447|NCT02937818|80788963|FG000|Overall Study|Disease progression|17|||
27714448|NCT02937818|80788964|FG001|Overall Study|Disease progression|15|||
27714449|NCT02937818|80788965|FG002|Overall Study|Disease progression|7|||
27714450|NCT02937818|80788966|FG003|Overall Study|Disease progression|19|||
27714451|NCT02937818|80788963|FG000|Overall Study|Condition under investigation worsened|0|||
27714452|NCT02937818|80788964|FG001|Overall Study|Condition under investigation worsened|0|||
27714453|NCT02937818|80788965|FG002|Overall Study|Condition under investigation worsened|1|||
27714454|NCT02937818|80788966|FG003|Overall Study|Condition under investigation worsened|0|||
27714455|NCT04417894|80788967|FG000|Overall Study|Lost to Follow-up|3|||
27714456|NCT04417894|80788968|FG001|Overall Study|Lost to Follow-up|0|||
27714457|NCT04417894|80788967|FG000|Overall Study|Withdrawal by Subject|7|||
27714458|NCT04417894|80788968|FG001|Overall Study|Withdrawal by Subject|6|||
27714459|NCT04417894|80788967|FG000|Overall Study|Lack of Efficacy|3|||
27714460|NCT04417894|80788968|FG001|Overall Study|Lack of Efficacy|1|||
27714461|NCT03325673|80788969|FG000|Overall Study|Adverse Event|4|||
27714462|NCT03325673|80788970|FG001|Overall Study|Adverse Event|0|||
27714463|NCT00631371|80788973|FG000|Overall Study|Lost to Follow-up|24|||
27714464|NCT00631371|80788974|FG001|Overall Study|Lost to Follow-up|19|||
27714465|NCT00631371|80788973|FG000|Overall Study|Other reason|5|||
27604974|NCT00642902|80395302|FG002|Overall Study|Other|1|||
27604975|NCT00642902|80395303|FG003|Overall Study|Other|4|||
27604976|NCT03299686|80395308|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
27604977|NCT03299686|80395309|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
27604978|NCT03299686|80395308|FG000|Treatment Epoch|Physician Decision|1|||
27604979|NCT03299686|80395309|FG001|Treatment Epoch|Physician Decision|0|||
27604980|NCT03299686|80395308|FG000|Treatment Epoch|Adverse Event|8|||
27604981|NCT03299686|80395309|FG001|Treatment Epoch|Adverse Event|4|||
27604982|NCT03299686|80395308|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
27604983|NCT03299686|80395309|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
27604984|NCT01106430|80395310|FG000|Overall Study|Adverse Event|8|||
27604985|NCT01106430|80395311|FG001|Overall Study|Adverse Event|10|||
27604986|NCT01106430|80395310|FG000|Overall Study|Lack of Efficacy|2|||
27604987|NCT01106430|80395311|FG001|Overall Study|Lack of Efficacy|13|||
27604988|NCT01106430|80395310|FG000|Overall Study|Lost to Follow-up|5|||
27604989|NCT01106430|80395311|FG001|Overall Study|Lost to Follow-up|1|||
27604990|NCT01106430|80395310|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
27604991|NCT01106430|80395311|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
27604992|NCT01106430|80395310|FG000|Overall Study|Moved Out Of State|0|||
27604993|NCT01106430|80395311|FG001|Overall Study|Moved Out Of State|1|||
27604994|NCT01106430|80395310|FG000|Overall Study|Refused To Take Medication|0|||
27604995|NCT01106430|80395311|FG001|Overall Study|Refused To Take Medication|1|||
27714466|NCT00631371|80788974|FG001|Overall Study|Other reason|12|||
27714467|NCT00631371|80788973|FG000|Overall Study|subject request|38|||
27714468|NCT00631371|80788974|FG001|Overall Study|subject request|45|||
27889865|NCT04739722|81430926|FG000|Overall Study|Lost to Follow-up|5301|||
27604996|NCT01106430|80395310|FG000|Overall Study|Noncompliance|0|||
27604997|NCT01106430|80395311|FG001|Overall Study|Noncompliance|1|||
27604998|NCT01106430|80395310|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
27604999|NCT01106430|80395311|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
27714469|NCT00631371|80788973|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
27714470|NCT00631371|80788974|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
27714471|NCT00631371|80788973|FG000|Overall Study|Death|263|||
27889866|NCT04739722|81430926|FG000|Overall Study|Withdrawal by Subject|42|||
27889867|NCT04739722|81430926|FG000|Overall Study|Non Average-risk|1157|||
27605000|NCT01106430|80395310|FG000|Overall Study|Previous Use Of Marijuana|1|||
27605001|NCT01106430|80395311|FG001|Overall Study|Previous Use Of Marijuana|0|||
27714472|NCT00631371|80788974|FG001|Overall Study|Death|239|||
27714473|NCT00838331|80788975|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
27714474|NCT00993928|80788976|FG000|Overall Study|Withdrawal by Subject|4|||
27714475|NCT00993928|80788977|FG001|Overall Study|Withdrawal by Subject|7|||
27714476|NCT00993928|80788976|FG000|Overall Study|ineligible|1|||
27714477|NCT00993928|80788977|FG001|Overall Study|ineligible|0|||
27714478|NCT04818593|80788978|FG000|Overall Study|Low Oocyte Yield|8|||
27714479|NCT04818593|80788979|FG001|Overall Study|Low Oocyte Yield|8|||
27714480|NCT04818593|80788978|FG000|Overall Study|Not ICSI Insemination|7|||
27714481|NCT04818593|80788979|FG001|Overall Study|Not ICSI Insemination|7|||
27714482|NCT04818593|80788978|FG000|Overall Study|Poor Sperm Quality|2|||
27714483|NCT04818593|80788979|FG001|Overall Study|Poor Sperm Quality|2|||
27714484|NCT04818593|80788978|FG000|Overall Study|Withdrawal by Subject|2|||
27714485|NCT04818593|80788979|FG001|Overall Study|Withdrawal by Subject|2|||
27714486|NCT04818593|80788978|FG000|Overall Study|Conversion to IUI due to low response|1|||
27714487|NCT04818593|80788979|FG001|Overall Study|Conversion to IUI due to low response|1|||
27714488|NCT00772954|80788980|FG000|Overall Study|Adverse Event|0|||
27714489|NCT00772954|80788981|FG001|Overall Study|Adverse Event|0|||
27714490|NCT00772954|80788982|FG002|Overall Study|Adverse Event|1|||
27714491|NCT03499028|80788983|FG000|Overall Study|Lost to Follow-up|12|||
27714492|NCT03499028|80788984|FG001|Overall Study|Lost to Follow-up|9|||
27714493|NCT03499028|80788983|FG000|Overall Study|Withdrawal by Subject|5|||
27714494|NCT03499028|80788984|FG001|Overall Study|Withdrawal by Subject|8|||
27714495|NCT03499028|80788983|FG000|Overall Study|Unplanned SNF discharge|5|||
27714496|NCT03499028|80788984|FG001|Overall Study|Unplanned SNF discharge|8|||
27714497|NCT02551159|80788985|FG000|Overall Study|Death|352|||
27714498|NCT02551159|80788986|FG001|Overall Study|Death|174|||
27714499|NCT02551159|80788987|FG002|Overall Study|Death|161|||
27714500|NCT02551159|80788985|FG000|Overall Study|Withdrawal by Subject|8|||
27714501|NCT02551159|80788986|FG001|Overall Study|Withdrawal by Subject|5|||
27605002|NCT01106430|80395310|FG000|Overall Study|Protocol Violation|7|||
27605003|NCT01106430|80395311|FG001|Overall Study|Protocol Violation|2|||
27605004|NCT01106430|80395310|FG000|Overall Study|Withdrawal by Subject|8|||
27605005|NCT01106430|80395311|FG001|Overall Study|Withdrawal by Subject|4|||
27605006|NCT01529008|80395314|FG000|Bone Marrow Harvesting|Physician Decision|1|||
27605007|NCT01529008|80395315|FG001|Bone Marrow Harvesting|Physician Decision|1|||
27714502|NCT02551159|80788987|FG002|Overall Study|Withdrawal by Subject|16|||
27714503|NCT02551159|80788985|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
27714504|NCT02551159|80788986|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
27714505|NCT02551159|80788987|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
27605008|NCT01529008|80395314|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
27605009|NCT01529008|80395315|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
27605010|NCT01529008|80395314|FG000|Treatment|Adverse Event|6|||
27605011|NCT01529008|80395315|FG001|Treatment|Adverse Event|0|||
27605012|NCT01529008|80395314|FG000|Treatment|Other|3|||
27605013|NCT01529008|80395315|FG001|Treatment|Other|1|||
27605014|NCT01529008|80395314|FG000|Efficacy Analysis|Protocol Violation|2|||
27605015|NCT01529008|80395315|FG001|Efficacy Analysis|Protocol Violation|0|||
27605016|NCT01529008|80395314|FG000|Efficacy Analysis|Physician Decision|0|||
27714506|NCT03313076|80788988|FG000|Overall Study|Withdrawal by Subject|2|||
27714507|NCT03313076|80788989|FG001|Overall Study|Withdrawal by Subject|0|||
27714508|NCT03313076|80788990|FG002|Overall Study|Withdrawal by Subject|0|||
27714509|NCT03313076|80788991|FG003|Overall Study|Withdrawal by Subject|0|||
27714510|NCT03313076|80788988|FG000|Overall Study|Lost to Follow-up|0|||
27714511|NCT03313076|80788989|FG001|Overall Study|Lost to Follow-up|2|||
27714512|NCT03313076|80788990|FG002|Overall Study|Lost to Follow-up|2|||
27714513|NCT03313076|80788991|FG003|Overall Study|Lost to Follow-up|2|||
27714514|NCT00574275|80788994|FG000|Overall Study|Randomized but not treated|2|||
27714515|NCT00574275|80788995|FG001|Overall Study|Randomized but not treated|3|||
27714516|NCT00574275|80788994|FG000|Overall Study|Adverse Event|32|||
27714517|NCT00574275|80788995|FG001|Overall Study|Adverse Event|76|||
27889868|NCT01598090|81430927|FG000|Treatment Period|Poor/non-compliance|0|||
27889869|NCT01598090|81430928|FG001|Treatment Period|Poor/non-compliance|2|||
27889870|NCT01598090|81430929|FG002|Treatment Period|Poor/non-compliance|0|||
27714518|NCT00574275|80788994|FG000|Overall Study|Disease progression|160|||
27714519|NCT00574275|80788995|FG001|Overall Study|Disease progression|146|||
27714520|NCT00574275|80788994|FG000|Overall Study|Lost to Follow-up|2|||
27714521|NCT00574275|80788995|FG001|Overall Study|Lost to Follow-up|1|||
27714522|NCT00574275|80788994|FG000|Overall Study|Study stopped based on DMC decision|62|||
27605017|NCT01529008|80395315|FG001|Efficacy Analysis|Physician Decision|1|||
27714523|NCT00574275|80788995|FG001|Overall Study|Study stopped based on DMC decision|23|||
27714524|NCT00574275|80788994|FG000|Overall Study|Withdrawal by Subject|15|||
27714525|NCT00574275|80788995|FG001|Overall Study|Withdrawal by Subject|17|||
27714526|NCT00574275|80788994|FG000|Overall Study|Error calculating tumor measurement|1|||
27714527|NCT00574275|80788995|FG001|Overall Study|Error calculating tumor measurement|0|||
27714528|NCT00574275|80788994|FG000|Overall Study|Physician Decision|1|||
27714529|NCT00574275|80788995|FG001|Overall Study|Physician Decision|1|||
27714530|NCT00574275|80788994|FG000|Overall Study|Protocol Violation|0|||
27714531|NCT00574275|80788995|FG001|Overall Study|Protocol Violation|1|||
27714532|NCT00574275|80788994|FG000|Overall Study|Patient and Investigator decision|0|||
27714533|NCT00574275|80788995|FG001|Overall Study|Patient and Investigator decision|1|||
27714534|NCT00574275|80788994|FG000|Overall Study|Insurance change|0|||
27714535|NCT00574275|80788995|FG001|Overall Study|Insurance change|1|||
27714536|NCT00574275|80788994|FG000|Overall Study|Operation for curative intent|0|||
27714537|NCT00574275|80788995|FG001|Overall Study|Operation for curative intent|1|||
27714538|NCT01081795|80788996|FG000|Overall Study|Adverse Event|18|||
27714539|NCT01081795|80788997|FG001|Overall Study|Adverse Event|23|||
27714540|NCT01081795|80788998|FG002|Overall Study|Adverse Event|6|||
27714541|NCT01081795|80788996|FG000|Overall Study|Lack of Efficacy|7|||
27714542|NCT01081795|80788997|FG001|Overall Study|Lack of Efficacy|5|||
27714543|NCT01081795|80788998|FG002|Overall Study|Lack of Efficacy|19|||
27714544|NCT01081795|80788996|FG000|Overall Study|Subject's schedule|1|||
27714545|NCT01081795|80788997|FG001|Overall Study|Subject's schedule|1|||
27714546|NCT01081795|80788998|FG002|Overall Study|Subject's schedule|2|||
27714547|NCT01081795|80788996|FG000|Overall Study|Revocation of informed consent|2|||
27714548|NCT01081795|80788997|FG001|Overall Study|Revocation of informed consent|0|||
27714549|NCT01081795|80788998|FG002|Overall Study|Revocation of informed consent|0|||
27714550|NCT01081795|80788996|FG000|Overall Study|Ineligible for participation|1|||
27714551|NCT01081795|80788997|FG001|Overall Study|Ineligible for participation|0|||
27714552|NCT01081795|80788998|FG002|Overall Study|Ineligible for participation|0|||
27714553|NCT01081795|80788996|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
27714554|NCT01081795|80788997|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
27714555|NCT01081795|80788998|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
27714556|NCT01081795|80788996|FG000|Overall Study|Using drug with restricted days of use|2|||
27714557|NCT01081795|80788997|FG001|Overall Study|Using drug with restricted days of use|3|||
27714558|NCT01081795|80788998|FG002|Overall Study|Using drug with restricted days of use|2|||
27714559|NCT01081795|80788996|FG000|Overall Study|Other|1|||
27714560|NCT01081795|80788997|FG001|Overall Study|Other|2|||
27714561|NCT01081795|80788998|FG002|Overall Study|Other|0|||
27714562|NCT01535729|80788999|FG000|Overall Study|Withdrawal by Subject|2|||
27714563|NCT01535729|80788999|FG000|Overall Study|Disease progression|230|||
27714564|NCT01535729|80788999|FG000|Overall Study|Discontinued treatment|25|||
27714565|NCT01535729|80788999|FG000|Overall Study|Lost to Follow-up|8|||
27714566|NCT01535729|80788999|FG000|Overall Study|Death|52|||
27714567|NCT01535729|80788999|FG000|Overall Study|Other|19|||
27714568|NCT01535729|80788999|FG000|Overall Study|Did not sign informed consent|1|||
27714569|NCT01535729|80788999|FG000|Overall Study|No previous chemotherapy|33|||
27714570|NCT01535729|80788999|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
27714571|NCT01535729|80788999|FG000|Overall Study|Protocol Violation|11|||
27714572|NCT01535729|80788999|FG000|Overall Study|Screening failure|1|||
27714573|NCT01535729|80788999|FG000|Overall Study|Not treated|9|||
27714574|NCT01535729|80788999|FG000|Overall Study|No participant record available|5|||
27714575|NCT00075504|80789000|FG000|Overall Study|Withdrawal by Subject|9|||
27714576|NCT00075504|80789001|FG001|Overall Study|Withdrawal by Subject|7|||
27714577|NCT03075527|80789002|FG000|Overall Study|Ongoing treatment|2|||
27714578|NCT00903175|80789004|FG000|Period 1 - First Line|Adverse Event|36|||
27714579|NCT00903175|80789005|FG001|Period 1 - First Line|Adverse Event|50|||
27714580|NCT00903175|80789004|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
27714581|NCT00903175|80789005|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
27714582|NCT00903175|80789004|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
27714583|NCT00903175|80789005|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
27605018|NCT01529008|80395314|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
27714584|NCT00903175|80789004|FG000|Period 1 - First Line|Protocol Violation|3|||
27714585|NCT00903175|80789005|FG001|Period 1 - First Line|Protocol Violation|3|||
27837114|NCT02218541|81232956|FG000|Overall Study|Implant Failure|4|||
27714586|NCT00903175|80789004|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
27714587|NCT00903175|80789005|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
27714588|NCT00903175|80789004|FG000|Period 1 - First Line|Administrative problems|12|||
27714589|NCT00903175|80789005|FG001|Period 1 - First Line|Administrative problems|13|||
27714590|NCT00903175|80789004|FG000|Period 1 - First Line|Death|17|||
27714591|NCT00903175|80789005|FG001|Period 1 - First Line|Death|10|||
27714592|NCT00903175|80789004|FG000|Period 2 - Second Line|Missing|1|||
27714593|NCT00903175|80789005|FG001|Period 2 - Second Line|Missing|0|||
27714594|NCT00903175|80789004|FG000|Period 2 - Second Line|Adverse Event|16|||
27714595|NCT00903175|80789005|FG001|Period 2 - Second Line|Adverse Event|20|||
27714596|NCT00903175|80789004|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
27714597|NCT00903175|80789005|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
27714598|NCT00903175|80789004|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
27714599|NCT00903175|80789005|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
27714600|NCT00903175|80789004|FG000|Period 2 - Second Line|Administrative problems|19|||
27714601|NCT00903175|80789005|FG001|Period 2 - Second Line|Administrative problems|9|||
27714602|NCT00903175|80789004|FG000|Period 2 - Second Line|Death|5|||
27714603|NCT00903175|80789005|FG001|Period 2 - Second Line|Death|2|||
27714604|NCT02966509|80789006|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
27605019|NCT01529008|80395315|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
27714605|NCT02966509|80789007|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
27714606|NCT02966509|80789006|FG000|Baseline Satisfaction Survey|Death|0|||
27714607|NCT02966509|80789007|FG001|Baseline Satisfaction Survey|Death|1|||
27714608|NCT02966509|80789006|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
27714609|NCT02966509|80789007|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
27714610|NCT02966509|80789006|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
27714611|NCT02966509|80789007|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
27714612|NCT02966509|80789006|FG000|6 Month Satisfaction Decision Survey|Death|22|||
27714613|NCT02966509|80789007|FG001|6 Month Satisfaction Decision Survey|Death|25|||
27714614|NCT02966509|80789006|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
27714615|NCT02966509|80789007|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
27714616|NCT02966509|80789006|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
27714617|NCT02966509|80789007|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
27714618|NCT02966509|80789006|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
27714619|NCT02966509|80789007|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
27714620|NCT02966509|80789006|FG000|6 Month Satisfaction Survey|Death|36|||
27714621|NCT02966509|80789007|FG001|6 Month Satisfaction Survey|Death|33|||
27714622|NCT02966509|80789006|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
27714623|NCT02966509|80789007|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
27714624|NCT02966509|80789006|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
27714625|NCT02966509|80789007|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
27714626|NCT02966509|80789006|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
27714627|NCT02966509|80789007|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
27714628|NCT02966509|80789006|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
27714629|NCT02966509|80789007|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
27714630|NCT02966509|80789006|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
27714631|NCT02966509|80789007|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
27714632|NCT03861559|80789008|FG000|Overall Study|Adverse Event|0|||
27714633|NCT03861559|80789009|FG001|Overall Study|Adverse Event|2|||
27714634|NCT03861559|80789008|FG000|Overall Study|Treatment failure|0|||
27714635|NCT03861559|80789009|FG001|Overall Study|Treatment failure|2|||
27714636|NCT03861559|80789008|FG000|Overall Study|Noncompliance|1|||
27889871|NCT01598090|81430927|FG000|Treatment Period|No longer meet study criteria|0|||
27714637|NCT03861559|80789009|FG001|Overall Study|Noncompliance|1|||
27714638|NCT03861559|80789008|FG000|Overall Study|Did not meet eligibility requirements|1|||
27714639|NCT03861559|80789009|FG001|Overall Study|Did not meet eligibility requirements|0|||
27714640|NCT01390272|80789020|FG000|Overall Study|Death|3|||
27714641|NCT01390272|80789021|FG001|Overall Study|Death|2|||
27714642|NCT01390272|80789020|FG000|Overall Study|Withdrawal by Subject|9|||
27714643|NCT01390272|80789021|FG001|Overall Study|Withdrawal by Subject|5|||
27714644|NCT01390272|80789020|FG000|Overall Study|Patient moved, no longer eligible|5|||
27714645|NCT01390272|80789021|FG001|Overall Study|Patient moved, no longer eligible|8|||
27714646|NCT03286842|80789028|FG000|Overall Study|Patients rolled over to another study|80|||
27714647|NCT01026831|80789029|FG000|Overall Study|Adverse Event|4|||
27714648|NCT01026831|80789030|FG001|Overall Study|Adverse Event|3|||
27714649|NCT01026831|80789029|FG000|Overall Study|Lost to Follow-up|2|||
27714650|NCT01026831|80789030|FG001|Overall Study|Lost to Follow-up|0|||
27714651|NCT01026831|80789029|FG000|Overall Study|Physician Decision|1|||
27714652|NCT01026831|80789030|FG001|Overall Study|Physician Decision|1|||
27714653|NCT01026831|80789029|FG000|Overall Study|Protocol Violation|0|||
27714654|NCT01026831|80789030|FG001|Overall Study|Protocol Violation|2|||
27714655|NCT01026831|80789029|FG000|Overall Study|Withdrawal by Subject|7|||
27714656|NCT01026831|80789030|FG001|Overall Study|Withdrawal by Subject|5|||
27714657|NCT00805480|80789032|FG000|Overall Study|Withdrawal by Subject|13|||
27714658|NCT00805480|80789033|FG001|Overall Study|Withdrawal by Subject|5|||
27714659|NCT00805480|80789034|FG002|Overall Study|Withdrawal by Subject|11|||
27714660|NCT00805480|80789035|FG003|Overall Study|Withdrawal by Subject|5|||
27714661|NCT00805480|80789032|FG000|Overall Study|Lost to Follow-up|1|||
27714662|NCT00805480|80789033|FG001|Overall Study|Lost to Follow-up|2|||
27714663|NCT00805480|80789034|FG002|Overall Study|Lost to Follow-up|0|||
27714664|NCT00805480|80789035|FG003|Overall Study|Lost to Follow-up|0|||
27714665|NCT00805480|80789032|FG000|Overall Study|Adverse Event|0|||
27714666|NCT00805480|80789033|FG001|Overall Study|Adverse Event|0|||
27714667|NCT00805480|80789034|FG002|Overall Study|Adverse Event|1|||
27714668|NCT00805480|80789035|FG003|Overall Study|Adverse Event|0|||
27714669|NCT01661140|80789037|FG000|Open-Label Period|Adverse Event|44|||
27714670|NCT01661140|80789038|FG001|Open-Label Period|Adverse Event|0|||
27714671|NCT01661140|80789039|FG002|Open-Label Period|Adverse Event|0|||
27714672|NCT01661140|80789037|FG000|Open-Label Period|Protocol Violation|3|||
27714673|NCT01661140|80789038|FG001|Open-Label Period|Protocol Violation|0|||
27714674|NCT01661140|80789039|FG002|Open-Label Period|Protocol Violation|0|||
27714675|NCT01661140|80789037|FG000|Open-Label Period|Withdrawal by Subject|5|||
27714676|NCT01661140|80789038|FG001|Open-Label Period|Withdrawal by Subject|0|||
27714677|NCT01661140|80789039|FG002|Open-Label Period|Withdrawal by Subject|0|||
27714678|NCT01661140|80789037|FG000|Open-Label Period|Investigator Decision|3|||
27714679|NCT01661140|80789038|FG001|Open-Label Period|Investigator Decision|0|||
27714680|NCT01661140|80789039|FG002|Open-Label Period|Investigator Decision|0|||
27714681|NCT01661140|80789037|FG000|Open-Label Period|Death|1|||
27714682|NCT01661140|80789038|FG001|Open-Label Period|Death|0|||
27714683|NCT01661140|80789039|FG002|Open-Label Period|Death|0|||
27714684|NCT01661140|80789037|FG000|Open-Label Period|Administrative/Other|1|||
27714685|NCT01661140|80789038|FG001|Open-Label Period|Administrative/Other|0|||
27714686|NCT01661140|80789039|FG002|Open-Label Period|Administrative/Other|0|||
27714687|NCT01661140|80789037|FG000|Open-Label Period|Sponsor termination|16|||
27889872|NCT01598090|81430928|FG001|Treatment Period|No longer meet study criteria|1|||
27889873|NCT01598090|81430929|FG002|Treatment Period|No longer meet study criteria|0|||
27889874|NCT01598090|81430927|FG000|Treatment Period|Lack of Efficacy|5|||
27889875|NCT01598090|81430928|FG001|Treatment Period|Lack of Efficacy|14|||
27714688|NCT01661140|80789038|FG001|Open-Label Period|Sponsor termination|0|||
27889876|NCT01598090|81430929|FG002|Treatment Period|Lack of Efficacy|6|||
27889877|NCT01598090|81430927|FG000|Treatment Period|Adverse Event|2|||
27714689|NCT01661140|80789039|FG002|Open-Label Period|Sponsor termination|0|||
27714690|NCT01661140|80789037|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
27714691|NCT01661140|80789038|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
27714692|NCT01661140|80789039|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
27714693|NCT01661140|80789037|FG000|Open-Label Period|Lost to Follow-up|2|||
27714694|NCT01661140|80789038|FG001|Open-Label Period|Lost to Follow-up|0|||
27889878|NCT01598090|81430928|FG001|Treatment Period|Adverse Event|33|||
27714695|NCT01661140|80789039|FG002|Open-Label Period|Lost to Follow-up|0|||
27714696|NCT01661140|80789037|FG000|Double-Blind Period|Refused Treatment|0|||
27714697|NCT01661140|80789038|FG001|Double-Blind Period|Refused Treatment|0|||
27714698|NCT01661140|80789039|FG002|Double-Blind Period|Refused Treatment|1|||
27714699|NCT01661140|80789037|FG000|Double-Blind Period|Adverse Event|0|||
27714700|NCT01661140|80789038|FG001|Double-Blind Period|Adverse Event|16|||
27714701|NCT01661140|80789039|FG002|Double-Blind Period|Adverse Event|18|||
27714702|NCT01661140|80789037|FG000|Double-Blind Period|Protocol Violation|0|||
27714703|NCT01661140|80789038|FG001|Double-Blind Period|Protocol Violation|2|||
27714704|NCT01661140|80789039|FG002|Double-Blind Period|Protocol Violation|3|||
27714705|NCT01661140|80789037|FG000|Double-Blind Period|Withdrawal by Subject|0|||
27714706|NCT01661140|80789038|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27714707|NCT01661140|80789039|FG002|Double-Blind Period|Withdrawal by Subject|3|||
27714708|NCT01661140|80789037|FG000|Double-Blind Period|Investigator's Decision|0|||
27714709|NCT01661140|80789038|FG001|Double-Blind Period|Investigator's Decision|1|||
27714710|NCT01661140|80789039|FG002|Double-Blind Period|Investigator's Decision|2|||
27714711|NCT01661140|80789037|FG000|Double-Blind Period|Sponsor Termination|0|||
27714712|NCT01661140|80789038|FG001|Double-Blind Period|Sponsor Termination|14|||
27714713|NCT01661140|80789039|FG002|Double-Blind Period|Sponsor Termination|17|||
27714714|NCT01661140|80789037|FG000|Double-Blind Period|Administrative/Other|0|||
27889879|NCT01598090|81430929|FG002|Treatment Period|Adverse Event|17|||
27889880|NCT01598090|81430927|FG000|Treatment Period|Other reasons|0|||
27889881|NCT01598090|81430928|FG001|Treatment Period|Other reasons|4|||
27889882|NCT01598090|81430929|FG002|Treatment Period|Other reasons|1|||
27889883|NCT01598090|81430927|FG000|Treatment Period|Withdrawal by Subject|3|||
27889884|NCT01598090|81430928|FG001|Treatment Period|Withdrawal by Subject|13|||
27889885|NCT01598090|81430929|FG002|Treatment Period|Withdrawal by Subject|10|||
27889886|NCT01598090|81430927|FG000|Treatment Period|Lost to Follow-up|1|||
27889887|NCT01598090|81430928|FG001|Treatment Period|Lost to Follow-up|5|||
27889888|NCT01598090|81430929|FG002|Treatment Period|Lost to Follow-up|1|||
27889889|NCT01598090|81430927|FG000|Follow-up Period|Death|0|||
27889890|NCT01598090|81430928|FG001|Follow-up Period|Death|1|||
27714715|NCT01661140|80789038|FG001|Double-Blind Period|Administrative/Other|7|||
27889891|NCT01598090|81430929|FG002|Follow-up Period|Death|0|||
27889892|NCT01598090|81430927|FG000|Follow-up Period|No longer required per protocol|1|||
27714716|NCT01661140|80789039|FG002|Double-Blind Period|Administrative/Other|6|||
27714717|NCT03311711|80789040|FG000|Overall Study|Death|1|||
27714718|NCT03311711|80789041|FG001|Overall Study|Death|0|||
27714719|NCT03311711|80789042|FG002|Overall Study|Death|0|||
27889893|NCT01598090|81430928|FG001|Follow-up Period|No longer required per protocol|3|||
27889894|NCT01598090|81430929|FG002|Follow-up Period|No longer required per protocol|2|||
27889895|NCT01598090|81430927|FG000|Follow-up Period|Not reported|0|||
27889896|NCT01598090|81430928|FG001|Follow-up Period|Not reported|10|||
27889897|NCT01598090|81430929|FG002|Follow-up Period|Not reported|4|||
27889898|NCT01598090|81430927|FG000|Follow-up Period|Withdrawal by Subject|0|||
27889899|NCT01598090|81430928|FG001|Follow-up Period|Withdrawal by Subject|3|||
27889900|NCT01598090|81430929|FG002|Follow-up Period|Withdrawal by Subject|2|||
27889901|NCT01598090|81430927|FG000|Follow-up Period|Other reasons|2|||
27889902|NCT01598090|81430928|FG001|Follow-up Period|Other reasons|8|||
27889903|NCT01598090|81430929|FG002|Follow-up Period|Other reasons|8|||
27889904|NCT01598090|81430927|FG000|Follow-up Period|Lost to Follow-up|2|||
27889905|NCT01598090|81430928|FG001|Follow-up Period|Lost to Follow-up|10|||
27889906|NCT01598090|81430929|FG002|Follow-up Period|Lost to Follow-up|12|||
27889907|NCT02419612|81430930|FG000|Short-term Treatment Period|Adverse Event|1|||
27714720|NCT03311711|80789043|FG003|Overall Study|Death|0|||
27714721|NCT03311711|80789044|FG004|Overall Study|Death|0|||
27714722|NCT03311711|80789045|FG005|Overall Study|Death|0|||
27714723|NCT03311711|80789046|FG006|Overall Study|Death|1|||
27714724|NCT03311711|80789047|FG007|Overall Study|Death|0|||
27889908|NCT02419612|81430931|FG001|Short-term Treatment Period|Adverse Event|1|||
27889909|NCT02419612|81430930|FG000|Short-term Treatment Period|Death|0|||
27889910|NCT02419612|81430931|FG001|Short-term Treatment Period|Death|2|||
27889911|NCT02419612|81430930|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
27714725|NCT03311711|80789048|FG008|Overall Study|Death|1|||
27714726|NCT03311711|80789049|FG009|Overall Study|Death|0|||
27714727|NCT03311711|80789040|FG000|Overall Study|Death of dyad partner|0|||
27714728|NCT03311711|80789041|FG001|Overall Study|Death of dyad partner|1|||
27714729|NCT03311711|80789042|FG002|Overall Study|Death of dyad partner|0|||
27714730|NCT03311711|80789043|FG003|Overall Study|Death of dyad partner|0|||
27714731|NCT03311711|80789044|FG004|Overall Study|Death of dyad partner|0|||
27714732|NCT03311711|80789045|FG005|Overall Study|Death of dyad partner|0|||
27889912|NCT02419612|81430931|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
27889913|NCT02419612|81430930|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
27889914|NCT02419612|81430931|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
27714733|NCT03311711|80789046|FG006|Overall Study|Death of dyad partner|0|||
27714734|NCT03311711|80789047|FG007|Overall Study|Death of dyad partner|1|||
27714735|NCT03311711|80789048|FG008|Overall Study|Death of dyad partner|0|||
27714736|NCT03311711|80789049|FG009|Overall Study|Death of dyad partner|1|||
27714737|NCT03311711|80789040|FG000|Overall Study|Lost to Follow-up|2|||
27714738|NCT03311711|80789041|FG001|Overall Study|Lost to Follow-up|2|||
27714739|NCT03311711|80789042|FG002|Overall Study|Lost to Follow-up|0|||
27714740|NCT03311711|80789043|FG003|Overall Study|Lost to Follow-up|0|||
27714741|NCT03311711|80789044|FG004|Overall Study|Lost to Follow-up|0|||
27714742|NCT03311711|80789045|FG005|Overall Study|Lost to Follow-up|0|||
27714743|NCT03311711|80789046|FG006|Overall Study|Lost to Follow-up|1|||
27714744|NCT03311711|80789047|FG007|Overall Study|Lost to Follow-up|1|||
27714745|NCT03311711|80789048|FG008|Overall Study|Lost to Follow-up|0|||
27714746|NCT03311711|80789049|FG009|Overall Study|Lost to Follow-up|0|||
27714747|NCT03311711|80789040|FG000|Overall Study|Withdrawal by Subject|1|||
27714748|NCT03311711|80789041|FG001|Overall Study|Withdrawal by Subject|1|||
27714749|NCT03311711|80789042|FG002|Overall Study|Withdrawal by Subject|0|||
27714750|NCT03311711|80789043|FG003|Overall Study|Withdrawal by Subject|0|||
27714751|NCT03311711|80789044|FG004|Overall Study|Withdrawal by Subject|0|||
27714752|NCT03311711|80789045|FG005|Overall Study|Withdrawal by Subject|0|||
27714753|NCT03311711|80789046|FG006|Overall Study|Withdrawal by Subject|3|||
27714754|NCT03311711|80789047|FG007|Overall Study|Withdrawal by Subject|3|||
27714755|NCT03311711|80789048|FG008|Overall Study|Withdrawal by Subject|0|||
27714756|NCT03311711|80789049|FG009|Overall Study|Withdrawal by Subject|0|||
27714757|NCT01836783|80789050|FG000|Overall Study|Withdrawal by Subject|0|||
27714758|NCT01836783|80789051|FG001|Overall Study|Withdrawal by Subject|2|||
27714759|NCT04294719|80789056|FG000|Overall Study|Withdrawal by Subject|1|||
27714760|NCT01984268|80789057|FG000|Overall Study|Study Terminated|15|||
27714761|NCT02325219|80789058|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
27714762|NCT02325219|80789059|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
27714763|NCT02325219|80789060|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
27714764|NCT02325219|80789061|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
27714765|NCT02325219|80789062|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
27714766|NCT02325219|80789058|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
27714767|NCT02325219|80789059|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
27714768|NCT02325219|80789060|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27714769|NCT02325219|80789061|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27714770|NCT02325219|80789062|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27605020|NCT01986881|80395316|FG000|Overall Study|Death|228|||
27605021|NCT01986881|80395317|FG001|Overall Study|Death|233|||
27605022|NCT01986881|80395318|FG002|Overall Study|Death|247|||
27605023|NCT01986881|80395316|FG000|Overall Study|Lost to Follow-up|51|||
27605024|NCT01986881|80395317|FG001|Overall Study|Lost to Follow-up|44|||
27714771|NCT02325219|80789058|FG000|Controlled Period (Week 0 - 16)|Other|0|||
27837115|NCT02218541|81232957|FG001|Overall Study|Implant Failure|1|||
27837116|NCT02451696|81232958|FG000|Overall Study|Surgery postponed|1|||
27889915|NCT02419612|81430930|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
27889916|NCT02419612|81430931|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
27889917|NCT02419612|81430930|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
27889918|NCT02419612|81430931|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
27837117|NCT02451696|81232959|FG001|Overall Study|Surgery postponed|0|||
27837118|NCT00021541|81232960|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
27837119|NCT00021541|81232961|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
27837120|NCT00021541|81232960|FG000|Period 1-First Treatment|Adverse Event|2|||
27837121|NCT00021541|81232961|FG001|Period 1-First Treatment|Adverse Event|1|||
27837122|NCT00021541|81232960|FG000|Period 1-First Treatment|non-adherence|3|||
27837123|NCT00021541|81232961|FG001|Period 1-First Treatment|non-adherence|0|||
27837124|NCT00021541|81232960|FG000|Period 1-First Treatment|Death|1|||
27837125|NCT00021541|81232961|FG001|Period 1-First Treatment|Death|0|||
27837126|NCT00021541|81232960|FG000|Period 1-First Treatment|Pts that did not progress|2|||
27837127|NCT00021541|81232961|FG001|Period 1-First Treatment|Pts that did not progress|2|||
27837128|NCT00021541|81232960|FG000|Period 1-First Treatment|Ineligible|0|||
27837129|NCT00021541|81232961|FG001|Period 1-First Treatment|Ineligible|2|||
27837130|NCT00021541|81232960|FG000|Period 2-crossover|refused phase B|2|||
27889919|NCT02419612|81430930|FG000|Short-term Treatment Period|Worsening of liver function|0|||
27889920|NCT02419612|81430931|FG001|Short-term Treatment Period|Worsening of liver function|1|||
27889921|NCT02419612|81430930|FG000|Short-term Treatment Period|Subject moved out of state|0|||
27889922|NCT02419612|81430931|FG001|Short-term Treatment Period|Subject moved out of state|1|||
27889923|NCT02419612|81430930|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
27889924|NCT02419612|81430931|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
27889925|NCT02419612|81430930|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
27605025|NCT01986881|80395318|FG002|Overall Study|Lost to Follow-up|55|||
27889926|NCT02419612|81430931|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
27889927|NCT02419612|81430930|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
27605026|NCT01986881|80395316|FG000|Overall Study|Physician Decision|7|||
27605027|NCT01986881|80395317|FG001|Overall Study|Physician Decision|4|||
27605028|NCT01986881|80395318|FG002|Overall Study|Physician Decision|6|||
27605029|NCT01986881|80395316|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
27605030|NCT01986881|80395317|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
27714772|NCT02325219|80789059|FG001|Controlled Period (Week 0 - 16)|Other|0|||
27714773|NCT02325219|80789060|FG002|Controlled Period (Week 0 - 16)|Other|1|||
27714774|NCT02325219|80789061|FG003|Controlled Period (Week 0 - 16)|Other|0|||
27714775|NCT02325219|80789062|FG004|Controlled Period (Week 0 - 16)|Other|0|||
27714776|NCT02325219|80789058|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27714777|NCT02325219|80789059|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27714778|NCT02325219|80789060|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27714779|NCT02325219|80789061|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
27714780|NCT02325219|80789062|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
27714781|NCT02325219|80789058|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27714782|NCT02325219|80789059|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
27714783|NCT02325219|80789060|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27714784|NCT02325219|80789061|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27714785|NCT02325219|80789062|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
27837131|NCT00021541|81232961|FG001|Period 2-crossover|refused phase B|2|||
27837132|NCT00021541|81232960|FG000|Period 2-crossover|Withdrawal by Subject|3|||
27837133|NCT00021541|81232961|FG001|Period 2-crossover|Withdrawal by Subject|4|||
27837134|NCT00021541|81232960|FG000|Period 2-crossover|Adverse Event|2|||
27837135|NCT00021541|81232961|FG001|Period 2-crossover|Adverse Event|2|||
27605031|NCT01986881|80395318|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
27837136|NCT00021541|81232960|FG000|Period 2-crossover|non-adherence|1|||
27605032|NCT01986881|80395316|FG000|Overall Study|Withdrawal by Subject|41|||
27605033|NCT01986881|80395317|FG001|Overall Study|Withdrawal by Subject|60|||
27605034|NCT01986881|80395318|FG002|Overall Study|Withdrawal by Subject|45|||
27605035|NCT01986881|80395316|FG000|Overall Study|Subject Moved|0|||
27714786|NCT02325219|80789058|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27714787|NCT02325219|80789059|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
27837137|NCT00021541|81232961|FG001|Period 2-crossover|non-adherence|0|||
27837138|NCT00021541|81232960|FG000|Period 2-crossover|Pts that did not progress|2|||
27837139|NCT00021541|81232961|FG001|Period 2-crossover|Pts that did not progress|3|||
27837140|NCT01828112|81232962|FG000|Overall Study|Adverse Event|6|||
27837141|NCT01828112|81232963|FG001|Overall Study|Adverse Event|8|||
27837142|NCT01828112|81232962|FG000|Overall Study|Death|9|||
27837143|NCT01828112|81232963|FG001|Overall Study|Death|5|||
27837144|NCT01828112|81232962|FG000|Overall Study|Physician Decision|5|||
27837145|NCT01828112|81232963|FG001|Overall Study|Physician Decision|5|||
27837146|NCT01828112|81232962|FG000|Overall Study|Progressive disease|56|||
27889928|NCT02419612|81430931|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
27837147|NCT01828112|81232963|FG001|Overall Study|Progressive disease|82|||
27837148|NCT01828112|81232962|FG000|Overall Study|Subject/guardian decision|6|||
27837149|NCT01828112|81232963|FG001|Overall Study|Subject/guardian decision|8|||
27714788|NCT02325219|80789060|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27714789|NCT02325219|80789061|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27714790|NCT02325219|80789062|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
27714791|NCT04225923|80789064|FG000|Overall Study|Protocol Violation|1|||
27714792|NCT04225923|80789065|FG001|Overall Study|Protocol Violation|0|||
27714793|NCT04225923|80789066|FG002|Overall Study|Protocol Violation|1|||
27714794|NCT04225923|80789064|FG000|Overall Study|Withdrawal by Subject|4|||
27714795|NCT04225923|80789065|FG001|Overall Study|Withdrawal by Subject|1|||
27714796|NCT04225923|80789066|FG002|Overall Study|Withdrawal by Subject|3|||
27714797|NCT04225923|80789064|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
27714798|NCT04225923|80789065|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
27714799|NCT04225923|80789066|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
27714800|NCT01714687|80789067|FG000|Overall Study|Withdrawal by Subject|1|||
27714801|NCT01714687|80789068|FG001|Overall Study|Withdrawal by Subject|0|||
27714802|NCT01714687|80789067|FG000|Overall Study|Lost to Follow-up|2|||
27714803|NCT01714687|80789068|FG001|Overall Study|Lost to Follow-up|4|||
27714804|NCT02919436|80789075|FG000|Overall Study|Did not undergo surgery|16|||
27714805|NCT02919436|80789076|FG001|Overall Study|Did not undergo surgery|20|||
27837150|NCT02751424|81232967|FG000|Part 2|Adverse Event|0|||
27837151|NCT02751424|81232968|FG001|Part 2|Adverse Event|0|||
27837152|NCT02751424|81232969|FG002|Part 2|Adverse Event|0|||
27837153|NCT02751424|81232970|FG003|Part 2|Adverse Event|0|||
27837154|NCT02751424|81232971|FG004|Part 2|Adverse Event|0|||
27837155|NCT02751424|81232972|FG005|Part 2|Adverse Event|0|||
27837156|NCT02751424|81232973|FG006|Part 2|Adverse Event|0|||
27837157|NCT02751424|81232974|FG007|Part 2|Adverse Event|5|||
27889929|NCT02419612|81430930|FG000|Long-term Treatment Period|Death|0|||
27889930|NCT02419612|81430931|FG001|Long-term Treatment Period|Death|1|||
27889931|NCT02419612|81430930|FG000|Long-term Treatment Period|Adverse Event|0|||
27889932|NCT02419612|81430931|FG001|Long-term Treatment Period|Adverse Event|5|||
27889933|NCT02419612|81430930|FG000|Long-term Treatment Period|Other|4|||
27889934|NCT02419612|81430931|FG001|Long-term Treatment Period|Other|4|||
27889935|NCT02419612|81430930|FG000|Long-term Treatment Period|Subject Decision|2|||
27889936|NCT02419612|81430931|FG001|Long-term Treatment Period|Subject Decision|4|||
27889937|NCT02419612|81430930|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
27889938|NCT02419612|81430931|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
27889939|NCT03164564|81430932|FG000|Overall Study|Death|3|||
27889940|NCT03164564|81430933|FG001|Overall Study|Death|0|||
27889941|NCT03164564|81430932|FG000|Overall Study|Withdrawal by Subject|20|||
27889942|NCT03164564|81430933|FG001|Overall Study|Withdrawal by Subject|15|||
27889943|NCT03164564|81430932|FG000|Overall Study|Lost to Follow-up|2|||
27889944|NCT03164564|81430933|FG001|Overall Study|Lost to Follow-up|0|||
27889945|NCT03164564|81430932|FG000|Overall Study|Physician Decision|0|||
27889946|NCT03164564|81430933|FG001|Overall Study|Physician Decision|1|||
27889947|NCT03164564|81430932|FG000|Overall Study|Adverse Event|0|||
27889948|NCT03164564|81430933|FG001|Overall Study|Adverse Event|1|||
27889949|NCT03164564|81430932|FG000|Overall Study|Ongoing|1586|||
27889950|NCT03164564|81430933|FG001|Overall Study|Ongoing|1586|||
27605036|NCT01986881|80395317|FG001|Overall Study|Subject Moved|1|||
27605037|NCT01986881|80395318|FG002|Overall Study|Subject Moved|0|||
27605038|NCT01986881|80395316|FG000|Overall Study|Other|1|||
27605039|NCT01986881|80395317|FG001|Overall Study|Other|2|||
27605040|NCT01986881|80395318|FG002|Overall Study|Other|2|||
27605041|NCT03138733|80395319|FG000|Overall Study|Death|17|||
27605042|NCT03138733|80395320|FG001|Overall Study|Death|18|||
27605043|NCT03138733|80395319|FG000|Overall Study|Withdrawal by Subject|11|||
27605044|NCT03138733|80395320|FG001|Overall Study|Withdrawal by Subject|6|||
27605045|NCT03138733|80395319|FG000|Overall Study|Lost to Follow-up|3|||
27605046|NCT03138733|80395320|FG001|Overall Study|Lost to Follow-up|2|||
27605047|NCT03138733|80395319|FG000|Overall Study|Adverse Event|1|||
27605048|NCT03138733|80395320|FG001|Overall Study|Adverse Event|0|||
27605049|NCT03138733|80395319|FG000|Overall Study|Protocol Violation|1|||
27605050|NCT03138733|80395320|FG001|Overall Study|Protocol Violation|3|||
27714806|NCT02919436|80789075|FG000|Overall Study|Enrolled before trial registration|44|||
27889951|NCT00954512|81430934|FG000|Overall Study|Withdrawal by Subject|0|||
27889952|NCT00954512|81430935|FG001|Overall Study|Withdrawal by Subject|0|||
27714807|NCT02919436|80789076|FG001|Overall Study|Enrolled before trial registration|33|||
27889953|NCT00954512|81430936|FG002|Overall Study|Withdrawal by Subject|0|||
27889954|NCT00954512|81430937|FG003|Overall Study|Withdrawal by Subject|0|||
27889955|NCT00954512|81430938|FG004|Overall Study|Withdrawal by Subject|0|||
27605051|NCT03138733|80395319|FG000|Overall Study|Administrative or logistical reason|1|||
27837158|NCT02751424|81232975|FG008|Part 2|Adverse Event|0|||
27837159|NCT02725515|81232978|FG000|Overall Study|Refused infusion (no study treatment)|1|||
27714808|NCT02228590|80789077|FG000|Overall Study|Withdrawal by Subject|1|||
27714809|NCT03033875|80789078|FG000|Overall Study|Withdrawal by Subject|5|||
27714810|NCT03033875|80789079|FG001|Overall Study|Withdrawal by Subject|9|||
27714811|NCT03033875|80789080|FG002|Overall Study|Withdrawal by Subject|4|||
27714812|NCT03033875|80789078|FG000|Overall Study|Other|14|||
27714813|NCT03033875|80789079|FG001|Overall Study|Other|15|||
27714814|NCT03033875|80789080|FG002|Overall Study|Other|8|||
27714815|NCT00450723|80789085|FG000|Overall Study|Physician Decision|5|||
27714816|NCT02646982|80789086|FG000|Overall Study|Adverse Event|1|||
27714817|NCT02646982|80789087|FG001|Overall Study|Adverse Event|1|||
27714818|NCT02646982|80789086|FG000|Overall Study|Withdrawal by Subject|2|||
27714819|NCT02646982|80789087|FG001|Overall Study|Withdrawal by Subject|1|||
27714820|NCT00464334|80789088|FG000|Overall Study|Adverse Event|0|||
27714821|NCT00464334|80789089|FG001|Overall Study|Adverse Event|0|||
27714822|NCT00464334|80789090|FG002|Overall Study|Adverse Event|0|||
27714823|NCT00464334|80789091|FG003|Overall Study|Adverse Event|1|||
27714824|NCT00464334|80789092|FG004|Overall Study|Adverse Event|1|||
27714825|NCT00464334|80789093|FG005|Overall Study|Adverse Event|1|||
27714826|NCT00464334|80789094|FG006|Overall Study|Adverse Event|0|||
27714827|NCT00464334|80789095|FG007|Overall Study|Adverse Event|0|||
27714828|NCT00464334|80789096|FG008|Overall Study|Adverse Event|2|||
27714829|NCT00464334|80789097|FG009|Overall Study|Adverse Event|1|||
27714830|NCT00464334|80789098|FG010|Overall Study|Adverse Event|2|||
27714831|NCT00464334|80789088|FG000|Overall Study|Lack of Efficacy|0|||
27714832|NCT00464334|80789089|FG001|Overall Study|Lack of Efficacy|1|||
27714833|NCT00464334|80789090|FG002|Overall Study|Lack of Efficacy|0|||
27714834|NCT00464334|80789091|FG003|Overall Study|Lack of Efficacy|0|||
27714835|NCT00464334|80789092|FG004|Overall Study|Lack of Efficacy|0|||
27714836|NCT00464334|80789093|FG005|Overall Study|Lack of Efficacy|0|||
27714837|NCT00464334|80789094|FG006|Overall Study|Lack of Efficacy|0|||
27714838|NCT00464334|80789095|FG007|Overall Study|Lack of Efficacy|0|||
27714839|NCT00464334|80789096|FG008|Overall Study|Lack of Efficacy|0|||
27714840|NCT00464334|80789097|FG009|Overall Study|Lack of Efficacy|0|||
27714841|NCT00464334|80789098|FG010|Overall Study|Lack of Efficacy|0|||
27714842|NCT00464334|80789088|FG000|Overall Study|Lost to Follow-up|0|||
27714843|NCT00464334|80789089|FG001|Overall Study|Lost to Follow-up|0|||
27714844|NCT00464334|80789090|FG002|Overall Study|Lost to Follow-up|1|||
27714845|NCT00464334|80789091|FG003|Overall Study|Lost to Follow-up|0|||
27714846|NCT00464334|80789092|FG004|Overall Study|Lost to Follow-up|1|||
27714847|NCT00464334|80789093|FG005|Overall Study|Lost to Follow-up|0|||
27714848|NCT00464334|80789094|FG006|Overall Study|Lost to Follow-up|1|||
27714849|NCT00464334|80789095|FG007|Overall Study|Lost to Follow-up|0|||
27714850|NCT00464334|80789096|FG008|Overall Study|Lost to Follow-up|0|||
27714851|NCT00464334|80789097|FG009|Overall Study|Lost to Follow-up|0|||
27714852|NCT00464334|80789098|FG010|Overall Study|Lost to Follow-up|2|||
27714853|NCT00464334|80789088|FG000|Overall Study|Progressive Disease|0|||
27714854|NCT00464334|80789089|FG001|Overall Study|Progressive Disease|0|||
27714855|NCT00464334|80789090|FG002|Overall Study|Progressive Disease|0|||
27714856|NCT00464334|80789091|FG003|Overall Study|Progressive Disease|0|||
27714857|NCT00464334|80789092|FG004|Overall Study|Progressive Disease|0|||
27714858|NCT00464334|80789093|FG005|Overall Study|Progressive Disease|1|||
27714859|NCT00464334|80789094|FG006|Overall Study|Progressive Disease|0|||
27714860|NCT00464334|80789095|FG007|Overall Study|Progressive Disease|0|||
27714861|NCT00464334|80789096|FG008|Overall Study|Progressive Disease|1|||
27714862|NCT00464334|80789097|FG009|Overall Study|Progressive Disease|0|||
27714863|NCT00464334|80789098|FG010|Overall Study|Progressive Disease|0|||
27714864|NCT00464334|80789088|FG000|Overall Study|Study Terminated by Sponsor|0|||
27714865|NCT00464334|80789089|FG001|Overall Study|Study Terminated by Sponsor|0|||
27714866|NCT00464334|80789090|FG002|Overall Study|Study Terminated by Sponsor|0|||
27714867|NCT00464334|80789091|FG003|Overall Study|Study Terminated by Sponsor|1|||
27714868|NCT00464334|80789092|FG004|Overall Study|Study Terminated by Sponsor|0|||
27714869|NCT00464334|80789093|FG005|Overall Study|Study Terminated by Sponsor|0|||
27714870|NCT00464334|80789094|FG006|Overall Study|Study Terminated by Sponsor|0|||
27714871|NCT00464334|80789095|FG007|Overall Study|Study Terminated by Sponsor|0|||
27714872|NCT00464334|80789096|FG008|Overall Study|Study Terminated by Sponsor|0|||
27714873|NCT00464334|80789097|FG009|Overall Study|Study Terminated by Sponsor|0|||
27714874|NCT00464334|80789098|FG010|Overall Study|Study Terminated by Sponsor|0|||
27714875|NCT00464334|80789088|FG000|Overall Study|Withdrawal by Subject|1|||
27714876|NCT00464334|80789089|FG001|Overall Study|Withdrawal by Subject|7|||
27714877|NCT00464334|80789090|FG002|Overall Study|Withdrawal by Subject|4|||
27714878|NCT00464334|80789091|FG003|Overall Study|Withdrawal by Subject|2|||
27714879|NCT00464334|80789092|FG004|Overall Study|Withdrawal by Subject|2|||
27714880|NCT00464334|80789093|FG005|Overall Study|Withdrawal by Subject|2|||
27714881|NCT00464334|80789094|FG006|Overall Study|Withdrawal by Subject|2|||
27714882|NCT00464334|80789095|FG007|Overall Study|Withdrawal by Subject|1|||
27714883|NCT00464334|80789096|FG008|Overall Study|Withdrawal by Subject|3|||
27714884|NCT00464334|80789097|FG009|Overall Study|Withdrawal by Subject|0|||
27714885|NCT00464334|80789098|FG010|Overall Study|Withdrawal by Subject|0|||
27714886|NCT01079182|80789099|FG000|Overall Study|Lost to Follow-up|1634|||
27714887|NCT01079182|80789099|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
27714888|NCT01079182|80789099|FG000|Overall Study|Lack of Efficacy|514|||
27714889|NCT01079182|80789099|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
27714890|NCT01079182|80789099|FG000|Overall Study|Reasons not Evaluated|271|||
27714891|NCT02636582|80789100|FG000|Overall Study|Surgical Pathology|1|||
27714892|NCT02636582|80789101|FG001|Overall Study|Surgical Pathology|0|||
27714893|NCT03581786|80789105|FG000|Overall Study|Death|17|||
27714894|NCT03581786|80789106|FG001|Overall Study|Death|12|||
27714895|NCT03581786|80789105|FG000|Overall Study|Withdrawal by Subject|2|||
27714896|NCT03581786|80789106|FG001|Overall Study|Withdrawal by Subject|4|||
27714897|NCT03581786|80789105|FG000|Overall Study|Lost to Follow-up|1|||
27714898|NCT03581786|80789106|FG001|Overall Study|Lost to Follow-up|0|||
27714899|NCT03581786|80789105|FG000|Overall Study|reason other than specified above|0|||
27714900|NCT03581786|80789106|FG001|Overall Study|reason other than specified above|1|||
27714901|NCT03581786|80789105|FG000|Overall Study|Ongoing in the study|123|||
27714902|NCT03581786|80789106|FG001|Overall Study|Ongoing in the study|129|||
27714903|NCT00333359|80789107|FG000|Overall Study|Adverse Event|29|||
27714904|NCT00333359|80789108|FG001|Overall Study|Adverse Event|35|||
27714905|NCT00333359|80789107|FG000|Overall Study|Withdrawal by Subject|19|||
27714906|NCT00333359|80789108|FG001|Overall Study|Withdrawal by Subject|37|||
27714907|NCT00333359|80789107|FG000|Overall Study|Physician Decision|2|||
27714908|NCT00333359|80789108|FG001|Overall Study|Physician Decision|2|||
27714909|NCT00333359|80789107|FG000|Overall Study|Protocol Non-compliance|2|||
27714910|NCT00333359|80789108|FG001|Overall Study|Protocol Non-compliance|8|||
27714911|NCT00333359|80789107|FG000|Overall Study|Lost to Follow-up|15|||
27714912|NCT00333359|80789108|FG001|Overall Study|Lost to Follow-up|25|||
27714913|NCT00333359|80789107|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
27714914|NCT00333359|80789108|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
27714915|NCT00333359|80789107|FG000|Overall Study|Treatment Failure|3|||
27714916|NCT00333359|80789108|FG001|Overall Study|Treatment Failure|8|||
27714917|NCT00333359|80789107|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
27714918|NCT00333359|80789108|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
27714919|NCT01464307|80789110|FG000|Main Period|Death|0|||
27714920|NCT01464307|80789111|FG001|Main Period|Death|1|||
27714921|NCT01464307|80789110|FG000|Main Period|Adverse Event|6|||
27714922|NCT01464307|80789111|FG001|Main Period|Adverse Event|1|||
27714923|NCT01464307|80789110|FG000|Main Period|Lack of Efficacy|2|||
27714924|NCT01464307|80789111|FG001|Main Period|Lack of Efficacy|0|||
27714925|NCT01464307|80789110|FG000|Main Period|Withdrawal by Subject|5|||
27714926|NCT01464307|80789111|FG001|Main Period|Withdrawal by Subject|2|||
27714927|NCT01464307|80789110|FG000|Main Period|Predefined discontinuation criteria|2|||
27714928|NCT01464307|80789111|FG001|Main Period|Predefined discontinuation criteria|1|||
27714929|NCT01464307|80789110|FG000|Open-Label Extension Period|Adverse Event|15|||
27714930|NCT01464307|80789111|FG001|Open-Label Extension Period|Adverse Event|0|||
27714931|NCT01464307|80789110|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
27714932|NCT01464307|80789111|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
27714933|NCT01464307|80789110|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
27714934|NCT01464307|80789111|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
27714935|NCT01464307|80789110|FG000|Open-Label Extension Period|Death|1|||
27714936|NCT01464307|80789111|FG001|Open-Label Extension Period|Death|0|||
27714937|NCT01464307|80789110|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
27714938|NCT01464307|80789111|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
27714939|NCT01464307|80789110|FG000|Open-Label Extension Period|Non-compliance|9|||
27714940|NCT01464307|80789111|FG001|Open-Label Extension Period|Non-compliance|0|||
27714941|NCT01464307|80789110|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
27714942|NCT01464307|80789111|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
27714943|NCT00205855|80789112|FG000|Overall Study|Only received temporary implants|16|||
27837160|NCT02725515|81232979|FG001|Overall Study|Refused infusion (no study treatment)|0|||
27837161|NCT02725515|81232978|FG000|Overall Study|Loss of Improvement per Protocol|14|||
27714944|NCT00205855|80789112|FG000|Overall Study|Withdrawal by Subject|5|||
27714945|NCT00250835|80792311|FG000|Overall Study|Withdrawal by Subject|1|||
27837162|NCT02725515|81232979|FG001|Overall Study|Loss of Improvement per Protocol|25|||
27714946|NCT00879697|80792312|FG000|Overall Study|Physician Decision|2|||
27714947|NCT00879697|80792313|FG001|Overall Study|Physician Decision|2|||
27837163|NCT02725515|81232978|FG000|Overall Study|Withdrawal by Subject|2|||
27714948|NCT02109484|80792314|FG000|Overall Study|Lost to Follow-up|0|||
27714949|NCT02109484|80792315|FG001|Overall Study|Lost to Follow-up|0|||
27714950|NCT02109484|80792316|FG002|Overall Study|Lost to Follow-up|0|||
27714951|NCT02109484|80792317|FG003|Overall Study|Lost to Follow-up|1|||
27714952|NCT02109484|80792318|FG004|Overall Study|Lost to Follow-up|1|||
27714953|NCT02109484|80792319|FG005|Overall Study|Lost to Follow-up|0|||
27714954|NCT02109484|80792320|FG006|Overall Study|Lost to Follow-up|1|||
27714955|NCT02109484|80792321|FG007|Overall Study|Lost to Follow-up|0|||
27714956|NCT02109484|80792314|FG000|Overall Study|Withdrawal by Subject|0|||
27714957|NCT02109484|80792315|FG001|Overall Study|Withdrawal by Subject|0|||
27714958|NCT02109484|80792316|FG002|Overall Study|Withdrawal by Subject|0|||
27714959|NCT02109484|80792317|FG003|Overall Study|Withdrawal by Subject|0|||
27714960|NCT02109484|80792318|FG004|Overall Study|Withdrawal by Subject|1|||
27714961|NCT02109484|80792319|FG005|Overall Study|Withdrawal by Subject|1|||
27714962|NCT02109484|80792320|FG006|Overall Study|Withdrawal by Subject|1|||
27714963|NCT02109484|80792321|FG007|Overall Study|Withdrawal by Subject|0|||
27714964|NCT02109484|80792314|FG000|Overall Study|Physician Decision|0|||
27714965|NCT02109484|80792315|FG001|Overall Study|Physician Decision|0|||
27714966|NCT02109484|80792316|FG002|Overall Study|Physician Decision|0|||
27714967|NCT02109484|80792317|FG003|Overall Study|Physician Decision|0|||
27714968|NCT02109484|80792318|FG004|Overall Study|Physician Decision|2|||
27714969|NCT02109484|80792319|FG005|Overall Study|Physician Decision|0|||
27714970|NCT02109484|80792320|FG006|Overall Study|Physician Decision|0|||
27714971|NCT02109484|80792321|FG007|Overall Study|Physician Decision|0|||
27714972|NCT02109484|80792314|FG000|Overall Study|Death|0|||
27714973|NCT02109484|80792315|FG001|Overall Study|Death|0|||
27714974|NCT02109484|80792316|FG002|Overall Study|Death|0|||
27714975|NCT02109484|80792317|FG003|Overall Study|Death|0|||
27714976|NCT02109484|80792318|FG004|Overall Study|Death|0|||
27714977|NCT02109484|80792319|FG005|Overall Study|Death|0|||
27714978|NCT02109484|80792320|FG006|Overall Study|Death|0|||
27714979|NCT02109484|80792321|FG007|Overall Study|Death|2|||
27714980|NCT02109484|80792314|FG000|Overall Study|Moved away from study area|0|||
27714981|NCT02109484|80792315|FG001|Overall Study|Moved away from study area|0|||
27714982|NCT02109484|80792316|FG002|Overall Study|Moved away from study area|0|||
27714983|NCT02109484|80792317|FG003|Overall Study|Moved away from study area|0|||
27714984|NCT02109484|80792318|FG004|Overall Study|Moved away from study area|0|||
27714985|NCT02109484|80792319|FG005|Overall Study|Moved away from study area|0|||
27714986|NCT02109484|80792320|FG006|Overall Study|Moved away from study area|1|||
27714987|NCT02109484|80792321|FG007|Overall Study|Moved away from study area|1|||
27714988|NCT01389752|80792322|FG000|Study Period 1|Sponsor decision|0|||
27714989|NCT01389752|80792323|FG001|Study Period 1|Sponsor decision|2|||
27714990|NCT01389752|80792322|FG000|Study Period 2|Sponsor decision|1|||
27714991|NCT01389752|80792323|FG001|Study Period 2|Sponsor decision|0|||
27714992|NCT00075023|80792326|FG000|Pilot Study|Physician Decision|1|||
27714993|NCT00075023|80792327|FG001|Pilot Study|Physician Decision|2|||
27714994|NCT00075023|80792326|FG000|Pilot Study|Withdrawal by Subject|1|||
27714995|NCT00075023|80792327|FG001|Pilot Study|Withdrawal by Subject|0|||
27714996|NCT00751400|80792328|FG000|Overall Study|Lost to Follow-up|10|||
27714997|NCT00583362|80792329|FG000|Overall Study|Adverse Event|44|||
27714998|NCT00583362|80792329|FG000|Overall Study|Lack of Efficacy|22|||
27714999|NCT00583362|80792329|FG000|Overall Study|Lost to Follow-up|4|||
27715000|NCT00583362|80792329|FG000|Overall Study|Non-compliance with study drug|28|||
27715001|NCT00583362|80792329|FG000|Overall Study|Pregnancy|7|||
27715002|NCT00583362|80792329|FG000|Overall Study|Miscommunication of visit window|5|||
27715003|NCT00583362|80792329|FG000|Overall Study|Current site closed|7|||
27715004|NCT00583362|80792329|FG000|Overall Study|Subject not dosed in LBSL99|1|||
27715005|NCT00583362|80792329|FG000|Overall Study|Subject moved out of the country/state|2|||
27715006|NCT00583362|80792329|FG000|Overall Study|Missed visits due to staff changes|1|||
27715007|NCT00583362|80792329|FG000|Overall Study|Misunderstanding of protocol|1|||
27715008|NCT00583362|80792329|FG000|Overall Study|Behavioral problems and non-compliance|1|||
27715009|NCT00583362|80792329|FG000|Overall Study|Sponsor request due to missed doses|1|||
27715010|NCT00583362|80792329|FG000|Overall Study|Physician Decision|19|||
27715011|NCT00583362|80792329|FG000|Overall Study|Protocol Violation|2|||
27715012|NCT00583362|80792329|FG000|Overall Study|Withdrawal by Subject|57|||
27715013|NCT03113500|80792332|FG000|Overall Study|Withdrawal by Subject|1|||
27715014|NCT03223428|80792333|FG000|Overall Study|No longer taking Xermelo|27|||
27715015|NCT03223428|80792333|FG000|Overall Study|Declined Consent|1|||
27715016|NCT03223428|80792333|FG000|Overall Study|Non-responders|56|||
27715017|NCT03223428|80792333|FG000|Overall Study|Withdrawal by Subject|14|||
27715018|NCT03864653|80792336|FG000|Overall Study|Withdrawal by Subject|1|||
27715019|NCT02018822|80792337|FG000|Overall Study|filling replaced by crown|0|||
27715020|NCT02018822|80792338|FG001|Overall Study|filling replaced by crown|1|||
27715021|NCT02018822|80792339|FG002|Overall Study|filling replaced by crown|0|||
27715022|NCT02018822|80792337|FG000|Overall Study|Physician Decision|0|||
27715023|NCT02018822|80792338|FG001|Overall Study|Physician Decision|1|||
27715024|NCT02018822|80792339|FG002|Overall Study|Physician Decision|1|||
27715025|NCT02018822|80792337|FG000|Overall Study|Lost to Follow-up|6|||
27715026|NCT02018822|80792338|FG001|Overall Study|Lost to Follow-up|6|||
27715027|NCT02018822|80792339|FG002|Overall Study|Lost to Follow-up|5|||
27715028|NCT02787863|80792340|FG000|Overall Study|Death|1|||
27715029|NCT02787863|80792341|FG001|Overall Study|Death|0|||
27715030|NCT02787863|80792342|FG002|Overall Study|Death|1|||
27715031|NCT02787863|80792343|FG003|Overall Study|Death|0|||
27715032|NCT02787863|80792344|FG004|Overall Study|Death|0|||
27715033|NCT02787863|80792345|FG005|Overall Study|Death|0|||
27715034|NCT02787863|80792346|FG006|Overall Study|Death|0|||
27715035|NCT02787863|80792347|FG007|Overall Study|Death|0|||
27715036|NCT02787863|80792340|FG000|Overall Study|Withdrawal by Subject|0|||
27715037|NCT02787863|80792341|FG001|Overall Study|Withdrawal by Subject|1|||
27715038|NCT02787863|80792342|FG002|Overall Study|Withdrawal by Subject|1|||
27715039|NCT02787863|80792343|FG003|Overall Study|Withdrawal by Subject|0|||
27715040|NCT02787863|80792344|FG004|Overall Study|Withdrawal by Subject|0|||
27715041|NCT02787863|80792345|FG005|Overall Study|Withdrawal by Subject|0|||
27715042|NCT02787863|80792346|FG006|Overall Study|Withdrawal by Subject|0|||
27715043|NCT02787863|80792347|FG007|Overall Study|Withdrawal by Subject|0|||
27715044|NCT01391507|80792352|FG000|Overall Study|Death|0|||
27715045|NCT01391507|80792353|FG001|Overall Study|Death|0|||
27715046|NCT01391507|80792354|FG002|Overall Study|Death|0|||
27715047|NCT01391507|80792355|FG003|Overall Study|Death|1|||
27715048|NCT01391507|80792352|FG000|Overall Study|Adverse Event|1|||
27715049|NCT01391507|80792353|FG001|Overall Study|Adverse Event|1|||
27715050|NCT01391507|80792354|FG002|Overall Study|Adverse Event|2|||
27715051|NCT01391507|80792355|FG003|Overall Study|Adverse Event|2|||
27715052|NCT01391507|80792352|FG000|Overall Study|Withdrawal by Subject|1|||
27715053|NCT01391507|80792353|FG001|Overall Study|Withdrawal by Subject|2|||
27715054|NCT01391507|80792354|FG002|Overall Study|Withdrawal by Subject|1|||
27715055|NCT01391507|80792355|FG003|Overall Study|Withdrawal by Subject|1|||
27715056|NCT01391507|80792352|FG000|Overall Study|Lack of Efficacy|0|||
27715057|NCT01391507|80792353|FG001|Overall Study|Lack of Efficacy|0|||
27715058|NCT01391507|80792354|FG002|Overall Study|Lack of Efficacy|0|||
27715059|NCT01391507|80792355|FG003|Overall Study|Lack of Efficacy|1|||
27715060|NCT01391507|80792352|FG000|Overall Study|Protocol Violation|2|||
27715061|NCT01391507|80792353|FG001|Overall Study|Protocol Violation|1|||
27715062|NCT01391507|80792354|FG002|Overall Study|Protocol Violation|1|||
27715063|NCT01391507|80792355|FG003|Overall Study|Protocol Violation|2|||
27715064|NCT00135668|80792356|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
27715065|NCT00135668|80792357|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
27715066|NCT00135668|80792358|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
27837164|NCT02725515|81232979|FG001|Overall Study|Withdrawal by Subject|1|||
27837165|NCT02725515|81232978|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27715067|NCT00135668|80792359|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
27715068|NCT02918864|80792360|FG000|Overall Study|Withdrawal by Subject|1|||
27715069|NCT02918864|80792361|FG001|Overall Study|Withdrawal by Subject|1|||
27715070|NCT02918864|80792360|FG000|Overall Study|Lost to Follow-up|3|||
27715071|NCT02918864|80792361|FG001|Overall Study|Lost to Follow-up|2|||
27715072|NCT00689871|80792362|FG000|Overall Study|Lost to Follow-up|123|||
27715073|NCT00689871|80792363|FG001|Overall Study|Lost to Follow-up|13|||
27715074|NCT00689871|80792364|FG002|Overall Study|Lost to Follow-up|37|||
27715075|NCT00689871|80792365|FG003|Overall Study|Lost to Follow-up|1|||
27715076|NCT00689871|80792362|FG000|Overall Study|Explanted of All Study Devices|36|||
27715077|NCT00689871|80792363|FG001|Overall Study|Explanted of All Study Devices|25|||
27715078|NCT00689871|80792364|FG002|Overall Study|Explanted of All Study Devices|29|||
27715079|NCT00689871|80792365|FG003|Overall Study|Explanted of All Study Devices|3|||
27715080|NCT00689871|80792362|FG000|Overall Study|Withdrawal by Subject|13|||
27715081|NCT00689871|80792363|FG001|Overall Study|Withdrawal by Subject|3|||
27715082|NCT00689871|80792364|FG002|Overall Study|Withdrawal by Subject|4|||
27715083|NCT00689871|80792365|FG003|Overall Study|Withdrawal by Subject|1|||
27715084|NCT00689871|80792362|FG000|Overall Study|Death|1|||
27715085|NCT00689871|80792363|FG001|Overall Study|Death|10|||
27715086|NCT00689871|80792364|FG002|Overall Study|Death|2|||
27715087|NCT00689871|80792365|FG003|Overall Study|Death|2|||
27715088|NCT00689871|80792362|FG000|Overall Study|Physician Decision|2|||
27837166|NCT02725515|81232979|FG001|Overall Study|Non-Compliance With Study Drug|3|||
27715089|NCT00689871|80792363|FG001|Overall Study|Physician Decision|1|||
27605052|NCT03138733|80395320|FG001|Overall Study|Administrative or logistical reason|0|||
27605053|NCT03138733|80395319|FG000|Overall Study|The patient was transferred to another hospital|1|||
27605054|NCT03138733|80395320|FG001|Overall Study|The patient was transferred to another hospital|0|||
27605055|NCT02768662|80395321|FG000|Overall Study|Adverse Event|1|||
27605056|NCT02768662|80395321|FG000|Overall Study|Lost to Follow-up|4|||
27605057|NCT02768662|80395321|FG000|Overall Study|Withdrawal by Subject|3|||
27605058|NCT02768662|80395321|FG000|Overall Study|Study terminated by Sponsor|78|||
27605059|NCT02944656|80395325|FG000|Overall Study|No longer eligible|3|||
27605060|NCT02944656|80395326|FG001|Overall Study|No longer eligible|0|||
27605061|NCT02944656|80395325|FG000|Overall Study|Lost to Follow-up|7|||
27605062|NCT02944656|80395326|FG001|Overall Study|Lost to Follow-up|10|||
27605063|NCT00514943|80395331|FG000|Stage 1|Progressive disease|4|||
27605064|NCT00514943|80395332|FG001|Stage 1|Progressive disease|8|||
27605065|NCT00514943|80395331|FG000|Stage 1|Other Adverse Event|16|||
27605066|NCT00514943|80395332|FG001|Stage 1|Other Adverse Event|6|||
27605067|NCT00514943|80395331|FG000|Stage 1|Not treated|1|||
27605068|NCT00514943|80395332|FG001|Stage 1|Not treated|2|||
27605069|NCT00514943|80395331|FG000|Stage 1|Patient refused to continue study meds|8|||
27605070|NCT00514943|80395332|FG001|Stage 1|Patient refused to continue study meds|3|||
27605071|NCT00514943|80395331|FG000|Stage 1|Other than stated above|1|||
27605072|NCT00514943|80395332|FG001|Stage 1|Other than stated above|7|||
27605073|NCT00514943|80395331|FG000|Stage 2|Progressive disease|27|||
27715090|NCT00689871|80792364|FG002|Overall Study|Physician Decision|1|||
27715091|NCT00689871|80792365|FG003|Overall Study|Physician Decision|0|||
27715092|NCT02788747|80792366|FG000|Overall Study|Adverse Event|1|||
27715093|NCT02788747|80792367|FG001|Overall Study|Adverse Event|0|||
27605074|NCT00514943|80395332|FG001|Stage 2|Progressive disease|24|||
27715094|NCT02788747|80792368|FG002|Overall Study|Adverse Event|0|||
27715095|NCT00835237|80792370|FG000|Overall Study|Lost to Follow-up|4|||
27715096|NCT00835237|80792371|FG001|Overall Study|Lost to Follow-up|0|||
27715097|NCT00835237|80792370|FG000|Overall Study|Withdrawal by Subject|2|||
27715098|NCT00835237|80792371|FG001|Overall Study|Withdrawal by Subject|0|||
27715099|NCT00457015|80792374|FG000|Overall Study|Left study site against medical advice|0|||
27715100|NCT00457015|80792375|FG001|Overall Study|Left study site against medical advice|1|||
27715101|NCT00762892|80792376|FG000|Overall Study|Lost to Follow-up|2|||
27715102|NCT00762892|80792377|FG001|Overall Study|Lost to Follow-up|5|||
27715103|NCT00762892|80792376|FG000|Overall Study|Withdrawal by Subject|0|||
27715104|NCT00762892|80792377|FG001|Overall Study|Withdrawal by Subject|1|||
27715105|NCT00762892|80792376|FG000|Overall Study|Death|1|||
27715106|NCT00762892|80792377|FG001|Overall Study|Death|0|||
27715107|NCT00762892|80792376|FG000|Overall Study|Pregnancy|1|||
27715108|NCT00762892|80792377|FG001|Overall Study|Pregnancy|0|||
27715109|NCT00762892|80792376|FG000|Overall Study|Incarceration|1|||
27715110|NCT00762892|80792377|FG001|Overall Study|Incarceration|0|||
27837167|NCT02725515|81232978|FG000|Overall Study|Lost to Follow-up|1|||
27837168|NCT02725515|81232979|FG001|Overall Study|Lost to Follow-up|1|||
27837169|NCT02725515|81232978|FG000|Overall Study|Adverse Event|7|||
27837170|NCT02725515|81232979|FG001|Overall Study|Adverse Event|2|||
27837171|NCT02725515|81232978|FG000|Overall Study|No Documented Disease Improvement|0|||
27837172|NCT02725515|81232979|FG001|Overall Study|No Documented Disease Improvement|1|||
27837173|NCT02725515|81232978|FG000|Overall Study|Completed Study Under Original Protocol|0|||
27837174|NCT02725515|81232979|FG001|Overall Study|Completed Study Under Original Protocol|1|||
27837175|NCT02725515|81232978|FG000|Overall Study|Lack of Response|0|||
27837176|NCT02725515|81232979|FG001|Overall Study|Lack of Response|1|||
27837177|NCT04129554|81232980|FG000|Overall Study|Withdrawal by Subject|4|||
27837178|NCT04129554|81232981|FG001|Overall Study|Withdrawal by Subject|3|||
27837179|NCT04129554|81232980|FG000|Overall Study|Other|0|||
27837180|NCT04129554|81232981|FG001|Overall Study|Other|2|||
27837181|NCT01663896|81232986|FG000|Overall Study|Various reasons|43|||
27837182|NCT01496118|81232987|FG000|Overall Study|Disease progression|3|||
27837183|NCT01496118|81232988|FG001|Overall Study|Disease progression|2|||
27837184|NCT01496118|81232989|FG002|Overall Study|Disease progression|3|||
27837185|NCT01496118|81232990|FG003|Overall Study|Disease progression|1|||
27837186|NCT01496118|81232991|FG004|Overall Study|Disease progression|2|||
27837187|NCT01496118|81232992|FG005|Overall Study|Disease progression|2|||
27837188|NCT01496118|81232993|FG006|Overall Study|Disease progression|14|||
27837189|NCT01496118|81232994|FG007|Overall Study|Disease progression|10|||
27837190|NCT01496118|81232987|FG000|Overall Study|Physician Decision|0|||
27837191|NCT01496118|81232988|FG001|Overall Study|Physician Decision|0|||
27837192|NCT01496118|81232989|FG002|Overall Study|Physician Decision|0|||
27837193|NCT01496118|81232990|FG003|Overall Study|Physician Decision|0|||
27889956|NCT00954512|81430939|FG005|Overall Study|Withdrawal by Subject|1|||
27605075|NCT00514943|80395331|FG000|Stage 2|Other Adverse Event|3|||
27605076|NCT00514943|80395332|FG001|Stage 2|Other Adverse Event|10|||
27715111|NCT00817531|80792380|FG000|Overall Study|Adverse Event|1|||
27715112|NCT00817531|80792380|FG000|Overall Study|Lack of Efficacy|1|||
27715113|NCT00488982|80792381|FG000|Course 1|Physician Decision|0|||
27715114|NCT00488982|80792382|FG001|Course 1|Physician Decision|2|||
27715115|NCT00488982|80792383|FG002|Course 1|Physician Decision|4|||
27837194|NCT01496118|81232991|FG004|Overall Study|Physician Decision|1|||
27605077|NCT00514943|80395331|FG000|Stage 2|Patient refused to continue study meds|2|||
27837195|NCT01496118|81232992|FG005|Overall Study|Physician Decision|0|||
27837196|NCT01496118|81232993|FG006|Overall Study|Physician Decision|3|||
27889957|NCT00954512|81430934|FG000|Overall Study|Adverse Event|0|||
27889958|NCT00954512|81430935|FG001|Overall Study|Adverse Event|0|||
27715116|NCT00488982|80792381|FG000|Course 1|Withdrawal by Subject|0|||
27715117|NCT00488982|80792382|FG001|Course 1|Withdrawal by Subject|8|||
27715118|NCT00488982|80792383|FG002|Course 1|Withdrawal by Subject|2|||
27889959|NCT00954512|81430936|FG002|Overall Study|Adverse Event|0|||
27889960|NCT00954512|81430937|FG003|Overall Study|Adverse Event|0|||
27837197|NCT01496118|81232994|FG007|Overall Study|Physician Decision|6|||
27837198|NCT01496118|81232987|FG000|Overall Study|Adverse Event|1|||
27837199|NCT01496118|81232988|FG001|Overall Study|Adverse Event|1|||
27837200|NCT01496118|81232989|FG002|Overall Study|Adverse Event|0|||
27837201|NCT01496118|81232990|FG003|Overall Study|Adverse Event|0|||
27837202|NCT01496118|81232991|FG004|Overall Study|Adverse Event|0|||
27837203|NCT01496118|81232992|FG005|Overall Study|Adverse Event|0|||
27837204|NCT01496118|81232993|FG006|Overall Study|Adverse Event|6|||
27837205|NCT01496118|81232994|FG007|Overall Study|Adverse Event|10|||
27837206|NCT01496118|81232987|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27889961|NCT00954512|81430938|FG004|Overall Study|Adverse Event|1|||
27837207|NCT01496118|81232988|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27837208|NCT01496118|81232989|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27837209|NCT01496118|81232990|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27837210|NCT01496118|81232991|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27837211|NCT01496118|81232992|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27837212|NCT01496118|81232993|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
27837213|NCT01496118|81232994|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
27837214|NCT01496118|81232987|FG000|Overall Study|Death|0|||
27837215|NCT01496118|81232988|FG001|Overall Study|Death|0|||
27837216|NCT01496118|81232989|FG002|Overall Study|Death|0|||
27837217|NCT01496118|81232990|FG003|Overall Study|Death|0|||
27605078|NCT00514943|80395332|FG001|Stage 2|Patient refused to continue study meds|0|||
27837218|NCT01496118|81232991|FG004|Overall Study|Death|0|||
27837219|NCT01496118|81232992|FG005|Overall Study|Death|0|||
27837220|NCT01496118|81232993|FG006|Overall Study|Death|1|||
27837221|NCT01496118|81232994|FG007|Overall Study|Death|1|||
27837222|NCT01496118|81232987|FG000|Overall Study|Withdrawal by Subject|0|||
27837223|NCT01496118|81232988|FG001|Overall Study|Withdrawal by Subject|0|||
27837224|NCT01496118|81232989|FG002|Overall Study|Withdrawal by Subject|0|||
27837225|NCT01496118|81232990|FG003|Overall Study|Withdrawal by Subject|2|||
27837226|NCT01496118|81232991|FG004|Overall Study|Withdrawal by Subject|0|||
27837227|NCT01496118|81232992|FG005|Overall Study|Withdrawal by Subject|1|||
27837228|NCT01496118|81232993|FG006|Overall Study|Withdrawal by Subject|6|||
27837229|NCT01496118|81232994|FG007|Overall Study|Withdrawal by Subject|3|||
27837230|NCT00450658|81232995|FG000|Overall Study|Adverse Event|24|||
27605079|NCT00514943|80395331|FG000|Stage 2|Other than stated above|0|||
27605080|NCT00514943|80395332|FG001|Stage 2|Other than stated above|2|||
27837231|NCT00450658|81232996|FG001|Overall Study|Adverse Event|15|||
27889962|NCT00954512|81430939|FG005|Overall Study|Adverse Event|2|||
27889963|NCT00954512|81430934|FG000|Overall Study|Physician Decision|0|||
27837232|NCT00450658|81232995|FG000|Overall Study|Withdrawal by Subject|43|||
27837233|NCT00450658|81232996|FG001|Overall Study|Withdrawal by Subject|26|||
27837234|NCT00450658|81232995|FG000|Overall Study|Lost to Follow-up|22|||
27837235|NCT00450658|81232996|FG001|Overall Study|Lost to Follow-up|5|||
27837236|NCT00450658|81232995|FG000|Overall Study|UGI ulcer|33|||
27837237|NCT00450658|81232996|FG001|Overall Study|UGI ulcer|34|||
27837238|NCT00450658|81232995|FG000|Overall Study|misc|21|||
27837239|NCT00450658|81232996|FG001|Overall Study|misc|10|||
27837240|NCT02416180|81232997|FG000|Overall Study|Withdrawal by Subject|1|||
27837241|NCT05665387|81232998|FG000|Overall Study|Withdrawal by Subject|1|||
27837242|NCT05665387|81232999|FG001|Overall Study|Withdrawal by Subject|0|||
27837243|NCT05665387|81233000|FG002|Overall Study|Withdrawal by Subject|1|||
27837244|NCT04553406|81233001|FG000|Overall Study|Study Discontinuation|0|||
27837245|NCT04553406|81233002|FG001|Overall Study|Study Discontinuation|1|||
27837246|NCT00613730|81233008|FG000|Overall Study|Disease progression|2|||
27837247|NCT00613730|81233008|FG000|Overall Study|Administrative decision|1|||
27837248|NCT01120691|81233012|FG000|Overall Study|Adverse Event|59|||
27837249|NCT01120691|81233013|FG001|Overall Study|Adverse Event|67|||
27837250|NCT01120691|81233014|FG002|Overall Study|Adverse Event|47|||
27837251|NCT01120691|81233012|FG000|Overall Study|Subject withdrew consent|33|||
27837252|NCT01120691|81233013|FG001|Overall Study|Subject withdrew consent|50|||
27715119|NCT00488982|80792381|FG000|Course 1|nonprotocol therapy|0|||
27837253|NCT01120691|81233014|FG002|Overall Study|Subject withdrew consent|44|||
27837254|NCT01120691|81233012|FG000|Overall Study|Death|21|||
27837255|NCT01120691|81233013|FG001|Overall Study|Death|22|||
27605081|NCT04534114|80395333|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
27605082|NCT04534114|80395334|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
27605083|NCT04534114|80395335|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
27605084|NCT04534114|80395336|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
27605085|NCT04534114|80395333|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
27605086|NCT04534114|80395334|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
27605087|NCT04534114|80395335|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
27605088|NCT04534114|80395336|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
27605089|NCT04534114|80395333|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
27605090|NCT04534114|80395334|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
27605091|NCT04534114|80395335|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
27605092|NCT04534114|80395336|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
27605093|NCT04534114|80395333|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
27605094|NCT04534114|80395334|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
27605095|NCT04534114|80395335|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
27605096|NCT04534114|80395336|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
27605097|NCT04534114|80395333|FG000|Main Treatment Period|Physician Decision|0|||
27605098|NCT04534114|80395334|FG001|Main Treatment Period|Physician Decision|0|||
27605099|NCT04534114|80395335|FG002|Main Treatment Period|Physician Decision|0|||
27605100|NCT04534114|80395336|FG003|Main Treatment Period|Physician Decision|1|||
27605101|NCT04534114|80395333|FG000|Main Treatment Period|Death|1|||
27605102|NCT04534114|80395334|FG001|Main Treatment Period|Death|0|||
27605103|NCT04534114|80395335|FG002|Main Treatment Period|Death|0|||
27605104|NCT04534114|80395336|FG003|Main Treatment Period|Death|1|||
27605105|NCT04534114|80395333|FG000|Main Treatment Period|Other reason|1|||
27605106|NCT04534114|80395334|FG001|Main Treatment Period|Other reason|1|||
27605107|NCT04534114|80395335|FG002|Main Treatment Period|Other reason|0|||
27605108|NCT04534114|80395336|FG003|Main Treatment Period|Other reason|0|||
27605109|NCT04534114|80395333|FG000|Main Treatment Period|Participant decision|1|||
27715120|NCT00488982|80792382|FG001|Course 1|nonprotocol therapy|2|||
27715121|NCT00488982|80792383|FG002|Course 1|nonprotocol therapy|2|||
27715122|NCT00488982|80792381|FG000|Course 1|Adverse Event|0|||
27605110|NCT04534114|80395334|FG001|Main Treatment Period|Participant decision|3|||
27605111|NCT04534114|80395335|FG002|Main Treatment Period|Participant decision|3|||
27605112|NCT04534114|80395336|FG003|Main Treatment Period|Participant decision|1|||
27715123|NCT00488982|80792382|FG001|Course 1|Adverse Event|0|||
27837256|NCT01120691|81233014|FG002|Overall Study|Death|24|||
27837257|NCT01120691|81233012|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
27837258|NCT01120691|81233013|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
27837259|NCT01120691|81233014|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
27715124|NCT00488982|80792383|FG002|Course 1|Adverse Event|6|||
27715125|NCT00769002|80792384|FG000|Overall Study|Study was not completed, no data|9|||
27837260|NCT01120691|81233012|FG000|Overall Study|Administrative problems|15|||
27837261|NCT01120691|81233013|FG001|Overall Study|Administrative problems|8|||
27837262|NCT01120691|81233014|FG002|Overall Study|Administrative problems|9|||
27837263|NCT01120691|81233012|FG000|Overall Study|Protocol deviation|13|||
27837264|NCT01120691|81233013|FG001|Overall Study|Protocol deviation|12|||
27837265|NCT01120691|81233014|FG002|Overall Study|Protocol deviation|12|||
27837266|NCT01120691|81233012|FG000|Overall Study|Lost to Follow-up|5|||
27837267|NCT01120691|81233013|FG001|Overall Study|Lost to Follow-up|6|||
27837268|NCT01120691|81233014|FG002|Overall Study|Lost to Follow-up|4|||
27837269|NCT01120691|81233012|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27837270|NCT01120691|81233013|FG001|Overall Study|Abnormal test procedure result(s)|2|||
27837271|NCT01120691|81233014|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27837272|NCT01120691|81233012|FG000|Overall Study|Patient's inability to use the device|3|||
27837273|NCT01120691|81233013|FG001|Overall Study|Patient's inability to use the device|1|||
27837274|NCT01120691|81233014|FG002|Overall Study|Patient's inability to use the device|0|||
27837275|NCT01120691|81233012|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27837276|NCT01120691|81233013|FG001|Overall Study|Abnormal laboratory value(s)|3|||
27837277|NCT01120691|81233014|FG002|Overall Study|Abnormal laboratory value(s)|4|||
27837278|NCT00385736|81233015|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
27837279|NCT00385736|81233016|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
27837280|NCT00385736|81233017|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
27837281|NCT00385736|81233015|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
27837282|NCT00385736|81233016|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
27837283|NCT00385736|81233017|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
27837284|NCT00385736|81233015|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
27837285|NCT00385736|81233016|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
27837286|NCT00385736|81233017|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
27837287|NCT00385736|81233015|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
27837288|NCT00385736|81233016|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
27837289|NCT00385736|81233017|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
27837290|NCT00385736|81233015|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
27837291|NCT00385736|81233016|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
27837292|NCT00385736|81233017|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
27837293|NCT00385736|81233015|FG000|Efficacy Analysis Set - Induction|Other|0|||
27837294|NCT00385736|81233016|FG001|Efficacy Analysis Set - Induction|Other|0|||
27837295|NCT00385736|81233017|FG002|Efficacy Analysis Set - Induction|Other|1|||
27837296|NCT00385736|81233015|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
27837297|NCT00385736|81233016|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
27837298|NCT00385736|81233017|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
27837299|NCT00385736|81233015|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
27837300|NCT00385736|81233016|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
27837301|NCT00385736|81233017|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
27837302|NCT00385736|81233015|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
27605113|NCT04534114|80395333|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
27605114|NCT04534114|80395334|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
27605115|NCT04534114|80395335|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
27605116|NCT04534114|80395336|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
27605117|NCT04534114|80395333|FG000|Main Treatment Period|Adverse Event|4|||
27605118|NCT04534114|80395334|FG001|Main Treatment Period|Adverse Event|2|||
27605119|NCT04534114|80395335|FG002|Main Treatment Period|Adverse Event|1|||
27605120|NCT04534114|80395336|FG003|Main Treatment Period|Adverse Event|2|||
27605121|NCT04534114|80395333|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
27605122|NCT04534114|80395334|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
27605123|NCT04534114|80395335|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
27605124|NCT04534114|80395336|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
27605125|NCT04534114|80395333|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
27605126|NCT04534114|80395334|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
27715126|NCT00769002|80792385|FG001|Overall Study|Study was not completed, no data|9|||
27715127|NCT01806779|80792390|FG000|Overall Study|Physician Decision|2|||
27715128|NCT01806779|80792391|FG001|Overall Study|Physician Decision|0|||
27715129|NCT01806779|80792392|FG002|Overall Study|Physician Decision|1|||
27715130|NCT01806779|80792390|FG000|Overall Study|Lack of Efficacy|1|||
27715131|NCT01806779|80792391|FG001|Overall Study|Lack of Efficacy|1|||
27715132|NCT01806779|80792392|FG002|Overall Study|Lack of Efficacy|0|||
27715133|NCT01806779|80792390|FG000|Overall Study|Lost to Follow-up|19|||
27715134|NCT01806779|80792391|FG001|Overall Study|Lost to Follow-up|20|||
27715135|NCT01806779|80792392|FG002|Overall Study|Lost to Follow-up|0|||
27715136|NCT01806779|80792390|FG000|Overall Study|Withdrawal by Subject|20|||
27837303|NCT00385736|81233016|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
27837304|NCT00385736|81233017|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
27837305|NCT00385736|81233015|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
27837306|NCT00385736|81233016|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
27837307|NCT00385736|81233017|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
27837308|NCT00385736|81233015|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
27837309|NCT00385736|81233016|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
27837310|NCT00385736|81233017|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
27837311|NCT00385736|81233015|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
27837312|NCT00385736|81233016|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
27837313|NCT00385736|81233017|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
27837314|NCT00385736|81233015|FG000|Safety Analysis Set|Adverse Event|23|||
27837315|NCT00385736|81233016|FG001|Safety Analysis Set|Adverse Event|15|||
27837316|NCT00385736|81233017|FG002|Safety Analysis Set|Adverse Event|23|||
27837317|NCT00385736|81233015|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
27837318|NCT00385736|81233016|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
27837319|NCT00385736|81233017|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
27837320|NCT00385736|81233015|FG000|Safety Analysis Set|Lost to Follow-up|0|||
27837321|NCT00385736|81233016|FG001|Safety Analysis Set|Lost to Follow-up|2|||
27837322|NCT00385736|81233017|FG002|Safety Analysis Set|Lost to Follow-up|2|||
27837323|NCT00385736|81233015|FG000|Safety Analysis Set|Lack of Efficacy|38|||
27715137|NCT01806779|80792391|FG001|Overall Study|Withdrawal by Subject|23|||
27715138|NCT01806779|80792392|FG002|Overall Study|Withdrawal by Subject|22|||
27715139|NCT01604265|80792393|FG000|Overall Study|Adverse Event|1|||
27715140|NCT01604265|80792394|FG001|Overall Study|Adverse Event|0|||
27715141|NCT01604265|80792393|FG000|Overall Study|Withdrawal by Subject|1|||
27715142|NCT01604265|80792394|FG001|Overall Study|Withdrawal by Subject|0|||
27715143|NCT03031301|80792396|FG000|Overall Study|Protocol Violation|4|||
27715144|NCT03031301|80792397|FG001|Overall Study|Protocol Violation|8|||
27715145|NCT03031301|80792396|FG000|Overall Study|Withdrawal by Subject|7|||
27715146|NCT03031301|80792397|FG001|Overall Study|Withdrawal by Subject|4|||
27715147|NCT03031301|80792396|FG000|Overall Study|Lost to Follow-up|4|||
27715148|NCT03031301|80792397|FG001|Overall Study|Lost to Follow-up|12|||
27715149|NCT03031301|80792396|FG000|Overall Study|Noncompliance|1|||
27715150|NCT03031301|80792397|FG001|Overall Study|Noncompliance|3|||
27715151|NCT03031301|80792396|FG000|Overall Study|Technical issue|1|||
27715152|NCT03031301|80792397|FG001|Overall Study|Technical issue|1|||
27715153|NCT03031301|80792396|FG000|Overall Study|Adverse Event|1|||
27715154|NCT03031301|80792397|FG001|Overall Study|Adverse Event|0|||
27715155|NCT01888640|80792398|FG000|Overall Study|Lost to Follow-up|1|||
27715156|NCT01888640|80792399|FG001|Overall Study|Lost to Follow-up|2|||
27715157|NCT01888640|80792400|FG002|Overall Study|Lost to Follow-up|0|||
27715158|NCT01888640|80792398|FG000|Overall Study|Withdrawal by Subject|15|||
27715159|NCT01888640|80792399|FG001|Overall Study|Withdrawal by Subject|11|||
27715160|NCT01888640|80792400|FG002|Overall Study|Withdrawal by Subject|4|||
27715161|NCT01888640|80792398|FG000|Overall Study|Minimum dose not met|10|||
27715162|NCT01888640|80792399|FG001|Overall Study|Minimum dose not met|16|||
27715163|NCT01888640|80792400|FG002|Overall Study|Minimum dose not met|0|||
27715164|NCT01888640|80792398|FG000|Overall Study|Given wrong unit (placebo)|1|||
27715165|NCT01888640|80792399|FG001|Overall Study|Given wrong unit (placebo)|0|||
27715166|NCT01888640|80792400|FG002|Overall Study|Given wrong unit (placebo)|0|||
27715167|NCT01888640|80792398|FG000|Overall Study|Excluded for prior TENS|0|||
27715168|NCT01888640|80792399|FG001|Overall Study|Excluded for prior TENS|1|||
27715169|NCT01888640|80792400|FG002|Overall Study|Excluded for prior TENS|0|||
27715170|NCT01888640|80792398|FG000|Overall Study|Researcher Termination of Participant|0|||
27715171|NCT01888640|80792399|FG001|Overall Study|Researcher Termination of Participant|1|||
27715172|NCT01888640|80792400|FG002|Overall Study|Researcher Termination of Participant|1|||
27715173|NCT01119248|80792401|FG000|Overall Study|Physician Decision|5|||
27715174|NCT01681433|80792404|FG000|Overall Study|Lack of Efficacy|23|||
27715175|NCT01681433|80792405|FG001|Overall Study|Lack of Efficacy|23|||
27715176|NCT01681433|80792404|FG000|Overall Study|Withdrawal by Subject|5|||
27715177|NCT01681433|80792405|FG001|Overall Study|Withdrawal by Subject|5|||
27715178|NCT01681433|80792404|FG000|Overall Study|Protocol Violation|2|||
27715179|NCT01681433|80792405|FG001|Overall Study|Protocol Violation|0|||
27715180|NCT01681433|80792404|FG000|Overall Study|Adverse Event|2|||
27715181|NCT01681433|80792405|FG001|Overall Study|Adverse Event|4|||
27715182|NCT01681433|80792404|FG000|Overall Study|Lost to Follow-up|0|||
27715183|NCT01681433|80792405|FG001|Overall Study|Lost to Follow-up|1|||
27715184|NCT00179309|80792406|FG000|Treatment|Toxicity|2|||
27715185|NCT00179309|80792407|FG001|Treatment|Toxicity|3|||
27715186|NCT00179309|80792406|FG000|Treatment|Withdrawal by Subject|1|||
27715187|NCT00179309|80792407|FG001|Treatment|Withdrawal by Subject|2|||
27715188|NCT00179309|80792406|FG000|Treatment|Allergy|1|||
27715189|NCT00179309|80792407|FG001|Treatment|Allergy|0|||
27715190|NCT00861744|80792408|FG000|Overall Study|Adverse Event|0|||
27715191|NCT00861744|80792409|FG001|Overall Study|Adverse Event|0|||
27715192|NCT00861744|80792410|FG002|Overall Study|Adverse Event|0|||
27715193|NCT00861744|80792411|FG003|Overall Study|Adverse Event|1|||
27715194|NCT00861744|80792408|FG000|Overall Study|Lost to Follow-up|7|||
27715195|NCT00861744|80792409|FG001|Overall Study|Lost to Follow-up|19|||
27715196|NCT00861744|80792410|FG002|Overall Study|Lost to Follow-up|17|||
27715197|NCT00861744|80792411|FG003|Overall Study|Lost to Follow-up|12|||
27715198|NCT00861744|80792408|FG000|Overall Study|Withdrawal by Subject|10|||
27715199|NCT00861744|80792409|FG001|Overall Study|Withdrawal by Subject|6|||
27715200|NCT00861744|80792410|FG002|Overall Study|Withdrawal by Subject|6|||
27715201|NCT00861744|80792411|FG003|Overall Study|Withdrawal by Subject|19|||
27715202|NCT00861744|80792408|FG000|Overall Study|Protocol Violation|0|||
27715203|NCT00861744|80792409|FG001|Overall Study|Protocol Violation|1|||
27715204|NCT00861744|80792410|FG002|Overall Study|Protocol Violation|0|||
27715205|NCT00861744|80792411|FG003|Overall Study|Protocol Violation|0|||
27715206|NCT00861744|80792408|FG000|Overall Study|Migration from study area|0|||
27715207|NCT00861744|80792409|FG001|Overall Study|Migration from study area|3|||
27715208|NCT00861744|80792410|FG002|Overall Study|Migration from study area|1|||
27715209|NCT00861744|80792411|FG003|Overall Study|Migration from study area|0|||
27715210|NCT00861744|80792408|FG000|Overall Study|Blood draws|0|||
27715211|NCT00861744|80792409|FG001|Overall Study|Blood draws|0|||
27715212|NCT00861744|80792410|FG002|Overall Study|Blood draws|0|||
27715213|NCT00861744|80792411|FG003|Overall Study|Blood draws|1|||
27715214|NCT01566773|80792412|FG000|Overall Study|Protocol specified criteria|4|||
27715215|NCT01566773|80792412|FG000|Overall Study|Protocol Violation|4|||
27715216|NCT01566773|80792412|FG000|Overall Study|Withdrawal by Subject|9|||
27715217|NCT01566773|80792412|FG000|Overall Study|Administrative reason|1|||
27715218|NCT01566773|80792412|FG000|Overall Study|Adverse Event|10|||
27715219|NCT01566773|80792412|FG000|Overall Study|Physician Decision|2|||
27715220|NCT04091087|80792413|FG000|Overall Study|Not treated|1|||
27715221|NCT04091087|80792414|FG001|Overall Study|Not treated|0|||
27715222|NCT04091087|80792413|FG000|Overall Study|Adverse Event|4|||
27715223|NCT04091087|80792414|FG001|Overall Study|Adverse Event|4|||
27715224|NCT04091087|80792413|FG000|Overall Study|Protocol Violation|0|||
27715225|NCT04091087|80792414|FG001|Overall Study|Protocol Violation|1|||
27715226|NCT04091087|80792413|FG000|Overall Study|Withdrawal by Subject|5|||
27715227|NCT04091087|80792414|FG001|Overall Study|Withdrawal by Subject|2|||
27715228|NCT02970292|80792415|FG000|Overall Study|Physician Decision|1|||
27715229|NCT02970292|80792416|FG001|Overall Study|Physician Decision|1|||
27715230|NCT02970292|80792415|FG000|Overall Study|Withdrawal by Subject|11|||
27715231|NCT02970292|80792416|FG001|Overall Study|Withdrawal by Subject|5|||
27715232|NCT02970292|80792415|FG000|Overall Study|Noncompliance with study drug|2|||
27715233|NCT02970292|80792416|FG001|Overall Study|Noncompliance with study drug|2|||
27715234|NCT02970292|80792415|FG000|Overall Study|Adverse Event|5|||
27715235|NCT02970292|80792416|FG001|Overall Study|Adverse Event|0|||
27715236|NCT02970292|80792415|FG000|Overall Study|Lack of Efficacy|1|||
27715237|NCT02970292|80792416|FG001|Overall Study|Lack of Efficacy|0|||
27715238|NCT02970292|80792415|FG000|Overall Study|Lost to Follow-up|1|||
27715239|NCT02970292|80792416|FG001|Overall Study|Lost to Follow-up|0|||
27715240|NCT02970292|80792415|FG000|Overall Study|Protocol Violation|2|||
27715241|NCT02970292|80792416|FG001|Overall Study|Protocol Violation|0|||
27715242|NCT02970292|80792415|FG000|Overall Study|Other|1|||
27715243|NCT02970292|80792416|FG001|Overall Study|Other|0|||
27715244|NCT00414453|80792418|FG000|Overall Study|Abnormal lab work|16|||
27715245|NCT01058096|80792419|FG000|Double-blind Treatment Phase|Adverse Event|11|||
27715246|NCT01058096|80792420|FG001|Double-blind Treatment Phase|Adverse Event|15|||
27715247|NCT01058096|80792419|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
27715248|NCT01058096|80792420|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
27715249|NCT01058096|80792419|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
27715250|NCT01058096|80792420|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
27715251|NCT01058096|80792419|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
27715252|NCT01058096|80792420|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
27715253|NCT01058096|80792419|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27715254|NCT01058096|80792420|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
27715255|NCT01058096|80792419|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
27715256|NCT01058096|80792420|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
27889964|NCT00954512|81430935|FG001|Overall Study|Physician Decision|1|||
27715257|NCT03002155|80792422|FG000|Overall Study|Lost to Follow-up|1|||
27715258|NCT03002155|80792423|FG001|Overall Study|Lost to Follow-up|2|||
27715259|NCT03002155|80792422|FG000|Overall Study|Withdrawal by Subject|1|||
27715260|NCT03002155|80792423|FG001|Overall Study|Withdrawal by Subject|0|||
27715261|NCT03002155|80792422|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
27715262|NCT03002155|80792423|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
27715263|NCT02370615|80792426|FG000|Overall Study|Adverse Event|1|||
27715264|NCT02370615|80792427|FG001|Overall Study|Adverse Event|0|||
27715265|NCT00088374|80792428|FG000|Overall Study|patient did not receive any 17AAG|1|||
27715266|NCT00088374|80792428|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
27715267|NCT03809611|80792434|FG000|Overall Study|Withdrawal by Subject|1|||
27715268|NCT03809611|80792435|FG001|Overall Study|Withdrawal by Subject|1|||
27715269|NCT04677959|80792436|FG000|Overall Study|Adverse Event|1|||
27715270|NCT04677959|80792437|FG001|Overall Study|Adverse Event|9|||
27715271|NCT04677959|80792436|FG000|Overall Study|Withdrawal by Subject|2|||
27715272|NCT04677959|80792437|FG001|Overall Study|Withdrawal by Subject|15|||
27715273|NCT04677959|80792436|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27715274|NCT04677959|80792437|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27715275|NCT04677959|80792436|FG000|Overall Study|Non-compliance with study drug|0|||
27715276|NCT04677959|80792437|FG001|Overall Study|Non-compliance with study drug|2|||
27715277|NCT04677959|80792436|FG000|Overall Study|Protocol deviation|0|||
27715278|NCT04677959|80792437|FG001|Overall Study|Protocol deviation|11|||
27715279|NCT04677959|80792436|FG000|Overall Study|Lost to Follow-up|9|||
27715280|NCT04677959|80792437|FG001|Overall Study|Lost to Follow-up|13|||
27715281|NCT04677959|80792436|FG000|Overall Study|Other than specified|0|||
27715282|NCT04677959|80792437|FG001|Overall Study|Other than specified|8|||
27715283|NCT00732303|80792439|FG000|Overall Study|Study Terminated|2|||
27715284|NCT03709654|80792446|FG000|Overall Study|Lost to Follow-up|1|||
27715285|NCT03709654|80792447|FG001|Overall Study|Lost to Follow-up|1|||
27715286|NCT03709654|80792446|FG000|Overall Study|Withdrawal by Subject|1|||
27715287|NCT03709654|80792447|FG001|Overall Study|Withdrawal by Subject|1|||
27715288|NCT03709654|80792446|FG000|Overall Study|Adverse Event|1|||
27715289|NCT03709654|80792447|FG001|Overall Study|Adverse Event|0|||
27715290|NCT00916357|80792448|FG000|Period 1|Withdrawal by Subject|1|||
27715291|NCT00916357|80792449|FG001|Period 1|Withdrawal by Subject|0|||
27715292|NCT00916357|80792450|FG002|Period 1|Withdrawal by Subject|0|||
27715293|NCT00916357|80792451|FG003|Period 1|Withdrawal by Subject|0|||
27715294|NCT00916357|80792452|FG004|Period 1|Withdrawal by Subject|0|||
27715295|NCT00916357|80792453|FG005|Period 1|Withdrawal by Subject|0|||
27715296|NCT00916357|80792448|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
27715297|NCT00916357|80792449|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
27715298|NCT00916357|80792450|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
27715299|NCT00916357|80792451|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
27715300|NCT00916357|80792452|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
27715301|NCT00916357|80792453|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
27715302|NCT00790907|80792454|FG000|Overall Study|Adverse Event|9|||
27715303|NCT00790907|80792455|FG001|Overall Study|Adverse Event|7|||
27715304|NCT00790907|80792456|FG002|Overall Study|Adverse Event|6|||
27715305|NCT00790907|80792454|FG000|Overall Study|Physician Decision|304|||
27715306|NCT00790907|80792455|FG001|Overall Study|Physician Decision|271|||
27715307|NCT00790907|80792456|FG002|Overall Study|Physician Decision|255|||
27715308|NCT00790907|80792454|FG000|Overall Study|Withdrawal by Subject|1|||
27715309|NCT00790907|80792455|FG001|Overall Study|Withdrawal by Subject|7|||
27715310|NCT00790907|80792456|FG002|Overall Study|Withdrawal by Subject|5|||
27715311|NCT00790907|80792454|FG000|Overall Study|Bleeding Event|11|||
27715312|NCT00790907|80792455|FG001|Overall Study|Bleeding Event|16|||
27715313|NCT00790907|80792456|FG002|Overall Study|Bleeding Event|21|||
27715314|NCT00790907|80792454|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
27715315|NCT00790907|80792455|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
27715316|NCT00790907|80792456|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
27715317|NCT00790907|80792454|FG000|Overall Study|Qualifying Condition Not Present|29|||
27715318|NCT00790907|80792455|FG001|Overall Study|Qualifying Condition Not Present|14|||
27715319|NCT00790907|80792456|FG002|Overall Study|Qualifying Condition Not Present|16|||
27715320|NCT00790907|80792454|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
27715321|NCT00790907|80792455|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
27715322|NCT00790907|80792456|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
27715323|NCT00790907|80792454|FG000|Overall Study|Did Not Receive Study Drug|10|||
27715324|NCT00790907|80792455|FG001|Overall Study|Did Not Receive Study Drug|0|||
27715325|NCT00790907|80792456|FG002|Overall Study|Did Not Receive Study Drug|0|||
27889965|NCT00954512|81430936|FG002|Overall Study|Physician Decision|0|||
27715326|NCT04029519|80792457|FG000|Overall Study|Protocol Violation|1|||
27715327|NCT04029519|80792457|FG000|Overall Study|Withdrawal by Subject|3|||
27715328|NCT04029519|80792457|FG000|Overall Study|Lost to Follow-up|1|||
27889966|NCT00954512|81430937|FG003|Overall Study|Physician Decision|1|||
27605127|NCT04534114|80395335|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
27605128|NCT04534114|80395336|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
27605129|NCT04534114|80395333|FG000|Extension Treatment Period|Other reason|0|||
27605130|NCT04534114|80395334|FG001|Extension Treatment Period|Other reason|1|||
27605131|NCT04534114|80395335|FG002|Extension Treatment Period|Other reason|0|||
27605132|NCT04534114|80395336|FG003|Extension Treatment Period|Other reason|0|||
27605133|NCT04534114|80395333|FG000|Extension Treatment Period|Death|0|||
27605134|NCT04534114|80395334|FG001|Extension Treatment Period|Death|0|||
27605135|NCT04534114|80395335|FG002|Extension Treatment Period|Death|1|||
27605136|NCT04534114|80395336|FG003|Extension Treatment Period|Death|2|||
27605137|NCT04534114|80395333|FG000|Extension Treatment Period|Adverse Event|0|||
27605138|NCT04534114|80395334|FG001|Extension Treatment Period|Adverse Event|1|||
27605139|NCT04534114|80395335|FG002|Extension Treatment Period|Adverse Event|0|||
27605140|NCT04534114|80395336|FG003|Extension Treatment Period|Adverse Event|1|||
27605141|NCT04534114|80395333|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
27715329|NCT01356589|80792458|FG000|Overall Study|Enrolled, but not treated|3|||
27715330|NCT01356589|80792458|FG000|Overall Study|Dose data not recorded|2|||
27715331|NCT00915681|80792459|FG000|Overall Study|Screening failures|46|||
27605142|NCT04534114|80395334|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
27715332|NCT01687712|80792462|FG000|Cycle 1|Not Biochemically Pregnant|386|||
27715333|NCT01687712|80792463|FG001|Cycle 1|Not Biochemically Pregnant|348|||
27715334|NCT01687712|80792462|FG000|Cycle 1|Early Pregnancy Loss|43|||
27715335|NCT01687712|80792463|FG001|Cycle 1|Early Pregnancy Loss|60|||
27715336|NCT01687712|80792462|FG000|Cycle 1|Ectopic Pregnancy|5|||
27715337|NCT01687712|80792463|FG001|Cycle 1|Ectopic Pregnancy|5|||
27715338|NCT01687712|80792462|FG000|Cycle 1|Heterotropic Pregnancy|1|||
27715339|NCT01687712|80792463|FG001|Cycle 1|Heterotropic Pregnancy|0|||
27715340|NCT01687712|80792462|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
27715341|NCT01687712|80792463|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
27715342|NCT01687712|80792462|FG000|Cycle 1|Abortion|3|||
27715343|NCT01687712|80792463|FG001|Cycle 1|Abortion|0|||
27715344|NCT01687712|80792462|FG000|Cycle 1|Intrauterine Fetal Death|0|||
27715345|NCT01687712|80792463|FG001|Cycle 1|Intrauterine Fetal Death|1|||
27715346|NCT01687712|80792462|FG000|Cycle 1|Lost to Follow-up|1|||
27715347|NCT01687712|80792463|FG001|Cycle 1|Lost to Follow-up|1|||
27715348|NCT01687712|80792462|FG000|Cycle 2|Not Biochemically Pregnant|74|||
27715349|NCT01687712|80792463|FG001|Cycle 2|Not Biochemically Pregnant|77|||
27715350|NCT01687712|80792462|FG000|Cycle 2|Early Pregnancy Loss|18|||
27715351|NCT01687712|80792463|FG001|Cycle 2|Early Pregnancy Loss|16|||
27715352|NCT01687712|80792462|FG000|Cycle 2|Ectopic Pregnancy|0|||
27715353|NCT01687712|80792463|FG001|Cycle 2|Ectopic Pregnancy|1|||
27715354|NCT01687712|80792462|FG000|Cycle 2|Still Birth|1|||
27715355|NCT01687712|80792463|FG001|Cycle 2|Still Birth|0|||
27715356|NCT01687712|80792462|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
27715357|NCT01687712|80792463|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
27715358|NCT01687712|80792462|FG000|Cycle 3|Not Biochemically Pregnant|21|||
27715359|NCT01687712|80792463|FG001|Cycle 3|Not Biochemically Pregnant|22|||
27715360|NCT01687712|80792462|FG000|Cycle 3|Early Pregnancy Loss|1|||
27715361|NCT01687712|80792463|FG001|Cycle 3|Early Pregnancy Loss|2|||
27715362|NCT01687712|80792462|FG000|Cycle 3|Ectopic Pregnancy|1|||
27715363|NCT01687712|80792463|FG001|Cycle 3|Ectopic Pregnancy|0|||
27715364|NCT01687712|80792462|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
27715365|NCT01687712|80792463|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
27715366|NCT00953758|80792464|FG000|Overall Study|Death|2|||
27715367|NCT00953758|80792465|FG001|Overall Study|Death|0|||
27715368|NCT00953758|80792466|FG002|Overall Study|Death|1|||
27715369|NCT00953758|80792467|FG003|Overall Study|Death|1|||
27715370|NCT00953758|80792468|FG004|Overall Study|Death|1|||
27715371|NCT00953758|80792469|FG005|Overall Study|Death|1|||
27715372|NCT00953758|80792470|FG006|Overall Study|Death|1|||
27715373|NCT00953758|80792471|FG007|Overall Study|Death|3|||
27715374|NCT00953758|80792472|FG008|Overall Study|Death|1|||
27715375|NCT00953758|80792473|FG009|Overall Study|Death|0|||
27715376|NCT00953758|80792464|FG000|Overall Study|Participant refused further follow-up|0|||
27715377|NCT00953758|80792465|FG001|Overall Study|Participant refused further follow-up|0|||
27715378|NCT00953758|80792466|FG002|Overall Study|Participant refused further follow-up|1|||
27715379|NCT00953758|80792467|FG003|Overall Study|Participant refused further follow-up|0|||
27715380|NCT00953758|80792468|FG004|Overall Study|Participant refused further follow-up|3|||
27837324|NCT00385736|81233016|FG001|Safety Analysis Set|Lack of Efficacy|16|||
27837325|NCT00385736|81233017|FG002|Safety Analysis Set|Lack of Efficacy|31|||
27837326|NCT00385736|81233015|FG000|Safety Analysis Set|Protocol Violation|2|||
27837327|NCT00385736|81233016|FG001|Safety Analysis Set|Protocol Violation|1|||
27837328|NCT00385736|81233017|FG002|Safety Analysis Set|Protocol Violation|6|||
27837329|NCT00385736|81233015|FG000|Safety Analysis Set|Other|1|||
27889967|NCT00954512|81430938|FG004|Overall Study|Physician Decision|0|||
27889968|NCT00954512|81430939|FG005|Overall Study|Physician Decision|0|||
27889969|NCT00954512|81430934|FG000|Overall Study|Symptomatic Deterioration|0|||
27889970|NCT00954512|81430935|FG001|Overall Study|Symptomatic Deterioration|1|||
27889971|NCT00954512|81430936|FG002|Overall Study|Symptomatic Deterioration|0|||
27837330|NCT00385736|81233016|FG001|Safety Analysis Set|Other|4|||
27837331|NCT00385736|81233017|FG002|Safety Analysis Set|Other|4|||
27889972|NCT00954512|81430937|FG003|Overall Study|Symptomatic Deterioration|0|||
27715381|NCT00953758|80792469|FG005|Overall Study|Participant refused further follow-up|0|||
27837332|NCT03277248|81233018|FG000|Overall Study|Adverse Event|3|||
27837333|NCT03277248|81233019|FG001|Overall Study|Adverse Event|1|||
27889973|NCT00954512|81430938|FG004|Overall Study|Symptomatic Deterioration|2|||
27715382|NCT00953758|80792470|FG006|Overall Study|Participant refused further follow-up|0|||
27715383|NCT00953758|80792471|FG007|Overall Study|Participant refused further follow-up|0|||
27715384|NCT00953758|80792472|FG008|Overall Study|Participant refused further follow-up|1|||
27837334|NCT03277248|81233018|FG000|Overall Study|Subject Withdrawal of Consent|6|||
27837335|NCT03277248|81233019|FG001|Overall Study|Subject Withdrawal of Consent|23|||
27889974|NCT00954512|81430939|FG005|Overall Study|Symptomatic Deterioration|0|||
27889975|NCT00954512|81430934|FG000|Overall Study|Progression of Disease|2|||
27889976|NCT00954512|81430935|FG001|Overall Study|Progression of Disease|1|||
27889977|NCT00954512|81430936|FG002|Overall Study|Progression of Disease|0|||
27715385|NCT00953758|80792473|FG009|Overall Study|Participant refused further follow-up|0|||
27715386|NCT00953758|80792464|FG000|Overall Study|Lost to Follow-up|0|||
27715387|NCT00953758|80792465|FG001|Overall Study|Lost to Follow-up|0|||
27715388|NCT00953758|80792466|FG002|Overall Study|Lost to Follow-up|0|||
27715389|NCT00953758|80792467|FG003|Overall Study|Lost to Follow-up|1|||
27715390|NCT00953758|80792468|FG004|Overall Study|Lost to Follow-up|0|||
27715391|NCT00953758|80792469|FG005|Overall Study|Lost to Follow-up|0|||
27715392|NCT00953758|80792470|FG006|Overall Study|Lost to Follow-up|0|||
27715393|NCT00953758|80792471|FG007|Overall Study|Lost to Follow-up|1|||
27715394|NCT00953758|80792472|FG008|Overall Study|Lost to Follow-up|0|||
27715395|NCT00953758|80792473|FG009|Overall Study|Lost to Follow-up|1|||
27715396|NCT00953758|80792464|FG000|Overall Study|Physician Decision|0|||
27715397|NCT00953758|80792465|FG001|Overall Study|Physician Decision|0|||
27715398|NCT00953758|80792466|FG002|Overall Study|Physician Decision|0|||
27715399|NCT00953758|80792467|FG003|Overall Study|Physician Decision|0|||
27715400|NCT00953758|80792468|FG004|Overall Study|Physician Decision|1|||
27715401|NCT00953758|80792469|FG005|Overall Study|Physician Decision|0|||
27715402|NCT00953758|80792470|FG006|Overall Study|Physician Decision|0|||
27715403|NCT00953758|80792471|FG007|Overall Study|Physician Decision|0|||
27715404|NCT00953758|80792472|FG008|Overall Study|Physician Decision|0|||
27715405|NCT00953758|80792473|FG009|Overall Study|Physician Decision|0|||
27715406|NCT00953758|80792464|FG000|Overall Study|Disease progression|0|||
27715407|NCT00953758|80792465|FG001|Overall Study|Disease progression|0|||
27715408|NCT00953758|80792466|FG002|Overall Study|Disease progression|0|||
27715409|NCT00953758|80792467|FG003|Overall Study|Disease progression|0|||
27715410|NCT00953758|80792468|FG004|Overall Study|Disease progression|1|||
27715411|NCT00953758|80792469|FG005|Overall Study|Disease progression|0|||
27715412|NCT00953758|80792470|FG006|Overall Study|Disease progression|0|||
27715413|NCT00953758|80792471|FG007|Overall Study|Disease progression|0|||
27605143|NCT04534114|80395335|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
27605144|NCT04534114|80395336|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
27605145|NCT02312856|80395337|FG000|Overall Study|Death|1|||
27605146|NCT02312856|80395337|FG000|Overall Study|Lost to Follow-up|3|||
27715414|NCT00953758|80792472|FG008|Overall Study|Disease progression|0|||
27715415|NCT00953758|80792473|FG009|Overall Study|Disease progression|0|||
27715416|NCT00953758|80792464|FG000|Overall Study|Participant went for transplant|0|||
27715417|NCT00953758|80792465|FG001|Overall Study|Participant went for transplant|0|||
27715418|NCT00953758|80792466|FG002|Overall Study|Participant went for transplant|0|||
27715419|NCT00953758|80792467|FG003|Overall Study|Participant went for transplant|0|||
27715420|NCT00953758|80792468|FG004|Overall Study|Participant went for transplant|0|||
27715421|NCT00953758|80792469|FG005|Overall Study|Participant went for transplant|0|||
27715422|NCT00953758|80792470|FG006|Overall Study|Participant went for transplant|0|||
27715423|NCT00953758|80792471|FG007|Overall Study|Participant went for transplant|0|||
27715424|NCT00953758|80792472|FG008|Overall Study|Participant went for transplant|1|||
27715425|NCT00953758|80792473|FG009|Overall Study|Participant went for transplant|0|||
27715426|NCT00004259|80792475|FG000|Overall Study|Protocol Violation|1|||
27715427|NCT00004259|80792476|FG001|Overall Study|Protocol Violation|2|||
27715428|NCT00004259|80792477|FG002|Overall Study|Protocol Violation|0|||
27715429|NCT00004259|80792478|FG003|Overall Study|Protocol Violation|0|||
27715430|NCT00004259|80792475|FG000|Overall Study|Withdrawal by Subject|0|||
27715431|NCT00004259|80792476|FG001|Overall Study|Withdrawal by Subject|2|||
27715432|NCT00004259|80792477|FG002|Overall Study|Withdrawal by Subject|0|||
27715433|NCT00004259|80792478|FG003|Overall Study|Withdrawal by Subject|0|||
27715434|NCT01391000|80792479|FG000|Overall Study|Lost to Follow-up|2|||
27715435|NCT01391000|80792480|FG001|Overall Study|Lost to Follow-up|0|||
27715436|NCT03124784|80792482|FG000|Overall Study|Adverse Event|1|||
27715437|NCT03124784|80792482|FG000|Overall Study|Computer/Equip Malfunction|1|||
27715438|NCT04962022|80792483|FG000|Period 1|Withdrawal by Subject|1|||
27715439|NCT04962022|80792484|FG001|Period 1|Withdrawal by Subject|0|||
27837336|NCT03277248|81233018|FG000|Overall Study|Investigator/Sponsor Decision|2|||
27605147|NCT03012061|80395340|FG000|Overall Study|Withdrawal by Subject|1|||
27837337|NCT03277248|81233019|FG001|Overall Study|Investigator/Sponsor Decision|2|||
27837338|NCT03277248|81233018|FG000|Overall Study|Pregnancy|4|||
27837339|NCT03277248|81233019|FG001|Overall Study|Pregnancy|1|||
27605148|NCT03012061|80395341|FG001|Overall Study|Withdrawal by Subject|5|||
27715440|NCT00957008|80792485|FG000|Overall Study|Withdrawal by Subject|13|||
27837340|NCT03277248|81233018|FG000|Overall Study|Lost to Follow-up|0|||
27837341|NCT03277248|81233019|FG001|Overall Study|Lost to Follow-up|2|||
27837342|NCT03277248|81233018|FG000|Overall Study|Lack of Efficacy|0|||
27837343|NCT03277248|81233019|FG001|Overall Study|Lack of Efficacy|2|||
27837344|NCT03277248|81233018|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
27715441|NCT00957008|80792486|FG001|Overall Study|Withdrawal by Subject|10|||
27715442|NCT00957008|80792487|FG002|Overall Study|Withdrawal by Subject|12|||
27715443|NCT00957008|80792488|FG003|Overall Study|Withdrawal by Subject|16|||
27715444|NCT00957008|80792485|FG000|Overall Study|Lost to Follow-up|3|||
27715445|NCT00957008|80792486|FG001|Overall Study|Lost to Follow-up|1|||
27715446|NCT00957008|80792487|FG002|Overall Study|Lost to Follow-up|3|||
27715447|NCT00957008|80792488|FG003|Overall Study|Lost to Follow-up|4|||
27715448|NCT00957008|80792485|FG000|Overall Study|Physician Decision|1|||
27715449|NCT00957008|80792486|FG001|Overall Study|Physician Decision|0|||
27715450|NCT00957008|80792487|FG002|Overall Study|Physician Decision|1|||
27715451|NCT00957008|80792488|FG003|Overall Study|Physician Decision|1|||
27715452|NCT00957008|80792485|FG000|Overall Study|Relocated; Family conflict|4|||
27715453|NCT00957008|80792486|FG001|Overall Study|Relocated; Family conflict|1|||
27715454|NCT00957008|80792487|FG002|Overall Study|Relocated; Family conflict|1|||
27715455|NCT00957008|80792488|FG003|Overall Study|Relocated; Family conflict|3|||
27715456|NCT00706134|80792489|FG000|Overall Study|Adverse Event|8|||
27715457|NCT00706134|80792490|FG001|Overall Study|Adverse Event|7|||
27715458|NCT00706134|80792491|FG002|Overall Study|Adverse Event|2|||
27715459|NCT00706134|80792492|FG003|Overall Study|Adverse Event|3|||
27715460|NCT00706134|80792489|FG000|Overall Study|Lost to Follow-up|0|||
27605149|NCT03012061|80395342|FG002|Overall Study|Withdrawal by Subject|4|||
27605150|NCT03012061|80395340|FG000|Overall Study|Investigator Site Closed|1|||
27605151|NCT03012061|80395341|FG001|Overall Study|Investigator Site Closed|2|||
27715461|NCT00706134|80792490|FG001|Overall Study|Lost to Follow-up|1|||
27715462|NCT00706134|80792491|FG002|Overall Study|Lost to Follow-up|0|||
27715463|NCT00706134|80792492|FG003|Overall Study|Lost to Follow-up|0|||
27715464|NCT00706134|80792489|FG000|Overall Study|Protocol Violation|0|||
27715465|NCT00706134|80792490|FG001|Overall Study|Protocol Violation|6|||
27715466|NCT00706134|80792491|FG002|Overall Study|Protocol Violation|0|||
27715467|NCT00706134|80792492|FG003|Overall Study|Protocol Violation|3|||
27715468|NCT00706134|80792489|FG000|Overall Study|Withdrawal by Subject|1|||
27715469|NCT00706134|80792490|FG001|Overall Study|Withdrawal by Subject|2|||
27715470|NCT00706134|80792491|FG002|Overall Study|Withdrawal by Subject|1|||
27715471|NCT00706134|80792492|FG003|Overall Study|Withdrawal by Subject|0|||
27715472|NCT00706134|80792489|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
27715473|NCT00706134|80792490|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27715474|NCT00706134|80792491|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
27715475|NCT00706134|80792492|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
27715476|NCT00706134|80792489|FG000|Overall Study|Did not meet study criteria|2|||
27715477|NCT00706134|80792490|FG001|Overall Study|Did not meet study criteria|0|||
27715478|NCT00706134|80792491|FG002|Overall Study|Did not meet study criteria|0|||
27715479|NCT00706134|80792492|FG003|Overall Study|Did not meet study criteria|0|||
27715480|NCT03099187|80792493|FG000|Double-blind Treatment|Adverse Event|19|||
27715481|NCT03099187|80792494|FG001|Double-blind Treatment|Adverse Event|1|||
27715482|NCT03099187|80792495|FG002|Double-blind Treatment|Adverse Event|0|||
27715483|NCT03099187|80792496|FG003|Double-blind Treatment|Adverse Event|0|||
27715484|NCT03099187|80792493|FG000|Double-blind Treatment|Death|1|||
27715485|NCT03099187|80792494|FG001|Double-blind Treatment|Death|3|||
27715486|NCT03099187|80792495|FG002|Double-blind Treatment|Death|0|||
27715487|NCT03099187|80792496|FG003|Double-blind Treatment|Death|0|||
27715488|NCT03099187|80792493|FG000|Double-blind Treatment|Lack of Efficacy|1|||
27715489|NCT03099187|80792494|FG001|Double-blind Treatment|Lack of Efficacy|0|||
27715490|NCT03099187|80792495|FG002|Double-blind Treatment|Lack of Efficacy|0|||
27715491|NCT03099187|80792496|FG003|Double-blind Treatment|Lack of Efficacy|0|||
27715492|NCT03099187|80792493|FG000|Double-blind Treatment|Physician Decision|2|||
27715493|NCT03099187|80792494|FG001|Double-blind Treatment|Physician Decision|1|||
27715494|NCT03099187|80792495|FG002|Double-blind Treatment|Physician Decision|0|||
27715495|NCT03099187|80792496|FG003|Double-blind Treatment|Physician Decision|0|||
27715496|NCT03099187|80792493|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
27715497|NCT03099187|80792494|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
27715498|NCT03099187|80792495|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
27715499|NCT03099187|80792496|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
27715500|NCT03099187|80792493|FG000|Double-blind Treatment|Lung transplantation|0|||
27715501|NCT03099187|80792494|FG001|Double-blind Treatment|Lung transplantation|1|||
27715502|NCT03099187|80792495|FG002|Double-blind Treatment|Lung transplantation|0|||
27715503|NCT03099187|80792496|FG003|Double-blind Treatment|Lung transplantation|0|||
27715504|NCT03099187|80792493|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
27715505|NCT03099187|80792494|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
27715506|NCT03099187|80792495|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
27715507|NCT03099187|80792496|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
27715508|NCT03099187|80792493|FG000|Double-blind Treatment|Disease progression|0|||
27715509|NCT03099187|80792494|FG001|Double-blind Treatment|Disease progression|1|||
27715510|NCT03099187|80792495|FG002|Double-blind Treatment|Disease progression|0|||
27715511|NCT03099187|80792496|FG003|Double-blind Treatment|Disease progression|0|||
27715512|NCT03099187|80792493|FG000|Double-blind Treatment|Randomization error|0|||
27715513|NCT03099187|80792494|FG001|Double-blind Treatment|Randomization error|2|||
27715514|NCT03099187|80792495|FG002|Double-blind Treatment|Randomization error|0|||
27715515|NCT03099187|80792496|FG003|Double-blind Treatment|Randomization error|0|||
27715516|NCT03099187|80792493|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
27715517|NCT03099187|80792494|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
27715518|NCT03099187|80792495|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
27715519|NCT03099187|80792496|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
27715520|NCT03099187|80792493|FG000|12-month Safety Follow-up|Adverse Event|0|||
27715521|NCT03099187|80792494|FG001|12-month Safety Follow-up|Adverse Event|0|||
27715522|NCT03099187|80792495|FG002|12-month Safety Follow-up|Adverse Event|5|||
27715523|NCT03099187|80792496|FG003|12-month Safety Follow-up|Adverse Event|12|||
27715524|NCT03099187|80792493|FG000|12-month Safety Follow-up|Death|0|||
27715525|NCT03099187|80792494|FG001|12-month Safety Follow-up|Death|0|||
27715526|NCT03099187|80792495|FG002|12-month Safety Follow-up|Death|7|||
27889978|NCT00954512|81430937|FG003|Overall Study|Progression of Disease|1|||
27715527|NCT03099187|80792496|FG003|12-month Safety Follow-up|Death|9|||
27715528|NCT03099187|80792493|FG000|12-month Safety Follow-up|Lung transplantation|0|||
27715529|NCT03099187|80792494|FG001|12-month Safety Follow-up|Lung transplantation|0|||
27715530|NCT03099187|80792495|FG002|12-month Safety Follow-up|Lung transplantation|2|||
27715531|NCT03099187|80792496|FG003|12-month Safety Follow-up|Lung transplantation|1|||
27715532|NCT03099187|80792493|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
27715533|NCT03099187|80792494|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
27715534|NCT03099187|80792495|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
27715535|NCT03099187|80792496|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
27715536|NCT03099187|80792493|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
27715537|NCT03099187|80792494|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
27715538|NCT03099187|80792495|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
27715539|NCT03099187|80792496|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
27715540|NCT03099187|80792493|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
27715541|NCT03099187|80792494|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
27715542|NCT03099187|80792495|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
27715543|NCT03099187|80792496|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
27715544|NCT03099187|80792493|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
27715545|NCT03099187|80792494|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
27715546|NCT03099187|80792495|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
27715547|NCT03099187|80792496|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
27715548|NCT00879229|80792497|FG000|Overall Study|Study terminated by Sponsor|13|||
27715549|NCT00879229|80792498|FG001|Overall Study|Study terminated by Sponsor|12|||
27715550|NCT00879229|80792497|FG000|Overall Study|Death|4|||
27715551|NCT00879229|80792498|FG001|Overall Study|Death|2|||
27715552|NCT00879229|80792497|FG000|Overall Study|Adverse Event|2|||
27715553|NCT00879229|80792498|FG001|Overall Study|Adverse Event|0|||
27715554|NCT00879229|80792497|FG000|Overall Study|Withdrawal by Subject|1|||
27605152|NCT03012061|80395342|FG002|Overall Study|Investigator Site Closed|0|||
27605153|NCT03012061|80395340|FG000|Overall Study|Lost to Follow-up|2|||
27605154|NCT03012061|80395341|FG001|Overall Study|Lost to Follow-up|1|||
27605155|NCT03012061|80395342|FG002|Overall Study|Lost to Follow-up|0|||
27605156|NCT03012061|80395340|FG000|Overall Study|Study closed/ Terminated|0|||
27605157|NCT03012061|80395341|FG001|Overall Study|Study closed/ Terminated|0|||
27889979|NCT00954512|81430938|FG004|Overall Study|Progression of Disease|1|||
27605158|NCT03012061|80395342|FG002|Overall Study|Study closed/ Terminated|1|||
27605159|NCT03012061|80395340|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
27605160|NCT03012061|80395341|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
27715555|NCT00879229|80792498|FG001|Overall Study|Withdrawal by Subject|0|||
27715556|NCT00879229|80792497|FG000|Overall Study|Clinical status did not improve|1|||
27715557|NCT00879229|80792498|FG001|Overall Study|Clinical status did not improve|0|||
27715558|NCT00879229|80792497|FG000|Overall Study|Other|1|||
27715559|NCT00879229|80792498|FG001|Overall Study|Other|0|||
27715560|NCT00517829|80792502|FG000|Overall Study|Adverse Event|22|||
27715561|NCT00517829|80792503|FG001|Overall Study|Adverse Event|34|||
27715562|NCT00517829|80792502|FG000|Overall Study|Disease Progression|39|||
27715563|NCT00517829|80792503|FG001|Overall Study|Disease Progression|32|||
27715564|NCT00517829|80792502|FG000|Overall Study|Patient Request|6|||
27715565|NCT00517829|80792503|FG001|Overall Study|Patient Request|5|||
27715566|NCT00517829|80792502|FG000|Overall Study|Investigator Request|5|||
27715567|NCT00517829|80792503|FG001|Overall Study|Investigator Request|3|||
27715568|NCT00517829|80792502|FG000|Overall Study|Other|3|||
27715569|NCT00517829|80792503|FG001|Overall Study|Other|1|||
27715570|NCT00401752|80792504|FG000|Overall Study|Adverse Event|2|||
27715571|NCT00401752|80792505|FG001|Overall Study|Adverse Event|5|||
27715572|NCT00401752|80792504|FG000|Overall Study|Withdrawal by Subject|2|||
27715573|NCT00401752|80792505|FG001|Overall Study|Withdrawal by Subject|6|||
27715574|NCT00401752|80792504|FG000|Overall Study|Lost to Follow-up|1|||
27889980|NCT00954512|81430939|FG005|Overall Study|Progression of Disease|1|||
27715575|NCT00401752|80792505|FG001|Overall Study|Lost to Follow-up|4|||
27715576|NCT00401752|80792504|FG000|Overall Study|Development of any exclusion criteria|4|||
27837345|NCT03277248|81233019|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
27837346|NCT01962298|81233020|FG000|Overall Study|Protocol Violation|1|||
27837347|NCT01962298|81233021|FG001|Overall Study|Protocol Violation|0|||
27837348|NCT01962298|81233022|FG002|Overall Study|Protocol Violation|1|||
27837349|NCT01962298|81233023|FG003|Overall Study|Protocol Violation|1|||
27837350|NCT01962298|81233024|FG004|Overall Study|Protocol Violation|0|||
27837351|NCT01962298|81233020|FG000|Overall Study|Data quality insufficient|2|||
27837352|NCT01962298|81233021|FG001|Overall Study|Data quality insufficient|0|||
27837353|NCT01962298|81233022|FG002|Overall Study|Data quality insufficient|3|||
27837354|NCT01962298|81233023|FG003|Overall Study|Data quality insufficient|1|||
27837355|NCT01962298|81233024|FG004|Overall Study|Data quality insufficient|4|||
27837356|NCT01962298|81233020|FG000|Overall Study|Insufficient data|0|||
27837357|NCT01962298|81233021|FG001|Overall Study|Insufficient data|2|||
27837358|NCT01962298|81233022|FG002|Overall Study|Insufficient data|1|||
27837359|NCT01962298|81233023|FG003|Overall Study|Insufficient data|0|||
27837360|NCT01962298|81233024|FG004|Overall Study|Insufficient data|1|||
27837361|NCT01962298|81233020|FG000|Overall Study|Incorrect data recorded|0|||
27837362|NCT01962298|81233021|FG001|Overall Study|Incorrect data recorded|1|||
27837363|NCT01962298|81233022|FG002|Overall Study|Incorrect data recorded|0|||
27837364|NCT01962298|81233023|FG003|Overall Study|Incorrect data recorded|0|||
27837365|NCT01962298|81233024|FG004|Overall Study|Incorrect data recorded|0|||
27837366|NCT01962298|81233020|FG000|Overall Study|Physician Decision|0|||
27837367|NCT01962298|81233021|FG001|Overall Study|Physician Decision|1|||
27837368|NCT01962298|81233022|FG002|Overall Study|Physician Decision|0|||
27837369|NCT01962298|81233023|FG003|Overall Study|Physician Decision|0|||
27605161|NCT03012061|80395342|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
27605162|NCT03012061|80395340|FG000|Overall Study|Protocol Violation|0|||
27837370|NCT01962298|81233024|FG004|Overall Study|Physician Decision|1|||
27837371|NCT01091363|81233029|FG000|Overall Study|Withdrawal by Subject|11|||
27837372|NCT01091363|81233030|FG001|Overall Study|Withdrawal by Subject|15|||
27837373|NCT01091363|81233029|FG000|Overall Study|Lost to Follow-up|2|||
27837374|NCT01091363|81233030|FG001|Overall Study|Lost to Follow-up|2|||
27837375|NCT00960154|81233031|FG000|Overall Study|Study termination|25|||
27889981|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
27889982|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
27889983|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
27889984|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
27889985|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
27889986|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
27889987|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
27889988|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
27889989|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
27889990|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
27889991|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
27889992|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
27715577|NCT00401752|80792505|FG001|Overall Study|Development of any exclusion criteria|2|||
27605163|NCT03012061|80395341|FG001|Overall Study|Protocol Violation|0|||
27605164|NCT03012061|80395342|FG002|Overall Study|Protocol Violation|2|||
27605165|NCT03012061|80395340|FG000|Overall Study|Lack of Efficacy|0|||
27605166|NCT03012061|80395341|FG001|Overall Study|Lack of Efficacy|1|||
27605167|NCT03012061|80395342|FG002|Overall Study|Lack of Efficacy|0|||
27605168|NCT03012061|80395340|FG000|Overall Study|Adverse Event|2|||
27605169|NCT03012061|80395341|FG001|Overall Study|Adverse Event|0|||
27605170|NCT03012061|80395342|FG002|Overall Study|Adverse Event|0|||
27605171|NCT00708435|80395343|FG000|Overall Study|Death / Serious Adverse Event|10|||
27605172|NCT00708435|80395344|FG001|Overall Study|Death / Serious Adverse Event|5|||
27837376|NCT00960154|81233032|FG001|Overall Study|Study termination|25|||
27837377|NCT00577655|81233033|FG000|Overall Study|Patient Request|0|||
27837378|NCT00577655|81233034|FG001|Overall Study|Patient Request|2|||
27837379|NCT00577655|81233033|FG000|Overall Study|Protocol Violation|0|||
27837380|NCT00577655|81233034|FG001|Overall Study|Protocol Violation|1|||
27837381|NCT00577655|81233033|FG000|Overall Study|Lost to Follow-up|1|||
27837382|NCT00577655|81233034|FG001|Overall Study|Lost to Follow-up|1|||
27837383|NCT01949532|81233039|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
27837384|NCT01949532|81233040|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
27837385|NCT02705716|81233047|FG000|Overall Study|Adverse Event|0|||
27837386|NCT02705716|81233048|FG001|Overall Study|Adverse Event|1|||
27837387|NCT02705716|81233047|FG000|Overall Study|Protocol Violation|3|||
27837388|NCT02705716|81233048|FG001|Overall Study|Protocol Violation|0|||
27837389|NCT02705716|81233047|FG000|Overall Study|Withdrawal of Consent|1|||
27837390|NCT02705716|81233048|FG001|Overall Study|Withdrawal of Consent|1|||
27837391|NCT01155531|81233049|FG000|Overall Study|Adverse Event|0|||
27837392|NCT01155531|81233050|FG001|Overall Study|Adverse Event|0|||
27837393|NCT01155531|81233051|FG002|Overall Study|Adverse Event|1|||
27605173|NCT00708435|80395343|FG000|Overall Study|Lost to Follow-up|9|||
27605174|NCT00708435|80395344|FG001|Overall Study|Lost to Follow-up|4|||
27605175|NCT00708435|80395343|FG000|Overall Study|Withdrawal by Subject|3|||
27837394|NCT01155531|81233052|FG003|Overall Study|Adverse Event|0|||
27837395|NCT01155531|81233049|FG000|Overall Study|Lost to Follow-up|0|||
27837396|NCT01155531|81233050|FG001|Overall Study|Lost to Follow-up|0|||
27837397|NCT01155531|81233051|FG002|Overall Study|Lost to Follow-up|0|||
27837398|NCT01155531|81233052|FG003|Overall Study|Lost to Follow-up|1|||
27837399|NCT01155531|81233049|FG000|Overall Study|Withdrawal by Subject|1|||
27837400|NCT01155531|81233050|FG001|Overall Study|Withdrawal by Subject|0|||
27837401|NCT01155531|81233051|FG002|Overall Study|Withdrawal by Subject|1|||
27837402|NCT01155531|81233052|FG003|Overall Study|Withdrawal by Subject|0|||
27837403|NCT02699866|81233057|FG000|Overall Study|Withdrawal by Subject|3|||
27837404|NCT02699866|81233057|FG000|Overall Study|Physician Decision|2|||
27837405|NCT02699866|81233057|FG000|Overall Study|Adverse Event|3|||
27837406|NCT01583530|81233058|FG000|Overall Study|Adverse Event|0|||
27837407|NCT01583530|81233059|FG001|Overall Study|Adverse Event|0|||
27837408|NCT01583530|81233060|FG002|Overall Study|Adverse Event|0|||
27837409|NCT01583530|81233061|FG003|Overall Study|Adverse Event|0|||
27837410|NCT01583530|81233062|FG004|Overall Study|Adverse Event|0|||
27837411|NCT01583530|81233063|FG005|Overall Study|Adverse Event|1|||
27837412|NCT01583530|81233058|FG000|Overall Study|Withdrawal by Subject|0|||
27837413|NCT01583530|81233059|FG001|Overall Study|Withdrawal by Subject|3|||
27605176|NCT00708435|80395344|FG001|Overall Study|Withdrawal by Subject|7|||
27605177|NCT00708435|80395343|FG000|Overall Study|Adverse Event|1|||
27605178|NCT00708435|80395344|FG001|Overall Study|Adverse Event|0|||
27605179|NCT00708435|80395343|FG000|Overall Study|Protocol Violation|0|||
27605180|NCT00708435|80395344|FG001|Overall Study|Protocol Violation|1|||
27605181|NCT00708435|80395343|FG000|Overall Study|Intervention by primary care physician|1|||
27605182|NCT00708435|80395344|FG001|Overall Study|Intervention by primary care physician|0|||
27605183|NCT00708435|80395343|FG000|Overall Study|Refused hospitalization|1|||
27605184|NCT00708435|80395344|FG001|Overall Study|Refused hospitalization|0|||
27837414|NCT01583530|81233060|FG002|Overall Study|Withdrawal by Subject|0|||
27837415|NCT01583530|81233061|FG003|Overall Study|Withdrawal by Subject|1|||
27837416|NCT01583530|81233062|FG004|Overall Study|Withdrawal by Subject|1|||
27837417|NCT01583530|81233063|FG005|Overall Study|Withdrawal by Subject|2|||
27837418|NCT01583530|81233058|FG000|Overall Study|Lost to Follow-up|0|||
27837419|NCT01583530|81233059|FG001|Overall Study|Lost to Follow-up|0|||
27837420|NCT01583530|81233060|FG002|Overall Study|Lost to Follow-up|0|||
27837421|NCT01583530|81233061|FG003|Overall Study|Lost to Follow-up|0|||
27837422|NCT01583530|81233062|FG004|Overall Study|Lost to Follow-up|3|||
27837423|NCT01583530|81233063|FG005|Overall Study|Lost to Follow-up|0|||
27605185|NCT02093663|80395345|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
27605186|NCT02093663|80395346|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27837424|NCT01583530|81233058|FG000|Overall Study|Lack of compliance|0|||
27837425|NCT01583530|81233059|FG001|Overall Study|Lack of compliance|0|||
27837426|NCT01583530|81233060|FG002|Overall Study|Lack of compliance|0|||
27837427|NCT01583530|81233061|FG003|Overall Study|Lack of compliance|0|||
27889993|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
27889994|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
27605187|NCT02093663|80395347|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27605188|NCT02093663|80395348|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27837428|NCT01583530|81233062|FG004|Overall Study|Lack of compliance|1|||
27837429|NCT01583530|81233063|FG005|Overall Study|Lack of compliance|0|||
27837430|NCT00691704|81233064|FG000|Induction Therapy|Disease Progression|1|||
27837431|NCT00691704|81233064|FG000|Induction Therapy|Active Hepatitis|1|||
27837432|NCT00691704|81233064|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
27605189|NCT02093663|80395349|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
27605190|NCT02093663|80395345|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
27605191|NCT02093663|80395346|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605192|NCT02093663|80395347|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605193|NCT02093663|80395348|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605194|NCT02093663|80395349|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605195|NCT02093663|80395345|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
27605196|NCT02093663|80395346|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
27605197|NCT02093663|80395347|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
27605198|NCT02093663|80395348|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
27605199|NCT02093663|80395349|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
27605200|NCT02093663|80395345|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27605201|NCT02093663|80395346|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27605202|NCT02093663|80395347|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
27605203|NCT02093663|80395348|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27605204|NCT02093663|80395349|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
27605205|NCT02093663|80395345|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605206|NCT02093663|80395346|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605207|NCT02093663|80395347|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
27605208|NCT02093663|80395348|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27605209|NCT02093663|80395349|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
27837433|NCT00691704|81233064|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
27837434|NCT00691704|81233064|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
27837435|NCT01835548|81233065|FG000|Dose Optimization Period|Adverse Event|0|||
27837436|NCT01835548|81233066|FG001|Dose Optimization Period|Adverse Event|0|||
27605210|NCT02093663|80395345|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
27605211|NCT02093663|80395346|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
27605212|NCT02093663|80395347|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
27605213|NCT02093663|80395348|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
27605214|NCT02093663|80395349|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
27605215|NCT02093663|80395345|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
27605216|NCT02093663|80395346|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
27715578|NCT00401752|80792504|FG000|Overall Study|Physician Decision|1|||
27715579|NCT00401752|80792505|FG001|Overall Study|Physician Decision|1|||
27837437|NCT01835548|81233067|FG002|Dose Optimization Period|Adverse Event|1|||
27837438|NCT01835548|81233065|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
27837439|NCT01835548|81233066|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
27837440|NCT01835548|81233067|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
27715580|NCT01634555|80792506|FG000|Overall Study|Adverse Event|3|||
27837441|NCT01835548|81233065|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27837442|NCT01835548|81233066|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27837443|NCT01835548|81233067|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27837444|NCT01835548|81233065|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27837445|NCT01835548|81233066|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27837446|NCT01835548|81233067|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27889995|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
27889996|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
27889997|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
27889998|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
27889999|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
27890000|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
27890001|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
27890002|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
27890003|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
27890004|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
27890005|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
27837447|NCT02933060|81233068|FG000|Overall Study|Withdrawal by Subject|0|||
27605217|NCT02093663|80395347|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
27837448|NCT02933060|81233069|FG001|Overall Study|Withdrawal by Subject|1|||
27837449|NCT00697619|81233070|FG000|Overall Study|Lack of Efficacy|2|||
27837450|NCT00697619|81233071|FG001|Overall Study|Lack of Efficacy|2|||
27837451|NCT00697619|81233070|FG000|Overall Study|Adverse Event|4|||
27837452|NCT00697619|81233071|FG001|Overall Study|Adverse Event|6|||
27837453|NCT02616380|81233072|FG000|Overall Study|Lost to Follow-up|1|||
27837454|NCT02616380|81233072|FG000|Overall Study|Other|2|||
27837455|NCT01728116|81233073|FG000|Overall Study|Sponsor Terminated Study|106|||
27837456|NCT01728116|81233074|FG001|Overall Study|Sponsor Terminated Study|35|||
27837457|NCT01728116|81233073|FG000|Overall Study|Withdrawal by Subject|16|||
27837458|NCT01728116|81233074|FG001|Overall Study|Withdrawal by Subject|9|||
27837459|NCT01728116|81233073|FG000|Overall Study|Adverse Event|13|||
27837460|NCT01728116|81233074|FG001|Overall Study|Adverse Event|0|||
27837461|NCT01728116|81233073|FG000|Overall Study|Procedure/device failure|7|||
27837462|NCT01728116|81233074|FG001|Overall Study|Procedure/device failure|0|||
27837463|NCT01728116|81233073|FG000|Overall Study|Lost to Follow-up|9|||
27837464|NCT01728116|81233074|FG001|Overall Study|Lost to Follow-up|2|||
27837465|NCT01728116|81233073|FG000|Overall Study|Physician Decision|2|||
27837466|NCT01728116|81233074|FG001|Overall Study|Physician Decision|0|||
27837467|NCT01728116|81233073|FG000|Overall Study|Subject Non-Compliance|2|||
27605218|NCT02093663|80395348|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
27605219|NCT02093663|80395349|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
27715581|NCT01634555|80792506|FG000|Overall Study|Physician Decision|1|||
27605220|NCT02093663|80395345|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
27605221|NCT02093663|80395346|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
27605222|NCT02093663|80395347|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
27605223|NCT02093663|80395348|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
27605224|NCT02093663|80395349|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
27715582|NCT00326898|80792516|FG000|Overall Study|Disease progression|52|||
27715583|NCT00326898|80792517|FG001|Overall Study|Disease progression|54|||
27715584|NCT00326898|80792518|FG002|Overall Study|Disease progression|102|||
27715585|NCT00326898|80792516|FG000|Overall Study|Adverse Event|124|||
27715586|NCT00326898|80792517|FG001|Overall Study|Adverse Event|128|||
27715587|NCT00326898|80792518|FG002|Overall Study|Adverse Event|33|||
27715588|NCT00326898|80792516|FG000|Overall Study|Death|2|||
27715589|NCT00326898|80792517|FG001|Overall Study|Death|0|||
27715590|NCT00326898|80792518|FG002|Overall Study|Death|0|||
27715591|NCT00326898|80792516|FG000|Overall Study|Withdrawal by Subject|134|||
27715592|NCT00326898|80792517|FG001|Overall Study|Withdrawal by Subject|128|||
27715593|NCT00326898|80792518|FG002|Overall Study|Withdrawal by Subject|32|||
27715594|NCT00326898|80792516|FG000|Overall Study|Alternative therapy|1|||
27715595|NCT00326898|80792517|FG001|Overall Study|Alternative therapy|0|||
27715596|NCT00326898|80792518|FG002|Overall Study|Alternative therapy|0|||
27715597|NCT00326898|80792516|FG000|Overall Study|Other complicating disease|5|||
27715598|NCT00326898|80792517|FG001|Overall Study|Other complicating disease|5|||
27715599|NCT00326898|80792518|FG002|Overall Study|Other complicating disease|4|||
27715600|NCT00326898|80792516|FG000|Overall Study|Other/Missing/Unknown|33|||
27715601|NCT00326898|80792517|FG001|Overall Study|Other/Missing/Unknown|28|||
27715602|NCT00326898|80792518|FG002|Overall Study|Other/Missing/Unknown|32|||
27715603|NCT00980200|80792519|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
27715604|NCT00980200|80792520|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
27715605|NCT00980200|80792521|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
27715606|NCT00980200|80792522|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
27715607|NCT00980200|80792523|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
27715608|NCT00980200|80792519|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
27715609|NCT00980200|80792520|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
27715610|NCT00980200|80792521|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
27715611|NCT00980200|80792522|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
27715612|NCT00980200|80792523|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
27715613|NCT01395394|80792524|FG000|Baseline Study Visit|Protocol Violation|1|||
27715614|NCT01395394|80792525|FG001|Baseline Study Visit|Protocol Violation|0|||
27715615|NCT01395394|80792526|FG002|Baseline Study Visit|Protocol Violation|0|||
27715616|NCT02678390|80792527|FG000|AE (1 Day)|Withdrawal by Subject|0|||
27715617|NCT02678390|80792528|FG001|AE (1 Day)|Withdrawal by Subject|1|||
27715618|NCT00884273|80792529|FG000|Overall Study|Adverse Event|0|||
27715619|NCT00884273|80792530|FG001|Overall Study|Adverse Event|2|||
27715620|NCT00884273|80792529|FG000|Overall Study|Protocol Violation|1|||
27715621|NCT00884273|80792530|FG001|Overall Study|Protocol Violation|3|||
27715622|NCT00884273|80792529|FG000|Overall Study|Practical reasons|1|||
27715623|NCT00884273|80792530|FG001|Overall Study|Practical reasons|0|||
27715624|NCT00223496|80792533|FG000|Overall Study|screen failure|9|||
27715625|NCT00223496|80792533|FG000|Overall Study|Lost to Follow-up|4|||
27715626|NCT00223496|80792533|FG000|Overall Study|Lack of Efficacy|6|||
27715627|NCT00223496|80792533|FG000|Overall Study|Withdrawal by Subject|1|||
27715628|NCT00223496|80792533|FG000|Overall Study|Physician Decision|2|||
27715629|NCT00264238|80792534|FG000|Overall Study|Protocol Violation|1|||
27715630|NCT02699892|80792536|FG000|Overall Study|Other|36|||
27715631|NCT01895322|80792537|FG000|Overall Study|Adverse Event|1|||
27715632|NCT01895322|80792537|FG000|Overall Study|Withdrawal by Subject|2|||
27715633|NCT01895322|80792537|FG000|Overall Study|Protocol Violation|10|||
27715634|NCT02597946|80792538|FG000|Overall Study|Withdrawal by Subject|1|||
27715635|NCT02597946|80792538|FG000|Overall Study|Progressive disease|16|||
27715636|NCT02597946|80792538|FG000|Overall Study|Other than above|1|||
27715637|NCT00183274|80792539|FG000|Phase 1: Open-Label|Adverse Event|31|||
27715638|NCT00183274|80792540|FG001|Phase 1: Open-Label|Adverse Event|0|||
27715639|NCT00183274|80792541|FG002|Phase 1: Open-Label|Adverse Event|0|||
27715640|NCT00183274|80792542|FG003|Phase 1: Open-Label|Adverse Event|0|||
27715641|NCT00183274|80792543|FG004|Phase 1: Open-Label|Adverse Event|0|||
27715642|NCT00183274|80792544|FG005|Phase 1: Open-Label|Adverse Event|0|||
27715643|NCT00183274|80792539|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
27715644|NCT00183274|80792540|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
27715645|NCT00183274|80792541|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
27715646|NCT00183274|80792542|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
27715647|NCT00183274|80792543|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
27715648|NCT00183274|80792544|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
27715649|NCT00183274|80792539|FG000|Phase 1: Open-Label|Protocol Violation|11|||
27715650|NCT00183274|80792540|FG001|Phase 1: Open-Label|Protocol Violation|0|||
27715651|NCT00183274|80792541|FG002|Phase 1: Open-Label|Protocol Violation|0|||
27715652|NCT00183274|80792542|FG003|Phase 1: Open-Label|Protocol Violation|0|||
27715653|NCT00183274|80792543|FG004|Phase 1: Open-Label|Protocol Violation|0|||
27715654|NCT00183274|80792544|FG005|Phase 1: Open-Label|Protocol Violation|0|||
27715655|NCT00183274|80792539|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
27715656|NCT00183274|80792540|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
27715657|NCT00183274|80792541|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
27715658|NCT00183274|80792542|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
27715659|NCT00183274|80792543|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
27715660|NCT00183274|80792544|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
27715661|NCT00183274|80792539|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
27715662|NCT00183274|80792540|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
27715663|NCT00183274|80792541|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
27715664|NCT00183274|80792542|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
27715665|NCT00183274|80792543|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
27715666|NCT00183274|80792544|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
27715667|NCT00183274|80792539|FG000|Phase 1: Open-Label|Other|9|||
27715668|NCT00183274|80792540|FG001|Phase 1: Open-Label|Other|0|||
27715669|NCT00183274|80792541|FG002|Phase 1: Open-Label|Other|0|||
27715670|NCT00183274|80792542|FG003|Phase 1: Open-Label|Other|0|||
27715671|NCT00183274|80792543|FG004|Phase 1: Open-Label|Other|0|||
27715672|NCT00183274|80792544|FG005|Phase 1: Open-Label|Other|0|||
27715673|NCT00183274|80792539|FG000|Phase 2: Double-Blind|Relapsed|0|||
27837468|NCT01728116|81233074|FG001|Overall Study|Subject Non-Compliance|0|||
27715674|NCT00183274|80792540|FG001|Phase 2: Double-Blind|Relapsed|8|||
27715675|NCT00183274|80792541|FG002|Phase 2: Double-Blind|Relapsed|29|||
27715676|NCT00183274|80792542|FG003|Phase 2: Double-Blind|Relapsed|0|||
27715677|NCT00183274|80792543|FG004|Phase 2: Double-Blind|Relapsed|0|||
27715678|NCT00183274|80792544|FG005|Phase 2: Double-Blind|Relapsed|0|||
27715679|NCT00183274|80792539|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
27715680|NCT00183274|80792540|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
27715681|NCT00183274|80792541|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
27837469|NCT01728116|81233073|FG000|Overall Study|Inter-current finding at procedure|1|||
27715682|NCT00183274|80792542|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
27715683|NCT00183274|80792543|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
27715684|NCT00183274|80792544|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
27715685|NCT00183274|80792539|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
27715686|NCT00183274|80792540|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
27715687|NCT00183274|80792541|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
27715688|NCT00183274|80792542|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
27715689|NCT00183274|80792543|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
27715690|NCT00183274|80792544|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
27715691|NCT00183274|80792539|FG000|Phase 3: Double-Blind|Relapsed|0|||
27715692|NCT00183274|80792540|FG001|Phase 3: Double-Blind|Relapsed|0|||
27715693|NCT00183274|80792541|FG002|Phase 3: Double-Blind|Relapsed|0|||
27715694|NCT00183274|80792542|FG003|Phase 3: Double-Blind|Relapsed|1|||
27715695|NCT00183274|80792543|FG004|Phase 3: Double-Blind|Relapsed|11|||
27715696|NCT00183274|80792544|FG005|Phase 3: Double-Blind|Relapsed|2|||
27715697|NCT01437397|80792545|FG000|Overall Study|Lost to Follow-up|9|||
27715698|NCT01437397|80792546|FG001|Overall Study|Lost to Follow-up|4|||
27715699|NCT01437397|80792547|FG002|Overall Study|Lost to Follow-up|2|||
27715700|NCT01437397|80792548|FG003|Overall Study|Lost to Follow-up|4|||
27715701|NCT01437397|80792549|FG004|Overall Study|Lost to Follow-up|5|||
27715702|NCT01437397|80792545|FG000|Overall Study|Withdrawal by Subject|11|||
27715703|NCT01437397|80792546|FG001|Overall Study|Withdrawal by Subject|12|||
27715704|NCT01437397|80792547|FG002|Overall Study|Withdrawal by Subject|24|||
27715705|NCT01437397|80792548|FG003|Overall Study|Withdrawal by Subject|11|||
27715706|NCT01437397|80792549|FG004|Overall Study|Withdrawal by Subject|22|||
27715707|NCT01437397|80792545|FG000|Overall Study|Protocol Violation|10|||
27715708|NCT01437397|80792546|FG001|Overall Study|Protocol Violation|12|||
27715709|NCT01437397|80792547|FG002|Overall Study|Protocol Violation|13|||
27715710|NCT01437397|80792548|FG003|Overall Study|Protocol Violation|21|||
27715711|NCT01437397|80792549|FG004|Overall Study|Protocol Violation|19|||
27715712|NCT01437397|80792545|FG000|Overall Study|Lack of Efficacy|5|||
27715713|NCT01437397|80792546|FG001|Overall Study|Lack of Efficacy|4|||
27715714|NCT01437397|80792547|FG002|Overall Study|Lack of Efficacy|8|||
27715715|NCT01437397|80792548|FG003|Overall Study|Lack of Efficacy|10|||
27715716|NCT01437397|80792549|FG004|Overall Study|Lack of Efficacy|20|||
27715717|NCT01437397|80792545|FG000|Overall Study|Adverse Event|21|||
27715718|NCT01437397|80792546|FG001|Overall Study|Adverse Event|22|||
27715719|NCT01437397|80792547|FG002|Overall Study|Adverse Event|16|||
27715720|NCT01437397|80792548|FG003|Overall Study|Adverse Event|14|||
27715721|NCT01437397|80792549|FG004|Overall Study|Adverse Event|21|||
27715722|NCT01437397|80792545|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
27715723|NCT01437397|80792546|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
27715724|NCT01437397|80792547|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
27715725|NCT01437397|80792548|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
27715726|NCT01437397|80792549|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
27837470|NCT01728116|81233074|FG001|Overall Study|Inter-current finding at procedure|0|||
27837471|NCT01728116|81233073|FG000|Overall Study|Incorrectly enrolled in Study|0|||
27837472|NCT01728116|81233074|FG001|Overall Study|Incorrectly enrolled in Study|1|||
27837473|NCT01728116|81233073|FG000|Overall Study|various not noted previously|5|||
27837474|NCT01728116|81233074|FG001|Overall Study|various not noted previously|0|||
27715727|NCT02182687|80792555|FG000|Overall Study|Withdrawal by Subject|4|||
27715728|NCT02182687|80792556|FG001|Overall Study|Withdrawal by Subject|0|||
27715729|NCT02182687|80792555|FG000|Overall Study|Adverse Event|1|||
27715730|NCT02182687|80792556|FG001|Overall Study|Adverse Event|0|||
27715731|NCT02182687|80792555|FG000|Overall Study|Lost to Follow-up|0|||
27715732|NCT02182687|80792556|FG001|Overall Study|Lost to Follow-up|1|||
27715733|NCT03110900|80792561|FG000|Overall Study|Sponsor withdrew|1|||
27715734|NCT03110900|80792562|FG001|Overall Study|Sponsor withdrew|1|||
27715735|NCT00820898|80792563|FG000|Overall Study|Inelgible - wrong primary site|1|||
27837475|NCT00743145|81233075|FG000|Overall Study|Withdrawal by Subject|1|||
27715736|NCT04766021|80792566|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
27715737|NCT04766021|80792566|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
27715738|NCT02821715|80792567|FG000|Overall Study|Protocol Violation|1|||
27715739|NCT02821715|80792568|FG001|Overall Study|Protocol Violation|0|||
27715740|NCT02821715|80792569|FG002|Overall Study|Protocol Violation|0|||
27715741|NCT02821715|80792570|FG003|Overall Study|Protocol Violation|0|||
27715742|NCT02821715|80792571|FG004|Overall Study|Protocol Violation|0|||
27715743|NCT02821715|80792572|FG005|Overall Study|Protocol Violation|0|||
27715744|NCT00109707|80792573|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
27715745|NCT00109707|80792574|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
27715746|NCT00109707|80792575|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
27715747|NCT00109707|80792573|FG000|Overall Study|Abnormal laboratory values|1|||
27715748|NCT00109707|80792574|FG001|Overall Study|Abnormal laboratory values|0|||
27605225|NCT02093663|80395345|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27715749|NCT00109707|80792575|FG002|Overall Study|Abnormal laboratory values|0|||
27715750|NCT00109707|80792573|FG000|Overall Study|Administrative problems|2|||
27715751|NCT00109707|80792574|FG001|Overall Study|Administrative problems|0|||
27715752|NCT00109707|80792575|FG002|Overall Study|Administrative problems|1|||
27837476|NCT00743145|81233075|FG000|Overall Study|Adverse Event|2|||
27837477|NCT00743145|81233075|FG000|Overall Study|Pregnancy|1|||
27837478|NCT02034513|81233076|FG000|Overall Study|Adverse Event|11|||
27605226|NCT02093663|80395346|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27837479|NCT02034513|81233077|FG001|Overall Study|Adverse Event|10|||
27715753|NCT00109707|80792573|FG000|Overall Study|Adverse Event|10|||
27715754|NCT00109707|80792574|FG001|Overall Study|Adverse Event|2|||
27715755|NCT00109707|80792575|FG002|Overall Study|Adverse Event|3|||
27715756|NCT00109707|80792573|FG000|Overall Study|Death|4|||
27715757|NCT00109707|80792574|FG001|Overall Study|Death|0|||
27715758|NCT00109707|80792575|FG002|Overall Study|Death|0|||
27715759|NCT00109707|80792573|FG000|Overall Study|Disease progression|12|||
27715760|NCT00109707|80792574|FG001|Overall Study|Disease progression|4|||
27715761|NCT00109707|80792575|FG002|Overall Study|Disease progression|3|||
27715762|NCT00109707|80792573|FG000|Overall Study|Lost to Follow-up|3|||
27715763|NCT00109707|80792574|FG001|Overall Study|Lost to Follow-up|0|||
27715764|NCT00109707|80792575|FG002|Overall Study|Lost to Follow-up|0|||
27715765|NCT00109707|80792573|FG000|Overall Study|Protocol Violation|1|||
27715766|NCT00109707|80792574|FG001|Overall Study|Protocol Violation|0|||
27715767|NCT00109707|80792575|FG002|Overall Study|Protocol Violation|0|||
27715768|NCT00109707|80792573|FG000|Overall Study|Patient withdrew consent|6|||
27715769|NCT00109707|80792574|FG001|Overall Study|Patient withdrew consent|1|||
27837480|NCT02034513|81233076|FG000|Overall Study|Lack of Efficacy|0|||
27837481|NCT02034513|81233077|FG001|Overall Study|Lack of Efficacy|1|||
27837482|NCT02034513|81233076|FG000|Overall Study|Lost to Follow-up|6|||
27837483|NCT02034513|81233077|FG001|Overall Study|Lost to Follow-up|7|||
27837484|NCT02034513|81233076|FG000|Overall Study|Pregnancy|0|||
27837485|NCT02034513|81233077|FG001|Overall Study|Pregnancy|3|||
27715770|NCT00109707|80792575|FG002|Overall Study|Patient withdrew consent|0|||
27715771|NCT00513500|80792576|FG000|Overall Study|Lost to Follow-up|35|||
27837486|NCT02034513|81233076|FG000|Overall Study|Protocol Violation|7|||
27837487|NCT02034513|81233077|FG001|Overall Study|Protocol Violation|10|||
27605227|NCT02093663|80395347|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27837488|NCT02034513|81233076|FG000|Overall Study|Withdrawal by Subject|25|||
27837489|NCT02034513|81233077|FG001|Overall Study|Withdrawal by Subject|25|||
27890006|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
27890007|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
27715772|NCT00513500|80792577|FG001|Overall Study|Lost to Follow-up|39|||
27715773|NCT00513500|80792576|FG000|Overall Study|Death|2|||
27715774|NCT00513500|80792577|FG001|Overall Study|Death|1|||
27715775|NCT00513500|80792576|FG000|Overall Study|Hospitalized|4|||
27837490|NCT02034513|81233076|FG000|Overall Study|Unclassified|0|||
27837491|NCT02034513|81233077|FG001|Overall Study|Unclassified|1|||
27837492|NCT01911429|81233081|FG000|Overall Study|Adverse Event|5|||
27715776|NCT00513500|80792577|FG001|Overall Study|Hospitalized|14|||
27837493|NCT01911429|81233082|FG001|Overall Study|Adverse Event|3|||
27837494|NCT01911429|81233083|FG002|Overall Study|Adverse Event|9|||
27837495|NCT01911429|81233081|FG000|Overall Study|Lack of Efficacy|1|||
27837496|NCT01911429|81233082|FG001|Overall Study|Lack of Efficacy|2|||
27837497|NCT01911429|81233083|FG002|Overall Study|Lack of Efficacy|4|||
27837498|NCT01911429|81233081|FG000|Overall Study|Lost to Follow-up|0|||
27837499|NCT01911429|81233082|FG001|Overall Study|Lost to Follow-up|0|||
27837500|NCT01911429|81233083|FG002|Overall Study|Lost to Follow-up|1|||
27837501|NCT01911429|81233081|FG000|Overall Study|Protocol Violation|0|||
27837502|NCT01911429|81233082|FG001|Overall Study|Protocol Violation|0|||
27837503|NCT01911429|81233083|FG002|Overall Study|Protocol Violation|1|||
27837504|NCT01911429|81233081|FG000|Overall Study|Withdrawal by Subject|5|||
27837505|NCT01911429|81233082|FG001|Overall Study|Withdrawal by Subject|5|||
27837506|NCT01911429|81233083|FG002|Overall Study|Withdrawal by Subject|4|||
27837507|NCT01911429|81233081|FG000|Overall Study|Accidental randomization|0|||
27837508|NCT01911429|81233082|FG001|Overall Study|Accidental randomization|0|||
27837509|NCT01911429|81233083|FG002|Overall Study|Accidental randomization|1|||
27837510|NCT01911429|81233081|FG000|Overall Study|subject left study|1|||
27837511|NCT01911429|81233082|FG001|Overall Study|subject left study|0|||
27837512|NCT01911429|81233083|FG002|Overall Study|subject left study|0|||
27837513|NCT01050764|81233084|FG000|Overall Study|Death, before HSCT|1|||
27837514|NCT01050764|81233084|FG000|Overall Study|Donor mobilization failure, death|1|||
27837515|NCT01050764|81233084|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
27837516|NCT02212457|81233085|FG000|Overall Study|Adverse Event|1|||
27837517|NCT02212457|81233086|FG001|Overall Study|Adverse Event|2|||
27837518|NCT02212457|81233087|FG002|Overall Study|Adverse Event|2|||
27837519|NCT02212457|81233088|FG003|Overall Study|Adverse Event|2|||
27605228|NCT02093663|80395348|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
27605229|NCT02093663|80395349|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
27605230|NCT01672853|80395350|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
27605231|NCT01672853|80395351|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
27605232|NCT01672853|80395352|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
27605233|NCT01672853|80395350|FG000|Overall Study|Pregnancy|0|||
27605234|NCT01672853|80395351|FG001|Overall Study|Pregnancy|1|||
27605235|NCT01672853|80395352|FG002|Overall Study|Pregnancy|0|||
27605236|NCT01672853|80395350|FG000|Overall Study|Investigator's Discretion|1|||
27605237|NCT01672853|80395351|FG001|Overall Study|Investigator's Discretion|0|||
27605238|NCT01672853|80395352|FG002|Overall Study|Investigator's Discretion|0|||
27605239|NCT01672853|80395350|FG000|Overall Study|Withdrew Consent|5|||
27605240|NCT01672853|80395351|FG001|Overall Study|Withdrew Consent|5|||
27605241|NCT01672853|80395352|FG002|Overall Study|Withdrew Consent|5|||
27605242|NCT01672853|80395350|FG000|Overall Study|Adverse Event|4|||
27605243|NCT01672853|80395351|FG001|Overall Study|Adverse Event|6|||
27605244|NCT01672853|80395352|FG002|Overall Study|Adverse Event|8|||
27605245|NCT01672853|80395350|FG000|Overall Study|Lost to Follow-up|0|||
27605246|NCT01672853|80395351|FG001|Overall Study|Lost to Follow-up|1|||
27605247|NCT01672853|80395352|FG002|Overall Study|Lost to Follow-up|0|||
27605248|NCT01672853|80395350|FG000|Overall Study|Randomized but Never Treated|0|||
27605249|NCT01672853|80395351|FG001|Overall Study|Randomized but Never Treated|0|||
27715777|NCT00720109|80792578|FG000|Induction Period|Did not meet eligibility criteria|3|||
27715778|NCT00720109|80792579|FG001|Induction Period|Did not meet eligibility criteria|0|||
27715779|NCT00720109|80792580|FG002|Induction Period|Did not meet eligibility criteria|0|||
27715780|NCT00720109|80792578|FG000|Induction Period|Bone Marrow Transplant|2|||
27715781|NCT00720109|80792579|FG001|Induction Period|Bone Marrow Transplant|0|||
27837520|NCT02212457|81233089|FG004|Overall Study|Adverse Event|0|||
27837521|NCT02212457|81233090|FG005|Overall Study|Adverse Event|1|||
27837522|NCT02212457|81233085|FG000|Overall Study|Withdrawal by Subject|8|||
27837523|NCT02212457|81233086|FG001|Overall Study|Withdrawal by Subject|10|||
27837524|NCT02212457|81233087|FG002|Overall Study|Withdrawal by Subject|8|||
27605250|NCT01672853|80395352|FG002|Overall Study|Randomized but Never Treated|1|||
27837525|NCT02212457|81233088|FG003|Overall Study|Withdrawal by Subject|6|||
27837526|NCT02212457|81233089|FG004|Overall Study|Withdrawal by Subject|5|||
27605251|NCT03573908|80395353|FG000|Treatment Period|Adverse Event|4|||
27715782|NCT00720109|80792580|FG002|Induction Period|Bone Marrow Transplant|0|||
27837527|NCT02212457|81233090|FG005|Overall Study|Withdrawal by Subject|4|||
27715783|NCT00720109|80792578|FG000|Induction Period|Physician Decision|1|||
27605252|NCT03573908|80395354|FG001|Treatment Period|Adverse Event|9|||
27605253|NCT03573908|80395355|FG002|Treatment Period|Adverse Event|0|||
27605254|NCT03573908|80395356|FG003|Treatment Period|Adverse Event|0|||
27715784|NCT00720109|80792579|FG001|Induction Period|Physician Decision|0|||
27715785|NCT00720109|80792580|FG002|Induction Period|Physician Decision|0|||
27715786|NCT00720109|80792578|FG000|Risk Stratification Period|Adverse Event|0|||
27715787|NCT00720109|80792579|FG001|Risk Stratification Period|Adverse Event|1|||
27715788|NCT00720109|80792580|FG002|Risk Stratification Period|Adverse Event|0|||
27715789|NCT00720109|80792578|FG000|Risk Stratification Period|Physician Decision|0|||
27715790|NCT00720109|80792579|FG001|Risk Stratification Period|Physician Decision|2|||
27715791|NCT00720109|80792580|FG002|Risk Stratification Period|Physician Decision|1|||
27715792|NCT00720109|80792578|FG000|Risk Stratification Period|Bone marrow transplant|0|||
27715793|NCT00720109|80792579|FG001|Risk Stratification Period|Bone marrow transplant|9|||
27715794|NCT00720109|80792580|FG002|Risk Stratification Period|Bone marrow transplant|7|||
27715795|NCT00720109|80792578|FG000|Risk Stratification Period|Disease progression or relapse|0|||
27715796|NCT00720109|80792579|FG001|Risk Stratification Period|Disease progression or relapse|2|||
27715797|NCT00720109|80792580|FG002|Risk Stratification Period|Disease progression or relapse|0|||
27715798|NCT00720109|80792578|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
27715799|NCT00720109|80792579|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
27715800|NCT00720109|80792580|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
27715801|NCT01314716|80792581|FG000|Double-Blind Phase|Randomized but not treated|1|||
27715802|NCT01314716|80792582|FG001|Double-Blind Phase|Randomized but not treated|1|||
27715803|NCT01314716|80792581|FG000|Double-Blind Phase|Adverse Event|10|||
27715804|NCT01314716|80792582|FG001|Double-Blind Phase|Adverse Event|4|||
27715805|NCT01314716|80792581|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
27715806|NCT01314716|80792582|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
27715807|NCT01314716|80792581|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27715808|NCT01314716|80792582|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27715809|NCT01314716|80792581|FG000|Double-Blind Phase|Sponsor request|1|||
27715810|NCT01314716|80792582|FG001|Double-Blind Phase|Sponsor request|2|||
27715811|NCT01314716|80792581|FG000|Double-Blind Phase|Physician Decision|0|||
27715812|NCT01314716|80792582|FG001|Double-Blind Phase|Physician Decision|1|||
27715813|NCT01314716|80792581|FG000|Open-Label Phase|Adverse Event|4|||
27715814|NCT01314716|80792582|FG001|Open-Label Phase|Adverse Event|6|||
27715815|NCT01314716|80792581|FG000|Open-Label Phase|Withdrawal by Subject|1|||
27715816|NCT01314716|80792582|FG001|Open-Label Phase|Withdrawal by Subject|2|||
27715817|NCT01314716|80792581|FG000|Open-Label Phase|Physician Decision|5|||
27715818|NCT01314716|80792582|FG001|Open-Label Phase|Physician Decision|4|||
27715819|NCT01452152|80792583|FG000|Overall Study|Study termination by sponsor|5|||
27715820|NCT01452152|80792584|FG001|Overall Study|Study termination by sponsor|0|||
27715821|NCT01452152|80792585|FG002|Overall Study|Study termination by sponsor|4|||
27715822|NCT00091832|80792587|FG000|Overall Study|Physician Decision|1|||
27715823|NCT00091832|80792588|FG001|Overall Study|Physician Decision|0|||
27715824|NCT00091832|80792589|FG002|Overall Study|Physician Decision|0|||
27715825|NCT00091832|80792590|FG003|Overall Study|Physician Decision|0|||
27715826|NCT00091832|80792591|FG004|Overall Study|Physician Decision|0|||
27715827|NCT00091832|80792592|FG005|Overall Study|Physician Decision|0|||
27715828|NCT00091832|80792587|FG000|Overall Study|Adverse Event|0|||
27715829|NCT00091832|80792588|FG001|Overall Study|Adverse Event|0|||
27715830|NCT00091832|80792589|FG002|Overall Study|Adverse Event|0|||
27715831|NCT00091832|80792590|FG003|Overall Study|Adverse Event|1|||
27715832|NCT00091832|80792591|FG004|Overall Study|Adverse Event|3|||
27715833|NCT00091832|80792592|FG005|Overall Study|Adverse Event|0|||
27715834|NCT00091832|80792587|FG000|Overall Study|Withdrawal by Subject|4|||
27715835|NCT00091832|80792588|FG001|Overall Study|Withdrawal by Subject|5|||
27715836|NCT00091832|80792589|FG002|Overall Study|Withdrawal by Subject|0|||
27715837|NCT00091832|80792590|FG003|Overall Study|Withdrawal by Subject|1|||
27715838|NCT00091832|80792591|FG004|Overall Study|Withdrawal by Subject|3|||
27715839|NCT00091832|80792592|FG005|Overall Study|Withdrawal by Subject|1|||
27715840|NCT00091832|80792587|FG000|Overall Study|Death|6|||
27715841|NCT00091832|80792588|FG001|Overall Study|Death|4|||
27715842|NCT00091832|80792589|FG002|Overall Study|Death|5|||
27715843|NCT00091832|80792590|FG003|Overall Study|Death|8|||
27715844|NCT00091832|80792591|FG004|Overall Study|Death|5|||
27715845|NCT00091832|80792592|FG005|Overall Study|Death|6|||
27715846|NCT00091832|80792587|FG000|Overall Study|Disease Progression|2|||
27715847|NCT00091832|80792588|FG001|Overall Study|Disease Progression|0|||
27715848|NCT00091832|80792589|FG002|Overall Study|Disease Progression|0|||
27837528|NCT02212457|81233085|FG000|Overall Study|Lost to Follow-up|6|||
27715849|NCT00091832|80792590|FG003|Overall Study|Disease Progression|1|||
27715850|NCT00091832|80792591|FG004|Overall Study|Disease Progression|1|||
27715851|NCT00091832|80792592|FG005|Overall Study|Disease Progression|2|||
27715852|NCT00091832|80792587|FG000|Overall Study|Ineligibility Determined|0|||
27715853|NCT00091832|80792588|FG001|Overall Study|Ineligibility Determined|0|||
27715854|NCT00091832|80792589|FG002|Overall Study|Ineligibility Determined|1|||
27715855|NCT00091832|80792590|FG003|Overall Study|Ineligibility Determined|0|||
27715856|NCT00091832|80792591|FG004|Overall Study|Ineligibility Determined|1|||
27715857|NCT00091832|80792592|FG005|Overall Study|Ineligibility Determined|0|||
27715858|NCT00091832|80792587|FG000|Overall Study|Lost to Follow-up|1|||
27715859|NCT00091832|80792588|FG001|Overall Study|Lost to Follow-up|0|||
27715860|NCT00091832|80792589|FG002|Overall Study|Lost to Follow-up|3|||
27715861|NCT00091832|80792590|FG003|Overall Study|Lost to Follow-up|3|||
27715862|NCT00091832|80792591|FG004|Overall Study|Lost to Follow-up|2|||
27715863|NCT00091832|80792592|FG005|Overall Study|Lost to Follow-up|1|||
27715864|NCT00091832|80792587|FG000|Overall Study|Noncompliance|0|||
27715865|NCT00091832|80792588|FG001|Overall Study|Noncompliance|1|||
27715866|NCT00091832|80792589|FG002|Overall Study|Noncompliance|0|||
27715867|NCT00091832|80792590|FG003|Overall Study|Noncompliance|0|||
27715868|NCT00091832|80792591|FG004|Overall Study|Noncompliance|0|||
27715869|NCT00091832|80792592|FG005|Overall Study|Noncompliance|0|||
27715870|NCT00091832|80792587|FG000|Overall Study|Other|0|||
27715871|NCT00091832|80792588|FG001|Overall Study|Other|1|||
27715872|NCT00091832|80792589|FG002|Overall Study|Other|2|||
27715873|NCT00091832|80792590|FG003|Overall Study|Other|0|||
27715874|NCT00091832|80792591|FG004|Overall Study|Other|0|||
27715875|NCT00091832|80792592|FG005|Overall Study|Other|0|||
27715876|NCT00091832|80792587|FG000|Overall Study|Protocol Violation|0|||
27715877|NCT00091832|80792588|FG001|Overall Study|Protocol Violation|0|||
27715878|NCT00091832|80792589|FG002|Overall Study|Protocol Violation|1|||
27715879|NCT00091832|80792590|FG003|Overall Study|Protocol Violation|0|||
27715880|NCT00091832|80792591|FG004|Overall Study|Protocol Violation|0|||
27715881|NCT00091832|80792592|FG005|Overall Study|Protocol Violation|1|||
27715882|NCT02573155|80792594|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
27605255|NCT03573908|80395357|FG004|Treatment Period|Adverse Event|0|||
27605256|NCT03573908|80395353|FG000|Treatment Period|Protocol Violation|1|||
27605257|NCT03573908|80395354|FG001|Treatment Period|Protocol Violation|0|||
27605258|NCT03573908|80395355|FG002|Treatment Period|Protocol Violation|0|||
27605259|NCT03573908|80395356|FG003|Treatment Period|Protocol Violation|0|||
27605260|NCT03573908|80395357|FG004|Treatment Period|Protocol Violation|0|||
27605261|NCT03573908|80395353|FG000|Treatment Period|Withdrawal by Subject|7|||
27605262|NCT03573908|80395354|FG001|Treatment Period|Withdrawal by Subject|5|||
27605263|NCT03573908|80395355|FG002|Treatment Period|Withdrawal by Subject|0|||
27605264|NCT03573908|80395356|FG003|Treatment Period|Withdrawal by Subject|0|||
27605265|NCT03573908|80395357|FG004|Treatment Period|Withdrawal by Subject|0|||
27605266|NCT03573908|80395353|FG000|Treatment Period|Lost to Follow-up|7|||
27605267|NCT03573908|80395354|FG001|Treatment Period|Lost to Follow-up|6|||
27605268|NCT03573908|80395355|FG002|Treatment Period|Lost to Follow-up|0|||
27605269|NCT03573908|80395356|FG003|Treatment Period|Lost to Follow-up|0|||
27605270|NCT03573908|80395357|FG004|Treatment Period|Lost to Follow-up|0|||
27605271|NCT03573908|80395353|FG000|Treatment Period|Pregnancy|1|||
27605272|NCT03573908|80395354|FG001|Treatment Period|Pregnancy|0|||
27605273|NCT03573908|80395355|FG002|Treatment Period|Pregnancy|0|||
27605274|NCT03573908|80395356|FG003|Treatment Period|Pregnancy|0|||
27605275|NCT03573908|80395357|FG004|Treatment Period|Pregnancy|0|||
27605276|NCT03573908|80395353|FG000|Treatment Period|Other, Not Specified|4|||
27605277|NCT03573908|80395354|FG001|Treatment Period|Other, Not Specified|6|||
27605278|NCT03573908|80395355|FG002|Treatment Period|Other, Not Specified|0|||
27605279|NCT03573908|80395356|FG003|Treatment Period|Other, Not Specified|0|||
27605280|NCT03573908|80395357|FG004|Treatment Period|Other, Not Specified|0|||
27605281|NCT03573908|80395353|FG000|Randomized Withdrawal Period|Adverse Event|0|||
27605282|NCT03573908|80395354|FG001|Randomized Withdrawal Period|Adverse Event|0|||
27605283|NCT03573908|80395355|FG002|Randomized Withdrawal Period|Adverse Event|3|||
27605284|NCT03573908|80395356|FG003|Randomized Withdrawal Period|Adverse Event|0|||
27605285|NCT03573908|80395357|FG004|Randomized Withdrawal Period|Adverse Event|0|||
27605286|NCT03573908|80395353|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27605287|NCT03573908|80395354|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27715883|NCT02573155|80792595|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
27715884|NCT02573155|80792594|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
27715885|NCT02573155|80792595|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
27605288|NCT03573908|80395355|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27605289|NCT03573908|80395356|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
27605290|NCT03573908|80395357|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
27605291|NCT03573908|80395353|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
27605292|NCT03573908|80395354|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
27605293|NCT03573908|80395355|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
27715886|NCT02573155|80792594|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
27715887|NCT02573155|80792595|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
27715888|NCT02573155|80792594|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
27715889|NCT02573155|80792595|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
27605294|NCT03573908|80395356|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
27605295|NCT03573908|80395357|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
27605296|NCT03573908|80395353|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
27605297|NCT03573908|80395354|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
27605298|NCT03573908|80395355|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
27605299|NCT03573908|80395356|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
27605300|NCT03573908|80395357|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
27605301|NCT02207725|80395358|FG000|Overall Study|Did Not Receive Treatment|0|||
27605302|NCT02207725|80395359|FG001|Overall Study|Did Not Receive Treatment|1|||
27605303|NCT02207725|80395360|FG002|Overall Study|Did Not Receive Treatment|1|||
27605304|NCT02207725|80395361|FG003|Overall Study|Did Not Receive Treatment|1|||
27605305|NCT02313909|80395362|FG000|Overall Study|Consent withdrawn by participant|33|||
27605306|NCT02313909|80395363|FG001|Overall Study|Consent withdrawn by participant|33|||
27605307|NCT02313909|80395362|FG000|Overall Study|Lost to Follow-up|24|||
27837529|NCT02212457|81233086|FG001|Overall Study|Lost to Follow-up|7|||
27837530|NCT02212457|81233087|FG002|Overall Study|Lost to Follow-up|4|||
27837531|NCT02212457|81233088|FG003|Overall Study|Lost to Follow-up|1|||
27837532|NCT02212457|81233089|FG004|Overall Study|Lost to Follow-up|8|||
27605308|NCT02313909|80395363|FG001|Overall Study|Lost to Follow-up|17|||
27605309|NCT03237858|80395378|FG000|Overall Study|Death|19|||
27605310|NCT03237858|80395378|FG000|Overall Study|Withdrawal by Subject|37|||
27605311|NCT00459342|80395379|FG000|Overall Study|Not eligible|1|||
27605312|NCT01396317|80395380|FG000|Overall Study|Adverse Event|1|||
27605313|NCT01396317|80395381|FG001|Overall Study|Adverse Event|0|||
27605314|NCT03541044|80395382|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
27605315|NCT03541044|80395383|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
27605316|NCT03541044|80395382|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
27605317|NCT03541044|80395383|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
27605318|NCT02002884|80395384|FG000|Main Period (MP)|Other|0|||
27605319|NCT02002884|80395385|FG001|Main Period (MP)|Other|3|||
27605320|NCT02002884|80395386|FG002|Main Period (MP)|Other|3|||
27605321|NCT02002884|80395387|FG003|Main Period (MP)|Other|0|||
27605322|NCT02002884|80395384|FG000|Main Period (MP)|Adverse Event|0|||
27605323|NCT02002884|80395385|FG001|Main Period (MP)|Adverse Event|1|||
27605324|NCT02002884|80395386|FG002|Main Period (MP)|Adverse Event|1|||
27605325|NCT02002884|80395387|FG003|Main Period (MP)|Adverse Event|0|||
27605326|NCT02002884|80395384|FG000|Main Period (MP)|Withdrawal by Subject|6|||
27605327|NCT02002884|80395385|FG001|Main Period (MP)|Withdrawal by Subject|2|||
27605328|NCT02002884|80395386|FG002|Main Period (MP)|Withdrawal by Subject|2|||
27605329|NCT02002884|80395387|FG003|Main Period (MP)|Withdrawal by Subject|0|||
27605330|NCT02002884|80395384|FG000|Main Period (MP)|Lost to Follow-up|0|||
27605331|NCT02002884|80395385|FG001|Main Period (MP)|Lost to Follow-up|0|||
27605332|NCT02002884|80395386|FG002|Main Period (MP)|Lost to Follow-up|2|||
27605333|NCT02002884|80395387|FG003|Main Period (MP)|Lost to Follow-up|0|||
27605334|NCT02002884|80395384|FG000|Open-Label Extension Period (OLEX)|Other|0|||
27605335|NCT02002884|80395385|FG001|Open-Label Extension Period (OLEX)|Other|0|||
27605336|NCT02002884|80395386|FG002|Open-Label Extension Period (OLEX)|Other|0|||
27605337|NCT02002884|80395387|FG003|Open-Label Extension Period (OLEX)|Other|24|||
27605338|NCT02002884|80395384|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
27605339|NCT02002884|80395385|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
27605340|NCT02002884|80395386|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
27605341|NCT02002884|80395387|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
27605342|NCT02002884|80395384|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
27605343|NCT02002884|80395385|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
27837533|NCT02212457|81233090|FG005|Overall Study|Lost to Follow-up|4|||
27605344|NCT02002884|80395386|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
27605345|NCT02002884|80395387|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
27605346|NCT02002884|80395384|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
27605347|NCT02002884|80395385|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
27605348|NCT02002884|80395386|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
27605349|NCT02002884|80395387|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
27605350|NCT02002884|80395384|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
27605351|NCT02002884|80395385|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
27837534|NCT02212457|81233085|FG000|Overall Study|Protocol Violation|2|||
27837535|NCT02212457|81233086|FG001|Overall Study|Protocol Violation|1|||
27837536|NCT02212457|81233087|FG002|Overall Study|Protocol Violation|0|||
27837537|NCT02212457|81233088|FG003|Overall Study|Protocol Violation|1|||
27837538|NCT02212457|81233089|FG004|Overall Study|Protocol Violation|2|||
27837539|NCT02212457|81233090|FG005|Overall Study|Protocol Violation|3|||
27837540|NCT02212457|81233085|FG000|Overall Study|Other|2|||
27837541|NCT02212457|81233086|FG001|Overall Study|Other|1|||
27837542|NCT02212457|81233087|FG002|Overall Study|Other|2|||
27837543|NCT02212457|81233088|FG003|Overall Study|Other|1|||
27837544|NCT02212457|81233089|FG004|Overall Study|Other|0|||
27837545|NCT02212457|81233090|FG005|Overall Study|Other|1|||
27837546|NCT04404725|81233093|FG000|First Intervention|Withdrawal by Subject|0|||
27837547|NCT04404725|81233094|FG001|First Intervention|Withdrawal by Subject|2|||
27837548|NCT04404725|81233093|FG000|Second Intervention|Adverse Event|1|||
27837549|NCT04404725|81233094|FG001|Second Intervention|Adverse Event|1|||
27837550|NCT04404725|81233093|FG000|Second Intervention|Withdrawal by Subject|0|||
27715890|NCT02573155|80792594|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
27715891|NCT02573155|80792595|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
27890008|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
27837551|NCT04404725|81233094|FG001|Second Intervention|Withdrawal by Subject|1|||
27837552|NCT02308241|81233095|FG000|Overall Study|Withdrawal by Subject|3|||
27605352|NCT02002884|80395386|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
27605353|NCT02002884|80395387|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
27605354|NCT00622180|80395388|FG000|Overall Study|Lost to Follow-up|1|||
27605355|NCT00622180|80395389|FG001|Overall Study|Lost to Follow-up|2|||
27605356|NCT03188120|80395390|FG000|Overall Study|Adverse Event|4|||
27605357|NCT03188120|80395390|FG000|Overall Study|Insufficient Effectiveness|8|||
27605358|NCT03188120|80395390|FG000|Overall Study|Improved|12|||
27605359|NCT03188120|80395390|FG000|Overall Study|Lost to Follow-up|7|||
27605360|NCT03188120|80395390|FG000|Overall Study|Other than specified|3|||
27605361|NCT03188120|80395390|FG000|Overall Study|No visit after the first visit|13|||
27605362|NCT01780935|80395391|FG000|Overall Study|Admin problems due to early termination|321|||
27605363|NCT01780935|80395392|FG001|Overall Study|Admin problems due to early termination|309|||
27605364|NCT01780935|80395391|FG000|Overall Study|Adverse Event|2|||
27605365|NCT01780935|80395392|FG001|Overall Study|Adverse Event|4|||
27890009|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
27890010|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
27890011|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
27890012|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
27958532|NCT01791517|81680064|FG006|Phase I: Period 2|Lost to Follow-up|0|||
27958533|NCT01791517|81680065|FG007|Phase I: Period 2|Lost to Follow-up|0|||
27958534|NCT01791517|81680066|FG008|Phase I: Period 2|Lost to Follow-up|0|||
27837553|NCT02583048|81233096|FG000|Overall Study|Withdrawal by Subject|0|||
27837554|NCT02583048|81233097|FG001|Overall Study|Withdrawal by Subject|1|||
27837555|NCT02583048|81233098|FG002|Overall Study|Withdrawal by Subject|0|||
27837556|NCT02583048|81233096|FG000|Overall Study|Failed to meet eligibility criterion|0|||
27837557|NCT02583048|81233097|FG001|Overall Study|Failed to meet eligibility criterion|0|||
27837558|NCT02583048|81233098|FG002|Overall Study|Failed to meet eligibility criterion|1|||
27837559|NCT03493919|81233101|FG000|Overall Study|Other|2|||
27837560|NCT03493919|81233102|FG001|Overall Study|Other|0|||
27837561|NCT03493919|81233103|FG002|Overall Study|Other|1|||
27837562|NCT03493919|81233104|FG003|Overall Study|Other|0|||
27837563|NCT03493919|81233101|FG000|Overall Study|Withdrawal by Subject|9|||
27837564|NCT03493919|81233102|FG001|Overall Study|Withdrawal by Subject|3|||
27837565|NCT03493919|81233103|FG002|Overall Study|Withdrawal by Subject|1|||
27837566|NCT03493919|81233104|FG003|Overall Study|Withdrawal by Subject|1|||
27837567|NCT03493919|81233101|FG000|Overall Study|Lost to Follow-up|5|||
27837568|NCT03493919|81233102|FG001|Overall Study|Lost to Follow-up|0|||
27837569|NCT03493919|81233103|FG002|Overall Study|Lost to Follow-up|0|||
27837570|NCT03493919|81233104|FG003|Overall Study|Lost to Follow-up|3|||
27837571|NCT03493919|81233101|FG000|Overall Study|Adverse Event|0|||
27837572|NCT03493919|81233102|FG001|Overall Study|Adverse Event|1|||
27837573|NCT03493919|81233103|FG002|Overall Study|Adverse Event|0|||
27837574|NCT03493919|81233104|FG003|Overall Study|Adverse Event|0|||
27837575|NCT01507662|81233106|FG000|Overall Study|Death|26|||
27837576|NCT01507662|81233107|FG001|Overall Study|Death|18|||
27837577|NCT01507662|81233106|FG000|Overall Study|Withdrawal by Subject|290|||
27837578|NCT01507662|81233107|FG001|Overall Study|Withdrawal by Subject|287|||
27837579|NCT01507662|81233106|FG000|Overall Study|Lost to Follow-up|498|||
27837580|NCT01507662|81233107|FG001|Overall Study|Lost to Follow-up|523|||
27837581|NCT01507662|81233106|FG000|Overall Study|Proxy interview done|2|||
27837582|NCT01507662|81233107|FG001|Overall Study|Proxy interview done|3|||
27837583|NCT00550147|81233109|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
27837584|NCT00550147|81233109|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
27837585|NCT00550147|81233109|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
27837586|NCT00550147|81233109|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
27958535|NCT01791517|81680067|FG009|Phase I: Period 2|Lost to Follow-up|0|||
27958536|NCT01791517|81680068|FG010|Phase I: Period 2|Lost to Follow-up|0|||
27958537|NCT01791517|81680069|FG011|Phase I: Period 2|Lost to Follow-up|0|||
27958538|NCT01791517|81680058|FG000|Phase I: Period 3|Lens Discomfort|0|||
27715892|NCT02573155|80792594|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
27715893|NCT02573155|80792595|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
27715894|NCT02573155|80792594|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
27890013|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
27890014|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
27605366|NCT01780935|80395391|FG000|Overall Study|Death|1|||
27605367|NCT01780935|80395392|FG001|Overall Study|Death|6|||
27715895|NCT02573155|80792595|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
27715896|NCT02573155|80792594|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
27715897|NCT02573155|80792595|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
27715898|NCT03074474|80792596|FG000|Overall Study|Lost to Follow-up|10|||
27715899|NCT03074474|80792596|FG000|Overall Study|Withdrawal by Subject|10|||
27715900|NCT03074474|80792596|FG000|Overall Study|Death|4|||
27715901|NCT03074474|80792596|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
27715902|NCT04697628|80792597|FG000|Overall Study|Withdrawal by Subject|17|||
27715903|NCT04697628|80792598|FG001|Overall Study|Withdrawal by Subject|23|||
27605368|NCT01780935|80395391|FG000|Overall Study|Lost to Follow-up|2|||
27605369|NCT01780935|80395392|FG001|Overall Study|Lost to Follow-up|6|||
27715904|NCT04697628|80792597|FG000|Overall Study|Lost to Follow-up|0|||
27715905|NCT04697628|80792598|FG001|Overall Study|Lost to Follow-up|4|||
27715906|NCT04697628|80792597|FG000|Overall Study|On-going in study|122|||
27715907|NCT04697628|80792598|FG001|Overall Study|On-going in study|91|||
27715908|NCT03259074|80792599|FG000|Overall Study|Adverse Event|9|||
27715909|NCT03259074|80792600|FG001|Overall Study|Adverse Event|12|||
27715910|NCT03259074|80792601|FG002|Overall Study|Adverse Event|8|||
27715911|NCT03259074|80792599|FG000|Overall Study|Death|1|||
27715912|NCT03259074|80792600|FG001|Overall Study|Death|1|||
27715913|NCT03259074|80792601|FG002|Overall Study|Death|3|||
27715914|NCT03259074|80792599|FG000|Overall Study|Lost to Follow-up|2|||
27715915|NCT03259074|80792600|FG001|Overall Study|Lost to Follow-up|4|||
27715916|NCT03259074|80792601|FG002|Overall Study|Lost to Follow-up|3|||
27715917|NCT03259074|80792599|FG000|Overall Study|New Therapy For Study Indication|1|||
27715918|NCT03259074|80792600|FG001|Overall Study|New Therapy For Study Indication|2|||
27715919|NCT03259074|80792601|FG002|Overall Study|New Therapy For Study Indication|2|||
27715920|NCT03259074|80792599|FG000|Overall Study|Physician Decision|4|||
27715921|NCT03259074|80792600|FG001|Overall Study|Physician Decision|12|||
27715922|NCT03259074|80792601|FG002|Overall Study|Physician Decision|10|||
27715923|NCT03259074|80792599|FG000|Overall Study|Pregnancy|1|||
27715924|NCT03259074|80792600|FG001|Overall Study|Pregnancy|1|||
27715925|NCT03259074|80792601|FG002|Overall Study|Pregnancy|0|||
27715926|NCT03259074|80792599|FG000|Overall Study|Progressive Disease|1|||
27715927|NCT03259074|80792600|FG001|Overall Study|Progressive Disease|0|||
27605370|NCT01780935|80395391|FG000|Overall Study|Physician Decision|1|||
27715928|NCT03259074|80792601|FG002|Overall Study|Progressive Disease|0|||
27715929|NCT03259074|80792599|FG000|Overall Study|Protocol Deviation|1|||
27715930|NCT03259074|80792600|FG001|Overall Study|Protocol Deviation|1|||
27715931|NCT03259074|80792601|FG002|Overall Study|Protocol Deviation|3|||
27715932|NCT03259074|80792599|FG000|Overall Study|Subject/Guardian Decision|13|||
27715933|NCT03259074|80792600|FG001|Overall Study|Subject/Guardian Decision|16|||
27605371|NCT01780935|80395392|FG001|Overall Study|Physician Decision|1|||
27605372|NCT01780935|80395391|FG000|Overall Study|Protocol deviation|0|||
27605373|NCT01780935|80395392|FG001|Overall Study|Protocol deviation|1|||
27605374|NCT01780935|80395391|FG000|Overall Study|Patient withdrew consent|8|||
27605375|NCT01780935|80395392|FG001|Overall Study|Patient withdrew consent|9|||
27605376|NCT03131960|80395397|FG000|Overall Study|Adverse Event|0|||
27605377|NCT03131960|80395398|FG001|Overall Study|Adverse Event|1|||
27605378|NCT01650519|80395399|FG000|Overall Study|Withdrawal by Subject|1|||
27605379|NCT01650519|80395400|FG001|Overall Study|Withdrawal by Subject|0|||
27605380|NCT00263328|80395409|FG000|Overall Study|Death|0|||
27605381|NCT00263328|80395410|FG001|Overall Study|Death|0|||
27605382|NCT00263328|80395411|FG002|Overall Study|Death|1|||
27605383|NCT00263328|80395409|FG000|Overall Study|Lost to Follow-up|1|||
27605384|NCT00263328|80395410|FG001|Overall Study|Lost to Follow-up|1|||
27605385|NCT00263328|80395411|FG002|Overall Study|Lost to Follow-up|0|||
27605386|NCT00263328|80395409|FG000|Overall Study|Withdrawal by Subject|3|||
27605387|NCT00263328|80395410|FG001|Overall Study|Withdrawal by Subject|0|||
27605388|NCT00263328|80395411|FG002|Overall Study|Withdrawal by Subject|1|||
27605389|NCT00263328|80395409|FG000|Overall Study|Other|3|||
27605390|NCT00263328|80395410|FG001|Overall Study|Other|0|||
27605391|NCT00263328|80395411|FG002|Overall Study|Other|1|||
27605392|NCT00263328|80395409|FG000|Overall Study|Adverse Event|1|||
27605393|NCT00263328|80395410|FG001|Overall Study|Adverse Event|1|||
27605394|NCT00263328|80395411|FG002|Overall Study|Adverse Event|4|||
27605395|NCT03502616|80395421|FG000|Up to Week 16|Withdrawal by Subject|1|||
27605396|NCT03502616|80395422|FG001|Up to Week 16|Withdrawal by Subject|2|||
27605397|NCT03502616|80395421|FG000|Up to Week 16|Lost to Follow-up|0|||
27605398|NCT03502616|80395422|FG001|Up to Week 16|Lost to Follow-up|1|||
27605399|NCT03502616|80395421|FG000|Up to Week 16|Randomized, but not treated|1|||
27605400|NCT03502616|80395422|FG001|Up to Week 16|Randomized, but not treated|0|||
27605401|NCT03502616|80395421|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
27605402|NCT03502616|80395422|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
27605403|NCT03502616|80395421|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
27605404|NCT03502616|80395422|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
27605405|NCT03351738|80395424|FG000|Overall Study|Withdrawal by Subject|0|||
27605406|NCT03351738|80395425|FG001|Overall Study|Withdrawal by Subject|1|||
27605407|NCT03351738|80395426|FG002|Overall Study|Withdrawal by Subject|0|||
27605408|NCT03351738|80395427|FG003|Overall Study|Withdrawal by Subject|1|||
27605409|NCT03351738|80395428|FG004|Overall Study|Withdrawal by Subject|0|||
27605410|NCT03351738|80395429|FG005|Overall Study|Withdrawal by Subject|0|||
27837587|NCT00550147|81233109|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
27605411|NCT01518946|80395430|FG000|Open-label Phase|Other|4|||
27605412|NCT01518946|80395431|FG001|Open-label Phase|Other|0|||
27605413|NCT01518946|80395432|FG002|Open-label Phase|Other|0|||
27605414|NCT01518946|80395430|FG000|Randomized Phase (First Intervention)|Other|0|||
27605415|NCT01518946|80395431|FG001|Randomized Phase (First Intervention)|Other|1|||
27605416|NCT01518946|80395432|FG002|Randomized Phase (First Intervention)|Other|0|||
27605417|NCT01483937|80395435|FG000|Overall Study|Withdrawal by Subject|4|||
27605418|NCT01483937|80395436|FG001|Overall Study|Withdrawal by Subject|3|||
27605419|NCT02696902|80395437|FG000|Overall Study|Lost to Follow-up|0|||
27605420|NCT02696902|80395438|FG001|Overall Study|Lost to Follow-up|1|||
27605421|NCT02696902|80395439|FG002|Overall Study|Lost to Follow-up|1|||
27605422|NCT02696902|80395437|FG000|Overall Study|Withdrawal by Subject|0|||
27605423|NCT02696902|80395438|FG001|Overall Study|Withdrawal by Subject|0|||
27605424|NCT02696902|80395439|FG002|Overall Study|Withdrawal by Subject|1|||
27605425|NCT02696902|80395437|FG000|Overall Study|Death|19|||
27605426|NCT02696902|80395438|FG001|Overall Study|Death|3|||
27605427|NCT02696902|80395439|FG002|Overall Study|Death|24|||
27605428|NCT02696902|80395437|FG000|Overall Study|Participant not fit post-randomization|0|||
27605429|NCT02696902|80395438|FG001|Overall Study|Participant not fit post-randomization|0|||
27605430|NCT02696902|80395439|FG002|Overall Study|Participant not fit post-randomization|1|||
27605431|NCT02696902|80395437|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
27605432|NCT02696902|80395438|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
27605433|NCT02696902|80395439|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
27605434|NCT02696902|80395437|FG000|Overall Study|Principal investigator's decision|1|||
27605435|NCT02696902|80395438|FG001|Overall Study|Principal investigator's decision|0|||
27605436|NCT02696902|80395439|FG002|Overall Study|Principal investigator's decision|0|||
27605437|NCT02696902|80395437|FG000|Overall Study|Sponsor's decision|1|||
27605438|NCT02696902|80395438|FG001|Overall Study|Sponsor's decision|0|||
27605439|NCT02696902|80395439|FG002|Overall Study|Sponsor's decision|0|||
27605440|NCT02696902|80395437|FG000|Overall Study|Transferred to other hospital|1|||
27605441|NCT02696902|80395438|FG001|Overall Study|Transferred to other hospital|0|||
27605442|NCT02696902|80395439|FG002|Overall Study|Transferred to other hospital|0|||
27605443|NCT03673462|80399591|FG000|Overall Study|Adverse Event|11|||
27605444|NCT03673462|80399592|FG001|Overall Study|Adverse Event|1|||
27715934|NCT03259074|80792601|FG002|Overall Study|Subject/Guardian Decision|14|||
27715935|NCT00522431|80792602|FG000|Overall Study|Adverse Event|5|||
27605445|NCT03673462|80399591|FG000|Overall Study|Protocol Violation|25|||
27605446|NCT03673462|80399592|FG001|Overall Study|Protocol Violation|11|||
27605447|NCT03673462|80399591|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
27605448|NCT03673462|80399592|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
27605449|NCT03673462|80399591|FG000|Overall Study|Lost to Follow-up|102|||
27715936|NCT00522431|80792602|FG000|Overall Study|Protocol Violation|2|||
27715937|NCT00522431|80792602|FG000|Overall Study|Withdrawal by Subject|2|||
27715938|NCT00522431|80792602|FG000|Overall Study|Subject non-compliance|1|||
27715939|NCT00522431|80792602|FG000|Overall Study|Other/unknown|1|||
27715940|NCT00847912|80792603|FG000|Overall Study|Protocol Violation|6|||
27715941|NCT00847912|80792604|FG001|Overall Study|Protocol Violation|7|||
27715942|NCT00847912|80792603|FG000|Overall Study|Withdrawal by Subject|3|||
27715943|NCT00847912|80792604|FG001|Overall Study|Withdrawal by Subject|6|||
27715944|NCT00513409|80792605|FG000|Overall Study|Adverse Event|0|||
27715945|NCT00513409|80792606|FG001|Overall Study|Adverse Event|1|||
27715946|NCT00513409|80792605|FG000|Overall Study|Withdrawal by Subject|0|||
27605450|NCT03673462|80399592|FG001|Overall Study|Lost to Follow-up|19|||
27605451|NCT01153269|80399593|FG000|Overall Study|Withdrawal by Subject|1|||
27605452|NCT01153269|80399593|FG000|Overall Study|Antiretroviral therapy break|1|||
27715947|NCT00513409|80792606|FG001|Overall Study|Withdrawal by Subject|2|||
27605453|NCT00405639|80399594|FG000|Overall Study|Withdrawal by Subject|1|||
27715948|NCT00513409|80792605|FG000|Overall Study|Lost to Follow-up|0|||
27715949|NCT00513409|80792606|FG001|Overall Study|Lost to Follow-up|1|||
27605454|NCT00405639|80399595|FG001|Overall Study|Withdrawal by Subject|0|||
27605455|NCT00405639|80399594|FG000|Overall Study|Adverse Event|1|||
27605456|NCT00405639|80399595|FG001|Overall Study|Adverse Event|0|||
27605457|NCT00405639|80399594|FG000|Overall Study|Seizure prior to receiving BNP|1|||
27605458|NCT00405639|80399595|FG001|Overall Study|Seizure prior to receiving BNP|0|||
27605459|NCT02799472|80399611|FG000|Overall Study|Withdrawal by Subject|2|||
27605460|NCT02799472|80399612|FG001|Overall Study|Withdrawal by Subject|4|||
27605461|NCT02799472|80399611|FG000|Overall Study|Lack of Efficacy|2|||
27605462|NCT02799472|80399612|FG001|Overall Study|Lack of Efficacy|0|||
27605463|NCT02799472|80399611|FG000|Overall Study|Lost to Follow-up|0|||
27605464|NCT02799472|80399612|FG001|Overall Study|Lost to Follow-up|1|||
27605465|NCT01872910|80399615|FG000|Overall Study|Lost to Follow-up|2|||
27605466|NCT01872910|80399616|FG001|Overall Study|Lost to Follow-up|0|||
27605467|NCT01872910|80399617|FG002|Overall Study|Lost to Follow-up|2|||
27605468|NCT01872910|80399618|FG003|Overall Study|Lost to Follow-up|0|||
27605469|NCT01872910|80399619|FG004|Overall Study|Lost to Follow-up|0|||
27605470|NCT01872910|80399620|FG005|Overall Study|Lost to Follow-up|0|||
27605471|NCT00633932|80399621|FG000|Overall Study|Adverse Event|1|||
27605472|NCT00633932|80399622|FG001|Overall Study|Adverse Event|3|||
27605473|NCT00633932|80399623|FG002|Overall Study|Adverse Event|4|||
27605474|NCT00633932|80399621|FG000|Overall Study|Withdrawal by Subject|3|||
27605475|NCT00633932|80399622|FG001|Overall Study|Withdrawal by Subject|9|||
27605476|NCT00633932|80399623|FG002|Overall Study|Withdrawal by Subject|1|||
27605477|NCT00633932|80399621|FG000|Overall Study|Lost to Follow-up|1|||
27605478|NCT00633932|80399622|FG001|Overall Study|Lost to Follow-up|0|||
27605479|NCT00633932|80399623|FG002|Overall Study|Lost to Follow-up|2|||
27605480|NCT00633932|80399621|FG000|Overall Study|Protocol Violation|5|||
27605481|NCT00633932|80399622|FG001|Overall Study|Protocol Violation|2|||
27605482|NCT00633932|80399623|FG002|Overall Study|Protocol Violation|3|||
27605483|NCT00633932|80399621|FG000|Overall Study|Physician Decision|0|||
27715950|NCT00513409|80792605|FG000|Overall Study|Physician Decision|1|||
27605484|NCT00633932|80399622|FG001|Overall Study|Physician Decision|0|||
27605485|NCT00633932|80399623|FG002|Overall Study|Physician Decision|1|||
27605486|NCT00633932|80399621|FG000|Overall Study|Doctor's judgement|1|||
27958539|NCT01791517|81680059|FG001|Phase I: Period 3|Lens Discomfort|0|||
27605487|NCT00633932|80399622|FG001|Overall Study|Doctor's judgement|0|||
27605488|NCT00633932|80399623|FG002|Overall Study|Doctor's judgement|0|||
27605489|NCT00633932|80399621|FG000|Overall Study|Moved Away|1|||
27605490|NCT00633932|80399622|FG001|Overall Study|Moved Away|0|||
27605491|NCT00633932|80399623|FG002|Overall Study|Moved Away|0|||
27605492|NCT04954586|80399624|FG000|Overall Study|Withdrawal by Subject|5|||
27605493|NCT00603265|80399625|FG000|Overall Study|Adverse Event|2|||
27605494|NCT00603265|80399626|FG001|Overall Study|Adverse Event|11|||
27605495|NCT00603265|80399627|FG002|Overall Study|Adverse Event|1|||
27605496|NCT00603265|80399625|FG000|Overall Study|Withdrawal by Subject|1|||
27605497|NCT00603265|80399626|FG001|Overall Study|Withdrawal by Subject|2|||
27605498|NCT00603265|80399627|FG002|Overall Study|Withdrawal by Subject|1|||
27605499|NCT00603265|80399625|FG000|Overall Study|Lack of Efficacy|3|||
27837588|NCT01617096|81233110|FG000|Overall Study|Withdrawal by Subject|96|||
27605500|NCT00603265|80399626|FG001|Overall Study|Lack of Efficacy|0|||
27605501|NCT00603265|80399627|FG002|Overall Study|Lack of Efficacy|3|||
27837589|NCT01617096|81233111|FG001|Overall Study|Withdrawal by Subject|81|||
27837590|NCT01617096|81233110|FG000|Overall Study|Lost to Follow-up|37|||
27837591|NCT01617096|81233111|FG001|Overall Study|Lost to Follow-up|32|||
27837592|NCT01617096|81233110|FG000|Overall Study|Physician Decision|10|||
27837593|NCT01617096|81233111|FG001|Overall Study|Physician Decision|18|||
27837594|NCT01617096|81233110|FG000|Overall Study|Death|4|||
27837595|NCT01617096|81233111|FG001|Overall Study|Death|3|||
27837596|NCT01617096|81233110|FG000|Overall Study|Other|1|||
27837597|NCT01617096|81233111|FG001|Overall Study|Other|3|||
27837598|NCT01824576|81233114|FG000|Overall Study|Device deficiency|2|||
27837599|NCT00640926|81233115|FG000|Overall Study|Adverse Event|2|||
27837600|NCT00640926|81233116|FG001|Overall Study|Adverse Event|3|||
27890015|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
27890016|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
27890017|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
27890018|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
27890019|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
27890020|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
27890021|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
27890022|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
27890023|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
27890024|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
27958540|NCT01791517|81680060|FG002|Phase I: Period 3|Lens Discomfort|0|||
27715951|NCT00513409|80792606|FG001|Overall Study|Physician Decision|0|||
27715952|NCT00513409|80792605|FG000|Overall Study|Visit 3 not done|1|||
27715953|NCT00513409|80792606|FG001|Overall Study|Visit 3 not done|2|||
27837601|NCT00640926|81233117|FG002|Overall Study|Adverse Event|2|||
27715954|NCT04042103|80795635|FG000|Overall Study|Lost to Follow-up|1|||
27715955|NCT04042103|80795635|FG000|Overall Study|Withdrawal by Subject|1|||
27837602|NCT00640926|81233115|FG000|Overall Study|Lack of Efficacy|0|||
27837603|NCT00640926|81233116|FG001|Overall Study|Lack of Efficacy|2|||
27715956|NCT03355300|80795638|FG000|Overall Study|Physician Decision|0|||
27715957|NCT03355300|80795639|FG001|Overall Study|Physician Decision|1|||
27715958|NCT03355300|80795638|FG000|Overall Study|Lack of Efficacy|2|||
27715959|NCT03355300|80795639|FG001|Overall Study|Lack of Efficacy|1|||
27715960|NCT03355300|80795638|FG000|Overall Study|Other reason|1|||
27715961|NCT03355300|80795639|FG001|Overall Study|Other reason|0|||
27715962|NCT00267748|80795645|FG000|Non-randomized Period|Progressive disease|10|||
27715963|NCT00267748|80795646|FG001|Non-randomized Period|Progressive disease|0|||
27837604|NCT00640926|81233117|FG002|Overall Study|Lack of Efficacy|1|||
27837605|NCT00640926|81233115|FG000|Overall Study|Protocol Violation|2|||
27837606|NCT00640926|81233116|FG001|Overall Study|Protocol Violation|0|||
27837607|NCT00640926|81233117|FG002|Overall Study|Protocol Violation|2|||
27605502|NCT00603265|80399625|FG000|Overall Study|Lost to Follow-up|0|||
27837608|NCT00640926|81233115|FG000|Overall Study|Lost to Follow-up|3|||
27837609|NCT00640926|81233116|FG001|Overall Study|Lost to Follow-up|1|||
27837610|NCT00640926|81233117|FG002|Overall Study|Lost to Follow-up|2|||
27837611|NCT00640926|81233115|FG000|Overall Study|Withdrawal by Subject|1|||
27837612|NCT00640926|81233116|FG001|Overall Study|Withdrawal by Subject|0|||
27715964|NCT00267748|80795647|FG002|Non-randomized Period|Progressive disease|0|||
27715965|NCT00267748|80795645|FG000|Non-randomized Period|Adverse Event|8|||
27715966|NCT00267748|80795646|FG001|Non-randomized Period|Adverse Event|0|||
27715967|NCT00267748|80795647|FG002|Non-randomized Period|Adverse Event|0|||
27715968|NCT00267748|80795645|FG000|Non-randomized Period|Death|1|||
27715969|NCT00267748|80795646|FG001|Non-randomized Period|Death|0|||
27715970|NCT00267748|80795647|FG002|Non-randomized Period|Death|0|||
27715971|NCT00267748|80795645|FG000|Non-randomized Period|Participant not willing to participate|1|||
27715972|NCT00267748|80795646|FG001|Non-randomized Period|Participant not willing to participate|0|||
27715973|NCT00267748|80795647|FG002|Non-randomized Period|Participant not willing to participate|0|||
27715974|NCT00267748|80795645|FG000|Non-randomized Period|Other|3|||
27715975|NCT00267748|80795646|FG001|Non-randomized Period|Other|0|||
27715976|NCT00267748|80795647|FG002|Non-randomized Period|Other|0|||
27715977|NCT00267748|80795645|FG000|Randomized Period|Death|0|||
27715978|NCT00267748|80795646|FG001|Randomized Period|Death|2|||
27715979|NCT00267748|80795647|FG002|Randomized Period|Death|3|||
27715980|NCT00267748|80795645|FG000|Randomized Period|Adverse Event|0|||
27715981|NCT00267748|80795646|FG001|Randomized Period|Adverse Event|23|||
27715982|NCT00267748|80795647|FG002|Randomized Period|Adverse Event|25|||
27715983|NCT00267748|80795645|FG000|Randomized Period|Global deterioration of health status|0|||
27715984|NCT00267748|80795646|FG001|Randomized Period|Global deterioration of health status|6|||
27715985|NCT00267748|80795647|FG002|Randomized Period|Global deterioration of health status|7|||
27715986|NCT00267748|80795645|FG000|Randomized Period|Lost to Follow-up|0|||
27890025|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
27890026|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
27605503|NCT00603265|80399626|FG001|Overall Study|Lost to Follow-up|1|||
27605504|NCT00603265|80399627|FG002|Overall Study|Lost to Follow-up|0|||
27715987|NCT00267748|80795646|FG001|Randomized Period|Lost to Follow-up|1|||
27715988|NCT00267748|80795647|FG002|Randomized Period|Lost to Follow-up|0|||
27715989|NCT00267748|80795645|FG000|Randomized Period|Objective progression or relapse|0|||
27715990|NCT00267748|80795646|FG001|Randomized Period|Objective progression or relapse|77|||
27837613|NCT00640926|81233117|FG002|Overall Study|Withdrawal by Subject|1|||
27837614|NCT01899053|81233118|FG000|Overall Study|Progressive Disease|4|||
27837615|NCT01899053|81233119|FG001|Overall Study|Progressive Disease|0|||
27837616|NCT01899053|81233120|FG002|Overall Study|Progressive Disease|3|||
27837617|NCT01899053|81233121|FG003|Overall Study|Progressive Disease|0|||
27837618|NCT01899053|81233122|FG004|Overall Study|Progressive Disease|3|||
27605505|NCT00603265|80399625|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
27715991|NCT00267748|80795647|FG002|Randomized Period|Objective progression or relapse|86|||
27715992|NCT00267748|80795645|FG000|Randomized Period|Withdrawal by Subject|0|||
27715993|NCT00267748|80795646|FG001|Randomized Period|Withdrawal by Subject|9|||
27715994|NCT00267748|80795647|FG002|Randomized Period|Withdrawal by Subject|2|||
27715995|NCT00267748|80795645|FG000|Randomized Period|Other|0|||
27715996|NCT00267748|80795646|FG001|Randomized Period|Other|9|||
27715997|NCT00267748|80795647|FG002|Randomized Period|Other|6|||
27715998|NCT00267748|80795645|FG000|Randomized Period|randomized but not treated|0|||
27715999|NCT00267748|80795646|FG001|Randomized Period|randomized but not treated|0|||
27716000|NCT00267748|80795647|FG002|Randomized Period|randomized but not treated|3|||
27716001|NCT01121393|80795648|FG000|Overall Study|Progressive disease|201|||
27716002|NCT01121393|80795649|FG001|Overall Study|Progressive disease|20|||
27716003|NCT01121393|80795648|FG000|Overall Study|Other Adverse events|24|||
27716004|NCT01121393|80795649|FG001|Overall Study|Other Adverse events|45|||
27716005|NCT01121393|80795648|FG000|Overall Study|Non-compliant with protocol|0|||
27716006|NCT01121393|80795649|FG001|Overall Study|Non-compliant with protocol|3|||
27716007|NCT01121393|80795648|FG000|Overall Study|Lost to Follow-up|1|||
27716008|NCT01121393|80795649|FG001|Overall Study|Lost to Follow-up|0|||
27716009|NCT01121393|80795648|FG000|Overall Study|Refused cont. medication|7|||
27716010|NCT01121393|80795649|FG001|Overall Study|Refused cont. medication|7|||
27716011|NCT01121393|80795648|FG000|Overall Study|Not treated|3|||
27716012|NCT01121393|80795649|FG001|Overall Study|Not treated|9|||
27716013|NCT01121393|80795648|FG000|Overall Study|Other than listed|6|||
27716014|NCT01121393|80795649|FG001|Overall Study|Other than listed|0|||
27716015|NCT01967550|80795652|FG000|Overall Study|Withdrawal by Subject|1|||
27716016|NCT01967550|80795653|FG001|Overall Study|Withdrawal by Subject|0|||
27716017|NCT01967550|80795652|FG000|Overall Study|Adverse Event|2|||
27716018|NCT01967550|80795653|FG001|Overall Study|Adverse Event|0|||
27716019|NCT01967550|80795652|FG000|Overall Study|Protocol Violation|2|||
27716020|NCT01967550|80795653|FG001|Overall Study|Protocol Violation|1|||
27716021|NCT01967550|80795652|FG000|Overall Study|Non Compliance|0|||
27716022|NCT01967550|80795653|FG001|Overall Study|Non Compliance|1|||
27716023|NCT02239939|80795655|FG000|Overall Study|Adverse Event|1|||
27716024|NCT02239939|80795656|FG001|Overall Study|Adverse Event|0|||
27716025|NCT02239939|80795655|FG000|Overall Study|Withdrawal by Subject|1|||
27716026|NCT02239939|80795656|FG001|Overall Study|Withdrawal by Subject|1|||
27716027|NCT02239939|80795655|FG000|Overall Study|Lost to Follow-up|0|||
27716028|NCT02239939|80795656|FG001|Overall Study|Lost to Follow-up|1|||
27716029|NCT00252057|80795672|FG000|Overall Study|Withdrawal by Subject|2|||
27716030|NCT00252057|80795673|FG001|Overall Study|Withdrawal by Subject|5|||
27716031|NCT00252057|80795672|FG000|Overall Study|Death|1|||
27716032|NCT00252057|80795673|FG001|Overall Study|Death|2|||
27716033|NCT00252057|80795672|FG000|Overall Study|Participant previously enrolled|0|||
27716034|NCT00252057|80795673|FG001|Overall Study|Participant previously enrolled|1|||
27716035|NCT00996944|80795675|FG000|Double-blind Treatment Period|Adverse Event|2|||
27716036|NCT00996944|80795676|FG001|Double-blind Treatment Period|Adverse Event|1|||
27837619|NCT01899053|81233123|FG005|Overall Study|Progressive Disease|1|||
27837620|NCT01899053|81233124|FG006|Overall Study|Progressive Disease|1|||
27837621|NCT01899053|81233125|FG007|Overall Study|Progressive Disease|1|||
27837622|NCT01899053|81233126|FG008|Overall Study|Progressive Disease|4|||
27837623|NCT01899053|81233127|FG009|Overall Study|Progressive Disease|3|||
27837624|NCT01899053|81233128|FG010|Overall Study|Progressive Disease|12|||
27837625|NCT01899053|81233129|FG011|Overall Study|Progressive Disease|5|||
27837626|NCT01899053|81233130|FG012|Overall Study|Progressive Disease|8|||
27837627|NCT01899053|81233131|FG013|Overall Study|Progressive Disease|17|||
27837628|NCT01899053|81233118|FG000|Overall Study|Adverse Event|1|||
27837629|NCT01899053|81233119|FG001|Overall Study|Adverse Event|1|||
27837630|NCT01899053|81233120|FG002|Overall Study|Adverse Event|1|||
27837631|NCT01899053|81233121|FG003|Overall Study|Adverse Event|3|||
27716037|NCT00996944|80795675|FG000|Double-blind Treatment Period|Protocol Violation|1|||
27716038|NCT00996944|80795676|FG001|Double-blind Treatment Period|Protocol Violation|0|||
27716039|NCT00996944|80795675|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
27716040|NCT00996944|80795676|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
27716041|NCT00996944|80795675|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
27716042|NCT00996944|80795676|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27716043|NCT00996944|80795675|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
27716044|NCT00996944|80795676|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
27716045|NCT00746252|80795679|FG000|Overall Study|weight gain >7.5 %|1|||
27716046|NCT00746252|80795680|FG001|Overall Study|weight gain >7.5 %|2|||
27716047|NCT03011333|80795681|FG000|Overall Study|Lost to Follow-up|0|||
27716048|NCT03011333|80795682|FG001|Overall Study|Lost to Follow-up|1|||
27837632|NCT01899053|81233122|FG004|Overall Study|Adverse Event|1|||
27716049|NCT03011333|80795683|FG002|Overall Study|Lost to Follow-up|0|||
27716050|NCT03011333|80795684|FG003|Overall Study|Lost to Follow-up|1|||
27716051|NCT03011333|80795685|FG004|Overall Study|Lost to Follow-up|4|||
27890027|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
27890028|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
27890029|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
27716052|NCT03011333|80795686|FG005|Overall Study|Lost to Follow-up|4|||
27716053|NCT03011333|80795687|FG006|Overall Study|Lost to Follow-up|5|||
27716054|NCT00262873|80795690|FG000|Overall Study|Adverse Event|3|||
27716055|NCT00262873|80795690|FG000|Overall Study|Withdrawal by Subject|5|||
27716056|NCT01617460|80795696|FG000|Overall Study|Adverse Event|10|||
27716057|NCT01617460|80795696|FG000|Overall Study|Physician Decision|16|||
27716058|NCT01617460|80795696|FG000|Overall Study|Protocol Violation|5|||
27716059|NCT01617460|80795696|FG000|Overall Study|Withdrawal by Subject|9|||
27716060|NCT00845728|80795697|FG000|Overall Study|Abnormal laboratory value (s)|2|||
27716061|NCT00845728|80795698|FG001|Overall Study|Abnormal laboratory value (s)|2|||
27716062|NCT00845728|80795697|FG000|Overall Study|Patient's inability to use the device|4|||
27716063|NCT00845728|80795698|FG001|Overall Study|Patient's inability to use the device|6|||
27716064|NCT00845728|80795697|FG000|Overall Study|Abnormal test procedure result (s)|7|||
27716065|NCT00845728|80795698|FG001|Overall Study|Abnormal test procedure result (s)|2|||
27716066|NCT00845728|80795697|FG000|Overall Study|Lost to Follow-up|22|||
27716067|NCT00845728|80795698|FG001|Overall Study|Lost to Follow-up|13|||
27716068|NCT00845728|80795697|FG000|Overall Study|Death|24|||
27716069|NCT00845728|80795698|FG001|Overall Study|Death|26|||
27716070|NCT00845728|80795697|FG000|Overall Study|Administrative Problems|34|||
27716071|NCT00845728|80795698|FG001|Overall Study|Administrative Problems|26|||
27716072|NCT00845728|80795697|FG000|Overall Study|Protocol Violation|36|||
27716073|NCT00845728|80795698|FG001|Overall Study|Protocol Violation|24|||
27716074|NCT00845728|80795697|FG000|Overall Study|Lack of Efficacy|51|||
27716075|NCT00845728|80795698|FG001|Overall Study|Lack of Efficacy|39|||
27716076|NCT00845728|80795697|FG000|Overall Study|Adverse Event|101|||
27716077|NCT00845728|80795698|FG001|Overall Study|Adverse Event|96|||
27716078|NCT00845728|80795697|FG000|Overall Study|Withdrawal by Subject|105|||
27716079|NCT00845728|80795698|FG001|Overall Study|Withdrawal by Subject|108|||
27716080|NCT03927105|80795699|FG000|Overall Study|Death|1|||
27716081|NCT03927105|80795699|FG000|Overall Study|In observation for potential re-treatment|2|||
27716082|NCT03927105|80795699|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
27716083|NCT00390546|80795705|FG000|Overall Study|Renal impairment|1|||
27716084|NCT00390546|80795706|FG001|Overall Study|Renal impairment|0|||
27716085|NCT00390546|80795705|FG000|Overall Study|Physician Decision|5|||
27890030|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
27890031|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
27890032|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
27890033|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
27890034|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
27890035|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
27890036|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
27890037|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
27890038|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
27716086|NCT00390546|80795706|FG001|Overall Study|Physician Decision|5|||
27890039|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
27958541|NCT01791517|81680061|FG003|Phase I: Period 3|Lens Discomfort|0|||
27716087|NCT00708500|80795709|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
27716088|NCT00708500|80795710|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
27716089|NCT00708500|80795711|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
27716090|NCT00708500|80795709|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
27716091|NCT00708500|80795710|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
27716092|NCT00708500|80795711|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
27716093|NCT00708500|80795709|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
27605506|NCT00603265|80399626|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
27605507|NCT00603265|80399627|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
27605508|NCT00603265|80399625|FG000|Overall Study|Participant Left Country, No Responses|0|||
27605509|NCT00603265|80399626|FG001|Overall Study|Participant Left Country, No Responses|1|||
27605510|NCT00603265|80399627|FG002|Overall Study|Participant Left Country, No Responses|0|||
27605511|NCT00603265|80399625|FG000|Overall Study|Protocol Violation|1|||
27605512|NCT00603265|80399626|FG001|Overall Study|Protocol Violation|0|||
27605513|NCT00603265|80399627|FG002|Overall Study|Protocol Violation|0|||
27605514|NCT00792103|80399640|FG000|Overall Study|Enrolled, not treated|15|||
27605515|NCT00792103|80399640|FG000|Overall Study|Lost to Follow-up|17|||
27605516|NCT00792103|80399640|FG000|Overall Study|Adverse Event|25|||
27605517|NCT00792103|80399640|FG000|Overall Study|Withdrawal by Subject|52|||
27605518|NCT00792103|80399640|FG000|Overall Study|Protocol Violation|10|||
27605519|NCT00792103|80399640|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
27605520|NCT01264380|80399643|FG000|Period C|Disease Progression|0|||
27605521|NCT01264380|80399644|FG001|Period C|Disease Progression|0|||
27716094|NCT00708500|80795710|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
27716095|NCT00708500|80795711|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
27716096|NCT00708500|80795709|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
27716097|NCT00708500|80795710|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
27716098|NCT00708500|80795711|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
27716099|NCT00708500|80795709|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
27716100|NCT00708500|80795710|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
27716101|NCT00708500|80795711|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
27716102|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
27716103|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
27716104|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
27716105|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
27837633|NCT01899053|81233123|FG005|Overall Study|Adverse Event|1|||
27837634|NCT01899053|81233124|FG006|Overall Study|Adverse Event|1|||
27837635|NCT01899053|81233125|FG007|Overall Study|Adverse Event|0|||
27837636|NCT01899053|81233126|FG008|Overall Study|Adverse Event|2|||
27716106|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
27716107|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
27716108|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
27716109|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
27837637|NCT01899053|81233127|FG009|Overall Study|Adverse Event|0|||
27837638|NCT01899053|81233128|FG010|Overall Study|Adverse Event|3|||
27837639|NCT01899053|81233129|FG011|Overall Study|Adverse Event|1|||
27837640|NCT01899053|81233130|FG012|Overall Study|Adverse Event|2|||
27837641|NCT01899053|81233131|FG013|Overall Study|Adverse Event|2|||
27837642|NCT01899053|81233118|FG000|Overall Study|Reason Not Specified|0|||
27837643|NCT01899053|81233119|FG001|Overall Study|Reason Not Specified|0|||
27837644|NCT01899053|81233120|FG002|Overall Study|Reason Not Specified|0|||
27837645|NCT01899053|81233121|FG003|Overall Study|Reason Not Specified|0|||
27837646|NCT01899053|81233122|FG004|Overall Study|Reason Not Specified|0|||
27837647|NCT01899053|81233123|FG005|Overall Study|Reason Not Specified|0|||
27837648|NCT01899053|81233124|FG006|Overall Study|Reason Not Specified|1|||
27837649|NCT01899053|81233125|FG007|Overall Study|Reason Not Specified|0|||
27837650|NCT01899053|81233126|FG008|Overall Study|Reason Not Specified|0|||
27837651|NCT01899053|81233127|FG009|Overall Study|Reason Not Specified|0|||
27837652|NCT01899053|81233128|FG010|Overall Study|Reason Not Specified|0|||
27837653|NCT01899053|81233129|FG011|Overall Study|Reason Not Specified|0|||
27837654|NCT01899053|81233130|FG012|Overall Study|Reason Not Specified|1|||
27837655|NCT01899053|81233131|FG013|Overall Study|Reason Not Specified|0|||
27605522|NCT01264380|80399645|FG002|Period C|Disease Progression|4|||
27605523|NCT01264380|80399643|FG000|Period C|Death|0|||
27605524|NCT01264380|80399644|FG001|Period C|Death|0|||
27837656|NCT01899053|81233118|FG000|Overall Study|Withdrawal by Subject|1|||
27837657|NCT01899053|81233119|FG001|Overall Study|Withdrawal by Subject|1|||
27837658|NCT01899053|81233120|FG002|Overall Study|Withdrawal by Subject|2|||
27837659|NCT01899053|81233121|FG003|Overall Study|Withdrawal by Subject|0|||
27605525|NCT01264380|80399645|FG002|Period C|Death|2|||
27605526|NCT01264380|80399643|FG000|Period C|Follow-up for survival status|0|||
27605527|NCT01264380|80399644|FG001|Period C|Follow-up for survival status|0|||
27605528|NCT01264380|80399645|FG002|Period C|Follow-up for survival status|6|||
27605529|NCT01264380|80399643|FG000|Period C|Withdrawal by Subject|0|||
27605530|NCT01264380|80399644|FG001|Period C|Withdrawal by Subject|0|||
27837660|NCT01899053|81233122|FG004|Overall Study|Withdrawal by Subject|2|||
27837661|NCT01899053|81233123|FG005|Overall Study|Withdrawal by Subject|0|||
27605531|NCT01264380|80399645|FG002|Period C|Withdrawal by Subject|1|||
27716110|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
27837662|NCT01899053|81233124|FG006|Overall Study|Withdrawal by Subject|0|||
27837663|NCT01899053|81233125|FG007|Overall Study|Withdrawal by Subject|1|||
27837664|NCT01899053|81233126|FG008|Overall Study|Withdrawal by Subject|0|||
27837665|NCT01899053|81233127|FG009|Overall Study|Withdrawal by Subject|0|||
27837666|NCT01899053|81233128|FG010|Overall Study|Withdrawal by Subject|0|||
27837667|NCT01899053|81233129|FG011|Overall Study|Withdrawal by Subject|0|||
27716111|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
27716112|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
27716113|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
27716114|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
27716115|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
27716116|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
27716117|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
27716118|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
27716119|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
27716120|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
27837668|NCT01899053|81233130|FG012|Overall Study|Withdrawal by Subject|1|||
27837669|NCT01899053|81233131|FG013|Overall Study|Withdrawal by Subject|1|||
27837670|NCT01899053|81233118|FG000|Overall Study|Protocol Violation|0|||
27716121|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
27716122|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
27716123|NCT00708500|80795709|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
27716124|NCT00708500|80795710|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
27716125|NCT00708500|80795711|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
27716126|NCT00708500|80795709|FG000|FOLLOWUP|Adverse Event|0|||
27716127|NCT00708500|80795710|FG001|FOLLOWUP|Adverse Event|1|||
27716128|NCT00708500|80795711|FG002|FOLLOWUP|Adverse Event|0|||
27716129|NCT00708500|80795709|FG000|FOLLOWUP|Lost to Follow-up|1|||
27716130|NCT00708500|80795710|FG001|FOLLOWUP|Lost to Follow-up|6|||
27716131|NCT00708500|80795711|FG002|FOLLOWUP|Lost to Follow-up|4|||
27716132|NCT00708500|80795709|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
27716133|NCT00708500|80795710|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
27716134|NCT00708500|80795711|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
27716135|NCT00708500|80795709|FG000|FOLLOWUP|Subject withdrew consent|31|||
27716136|NCT00708500|80795710|FG001|FOLLOWUP|Subject withdrew consent|4|||
27716137|NCT00708500|80795711|FG002|FOLLOWUP|Subject withdrew consent|5|||
27716138|NCT00708500|80795709|FG000|FOLLOWUP|Non-compliance with protocol|5|||
27716139|NCT00708500|80795710|FG001|FOLLOWUP|Non-compliance with protocol|0|||
27716140|NCT00708500|80795711|FG002|FOLLOWUP|Non-compliance with protocol|1|||
27716141|NCT01006265|80795713|FG000|Overall Study|Lost to Follow-up|1|||
27716142|NCT01006265|80795714|FG001|Overall Study|Lost to Follow-up|0|||
27716143|NCT01006265|80795715|FG002|Overall Study|Lost to Follow-up|1|||
27716144|NCT01006265|80795716|FG003|Overall Study|Lost to Follow-up|0|||
27716145|NCT01006265|80795713|FG000|Overall Study|Withdrawal by Subject|4|||
27716146|NCT01006265|80795714|FG001|Overall Study|Withdrawal by Subject|7|||
27716147|NCT01006265|80795715|FG002|Overall Study|Withdrawal by Subject|5|||
27716148|NCT01006265|80795716|FG003|Overall Study|Withdrawal by Subject|5|||
27716149|NCT01006265|80795713|FG000|Overall Study|Administrative reason|1|||
27716150|NCT01006265|80795714|FG001|Overall Study|Administrative reason|2|||
27716151|NCT01006265|80795715|FG002|Overall Study|Administrative reason|3|||
27837671|NCT01899053|81233119|FG001|Overall Study|Protocol Violation|0|||
27837672|NCT01899053|81233120|FG002|Overall Study|Protocol Violation|1|||
27837673|NCT01899053|81233121|FG003|Overall Study|Protocol Violation|0|||
27890040|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
27890041|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
27716152|NCT01006265|80795716|FG003|Overall Study|Administrative reason|0|||
27716153|NCT00936208|80795719|FG000|Overall Study|Protocol Violation|37|||
27716154|NCT00936208|80795720|FG001|Overall Study|Protocol Violation|22|||
27890042|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
27890043|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
27890044|NCT04526509|81430940|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
27716155|NCT02425826|80795721|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
27716156|NCT02425826|80795722|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
27716157|NCT02425826|80795723|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
27837674|NCT01899053|81233122|FG004|Overall Study|Protocol Violation|0|||
27837675|NCT01899053|81233123|FG005|Overall Study|Protocol Violation|0|||
27837676|NCT01899053|81233124|FG006|Overall Study|Protocol Violation|0|||
27837677|NCT01899053|81233125|FG007|Overall Study|Protocol Violation|0|||
27837678|NCT01899053|81233126|FG008|Overall Study|Protocol Violation|0|||
27837679|NCT01899053|81233127|FG009|Overall Study|Protocol Violation|0|||
27837680|NCT01899053|81233128|FG010|Overall Study|Protocol Violation|0|||
27837681|NCT01899053|81233129|FG011|Overall Study|Protocol Violation|0|||
27837682|NCT01899053|81233130|FG012|Overall Study|Protocol Violation|0|||
27837683|NCT01899053|81233131|FG013|Overall Study|Protocol Violation|0|||
27837684|NCT01899053|81233118|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
27837685|NCT01899053|81233119|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
27837686|NCT01899053|81233120|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837687|NCT01899053|81233121|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837688|NCT01899053|81233122|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837689|NCT01899053|81233123|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837690|NCT01899053|81233124|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837691|NCT01899053|81233125|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837692|NCT01899053|81233126|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837693|NCT01899053|81233127|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837694|NCT01899053|81233128|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
27837695|NCT01899053|81233129|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837696|NCT01899053|81233130|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837697|NCT01899053|81233131|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
27837698|NCT01899053|81233118|FG000|Overall Study|Symptomatic Deterioration|0|||
27837699|NCT01899053|81233119|FG001|Overall Study|Symptomatic Deterioration|0|||
27837700|NCT01899053|81233120|FG002|Overall Study|Symptomatic Deterioration|0|||
27837701|NCT01899053|81233121|FG003|Overall Study|Symptomatic Deterioration|0|||
27837702|NCT01899053|81233122|FG004|Overall Study|Symptomatic Deterioration|0|||
27837703|NCT01899053|81233123|FG005|Overall Study|Symptomatic Deterioration|1|||
27605532|NCT01264380|80399643|FG000|Period C|Adverse Event|0|||
27605533|NCT01264380|80399644|FG001|Period C|Adverse Event|0|||
27605534|NCT01264380|80399645|FG002|Period C|Adverse Event|1|||
27605535|NCT02716038|80399647|FG000|Overall Study|Not evaluable|1|||
27605536|NCT02716038|80399647|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
27605537|NCT02716038|80399647|FG000|Overall Study|Unresectable|3|||
27605538|NCT05674890|80399650|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
27605539|NCT05674890|80399651|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
27605540|NCT05674890|80399650|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
27605541|NCT05674890|80399651|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
27605542|NCT05674890|80399650|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
27605543|NCT05674890|80399651|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
27605544|NCT00782496|80399658|FG000|Overall Study|Lost to Follow-up|14|||
27605545|NCT00782496|80399659|FG001|Overall Study|Lost to Follow-up|15|||
27605546|NCT03916744|80399660|FG000|Overall Study|Withdrawal by Subject|0|||
27605547|NCT03916744|80399661|FG001|Overall Study|Withdrawal by Subject|1|||
27605548|NCT03916744|80399662|FG002|Overall Study|Withdrawal by Subject|2|||
27605549|NCT00638235|80399663|FG000|Overall Study|Lost to Follow-up|31|||
27605550|NCT00638235|80399664|FG001|Overall Study|Lost to Follow-up|3|||
27837704|NCT01899053|81233124|FG006|Overall Study|Symptomatic Deterioration|0|||
27837705|NCT01899053|81233125|FG007|Overall Study|Symptomatic Deterioration|1|||
27837706|NCT01899053|81233126|FG008|Overall Study|Symptomatic Deterioration|0|||
27837707|NCT01899053|81233127|FG009|Overall Study|Symptomatic Deterioration|0|||
27605551|NCT00638235|80399665|FG002|Overall Study|Lost to Follow-up|18|||
27837708|NCT01899053|81233128|FG010|Overall Study|Symptomatic Deterioration|0|||
27837709|NCT01899053|81233129|FG011|Overall Study|Symptomatic Deterioration|1|||
27837710|NCT01899053|81233130|FG012|Overall Study|Symptomatic Deterioration|2|||
27837711|NCT01899053|81233131|FG013|Overall Study|Symptomatic Deterioration|0|||
27837712|NCT00127166|81233132|FG000|Period I|Protocol Violation|0|||
27837713|NCT00127166|81233133|FG001|Period I|Protocol Violation|2|||
27837714|NCT00127166|81233132|FG000|Period I|Withdrawal by Subject|2|||
27837715|NCT00127166|81233133|FG001|Period I|Withdrawal by Subject|0|||
27837716|NCT00127166|81233132|FG000|Period I|Patient did not meet inclusion criteria|1|||
27837717|NCT00127166|81233133|FG001|Period I|Patient did not meet inclusion criteria|0|||
27837718|NCT00127166|81233132|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
27837719|NCT00127166|81233133|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
27837720|NCT00127166|81233132|FG000|Period II|Withdrawal by Subject|2|||
27837721|NCT00127166|81233133|FG001|Period II|Withdrawal by Subject|0|||
27837722|NCT00127166|81233132|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
27837723|NCT00127166|81233133|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
27837724|NCT02121184|81233140|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
27837725|NCT02121184|81233141|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
27837726|NCT02121184|81233140|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
27837727|NCT02121184|81233141|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
27837728|NCT02121184|81233140|FG000|Overall Study|Emergency cesarean section required|0|||
27837729|NCT02121184|81233141|FG001|Overall Study|Emergency cesarean section required|2|||
27837730|NCT02121184|81233140|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
27837731|NCT02121184|81233141|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
27837732|NCT02727192|81233143|FG000|Overall Study|Lost to Follow-up|1|||
27890045|NCT04526509|81430941|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
27890046|NCT04526509|81430942|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
27890047|NCT04526509|81430943|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
27958542|NCT01791517|81680062|FG004|Phase I: Period 3|Lens Discomfort|0|||
27605552|NCT00638235|80399666|FG003|Overall Study|Lost to Follow-up|10|||
27605553|NCT00638235|80399667|FG004|Overall Study|Lost to Follow-up|13|||
27837733|NCT02727192|81233144|FG001|Overall Study|Lost to Follow-up|0|||
27837734|NCT02727192|81233145|FG002|Overall Study|Lost to Follow-up|0|||
27837735|NCT01151618|81233148|FG000|Overall Study|Adverse Event|2|||
27837736|NCT01151618|81233148|FG000|Overall Study|Withdrawal by Subject|7|||
27837737|NCT00562718|81233149|FG000|Overall Study|Death|1|||
27605554|NCT00638235|80399668|FG005|Overall Study|Lost to Follow-up|26|||
27837738|NCT00562718|81233149|FG000|Overall Study|Withdrawal by Subject|3|||
27837739|NCT00562718|81233149|FG000|Overall Study|Adverse Event|4|||
27837740|NCT00562718|81233149|FG000|Overall Study|Lack of Efficacy|2|||
27837741|NCT00562718|81233149|FG000|Overall Study|not stated|1|||
27837742|NCT00926367|81236495|FG000|Overall Study|Withdrawal by Subject|0|||
27837743|NCT00926367|81236496|FG001|Overall Study|Withdrawal by Subject|1|||
27837744|NCT00926367|81236495|FG000|Overall Study|Lost to Follow-up|1|||
27837745|NCT00926367|81236496|FG001|Overall Study|Lost to Follow-up|0|||
27837746|NCT00926367|81236495|FG000|Overall Study|Skin Irritation|1|||
27837747|NCT00926367|81236496|FG001|Overall Study|Skin Irritation|2|||
27837748|NCT00642811|81236497|FG000|Overall Study|Adverse Event|2|||
27837749|NCT00642811|81236498|FG001|Overall Study|Adverse Event|3|||
27837750|NCT00642811|81236499|FG002|Overall Study|Adverse Event|0|||
27837751|NCT00642811|81236500|FG003|Overall Study|Adverse Event|0|||
27837752|NCT00642811|81236501|FG004|Overall Study|Adverse Event|0|||
27837753|NCT00642811|81236502|FG005|Overall Study|Adverse Event|1|||
27837754|NCT00642811|81236497|FG000|Overall Study|Developement of discontinuation criteria|0|||
27837755|NCT00642811|81236498|FG001|Overall Study|Developement of discontinuation criteria|0|||
27837756|NCT00642811|81236499|FG002|Overall Study|Developement of discontinuation criteria|0|||
27837757|NCT00642811|81236500|FG003|Overall Study|Developement of discontinuation criteria|0|||
27837758|NCT00642811|81236501|FG004|Overall Study|Developement of discontinuation criteria|1|||
27837759|NCT00642811|81236502|FG005|Overall Study|Developement of discontinuation criteria|0|||
27837760|NCT00642811|81236497|FG000|Overall Study|Severe Non-compliance to protocol|1|||
27837761|NCT00642811|81236498|FG001|Overall Study|Severe Non-compliance to protocol|0|||
27837762|NCT00642811|81236499|FG002|Overall Study|Severe Non-compliance to protocol|0|||
27837763|NCT00642811|81236500|FG003|Overall Study|Severe Non-compliance to protocol|0|||
27837764|NCT00642811|81236501|FG004|Overall Study|Severe Non-compliance to protocol|0|||
27837765|NCT00642811|81236502|FG005|Overall Study|Severe Non-compliance to protocol|0|||
27837766|NCT00642811|81236497|FG000|Overall Study|Other|0|||
27837767|NCT00642811|81236498|FG001|Overall Study|Other|1|||
27837768|NCT00642811|81236499|FG002|Overall Study|Other|0|||
27837769|NCT00642811|81236500|FG003|Overall Study|Other|1|||
27837770|NCT00642811|81236501|FG004|Overall Study|Other|0|||
27837771|NCT00642811|81236502|FG005|Overall Study|Other|0|||
27837772|NCT00928057|81236505|FG000|Overall Study|Adverse Event|1|||
27837773|NCT00928057|81236506|FG001|Overall Study|Adverse Event|2|||
27837774|NCT00928057|81236505|FG000|Overall Study|Withdrawal by Subject|1|||
27837775|NCT00928057|81236506|FG001|Overall Study|Withdrawal by Subject|0|||
27837776|NCT00928057|81236505|FG000|Overall Study|Lost to Follow-up|0|||
27837777|NCT00928057|81236506|FG001|Overall Study|Lost to Follow-up|1|||
27837778|NCT00928057|81236505|FG000|Overall Study|Protocol Violation|0|||
27837779|NCT00928057|81236506|FG001|Overall Study|Protocol Violation|1|||
27837780|NCT02832167|81236510|FG000|Treatment Period 1|Disease progression|90|||
27837781|NCT02832167|81236510|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
27837782|NCT02832167|81236510|FG000|Treatment Period 1|Death|2|||
27837783|NCT02832167|81236510|FG000|Treatment Period 1|Study Drug Toxicity|6|||
27837784|NCT02832167|81236510|FG000|Treatment Period 1|Participant request to discontinue|9|||
27837785|NCT02832167|81236510|FG000|Treatment Period 1|No longer meet study criteria|1|||
27837786|NCT02832167|81236510|FG000|Treatment Period 1|Participant withdrew consent|3|||
27837787|NCT02832167|81236510|FG000|Treatment Period 1|Other reasons|6|||
27837788|NCT02832167|81236510|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
27837789|NCT02832167|81236510|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
27837790|NCT02832167|81236510|FG000|Transition From Period 1 to Period 2|Death|2|||
27837791|NCT02832167|81236510|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
27837792|NCT02832167|81236510|FG000|Treatment Period 2|Disease progression|69|||
27837793|NCT02832167|81236510|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
27837794|NCT02832167|81236510|FG000|Treatment Period 2|Maximum clinical benefit|1|||
27837795|NCT02832167|81236510|FG000|Treatment Period 2|Study Drug Toxicity|5|||
27837796|NCT02832167|81236510|FG000|Treatment Period 2|Participant request to discontinue|2|||
27837797|NCT02832167|81236510|FG000|Treatment Period 2|Participant withdrew consent|3|||
27837798|NCT02832167|81236510|FG000|Treatment Period 2|Other reasons|3|||
27837799|NCT03366194|81236513|FG000|Overall Study|Lost to Follow-up|2|||
27837800|NCT02174276|81236519|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
27837801|NCT02174276|81236520|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
27837802|NCT02174276|81236521|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
27837803|NCT02174276|81236522|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
27837804|NCT02174276|81236519|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
27837805|NCT02174276|81236520|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
27837806|NCT02174276|81236521|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
27837807|NCT02174276|81236522|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
27837808|NCT02174276|81236519|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
27837809|NCT02174276|81236520|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
27837810|NCT02174276|81236521|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
27837811|NCT02174276|81236522|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
27837812|NCT02174276|81236519|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
27837813|NCT02174276|81236520|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
27837814|NCT02174276|81236521|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
27837815|NCT02174276|81236522|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
27837816|NCT02174276|81236519|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
27837817|NCT02174276|81236520|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
27837818|NCT02174276|81236521|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
27837819|NCT02174276|81236522|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
27837820|NCT02174276|81236519|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
27837821|NCT02174276|81236520|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
27837822|NCT02174276|81236521|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
27837823|NCT02174276|81236522|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
27837824|NCT00766493|81236524|FG000|30 Days Post-Procedure|Discontinued|7|||
27837825|NCT00766493|81236524|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
27837826|NCT00766493|81236524|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
27605555|NCT00638235|80399669|FG006|Overall Study|Lost to Follow-up|0|||
27837827|NCT02161549|81236525|FG000|Overall Study|Physician Decision|6|||
27605556|NCT00638235|80399670|FG007|Overall Study|Lost to Follow-up|1|||
27837828|NCT02161549|81236526|FG001|Overall Study|Physician Decision|2|||
27837829|NCT03428945|81236528|FG000|Overall Study|Lost to Follow-up|5|||
27605557|NCT00638235|80399671|FG008|Overall Study|Lost to Follow-up|18|||
27605558|NCT00067990|80399672|FG000|Overall Study|Death|5|||
27605559|NCT00067990|80399673|FG001|Overall Study|Death|7|||
27605560|NCT00067990|80399672|FG000|Overall Study|ESRD, Non IF/TA|1|||
27605561|NCT00067990|80399673|FG001|Overall Study|ESRD, Non IF/TA|3|||
27716158|NCT02425826|80795721|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
27716159|NCT02425826|80795722|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
27605562|NCT00067990|80399672|FG000|Overall Study|Withdrawal by Subject|4|||
27605563|NCT00067990|80399673|FG001|Overall Study|Withdrawal by Subject|12|||
27605564|NCT00744328|80399674|FG000|Overall Study|Lost to Follow-up|2|||
27605565|NCT00744328|80399675|FG001|Overall Study|Lost to Follow-up|5|||
27605566|NCT00744328|80399676|FG002|Overall Study|Lost to Follow-up|3|||
27605567|NCT00744328|80399674|FG000|Overall Study|Withdrawal by Subject|5|||
27605568|NCT00744328|80399675|FG001|Overall Study|Withdrawal by Subject|3|||
27605569|NCT00744328|80399676|FG002|Overall Study|Withdrawal by Subject|4|||
27605570|NCT00744328|80399674|FG000|Overall Study|Found ineligible after randomization|0|||
27605571|NCT00744328|80399675|FG001|Overall Study|Found ineligible after randomization|0|||
27605572|NCT00744328|80399676|FG002|Overall Study|Found ineligible after randomization|1|||
27605573|NCT00990340|80399677|FG000|First 14-day Treatment|Not Compliant|2|||
27605574|NCT00990340|80399678|FG001|First 14-day Treatment|Not Compliant|1|||
27605575|NCT00990340|80399677|FG000|First 14-day Treatment|Lost to Follow-up|2|||
27605576|NCT00990340|80399678|FG001|First 14-day Treatment|Lost to Follow-up|1|||
27605577|NCT00990340|80399677|FG000|First 14-day Treatment|Protocol Violation|2|||
27605578|NCT00990340|80399678|FG001|First 14-day Treatment|Protocol Violation|2|||
27605579|NCT00185640|80399679|FG000|Overall Study|Not Eligible|4|||
27605580|NCT00185640|80399679|FG000|Overall Study|Withdrawal by Subject|3|||
27605581|NCT00185640|80399679|FG000|Overall Study|Death|138|||
27605582|NCT01857622|80399680|FG000|Overall Study|Adverse Event|5|||
27605583|NCT01857622|80399681|FG001|Overall Study|Adverse Event|0|||
27605584|NCT01857622|80399682|FG002|Overall Study|Adverse Event|2|||
27605585|NCT01857622|80399680|FG000|Overall Study|Physician Decision|1|||
27605586|NCT01857622|80399681|FG001|Overall Study|Physician Decision|0|||
27605587|NCT01857622|80399682|FG002|Overall Study|Physician Decision|0|||
27605588|NCT01857622|80399680|FG000|Overall Study|Protocol Violation|4|||
27605589|NCT01857622|80399681|FG001|Overall Study|Protocol Violation|1|||
27605590|NCT01857622|80399682|FG002|Overall Study|Protocol Violation|0|||
27605591|NCT01857622|80399680|FG000|Overall Study|Withdrawal by Subject|1|||
27605592|NCT01857622|80399681|FG001|Overall Study|Withdrawal by Subject|0|||
27605593|NCT01857622|80399682|FG002|Overall Study|Withdrawal by Subject|0|||
27605594|NCT04146896|80399683|FG000|Overall Study|Adverse Event|5|||
27605595|NCT04146896|80399684|FG001|Overall Study|Adverse Event|8|||
27605596|NCT04146896|80399683|FG000|Overall Study|Lack of Efficacy|3|||
27605597|NCT04146896|80399684|FG001|Overall Study|Lack of Efficacy|2|||
27605598|NCT04146896|80399683|FG000|Overall Study|Lost to Follow-up|0|||
27605599|NCT04146896|80399684|FG001|Overall Study|Lost to Follow-up|1|||
27605600|NCT04146896|80399683|FG000|Overall Study|Non-compliance|5|||
27605601|NCT04146896|80399684|FG001|Overall Study|Non-compliance|4|||
27605602|NCT04146896|80399683|FG000|Overall Study|Withdrawal by Subject|3|||
27605603|NCT04146896|80399684|FG001|Overall Study|Withdrawal by Subject|5|||
27605604|NCT04146896|80399683|FG000|Overall Study|Randomized in error|1|||
27605605|NCT04146896|80399684|FG001|Overall Study|Randomized in error|2|||
27605606|NCT01728792|80399687|FG000|Overall Study|Withdrawal of Consent|1|||
27605607|NCT01728792|80399688|FG001|Overall Study|Withdrawal of Consent|1|||
27605608|NCT01728792|80399689|FG002|Overall Study|Withdrawal of Consent|0|||
27605609|NCT01728792|80399690|FG003|Overall Study|Withdrawal of Consent|1|||
27605610|NCT01728792|80399691|FG004|Overall Study|Withdrawal of Consent|0|||
27605611|NCT01728792|80399687|FG000|Overall Study|Lost to Follow-up|2|||
27605612|NCT01728792|80399688|FG001|Overall Study|Lost to Follow-up|1|||
27605613|NCT01728792|80399689|FG002|Overall Study|Lost to Follow-up|4|||
27605614|NCT01728792|80399690|FG003|Overall Study|Lost to Follow-up|2|||
27605615|NCT01728792|80399691|FG004|Overall Study|Lost to Follow-up|0|||
27605616|NCT04707196|80399694|FG000|Overall Study|Withdrawal by Subject|9|||
27605617|NCT04707196|80399695|FG001|Overall Study|Withdrawal by Subject|6|||
27605618|NCT04707196|80399694|FG000|Overall Study|Lost to Follow-up|1|||
27605619|NCT04707196|80399695|FG001|Overall Study|Lost to Follow-up|0|||
27605620|NCT04707196|80399694|FG000|Overall Study|Protocol Violation|4|||
27605621|NCT04707196|80399695|FG001|Overall Study|Protocol Violation|1|||
27605622|NCT04707196|80399694|FG000|Overall Study|Adverse Event|2|||
27605623|NCT04707196|80399695|FG001|Overall Study|Adverse Event|2|||
27605624|NCT04707196|80399694|FG000|Overall Study|Death|3|||
27605625|NCT04707196|80399695|FG001|Overall Study|Death|1|||
27605626|NCT04707196|80399694|FG000|Overall Study|Non-compliance with study drug|1|||
27605627|NCT04707196|80399695|FG001|Overall Study|Non-compliance with study drug|0|||
27605628|NCT04707196|80399694|FG000|Overall Study|Progressive disease|9|||
27605629|NCT04707196|80399695|FG001|Overall Study|Progressive disease|10|||
27605630|NCT00462670|80399696|FG000|Overall Study|Adverse Event|3|||
27605631|NCT00462670|80399697|FG001|Overall Study|Adverse Event|5|||
27605632|NCT00462670|80399696|FG000|Overall Study|Lack of Efficacy|1|||
27605633|NCT00462670|80399697|FG001|Overall Study|Lack of Efficacy|0|||
27605634|NCT00462670|80399696|FG000|Overall Study|Protocol Violation|1|||
27605635|NCT00462670|80399697|FG001|Overall Study|Protocol Violation|0|||
27605636|NCT00462670|80399696|FG000|Overall Study|Resolution of signs and symptoms|0|||
27605637|NCT00462670|80399697|FG001|Overall Study|Resolution of signs and symptoms|2|||
27605638|NCT02204579|80399702|FG000|Overall Study|Screen failures|2|||
27605639|NCT04555096|80399704|FG000|Overall Study|Death|4|||
27605640|NCT04555096|80399705|FG001|Overall Study|Death|4|||
27605641|NCT04555096|80399704|FG000|Overall Study|Withdrawal by Subject|1|||
27605642|NCT04555096|80399705|FG001|Overall Study|Withdrawal by Subject|0|||
27605643|NCT04555096|80399704|FG000|Overall Study|Other|0|||
27605644|NCT04555096|80399705|FG001|Overall Study|Other|1|||
27605645|NCT01036022|80399710|FG000|Overall Study|Adverse Event|1|||
27605646|NCT01036022|80399711|FG001|Overall Study|Adverse Event|3|||
27605647|NCT01036022|80399712|FG002|Overall Study|Adverse Event|2|||
27605648|NCT01036022|80399713|FG003|Overall Study|Adverse Event|1|||
27605649|NCT01036022|80399714|FG004|Overall Study|Adverse Event|0|||
27605650|NCT01036022|80399715|FG005|Overall Study|Adverse Event|2|||
27605651|NCT01036022|80399710|FG000|Overall Study|Lack of Efficacy|1|||
27605652|NCT01036022|80399711|FG001|Overall Study|Lack of Efficacy|1|||
27605653|NCT01036022|80399712|FG002|Overall Study|Lack of Efficacy|1|||
27605654|NCT01036022|80399713|FG003|Overall Study|Lack of Efficacy|0|||
27605655|NCT01036022|80399714|FG004|Overall Study|Lack of Efficacy|1|||
27605656|NCT01036022|80399715|FG005|Overall Study|Lack of Efficacy|1|||
27605657|NCT01036022|80399710|FG000|Overall Study|Physician Decision|0|||
27605658|NCT01036022|80399711|FG001|Overall Study|Physician Decision|0|||
27605659|NCT01036022|80399712|FG002|Overall Study|Physician Decision|1|||
27605660|NCT01036022|80399713|FG003|Overall Study|Physician Decision|0|||
27605661|NCT01036022|80399714|FG004|Overall Study|Physician Decision|0|||
27605662|NCT01036022|80399715|FG005|Overall Study|Physician Decision|0|||
27605663|NCT01036022|80399710|FG000|Overall Study|Withdrawal by Subject|0|||
27605664|NCT01036022|80399711|FG001|Overall Study|Withdrawal by Subject|0|||
27605665|NCT01036022|80399712|FG002|Overall Study|Withdrawal by Subject|0|||
27605666|NCT01036022|80399713|FG003|Overall Study|Withdrawal by Subject|1|||
27605667|NCT01036022|80399714|FG004|Overall Study|Withdrawal by Subject|2|||
27605668|NCT01036022|80399715|FG005|Overall Study|Withdrawal by Subject|0|||
27605669|NCT04074590|80399716|FG000|Overall Study|Adverse Event|1|||
27605670|NCT04074590|80399717|FG001|Overall Study|Adverse Event|0|||
27605671|NCT04074590|80399716|FG000|Overall Study|Physician Decision|1|||
27605672|NCT04074590|80399717|FG001|Overall Study|Physician Decision|0|||
27605673|NCT04074590|80399716|FG000|Overall Study|Withdrawal by Subject|2|||
27605674|NCT04074590|80399717|FG001|Overall Study|Withdrawal by Subject|0|||
27605675|NCT02343003|80399718|FG000|Overall Study|Withdrawal by Subject|9|||
27605676|NCT02343003|80399719|FG001|Overall Study|Withdrawal by Subject|4|||
27605677|NCT02343003|80399718|FG000|Overall Study|Lost to Follow-up|5|||
27605678|NCT02343003|80399719|FG001|Overall Study|Lost to Follow-up|1|||
27605679|NCT02343003|80399718|FG000|Overall Study|Protocol Violation|1|||
27605680|NCT02343003|80399719|FG001|Overall Study|Protocol Violation|0|||
27605681|NCT02343003|80399718|FG000|Overall Study|Death|0|||
27605682|NCT02343003|80399719|FG001|Overall Study|Death|1|||
27605683|NCT02343003|80399718|FG000|Overall Study|exclusion criteria met|1|||
27605684|NCT02343003|80399719|FG001|Overall Study|exclusion criteria met|1|||
27605685|NCT02343003|80399718|FG000|Overall Study|terminated by sponsor|2|||
27605686|NCT02343003|80399719|FG001|Overall Study|terminated by sponsor|0|||
27605687|NCT01871558|80399720|FG000|Overall Study|Other reason|0|||
27605688|NCT01871558|80399721|FG001|Overall Study|Other reason|1|||
27605689|NCT01871558|80399720|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
27605690|NCT01871558|80399721|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
27605691|NCT01871558|80399720|FG000|Overall Study|Withdrawal by Subject|2|||
27605692|NCT01871558|80399721|FG001|Overall Study|Withdrawal by Subject|0|||
27605693|NCT01787097|80399722|FG000|Overall Study|Withdrawal by Subject|1|||
27605694|NCT01787097|80399723|FG001|Overall Study|Withdrawal by Subject|0|||
27605695|NCT01787097|80399724|FG002|Overall Study|Withdrawal by Subject|0|||
27605696|NCT01787097|80399725|FG003|Overall Study|Withdrawal by Subject|0|||
27605697|NCT00117156|80399726|FG000|Overall Study|Adverse Event|9|||
27605698|NCT00117156|80399726|FG000|Overall Study|Physician Decision|1|||
27605699|NCT00117156|80399726|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
27605700|NCT02567825|80399730|FG000|Overall Study|No follow-up post-randomization|5|||
27605701|NCT02567825|80399731|FG001|Overall Study|No follow-up post-randomization|1|||
27605702|NCT02567825|80399730|FG000|Overall Study|Follow-up less than 23 months|16|||
27605703|NCT02567825|80399731|FG001|Overall Study|Follow-up less than 23 months|20|||
27605704|NCT01755702|80399734|FG000|Wash Out Period I|Other Reason|3|||
27605705|NCT01755702|80399734|FG000|Washout Period II|Other Reason|5|||
27605706|NCT02228395|80399735|FG000|First Intervention Period|No longer willing to participate|1|||
27605707|NCT02228395|80399736|FG001|First Intervention Period|No longer willing to participate|0|||
27605708|NCT02228395|80399737|FG002|First Intervention Period|No longer willing to participate|0|||
27605709|NCT02228395|80399735|FG000|First Intervention Period|Unable to comply with study dates|0|||
27605710|NCT02228395|80399736|FG001|First Intervention Period|Unable to comply with study dates|1|||
27605711|NCT02228395|80399737|FG002|First Intervention Period|Unable to comply with study dates|1|||
27605712|NCT01255592|80399738|FG000|Overall Study|Adverse Event|5|||
27605713|NCT01255592|80399739|FG001|Overall Study|Adverse Event|0|||
27605714|NCT01255592|80399738|FG000|Overall Study|Withdrawal by Subject|1|||
27605715|NCT01255592|80399739|FG001|Overall Study|Withdrawal by Subject|0|||
27605716|NCT01255592|80399738|FG000|Overall Study|Other|0|||
27605717|NCT01255592|80399739|FG001|Overall Study|Other|1|||
27605718|NCT02613221|80399740|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
27605719|NCT02613221|80399740|FG000|Overall Study|Adverse Event|2|||
27605720|NCT02613221|80399740|FG000|Overall Study|Voluntary Discontinuation|1|||
27605721|NCT02613221|80399740|FG000|Overall Study|Delayed Treatment|1|||
27605722|NCT02613221|80399740|FG000|Overall Study|Enrolled but Not Treated|1|||
27605723|NCT04525547|80399741|FG000|Overall Study|Not treated with Ofev|2|||
27605724|NCT04525547|80399741|FG000|Overall Study|Off-label use|2|||
27605725|NCT04525547|80399741|FG000|Overall Study|Lost to Follow-up|1|||
27605726|NCT02301156|80399742|FG000|Overall Study|Adverse Event|13|||
27605727|NCT02301156|80399743|FG001|Overall Study|Adverse Event|14|||
27605728|NCT02301156|80399742|FG000|Overall Study|Death|1|||
27605729|NCT02301156|80399743|FG001|Overall Study|Death|5|||
27605730|NCT02301156|80399742|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
27605731|NCT02301156|80399743|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
27605732|NCT02301156|80399742|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
27605733|NCT02301156|80399743|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
27605734|NCT02301156|80399742|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
27605735|NCT02301156|80399743|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
27605736|NCT02301156|80399742|FG000|Overall Study|Reason not Specified|6|||
27605737|NCT02301156|80399743|FG001|Overall Study|Reason not Specified|3|||
27605738|NCT03976466|80399753|FG000|Overall Study|Lost to Follow-up|1|||
27605739|NCT03976466|80399754|FG001|Overall Study|Lost to Follow-up|3|||
27605740|NCT00998400|80399759|FG000|Overall Study|Lack of interest/motivation|1|||
27605741|NCT00998400|80399760|FG001|Overall Study|Lack of interest/motivation|2|||
27605742|NCT00998400|80399759|FG000|Overall Study|Logistical problems|1|||
27605743|NCT00998400|80399760|FG001|Overall Study|Logistical problems|0|||
27605744|NCT02323646|80399761|FG000|Treatment Course 1|Adverse Event|1|||
27605745|NCT02323646|80399762|FG001|Treatment Course 1|Adverse Event|0|||
27605746|NCT02323646|80399763|FG002|Treatment Course 1|Adverse Event|1|||
27605747|NCT02323646|80399761|FG000|Treatment Course 1|Heavy Bleeding|1|||
27605748|NCT02323646|80399762|FG001|Treatment Course 1|Heavy Bleeding|1|||
27605749|NCT02323646|80399763|FG002|Treatment Course 1|Heavy Bleeding|0|||
27605750|NCT02323646|80399761|FG000|Treatment Course 1|Lost to Follow-up|1|||
27605751|NCT02323646|80399762|FG001|Treatment Course 1|Lost to Follow-up|0|||
27605752|NCT02323646|80399763|FG002|Treatment Course 1|Lost to Follow-up|2|||
27605753|NCT02323646|80399761|FG000|Treatment Course 1|Withdrawal by Subject|0|||
27605754|NCT02323646|80399762|FG001|Treatment Course 1|Withdrawal by Subject|2|||
27605755|NCT02323646|80399763|FG002|Treatment Course 1|Withdrawal by Subject|0|||
27605756|NCT02323646|80399761|FG000|Treatment Course 2|Adverse Event|1|||
27605757|NCT02323646|80399762|FG001|Treatment Course 2|Adverse Event|0|||
27605758|NCT02323646|80399763|FG002|Treatment Course 2|Adverse Event|1|||
27605759|NCT02323646|80399761|FG000|Treatment Course 2|Lost to Follow-up|0|||
27605760|NCT02323646|80399762|FG001|Treatment Course 2|Lost to Follow-up|0|||
27605761|NCT02323646|80399763|FG002|Treatment Course 2|Lost to Follow-up|1|||
27605762|NCT02323646|80399761|FG000|Treatment Course 2|Non-compliance|0|||
27605763|NCT02323646|80399762|FG001|Treatment Course 2|Non-compliance|1|||
27605764|NCT02323646|80399763|FG002|Treatment Course 2|Non-compliance|1|||
27605765|NCT05340751|80399764|FG000|Overall Study|Physician Decision|3|||
27605766|NCT04836858|80399765|FG000|Overall Study|Adverse Event|0|||
27605767|NCT04836858|80399766|FG001|Overall Study|Adverse Event|0|||
27605768|NCT04836858|80399767|FG002|Overall Study|Adverse Event|0|||
27605769|NCT04836858|80399768|FG003|Overall Study|Adverse Event|1|||
27605770|NCT04836858|80399765|FG000|Overall Study|Lost to Follow-up|1|||
27605771|NCT04836858|80399766|FG001|Overall Study|Lost to Follow-up|0|||
27605772|NCT04836858|80399767|FG002|Overall Study|Lost to Follow-up|0|||
27605773|NCT04836858|80399768|FG003|Overall Study|Lost to Follow-up|0|||
27605774|NCT04836858|80399765|FG000|Overall Study|Subject/Guardian decision|3|||
27605775|NCT04836858|80399766|FG001|Overall Study|Subject/Guardian decision|0|||
27605776|NCT04836858|80399767|FG002|Overall Study|Subject/Guardian decision|0|||
27605777|NCT04836858|80399768|FG003|Overall Study|Subject/Guardian decision|1|||
27605778|NCT04836858|80399765|FG000|Overall Study|Randomized but not treated|4|||
27605779|NCT04836858|80399766|FG001|Overall Study|Randomized but not treated|0|||
27605780|NCT04836858|80399767|FG002|Overall Study|Randomized but not treated|0|||
27605781|NCT04836858|80399768|FG003|Overall Study|Randomized but not treated|0|||
27605782|NCT02696564|80399772|FG000|Overall Study|Death|1|||
27605783|NCT02696564|80399773|FG001|Overall Study|Death|2|||
27605784|NCT02696564|80399772|FG000|Overall Study|Withdrawal by Subject|3|||
27605785|NCT02696564|80399773|FG001|Overall Study|Withdrawal by Subject|2|||
27605786|NCT02696564|80399772|FG000|Overall Study|Lost to Follow-up|3|||
27605787|NCT02696564|80399773|FG001|Overall Study|Lost to Follow-up|3|||
27605788|NCT02696564|80399772|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
27605789|NCT02696564|80399773|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
27605790|NCT02696564|80399772|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
27605791|NCT02696564|80399773|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
27605792|NCT02696564|80399772|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
27605793|NCT02696564|80399773|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
27605794|NCT02696564|80399772|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
27605795|NCT02696564|80399773|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
27605796|NCT02696564|80399772|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
27605797|NCT02696564|80399773|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
27605798|NCT03980184|80399774|FG000|Overall Study|Dropped out before treatment|2|||
27605799|NCT03980184|80399775|FG001|Overall Study|Dropped out before treatment|2|||
27605800|NCT03980184|80399774|FG000|Overall Study|Lost to Follow-up|11|||
27605801|NCT03980184|80399775|FG001|Overall Study|Lost to Follow-up|13|||
27605802|NCT05375955|80399778|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
27605803|NCT05375955|80399779|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
27605804|NCT05375955|80399780|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
27837830|NCT03428945|81236529|FG001|Overall Study|Lost to Follow-up|3|||
27837831|NCT03428945|81236528|FG000|Overall Study|Withdrawal by Subject|10|||
27837832|NCT03428945|81236529|FG001|Overall Study|Withdrawal by Subject|10|||
27837833|NCT01881737|81236532|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
27837834|NCT01881737|81236532|FG000|Overall Study|Withdrawal by Subject|1|||
27837835|NCT01881737|81236532|FG000|Overall Study|Worsening of baseline behavior|1|||
27837836|NCT03358147|81236533|FG000|Overall Study|Withdrawal by Subject|13|||
27837837|NCT03358147|81236534|FG001|Overall Study|Withdrawal by Subject|19|||
27837838|NCT03358147|81236535|FG002|Overall Study|Withdrawal by Subject|16|||
27837839|NCT03358147|81236536|FG003|Overall Study|Withdrawal by Subject|10|||
27837840|NCT03358147|81236537|FG004|Overall Study|Withdrawal by Subject|5|||
27837841|NCT03358147|81236533|FG000|Overall Study|Adverse Event|3|||
27890048|NCT04526509|81430944|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
27958543|NCT01791517|81680063|FG005|Phase I: Period 3|Lens Discomfort|0|||
27605805|NCT05375955|80399781|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
27605806|NCT05375955|80399782|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
27605807|NCT05375955|80399783|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
27605808|NCT05375955|80399784|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
27605809|NCT05375955|80399778|FG000|Treatment (12 Weeks)|Physician Decision|4|||
27837842|NCT03358147|81236534|FG001|Overall Study|Adverse Event|9|||
27837843|NCT03358147|81236535|FG002|Overall Study|Adverse Event|7|||
27837844|NCT03358147|81236536|FG003|Overall Study|Adverse Event|5|||
27605810|NCT05375955|80399779|FG001|Treatment (12 Weeks)|Physician Decision|1|||
27605811|NCT05375955|80399780|FG002|Treatment (12 Weeks)|Physician Decision|3|||
27605812|NCT05375955|80399781|FG003|Treatment (12 Weeks)|Physician Decision|0|||
27605813|NCT05375955|80399782|FG004|Treatment (12 Weeks)|Physician Decision|0|||
27605814|NCT05375955|80399783|FG005|Treatment (12 Weeks)|Physician Decision|1|||
27605815|NCT05375955|80399784|FG006|Treatment (12 Weeks)|Physician Decision|0|||
27605816|NCT05375955|80399778|FG000|Treatment (12 Weeks)|Other|0|||
27605817|NCT05375955|80399779|FG001|Treatment (12 Weeks)|Other|1|||
27605818|NCT05375955|80399780|FG002|Treatment (12 Weeks)|Other|0|||
27605819|NCT05375955|80399781|FG003|Treatment (12 Weeks)|Other|0|||
27605820|NCT05375955|80399782|FG004|Treatment (12 Weeks)|Other|0|||
27605821|NCT05375955|80399783|FG005|Treatment (12 Weeks)|Other|0|||
27605822|NCT05375955|80399784|FG006|Treatment (12 Weeks)|Other|0|||
27605823|NCT05375955|80399778|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
27605824|NCT05375955|80399779|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
27605825|NCT05375955|80399780|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
27605826|NCT05375955|80399781|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
27605827|NCT05375955|80399782|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
27605828|NCT05375955|80399783|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
27605829|NCT05375955|80399784|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
27605830|NCT05375955|80399778|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
27605831|NCT05375955|80399779|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
27605832|NCT05375955|80399780|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
27605833|NCT05375955|80399781|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
27605834|NCT05375955|80399782|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
27605835|NCT05375955|80399783|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
27605836|NCT05375955|80399784|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
27605837|NCT05375955|80399778|FG000|Treatment (12 Weeks)|Pregnancy|0|||
27605838|NCT05375955|80399779|FG001|Treatment (12 Weeks)|Pregnancy|0|||
27605839|NCT05375955|80399780|FG002|Treatment (12 Weeks)|Pregnancy|1|||
27605840|NCT05375955|80399781|FG003|Treatment (12 Weeks)|Pregnancy|0|||
27605841|NCT05375955|80399782|FG004|Treatment (12 Weeks)|Pregnancy|0|||
27605842|NCT05375955|80399783|FG005|Treatment (12 Weeks)|Pregnancy|0|||
27605843|NCT05375955|80399784|FG006|Treatment (12 Weeks)|Pregnancy|0|||
27605844|NCT05375955|80399778|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
27605845|NCT05375955|80399779|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
27605846|NCT05375955|80399780|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
27605847|NCT05375955|80399781|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
27605848|NCT05375955|80399782|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
27605849|NCT05375955|80399783|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
27605850|NCT05375955|80399784|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
27605851|NCT05375955|80399778|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
27605852|NCT05375955|80399779|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
27605853|NCT05375955|80399780|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
27605854|NCT05375955|80399781|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
27605855|NCT05375955|80399782|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
27605856|NCT05375955|80399783|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
27605857|NCT05375955|80399784|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
27605858|NCT05375955|80399778|FG000|Follow-up (up to 5 Weeks)|Other|0|||
27605859|NCT05375955|80399779|FG001|Follow-up (up to 5 Weeks)|Other|1|||
27605860|NCT05375955|80399780|FG002|Follow-up (up to 5 Weeks)|Other|0|||
27605861|NCT05375955|80399781|FG003|Follow-up (up to 5 Weeks)|Other|0|||
27605862|NCT05375955|80399782|FG004|Follow-up (up to 5 Weeks)|Other|0|||
27605863|NCT05375955|80399783|FG005|Follow-up (up to 5 Weeks)|Other|0|||
27605864|NCT05375955|80399784|FG006|Follow-up (up to 5 Weeks)|Other|0|||
27605865|NCT05375955|80399778|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
27605866|NCT05375955|80399779|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
27605867|NCT05375955|80399780|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
27605868|NCT05375955|80399781|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
27605869|NCT05375955|80399782|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
27605870|NCT05375955|80399783|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
27605871|NCT05375955|80399784|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
27605872|NCT05375955|80399778|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
27837845|NCT03358147|81236537|FG004|Overall Study|Adverse Event|2|||
27837846|NCT03358147|81236533|FG000|Overall Study|Lost to Follow-up|4|||
27837847|NCT03358147|81236534|FG001|Overall Study|Lost to Follow-up|3|||
27837848|NCT03358147|81236535|FG002|Overall Study|Lost to Follow-up|7|||
27837849|NCT03358147|81236536|FG003|Overall Study|Lost to Follow-up|6|||
27837850|NCT03358147|81236537|FG004|Overall Study|Lost to Follow-up|4|||
27837851|NCT03358147|81236533|FG000|Overall Study|Major Protocol Deviation|11|||
27837852|NCT03358147|81236534|FG001|Overall Study|Major Protocol Deviation|3|||
27837853|NCT03358147|81236535|FG002|Overall Study|Major Protocol Deviation|2|||
27716160|NCT02425826|80795723|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
27837854|NCT03358147|81236536|FG003|Overall Study|Major Protocol Deviation|3|||
27837855|NCT03358147|81236537|FG004|Overall Study|Major Protocol Deviation|1|||
27716161|NCT02425826|80795721|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
27716162|NCT02425826|80795722|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
27716163|NCT02425826|80795723|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
27716164|NCT02425826|80795721|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
27716165|NCT02425826|80795722|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
27716166|NCT02425826|80795723|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
27716167|NCT02425826|80795721|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
27716168|NCT02425826|80795722|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
27716169|NCT02425826|80795723|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
27716170|NCT02425826|80795721|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
27716171|NCT02425826|80795722|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
27716172|NCT02425826|80795723|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
27716173|NCT02425826|80795721|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
27837856|NCT03358147|81236533|FG000|Overall Study|Protocol specified criteria|2|||
27837857|NCT03358147|81236534|FG001|Overall Study|Protocol specified criteria|3|||
27837858|NCT03358147|81236535|FG002|Overall Study|Protocol specified criteria|0|||
27837859|NCT03358147|81236536|FG003|Overall Study|Protocol specified criteria|3|||
27837860|NCT03358147|81236537|FG004|Overall Study|Protocol specified criteria|1|||
27837861|NCT03358147|81236533|FG000|Overall Study|Physician Decision|1|||
27837862|NCT03358147|81236534|FG001|Overall Study|Physician Decision|0|||
27837863|NCT03358147|81236535|FG002|Overall Study|Physician Decision|1|||
27837864|NCT03358147|81236536|FG003|Overall Study|Physician Decision|6|||
27837865|NCT03358147|81236537|FG004|Overall Study|Physician Decision|1|||
27837866|NCT03358147|81236533|FG000|Overall Study|Administrative reasons|0|||
27837867|NCT03358147|81236534|FG001|Overall Study|Administrative reasons|1|||
27837868|NCT03358147|81236535|FG002|Overall Study|Administrative reasons|0|||
27837869|NCT03358147|81236536|FG003|Overall Study|Administrative reasons|3|||
27837870|NCT03358147|81236537|FG004|Overall Study|Administrative reasons|0|||
27837871|NCT03358147|81236533|FG000|Overall Study|Lack of Efficacy|0|||
27837872|NCT03358147|81236534|FG001|Overall Study|Lack of Efficacy|1|||
27837873|NCT03358147|81236535|FG002|Overall Study|Lack of Efficacy|1|||
27837874|NCT03358147|81236536|FG003|Overall Study|Lack of Efficacy|0|||
27837875|NCT03358147|81236537|FG004|Overall Study|Lack of Efficacy|0|||
27837876|NCT00530348|81236538|FG000|Overall Study|Adverse Event|5|||
27837877|NCT00530348|81236539|FG001|Overall Study|Adverse Event|1|||
27837878|NCT00530348|81236538|FG000|Overall Study|Death|0|||
27837879|NCT00530348|81236539|FG001|Overall Study|Death|1|||
27837880|NCT00530348|81236538|FG000|Overall Study|Lack of Efficacy|2|||
27837881|NCT00530348|81236539|FG001|Overall Study|Lack of Efficacy|0|||
27958544|NCT01791517|81680064|FG006|Phase I: Period 3|Lens Discomfort|0|||
27605873|NCT05375955|80399779|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
27837882|NCT00530348|81236538|FG000|Overall Study|Lost to Follow-up|0|||
27837883|NCT00530348|81236539|FG001|Overall Study|Lost to Follow-up|2|||
27605874|NCT05375955|80399780|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
27837884|NCT00530348|81236538|FG000|Overall Study|Physician Decision|1|||
27837885|NCT00530348|81236539|FG001|Overall Study|Physician Decision|2|||
27837886|NCT00530348|81236538|FG000|Overall Study|Pregnancy|1|||
27605875|NCT05375955|80399781|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
27605876|NCT05375955|80399782|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
27605877|NCT05375955|80399783|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
27605878|NCT05375955|80399784|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
27605879|NCT01662063|80399791|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
27605880|NCT01662063|80399792|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
27605881|NCT01662063|80399793|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
27605882|NCT01662063|80399791|FG000|Overall Study|Lack of Efficacy|1|||
27605883|NCT01662063|80399792|FG001|Overall Study|Lack of Efficacy|6|||
27605884|NCT01662063|80399793|FG002|Overall Study|Lack of Efficacy|0|||
27605885|NCT01662063|80399791|FG000|Overall Study|Lost to Follow-up|0|||
27605886|NCT01662063|80399792|FG001|Overall Study|Lost to Follow-up|4|||
27605887|NCT01662063|80399793|FG002|Overall Study|Lost to Follow-up|0|||
27605888|NCT01662063|80399791|FG000|Overall Study|Protocol Violation|1|||
27605889|NCT01662063|80399792|FG001|Overall Study|Protocol Violation|0|||
27605890|NCT01662063|80399793|FG002|Overall Study|Protocol Violation|0|||
27605891|NCT01662063|80399791|FG000|Overall Study|Withdrawal by Subject|2|||
27605892|NCT01662063|80399792|FG001|Overall Study|Withdrawal by Subject|4|||
27605893|NCT01662063|80399793|FG002|Overall Study|Withdrawal by Subject|1|||
27605894|NCT01662063|80399791|FG000|Overall Study|Physician Decision|0|||
27605895|NCT01662063|80399792|FG001|Overall Study|Physician Decision|2|||
27605896|NCT01662063|80399793|FG002|Overall Study|Physician Decision|0|||
27605897|NCT01662063|80399791|FG000|Overall Study|Other|0|||
27605898|NCT01662063|80399792|FG001|Overall Study|Other|1|||
27605899|NCT01662063|80399793|FG002|Overall Study|Other|0|||
27605900|NCT03303469|80399794|FG000|Overall Study|Lost to Follow-up|2|||
27605901|NCT00661661|80399796|FG000|Overall Study|Adverse Event|99|||
27605902|NCT00661661|80399797|FG001|Overall Study|Adverse Event|24|||
27605903|NCT00661661|80399796|FG000|Overall Study|Lack of Efficacy|3|||
27605904|NCT00661661|80399797|FG001|Overall Study|Lack of Efficacy|2|||
27605905|NCT00661661|80399796|FG000|Overall Study|Lost to Follow-up|0|||
27605906|NCT00661661|80399797|FG001|Overall Study|Lost to Follow-up|1|||
27605907|NCT00661661|80399796|FG000|Overall Study|Withdrawal by Subject|15|||
27605908|NCT00661661|80399797|FG001|Overall Study|Withdrawal by Subject|5|||
27605909|NCT00661661|80399796|FG000|Overall Study|Other|22|||
27605910|NCT00661661|80399797|FG001|Overall Study|Other|7|||
27605911|NCT00661661|80399796|FG000|Overall Study|Not assigned treatment|1|||
27605912|NCT00661661|80399797|FG001|Overall Study|Not assigned treatment|0|||
27605913|NCT02293395|80399798|FG000|Overall Study|Lost to Follow-up|1|||
27605914|NCT02293395|80399799|FG001|Overall Study|Lost to Follow-up|0|||
27605915|NCT02293395|80399798|FG000|Overall Study|Withdrawal by Subject|8|||
27605916|NCT02293395|80399799|FG001|Overall Study|Withdrawal by Subject|7|||
27605917|NCT01889186|80399800|FG000|Overall Study|Adverse event- not related to progression|18|||
27605918|NCT01889186|80399801|FG001|Overall Study|Adverse event- not related to progression|5|||
27605919|NCT01889186|80399800|FG000|Overall Study|Adverse event- related to progression|7|||
27605920|NCT01889186|80399801|FG001|Overall Study|Adverse event- related to progression|2|||
27605921|NCT01889186|80399800|FG000|Overall Study|COVID-19 logistical restrictions|1|||
27605922|NCT01889186|80399801|FG001|Overall Study|COVID-19 logistical restrictions|0|||
27605923|NCT01889186|80399800|FG000|Overall Study|Investigator request|1|||
27605924|NCT01889186|80399801|FG001|Overall Study|Investigator request|1|||
27605925|NCT01889186|80399800|FG000|Overall Study|Progressive disease- Richter's|12|||
27605926|NCT01889186|80399801|FG001|Overall Study|Progressive disease- Richter's|7|||
27605927|NCT01889186|80399800|FG000|Overall Study|Progressive disease per protocol|46|||
27605928|NCT01889186|80399801|FG001|Overall Study|Progressive disease per protocol|17|||
27605929|NCT01889186|80399800|FG000|Overall Study|Stem cell transplant|2|||
27605930|NCT01889186|80399801|FG001|Overall Study|Stem cell transplant|1|||
27605931|NCT01889186|80399800|FG000|Overall Study|Withdrew consent|2|||
27605932|NCT01889186|80399801|FG001|Overall Study|Withdrew consent|3|||
27605933|NCT01889186|80399800|FG000|Overall Study|Other, not specified|18|||
27605934|NCT01889186|80399801|FG001|Overall Study|Other, not specified|15|||
27605935|NCT02508532|80399802|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27837887|NCT00530348|81236539|FG001|Overall Study|Pregnancy|0|||
27837888|NCT00530348|81236538|FG000|Overall Study|Withdrawal by Subject|12|||
27837889|NCT00530348|81236539|FG001|Overall Study|Withdrawal by Subject|12|||
27605936|NCT02508532|80399803|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27837890|NCT00530348|81236538|FG000|Overall Study|Randomised in error|1|||
27837891|NCT00530348|81236539|FG001|Overall Study|Randomised in error|0|||
27837892|NCT00530348|81236538|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
27716174|NCT02425826|80795722|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
27716175|NCT02425826|80795723|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
27716176|NCT02425826|80795721|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
27716177|NCT02425826|80795722|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
27716178|NCT02425826|80795723|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
27716179|NCT02425826|80795721|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
27716180|NCT02425826|80795722|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
27716181|NCT02425826|80795723|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
27716182|NCT02425826|80795721|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
27716183|NCT02425826|80795722|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
27716184|NCT02425826|80795723|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
27716185|NCT02268058|80795727|FG000|Overall Study|Protocol Violation|1|||
27716186|NCT02268058|80795728|FG001|Overall Study|Protocol Violation|0|||
27716187|NCT02268058|80795729|FG002|Overall Study|Protocol Violation|0|||
27716188|NCT02268058|80795730|FG003|Overall Study|Protocol Violation|0|||
27716189|NCT00640328|80795731|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
27716190|NCT00640328|80795732|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
27716191|NCT00640328|80795733|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
27716192|NCT00640328|80795734|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
27716193|NCT00640328|80795735|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
27716194|NCT00640328|80795736|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
27716195|NCT00640328|80795731|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
27716196|NCT00640328|80795732|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
27716197|NCT00640328|80795733|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
27716198|NCT00640328|80795734|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
27716199|NCT00640328|80795735|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
27716200|NCT00640328|80795736|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
27716201|NCT00640328|80795731|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
27716202|NCT00640328|80795732|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
27716203|NCT00640328|80795733|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
27716204|NCT00640328|80795734|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
27716205|NCT00640328|80795735|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
27716206|NCT00640328|80795736|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
27716207|NCT00640328|80795731|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
27716208|NCT00640328|80795732|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
27716209|NCT00640328|80795733|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
27716210|NCT00640328|80795734|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
27837893|NCT00530348|81236539|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
27837894|NCT00562120|81236540|FG000|First Intervention Period|Adverse Event|1|||
27837895|NCT00562120|81236541|FG001|First Intervention Period|Adverse Event|0|||
27837896|NCT00562120|81236542|FG002|First Intervention Period|Adverse Event|0|||
27837897|NCT00562120|81236543|FG003|First Intervention Period|Adverse Event|0|||
27605937|NCT02508532|80399804|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27716211|NCT00640328|80795735|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
27716212|NCT00640328|80795736|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
27716213|NCT03972969|80795737|FG000|3-month Follow-up|Death|1|||
27716214|NCT03972969|80795738|FG001|3-month Follow-up|Death|1|||
27716215|NCT03972969|80795739|FG002|3-month Follow-up|Death|0|||
27716216|NCT03972969|80795737|FG000|6-month Follow-up|Death|1|||
27716217|NCT03972969|80795738|FG001|6-month Follow-up|Death|1|||
27716218|NCT03972969|80795739|FG002|6-month Follow-up|Death|1|||
27716219|NCT03972969|80795737|FG000|6-month Follow-up|Lost to Follow-up|2|||
27716220|NCT03972969|80795738|FG001|6-month Follow-up|Lost to Follow-up|2|||
27716221|NCT03972969|80795739|FG002|6-month Follow-up|Lost to Follow-up|2|||
27716222|NCT00307151|80795740|FG000|Overall Study|Death|4|||
27716223|NCT00307151|80795741|FG001|Overall Study|Death|3|||
27716224|NCT00307151|80795742|FG002|Overall Study|Death|10|||
27716225|NCT00307151|80795743|FG003|Overall Study|Death|3|||
27716226|NCT00307151|80795740|FG000|Overall Study|Severe debilitation, unable to continue|1|||
27716227|NCT00307151|80795741|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27716228|NCT00307151|80795742|FG002|Overall Study|Severe debilitation, unable to continue|0|||
27716229|NCT00307151|80795743|FG003|Overall Study|Severe debilitation, unable to continue|0|||
27716230|NCT00307151|80795740|FG000|Overall Study|Subject unable to get to clinic|1|||
27716231|NCT00307151|80795741|FG001|Overall Study|Subject unable to get to clinic|0|||
27716232|NCT00307151|80795742|FG002|Overall Study|Subject unable to get to clinic|6|||
27716233|NCT00307151|80795743|FG003|Overall Study|Subject unable to get to clinic|2|||
27716234|NCT00307151|80795740|FG000|Overall Study|Withdrew consent|0|||
27716235|NCT00307151|80795741|FG001|Overall Study|Withdrew consent|1|||
27716236|NCT00307151|80795742|FG002|Overall Study|Withdrew consent|1|||
27716237|NCT00307151|80795743|FG003|Overall Study|Withdrew consent|3|||
27716238|NCT00307151|80795740|FG000|Overall Study|Not willing to adhere to study reqs|2|||
27716239|NCT00307151|80795741|FG001|Overall Study|Not willing to adhere to study reqs|0|||
27716240|NCT00307151|80795742|FG002|Overall Study|Not willing to adhere to study reqs|2|||
27716241|NCT00307151|80795743|FG003|Overall Study|Not willing to adhere to study reqs|2|||
27716242|NCT00307151|80795740|FG000|Overall Study|Clinic unable to contact subject|3|||
27716243|NCT00307151|80795741|FG001|Overall Study|Clinic unable to contact subject|3|||
27716244|NCT00307151|80795742|FG002|Overall Study|Clinic unable to contact subject|1|||
27716245|NCT00307151|80795743|FG003|Overall Study|Clinic unable to contact subject|1|||
27716246|NCT03021642|80795744|FG000|Washout Period (21 Days)|Adverse Event|1|||
27716247|NCT03021642|80795745|FG001|Washout Period (21 Days)|Adverse Event|1|||
27716248|NCT03189446|80795750|FG000|Overall Study|Adverse Event|2|||
27716249|NCT03189446|80795750|FG000|Overall Study|Withdrawal by Subject|2|||
27716250|NCT03189446|80795750|FG000|Overall Study|Physician Decision|1|||
27716251|NCT01453855|80795756|FG000|Overall Study|Adverse Event|3|||
27716252|NCT01453855|80795757|FG001|Overall Study|Adverse Event|4|||
27716253|NCT01453855|80795756|FG000|Overall Study|Lost to Follow-up|2|||
27716254|NCT01453855|80795757|FG001|Overall Study|Lost to Follow-up|1|||
27716255|NCT01453855|80795756|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
27716256|NCT01453855|80795757|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
27716257|NCT01453855|80795756|FG000|Overall Study|Noncompliance|1|||
27716258|NCT01453855|80795757|FG001|Overall Study|Noncompliance|0|||
27716259|NCT01453855|80795756|FG000|Overall Study|Inadequate Control of IOP|1|||
27716260|NCT01453855|80795757|FG001|Overall Study|Inadequate Control of IOP|5|||
27716261|NCT01453855|80795756|FG000|Overall Study|Other|0|||
27716262|NCT01453855|80795757|FG001|Overall Study|Other|1|||
27716263|NCT01496066|80795760|FG000|Overall Study|Lost to Follow-up|8|||
27716264|NCT01496066|80795761|FG001|Overall Study|Lost to Follow-up|5|||
27716265|NCT01496066|80795760|FG000|Overall Study|Explant|3|||
27716266|NCT01496066|80795761|FG001|Overall Study|Explant|0|||
27716267|NCT01496066|80795760|FG000|Overall Study|Death|1|||
27716268|NCT01496066|80795761|FG001|Overall Study|Death|4|||
27716269|NCT03713944|80795767|FG000|Study Treatment|Patient non-compliance|1|||
27716270|NCT03713944|80795767|FG000|Study Treatment|Alternative Cancer Therapy|3|||
27716271|NCT03713944|80795767|FG000|Study Treatment|Disease Progression|18|||
27716272|NCT03713944|80795767|FG000|Study Treatment|AE/Side Effects/Complications|2|||
27716273|NCT03713944|80795767|FG000|Study Treatment|Death|2|||
27716274|NCT03713944|80795767|FG000|Study Treatment|Withdrawal by Subject|1|||
27716275|NCT03713944|80795767|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
27716276|NCT03713944|80795767|FG000|Study Treatment|Symptomatic Deterioration|2|||
27716277|NCT03713944|80795767|FG000|Follow up|Withdrawal by Subject|2|||
27716278|NCT03713944|80795767|FG000|Follow up|Death|11|||
27716279|NCT03713944|80795767|FG000|Follow up|Study Terminated|3|||
27716280|NCT00971945|80795770|FG000|Overall Study|Progressive Disease|3|||
27716281|NCT00971945|80795770|FG000|Overall Study|Change in treatment policy|1|||
27716282|NCT00971945|80795770|FG000|Overall Study|Other reasons|2|||
27716283|NCT02797808|80795771|FG000|Overall Study|Withdrawal by Subject|1|||
27716284|NCT02797808|80795772|FG001|Overall Study|Withdrawal by Subject|1|||
27716285|NCT02797808|80795771|FG000|Overall Study|Physician Decision|6|||
27716286|NCT02797808|80795772|FG001|Overall Study|Physician Decision|2|||
27716287|NCT03354663|80795776|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
27716288|NCT03354663|80795776|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
27716289|NCT03354663|80795776|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
27716290|NCT03354663|80795776|FG000|Completed 30-day Visit|Missed Visit|1|||
27716291|NCT01929408|80795778|FG000|Overall Study|received HCT as initial treatment|8|||
27716292|NCT01212185|80795779|FG000|Overall Study|Protocol Violation|2|||
27716293|NCT01212185|80795780|FG001|Overall Study|Protocol Violation|1|||
27716294|NCT03178487|80795782|FG000|Period 1|Adverse Event|1|||
27716295|NCT03178487|80795783|FG001|Period 1|Adverse Event|2|||
27716296|NCT03178487|80795782|FG000|Period 1|Withdrawal by Subject|2|||
27716297|NCT03178487|80795783|FG001|Period 1|Withdrawal by Subject|1|||
27716298|NCT03178487|80795782|FG000|Period 1|Lost to Follow-up|1|||
27716299|NCT03178487|80795783|FG001|Period 1|Lost to Follow-up|0|||
27716300|NCT03178487|80795782|FG000|Period 1|Other|0|||
27716301|NCT03178487|80795783|FG001|Period 1|Other|1|||
27716302|NCT03178487|80795782|FG000|Period 2|Adverse Event|4|||
27716303|NCT03178487|80795783|FG001|Period 2|Adverse Event|4|||
27716304|NCT03178487|80795782|FG000|Period 2|Withdrawal by Subject|6|||
27716305|NCT03178487|80795783|FG001|Period 2|Withdrawal by Subject|6|||
27716306|NCT03178487|80795782|FG000|Period 2|Lost to Follow-up|2|||
27716307|NCT03178487|80795783|FG001|Period 2|Lost to Follow-up|2|||
27716308|NCT03178487|80795782|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
27716309|NCT03178487|80795783|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
27716310|NCT03178487|80795782|FG000|Period 2|Other|8|||
27716311|NCT03178487|80795783|FG001|Period 2|Other|7|||
27716312|NCT00283595|80795785|FG000|Overall Study|Withdrawal by Subject|1|||
27716313|NCT00283595|80795786|FG001|Overall Study|Withdrawal by Subject|2|||
27716314|NCT03670953|80795788|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
27716315|NCT03670953|80795789|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
27716316|NCT03670953|80795790|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
27716317|NCT03670953|80795791|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
27716318|NCT03670953|80795788|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
27716319|NCT03670953|80795789|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
27716320|NCT03670953|80795790|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
27716321|NCT03670953|80795791|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
27716322|NCT03670953|80795788|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
27716323|NCT03670953|80795789|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
27716324|NCT03670953|80795790|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
27716325|NCT03670953|80795791|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
27716326|NCT03670953|80795788|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
27716327|NCT03670953|80795789|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
27716328|NCT03670953|80795790|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
27837898|NCT00562120|81236540|FG000|First Intervention Period|Randomized but not Treated|1|||
27716329|NCT03670953|80795791|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
27716330|NCT03670953|80795788|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
27716331|NCT03670953|80795789|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
27716332|NCT03670953|80795790|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
27716333|NCT03670953|80795791|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
27716334|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
27716335|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
27716336|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
27716337|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
27716338|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
27716339|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
27716340|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
27716341|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
27716342|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
27716343|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
27716344|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
27716345|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
27716346|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
27716347|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
27716348|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
27716349|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
27716350|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
27716351|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
27716352|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
27716353|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
27716354|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
27716355|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
27716356|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
27716357|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
27716358|NCT03670953|80795788|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
27716359|NCT03670953|80795789|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
27716360|NCT03670953|80795790|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
27716361|NCT03670953|80795791|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
27716362|NCT03670953|80795788|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
27716363|NCT03670953|80795789|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
27716364|NCT03670953|80795790|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
27716365|NCT03670953|80795791|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
27716366|NCT03670953|80795788|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
27716367|NCT03670953|80795789|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
27716368|NCT03670953|80795790|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
27716369|NCT03670953|80795791|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
27716370|NCT03670953|80795788|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
27716371|NCT03670953|80795789|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
27716372|NCT03670953|80795790|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
27716373|NCT03670953|80795791|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
27716374|NCT03670953|80795788|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
27716375|NCT03670953|80795789|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
27716376|NCT03670953|80795790|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
27716377|NCT03670953|80795791|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
27890049|NCT04526509|81430945|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
27958545|NCT01791517|81680065|FG007|Phase I: Period 3|Lens Discomfort|0|||
27716378|NCT03670953|80795788|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
27716379|NCT03670953|80795789|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
27716380|NCT03670953|80795790|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
27716381|NCT03670953|80795791|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
27716382|NCT03670953|80795788|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
27716383|NCT03670953|80795789|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
27716384|NCT03670953|80795790|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
27716385|NCT03670953|80795791|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
27716386|NCT00546052|80795792|FG000|Overall Study|Adverse Event|47|||
27716387|NCT00546052|80795792|FG000|Overall Study|Lost to Follow-up|144|||
27837899|NCT00562120|81236541|FG001|First Intervention Period|Randomized but not Treated|0|||
27837900|NCT00562120|81236542|FG002|First Intervention Period|Randomized but not Treated|0|||
27605938|NCT02508532|80399805|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27837901|NCT00562120|81236543|FG003|First Intervention Period|Randomized but not Treated|0|||
27605939|NCT02508532|80399806|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27605940|NCT02508532|80399807|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27605941|NCT02508532|80399808|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
27605942|NCT02508532|80399809|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27605943|NCT02508532|80399810|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
27605944|NCT02508532|80399802|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605945|NCT02508532|80399803|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605946|NCT02508532|80399804|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605947|NCT02508532|80399805|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605948|NCT02508532|80399806|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605949|NCT02508532|80399807|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605950|NCT02508532|80399808|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605951|NCT02508532|80399809|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
27605952|NCT02508532|80399810|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
27605953|NCT02508532|80399802|FG000|Part 2 - Treatment|Disease Progression|0|||
27605954|NCT02508532|80399803|FG001|Part 2 - Treatment|Disease Progression|0|||
27605955|NCT02508532|80399804|FG002|Part 2 - Treatment|Disease Progression|0|||
27605956|NCT02508532|80399805|FG003|Part 2 - Treatment|Disease Progression|0|||
27605957|NCT02508532|80399806|FG004|Part 2 - Treatment|Disease Progression|0|||
27605958|NCT02508532|80399807|FG005|Part 2 - Treatment|Disease Progression|0|||
27605959|NCT02508532|80399808|FG006|Part 2 - Treatment|Disease Progression|0|||
27605960|NCT02508532|80399809|FG007|Part 2 - Treatment|Disease Progression|0|||
27605961|NCT02508532|80399810|FG008|Part 2 - Treatment|Disease Progression|118|||
27605962|NCT02508532|80399802|FG000|Part 2 - Treatment|Adverse Event|0|||
27605963|NCT02508532|80399803|FG001|Part 2 - Treatment|Adverse Event|0|||
27605964|NCT02508532|80399804|FG002|Part 2 - Treatment|Adverse Event|0|||
27605965|NCT02508532|80399805|FG003|Part 2 - Treatment|Adverse Event|0|||
27605966|NCT02508532|80399806|FG004|Part 2 - Treatment|Adverse Event|0|||
27605967|NCT02508532|80399807|FG005|Part 2 - Treatment|Adverse Event|0|||
27605968|NCT02508532|80399808|FG006|Part 2 - Treatment|Adverse Event|0|||
27605969|NCT02508532|80399809|FG007|Part 2 - Treatment|Adverse Event|0|||
27605970|NCT02508532|80399810|FG008|Part 2 - Treatment|Adverse Event|49|||
27605971|NCT02508532|80399802|FG000|Part 2 - Treatment|Physician Decision|0|||
27605972|NCT02508532|80399803|FG001|Part 2 - Treatment|Physician Decision|0|||
27605973|NCT02508532|80399804|FG002|Part 2 - Treatment|Physician Decision|0|||
27605974|NCT02508532|80399805|FG003|Part 2 - Treatment|Physician Decision|0|||
27716388|NCT00546052|80795792|FG000|Overall Study|Protocol Violation|9|||
27716389|NCT00546052|80795792|FG000|Overall Study|Withdrawal by Subject|20|||
27837902|NCT02260258|81236544|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
27837903|NCT02260258|81236545|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
27837904|NCT01098539|81236546|FG000|Overall Study|Adverse Event|26|||
27605975|NCT02508532|80399806|FG004|Part 2 - Treatment|Physician Decision|0|||
27837905|NCT01098539|81236547|FG001|Overall Study|Adverse Event|26|||
27837906|NCT01098539|81236546|FG000|Overall Study|Protocol Violation|1|||
27837907|NCT01098539|81236547|FG001|Overall Study|Protocol Violation|4|||
27837908|NCT01098539|81236546|FG000|Overall Study|Noncompliance|3|||
27837909|NCT01098539|81236547|FG001|Overall Study|Noncompliance|5|||
27837910|NCT01098539|81236546|FG000|Overall Study|Lost to Follow-up|4|||
27837911|NCT01098539|81236547|FG001|Overall Study|Lost to Follow-up|4|||
27837912|NCT01098539|81236546|FG000|Overall Study|Withdrawal by Subject|12|||
27605976|NCT02508532|80399807|FG005|Part 2 - Treatment|Physician Decision|0|||
27605977|NCT02508532|80399808|FG006|Part 2 - Treatment|Physician Decision|0|||
27716390|NCT00546052|80795792|FG000|Overall Study|Non Compliance|7|||
27837913|NCT01098539|81236547|FG001|Overall Study|Withdrawal by Subject|26|||
27837914|NCT01098539|81236546|FG000|Overall Study|Physician Decision|5|||
27605978|NCT02508532|80399809|FG007|Part 2 - Treatment|Physician Decision|0|||
27605979|NCT02508532|80399810|FG008|Part 2 - Treatment|Physician Decision|12|||
27605980|NCT02508532|80399802|FG000|Part 2 - Treatment|Administrative|0|||
27605981|NCT02508532|80399803|FG001|Part 2 - Treatment|Administrative|0|||
27605982|NCT02508532|80399804|FG002|Part 2 - Treatment|Administrative|0|||
27605983|NCT02508532|80399805|FG003|Part 2 - Treatment|Administrative|0|||
27605984|NCT02508532|80399806|FG004|Part 2 - Treatment|Administrative|0|||
27605985|NCT02508532|80399807|FG005|Part 2 - Treatment|Administrative|0|||
27837915|NCT01098539|81236547|FG001|Overall Study|Physician Decision|3|||
27837916|NCT00965731|81236552|FG000|Overall Study|Death|0|||
27837917|NCT00965731|81236553|FG001|Overall Study|Death|4|||
27837918|NCT00965731|81236552|FG000|Overall Study|Withdrawal by Subject|0|||
27837919|NCT00965731|81236553|FG001|Overall Study|Withdrawal by Subject|1|||
27837920|NCT00965731|81236552|FG000|Overall Study|Other|7|||
27837921|NCT00965731|81236553|FG001|Overall Study|Other|15|||
27837922|NCT00724958|81236554|FG000|Overall Study|Adverse Event|28|||
27837923|NCT00724958|81236554|FG000|Overall Study|Loss of Response|40|||
27837924|NCT00724958|81236554|FG000|Overall Study|No Response|18|||
27837925|NCT00724958|81236554|FG000|Overall Study|Remission|7|||
27837926|NCT00724958|81236554|FG000|Overall Study|Other Reason|76|||
27837927|NCT00724958|81236554|FG000|Overall Study|No documentation for end of therapy|13|||
27837928|NCT01992094|81236555|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
27837929|NCT01992094|81236556|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
27837930|NCT01992094|81236557|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
27837931|NCT01992094|81236555|FG000|Overall Study|Adverse Event|1|||
27605986|NCT02508532|80399808|FG006|Part 2 - Treatment|Administrative|0|||
27837932|NCT01992094|81236556|FG001|Overall Study|Adverse Event|0|||
27837933|NCT01992094|81236557|FG002|Overall Study|Adverse Event|0|||
27605987|NCT02508532|80399809|FG007|Part 2 - Treatment|Administrative|0|||
27837934|NCT01992094|81236555|FG000|Overall Study|Death|5|||
27837935|NCT01992094|81236556|FG001|Overall Study|Death|5|||
27837936|NCT01992094|81236557|FG002|Overall Study|Death|2|||
27716391|NCT02064387|80795793|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716392|NCT02064387|80795794|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716393|NCT02064387|80795795|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716394|NCT02064387|80795796|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716395|NCT02064387|80795797|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716396|NCT02064387|80795798|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716397|NCT02064387|80795799|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716398|NCT02064387|80795800|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
27716399|NCT02064387|80795801|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716400|NCT02064387|80795802|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
27716401|NCT02064387|80795803|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716402|NCT02064387|80795804|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
27716403|NCT02064387|80795793|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716404|NCT02064387|80795794|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716405|NCT02064387|80795795|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716406|NCT02064387|80795796|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716407|NCT02064387|80795797|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716408|NCT02064387|80795798|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716409|NCT02064387|80795799|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716410|NCT02064387|80795800|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
27716411|NCT02064387|80795801|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716412|NCT02064387|80795802|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716413|NCT02064387|80795803|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716414|NCT02064387|80795804|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
27716415|NCT02064387|80795793|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716416|NCT02064387|80795794|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716417|NCT02064387|80795795|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716418|NCT02064387|80795796|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716419|NCT02064387|80795797|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716420|NCT02064387|80795798|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716421|NCT02064387|80795799|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716422|NCT02064387|80795800|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716423|NCT02064387|80795801|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
27716424|NCT02064387|80795802|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716425|NCT02064387|80795803|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716426|NCT02064387|80795804|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
27716427|NCT02064387|80795793|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
27716428|NCT02064387|80795794|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
27605988|NCT02508532|80399810|FG008|Part 2 - Treatment|Administrative|3|||
27716429|NCT02064387|80795795|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
27716430|NCT02064387|80795796|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
27716431|NCT02064387|80795797|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
27716432|NCT02064387|80795798|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
27716433|NCT02064387|80795799|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
27716434|NCT02064387|80795800|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
27716435|NCT02064387|80795801|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
27716436|NCT02064387|80795802|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
27716437|NCT02064387|80795803|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
27716438|NCT02064387|80795804|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
27716439|NCT02064387|80795793|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716440|NCT02064387|80795794|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716441|NCT02064387|80795795|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716442|NCT02064387|80795796|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27605989|NCT02508532|80399802|FG000|Part 2 - Treatment|Sponsor Decision|0|||
27605990|NCT02508532|80399803|FG001|Part 2 - Treatment|Sponsor Decision|0|||
27605991|NCT02508532|80399804|FG002|Part 2 - Treatment|Sponsor Decision|0|||
27605992|NCT02508532|80399805|FG003|Part 2 - Treatment|Sponsor Decision|0|||
27716443|NCT02064387|80795797|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716444|NCT02064387|80795798|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716445|NCT02064387|80795799|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716446|NCT02064387|80795800|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716447|NCT02064387|80795801|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716448|NCT02064387|80795802|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716449|NCT02064387|80795803|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
27716450|NCT02064387|80795804|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
27716451|NCT00730639|80795805|FG000|Overall Study|Adverse Event|3|||
27716452|NCT00730639|80795806|FG001|Overall Study|Adverse Event|0|||
27716453|NCT00730639|80795807|FG002|Overall Study|Adverse Event|9|||
27716454|NCT00730639|80795808|FG003|Overall Study|Adverse Event|8|||
27716455|NCT00730639|80795809|FG004|Overall Study|Adverse Event|23|||
27837937|NCT01992094|81236555|FG000|Overall Study|Lost to Follow-up|26|||
27837938|NCT01992094|81236556|FG001|Overall Study|Lost to Follow-up|9|||
27605993|NCT02508532|80399806|FG004|Part 2 - Treatment|Sponsor Decision|0|||
27605994|NCT02508532|80399807|FG005|Part 2 - Treatment|Sponsor Decision|0|||
27605995|NCT02508532|80399808|FG006|Part 2 - Treatment|Sponsor Decision|0|||
27605996|NCT02508532|80399809|FG007|Part 2 - Treatment|Sponsor Decision|0|||
27605997|NCT02508532|80399810|FG008|Part 2 - Treatment|Sponsor Decision|28|||
27605998|NCT02508532|80399802|FG000|Part 2 - Treatment|Death|0|||
27605999|NCT02508532|80399803|FG001|Part 2 - Treatment|Death|0|||
27606000|NCT02508532|80399804|FG002|Part 2 - Treatment|Death|0|||
27606001|NCT02508532|80399805|FG003|Part 2 - Treatment|Death|0|||
27606002|NCT02508532|80399806|FG004|Part 2 - Treatment|Death|0|||
27606003|NCT02508532|80399807|FG005|Part 2 - Treatment|Death|0|||
27606004|NCT02508532|80399808|FG006|Part 2 - Treatment|Death|0|||
27606005|NCT02508532|80399809|FG007|Part 2 - Treatment|Death|0|||
27606006|NCT02508532|80399810|FG008|Part 2 - Treatment|Death|1|||
27606007|NCT02508532|80399802|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
27716456|NCT00730639|80795805|FG000|Overall Study|Complete Response|0|||
27716457|NCT00730639|80795806|FG001|Overall Study|Complete Response|0|||
27716458|NCT00730639|80795807|FG002|Overall Study|Complete Response|2|||
27606008|NCT02508532|80399803|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
27606009|NCT02508532|80399804|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
27606010|NCT02508532|80399805|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
27606011|NCT02508532|80399806|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
27606012|NCT02508532|80399807|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
27606013|NCT02508532|80399808|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
27606014|NCT02508532|80399809|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
27606015|NCT02508532|80399810|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
27606016|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
27606017|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
27606018|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
27606019|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
27606020|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
27606021|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
27606022|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
27606023|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
27606024|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
27716459|NCT00730639|80795808|FG003|Overall Study|Complete Response|2|||
27716460|NCT00730639|80795809|FG004|Overall Study|Complete Response|1|||
27716461|NCT00730639|80795805|FG000|Overall Study|Completed Maximum Cycles|0|||
27716462|NCT00730639|80795806|FG001|Overall Study|Completed Maximum Cycles|0|||
27606025|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
27606026|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
27606027|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
27606028|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
27606029|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
27606030|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
27606031|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
27606032|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
27606033|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
27606034|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Death|0|||
27606035|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Death|4|||
27716463|NCT00730639|80795807|FG002|Overall Study|Completed Maximum Cycles|11|||
27716464|NCT00730639|80795808|FG003|Overall Study|Completed Maximum Cycles|3|||
27606036|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Death|2|||
27606037|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Death|4|||
27716465|NCT00730639|80795809|FG004|Overall Study|Completed Maximum Cycles|6|||
27837939|NCT01992094|81236557|FG002|Overall Study|Lost to Follow-up|13|||
27837940|NCT01992094|81236555|FG000|Overall Study|OTHER|4|||
27606038|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Death|3|||
27606039|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Death|0|||
27606040|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Death|0|||
27606041|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Death|1|||
27606042|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Death|111|||
27606043|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
27606044|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
27606045|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
27606046|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
27606047|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
27606048|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
27606049|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
27606050|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
27606051|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
27606052|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606053|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606054|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606055|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606056|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606057|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606058|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606059|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
27606060|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
27606061|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
27606062|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
27606063|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
27606064|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
27606065|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
27606066|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
27606067|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
27606068|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
27606069|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
27606070|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606071|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606072|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606073|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606074|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606075|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606076|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606077|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
27606078|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
27606079|NCT02508532|80399802|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
27716466|NCT00730639|80795805|FG000|Overall Study|Death|0|||
27716467|NCT00730639|80795806|FG001|Overall Study|Death|0|||
27606080|NCT02508532|80399803|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
27606081|NCT02508532|80399804|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
27716468|NCT00730639|80795807|FG002|Overall Study|Death|0|||
27716469|NCT00730639|80795808|FG003|Overall Study|Death|0|||
27716470|NCT00730639|80795809|FG004|Overall Study|Death|2|||
27890050|NCT04526509|81430946|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
27890051|NCT04526509|81430940|FG000|Enrolled|Study Terminated by Sponsor|0|||
27890052|NCT04526509|81430941|FG001|Enrolled|Study Terminated by Sponsor|0|||
27890053|NCT04526509|81430942|FG002|Enrolled|Study Terminated by Sponsor|0|||
27890054|NCT04526509|81430943|FG003|Enrolled|Study Terminated by Sponsor|0|||
27890055|NCT04526509|81430944|FG004|Enrolled|Study Terminated by Sponsor|0|||
27890056|NCT04526509|81430945|FG005|Enrolled|Study Terminated by Sponsor|0|||
27890057|NCT04526509|81430946|FG006|Enrolled|Study Terminated by Sponsor|1|||
27890058|NCT04526509|81430940|FG000|Enrolled|Death prior to lymphodepletion|0|||
27890059|NCT04526509|81430941|FG001|Enrolled|Death prior to lymphodepletion|0|||
27890060|NCT04526509|81430942|FG002|Enrolled|Death prior to lymphodepletion|0|||
27890061|NCT04526509|81430943|FG003|Enrolled|Death prior to lymphodepletion|1|||
27716471|NCT00730639|80795805|FG000|Overall Study|Disease Progression|12|||
27606082|NCT02508532|80399805|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
27606083|NCT02508532|80399806|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
27837941|NCT01992094|81236556|FG001|Overall Study|OTHER|0|||
27837942|NCT01992094|81236557|FG002|Overall Study|OTHER|0|||
27837943|NCT01992094|81236555|FG000|Overall Study|Protocol Violation|1|||
27837944|NCT01992094|81236556|FG001|Overall Study|Protocol Violation|0|||
27837945|NCT01992094|81236557|FG002|Overall Study|Protocol Violation|1|||
27837946|NCT01992094|81236555|FG000|Overall Study|Withdrawal by Subject|7|||
27837947|NCT01992094|81236556|FG001|Overall Study|Withdrawal by Subject|3|||
27837948|NCT01992094|81236557|FG002|Overall Study|Withdrawal by Subject|4|||
27837949|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
27837950|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
27837951|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
27837952|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
27837953|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
27837954|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
27837955|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
27837956|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
27837957|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
27837958|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
27837959|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
27837960|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
27837961|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
27837962|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
27837963|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
27837964|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
27837965|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
27606084|NCT02508532|80399807|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
27606085|NCT02508532|80399808|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
27606086|NCT02508532|80399809|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
27606087|NCT02508532|80399810|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
27606088|NCT03333915|80399811|FG000|Overall Study|Lost to Follow-up|0|||
27606089|NCT03333915|80399812|FG001|Overall Study|Lost to Follow-up|0|||
27606090|NCT03333915|80399813|FG002|Overall Study|Lost to Follow-up|1|||
27606091|NCT03333915|80399814|FG003|Overall Study|Lost to Follow-up|0|||
27606092|NCT03333915|80399815|FG004|Overall Study|Lost to Follow-up|0|||
27606093|NCT03333915|80399811|FG000|Overall Study|Disease Progression|0|||
27606094|NCT03333915|80399812|FG001|Overall Study|Disease Progression|1|||
27606095|NCT03333915|80399813|FG002|Overall Study|Disease Progression|0|||
27606096|NCT03333915|80399814|FG003|Overall Study|Disease Progression|0|||
27606097|NCT03333915|80399815|FG004|Overall Study|Disease Progression|0|||
27606098|NCT03333915|80399811|FG000|Overall Study|Death|0|||
27606099|NCT03333915|80399812|FG001|Overall Study|Death|0|||
27606100|NCT03333915|80399813|FG002|Overall Study|Death|0|||
27606101|NCT03333915|80399814|FG003|Overall Study|Death|37|||
27606102|NCT03333915|80399815|FG004|Overall Study|Death|18|||
27606103|NCT03333915|80399811|FG000|Overall Study|Sponsor's Decision|0|||
27606104|NCT03333915|80399812|FG001|Overall Study|Sponsor's Decision|0|||
27606105|NCT03333915|80399813|FG002|Overall Study|Sponsor's Decision|0|||
27606106|NCT03333915|80399814|FG003|Overall Study|Sponsor's Decision|48|||
27606107|NCT03333915|80399815|FG004|Overall Study|Sponsor's Decision|4|||
27606108|NCT03333915|80399811|FG000|Overall Study|Withdrawal by Subject|0|||
27606109|NCT03333915|80399812|FG001|Overall Study|Withdrawal by Subject|0|||
27606110|NCT03333915|80399813|FG002|Overall Study|Withdrawal by Subject|0|||
27606111|NCT03333915|80399814|FG003|Overall Study|Withdrawal by Subject|5|||
27606112|NCT03333915|80399815|FG004|Overall Study|Withdrawal by Subject|1|||
27606113|NCT01377480|80399816|FG000|Overall Study|Protocol Violation|0|||
27606114|NCT01377480|80399817|FG001|Overall Study|Protocol Violation|0|||
27606115|NCT01377480|80399818|FG002|Overall Study|Protocol Violation|0|||
27606116|NCT01377480|80399819|FG003|Overall Study|Protocol Violation|4|||
27606117|NCT01377480|80399816|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
27837966|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
27837967|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
27606118|NCT01377480|80399817|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
27606119|NCT01377480|80399818|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
27716472|NCT00730639|80795806|FG001|Overall Study|Disease Progression|13|||
27606120|NCT01377480|80399819|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
27606121|NCT01377480|80399816|FG000|Overall Study|Withdrawal by Subject|0|||
27606122|NCT01377480|80399817|FG001|Overall Study|Withdrawal by Subject|0|||
27606123|NCT01377480|80399818|FG002|Overall Study|Withdrawal by Subject|1|||
27606124|NCT01377480|80399819|FG003|Overall Study|Withdrawal by Subject|0|||
27606125|NCT01377480|80399816|FG000|Overall Study|Serious adverse event|0|||
27606126|NCT01377480|80399817|FG001|Overall Study|Serious adverse event|0|||
27606127|NCT01377480|80399818|FG002|Overall Study|Serious adverse event|1|||
27606128|NCT01377480|80399819|FG003|Overall Study|Serious adverse event|1|||
27606129|NCT01377480|80399816|FG000|Overall Study|Other|0|||
27716473|NCT00730639|80795807|FG002|Overall Study|Disease Progression|48|||
27716474|NCT00730639|80795808|FG003|Overall Study|Disease Progression|32|||
27716475|NCT00730639|80795809|FG004|Overall Study|Disease Progression|88|||
27606130|NCT01377480|80399817|FG001|Overall Study|Other|0|||
27716476|NCT00730639|80795805|FG000|Overall Study|non-specified|0|||
27716477|NCT00730639|80795806|FG001|Overall Study|non-specified|0|||
27716478|NCT00730639|80795807|FG002|Overall Study|non-specified|4|||
27716479|NCT00730639|80795808|FG003|Overall Study|non-specified|2|||
27716480|NCT00730639|80795809|FG004|Overall Study|non-specified|3|||
27716481|NCT00730639|80795805|FG000|Overall Study|Protocol Violation|0|||
27716482|NCT00730639|80795806|FG001|Overall Study|Protocol Violation|0|||
27716483|NCT00730639|80795807|FG002|Overall Study|Protocol Violation|1|||
27716484|NCT00730639|80795808|FG003|Overall Study|Protocol Violation|0|||
27958546|NCT01791517|81680066|FG008|Phase I: Period 3|Lens Discomfort|0|||
27716485|NCT00730639|80795809|FG004|Overall Study|Protocol Violation|0|||
27716486|NCT00730639|80795805|FG000|Overall Study|Withdrawal by Subject|0|||
27606131|NCT01377480|80399818|FG002|Overall Study|Other|7|||
27606132|NCT01377480|80399819|FG003|Overall Study|Other|6|||
27716487|NCT00730639|80795806|FG001|Overall Study|Withdrawal by Subject|0|||
27958547|NCT01791517|81680067|FG009|Phase I: Period 3|Lens Discomfort|0|||
27958548|NCT01791517|81680068|FG010|Phase I: Period 3|Lens Discomfort|0|||
27958549|NCT01791517|81680069|FG011|Phase I: Period 3|Lens Discomfort|1|||
27958550|NCT01791517|81680058|FG000|Phase I: Period 3|Lost to Follow-up|0|||
27958551|NCT01791517|81680059|FG001|Phase I: Period 3|Lost to Follow-up|1|||
27958552|NCT01791517|81680060|FG002|Phase I: Period 3|Lost to Follow-up|0|||
27958553|NCT01791517|81680061|FG003|Phase I: Period 3|Lost to Follow-up|0|||
27958554|NCT01791517|81680062|FG004|Phase I: Period 3|Lost to Follow-up|1|||
27958555|NCT01791517|81680063|FG005|Phase I: Period 3|Lost to Follow-up|0|||
27958556|NCT01791517|81680064|FG006|Phase I: Period 3|Lost to Follow-up|0|||
27958557|NCT01791517|81680065|FG007|Phase I: Period 3|Lost to Follow-up|0|||
27958558|NCT01791517|81680066|FG008|Phase I: Period 3|Lost to Follow-up|0|||
27958559|NCT01791517|81680067|FG009|Phase I: Period 3|Lost to Follow-up|0|||
27958560|NCT01791517|81680068|FG010|Phase I: Period 3|Lost to Follow-up|0|||
27958561|NCT01791517|81680069|FG011|Phase I: Period 3|Lost to Follow-up|0|||
27958562|NCT01791517|81680058|FG000|Phase I: Period 3|Adverse Event|0|||
27958563|NCT01791517|81680059|FG001|Phase I: Period 3|Adverse Event|0|||
27958564|NCT01791517|81680060|FG002|Phase I: Period 3|Adverse Event|0|||
27958565|NCT01791517|81680061|FG003|Phase I: Period 3|Adverse Event|1|||
27958566|NCT01791517|81680062|FG004|Phase I: Period 3|Adverse Event|0|||
27958567|NCT01791517|81680063|FG005|Phase I: Period 3|Adverse Event|0|||
27958568|NCT01791517|81680064|FG006|Phase I: Period 3|Adverse Event|0|||
27958569|NCT01791517|81680065|FG007|Phase I: Period 3|Adverse Event|0|||
27958570|NCT01791517|81680066|FG008|Phase I: Period 3|Adverse Event|0|||
27958571|NCT01791517|81680067|FG009|Phase I: Period 3|Adverse Event|0|||
27958572|NCT01791517|81680068|FG010|Phase I: Period 3|Adverse Event|0|||
27958573|NCT01791517|81680069|FG011|Phase I: Period 3|Adverse Event|0|||
27958574|NCT01791517|81680058|FG000|Phase II|Lost to Follow-up|1|||
27958575|NCT01791517|81680059|FG001|Phase II|Lost to Follow-up|0|||
27958576|NCT01791517|81680060|FG002|Phase II|Lost to Follow-up|1|||
27958577|NCT01791517|81680061|FG003|Phase II|Lost to Follow-up|0|||
27958578|NCT01791517|81680062|FG004|Phase II|Lost to Follow-up|1|||
27837968|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
27837969|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
27837970|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
27837971|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
27837972|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
27837973|NCT01710358|81236558|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
27837974|NCT01710358|81236559|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
27837975|NCT01710358|81236560|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
27837976|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
27837977|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
27837978|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
27837979|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
27837980|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
27606133|NCT03183388|80399820|FG000|Overall Study|Lost to Follow-up|3|||
27606134|NCT03183388|80399821|FG001|Overall Study|Lost to Follow-up|5|||
27606135|NCT03183388|80399820|FG000|Overall Study|Physician Decision|1|||
27606136|NCT03183388|80399821|FG001|Overall Study|Physician Decision|4|||
27606137|NCT03183388|80399820|FG000|Overall Study|Withdrawal by Subject|4|||
27606138|NCT03183388|80399821|FG001|Overall Study|Withdrawal by Subject|1|||
27606139|NCT03183388|80399820|FG000|Overall Study|Moved|1|||
27837981|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
27837982|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
27837983|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
27837984|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
27837985|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
27837986|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
27837987|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
27837988|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
27837989|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
27837990|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
27837991|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
27837992|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
27837993|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
27837994|NCT01710358|81236558|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
27837995|NCT01710358|81236559|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
27837996|NCT01710358|81236560|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
27837997|NCT01710358|81236558|FG000|Rescue Period|Adverse Event|0|||
27837998|NCT01710358|81236559|FG001|Rescue Period|Adverse Event|15|||
27837999|NCT01710358|81236560|FG002|Rescue Period|Adverse Event|0|||
27838000|NCT01710358|81236558|FG000|Rescue Period|Death|0|||
27838001|NCT01710358|81236559|FG001|Rescue Period|Death|1|||
27838002|NCT01710358|81236560|FG002|Rescue Period|Death|0|||
27838003|NCT01710358|81236558|FG000|Rescue Period|Lack of Efficacy|0|||
27838004|NCT01710358|81236559|FG001|Rescue Period|Lack of Efficacy|7|||
27838005|NCT01710358|81236560|FG002|Rescue Period|Lack of Efficacy|0|||
27838006|NCT01710358|81236558|FG000|Rescue Period|Withdrawal by Subject|0|||
27838007|NCT01710358|81236559|FG001|Rescue Period|Withdrawal by Subject|8|||
27838008|NCT01710358|81236560|FG002|Rescue Period|Withdrawal by Subject|0|||
27838009|NCT00113919|81236561|FG000|Overall Study|Physician Decision|8|||
27838010|NCT00113919|81236561|FG000|Overall Study|Death|6|||
27838011|NCT01541215|81236564|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
27838012|NCT01541215|81236565|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
27838013|NCT01541215|81236564|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
27838014|NCT01541215|81236565|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
27838015|NCT01541215|81236564|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
27838016|NCT01541215|81236565|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
27838017|NCT01541215|81236564|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
27838018|NCT01541215|81236565|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
27838019|NCT01541215|81236564|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
27838020|NCT01541215|81236565|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
27838021|NCT01541215|81236564|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
27838022|NCT01541215|81236565|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
27838023|NCT04531527|81236569|FG000|Overall Study|Found to be Ineligible|3|||
27838024|NCT02377349|81236570|FG000|Overall Study|Serious Adverse Event|1|||
27838025|NCT02377349|81236571|FG001|Overall Study|Serious Adverse Event|0|||
27838026|NCT02377349|81236570|FG000|Overall Study|Protocol Violation|3|||
27838027|NCT02377349|81236571|FG001|Overall Study|Protocol Violation|2|||
27838028|NCT02377349|81236570|FG000|Overall Study|Withdrawal by Subject|5|||
27838029|NCT02377349|81236571|FG001|Overall Study|Withdrawal by Subject|3|||
27838030|NCT02377349|81236570|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
27838031|NCT02377349|81236571|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
27838032|NCT02377349|81236570|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
27838033|NCT02377349|81236571|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
27838034|NCT02377349|81236570|FG000|Overall Study|Other|0|||
27838035|NCT02377349|81236571|FG001|Overall Study|Other|1|||
27838036|NCT01688882|81236572|FG000|Overall Study|Adverse Event|1|||
27838037|NCT01688882|81236573|FG001|Overall Study|Adverse Event|0|||
27838038|NCT01688882|81236572|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27838039|NCT01688882|81236573|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27838040|NCT01688882|81236572|FG000|Overall Study|Administrative problems|1|||
27838041|NCT01688882|81236573|FG001|Overall Study|Administrative problems|0|||
27838042|NCT03023137|81236575|FG000|Overall Study|Multiple pregnancy|2|||
27838043|NCT03023137|81236576|FG001|Overall Study|Multiple pregnancy|4|||
27606140|NCT03183388|80399821|FG001|Overall Study|Moved|0|||
27838044|NCT03023137|81236575|FG000|Overall Study|Lost to Follow-up|1|||
27838045|NCT03023137|81236576|FG001|Overall Study|Lost to Follow-up|1|||
27838046|NCT03023137|81236575|FG000|Overall Study|Protocol Violation|0|||
27838047|NCT03023137|81236576|FG001|Overall Study|Protocol Violation|4|||
27838048|NCT03023137|81236575|FG000|Overall Study|Lost the baby in a car accident|1|||
27838049|NCT03023137|81236576|FG001|Overall Study|Lost the baby in a car accident|0|||
27606141|NCT03183388|80399820|FG000|Overall Study|Met Exclusion Criteria|2|||
27606142|NCT03183388|80399821|FG001|Overall Study|Met Exclusion Criteria|2|||
27606143|NCT03183388|80399820|FG000|Overall Study|COVID Pandemic Related|2|||
27606144|NCT03183388|80399821|FG001|Overall Study|COVID Pandemic Related|4|||
27606145|NCT02202434|80399822|FG000|Overall Study|Death|70|||
27606146|NCT02202434|80399823|FG001|Overall Study|Death|39|||
27606147|NCT02202434|80399824|FG002|Overall Study|Death|13|||
27606148|NCT02202434|80399825|FG003|Overall Study|Death|27|||
27606149|NCT02202434|80399822|FG000|Overall Study|Lost to Follow-up|1|||
27606150|NCT02202434|80399823|FG001|Overall Study|Lost to Follow-up|1|||
27606151|NCT02202434|80399824|FG002|Overall Study|Lost to Follow-up|1|||
27606152|NCT02202434|80399825|FG003|Overall Study|Lost to Follow-up|0|||
27606153|NCT02202434|80399822|FG000|Overall Study|Physician Decision|2|||
27606154|NCT02202434|80399823|FG001|Overall Study|Physician Decision|3|||
27606155|NCT02202434|80399824|FG002|Overall Study|Physician Decision|0|||
27606156|NCT02202434|80399825|FG003|Overall Study|Physician Decision|0|||
27606157|NCT02202434|80399822|FG000|Overall Study|Withdrawal by Subject|13|||
27606158|NCT02202434|80399823|FG001|Overall Study|Withdrawal by Subject|14|||
27606159|NCT02202434|80399824|FG002|Overall Study|Withdrawal by Subject|1|||
27606160|NCT02202434|80399825|FG003|Overall Study|Withdrawal by Subject|4|||
27606161|NCT02202434|80399822|FG000|Overall Study|Completed Study|1|||
27606162|NCT02202434|80399823|FG001|Overall Study|Completed Study|0|||
27606163|NCT02202434|80399824|FG002|Overall Study|Completed Study|0|||
27606164|NCT02202434|80399825|FG003|Overall Study|Completed Study|0|||
27606165|NCT02202434|80399822|FG000|Overall Study|Visit Missed|21|||
27606166|NCT02202434|80399823|FG001|Overall Study|Visit Missed|12|||
27606167|NCT02202434|80399824|FG002|Overall Study|Visit Missed|0|||
27606168|NCT02202434|80399825|FG003|Overall Study|Visit Missed|5|||
27606169|NCT02202434|80399822|FG000|Overall Study|Other|1|||
27606170|NCT02202434|80399823|FG001|Overall Study|Other|0|||
27606171|NCT02202434|80399824|FG002|Overall Study|Other|0|||
27606172|NCT02202434|80399825|FG003|Overall Study|Other|1|||
27606173|NCT01691521|80399827|FG000|Overall Study|Adverse Event|4|||
27606174|NCT01691521|80399828|FG001|Overall Study|Adverse Event|0|||
27606175|NCT01691521|80399829|FG002|Overall Study|Adverse Event|1|||
27606176|NCT01691521|80399827|FG000|Overall Study|Lack of Efficacy|1|||
27606177|NCT01691521|80399828|FG001|Overall Study|Lack of Efficacy|1|||
27606178|NCT01691521|80399829|FG002|Overall Study|Lack of Efficacy|2|||
27606179|NCT01691521|80399827|FG000|Overall Study|Protocol Violation|0|||
27606180|NCT01691521|80399828|FG001|Overall Study|Protocol Violation|3|||
27606181|NCT01691521|80399829|FG002|Overall Study|Protocol Violation|0|||
27606182|NCT01691521|80399827|FG000|Overall Study|Lost to Follow-up|0|||
27606183|NCT01691521|80399828|FG001|Overall Study|Lost to Follow-up|2|||
27716488|NCT00730639|80795807|FG002|Overall Study|Withdrawal by Subject|6|||
27716489|NCT00730639|80795808|FG003|Overall Study|Withdrawal by Subject|3|||
27606184|NCT01691521|80399829|FG002|Overall Study|Lost to Follow-up|2|||
27606185|NCT01691521|80399827|FG000|Overall Study|Physician Decision|2|||
27606186|NCT01691521|80399828|FG001|Overall Study|Physician Decision|1|||
27606187|NCT01691521|80399829|FG002|Overall Study|Physician Decision|0|||
27606188|NCT01691521|80399827|FG000|Overall Study|Withdrawal by Subject|5|||
27606189|NCT01691521|80399828|FG001|Overall Study|Withdrawal by Subject|9|||
27606190|NCT01691521|80399829|FG002|Overall Study|Withdrawal by Subject|4|||
27606191|NCT01859793|80399830|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
27606192|NCT01859793|80399831|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
27606193|NCT01859793|80399830|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
27606194|NCT01859793|80399831|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
27716490|NCT00730639|80795809|FG004|Overall Study|Withdrawal by Subject|4|||
27716491|NCT00730639|80795805|FG000|Overall Study|Treatment on-going|2|||
27716492|NCT00730639|80795806|FG001|Overall Study|Treatment on-going|5|||
27716493|NCT00730639|80795807|FG002|Overall Study|Treatment on-going|5|||
27716494|NCT00730639|80795808|FG003|Overall Study|Treatment on-going|4|||
27716495|NCT00730639|80795809|FG004|Overall Study|Treatment on-going|4|||
27716496|NCT01324232|80795815|FG000|Overall Study|Protocol Violation|0|||
27716497|NCT01324232|80795816|FG001|Overall Study|Protocol Violation|0|||
27716498|NCT01324232|80795817|FG002|Overall Study|Protocol Violation|0|||
27716499|NCT01324232|80795818|FG003|Overall Study|Protocol Violation|2|||
27716500|NCT01324232|80795815|FG000|Overall Study|Missing|0|||
27716501|NCT01324232|80795816|FG001|Overall Study|Missing|0|||
27716502|NCT01324232|80795817|FG002|Overall Study|Missing|1|||
27716503|NCT01324232|80795818|FG003|Overall Study|Missing|0|||
27716504|NCT01324232|80795815|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
27716505|NCT01324232|80795816|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
27716506|NCT01324232|80795817|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
27716507|NCT01324232|80795818|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
27716508|NCT01324232|80795815|FG000|Overall Study|Lack of Efficacy|2|||
27716509|NCT01324232|80795816|FG001|Overall Study|Lack of Efficacy|1|||
27716510|NCT01324232|80795817|FG002|Overall Study|Lack of Efficacy|2|||
27716511|NCT01324232|80795818|FG003|Overall Study|Lack of Efficacy|2|||
27716512|NCT01324232|80795815|FG000|Overall Study|Participant Refused Medication|0|||
27716513|NCT01324232|80795816|FG001|Overall Study|Participant Refused Medication|1|||
27716514|NCT01324232|80795817|FG002|Overall Study|Participant Refused Medication|0|||
27716515|NCT01324232|80795818|FG003|Overall Study|Participant Refused Medication|0|||
27716516|NCT01324232|80795815|FG000|Overall Study|Intercurrent illness|0|||
27716517|NCT01324232|80795816|FG001|Overall Study|Intercurrent illness|0|||
27716518|NCT01324232|80795817|FG002|Overall Study|Intercurrent illness|0|||
27716519|NCT01324232|80795818|FG003|Overall Study|Intercurrent illness|1|||
27716520|NCT01324232|80795815|FG000|Overall Study|Adverse Event|2|||
27716521|NCT01324232|80795816|FG001|Overall Study|Adverse Event|5|||
27716522|NCT01324232|80795817|FG002|Overall Study|Adverse Event|6|||
27716523|NCT01324232|80795818|FG003|Overall Study|Adverse Event|6|||
27716524|NCT01324232|80795815|FG000|Overall Study|Withdrawal by Subject|0|||
27716525|NCT01324232|80795816|FG001|Overall Study|Withdrawal by Subject|3|||
27716526|NCT01324232|80795817|FG002|Overall Study|Withdrawal by Subject|4|||
27716527|NCT01324232|80795818|FG003|Overall Study|Withdrawal by Subject|0|||
27716528|NCT01324232|80795815|FG000|Overall Study|Lost to Follow-up|1|||
27716529|NCT01324232|80795816|FG001|Overall Study|Lost to Follow-up|0|||
27716530|NCT01324232|80795817|FG002|Overall Study|Lost to Follow-up|0|||
27716531|NCT01324232|80795818|FG003|Overall Study|Lost to Follow-up|0|||
27716532|NCT01890421|80795819|FG000|Overall Study|Adverse Event|1|||
27716533|NCT01890421|80795819|FG000|Overall Study|Other reason|10|||
27716534|NCT01665144|80795822|FG000|Core Part|Withdrawal by Subject|96|||
27716535|NCT01665144|80795823|FG001|Core Part|Withdrawal by Subject|77|||
27716536|NCT01665144|80795824|FG002|Core Part|Withdrawal by Subject|0|||
27716537|NCT01665144|80795822|FG000|Core Part|Adverse Event|45|||
27716538|NCT01665144|80795823|FG001|Core Part|Adverse Event|18|||
27716539|NCT01665144|80795824|FG002|Core Part|Adverse Event|0|||
27716540|NCT01665144|80795822|FG000|Core Part|Lack of Efficacy|16|||
27716541|NCT01665144|80795823|FG001|Core Part|Lack of Efficacy|11|||
27716542|NCT01665144|80795824|FG002|Core Part|Lack of Efficacy|0|||
27716543|NCT01665144|80795822|FG000|Core Part|Lost to Follow-up|9|||
27716544|NCT01665144|80795823|FG001|Core Part|Lost to Follow-up|8|||
27716545|NCT01665144|80795824|FG002|Core Part|Lost to Follow-up|0|||
27716546|NCT01665144|80795822|FG000|Core Part|Physician Decision|13|||
27716547|NCT01665144|80795823|FG001|Core Part|Physician Decision|1|||
27716548|NCT01665144|80795824|FG002|Core Part|Physician Decision|0|||
27716549|NCT01665144|80795822|FG000|Core Part|Progressive disease|8|||
27716550|NCT01665144|80795823|FG001|Core Part|Progressive disease|4|||
27716551|NCT01665144|80795824|FG002|Core Part|Progressive disease|0|||
27716552|NCT01665144|80795822|FG000|Core Part|Non-compliance with study treatment|5|||
27716553|NCT01665144|80795823|FG001|Core Part|Non-compliance with study treatment|0|||
27716554|NCT01665144|80795824|FG002|Core Part|Non-compliance with study treatment|0|||
27606195|NCT01859793|80399830|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
27606196|NCT01859793|80399831|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
27606197|NCT01859793|80399830|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
27716555|NCT01665144|80795822|FG000|Core Part|Death|3|||
27716556|NCT01665144|80795823|FG001|Core Part|Death|1|||
27716557|NCT01665144|80795824|FG002|Core Part|Death|0|||
27716558|NCT01665144|80795822|FG000|Core Part|Protocol deviation|3|||
27716559|NCT01665144|80795823|FG001|Core Part|Protocol deviation|1|||
27716560|NCT01665144|80795824|FG002|Core Part|Protocol deviation|0|||
27716561|NCT01665144|80795822|FG000|Core Part|New therapy for study indication|2|||
27716562|NCT01665144|80795823|FG001|Core Part|New therapy for study indication|1|||
27716563|NCT01665144|80795824|FG002|Core Part|New therapy for study indication|0|||
27716564|NCT01665144|80795822|FG000|Core Part|Technical problems|2|||
27716565|NCT01665144|80795823|FG001|Core Part|Technical problems|0|||
27716566|NCT01665144|80795824|FG002|Core Part|Technical problems|0|||
27716567|NCT01665144|80795822|FG000|Extension Part|Patient/guardian decision|180|||
27716568|NCT01665144|80795823|FG001|Extension Part|Patient/guardian decision|0|||
27716569|NCT01665144|80795824|FG002|Extension Part|Patient/guardian decision|98|||
27716570|NCT01665144|80795822|FG000|Extension Part|Adverse Event|104|||
27716571|NCT01665144|80795823|FG001|Extension Part|Adverse Event|0|||
27716572|NCT01665144|80795824|FG002|Extension Part|Adverse Event|59|||
27716573|NCT01665144|80795822|FG000|Extension Part|Study closed early|42|||
27716574|NCT01665144|80795823|FG001|Extension Part|Study closed early|0|||
27716575|NCT01665144|80795824|FG002|Extension Part|Study closed early|19|||
27716576|NCT01665144|80795822|FG000|Extension Part|Progressive disease|36|||
27716577|NCT01665144|80795823|FG001|Extension Part|Progressive disease|0|||
27716578|NCT01665144|80795824|FG002|Extension Part|Progressive disease|14|||
27716579|NCT01665144|80795822|FG000|Extension Part|Lack of Efficacy|37|||
27716580|NCT01665144|80795823|FG001|Extension Part|Lack of Efficacy|0|||
27716581|NCT01665144|80795824|FG002|Extension Part|Lack of Efficacy|12|||
27716582|NCT01665144|80795822|FG000|Extension Part|Physician Decision|29|||
27716583|NCT01665144|80795823|FG001|Extension Part|Physician Decision|0|||
27716584|NCT01665144|80795824|FG002|Extension Part|Physician Decision|13|||
27838050|NCT00688844|81236577|FG000|Overall Study|Lost to Follow-up|10|||
27606198|NCT01859793|80399831|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
27716585|NCT01665144|80795822|FG000|Extension Part|Technical problems|20|||
27716586|NCT01665144|80795823|FG001|Extension Part|Technical problems|0|||
27716587|NCT01665144|80795824|FG002|Extension Part|Technical problems|8|||
27716588|NCT01665144|80795822|FG000|Extension Part|Death|20|||
27716589|NCT01665144|80795823|FG001|Extension Part|Death|0|||
27716590|NCT01665144|80795824|FG002|Extension Part|Death|4|||
27716591|NCT01665144|80795822|FG000|Extension Part|Missing|12|||
27716592|NCT01665144|80795823|FG001|Extension Part|Missing|0|||
27716593|NCT01665144|80795824|FG002|Extension Part|Missing|6|||
27716594|NCT01665144|80795822|FG000|Extension Part|Lost to Follow-up|9|||
27716595|NCT01665144|80795823|FG001|Extension Part|Lost to Follow-up|0|||
27716596|NCT01665144|80795824|FG002|Extension Part|Lost to Follow-up|5|||
27838051|NCT00393705|81236578|FG000|Overall Study|Adverse Event|0|||
27716597|NCT01665144|80795822|FG000|Extension Part|New therapy for study indication|3|||
27716598|NCT01665144|80795823|FG001|Extension Part|New therapy for study indication|0|||
27716599|NCT01665144|80795824|FG002|Extension Part|New therapy for study indication|2|||
27716600|NCT01665144|80795822|FG000|Extension Part|Protocol deviation|3|||
27716601|NCT01665144|80795823|FG001|Extension Part|Protocol deviation|0|||
27716602|NCT01665144|80795824|FG002|Extension Part|Protocol deviation|0|||
27716603|NCT02695628|80795825|FG000|Overall Study|Withdrawal by Subject|1|||
27716604|NCT02161211|80795826|FG000|Overall Study|Lost to Follow-up|21|||
27716605|NCT02161211|80795827|FG001|Overall Study|Lost to Follow-up|27|||
27716606|NCT02161211|80795828|FG002|Overall Study|Lost to Follow-up|21|||
27716607|NCT02161211|80795826|FG000|Overall Study|Dropped|12|||
27716608|NCT02161211|80795827|FG001|Overall Study|Dropped|5|||
27716609|NCT02161211|80795828|FG002|Overall Study|Dropped|9|||
27716610|NCT01632566|80795829|FG000|Overall Study|Withdrawal by Subject|0|||
27716611|NCT01632566|80795830|FG001|Overall Study|Withdrawal by Subject|1|||
27716612|NCT01632566|80795831|FG002|Overall Study|Withdrawal by Subject|0|||
27716613|NCT01632566|80795832|FG003|Overall Study|Withdrawal by Subject|0|||
27716614|NCT01632566|80795833|FG004|Overall Study|Withdrawal by Subject|0|||
27716615|NCT01632566|80795829|FG000|Overall Study|Sponsor Decision|0|||
27716616|NCT01632566|80795830|FG001|Overall Study|Sponsor Decision|2|||
27716617|NCT01632566|80795831|FG002|Overall Study|Sponsor Decision|9|||
27716618|NCT01632566|80795832|FG003|Overall Study|Sponsor Decision|2|||
27716619|NCT01632566|80795833|FG004|Overall Study|Sponsor Decision|2|||
27716620|NCT03124563|80795834|FG000|Overall Study|Lost to Follow-up|1|||
27716621|NCT03124563|80795835|FG001|Overall Study|Lost to Follow-up|1|||
27716622|NCT03124563|80795834|FG000|Overall Study|Withdrawal by Subject|1|||
27716623|NCT03124563|80795835|FG001|Overall Study|Withdrawal by Subject|1|||
27716624|NCT01870401|80795836|FG000|Overall Study|Death|48|||
27716625|NCT01870401|80795837|FG001|Overall Study|Death|24|||
27716626|NCT01870401|80795836|FG000|Overall Study|Withdrawal by Subject|39|||
27716627|NCT01870401|80795837|FG001|Overall Study|Withdrawal by Subject|26|||
27716628|NCT01870401|80795836|FG000|Overall Study|Lost to Follow-up|19|||
27716629|NCT01870401|80795837|FG001|Overall Study|Lost to Follow-up|14|||
27716630|NCT01870401|80795836|FG000|Overall Study|Other|9|||
27716631|NCT01870401|80795837|FG001|Overall Study|Other|7|||
27716632|NCT01870401|80795836|FG000|Overall Study|On-going in the Study|35|||
27838052|NCT00393705|81236579|FG001|Overall Study|Adverse Event|2|||
27838053|NCT00393705|81236578|FG000|Overall Study|Death|0|||
27838054|NCT00393705|81236579|FG001|Overall Study|Death|1|||
27606199|NCT03704584|80399835|FG000|Overall Study|Withdrawal by Subject|1|||
27716633|NCT01870401|80795837|FG001|Overall Study|On-going in the Study|25|||
27716634|NCT00411554|80795838|FG000|Overall Study|Adverse Event|2|||
27716635|NCT00411554|80795839|FG001|Overall Study|Adverse Event|4|||
27716636|NCT00411554|80795838|FG000|Overall Study|Lack of Efficacy|2|||
27716637|NCT00411554|80795839|FG001|Overall Study|Lack of Efficacy|5|||
27716638|NCT00411554|80795838|FG000|Overall Study|Withdrawal by Subject|3|||
27716639|NCT00411554|80795839|FG001|Overall Study|Withdrawal by Subject|0|||
27716640|NCT00411554|80795838|FG000|Overall Study|Patient Moved|1|||
27716641|NCT00411554|80795839|FG001|Overall Study|Patient Moved|0|||
27716642|NCT04036708|80795840|FG000|Overall Study|Lost to Follow-up|14|||
27716643|NCT04036708|80795841|FG001|Overall Study|Lost to Follow-up|4|||
27716644|NCT04036708|80795842|FG002|Overall Study|Lost to Follow-up|14|||
27716645|NCT04036708|80795843|FG003|Overall Study|Lost to Follow-up|4|||
27716646|NCT03775421|80795844|FG000|Overall Study|Lost to Follow-up|2|||
27716647|NCT03775421|80795844|FG000|Overall Study|Withdrawal by Subject|10|||
27716648|NCT03775421|80795844|FG000|Overall Study|Physician Decision|3|||
27716649|NCT03775421|80795844|FG000|Overall Study|Death|1|||
27716650|NCT03775421|80795844|FG000|Overall Study|Study Terminated by Sponsor|94|||
27716651|NCT01074190|80795847|FG000|Overall Study|Emergency Cesarean Delivery|1|||
27716652|NCT01074190|80795848|FG001|Overall Study|Emergency Cesarean Delivery|2|||
27716653|NCT01074190|80795849|FG002|Overall Study|Emergency Cesarean Delivery|1|||
27716654|NCT01074190|80795847|FG000|Overall Study|Protocol Violation|2|||
27716655|NCT01074190|80795848|FG001|Overall Study|Protocol Violation|1|||
27606200|NCT03704584|80399836|FG001|Overall Study|Withdrawal by Subject|0|||
27716656|NCT01074190|80795849|FG002|Overall Study|Protocol Violation|0|||
27716657|NCT01074190|80795847|FG000|Overall Study|Delivered in under 90 minutes|0|||
27716658|NCT01074190|80795848|FG001|Overall Study|Delivered in under 90 minutes|2|||
27716659|NCT01074190|80795849|FG002|Overall Study|Delivered in under 90 minutes|1|||
27716660|NCT01074190|80795847|FG000|Overall Study|Subject withdrew consent|1|||
27716661|NCT01074190|80795848|FG001|Overall Study|Subject withdrew consent|1|||
27716662|NCT01074190|80795849|FG002|Overall Study|Subject withdrew consent|1|||
27716663|NCT04899232|80795850|FG000|Screening Period|Physician Decision|1|||
27716664|NCT04899232|80795851|FG001|Screening Period|Physician Decision|0|||
27716665|NCT04899232|80795852|FG002|Screening Period|Physician Decision|0|||
27716666|NCT04899232|80795850|FG000|Screening Period|Withdrawal by Subject|1|||
27716667|NCT04899232|80795851|FG001|Screening Period|Withdrawal by Subject|0|||
27716668|NCT04899232|80795852|FG002|Screening Period|Withdrawal by Subject|0|||
27716669|NCT04899232|80795850|FG000|Screening Period|Participant discharged before receiving intervention|3|||
27716670|NCT04899232|80795851|FG001|Screening Period|Participant discharged before receiving intervention|0|||
27716671|NCT04899232|80795852|FG002|Screening Period|Participant discharged before receiving intervention|0|||
27716672|NCT00927095|80795853|FG000|Overall Study|Adverse Event|3|||
27716673|NCT00927095|80795854|FG001|Overall Study|Adverse Event|1|||
27716674|NCT00927095|80795855|FG002|Overall Study|Adverse Event|0|||
27716675|NCT00927095|80795853|FG000|Overall Study|Withdrawal by Subject|2|||
27716676|NCT00927095|80795854|FG001|Overall Study|Withdrawal by Subject|1|||
27716677|NCT00927095|80795855|FG002|Overall Study|Withdrawal by Subject|1|||
27716678|NCT00927095|80795853|FG000|Overall Study|Physician Decision|1|||
27716679|NCT00927095|80795854|FG001|Overall Study|Physician Decision|2|||
27716680|NCT00927095|80795855|FG002|Overall Study|Physician Decision|1|||
27716681|NCT02474082|80795856|FG000|Overall Study|Adverse Event|2|||
27716682|NCT02474082|80795857|FG001|Overall Study|Adverse Event|32|||
27716683|NCT02474082|80795856|FG000|Overall Study|Withdrawal of informed consent|1|||
27716684|NCT02474082|80795857|FG001|Overall Study|Withdrawal of informed consent|11|||
27716685|NCT02474082|80795856|FG000|Overall Study|Lost to Follow-up|2|||
27716686|NCT02474082|80795857|FG001|Overall Study|Lost to Follow-up|2|||
27716687|NCT02474082|80795856|FG000|Overall Study|Dose tapering not achieved|0|||
27716688|NCT02474082|80795857|FG001|Overall Study|Dose tapering not achieved|4|||
27716689|NCT02474082|80795856|FG000|Overall Study|Participant/guardian decision|1|||
27716690|NCT02474082|80795857|FG001|Overall Study|Participant/guardian decision|2|||
27716691|NCT02474082|80795856|FG000|Overall Study|Non-compliance with study treatment|0|||
27716692|NCT02474082|80795857|FG001|Overall Study|Non-compliance with study treatment|2|||
27716693|NCT02474082|80795856|FG000|Overall Study|Protocol deviation|0|||
27716694|NCT02474082|80795857|FG001|Overall Study|Protocol deviation|1|||
27716695|NCT03728309|80795860|FG000|Overall Study|Randomized but not Treated|0|||
27716696|NCT03728309|80795861|FG001|Overall Study|Randomized but not Treated|1|||
27716697|NCT03728309|80795860|FG000|Overall Study|Adverse Event|0|||
27716698|NCT03728309|80795861|FG001|Overall Study|Adverse Event|1|||
27716699|NCT03728309|80795860|FG000|Overall Study|Withdrawal by Subject|2|||
27716700|NCT03728309|80795861|FG001|Overall Study|Withdrawal by Subject|8|||
27716701|NCT03728309|80795860|FG000|Overall Study|Lost to Follow-up|9|||
27716702|NCT03728309|80795861|FG001|Overall Study|Lost to Follow-up|10|||
27716703|NCT03728309|80795860|FG000|Overall Study|Protocol Deviation|0|||
27716704|NCT03728309|80795861|FG001|Overall Study|Protocol Deviation|1|||
27716705|NCT03728309|80795860|FG000|Overall Study|Due to COVID|1|||
27716706|NCT03728309|80795861|FG001|Overall Study|Due to COVID|3|||
27716707|NCT01844895|80795862|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
27716708|NCT01844895|80795862|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
27716709|NCT01844895|80795862|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
27716710|NCT01844895|80795862|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
27716711|NCT01844895|80795862|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
27716712|NCT01844895|80795862|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
27716713|NCT01844895|80795862|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
27716714|NCT00606086|80795863|FG000|Overall Study|Adverse Event|1|||
27716715|NCT00606086|80795864|FG001|Overall Study|Adverse Event|1|||
27716716|NCT00606086|80795863|FG000|Overall Study|Lost to Follow-up|4|||
27716717|NCT00606086|80795864|FG001|Overall Study|Lost to Follow-up|8|||
27716718|NCT00606086|80795863|FG000|Overall Study|Protocol Violation|1|||
27716719|NCT00606086|80795864|FG001|Overall Study|Protocol Violation|0|||
27716720|NCT00606086|80795863|FG000|Overall Study|Withdrawal by Subject|5|||
27716721|NCT00606086|80795864|FG001|Overall Study|Withdrawal by Subject|3|||
27716722|NCT00606086|80795863|FG000|Overall Study|Non-compliance|0|||
27716723|NCT00606086|80795864|FG001|Overall Study|Non-compliance|1|||
27716724|NCT00606086|80795863|FG000|Overall Study|Randomized, not treated|1|||
27716725|NCT00606086|80795864|FG001|Overall Study|Randomized, not treated|2|||
27716726|NCT02595450|80795865|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
27716727|NCT02595450|80795865|FG000|Overall Study|Enrolled, but not treated|8|||
27716728|NCT01285908|80795866|FG000|Baseline Measurement|unable to insert catheter|1|||
27716729|NCT01285908|80795867|FG001|Baseline Measurement|unable to insert catheter|0|||
27716730|NCT01285908|80795868|FG002|Baseline Measurement|unable to insert catheter|0|||
27716731|NCT01285908|80795866|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
27716732|NCT01285908|80795867|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
27716733|NCT01285908|80795868|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
27716734|NCT01285908|80795866|FG000|Baseline Measurement|unable to tolerate procedure|1|||
27716735|NCT01285908|80795867|FG001|Baseline Measurement|unable to tolerate procedure|0|||
27716736|NCT01285908|80795868|FG002|Baseline Measurement|unable to tolerate procedure|0|||
27716737|NCT03548558|80795870|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
27716738|NCT03548558|80795871|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
27716739|NCT03548558|80795872|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
27716740|NCT03548558|80795873|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
27716741|NCT03548558|80795874|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
27716742|NCT03548558|80795875|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
27716743|NCT03548558|80795876|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
27716744|NCT03548558|80795870|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
27716745|NCT03548558|80795871|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
27716746|NCT03548558|80795872|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
27716747|NCT03548558|80795873|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
27716748|NCT03548558|80795874|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
27716749|NCT03548558|80795875|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
27890062|NCT04526509|81430944|FG004|Enrolled|Death prior to lymphodepletion|0|||
27890063|NCT04526509|81430945|FG005|Enrolled|Death prior to lymphodepletion|0|||
27716750|NCT03548558|80795876|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
27716751|NCT03548558|80795870|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
27838055|NCT00393705|81236578|FG000|Overall Study|Lost to Follow-up|2|||
27838056|NCT00393705|81236579|FG001|Overall Study|Lost to Follow-up|2|||
27838057|NCT00393705|81236578|FG000|Overall Study|Entry Criteria Not Met|10|||
27838058|NCT00393705|81236579|FG001|Overall Study|Entry Criteria Not Met|10|||
27838059|NCT00393705|81236578|FG000|Overall Study|Protocol Violation|4|||
27838060|NCT00393705|81236579|FG001|Overall Study|Protocol Violation|3|||
27838061|NCT00393705|81236578|FG000|Overall Study|Withdrawal by Subject|5|||
27838062|NCT00393705|81236579|FG001|Overall Study|Withdrawal by Subject|3|||
27838063|NCT00393705|81236578|FG000|Overall Study|Physician Decision|2|||
27606208|NCT02364180|80399839|FG000|Overall Study|Screen Fail|1|||
27716752|NCT03548558|80795871|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
27716753|NCT03548558|80795872|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
27716754|NCT03548558|80795873|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
27716755|NCT03548558|80795874|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
27716756|NCT03548558|80795875|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
27716757|NCT03548558|80795876|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
27716758|NCT03548558|80795870|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
27716759|NCT03548558|80795871|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
27716760|NCT03548558|80795872|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
27716761|NCT03548558|80795873|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
27716762|NCT03548558|80795874|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
27716763|NCT03548558|80795875|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
27716764|NCT03548558|80795876|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
27716765|NCT03548558|80795870|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
27716766|NCT03548558|80795871|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
27716767|NCT03548558|80795872|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
27716768|NCT03548558|80795873|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
27716769|NCT03548558|80795874|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
27716770|NCT03548558|80795875|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
27716771|NCT03548558|80795876|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
27716772|NCT03548558|80795870|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
27716773|NCT03548558|80795871|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
27716774|NCT03548558|80795872|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
27716775|NCT03548558|80795873|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
27716776|NCT03548558|80795874|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
27716777|NCT03548558|80795875|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
27716778|NCT03548558|80795876|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
27716779|NCT00978029|80795880|FG000|Overall Study|Adverse Event|1|||
27716780|NCT00978029|80795881|FG001|Overall Study|Adverse Event|2|||
27716781|NCT00978029|80795882|FG002|Overall Study|Adverse Event|5|||
27716782|NCT00978029|80795880|FG000|Overall Study|Withdrawal by Subject|0|||
27716783|NCT00978029|80795881|FG001|Overall Study|Withdrawal by Subject|0|||
27716784|NCT00978029|80795882|FG002|Overall Study|Withdrawal by Subject|1|||
27716785|NCT00978029|80795880|FG000|Overall Study|Protocol Violation|0|||
27716786|NCT00978029|80795881|FG001|Overall Study|Protocol Violation|1|||
27716787|NCT00978029|80795882|FG002|Overall Study|Protocol Violation|0|||
27716788|NCT04951037|80795883|FG000|Overall Study|Lost to Follow-up|16|||
27716789|NCT04951037|80795883|FG000|Overall Study|Withdrawal by Subject|5|||
27716790|NCT04951037|80795883|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
27716791|NCT01594853|80795884|FG000|Overall Study|Withdrawal by Subject|1|||
27716792|NCT01594853|80795885|FG001|Overall Study|Withdrawal by Subject|1|||
27716793|NCT01594853|80795884|FG000|Overall Study|Lost to Follow-up|1|||
27716794|NCT01594853|80795885|FG001|Overall Study|Lost to Follow-up|1|||
27716795|NCT01594853|80795884|FG000|Overall Study|noncompliance with exercise|0|||
27716796|NCT01594853|80795885|FG001|Overall Study|noncompliance with exercise|1|||
27716797|NCT00429858|80795888|FG000|Overall Study|Withdrawal by Subject|1|||
27716798|NCT00429858|80795888|FG000|Overall Study|Study Termination|1|||
27890064|NCT04526509|81430946|FG006|Enrolled|Death prior to lymphodepletion|0|||
27716799|NCT02751502|80795889|FG000|Overall Study|Lack of funding|4|||
27606209|NCT00691132|80399840|FG000|Overall Study|Adverse Event|2|||
27606210|NCT00691132|80399841|FG001|Overall Study|Adverse Event|3|||
27838064|NCT00393705|81236579|FG001|Overall Study|Physician Decision|2|||
27838065|NCT00772148|81236580|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
27838066|NCT00772148|81236581|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
27838067|NCT00772148|81236580|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
27838068|NCT00772148|81236581|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
27838069|NCT00772148|81236580|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
27606211|NCT00691132|80399840|FG000|Overall Study|Withdrawal by Subject|10|||
27606212|NCT00691132|80399841|FG001|Overall Study|Withdrawal by Subject|10|||
27606213|NCT03489057|80399842|FG000|Overall Study|Lost to Follow-up|16|||
27606214|NCT03489057|80399843|FG001|Overall Study|Lost to Follow-up|16|||
27606215|NCT03489057|80399844|FG002|Overall Study|Lost to Follow-up|14|||
27606216|NCT03489057|80399845|FG003|Overall Study|Lost to Follow-up|14|||
27606217|NCT03489057|80399842|FG000|Overall Study|Withdrawal by Subject|12|||
27606218|NCT03489057|80399843|FG001|Overall Study|Withdrawal by Subject|12|||
27606219|NCT03489057|80399844|FG002|Overall Study|Withdrawal by Subject|8|||
27606220|NCT03489057|80399845|FG003|Overall Study|Withdrawal by Subject|8|||
27606221|NCT03489057|80399842|FG000|Overall Study|Protocol Violation|7|||
27716800|NCT01445951|80795890|FG000|Overall Study|Adverse Event|16|||
27716801|NCT01445951|80795891|FG001|Overall Study|Adverse Event|9|||
27716802|NCT01445951|80795892|FG002|Overall Study|Adverse Event|0|||
27716803|NCT01445951|80795890|FG000|Overall Study|Protocol Violation|2|||
27606222|NCT03489057|80399843|FG001|Overall Study|Protocol Violation|7|||
27606223|NCT03489057|80399844|FG002|Overall Study|Protocol Violation|2|||
27606224|NCT03489057|80399845|FG003|Overall Study|Protocol Violation|2|||
27606225|NCT03713021|80399850|FG000|Overall Study|Did not have CT sim scan available|6|||
27716804|NCT01445951|80795891|FG001|Overall Study|Protocol Violation|2|||
27716805|NCT01445951|80795892|FG002|Overall Study|Protocol Violation|2|||
27716806|NCT01445951|80795890|FG000|Overall Study|Withdrawal by Subject|21|||
27716807|NCT01445951|80795891|FG001|Overall Study|Withdrawal by Subject|16|||
27716808|NCT01445951|80795892|FG002|Overall Study|Withdrawal by Subject|8|||
27716809|NCT01445951|80795890|FG000|Overall Study|Physician Decision|3|||
27838070|NCT00772148|81236581|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
27606226|NCT03713021|80399850|FG000|Overall Study|Not eligible|4|||
27606227|NCT03713021|80399850|FG000|Overall Study|Issues with TraceIT markers|5|||
27606228|NCT02832622|80399853|FG000|Overall Study|MPP not programmed|1259|||
27606229|NCT02832622|80399853|FG000|Overall Study|Withdrawal by Subject|123|||
27838071|NCT00772148|81236580|FG000|Maintenance Phase (Week 52)|Death|2|||
27606230|NCT02832622|80399853|FG000|Overall Study|Death|119|||
27606231|NCT02832622|80399853|FG000|Overall Study|Unsuccessful CRT implant|93|||
27716810|NCT01445951|80795891|FG001|Overall Study|Physician Decision|1|||
27838072|NCT00772148|81236581|FG001|Maintenance Phase (Week 52)|Death|2|||
27606232|NCT02832622|80399853|FG000|Overall Study|Lost to Follow-up|45|||
27606233|NCT02832622|80399853|FG000|Overall Study|Patient non-compliance|42|||
27606234|NCT02832622|80399853|FG000|Overall Study|Withdrawal by other reasons|25|||
27606235|NCT02832622|80399853|FG000|Overall Study|System explant|24|||
27606236|NCT02832622|80399853|FG000|Overall Study|Physician Decision|6|||
27606237|NCT00553501|80399857|FG000|Overall Study|Adverse Event|2|||
27606238|NCT00553501|80399857|FG000|Overall Study|Death|1|||
27606239|NCT00553501|80399857|FG000|Overall Study|Progression|1|||
27606240|NCT04152343|80399860|FG000|Overall Study|Transplanted|5|||
27606241|NCT04152343|80399860|FG000|Overall Study|Death|20|||
27606242|NCT04152343|80399860|FG000|Overall Study|Lost to Follow-up|3|||
27606243|NCT04359771|80399861|FG000|Overall Study|Lack of Efficacy|2|||
27606244|NCT04359771|80399862|FG001|Overall Study|Lack of Efficacy|2|||
27606245|NCT03966053|80399863|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
27606246|NCT01933880|80399865|FG000|Overall Study|Withdrawal by Subject|5|||
27606247|NCT01933880|80399866|FG001|Overall Study|Withdrawal by Subject|0|||
27606248|NCT01933880|80399865|FG000|Overall Study|Lack of Efficacy|1|||
27606249|NCT01933880|80399866|FG001|Overall Study|Lack of Efficacy|0|||
27606250|NCT01933880|80399865|FG000|Overall Study|Concomitant medication Interference|0|||
27606251|NCT01933880|80399866|FG001|Overall Study|Concomitant medication Interference|1|||
27606252|NCT01933880|80399865|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
27606253|NCT01933880|80399866|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
27606254|NCT01933880|80399865|FG000|Overall Study|Other|4|||
27606255|NCT01933880|80399866|FG001|Overall Study|Other|0|||
27606256|NCT01933880|80399865|FG000|Overall Study|Protocol Violation|1|||
27606257|NCT01933880|80399866|FG001|Overall Study|Protocol Violation|0|||
27606258|NCT01686581|80399867|FG000|Overall Study|Side-effects or Health Problems|15|||
27606259|NCT01686581|80399867|FG000|Overall Study|Lack of Efficacy|90|||
27606260|NCT01686581|80399867|FG000|Overall Study|Participant Concerned about Risks|6|||
27606261|NCT01686581|80399867|FG000|Overall Study|Thinks Injections Too Painful|8|||
27606262|NCT01686581|80399867|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
27606263|NCT01686581|80399867|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
27606264|NCT01686581|80399867|FG000|Overall Study|Thinks it is Inconvenient|17|||
27606265|NCT01686581|80399867|FG000|Overall Study|Other Miscellaneous Reasons|36|||
27606266|NCT01686581|80399867|FG000|Overall Study|Reason Missing|1|||
27606267|NCT02322814|80399868|FG000|Overall Study|Death|7|||
27606268|NCT02322814|80399869|FG001|Overall Study|Death|29|||
27606269|NCT02322814|80399870|FG002|Overall Study|Death|32|||
27606270|NCT02322814|80399871|FG003|Overall Study|Death|23|||
27606271|NCT02322814|80399872|FG004|Overall Study|Death|14|||
27606272|NCT02322814|80399868|FG000|Overall Study|Lost to Follow-up|1|||
27716811|NCT01445951|80795892|FG002|Overall Study|Physician Decision|0|||
27716812|NCT01445951|80795890|FG000|Overall Study|Lost to Follow-up|1|||
27716813|NCT01445951|80795891|FG001|Overall Study|Lost to Follow-up|2|||
27716814|NCT01445951|80795892|FG002|Overall Study|Lost to Follow-up|4|||
27716815|NCT01445951|80795890|FG000|Overall Study|Pregnancy|0|||
27716816|NCT01445951|80795891|FG001|Overall Study|Pregnancy|1|||
27716817|NCT01445951|80795892|FG002|Overall Study|Pregnancy|4|||
27716818|NCT01445951|80795890|FG000|Overall Study|Death|0|||
27716819|NCT01445951|80795891|FG001|Overall Study|Death|0|||
27716820|NCT01445951|80795892|FG002|Overall Study|Death|1|||
27716821|NCT01445951|80795890|FG000|Overall Study|Non-compliance with study drug|1|||
27716822|NCT01445951|80795891|FG001|Overall Study|Non-compliance with study drug|2|||
27716823|NCT01445951|80795892|FG002|Overall Study|Non-compliance with study drug|0|||
27716824|NCT01445951|80795890|FG000|Overall Study|Non-compliance with protocol|0|||
27716825|NCT01445951|80795891|FG001|Overall Study|Non-compliance with protocol|1|||
27716826|NCT01445951|80795892|FG002|Overall Study|Non-compliance with protocol|0|||
27716827|NCT01445951|80795890|FG000|Overall Study|Sponsor decision - subject travel|0|||
27716828|NCT01445951|80795891|FG001|Overall Study|Sponsor decision - subject travel|1|||
27838073|NCT00772148|81236580|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
27716829|NCT01445951|80795892|FG002|Overall Study|Sponsor decision - subject travel|0|||
27606273|NCT02322814|80399869|FG001|Overall Study|Lost to Follow-up|3|||
27606274|NCT02322814|80399870|FG002|Overall Study|Lost to Follow-up|3|||
27606275|NCT02322814|80399871|FG003|Overall Study|Lost to Follow-up|1|||
27606276|NCT02322814|80399872|FG004|Overall Study|Lost to Follow-up|0|||
27606277|NCT02322814|80399868|FG000|Overall Study|Various Reasons|2|||
27606278|NCT02322814|80399869|FG001|Overall Study|Various Reasons|0|||
27606279|NCT02322814|80399870|FG002|Overall Study|Various Reasons|1|||
27838074|NCT00772148|81236581|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
27716830|NCT01445951|80795890|FG000|Overall Study|Cough|0|||
27716831|NCT01445951|80795891|FG001|Overall Study|Cough|1|||
27716832|NCT01445951|80795892|FG002|Overall Study|Cough|0|||
27838075|NCT00772148|81236580|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
27838076|NCT00772148|81236581|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
27838077|NCT00772148|81236580|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
27838078|NCT00772148|81236581|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
27838079|NCT01169038|81236582|FG000|Overall Study|Death|1|||
27838080|NCT01169038|81236582|FG000|Overall Study|Adverse Event|5|||
27838081|NCT01169038|81236582|FG000|Overall Study|Required antibiotic administration|1|||
27838082|NCT03540160|81236583|FG000|Overall Study|Protocol Violation|1|||
27838083|NCT03540160|81236583|FG000|Overall Study|Physician Decision|8|||
27838084|NCT03540160|81236583|FG000|Overall Study|Lack of Efficacy|60|||
27838085|NCT03540160|81236583|FG000|Overall Study|Pregnancy|1|||
27838086|NCT03540160|81236583|FG000|Overall Study|Adverse Event|20|||
27838087|NCT03540160|81236583|FG000|Overall Study|Withdrawal by Subject|68|||
27838088|NCT03540160|81236583|FG000|Overall Study|COVID-19|2|||
27838089|NCT03540160|81236583|FG000|Overall Study|Study Closure|10|||
27838090|NCT03540160|81236583|FG000|Overall Study|Lost to Follow-up|18|||
27838091|NCT03540160|81236583|FG000|Overall Study|Sponsor decision|191|||
27838092|NCT01160640|81236585|FG000|Overall Study|Physician Decision|3|||
27838093|NCT01160640|81236586|FG001|Overall Study|Physician Decision|3|||
27838094|NCT01160640|81236585|FG000|Overall Study|Incarceration|1|||
27838095|NCT01160640|81236586|FG001|Overall Study|Incarceration|0|||
27838096|NCT01160640|81236585|FG000|Overall Study|Withdrawal by Subject|0|||
27838097|NCT01160640|81236586|FG001|Overall Study|Withdrawal by Subject|3|||
27838098|NCT01142908|81236592|FG000|Overall Study|Lost to Follow-up|19|||
27838099|NCT01142908|81236593|FG001|Overall Study|Lost to Follow-up|13|||
27838100|NCT01142908|81236592|FG000|Overall Study|Death|1|||
27838101|NCT01142908|81236593|FG001|Overall Study|Death|4|||
27838102|NCT01142908|81236592|FG000|Overall Study|Excluded - did not meet criteria|9|||
27838103|NCT01142908|81236593|FG001|Overall Study|Excluded - did not meet criteria|5|||
27838104|NCT01142908|81236592|FG000|Overall Study|Withdrawal by Subject|3|||
27606280|NCT02322814|80399871|FG003|Overall Study|Various Reasons|1|||
27716833|NCT03699007|80795893|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
27716834|NCT03699007|80795894|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
27716835|NCT03699007|80795893|FG000|6-month Follow Up|Lost to Follow-up|2|||
27716836|NCT03699007|80795894|FG001|6-month Follow Up|Lost to Follow-up|3|||
27716837|NCT03595553|80795895|FG000|Overall Study|Withdrawal by Subject|20|||
27716838|NCT03595553|80795896|FG001|Overall Study|Withdrawal by Subject|8|||
27716839|NCT03595553|80795895|FG000|Overall Study|Physician Decision|3|||
27716840|NCT03595553|80795896|FG001|Overall Study|Physician Decision|2|||
27716841|NCT03595553|80795895|FG000|Overall Study|Adverse Event|2|||
27716842|NCT03595553|80795896|FG001|Overall Study|Adverse Event|5|||
27838105|NCT01142908|81236593|FG001|Overall Study|Withdrawal by Subject|0|||
27838106|NCT03343639|81236598|FG000|Overall Study|Withdrawal by Subject|10|||
27838107|NCT03343639|81236599|FG001|Overall Study|Withdrawal by Subject|6|||
27838108|NCT03343639|81236598|FG000|Overall Study|Lost to Follow-up|4|||
27606281|NCT02322814|80399872|FG004|Overall Study|Various Reasons|0|||
27606282|NCT02322814|80399868|FG000|Overall Study|Progressive Disease|0|||
27606283|NCT02322814|80399869|FG001|Overall Study|Progressive Disease|0|||
27606284|NCT02322814|80399870|FG002|Overall Study|Progressive Disease|0|||
27606285|NCT02322814|80399871|FG003|Overall Study|Progressive Disease|1|||
27606286|NCT02322814|80399872|FG004|Overall Study|Progressive Disease|1|||
27606287|NCT02322814|80399868|FG000|Overall Study|Protocol Violation|1|||
27606288|NCT02322814|80399869|FG001|Overall Study|Protocol Violation|0|||
27606289|NCT02322814|80399870|FG002|Overall Study|Protocol Violation|0|||
27606290|NCT02322814|80399871|FG003|Overall Study|Protocol Violation|0|||
27606291|NCT02322814|80399872|FG004|Overall Study|Protocol Violation|0|||
27606292|NCT02322814|80399868|FG000|Overall Study|Study Terminated by Sponsor|0|||
27606293|NCT02322814|80399869|FG001|Overall Study|Study Terminated by Sponsor|7|||
27606294|NCT02322814|80399870|FG002|Overall Study|Study Terminated by Sponsor|9|||
27606295|NCT02322814|80399871|FG003|Overall Study|Study Terminated by Sponsor|5|||
27606296|NCT02322814|80399872|FG004|Overall Study|Study Terminated by Sponsor|13|||
27606297|NCT02322814|80399868|FG000|Overall Study|Withdrawal by Subject|5|||
27606298|NCT02322814|80399869|FG001|Overall Study|Withdrawal by Subject|4|||
27606299|NCT02322814|80399870|FG002|Overall Study|Withdrawal by Subject|2|||
27606300|NCT02322814|80399871|FG003|Overall Study|Withdrawal by Subject|1|||
27606301|NCT02322814|80399872|FG004|Overall Study|Withdrawal by Subject|3|||
27606302|NCT01874145|80399877|FG000|Core Period|Non-compliance|1|||
27606303|NCT01874145|80399878|FG001|Core Period|Non-compliance|0|||
27606304|NCT01874145|80399877|FG000|Core Period|Protocol Violation|1|||
27606305|NCT01874145|80399878|FG001|Core Period|Protocol Violation|1|||
27606306|NCT01874145|80399877|FG000|Core Period|Physician Decision|1|||
27606307|NCT01874145|80399878|FG001|Core Period|Physician Decision|1|||
27606308|NCT01874145|80399877|FG000|Core Period|Adverse Event|0|||
27606309|NCT01874145|80399878|FG001|Core Period|Adverse Event|1|||
27606310|NCT01874145|80399877|FG000|Core Period|Withdrawal by Subject|0|||
27606311|NCT01874145|80399878|FG001|Core Period|Withdrawal by Subject|4|||
27606312|NCT01874145|80399877|FG000|Extension Period|Adverse Event|3|||
27606313|NCT01874145|80399878|FG001|Extension Period|Adverse Event|2|||
27606314|NCT01874145|80399877|FG000|Extension Period|Withdrawal by Subject|2|||
27606315|NCT01874145|80399878|FG001|Extension Period|Withdrawal by Subject|1|||
27606316|NCT01874145|80399877|FG000|Extension Period|Lost to Follow-up|1|||
27606317|NCT01874145|80399878|FG001|Extension Period|Lost to Follow-up|1|||
27606318|NCT04858802|80399886|FG000|Overall Study|Lost to Follow-up|1|||
27606319|NCT04858802|80399887|FG001|Overall Study|Lost to Follow-up|1|||
27606320|NCT04858802|80399886|FG000|Overall Study|Withdrawal by Subject|1|||
27606321|NCT04858802|80399887|FG001|Overall Study|Withdrawal by Subject|1|||
27606322|NCT00695786|80399888|FG000|Overall Study|Adverse Event|0|||
27606323|NCT00695786|80399889|FG001|Overall Study|Adverse Event|3|||
27606324|NCT00695786|80399890|FG002|Overall Study|Adverse Event|4|||
27606325|NCT00695786|80399891|FG003|Overall Study|Adverse Event|2|||
27606326|NCT00695786|80399888|FG000|Overall Study|Lost to Follow-up|0|||
27606327|NCT00695786|80399889|FG001|Overall Study|Lost to Follow-up|5|||
27606328|NCT00695786|80399890|FG002|Overall Study|Lost to Follow-up|1|||
27606329|NCT00695786|80399891|FG003|Overall Study|Lost to Follow-up|1|||
27606330|NCT00695786|80399888|FG000|Overall Study|Withdrawal by Subject|0|||
27606331|NCT00695786|80399889|FG001|Overall Study|Withdrawal by Subject|4|||
27606332|NCT00695786|80399890|FG002|Overall Study|Withdrawal by Subject|3|||
27606333|NCT00695786|80399891|FG003|Overall Study|Withdrawal by Subject|1|||
27606334|NCT00695786|80399888|FG000|Overall Study|Deemed Ineligible|1|||
27606335|NCT00695786|80399889|FG001|Overall Study|Deemed Ineligible|0|||
27606336|NCT00695786|80399890|FG002|Overall Study|Deemed Ineligible|0|||
27606337|NCT00695786|80399891|FG003|Overall Study|Deemed Ineligible|0|||
27606338|NCT00695786|80399888|FG000|Overall Study|Lack of Efficacy|0|||
27606339|NCT00695786|80399889|FG001|Overall Study|Lack of Efficacy|0|||
27606340|NCT00695786|80399890|FG002|Overall Study|Lack of Efficacy|0|||
27606341|NCT00695786|80399891|FG003|Overall Study|Lack of Efficacy|4|||
27606342|NCT02243202|80399892|FG000|Overall Study|Adverse Event|5|||
27606343|NCT02243202|80399893|FG001|Overall Study|Adverse Event|6|||
27606344|NCT02243202|80399894|FG002|Overall Study|Adverse Event|10|||
27838109|NCT03343639|81236599|FG001|Overall Study|Lost to Follow-up|5|||
27838110|NCT03343639|81236598|FG000|Overall Study|Protocol Violation|0|||
27838111|NCT03343639|81236599|FG001|Overall Study|Protocol Violation|1|||
27606345|NCT02243202|80399895|FG003|Overall Study|Adverse Event|4|||
27606346|NCT02243202|80399892|FG000|Overall Study|Lost to Follow-up|9|||
27606347|NCT02243202|80399893|FG001|Overall Study|Lost to Follow-up|9|||
27606348|NCT02243202|80399894|FG002|Overall Study|Lost to Follow-up|14|||
27606349|NCT02243202|80399895|FG003|Overall Study|Lost to Follow-up|11|||
27606350|NCT02243202|80399892|FG000|Overall Study|Protocol Violation|3|||
27606351|NCT02243202|80399893|FG001|Overall Study|Protocol Violation|1|||
27606352|NCT02243202|80399894|FG002|Overall Study|Protocol Violation|2|||
27838112|NCT00265785|81236604|FG000|Overall Study|Adverse Event|4|||
27838113|NCT00265785|81236604|FG000|Overall Study|Withdrawal by Subject|3|||
27606353|NCT02243202|80399895|FG003|Overall Study|Protocol Violation|1|||
27606354|NCT02243202|80399892|FG000|Overall Study|Withdrawal by Subject|7|||
27838114|NCT00265785|81236604|FG000|Overall Study|Progression/Relapse|15|||
27606355|NCT02243202|80399893|FG001|Overall Study|Withdrawal by Subject|6|||
27606356|NCT02243202|80399894|FG002|Overall Study|Withdrawal by Subject|4|||
27606357|NCT02243202|80399895|FG003|Overall Study|Withdrawal by Subject|4|||
27606358|NCT02243202|80399892|FG000|Overall Study|Other|1|||
27606359|NCT02243202|80399893|FG001|Overall Study|Other|3|||
27606360|NCT02243202|80399894|FG002|Overall Study|Other|1|||
27606361|NCT02243202|80399895|FG003|Overall Study|Other|2|||
27606362|NCT02243202|80399892|FG000|Overall Study|Randomized but not received treatment|0|||
27606363|NCT02243202|80399893|FG001|Overall Study|Randomized but not received treatment|0|||
27606364|NCT02243202|80399894|FG002|Overall Study|Randomized but not received treatment|0|||
27606365|NCT02243202|80399895|FG003|Overall Study|Randomized but not received treatment|1|||
27606366|NCT00265330|80399898|FG000|Overall Study|Adverse Event|41|||
27606367|NCT00265330|80399898|FG000|Overall Study|Lost to Follow-up|8|||
27606368|NCT00265330|80399898|FG000|Overall Study|Withdrawal by Subject|34|||
27606369|NCT00265330|80399898|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
27606370|NCT00265330|80399898|FG000|Overall Study|Lack of Efficacy|4|||
27606371|NCT00265330|80399898|FG000|Overall Study|Family Scheduling Conflicts|1|||
27606372|NCT00265330|80399898|FG000|Overall Study|Began Taking Formulary Geodon|1|||
27606373|NCT00265330|80399898|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
27606374|NCT00265330|80399898|FG000|Overall Study|Site Closed by Sponsor|1|||
27606375|NCT00265330|80399898|FG000|Overall Study|Principal Investigators Request|1|||
27606376|NCT00265330|80399898|FG000|Overall Study|Withdrew Consent|1|||
27606377|NCT00265330|80399898|FG000|Overall Study|Protocol Violation|1|||
27606378|NCT01287520|80399899|FG000|Overall Study|Adverse Event|2|||
27606379|NCT01287520|80399900|FG001|Overall Study|Adverse Event|2|||
27606380|NCT01287520|80399901|FG002|Overall Study|Adverse Event|2|||
27606381|NCT01287520|80399902|FG003|Overall Study|Adverse Event|1|||
27606382|NCT01287520|80399903|FG004|Overall Study|Adverse Event|1|||
27606383|NCT01287520|80399904|FG005|Overall Study|Adverse Event|2|||
27606384|NCT01287520|80399905|FG006|Overall Study|Adverse Event|0|||
27606385|NCT01287520|80399906|FG007|Overall Study|Adverse Event|2|||
27606386|NCT01287520|80399907|FG008|Overall Study|Adverse Event|0|||
27716843|NCT03595553|80795895|FG000|Overall Study|Death|24|||
27716844|NCT03595553|80795896|FG001|Overall Study|Death|22|||
27716845|NCT03595553|80795895|FG000|Overall Study|Lost to Follow-up|6|||
27716846|NCT03595553|80795896|FG001|Overall Study|Lost to Follow-up|7|||
27716847|NCT03595553|80795895|FG000|Overall Study|Other as indicated in CSR|3|||
27716848|NCT03595553|80795896|FG001|Overall Study|Other as indicated in CSR|3|||
27716849|NCT03595553|80795895|FG000|Overall Study|Sponsor Decision|0|||
27716850|NCT03595553|80795896|FG001|Overall Study|Sponsor Decision|1|||
27716851|NCT00290433|80795908|FG000|Overall Study|Disease Progression|13|||
27838115|NCT00265785|81236604|FG000|Overall Study|Not protocol specified|2|||
27606387|NCT01287520|80399899|FG000|Overall Study|Physician Decision|1|||
27606388|NCT01287520|80399900|FG001|Overall Study|Physician Decision|1|||
27606389|NCT01287520|80399901|FG002|Overall Study|Physician Decision|2|||
27606390|NCT01287520|80399902|FG003|Overall Study|Physician Decision|0|||
27890065|NCT04526509|81430940|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
27890066|NCT04526509|81430941|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
27890067|NCT04526509|81430942|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
27890068|NCT04526509|81430943|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
27890069|NCT04526509|81430944|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
27890070|NCT04526509|81430945|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
27890071|NCT04526509|81430946|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
27890072|NCT04526509|81430940|FG000|Enrolled|Physician Decision|0|||
27890073|NCT04526509|81430941|FG001|Enrolled|Physician Decision|1|||
27606391|NCT01287520|80399903|FG004|Overall Study|Physician Decision|1|||
27606392|NCT01287520|80399904|FG005|Overall Study|Physician Decision|1|||
27606393|NCT01287520|80399905|FG006|Overall Study|Physician Decision|0|||
27838116|NCT00265785|81236604|FG000|Overall Study|Ineligible|1|||
27838117|NCT00265785|81236604|FG000|Overall Study|Did not receive protocol treatment|2|||
27838118|NCT02169336|81236605|FG000|Overall Study|Lack of Efficacy|1|||
27838119|NCT02169336|81236606|FG001|Overall Study|Lack of Efficacy|1|||
27838120|NCT02169336|81236607|FG002|Overall Study|Lack of Efficacy|0|||
27838121|NCT02169336|81236605|FG000|Overall Study|Adverse Event|2|||
27838122|NCT02169336|81236606|FG001|Overall Study|Adverse Event|3|||
27838123|NCT02169336|81236607|FG002|Overall Study|Adverse Event|1|||
27838124|NCT02169336|81236605|FG000|Overall Study|Withdrawal by Subject|1|||
27838125|NCT02169336|81236606|FG001|Overall Study|Withdrawal by Subject|0|||
27838126|NCT02169336|81236607|FG002|Overall Study|Withdrawal by Subject|0|||
27838127|NCT02169336|81236605|FG000|Overall Study|Physician Decision|0|||
27838128|NCT02169336|81236606|FG001|Overall Study|Physician Decision|0|||
27838129|NCT02169336|81236607|FG002|Overall Study|Physician Decision|1|||
27890074|NCT04526509|81430942|FG002|Enrolled|Physician Decision|0|||
27890075|NCT04526509|81430943|FG003|Enrolled|Physician Decision|0|||
27606394|NCT01287520|80399906|FG007|Overall Study|Physician Decision|1|||
27606395|NCT01287520|80399907|FG008|Overall Study|Physician Decision|0|||
27890076|NCT04526509|81430944|FG004|Enrolled|Physician Decision|0|||
27890077|NCT04526509|81430945|FG005|Enrolled|Physician Decision|0|||
27716852|NCT00290433|80795908|FG000|Overall Study|Adverse Event|14|||
27838130|NCT02169336|81236605|FG000|Overall Study|Subject declined to continue dosing|0|||
27838131|NCT02169336|81236606|FG001|Overall Study|Subject declined to continue dosing|0|||
27716853|NCT00290433|80795908|FG000|Overall Study|Withdrawal by Subject|1|||
27716854|NCT00290433|80795908|FG000|Overall Study|Non-Compliance|1|||
27716855|NCT00290433|80795908|FG000|Overall Study|Congestive Heart Failure|1|||
27716856|NCT00290433|80795908|FG000|Overall Study|Transplant in CR|5|||
27716857|NCT00290433|80795908|FG000|Overall Study|Unrelated Infection/Death|1|||
27716858|NCT02706873|80795909|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
27716859|NCT02706873|80795910|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
27716860|NCT02706873|80795911|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
27716861|NCT02706873|80795912|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
27716862|NCT02706873|80795909|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
27716863|NCT02706873|80795910|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
27716864|NCT02706873|80795911|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
27716865|NCT02706873|80795912|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
27716866|NCT02706873|80795909|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
27716867|NCT02706873|80795910|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
27716868|NCT02706873|80795911|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
27716869|NCT02706873|80795912|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
27716870|NCT02706873|80795909|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
27716871|NCT02706873|80795910|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
27716872|NCT02706873|80795911|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
27716873|NCT02706873|80795912|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
27716874|NCT02706873|80795909|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
27716875|NCT02706873|80795910|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
27716876|NCT02706873|80795911|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
27716877|NCT02706873|80795912|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
27716878|NCT02706873|80795909|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
27716879|NCT02706873|80795910|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
27716880|NCT02706873|80795911|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
27716881|NCT02706873|80795912|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
27716882|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
27716883|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
27716884|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
27716885|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
27716886|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
27716887|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
27716888|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
27716889|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
27716890|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
27716891|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
27716892|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
27716893|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
27716894|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
27716895|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
27716896|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
27716897|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
27716898|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
27716899|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
27716900|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
27716901|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
27716902|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
27716903|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
27716904|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
27716905|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
27716906|NCT02706873|80795909|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
27716907|NCT02706873|80795910|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
27716908|NCT02706873|80795911|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
27716909|NCT02706873|80795912|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
27716910|NCT01834729|80795913|FG000|Overall Study|Did not return bowel diaries|0|||
27716911|NCT01834729|80795914|FG001|Overall Study|Did not return bowel diaries|0|||
27716912|NCT01834729|80795915|FG002|Overall Study|Did not return bowel diaries|3|||
27716913|NCT01834729|80795916|FG003|Overall Study|Did not return bowel diaries|0|||
27716914|NCT01834729|80795913|FG000|Overall Study|Withdrawal by Subject|1|||
27716915|NCT01834729|80795914|FG001|Overall Study|Withdrawal by Subject|1|||
27716916|NCT01834729|80795915|FG002|Overall Study|Withdrawal by Subject|0|||
27716917|NCT01834729|80795916|FG003|Overall Study|Withdrawal by Subject|0|||
27716918|NCT01834729|80795913|FG000|Overall Study|Adverse Event|0|||
27716919|NCT01834729|80795914|FG001|Overall Study|Adverse Event|0|||
27716920|NCT01834729|80795915|FG002|Overall Study|Adverse Event|0|||
27716921|NCT01834729|80795916|FG003|Overall Study|Adverse Event|2|||
27716922|NCT00797823|80795918|FG000|First Period (Initial Randomization)|Physician Decision|1|||
27716923|NCT00797823|80795919|FG001|First Period (Initial Randomization)|Physician Decision|0|||
27716924|NCT00797823|80795920|FG002|First Period (Initial Randomization)|Physician Decision|0|||
27716925|NCT00253630|80795921|FG000|Overall Study|ineligible|2|||
27716926|NCT00452699|80795923|FG000|Overall Study|Adverse Event|10|||
27716927|NCT00452699|80795924|FG001|Overall Study|Adverse Event|3|||
27716928|NCT00452699|80795923|FG000|Overall Study|Lack of Efficacy|6|||
27716929|NCT00452699|80795924|FG001|Overall Study|Lack of Efficacy|4|||
27716930|NCT00452699|80795923|FG000|Overall Study|Lost to Follow-up|6|||
27716931|NCT00452699|80795924|FG001|Overall Study|Lost to Follow-up|9|||
27716932|NCT00452699|80795923|FG000|Overall Study|Protocol Violation|21|||
27716933|NCT00452699|80795924|FG001|Overall Study|Protocol Violation|25|||
27716934|NCT00452699|80795923|FG000|Overall Study|Withdrawal by Subject|26|||
27716935|NCT00452699|80795924|FG001|Overall Study|Withdrawal by Subject|25|||
27838132|NCT02169336|81236607|FG002|Overall Study|Subject declined to continue dosing|1|||
27838133|NCT00569777|81236608|FG000|Overall Study|Withdrawal by Subject|4|||
27838134|NCT00569777|81236609|FG001|Overall Study|Withdrawal by Subject|0|||
27838135|NCT00569777|81236608|FG000|Overall Study|Adverse Event|3|||
27716936|NCT00452699|80795923|FG000|Overall Study|Other|12|||
27716937|NCT00452699|80795924|FG001|Overall Study|Other|7|||
27716938|NCT01148537|80795932|FG000|Overall Study|Withdrawal by Subject|1|||
27716939|NCT01148537|80795933|FG001|Overall Study|Withdrawal by Subject|0|||
27716940|NCT01148537|80795934|FG002|Overall Study|Withdrawal by Subject|2|||
27716941|NCT01148537|80795932|FG000|Overall Study|Adverse Event|2|||
27716942|NCT01148537|80795933|FG001|Overall Study|Adverse Event|0|||
27716943|NCT01148537|80795934|FG002|Overall Study|Adverse Event|1|||
27716944|NCT00264875|80795935|FG000|Overall Study|Adverse Event|6|||
27716945|NCT00264875|80795935|FG000|Overall Study|Lost to Follow-up|6|||
27716946|NCT00264875|80795935|FG000|Overall Study|Protocol Violation|11|||
27716947|NCT00264875|80795935|FG000|Overall Study|Withdrawal by Subject|7|||
27716948|NCT01368835|80795936|FG000|Overall Study|Inclusion criteria/photography quality|22|||
27716949|NCT01368835|80795936|FG000|Overall Study|Lost to Follow-up|11|||
27716950|NCT04315181|80795937|FG000|Overall Study|Non-responsive to drug conditions.|1|||
27716951|NCT02264990|80795938|FG000|Overall Study|Death|255|||
27716952|NCT02264990|80795939|FG001|Overall Study|Death|250|||
27716953|NCT02264990|80795938|FG000|Overall Study|Withdrawal by Subject|4|||
27716954|NCT02264990|80795939|FG001|Overall Study|Withdrawal by Subject|5|||
27716955|NCT02264990|80795938|FG000|Overall Study|Lost to Follow-up|1|||
27716956|NCT02264990|80795939|FG001|Overall Study|Lost to Follow-up|3|||
27716957|NCT02264990|80795938|FG000|Overall Study|Other|0|||
27716958|NCT02264990|80795939|FG001|Overall Study|Other|1|||
27716959|NCT02111993|80795942|FG000|Overall Study|Physician Decision|5|||
27716960|NCT02111993|80795943|FG001|Overall Study|Physician Decision|4|||
27716961|NCT01902290|80795946|FG000|Overall Study|Withdrawal by Subject|19|||
27716962|NCT01902290|80795947|FG001|Overall Study|Withdrawal by Subject|27|||
27716963|NCT01902290|80795946|FG000|Overall Study|Lost to Follow-up|2|||
27716964|NCT01902290|80795947|FG001|Overall Study|Lost to Follow-up|2|||
27716965|NCT01902290|80795946|FG000|Overall Study|Death|1|||
27716966|NCT01902290|80795947|FG001|Overall Study|Death|0|||
27716967|NCT01902290|80795946|FG000|Overall Study|Sponsor Decision|26|||
27716968|NCT01902290|80795947|FG001|Overall Study|Sponsor Decision|24|||
27716969|NCT00487539|80799390|FG000|Overall Study|Adverse Event|3|||
27716970|NCT00487539|80799391|FG001|Overall Study|Adverse Event|2|||
27716971|NCT00487539|80799392|FG002|Overall Study|Adverse Event|1|||
27716972|NCT00487539|80799393|FG003|Overall Study|Adverse Event|1|||
27716973|NCT00487539|80799390|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27716974|NCT00487539|80799391|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27716975|NCT00487539|80799392|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27716976|NCT00487539|80799393|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
27716977|NCT00487539|80799390|FG000|Overall Study|Other|3|||
27716978|NCT00487539|80799391|FG001|Overall Study|Other|1|||
27716979|NCT00487539|80799392|FG002|Overall Study|Other|2|||
27716980|NCT00487539|80799393|FG003|Overall Study|Other|2|||
27716981|NCT05661851|80799394|FG000|Overall Study|Protocol Violation|1|||
27716982|NCT05661851|80799395|FG001|Overall Study|Protocol Violation|1|||
27716983|NCT05661851|80799394|FG000|Overall Study|Covid-19 Related|3|||
27716984|NCT05661851|80799395|FG001|Overall Study|Covid-19 Related|4|||
27716985|NCT05661851|80799394|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
27716986|NCT05661851|80799395|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
27754859|NCT01067508|80929627|FG001|Overall Study|Withdrawal by Subject|1|||
27838136|NCT00569777|81236609|FG001|Overall Study|Adverse Event|0|||
27838137|NCT00569777|81236608|FG000|Overall Study|Lost to Follow-up|1|||
27716987|NCT05661851|80799394|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
27716988|NCT05661851|80799395|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
27716989|NCT00430508|80799396|FG000|Overall Study|Adverse Event|2|||
27716990|NCT00430508|80799397|FG001|Overall Study|Adverse Event|3|||
27716991|NCT00430508|80799398|FG002|Overall Study|Adverse Event|5|||
27716992|NCT00430508|80799399|FG003|Overall Study|Adverse Event|3|||
27716993|NCT00430508|80799396|FG000|Overall Study|Withdrawal by Subject|0|||
27716994|NCT00430508|80799397|FG001|Overall Study|Withdrawal by Subject|1|||
27716995|NCT00430508|80799398|FG002|Overall Study|Withdrawal by Subject|1|||
27716996|NCT00430508|80799399|FG003|Overall Study|Withdrawal by Subject|1|||
27716997|NCT00430508|80799396|FG000|Overall Study|responder at visit 4|0|||
27716998|NCT00430508|80799397|FG001|Overall Study|responder at visit 4|0|||
27716999|NCT00430508|80799398|FG002|Overall Study|responder at visit 4|2|||
27717000|NCT00430508|80799399|FG003|Overall Study|responder at visit 4|0|||
27717001|NCT00430508|80799396|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
27717002|NCT00430508|80799397|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
27717003|NCT00430508|80799398|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
27717004|NCT00430508|80799399|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
27717005|NCT00430508|80799396|FG000|Overall Study|Other|1|||
27717006|NCT00430508|80799397|FG001|Overall Study|Other|1|||
27717007|NCT00430508|80799398|FG002|Overall Study|Other|3|||
27717008|NCT00430508|80799399|FG003|Overall Study|Other|0|||
27717009|NCT00866307|80799400|FG000|Induction|Adverse Event|5|||
27717010|NCT00866307|80799401|FG001|Induction|Adverse Event|0|||
27717011|NCT00866307|80799402|FG002|Induction|Adverse Event|0|||
27717012|NCT00866307|80799400|FG000|Induction|Death|2|||
27717013|NCT00866307|80799401|FG001|Induction|Death|0|||
27717014|NCT00866307|80799402|FG002|Induction|Death|0|||
27717015|NCT00866307|80799400|FG000|Induction|Physician Decision|5|||
27717016|NCT00866307|80799401|FG001|Induction|Physician Decision|0|||
27717017|NCT00866307|80799402|FG002|Induction|Physician Decision|0|||
27717018|NCT00866307|80799400|FG000|Induction|Progressive Disease|1|||
27717019|NCT00866307|80799401|FG001|Induction|Progressive Disease|0|||
27717020|NCT00866307|80799402|FG002|Induction|Progressive Disease|0|||
27717021|NCT00866307|80799400|FG000|Induction|Identification of Patients with Day 29 M|3|||
27717022|NCT00866307|80799401|FG001|Induction|Identification of Patients with Day 29 M|0|||
27717023|NCT00866307|80799402|FG002|Induction|Identification of Patients with Day 29 M|0|||
27717024|NCT00866307|80799400|FG000|Induction|Inadequate cytognetic samples th|1|||
27717025|NCT00866307|80799401|FG001|Induction|Inadequate cytognetic samples th|0|||
27717026|NCT00866307|80799402|FG002|Induction|Inadequate cytognetic samples th|0|||
27717027|NCT00866307|80799400|FG000|Induction|Improper post-induction consent|2|||
27717028|NCT00866307|80799401|FG001|Induction|Improper post-induction consent|0|||
27717029|NCT00866307|80799402|FG002|Induction|Improper post-induction consent|0|||
27717030|NCT00866307|80799400|FG000|Induction|Study was closed at the time|1|||
27717031|NCT00866307|80799401|FG001|Induction|Study was closed at the time|0|||
27717032|NCT00866307|80799402|FG002|Induction|Study was closed at the time|0|||
27717033|NCT00866307|80799400|FG000|Consolidation/Maintenance|Adverse Event|0|||
27717034|NCT00866307|80799401|FG001|Consolidation/Maintenance|Adverse Event|0|||
27838138|NCT00569777|81236609|FG001|Overall Study|Lost to Follow-up|0|||
27838139|NCT00569777|81236608|FG000|Overall Study|scheduled eye surgery|0|||
27838140|NCT00569777|81236609|FG001|Overall Study|scheduled eye surgery|1|||
27838141|NCT00569777|81236608|FG000|Overall Study|did not meet exclusion criteria|1|||
27838142|NCT00569777|81236609|FG001|Overall Study|did not meet exclusion criteria|2|||
27838143|NCT00569777|81236608|FG000|Overall Study|pregnant|1|||
27717035|NCT00866307|80799402|FG002|Consolidation/Maintenance|Adverse Event|8|||
27717036|NCT00866307|80799400|FG000|Consolidation/Maintenance|Death|0|||
27838144|NCT00569777|81236609|FG001|Overall Study|pregnant|0|||
27717037|NCT00866307|80799401|FG001|Consolidation/Maintenance|Death|0|||
27717038|NCT00866307|80799402|FG002|Consolidation/Maintenance|Death|1|||
27717039|NCT00866307|80799400|FG000|Consolidation/Maintenance|Physician Decision|0|||
27717040|NCT00866307|80799401|FG001|Consolidation/Maintenance|Physician Decision|3|||
27838145|NCT01073631|81236610|FG000|Overall Study|Death|82|||
27838146|NCT01073631|81236610|FG000|Overall Study|Adverse Event|24|||
27838147|NCT01073631|81236610|FG000|Overall Study|Other|63|||
27838148|NCT04449341|81236612|FG000|Overall Study|Protocol Violation|1|||
27838149|NCT04449341|81236613|FG001|Overall Study|Protocol Violation|0|||
27838150|NCT03693950|81236614|FG000|Overall Study|Withdrawal by Subject|1|||
27838151|NCT03693950|81236615|FG001|Overall Study|Withdrawal by Subject|0|||
27838152|NCT01977456|81236616|FG000|Overall Study|Death|5|||
27838153|NCT02906917|81236617|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
27838154|NCT02906917|81236618|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
27838155|NCT02906917|81236617|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
27838156|NCT02906917|81236618|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
27838157|NCT02906917|81236617|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
27838158|NCT02906917|81236618|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
27838159|NCT02906917|81236617|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
27838160|NCT02906917|81236618|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
27838161|NCT02906917|81236617|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
27838162|NCT02906917|81236618|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
27838163|NCT02906917|81236617|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
27838164|NCT02906917|81236618|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
27838165|NCT02906917|81236617|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
27838166|NCT02906917|81236618|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
27838167|NCT02906917|81236617|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
27838168|NCT02906917|81236618|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
27838169|NCT05263505|81236619|FG000|Overall Study|Adverse Event|0|||
27838170|NCT05263505|81236620|FG001|Overall Study|Adverse Event|1|||
27838171|NCT03450629|81236621|FG000|Overall Study|Adverse Event|15|||
27838172|NCT03450629|81236622|FG001|Overall Study|Adverse Event|14|||
27838173|NCT03450629|81236621|FG000|Overall Study|Physician Decision|2|||
27838174|NCT03450629|81236622|FG001|Overall Study|Physician Decision|2|||
27838175|NCT03450629|81236621|FG000|Overall Study|Lack of Efficacy|2|||
27838176|NCT03450629|81236622|FG001|Overall Study|Lack of Efficacy|0|||
27838177|NCT03450629|81236621|FG000|Overall Study|Lost to Follow-up|4|||
27838178|NCT03450629|81236622|FG001|Overall Study|Lost to Follow-up|2|||
27838179|NCT03450629|81236621|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27838180|NCT03450629|81236622|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
27838181|NCT03450629|81236621|FG000|Overall Study|Non-Compliance With Study Drug|2|||
27838182|NCT03450629|81236622|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27838183|NCT03450629|81236621|FG000|Overall Study|Protocol Violation|11|||
27838184|NCT03450629|81236622|FG001|Overall Study|Protocol Violation|8|||
27838185|NCT03450629|81236621|FG000|Overall Study|Withdrawal by Subject|12|||
27838186|NCT03450629|81236622|FG001|Overall Study|Withdrawal by Subject|6|||
27838187|NCT01148225|81236623|FG000|Overall Study|Other|185|||
27606396|NCT01287520|80399899|FG000|Overall Study|Progressive disease|0|||
27606397|NCT01287520|80399900|FG001|Overall Study|Progressive disease|4|||
27606398|NCT01287520|80399901|FG002|Overall Study|Progressive disease|1|||
27606399|NCT01287520|80399902|FG003|Overall Study|Progressive disease|6|||
27606400|NCT01287520|80399903|FG004|Overall Study|Progressive disease|1|||
27606401|NCT01287520|80399904|FG005|Overall Study|Progressive disease|0|||
27606402|NCT01287520|80399905|FG006|Overall Study|Progressive disease|2|||
27606403|NCT01287520|80399906|FG007|Overall Study|Progressive disease|2|||
27606404|NCT01287520|80399907|FG008|Overall Study|Progressive disease|4|||
27606405|NCT01287520|80399899|FG000|Overall Study|Withdrawal by Subject|0|||
27606406|NCT01287520|80399900|FG001|Overall Study|Withdrawal by Subject|0|||
27606407|NCT01287520|80399901|FG002|Overall Study|Withdrawal by Subject|0|||
27606408|NCT01287520|80399902|FG003|Overall Study|Withdrawal by Subject|0|||
27838188|NCT03206749|81236624|FG000|Overall Study|Withdrawal of consent|5|||
27838189|NCT03206749|81236625|FG001|Overall Study|Withdrawal of consent|3|||
27838190|NCT03206749|81236626|FG002|Overall Study|Withdrawal of consent|6|||
27838191|NCT03206749|81236624|FG000|Overall Study|Lost to Follow-up|0|||
27838192|NCT03206749|81236625|FG001|Overall Study|Lost to Follow-up|0|||
27838193|NCT03206749|81236626|FG002|Overall Study|Lost to Follow-up|1|||
27838194|NCT02219009|81236630|FG000|Overall Study|Withdrawal by Subject|5|||
27838195|NCT02219009|81236631|FG001|Overall Study|Withdrawal by Subject|1|||
27606409|NCT01287520|80399903|FG004|Overall Study|Withdrawal by Subject|0|||
27606410|NCT01287520|80399904|FG005|Overall Study|Withdrawal by Subject|1|||
27606411|NCT01287520|80399905|FG006|Overall Study|Withdrawal by Subject|0|||
27838196|NCT02219009|81236630|FG000|Overall Study|Adverse Event|2|||
27838197|NCT02219009|81236631|FG001|Overall Study|Adverse Event|4|||
27838198|NCT02219009|81236630|FG000|Overall Study|Lost to Follow-up|2|||
27838199|NCT02219009|81236631|FG001|Overall Study|Lost to Follow-up|2|||
27717041|NCT00866307|80799402|FG002|Consolidation/Maintenance|Physician Decision|2|||
27838200|NCT02219009|81236630|FG000|Overall Study|Protocol deviation|1|||
27838201|NCT02219009|81236631|FG001|Overall Study|Protocol deviation|0|||
27838202|NCT02219009|81236630|FG000|Overall Study|Physician Decision|0|||
27838203|NCT02219009|81236631|FG001|Overall Study|Physician Decision|1|||
27838204|NCT03920280|81236639|FG000|Overall Study|Adverse Event|2|||
27838205|NCT03920280|81236640|FG001|Overall Study|Adverse Event|3|||
27838206|NCT03920280|81236639|FG000|Overall Study|Lost to Follow-up|0|||
27838207|NCT03920280|81236640|FG001|Overall Study|Lost to Follow-up|1|||
27838208|NCT03920280|81236639|FG000|Overall Study|Withdrawal by Subject|1|||
27838209|NCT03920280|81236640|FG001|Overall Study|Withdrawal by Subject|1|||
27838210|NCT03920280|81236639|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
27838211|NCT03920280|81236640|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
27838212|NCT02340780|81236641|FG000|Overall Study|Ineligible|1|||
27838213|NCT02587143|81236642|FG000|Overall Study|Adverse Event|1|||
27717042|NCT00866307|80799400|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
27717043|NCT00866307|80799401|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
27717044|NCT00866307|80799402|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
27717045|NCT00866307|80799400|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
27717046|NCT00866307|80799401|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
27717047|NCT00866307|80799402|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
27717048|NCT00866307|80799400|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
27717049|NCT00866307|80799401|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
27717050|NCT00866307|80799402|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
27717051|NCT00866307|80799400|FG000|Consolidation/Maintenance|Therapy error|0|||
27717052|NCT00866307|80799401|FG001|Consolidation/Maintenance|Therapy error|1|||
27717053|NCT00866307|80799402|FG002|Consolidation/Maintenance|Therapy error|0|||
27717054|NCT00866307|80799400|FG000|Consolidation/Maintenance|Non-compliance|0|||
27717055|NCT00866307|80799401|FG001|Consolidation/Maintenance|Non-compliance|0|||
27717056|NCT00866307|80799402|FG002|Consolidation/Maintenance|Non-compliance|1|||
27717057|NCT00866307|80799400|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
27717058|NCT00866307|80799401|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
27717059|NCT00866307|80799402|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
27717060|NCT00852995|80799403|FG000|Overall Study|Adverse Event|1|||
27717061|NCT00852995|80799404|FG001|Overall Study|Adverse Event|0|||
27717062|NCT00852995|80799405|FG002|Overall Study|Adverse Event|4|||
27838214|NCT02587143|81236643|FG001|Overall Study|Adverse Event|0|||
27838215|NCT04203823|81236646|FG000|Overall Study|Withdrawal by Subject|2|||
27838216|NCT04203823|81236647|FG001|Overall Study|Withdrawal by Subject|2|||
27717063|NCT00852995|80799406|FG003|Overall Study|Adverse Event|0|||
27838217|NCT04203823|81236646|FG000|Overall Study|Adverse Event|1|||
27838218|NCT04203823|81236647|FG001|Overall Study|Adverse Event|1|||
27890078|NCT04526509|81430946|FG006|Enrolled|Physician Decision|0|||
27606412|NCT01287520|80399906|FG007|Overall Study|Withdrawal by Subject|0|||
27606413|NCT01287520|80399907|FG008|Overall Study|Withdrawal by Subject|1|||
27606414|NCT01054573|80399908|FG000|Overall Study|Adverse Event|1|||
27606415|NCT01054573|80399909|FG001|Overall Study|Adverse Event|0|||
27606416|NCT01054573|80399910|FG002|Overall Study|Adverse Event|1|||
27606417|NCT01054573|80399911|FG003|Overall Study|Adverse Event|1|||
27606418|NCT01054573|80399908|FG000|Overall Study|Lost to Follow-up|0|||
27606419|NCT01054573|80399909|FG001|Overall Study|Lost to Follow-up|2|||
27606420|NCT01054573|80399910|FG002|Overall Study|Lost to Follow-up|0|||
27606421|NCT01054573|80399911|FG003|Overall Study|Lost to Follow-up|0|||
27606422|NCT01054573|80399908|FG000|Overall Study|Withdrawal by Subject|0|||
27606423|NCT01054573|80399909|FG001|Overall Study|Withdrawal by Subject|2|||
27606424|NCT01054573|80399910|FG002|Overall Study|Withdrawal by Subject|2|||
27606425|NCT01054573|80399911|FG003|Overall Study|Withdrawal by Subject|1|||
27606426|NCT02923739|80399912|FG000|Overall Study|Withdrawal by Subject|2|||
27717064|NCT00852995|80799407|FG004|Overall Study|Adverse Event|0|||
27717065|NCT00852995|80799403|FG000|Overall Study|Lost to Follow-up|0|||
27717066|NCT00852995|80799404|FG001|Overall Study|Lost to Follow-up|1|||
27717067|NCT00852995|80799405|FG002|Overall Study|Lost to Follow-up|1|||
27717068|NCT00852995|80799406|FG003|Overall Study|Lost to Follow-up|0|||
27890079|NCT04016779|81430947|FG000|Overall Study|Adverse Event|9|||
27890080|NCT04016779|81430948|FG001|Overall Study|Adverse Event|17|||
27890081|NCT04016779|81430947|FG000|Overall Study|Lack of Efficacy|4|||
27606427|NCT02923739|80399913|FG001|Overall Study|Withdrawal by Subject|0|||
27606428|NCT02923739|80399914|FG002|Overall Study|Withdrawal by Subject|0|||
27717069|NCT00852995|80799407|FG004|Overall Study|Lost to Follow-up|0|||
27717070|NCT00852995|80799403|FG000|Overall Study|Withdrawal by Subject|4|||
27717071|NCT00852995|80799404|FG001|Overall Study|Withdrawal by Subject|0|||
27717072|NCT00852995|80799405|FG002|Overall Study|Withdrawal by Subject|0|||
27717073|NCT00852995|80799406|FG003|Overall Study|Withdrawal by Subject|1|||
27717074|NCT00852995|80799407|FG004|Overall Study|Withdrawal by Subject|2|||
27717075|NCT00852995|80799403|FG000|Overall Study|Non-Compliance|0|||
27717076|NCT00852995|80799404|FG001|Overall Study|Non-Compliance|0|||
27717077|NCT00852995|80799405|FG002|Overall Study|Non-Compliance|0|||
27717078|NCT00852995|80799406|FG003|Overall Study|Non-Compliance|2|||
27717079|NCT00852995|80799407|FG004|Overall Study|Non-Compliance|0|||
27717080|NCT00852995|80799403|FG000|Overall Study|Progressive Disease|1|||
27717081|NCT00852995|80799404|FG001|Overall Study|Progressive Disease|0|||
27717082|NCT00852995|80799405|FG002|Overall Study|Progressive Disease|0|||
27606429|NCT02923739|80399915|FG003|Overall Study|Withdrawal by Subject|0|||
27606430|NCT02923739|80399912|FG000|Overall Study|Failed Screening|3|||
27606431|NCT02923739|80399913|FG001|Overall Study|Failed Screening|0|||
27606432|NCT02923739|80399914|FG002|Overall Study|Failed Screening|0|||
27606433|NCT02923739|80399915|FG003|Overall Study|Failed Screening|0|||
27606434|NCT03635489|80399916|FG000|Overall Study|Death|19|||
27606435|NCT03635489|80399917|FG001|Overall Study|Death|13|||
27606436|NCT03635489|80399916|FG000|Overall Study|Lost to Follow-up|1|||
27606437|NCT03635489|80399917|FG001|Overall Study|Lost to Follow-up|2|||
27606438|NCT03635489|80399916|FG000|Overall Study|Withdrawal by Subject|1|||
27606439|NCT03635489|80399917|FG001|Overall Study|Withdrawal by Subject|2|||
27606440|NCT03635489|80399916|FG000|Overall Study|Study Ended by Sponsor|28|||
27606441|NCT03635489|80399917|FG001|Overall Study|Study Ended by Sponsor|34|||
27606442|NCT03565068|80399918|FG000|Overall Study|Protocol Violation|0|||
27606443|NCT03565068|80399919|FG001|Overall Study|Protocol Violation|0|||
27606444|NCT03565068|80399920|FG002|Overall Study|Protocol Violation|0|||
27606445|NCT03565068|80399921|FG003|Overall Study|Protocol Violation|0|||
27606446|NCT03565068|80399922|FG004|Overall Study|Protocol Violation|1|||
27606447|NCT03565068|80399923|FG005|Overall Study|Protocol Violation|0|||
27606448|NCT03565068|80399924|FG006|Overall Study|Protocol Violation|0|||
27606449|NCT03565068|80399925|FG007|Overall Study|Protocol Violation|1|||
27606450|NCT03565068|80399926|FG008|Overall Study|Protocol Violation|0|||
27606451|NCT03565068|80399918|FG000|Overall Study|Sponsor decision|0|||
27606452|NCT03565068|80399919|FG001|Overall Study|Sponsor decision|0|||
27606453|NCT03565068|80399920|FG002|Overall Study|Sponsor decision|0|||
27606454|NCT03565068|80399921|FG003|Overall Study|Sponsor decision|0|||
27606455|NCT03565068|80399922|FG004|Overall Study|Sponsor decision|1|||
27838219|NCT04203823|81236646|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27838220|NCT04203823|81236647|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
27838221|NCT00645944|81236648|FG000|Randomized|Withdrawal by Subject|1|||
27606456|NCT03565068|80399923|FG005|Overall Study|Sponsor decision|1|||
27606457|NCT03565068|80399924|FG006|Overall Study|Sponsor decision|0|||
27717083|NCT00852995|80799406|FG003|Overall Study|Progressive Disease|2|||
27717084|NCT00852995|80799407|FG004|Overall Study|Progressive Disease|1|||
27717085|NCT00852995|80799403|FG000|Overall Study|Physician Decision|1|||
27717086|NCT00852995|80799404|FG001|Overall Study|Physician Decision|0|||
27717087|NCT00852995|80799405|FG002|Overall Study|Physician Decision|0|||
27717088|NCT00852995|80799406|FG003|Overall Study|Physician Decision|0|||
27717089|NCT00852995|80799407|FG004|Overall Study|Physician Decision|0|||
27717090|NCT00852995|80799403|FG000|Overall Study|Protocol Violation|0|||
27717091|NCT00852995|80799404|FG001|Overall Study|Protocol Violation|0|||
27717092|NCT00852995|80799405|FG002|Overall Study|Protocol Violation|0|||
27717093|NCT00852995|80799406|FG003|Overall Study|Protocol Violation|0|||
27717094|NCT00852995|80799407|FG004|Overall Study|Protocol Violation|1|||
27717095|NCT00852995|80799403|FG000|Overall Study|Moved Out of Area|1|||
27890082|NCT04016779|81430948|FG001|Overall Study|Lack of Efficacy|1|||
27606458|NCT03565068|80399925|FG007|Overall Study|Sponsor decision|0|||
27606459|NCT03565068|80399926|FG008|Overall Study|Sponsor decision|0|||
27606460|NCT03565068|80399918|FG000|Overall Study|Withdrawal by Subject|0|||
27606461|NCT03565068|80399919|FG001|Overall Study|Withdrawal by Subject|0|||
27717096|NCT00852995|80799404|FG001|Overall Study|Moved Out of Area|0|||
27717097|NCT00852995|80799405|FG002|Overall Study|Moved Out of Area|0|||
27717098|NCT00852995|80799406|FG003|Overall Study|Moved Out of Area|0|||
27838222|NCT00645944|81236649|FG001|Randomized|Withdrawal by Subject|2|||
27838223|NCT00645944|81236648|FG000|Received Medication|Adverse Event|2|||
27838224|NCT00645944|81236649|FG001|Received Medication|Adverse Event|1|||
27838225|NCT00645944|81236648|FG000|Received Medication|Withdrawal by Subject|1|||
27838226|NCT00645944|81236649|FG001|Received Medication|Withdrawal by Subject|1|||
27838227|NCT00645944|81236648|FG000|Received Medication|Lost to Follow-up|1|||
27838228|NCT00645944|81236649|FG001|Received Medication|Lost to Follow-up|0|||
27838229|NCT00645944|81236648|FG000|Received Medication|Protocol Violation|2|||
27838230|NCT00645944|81236649|FG001|Received Medication|Protocol Violation|1|||
27838231|NCT01525628|81236650|FG000|Overall Study|Adverse Event|1|||
27838232|NCT01525628|81236651|FG001|Overall Study|Adverse Event|1|||
27838233|NCT01525628|81236652|FG002|Overall Study|Adverse Event|2|||
27838234|NCT01525628|81236653|FG003|Overall Study|Adverse Event|0|||
27838235|NCT01525628|81236654|FG004|Overall Study|Adverse Event|1|||
27890083|NCT04016779|81430947|FG000|Overall Study|Lost to Follow-up|5|||
27890084|NCT04016779|81430948|FG001|Overall Study|Lost to Follow-up|14|||
27890085|NCT04016779|81430947|FG000|Overall Study|Physician Decision|1|||
27890086|NCT04016779|81430948|FG001|Overall Study|Physician Decision|3|||
27606462|NCT03565068|80399920|FG002|Overall Study|Withdrawal by Subject|1|||
27606463|NCT03565068|80399921|FG003|Overall Study|Withdrawal by Subject|0|||
27606464|NCT03565068|80399922|FG004|Overall Study|Withdrawal by Subject|2|||
27606465|NCT03565068|80399923|FG005|Overall Study|Withdrawal by Subject|0|||
27606466|NCT03565068|80399924|FG006|Overall Study|Withdrawal by Subject|1|||
27717099|NCT00852995|80799407|FG004|Overall Study|Moved Out of Area|0|||
27717100|NCT00749996|80799410|FG000|Overall Study|Lost to Follow-up|7|||
27717101|NCT00749996|80799411|FG001|Overall Study|Lost to Follow-up|4|||
27838236|NCT01525628|81236650|FG000|Overall Study|Lack of Efficacy|0|||
27838237|NCT01525628|81236651|FG001|Overall Study|Lack of Efficacy|2|||
27717102|NCT00749996|80799410|FG000|Overall Study|Withdrawal by Subject|5|||
27717103|NCT00749996|80799411|FG001|Overall Study|Withdrawal by Subject|4|||
27717104|NCT00749996|80799410|FG000|Overall Study|Protocol Violation|2|||
27717105|NCT00749996|80799411|FG001|Overall Study|Protocol Violation|3|||
27717106|NCT00749996|80799410|FG000|Overall Study|Physician Decision|2|||
27717107|NCT00749996|80799411|FG001|Overall Study|Physician Decision|0|||
27717108|NCT00749996|80799410|FG000|Overall Study|Pregnancy|0|||
27717109|NCT00749996|80799411|FG001|Overall Study|Pregnancy|2|||
27717110|NCT00749996|80799410|FG000|Overall Study|Adverse Event|1|||
27717111|NCT00749996|80799411|FG001|Overall Study|Adverse Event|0|||
27717112|NCT00749996|80799410|FG000|Overall Study|Death|1|||
27717113|NCT00749996|80799411|FG001|Overall Study|Death|0|||
27717114|NCT02164981|80799412|FG000|Started|Withdrawal by Subject|2|||
27717115|NCT02164981|80799413|FG001|Started|Withdrawal by Subject|1|||
27717116|NCT02164981|80799414|FG002|Started|Withdrawal by Subject|0|||
27717117|NCT02164981|80799412|FG000|Started|Protocol Violation|2|||
27717118|NCT02164981|80799413|FG001|Started|Protocol Violation|0|||
27717119|NCT02164981|80799414|FG002|Started|Protocol Violation|0|||
27717120|NCT02164981|80799412|FG000|Started|Adverse Event|1|||
27717121|NCT02164981|80799413|FG001|Started|Adverse Event|2|||
27717122|NCT02164981|80799414|FG002|Started|Adverse Event|0|||
27717123|NCT02164981|80799412|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
27717124|NCT02164981|80799413|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
27717125|NCT02164981|80799414|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
27717126|NCT02164981|80799412|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
27717127|NCT02164981|80799413|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
27838238|NCT01525628|81236652|FG002|Overall Study|Lack of Efficacy|2|||
27717128|NCT02164981|80799414|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
27717129|NCT02164981|80799412|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
27717130|NCT02164981|80799413|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
27717131|NCT02164981|80799414|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
27717132|NCT01536860|80799415|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
27717133|NCT01536860|80799416|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
27717134|NCT01536860|80799417|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
27717135|NCT01227902|80799418|FG000|Overall Study|Adverse Event|12|||
27717136|NCT01227902|80799419|FG001|Overall Study|Adverse Event|8|||
27717137|NCT01227902|80799420|FG002|Overall Study|Adverse Event|11|||
27717138|NCT01227902|80799421|FG003|Overall Study|Adverse Event|4|||
27717139|NCT01227902|80799418|FG000|Overall Study|Lack of Efficacy|1|||
27717140|NCT01227902|80799419|FG001|Overall Study|Lack of Efficacy|2|||
27717141|NCT01227902|80799420|FG002|Overall Study|Lack of Efficacy|2|||
27717142|NCT01227902|80799421|FG003|Overall Study|Lack of Efficacy|1|||
27717143|NCT01227902|80799418|FG000|Overall Study|Protocol Violation|1|||
27717144|NCT01227902|80799419|FG001|Overall Study|Protocol Violation|0|||
27717145|NCT01227902|80799420|FG002|Overall Study|Protocol Violation|0|||
27717146|NCT01227902|80799421|FG003|Overall Study|Protocol Violation|0|||
27717147|NCT01227902|80799418|FG000|Overall Study|Lost to Follow-up|0|||
27717148|NCT01227902|80799419|FG001|Overall Study|Lost to Follow-up|0|||
27717149|NCT01227902|80799420|FG002|Overall Study|Lost to Follow-up|1|||
27717150|NCT01227902|80799421|FG003|Overall Study|Lost to Follow-up|2|||
27717151|NCT01227902|80799418|FG000|Overall Study|Physician Decision|0|||
27717152|NCT01227902|80799419|FG001|Overall Study|Physician Decision|1|||
27717153|NCT01227902|80799420|FG002|Overall Study|Physician Decision|1|||
27717154|NCT01227902|80799421|FG003|Overall Study|Physician Decision|0|||
27717155|NCT01227902|80799418|FG000|Overall Study|Withdrawal by Subject|4|||
27717156|NCT01227902|80799419|FG001|Overall Study|Withdrawal by Subject|2|||
27717157|NCT01227902|80799420|FG002|Overall Study|Withdrawal by Subject|4|||
27717158|NCT01227902|80799421|FG003|Overall Study|Withdrawal by Subject|3|||
27717159|NCT03344003|80799422|FG000|Overall Study|Switched to alternative treatment|1|||
27717160|NCT03344003|80799423|FG001|Overall Study|Switched to alternative treatment|0|||
27717161|NCT03344003|80799422|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
27717162|NCT03344003|80799423|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
27717163|NCT01263639|80799424|FG000|Overall Study|Lost to Follow-up|66|||
27717164|NCT01263639|80799425|FG001|Overall Study|Lost to Follow-up|70|||
27717165|NCT01263639|80799424|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
27717166|NCT01263639|80799425|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
27717167|NCT02436876|80799426|FG000|Overall Study|Lost to Follow-up|0|||
27717168|NCT02436876|80799427|FG001|Overall Study|Lost to Follow-up|1|||
27717169|NCT02436876|80799428|FG002|Overall Study|Lost to Follow-up|1|||
27717170|NCT02436876|80799429|FG003|Overall Study|Lost to Follow-up|1|||
27717171|NCT02436876|80799426|FG000|Overall Study|Withdrawal by Subject|1|||
27717172|NCT02436876|80799427|FG001|Overall Study|Withdrawal by Subject|0|||
27717173|NCT02436876|80799428|FG002|Overall Study|Withdrawal by Subject|0|||
27717174|NCT02436876|80799429|FG003|Overall Study|Withdrawal by Subject|1|||
27717175|NCT02436876|80799426|FG000|Overall Study|Physician Decision|0|||
27717176|NCT02436876|80799427|FG001|Overall Study|Physician Decision|2|||
27717177|NCT02436876|80799428|FG002|Overall Study|Physician Decision|1|||
27717178|NCT02436876|80799429|FG003|Overall Study|Physician Decision|0|||
27717179|NCT02436876|80799426|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
27717180|NCT02436876|80799427|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
27717181|NCT02436876|80799428|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
27717182|NCT02436876|80799429|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
27717183|NCT03048422|80799430|FG000|Overall Study|Death|1|||
27717184|NCT03048422|80799431|FG001|Overall Study|Death|0|||
27717185|NCT03048422|80799432|FG002|Overall Study|Death|0|||
27717186|NCT03048422|80799430|FG000|Overall Study|Lost to Follow-up|5|||
27717187|NCT03048422|80799431|FG001|Overall Study|Lost to Follow-up|0|||
27717188|NCT03048422|80799432|FG002|Overall Study|Lost to Follow-up|1|||
27717189|NCT03048422|80799430|FG000|Overall Study|Withdrawal by Subject|5|||
27717190|NCT03048422|80799431|FG001|Overall Study|Withdrawal by Subject|7|||
27717191|NCT03048422|80799432|FG002|Overall Study|Withdrawal by Subject|4|||
27717192|NCT03048422|80799430|FG000|Overall Study|Moved|3|||
27717193|NCT03048422|80799431|FG001|Overall Study|Moved|2|||
27717194|NCT03048422|80799432|FG002|Overall Study|Moved|2|||
27717195|NCT03048422|80799430|FG000|Overall Study|Noncompliant with Study Requirements|2|||
27717196|NCT03048422|80799431|FG001|Overall Study|Noncompliant with Study Requirements|1|||
27717197|NCT03048422|80799432|FG002|Overall Study|Noncompliant with Study Requirements|2|||
27717198|NCT03048422|80799430|FG000|Overall Study|Not Able to Get to Clinic|1|||
27717199|NCT03048422|80799431|FG001|Overall Study|Not Able to Get to Clinic|0|||
27717200|NCT03048422|80799432|FG002|Overall Study|Not Able to Get to Clinic|0|||
27717201|NCT02474329|80799434|FG000|Overall Study|Withdraw or did not contribute data.|13|||
27717202|NCT03451773|80799446|FG000|Overall Study|Death on study|1|||
27717203|NCT03451773|80799447|FG001|Overall Study|Death on study|5|||
27717204|NCT03451773|80799446|FG000|Overall Study|Death during follow-up period|0|||
27717205|NCT03451773|80799447|FG001|Overall Study|Death during follow-up period|1|||
27717206|NCT04677712|80799448|FG000|Overall Study|Lost to Follow-up|0|||
27717207|NCT04677712|80799449|FG001|Overall Study|Lost to Follow-up|1|||
27717208|NCT04677712|80799450|FG002|Overall Study|Lost to Follow-up|0|||
27717209|NCT04677712|80799451|FG003|Overall Study|Lost to Follow-up|0|||
27717210|NCT04677712|80799452|FG004|Overall Study|Lost to Follow-up|0|||
27717211|NCT04677712|80799453|FG005|Overall Study|Lost to Follow-up|0|||
27717212|NCT02429414|80799455|FG000|Overall Study|Physician Decision|0|||
27717213|NCT02429414|80799456|FG001|Overall Study|Physician Decision|1|||
27717214|NCT03548051|80799457|FG000|Overall Study|Death|1|||
27717215|NCT03548051|80799458|FG001|Overall Study|Death|1|||
27717216|NCT03548051|80799457|FG000|Overall Study|Withdrawal by Subject|1|||
27717217|NCT03548051|80799458|FG001|Overall Study|Withdrawal by Subject|0|||
27717218|NCT03571646|80799459|FG000|Overall Study|Adverse Event|1|||
27717219|NCT03571646|80799460|FG001|Overall Study|Adverse Event|0|||
27717220|NCT03571646|80799459|FG000|Overall Study|Withdrawal by Subject|1|||
27717221|NCT03571646|80799460|FG001|Overall Study|Withdrawal by Subject|1|||
27717222|NCT00424827|80799461|FG000|Overall Study|Adverse Event|1|||
27717223|NCT00713700|80799473|FG000|Overall Study|Lost to Follow-up|3|||
27717224|NCT00713700|80799473|FG000|Overall Study|Withdrawal by Subject|1|||
27717225|NCT03839459|80799474|FG000|Overall Study|Withdrawal by Subject|2|||
27717226|NCT03839459|80799474|FG000|Overall Study|progression of disease|3|||
27717227|NCT03237065|80799479|FG000|Overall Study|Adverse Event|0|||
27717228|NCT03237065|80799480|FG001|Overall Study|Adverse Event|2|||
27717229|NCT03237065|80799479|FG000|Overall Study|Protocol Violation|0|||
27717230|NCT03237065|80799480|FG001|Overall Study|Protocol Violation|1|||
27717231|NCT03237065|80799479|FG000|Overall Study|Withdrawal by Subject|3|||
27838239|NCT01525628|81236653|FG003|Overall Study|Lack of Efficacy|1|||
27717232|NCT03237065|80799480|FG001|Overall Study|Withdrawal by Subject|0|||
27717233|NCT03237065|80799479|FG000|Overall Study|Lost to Follow-up|1|||
27717234|NCT03237065|80799480|FG001|Overall Study|Lost to Follow-up|0|||
27717235|NCT03237065|80799479|FG000|Overall Study|Unable to obtain venous access|0|||
27717236|NCT03237065|80799480|FG001|Overall Study|Unable to obtain venous access|1|||
27838240|NCT01525628|81236654|FG004|Overall Study|Lack of Efficacy|2|||
27838241|NCT01525628|81236650|FG000|Overall Study|Protocol Violation|0|||
27838242|NCT01525628|81236651|FG001|Overall Study|Protocol Violation|0|||
27838243|NCT01525628|81236652|FG002|Overall Study|Protocol Violation|1|||
27838244|NCT01525628|81236653|FG003|Overall Study|Protocol Violation|0|||
27838245|NCT01525628|81236654|FG004|Overall Study|Protocol Violation|0|||
27838246|NCT01525628|81236650|FG000|Overall Study|Lost to Follow-up|1|||
27838247|NCT01525628|81236651|FG001|Overall Study|Lost to Follow-up|1|||
27838248|NCT01525628|81236652|FG002|Overall Study|Lost to Follow-up|0|||
27838249|NCT01525628|81236653|FG003|Overall Study|Lost to Follow-up|0|||
27838250|NCT01525628|81236654|FG004|Overall Study|Lost to Follow-up|0|||
27838251|NCT01525628|81236650|FG000|Overall Study|Withdrawal by Subject|0|||
27838252|NCT01525628|81236651|FG001|Overall Study|Withdrawal by Subject|1|||
27838253|NCT01525628|81236652|FG002|Overall Study|Withdrawal by Subject|0|||
27838254|NCT01525628|81236653|FG003|Overall Study|Withdrawal by Subject|0|||
27717237|NCT04016311|80799483|FG000|Overall Study|Withdrawal by Subject|1|||
27717238|NCT04016311|80799484|FG001|Overall Study|Withdrawal by Subject|0|||
27838255|NCT01525628|81236654|FG004|Overall Study|Withdrawal by Subject|0|||
27838256|NCT01525628|81236650|FG000|Overall Study|Other reason not defined above|0|||
27717239|NCT01534533|80799485|FG000|Overall Study|Lost to Follow-up|3|||
27717240|NCT01534533|80799486|FG001|Overall Study|Lost to Follow-up|0|||
27717241|NCT01534533|80799487|FG002|Overall Study|Lost to Follow-up|4|||
27717242|NCT01534533|80799488|FG003|Overall Study|Lost to Follow-up|3|||
27838257|NCT01525628|81236651|FG001|Overall Study|Other reason not defined above|0|||
27838258|NCT01525628|81236652|FG002|Overall Study|Other reason not defined above|0|||
27838259|NCT01525628|81236653|FG003|Overall Study|Other reason not defined above|3|||
27717243|NCT01534533|80799485|FG000|Overall Study|Withdrawal by Subject|5|||
27717244|NCT01534533|80799486|FG001|Overall Study|Withdrawal by Subject|3|||
27754860|NCT02065622|80929630|FG000|Induction Study|Adverse Event|13|||
27717245|NCT01534533|80799487|FG002|Overall Study|Withdrawal by Subject|4|||
27717246|NCT01534533|80799488|FG003|Overall Study|Withdrawal by Subject|1|||
27717247|NCT02669017|80799491|FG000|Overall Study|Death|1|||
27717248|NCT02669017|80799492|FG001|Overall Study|Death|2|||
27717249|NCT02669017|80799493|FG002|Overall Study|Death|2|||
27717250|NCT02669017|80799494|FG003|Overall Study|Death|3|||
27717251|NCT02669017|80799495|FG004|Overall Study|Death|8|||
27717252|NCT02669017|80799496|FG005|Overall Study|Death|18|||
27717253|NCT02669017|80799497|FG006|Overall Study|Death|10|||
27717254|NCT02669017|80799498|FG007|Overall Study|Death|47|||
27717255|NCT02669017|80799499|FG008|Overall Study|Death|20|||
27717256|NCT02669017|80799491|FG000|Overall Study|Withdrawal by Subject|0|||
27717257|NCT02669017|80799492|FG001|Overall Study|Withdrawal by Subject|0|||
27717258|NCT02669017|80799493|FG002|Overall Study|Withdrawal by Subject|0|||
27717259|NCT02669017|80799494|FG003|Overall Study|Withdrawal by Subject|1|||
27717260|NCT02669017|80799495|FG004|Overall Study|Withdrawal by Subject|2|||
27717261|NCT02669017|80799496|FG005|Overall Study|Withdrawal by Subject|0|||
27717262|NCT02669017|80799497|FG006|Overall Study|Withdrawal by Subject|0|||
27717263|NCT02669017|80799498|FG007|Overall Study|Withdrawal by Subject|2|||
27717264|NCT02669017|80799499|FG008|Overall Study|Withdrawal by Subject|2|||
27717265|NCT02669017|80799491|FG000|Overall Study|Lost to Follow-up|0|||
27717266|NCT02669017|80799492|FG001|Overall Study|Lost to Follow-up|0|||
27717267|NCT02669017|80799493|FG002|Overall Study|Lost to Follow-up|0|||
27717268|NCT02669017|80799494|FG003|Overall Study|Lost to Follow-up|0|||
27717269|NCT02669017|80799495|FG004|Overall Study|Lost to Follow-up|0|||
27717270|NCT02669017|80799496|FG005|Overall Study|Lost to Follow-up|0|||
27717271|NCT02669017|80799497|FG006|Overall Study|Lost to Follow-up|0|||
27717272|NCT02669017|80799498|FG007|Overall Study|Lost to Follow-up|0|||
27717273|NCT02669017|80799499|FG008|Overall Study|Lost to Follow-up|1|||
27717274|NCT02669017|80799491|FG000|Overall Study|Miscellaneous|0|||
27717275|NCT02669017|80799492|FG001|Overall Study|Miscellaneous|0|||
27838260|NCT01525628|81236654|FG004|Overall Study|Other reason not defined above|0|||
27838261|NCT02888743|81236655|FG000|Overall Study|Withdrawal by Subject|1|||
27838262|NCT02888743|81236656|FG001|Overall Study|Withdrawal by Subject|2|||
27838263|NCT02888743|81236657|FG002|Overall Study|Withdrawal by Subject|2|||
27838264|NCT02888743|81236658|FG003|Overall Study|Withdrawal by Subject|0|||
27838265|NCT02888743|81236659|FG004|Overall Study|Withdrawal by Subject|1|||
27717276|NCT02669017|80799493|FG002|Overall Study|Miscellaneous|0|||
27717277|NCT02669017|80799494|FG003|Overall Study|Miscellaneous|0|||
27717278|NCT02669017|80799495|FG004|Overall Study|Miscellaneous|2|||
27606467|NCT03565068|80399925|FG007|Overall Study|Withdrawal by Subject|5|||
27606468|NCT03565068|80399926|FG008|Overall Study|Withdrawal by Subject|1|||
27606469|NCT03565068|80399918|FG000|Overall Study|Physician Decision|0|||
27606470|NCT03565068|80399919|FG001|Overall Study|Physician Decision|0|||
27606471|NCT03565068|80399920|FG002|Overall Study|Physician Decision|0|||
27606472|NCT03565068|80399921|FG003|Overall Study|Physician Decision|0|||
27606473|NCT03565068|80399922|FG004|Overall Study|Physician Decision|0|||
27606474|NCT03565068|80399923|FG005|Overall Study|Physician Decision|0|||
27606475|NCT03565068|80399924|FG006|Overall Study|Physician Decision|0|||
27717279|NCT02669017|80799496|FG005|Overall Study|Miscellaneous|1|||
27717280|NCT02669017|80799497|FG006|Overall Study|Miscellaneous|1|||
27717281|NCT02669017|80799498|FG007|Overall Study|Miscellaneous|13|||
27717282|NCT02669017|80799499|FG008|Overall Study|Miscellaneous|2|||
27717283|NCT01849874|80799502|FG000|Overall Study|Death|89|||
27717284|NCT01849874|80799503|FG001|Overall Study|Death|42|||
27717285|NCT01849874|80799502|FG000|Overall Study|Withdrawal by Subject|17|||
27717286|NCT01849874|80799503|FG001|Overall Study|Withdrawal by Subject|16|||
27838266|NCT02888743|81236655|FG000|Overall Study|Disease progression before treatment|2|||
27838267|NCT02888743|81236656|FG001|Overall Study|Disease progression before treatment|0|||
27958579|NCT01791517|81680063|FG005|Phase II|Lost to Follow-up|2|||
27606476|NCT03565068|80399925|FG007|Overall Study|Physician Decision|1|||
27606477|NCT03565068|80399926|FG008|Overall Study|Physician Decision|0|||
27717287|NCT01849874|80799502|FG000|Overall Study|Lost to Follow-up|3|||
27717288|NCT01849874|80799503|FG001|Overall Study|Lost to Follow-up|2|||
27606478|NCT03565068|80399918|FG000|Overall Study|Lost to Follow-up|0|||
27606479|NCT03565068|80399919|FG001|Overall Study|Lost to Follow-up|0|||
27606480|NCT03565068|80399920|FG002|Overall Study|Lost to Follow-up|0|||
27606481|NCT03565068|80399921|FG003|Overall Study|Lost to Follow-up|0|||
27606482|NCT03565068|80399922|FG004|Overall Study|Lost to Follow-up|0|||
27606483|NCT03565068|80399923|FG005|Overall Study|Lost to Follow-up|0|||
27606484|NCT03565068|80399924|FG006|Overall Study|Lost to Follow-up|0|||
27606485|NCT03565068|80399925|FG007|Overall Study|Lost to Follow-up|1|||
27606486|NCT03565068|80399926|FG008|Overall Study|Lost to Follow-up|0|||
27606487|NCT02823964|80402747|FG000|Overall Study|Adverse Event|2|||
27717289|NCT01849874|80799502|FG000|Overall Study|Study Termination By Sponsor|93|||
27717290|NCT01849874|80799503|FG001|Overall Study|Study Termination By Sponsor|48|||
27717291|NCT01849874|80799502|FG000|Overall Study|Completed as per protocol amendment 6|3|||
27717292|NCT01849874|80799503|FG001|Overall Study|Completed as per protocol amendment 6|0|||
27717293|NCT01849874|80799502|FG000|Overall Study|Physician Decision|7|||
27717294|NCT01849874|80799503|FG001|Overall Study|Physician Decision|1|||
27717295|NCT01849874|80799502|FG000|Overall Study|Other|16|||
27717296|NCT01849874|80799503|FG001|Overall Study|Other|4|||
27717297|NCT03047980|80799504|FG000|Overall Study|Adverse Event|1|||
27717298|NCT00584194|80799505|FG000|Overall Study|Other|135|||
27717299|NCT04327388|80799506|FG000|Overall Study|Adverse Event|17|||
27717300|NCT04327388|80799507|FG001|Overall Study|Adverse Event|18|||
27717301|NCT04327388|80799508|FG002|Overall Study|Adverse Event|9|||
27717302|NCT04327388|80799506|FG000|Overall Study|Other|1|||
27717303|NCT04327388|80799507|FG001|Overall Study|Other|2|||
27717304|NCT04327388|80799508|FG002|Overall Study|Other|0|||
27717305|NCT04327388|80799506|FG000|Overall Study|Randomized and not treated|2|||
27717306|NCT04327388|80799507|FG001|Overall Study|Randomized and not treated|0|||
27717307|NCT04327388|80799508|FG002|Overall Study|Randomized and not treated|2|||
27717308|NCT01926782|80799512|FG000|Overall Study|Participant moved|2|||
27717309|NCT01926782|80799513|FG001|Overall Study|Participant moved|0|||
27838268|NCT02888743|81236657|FG002|Overall Study|Disease progression before treatment|2|||
27838269|NCT02888743|81236658|FG003|Overall Study|Disease progression before treatment|0|||
27838270|NCT02888743|81236659|FG004|Overall Study|Disease progression before treatment|0|||
27838271|NCT02888743|81236655|FG000|Overall Study|Patient ineligible|1|||
27838272|NCT02888743|81236656|FG001|Overall Study|Patient ineligible|2|||
27838273|NCT02888743|81236657|FG002|Overall Study|Patient ineligible|0|||
27838274|NCT02888743|81236658|FG003|Overall Study|Patient ineligible|0|||
27838275|NCT02888743|81236659|FG004|Overall Study|Patient ineligible|0|||
27838276|NCT00659815|81236660|FG000|Overall Study|Study related symptoms and complaints|2|||
27838277|NCT00659815|81236661|FG001|Overall Study|Study related symptoms and complaints|1|||
27838278|NCT00659815|81236660|FG000|Overall Study|Inability to maintain wearing schedule|1|||
27838279|NCT00659815|81236661|FG001|Overall Study|Inability to maintain wearing schedule|2|||
27958580|NCT01791517|81680064|FG006|Phase II|Lost to Follow-up|0|||
27606488|NCT02823964|80402747|FG000|Overall Study|Physician Decision|1|||
27606489|NCT02823964|80402747|FG000|Overall Study|Lack of Efficacy|1|||
27717310|NCT01926782|80799514|FG002|Overall Study|Participant moved|1|||
27717311|NCT01926782|80799515|FG003|Overall Study|Participant moved|1|||
27717312|NCT01926782|80799516|FG004|Overall Study|Participant moved|0|||
27717313|NCT01926782|80799517|FG005|Overall Study|Participant moved|3|||
27717314|NCT01926782|80799512|FG000|Overall Study|Physician Decision|0|||
27717315|NCT01926782|80799513|FG001|Overall Study|Physician Decision|2|||
27717316|NCT01926782|80799514|FG002|Overall Study|Physician Decision|1|||
27717317|NCT01926782|80799515|FG003|Overall Study|Physician Decision|1|||
27717318|NCT01926782|80799516|FG004|Overall Study|Physician Decision|0|||
27717319|NCT01926782|80799517|FG005|Overall Study|Physician Decision|0|||
27717320|NCT01926782|80799512|FG000|Overall Study|Other than specified|2|||
27717321|NCT01926782|80799513|FG001|Overall Study|Other than specified|3|||
27717322|NCT01926782|80799514|FG002|Overall Study|Other than specified|5|||
27717323|NCT01926782|80799515|FG003|Overall Study|Other than specified|12|||
27717324|NCT01926782|80799516|FG004|Overall Study|Other than specified|4|||
27717325|NCT01926782|80799517|FG005|Overall Study|Other than specified|11|||
27717326|NCT01926782|80799512|FG000|Overall Study|Adverse Event|13|||
27717327|NCT01926782|80799513|FG001|Overall Study|Adverse Event|4|||
27717328|NCT01926782|80799514|FG002|Overall Study|Adverse Event|17|||
27717329|NCT01926782|80799515|FG003|Overall Study|Adverse Event|4|||
27717330|NCT01926782|80799516|FG004|Overall Study|Adverse Event|3|||
27717331|NCT01926782|80799517|FG005|Overall Study|Adverse Event|14|||
27717332|NCT01926782|80799512|FG000|Overall Study|Poor compliance to protocol|5|||
27717333|NCT01926782|80799513|FG001|Overall Study|Poor compliance to protocol|3|||
27717334|NCT01926782|80799514|FG002|Overall Study|Poor compliance to protocol|8|||
27717335|NCT01926782|80799515|FG003|Overall Study|Poor compliance to protocol|0|||
27717336|NCT01926782|80799516|FG004|Overall Study|Poor compliance to protocol|1|||
27717337|NCT01926782|80799517|FG005|Overall Study|Poor compliance to protocol|6|||
27717338|NCT01926782|80799512|FG000|Overall Study|Randomized and not treated|0|||
27717339|NCT01926782|80799513|FG001|Overall Study|Randomized and not treated|0|||
27890087|NCT04016779|81430947|FG000|Overall Study|Withdrawal by Subject|6|||
27890088|NCT04016779|81430948|FG001|Overall Study|Withdrawal by Subject|8|||
27717340|NCT01926782|80799514|FG002|Overall Study|Randomized and not treated|0|||
27717341|NCT01926782|80799515|FG003|Overall Study|Randomized and not treated|1|||
27717342|NCT01926782|80799516|FG004|Overall Study|Randomized and not treated|0|||
27717343|NCT01926782|80799517|FG005|Overall Study|Randomized and not treated|0|||
27717344|NCT01926782|80799512|FG000|Overall Study|Withdrawal by Subject|6|||
27717345|NCT01926782|80799513|FG001|Overall Study|Withdrawal by Subject|1|||
27717346|NCT01926782|80799514|FG002|Overall Study|Withdrawal by Subject|8|||
27717347|NCT01926782|80799515|FG003|Overall Study|Withdrawal by Subject|1|||
27717348|NCT01926782|80799516|FG004|Overall Study|Withdrawal by Subject|0|||
27717349|NCT01926782|80799517|FG005|Overall Study|Withdrawal by Subject|5|||
27717350|NCT01926782|80799512|FG000|Overall Study|Related to study drug administration|0|||
27717351|NCT01926782|80799513|FG001|Overall Study|Related to study drug administration|0|||
27717352|NCT01926782|80799514|FG002|Overall Study|Related to study drug administration|0|||
27717353|NCT01926782|80799515|FG003|Overall Study|Related to study drug administration|0|||
27717354|NCT01926782|80799516|FG004|Overall Study|Related to study drug administration|0|||
27717355|NCT01926782|80799517|FG005|Overall Study|Related to study drug administration|2|||
27717356|NCT02286947|80799518|FG000|Overall Study|Withdrawal by Subject|2|||
27717357|NCT02937350|80799522|FG000|Overall Study|Withdrawal by Subject|0|||
27717358|NCT02937350|80799523|FG001|Overall Study|Withdrawal by Subject|1|||
27717359|NCT02937350|80799524|FG002|Overall Study|Withdrawal by Subject|0|||
27717360|NCT01489527|80799525|FG000|Overall Study|Pregnancy|9|||
27717361|NCT01489527|80799526|FG001|Overall Study|Pregnancy|14|||
27717362|NCT01489527|80799525|FG000|Overall Study|Participant moved|6|||
27717363|NCT01489527|80799526|FG001|Overall Study|Participant moved|7|||
27717364|NCT01489527|80799525|FG000|Overall Study|Withdrawal by Subject|0|||
27717365|NCT01489527|80799526|FG001|Overall Study|Withdrawal by Subject|4|||
27717366|NCT01489527|80799525|FG000|Overall Study|Lost to Follow-up|5|||
27717367|NCT01489527|80799526|FG001|Overall Study|Lost to Follow-up|1|||
27717368|NCT01489527|80799525|FG000|Overall Study|Procedures|1|||
27717369|NCT01489527|80799526|FG001|Overall Study|Procedures|0|||
27717370|NCT01489527|80799525|FG000|Overall Study|Not compliant|1|||
27717371|NCT01489527|80799526|FG001|Overall Study|Not compliant|0|||
27717372|NCT01562548|80799530|FG000|Overall Study|Lost to Follow-up|0|||
27717373|NCT01562548|80799531|FG001|Overall Study|Lost to Follow-up|0|||
27717374|NCT01562548|80799532|FG002|Overall Study|Lost to Follow-up|1|||
27717375|NCT01562548|80799533|FG003|Overall Study|Lost to Follow-up|0|||
27717376|NCT03468855|80799534|FG000|Overall Study|Adverse Event|2|||
27717377|NCT03468855|80799534|FG000|Overall Study|Lost to Follow-up|5|||
27717378|NCT03468855|80799534|FG000|Overall Study|Withdrawal by Subject|3|||
27717379|NCT03468855|80799534|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
27717380|NCT00132132|80799535|FG000|Overall Study|Lost to Follow-up|7|||
27717381|NCT00132132|80799536|FG001|Overall Study|Lost to Follow-up|2|||
27717382|NCT02556255|80799539|FG000|Overall Study|Lost to Follow-up|4|||
27717383|NCT02889796|80799540|FG000|Overall Study|Withdrew Consent|18|||
27717384|NCT02889796|80799541|FG001|Overall Study|Withdrew Consent|29|||
27717385|NCT02889796|80799542|FG002|Overall Study|Withdrew Consent|20|||
27717386|NCT02889796|80799543|FG003|Overall Study|Withdrew Consent|1|||
27717387|NCT02889796|80799544|FG004|Overall Study|Withdrew Consent|2|||
27717388|NCT02889796|80799545|FG005|Overall Study|Withdrew Consent|35|||
27717389|NCT02889796|80799540|FG000|Overall Study|Investigator's Discretion|10|||
27717390|NCT02889796|80799541|FG001|Overall Study|Investigator's Discretion|9|||
27717391|NCT02889796|80799542|FG002|Overall Study|Investigator's Discretion|10|||
27717392|NCT02889796|80799543|FG003|Overall Study|Investigator's Discretion|3|||
27717393|NCT02889796|80799544|FG004|Overall Study|Investigator's Discretion|0|||
27717394|NCT02889796|80799545|FG005|Overall Study|Investigator's Discretion|15|||
27717395|NCT02889796|80799540|FG000|Overall Study|Adverse Event|17|||
27717396|NCT02889796|80799541|FG001|Overall Study|Adverse Event|8|||
27717397|NCT02889796|80799542|FG002|Overall Study|Adverse Event|8|||
27717398|NCT02889796|80799543|FG003|Overall Study|Adverse Event|4|||
27717399|NCT02889796|80799544|FG004|Overall Study|Adverse Event|1|||
27717400|NCT02889796|80799545|FG005|Overall Study|Adverse Event|7|||
27606490|NCT02823964|80402747|FG000|Overall Study|Withdrawal by Subject|1|||
27717401|NCT02889796|80799540|FG000|Overall Study|Lost to Follow-up|5|||
27717402|NCT02889796|80799541|FG001|Overall Study|Lost to Follow-up|7|||
27717403|NCT02889796|80799542|FG002|Overall Study|Lost to Follow-up|2|||
27717404|NCT02889796|80799543|FG003|Overall Study|Lost to Follow-up|0|||
27717405|NCT02889796|80799544|FG004|Overall Study|Lost to Follow-up|2|||
27717406|NCT02889796|80799545|FG005|Overall Study|Lost to Follow-up|6|||
27717407|NCT02889796|80799540|FG000|Overall Study|Protocol Violation|0|||
27717408|NCT02889796|80799541|FG001|Overall Study|Protocol Violation|1|||
27717409|NCT02889796|80799542|FG002|Overall Study|Protocol Violation|3|||
27717410|NCT02889796|80799543|FG003|Overall Study|Protocol Violation|0|||
27717411|NCT02889796|80799544|FG004|Overall Study|Protocol Violation|0|||
27606491|NCT04704154|80402748|FG000|Overall Study|Adverse Event|2|||
27606492|NCT04704154|80402749|FG001|Overall Study|Adverse Event|1|||
27606493|NCT04704154|80402750|FG002|Overall Study|Adverse Event|3|||
27717412|NCT02889796|80799545|FG005|Overall Study|Protocol Violation|4|||
27717413|NCT02889796|80799540|FG000|Overall Study|Non-compliance With Study Drug|0|||
27717414|NCT02889796|80799541|FG001|Overall Study|Non-compliance With Study Drug|2|||
27717415|NCT02889796|80799542|FG002|Overall Study|Non-compliance With Study Drug|0|||
27717416|NCT02889796|80799543|FG003|Overall Study|Non-compliance With Study Drug|0|||
27717417|NCT02889796|80799544|FG004|Overall Study|Non-compliance With Study Drug|1|||
27717418|NCT02889796|80799545|FG005|Overall Study|Non-compliance With Study Drug|2|||
27717419|NCT02889796|80799540|FG000|Overall Study|Death|1|||
27717420|NCT02889796|80799541|FG001|Overall Study|Death|1|||
27717421|NCT02889796|80799542|FG002|Overall Study|Death|0|||
27606494|NCT04704154|80402751|FG003|Overall Study|Adverse Event|2|||
27717422|NCT02889796|80799543|FG003|Overall Study|Death|1|||
27606495|NCT04704154|80402752|FG004|Overall Study|Adverse Event|3|||
27606496|NCT04704154|80402753|FG005|Overall Study|Adverse Event|0|||
27606497|NCT04704154|80402748|FG000|Overall Study|Death|3|||
27606498|NCT04704154|80402749|FG001|Overall Study|Death|0|||
27606499|NCT04704154|80402750|FG002|Overall Study|Death|0|||
27606500|NCT04704154|80402751|FG003|Overall Study|Death|0|||
27606501|NCT04704154|80402752|FG004|Overall Study|Death|3|||
27606502|NCT04704154|80402753|FG005|Overall Study|Death|0|||
27606503|NCT04704154|80402748|FG000|Overall Study|Physician Decision|1|||
27606504|NCT04704154|80402749|FG001|Overall Study|Physician Decision|0|||
27606505|NCT04704154|80402750|FG002|Overall Study|Physician Decision|0|||
27606506|NCT04704154|80402751|FG003|Overall Study|Physician Decision|0|||
27606507|NCT04704154|80402752|FG004|Overall Study|Physician Decision|1|||
27606508|NCT04704154|80402753|FG005|Overall Study|Physician Decision|0|||
27606509|NCT04704154|80402748|FG000|Overall Study|Participant Decision|1|||
27606510|NCT04704154|80402749|FG001|Overall Study|Participant Decision|1|||
27606511|NCT04704154|80402750|FG002|Overall Study|Participant Decision|0|||
27606512|NCT04704154|80402751|FG003|Overall Study|Participant Decision|0|||
27606513|NCT04704154|80402752|FG004|Overall Study|Participant Decision|0|||
27606514|NCT04704154|80402753|FG005|Overall Study|Participant Decision|0|||
27606515|NCT04704154|80402748|FG000|Overall Study|Progressive Disease|16|||
27606516|NCT04704154|80402749|FG001|Overall Study|Progressive Disease|17|||
27606517|NCT04704154|80402750|FG002|Overall Study|Progressive Disease|20|||
27606518|NCT04704154|80402751|FG003|Overall Study|Progressive Disease|18|||
27606519|NCT04704154|80402752|FG004|Overall Study|Progressive Disease|36|||
27606520|NCT04704154|80402753|FG005|Overall Study|Progressive Disease|30|||
27606521|NCT04704154|80402748|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
27606522|NCT04704154|80402749|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
27606523|NCT04704154|80402750|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
27606524|NCT04704154|80402751|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
27606525|NCT04704154|80402752|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
27606526|NCT04704154|80402753|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
27606527|NCT01203930|80402754|FG000|Overall Study|Disease Progression|0|||
27606528|NCT01203930|80402755|FG001|Overall Study|Disease Progression|4|||
27606529|NCT01203930|80402754|FG000|Overall Study|Death|3|||
27606530|NCT01203930|80402755|FG001|Overall Study|Death|1|||
27606531|NCT01203930|80402754|FG000|Overall Study|Withdrew Consent|1|||
27606532|NCT01203930|80402755|FG001|Overall Study|Withdrew Consent|10|||
27606533|NCT01203930|80402754|FG000|Overall Study|Investigator Request|0|||
27606534|NCT01203930|80402755|FG001|Overall Study|Investigator Request|8|||
27606535|NCT01203930|80402754|FG000|Overall Study|Study Terminated by Sponsor|0|||
27606536|NCT01203930|80402755|FG001|Overall Study|Study Terminated by Sponsor|12|||
27606537|NCT01203930|80402754|FG000|Overall Study|Poor tolerance of study drug|0|||
27606538|NCT01203930|80402755|FG001|Overall Study|Poor tolerance of study drug|1|||
27606539|NCT01203930|80402754|FG000|Overall Study|Adverse Event|17|||
27606540|NCT01203930|80402755|FG001|Overall Study|Adverse Event|5|||
27606541|NCT04522180|80402756|FG000|Overall Study|Investigator judgement|3|||
27606542|NCT04522180|80402757|FG001|Overall Study|Investigator judgement|4|||
27606543|NCT04522180|80402756|FG000|Overall Study|Voluntary withdrawal|1|||
27606544|NCT04522180|80402757|FG001|Overall Study|Voluntary withdrawal|0|||
27606545|NCT04522180|80402756|FG000|Overall Study|Pregnancy|0|||
27606546|NCT04522180|80402757|FG001|Overall Study|Pregnancy|1|||
27606547|NCT04522180|80402756|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
27606548|NCT04522180|80402757|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
27606549|NCT04522180|80402756|FG000|Overall Study|Reason not specified|8|||
27606550|NCT04522180|80402757|FG001|Overall Study|Reason not specified|5|||
27606551|NCT04737109|80402763|FG000|Study Treatment|Disease Progression|5|||
27606552|NCT04737109|80402764|FG001|Study Treatment|Disease Progression|0|||
27606553|NCT04737109|80402765|FG002|Study Treatment|Disease Progression|0|||
27606554|NCT04737109|80402766|FG003|Study Treatment|Disease Progression|0|||
27717423|NCT02889796|80799544|FG004|Overall Study|Death|0|||
27717424|NCT02889796|80799545|FG005|Overall Study|Death|1|||
27717425|NCT02889796|80799540|FG000|Overall Study|Pregnancy|0|||
27717426|NCT02889796|80799541|FG001|Overall Study|Pregnancy|1|||
27717427|NCT02889796|80799542|FG002|Overall Study|Pregnancy|1|||
27717428|NCT02889796|80799543|FG003|Overall Study|Pregnancy|0|||
27717429|NCT02889796|80799544|FG004|Overall Study|Pregnancy|0|||
27717430|NCT02889796|80799545|FG005|Overall Study|Pregnancy|0|||
27717431|NCT02889796|80799540|FG000|Overall Study|Randomized but not Dosed|2|||
27717432|NCT02889796|80799541|FG001|Overall Study|Randomized but not Dosed|0|||
27717433|NCT02889796|80799542|FG002|Overall Study|Randomized but not Dosed|0|||
27717434|NCT02889796|80799543|FG003|Overall Study|Randomized but not Dosed|0|||
27717435|NCT02889796|80799544|FG004|Overall Study|Randomized but not Dosed|0|||
27717436|NCT02889796|80799545|FG005|Overall Study|Randomized but not Dosed|2|||
27717437|NCT00772668|80799546|FG000|Overall Study|Physician Decision|3|||
27717438|NCT02104583|80799555|FG000|Overall Study|New ICD or CRT-D implanted|2|||
27717439|NCT02104583|80799556|FG001|Overall Study|New ICD or CRT-D implanted|0|||
27717440|NCT02104583|80799557|FG002|Overall Study|New ICD or CRT-D implanted|1|||
27717441|NCT02104583|80799558|FG003|Overall Study|New ICD or CRT-D implanted|0|||
27717442|NCT02104583|80799559|FG004|Overall Study|New ICD or CRT-D implanted|0|||
27717443|NCT02104583|80799555|FG000|Overall Study|Death|2|||
27717444|NCT02104583|80799556|FG001|Overall Study|Death|1|||
27717445|NCT02104583|80799557|FG002|Overall Study|Death|3|||
27717446|NCT02104583|80799558|FG003|Overall Study|Death|3|||
27717447|NCT02104583|80799559|FG004|Overall Study|Death|5|||
27717448|NCT02104583|80799555|FG000|Overall Study|Subject required cardiac ablation|6|||
27717449|NCT02104583|80799556|FG001|Overall Study|Subject required cardiac ablation|4|||
27717450|NCT02104583|80799557|FG002|Overall Study|Subject required cardiac ablation|4|||
27717451|NCT02104583|80799558|FG003|Overall Study|Subject required cardiac ablation|5|||
27717452|NCT02104583|80799559|FG004|Overall Study|Subject required cardiac ablation|4|||
27717453|NCT02104583|80799555|FG000|Overall Study|Subject required prohibited medication|0|||
27717454|NCT02104583|80799556|FG001|Overall Study|Subject required prohibited medication|1|||
27717455|NCT02104583|80799557|FG002|Overall Study|Subject required prohibited medication|1|||
27717456|NCT02104583|80799558|FG003|Overall Study|Subject required prohibited medication|0|||
27717457|NCT02104583|80799559|FG004|Overall Study|Subject required prohibited medication|1|||
27717458|NCT02104583|80799555|FG000|Overall Study|Withdrew Consent|3|||
27717459|NCT02104583|80799556|FG001|Overall Study|Withdrew Consent|2|||
27717460|NCT02104583|80799557|FG002|Overall Study|Withdrew Consent|0|||
27717461|NCT02104583|80799558|FG003|Overall Study|Withdrew Consent|2|||
27717462|NCT02104583|80799559|FG004|Overall Study|Withdrew Consent|1|||
27717463|NCT02104583|80799555|FG000|Overall Study|Investigator's Discretion|1|||
27717464|NCT02104583|80799556|FG001|Overall Study|Investigator's Discretion|0|||
27717465|NCT02104583|80799557|FG002|Overall Study|Investigator's Discretion|0|||
27717466|NCT02104583|80799558|FG003|Overall Study|Investigator's Discretion|0|||
27717467|NCT02104583|80799559|FG004|Overall Study|Investigator's Discretion|0|||
27717468|NCT02104583|80799555|FG000|Overall Study|Protocol Violation|0|||
27717469|NCT02104583|80799556|FG001|Overall Study|Protocol Violation|0|||
27717470|NCT02104583|80799557|FG002|Overall Study|Protocol Violation|1|||
27717471|NCT02104583|80799558|FG003|Overall Study|Protocol Violation|0|||
27717472|NCT02104583|80799559|FG004|Overall Study|Protocol Violation|0|||
27717473|NCT02104583|80799555|FG000|Overall Study|Adverse Event|3|||
27717474|NCT02104583|80799556|FG001|Overall Study|Adverse Event|3|||
27717475|NCT02104583|80799557|FG002|Overall Study|Adverse Event|6|||
27717476|NCT02104583|80799558|FG003|Overall Study|Adverse Event|6|||
27717477|NCT02104583|80799559|FG004|Overall Study|Adverse Event|1|||
27717478|NCT02104583|80799555|FG000|Overall Study|Lost to Follow-up|1|||
27717479|NCT02104583|80799556|FG001|Overall Study|Lost to Follow-up|0|||
27717480|NCT02104583|80799557|FG002|Overall Study|Lost to Follow-up|0|||
27717481|NCT02104583|80799558|FG003|Overall Study|Lost to Follow-up|0|||
27717482|NCT02104583|80799559|FG004|Overall Study|Lost to Follow-up|0|||
27717483|NCT02104583|80799555|FG000|Overall Study|Randomized but Never Treated|0|||
27717484|NCT02104583|80799556|FG001|Overall Study|Randomized but Never Treated|0|||
27717485|NCT02104583|80799557|FG002|Overall Study|Randomized but Never Treated|0|||
27717486|NCT02104583|80799558|FG003|Overall Study|Randomized but Never Treated|1|||
27717487|NCT02104583|80799559|FG004|Overall Study|Randomized but Never Treated|0|||
27717488|NCT00711100|80799560|FG000|Overall Study|Lack of Efficacy|5|||
27606555|NCT04737109|80402763|FG000|Study Treatment|Death on study|1|||
27606556|NCT04737109|80402764|FG001|Study Treatment|Death on study|0|||
27606557|NCT04737109|80402765|FG002|Study Treatment|Death on study|0|||
27606558|NCT04737109|80402766|FG003|Study Treatment|Death on study|0|||
27606559|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
27606560|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
27606561|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
27606562|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
27606563|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
27606564|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
27606565|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
27606566|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
27606567|NCT01336621|80402767|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
27606568|NCT01336621|80402767|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
27606569|NCT01336621|80402767|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
27606570|NCT01336621|80402767|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
27606571|NCT01336621|80402767|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
27606572|NCT01336621|80402767|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
27606573|NCT03560245|80402768|FG000|Overall Study|Withdrawal by Subject|3|||
27606574|NCT03560245|80402769|FG001|Overall Study|Withdrawal by Subject|2|||
27606575|NCT03560245|80402768|FG000|Overall Study|Adverse Event|1|||
27606576|NCT03560245|80402769|FG001|Overall Study|Adverse Event|1|||
27606577|NCT03560245|80402768|FG000|Overall Study|Protocol Violation|1|||
27606578|NCT03560245|80402769|FG001|Overall Study|Protocol Violation|0|||
27606579|NCT03560245|80402768|FG000|Overall Study|Death|0|||
27606580|NCT03560245|80402769|FG001|Overall Study|Death|1|||
27606581|NCT03560245|80402768|FG000|Overall Study|Lost to Follow-up|0|||
27606582|NCT03560245|80402769|FG001|Overall Study|Lost to Follow-up|1|||
27606583|NCT03560245|80402768|FG000|Overall Study|Physician Decision|0|||
27606584|NCT03560245|80402769|FG001|Overall Study|Physician Decision|1|||
27606585|NCT03560245|80402768|FG000|Overall Study|Other|0|||
27606586|NCT03560245|80402769|FG001|Overall Study|Other|1|||
27606587|NCT04207840|80402770|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
27606588|NCT04207840|80402771|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
27606589|NCT04207840|80402772|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
27606590|NCT04207840|80402770|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
27606591|NCT04207840|80402771|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
27606592|NCT04207840|80402772|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
27606593|NCT01576367|80402775|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27606594|NCT01576367|80402775|FG000|Overall Study|Moved to commercial use after 6 months|1|||
27606595|NCT04631705|80402776|FG000|Overall Study|Withdrawal by Subject|0|||
27606596|NCT04631705|80402777|FG001|Overall Study|Withdrawal by Subject|0|||
27606597|NCT04631705|80402778|FG002|Overall Study|Withdrawal by Subject|0|||
27606598|NCT04631705|80402779|FG003|Overall Study|Withdrawal by Subject|0|||
27606599|NCT04631705|80402780|FG004|Overall Study|Withdrawal by Subject|0|||
27606600|NCT04631705|80402781|FG005|Overall Study|Withdrawal by Subject|0|||
27606601|NCT04631705|80402782|FG006|Overall Study|Withdrawal by Subject|1|||
27606602|NCT04631705|80402783|FG007|Overall Study|Withdrawal by Subject|0|||
27606603|NCT04631705|80402784|FG008|Overall Study|Withdrawal by Subject|0|||
27606604|NCT01164228|80402785|FG000|Overall Study|Progression|24|||
27606605|NCT01164228|80402786|FG001|Overall Study|Progression|25|||
27606606|NCT01164228|80402785|FG000|Overall Study|Adverse Event|13|||
27606607|NCT01164228|80402786|FG001|Overall Study|Adverse Event|7|||
27606608|NCT01164228|80402785|FG000|Overall Study|Death|1|||
27606609|NCT01164228|80402786|FG001|Overall Study|Death|1|||
27606610|NCT01164228|80402785|FG000|Overall Study|Withdrawal by Subject|2|||
27606611|NCT01164228|80402786|FG001|Overall Study|Withdrawal by Subject|0|||
27606612|NCT01164228|80402785|FG000|Overall Study|Physician Decision|1|||
27838280|NCT00659815|81236660|FG000|Overall Study|Withdrawal by Subject|1|||
27838281|NCT00659815|81236661|FG001|Overall Study|Withdrawal by Subject|1|||
27838282|NCT01968031|81236666|FG000|Overall Study|Adverse Event|13|||
27606613|NCT01164228|80402786|FG001|Overall Study|Physician Decision|2|||
27838283|NCT01968031|81236667|FG001|Overall Study|Adverse Event|10|||
27838284|NCT01968031|81236668|FG002|Overall Study|Adverse Event|22|||
27606614|NCT01164228|80402785|FG000|Overall Study|Symptomatic deterioration|1|||
27838285|NCT01968031|81236666|FG000|Overall Study|Withdrawal by Subject|3|||
27606615|NCT01164228|80402786|FG001|Overall Study|Symptomatic deterioration|0|||
27838286|NCT01968031|81236667|FG001|Overall Study|Withdrawal by Subject|7|||
27606616|NCT01164228|80402785|FG000|Overall Study|Never started treatment|1|||
27606617|NCT01164228|80402786|FG001|Overall Study|Never started treatment|3|||
27606618|NCT01164228|80402785|FG000|Overall Study|Ineligible|1|||
27717489|NCT00711100|80799560|FG000|Overall Study|Withdrawal by Subject|8|||
27717490|NCT02095535|80799561|FG000|Recruitment|Protocol Violation|2|||
27717491|NCT01462266|80799562|FG000|Overall Study|Adverse Event|7|||
27606619|NCT01164228|80402786|FG001|Overall Study|Ineligible|0|||
27717492|NCT01462266|80799563|FG001|Overall Study|Adverse Event|6|||
27606620|NCT00510458|80402789|FG000|Overall Study|5 year not evaluable/missed|21|||
27606621|NCT00510458|80402789|FG000|Overall Study|Death|1|||
27606622|NCT00510458|80402789|FG000|Overall Study|Terminated|14|||
27606623|NCT00510458|80402789|FG000|Overall Study|Lost to Follow-up|6|||
27606624|NCT00510458|80402789|FG000|Overall Study|Withdrawal by Subject|3|||
27606625|NCT00510458|80402789|FG000|Overall Study|Revision|2|||
27890089|NCT04016779|81430947|FG000|Overall Study|Non-compliance with Study Drug|2|||
27890090|NCT04016779|81430948|FG001|Overall Study|Non-compliance with Study Drug|3|||
27606626|NCT02736968|80402790|FG000|Overall Study|Lost to Follow-up|0|||
27606627|NCT02736968|80402791|FG001|Overall Study|Lost to Follow-up|0|||
27606628|NCT02736968|80402792|FG002|Overall Study|Lost to Follow-up|0|||
27606629|NCT02736968|80402793|FG003|Overall Study|Lost to Follow-up|0|||
27606630|NCT02736968|80402794|FG004|Overall Study|Lost to Follow-up|0|||
27606631|NCT02736968|80402795|FG005|Overall Study|Lost to Follow-up|0|||
27606632|NCT02736968|80402796|FG006|Overall Study|Lost to Follow-up|5|||
27606633|NCT02736968|80402797|FG007|Overall Study|Lost to Follow-up|2|||
27606634|NCT02736968|80402790|FG000|Overall Study|COVID-19 Pandemic|0|||
27606635|NCT02736968|80402791|FG001|Overall Study|COVID-19 Pandemic|0|||
27606636|NCT02736968|80402792|FG002|Overall Study|COVID-19 Pandemic|0|||
27606637|NCT02736968|80402793|FG003|Overall Study|COVID-19 Pandemic|0|||
27606638|NCT02736968|80402794|FG004|Overall Study|COVID-19 Pandemic|0|||
27606639|NCT02736968|80402795|FG005|Overall Study|COVID-19 Pandemic|0|||
27606640|NCT02736968|80402796|FG006|Overall Study|COVID-19 Pandemic|2|||
27890091|NCT04016779|81430947|FG000|Overall Study|Other, Multiple categories|17|||
27606641|NCT02736968|80402797|FG007|Overall Study|COVID-19 Pandemic|0|||
27606642|NCT02736968|80402790|FG000|Overall Study|Withdrawal by Subject|0|||
27606643|NCT02736968|80402791|FG001|Overall Study|Withdrawal by Subject|0|||
27606644|NCT02736968|80402792|FG002|Overall Study|Withdrawal by Subject|0|||
27606645|NCT02736968|80402793|FG003|Overall Study|Withdrawal by Subject|0|||
27606646|NCT02736968|80402794|FG004|Overall Study|Withdrawal by Subject|0|||
27606647|NCT02736968|80402795|FG005|Overall Study|Withdrawal by Subject|0|||
27606648|NCT02736968|80402796|FG006|Overall Study|Withdrawal by Subject|1|||
27606649|NCT02736968|80402797|FG007|Overall Study|Withdrawal by Subject|0|||
27606650|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
27606651|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
27606652|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
27606653|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
27717493|NCT01462266|80799562|FG000|Overall Study|Death|2|||
27838287|NCT01968031|81236668|FG002|Overall Study|Withdrawal by Subject|3|||
27838288|NCT01968031|81236666|FG000|Overall Study|Did not meet entry criteria|1|||
27838289|NCT01968031|81236667|FG001|Overall Study|Did not meet entry criteria|1|||
27838290|NCT01968031|81236668|FG002|Overall Study|Did not meet entry criteria|1|||
27838291|NCT01968031|81236666|FG000|Overall Study|Noncompliance|0|||
27838292|NCT01968031|81236667|FG001|Overall Study|Noncompliance|0|||
27838293|NCT01968031|81236668|FG002|Overall Study|Noncompliance|2|||
27838294|NCT01968031|81236666|FG000|Overall Study|Failed inclusion criteria|0|||
27838295|NCT01968031|81236667|FG001|Overall Study|Failed inclusion criteria|2|||
27838296|NCT01968031|81236668|FG002|Overall Study|Failed inclusion criteria|0|||
27838297|NCT01968031|81236666|FG000|Overall Study|Death|0|||
27838298|NCT01968031|81236667|FG001|Overall Study|Death|0|||
27838299|NCT01968031|81236668|FG002|Overall Study|Death|1|||
27838300|NCT01968031|81236666|FG000|Overall Study|Prohibited concomitant medication|1|||
27838301|NCT01968031|81236667|FG001|Overall Study|Prohibited concomitant medication|0|||
27838302|NCT01968031|81236668|FG002|Overall Study|Prohibited concomitant medication|0|||
27838303|NCT01041495|81236670|FG000|Overall Study|Withdrawal by Subject|2|||
27838304|NCT01041495|81236671|FG001|Overall Study|Withdrawal by Subject|5|||
27838305|NCT01041495|81236670|FG000|Overall Study|Adverse Event|2|||
27838306|NCT01041495|81236671|FG001|Overall Study|Adverse Event|1|||
27838307|NCT01041495|81236670|FG000|Overall Study|Lost to Follow-up|0|||
27838308|NCT01041495|81236671|FG001|Overall Study|Lost to Follow-up|1|||
27838309|NCT01924364|81236672|FG000|Overall Study|Physician Decision|3|||
27838310|NCT03573336|81236673|FG000|Overall Study|Study terminated|2|||
27838311|NCT03573336|81236674|FG001|Overall Study|Study terminated|4|||
27606654|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
27606655|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
27606656|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
27606657|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
27606658|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
27606659|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
27606660|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
27606661|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
27606662|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
27606663|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
27606664|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
27606665|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
27606666|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
27606667|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
27606668|NCT00365378|80402799|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
27606669|NCT00365378|80402800|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
27606670|NCT00365378|80402801|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
27606671|NCT00365378|80402799|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
27606672|NCT00365378|80402800|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
27606673|NCT00365378|80402801|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
27606674|NCT00365378|80402799|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
27606675|NCT00365378|80402800|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
27606676|NCT00365378|80402801|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
27606677|NCT00365378|80402799|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
27606678|NCT00365378|80402800|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
27606679|NCT00365378|80402801|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
27606680|NCT00365378|80402799|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
27606681|NCT00365378|80402800|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
27606682|NCT00365378|80402801|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
27606683|NCT00365378|80402799|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
27606684|NCT00365378|80402800|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
27606685|NCT00365378|80402801|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
27606686|NCT00365378|80402799|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
27606687|NCT00365378|80402800|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
27606688|NCT00365378|80402801|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
27606689|NCT00365378|80402799|FG000|Extension|Adverse Event|0|||
27606690|NCT00365378|80402800|FG001|Extension|Adverse Event|0|||
27606691|NCT00365378|80402801|FG002|Extension|Adverse Event|1|||
27606692|NCT00365378|80402799|FG000|Extension|Moved|0|||
27606693|NCT00365378|80402800|FG001|Extension|Moved|0|||
27606694|NCT00365378|80402801|FG002|Extension|Moved|8|||
27606695|NCT00365378|80402799|FG000|Extension|Lost to Follow-up|0|||
27606696|NCT00365378|80402800|FG001|Extension|Lost to Follow-up|0|||
27606697|NCT00365378|80402801|FG002|Extension|Lost to Follow-up|57|||
27606698|NCT00365378|80402799|FG000|Extension|Protocol Violation|0|||
27606699|NCT00365378|80402800|FG001|Extension|Protocol Violation|0|||
27717494|NCT01462266|80799563|FG001|Overall Study|Death|1|||
27717495|NCT01462266|80799562|FG000|Overall Study|Lack of Efficacy|0|||
27717496|NCT01462266|80799563|FG001|Overall Study|Lack of Efficacy|2|||
27717497|NCT01462266|80799562|FG000|Overall Study|Lost to Follow-up|4|||
27717498|NCT01462266|80799563|FG001|Overall Study|Lost to Follow-up|3|||
27717499|NCT01462266|80799562|FG000|Overall Study|Non-compliance with study drug|3|||
27717500|NCT01462266|80799563|FG001|Overall Study|Non-compliance with study drug|0|||
27717501|NCT01462266|80799562|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
27717502|NCT01462266|80799563|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
27717503|NCT01462266|80799562|FG000|Overall Study|Physician Decision|2|||
27717504|NCT01462266|80799563|FG001|Overall Study|Physician Decision|5|||
27717505|NCT01462266|80799562|FG000|Overall Study|Protocol Violation|1|||
27717506|NCT01462266|80799563|FG001|Overall Study|Protocol Violation|3|||
27717507|NCT01462266|80799562|FG000|Overall Study|Withdrawal by Subject|7|||
27717508|NCT01462266|80799563|FG001|Overall Study|Withdrawal by Subject|2|||
27717509|NCT01462266|80799562|FG000|Overall Study|Screen failure|1|||
27717510|NCT01462266|80799563|FG001|Overall Study|Screen failure|1|||
27717511|NCT03655756|80799566|FG000|Overall Study|Death|1|||
27717512|NCT00278993|80799567|FG000|Overall Study|Adverse Event|24|||
27717513|NCT00278993|80799567|FG000|Overall Study|Withdrawal by Subject|5|||
27717514|NCT00278993|80799567|FG000|Overall Study|Progressive Disease|65|||
27717515|NCT00278993|80799567|FG000|Overall Study|Physician Decision|9|||
27717516|NCT00278993|80799567|FG000|Overall Study|Not Otherwise Specified|4|||
27717517|NCT02867761|80799568|FG000|Overall Study|Participant withdrawn by investigator|0|||
27717518|NCT02867761|80799569|FG001|Overall Study|Participant withdrawn by investigator|1|||
27717519|NCT02867761|80799568|FG000|Overall Study|Lost to Follow-up|25|||
27717520|NCT02867761|80799569|FG001|Overall Study|Lost to Follow-up|18|||
27717521|NCT02867761|80799568|FG000|Overall Study|Unable to complete protocol|3|||
27717522|NCT02867761|80799569|FG001|Overall Study|Unable to complete protocol|7|||
27717523|NCT03920670|80799574|FG000|Overall Study|Protocol Violation|2|||
27717524|NCT03920670|80799575|FG001|Overall Study|Protocol Violation|2|||
27717525|NCT03920670|80799574|FG000|Overall Study|Adverse Event|1|||
27717526|NCT03920670|80799575|FG001|Overall Study|Adverse Event|0|||
27717527|NCT00371865|80799585|FG000|Overall Study|Lack of Efficacy|0|||
27717528|NCT00371865|80799586|FG001|Overall Study|Lack of Efficacy|2|||
27717529|NCT00371865|80799585|FG000|Overall Study|Protocol Violation|3|||
27717530|NCT00371865|80799586|FG001|Overall Study|Protocol Violation|2|||
27717531|NCT00371865|80799585|FG000|Overall Study|Withdrawal by Subject|12|||
27717532|NCT00371865|80799586|FG001|Overall Study|Withdrawal by Subject|10|||
27717533|NCT02347176|80799587|FG000|Overall Study|Lost to Follow-up|2|||
27717534|NCT02347176|80799588|FG001|Overall Study|Lost to Follow-up|3|||
27717535|NCT02347176|80799589|FG002|Overall Study|Lost to Follow-up|1|||
27717536|NCT02347176|80799590|FG003|Overall Study|Lost to Follow-up|1|||
27717537|NCT02347176|80799587|FG000|Overall Study|Withdrawal by Subject|9|||
27890092|NCT04016779|81430948|FG001|Overall Study|Other, Multiple categories|17|||
27890093|NCT02949843|81430949|FG000|Overall Study|Withdrawal by Subject|0|||
27890094|NCT02949843|81430950|FG001|Overall Study|Withdrawal by Subject|1|||
27890095|NCT02949843|81430951|FG002|Overall Study|Withdrawal by Subject|1|||
27717538|NCT02347176|80799588|FG001|Overall Study|Withdrawal by Subject|5|||
27717539|NCT02347176|80799589|FG002|Overall Study|Withdrawal by Subject|5|||
27717540|NCT02347176|80799590|FG003|Overall Study|Withdrawal by Subject|3|||
27717541|NCT02347176|80799587|FG000|Overall Study|Other|1|||
27717542|NCT02347176|80799588|FG001|Overall Study|Other|2|||
27717543|NCT02347176|80799589|FG002|Overall Study|Other|2|||
27717544|NCT02347176|80799590|FG003|Overall Study|Other|0|||
27717545|NCT01137773|80799591|FG000|Overall Study|Death|3|||
27717546|NCT01137773|80799592|FG001|Overall Study|Death|3|||
27717547|NCT01137773|80799591|FG000|Overall Study|Lost to Follow-up|6|||
27606700|NCT00365378|80402801|FG002|Extension|Protocol Violation|2|||
27606701|NCT00365378|80402799|FG000|Extension|Withdrawal by Subject|0|||
27606702|NCT00365378|80402800|FG001|Extension|Withdrawal by Subject|0|||
27606703|NCT00365378|80402801|FG002|Extension|Withdrawal by Subject|98|||
27606704|NCT00365378|80402799|FG000|Extension|Other|0|||
27606705|NCT00365378|80402800|FG001|Extension|Other|0|||
27717548|NCT01137773|80799592|FG001|Overall Study|Lost to Follow-up|0|||
27717549|NCT00586495|80799593|FG000|Treatment Period|Adverse Event|11|||
27717550|NCT00586495|80799593|FG000|Treatment Period|Death|1|||
27717551|NCT00586495|80799593|FG000|Treatment Period|Protocol Violation|1|||
27717552|NCT00586495|80799593|FG000|Treatment Period|Withdrawal by Subject|1|||
27717553|NCT00586495|80799593|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
27717554|NCT00586495|80799593|FG000|Treatment Period|Switch to commercial drug|10|||
27717555|NCT00586495|80799593|FG000|Follow-up|Death|40|||
27717556|NCT00586495|80799593|FG000|Follow-up|Lost to Follow-up|1|||
27717557|NCT00586495|80799593|FG000|Follow-up|Withdrawal by Subject|4|||
27717558|NCT00586495|80799593|FG000|Follow-up|Protocol driven decision point|37|||
27717559|NCT00586495|80799593|FG000|Follow-up|Switch to commercial drug|10|||
27717560|NCT01035905|80799594|FG000|Overall Study|Lack of Efficacy|1|||
27717561|NCT01035905|80799595|FG001|Overall Study|Lack of Efficacy|1|||
27717562|NCT01339559|80799596|FG000|Overall Study|Adverse Event|92|||
27717563|NCT01339559|80799596|FG000|Overall Study|Death|5|||
27717564|NCT01339559|80799596|FG000|Overall Study|Lack of Efficacy|164|||
27717565|NCT01339559|80799596|FG000|Overall Study|Lost to Follow-up|22|||
27717566|NCT01339559|80799596|FG000|Overall Study|Subject choice|89|||
27838312|NCT03573336|81236675|FG002|Overall Study|Study terminated|2|||
27606706|NCT00365378|80402801|FG002|Extension|Other|31|||
27606707|NCT03176238|80402804|FG000|Overall Study|Unacceptable AEs|15|||
27606708|NCT03176238|80402805|FG001|Overall Study|Unacceptable AEs|8|||
27606709|NCT03176238|80402804|FG000|Overall Study|Abnormal lab value(s)|2|||
27606710|NCT03176238|80402805|FG001|Overall Study|Abnormal lab value(s)|0|||
27717567|NCT01339559|80799596|FG000|Overall Study|Protocol Violation|15|||
27717568|NCT01339559|80799596|FG000|Overall Study|Study closure at site|1|||
27717569|NCT01339559|80799596|FG000|Overall Study|Incarcerated|2|||
27717570|NCT01339559|80799596|FG000|Overall Study|Epilepsy surgery|1|||
27838313|NCT00668395|81236676|FG000|Overall Study|Withdrawal by Subject|4|||
27838314|NCT00668395|81236677|FG001|Overall Study|Withdrawal by Subject|4|||
27838315|NCT00668395|81236678|FG002|Overall Study|Withdrawal by Subject|1|||
27606711|NCT03176238|80402804|FG000|Overall Study|Inter-current illness|0|||
27606712|NCT03176238|80402805|FG001|Overall Study|Inter-current illness|1|||
27606713|NCT03176238|80402804|FG000|Overall Study|Consent withdrawal|14|||
27606714|NCT03176238|80402805|FG001|Overall Study|Consent withdrawal|2|||
27606715|NCT03176238|80402804|FG000|Overall Study|Lost to Follow-up|3|||
27606716|NCT03176238|80402805|FG001|Overall Study|Lost to Follow-up|0|||
27606717|NCT03176238|80402804|FG000|Overall Study|Administrative problems|1|||
27606718|NCT03176238|80402805|FG001|Overall Study|Administrative problems|0|||
27606719|NCT03176238|80402804|FG000|Overall Study|Death|3|||
27606720|NCT03176238|80402805|FG001|Overall Study|Death|0|||
27606721|NCT03176238|80402804|FG000|Overall Study|Disease Progression|133|||
27606722|NCT03176238|80402805|FG001|Overall Study|Disease Progression|22|||
27606723|NCT03176238|80402804|FG000|Overall Study|Tx duration completed per EAP|0|||
27606724|NCT03176238|80402805|FG001|Overall Study|Tx duration completed per EAP|1|||
27606725|NCT03176238|80402804|FG000|Overall Study|Patient is switched to commercial drug|16|||
27606726|NCT03176238|80402805|FG001|Overall Study|Patient is switched to commercial drug|1|||
27606727|NCT03176238|80402804|FG000|Overall Study|Protocol Violation|1|||
27606728|NCT03176238|80402805|FG001|Overall Study|Protocol Violation|0|||
27606729|NCT03176238|80402804|FG000|Overall Study|Changes in the patient's condition|2|||
27606730|NCT03176238|80402805|FG001|Overall Study|Changes in the patient's condition|1|||
27606731|NCT03176238|80402804|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
27606732|NCT03176238|80402805|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
27606733|NCT03610737|80402806|FG000|Overall Study|Withdrawal by Subject|1|||
27606734|NCT03610737|80402807|FG001|Overall Study|Withdrawal by Subject|5|||
27606735|NCT03610737|80402806|FG000|Overall Study|Death|1|||
27606736|NCT03610737|80402807|FG001|Overall Study|Death|0|||
27606737|NCT03610737|80402806|FG000|Overall Study|Not treated|5|||
27606738|NCT03610737|80402807|FG001|Overall Study|Not treated|2|||
27606739|NCT03610737|80402806|FG000|Overall Study|Missed Visit|1|||
27717571|NCT01339559|80799596|FG000|Overall Study|Pregnancy planned|2|||
27717572|NCT01339559|80799596|FG000|Overall Study|Left the country|1|||
27717573|NCT01339559|80799596|FG000|Overall Study|Investigator decision|2|||
27717574|NCT01339559|80799596|FG000|Overall Study|Patient didn't wish to continue|1|||
27717575|NCT01339559|80799596|FG000|Overall Study|PI decision|1|||
27717576|NCT01908101|80799597|FG000|Overall Study|Physician Decision|1|||
27717577|NCT01908101|80799597|FG000|Overall Study|Withdrawal by Subject|1|||
27717578|NCT01908101|80799597|FG000|Overall Study|Incorrect Diagnosis|2|||
27717579|NCT01908101|80799597|FG000|Overall Study|Incorrect Starting Dose|1|||
27717580|NCT01908101|80799597|FG000|Overall Study|Did not complete the first cycle|4|||
27717581|NCT03603496|80799599|FG000|Overall Study|Death|19|||
27606740|NCT03610737|80402807|FG001|Overall Study|Missed Visit|2|||
27606741|NCT01370005|80402808|FG000|Overall Study|Not treated|1|||
27606742|NCT01370005|80402809|FG001|Overall Study|Not treated|0|||
27606743|NCT01370005|80402810|FG002|Overall Study|Not treated|0|||
27606744|NCT01370005|80402808|FG000|Overall Study|Adverse Event|5|||
27606745|NCT01370005|80402809|FG001|Overall Study|Adverse Event|5|||
27717582|NCT03603496|80799600|FG001|Overall Study|Death|24|||
27717583|NCT03603496|80799599|FG000|Overall Study|Lost to Follow-up|141|||
27717584|NCT03603496|80799600|FG001|Overall Study|Lost to Follow-up|141|||
27717585|NCT03603496|80799599|FG000|Overall Study|Withdrawal by Subject|26|||
27717586|NCT03603496|80799600|FG001|Overall Study|Withdrawal by Subject|20|||
27717587|NCT01290692|80799601|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
27717588|NCT04942925|80799602|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
27717589|NCT04942925|80799603|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
27717590|NCT04942925|80799602|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
27717591|NCT04942925|80799603|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
27717592|NCT02135692|80799605|FG000|Overall Study|Adverse Event|3|||
27717593|NCT02135692|80799605|FG000|Overall Study|Lack of Efficacy|2|||
27717594|NCT02135692|80799605|FG000|Overall Study|Protocol Violation|2|||
27717595|NCT02135692|80799605|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
27717596|NCT02135692|80799605|FG000|Overall Study|Product commercially available|159|||
27717597|NCT02135692|80799605|FG000|Overall Study|Study closed/terminated|153|||
27717598|NCT02135692|80799605|FG000|Overall Study|Lost to Follow-up|4|||
27717599|NCT02135692|80799605|FG000|Overall Study|Withdrawal by Subject|15|||
27717600|NCT01100437|80799607|FG000|Titration/Stabilization|Adverse Event|0|||
27717601|NCT01100437|80799608|FG001|Titration/Stabilization|Adverse Event|0|||
27717602|NCT01100437|80799609|FG002|Titration/Stabilization|Adverse Event|4|||
27717603|NCT01100437|80799607|FG000|Titration/Stabilization|Non-compliance|0|||
27717604|NCT01100437|80799608|FG001|Titration/Stabilization|Non-compliance|0|||
27717605|NCT01100437|80799609|FG002|Titration/Stabilization|Non-compliance|1|||
27717606|NCT01100437|80799607|FG000|Titration/Stabilization|Sponsor canceled study|0|||
27717607|NCT01100437|80799608|FG001|Titration/Stabilization|Sponsor canceled study|0|||
27717608|NCT01100437|80799609|FG002|Titration/Stabilization|Sponsor canceled study|1|||
27717609|NCT01100437|80799607|FG000|Maintenance|Withdrawal by Subject|0|||
27717610|NCT01100437|80799608|FG001|Maintenance|Withdrawal by Subject|0|||
27717611|NCT01100437|80799609|FG002|Maintenance|Withdrawal by Subject|1|||
27717612|NCT01100437|80799607|FG000|Maintenance|Sponsor termination of study|0|||
27717613|NCT01100437|80799608|FG001|Maintenance|Sponsor termination of study|0|||
27717614|NCT01100437|80799609|FG002|Maintenance|Sponsor termination of study|1|||
27717615|NCT00812214|80799610|FG000|Overall Study|Lost to Follow-up|3|||
27717616|NCT00812214|80799611|FG001|Overall Study|Lost to Follow-up|1|||
27717617|NCT01262365|80799612|FG000|Overall Study|Lack of Efficacy|35|||
27717618|NCT01262365|80799613|FG001|Overall Study|Lack of Efficacy|30|||
27717619|NCT01262365|80799614|FG002|Overall Study|Lack of Efficacy|47|||
27717620|NCT01262365|80799612|FG000|Overall Study|Protocol Violation|3|||
27717621|NCT01262365|80799613|FG001|Overall Study|Protocol Violation|1|||
27717622|NCT01262365|80799614|FG002|Overall Study|Protocol Violation|1|||
27838316|NCT00668395|81236676|FG000|Overall Study|Adverse Event|1|||
27838317|NCT00668395|81236677|FG001|Overall Study|Adverse Event|1|||
27838318|NCT00668395|81236678|FG002|Overall Study|Adverse Event|0|||
27838319|NCT00668395|81236676|FG000|Overall Study|Physician Decision|1|||
27606746|NCT01370005|80402810|FG002|Overall Study|Adverse Event|6|||
27717623|NCT01262365|80799612|FG000|Overall Study|Lost to Follow-up|3|||
27717624|NCT01262365|80799613|FG001|Overall Study|Lost to Follow-up|7|||
27717625|NCT01262365|80799614|FG002|Overall Study|Lost to Follow-up|6|||
27717626|NCT01262365|80799612|FG000|Overall Study|Withdrawal by Subject|17|||
27717627|NCT01262365|80799613|FG001|Overall Study|Withdrawal by Subject|22|||
27717628|NCT01262365|80799614|FG002|Overall Study|Withdrawal by Subject|22|||
27717629|NCT01262365|80799612|FG000|Overall Study|Death|1|||
27717630|NCT01262365|80799613|FG001|Overall Study|Death|2|||
27717631|NCT01262365|80799614|FG002|Overall Study|Death|1|||
27717632|NCT01262365|80799612|FG000|Overall Study|Adverse Event|26|||
27717633|NCT01262365|80799613|FG001|Overall Study|Adverse Event|16|||
27717634|NCT01262365|80799614|FG002|Overall Study|Adverse Event|11|||
27717635|NCT01262365|80799612|FG000|Overall Study|sponsor decision|1|||
27717636|NCT01262365|80799613|FG001|Overall Study|sponsor decision|1|||
27717637|NCT01262365|80799614|FG002|Overall Study|sponsor decision|0|||
27717638|NCT01262365|80799612|FG000|Overall Study|Randomization error|1|||
27717639|NCT01262365|80799613|FG001|Overall Study|Randomization error|0|||
27717640|NCT01262365|80799614|FG002|Overall Study|Randomization error|2|||
27717641|NCT01262365|80799612|FG000|Overall Study|Non-compliance|1|||
27717642|NCT01262365|80799613|FG001|Overall Study|Non-compliance|0|||
27717643|NCT01262365|80799614|FG002|Overall Study|Non-compliance|2|||
27717644|NCT01262365|80799612|FG000|Overall Study|Suspected pregnancy|1|||
27717645|NCT01262365|80799613|FG001|Overall Study|Suspected pregnancy|0|||
27717646|NCT01262365|80799614|FG002|Overall Study|Suspected pregnancy|0|||
27717647|NCT01262365|80799612|FG000|Overall Study|Patient pregnant|1|||
27717648|NCT01262365|80799613|FG001|Overall Study|Patient pregnant|0|||
27717649|NCT01262365|80799614|FG002|Overall Study|Patient pregnant|1|||
27717650|NCT01262365|80799612|FG000|Overall Study|Toxicity related to study drug|0|||
27717651|NCT01262365|80799613|FG001|Overall Study|Toxicity related to study drug|1|||
27717652|NCT01262365|80799614|FG002|Overall Study|Toxicity related to study drug|0|||
27717653|NCT01262365|80799612|FG000|Overall Study|Cannot tolerate the protocol|0|||
27717654|NCT01262365|80799613|FG001|Overall Study|Cannot tolerate the protocol|1|||
27717655|NCT01262365|80799614|FG002|Overall Study|Cannot tolerate the protocol|0|||
27717656|NCT01262365|80799612|FG000|Overall Study|Patient unavailable|0|||
27717657|NCT01262365|80799613|FG001|Overall Study|Patient unavailable|0|||
27717658|NCT01262365|80799614|FG002|Overall Study|Patient unavailable|1|||
27717659|NCT02415712|80799617|FG000|Overall Study|Protocol Violation|16|||
27717660|NCT00783094|80799618|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
27717661|NCT00783094|80799619|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
27717662|NCT00783094|80799620|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
27717663|NCT00783094|80799618|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
27717664|NCT00783094|80799619|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
27717665|NCT00783094|80799620|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
27717666|NCT00783094|80799618|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
27717667|NCT00783094|80799619|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
27717668|NCT00783094|80799620|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
27717669|NCT00783094|80799618|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
27717670|NCT00783094|80799619|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
27717671|NCT00783094|80799620|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
27717672|NCT00783094|80799618|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
27717673|NCT00783094|80799619|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
27717674|NCT00783094|80799620|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
27717675|NCT00783094|80799618|FG000|Open-Label Extension Period|Adverse Event|12|||
27717676|NCT00783094|80799619|FG001|Open-Label Extension Period|Adverse Event|7|||
27890096|NCT02353442|81430959|FG000|Overall Study|Withdrawal by Subject|3|||
27890097|NCT02353442|81430960|FG001|Overall Study|Withdrawal by Subject|4|||
27717677|NCT00783094|80799620|FG002|Open-Label Extension Period|Adverse Event|16|||
27717678|NCT00783094|80799618|FG000|Open-Label Extension Period|Death|0|||
27717679|NCT00783094|80799619|FG001|Open-Label Extension Period|Death|0|||
27717680|NCT00783094|80799620|FG002|Open-Label Extension Period|Death|1|||
27717681|NCT00783094|80799618|FG000|Open-Label Extension Period|Protocol Violation|4|||
27717682|NCT00783094|80799619|FG001|Open-Label Extension Period|Protocol Violation|5|||
27717683|NCT00783094|80799620|FG002|Open-Label Extension Period|Protocol Violation|7|||
27717684|NCT00783094|80799618|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
27717685|NCT00783094|80799619|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
27717686|NCT00783094|80799620|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
27717687|NCT00783094|80799618|FG000|Open-Label Extension Period|Physician Decision|4|||
27717688|NCT00783094|80799619|FG001|Open-Label Extension Period|Physician Decision|2|||
27717689|NCT00783094|80799620|FG002|Open-Label Extension Period|Physician Decision|3|||
27717690|NCT00783094|80799618|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
27717691|NCT00783094|80799619|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
27717692|NCT00783094|80799620|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
27717693|NCT00623428|80799623|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
27717694|NCT00623428|80799624|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
27717695|NCT00623428|80799623|FG000|Treatment Period|Death|0|||
27717696|NCT00623428|80799624|FG001|Treatment Period|Death|1|||
27717697|NCT00623428|80799623|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
27717698|NCT00623428|80799624|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
27717699|NCT00623428|80799623|FG000|Treatment Period|Insufficient therapeutic response|0|||
27717700|NCT00623428|80799624|FG001|Treatment Period|Insufficient therapeutic response|2|||
27717701|NCT00623428|80799623|FG000|Treatment Period|Other|0|||
27717702|NCT00623428|80799624|FG001|Treatment Period|Other|1|||
27717703|NCT00623428|80799623|FG000|Treatment Period|Withdrawal by Subject|0|||
27717704|NCT00623428|80799624|FG001|Treatment Period|Withdrawal by Subject|1|||
27717705|NCT00623428|80799623|FG000|Follow-up Period|Relapse post-treatment|11|||
27717706|NCT00623428|80799624|FG001|Follow-up Period|Relapse post-treatment|3|||
27717707|NCT00623428|80799623|FG000|Follow-up Period|Failure to return|10|||
27717708|NCT00623428|80799624|FG001|Follow-up Period|Failure to return|2|||
27717709|NCT00623428|80799623|FG000|Follow-up Period|Patient withdrew consent|5|||
27717710|NCT00623428|80799624|FG001|Follow-up Period|Patient withdrew consent|4|||
27717711|NCT00623428|80799623|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
27717712|NCT00623428|80799624|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
27717713|NCT00623428|80799623|FG000|Follow-up Period|Did not cooperate|0|||
27717714|NCT00623428|80799624|FG001|Follow-up Period|Did not cooperate|3|||
27717715|NCT00623428|80799623|FG000|Follow-up Period|Reason not specified|1|||
27717716|NCT00623428|80799624|FG001|Follow-up Period|Reason not specified|1|||
27717717|NCT00623428|80799623|FG000|Follow-up Period|Death|0|||
27717718|NCT00623428|80799624|FG001|Follow-up Period|Death|1|||
27717719|NCT01294670|80799630|FG000|Overall Study|Not treated|1|||
27717720|NCT01294670|80799631|FG001|Overall Study|Not treated|0|||
27717721|NCT01294670|80799632|FG002|Overall Study|Not treated|0|||
27717722|NCT01294670|80799633|FG003|Overall Study|Not treated|0|||
27717723|NCT01294670|80799634|FG004|Overall Study|Not treated|0|||
27717724|NCT04041284|80799635|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
27717725|NCT04041284|80799636|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
27717726|NCT04041284|80799635|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
27717727|NCT04041284|80799636|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
27717728|NCT04041284|80799635|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
27717729|NCT04041284|80799636|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
27838320|NCT00668395|81236677|FG001|Overall Study|Physician Decision|1|||
27838321|NCT00668395|81236678|FG002|Overall Study|Physician Decision|0|||
27838322|NCT01898598|81236679|FG000|Overall Study|Adverse Event|1|||
27838323|NCT01898598|81236680|FG001|Overall Study|Adverse Event|0|||
27838324|NCT01898598|81236679|FG000|Overall Study|Withdrawal by Subject|3|||
27838325|NCT01898598|81236680|FG001|Overall Study|Withdrawal by Subject|0|||
27838326|NCT01898598|81236679|FG000|Overall Study|Lost to Follow-up|0|||
27838327|NCT01898598|81236680|FG001|Overall Study|Lost to Follow-up|1|||
27838328|NCT01898598|81236679|FG000|Overall Study|Other|0|||
27838329|NCT01898598|81236680|FG001|Overall Study|Other|1|||
27838330|NCT02105701|81236681|FG000|Overall Study|Lost to Follow-up|1|||
27838331|NCT02105701|81236682|FG001|Overall Study|Lost to Follow-up|0|||
27838332|NCT02105701|81236683|FG002|Overall Study|Lost to Follow-up|2|||
27838333|NCT02105701|81236684|FG003|Overall Study|Lost to Follow-up|1|||
27838334|NCT02105701|81236681|FG000|Overall Study|Protocol Violation|0|||
27838335|NCT02105701|81236682|FG001|Overall Study|Protocol Violation|0|||
27838336|NCT02105701|81236683|FG002|Overall Study|Protocol Violation|1|||
27838337|NCT02105701|81236684|FG003|Overall Study|Protocol Violation|0|||
27717730|NCT04041284|80799635|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
27838338|NCT02105701|81236681|FG000|Overall Study|Withdrawal by Subject|2|||
27838339|NCT02105701|81236682|FG001|Overall Study|Withdrawal by Subject|1|||
27838340|NCT02105701|81236683|FG002|Overall Study|Withdrawal by Subject|0|||
27838341|NCT02105701|81236684|FG003|Overall Study|Withdrawal by Subject|1|||
27838342|NCT02105701|81236681|FG000|Overall Study|Death|1|||
27838343|NCT02105701|81236682|FG001|Overall Study|Death|0|||
27838344|NCT02105701|81236683|FG002|Overall Study|Death|0|||
27838345|NCT02105701|81236684|FG003|Overall Study|Death|0|||
27717731|NCT04041284|80799636|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
27838346|NCT00469898|81236687|FG000|Overall Study|Adverse Event|7|||
27717732|NCT04041284|80799635|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
27717733|NCT04041284|80799636|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
27717734|NCT04041284|80799635|FG000|DB Phase (12 Weeks)|Other than specified|1|||
27717735|NCT04041284|80799636|FG001|DB Phase (12 Weeks)|Other than specified|0|||
27717736|NCT04041284|80799635|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
27717737|NCT04041284|80799636|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
27717738|NCT04041284|80799635|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
27717739|NCT04041284|80799636|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
27717740|NCT04041284|80799635|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
27717741|NCT04041284|80799636|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
27717742|NCT04041284|80799635|FG000|OL Phase (12 Weeks)|Other than specified|6|||
27717743|NCT04041284|80799636|FG001|OL Phase (12 Weeks)|Other than specified|2|||
27717744|NCT02830880|80799637|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
27717745|NCT02830880|80799637|FG000|Overall Study|Death|1|||
27717746|NCT02830880|80799637|FG000|Overall Study|Physician Decision|1|||
27717747|NCT01928381|80799638|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
27717748|NCT01928381|80799639|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27717749|NCT01928381|80799640|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27717750|NCT01928381|80799641|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27717751|NCT01928381|80799642|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27717752|NCT01928381|80799643|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27717753|NCT01928381|80799644|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
27717754|NCT01928381|80799638|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
27717755|NCT01928381|80799639|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
27717756|NCT01928381|80799640|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
27717757|NCT01928381|80799641|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
27717758|NCT01928381|80799642|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
27717759|NCT01928381|80799643|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
27717760|NCT01928381|80799644|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
27717761|NCT01928381|80799638|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
27717762|NCT01928381|80799639|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
27717763|NCT01928381|80799640|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
27717764|NCT01928381|80799641|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
27717765|NCT01928381|80799642|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
27717766|NCT01928381|80799643|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
27717767|NCT01928381|80799644|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
27717768|NCT01928381|80799638|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
27717769|NCT01928381|80799639|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
27717770|NCT01928381|80799640|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
27717771|NCT01928381|80799641|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
27717772|NCT01928381|80799642|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
27717773|NCT01928381|80799643|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
27717774|NCT01928381|80799644|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
27717775|NCT01928381|80799638|FG000|Part 1 - Pain Training|Protocol Violation|1|||
27717776|NCT01928381|80799639|FG001|Part 1 - Pain Training|Protocol Violation|0|||
27717777|NCT01928381|80799640|FG002|Part 1 - Pain Training|Protocol Violation|0|||
27717778|NCT01928381|80799641|FG003|Part 1 - Pain Training|Protocol Violation|0|||
27717779|NCT01928381|80799642|FG004|Part 1 - Pain Training|Protocol Violation|0|||
27717780|NCT01928381|80799643|FG005|Part 1 - Pain Training|Protocol Violation|0|||
27717781|NCT01928381|80799644|FG006|Part 1 - Pain Training|Protocol Violation|0|||
27717782|NCT01928381|80799638|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
27717783|NCT01928381|80799639|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27717784|NCT01928381|80799640|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27717785|NCT01928381|80799641|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27717786|NCT01928381|80799642|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27717787|NCT01928381|80799643|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27717788|NCT01928381|80799644|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
27717789|NCT01928381|80799638|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
27717790|NCT01928381|80799639|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27717791|NCT01928381|80799640|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27717792|NCT01928381|80799641|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27717793|NCT01928381|80799642|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27717794|NCT01928381|80799643|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27717795|NCT01928381|80799644|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
27717796|NCT01928381|80799638|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
27717797|NCT01928381|80799639|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27606747|NCT01370005|80402808|FG000|Overall Study|Lack of Efficacy|1|||
27717798|NCT01928381|80799640|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27717799|NCT01928381|80799641|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27890098|NCT04505540|81430974|FG000|Baseline|Protocol Violation|10|||
27890099|NCT04505540|81430974|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
27890100|NCT04505540|81430974|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
27890101|NCT04505540|81430974|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
27890102|NCT04505540|81430974|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
27890103|NCT04505540|81430974|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
27890104|NCT04505540|81430974|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
27890105|NCT04505540|81430974|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
27890106|NCT04505540|81430974|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
27890107|NCT04505540|81430974|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
27890108|NCT04505540|81430974|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
27890109|NCT04505540|81430974|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
27890110|NCT04505540|81430974|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
27890111|NCT01154088|81430975|FG000|Overall Study|Lost to Follow-up|4|||
27890112|NCT01154088|81430976|FG001|Overall Study|Lost to Follow-up|6|||
27890113|NCT01154088|81430977|FG002|Overall Study|Lost to Follow-up|7|||
27890114|NCT03429244|81430978|FG000|Overall Study|Withdrawal by Subject|2|||
27890115|NCT03429244|81430979|FG001|Overall Study|Withdrawal by Subject|1|||
27717800|NCT01928381|80799642|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27717801|NCT01928381|80799643|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27717802|NCT01928381|80799644|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
27717803|NCT01928381|80799638|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
27717804|NCT01928381|80799639|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27717805|NCT01928381|80799640|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27717806|NCT01928381|80799641|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27717807|NCT01928381|80799642|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27717808|NCT01928381|80799643|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27717809|NCT01928381|80799644|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
27717810|NCT01928381|80799638|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
27717811|NCT01928381|80799639|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
27717812|NCT01928381|80799640|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
27717813|NCT01928381|80799641|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
27717814|NCT01928381|80799642|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
27717815|NCT01928381|80799643|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
27717816|NCT01928381|80799644|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
27717817|NCT01928381|80799638|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27717818|NCT01928381|80799639|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27717819|NCT01928381|80799640|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
27717820|NCT01928381|80799641|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27717821|NCT01928381|80799642|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27717822|NCT01928381|80799643|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27717823|NCT01928381|80799644|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
27717824|NCT01928381|80799638|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
27717825|NCT01928381|80799639|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
27717826|NCT01928381|80799640|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
27717827|NCT01928381|80799641|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
27717828|NCT01928381|80799642|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
27717829|NCT01928381|80799643|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
27717830|NCT01928381|80799644|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
27717831|NCT01928381|80799638|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
27717832|NCT01928381|80799639|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
27717833|NCT01928381|80799640|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
27717834|NCT01928381|80799641|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
27717835|NCT01928381|80799642|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
27717836|NCT01928381|80799643|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
27717837|NCT01928381|80799644|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
27890116|NCT03429244|81430980|FG002|Overall Study|Withdrawal by Subject|1|||
27890117|NCT00656851|81430981|FG000|Overall Study|Withdrawal by Subject|0|||
27890118|NCT00656851|81430982|FG001|Overall Study|Withdrawal by Subject|4|||
27717838|NCT01928381|80799638|FG000|Washout First Intervention|Protocol Violation|0|||
27717839|NCT01928381|80799639|FG001|Washout First Intervention|Protocol Violation|0|||
27717840|NCT01928381|80799640|FG002|Washout First Intervention|Protocol Violation|0|||
27717841|NCT01928381|80799641|FG003|Washout First Intervention|Protocol Violation|0|||
27717842|NCT01928381|80799642|FG004|Washout First Intervention|Protocol Violation|1|||
27717843|NCT01928381|80799643|FG005|Washout First Intervention|Protocol Violation|0|||
27717844|NCT01928381|80799644|FG006|Washout First Intervention|Protocol Violation|0|||
27717845|NCT01928381|80799638|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
27717846|NCT01928381|80799639|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
27717847|NCT01928381|80799640|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
27717848|NCT01928381|80799641|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
27717849|NCT01928381|80799642|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
27717850|NCT01928381|80799643|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
27717851|NCT01928381|80799644|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
27717852|NCT01928381|80799638|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
27717853|NCT01928381|80799639|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
27717854|NCT01928381|80799640|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
27717855|NCT01928381|80799641|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
27717856|NCT01928381|80799642|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
27717857|NCT01928381|80799643|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
27717858|NCT01928381|80799644|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
27717859|NCT02229552|80799647|FG000|Baseline|Withdrawal by Subject|6|||
27717860|NCT02229552|80799647|FG000|1-year Follow up|Withdrawal by Subject|7|||
27717861|NCT02229552|80799647|FG000|1-year Follow up|Lost to Follow-up|18|||
27717862|NCT02229552|80799647|FG000|2-Year Follow up|Withdrawal by Subject|9|||
27717863|NCT02229552|80799647|FG000|2-Year Follow up|Lost to Follow-up|17|||
27717864|NCT01568593|80799648|FG000|Overall Study|Lack of Efficacy|4|||
27717865|NCT01568593|80799649|FG001|Overall Study|Lack of Efficacy|1|||
27717866|NCT01568593|80799648|FG000|Overall Study|Adverse Event|3|||
27717867|NCT01568593|80799649|FG001|Overall Study|Adverse Event|2|||
27717868|NCT01029366|80799650|FG000|Overall Study|Withdrawal by Subject|1|||
27717869|NCT01029366|80799651|FG001|Overall Study|Withdrawal by Subject|0|||
27717870|NCT01029366|80799650|FG000|Overall Study|Death|1|||
27717871|NCT01029366|80799651|FG001|Overall Study|Death|1|||
27717872|NCT01029366|80799650|FG000|Overall Study|disease progression|2|||
27717873|NCT01029366|80799651|FG001|Overall Study|disease progression|0|||
27717874|NCT01029366|80799650|FG000|Overall Study|manufacturing failure|0|||
27717875|NCT01029366|80799651|FG001|Overall Study|manufacturing failure|1|||
27717876|NCT01780662|80799652|FG000|Overall Study|Adverse Event|1|||
27717877|NCT01780662|80799653|FG001|Overall Study|Adverse Event|0|||
27717878|NCT01780662|80799654|FG002|Overall Study|Adverse Event|2|||
27717879|NCT01780662|80799652|FG000|Overall Study|Physician Decision|0|||
27717880|NCT01780662|80799653|FG001|Overall Study|Physician Decision|5|||
27717881|NCT01780662|80799654|FG002|Overall Study|Physician Decision|7|||
27717882|NCT01780662|80799652|FG000|Overall Study|Protocol Violation|0|||
27717883|NCT01780662|80799653|FG001|Overall Study|Protocol Violation|1|||
27717884|NCT01780662|80799654|FG002|Overall Study|Protocol Violation|0|||
27717885|NCT01780662|80799652|FG000|Overall Study|Ineligible|0|||
27717886|NCT01780662|80799653|FG001|Overall Study|Ineligible|0|||
27717887|NCT01780662|80799654|FG002|Overall Study|Ineligible|1|||
27717888|NCT02971670|80799655|FG000|Overall Study|Withdrawal by Subject|4|||
27717889|NCT02971670|80799656|FG001|Overall Study|Withdrawal by Subject|1|||
27717890|NCT02971670|80799657|FG002|Overall Study|Withdrawal by Subject|1|||
27717891|NCT02971670|80799658|FG003|Overall Study|Withdrawal by Subject|2|||
27717892|NCT00412750|80799659|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27717893|NCT00412750|80799660|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27717894|NCT00412750|80799661|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27717895|NCT00412750|80799659|FG000|Overall Study|Administrative problems|21|||
27717896|NCT00412750|80799660|FG001|Overall Study|Administrative problems|17|||
27717897|NCT00412750|80799661|FG002|Overall Study|Administrative problems|14|||
27717898|NCT00412750|80799659|FG000|Overall Study|Adverse Event|8|||
27717899|NCT00412750|80799660|FG001|Overall Study|Adverse Event|3|||
27717900|NCT00412750|80799661|FG002|Overall Study|Adverse Event|3|||
27717901|NCT00412750|80799659|FG000|Overall Study|Lost to Follow-up|1|||
27717902|NCT00412750|80799660|FG001|Overall Study|Lost to Follow-up|0|||
27717903|NCT00412750|80799661|FG002|Overall Study|Lost to Follow-up|1|||
27717904|NCT00412750|80799659|FG000|Overall Study|Withdrawal by Subject|0|||
27838347|NCT00469898|81236687|FG000|Overall Study|Withdrawal by Subject|4|||
27890119|NCT03057054|81430985|FG000|Overall Study|Death|4|||
27717905|NCT00412750|80799660|FG001|Overall Study|Withdrawal by Subject|1|||
27717906|NCT00412750|80799661|FG002|Overall Study|Withdrawal by Subject|2|||
27717907|NCT00412750|80799659|FG000|Overall Study|Lack of Efficacy|0|||
27838348|NCT00469898|81236687|FG000|Overall Study|Death|4|||
27717908|NCT00412750|80799660|FG001|Overall Study|Lack of Efficacy|0|||
27838349|NCT00469898|81236687|FG000|Overall Study|Disease progression|9|||
27838350|NCT00469898|81236687|FG000|Overall Study|Decreased performance status|1|||
27717909|NCT00412750|80799661|FG002|Overall Study|Lack of Efficacy|3|||
27717910|NCT02982954|80799662|FG000|Overall Study|Death|55|||
27717911|NCT02982954|80799663|FG001|Overall Study|Death|29|||
27717912|NCT02982954|80799664|FG002|Overall Study|Death|15|||
27717913|NCT02982954|80799665|FG003|Overall Study|Death|20|||
27717914|NCT02982954|80799662|FG000|Overall Study|Lost to Follow-up|2|||
27717915|NCT02982954|80799663|FG001|Overall Study|Lost to Follow-up|1|||
27717916|NCT02982954|80799664|FG002|Overall Study|Lost to Follow-up|0|||
27717917|NCT02982954|80799665|FG003|Overall Study|Lost to Follow-up|0|||
27717918|NCT02982954|80799662|FG000|Overall Study|Participant withdrew consent|7|||
27717919|NCT02982954|80799663|FG001|Overall Study|Participant withdrew consent|5|||
27717920|NCT02982954|80799664|FG002|Overall Study|Participant withdrew consent|1|||
27717921|NCT02982954|80799665|FG003|Overall Study|Participant withdrew consent|1|||
27717922|NCT02982954|80799662|FG000|Overall Study|Other reasons|42|||
27717923|NCT02982954|80799663|FG001|Overall Study|Other reasons|17|||
27717924|NCT02982954|80799664|FG002|Overall Study|Other reasons|12|||
27717925|NCT02982954|80799665|FG003|Overall Study|Other reasons|3|||
27717926|NCT02982954|80799662|FG000|Overall Study|Premature site closure|0|||
27717927|NCT02982954|80799663|FG001|Overall Study|Premature site closure|0|||
27717928|NCT02982954|80799664|FG002|Overall Study|Premature site closure|0|||
27717929|NCT02982954|80799665|FG003|Overall Study|Premature site closure|1|||
27717930|NCT01618214|80799666|FG000|Overall Study|Adverse Event|3|||
27717931|NCT01618214|80799667|FG001|Overall Study|Adverse Event|1|||
27717932|NCT01618214|80799666|FG000|Overall Study|Lack of Efficacy|1|||
27717933|NCT01618214|80799667|FG001|Overall Study|Lack of Efficacy|1|||
27717934|NCT01618214|80799666|FG000|Overall Study|Protocol Violation|1|||
27717935|NCT01618214|80799667|FG001|Overall Study|Protocol Violation|4|||
27717936|NCT01618214|80799666|FG000|Overall Study|Withdrawal Criteria|1|||
27717937|NCT01618214|80799667|FG001|Overall Study|Withdrawal Criteria|2|||
27717938|NCT01618214|80799666|FG000|Overall Study|Unclassified|4|||
27717939|NCT01618214|80799667|FG001|Overall Study|Unclassified|5|||
27717940|NCT00691483|80799668|FG000|Overall Study|Adverse Event|14|||
27717941|NCT00691483|80799669|FG001|Overall Study|Adverse Event|6|||
27717942|NCT00691483|80799668|FG000|Overall Study|Lost to Follow-up|17|||
27717943|NCT00691483|80799669|FG001|Overall Study|Lost to Follow-up|10|||
27717944|NCT00691483|80799668|FG000|Overall Study|Withdrawal by Subject|24|||
27717945|NCT00691483|80799669|FG001|Overall Study|Withdrawal by Subject|7|||
27717946|NCT00691483|80799668|FG000|Overall Study|Other known cause|6|||
27717947|NCT00691483|80799669|FG001|Overall Study|Other known cause|1|||
27717948|NCT00691483|80799668|FG000|Overall Study|Randomized by not treated|7|||
27717949|NCT00691483|80799669|FG001|Overall Study|Randomized by not treated|1|||
27717950|NCT02482129|80799670|FG000|Overall Study|Adverse Event-prior to treatment|0|||
27717951|NCT02482129|80799671|FG001|Overall Study|Adverse Event-prior to treatment|1|||
27717952|NCT02482129|80799670|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
27717953|NCT02482129|80799671|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
27717954|NCT02482129|80799670|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
27717955|NCT02482129|80799671|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
27717956|NCT02482129|80799670|FG000|Overall Study|Criteria not met-prior to treatment|1|||
27717957|NCT02482129|80799671|FG001|Overall Study|Criteria not met-prior to treatment|0|||
27717958|NCT02482129|80799670|FG000|Overall Study|Adverse Event|1|||
27717959|NCT02482129|80799671|FG001|Overall Study|Adverse Event|0|||
27717960|NCT02482129|80799670|FG000|Overall Study|Withdrawal by Subject|2|||
27717961|NCT02482129|80799671|FG001|Overall Study|Withdrawal by Subject|0|||
27717962|NCT02482129|80799670|FG000|Overall Study|Criteria not met|1|||
27717963|NCT02482129|80799671|FG001|Overall Study|Criteria not met|0|||
27717964|NCT01340209|80799672|FG000|Overall Study|Adverse Event|1|||
27717965|NCT01340209|80799673|FG001|Overall Study|Adverse Event|1|||
27717966|NCT01340209|80799674|FG002|Overall Study|Adverse Event|2|||
27717967|NCT01340209|80799672|FG000|Overall Study|Protocol Violation|1|||
27717968|NCT01340209|80799673|FG001|Overall Study|Protocol Violation|2|||
27717969|NCT01340209|80799674|FG002|Overall Study|Protocol Violation|1|||
27717970|NCT01340209|80799672|FG000|Overall Study|Withdrawal by Subject|0|||
27717971|NCT01340209|80799673|FG001|Overall Study|Withdrawal by Subject|0|||
27717972|NCT01340209|80799674|FG002|Overall Study|Withdrawal by Subject|1|||
27717973|NCT01340209|80799672|FG000|Overall Study|Other reason not defined above|3|||
27717974|NCT01340209|80799673|FG001|Overall Study|Other reason not defined above|5|||
27717975|NCT01340209|80799674|FG002|Overall Study|Other reason not defined above|4|||
27717976|NCT03979274|80799677|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27717977|NCT03979274|80799678|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27717978|NCT04312009|80799679|FG000|Overall Study|Withdrawal by Subject|2|||
27717979|NCT04312009|80799680|FG001|Overall Study|Withdrawal by Subject|1|||
27717980|NCT00744874|80799686|FG000|Overall Study|Lost to Follow-up|1|||
27717981|NCT00744874|80799686|FG000|Overall Study|Withdrawal by Subject|1|||
27717982|NCT00744874|80799686|FG000|Overall Study|Study Device not available at procedure|1|||
27717983|NCT00744874|80799686|FG000|Overall Study|Unable to accomodate schedule|1|||
27717984|NCT00512798|80799690|FG000|Overall Study|Death|0|||
27717985|NCT00512798|80799691|FG001|Overall Study|Death|3|||
27717986|NCT00512798|80799690|FG000|Overall Study|Adverse Event|2|||
27717987|NCT00512798|80799691|FG001|Overall Study|Adverse Event|4|||
27717988|NCT00512798|80799690|FG000|Overall Study|Progression of disease|14|||
27717989|NCT00512798|80799691|FG001|Overall Study|Progression of disease|20|||
27717990|NCT00512798|80799690|FG000|Overall Study|Withdrawal by Subject|3|||
27717991|NCT00512798|80799691|FG001|Overall Study|Withdrawal by Subject|0|||
27717992|NCT04081363|80799692|FG000|Overall Study|Withdrawal by Subject|1|||
27717993|NCT04081363|80799693|FG001|Overall Study|Withdrawal by Subject|0|||
27717994|NCT00511355|80799715|FG000|Overall Study|Adverse Event|4|||
27717995|NCT00511355|80799716|FG001|Overall Study|Adverse Event|4|||
27717996|NCT00511355|80799715|FG000|Overall Study|Pregnancy Wish|1|||
27717997|NCT00511355|80799716|FG001|Overall Study|Pregnancy Wish|0|||
27717998|NCT00511355|80799715|FG000|Overall Study|Lost to Follow-up|2|||
27717999|NCT00511355|80799716|FG001|Overall Study|Lost to Follow-up|1|||
27718000|NCT00511355|80799715|FG000|Overall Study|Other Reason|0|||
27718001|NCT00511355|80799716|FG001|Overall Study|Other Reason|1|||
27718002|NCT00511355|80799715|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
27718003|NCT00511355|80799716|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
27718004|NCT00511355|80799715|FG000|Overall Study|Withdrawal of informed consent|0|||
27718005|NCT00511355|80799716|FG001|Overall Study|Withdrawal of informed consent|1|||
27718006|NCT00511355|80799715|FG000|Overall Study|Other reason pre-treatment|0|||
27718007|NCT00511355|80799716|FG001|Overall Study|Other reason pre-treatment|1|||
27718008|NCT03691974|80799717|FG000|Overall Study|Physician Decision|1|||
27718009|NCT03691974|80799718|FG001|Overall Study|Physician Decision|0|||
27718010|NCT03691974|80799717|FG000|Overall Study|Adverse Event|1|||
27718011|NCT03691974|80799718|FG001|Overall Study|Adverse Event|0|||
27718012|NCT03691974|80799717|FG000|Overall Study|Withdrawal by Subject|11|||
27718013|NCT03691974|80799718|FG001|Overall Study|Withdrawal by Subject|9|||
27718014|NCT03691974|80799717|FG000|Overall Study|Protocol Violation|1|||
27718015|NCT03691974|80799718|FG001|Overall Study|Protocol Violation|0|||
27718016|NCT03691974|80799717|FG000|Overall Study|Lost to Follow-up|8|||
27718017|NCT03691974|80799718|FG001|Overall Study|Lost to Follow-up|7|||
27718018|NCT03436862|80799719|FG000|Overall Study|Adverse Event|4|||
27718019|NCT03436862|80799719|FG000|Overall Study|Progressive Disease|2|||
27718020|NCT02462473|80802238|FG000|Overall Study|Death|1|||
27718021|NCT02462473|80802238|FG000|Overall Study|Other|3|||
27718022|NCT02828358|80802239|FG000|Overall Study|Physician Decision|7|||
27718023|NCT02828358|80802240|FG001|Overall Study|Physician Decision|1|||
27718024|NCT02828358|80802239|FG000|Overall Study|Treatment Failure|6|||
27718025|NCT02828358|80802240|FG001|Overall Study|Treatment Failure|0|||
27718026|NCT02828358|80802239|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
27718027|NCT02828358|80802240|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
27718028|NCT02828358|80802239|FG000|Overall Study|Refusal of further protocol therapy|2|||
27718029|NCT02828358|80802240|FG001|Overall Study|Refusal of further protocol therapy|0|||
27718030|NCT02828358|80802239|FG000|Overall Study|Relapse|25|||
27718031|NCT02828358|80802240|FG001|Overall Study|Relapse|0|||
27718032|NCT02828358|80802239|FG000|Overall Study|Still on therapy|5|||
27718033|NCT02828358|80802240|FG001|Overall Study|Still on therapy|0|||
27718034|NCT04849780|80802243|FG000|Period 1|Covid-19 Related|1|||
27718035|NCT04849780|80802244|FG001|Period 1|Covid-19 Related|0|||
27718036|NCT04849780|80802243|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
27718037|NCT04849780|80802244|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
27890120|NCT03057054|81430986|FG001|Overall Study|Death|4|||
27718038|NCT04849780|80802243|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
27718039|NCT04849780|80802244|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
27890121|NCT03057054|81430985|FG000|Overall Study|Withdrawal by Subject|6|||
27890122|NCT03057054|81430986|FG001|Overall Study|Withdrawal by Subject|3|||
27718040|NCT00705783|80802246|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
27718041|NCT00705783|80802247|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
27718042|NCT00705783|80802248|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
27718043|NCT00705783|80802246|FG000|Conversion Phase|Lost to Follow-up|13|||
27718044|NCT00705783|80802247|FG001|Conversion Phase|Lost to Follow-up|0|||
27718045|NCT00705783|80802248|FG002|Conversion Phase|Lost to Follow-up|0|||
27718046|NCT00705783|80802246|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
27718047|NCT00705783|80802247|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
27718048|NCT00705783|80802248|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
27718049|NCT00705783|80802246|FG000|Conversion Phase|Withdrawn by Investigator|4|||
27718050|NCT00705783|80802247|FG001|Conversion Phase|Withdrawn by Investigator|0|||
27718051|NCT00705783|80802248|FG002|Conversion Phase|Withdrawn by Investigator|0|||
27718052|NCT00705783|80802246|FG000|Conversion Phase|Withdrew Consent|24|||
27718053|NCT00705783|80802247|FG001|Conversion Phase|Withdrew Consent|0|||
27718054|NCT00705783|80802248|FG002|Conversion Phase|Withdrew Consent|0|||
27718055|NCT00705783|80802246|FG000|Conversion Phase|Protocol Deviation|2|||
27718056|NCT00705783|80802247|FG001|Conversion Phase|Protocol Deviation|0|||
27718057|NCT00705783|80802248|FG002|Conversion Phase|Protocol Deviation|0|||
27718058|NCT00705783|80802246|FG000|Conversion Phase|Adverse Event|11|||
27718059|NCT00705783|80802247|FG001|Conversion Phase|Adverse Event|0|||
27718060|NCT00705783|80802248|FG002|Conversion Phase|Adverse Event|0|||
27718061|NCT00705783|80802246|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
27718062|NCT00705783|80802247|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27718063|NCT00705783|80802248|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
27718064|NCT00705783|80802246|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
27718065|NCT00705783|80802247|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27718066|NCT00705783|80802248|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
27718067|NCT00705783|80802246|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
27718068|NCT00705783|80802247|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
27718069|NCT00705783|80802248|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
27718070|NCT00705783|80802246|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
27718071|NCT00705783|80802247|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
27718072|NCT00705783|80802248|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
27718073|NCT00705783|80802246|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
27890123|NCT03057054|81430985|FG000|Overall Study|Ineligible|1|||
27890124|NCT03057054|81430986|FG001|Overall Study|Ineligible|1|||
27718074|NCT00705783|80802247|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27718075|NCT00705783|80802248|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
27718076|NCT00705783|80802246|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
27718077|NCT00705783|80802247|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27718078|NCT00705783|80802248|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
27718079|NCT00705783|80802246|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
27718080|NCT00705783|80802247|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
27718081|NCT00705783|80802248|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
27718082|NCT00705783|80802246|FG000|Oral Stabilization Phase|Adverse Event|14|||
27718083|NCT00705783|80802247|FG001|Oral Stabilization Phase|Adverse Event|0|||
27718084|NCT00705783|80802248|FG002|Oral Stabilization Phase|Adverse Event|0|||
27718085|NCT00705783|80802246|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
27718086|NCT00705783|80802247|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27718087|NCT00705783|80802248|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27718088|NCT00705783|80802246|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
27718089|NCT00705783|80802247|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27718090|NCT00705783|80802248|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27718091|NCT00705783|80802246|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
27718092|NCT00705783|80802247|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
27718093|NCT00705783|80802248|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
27718094|NCT00705783|80802246|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
27718095|NCT00705783|80802247|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
27718096|NCT00705783|80802248|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
27718097|NCT00705783|80802246|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
27718098|NCT00705783|80802247|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
27718099|NCT00705783|80802248|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
27718100|NCT00705783|80802246|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
27718101|NCT00705783|80802247|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
27718102|NCT00705783|80802248|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
27718103|NCT00705783|80802246|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
27718104|NCT00705783|80802247|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
27718105|NCT00705783|80802248|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
27718106|NCT00705783|80802246|FG000|Depot Stabilization Phase|Adverse Event|17|||
27718107|NCT00705783|80802247|FG001|Depot Stabilization Phase|Adverse Event|0|||
27718108|NCT00705783|80802248|FG002|Depot Stabilization Phase|Adverse Event|0|||
27718109|NCT00705783|80802246|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
27718110|NCT00705783|80802247|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27718111|NCT00705783|80802248|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
27718112|NCT00705783|80802246|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
27718113|NCT00705783|80802247|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27718114|NCT00705783|80802248|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
27718115|NCT00705783|80802246|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
27718116|NCT00705783|80802247|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
27718117|NCT00705783|80802248|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
27718118|NCT00705783|80802246|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
27718119|NCT00705783|80802247|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
27718120|NCT00705783|80802248|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
27718121|NCT00705783|80802246|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
27718122|NCT00705783|80802247|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
27718123|NCT00705783|80802248|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
27718124|NCT00705783|80802246|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
27718125|NCT00705783|80802247|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
27718126|NCT00705783|80802248|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
27718127|NCT00705783|80802246|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
27718128|NCT00705783|80802247|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
27718129|NCT00705783|80802248|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
27718130|NCT00705783|80802246|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
27718131|NCT00705783|80802247|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
27718132|NCT00705783|80802248|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
27718133|NCT00705783|80802246|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
27718134|NCT00705783|80802247|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
27718135|NCT00705783|80802248|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
27718136|NCT00705783|80802246|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
27718137|NCT00705783|80802247|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
27718138|NCT00705783|80802248|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
27718139|NCT00705783|80802246|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
27718140|NCT00705783|80802247|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
27718141|NCT00705783|80802248|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
27718142|NCT00848354|80802261|FG000|Phase 1|Adverse Event|5|||
27718143|NCT00848354|80802262|FG001|Phase 1|Adverse Event|4|||
27606748|NCT01370005|80402809|FG001|Overall Study|Lack of Efficacy|0|||
27606749|NCT01370005|80402810|FG002|Overall Study|Lack of Efficacy|0|||
27606750|NCT01370005|80402808|FG000|Overall Study|Non compliant with protocol|0|||
27606751|NCT01370005|80402809|FG001|Overall Study|Non compliant with protocol|1|||
27606752|NCT01370005|80402810|FG002|Overall Study|Non compliant with protocol|2|||
27606753|NCT01370005|80402808|FG000|Overall Study|Lost to Follow-up|1|||
27606754|NCT01370005|80402809|FG001|Overall Study|Lost to Follow-up|1|||
27606755|NCT01370005|80402810|FG002|Overall Study|Lost to Follow-up|1|||
27606756|NCT01370005|80402808|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
27606757|NCT01370005|80402809|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
27606758|NCT01370005|80402810|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
27606759|NCT01370005|80402808|FG000|Overall Study|Other reason not defined above|3|||
27606760|NCT01370005|80402809|FG001|Overall Study|Other reason not defined above|0|||
27606761|NCT01370005|80402810|FG002|Overall Study|Other reason not defined above|2|||
27606762|NCT01289418|80402811|FG000|Day 8 Survey|email address invalid|283|||
27606763|NCT01289418|80402811|FG000|Day 8 Survey|participants did not complete the survey|1935|||
27606764|NCT01289418|80402811|FG000|Day 29 Survey|email address invalid|283|||
27606765|NCT01289418|80402811|FG000|Day 29 Survey|participants did not complete the survey|2185|||
27606766|NCT01802437|80402814|FG000|Overall Study|Lost to Follow-up|1|||
27606767|NCT01802437|80402815|FG001|Overall Study|Lost to Follow-up|0|||
27606768|NCT01802437|80402814|FG000|Overall Study|Withdrawal by Subject|3|||
27606769|NCT01802437|80402815|FG001|Overall Study|Withdrawal by Subject|4|||
27606770|NCT00245102|80402816|FG000|Overall Study|Not Treated|1|||
27606771|NCT00245102|80402817|FG001|Overall Study|Not Treated|0|||
27718144|NCT00848354|80802261|FG000|Phase 1|Discontinuation of study by sponsor|2|||
27838351|NCT02614898|81236688|FG000|Overall Study|Participated until study termination|10|||
27606772|NCT00245102|80402818|FG002|Overall Study|Not Treated|1|||
27606773|NCT00245102|80402819|FG003|Overall Study|Not Treated|0|||
27606774|NCT00245102|80402820|FG004|Overall Study|Not Treated|0|||
27606775|NCT00245102|80402821|FG005|Overall Study|Not Treated|0|||
27606776|NCT00245102|80402816|FG000|Overall Study|Protocol Violation|1|||
27606777|NCT00245102|80402817|FG001|Overall Study|Protocol Violation|0|||
27718145|NCT00848354|80802262|FG001|Phase 1|Discontinuation of study by sponsor|1|||
27718146|NCT00848354|80802261|FG000|Phase 1|Failed to return|0|||
27718147|NCT00848354|80802262|FG001|Phase 1|Failed to return|1|||
27606778|NCT00245102|80402818|FG002|Overall Study|Protocol Violation|0|||
27606779|NCT00245102|80402819|FG003|Overall Study|Protocol Violation|0|||
27606780|NCT00245102|80402820|FG004|Overall Study|Protocol Violation|0|||
27606781|NCT00245102|80402821|FG005|Overall Study|Protocol Violation|0|||
27718148|NCT00848354|80802261|FG000|Phase 1|Lost to Follow-up|1|||
27718149|NCT00848354|80802262|FG001|Phase 1|Lost to Follow-up|1|||
27606782|NCT00245102|80402816|FG000|Overall Study|Death|0|||
27606783|NCT00245102|80402817|FG001|Overall Study|Death|0|||
27606784|NCT00245102|80402818|FG002|Overall Study|Death|0|||
27606785|NCT00245102|80402819|FG003|Overall Study|Death|1|||
27606786|NCT00245102|80402820|FG004|Overall Study|Death|0|||
27606787|NCT00245102|80402821|FG005|Overall Study|Death|0|||
27606788|NCT00245102|80402816|FG000|Overall Study|Adverse Event|4|||
27606789|NCT00245102|80402817|FG001|Overall Study|Adverse Event|2|||
27606790|NCT00245102|80402818|FG002|Overall Study|Adverse Event|5|||
27606791|NCT00245102|80402819|FG003|Overall Study|Adverse Event|1|||
27718150|NCT00848354|80802261|FG000|Phase 1|Unspecified Reason|1|||
27718151|NCT00848354|80802262|FG001|Phase 1|Unspecified Reason|1|||
27718152|NCT00848354|80802261|FG000|Phase 1|Protocol Violation|1|||
27718153|NCT00848354|80802262|FG001|Phase 1|Protocol Violation|1|||
27718154|NCT00848354|80802261|FG000|Phase 1|Withdrawal by Subject|2|||
27718155|NCT00848354|80802262|FG001|Phase 1|Withdrawal by Subject|4|||
27718156|NCT00848354|80802261|FG000|Phase 1|Lack of Efficacy|0|||
27838352|NCT02614898|81236689|FG001|Overall Study|Participated until study termination|26|||
27606792|NCT00245102|80402820|FG004|Overall Study|Adverse Event|0|||
27718157|NCT00848354|80802262|FG001|Phase 1|Lack of Efficacy|1|||
27718158|NCT00848354|80802261|FG000|Phase 2 Year 1|Adverse Event|7|||
27838353|NCT02614898|81236688|FG000|Overall Study|Lost to Follow-up|0|||
27838354|NCT02614898|81236689|FG001|Overall Study|Lost to Follow-up|2|||
27606793|NCT00245102|80402821|FG005|Overall Study|Adverse Event|2|||
27606794|NCT00245102|80402816|FG000|Overall Study|Decline in performance|0|||
27606795|NCT00245102|80402817|FG001|Overall Study|Decline in performance|2|||
27606796|NCT00245102|80402818|FG002|Overall Study|Decline in performance|0|||
27718159|NCT00848354|80802262|FG001|Phase 2 Year 1|Adverse Event|2|||
27838355|NCT02614898|81236688|FG000|Overall Study|Physician Decision|1|||
27606797|NCT00245102|80402819|FG003|Overall Study|Decline in performance|1|||
27606798|NCT00245102|80402820|FG004|Overall Study|Decline in performance|0|||
27606799|NCT00245102|80402821|FG005|Overall Study|Decline in performance|2|||
27606800|NCT00245102|80402816|FG000|Overall Study|Participant needed surgery|0|||
27606801|NCT00245102|80402817|FG001|Overall Study|Participant needed surgery|0|||
27606802|NCT00245102|80402818|FG002|Overall Study|Participant needed surgery|1|||
27606803|NCT00245102|80402819|FG003|Overall Study|Participant needed surgery|0|||
27606804|NCT00245102|80402820|FG004|Overall Study|Participant needed surgery|0|||
27606805|NCT00245102|80402821|FG005|Overall Study|Participant needed surgery|0|||
27606806|NCT00245102|80402816|FG000|Overall Study|Clinical progression|1|||
27606807|NCT00245102|80402817|FG001|Overall Study|Clinical progression|0|||
27606808|NCT00245102|80402818|FG002|Overall Study|Clinical progression|0|||
27606809|NCT00245102|80402819|FG003|Overall Study|Clinical progression|0|||
27606810|NCT00245102|80402820|FG004|Overall Study|Clinical progression|0|||
27606811|NCT00245102|80402821|FG005|Overall Study|Clinical progression|0|||
27606812|NCT01598298|80402822|FG000|Overall Study|Not eligible|5|||
27606813|NCT01598298|80402823|FG001|Overall Study|Not eligible|5|||
27606814|NCT01598298|80402822|FG000|Overall Study|Adverse Event|21|||
27606815|NCT01598298|80402823|FG001|Overall Study|Adverse Event|19|||
27606816|NCT01598298|80402822|FG000|Overall Study|Progression/relapse|0|||
27606817|NCT01598298|80402823|FG001|Overall Study|Progression/relapse|2|||
27606818|NCT01598298|80402822|FG000|Overall Study|Withdrawal by Subject|10|||
27606819|NCT01598298|80402823|FG001|Overall Study|Withdrawal by Subject|15|||
27606820|NCT01598298|80402822|FG000|Overall Study|Other reason (not protocol specified)|4|||
27606821|NCT01598298|80402823|FG001|Overall Study|Other reason (not protocol specified)|0|||
27606822|NCT04128293|80402831|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
27606823|NCT04128293|80402832|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
27606824|NCT04128293|80402833|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
27606825|NCT04128293|80402834|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
27606826|NCT00041756|80402837|FG000|Overall Study|Adverse Event|4|||
27606827|NCT00041756|80402838|FG001|Overall Study|Adverse Event|10|||
27606828|NCT00041756|80402839|FG002|Overall Study|Adverse Event|6|||
27606829|NCT00041756|80402840|FG003|Overall Study|Adverse Event|11|||
27606830|NCT00041756|80402841|FG004|Overall Study|Adverse Event|34|||
27606831|NCT00041756|80402837|FG000|Overall Study|Protocol Violation|1|||
27606832|NCT00041756|80402838|FG001|Overall Study|Protocol Violation|1|||
27606833|NCT00041756|80402839|FG002|Overall Study|Protocol Violation|2|||
27606834|NCT00041756|80402840|FG003|Overall Study|Protocol Violation|2|||
27606835|NCT00041756|80402841|FG004|Overall Study|Protocol Violation|1|||
27606836|NCT00041756|80402837|FG000|Overall Study|Withdrawal by Subject|3|||
27606837|NCT00041756|80402838|FG001|Overall Study|Withdrawal by Subject|3|||
27606838|NCT00041756|80402839|FG002|Overall Study|Withdrawal by Subject|4|||
27606839|NCT00041756|80402840|FG003|Overall Study|Withdrawal by Subject|2|||
27606840|NCT00041756|80402841|FG004|Overall Study|Withdrawal by Subject|3|||
27606841|NCT00041756|80402837|FG000|Overall Study|Lost to Follow-up|0|||
27606842|NCT00041756|80402838|FG001|Overall Study|Lost to Follow-up|1|||
27606843|NCT00041756|80402839|FG002|Overall Study|Lost to Follow-up|0|||
27606844|NCT00041756|80402840|FG003|Overall Study|Lost to Follow-up|1|||
27606845|NCT00041756|80402841|FG004|Overall Study|Lost to Follow-up|0|||
27606846|NCT00041756|80402837|FG000|Overall Study|Unable to meet protocol criteria|0|||
27606847|NCT00041756|80402838|FG001|Overall Study|Unable to meet protocol criteria|0|||
27606848|NCT00041756|80402839|FG002|Overall Study|Unable to meet protocol criteria|1|||
27606849|NCT00041756|80402840|FG003|Overall Study|Unable to meet protocol criteria|0|||
27606850|NCT00041756|80402841|FG004|Overall Study|Unable to meet protocol criteria|1|||
27606851|NCT00041756|80402837|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
27606852|NCT00041756|80402838|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
27606853|NCT00041756|80402839|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
27606854|NCT00041756|80402840|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
27606855|NCT00041756|80402841|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
27606856|NCT04615182|80402842|FG000|Overall Study|Re-transplanted|2|||
27606857|NCT04615182|80402842|FG000|Overall Study|Protocol Violation|6|||
27606858|NCT04615182|80402842|FG000|Overall Study|Death|6|||
27606859|NCT04615182|80402842|FG000|Overall Study|Death and protocol violation|1|||
27606860|NCT05061537|80402843|FG000|Treatment Phase|Progressive disease|0|||
27606861|NCT05061537|80402844|FG001|Treatment Phase|Progressive disease|1|||
27606862|NCT05061537|80402845|FG002|Treatment Phase|Progressive disease|2|||
27606863|NCT05061537|80402846|FG003|Treatment Phase|Progressive disease|0|||
27606864|NCT05061537|80402847|FG004|Treatment Phase|Progressive disease|0|||
27606865|NCT05061537|80402843|FG000|Treatment Phase|Adverse Event|0|||
27606866|NCT05061537|80402844|FG001|Treatment Phase|Adverse Event|0|||
27606867|NCT05061537|80402845|FG002|Treatment Phase|Adverse Event|2|||
27606868|NCT05061537|80402846|FG003|Treatment Phase|Adverse Event|0|||
27606869|NCT05061537|80402847|FG004|Treatment Phase|Adverse Event|0|||
27606870|NCT05061537|80402843|FG000|Treatment Phase|Global deterioration of health status|0|||
27606871|NCT05061537|80402844|FG001|Treatment Phase|Global deterioration of health status|1|||
27606872|NCT05061537|80402845|FG002|Treatment Phase|Global deterioration of health status|0|||
27606873|NCT05061537|80402846|FG003|Treatment Phase|Global deterioration of health status|0|||
27606874|NCT05061537|80402847|FG004|Treatment Phase|Global deterioration of health status|0|||
27606875|NCT05061537|80402843|FG000|Follow up|Other|2|||
27606876|NCT05061537|80402844|FG001|Follow up|Other|0|||
27606877|NCT05061537|80402845|FG002|Follow up|Other|2|||
27606878|NCT05061537|80402846|FG003|Follow up|Other|0|||
27606879|NCT05061537|80402847|FG004|Follow up|Other|0|||
27606880|NCT05061537|80402843|FG000|Follow up|Study terminated by sponsor|0|||
27606881|NCT05061537|80402844|FG001|Follow up|Study terminated by sponsor|0|||
27606882|NCT05061537|80402845|FG002|Follow up|Study terminated by sponsor|2|||
27606883|NCT05061537|80402846|FG003|Follow up|Study terminated by sponsor|0|||
27606884|NCT05061537|80402847|FG004|Follow up|Study terminated by sponsor|0|||
27606885|NCT05061537|80402843|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
27606886|NCT05061537|80402844|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
27606887|NCT05061537|80402845|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
27606888|NCT05061537|80402846|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
27606889|NCT05061537|80402847|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
27606890|NCT05061537|80402843|FG000|Long-term Follow-up|Death|0|||
27606891|NCT05061537|80402844|FG001|Long-term Follow-up|Death|1|||
27606892|NCT05061537|80402845|FG002|Long-term Follow-up|Death|0|||
27606893|NCT05061537|80402846|FG003|Long-term Follow-up|Death|0|||
27606894|NCT05061537|80402847|FG004|Long-term Follow-up|Death|0|||
27606895|NCT00591864|80402848|FG000|Overall Study|Incomplete Imaging|5|||
27606896|NCT02759185|80402849|FG000|Stage 1|Adverse Event|0|||
27606897|NCT02759185|80402850|FG001|Stage 1|Adverse Event|1|||
27606898|NCT02759185|80402851|FG002|Stage 1|Adverse Event|3|||
27606899|NCT02759185|80402852|FG003|Stage 1|Adverse Event|0|||
27606900|NCT02759185|80402853|FG004|Stage 1|Adverse Event|0|||
27606901|NCT02759185|80402854|FG005|Stage 1|Adverse Event|0|||
27606902|NCT02759185|80402855|FG006|Stage 1|Adverse Event|0|||
27606903|NCT02759185|80402849|FG000|Stage 1|Withdrawal by Subject|1|||
27606904|NCT02759185|80402850|FG001|Stage 1|Withdrawal by Subject|0|||
27606905|NCT02759185|80402851|FG002|Stage 1|Withdrawal by Subject|0|||
27606906|NCT02759185|80402852|FG003|Stage 1|Withdrawal by Subject|0|||
27606907|NCT02759185|80402853|FG004|Stage 1|Withdrawal by Subject|0|||
27606908|NCT02759185|80402854|FG005|Stage 1|Withdrawal by Subject|0|||
27606909|NCT02759185|80402855|FG006|Stage 1|Withdrawal by Subject|0|||
27606910|NCT02759185|80402849|FG000|Stage 2|Adverse Event|0|||
27606911|NCT02759185|80402850|FG001|Stage 2|Adverse Event|0|||
27606912|NCT02759185|80402851|FG002|Stage 2|Adverse Event|0|||
27606913|NCT02759185|80402852|FG003|Stage 2|Adverse Event|0|||
27606914|NCT02759185|80402853|FG004|Stage 2|Adverse Event|1|||
27606915|NCT02759185|80402854|FG005|Stage 2|Adverse Event|2|||
27606916|NCT02759185|80402855|FG006|Stage 2|Adverse Event|0|||
27606917|NCT02759185|80402849|FG000|Stage 2|Withdrawal by Subject|0|||
27606918|NCT02759185|80402850|FG001|Stage 2|Withdrawal by Subject|0|||
27606919|NCT02759185|80402851|FG002|Stage 2|Withdrawal by Subject|0|||
27606920|NCT02759185|80402852|FG003|Stage 2|Withdrawal by Subject|0|||
27606921|NCT02759185|80402853|FG004|Stage 2|Withdrawal by Subject|1|||
27606922|NCT02759185|80402854|FG005|Stage 2|Withdrawal by Subject|1|||
27606923|NCT02759185|80402855|FG006|Stage 2|Withdrawal by Subject|1|||
27606924|NCT02091739|80402858|FG000|MP: 16 Weeks|Adverse Event|1|||
27606925|NCT02091739|80402859|FG001|MP: 16 Weeks|Adverse Event|1|||
27606926|NCT02091739|80402860|FG002|MP: 16 Weeks|Adverse Event|1|||
27606927|NCT02091739|80402861|FG003|MP: 16 Weeks|Adverse Event|0|||
27606928|NCT02091739|80402862|FG004|MP: 16 Weeks|Adverse Event|0|||
27606929|NCT02091739|80402858|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
27606930|NCT02091739|80402859|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
27606931|NCT02091739|80402860|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
27606932|NCT02091739|80402861|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
27606933|NCT02091739|80402862|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
27606934|NCT02091739|80402858|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
27606935|NCT02091739|80402859|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
27606936|NCT02091739|80402860|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
27606937|NCT02091739|80402861|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
27606938|NCT02091739|80402862|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
27606939|NCT02091739|80402858|FG000|EP: 48 Weeks|Other|0|||
27606940|NCT02091739|80402859|FG001|EP: 48 Weeks|Other|0|||
27606941|NCT02091739|80402860|FG002|EP: 48 Weeks|Other|0|||
27606942|NCT02091739|80402861|FG003|EP: 48 Weeks|Other|1|||
27606943|NCT02091739|80402862|FG004|EP: 48 Weeks|Other|0|||
27606944|NCT02091739|80402858|FG000|EP: 48 Weeks|Death|0|||
27606945|NCT02091739|80402859|FG001|EP: 48 Weeks|Death|0|||
27606946|NCT02091739|80402860|FG002|EP: 48 Weeks|Death|0|||
27606947|NCT02091739|80402861|FG003|EP: 48 Weeks|Death|3|||
27606948|NCT02091739|80402862|FG004|EP: 48 Weeks|Death|2|||
27606949|NCT02091739|80402858|FG000|EP: 48 Weeks|Adverse Event|0|||
27606950|NCT02091739|80402859|FG001|EP: 48 Weeks|Adverse Event|0|||
27606951|NCT02091739|80402860|FG002|EP: 48 Weeks|Adverse Event|0|||
27606952|NCT02091739|80402861|FG003|EP: 48 Weeks|Adverse Event|2|||
27606953|NCT02091739|80402862|FG004|EP: 48 Weeks|Adverse Event|6|||
27606954|NCT02091739|80402858|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
27606955|NCT02091739|80402859|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
27606956|NCT02091739|80402860|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
27606957|NCT02091739|80402861|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
27606958|NCT02091739|80402862|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
27606959|NCT03724396|80402863|FG000|Overall Study|Lost to Follow-up|1|||
27606960|NCT03724396|80402864|FG001|Overall Study|Lost to Follow-up|1|||
27606961|NCT03724396|80402863|FG000|Overall Study|Withdrawal by Subject|1|||
27606962|NCT03724396|80402864|FG001|Overall Study|Withdrawal by Subject|0|||
27606963|NCT03066622|80402866|FG000|Overall Study|Lost to Follow-up|24|||
27606964|NCT03066622|80402867|FG001|Overall Study|Lost to Follow-up|25|||
27606965|NCT03066622|80402866|FG000|Overall Study|Withdrawal by Subject|2|||
27606966|NCT03066622|80402867|FG001|Overall Study|Withdrawal by Subject|1|||
27606967|NCT01121484|80402873|FG000|Overall Study|Adverse Event|12|||
27606968|NCT01121484|80402874|FG001|Overall Study|Adverse Event|5|||
27606969|NCT01121484|80402873|FG000|Overall Study|Lack of Efficacy|3|||
27606970|NCT01121484|80402874|FG001|Overall Study|Lack of Efficacy|11|||
27606971|NCT01121484|80402873|FG000|Overall Study|Lost to Follow-up|5|||
27606972|NCT01121484|80402874|FG001|Overall Study|Lost to Follow-up|9|||
27606973|NCT01121484|80402873|FG000|Overall Study|Physician Decision|0|||
27606974|NCT01121484|80402874|FG001|Overall Study|Physician Decision|3|||
27606975|NCT01121484|80402873|FG000|Overall Study|Protocol Violation|1|||
27606976|NCT01121484|80402874|FG001|Overall Study|Protocol Violation|0|||
27606977|NCT01121484|80402873|FG000|Overall Study|Withdrawal by Subject|8|||
27606978|NCT01121484|80402874|FG001|Overall Study|Withdrawal by Subject|7|||
27606979|NCT01121484|80402873|FG000|Overall Study|Discontinuation of study by sponsor|0|||
27606980|NCT01121484|80402874|FG001|Overall Study|Discontinuation of study by sponsor|1|||
27606981|NCT01121484|80402873|FG000|Overall Study|Other|3|||
27606982|NCT01121484|80402874|FG001|Overall Study|Other|3|||
27606983|NCT01121484|80402873|FG000|Overall Study|Randomized, not treated|1|||
27606984|NCT01121484|80402874|FG001|Overall Study|Randomized, not treated|4|||
27606985|NCT03579290|80402877|FG000|Overall Study|Lost to Follow-up|9|||
27606986|NCT04503096|80402878|FG000|Overall Study|Withdrawal by Subject|3|||
27606987|NCT00885352|80402885|FG000|Overall Study|Adverse Event|2|||
27606988|NCT00885352|80402886|FG001|Overall Study|Adverse Event|3|||
27606989|NCT00885352|80402885|FG000|Overall Study|Lost to Follow-up|2|||
27606990|NCT00885352|80402886|FG001|Overall Study|Lost to Follow-up|2|||
27606991|NCT00885352|80402885|FG000|Overall Study|Physician Decision|0|||
27606992|NCT00885352|80402886|FG001|Overall Study|Physician Decision|3|||
27606993|NCT00885352|80402885|FG000|Overall Study|Protocol Violation|0|||
27606994|NCT00885352|80402886|FG001|Overall Study|Protocol Violation|2|||
27606995|NCT00885352|80402885|FG000|Overall Study|Withdrawal by Subject|1|||
27606996|NCT00885352|80402886|FG001|Overall Study|Withdrawal by Subject|5|||
27606997|NCT00885352|80402885|FG000|Overall Study|Contradiction to study medication|0|||
27606998|NCT00885352|80402886|FG001|Overall Study|Contradiction to study medication|2|||
27606999|NCT00885352|80402885|FG000|Overall Study|Excluded medication|2|||
27607000|NCT00885352|80402886|FG001|Overall Study|Excluded medication|2|||
27607001|NCT00885352|80402885|FG000|Overall Study|Lab abnormalities|1|||
27607002|NCT00885352|80402886|FG001|Overall Study|Lab abnormalities|1|||
27607003|NCT00770432|80402887|FG000|Overall Study|Other|4|||
27607004|NCT00770432|80402888|FG001|Overall Study|Other|6|||
27607005|NCT00770432|80402887|FG000|Overall Study|Non-compliance|0|||
27607006|NCT00770432|80402888|FG001|Overall Study|Non-compliance|1|||
27607007|NCT00962247|80402889|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
27607008|NCT00962247|80402889|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
27607009|NCT03559218|80402890|FG000|Overall Study|Withdrawal by Subject|1|||
27607010|NCT03559218|80402891|FG001|Overall Study|Withdrawal by Subject|0|||
27607011|NCT00927355|80402893|FG000|Overall Study|Adverse Event|1|||
27607012|NCT00927355|80402894|FG001|Overall Study|Adverse Event|1|||
27607013|NCT01492686|80402895|FG000|Double-blind Phase|Adverse Event|0|||
27607014|NCT01492686|80402896|FG001|Double-blind Phase|Adverse Event|2|||
27607015|NCT01492686|80402895|FG000|Double-blind Phase|Physician Decision|0|||
27607016|NCT01492686|80402896|FG001|Double-blind Phase|Physician Decision|1|||
27607017|NCT01492686|80402895|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27607018|NCT01492686|80402896|FG001|Double-blind Phase|Withdrawal by Subject|2|||
27607019|NCT01492686|80402895|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
27607020|NCT01492686|80402896|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
27607021|NCT01492686|80402895|FG000|Open-label Phase|Adverse Event|1|||
27607022|NCT01492686|80402896|FG001|Open-label Phase|Adverse Event|2|||
27607023|NCT01492686|80402895|FG000|Open-label Phase|Physician Decision|1|||
27607024|NCT01492686|80402896|FG001|Open-label Phase|Physician Decision|0|||
27607025|NCT01492686|80402895|FG000|Open-label Phase|Withdrawal by Subject|6|||
27607026|NCT01492686|80402896|FG001|Open-label Phase|Withdrawal by Subject|7|||
27607027|NCT01492686|80402895|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
27607028|NCT01492686|80402896|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
27607029|NCT00988221|80402899|FG000|Part I|Adverse Event|0|||
27607030|NCT00988221|80402900|FG001|Part I|Adverse Event|1|||
27607031|NCT00988221|80402901|FG002|Part I|Adverse Event|2|||
27607032|NCT00988221|80402902|FG003|Part I|Adverse Event|0|||
27607033|NCT00988221|80402899|FG000|Part I|Insufficient Therapeutic Response|4|||
27607034|NCT00988221|80402900|FG001|Part I|Insufficient Therapeutic Response|6|||
27607035|NCT00988221|80402901|FG002|Part I|Insufficient Therapeutic Response|5|||
27607036|NCT00988221|80402902|FG003|Part I|Insufficient Therapeutic Response|0|||
27607037|NCT00988221|80402899|FG000|Part I|Refused Treatment|0|||
27607038|NCT00988221|80402900|FG001|Part I|Refused Treatment|2|||
27607039|NCT00988221|80402901|FG002|Part I|Refused Treatment|1|||
27607040|NCT00988221|80402902|FG003|Part I|Refused Treatment|0|||
27838356|NCT02614898|81236689|FG001|Overall Study|Physician Decision|8|||
27838357|NCT02614898|81236688|FG000|Overall Study|Study Terminated by Sponsor|3|||
27607041|NCT00988221|80402899|FG000|Part I|Lost to Follow-up|0|||
27607042|NCT00988221|80402900|FG001|Part I|Lost to Follow-up|1|||
27607043|NCT00988221|80402901|FG002|Part I|Lost to Follow-up|0|||
27607044|NCT00988221|80402902|FG003|Part I|Lost to Follow-up|0|||
27607045|NCT00988221|80402899|FG000|Part II|Adverse Event|1|||
27607046|NCT00988221|80402900|FG001|Part II|Adverse Event|0|||
27607047|NCT00988221|80402901|FG002|Part II|Adverse Event|0|||
27607048|NCT00988221|80402902|FG003|Part II|Adverse Event|1|||
27607049|NCT00988221|80402899|FG000|Part II|Withdrawal by Subject|0|||
27607050|NCT00988221|80402900|FG001|Part II|Withdrawal by Subject|0|||
27607051|NCT00988221|80402901|FG002|Part II|Withdrawal by Subject|2|||
27607052|NCT00988221|80402902|FG003|Part II|Withdrawal by Subject|2|||
27607053|NCT00988221|80402899|FG000|Part II|Reason not Specified|0|||
27607054|NCT00988221|80402900|FG001|Part II|Reason not Specified|0|||
27607055|NCT00988221|80402901|FG002|Part II|Reason not Specified|1|||
27607056|NCT00988221|80402902|FG003|Part II|Reason not Specified|0|||
27607057|NCT00988221|80402899|FG000|Part III|Adverse Event|1|||
27718160|NCT00848354|80802261|FG000|Phase 2 Year 1|Death|1|||
27607058|NCT00988221|80402900|FG001|Part III|Adverse Event|0|||
27607059|NCT00988221|80402901|FG002|Part III|Adverse Event|1|||
27607060|NCT00988221|80402902|FG003|Part III|Adverse Event|0|||
27607061|NCT00988221|80402899|FG000|Part III|Insufficient Therapeutic Response|0|||
27838358|NCT02614898|81236689|FG001|Overall Study|Study Terminated by Sponsor|0|||
27838359|NCT02614898|81236688|FG000|Overall Study|Withdrawal by Subject|0|||
27838360|NCT02614898|81236689|FG001|Overall Study|Withdrawal by Subject|2|||
27838361|NCT02614898|81236688|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27838362|NCT02614898|81236689|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27838363|NCT02614898|81236688|FG000|Overall Study|Other-Additional Information Unavailable|0|||
27838364|NCT02614898|81236689|FG001|Overall Study|Other-Additional Information Unavailable|11|||
27607062|NCT00988221|80402900|FG001|Part III|Insufficient Therapeutic Response|1|||
27607063|NCT00988221|80402901|FG002|Part III|Insufficient Therapeutic Response|1|||
27607064|NCT00988221|80402902|FG003|Part III|Insufficient Therapeutic Response|0|||
27607065|NCT00988221|80402899|FG000|Part III|Refused Treatment|0|||
27607066|NCT00988221|80402900|FG001|Part III|Refused Treatment|0|||
27607067|NCT00988221|80402901|FG002|Part III|Refused Treatment|1|||
27607068|NCT00988221|80402902|FG003|Part III|Refused Treatment|0|||
27607069|NCT04399551|80402903|FG000|Overall Study|Adverse Event|15|||
27607070|NCT04399551|80402903|FG000|Overall Study|Withdrawal by Subject|6|||
27607071|NCT04399551|80402903|FG000|Overall Study|Physician Decision|3|||
27607072|NCT04399551|80402903|FG000|Overall Study|Lost to Follow-up|2|||
27607073|NCT04399551|80402903|FG000|Overall Study|Protocol Deviation|2|||
27607074|NCT01119768|80402906|FG000|Treatment Period|Lack of Efficacy|18|||
27607075|NCT01119768|80402907|FG001|Treatment Period|Lack of Efficacy|25|||
27607076|NCT02013388|80402908|FG000|Overall Study|work emergency|1|||
27607077|NCT02013388|80402909|FG001|Overall Study|work emergency|0|||
27607078|NCT02013388|80402910|FG002|Overall Study|work emergency|0|||
27607079|NCT02013388|80402911|FG003|Overall Study|work emergency|0|||
27607080|NCT02013388|80402912|FG004|Overall Study|work emergency|1|||
27607081|NCT02013388|80402913|FG005|Overall Study|work emergency|0|||
27607082|NCT02013388|80402914|FG006|Overall Study|work emergency|0|||
27607083|NCT02013388|80402915|FG007|Overall Study|work emergency|0|||
27718161|NCT00848354|80802262|FG001|Phase 2 Year 1|Death|0|||
27607084|NCT02180438|80402916|FG000|Overall Study|Lost to Follow-up|1|||
27607085|NCT01364597|80402917|FG000|Overall Study|Adverse Event|4|||
27607086|NCT01364597|80402918|FG001|Overall Study|Adverse Event|5|||
27607087|NCT01364597|80402919|FG002|Overall Study|Adverse Event|16|||
27607088|NCT01364597|80402920|FG003|Overall Study|Adverse Event|7|||
27607089|NCT01364597|80402917|FG000|Overall Study|Lack of Efficacy|4|||
27607090|NCT01364597|80402918|FG001|Overall Study|Lack of Efficacy|4|||
27607091|NCT01364597|80402919|FG002|Overall Study|Lack of Efficacy|23|||
27607092|NCT01364597|80402920|FG003|Overall Study|Lack of Efficacy|8|||
27607093|NCT01364597|80402917|FG000|Overall Study|Protocol Violation|0|||
27607094|NCT01364597|80402918|FG001|Overall Study|Protocol Violation|0|||
27607095|NCT01364597|80402919|FG002|Overall Study|Protocol Violation|2|||
27607096|NCT01364597|80402920|FG003|Overall Study|Protocol Violation|0|||
27607097|NCT01364597|80402917|FG000|Overall Study|Lost to Follow-up|0|||
27607098|NCT01364597|80402918|FG001|Overall Study|Lost to Follow-up|0|||
27607099|NCT01364597|80402919|FG002|Overall Study|Lost to Follow-up|5|||
27607100|NCT01364597|80402920|FG003|Overall Study|Lost to Follow-up|3|||
27607101|NCT01364597|80402917|FG000|Overall Study|Withdrawal by Subject|4|||
27607102|NCT01364597|80402918|FG001|Overall Study|Withdrawal by Subject|1|||
27607103|NCT01364597|80402919|FG002|Overall Study|Withdrawal by Subject|18|||
27607104|NCT01364597|80402920|FG003|Overall Study|Withdrawal by Subject|6|||
27607105|NCT01364597|80402917|FG000|Overall Study|Non compliance|1|||
27607106|NCT01364597|80402918|FG001|Overall Study|Non compliance|0|||
27838365|NCT02614898|81236688|FG000|Overall Study|Missing|0|||
27838366|NCT02614898|81236689|FG001|Overall Study|Missing|1|||
27838367|NCT01945580|81236692|FG000|Overall Study|Withdrawal by Subject|13|||
27838368|NCT01945580|81236693|FG001|Overall Study|Withdrawal by Subject|35|||
27607107|NCT01364597|80402919|FG002|Overall Study|Non compliance|1|||
27607108|NCT01364597|80402920|FG003|Overall Study|Non compliance|0|||
27607109|NCT01364597|80402917|FG000|Overall Study|Lack of compliance|1|||
27607110|NCT01364597|80402918|FG001|Overall Study|Lack of compliance|0|||
27607111|NCT01364597|80402919|FG002|Overall Study|Lack of compliance|0|||
27607112|NCT01364597|80402920|FG003|Overall Study|Lack of compliance|0|||
27607113|NCT01364597|80402917|FG000|Overall Study|End of treatment epilepsy|1|||
27607114|NCT01364597|80402918|FG001|Overall Study|End of treatment epilepsy|0|||
27607115|NCT01364597|80402919|FG002|Overall Study|End of treatment epilepsy|0|||
27607116|NCT01364597|80402920|FG003|Overall Study|End of treatment epilepsy|0|||
27607117|NCT01364597|80402917|FG000|Overall Study|No Seizures|1|||
27607118|NCT01364597|80402918|FG001|Overall Study|No Seizures|0|||
27607119|NCT01364597|80402919|FG002|Overall Study|No Seizures|0|||
27607120|NCT01364597|80402920|FG003|Overall Study|No Seizures|0|||
27607121|NCT01364597|80402917|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
27607122|NCT01364597|80402918|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
27607123|NCT01364597|80402919|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
27607124|NCT01364597|80402920|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
27607125|NCT01364597|80402917|FG000|Overall Study|Cure|1|||
27607126|NCT01364597|80402918|FG001|Overall Study|Cure|0|||
27607127|NCT01364597|80402919|FG002|Overall Study|Cure|0|||
27607128|NCT01364597|80402920|FG003|Overall Study|Cure|0|||
27607129|NCT01364597|80402917|FG000|Overall Study|Patient was moving|0|||
27607130|NCT01364597|80402918|FG001|Overall Study|Patient was moving|1|||
27607131|NCT01364597|80402919|FG002|Overall Study|Patient was moving|0|||
27607132|NCT01364597|80402920|FG003|Overall Study|Patient was moving|0|||
27607133|NCT01364597|80402917|FG000|Overall Study|Seizures resolved|0|||
27607134|NCT01364597|80402918|FG001|Overall Study|Seizures resolved|0|||
27607135|NCT01364597|80402919|FG002|Overall Study|Seizures resolved|1|||
27607136|NCT01364597|80402920|FG003|Overall Study|Seizures resolved|0|||
27607137|NCT01364597|80402917|FG000|Overall Study|Patient became seizure-free after surgery|0|||
27607138|NCT01364597|80402918|FG001|Overall Study|Patient became seizure-free after surgery|0|||
27607139|NCT01364597|80402919|FG002|Overall Study|Patient became seizure-free after surgery|1|||
27607140|NCT01364597|80402920|FG003|Overall Study|Patient became seizure-free after surgery|0|||
27607141|NCT01364597|80402917|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
27607142|NCT01364597|80402918|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
27718162|NCT00848354|80802261|FG000|Phase 2 Year 1|Failed to Return|1|||
27718163|NCT00848354|80802262|FG001|Phase 2 Year 1|Failed to Return|1|||
27718164|NCT00848354|80802261|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
27718165|NCT00848354|80802262|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
27838369|NCT01945580|81236692|FG000|Overall Study|Physician Decision|3|||
27838370|NCT01945580|81236693|FG001|Overall Study|Physician Decision|2|||
27607143|NCT01364597|80402919|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
27607144|NCT01364597|80402920|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
27607145|NCT01364597|80402917|FG000|Overall Study|Patient cured from Epilepsy|0|||
27607146|NCT01364597|80402918|FG001|Overall Study|Patient cured from Epilepsy|0|||
27607147|NCT01364597|80402919|FG002|Overall Study|Patient cured from Epilepsy|1|||
27607148|NCT01364597|80402920|FG003|Overall Study|Patient cured from Epilepsy|0|||
27607149|NCT01364597|80402917|FG000|Overall Study|Investigator decision|0|||
27607150|NCT01364597|80402918|FG001|Overall Study|Investigator decision|0|||
27607151|NCT01364597|80402919|FG002|Overall Study|Investigator decision|1|||
27607152|NCT01364597|80402920|FG003|Overall Study|Investigator decision|0|||
27607153|NCT01364597|80402917|FG000|Overall Study|Sponsor recommended discontinuation|0|||
27607154|NCT01364597|80402918|FG001|Overall Study|Sponsor recommended discontinuation|0|||
27838371|NCT01945580|81236692|FG000|Overall Study|Lost to Follow-up|26|||
27838372|NCT01945580|81236693|FG001|Overall Study|Lost to Follow-up|39|||
27718166|NCT00848354|80802261|FG000|Phase 2 Year 1|Unspecified Reason|3|||
27718167|NCT00848354|80802262|FG001|Phase 2 Year 1|Unspecified Reason|0|||
27718168|NCT00848354|80802261|FG000|Phase 2 Year 1|Protocol Violation|4|||
27718169|NCT00848354|80802262|FG001|Phase 2 Year 1|Protocol Violation|1|||
27718170|NCT00848354|80802261|FG000|Phase 2 Year 1|Subject Request|1|||
27718171|NCT00848354|80802262|FG001|Phase 2 Year 1|Subject Request|2|||
27718172|NCT00848354|80802261|FG000|Phase 2 Year 2|Adverse Event|12|||
27718173|NCT00848354|80802262|FG001|Phase 2 Year 2|Adverse Event|2|||
27718174|NCT00848354|80802261|FG000|Phase 2 Year 2|Death|2|||
27718175|NCT00848354|80802262|FG001|Phase 2 Year 2|Death|0|||
27718176|NCT00848354|80802261|FG000|Phase 2 Year 2|Failed to return|3|||
27718177|NCT00848354|80802262|FG001|Phase 2 Year 2|Failed to return|0|||
27718178|NCT00848354|80802261|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
27718179|NCT00848354|80802262|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
27718180|NCT00848354|80802261|FG000|Phase 2 Year 2|Unspecified Reason|1|||
27718181|NCT00848354|80802262|FG001|Phase 2 Year 2|Unspecified Reason|0|||
27718182|NCT00848354|80802261|FG000|Phase 2 Year 2|Protocol Violation|1|||
27890125|NCT03315286|81430987|FG000|Overall Study|Lost to Follow-up|0|||
27890126|NCT03315286|81430988|FG001|Overall Study|Lost to Follow-up|3|||
27718183|NCT00848354|80802262|FG001|Phase 2 Year 2|Protocol Violation|1|||
27718184|NCT00848354|80802261|FG000|Phase 2 Year 2|Subject Request|1|||
27718185|NCT00848354|80802262|FG001|Phase 2 Year 2|Subject Request|1|||
27718186|NCT00848354|80802261|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
27718187|NCT00848354|80802262|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
27718188|NCT01659320|80802265|FG000|Overall Study|Withdrawal by Subject|2|||
27607155|NCT01364597|80402919|FG002|Overall Study|Sponsor recommended discontinuation|0|||
27607156|NCT01364597|80402920|FG003|Overall Study|Sponsor recommended discontinuation|1|||
27607157|NCT01364597|80402917|FG000|Overall Study|Parents went abroad with the patient|0|||
27607158|NCT01364597|80402918|FG001|Overall Study|Parents went abroad with the patient|0|||
27607159|NCT01364597|80402919|FG002|Overall Study|Parents went abroad with the patient|1|||
27838373|NCT01945580|81236692|FG000|Overall Study|Death|7|||
27838374|NCT01945580|81236693|FG001|Overall Study|Death|2|||
27838375|NCT01945580|81236692|FG000|Overall Study|Patient moved out of state|0|||
27838376|NCT01945580|81236693|FG001|Overall Study|Patient moved out of state|1|||
27890127|NCT03315286|81430987|FG000|Overall Study|Withdrawal by Subject|1|||
27890128|NCT03315286|81430988|FG001|Overall Study|Withdrawal by Subject|0|||
27890129|NCT03315286|81430987|FG000|Overall Study|Protocol Violation|0|||
27890130|NCT03315286|81430988|FG001|Overall Study|Protocol Violation|1|||
27890131|NCT00956592|81430989|FG000|Overall Study|Protocol Violation|1|||
27890132|NCT00956592|81430990|FG001|Overall Study|Protocol Violation|3|||
27890133|NCT02005692|81430991|FG000|Overall Study|Protocol Violation|1|||
27890134|NCT02005692|81430991|FG000|Overall Study|Withdrawal by Subject|1|||
27890135|NCT02005692|81430991|FG000|Overall Study|Discharged earlier than anticipated|5|||
27890136|NCT02162719|81430993|FG000|Overall Study|Death|41|||
27890137|NCT02162719|81430994|FG001|Overall Study|Death|46|||
27890138|NCT02162719|81430993|FG000|Overall Study|Lost to Follow-up|1|||
27890139|NCT02162719|81430994|FG001|Overall Study|Lost to Follow-up|3|||
27890140|NCT02162719|81430993|FG000|Overall Study|Disease Progression|2|||
27890141|NCT02162719|81430994|FG001|Overall Study|Disease Progression|1|||
27890142|NCT02162719|81430993|FG000|Overall Study|Withdrawal by Subject|8|||
27890143|NCT02162719|81430994|FG001|Overall Study|Withdrawal by Subject|2|||
27890144|NCT02162719|81430993|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
27890145|NCT02162719|81430994|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
27890146|NCT02272842|81430995|FG000|Overall Study|Lost to Follow-up|8|||
27890147|NCT02272842|81430996|FG001|Overall Study|Lost to Follow-up|8|||
27890148|NCT02272842|81430995|FG000|Overall Study|Withdrawal by Subject|8|||
27890149|NCT02272842|81430996|FG001|Overall Study|Withdrawal by Subject|2|||
27890150|NCT00679289|81430997|FG000|Overall Study|Progressive disease|4|||
27890151|NCT00679289|81430998|FG001|Overall Study|Progressive disease|5|||
27890152|NCT00679289|81430999|FG002|Overall Study|Progressive disease|18|||
27890153|NCT00679289|81430997|FG000|Overall Study|Withdrawal by Subject|0|||
27890154|NCT00679289|81430998|FG001|Overall Study|Withdrawal by Subject|1|||
27890155|NCT00679289|81430999|FG002|Overall Study|Withdrawal by Subject|1|||
27890156|NCT00679289|81430997|FG000|Overall Study|Adverse Event|0|||
27838377|NCT01945580|81236692|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
27838378|NCT01945580|81236693|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
27838379|NCT01945580|81236692|FG000|Overall Study|Family illness - unable to return|0|||
27838380|NCT01945580|81236693|FG001|Overall Study|Family illness - unable to return|1|||
27890157|NCT00679289|81430998|FG001|Overall Study|Adverse Event|0|||
27890158|NCT00679289|81430999|FG002|Overall Study|Adverse Event|3|||
27890159|NCT00679289|81430997|FG000|Overall Study|Physician Decision|1|||
27890160|NCT00679289|81430998|FG001|Overall Study|Physician Decision|0|||
27890161|NCT00679289|81430999|FG002|Overall Study|Physician Decision|1|||
27607160|NCT01364597|80402920|FG003|Overall Study|Parents went abroad with the patient|0|||
27890162|NCT00076752|81431000|FG000|Overall Study|Death|2|||
27607161|NCT01364597|80402917|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
27607162|NCT01364597|80402918|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
27607163|NCT01364597|80402919|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
27607164|NCT01364597|80402920|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
27607165|NCT01364597|80402917|FG000|Overall Study|BRV administration dropout|0|||
27607166|NCT01364597|80402918|FG001|Overall Study|BRV administration dropout|0|||
27607167|NCT01364597|80402919|FG002|Overall Study|BRV administration dropout|1|||
27607168|NCT01364597|80402920|FG003|Overall Study|BRV administration dropout|0|||
27607169|NCT01364597|80402917|FG000|Overall Study|Dropout|0|||
27607170|NCT01364597|80402918|FG001|Overall Study|Dropout|0|||
27607171|NCT01364597|80402919|FG002|Overall Study|Dropout|3|||
27607172|NCT01364597|80402920|FG003|Overall Study|Dropout|1|||
27607173|NCT01364597|80402917|FG000|Overall Study|Unreliable subject|0|||
27607174|NCT01364597|80402918|FG001|Overall Study|Unreliable subject|0|||
27607175|NCT01364597|80402919|FG002|Overall Study|Unreliable subject|0|||
27607176|NCT01364597|80402920|FG003|Overall Study|Unreliable subject|1|||
27607177|NCT01364597|80402917|FG000|Overall Study|Other|0|||
27607178|NCT01364597|80402918|FG001|Overall Study|Other|0|||
27607179|NCT01364597|80402919|FG002|Overall Study|Other|0|||
27607180|NCT01364597|80402920|FG003|Overall Study|Other|1|||
27607181|NCT01785563|80402923|FG000|Overall Study|Physician Decision|10|||
27607182|NCT01785563|80402923|FG000|Overall Study|Withdrawal by Subject|1|||
27607183|NCT01785563|80402923|FG000|Overall Study|Protocol Violation|2|||
27607184|NCT01722162|80402924|FG000|Overall Study|Withdrawal by Subject|1|||
27607185|NCT01722162|80402925|FG001|Overall Study|Withdrawal by Subject|1|||
27607186|NCT01722162|80402924|FG000|Overall Study|Found ineligible|1|||
27607187|NCT01722162|80402925|FG001|Overall Study|Found ineligible|0|||
27607188|NCT01722162|80402924|FG000|Overall Study|Unrelated to study adverse event|2|||
27607189|NCT01722162|80402925|FG001|Overall Study|Unrelated to study adverse event|2|||
27607190|NCT01722162|80402924|FG000|Overall Study|Adverse Event|1|||
27607191|NCT01722162|80402925|FG001|Overall Study|Adverse Event|1|||
27607192|NCT01722162|80402924|FG000|Overall Study|Insurance denial post enrollment|0|||
27607193|NCT01722162|80402925|FG001|Overall Study|Insurance denial post enrollment|1|||
27607194|NCT01722162|80402924|FG000|Overall Study|Noncompliance|0|||
27607195|NCT01722162|80402925|FG001|Overall Study|Noncompliance|1|||
27607196|NCT00255346|80402928|FG000|Overall Study|Adverse Event|1|||
27607197|NCT00255346|80402929|FG001|Overall Study|Adverse Event|0|||
27607198|NCT00255346|80402930|FG002|Overall Study|Adverse Event|0|||
27607199|NCT00255346|80402931|FG003|Overall Study|Adverse Event|0|||
27607200|NCT00255346|80402932|FG004|Overall Study|Adverse Event|0|||
27607201|NCT00550550|80402933|FG000|Overall Study|Adverse Event|13|||
27607202|NCT00550550|80402934|FG001|Overall Study|Adverse Event|5|||
27607203|NCT00550550|80402933|FG000|Overall Study|Treatment Failure|0|||
27607204|NCT00550550|80402934|FG001|Overall Study|Treatment Failure|1|||
27607205|NCT00550550|80402933|FG000|Overall Study|Lost to Follow-up|4|||
27607206|NCT00550550|80402934|FG001|Overall Study|Lost to Follow-up|0|||
27607207|NCT00550550|80402933|FG000|Overall Study|Withdrawal by Subject|10|||
27607208|NCT00550550|80402934|FG001|Overall Study|Withdrawal by Subject|8|||
27607209|NCT00550550|80402933|FG000|Overall Study|Protocol Violation|5|||
27607210|NCT00550550|80402934|FG001|Overall Study|Protocol Violation|14|||
27607211|NCT00550550|80402933|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
27607212|NCT00550550|80402934|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
27607213|NCT00550550|80402933|FG000|Overall Study|Randomized But Not Treated|1|||
27607214|NCT00550550|80402934|FG001|Overall Study|Randomized But Not Treated|0|||
27607215|NCT01782742|80402935|FG000|Double-blind Treatment Phase|Adverse Event|1|||
27607216|NCT01782742|80402936|FG001|Double-blind Treatment Phase|Adverse Event|0|||
27607217|NCT00944658|80402937|FG000|Treatment 12 Weeks|Adverse Event|0|||
27607218|NCT00944658|80402938|FG001|Treatment 12 Weeks|Adverse Event|2|||
27607219|NCT01642602|80402939|FG000|Overall Study|Adverse Event|2|||
27607220|NCT02276066|80402940|FG000|Overall Study|Lost to Follow-up|21|||
27607221|NCT02276066|80402941|FG001|Overall Study|Lost to Follow-up|11|||
27607222|NCT00856661|80402942|FG000|Overall Study|Death|15|||
27838381|NCT01945580|81236692|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
27890163|NCT00076752|81431000|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
27607223|NCT00856661|80402943|FG001|Overall Study|Death|18|||
27607224|NCT00856661|80402942|FG000|Overall Study|Protocol Violation|2|||
27607225|NCT00856661|80402943|FG001|Overall Study|Protocol Violation|1|||
27607226|NCT00856661|80402942|FG000|Overall Study|Withdrawal by Subject|1|||
27607227|NCT00856661|80402943|FG001|Overall Study|Withdrawal by Subject|2|||
27607228|NCT00856661|80402942|FG000|Overall Study|Lost to Follow-up|1|||
27607229|NCT00856661|80402943|FG001|Overall Study|Lost to Follow-up|3|||
27607230|NCT00856661|80402942|FG000|Overall Study|Physician Judgement|8|||
27607231|NCT00856661|80402943|FG001|Overall Study|Physician Judgement|5|||
27607232|NCT01282801|80402944|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
27607233|NCT01282801|80402945|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
27607234|NCT03021486|80402948|FG000|Overall Study|Withdrawal by Subject|1|||
27607235|NCT03021486|80402949|FG001|Overall Study|Withdrawal by Subject|1|||
27718189|NCT01659320|80802265|FG000|Overall Study|Physician Decision|1|||
27890164|NCT01597375|81431002|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
27607236|NCT03021486|80402950|FG002|Overall Study|Withdrawal by Subject|3|||
27607237|NCT03021486|80402948|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
27607238|NCT03021486|80402949|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
27607239|NCT03021486|80402950|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
27607240|NCT00747123|80402953|FG000|Overall Study|Investigator's request|0|||
27607241|NCT00747123|80402954|FG001|Overall Study|Investigator's request|0|||
27607242|NCT00747123|80402955|FG002|Overall Study|Investigator's request|1|||
27607243|NCT00747123|80402956|FG003|Overall Study|Investigator's request|0|||
27607244|NCT00747123|80402953|FG000|Overall Study|Withdrew consent|0|||
27607245|NCT00747123|80402954|FG001|Overall Study|Withdrew consent|1|||
27607246|NCT00747123|80402955|FG002|Overall Study|Withdrew consent|0|||
27607247|NCT00747123|80402956|FG003|Overall Study|Withdrew consent|0|||
27607248|NCT00747123|80402953|FG000|Overall Study|Adverse Event|0|||
27607249|NCT00747123|80402954|FG001|Overall Study|Adverse Event|1|||
27607250|NCT00747123|80402955|FG002|Overall Study|Adverse Event|0|||
27607251|NCT00747123|80402956|FG003|Overall Study|Adverse Event|1|||
27607252|NCT01852058|80402957|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
27607253|NCT01852058|80402958|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27718190|NCT01965262|80802266|FG000|Second Intervention (7 Days)|Discontinued|0|||
27890165|NCT01597375|81431003|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
27890166|NCT01597375|81431002|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
27890167|NCT01597375|81431003|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
27890168|NCT01597375|81431002|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
27718191|NCT01965262|80802267|FG001|Second Intervention (7 Days)|Discontinued|1|||
27890169|NCT01597375|81431003|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
27890170|NCT01597375|81431002|FG000|Washout (2 Weeks)|Adverse Event|1|||
27890171|NCT01597375|81431003|FG001|Washout (2 Weeks)|Adverse Event|0|||
27890172|NCT01597375|81431002|FG000|Second Intervention|Failed to react at both Aspirin|1|||
27890173|NCT01597375|81431003|FG001|Second Intervention|Failed to react at both Aspirin|1|||
27890174|NCT00976820|81431004|FG000|Overall Study|Lost to Follow-up|5|||
27890175|NCT00976820|81431005|FG001|Overall Study|Lost to Follow-up|16|||
27890176|NCT00976820|81431006|FG002|Overall Study|Lost to Follow-up|2|||
27890177|NCT00976820|81431007|FG003|Overall Study|Lost to Follow-up|3|||
27890178|NCT00976820|81431004|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
27890179|NCT00976820|81431005|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
27890180|NCT00976820|81431006|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
27890181|NCT00976820|81431007|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
27890182|NCT00976820|81431004|FG000|Overall Study|Withdrawal by Subject|2|||
27890183|NCT00976820|81431005|FG001|Overall Study|Withdrawal by Subject|4|||
27890184|NCT00976820|81431006|FG002|Overall Study|Withdrawal by Subject|1|||
27890185|NCT00976820|81431007|FG003|Overall Study|Withdrawal by Subject|4|||
27890186|NCT01899742|81431012|FG000|Overall Study|Adverse Event|5|||
27890187|NCT01899742|81431013|FG001|Overall Study|Adverse Event|4|||
27890188|NCT01899742|81431012|FG000|Overall Study|Lack of Efficacy|1|||
27890189|NCT01899742|81431013|FG001|Overall Study|Lack of Efficacy|5|||
27890190|NCT01899742|81431012|FG000|Overall Study|Protocol Violation|2|||
27890191|NCT01899742|81431013|FG001|Overall Study|Protocol Violation|2|||
27890192|NCT01899742|81431012|FG000|Overall Study|Withdrawal by Subject|9|||
27890193|NCT01899742|81431013|FG001|Overall Study|Withdrawal by Subject|5|||
27890194|NCT03452488|81431018|FG000|Overall Study|Adverse Event|4|||
27890195|NCT03452488|81431019|FG001|Overall Study|Adverse Event|6|||
27890196|NCT03452488|81431020|FG002|Overall Study|Adverse Event|1|||
27890197|NCT03452488|81431018|FG000|Overall Study|Death|0|||
27890198|NCT03452488|81431019|FG001|Overall Study|Death|0|||
27890199|NCT03452488|81431020|FG002|Overall Study|Death|1|||
27754861|NCT02065622|80929631|FG001|Induction Study|Adverse Event|19|||
27890200|NCT03452488|81431018|FG000|Overall Study|Lost to Follow-up|1|||
27890201|NCT03452488|81431019|FG001|Overall Study|Lost to Follow-up|2|||
27890202|NCT03452488|81431020|FG002|Overall Study|Lost to Follow-up|0|||
27890203|NCT03452488|81431018|FG000|Overall Study|PI Decision|1|||
27607254|NCT01852058|80402959|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607255|NCT01852058|80402960|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27890204|NCT03452488|81431019|FG001|Overall Study|PI Decision|0|||
27890205|NCT03452488|81431020|FG002|Overall Study|PI Decision|0|||
27890206|NCT03452488|81431018|FG000|Overall Study|Withdrew consent|4|||
27607256|NCT01852058|80402961|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607257|NCT01852058|80402962|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607258|NCT01852058|80402963|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607259|NCT01852058|80402964|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607260|NCT01852058|80402965|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607261|NCT01852058|80402966|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607262|NCT01852058|80402967|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607263|NCT01852058|80402968|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
27607264|NCT01852058|80402957|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607265|NCT01852058|80402958|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607266|NCT01852058|80402959|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607267|NCT01852058|80402960|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607268|NCT01852058|80402961|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
27607269|NCT01852058|80402962|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607270|NCT01852058|80402963|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607271|NCT01852058|80402964|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607272|NCT01852058|80402965|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607273|NCT01852058|80402966|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607274|NCT01852058|80402967|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607275|NCT01852058|80402968|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
27607276|NCT01852058|80402957|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607277|NCT01852058|80402958|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607278|NCT01852058|80402959|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607279|NCT01852058|80402960|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607280|NCT01852058|80402961|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
27607281|NCT01852058|80402962|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
27607282|NCT01852058|80402963|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607283|NCT01852058|80402964|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607284|NCT01852058|80402965|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607285|NCT01852058|80402966|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607286|NCT01852058|80402967|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607287|NCT01852058|80402968|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
27607288|NCT01852058|80402957|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27754862|NCT02065622|80929632|FG002|Induction Study|Adverse Event|0|||
27838382|NCT01945580|81236693|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
27838383|NCT01945580|81236692|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
27838384|NCT01945580|81236693|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
27838385|NCT01945580|81236692|FG000|Overall Study|Noncompliance with 36 month visit|1|||
27838386|NCT01945580|81236693|FG001|Overall Study|Noncompliance with 36 month visit|0|||
27838387|NCT01945580|81236692|FG000|Overall Study|The patient moved.|1|||
27838388|NCT01945580|81236693|FG001|Overall Study|The patient moved.|0|||
27838389|NCT01945580|81236692|FG000|Overall Study|No data available|0|||
27838390|NCT01945580|81236693|FG001|Overall Study|No data available|2|||
27838391|NCT03573544|81236696|FG000|Overall Study|Adverse Event|0|||
27838392|NCT03573544|81236697|FG001|Overall Study|Adverse Event|0|||
27718192|NCT01965262|80802266|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
27718193|NCT01965262|80802267|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
27718194|NCT01965262|80802266|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
27718195|NCT01965262|80802267|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
27718196|NCT00705939|80802268|FG000|Overall Study|Protocol Violation|0|||
27718197|NCT00705939|80802269|FG001|Overall Study|Protocol Violation|0|||
27718198|NCT00705939|80802270|FG002|Overall Study|Protocol Violation|1|||
27718199|NCT00705939|80802268|FG000|Overall Study|Withdrawal by Subject|0|||
27718200|NCT00705939|80802269|FG001|Overall Study|Withdrawal by Subject|1|||
27718201|NCT00705939|80802270|FG002|Overall Study|Withdrawal by Subject|3|||
27718202|NCT00705939|80802268|FG000|Overall Study|Physician Decision|0|||
27718203|NCT00705939|80802269|FG001|Overall Study|Physician Decision|1|||
27718204|NCT00705939|80802270|FG002|Overall Study|Physician Decision|0|||
27718205|NCT01127165|80802277|FG000|Overall Study|Adverse Event|2|||
27718206|NCT01127165|80802278|FG001|Overall Study|Adverse Event|2|||
27718207|NCT01127165|80802277|FG000|Overall Study|Lack of Efficacy|10|||
27718208|NCT01127165|80802278|FG001|Overall Study|Lack of Efficacy|8|||
27718209|NCT01127165|80802277|FG000|Overall Study|Lost to Follow-up|3|||
27718210|NCT01127165|80802278|FG001|Overall Study|Lost to Follow-up|5|||
27718211|NCT01127165|80802277|FG000|Overall Study|Withdrawal by Subject|1|||
27718212|NCT01127165|80802278|FG001|Overall Study|Withdrawal by Subject|3|||
27718213|NCT01127165|80802277|FG000|Overall Study|Protocol Violation|0|||
27718214|NCT01127165|80802278|FG001|Overall Study|Protocol Violation|1|||
27718215|NCT01964352|80802279|FG000|Overall Study|Adverse Event|13|||
27718216|NCT01964352|80802280|FG001|Overall Study|Adverse Event|3|||
27718217|NCT01964352|80802281|FG002|Overall Study|Adverse Event|4|||
27718218|NCT01964352|80802282|FG003|Overall Study|Adverse Event|3|||
27718219|NCT01964352|80802279|FG000|Overall Study|Lack of Efficacy|6|||
27718220|NCT01964352|80802280|FG001|Overall Study|Lack of Efficacy|0|||
27718221|NCT01964352|80802281|FG002|Overall Study|Lack of Efficacy|0|||
27718222|NCT01964352|80802282|FG003|Overall Study|Lack of Efficacy|0|||
27718223|NCT01964352|80802279|FG000|Overall Study|Protocol Violation|2|||
27718224|NCT01964352|80802280|FG001|Overall Study|Protocol Violation|4|||
27718225|NCT01964352|80802281|FG002|Overall Study|Protocol Violation|0|||
27838393|NCT03573544|81236698|FG002|Overall Study|Adverse Event|0|||
27838394|NCT03573544|81236699|FG003|Overall Study|Adverse Event|3|||
27838395|NCT03573544|81236700|FG004|Overall Study|Adverse Event|1|||
27838396|NCT03573544|81236701|FG005|Overall Study|Adverse Event|0|||
27718226|NCT01964352|80802282|FG003|Overall Study|Protocol Violation|2|||
27718227|NCT01964352|80802279|FG000|Overall Study|Lost to Follow-up|1|||
27718228|NCT01964352|80802280|FG001|Overall Study|Lost to Follow-up|0|||
27718229|NCT01964352|80802281|FG002|Overall Study|Lost to Follow-up|0|||
27718230|NCT01964352|80802282|FG003|Overall Study|Lost to Follow-up|1|||
27718231|NCT01964352|80802279|FG000|Overall Study|Withdrawal by Subject|4|||
27718232|NCT01964352|80802280|FG001|Overall Study|Withdrawal by Subject|2|||
27718233|NCT01964352|80802281|FG002|Overall Study|Withdrawal by Subject|1|||
27718234|NCT01964352|80802282|FG003|Overall Study|Withdrawal by Subject|0|||
27718235|NCT01964352|80802279|FG000|Overall Study|Other than stated above|0|||
27718236|NCT01964352|80802280|FG001|Overall Study|Other than stated above|2|||
27718237|NCT01964352|80802281|FG002|Overall Study|Other than stated above|1|||
27718238|NCT01964352|80802282|FG003|Overall Study|Other than stated above|2|||
27718239|NCT00661531|80802287|FG000|Overall Study|Withdrawal by Subject|3|||
27718240|NCT01823679|80802288|FG000|Overall Study|Death|1|||
27718241|NCT01902966|80802289|FG000|Overall Study|Death|1|||
27718242|NCT01902966|80802289|FG000|Overall Study|Physician Decision|1|||
27718243|NCT01902966|80802289|FG000|Overall Study|Withdrawal by Subject|1|||
27718244|NCT03686397|80802290|FG000|Overall Study|Lack of Efficacy|3|||
27718245|NCT03686397|80802291|FG001|Overall Study|Lack of Efficacy|5|||
27718246|NCT03686397|80802290|FG000|Overall Study|Adverse Event|0|||
27718247|NCT03686397|80802291|FG001|Overall Study|Adverse Event|1|||
27718248|NCT03686397|80802290|FG000|Overall Study|Protocol Violation|0|||
27718249|NCT03686397|80802291|FG001|Overall Study|Protocol Violation|1|||
27718250|NCT03686397|80802290|FG000|Overall Study|Withdrawal by Subject|0|||
27718251|NCT03686397|80802291|FG001|Overall Study|Withdrawal by Subject|1|||
27718252|NCT03686397|80802290|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
27718253|NCT03686397|80802291|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
27718254|NCT00699907|80802292|FG000|Overall Study|Withdrawal by Subject|2|||
27718255|NCT00699907|80802293|FG001|Overall Study|Withdrawal by Subject|1|||
27718256|NCT00699907|80802294|FG002|Overall Study|Withdrawal by Subject|0|||
27718257|NCT00699907|80802292|FG000|Overall Study|No usable sample|0|||
27718258|NCT00699907|80802293|FG001|Overall Study|No usable sample|9|||
27718259|NCT00699907|80802294|FG002|Overall Study|No usable sample|8|||
27718260|NCT00763139|80802297|FG000|Overall Study|Adverse Event|4|||
27718261|NCT00763139|80802298|FG001|Overall Study|Adverse Event|2|||
27718262|NCT00763139|80802297|FG000|Overall Study|Withdrawal by Subject|0|||
27718263|NCT00763139|80802298|FG001|Overall Study|Withdrawal by Subject|1|||
27718264|NCT00763139|80802297|FG000|Overall Study|med change not allowed by protocol|1|||
27718265|NCT00763139|80802298|FG001|Overall Study|med change not allowed by protocol|0|||
27718266|NCT01777152|80802313|FG000|Overall Study|Withdrawal by Subject|22|||
27718267|NCT01777152|80802314|FG001|Overall Study|Withdrawal by Subject|16|||
27718268|NCT01777152|80802313|FG000|Overall Study|Lost to Follow-up|3|||
27718269|NCT01777152|80802314|FG001|Overall Study|Lost to Follow-up|5|||
27718270|NCT01777152|80802313|FG000|Overall Study|Death|68|||
27718271|NCT01777152|80802314|FG001|Overall Study|Death|89|||
27718272|NCT01777152|80802313|FG000|Overall Study|Not eligible, no study drug received|1|||
27718273|NCT01777152|80802314|FG001|Overall Study|Not eligible, no study drug received|0|||
27718274|NCT01777152|80802313|FG000|Overall Study|Change of diagnosis|1|||
27718275|NCT01777152|80802314|FG001|Overall Study|Change of diagnosis|0|||
27718276|NCT00209339|80802315|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
27718277|NCT00209339|80802315|FG000|At 12 Months Follow-up|Death|1|||
27718278|NCT00209339|80802315|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
27718279|NCT00209339|80802315|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
27718280|NCT00209339|80802315|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
27718281|NCT00209339|80802315|FG000|At 24 Months Follow-up|Death|1|||
27718282|NCT00209339|80802315|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
27838397|NCT03573544|81236702|FG006|Overall Study|Adverse Event|2|||
27838398|NCT03573544|81236703|FG007|Overall Study|Adverse Event|0|||
27838399|NCT03573544|81236696|FG000|Overall Study|Physician Decision|0|||
27838400|NCT03573544|81236697|FG001|Overall Study|Physician Decision|0|||
27838401|NCT03573544|81236698|FG002|Overall Study|Physician Decision|0|||
27838402|NCT03573544|81236699|FG003|Overall Study|Physician Decision|0|||
27838403|NCT03573544|81236700|FG004|Overall Study|Physician Decision|0|||
27838404|NCT03573544|81236701|FG005|Overall Study|Physician Decision|0|||
27838405|NCT03573544|81236702|FG006|Overall Study|Physician Decision|1|||
27838406|NCT03573544|81236703|FG007|Overall Study|Physician Decision|0|||
27718283|NCT00209339|80802315|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
27718284|NCT00209339|80802315|FG000|At 4 Years Follow-up|Death|1|||
27838407|NCT03573544|81236696|FG000|Overall Study|Withdrawal by Subject|2|||
27838408|NCT03573544|81236697|FG001|Overall Study|Withdrawal by Subject|0|||
27838409|NCT03573544|81236698|FG002|Overall Study|Withdrawal by Subject|0|||
27838410|NCT03573544|81236699|FG003|Overall Study|Withdrawal by Subject|1|||
27718285|NCT00209339|80802315|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
27718286|NCT00209339|80802315|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
27718287|NCT00209339|80802315|FG000|At 5 Years Follow-up|Death|1|||
27718288|NCT00356278|80802316|FG000|Overall Study|Withdrawal by Subject|25|||
27718289|NCT00356278|80802317|FG001|Overall Study|Withdrawal by Subject|15|||
27718290|NCT00356278|80802318|FG002|Overall Study|Withdrawal by Subject|19|||
27718291|NCT00880893|80802319|FG000|Overall Study|Protocol Violation|13|||
27718292|NCT00880893|80802320|FG001|Overall Study|Protocol Violation|1|||
27718293|NCT00880893|80802319|FG000|Overall Study|Withdrawal by Subject|15|||
27838411|NCT03573544|81236700|FG004|Overall Study|Withdrawal by Subject|1|||
27890207|NCT03452488|81431019|FG001|Overall Study|Withdrew consent|2|||
27718294|NCT00880893|80802320|FG001|Overall Study|Withdrawal by Subject|11|||
27718295|NCT00880893|80802319|FG000|Overall Study|Lost to Follow-up|76|||
27718296|NCT00880893|80802320|FG001|Overall Study|Lost to Follow-up|33|||
27718297|NCT00880893|80802319|FG000|Overall Study|Serious adverse event|3|||
27718298|NCT00880893|80802320|FG001|Overall Study|Serious adverse event|0|||
27718299|NCT03434977|80802321|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
27718300|NCT03434977|80802322|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
27718301|NCT01780831|80802334|FG000|Overall Study|Withdrawal by Subject|0|||
27718302|NCT01780831|80802335|FG001|Overall Study|Withdrawal by Subject|0|||
27718303|NCT01780831|80802336|FG002|Overall Study|Withdrawal by Subject|4|||
27718304|NCT01780831|80802337|FG003|Overall Study|Withdrawal by Subject|0|||
27718305|NCT01780831|80802334|FG000|Overall Study|Lost to Follow-up|0|||
27718306|NCT01780831|80802335|FG001|Overall Study|Lost to Follow-up|0|||
27718307|NCT01780831|80802336|FG002|Overall Study|Lost to Follow-up|0|||
27718308|NCT01780831|80802337|FG003|Overall Study|Lost to Follow-up|1|||
27718309|NCT00603915|80802340|FG000|Overall Study|Physician Decision|1|||
27718310|NCT02363686|80802341|FG000|Overall Study|Withdrawal by Subject|22|||
27718311|NCT02363686|80802341|FG000|Overall Study|incomplete FEES examinations|13|||
27718312|NCT03776175|80802342|FG000|Treatment Period (42 Days)|Adverse Event|0|||
27718313|NCT03776175|80802343|FG001|Treatment Period (42 Days)|Adverse Event|1|||
27718314|NCT03776175|80802344|FG002|Treatment Period (42 Days)|Adverse Event|1|||
27718315|NCT03776175|80802345|FG003|Treatment Period (42 Days)|Adverse Event|0|||
27718316|NCT03776175|80802342|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
27718317|NCT03776175|80802343|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
27718318|NCT03776175|80802344|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
27718319|NCT03776175|80802345|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
27718320|NCT03776175|80802342|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
27718321|NCT03776175|80802343|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
27718322|NCT03776175|80802344|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
27718323|NCT03776175|80802345|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
27718324|NCT03776175|80802342|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
27718325|NCT03776175|80802343|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
27718326|NCT03776175|80802344|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
27718327|NCT03776175|80802345|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
27718328|NCT03776175|80802342|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
27718329|NCT03776175|80802343|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
27718330|NCT03776175|80802344|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
27718331|NCT03776175|80802345|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
27718332|NCT03776175|80802342|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
27718333|NCT03776175|80802343|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
27718334|NCT03776175|80802344|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
27718335|NCT03776175|80802345|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
27718336|NCT03115151|80802346|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
27718337|NCT03115151|80802347|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
27718338|NCT03115151|80802346|FG000|Overall Study|Epidural catheter removal|1|||
27718339|NCT03115151|80802347|FG001|Overall Study|Epidural catheter removal|0|||
27718340|NCT03115151|80802346|FG000|Overall Study|Withdrawal by Subject|0|||
27718341|NCT03115151|80802347|FG001|Overall Study|Withdrawal by Subject|1|||
27718342|NCT03115151|80802346|FG000|Overall Study|Intervention not received according to the protocol.|1|||
27718343|NCT03115151|80802347|FG001|Overall Study|Intervention not received according to the protocol.|1|||
27718344|NCT03115151|80802346|FG000|Overall Study|Physician Decision|1|||
27718345|NCT03115151|80802347|FG001|Overall Study|Physician Decision|0|||
27718346|NCT03115151|80802346|FG000|Overall Study|Randomization not applied|1|||
27718347|NCT03115151|80802347|FG001|Overall Study|Randomization not applied|1|||
27718348|NCT04093531|80802348|FG000|Overall Study|failed screening|4|||
27718349|NCT03718143|80802349|FG000|Overall Study|Death|1|||
27718350|NCT03718143|80802350|FG001|Overall Study|Death|0|||
27718351|NCT03718143|80802351|FG002|Overall Study|Death|0|||
27718352|NCT03718143|80802349|FG000|Overall Study|Progression of Disease|1|||
27890208|NCT03452488|81431020|FG002|Overall Study|Withdrew consent|2|||
27718353|NCT03718143|80802350|FG001|Overall Study|Progression of Disease|0|||
27718354|NCT03718143|80802351|FG002|Overall Study|Progression of Disease|0|||
27718355|NCT03718143|80802349|FG000|Overall Study|Withdrawal of Informed Consent|1|||
27718356|NCT03718143|80802350|FG001|Overall Study|Withdrawal of Informed Consent|2|||
27718357|NCT03718143|80802351|FG002|Overall Study|Withdrawal of Informed Consent|1|||
27718358|NCT02682901|80802352|FG000|Overall Study|Adverse Event|10|||
27718359|NCT02682901|80802353|FG001|Overall Study|Adverse Event|3|||
27718360|NCT02682901|80802352|FG000|Overall Study|Lack of Efficacy|0|||
27718361|NCT02682901|80802353|FG001|Overall Study|Lack of Efficacy|1|||
27718362|NCT04356183|80802356|FG000|Overall Study|Lost to Follow-up|1|||
27718363|NCT04356183|80802357|FG001|Overall Study|Lost to Follow-up|0|||
27718364|NCT04356183|80802356|FG000|Overall Study|Withdrawal by Subject|1|||
27718365|NCT04356183|80802357|FG001|Overall Study|Withdrawal by Subject|1|||
27718366|NCT03245450|80802360|FG000|Overall Study|Radiological disease progression|3|||
27718367|NCT03245450|80802361|FG001|Overall Study|Radiological disease progression|3|||
27718368|NCT03245450|80802362|FG002|Overall Study|Radiological disease progression|2|||
27718369|NCT03245450|80802363|FG003|Overall Study|Radiological disease progression|2|||
27718370|NCT03245450|80802364|FG004|Overall Study|Radiological disease progression|7|||
27890209|NCT03452488|81431018|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
27890210|NCT03452488|81431019|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
27890211|NCT03452488|81431020|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
27890212|NCT03452488|81431018|FG000|Overall Study|Other|0|||
27890213|NCT03452488|81431019|FG001|Overall Study|Other|2|||
27890214|NCT03452488|81431020|FG002|Overall Study|Other|2|||
27890215|NCT05036668|81434030|FG000|Overall Study|lost to follow Up|0|||
27890216|NCT05036668|81434031|FG001|Overall Study|lost to follow Up|0|||
27890217|NCT05036668|81434032|FG002|Overall Study|lost to follow Up|1|||
27890218|NCT00138073|81434033|FG000|Overall Study|lack of resources|55|||
27890219|NCT03214380|81434034|FG000|Lead-in|Adverse Event|3|||
27890220|NCT03214380|81434035|FG001|Lead-in|Adverse Event|0|||
27890221|NCT03214380|81434036|FG002|Lead-in|Adverse Event|0|||
27607289|NCT01852058|80402958|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27607290|NCT01852058|80402959|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27718371|NCT03245450|80802365|FG005|Overall Study|Radiological disease progression|6|||
27718372|NCT03245450|80802366|FG006|Overall Study|Radiological disease progression|6|||
27718373|NCT03245450|80802360|FG000|Overall Study|Clinical disease progression|0|||
27718374|NCT03245450|80802361|FG001|Overall Study|Clinical disease progression|0|||
27718375|NCT03245450|80802362|FG002|Overall Study|Clinical disease progression|1|||
27718376|NCT03245450|80802363|FG003|Overall Study|Clinical disease progression|0|||
27838412|NCT03573544|81236701|FG005|Overall Study|Withdrawal by Subject|1|||
27838413|NCT03573544|81236702|FG006|Overall Study|Withdrawal by Subject|0|||
27838414|NCT03573544|81236703|FG007|Overall Study|Withdrawal by Subject|1|||
27838415|NCT03573544|81236696|FG000|Overall Study|Disease progression|3|||
27838416|NCT03573544|81236697|FG001|Overall Study|Disease progression|3|||
27838417|NCT03573544|81236698|FG002|Overall Study|Disease progression|6|||
27838418|NCT03573544|81236699|FG003|Overall Study|Disease progression|4|||
27838419|NCT03573544|81236700|FG004|Overall Study|Disease progression|5|||
27838420|NCT03573544|81236701|FG005|Overall Study|Disease progression|7|||
27838421|NCT03573544|81236702|FG006|Overall Study|Disease progression|6|||
27838422|NCT03573544|81236703|FG007|Overall Study|Disease progression|7|||
27838423|NCT00283842|81236704|FG000|Overall Study|Adverse Event|8|||
27838424|NCT00283842|81236705|FG001|Overall Study|Adverse Event|7|||
27838425|NCT00283842|81236706|FG002|Overall Study|Adverse Event|21|||
27838426|NCT00283842|81236707|FG003|Overall Study|Adverse Event|21|||
27838427|NCT00283842|81236708|FG004|Overall Study|Adverse Event|5|||
27838428|NCT00283842|81236704|FG000|Overall Study|Protocol Violation|1|||
27838429|NCT00283842|81236705|FG001|Overall Study|Protocol Violation|5|||
27838430|NCT00283842|81236706|FG002|Overall Study|Protocol Violation|4|||
27838431|NCT00283842|81236707|FG003|Overall Study|Protocol Violation|0|||
27838432|NCT00283842|81236708|FG004|Overall Study|Protocol Violation|0|||
27838433|NCT00283842|81236704|FG000|Overall Study|Protocol deviation|0|||
27890222|NCT03214380|81434037|FG003|Lead-in|Adverse Event|1|||
27718377|NCT03245450|80802364|FG004|Overall Study|Clinical disease progression|0|||
27718378|NCT03245450|80802365|FG005|Overall Study|Clinical disease progression|2|||
27890223|NCT03214380|81434038|FG004|Lead-in|Adverse Event|0|||
27838434|NCT00283842|81236705|FG001|Overall Study|Protocol deviation|0|||
27890224|NCT03214380|81434039|FG005|Lead-in|Adverse Event|0|||
27607291|NCT01852058|80402960|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27607292|NCT01852058|80402961|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
27607293|NCT01852058|80402962|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27718379|NCT03245450|80802366|FG006|Overall Study|Clinical disease progression|0|||
27718380|NCT03245450|80802360|FG000|Overall Study|Other|0|||
27718381|NCT03245450|80802361|FG001|Overall Study|Other|0|||
27718382|NCT03245450|80802362|FG002|Overall Study|Other|0|||
27718383|NCT03245450|80802363|FG003|Overall Study|Other|1|||
27718384|NCT03245450|80802364|FG004|Overall Study|Other|1|||
27718385|NCT03245450|80802365|FG005|Overall Study|Other|1|||
27718386|NCT03245450|80802366|FG006|Overall Study|Other|1|||
27718387|NCT03245450|80802360|FG000|Overall Study|Withdrawal by Subject|0|||
27718388|NCT03245450|80802361|FG001|Overall Study|Withdrawal by Subject|1|||
27718389|NCT03245450|80802362|FG002|Overall Study|Withdrawal by Subject|0|||
27718390|NCT03245450|80802363|FG003|Overall Study|Withdrawal by Subject|0|||
27718391|NCT03245450|80802364|FG004|Overall Study|Withdrawal by Subject|0|||
27718392|NCT03245450|80802365|FG005|Overall Study|Withdrawal by Subject|0|||
27718393|NCT03245450|80802366|FG006|Overall Study|Withdrawal by Subject|0|||
27718394|NCT03245450|80802360|FG000|Overall Study|Adverse Event|0|||
27718395|NCT03245450|80802361|FG001|Overall Study|Adverse Event|0|||
27718396|NCT03245450|80802362|FG002|Overall Study|Adverse Event|0|||
27718397|NCT03245450|80802363|FG003|Overall Study|Adverse Event|0|||
27718398|NCT03245450|80802364|FG004|Overall Study|Adverse Event|1|||
27718399|NCT03245450|80802365|FG005|Overall Study|Adverse Event|0|||
27718400|NCT03245450|80802366|FG006|Overall Study|Adverse Event|2|||
27718401|NCT01500057|80802368|FG000|Overall Study|Lost to Follow-up|6|||
27718402|NCT01500057|80802369|FG001|Overall Study|Lost to Follow-up|4|||
27718403|NCT00049673|80802370|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
27718404|NCT00049673|80802371|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
27718405|NCT00774345|80802374|FG000|Pre-treatment|Other reasons|2|||
27718406|NCT00774345|80802375|FG001|Pre-treatment|Other reasons|0|||
27718407|NCT00774345|80802374|FG000|Treatment|Adverse Event|61|||
27607294|NCT01852058|80402963|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27838435|NCT00283842|81236706|FG002|Overall Study|Protocol deviation|0|||
27838436|NCT00283842|81236707|FG003|Overall Study|Protocol deviation|0|||
27838437|NCT00283842|81236708|FG004|Overall Study|Protocol deviation|2|||
27838438|NCT00283842|81236704|FG000|Overall Study|Withdrawal by Subject|2|||
27838439|NCT00283842|81236705|FG001|Overall Study|Withdrawal by Subject|1|||
27838440|NCT00283842|81236706|FG002|Overall Study|Withdrawal by Subject|1|||
27890225|NCT03214380|81434034|FG000|Lead-in|Lost to Follow-up|4|||
27607295|NCT01852058|80402964|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27607296|NCT01852058|80402965|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27607297|NCT01852058|80402966|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27718408|NCT00774345|80802375|FG001|Treatment|Adverse Event|15|||
27718409|NCT00774345|80802374|FG000|Treatment|Progressive Disease without histologic transformation|51|||
27718410|NCT00774345|80802375|FG001|Treatment|Progressive Disease without histologic transformation|111|||
27838441|NCT00283842|81236707|FG003|Overall Study|Withdrawal by Subject|5|||
27838442|NCT00283842|81236708|FG004|Overall Study|Withdrawal by Subject|4|||
27838443|NCT00283842|81236704|FG000|Overall Study|Lack of Efficacy|1|||
27838444|NCT00283842|81236705|FG001|Overall Study|Lack of Efficacy|3|||
27890226|NCT03214380|81434035|FG001|Lead-in|Lost to Follow-up|0|||
27890227|NCT03214380|81434036|FG002|Lead-in|Lost to Follow-up|0|||
27890228|NCT03214380|81434037|FG003|Lead-in|Lost to Follow-up|1|||
27890229|NCT03214380|81434038|FG004|Lead-in|Lost to Follow-up|0|||
27890230|NCT03214380|81434039|FG005|Lead-in|Lost to Follow-up|0|||
27890231|NCT03214380|81434034|FG000|Lead-in|Eligibility Criteria|3|||
27890232|NCT03214380|81434035|FG001|Lead-in|Eligibility Criteria|0|||
27890233|NCT03214380|81434036|FG002|Lead-in|Eligibility Criteria|0|||
27890234|NCT03214380|81434037|FG003|Lead-in|Eligibility Criteria|0|||
27718411|NCT00774345|80802374|FG000|Treatment|Progressive Disease with histologic transformation|4|||
27718412|NCT00774345|80802375|FG001|Treatment|Progressive Disease with histologic transformation|2|||
27890235|NCT03214380|81434038|FG004|Lead-in|Eligibility Criteria|0|||
27718413|NCT00774345|80802374|FG000|Treatment|Withdrawal by Subject|5|||
27838445|NCT00283842|81236706|FG002|Overall Study|Lack of Efficacy|1|||
27890236|NCT03214380|81434039|FG005|Lead-in|Eligibility Criteria|0|||
27607298|NCT01852058|80402967|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27890237|NCT03214380|81434034|FG000|Lead-in|Physician Decision|6|||
27890238|NCT03214380|81434035|FG001|Lead-in|Physician Decision|0|||
27890239|NCT03214380|81434036|FG002|Lead-in|Physician Decision|0|||
27890240|NCT03214380|81434037|FG003|Lead-in|Physician Decision|0|||
27890241|NCT03214380|81434038|FG004|Lead-in|Physician Decision|0|||
27890242|NCT03214380|81434039|FG005|Lead-in|Physician Decision|0|||
27890243|NCT03214380|81434034|FG000|Lead-in|Protocol Deviation|7|||
27890244|NCT03214380|81434035|FG001|Lead-in|Protocol Deviation|0|||
27607299|NCT01852058|80402968|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
27607300|NCT01852058|80402957|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607301|NCT01852058|80402958|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607302|NCT01852058|80402959|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607303|NCT01852058|80402960|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607304|NCT01852058|80402961|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
27607305|NCT01852058|80402962|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
27607306|NCT01852058|80402963|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607307|NCT01852058|80402964|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607308|NCT01852058|80402965|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607309|NCT01852058|80402966|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607310|NCT01852058|80402967|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27607311|NCT01852058|80402968|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
27718414|NCT00774345|80802375|FG001|Treatment|Withdrawal by Subject|2|||
27718415|NCT00774345|80802374|FG000|Treatment|Lost to Follow-up|1|||
27718416|NCT00774345|80802375|FG001|Treatment|Lost to Follow-up|1|||
27718417|NCT00774345|80802374|FG000|Treatment|Death|4|||
27718418|NCT00774345|80802375|FG001|Treatment|Death|0|||
27718419|NCT00774345|80802374|FG000|Treatment|Other Reasons|32|||
27718420|NCT00774345|80802375|FG001|Treatment|Other Reasons|26|||
27718421|NCT02002975|80802376|FG000|Overall Study|Case Report Forms Uncollected|135|||
27718422|NCT02002975|80802376|FG000|Overall Study|Protocol Deviation|437|||
27718423|NCT00903929|80802377|FG000|Overall Study|Withdrawal by Subject|0|||
27718424|NCT00903929|80802378|FG001|Overall Study|Withdrawal by Subject|0|||
27718425|NCT00903929|80802379|FG002|Overall Study|Withdrawal by Subject|1|||
27718426|NCT00903929|80802380|FG003|Overall Study|Withdrawal by Subject|2|||
27718427|NCT00903929|80802377|FG000|Overall Study|Adverse Event|0|||
27718428|NCT00903929|80802378|FG001|Overall Study|Adverse Event|0|||
27890245|NCT03214380|81434036|FG002|Lead-in|Protocol Deviation|0|||
27718429|NCT00903929|80802379|FG002|Overall Study|Adverse Event|0|||
27718430|NCT00903929|80802380|FG003|Overall Study|Adverse Event|1|||
27718431|NCT01394939|80802381|FG000|Overall Study|Adverse Event|1|||
27890246|NCT03214380|81434037|FG003|Lead-in|Protocol Deviation|3|||
27890247|NCT03214380|81434038|FG004|Lead-in|Protocol Deviation|0|||
27607312|NCT01852058|80402957|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607313|NCT01852058|80402958|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607314|NCT01852058|80402959|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607315|NCT01852058|80402960|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
27607316|NCT01852058|80402961|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27718432|NCT01394939|80802382|FG001|Overall Study|Adverse Event|3|||
27890248|NCT03214380|81434039|FG005|Lead-in|Protocol Deviation|0|||
27890249|NCT03214380|81434034|FG000|Lead-in|Withdrawal by Subject|41|||
27890250|NCT03214380|81434035|FG001|Lead-in|Withdrawal by Subject|0|||
27890251|NCT03214380|81434036|FG002|Lead-in|Withdrawal by Subject|0|||
27890252|NCT03214380|81434037|FG003|Lead-in|Withdrawal by Subject|14|||
27890253|NCT03214380|81434038|FG004|Lead-in|Withdrawal by Subject|0|||
27607317|NCT01852058|80402962|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607318|NCT01852058|80402963|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607319|NCT01852058|80402964|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607320|NCT01852058|80402965|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607321|NCT01852058|80402966|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607322|NCT01852058|80402967|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607323|NCT01852058|80402968|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
27607324|NCT01852058|80402957|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607325|NCT01852058|80402958|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607326|NCT01852058|80402959|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607327|NCT01852058|80402960|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607328|NCT01852058|80402961|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
27607329|NCT01852058|80402962|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
27607330|NCT01852058|80402963|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607331|NCT01852058|80402964|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607332|NCT01852058|80402965|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27718433|NCT01394939|80802383|FG002|Overall Study|Adverse Event|0|||
27607333|NCT01852058|80402966|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607334|NCT01852058|80402967|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607335|NCT01852058|80402968|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
27607336|NCT01852058|80402957|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607337|NCT01852058|80402958|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607338|NCT01852058|80402959|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607339|NCT01852058|80402960|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607340|NCT01852058|80402961|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607341|NCT01852058|80402962|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607342|NCT01852058|80402963|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607343|NCT01852058|80402964|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
27607344|NCT01852058|80402965|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607345|NCT01852058|80402966|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607346|NCT01852058|80402967|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607347|NCT01852058|80402968|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
27607348|NCT01852058|80402957|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607349|NCT01852058|80402958|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607350|NCT01852058|80402959|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27718434|NCT01394939|80802384|FG003|Overall Study|Adverse Event|2|||
27718435|NCT01394939|80802381|FG000|Overall Study|Death|0|||
27718436|NCT01394939|80802382|FG001|Overall Study|Death|2|||
27607351|NCT01852058|80402960|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607352|NCT01852058|80402961|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607353|NCT01852058|80402962|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607354|NCT01852058|80402963|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607355|NCT01852058|80402964|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607356|NCT01852058|80402965|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
27607357|NCT01852058|80402966|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607358|NCT01852058|80402967|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607359|NCT01852058|80402968|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
27607360|NCT04244396|80402969|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
27607361|NCT04244396|80402969|FG000|Overall Study|Withdrawal by Subject|2|||
27607362|NCT04244396|80402969|FG000|Overall Study|Study termination|37|||
27607363|NCT03342053|80402971|FG000|Overall Study|Adverse Event|2|||
27607364|NCT03342053|80402972|FG001|Overall Study|Adverse Event|0|||
27607365|NCT03342053|80402971|FG000|Overall Study|Withdrawal by Subject|0|||
27607366|NCT03342053|80402972|FG001|Overall Study|Withdrawal by Subject|1|||
27607367|NCT00882921|80402976|FG000|Overall Study|Death|2|||
27607368|NCT00882921|80402976|FG000|Overall Study|Other|3|||
27607369|NCT00882921|80402976|FG000|Overall Study|Lost to Follow-up|2|||
27607370|NCT00882921|80402976|FG000|Overall Study|Termination By Investigator|3|||
27607371|NCT00882921|80402976|FG000|Overall Study|Withdrawal Of Consent|1|||
27607372|NCT01498822|80402977|FG000|Overall Study|Protocol Violation|8|||
27607373|NCT01498822|80402978|FG001|Overall Study|Protocol Violation|4|||
27607374|NCT01498822|80402977|FG000|Overall Study|Other Reason|5|||
27607375|NCT01498822|80402978|FG001|Overall Study|Other Reason|2|||
27607376|NCT01498822|80402977|FG000|Overall Study|Lack of Efficacy|7|||
27607377|NCT01498822|80402978|FG001|Overall Study|Lack of Efficacy|2|||
27607378|NCT01498822|80402977|FG000|Overall Study|AE, non-serious non-fatal|8|||
27607379|NCT01498822|80402978|FG001|Overall Study|AE, non-serious non-fatal|17|||
27718437|NCT01394939|80802383|FG002|Overall Study|Death|0|||
27718438|NCT01394939|80802384|FG003|Overall Study|Death|0|||
27718439|NCT01394939|80802381|FG000|Overall Study|Physician Decision|0|||
27718440|NCT01394939|80802382|FG001|Overall Study|Physician Decision|1|||
27718441|NCT01394939|80802383|FG002|Overall Study|Physician Decision|0|||
27607380|NCT01498822|80402977|FG000|Overall Study|SAE, non-fatal|2|||
27607381|NCT01498822|80402978|FG001|Overall Study|SAE, non-fatal|2|||
27607382|NCT01498822|80402977|FG000|Overall Study|Adverse Event, serious fatal|1|||
27607383|NCT01498822|80402978|FG001|Overall Study|Adverse Event, serious fatal|1|||
27607384|NCT01498822|80402977|FG000|Overall Study|Withdrawal by Subject|15|||
27607385|NCT01498822|80402978|FG001|Overall Study|Withdrawal by Subject|25|||
27607386|NCT01498822|80402977|FG000|Overall Study|Lost to Follow-up|8|||
27607387|NCT01498822|80402978|FG001|Overall Study|Lost to Follow-up|3|||
27607388|NCT00744263|80402979|FG000|Overall Study|Death|3006|||
27607389|NCT00744263|80402980|FG001|Overall Study|Death|3005|||
27607390|NCT00744263|80402979|FG000|Overall Study|Lost to Follow-up|2038|||
27607391|NCT00744263|80402980|FG001|Overall Study|Lost to Follow-up|2135|||
27607392|NCT00744263|80402979|FG000|Overall Study|Withdrawal by Subject|166|||
27607393|NCT00744263|80402980|FG001|Overall Study|Withdrawal by Subject|150|||
27607394|NCT00744263|80402979|FG000|Overall Study|Physician Decision|20|||
27607395|NCT00744263|80402980|FG001|Overall Study|Physician Decision|23|||
27607396|NCT00744263|80402979|FG000|Overall Study|Protocol Violation|3|||
27607397|NCT00744263|80402980|FG001|Overall Study|Protocol Violation|5|||
27607398|NCT00744263|80402979|FG000|Overall Study|Adverse Event|1|||
27607399|NCT00744263|80402980|FG001|Overall Study|Adverse Event|0|||
27607400|NCT00744263|80402979|FG000|Overall Study|Other|2|||
27607401|NCT00744263|80402980|FG001|Overall Study|Other|2|||
27607402|NCT02002182|80402983|FG000|Overall Study|Withdraw from study|3|||
27607403|NCT02002182|80402984|FG001|Overall Study|Withdraw from study|1|||
27607404|NCT02002182|80402983|FG000|Overall Study|Health Reasons|1|||
27607405|NCT02002182|80402984|FG001|Overall Study|Health Reasons|0|||
27607406|NCT02002182|80402983|FG000|Overall Study|Death|1|||
27607407|NCT02002182|80402984|FG001|Overall Study|Death|0|||
27607408|NCT02281760|80402985|FG000|Overall Study|Withdrawal by Subject|1|||
27607409|NCT03439189|80402990|FG000|Overall Study|Protocol Violation|19|||
27607410|NCT03439189|80402990|FG000|Overall Study|Lack of Efficacy|63|||
27607411|NCT00876460|80402991|FG000|Combination Therapy Phase|Progressive disease|2|||
27607412|NCT00876460|80402992|FG001|Combination Therapy Phase|Progressive disease|3|||
27607413|NCT00876460|80402993|FG002|Combination Therapy Phase|Progressive disease|3|||
27607414|NCT00876460|80402994|FG003|Combination Therapy Phase|Progressive disease|3|||
27607415|NCT00876460|80402995|FG004|Combination Therapy Phase|Progressive disease|3|||
27607416|NCT00876460|80402996|FG005|Combination Therapy Phase|Progressive disease|1|||
27607417|NCT00876460|80402997|FG006|Combination Therapy Phase|Progressive disease|1|||
27607418|NCT00876460|80402998|FG007|Combination Therapy Phase|Progressive disease|1|||
27607419|NCT00876460|80402991|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
27607420|NCT00876460|80402992|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
27607421|NCT00876460|80402993|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
27607422|NCT00876460|80402994|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
27607423|NCT00876460|80402995|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
27607424|NCT00876460|80402996|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
27607425|NCT00876460|80402997|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
27607426|NCT00876460|80402998|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
27607427|NCT00876460|80402991|FG000|Combination Therapy Phase|Adverse Event|0|||
27607428|NCT00876460|80402992|FG001|Combination Therapy Phase|Adverse Event|2|||
27607429|NCT00876460|80402993|FG002|Combination Therapy Phase|Adverse Event|0|||
27607430|NCT00876460|80402994|FG003|Combination Therapy Phase|Adverse Event|2|||
27607431|NCT00876460|80402995|FG004|Combination Therapy Phase|Adverse Event|2|||
27607432|NCT00876460|80402996|FG005|Combination Therapy Phase|Adverse Event|0|||
27607433|NCT00876460|80402997|FG006|Combination Therapy Phase|Adverse Event|3|||
27607434|NCT00876460|80402998|FG007|Combination Therapy Phase|Adverse Event|2|||
27607435|NCT00876460|80402991|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
27607436|NCT00876460|80402992|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
27718442|NCT01394939|80802384|FG003|Overall Study|Physician Decision|0|||
27607437|NCT00876460|80402993|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
27607438|NCT00876460|80402994|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
27607439|NCT00876460|80402995|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
27607440|NCT00876460|80402996|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
27607441|NCT00876460|80402997|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
27718443|NCT01394939|80802381|FG000|Overall Study|Withdrawal by Subject|0|||
27607442|NCT00876460|80402998|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
27718444|NCT01394939|80802382|FG001|Overall Study|Withdrawal by Subject|2|||
27718445|NCT01394939|80802383|FG002|Overall Study|Withdrawal by Subject|0|||
27607443|NCT00876460|80402991|FG000|Combination Therapy Phase|Other reason not defined above|0|||
27607444|NCT00876460|80402992|FG001|Combination Therapy Phase|Other reason not defined above|0|||
27718446|NCT01394939|80802384|FG003|Overall Study|Withdrawal by Subject|2|||
27607445|NCT00876460|80402993|FG002|Combination Therapy Phase|Other reason not defined above|0|||
27607446|NCT00876460|80402994|FG003|Combination Therapy Phase|Other reason not defined above|0|||
27607447|NCT00876460|80402995|FG004|Combination Therapy Phase|Other reason not defined above|0|||
27607448|NCT00876460|80402996|FG005|Combination Therapy Phase|Other reason not defined above|0|||
27607449|NCT00876460|80402997|FG006|Combination Therapy Phase|Other reason not defined above|1|||
27607450|NCT00876460|80402998|FG007|Combination Therapy Phase|Other reason not defined above|2|||
27838446|NCT00283842|81236707|FG003|Overall Study|Lack of Efficacy|0|||
27838447|NCT00283842|81236708|FG004|Overall Study|Lack of Efficacy|3|||
27838448|NCT00283842|81236704|FG000|Overall Study|Lost to Follow-up|0|||
27838449|NCT00283842|81236705|FG001|Overall Study|Lost to Follow-up|2|||
27838450|NCT00283842|81236706|FG002|Overall Study|Lost to Follow-up|4|||
27838451|NCT00283842|81236707|FG003|Overall Study|Lost to Follow-up|1|||
27838452|NCT00283842|81236708|FG004|Overall Study|Lost to Follow-up|1|||
27838453|NCT01868243|81236709|FG000|Overall Study|Death|0|||
27838454|NCT01868243|81236710|FG001|Overall Study|Death|1|||
27838455|NCT04194151|81236711|FG000|Overall Study|Physician Decision|1|||
27838456|NCT04194151|81236712|FG001|Overall Study|Physician Decision|1|||
27838457|NCT04194151|81236713|FG002|Overall Study|Physician Decision|1|||
27838458|NCT04194151|81236714|FG003|Overall Study|Physician Decision|1|||
27838459|NCT04194151|81236715|FG004|Overall Study|Physician Decision|0|||
27838460|NCT04194151|81236716|FG005|Overall Study|Physician Decision|1|||
27838461|NCT04194151|81236711|FG000|Overall Study|Monitorization problem|0|||
27607451|NCT00876460|80402991|FG000|Combination Therapy Phase|Not treated|0|||
27607452|NCT00876460|80402992|FG001|Combination Therapy Phase|Not treated|0|||
27607453|NCT00876460|80402993|FG002|Combination Therapy Phase|Not treated|0|||
27607454|NCT00876460|80402994|FG003|Combination Therapy Phase|Not treated|0|||
27607455|NCT00876460|80402995|FG004|Combination Therapy Phase|Not treated|0|||
27607456|NCT00876460|80402996|FG005|Combination Therapy Phase|Not treated|0|||
27607457|NCT00876460|80402997|FG006|Combination Therapy Phase|Not treated|1|||
27607458|NCT00876460|80402998|FG007|Combination Therapy Phase|Not treated|0|||
27607459|NCT00876460|80402991|FG000|Mono Therapy Phase|Progressive disease|0|||
27607460|NCT00876460|80402992|FG001|Mono Therapy Phase|Progressive disease|0|||
27607461|NCT00876460|80402993|FG002|Mono Therapy Phase|Progressive disease|0|||
27607462|NCT00876460|80402994|FG003|Mono Therapy Phase|Progressive disease|0|||
27607463|NCT00876460|80402995|FG004|Mono Therapy Phase|Progressive disease|2|||
27607464|NCT00876460|80402996|FG005|Mono Therapy Phase|Progressive disease|0|||
27607465|NCT00876460|80402997|FG006|Mono Therapy Phase|Progressive disease|1|||
27607466|NCT00876460|80402998|FG007|Mono Therapy Phase|Progressive disease|3|||
27607467|NCT00876460|80402991|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
27607468|NCT00876460|80402992|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
27607469|NCT00876460|80402993|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
27607470|NCT00876460|80402994|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
27607471|NCT00876460|80402995|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
27607472|NCT00876460|80402996|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
27607473|NCT00876460|80402997|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
27607474|NCT00876460|80402998|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
27607475|NCT00876460|80402991|FG000|Mono Therapy Phase|Adverse Event|0|||
27607476|NCT00876460|80402992|FG001|Mono Therapy Phase|Adverse Event|0|||
27607477|NCT00876460|80402993|FG002|Mono Therapy Phase|Adverse Event|0|||
27607478|NCT00876460|80402994|FG003|Mono Therapy Phase|Adverse Event|1|||
27607479|NCT00876460|80402995|FG004|Mono Therapy Phase|Adverse Event|0|||
27607480|NCT00876460|80402996|FG005|Mono Therapy Phase|Adverse Event|0|||
27838462|NCT04194151|81236712|FG001|Overall Study|Monitorization problem|1|||
27838463|NCT04194151|81236713|FG002|Overall Study|Monitorization problem|0|||
27838464|NCT04194151|81236714|FG003|Overall Study|Monitorization problem|0|||
27838465|NCT04194151|81236715|FG004|Overall Study|Monitorization problem|0|||
27838466|NCT04194151|81236716|FG005|Overall Study|Monitorization problem|0|||
27838467|NCT04473326|81236718|FG000|Overall Study|Death|0|||
27838468|NCT04473326|81236719|FG001|Overall Study|Death|1|||
27838469|NCT04473326|81236718|FG000|Overall Study|Withdrawal by Subject|1|||
27838470|NCT04473326|81236719|FG001|Overall Study|Withdrawal by Subject|2|||
27838471|NCT00721955|81236722|FG000|Overall Study|Adverse Event|0|||
27838472|NCT00721955|81236723|FG001|Overall Study|Adverse Event|0|||
27838473|NCT00721955|81236724|FG002|Overall Study|Adverse Event|2|||
27838474|NCT00397254|81236726|FG000|Overall Study|Lost to Follow-up|2|||
27838475|NCT00397254|81236727|FG001|Overall Study|Lost to Follow-up|2|||
27838476|NCT01721772|81236728|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
27838477|NCT01721772|81236729|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
27838478|NCT01721772|81236728|FG000|Pre-Treatment|Poor/non-compliance|0|||
27838479|NCT01721772|81236729|FG001|Pre-Treatment|Poor/non-compliance|1|||
27838480|NCT01721772|81236728|FG000|Pre-Treatment|Participant withdrew consent|0|||
27838481|NCT01721772|81236729|FG001|Pre-Treatment|Participant withdrew consent|1|||
27838482|NCT01721772|81236728|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
27607481|NCT00876460|80402997|FG006|Mono Therapy Phase|Adverse Event|0|||
27607482|NCT00876460|80402998|FG007|Mono Therapy Phase|Adverse Event|0|||
27607483|NCT01862991|80402999|FG000|Overall Study|Lost to Follow-up|2|||
27607484|NCT01862991|80403000|FG001|Overall Study|Lost to Follow-up|1|||
27838483|NCT01721772|81236729|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
27838484|NCT01721772|81236728|FG000|Treatment|Disease progression|119|||
27838485|NCT01721772|81236729|FG001|Treatment|Disease progression|168|||
27838486|NCT01721772|81236728|FG000|Treatment|Study drug toxicity|19|||
27838487|NCT01721772|81236729|FG001|Treatment|Study drug toxicity|10|||
27838488|NCT01721772|81236728|FG000|Treatment|Adverse event unrelated to study drug|7|||
27607485|NCT01862991|80403001|FG002|Overall Study|Lost to Follow-up|1|||
27607486|NCT01862991|80402999|FG000|Overall Study|Protocol Violation|1|||
27838489|NCT01721772|81236729|FG001|Treatment|Adverse event unrelated to study drug|7|||
27838490|NCT01721772|81236728|FG000|Treatment|Maximum clinical benefit|16|||
27838491|NCT01721772|81236729|FG001|Treatment|Maximum clinical benefit|4|||
27607487|NCT01862991|80403000|FG001|Overall Study|Protocol Violation|0|||
27607488|NCT01862991|80403001|FG002|Overall Study|Protocol Violation|0|||
27607489|NCT04399356|80403002|FG000|Overall Study|Lost to Follow-up|1|||
27607490|NCT04399356|80403003|FG001|Overall Study|Lost to Follow-up|1|||
27607491|NCT04399356|80403002|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
27607492|NCT04399356|80403003|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
27607493|NCT04399356|80403002|FG000|Overall Study|Withdrawal by Subject|1|||
27607494|NCT04399356|80403003|FG001|Overall Study|Withdrawal by Subject|0|||
27607495|NCT00787319|80403007|FG000|Overall Study|Lost to Follow-up|2|||
27607496|NCT00787319|80403007|FG000|Overall Study|Withdrawal by Subject|15|||
27607497|NCT00787319|80403007|FG000|Overall Study|Adverse Event|3|||
27607498|NCT00787319|80403007|FG000|Overall Study|Objective progression or relapse|30|||
27890254|NCT03214380|81434039|FG005|Lead-in|Withdrawal by Subject|0|||
27890255|NCT03214380|81434034|FG000|Lead-in|Family Emergency|1|||
27890256|NCT03214380|81434035|FG001|Lead-in|Family Emergency|0|||
27890257|NCT03214380|81434036|FG002|Lead-in|Family Emergency|0|||
27607499|NCT00787319|80403007|FG000|Overall Study|Lack of Efficacy|1|||
27890258|NCT03214380|81434037|FG003|Lead-in|Family Emergency|0|||
27607500|NCT00787319|80403007|FG000|Overall Study|Budget exhausted/exceeded|1|||
27607501|NCT00787319|80403007|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
27607502|NCT00787319|80403007|FG000|Overall Study|No health insurance reimbursement|2|||
27607503|NCT00787319|80403007|FG000|Overall Study|Stabilized disease findings|3|||
27607504|NCT00787319|80403007|FG000|Overall Study|Inactive disease|5|||
27607505|NCT05822921|80403008|FG000|Overall Study|Lost to Follow-up|1|||
27607506|NCT05822921|80403009|FG001|Overall Study|Lost to Follow-up|1|||
27607507|NCT01782872|80403010|FG000|Overall Study|Protocol Violation|0|||
27607508|NCT01782872|80403011|FG001|Overall Study|Protocol Violation|0|||
27607509|NCT01782872|80403012|FG002|Overall Study|Protocol Violation|0|||
27607510|NCT01782872|80403013|FG003|Overall Study|Protocol Violation|1|||
27607511|NCT01782872|80403010|FG000|Overall Study|Withdrawal by Subject|0|||
27607512|NCT01782872|80403011|FG001|Overall Study|Withdrawal by Subject|1|||
27607513|NCT01782872|80403012|FG002|Overall Study|Withdrawal by Subject|0|||
27607514|NCT01782872|80403013|FG003|Overall Study|Withdrawal by Subject|0|||
27607515|NCT01446796|80403032|FG000|Overall Study|Withdrawal by Subject|1|||
27607516|NCT01446796|80403033|FG001|Overall Study|Withdrawal by Subject|0|||
27607517|NCT03391960|80403037|FG000|Overall Study|Protocol Violation|0|||
27607518|NCT03391960|80403038|FG001|Overall Study|Protocol Violation|0|||
27607519|NCT01338012|80403050|FG000|Overall Study|Death|4|||
27607520|NCT01338012|80403050|FG000|Overall Study|Study terminated|4|||
27607521|NCT04599101|80403053|FG000|Overall Study|Lost to Follow-up|5|||
27607522|NCT04599101|80403054|FG001|Overall Study|Lost to Follow-up|5|||
27607523|NCT02669095|80403055|FG000|Overall Study|Adverse Event|1|||
27607524|NCT02669095|80403056|FG001|Overall Study|Adverse Event|0|||
27607525|NCT02669095|80403055|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
27607526|NCT02669095|80403056|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27607527|NCT02669095|80403055|FG000|Overall Study|Torn Lens|0|||
27607528|NCT02669095|80403056|FG001|Overall Study|Torn Lens|1|||
27607529|NCT02669095|80403055|FG000|Overall Study|Visit 5 assessments not completed|0|||
27607530|NCT02669095|80403056|FG001|Overall Study|Visit 5 assessments not completed|1|||
27607531|NCT01862796|80403058|FG000|Overall Study|Prohibited medications|0|||
27607532|NCT01862796|80403059|FG001|Overall Study|Prohibited medications|0|||
27607533|NCT01862796|80403060|FG002|Overall Study|Prohibited medications|1|||
27607534|NCT00954733|80403063|FG000|Overall Study|blood gas machine did not work|1|||
27607535|NCT00622713|80403064|FG000|Overall Study|Adverse Event|35|||
27607536|NCT00622713|80403064|FG000|Overall Study|Administrative problems|4|||
27607537|NCT00622713|80403064|FG000|Overall Study|Withdrawal by Subject|11|||
27607538|NCT00622713|80403064|FG000|Overall Study|Lost to Follow-up|5|||
27607539|NCT00622713|80403064|FG000|Overall Study|Death|2|||
27607540|NCT00622713|80403064|FG000|Overall Study|Subject no longer required study drug|1|||
27607541|NCT00622713|80403064|FG000|Overall Study|Did not meet eligibility criteria|1|||
27607542|NCT03203694|80403065|FG000|Overall Study|Withdrawal by Subject|2|||
27607543|NCT03203694|80403066|FG001|Overall Study|Withdrawal by Subject|0|||
27718447|NCT01394939|80802381|FG000|Overall Study|Others|0|||
27718448|NCT01394939|80802382|FG001|Overall Study|Others|2|||
27718449|NCT01394939|80802383|FG002|Overall Study|Others|0|||
27718450|NCT01394939|80802384|FG003|Overall Study|Others|3|||
27718451|NCT00150592|80802385|FG000|Overall Study|Adverse Event|4|||
27718452|NCT00150592|80802386|FG001|Overall Study|Adverse Event|1|||
27718453|NCT00150592|80802385|FG000|Overall Study|Protocol Violation|1|||
27718454|NCT00150592|80802386|FG001|Overall Study|Protocol Violation|0|||
27718455|NCT00150592|80802385|FG000|Overall Study|Withdrawal by Subject|1|||
27718456|NCT00150592|80802386|FG001|Overall Study|Withdrawal by Subject|2|||
27718457|NCT00150592|80802385|FG000|Overall Study|Non-compliance|1|||
27718458|NCT00150592|80802386|FG001|Overall Study|Non-compliance|0|||
27718459|NCT03657043|80802390|FG000|Overall Study|Withdrawal by Subject|1|||
27718460|NCT03657043|80802391|FG001|Overall Study|Withdrawal by Subject|1|||
27718461|NCT03657043|80802392|FG002|Overall Study|Withdrawal by Subject|0|||
27718462|NCT03657043|80802393|FG003|Overall Study|Withdrawal by Subject|0|||
27718463|NCT03657043|80802394|FG004|Overall Study|Withdrawal by Subject|4|||
27718464|NCT03657043|80802390|FG000|Overall Study|Study closure by Sponsor|0|||
27718465|NCT03657043|80802391|FG001|Overall Study|Study closure by Sponsor|2|||
27718466|NCT03657043|80802392|FG002|Overall Study|Study closure by Sponsor|0|||
27607544|NCT03203694|80403067|FG002|Overall Study|Withdrawal by Subject|0|||
27607545|NCT03203694|80403068|FG003|Overall Study|Withdrawal by Subject|0|||
27607546|NCT03203694|80403069|FG004|Overall Study|Withdrawal by Subject|0|||
27607547|NCT03203694|80403070|FG005|Overall Study|Withdrawal by Subject|0|||
27607548|NCT01845974|80405739|FG000|Overall Study|screen failure|1|||
27607549|NCT01845974|80405740|FG001|Overall Study|screen failure|0|||
27607550|NCT04250337|80405742|FG000|Overall Study|Adverse Event|0|||
27607551|NCT04250337|80405743|FG001|Overall Study|Adverse Event|3|||
27607552|NCT04250337|80405742|FG000|Overall Study|Lack of Efficacy|1|||
27607553|NCT04250337|80405743|FG001|Overall Study|Lack of Efficacy|3|||
27718467|NCT03657043|80802393|FG003|Overall Study|Study closure by Sponsor|0|||
27718468|NCT03657043|80802394|FG004|Overall Study|Study closure by Sponsor|17|||
27718469|NCT03657043|80802390|FG000|Overall Study|Lost to Follow-up|0|||
27718470|NCT03657043|80802391|FG001|Overall Study|Lost to Follow-up|0|||
27718471|NCT03657043|80802392|FG002|Overall Study|Lost to Follow-up|0|||
27718472|NCT03657043|80802393|FG003|Overall Study|Lost to Follow-up|0|||
27718473|NCT03657043|80802394|FG004|Overall Study|Lost to Follow-up|4|||
27718474|NCT03657043|80802390|FG000|Overall Study|Death|6|||
27718475|NCT03657043|80802391|FG001|Overall Study|Death|5|||
27718476|NCT03657043|80802392|FG002|Overall Study|Death|0|||
27718477|NCT03657043|80802393|FG003|Overall Study|Death|0|||
27718478|NCT03657043|80802394|FG004|Overall Study|Death|53|||
27718479|NCT03657043|80802390|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
27718480|NCT03657043|80802391|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
27718481|NCT03657043|80802392|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
27718482|NCT03657043|80802393|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
27718483|NCT03657043|80802394|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
27718484|NCT03657043|80802390|FG000|Overall Study|Adverse Event|0|||
27718485|NCT03657043|80802391|FG001|Overall Study|Adverse Event|0|||
27718486|NCT03657043|80802392|FG002|Overall Study|Adverse Event|0|||
27718487|NCT03657043|80802393|FG003|Overall Study|Adverse Event|0|||
27718488|NCT03657043|80802394|FG004|Overall Study|Adverse Event|2|||
27718489|NCT03657043|80802390|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
27718490|NCT03657043|80802391|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
27718491|NCT03657043|80802392|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
27718492|NCT03657043|80802393|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
27718493|NCT03657043|80802394|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
27718494|NCT03657043|80802390|FG000|Overall Study|Withdrawal - declined follow-up|0|||
27718495|NCT03657043|80802391|FG001|Overall Study|Withdrawal - declined follow-up|0|||
27718496|NCT03657043|80802392|FG002|Overall Study|Withdrawal - declined follow-up|0|||
27718497|NCT03657043|80802393|FG003|Overall Study|Withdrawal - declined follow-up|0|||
27718498|NCT03657043|80802394|FG004|Overall Study|Withdrawal - declined follow-up|1|||
27718499|NCT03847987|80802395|FG000|Overall Study|Lost to Follow-up|1|||
27718500|NCT03847987|80802396|FG001|Overall Study|Lost to Follow-up|0|||
27718501|NCT03847987|80802395|FG000|Overall Study|Adverse Event|2|||
27718502|NCT03847987|80802396|FG001|Overall Study|Adverse Event|0|||
27718503|NCT01273883|80802397|FG000|First Intervention|Adverse Event|2|||
27718504|NCT01273883|80802398|FG001|First Intervention|Adverse Event|1|||
27838492|NCT01721772|81236728|FG000|Treatment|Other|19|||
27838493|NCT01721772|81236729|FG001|Treatment|Other|2|||
27838494|NCT01721772|81236728|FG000|Treatment|Participant withdrew consent|2|||
27838495|NCT01721772|81236729|FG001|Treatment|Participant withdrew consent|5|||
27838496|NCT01721772|81236728|FG000|Treatment|Participant request to discontinue study treatment|21|||
27838497|NCT01721772|81236729|FG001|Treatment|Participant request to discontinue study treatment|8|||
27838498|NCT01721772|81236728|FG000|Treatment|Death|1|||
27838499|NCT01721772|81236729|FG001|Treatment|Death|0|||
27838500|NCT01721772|81236728|FG000|Treatment|Not reported|1|||
27838501|NCT01721772|81236729|FG001|Treatment|Not reported|0|||
27838502|NCT01721772|81236728|FG000|Treatment|Poor/non-compliance|1|||
27838503|NCT01721772|81236729|FG001|Treatment|Poor/non-compliance|0|||
27838504|NCT01721772|81236728|FG000|Treatment|Lost to Follow-up|0|||
27838505|NCT01721772|81236729|FG001|Treatment|Lost to Follow-up|1|||
27838506|NCT02416934|81236731|FG000|Overall Study|given steroids|1|||
27607554|NCT04250337|80405742|FG000|Overall Study|Physician Decision|1|||
27718505|NCT01273883|80802397|FG000|Second Intervention|Lost to Follow-up|1|||
27718506|NCT01273883|80802398|FG001|Second Intervention|Lost to Follow-up|1|||
27718507|NCT01273883|80802397|FG000|Second Intervention|Lack of Efficacy|1|||
27838507|NCT02416934|81236732|FG001|Overall Study|given steroids|2|||
27718508|NCT01273883|80802398|FG001|Second Intervention|Lack of Efficacy|0|||
27718509|NCT01411085|80802399|FG000|Overall Study|Physician Decision|1|||
27718510|NCT01411085|80802399|FG000|Overall Study|Protocol Violation|1|||
27718511|NCT01411085|80802399|FG000|Overall Study|Adverse Event|1|||
27838508|NCT02416934|81236731|FG000|Overall Study|Lost to Follow-up|0|||
27838509|NCT02416934|81236732|FG001|Overall Study|Lost to Follow-up|2|||
27838510|NCT02416934|81236731|FG000|Overall Study|Withdrawal by Subject|1|||
27607555|NCT04250337|80405743|FG001|Overall Study|Physician Decision|0|||
27607556|NCT04250337|80405742|FG000|Overall Study|Protocol Deviation|2|||
27607557|NCT04250337|80405743|FG001|Overall Study|Protocol Deviation|2|||
27607558|NCT04250337|80405742|FG000|Overall Study|Withdrawal by Subject|4|||
27607559|NCT04250337|80405743|FG001|Overall Study|Withdrawal by Subject|3|||
27607560|NCT02344537|80405744|FG000|Overall Study|Protocol Violation|1|||
27607561|NCT02344537|80405745|FG001|Overall Study|Protocol Violation|1|||
27607562|NCT02344537|80405744|FG000|Overall Study|Subject started another treatment after wk 6|1|||
27607563|NCT02344537|80405745|FG001|Overall Study|Subject started another treatment after wk 6|0|||
27607564|NCT02344537|80405744|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
27607565|NCT02344537|80405745|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
27607566|NCT01975220|80405746|FG000|Test Period 1|Not treated|0|||
27607567|NCT01975220|80405747|FG001|Test Period 1|Not treated|1|||
27607568|NCT01975220|80405748|FG002|Test Period 1|Not treated|0|||
27607569|NCT01975220|80405749|FG003|Test Period 1|Not treated|0|||
27607570|NCT01975220|80405750|FG004|Test Period 1|Not treated|0|||
27607571|NCT01975220|80405751|FG005|Test Period 1|Not treated|0|||
27607572|NCT02798211|80405752|FG000|Period 1|Adverse Event|1|||
27607573|NCT02798211|80405753|FG001|Period 1|Adverse Event|1|||
27607574|NCT02798211|80405754|FG002|Period 1|Adverse Event|0|||
27607575|NCT02798211|80405755|FG003|Period 1|Adverse Event|0|||
27607576|NCT02798211|80405756|FG004|Period 1|Adverse Event|0|||
27607577|NCT02798211|80405757|FG005|Period 1|Adverse Event|0|||
27607578|NCT02798211|80405752|FG000|Period 1|Lost to Follow-up|2|||
27607579|NCT02798211|80405753|FG001|Period 1|Lost to Follow-up|1|||
27607580|NCT02798211|80405754|FG002|Period 1|Lost to Follow-up|0|||
27607581|NCT02798211|80405755|FG003|Period 1|Lost to Follow-up|0|||
27607582|NCT02798211|80405756|FG004|Period 1|Lost to Follow-up|0|||
27607583|NCT02798211|80405757|FG005|Period 1|Lost to Follow-up|0|||
27607584|NCT02798211|80405752|FG000|Period 1|Protocol Violation|0|||
27607585|NCT02798211|80405753|FG001|Period 1|Protocol Violation|0|||
27607586|NCT02798211|80405754|FG002|Period 1|Protocol Violation|2|||
27607587|NCT02798211|80405755|FG003|Period 1|Protocol Violation|0|||
27607588|NCT02798211|80405756|FG004|Period 1|Protocol Violation|0|||
27607589|NCT02798211|80405757|FG005|Period 1|Protocol Violation|0|||
27607590|NCT02798211|80405752|FG000|Period 1|Withdrawal by Subject|1|||
27607591|NCT02798211|80405753|FG001|Period 1|Withdrawal by Subject|1|||
27607592|NCT02798211|80405754|FG002|Period 1|Withdrawal by Subject|0|||
27607593|NCT02798211|80405755|FG003|Period 1|Withdrawal by Subject|0|||
27607594|NCT02798211|80405756|FG004|Period 1|Withdrawal by Subject|0|||
27607595|NCT02798211|80405757|FG005|Period 1|Withdrawal by Subject|0|||
27607596|NCT02798211|80405752|FG000|Period 1|Death|0|||
27607597|NCT02798211|80405753|FG001|Period 1|Death|0|||
27607598|NCT02798211|80405754|FG002|Period 1|Death|1|||
27607599|NCT02798211|80405755|FG003|Period 1|Death|0|||
27607600|NCT02798211|80405756|FG004|Period 1|Death|0|||
27607601|NCT02798211|80405757|FG005|Period 1|Death|0|||
27607602|NCT02798211|80405752|FG000|Period 1|Withdrawal of Informed Consent|2|||
27607603|NCT02798211|80405753|FG001|Period 1|Withdrawal of Informed Consent|7|||
27607604|NCT02798211|80405754|FG002|Period 1|Withdrawal of Informed Consent|3|||
27607605|NCT02798211|80405755|FG003|Period 1|Withdrawal of Informed Consent|0|||
27607606|NCT02798211|80405756|FG004|Period 1|Withdrawal of Informed Consent|0|||
27607607|NCT02798211|80405757|FG005|Period 1|Withdrawal of Informed Consent|0|||
27607608|NCT02798211|80405752|FG000|Period 2|Withdrawal by Subject|2|||
27607609|NCT02798211|80405753|FG001|Period 2|Withdrawal by Subject|0|||
27607610|NCT02798211|80405754|FG002|Period 2|Withdrawal by Subject|0|||
27607611|NCT02798211|80405755|FG003|Period 2|Withdrawal by Subject|0|||
27607612|NCT02798211|80405756|FG004|Period 2|Withdrawal by Subject|2|||
27607613|NCT02798211|80405757|FG005|Period 2|Withdrawal by Subject|2|||
27607614|NCT02798211|80405752|FG000|Period 2|Adverse Event|5|||
27607615|NCT02798211|80405753|FG001|Period 2|Adverse Event|0|||
27607616|NCT02798211|80405754|FG002|Period 2|Adverse Event|0|||
27607617|NCT02798211|80405755|FG003|Period 2|Adverse Event|0|||
27607618|NCT02798211|80405756|FG004|Period 2|Adverse Event|1|||
27607619|NCT02798211|80405757|FG005|Period 2|Adverse Event|0|||
27607620|NCT02798211|80405752|FG000|Period 2|Lack of Efficacy|1|||
27607621|NCT02798211|80405753|FG001|Period 2|Lack of Efficacy|0|||
27607622|NCT02798211|80405754|FG002|Period 2|Lack of Efficacy|0|||
27607623|NCT02798211|80405755|FG003|Period 2|Lack of Efficacy|1|||
27607624|NCT02798211|80405756|FG004|Period 2|Lack of Efficacy|0|||
27607625|NCT02798211|80405757|FG005|Period 2|Lack of Efficacy|1|||
27607626|NCT02798211|80405752|FG000|Period 2|Lost to Follow-up|3|||
27607627|NCT02798211|80405753|FG001|Period 2|Lost to Follow-up|0|||
27607628|NCT02798211|80405754|FG002|Period 2|Lost to Follow-up|0|||
27607629|NCT02798211|80405755|FG003|Period 2|Lost to Follow-up|0|||
27607630|NCT02798211|80405756|FG004|Period 2|Lost to Follow-up|2|||
27607631|NCT02798211|80405757|FG005|Period 2|Lost to Follow-up|0|||
27607632|NCT02798211|80405752|FG000|Period 2|Physician Decision|1|||
27607633|NCT02798211|80405753|FG001|Period 2|Physician Decision|0|||
27607634|NCT02798211|80405754|FG002|Period 2|Physician Decision|0|||
27607635|NCT02798211|80405755|FG003|Period 2|Physician Decision|1|||
27607636|NCT02798211|80405756|FG004|Period 2|Physician Decision|1|||
27890259|NCT03214380|81434038|FG004|Lead-in|Family Emergency|0|||
27890260|NCT03214380|81434039|FG005|Lead-in|Family Emergency|0|||
27890261|NCT03214380|81434034|FG000|Lead-in|Natural Disaster|9|||
27890262|NCT03214380|81434035|FG001|Lead-in|Natural Disaster|0|||
27890263|NCT03214380|81434036|FG002|Lead-in|Natural Disaster|0|||
27607637|NCT02798211|80405757|FG005|Period 2|Physician Decision|0|||
27607638|NCT02798211|80405752|FG000|Period 2|Pregnancy|0|||
27607639|NCT02798211|80405753|FG001|Period 2|Pregnancy|0|||
27607640|NCT02798211|80405754|FG002|Period 2|Pregnancy|0|||
27607641|NCT02798211|80405755|FG003|Period 2|Pregnancy|2|||
27607642|NCT02798211|80405756|FG004|Period 2|Pregnancy|0|||
27607643|NCT02798211|80405757|FG005|Period 2|Pregnancy|0|||
27607644|NCT02798211|80405752|FG000|Period 2|Technical problems|1|||
27607645|NCT02798211|80405753|FG001|Period 2|Technical problems|0|||
27890264|NCT03214380|81434037|FG003|Lead-in|Natural Disaster|0|||
27607646|NCT02798211|80405754|FG002|Period 2|Technical problems|0|||
27718512|NCT00159861|80802400|FG000|Core Study - 16 Weeks|Death|3|||
27718513|NCT00159861|80802401|FG001|Core Study - 16 Weeks|Death|0|||
27718514|NCT00159861|80802400|FG000|Core Study - 16 Weeks|Adverse Event|12|||
27718515|NCT00159861|80802401|FG001|Core Study - 16 Weeks|Adverse Event|6|||
27718516|NCT00159861|80802400|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
27718517|NCT00159861|80802401|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
27718518|NCT00159861|80802400|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
27718519|NCT00159861|80802401|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
27718520|NCT00159861|80802400|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
27718521|NCT00159861|80802401|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
27718522|NCT00159861|80802400|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
27718523|NCT00159861|80802401|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
27718524|NCT00159861|80802400|FG000|Extension Study - up to 3 Years|Death|24|||
27718525|NCT00159861|80802401|FG001|Extension Study - up to 3 Years|Death|28|||
27718526|NCT00159861|80802400|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
27718527|NCT00159861|80802401|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
27718528|NCT00159861|80802400|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
27718529|NCT00159861|80802401|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
27718530|NCT00159861|80802400|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
27718531|NCT00159861|80802401|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
27718532|NCT00159861|80802400|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
27718533|NCT00159861|80802401|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
27718534|NCT00516737|80802406|FG000|Overall Study|Lost to Follow-up|2|||
27718535|NCT00516737|80802407|FG001|Overall Study|Lost to Follow-up|0|||
27718536|NCT00516737|80802406|FG000|Overall Study|Physician Decision|0|||
27718537|NCT00516737|80802407|FG001|Overall Study|Physician Decision|1|||
27718538|NCT00516737|80802406|FG000|Overall Study|Withdrawal by Subject|0|||
27718539|NCT00516737|80802407|FG001|Overall Study|Withdrawal by Subject|1|||
27890265|NCT03214380|81434038|FG004|Lead-in|Natural Disaster|0|||
27890266|NCT03214380|81434039|FG005|Lead-in|Natural Disaster|0|||
27718540|NCT00516737|80802406|FG000|Overall Study|Lack of Qualifying Event|9|||
27718541|NCT00516737|80802407|FG001|Overall Study|Lack of Qualifying Event|6|||
27718542|NCT00623480|80802408|FG000|Overall Study|Lost to Follow-up|0|||
27718543|NCT00623480|80802409|FG001|Overall Study|Lost to Follow-up|1|||
27718544|NCT00623480|80802408|FG000|Overall Study|Withdrawal by Subject|2|||
27718545|NCT00623480|80802409|FG001|Overall Study|Withdrawal by Subject|4|||
27718546|NCT00623480|80802408|FG000|Overall Study|Lack of Efficacy|1|||
27718547|NCT00623480|80802409|FG001|Overall Study|Lack of Efficacy|0|||
27718548|NCT00623480|80802408|FG000|Overall Study|Non-compliant with study medication|4|||
27718549|NCT00623480|80802409|FG001|Overall Study|Non-compliant with study medication|0|||
27718550|NCT00623480|80802408|FG000|Overall Study|Protocol Violation|0|||
27718551|NCT00623480|80802409|FG001|Overall Study|Protocol Violation|1|||
27718552|NCT00623480|80802408|FG000|Overall Study|Site closed by sponsor|0|||
27718553|NCT00623480|80802409|FG001|Overall Study|Site closed by sponsor|1|||
27718554|NCT02926209|80802410|FG000|Study Cohort|Poor Bowel Preparation|1|||
27718555|NCT02926209|80802411|FG001|Study Cohort|Poor Bowel Preparation|0|||
27718556|NCT00243659|80802412|FG000|Overall Study|Withdrawal by Subject|1|||
27718557|NCT00243659|80802413|FG001|Overall Study|Withdrawal by Subject|1|||
27718558|NCT00243659|80802412|FG000|Overall Study|Protocol Violation|1|||
27718559|NCT00243659|80802413|FG001|Overall Study|Protocol Violation|2|||
27718560|NCT00490568|80802414|FG000|Overall Study|Adverse Event|116|||
27718561|NCT00490568|80802414|FG000|Overall Study|Lost to Follow-up|13|||
27718562|NCT00490568|80802414|FG000|Overall Study|Protocol Violation|45|||
27718563|NCT00490568|80802414|FG000|Overall Study|Withdrawal by Subject|135|||
27718564|NCT00490568|80802414|FG000|Overall Study|Still in the study at termination|974|||
27718565|NCT00490568|80802414|FG000|Overall Study|Other|1|||
27718566|NCT00490568|80802414|FG000|Overall Study|Exclusion criteria met|1|||
27718567|NCT00490568|80802414|FG000|Overall Study|Caregiver related|20|||
27718568|NCT00490568|80802414|FG000|Overall Study|Abnormal ECG|25|||
27718569|NCT00490568|80802414|FG000|Overall Study|Participant refused follow-up|9|||
27718570|NCT00490568|80802414|FG000|Overall Study|Legal representative withdrew consent|1|||
27718571|NCT00490568|80802414|FG000|Overall Study|Disease progression|4|||
27718572|NCT00490568|80802414|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
27718573|NCT00490568|80802414|FG000|Overall Study|Investigator decision|3|||
27718574|NCT00490568|80802414|FG000|Overall Study|Non-Compliance|7|||
27718575|NCT00490568|80802414|FG000|Overall Study|Efficacy related|3|||
27718576|NCT00490568|80802414|FG000|Overall Study|Participant died|1|||
27718577|NCT00490568|80802414|FG000|Overall Study|Participant withdrawal due to surgery|1|||
27718578|NCT01425203|80802415|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
27718579|NCT01425203|80802416|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
27838511|NCT02416934|81236732|FG001|Overall Study|Withdrawal by Subject|0|||
27838512|NCT02416934|81236731|FG000|Overall Study|recruited during continuing renewal proc|0|||
27838513|NCT02416934|81236732|FG001|Overall Study|recruited during continuing renewal proc|1|||
27838514|NCT02416934|81236731|FG000|Overall Study|Protocol Violation|0|||
27838515|NCT02416934|81236732|FG001|Overall Study|Protocol Violation|1|||
27838516|NCT02416934|81236731|FG000|Overall Study|surgery started late|0|||
27838517|NCT02416934|81236732|FG001|Overall Study|surgery started late|1|||
27838518|NCT02416934|81236731|FG000|Overall Study|re-operation|1|||
27838519|NCT02416934|81236732|FG001|Overall Study|re-operation|0|||
27838520|NCT00090753|81236733|FG000|First Treatment Period|Adverse Event|20|||
27838521|NCT00090753|81236734|FG001|First Treatment Period|Adverse Event|8|||
27838522|NCT00090753|81236733|FG000|First Treatment Period|Death|88|||
27838523|NCT00090753|81236734|FG001|First Treatment Period|Death|62|||
27838524|NCT00090753|81236733|FG000|First Treatment Period|Lack of Efficacy|2|||
27838525|NCT00090753|81236734|FG001|First Treatment Period|Lack of Efficacy|1|||
27838526|NCT00090753|81236733|FG000|First Treatment Period|Refused Treatment|32|||
27838527|NCT00090753|81236734|FG001|First Treatment Period|Refused Treatment|25|||
27838528|NCT00090753|81236733|FG000|First Treatment Period|Lost to Follow-up|4|||
27838529|NCT00090753|81236734|FG001|First Treatment Period|Lost to Follow-up|4|||
27838530|NCT00090753|81236733|FG000|First Treatment Period|Renal Transplant|70|||
27838531|NCT00090753|81236734|FG001|First Treatment Period|Renal Transplant|50|||
27718580|NCT01425203|80802417|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
27718581|NCT01425203|80802415|FG000|Treatment Phase|Failure at futility timepoint|8|||
27718582|NCT01425203|80802416|FG001|Treatment Phase|Failure at futility timepoint|27|||
27718583|NCT01425203|80802417|FG002|Treatment Phase|Failure at futility timepoint|0|||
27718584|NCT01425203|80802415|FG000|Treatment Phase|Other virologic failure criteria|5|||
27718585|NCT01425203|80802416|FG001|Treatment Phase|Other virologic failure criteria|3|||
27718586|NCT01425203|80802417|FG002|Treatment Phase|Other virologic failure criteria|0|||
27718587|NCT01425203|80802415|FG000|Treatment Phase|Unidentified reasons|11|||
27838532|NCT00090753|81236733|FG000|First Treatment Period|Mircera Commercialization|1|||
27838533|NCT00090753|81236734|FG001|First Treatment Period|Mircera Commercialization|0|||
27838534|NCT00090753|81236733|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
27838535|NCT00090753|81236734|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
27838536|NCT00090753|81236733|FG000|Extended Treatment Period|Adverse Event|11|||
27838537|NCT00090753|81236734|FG001|Extended Treatment Period|Adverse Event|0|||
27718588|NCT01425203|80802416|FG001|Treatment Phase|Unidentified reasons|5|||
27718589|NCT01425203|80802417|FG002|Treatment Phase|Unidentified reasons|0|||
27718590|NCT01425203|80802415|FG000|Treatment Phase|Did not receive treatment|0|||
27718591|NCT01425203|80802416|FG001|Treatment Phase|Did not receive treatment|1|||
27718592|NCT01425203|80802417|FG002|Treatment Phase|Did not receive treatment|0|||
27718593|NCT01425203|80802415|FG000|Crossover Phase|Failure at futility timepoint|0|||
27718594|NCT01425203|80802416|FG001|Crossover Phase|Failure at futility timepoint|0|||
27718595|NCT01425203|80802417|FG002|Crossover Phase|Failure at futility timepoint|3|||
27718596|NCT01425203|80802415|FG000|Crossover Phase|Other virologic failure criteria|0|||
27718597|NCT01425203|80802416|FG001|Crossover Phase|Other virologic failure criteria|0|||
27718598|NCT01425203|80802417|FG002|Crossover Phase|Other virologic failure criteria|3|||
27718599|NCT00506883|80802418|FG000|Overall Study|Lost to Follow-up|1|||
27718600|NCT00506883|80802419|FG001|Overall Study|Lost to Follow-up|1|||
27718601|NCT00506883|80802420|FG002|Overall Study|Lost to Follow-up|1|||
27718602|NCT00506883|80802418|FG000|Overall Study|Withdrawal by Subject|1|||
27718603|NCT00506883|80802419|FG001|Overall Study|Withdrawal by Subject|0|||
27718604|NCT00506883|80802420|FG002|Overall Study|Withdrawal by Subject|1|||
27718605|NCT00506883|80802418|FG000|Overall Study|Lack of Efficacy|0|||
27718606|NCT00506883|80802419|FG001|Overall Study|Lack of Efficacy|1|||
27718607|NCT00506883|80802420|FG002|Overall Study|Lack of Efficacy|1|||
27718608|NCT00506883|80802418|FG000|Overall Study|Other|5|||
27718609|NCT00506883|80802419|FG001|Overall Study|Other|1|||
27718610|NCT00506883|80802420|FG002|Overall Study|Other|1|||
27718611|NCT03847610|80802421|FG000|Overall Study|Withdrawal by Subject|1|||
27718612|NCT03273166|80802423|FG000|Overall Study|Withdrawn prior to Completion|31|||
27718613|NCT00993031|80802424|FG000|Overall Study|Death|0|||
27718614|NCT00993031|80802425|FG001|Overall Study|Death|1|||
27718615|NCT00993031|80802424|FG000|Overall Study|Physician Decision|0|||
27718616|NCT00993031|80802425|FG001|Overall Study|Physician Decision|2|||
27718617|NCT00993031|80802424|FG000|Overall Study|Withdrawal by Subject|3|||
27718618|NCT00993031|80802425|FG001|Overall Study|Withdrawal by Subject|3|||
27718619|NCT00993031|80802424|FG000|Overall Study|Lost to Follow-up|19|||
27718620|NCT00993031|80802425|FG001|Overall Study|Lost to Follow-up|13|||
27718621|NCT02447848|80802426|FG000|Overall Study|Patient discharged|3|||
27718622|NCT02447848|80802426|FG000|Overall Study|Lack of Efficacy|4|||
27718623|NCT02447848|80802426|FG000|Overall Study|Withdrawal by Subject|4|||
27718624|NCT01375764|80802431|FG000|Overall Study|Lost to Follow-up|0|||
27718625|NCT01375764|80802432|FG001|Overall Study|Lost to Follow-up|1|||
27718626|NCT01375764|80802433|FG002|Overall Study|Lost to Follow-up|0|||
27718627|NCT01375764|80802434|FG003|Overall Study|Lost to Follow-up|0|||
27718628|NCT01375764|80802435|FG004|Overall Study|Lost to Follow-up|0|||
27718629|NCT01375764|80802431|FG000|Overall Study|Withdrawal by Subject|2|||
27718630|NCT01375764|80802432|FG001|Overall Study|Withdrawal by Subject|0|||
27718631|NCT01375764|80802433|FG002|Overall Study|Withdrawal by Subject|0|||
27718632|NCT01375764|80802434|FG003|Overall Study|Withdrawal by Subject|0|||
27718633|NCT01375764|80802435|FG004|Overall Study|Withdrawal by Subject|1|||
27718634|NCT01375764|80802431|FG000|Overall Study|Other|0|||
27718635|NCT01375764|80802432|FG001|Overall Study|Other|0|||
27718636|NCT01375764|80802433|FG002|Overall Study|Other|0|||
27718637|NCT01375764|80802434|FG003|Overall Study|Other|1|||
27718638|NCT01375764|80802435|FG004|Overall Study|Other|0|||
27718639|NCT03804684|80802436|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
27718640|NCT03804684|80802437|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
27718641|NCT01784861|80802438|FG000|Overall Study|Adverse Event|0|||
27718642|NCT01784861|80802439|FG001|Overall Study|Adverse Event|0|||
27718643|NCT01784861|80802440|FG002|Overall Study|Adverse Event|1|||
27718644|NCT01784861|80802441|FG003|Overall Study|Adverse Event|2|||
27718645|NCT01784861|80802442|FG004|Overall Study|Adverse Event|1|||
27718646|NCT01784861|80802443|FG005|Overall Study|Adverse Event|0|||
27718647|NCT01784861|80802438|FG000|Overall Study|Withdrawal by Subject|0|||
27718648|NCT01784861|80802439|FG001|Overall Study|Withdrawal by Subject|0|||
27718649|NCT01784861|80802440|FG002|Overall Study|Withdrawal by Subject|0|||
27718650|NCT01784861|80802441|FG003|Overall Study|Withdrawal by Subject|1|||
27838538|NCT00090753|81236733|FG000|Extended Treatment Period|Death|58|||
27718651|NCT01784861|80802442|FG004|Overall Study|Withdrawal by Subject|0|||
27718652|NCT01784861|80802443|FG005|Overall Study|Withdrawal by Subject|0|||
27718653|NCT01784861|80802438|FG000|Overall Study|Physician Decision|0|||
27718654|NCT01784861|80802439|FG001|Overall Study|Physician Decision|0|||
27718655|NCT01784861|80802440|FG002|Overall Study|Physician Decision|0|||
27718656|NCT01784861|80802441|FG003|Overall Study|Physician Decision|2|||
27718657|NCT01784861|80802442|FG004|Overall Study|Physician Decision|0|||
27718658|NCT01784861|80802443|FG005|Overall Study|Physician Decision|1|||
27718659|NCT02531646|80802446|FG000|Overall Study|equip. image processing issue|5|||
27718660|NCT02531646|80802447|FG001|Overall Study|equip. image processing issue|1|||
27718661|NCT02531646|80802448|FG002|Overall Study|equip. image processing issue|0|||
27718662|NCT01192022|80802453|FG000|Overall Study|Withdrawal of Consent|3|||
27718663|NCT01192022|80802454|FG001|Overall Study|Withdrawal of Consent|1|||
27718664|NCT01192022|80802455|FG002|Overall Study|Withdrawal of Consent|0|||
27718665|NCT01192022|80802456|FG003|Overall Study|Withdrawal of Consent|0|||
27718666|NCT01192022|80802457|FG004|Overall Study|Withdrawal of Consent|0|||
27718667|NCT01192022|80802453|FG000|Overall Study|Lost to Follow-up|4|||
27718668|NCT01192022|80802454|FG001|Overall Study|Lost to Follow-up|2|||
27718669|NCT01192022|80802455|FG002|Overall Study|Lost to Follow-up|1|||
27718670|NCT01192022|80802456|FG003|Overall Study|Lost to Follow-up|1|||
27718671|NCT01192022|80802457|FG004|Overall Study|Lost to Follow-up|0|||
27718672|NCT01192022|80802453|FG000|Overall Study|Adverse Event|1|||
27718673|NCT01192022|80802454|FG001|Overall Study|Adverse Event|0|||
27718674|NCT01192022|80802455|FG002|Overall Study|Adverse Event|0|||
27718675|NCT01192022|80802456|FG003|Overall Study|Adverse Event|0|||
27718676|NCT01192022|80802457|FG004|Overall Study|Adverse Event|0|||
27718677|NCT01192022|80802453|FG000|Overall Study|Fatal Adverse Event|4|||
27718678|NCT01192022|80802454|FG001|Overall Study|Fatal Adverse Event|6|||
27718679|NCT01192022|80802455|FG002|Overall Study|Fatal Adverse Event|0|||
27718680|NCT01192022|80802456|FG003|Overall Study|Fatal Adverse Event|0|||
27718681|NCT01192022|80802457|FG004|Overall Study|Fatal Adverse Event|1|||
27718682|NCT01192022|80802453|FG000|Overall Study|Physician withdrew-patient hardship|1|||
27718683|NCT01192022|80802454|FG001|Overall Study|Physician withdrew-patient hardship|0|||
27718684|NCT01192022|80802455|FG002|Overall Study|Physician withdrew-patient hardship|0|||
27718685|NCT01192022|80802456|FG003|Overall Study|Physician withdrew-patient hardship|0|||
27718686|NCT01192022|80802457|FG004|Overall Study|Physician withdrew-patient hardship|0|||
27718687|NCT01192022|80802453|FG000|Overall Study|Patient too sick from chemotherapy|0|||
27718688|NCT01192022|80802454|FG001|Overall Study|Patient too sick from chemotherapy|1|||
27718689|NCT01192022|80802455|FG002|Overall Study|Patient too sick from chemotherapy|0|||
27718690|NCT01192022|80802456|FG003|Overall Study|Patient too sick from chemotherapy|0|||
27718691|NCT01192022|80802457|FG004|Overall Study|Patient too sick from chemotherapy|0|||
27718692|NCT01192022|80802453|FG000|Overall Study|Patient needed surgery|0|||
27718693|NCT01192022|80802454|FG001|Overall Study|Patient needed surgery|1|||
27718694|NCT01192022|80802455|FG002|Overall Study|Patient needed surgery|0|||
27718695|NCT01192022|80802456|FG003|Overall Study|Patient needed surgery|0|||
27718696|NCT01192022|80802457|FG004|Overall Study|Patient needed surgery|0|||
27718697|NCT01192022|80802453|FG000|Overall Study|Parents did not allow all follow up|0|||
27718698|NCT01192022|80802454|FG001|Overall Study|Parents did not allow all follow up|0|||
27718699|NCT01192022|80802455|FG002|Overall Study|Parents did not allow all follow up|0|||
27718700|NCT01192022|80802456|FG003|Overall Study|Parents did not allow all follow up|1|||
27754863|NCT02065622|80929633|FG003|Induction Study|Adverse Event|0|||
27838539|NCT00090753|81236734|FG001|Extended Treatment Period|Death|30|||
27838540|NCT00090753|81236733|FG000|Extended Treatment Period|Lack of Efficacy|1|||
27838541|NCT00090753|81236734|FG001|Extended Treatment Period|Lack of Efficacy|0|||
27838542|NCT00090753|81236733|FG000|Extended Treatment Period|Refused Treatment|18|||
27607647|NCT02798211|80405755|FG003|Period 2|Technical problems|1|||
27838543|NCT00090753|81236734|FG001|Extended Treatment Period|Refused Treatment|12|||
27838544|NCT00090753|81236733|FG000|Extended Treatment Period|Lost to Follow-up|3|||
27838545|NCT00090753|81236734|FG001|Extended Treatment Period|Lost to Follow-up|1|||
27838546|NCT00090753|81236733|FG000|Extended Treatment Period|Renal Transplant|15|||
27838547|NCT00090753|81236734|FG001|Extended Treatment Period|Renal Transplant|12|||
27838548|NCT00090753|81236733|FG000|Extended Treatment Period|Mircera Commercialization|188|||
27607648|NCT02798211|80405756|FG004|Period 2|Technical problems|0|||
27838549|NCT00090753|81236734|FG001|Extended Treatment Period|Mircera Commercialization|93|||
27607649|NCT02798211|80405757|FG005|Period 2|Technical problems|0|||
27838550|NCT00090753|81236733|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
27607650|NCT02798211|80405752|FG000|Period 2|Withdrawal of Informed Consent|1|||
27718701|NCT01192022|80802457|FG004|Overall Study|Parents did not allow all follow up|0|||
27718702|NCT01736579|80802459|FG000|Overall Study|Termination of Study by Sponsor|2|||
27718703|NCT01736579|80802460|FG001|Overall Study|Termination of Study by Sponsor|2|||
27718704|NCT01297270|80802462|FG000|Overall Study|Adverse Event|19|||
27718705|NCT01297270|80802463|FG001|Overall Study|Adverse Event|32|||
27718706|NCT01297270|80802464|FG002|Overall Study|Adverse Event|5|||
27890267|NCT03214380|81434034|FG000|Lead-in|Non Compliance|1|||
27890268|NCT03214380|81434035|FG001|Lead-in|Non Compliance|0|||
27890269|NCT03214380|81434036|FG002|Lead-in|Non Compliance|0|||
27890270|NCT03214380|81434037|FG003|Lead-in|Non Compliance|0|||
27890271|NCT03214380|81434038|FG004|Lead-in|Non Compliance|0|||
27890272|NCT03214380|81434039|FG005|Lead-in|Non Compliance|0|||
27890273|NCT03214380|81434034|FG000|Lead-in|Participant Schedule|2|||
27890274|NCT03214380|81434035|FG001|Lead-in|Participant Schedule|0|||
27890275|NCT03214380|81434036|FG002|Lead-in|Participant Schedule|0|||
27890276|NCT03214380|81434037|FG003|Lead-in|Participant Schedule|0|||
27890277|NCT03214380|81434038|FG004|Lead-in|Participant Schedule|0|||
27890278|NCT03214380|81434039|FG005|Lead-in|Participant Schedule|0|||
27890279|NCT03214380|81434034|FG000|Treatment Period|Adverse Event|0|||
27890280|NCT03214380|81434035|FG001|Treatment Period|Adverse Event|1|||
27890281|NCT03214380|81434036|FG002|Treatment Period|Adverse Event|1|||
27890282|NCT03214380|81434037|FG003|Treatment Period|Adverse Event|0|||
27890283|NCT03214380|81434038|FG004|Treatment Period|Adverse Event|1|||
27890284|NCT03214380|81434039|FG005|Treatment Period|Adverse Event|0|||
27890285|NCT03214380|81434034|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
27890286|NCT03214380|81434035|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
27890287|NCT03214380|81434036|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
27890288|NCT03214380|81434037|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
27890289|NCT03214380|81434038|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
27890290|NCT03214380|81434039|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
27890291|NCT03214380|81434034|FG000|Treatment Period|Withdrawal by Subject|0|||
27890292|NCT03214380|81434035|FG001|Treatment Period|Withdrawal by Subject|10|||
27890293|NCT03214380|81434036|FG002|Treatment Period|Withdrawal by Subject|8|||
27890294|NCT03214380|81434037|FG003|Treatment Period|Withdrawal by Subject|0|||
27890295|NCT03214380|81434038|FG004|Treatment Period|Withdrawal by Subject|7|||
27890296|NCT03214380|81434039|FG005|Treatment Period|Withdrawal by Subject|11|||
27890297|NCT03214380|81434034|FG000|Treatment Period|Death|0|||
27890298|NCT03214380|81434035|FG001|Treatment Period|Death|1|||
27718707|NCT01297270|80802462|FG000|Overall Study|Lack of Efficacy|15|||
27718708|NCT01297270|80802463|FG001|Overall Study|Lack of Efficacy|17|||
27718709|NCT01297270|80802464|FG002|Overall Study|Lack of Efficacy|15|||
27718710|NCT01297270|80802462|FG000|Overall Study|Lost to Follow-up|1|||
27718711|NCT01297270|80802463|FG001|Overall Study|Lost to Follow-up|2|||
27890299|NCT03214380|81434036|FG002|Treatment Period|Death|2|||
27890300|NCT03214380|81434037|FG003|Treatment Period|Death|0|||
27890301|NCT03214380|81434038|FG004|Treatment Period|Death|0|||
27890302|NCT03214380|81434039|FG005|Treatment Period|Death|0|||
27890303|NCT03214380|81434034|FG000|Treatment Period|Lost to Follow-up|0|||
27890304|NCT03214380|81434035|FG001|Treatment Period|Lost to Follow-up|6|||
27890305|NCT03214380|81434036|FG002|Treatment Period|Lost to Follow-up|3|||
27890306|NCT03214380|81434037|FG003|Treatment Period|Lost to Follow-up|0|||
27890307|NCT03214380|81434038|FG004|Treatment Period|Lost to Follow-up|0|||
27838551|NCT00090753|81236734|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
27607651|NCT02798211|80405753|FG001|Period 2|Withdrawal of Informed Consent|0|||
27607652|NCT02798211|80405754|FG002|Period 2|Withdrawal of Informed Consent|0|||
27838552|NCT01964950|81236735|FG000|Overall Study|Protocol Violation|25|||
27838553|NCT00522041|81236736|FG000|Overall Study|Adverse Event|9|||
27838554|NCT00522041|81236737|FG001|Overall Study|Adverse Event|3|||
27838555|NCT00522041|81236736|FG000|Overall Study|Protocol Violation|2|||
27838556|NCT00522041|81236737|FG001|Overall Study|Protocol Violation|0|||
27838557|NCT00522041|81236736|FG000|Overall Study|Lost to Follow-up|1|||
27607653|NCT02798211|80405755|FG003|Period 2|Withdrawal of Informed Consent|2|||
27607654|NCT02798211|80405756|FG004|Period 2|Withdrawal of Informed Consent|2|||
27607655|NCT02798211|80405757|FG005|Period 2|Withdrawal of Informed Consent|3|||
27607656|NCT03185832|80405760|FG000|Overall Study|Death|9|||
27838558|NCT00522041|81236737|FG001|Overall Study|Lost to Follow-up|4|||
27958581|NCT01791517|81680065|FG007|Phase II|Lost to Follow-up|1|||
27958582|NCT01791517|81680066|FG008|Phase II|Lost to Follow-up|1|||
27958583|NCT01791517|81680067|FG009|Phase II|Lost to Follow-up|1|||
27958584|NCT01791517|81680068|FG010|Phase II|Lost to Follow-up|0|||
27958585|NCT01791517|81680069|FG011|Phase II|Lost to Follow-up|0|||
27958586|NCT01791517|81680058|FG000|Phase II|Withdrawal by Subject|1|||
27607657|NCT03185832|80405761|FG001|Overall Study|Death|14|||
27607658|NCT03185832|80405762|FG002|Overall Study|Death|9|||
27607659|NCT03185832|80405763|FG003|Overall Study|Death|7|||
27607660|NCT03185832|80405760|FG000|Overall Study|Withdrawn - vital status available|0|||
27607661|NCT03185832|80405761|FG001|Overall Study|Withdrawn - vital status available|1|||
27838559|NCT00522041|81236736|FG000|Overall Study|Voluntary withdrawal|5|||
27838560|NCT00522041|81236737|FG001|Overall Study|Voluntary withdrawal|4|||
27838561|NCT00522041|81236736|FG000|Overall Study|Did not receive treatment|0|||
27838562|NCT00522041|81236737|FG001|Overall Study|Did not receive treatment|1|||
27838563|NCT01802216|81236738|FG000|4 Month Visit|Participant did not show to visit|3|||
27838564|NCT01802216|81236739|FG001|4 Month Visit|Participant did not show to visit|4|||
27838565|NCT01802216|81236738|FG000|8 Month Visit|Participant did not show to visit|3|||
27838566|NCT01802216|81236739|FG001|8 Month Visit|Participant did not show to visit|5|||
27838567|NCT01802216|81236738|FG000|12 Month Visit|Participant did not show to visit|3|||
27838568|NCT01802216|81236739|FG001|12 Month Visit|Participant did not show to visit|4|||
27838569|NCT03868631|81236740|FG000|Baseline to Week 6|Adverse Event|0|||
27838570|NCT03868631|81236741|FG001|Baseline to Week 6|Adverse Event|3|||
27838571|NCT03868631|81236740|FG000|Baseline to Week 6|Protocol Violation|1|||
27838572|NCT03868631|81236741|FG001|Baseline to Week 6|Protocol Violation|1|||
27838573|NCT03868631|81236740|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
27838574|NCT03868631|81236741|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
27838575|NCT03868631|81236740|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
27838576|NCT03868631|81236741|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
27890308|NCT03214380|81434039|FG005|Treatment Period|Lost to Follow-up|0|||
27890309|NCT03214380|81434034|FG000|Treatment Period|Participant schedule|0|||
27890310|NCT03214380|81434035|FG001|Treatment Period|Participant schedule|0|||
27890311|NCT03214380|81434036|FG002|Treatment Period|Participant schedule|1|||
27607662|NCT03185832|80405762|FG002|Overall Study|Withdrawn - vital status available|1|||
27607663|NCT03185832|80405763|FG003|Overall Study|Withdrawn - vital status available|4|||
27838577|NCT03868631|81236740|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
27838578|NCT03868631|81236741|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
27838579|NCT03868631|81236740|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
27838580|NCT03868631|81236741|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
27838581|NCT01223027|81236747|FG000|Overall Study|Adverse Event|20|||
27838582|NCT01223027|81236748|FG001|Overall Study|Adverse Event|10|||
27838583|NCT01223027|81236747|FG000|Overall Study|Death|42|||
27838584|NCT01223027|81236748|FG001|Overall Study|Death|42|||
27838585|NCT01223027|81236747|FG000|Overall Study|Lost to Follow-up|2|||
27838586|NCT01223027|81236748|FG001|Overall Study|Lost to Follow-up|1|||
27838587|NCT01223027|81236747|FG000|Overall Study|Physician Decision|4|||
27838588|NCT01223027|81236748|FG001|Overall Study|Physician Decision|8|||
27838589|NCT01223027|81236747|FG000|Overall Study|Progressive Disease|167|||
27838590|NCT01223027|81236748|FG001|Overall Study|Progressive Disease|183|||
27838591|NCT01223027|81236747|FG000|Overall Study|Protocol Violation|2|||
27838592|NCT01223027|81236748|FG001|Overall Study|Protocol Violation|1|||
27838593|NCT01223027|81236747|FG000|Overall Study|Subject/guardian decicion|18|||
27838594|NCT01223027|81236748|FG001|Overall Study|Subject/guardian decicion|16|||
27838595|NCT01223027|81236747|FG000|Overall Study|New therapy for study indication|17|||
27838596|NCT01223027|81236748|FG001|Overall Study|New therapy for study indication|8|||
27838597|NCT01223027|81236747|FG000|Overall Study|Study terminated by sponsor|2|||
27838598|NCT01223027|81236748|FG001|Overall Study|Study terminated by sponsor|8|||
27890312|NCT03214380|81434037|FG003|Treatment Period|Participant schedule|0|||
27890313|NCT03214380|81434038|FG004|Treatment Period|Participant schedule|0|||
27890314|NCT03214380|81434039|FG005|Treatment Period|Participant schedule|0|||
27890315|NCT03214380|81434034|FG000|Treatment Period|Treatment Interruption|0|||
27890316|NCT03214380|81434035|FG001|Treatment Period|Treatment Interruption|0|||
27890317|NCT03214380|81434036|FG002|Treatment Period|Treatment Interruption|1|||
27890318|NCT03214380|81434037|FG003|Treatment Period|Treatment Interruption|0|||
27890319|NCT03214380|81434038|FG004|Treatment Period|Treatment Interruption|0|||
27890320|NCT03214380|81434039|FG005|Treatment Period|Treatment Interruption|0|||
27890321|NCT03155178|81434040|FG000|Overall Study|Did not meet treatment day baseline|7|||
27890322|NCT03155178|81434041|FG001|Overall Study|Did not meet treatment day baseline|7|||
27890323|NCT03155178|81434042|FG002|Overall Study|Did not meet treatment day baseline|7|||
27890324|NCT03155178|81434043|FG003|Overall Study|Did not meet treatment day baseline|7|||
27890325|NCT03891862|81434046|FG000|Open-label Period|Adverse Event|2|||
27890326|NCT03891862|81434047|FG001|Open-label Period|Adverse Event|0|||
27890327|NCT03891862|81434048|FG002|Open-label Period|Adverse Event|0|||
27890328|NCT03891862|81434046|FG000|Open-label Period|Protocol Violation|5|||
27607664|NCT02087501|80405768|FG000|Overall Study|Death|7|||
27607665|NCT02087501|80405768|FG000|Overall Study|Open repair of aneurysm|1|||
27607666|NCT02087501|80405768|FG000|Overall Study|Lost to Follow-up|2|||
27607667|NCT01861522|80405782|FG000|Overall Study|Adverse Event|1|||
27607668|NCT01861522|80405783|FG001|Overall Study|Adverse Event|0|||
27607669|NCT01861522|80405782|FG000|Overall Study|Withdrawal by Subject|2|||
27607670|NCT01861522|80405783|FG001|Overall Study|Withdrawal by Subject|0|||
27607671|NCT02066402|80405784|FG000|Overall Study|Adverse Event|1|||
27607672|NCT02066402|80405785|FG001|Overall Study|Adverse Event|2|||
27607673|NCT02066402|80405784|FG000|Overall Study|Lost to Follow-up|11|||
27607674|NCT02066402|80405785|FG001|Overall Study|Lost to Follow-up|8|||
27607675|NCT02066402|80405784|FG000|Overall Study|Withdrawal by Subject|14|||
27607676|NCT02066402|80405785|FG001|Overall Study|Withdrawal by Subject|11|||
27607677|NCT02066402|80405784|FG000|Overall Study|Progressive disease-clinical progression|0|||
27607678|NCT02066402|80405785|FG001|Overall Study|Progressive disease-clinical progression|1|||
27607679|NCT02066402|80405784|FG000|Overall Study|Protocol driven decision point|0|||
27607680|NCT02066402|80405785|FG001|Overall Study|Protocol driven decision point|1|||
27607681|NCT00301080|80405795|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
27607682|NCT00301080|80405796|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
27607683|NCT00301080|80405797|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
27607684|NCT00301080|80405798|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
27607685|NCT00301080|80405799|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
27607686|NCT02044458|80405801|FG000|Overall Study|Protocol Violation|3|||
27607687|NCT02044458|80405802|FG001|Overall Study|Protocol Violation|8|||
27718712|NCT01297270|80802464|FG002|Overall Study|Lost to Follow-up|1|||
27838599|NCT01243151|81236752|FG000|Overall Study|Adverse Event|0|||
27838600|NCT01243151|81236753|FG001|Overall Study|Adverse Event|1|||
27838601|NCT01243151|81236754|FG002|Overall Study|Adverse Event|0|||
27838602|NCT01243151|81236755|FG003|Overall Study|Adverse Event|0|||
27718713|NCT01297270|80802462|FG000|Overall Study|Protocol Violation|0|||
27890329|NCT03891862|81434047|FG001|Open-label Period|Protocol Violation|0|||
27890330|NCT03891862|81434048|FG002|Open-label Period|Protocol Violation|0|||
27607688|NCT02460263|80405803|FG000|Transition Period|Withdrawal by Subject|1|||
27607689|NCT02460263|80405803|FG000|Transition Period|Death|1|||
27607690|NCT00861614|80405804|FG000|Overall Study|Disease Progression|182|||
27607691|NCT00861614|80405805|FG001|Overall Study|Disease Progression|263|||
27607692|NCT00861614|80405804|FG000|Overall Study|Study Drug Toxicity|79|||
27607693|NCT00861614|80405805|FG001|Overall Study|Study Drug Toxicity|6|||
27607694|NCT00861614|80405804|FG000|Overall Study|Death|32|||
27607695|NCT00861614|80405805|FG001|Overall Study|Death|19|||
27607696|NCT00861614|80405804|FG000|Overall Study|Adverse Event|27|||
27607697|NCT00861614|80405805|FG001|Overall Study|Adverse Event|23|||
27607698|NCT00861614|80405804|FG000|Overall Study|Withdrawal by Subject|34|||
27607699|NCT00861614|80405805|FG001|Overall Study|Withdrawal by Subject|35|||
27838603|NCT01243151|81236756|FG004|Overall Study|Adverse Event|0|||
27607700|NCT00861614|80405804|FG000|Overall Study|Other|17|||
27607701|NCT00861614|80405805|FG001|Overall Study|Other|22|||
27838604|NCT01243151|81236752|FG000|Overall Study|Protocol Violation|0|||
27838605|NCT01243151|81236753|FG001|Overall Study|Protocol Violation|0|||
27838606|NCT01243151|81236754|FG002|Overall Study|Protocol Violation|1|||
27838607|NCT01243151|81236755|FG003|Overall Study|Protocol Violation|0|||
27838608|NCT01243151|81236756|FG004|Overall Study|Protocol Violation|0|||
27838609|NCT01243151|81236752|FG000|Overall Study|Other|0|||
27607702|NCT04461795|80405806|FG000|Overall Study|Lost to Follow-up|2|||
27838610|NCT01243151|81236753|FG001|Overall Study|Other|0|||
27838611|NCT01243151|81236754|FG002|Overall Study|Other|0|||
27838612|NCT01243151|81236755|FG003|Overall Study|Other|1|||
27607703|NCT04461795|80405806|FG000|Overall Study|Withdrawal by Subject|2|||
27607704|NCT04461795|80405806|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
27607705|NCT01725386|80405813|FG000|Overall Study|Death|84|||
27838613|NCT01243151|81236756|FG004|Overall Study|Other|0|||
27607706|NCT01725386|80405814|FG001|Overall Study|Death|40|||
27890331|NCT03891862|81434046|FG000|Open-label Period|Withdrawal by Subject|6|||
27890332|NCT03891862|81434047|FG001|Open-label Period|Withdrawal by Subject|0|||
27890333|NCT03891862|81434048|FG002|Open-label Period|Withdrawal by Subject|0|||
27890334|NCT03891862|81434046|FG000|Open-label Period|Death|1|||
27890335|NCT03891862|81434047|FG001|Open-label Period|Death|0|||
27890336|NCT03891862|81434048|FG002|Open-label Period|Death|0|||
27890337|NCT03891862|81434046|FG000|Open-label Period|Lost to Follow-up|2|||
27890338|NCT03891862|81434047|FG001|Open-label Period|Lost to Follow-up|0|||
27890339|NCT03891862|81434048|FG002|Open-label Period|Lost to Follow-up|0|||
27607707|NCT01725386|80405813|FG000|Overall Study|Lost to Follow-up|81|||
27607708|NCT01725386|80405814|FG001|Overall Study|Lost to Follow-up|6|||
27607709|NCT01725386|80405813|FG000|Overall Study|Withdrawal by Subject|10|||
27607710|NCT01725386|80405814|FG001|Overall Study|Withdrawal by Subject|0|||
27607711|NCT00105586|80405816|FG000|Overall Study|Adverse Event|4|||
27607712|NCT00105586|80405817|FG001|Overall Study|Adverse Event|3|||
27607713|NCT00105586|80405816|FG000|Overall Study|Physician Decision|13|||
27890340|NCT03891862|81434046|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
27890341|NCT03891862|81434047|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
27890342|NCT03891862|81434048|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
27890343|NCT03891862|81434046|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
27890344|NCT03891862|81434047|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
27890345|NCT03891862|81434048|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
27890346|NCT03891862|81434046|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
27890347|NCT03891862|81434047|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
27890348|NCT03891862|81434048|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
27890349|NCT03891862|81434046|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
27890350|NCT03891862|81434047|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
27890351|NCT03891862|81434048|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
27890352|NCT01438294|81434049|FG000|Overall Study|Lost to Follow-up|3|||
27607714|NCT00105586|80405817|FG001|Overall Study|Physician Decision|13|||
27607715|NCT00192023|80405819|FG000|Period III - Double-Blind|Adverse Event|3|||
27607716|NCT00192023|80405820|FG001|Period III - Double-Blind|Adverse Event|0|||
27607717|NCT00192023|80405819|FG000|Period III - Double-Blind|Physician Decision|2|||
27607718|NCT00192023|80405820|FG001|Period III - Double-Blind|Physician Decision|0|||
27607719|NCT00192023|80405819|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
27607720|NCT00192023|80405820|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
27607721|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
27607722|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
27718714|NCT01297270|80802463|FG001|Overall Study|Protocol Violation|2|||
27718715|NCT01297270|80802464|FG002|Overall Study|Protocol Violation|0|||
27718716|NCT01297270|80802462|FG000|Overall Study|Withdrawal by Subject|7|||
27718717|NCT01297270|80802463|FG001|Overall Study|Withdrawal by Subject|15|||
27718718|NCT01297270|80802464|FG002|Overall Study|Withdrawal by Subject|7|||
27718719|NCT01297270|80802462|FG000|Overall Study|Other reason not defined above|3|||
27718720|NCT01297270|80802463|FG001|Overall Study|Other reason not defined above|3|||
27718721|NCT01297270|80802464|FG002|Overall Study|Other reason not defined above|1|||
27718722|NCT01297270|80802462|FG000|Overall Study|Not treated|0|||
27718723|NCT01297270|80802463|FG001|Overall Study|Not treated|1|||
27718724|NCT01297270|80802464|FG002|Overall Study|Not treated|0|||
27890353|NCT01438294|81434050|FG001|Overall Study|Lost to Follow-up|7|||
27890354|NCT00638443|81434051|FG000|First Intervention|Adverse Event|2|||
27890355|NCT00638443|81434052|FG001|First Intervention|Adverse Event|1|||
27607723|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
27958587|NCT01791517|81680059|FG001|Phase II|Withdrawal by Subject|0|||
27607724|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
27607725|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
27718725|NCT00464178|80802467|FG000|Overall Study|Protocol Violation|1|||
27718726|NCT00464178|80802467|FG000|Overall Study|Withdrawal by Subject|1|||
27718727|NCT01789970|80802470|FG000|Open-label Titration Period|Adverse Event|68|||
27718728|NCT01789970|80802471|FG001|Open-label Titration Period|Adverse Event|0|||
27718729|NCT01789970|80802472|FG002|Open-label Titration Period|Adverse Event|0|||
27718730|NCT01789970|80802470|FG000|Open-label Titration Period|Lack of Efficacy|31|||
27718731|NCT01789970|80802471|FG001|Open-label Titration Period|Lack of Efficacy|0|||
27718732|NCT01789970|80802472|FG002|Open-label Titration Period|Lack of Efficacy|0|||
27718733|NCT01789970|80802470|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
27718734|NCT01789970|80802471|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
27718735|NCT01789970|80802472|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
27718736|NCT01789970|80802470|FG000|Open-label Titration Period|Protocol Violation|18|||
27718737|NCT01789970|80802471|FG001|Open-label Titration Period|Protocol Violation|0|||
27718738|NCT01789970|80802472|FG002|Open-label Titration Period|Protocol Violation|0|||
27718739|NCT01789970|80802470|FG000|Open-label Titration Period|Lost to Follow-up|5|||
27718740|NCT01789970|80802471|FG001|Open-label Titration Period|Lost to Follow-up|0|||
27718741|NCT01789970|80802472|FG002|Open-label Titration Period|Lost to Follow-up|0|||
27718742|NCT01789970|80802470|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
27718743|NCT01789970|80802471|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
27718744|NCT01789970|80802472|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
27718745|NCT01789970|80802470|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
27718746|NCT01789970|80802471|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
27718747|NCT01789970|80802472|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
27718748|NCT01789970|80802470|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
27718749|NCT01789970|80802471|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
27718750|NCT01789970|80802472|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
27718751|NCT01789970|80802470|FG000|Open-label Titration Period|Pregnancy|2|||
27718752|NCT01789970|80802471|FG001|Open-label Titration Period|Pregnancy|0|||
27718753|NCT01789970|80802472|FG002|Open-label Titration Period|Pregnancy|0|||
27718754|NCT01789970|80802470|FG000|Open-label Titration Period|Other|76|||
27718755|NCT01789970|80802471|FG001|Open-label Titration Period|Other|0|||
27718756|NCT01789970|80802472|FG002|Open-label Titration Period|Other|0|||
27718757|NCT01789970|80802470|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
27718758|NCT01789970|80802471|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
27718759|NCT01789970|80802472|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
27718760|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
27718761|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
27718762|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
27718763|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27718764|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
27718765|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
27718766|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27718767|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
27718768|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
27718769|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
27718770|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
27718771|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
27718772|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
27718773|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
27718774|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
27718775|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
27718776|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
27718777|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
27718778|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
27718779|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27718780|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
27718781|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
27718782|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
27718783|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
27718784|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
27718785|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
27718786|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
27718787|NCT01789970|80802470|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
27718788|NCT01789970|80802471|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
27718789|NCT01789970|80802472|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
27718790|NCT01446419|80802474|FG000|Overall Study|Death|1|||
27718791|NCT01446419|80802475|FG001|Overall Study|Death|0|||
27718792|NCT01446419|80802474|FG000|Overall Study|Withdrawal by Subject|1|||
27838614|NCT01243151|81236752|FG000|Overall Study|Randomized but not treated|0|||
27838615|NCT01243151|81236753|FG001|Overall Study|Randomized but not treated|0|||
27838616|NCT01243151|81236754|FG002|Overall Study|Randomized but not treated|0|||
27838617|NCT01243151|81236755|FG003|Overall Study|Randomized but not treated|1|||
27607726|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
27607727|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
27607728|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
27607729|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
27607730|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
27607731|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
27607732|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
27607733|NCT00192023|80405819|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
27607734|NCT00192023|80405820|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
27607735|NCT03311230|80405823|FG000|Overall Study|Withdrawal by Subject|1|||
27607736|NCT03311230|80405824|FG001|Overall Study|Withdrawal by Subject|4|||
27607737|NCT03311230|80405825|FG002|Overall Study|Withdrawal by Subject|2|||
27607738|NCT03311230|80405826|FG003|Overall Study|Withdrawal by Subject|7|||
27607739|NCT03311230|80405823|FG000|Overall Study|Unrelated injury|0|||
27607740|NCT03311230|80405824|FG001|Overall Study|Unrelated injury|1|||
27607741|NCT03311230|80405825|FG002|Overall Study|Unrelated injury|0|||
27607742|NCT03311230|80405826|FG003|Overall Study|Unrelated injury|0|||
27607743|NCT01078662|80405827|FG000|Overall Study|Death|41|||
27607744|NCT01078662|80405828|FG001|Overall Study|Death|103|||
27607745|NCT01078662|80405829|FG002|Overall Study|Death|18|||
27607746|NCT01078662|80405830|FG003|Overall Study|Death|5|||
27607747|NCT01078662|80405831|FG004|Overall Study|Death|8|||
27607748|NCT01078662|80405827|FG000|Overall Study|Patients reached data cut-off|12|||
27607749|NCT01078662|80405828|FG001|Overall Study|Patients reached data cut-off|53|||
27607750|NCT01078662|80405829|FG002|Overall Study|Patients reached data cut-off|2|||
27607751|NCT01078662|80405830|FG003|Overall Study|Patients reached data cut-off|2|||
27607752|NCT01078662|80405831|FG004|Overall Study|Patients reached data cut-off|3|||
27607753|NCT01078662|80405827|FG000|Overall Study|Withdrawal by Subject|4|||
27607754|NCT01078662|80405828|FG001|Overall Study|Withdrawal by Subject|11|||
27607755|NCT01078662|80405829|FG002|Overall Study|Withdrawal by Subject|1|||
27607756|NCT01078662|80405830|FG003|Overall Study|Withdrawal by Subject|0|||
27607757|NCT01078662|80405831|FG004|Overall Study|Withdrawal by Subject|0|||
27607758|NCT01078662|80405827|FG000|Overall Study|Protocol Violation|0|||
27607759|NCT01078662|80405828|FG001|Overall Study|Protocol Violation|1|||
27607760|NCT01078662|80405829|FG002|Overall Study|Protocol Violation|0|||
27607761|NCT01078662|80405830|FG003|Overall Study|Protocol Violation|0|||
27607762|NCT01078662|80405831|FG004|Overall Study|Protocol Violation|0|||
27607763|NCT01078662|80405827|FG000|Overall Study|Lost to Follow-up|1|||
27607764|NCT01078662|80405828|FG001|Overall Study|Lost to Follow-up|0|||
27607765|NCT01078662|80405829|FG002|Overall Study|Lost to Follow-up|0|||
27607766|NCT01078662|80405830|FG003|Overall Study|Lost to Follow-up|0|||
27607767|NCT01078662|80405831|FG004|Overall Study|Lost to Follow-up|0|||
27607768|NCT03321006|80405832|FG000|Overall Study|Death|1|||
27607769|NCT03321006|80405833|FG001|Overall Study|Death|0|||
27607770|NCT03321006|80405832|FG000|Overall Study|Lack of Efficacy|1|||
27607771|NCT03321006|80405833|FG001|Overall Study|Lack of Efficacy|0|||
27607772|NCT02821819|80405835|FG000|Overall Study|Protocol Violation|1|||
27607773|NCT03002038|80405846|FG000|Overall Study|Adverse Event|3|||
27607774|NCT03002038|80405847|FG001|Overall Study|Adverse Event|1|||
27607775|NCT03002038|80405846|FG000|Overall Study|Withdrawal by Subject|8|||
27607776|NCT03002038|80405847|FG001|Overall Study|Withdrawal by Subject|4|||
27607777|NCT03002038|80405846|FG000|Overall Study|Immigration to another region|0|||
27607778|NCT03002038|80405847|FG001|Overall Study|Immigration to another region|2|||
27607779|NCT02914314|80405848|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
27607780|NCT02914314|80405849|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
27607781|NCT02914314|80405850|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
27607782|NCT02914314|80405851|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
27607783|NCT02914314|80405848|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
27607784|NCT02914314|80405849|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
27607785|NCT02914314|80405850|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
27607786|NCT02914314|80405851|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
27607787|NCT02914314|80405848|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
27607788|NCT02914314|80405849|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
27607789|NCT02914314|80405850|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
27607790|NCT02914314|80405851|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
27607791|NCT02914314|80405848|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
27607792|NCT02914314|80405849|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
27754864|NCT02065622|80929634|FG004|Induction Study|Adverse Event|0|||
27754865|NCT02065622|80929630|FG000|Induction Study|Withdrawal by Subject|3|||
27718793|NCT01446419|80802475|FG001|Overall Study|Withdrawal by Subject|1|||
27718794|NCT01446419|80802474|FG000|Overall Study|Terminated per protocol|3|||
27718795|NCT01446419|80802475|FG001|Overall Study|Terminated per protocol|0|||
27718796|NCT02387580|80802476|FG000|Overall Study|Withdrawal by Subject|0|||
27718797|NCT02387580|80802477|FG001|Overall Study|Withdrawal by Subject|0|||
27718798|NCT02387580|80802478|FG002|Overall Study|Withdrawal by Subject|0|||
27718799|NCT02387580|80802479|FG003|Overall Study|Withdrawal by Subject|1|||
27718800|NCT02387580|80802480|FG004|Overall Study|Withdrawal by Subject|0|||
27718801|NCT02387580|80802481|FG005|Overall Study|Withdrawal by Subject|0|||
27718802|NCT01060059|80802482|FG000|Overall Study|Adverse Event|1|||
27838618|NCT01243151|81236756|FG004|Overall Study|Randomized but not treated|0|||
27838619|NCT03119662|81236757|FG000|Overall Study|Withdrawal by Subject|0|||
27838620|NCT03119662|81236758|FG001|Overall Study|Withdrawal by Subject|1|||
27838621|NCT02328040|81236765|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
27838622|NCT02328040|81236766|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
27838623|NCT01833169|81236767|FG000|Overall Study|Disease Progression|99|||
27838624|NCT01833169|81236767|FG000|Overall Study|Adverse Event|33|||
27838625|NCT01833169|81236767|FG000|Overall Study|Withdrawal by Subject|9|||
27838626|NCT01833169|81236767|FG000|Overall Study|Death|3|||
27838627|NCT01833169|81236767|FG000|Overall Study|Physician Decision|2|||
27718803|NCT01060059|80802483|FG001|Overall Study|Adverse Event|1|||
27718804|NCT01060059|80802482|FG000|Overall Study|Death|2|||
27718805|NCT01060059|80802483|FG001|Overall Study|Death|3|||
27718806|NCT01060059|80802482|FG000|Overall Study|Lost to Follow-up|18|||
27718807|NCT01060059|80802483|FG001|Overall Study|Lost to Follow-up|34|||
27718808|NCT01060059|80802482|FG000|Overall Study|entry criteria not met|4|||
27718809|NCT01060059|80802483|FG001|Overall Study|entry criteria not met|3|||
27718810|NCT01060059|80802482|FG000|Overall Study|Withdrawal by Subject|35|||
27718811|NCT01060059|80802483|FG001|Overall Study|Withdrawal by Subject|23|||
27718812|NCT01060059|80802482|FG000|Overall Study|lack of glycemic control|2|||
27718813|NCT01060059|80802483|FG001|Overall Study|lack of glycemic control|1|||
27718814|NCT01060059|80802482|FG000|Overall Study|lack of compliance|5|||
27718815|NCT01060059|80802483|FG001|Overall Study|lack of compliance|2|||
27718816|NCT01098071|80802486|FG000|Overall Study|Surgery (adenoidectomy)|2|||
27718817|NCT01098071|80802486|FG000|Overall Study|Lost to Follow-up|13|||
27718818|NCT00590590|80802487|FG000|Overall Study|Lack of Efficacy|1|||
27838628|NCT00942734|81236769|FG000|Overall Study|Adverse Event|2|||
27838629|NCT00942734|81236769|FG000|Overall Study|Protocol Violation|3|||
27890356|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
27890357|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
27890358|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
27718819|NCT00590590|80802488|FG001|Overall Study|Lack of Efficacy|2|||
27718820|NCT00590590|80802489|FG002|Overall Study|Lack of Efficacy|0|||
27718821|NCT00590590|80802487|FG000|Overall Study|Adverse Event|1|||
27718822|NCT00590590|80802488|FG001|Overall Study|Adverse Event|0|||
27718823|NCT00590590|80802489|FG002|Overall Study|Adverse Event|0|||
27718824|NCT00590590|80802487|FG000|Overall Study|Protocol Violation|0|||
27718825|NCT00590590|80802488|FG001|Overall Study|Protocol Violation|0|||
27718826|NCT00590590|80802489|FG002|Overall Study|Protocol Violation|2|||
27838630|NCT00942734|81236769|FG000|Overall Study|Disease Progression|2|||
27718827|NCT00590590|80802487|FG000|Overall Study|Lost to Follow-up|4|||
27838631|NCT00942734|81236769|FG000|Overall Study|Physician Decision|1|||
27838632|NCT02834390|81236770|FG000|Induction Phase|Progressive disease|0|||
27718828|NCT00590590|80802488|FG001|Overall Study|Lost to Follow-up|1|||
27718829|NCT00590590|80802489|FG002|Overall Study|Lost to Follow-up|2|||
27718830|NCT00590590|80802487|FG000|Overall Study|Withdrawal by Subject|0|||
27718831|NCT00590590|80802488|FG001|Overall Study|Withdrawal by Subject|1|||
27718832|NCT00590590|80802489|FG002|Overall Study|Withdrawal by Subject|1|||
27718833|NCT00590590|80802487|FG000|Overall Study|Did not complete due to study closure|1|||
27718834|NCT00590590|80802488|FG001|Overall Study|Did not complete due to study closure|1|||
27718835|NCT00590590|80802489|FG002|Overall Study|Did not complete due to study closure|1|||
27718836|NCT00590590|80802487|FG000|Overall Study|Did not complete study|0|||
27718837|NCT00590590|80802488|FG001|Overall Study|Did not complete study|1|||
27718838|NCT00590590|80802489|FG002|Overall Study|Did not complete study|0|||
27718839|NCT05594173|80802492|FG000|Overall Study|Adverse Event|1|||
27718840|NCT05594173|80802492|FG000|Overall Study|COVID-19 Pandemic|2|||
27718841|NCT01784965|80802493|FG000|Overall Study|Withdrawal by Subject|6|||
27718842|NCT01784965|80802494|FG001|Overall Study|Withdrawal by Subject|3|||
27718843|NCT01784965|80802493|FG000|Overall Study|Adverse Event|0|||
27718844|NCT01784965|80802494|FG001|Overall Study|Adverse Event|8|||
27718845|NCT00803179|80802495|FG000|Overall Study|Lost to Follow-up|3|||
27718846|NCT01338415|80802498|FG000|Core + Extension|Adverse Event|8|||
27718847|NCT01338415|80802499|FG001|Core + Extension|Adverse Event|6|||
27718848|NCT01338415|80802500|FG002|Core + Extension|Adverse Event|0|||
27718849|NCT01338415|80802498|FG000|Core + Extension|Withdrawal by Subject|1|||
27718850|NCT01338415|80802499|FG001|Core + Extension|Withdrawal by Subject|1|||
27718851|NCT01338415|80802500|FG002|Core + Extension|Withdrawal by Subject|0|||
27718852|NCT01338415|80802498|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
27718853|NCT01338415|80802499|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
27718854|NCT01338415|80802500|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
27718855|NCT01338415|80802498|FG000|Core + Extension|Other (administrative reason)|1|||
27718856|NCT01338415|80802499|FG001|Core + Extension|Other (administrative reason)|0|||
27718857|NCT01338415|80802500|FG002|Core + Extension|Other (administrative reason)|0|||
27718858|NCT01338415|80802498|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
27718859|NCT01338415|80802499|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
27718860|NCT01338415|80802500|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
27718861|NCT01338415|80802498|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
27718862|NCT01338415|80802499|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
27718863|NCT01338415|80802500|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
27718864|NCT01338415|80802498|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
27718865|NCT01338415|80802499|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
27718866|NCT01338415|80802500|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
27718867|NCT01338415|80802498|FG000|Exceptional Use Treatment Period|Death|0|||
27718868|NCT01338415|80802499|FG001|Exceptional Use Treatment Period|Death|0|||
27718869|NCT01338415|80802500|FG002|Exceptional Use Treatment Period|Death|1|||
27718870|NCT02222207|80802501|FG000|Overall Study|Death|1|||
27718871|NCT02222207|80802501|FG000|Overall Study|Other reasons|2|||
27718872|NCT02222207|80802501|FG000|Overall Study|Adverse Event|1|||
27718873|NCT00781456|80802502|FG000|Overall Study|Adverse Event|3|||
27718874|NCT00781456|80802503|FG001|Overall Study|Adverse Event|3|||
27718875|NCT00781456|80802502|FG000|Overall Study|Withdrawal by Subject|3|||
27718876|NCT00781456|80802503|FG001|Overall Study|Withdrawal by Subject|5|||
27718877|NCT00781456|80802502|FG000|Overall Study|Protocol Violation|4|||
27718878|NCT00781456|80802503|FG001|Overall Study|Protocol Violation|1|||
27718879|NCT00781456|80802502|FG000|Overall Study|Noncompliance With Protocol|1|||
27718880|NCT00781456|80802503|FG001|Overall Study|Noncompliance With Protocol|1|||
27718881|NCT00781456|80802502|FG000|Overall Study|Lost to Follow-up|10|||
27718882|NCT00781456|80802503|FG001|Overall Study|Lost to Follow-up|5|||
27718883|NCT00781456|80802502|FG000|Overall Study|Other Reason, Unknown|0|||
27718884|NCT00781456|80802503|FG001|Overall Study|Other Reason, Unknown|1|||
27718885|NCT02568046|80802504|FG000|Overall Study|Adverse Event|0|||
27718886|NCT02568046|80802505|FG001|Overall Study|Adverse Event|1|||
27718887|NCT02568046|80802504|FG000|Overall Study|Death|2|||
27718888|NCT02568046|80802505|FG001|Overall Study|Death|0|||
27718889|NCT02568046|80802504|FG000|Overall Study|Progressive Disease|1|||
27718890|NCT02568046|80802505|FG001|Overall Study|Progressive Disease|0|||
27718891|NCT02568046|80802504|FG000|Overall Study|Withdrawal by Subject|2|||
27718892|NCT02568046|80802505|FG001|Overall Study|Withdrawal by Subject|1|||
27718893|NCT02568046|80802504|FG000|Overall Study|Other Events|0|||
27718894|NCT02568046|80802505|FG001|Overall Study|Other Events|1|||
27718895|NCT00419380|80802506|FG000|Overall Study|Lack of Efficacy|1|||
27718896|NCT00419380|80802507|FG001|Overall Study|Lack of Efficacy|7|||
27718897|NCT00419380|80802506|FG000|Overall Study|Physician Decision|0|||
27718898|NCT00419380|80802507|FG001|Overall Study|Physician Decision|1|||
27718899|NCT00419380|80802506|FG000|Overall Study|Lost to Follow-up|0|||
27718900|NCT00419380|80802507|FG001|Overall Study|Lost to Follow-up|1|||
27718901|NCT00419380|80802506|FG000|Overall Study|Withdrawal by Subject|0|||
27718902|NCT00419380|80802507|FG001|Overall Study|Withdrawal by Subject|1|||
27718903|NCT03298022|80802510|FG000|Overall Study|Lack of Efficacy|4|||
27718904|NCT03298022|80802510|FG000|Overall Study|Withdrawal by Subject|7|||
27718905|NCT03298022|80802510|FG000|Overall Study|Adverse Event|1|||
27718906|NCT03298022|80802510|FG000|Overall Study|disease relapse|1|||
27718907|NCT01514682|80806345|FG000|Overall Study|Withdrawal by Subject|2|||
27718908|NCT01514682|80806346|FG001|Overall Study|Withdrawal by Subject|3|||
27718909|NCT01514682|80806345|FG000|Overall Study|Physician Decision|4|||
27718910|NCT01514682|80806346|FG001|Overall Study|Physician Decision|3|||
27718911|NCT00268242|80806350|FG000|Overall Study|Death|1|||
27718912|NCT01877083|80806351|FG000|Treatment Phase|Disease Progression|10|||
27718913|NCT01877083|80806351|FG000|Treatment Phase|Clinical Progression|1|||
27718914|NCT01877083|80806351|FG000|Treatment Phase|Adverse Event|6|||
27718915|NCT01877083|80806351|FG000|Treatment Phase|Withdrawal by Subject|2|||
27718916|NCT01877083|80806351|FG000|Treatment Phase|Lost to Follow-up|1|||
27718917|NCT01877083|80806351|FG000|Extension Phase|Disease Progression|3|||
27718918|NCT01877083|80806351|FG000|Extension Phase|Adverse Event|2|||
27607793|NCT02914314|80405850|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
27718919|NCT01587079|80806352|FG000|Overall Study|Protocol-specified criteria|9|||
27718920|NCT01587079|80806352|FG000|Overall Study|Protocol Violation|5|||
27718921|NCT01587079|80806352|FG000|Overall Study|Lost to Follow-up|2|||
27718922|NCT01587079|80806352|FG000|Overall Study|Physician Decision|2|||
27718923|NCT01587079|80806352|FG000|Overall Study|Withdrawal by Subject|7|||
27718924|NCT01587079|80806352|FG000|Overall Study|Adverse Event|14|||
27718925|NCT01678144|80806353|FG000|Stage 1: MAR Classic|Adverse Event|1|||
27718926|NCT01978093|80806354|FG000|Overall Study|Death|1|||
27718927|NCT01978093|80806355|FG001|Overall Study|Death|0|||
27718928|NCT01978093|80806354|FG000|Overall Study|Adverse Event|0|||
27718929|NCT01978093|80806355|FG001|Overall Study|Adverse Event|5|||
27718930|NCT01978093|80806354|FG000|Overall Study|Protocol Violation|8|||
27718931|NCT01978093|80806355|FG001|Overall Study|Protocol Violation|2|||
27718932|NCT01978093|80806354|FG000|Overall Study|Withdrawal by Subject|29|||
27718933|NCT01978093|80806355|FG001|Overall Study|Withdrawal by Subject|25|||
27718934|NCT01978093|80806354|FG000|Overall Study|Lost to Follow-up|11|||
27718935|NCT01978093|80806355|FG001|Overall Study|Lost to Follow-up|15|||
27718936|NCT01978093|80806354|FG000|Overall Study|Migrated/moved from study area|11|||
27718937|NCT01978093|80806355|FG001|Overall Study|Migrated/moved from study area|13|||
27718938|NCT01978093|80806354|FG000|Overall Study|Loss of kaiser coverage|4|||
27718939|NCT01978093|80806355|FG001|Overall Study|Loss of kaiser coverage|10|||
27718940|NCT01978093|80806354|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
27718941|NCT01978093|80806355|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
27718942|NCT01978093|80806354|FG000|Overall Study|Mother lost custody of child|0|||
27718943|NCT01978093|80806355|FG001|Overall Study|Mother lost custody of child|1|||
27718944|NCT01978093|80806354|FG000|Overall Study|Child was in care of grandmother|0|||
27718945|NCT01978093|80806355|FG001|Overall Study|Child was in care of grandmother|1|||
27718946|NCT01978093|80806354|FG000|Overall Study|N/A for vaccine administration|0|||
27718947|NCT01978093|80806355|FG001|Overall Study|N/A for vaccine administration|1|||
27718948|NCT01609842|80806358|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
27718949|NCT01609842|80806359|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
27718950|NCT02921971|80806361|FG000|Overall Study|Adverse Event|1|||
27718951|NCT02921971|80806362|FG001|Overall Study|Adverse Event|2|||
27718952|NCT02921971|80806361|FG000|Overall Study|Lack of Efficacy|3|||
27718953|NCT02921971|80806362|FG001|Overall Study|Lack of Efficacy|1|||
27718954|NCT02921971|80806361|FG000|Overall Study|Other than specified above|2|||
27718955|NCT02921971|80806362|FG001|Overall Study|Other than specified above|1|||
27718956|NCT00288080|80806368|FG000|Overall Study|Withdrawal by Subject|1|||
27718957|NCT00288080|80806369|FG001|Overall Study|Withdrawal by Subject|3|||
27718958|NCT00288080|80806368|FG000|Overall Study|Protocol Violation|25|||
27718959|NCT00288080|80806369|FG001|Overall Study|Protocol Violation|20|||
27718960|NCT01106846|80806378|FG000|Overall Study|Change in surgical procedure|0|||
27718961|NCT01106846|80806379|FG001|Overall Study|Change in surgical procedure|1|||
27718962|NCT01731678|80806380|FG000|Overall Study|Withdrawal by Subject|3|||
27718963|NCT01731678|80806380|FG000|Overall Study|Did not meet inclusion criteria|1|||
27718964|NCT01731678|80806380|FG000|Overall Study|RMT too high, making TMS difficult|3|||
27718965|NCT00874120|80806383|FG000|First Intervention|Adverse Event|0|||
27718966|NCT00874120|80806384|FG001|First Intervention|Adverse Event|1|||
27718967|NCT00874120|80806383|FG000|First Intervention|Withdrawal by Subject|2|||
27718968|NCT00874120|80806384|FG001|First Intervention|Withdrawal by Subject|0|||
27718969|NCT00874120|80806383|FG000|First Intervention|Lost to Follow-up|0|||
27718970|NCT00874120|80806384|FG001|First Intervention|Lost to Follow-up|1|||
27718971|NCT00874120|80806383|FG000|First Intervention|Protocol Violation|3|||
27718972|NCT00874120|80806384|FG001|First Intervention|Protocol Violation|0|||
27718973|NCT00874120|80806383|FG000|First Intervention|positive drug test|1|||
27718974|NCT00874120|80806384|FG001|First Intervention|positive drug test|0|||
27718975|NCT00874120|80806383|FG000|Second Intervention|Withdrawal by Subject|1|||
27718976|NCT00874120|80806384|FG001|Second Intervention|Withdrawal by Subject|0|||
27890359|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
27890360|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
27890361|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
27890362|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
27718977|NCT00874120|80806383|FG000|Second Intervention|Protocol Violation|1|||
27718978|NCT00874120|80806384|FG001|Second Intervention|Protocol Violation|0|||
27718979|NCT02469090|80806385|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
27718980|NCT02469090|80806386|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
27890363|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
27890364|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
27890365|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
27890366|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
27890367|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
27890368|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
27890369|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
27958588|NCT01791517|81680060|FG002|Phase II|Withdrawal by Subject|0|||
27718981|NCT02469090|80806387|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
27718982|NCT02469090|80806385|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
27718983|NCT02469090|80806386|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
27718984|NCT02469090|80806387|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
27718985|NCT02469090|80806385|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
27718986|NCT02469090|80806386|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
27718987|NCT02469090|80806387|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
27718988|NCT02469090|80806385|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
27718989|NCT02469090|80806386|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
27718990|NCT02469090|80806387|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
27718991|NCT02469090|80806385|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
27718992|NCT02469090|80806386|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
27718993|NCT02469090|80806387|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
27718994|NCT02469090|80806385|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
27718995|NCT02469090|80806386|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
27718996|NCT02469090|80806387|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
27718997|NCT02469090|80806385|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
27718998|NCT02469090|80806386|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
27718999|NCT02469090|80806387|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
27719000|NCT02469090|80806385|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
27719001|NCT02469090|80806386|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
27719002|NCT02469090|80806387|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
27719003|NCT01637142|80806400|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
27719004|NCT01662895|80806404|FG000|Overall Study|Lost to Follow-up|0|||
27719005|NCT01662895|80806405|FG001|Overall Study|Lost to Follow-up|1|||
27719006|NCT02068547|80806406|FG000|Overall Study|Lost to Follow-up|3|||
27719007|NCT02068547|80806407|FG001|Overall Study|Lost to Follow-up|3|||
27719008|NCT02068547|80806406|FG000|Overall Study|Physician Decision|1|||
27719009|NCT02068547|80806407|FG001|Overall Study|Physician Decision|0|||
27719010|NCT03064841|80806411|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
27719011|NCT03064841|80806411|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
27719012|NCT03064841|80806411|FG000|Overall Study|Screen failure|2|||
27719013|NCT01097863|80806414|FG000|Overall Study|Discomfort|1|||
27719014|NCT01097863|80806415|FG001|Overall Study|Discomfort|0|||
27719015|NCT01097863|80806416|FG002|Overall Study|Discomfort|1|||
27719016|NCT01097863|80806414|FG000|Overall Study|Did not return for final visit|0|||
27719017|NCT01097863|80806415|FG001|Overall Study|Did not return for final visit|0|||
27719018|NCT01097863|80806416|FG002|Overall Study|Did not return for final visit|1|||
27719019|NCT02863809|80806417|FG000|Overall Study|Adverse Event|8|||
27719020|NCT02863809|80806418|FG001|Overall Study|Adverse Event|8|||
27719021|NCT02863809|80806417|FG000|Overall Study|Withdrawal by Subject|0|||
27719022|NCT02863809|80806418|FG001|Overall Study|Withdrawal by Subject|1|||
27719023|NCT02863809|80806417|FG000|Overall Study|Lost to Follow-up|1|||
27719024|NCT02863809|80806418|FG001|Overall Study|Lost to Follow-up|1|||
27719025|NCT02863809|80806417|FG000|Overall Study|Death|1|||
27719026|NCT02863809|80806418|FG001|Overall Study|Death|0|||
27719027|NCT01738971|80806426|FG000|Overall Study|Lost to Follow-up|19|||
27719028|NCT01738971|80806427|FG001|Overall Study|Lost to Follow-up|30|||
27719029|NCT01738971|80806428|FG002|Overall Study|Lost to Follow-up|17|||
27719030|NCT01580488|80806429|FG000|Overall Study|Withdrawal by Subject|1|||
27719031|NCT04673786|80806431|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
27719032|NCT04673786|80806432|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
27719033|NCT04673786|80806433|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
27719034|NCT04673786|80806431|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
27719035|NCT04673786|80806432|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
27719036|NCT04673786|80806433|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
27719037|NCT04673786|80806431|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
27719038|NCT04673786|80806432|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
27719039|NCT04673786|80806433|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
27719040|NCT04673786|80806431|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
27719041|NCT04673786|80806432|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
27719042|NCT04673786|80806433|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
27719043|NCT04673786|80806431|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
27607794|NCT02914314|80405851|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
27607795|NCT02914314|80405848|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
27607796|NCT02914314|80405849|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
27607797|NCT02914314|80405850|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
27607798|NCT02914314|80405851|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
27719044|NCT04673786|80806432|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
27719045|NCT04673786|80806433|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
27719046|NCT04673786|80806431|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
27719047|NCT04673786|80806432|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
27719048|NCT04673786|80806433|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
27719049|NCT00391222|80806434|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
27719050|NCT00391222|80806435|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
27719051|NCT00391222|80806436|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
27719052|NCT00391222|80806437|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
27719053|NCT00391222|80806434|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
27719054|NCT00391222|80806435|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
27719055|NCT00391222|80806436|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
27719056|NCT00391222|80806437|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
27719057|NCT00391222|80806434|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
27719058|NCT00391222|80806435|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
27719059|NCT00391222|80806436|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
27719060|NCT00391222|80806437|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
27719061|NCT00391222|80806434|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
27719062|NCT00391222|80806435|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
27719063|NCT00391222|80806436|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
27719064|NCT00391222|80806437|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
27719065|NCT00391222|80806434|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
27719066|NCT00391222|80806435|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
27719067|NCT00391222|80806436|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
27719068|NCT00391222|80806437|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
27719069|NCT00391222|80806434|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
27719070|NCT00391222|80806435|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
27719071|NCT00391222|80806436|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
27719072|NCT00391222|80806437|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
27719073|NCT00391222|80806434|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
27719074|NCT00391222|80806435|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
27719075|NCT00391222|80806436|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
27719076|NCT00391222|80806437|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
27719077|NCT00391222|80806434|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
27719078|NCT00391222|80806435|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
27719079|NCT00391222|80806436|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
27719080|NCT00391222|80806437|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
27719081|NCT00391222|80806434|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
27719082|NCT00391222|80806435|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
27719083|NCT00391222|80806436|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
27719084|NCT00391222|80806437|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
27719085|NCT00391222|80806434|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
27719086|NCT00391222|80806435|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
27719087|NCT00391222|80806436|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
27719088|NCT00391222|80806437|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
27719089|NCT00391222|80806434|FG000|Period III (Double-Blind Treatment)|Other|6|||
27719090|NCT00391222|80806435|FG001|Period III (Double-Blind Treatment)|Other|1|||
27719091|NCT00391222|80806436|FG002|Period III (Double-Blind Treatment)|Other|6|||
27719092|NCT00391222|80806437|FG003|Period III (Double-Blind Treatment)|Other|0|||
27719093|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
27719094|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
27719095|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
27719096|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
27719097|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
27719098|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
27719099|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
27719100|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
27719101|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
27719102|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
27719103|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
27719104|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
27719105|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
27719106|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
27719107|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
27719108|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
27719109|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
27719110|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
27719111|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
27719112|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
27719113|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
27719114|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
27719115|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
27719116|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
27719117|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
27719118|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
27719119|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
27719120|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
27719121|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
27719122|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
27719123|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
27719124|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
27719125|NCT03605680|80806438|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
27719126|NCT03605680|80806439|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
27719127|NCT03605680|80806440|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
27719128|NCT03605680|80806441|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
27719129|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
27719130|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
27719131|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
27719132|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
27719133|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
27719134|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
27719135|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
27719136|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
27719137|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27719138|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27719139|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27719140|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
27719141|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
27719142|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
27719143|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
27719144|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
27719145|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
27719146|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
27719147|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
27719148|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
27719149|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
27719150|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
27719151|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
27719152|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
27719153|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
27719154|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
27719155|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
27719156|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
27719157|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
27719158|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
27719159|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
27719160|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
27719161|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
27719162|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
27719163|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
27838633|NCT02834390|81236771|FG001|Induction Phase|Progressive disease|1|||
27838634|NCT02834390|81236770|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
27838635|NCT02834390|81236771|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
27838636|NCT02834390|81236770|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
27607799|NCT03560258|80405858|FG000|Overall Study|Lost to Follow-up|3|||
27607800|NCT03560258|80405859|FG001|Overall Study|Lost to Follow-up|0|||
27607801|NCT03560258|80405860|FG002|Overall Study|Lost to Follow-up|0|||
27607802|NCT03560258|80405858|FG000|Overall Study|Protocol Violation|0|||
27607803|NCT03560258|80405859|FG001|Overall Study|Protocol Violation|1|||
27719164|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
27838637|NCT02834390|81236771|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
27838638|NCT02834390|81236770|FG000|Consolidation Phase|Physician Decision|1|||
27838639|NCT02834390|81236771|FG001|Consolidation Phase|Physician Decision|1|||
27838640|NCT01086969|81236774|FG000|Overall Study|Withdrawal by Subject|1|||
27838641|NCT01086969|81236775|FG001|Overall Study|Withdrawal by Subject|2|||
27838642|NCT01086969|81236776|FG002|Overall Study|Withdrawal by Subject|0|||
27838643|NCT01044433|81236777|FG000|Overall Study|Lost to Follow-up|3|||
27838644|NCT01044433|81236777|FG000|Overall Study|Withdrawal by Subject|3|||
27838645|NCT02107196|81236780|FG000|12-week Treatment Period|Adverse Event|6|||
27838646|NCT02107196|81236781|FG001|12-week Treatment Period|Adverse Event|3|||
27838647|NCT02107196|81236780|FG000|12-week Treatment Period|Lack of Efficacy|2|||
27838648|NCT02107196|81236781|FG001|12-week Treatment Period|Lack of Efficacy|1|||
27838649|NCT02107196|81236780|FG000|12-week Treatment Period|Lost to Follow-up|3|||
27838650|NCT02107196|81236781|FG001|12-week Treatment Period|Lost to Follow-up|6|||
27838651|NCT02107196|81236780|FG000|12-week Treatment Period|Physician Decision|0|||
27838652|NCT02107196|81236781|FG001|12-week Treatment Period|Physician Decision|1|||
27838653|NCT02107196|81236780|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
27838654|NCT02107196|81236781|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
27838655|NCT02107196|81236780|FG000|12-week Treatment Period|Protocol Violation|7|||
27838656|NCT02107196|81236781|FG001|12-week Treatment Period|Protocol Violation|8|||
27838657|NCT02107196|81236780|FG000|12-week Treatment Period|Reason Missing|11|||
27838658|NCT02107196|81236781|FG001|12-week Treatment Period|Reason Missing|8|||
27838659|NCT02107196|81236780|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
27838660|NCT02107196|81236781|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
27838661|NCT02107196|81236780|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
27838662|NCT02107196|81236781|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27838663|NCT02107196|81236780|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
27838664|NCT02107196|81236781|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
27838665|NCT02107196|81236780|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
27838666|NCT02107196|81236781|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
27838667|NCT03183141|81236801|FG000|Overall Study|Withdrawal by Subject|2|||
27838668|NCT03183141|81236802|FG001|Overall Study|Withdrawal by Subject|4|||
27838669|NCT03183141|81236801|FG000|Overall Study|Death|0|||
27838670|NCT03183141|81236802|FG001|Overall Study|Death|8|||
27838671|NCT00683592|81236805|FG000|Overall Study|Adverse Event|12|||
27838672|NCT00683592|81236806|FG001|Overall Study|Adverse Event|4|||
27838673|NCT00683592|81236805|FG000|Overall Study|Withdrawal by Subject|11|||
27838674|NCT00683592|81236806|FG001|Overall Study|Withdrawal by Subject|11|||
27838675|NCT00683592|81236805|FG000|Overall Study|Lost to Follow-up|17|||
27838676|NCT00683592|81236806|FG001|Overall Study|Lost to Follow-up|17|||
27838677|NCT00683592|81236805|FG000|Overall Study|Lack of Efficacy|3|||
27838678|NCT00683592|81236806|FG001|Overall Study|Lack of Efficacy|7|||
27838679|NCT00683592|81236805|FG000|Overall Study|Physician Decision|0|||
27838680|NCT00683592|81236806|FG001|Overall Study|Physician Decision|1|||
27838681|NCT00683592|81236805|FG000|Overall Study|Non-compliance|3|||
27838682|NCT00683592|81236806|FG001|Overall Study|Non-compliance|5|||
27838683|NCT00683592|81236805|FG000|Overall Study|Other|1|||
27838684|NCT00683592|81236806|FG001|Overall Study|Other|1|||
27838685|NCT01483820|81236807|FG000|Overall Study|Lack of Efficacy|6|||
27838686|NCT01483820|81236807|FG000|Overall Study|Adverse Event|1|||
27838687|NCT01483820|81236807|FG000|Overall Study|Death|1|||
27838688|NCT05889039|81236808|FG000|Overall Study|error in completing survey|0|||
27838689|NCT05889039|81236809|FG001|Overall Study|error in completing survey|2|||
27838690|NCT05889039|81236810|FG002|Overall Study|error in completing survey|0|||
27838691|NCT05889039|81236811|FG003|Overall Study|error in completing survey|0|||
27838692|NCT05889039|81236808|FG000|Overall Study|Lost to Follow-up|4|||
27838693|NCT05889039|81236809|FG001|Overall Study|Lost to Follow-up|0|||
27838694|NCT05889039|81236810|FG002|Overall Study|Lost to Follow-up|0|||
27838695|NCT05889039|81236811|FG003|Overall Study|Lost to Follow-up|0|||
27838696|NCT04320745|81239432|FG000|Overall Study|Adverse Event|26|||
27607804|NCT03560258|80405860|FG002|Overall Study|Protocol Violation|0|||
27607805|NCT03560258|80405858|FG000|Overall Study|Withdrawal by Subject|0|||
27719165|NCT03605680|80806438|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
27719166|NCT03605680|80806439|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
27719167|NCT03605680|80806440|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
27890370|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
27890371|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
27719168|NCT03605680|80806441|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
27719169|NCT01913483|80806444|FG000|Overall Study|Withdrawal by Subject|1|||
27719170|NCT01913483|80806445|FG001|Overall Study|Withdrawal by Subject|2|||
27719171|NCT01913483|80806444|FG000|Overall Study|Lost to Follow-up|6|||
27719172|NCT01913483|80806445|FG001|Overall Study|Lost to Follow-up|3|||
27719173|NCT01913483|80806444|FG000|Overall Study|Death|14|||
27719174|NCT01913483|80806445|FG001|Overall Study|Death|17|||
27719175|NCT00577993|80806446|FG000|Overall Study|Adverse Event|1|||
27719176|NCT00577993|80806447|FG001|Overall Study|Adverse Event|0|||
27719177|NCT00577993|80806448|FG002|Overall Study|Adverse Event|0|||
27719178|NCT00577993|80806446|FG000|Overall Study|Death|0|||
27890372|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
27719179|NCT00577993|80806447|FG001|Overall Study|Death|1|||
27719180|NCT00577993|80806448|FG002|Overall Study|Death|1|||
27719181|NCT00577993|80806446|FG000|Overall Study|Lack of Efficacy|0|||
27719182|NCT00577993|80806447|FG001|Overall Study|Lack of Efficacy|1|||
27838697|NCT04320745|81239432|FG000|Overall Study|Withdrawal by Subject|4|||
27838698|NCT04320745|81239432|FG000|Overall Study|Lost to Follow-up|12|||
27838699|NCT04320745|81239432|FG000|Overall Study|Protocol Deviation|2|||
27838700|NCT04320745|81239432|FG000|Overall Study|Non-compliance With Study Drug|2|||
27838701|NCT04320745|81239432|FG000|Overall Study|Reason Not Specified|1|||
27838702|NCT00751023|81239433|FG000|Overall Study|Lost to Follow-up|11|||
27838703|NCT00751023|81239434|FG001|Overall Study|Lost to Follow-up|7|||
27838704|NCT01609582|81239435|FG000|Overall Study|Adverse Event|20|||
27838705|NCT01609582|81239436|FG001|Overall Study|Adverse Event|18|||
27838706|NCT01609582|81239435|FG000|Overall Study|Lost to Follow-up|10|||
27719183|NCT00577993|80806448|FG002|Overall Study|Lack of Efficacy|0|||
27719184|NCT00577993|80806446|FG000|Overall Study|Protocol Violation|2|||
27719185|NCT00577993|80806447|FG001|Overall Study|Protocol Violation|3|||
27719186|NCT00577993|80806448|FG002|Overall Study|Protocol Violation|0|||
27719187|NCT00577993|80806446|FG000|Overall Study|Withdrawal by Subject|1|||
27719188|NCT00577993|80806447|FG001|Overall Study|Withdrawal by Subject|0|||
27719189|NCT00577993|80806448|FG002|Overall Study|Withdrawal by Subject|2|||
27719190|NCT00577993|80806446|FG000|Overall Study|Conversion|2|||
27719191|NCT00577993|80806447|FG001|Overall Study|Conversion|5|||
27719192|NCT00577993|80806448|FG002|Overall Study|Conversion|0|||
27719193|NCT00577993|80806446|FG000|Overall Study|Uninsured|1|||
27719194|NCT00577993|80806447|FG001|Overall Study|Uninsured|0|||
27719195|NCT00577993|80806448|FG002|Overall Study|Uninsured|0|||
27719196|NCT03988907|80806453|FG000|Overall Study|Unable to complete visit|0|||
27719197|NCT03988907|80806454|FG001|Overall Study|Unable to complete visit|1|||
27719198|NCT01692301|80806459|FG000|Overall Study|Adverse Event|15|||
27719199|NCT01692301|80806460|FG001|Overall Study|Adverse Event|12|||
27719200|NCT01692301|80806459|FG000|Overall Study|Death|1|||
27719201|NCT01692301|80806460|FG001|Overall Study|Death|2|||
27719202|NCT01692301|80806459|FG000|Overall Study|Lack of Efficacy|0|||
27719203|NCT01692301|80806460|FG001|Overall Study|Lack of Efficacy|5|||
27719204|NCT01692301|80806459|FG000|Overall Study|Non-compliance with study treatment|1|||
27719205|NCT01692301|80806460|FG001|Overall Study|Non-compliance with study treatment|2|||
27719206|NCT01692301|80806459|FG000|Overall Study|Protocol deviation|9|||
27719207|NCT01692301|80806460|FG001|Overall Study|Protocol deviation|2|||
27719208|NCT01692301|80806459|FG000|Overall Study|Patient/guardian decision|16|||
27719209|NCT01692301|80806460|FG001|Overall Study|Patient/guardian decision|15|||
27719210|NCT01692301|80806459|FG000|Overall Study|Technical problems|0|||
27719211|NCT01692301|80806460|FG001|Overall Study|Technical problems|1|||
27838707|NCT01609582|81239436|FG001|Overall Study|Lost to Follow-up|10|||
27838708|NCT01609582|81239435|FG000|Overall Study|Withdrawal by Subject|21|||
27838709|NCT01609582|81239436|FG001|Overall Study|Withdrawal by Subject|15|||
27838710|NCT01609582|81239435|FG000|Overall Study|Study Terminated by Sponsor|1543|||
27838711|NCT01609582|81239436|FG001|Overall Study|Study Terminated by Sponsor|1548|||
27838712|NCT01609582|81239435|FG000|Overall Study|Other|9|||
27838713|NCT01609582|81239436|FG001|Overall Study|Other|10|||
27719212|NCT01692301|80806459|FG000|Overall Study|Physician Decision|2|||
27719213|NCT01692301|80806460|FG001|Overall Study|Physician Decision|2|||
27719214|NCT01692301|80806459|FG000|Overall Study|Lost to Follow-up|1|||
27838714|NCT01609582|81239435|FG000|Overall Study|Randomized, but not treated|0|||
27719215|NCT01692301|80806460|FG001|Overall Study|Lost to Follow-up|1|||
27719216|NCT01396005|80806461|FG000|Overall Study|Withdrawal by Subject|0|||
27719217|NCT01396005|80806462|FG001|Overall Study|Withdrawal by Subject|1|||
27719218|NCT01396005|80806461|FG000|Overall Study|Non-compliance with protocol|0|||
27838715|NCT01609582|81239436|FG001|Overall Study|Randomized, but not treated|3|||
27719219|NCT01396005|80806462|FG001|Overall Study|Non-compliance with protocol|1|||
27719220|NCT01294800|80806463|FG000|Overall Study|Adverse Event|7|||
27719221|NCT01294800|80806464|FG001|Overall Study|Adverse Event|6|||
27719222|NCT01294800|80806465|FG002|Overall Study|Adverse Event|12|||
27719223|NCT01294800|80806466|FG003|Overall Study|Adverse Event|5|||
27719224|NCT01294800|80806463|FG000|Overall Study|Subject Withdrew Consent|2|||
27719225|NCT01294800|80806464|FG001|Overall Study|Subject Withdrew Consent|2|||
27719226|NCT01294800|80806465|FG002|Overall Study|Subject Withdrew Consent|2|||
27719227|NCT01294800|80806466|FG003|Overall Study|Subject Withdrew Consent|11|||
27719228|NCT01294800|80806463|FG000|Overall Study|Lost to Follow-up|0|||
27719229|NCT01294800|80806464|FG001|Overall Study|Lost to Follow-up|0|||
27719230|NCT01294800|80806465|FG002|Overall Study|Lost to Follow-up|1|||
27719231|NCT01294800|80806466|FG003|Overall Study|Lost to Follow-up|0|||
27719232|NCT01294800|80806463|FG000|Overall Study|Non-compliance With Protocol|0|||
27719233|NCT01294800|80806464|FG001|Overall Study|Non-compliance With Protocol|1|||
27719234|NCT01294800|80806465|FG002|Overall Study|Non-compliance With Protocol|1|||
27719235|NCT01294800|80806466|FG003|Overall Study|Non-compliance With Protocol|0|||
27719236|NCT01294800|80806463|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
27719237|NCT01294800|80806464|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
27719238|NCT01294800|80806465|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
27719239|NCT01294800|80806466|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
27719240|NCT01110200|80806467|FG000|Overall Study|Adverse Event|28|||
27719241|NCT01110200|80806468|FG001|Overall Study|Adverse Event|28|||
27719242|NCT01110200|80806467|FG000|Overall Study|Withdrawal by Subject|25|||
27719243|NCT01110200|80806468|FG001|Overall Study|Withdrawal by Subject|32|||
27719244|NCT01110200|80806467|FG000|Overall Study|Lack of Efficacy|16|||
27719245|NCT01110200|80806468|FG001|Overall Study|Lack of Efficacy|25|||
27719246|NCT01110200|80806467|FG000|Overall Study|Protocol Violation|14|||
27719247|NCT01110200|80806468|FG001|Overall Study|Protocol Violation|12|||
27719248|NCT01110200|80806467|FG000|Overall Study|Physician Decision|13|||
27719249|NCT01110200|80806468|FG001|Overall Study|Physician Decision|17|||
27719250|NCT01110200|80806467|FG000|Overall Study|Lost to Follow-up|10|||
27719251|NCT01110200|80806468|FG001|Overall Study|Lost to Follow-up|7|||
27719252|NCT04428424|80806469|FG000|Overall Study|Does not meet entrance criteria|132|||
27719253|NCT04428424|80806469|FG000|Overall Study|Lost to Follow-up|115|||
27719254|NCT01325428|80806472|FG000|Part A|Progressive disease according to RECIST|9|||
27719255|NCT01325428|80806472|FG000|Part A|Clinical signs, symptoms of progression|2|||
27719256|NCT01325428|80806472|FG000|Part A|Other adverse event|1|||
27719257|NCT01325428|80806472|FG000|Part A|Refused continue taking trial medication|2|||
27719258|NCT01325428|80806472|FG000|Part A|Other reason not defined above|2|||
27719259|NCT01325428|80806472|FG000|Part B|Refused continue taking trial medication|2|||
27719260|NCT01325428|80806472|FG000|Part B|Other reason not defined above|1|||
27719261|NCT00666458|80806475|FG000|Overall Study|Adverse Event|8|||
27719262|NCT00666458|80806476|FG001|Overall Study|Adverse Event|7|||
27719263|NCT00666458|80806475|FG000|Overall Study|Withdrawal by Subject|5|||
27719264|NCT00666458|80806476|FG001|Overall Study|Withdrawal by Subject|4|||
27719265|NCT00666458|80806475|FG000|Overall Study|Lost to Follow-up|0|||
27719266|NCT00666458|80806476|FG001|Overall Study|Lost to Follow-up|3|||
27719267|NCT00666458|80806475|FG000|Overall Study|Administrative reason by sponsor|1|||
27719268|NCT00666458|80806476|FG001|Overall Study|Administrative reason by sponsor|1|||
27719269|NCT00666458|80806475|FG000|Overall Study|Incorrect enrollment|7|||
27719270|NCT00666458|80806476|FG001|Overall Study|Incorrect enrollment|1|||
27719271|NCT00666458|80806475|FG000|Overall Study|Study specific discontinuation criteria|14|||
27719272|NCT00666458|80806476|FG001|Overall Study|Study specific discontinuation criteria|7|||
27719273|NCT00666458|80806475|FG000|Overall Study|Severe non-compliance to the protocol|1|||
27719274|NCT00666458|80806476|FG001|Overall Study|Severe non-compliance to the protocol|1|||
27719275|NCT00666458|80806475|FG000|Overall Study|Safety reasons|1|||
27719276|NCT00666458|80806476|FG001|Overall Study|Safety reasons|0|||
27719277|NCT00666458|80806475|FG000|Overall Study|Medical history of anemia|1|||
27719278|NCT00666458|80806476|FG001|Overall Study|Medical history of anemia|0|||
27719279|NCT03665285|80806477|FG000|Overall Study|Started New Anticancer Treatment|1|||
27719280|NCT03665285|80806478|FG001|Overall Study|Started New Anticancer Treatment|1|||
27838716|NCT04164758|81239440|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
27719281|NCT03665285|80806479|FG002|Overall Study|Started New Anticancer Treatment|2|||
27719282|NCT03665285|80806480|FG003|Overall Study|Started New Anticancer Treatment|4|||
27719283|NCT03665285|80806481|FG004|Overall Study|Started New Anticancer Treatment|1|||
27838717|NCT04164758|81239441|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
27838718|NCT04164758|81239442|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
27838719|NCT04164758|81239440|FG000|Overall Study|Adverse Event|0|||
27838720|NCT04164758|81239441|FG001|Overall Study|Adverse Event|1|||
27838721|NCT04164758|81239442|FG002|Overall Study|Adverse Event|0|||
27838722|NCT01097694|81239444|FG000|Overall Study|Adverse Event|5|||
27838723|NCT01097694|81239445|FG001|Overall Study|Adverse Event|0|||
27838724|NCT01097694|81239444|FG000|Overall Study|Lost to Follow-up|0|||
27838725|NCT01097694|81239445|FG001|Overall Study|Lost to Follow-up|3|||
27890373|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
27890374|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
27890375|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
27890376|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
27890377|NCT04505722|81434053|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
27890378|NCT04505722|81434054|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
27890379|NCT04505722|81434055|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
27890380|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
27890381|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
27890382|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
27890383|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
27890384|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
27890385|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
27890386|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
27890387|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
27890388|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
27890389|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
27890390|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
27890391|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
27890392|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
27838726|NCT01097694|81239444|FG000|Overall Study|Withdrawal by Subject|3|||
27607806|NCT03560258|80405859|FG001|Overall Study|Withdrawal by Subject|0|||
27838727|NCT01097694|81239445|FG001|Overall Study|Withdrawal by Subject|1|||
27838728|NCT03294317|81239451|FG000|Overall Study|Physician Decision|1|||
27838729|NCT03294317|81239451|FG000|Overall Study|Withdrawal by Subject|6|||
27838730|NCT03294317|81239451|FG000|Overall Study|Lost to Follow-up|1|||
27838731|NCT03294317|81239451|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
27838732|NCT03294317|81239451|FG000|Overall Study|Failed HB lead implant|8|||
27838733|NCT03294317|81239451|FG000|Overall Study|Received CRT instead|1|||
27838734|NCT03294317|81239451|FG000|Overall Study|Exited after lead revision|2|||
27838735|NCT02448563|81239452|FG000|Overall Study|Lost to Follow-up|16|||
27838736|NCT02448563|81239453|FG001|Overall Study|Lost to Follow-up|10|||
27890393|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
27890394|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
27607807|NCT03560258|80405860|FG002|Overall Study|Withdrawal by Subject|1|||
27838737|NCT02448563|81239452|FG000|Overall Study|Withdrawal by Subject|0|||
27838738|NCT02448563|81239453|FG001|Overall Study|Withdrawal by Subject|1|||
27838739|NCT00762411|81239454|FG000|Initial Treatment|Death|7|||
27838740|NCT00762411|81239455|FG001|Initial Treatment|Death|6|||
27607808|NCT02924389|80405861|FG000|Overall Study|Lost to Follow-up|1|||
27607809|NCT02924389|80405862|FG001|Overall Study|Lost to Follow-up|0|||
27607810|NCT02924389|80405861|FG000|Overall Study|Physician Decision|2|||
27607811|NCT02924389|80405862|FG001|Overall Study|Physician Decision|0|||
27607812|NCT02924389|80405861|FG000|Overall Study|Withdrawal by Subject|3|||
27607813|NCT02924389|80405862|FG001|Overall Study|Withdrawal by Subject|0|||
27607814|NCT02924389|80405861|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
27607815|NCT02924389|80405862|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
27607816|NCT02667886|80405870|FG000|Dose Escalation (Part A)|Adverse Event|1|||
27607817|NCT02667886|80405871|FG001|Dose Escalation (Part A)|Adverse Event|3|||
27607818|NCT02667886|80405872|FG002|Dose Escalation (Part A)|Adverse Event|1|||
27607819|NCT02667886|80405873|FG003|Dose Escalation (Part A)|Adverse Event|0|||
27607820|NCT02667886|80405874|FG004|Dose Escalation (Part A)|Adverse Event|0|||
27607821|NCT02667886|80405870|FG000|Dose Escalation (Part A)|Disease Progression|1|||
27607822|NCT02667886|80405871|FG001|Dose Escalation (Part A)|Disease Progression|4|||
27607823|NCT02667886|80405872|FG002|Dose Escalation (Part A)|Disease Progression|3|||
27607824|NCT02667886|80405873|FG003|Dose Escalation (Part A)|Disease Progression|0|||
27607825|NCT02667886|80405874|FG004|Dose Escalation (Part A)|Disease Progression|0|||
27607826|NCT02667886|80405870|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
27607827|NCT02667886|80405871|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
27607828|NCT02667886|80405872|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
27607829|NCT02667886|80405873|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
27607830|NCT02667886|80405874|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
27607831|NCT02667886|80405870|FG000|Dose Expansion (Part B)|Adverse Event|0|||
27607832|NCT02667886|80405871|FG001|Dose Expansion (Part B)|Adverse Event|0|||
27607833|NCT02667886|80405872|FG002|Dose Expansion (Part B)|Adverse Event|0|||
27607834|NCT02667886|80405873|FG003|Dose Expansion (Part B)|Adverse Event|9|||
27607835|NCT02667886|80405874|FG004|Dose Expansion (Part B)|Adverse Event|0|||
27607836|NCT02667886|80405870|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
27607837|NCT02667886|80405871|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
27607838|NCT02667886|80405872|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
27607839|NCT02667886|80405873|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
27719284|NCT03665285|80806482|FG005|Overall Study|Started New Anticancer Treatment|1|||
27719285|NCT03665285|80806483|FG006|Overall Study|Started New Anticancer Treatment|2|||
27719286|NCT03665285|80806484|FG007|Overall Study|Started New Anticancer Treatment|15|||
27719287|NCT03665285|80806485|FG008|Overall Study|Started New Anticancer Treatment|1|||
27719288|NCT03665285|80806477|FG000|Overall Study|Disease Progression|0|||
27719289|NCT03665285|80806478|FG001|Overall Study|Disease Progression|0|||
27719290|NCT03665285|80806479|FG002|Overall Study|Disease Progression|3|||
27719291|NCT03665285|80806480|FG003|Overall Study|Disease Progression|1|||
27719292|NCT03665285|80806481|FG004|Overall Study|Disease Progression|0|||
27607840|NCT02667886|80405874|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
27719293|NCT03665285|80806482|FG005|Overall Study|Disease Progression|0|||
27719294|NCT03665285|80806483|FG006|Overall Study|Disease Progression|0|||
27719295|NCT03665285|80806484|FG007|Overall Study|Disease Progression|7|||
27719296|NCT03665285|80806485|FG008|Overall Study|Disease Progression|1|||
27719297|NCT03665285|80806477|FG000|Overall Study|Hospice|0|||
27838741|NCT00762411|81239454|FG000|Initial Treatment|Adverse Event|132|||
27838742|NCT00762411|81239455|FG001|Initial Treatment|Adverse Event|40|||
27838743|NCT00762411|81239454|FG000|Initial Treatment|Protocol Violation|4|||
27838744|NCT00762411|81239455|FG001|Initial Treatment|Protocol Violation|1|||
27719298|NCT03665285|80806478|FG001|Overall Study|Hospice|0|||
27607841|NCT02667886|80405870|FG000|Dose Expansion (Part B)|Disease Progression|0|||
27719299|NCT03665285|80806479|FG002|Overall Study|Hospice|0|||
27838745|NCT00762411|81239454|FG000|Initial Treatment|Withdrawal by Subject|65|||
27719300|NCT03665285|80806480|FG003|Overall Study|Hospice|0|||
27838746|NCT00762411|81239455|FG001|Initial Treatment|Withdrawal by Subject|52|||
27838747|NCT00762411|81239454|FG000|Initial Treatment|Physician Decision|1|||
27607842|NCT02667886|80405871|FG001|Dose Expansion (Part B)|Disease Progression|0|||
27607843|NCT02667886|80405872|FG002|Dose Expansion (Part B)|Disease Progression|0|||
27719301|NCT03665285|80806481|FG004|Overall Study|Hospice|0|||
27719302|NCT03665285|80806482|FG005|Overall Study|Hospice|0|||
27719303|NCT03665285|80806483|FG006|Overall Study|Hospice|0|||
27838748|NCT00762411|81239455|FG001|Initial Treatment|Physician Decision|0|||
27890395|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
27890396|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
27719304|NCT03665285|80806484|FG007|Overall Study|Hospice|2|||
27719305|NCT03665285|80806485|FG008|Overall Study|Hospice|0|||
27719306|NCT03665285|80806477|FG000|Overall Study|Withdrawal by Subject|0|||
27719307|NCT03665285|80806478|FG001|Overall Study|Withdrawal by Subject|0|||
27719308|NCT03665285|80806479|FG002|Overall Study|Withdrawal by Subject|0|||
27719309|NCT03665285|80806480|FG003|Overall Study|Withdrawal by Subject|0|||
27719310|NCT03665285|80806481|FG004|Overall Study|Withdrawal by Subject|1|||
27719311|NCT03665285|80806482|FG005|Overall Study|Withdrawal by Subject|0|||
27719312|NCT03665285|80806483|FG006|Overall Study|Withdrawal by Subject|0|||
27719313|NCT03665285|80806484|FG007|Overall Study|Withdrawal by Subject|2|||
27719314|NCT03665285|80806485|FG008|Overall Study|Withdrawal by Subject|0|||
27719315|NCT03665285|80806477|FG000|Overall Study|Physician Decision|0|||
27719316|NCT03665285|80806478|FG001|Overall Study|Physician Decision|0|||
27719317|NCT03665285|80806479|FG002|Overall Study|Physician Decision|0|||
27719318|NCT03665285|80806480|FG003|Overall Study|Physician Decision|0|||
27719319|NCT03665285|80806481|FG004|Overall Study|Physician Decision|0|||
27719320|NCT03665285|80806482|FG005|Overall Study|Physician Decision|0|||
27719321|NCT03665285|80806483|FG006|Overall Study|Physician Decision|0|||
27719322|NCT03665285|80806484|FG007|Overall Study|Physician Decision|2|||
27719323|NCT03665285|80806485|FG008|Overall Study|Physician Decision|0|||
27890397|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
27890398|NCT04505722|81434053|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
27890399|NCT04505722|81434054|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
27890400|NCT04505722|81434055|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
27890401|NCT01608087|81434056|FG000|Overall Study|Lost to Follow-up|0|||
27890402|NCT01608087|81434057|FG001|Overall Study|Lost to Follow-up|1|||
27890403|NCT01608087|81434058|FG002|Overall Study|Lost to Follow-up|0|||
27890404|NCT01608087|81434056|FG000|Overall Study|Other Reason|0|||
27890405|NCT01608087|81434057|FG001|Overall Study|Other Reason|1|||
27890406|NCT01608087|81434058|FG002|Overall Study|Other Reason|0|||
27890407|NCT03467217|81434059|FG000|Overall Study|Trial stopped early|5|||
27890408|NCT03467217|81434060|FG001|Overall Study|Trial stopped early|2|||
27890409|NCT03467217|81434059|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
27890410|NCT03467217|81434060|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
27890411|NCT03467217|81434059|FG000|Overall Study|Lost to Follow-up|0|||
27890412|NCT03467217|81434060|FG001|Overall Study|Lost to Follow-up|2|||
27890413|NCT02218736|81434061|FG000|Overall Study|Withdrawal by Subject|10|||
27890414|NCT02218736|81434062|FG001|Overall Study|Withdrawal by Subject|9|||
27890415|NCT02218736|81434061|FG000|Overall Study|Protocol Violation|2|||
27890416|NCT02218736|81434062|FG001|Overall Study|Protocol Violation|0|||
27890417|NCT01346189|81434063|FG000|Overall Study|Withdrawal by Subject|7|||
27890418|NCT01346189|81434064|FG001|Overall Study|Withdrawal by Subject|5|||
27890419|NCT01346189|81434065|FG002|Overall Study|Withdrawal by Subject|3|||
27890420|NCT01346189|81434066|FG003|Overall Study|Withdrawal by Subject|5|||
27890421|NCT01346189|81434063|FG000|Overall Study|Physician Decision|4|||
27890422|NCT01346189|81434064|FG001|Overall Study|Physician Decision|0|||
27890423|NCT01346189|81434065|FG002|Overall Study|Physician Decision|0|||
27719324|NCT02175680|80806486|FG000|Overall Study|non-compliance|1|||
27890424|NCT01346189|81434066|FG003|Overall Study|Physician Decision|0|||
27890425|NCT01346189|81434063|FG000|Overall Study|Moved|3|||
27890426|NCT01346189|81434064|FG001|Overall Study|Moved|0|||
27890427|NCT01346189|81434065|FG002|Overall Study|Moved|4|||
27890428|NCT01346189|81434066|FG003|Overall Study|Moved|0|||
27890429|NCT01346189|81434063|FG000|Overall Study|Other|2|||
27890430|NCT01346189|81434064|FG001|Overall Study|Other|4|||
27890431|NCT01346189|81434065|FG002|Overall Study|Other|7|||
27890432|NCT01346189|81434066|FG003|Overall Study|Other|3|||
27890433|NCT01346189|81434063|FG000|Overall Study|Death|0|||
27890434|NCT01346189|81434064|FG001|Overall Study|Death|3|||
27890435|NCT01346189|81434065|FG002|Overall Study|Death|0|||
27890436|NCT01346189|81434066|FG003|Overall Study|Death|0|||
27890437|NCT01346189|81434063|FG000|Overall Study|Non-health system primary care physician|0|||
27890438|NCT01346189|81434064|FG001|Overall Study|Non-health system primary care physician|5|||
27890439|NCT01346189|81434065|FG002|Overall Study|Non-health system primary care physician|0|||
27890440|NCT01346189|81434066|FG003|Overall Study|Non-health system primary care physician|0|||
27890441|NCT01346189|81434063|FG000|Overall Study|Travel|0|||
27890442|NCT01346189|81434064|FG001|Overall Study|Travel|0|||
27890443|NCT01346189|81434065|FG002|Overall Study|Travel|0|||
27890444|NCT01346189|81434066|FG003|Overall Study|Travel|3|||
27890445|NCT03702010|81434067|FG000|Follow-up (30days)|Lack of Efficacy|2|||
27890446|NCT03702010|81434068|FG001|Follow-up (30days)|Lack of Efficacy|2|||
27890447|NCT00727844|81434070|FG000|Initial Randomization|Physician Decision|2|||
27890448|NCT00727844|81434071|FG001|Initial Randomization|Physician Decision|0|||
27890449|NCT00727844|81434072|FG002|Initial Randomization|Physician Decision|0|||
27890450|NCT00727844|81434073|FG003|Initial Randomization|Physician Decision|0|||
27890451|NCT00748189|81434077|FG000|Overall Study|Death|99|||
27890452|NCT00748189|81434078|FG001|Overall Study|Death|84|||
27890453|NCT00748189|81434077|FG000|Overall Study|Withdrawal by Subject|23|||
27838749|NCT00762411|81239454|FG000|Initial Treatment|Sponsor Decision|293|||
27838750|NCT00762411|81239455|FG001|Initial Treatment|Sponsor Decision|401|||
27890454|NCT00748189|81434078|FG001|Overall Study|Withdrawal by Subject|29|||
27890455|NCT00748189|81434077|FG000|Overall Study|Physician Decision|16|||
27890456|NCT00748189|81434078|FG001|Overall Study|Physician Decision|5|||
27890457|NCT00748189|81434077|FG000|Overall Study|Lost to Follow-up|8|||
27890458|NCT00748189|81434078|FG001|Overall Study|Lost to Follow-up|15|||
27890459|NCT00748189|81434077|FG000|Overall Study|Study terminated by Sponsor|70|||
27890460|NCT00748189|81434078|FG001|Overall Study|Study terminated by Sponsor|79|||
27890461|NCT03782298|81434080|FG000|Overall Study|Protocol Deviation|4|||
27890462|NCT00281632|81434085|FG000|Overall Study|Adverse Event|7|||
27890463|NCT00281632|81434085|FG000|Overall Study|Withdrawal by Subject|2|||
27890464|NCT00281632|81434085|FG000|Overall Study|Disease Progression|22|||
27890465|NCT00281632|81434085|FG000|Overall Study|Death|1|||
27890466|NCT00281632|81434085|FG000|Overall Study|Physician Decision|1|||
27890467|NCT00281632|81434085|FG000|Overall Study|Ongoing|3|||
27890468|NCT04791319|81434086|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
27890469|NCT04791319|81434087|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
27607844|NCT02667886|80405873|FG003|Dose Expansion (Part B)|Disease Progression|38|||
27838751|NCT00762411|81239454|FG000|Initial Treatment|Lost to Follow-up|5|||
27838752|NCT00762411|81239455|FG001|Initial Treatment|Lost to Follow-up|0|||
27838753|NCT00762411|81239454|FG000|Initial Treatment|Caregiver Decision|21|||
27838754|NCT00762411|81239455|FG001|Initial Treatment|Caregiver Decision|16|||
27838755|NCT00762411|81239454|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
27838756|NCT00762411|81239455|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
27838757|NCT00762411|81239454|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
27838758|NCT00762411|81239455|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
27838759|NCT00762411|81239454|FG000|Delayed Start|Adverse Event|0|||
27838760|NCT00762411|81239455|FG001|Delayed Start|Adverse Event|4|||
27838761|NCT00762411|81239454|FG000|Delayed Start|Protocol Violation|0|||
27838762|NCT00762411|81239455|FG001|Delayed Start|Protocol Violation|1|||
27838763|NCT00762411|81239454|FG000|Delayed Start|Sponsor Decision|16|||
27838764|NCT00762411|81239455|FG001|Delayed Start|Sponsor Decision|20|||
27838765|NCT00762411|81239454|FG000|Delayed Start|Caregiver Decision|1|||
27838766|NCT00762411|81239455|FG001|Delayed Start|Caregiver Decision|1|||
27838767|NCT00762411|81239454|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
27838768|NCT00762411|81239455|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
27838769|NCT00762411|81239454|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
27838770|NCT00762411|81239455|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
27838771|NCT00762411|81239454|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
27838772|NCT00762411|81239455|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
27838773|NCT00762411|81239454|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
27838774|NCT00762411|81239455|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
27890470|NCT04791319|81434088|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
27890471|NCT04791319|81434089|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
27890472|NCT04791319|81434090|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27890473|NCT04791319|81434091|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27890474|NCT04791319|81434092|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27890475|NCT04791319|81434093|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27890476|NCT04791319|81434094|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27890477|NCT04791319|81434095|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27890478|NCT04791319|81434096|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
27607845|NCT02667886|80405874|FG004|Dose Expansion (Part B)|Disease Progression|0|||
27890479|NCT04791319|81434086|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
27890480|NCT04791319|81434087|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27838775|NCT00762411|81239454|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
27838776|NCT00762411|81239455|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
27890481|NCT04791319|81434088|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
27890482|NCT04791319|81434089|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
27890483|NCT04791319|81434090|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27607846|NCT02667886|80405870|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
27607847|NCT02667886|80405871|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
27607848|NCT02667886|80405872|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
27607849|NCT02667886|80405873|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
27607850|NCT02667886|80405874|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
27607851|NCT02667886|80405870|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
27607852|NCT02667886|80405871|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
27719325|NCT02175680|80806486|FG000|Overall Study|other non-medical reason|1|||
27719326|NCT00191451|80806489|FG000|Overall Study|Withdrawal by Subject|2|||
27719327|NCT00191451|80806490|FG001|Overall Study|Withdrawal by Subject|3|||
27719328|NCT00191451|80806491|FG002|Overall Study|Withdrawal by Subject|5|||
27719329|NCT00191451|80806489|FG000|Overall Study|Physician Decision|2|||
27719330|NCT00191451|80806490|FG001|Overall Study|Physician Decision|9|||
27719331|NCT00191451|80806491|FG002|Overall Study|Physician Decision|6|||
27719332|NCT00191451|80806489|FG000|Overall Study|Sponsor Decision|1|||
27719333|NCT00191451|80806490|FG001|Overall Study|Sponsor Decision|0|||
27719334|NCT00191451|80806491|FG002|Overall Study|Sponsor Decision|0|||
27719335|NCT00191451|80806489|FG000|Overall Study|Ineligible|0|||
27719336|NCT00191451|80806490|FG001|Overall Study|Ineligible|1|||
27719337|NCT00191451|80806491|FG002|Overall Study|Ineligible|0|||
27719338|NCT00191451|80806489|FG000|Overall Study|Reason Not Specified|2|||
27719339|NCT00191451|80806490|FG001|Overall Study|Reason Not Specified|1|||
27719340|NCT00191451|80806491|FG002|Overall Study|Reason Not Specified|3|||
27719341|NCT00789529|80806496|FG000|Overall Study|Withdrawal by Subject|0|||
27719342|NCT00789529|80806497|FG001|Overall Study|Withdrawal by Subject|1|||
27719343|NCT00789529|80806496|FG000|Overall Study|Other Reason|1|||
27719344|NCT00789529|80806497|FG001|Overall Study|Other Reason|0|||
27719345|NCT02302963|80806500|FG000|Overall Study|Withdrawal by Subject|2|||
27719346|NCT02302963|80806501|FG001|Overall Study|Withdrawal by Subject|1|||
27719347|NCT02302963|80806500|FG000|Overall Study|Steroid injection|0|||
27719348|NCT02302963|80806501|FG001|Overall Study|Steroid injection|1|||
27719349|NCT02302963|80806500|FG000|Overall Study|Physician Decision|1|||
27838777|NCT00762411|81239454|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
27838778|NCT00762411|81239455|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
27838779|NCT05278858|81239458|FG000|Overall Study|Withdrawal by Subject|1|||
27838780|NCT02896296|81239461|FG000|Overall Study|Adverse Event|1|||
27838781|NCT02896296|81239461|FG000|Overall Study|Lost to Follow-up|19|||
27838782|NCT02896296|81239461|FG000|Overall Study|Pregnancy|1|||
27838783|NCT02896296|81239461|FG000|Overall Study|Physician Decision|2|||
27838784|NCT02896296|81239461|FG000|Overall Study|Withdrawal by Subject|10|||
27838785|NCT02896296|81239461|FG000|Overall Study|Site closing|7|||
27838786|NCT02896296|81239461|FG000|Overall Study|Incarceration|1|||
27838787|NCT02896296|81239461|FG000|Overall Study|Relocation|1|||
27890484|NCT04791319|81434091|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27890485|NCT04791319|81434092|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27890486|NCT04791319|81434093|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27890487|NCT04791319|81434094|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27890488|NCT04791319|81434095|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27719350|NCT02302963|80806501|FG001|Overall Study|Physician Decision|0|||
27719351|NCT02361216|80806502|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
27719352|NCT02361216|80806503|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
27719353|NCT02361216|80806502|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
27719354|NCT02361216|80806503|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
27719355|NCT02361216|80806502|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
27719356|NCT02361216|80806503|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
27719357|NCT02361216|80806502|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
27719358|NCT02361216|80806503|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
27719359|NCT02361216|80806502|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
27719360|NCT02361216|80806503|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
27719361|NCT02361216|80806502|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
27838788|NCT01691612|81239462|FG000|Overall Study|deemed ineligible after 1st visit|6|||
27838789|NCT01691612|81239462|FG000|Overall Study|Adverse Event|1|||
27838790|NCT02250651|81239465|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
27838791|NCT02250651|81239466|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
27890489|NCT04791319|81434096|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
27890490|NCT04791319|81434086|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
27719362|NCT02361216|80806503|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
27838792|NCT02250651|81239467|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
27607853|NCT02667886|80405872|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
27607854|NCT02667886|80405873|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
27607855|NCT02667886|80405874|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
27607856|NCT02667886|80405870|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
27607857|NCT02667886|80405871|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
27607858|NCT02667886|80405872|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
27607859|NCT02667886|80405873|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
27607860|NCT02667886|80405874|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
27607861|NCT04041440|80405875|FG000|Overall Study|Withdrawal by Subject|0|||
27607862|NCT04041440|80405876|FG001|Overall Study|Withdrawal by Subject|1|||
27607863|NCT04041440|80405875|FG000|Overall Study|Lost to Follow-up|0|||
27607864|NCT04041440|80405876|FG001|Overall Study|Lost to Follow-up|1|||
27607865|NCT00874432|80405879|FG000|Overall Study|Withdrawal by Subject|1|||
27607866|NCT00874432|80405880|FG001|Overall Study|Withdrawal by Subject|0|||
27607867|NCT00874432|80405881|FG002|Overall Study|Withdrawal by Subject|0|||
27607868|NCT00874432|80405882|FG003|Overall Study|Withdrawal by Subject|0|||
27607869|NCT00874432|80405879|FG000|Overall Study|Physician Decision|1|||
27607870|NCT00874432|80405880|FG001|Overall Study|Physician Decision|0|||
27607871|NCT00874432|80405881|FG002|Overall Study|Physician Decision|0|||
27607872|NCT00874432|80405882|FG003|Overall Study|Physician Decision|0|||
27607873|NCT00874432|80405879|FG000|Overall Study|Other|1|||
27607874|NCT00874432|80405880|FG001|Overall Study|Other|2|||
27607875|NCT00874432|80405881|FG002|Overall Study|Other|8|||
27607876|NCT00874432|80405882|FG003|Overall Study|Other|3|||
27607877|NCT00785707|80405887|FG000|Overall Study|Lost to Follow-up|7|||
27607878|NCT01382602|80405890|FG000|Overall Study|Protocol Violation|0|||
27607879|NCT01382602|80405891|FG001|Overall Study|Protocol Violation|3|||
27607880|NCT01382602|80405890|FG000|Overall Study|Withdrawal by Subject|0|||
27607881|NCT01382602|80405891|FG001|Overall Study|Withdrawal by Subject|1|||
27607882|NCT01372605|80405900|FG000|Overall Study|Death|1|||
27607883|NCT01372605|80405901|FG001|Overall Study|Death|2|||
27607884|NCT01372605|80405900|FG000|Overall Study|Lost to Follow-up|2|||
27607885|NCT01372605|80405901|FG001|Overall Study|Lost to Follow-up|1|||
27607886|NCT01372605|80405900|FG000|Overall Study|Withdrawal by Subject|4|||
27607887|NCT01372605|80405901|FG001|Overall Study|Withdrawal by Subject|7|||
27607888|NCT01372605|80405900|FG000|Overall Study|Moved|3|||
27607889|NCT01372605|80405901|FG001|Overall Study|Moved|0|||
27607890|NCT01372605|80405900|FG000|Overall Study|Changed medical home|2|||
27607891|NCT01372605|80405901|FG001|Overall Study|Changed medical home|0|||
27607892|NCT02563002|80405906|FG000|Overall Study|Death|72|||
27607893|NCT02563002|80405907|FG001|Overall Study|Death|87|||
27607894|NCT02563002|80405906|FG000|Overall Study|Lost to Follow-up|5|||
27607895|NCT02563002|80405907|FG001|Overall Study|Lost to Follow-up|0|||
27607896|NCT02563002|80405906|FG000|Overall Study|Physician Decision|0|||
27607897|NCT02563002|80405907|FG001|Overall Study|Physician Decision|2|||
27607898|NCT02563002|80405906|FG000|Overall Study|Withdrawal by Subject|2|||
27607899|NCT02563002|80405907|FG001|Overall Study|Withdrawal by Subject|10|||
27607900|NCT02563002|80405906|FG000|Overall Study|Sponsor decision|74|||
27607901|NCT02563002|80405907|FG001|Overall Study|Sponsor decision|55|||
27607902|NCT02459093|80405909|FG000|Overall Study|Protocol Violation|6|||
27607903|NCT02459093|80405910|FG001|Overall Study|Protocol Violation|11|||
27607904|NCT02459093|80405909|FG000|Overall Study|Lost to Follow-up|6|||
27607905|NCT02459093|80405910|FG001|Overall Study|Lost to Follow-up|7|||
27607906|NCT04887948|80405915|FG000|Overall Study|Death|1|||
27719363|NCT00272038|80806505|FG000|Overall Study|withdrew before they received 2 cycles|7|||
27719364|NCT01543087|80806506|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
27607907|NCT04887948|80405916|FG001|Overall Study|Death|0|||
27607908|NCT04887948|80405917|FG002|Overall Study|Death|0|||
27607909|NCT04887948|80405915|FG000|Overall Study|Lost to Follow-up|1|||
27607910|NCT04887948|80405916|FG001|Overall Study|Lost to Follow-up|0|||
27607911|NCT04887948|80405917|FG002|Overall Study|Lost to Follow-up|3|||
27719365|NCT01543087|80806507|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
27719366|NCT01543087|80806508|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
27607912|NCT04887948|80405915|FG000|Overall Study|Physician Decision|0|||
27607913|NCT04887948|80405916|FG001|Overall Study|Physician Decision|4|||
27607914|NCT04887948|80405917|FG002|Overall Study|Physician Decision|1|||
27607915|NCT04887948|80405915|FG000|Overall Study|Protocol Violation|1|||
27607916|NCT04887948|80405916|FG001|Overall Study|Protocol Violation|1|||
27719367|NCT01543087|80806509|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
27890491|NCT04791319|81434087|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
27890492|NCT04791319|81434088|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
27890493|NCT04791319|81434089|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
27958589|NCT01791517|81680061|FG003|Phase II|Withdrawal by Subject|0|||
27607917|NCT04887948|80405917|FG002|Overall Study|Protocol Violation|0|||
27607918|NCT04887948|80405915|FG000|Overall Study|Withdrawal by Subject|0|||
27607919|NCT04887948|80405916|FG001|Overall Study|Withdrawal by Subject|6|||
27607920|NCT04887948|80405917|FG002|Overall Study|Withdrawal by Subject|1|||
27607921|NCT04887948|80405915|FG000|Overall Study|No longer met eligibility criteria|1|||
27607922|NCT04887948|80405916|FG001|Overall Study|No longer met eligibility criteria|2|||
27607923|NCT04887948|80405917|FG002|Overall Study|No longer met eligibility criteria|1|||
27607924|NCT04887948|80405915|FG000|Overall Study|Other|2|||
27890494|NCT04791319|81434090|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27890495|NCT04791319|81434091|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27890496|NCT04791319|81434092|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27890497|NCT04791319|81434093|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27890498|NCT04791319|81434094|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27890499|NCT04791319|81434095|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27890500|NCT04791319|81434096|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
27607925|NCT04887948|80405916|FG001|Overall Study|Other|1|||
27607926|NCT04887948|80405917|FG002|Overall Study|Other|1|||
27607927|NCT01540565|80405918|FG000|Overall Study|Ineligible|2|||
27607928|NCT02026232|80405922|FG000|Overall Study|incomplete visit/missing data|3|||
27607929|NCT02026232|80405923|FG001|Overall Study|incomplete visit/missing data|2|||
27607930|NCT02086552|80405953|FG000|Overall Study|Withdrawal by Subject|1|||
27607931|NCT02966002|80405954|FG000|Overall Study|Withdrawal by Subject|2|||
27607932|NCT02966002|80405954|FG000|Overall Study|Adverse Event|1|||
27607933|NCT02966002|80405954|FG000|Overall Study|Lost to Follow-up|1|||
27607934|NCT01215357|80405956|FG000|Overall Study|Withdrawal by Subject|3|||
27607935|NCT01215357|80405956|FG000|Overall Study|Protocol Violation|9|||
27607936|NCT01161472|80405959|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
27607937|NCT01161472|80405960|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
27607938|NCT01161472|80405961|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
27607939|NCT01161472|80405962|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
27607940|NCT02309112|80405966|FG000|Overall Study|Withdrawal by Subject|1|||
27607941|NCT02309112|80405967|FG001|Overall Study|Withdrawal by Subject|0|||
27838793|NCT02250651|81239465|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
27838794|NCT02250651|81239466|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
27838795|NCT02250651|81239467|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
27838796|NCT02250651|81239465|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
27838797|NCT02250651|81239466|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
27838798|NCT02250651|81239467|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
27838799|NCT02250651|81239465|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
27838800|NCT02250651|81239466|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
27838801|NCT02250651|81239467|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
27838802|NCT02250651|81239465|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
27838803|NCT02250651|81239466|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
27838804|NCT02250651|81239467|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
27838805|NCT02250651|81239465|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
27890501|NCT04791319|81434086|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
27958590|NCT01791517|81680062|FG004|Phase II|Withdrawal by Subject|0|||
27607942|NCT02309112|80405968|FG002|Overall Study|Withdrawal by Subject|1|||
27607943|NCT02309112|80405966|FG000|Overall Study|Lost to Follow-up|0|||
27607944|NCT02309112|80405967|FG001|Overall Study|Lost to Follow-up|1|||
27607945|NCT02309112|80405968|FG002|Overall Study|Lost to Follow-up|0|||
27607946|NCT02912468|80405972|FG000|Overall Study|Adverse Event|3|||
27607947|NCT02912468|80405973|FG001|Overall Study|Adverse Event|2|||
27607948|NCT02912468|80405972|FG000|Overall Study|Withdrawal by Subject|6|||
27607949|NCT02912468|80405973|FG001|Overall Study|Withdrawal by Subject|2|||
27607950|NCT02912468|80405972|FG000|Overall Study|Randomized and not treated|0|||
27607951|NCT02912468|80405973|FG001|Overall Study|Randomized and not treated|1|||
27607952|NCT00920621|80405974|FG000|Overall Study|Lost to Follow-up|16|||
27607953|NCT00920621|80405975|FG001|Overall Study|Lost to Follow-up|17|||
27607954|NCT00920621|80405976|FG002|Overall Study|Lost to Follow-up|19|||
27607955|NCT00920621|80405977|FG003|Overall Study|Lost to Follow-up|21|||
27607956|NCT00920621|80405974|FG000|Overall Study|Fetal/neonatal deaths|16|||
27607957|NCT00920621|80405975|FG001|Overall Study|Fetal/neonatal deaths|14|||
27607958|NCT00920621|80405976|FG002|Overall Study|Fetal/neonatal deaths|16|||
27607959|NCT00920621|80405977|FG003|Overall Study|Fetal/neonatal deaths|14|||
27607960|NCT00920621|80405974|FG000|Overall Study|Blood sample not collected|22|||
27607961|NCT00920621|80405975|FG001|Overall Study|Blood sample not collected|14|||
27607962|NCT00920621|80405976|FG002|Overall Study|Blood sample not collected|0|||
27607963|NCT00920621|80405977|FG003|Overall Study|Blood sample not collected|0|||
27607964|NCT01396395|80405978|FG000|Overall Study|Withdrawal by Subject|10|||
27607965|NCT01396395|80405979|FG001|Overall Study|Withdrawal by Subject|12|||
27607966|NCT01396395|80405978|FG000|Overall Study|Protocol Violation|3|||
27607967|NCT01396395|80405979|FG001|Overall Study|Protocol Violation|1|||
27607968|NCT01396395|80405978|FG000|Overall Study|Adverse Event|10|||
27607969|NCT01396395|80405979|FG001|Overall Study|Adverse Event|2|||
27607970|NCT01396395|80405978|FG000|Overall Study|Lost to Follow-up|17|||
27607971|NCT01396395|80405979|FG001|Overall Study|Lost to Follow-up|11|||
27607972|NCT01396395|80405978|FG000|Overall Study|Other|0|||
27607973|NCT01396395|80405979|FG001|Overall Study|Other|1|||
27607974|NCT02961881|80405987|FG000|Overall Study|Adverse Event|1|||
27607975|NCT02961881|80405988|FG001|Overall Study|Adverse Event|2|||
27607976|NCT02961881|80405989|FG002|Overall Study|Adverse Event|2|||
27607977|NCT02961881|80405990|FG003|Overall Study|Adverse Event|0|||
27607978|NCT02961881|80405991|FG004|Overall Study|Adverse Event|1|||
27607979|NCT02961881|80405987|FG000|Overall Study|Participant request|0|||
27607980|NCT02961881|80405988|FG001|Overall Study|Participant request|2|||
27607981|NCT02961881|80405989|FG002|Overall Study|Participant request|0|||
27607982|NCT02961881|80405990|FG003|Overall Study|Participant request|0|||
27607983|NCT02961881|80405991|FG004|Overall Study|Participant request|0|||
27607984|NCT02961881|80405987|FG000|Overall Study|Disease progression|1|||
27607985|NCT02961881|80405988|FG001|Overall Study|Disease progression|0|||
27719368|NCT01543087|80806510|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
27719369|NCT01543087|80806511|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
27719370|NCT01543087|80806506|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
27719371|NCT01543087|80806507|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
27719372|NCT01543087|80806508|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
27719373|NCT01543087|80806509|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
27719374|NCT01543087|80806510|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
27719375|NCT01543087|80806511|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
27719376|NCT01543087|80806506|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
27719377|NCT01543087|80806507|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
27719378|NCT01543087|80806508|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
27719379|NCT01543087|80806509|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
27719380|NCT01543087|80806510|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
27719381|NCT01543087|80806511|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
27719382|NCT01543087|80806506|FG000|Stage 1 (48 Months)|Other than specified|5|||
27719383|NCT01543087|80806507|FG001|Stage 1 (48 Months)|Other than specified|0|||
27719384|NCT01543087|80806508|FG002|Stage 1 (48 Months)|Other than specified|9|||
27719385|NCT01543087|80806509|FG003|Stage 1 (48 Months)|Other than specified|0|||
27719386|NCT01543087|80806510|FG004|Stage 1 (48 Months)|Other than specified|0|||
27719387|NCT01543087|80806511|FG005|Stage 1 (48 Months)|Other than specified|0|||
27719388|NCT01543087|80806506|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
27719389|NCT01543087|80806507|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
27719390|NCT01543087|80806508|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
27719391|NCT01543087|80806509|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
27719392|NCT01543087|80806510|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
27719393|NCT01543087|80806511|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
27719394|NCT01543087|80806506|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27719395|NCT01543087|80806507|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
27719396|NCT01543087|80806508|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27719397|NCT01543087|80806509|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27719398|NCT01543087|80806510|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
27719399|NCT01543087|80806511|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
27719400|NCT01543087|80806506|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
27719401|NCT01543087|80806507|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
27719402|NCT01543087|80806508|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
27719403|NCT01543087|80806509|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
27719404|NCT01543087|80806510|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
27719405|NCT01543087|80806511|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
27719406|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
27719407|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
27719408|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
27719409|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
27719410|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
27719411|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
27719412|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
27719413|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
27719414|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
27719415|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
27719416|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
27719417|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
27719418|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
27719419|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
27719420|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
27719421|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
27719422|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
27719423|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
27719424|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
27719425|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
27838806|NCT02250651|81239466|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
27838807|NCT02250651|81239467|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
27838808|NCT02250651|81239465|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
27838809|NCT02250651|81239466|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
27838810|NCT02250651|81239467|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
27838811|NCT02250651|81239465|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
27838812|NCT02250651|81239466|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
27607986|NCT02961881|80405989|FG002|Overall Study|Disease progression|1|||
27838813|NCT02250651|81239467|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
27838814|NCT02250651|81239465|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
27607987|NCT02961881|80405990|FG003|Overall Study|Disease progression|0|||
27607988|NCT02961881|80405991|FG004|Overall Study|Disease progression|0|||
27607989|NCT02421666|80405994|FG000|6-month Follow-up|Lost to Follow-up|8|||
27607990|NCT02421666|80405995|FG001|6-month Follow-up|Lost to Follow-up|7|||
27607991|NCT02421666|80405994|FG000|6-month Follow-up|Withdrawal by Subject|5|||
27607992|NCT02421666|80405995|FG001|6-month Follow-up|Withdrawal by Subject|6|||
27607993|NCT02421666|80405994|FG000|12-month Follow-up|Lost to Follow-up|5|||
27607994|NCT02421666|80405995|FG001|12-month Follow-up|Lost to Follow-up|5|||
27607995|NCT02421666|80405994|FG000|12-month Follow-up|Withdrawal by Subject|6|||
27607996|NCT02421666|80405995|FG001|12-month Follow-up|Withdrawal by Subject|11|||
27607997|NCT01350505|80405996|FG000|Overall Study|Lost to Follow-up|4|||
27719426|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
27719427|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
27719428|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
27719429|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
27719430|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
27719431|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
27719432|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
27719433|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
27719434|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
27719435|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
27719436|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
27719437|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
27719438|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
27719439|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
27719440|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
27719441|NCT02831673|80806513|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
27719442|NCT02831673|80806514|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
27838815|NCT02250651|81239466|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
27838816|NCT02250651|81239467|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
27838817|NCT02250651|81239465|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
27607998|NCT00672958|80405997|FG000|Overall Study|Adverse Event|11|||
27719443|NCT02831673|80806515|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
27719444|NCT02831673|80806516|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
27890502|NCT04791319|81434087|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
27890503|NCT04791319|81434088|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
27890504|NCT04791319|81434089|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
27890505|NCT04791319|81434090|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27890506|NCT04791319|81434091|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27890507|NCT04791319|81434092|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27890508|NCT04791319|81434093|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27890509|NCT04791319|81434094|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27890510|NCT04791319|81434095|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27838818|NCT02250651|81239466|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
27838819|NCT02250651|81239467|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
27838820|NCT02250651|81239465|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
27838821|NCT02250651|81239466|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
27838822|NCT02250651|81239467|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
27838823|NCT02250651|81239465|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
27838824|NCT02250651|81239466|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
27838825|NCT02250651|81239467|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
27607999|NCT00672958|80405998|FG001|Overall Study|Adverse Event|9|||
27608000|NCT00672958|80405997|FG000|Overall Study|Lack of Efficacy|6|||
27608001|NCT00672958|80405998|FG001|Overall Study|Lack of Efficacy|11|||
27719445|NCT02831673|80806517|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
27719446|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
27719447|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
27719448|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
27719449|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
27719450|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
27719451|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
27719452|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
27719453|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
27719454|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
27719455|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
27719456|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
27719457|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
27719458|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
27719459|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
27719460|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
27719461|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
27719462|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
27719463|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
27719464|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
27719465|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
27719466|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
27719467|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
27719468|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
27719469|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
27719470|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
27719471|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
27719472|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
27719473|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
27890511|NCT04791319|81434096|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
27608002|NCT00672958|80405997|FG000|Overall Study|Non-compliance with study drug|2|||
27890512|NCT04791319|81434086|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890513|NCT04791319|81434087|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890514|NCT04791319|81434088|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890515|NCT04791319|81434089|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
27890516|NCT04791319|81434090|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890517|NCT04791319|81434091|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890518|NCT04791319|81434092|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890519|NCT04791319|81434093|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890520|NCT04791319|81434094|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890521|NCT04791319|81434095|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890522|NCT04791319|81434096|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
27890523|NCT04791319|81434086|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890524|NCT04791319|81434087|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890525|NCT04791319|81434088|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890526|NCT04791319|81434089|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890527|NCT04791319|81434090|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
27890528|NCT04791319|81434091|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
27890529|NCT04791319|81434092|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
27890530|NCT04791319|81434093|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890531|NCT04791319|81434094|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890532|NCT04791319|81434095|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
27890533|NCT04791319|81434096|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
27890534|NCT04791319|81434086|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890535|NCT04791319|81434087|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890536|NCT04791319|81434088|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890537|NCT04791319|81434089|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890538|NCT04791319|81434090|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890539|NCT04791319|81434091|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890540|NCT04791319|81434092|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890541|NCT04791319|81434093|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890542|NCT04791319|81434094|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890543|NCT04791319|81434095|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
27890544|NCT04791319|81434096|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
27890545|NCT04791319|81434086|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27890546|NCT04791319|81434087|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27890547|NCT04791319|81434088|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27890548|NCT04791319|81434089|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27890549|NCT04791319|81434090|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
27890550|NCT04791319|81434091|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
27890551|NCT04791319|81434092|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
27890552|NCT04791319|81434093|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
27890553|NCT04791319|81434094|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
27608003|NCT00672958|80405998|FG001|Overall Study|Non-compliance with study drug|3|||
27608004|NCT00672958|80405997|FG000|Overall Study|Protocol deviations|11|||
27608005|NCT00672958|80405998|FG001|Overall Study|Protocol deviations|5|||
27608006|NCT00672958|80405997|FG000|Overall Study|Voluntary withdrawal|12|||
27608007|NCT00672958|80405998|FG001|Overall Study|Voluntary withdrawal|8|||
27608008|NCT00672958|80405997|FG000|Overall Study|Lost to Follow-up|22|||
27608009|NCT00672958|80405998|FG001|Overall Study|Lost to Follow-up|17|||
27608010|NCT00672958|80405997|FG000|Overall Study|Reason not specified|0|||
27719474|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
27719475|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
27608011|NCT00672958|80405998|FG001|Overall Study|Reason not specified|3|||
27608012|NCT01953003|80406002|FG000|Overall Study|Not treated|0|||
27608013|NCT01953003|80406003|FG001|Overall Study|Not treated|1|||
27608014|NCT01953003|80406002|FG000|Overall Study|Progressive disease|35|||
27608015|NCT01953003|80406003|FG001|Overall Study|Progressive disease|45|||
27608016|NCT01953003|80406002|FG000|Overall Study|Related Adverse events|7|||
27608017|NCT01953003|80406003|FG001|Overall Study|Related Adverse events|2|||
27608018|NCT01953003|80406002|FG000|Overall Study|Non-related adverse events|0|||
27608019|NCT01953003|80406003|FG001|Overall Study|Non-related adverse events|2|||
27608020|NCT01953003|80406002|FG000|Overall Study|Protocol Violation|0|||
27608021|NCT01953003|80406003|FG001|Overall Study|Protocol Violation|1|||
27719476|NCT02831673|80806513|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
27719477|NCT02831673|80806514|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
27608022|NCT01953003|80406002|FG000|Overall Study|Withdrawal by Subject|14|||
27608023|NCT01953003|80406003|FG001|Overall Study|Withdrawal by Subject|4|||
27608024|NCT01781390|80406004|FG000|Overall Study|Withdrawal of Consent|0|||
27608025|NCT01781390|80406005|FG001|Overall Study|Withdrawal of Consent|3|||
27608026|NCT01781390|80406006|FG002|Overall Study|Withdrawal of Consent|1|||
27608027|NCT01781390|80406004|FG000|Overall Study|Lost to Follow-up|1|||
27608028|NCT01781390|80406005|FG001|Overall Study|Lost to Follow-up|1|||
27608029|NCT01781390|80406006|FG002|Overall Study|Lost to Follow-up|1|||
27608030|NCT01781390|80406004|FG000|Overall Study|Adverse Event|1|||
27608031|NCT01781390|80406005|FG001|Overall Study|Adverse Event|2|||
27608032|NCT01781390|80406006|FG002|Overall Study|Adverse Event|1|||
27608033|NCT01781390|80406004|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
27608034|NCT01781390|80406005|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
27608035|NCT01781390|80406006|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
27608036|NCT03072238|80406011|FG000|Overall Study|Withdrawal by Subject|30|||
27608037|NCT03072238|80406012|FG001|Overall Study|Withdrawal by Subject|51|||
27608038|NCT03072238|80406011|FG000|Overall Study|Lost to Follow-up|7|||
27608039|NCT03072238|80406012|FG001|Overall Study|Lost to Follow-up|4|||
27608040|NCT03072238|80406011|FG000|Overall Study|Physician Decision|1|||
27608041|NCT03072238|80406012|FG001|Overall Study|Physician Decision|3|||
27608042|NCT03072238|80406011|FG000|Overall Study|Death|139|||
27719478|NCT02831673|80806515|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
27719479|NCT02831673|80806516|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
27719480|NCT02831673|80806517|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
27719481|NCT02831673|80806513|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
27719482|NCT02831673|80806514|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
27608043|NCT03072238|80406012|FG001|Overall Study|Death|121|||
27608044|NCT03072238|80406011|FG000|Overall Study|Other|0|||
27608045|NCT03072238|80406012|FG001|Overall Study|Other|1|||
27890554|NCT04791319|81434095|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
27608046|NCT03072238|80406011|FG000|Overall Study|Ongoing on study|377|||
27608047|NCT03072238|80406012|FG001|Overall Study|Ongoing on study|367|||
27608048|NCT00949884|80406016|FG000|Overall Study|Adverse Event|14|||
27719483|NCT02831673|80806515|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
27719484|NCT02831673|80806516|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
27719485|NCT02831673|80806517|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
27719486|NCT02831673|80806513|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
27719487|NCT02831673|80806514|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
27719488|NCT02831673|80806515|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
27608049|NCT00949884|80406017|FG001|Overall Study|Adverse Event|3|||
27608050|NCT00949884|80406018|FG002|Overall Study|Adverse Event|12|||
27608051|NCT00949884|80406016|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
27608052|NCT00949884|80406017|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
27608053|NCT00949884|80406018|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
27608054|NCT00949884|80406016|FG000|Overall Study|Lost to Follow-up|7|||
27608055|NCT00949884|80406017|FG001|Overall Study|Lost to Follow-up|5|||
27608056|NCT00949884|80406018|FG002|Overall Study|Lost to Follow-up|5|||
27608057|NCT00949884|80406016|FG000|Overall Study|Physician Decision|5|||
27608058|NCT00949884|80406017|FG001|Overall Study|Physician Decision|0|||
27608059|NCT00949884|80406018|FG002|Overall Study|Physician Decision|6|||
27608060|NCT00949884|80406016|FG000|Overall Study|Treatment non-compliance|5|||
27608061|NCT00949884|80406017|FG001|Overall Study|Treatment non-compliance|0|||
27608062|NCT00949884|80406018|FG002|Overall Study|Treatment non-compliance|8|||
27608063|NCT00949884|80406016|FG000|Overall Study|Withdrawal by Subject|13|||
27608064|NCT00949884|80406017|FG001|Overall Study|Withdrawal by Subject|4|||
27608065|NCT00949884|80406018|FG002|Overall Study|Withdrawal by Subject|16|||
27608066|NCT00949884|80406016|FG000|Overall Study|Lack of Efficacy|4|||
27608067|NCT00949884|80406017|FG001|Overall Study|Lack of Efficacy|2|||
27608068|NCT00949884|80406018|FG002|Overall Study|Lack of Efficacy|7|||
27608069|NCT00949884|80406016|FG000|Overall Study|Study terminated by sponsor|0|||
27719489|NCT02831673|80806516|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
27719490|NCT02831673|80806517|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
27719491|NCT02831673|80806513|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
27719492|NCT02831673|80806514|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
27719493|NCT02831673|80806515|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
27719494|NCT02831673|80806516|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
27719495|NCT02831673|80806517|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
27719496|NCT02831673|80806513|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
27719497|NCT02831673|80806514|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
27719498|NCT02831673|80806515|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
27719499|NCT02831673|80806516|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
27719500|NCT02831673|80806517|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
27719501|NCT02831673|80806513|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
27719502|NCT02831673|80806514|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
27719503|NCT02831673|80806515|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
27719504|NCT02831673|80806516|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
27719505|NCT02831673|80806517|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
27719506|NCT01463098|80806518|FG000|Part A (11 Days)|Participant Choice|2|||
27719507|NCT01463098|80806519|FG001|Part A (11 Days)|Participant Choice|0|||
27719508|NCT01463098|80806520|FG002|Part A (11 Days)|Participant Choice|0|||
27719509|NCT01463098|80806521|FG003|Part A (11 Days)|Participant Choice|0|||
27719510|NCT01463098|80806522|FG004|Part A (11 Days)|Participant Choice|0|||
27719511|NCT01463098|80806523|FG005|Part A (11 Days)|Participant Choice|0|||
27719512|NCT01463098|80806524|FG006|Part A (11 Days)|Participant Choice|0|||
27719513|NCT01463098|80806525|FG007|Part A (11 Days)|Participant Choice|0|||
27719514|NCT01463098|80806526|FG008|Part A (11 Days)|Participant Choice|1|||
27719515|NCT01463098|80806527|FG009|Part A (11 Days)|Participant Choice|0|||
27719516|NCT01463098|80806528|FG010|Part A (11 Days)|Participant Choice|0|||
27719517|NCT01463098|80806529|FG011|Part A (11 Days)|Participant Choice|0|||
27719518|NCT01463098|80806530|FG012|Part A (11 Days)|Participant Choice|0|||
27719519|NCT01463098|80806531|FG013|Part A (11 Days)|Participant Choice|0|||
27719520|NCT01463098|80806518|FG000|Part A (11 Days)|Lost to Follow-up|0|||
27719521|NCT01463098|80806519|FG001|Part A (11 Days)|Lost to Follow-up|0|||
27719522|NCT01463098|80806520|FG002|Part A (11 Days)|Lost to Follow-up|0|||
27719523|NCT01463098|80806521|FG003|Part A (11 Days)|Lost to Follow-up|0|||
27719524|NCT01463098|80806522|FG004|Part A (11 Days)|Lost to Follow-up|1|||
27608070|NCT00949884|80406017|FG001|Overall Study|Study terminated by sponsor|0|||
27608071|NCT00949884|80406018|FG002|Overall Study|Study terminated by sponsor|1|||
27608072|NCT04741802|80406019|FG000|Overall Study|Death|1|||
27608073|NCT04741802|80406019|FG000|Overall Study|Lost to Follow-up|11|||
27608074|NCT01336634|80406022|FG000|Overall Study|Study closed/terminated|5|||
27719525|NCT01463098|80806523|FG005|Part A (11 Days)|Lost to Follow-up|0|||
27719526|NCT01463098|80806524|FG006|Part A (11 Days)|Lost to Follow-up|0|||
27608075|NCT01336634|80406023|FG001|Overall Study|Study closed/terminated|6|||
27608076|NCT01336634|80406024|FG002|Overall Study|Study closed/terminated|6|||
27608077|NCT01336634|80406022|FG000|Overall Study|Lost to Follow-up|2|||
27608078|NCT01336634|80406023|FG001|Overall Study|Lost to Follow-up|1|||
27608079|NCT01336634|80406024|FG002|Overall Study|Lost to Follow-up|1|||
27608080|NCT01336634|80406022|FG000|Overall Study|Physician Decision|1|||
27608081|NCT01336634|80406023|FG001|Overall Study|Physician Decision|1|||
27608082|NCT01336634|80406024|FG002|Overall Study|Physician Decision|0|||
27608083|NCT01336634|80406022|FG000|Overall Study|Withdrawal by Subject|6|||
27608084|NCT01336634|80406023|FG001|Overall Study|Withdrawal by Subject|0|||
27608085|NCT01336634|80406024|FG002|Overall Study|Withdrawal by Subject|2|||
27608086|NCT04404478|80406025|FG000|Overall Study|Withdrawal by Subject|1|||
27608087|NCT04404478|80406026|FG001|Overall Study|Withdrawal by Subject|3|||
27608088|NCT01535274|80406027|FG000|Overall Study|Determined to be ineligible|0|||
27608089|NCT01535274|80406028|FG001|Overall Study|Determined to be ineligible|1|||
27608090|NCT01535274|80406027|FG000|Overall Study|Misallocated to propofol intervention|0|||
27608091|NCT01535274|80406028|FG001|Overall Study|Misallocated to propofol intervention|1|||
27608092|NCT02392611|80406029|FG000|Overall Study|Adverse Event|0|||
27608093|NCT02392611|80406030|FG001|Overall Study|Adverse Event|0|||
27608094|NCT02392611|80406031|FG002|Overall Study|Adverse Event|0|||
27608095|NCT02392611|80406032|FG003|Overall Study|Adverse Event|1|||
27608096|NCT02392611|80406033|FG004|Overall Study|Adverse Event|0|||
27608097|NCT02392611|80406034|FG005|Overall Study|Adverse Event|0|||
27608098|NCT02392611|80406035|FG006|Overall Study|Adverse Event|0|||
27608099|NCT02392611|80406036|FG007|Overall Study|Adverse Event|0|||
27608100|NCT02392611|80406037|FG008|Overall Study|Adverse Event|0|||
27608101|NCT02392611|80406029|FG000|Overall Study|Progressive disease|0|||
27608102|NCT02392611|80406030|FG001|Overall Study|Progressive disease|0|||
27608103|NCT02392611|80406031|FG002|Overall Study|Progressive disease|0|||
27608104|NCT02392611|80406032|FG003|Overall Study|Progressive disease|2|||
27608105|NCT02392611|80406033|FG004|Overall Study|Progressive disease|1|||
27608106|NCT02392611|80406034|FG005|Overall Study|Progressive disease|0|||
27608107|NCT02392611|80406035|FG006|Overall Study|Progressive disease|0|||
27608108|NCT02392611|80406036|FG007|Overall Study|Progressive disease|0|||
27608109|NCT02392611|80406037|FG008|Overall Study|Progressive disease|0|||
27608110|NCT02392611|80406029|FG000|Overall Study|Death|1|||
27838826|NCT02250651|81239465|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
27838827|NCT02250651|81239466|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
27838828|NCT02250651|81239467|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
27838829|NCT02250651|81239465|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
27608111|NCT02392611|80406030|FG001|Overall Study|Death|0|||
27838830|NCT02250651|81239466|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
27838831|NCT02250651|81239467|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
27838832|NCT02250651|81239465|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
27838833|NCT02250651|81239466|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
27838834|NCT02250651|81239467|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
27838835|NCT00379353|81239470|FG000|Overall Study|Hospitalization|3|||
27719527|NCT01463098|80806525|FG007|Part A (11 Days)|Lost to Follow-up|0|||
27608112|NCT02392611|80406031|FG002|Overall Study|Death|0|||
27608113|NCT02392611|80406032|FG003|Overall Study|Death|0|||
27608114|NCT02392611|80406033|FG004|Overall Study|Death|0|||
27608115|NCT02392611|80406034|FG005|Overall Study|Death|1|||
27608116|NCT02392611|80406035|FG006|Overall Study|Death|0|||
27608117|NCT02392611|80406036|FG007|Overall Study|Death|0|||
27608118|NCT02392611|80406037|FG008|Overall Study|Death|0|||
27608119|NCT02392611|80406029|FG000|Overall Study|Withdrawal by Subject|0|||
27608120|NCT02392611|80406030|FG001|Overall Study|Withdrawal by Subject|0|||
27608121|NCT02392611|80406031|FG002|Overall Study|Withdrawal by Subject|0|||
27608122|NCT02392611|80406032|FG003|Overall Study|Withdrawal by Subject|1|||
27608123|NCT02392611|80406033|FG004|Overall Study|Withdrawal by Subject|0|||
27608124|NCT02392611|80406034|FG005|Overall Study|Withdrawal by Subject|0|||
27608125|NCT02392611|80406035|FG006|Overall Study|Withdrawal by Subject|0|||
27608126|NCT02392611|80406036|FG007|Overall Study|Withdrawal by Subject|0|||
27608127|NCT02392611|80406037|FG008|Overall Study|Withdrawal by Subject|0|||
27608128|NCT02392611|80406029|FG000|Overall Study|Lost to Follow-up|0|||
27608129|NCT02392611|80406030|FG001|Overall Study|Lost to Follow-up|0|||
27608130|NCT02392611|80406031|FG002|Overall Study|Lost to Follow-up|0|||
27608131|NCT02392611|80406032|FG003|Overall Study|Lost to Follow-up|0|||
27608132|NCT02392611|80406033|FG004|Overall Study|Lost to Follow-up|0|||
27608133|NCT02392611|80406034|FG005|Overall Study|Lost to Follow-up|0|||
27608134|NCT02392611|80406035|FG006|Overall Study|Lost to Follow-up|1|||
27608135|NCT02392611|80406036|FG007|Overall Study|Lost to Follow-up|0|||
27608136|NCT02392611|80406037|FG008|Overall Study|Lost to Follow-up|0|||
27719528|NCT01463098|80806526|FG008|Part A (11 Days)|Lost to Follow-up|0|||
27719529|NCT01463098|80806527|FG009|Part A (11 Days)|Lost to Follow-up|0|||
27719530|NCT01463098|80806528|FG010|Part A (11 Days)|Lost to Follow-up|0|||
27719531|NCT01463098|80806529|FG011|Part A (11 Days)|Lost to Follow-up|0|||
27719532|NCT01463098|80806530|FG012|Part A (11 Days)|Lost to Follow-up|0|||
27719533|NCT01463098|80806531|FG013|Part A (11 Days)|Lost to Follow-up|0|||
27719534|NCT01463098|80806518|FG000|Part B (11 Days)|Participant Choice|0|||
27719535|NCT01463098|80806519|FG001|Part B (11 Days)|Participant Choice|0|||
27719536|NCT01463098|80806520|FG002|Part B (11 Days)|Participant Choice|0|||
27719537|NCT01463098|80806521|FG003|Part B (11 Days)|Participant Choice|0|||
27719538|NCT01463098|80806522|FG004|Part B (11 Days)|Participant Choice|0|||
27719539|NCT01463098|80806523|FG005|Part B (11 Days)|Participant Choice|0|||
27719540|NCT01463098|80806524|FG006|Part B (11 Days)|Participant Choice|0|||
27719541|NCT01463098|80806525|FG007|Part B (11 Days)|Participant Choice|0|||
27719542|NCT01463098|80806526|FG008|Part B (11 Days)|Participant Choice|0|||
27719543|NCT01463098|80806527|FG009|Part B (11 Days)|Participant Choice|0|||
27719544|NCT01463098|80806528|FG010|Part B (11 Days)|Participant Choice|0|||
27719545|NCT01463098|80806529|FG011|Part B (11 Days)|Participant Choice|1|||
27719546|NCT01463098|80806530|FG012|Part B (11 Days)|Participant Choice|0|||
27719547|NCT01463098|80806531|FG013|Part B (11 Days)|Participant Choice|0|||
27719548|NCT01999582|80806532|FG000|Overall Study|Withdrawal by Subject|0|||
27719549|NCT01999582|80806533|FG001|Overall Study|Withdrawal by Subject|0|||
27719550|NCT01999582|80806534|FG002|Overall Study|Withdrawal by Subject|0|||
27719551|NCT01999582|80806535|FG003|Overall Study|Withdrawal by Subject|1|||
27719552|NCT01999582|80806536|FG004|Overall Study|Withdrawal by Subject|0|||
27719553|NCT01999582|80806537|FG005|Overall Study|Withdrawal by Subject|0|||
27838836|NCT00379353|81239471|FG001|Overall Study|Hospitalization|3|||
27838837|NCT00379353|81239470|FG000|Overall Study|Withdrawal by Subject|5|||
27838838|NCT00379353|81239471|FG001|Overall Study|Withdrawal by Subject|2|||
27838839|NCT00379353|81239470|FG000|Overall Study|Death|1|||
27838840|NCT00379353|81239471|FG001|Overall Study|Death|0|||
27838841|NCT00379353|81239470|FG000|Overall Study|Cardiac Tamponade|1|||
27838842|NCT00379353|81239471|FG001|Overall Study|Cardiac Tamponade|0|||
27838843|NCT00379353|81239470|FG000|Overall Study|Non-compliance|1|||
27838844|NCT00379353|81239471|FG001|Overall Study|Non-compliance|0|||
27838845|NCT00379353|81239470|FG000|Overall Study|Conflicting drug treatment|0|||
27838846|NCT00379353|81239471|FG001|Overall Study|Conflicting drug treatment|1|||
27838847|NCT04129944|81239484|FG000|Overall Study|Death|0|||
27838848|NCT04129944|81239485|FG001|Overall Study|Death|0|||
27838849|NCT04129944|81239486|FG002|Overall Study|Death|0|||
27838850|NCT04129944|81239487|FG003|Overall Study|Death|1|||
27838851|NCT04129944|81239484|FG000|Overall Study|Lost to Follow-up|1|||
27838852|NCT04129944|81239485|FG001|Overall Study|Lost to Follow-up|0|||
27838853|NCT04129944|81239486|FG002|Overall Study|Lost to Follow-up|0|||
27838854|NCT04129944|81239487|FG003|Overall Study|Lost to Follow-up|0|||
27719554|NCT01999582|80806532|FG000|Overall Study|Adverse Event|0|||
27719555|NCT01999582|80806533|FG001|Overall Study|Adverse Event|0|||
27838855|NCT04129944|81239484|FG000|Overall Study|Withdrawal by Subject|1|||
27838856|NCT04129944|81239485|FG001|Overall Study|Withdrawal by Subject|0|||
27838857|NCT04129944|81239486|FG002|Overall Study|Withdrawal by Subject|1|||
27838858|NCT04129944|81239487|FG003|Overall Study|Withdrawal by Subject|2|||
27608137|NCT02392611|80406029|FG000|Overall Study|Enrolled, not treated|0|||
27838859|NCT00474188|81239488|FG000|Overall Study|Withdrawal by Subject|1|||
27608138|NCT02392611|80406030|FG001|Overall Study|Enrolled, not treated|0|||
27608139|NCT02392611|80406031|FG002|Overall Study|Enrolled, not treated|0|||
27719556|NCT01999582|80806534|FG002|Overall Study|Adverse Event|3|||
27719557|NCT01999582|80806535|FG003|Overall Study|Adverse Event|0|||
27719558|NCT01999582|80806536|FG004|Overall Study|Adverse Event|1|||
27719559|NCT01999582|80806537|FG005|Overall Study|Adverse Event|0|||
27719560|NCT01999582|80806532|FG000|Overall Study|Other Reasons|1|||
27719561|NCT01999582|80806533|FG001|Overall Study|Other Reasons|0|||
27719562|NCT01999582|80806534|FG002|Overall Study|Other Reasons|3|||
27719563|NCT01999582|80806535|FG003|Overall Study|Other Reasons|1|||
27719564|NCT01999582|80806536|FG004|Overall Study|Other Reasons|1|||
27719565|NCT01999582|80806537|FG005|Overall Study|Other Reasons|2|||
27719566|NCT01999582|80806532|FG000|Overall Study|Protocol Violation|1|||
27719567|NCT01999582|80806533|FG001|Overall Study|Protocol Violation|0|||
27719568|NCT01999582|80806534|FG002|Overall Study|Protocol Violation|0|||
27719569|NCT01999582|80806535|FG003|Overall Study|Protocol Violation|0|||
27719570|NCT01999582|80806536|FG004|Overall Study|Protocol Violation|0|||
27719571|NCT01999582|80806537|FG005|Overall Study|Protocol Violation|1|||
27719572|NCT01999582|80806532|FG000|Overall Study|Lack of Efficacy|1|||
27719573|NCT01999582|80806533|FG001|Overall Study|Lack of Efficacy|3|||
27719574|NCT01999582|80806534|FG002|Overall Study|Lack of Efficacy|0|||
27719575|NCT01999582|80806535|FG003|Overall Study|Lack of Efficacy|1|||
27719576|NCT01999582|80806536|FG004|Overall Study|Lack of Efficacy|0|||
27719577|NCT01999582|80806537|FG005|Overall Study|Lack of Efficacy|0|||
27719578|NCT03529773|80806538|FG000|Overall Study|Adverse Event|0|||
27719579|NCT03529773|80806539|FG001|Overall Study|Adverse Event|0|||
27719580|NCT03529773|80806540|FG002|Overall Study|Adverse Event|0|||
27719581|NCT03529773|80806541|FG003|Overall Study|Adverse Event|0|||
27719582|NCT03529773|80806542|FG004|Overall Study|Adverse Event|0|||
27719583|NCT03529773|80806543|FG005|Overall Study|Adverse Event|0|||
27719584|NCT03529773|80806544|FG006|Overall Study|Adverse Event|0|||
27719585|NCT03529773|80806545|FG007|Overall Study|Adverse Event|0|||
27719586|NCT03529773|80806546|FG008|Overall Study|Adverse Event|0|||
27719587|NCT03529773|80806547|FG009|Overall Study|Adverse Event|0|||
27719588|NCT03529773|80806548|FG010|Overall Study|Adverse Event|0|||
27719589|NCT03529773|80806549|FG011|Overall Study|Adverse Event|0|||
27719590|NCT03529773|80806550|FG012|Overall Study|Adverse Event|0|||
27719591|NCT03529773|80806551|FG013|Overall Study|Adverse Event|0|||
27719592|NCT03529773|80806552|FG014|Overall Study|Adverse Event|0|||
27719593|NCT03529773|80806553|FG015|Overall Study|Adverse Event|0|||
27719594|NCT03529773|80806554|FG016|Overall Study|Adverse Event|0|||
27719595|NCT03529773|80806555|FG017|Overall Study|Adverse Event|0|||
27719596|NCT03529773|80806556|FG018|Overall Study|Adverse Event|0|||
27719597|NCT03529773|80806557|FG019|Overall Study|Adverse Event|0|||
27719598|NCT03529773|80806558|FG020|Overall Study|Adverse Event|0|||
27719599|NCT03529773|80806559|FG021|Overall Study|Adverse Event|0|||
27719600|NCT03529773|80806560|FG022|Overall Study|Adverse Event|0|||
27719601|NCT03529773|80806561|FG023|Overall Study|Adverse Event|0|||
27719602|NCT03529773|80806562|FG024|Overall Study|Adverse Event|0|||
27719603|NCT03529773|80806563|FG025|Overall Study|Adverse Event|0|||
27719604|NCT03529773|80806564|FG026|Overall Study|Adverse Event|0|||
27719605|NCT03529773|80806565|FG027|Overall Study|Adverse Event|0|||
27719606|NCT03529773|80806566|FG028|Overall Study|Adverse Event|0|||
27719607|NCT03529773|80806567|FG029|Overall Study|Adverse Event|0|||
27719608|NCT03529773|80806568|FG030|Overall Study|Adverse Event|1|||
27719609|NCT03529773|80806569|FG031|Overall Study|Adverse Event|0|||
27719610|NCT03529773|80806570|FG032|Overall Study|Adverse Event|0|||
27719611|NCT03529773|80806571|FG033|Overall Study|Adverse Event|0|||
27719612|NCT03529773|80806572|FG034|Overall Study|Adverse Event|0|||
27719613|NCT03529773|80806573|FG035|Overall Study|Adverse Event|1|||
27719614|NCT03529773|80806574|FG036|Overall Study|Adverse Event|0|||
27719615|NCT03529773|80806575|FG037|Overall Study|Adverse Event|0|||
27719616|NCT03529773|80806576|FG038|Overall Study|Adverse Event|1|||
27719617|NCT03529773|80806577|FG039|Overall Study|Adverse Event|1|||
27719618|NCT03529773|80806538|FG000|Overall Study|Death|0|||
27719619|NCT03529773|80806539|FG001|Overall Study|Death|0|||
27719620|NCT03529773|80806540|FG002|Overall Study|Death|0|||
27719621|NCT03529773|80806541|FG003|Overall Study|Death|0|||
27719622|NCT03529773|80806542|FG004|Overall Study|Death|0|||
27719623|NCT03529773|80806543|FG005|Overall Study|Death|0|||
27719624|NCT03529773|80806544|FG006|Overall Study|Death|0|||
27719625|NCT03529773|80806545|FG007|Overall Study|Death|0|||
27719626|NCT03529773|80806546|FG008|Overall Study|Death|0|||
27719627|NCT03529773|80806547|FG009|Overall Study|Death|0|||
27719628|NCT03529773|80806548|FG010|Overall Study|Death|0|||
27719629|NCT03529773|80806549|FG011|Overall Study|Death|0|||
27719630|NCT03529773|80806550|FG012|Overall Study|Death|1|||
27719631|NCT03529773|80806551|FG013|Overall Study|Death|0|||
27719632|NCT03529773|80806552|FG014|Overall Study|Death|0|||
27719633|NCT03529773|80806553|FG015|Overall Study|Death|0|||
27719634|NCT03529773|80806554|FG016|Overall Study|Death|0|||
27719635|NCT03529773|80806555|FG017|Overall Study|Death|0|||
27608140|NCT02392611|80406032|FG003|Overall Study|Enrolled, not treated|2|||
27608141|NCT02392611|80406033|FG004|Overall Study|Enrolled, not treated|0|||
27608142|NCT02392611|80406034|FG005|Overall Study|Enrolled, not treated|0|||
27608143|NCT02392611|80406035|FG006|Overall Study|Enrolled, not treated|0|||
27608144|NCT02392611|80406036|FG007|Overall Study|Enrolled, not treated|0|||
27608145|NCT02392611|80406037|FG008|Overall Study|Enrolled, not treated|0|||
27719636|NCT03529773|80806556|FG018|Overall Study|Death|0|||
27719637|NCT03529773|80806557|FG019|Overall Study|Death|1|||
27719638|NCT03529773|80806558|FG020|Overall Study|Death|0|||
27838860|NCT00474188|81239488|FG000|Overall Study|Study discontinued by sponsor|5|||
27838861|NCT01015287|81239489|FG000|Overall Study|Death|21|||
27608146|NCT00113360|80409189|FG000|Overall Study|Adverse Event|3|||
27608147|NCT00113360|80409189|FG000|Overall Study|Subject required surgery|1|||
27719639|NCT03529773|80806559|FG021|Overall Study|Death|0|||
27719640|NCT03529773|80806560|FG022|Overall Study|Death|1|||
27719641|NCT03529773|80806561|FG023|Overall Study|Death|0|||
27608148|NCT00113360|80409189|FG000|Overall Study|Did not meet eligibility criteria|3|||
27719642|NCT03529773|80806562|FG024|Overall Study|Death|0|||
27719643|NCT03529773|80806563|FG025|Overall Study|Death|0|||
27719644|NCT03529773|80806564|FG026|Overall Study|Death|0|||
27719645|NCT03529773|80806565|FG027|Overall Study|Death|0|||
27719646|NCT03529773|80806566|FG028|Overall Study|Death|0|||
27719647|NCT03529773|80806567|FG029|Overall Study|Death|0|||
27719648|NCT03529773|80806568|FG030|Overall Study|Death|0|||
27719649|NCT03529773|80806569|FG031|Overall Study|Death|0|||
27719650|NCT03529773|80806570|FG032|Overall Study|Death|0|||
27719651|NCT03529773|80806571|FG033|Overall Study|Death|1|||
27719652|NCT03529773|80806572|FG034|Overall Study|Death|1|||
27719653|NCT03529773|80806573|FG035|Overall Study|Death|0|||
27719654|NCT03529773|80806574|FG036|Overall Study|Death|1|||
27719655|NCT03529773|80806575|FG037|Overall Study|Death|0|||
27719656|NCT03529773|80806576|FG038|Overall Study|Death|0|||
27719657|NCT03529773|80806577|FG039|Overall Study|Death|0|||
27719658|NCT03529773|80806538|FG000|Overall Study|Lost to Follow-up|0|||
27719659|NCT03529773|80806539|FG001|Overall Study|Lost to Follow-up|0|||
27719660|NCT03529773|80806540|FG002|Overall Study|Lost to Follow-up|1|||
27719661|NCT03529773|80806541|FG003|Overall Study|Lost to Follow-up|0|||
27719662|NCT03529773|80806542|FG004|Overall Study|Lost to Follow-up|1|||
27719663|NCT03529773|80806543|FG005|Overall Study|Lost to Follow-up|1|||
27719664|NCT03529773|80806544|FG006|Overall Study|Lost to Follow-up|0|||
27719665|NCT03529773|80806545|FG007|Overall Study|Lost to Follow-up|0|||
27719666|NCT03529773|80806546|FG008|Overall Study|Lost to Follow-up|0|||
27719667|NCT03529773|80806547|FG009|Overall Study|Lost to Follow-up|0|||
27719668|NCT03529773|80806548|FG010|Overall Study|Lost to Follow-up|0|||
27719669|NCT03529773|80806549|FG011|Overall Study|Lost to Follow-up|0|||
27719670|NCT03529773|80806550|FG012|Overall Study|Lost to Follow-up|0|||
27719671|NCT03529773|80806551|FG013|Overall Study|Lost to Follow-up|1|||
27719672|NCT03529773|80806552|FG014|Overall Study|Lost to Follow-up|4|||
27719673|NCT03529773|80806553|FG015|Overall Study|Lost to Follow-up|1|||
27719674|NCT03529773|80806554|FG016|Overall Study|Lost to Follow-up|1|||
27719675|NCT03529773|80806555|FG017|Overall Study|Lost to Follow-up|0|||
27719676|NCT03529773|80806556|FG018|Overall Study|Lost to Follow-up|1|||
27719677|NCT03529773|80806557|FG019|Overall Study|Lost to Follow-up|1|||
27719678|NCT03529773|80806558|FG020|Overall Study|Lost to Follow-up|2|||
27719679|NCT03529773|80806559|FG021|Overall Study|Lost to Follow-up|4|||
27719680|NCT03529773|80806560|FG022|Overall Study|Lost to Follow-up|3|||
27719681|NCT03529773|80806561|FG023|Overall Study|Lost to Follow-up|4|||
27719682|NCT03529773|80806562|FG024|Overall Study|Lost to Follow-up|3|||
27719683|NCT03529773|80806563|FG025|Overall Study|Lost to Follow-up|5|||
27719684|NCT03529773|80806564|FG026|Overall Study|Lost to Follow-up|5|||
27719685|NCT03529773|80806565|FG027|Overall Study|Lost to Follow-up|0|||
27719686|NCT03529773|80806566|FG028|Overall Study|Lost to Follow-up|0|||
27719687|NCT03529773|80806567|FG029|Overall Study|Lost to Follow-up|0|||
27719688|NCT03529773|80806568|FG030|Overall Study|Lost to Follow-up|1|||
27719689|NCT03529773|80806569|FG031|Overall Study|Lost to Follow-up|0|||
27719690|NCT03529773|80806570|FG032|Overall Study|Lost to Follow-up|0|||
27719691|NCT03529773|80806571|FG033|Overall Study|Lost to Follow-up|1|||
27838862|NCT01015287|81239490|FG001|Overall Study|Death|16|||
27838863|NCT01015287|81239489|FG000|Overall Study|Adverse Event|1|||
27719692|NCT03529773|80806572|FG034|Overall Study|Lost to Follow-up|1|||
27719693|NCT03529773|80806573|FG035|Overall Study|Lost to Follow-up|0|||
27719694|NCT03529773|80806574|FG036|Overall Study|Lost to Follow-up|0|||
27719695|NCT03529773|80806575|FG037|Overall Study|Lost to Follow-up|3|||
27719696|NCT03529773|80806576|FG038|Overall Study|Lost to Follow-up|1|||
27719697|NCT03529773|80806577|FG039|Overall Study|Lost to Follow-up|1|||
27719698|NCT03529773|80806538|FG000|Overall Study|No longer meets eligibility criteria|0|||
27838864|NCT01015287|81239490|FG001|Overall Study|Adverse Event|0|||
27838865|NCT01015287|81239489|FG000|Overall Study|Sponsor Decision|3|||
27838866|NCT01015287|81239490|FG001|Overall Study|Sponsor Decision|7|||
27838867|NCT01015287|81239489|FG000|Overall Study|Physician Decision|19|||
27838868|NCT01015287|81239490|FG001|Overall Study|Physician Decision|21|||
27838869|NCT01015287|81239489|FG000|Overall Study|Withdrawal by Subject|14|||
27838870|NCT01015287|81239490|FG001|Overall Study|Withdrawal by Subject|19|||
27838871|NCT01015287|81239489|FG000|Overall Study|Entry Criteria not Met|11|||
27838872|NCT01015287|81239490|FG001|Overall Study|Entry Criteria not Met|14|||
27719699|NCT03529773|80806539|FG001|Overall Study|No longer meets eligibility criteria|0|||
27719700|NCT03529773|80806540|FG002|Overall Study|No longer meets eligibility criteria|0|||
27719701|NCT03529773|80806541|FG003|Overall Study|No longer meets eligibility criteria|0|||
27719702|NCT03529773|80806542|FG004|Overall Study|No longer meets eligibility criteria|0|||
27838873|NCT01015287|81239489|FG000|Overall Study|Lost to Follow-up|2|||
27719703|NCT03529773|80806543|FG005|Overall Study|No longer meets eligibility criteria|0|||
27719704|NCT03529773|80806544|FG006|Overall Study|No longer meets eligibility criteria|0|||
27719705|NCT03529773|80806545|FG007|Overall Study|No longer meets eligibility criteria|0|||
27719706|NCT03529773|80806546|FG008|Overall Study|No longer meets eligibility criteria|0|||
27719707|NCT03529773|80806547|FG009|Overall Study|No longer meets eligibility criteria|0|||
27719708|NCT03529773|80806548|FG010|Overall Study|No longer meets eligibility criteria|0|||
27719709|NCT03529773|80806549|FG011|Overall Study|No longer meets eligibility criteria|0|||
27719710|NCT03529773|80806550|FG012|Overall Study|No longer meets eligibility criteria|0|||
27838874|NCT01015287|81239490|FG001|Overall Study|Lost to Follow-up|1|||
27838875|NCT01015287|81239489|FG000|Overall Study|Protocol Violation|1|||
27838876|NCT01015287|81239490|FG001|Overall Study|Protocol Violation|1|||
27890555|NCT04791319|81434096|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
27890556|NCT04791319|81434086|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27719711|NCT03529773|80806551|FG013|Overall Study|No longer meets eligibility criteria|0|||
27719712|NCT03529773|80806552|FG014|Overall Study|No longer meets eligibility criteria|0|||
27719713|NCT03529773|80806553|FG015|Overall Study|No longer meets eligibility criteria|0|||
27719714|NCT03529773|80806554|FG016|Overall Study|No longer meets eligibility criteria|0|||
27719715|NCT03529773|80806555|FG017|Overall Study|No longer meets eligibility criteria|0|||
27719716|NCT03529773|80806556|FG018|Overall Study|No longer meets eligibility criteria|0|||
27719717|NCT03529773|80806557|FG019|Overall Study|No longer meets eligibility criteria|0|||
27719718|NCT03529773|80806558|FG020|Overall Study|No longer meets eligibility criteria|0|||
27719719|NCT03529773|80806559|FG021|Overall Study|No longer meets eligibility criteria|0|||
27719720|NCT03529773|80806560|FG022|Overall Study|No longer meets eligibility criteria|1|||
27719721|NCT03529773|80806561|FG023|Overall Study|No longer meets eligibility criteria|0|||
27719722|NCT03529773|80806562|FG024|Overall Study|No longer meets eligibility criteria|0|||
27719723|NCT03529773|80806563|FG025|Overall Study|No longer meets eligibility criteria|0|||
27719724|NCT03529773|80806564|FG026|Overall Study|No longer meets eligibility criteria|0|||
27719725|NCT03529773|80806565|FG027|Overall Study|No longer meets eligibility criteria|0|||
27719726|NCT03529773|80806566|FG028|Overall Study|No longer meets eligibility criteria|0|||
27719727|NCT03529773|80806567|FG029|Overall Study|No longer meets eligibility criteria|0|||
27719728|NCT03529773|80806568|FG030|Overall Study|No longer meets eligibility criteria|0|||
27719729|NCT03529773|80806569|FG031|Overall Study|No longer meets eligibility criteria|0|||
27719730|NCT03529773|80806570|FG032|Overall Study|No longer meets eligibility criteria|0|||
27719731|NCT03529773|80806571|FG033|Overall Study|No longer meets eligibility criteria|0|||
27719732|NCT03529773|80806572|FG034|Overall Study|No longer meets eligibility criteria|0|||
27719733|NCT03529773|80806573|FG035|Overall Study|No longer meets eligibility criteria|0|||
27719734|NCT03529773|80806574|FG036|Overall Study|No longer meets eligibility criteria|0|||
27719735|NCT03529773|80806575|FG037|Overall Study|No longer meets eligibility criteria|0|||
27719736|NCT03529773|80806576|FG038|Overall Study|No longer meets eligibility criteria|1|||
27719737|NCT03529773|80806577|FG039|Overall Study|No longer meets eligibility criteria|0|||
27719738|NCT03529773|80806538|FG000|Overall Study|Other|0|||
27719739|NCT03529773|80806539|FG001|Overall Study|Other|0|||
27719740|NCT03529773|80806540|FG002|Overall Study|Other|0|||
27719741|NCT03529773|80806541|FG003|Overall Study|Other|0|||
27719742|NCT03529773|80806542|FG004|Overall Study|Other|0|||
27719743|NCT03529773|80806543|FG005|Overall Study|Other|0|||
27719744|NCT03529773|80806544|FG006|Overall Study|Other|0|||
27719745|NCT03529773|80806545|FG007|Overall Study|Other|0|||
27719746|NCT03529773|80806546|FG008|Overall Study|Other|0|||
27719747|NCT03529773|80806547|FG009|Overall Study|Other|0|||
27719748|NCT03529773|80806548|FG010|Overall Study|Other|0|||
27719749|NCT03529773|80806549|FG011|Overall Study|Other|0|||
27719750|NCT03529773|80806550|FG012|Overall Study|Other|1|||
27719751|NCT03529773|80806551|FG013|Overall Study|Other|0|||
27719752|NCT03529773|80806552|FG014|Overall Study|Other|2|||
27719753|NCT03529773|80806553|FG015|Overall Study|Other|0|||
27719754|NCT03529773|80806554|FG016|Overall Study|Other|0|||
27719755|NCT03529773|80806555|FG017|Overall Study|Other|3|||
27719756|NCT03529773|80806556|FG018|Overall Study|Other|0|||
27719757|NCT03529773|80806557|FG019|Overall Study|Other|0|||
27719758|NCT03529773|80806558|FG020|Overall Study|Other|1|||
27719759|NCT03529773|80806559|FG021|Overall Study|Other|0|||
27719760|NCT03529773|80806560|FG022|Overall Study|Other|1|||
27719761|NCT03529773|80806561|FG023|Overall Study|Other|0|||
27890557|NCT04791319|81434087|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27719762|NCT03529773|80806562|FG024|Overall Study|Other|3|||
27719763|NCT03529773|80806563|FG025|Overall Study|Other|2|||
27719764|NCT03529773|80806564|FG026|Overall Study|Other|2|||
27719765|NCT03529773|80806565|FG027|Overall Study|Other|0|||
27719766|NCT03529773|80806566|FG028|Overall Study|Other|0|||
27719767|NCT03529773|80806567|FG029|Overall Study|Other|0|||
27719768|NCT03529773|80806568|FG030|Overall Study|Other|0|||
27719769|NCT03529773|80806569|FG031|Overall Study|Other|0|||
27719770|NCT03529773|80806570|FG032|Overall Study|Other|0|||
27719771|NCT03529773|80806571|FG033|Overall Study|Other|0|||
27719772|NCT03529773|80806572|FG034|Overall Study|Other|1|||
27719773|NCT03529773|80806573|FG035|Overall Study|Other|1|||
27719774|NCT03529773|80806574|FG036|Overall Study|Other|0|||
27719775|NCT03529773|80806575|FG037|Overall Study|Other|0|||
27719776|NCT03529773|80806576|FG038|Overall Study|Other|0|||
27719777|NCT03529773|80806577|FG039|Overall Study|Other|0|||
27719778|NCT03529773|80806538|FG000|Overall Study|Physician Decision|0|||
27719779|NCT03529773|80806539|FG001|Overall Study|Physician Decision|0|||
27719780|NCT03529773|80806540|FG002|Overall Study|Physician Decision|0|||
27719781|NCT03529773|80806541|FG003|Overall Study|Physician Decision|0|||
27719782|NCT03529773|80806542|FG004|Overall Study|Physician Decision|0|||
27719783|NCT03529773|80806543|FG005|Overall Study|Physician Decision|0|||
27719784|NCT03529773|80806544|FG006|Overall Study|Physician Decision|0|||
27719785|NCT03529773|80806545|FG007|Overall Study|Physician Decision|0|||
27719786|NCT03529773|80806546|FG008|Overall Study|Physician Decision|0|||
27719787|NCT03529773|80806547|FG009|Overall Study|Physician Decision|0|||
27719788|NCT03529773|80806548|FG010|Overall Study|Physician Decision|0|||
27719789|NCT03529773|80806549|FG011|Overall Study|Physician Decision|0|||
27719790|NCT03529773|80806550|FG012|Overall Study|Physician Decision|0|||
27719791|NCT03529773|80806551|FG013|Overall Study|Physician Decision|0|||
27719792|NCT03529773|80806552|FG014|Overall Study|Physician Decision|0|||
27719793|NCT03529773|80806553|FG015|Overall Study|Physician Decision|0|||
27719794|NCT03529773|80806554|FG016|Overall Study|Physician Decision|0|||
27719795|NCT03529773|80806555|FG017|Overall Study|Physician Decision|0|||
27719796|NCT03529773|80806556|FG018|Overall Study|Physician Decision|0|||
27719797|NCT03529773|80806557|FG019|Overall Study|Physician Decision|1|||
27719798|NCT03529773|80806558|FG020|Overall Study|Physician Decision|1|||
27719799|NCT03529773|80806559|FG021|Overall Study|Physician Decision|0|||
27719800|NCT03529773|80806560|FG022|Overall Study|Physician Decision|0|||
27719801|NCT03529773|80806561|FG023|Overall Study|Physician Decision|0|||
27719802|NCT03529773|80806562|FG024|Overall Study|Physician Decision|0|||
27719803|NCT03529773|80806563|FG025|Overall Study|Physician Decision|0|||
27719804|NCT03529773|80806564|FG026|Overall Study|Physician Decision|0|||
27719805|NCT03529773|80806565|FG027|Overall Study|Physician Decision|0|||
27719806|NCT03529773|80806566|FG028|Overall Study|Physician Decision|0|||
27719807|NCT03529773|80806567|FG029|Overall Study|Physician Decision|0|||
27719808|NCT03529773|80806568|FG030|Overall Study|Physician Decision|0|||
27719809|NCT03529773|80806569|FG031|Overall Study|Physician Decision|0|||
27719810|NCT03529773|80806570|FG032|Overall Study|Physician Decision|0|||
27719811|NCT03529773|80806571|FG033|Overall Study|Physician Decision|0|||
27719812|NCT03529773|80806572|FG034|Overall Study|Physician Decision|0|||
27719813|NCT03529773|80806573|FG035|Overall Study|Physician Decision|0|||
27719814|NCT03529773|80806574|FG036|Overall Study|Physician Decision|0|||
27719815|NCT03529773|80806575|FG037|Overall Study|Physician Decision|0|||
27838877|NCT03496298|81239495|FG000|Overall Study|Adverse Event|49|||
27838878|NCT03496298|81239496|FG001|Overall Study|Adverse Event|68|||
27719816|NCT03529773|80806576|FG038|Overall Study|Physician Decision|0|||
27719817|NCT03529773|80806577|FG039|Overall Study|Physician Decision|0|||
27719818|NCT03529773|80806538|FG000|Overall Study|Protocol Violation|0|||
27719819|NCT03529773|80806539|FG001|Overall Study|Protocol Violation|0|||
27719820|NCT03529773|80806540|FG002|Overall Study|Protocol Violation|0|||
27719821|NCT03529773|80806541|FG003|Overall Study|Protocol Violation|0|||
27719822|NCT03529773|80806542|FG004|Overall Study|Protocol Violation|0|||
27719823|NCT03529773|80806543|FG005|Overall Study|Protocol Violation|0|||
27719824|NCT03529773|80806544|FG006|Overall Study|Protocol Violation|0|||
27719825|NCT03529773|80806545|FG007|Overall Study|Protocol Violation|0|||
27719826|NCT03529773|80806546|FG008|Overall Study|Protocol Violation|0|||
27719827|NCT03529773|80806547|FG009|Overall Study|Protocol Violation|0|||
27719828|NCT03529773|80806548|FG010|Overall Study|Protocol Violation|0|||
27608149|NCT02690077|80409192|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
27608150|NCT02690077|80409193|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
27608151|NCT02690077|80409192|FG000|Overall Study|Withdrawal by Subject|0|||
27608152|NCT02690077|80409193|FG001|Overall Study|Withdrawal by Subject|5|||
27608153|NCT02690077|80409192|FG000|Overall Study|Excluded by IRB|0|||
27608154|NCT02690077|80409193|FG001|Overall Study|Excluded by IRB|2|||
27608155|NCT03406702|80409194|FG000|Overall Study|Missed Day 27 Dosing|1|||
27608156|NCT01108458|80409203|FG000|Overall Study|Withdrawal by Subject|1|||
27608157|NCT03015116|80409205|FG000|Overall Study|Lost to Follow-up|3|||
27608158|NCT03015116|80409206|FG001|Overall Study|Lost to Follow-up|0|||
27608159|NCT03015116|80409207|FG002|Overall Study|Lost to Follow-up|2|||
27608160|NCT03015116|80409205|FG000|Overall Study|Withdrawal by Subject|3|||
27719829|NCT03529773|80806549|FG011|Overall Study|Protocol Violation|0|||
27719830|NCT03529773|80806550|FG012|Overall Study|Protocol Violation|0|||
27608161|NCT03015116|80409206|FG001|Overall Study|Withdrawal by Subject|1|||
27608162|NCT03015116|80409207|FG002|Overall Study|Withdrawal by Subject|0|||
27608163|NCT03015116|80409205|FG000|Overall Study|Subject has New Medical Status|1|||
27719831|NCT03529773|80806551|FG013|Overall Study|Protocol Violation|0|||
27719832|NCT03529773|80806552|FG014|Overall Study|Protocol Violation|0|||
27719833|NCT03529773|80806553|FG015|Overall Study|Protocol Violation|0|||
27719834|NCT03529773|80806554|FG016|Overall Study|Protocol Violation|0|||
27719835|NCT03529773|80806555|FG017|Overall Study|Protocol Violation|0|||
27608164|NCT03015116|80409206|FG001|Overall Study|Subject has New Medical Status|0|||
27608165|NCT03015116|80409207|FG002|Overall Study|Subject has New Medical Status|0|||
27608166|NCT03015116|80409205|FG000|Overall Study|Physician Decision|0|||
27608167|NCT03015116|80409206|FG001|Overall Study|Physician Decision|1|||
27608168|NCT03015116|80409207|FG002|Overall Study|Physician Decision|0|||
27608169|NCT00152009|80409208|FG000|Overall Study|Adverse Event|9|||
27608170|NCT00152009|80409209|FG001|Overall Study|Adverse Event|13|||
27608171|NCT00152009|80409210|FG002|Overall Study|Adverse Event|20|||
27608172|NCT00152009|80409211|FG003|Overall Study|Adverse Event|1|||
27608173|NCT00152009|80409208|FG000|Overall Study|Protocol Violation|3|||
27608174|NCT00152009|80409209|FG001|Overall Study|Protocol Violation|0|||
27719836|NCT03529773|80806556|FG018|Overall Study|Protocol Violation|0|||
27719837|NCT03529773|80806557|FG019|Overall Study|Protocol Violation|0|||
27838879|NCT03496298|81239497|FG002|Overall Study|Adverse Event|79|||
27838880|NCT03496298|81239495|FG000|Overall Study|Study terminated by Sponsor|1050|||
27838881|NCT03496298|81239496|FG001|Overall Study|Study terminated by Sponsor|1063|||
27838882|NCT03496298|81239497|FG002|Overall Study|Study terminated by Sponsor|1071|||
27838883|NCT03496298|81239495|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
27838884|NCT03496298|81239496|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
27838885|NCT03496298|81239497|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
27838886|NCT03496298|81239495|FG000|Overall Study|Withdrawal by Subject|176|||
27838887|NCT03496298|81239496|FG001|Overall Study|Withdrawal by Subject|154|||
27838888|NCT03496298|81239497|FG002|Overall Study|Withdrawal by Subject|151|||
27838889|NCT03496298|81239495|FG000|Overall Study|Other|29|||
27838890|NCT03496298|81239496|FG001|Overall Study|Other|20|||
27838891|NCT03496298|81239497|FG002|Overall Study|Other|23|||
27838892|NCT03496298|81239495|FG000|Overall Study|Randomized and not treated|1|||
27838893|NCT03496298|81239496|FG001|Overall Study|Randomized and not treated|1|||
27838894|NCT03496298|81239497|FG002|Overall Study|Randomized and not treated|1|||
27838895|NCT01390948|81239499|FG000|Overall Study|End of Study|1|||
27838896|NCT01390948|81239500|FG001|Overall Study|End of Study|0|||
27838897|NCT01390948|81239501|FG002|Overall Study|End of Study|0|||
27608175|NCT00152009|80409210|FG002|Overall Study|Protocol Violation|0|||
27608176|NCT00152009|80409211|FG003|Overall Study|Protocol Violation|1|||
27608177|NCT00152009|80409208|FG000|Overall Study|Withdrawal by Subject|2|||
27719838|NCT03529773|80806558|FG020|Overall Study|Protocol Violation|0|||
27838898|NCT01390948|81239499|FG000|Overall Study|Withdrew consent|2|||
27838899|NCT01390948|81239500|FG001|Overall Study|Withdrew consent|2|||
27838900|NCT01390948|81239501|FG002|Overall Study|Withdrew consent|0|||
27719839|NCT03529773|80806559|FG021|Overall Study|Protocol Violation|0|||
27838901|NCT01390948|81239499|FG000|Overall Study|Progressive Disease|2|||
27719840|NCT03529773|80806560|FG022|Overall Study|Protocol Violation|0|||
27719841|NCT03529773|80806561|FG023|Overall Study|Protocol Violation|0|||
27719842|NCT03529773|80806562|FG024|Overall Study|Protocol Violation|0|||
27719843|NCT03529773|80806563|FG025|Overall Study|Protocol Violation|0|||
27719844|NCT03529773|80806564|FG026|Overall Study|Protocol Violation|0|||
27719845|NCT03529773|80806565|FG027|Overall Study|Protocol Violation|0|||
27719846|NCT03529773|80806566|FG028|Overall Study|Protocol Violation|0|||
27719847|NCT03529773|80806567|FG029|Overall Study|Protocol Violation|0|||
27719848|NCT03529773|80806568|FG030|Overall Study|Protocol Violation|1|||
27719849|NCT03529773|80806569|FG031|Overall Study|Protocol Violation|0|||
27719850|NCT03529773|80806570|FG032|Overall Study|Protocol Violation|0|||
27719851|NCT03529773|80806571|FG033|Overall Study|Protocol Violation|0|||
27719852|NCT03529773|80806572|FG034|Overall Study|Protocol Violation|0|||
27719853|NCT03529773|80806573|FG035|Overall Study|Protocol Violation|0|||
27719854|NCT03529773|80806574|FG036|Overall Study|Protocol Violation|0|||
27838902|NCT01390948|81239500|FG001|Overall Study|Progressive Disease|5|||
27838903|NCT01390948|81239501|FG002|Overall Study|Progressive Disease|0|||
27608178|NCT00152009|80409209|FG001|Overall Study|Withdrawal by Subject|3|||
27608179|NCT00152009|80409210|FG002|Overall Study|Withdrawal by Subject|4|||
27608180|NCT00152009|80409211|FG003|Overall Study|Withdrawal by Subject|9|||
27608181|NCT00152009|80409208|FG000|Overall Study|Lost to Follow-up|2|||
27608182|NCT00152009|80409209|FG001|Overall Study|Lost to Follow-up|4|||
27719855|NCT03529773|80806575|FG037|Overall Study|Protocol Violation|0|||
27838904|NCT01390948|81239499|FG000|Overall Study|Death during follow-up|10|||
27838905|NCT01390948|81239500|FG001|Overall Study|Death during follow-up|11|||
27838906|NCT01390948|81239501|FG002|Overall Study|Death during follow-up|1|||
27838907|NCT00434590|81239504|FG000|Overall Study|Administrative problems|5|||
27838908|NCT00434590|81239505|FG001|Overall Study|Administrative problems|5|||
27838909|NCT01077258|81239508|FG000|Overall Study|Lost to Follow-up|1390|||
27838910|NCT01077258|81239508|FG000|Overall Study|Adverse drug reaction|218|||
27838911|NCT01077258|81239508|FG000|Overall Study|Lack of Efficacy|663|||
27838912|NCT01077258|81239508|FG000|Overall Study|Clinical remission|37|||
27838913|NCT01077258|81239508|FG000|Overall Study|Other reasons|260|||
27838914|NCT02986139|81239512|FG000|Overall Study|Sponsor Decision|1|||
27838915|NCT02986139|81239513|FG001|Overall Study|Sponsor Decision|2|||
27719856|NCT03529773|80806576|FG038|Overall Study|Protocol Violation|0|||
27719857|NCT03529773|80806577|FG039|Overall Study|Protocol Violation|0|||
27719858|NCT03529773|80806538|FG000|Overall Study|Withdrawal by Subject|0|||
27719859|NCT03529773|80806539|FG001|Overall Study|Withdrawal by Subject|0|||
27719860|NCT03529773|80806540|FG002|Overall Study|Withdrawal by Subject|0|||
27719861|NCT03529773|80806541|FG003|Overall Study|Withdrawal by Subject|0|||
27838916|NCT02986139|81239512|FG000|Overall Study|Withdrawal by Subject|0|||
27838917|NCT02986139|81239513|FG001|Overall Study|Withdrawal by Subject|1|||
27890558|NCT04791319|81434088|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27890559|NCT04791319|81434089|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
27890560|NCT04791319|81434090|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
27719862|NCT03529773|80806542|FG004|Overall Study|Withdrawal by Subject|0|||
27719863|NCT03529773|80806543|FG005|Overall Study|Withdrawal by Subject|0|||
27719864|NCT03529773|80806544|FG006|Overall Study|Withdrawal by Subject|0|||
27719865|NCT03529773|80806545|FG007|Overall Study|Withdrawal by Subject|1|||
27719866|NCT03529773|80806546|FG008|Overall Study|Withdrawal by Subject|0|||
27719867|NCT03529773|80806547|FG009|Overall Study|Withdrawal by Subject|1|||
27719868|NCT03529773|80806548|FG010|Overall Study|Withdrawal by Subject|1|||
27838918|NCT02986139|81239512|FG000|Overall Study|Lost to Follow-up|0|||
27719869|NCT03529773|80806549|FG011|Overall Study|Withdrawal by Subject|0|||
27838919|NCT02986139|81239513|FG001|Overall Study|Lost to Follow-up|1|||
27838920|NCT00654641|81239516|FG000|Overall Study|Lost to Follow-up|2|||
27838921|NCT00654641|81239517|FG001|Overall Study|Lost to Follow-up|3|||
27838922|NCT02308696|81239518|FG000|Overall Study|Lost to Follow-up|28|||
27838923|NCT02308696|81239519|FG001|Overall Study|Lost to Follow-up|21|||
27838924|NCT02308696|81239518|FG000|Overall Study|Death|8|||
27838925|NCT02308696|81239519|FG001|Overall Study|Death|4|||
27838926|NCT02308696|81239518|FG000|Overall Study|Moved to a Higher Level of Care|17|||
27838927|NCT02308696|81239519|FG001|Overall Study|Moved to a Higher Level of Care|6|||
27838928|NCT01653704|81239520|FG000|Overall Study|Technical failure during recording|1|||
27719870|NCT03529773|80806550|FG012|Overall Study|Withdrawal by Subject|0|||
27719871|NCT03529773|80806551|FG013|Overall Study|Withdrawal by Subject|0|||
27719872|NCT03529773|80806552|FG014|Overall Study|Withdrawal by Subject|0|||
27719873|NCT03529773|80806553|FG015|Overall Study|Withdrawal by Subject|3|||
27719874|NCT03529773|80806554|FG016|Overall Study|Withdrawal by Subject|0|||
27719875|NCT03529773|80806555|FG017|Overall Study|Withdrawal by Subject|2|||
27719876|NCT03529773|80806556|FG018|Overall Study|Withdrawal by Subject|3|||
27719877|NCT03529773|80806557|FG019|Overall Study|Withdrawal by Subject|1|||
27719878|NCT03529773|80806558|FG020|Overall Study|Withdrawal by Subject|3|||
27719879|NCT03529773|80806559|FG021|Overall Study|Withdrawal by Subject|1|||
27719880|NCT03529773|80806560|FG022|Overall Study|Withdrawal by Subject|1|||
27719881|NCT03529773|80806561|FG023|Overall Study|Withdrawal by Subject|2|||
27719882|NCT03529773|80806562|FG024|Overall Study|Withdrawal by Subject|2|||
27719883|NCT03529773|80806563|FG025|Overall Study|Withdrawal by Subject|4|||
27719884|NCT03529773|80806564|FG026|Overall Study|Withdrawal by Subject|2|||
27719885|NCT03529773|80806565|FG027|Overall Study|Withdrawal by Subject|1|||
27719886|NCT03529773|80806566|FG028|Overall Study|Withdrawal by Subject|1|||
27719887|NCT03529773|80806567|FG029|Overall Study|Withdrawal by Subject|0|||
27719888|NCT03529773|80806568|FG030|Overall Study|Withdrawal by Subject|0|||
27719889|NCT03529773|80806569|FG031|Overall Study|Withdrawal by Subject|0|||
27719890|NCT03529773|80806570|FG032|Overall Study|Withdrawal by Subject|0|||
27719891|NCT03529773|80806571|FG033|Overall Study|Withdrawal by Subject|0|||
27719892|NCT03529773|80806572|FG034|Overall Study|Withdrawal by Subject|1|||
27719893|NCT03529773|80806573|FG035|Overall Study|Withdrawal by Subject|2|||
27719894|NCT03529773|80806574|FG036|Overall Study|Withdrawal by Subject|0|||
27719895|NCT03529773|80806575|FG037|Overall Study|Withdrawal by Subject|2|||
27719896|NCT03529773|80806576|FG038|Overall Study|Withdrawal by Subject|1|||
27719897|NCT03529773|80806577|FG039|Overall Study|Withdrawal by Subject|1|||
27719898|NCT03529773|80806538|FG000|Overall Study|Screen Failure|0|||
27719899|NCT03529773|80806539|FG001|Overall Study|Screen Failure|0|||
27719900|NCT03529773|80806540|FG002|Overall Study|Screen Failure|0|||
27719901|NCT03529773|80806541|FG003|Overall Study|Screen Failure|0|||
27719902|NCT03529773|80806542|FG004|Overall Study|Screen Failure|0|||
27719903|NCT03529773|80806543|FG005|Overall Study|Screen Failure|0|||
27719904|NCT03529773|80806544|FG006|Overall Study|Screen Failure|0|||
27719905|NCT03529773|80806545|FG007|Overall Study|Screen Failure|0|||
27719906|NCT03529773|80806546|FG008|Overall Study|Screen Failure|0|||
27719907|NCT03529773|80806547|FG009|Overall Study|Screen Failure|0|||
27719908|NCT03529773|80806548|FG010|Overall Study|Screen Failure|0|||
27719909|NCT03529773|80806549|FG011|Overall Study|Screen Failure|0|||
27719910|NCT03529773|80806550|FG012|Overall Study|Screen Failure|0|||
27719911|NCT03529773|80806551|FG013|Overall Study|Screen Failure|0|||
27719912|NCT03529773|80806552|FG014|Overall Study|Screen Failure|0|||
27719913|NCT03529773|80806553|FG015|Overall Study|Screen Failure|0|||
27719914|NCT03529773|80806554|FG016|Overall Study|Screen Failure|0|||
27719915|NCT03529773|80806555|FG017|Overall Study|Screen Failure|0|||
27719916|NCT03529773|80806556|FG018|Overall Study|Screen Failure|0|||
27719917|NCT03529773|80806557|FG019|Overall Study|Screen Failure|0|||
27958591|NCT01791517|81680063|FG005|Phase II|Withdrawal by Subject|2|||
27719918|NCT03529773|80806558|FG020|Overall Study|Screen Failure|0|||
27719919|NCT03529773|80806559|FG021|Overall Study|Screen Failure|0|||
27719920|NCT03529773|80806560|FG022|Overall Study|Screen Failure|0|||
27719921|NCT03529773|80806561|FG023|Overall Study|Screen Failure|0|||
27719922|NCT03529773|80806562|FG024|Overall Study|Screen Failure|0|||
27719923|NCT03529773|80806563|FG025|Overall Study|Screen Failure|0|||
27719924|NCT03529773|80806564|FG026|Overall Study|Screen Failure|0|||
27719925|NCT03529773|80806565|FG027|Overall Study|Screen Failure|0|||
27719926|NCT03529773|80806566|FG028|Overall Study|Screen Failure|0|||
27719927|NCT03529773|80806567|FG029|Overall Study|Screen Failure|0|||
27719928|NCT03529773|80806568|FG030|Overall Study|Screen Failure|0|||
27719929|NCT03529773|80806569|FG031|Overall Study|Screen Failure|0|||
27608183|NCT00152009|80409210|FG002|Overall Study|Lost to Follow-up|3|||
27719930|NCT03529773|80806570|FG032|Overall Study|Screen Failure|0|||
27719931|NCT03529773|80806571|FG033|Overall Study|Screen Failure|0|||
27719932|NCT03529773|80806572|FG034|Overall Study|Screen Failure|0|||
27719933|NCT03529773|80806573|FG035|Overall Study|Screen Failure|0|||
27719934|NCT03529773|80806574|FG036|Overall Study|Screen Failure|1|||
27719935|NCT03529773|80806575|FG037|Overall Study|Screen Failure|1|||
27719936|NCT03529773|80806576|FG038|Overall Study|Screen Failure|0|||
27719937|NCT03529773|80806577|FG039|Overall Study|Screen Failure|1|||
27719938|NCT03529773|80806538|FG000|Overall Study|Randomized but not vaccinated|0|||
27719939|NCT03529773|80806539|FG001|Overall Study|Randomized but not vaccinated|0|||
27719940|NCT03529773|80806540|FG002|Overall Study|Randomized but not vaccinated|0|||
27719941|NCT03529773|80806541|FG003|Overall Study|Randomized but not vaccinated|0|||
27719942|NCT03529773|80806542|FG004|Overall Study|Randomized but not vaccinated|0|||
27719943|NCT03529773|80806543|FG005|Overall Study|Randomized but not vaccinated|0|||
27719944|NCT03529773|80806544|FG006|Overall Study|Randomized but not vaccinated|0|||
27719945|NCT03529773|80806545|FG007|Overall Study|Randomized but not vaccinated|0|||
27719946|NCT03529773|80806546|FG008|Overall Study|Randomized but not vaccinated|0|||
27719947|NCT03529773|80806547|FG009|Overall Study|Randomized but not vaccinated|0|||
27719948|NCT03529773|80806548|FG010|Overall Study|Randomized but not vaccinated|0|||
27719949|NCT03529773|80806549|FG011|Overall Study|Randomized but not vaccinated|0|||
27719950|NCT03529773|80806550|FG012|Overall Study|Randomized but not vaccinated|0|||
27719951|NCT03529773|80806551|FG013|Overall Study|Randomized but not vaccinated|0|||
27719952|NCT03529773|80806552|FG014|Overall Study|Randomized but not vaccinated|0|||
27719953|NCT03529773|80806553|FG015|Overall Study|Randomized but not vaccinated|0|||
27719954|NCT03529773|80806554|FG016|Overall Study|Randomized but not vaccinated|0|||
27719955|NCT03529773|80806555|FG017|Overall Study|Randomized but not vaccinated|1|||
27719956|NCT03529773|80806556|FG018|Overall Study|Randomized but not vaccinated|0|||
27719957|NCT03529773|80806557|FG019|Overall Study|Randomized but not vaccinated|0|||
27719958|NCT03529773|80806558|FG020|Overall Study|Randomized but not vaccinated|0|||
27719959|NCT03529773|80806559|FG021|Overall Study|Randomized but not vaccinated|0|||
27719960|NCT03529773|80806560|FG022|Overall Study|Randomized but not vaccinated|0|||
27719961|NCT03529773|80806561|FG023|Overall Study|Randomized but not vaccinated|0|||
27719962|NCT03529773|80806562|FG024|Overall Study|Randomized but not vaccinated|0|||
27719963|NCT03529773|80806563|FG025|Overall Study|Randomized but not vaccinated|0|||
27719964|NCT03529773|80806564|FG026|Overall Study|Randomized but not vaccinated|0|||
27719965|NCT03529773|80806565|FG027|Overall Study|Randomized but not vaccinated|1|||
27719966|NCT03529773|80806566|FG028|Overall Study|Randomized but not vaccinated|0|||
27719967|NCT03529773|80806567|FG029|Overall Study|Randomized but not vaccinated|0|||
27719968|NCT03529773|80806568|FG030|Overall Study|Randomized but not vaccinated|0|||
27719969|NCT03529773|80806569|FG031|Overall Study|Randomized but not vaccinated|0|||
27719970|NCT03529773|80806570|FG032|Overall Study|Randomized but not vaccinated|0|||
27719971|NCT03529773|80806571|FG033|Overall Study|Randomized but not vaccinated|0|||
27719972|NCT03529773|80806572|FG034|Overall Study|Randomized but not vaccinated|0|||
27838929|NCT01653704|81239521|FG001|Overall Study|Technical failure during recording|1|||
27838930|NCT01653704|81239520|FG000|Overall Study|Performance not reflective of training|1|||
27838931|NCT01653704|81239521|FG001|Overall Study|Performance not reflective of training|0|||
27838932|NCT04610580|81239524|FG000|Two-way Crossover Period|Adverse Event|1|||
27838933|NCT04610580|81239525|FG001|Two-way Crossover Period|Adverse Event|0|||
27838934|NCT04610580|81239526|FG002|Two-way Crossover Period|Adverse Event|0|||
27838935|NCT04610580|81239527|FG003|Two-way Crossover Period|Adverse Event|0|||
27838936|NCT04610580|81239528|FG004|Two-way Crossover Period|Adverse Event|0|||
27838937|NCT04610580|81239529|FG005|Two-way Crossover Period|Adverse Event|0|||
27838938|NCT04610580|81239524|FG000|Two-way Crossover Period|Physician Decision|1|||
27838939|NCT04610580|81239525|FG001|Two-way Crossover Period|Physician Decision|0|||
27838940|NCT04610580|81239526|FG002|Two-way Crossover Period|Physician Decision|0|||
27719973|NCT03529773|80806573|FG035|Overall Study|Randomized but not vaccinated|0|||
27719974|NCT03529773|80806574|FG036|Overall Study|Randomized but not vaccinated|0|||
27719975|NCT03529773|80806575|FG037|Overall Study|Randomized but not vaccinated|0|||
27719976|NCT03529773|80806576|FG038|Overall Study|Randomized but not vaccinated|0|||
27719977|NCT03529773|80806577|FG039|Overall Study|Randomized but not vaccinated|0|||
27719978|NCT01816243|80806578|FG000|Overall Study|Adverse Event|6|||
27719979|NCT01816243|80806578|FG000|Overall Study|Lost to Follow-up|1|||
27719980|NCT01816243|80806578|FG000|Overall Study|Lack of Efficacy|1|||
27838941|NCT04610580|81239527|FG003|Two-way Crossover Period|Physician Decision|0|||
27838942|NCT04610580|81239528|FG004|Two-way Crossover Period|Physician Decision|0|||
27608184|NCT00152009|80409211|FG003|Overall Study|Lost to Follow-up|3|||
27719981|NCT01816243|80806578|FG000|Overall Study|Not eligible for the study|1|||
27719982|NCT01816243|80806578|FG000|Overall Study|Amputation|3|||
27719983|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
27719984|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
27719985|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
27719986|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
27719987|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27719988|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27719989|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
27719990|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27719991|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
27719992|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27719993|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27719994|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27719995|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
27719996|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
27719997|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
27719998|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
27719999|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
27720000|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
27720001|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
27720002|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
27720003|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
27720004|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
27720005|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
27720006|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
27720007|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
27720008|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
27720009|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
27720010|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
27720011|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
27720012|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
27720013|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
27720014|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
27720015|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
27720016|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
27720017|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
27720018|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
27720019|NCT03403205|80806579|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
27838943|NCT04610580|81239529|FG005|Two-way Crossover Period|Physician Decision|0|||
27838944|NCT04610580|81239524|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
27838945|NCT04610580|81239525|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
27838946|NCT04610580|81239526|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
27838947|NCT04610580|81239527|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
27838948|NCT04610580|81239528|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
27838949|NCT04610580|81239529|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
27608185|NCT00152009|80409208|FG000|Overall Study|Lack of Efficacy|8|||
27608186|NCT00152009|80409209|FG001|Overall Study|Lack of Efficacy|6|||
27608187|NCT00152009|80409210|FG002|Overall Study|Lack of Efficacy|7|||
27608188|NCT00152009|80409211|FG003|Overall Study|Lack of Efficacy|15|||
27608189|NCT00152009|80409208|FG000|Overall Study|ECG abnormalities|2|||
27608190|NCT00152009|80409209|FG001|Overall Study|ECG abnormalities|2|||
27608191|NCT00152009|80409210|FG002|Overall Study|ECG abnormalities|2|||
27608192|NCT00152009|80409211|FG003|Overall Study|ECG abnormalities|1|||
27608193|NCT00152009|80409208|FG000|Overall Study|Sponsor's decision|3|||
27608194|NCT00152009|80409209|FG001|Overall Study|Sponsor's decision|3|||
27608195|NCT00152009|80409210|FG002|Overall Study|Sponsor's decision|1|||
27608196|NCT00152009|80409211|FG003|Overall Study|Sponsor's decision|3|||
27608197|NCT02176421|80409212|FG000|Overall Study|Lost to Follow-up|4|||
27608198|NCT02176421|80409212|FG000|Overall Study|Adverse Event|1|||
27608199|NCT03107377|80409213|FG000|Overall Study|Adverse Event|3|||
27838950|NCT04610580|81239524|FG000|Two-way Crossover Period|Other than specified|0|||
27608200|NCT03107377|80409214|FG001|Overall Study|Adverse Event|3|||
27608201|NCT03107377|80409213|FG000|Overall Study|Protocol Violation|9|||
27608202|NCT03107377|80409214|FG001|Overall Study|Protocol Violation|12|||
27608203|NCT03107377|80409213|FG000|Overall Study|Physician Decision|3|||
27608204|NCT03107377|80409214|FG001|Overall Study|Physician Decision|6|||
27608205|NCT03107377|80409213|FG000|Overall Study|Pregnancy|7|||
27608206|NCT03107377|80409214|FG001|Overall Study|Pregnancy|7|||
27608207|NCT03107377|80409213|FG000|Overall Study|Withdrawal by Subject|16|||
27608208|NCT03107377|80409214|FG001|Overall Study|Withdrawal by Subject|22|||
27608209|NCT03107377|80409213|FG000|Overall Study|Lost to Follow-up|37|||
27608210|NCT03107377|80409214|FG001|Overall Study|Lost to Follow-up|34|||
27608211|NCT03107377|80409213|FG000|Overall Study|Other reason not specified|16|||
27838951|NCT04610580|81239525|FG001|Two-way Crossover Period|Other than specified|1|||
27838952|NCT04610580|81239526|FG002|Two-way Crossover Period|Other than specified|0|||
27838953|NCT04610580|81239527|FG003|Two-way Crossover Period|Other than specified|0|||
27838954|NCT04610580|81239528|FG004|Two-way Crossover Period|Other than specified|0|||
27890561|NCT04791319|81434091|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
27890562|NCT04791319|81434092|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
27890563|NCT04791319|81434093|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
27890564|NCT04791319|81434094|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
27890565|NCT04791319|81434095|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
27890566|NCT04791319|81434096|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
27890567|NCT01669174|81434097|FG000|Overall Study|Subject withdrew consent|2|||
27890568|NCT01669174|81434098|FG001|Overall Study|Subject withdrew consent|2|||
27890569|NCT01669174|81434097|FG000|Overall Study|Lost to Follow-up|1|||
27890570|NCT01669174|81434098|FG001|Overall Study|Lost to Follow-up|0|||
27890571|NCT01669174|81434097|FG000|Overall Study|Adverse Event|2|||
27890572|NCT01669174|81434098|FG001|Overall Study|Adverse Event|2|||
27890573|NCT01669174|81434097|FG000|Overall Study|Administrative problems|1|||
27890574|NCT01669174|81434098|FG001|Overall Study|Administrative problems|2|||
27890575|NCT01075646|81434099|FG000|Overall Study|Lost to Follow-up|4|||
27890576|NCT01075646|81434100|FG001|Overall Study|Lost to Follow-up|3|||
27890577|NCT01075646|81434101|FG002|Overall Study|Lost to Follow-up|1|||
27890578|NCT01075646|81434102|FG003|Overall Study|Lost to Follow-up|2|||
27890579|NCT03200704|81434103|FG000|Overall Study|Withdrawal by Subject|1|||
27890580|NCT04413552|81434104|FG000|Overall Study|Adverse Event|0|||
27890581|NCT04413552|81434105|FG001|Overall Study|Adverse Event|0|||
27890582|NCT04413552|81434106|FG002|Overall Study|Adverse Event|0|||
27890583|NCT04413552|81434107|FG003|Overall Study|Adverse Event|0|||
27890584|NCT04413552|81434108|FG004|Overall Study|Adverse Event|0|||
27890585|NCT04413552|81434109|FG005|Overall Study|Adverse Event|0|||
27890586|NCT04413552|81434110|FG006|Overall Study|Adverse Event|1|||
27890587|NCT04413552|81434111|FG007|Overall Study|Adverse Event|0|||
27890588|NCT04413552|81434112|FG008|Overall Study|Adverse Event|0|||
27890589|NCT04413552|81434113|FG009|Overall Study|Adverse Event|0|||
27890590|NCT03053063|81434122|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
27890591|NCT03053063|81434123|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
27890592|NCT03053063|81434124|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
27890593|NCT03053063|81434125|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
27890594|NCT03053063|81434122|FG000|Randomized Phase|Withdrew consent|8|||
27890595|NCT03053063|81434123|FG001|Randomized Phase|Withdrew consent|11|||
27890596|NCT03053063|81434124|FG002|Randomized Phase|Withdrew consent|5|||
27838955|NCT04610580|81239529|FG005|Two-way Crossover Period|Other than specified|0|||
27838956|NCT04610580|81239524|FG000|Washout Before Extension Period|Other than specified|0|||
27838957|NCT04610580|81239525|FG001|Washout Before Extension Period|Other than specified|1|||
27838958|NCT04610580|81239526|FG002|Washout Before Extension Period|Other than specified|0|||
27838959|NCT04610580|81239527|FG003|Washout Before Extension Period|Other than specified|0|||
27838960|NCT04610580|81239528|FG004|Washout Before Extension Period|Other than specified|0|||
27838961|NCT04610580|81239529|FG005|Washout Before Extension Period|Other than specified|0|||
27838962|NCT04610580|81239524|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
27838963|NCT04610580|81239525|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
27838964|NCT04610580|81239526|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
27838965|NCT04610580|81239527|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
27838966|NCT04610580|81239528|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
27838967|NCT04610580|81239529|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
27838968|NCT04610580|81239524|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
27838969|NCT04610580|81239525|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
27838970|NCT04610580|81239526|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
27838971|NCT04610580|81239527|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
27838972|NCT04610580|81239528|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
27838973|NCT04610580|81239529|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
27838974|NCT02914457|81239532|FG000|Overall Study|Withdrawal by Subject|1|||
27838975|NCT02914457|81239532|FG000|Overall Study|Physician Decision|1|||
27890597|NCT03053063|81434125|FG003|Randomized Phase|Withdrew consent|0|||
27890598|NCT03053063|81434122|FG000|Randomized Phase|Investigator's Discretion|8|||
27890599|NCT03053063|81434123|FG001|Randomized Phase|Investigator's Discretion|6|||
27890600|NCT03053063|81434124|FG002|Randomized Phase|Investigator's Discretion|2|||
27890601|NCT03053063|81434125|FG003|Randomized Phase|Investigator's Discretion|0|||
27890602|NCT03053063|81434122|FG000|Randomized Phase|Lost to Follow-up|3|||
27890603|NCT03053063|81434123|FG001|Randomized Phase|Lost to Follow-up|5|||
27838976|NCT02914457|81239532|FG000|Overall Study|No veins available for lead placement|1|||
27890604|NCT03053063|81434124|FG002|Randomized Phase|Lost to Follow-up|1|||
27890605|NCT03053063|81434125|FG003|Randomized Phase|Lost to Follow-up|0|||
27890606|NCT03053063|81434122|FG000|Randomized Phase|Adverse Event|0|||
27890607|NCT03053063|81434123|FG001|Randomized Phase|Adverse Event|1|||
27890608|NCT03053063|81434124|FG002|Randomized Phase|Adverse Event|0|||
27890609|NCT03053063|81434125|FG003|Randomized Phase|Adverse Event|0|||
27890610|NCT03053063|81434122|FG000|Randomized Phase|Randomized but Never Treated|1|||
27890611|NCT03053063|81434123|FG001|Randomized Phase|Randomized but Never Treated|3|||
27890612|NCT03053063|81434124|FG002|Randomized Phase|Randomized but Never Treated|2|||
27890613|NCT03053063|81434125|FG003|Randomized Phase|Randomized but Never Treated|0|||
27890614|NCT03053063|81434122|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
27890615|NCT03053063|81434123|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
27890616|NCT03053063|81434124|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
27890617|NCT03053063|81434125|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
27890618|NCT03053063|81434122|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
27890619|NCT03053063|81434123|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
27890620|NCT03053063|81434124|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
27890621|NCT03053063|81434125|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
27890622|NCT03053063|81434122|FG000|Open-Label Phase|Death|0|||
27890623|NCT03053063|81434123|FG001|Open-Label Phase|Death|0|||
27890624|NCT03053063|81434124|FG002|Open-Label Phase|Death|0|||
27890625|NCT03053063|81434125|FG003|Open-Label Phase|Death|2|||
27890626|NCT03053063|81434122|FG000|Open-Label Phase|Investigator's discretion|0|||
27890627|NCT03053063|81434123|FG001|Open-Label Phase|Investigator's discretion|0|||
27890628|NCT03053063|81434124|FG002|Open-Label Phase|Investigator's discretion|0|||
27890629|NCT03053063|81434125|FG003|Open-Label Phase|Investigator's discretion|2|||
27890630|NCT01167881|81434126|FG000|Overall Study|Adverse Event|47|||
27890631|NCT01167881|81434127|FG001|Overall Study|Adverse Event|51|||
27890632|NCT01167881|81434126|FG000|Overall Study|Lack of Efficacy|4|||
27890633|NCT01167881|81434127|FG001|Overall Study|Lack of Efficacy|7|||
27890634|NCT01167881|81434126|FG000|Overall Study|Non compliant with protocol|9|||
27890635|NCT01167881|81434127|FG001|Overall Study|Non compliant with protocol|18|||
27608212|NCT03107377|80409214|FG001|Overall Study|Other reason not specified|15|||
27608213|NCT04277455|80409215|FG000|Overall Study|Lost to Follow-up|1|||
27608214|NCT02496767|80409216|FG000|Open-label Lead-in Phase|Adverse Event|176|||
27608215|NCT02496767|80409217|FG001|Open-label Lead-in Phase|Adverse Event|0|||
27608216|NCT02496767|80409218|FG002|Open-label Lead-in Phase|Adverse Event|0|||
27608217|NCT02496767|80409219|FG003|Open-label Lead-in Phase|Adverse Event|0|||
27608218|NCT02496767|80409220|FG004|Open-label Lead-in Phase|Adverse Event|0|||
27608219|NCT02496767|80409221|FG005|Open-label Lead-in Phase|Adverse Event|0|||
27608220|NCT02496767|80409222|FG006|Open-label Lead-in Phase|Adverse Event|0|||
27608221|NCT02496767|80409223|FG007|Open-label Lead-in Phase|Adverse Event|0|||
27608222|NCT02496767|80409216|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
27608223|NCT02496767|80409217|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
27608224|NCT02496767|80409218|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
27720020|NCT03403205|80806580|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
27720021|NCT03403205|80806581|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
27720022|NCT03403205|80806582|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
27720023|NCT03403205|80806583|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
27720024|NCT03403205|80806584|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
27720025|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
27720026|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
27720027|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
27720028|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
27890636|NCT01167881|81434126|FG000|Overall Study|Lost to Follow-up|19|||
27890637|NCT01167881|81434127|FG001|Overall Study|Lost to Follow-up|20|||
27890638|NCT01167881|81434126|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
27890639|NCT01167881|81434127|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
27608225|NCT02496767|80409219|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
27890640|NCT01167881|81434126|FG000|Overall Study|Not treated|4|||
27720029|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
27720030|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
27720031|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
27720032|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
27720033|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
27720034|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
27720035|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
27720036|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
27720037|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Death|1|||
27608226|NCT02496767|80409220|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
27608227|NCT02496767|80409221|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
27608228|NCT02496767|80409222|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
27608229|NCT02496767|80409223|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
27608230|NCT02496767|80409216|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
27608231|NCT02496767|80409217|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
27608232|NCT02496767|80409218|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
27608233|NCT02496767|80409219|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
27720038|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Death|0|||
27720039|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Death|0|||
27608234|NCT02496767|80409220|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
27608235|NCT02496767|80409221|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
27720040|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Death|0|||
27608236|NCT02496767|80409222|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
27608237|NCT02496767|80409223|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
27720041|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Death|0|||
27608238|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27890641|NCT01167881|81434127|FG001|Overall Study|Not treated|0|||
27608239|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
27608240|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
27608241|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
27608242|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
27608243|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27608244|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27608245|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
27608246|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27608247|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
27608248|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
27608249|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
27608250|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
27608251|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27838977|NCT02914457|81239532|FG000|Overall Study|Electrical instability of patient|1|||
27608252|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27608253|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
27608254|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
27608255|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
27608256|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
27958592|NCT01791517|81680064|FG006|Phase II|Withdrawal by Subject|0|||
27838978|NCT02914457|81239532|FG000|Overall Study|ECG acquisition error due to sweating|1|||
27838979|NCT02914457|81239532|FG000|Overall Study|Protocol Violation|1|||
27838980|NCT00089973|81239533|FG000|Overall Study|Adverse Event|3|||
27838981|NCT00089973|81239533|FG000|Overall Study|Withdrawal by Subject|1|||
27838982|NCT00089973|81239533|FG000|Overall Study|Disease progression|45|||
27838983|NCT00089973|81239533|FG000|Overall Study|Death|1|||
27838984|NCT04019054|81239534|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
27838985|NCT04019054|81239535|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
27838986|NCT04019054|81239534|FG000|Overall Study|Withdrawal by Subject|3|||
27838987|NCT04019054|81239535|FG001|Overall Study|Withdrawal by Subject|1|||
27838988|NCT00879684|81239540|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
27838989|NCT00879684|81239541|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
27838990|NCT00879684|81239542|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
27838991|NCT00879684|81239543|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
27838992|NCT00879684|81239544|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
27890642|NCT01167881|81434126|FG000|Overall Study|Other not defined above|31|||
27890643|NCT01167881|81434127|FG001|Overall Study|Other not defined above|55|||
27499988|NCT03924622|80024817|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
27499989|NCT03924622|80024818|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
27499990|NCT03924622|80024819|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
27499991|NCT03924622|80024820|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
27499992|NCT03924622|80024821|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
27499993|NCT03924622|80024822|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
27499994|NCT05106959|80024823|FG000|Overall Study|Lost to Follow-up|1|||
27499995|NCT01584232|80024826|FG000|Overall Study|Adverse Event|3|||
27499996|NCT01584232|80024827|FG001|Overall Study|Adverse Event|1|||
27499997|NCT01584232|80024826|FG000|Overall Study|Withdrawal by Subject|2|||
27499998|NCT01584232|80024827|FG001|Overall Study|Withdrawal by Subject|1|||
27720042|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Death|0|||
27838993|NCT00879684|81239545|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
27838994|NCT00879684|81239546|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
27608257|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
27608258|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
27608259|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
27608260|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
27608261|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
27608262|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
27608263|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
27608264|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
27608265|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
27608266|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
27608267|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
27608268|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
27608269|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
27608270|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27608271|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
27608272|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
27608273|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
27608274|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
27608275|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27608276|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27608277|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
27608278|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27608279|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
27608280|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
27608281|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27608282|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27608283|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27890644|NCT04526665|81434128|FG000|Overall Study|Withdrawal by Subject|6|||
27890645|NCT04526665|81434129|FG001|Overall Study|Withdrawal by Subject|3|||
27890646|NCT04526665|81434128|FG000|Overall Study|Adverse Event|4|||
27890647|NCT04526665|81434129|FG001|Overall Study|Adverse Event|1|||
27890648|NCT04526665|81434128|FG000|Overall Study|Physician Decision|2|||
27890649|NCT04526665|81434129|FG001|Overall Study|Physician Decision|2|||
27890650|NCT04526665|81434128|FG000|Overall Study|Death|2|||
27890651|NCT04526665|81434129|FG001|Overall Study|Death|0|||
27890652|NCT04526665|81434128|FG000|Overall Study|Other|0|||
27608284|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27608285|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
27608286|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27608287|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
27890653|NCT04526665|81434129|FG001|Overall Study|Other|1|||
27890654|NCT05148234|81434142|FG000|Phase I|Ineligible|0|||
27890655|NCT05148234|81434143|FG001|Phase I|Ineligible|0|||
27890656|NCT05148234|81434144|FG002|Phase I|Ineligible|0|||
27890657|NCT05148234|81434145|FG003|Phase I|Ineligible|0|||
27890658|NCT05148234|81434146|FG004|Phase I|Ineligible|0|||
27890659|NCT05148234|81434147|FG005|Phase I|Ineligible|0|||
27890660|NCT05148234|81434148|FG006|Phase I|Ineligible|0|||
27890661|NCT05148234|81434149|FG007|Phase I|Ineligible|1|||
27890662|NCT05148234|81434142|FG000|Phase I|Company closed the trial.|0|||
27890663|NCT05148234|81434143|FG001|Phase I|Company closed the trial.|1|||
27890664|NCT05148234|81434144|FG002|Phase I|Company closed the trial.|0|||
27890665|NCT05148234|81434145|FG003|Phase I|Company closed the trial.|0|||
27890666|NCT05148234|81434146|FG004|Phase I|Company closed the trial.|0|||
27890667|NCT05148234|81434147|FG005|Phase I|Company closed the trial.|0|||
27890668|NCT05148234|81434148|FG006|Phase I|Company closed the trial.|0|||
27890669|NCT05148234|81434149|FG007|Phase I|Company closed the trial.|0|||
27890670|NCT02394340|81434154|FG000|Overall Study|Failed drug screen test|1|||
27890671|NCT02394340|81434154|FG000|Overall Study|Adverse Event|1|||
27890672|NCT02031640|81434155|FG000|Screening Period|Adverse Event|1|||
27890673|NCT02031640|81434156|FG001|Screening Period|Adverse Event|0|||
27890674|NCT02031640|81434157|FG002|Screening Period|Adverse Event|0|||
27890675|NCT02031640|81434158|FG003|Screening Period|Adverse Event|0|||
27890676|NCT02031640|81434159|FG004|Screening Period|Adverse Event|0|||
27890677|NCT02031640|81434160|FG005|Screening Period|Adverse Event|0|||
27890678|NCT02031640|81434155|FG000|Screening Period|Withdrawal by Subject|29|||
27890679|NCT02031640|81434156|FG001|Screening Period|Withdrawal by Subject|0|||
27890680|NCT02031640|81434157|FG002|Screening Period|Withdrawal by Subject|0|||
27890681|NCT02031640|81434158|FG003|Screening Period|Withdrawal by Subject|0|||
27890682|NCT02031640|81434159|FG004|Screening Period|Withdrawal by Subject|0|||
27890683|NCT02031640|81434160|FG005|Screening Period|Withdrawal by Subject|0|||
27608288|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27608289|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
27608290|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
27608291|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27608292|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27608293|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
27608294|NCT02496767|80409216|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27608295|NCT02496767|80409217|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
27608296|NCT02496767|80409218|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27838995|NCT00879684|81239540|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
27838996|NCT00879684|81239541|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
27838997|NCT00879684|81239542|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
27838998|NCT00879684|81239543|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
27838999|NCT00879684|81239544|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
27839000|NCT00879684|81239545|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
27839001|NCT00879684|81239546|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
27890684|NCT02031640|81434155|FG000|Screening Period|Inclusion criteria not met|312|||
27499999|NCT01584232|80024826|FG000|Overall Study|Physician Decision|2|||
27500000|NCT01584232|80024827|FG001|Overall Study|Physician Decision|1|||
27500001|NCT01584232|80024826|FG000|Overall Study|Lost to Follow-up|1|||
27500002|NCT01584232|80024827|FG001|Overall Study|Lost to Follow-up|0|||
27500003|NCT05468814|80024838|FG000|Overall Study|Lost to Follow-up|5|||
27500004|NCT05468814|80024839|FG001|Overall Study|Lost to Follow-up|6|||
27500005|NCT02558894|80024848|FG000|Overall Study|Death; any cause, entire study duration|28|||
27500006|NCT02558894|80024849|FG001|Overall Study|Death; any cause, entire study duration|31|||
27500007|NCT02558894|80024848|FG000|Overall Study|Withdrawal by Subject|2|||
27608297|NCT02496767|80409219|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27608298|NCT02496767|80409220|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27608299|NCT02496767|80409221|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27608300|NCT02496767|80409222|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27890685|NCT02031640|81434156|FG001|Screening Period|Inclusion criteria not met|0|||
27890686|NCT02031640|81434157|FG002|Screening Period|Inclusion criteria not met|0|||
27608301|NCT02496767|80409223|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
27608302|NCT02496767|80409216|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
27608303|NCT02496767|80409217|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
27608304|NCT02496767|80409218|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
27608305|NCT02496767|80409219|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
27608306|NCT02496767|80409220|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
27608307|NCT02496767|80409221|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
27608308|NCT02496767|80409222|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
27608309|NCT02496767|80409223|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
27608310|NCT02496767|80409216|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
27608311|NCT02496767|80409217|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
27608312|NCT02496767|80409218|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
27608313|NCT02496767|80409219|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
27608314|NCT02496767|80409220|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
27608315|NCT02496767|80409221|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
27608316|NCT02496767|80409222|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
27608317|NCT02496767|80409223|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
27608318|NCT02496767|80409216|FG000|Double-blind, Withdrawal Phase|Death|0|||
27608319|NCT02496767|80409217|FG001|Double-blind, Withdrawal Phase|Death|0|||
27608320|NCT02496767|80409218|FG002|Double-blind, Withdrawal Phase|Death|0|||
27608321|NCT02496767|80409219|FG003|Double-blind, Withdrawal Phase|Death|0|||
27608322|NCT02496767|80409220|FG004|Double-blind, Withdrawal Phase|Death|0|||
27608323|NCT02496767|80409221|FG005|Double-blind, Withdrawal Phase|Death|0|||
27608324|NCT02496767|80409222|FG006|Double-blind, Withdrawal Phase|Death|1|||
27608325|NCT02496767|80409223|FG007|Double-blind, Withdrawal Phase|Death|2|||
27608326|NCT02496767|80409216|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27720043|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
27720044|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
27608327|NCT02496767|80409217|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27608328|NCT02496767|80409218|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27608329|NCT02496767|80409219|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27608330|NCT02496767|80409220|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
27608331|NCT02496767|80409221|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
27608332|NCT02496767|80409222|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
27720045|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
27720046|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
27720047|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
27720048|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
27720049|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
27720050|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
27720051|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
27720052|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
27720053|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
27608333|NCT02496767|80409223|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
27608334|NCT01567865|80409224|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
27608335|NCT01567865|80409225|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
27608336|NCT01567865|80409226|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
27608337|NCT01567865|80409227|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
27608338|NCT01567865|80409224|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
27608339|NCT01567865|80409225|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
27720054|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
27720055|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
27958593|NCT01791517|81680065|FG007|Phase II|Withdrawal by Subject|1|||
27500008|NCT02558894|80024849|FG001|Overall Study|Withdrawal by Subject|1|||
27500009|NCT02558894|80024848|FG000|Overall Study|Closure of Part A|2|||
27500010|NCT02558894|80024849|FG001|Overall Study|Closure of Part A|1|||
27500011|NCT04097678|80024850|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
27500012|NCT04097678|80024851|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
27500013|NCT01903356|80024856|FG000|Overall Study|Lost to Follow-up|7|||
27500014|NCT01903356|80024856|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
27500015|NCT01903356|80024856|FG000|Overall Study|Violated the dosage and administration|3|||
27720056|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
27720057|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
27720058|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
27720059|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
27720060|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
27720061|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
27720062|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
27720063|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
27720064|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
27720065|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
27720066|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
27720067|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
27720068|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
27720069|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
27720070|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
27720071|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
27720072|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
27720073|NCT03403205|80806579|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
27720074|NCT03403205|80806580|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
27720075|NCT03403205|80806581|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
27720076|NCT03403205|80806582|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
27720077|NCT03403205|80806583|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
27720078|NCT03403205|80806584|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
27720079|NCT03107793|80806586|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
27720080|NCT03107793|80806587|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
27720081|NCT03107793|80806588|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
27720082|NCT03107793|80806589|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
27839002|NCT00879684|81239540|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
27839003|NCT00879684|81239541|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
27839004|NCT00879684|81239542|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
27839005|NCT00879684|81239543|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
27839006|NCT00879684|81239544|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
27839007|NCT00879684|81239545|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
27839008|NCT00879684|81239546|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
27839009|NCT00879684|81239540|FG000|Stage 1: Dose Escalation|Death|0|||
27720083|NCT03107793|80806590|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
27720084|NCT03107793|80806586|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
27720085|NCT03107793|80806587|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
27720086|NCT03107793|80806588|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
27720087|NCT03107793|80806589|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
27720088|NCT03107793|80806590|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
27720089|NCT03107793|80806586|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
27720090|NCT03107793|80806587|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
27720091|NCT03107793|80806588|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
27890687|NCT02031640|81434158|FG003|Screening Period|Inclusion criteria not met|0|||
27890688|NCT02031640|81434159|FG004|Screening Period|Inclusion criteria not met|0|||
27720092|NCT03107793|80806589|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
27720093|NCT03107793|80806590|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
27720094|NCT03107793|80806586|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
27720095|NCT03107793|80806587|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27720096|NCT03107793|80806588|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27720097|NCT03107793|80806589|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27720098|NCT03107793|80806590|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27720099|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27720100|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
27720101|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
27720102|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27720103|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
27720104|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27720105|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
27720106|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
27720107|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27720108|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
27720109|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27720110|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27720111|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
27720112|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27720113|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
27720114|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27890689|NCT02031640|81434160|FG005|Screening Period|Inclusion criteria not met|0|||
27890690|NCT02031640|81434155|FG000|Screening Period|Exclusion criteria met|30|||
27890691|NCT02031640|81434156|FG001|Screening Period|Exclusion criteria met|0|||
27890692|NCT02031640|81434157|FG002|Screening Period|Exclusion criteria met|0|||
27890693|NCT02031640|81434158|FG003|Screening Period|Exclusion criteria met|0|||
27890694|NCT02031640|81434159|FG004|Screening Period|Exclusion criteria met|0|||
27890695|NCT02031640|81434160|FG005|Screening Period|Exclusion criteria met|0|||
27890696|NCT02031640|81434155|FG000|Screening Period|Lost to Follow-up|14|||
27890697|NCT02031640|81434156|FG001|Screening Period|Lost to Follow-up|0|||
27890698|NCT02031640|81434157|FG002|Screening Period|Lost to Follow-up|0|||
27890699|NCT02031640|81434158|FG003|Screening Period|Lost to Follow-up|0|||
27890700|NCT02031640|81434159|FG004|Screening Period|Lost to Follow-up|0|||
27890701|NCT02031640|81434160|FG005|Screening Period|Lost to Follow-up|0|||
27890702|NCT02031640|81434155|FG000|Screening Period|Enrollment closed|26|||
27890703|NCT02031640|81434156|FG001|Screening Period|Enrollment closed|0|||
27890704|NCT02031640|81434157|FG002|Screening Period|Enrollment closed|0|||
27890705|NCT02031640|81434158|FG003|Screening Period|Enrollment closed|0|||
27890706|NCT02031640|81434159|FG004|Screening Period|Enrollment closed|0|||
27720115|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
27720116|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
27720117|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27720118|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
27720119|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
27720120|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
27720121|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
27720122|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
27720123|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
27720124|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
27720125|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
27890707|NCT02031640|81434160|FG005|Screening Period|Enrollment closed|0|||
27720126|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
27720127|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
27890708|NCT02031640|81434155|FG000|Run-In Period|Adverse Event|4|||
27720128|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
27720129|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27720130|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
27720131|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27720132|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27720133|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
27720134|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
27720135|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
27720136|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
27720137|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
27720138|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
27720139|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27720140|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27720141|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
27720142|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27720143|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
27720144|NCT03107793|80806586|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27720145|NCT03107793|80806587|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
27720146|NCT03107793|80806588|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
27720147|NCT03107793|80806589|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27720148|NCT03107793|80806590|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
27720149|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
27720150|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
27720151|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
27720152|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
27720153|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
27720154|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27720155|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27720156|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27720157|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
27720158|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
27720159|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
27720160|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
27720161|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
27720162|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
27720163|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
27720164|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Death|0|||
27720165|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Death|0|||
27720166|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Death|0|||
27720167|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Death|0|||
27720168|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Death|1|||
27720169|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27720170|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27720171|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27839010|NCT00879684|81239541|FG001|Stage 1: Dose Escalation|Death|0|||
27720172|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
27720173|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
27720174|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
27720175|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
27720176|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
27720177|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
27720178|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
27720179|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
27720180|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
27720181|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
27720182|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
27720183|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
27839011|NCT00879684|81239542|FG002|Stage 1: Dose Escalation|Death|1|||
27839012|NCT00879684|81239543|FG003|Stage 1: Dose Escalation|Death|0|||
27839013|NCT00879684|81239544|FG004|Stage 1: Dose Escalation|Death|0|||
27839014|NCT00879684|81239545|FG005|Stage 1: Dose Escalation|Death|0|||
27839015|NCT00879684|81239546|FG006|Stage 1: Dose Escalation|Death|0|||
27839016|NCT00879684|81239540|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27839017|NCT00879684|81239541|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27839018|NCT00879684|81239542|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27839019|NCT00879684|81239543|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27839020|NCT00879684|81239544|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27839021|NCT00879684|81239545|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
27839022|NCT00879684|81239546|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
27839023|NCT00879684|81239540|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
27839024|NCT00879684|81239541|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
27839025|NCT00879684|81239542|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
27839026|NCT00879684|81239543|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
27839027|NCT00879684|81239544|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
27839028|NCT00879684|81239545|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
27839029|NCT00879684|81239546|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
27839030|NCT00879684|81239540|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27839031|NCT00879684|81239541|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27839032|NCT00879684|81239542|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27839033|NCT00879684|81239543|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27839034|NCT00879684|81239544|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27839035|NCT00879684|81239545|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
27839036|NCT00879684|81239546|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
27839037|NCT00716625|81239549|FG000|Overall Study|Safety was not Assessable|1|||
27839038|NCT02340962|81239550|FG000|Overall Study|Lost to Follow-up|1|||
27720184|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27720185|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27720186|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27720187|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
27720188|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
27720189|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27720190|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27720191|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27720192|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
27720193|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
27720194|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Other|0|||
27720195|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Other|0|||
27720196|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Other|0|||
27720197|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Other|1|||
27720198|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Other|3|||
27720199|NCT03107793|80806586|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
27720200|NCT03107793|80806587|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
27720201|NCT03107793|80806588|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
27720202|NCT03107793|80806589|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
27720203|NCT03107793|80806590|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
27720204|NCT01073566|80806591|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
27720205|NCT01073566|80806592|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
27720206|NCT00915343|80806593|FG000|Part B - Open Label Period|Treatment switch|0|||
27720207|NCT00915343|80806594|FG001|Part B - Open Label Period|Treatment switch|0|||
27720208|NCT00915343|80806595|FG002|Part B - Open Label Period|Treatment switch|1|||
27720209|NCT00915343|80806593|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
27720210|NCT00915343|80806594|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
27720211|NCT00915343|80806595|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
27720212|NCT05779072|80806597|FG000|Overall Study|Lost to Follow-up|0|||
27720213|NCT05779072|80806598|FG001|Overall Study|Lost to Follow-up|1|||
27720214|NCT05779072|80806597|FG000|Overall Study|Withdrawal by Subject|1|||
27720215|NCT05779072|80806598|FG001|Overall Study|Withdrawal by Subject|5|||
27720216|NCT03891901|80806599|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
27720217|NCT03891901|80806600|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720218|NCT03891901|80806601|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720219|NCT03891901|80806602|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720220|NCT03891901|80806603|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720221|NCT03891901|80806604|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720222|NCT03891901|80806605|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720223|NCT03891901|80806606|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27720224|NCT03891901|80806607|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
27839039|NCT02340962|81239551|FG001|Overall Study|Lost to Follow-up|0|||
27839040|NCT03105297|81239552|FG000|Baseline Phase (Day 1)|Other|21|||
27839041|NCT03105297|81239552|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
27839042|NCT03105297|81239552|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
27839043|NCT00919711|81239553|FG000|Overall Study|Withdrawal by Subject|15|||
27839044|NCT00919711|81239554|FG001|Overall Study|Withdrawal by Subject|7|||
27839045|NCT00919711|81239553|FG000|Overall Study|Adverse Event|13|||
27839046|NCT00919711|81239554|FG001|Overall Study|Adverse Event|3|||
27839047|NCT00919711|81239553|FG000|Overall Study|Other|1|||
27890709|NCT02031640|81434156|FG001|Run-In Period|Adverse Event|0|||
27608340|NCT01567865|80409226|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
27890710|NCT02031640|81434157|FG002|Run-In Period|Adverse Event|0|||
27608341|NCT01567865|80409227|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
27608342|NCT04498247|80409230|FG000|Overall Study|Lost to Follow-up|0|||
27608343|NCT04498247|80409231|FG001|Overall Study|Lost to Follow-up|0|||
27720225|NCT03891901|80806599|FG000|Overall Study|Adverse Event|2|||
27720226|NCT03891901|80806600|FG001|Overall Study|Adverse Event|2|||
27720227|NCT03891901|80806601|FG002|Overall Study|Adverse Event|0|||
27720228|NCT03891901|80806602|FG003|Overall Study|Adverse Event|0|||
27720229|NCT03891901|80806603|FG004|Overall Study|Adverse Event|0|||
27720230|NCT03891901|80806604|FG005|Overall Study|Adverse Event|0|||
27720231|NCT03891901|80806605|FG006|Overall Study|Adverse Event|0|||
27720232|NCT03891901|80806606|FG007|Overall Study|Adverse Event|0|||
27720233|NCT03891901|80806607|FG008|Overall Study|Adverse Event|0|||
27720234|NCT03891901|80806599|FG000|Overall Study|Poor venous access|1|||
27720235|NCT03891901|80806600|FG001|Overall Study|Poor venous access|0|||
27720236|NCT03891901|80806601|FG002|Overall Study|Poor venous access|0|||
27720237|NCT03891901|80806602|FG003|Overall Study|Poor venous access|0|||
27720238|NCT03891901|80806603|FG004|Overall Study|Poor venous access|0|||
27720239|NCT03891901|80806604|FG005|Overall Study|Poor venous access|0|||
27720240|NCT03891901|80806605|FG006|Overall Study|Poor venous access|0|||
27720241|NCT03891901|80806606|FG007|Overall Study|Poor venous access|0|||
27720242|NCT03891901|80806607|FG008|Overall Study|Poor venous access|0|||
27720243|NCT03891901|80806599|FG000|Overall Study|Withdrawal by Subject|0|||
27720244|NCT03891901|80806600|FG001|Overall Study|Withdrawal by Subject|2|||
27720245|NCT03891901|80806601|FG002|Overall Study|Withdrawal by Subject|0|||
27720246|NCT03891901|80806602|FG003|Overall Study|Withdrawal by Subject|0|||
27720247|NCT03891901|80806603|FG004|Overall Study|Withdrawal by Subject|0|||
27720248|NCT03891901|80806604|FG005|Overall Study|Withdrawal by Subject|0|||
27720249|NCT03891901|80806605|FG006|Overall Study|Withdrawal by Subject|0|||
27720250|NCT03891901|80806606|FG007|Overall Study|Withdrawal by Subject|0|||
27720251|NCT03891901|80806607|FG008|Overall Study|Withdrawal by Subject|0|||
27720252|NCT02740478|80806608|FG000|Overall Study|Withdrawal by Subject|1|||
27720253|NCT00700271|80806609|FG000|Overall Study|Adverse Event|4|||
27720254|NCT00700271|80806610|FG001|Overall Study|Adverse Event|6|||
27720255|NCT00700271|80806609|FG000|Overall Study|Protocol Violation|1|||
27720256|NCT00700271|80806610|FG001|Overall Study|Protocol Violation|0|||
27720257|NCT00700271|80806609|FG000|Overall Study|Administrative Reasons|1|||
27720258|NCT00700271|80806610|FG001|Overall Study|Administrative Reasons|0|||
27720259|NCT00700271|80806609|FG000|Overall Study|Withdrawal by Subject|6|||
27839048|NCT00919711|81239554|FG001|Overall Study|Other|2|||
27839049|NCT00919711|81239553|FG000|Overall Study|Administrative Decision|0|||
27500062|NCT00521079|80024875|FG000|Overall Study|Adverse Event|7|||
27500063|NCT00521079|80024876|FG001|Overall Study|Adverse Event|1|||
27500064|NCT00521079|80024875|FG000|Overall Study|Lost to Follow-up|2|||
27500065|NCT00521079|80024876|FG001|Overall Study|Lost to Follow-up|1|||
27500066|NCT00521079|80024875|FG000|Overall Study|Withdrawal by Subject|5|||
27720260|NCT00700271|80806610|FG001|Overall Study|Withdrawal by Subject|4|||
27720261|NCT00700271|80806609|FG000|Overall Study|Lost to Follow-up|2|||
27720262|NCT00700271|80806610|FG001|Overall Study|Lost to Follow-up|2|||
27720263|NCT00523991|80806614|FG000|Overall Study|Adverse Event|6|||
27720264|NCT00523991|80806615|FG001|Overall Study|Adverse Event|5|||
27720265|NCT00523991|80806614|FG000|Overall Study|Protocol Violation|1|||
27720266|NCT00523991|80806615|FG001|Overall Study|Protocol Violation|4|||
27720267|NCT00523991|80806614|FG000|Overall Study|Lost to Follow-up|4|||
27720268|NCT00523991|80806615|FG001|Overall Study|Lost to Follow-up|1|||
27720269|NCT00523991|80806614|FG000|Overall Study|Withdrawal by Subject|7|||
27720270|NCT00523991|80806615|FG001|Overall Study|Withdrawal by Subject|17|||
27720271|NCT00523991|80806614|FG000|Overall Study|Other reason (not specified)|3|||
27720272|NCT00523991|80806615|FG001|Overall Study|Other reason (not specified)|0|||
27720273|NCT00911989|80806617|FG000|Overall Study|Adverse Event|1|||
27720274|NCT01353703|80806621|FG000|Overall Study|Migrated/moved from study area|1|||
27720275|NCT01353703|80806622|FG001|Overall Study|Migrated/moved from study area|0|||
27720276|NCT04161131|80806623|FG000|Overall Study|Ineligible|2|||
27839050|NCT00919711|81239554|FG001|Overall Study|Administrative Decision|1|||
27839051|NCT00919711|81239553|FG000|Overall Study|Lost to Follow-up|2|||
27839052|NCT00919711|81239554|FG001|Overall Study|Lost to Follow-up|0|||
27839053|NCT00919711|81239553|FG000|Overall Study|Death|1|||
27500067|NCT00521079|80024876|FG001|Overall Study|Withdrawal by Subject|3|||
27720277|NCT04161131|80806623|FG000|Overall Study|Lost to Follow-up|4|||
27839054|NCT00919711|81239554|FG001|Overall Study|Death|0|||
27839055|NCT00919711|81239553|FG000|Overall Study|Noncompliance|1|||
27839056|NCT00919711|81239554|FG001|Overall Study|Noncompliance|0|||
27839057|NCT03370510|81239558|FG000|Overall Study|COVID-19|2|||
27839058|NCT03370510|81239559|FG001|Overall Study|COVID-19|0|||
27839059|NCT02697617|81239560|FG000|Overall Study|Withdrawal by Subject|0|||
27839060|NCT02697617|81239561|FG001|Overall Study|Withdrawal by Subject|2|||
27839061|NCT02697617|81239560|FG000|Overall Study|Pregnancy|1|||
27839062|NCT02697617|81239561|FG001|Overall Study|Pregnancy|0|||
27839063|NCT00544167|81239562|FG000|Overall Study|Adverse Event|21|||
27839064|NCT00544167|81239562|FG000|Overall Study|Physician Decision|8|||
27839065|NCT01853176|81239563|FG000|Overall Study|Study terminated|4|||
27839066|NCT01853176|81239564|FG001|Overall Study|Study terminated|0|||
27839067|NCT00748566|81239565|FG000|Overall Study|Adverse Event|49|||
27839068|NCT00748566|81239565|FG000|Overall Study|Death|1|||
27839069|NCT00748566|81239565|FG000|Overall Study|Lack of Efficacy|12|||
27839070|NCT00748566|81239565|FG000|Overall Study|Lost to Follow-up|1|||
27839071|NCT00748566|81239565|FG000|Overall Study|Protocol Violation|13|||
27839072|NCT00748566|81239565|FG000|Overall Study|Withdrawal by Subject|22|||
27839073|NCT00748566|81239565|FG000|Overall Study|Study terminated by sponsor|5|||
27839074|NCT00748566|81239565|FG000|Overall Study|Other|9|||
27839075|NCT01664039|81239568|FG000|Overall Study|Adverse Event|3|||
27839076|NCT01664039|81239569|FG001|Overall Study|Adverse Event|4|||
27839077|NCT01664039|81239568|FG000|Overall Study|Lost to Follow-up|1|||
27839078|NCT01664039|81239569|FG001|Overall Study|Lost to Follow-up|1|||
27839079|NCT01664039|81239568|FG000|Overall Study|Withdrawal by Subject|1|||
27839080|NCT01664039|81239569|FG001|Overall Study|Withdrawal by Subject|3|||
27839081|NCT01664039|81239568|FG000|Overall Study|Noncompliance|1|||
27839082|NCT01664039|81239569|FG001|Overall Study|Noncompliance|1|||
27839083|NCT01450800|81239570|FG000|Overall Study|Protocol Violation|1|||
27839084|NCT01450800|81239571|FG001|Overall Study|Protocol Violation|3|||
27839085|NCT02943096|81239572|FG000|Overall Study|Lack of Efficacy|0|||
27839086|NCT02943096|81239573|FG001|Overall Study|Lack of Efficacy|1|||
27839087|NCT01532908|81239575|FG000|Overall Study|Not Transplanted|1|||
27839088|NCT01532908|81239576|FG001|Overall Study|Not Transplanted|0|||
27839089|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
27839090|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
27839091|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
27839092|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
27839093|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
27839094|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
27890711|NCT02031640|81434158|FG003|Run-In Period|Adverse Event|0|||
27890712|NCT02031640|81434159|FG004|Run-In Period|Adverse Event|0|||
27890713|NCT02031640|81434160|FG005|Run-In Period|Adverse Event|0|||
27890714|NCT02031640|81434155|FG000|Run-In Period|Withdrawal by Subject|17|||
27890715|NCT02031640|81434156|FG001|Run-In Period|Withdrawal by Subject|0|||
27890716|NCT02031640|81434157|FG002|Run-In Period|Withdrawal by Subject|0|||
27890717|NCT02031640|81434158|FG003|Run-In Period|Withdrawal by Subject|0|||
27720278|NCT02706730|80806624|FG000|Overall Study|Adverse Event|3|||
27839095|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
27839096|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
27839097|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
27839098|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
27839099|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
27839100|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
27839101|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
27839102|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
27839103|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
27839104|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
27839105|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
27890718|NCT02031640|81434159|FG004|Run-In Period|Withdrawal by Subject|0|||
27890719|NCT02031640|81434160|FG005|Run-In Period|Withdrawal by Subject|0|||
27608344|NCT04498247|80409232|FG002|Overall Study|Lost to Follow-up|0|||
27839106|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
27839107|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
27839108|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
27839109|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
27839110|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
27839111|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
27839112|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
27839113|NCT01435928|81239577|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
27839114|NCT01435928|81239578|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
27839115|NCT01435928|81239579|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
27839116|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
27839117|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
27839118|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
27839119|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
27839120|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
27839121|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
27839122|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
27839123|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
27839124|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
27839125|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
27839126|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
27839127|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
27839128|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
27839129|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
27839130|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
27839131|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
27839132|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
27839133|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
27839134|NCT01435928|81239577|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
27839135|NCT01435928|81239578|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
27839136|NCT01435928|81239579|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
27839137|NCT00566722|81239580|FG000|Overall Study|Adverse Event|0|||
27839138|NCT00566722|81239581|FG001|Overall Study|Adverse Event|1|||
27839139|NCT00566722|81239582|FG002|Overall Study|Adverse Event|0|||
27839140|NCT00566722|81239580|FG000|Overall Study|Withdrawal by Subject|0|||
27839141|NCT00566722|81239581|FG001|Overall Study|Withdrawal by Subject|0|||
27839142|NCT00566722|81239582|FG002|Overall Study|Withdrawal by Subject|1|||
27839143|NCT00566722|81239580|FG000|Overall Study|Lost to Follow-up|1|||
27839144|NCT00566722|81239581|FG001|Overall Study|Lost to Follow-up|1|||
27839145|NCT00566722|81239582|FG002|Overall Study|Lost to Follow-up|1|||
27839146|NCT00566722|81239580|FG000|Overall Study|Lack of Efficacy|1|||
27839147|NCT00566722|81239581|FG001|Overall Study|Lack of Efficacy|2|||
27839148|NCT00566722|81239582|FG002|Overall Study|Lack of Efficacy|4|||
27839149|NCT00566722|81239580|FG000|Overall Study|Did not meet exclusion criteria|0|||
27839150|NCT00566722|81239581|FG001|Overall Study|Did not meet exclusion criteria|0|||
27839151|NCT00566722|81239582|FG002|Overall Study|Did not meet exclusion criteria|2|||
27839152|NCT00566722|81239580|FG000|Overall Study|Serious adverse event|0|||
27839153|NCT00566722|81239581|FG001|Overall Study|Serious adverse event|1|||
27839154|NCT00566722|81239582|FG002|Overall Study|Serious adverse event|0|||
27839155|NCT00566722|81239580|FG000|Overall Study|Noncompliant with drug administration|0|||
27839156|NCT00566722|81239581|FG001|Overall Study|Noncompliant with drug administration|0|||
27839157|NCT00566722|81239582|FG002|Overall Study|Noncompliant with drug administration|1|||
27839158|NCT00377156|81239583|FG000|Overall Study|Death|23|||
27839159|NCT00377156|81239584|FG001|Overall Study|Death|19|||
27839160|NCT00377156|81239583|FG000|Overall Study|Withdrawal by Subject|16|||
27839161|NCT00377156|81239584|FG001|Overall Study|Withdrawal by Subject|24|||
27839162|NCT00377156|81239583|FG000|Overall Study|Had follow-up <90 d|3|||
27839163|NCT00377156|81239584|FG001|Overall Study|Had follow-up <90 d|6|||
27839164|NCT00377156|81239583|FG000|Overall Study|Cancellation|1|||
27839165|NCT00377156|81239584|FG001|Overall Study|Cancellation|0|||
27839166|NCT00377156|81239583|FG000|Overall Study|Refused testing|0|||
27839167|NCT00377156|81239584|FG001|Overall Study|Refused testing|1|||
27839168|NCT00377156|81239583|FG000|Overall Study|Ineligible|0|||
27839169|NCT00377156|81239584|FG001|Overall Study|Ineligible|1|||
27839170|NCT00377156|81239583|FG000|Overall Study|Disability or language problem|0|||
27839171|NCT00377156|81239584|FG001|Overall Study|Disability or language problem|1|||
27958594|NCT01791517|81680066|FG008|Phase II|Withdrawal by Subject|0|||
27839172|NCT00377156|81239583|FG000|Overall Study|Other|5|||
27839173|NCT00377156|81239584|FG001|Overall Study|Other|2|||
27839174|NCT01958476|81239585|FG000|Overall Study|Parent requested exclusion from analysis|1|||
27839175|NCT01958476|81239586|FG001|Overall Study|Parent requested exclusion from analysis|0|||
27839176|NCT04158687|81239587|FG000|Overall Study|Adverse Event|2|||
27839177|NCT04158687|81239588|FG001|Overall Study|Adverse Event|3|||
27839178|NCT04158687|81239589|FG002|Overall Study|Adverse Event|0|||
27890720|NCT02031640|81434155|FG000|Run-In Period|Inclusion criteria not met|38|||
27890721|NCT02031640|81434156|FG001|Run-In Period|Inclusion criteria not met|0|||
27608345|NCT04498247|80409233|FG003|Overall Study|Lost to Follow-up|1|||
27608346|NCT04498247|80409234|FG004|Overall Study|Lost to Follow-up|0|||
27608347|NCT04498247|80409235|FG005|Overall Study|Lost to Follow-up|0|||
27839179|NCT04158687|81239590|FG003|Overall Study|Adverse Event|3|||
27839180|NCT04158687|81239587|FG000|Overall Study|Lost to Follow-up|5|||
27839181|NCT04158687|81239588|FG001|Overall Study|Lost to Follow-up|12|||
27839182|NCT04158687|81239589|FG002|Overall Study|Lost to Follow-up|4|||
27839183|NCT04158687|81239590|FG003|Overall Study|Lost to Follow-up|5|||
27839184|NCT04158687|81239587|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
27839185|NCT04158687|81239588|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
27839186|NCT04158687|81239589|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
27839187|NCT04158687|81239590|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
27839188|NCT04158687|81239587|FG000|Overall Study|Non-Compliance with Study Medication|2|||
27890722|NCT02031640|81434157|FG002|Run-In Period|Inclusion criteria not met|0|||
27890723|NCT02031640|81434158|FG003|Run-In Period|Inclusion criteria not met|0|||
27890724|NCT02031640|81434159|FG004|Run-In Period|Inclusion criteria not met|0|||
27890725|NCT02031640|81434160|FG005|Run-In Period|Inclusion criteria not met|0|||
27890726|NCT02031640|81434155|FG000|Run-In Period|Exclusion criteria met|8|||
27890727|NCT02031640|81434156|FG001|Run-In Period|Exclusion criteria met|0|||
27890728|NCT02031640|81434157|FG002|Run-In Period|Exclusion criteria met|0|||
27608348|NCT04498247|80409236|FG006|Overall Study|Lost to Follow-up|0|||
27608349|NCT04498247|80409237|FG007|Overall Study|Lost to Follow-up|0|||
27608350|NCT04498247|80409230|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
27608351|NCT04498247|80409231|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608352|NCT04498247|80409232|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608353|NCT04498247|80409233|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608354|NCT04498247|80409234|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608355|NCT04498247|80409235|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608356|NCT04498247|80409236|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608357|NCT04498247|80409237|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
27608358|NCT04498247|80409230|FG000|Overall Study|Withdrawal by Subject|0|||
27608359|NCT04498247|80409231|FG001|Overall Study|Withdrawal by Subject|8|||
27608360|NCT04498247|80409232|FG002|Overall Study|Withdrawal by Subject|0|||
27608361|NCT04498247|80409233|FG003|Overall Study|Withdrawal by Subject|7|||
27608362|NCT04498247|80409234|FG004|Overall Study|Withdrawal by Subject|0|||
27608363|NCT04498247|80409235|FG005|Overall Study|Withdrawal by Subject|0|||
27608364|NCT04498247|80409236|FG006|Overall Study|Withdrawal by Subject|1|||
27608365|NCT04498247|80409237|FG007|Overall Study|Withdrawal by Subject|0|||
27608366|NCT04498247|80409230|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27608367|NCT04498247|80409231|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
27608368|NCT04498247|80409232|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27608369|NCT04498247|80409233|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
27608370|NCT04498247|80409234|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27608371|NCT04498247|80409235|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27839189|NCT04158687|81239588|FG001|Overall Study|Non-Compliance with Study Medication|2|||
27890729|NCT02031640|81434158|FG003|Run-In Period|Exclusion criteria met|0|||
27890730|NCT02031640|81434159|FG004|Run-In Period|Exclusion criteria met|0|||
27839190|NCT04158687|81239589|FG002|Overall Study|Non-Compliance with Study Medication|3|||
27890731|NCT02031640|81434160|FG005|Run-In Period|Exclusion criteria met|0|||
27890732|NCT02031640|81434155|FG000|Run-In Period|Randomization criteria not met|85|||
27890733|NCT02031640|81434156|FG001|Run-In Period|Randomization criteria not met|0|||
27608372|NCT04498247|80409236|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
27608373|NCT04498247|80409237|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
27608374|NCT03328143|80409247|FG000|Overall Study|Declined|3|||
27608375|NCT03328143|80409247|FG000|Overall Study|Required increased sedation|4|||
27608376|NCT03328143|80409247|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
27608377|NCT03328143|80409247|FG000|Overall Study|Surgery cancelled|1|||
27608378|NCT01964521|80409254|FG000|Overall Study|Lost to Follow-up|4|||
27608379|NCT00399763|80409255|FG000|Overall Study|Lost to Follow-up|2|||
27608380|NCT00399763|80409256|FG001|Overall Study|Lost to Follow-up|3|||
27608381|NCT02588261|80409266|FG000|Overall Study|Study Terminated by Sponsor|157|||
27608382|NCT02588261|80409267|FG001|Overall Study|Study Terminated by Sponsor|142|||
27608383|NCT02588261|80409266|FG000|Overall Study|Protocol Deviation|1|||
27608384|NCT02588261|80409267|FG001|Overall Study|Protocol Deviation|0|||
27608385|NCT02588261|80409266|FG000|Overall Study|Death|1|||
27608386|NCT02588261|80409267|FG001|Overall Study|Death|2|||
27608387|NCT02588261|80409266|FG000|Overall Study|Withdrawal by Subject|12|||
27608388|NCT02588261|80409267|FG001|Overall Study|Withdrawal by Subject|8|||
27608389|NCT02588261|80409266|FG000|Overall Study|Noncompliance with Study Drug|0|||
27608390|NCT02588261|80409267|FG001|Overall Study|Noncompliance with Study Drug|1|||
27608391|NCT02588261|80409266|FG000|Overall Study|Miscellaneous|5|||
27608392|NCT02588261|80409267|FG001|Overall Study|Miscellaneous|4|||
27608393|NCT02588261|80409266|FG000|Overall Study|Progressive Disease|61|||
27608394|NCT02588261|80409267|FG001|Overall Study|Progressive Disease|82|||
27720279|NCT02706730|80806624|FG000|Overall Study|Lack of Efficacy|5|||
27720280|NCT02706730|80806624|FG000|Overall Study|Withdrawal by Subject|11|||
27720281|NCT02706730|80806624|FG000|Overall Study|Study Terminated by Sponsor|11|||
27720282|NCT02706730|80806624|FG000|Overall Study|Subject chose not to receive injection|3|||
27720283|NCT01344876|80806626|FG000|Overall Study|Adverse Event|0|||
27720284|NCT01344876|80806627|FG001|Overall Study|Adverse Event|0|||
27720285|NCT01344876|80806628|FG002|Overall Study|Adverse Event|0|||
27720286|NCT01344876|80806629|FG003|Overall Study|Adverse Event|0|||
27720287|NCT01344876|80806630|FG004|Overall Study|Adverse Event|1|||
27720288|NCT01344876|80806626|FG000|Overall Study|Withdrawal by Subject|0|||
27720289|NCT01344876|80806627|FG001|Overall Study|Withdrawal by Subject|0|||
27720290|NCT01344876|80806628|FG002|Overall Study|Withdrawal by Subject|1|||
27720291|NCT01344876|80806629|FG003|Overall Study|Withdrawal by Subject|0|||
27720292|NCT01344876|80806630|FG004|Overall Study|Withdrawal by Subject|0|||
27720293|NCT01344876|80806626|FG000|Overall Study|Definite progression of primary disease|1|||
27720294|NCT01344876|80806627|FG001|Overall Study|Definite progression of primary disease|0|||
27720295|NCT01344876|80806628|FG002|Overall Study|Definite progression of primary disease|0|||
27720296|NCT01344876|80806629|FG003|Overall Study|Definite progression of primary disease|3|||
27720297|NCT01344876|80806630|FG004|Overall Study|Definite progression of primary disease|0|||
27839191|NCT04158687|81239590|FG003|Overall Study|Non-Compliance with Study Medication|0|||
27839192|NCT04158687|81239587|FG000|Overall Study|Investigator Decision|0|||
27839193|NCT04158687|81239588|FG001|Overall Study|Investigator Decision|0|||
27839194|NCT04158687|81239589|FG002|Overall Study|Investigator Decision|2|||
27608395|NCT02588261|80409266|FG000|Overall Study|Adverse Event|29|||
27608396|NCT02588261|80409267|FG001|Overall Study|Adverse Event|24|||
27608397|NCT02588261|80409266|FG000|Overall Study|Lost to Follow-up|1|||
27608398|NCT02588261|80409267|FG001|Overall Study|Lost to Follow-up|0|||
27608399|NCT00659984|80409268|FG000|Overall Study|Adverse Event|1|||
27608400|NCT00960752|80409269|FG000|Overall Study|Adverse Event|0|||
27608401|NCT00960752|80409270|FG001|Overall Study|Adverse Event|0|||
27720298|NCT01049035|80806631|FG000|Overall Study|Serious adverse event|0|||
27500108|NCT04685798|80024890|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
27500109|NCT03019406|80024896|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
27720299|NCT01049035|80806632|FG001|Overall Study|Serious adverse event|1|||
27720300|NCT01049035|80806633|FG002|Overall Study|Serious adverse event|1|||
27720301|NCT01049035|80806634|FG003|Overall Study|Serious adverse event|2|||
27720302|NCT01049035|80806635|FG004|Overall Study|Serious adverse event|0|||
27720303|NCT01049035|80806636|FG005|Overall Study|Serious adverse event|0|||
27720304|NCT01049035|80806637|FG006|Overall Study|Serious adverse event|0|||
27720305|NCT01049035|80806631|FG000|Overall Study|Other adverse event (AE)|0|||
27720306|NCT01049035|80806632|FG001|Overall Study|Other adverse event (AE)|0|||
27720307|NCT01049035|80806633|FG002|Overall Study|Other adverse event (AE)|0|||
27720308|NCT01049035|80806634|FG003|Overall Study|Other adverse event (AE)|1|||
27720309|NCT01049035|80806635|FG004|Overall Study|Other adverse event (AE)|0|||
27839195|NCT04158687|81239590|FG003|Overall Study|Investigator Decision|0|||
27839196|NCT04158687|81239587|FG000|Overall Study|Protocol Violation|0|||
27839197|NCT04158687|81239588|FG001|Overall Study|Protocol Violation|2|||
27839198|NCT04158687|81239589|FG002|Overall Study|Protocol Violation|1|||
27839199|NCT04158687|81239590|FG003|Overall Study|Protocol Violation|0|||
27839200|NCT04158687|81239587|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
27839201|NCT04158687|81239588|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
27839202|NCT04158687|81239589|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
27839203|NCT04158687|81239590|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
27839204|NCT04158687|81239587|FG000|Overall Study|Reason not Specified|3|||
27839205|NCT04158687|81239588|FG001|Overall Study|Reason not Specified|2|||
27839206|NCT04158687|81239589|FG002|Overall Study|Reason not Specified|4|||
27839207|NCT04158687|81239590|FG003|Overall Study|Reason not Specified|4|||
27839208|NCT05070754|81239591|FG000|Overall Study|Withdrawal by Subject|0|||
27839209|NCT05070754|81239592|FG001|Overall Study|Withdrawal by Subject|0|||
27839210|NCT05070754|81239593|FG002|Overall Study|Withdrawal by Subject|0|||
27608402|NCT00960752|80409271|FG002|Overall Study|Adverse Event|1|||
27608403|NCT00960752|80409269|FG000|Overall Study|Progression|0|||
27839211|NCT05070754|81239594|FG003|Overall Study|Withdrawal by Subject|1|||
27500110|NCT03019406|80024897|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
27500111|NCT03019406|80024898|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
27500112|NCT03019406|80024899|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
27500113|NCT02182895|80024902|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
27608404|NCT00960752|80409270|FG001|Overall Study|Progression|0|||
27839212|NCT05070754|81239591|FG000|Overall Study|Protocol Violation|0|||
27839213|NCT05070754|81239592|FG001|Overall Study|Protocol Violation|0|||
27500114|NCT02182895|80024903|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
27500115|NCT03524612|80024904|FG000|Overall Study|Lack of Efficacy|10|||
27500116|NCT03524612|80024904|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
27500117|NCT03524612|80024904|FG000|Overall Study|Adverse Event|10|||
27890734|NCT02031640|81434157|FG002|Run-In Period|Randomization criteria not met|0|||
27890735|NCT02031640|81434158|FG003|Run-In Period|Randomization criteria not met|0|||
27500118|NCT03524612|80024904|FG000|Overall Study|Withdrawal by Subject|7|||
27500119|NCT03524612|80024904|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
27608405|NCT00960752|80409271|FG002|Overall Study|Progression|1|||
27608406|NCT02306265|80409282|FG000|Overall Study|Withdrawal by Subject|1|||
27608407|NCT01267253|80409283|FG000|Overall Study|Ineligible - required test not done|1|||
27608408|NCT01267253|80409283|FG000|Overall Study|Inevaluable-never received study treatme|2|||
27608409|NCT03820323|80409284|FG000|Overall Study|Lost to Follow-up|2|||
27608410|NCT03820323|80409285|FG001|Overall Study|Lost to Follow-up|1|||
27608411|NCT03820323|80409284|FG000|Overall Study|Missed 12-month visit|22|||
27608412|NCT03820323|80409285|FG001|Overall Study|Missed 12-month visit|14|||
27608413|NCT03820323|80409284|FG000|Overall Study|Death|2|||
27608414|NCT03820323|80409285|FG001|Overall Study|Death|1|||
27608415|NCT03820323|80409284|FG000|Overall Study|Transferred out|13|||
27890736|NCT02031640|81434159|FG004|Run-In Period|Randomization criteria not met|0|||
27500120|NCT03524612|80024904|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
27500121|NCT03524612|80024904|FG000|Overall Study|New therapy for study indication|6|||
27500122|NCT03524612|80024904|FG000|Overall Study|Death|3|||
27500123|NCT03524612|80024904|FG000|Overall Study|Lost to Follow-up|2|||
27500124|NCT03524612|80024904|FG000|Overall Study|Protocol Violation|1|||
27608416|NCT03820323|80409285|FG001|Overall Study|Transferred out|11|||
27608417|NCT03820323|80409284|FG000|Overall Study|Terminated|0|||
27608418|NCT03820323|80409285|FG001|Overall Study|Terminated|3|||
27608419|NCT03820323|80409284|FG000|Overall Study|Withdrawal by Subject|1|||
27500176|NCT01251965|80024918|FG000|Overall Study|Participant/physician decision|1|||
27500177|NCT01251965|80024919|FG001|Overall Study|Participant/physician decision|2|||
27500178|NCT01251965|80024920|FG002|Overall Study|Participant/physician decision|0|||
27500179|NCT01251965|80024918|FG000|Overall Study|Death|0|||
27500180|NCT01251965|80024919|FG001|Overall Study|Death|0|||
27500181|NCT01251965|80024920|FG002|Overall Study|Death|11|||
27500182|NCT01345240|80024921|FG000|Overall Study|Adverse Event|3|||
27500183|NCT01345240|80024922|FG001|Overall Study|Adverse Event|5|||
27500184|NCT01345240|80024923|FG002|Overall Study|Adverse Event|4|||
27608420|NCT03820323|80409285|FG001|Overall Study|Withdrawal by Subject|6|||
27608421|NCT01547299|80409289|FG000|Overall Study|Withdrawal by Subject|2|||
27608422|NCT01547299|80409290|FG001|Overall Study|Withdrawal by Subject|2|||
27608423|NCT02223754|80409291|FG000|Period 1|Adverse Event|1|||
27608424|NCT02223754|80409292|FG001|Period 1|Adverse Event|0|||
27608425|NCT02223754|80409291|FG000|Period 1|Lost to Follow-up|0|||
27608426|NCT02223754|80409292|FG001|Period 1|Lost to Follow-up|1|||
27608427|NCT02223754|80409291|FG000|Period 1|Protocol Violation|2|||
27608428|NCT02223754|80409292|FG001|Period 1|Protocol Violation|4|||
27608429|NCT02223754|80409291|FG000|Period 1|Withdrawal by Subject|0|||
27608430|NCT02223754|80409292|FG001|Period 1|Withdrawal by Subject|4|||
27608431|NCT02223754|80409291|FG000|Period 1|Test Article No Longer Available|1|||
27608432|NCT02223754|80409292|FG001|Period 1|Test Article No Longer Available|5|||
27608433|NCT02223754|80409291|FG000|Period 1|Unsatisfactory Visual Response|0|||
27608434|NCT02223754|80409292|FG001|Period 1|Unsatisfactory Visual Response|1|||
27500185|NCT01345240|80024924|FG003|Overall Study|Adverse Event|2|||
27500186|NCT01345240|80024925|FG004|Overall Study|Adverse Event|1|||
27500187|NCT01345240|80024921|FG000|Overall Study|Lost to Follow-up|8|||
27500188|NCT01345240|80024922|FG001|Overall Study|Lost to Follow-up|9|||
27500189|NCT01345240|80024923|FG002|Overall Study|Lost to Follow-up|14|||
27500190|NCT01345240|80024924|FG003|Overall Study|Lost to Follow-up|7|||
27500191|NCT01345240|80024925|FG004|Overall Study|Lost to Follow-up|9|||
27608435|NCT02223754|80409291|FG000|Period 2|Adverse Event|0|||
27608436|NCT02223754|80409292|FG001|Period 2|Adverse Event|1|||
27608437|NCT02223754|80409291|FG000|Period 2|Protocol Violation|1|||
27608438|NCT02223754|80409292|FG001|Period 2|Protocol Violation|0|||
27608439|NCT02223754|80409291|FG000|Period 2|Lens Discomfort|1|||
27608440|NCT02223754|80409292|FG001|Period 2|Lens Discomfort|1|||
27500208|NCT00079417|80024943|FG000|Overall Study|Physician Decision|2|||
27608441|NCT02223754|80409291|FG000|Period 2|Lost to Follow-up|1|||
27608442|NCT02223754|80409292|FG001|Period 2|Lost to Follow-up|0|||
27608443|NCT02223754|80409291|FG000|Period 2|Test Article No Longer Available|0|||
27890737|NCT02031640|81434160|FG005|Run-In Period|Randomization criteria not met|0|||
27608444|NCT02223754|80409292|FG001|Period 2|Test Article No Longer Available|1|||
27608445|NCT02306122|80409293|FG000|Initial Physician Randomization|Physician Decision|0|||
27608446|NCT02306122|80409294|FG001|Initial Physician Randomization|Physician Decision|0|||
27608447|NCT02306122|80409295|FG002|Initial Physician Randomization|Physician Decision|0|||
27608448|NCT02306122|80409296|FG003|Initial Physician Randomization|Physician Decision|0|||
27608449|NCT02306122|80409297|FG004|Initial Physician Randomization|Physician Decision|0|||
27608450|NCT02306122|80409298|FG005|Initial Physician Randomization|Physician Decision|0|||
27608451|NCT02306122|80409299|FG006|Initial Physician Randomization|Physician Decision|0|||
27608452|NCT02306122|80409300|FG007|Initial Physician Randomization|Physician Decision|0|||
27608453|NCT02306122|80409301|FG008|Initial Physician Randomization|Physician Decision|1|||
27608454|NCT02306122|80409302|FG009|Initial Physician Randomization|Physician Decision|0|||
27608455|NCT02306122|80409303|FG010|Initial Physician Randomization|Physician Decision|0|||
27608456|NCT02914184|80409306|FG000|Overall Study|Lost to Follow-up|7|||
27608457|NCT02914184|80409307|FG001|Overall Study|Lost to Follow-up|10|||
27608458|NCT02914184|80409308|FG002|Overall Study|Lost to Follow-up|8|||
27608459|NCT02914184|80409309|FG003|Overall Study|Lost to Follow-up|7|||
27608460|NCT02914184|80409306|FG000|Overall Study|Withdrawal by Subject|4|||
27608461|NCT02914184|80409307|FG001|Overall Study|Withdrawal by Subject|2|||
27608462|NCT02914184|80409308|FG002|Overall Study|Withdrawal by Subject|7|||
27608463|NCT02914184|80409309|FG003|Overall Study|Withdrawal by Subject|3|||
27608464|NCT02914184|80409306|FG000|Overall Study|Other|1|||
27608465|NCT02914184|80409307|FG001|Overall Study|Other|0|||
27608466|NCT02914184|80409308|FG002|Overall Study|Other|0|||
27608467|NCT02914184|80409309|FG003|Overall Study|Other|0|||
27608468|NCT02914184|80409306|FG000|Overall Study|Migrated/moved from the study area|2|||
27608469|NCT02914184|80409307|FG001|Overall Study|Migrated/moved from the study area|1|||
27608470|NCT02914184|80409308|FG002|Overall Study|Migrated/moved from the study area|2|||
27608471|NCT02914184|80409309|FG003|Overall Study|Migrated/moved from the study area|1|||
27608472|NCT00879996|80409310|FG000|Overall Study|Lost to Follow-up|7|||
27608473|NCT00879996|80409311|FG001|Overall Study|Lost to Follow-up|6|||
27608474|NCT00879996|80409310|FG000|Overall Study|non-compliance|6|||
27608475|NCT00879996|80409311|FG001|Overall Study|non-compliance|4|||
27608476|NCT00879996|80409310|FG000|Overall Study|Physician Decision|1|||
27608477|NCT00879996|80409311|FG001|Overall Study|Physician Decision|2|||
27608478|NCT00879996|80409310|FG000|Overall Study|psychiatric problem|0|||
27608479|NCT00879996|80409311|FG001|Overall Study|psychiatric problem|1|||
27608480|NCT00879996|80409310|FG000|Overall Study|put on parole|1|||
27608481|NCT00879996|80409311|FG001|Overall Study|put on parole|0|||
27608482|NCT02254421|80409312|FG000|Overall Study|Randomized but Not Treated|1|||
27608483|NCT02254421|80409313|FG001|Overall Study|Randomized but Not Treated|0|||
27608484|NCT02254421|80409312|FG000|Overall Study|Death|0|||
27608485|NCT02254421|80409313|FG001|Overall Study|Death|2|||
27608486|NCT02254421|80409312|FG000|Overall Study|Withdrew Consent|1|||
27608487|NCT02254421|80409313|FG001|Overall Study|Withdrew Consent|1|||
27608488|NCT01126060|80409315|FG000|Overall Study|Protocol Violation|0|||
27608489|NCT01126060|80409316|FG001|Overall Study|Protocol Violation|2|||
27608490|NCT01763788|80409317|FG000|Overall Study|Lost to Follow-up|0|||
27608491|NCT01763788|80409318|FG001|Overall Study|Lost to Follow-up|0|||
27608492|NCT01763788|80409319|FG002|Overall Study|Lost to Follow-up|1|||
27608493|NCT01763788|80409320|FG003|Overall Study|Lost to Follow-up|0|||
27608494|NCT03749447|80409332|FG000|Overall Study|Adverse Event|11|||
27890738|NCT02031640|81434155|FG000|Run-In Period|Various administrative reasons|17|||
27890739|NCT02031640|81434156|FG001|Run-In Period|Various administrative reasons|0|||
27890740|NCT02031640|81434157|FG002|Run-In Period|Various administrative reasons|0|||
27890741|NCT02031640|81434158|FG003|Run-In Period|Various administrative reasons|0|||
27608495|NCT03749447|80409333|FG001|Overall Study|Adverse Event|3|||
27608496|NCT03749447|80409332|FG000|Overall Study|Death|1|||
27608497|NCT03749447|80409333|FG001|Overall Study|Death|1|||
27608498|NCT03749447|80409332|FG000|Overall Study|Lost to Follow-up|2|||
27608499|NCT03749447|80409333|FG001|Overall Study|Lost to Follow-up|2|||
27608500|NCT03749447|80409332|FG000|Overall Study|Reason Not Specified|0|||
27608501|NCT03749447|80409333|FG001|Overall Study|Reason Not Specified|3|||
27608502|NCT03749447|80409332|FG000|Overall Study|Physician Decision|4|||
27500209|NCT00079417|80024943|FG000|Overall Study|Ineligible|7|||
27608503|NCT03749447|80409333|FG001|Overall Study|Physician Decision|3|||
27608504|NCT03749447|80409332|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
27608505|NCT03749447|80409333|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
27720310|NCT01049035|80806636|FG005|Overall Study|Other adverse event (AE)|0|||
27720311|NCT01049035|80806637|FG006|Overall Study|Other adverse event (AE)|0|||
27720312|NCT01049035|80806631|FG000|Overall Study|Non-compliance with the protocol|12|||
27720313|NCT01049035|80806632|FG001|Overall Study|Non-compliance with the protocol|6|||
27720314|NCT01049035|80806633|FG002|Overall Study|Non-compliance with the protocol|14|||
27720315|NCT01049035|80806634|FG003|Overall Study|Non-compliance with the protocol|5|||
27720316|NCT01049035|80806635|FG004|Overall Study|Non-compliance with the protocol|3|||
27720317|NCT01049035|80806636|FG005|Overall Study|Non-compliance with the protocol|4|||
27720318|NCT01049035|80806637|FG006|Overall Study|Non-compliance with the protocol|10|||
27720319|NCT01049035|80806631|FG000|Overall Study|Lost to Follow-up|5|||
27720320|NCT01049035|80806632|FG001|Overall Study|Lost to Follow-up|4|||
27720321|NCT01049035|80806633|FG002|Overall Study|Lost to Follow-up|4|||
27720322|NCT01049035|80806634|FG003|Overall Study|Lost to Follow-up|1|||
27720323|NCT01049035|80806635|FG004|Overall Study|Lost to Follow-up|0|||
27720324|NCT01049035|80806636|FG005|Overall Study|Lost to Follow-up|3|||
27720325|NCT01049035|80806637|FG006|Overall Study|Lost to Follow-up|3|||
27720326|NCT01049035|80806631|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
27720327|NCT01049035|80806632|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
27720328|NCT01049035|80806633|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
27720329|NCT01049035|80806634|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
27720330|NCT01049035|80806635|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
27720331|NCT01049035|80806636|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
27720332|NCT01049035|80806637|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
27720333|NCT01745146|80806650|FG000|Overall Study|Withdrawal by Subject|1|||
27720334|NCT01745146|80806651|FG001|Overall Study|Withdrawal by Subject|3|||
27720335|NCT01745146|80806650|FG000|Overall Study|Lost to Follow-up|2|||
27720336|NCT01745146|80806651|FG001|Overall Study|Lost to Follow-up|0|||
27720337|NCT01496885|80806652|FG000|Overall Study|Lost to Follow-up|13|||
27720338|NCT01496885|80806652|FG000|Overall Study|Withdrawal by Subject|7|||
27720339|NCT01496885|80806652|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
27720340|NCT01496885|80806652|FG000|Overall Study|Death|1|||
27720341|NCT01537211|80806655|FG000|Overall Study|Lost to Follow-up|0|||
27720342|NCT01537211|80806656|FG001|Overall Study|Lost to Follow-up|1|||
27720343|NCT03557281|80806661|FG000|Overall Study|Investigator discretion|0|||
27720344|NCT03557281|80806662|FG001|Overall Study|Investigator discretion|0|||
27720345|NCT03557281|80806663|FG002|Overall Study|Investigator discretion|1|||
27720346|NCT03557281|80806664|FG003|Overall Study|Investigator discretion|0|||
27720347|NCT03557281|80806665|FG004|Overall Study|Investigator discretion|0|||
27720348|NCT03557281|80806661|FG000|Overall Study|Withdrawal by Subject|0|||
27720349|NCT03557281|80806662|FG001|Overall Study|Withdrawal by Subject|1|||
27720350|NCT03557281|80806663|FG002|Overall Study|Withdrawal by Subject|1|||
27720351|NCT03557281|80806664|FG003|Overall Study|Withdrawal by Subject|1|||
27720352|NCT03557281|80806665|FG004|Overall Study|Withdrawal by Subject|2|||
27608506|NCT03749447|80409332|FG000|Overall Study|Study Terminated By Sponsor|112|||
27608507|NCT03749447|80409333|FG001|Overall Study|Study Terminated By Sponsor|105|||
27608508|NCT03749447|80409332|FG000|Overall Study|Withdrawal by Subject|12|||
27608509|NCT03749447|80409333|FG001|Overall Study|Withdrawal by Subject|6|||
27608510|NCT03749447|80409332|FG000|Overall Study|Non-compliance With Study Drug|0|||
27608511|NCT03749447|80409333|FG001|Overall Study|Non-compliance With Study Drug|1|||
27608512|NCT00003511|80409334|FG000|Overall Study|Not evaluable|4|||
27608513|NCT02778399|80409335|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
27608514|NCT02778399|80409336|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
27608515|NCT02778399|80409337|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
27608516|NCT02778399|80409338|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
27608517|NCT02778399|80409339|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
27608518|NCT02778399|80409340|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
27608519|NCT02778399|80409335|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
27608520|NCT02778399|80409336|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
27608521|NCT02778399|80409337|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
27608522|NCT02778399|80409338|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
27608523|NCT02778399|80409339|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
27608524|NCT02778399|80409340|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
27608525|NCT02778399|80409335|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
27608526|NCT02778399|80409336|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
27608527|NCT02778399|80409337|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
27608528|NCT02778399|80409338|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
27608529|NCT02778399|80409339|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
27608530|NCT02778399|80409340|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
27608531|NCT02778399|80409335|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
27608532|NCT02778399|80409336|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
27608533|NCT02778399|80409337|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
27608534|NCT02778399|80409338|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
27608535|NCT02778399|80409339|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
27608536|NCT02778399|80409340|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
27608537|NCT02778399|80409335|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
27608538|NCT02778399|80409336|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
27608539|NCT02778399|80409337|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
27608540|NCT02778399|80409338|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
27608541|NCT02778399|80409339|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
27608542|NCT02778399|80409340|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
27608543|NCT02778399|80409335|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
27608544|NCT02778399|80409336|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
27608545|NCT02778399|80409337|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
27608546|NCT02778399|80409338|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
27608547|NCT02778399|80409339|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
27608548|NCT02778399|80409340|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
27608549|NCT02778399|80409335|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
27608550|NCT02778399|80409336|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
27608551|NCT02778399|80409337|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
27608552|NCT02778399|80409338|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
27608553|NCT02778399|80409339|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
27608554|NCT02778399|80409340|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
27608555|NCT02778399|80409335|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
27608556|NCT02778399|80409336|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
27608557|NCT02778399|80409337|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
27608558|NCT02778399|80409338|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
27608559|NCT02778399|80409339|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
27608560|NCT02778399|80409340|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
27608561|NCT02778399|80409335|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
27608562|NCT02778399|80409336|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
27608563|NCT02778399|80409337|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
27608564|NCT02778399|80409338|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
27608565|NCT02778399|80409339|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
27608566|NCT02778399|80409340|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
27608567|NCT02778399|80409335|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
27608568|NCT02778399|80409336|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
27608569|NCT02778399|80409337|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
27608570|NCT02778399|80409338|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
27608571|NCT02778399|80409339|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
27608572|NCT02778399|80409340|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
27720353|NCT03557281|80806661|FG000|Overall Study|Randomized, but did not receive treatment|0|||
27608573|NCT02778399|80409335|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
27608574|NCT02778399|80409336|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
27608575|NCT02778399|80409337|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
27608576|NCT02778399|80409338|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
27608577|NCT02778399|80409339|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
27608578|NCT02778399|80409340|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
27608579|NCT00100932|80409343|FG000|Overall Study|Adverse Event|11|||
27608580|NCT00100932|80409344|FG001|Overall Study|Adverse Event|2|||
27608581|NCT00100932|80409343|FG000|Overall Study|Withdrawal by Subject|6|||
27608582|NCT00100932|80409344|FG001|Overall Study|Withdrawal by Subject|0|||
27608583|NCT00100932|80409343|FG000|Overall Study|Progressive Disease|44|||
27608584|NCT00100932|80409344|FG001|Overall Study|Progressive Disease|18|||
27608585|NCT00100932|80409343|FG000|Overall Study|Physician Decision|7|||
27608586|NCT00100932|80409344|FG001|Overall Study|Physician Decision|5|||
27608587|NCT00100932|80409343|FG000|Overall Study|Other|5|||
27608588|NCT00100932|80409344|FG001|Overall Study|Other|2|||
27608589|NCT04772053|80409345|FG000|Overall Study|Physician Decision|2|||
27608590|NCT04772053|80409345|FG000|Overall Study|Withdrawal by Subject|3|||
27608591|NCT04772053|80409345|FG000|Overall Study|Study Terminated by Sponsor|1|||
27608592|NCT00369681|80409346|FG000|Overall Study|Death|1|||
27608593|NCT03097861|80409352|FG000|Overall Study|Adverse Event|3|||
27608594|NCT03097861|80409353|FG001|Overall Study|Adverse Event|8|||
27608595|NCT03097861|80409354|FG002|Overall Study|Adverse Event|4|||
27608596|NCT03097861|80409352|FG000|Overall Study|Investigator Decision|0|||
27608597|NCT03097861|80409353|FG001|Overall Study|Investigator Decision|1|||
27608598|NCT03097861|80409354|FG002|Overall Study|Investigator Decision|0|||
27608599|NCT03097861|80409352|FG000|Overall Study|Lost to Follow-up|0|||
27608600|NCT03097861|80409353|FG001|Overall Study|Lost to Follow-up|7|||
27608601|NCT03097861|80409354|FG002|Overall Study|Lost to Follow-up|1|||
27608602|NCT03097861|80409352|FG000|Overall Study|Withdrawal by Subject|1|||
27608603|NCT03097861|80409353|FG001|Overall Study|Withdrawal by Subject|5|||
27608604|NCT03097861|80409354|FG002|Overall Study|Withdrawal by Subject|3|||
27608605|NCT03097861|80409352|FG000|Overall Study|Reason not provided|3|||
27608606|NCT03097861|80409353|FG001|Overall Study|Reason not provided|1|||
27608607|NCT03097861|80409354|FG002|Overall Study|Reason not provided|1|||
27608608|NCT02118337|80409355|FG000|Overall Study|Other|1|||
27608609|NCT02118337|80409356|FG001|Overall Study|Other|0|||
27608610|NCT02118337|80409357|FG002|Overall Study|Other|0|||
27608611|NCT02118337|80409358|FG003|Overall Study|Other|0|||
27608612|NCT02118337|80409359|FG004|Overall Study|Other|2|||
27608613|NCT02118337|80409360|FG005|Overall Study|Other|3|||
27608614|NCT02118337|80409361|FG006|Overall Study|Other|1|||
27608615|NCT02118337|80409362|FG007|Overall Study|Other|28|||
27608616|NCT02118337|80409363|FG008|Overall Study|Other|15|||
27608617|NCT02118337|80409355|FG000|Overall Study|Lost to Follow-up|0|||
27608618|NCT02118337|80409356|FG001|Overall Study|Lost to Follow-up|0|||
27608619|NCT02118337|80409357|FG002|Overall Study|Lost to Follow-up|0|||
27608620|NCT02118337|80409358|FG003|Overall Study|Lost to Follow-up|0|||
27608621|NCT02118337|80409359|FG004|Overall Study|Lost to Follow-up|0|||
27608622|NCT02118337|80409360|FG005|Overall Study|Lost to Follow-up|0|||
27608623|NCT02118337|80409361|FG006|Overall Study|Lost to Follow-up|0|||
27608624|NCT02118337|80409362|FG007|Overall Study|Lost to Follow-up|1|||
27608625|NCT02118337|80409363|FG008|Overall Study|Lost to Follow-up|0|||
27608626|NCT02118337|80409355|FG000|Overall Study|Withdrawal by Subject|1|||
27608627|NCT02118337|80409356|FG001|Overall Study|Withdrawal by Subject|3|||
27608628|NCT02118337|80409357|FG002|Overall Study|Withdrawal by Subject|2|||
27608629|NCT02118337|80409358|FG003|Overall Study|Withdrawal by Subject|1|||
27608630|NCT02118337|80409359|FG004|Overall Study|Withdrawal by Subject|2|||
27608631|NCT02118337|80409360|FG005|Overall Study|Withdrawal by Subject|2|||
27608632|NCT02118337|80409361|FG006|Overall Study|Withdrawal by Subject|1|||
27608633|NCT02118337|80409362|FG007|Overall Study|Withdrawal by Subject|4|||
27608634|NCT02118337|80409363|FG008|Overall Study|Withdrawal by Subject|2|||
27608635|NCT02118337|80409355|FG000|Overall Study|Death|2|||
27608636|NCT02118337|80409356|FG001|Overall Study|Death|2|||
27608637|NCT02118337|80409357|FG002|Overall Study|Death|1|||
27608638|NCT02118337|80409358|FG003|Overall Study|Death|2|||
27608639|NCT02118337|80409359|FG004|Overall Study|Death|5|||
27608640|NCT02118337|80409360|FG005|Overall Study|Death|1|||
27608641|NCT02118337|80409361|FG006|Overall Study|Death|2|||
27608642|NCT02118337|80409362|FG007|Overall Study|Death|9|||
27608643|NCT02118337|80409363|FG008|Overall Study|Death|4|||
27608644|NCT01160484|80409365|FG000|Overall Study|Lack of Efficacy|9|||
27608645|NCT01160484|80409365|FG000|Overall Study|Adverse Event|6|||
27608646|NCT01160484|80409365|FG000|Overall Study|Withdrawal by Subject|2|||
27839214|NCT05070754|81239593|FG002|Overall Study|Protocol Violation|0|||
27839215|NCT05070754|81239594|FG003|Overall Study|Protocol Violation|1|||
27839216|NCT00381849|81239597|FG000|Wash Out|Withdrawal by Subject|0|||
27839217|NCT00381849|81239598|FG001|Wash Out|Withdrawal by Subject|1|||
27839218|NCT01198873|81239599|FG000|Overall Study|Adverse Event|4|||
27839219|NCT01198873|81239600|FG001|Overall Study|Adverse Event|7|||
27839220|NCT01198873|81239599|FG000|Overall Study|Study closure|29|||
27608647|NCT01160484|80409365|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
27608648|NCT02593305|80409366|FG000|Post 1|Comparison only group. No intervention.|0|||
27608649|NCT02593305|80409367|FG001|Post 1|Comparison only group. No intervention.|0|||
27608650|NCT02593305|80409368|FG002|Post 1|Comparison only group. No intervention.|10|||
27608651|NCT01834222|80409369|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
27608652|NCT00860067|80409373|FG000|Overall Study|Lost to Follow-up|46|||
27608653|NCT00860067|80409374|FG001|Overall Study|Lost to Follow-up|9|||
27608654|NCT00860067|80409375|FG002|Overall Study|Lost to Follow-up|9|||
27608655|NCT00860067|80409373|FG000|Overall Study|Withdrawal by Subject|4|||
27608656|NCT00860067|80409374|FG001|Overall Study|Withdrawal by Subject|0|||
27608657|NCT00860067|80409375|FG002|Overall Study|Withdrawal by Subject|0|||
27608658|NCT00860067|80409373|FG000|Overall Study|Pregnancy|1|||
27608659|NCT00860067|80409374|FG001|Overall Study|Pregnancy|0|||
27608660|NCT00860067|80409375|FG002|Overall Study|Pregnancy|0|||
27608661|NCT02041923|80409376|FG000|Overall Study|Lost to Follow-up|26|||
27608662|NCT02041923|80409377|FG001|Overall Study|Lost to Follow-up|30|||
27608663|NCT01993017|80409378|FG000|Overall Study|Death|23|||
27608664|NCT01993017|80409379|FG001|Overall Study|Death|26|||
27608665|NCT01993017|80409380|FG002|Overall Study|Death|18|||
27608666|NCT01993017|80409378|FG000|Overall Study|Could not be contacted|43|||
27608667|NCT01993017|80409379|FG001|Overall Study|Could not be contacted|42|||
27608668|NCT01993017|80409380|FG002|Overall Study|Could not be contacted|38|||
27608669|NCT01993017|80409378|FG000|Overall Study|Dropped out|19|||
27608670|NCT01993017|80409379|FG001|Overall Study|Dropped out|6|||
27608671|NCT01993017|80409380|FG002|Overall Study|Dropped out|11|||
27608672|NCT01993017|80409378|FG000|Overall Study|Other reasons|17|||
27608673|NCT01993017|80409379|FG001|Overall Study|Other reasons|11|||
27608674|NCT01993017|80409380|FG002|Overall Study|Other reasons|7|||
27608675|NCT01993017|80409378|FG000|Overall Study|Ineligible after randomization|4|||
27608676|NCT01993017|80409379|FG001|Overall Study|Ineligible after randomization|5|||
27608677|NCT01993017|80409380|FG002|Overall Study|Ineligible after randomization|5|||
27608678|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
27608679|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
27608680|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Adverse Event|2|||
27608681|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Adverse Event|5|||
27608682|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
27608683|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
27608684|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
27608685|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
27608686|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Randomized by error|0|||
27608687|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Randomized by error|5|||
27608688|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
27608689|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
27608690|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
27608691|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
27608692|NCT02948959|80409383|FG000|52 Weeks Treatment Period|Change of residence location|0|||
27608693|NCT02948959|80409384|FG001|52 Weeks Treatment Period|Change of residence location|1|||
27608694|NCT02948959|80409383|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
27608695|NCT02948959|80409384|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
27608696|NCT02948959|80409383|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
27608697|NCT02948959|80409384|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
27608698|NCT02948959|80409383|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
27608699|NCT02948959|80409384|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
27608700|NCT02948959|80409383|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
27839221|NCT01198873|81239600|FG001|Overall Study|Study closure|23|||
27839222|NCT01198873|81239599|FG000|Overall Study|Other than above|4|||
27839223|NCT01198873|81239600|FG001|Overall Study|Other than above|2|||
27608701|NCT02948959|80409384|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
27608702|NCT02948959|80409383|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
27608703|NCT02948959|80409384|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
27608704|NCT02948959|80409383|FG000|12 Weeks Follow-up Period|Study site closure|1|||
27608705|NCT02948959|80409384|FG001|12 Weeks Follow-up Period|Study site closure|0|||
27720354|NCT03557281|80806662|FG001|Overall Study|Randomized, but did not receive treatment|0|||
27839224|NCT02578641|81239601|FG000|Overall Study|Adverse Event|5|||
27839225|NCT02578641|81239602|FG001|Overall Study|Adverse Event|15|||
27839226|NCT02578641|81239601|FG000|Overall Study|Death|16|||
27839227|NCT02578641|81239602|FG001|Overall Study|Death|8|||
27839228|NCT02578641|81239601|FG000|Overall Study|Lost to Follow-up|0|||
27839229|NCT02578641|81239602|FG001|Overall Study|Lost to Follow-up|1|||
27839230|NCT02578641|81239601|FG000|Overall Study|Withdrawal by Subject|14|||
27839231|NCT02578641|81239602|FG001|Overall Study|Withdrawal by Subject|7|||
27839232|NCT02578641|81239601|FG000|Overall Study|Progressive Disease|69|||
27839233|NCT02578641|81239602|FG001|Overall Study|Progressive Disease|21|||
27890742|NCT02031640|81434159|FG004|Run-In Period|Various administrative reasons|0|||
27890743|NCT02031640|81434160|FG005|Run-In Period|Various administrative reasons|0|||
27890744|NCT02031640|81434155|FG000|Double-blind Treatment Period|Protocol deviation|0|||
27890745|NCT02031640|81434156|FG001|Double-blind Treatment Period|Protocol deviation|2|||
27890746|NCT02031640|81434157|FG002|Double-blind Treatment Period|Protocol deviation|0|||
27890747|NCT02031640|81434158|FG003|Double-blind Treatment Period|Protocol deviation|1|||
27890748|NCT02031640|81434159|FG004|Double-blind Treatment Period|Protocol deviation|3|||
27890749|NCT02031640|81434160|FG005|Double-blind Treatment Period|Protocol deviation|1|||
27890750|NCT02031640|81434155|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27890751|NCT02031640|81434156|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
27890752|NCT02031640|81434157|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
27890753|NCT02031640|81434158|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
27890754|NCT02031640|81434159|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
27608706|NCT04318093|80409385|FG000|Overall Study|Adverse Event|2|||
27608707|NCT04318093|80409386|FG001|Overall Study|Adverse Event|2|||
27608708|NCT04318093|80409385|FG000|Overall Study|Participant withdrew consent|1|||
27608709|NCT04318093|80409386|FG001|Overall Study|Participant withdrew consent|0|||
27608710|NCT04318093|80409385|FG000|Overall Study|Other reasons|0|||
27608711|NCT04318093|80409386|FG001|Overall Study|Other reasons|1|||
27608712|NCT00979602|80409389|FG000|Overall Study|Serious Adverse Event|5|||
27608713|NCT00979602|80409390|FG001|Overall Study|Serious Adverse Event|3|||
27608714|NCT00979602|80409389|FG000|Overall Study|Protocol Violation|3|||
27608715|NCT00979602|80409390|FG001|Overall Study|Protocol Violation|0|||
27608716|NCT00979602|80409389|FG000|Overall Study|Withdrawal by Subject|31|||
27608717|NCT00979602|80409390|FG001|Overall Study|Withdrawal by Subject|25|||
27608718|NCT00979602|80409389|FG000|Overall Study|Lost to Follow-up|100|||
27608719|NCT00979602|80409390|FG001|Overall Study|Lost to Follow-up|96|||
27608720|NCT00979602|80409389|FG000|Overall Study|Migrated/moved from study area|3|||
27608721|NCT00979602|80409390|FG001|Overall Study|Migrated/moved from study area|6|||
27608722|NCT00979602|80409389|FG000|Overall Study|Others|3|||
27608723|NCT00979602|80409390|FG001|Overall Study|Others|3|||
27608724|NCT01719237|80409391|FG000|Overall Study|Physician Decision|0|||
27608725|NCT01719237|80409392|FG001|Overall Study|Physician Decision|1|||
27608726|NCT01674621|80409393|FG000|Overall Study|Adverse Event|3|||
27608727|NCT01674621|80409394|FG001|Overall Study|Adverse Event|2|||
27608728|NCT01674621|80409395|FG002|Overall Study|Adverse Event|5|||
27608729|NCT01674621|80409396|FG003|Overall Study|Adverse Event|5|||
27608730|NCT01674621|80409397|FG004|Overall Study|Adverse Event|1|||
27608731|NCT01674621|80409393|FG000|Overall Study|Inability to Complete Study Procedures|0|||
27608732|NCT01674621|80409394|FG001|Overall Study|Inability to Complete Study Procedures|0|||
27839234|NCT02578641|81239601|FG000|Overall Study|No Study Drug|2|||
27890755|NCT02031640|81434160|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
27890756|NCT02031640|81434155|FG000|Double-blind Treatment Period|Non-compliance|0|||
27890757|NCT02031640|81434156|FG001|Double-blind Treatment Period|Non-compliance|1|||
27839235|NCT02578641|81239602|FG001|Overall Study|No Study Drug|0|||
27608733|NCT01674621|80409395|FG002|Overall Study|Inability to Complete Study Procedures|0|||
27608734|NCT01674621|80409396|FG003|Overall Study|Inability to Complete Study Procedures|0|||
27839236|NCT02578641|81239601|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
27890758|NCT02031640|81434157|FG002|Double-blind Treatment Period|Non-compliance|0|||
27890759|NCT02031640|81434158|FG003|Double-blind Treatment Period|Non-compliance|1|||
27608735|NCT01674621|80409397|FG004|Overall Study|Inability to Complete Study Procedures|2|||
27720355|NCT03557281|80806663|FG002|Overall Study|Randomized, but did not receive treatment|0|||
27720356|NCT03557281|80806664|FG003|Overall Study|Randomized, but did not receive treatment|0|||
27720357|NCT03557281|80806665|FG004|Overall Study|Randomized, but did not receive treatment|1|||
27720358|NCT01564862|80806666|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
27720359|NCT01564862|80806667|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
27720360|NCT01564862|80806668|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
27720361|NCT01564862|80806666|FG000|Overall Study|Major Protocol Deviation|3|||
27720362|NCT01564862|80806667|FG001|Overall Study|Major Protocol Deviation|3|||
27720363|NCT01564862|80806668|FG002|Overall Study|Major Protocol Deviation|4|||
27720364|NCT01564862|80806666|FG000|Overall Study|Lost to Follow-up|10|||
27720365|NCT01564862|80806667|FG001|Overall Study|Lost to Follow-up|8|||
27720366|NCT01564862|80806668|FG002|Overall Study|Lost to Follow-up|6|||
27720367|NCT01564862|80806666|FG000|Overall Study|Voluntary Withdrawal|9|||
27720368|NCT01564862|80806667|FG001|Overall Study|Voluntary Withdrawal|6|||
27839237|NCT02578641|81239602|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
27839238|NCT02578641|81239601|FG000|Overall Study|Non-compliance with Study Schedule|1|||
27839239|NCT02578641|81239602|FG001|Overall Study|Non-compliance with Study Schedule|0|||
27839240|NCT02578641|81239601|FG000|Overall Study|Other|1|||
27839241|NCT02578641|81239602|FG001|Overall Study|Other|10|||
27839242|NCT02578641|81239601|FG000|Overall Study|Not treated|1|||
27839243|NCT02578641|81239602|FG001|Overall Study|Not treated|4|||
27839244|NCT01781234|81239609|FG000|Overall Study|Adverse Event|2|||
27839245|NCT01781234|81239610|FG001|Overall Study|Adverse Event|0|||
27839246|NCT01781234|81239609|FG000|Overall Study|Protocol Violation|3|||
27839247|NCT01781234|81239610|FG001|Overall Study|Protocol Violation|0|||
27839248|NCT01781234|81239609|FG000|Overall Study|Withdrawal by Subject|4|||
27839249|NCT01781234|81239610|FG001|Overall Study|Withdrawal by Subject|3|||
27839250|NCT02941523|81239625|FG000|Monotherapy|Withdrawal by Subject|0|||
27839251|NCT02941523|81239626|FG001|Monotherapy|Withdrawal by Subject|1|||
27839252|NCT02941523|81239625|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
27839253|NCT02941523|81239626|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
27839254|NCT02941523|81239625|FG000|Carboplatin Combination Therapy|Death|1|||
27839255|NCT02941523|81239626|FG001|Carboplatin Combination Therapy|Death|2|||
27839256|NCT02941523|81239625|FG000|Carboplatin Combination Therapy|Disease progression|2|||
27839257|NCT02941523|81239626|FG001|Carboplatin Combination Therapy|Disease progression|0|||
27839258|NCT02941523|81239625|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
27839259|NCT02941523|81239626|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
27839260|NCT02611323|81239629|FG000|Overall Study|Death|3|||
27890760|NCT02031640|81434159|FG004|Double-blind Treatment Period|Non-compliance|1|||
27890761|NCT02031640|81434160|FG005|Double-blind Treatment Period|Non-compliance|0|||
27890762|NCT02031640|81434155|FG000|Double-blind Treatment Period|Adverse Event|0|||
27890763|NCT02031640|81434156|FG001|Double-blind Treatment Period|Adverse Event|0|||
27890764|NCT02031640|81434157|FG002|Double-blind Treatment Period|Adverse Event|0|||
27890765|NCT02031640|81434158|FG003|Double-blind Treatment Period|Adverse Event|2|||
27890766|NCT02031640|81434159|FG004|Double-blind Treatment Period|Adverse Event|0|||
27890767|NCT02031640|81434160|FG005|Double-blind Treatment Period|Adverse Event|0|||
27890768|NCT02031640|81434155|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27890769|NCT02031640|81434156|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
27890770|NCT02031640|81434157|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
27890771|NCT02031640|81434158|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
27890772|NCT02031640|81434159|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
27890773|NCT02031640|81434160|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
27890774|NCT02031640|81434155|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27890775|NCT02031640|81434156|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
27890776|NCT02031640|81434157|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27890777|NCT02031640|81434158|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27890778|NCT02031640|81434159|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
27608736|NCT01674621|80409393|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27608737|NCT01674621|80409394|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27720369|NCT01564862|80806668|FG002|Overall Study|Voluntary Withdrawal|8|||
27720370|NCT01564862|80806666|FG000|Overall Study|Lack of Efficacy|1|||
27839261|NCT02611323|81239630|FG001|Overall Study|Death|1|||
27890779|NCT02031640|81434160|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
27890780|NCT04064411|81434163|FG000|Overall Study|Adverse Event|29|||
27839262|NCT02611323|81239631|FG002|Overall Study|Death|0|||
27839263|NCT02611323|81239632|FG003|Overall Study|Death|0|||
27890781|NCT04064411|81434164|FG001|Overall Study|Adverse Event|19|||
27890782|NCT04064411|81434163|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
27839264|NCT02611323|81239633|FG004|Overall Study|Death|1|||
27839265|NCT02611323|81239634|FG005|Overall Study|Death|1|||
27608738|NCT01674621|80409395|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27608739|NCT01674621|80409396|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
27608740|NCT01674621|80409397|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
27608741|NCT01674621|80409393|FG000|Overall Study|Withdrawal by Subject|2|||
27608742|NCT01674621|80409394|FG001|Overall Study|Withdrawal by Subject|5|||
27608743|NCT01674621|80409395|FG002|Overall Study|Withdrawal by Subject|2|||
27608744|NCT01674621|80409396|FG003|Overall Study|Withdrawal by Subject|0|||
27890783|NCT04064411|81434164|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
27890784|NCT04064411|81434163|FG000|Overall Study|Protocol Deviation|0|||
27890785|NCT04064411|81434164|FG001|Overall Study|Protocol Deviation|2|||
27890786|NCT04064411|81434163|FG000|Overall Study|Withdrawal by Subject|25|||
27890787|NCT04064411|81434164|FG001|Overall Study|Withdrawal by Subject|29|||
27890788|NCT04064411|81434163|FG000|Overall Study|Lost to Follow-up|5|||
27608745|NCT01674621|80409397|FG004|Overall Study|Withdrawal by Subject|1|||
27608746|NCT01674621|80409393|FG000|Overall Study|Other than specified|0|||
27608747|NCT01674621|80409394|FG001|Overall Study|Other than specified|1|||
27608748|NCT01674621|80409395|FG002|Overall Study|Other than specified|0|||
27608749|NCT01674621|80409396|FG003|Overall Study|Other than specified|0|||
27608750|NCT01674621|80409397|FG004|Overall Study|Other than specified|2|||
27608751|NCT02601937|80409400|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608752|NCT02601937|80409401|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
27890789|NCT04064411|81434164|FG001|Overall Study|Lost to Follow-up|2|||
27890790|NCT04064411|81434163|FG000|Overall Study|Other than Specified|4|||
27890791|NCT04064411|81434164|FG001|Overall Study|Other than Specified|1|||
27890792|NCT04064411|81434163|FG000|Overall Study|Death|1|||
27890793|NCT04064411|81434164|FG001|Overall Study|Death|0|||
27890794|NCT02288091|81434166|FG000|Overall Study|Lost to Follow-up|1|||
27890795|NCT02288091|81434166|FG000|Overall Study|Screen fail|7|||
27890796|NCT00256854|81434167|FG000|Overall Study|Withdrawal by Subject|2|||
27890797|NCT00256854|81434168|FG001|Overall Study|Withdrawal by Subject|3|||
27890798|NCT00256854|81434169|FG002|Overall Study|Withdrawal by Subject|0|||
27608753|NCT02601937|80409402|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608754|NCT02601937|80409403|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608755|NCT02601937|80409404|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608756|NCT02601937|80409405|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
27608757|NCT02601937|80409406|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608758|NCT02601937|80409407|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608759|NCT02601937|80409408|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608760|NCT02601937|80409409|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
27608761|NCT02601937|80409410|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
27890799|NCT00256854|81434170|FG003|Overall Study|Withdrawal by Subject|0|||
27890800|NCT00256854|81434171|FG004|Overall Study|Withdrawal by Subject|0|||
27890801|NCT00256854|81434172|FG005|Overall Study|Withdrawal by Subject|0|||
27608762|NCT02601937|80409400|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
27720371|NCT01564862|80806667|FG001|Overall Study|Lack of Efficacy|5|||
27890802|NCT00256854|81434167|FG000|Overall Study|Lack of Efficacy|1|||
27890803|NCT00256854|81434168|FG001|Overall Study|Lack of Efficacy|0|||
27890804|NCT00256854|81434169|FG002|Overall Study|Lack of Efficacy|0|||
27608763|NCT02601937|80409401|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608764|NCT02601937|80409402|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608765|NCT02601937|80409403|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608766|NCT02601937|80409404|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608767|NCT02601937|80409405|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608768|NCT02601937|80409406|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
27608769|NCT02601937|80409407|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608770|NCT02601937|80409408|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608771|NCT02601937|80409409|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608772|NCT02601937|80409410|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
27608773|NCT02601937|80409400|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608774|NCT02601937|80409401|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608775|NCT02601937|80409402|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
27608776|NCT02601937|80409403|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608777|NCT02601937|80409404|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608778|NCT02601937|80409405|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608779|NCT02601937|80409406|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608780|NCT02601937|80409407|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608781|NCT02601937|80409408|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608782|NCT02601937|80409409|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608783|NCT02601937|80409410|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
27608784|NCT02601937|80409400|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
27608785|NCT02601937|80409401|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
27608786|NCT02601937|80409402|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
27608787|NCT02601937|80409403|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
27608788|NCT02601937|80409404|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
27608789|NCT02601937|80409405|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
27720372|NCT01564862|80806668|FG002|Overall Study|Lack of Efficacy|6|||
27720373|NCT01564862|80806666|FG000|Overall Study|Other reason(s)|1|||
27720374|NCT01564862|80806667|FG001|Overall Study|Other reason(s)|0|||
27720375|NCT01564862|80806668|FG002|Overall Study|Other reason(s)|0|||
27720376|NCT01133171|80806671|FG000|Overall Study|Withdrawal by Subject|1|||
27839266|NCT02611323|81239635|FG006|Overall Study|Death|8|||
27608790|NCT02601937|80409406|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
27608791|NCT02601937|80409407|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
27839267|NCT02611323|81239636|FG007|Overall Study|Death|0|||
27839268|NCT02611323|81239637|FG008|Overall Study|Death|4|||
27839269|NCT02611323|81239638|FG009|Overall Study|Death|6|||
27839270|NCT02611323|81239639|FG010|Overall Study|Death|26|||
27839271|NCT02611323|81239629|FG000|Overall Study|Lost to Follow-up|1|||
27839272|NCT02611323|81239630|FG001|Overall Study|Lost to Follow-up|0|||
27839273|NCT02611323|81239631|FG002|Overall Study|Lost to Follow-up|0|||
27839274|NCT02611323|81239632|FG003|Overall Study|Lost to Follow-up|0|||
27839275|NCT02611323|81239633|FG004|Overall Study|Lost to Follow-up|0|||
27890805|NCT00256854|81434170|FG003|Overall Study|Lack of Efficacy|0|||
27608792|NCT02601937|80409408|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
27608793|NCT02601937|80409409|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
27608794|NCT02601937|80409410|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
27608795|NCT02601937|80409400|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608796|NCT02601937|80409401|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608797|NCT02601937|80409402|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608798|NCT02601937|80409403|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608799|NCT02601937|80409404|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608800|NCT02601937|80409405|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608801|NCT02601937|80409406|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608802|NCT02601937|80409407|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608803|NCT02601937|80409408|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608804|NCT02601937|80409409|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
27608805|NCT02601937|80409410|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
27608806|NCT02601937|80409400|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608807|NCT02601937|80409401|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608808|NCT02601937|80409402|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608809|NCT02601937|80409403|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608810|NCT02601937|80409404|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608811|NCT02601937|80409405|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608812|NCT02601937|80409406|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608813|NCT02601937|80409407|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
27608814|NCT02601937|80409408|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608815|NCT02601937|80409409|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608816|NCT02601937|80409410|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
27608817|NCT02601937|80409400|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27720377|NCT01133171|80806672|FG001|Overall Study|Withdrawal by Subject|2|||
27720378|NCT01133171|80806673|FG002|Overall Study|Withdrawal by Subject|0|||
27720379|NCT02926950|80806674|FG000|Overall Study|Adverse Event|4|||
27720380|NCT02926950|80806675|FG001|Overall Study|Adverse Event|6|||
27720381|NCT02926950|80806674|FG000|Overall Study|At the participant's own request|21|||
27839276|NCT02611323|81239634|FG005|Overall Study|Lost to Follow-up|0|||
27839277|NCT02611323|81239635|FG006|Overall Study|Lost to Follow-up|3|||
27839278|NCT02611323|81239636|FG007|Overall Study|Lost to Follow-up|0|||
27839279|NCT02611323|81239637|FG008|Overall Study|Lost to Follow-up|0|||
27839280|NCT02611323|81239638|FG009|Overall Study|Lost to Follow-up|0|||
27839281|NCT02611323|81239639|FG010|Overall Study|Lost to Follow-up|2|||
27839282|NCT02611323|81239629|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839283|NCT02611323|81239630|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839284|NCT02611323|81239631|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839285|NCT02611323|81239632|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839286|NCT02611323|81239633|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839287|NCT02611323|81239634|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839288|NCT02611323|81239635|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839289|NCT02611323|81239636|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839290|NCT02611323|81239637|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839291|NCT02611323|81239638|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
27839292|NCT02611323|81239639|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
27839293|NCT02611323|81239629|FG000|Overall Study|Progressive Disease|0|||
27839294|NCT02611323|81239630|FG001|Overall Study|Progressive Disease|0|||
27839295|NCT02611323|81239631|FG002|Overall Study|Progressive Disease|0|||
27839296|NCT02611323|81239632|FG003|Overall Study|Progressive Disease|0|||
27720382|NCT02926950|80806675|FG001|Overall Study|At the participant's own request|25|||
27839297|NCT02611323|81239633|FG004|Overall Study|Progressive Disease|0|||
27839298|NCT02611323|81239634|FG005|Overall Study|Progressive Disease|0|||
27500304|NCT00005906|80024958|FG000|Overall Study|Lack of Efficacy|3|||
27500305|NCT00005780|80024961|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
27500306|NCT02814916|80024962|FG000|Overall Study|Withdrawal of consent|0|||
27500307|NCT02814916|80024963|FG001|Overall Study|Withdrawal of consent|2|||
27500308|NCT02814916|80024964|FG002|Overall Study|Withdrawal of consent|0|||
27500309|NCT02814916|80024962|FG000|Overall Study|Lost to Follow-up|0|||
27500310|NCT02814916|80024963|FG001|Overall Study|Lost to Follow-up|1|||
27500311|NCT02814916|80024964|FG002|Overall Study|Lost to Follow-up|0|||
27500312|NCT02814916|80024962|FG000|Overall Study|Other, not specified|0|||
27500313|NCT02814916|80024963|FG001|Overall Study|Other, not specified|1|||
27500314|NCT02814916|80024964|FG002|Overall Study|Other, not specified|0|||
27500315|NCT03284710|80024967|FG000|Overall Study|Withdrawal by Subject|1|||
27500316|NCT03284710|80024968|FG001|Overall Study|Withdrawal by Subject|0|||
27500317|NCT03284710|80024969|FG002|Overall Study|Withdrawal by Subject|1|||
27500318|NCT03284710|80024970|FG003|Overall Study|Withdrawal by Subject|6|||
27500319|NCT03284710|80024967|FG000|Overall Study|Lost to Follow-up|3|||
27500320|NCT03284710|80024968|FG001|Overall Study|Lost to Follow-up|3|||
27500321|NCT03284710|80024969|FG002|Overall Study|Lost to Follow-up|1|||
27500322|NCT03284710|80024970|FG003|Overall Study|Lost to Follow-up|0|||
27500323|NCT03284710|80024967|FG000|Overall Study|Physician Decision|1|||
27500324|NCT03284710|80024968|FG001|Overall Study|Physician Decision|0|||
27500325|NCT03284710|80024969|FG002|Overall Study|Physician Decision|0|||
27500326|NCT03284710|80024970|FG003|Overall Study|Physician Decision|0|||
27500327|NCT03284710|80024967|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
27500328|NCT03284710|80024968|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27500329|NCT03284710|80024969|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
27500330|NCT03284710|80024970|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
27500331|NCT03284710|80024967|FG000|Overall Study|HIV Infection|0|||
27500332|NCT03284710|80024968|FG001|Overall Study|HIV Infection|2|||
27500333|NCT03284710|80024969|FG002|Overall Study|HIV Infection|2|||
27500334|NCT03284710|80024970|FG003|Overall Study|HIV Infection|1|||
27500335|NCT00904969|80024971|FG000|Overall Study|Lost to Follow-up|4|||
27500336|NCT00904969|80024971|FG000|Overall Study|Withdrawal by Subject|3|||
27500337|NCT00904969|80024971|FG000|Overall Study|Additional Treatments|11|||
27500338|NCT00904969|80024971|FG000|Overall Study|Case Aborted; Subject Exited|1|||
27608818|NCT02601937|80409401|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27839299|NCT02611323|81239635|FG006|Overall Study|Progressive Disease|0|||
27608819|NCT02601937|80409402|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27839300|NCT02611323|81239636|FG007|Overall Study|Progressive Disease|0|||
27839301|NCT02611323|81239637|FG008|Overall Study|Progressive Disease|0|||
27720383|NCT02926950|80806674|FG000|Overall Study|Reason not Specified|17|||
27720384|NCT02926950|80806675|FG001|Overall Study|Reason not Specified|9|||
27839302|NCT02611323|81239638|FG009|Overall Study|Progressive Disease|0|||
27839303|NCT02611323|81239639|FG010|Overall Study|Progressive Disease|1|||
27608820|NCT02601937|80409403|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27608821|NCT02601937|80409404|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27608822|NCT02601937|80409405|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27608823|NCT02601937|80409406|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27608824|NCT02601937|80409407|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27608825|NCT02601937|80409408|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
27608826|NCT02601937|80409409|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
27608827|NCT02601937|80409410|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
27608828|NCT02601937|80409400|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608829|NCT02601937|80409401|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608830|NCT02601937|80409402|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608831|NCT02601937|80409403|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608832|NCT02601937|80409404|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608833|NCT02601937|80409405|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608834|NCT02601937|80409406|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
27608835|NCT02601937|80409407|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
27608836|NCT02601937|80409408|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
27608837|NCT02601937|80409409|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
27608838|NCT02601937|80409410|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
27608839|NCT02601937|80409400|FG000|Period 2: Dose Expansion Cohort|Other|0|||
27608840|NCT02601937|80409401|FG001|Period 2: Dose Expansion Cohort|Other|0|||
27608841|NCT02601937|80409402|FG002|Period 2: Dose Expansion Cohort|Other|0|||
27608842|NCT02601937|80409403|FG003|Period 2: Dose Expansion Cohort|Other|0|||
27608843|NCT02601937|80409404|FG004|Period 2: Dose Expansion Cohort|Other|0|||
27608844|NCT02601937|80409405|FG005|Period 2: Dose Expansion Cohort|Other|0|||
27608845|NCT02601937|80409406|FG006|Period 2: Dose Expansion Cohort|Other|0|||
27608846|NCT02601937|80409407|FG007|Period 2: Dose Expansion Cohort|Other|0|||
27608847|NCT02601937|80409408|FG008|Period 2: Dose Expansion Cohort|Other|2|||
27608848|NCT02601937|80409409|FG009|Period 2: Dose Expansion Cohort|Other|2|||
27608849|NCT02601937|80409410|FG010|Period 2: Dose Expansion Cohort|Other|0|||
27608850|NCT02601937|80409400|FG000|Period 2: Dose Expansion Cohort|Death|0|||
27608851|NCT02601937|80409401|FG001|Period 2: Dose Expansion Cohort|Death|0|||
27608852|NCT02601937|80409402|FG002|Period 2: Dose Expansion Cohort|Death|0|||
27608853|NCT02601937|80409403|FG003|Period 2: Dose Expansion Cohort|Death|0|||
27608854|NCT02601937|80409404|FG004|Period 2: Dose Expansion Cohort|Death|0|||
27608855|NCT02601937|80409405|FG005|Period 2: Dose Expansion Cohort|Death|0|||
27608856|NCT02601937|80409406|FG006|Period 2: Dose Expansion Cohort|Death|0|||
27608857|NCT02601937|80409407|FG007|Period 2: Dose Expansion Cohort|Death|0|||
27608858|NCT02601937|80409408|FG008|Period 2: Dose Expansion Cohort|Death|1|||
27608859|NCT02601937|80409409|FG009|Period 2: Dose Expansion Cohort|Death|0|||
27608860|NCT02601937|80409410|FG010|Period 2: Dose Expansion Cohort|Death|0|||
27608861|NCT04170686|80409419|FG000|Screening|Physician Decision|12|||
27608862|NCT04170686|80409420|FG001|Screening|Physician Decision|13|||
27608863|NCT04170686|80409419|FG000|Randomization and Treatment|Lost to Follow-up|26|||
27608864|NCT04170686|80409420|FG001|Randomization and Treatment|Lost to Follow-up|15|||
27608865|NCT03443713|80409421|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
27608866|NCT03443713|80409422|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
27608867|NCT03443713|80409423|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
27608868|NCT04395183|80409424|FG000|Overall Study|Withdrawal by Subject|1|||
27608869|NCT04395183|80409425|FG001|Overall Study|Withdrawal by Subject|0|||
27608870|NCT04395183|80409426|FG002|Overall Study|Withdrawal by Subject|2|||
27608871|NCT04395183|80409427|FG003|Overall Study|Withdrawal by Subject|2|||
27608872|NCT00669903|80409428|FG000|Overall Study|Adverse Event|0|||
27608873|NCT00669903|80409429|FG001|Overall Study|Adverse Event|1|||
27839304|NCT02611323|81239629|FG000|Overall Study|Withdrawal by Subject|1|||
27839305|NCT02611323|81239630|FG001|Overall Study|Withdrawal by Subject|0|||
27839306|NCT02611323|81239631|FG002|Overall Study|Withdrawal by Subject|0|||
27839307|NCT02611323|81239632|FG003|Overall Study|Withdrawal by Subject|0|||
27839308|NCT02611323|81239633|FG004|Overall Study|Withdrawal by Subject|0|||
27839309|NCT02611323|81239634|FG005|Overall Study|Withdrawal by Subject|0|||
27608874|NCT00669903|80409430|FG002|Overall Study|Adverse Event|3|||
27608875|NCT00669903|80409431|FG003|Overall Study|Adverse Event|1|||
27608876|NCT00669903|80409428|FG000|Overall Study|Withdrawal by Subject|0|||
27608877|NCT00669903|80409429|FG001|Overall Study|Withdrawal by Subject|2|||
27608878|NCT00669903|80409430|FG002|Overall Study|Withdrawal by Subject|2|||
27608879|NCT00669903|80409431|FG003|Overall Study|Withdrawal by Subject|2|||
27608880|NCT00669903|80409428|FG000|Overall Study|Lost to Follow-up|1|||
27608881|NCT00669903|80409429|FG001|Overall Study|Lost to Follow-up|1|||
27839310|NCT02611323|81239635|FG006|Overall Study|Withdrawal by Subject|0|||
27839311|NCT02611323|81239636|FG007|Overall Study|Withdrawal by Subject|1|||
27839312|NCT02611323|81239637|FG008|Overall Study|Withdrawal by Subject|0|||
27608882|NCT00669903|80409430|FG002|Overall Study|Lost to Follow-up|0|||
27608883|NCT00669903|80409431|FG003|Overall Study|Lost to Follow-up|1|||
27608884|NCT00669903|80409428|FG000|Overall Study|Protocol Violation|0|||
27608885|NCT00669903|80409429|FG001|Overall Study|Protocol Violation|1|||
27608886|NCT00669903|80409430|FG002|Overall Study|Protocol Violation|0|||
27608887|NCT00669903|80409431|FG003|Overall Study|Protocol Violation|0|||
27608888|NCT02153359|80409438|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
27608889|NCT02153359|80409439|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
27608890|NCT02960763|80409440|FG000|Step 1|Withdrawal by Subject|10|||
27608891|NCT02960763|80409441|FG001|Step 1|Withdrawal by Subject|8|||
27608892|NCT02960763|80409442|FG002|Step 1|Withdrawal by Subject|13|||
27608893|NCT02960763|80409443|FG003|Step 1|Withdrawal by Subject|0|||
27608894|NCT02960763|80409444|FG004|Step 1|Withdrawal by Subject|0|||
27608895|NCT02960763|80409440|FG000|Step 1|Lost to Follow-up|7|||
27608896|NCT02960763|80409441|FG001|Step 1|Lost to Follow-up|9|||
27608897|NCT02960763|80409442|FG002|Step 1|Lost to Follow-up|12|||
27608898|NCT02960763|80409443|FG003|Step 1|Lost to Follow-up|0|||
27608899|NCT02960763|80409444|FG004|Step 1|Lost to Follow-up|0|||
27608900|NCT02960763|80409440|FG000|Step 1|Death|1|||
27608901|NCT02960763|80409441|FG001|Step 1|Death|1|||
27608902|NCT02960763|80409442|FG002|Step 1|Death|1|||
27608903|NCT02960763|80409443|FG003|Step 1|Death|0|||
27608904|NCT02960763|80409444|FG004|Step 1|Death|0|||
27608905|NCT02960763|80409440|FG000|Step 1|Investigator discretion|1|||
27608906|NCT02960763|80409441|FG001|Step 1|Investigator discretion|0|||
27608907|NCT02960763|80409442|FG002|Step 1|Investigator discretion|1|||
27608908|NCT02960763|80409443|FG003|Step 1|Investigator discretion|0|||
27608909|NCT02960763|80409444|FG004|Step 1|Investigator discretion|0|||
27608910|NCT02960763|80409440|FG000|Step 1|Other|0|||
27839313|NCT02611323|81239638|FG009|Overall Study|Withdrawal by Subject|1|||
27839314|NCT02611323|81239639|FG010|Overall Study|Withdrawal by Subject|0|||
27839315|NCT01023061|81239640|FG000|Overall Study|Withdrawal prior to treatment|2|||
27839316|NCT01970592|81239642|FG000|Overall Study|Withdrawal by Subject|4|||
27839317|NCT01970592|81239642|FG000|Overall Study|Physician Decision|1|||
27608911|NCT02960763|80409441|FG001|Step 1|Other|0|||
27608912|NCT02960763|80409442|FG002|Step 1|Other|1|||
27608913|NCT02960763|80409443|FG003|Step 1|Other|0|||
27608914|NCT02960763|80409444|FG004|Step 1|Other|0|||
27608915|NCT02960763|80409440|FG000|Step 2|Withdrawal by Subject|0|||
27608916|NCT02960763|80409441|FG001|Step 2|Withdrawal by Subject|0|||
27608917|NCT02960763|80409442|FG002|Step 2|Withdrawal by Subject|0|||
27608918|NCT02960763|80409443|FG003|Step 2|Withdrawal by Subject|7|||
27608919|NCT02960763|80409444|FG004|Step 2|Withdrawal by Subject|3|||
27608920|NCT02960763|80409440|FG000|Step 2|Lost to Follow-up|0|||
27608921|NCT02960763|80409441|FG001|Step 2|Lost to Follow-up|0|||
27608922|NCT02960763|80409442|FG002|Step 2|Lost to Follow-up|0|||
27608923|NCT02960763|80409443|FG003|Step 2|Lost to Follow-up|4|||
27608924|NCT02960763|80409444|FG004|Step 2|Lost to Follow-up|1|||
27608925|NCT02960763|80409440|FG000|Step 2|Investigator discretion|0|||
27608926|NCT02960763|80409441|FG001|Step 2|Investigator discretion|0|||
27608927|NCT02960763|80409442|FG002|Step 2|Investigator discretion|0|||
27608928|NCT02960763|80409443|FG003|Step 2|Investigator discretion|0|||
27608929|NCT02960763|80409444|FG004|Step 2|Investigator discretion|1|||
27608930|NCT01965158|80409445|FG000|Overall Study|Adverse Event|14|||
27608931|NCT01965158|80409446|FG001|Overall Study|Adverse Event|5|||
27608932|NCT01965158|80409445|FG000|Overall Study|Withdrawal by Subject|16|||
27608933|NCT01965158|80409446|FG001|Overall Study|Withdrawal by Subject|24|||
27608934|NCT01965158|80409445|FG000|Overall Study|Lost to Follow-up|7|||
27608935|NCT01965158|80409446|FG001|Overall Study|Lost to Follow-up|5|||
27608936|NCT01965158|80409445|FG000|Overall Study|Protocol Violation|1|||
27608937|NCT01965158|80409446|FG001|Overall Study|Protocol Violation|1|||
27839318|NCT01970592|81239642|FG000|Overall Study|Adverse Event|1|||
27608938|NCT01965158|80409445|FG000|Overall Study|Other - Miscellaneous|3|||
27608939|NCT01965158|80409446|FG001|Overall Study|Other - Miscellaneous|0|||
27839319|NCT03942211|81239643|FG000|Overall Study|Death|1|||
27839320|NCT03942211|81239644|FG001|Overall Study|Death|0|||
27608940|NCT04145037|80409447|FG000|Overall Study|Study terminated|2|||
27608941|NCT04145037|80409448|FG001|Overall Study|Study terminated|0|||
27839321|NCT03942211|81239643|FG000|Overall Study|Study terminated by sponsor|5|||
27839322|NCT03942211|81239644|FG001|Overall Study|Study terminated by sponsor|3|||
27608942|NCT04145037|80409447|FG000|Overall Study|Withdrawal by Subject|1|||
27608943|NCT04145037|80409448|FG001|Overall Study|Withdrawal by Subject|0|||
27608944|NCT04145037|80409447|FG000|Overall Study|Lost to Follow-up|1|||
27608945|NCT04145037|80409448|FG001|Overall Study|Lost to Follow-up|0|||
27608946|NCT01576718|80409449|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
27608947|NCT01576718|80409450|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27608948|NCT01576718|80409451|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27608949|NCT01576718|80409452|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27608950|NCT01576718|80409453|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27608951|NCT01576718|80409454|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27608952|NCT01576718|80409455|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
27608953|NCT01576718|80409449|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
27608954|NCT01576718|80409450|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27608955|NCT01576718|80409451|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27608956|NCT01576718|80409452|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27608957|NCT01576718|80409453|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27608958|NCT01576718|80409454|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27608959|NCT01576718|80409455|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
27608960|NCT01576718|80409449|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
27608961|NCT01576718|80409450|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27608962|NCT01576718|80409451|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27608963|NCT01576718|80409452|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27608964|NCT01576718|80409453|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27608965|NCT01576718|80409454|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27608966|NCT01576718|80409455|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
27608967|NCT01576718|80409449|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
27608968|NCT01576718|80409450|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27608969|NCT01576718|80409451|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27608970|NCT01576718|80409452|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27608971|NCT01576718|80409453|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27608972|NCT01576718|80409454|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27608973|NCT01576718|80409455|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
27608974|NCT01576718|80409449|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
27608975|NCT01576718|80409450|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27608976|NCT01576718|80409451|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27608977|NCT01576718|80409452|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27608978|NCT01576718|80409453|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27608979|NCT01576718|80409454|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27608980|NCT01576718|80409455|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
27608981|NCT01576718|80409449|FG000|Treatment Period|Adverse Event|0|||
27890806|NCT00256854|81434171|FG004|Overall Study|Lack of Efficacy|0|||
27608982|NCT01576718|80409450|FG001|Treatment Period|Adverse Event|1|||
27608983|NCT01576718|80409451|FG002|Treatment Period|Adverse Event|1|||
27608984|NCT01576718|80409452|FG003|Treatment Period|Adverse Event|1|||
27608985|NCT01576718|80409453|FG004|Treatment Period|Adverse Event|1|||
27608986|NCT01576718|80409454|FG005|Treatment Period|Adverse Event|1|||
27608987|NCT01576718|80409455|FG006|Treatment Period|Adverse Event|0|||
27608988|NCT01576718|80409449|FG000|Treatment Period|Withdrawal by Subject|0|||
27608989|NCT01576718|80409450|FG001|Treatment Period|Withdrawal by Subject|1|||
27608990|NCT01576718|80409451|FG002|Treatment Period|Withdrawal by Subject|1|||
27608991|NCT01576718|80409452|FG003|Treatment Period|Withdrawal by Subject|0|||
27608992|NCT01576718|80409453|FG004|Treatment Period|Withdrawal by Subject|2|||
27608993|NCT01576718|80409454|FG005|Treatment Period|Withdrawal by Subject|4|||
27608994|NCT01576718|80409455|FG006|Treatment Period|Withdrawal by Subject|2|||
27608995|NCT01576718|80409449|FG000|Treatment Period|Physician Decision|0|||
27608996|NCT01576718|80409450|FG001|Treatment Period|Physician Decision|1|||
27608997|NCT01576718|80409451|FG002|Treatment Period|Physician Decision|1|||
27608998|NCT01576718|80409452|FG003|Treatment Period|Physician Decision|1|||
27608999|NCT01576718|80409453|FG004|Treatment Period|Physician Decision|1|||
27609000|NCT01576718|80409454|FG005|Treatment Period|Physician Decision|0|||
27609001|NCT01576718|80409455|FG006|Treatment Period|Physician Decision|0|||
27609002|NCT01576718|80409449|FG000|Treatment Period|Protocol Violation|0|||
27609003|NCT01576718|80409450|FG001|Treatment Period|Protocol Violation|5|||
27720385|NCT02926950|80806674|FG000|Overall Study|Lost to Follow-up|7|||
27609004|NCT01576718|80409451|FG002|Treatment Period|Protocol Violation|4|||
27609005|NCT01576718|80409452|FG003|Treatment Period|Protocol Violation|10|||
27720386|NCT02926950|80806675|FG001|Overall Study|Lost to Follow-up|8|||
27609006|NCT01576718|80409453|FG004|Treatment Period|Protocol Violation|6|||
27609007|NCT01576718|80409454|FG005|Treatment Period|Protocol Violation|8|||
27609008|NCT01576718|80409455|FG006|Treatment Period|Protocol Violation|12|||
27839323|NCT03942211|81239643|FG000|Overall Study|Adverse Event|0|||
27839324|NCT03942211|81239644|FG001|Overall Study|Adverse Event|1|||
27839325|NCT00651183|81239648|FG000|Overall Study|Lack of Efficacy|1|||
27839326|NCT00651183|81239649|FG001|Overall Study|Lack of Efficacy|0|||
27839327|NCT00651183|81239648|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
27839328|NCT00651183|81239649|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
27839329|NCT00651183|81239648|FG000|Overall Study|Tolerability insufficient|5|||
27839330|NCT00651183|81239649|FG001|Overall Study|Tolerability insufficient|2|||
27839331|NCT00651183|81239648|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
27609009|NCT01576718|80409449|FG000|Treatment Period|Sponsor request|0|||
27609010|NCT01576718|80409450|FG001|Treatment Period|Sponsor request|1|||
27609011|NCT01576718|80409451|FG002|Treatment Period|Sponsor request|0|||
27609012|NCT01576718|80409452|FG003|Treatment Period|Sponsor request|0|||
27609013|NCT01576718|80409453|FG004|Treatment Period|Sponsor request|0|||
27609014|NCT01576718|80409454|FG005|Treatment Period|Sponsor request|1|||
27609015|NCT01576718|80409455|FG006|Treatment Period|Sponsor request|0|||
27609016|NCT01576718|80409449|FG000|Treatment Period|Met stopping criteria|0|||
27609017|NCT01576718|80409450|FG001|Treatment Period|Met stopping criteria|16|||
27609018|NCT01576718|80409451|FG002|Treatment Period|Met stopping criteria|13|||
27609019|NCT01576718|80409452|FG003|Treatment Period|Met stopping criteria|19|||
27609020|NCT01576718|80409453|FG004|Treatment Period|Met stopping criteria|16|||
27609021|NCT01576718|80409454|FG005|Treatment Period|Met stopping criteria|33|||
27609022|NCT01576718|80409455|FG006|Treatment Period|Met stopping criteria|15|||
27609023|NCT01576718|80409449|FG000|Treatment Period|Lost to Follow-up|0|||
27609024|NCT01576718|80409450|FG001|Treatment Period|Lost to Follow-up|0|||
27609025|NCT01576718|80409451|FG002|Treatment Period|Lost to Follow-up|0|||
27609026|NCT01576718|80409452|FG003|Treatment Period|Lost to Follow-up|0|||
27609027|NCT01576718|80409453|FG004|Treatment Period|Lost to Follow-up|1|||
27609028|NCT01576718|80409454|FG005|Treatment Period|Lost to Follow-up|0|||
27609029|NCT01576718|80409455|FG006|Treatment Period|Lost to Follow-up|0|||
27609030|NCT01576718|80409449|FG000|Treatment Period|Noncompliance to study medication|0|||
27609031|NCT01576718|80409450|FG001|Treatment Period|Noncompliance to study medication|0|||
27609032|NCT01576718|80409451|FG002|Treatment Period|Noncompliance to study medication|0|||
27609033|NCT01576718|80409452|FG003|Treatment Period|Noncompliance to study medication|0|||
27609034|NCT01576718|80409453|FG004|Treatment Period|Noncompliance to study medication|0|||
27609035|NCT01576718|80409454|FG005|Treatment Period|Noncompliance to study medication|1|||
27609036|NCT01576718|80409455|FG006|Treatment Period|Noncompliance to study medication|1|||
27839332|NCT00651183|81239649|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
27839333|NCT00651183|81239648|FG000|Overall Study|Withdrawal by Subject|6|||
27839334|NCT00651183|81239649|FG001|Overall Study|Withdrawal by Subject|3|||
27839335|NCT00651183|81239648|FG000|Overall Study|Lost to Follow-up|3|||
27839336|NCT00651183|81239649|FG001|Overall Study|Lost to Follow-up|1|||
27839337|NCT00651183|81239648|FG000|Overall Study|Other reasons|4|||
27839338|NCT00651183|81239649|FG001|Overall Study|Other reasons|2|||
27839339|NCT00651183|81239648|FG000|Overall Study|missing|1|||
27839340|NCT00651183|81239649|FG001|Overall Study|missing|0|||
27839341|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
27839342|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
27839343|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
27609037|NCT00709059|80409456|FG000|Overall Study|Lost to Follow-up|34|||
27720387|NCT03551743|80806676|FG000|Overall Study|Adverse Event|1|||
27839344|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
27839345|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
27890807|NCT00256854|81434172|FG005|Overall Study|Lack of Efficacy|0|||
27890808|NCT00256854|81434167|FG000|Overall Study|Protocol Violation|0|||
27890809|NCT00256854|81434168|FG001|Overall Study|Protocol Violation|1|||
27890810|NCT00256854|81434169|FG002|Overall Study|Protocol Violation|1|||
27890811|NCT00256854|81434170|FG003|Overall Study|Protocol Violation|1|||
27890812|NCT00256854|81434171|FG004|Overall Study|Protocol Violation|0|||
27890813|NCT00256854|81434172|FG005|Overall Study|Protocol Violation|0|||
27890814|NCT00256854|81434167|FG000|Overall Study|Adverse Event|0|||
27890815|NCT00256854|81434168|FG001|Overall Study|Adverse Event|0|||
27890816|NCT00256854|81434169|FG002|Overall Study|Adverse Event|2|||
27839346|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
27839347|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27839348|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27839349|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
27839350|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
27839351|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
27839352|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27839353|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
27839354|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
27839355|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
27839356|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
27839357|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Death|2|||
27890817|NCT00256854|81434170|FG003|Overall Study|Adverse Event|2|||
27890818|NCT00256854|81434171|FG004|Overall Study|Adverse Event|0|||
27890819|NCT00256854|81434172|FG005|Overall Study|Adverse Event|1|||
27890820|NCT00256854|81434167|FG000|Overall Study|Not compliant with the study drug|0|||
27890821|NCT00256854|81434168|FG001|Overall Study|Not compliant with the study drug|0|||
27890822|NCT00256854|81434169|FG002|Overall Study|Not compliant with the study drug|0|||
27890823|NCT00256854|81434170|FG003|Overall Study|Not compliant with the study drug|0|||
27890824|NCT00256854|81434171|FG004|Overall Study|Not compliant with the study drug|1|||
27890825|NCT00256854|81434172|FG005|Overall Study|Not compliant with the study drug|0|||
27890826|NCT05845567|81434173|FG000|Overall Study|Withdrawal by Subject|1|||
27890827|NCT05343364|81434174|FG000|Overall Study|Miscellaneous|0|||
27890828|NCT05343364|81434175|FG001|Overall Study|Miscellaneous|1|||
27890829|NCT02682823|81434183|FG000|Overall Study|Withdrawal by Subject|0|||
27839358|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Death|1|||
27839359|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Death|0|||
27839360|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Death|0|||
27839361|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
27839362|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
27839363|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
27839364|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
27839365|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
27839366|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
27839367|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
27839368|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
27839369|NCT03110380|81239650|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
27839370|NCT03110380|81239651|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
27839371|NCT03110380|81239652|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
27839372|NCT03110380|81239653|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
27890830|NCT02682823|81434184|FG001|Overall Study|Withdrawal by Subject|0|||
27890831|NCT02682823|81434185|FG002|Overall Study|Withdrawal by Subject|1|||
27720388|NCT03551743|80806677|FG001|Overall Study|Adverse Event|0|||
27839373|NCT03110380|81239650|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
27839374|NCT03110380|81239651|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
27890832|NCT02682823|81434186|FG003|Overall Study|Withdrawal by Subject|0|||
27890833|NCT02682823|81434187|FG004|Overall Study|Withdrawal by Subject|1|||
27890834|NCT02682823|81434183|FG000|Overall Study|Protocol Deviation|0|||
27890835|NCT02682823|81434184|FG001|Overall Study|Protocol Deviation|1|||
27720389|NCT03551743|80806678|FG002|Overall Study|Adverse Event|0|||
27720390|NCT03551743|80806679|FG003|Overall Study|Adverse Event|0|||
27720391|NCT03551743|80806676|FG000|Overall Study|Withdrawal by Subject|1|||
27720392|NCT03551743|80806677|FG001|Overall Study|Withdrawal by Subject|0|||
27720393|NCT03551743|80806678|FG002|Overall Study|Withdrawal by Subject|0|||
27720394|NCT03551743|80806679|FG003|Overall Study|Withdrawal by Subject|0|||
27720395|NCT00676715|80806680|FG000|Overall Study|Withdrawal by Subject|7|||
27720396|NCT00676715|80806681|FG001|Overall Study|Withdrawal by Subject|9|||
27720397|NCT00676715|80806682|FG002|Overall Study|Withdrawal by Subject|10|||
27720398|NCT00676715|80806683|FG003|Overall Study|Withdrawal by Subject|10|||
27720399|NCT00676715|80806680|FG000|Overall Study|Other|2|||
27720400|NCT00676715|80806681|FG001|Overall Study|Other|6|||
27720401|NCT00676715|80806682|FG002|Overall Study|Other|4|||
27720402|NCT00676715|80806683|FG003|Overall Study|Other|3|||
27720403|NCT00676715|80806680|FG000|Overall Study|Lost to Follow-up|1|||
27720404|NCT00676715|80806681|FG001|Overall Study|Lost to Follow-up|1|||
27720405|NCT00676715|80806682|FG002|Overall Study|Lost to Follow-up|7|||
27720406|NCT00676715|80806683|FG003|Overall Study|Lost to Follow-up|3|||
27720407|NCT00676715|80806680|FG000|Overall Study|Death|1|||
27720408|NCT00676715|80806681|FG001|Overall Study|Death|1|||
27720409|NCT00676715|80806682|FG002|Overall Study|Death|1|||
27720410|NCT00676715|80806683|FG003|Overall Study|Death|0|||
27720411|NCT00676715|80806680|FG000|Overall Study|Adverse Event|0|||
27720412|NCT00676715|80806681|FG001|Overall Study|Adverse Event|1|||
27720413|NCT00676715|80806682|FG002|Overall Study|Adverse Event|2|||
27720414|NCT00676715|80806683|FG003|Overall Study|Adverse Event|0|||
27720415|NCT00676715|80806680|FG000|Overall Study|Participants Ongoing|29|||
27720416|NCT00676715|80806681|FG001|Overall Study|Participants Ongoing|29|||
27720417|NCT00676715|80806682|FG002|Overall Study|Participants Ongoing|17|||
27720418|NCT00676715|80806683|FG003|Overall Study|Participants Ongoing|24|||
27720419|NCT02275338|80806684|FG000|Overall Study|Adverse Event|15|||
27720420|NCT02275338|80806684|FG000|Overall Study|Lack of Efficacy|3|||
27720421|NCT02275338|80806684|FG000|Overall Study|Withdrawal by Subject|4|||
27720422|NCT02275338|80806684|FG000|Overall Study|Disease progression (death)|1|||
27720423|NCT02275338|80806684|FG000|Overall Study|Ineligible to start Phase 2|4|||
27720424|NCT02275338|80806684|FG000|Overall Study|Reason not specified|5|||
27720425|NCT02275338|80806684|FG000|Overall Study|Does not meet entry criteria|1|||
27720426|NCT01614093|80806685|FG000|Overall Study|Withdrawal by Subject|1|||
27720427|NCT00687362|80806686|FG000|Overall Study|Protocol Violation|2|||
27720428|NCT00687362|80806686|FG000|Overall Study|Withdrawal by Subject|1|||
27720429|NCT00883337|80806689|FG000|Core Treatment Period|Adverse Event|9|||
27720430|NCT00883337|80806690|FG001|Core Treatment Period|Adverse Event|12|||
27720431|NCT00883337|80806691|FG002|Core Treatment Period|Adverse Event|22|||
27720432|NCT00883337|80806689|FG000|Core Treatment Period|Lack of Efficacy|7|||
27720433|NCT00883337|80806690|FG001|Core Treatment Period|Lack of Efficacy|4|||
27720434|NCT00883337|80806691|FG002|Core Treatment Period|Lack of Efficacy|2|||
27720435|NCT00883337|80806689|FG000|Core Treatment Period|Lost to Follow-up|1|||
27720436|NCT00883337|80806690|FG001|Core Treatment Period|Lost to Follow-up|1|||
27720437|NCT00883337|80806691|FG002|Core Treatment Period|Lost to Follow-up|0|||
27720438|NCT00883337|80806689|FG000|Core Treatment Period|Withdrawal by Subject|2|||
27720439|NCT00883337|80806690|FG001|Core Treatment Period|Withdrawal by Subject|2|||
27720440|NCT00883337|80806691|FG002|Core Treatment Period|Withdrawal by Subject|6|||
27720441|NCT00883337|80806689|FG000|Core Treatment Period|Wish to be pregnant|1|||
27720442|NCT00883337|80806690|FG001|Core Treatment Period|Wish to be pregnant|2|||
27720443|NCT00883337|80806691|FG002|Core Treatment Period|Wish to be pregnant|1|||
27720444|NCT00883337|80806689|FG000|Core Treatment Period|Poor compliance to protocol|0|||
27720445|NCT00883337|80806690|FG001|Core Treatment Period|Poor compliance to protocol|0|||
27720446|NCT00883337|80806691|FG002|Core Treatment Period|Poor compliance to protocol|1|||
27720447|NCT00883337|80806689|FG000|Core Treatment Period|Other than above|0|||
27720448|NCT00883337|80806690|FG001|Core Treatment Period|Other than above|1|||
27720449|NCT00883337|80806691|FG002|Core Treatment Period|Other than above|1|||
27720450|NCT00883337|80806689|FG000|Extension Treatment Period|Adverse Event|8|||
27720451|NCT00883337|80806690|FG001|Extension Treatment Period|Adverse Event|5|||
27720452|NCT00883337|80806691|FG002|Extension Treatment Period|Adverse Event|5|||
27720453|NCT00883337|80806689|FG000|Extension Treatment Period|Lack of Efficacy|8|||
27720454|NCT00883337|80806690|FG001|Extension Treatment Period|Lack of Efficacy|8|||
27720455|NCT00883337|80806691|FG002|Extension Treatment Period|Lack of Efficacy|8|||
27720456|NCT00883337|80806689|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
27720457|NCT00883337|80806690|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
27890836|NCT02682823|81434185|FG002|Overall Study|Protocol Deviation|0|||
27720458|NCT00883337|80806691|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
27720459|NCT00883337|80806689|FG000|Extension Treatment Period|Lost to Follow-up|1|||
27720460|NCT00883337|80806690|FG001|Extension Treatment Period|Lost to Follow-up|0|||
27720461|NCT00883337|80806691|FG002|Extension Treatment Period|Lost to Follow-up|0|||
27720462|NCT00883337|80806689|FG000|Extension Treatment Period|Other than above|10|||
27720463|NCT00883337|80806690|FG001|Extension Treatment Period|Other than above|9|||
27720464|NCT00883337|80806691|FG002|Extension Treatment Period|Other than above|5|||
27720465|NCT02792842|80806692|FG000|Overall Study|Adverse Event|4|||
27720466|NCT02792842|80806693|FG001|Overall Study|Adverse Event|2|||
27720467|NCT02792842|80806694|FG002|Overall Study|Adverse Event|3|||
27720468|NCT02792842|80806692|FG000|Overall Study|Withdrawal by Subject|0|||
27720469|NCT02792842|80806693|FG001|Overall Study|Withdrawal by Subject|1|||
27720470|NCT02792842|80806694|FG002|Overall Study|Withdrawal by Subject|2|||
27720471|NCT02792842|80806692|FG000|Overall Study|Lost to Follow-up|0|||
27720472|NCT02792842|80806693|FG001|Overall Study|Lost to Follow-up|0|||
27720473|NCT02792842|80806694|FG002|Overall Study|Lost to Follow-up|1|||
27720474|NCT02792842|80806692|FG000|Overall Study|Schedule delay|0|||
27720475|NCT02792842|80806693|FG001|Overall Study|Schedule delay|1|||
27720476|NCT02792842|80806694|FG002|Overall Study|Schedule delay|1|||
27720477|NCT03175549|80806695|FG000|Overall Study|Lost to Follow-up|2|||
27720478|NCT03175549|80806696|FG001|Overall Study|Lost to Follow-up|2|||
27720479|NCT03175549|80806695|FG000|Overall Study|Medication non-compliance|2|||
27720480|NCT03175549|80806696|FG001|Overall Study|Medication non-compliance|2|||
27720481|NCT02543528|80806700|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27720482|NCT02543528|80806701|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27720483|NCT02543528|80806702|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27720484|NCT02543528|80806703|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
27720485|NCT02543528|80806704|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
27720486|NCT02543528|80806700|FG000|Adaptation Period|Lens Handling Difficultes|0|||
27720487|NCT02543528|80806701|FG001|Adaptation Period|Lens Handling Difficultes|0|||
27720488|NCT02543528|80806702|FG002|Adaptation Period|Lens Handling Difficultes|0|||
27720489|NCT02543528|80806703|FG003|Adaptation Period|Lens Handling Difficultes|0|||
27720490|NCT02543528|80806704|FG004|Adaptation Period|Lens Handling Difficultes|8|||
27720491|NCT02543528|80806700|FG000|Adaptation Period|Lost to Follow-up|0|||
27720492|NCT02543528|80806701|FG001|Adaptation Period|Lost to Follow-up|0|||
27720493|NCT02543528|80806702|FG002|Adaptation Period|Lost to Follow-up|0|||
27720494|NCT02543528|80806703|FG003|Adaptation Period|Lost to Follow-up|0|||
27720495|NCT02543528|80806704|FG004|Adaptation Period|Lost to Follow-up|14|||
27720496|NCT02543528|80806700|FG000|Adaptation Period|Adverse Event|0|||
27720497|NCT02543528|80806701|FG001|Adaptation Period|Adverse Event|0|||
27720498|NCT02543528|80806702|FG002|Adaptation Period|Adverse Event|0|||
27720499|NCT02543528|80806703|FG003|Adaptation Period|Adverse Event|0|||
27720500|NCT02543528|80806704|FG004|Adaptation Period|Adverse Event|2|||
27720501|NCT02543528|80806700|FG000|Extended Wear Period|Adverse Event|17|||
27720502|NCT02543528|80806701|FG001|Extended Wear Period|Adverse Event|11|||
27720503|NCT02543528|80806702|FG002|Extended Wear Period|Adverse Event|16|||
27720504|NCT02543528|80806703|FG003|Extended Wear Period|Adverse Event|3|||
27720505|NCT02543528|80806704|FG004|Extended Wear Period|Adverse Event|0|||
27720506|NCT02543528|80806700|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
27720507|NCT02543528|80806701|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
27720508|NCT02543528|80806702|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
27720509|NCT02543528|80806703|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
27720510|NCT02543528|80806704|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
27720511|NCT02543528|80806700|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
27720512|NCT02543528|80806701|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27720513|NCT02543528|80806702|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27720514|NCT02543528|80806703|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27720515|NCT02543528|80806704|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
27720516|NCT02543528|80806700|FG000|Extended Wear Period|Lost to Follow-up|0|||
27890837|NCT02682823|81434186|FG003|Overall Study|Protocol Deviation|0|||
27720517|NCT02543528|80806701|FG001|Extended Wear Period|Lost to Follow-up|1|||
27720518|NCT02543528|80806702|FG002|Extended Wear Period|Lost to Follow-up|2|||
27720519|NCT02543528|80806703|FG003|Extended Wear Period|Lost to Follow-up|1|||
27720520|NCT02543528|80806704|FG004|Extended Wear Period|Lost to Follow-up|0|||
27720521|NCT02543528|80806700|FG000|Extended Wear Period|Withdrawal by Subject|10|||
27720522|NCT02543528|80806701|FG001|Extended Wear Period|Withdrawal by Subject|9|||
27720523|NCT02543528|80806702|FG002|Extended Wear Period|Withdrawal by Subject|4|||
27720524|NCT02543528|80806703|FG003|Extended Wear Period|Withdrawal by Subject|5|||
27720525|NCT02543528|80806704|FG004|Extended Wear Period|Withdrawal by Subject|0|||
27720526|NCT01445678|80806705|FG000|Overall Study|Adverse Event|12|||
27720527|NCT01445678|80806706|FG001|Overall Study|Adverse Event|8|||
27720528|NCT01445678|80806705|FG000|Overall Study|Lack of Efficacy|0|||
27720529|NCT01445678|80806706|FG001|Overall Study|Lack of Efficacy|2|||
27720530|NCT01445678|80806705|FG000|Overall Study|Lost to Follow-up|8|||
27720531|NCT01445678|80806706|FG001|Overall Study|Lost to Follow-up|5|||
27720532|NCT01445678|80806705|FG000|Overall Study|Protocol Violation|1|||
27720533|NCT01445678|80806706|FG001|Overall Study|Protocol Violation|1|||
27720534|NCT01445678|80806705|FG000|Overall Study|Withdrawal by Subject|9|||
27720535|NCT01445678|80806706|FG001|Overall Study|Withdrawal by Subject|5|||
27720536|NCT01414257|80806709|FG000|Overall Study|No Visit After First Day of Treatment|12|||
27720537|NCT01414257|80806709|FG000|Overall Study|Protocol Violation|10|||
27720538|NCT01182428|80806710|FG000|Overall Study|Physician Decision|1|||
27720539|NCT01182428|80806711|FG001|Overall Study|Physician Decision|0|||
27839375|NCT03110380|81239652|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
27839376|NCT03110380|81239653|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
27839377|NCT03110380|81239650|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
27839378|NCT03110380|81239651|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
27839379|NCT03110380|81239652|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
27839380|NCT03110380|81239653|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
27839381|NCT03110380|81239650|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
27839382|NCT03110380|81239651|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
27839383|NCT03110380|81239652|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
27839384|NCT03110380|81239653|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
27839385|NCT00046839|81239661|FG000|Overall Study|Ineligible / No protocol treatment|0|||
27839386|NCT00046839|81239662|FG001|Overall Study|Ineligible / No protocol treatment|2|||
27839387|NCT00046839|81239661|FG000|Overall Study|Withdrawal of consent|1|||
27839388|NCT00046839|81239662|FG001|Overall Study|Withdrawal of consent|0|||
27839389|NCT04661202|81239665|FG000|Overall Study|Withdrawal by Subject|1|||
27839390|NCT04661202|81239666|FG001|Overall Study|Withdrawal by Subject|1|||
27839391|NCT04661202|81239665|FG000|Overall Study|Lack of Efficacy|2|||
27839392|NCT04661202|81239666|FG001|Overall Study|Lack of Efficacy|0|||
27839393|NCT00856349|81239674|FG000|Overall Study|Death|418|||
27839394|NCT00856349|81239674|FG000|Overall Study|Withdrawal by Subject|116|||
27890838|NCT02682823|81434187|FG004|Overall Study|Protocol Deviation|0|||
27890839|NCT02682823|81434183|FG000|Overall Study|Adverse Event|0|||
27890840|NCT02682823|81434184|FG001|Overall Study|Adverse Event|0|||
27720540|NCT01182428|80806710|FG000|Overall Study|Lost to Follow-up|9|||
27720541|NCT01182428|80806711|FG001|Overall Study|Lost to Follow-up|1|||
27839395|NCT00856349|81239674|FG000|Overall Study|Lost to Follow-up|91|||
27890841|NCT02682823|81434185|FG002|Overall Study|Adverse Event|0|||
27890842|NCT02682823|81434186|FG003|Overall Study|Adverse Event|1|||
27890843|NCT02682823|81434187|FG004|Overall Study|Adverse Event|0|||
27720542|NCT01182428|80806710|FG000|Overall Study|Withdrawal by Subject|1|||
27720543|NCT01182428|80806711|FG001|Overall Study|Withdrawal by Subject|0|||
27720544|NCT00626093|80806712|FG000|Overall Study|Lost to Follow-up|5|||
27720545|NCT00626093|80806712|FG000|Overall Study|Death|1|||
27720546|NCT00626093|80806712|FG000|Overall Study|Physician Decision|4|||
27720547|NCT00626093|80806712|FG000|Overall Study|Withdrawal by Subject|6|||
27720548|NCT00626093|80806712|FG000|Overall Study|Protocol Violation|1|||
27720549|NCT00626093|80806712|FG000|Overall Study|One of the required devices not implante|6|||
27720550|NCT01903837|80810126|FG000|Part A|Withdrawal by Subject|4|||
27720551|NCT01903837|80810127|FG001|Part A|Withdrawal by Subject|9|||
27720552|NCT01903837|80810128|FG002|Part A|Withdrawal by Subject|8|||
27720553|NCT01903837|80810129|FG003|Part A|Withdrawal by Subject|5|||
27720554|NCT01903837|80810126|FG000|Part A|Adverse Event|3|||
27720555|NCT01903837|80810127|FG001|Part A|Adverse Event|6|||
27720556|NCT01903837|80810128|FG002|Part A|Adverse Event|9|||
27720557|NCT01903837|80810129|FG003|Part A|Adverse Event|6|||
27720558|NCT01903837|80810126|FG000|Part A|Lost to Follow-up|9|||
27500402|NCT02358473|80025004|FG000|Overall Study|Disease Progession|6|||
27720559|NCT01903837|80810127|FG001|Part A|Lost to Follow-up|7|||
27720560|NCT01903837|80810128|FG002|Part A|Lost to Follow-up|7|||
27720561|NCT01903837|80810129|FG003|Part A|Lost to Follow-up|2|||
27720562|NCT01903837|80810126|FG000|Part A|Non-compliance with study drug|1|||
27839396|NCT00856349|81239674|FG000|Overall Study|Protocol Violation|38|||
27839397|NCT00856349|81239674|FG000|Overall Study|Physician Decision|13|||
27839398|NCT00856349|81239674|FG000|Overall Study|Subject relocation|104|||
27839399|NCT00856349|81239674|FG000|Overall Study|Device explant|33|||
27839400|NCT00856349|81239674|FG000|Overall Study|Site closure|78|||
27839401|NCT00856349|81239674|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
27839402|NCT03108820|81239686|FG000|Overall Study|Lost to Follow-up|30|||
27839403|NCT03108820|81239687|FG001|Overall Study|Lost to Follow-up|28|||
27839404|NCT03108820|81239686|FG000|Overall Study|Withdrawal by Subject|32|||
27839405|NCT03108820|81239687|FG001|Overall Study|Withdrawal by Subject|24|||
27839406|NCT03108820|81239686|FG000|Overall Study|Death|6|||
27839407|NCT03108820|81239687|FG001|Overall Study|Death|11|||
27839408|NCT01634854|81239688|FG000|Overall Study|Cesarean delivery|2|||
27839409|NCT01634854|81239689|FG001|Overall Study|Cesarean delivery|7|||
27839410|NCT01398787|81239691|FG000|Overall Study|Adverse Event|1|||
27839411|NCT02166606|81239692|FG000|Overall Study|Adverse Event|3|||
27839412|NCT02166606|81239692|FG000|Overall Study|Death|31|||
27839413|NCT02166606|81239692|FG000|Overall Study|Protocol Violation|7|||
27839414|NCT02166606|81239692|FG000|Overall Study|Lost to Follow-up|30|||
27839415|NCT02166606|81239692|FG000|Overall Study|Withdrawal by Subject|1|||
27839416|NCT02166606|81239692|FG000|Overall Study|Physician Decision|1|||
27839417|NCT02166606|81239692|FG000|Overall Study|Device upgrade|1|||
27839418|NCT02166606|81239692|FG000|Overall Study|Enrolled after End of Enrollment|4|||
27839419|NCT02229084|81239695|FG000|Overall Study|Adverse Event|1|||
27839420|NCT02229084|81239696|FG001|Overall Study|Adverse Event|0|||
27839421|NCT02229084|81239697|FG002|Overall Study|Adverse Event|0|||
27839422|NCT02229084|81239698|FG003|Overall Study|Adverse Event|0|||
27839423|NCT02229084|81239699|FG004|Overall Study|Adverse Event|0|||
27839424|NCT02229084|81239700|FG005|Overall Study|Adverse Event|0|||
27839425|NCT02229084|81239701|FG006|Overall Study|Adverse Event|0|||
27839426|NCT02229084|81239695|FG000|Overall Study|Lost to Follow-up|0|||
27839427|NCT02229084|81239696|FG001|Overall Study|Lost to Follow-up|0|||
27839428|NCT02229084|81239697|FG002|Overall Study|Lost to Follow-up|1|||
27839429|NCT02229084|81239698|FG003|Overall Study|Lost to Follow-up|1|||
27839430|NCT02229084|81239699|FG004|Overall Study|Lost to Follow-up|0|||
27839431|NCT02229084|81239700|FG005|Overall Study|Lost to Follow-up|0|||
27839432|NCT02229084|81239701|FG006|Overall Study|Lost to Follow-up|1|||
27839433|NCT02229084|81239695|FG000|Overall Study|Physician Decision|0|||
27720563|NCT01903837|80810127|FG001|Part A|Non-compliance with study drug|4|||
27720564|NCT01903837|80810128|FG002|Part A|Non-compliance with study drug|4|||
27720565|NCT01903837|80810129|FG003|Part A|Non-compliance with study drug|0|||
27720566|NCT01903837|80810126|FG000|Part A|Physician Decision|1|||
27720567|NCT01903837|80810127|FG001|Part A|Physician Decision|1|||
27720568|NCT01903837|80810128|FG002|Part A|Physician Decision|0|||
27720569|NCT01903837|80810129|FG003|Part A|Physician Decision|0|||
27720570|NCT01903837|80810126|FG000|Part A|Protocol Violation|1|||
27720571|NCT01903837|80810127|FG001|Part A|Protocol Violation|1|||
27720572|NCT01903837|80810128|FG002|Part A|Protocol Violation|0|||
27720573|NCT01903837|80810129|FG003|Part A|Protocol Violation|0|||
27720574|NCT01903837|80810126|FG000|Part B|Lost to Follow-up|0|||
27720575|NCT01903837|80810127|FG001|Part B|Lost to Follow-up|3|||
27720576|NCT01903837|80810128|FG002|Part B|Lost to Follow-up|3|||
27720577|NCT01903837|80810129|FG003|Part B|Lost to Follow-up|4|||
27720578|NCT01903837|80810126|FG000|Part B|Withdrawal by Subject|1|||
27720579|NCT01903837|80810127|FG001|Part B|Withdrawal by Subject|2|||
27720580|NCT01903837|80810128|FG002|Part B|Withdrawal by Subject|0|||
27720581|NCT01903837|80810129|FG003|Part B|Withdrawal by Subject|3|||
27720582|NCT01903837|80810126|FG000|Part B|Adverse Event|3|||
27720583|NCT01903837|80810127|FG001|Part B|Adverse Event|0|||
27720584|NCT01903837|80810128|FG002|Part B|Adverse Event|2|||
27720585|NCT01903837|80810129|FG003|Part B|Adverse Event|0|||
27720586|NCT01903837|80810126|FG000|Part B|Non-compliance with study drug|2|||
27720587|NCT01903837|80810127|FG001|Part B|Non-compliance with study drug|0|||
27720588|NCT01903837|80810128|FG002|Part B|Non-compliance with study drug|0|||
27720589|NCT01903837|80810129|FG003|Part B|Non-compliance with study drug|1|||
27720590|NCT01903837|80810126|FG000|Part B|Incarceration|2|||
27720591|NCT01903837|80810127|FG001|Part B|Incarceration|0|||
27720592|NCT01903837|80810128|FG002|Part B|Incarceration|0|||
27720593|NCT01903837|80810129|FG003|Part B|Incarceration|1|||
27720594|NCT01903837|80810126|FG000|Part B|Physician Decision|1|||
27720595|NCT01903837|80810127|FG001|Part B|Physician Decision|0|||
27720596|NCT01903837|80810128|FG002|Part B|Physician Decision|0|||
27720597|NCT01903837|80810129|FG003|Part B|Physician Decision|2|||
27720598|NCT01903837|80810126|FG000|Part B|Lack of Efficacy|0|||
27720599|NCT01903837|80810127|FG001|Part B|Lack of Efficacy|1|||
27720600|NCT01903837|80810128|FG002|Part B|Lack of Efficacy|0|||
27720601|NCT01903837|80810129|FG003|Part B|Lack of Efficacy|0|||
27720602|NCT02362503|80810130|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
27720603|NCT02362503|80810131|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
27720604|NCT02362503|80810132|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
27720605|NCT02362503|80810130|FG000|Double-blind Period-Up to 8 Days|Death|1|||
27720606|NCT02362503|80810131|FG001|Double-blind Period-Up to 8 Days|Death|0|||
27720607|NCT02362503|80810132|FG002|Double-blind Period-Up to 8 Days|Death|0|||
27720608|NCT02362503|80810130|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
27720609|NCT02362503|80810131|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
27720610|NCT02362503|80810132|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
27720611|NCT02362503|80810130|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
27720612|NCT02362503|80810131|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
27720613|NCT02362503|80810132|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
27720614|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
27720615|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
27890844|NCT00068393|81434193|FG000|Overall Study|Adverse Event|2|||
27890845|NCT00068393|81434193|FG000|Overall Study|Death|3|||
27720616|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
27720617|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
27720618|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
27720619|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
27720620|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
27890846|NCT00068393|81434193|FG000|Overall Study|Withdrawal by Subject|3|||
27720621|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
27720622|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
27720623|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
27720624|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
27890847|NCT00068393|81434193|FG000|Overall Study|Alternative treatment|1|||
27609038|NCT00709059|80409456|FG000|Overall Study|Withdrawal by Subject|19|||
27609039|NCT00709059|80409456|FG000|Overall Study|Physician Decision|7|||
27609040|NCT00709059|80409456|FG000|Overall Study|Disease complication|3|||
27609041|NCT00709059|80409456|FG000|Overall Study|Side effects|20|||
27609042|NCT00709059|80409456|FG000|Overall Study|Serious side effects|11|||
27609043|NCT04186403|80409457|FG000|Overall Study|Adverse Event|1|||
27609044|NCT04186403|80409458|FG001|Overall Study|Adverse Event|8|||
27609045|NCT04186403|80409457|FG000|Overall Study|Lost to Follow-up|7|||
27609046|NCT04186403|80409458|FG001|Overall Study|Lost to Follow-up|3|||
27609047|NCT04186403|80409457|FG000|Overall Study|Physician Decision|1|||
27609048|NCT04186403|80409458|FG001|Overall Study|Physician Decision|0|||
27609049|NCT04186403|80409457|FG000|Overall Study|Withdrawal by Subject|7|||
27609050|NCT04186403|80409458|FG001|Overall Study|Withdrawal by Subject|8|||
27609051|NCT04186403|80409457|FG000|Overall Study|Other: Not Related to Covid-19|3|||
27609052|NCT04186403|80409458|FG001|Overall Study|Other: Not Related to Covid-19|0|||
27609053|NCT00171873|80409459|FG000|Overall Study|Withdrawal by Subject|4|||
27609054|NCT00171873|80409460|FG001|Overall Study|Withdrawal by Subject|2|||
27609055|NCT00171873|80409459|FG000|Overall Study|Adverse Event|5|||
27609056|NCT00171873|80409460|FG001|Overall Study|Adverse Event|0|||
27609057|NCT00171873|80409459|FG000|Overall Study|Switched to Octreotide|0|||
27609058|NCT00171873|80409460|FG001|Overall Study|Switched to Octreotide|1|||
27609059|NCT00674323|80409463|FG000|Overall Study|Adverse Event|0|||
27609060|NCT00674323|80409464|FG001|Overall Study|Adverse Event|1|||
27500403|NCT02358473|80025004|FG000|Overall Study|Adverse Event|3|||
27500404|NCT02358473|80025004|FG000|Overall Study|Withdrawal by Subject|2|||
27500405|NCT02358473|80025004|FG000|Overall Study|Physician Decision|2|||
27500406|NCT00129402|80025005|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
27500407|NCT00129402|80025006|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
27500408|NCT00129402|80025007|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
27500409|NCT00129402|80025008|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
27500410|NCT00129402|80025009|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
27500411|NCT00129402|80025010|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
27500412|NCT00129402|80025011|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
27500413|NCT00129402|80025005|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
27500414|NCT00129402|80025006|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
27500415|NCT00129402|80025007|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
27500416|NCT00129402|80025008|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
27500417|NCT00129402|80025009|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
27500418|NCT00129402|80025010|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
27500419|NCT00129402|80025011|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
27500420|NCT00129402|80025005|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
27500421|NCT00129402|80025006|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
27500422|NCT00129402|80025007|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
27500423|NCT00129402|80025008|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
27500424|NCT00129402|80025009|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
27500425|NCT00129402|80025010|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
27500426|NCT00129402|80025011|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
27500427|NCT00129402|80025005|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
27500428|NCT00129402|80025006|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
27500429|NCT00129402|80025007|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
27500430|NCT00129402|80025008|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
27500431|NCT00129402|80025009|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
27500432|NCT00129402|80025010|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
27609061|NCT00674323|80409465|FG002|Overall Study|Adverse Event|0|||
27609062|NCT00674323|80409463|FG000|Overall Study|Protocol Violation|1|||
27609063|NCT00674323|80409464|FG001|Overall Study|Protocol Violation|0|||
27609064|NCT00674323|80409465|FG002|Overall Study|Protocol Violation|0|||
27609065|NCT01462162|80409466|FG000|Overall Study|Adverse Event|5|||
27500433|NCT00129402|80025011|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
27609066|NCT01462162|80409466|FG000|Overall Study|Lack of Efficacy|4|||
27609067|NCT01462162|80409466|FG000|Overall Study|Abnormal laboratory parameters|1|||
27609068|NCT01462162|80409466|FG000|Overall Study|Other|2|||
27720625|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
27720626|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
27720627|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
27720628|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
27720629|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
27720630|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
27720631|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
27720632|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
27720633|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
27720634|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
27720635|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
27720636|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
27720637|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
27720638|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
27720639|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
27839434|NCT02229084|81239696|FG001|Overall Study|Physician Decision|0|||
27839435|NCT02229084|81239697|FG002|Overall Study|Physician Decision|0|||
27500434|NCT00129402|80025005|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
27500435|NCT00129402|80025006|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
27500436|NCT00129402|80025007|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
27500437|NCT00129402|80025008|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
27500438|NCT00129402|80025009|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
27500439|NCT00129402|80025010|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
27500440|NCT00129402|80025011|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
27500441|NCT00129402|80025005|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
27500442|NCT00129402|80025006|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
27500443|NCT00129402|80025007|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
27500444|NCT00129402|80025008|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
27500445|NCT00129402|80025009|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
27500446|NCT00129402|80025010|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
27500447|NCT00129402|80025011|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
27500448|NCT00129402|80025005|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
27500449|NCT00129402|80025006|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
27500450|NCT00129402|80025007|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
27500451|NCT00129402|80025008|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
27500452|NCT00129402|80025009|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
27500453|NCT00129402|80025010|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
27500454|NCT00129402|80025011|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
27609069|NCT00337662|80409467|FG000|Study Period II|Lost to Follow-up|0|||
27609070|NCT00337662|80409468|FG001|Study Period II|Lost to Follow-up|0|||
27839436|NCT02229084|81239698|FG003|Overall Study|Physician Decision|1|||
27839437|NCT02229084|81239699|FG004|Overall Study|Physician Decision|3|||
27839438|NCT02229084|81239700|FG005|Overall Study|Physician Decision|0|||
27720640|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
27839439|NCT02229084|81239701|FG006|Overall Study|Physician Decision|1|||
27839440|NCT02229084|81239695|FG000|Overall Study|Withdrawal by Subject|0|||
27839441|NCT02229084|81239696|FG001|Overall Study|Withdrawal by Subject|0|||
27839442|NCT02229084|81239697|FG002|Overall Study|Withdrawal by Subject|1|||
27839443|NCT02229084|81239698|FG003|Overall Study|Withdrawal by Subject|0|||
27839444|NCT02229084|81239699|FG004|Overall Study|Withdrawal by Subject|1|||
27839445|NCT02229084|81239700|FG005|Overall Study|Withdrawal by Subject|1|||
27839446|NCT02229084|81239701|FG006|Overall Study|Withdrawal by Subject|1|||
27839447|NCT02229084|81239695|FG000|Overall Study|Death|0|||
27839448|NCT02229084|81239696|FG001|Overall Study|Death|0|||
27839449|NCT02229084|81239697|FG002|Overall Study|Death|0|||
27609071|NCT00337662|80409469|FG002|Study Period II|Lost to Follow-up|0|||
27839450|NCT02229084|81239698|FG003|Overall Study|Death|0|||
27839451|NCT02229084|81239699|FG004|Overall Study|Death|0|||
27839452|NCT02229084|81239700|FG005|Overall Study|Death|0|||
27839453|NCT02229084|81239701|FG006|Overall Study|Death|1|||
27839454|NCT00640393|81239702|FG000|Part 1|Lost to Follow-up|2|||
27839455|NCT00640393|81239703|FG001|Part 1|Lost to Follow-up|0|||
27839456|NCT00640393|81239704|FG002|Part 1|Lost to Follow-up|0|||
27839457|NCT00640393|81239702|FG000|Part 1|Withdrawal by Subject|3|||
27839458|NCT00640393|81239703|FG001|Part 1|Withdrawal by Subject|0|||
27839459|NCT00640393|81239704|FG002|Part 1|Withdrawal by Subject|0|||
27839460|NCT00640393|81239702|FG000|Randomization|Withdrawn per protocol|17|||
27839461|NCT00640393|81239703|FG001|Randomization|Withdrawn per protocol|0|||
27839462|NCT00640393|81239704|FG002|Randomization|Withdrawn per protocol|0|||
27839463|NCT00640393|81239702|FG000|Randomization|Never randomized by site|2|||
27839464|NCT00640393|81239703|FG001|Randomization|Never randomized by site|0|||
27839465|NCT00640393|81239704|FG002|Randomization|Never randomized by site|0|||
27839466|NCT00640393|81239702|FG000|Part 2|Lost to Follow-up|0|||
27839467|NCT00640393|81239703|FG001|Part 2|Lost to Follow-up|2|||
27839468|NCT00640393|81239704|FG002|Part 2|Lost to Follow-up|2|||
27839469|NCT00640393|81239702|FG000|Part 2|Withdrawal by Subject|0|||
27839470|NCT00640393|81239703|FG001|Part 2|Withdrawal by Subject|6|||
27839471|NCT00640393|81239704|FG002|Part 2|Withdrawal by Subject|1|||
27839472|NCT00640393|81239702|FG000|Part 2|Non-adherence|0|||
27839473|NCT00640393|81239703|FG001|Part 2|Non-adherence|1|||
27839474|NCT00640393|81239704|FG002|Part 2|Non-adherence|0|||
27839475|NCT00640393|81239702|FG000|Part 2|Adverse Event|0|||
27839476|NCT00640393|81239703|FG001|Part 2|Adverse Event|1|||
27839477|NCT00640393|81239704|FG002|Part 2|Adverse Event|0|||
27839478|NCT01386125|81239707|FG000|Overall Study|Lost to Follow-up|3|||
27839479|NCT01386125|81239708|FG001|Overall Study|Lost to Follow-up|9|||
27839480|NCT01386125|81239707|FG000|Overall Study|Physician Decision|0|||
27839481|NCT01386125|81239708|FG001|Overall Study|Physician Decision|1|||
27839482|NCT01386125|81239707|FG000|Overall Study|Protocol Violation|5|||
27839483|NCT01386125|81239708|FG001|Overall Study|Protocol Violation|7|||
27839484|NCT01386125|81239707|FG000|Overall Study|Disease Progress|1|||
27839485|NCT01386125|81239708|FG001|Overall Study|Disease Progress|2|||
27839486|NCT01386125|81239707|FG000|Overall Study|Withdrawal by Subject|13|||
27839487|NCT01386125|81239708|FG001|Overall Study|Withdrawal by Subject|12|||
27839488|NCT01386125|81239707|FG000|Overall Study|Adverse Event|2|||
27839489|NCT01386125|81239708|FG001|Overall Study|Adverse Event|5|||
27839490|NCT01386125|81239707|FG000|Overall Study|Lack of Efficacy|0|||
27839491|NCT01386125|81239708|FG001|Overall Study|Lack of Efficacy|1|||
27839492|NCT01386125|81239707|FG000|Overall Study|Participant Leaving Country|1|||
27839493|NCT01386125|81239708|FG001|Overall Study|Participant Leaving Country|0|||
27839494|NCT00725764|81239709|FG000|Overall Study|Withdrawal by Subject|2|||
27839495|NCT00725764|81239709|FG000|Overall Study|Physician Decision|1|||
27839496|NCT00725764|81239709|FG000|Overall Study|Progressive Disease|7|||
27839497|NCT00725764|81239709|FG000|Overall Study|Lost to Follow-up|1|||
27839498|NCT00725764|81239709|FG000|Overall Study|Death|1|||
27839499|NCT00725764|81239709|FG000|Overall Study|Participant non compliant with protocol|1|||
27839500|NCT00725764|81239709|FG000|Overall Study|Decline in performance status|1|||
27839501|NCT01203917|81239710|FG000|Overall Study|Death|29|||
27839502|NCT01203917|81239710|FG000|Overall Study|Lost to Follow-up|2|||
27839503|NCT01203917|81239710|FG000|Overall Study|Withdrawal by Subject|3|||
27839504|NCT01203917|81239710|FG000|Overall Study|Due to objective disease progression|1|||
27839505|NCT01203917|81239710|FG000|Overall Study|Due to EGFR M+I patient|1|||
27839506|NCT01004510|81239711|FG000|Overall Study|Adverse Event|1|||
27839507|NCT01181531|81239712|FG000|Overall Study|Other|17|||
27839508|NCT01181531|81239713|FG001|Overall Study|Other|12|||
27839509|NCT01181531|81239712|FG000|Overall Study|Partial consent by subject withdrawn|0|||
27839510|NCT01181531|81239713|FG001|Overall Study|Partial consent by subject withdrawn|1|||
27839511|NCT01181531|81239712|FG000|Overall Study|Physician Decision|3|||
27839512|NCT01181531|81239713|FG001|Overall Study|Physician Decision|1|||
27839513|NCT01181531|81239712|FG000|Overall Study|Noncompliance|2|||
27839514|NCT01181531|81239713|FG001|Overall Study|Noncompliance|2|||
27839515|NCT01181531|81239712|FG000|Overall Study|Ineligibility determined|1|||
27839516|NCT01181531|81239713|FG001|Overall Study|Ineligibility determined|2|||
27839517|NCT01181531|81239712|FG000|Overall Study|Protocol Specified Criteria|15|||
27839518|NCT01181531|81239713|FG001|Overall Study|Protocol Specified Criteria|8|||
27839519|NCT01181531|81239712|FG000|Overall Study|Pregnancy|0|||
27839520|NCT01181531|81239713|FG001|Overall Study|Pregnancy|1|||
27839521|NCT01181531|81239712|FG000|Overall Study|Withdrawal by Subject|8|||
27839522|NCT01181531|81239713|FG001|Overall Study|Withdrawal by Subject|7|||
27839523|NCT01181531|81239712|FG000|Overall Study|Protocol Violation|6|||
27839524|NCT01181531|81239713|FG001|Overall Study|Protocol Violation|6|||
27839525|NCT01181531|81239712|FG000|Overall Study|Death|9|||
27839526|NCT01181531|81239713|FG001|Overall Study|Death|12|||
27839527|NCT01181531|81239712|FG000|Overall Study|Adverse Event|0|||
27839528|NCT01181531|81239713|FG001|Overall Study|Adverse Event|1|||
27839529|NCT01475487|81239717|FG000|Overall Study|had to leave early for personal reasons|2|||
27839530|NCT01475487|81239718|FG001|Overall Study|had to leave early for personal reasons|1|||
27839531|NCT02412722|81239719|FG000|Overall Study|Adverse Event|0|||
27839532|NCT02412722|81239720|FG001|Overall Study|Adverse Event|2|||
27839533|NCT02412722|81239721|FG002|Overall Study|Adverse Event|0|||
27839534|NCT02412722|81239722|FG003|Overall Study|Adverse Event|3|||
27839535|NCT02412722|81239723|FG004|Overall Study|Adverse Event|0|||
27839536|NCT02412722|81239724|FG005|Overall Study|Adverse Event|3|||
27839537|NCT02412722|81239719|FG000|Overall Study|Progressive Disease|6|||
27839538|NCT02412722|81239720|FG001|Overall Study|Progressive Disease|4|||
27839539|NCT02412722|81239721|FG002|Overall Study|Progressive Disease|4|||
27839540|NCT02412722|81239722|FG003|Overall Study|Progressive Disease|9|||
27839541|NCT02412722|81239723|FG004|Overall Study|Progressive Disease|3|||
27839542|NCT02412722|81239724|FG005|Overall Study|Progressive Disease|3|||
27839543|NCT02412722|81239719|FG000|Overall Study|Withdrawal by Subject|2|||
27839544|NCT02412722|81239720|FG001|Overall Study|Withdrawal by Subject|0|||
27839545|NCT02412722|81239721|FG002|Overall Study|Withdrawal by Subject|1|||
27839546|NCT02412722|81239722|FG003|Overall Study|Withdrawal by Subject|2|||
27839547|NCT02412722|81239723|FG004|Overall Study|Withdrawal by Subject|1|||
27839548|NCT02412722|81239724|FG005|Overall Study|Withdrawal by Subject|1|||
27839549|NCT02412722|81239719|FG000|Overall Study|Lost to Follow-up|0|||
27839550|NCT02412722|81239720|FG001|Overall Study|Lost to Follow-up|0|||
27839551|NCT02412722|81239721|FG002|Overall Study|Lost to Follow-up|0|||
27839552|NCT02412722|81239722|FG003|Overall Study|Lost to Follow-up|0|||
27890848|NCT00068393|81434193|FG000|Overall Study|Quality of life worsening|1|||
27890849|NCT03843632|81434194|FG000|Overall Study|Withdrawal by Subject|1|||
27890850|NCT03843632|81434195|FG001|Overall Study|Withdrawal by Subject|0|||
27890851|NCT03843632|81434196|FG002|Overall Study|Withdrawal by Subject|0|||
27890852|NCT03843632|81434197|FG003|Overall Study|Withdrawal by Subject|0|||
27500455|NCT00129402|80025005|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
27500456|NCT00129402|80025006|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
27500457|NCT00129402|80025007|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
27500458|NCT00129402|80025008|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
27839553|NCT02412722|81239723|FG004|Overall Study|Lost to Follow-up|1|||
27890853|NCT02892422|81434198|FG000|Overall Study|Enrolled not treated|4|||
27890854|NCT02892422|81434198|FG000|Overall Study|Adverse Event|38|||
27890855|NCT02892422|81434198|FG000|Overall Study|Lack of Efficacy|32|||
27890856|NCT02892422|81434198|FG000|Overall Study|Non-compliance with study drug|11|||
27890857|NCT02892422|81434198|FG000|Overall Study|Protocol Violation|4|||
27890858|NCT02892422|81434198|FG000|Overall Study|Withdrawal by Subject|56|||
27890859|NCT02892422|81434198|FG000|Overall Study|Lost to Follow-up|5|||
27890860|NCT02892422|81434198|FG000|Overall Study|sponsor information 16159A results|21|||
27890861|NCT02892422|81434198|FG000|Overall Study|withdrawal of consent|13|||
27890862|NCT02892422|81434198|FG000|Overall Study|exclusion criteria met|3|||
27890863|NCT02892422|81434198|FG000|Overall Study|moving elsewhere|4|||
27890864|NCT02892422|81434198|FG000|Overall Study|non-compliance|10|||
27890865|NCT02892422|81434198|FG000|Overall Study|patient legally incapable|1|||
27890866|NCT02892422|81434198|FG000|Overall Study|patient decision|7|||
27839554|NCT02412722|81239724|FG005|Overall Study|Lost to Follow-up|0|||
27839555|NCT02412722|81239719|FG000|Overall Study|Received drug in run-in and discontinued|0|||
27839556|NCT02412722|81239720|FG001|Overall Study|Received drug in run-in and discontinued|2|||
27839557|NCT02412722|81239721|FG002|Overall Study|Received drug in run-in and discontinued|0|||
27839558|NCT02412722|81239722|FG003|Overall Study|Received drug in run-in and discontinued|0|||
27839559|NCT02412722|81239723|FG004|Overall Study|Received drug in run-in and discontinued|0|||
27839560|NCT02412722|81239724|FG005|Overall Study|Received drug in run-in and discontinued|0|||
27839561|NCT02412722|81239719|FG000|Overall Study|Reason not Specified|3|||
27839562|NCT02412722|81239720|FG001|Overall Study|Reason not Specified|0|||
27839563|NCT02412722|81239721|FG002|Overall Study|Reason not Specified|2|||
27839564|NCT02412722|81239722|FG003|Overall Study|Reason not Specified|1|||
27839565|NCT02412722|81239723|FG004|Overall Study|Reason not Specified|2|||
27500459|NCT00129402|80025009|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
27839566|NCT02412722|81239724|FG005|Overall Study|Reason not Specified|6|||
27500460|NCT00129402|80025010|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
27500461|NCT00129402|80025011|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
27609072|NCT00337662|80409470|FG003|Study Period II|Lost to Follow-up|35|||
27609073|NCT00337662|80409467|FG000|Study Period II|Withdrawal by Subject|0|||
27609074|NCT00337662|80409468|FG001|Study Period II|Withdrawal by Subject|0|||
27609075|NCT00337662|80409469|FG002|Study Period II|Withdrawal by Subject|0|||
27609076|NCT00337662|80409470|FG003|Study Period II|Withdrawal by Subject|20|||
27609077|NCT00337662|80409467|FG000|Study Period II|Adverse Event|0|||
27609078|NCT00337662|80409468|FG001|Study Period II|Adverse Event|0|||
27609079|NCT00337662|80409469|FG002|Study Period II|Adverse Event|0|||
27609080|NCT00337662|80409470|FG003|Study Period II|Adverse Event|16|||
27609081|NCT00337662|80409467|FG000|Study Period II|Physician Decision|0|||
27609082|NCT00337662|80409468|FG001|Study Period II|Physician Decision|0|||
27609083|NCT00337662|80409469|FG002|Study Period II|Physician Decision|0|||
27609084|NCT00337662|80409470|FG003|Study Period II|Physician Decision|13|||
27609085|NCT00337662|80409467|FG000|Study Period II|Entry Criteria Not Met|0|||
27609086|NCT00337662|80409468|FG001|Study Period II|Entry Criteria Not Met|0|||
27609087|NCT00337662|80409469|FG002|Study Period II|Entry Criteria Not Met|0|||
27609088|NCT00337662|80409470|FG003|Study Period II|Entry Criteria Not Met|6|||
27609089|NCT00337662|80409467|FG000|Study Period II|Protocol Violation|0|||
27609090|NCT00337662|80409468|FG001|Study Period II|Protocol Violation|0|||
27609091|NCT00337662|80409469|FG002|Study Period II|Protocol Violation|0|||
27609092|NCT00337662|80409470|FG003|Study Period II|Protocol Violation|6|||
27609093|NCT00337662|80409467|FG000|Study Period II|Lack of Efficacy|0|||
27609094|NCT00337662|80409468|FG001|Study Period II|Lack of Efficacy|0|||
27609095|NCT00337662|80409469|FG002|Study Period II|Lack of Efficacy|0|||
27609096|NCT00337662|80409470|FG003|Study Period II|Lack of Efficacy|7|||
27500462|NCT00129402|80025005|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
27500463|NCT00129402|80025006|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
27500464|NCT00129402|80025007|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
27500465|NCT00129402|80025008|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
27609097|NCT00337662|80409467|FG000|Study Period II|Sponsor Decision|0|||
27609098|NCT00337662|80409468|FG001|Study Period II|Sponsor Decision|0|||
27609099|NCT00337662|80409469|FG002|Study Period II|Sponsor Decision|0|||
27609100|NCT00337662|80409470|FG003|Study Period II|Sponsor Decision|2|||
27609101|NCT00337662|80409467|FG000|Study Period II|Parent/Caregiver Decision|0|||
27609102|NCT00337662|80409468|FG001|Study Period II|Parent/Caregiver Decision|0|||
27609103|NCT00337662|80409469|FG002|Study Period II|Parent/Caregiver Decision|0|||
27609104|NCT00337662|80409470|FG003|Study Period II|Parent/Caregiver Decision|1|||
27609105|NCT00337662|80409467|FG000|Study Period III|Lost to Follow-up|14|||
27609106|NCT00337662|80409468|FG001|Study Period III|Lost to Follow-up|16|||
27609107|NCT00337662|80409469|FG002|Study Period III|Lost to Follow-up|14|||
27609108|NCT00337662|80409470|FG003|Study Period III|Lost to Follow-up|0|||
27609109|NCT00337662|80409467|FG000|Study Period III|Withdrawal by Subject|18|||
27609110|NCT00337662|80409468|FG001|Study Period III|Withdrawal by Subject|14|||
27609111|NCT00337662|80409469|FG002|Study Period III|Withdrawal by Subject|12|||
27609112|NCT00337662|80409470|FG003|Study Period III|Withdrawal by Subject|0|||
27609113|NCT00337662|80409467|FG000|Study Period III|Adverse Event|9|||
27609114|NCT00337662|80409468|FG001|Study Period III|Adverse Event|10|||
27609115|NCT00337662|80409469|FG002|Study Period III|Adverse Event|8|||
27609116|NCT00337662|80409470|FG003|Study Period III|Adverse Event|0|||
27609117|NCT00337662|80409467|FG000|Study Period III|Protocol Violation|3|||
27609118|NCT00337662|80409468|FG001|Study Period III|Protocol Violation|8|||
27609119|NCT00337662|80409469|FG002|Study Period III|Protocol Violation|2|||
27609120|NCT00337662|80409470|FG003|Study Period III|Protocol Violation|0|||
27609121|NCT00337662|80409467|FG000|Study Period III|Physician Decision|6|||
27609122|NCT00337662|80409468|FG001|Study Period III|Physician Decision|5|||
27609123|NCT00337662|80409469|FG002|Study Period III|Physician Decision|0|||
27609124|NCT00337662|80409470|FG003|Study Period III|Physician Decision|0|||
27609125|NCT00337662|80409467|FG000|Study Period III|Entry Criteria Not Met|4|||
27609126|NCT00337662|80409468|FG001|Study Period III|Entry Criteria Not Met|1|||
27609127|NCT00337662|80409469|FG002|Study Period III|Entry Criteria Not Met|3|||
27609128|NCT00337662|80409470|FG003|Study Period III|Entry Criteria Not Met|0|||
27839567|NCT02786927|81239726|FG000|Overall Study|Adverse Event|1|||
27609129|NCT00337662|80409467|FG000|Study Period III|Lack of Efficacy|4|||
27839568|NCT02786927|81239726|FG000|Overall Study|Protocol Violation|4|||
27609130|NCT00337662|80409468|FG001|Study Period III|Lack of Efficacy|4|||
27609131|NCT00337662|80409469|FG002|Study Period III|Lack of Efficacy|2|||
27609132|NCT00337662|80409470|FG003|Study Period III|Lack of Efficacy|0|||
27609133|NCT00337662|80409467|FG000|Study Period III|Parent/Caregiver Decision|0|||
27839569|NCT01055834|81239732|FG000|Treatment Period I|Adverse Event|1|||
27839570|NCT01055834|81239733|FG001|Treatment Period I|Adverse Event|0|||
27609134|NCT00337662|80409468|FG001|Study Period III|Parent/Caregiver Decision|0|||
27609135|NCT00337662|80409469|FG002|Study Period III|Parent/Caregiver Decision|2|||
27609136|NCT00337662|80409470|FG003|Study Period III|Parent/Caregiver Decision|0|||
27609137|NCT00337662|80409467|FG000|Study Period III|Sponsor Decision|1|||
27609138|NCT00337662|80409468|FG001|Study Period III|Sponsor Decision|0|||
27609139|NCT00337662|80409469|FG002|Study Period III|Sponsor Decision|1|||
27609140|NCT00337662|80409470|FG003|Study Period III|Sponsor Decision|0|||
27609141|NCT00337662|80409467|FG000|Study Period III|Clinical Relapse|1|||
27609142|NCT00337662|80409468|FG001|Study Period III|Clinical Relapse|0|||
27609143|NCT00337662|80409469|FG002|Study Period III|Clinical Relapse|0|||
27500466|NCT00129402|80025009|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
27500467|NCT00129402|80025010|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
27500468|NCT00129402|80025011|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
27500469|NCT00129402|80025005|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
27500470|NCT00129402|80025006|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
27609144|NCT00337662|80409470|FG003|Study Period III|Clinical Relapse|0|||
27609145|NCT01381874|80409471|FG000|Overall Study|Lost to Follow-up|1|||
27609146|NCT01381874|80409472|FG001|Overall Study|Lost to Follow-up|1|||
27609147|NCT01381874|80409473|FG002|Overall Study|Lost to Follow-up|0|||
27609148|NCT01381874|80409471|FG000|Overall Study|Withdrawal by Subject|9|||
27609149|NCT01381874|80409472|FG001|Overall Study|Withdrawal by Subject|10|||
27609150|NCT01381874|80409473|FG002|Overall Study|Withdrawal by Subject|9|||
27609151|NCT01381874|80409471|FG000|Overall Study|Other|67|||
27609152|NCT01381874|80409472|FG001|Overall Study|Other|52|||
27609153|NCT01381874|80409473|FG002|Overall Study|Other|67|||
27609154|NCT01893827|80409476|FG000|Overall Study|Lost to Follow-up|19|||
27609155|NCT01893827|80409477|FG001|Overall Study|Lost to Follow-up|26|||
27890867|NCT02892422|81434198|FG000|Overall Study|Investigator decision|1|||
27500471|NCT00129402|80025007|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
27500472|NCT00129402|80025008|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
27500473|NCT00129402|80025009|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
27500474|NCT00129402|80025010|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
27500475|NCT00129402|80025011|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
27500476|NCT00129402|80025005|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
27500477|NCT00129402|80025006|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
27500478|NCT00129402|80025007|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
27500479|NCT00129402|80025008|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
27500480|NCT00129402|80025009|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
27500481|NCT00129402|80025010|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
27500482|NCT00129402|80025011|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
27500483|NCT00129402|80025005|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
27500484|NCT00129402|80025006|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
27500485|NCT00129402|80025007|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
27500486|NCT00129402|80025008|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
27609156|NCT00482274|80409479|FG000|Overall Study|Adverse Event|1|||
27609157|NCT04035200|80409480|FG000|Overall Study|Lost to Follow-up|0|||
27609158|NCT04035200|80409481|FG001|Overall Study|Lost to Follow-up|1|||
27609159|NCT04035200|80409482|FG002|Overall Study|Lost to Follow-up|0|||
27609160|NCT04035200|80409480|FG000|Overall Study|Withdrawal by Subject|1|||
27609161|NCT04035200|80409481|FG001|Overall Study|Withdrawal by Subject|4|||
27500487|NCT00129402|80025009|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
27500488|NCT00129402|80025010|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
27500489|NCT00129402|80025011|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
27500490|NCT00129402|80025005|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
27500491|NCT00129402|80025006|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
27500492|NCT00129402|80025007|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
27500493|NCT00129402|80025008|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
27500494|NCT00129402|80025009|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
27500495|NCT00129402|80025010|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
27500496|NCT00129402|80025011|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
27500497|NCT02647281|80025016|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500498|NCT02647281|80025017|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500499|NCT02647281|80025018|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500500|NCT02647281|80025019|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27609162|NCT04035200|80409482|FG002|Overall Study|Withdrawal by Subject|4|||
27609163|NCT04035200|80409480|FG000|Overall Study|COVID-19|1|||
27609164|NCT04035200|80409481|FG001|Overall Study|COVID-19|0|||
27609165|NCT04035200|80409482|FG002|Overall Study|COVID-19|0|||
27609166|NCT04035200|80409480|FG000|Overall Study|Early Termination|0|||
27609167|NCT04035200|80409481|FG001|Overall Study|Early Termination|1|||
27609168|NCT04035200|80409482|FG002|Overall Study|Early Termination|0|||
27609169|NCT04035200|80409480|FG000|Overall Study|Non-compliance|0|||
27609170|NCT04035200|80409481|FG001|Overall Study|Non-compliance|1|||
27609171|NCT04035200|80409482|FG002|Overall Study|Non-compliance|0|||
27609172|NCT00284141|80409483|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
27609173|NCT00284141|80409483|FG000|Overall Study|Adverse Event|19|||
27609174|NCT00284141|80409483|FG000|Overall Study|Participant's request|9|||
27609175|NCT00284141|80409483|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
27609176|NCT00284141|80409483|FG000|Overall Study|Clinical deterioration / death|2|||
27609177|NCT00284141|80409483|FG000|Overall Study|General decline|1|||
27609178|NCT00284141|80409483|FG000|Overall Study|Pneumonia|1|||
27609179|NCT00284141|80409483|FG000|Overall Study|Did not take study medication|2|||
27609180|NCT00284141|80409483|FG000|Overall Study|Ongoing treatment|2|||
27609181|NCT01090310|80409484|FG000|Core Study|Adverse Event|2|||
27609182|NCT01090310|80409485|FG001|Core Study|Adverse Event|2|||
27609183|NCT01090310|80409486|FG002|Core Study|Adverse Event|1|||
27609184|NCT01090310|80409487|FG003|Core Study|Adverse Event|1|||
27609185|NCT01090310|80409484|FG000|Core Study|Subject withdrew consent|0|||
27609186|NCT01090310|80409485|FG001|Core Study|Subject withdrew consent|3|||
27609187|NCT01090310|80409486|FG002|Core Study|Subject withdrew consent|1|||
27609188|NCT01090310|80409487|FG003|Core Study|Subject withdrew consent|1|||
27609189|NCT01090310|80409484|FG000|Core Study|Abnormal test procedure result|0|||
27609190|NCT01090310|80409485|FG001|Core Study|Abnormal test procedure result|0|||
27609191|NCT01090310|80409486|FG002|Core Study|Abnormal test procedure result|1|||
27609192|NCT01090310|80409487|FG003|Core Study|Abnormal test procedure result|0|||
27609193|NCT01090310|80409484|FG000|Core Study|Administrative reasons|5|||
27609194|NCT01090310|80409485|FG001|Core Study|Administrative reasons|6|||
27609195|NCT01090310|80409486|FG002|Core Study|Administrative reasons|4|||
27500501|NCT02647281|80025020|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500502|NCT02647281|80025021|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500503|NCT02647281|80025022|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500504|NCT02647281|80025023|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
27500505|NCT02647281|80025024|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
27609196|NCT01090310|80409487|FG003|Core Study|Administrative reasons|4|||
27609197|NCT01090310|80409484|FG000|Core Study|Protocol deviation|1|||
27609198|NCT01090310|80409485|FG001|Core Study|Protocol deviation|0|||
27609199|NCT01090310|80409486|FG002|Core Study|Protocol deviation|0|||
27609200|NCT01090310|80409487|FG003|Core Study|Protocol deviation|1|||
27609201|NCT01090310|80409484|FG000|Extension Study|Aministrative problems|13|||
27609202|NCT01090310|80409485|FG001|Extension Study|Aministrative problems|15|||
27609203|NCT01090310|80409486|FG002|Extension Study|Aministrative problems|14|||
27609204|NCT01090310|80409487|FG003|Extension Study|Aministrative problems|18|||
27609205|NCT01090310|80409484|FG000|Extension Study|Adverse Event|0|||
27609206|NCT01090310|80409485|FG001|Extension Study|Adverse Event|0|||
27609207|NCT01090310|80409486|FG002|Extension Study|Adverse Event|0|||
27609208|NCT01090310|80409487|FG003|Extension Study|Adverse Event|1|||
27609209|NCT01090310|80409484|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
27609210|NCT01090310|80409485|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
27609211|NCT01090310|80409486|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
27609212|NCT01090310|80409487|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
27609213|NCT01090310|80409484|FG000|Extension Study|Subject withdrew consent|0|||
27609214|NCT01090310|80409485|FG001|Extension Study|Subject withdrew consent|1|||
27609215|NCT01090310|80409486|FG002|Extension Study|Subject withdrew consent|0|||
27839571|NCT01120899|81242405|FG000|Overall Study|Withdrawal by Subject|3|||
27839572|NCT03168906|81242413|FG000|Overall Study|Lack of Efficacy|6|||
27839573|NCT03168906|81242414|FG001|Overall Study|Lack of Efficacy|6|||
27890868|NCT01190267|81434199|FG000|Overall Study|Adverse Event|10|||
27609216|NCT01090310|80409487|FG003|Extension Study|Subject withdrew consent|0|||
27609217|NCT03485911|80409488|FG000|Part 1|Perceived lack of efficacy|1|||
27609218|NCT03485911|80409489|FG001|Part 1|Perceived lack of efficacy|1|||
27609219|NCT03485911|80409490|FG002|Part 1|Perceived lack of efficacy|2|||
27609220|NCT03485911|80409491|FG003|Part 1|Perceived lack of efficacy|0|||
27609221|NCT03485911|80409488|FG000|Part 1|Subject withdrew consent|0|||
27609222|NCT03485911|80409489|FG001|Part 1|Subject withdrew consent|1|||
27609223|NCT03485911|80409490|FG002|Part 1|Subject withdrew consent|0|||
27609224|NCT03485911|80409491|FG003|Part 1|Subject withdrew consent|1|||
27609225|NCT03485911|80409488|FG000|Part 1|Lab abnormalities/AEs|3|||
27609226|NCT03485911|80409489|FG001|Part 1|Lab abnormalities/AEs|1|||
27609227|NCT03485911|80409490|FG002|Part 1|Lab abnormalities/AEs|1|||
27609228|NCT03485911|80409491|FG003|Part 1|Lab abnormalities/AEs|0|||
27609229|NCT03485911|80409488|FG000|Part 1|Withdrew Consent prior to dosing|0|||
27609230|NCT03485911|80409489|FG001|Part 1|Withdrew Consent prior to dosing|0|||
27839574|NCT04660032|81242415|FG000|Overall Study|Protocol Violation|1|||
27839575|NCT04660032|81242416|FG001|Overall Study|Protocol Violation|1|||
27839576|NCT00685750|81242419|FG000|Overall Study|Tumor sampling failure|0|||
27839577|NCT00685750|81242420|FG001|Overall Study|Tumor sampling failure|0|||
27839578|NCT00685750|81242421|FG002|Overall Study|Tumor sampling failure|1|||
27839579|NCT00685750|81242422|FG003|Overall Study|Tumor sampling failure|0|||
27839580|NCT00685750|81242423|FG004|Overall Study|Tumor sampling failure|0|||
27839581|NCT00685750|81242424|FG005|Overall Study|Tumor sampling failure|0|||
27839582|NCT00685750|81242425|FG006|Overall Study|Tumor sampling failure|0|||
27839583|NCT00685750|81242419|FG000|Overall Study|Patient didn't receive the treatment|0|||
27839584|NCT00685750|81242420|FG001|Overall Study|Patient didn't receive the treatment|0|||
27890869|NCT01190267|81434200|FG001|Overall Study|Adverse Event|0|||
27890870|NCT01190267|81434199|FG000|Overall Study|Treatment Failure|8|||
27890871|NCT01190267|81434200|FG001|Overall Study|Treatment Failure|2|||
27890872|NCT01190267|81434199|FG000|Overall Study|Lost to Follow-up|2|||
27890873|NCT01190267|81434200|FG001|Overall Study|Lost to Follow-up|0|||
27890874|NCT01190267|81434199|FG000|Overall Study|Withdrawal by Subject|13|||
27890875|NCT01190267|81434200|FG001|Overall Study|Withdrawal by Subject|1|||
27890876|NCT01190267|81434199|FG000|Overall Study|Protocol Violation|8|||
27890877|NCT01190267|81434200|FG001|Overall Study|Protocol Violation|1|||
27890878|NCT03030989|81434203|FG000|Overall Study|Fever|2|||
27890879|NCT03030989|81434204|FG001|Overall Study|Fever|2|||
27890880|NCT03030989|81434203|FG000|Overall Study|Rash|2|||
27890881|NCT03030989|81434204|FG001|Overall Study|Rash|1|||
27890882|NCT03030989|81434203|FG000|Overall Study|Fatigue/Overwhelmed|1|||
27890883|NCT03030989|81434204|FG001|Overall Study|Fatigue/Overwhelmed|5|||
27890884|NCT03030989|81434203|FG000|Overall Study|Positive Blood Cultures|2|||
27609231|NCT03485911|80409490|FG002|Part 1|Withdrew Consent prior to dosing|0|||
27609232|NCT03485911|80409491|FG003|Part 1|Withdrew Consent prior to dosing|1|||
27609233|NCT03485911|80409488|FG000|Part 1|Other NOS|0|||
27609234|NCT03485911|80409489|FG001|Part 1|Other NOS|0|||
27609235|NCT03485911|80409490|FG002|Part 1|Other NOS|0|||
27609236|NCT03485911|80409491|FG003|Part 1|Other NOS|1|||
27839585|NCT00685750|81242421|FG002|Overall Study|Patient didn't receive the treatment|0|||
27890885|NCT03030989|81434204|FG001|Overall Study|Positive Blood Cultures|1|||
27890886|NCT03030989|81434203|FG000|Overall Study|Line Removed|0|||
27890887|NCT03030989|81434204|FG001|Overall Study|Line Removed|2|||
27890888|NCT03030989|81434203|FG000|Overall Study|No longer interested|5|||
27890889|NCT03030989|81434204|FG001|Overall Study|No longer interested|3|||
27890890|NCT00537316|81434205|FG000|Part 1|Adverse Event|7|||
27890891|NCT00537316|81434206|FG001|Part 1|Adverse Event|11|||
27890892|NCT00537316|81434207|FG002|Part 1|Adverse Event|8|||
27890893|NCT00537316|81434208|FG003|Part 1|Adverse Event|0|||
27890894|NCT00537316|81434209|FG004|Part 1|Adverse Event|0|||
27609237|NCT03485911|80409488|FG000|Part 2|Perceived lack of efficacy|5|||
27609238|NCT03485911|80409489|FG001|Part 2|Perceived lack of efficacy|3|||
27839586|NCT00685750|81242422|FG003|Overall Study|Patient didn't receive the treatment|0|||
27890895|NCT00537316|81434210|FG005|Part 1|Adverse Event|0|||
27890896|NCT00537316|81434211|FG006|Part 1|Adverse Event|0|||
27890897|NCT00537316|81434205|FG000|Part 1|Protocol defined clinical event|1|||
27609239|NCT03485911|80409490|FG002|Part 2|Perceived lack of efficacy|0|||
27609240|NCT03485911|80409491|FG003|Part 2|Perceived lack of efficacy|2|||
27609241|NCT03485911|80409488|FG000|Part 2|Subject withdrew consent|1|||
27609242|NCT03485911|80409489|FG001|Part 2|Subject withdrew consent|0|||
27609243|NCT03485911|80409490|FG002|Part 2|Subject withdrew consent|2|||
27609244|NCT03485911|80409491|FG003|Part 2|Subject withdrew consent|1|||
27609245|NCT03485911|80409488|FG000|Part 2|Lab abnormalities/AEs|1|||
27609246|NCT03485911|80409489|FG001|Part 2|Lab abnormalities/AEs|2|||
27609247|NCT03485911|80409490|FG002|Part 2|Lab abnormalities/AEs|0|||
27609248|NCT03485911|80409491|FG003|Part 2|Lab abnormalities/AEs|0|||
27609249|NCT03485911|80409488|FG000|Part 2|Other NOS|0|||
27609250|NCT03485911|80409489|FG001|Part 2|Other NOS|1|||
27609251|NCT03485911|80409490|FG002|Part 2|Other NOS|0|||
27609252|NCT03485911|80409491|FG003|Part 2|Other NOS|0|||
27609253|NCT03485911|80409488|FG000|Part 2|Intercurrent illness/new medical condition|1|||
27609254|NCT03485911|80409489|FG001|Part 2|Intercurrent illness/new medical condition|0|||
27609255|NCT03485911|80409490|FG002|Part 2|Intercurrent illness/new medical condition|0|||
27609256|NCT03485911|80409491|FG003|Part 2|Intercurrent illness/new medical condition|0|||
27609257|NCT03485911|80409488|FG000|Part 2|Investigator judgement|1|||
27609258|NCT03485911|80409489|FG001|Part 2|Investigator judgement|0|||
27609259|NCT03485911|80409490|FG002|Part 2|Investigator judgement|0|||
27609260|NCT03485911|80409491|FG003|Part 2|Investigator judgement|0|||
27609261|NCT03485911|80409488|FG000|Part 3|Perceived lack of efficacy|2|||
27609262|NCT03485911|80409489|FG001|Part 3|Perceived lack of efficacy|2|||
27609263|NCT03485911|80409490|FG002|Part 3|Perceived lack of efficacy|2|||
27609264|NCT03485911|80409491|FG003|Part 3|Perceived lack of efficacy|0|||
27609265|NCT03485911|80409488|FG000|Part 3|Subject withdrew consent|1|||
27609266|NCT03485911|80409489|FG001|Part 3|Subject withdrew consent|4|||
27609267|NCT03485911|80409490|FG002|Part 3|Subject withdrew consent|0|||
27609268|NCT03485911|80409491|FG003|Part 3|Subject withdrew consent|1|||
27609269|NCT03485911|80409488|FG000|Part 3|Lab abnormalities/AEs|1|||
27609270|NCT03485911|80409489|FG001|Part 3|Lab abnormalities/AEs|1|||
27609271|NCT03485911|80409490|FG002|Part 3|Lab abnormalities/AEs|0|||
27609272|NCT03485911|80409491|FG003|Part 3|Lab abnormalities/AEs|2|||
27609273|NCT03485911|80409488|FG000|Part 3|Other NOS|1|||
27609274|NCT03485911|80409489|FG001|Part 3|Other NOS|1|||
27609275|NCT03485911|80409490|FG002|Part 3|Other NOS|0|||
27609276|NCT03485911|80409491|FG003|Part 3|Other NOS|0|||
27609277|NCT03485911|80409488|FG000|Part 3|Intercurrent illness/new medical condition|0|||
27609278|NCT03485911|80409489|FG001|Part 3|Intercurrent illness/new medical condition|1|||
27609279|NCT03485911|80409490|FG002|Part 3|Intercurrent illness/new medical condition|1|||
27609280|NCT03485911|80409491|FG003|Part 3|Intercurrent illness/new medical condition|0|||
27609281|NCT03485911|80409488|FG000|Part 3|Sponsor discontinuation|1|||
27609282|NCT03485911|80409489|FG001|Part 3|Sponsor discontinuation|0|||
27609283|NCT03485911|80409490|FG002|Part 3|Sponsor discontinuation|0|||
27609284|NCT03485911|80409491|FG003|Part 3|Sponsor discontinuation|0|||
27609285|NCT03485911|80409488|FG000|Part 3|Berotralstat provided by alternative means|13|||
27609286|NCT03485911|80409489|FG001|Part 3|Berotralstat provided by alternative means|13|||
27609287|NCT03485911|80409490|FG002|Part 3|Berotralstat provided by alternative means|7|||
27609288|NCT03485911|80409491|FG003|Part 3|Berotralstat provided by alternative means|7|||
27609289|NCT01735396|80409492|FG000|Overall Study|not evaluable|1|||
27609290|NCT01350141|80412538|FG000|Overall Study|Lost to Follow-up|1|||
27609291|NCT01350141|80412539|FG001|Overall Study|Lost to Follow-up|0|||
27609292|NCT01350141|80412540|FG002|Overall Study|Lost to Follow-up|1|||
27609293|NCT01350141|80412538|FG000|Overall Study|Withdrawal by Subject|1|||
27609294|NCT01350141|80412539|FG001|Overall Study|Withdrawal by Subject|0|||
27890898|NCT00537316|81434206|FG001|Part 1|Protocol defined clinical event|0|||
27890899|NCT00537316|81434207|FG002|Part 1|Protocol defined clinical event|0|||
27890900|NCT00537316|81434208|FG003|Part 1|Protocol defined clinical event|0|||
27890901|NCT00537316|81434209|FG004|Part 1|Protocol defined clinical event|0|||
27890902|NCT00537316|81434210|FG005|Part 1|Protocol defined clinical event|0|||
27609295|NCT01350141|80412540|FG002|Overall Study|Withdrawal by Subject|0|||
27609296|NCT01350141|80412538|FG000|Overall Study|Randomized but not treated|1|||
27609297|NCT01350141|80412539|FG001|Overall Study|Randomized but not treated|0|||
27609298|NCT01350141|80412540|FG002|Overall Study|Randomized but not treated|0|||
27609299|NCT01616771|80412543|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
27609300|NCT02712398|80412544|FG000|Overall Study|Withdrawal by Subject|6|||
27609301|NCT02712398|80412544|FG000|Overall Study|Lost to Follow-up|6|||
27609302|NCT02712398|80412544|FG000|Overall Study|Sponsor Decision|1|||
27890903|NCT00537316|81434211|FG006|Part 1|Protocol defined clinical event|0|||
27890904|NCT00537316|81434205|FG000|Part 1|Lost to Follow-up|1|||
27609303|NCT02712398|80412544|FG000|Overall Study|Physician Decision|1|||
27609304|NCT02712398|80412544|FG000|Overall Study|Death|2|||
27609305|NCT02712398|80412544|FG000|Overall Study|Re-operation|21|||
27609306|NCT01103960|80412545|FG000|Overall Study|Adverse Event|2|||
27609307|NCT01103960|80412546|FG001|Overall Study|Adverse Event|1|||
27609308|NCT01103960|80412545|FG000|Overall Study|Withdrawal by Subject|2|||
27609309|NCT01103960|80412546|FG001|Overall Study|Withdrawal by Subject|1|||
27609310|NCT01103960|80412545|FG000|Overall Study|Other|1|||
27609311|NCT01103960|80412546|FG001|Overall Study|Other|0|||
27609312|NCT01306201|80412547|FG000|Overall Study|Arrhythmia|4|||
27609313|NCT01306201|80412547|FG000|Overall Study|Files could not be processed|3|||
27609314|NCT01306201|80412547|FG000|Overall Study|Files unreadable|3|||
27609315|NCT01821898|80412548|FG000|Overall Study|Withdrawal by Subject|2|||
27609316|NCT01821898|80412549|FG001|Overall Study|Withdrawal by Subject|1|||
27609317|NCT01216163|80412554|FG000|Overall Study|Withdrawal by Subject|1|||
27839587|NCT00685750|81242423|FG004|Overall Study|Patient didn't receive the treatment|0|||
27839588|NCT00685750|81242424|FG005|Overall Study|Patient didn't receive the treatment|0|||
27839589|NCT00685750|81242425|FG006|Overall Study|Patient didn't receive the treatment|1|||
27839590|NCT00685750|81242419|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27839591|NCT00685750|81242420|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27609318|NCT01216163|80412555|FG001|Overall Study|Withdrawal by Subject|1|||
27609319|NCT01216163|80412556|FG002|Overall Study|Withdrawal by Subject|0|||
27609320|NCT02357810|80412557|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
27609321|NCT02357810|80412557|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
27839592|NCT00685750|81242421|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27609322|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Adverse Event|5|||
27609323|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
27609324|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
27609325|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
27609326|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Death|1|||
27609327|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Physician Decision|1|||
27609328|NCT02357810|80412557|FG000|Reached 12 Weeks Response|Other|1|||
27609329|NCT02357810|80412557|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
27609330|NCT02357810|80412557|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
27609331|NCT02357810|80412557|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
27609332|NCT02357810|80412557|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
27609333|NCT02357810|80412557|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
27609334|NCT02357810|80412557|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
27609335|NCT00803101|80412558|FG000|Overall Study|Death / Serious Adverse Event|4|||
27609336|NCT00803101|80412559|FG001|Overall Study|Death / Serious Adverse Event|6|||
27609337|NCT00803101|80412558|FG000|Overall Study|Withdrawal by Subject|6|||
27609338|NCT00803101|80412559|FG001|Overall Study|Withdrawal by Subject|4|||
27609339|NCT00803101|80412558|FG000|Overall Study|Lost to Follow-up|2|||
27609340|NCT00803101|80412559|FG001|Overall Study|Lost to Follow-up|2|||
27609341|NCT00803101|80412558|FG000|Overall Study|Protocol Violation|1|||
27609342|NCT00803101|80412559|FG001|Overall Study|Protocol Violation|7|||
27609343|NCT00803101|80412558|FG000|Overall Study|Surgery finished outside protocol window|1|||
27609344|NCT00803101|80412559|FG001|Overall Study|Surgery finished outside protocol window|1|||
27609345|NCT00803101|80412558|FG000|Overall Study|Patient died outside SAE report period|1|||
27609346|NCT00803101|80412559|FG001|Overall Study|Patient died outside SAE report period|0|||
27609347|NCT00803101|80412558|FG000|Overall Study|Patient did not attend scheduled visit|2|||
27609348|NCT00803101|80412559|FG001|Overall Study|Patient did not attend scheduled visit|1|||
27609349|NCT00803101|80412558|FG000|Overall Study|Patient did not have surgery|1|||
27609350|NCT00803101|80412559|FG001|Overall Study|Patient did not have surgery|1|||
27609351|NCT02006121|80412560|FG000|Double Blind Phase|Adverse Event|6|||
27609352|NCT02006121|80412561|FG001|Double Blind Phase|Adverse Event|0|||
27609353|NCT02006121|80412560|FG000|Double Blind Phase|Lack of Efficacy|1|||
27609354|NCT02006121|80412561|FG001|Double Blind Phase|Lack of Efficacy|16|||
27609355|NCT02006121|80412560|FG000|Double Blind Phase|Withdrawal by Subject|3|||
27609356|NCT02006121|80412561|FG001|Double Blind Phase|Withdrawal by Subject|4|||
27609357|NCT02006121|80412560|FG000|Double Blind Phase|Non-compliance with study drug|1|||
27609358|NCT02006121|80412561|FG001|Double Blind Phase|Non-compliance with study drug|3|||
27609359|NCT02006121|80412560|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
27609360|NCT02006121|80412561|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
27609361|NCT02006121|80412560|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
27609362|NCT02006121|80412561|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
27609363|NCT02006121|80412560|FG000|Open Label Phase|Adverse Event|15|||
27609364|NCT02006121|80412561|FG001|Open Label Phase|Adverse Event|0|||
27609365|NCT02006121|80412560|FG000|Open Label Phase|Lack of Efficacy|2|||
27609366|NCT02006121|80412561|FG001|Open Label Phase|Lack of Efficacy|0|||
27609367|NCT02006121|80412560|FG000|Open Label Phase|Protocol Violation|2|||
27609368|NCT02006121|80412561|FG001|Open Label Phase|Protocol Violation|0|||
27609369|NCT02006121|80412560|FG000|Open Label Phase|Withdrawal by Subject|3|||
27609370|NCT02006121|80412561|FG001|Open Label Phase|Withdrawal by Subject|0|||
27609371|NCT02006121|80412560|FG000|Open Label Phase|Non-compliance with study drug|3|||
27609372|NCT02006121|80412561|FG001|Open Label Phase|Non-compliance with study drug|0|||
27609373|NCT00245856|80412562|FG000|Period Two|Withdrawal by Subject|0|||
27609374|NCT00245856|80412563|FG001|Period Two|Withdrawal by Subject|1|||
27609375|NCT04105972|80412565|FG000|Overall Study|Adverse Event|2|||
27609376|NCT04105972|80412566|FG001|Overall Study|Adverse Event|1|||
27609377|NCT01709305|80412571|FG000|Phase 1|Clinical Adverse Event|80|||
27609378|NCT01709305|80412572|FG001|Phase 1|Clinical Adverse Event|0|||
27609379|NCT01709305|80412573|FG002|Phase 1|Clinical Adverse Event|0|||
27609380|NCT01709305|80412574|FG003|Phase 1|Clinical Adverse Event|0|||
27609381|NCT01709305|80412575|FG004|Phase 1|Clinical Adverse Event|0|||
27609382|NCT01709305|80412571|FG000|Phase 1|Death|2|||
27609383|NCT01709305|80412572|FG001|Phase 1|Death|0|||
27609384|NCT01709305|80412573|FG002|Phase 1|Death|0|||
27839593|NCT00685750|81242422|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
27839594|NCT00685750|81242423|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
27609385|NCT01709305|80412574|FG003|Phase 1|Death|0|||
27609386|NCT01709305|80412575|FG004|Phase 1|Death|0|||
27609387|NCT01709305|80412571|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
27609388|NCT01709305|80412572|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27609389|NCT01709305|80412573|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27720641|NCT02362503|80810130|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
27839595|NCT00685750|81242424|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
27839596|NCT00685750|81242425|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
27890905|NCT00537316|81434206|FG001|Part 1|Lost to Follow-up|0|||
27890906|NCT00537316|81434207|FG002|Part 1|Lost to Follow-up|0|||
27890907|NCT00537316|81434208|FG003|Part 1|Lost to Follow-up|0|||
27890908|NCT00537316|81434209|FG004|Part 1|Lost to Follow-up|0|||
27890909|NCT00537316|81434210|FG005|Part 1|Lost to Follow-up|0|||
27890910|NCT00537316|81434211|FG006|Part 1|Lost to Follow-up|0|||
27890911|NCT00537316|81434205|FG000|Part 1|Withdrawal by Subject|3|||
27500579|NCT05119569|80027668|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
27500580|NCT05119569|80027669|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
27500581|NCT05119569|80027670|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
27500582|NCT05119569|80027671|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
27500583|NCT05119569|80027668|FG000|Double Blind Treatment Phase|Adverse Event|6|||
27500584|NCT05119569|80027669|FG001|Double Blind Treatment Phase|Adverse Event|0|||
27500585|NCT05119569|80027670|FG002|Double Blind Treatment Phase|Adverse Event|0|||
27500586|NCT05119569|80027671|FG003|Double Blind Treatment Phase|Adverse Event|0|||
27500587|NCT05119569|80027668|FG000|Open Label Extension Phase|Ongoing in the study|0|||
27500588|NCT05119569|80027669|FG001|Open Label Extension Phase|Ongoing in the study|0|||
27500589|NCT05119569|80027670|FG002|Open Label Extension Phase|Ongoing in the study|65|||
27500590|NCT05119569|80027671|FG003|Open Label Extension Phase|Ongoing in the study|34|||
27500591|NCT00262860|80027672|FG000|Overall Study|Adverse Event|2|||
27500592|NCT03988400|80027673|FG000|Overall Study|Adverse Event|1|||
27500593|NCT03988400|80027674|FG001|Overall Study|Adverse Event|0|||
27500594|NCT03988400|80027673|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
27500595|NCT03988400|80027674|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
27500596|NCT03988400|80027673|FG000|Overall Study|Lost to Follow-up|0|||
27500597|NCT03988400|80027674|FG001|Overall Study|Lost to Follow-up|1|||
27500598|NCT02177695|80027675|FG000|ITT Analysis|Ineligible|5|||
27500599|NCT02177695|80027676|FG001|ITT Analysis|Ineligible|5|||
27500600|NCT02177695|80027675|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
27500601|NCT02177695|80027676|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
27500602|NCT02177695|80027675|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
27500603|NCT02177695|80027676|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
27500604|NCT02177695|80027675|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
27500605|NCT02177695|80027676|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
27500606|NCT03379675|80027677|FG000|Overall Study|Lost to Follow-up|0|||
27500607|NCT03379675|80027678|FG001|Overall Study|Lost to Follow-up|1|||
27500608|NCT03379675|80027679|FG002|Overall Study|Lost to Follow-up|0|||
27500609|NCT03379675|80027677|FG000|Overall Study|Adverse Event|2|||
27500610|NCT03379675|80027678|FG001|Overall Study|Adverse Event|0|||
27500611|NCT03379675|80027679|FG002|Overall Study|Adverse Event|0|||
27500612|NCT03379675|80027677|FG000|Overall Study|Withdrawal by Subject|2|||
27500613|NCT03379675|80027678|FG001|Overall Study|Withdrawal by Subject|1|||
27500614|NCT03379675|80027679|FG002|Overall Study|Withdrawal by Subject|2|||
27500615|NCT04742556|80027681|FG000|Overall Study|Withdrawal by Subject|0|||
27500616|NCT04742556|80027682|FG001|Overall Study|Withdrawal by Subject|1|||
27500617|NCT04742556|80027683|FG002|Overall Study|Withdrawal by Subject|0|||
27500618|NCT04742556|80027681|FG000|Overall Study|Adverse Event|0|||
27500619|NCT04742556|80027682|FG001|Overall Study|Adverse Event|0|||
27500620|NCT04742556|80027683|FG002|Overall Study|Adverse Event|2|||
27500621|NCT04742556|80027681|FG000|Overall Study|Clinical disease progression|0|||
27500622|NCT04742556|80027682|FG001|Overall Study|Clinical disease progression|1|||
27500623|NCT04742556|80027683|FG002|Overall Study|Clinical disease progression|2|||
27500624|NCT04742556|80027681|FG000|Overall Study|Objective disease progression|3|||
27500625|NCT04742556|80027682|FG001|Overall Study|Objective disease progression|2|||
27890912|NCT00537316|81434206|FG001|Part 1|Withdrawal by Subject|8|||
27890913|NCT00537316|81434207|FG002|Part 1|Withdrawal by Subject|4|||
27890914|NCT00537316|81434208|FG003|Part 1|Withdrawal by Subject|0|||
27890915|NCT00537316|81434209|FG004|Part 1|Withdrawal by Subject|0|||
27500626|NCT04742556|80027683|FG002|Overall Study|Objective disease progression|4|||
27500627|NCT03985761|80027684|FG000|Overall Study|Withdrawal by Subject|2|||
27500628|NCT03985761|80027685|FG001|Overall Study|Withdrawal by Subject|3|||
27500629|NCT02063724|80027686|FG000|Overall Study|Disease progression|1|||
27500630|NCT04515771|80027687|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
27500631|NCT04515771|80027688|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
27500632|NCT04515771|80027687|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
27890916|NCT00537316|81434210|FG005|Part 1|Withdrawal by Subject|0|||
27890917|NCT00537316|81434211|FG006|Part 1|Withdrawal by Subject|0|||
27890918|NCT00537316|81434205|FG000|Part 1|Protocol Violation|1|||
27890919|NCT00537316|81434206|FG001|Part 1|Protocol Violation|5|||
27890920|NCT00537316|81434207|FG002|Part 1|Protocol Violation|1|||
27890921|NCT00537316|81434208|FG003|Part 1|Protocol Violation|0|||
27890922|NCT00537316|81434209|FG004|Part 1|Protocol Violation|0|||
27890923|NCT00537316|81434210|FG005|Part 1|Protocol Violation|0|||
27609390|NCT01709305|80412574|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27609391|NCT01709305|80412575|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
27609392|NCT01709305|80412571|FG000|Phase 1|Laboratory Adverse Event|16|||
27609393|NCT01709305|80412572|FG001|Phase 1|Laboratory Adverse Event|0|||
27609394|NCT01709305|80412573|FG002|Phase 1|Laboratory Adverse Event|0|||
27609395|NCT01709305|80412574|FG003|Phase 1|Laboratory Adverse Event|0|||
27609396|NCT01709305|80412575|FG004|Phase 1|Laboratory Adverse Event|0|||
27609397|NCT01709305|80412571|FG000|Phase 1|Lost to Follow-up|147|||
27609398|NCT01709305|80412572|FG001|Phase 1|Lost to Follow-up|0|||
27609399|NCT01709305|80412573|FG002|Phase 1|Lost to Follow-up|0|||
27609400|NCT01709305|80412574|FG003|Phase 1|Lost to Follow-up|0|||
27609401|NCT01709305|80412575|FG004|Phase 1|Lost to Follow-up|0|||
27890924|NCT00537316|81434211|FG006|Part 1|Protocol Violation|0|||
27890925|NCT00537316|81434205|FG000|Part 1|Did not meet protocol eligibility|1|||
27890926|NCT00537316|81434206|FG001|Part 1|Did not meet protocol eligibility|3|||
27609402|NCT01709305|80412571|FG000|Phase 1|Travel, moving, etc.|30|||
27890927|NCT00537316|81434207|FG002|Part 1|Did not meet protocol eligibility|2|||
27890928|NCT00537316|81434208|FG003|Part 1|Did not meet protocol eligibility|0|||
27890929|NCT00537316|81434209|FG004|Part 1|Did not meet protocol eligibility|0|||
27890930|NCT00537316|81434210|FG005|Part 1|Did not meet protocol eligibility|0|||
27890931|NCT00537316|81434211|FG006|Part 1|Did not meet protocol eligibility|0|||
27890932|NCT00537316|81434205|FG000|Part 1|Administrative|0|||
27890933|NCT00537316|81434206|FG001|Part 1|Administrative|0|||
27890934|NCT00537316|81434207|FG002|Part 1|Administrative|2|||
27609403|NCT01709305|80412572|FG001|Phase 1|Travel, moving, etc.|0|||
27609404|NCT01709305|80412573|FG002|Phase 1|Travel, moving, etc.|0|||
27609405|NCT01709305|80412574|FG003|Phase 1|Travel, moving, etc.|0|||
27609406|NCT01709305|80412575|FG004|Phase 1|Travel, moving, etc.|0|||
27609407|NCT01709305|80412571|FG000|Phase 1|Physician Decision|13|||
27609408|NCT01709305|80412572|FG001|Phase 1|Physician Decision|0|||
27609409|NCT01709305|80412573|FG002|Phase 1|Physician Decision|0|||
27609410|NCT01709305|80412574|FG003|Phase 1|Physician Decision|0|||
27609411|NCT01709305|80412575|FG004|Phase 1|Physician Decision|0|||
27609412|NCT01709305|80412571|FG000|Phase 1|Protocol Violation|118|||
27890935|NCT00537316|81434208|FG003|Part 1|Administrative|0|||
27890936|NCT00537316|81434209|FG004|Part 1|Administrative|0|||
27890937|NCT00537316|81434210|FG005|Part 1|Administrative|0|||
27890938|NCT00537316|81434211|FG006|Part 1|Administrative|0|||
27890939|NCT00537316|81434205|FG000|Part 2|Never entered follow-up|0|||
27890940|NCT00537316|81434206|FG001|Part 2|Never entered follow-up|0|||
27890941|NCT00537316|81434207|FG002|Part 2|Never entered follow-up|0|||
27890942|NCT00537316|81434208|FG003|Part 2|Never entered follow-up|0|||
27890943|NCT00537316|81434209|FG004|Part 2|Never entered follow-up|0|||
27609413|NCT01709305|80412572|FG001|Phase 1|Protocol Violation|0|||
27609414|NCT01709305|80412573|FG002|Phase 1|Protocol Violation|0|||
27609415|NCT01709305|80412574|FG003|Phase 1|Protocol Violation|0|||
27890944|NCT00537316|81434210|FG005|Part 2|Never entered follow-up|0|||
27890945|NCT00537316|81434211|FG006|Part 2|Never entered follow-up|1|||
27890946|NCT00537316|81434205|FG000|Part 2|Adverse Event|4|||
27890947|NCT00537316|81434206|FG001|Part 2|Adverse Event|0|||
27609416|NCT01709305|80412575|FG004|Phase 1|Protocol Violation|0|||
27609417|NCT01709305|80412571|FG000|Phase 1|Withdrawal by Subject|218|||
27609418|NCT01709305|80412572|FG001|Phase 1|Withdrawal by Subject|0|||
27609419|NCT01709305|80412573|FG002|Phase 1|Withdrawal by Subject|0|||
27609420|NCT01709305|80412574|FG003|Phase 1|Withdrawal by Subject|0|||
27609421|NCT01709305|80412575|FG004|Phase 1|Withdrawal by Subject|0|||
27609422|NCT01709305|80412571|FG000|Phase 2|Clinical Adverse Event|0|||
27609423|NCT01709305|80412572|FG001|Phase 2|Clinical Adverse Event|10|||
27609424|NCT01709305|80412573|FG002|Phase 2|Clinical Adverse Event|10|||
27609425|NCT01709305|80412574|FG003|Phase 2|Clinical Adverse Event|6|||
27609426|NCT01709305|80412575|FG004|Phase 2|Clinical Adverse Event|11|||
27609427|NCT01709305|80412571|FG000|Phase 2|Death|0|||
27609428|NCT01709305|80412572|FG001|Phase 2|Death|0|||
27609429|NCT01709305|80412573|FG002|Phase 2|Death|1|||
27609430|NCT01709305|80412574|FG003|Phase 2|Death|0|||
27609431|NCT01709305|80412575|FG004|Phase 2|Death|0|||
27609432|NCT01709305|80412571|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27609433|NCT01709305|80412572|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27609434|NCT01709305|80412573|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27609435|NCT01709305|80412574|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
27609436|NCT01709305|80412575|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
27609437|NCT01709305|80412571|FG000|Phase 2|Laboratory Adverse Event|0|||
27609438|NCT01709305|80412572|FG001|Phase 2|Laboratory Adverse Event|1|||
27609439|NCT01709305|80412573|FG002|Phase 2|Laboratory Adverse Event|0|||
27609440|NCT01709305|80412574|FG003|Phase 2|Laboratory Adverse Event|1|||
27609441|NCT01709305|80412575|FG004|Phase 2|Laboratory Adverse Event|1|||
27609442|NCT01709305|80412571|FG000|Phase 2|Lost to Follow-up|0|||
27609443|NCT01709305|80412572|FG001|Phase 2|Lost to Follow-up|10|||
27609444|NCT01709305|80412573|FG002|Phase 2|Lost to Follow-up|6|||
27609445|NCT01709305|80412574|FG003|Phase 2|Lost to Follow-up|9|||
27609446|NCT01709305|80412575|FG004|Phase 2|Lost to Follow-up|5|||
27609447|NCT01709305|80412571|FG000|Phase 2|Travel, moving, etc.|0|||
27609448|NCT01709305|80412572|FG001|Phase 2|Travel, moving, etc.|2|||
27609449|NCT01709305|80412573|FG002|Phase 2|Travel, moving, etc.|3|||
27609450|NCT01709305|80412574|FG003|Phase 2|Travel, moving, etc.|3|||
27609451|NCT01709305|80412575|FG004|Phase 2|Travel, moving, etc.|5|||
27609452|NCT01709305|80412571|FG000|Phase 2|Physician Decision|0|||
27609453|NCT01709305|80412572|FG001|Phase 2|Physician Decision|2|||
27609454|NCT01709305|80412573|FG002|Phase 2|Physician Decision|0|||
27609455|NCT01709305|80412574|FG003|Phase 2|Physician Decision|1|||
27609456|NCT01709305|80412575|FG004|Phase 2|Physician Decision|2|||
27609457|NCT01709305|80412571|FG000|Phase 2|Protocol Violation|0|||
27609458|NCT01709305|80412572|FG001|Phase 2|Protocol Violation|19|||
27609459|NCT01709305|80412573|FG002|Phase 2|Protocol Violation|19|||
27609460|NCT01709305|80412574|FG003|Phase 2|Protocol Violation|13|||
27609461|NCT01709305|80412575|FG004|Phase 2|Protocol Violation|9|||
27609462|NCT01709305|80412571|FG000|Phase 2|Withdrawal by Subject|0|||
27609463|NCT01709305|80412572|FG001|Phase 2|Withdrawal by Subject|8|||
27609464|NCT01709305|80412573|FG002|Phase 2|Withdrawal by Subject|6|||
27720642|NCT02362503|80810131|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
27609465|NCT01709305|80412574|FG003|Phase 2|Withdrawal by Subject|15|||
27609466|NCT01709305|80412575|FG004|Phase 2|Withdrawal by Subject|12|||
27609467|NCT00621296|80412576|FG000|Overall Study|Adverse Event|2|||
27609468|NCT00621296|80412576|FG000|Overall Study|Lack of Efficacy|1|||
27609469|NCT00621296|80412576|FG000|Overall Study|Physician Decision|7|||
27609470|NCT00621296|80412576|FG000|Overall Study|Unmatch Criteria|1|||
27609471|NCT00621296|80412576|FG000|Overall Study|Stopping Criteria|3|||
27609472|NCT01014975|80412578|FG000|Overall Study|Withdrawal by Subject|1|||
27609473|NCT01014975|80412579|FG001|Overall Study|Withdrawal by Subject|0|||
27839597|NCT00799708|81242426|FG000|Overall Study|non-compliance|1|||
27609474|NCT01014975|80412580|FG002|Overall Study|Withdrawal by Subject|1|||
27609475|NCT01014975|80412578|FG000|Overall Study|Death|3|||
27609476|NCT01014975|80412579|FG001|Overall Study|Death|3|||
27609477|NCT01014975|80412580|FG002|Overall Study|Death|4|||
27609478|NCT01014975|80412578|FG000|Overall Study|Lost to Follow-up|0|||
27609479|NCT01014975|80412579|FG001|Overall Study|Lost to Follow-up|0|||
27609480|NCT01014975|80412580|FG002|Overall Study|Lost to Follow-up|1|||
27609481|NCT02906202|80412581|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
27839598|NCT00799708|81242427|FG001|Overall Study|non-compliance|0|||
27839599|NCT00799708|81242428|FG002|Overall Study|non-compliance|0|||
27839600|NCT02259348|81242430|FG000|Overall Study|Donors|6|||
27839601|NCT02259348|81242430|FG000|Overall Study|Death|4|||
27839602|NCT05061992|81242431|FG000|Overall Study|Excess bowel movements|1|||
27839603|NCT05061992|81242432|FG001|Overall Study|Excess bowel movements|0|||
27839604|NCT05061992|81242431|FG000|Overall Study|Complications of Medical Care|1|||
27839605|NCT05061992|81242432|FG001|Overall Study|Complications of Medical Care|0|||
27839606|NCT05061992|81242431|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
27839607|NCT05061992|81242432|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
27839608|NCT05061992|81242431|FG000|Overall Study|Withdrawal by Subject|0|||
27839609|NCT05061992|81242432|FG001|Overall Study|Withdrawal by Subject|1|||
27500633|NCT04515771|80027688|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
27500634|NCT04515771|80027687|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
27500635|NCT04515771|80027688|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
27500636|NCT03748823|80027689|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
27500637|NCT03748823|80027690|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
27500638|NCT03748823|80027689|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
27500639|NCT03748823|80027690|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
27500640|NCT03748823|80027689|FG000|Extension Period|Withdrawal by Subject|9|||
27500641|NCT03748823|80027690|FG001|Extension Period|Withdrawal by Subject|12|||
27500642|NCT03748823|80027689|FG000|Extension Period|Death|2|||
27500643|NCT03748823|80027690|FG001|Extension Period|Death|2|||
27500644|NCT03748823|80027689|FG000|Extension Period|Other than Specified|0|||
27500645|NCT03748823|80027690|FG001|Extension Period|Other than Specified|1|||
27500646|NCT03748823|80027689|FG000|Extension Period|Protocol Violation|1|||
27500647|NCT03748823|80027690|FG001|Extension Period|Protocol Violation|0|||
27500648|NCT03748823|80027689|FG000|Extension Period|Lost to Follow-up|0|||
27500649|NCT03748823|80027690|FG001|Extension Period|Lost to Follow-up|1|||
27500650|NCT03748823|80027689|FG000|Extension Period|Lack of Efficacy|0|||
27500651|NCT03748823|80027690|FG001|Extension Period|Lack of Efficacy|1|||
27500652|NCT03748823|80027689|FG000|Extension Period|Physician Decision|1|||
27500653|NCT03748823|80027690|FG001|Extension Period|Physician Decision|2|||
27609482|NCT01678820|80412582|FG000|Overall Study|Study Terminated by Sponsor|45|||
27609483|NCT01678820|80412583|FG001|Overall Study|Study Terminated by Sponsor|43|||
27609484|NCT01678820|80412584|FG002|Overall Study|Study Terminated by Sponsor|43|||
27609485|NCT01678820|80412582|FG000|Overall Study|Withdrawal by Subject|2|||
27609486|NCT01678820|80412583|FG001|Overall Study|Withdrawal by Subject|5|||
27609487|NCT01678820|80412584|FG002|Overall Study|Withdrawal by Subject|2|||
27609488|NCT01678820|80412582|FG000|Overall Study|Protocol Specified Criteria|2|||
27609489|NCT01678820|80412583|FG001|Overall Study|Protocol Specified Criteria|3|||
27609490|NCT01678820|80412584|FG002|Overall Study|Protocol Specified Criteria|1|||
27609491|NCT01678820|80412582|FG000|Overall Study|Adverse Event|2|||
27609492|NCT01678820|80412583|FG001|Overall Study|Adverse Event|2|||
27609493|NCT01678820|80412584|FG002|Overall Study|Adverse Event|2|||
27609494|NCT01678820|80412582|FG000|Overall Study|Lost to Follow-up|7|||
27609495|NCT01678820|80412583|FG001|Overall Study|Lost to Follow-up|2|||
27609496|NCT01678820|80412584|FG002|Overall Study|Lost to Follow-up|2|||
27609497|NCT01678820|80412582|FG000|Overall Study|Non-compliance with study drug|0|||
27609498|NCT01678820|80412583|FG001|Overall Study|Non-compliance with study drug|1|||
27609499|NCT01678820|80412584|FG002|Overall Study|Non-compliance with study drug|0|||
27609500|NCT01678820|80412582|FG000|Overall Study|Physician Decision|0|||
27609501|NCT01678820|80412583|FG001|Overall Study|Physician Decision|0|||
27609502|NCT01678820|80412584|FG002|Overall Study|Physician Decision|1|||
27609503|NCT01678820|80412582|FG000|Overall Study|Protocol Violation|4|||
27609504|NCT01678820|80412583|FG001|Overall Study|Protocol Violation|5|||
27609505|NCT01678820|80412584|FG002|Overall Study|Protocol Violation|4|||
27609506|NCT01678820|80412582|FG000|Overall Study|Not treated with double-blind study drug|0|||
27839610|NCT01211262|81242433|FG000|Overall Study|Progressive Disease|18|||
27839611|NCT01211262|81242434|FG001|Overall Study|Progressive Disease|9|||
27839612|NCT01211262|81242433|FG000|Overall Study|Adverse Event|4|||
27839613|NCT01211262|81242434|FG001|Overall Study|Adverse Event|0|||
27839614|NCT01211262|81242433|FG000|Overall Study|Withdrawal of Consent|1|||
27839615|NCT01211262|81242434|FG001|Overall Study|Withdrawal of Consent|0|||
27839616|NCT01211262|81242433|FG000|Overall Study|Other|0|||
27839617|NCT01211262|81242434|FG001|Overall Study|Other|1|||
27839618|NCT01256060|81242435|FG000|Overall Study|Lost to Follow-up|0|||
27839619|NCT01256060|81242436|FG001|Overall Study|Lost to Follow-up|1|||
27839620|NCT01256060|81242437|FG002|Overall Study|Lost to Follow-up|0|||
27839621|NCT01256060|81242438|FG003|Overall Study|Lost to Follow-up|0|||
27839622|NCT00842309|81242439|FG000|Overall Study|Withdrawal by Subject|3|||
27500654|NCT02250326|80027694|FG000|Treatment|Death|1|||
27500655|NCT02250326|80027695|FG001|Treatment|Death|13|||
27500656|NCT02250326|80027696|FG002|Treatment|Death|2|||
27500657|NCT02250326|80027694|FG000|Treatment|Adverse Event|8|||
27500658|NCT02250326|80027695|FG001|Treatment|Adverse Event|8|||
27500659|NCT02250326|80027696|FG002|Treatment|Adverse Event|9|||
27500660|NCT02250326|80027694|FG000|Treatment|Progressive Disease|42|||
27500661|NCT02250326|80027695|FG001|Treatment|Progressive Disease|40|||
27500662|NCT02250326|80027696|FG002|Treatment|Progressive Disease|47|||
27500663|NCT02250326|80027694|FG000|Treatment|Symptomatic Deterioration|9|||
27609507|NCT01678820|80412583|FG001|Overall Study|Not treated with double-blind study drug|2|||
27609508|NCT01678820|80412584|FG002|Overall Study|Not treated with double-blind study drug|2|||
27609509|NCT01008475|80412585|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
27609510|NCT01008475|80412586|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
27609511|NCT01008475|80412587|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
27839623|NCT00842309|81242440|FG001|Overall Study|Withdrawal by Subject|1|||
27839624|NCT02435433|81242441|FG000|Overall Study|Withdrawal by Subject|2|||
27839625|NCT02435433|81242442|FG001|Overall Study|Withdrawal by Subject|3|||
27890948|NCT00537316|81434207|FG002|Part 2|Adverse Event|2|||
27890949|NCT00537316|81434208|FG003|Part 2|Adverse Event|0|||
27890950|NCT00537316|81434209|FG004|Part 2|Adverse Event|0|||
27890951|NCT00537316|81434210|FG005|Part 2|Adverse Event|0|||
27890952|NCT00537316|81434211|FG006|Part 2|Adverse Event|0|||
27890953|NCT00537316|81434205|FG000|Part 2|Lost to Follow-up|1|||
27890954|NCT00537316|81434206|FG001|Part 2|Lost to Follow-up|0|||
27890955|NCT00537316|81434207|FG002|Part 2|Lost to Follow-up|2|||
27890956|NCT00537316|81434208|FG003|Part 2|Lost to Follow-up|0|||
27839626|NCT02435433|81242443|FG002|Overall Study|Withdrawal by Subject|1|||
27839627|NCT02435433|81242444|FG003|Overall Study|Withdrawal by Subject|0|||
27839628|NCT02435433|81242445|FG004|Overall Study|Withdrawal by Subject|0|||
27839629|NCT02435433|81242441|FG000|Overall Study|Lost to Follow-up|2|||
27839630|NCT02435433|81242442|FG001|Overall Study|Lost to Follow-up|2|||
27839631|NCT02435433|81242443|FG002|Overall Study|Lost to Follow-up|4|||
27839632|NCT02435433|81242444|FG003|Overall Study|Lost to Follow-up|1|||
27839633|NCT02435433|81242445|FG004|Overall Study|Lost to Follow-up|0|||
27839634|NCT00609154|81242454|FG000|Overall Study|Protocol Violation|1|||
27839635|NCT00609154|81242455|FG001|Overall Study|Protocol Violation|2|||
27839636|NCT00609154|81242454|FG000|Overall Study|Unable to establish IV access|0|||
27839637|NCT00609154|81242455|FG001|Overall Study|Unable to establish IV access|4|||
27839638|NCT00609154|81242454|FG000|Overall Study|Adverse Event|0|||
27839639|NCT00609154|81242455|FG001|Overall Study|Adverse Event|2|||
27839640|NCT01408888|81242458|FG000|First Intervention|Adverse Event|0|||
27839641|NCT01408888|81242459|FG001|First Intervention|Adverse Event|1|||
27839642|NCT01408888|81242458|FG000|First Intervention|Withdrawal by Subject|0|||
27839643|NCT01408888|81242459|FG001|First Intervention|Withdrawal by Subject|2|||
27839644|NCT01408888|81242458|FG000|Second Intervention|Withdrawal by Subject|1|||
27609512|NCT01008475|80412588|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
27609513|NCT01008475|80412589|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
27609514|NCT01008475|80412590|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
27609515|NCT01008475|80412591|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
27609516|NCT01913639|80412592|FG000|Overall Study|Not Eligible|3|||
27609517|NCT03556358|80412593|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
27609518|NCT03556358|80412594|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
27609519|NCT03556358|80412593|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
27609520|NCT03556358|80412594|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
27609521|NCT03556358|80412593|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
27609522|NCT03556358|80412594|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
27839645|NCT01408888|81242459|FG001|Second Intervention|Withdrawal by Subject|0|||
27839646|NCT01408888|81242458|FG000|Second Intervention|Adverse Event|1|||
27839647|NCT01408888|81242459|FG001|Second Intervention|Adverse Event|0|||
27839648|NCT00250705|81242460|FG000|Overall Study|Lack of Efficacy|2|||
27839649|NCT03414034|81242463|FG000|Overall Study|Adverse Event|6|||
27839650|NCT03414034|81242464|FG001|Overall Study|Adverse Event|1|||
27890957|NCT00537316|81434209|FG004|Part 2|Lost to Follow-up|0|||
27609523|NCT03556358|80412593|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
27609524|NCT03556358|80412594|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
27839651|NCT03414034|81242465|FG002|Overall Study|Adverse Event|1|||
27839652|NCT03414034|81242463|FG000|Overall Study|Death|0|||
27890958|NCT00537316|81434210|FG005|Part 2|Lost to Follow-up|0|||
27890959|NCT00537316|81434211|FG006|Part 2|Lost to Follow-up|0|||
27890960|NCT00537316|81434205|FG000|Part 2|Withdrawal by Subject|5|||
27890961|NCT00537316|81434206|FG001|Part 2|Withdrawal by Subject|1|||
27890962|NCT00537316|81434207|FG002|Part 2|Withdrawal by Subject|4|||
27890963|NCT00537316|81434208|FG003|Part 2|Withdrawal by Subject|0|||
27890964|NCT00537316|81434209|FG004|Part 2|Withdrawal by Subject|0|||
27890965|NCT00537316|81434210|FG005|Part 2|Withdrawal by Subject|0|||
27890966|NCT00537316|81434211|FG006|Part 2|Withdrawal by Subject|0|||
27609525|NCT03556358|80412593|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
27839653|NCT03414034|81242464|FG001|Overall Study|Death|0|||
27839654|NCT03414034|81242465|FG002|Overall Study|Death|1|||
27839655|NCT03414034|81242463|FG000|Overall Study|Non-compliance With Study Drug|0|||
27839656|NCT03414034|81242464|FG001|Overall Study|Non-compliance With Study Drug|0|||
27609526|NCT03556358|80412594|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
27609527|NCT03556358|80412593|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
27609528|NCT03556358|80412594|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
27609529|NCT03556358|80412593|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
27609530|NCT03556358|80412594|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
27609531|NCT01027364|80412595|FG000|Overall Study|Adverse Event|1|||
27609532|NCT01027364|80412596|FG001|Overall Study|Adverse Event|0|||
27609533|NCT01027364|80412597|FG002|Overall Study|Adverse Event|1|||
27609534|NCT01027364|80412598|FG003|Overall Study|Adverse Event|0|||
27609535|NCT01027364|80412595|FG000|Overall Study|Lost to Follow-up|1|||
27720643|NCT02362503|80810132|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
27720644|NCT00608985|80810139|FG000|Overall Study|Adverse Event|2|||
27720645|NCT00608985|80810140|FG001|Overall Study|Adverse Event|7|||
27720646|NCT00608985|80810141|FG002|Overall Study|Adverse Event|4|||
27720647|NCT00608985|80810142|FG003|Overall Study|Adverse Event|6|||
27720648|NCT00608985|80810139|FG000|Overall Study|Administrative/Other|7|||
27720649|NCT00608985|80810140|FG001|Overall Study|Administrative/Other|4|||
27720650|NCT00608985|80810141|FG002|Overall Study|Administrative/Other|1|||
27720651|NCT00608985|80810142|FG003|Overall Study|Administrative/Other|2|||
27720652|NCT00608985|80810139|FG000|Overall Study|Withdrawal of Consent|5|||
27720653|NCT00608985|80810140|FG001|Overall Study|Withdrawal of Consent|1|||
27720654|NCT00608985|80810141|FG002|Overall Study|Withdrawal of Consent|1|||
27720655|NCT00608985|80810142|FG003|Overall Study|Withdrawal of Consent|1|||
27720656|NCT00608985|80810139|FG000|Overall Study|Lost to Follow-up|2|||
27720657|NCT00608985|80810140|FG001|Overall Study|Lost to Follow-up|1|||
27720658|NCT00608985|80810141|FG002|Overall Study|Lost to Follow-up|0|||
27720659|NCT00608985|80810142|FG003|Overall Study|Lost to Follow-up|0|||
27609536|NCT01027364|80412596|FG001|Overall Study|Lost to Follow-up|0|||
27609537|NCT01027364|80412597|FG002|Overall Study|Lost to Follow-up|0|||
27720660|NCT02918019|80810171|FG000|Overall Study|Death|0|||
27720661|NCT02918019|80810172|FG001|Overall Study|Death|0|||
27500664|NCT02250326|80027695|FG001|Treatment|Symptomatic Deterioration|4|||
27500665|NCT02250326|80027696|FG002|Treatment|Symptomatic Deterioration|10|||
27500666|NCT02250326|80027694|FG000|Treatment|Withdrawal by Subject|11|||
27500667|NCT02250326|80027695|FG001|Treatment|Withdrawal by Subject|6|||
27500668|NCT02250326|80027696|FG002|Treatment|Withdrawal by Subject|4|||
27500669|NCT02250326|80027694|FG000|Treatment|Other reasons|8|||
27500670|NCT02250326|80027695|FG001|Treatment|Other reasons|7|||
27500671|NCT02250326|80027696|FG002|Treatment|Other reasons|7|||
27500672|NCT02250326|80027694|FG000|Extension Period|Progressive Disease|0|||
27500673|NCT02250326|80027695|FG001|Extension Period|Progressive Disease|2|||
27500674|NCT02250326|80027696|FG002|Extension Period|Progressive Disease|0|||
27500675|NCT02250326|80027694|FG000|Extension Period|Withdrawal by Subject|0|||
27500676|NCT02250326|80027695|FG001|Extension Period|Withdrawal by Subject|1|||
27500677|NCT02250326|80027696|FG002|Extension Period|Withdrawal by Subject|0|||
27500678|NCT02250326|80027694|FG000|Extension Period|Withdrawal by investigator|0|||
27500679|NCT02250326|80027695|FG001|Extension Period|Withdrawal by investigator|1|||
27609538|NCT01027364|80412598|FG003|Overall Study|Lost to Follow-up|0|||
27609539|NCT01027364|80412595|FG000|Overall Study|Protocol Violation|1|||
27609540|NCT01027364|80412596|FG001|Overall Study|Protocol Violation|0|||
27609541|NCT01027364|80412597|FG002|Overall Study|Protocol Violation|0|||
27609542|NCT01027364|80412598|FG003|Overall Study|Protocol Violation|1|||
27609543|NCT01027364|80412595|FG000|Overall Study|Withdrawal by Subject|1|||
27609544|NCT01027364|80412596|FG001|Overall Study|Withdrawal by Subject|2|||
27609545|NCT01027364|80412597|FG002|Overall Study|Withdrawal by Subject|0|||
27609546|NCT01027364|80412598|FG003|Overall Study|Withdrawal by Subject|0|||
27609547|NCT02387996|80412599|FG000|Overall Study|Disease Progression|167|||
27609548|NCT02387996|80412599|FG000|Overall Study|Study Drug Toxicity|31|||
27609549|NCT02387996|80412599|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
27609550|NCT02387996|80412599|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
27609551|NCT02387996|80412599|FG000|Overall Study|Subject Withdrew Consent|5|||
27609552|NCT02387996|80412599|FG000|Overall Study|Lost to Follow-up|1|||
27609553|NCT02387996|80412599|FG000|Overall Study|Poor/Non-Compliance|1|||
27609554|NCT02387996|80412599|FG000|Overall Study|Other Reasons|5|||
27609555|NCT02387996|80412599|FG000|Overall Study|Death|1|||
27609556|NCT03086018|80412604|FG000|Final Testing for End of Trial|Adverse Event|1|||
27609557|NCT03086018|80412604|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
27609558|NCT02302066|80412605|FG000|Overall Study|Adverse Event|1|||
27609559|NCT02302066|80412606|FG001|Overall Study|Adverse Event|1|||
27609560|NCT02302066|80412607|FG002|Overall Study|Adverse Event|3|||
27609561|NCT02302066|80412608|FG003|Overall Study|Adverse Event|0|||
27609562|NCT02302066|80412605|FG000|Overall Study|Lost to Follow-up|4|||
27609563|NCT02302066|80412606|FG001|Overall Study|Lost to Follow-up|5|||
27609564|NCT02302066|80412607|FG002|Overall Study|Lost to Follow-up|24|||
27609565|NCT02302066|80412608|FG003|Overall Study|Lost to Follow-up|7|||
27609566|NCT02302066|80412605|FG000|Overall Study|Withdrawal by Subject|25|||
27609567|NCT02302066|80412606|FG001|Overall Study|Withdrawal by Subject|58|||
27609568|NCT02302066|80412607|FG002|Overall Study|Withdrawal by Subject|124|||
27609569|NCT02302066|80412608|FG003|Overall Study|Withdrawal by Subject|33|||
27609570|NCT02302066|80412605|FG000|Overall Study|Pregnancy|2|||
27609571|NCT02302066|80412606|FG001|Overall Study|Pregnancy|10|||
27609572|NCT02302066|80412607|FG002|Overall Study|Pregnancy|12|||
27609573|NCT02302066|80412608|FG003|Overall Study|Pregnancy|0|||
27609574|NCT02302066|80412605|FG000|Overall Study|Reason Not Specified|1|||
27609575|NCT02302066|80412606|FG001|Overall Study|Reason Not Specified|1|||
27609576|NCT02302066|80412607|FG002|Overall Study|Reason Not Specified|9|||
27609577|NCT02302066|80412608|FG003|Overall Study|Reason Not Specified|1|||
27609578|NCT02120664|80412609|FG000|Overall Study|Withdrawal by Subject|0|||
27609579|NCT02120664|80412610|FG001|Overall Study|Withdrawal by Subject|0|||
27720662|NCT02918019|80810173|FG002|Overall Study|Death|1|||
27720663|NCT02918019|80810174|FG003|Overall Study|Death|0|||
27500680|NCT02250326|80027696|FG002|Extension Period|Withdrawal by investigator|0|||
27500681|NCT04065048|80027700|FG000|Overall Study|Withdrawal by Subject|1|||
27500682|NCT04065048|80027701|FG001|Overall Study|Withdrawal by Subject|2|||
27500683|NCT04065048|80027702|FG002|Overall Study|Withdrawal by Subject|1|||
27500684|NCT04065048|80027703|FG003|Overall Study|Withdrawal by Subject|1|||
27609580|NCT02120664|80412611|FG002|Overall Study|Withdrawal by Subject|0|||
27609581|NCT02120664|80412612|FG003|Overall Study|Withdrawal by Subject|1|||
27609582|NCT02120664|80412613|FG004|Overall Study|Withdrawal by Subject|0|||
27609583|NCT01932294|80412619|FG000|Overall Study|Death|43|||
27609584|NCT01932294|80412619|FG000|Overall Study|Lost to Follow-up|8|||
27609585|NCT01932294|80412619|FG000|Overall Study|VAD Implantation|20|||
27609586|NCT01932294|80412619|FG000|Overall Study|Heart Transplantation|16|||
27609587|NCT01932294|80412619|FG000|Overall Study|Transferred to other hospitals|12|||
27609588|NCT00119262|80412626|FG000|Overall Study|Lack of Efficacy|0|||
27609589|NCT00119262|80412627|FG001|Overall Study|Lack of Efficacy|3|||
27609590|NCT00119262|80412626|FG000|Overall Study|Withdrawal by Subject|12|||
27720664|NCT02918019|80810171|FG000|Overall Study|Lost to Follow-up|1|||
27720665|NCT02918019|80810172|FG001|Overall Study|Lost to Follow-up|1|||
27609591|NCT00119262|80412627|FG001|Overall Study|Withdrawal by Subject|11|||
27609592|NCT00119262|80412626|FG000|Overall Study|Adverse Event|33|||
27609593|NCT00119262|80412627|FG001|Overall Study|Adverse Event|35|||
27609594|NCT00119262|80412626|FG000|Overall Study|other disease|0|||
27609595|NCT00119262|80412627|FG001|Overall Study|other disease|2|||
27609596|NCT00119262|80412626|FG000|Overall Study|ineligble|1|||
27609597|NCT00119262|80412627|FG001|Overall Study|ineligble|2|||
27609598|NCT00119262|80412626|FG000|Overall Study|others|0|||
27609599|NCT00119262|80412627|FG001|Overall Study|others|5|||
27609600|NCT02401308|80412628|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
27609601|NCT02401308|80412629|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
27609602|NCT02294474|80412633|FG000|Overall Study|Adverse Event|7|||
27609603|NCT02294474|80412634|FG001|Overall Study|Adverse Event|7|||
27609604|NCT02294474|80412633|FG000|Overall Study|Lack of Efficacy|2|||
27500685|NCT04065048|80027700|FG000|Overall Study|Adverse Event|1|||
27500686|NCT04065048|80027701|FG001|Overall Study|Adverse Event|0|||
27500687|NCT04065048|80027702|FG002|Overall Study|Adverse Event|1|||
27500688|NCT04065048|80027703|FG003|Overall Study|Adverse Event|0|||
27500689|NCT00633477|80027706|FG000|Overall Study|Death|1|||
27500690|NCT00633477|80027707|FG001|Overall Study|Death|0|||
27500691|NCT00633477|80027706|FG000|Overall Study|Randomized but not treated|1|||
27500692|NCT00633477|80027707|FG001|Overall Study|Randomized but not treated|0|||
27500693|NCT00392327|80027708|FG000|Overall Study|Death|1|||
27500694|NCT00392327|80027709|FG001|Overall Study|Death|0|||
27500695|NCT00392327|80027710|FG002|Overall Study|Death|1|||
27500696|NCT00392327|80027711|FG003|Overall Study|Death|0|||
27500697|NCT00392327|80027712|FG004|Overall Study|Death|0|||
27500698|NCT00392327|80027713|FG005|Overall Study|Death|0|||
27500699|NCT00392327|80027714|FG006|Overall Study|Death|0|||
27500700|NCT00392327|80027715|FG007|Overall Study|Death|0|||
27500701|NCT00392327|80027708|FG000|Overall Study|Lack of Efficacy|8|||
27500702|NCT00392327|80027709|FG001|Overall Study|Lack of Efficacy|8|||
27500703|NCT00392327|80027710|FG002|Overall Study|Lack of Efficacy|9|||
27500704|NCT00392327|80027711|FG003|Overall Study|Lack of Efficacy|6|||
27500705|NCT00392327|80027712|FG004|Overall Study|Lack of Efficacy|3|||
27500706|NCT00392327|80027713|FG005|Overall Study|Lack of Efficacy|3|||
27500707|NCT00392327|80027714|FG006|Overall Study|Lack of Efficacy|3|||
27500708|NCT00392327|80027715|FG007|Overall Study|Lack of Efficacy|3|||
27500709|NCT00392327|80027708|FG000|Overall Study|Physician Decision|3|||
27500710|NCT00392327|80027709|FG001|Overall Study|Physician Decision|5|||
27500711|NCT00392327|80027710|FG002|Overall Study|Physician Decision|2|||
27609605|NCT02294474|80412634|FG001|Overall Study|Lack of Efficacy|1|||
27609606|NCT02294474|80412633|FG000|Overall Study|Protocol Violation|4|||
27609607|NCT02294474|80412634|FG001|Overall Study|Protocol Violation|2|||
27609608|NCT02294474|80412633|FG000|Overall Study|Other than specified above|12|||
27609609|NCT02294474|80412634|FG001|Overall Study|Other than specified above|12|||
27609610|NCT01777321|80412636|FG000|Overall Study|Withdrawal by Subject|0|||
27609611|NCT01777321|80412637|FG001|Overall Study|Withdrawal by Subject|1|||
27609612|NCT03469349|80412638|FG000|Overall Study|Withdrawal by Subject|1|||
27609613|NCT03469349|80412639|FG001|Overall Study|Withdrawal by Subject|3|||
27609614|NCT03469349|80412638|FG000|Overall Study|Progressive Disease|0|||
27609615|NCT03469349|80412639|FG001|Overall Study|Progressive Disease|1|||
27609616|NCT03469349|80412638|FG000|Overall Study|Lost to Follow-up|2|||
27609617|NCT03469349|80412639|FG001|Overall Study|Lost to Follow-up|2|||
27839657|NCT03414034|81242465|FG002|Overall Study|Non-compliance With Study Drug|1|||
27500712|NCT00392327|80027711|FG003|Overall Study|Physician Decision|2|||
27500713|NCT00392327|80027712|FG004|Overall Study|Physician Decision|0|||
27500714|NCT00392327|80027713|FG005|Overall Study|Physician Decision|1|||
27500715|NCT00392327|80027714|FG006|Overall Study|Physician Decision|5|||
27500716|NCT00392327|80027715|FG007|Overall Study|Physician Decision|3|||
27500717|NCT00392327|80027708|FG000|Overall Study|Protocol Violation|0|||
27500718|NCT00392327|80027709|FG001|Overall Study|Protocol Violation|0|||
27500719|NCT00392327|80027710|FG002|Overall Study|Protocol Violation|1|||
27500720|NCT00392327|80027711|FG003|Overall Study|Protocol Violation|0|||
27500721|NCT00392327|80027712|FG004|Overall Study|Protocol Violation|0|||
27500722|NCT00392327|80027713|FG005|Overall Study|Protocol Violation|0|||
27500723|NCT00392327|80027714|FG006|Overall Study|Protocol Violation|0|||
27609618|NCT03469349|80412638|FG000|Overall Study|Adverse Event|2|||
27609619|NCT03469349|80412639|FG001|Overall Study|Adverse Event|4|||
27609620|NCT03292146|80412643|FG000|Baseline to 12 Months|Relocation|1|||
27609621|NCT03292146|80412644|FG001|Baseline to 12 Months|Relocation|0|||
27609622|NCT03292146|80412643|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
27720666|NCT02918019|80810173|FG002|Overall Study|Lost to Follow-up|0|||
27500724|NCT00392327|80027715|FG007|Overall Study|Protocol Violation|0|||
27500725|NCT00392327|80027708|FG000|Overall Study|Withdrawal by Subject|3|||
27500726|NCT00392327|80027709|FG001|Overall Study|Withdrawal by Subject|2|||
27500727|NCT00392327|80027710|FG002|Overall Study|Withdrawal by Subject|4|||
27500728|NCT00392327|80027711|FG003|Overall Study|Withdrawal by Subject|6|||
27500729|NCT00392327|80027712|FG004|Overall Study|Withdrawal by Subject|0|||
27500730|NCT00392327|80027713|FG005|Overall Study|Withdrawal by Subject|1|||
27500731|NCT00392327|80027714|FG006|Overall Study|Withdrawal by Subject|1|||
27500732|NCT00392327|80027715|FG007|Overall Study|Withdrawal by Subject|5|||
27500733|NCT00392327|80027708|FG000|Overall Study|Ineligible|0|||
27500734|NCT00392327|80027709|FG001|Overall Study|Ineligible|4|||
27500735|NCT00392327|80027710|FG002|Overall Study|Ineligible|3|||
27500736|NCT00392327|80027711|FG003|Overall Study|Ineligible|2|||
27500737|NCT00392327|80027712|FG004|Overall Study|Ineligible|0|||
27500738|NCT00392327|80027713|FG005|Overall Study|Ineligible|0|||
27500739|NCT00392327|80027714|FG006|Overall Study|Ineligible|0|||
27500740|NCT00392327|80027715|FG007|Overall Study|Ineligible|0|||
27500741|NCT00829426|80027716|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27500742|NCT00829426|80027717|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27500743|NCT05131165|80027720|FG000|Overall Study|Death|1|||
27500744|NCT05131165|80027721|FG001|Overall Study|Death|1|||
27500745|NCT05131165|80027722|FG002|Overall Study|Death|0|||
27500746|NCT05131165|80027720|FG000|Overall Study|Lost to Follow-up|2|||
27500747|NCT05131165|80027721|FG001|Overall Study|Lost to Follow-up|2|||
27500748|NCT05131165|80027722|FG002|Overall Study|Lost to Follow-up|5|||
27500749|NCT05131165|80027720|FG000|Overall Study|Transferred out of clinic|1|||
27500750|NCT05131165|80027721|FG001|Overall Study|Transferred out of clinic|0|||
27500751|NCT05131165|80027722|FG002|Overall Study|Transferred out of clinic|3|||
27500752|NCT05131165|80027720|FG000|Overall Study|Dropped out|1|||
27500753|NCT05131165|80027721|FG001|Overall Study|Dropped out|2|||
27500754|NCT05131165|80027722|FG002|Overall Study|Dropped out|0|||
27500755|NCT03346434|80027723|FG000|Overall Study|Randomized in Error|0|||
27500756|NCT03346434|80027724|FG001|Overall Study|Randomized in Error|0|||
27500757|NCT03346434|80027725|FG002|Overall Study|Randomized in Error|0|||
27500758|NCT03346434|80027726|FG003|Overall Study|Randomized in Error|0|||
27720667|NCT02918019|80810174|FG003|Overall Study|Lost to Follow-up|1|||
27500759|NCT03346434|80027727|FG004|Overall Study|Randomized in Error|1|||
27500760|NCT03346434|80027728|FG005|Overall Study|Randomized in Error|0|||
27500761|NCT03346434|80027723|FG000|Overall Study|Withdrawal by Subject|0|||
27500762|NCT03346434|80027724|FG001|Overall Study|Withdrawal by Subject|0|||
27500763|NCT03346434|80027725|FG002|Overall Study|Withdrawal by Subject|1|||
27500764|NCT03346434|80027726|FG003|Overall Study|Withdrawal by Subject|0|||
27500765|NCT03346434|80027727|FG004|Overall Study|Withdrawal by Subject|1|||
27500766|NCT03346434|80027728|FG005|Overall Study|Withdrawal by Subject|0|||
27500767|NCT03346434|80027723|FG000|Overall Study|Lost to Follow-up|0|||
27500768|NCT03346434|80027724|FG001|Overall Study|Lost to Follow-up|0|||
27500769|NCT03346434|80027725|FG002|Overall Study|Lost to Follow-up|0|||
27500770|NCT03346434|80027726|FG003|Overall Study|Lost to Follow-up|0|||
27609623|NCT03292146|80412644|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
27609624|NCT03292146|80412643|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
27609625|NCT03292146|80412644|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
27609626|NCT03292146|80412643|FG000|12 Months to 24 Months|Planning pregnancy|2|||
27609627|NCT03292146|80412644|FG001|12 Months to 24 Months|Planning pregnancy|2|||
27609628|NCT03292146|80412643|FG000|12 Months to 24 Months|Personal reasons|1|||
27609629|NCT03292146|80412644|FG001|12 Months to 24 Months|Personal reasons|0|||
27609630|NCT03292146|80412643|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
27609631|NCT03292146|80412644|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
27609632|NCT04844918|80412645|FG000|Overall Study|Adverse Event|7|||
27609633|NCT04844918|80412646|FG001|Overall Study|Adverse Event|8|||
27609634|NCT04844918|80412647|FG002|Overall Study|Adverse Event|5|||
27609635|NCT04844918|80412645|FG000|Overall Study|Physician Decision|0|||
27609636|NCT04844918|80412646|FG001|Overall Study|Physician Decision|1|||
27609637|NCT04844918|80412647|FG002|Overall Study|Physician Decision|0|||
27609638|NCT04844918|80412645|FG000|Overall Study|Withdrawal by Subject|6|||
27609639|NCT04844918|80412646|FG001|Overall Study|Withdrawal by Subject|3|||
27609640|NCT04844918|80412647|FG002|Overall Study|Withdrawal by Subject|3|||
27609641|NCT04844918|80412645|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
27609642|NCT04844918|80412646|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
27609643|NCT04844918|80412647|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
27609644|NCT03447730|80412648|FG000|Overall Study|Adverse Event|0|||
27609645|NCT03447730|80412649|FG001|Overall Study|Adverse Event|2|||
27609646|NCT03447730|80412650|FG002|Overall Study|Adverse Event|0|||
27609647|NCT02796963|80412652|FG000|Overall Study|Lost to Follow-up|89|||
27609648|NCT02796963|80412653|FG001|Overall Study|Lost to Follow-up|76|||
27609649|NCT02796963|80412654|FG002|Overall Study|Lost to Follow-up|69|||
27609650|NCT02796963|80412655|FG003|Overall Study|Lost to Follow-up|72|||
27609651|NCT02200939|80412656|FG000|Overall Study|Participant withdrew consent|0|||
27609652|NCT02200939|80412657|FG001|Overall Study|Participant withdrew consent|1|||
27839658|NCT03414034|81242463|FG000|Overall Study|Physician Decision|1|||
27839659|NCT03414034|81242464|FG001|Overall Study|Physician Decision|3|||
27839660|NCT03414034|81242465|FG002|Overall Study|Physician Decision|2|||
27500771|NCT03346434|80027727|FG004|Overall Study|Lost to Follow-up|1|||
27500772|NCT03346434|80027728|FG005|Overall Study|Lost to Follow-up|1|||
27500773|NCT03346434|80027723|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
27500774|NCT03346434|80027724|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
27609653|NCT02200939|80412656|FG000|Overall Study|Lost to Follow-up|2|||
27609654|NCT02200939|80412657|FG001|Overall Study|Lost to Follow-up|9|||
27609655|NCT02200939|80412656|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
27609656|NCT02200939|80412657|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
27609657|NCT00810082|80412659|FG000|Overall Study|Lost to Follow-up|0|||
27609658|NCT00810082|80412660|FG001|Overall Study|Lost to Follow-up|4|||
27839661|NCT03414034|81242463|FG000|Overall Study|Withdrawal of Informed Consent|2|||
27839662|NCT03414034|81242464|FG001|Overall Study|Withdrawal of Informed Consent|1|||
27839663|NCT03414034|81242465|FG002|Overall Study|Withdrawal of Informed Consent|4|||
27839664|NCT03414034|81242463|FG000|Overall Study|Progressive Disease|15|||
27839665|NCT03414034|81242464|FG001|Overall Study|Progressive Disease|15|||
27609659|NCT00077636|80412661|FG000|Overall Study|Refused Treatment|9|||
27609660|NCT00077636|80412662|FG001|Overall Study|Refused Treatment|31|||
27609661|NCT00077636|80412661|FG000|Overall Study|Admin|3|||
27609662|NCT00077636|80412662|FG001|Overall Study|Admin|3|||
27609663|NCT00077636|80412661|FG000|Overall Study|Withdrawal by Subject|2|||
27609664|NCT00077636|80412662|FG001|Overall Study|Withdrawal by Subject|2|||
27609665|NCT00077636|80412661|FG000|Overall Study|Adverse Event|17|||
27609666|NCT00077636|80412662|FG001|Overall Study|Adverse Event|34|||
27609667|NCT00077636|80412661|FG000|Overall Study|Protocol Violation|0|||
27609668|NCT00077636|80412662|FG001|Overall Study|Protocol Violation|2|||
27609669|NCT00077636|80412661|FG000|Overall Study|Lost to Follow-up|10|||
27609670|NCT00077636|80412662|FG001|Overall Study|Lost to Follow-up|18|||
27609671|NCT00077636|80412661|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
27609672|NCT00077636|80412662|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
27839666|NCT03414034|81242465|FG002|Overall Study|Progressive Disease|17|||
27839667|NCT03414034|81242463|FG000|Overall Study|Miscellaneous|0|||
27839668|NCT03414034|81242464|FG001|Overall Study|Miscellaneous|0|||
27500775|NCT03346434|80027725|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
27500776|NCT03346434|80027726|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
27500777|NCT03346434|80027727|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
27500778|NCT03346434|80027728|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
27500779|NCT02953652|80027729|FG000|Overall Study|Adverse Event|18|||
27500780|NCT02953652|80027729|FG000|Overall Study|Withdrawal by Subject|6|||
27500781|NCT02953652|80027729|FG000|Overall Study|Protocol Violation|1|||
27500782|NCT02953652|80027729|FG000|Overall Study|Disease Progression|27|||
27500783|NCT03995368|80027730|FG000|Overall Study|Lost to Follow-up|1|||
27500784|NCT03995368|80027731|FG001|Overall Study|Lost to Follow-up|4|||
27609673|NCT01351025|80412666|FG000|Week 0 - 20|Lost to Follow-up|2|||
27609674|NCT01351025|80412667|FG001|Week 0 - 20|Lost to Follow-up|1|||
27609675|NCT01351025|80412666|FG000|Week 0 - 20|Withdrawal by Subject|1|||
27609676|NCT01351025|80412667|FG001|Week 0 - 20|Withdrawal by Subject|0|||
27839669|NCT03414034|81242465|FG002|Overall Study|Miscellaneous|2|||
27839670|NCT05258630|81242466|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
27839671|NCT05258630|81242467|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
27839672|NCT05258630|81242466|FG000|Overall Study|Lost to Follow-up|0|||
27839673|NCT05258630|81242467|FG001|Overall Study|Lost to Follow-up|2|||
27839674|NCT00526162|81242468|FG000|Overall Study|Device not implanted|3|||
27839675|NCT02597049|81242469|FG000|Overall Study|Lost to Follow-up|0|||
27839676|NCT02597049|81242470|FG001|Overall Study|Lost to Follow-up|3|||
27839677|NCT02597049|81242471|FG002|Overall Study|Lost to Follow-up|2|||
27839678|NCT02597049|81242469|FG000|Overall Study|Withdrawal by Subject|2|||
27839679|NCT02597049|81242470|FG001|Overall Study|Withdrawal by Subject|2|||
27839680|NCT02597049|81242471|FG002|Overall Study|Withdrawal by Subject|1|||
27839681|NCT02597049|81242469|FG000|Overall Study|Adverse Event|2|||
27839682|NCT02597049|81242470|FG001|Overall Study|Adverse Event|0|||
27839683|NCT02597049|81242471|FG002|Overall Study|Adverse Event|0|||
27839684|NCT02597049|81242469|FG000|Overall Study|Death|2|||
27839685|NCT02597049|81242470|FG001|Overall Study|Death|0|||
27839686|NCT02597049|81242471|FG002|Overall Study|Death|0|||
27839687|NCT02597049|81242469|FG000|Overall Study|Noncompliant with Study Visits|1|||
27839688|NCT02597049|81242470|FG001|Overall Study|Noncompliant with Study Visits|0|||
27839689|NCT02597049|81242471|FG002|Overall Study|Noncompliant with Study Visits|0|||
27839690|NCT01958060|81242472|FG000|Overall Study|Not treated|2|||
27839691|NCT01958060|81242473|FG001|Overall Study|Not treated|0|||
27839692|NCT01958060|81242474|FG002|Overall Study|Not treated|0|||
27839693|NCT01958060|81242475|FG003|Overall Study|Not treated|0|||
27890967|NCT00537316|81434205|FG000|Part 2|Administrative|16|||
27609677|NCT01351025|80412666|FG000|Week 24 - 44|Lost to Follow-up|0|||
27839694|NCT01958060|81242476|FG004|Overall Study|Not treated|1|||
27839695|NCT01958060|81242477|FG005|Overall Study|Not treated|0|||
27839696|NCT04573309|81242478|FG000|Overall Study|Protocol Violation|1|||
27839697|NCT04573309|81242479|FG001|Overall Study|Protocol Violation|0|||
27839698|NCT02805309|81242483|FG000|Overall Study|Lost to Follow-up|2|||
27839699|NCT02805309|81242484|FG001|Overall Study|Lost to Follow-up|2|||
27890968|NCT00537316|81434206|FG001|Part 2|Administrative|8|||
27890969|NCT00537316|81434207|FG002|Part 2|Administrative|24|||
27500785|NCT03995368|80027732|FG002|Overall Study|Lost to Follow-up|1|||
27500786|NCT03995368|80027730|FG000|Overall Study|Did not meet inclusion criteria|1|||
27839700|NCT02805309|81242485|FG002|Overall Study|Lost to Follow-up|2|||
27839701|NCT02805309|81242483|FG000|Overall Study|Post-Randomization Exclusion|0|||
27839702|NCT02805309|81242484|FG001|Overall Study|Post-Randomization Exclusion|2|||
27609678|NCT01351025|80412667|FG001|Week 24 - 44|Lost to Follow-up|2|||
27609679|NCT01351025|80412666|FG000|Week 24 - 44|Site closed|0|||
27609680|NCT01351025|80412667|FG001|Week 24 - 44|Site closed|1|||
27839703|NCT02805309|81242485|FG002|Overall Study|Post-Randomization Exclusion|1|||
27890970|NCT00537316|81434208|FG003|Part 2|Administrative|3|||
27609681|NCT01351025|80412666|FG000|Week 24 - 44|unable to get to clinic|1|||
27609682|NCT01351025|80412667|FG001|Week 24 - 44|unable to get to clinic|1|||
27609683|NCT00926003|80412673|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
27609684|NCT00926003|80412674|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
27609685|NCT00926003|80412675|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
27609686|NCT00926003|80412673|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
27500787|NCT03995368|80027731|FG001|Overall Study|Did not meet inclusion criteria|6|||
27500788|NCT03995368|80027732|FG002|Overall Study|Did not meet inclusion criteria|3|||
27500789|NCT03995368|80027730|FG000|Overall Study|Withdrawal by Subject|0|||
27500790|NCT03995368|80027731|FG001|Overall Study|Withdrawal by Subject|1|||
27500791|NCT03995368|80027732|FG002|Overall Study|Withdrawal by Subject|1|||
27500792|NCT00886379|80027733|FG000|Overall Study|Transferred Schools|0|||
27500793|NCT00886379|80027734|FG001|Overall Study|Transferred Schools|0|||
27500794|NCT00886379|80027735|FG002|Overall Study|Transferred Schools|2|||
27500795|NCT00886379|80027736|FG003|Overall Study|Transferred Schools|1|||
27500796|NCT00886379|80027737|FG004|Overall Study|Transferred Schools|1|||
27500797|NCT00886379|80027733|FG000|Overall Study|Final blood draw not obtained|3|||
27500798|NCT00886379|80027734|FG001|Overall Study|Final blood draw not obtained|3|||
27500799|NCT00886379|80027735|FG002|Overall Study|Final blood draw not obtained|4|||
27500800|NCT00886379|80027736|FG003|Overall Study|Final blood draw not obtained|2|||
27500801|NCT00886379|80027737|FG004|Overall Study|Final blood draw not obtained|2|||
27500802|NCT04531176|80027738|FG000|Overall Study|Study was stopped early|24|||
27500803|NCT04531176|80027739|FG001|Overall Study|Study was stopped early|26|||
27500804|NCT04531176|80027740|FG002|Overall Study|Study was stopped early|24|||
27500805|NCT04038359|80027741|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
27500806|NCT04038359|80027742|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
27500807|NCT04038359|80027741|FG000|Overall Study|Death|8|||
27500808|NCT04038359|80027742|FG001|Overall Study|Death|7|||
27500809|NCT04038359|80027741|FG000|Overall Study|Lost to Follow-up|3|||
27500810|NCT04038359|80027742|FG001|Overall Study|Lost to Follow-up|0|||
27500811|NCT04038359|80027741|FG000|Overall Study|Participant Moved|1|||
27500812|NCT04038359|80027742|FG001|Overall Study|Participant Moved|0|||
27500813|NCT04038359|80027741|FG000|Overall Study|Withdrawal by Subject|4|||
27500814|NCT04038359|80027742|FG001|Overall Study|Withdrawal by Subject|3|||
27500815|NCT04038359|80027741|FG000|Overall Study|Physician Decision|3|||
27500816|NCT04038359|80027742|FG001|Overall Study|Physician Decision|2|||
27500817|NCT04038359|80027741|FG000|Overall Study|Adverse Event|0|||
27500818|NCT04038359|80027742|FG001|Overall Study|Adverse Event|2|||
27609687|NCT00926003|80412674|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
27609688|NCT00926003|80412675|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
27609689|NCT03101241|80412676|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
27720668|NCT02918019|80810171|FG000|Overall Study|Principal investigator request|0|||
27500819|NCT04038359|80027741|FG000|Overall Study|Progressive Disease|0|||
27500820|NCT04038359|80027742|FG001|Overall Study|Progressive Disease|1|||
27500821|NCT03629886|80027745|FG000|Overall Study|Migrated / moved from the study area|0|||
27500822|NCT03629886|80027746|FG001|Overall Study|Migrated / moved from the study area|55|||
27720669|NCT02918019|80810172|FG001|Overall Study|Principal investigator request|0|||
27500823|NCT03629886|80027745|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
27500824|NCT03629886|80027746|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
27500825|NCT03629886|80027745|FG000|Overall Study|Study vaccine not administrated|0|||
27500826|NCT03629886|80027746|FG001|Overall Study|Study vaccine not administrated|3|||
27500827|NCT03629886|80027745|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
27500828|NCT03629886|80027746|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
27609690|NCT03101241|80412677|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
27500829|NCT03629886|80027745|FG000|Overall Study|Refused vaccination step of the study|0|||
27500830|NCT03629886|80027746|FG001|Overall Study|Refused vaccination step of the study|44|||
27500831|NCT00878501|80027747|FG000|Overall Study|Adverse Event|11|||
27500832|NCT00878501|80027748|FG001|Overall Study|Adverse Event|3|||
27500833|NCT00878501|80027749|FG002|Overall Study|Adverse Event|3|||
27500834|NCT00878501|80027747|FG000|Overall Study|Lack of Efficacy|2|||
27609691|NCT03101241|80412676|FG000|Overall Study|Participant withdrew consent|3|||
27609692|NCT03101241|80412677|FG001|Overall Study|Participant withdrew consent|1|||
27609693|NCT03101241|80412676|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
27609694|NCT03101241|80412677|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
27609695|NCT03101241|80412676|FG000|Overall Study|Lost to Follow-up|2|||
27609696|NCT03101241|80412677|FG001|Overall Study|Lost to Follow-up|0|||
27609697|NCT03101241|80412676|FG000|Overall Study|Lack of Efficacy|0|||
27609698|NCT03101241|80412677|FG001|Overall Study|Lack of Efficacy|1|||
27609699|NCT03101241|80412676|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
27609700|NCT03101241|80412677|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
27500835|NCT00878501|80027748|FG001|Overall Study|Lack of Efficacy|1|||
27500836|NCT00878501|80027749|FG002|Overall Study|Lack of Efficacy|0|||
27500837|NCT00878501|80027747|FG000|Overall Study|Withdrawal by Subject|2|||
27500838|NCT00878501|80027748|FG001|Overall Study|Withdrawal by Subject|1|||
27500839|NCT00878501|80027749|FG002|Overall Study|Withdrawal by Subject|2|||
27500840|NCT00878501|80027747|FG000|Overall Study|Protocol Violation|0|||
27500841|NCT00878501|80027748|FG001|Overall Study|Protocol Violation|0|||
27500842|NCT00878501|80027749|FG002|Overall Study|Protocol Violation|1|||
27500843|NCT00878501|80027747|FG000|Overall Study|Incorrect enrolment|1|||
27500844|NCT00878501|80027748|FG001|Overall Study|Incorrect enrolment|2|||
27609701|NCT03714022|80412678|FG000|Overall Study|Adverse Event|1|||
27609702|NCT03714022|80412679|FG001|Overall Study|Adverse Event|0|||
27609703|NCT03714022|80412678|FG000|Overall Study|Consent withdrawal|0|||
27720670|NCT02918019|80810173|FG002|Overall Study|Principal investigator request|0|||
27500845|NCT00878501|80027749|FG002|Overall Study|Incorrect enrolment|0|||
27500846|NCT00878501|80027747|FG000|Overall Study|Intake of prohibited concom. medication|0|||
27500847|NCT00878501|80027748|FG001|Overall Study|Intake of prohibited concom. medication|0|||
27500848|NCT00878501|80027749|FG002|Overall Study|Intake of prohibited concom. medication|1|||
27609704|NCT03714022|80412679|FG001|Overall Study|Consent withdrawal|1|||
27609705|NCT03714022|80412678|FG000|Overall Study|Lost to Follow-up|3|||
27609706|NCT03714022|80412679|FG001|Overall Study|Lost to Follow-up|2|||
27609707|NCT04651114|80412680|FG000|Overall Study|Withdrawal by Subject|8|||
27609708|NCT00871403|80412681|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
27609709|NCT00871403|80412682|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
27609710|NCT00871403|80412683|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
27609711|NCT00871403|80412681|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
27500849|NCT00878501|80027747|FG000|Overall Study|Mis-randomisation of patient|1|||
27500850|NCT00878501|80027748|FG001|Overall Study|Mis-randomisation of patient|0|||
27500851|NCT00878501|80027749|FG002|Overall Study|Mis-randomisation of patient|0|||
27500852|NCT00878501|80027747|FG000|Overall Study|Administrative|0|||
27500853|NCT00878501|80027748|FG001|Overall Study|Administrative|0|||
27500854|NCT00878501|80027749|FG002|Overall Study|Administrative|1|||
27500855|NCT00374140|80027755|FG000|Overall Study|Lost to Follow-up|1|||
27500856|NCT00374140|80027755|FG000|Overall Study|Protocol Violation|1|||
27720671|NCT02918019|80810174|FG003|Overall Study|Principal investigator request|1|||
27720672|NCT02918019|80810171|FG000|Overall Study|Physician Decision|1|||
27720673|NCT02918019|80810172|FG001|Overall Study|Physician Decision|3|||
27720674|NCT02918019|80810173|FG002|Overall Study|Physician Decision|2|||
27720675|NCT02918019|80810174|FG003|Overall Study|Physician Decision|0|||
27720676|NCT02918019|80810171|FG000|Overall Study|Protocol deviation|1|||
27720677|NCT02918019|80810172|FG001|Overall Study|Protocol deviation|1|||
27720678|NCT02918019|80810173|FG002|Overall Study|Protocol deviation|0|||
27720679|NCT02918019|80810174|FG003|Overall Study|Protocol deviation|2|||
27720680|NCT02918019|80810171|FG000|Overall Study|Withdrawal by Subject|3|||
27720681|NCT02918019|80810172|FG001|Overall Study|Withdrawal by Subject|4|||
27720682|NCT02918019|80810173|FG002|Overall Study|Withdrawal by Subject|6|||
27720683|NCT02918019|80810174|FG003|Overall Study|Withdrawal by Subject|4|||
27720684|NCT02918019|80810171|FG000|Overall Study|Adverse Event|0|||
27720685|NCT02918019|80810172|FG001|Overall Study|Adverse Event|1|||
27720686|NCT02918019|80810173|FG002|Overall Study|Adverse Event|0|||
27720687|NCT02918019|80810174|FG003|Overall Study|Adverse Event|1|||
27720688|NCT00527605|80810179|FG000|Overall Study|Adverse Event|3|||
27720689|NCT00527605|80810180|FG001|Overall Study|Adverse Event|0|||
27720690|NCT00527605|80810179|FG000|Overall Study|Withdrawal by Subject|3|||
27720691|NCT00527605|80810180|FG001|Overall Study|Withdrawal by Subject|7|||
27720692|NCT00527605|80810179|FG000|Overall Study|Lost to Follow-up|6|||
27720693|NCT00527605|80810180|FG001|Overall Study|Lost to Follow-up|2|||
27720694|NCT00527605|80810179|FG000|Overall Study|Protocol Violation|1|||
27720695|NCT00527605|80810180|FG001|Overall Study|Protocol Violation|2|||
27720696|NCT04372927|80810181|FG000|Overall Study|Death|1|||
27720697|NCT02665286|80810182|FG000|Overall Study|Lost to Follow-up|3|||
27720698|NCT02665286|80810183|FG001|Overall Study|Lost to Follow-up|2|||
27720699|NCT02665286|80810184|FG002|Overall Study|Lost to Follow-up|1|||
27720700|NCT01046877|80810188|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
27720701|NCT01046877|80810188|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
27720702|NCT02301403|80810191|FG000|Overall Study|Withdrawal by Subject|28|||
27720703|NCT02301403|80810192|FG001|Overall Study|Withdrawal by Subject|41|||
27720704|NCT00796315|80810193|FG000|Overall Study|Protocol Violation|0|||
27720705|NCT00796315|80810194|FG001|Overall Study|Protocol Violation|1|||
27720706|NCT00796315|80810195|FG002|Overall Study|Protocol Violation|0|||
27720707|NCT03948178|80810196|FG000|Overall Study|Protocol Violation|1|||
27839704|NCT01214239|81242486|FG000|Overall Study|Adverse Event|3|||
27890971|NCT00537316|81434209|FG004|Part 2|Administrative|1|||
27500857|NCT04739982|80027757|FG000|Overall Study|Lost to Follow-up|176|||
27500858|NCT04739982|80027758|FG001|Overall Study|Lost to Follow-up|65|||
27720708|NCT03948178|80810196|FG000|Overall Study|Lost to Follow-up|2|||
27839705|NCT01214239|81242487|FG001|Overall Study|Adverse Event|4|||
27839706|NCT01214239|81242486|FG000|Overall Study|Protocol Violation|2|||
27839707|NCT01214239|81242487|FG001|Overall Study|Protocol Violation|1|||
27839708|NCT01214239|81242486|FG000|Overall Study|Lost to Follow-up|1|||
27839709|NCT01214239|81242487|FG001|Overall Study|Lost to Follow-up|1|||
27839710|NCT01214239|81242486|FG000|Overall Study|Withdrawal by Subject|4|||
27839711|NCT01214239|81242487|FG001|Overall Study|Withdrawal by Subject|9|||
27839712|NCT01214239|81242486|FG000|Overall Study|Lack of Efficacy|1|||
27839713|NCT01214239|81242487|FG001|Overall Study|Lack of Efficacy|2|||
27839714|NCT01214239|81242486|FG000|Overall Study|patient's private reason|1|||
27839715|NCT01214239|81242487|FG001|Overall Study|patient's private reason|1|||
27500859|NCT04739982|80027757|FG000|Overall Study|Withdrawal by Subject|19|||
27609712|NCT00871403|80412682|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
27609713|NCT00871403|80412683|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
27720709|NCT03948178|80810196|FG000|Overall Study|Withdrawal by Subject|2|||
27720710|NCT03948178|80810196|FG000|Overall Study|Reason not known|2|||
27720711|NCT03948178|80810196|FG000|Overall Study|Personal reason|14|||
27839716|NCT05497557|81242492|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
27839717|NCT05497557|81242493|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
27890972|NCT00537316|81434210|FG005|Part 2|Administrative|4|||
27500860|NCT04739982|80027758|FG001|Overall Study|Withdrawal by Subject|0|||
27720712|NCT03948178|80810196|FG000|Overall Study|Disease progression|30|||
27720713|NCT03948178|80810196|FG000|Overall Study|Adverse Event|12|||
27720714|NCT03948178|80810196|FG000|Overall Study|Sponsor terminated study|164|||
27720715|NCT02721355|80810197|FG000|Overall Study|Lost to Follow-up|6|||
27720716|NCT02721355|80810198|FG001|Overall Study|Lost to Follow-up|1|||
27720717|NCT01145066|80810202|FG000|Overall Study|To resume NSAIDs|2|||
27720718|NCT01145066|80810203|FG001|Overall Study|To resume NSAIDs|2|||
27720719|NCT01145066|80810204|FG002|Overall Study|To resume NSAIDs|1|||
27720720|NCT01145066|80810202|FG000|Overall Study|Non-related surgery|0|||
27720721|NCT01145066|80810203|FG001|Overall Study|Non-related surgery|0|||
27720722|NCT01145066|80810204|FG002|Overall Study|Non-related surgery|1|||
27720723|NCT01145066|80810202|FG000|Overall Study|Withdrawal by Subject|0|||
27720724|NCT01145066|80810203|FG001|Overall Study|Withdrawal by Subject|0|||
27720725|NCT01145066|80810204|FG002|Overall Study|Withdrawal by Subject|2|||
27720726|NCT01145066|80810202|FG000|Overall Study|To start new med|1|||
27720727|NCT01145066|80810203|FG001|Overall Study|To start new med|0|||
27720728|NCT01145066|80810204|FG002|Overall Study|To start new med|0|||
27720729|NCT01145066|80810202|FG000|Overall Study|problems swallowing capsule|1|||
27720730|NCT01145066|80810203|FG001|Overall Study|problems swallowing capsule|0|||
27720731|NCT01145066|80810204|FG002|Overall Study|problems swallowing capsule|0|||
27720732|NCT01145066|80810202|FG000|Overall Study|Abdominal discomfort|0|||
27720733|NCT01145066|80810203|FG001|Overall Study|Abdominal discomfort|1|||
27720734|NCT01145066|80810204|FG002|Overall Study|Abdominal discomfort|0|||
27720735|NCT01145066|80810202|FG000|Overall Study|Low platelet count|0|||
27720736|NCT01145066|80810203|FG001|Overall Study|Low platelet count|1|||
27720737|NCT01145066|80810204|FG002|Overall Study|Low platelet count|0|||
27720738|NCT00573794|80810205|FG000|Overall Study|Adverse Event|81|||
27720739|NCT00573794|80810205|FG000|Overall Study|Withdrew Consent|90|||
27720740|NCT00573794|80810205|FG000|Overall Study|Lost to Follow-up|13|||
27720741|NCT00573794|80810205|FG000|Overall Study|Protocol Violation|6|||
27720742|NCT00573794|80810205|FG000|Overall Study|Lack of Efficacy|94|||
27720743|NCT00573794|80810205|FG000|Overall Study|Other|46|||
27720744|NCT02435849|80810208|FG000|Overall Study|Death|23|||
27720745|NCT02435849|80810209|FG001|Overall Study|Death|0|||
27720746|NCT02435849|80810208|FG000|Overall Study|Lack of Efficacy|10|||
27720747|NCT02435849|80810209|FG001|Overall Study|Lack of Efficacy|0|||
27720748|NCT02435849|80810208|FG000|Overall Study|New therapy for study indication|8|||
27720749|NCT02435849|80810209|FG001|Overall Study|New therapy for study indication|0|||
27720750|NCT02435849|80810208|FG000|Overall Study|Subject/guardian decision|5|||
27720751|NCT02435849|80810209|FG001|Overall Study|Subject/guardian decision|1|||
27720752|NCT02435849|80810208|FG000|Overall Study|Lost to Follow-up|1|||
27720753|NCT02435849|80810209|FG001|Overall Study|Lost to Follow-up|0|||
27720754|NCT02435849|80810208|FG000|Overall Study|Physician Decision|1|||
27720755|NCT02435849|80810209|FG001|Overall Study|Physician Decision|0|||
27720756|NCT01765673|80810210|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
27720757|NCT02615990|80810211|FG000|Overall Study|study terminated|1|||
27720758|NCT02615990|80810212|FG001|Overall Study|study terminated|1|||
27720759|NCT00493870|80810213|FG000|Overall Study|Lost to Follow-up|12|||
27720760|NCT00493870|80810214|FG001|Overall Study|Lost to Follow-up|15|||
27720761|NCT02526550|80810219|FG000|Overall Study|Lost to Follow-up|1|||
27839718|NCT05497557|81242494|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
27839719|NCT03732833|81242495|FG000|Overall Study|Adverse Event|0|||
27839720|NCT03732833|81242496|FG001|Overall Study|Adverse Event|3|||
27839721|NCT03732833|81242497|FG002|Overall Study|Adverse Event|1|||
27839722|NCT03732833|81242495|FG000|Overall Study|Withdrawal by Subject|11|||
27839723|NCT03732833|81242496|FG001|Overall Study|Withdrawal by Subject|13|||
27839724|NCT03732833|81242497|FG002|Overall Study|Withdrawal by Subject|8|||
27839725|NCT03732833|81242495|FG000|Overall Study|Lost to Follow-up|3|||
27839726|NCT03732833|81242496|FG001|Overall Study|Lost to Follow-up|5|||
27839727|NCT03732833|81242497|FG002|Overall Study|Lost to Follow-up|4|||
27839728|NCT03732833|81242495|FG000|Overall Study|Pregnancy|0|||
27839729|NCT03732833|81242496|FG001|Overall Study|Pregnancy|2|||
27839730|NCT03732833|81242497|FG002|Overall Study|Pregnancy|0|||
27839731|NCT03732833|81242495|FG000|Overall Study|Physician Decision|2|||
27890973|NCT00537316|81434211|FG006|Part 2|Administrative|1|||
27839732|NCT03732833|81242496|FG001|Overall Study|Physician Decision|3|||
27839733|NCT03732833|81242497|FG002|Overall Study|Physician Decision|1|||
27839734|NCT03732833|81242495|FG000|Overall Study|Covid-19 related and other reasons|2|||
27720762|NCT03509350|80810222|FG000|Overall Study|Withdrawal by Subject|0|||
27720763|NCT03509350|80810223|FG001|Overall Study|Withdrawal by Subject|2|||
27720764|NCT01064167|80810241|FG000|Overall Study|Protocol Violation|14|||
27720765|NCT01064167|80810242|FG001|Overall Study|Protocol Violation|15|||
27720766|NCT02307370|80810243|FG000|Overall Study|Death|5|||
27720767|NCT02307370|80810243|FG000|Overall Study|Lost to Follow-up|1|||
27720768|NCT02307370|80810243|FG000|Overall Study|Withdrawal by Subject|1|||
27720769|NCT02307370|80810243|FG000|Overall Study|Declined Addendum ICF|6|||
27720770|NCT02307370|80810243|FG000|Overall Study|No response during telephone contact|5|||
27720771|NCT02307370|80810243|FG000|Overall Study|Protocol Violation|1|||
27839735|NCT03732833|81242496|FG001|Overall Study|Covid-19 related and other reasons|7|||
27720772|NCT01042600|80810244|FG000|Overall Study|Ineligible|1|||
27720773|NCT01042600|80810245|FG001|Overall Study|Ineligible|0|||
27839736|NCT03732833|81242497|FG002|Overall Study|Covid-19 related and other reasons|3|||
27720774|NCT02684981|80810246|FG000|Overall Study|Permanently discontinued the treatment|157|||
27839737|NCT02359864|81242501|FG000|Overall Study|Withdrawal by Subject|1|||
27839738|NCT02359864|81242502|FG001|Overall Study|Withdrawal by Subject|0|||
27839739|NCT04501094|81242508|FG000|Overall Study|Death (unrelated to research)|1|||
27839740|NCT04501094|81242509|FG001|Overall Study|Death (unrelated to research)|0|||
27839741|NCT01745094|81242512|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
27839742|NCT01745094|81242513|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
27839743|NCT01745094|81242514|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
27839744|NCT01745094|81242515|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
27839745|NCT01745094|81242512|FG000|Overall Study|Adverse Event|0|||
27839746|NCT01745094|81242513|FG001|Overall Study|Adverse Event|0|||
27839747|NCT01745094|81242514|FG002|Overall Study|Adverse Event|3|||
27839748|NCT01745094|81242515|FG003|Overall Study|Adverse Event|0|||
27839749|NCT01745094|81242512|FG000|Overall Study|Withdrawal by Subject|2|||
27839750|NCT01745094|81242513|FG001|Overall Study|Withdrawal by Subject|0|||
27839751|NCT01745094|81242514|FG002|Overall Study|Withdrawal by Subject|1|||
27839752|NCT01745094|81242515|FG003|Overall Study|Withdrawal by Subject|2|||
27839753|NCT01745094|81242512|FG000|Overall Study|Protocol Violation|1|||
27839754|NCT01745094|81242513|FG001|Overall Study|Protocol Violation|0|||
27839755|NCT01745094|81242514|FG002|Overall Study|Protocol Violation|3|||
27839756|NCT01745094|81242515|FG003|Overall Study|Protocol Violation|1|||
27839757|NCT01745094|81242512|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
27839758|NCT01745094|81242513|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
27839759|NCT01745094|81242514|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
27839760|NCT01745094|81242515|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
27839761|NCT01745094|81242512|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
27839762|NCT01745094|81242513|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
27839763|NCT01745094|81242514|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
27839764|NCT01745094|81242515|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
27839765|NCT01745094|81242512|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
27839766|NCT01745094|81242513|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
27839767|NCT01745094|81242514|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
27839768|NCT01745094|81242515|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
27839769|NCT00880334|81242519|FG000|Randomized Phase|Physician Decision|1|||
27839770|NCT00880334|81242520|FG001|Randomized Phase|Physician Decision|0|||
27839771|NCT00880334|81242519|FG000|Randomized Phase|Withdrawal by Subject|2|||
27839772|NCT00880334|81242520|FG001|Randomized Phase|Withdrawal by Subject|1|||
27839773|NCT00880334|81242519|FG000|Randomized Phase|Inadequate Labs|1|||
27839774|NCT00880334|81242520|FG001|Randomized Phase|Inadequate Labs|1|||
27839775|NCT00880334|81242519|FG000|Randomized Phase|Brain Metastasis|0|||
27839776|NCT00880334|81242520|FG001|Randomized Phase|Brain Metastasis|1|||
27839777|NCT00880334|81242519|FG000|Randomized Phase|Crossover Participants|0|||
27839778|NCT00880334|81242520|FG001|Randomized Phase|Crossover Participants|37|||
27839779|NCT00820599|81242521|FG000|Overall Study|Death|129|||
27839780|NCT00820599|81242521|FG000|Overall Study|Withdrawal by Subject|2|||
27839781|NCT01872715|81242522|FG000|Overall Study|Adverse Event|1|||
27839782|NCT01872715|81242522|FG000|Overall Study|Protocol Violation|1|||
27839783|NCT01872715|81242522|FG000|Overall Study|Withdrawal by Subject|2|||
27839784|NCT03303417|81242531|FG000|Overall Study|Withdrawal by Subject|1|||
27839785|NCT03303417|81242532|FG001|Overall Study|Withdrawal by Subject|1|||
27839786|NCT03578809|81242534|FG000|Overall Study|Death|0|||
27839787|NCT03578809|81242535|FG001|Overall Study|Death|2|||
27839788|NCT03578809|81242536|FG002|Overall Study|Death|0|||
27839789|NCT03578809|81242537|FG003|Overall Study|Death|1|||
27839790|NCT03578809|81242534|FG000|Overall Study|Lost to Follow-up|0|||
27839791|NCT03578809|81242535|FG001|Overall Study|Lost to Follow-up|1|||
27839792|NCT03578809|81242536|FG002|Overall Study|Lost to Follow-up|0|||
27839793|NCT03578809|81242537|FG003|Overall Study|Lost to Follow-up|0|||
27839794|NCT03578809|81242534|FG000|Overall Study|Withdrawal by Subject|3|||
27839795|NCT03578809|81242535|FG001|Overall Study|Withdrawal by Subject|5|||
27839796|NCT03578809|81242536|FG002|Overall Study|Withdrawal by Subject|2|||
27839797|NCT03578809|81242537|FG003|Overall Study|Withdrawal by Subject|0|||
27839798|NCT03578809|81242534|FG000|Overall Study|Other|3|||
27839799|NCT03578809|81242535|FG001|Overall Study|Other|6|||
27839800|NCT03578809|81242536|FG002|Overall Study|Other|2|||
27839801|NCT03578809|81242537|FG003|Overall Study|Other|8|||
27839802|NCT02005562|81242548|FG000|Overall Study|Death|2|||
27839803|NCT02005562|81242549|FG001|Overall Study|Death|2|||
27839804|NCT02005562|81242548|FG000|Overall Study|Graft loss|7|||
27890974|NCT00231114|81434212|FG000|Randomized|Withdrawal by Subject|6|||
27890975|NCT00231114|81434213|FG001|Randomized|Withdrawal by Subject|3|||
27890976|NCT00231114|81434212|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
27890977|NCT00231114|81434213|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
27890978|NCT00231114|81434212|FG000|Post-Treatment Period|Lost to Follow-up|6|||
27890979|NCT00231114|81434213|FG001|Post-Treatment Period|Lost to Follow-up|1|||
27890980|NCT00231114|81434212|FG000|Post-Treatment Period|Physician Decision|1|||
27720775|NCT02684981|80810247|FG001|Overall Study|Permanently discontinued the treatment|161|||
27720776|NCT02684981|80810248|FG002|Overall Study|Permanently discontinued the treatment|110|||
27720777|NCT02684981|80810246|FG000|Overall Study|Other|83|||
27720778|NCT02684981|80810247|FG001|Overall Study|Other|49|||
27720779|NCT02684981|80810248|FG002|Overall Study|Other|17|||
27720780|NCT02432235|80810249|FG000|Overall Study|Death|1|||
27720781|NCT02432235|80810250|FG001|Overall Study|Death|1|||
27720782|NCT02432235|80810251|FG002|Overall Study|Death|2|||
27720783|NCT02432235|80810252|FG003|Overall Study|Death|2|||
27720784|NCT02432235|80810253|FG004|Overall Study|Death|1|||
27839805|NCT02005562|81242549|FG001|Overall Study|Graft loss|6|||
27839806|NCT02005562|81242548|FG000|Overall Study|Withdrawal by Subject|2|||
27839807|NCT02005562|81242549|FG001|Overall Study|Withdrawal by Subject|2|||
27839808|NCT02005562|81242548|FG000|Overall Study|No transplant|1|||
27839809|NCT02005562|81242549|FG001|Overall Study|No transplant|4|||
27839810|NCT02005562|81242548|FG000|Overall Study|Physician Decision|0|||
27839811|NCT02005562|81242549|FG001|Overall Study|Physician Decision|1|||
27839812|NCT01952691|81242552|FG000|Overall Study|Lost to Follow-up|2|||
27839813|NCT03619876|81242553|FG000|Overall Study|Withdrawal by Subject|1|||
27839814|NCT03619876|81242554|FG001|Overall Study|Withdrawal by Subject|2|||
27839815|NCT03619876|81242553|FG000|Overall Study|Withdrawal due to incidental finding|0|||
27839816|NCT03619876|81242554|FG001|Overall Study|Withdrawal due to incidental finding|2|||
27839817|NCT02004691|81242562|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
27839818|NCT02004691|81242563|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
27839819|NCT02004691|81242562|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
27839820|NCT02004691|81242563|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
27839821|NCT02004691|81242562|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
27839822|NCT02004691|81242563|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
27839823|NCT02004691|81242562|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
27839824|NCT02004691|81242563|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
27839825|NCT02004691|81242562|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
27839826|NCT02004691|81242563|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
27839827|NCT02004691|81242562|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
27839828|NCT02004691|81242563|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
27839829|NCT04307849|81242564|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
27839830|NCT04307849|81242565|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
27839831|NCT04307849|81242566|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
27839832|NCT04307849|81242567|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
27839833|NCT04307849|81242568|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
27839834|NCT04307849|81242569|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
27839835|NCT04307849|81242564|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
27839836|NCT04307849|81242565|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
27839837|NCT04307849|81242566|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
27839838|NCT04307849|81242567|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
27839839|NCT04307849|81242568|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
27839840|NCT04307849|81242569|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
27839841|NCT04307849|81242564|FG000|Overall Study|Family member did not want them to continue|0|||
27839842|NCT04307849|81242565|FG001|Overall Study|Family member did not want them to continue|0|||
27839843|NCT04307849|81242566|FG002|Overall Study|Family member did not want them to continue|1|||
27839844|NCT04307849|81242567|FG003|Overall Study|Family member did not want them to continue|0|||
27839845|NCT04307849|81242568|FG004|Overall Study|Family member did not want them to continue|0|||
27839846|NCT04307849|81242569|FG005|Overall Study|Family member did not want them to continue|0|||
27839847|NCT04307849|81242564|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
27839848|NCT04307849|81242565|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
27839849|NCT04307849|81242566|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
27839850|NCT04307849|81242567|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
27839851|NCT04307849|81242568|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
27839852|NCT04307849|81242569|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
27839853|NCT01109849|81242570|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
27839854|NCT01109849|81242571|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
27839855|NCT01109849|81242572|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
27720785|NCT02432235|80810254|FG005|Overall Study|Death|3|||
27720786|NCT02432235|80810255|FG006|Overall Study|Death|11|||
27720787|NCT02432235|80810256|FG007|Overall Study|Death|15|||
27720788|NCT02432235|80810257|FG008|Overall Study|Death|15|||
27500861|NCT04739982|80027757|FG000|Overall Study|Protocol Violation|0|||
27500862|NCT04739982|80027758|FG001|Overall Study|Protocol Violation|5|||
27500863|NCT05526716|80027759|FG000|Overall Study|Death|1|||
27500864|NCT05526716|80027760|FG001|Overall Study|Death|2|||
27500865|NCT05526716|80027759|FG000|Overall Study|Lost to Follow-up|17|||
27500866|NCT05526716|80027760|FG001|Overall Study|Lost to Follow-up|15|||
27500867|NCT05526716|80027759|FG000|Overall Study|Physician Decision|0|||
27500868|NCT05526716|80027760|FG001|Overall Study|Physician Decision|1|||
27500869|NCT05526716|80027759|FG000|Overall Study|Randomized by mistake without study treatment|0|||
27500870|NCT05526716|80027760|FG001|Overall Study|Randomized by mistake without study treatment|1|||
27500871|NCT05526716|80027759|FG000|Overall Study|Withdrawal by Subject|12|||
27500872|NCT05526716|80027760|FG001|Overall Study|Withdrawal by Subject|12|||
27500873|NCT05526716|80027759|FG000|Overall Study|Not reported|0|||
27500874|NCT05526716|80027760|FG001|Overall Study|Not reported|2|||
27500875|NCT06271993|80027761|FG000|Overall Study|Not reactive to histamine|5|||
27500876|NCT06271993|80027762|FG001|Overall Study|Not reactive to histamine|5|||
27500877|NCT06271993|80027763|FG002|Overall Study|Not reactive to histamine|5|||
27500878|NCT05712460|80027764|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500879|NCT05712460|80027765|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500880|NCT05712460|80027766|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500881|NCT05712460|80027767|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500882|NCT05712460|80027768|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500883|NCT05712460|80027769|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500884|NCT05712460|80027770|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500885|NCT05712460|80027771|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
27500886|NCT05712460|80027772|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500887|NCT05712460|80027773|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500888|NCT05712460|80027774|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500889|NCT05712460|80027775|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
27500890|NCT03532451|80027779|FG000|Overall Study|Withdrawal by Subject|0|||
27500891|NCT03532451|80027780|FG001|Overall Study|Withdrawal by Subject|1|||
27500892|NCT03532451|80027779|FG000|Overall Study|Did not undergo surgery|1|||
27500893|NCT03532451|80027780|FG001|Overall Study|Did not undergo surgery|1|||
27500894|NCT02163538|80027786|FG000|Overall Study|Protocol Violation|1|||
27500895|NCT02163538|80027787|FG001|Overall Study|Protocol Violation|0|||
27500896|NCT02163538|80027786|FG000|Overall Study|Physician Decision|0|||
27500897|NCT02163538|80027787|FG001|Overall Study|Physician Decision|1|||
27500898|NCT04913610|80027788|FG000|Randomized Participants|Did Not Receive Treatment|0|||
27500899|NCT04913610|80027789|FG001|Randomized Participants|Did Not Receive Treatment|0|||
27500900|NCT04913610|80027790|FG002|Randomized Participants|Did Not Receive Treatment|1|||
27500901|NCT04913610|80027791|FG003|Randomized Participants|Did Not Receive Treatment|1|||
27500902|NCT04913610|80027792|FG004|Randomized Participants|Did Not Receive Treatment|0|||
27500903|NCT04913610|80027788|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
27500904|NCT04913610|80027789|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
27500905|NCT04913610|80027790|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
27500906|NCT04913610|80027791|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
27500907|NCT04913610|80027792|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
27500908|NCT05430854|80027793|FG000|Overall Study|Trial terminated by Sponsor|39|||
27500909|NCT05430854|80027794|FG001|Overall Study|Trial terminated by Sponsor|50|||
27500910|NCT05430854|80027795|FG002|Overall Study|Trial terminated by Sponsor|46|||
27500911|NCT05430854|80027793|FG000|Overall Study|Withdrawal by Subject|0|||
27500912|NCT05430854|80027794|FG001|Overall Study|Withdrawal by Subject|3|||
27500913|NCT05430854|80027795|FG002|Overall Study|Withdrawal by Subject|0|||
27500914|NCT03096834|80027796|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
27500915|NCT03096834|80027797|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
27500916|NCT03096834|80027798|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
27500917|NCT03096834|80027799|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
27500918|NCT03096834|80027796|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
27500919|NCT03096834|80027797|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
27890981|NCT00231114|81434213|FG001|Post-Treatment Period|Physician Decision|0|||
27500920|NCT03096834|80027798|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
27500921|NCT03096834|80027799|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
27500922|NCT03096834|80027796|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
27500923|NCT03096834|80027797|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
27500924|NCT03096834|80027798|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
27500925|NCT03096834|80027799|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
27500926|NCT03096834|80027796|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
27720789|NCT02432235|80810258|FG009|Overall Study|Death|3|||
27720790|NCT02432235|80810259|FG010|Overall Study|Death|1|||
27500927|NCT03096834|80027797|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
27500928|NCT03096834|80027798|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
27500929|NCT03096834|80027799|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
27500930|NCT03096834|80027796|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
27500931|NCT03096834|80027797|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
27500932|NCT03096834|80027798|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
27500933|NCT03096834|80027799|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
27500934|NCT03096834|80027796|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
27500935|NCT03096834|80027797|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
27500936|NCT03096834|80027798|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
27500937|NCT03096834|80027799|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
27500938|NCT03096834|80027796|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
27500939|NCT03096834|80027797|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
27500940|NCT03096834|80027798|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
27500941|NCT03096834|80027799|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
27609714|NCT00871403|80412681|FG000|Combination Treatment Phase|Adverse Event|0|||
27609715|NCT00871403|80412682|FG001|Combination Treatment Phase|Adverse Event|17|||
27609716|NCT00871403|80412683|FG002|Combination Treatment Phase|Adverse Event|2|||
27609717|NCT00871403|80412681|FG000|Combination Treatment Phase|Disease Progression|0|||
27609718|NCT00871403|80412682|FG001|Combination Treatment Phase|Disease Progression|8|||
27609719|NCT00871403|80412683|FG002|Combination Treatment Phase|Disease Progression|5|||
27609720|NCT00871403|80412681|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
27609721|NCT00871403|80412682|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
27609722|NCT00871403|80412683|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
27609723|NCT00871403|80412681|FG000|Combination Treatment Phase|Physician Decision|0|||
27500942|NCT03096834|80027796|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
27500943|NCT03096834|80027797|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
27500944|NCT03096834|80027798|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
27500945|NCT03096834|80027799|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
27609724|NCT00871403|80412682|FG001|Combination Treatment Phase|Physician Decision|1|||
27609725|NCT00871403|80412683|FG002|Combination Treatment Phase|Physician Decision|3|||
27609726|NCT00871403|80412681|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
27609727|NCT00871403|80412682|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
27609728|NCT00871403|80412683|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
27609729|NCT00871403|80412681|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
27609730|NCT00871403|80412682|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
27609731|NCT00871403|80412683|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
27609732|NCT04000594|80412684|FG000|Overall Study|Withdrawal by Subject|1|||
27609733|NCT04000594|80412685|FG001|Overall Study|Withdrawal by Subject|0|||
27609734|NCT04000594|80412686|FG002|Overall Study|Withdrawal by Subject|0|||
27609735|NCT03592277|80412687|FG000|Overall Study|Withdrawal by Subject|6|||
27609736|NCT03592277|80412688|FG001|Overall Study|Withdrawal by Subject|8|||
27609737|NCT02213328|80412689|FG000|Overall Study|Withdrawal by Subject|10|||
27609738|NCT02213328|80412689|FG000|Overall Study|Physician Decision|2|||
27609739|NCT02213328|80412689|FG000|Overall Study|Lost to Follow-up|16|||
27609740|NCT02904902|80412690|FG000|Overall Study|Withdrawal by Subject|1|||
27609741|NCT00728962|80412698|FG000|Implant Placement Surgery|Adverse Event|8|||
27609742|NCT00728962|80412698|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
27609743|NCT00728962|80412698|FG000|Implant Placement Surgery|Protocol Violation|1|||
27500946|NCT03096834|80027796|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
27500947|NCT03096834|80027797|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
27500948|NCT03096834|80027798|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
27500949|NCT03096834|80027799|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
27500950|NCT03096834|80027796|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
27500951|NCT03096834|80027797|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
27500952|NCT03096834|80027798|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
27609744|NCT00728962|80412698|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
27609745|NCT00728962|80412698|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
27609746|NCT03363659|80412703|FG000|Overall Study|Adverse Event|1|||
27609747|NCT03363659|80412703|FG000|Overall Study|Screen fail|1|||
27609748|NCT03363659|80412703|FG000|Overall Study|Withdrawal by Subject|1|||
27609749|NCT00114634|80412704|FG000|Overall Study|failure to return forms|3|||
27839856|NCT01109849|81242573|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
27609750|NCT02254408|80412705|FG000|Overall Study|Randomized But Not Treated|1|||
27609751|NCT02254408|80412706|FG001|Overall Study|Randomized But Not Treated|3|||
27609752|NCT02254408|80412705|FG000|Overall Study|Adverse Event|1|||
27609753|NCT02254408|80412706|FG001|Overall Study|Adverse Event|0|||
27609754|NCT02254408|80412705|FG000|Overall Study|Death|2|||
27609755|NCT02254408|80412706|FG001|Overall Study|Death|3|||
27609756|NCT02254408|80412705|FG000|Overall Study|Investigator's Discretion|0|||
27609757|NCT02254408|80412706|FG001|Overall Study|Investigator's Discretion|1|||
27609758|NCT02254408|80412705|FG000|Overall Study|Withdrawal by Subject|3|||
27609759|NCT02254408|80412706|FG001|Overall Study|Withdrawal by Subject|3|||
27609760|NCT02254408|80412705|FG000|Overall Study|Lost to Follow-up|1|||
27609761|NCT02254408|80412706|FG001|Overall Study|Lost to Follow-up|0|||
27609762|NCT00720902|80412707|FG000|Overall Study|Withdrawal by Subject|1|||
27609763|NCT00720902|80412708|FG001|Overall Study|Withdrawal by Subject|0|||
27609764|NCT00720902|80412707|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
27609765|NCT00720902|80412708|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
27609766|NCT01464021|80412716|FG000|Overall Study|Withdrawal by Subject|13|||
27609767|NCT01464021|80412716|FG000|Overall Study|Lost to Follow-up|1|||
27609768|NCT01464021|80412716|FG000|Overall Study|Lack of Efficacy|1|||
27609769|NCT01464021|80412716|FG000|Overall Study|various|11|||
27609770|NCT01032044|80412717|FG000|Overall Study|Protocol Violation|14|||
27609771|NCT01032044|80412718|FG001|Overall Study|Protocol Violation|8|||
27609772|NCT01032044|80412717|FG000|Overall Study|Adverse Event|0|||
27609773|NCT01032044|80412718|FG001|Overall Study|Adverse Event|1|||
27609774|NCT01032044|80412717|FG000|Overall Study|Lost to Follow-up|11|||
27609775|NCT01032044|80412718|FG001|Overall Study|Lost to Follow-up|11|||
27609776|NCT01190215|80412719|FG000|Up to Month 6|Lost to Follow-up|2|||
27609777|NCT01190215|80412720|FG001|Up to Month 6|Lost to Follow-up|0|||
27500953|NCT03096834|80027799|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
27500954|NCT03096834|80027796|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
27500955|NCT03096834|80027797|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
27500956|NCT03096834|80027798|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
27500957|NCT03096834|80027799|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
27500958|NCT03096834|80027796|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
27500959|NCT03096834|80027797|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
27500960|NCT03096834|80027798|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
27500961|NCT03096834|80027799|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
27500962|NCT02004236|80027800|FG000|Overall Study|Lack of Efficacy|0|||
27500963|NCT02004236|80027801|FG001|Overall Study|Lack of Efficacy|0|||
27500964|NCT02004236|80027802|FG002|Overall Study|Lack of Efficacy|16|||
27500965|NCT03818256|80027805|FG000|Overall Study|Withdrawal by Subject|2|||
27500966|NCT03818256|80027806|FG001|Overall Study|Withdrawal by Subject|2|||
27500967|NCT03818256|80027805|FG000|Overall Study|Adverse Event|3|||
27500968|NCT03818256|80027806|FG001|Overall Study|Adverse Event|1|||
27500969|NCT03818256|80027805|FG000|Overall Study|Lost to Follow-up|0|||
27500970|NCT03818256|80027806|FG001|Overall Study|Lost to Follow-up|5|||
27500971|NCT03818256|80027805|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
27500972|NCT03818256|80027806|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
27609778|NCT03077620|80412721|FG000|Overall Study|Unable to place lumbar catheter|1|||
27609779|NCT03077620|80412722|FG001|Overall Study|Unable to place lumbar catheter|0|||
27609780|NCT03077620|80412723|FG002|Overall Study|Unable to place lumbar catheter|1|||
27609781|NCT03077620|80412724|FG003|Overall Study|Unable to place lumbar catheter|0|||
27609782|NCT03077620|80412721|FG000|Overall Study|Withdrawal by Subject|0|||
27609783|NCT03077620|80412722|FG001|Overall Study|Withdrawal by Subject|1|||
27720791|NCT02432235|80810260|FG011|Overall Study|Death|0|||
27720792|NCT02432235|80810249|FG000|Overall Study|Withdrawal by Subject|0|||
27720793|NCT02432235|80810250|FG001|Overall Study|Withdrawal by Subject|1|||
27720794|NCT02432235|80810251|FG002|Overall Study|Withdrawal by Subject|0|||
27720795|NCT02432235|80810252|FG003|Overall Study|Withdrawal by Subject|0|||
27720796|NCT02432235|80810253|FG004|Overall Study|Withdrawal by Subject|0|||
27720797|NCT02432235|80810254|FG005|Overall Study|Withdrawal by Subject|2|||
27720798|NCT02432235|80810255|FG006|Overall Study|Withdrawal by Subject|5|||
27720799|NCT02432235|80810256|FG007|Overall Study|Withdrawal by Subject|3|||
27720800|NCT02432235|80810257|FG008|Overall Study|Withdrawal by Subject|1|||
27500973|NCT03818256|80027805|FG000|Overall Study|Not reporting for scheduled visits|1|||
27500974|NCT03818256|80027806|FG001|Overall Study|Not reporting for scheduled visits|0|||
27500975|NCT03818256|80027805|FG000|Overall Study|Non-compliant with investigational product|1|||
27500976|NCT03818256|80027806|FG001|Overall Study|Non-compliant with investigational product|0|||
27500977|NCT04617782|80027807|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
27500978|NCT04617782|80027807|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
27609784|NCT03077620|80412723|FG002|Overall Study|Withdrawal by Subject|0|||
27609785|NCT03077620|80412724|FG003|Overall Study|Withdrawal by Subject|0|||
27609786|NCT03077620|80412721|FG000|Overall Study|Physician Decision|0|||
27609787|NCT03077620|80412722|FG001|Overall Study|Physician Decision|0|||
27609788|NCT03077620|80412723|FG002|Overall Study|Physician Decision|1|||
27609789|NCT03077620|80412724|FG003|Overall Study|Physician Decision|0|||
27720801|NCT02432235|80810258|FG009|Overall Study|Withdrawal by Subject|0|||
27500979|NCT04617782|80027807|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
27500980|NCT04617782|80027807|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
27500981|NCT04617782|80027807|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
27500982|NCT04617782|80027807|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
27500983|NCT00948246|80027810|FG000|Overall Study|Lost to Follow-up|11|||
27500984|NCT00948246|80027810|FG000|Overall Study|Adverse Event|11|||
27500985|NCT00948246|80027810|FG000|Overall Study|Death|1|||
27500986|NCT00948246|80027810|FG000|Overall Study|Withdrawal by Subject|1|||
27500987|NCT05291520|80027811|FG000|Overall Study|Lost to Follow-up|0|||
27500988|NCT05291520|80027812|FG001|Overall Study|Lost to Follow-up|0|||
27500989|NCT05291520|80027813|FG002|Overall Study|Lost to Follow-up|1|||
27500990|NCT03363841|80027814|FG000|Overall Study|Adverse Event|1|||
27500991|NCT03363841|80027814|FG000|Overall Study|Withdrawal by Subject|1|||
27500992|NCT03363841|80027814|FG000|Overall Study|Death|7|||
27500993|NCT03363841|80027814|FG000|Overall Study|Physician Decision|1|||
27500994|NCT03459079|80027815|FG000|Overall Study|Adverse Event|4|||
27609790|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
27609791|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
27890982|NCT00231114|81434212|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
27890983|NCT00231114|81434213|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
27500995|NCT03459079|80027816|FG001|Overall Study|Adverse Event|2|||
27500996|NCT03459079|80027817|FG002|Overall Study|Adverse Event|0|||
27500997|NCT03459079|80027815|FG000|Overall Study|Withdrawal by Subject|2|||
27500998|NCT03459079|80027816|FG001|Overall Study|Withdrawal by Subject|2|||
27500999|NCT03459079|80027817|FG002|Overall Study|Withdrawal by Subject|0|||
27501000|NCT01690143|80027830|FG000|Overall Study|Withdrawal by Subject|1|||
27890984|NCT02256982|81434215|FG000|Overall Study|Disease Progression|0|||
27890985|NCT02256982|81434216|FG001|Overall Study|Disease Progression|1|||
27890986|NCT01701193|81434217|FG000|Overall Study|Withdrawal by Subject|2|||
27890987|NCT01701193|81434218|FG001|Overall Study|Withdrawal by Subject|2|||
27890988|NCT01701193|81434219|FG002|Overall Study|Withdrawal by Subject|1|||
27501007|NCT04338321|80027835|FG000|Overall Study|Adverse Event|4|||
27609792|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
27501008|NCT04338321|80027836|FG001|Overall Study|Adverse Event|10|||
27501009|NCT04338321|80027835|FG000|Overall Study|Death|1|||
27501010|NCT04338321|80027836|FG001|Overall Study|Death|1|||
27609793|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
27890989|NCT01701193|81434220|FG003|Overall Study|Withdrawal by Subject|2|||
27890990|NCT01701193|81434217|FG000|Overall Study|Adverse Event|1|||
27501011|NCT04338321|80027835|FG000|Overall Study|Lost to Follow-up|4|||
27609794|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
27501012|NCT04338321|80027836|FG001|Overall Study|Lost to Follow-up|9|||
27501013|NCT04338321|80027835|FG000|Overall Study|Withdrawal by Subject|45|||
27501014|NCT04338321|80027836|FG001|Overall Study|Withdrawal by Subject|69|||
27501015|NCT04338321|80027835|FG000|Overall Study|Physician Decision|5|||
27501016|NCT04338321|80027836|FG001|Overall Study|Physician Decision|9|||
27501017|NCT04338321|80027835|FG000|Overall Study|Other|3|||
27501018|NCT04338321|80027836|FG001|Overall Study|Other|10|||
27501019|NCT03391466|80027839|FG000|Overall Study|Death|82|||
27501020|NCT03391466|80027840|FG001|Overall Study|Death|85|||
27501021|NCT03391466|80027839|FG000|Overall Study|Still on study|93|||
27501022|NCT03391466|80027840|FG001|Overall Study|Still on study|74|||
27501023|NCT03391466|80027839|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
27501024|NCT03391466|80027840|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
27501025|NCT03391466|80027839|FG000|Overall Study|Lost to Follow-up|5|||
27501026|NCT03391466|80027840|FG001|Overall Study|Lost to Follow-up|5|||
27501027|NCT03391466|80027839|FG000|Overall Study|Investigator decision|0|||
27501028|NCT03391466|80027840|FG001|Overall Study|Investigator decision|1|||
27501029|NCT03391466|80027839|FG000|Overall Study|Other|0|||
27501030|NCT03391466|80027840|FG001|Overall Study|Other|1|||
27501031|NCT02741128|80027841|FG000|Overall Study|Protocol Violation|4|||
27501032|NCT02741128|80027842|FG001|Overall Study|Protocol Violation|1|||
27501033|NCT02741128|80027841|FG000|Overall Study|Withdrawal by Subject|2|||
27501034|NCT02741128|80027842|FG001|Overall Study|Withdrawal by Subject|0|||
27501035|NCT02741128|80027841|FG000|Overall Study|Lost to Follow-up|1|||
27501036|NCT02741128|80027842|FG001|Overall Study|Lost to Follow-up|0|||
27501037|NCT02731638|80027843|FG000|Overall Study|Lost to Follow-up|6|||
27501038|NCT02731638|80027844|FG001|Overall Study|Lost to Follow-up|9|||
27501039|NCT04408989|80027845|FG000|Overall Study|Lost to Follow-up|0|||
27501040|NCT04408989|80027846|FG001|Overall Study|Lost to Follow-up|0|||
27501041|NCT04408989|80027847|FG002|Overall Study|Lost to Follow-up|1|||
27501042|NCT04408989|80027845|FG000|Overall Study|Withdrawal by Subject|0|||
27501043|NCT04408989|80027846|FG001|Overall Study|Withdrawal by Subject|0|||
27501044|NCT04408989|80027847|FG002|Overall Study|Withdrawal by Subject|2|||
27501045|NCT00687596|80027848|FG000|Overall Study|Adverse Event (AE)|10|||
27501046|NCT00687596|80027849|FG001|Overall Study|Adverse Event (AE)|3|||
27501047|NCT00687596|80027848|FG000|Overall Study|Radiological Disease Progression|6|||
27501048|NCT00687596|80027849|FG001|Overall Study|Radiological Disease Progression|2|||
27501049|NCT00687596|80027848|FG000|Overall Study|Clinical Disease Progression|1|||
27501050|NCT00687596|80027849|FG001|Overall Study|Clinical Disease Progression|3|||
27501051|NCT00687596|80027848|FG000|Overall Study|Investigator Discretion|3|||
27501052|NCT00687596|80027849|FG001|Overall Study|Investigator Discretion|1|||
27501053|NCT00687596|80027848|FG000|Overall Study|Sponsor Terminated Study|6|||
27501054|NCT00687596|80027849|FG001|Overall Study|Sponsor Terminated Study|17|||
27501055|NCT04780061|80027855|FG000|Overall Study|Withdrawal by Subject|5|||
27890991|NCT01701193|81434218|FG001|Overall Study|Adverse Event|0|||
27890992|NCT01701193|81434219|FG002|Overall Study|Adverse Event|0|||
27501056|NCT04780061|80027856|FG001|Overall Study|Withdrawal by Subject|8|||
27501057|NCT04780061|80027855|FG000|Overall Study|Adverse Event|2|||
27501058|NCT04780061|80027856|FG001|Overall Study|Adverse Event|2|||
27501059|NCT04780061|80027855|FG000|Overall Study|Lost to Follow-up|1|||
27501060|NCT04780061|80027856|FG001|Overall Study|Lost to Follow-up|5|||
27501061|NCT05082857|80027857|FG000|Overall Study|participants relocated and could not continue|2|||
27501062|NCT05082857|80027858|FG001|Overall Study|participants relocated and could not continue|1|||
27501063|NCT05082857|80027857|FG000|Overall Study|Lost to Follow-up|1|||
27720802|NCT02432235|80810259|FG010|Overall Study|Withdrawal by Subject|0|||
27839857|NCT01109849|81242574|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
27839858|NCT01109849|81242570|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
27839859|NCT01109849|81242571|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27839860|NCT01109849|81242572|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27839861|NCT01109849|81242573|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27839862|NCT01109849|81242574|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
27839863|NCT01109849|81242570|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
27839864|NCT01109849|81242571|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
27839865|NCT01109849|81242572|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
27839866|NCT01109849|81242573|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
27839867|NCT01109849|81242574|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
27839868|NCT01109849|81242570|FG000|Initial Randomization: ADHD Treatment|move away|2|||
27839869|NCT01109849|81242571|FG001|Initial Randomization: ADHD Treatment|move away|7|||
27839870|NCT01109849|81242572|FG002|Initial Randomization: ADHD Treatment|move away|0|||
27839871|NCT01109849|81242573|FG003|Initial Randomization: ADHD Treatment|move away|0|||
27839872|NCT01109849|81242574|FG004|Initial Randomization: ADHD Treatment|move away|0|||
27839873|NCT01109849|81242570|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
27839874|NCT01109849|81242571|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
27839875|NCT01109849|81242572|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
27501064|NCT05082857|80027858|FG001|Overall Study|Lost to Follow-up|3|||
27501065|NCT04199351|80027859|FG000|Overall Study|Decision by sponsor|0|||
27501066|NCT04199351|80027860|FG001|Overall Study|Decision by sponsor|0|||
27501067|NCT04199351|80027861|FG002|Overall Study|Decision by sponsor|0|||
27501068|NCT04199351|80027862|FG003|Overall Study|Decision by sponsor|2|||
27501069|NCT04199351|80027863|FG004|Overall Study|Decision by sponsor|0|||
27501070|NCT04199351|80027864|FG005|Overall Study|Decision by sponsor|0|||
27501071|NCT04199351|80027865|FG006|Overall Study|Decision by sponsor|0|||
27501072|NCT04199351|80027866|FG007|Overall Study|Decision by sponsor|0|||
27501073|NCT04199351|80027867|FG008|Overall Study|Decision by sponsor|0|||
27501074|NCT04199351|80027868|FG009|Overall Study|Decision by sponsor|6|||
27501075|NCT04199351|80027859|FG000|Overall Study|Lost to Follow-up|0|||
27501076|NCT04199351|80027860|FG001|Overall Study|Lost to Follow-up|0|||
27501077|NCT04199351|80027861|FG002|Overall Study|Lost to Follow-up|1|||
27501078|NCT04199351|80027862|FG003|Overall Study|Lost to Follow-up|0|||
27501079|NCT04199351|80027863|FG004|Overall Study|Lost to Follow-up|0|||
27501080|NCT04199351|80027864|FG005|Overall Study|Lost to Follow-up|1|||
27501081|NCT04199351|80027865|FG006|Overall Study|Lost to Follow-up|0|||
27501082|NCT04199351|80027866|FG007|Overall Study|Lost to Follow-up|0|||
27501083|NCT04199351|80027867|FG008|Overall Study|Lost to Follow-up|0|||
27501084|NCT04199351|80027868|FG009|Overall Study|Lost to Follow-up|0|||
27501085|NCT04199351|80027859|FG000|Overall Study|Withdrawal by Subject|0|||
27501086|NCT04199351|80027860|FG001|Overall Study|Withdrawal by Subject|1|||
27501087|NCT04199351|80027861|FG002|Overall Study|Withdrawal by Subject|0|||
27501088|NCT04199351|80027862|FG003|Overall Study|Withdrawal by Subject|0|||
27501089|NCT04199351|80027863|FG004|Overall Study|Withdrawal by Subject|1|||
27501090|NCT04199351|80027864|FG005|Overall Study|Withdrawal by Subject|4|||
27501091|NCT04199351|80027865|FG006|Overall Study|Withdrawal by Subject|2|||
27501092|NCT04199351|80027866|FG007|Overall Study|Withdrawal by Subject|0|||
27501093|NCT04199351|80027867|FG008|Overall Study|Withdrawal by Subject|3|||
27501094|NCT04199351|80027868|FG009|Overall Study|Withdrawal by Subject|0|||
27501095|NCT04179175|80027869|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
27501096|NCT04179175|80027870|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
27501097|NCT04179175|80027871|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
27501098|NCT04179175|80027872|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
27501099|NCT04179175|80027873|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
27501100|NCT04179175|80027874|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
27501101|NCT04179175|80027869|FG000|Overall Study|Adverse Event|5|||
27501102|NCT04179175|80027870|FG001|Overall Study|Adverse Event|3|||
27501103|NCT04179175|80027871|FG002|Overall Study|Adverse Event|3|||
27501104|NCT04179175|80027872|FG003|Overall Study|Adverse Event|4|||
27501105|NCT04179175|80027873|FG004|Overall Study|Adverse Event|6|||
27501106|NCT04179175|80027874|FG005|Overall Study|Adverse Event|6|||
27501107|NCT04179175|80027869|FG000|Overall Study|Lack of Efficacy|5|||
27501108|NCT04179175|80027870|FG001|Overall Study|Lack of Efficacy|1|||
27501109|NCT04179175|80027871|FG002|Overall Study|Lack of Efficacy|3|||
27609795|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
27720803|NCT02432235|80810260|FG011|Overall Study|Withdrawal by Subject|0|||
27720804|NCT02432235|80810249|FG000|Overall Study|Lost to Follow-up|0|||
27501110|NCT04179175|80027872|FG003|Overall Study|Lack of Efficacy|2|||
27501111|NCT04179175|80027873|FG004|Overall Study|Lack of Efficacy|18|||
27501112|NCT04179175|80027874|FG005|Overall Study|Lack of Efficacy|7|||
27501113|NCT04179175|80027869|FG000|Overall Study|Lost to Follow-up|5|||
27501114|NCT04179175|80027870|FG001|Overall Study|Lost to Follow-up|3|||
27501115|NCT04179175|80027871|FG002|Overall Study|Lost to Follow-up|2|||
27501116|NCT04179175|80027872|FG003|Overall Study|Lost to Follow-up|2|||
27501117|NCT04179175|80027873|FG004|Overall Study|Lost to Follow-up|4|||
27501118|NCT04179175|80027874|FG005|Overall Study|Lost to Follow-up|5|||
27501119|NCT04179175|80027869|FG000|Overall Study|Physician Decision|2|||
27501120|NCT04179175|80027870|FG001|Overall Study|Physician Decision|0|||
27501121|NCT04179175|80027871|FG002|Overall Study|Physician Decision|2|||
27501122|NCT04179175|80027872|FG003|Overall Study|Physician Decision|3|||
27501123|NCT04179175|80027873|FG004|Overall Study|Physician Decision|1|||
27501124|NCT04179175|80027874|FG005|Overall Study|Physician Decision|1|||
27501125|NCT04179175|80027869|FG000|Overall Study|Pregnancy|3|||
27501126|NCT04179175|80027870|FG001|Overall Study|Pregnancy|0|||
27890993|NCT01701193|81434220|FG003|Overall Study|Adverse Event|0|||
27890994|NCT02968433|81434221|FG000|Overall Study|Withdrawal by Subject|1|||
27890995|NCT01869699|81434222|FG000|Overall Study|Withdrawal by Subject|1|||
27501127|NCT04179175|80027871|FG002|Overall Study|Pregnancy|3|||
27501128|NCT04179175|80027872|FG003|Overall Study|Pregnancy|0|||
27890996|NCT01869699|81434223|FG001|Overall Study|Withdrawal by Subject|0|||
27890997|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
27501129|NCT04179175|80027873|FG004|Overall Study|Pregnancy|1|||
27501130|NCT04179175|80027874|FG005|Overall Study|Pregnancy|2|||
27501131|NCT04179175|80027869|FG000|Overall Study|Withdrawal by Subject|22|||
27890998|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
27890999|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
27891000|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
27891001|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
27891002|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
27891003|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
27891004|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
27891005|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
27891006|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
27501132|NCT04179175|80027870|FG001|Overall Study|Withdrawal by Subject|10|||
27501133|NCT04179175|80027871|FG002|Overall Study|Withdrawal by Subject|12|||
27501134|NCT04179175|80027872|FG003|Overall Study|Withdrawal by Subject|8|||
27501135|NCT04179175|80027873|FG004|Overall Study|Withdrawal by Subject|23|||
27501136|NCT04179175|80027874|FG005|Overall Study|Withdrawal by Subject|31|||
27501137|NCT04179175|80027869|FG000|Overall Study|Technical problems|0|||
27501138|NCT04179175|80027870|FG001|Overall Study|Technical problems|0|||
27501139|NCT04179175|80027871|FG002|Overall Study|Technical problems|1|||
27501140|NCT04179175|80027872|FG003|Overall Study|Technical problems|1|||
27501141|NCT04179175|80027873|FG004|Overall Study|Technical problems|0|||
27501142|NCT04179175|80027874|FG005|Overall Study|Technical problems|0|||
27501143|NCT03409796|80027875|FG000|Overall Study|Adverse Event|2|||
27501144|NCT03409796|80027876|FG001|Overall Study|Adverse Event|0|||
27501145|NCT03409796|80027875|FG000|Overall Study|Other|0|||
27501146|NCT03409796|80027876|FG001|Overall Study|Other|1|||
27501147|NCT02018562|80027877|FG000|Overall Study|Withdrawal by Subject|2|||
27501148|NCT02018562|80027878|FG001|Overall Study|Withdrawal by Subject|0|||
27501149|NCT02018562|80027877|FG000|Overall Study|Discharged prior to study completion|1|||
27501150|NCT02018562|80027878|FG001|Overall Study|Discharged prior to study completion|0|||
27501151|NCT04698343|80027879|FG000|Overall Study|Withdrawal by Subject|6|||
27501152|NCT04698343|80027879|FG000|Overall Study|Physician Decision|2|||
27501153|NCT04698343|80027879|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
27501154|NCT04698343|80027879|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
27501155|NCT04698343|80027879|FG000|Overall Study|Personal reasons|3|||
27501156|NCT04698343|80027879|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
27501157|NCT05137041|80027884|FG000|Overall Study|Lost to Follow-up|1|||
27501158|NCT05137041|80027885|FG001|Overall Study|Lost to Follow-up|1|||
27501159|NCT05137041|80027884|FG000|Overall Study|Withdrawal by Subject|0|||
27501160|NCT05137041|80027885|FG001|Overall Study|Withdrawal by Subject|2|||
27839876|NCT01109849|81242573|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
27839877|NCT01109849|81242574|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
27839878|NCT01109849|81242570|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
27839879|NCT01109849|81242571|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
27839880|NCT01109849|81242572|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
27839881|NCT01109849|81242573|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
27839882|NCT01109849|81242574|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
27839883|NCT03727139|81242576|FG000|Overall Study|Protocol Violation|60|||
27839884|NCT03448692|81242577|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
27839885|NCT03448692|81242578|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
27839886|NCT03448692|81242577|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
27891007|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Death|1|||
27891008|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Death|0|||
27501161|NCT05137041|80027884|FG000|Overall Study|Reason not Specified|0|||
27501162|NCT05137041|80027885|FG001|Overall Study|Reason not Specified|1|||
27501163|NCT00581308|80027888|FG000|Pre Discharge|Lost to Follow-up|1|||
27501164|NCT00581308|80027888|FG000|Pre Discharge|Device Removed|1|||
27501165|NCT00581308|80027888|FG000|Month 1|Lost to Follow-up|3|||
27839887|NCT03448692|81242578|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
27839888|NCT03448692|81242577|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
27839889|NCT03448692|81242578|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
27839890|NCT03448692|81242577|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
27839891|NCT03448692|81242578|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
27839892|NCT03448692|81242577|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
27839893|NCT03448692|81242578|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
27839894|NCT02058160|81242579|FG000|Overall Study|Randomized but not treated|2|||
27839895|NCT02058160|81242580|FG001|Overall Study|Randomized but not treated|4|||
27839896|NCT02058160|81242579|FG000|Overall Study|Poor compliance to protocol|4|||
27839897|NCT02058160|81242580|FG001|Overall Study|Poor compliance to protocol|1|||
27839898|NCT02058160|81242579|FG000|Overall Study|Adverse Event|12|||
27839899|NCT02058160|81242580|FG001|Overall Study|Adverse Event|3|||
27839900|NCT02058160|81242579|FG000|Overall Study|Lost to Follow-up|1|||
27839901|NCT02058160|81242580|FG001|Overall Study|Lost to Follow-up|0|||
27839902|NCT02058160|81242579|FG000|Overall Study|Other than specified above|12|||
27839903|NCT02058160|81242580|FG001|Overall Study|Other than specified above|6|||
27839904|NCT01341405|81242581|FG000|Overall Study|Adverse Event|0|||
27839905|NCT01341405|81242582|FG001|Overall Study|Adverse Event|1|||
27839906|NCT01341405|81242583|FG002|Overall Study|Adverse Event|1|||
27839907|NCT01341405|81242581|FG000|Overall Study|Withdrawal by Subject|3|||
27839908|NCT01341405|81242582|FG001|Overall Study|Withdrawal by Subject|2|||
27839909|NCT01341405|81242583|FG002|Overall Study|Withdrawal by Subject|1|||
27839910|NCT00939523|81242587|FG000|Overall Study|Lack of Efficacy|1|||
27839911|NCT00939523|81242587|FG000|Overall Study|Physician Decision|2|||
27839912|NCT03407729|81242588|FG000|Overall Study|Lost to Follow-up|2|||
27839913|NCT03407729|81242589|FG001|Overall Study|Lost to Follow-up|0|||
27839914|NCT03407729|81242588|FG000|Overall Study|Unable to schedule|0|||
27839915|NCT03407729|81242589|FG001|Overall Study|Unable to schedule|3|||
27839916|NCT00084864|81242592|FG000|Overall Study|Adverse Event|1|||
27839917|NCT00084864|81242593|FG001|Overall Study|Adverse Event|0|||
27891009|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
27891010|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
27891011|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
27891012|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
27891013|NCT01876784|81434227|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
27891014|NCT01876784|81434228|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
27891015|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
27891016|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
27891017|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Adverse Event|2|||
27891018|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Adverse Event|6|||
27891019|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
27891020|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
27891021|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Progressive disease|4|||
27891022|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Progressive disease|35|||
27891023|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
27891024|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
27891025|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
27891026|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
27891027|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Death|0|||
27891028|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Death|1|||
27891029|NCT01876784|81434227|FG000|Open-label Period (31 Months)|Other than specified above|9|||
27891030|NCT01876784|81434228|FG001|Open-label Period (31 Months)|Other than specified above|18|||
27891031|NCT01646021|81434229|FG000|Overall Study|Death|77|||
27891032|NCT01646021|81434230|FG001|Overall Study|Death|83|||
27891033|NCT01646021|81434229|FG000|Overall Study|Study Terminated by Sponsor|50|||
27891034|NCT01646021|81434230|FG001|Overall Study|Study Terminated by Sponsor|41|||
27891035|NCT01646021|81434229|FG000|Overall Study|Lost to Follow-up|2|||
27891036|NCT01646021|81434230|FG001|Overall Study|Lost to Follow-up|2|||
27839918|NCT00084864|81242594|FG002|Overall Study|Adverse Event|0|||
27839919|NCT00084864|81242595|FG003|Overall Study|Adverse Event|0|||
27839920|NCT02754492|81242596|FG000|Overall Study|Protocol Violation|2|||
27891037|NCT01646021|81434229|FG000|Overall Study|Withdrawal by Subject|10|||
27891038|NCT01646021|81434230|FG001|Overall Study|Withdrawal by Subject|15|||
27891039|NCT02541669|81434233|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
27720805|NCT02432235|80810250|FG001|Overall Study|Lost to Follow-up|0|||
27891040|NCT02541669|81434234|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
27891041|NCT02541669|81434235|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
27839921|NCT02754492|81242597|FG001|Overall Study|Protocol Violation|2|||
27839922|NCT02754492|81242598|FG002|Overall Study|Protocol Violation|0|||
27839923|NCT02754492|81242599|FG003|Overall Study|Protocol Violation|1|||
27891042|NCT02541669|81434236|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
27891043|NCT02541669|81434237|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
27891044|NCT01095978|81434250|FG000|Overall Study|Did not take Klacid SR|2|||
27891045|NCT01095978|81434250|FG000|Overall Study|Adverse Event|1|||
27891046|NCT04434469|81434251|FG000|Overall Study|Death|2|||
27839924|NCT02754492|81242596|FG000|Overall Study|Withdrawal by Subject|2|||
27839925|NCT02754492|81242597|FG001|Overall Study|Withdrawal by Subject|0|||
27839926|NCT02754492|81242598|FG002|Overall Study|Withdrawal by Subject|0|||
27839927|NCT02754492|81242599|FG003|Overall Study|Withdrawal by Subject|0|||
27839928|NCT02754492|81242596|FG000|Overall Study|Equipment malfuntion|0|||
27839929|NCT02754492|81242597|FG001|Overall Study|Equipment malfuntion|0|||
27839930|NCT02754492|81242598|FG002|Overall Study|Equipment malfuntion|2|||
27839931|NCT02754492|81242599|FG003|Overall Study|Equipment malfuntion|5|||
27839932|NCT02754492|81242596|FG000|Overall Study|Adverse Event|0|||
27839933|NCT02754492|81242597|FG001|Overall Study|Adverse Event|0|||
27839934|NCT02754492|81242598|FG002|Overall Study|Adverse Event|0|||
27839935|NCT02754492|81242599|FG003|Overall Study|Adverse Event|13|||
27839936|NCT02754492|81242596|FG000|Overall Study|Venous access issues not resulting in AE|0|||
27839937|NCT02754492|81242597|FG001|Overall Study|Venous access issues not resulting in AE|0|||
27839938|NCT02754492|81242598|FG002|Overall Study|Venous access issues not resulting in AE|0|||
27839939|NCT02754492|81242599|FG003|Overall Study|Venous access issues not resulting in AE|4|||
27839940|NCT01863433|81242600|FG000|Overall Study|Protocol Violation|1|||
27839941|NCT01928615|81242603|FG000|Overall Study|Study Terminated by Sponsor|2|||
27839942|NCT04729101|81242605|FG000|Overall Study|Adverse Event|1|||
27839943|NCT04729101|81242606|FG001|Overall Study|Adverse Event|0|||
27839944|NCT04729101|81242605|FG000|Overall Study|Physician Decision|1|||
27839945|NCT04729101|81242606|FG001|Overall Study|Physician Decision|0|||
27839946|NCT04729101|81242605|FG000|Overall Study|Withdrawal by Subject|1|||
27839947|NCT04729101|81242606|FG001|Overall Study|Withdrawal by Subject|0|||
27839948|NCT01691430|81242607|FG000|Overall Study|Death|17|||
27839949|NCT01691430|81242608|FG001|Overall Study|Death|16|||
27839950|NCT01691430|81242607|FG000|Overall Study|Withdrawal by Subject|5|||
27839951|NCT01691430|81242608|FG001|Overall Study|Withdrawal by Subject|1|||
27839952|NCT01691430|81242607|FG000|Overall Study|Lost to Follow-up|0|||
27839953|NCT01691430|81242608|FG001|Overall Study|Lost to Follow-up|3|||
27839954|NCT02197416|81242610|FG000|Overall Study|Other reasons|0|||
27839955|NCT02197416|81242611|FG001|Overall Study|Other reasons|2|||
27839956|NCT02197416|81242612|FG002|Overall Study|Other reasons|5|||
27839957|NCT02197416|81242610|FG000|Overall Study|Withdrawal by Subject|0|||
27839958|NCT02197416|81242611|FG001|Overall Study|Withdrawal by Subject|2|||
27839959|NCT02197416|81242612|FG002|Overall Study|Withdrawal by Subject|1|||
27839960|NCT02197416|81242610|FG000|Overall Study|Protocol Violation|1|||
27839961|NCT02197416|81242611|FG001|Overall Study|Protocol Violation|0|||
27839962|NCT02197416|81242612|FG002|Overall Study|Protocol Violation|1|||
27839963|NCT02197416|81242610|FG000|Overall Study|Adverse Event|0|||
27839964|NCT02197416|81242611|FG001|Overall Study|Adverse Event|0|||
27839965|NCT02197416|81242612|FG002|Overall Study|Adverse Event|1|||
27839966|NCT04232540|81242613|FG000|Overall Study|Lost to Follow-up|1|||
27839967|NCT04232540|81242614|FG001|Overall Study|Lost to Follow-up|0|||
27839968|NCT01632306|81242615|FG000|Overall Study|Protocol Violation|1|||
27839969|NCT01632306|81242616|FG001|Overall Study|Protocol Violation|0|||
27839970|NCT01632306|81242617|FG002|Overall Study|Protocol Violation|0|||
27839971|NCT04439123|81242627|FG000|Overall Study|Adverse Event|11|||
27839972|NCT04439123|81242627|FG000|Overall Study|Death|1|||
27839973|NCT04439123|81242627|FG000|Overall Study|Disease progression|19|||
27839974|NCT04439123|81242627|FG000|Overall Study|Withdrawal by Subject|2|||
27839975|NCT04439123|81242627|FG000|Overall Study|Still on treatment|2|||
27839976|NCT01337596|81242628|FG000|Overall Study|Withdrawal by Subject|0|||
27839977|NCT01337596|81242629|FG001|Overall Study|Withdrawal by Subject|0|||
27839978|NCT01337596|81242630|FG002|Overall Study|Withdrawal by Subject|0|||
27839979|NCT01337596|81242631|FG003|Overall Study|Withdrawal by Subject|0|||
27839980|NCT01337596|81242632|FG004|Overall Study|Withdrawal by Subject|2|||
27839981|NCT01337596|81242633|FG005|Overall Study|Withdrawal by Subject|0|||
27839982|NCT01337596|81242634|FG006|Overall Study|Withdrawal by Subject|0|||
27839983|NCT01337596|81242635|FG007|Overall Study|Withdrawal by Subject|0|||
27839984|NCT01337596|81242636|FG008|Overall Study|Withdrawal by Subject|0|||
27839985|NCT01630616|81242638|FG000|Overall Study|Adverse Event|0|||
27839986|NCT01630616|81242639|FG001|Overall Study|Adverse Event|0|||
27839987|NCT01630616|81242640|FG002|Overall Study|Adverse Event|0|||
27839988|NCT01630616|81242641|FG003|Overall Study|Adverse Event|1|||
27839989|NCT01630616|81242642|FG004|Overall Study|Adverse Event|0|||
27839990|NCT01630616|81242643|FG005|Overall Study|Adverse Event|0|||
27891047|NCT04434469|81434252|FG001|Overall Study|Death|3|||
27891048|NCT04434469|81434253|FG002|Overall Study|Death|2|||
27839991|NCT01630616|81242638|FG000|Overall Study|Withdrawal by Subject|0|||
27839992|NCT01630616|81242639|FG001|Overall Study|Withdrawal by Subject|0|||
27891049|NCT04434469|81434254|FG003|Overall Study|Death|2|||
27891050|NCT04434469|81434255|FG004|Overall Study|Death|2|||
27891051|NCT04434469|81434256|FG005|Overall Study|Death|0|||
27891052|NCT04434469|81434251|FG000|Overall Study|Lost to Follow-up|0|||
27891053|NCT04434469|81434252|FG001|Overall Study|Lost to Follow-up|0|||
27891054|NCT04434469|81434253|FG002|Overall Study|Lost to Follow-up|0|||
27891055|NCT04434469|81434254|FG003|Overall Study|Lost to Follow-up|1|||
27891056|NCT04434469|81434255|FG004|Overall Study|Lost to Follow-up|1|||
27891057|NCT04434469|81434256|FG005|Overall Study|Lost to Follow-up|0|||
27891058|NCT04434469|81434251|FG000|Overall Study|Study terminated by sponsor|1|||
27891059|NCT04434469|81434252|FG001|Overall Study|Study terminated by sponsor|1|||
27891060|NCT04434469|81434253|FG002|Overall Study|Study terminated by sponsor|1|||
27891061|NCT04434469|81434254|FG003|Overall Study|Study terminated by sponsor|2|||
27891062|NCT04434469|81434255|FG004|Overall Study|Study terminated by sponsor|3|||
27891063|NCT04434469|81434256|FG005|Overall Study|Study terminated by sponsor|3|||
27891064|NCT04434469|81434251|FG000|Overall Study|Withdrawal by Subject|0|||
27891065|NCT04434469|81434252|FG001|Overall Study|Withdrawal by Subject|0|||
27891066|NCT04434469|81434253|FG002|Overall Study|Withdrawal by Subject|1|||
27891067|NCT04434469|81434254|FG003|Overall Study|Withdrawal by Subject|0|||
27891068|NCT04434469|81434255|FG004|Overall Study|Withdrawal by Subject|0|||
27891069|NCT04434469|81434256|FG005|Overall Study|Withdrawal by Subject|0|||
27891070|NCT01855243|81434257|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
27891071|NCT01855243|81434258|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
27891072|NCT01855243|81434259|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
27891073|NCT01790828|81434260|FG000|Overall Study|Other|34|||
27891074|NCT01820572|81434263|FG000|Randomization|Not Treated|2|||
27891075|NCT01820572|81434264|FG001|Randomization|Not Treated|1|||
27891076|NCT01820572|81434263|FG000|Treatment Period|Adverse Event|12|||
27891077|NCT01820572|81434264|FG001|Treatment Period|Adverse Event|7|||
27891078|NCT01820572|81434263|FG000|Treatment Period|Death|3|||
27891079|NCT01820572|81434264|FG001|Treatment Period|Death|3|||
27891080|NCT01820572|81434263|FG000|Treatment Period|Lack of Efficacy|1|||
27891081|NCT01820572|81434264|FG001|Treatment Period|Lack of Efficacy|0|||
27891082|NCT01820572|81434263|FG000|Treatment Period|poor/non compliance|0|||
27891083|NCT01820572|81434264|FG001|Treatment Period|poor/non compliance|3|||
27891084|NCT01820572|81434263|FG000|Treatment Period|request to discontinue|6|||
27891085|NCT01820572|81434264|FG001|Treatment Period|request to discontinue|11|||
27891086|NCT01820572|81434263|FG000|Treatment Period|No longer meets study criteria|3|||
27891087|NCT01820572|81434264|FG001|Treatment Period|No longer meets study criteria|10|||
27891088|NCT01820572|81434263|FG000|Treatment Period|withdrew consent|1|||
27609796|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Death|0|||
27609797|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Death|1|||
27609798|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Adverse Event|11|||
27720806|NCT02432235|80810251|FG002|Overall Study|Lost to Follow-up|0|||
27720807|NCT02432235|80810252|FG003|Overall Study|Lost to Follow-up|0|||
27720808|NCT02432235|80810253|FG004|Overall Study|Lost to Follow-up|0|||
27720809|NCT02432235|80810254|FG005|Overall Study|Lost to Follow-up|1|||
27720810|NCT02432235|80810255|FG006|Overall Study|Lost to Follow-up|0|||
27720811|NCT02432235|80810256|FG007|Overall Study|Lost to Follow-up|0|||
27720812|NCT02432235|80810257|FG008|Overall Study|Lost to Follow-up|1|||
27720813|NCT02432235|80810258|FG009|Overall Study|Lost to Follow-up|0|||
27720814|NCT02432235|80810259|FG010|Overall Study|Lost to Follow-up|0|||
27720815|NCT02432235|80810260|FG011|Overall Study|Lost to Follow-up|0|||
27720816|NCT02432235|80810249|FG000|Overall Study|Miscellaneous|0|||
27720817|NCT02432235|80810250|FG001|Overall Study|Miscellaneous|0|||
27720818|NCT02432235|80810251|FG002|Overall Study|Miscellaneous|0|||
27720819|NCT02432235|80810252|FG003|Overall Study|Miscellaneous|0|||
27720820|NCT02432235|80810253|FG004|Overall Study|Miscellaneous|1|||
27720821|NCT02432235|80810254|FG005|Overall Study|Miscellaneous|6|||
27720822|NCT02432235|80810255|FG006|Overall Study|Miscellaneous|2|||
27720823|NCT02432235|80810256|FG007|Overall Study|Miscellaneous|2|||
27720824|NCT02432235|80810257|FG008|Overall Study|Miscellaneous|4|||
27720825|NCT02432235|80810258|FG009|Overall Study|Miscellaneous|0|||
27720826|NCT02432235|80810259|FG010|Overall Study|Miscellaneous|0|||
27720827|NCT02432235|80810260|FG011|Overall Study|Miscellaneous|1|||
27720828|NCT02317562|80810265|FG000|Overall Study|Physician Decision|1|||
27720829|NCT02317562|80810265|FG000|Overall Study|early termination of the study|8|||
27720830|NCT02317562|80810265|FG000|Overall Study|Lack of Efficacy|4|||
27720831|NCT02317562|80810265|FG000|Overall Study|Withdrawal by Subject|1|||
27720832|NCT04506294|80810266|FG000|Overall Study|Lost to Follow-up|70|||
27720833|NCT04506294|80810267|FG001|Overall Study|Lost to Follow-up|20|||
27720834|NCT04506294|80810266|FG000|Overall Study|Withdrawal by Subject|16|||
27720835|NCT04506294|80810267|FG001|Overall Study|Withdrawal by Subject|2|||
27891089|NCT01820572|81434264|FG001|Treatment Period|withdrew consent|2|||
27891090|NCT01137110|81434268|FG000|Overall Study|Protocol Violation|1|||
27891091|NCT01137110|81434269|FG001|Overall Study|Protocol Violation|0|||
27891092|NCT02847494|81434270|FG000|Overall Study|Lost to Follow-up|8|||
27891093|NCT02847494|81434271|FG001|Overall Study|Lost to Follow-up|5|||
27891094|NCT03852628|81434275|FG000|Overall Study|Lost to Follow-up|7|||
27839993|NCT01630616|81242640|FG002|Overall Study|Withdrawal by Subject|0|||
27839994|NCT01630616|81242641|FG003|Overall Study|Withdrawal by Subject|2|||
27839995|NCT01630616|81242642|FG004|Overall Study|Withdrawal by Subject|0|||
27609799|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Adverse Event|11|||
27609800|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
27609801|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
27609802|NCT02936037|80412725|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27609803|NCT02936037|80412726|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
27609804|NCT02936037|80412725|FG000|Open Label Extension|Adverse Event|0|||
27609805|NCT02936037|80412726|FG001|Open Label Extension|Adverse Event|3|||
27609806|NCT02936037|80412725|FG000|Open Label Extension|Other|0|||
27609807|NCT02936037|80412726|FG001|Open Label Extension|Other|3|||
27609808|NCT02936037|80412725|FG000|Open Label Extension|Withdrawal by Subject|0|||
27609809|NCT02936037|80412726|FG001|Open Label Extension|Withdrawal by Subject|4|||
27609810|NCT02396537|80412727|FG000|Overall Study|Protocol Violation|0|||
27609811|NCT02396537|80412728|FG001|Overall Study|Protocol Violation|1|||
27609812|NCT04827134|80412729|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
27609813|NCT04827134|80412730|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
27609814|NCT04827134|80412731|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
27609815|NCT04827134|80412732|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
27609816|NCT02086162|80412734|FG000|Overall Study|Withdrawal by Subject|4|||
27609817|NCT02086162|80412735|FG001|Overall Study|Withdrawal by Subject|4|||
27609818|NCT02086162|80412734|FG000|Overall Study|moved|1|||
27609819|NCT02086162|80412735|FG001|Overall Study|moved|1|||
27609820|NCT02086162|80412734|FG000|Overall Study|Lost to Follow-up|4|||
27609821|NCT02086162|80412735|FG001|Overall Study|Lost to Follow-up|2|||
27609822|NCT02086162|80412734|FG000|Overall Study|Death|1|||
27609823|NCT02086162|80412735|FG001|Overall Study|Death|0|||
27609824|NCT00980005|80412736|FG000|Overall Study|Withdrawal by Subject|6|||
27609825|NCT00980005|80412737|FG001|Overall Study|Withdrawal by Subject|17|||
27609826|NCT00980005|80412736|FG000|Overall Study|Lost to Follow-up|37|||
27609827|NCT00980005|80412737|FG001|Overall Study|Lost to Follow-up|43|||
27609828|NCT00980005|80412736|FG000|Overall Study|Other|4|||
27609829|NCT00980005|80412737|FG001|Overall Study|Other|3|||
27609830|NCT03528174|80412739|FG000|Overall Study|Adverse Event|1|||
27609831|NCT03528174|80412739|FG000|Overall Study|sensors dislodged|1|||
27609832|NCT02961374|80412748|FG000|Overall Study|Adverse Event|4|||
27609833|NCT00544544|80412749|FG000|Overall Study|Withdrawal by Subject|1|||
27609834|NCT00544544|80412749|FG000|Overall Study|Adverse Event|1|||
27609835|NCT00544544|80412749|FG000|Overall Study|Lost to Follow-up|1|||
27609836|NCT02424591|80412751|FG000|Overall Study|Protocol Violation|2|||
27609837|NCT02424591|80412752|FG001|Overall Study|Protocol Violation|3|||
27609838|NCT01844115|80412754|FG000|Overall Study|Adverse Event|4|||
27609839|NCT01844115|80412755|FG001|Overall Study|Adverse Event|22|||
27609840|NCT01844115|80412754|FG000|Overall Study|Lack of Efficacy|1|||
27609841|NCT01844115|80412755|FG001|Overall Study|Lack of Efficacy|4|||
27609842|NCT01844115|80412754|FG000|Overall Study|Protocol Violation|12|||
27609843|NCT01844115|80412755|FG001|Overall Study|Protocol Violation|10|||
27609844|NCT01844115|80412754|FG000|Overall Study|Withdrawal by Subject|11|||
27839996|NCT01630616|81242643|FG005|Overall Study|Withdrawal by Subject|0|||
27839997|NCT04480307|81242646|FG000|Overall Study|Withdrawal by Subject|0|||
27501166|NCT00581308|80027888|FG000|Month 1|Withdrawal by Subject|2|||
27501167|NCT00581308|80027888|FG000|Month 1|Device Removed|2|||
27609845|NCT01844115|80412755|FG001|Overall Study|Withdrawal by Subject|11|||
27609846|NCT01844115|80412754|FG000|Overall Study|Lost to Follow-up|11|||
27609847|NCT01844115|80412755|FG001|Overall Study|Lost to Follow-up|10|||
27609848|NCT01844115|80412754|FG000|Overall Study|Pregnancy|0|||
27609849|NCT01844115|80412755|FG001|Overall Study|Pregnancy|1|||
27609850|NCT01118455|80412756|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
27609851|NCT01118455|80412757|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
27609852|NCT01375205|80412758|FG000|Overall Study|Lost to Follow-up|15|||
27609853|NCT01375205|80412759|FG001|Overall Study|Lost to Follow-up|12|||
27609854|NCT01375205|80412758|FG000|Overall Study|Withdrawal by Subject|6|||
27609855|NCT01375205|80412759|FG001|Overall Study|Withdrawal by Subject|1|||
27839998|NCT04480307|81242647|FG001|Overall Study|Withdrawal by Subject|1|||
27839999|NCT04480307|81242648|FG002|Overall Study|Withdrawal by Subject|0|||
27840000|NCT04480307|81242649|FG003|Overall Study|Withdrawal by Subject|0|||
27840001|NCT04480307|81242646|FG000|Overall Study|Adverse Event|0|||
27840002|NCT04480307|81242647|FG001|Overall Study|Adverse Event|0|||
27840003|NCT04480307|81242648|FG002|Overall Study|Adverse Event|0|||
27840004|NCT04480307|81242649|FG003|Overall Study|Adverse Event|1|||
27840005|NCT03904147|81242650|FG000|Overall Study|Death|15|||
27840006|NCT03904147|81242651|FG001|Overall Study|Death|13|||
27609856|NCT01302938|80412760|FG000|Overall Study|Withdrawal by Subject|1|||
27609857|NCT01302938|80412761|FG001|Overall Study|Withdrawal by Subject|0|||
27609858|NCT01302938|80412760|FG000|Overall Study|Adverse Event|1|||
27609859|NCT01302938|80412761|FG001|Overall Study|Adverse Event|0|||
27609860|NCT00779584|80412764|FG000|Overall Study|Protocol Violation|0|||
27609861|NCT00779584|80412765|FG001|Overall Study|Protocol Violation|0|||
27609862|NCT00779584|80412766|FG002|Overall Study|Protocol Violation|0|||
27609863|NCT00779584|80412767|FG003|Overall Study|Protocol Violation|0|||
27609864|NCT00779584|80412768|FG004|Overall Study|Protocol Violation|0|||
27609865|NCT00779584|80412769|FG005|Overall Study|Protocol Violation|1|||
27609866|NCT00779584|80412770|FG006|Overall Study|Protocol Violation|0|||
27609867|NCT00779584|80412771|FG007|Overall Study|Protocol Violation|0|||
27609868|NCT00779584|80412772|FG008|Overall Study|Protocol Violation|0|||
27720836|NCT01641939|80810268|FG000|Overall Study|Death|90|||
27720837|NCT01641939|80810269|FG001|Overall Study|Death|187|||
27720838|NCT01641939|80810270|FG002|Overall Study|Death|61|||
27720839|NCT01641939|80810268|FG000|Overall Study|Lost to Follow-up|3|||
27720840|NCT01641939|80810269|FG001|Overall Study|Lost to Follow-up|2|||
27720841|NCT01641939|80810270|FG002|Overall Study|Lost to Follow-up|1|||
27720842|NCT01641939|80810268|FG000|Overall Study|Withdrawal by Subject|14|||
27891095|NCT03852628|81434276|FG001|Overall Study|Lost to Follow-up|6|||
27891096|NCT03852628|81434275|FG000|Overall Study|Lack of Efficacy|6|||
27891097|NCT03852628|81434276|FG001|Overall Study|Lack of Efficacy|6|||
27891098|NCT04021121|81434278|FG000|Overall Study|Death|3|||
27891099|NCT04021121|81434279|FG001|Overall Study|Death|3|||
27891100|NCT04021121|81434280|FG002|Overall Study|Death|5|||
27891101|NCT04021121|81434281|FG003|Overall Study|Death|4|||
27891102|NCT01194531|81434283|FG000|Overall Study|Withdrawal by Subject|1|||
27891103|NCT01194531|81434284|FG001|Overall Study|Withdrawal by Subject|0|||
27891104|NCT01194531|81434283|FG000|Overall Study|Protocol Violation|4|||
27891105|NCT01194531|81434284|FG001|Overall Study|Protocol Violation|1|||
27891106|NCT01194531|81434283|FG000|Overall Study|Physician Decision|0|||
27891107|NCT01194531|81434284|FG001|Overall Study|Physician Decision|2|||
27720843|NCT01641939|80810269|FG001|Overall Study|Withdrawal by Subject|11|||
27720844|NCT01641939|80810270|FG002|Overall Study|Withdrawal by Subject|5|||
27720845|NCT01641939|80810268|FG000|Overall Study|Study Terminated by Sponsor|10|||
27720846|NCT01641939|80810269|FG001|Overall Study|Study Terminated by Sponsor|28|||
27720847|NCT01641939|80810270|FG002|Overall Study|Study Terminated by Sponsor|3|||
27720848|NCT02486757|80810274|FG000|Overall Study|Lost to Follow-up|1|||
27609869|NCT00779584|80412764|FG000|Overall Study|Withdrawal by Subject|1|||
27720849|NCT00291551|80810275|FG000|Overall Study|Death|7|||
27720850|NCT00291551|80810275|FG000|Overall Study|Withdrawal by Subject|6|||
27720851|NCT01534676|80810276|FG000|Overall Study|Study closed due to poor enrollment|2|||
27720852|NCT01534676|80810277|FG001|Overall Study|Study closed due to poor enrollment|1|||
27891108|NCT01083186|81434285|FG000|Overall Study|Lost to Follow-up|48|||
27891109|NCT01083186|81434285|FG000|Overall Study|Consent Withdrawal|7|||
27609870|NCT00779584|80412765|FG001|Overall Study|Withdrawal by Subject|1|||
27609871|NCT00779584|80412766|FG002|Overall Study|Withdrawal by Subject|2|||
27609872|NCT00779584|80412767|FG003|Overall Study|Withdrawal by Subject|0|||
27609873|NCT00779584|80412768|FG004|Overall Study|Withdrawal by Subject|0|||
27891110|NCT01083186|81434285|FG000|Overall Study|Death|3|||
27891111|NCT01083186|81434285|FG000|Overall Study|Adverse Event|3|||
27840007|NCT03904147|81242652|FG002|Overall Study|Death|15|||
27840008|NCT03904147|81242650|FG000|Overall Study|Withdrawal by Subject|7|||
27840009|NCT03904147|81242651|FG001|Overall Study|Withdrawal by Subject|12|||
27840010|NCT03904147|81242652|FG002|Overall Study|Withdrawal by Subject|1|||
27840011|NCT03904147|81242650|FG000|Overall Study|1Y visit completed after 365 days|1|||
27840012|NCT03904147|81242651|FG001|Overall Study|1Y visit completed after 365 days|1|||
27840013|NCT03904147|81242652|FG002|Overall Study|1Y visit completed after 365 days|0|||
27840014|NCT01292837|81242653|FG000|Overall Study|Adverse Event|1|||
27840015|NCT01292837|81242653|FG000|Overall Study|Further treatment determined|1|||
27840016|NCT00493792|81242659|FG000|Overall Study|Death|55|||
27720853|NCT01469000|80810278|FG000|Overall Study|Withdrawal by Subject|16|||
27720854|NCT01469000|80810279|FG001|Overall Study|Withdrawal by Subject|3|||
27720855|NCT01469000|80810278|FG000|Overall Study|Sponsor Decision|4|||
27720856|NCT01469000|80810279|FG001|Overall Study|Sponsor Decision|1|||
27720857|NCT02062658|80810282|FG000|Overall Study|Withdrawal by Subject|1|||
27720858|NCT02062658|80810282|FG000|Overall Study|Lack of Efficacy|1|||
27720859|NCT00772629|80810283|FG000|Overall Study|Subject was not vaccinated|1|||
27720860|NCT00772629|80810284|FG001|Overall Study|Subject was not vaccinated|0|||
27720861|NCT00797732|80810291|FG000|Overall Study|Withdrawal by Subject|3|||
27720862|NCT00797732|80810292|FG001|Overall Study|Withdrawal by Subject|3|||
27720863|NCT00797732|80810293|FG002|Overall Study|Withdrawal by Subject|0|||
27840017|NCT00493792|81242660|FG001|Overall Study|Death|50|||
27840018|NCT00493792|81242659|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
27891112|NCT01083186|81434285|FG000|Overall Study|Lack of Efficacy|2|||
27891113|NCT01083186|81434285|FG000|Overall Study|Hemodialysis Initiation|28|||
27891114|NCT01083186|81434285|FG000|Overall Study|Administrative Reasons|2|||
27720864|NCT00797732|80810291|FG000|Overall Study|Lost to Follow-up|1|||
27720865|NCT00797732|80810292|FG001|Overall Study|Lost to Follow-up|0|||
27720866|NCT00797732|80810293|FG002|Overall Study|Lost to Follow-up|0|||
27720867|NCT00797732|80810291|FG000|Overall Study|Death|1|||
27720868|NCT00797732|80810292|FG001|Overall Study|Death|0|||
27840019|NCT00493792|81242660|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
27840020|NCT00152516|81242663|FG000|Overall Study|Adverse Event|18|||
27891115|NCT01083186|81434285|FG000|Overall Study|Non-compliance to Study Treatment|1|||
27891116|NCT00965341|81434286|FG000|Overall Study|Withdrew consent|1|||
27720869|NCT00797732|80810293|FG002|Overall Study|Death|0|||
27720870|NCT00797732|80810291|FG000|Overall Study|Not meet inclusion criteria|0|||
27720871|NCT00797732|80810292|FG001|Overall Study|Not meet inclusion criteria|0|||
27720872|NCT00797732|80810293|FG002|Overall Study|Not meet inclusion criteria|7|||
27720873|NCT00797732|80810291|FG000|Overall Study|Excluded due to time constraints|0|||
27720874|NCT00797732|80810292|FG001|Overall Study|Excluded due to time constraints|0|||
27720875|NCT00797732|80810293|FG002|Overall Study|Excluded due to time constraints|24|||
27720876|NCT00797732|80810291|FG000|Overall Study|Refused to Participate|0|||
27720877|NCT00797732|80810292|FG001|Overall Study|Refused to Participate|0|||
27720878|NCT00797732|80810293|FG002|Overall Study|Refused to Participate|123|||
27720879|NCT05048719|80810294|FG000|Overall Study|Withdrawal by Subject|2|||
27720880|NCT05048719|80810295|FG001|Overall Study|Withdrawal by Subject|1|||
27720881|NCT05048719|80810296|FG002|Overall Study|Withdrawal by Subject|3|||
27720882|NCT05048719|80810297|FG003|Overall Study|Withdrawal by Subject|1|||
27720883|NCT05048719|80810298|FG004|Overall Study|Withdrawal by Subject|0|||
27720884|NCT05048719|80810299|FG005|Overall Study|Withdrawal by Subject|2|||
27720885|NCT05048719|80810300|FG006|Overall Study|Withdrawal by Subject|1|||
27720886|NCT05048719|80810301|FG007|Overall Study|Withdrawal by Subject|1|||
27720887|NCT05048719|80810302|FG008|Overall Study|Withdrawal by Subject|0|||
27720888|NCT05048719|80810294|FG000|Overall Study|Death|1|||
27720889|NCT05048719|80810295|FG001|Overall Study|Death|0|||
27720890|NCT05048719|80810296|FG002|Overall Study|Death|0|||
27720891|NCT05048719|80810297|FG003|Overall Study|Death|0|||
27720892|NCT05048719|80810298|FG004|Overall Study|Death|0|||
27720893|NCT05048719|80810299|FG005|Overall Study|Death|0|||
27720894|NCT05048719|80810300|FG006|Overall Study|Death|0|||
27720895|NCT05048719|80810301|FG007|Overall Study|Death|0|||
27720896|NCT05048719|80810302|FG008|Overall Study|Death|0|||
27840021|NCT00152516|81242663|FG000|Overall Study|Lack and Loss of Efficacy|30|||
27840022|NCT00152516|81242663|FG000|Overall Study|Lost to Follow-up|5|||
27840023|NCT00152516|81242663|FG000|Overall Study|Withdrawal by Subject|8|||
27840024|NCT00152516|81242663|FG000|Overall Study|Protocol Violation|3|||
27720897|NCT05048719|80810294|FG000|Overall Study|Adverse Event|0|||
27720898|NCT05048719|80810295|FG001|Overall Study|Adverse Event|1|||
27840025|NCT00152516|81242663|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
27609874|NCT00779584|80412769|FG005|Overall Study|Withdrawal by Subject|2|||
27609875|NCT00779584|80412770|FG006|Overall Study|Withdrawal by Subject|1|||
27720899|NCT05048719|80810296|FG002|Overall Study|Adverse Event|2|||
27720900|NCT05048719|80810297|FG003|Overall Study|Adverse Event|0|||
27720901|NCT05048719|80810298|FG004|Overall Study|Adverse Event|1|||
27720902|NCT05048719|80810299|FG005|Overall Study|Adverse Event|0|||
27720903|NCT05048719|80810300|FG006|Overall Study|Adverse Event|0|||
27720904|NCT05048719|80810301|FG007|Overall Study|Adverse Event|0|||
27720905|NCT05048719|80810302|FG008|Overall Study|Adverse Event|0|||
27720906|NCT05048719|80810294|FG000|Overall Study|Lost to Follow-up|0|||
27720907|NCT05048719|80810295|FG001|Overall Study|Lost to Follow-up|0|||
27720908|NCT05048719|80810296|FG002|Overall Study|Lost to Follow-up|1|||
27720909|NCT05048719|80810297|FG003|Overall Study|Lost to Follow-up|3|||
27720910|NCT05048719|80810298|FG004|Overall Study|Lost to Follow-up|1|||
27720911|NCT05048719|80810299|FG005|Overall Study|Lost to Follow-up|1|||
27720912|NCT05048719|80810300|FG006|Overall Study|Lost to Follow-up|1|||
27720913|NCT05048719|80810301|FG007|Overall Study|Lost to Follow-up|1|||
27840026|NCT00152516|81242663|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
27720914|NCT05048719|80810302|FG008|Overall Study|Lost to Follow-up|0|||
27720915|NCT05048719|80810294|FG000|Overall Study|Physician Decision|0|||
27720916|NCT05048719|80810295|FG001|Overall Study|Physician Decision|0|||
27720917|NCT05048719|80810296|FG002|Overall Study|Physician Decision|0|||
27840027|NCT00152516|81242663|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
27840028|NCT00152516|81242663|FG000|Overall Study|Other: Non-Compliance|2|||
27840029|NCT00152516|81242663|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
27840030|NCT00152516|81242663|FG000|Overall Study|Other: Moved Out Of State|1|||
27840031|NCT00152516|81242663|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
27840032|NCT00152516|81242663|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
27840033|NCT04668274|81242664|FG000|Part 1 Study Period 1|Adverse Event|3|||
27840034|NCT04668274|81242665|FG001|Part 1 Study Period 1|Adverse Event|0|||
27720918|NCT05048719|80810297|FG003|Overall Study|Physician Decision|0|||
27720919|NCT05048719|80810298|FG004|Overall Study|Physician Decision|0|||
27720920|NCT05048719|80810299|FG005|Overall Study|Physician Decision|0|||
27720921|NCT05048719|80810300|FG006|Overall Study|Physician Decision|0|||
27720922|NCT05048719|80810301|FG007|Overall Study|Physician Decision|1|||
27720923|NCT05048719|80810302|FG008|Overall Study|Physician Decision|1|||
27720924|NCT05048719|80810294|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
27720925|NCT05048719|80810295|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720926|NCT05048719|80810296|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720927|NCT05048719|80810297|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720928|NCT05048719|80810298|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720929|NCT05048719|80810299|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720930|NCT05048719|80810300|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720931|NCT05048719|80810301|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720932|NCT05048719|80810302|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
27720933|NCT05048719|80810294|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720934|NCT05048719|80810295|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
27720935|NCT05048719|80810296|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720936|NCT05048719|80810297|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720937|NCT05048719|80810298|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720938|NCT05048719|80810299|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720939|NCT05048719|80810300|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720940|NCT05048719|80810301|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720941|NCT05048719|80810302|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
27720942|NCT05048719|80810294|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27840035|NCT04668274|81242666|FG002|Part 1 Study Period 1|Adverse Event|0|||
27840036|NCT04668274|81242667|FG003|Part 1 Study Period 1|Adverse Event|0|||
27840037|NCT04668274|81242664|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
27840038|NCT04668274|81242665|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
27840039|NCT04668274|81242666|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
27840040|NCT04668274|81242667|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
27840041|NCT04668274|81242664|FG000|Part 1 Study Period 2|Other|0|||
27840042|NCT04668274|81242665|FG001|Part 1 Study Period 2|Other|1|||
27840043|NCT04668274|81242666|FG002|Part 1 Study Period 2|Other|0|||
27840044|NCT04668274|81242667|FG003|Part 1 Study Period 2|Other|0|||
27840045|NCT04668274|81242664|FG000|Part 1 Study Period 3|Adverse Event|0|||
27840046|NCT04668274|81242665|FG001|Part 1 Study Period 3|Adverse Event|0|||
27609876|NCT00779584|80412771|FG007|Overall Study|Withdrawal by Subject|0|||
27840047|NCT04668274|81242666|FG002|Part 1 Study Period 3|Adverse Event|1|||
27840048|NCT04668274|81242667|FG003|Part 1 Study Period 3|Adverse Event|0|||
27840049|NCT04668274|81242664|FG000|Part 1 Study Period 3|Other|0|||
27840050|NCT04668274|81242665|FG001|Part 1 Study Period 3|Other|0|||
27840051|NCT04668274|81242666|FG002|Part 1 Study Period 3|Other|2|||
27840052|NCT04668274|81242667|FG003|Part 1 Study Period 3|Other|0|||
27840053|NCT04668274|81242664|FG000|Part 2 Study Period 4|Other|0|||
27840054|NCT04668274|81242665|FG001|Part 2 Study Period 4|Other|0|||
27840055|NCT04668274|81242666|FG002|Part 2 Study Period 4|Other|0|||
27840056|NCT04668274|81242667|FG003|Part 2 Study Period 4|Other|1|||
27609877|NCT00779584|80412772|FG008|Overall Study|Withdrawal by Subject|0|||
27840057|NCT01499160|81242668|FG000|Overall Study|Adverse Event|1|||
27840058|NCT01499160|81242668|FG000|Overall Study|Withdrawal by Subject|1|||
27840059|NCT02725411|81242672|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
27840060|NCT02725411|81242673|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
27609878|NCT00779584|80412764|FG000|Overall Study|Lost to Follow-up|0|||
27720943|NCT05048719|80810295|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
27720944|NCT05048719|80810296|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720945|NCT05048719|80810297|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720946|NCT05048719|80810298|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720947|NCT05048719|80810299|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720948|NCT05048719|80810300|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720949|NCT05048719|80810301|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720950|NCT05048719|80810302|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
27720951|NCT05048719|80810294|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720952|NCT05048719|80810295|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720953|NCT05048719|80810296|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720954|NCT05048719|80810297|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
27720955|NCT05048719|80810298|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720956|NCT05048719|80810299|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720957|NCT05048719|80810300|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720958|NCT05048719|80810301|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720959|NCT05048719|80810302|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
27720960|NCT05048719|80810294|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720961|NCT05048719|80810295|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720962|NCT05048719|80810296|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720963|NCT05048719|80810297|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720964|NCT05048719|80810298|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720965|NCT05048719|80810299|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
27720966|NCT05048719|80810300|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720967|NCT05048719|80810301|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720968|NCT05048719|80810302|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
27720969|NCT03969888|80810303|FG000|Overall Study|Never Received Study Drug|0|||
27720970|NCT03969888|80810304|FG001|Overall Study|Never Received Study Drug|0|||
27720971|NCT03969888|80810305|FG002|Overall Study|Never Received Study Drug|1|||
27720972|NCT03969888|80810306|FG003|Overall Study|Never Received Study Drug|0|||
27720973|NCT03969888|80810307|FG004|Overall Study|Never Received Study Drug|0|||
27720974|NCT03969888|80810308|FG005|Overall Study|Never Received Study Drug|0|||
27720975|NCT03969888|80810309|FG006|Overall Study|Never Received Study Drug|1|||
27720976|NCT03969888|80810310|FG007|Overall Study|Never Received Study Drug|0|||
27720977|NCT03969888|80810303|FG000|Overall Study|Reason Not Specified|0|||
27720978|NCT03969888|80810304|FG001|Overall Study|Reason Not Specified|0|||
27720979|NCT03969888|80810305|FG002|Overall Study|Reason Not Specified|0|||
27720980|NCT03969888|80810306|FG003|Overall Study|Reason Not Specified|0|||
27720981|NCT03969888|80810307|FG004|Overall Study|Reason Not Specified|0|||
27720982|NCT03969888|80810308|FG005|Overall Study|Reason Not Specified|0|||
27720983|NCT03969888|80810309|FG006|Overall Study|Reason Not Specified|0|||
27720984|NCT03969888|80810310|FG007|Overall Study|Reason Not Specified|1|||
27720985|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
27720986|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
27720987|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
27720988|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
27720989|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
27720990|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
27720991|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
27720992|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
27720993|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
27720994|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
27720995|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
27720996|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
27720997|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
27720998|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
27720999|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
27721000|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
27721001|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
27721002|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
27721003|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
27721004|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
27721005|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
27721006|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
27721007|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
27721008|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
27501168|NCT00581308|80027888|FG000|Month 1|Uknown|1|||
27501169|NCT00581308|80027888|FG000|Month 6|Lost to Follow-up|1|||
27501170|NCT00581308|80027888|FG000|Month 6|Withdrawal by Subject|2|||
27501171|NCT00581308|80027888|FG000|Month 12|Death|1|||
27501172|NCT00581308|80027888|FG000|Month 12|Lost to Follow-up|14|||
27501173|NCT00581308|80027888|FG000|Month 12|Withdrawal by Subject|3|||
27501174|NCT00581308|80027888|FG000|Month 12|Device Removed|1|||
27501175|NCT00581308|80027888|FG000|Month 12|Other|1|||
27501176|NCT05131204|80027889|FG000|Overall Study|Sponsor request|2|||
27501177|NCT05131204|80027890|FG001|Overall Study|Sponsor request|1|||
27501178|NCT00882440|80027891|FG000|Overall Study|Adverse Event|2|||
27501179|NCT00882440|80027892|FG001|Overall Study|Adverse Event|2|||
27501180|NCT00882440|80027893|FG002|Overall Study|Adverse Event|2|||
27501181|NCT00882440|80027894|FG003|Overall Study|Adverse Event|1|||
27501182|NCT00882440|80027895|FG004|Overall Study|Adverse Event|1|||
27501183|NCT00882440|80027896|FG005|Overall Study|Adverse Event|4|||
27501184|NCT00882440|80027897|FG006|Overall Study|Adverse Event|2|||
27501185|NCT00882440|80027891|FG000|Overall Study|Lack of Efficacy|3|||
27501186|NCT00882440|80027892|FG001|Overall Study|Lack of Efficacy|5|||
27501187|NCT00882440|80027893|FG002|Overall Study|Lack of Efficacy|2|||
27501188|NCT00882440|80027894|FG003|Overall Study|Lack of Efficacy|0|||
27501189|NCT00882440|80027895|FG004|Overall Study|Lack of Efficacy|0|||
27501190|NCT00882440|80027896|FG005|Overall Study|Lack of Efficacy|3|||
27501191|NCT00882440|80027897|FG006|Overall Study|Lack of Efficacy|0|||
27501192|NCT00882440|80027891|FG000|Overall Study|Lost to Follow-up|2|||
27721009|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
27721010|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
27721011|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
27721012|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
27721013|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
27721014|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
27721015|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
27721016|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
27721017|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
27721018|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
27721019|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
27721020|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
27721021|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
27721022|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
27721023|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
27721024|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
27721025|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
27721026|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
27721027|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
27721028|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
27721029|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
27721030|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
27721031|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
27721032|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
27721033|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
27721034|NCT03742037|80810313|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
27721035|NCT03742037|80810314|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
27721036|NCT03742037|80810315|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
27721037|NCT03742037|80810316|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
27721038|NCT03742037|80810317|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
27721039|NCT03742037|80810318|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
27721040|NCT03742037|80810319|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
27721041|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
27721042|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
27721043|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
27721044|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
27721045|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
27501193|NCT00882440|80027892|FG001|Overall Study|Lost to Follow-up|0|||
27501194|NCT00882440|80027893|FG002|Overall Study|Lost to Follow-up|1|||
27501195|NCT00882440|80027894|FG003|Overall Study|Lost to Follow-up|1|||
27501196|NCT00882440|80027895|FG004|Overall Study|Lost to Follow-up|1|||
27501197|NCT00882440|80027896|FG005|Overall Study|Lost to Follow-up|0|||
27501198|NCT00882440|80027897|FG006|Overall Study|Lost to Follow-up|1|||
27501199|NCT00882440|80027891|FG000|Overall Study|Protocol Violation|0|||
27501200|NCT00882440|80027892|FG001|Overall Study|Protocol Violation|0|||
27501201|NCT00882440|80027893|FG002|Overall Study|Protocol Violation|1|||
27501202|NCT00882440|80027894|FG003|Overall Study|Protocol Violation|1|||
27501203|NCT00882440|80027895|FG004|Overall Study|Protocol Violation|1|||
27501204|NCT00882440|80027896|FG005|Overall Study|Protocol Violation|0|||
27501205|NCT00882440|80027897|FG006|Overall Study|Protocol Violation|0|||
27501206|NCT00882440|80027891|FG000|Overall Study|Withdrawal by Subject|2|||
27501207|NCT00882440|80027892|FG001|Overall Study|Withdrawal by Subject|1|||
27501208|NCT00882440|80027893|FG002|Overall Study|Withdrawal by Subject|1|||
27721046|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
27721047|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
27721048|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
27721049|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
27721050|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
27721051|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
27721052|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
27721053|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
27721054|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
27721055|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
27721056|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
27721057|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
27721058|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
27721059|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
27721060|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
27721061|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
27721062|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
27721063|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
27721064|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
27721065|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
27721066|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
27721067|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
27721068|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
27721069|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
27721070|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
27721071|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
27721072|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
27721073|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
27721074|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
27721075|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
27721076|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
27721077|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
27721078|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
27501209|NCT00882440|80027894|FG003|Overall Study|Withdrawal by Subject|0|||
27501210|NCT00882440|80027895|FG004|Overall Study|Withdrawal by Subject|6|||
27501211|NCT00882440|80027896|FG005|Overall Study|Withdrawal by Subject|0|||
27501212|NCT00882440|80027897|FG006|Overall Study|Withdrawal by Subject|1|||
27721079|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
27721080|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
27721081|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
27721082|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
27721083|NCT03742037|80810313|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
27721084|NCT03742037|80810314|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
27721085|NCT03742037|80810315|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
27721086|NCT03742037|80810316|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
27721087|NCT03742037|80810317|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
27754866|NCT02065622|80929631|FG001|Induction Study|Withdrawal by Subject|5|||
27840061|NCT02725411|81242674|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
27501213|NCT00882440|80027891|FG000|Overall Study|Patient Uncooperative|2|||
27501214|NCT00882440|80027892|FG001|Overall Study|Patient Uncooperative|0|||
27501215|NCT00882440|80027893|FG002|Overall Study|Patient Uncooperative|0|||
27501216|NCT00882440|80027894|FG003|Overall Study|Patient Uncooperative|0|||
27501217|NCT00882440|80027895|FG004|Overall Study|Patient Uncooperative|1|||
27501218|NCT00882440|80027896|FG005|Overall Study|Patient Uncooperative|0|||
27501219|NCT00882440|80027897|FG006|Overall Study|Patient Uncooperative|0|||
27501220|NCT03486912|80027898|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
27501221|NCT03486912|80027899|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
27501222|NCT03486912|80027900|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
27501223|NCT03486912|80027901|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
27501224|NCT03486912|80027898|FG000|Treatment Period|Withdrawal by Subject|3|||
27501225|NCT03486912|80027899|FG001|Treatment Period|Withdrawal by Subject|3|||
27501226|NCT03486912|80027900|FG002|Treatment Period|Withdrawal by Subject|3|||
27501227|NCT03486912|80027901|FG003|Treatment Period|Withdrawal by Subject|2|||
27501228|NCT03486912|80027898|FG000|Treatment Period|Other Reasons|0|||
27501229|NCT03486912|80027899|FG001|Treatment Period|Other Reasons|2|||
27501230|NCT03486912|80027900|FG002|Treatment Period|Other Reasons|1|||
27501231|NCT03486912|80027901|FG003|Treatment Period|Other Reasons|1|||
27501232|NCT03486912|80027898|FG000|Treatment Period|Adverse Event|0|||
27501233|NCT03486912|80027899|FG001|Treatment Period|Adverse Event|1|||
27501234|NCT03486912|80027900|FG002|Treatment Period|Adverse Event|1|||
27501235|NCT03486912|80027901|FG003|Treatment Period|Adverse Event|0|||
27501236|NCT03486912|80027898|FG000|Treatment Period|Lost to Follow-up|1|||
27501237|NCT03486912|80027899|FG001|Treatment Period|Lost to Follow-up|0|||
27501238|NCT03486912|80027900|FG002|Treatment Period|Lost to Follow-up|0|||
27501239|NCT03486912|80027901|FG003|Treatment Period|Lost to Follow-up|2|||
27501240|NCT05083351|80027902|FG000|Overall Study|Adverse Event|3|||
27501241|NCT05083351|80027902|FG000|Overall Study|Did not meet data inclusion criteria|8|||
27501242|NCT05083351|80027902|FG000|Overall Study|Did not meet eligibility criteria|19|||
27501243|NCT05083351|80027902|FG000|Overall Study|Study Staff Decision|19|||
27609879|NCT00779584|80412765|FG001|Overall Study|Lost to Follow-up|0|||
27609880|NCT00779584|80412766|FG002|Overall Study|Lost to Follow-up|0|||
27609881|NCT00779584|80412767|FG003|Overall Study|Lost to Follow-up|0|||
27609882|NCT00779584|80412768|FG004|Overall Study|Lost to Follow-up|1|||
27609883|NCT00779584|80412769|FG005|Overall Study|Lost to Follow-up|0|||
27609884|NCT00779584|80412770|FG006|Overall Study|Lost to Follow-up|0|||
27609885|NCT00779584|80412771|FG007|Overall Study|Lost to Follow-up|0|||
27609886|NCT00779584|80412772|FG008|Overall Study|Lost to Follow-up|0|||
27609887|NCT00779584|80412764|FG000|Overall Study|Progression of Disease|0|||
27609888|NCT00779584|80412765|FG001|Overall Study|Progression of Disease|1|||
27609889|NCT00779584|80412766|FG002|Overall Study|Progression of Disease|2|||
27609890|NCT00779584|80412767|FG003|Overall Study|Progression of Disease|6|||
27609891|NCT00779584|80412768|FG004|Overall Study|Progression of Disease|5|||
27609892|NCT00779584|80412769|FG005|Overall Study|Progression of Disease|1|||
27609893|NCT00779584|80412770|FG006|Overall Study|Progression of Disease|4|||
27609894|NCT00779584|80412771|FG007|Overall Study|Progression of Disease|2|||
27609895|NCT00779584|80412772|FG008|Overall Study|Progression of Disease|1|||
27609896|NCT00779584|80412764|FG000|Overall Study|Adverse Event|1|||
27609897|NCT00779584|80412765|FG001|Overall Study|Adverse Event|0|||
27609898|NCT00779584|80412766|FG002|Overall Study|Adverse Event|2|||
27609899|NCT00779584|80412767|FG003|Overall Study|Adverse Event|0|||
27609900|NCT00779584|80412768|FG004|Overall Study|Adverse Event|0|||
27609901|NCT00779584|80412769|FG005|Overall Study|Adverse Event|0|||
27609902|NCT00779584|80412770|FG006|Overall Study|Adverse Event|2|||
27609903|NCT00779584|80412771|FG007|Overall Study|Adverse Event|1|||
27609904|NCT00779584|80412772|FG008|Overall Study|Adverse Event|1|||
27609905|NCT00779584|80412764|FG000|Overall Study|Symptomatic Deterioration|1|||
27609906|NCT00779584|80412765|FG001|Overall Study|Symptomatic Deterioration|1|||
27721088|NCT03742037|80810318|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
27891117|NCT00965341|81434287|FG001|Overall Study|Withdrew consent|5|||
27501244|NCT00179621|80027908|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
27501245|NCT00179621|80027909|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
27501246|NCT00179621|80027910|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
27501247|NCT00179621|80027911|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
27501248|NCT00179621|80027908|FG000|Double-Blind Period|Adverse Event|2|||
27501249|NCT00179621|80027909|FG001|Double-Blind Period|Adverse Event|7|||
27609907|NCT00779584|80412766|FG002|Overall Study|Symptomatic Deterioration|1|||
27609908|NCT00779584|80412767|FG003|Overall Study|Symptomatic Deterioration|0|||
27609909|NCT00779584|80412768|FG004|Overall Study|Symptomatic Deterioration|0|||
27501250|NCT00179621|80027910|FG002|Double-Blind Period|Adverse Event|4|||
27501251|NCT00179621|80027911|FG003|Double-Blind Period|Adverse Event|0|||
27501252|NCT00179621|80027908|FG000|Double-Blind Period|Withdrawal by Subject|2|||
27501253|NCT00179621|80027909|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27501254|NCT00179621|80027910|FG002|Double-Blind Period|Withdrawal by Subject|3|||
27501255|NCT00179621|80027911|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27609910|NCT00779584|80412769|FG005|Overall Study|Symptomatic Deterioration|1|||
27609911|NCT00779584|80412770|FG006|Overall Study|Symptomatic Deterioration|1|||
27609912|NCT00779584|80412771|FG007|Overall Study|Symptomatic Deterioration|0|||
27609913|NCT00779584|80412772|FG008|Overall Study|Symptomatic Deterioration|0|||
27609914|NCT00779584|80412764|FG000|Overall Study|Ongoing in Study|0|||
27609915|NCT00779584|80412765|FG001|Overall Study|Ongoing in Study|0|||
27609916|NCT00779584|80412766|FG002|Overall Study|Ongoing in Study|0|||
27609917|NCT00779584|80412767|FG003|Overall Study|Ongoing in Study|0|||
27609918|NCT00779584|80412768|FG004|Overall Study|Ongoing in Study|1|||
27609919|NCT00779584|80412769|FG005|Overall Study|Ongoing in Study|1|||
27609920|NCT00779584|80412770|FG006|Overall Study|Ongoing in Study|0|||
27609921|NCT00779584|80412771|FG007|Overall Study|Ongoing in Study|0|||
27609922|NCT00779584|80412772|FG008|Overall Study|Ongoing in Study|0|||
27501256|NCT00179621|80027908|FG000|Double-Blind Period|Death|0|||
27501257|NCT00179621|80027909|FG001|Double-Blind Period|Death|1|||
27501258|NCT00179621|80027910|FG002|Double-Blind Period|Death|2|||
27501259|NCT00179621|80027911|FG003|Double-Blind Period|Death|0|||
27501260|NCT00179621|80027908|FG000|Double-Blind Period|Protocol Violation|1|||
27501261|NCT00179621|80027909|FG001|Double-Blind Period|Protocol Violation|0|||
27501262|NCT00179621|80027910|FG002|Double-Blind Period|Protocol Violation|0|||
27501263|NCT00179621|80027911|FG003|Double-Blind Period|Protocol Violation|0|||
27501264|NCT00179621|80027908|FG000|Double-Blind Period|Other|0|||
27501265|NCT00179621|80027909|FG001|Double-Blind Period|Other|2|||
27501266|NCT00179621|80027910|FG002|Double-Blind Period|Other|2|||
27501267|NCT00179621|80027911|FG003|Double-Blind Period|Other|0|||
27501268|NCT00179621|80027908|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
27501269|NCT00179621|80027909|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
27501270|NCT00179621|80027910|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
27501271|NCT00179621|80027911|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
27501272|NCT00179621|80027908|FG000|Open-Label Period|Adverse Event|0|||
27501273|NCT00179621|80027909|FG001|Open-Label Period|Adverse Event|6|||
27501274|NCT00179621|80027910|FG002|Open-Label Period|Adverse Event|5|||
27501275|NCT00179621|80027911|FG003|Open-Label Period|Adverse Event|6|||
27501276|NCT00179621|80027908|FG000|Open-Label Period|Withdrawal by Subject|0|||
27501277|NCT00179621|80027909|FG001|Open-Label Period|Withdrawal by Subject|2|||
27501278|NCT00179621|80027910|FG002|Open-Label Period|Withdrawal by Subject|2|||
27501279|NCT00179621|80027911|FG003|Open-Label Period|Withdrawal by Subject|2|||
27501280|NCT00179621|80027908|FG000|Open-Label Period|Death|0|||
27501281|NCT00179621|80027909|FG001|Open-Label Period|Death|0|||
27501282|NCT00179621|80027910|FG002|Open-Label Period|Death|1|||
27501283|NCT00179621|80027911|FG003|Open-Label Period|Death|2|||
27609923|NCT00244374|80412773|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
27609924|NCT00244374|80412774|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27609925|NCT00244374|80412775|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27609926|NCT00244374|80412776|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27609927|NCT00244374|80412777|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
27609928|NCT00244374|80412773|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
27609929|NCT00244374|80412774|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27609930|NCT00244374|80412775|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27609931|NCT00244374|80412776|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27609932|NCT00244374|80412777|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
27609933|NCT00244374|80412773|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
27609934|NCT00244374|80412774|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27609935|NCT00244374|80412775|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27609936|NCT00244374|80412776|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27721089|NCT03742037|80810319|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
27721090|NCT02217566|80810320|FG000|Overall Study|Lost to Follow-up|2|||
27721091|NCT02217566|80810320|FG000|Overall Study|Death|3|||
27501284|NCT00179621|80027908|FG000|Open-Label Period|Other|0|||
27501285|NCT00179621|80027909|FG001|Open-Label Period|Other|1|||
27501286|NCT00179621|80027910|FG002|Open-Label Period|Other|1|||
27501287|NCT00179621|80027911|FG003|Open-Label Period|Other|2|||
27501288|NCT01231906|80027916|FG000|Overall Study|Lack of Efficacy|75|||
27501289|NCT01231906|80027917|FG001|Overall Study|Lack of Efficacy|68|||
27501290|NCT01231906|80027916|FG000|Overall Study|Lost to Follow-up|1|||
27501291|NCT01231906|80027917|FG001|Overall Study|Lost to Follow-up|0|||
27501292|NCT01231906|80027916|FG000|Overall Study|Physician Decision|34|||
27609937|NCT00244374|80412777|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
27609938|NCT00244374|80412773|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
27609939|NCT00244374|80412774|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27609940|NCT00244374|80412775|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27609941|NCT00244374|80412776|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27609942|NCT00244374|80412777|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
27609943|NCT00244374|80412773|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
27609944|NCT00244374|80412774|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27609945|NCT00244374|80412775|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27609946|NCT00244374|80412776|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27609947|NCT00244374|80412777|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
27609948|NCT00244374|80412773|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
27721092|NCT02217566|80810320|FG000|Overall Study|Early study termination|6|||
27721093|NCT05162066|80810321|FG000|Overall Study|Adverse Event|1|||
27891118|NCT00965341|81434286|FG000|Overall Study|Lost to Follow-up|1|||
27891119|NCT00965341|81434287|FG001|Overall Study|Lost to Follow-up|0|||
27891120|NCT00965341|81434286|FG000|Overall Study|Transportation issues|4|||
27891121|NCT00965341|81434287|FG001|Overall Study|Transportation issues|3|||
27891122|NCT02234596|81434288|FG000|Overall Study|Participant not treated|2|||
27891123|NCT02004886|81434289|FG000|Overall Study|Adverse Event|0|||
27891124|NCT02004886|81434290|FG001|Overall Study|Adverse Event|1|||
27891125|NCT02004886|81434291|FG002|Overall Study|Adverse Event|0|||
27891126|NCT02004886|81434292|FG003|Overall Study|Adverse Event|0|||
27891127|NCT02004886|81434289|FG000|Overall Study|Unable to attend future visits|1|||
27891128|NCT02004886|81434290|FG001|Overall Study|Unable to attend future visits|0|||
27891129|NCT02004886|81434291|FG002|Overall Study|Unable to attend future visits|0|||
27891130|NCT02004886|81434292|FG003|Overall Study|Unable to attend future visits|0|||
27721094|NCT05162066|80810322|FG001|Overall Study|Adverse Event|0|||
27721095|NCT05162066|80810323|FG002|Overall Study|Adverse Event|0|||
27721096|NCT05162066|80810321|FG000|Overall Study|Perceived lack of efficacy|1|||
27721097|NCT05162066|80810322|FG001|Overall Study|Perceived lack of efficacy|0|||
27721098|NCT05162066|80810323|FG002|Overall Study|Perceived lack of efficacy|0|||
27721099|NCT02450578|80810324|FG000|Overall Study|ECG abnormality so not treated|1|||
27721100|NCT02450578|80810325|FG001|Overall Study|ECG abnormality so not treated|0|||
27721101|NCT02450578|80810326|FG002|Overall Study|ECG abnormality so not treated|0|||
27721102|NCT02450578|80810327|FG003|Overall Study|ECG abnormality so not treated|0|||
27721103|NCT00433329|80810338|FG000|Overall Study|Adverse Event|9|||
27721104|NCT00433329|80810338|FG000|Overall Study|Death|4|||
27721105|NCT00433329|80810338|FG000|Overall Study|Withdrew consent|3|||
27721106|NCT00433329|80810338|FG000|Overall Study|Discontinued sildenafil|2|||
27721107|NCT00433329|80810338|FG000|Overall Study|Moved out of state|1|||
27721108|NCT00433329|80810338|FG000|Overall Study|Lost to Follow-up|1|||
27721109|NCT00433329|80810338|FG000|Overall Study|Physician Decision|1|||
27721110|NCT01482910|80810339|FG000|Overall Study|Adverse Event|6|||
27721111|NCT01482910|80810340|FG001|Overall Study|Adverse Event|5|||
27721112|NCT01482910|80810339|FG000|Overall Study|Lost to Follow-up|0|||
27721113|NCT01482910|80810340|FG001|Overall Study|Lost to Follow-up|1|||
27721114|NCT01482910|80810339|FG000|Overall Study|Protocol Violation|1|||
27721115|NCT01482910|80810340|FG001|Overall Study|Protocol Violation|1|||
27840062|NCT02725411|81242672|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
27721116|NCT01482910|80810339|FG000|Overall Study|Withdrawal by Subject|7|||
27721117|NCT01482910|80810340|FG001|Overall Study|Withdrawal by Subject|2|||
27721118|NCT01482910|80810339|FG000|Overall Study|Death|1|||
27721119|NCT01482910|80810340|FG001|Overall Study|Death|0|||
27721120|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
27721121|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
27721122|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
27840063|NCT02725411|81242673|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
27840064|NCT02725411|81242674|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
27840065|NCT02725411|81242672|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
27840066|NCT02725411|81242673|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
27840067|NCT02725411|81242674|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
27840068|NCT02725411|81242672|FG000|Treatment Period (56 Weeks)|Other|1|||
27840069|NCT02725411|81242673|FG001|Treatment Period (56 Weeks)|Other|4|||
27840070|NCT02725411|81242674|FG002|Treatment Period (56 Weeks)|Other|5|||
27891131|NCT00824382|81434293|FG000|Overall Study|Adverse Event|4|||
27891132|NCT00824382|81434294|FG001|Overall Study|Adverse Event|1|||
27891133|NCT00824382|81434295|FG002|Overall Study|Adverse Event|1|||
27891134|NCT00824382|81434296|FG003|Overall Study|Adverse Event|4|||
27891135|NCT00824382|81434293|FG000|Overall Study|Protocol Violation|1|||
27891136|NCT00824382|81434294|FG001|Overall Study|Protocol Violation|0|||
27840071|NCT02725411|81242672|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
27609949|NCT00244374|80412774|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27609950|NCT00244374|80412775|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27609951|NCT00244374|80412776|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27609952|NCT00244374|80412777|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
27609953|NCT00244374|80412773|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
27609954|NCT00244374|80412774|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27609955|NCT00244374|80412775|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27609956|NCT00244374|80412776|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27609957|NCT00244374|80412777|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
27609958|NCT00244374|80412773|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
27609959|NCT00244374|80412774|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27609960|NCT00244374|80412775|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27609961|NCT00244374|80412776|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27609962|NCT00244374|80412777|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
27609963|NCT00244374|80412773|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
27609964|NCT00244374|80412774|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27609965|NCT00244374|80412775|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27609966|NCT00244374|80412776|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27609967|NCT00244374|80412777|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
27609968|NCT01233609|80412789|FG000|Overall Study|Death|1|||
27609969|NCT01233609|80412790|FG001|Overall Study|Death|0|||
27609970|NCT01233609|80412789|FG000|Overall Study|Lost to Follow-up|3|||
27891137|NCT00824382|81434295|FG002|Overall Study|Protocol Violation|0|||
27891138|NCT00824382|81434296|FG003|Overall Study|Protocol Violation|1|||
27891139|NCT00824382|81434293|FG000|Overall Study|Investigator's decision|0|||
27891140|NCT00824382|81434294|FG001|Overall Study|Investigator's decision|1|||
27891141|NCT00824382|81434295|FG002|Overall Study|Investigator's decision|2|||
27609971|NCT01233609|80412790|FG001|Overall Study|Lost to Follow-up|1|||
27609972|NCT01233609|80412789|FG000|Overall Study|Adverse Event|2|||
27609973|NCT01233609|80412790|FG001|Overall Study|Adverse Event|1|||
27891142|NCT00824382|81434296|FG003|Overall Study|Investigator's decision|0|||
27891143|NCT03813147|81434307|FG000|Overall Study|Lack of Efficacy|4|||
27501293|NCT01231906|80027917|FG001|Overall Study|Physician Decision|24|||
27609974|NCT01233609|80412789|FG000|Overall Study|Withdrawal by Subject|3|||
27609975|NCT01233609|80412790|FG001|Overall Study|Withdrawal by Subject|0|||
27609976|NCT01923896|80412791|FG000|Overall Study|Adverse Event|1|||
27609977|NCT01923896|80412792|FG001|Overall Study|Adverse Event|0|||
27609978|NCT01512745|80412793|FG000|Overall Study|Adverse Event|22|||
27609979|NCT01512745|80412794|FG001|Overall Study|Adverse Event|3|||
27609980|NCT01512745|80412793|FG000|Overall Study|Death|9|||
27609981|NCT01512745|80412794|FG001|Overall Study|Death|13|||
27609982|NCT01512745|80412793|FG000|Overall Study|Withdrawal by Subject|2|||
27609983|NCT01512745|80412794|FG001|Overall Study|Withdrawal by Subject|2|||
27609984|NCT01512745|80412793|FG000|Overall Study|Lost to Follow-up|4|||
27609985|NCT01512745|80412794|FG001|Overall Study|Lost to Follow-up|0|||
27609986|NCT01512745|80412793|FG000|Overall Study|Lack of Efficacy|2|||
27609987|NCT01512745|80412794|FG001|Overall Study|Lack of Efficacy|2|||
27609988|NCT01512745|80412793|FG000|Overall Study|Protocol Violation|1|||
27609989|NCT01512745|80412794|FG001|Overall Study|Protocol Violation|0|||
27609990|NCT00251927|80412796|FG000|Overall Study|Adverse Event|3|||
27609991|NCT00251927|80412797|FG001|Overall Study|Adverse Event|15|||
27609992|NCT00251927|80412796|FG000|Overall Study|Lack of Efficacy|22|||
27609993|NCT00251927|80412797|FG001|Overall Study|Lack of Efficacy|16|||
27609994|NCT00251927|80412796|FG000|Overall Study|Lost to Follow-up|22|||
27609995|NCT00251927|80412797|FG001|Overall Study|Lost to Follow-up|8|||
27609996|NCT00251927|80412796|FG000|Overall Study|Protocol Violation|1|||
27609997|NCT00251927|80412797|FG001|Overall Study|Protocol Violation|2|||
27609998|NCT00251927|80412796|FG000|Overall Study|Pregnancy|2|||
27609999|NCT00251927|80412797|FG001|Overall Study|Pregnancy|0|||
27840072|NCT02725411|81242673|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
27840073|NCT02725411|81242674|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
27840074|NCT02725411|81242672|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
27840075|NCT02725411|81242673|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
27840076|NCT02725411|81242674|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
27840077|NCT02725411|81242672|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
27840078|NCT02725411|81242673|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
27840079|NCT02725411|81242674|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
27840080|NCT02725411|81242672|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
27840081|NCT02725411|81242673|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
27840082|NCT02725411|81242674|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
27610000|NCT00251927|80412796|FG000|Overall Study|Withdrawal by Subject|40|||
27610001|NCT00251927|80412797|FG001|Overall Study|Withdrawal by Subject|25|||
27610002|NCT00251927|80412796|FG000|Overall Study|Study-specific discont. achieved|13|||
27610003|NCT00251927|80412797|FG001|Overall Study|Study-specific discont. achieved|2|||
27610004|NCT00251927|80412796|FG000|Overall Study|Study procedure non-compliance|5|||
27610005|NCT00251927|80412797|FG001|Overall Study|Study procedure non-compliance|6|||
27610006|NCT01380990|80412800|FG000|Overall Study|Treatment Failure|1|||
27610007|NCT01380990|80412801|FG001|Overall Study|Treatment Failure|0|||
27610008|NCT01380990|80412800|FG000|Overall Study|Death|0|||
27610009|NCT01380990|80412801|FG001|Overall Study|Death|1|||
27610010|NCT01463293|80412813|FG000|Overall Study|Lost to Follow-up|1|||
27610011|NCT01463293|80412814|FG001|Overall Study|Lost to Follow-up|4|||
27610012|NCT01463293|80412815|FG002|Overall Study|Lost to Follow-up|5|||
27610013|NCT01463293|80412813|FG000|Overall Study|Adverse Event|1|||
27610014|NCT01463293|80412814|FG001|Overall Study|Adverse Event|2|||
27610015|NCT01463293|80412815|FG002|Overall Study|Adverse Event|0|||
27610016|NCT01463293|80412813|FG000|Overall Study|Withdrawal by Subject|4|||
27610017|NCT01463293|80412814|FG001|Overall Study|Withdrawal by Subject|10|||
27610018|NCT01463293|80412815|FG002|Overall Study|Withdrawal by Subject|5|||
27610019|NCT01463293|80412813|FG000|Overall Study|Other|0|||
27610020|NCT01463293|80412814|FG001|Overall Study|Other|0|||
27610021|NCT01463293|80412815|FG002|Overall Study|Other|2|||
27610022|NCT01083641|80412819|FG000|Overall Study|Withdrawal by Subject|2|||
27610023|NCT02714868|80412820|FG000|Overall Study|Withdrawal by Subject|3|||
27610024|NCT02714868|80412821|FG001|Overall Study|Withdrawal by Subject|0|||
27610025|NCT02714868|80412820|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
27610026|NCT02714868|80412821|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
27610027|NCT02714868|80412820|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
27610028|NCT02714868|80412821|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
27610029|NCT02875834|80412823|FG000|Open-label Phase|Withdrawal by Subject|3|||
27610030|NCT02875834|80412824|FG001|Open-label Phase|Withdrawal by Subject|0|||
27610031|NCT02875834|80412825|FG002|Open-label Phase|Withdrawal by Subject|0|||
27610032|NCT02875834|80412826|FG003|Open-label Phase|Withdrawal by Subject|0|||
27610033|NCT02875834|80412823|FG000|Open-label Phase|(Not collected)|4|||
27610034|NCT02875834|80412824|FG001|Open-label Phase|(Not collected)|0|||
27610035|NCT02875834|80412825|FG002|Open-label Phase|(Not collected)|0|||
27610036|NCT02875834|80412826|FG003|Open-label Phase|(Not collected)|0|||
27610037|NCT02875834|80412823|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
27610038|NCT02875834|80412824|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
27610039|NCT02875834|80412825|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
27610040|NCT02875834|80412826|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
27610041|NCT02875834|80412823|FG000|Randomized Treatment Phase|Protocol Violation|0|||
27610042|NCT02875834|80412824|FG001|Randomized Treatment Phase|Protocol Violation|2|||
27610043|NCT02875834|80412825|FG002|Randomized Treatment Phase|Protocol Violation|0|||
27610044|NCT02875834|80412826|FG003|Randomized Treatment Phase|Protocol Violation|0|||
27610045|NCT02875834|80412823|FG000|Randomized Treatment Phase|(Not collected)|0|||
27610046|NCT02875834|80412824|FG001|Randomized Treatment Phase|(Not collected)|9|||
27610047|NCT02875834|80412825|FG002|Randomized Treatment Phase|(Not collected)|10|||
27610048|NCT02875834|80412826|FG003|Randomized Treatment Phase|(Not collected)|9|||
27610049|NCT00857805|80412827|FG000|Overall Study|Withdrawal by Subject|1|||
27501294|NCT01231906|80027916|FG000|Overall Study|Withdrawal by Subject|0|||
27501295|NCT01231906|80027917|FG001|Overall Study|Withdrawal by Subject|4|||
27610050|NCT00857805|80412828|FG001|Overall Study|Withdrawal by Subject|1|||
27610051|NCT01148862|80412829|FG000|Second Intervention|Withdrawal by Subject|0|||
27610052|NCT01148862|80412830|FG001|Second Intervention|Withdrawal by Subject|2|||
27610053|NCT05033080|80412834|FG000|Overall Study|Adverse Event|4|||
27610054|NCT05033080|80412835|FG001|Overall Study|Adverse Event|4|||
27610055|NCT05033080|80412834|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
27610056|NCT05033080|80412835|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
27610057|NCT05033080|80412834|FG000|Overall Study|Lost to Follow-up|1|||
27610058|NCT05033080|80412835|FG001|Overall Study|Lost to Follow-up|0|||
27610059|NCT05033080|80412834|FG000|Overall Study|Other non-compliance|0|||
27610060|NCT05033080|80412835|FG001|Overall Study|Other non-compliance|1|||
27610061|NCT05033080|80412834|FG000|Overall Study|Physician Decision|0|||
27610062|NCT05033080|80412835|FG001|Overall Study|Physician Decision|1|||
27610063|NCT05033080|80412834|FG000|Overall Study|Other|1|||
27610064|NCT05033080|80412835|FG001|Overall Study|Other|1|||
27501296|NCT01231906|80027916|FG000|Overall Study|Ineligible|10|||
27501297|NCT01231906|80027917|FG001|Overall Study|Ineligible|3|||
27501298|NCT01231906|80027916|FG000|Overall Study|No treatment|1|||
27501299|NCT01231906|80027917|FG001|Overall Study|No treatment|2|||
27501300|NCT05635461|80027921|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
27610065|NCT01473381|80412840|FG000|Overall Study|Adverse Event|8|||
27610066|NCT01473381|80412841|FG001|Overall Study|Adverse Event|20|||
27610067|NCT01473381|80412842|FG002|Overall Study|Adverse Event|25|||
27610068|NCT01473381|80412843|FG003|Overall Study|Adverse Event|17|||
27610069|NCT01473381|80412840|FG000|Overall Study|Insufficient Therapeutic Response|10|||
27610070|NCT01473381|80412841|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27610071|NCT01473381|80412842|FG002|Overall Study|Insufficient Therapeutic Response|2|||
27610072|NCT01473381|80412843|FG003|Overall Study|Insufficient Therapeutic Response|3|||
27610073|NCT01473381|80412840|FG000|Overall Study|Protocol Violation|17|||
27610074|NCT01473381|80412841|FG001|Overall Study|Protocol Violation|23|||
27610075|NCT01473381|80412842|FG002|Overall Study|Protocol Violation|19|||
27610076|NCT01473381|80412843|FG003|Overall Study|Protocol Violation|17|||
27610077|NCT01473381|80412840|FG000|Overall Study|Withdrawal of Consent|20|||
27610078|NCT01473381|80412841|FG001|Overall Study|Withdrawal of Consent|21|||
27610079|NCT01473381|80412842|FG002|Overall Study|Withdrawal of Consent|20|||
27610080|NCT01473381|80412843|FG003|Overall Study|Withdrawal of Consent|26|||
27610081|NCT01473381|80412840|FG000|Overall Study|Lost to Follow-up|25|||
27610082|NCT01473381|80412841|FG001|Overall Study|Lost to Follow-up|28|||
27610083|NCT01473381|80412842|FG002|Overall Study|Lost to Follow-up|35|||
27610084|NCT01473381|80412843|FG003|Overall Study|Lost to Follow-up|23|||
27610085|NCT01473381|80412840|FG000|Overall Study|Other Reasons|0|||
27610086|NCT01473381|80412841|FG001|Overall Study|Other Reasons|0|||
27610087|NCT01473381|80412842|FG002|Overall Study|Other Reasons|1|||
27610088|NCT01473381|80412843|FG003|Overall Study|Other Reasons|3|||
27610089|NCT02748694|80412845|FG000|Overall Study|Voluntary Withdrawal|0|||
27610090|NCT02748694|80412846|FG001|Overall Study|Voluntary Withdrawal|0|||
27610091|NCT02748694|80412847|FG002|Overall Study|Voluntary Withdrawal|0|||
27610092|NCT02748694|80412848|FG003|Overall Study|Voluntary Withdrawal|0|||
27610093|NCT02748694|80412849|FG004|Overall Study|Voluntary Withdrawal|0|||
27610094|NCT02748694|80412850|FG005|Overall Study|Voluntary Withdrawal|0|||
27610095|NCT02748694|80412851|FG006|Overall Study|Voluntary Withdrawal|0|||
27610096|NCT02748694|80412852|FG007|Overall Study|Voluntary Withdrawal|0|||
27610097|NCT02748694|80412853|FG008|Overall Study|Voluntary Withdrawal|0|||
27610098|NCT02748694|80412854|FG009|Overall Study|Voluntary Withdrawal|0|||
27610099|NCT02748694|80412855|FG010|Overall Study|Voluntary Withdrawal|0|||
27610100|NCT02748694|80412856|FG011|Overall Study|Voluntary Withdrawal|0|||
27610101|NCT02748694|80412857|FG012|Overall Study|Voluntary Withdrawal|0|||
27610102|NCT02748694|80412858|FG013|Overall Study|Voluntary Withdrawal|0|||
27610103|NCT02748694|80412859|FG014|Overall Study|Voluntary Withdrawal|2|||
27610104|NCT03327402|80412861|FG000|Overall Study|Withdrawal by Subject|1|||
27610105|NCT03327402|80412861|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
27610106|NCT02387216|80412862|FG000|Overall Study|Progressive disease|2|||
27721123|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
27721124|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
27891144|NCT03813147|81434308|FG001|Overall Study|Lack of Efficacy|4|||
27501301|NCT05635461|80027922|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
27501302|NCT05635461|80027923|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
27501303|NCT05635461|80027924|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
27501304|NCT05635461|80027925|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
27501305|NCT05635461|80027926|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
27501306|NCT05635461|80027921|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
27501307|NCT05635461|80027922|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
27501308|NCT05635461|80027923|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
27501309|NCT05635461|80027924|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
27501310|NCT05635461|80027925|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
27501311|NCT05635461|80027926|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
27501312|NCT05635461|80027921|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
27501313|NCT05635461|80027922|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
27501314|NCT05635461|80027923|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
27501315|NCT05635461|80027924|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
27501316|NCT05635461|80027925|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
27501317|NCT05635461|80027926|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
27501318|NCT03157830|80027927|FG000|Overall Study|Lost to Follow-up|1|||
27501319|NCT03157830|80027927|FG000|Overall Study|Withdrawal by Subject|1|||
27610107|NCT02387216|80412863|FG001|Overall Study|Progressive disease|0|||
27610108|NCT02387216|80412862|FG000|Overall Study|Withdrawal by Subject|3|||
27610109|NCT02387216|80412863|FG001|Overall Study|Withdrawal by Subject|5|||
27610110|NCT02387216|80412862|FG000|Overall Study|Physician Decision|2|||
27501320|NCT04244253|80027931|FG000|Overall Study|Adverse Event|2|||
27501321|NCT04244253|80027932|FG001|Overall Study|Adverse Event|2|||
27501322|NCT04244253|80027933|FG002|Overall Study|Adverse Event|4|||
27610111|NCT02387216|80412863|FG001|Overall Study|Physician Decision|0|||
27610112|NCT02387216|80412862|FG000|Overall Study|Sponsor Decision|28|||
27610113|NCT02387216|80412863|FG001|Overall Study|Sponsor Decision|12|||
27610114|NCT02387216|80412862|FG000|Overall Study|Death|60|||
27610115|NCT02387216|80412863|FG001|Overall Study|Death|23|||
27610116|NCT02387216|80412862|FG000|Overall Study|Other|5|||
27610117|NCT02387216|80412863|FG001|Overall Study|Other|4|||
27610118|NCT02387216|80412862|FG000|Overall Study|Lost to Follow-up|0|||
27610119|NCT02387216|80412863|FG001|Overall Study|Lost to Follow-up|3|||
27610120|NCT02049710|80415550|FG000|Overall Study|Lost to Follow-up|319|||
27610121|NCT02049710|80415551|FG001|Overall Study|Lost to Follow-up|324|||
27610122|NCT00154310|80415552|FG000|Overall Study|Adverse Event|19|||
27610123|NCT00154310|80415553|FG001|Overall Study|Adverse Event|9|||
27610124|NCT00154310|80415552|FG000|Overall Study|Lack of Efficacy|5|||
27610125|NCT00154310|80415553|FG001|Overall Study|Lack of Efficacy|4|||
27501323|NCT04244253|80027931|FG000|Overall Study|Protocol Violation|1|||
27501324|NCT04244253|80027932|FG001|Overall Study|Protocol Violation|2|||
27501325|NCT04244253|80027933|FG002|Overall Study|Protocol Violation|1|||
27501326|NCT04244253|80027931|FG000|Overall Study|Withdrawal by Subject|0|||
27501327|NCT04244253|80027932|FG001|Overall Study|Withdrawal by Subject|1|||
27501328|NCT04244253|80027933|FG002|Overall Study|Withdrawal by Subject|6|||
27610126|NCT00154310|80415552|FG000|Overall Study|Protocol Violation|4|||
27610127|NCT00154310|80415553|FG001|Overall Study|Protocol Violation|2|||
27610128|NCT00154310|80415552|FG000|Overall Study|Withdrawal by Subject|9|||
27610129|NCT00154310|80415553|FG001|Overall Study|Withdrawal by Subject|3|||
27610130|NCT00154310|80415552|FG000|Overall Study|Lost to Follow-up|0|||
27610131|NCT00154310|80415553|FG001|Overall Study|Lost to Follow-up|8|||
27891145|NCT03813147|81434307|FG000|Overall Study|Physician Decision|2|||
27891146|NCT03813147|81434308|FG001|Overall Study|Physician Decision|1|||
27891147|NCT00658775|81434309|FG000|Overall Study|Adverse Event|4|||
27891148|NCT00658775|81434310|FG001|Overall Study|Adverse Event|6|||
27891149|NCT00658775|81434309|FG000|Overall Study|Lost to Follow-up|17|||
27891150|NCT00658775|81434310|FG001|Overall Study|Lost to Follow-up|18|||
27891151|NCT00658775|81434309|FG000|Overall Study|Withdrawal by Subject|6|||
27891152|NCT00658775|81434310|FG001|Overall Study|Withdrawal by Subject|4|||
27891153|NCT00658775|81434309|FG000|Overall Study|Withdrawal of consent|8|||
27891154|NCT00658775|81434310|FG001|Overall Study|Withdrawal of consent|7|||
27891155|NCT00658775|81434309|FG000|Overall Study|Other|7|||
27891156|NCT00658775|81434310|FG001|Overall Study|Other|8|||
27891157|NCT01676896|81434314|FG000|Overall Study|Withdrawal by Subject|12|||
27891158|NCT01676896|81434315|FG001|Overall Study|Withdrawal by Subject|7|||
27501329|NCT04244253|80027931|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27501330|NCT04244253|80027932|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27501331|NCT04244253|80027933|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27501332|NCT04227899|80027934|FG000|Overall Study|Withdrawal by Subject|6|||
27501333|NCT04227899|80027935|FG001|Overall Study|Withdrawal by Subject|3|||
27501334|NCT04227899|80027934|FG000|Overall Study|Death|12|||
27610132|NCT00154310|80415552|FG000|Overall Study|Administrative problems|0|||
27610133|NCT00154310|80415553|FG001|Overall Study|Administrative problems|1|||
27610134|NCT00154310|80415552|FG000|Overall Study|Death|0|||
27610135|NCT00154310|80415553|FG001|Overall Study|Death|1|||
27610136|NCT03691948|80415555|FG000|Overall Study|Lost to Follow-up|1|||
27610137|NCT03691948|80415556|FG001|Overall Study|Lost to Follow-up|3|||
27501335|NCT04227899|80027935|FG001|Overall Study|Death|6|||
27501336|NCT04227899|80027934|FG000|Overall Study|Lost to Follow-up|2|||
27501337|NCT04227899|80027935|FG001|Overall Study|Lost to Follow-up|1|||
27501338|NCT03779334|80027936|FG000|Overall Study|Withdrawal by Subject|3|||
27501339|NCT03779334|80027937|FG001|Overall Study|Withdrawal by Subject|0|||
27610138|NCT04397523|80415557|FG000|Overall Study|Lost to Follow-up|3|||
27610139|NCT04397523|80415557|FG000|Overall Study|Transfer from/to other hospital|8|||
27610140|NCT01486758|80415558|FG000|Overall Study|Lost to Follow-up|0|||
27610141|NCT01486758|80415559|FG001|Overall Study|Lost to Follow-up|1|||
27610142|NCT00996580|80415566|FG000|Overall Study|Adverse Event|466|||
27721125|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
27721126|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
27610143|NCT00996580|80415566|FG000|Overall Study|Lost to Follow-up|480|||
27610144|NCT00996580|80415566|FG000|Overall Study|Noncompliance with the protocol|137|||
27610145|NCT00996580|80415566|FG000|Overall Study|Physician Decision|5|||
27610146|NCT00996580|80415566|FG000|Overall Study|Pregnancy|68|||
27891159|NCT01676896|81434316|FG002|Overall Study|Withdrawal by Subject|19|||
27891160|NCT02247440|81434320|FG000|Overall Study|Withdrawal by Subject|1|||
27891161|NCT02247440|81434320|FG000|Overall Study|Lack of Efficacy|3|||
27891162|NCT03075891|81434321|FG000|Overall Study|Withdrawal by Subject|3|||
27891163|NCT03075891|81434322|FG001|Overall Study|Withdrawal by Subject|6|||
27891164|NCT03075891|81434321|FG000|Overall Study|Lost to Follow-up|1|||
27501340|NCT03779334|80027938|FG002|Overall Study|Withdrawal by Subject|0|||
27501341|NCT03779334|80027936|FG000|Overall Study|Ongoing in Study|5|||
27610147|NCT00996580|80415566|FG000|Overall Study|Protocol Violation|16|||
27891165|NCT03075891|81434322|FG001|Overall Study|Lost to Follow-up|0|||
27891166|NCT03075891|81434321|FG000|Overall Study|Pregnancy|3|||
27610148|NCT00996580|80415566|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
27610149|NCT00996580|80415566|FG000|Overall Study|Withdrawal by Subject|217|||
27610150|NCT00996580|80415566|FG000|Overall Study|Other|29|||
27610151|NCT01719224|80415567|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
27610152|NCT01719224|80415568|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
27610153|NCT00308737|80415569|FG000|Overall Study|Adverse Event|104|||
27610154|NCT00308737|80415570|FG001|Overall Study|Adverse Event|9|||
27610155|NCT00308737|80415571|FG002|Overall Study|Adverse Event|0|||
27610156|NCT00308737|80415569|FG000|Overall Study|Death|4|||
27610157|NCT00308737|80415570|FG001|Overall Study|Death|3|||
27610158|NCT00308737|80415571|FG002|Overall Study|Death|0|||
27610159|NCT00308737|80415569|FG000|Overall Study|Lost to Follow-up|56|||
27610160|NCT00308737|80415570|FG001|Overall Study|Lost to Follow-up|80|||
27501342|NCT03779334|80027937|FG001|Overall Study|Ongoing in Study|13|||
27501343|NCT03779334|80027938|FG002|Overall Study|Ongoing in Study|5|||
27501344|NCT03199976|80030230|FG000|Overall Study|Lack of Efficacy|3|||
27501345|NCT03199976|80030231|FG001|Overall Study|Lack of Efficacy|6|||
27501346|NCT03199976|80030232|FG002|Overall Study|Lack of Efficacy|13|||
27501347|NCT03199976|80030230|FG000|Overall Study|Withdrawal by Subject|1|||
27501348|NCT03199976|80030231|FG001|Overall Study|Withdrawal by Subject|0|||
27501349|NCT03199976|80030232|FG002|Overall Study|Withdrawal by Subject|0|||
27501350|NCT03199976|80030230|FG000|Overall Study|Lost to Follow-up|0|||
27501351|NCT03199976|80030231|FG001|Overall Study|Lost to Follow-up|1|||
27501352|NCT03199976|80030232|FG002|Overall Study|Lost to Follow-up|1|||
27610161|NCT00308737|80415571|FG002|Overall Study|Lost to Follow-up|5|||
27610162|NCT00308737|80415569|FG000|Overall Study|Physician Decision|15|||
27501353|NCT01607957|80030234|FG000|Overall Study|Not treated|1|||
27501354|NCT01607957|80030235|FG001|Overall Study|Not treated|1|||
27501355|NCT01607957|80030234|FG000|Overall Study|Death|367|||
27721127|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
27721128|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
27721129|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
27721130|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
27721131|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
27501356|NCT01607957|80030235|FG001|Overall Study|Death|211|||
27501357|NCT01607957|80030234|FG000|Overall Study|Lost to Follow-up|3|||
27501358|NCT01607957|80030235|FG001|Overall Study|Lost to Follow-up|3|||
27501359|NCT01607957|80030234|FG000|Overall Study|Participant refusal|1|||
27610163|NCT00308737|80415570|FG001|Overall Study|Physician Decision|2|||
27610164|NCT00308737|80415571|FG002|Overall Study|Physician Decision|1|||
27610165|NCT00308737|80415569|FG000|Overall Study|Protocol Violation|34|||
27610166|NCT00308737|80415570|FG001|Overall Study|Protocol Violation|9|||
27610167|NCT00308737|80415571|FG002|Overall Study|Protocol Violation|5|||
27721132|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
27721133|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
27721134|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
27721135|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
27501360|NCT01607957|80030235|FG001|Overall Study|Participant refusal|0|||
27610168|NCT00308737|80415569|FG000|Overall Study|Withdrawal by Subject|218|||
27610169|NCT00308737|80415570|FG001|Overall Study|Withdrawal by Subject|166|||
27610170|NCT00308737|80415571|FG002|Overall Study|Withdrawal by Subject|18|||
27721136|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
27610171|NCT00308737|80415569|FG000|Overall Study|Various|32|||
27501361|NCT02432703|80030245|FG000|Overall Study|Adverse Event|1|||
27610172|NCT00308737|80415570|FG001|Overall Study|Various|20|||
27610173|NCT00308737|80415571|FG002|Overall Study|Various|8|||
27610174|NCT03283696|80415572|FG000|Overall Study|Physician Decision|5|||
27610175|NCT03283696|80415573|FG001|Overall Study|Physician Decision|6|||
27891167|NCT03075891|81434322|FG001|Overall Study|Pregnancy|1|||
27840083|NCT02725411|81242672|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
27840084|NCT02725411|81242673|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
27840085|NCT02725411|81242674|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
27840086|NCT02725411|81242672|FG000|Follow-up Period (24 Weeks)|Other|1|||
27840087|NCT02725411|81242673|FG001|Follow-up Period (24 Weeks)|Other|4|||
27840088|NCT02725411|81242674|FG002|Follow-up Period (24 Weeks)|Other|2|||
27891168|NCT03075891|81434321|FG000|Overall Study|visits not performed (no time)|1|||
27891169|NCT03075891|81434322|FG001|Overall Study|visits not performed (no time)|0|||
27891170|NCT03075891|81434321|FG000|Overall Study|Drug abuse relapse issue|0|||
27891171|NCT03075891|81434322|FG001|Overall Study|Drug abuse relapse issue|1|||
27891172|NCT03075891|81434321|FG000|Overall Study|Participant requiring study withdrawal|0|||
27891173|NCT03075891|81434322|FG001|Overall Study|Participant requiring study withdrawal|1|||
27891174|NCT03075891|81434321|FG000|Overall Study|Adverse event, non-fatal|1|||
27891175|NCT03075891|81434322|FG001|Overall Study|Adverse event, non-fatal|4|||
27891176|NCT01053962|81434326|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
27891177|NCT01053962|81434327|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
27891178|NCT01053962|81434328|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
27891179|NCT01053962|81434329|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
27891180|NCT01053962|81434330|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
27610176|NCT03283696|80415572|FG000|Overall Study|Withdrawal by Subject|2|||
27610177|NCT03283696|80415573|FG001|Overall Study|Withdrawal by Subject|0|||
27610178|NCT02035332|80415575|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
27610179|NCT02367716|80415576|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
27610180|NCT02917941|80415578|FG000|Treatment Period|Adverse Event|11|||
27610181|NCT02917941|80415578|FG000|Treatment Period|Progressive Disease|11|||
27610182|NCT02917941|80415578|FG000|Treatment Period|Reason not Specified|2|||
27840089|NCT02725411|81242672|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
27840090|NCT02725411|81242673|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
27840091|NCT02725411|81242674|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
27891181|NCT01053962|81434326|FG000|Pretreatment Period|Venipuncture Failure|0|||
27891182|NCT01053962|81434327|FG001|Pretreatment Period|Venipuncture Failure|0|||
27891183|NCT01053962|81434328|FG002|Pretreatment Period|Venipuncture Failure|1|||
27958595|NCT01791517|81680067|FG009|Phase II|Withdrawal by Subject|0|||
27610183|NCT02917941|80415578|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
27610184|NCT02917941|80415578|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
27891184|NCT01053962|81434329|FG003|Pretreatment Period|Venipuncture Failure|0|||
27891185|NCT01053962|81434330|FG004|Pretreatment Period|Venipuncture Failure|0|||
27891186|NCT01053962|81434326|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27891187|NCT01053962|81434327|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
27891188|NCT01053962|81434328|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27891189|NCT01053962|81434329|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27840110|NCT04499482|81244932|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
27840111|NCT04264819|81244934|FG000|Overall Study|Physician Decision|19|||
27840112|NCT04264819|81244934|FG000|Overall Study|Adverse Event|12|||
27840113|NCT04264819|81244934|FG000|Overall Study|Withdrawal by Subject|11|||
27840114|NCT04264819|81244934|FG000|Overall Study|Lost to Follow-up|2|||
27840115|NCT04264819|81244934|FG000|Overall Study|Death|2|||
27840116|NCT00440115|81244939|FG000|Overall Study|Death|7|||
27840117|NCT00440115|81244940|FG001|Overall Study|Death|9|||
27840118|NCT00440115|81244941|FG002|Overall Study|Death|5|||
27840119|NCT00440115|81244939|FG000|Overall Study|Incarceration|0|||
27840120|NCT00440115|81244940|FG001|Overall Study|Incarceration|2|||
27840121|NCT00440115|81244941|FG002|Overall Study|Incarceration|1|||
27840122|NCT01937117|81244943|FG000|Overall Study|Disease Progression|7|||
27840123|NCT01937117|81244943|FG000|Overall Study|Physician Decision|4|||
27840124|NCT01937117|81244943|FG000|Overall Study|Adverse Event|2|||
27840125|NCT02000115|81244944|FG000|Overall Study|Death|56|||
27840126|NCT02000115|81244945|FG001|Overall Study|Death|45|||
27840127|NCT02000115|81244946|FG002|Overall Study|Death|0|||
27840128|NCT02000115|81244947|FG003|Overall Study|Death|0|||
27840129|NCT02000115|81244944|FG000|Overall Study|Missed Visit|6|||
27840130|NCT02000115|81244945|FG001|Overall Study|Missed Visit|8|||
27891190|NCT01053962|81434330|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
27891191|NCT01053962|81434326|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27891192|NCT01053962|81434327|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27891193|NCT01053962|81434328|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27891194|NCT01053962|81434329|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
27891195|NCT01053962|81434330|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
27891196|NCT01053962|81434326|FG000|Treatment Period|Lack of Efficacy|0|||
27891197|NCT01053962|81434327|FG001|Treatment Period|Lack of Efficacy|0|||
27891198|NCT01053962|81434328|FG002|Treatment Period|Lack of Efficacy|0|||
27891199|NCT01053962|81434329|FG003|Treatment Period|Lack of Efficacy|0|||
27891200|NCT01053962|81434330|FG004|Treatment Period|Lack of Efficacy|1|||
27891201|NCT01053962|81434326|FG000|Treatment Period|Adverse Event|0|||
27891202|NCT01053962|81434327|FG001|Treatment Period|Adverse Event|0|||
27891203|NCT01053962|81434328|FG002|Treatment Period|Adverse Event|0|||
27891204|NCT01053962|81434329|FG003|Treatment Period|Adverse Event|0|||
27891205|NCT01053962|81434330|FG004|Treatment Period|Adverse Event|1|||
27840131|NCT02000115|81244946|FG002|Overall Study|Missed Visit|1|||
27840132|NCT02000115|81244947|FG003|Overall Study|Missed Visit|0|||
27840133|NCT02000115|81244944|FG000|Overall Study|Protocol Violation|2|||
27840134|NCT02000115|81244945|FG001|Overall Study|Protocol Violation|1|||
27891206|NCT01053962|81434326|FG000|Treatment Period|Withdrawal by Subject|0|||
27840135|NCT02000115|81244946|FG002|Overall Study|Protocol Violation|0|||
27840136|NCT02000115|81244947|FG003|Overall Study|Protocol Violation|0|||
27840137|NCT02000115|81244944|FG000|Overall Study|Physician Decision|2|||
27840138|NCT02000115|81244945|FG001|Overall Study|Physician Decision|0|||
27891207|NCT01053962|81434327|FG001|Treatment Period|Withdrawal by Subject|0|||
27891208|NCT01053962|81434328|FG002|Treatment Period|Withdrawal by Subject|0|||
27610185|NCT02001974|80415579|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
27840139|NCT02000115|81244946|FG002|Overall Study|Physician Decision|0|||
27840140|NCT02000115|81244947|FG003|Overall Study|Physician Decision|0|||
27840141|NCT02000115|81244944|FG000|Overall Study|Withdrawal by Subject|11|||
27840142|NCT02000115|81244945|FG001|Overall Study|Withdrawal by Subject|11|||
27721137|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
27721138|NCT04418765|80810341|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
27721139|NCT04418765|80810342|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
27721140|NCT04418765|80810343|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
27721141|NCT04418765|80810341|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
27721142|NCT04418765|80810342|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
27721143|NCT04418765|80810343|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
27721144|NCT04418765|80810341|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
27721145|NCT04418765|80810342|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
27721146|NCT04418765|80810343|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
27721147|NCT04418765|80810341|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
27721148|NCT04418765|80810342|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
27721149|NCT04418765|80810343|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
27721150|NCT04418765|80810341|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
27721151|NCT04418765|80810342|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
27721152|NCT04418765|80810343|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
27721153|NCT04418765|80810341|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
27721154|NCT04418765|80810342|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
27721155|NCT04418765|80810343|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
27721156|NCT04418765|80810341|FG000|Extension Period (48 Weeks)|Other than specified|0|||
27721157|NCT04418765|80810342|FG001|Extension Period (48 Weeks)|Other than specified|5|||
27721158|NCT04418765|80810343|FG002|Extension Period (48 Weeks)|Other than specified|2|||
27721159|NCT02559687|80810344|FG000|Overall Study|Death|112|||
27840143|NCT02000115|81244946|FG002|Overall Study|Withdrawal by Subject|0|||
27840144|NCT02000115|81244947|FG003|Overall Study|Withdrawal by Subject|0|||
27840145|NCT02000115|81244944|FG000|Overall Study|Lost to Follow-up|0|||
27840146|NCT02000115|81244945|FG001|Overall Study|Lost to Follow-up|1|||
27840147|NCT02000115|81244946|FG002|Overall Study|Lost to Follow-up|0|||
27840148|NCT02000115|81244947|FG003|Overall Study|Lost to Follow-up|0|||
27840149|NCT02000115|81244944|FG000|Overall Study|Non-compliance|2|||
27840150|NCT02000115|81244945|FG001|Overall Study|Non-compliance|1|||
27840151|NCT02000115|81244946|FG002|Overall Study|Non-compliance|0|||
27840152|NCT02000115|81244947|FG003|Overall Study|Non-compliance|0|||
27840153|NCT02000115|81244944|FG000|Overall Study|Withdrawn on day of randomization|0|||
27840154|NCT02000115|81244945|FG001|Overall Study|Withdrawn on day of randomization|1|||
27840155|NCT02000115|81244946|FG002|Overall Study|Withdrawn on day of randomization|0|||
27840156|NCT02000115|81244947|FG003|Overall Study|Withdrawn on day of randomization|0|||
27840157|NCT02000115|81244944|FG000|Overall Study|Still on Study|0|||
27840158|NCT02000115|81244945|FG001|Overall Study|Still on Study|0|||
27840159|NCT02000115|81244946|FG002|Overall Study|Still on Study|0|||
27840160|NCT02000115|81244947|FG003|Overall Study|Still on Study|53|||
27840161|NCT01557751|81244948|FG000|Overall Study|Physician Decision|3|||
27840162|NCT00570128|81244949|FG000|Overall Study|Adverse Event|1|||
27840163|NCT00570128|81244950|FG001|Overall Study|Adverse Event|0|||
27840164|NCT00570128|81244949|FG000|Overall Study|Lost to Follow-up|1|||
27840165|NCT00570128|81244950|FG001|Overall Study|Lost to Follow-up|0|||
27840166|NCT00570128|81244949|FG000|Overall Study|Withdrawal by Subject|2|||
27721160|NCT02559687|80810344|FG000|Overall Study|Sponsor Decision|5|||
27840167|NCT00570128|81244950|FG001|Overall Study|Withdrawal by Subject|0|||
27891209|NCT01053962|81434329|FG003|Treatment Period|Withdrawal by Subject|0|||
27891210|NCT01053962|81434330|FG004|Treatment Period|Withdrawal by Subject|1|||
27891211|NCT01053962|81434326|FG000|Treatment Period|Noncompliance with protocol|1|||
27891212|NCT01053962|81434327|FG001|Treatment Period|Noncompliance with protocol|0|||
27891213|NCT01053962|81434328|FG002|Treatment Period|Noncompliance with protocol|0|||
27891214|NCT01053962|81434329|FG003|Treatment Period|Noncompliance with protocol|0|||
27891215|NCT01053962|81434330|FG004|Treatment Period|Noncompliance with protocol|0|||
27891216|NCT02828124|81434331|FG000|Overall Study|Disease Progression|1|||
27891217|NCT02828124|81434332|FG001|Overall Study|Disease Progression|2|||
27891218|NCT02828124|81434333|FG002|Overall Study|Disease Progression|1|||
27891219|NCT02828124|81434334|FG003|Overall Study|Disease Progression|4|||
27891220|NCT02828124|81434331|FG000|Overall Study|AE Unrelated to Study Drug|0|||
27891221|NCT02828124|81434332|FG001|Overall Study|AE Unrelated to Study Drug|0|||
27891222|NCT02828124|81434333|FG002|Overall Study|AE Unrelated to Study Drug|0|||
27891223|NCT02828124|81434334|FG003|Overall Study|AE Unrelated to Study Drug|1|||
27891224|NCT02828124|81434331|FG000|Overall Study|Subject Withdrew Consent|0|||
27891225|NCT02828124|81434332|FG001|Overall Study|Subject Withdrew Consent|0|||
27891226|NCT02828124|81434333|FG002|Overall Study|Subject Withdrew Consent|0|||
27891227|NCT02828124|81434334|FG003|Overall Study|Subject Withdrew Consent|1|||
27891228|NCT03197324|81434345|FG000|Overall Study|Adverse Event|0|||
27891229|NCT03197324|81434346|FG001|Overall Study|Adverse Event|1|||
27891230|NCT03937908|81434347|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
27891231|NCT03937908|81434348|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
27891232|NCT01447446|81434349|FG000|Overall Study|Death|6|||
27891233|NCT01447446|81434350|FG001|Overall Study|Death|3|||
27891234|NCT01447446|81434351|FG002|Overall Study|Death|2|||
27891235|NCT01447446|81434352|FG003|Overall Study|Death|1|||
27891236|NCT01447446|81434353|FG004|Overall Study|Death|7|||
27891237|NCT01447446|81434354|FG005|Overall Study|Death|0|||
27891238|NCT01447446|81434349|FG000|Overall Study|Adverse Event|3|||
27891239|NCT01447446|81434350|FG001|Overall Study|Adverse Event|0|||
27891240|NCT01447446|81434351|FG002|Overall Study|Adverse Event|1|||
27891241|NCT01447446|81434352|FG003|Overall Study|Adverse Event|0|||
27840170|NCT02339740|81244953|FG000|Overall Study|Death|1|||
27840171|NCT02339740|81244954|FG001|Overall Study|Death|0|||
27840172|NCT02339740|81244953|FG000|Overall Study|Physician Decision|0|||
27501362|NCT02432703|80030246|FG001|Overall Study|Adverse Event|4|||
27501363|NCT02432703|80030245|FG000|Overall Study|Lack of Efficacy|1|||
27501364|NCT02432703|80030246|FG001|Overall Study|Lack of Efficacy|0|||
27501365|NCT02432703|80030245|FG000|Overall Study|Lost to Follow-up|5|||
27501366|NCT02432703|80030246|FG001|Overall Study|Lost to Follow-up|3|||
27501367|NCT02432703|80030245|FG000|Overall Study|Withdrawal by Subject|9|||
27501368|NCT02432703|80030246|FG001|Overall Study|Withdrawal by Subject|6|||
27501369|NCT02432703|80030245|FG000|Overall Study|Other|6|||
27501370|NCT02432703|80030246|FG001|Overall Study|Other|5|||
27721161|NCT02559687|80810344|FG000|Overall Study|Withdrawal by Subject|4|||
27840173|NCT02339740|81244954|FG001|Overall Study|Physician Decision|2|||
27840174|NCT02339740|81244953|FG000|Overall Study|Withdrawal by Subject|5|||
27840175|NCT02339740|81244954|FG001|Overall Study|Withdrawal by Subject|1|||
27840176|NCT02339740|81244953|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
27840177|NCT02339740|81244954|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
27840178|NCT00258856|81244956|FG000|Overall Study|Lost to Follow-up|1|||
27840179|NCT00258856|81244957|FG001|Overall Study|Lost to Follow-up|0|||
27840180|NCT00258856|81244958|FG002|Overall Study|Lost to Follow-up|2|||
27840181|NCT00258856|81244959|FG003|Overall Study|Lost to Follow-up|0|||
27891242|NCT01447446|81434353|FG004|Overall Study|Adverse Event|2|||
27840182|NCT00258856|81244956|FG000|Overall Study|Non-compliance|2|||
27840183|NCT00258856|81244957|FG001|Overall Study|Non-compliance|0|||
27840184|NCT00258856|81244958|FG002|Overall Study|Non-compliance|0|||
27840185|NCT00258856|81244959|FG003|Overall Study|Non-compliance|1|||
27840186|NCT03433703|81244962|FG000|Overall Study|Study terminated by Sponsor|2|||
27891243|NCT01447446|81434354|FG005|Overall Study|Adverse Event|0|||
27501371|NCT02435212|80030248|FG000|Core Phase|Adverse Event|8|||
27891244|NCT01447446|81434349|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
27721162|NCT01298492|80810345|FG000|Overall Study|Death|2|||
27840187|NCT02427399|81244965|FG000|Overall Study|Protocol Violation|14|||
27840188|NCT02427399|81244966|FG001|Overall Study|Protocol Violation|16|||
27840189|NCT02427399|81244967|FG002|Overall Study|Protocol Violation|12|||
27891245|NCT01447446|81434350|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
27891246|NCT01447446|81434351|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
27891247|NCT01447446|81434352|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
27891248|NCT01447446|81434353|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
27891249|NCT01447446|81434354|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
27891250|NCT01447446|81434349|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
27958596|NCT01791517|81680068|FG010|Phase II|Withdrawal by Subject|1|||
27501372|NCT02435212|80030249|FG001|Core Phase|Adverse Event|5|||
27840190|NCT02427399|81244968|FG003|Overall Study|Protocol Violation|18|||
27501373|NCT02435212|80030248|FG000|Core Phase|Withdrawal by Subject|3|||
27501374|NCT02435212|80030249|FG001|Core Phase|Withdrawal by Subject|0|||
27610186|NCT02001974|80415580|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
27610187|NCT02001974|80415581|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
27610188|NCT02001974|80415579|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
27610189|NCT02001974|80415580|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
27610190|NCT02001974|80415581|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
27610191|NCT02001974|80415579|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
27610192|NCT02001974|80415580|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
27610193|NCT02001974|80415581|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
27610194|NCT02001974|80415579|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
27610195|NCT02001974|80415580|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
27610196|NCT02001974|80415581|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
27610197|NCT02468934|80415582|FG000|Overall Study|Withdrawal by Subject|4|||
27610198|NCT02468934|80415582|FG000|Overall Study|Screen Failure|3|||
27610199|NCT03872388|80415586|FG000|Overall Study|Disease Progression|0|||
27610200|NCT03872388|80415587|FG001|Overall Study|Disease Progression|0|||
27721163|NCT01298492|80810345|FG000|Overall Study|Insufficient Clinical Response|22|||
27721164|NCT01298492|80810345|FG000|Overall Study|Lost to Follow-up|12|||
27840191|NCT02427399|81244969|FG004|Overall Study|Protocol Violation|15|||
27840192|NCT00982228|81244970|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
27840193|NCT00982228|81244971|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
27840194|NCT00982228|81244970|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
27840195|NCT00982228|81244971|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
27840196|NCT00982228|81244970|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
27840197|NCT00982228|81244971|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
27840198|NCT00982228|81244970|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
27891251|NCT01447446|81434350|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
27891252|NCT01447446|81434351|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
27891253|NCT01447446|81434352|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
27891254|NCT01447446|81434353|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
27501375|NCT02435212|80030248|FG000|Core Phase|Withdrawal by parent/guardian|9|||
27501376|NCT02435212|80030249|FG001|Core Phase|Withdrawal by parent/guardian|4|||
27501377|NCT02435212|80030248|FG000|Core Phase|Protocol Violation|1|||
27501378|NCT02435212|80030249|FG001|Core Phase|Protocol Violation|2|||
27501379|NCT02435212|80030248|FG000|Core Phase|Physician Decision|3|||
27501380|NCT02435212|80030249|FG001|Core Phase|Physician Decision|0|||
27501381|NCT02435212|80030248|FG000|Core Phase|Lost to Follow-up|0|||
27501382|NCT02435212|80030249|FG001|Core Phase|Lost to Follow-up|1|||
27501383|NCT02435212|80030248|FG000|Core Phase|Lack of Efficacy|0|||
27501384|NCT02435212|80030249|FG001|Core Phase|Lack of Efficacy|1|||
27501385|NCT02435212|80030248|FG000|Core Phase|Recovery|1|||
27501386|NCT02435212|80030249|FG001|Core Phase|Recovery|0|||
27501387|NCT02435212|80030248|FG000|Optional Extension Phase|Adverse Event|3|||
27501388|NCT02435212|80030249|FG001|Optional Extension Phase|Adverse Event|9|||
27501389|NCT02435212|80030248|FG000|Optional Extension Phase|Physician Decision|6|||
27501390|NCT02435212|80030249|FG001|Optional Extension Phase|Physician Decision|8|||
27501391|NCT02435212|80030248|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
27610201|NCT03872388|80415588|FG002|Overall Study|Disease Progression|0|||
27610202|NCT03872388|80415589|FG003|Overall Study|Disease Progression|0|||
27891255|NCT01447446|81434354|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
27610203|NCT03872388|80415590|FG004|Overall Study|Disease Progression|0|||
27610204|NCT03872388|80415591|FG005|Overall Study|Disease Progression|0|||
27610205|NCT03872388|80415592|FG006|Overall Study|Disease Progression|1|||
27721165|NCT01298492|80810345|FG000|Overall Study|Withdrawal by Subject|47|||
27721166|NCT01298492|80810345|FG000|Overall Study|Other (Unspecified)|7|||
27721167|NCT01298492|80810345|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
27721168|NCT01298492|80810345|FG000|Overall Study|Protocol Violation|2|||
27721169|NCT01298492|80810345|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
27721170|NCT01298492|80810345|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
27721171|NCT03310970|80810346|FG000|Overall Study|Withdrawal by Subject|0|||
27721172|NCT03310970|80810347|FG001|Overall Study|Withdrawal by Subject|1|||
27840199|NCT00982228|81244971|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
27840200|NCT00982228|81244970|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
27840201|NCT00982228|81244971|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
27840202|NCT00982228|81244970|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
27840203|NCT00982228|81244971|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
27840204|NCT00982228|81244970|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
27840205|NCT00982228|81244971|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
27840206|NCT00982228|81244970|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
27840207|NCT00982228|81244971|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
27840208|NCT00982228|81244970|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
27891256|NCT01447446|81434349|FG000|Overall Study|Administrative/Other|34|||
27891257|NCT01447446|81434350|FG001|Overall Study|Administrative/Other|9|||
27891258|NCT01447446|81434351|FG002|Overall Study|Administrative/Other|10|||
27891259|NCT01447446|81434352|FG003|Overall Study|Administrative/Other|2|||
27891260|NCT01447446|81434353|FG004|Overall Study|Administrative/Other|33|||
27610206|NCT03872388|80415593|FG007|Overall Study|Disease Progression|1|||
27610207|NCT01265823|80415594|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
27610208|NCT01265823|80415594|FG000|Overall Study|Failure to Return|4|||
27610209|NCT01265823|80415594|FG000|Overall Study|Protocol Violation|1|||
27610210|NCT01265823|80415594|FG000|Overall Study|Participant Request|1|||
27610211|NCT01679301|80415595|FG000|Screening Period|screen failure|3|||
27610212|NCT01679301|80415596|FG001|Screening Period|screen failure|0|||
27610213|NCT01679301|80415597|FG002|Screening Period|screen failure|0|||
27610214|NCT00847301|80415598|FG000|Overall Study|Adverse Event|35|||
27610215|NCT00847301|80415598|FG000|Overall Study|Switch to other anticoagulants|16|||
27610216|NCT00847301|80415598|FG000|Overall Study|Lost to Follow-up|1|||
27610217|NCT00847301|80415598|FG000|Overall Study|No prescription after hospital discharge|1|||
27610218|NCT00847301|80415598|FG000|Overall Study|Other reason not defined above|1|||
27610219|NCT03151395|80415599|FG000|Overall Study|Adverse Event|2|||
27610220|NCT03151395|80415599|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
27610221|NCT03151395|80415599|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
27610222|NCT03151395|80415599|FG000|Overall Study|Unspecified reason|4|||
27610223|NCT01597505|80415613|FG000|Overall Study|Physician Decision|5|||
27840209|NCT00982228|81244971|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
27840210|NCT00982228|81244970|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
27891261|NCT01447446|81434354|FG005|Overall Study|Administrative/Other|4|||
27891262|NCT01447446|81434349|FG000|Overall Study|SVR12 Assessment|13|||
27891263|NCT01447446|81434350|FG001|Overall Study|SVR12 Assessment|1|||
27610224|NCT01597505|80415614|FG001|Overall Study|Physician Decision|0|||
27610225|NCT01597505|80415613|FG000|Overall Study|Adverse Event|19|||
27891264|NCT01447446|81434351|FG002|Overall Study|SVR12 Assessment|2|||
27610226|NCT01597505|80415614|FG001|Overall Study|Adverse Event|7|||
27721173|NCT00695565|80810348|FG000|Overall Study|Lost to Follow-up|4|||
27721174|NCT00695565|80810349|FG001|Overall Study|Lost to Follow-up|4|||
27891265|NCT01447446|81434352|FG003|Overall Study|SVR12 Assessment|1|||
27891266|NCT01447446|81434353|FG004|Overall Study|SVR12 Assessment|5|||
27891267|NCT01447446|81434354|FG005|Overall Study|SVR12 Assessment|5|||
27891268|NCT01447446|81434349|FG000|Overall Study|New Treatment Started|8|||
27721175|NCT00695565|80810348|FG000|Overall Study|Adverse Event|3|||
27721176|NCT00695565|80810349|FG001|Overall Study|Adverse Event|1|||
27721177|NCT00695565|80810348|FG000|Overall Study|Protocol Violation|3|||
27721178|NCT00695565|80810349|FG001|Overall Study|Protocol Violation|1|||
27721179|NCT00695565|80810348|FG000|Overall Study|Withdrawal by Subject|1|||
27721180|NCT00695565|80810349|FG001|Overall Study|Withdrawal by Subject|1|||
27721181|NCT00695565|80810348|FG000|Overall Study|Lack of Efficacy|1|||
27721182|NCT00695565|80810349|FG001|Overall Study|Lack of Efficacy|1|||
27721183|NCT00695565|80810348|FG000|Overall Study|Subject did not follow instructions|1|||
27721184|NCT00695565|80810349|FG001|Overall Study|Subject did not follow instructions|1|||
27721185|NCT02599961|80810350|FG000|Overall Study|Withdrawal by Subject|1|||
27721186|NCT02599961|80810350|FG000|Overall Study|Subject Non-Compliance|2|||
27721187|NCT02599961|80810350|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
27721188|NCT02599961|80810350|FG000|Overall Study|Other, Not Specified|3|||
27721189|NCT02627495|80810351|FG000|Overall Study|Withdrawal by Subject|4|||
27721190|NCT02445586|80810356|FG000|Overall Study|Death|14|||
27721191|NCT02445586|80810356|FG000|Overall Study|Withdrawal by Subject|13|||
27721192|NCT02445586|80810356|FG000|Overall Study|Disease Progression|10|||
27721193|NCT02445586|80810356|FG000|Overall Study|Protocol Violation|1|||
27721194|NCT02445586|80810356|FG000|Overall Study|Medical Condition|1|||
27721195|NCT00999908|80810357|FG000|Treatment Period 1|Subject withdrew consent|2|||
27721196|NCT00999908|80810358|FG001|Treatment Period 1|Subject withdrew consent|0|||
27721197|NCT00999908|80810359|FG002|Treatment Period 1|Subject withdrew consent|0|||
27721198|NCT00999908|80810357|FG000|Treatment Period 2|Protocol Violation|1|||
27721199|NCT00999908|80810358|FG001|Treatment Period 2|Protocol Violation|0|||
27721200|NCT00999908|80810359|FG002|Treatment Period 2|Protocol Violation|0|||
27721201|NCT00841763|80810360|FG000|Overall Study|Withdrawal by Subject|60|||
27721202|NCT00841763|80810361|FG001|Overall Study|Withdrawal by Subject|17|||
27721203|NCT00841763|80810362|FG002|Overall Study|Withdrawal by Subject|4|||
27721204|NCT00841763|80810363|FG003|Overall Study|Withdrawal by Subject|1|||
27721205|NCT00841763|80810360|FG000|Overall Study|Adverse Event|9|||
27721206|NCT00841763|80810361|FG001|Overall Study|Adverse Event|10|||
27891269|NCT01447446|81434350|FG001|Overall Study|New Treatment Started|2|||
27891270|NCT01447446|81434351|FG002|Overall Study|New Treatment Started|1|||
27721207|NCT00841763|80810362|FG002|Overall Study|Adverse Event|3|||
27721208|NCT00841763|80810363|FG003|Overall Study|Adverse Event|2|||
27721209|NCT00841763|80810360|FG000|Overall Study|Lost to Follow-up|63|||
27721210|NCT00841763|80810361|FG001|Overall Study|Lost to Follow-up|25|||
27721211|NCT00841763|80810362|FG002|Overall Study|Lost to Follow-up|0|||
27721212|NCT00841763|80810363|FG003|Overall Study|Lost to Follow-up|0|||
27721213|NCT00841763|80810360|FG000|Overall Study|Protocol Violation|20|||
27721214|NCT00841763|80810361|FG001|Overall Study|Protocol Violation|3|||
27721215|NCT00841763|80810362|FG002|Overall Study|Protocol Violation|1|||
27721216|NCT00841763|80810363|FG003|Overall Study|Protocol Violation|0|||
27721217|NCT00841763|80810360|FG000|Overall Study|Administrative Reasons|3|||
27721218|NCT00841763|80810361|FG001|Overall Study|Administrative Reasons|1|||
27721219|NCT00841763|80810362|FG002|Overall Study|Administrative Reasons|0|||
27721220|NCT00841763|80810363|FG003|Overall Study|Administrative Reasons|0|||
27721221|NCT00841763|80810360|FG000|Overall Study|Unable to Classify|7|||
27721222|NCT00841763|80810361|FG001|Overall Study|Unable to Classify|1|||
27721223|NCT00841763|80810362|FG002|Overall Study|Unable to Classify|0|||
27721224|NCT00841763|80810363|FG003|Overall Study|Unable to Classify|0|||
27721225|NCT02902120|80810364|FG000|Overall Study|Lack of Efficacy|1|||
27721226|NCT02105454|80810365|FG000|Overall Study|Withdrawal by Subject|1|||
27721227|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
27721228|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
27721229|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
27721230|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
27721231|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
27721232|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
27721233|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
27721234|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
27721235|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
27721236|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
27721237|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
27721238|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
27721239|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
27721240|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
27721241|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
27721242|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
27721243|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
27721244|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
27721245|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
27721246|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
27721247|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
27721248|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
27721249|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
27721250|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
27721251|NCT04660643|80810366|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
27721252|NCT04660643|80810367|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
27721253|NCT04660643|80810368|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
27721254|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
27721255|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
27721256|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
27721257|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
27721258|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
27721259|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
27721260|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
27721261|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
27721262|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
27721263|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
27721264|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
27721265|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
27721266|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
27721267|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
27721268|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
27721269|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
27721270|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
27721271|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
27721272|NCT04660643|80810366|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
27721273|NCT04660643|80810367|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
27721274|NCT04660643|80810368|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
27721275|NCT02793232|80810369|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721276|NCT02793232|80810370|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721277|NCT02793232|80810371|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721278|NCT02793232|80810372|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721279|NCT02793232|80810373|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
27721280|NCT02793232|80810374|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721281|NCT02793232|80810375|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
27721282|NCT02793232|80810376|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721283|NCT02793232|80810377|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
27721284|NCT02532855|80810378|FG000|Overall Study|Lost to Follow-up|4|||
27721285|NCT02532855|80810379|FG001|Overall Study|Lost to Follow-up|3|||
27721286|NCT02532855|80810378|FG000|Overall Study|Withdrawal by Subject|4|||
27721287|NCT02532855|80810379|FG001|Overall Study|Withdrawal by Subject|8|||
27721288|NCT00293579|80810380|FG000|Overall Study|Withdrawal by Subject|1|||
27721289|NCT00684957|80810381|FG000|Overall Study|Withdrawal by Subject|1|||
27721290|NCT00684957|80810382|FG001|Overall Study|Withdrawal by Subject|1|||
27721291|NCT00684957|80810381|FG000|Overall Study|Lost to Follow-up|1|||
27501392|NCT02435212|80030249|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
27501393|NCT02435212|80030248|FG000|Optional Extension Phase|Lack of Efficacy|2|||
27721292|NCT00684957|80810382|FG001|Overall Study|Lost to Follow-up|0|||
27721293|NCT02340663|80810384|FG000|Overall Study|Lost to Follow-up|1|||
27840211|NCT00982228|81244971|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
27840212|NCT04254809|81244972|FG000|Overall Study|Lost to Follow-up|5|||
27840213|NCT04254809|81244973|FG001|Overall Study|Lost to Follow-up|10|||
27840214|NCT01261624|81244974|FG000|Week 0 to Week 12|Disease Progression|1|||
27840215|NCT01261624|81244975|FG001|Week 0 to Week 12|Disease Progression|1|||
27840216|NCT01261624|81244974|FG000|Week 0 to Week 12|Insufficient Response|0|||
27840217|NCT01261624|81244975|FG001|Week 0 to Week 12|Insufficient Response|2|||
27721294|NCT02340663|80810385|FG001|Overall Study|Lost to Follow-up|0|||
27721295|NCT02340663|80810384|FG000|Overall Study|Protocol Violation|1|||
27721296|NCT02340663|80810385|FG001|Overall Study|Protocol Violation|0|||
27721297|NCT02340663|80810384|FG000|Overall Study|Withdrawal by Subject|3|||
27721298|NCT02340663|80810385|FG001|Overall Study|Withdrawal by Subject|1|||
27721299|NCT00429585|80810386|FG000|Overall Study|Death|1|||
27721300|NCT00429585|80810387|FG001|Overall Study|Death|0|||
27721301|NCT00429585|80810386|FG000|Overall Study|Lost to Follow-up|27|||
27721302|NCT00429585|80810387|FG001|Overall Study|Lost to Follow-up|20|||
27721303|NCT00429585|80810386|FG000|Overall Study|Physician Decision|2|||
27721304|NCT00429585|80810387|FG001|Overall Study|Physician Decision|0|||
27721305|NCT01777581|80810388|FG000|Overall Study|Lost to Follow-up|1|||
27721306|NCT01777581|80810389|FG001|Overall Study|Lost to Follow-up|1|||
27721307|NCT01777581|80810388|FG000|Overall Study|Adverse Event|2|||
27721308|NCT01777581|80810389|FG001|Overall Study|Adverse Event|0|||
27721309|NCT01777581|80810388|FG000|Overall Study|Lack of Efficacy|0|||
27721310|NCT01777581|80810389|FG001|Overall Study|Lack of Efficacy|1|||
27721311|NCT02437162|80810393|FG000|Overall Study|Protocol Violation|0|||
27721312|NCT02437162|80810394|FG001|Overall Study|Protocol Violation|1|||
27721313|NCT02437162|80810395|FG002|Overall Study|Protocol Violation|0|||
27721314|NCT02437162|80810393|FG000|Overall Study|Randomized but not treated|0|||
27721315|NCT02437162|80810394|FG001|Overall Study|Randomized but not treated|0|||
27721316|NCT02437162|80810395|FG002|Overall Study|Randomized but not treated|1|||
27721317|NCT02437162|80810393|FG000|Overall Study|Study discontinued by Sponsor|93|||
27721318|NCT02437162|80810394|FG001|Overall Study|Study discontinued by Sponsor|98|||
27721319|NCT02437162|80810395|FG002|Overall Study|Study discontinued by Sponsor|97|||
27721320|NCT02437162|80810393|FG000|Overall Study|Withdrawal by Subject|13|||
27721321|NCT02437162|80810394|FG001|Overall Study|Withdrawal by Subject|7|||
27721322|NCT02437162|80810395|FG002|Overall Study|Withdrawal by Subject|9|||
27721323|NCT02437162|80810393|FG000|Overall Study|Adverse Event|0|||
27721324|NCT02437162|80810394|FG001|Overall Study|Adverse Event|1|||
27721325|NCT02437162|80810395|FG002|Overall Study|Adverse Event|0|||
27721326|NCT02437162|80810393|FG000|Overall Study|Lost to Follow-up|1|||
27840218|NCT01261624|81244974|FG000|Week 13 to Week 24|Insufficient Response|0|||
27840219|NCT01261624|81244975|FG001|Week 13 to Week 24|Insufficient Response|1|||
27840220|NCT05511935|81244980|FG000|Overall Study|Lost to Follow-up|9|||
27840221|NCT05511935|81244981|FG001|Overall Study|Lost to Follow-up|27|||
27840222|NCT05412121|81244982|FG000|Overall Study|Withdrawal by Subject|4|||
27840223|NCT05412121|81244982|FG000|Overall Study|Physician Decision|1|||
27840224|NCT05412121|81244982|FG000|Overall Study|Lost to Follow-up|5|||
27840225|NCT04832971|81244983|FG000|Overall Study|Death|1|||
27840226|NCT04832971|81244984|FG001|Overall Study|Death|0|||
27840227|NCT04832971|81244985|FG002|Overall Study|Death|0|||
27840228|NCT04832971|81244986|FG003|Overall Study|Death|0|||
27840229|NCT04832971|81244983|FG000|Overall Study|Lost to Follow-up|1|||
27501394|NCT02435212|80030249|FG001|Optional Extension Phase|Lack of Efficacy|3|||
27721327|NCT02437162|80810394|FG001|Overall Study|Lost to Follow-up|0|||
27721328|NCT02437162|80810395|FG002|Overall Study|Lost to Follow-up|1|||
27721329|NCT02437162|80810393|FG000|Overall Study|Death|0|||
27721330|NCT02437162|80810394|FG001|Overall Study|Death|1|||
27721331|NCT02437162|80810395|FG002|Overall Study|Death|0|||
27721332|NCT02437162|80810393|FG000|Overall Study|Other|0|||
27721333|NCT02437162|80810394|FG001|Overall Study|Other|0|||
27721334|NCT02437162|80810395|FG002|Overall Study|Other|1|||
27721335|NCT00323557|80810396|FG000|Overall Study|Physician Decision|1|||
27721336|NCT00323557|80810397|FG001|Overall Study|Physician Decision|0|||
27721337|NCT01699087|80810400|FG000|Overall Study|Lost to Follow-up|7|||
27840230|NCT04832971|81244984|FG001|Overall Study|Lost to Follow-up|1|||
27840231|NCT04832971|81244985|FG002|Overall Study|Lost to Follow-up|1|||
27840232|NCT04832971|81244986|FG003|Overall Study|Lost to Follow-up|0|||
27840233|NCT04832971|81244983|FG000|Overall Study|Withdrawal by Subject|1|||
27501395|NCT02435212|80030248|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
27840234|NCT04832971|81244984|FG001|Overall Study|Withdrawal by Subject|3|||
27501396|NCT02435212|80030249|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
27721338|NCT01699087|80810400|FG000|Overall Study|Screen failure (prior to treatment)|15|||
27721339|NCT01699087|80810400|FG000|Overall Study|Unable to make future visits|2|||
27721340|NCT02634580|80810403|FG000|Double-blind Treatment Period|Subject Request|1|||
27721341|NCT02634580|80810404|FG001|Double-blind Treatment Period|Subject Request|0|||
27721342|NCT02634580|80810405|FG002|Double-blind Treatment Period|Subject Request|1|||
27721343|NCT02634580|80810406|FG003|Double-blind Treatment Period|Subject Request|1|||
27501397|NCT02435212|80030248|FG000|Optional Extension Phase|Protocol Violation|0|||
27840235|NCT04832971|81244985|FG002|Overall Study|Withdrawal by Subject|2|||
27501398|NCT02435212|80030249|FG001|Optional Extension Phase|Protocol Violation|1|||
27501399|NCT02435212|80030248|FG000|Optional Extension Phase|Recovery|1|||
27501400|NCT02435212|80030249|FG001|Optional Extension Phase|Recovery|1|||
27501401|NCT02435212|80030248|FG000|Optional Extension Phase|Death|1|||
27501402|NCT02435212|80030249|FG001|Optional Extension Phase|Death|0|||
27501403|NCT02435212|80030248|FG000|Optional Extension Phase|Technical problems|2|||
27501404|NCT02435212|80030249|FG001|Optional Extension Phase|Technical problems|0|||
27501405|NCT01506596|80030250|FG000|Overall Study|ineligible pathology|1|||
27501406|NCT01775501|80030251|FG000|Overall Study|Discontinued prior to treatment|1|||
27501407|NCT05543265|80030254|FG000|Overall Study|Lost to Follow-up|3|||
27501408|NCT05543265|80030255|FG001|Overall Study|Lost to Follow-up|3|||
27501409|NCT05543265|80030254|FG000|Overall Study|Withdrawal by Subject|0|||
27501410|NCT05543265|80030255|FG001|Overall Study|Withdrawal by Subject|1|||
27501411|NCT05720897|80030259|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
27501412|NCT05720897|80030260|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
27501413|NCT03624881|80030262|FG000|Overall Study|Screen Failure|14|||
27610227|NCT01597505|80415613|FG000|Overall Study|Lost to Follow-up|4|||
27610228|NCT01597505|80415614|FG001|Overall Study|Lost to Follow-up|2|||
27610229|NCT01597505|80415613|FG000|Overall Study|Withdrawal by Subject|10|||
27840236|NCT04832971|81244986|FG003|Overall Study|Withdrawal by Subject|2|||
27610230|NCT01597505|80415614|FG001|Overall Study|Withdrawal by Subject|18|||
27610231|NCT01597505|80415613|FG000|Overall Study|Other|5|||
27610232|NCT01597505|80415614|FG001|Overall Study|Other|6|||
27610233|NCT01597505|80415613|FG000|Overall Study|Missing|1|||
27610234|NCT01597505|80415614|FG001|Overall Study|Missing|0|||
27610235|NCT01659658|80415615|FG000|Overall Study|Withdrawal by Patient|18|||
27610236|NCT01659658|80415616|FG001|Overall Study|Withdrawal by Patient|4|||
27610237|NCT01659658|80415617|FG002|Overall Study|Withdrawal by Patient|2|||
27610238|NCT01659658|80415618|FG003|Overall Study|Withdrawal by Patient|0|||
27610239|NCT01659658|80415619|FG004|Overall Study|Withdrawal by Patient|11|||
27610240|NCT01659658|80415615|FG000|Overall Study|Study Terminated by Sponsor|9|||
27610241|NCT01659658|80415616|FG001|Overall Study|Study Terminated by Sponsor|7|||
27840237|NCT04832971|81244983|FG000|Overall Study|Other, Not Specified|0|||
27840238|NCT04832971|81244984|FG001|Overall Study|Other, Not Specified|0|||
27840239|NCT04832971|81244985|FG002|Overall Study|Other, Not Specified|1|||
27840240|NCT04832971|81244986|FG003|Overall Study|Other, Not Specified|0|||
27840241|NCT03843125|81244987|FG000|Overall Study|Adverse Event|17|||
27610242|NCT01659658|80415617|FG002|Overall Study|Study Terminated by Sponsor|0|||
27610243|NCT01659658|80415618|FG003|Overall Study|Study Terminated by Sponsor|1|||
27840242|NCT03843125|81244988|FG001|Overall Study|Adverse Event|13|||
27840243|NCT03843125|81244989|FG002|Overall Study|Adverse Event|5|||
27840244|NCT03843125|81244990|FG003|Overall Study|Adverse Event|9|||
27840245|NCT03843125|81244987|FG000|Overall Study|Death|0|||
27840246|NCT03843125|81244988|FG001|Overall Study|Death|6|||
27840247|NCT03843125|81244989|FG002|Overall Study|Death|2|||
27840248|NCT03843125|81244990|FG003|Overall Study|Death|0|||
27840249|NCT03843125|81244987|FG000|Overall Study|Lack of Efficacy|14|||
27501414|NCT03624881|80030263|FG001|Overall Study|Screen Failure|0|||
27610244|NCT01659658|80415619|FG004|Overall Study|Study Terminated by Sponsor|4|||
27610245|NCT01659658|80415615|FG000|Overall Study|Reason not Specified|61|||
27840250|NCT03843125|81244988|FG001|Overall Study|Lack of Efficacy|11|||
27840251|NCT03843125|81244989|FG002|Overall Study|Lack of Efficacy|9|||
27840252|NCT03843125|81244990|FG003|Overall Study|Lack of Efficacy|4|||
27840253|NCT03843125|81244987|FG000|Overall Study|Lost to Follow-up|3|||
27840254|NCT03843125|81244988|FG001|Overall Study|Lost to Follow-up|4|||
27610246|NCT01659658|80415616|FG001|Overall Study|Reason not Specified|15|||
27610247|NCT01659658|80415617|FG002|Overall Study|Reason not Specified|8|||
27610248|NCT01659658|80415618|FG003|Overall Study|Reason not Specified|1|||
27610249|NCT01659658|80415619|FG004|Overall Study|Reason not Specified|34|||
27610250|NCT01659658|80415615|FG000|Overall Study|Lost to Follow-up|2|||
27610251|NCT01659658|80415616|FG001|Overall Study|Lost to Follow-up|0|||
27610252|NCT01659658|80415617|FG002|Overall Study|Lost to Follow-up|0|||
27610253|NCT01659658|80415618|FG003|Overall Study|Lost to Follow-up|0|||
27610254|NCT01659658|80415619|FG004|Overall Study|Lost to Follow-up|0|||
27610255|NCT03430063|80415620|FG000|Overall Study|Adverse Event|0|||
27610256|NCT03430063|80415621|FG001|Overall Study|Adverse Event|1|||
27610257|NCT03430063|80415622|FG002|Overall Study|Adverse Event|0|||
27610258|NCT03430063|80415620|FG000|Overall Study|Death|3|||
27610259|NCT03430063|80415621|FG001|Overall Study|Death|2|||
27610260|NCT03430063|80415622|FG002|Overall Study|Death|3|||
27610261|NCT03430063|80415620|FG000|Overall Study|Lost to Follow-up|0|||
27610262|NCT03430063|80415621|FG001|Overall Study|Lost to Follow-up|1|||
27610263|NCT03430063|80415622|FG002|Overall Study|Lost to Follow-up|0|||
27840255|NCT03843125|81244989|FG002|Overall Study|Lost to Follow-up|0|||
27610264|NCT03430063|80415620|FG000|Overall Study|Withdrawal by Subject|0|||
27610265|NCT03430063|80415621|FG001|Overall Study|Withdrawal by Subject|0|||
27610266|NCT03430063|80415622|FG002|Overall Study|Withdrawal by Subject|1|||
27610267|NCT03430063|80415620|FG000|Overall Study|Withdrawal of consent|3|||
27610268|NCT03430063|80415621|FG001|Overall Study|Withdrawal of consent|1|||
27610269|NCT03430063|80415622|FG002|Overall Study|Withdrawal of consent|2|||
27610270|NCT03430063|80415620|FG000|Overall Study|Progressive disease|1|||
27610271|NCT03430063|80415621|FG001|Overall Study|Progressive disease|2|||
27610272|NCT03430063|80415622|FG002|Overall Study|Progressive disease|1|||
27610273|NCT03430063|80415620|FG000|Overall Study|Other un-specified|1|||
27610274|NCT03430063|80415621|FG001|Overall Study|Other un-specified|1|||
27610275|NCT03430063|80415622|FG002|Overall Study|Other un-specified|0|||
27610276|NCT03430063|80415620|FG000|Overall Study|Randomized, but never treated|0|||
27610277|NCT03430063|80415621|FG001|Overall Study|Randomized, but never treated|0|||
27610278|NCT03430063|80415622|FG002|Overall Study|Randomized, but never treated|1|||
27610279|NCT02959671|80415624|FG000|Overall Study|Adverse Event|2|||
27610280|NCT02959671|80415624|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
27501415|NCT03624881|80030262|FG000|Overall Study|No Catheter Inserted|6|||
27610281|NCT01493960|80415625|FG000|Overall Study|Adverse Event|0|||
27610282|NCT01493960|80415626|FG001|Overall Study|Adverse Event|1|||
27610283|NCT01493960|80415625|FG000|Overall Study|Lack of Efficacy|15|||
27610284|NCT01493960|80415626|FG001|Overall Study|Lack of Efficacy|9|||
27610285|NCT01493960|80415625|FG000|Overall Study|Protocol Violation|3|||
27610286|NCT01493960|80415626|FG001|Overall Study|Protocol Violation|0|||
27610287|NCT01493960|80415625|FG000|Overall Study|Withdrawal by Subject|10|||
27610288|NCT01493960|80415626|FG001|Overall Study|Withdrawal by Subject|4|||
27610289|NCT01493960|80415625|FG000|Overall Study|Non-specified|4|||
27610290|NCT01493960|80415626|FG001|Overall Study|Non-specified|4|||
27610291|NCT01912781|80415627|FG000|Overall Study|Withdrawal by Subject|2|||
27610292|NCT01912781|80415628|FG001|Overall Study|Withdrawal by Subject|0|||
27610293|NCT00684762|80415629|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
27610294|NCT00684762|80415630|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
27610295|NCT04278417|80415632|FG000|Overall Study|Withdrawal by Subject|13|||
27610296|NCT04278417|80415633|FG001|Overall Study|Withdrawal by Subject|12|||
27501416|NCT03624881|80030263|FG001|Overall Study|No Catheter Inserted|1|||
27891271|NCT01447446|81434352|FG003|Overall Study|New Treatment Started|0|||
27891272|NCT01447446|81434353|FG004|Overall Study|New Treatment Started|2|||
27891273|NCT01447446|81434354|FG005|Overall Study|New Treatment Started|0|||
27891274|NCT01447446|81434349|FG000|Overall Study|Reason not Specified|1|||
27501417|NCT03624881|80030262|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
27501418|NCT03624881|80030263|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
27501419|NCT03624881|80030262|FG000|Overall Study|Death|2|||
27501420|NCT03624881|80030263|FG001|Overall Study|Death|0|||
27501421|NCT03624881|80030262|FG000|Overall Study|Lost to Follow-up|10|||
27501422|NCT03624881|80030263|FG001|Overall Study|Lost to Follow-up|4|||
27501423|NCT03624881|80030262|FG000|Overall Study|Withdrawal by Subject|12|||
27501424|NCT03624881|80030263|FG001|Overall Study|Withdrawal by Subject|1|||
27501425|NCT00626106|80030270|FG000|Overall Study|Withdrawal by Subject|2|||
27501426|NCT00626106|80030271|FG001|Overall Study|Withdrawal by Subject|1|||
27501427|NCT00626106|80030270|FG000|Overall Study|Lost to Follow-up|1|||
27501428|NCT00626106|80030271|FG001|Overall Study|Lost to Follow-up|4|||
27501429|NCT00626106|80030270|FG000|Overall Study|Death|64|||
27501430|NCT00626106|80030271|FG001|Overall Study|Death|19|||
27501431|NCT01346358|80030272|FG000|Overall Study|Withdrawal by Subject|1|||
27501432|NCT01346358|80030273|FG001|Overall Study|Withdrawal by Subject|0|||
27501433|NCT01346358|80030274|FG002|Overall Study|Withdrawal by Subject|1|||
27501434|NCT01346358|80030275|FG003|Overall Study|Withdrawal by Subject|1|||
27501435|NCT01346358|80030276|FG004|Overall Study|Withdrawal by Subject|0|||
27501436|NCT01346358|80030277|FG005|Overall Study|Withdrawal by Subject|2|||
27501437|NCT01346358|80030278|FG006|Overall Study|Withdrawal by Subject|1|||
27610297|NCT04278417|80415632|FG000|Overall Study|Progressive disease|0|||
27891275|NCT01447446|81434350|FG001|Overall Study|Reason not Specified|1|||
27501438|NCT01346358|80030279|FG007|Overall Study|Withdrawal by Subject|1|||
27501439|NCT01346358|80030280|FG008|Overall Study|Withdrawal by Subject|1|||
27610298|NCT04278417|80415633|FG001|Overall Study|Progressive disease|1|||
27610299|NCT04278417|80415632|FG000|Overall Study|Physician Decision|2|||
27501440|NCT01346358|80030272|FG000|Overall Study|Adverse Event|1|||
27610300|NCT04278417|80415633|FG001|Overall Study|Physician Decision|1|||
27610301|NCT04278417|80415632|FG000|Overall Study|Lost to Follow-up|7|||
27891276|NCT01447446|81434351|FG002|Overall Study|Reason not Specified|1|||
27891277|NCT01447446|81434352|FG003|Overall Study|Reason not Specified|1|||
27501441|NCT01346358|80030273|FG001|Overall Study|Adverse Event|0|||
27610302|NCT04278417|80415633|FG001|Overall Study|Lost to Follow-up|8|||
27958597|NCT01791517|81680069|FG011|Phase II|Withdrawal by Subject|0|||
27610303|NCT04278417|80415632|FG000|Overall Study|Death|6|||
27610304|NCT04278417|80415633|FG001|Overall Study|Death|3|||
27610305|NCT04278417|80415632|FG000|Overall Study|Adverse Event|2|||
27610306|NCT04278417|80415633|FG001|Overall Study|Adverse Event|4|||
27610307|NCT04278417|80415632|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
27610308|NCT04278417|80415633|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
27610309|NCT04567693|80415634|FG000|Overall Study|Death|0|||
27610310|NCT04567693|80415635|FG001|Overall Study|Death|0|||
27610311|NCT04567693|80415636|FG002|Overall Study|Death|2|||
27610312|NCT04567693|80415634|FG000|Overall Study|Lost to Follow-up|1|||
27610313|NCT04567693|80415635|FG001|Overall Study|Lost to Follow-up|0|||
27610314|NCT04567693|80415636|FG002|Overall Study|Lost to Follow-up|2|||
27610315|NCT04567693|80415634|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
27610316|NCT04567693|80415635|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
27610317|NCT04567693|80415636|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
27610318|NCT00393523|80415639|FG000|Overall Study|Lost to Follow-up|0|||
27610319|NCT00393523|80415640|FG001|Overall Study|Lost to Follow-up|0|||
27610320|NCT00393523|80415641|FG002|Overall Study|Lost to Follow-up|0|||
27610321|NCT00393523|80415642|FG003|Overall Study|Lost to Follow-up|2|||
27610322|NCT00393523|80415643|FG004|Overall Study|Lost to Follow-up|1|||
27610323|NCT00393523|80415639|FG000|Overall Study|Protocol Violation|6|||
27610324|NCT00393523|80415640|FG001|Overall Study|Protocol Violation|2|||
27610325|NCT00393523|80415641|FG002|Overall Study|Protocol Violation|0|||
27610326|NCT00393523|80415642|FG003|Overall Study|Protocol Violation|1|||
27610327|NCT00393523|80415643|FG004|Overall Study|Protocol Violation|0|||
27610328|NCT00393523|80415639|FG000|Overall Study|Withdrawal by Subject|6|||
27610329|NCT00393523|80415640|FG001|Overall Study|Withdrawal by Subject|7|||
27610330|NCT00393523|80415641|FG002|Overall Study|Withdrawal by Subject|2|||
27610331|NCT00393523|80415642|FG003|Overall Study|Withdrawal by Subject|3|||
27610332|NCT00393523|80415643|FG004|Overall Study|Withdrawal by Subject|0|||
27610333|NCT00393523|80415639|FG000|Overall Study|Difficulties in specimen collection|0|||
27610334|NCT00393523|80415640|FG001|Overall Study|Difficulties in specimen collection|0|||
27610335|NCT00393523|80415641|FG002|Overall Study|Difficulties in specimen collection|1|||
27610336|NCT00393523|80415642|FG003|Overall Study|Difficulties in specimen collection|0|||
27610337|NCT00393523|80415643|FG004|Overall Study|Difficulties in specimen collection|0|||
27610338|NCT00393523|80415639|FG000|Overall Study|Vaccine supply issue|0|||
27610339|NCT00393523|80415640|FG001|Overall Study|Vaccine supply issue|0|||
27610340|NCT00393523|80415641|FG002|Overall Study|Vaccine supply issue|1|||
27610341|NCT00393523|80415642|FG003|Overall Study|Vaccine supply issue|0|||
27610342|NCT00393523|80415643|FG004|Overall Study|Vaccine supply issue|0|||
27610343|NCT01354106|80415644|FG000|Overall Study|Withdrawal by Subject|2|||
27610344|NCT04161807|80415645|FG000|Overall Study|Withdrawal by Subject|2|||
27610345|NCT04161807|80415645|FG000|Overall Study|Performed only 1 treatment|2|||
27610346|NCT01250119|80415647|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
27610347|NCT01250119|80415648|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
27610348|NCT01250119|80415647|FG000|Diagnostic Phase|Participants Not Tested|44|||
27610349|NCT01250119|80415648|FG001|Diagnostic Phase|Participants Not Tested|0|||
27610350|NCT01250119|80415647|FG000|Treatment Phase|Progressive Disease|0|||
27610351|NCT01250119|80415648|FG001|Treatment Phase|Progressive Disease|32|||
27891278|NCT01447446|81434353|FG004|Overall Study|Reason not Specified|1|||
27891279|NCT01447446|81434354|FG005|Overall Study|Reason not Specified|0|||
27610352|NCT01250119|80415647|FG000|Treatment Phase|Death|0|||
27610353|NCT01250119|80415648|FG001|Treatment Phase|Death|2|||
27610354|NCT01250119|80415647|FG000|Treatment Phase|Withdrawal by Subject|0|||
27610355|NCT01250119|80415648|FG001|Treatment Phase|Withdrawal by Subject|1|||
27610356|NCT01250119|80415647|FG000|Treatment Phase|Adverse Event|0|||
27610357|NCT01250119|80415648|FG001|Treatment Phase|Adverse Event|2|||
27610358|NCT01250119|80415647|FG000|Treatment Phase|Unknown reason|0|||
27610359|NCT01250119|80415648|FG001|Treatment Phase|Unknown reason|4|||
27610360|NCT00692406|80415653|FG000|Overall Study|PI dropped, bad data|57|||
27610361|NCT01062763|80415654|FG000|Overall Study|Adverse Event|3|||
27891280|NCT01471340|81437226|FG000|Overall Study|Death|5|||
27610362|NCT01062763|80415655|FG001|Overall Study|Adverse Event|4|||
27610363|NCT02756832|80415661|FG000|Overall Study|Lost for Observation after Baseline|6|||
27610364|NCT02756832|80415661|FG000|Overall Study|Lost for Observation|13|||
27610365|NCT02756832|80415661|FG000|Overall Study|Patient's Unwillingness|12|||
27610366|NCT02756832|80415661|FG000|Overall Study|Insufficient Efficacy|2|||
27610367|NCT02756832|80415661|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
27610368|NCT02756832|80415661|FG000|Overall Study|Reason not Specified|9|||
27610369|NCT02756832|80415661|FG000|Overall Study|Protocol Deviation|10|||
27610370|NCT00390455|80415665|FG000|Overall Study|Adverse Event|17|||
27610371|NCT00390455|80415666|FG001|Overall Study|Adverse Event|3|||
27610372|NCT00390455|80415665|FG000|Overall Study|Withdrawal by Subject|8|||
27610373|NCT00390455|80415666|FG001|Overall Study|Withdrawal by Subject|8|||
27610374|NCT00390455|80415665|FG000|Overall Study|Alternate Treatment|0|||
27610375|NCT00390455|80415666|FG001|Overall Study|Alternate Treatment|1|||
27610376|NCT00390455|80415665|FG000|Overall Study|Other Medical Reasons|7|||
27610377|NCT00390455|80415666|FG001|Overall Study|Other Medical Reasons|11|||
27610378|NCT04422639|80415667|FG000|Overall Study|Death|1|||
27610379|NCT04422639|80415668|FG001|Overall Study|Death|0|||
27610380|NCT04422639|80415667|FG000|Overall Study|study closed prior to completion of FU visits|0|||
27610381|NCT04422639|80415668|FG001|Overall Study|study closed prior to completion of FU visits|2|||
27610382|NCT03239873|80415671|FG000|Overall Study|Lost to Follow-up|15|||
27610383|NCT03239873|80415672|FG001|Overall Study|Lost to Follow-up|16|||
27610384|NCT03239873|80415671|FG000|Overall Study|Physician Decision|1|||
27610385|NCT03239873|80415672|FG001|Overall Study|Physician Decision|0|||
27610386|NCT03239873|80415671|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
27610387|NCT03239873|80415672|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
27610388|NCT03239873|80415671|FG000|Overall Study|Withdrawal by Subject|2|||
27610389|NCT03239873|80415672|FG001|Overall Study|Withdrawal by Subject|0|||
27610390|NCT03239873|80415671|FG000|Overall Study|Contraindication to study medication|1|||
27610391|NCT03239873|80415672|FG001|Overall Study|Contraindication to study medication|0|||
27610392|NCT03239873|80415671|FG000|Overall Study|Protocol Violation|1|||
27610393|NCT03239873|80415672|FG001|Overall Study|Protocol Violation|0|||
27610394|NCT01216176|80415673|FG000|Overall Study|Adverse Event|0|||
27610395|NCT01216176|80415674|FG001|Overall Study|Adverse Event|8|||
27610396|NCT01216176|80415675|FG002|Overall Study|Adverse Event|0|||
27610397|NCT01216176|80415673|FG000|Overall Study|Physician Decision|0|||
27610398|NCT01216176|80415674|FG001|Overall Study|Physician Decision|0|||
27610399|NCT01216176|80415675|FG002|Overall Study|Physician Decision|1|||
27610400|NCT00976482|80415676|FG000|Overall Study|Death|208|||
27610401|NCT00976482|80415676|FG000|Overall Study|Withdrawal by Subject|45|||
27610402|NCT00976482|80415676|FG000|Overall Study|Center terminated|1|||
27610403|NCT00976482|80415676|FG000|Overall Study|Protocol Violation|5|||
27610404|NCT01248962|80415677|FG000|Overall Study|Withdrawal by Subject|1|||
27610405|NCT01248962|80415678|FG001|Overall Study|Withdrawal by Subject|1|||
27610406|NCT01248962|80415677|FG000|Overall Study|Adverse Event|2|||
27610407|NCT01248962|80415678|FG001|Overall Study|Adverse Event|1|||
27610408|NCT01248962|80415677|FG000|Overall Study|Complete Response after 4 Cycles|1|||
27610409|NCT01248962|80415678|FG001|Overall Study|Complete Response after 4 Cycles|0|||
27610410|NCT01248962|80415677|FG000|Overall Study|Complete Response after 3 Cycles|0|||
27610411|NCT01248962|80415678|FG001|Overall Study|Complete Response after 3 Cycles|1|||
27610412|NCT01248962|80415677|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
27610413|NCT01248962|80415678|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
27610414|NCT00525265|80415679|FG000|Overall Study|Protocol Violation|1|||
27610415|NCT00525265|80415680|FG001|Overall Study|Protocol Violation|0|||
27610416|NCT02762981|80415682|FG000|Overall Study|Adverse Event|2|||
27610417|NCT02762981|80415683|FG001|Overall Study|Adverse Event|3|||
27610418|NCT02762981|80415684|FG002|Overall Study|Adverse Event|1|||
27610419|NCT02762981|80415685|FG003|Overall Study|Adverse Event|1|||
27610420|NCT02762981|80415686|FG004|Overall Study|Adverse Event|3|||
27610421|NCT02762981|80415682|FG000|Overall Study|Physician Decision|0|||
27610422|NCT02762981|80415683|FG001|Overall Study|Physician Decision|1|||
27610423|NCT02762981|80415684|FG002|Overall Study|Physician Decision|0|||
27610424|NCT02762981|80415685|FG003|Overall Study|Physician Decision|0|||
27610425|NCT02762981|80415686|FG004|Overall Study|Physician Decision|1|||
27610426|NCT02762981|80415682|FG000|Overall Study|Disease progression|11|||
27891281|NCT01471340|81437227|FG001|Overall Study|Death|4|||
27610427|NCT02762981|80415683|FG001|Overall Study|Disease progression|23|||
27610428|NCT02762981|80415684|FG002|Overall Study|Disease progression|4|||
27610429|NCT02762981|80415685|FG003|Overall Study|Disease progression|10|||
27610430|NCT02762981|80415686|FG004|Overall Study|Disease progression|1|||
27610431|NCT02762981|80415682|FG000|Overall Study|Enrolled not treated|1|||
27610432|NCT02762981|80415683|FG001|Overall Study|Enrolled not treated|5|||
27610433|NCT02762981|80415684|FG002|Overall Study|Enrolled not treated|0|||
27610434|NCT02762981|80415685|FG003|Overall Study|Enrolled not treated|2|||
27610435|NCT02762981|80415686|FG004|Overall Study|Enrolled not treated|0|||
27610436|NCT02762981|80415682|FG000|Overall Study|Other|2|||
27610437|NCT02762981|80415683|FG001|Overall Study|Other|3|||
27610438|NCT02762981|80415684|FG002|Overall Study|Other|1|||
27610439|NCT02762981|80415685|FG003|Overall Study|Other|0|||
27610440|NCT02762981|80415686|FG004|Overall Study|Other|0|||
27891282|NCT01471340|81437226|FG000|Overall Study|Lost to Follow-up|0|||
27891283|NCT01471340|81437227|FG001|Overall Study|Lost to Follow-up|1|||
27891284|NCT01471340|81437226|FG000|Overall Study|Investigational site closure|0|||
27891285|NCT01471340|81437227|FG001|Overall Study|Investigational site closure|1|||
27891286|NCT01471340|81437226|FG000|Overall Study|Invalid informed consent|1|||
27891287|NCT01471340|81437227|FG001|Overall Study|Invalid informed consent|0|||
27891288|NCT01645891|81437229|FG000|Overall Study|Adverse Event|6|||
27891289|NCT01645891|81437230|FG001|Overall Study|Adverse Event|10|||
27891290|NCT01645891|81437229|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
27891291|NCT01645891|81437230|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
27891292|NCT01645891|81437229|FG000|Overall Study|Withdrawal by Subject|3|||
27891293|NCT01645891|81437230|FG001|Overall Study|Withdrawal by Subject|3|||
27891294|NCT01645891|81437229|FG000|Overall Study|Protocol Violation|4|||
27891295|NCT01645891|81437230|FG001|Overall Study|Protocol Violation|0|||
27891296|NCT01645891|81437229|FG000|Overall Study|Lost to Follow-up|4|||
27891297|NCT01645891|81437230|FG001|Overall Study|Lost to Follow-up|1|||
27891298|NCT01645891|81437229|FG000|Overall Study|Death|0|||
27891299|NCT01645891|81437230|FG001|Overall Study|Death|2|||
27891300|NCT02345889|81437231|FG000|Overall Study|Inadequate Bowel Prep|17|||
27891301|NCT02345889|81437232|FG001|Overall Study|Inadequate Bowel Prep|16|||
27891302|NCT02345889|81437233|FG002|Overall Study|Inadequate Bowel Prep|18|||
27891303|NCT02345889|81437234|FG003|Overall Study|Inadequate Bowel Prep|14|||
27891304|NCT02345889|81437231|FG000|Overall Study|Polyposis identified during procedure|1|||
27891305|NCT02345889|81437232|FG001|Overall Study|Polyposis identified during procedure|1|||
27891306|NCT02345889|81437233|FG002|Overall Study|Polyposis identified during procedure|0|||
27891307|NCT02345889|81437234|FG003|Overall Study|Polyposis identified during procedure|1|||
27891308|NCT02345889|81437231|FG000|Overall Study|Recognized ineligible post-randomization|1|||
27891309|NCT02345889|81437232|FG001|Overall Study|Recognized ineligible post-randomization|0|||
27891310|NCT02345889|81437233|FG002|Overall Study|Recognized ineligible post-randomization|2|||
27891311|NCT02345889|81437234|FG003|Overall Study|Recognized ineligible post-randomization|1|||
27891312|NCT02345889|81437231|FG000|Overall Study|Ulcerative Colitis identified|1|||
27891313|NCT02345889|81437232|FG001|Overall Study|Ulcerative Colitis identified|0|||
27891314|NCT02345889|81437233|FG002|Overall Study|Ulcerative Colitis identified|0|||
27721344|NCT02634580|80810403|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
27721345|NCT02634580|80810404|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
27721346|NCT02634580|80810405|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
27721347|NCT02634580|80810406|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
27721348|NCT00130832|80810413|FG000|Overall Study|Adverse Event|1|||
27721349|NCT00130832|80810414|FG001|Overall Study|Adverse Event|1|||
27721350|NCT00130832|80810413|FG000|Overall Study|Lost to Follow-up|1|||
27721351|NCT00130832|80810414|FG001|Overall Study|Lost to Follow-up|2|||
27721352|NCT00130832|80810413|FG000|Overall Study|Protocol Violation|6|||
27721353|NCT00130832|80810414|FG001|Overall Study|Protocol Violation|8|||
27721354|NCT00130832|80810413|FG000|Overall Study|Withdrawal by Subject|6|||
27721355|NCT00130832|80810414|FG001|Overall Study|Withdrawal by Subject|1|||
27721356|NCT00130832|80810413|FG000|Overall Study|Moved|2|||
27721357|NCT00130832|80810414|FG001|Overall Study|Moved|2|||
27721358|NCT00130832|80810413|FG000|Overall Study|Other|0|||
27721359|NCT00130832|80810414|FG001|Overall Study|Other|3|||
27721360|NCT01292057|80810415|FG000|Overall Study|Protocol Violation|1|||
27721361|NCT01292057|80810416|FG001|Overall Study|Protocol Violation|1|||
27721362|NCT01292057|80810415|FG000|Overall Study|Lost to Follow-up|1|||
27721363|NCT01292057|80810416|FG001|Overall Study|Lost to Follow-up|1|||
27721364|NCT04599062|80810417|FG000|Overall Study|Physician Decision|1|||
27840256|NCT03843125|81244990|FG003|Overall Study|Lost to Follow-up|2|||
27840257|NCT03843125|81244987|FG000|Overall Study|Other|12|||
27840258|NCT03843125|81244988|FG001|Overall Study|Other|14|||
27840259|NCT03843125|81244989|FG002|Overall Study|Other|3|||
27840260|NCT03843125|81244990|FG003|Overall Study|Other|4|||
27840261|NCT03843125|81244987|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
27840262|NCT03843125|81244988|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
27891315|NCT02345889|81437234|FG003|Overall Study|Ulcerative Colitis identified|0|||
27891316|NCT02345889|81437231|FG000|Overall Study|Cecum not intubated|1|||
27721365|NCT04599062|80810418|FG001|Overall Study|Physician Decision|0|||
27721366|NCT01639833|80810419|FG000|Overall Study|Death|4|||
27840263|NCT03843125|81244989|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
27891317|NCT02345889|81437232|FG001|Overall Study|Cecum not intubated|0|||
27891318|NCT02345889|81437233|FG002|Overall Study|Cecum not intubated|0|||
27891319|NCT02345889|81437234|FG003|Overall Study|Cecum not intubated|0|||
27891320|NCT03555565|81437235|FG000|Overall Study|Case Report Forms Uncollected|2|||
27840264|NCT03843125|81244990|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
27891321|NCT03555565|81437235|FG000|Overall Study|Protocol Deviation|13|||
27891322|NCT01992653|81437236|FG000|Overall Study|Death|0|||
27501442|NCT01346358|80030274|FG002|Overall Study|Adverse Event|0|||
27840265|NCT03843125|81244987|FG000|Overall Study|Study Terminated by Sponsor|318|||
27721367|NCT01639833|80810420|FG001|Overall Study|Death|2|||
27721368|NCT01639833|80810419|FG000|Overall Study|Withdrawal by Subject|2|||
27501443|NCT01346358|80030275|FG003|Overall Study|Adverse Event|0|||
27501444|NCT01346358|80030276|FG004|Overall Study|Adverse Event|1|||
27501445|NCT01346358|80030277|FG005|Overall Study|Adverse Event|0|||
27501446|NCT01346358|80030278|FG006|Overall Study|Adverse Event|0|||
27501447|NCT01346358|80030279|FG007|Overall Study|Adverse Event|0|||
27610441|NCT02762981|80415682|FG000|Overall Study|Missing|1|||
27610442|NCT02762981|80415683|FG001|Overall Study|Missing|0|||
27610443|NCT02762981|80415684|FG002|Overall Study|Missing|0|||
27610444|NCT02762981|80415685|FG003|Overall Study|Missing|0|||
27610445|NCT02762981|80415686|FG004|Overall Study|Missing|0|||
27610446|NCT02762981|80415682|FG000|Overall Study|Withdrawal by Subject|0|||
27610447|NCT02762981|80415683|FG001|Overall Study|Withdrawal by Subject|5|||
27610448|NCT02762981|80415684|FG002|Overall Study|Withdrawal by Subject|1|||
27610449|NCT02762981|80415685|FG003|Overall Study|Withdrawal by Subject|3|||
27610450|NCT02762981|80415686|FG004|Overall Study|Withdrawal by Subject|0|||
27610451|NCT00313911|80415687|FG000|Overall Study|Serious adverse event|6|||
27610452|NCT00313911|80415688|FG001|Overall Study|Serious adverse event|1|||
27610453|NCT00313911|80415687|FG000|Overall Study|Adverse Event|2|||
27610454|NCT00313911|80415688|FG001|Overall Study|Adverse Event|3|||
27610455|NCT00313911|80415687|FG000|Overall Study|Protocol Violation|19|||
27610456|NCT00313911|80415688|FG001|Overall Study|Protocol Violation|10|||
27610457|NCT00313911|80415687|FG000|Overall Study|Lost to Follow-up|27|||
27610458|NCT00313911|80415688|FG001|Overall Study|Lost to Follow-up|14|||
27610459|NCT00313911|80415687|FG000|Overall Study|Withdrawal by Subject|39|||
27610460|NCT00313911|80415688|FG001|Overall Study|Withdrawal by Subject|12|||
27610461|NCT00313911|80415687|FG000|Overall Study|Did not meet age criteria|1|||
27501448|NCT01346358|80030280|FG008|Overall Study|Adverse Event|1|||
27610462|NCT00313911|80415688|FG001|Overall Study|Did not meet age criteria|1|||
27610463|NCT02305381|80415689|FG000|Overall Study|Unclassified|5|||
27610464|NCT02305381|80415690|FG001|Overall Study|Unclassified|5|||
27610465|NCT02305381|80415691|FG002|Overall Study|Unclassified|7|||
27610466|NCT02802319|80415692|FG000|Overall Study|Physician Decision|2|||
27840266|NCT03843125|81244988|FG001|Overall Study|Study Terminated by Sponsor|318|||
27501449|NCT01346358|80030272|FG000|Overall Study|Non-Compliance|0|||
27501450|NCT01346358|80030273|FG001|Overall Study|Non-Compliance|0|||
27610467|NCT02802319|80415693|FG001|Overall Study|Physician Decision|1|||
27610468|NCT02802319|80415692|FG000|Overall Study|Lost to Follow-up|0|||
27610469|NCT02802319|80415693|FG001|Overall Study|Lost to Follow-up|4|||
27610470|NCT01024959|80415694|FG000|Overall Study|ineligible|12|||
27610471|NCT01024959|80415694|FG000|Overall Study|results not evaluable|12|||
27610472|NCT01024959|80415694|FG000|Overall Study|missing results required for analysis|17|||
27610473|NCT01263106|80415704|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
27610474|NCT01263106|80415705|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
27610475|NCT00406419|80415706|FG000|Overall Study|Death|3|||
27610476|NCT00406419|80415707|FG001|Overall Study|Death|1|||
27610477|NCT00406419|80415708|FG002|Overall Study|Death|4|||
27610478|NCT00406419|80415706|FG000|Overall Study|Protocol Violation|6|||
27610479|NCT00406419|80415707|FG001|Overall Study|Protocol Violation|2|||
27610480|NCT00406419|80415708|FG002|Overall Study|Protocol Violation|5|||
27610481|NCT00406419|80415706|FG000|Overall Study|Study Terminated by Sponsor|260|||
27610482|NCT00406419|80415707|FG001|Overall Study|Study Terminated by Sponsor|288|||
27610483|NCT00406419|80415708|FG002|Overall Study|Study Terminated by Sponsor|282|||
27610484|NCT00406419|80415706|FG000|Overall Study|Withdrawal by Subject|17|||
27610485|NCT00406419|80415707|FG001|Overall Study|Withdrawal by Subject|24|||
27610486|NCT00406419|80415708|FG002|Overall Study|Withdrawal by Subject|26|||
27610487|NCT00406419|80415706|FG000|Overall Study|Lack of Efficacy|12|||
27610488|NCT00406419|80415707|FG001|Overall Study|Lack of Efficacy|1|||
27610489|NCT00406419|80415708|FG002|Overall Study|Lack of Efficacy|6|||
27610490|NCT00406419|80415706|FG000|Overall Study|Non-Compliance with Study Drug|5|||
27610491|NCT00406419|80415707|FG001|Overall Study|Non-Compliance with Study Drug|6|||
27610492|NCT00406419|80415708|FG002|Overall Study|Non-Compliance with Study Drug|3|||
27610493|NCT00406419|80415706|FG000|Overall Study|Adverse Event|10|||
27610494|NCT00406419|80415707|FG001|Overall Study|Adverse Event|12|||
27610495|NCT00406419|80415708|FG002|Overall Study|Adverse Event|16|||
27610496|NCT00406419|80415706|FG000|Overall Study|Lost to Follow-up|11|||
27891323|NCT01992653|81437237|FG001|Overall Study|Death|0|||
27610497|NCT00406419|80415707|FG001|Overall Study|Lost to Follow-up|10|||
27610498|NCT00406419|80415708|FG002|Overall Study|Lost to Follow-up|5|||
27610499|NCT03856996|80415709|FG000|Overall Study|Withdrawal by Subject|1|||
27610500|NCT03856996|80415710|FG001|Overall Study|Withdrawal by Subject|0|||
27610501|NCT03856996|80415709|FG000|Overall Study|Lost to Follow-up|0|||
27610502|NCT03856996|80415710|FG001|Overall Study|Lost to Follow-up|1|||
27610503|NCT03856996|80415709|FG000|Overall Study|Adverse Event|1|||
27610504|NCT03856996|80415710|FG001|Overall Study|Adverse Event|1|||
27610505|NCT03856996|80415709|FG000|Overall Study|Other|1|||
27610506|NCT03856996|80415710|FG001|Overall Study|Other|0|||
27610507|NCT02584855|80415715|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
27610508|NCT02584855|80415716|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
27610509|NCT02584855|80415717|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
27610510|NCT02584855|80415718|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
27610511|NCT02584855|80415719|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
27610512|NCT02584855|80415720|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
27610513|NCT02584855|80415715|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
27610514|NCT02584855|80415716|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
27610515|NCT02584855|80415717|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
27610516|NCT02584855|80415718|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
27610517|NCT02584855|80415719|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
27610518|NCT02584855|80415720|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
27610519|NCT02584855|80415715|FG000|Open-Label Treatment Period|Adverse Event|14|||
27891324|NCT01992653|81437238|FG002|Overall Study|Death|1|||
27891325|NCT01992653|81437239|FG003|Overall Study|Death|0|||
27891326|NCT01992653|81437240|FG004|Overall Study|Death|1|||
27891327|NCT01992653|81437241|FG005|Overall Study|Death|0|||
27501451|NCT01346358|80030274|FG002|Overall Study|Non-Compliance|0|||
27501452|NCT01346358|80030275|FG003|Overall Study|Non-Compliance|0|||
27501453|NCT01346358|80030276|FG004|Overall Study|Non-Compliance|0|||
27501454|NCT01346358|80030277|FG005|Overall Study|Non-Compliance|0|||
27610520|NCT02584855|80415716|FG001|Open-Label Treatment Period|Adverse Event|0|||
27610521|NCT02584855|80415717|FG002|Open-Label Treatment Period|Adverse Event|0|||
27610522|NCT02584855|80415718|FG003|Open-Label Treatment Period|Adverse Event|0|||
27610523|NCT02584855|80415719|FG004|Open-Label Treatment Period|Adverse Event|0|||
27610524|NCT02584855|80415720|FG005|Open-Label Treatment Period|Adverse Event|0|||
27610525|NCT02584855|80415715|FG000|Open-Label Treatment Period|Death|2|||
27610526|NCT02584855|80415716|FG001|Open-Label Treatment Period|Death|0|||
27610527|NCT02584855|80415717|FG002|Open-Label Treatment Period|Death|0|||
27610528|NCT02584855|80415718|FG003|Open-Label Treatment Period|Death|0|||
27610529|NCT02584855|80415719|FG004|Open-Label Treatment Period|Death|0|||
27610530|NCT02584855|80415720|FG005|Open-Label Treatment Period|Death|0|||
27610531|NCT02584855|80415715|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
27610532|NCT02584855|80415716|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
27610533|NCT02584855|80415717|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
27610534|NCT02584855|80415718|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
27610535|NCT02584855|80415719|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
27610536|NCT02584855|80415720|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
27610537|NCT02584855|80415715|FG000|Open-Label Treatment Period|Protocol Violation|1|||
27610538|NCT02584855|80415716|FG001|Open-Label Treatment Period|Protocol Violation|0|||
27610539|NCT02584855|80415717|FG002|Open-Label Treatment Period|Protocol Violation|0|||
27610540|NCT02584855|80415718|FG003|Open-Label Treatment Period|Protocol Violation|0|||
27610541|NCT02584855|80415719|FG004|Open-Label Treatment Period|Protocol Violation|0|||
27610542|NCT02584855|80415720|FG005|Open-Label Treatment Period|Protocol Violation|0|||
27610543|NCT02584855|80415715|FG000|Open-Label Treatment Period|No PI Available|2|||
27610544|NCT02584855|80415716|FG001|Open-Label Treatment Period|No PI Available|0|||
27610545|NCT02584855|80415717|FG002|Open-Label Treatment Period|No PI Available|0|||
27610546|NCT02584855|80415718|FG003|Open-Label Treatment Period|No PI Available|0|||
27610547|NCT02584855|80415719|FG004|Open-Label Treatment Period|No PI Available|0|||
27610548|NCT02584855|80415720|FG005|Open-Label Treatment Period|No PI Available|0|||
27610549|NCT02584855|80415715|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
27610550|NCT02584855|80415716|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
27610551|NCT02584855|80415717|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
27610552|NCT02584855|80415718|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
27610553|NCT02584855|80415719|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
27610554|NCT02584855|80415720|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
27610555|NCT02584855|80415715|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27610556|NCT02584855|80415716|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27610557|NCT02584855|80415717|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
27610558|NCT02584855|80415718|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27610559|NCT02584855|80415719|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27610560|NCT02584855|80415720|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
27610561|NCT02584855|80415715|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
27610562|NCT02584855|80415716|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
27610563|NCT02584855|80415717|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
27610564|NCT02584855|80415718|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
27610565|NCT02584855|80415719|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
27610566|NCT02584855|80415720|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
27610567|NCT02584855|80415715|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27610568|NCT02584855|80415716|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
27610569|NCT02584855|80415717|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27610570|NCT02584855|80415718|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27610571|NCT02584855|80415719|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27610572|NCT02584855|80415720|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
27610573|NCT02584855|80415715|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27610574|NCT02584855|80415716|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
27840267|NCT03843125|81244989|FG002|Overall Study|Study Terminated by Sponsor|163|||
27840268|NCT03843125|81244990|FG003|Overall Study|Study Terminated by Sponsor|163|||
27840269|NCT03843125|81244987|FG000|Overall Study|Withdrawal by Subject|23|||
27840270|NCT03843125|81244988|FG001|Overall Study|Withdrawal by Subject|12|||
27840271|NCT03843125|81244989|FG002|Overall Study|Withdrawal by Subject|6|||
27501455|NCT01346358|80030278|FG006|Overall Study|Non-Compliance|0|||
27610575|NCT02584855|80415717|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27610576|NCT02584855|80415718|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27610577|NCT02584855|80415719|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27610578|NCT02584855|80415720|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
27610579|NCT02584855|80415715|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27610580|NCT02584855|80415716|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27610581|NCT02584855|80415717|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27610582|NCT02584855|80415718|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27610583|NCT02584855|80415719|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
27610584|NCT02584855|80415720|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
27610585|NCT02584855|80415715|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
27840272|NCT03843125|81244990|FG003|Overall Study|Withdrawal by Subject|9|||
27840273|NCT03843125|81244987|FG000|Overall Study|Missing data|0|||
27840274|NCT03843125|81244988|FG001|Overall Study|Missing data|1|||
27840275|NCT03843125|81244989|FG002|Overall Study|Missing data|1|||
27721369|NCT01639833|80810420|FG001|Overall Study|Withdrawal by Subject|2|||
27721370|NCT05019131|80810421|FG000|Overall Study|Lost to Follow-up|0|||
27721371|NCT05019131|80810422|FG001|Overall Study|Lost to Follow-up|3|||
27721372|NCT01707693|80810423|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
27721373|NCT01707693|80810424|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
27721374|NCT01707693|80810423|FG000|Overall Study Allocation|Protocol Violation|4|||
27721375|NCT01707693|80810424|FG001|Overall Study Allocation|Protocol Violation|3|||
27721376|NCT01707693|80810423|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
27721377|NCT01707693|80810424|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
27721378|NCT01707693|80810423|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
27721379|NCT01707693|80810424|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
27721380|NCT03733392|80810425|FG000|Overall Study|Withdrawal by Subject|11|||
27721381|NCT03733392|80810426|FG001|Overall Study|Withdrawal by Subject|1|||
27721382|NCT03733392|80810425|FG000|Overall Study|Death|1|||
27721383|NCT03733392|80810426|FG001|Overall Study|Death|0|||
27721384|NCT03733392|80810425|FG000|Overall Study|Lost to Follow-up|5|||
27501456|NCT01346358|80030279|FG007|Overall Study|Non-Compliance|2|||
27501457|NCT01346358|80030280|FG008|Overall Study|Non-Compliance|0|||
27501458|NCT01346358|80030272|FG000|Overall Study|Physician Decision|0|||
27721385|NCT03733392|80810426|FG001|Overall Study|Lost to Follow-up|0|||
27721386|NCT03733392|80810425|FG000|Overall Study|Protocol Violation|0|||
27721387|NCT03733392|80810426|FG001|Overall Study|Protocol Violation|1|||
27721388|NCT03733392|80810425|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
27721389|NCT03733392|80810426|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
27721390|NCT03733392|80810425|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
27721391|NCT03733392|80810426|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
27721392|NCT03733392|80810425|FG000|Overall Study|Patient Non-Compliance|2|||
27721393|NCT03733392|80810426|FG001|Overall Study|Patient Non-Compliance|1|||
27721394|NCT03733392|80810425|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
27721395|NCT03733392|80810426|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
27721396|NCT03733392|80810425|FG000|Overall Study|Withdrawal prior to procedure|5|||
27721397|NCT03733392|80810426|FG001|Overall Study|Withdrawal prior to procedure|2|||
27721398|NCT01995071|80810430|FG000|Overall Study|Adverse Event|0|||
27721399|NCT01995071|80810431|FG001|Overall Study|Adverse Event|0|||
27721400|NCT01995071|80810432|FG002|Overall Study|Adverse Event|0|||
27721401|NCT01995071|80810433|FG003|Overall Study|Adverse Event|0|||
27501459|NCT01346358|80030273|FG001|Overall Study|Physician Decision|1|||
27501460|NCT01346358|80030274|FG002|Overall Study|Physician Decision|0|||
27501461|NCT01346358|80030275|FG003|Overall Study|Physician Decision|0|||
27501462|NCT01346358|80030276|FG004|Overall Study|Physician Decision|0|||
27501463|NCT01346358|80030277|FG005|Overall Study|Physician Decision|0|||
27501464|NCT01346358|80030278|FG006|Overall Study|Physician Decision|0|||
27501465|NCT01346358|80030279|FG007|Overall Study|Physician Decision|1|||
27501466|NCT01346358|80030280|FG008|Overall Study|Physician Decision|1|||
27501467|NCT01074970|80030281|FG000|Overall Study|Never Treated|0|||
27501468|NCT01074970|80030282|FG001|Overall Study|Never Treated|0|||
27501469|NCT01074970|80030283|FG002|Overall Study|Never Treated|8|||
27501470|NCT01074970|80030284|FG003|Overall Study|Never Treated|1|||
27501471|NCT01074970|80030281|FG000|Overall Study|Adverse Event|1|||
27721402|NCT01995071|80810434|FG004|Overall Study|Adverse Event|0|||
27721403|NCT01995071|80810435|FG005|Overall Study|Adverse Event|0|||
27721404|NCT01995071|80810436|FG006|Overall Study|Adverse Event|1|||
27721405|NCT01995071|80810437|FG007|Overall Study|Adverse Event|0|||
27721406|NCT01995071|80810438|FG008|Overall Study|Adverse Event|0|||
27840276|NCT03843125|81244990|FG003|Overall Study|Missing data|0|||
27501472|NCT01074970|80030282|FG001|Overall Study|Adverse Event|0|||
27501473|NCT01074970|80030283|FG002|Overall Study|Adverse Event|4|||
27610586|NCT02584855|80415716|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
27501474|NCT01074970|80030284|FG003|Overall Study|Adverse Event|3|||
27721407|NCT01995071|80810439|FG009|Overall Study|Adverse Event|0|||
27840277|NCT03833427|81244991|FG000|Overall Study|Death|4|||
27721408|NCT01995071|80810440|FG010|Overall Study|Adverse Event|0|||
27721409|NCT01995071|80810441|FG011|Overall Study|Adverse Event|0|||
27721410|NCT01995071|80810430|FG000|Overall Study|Moved|0|||
27721411|NCT01995071|80810431|FG001|Overall Study|Moved|0|||
27721412|NCT01995071|80810432|FG002|Overall Study|Moved|1|||
27721413|NCT01995071|80810433|FG003|Overall Study|Moved|0|||
27721414|NCT01995071|80810434|FG004|Overall Study|Moved|1|||
27721415|NCT01995071|80810435|FG005|Overall Study|Moved|0|||
27721416|NCT01995071|80810436|FG006|Overall Study|Moved|0|||
27721417|NCT01995071|80810437|FG007|Overall Study|Moved|0|||
27721418|NCT01995071|80810438|FG008|Overall Study|Moved|0|||
27721419|NCT01995071|80810439|FG009|Overall Study|Moved|0|||
27721420|NCT01995071|80810440|FG010|Overall Study|Moved|1|||
27721421|NCT01995071|80810441|FG011|Overall Study|Moved|0|||
27721422|NCT01995071|80810430|FG000|Overall Study|Lost to Follow-up|1|||
27721423|NCT01995071|80810431|FG001|Overall Study|Lost to Follow-up|0|||
27721424|NCT01995071|80810432|FG002|Overall Study|Lost to Follow-up|0|||
27721425|NCT01995071|80810433|FG003|Overall Study|Lost to Follow-up|0|||
27721426|NCT01995071|80810434|FG004|Overall Study|Lost to Follow-up|0|||
27721427|NCT01995071|80810435|FG005|Overall Study|Lost to Follow-up|0|||
27721428|NCT01995071|80810436|FG006|Overall Study|Lost to Follow-up|0|||
27721429|NCT01995071|80810437|FG007|Overall Study|Lost to Follow-up|1|||
27721430|NCT01995071|80810438|FG008|Overall Study|Lost to Follow-up|1|||
27721431|NCT01995071|80810439|FG009|Overall Study|Lost to Follow-up|0|||
27721432|NCT01995071|80810440|FG010|Overall Study|Lost to Follow-up|0|||
27721433|NCT01995071|80810441|FG011|Overall Study|Lost to Follow-up|0|||
27721434|NCT01995071|80810430|FG000|Overall Study|Incarcerated|0|||
27721435|NCT01995071|80810431|FG001|Overall Study|Incarcerated|0|||
27721436|NCT01995071|80810432|FG002|Overall Study|Incarcerated|0|||
27721437|NCT01995071|80810433|FG003|Overall Study|Incarcerated|0|||
27721438|NCT01995071|80810434|FG004|Overall Study|Incarcerated|0|||
27721439|NCT01995071|80810435|FG005|Overall Study|Incarcerated|0|||
27721440|NCT01995071|80810436|FG006|Overall Study|Incarcerated|0|||
27721441|NCT01995071|80810437|FG007|Overall Study|Incarcerated|1|||
27721442|NCT01995071|80810438|FG008|Overall Study|Incarcerated|0|||
27721443|NCT01995071|80810439|FG009|Overall Study|Incarcerated|0|||
27721444|NCT01995071|80810440|FG010|Overall Study|Incarcerated|0|||
27721445|NCT01995071|80810441|FG011|Overall Study|Incarcerated|0|||
27721446|NCT00854828|80810442|FG000|Overall Study|Death|1|||
27721447|NCT00854828|80810443|FG001|Overall Study|Death|0|||
27721448|NCT00854828|80810444|FG002|Overall Study|Death|0|||
27721449|NCT00854828|80810445|FG003|Overall Study|Death|0|||
27721450|NCT00854828|80810442|FG000|Overall Study|Withdrawal by Subject|1|||
27721451|NCT00854828|80810443|FG001|Overall Study|Withdrawal by Subject|1|||
27721452|NCT00854828|80810444|FG002|Overall Study|Withdrawal by Subject|0|||
27721453|NCT00854828|80810445|FG003|Overall Study|Withdrawal by Subject|9|||
27721454|NCT00854828|80810442|FG000|Overall Study|Missed 24mo visit|1|||
27721455|NCT00854828|80810443|FG001|Overall Study|Missed 24mo visit|1|||
27721456|NCT00854828|80810444|FG002|Overall Study|Missed 24mo visit|8|||
27721457|NCT00854828|80810445|FG003|Overall Study|Missed 24mo visit|8|||
27721458|NCT00700180|80810447|FG000|Overall Study|Death|99|||
27721459|NCT00700180|80810448|FG001|Overall Study|Death|114|||
27721460|NCT00700180|80810447|FG000|Overall Study|Alive on treatment|5|||
27721461|NCT00700180|80810448|FG001|Overall Study|Alive on treatment|3|||
27721462|NCT00700180|80810447|FG000|Overall Study|Alive in follow-up|46|||
27721463|NCT00700180|80810448|FG001|Overall Study|Alive in follow-up|27|||
27721464|NCT00700180|80810447|FG000|Overall Study|Lost to Follow-up|4|||
27721465|NCT00700180|80810448|FG001|Overall Study|Lost to Follow-up|5|||
27721466|NCT00686647|80810455|FG000|Overall Study|Lost to Follow-up|1|||
27721467|NCT00686647|80810455|FG000|Overall Study|Death|1|||
27721468|NCT01400451|80810456|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
27721469|NCT01400451|80810457|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
27721470|NCT01400451|80810458|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
27721471|NCT01400451|80810456|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
27721472|NCT01400451|80810457|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
27721473|NCT01400451|80810458|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
27721474|NCT01400451|80810456|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
27721475|NCT01400451|80810457|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
27721476|NCT01400451|80810458|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
27721477|NCT01400451|80810456|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
27721478|NCT01400451|80810457|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
27721479|NCT01400451|80810458|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
27840278|NCT03833427|81244992|FG001|Overall Study|Death|2|||
27840279|NCT03833427|81244993|FG002|Overall Study|Death|9|||
27840280|NCT03833427|81244994|FG003|Overall Study|Death|11|||
27840281|NCT03833427|81244995|FG004|Overall Study|Death|0|||
27840282|NCT03833427|81244996|FG005|Overall Study|Death|0|||
27840283|NCT03833427|81244997|FG006|Overall Study|Death|0|||
27840284|NCT03833427|81244991|FG000|Overall Study|Withdrawal by Subject|0|||
27721480|NCT01400451|80810456|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
27721481|NCT01400451|80810457|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
27721482|NCT01400451|80810458|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
27721483|NCT01652287|80810459|FG000|Overall Study|Withdrawal by Subject|2|||
27721484|NCT01652287|80810460|FG001|Overall Study|Withdrawal by Subject|0|||
27721485|NCT00865020|80810461|FG000|Overall Study|Withdrawal by Subject|22|||
27721486|NCT00865020|80810462|FG001|Overall Study|Withdrawal by Subject|16|||
27721487|NCT00865020|80810461|FG000|Overall Study|Adverse Event|9|||
27721488|NCT00865020|80810462|FG001|Overall Study|Adverse Event|14|||
27721489|NCT00865020|80810461|FG000|Overall Study|Abnormal test procedure result(s)|6|||
27721490|NCT00865020|80810462|FG001|Overall Study|Abnormal test procedure result(s)|8|||
27721491|NCT00865020|80810461|FG000|Overall Study|Lost to Follow-up|6|||
27721492|NCT00865020|80810462|FG001|Overall Study|Lost to Follow-up|4|||
27721493|NCT00865020|80810461|FG000|Overall Study|Protocol deviation|4|||
27721494|NCT00865020|80810462|FG001|Overall Study|Protocol deviation|1|||
27721495|NCT00865020|80810461|FG000|Overall Study|Administrative problems|0|||
27721496|NCT00865020|80810462|FG001|Overall Study|Administrative problems|2|||
27721497|NCT00865020|80810461|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27721498|NCT00865020|80810462|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27721499|NCT00865020|80810461|FG000|Overall Study|Death|0|||
27721500|NCT00865020|80810462|FG001|Overall Study|Death|1|||
27721501|NCT00865020|80810461|FG000|Overall Study|Randomized but discontinued|2|||
27721502|NCT00865020|80810462|FG001|Overall Study|Randomized but discontinued|4|||
27721503|NCT01017952|80810463|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
27721504|NCT01017952|80810464|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27721505|NCT01017952|80810465|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27721506|NCT01017952|80810466|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27721507|NCT01017952|80810467|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27721508|NCT01017952|80810463|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
27721509|NCT01017952|80810464|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
27721510|NCT01017952|80810465|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
27721511|NCT01017952|80810466|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
27721512|NCT01017952|80810467|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
27721513|NCT01017952|80810463|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
27721514|NCT01017952|80810464|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27721515|NCT01017952|80810465|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27721516|NCT01017952|80810466|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27721517|NCT01017952|80810467|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
27721518|NCT01017952|80810463|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
27721519|NCT01017952|80810464|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27721520|NCT01017952|80810465|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27721521|NCT01017952|80810466|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27721522|NCT01017952|80810467|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27721523|NCT01017952|80810463|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
27721524|NCT01017952|80810464|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
27721525|NCT01017952|80810465|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
27840285|NCT03833427|81244992|FG001|Overall Study|Withdrawal by Subject|1|||
27721526|NCT01017952|80810466|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
27721527|NCT01017952|80810467|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
27721528|NCT01017952|80810463|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
27721529|NCT01017952|80810464|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27721530|NCT01017952|80810465|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27721531|NCT01017952|80810466|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27721532|NCT01017952|80810467|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27721533|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
27721534|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
27721535|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
27721536|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
27721537|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
27721538|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27721539|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
27721540|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
27721541|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
27721542|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
27721543|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27721544|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
27721545|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
27721546|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
27721547|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
27721548|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
27721549|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
27721550|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
27721551|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
27721552|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
27721553|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27721554|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
27721555|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
27721556|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
27721557|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
27721558|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27721559|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
27721560|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
27721561|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27721562|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27721563|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27721564|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
27721565|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
27721566|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
27721567|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
27721568|NCT01017952|80810463|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
27721569|NCT01017952|80810464|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
27721570|NCT01017952|80810465|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
27721571|NCT01017952|80810466|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
27721572|NCT01017952|80810467|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
27721573|NCT01870739|80810469|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
27721574|NCT01870739|80810470|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
27721575|NCT01870739|80810469|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
27721576|NCT01870739|80810470|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
27721577|NCT01870739|80810469|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
27721578|NCT01870739|80810470|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
27721579|NCT01870739|80810469|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
27721580|NCT01870739|80810470|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
27721581|NCT01870739|80810469|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
27721582|NCT01870739|80810470|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
27891328|NCT01992653|81437242|FG006|Overall Study|Death|4|||
27891329|NCT01992653|81437243|FG007|Overall Study|Death|2|||
27891330|NCT01992653|81437236|FG000|Overall Study|Lost to Follow-up|0|||
27891331|NCT01992653|81437237|FG001|Overall Study|Lost to Follow-up|0|||
27501475|NCT01074970|80030281|FG000|Overall Study|Disease progression during treatment|3|||
27891332|NCT01992653|81437238|FG002|Overall Study|Lost to Follow-up|0|||
27891333|NCT01992653|81437239|FG003|Overall Study|Lost to Follow-up|0|||
27891334|NCT01992653|81437240|FG004|Overall Study|Lost to Follow-up|0|||
27891335|NCT01992653|81437241|FG005|Overall Study|Lost to Follow-up|0|||
27891336|NCT01992653|81437242|FG006|Overall Study|Lost to Follow-up|0|||
27891337|NCT01992653|81437243|FG007|Overall Study|Lost to Follow-up|1|||
27721583|NCT01870739|80810469|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
27721584|NCT01870739|80810470|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
27721585|NCT01870739|80810469|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
27891338|NCT01992653|81437236|FG000|Overall Study|Study Completed|0|||
27721586|NCT01870739|80810470|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
27721587|NCT03595280|80815207|FG000|Overall Study|Lost to Follow-up|6|||
27721588|NCT03595280|80815208|FG001|Overall Study|Lost to Follow-up|9|||
27721589|NCT03595280|80815209|FG002|Overall Study|Lost to Follow-up|15|||
27721590|NCT01405053|80815210|FG000|Overall Study|Adverse Event|3|||
27721591|NCT01405053|80815211|FG001|Overall Study|Adverse Event|0|||
27721592|NCT01405053|80815210|FG000|Overall Study|Lost to Follow-up|0|||
27721593|NCT01405053|80815211|FG001|Overall Study|Lost to Follow-up|1|||
27721594|NCT01405053|80815210|FG000|Overall Study|Participant choice|2|||
27721595|NCT01405053|80815211|FG001|Overall Study|Participant choice|1|||
27721596|NCT01405053|80815210|FG000|Overall Study|Inadequate therapeutic effect|2|||
27721597|NCT01405053|80815211|FG001|Overall Study|Inadequate therapeutic effect|1|||
27721598|NCT01405053|80815210|FG000|Overall Study|Withdrawal by Subject|3|||
27721599|NCT01405053|80815211|FG001|Overall Study|Withdrawal by Subject|4|||
27721600|NCT01405053|80815210|FG000|Overall Study|Other|0|||
27721601|NCT01405053|80815211|FG001|Overall Study|Other|1|||
27721602|NCT01192347|80815212|FG000|Overall Study|Death|3|||
27721603|NCT01192347|80815212|FG000|Overall Study|Lost to Follow-up|3|||
27721604|NCT01192347|80815212|FG000|Overall Study|Withdrawal by Subject|1|||
27721605|NCT01192347|80815212|FG000|Overall Study|Adverse Event|1|||
27721606|NCT01192347|80815212|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
27721607|NCT01192347|80815212|FG000|Overall Study|Patient seen in different hospital|1|||
27721608|NCT01192347|80815212|FG000|Overall Study|Patient not visiting hospital regularly|1|||
27721609|NCT01192347|80815212|FG000|Overall Study|Patient did not show up for visits|1|||
27721610|NCT02631538|80815216|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
27721611|NCT02631538|80815217|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
27721612|NCT02631538|80815218|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
27721613|NCT02631538|80815219|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
27721614|NCT02631538|80815216|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
27721615|NCT02631538|80815217|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
27721616|NCT02631538|80815218|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
27721617|NCT02631538|80815219|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
27721618|NCT02631538|80815216|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
27840286|NCT03833427|81244993|FG002|Overall Study|Withdrawal by Subject|1|||
27840287|NCT03833427|81244994|FG003|Overall Study|Withdrawal by Subject|0|||
27840288|NCT03833427|81244995|FG004|Overall Study|Withdrawal by Subject|0|||
27840289|NCT03833427|81244996|FG005|Overall Study|Withdrawal by Subject|0|||
27840290|NCT03833427|81244997|FG006|Overall Study|Withdrawal by Subject|0|||
27840291|NCT03833427|81244991|FG000|Overall Study|Sponsor Decision|0|||
27840292|NCT03833427|81244992|FG001|Overall Study|Sponsor Decision|0|||
27840293|NCT03833427|81244993|FG002|Overall Study|Sponsor Decision|1|||
27840294|NCT03833427|81244994|FG003|Overall Study|Sponsor Decision|3|||
27840295|NCT03833427|81244995|FG004|Overall Study|Sponsor Decision|0|||
27840296|NCT03833427|81244996|FG005|Overall Study|Sponsor Decision|0|||
27840297|NCT03833427|81244997|FG006|Overall Study|Sponsor Decision|0|||
27501476|NCT01074970|80030282|FG001|Overall Study|Disease progression during treatment|1|||
27840298|NCT02169791|81244998|FG000|Overall Study|Death|6|||
27840299|NCT02169791|81244998|FG000|Overall Study|patient withdrew consent|1|||
27840300|NCT02129062|81245000|FG000|Overall Study|Death|1|||
27840301|NCT02129062|81245000|FG000|Overall Study|Disease Progression|2|||
27891339|NCT01992653|81437237|FG001|Overall Study|Study Completed|0|||
27891340|NCT01992653|81437238|FG002|Overall Study|Study Completed|0|||
27721619|NCT02631538|80815217|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
27721620|NCT02631538|80815218|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
27891341|NCT01992653|81437239|FG003|Overall Study|Study Completed|0|||
27891342|NCT01992653|81437240|FG004|Overall Study|Study Completed|0|||
27891343|NCT01992653|81437241|FG005|Overall Study|Study Completed|0|||
27891344|NCT01992653|81437242|FG006|Overall Study|Study Completed|0|||
27891345|NCT01992653|81437243|FG007|Overall Study|Study Completed|1|||
27891346|NCT01992653|81437236|FG000|Overall Study|Disease Progression|0|||
27891347|NCT01992653|81437237|FG001|Overall Study|Disease Progression|0|||
27891348|NCT01992653|81437238|FG002|Overall Study|Disease Progression|0|||
27891349|NCT01992653|81437239|FG003|Overall Study|Disease Progression|0|||
27891350|NCT01992653|81437240|FG004|Overall Study|Disease Progression|0|||
27891351|NCT01992653|81437241|FG005|Overall Study|Disease Progression|0|||
27891352|NCT01992653|81437242|FG006|Overall Study|Disease Progression|4|||
27891353|NCT01992653|81437243|FG007|Overall Study|Disease Progression|0|||
27891354|NCT01253174|81437246|FG000|Period 1|Randomized but not treated|0|||
27891355|NCT01253174|81437247|FG001|Period 1|Randomized but not treated|1|||
27891356|NCT01253174|81437248|FG002|Period 1|Randomized but not treated|1|||
27891357|NCT01253174|81437249|FG003|Period 1|Randomized but not treated|0|||
27891358|NCT01253174|81437250|FG004|Period 1|Randomized but not treated|1|||
27891359|NCT01253174|81437251|FG005|Period 1|Randomized but not treated|0|||
27891360|NCT01253174|81437246|FG000|Period 2|Adverse Event|0|||
27721621|NCT02631538|80815219|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
27721622|NCT02631538|80815216|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
27721623|NCT02631538|80815217|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
27721624|NCT02631538|80815218|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
27721625|NCT02631538|80815219|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
27721626|NCT02631538|80815216|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
27721627|NCT02631538|80815217|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
27721628|NCT02631538|80815218|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
27891361|NCT01253174|81437247|FG001|Period 2|Adverse Event|0|||
27891362|NCT01253174|81437248|FG002|Period 2|Adverse Event|1|||
27721629|NCT02631538|80815219|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
27721630|NCT02631538|80815216|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
27721631|NCT02631538|80815217|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
27721632|NCT02631538|80815218|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
27721633|NCT02631538|80815219|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
27721634|NCT00331409|80815222|FG000|Overall Study|Lack of Efficacy|4|||
27721635|NCT01282229|80815223|FG000|Overall Study|Protocol Violation|2|||
27721636|NCT03604445|80815224|FG000|Overall Study|Death|0|||
27721637|NCT03604445|80815225|FG001|Overall Study|Death|0|||
27721638|NCT03604445|80815226|FG002|Overall Study|Death|0|||
27721639|NCT03604445|80815227|FG003|Overall Study|Death|0|||
27721640|NCT03604445|80815228|FG004|Overall Study|Death|0|||
27721641|NCT03604445|80815229|FG005|Overall Study|Death|0|||
27721642|NCT03604445|80815230|FG006|Overall Study|Death|0|||
27721643|NCT03604445|80815231|FG007|Overall Study|Death|0|||
27891363|NCT01253174|81437249|FG003|Period 2|Adverse Event|0|||
27891364|NCT01253174|81437250|FG004|Period 2|Adverse Event|0|||
27891365|NCT01253174|81437251|FG005|Period 2|Adverse Event|0|||
27891366|NCT01253174|81437246|FG000|Period 3|Withdrawal by Subject|0|||
27891367|NCT01253174|81437247|FG001|Period 3|Withdrawal by Subject|1|||
27891368|NCT01253174|81437248|FG002|Period 3|Withdrawal by Subject|0|||
27891369|NCT01253174|81437249|FG003|Period 3|Withdrawal by Subject|0|||
27891370|NCT01253174|81437250|FG004|Period 3|Withdrawal by Subject|1|||
27891371|NCT01253174|81437251|FG005|Period 3|Withdrawal by Subject|0|||
27891372|NCT01253174|81437246|FG000|Period 3|Pregnancy|0|||
27891373|NCT01253174|81437247|FG001|Period 3|Pregnancy|0|||
27501477|NCT01074970|80030283|FG002|Overall Study|Disease progression during treatment|2|||
27891374|NCT01253174|81437248|FG002|Period 3|Pregnancy|1|||
27891375|NCT01253174|81437249|FG003|Period 3|Pregnancy|0|||
27891376|NCT01253174|81437250|FG004|Period 3|Pregnancy|0|||
27891377|NCT01253174|81437251|FG005|Period 3|Pregnancy|0|||
27891378|NCT01054300|81437256|FG000|Period 1|Adverse Event|1|||
27891379|NCT01054300|81437257|FG001|Period 1|Adverse Event|0|||
27891380|NCT01054300|81437258|FG002|Period 1|Adverse Event|0|||
27891381|NCT01054300|81437259|FG003|Period 1|Adverse Event|0|||
27891382|NCT01054300|81437256|FG000|Period 2|Withdrawal by Subject|0|||
27891383|NCT01054300|81437257|FG001|Period 2|Withdrawal by Subject|0|||
27891384|NCT01054300|81437258|FG002|Period 2|Withdrawal by Subject|1|||
27891385|NCT01054300|81437259|FG003|Period 2|Withdrawal by Subject|0|||
27891386|NCT00381043|81437261|FG000|Overall Study|Lost to Follow-up|8|||
27891387|NCT00381043|81437262|FG001|Overall Study|Lost to Follow-up|6|||
27891388|NCT00381043|81437261|FG000|Overall Study|Withdrawal by Subject|3|||
27891389|NCT00381043|81437262|FG001|Overall Study|Withdrawal by Subject|1|||
27891390|NCT00381043|81437261|FG000|Overall Study|wanted more care|0|||
27501478|NCT01074970|80030284|FG003|Overall Study|Disease progression during treatment|9|||
27501479|NCT01074970|80030281|FG000|Overall Study|Lost to Follow-up|0|||
27501480|NCT01074970|80030282|FG001|Overall Study|Lost to Follow-up|0|||
27501481|NCT01074970|80030283|FG002|Overall Study|Lost to Follow-up|1|||
27501482|NCT01074970|80030284|FG003|Overall Study|Lost to Follow-up|0|||
27721644|NCT03604445|80815232|FG008|Overall Study|Death|1|||
27721645|NCT03604445|80815224|FG000|Overall Study|Withdrawal by Subject|0|||
27721646|NCT03604445|80815225|FG001|Overall Study|Withdrawal by Subject|0|||
27721647|NCT03604445|80815226|FG002|Overall Study|Withdrawal by Subject|0|||
27721648|NCT03604445|80815227|FG003|Overall Study|Withdrawal by Subject|0|||
27721649|NCT03604445|80815228|FG004|Overall Study|Withdrawal by Subject|0|||
27721650|NCT03604445|80815229|FG005|Overall Study|Withdrawal by Subject|0|||
27721651|NCT03604445|80815230|FG006|Overall Study|Withdrawal by Subject|1|||
27721652|NCT03604445|80815231|FG007|Overall Study|Withdrawal by Subject|0|||
27721653|NCT03604445|80815232|FG008|Overall Study|Withdrawal by Subject|0|||
27721654|NCT03604445|80815224|FG000|Overall Study|Missing visit|0|||
27721655|NCT03604445|80815225|FG001|Overall Study|Missing visit|0|||
27721656|NCT03604445|80815226|FG002|Overall Study|Missing visit|0|||
27721657|NCT03604445|80815227|FG003|Overall Study|Missing visit|0|||
27721658|NCT03604445|80815228|FG004|Overall Study|Missing visit|0|||
27721659|NCT03604445|80815229|FG005|Overall Study|Missing visit|1|||
27721660|NCT03604445|80815230|FG006|Overall Study|Missing visit|0|||
27721661|NCT03604445|80815231|FG007|Overall Study|Missing visit|1|||
27721662|NCT03604445|80815232|FG008|Overall Study|Missing visit|0|||
27721663|NCT03604445|80815224|FG000|Overall Study|Adverse Event|0|||
27721664|NCT03604445|80815225|FG001|Overall Study|Adverse Event|0|||
27721665|NCT03604445|80815226|FG002|Overall Study|Adverse Event|0|||
27721666|NCT03604445|80815227|FG003|Overall Study|Adverse Event|1|||
27721667|NCT03604445|80815228|FG004|Overall Study|Adverse Event|0|||
27721668|NCT03604445|80815229|FG005|Overall Study|Adverse Event|0|||
27721669|NCT03604445|80815230|FG006|Overall Study|Adverse Event|0|||
27721670|NCT03604445|80815231|FG007|Overall Study|Adverse Event|0|||
27721671|NCT03604445|80815232|FG008|Overall Study|Adverse Event|1|||
27721672|NCT00605085|80815233|FG000|Overall Study|Withdrawal by Subject|8|||
27721673|NCT00605085|80815234|FG001|Overall Study|Withdrawal by Subject|5|||
27721674|NCT00605085|80815233|FG000|Overall Study|Adverse Event|9|||
27721675|NCT00605085|80815234|FG001|Overall Study|Adverse Event|5|||
27721676|NCT00605085|80815233|FG000|Overall Study|Pregnancy|2|||
27721677|NCT00605085|80815234|FG001|Overall Study|Pregnancy|0|||
27501483|NCT01074970|80030281|FG000|Overall Study|Withdrawal by Subject|0|||
27501484|NCT01074970|80030282|FG001|Overall Study|Withdrawal by Subject|0|||
27721678|NCT00605085|80815233|FG000|Overall Study|Protocol Violation|3|||
27721679|NCT00605085|80815234|FG001|Overall Study|Protocol Violation|2|||
27721680|NCT00605085|80815233|FG000|Overall Study|Lost to Follow-up|10|||
27721681|NCT00605085|80815234|FG001|Overall Study|Lost to Follow-up|5|||
27721682|NCT00605085|80815233|FG000|Overall Study|administrative reasons|18|||
27721683|NCT00605085|80815234|FG001|Overall Study|administrative reasons|8|||
27891391|NCT00381043|81437262|FG001|Overall Study|wanted more care|1|||
27891392|NCT00381043|81437261|FG000|Overall Study|incarcerated|1|||
27891393|NCT00381043|81437262|FG001|Overall Study|incarcerated|0|||
27891394|NCT04143594|81437265|FG000|Overall Study|Withdrew consent|3|||
27891395|NCT04143594|81437266|FG001|Overall Study|Withdrew consent|10|||
27721684|NCT01582308|80815235|FG000|Period 1|Withdrawal by Subject|0|||
27721685|NCT01582308|80815236|FG001|Period 1|Withdrawal by Subject|0|||
27721686|NCT01582308|80815237|FG002|Period 1|Withdrawal by Subject|0|||
27721687|NCT01582308|80815238|FG003|Period 1|Withdrawal by Subject|0|||
27891396|NCT04143594|81437267|FG002|Overall Study|Withdrew consent|3|||
27610587|NCT02584855|80415717|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
27610588|NCT02584855|80415718|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
27610589|NCT02584855|80415719|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
27610590|NCT02584855|80415720|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
27610591|NCT01613027|80415723|FG000|Overall Study|Lost to Follow-up|5|||
27610592|NCT01613027|80415723|FG000|Overall Study|Switched Physician|1|||
27610593|NCT01613027|80415723|FG000|Overall Study|Lack of Efficacy|1|||
27610594|NCT01613027|80415723|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
27610595|NCT04581200|80415728|FG000|Overall Study|Lost to Follow-up|6|||
27610596|NCT04581200|80415729|FG001|Overall Study|Lost to Follow-up|5|||
27610597|NCT00332332|80415735|FG000|Overall Study|Adverse Event|13|||
27610598|NCT00332332|80415735|FG000|Overall Study|Death|1|||
27610599|NCT00332332|80415735|FG000|Overall Study|Withdrawal by Subject|8|||
27610600|NCT00332332|80415735|FG000|Overall Study|Physician Decision|1|||
27610601|NCT00332332|80415735|FG000|Overall Study|Lost to Follow-up|3|||
27610602|NCT00332332|80415735|FG000|Overall Study|Protocol deviation|4|||
27610603|NCT00332332|80415735|FG000|Overall Study|Noncompliance|2|||
27610604|NCT00332332|80415735|FG000|Overall Study|Disease progression|2|||
27610605|NCT00332332|80415735|FG000|Overall Study|Other|18|||
27610606|NCT00332332|80415735|FG000|Overall Study|Did not receive study treatment|16|||
27610607|NCT00636792|80415736|FG000|Overall Study|Adverse Event|16|||
27610608|NCT00636792|80415736|FG000|Overall Study|Physician Decision|7|||
27610609|NCT00636792|80415736|FG000|Overall Study|Progressive Disease|4|||
27610610|NCT00636792|80415736|FG000|Overall Study|Withdrawal by Subject|3|||
27610611|NCT00636792|80415736|FG000|Overall Study|Other|3|||
27610612|NCT04488003|80415740|FG000|Assessed for Eligibility|Screen Failure|24|||
27610613|NCT04488003|80415741|FG001|Assessed for Eligibility|Screen Failure|0|||
27610614|NCT04488003|80415742|FG002|Assessed for Eligibility|Screen Failure|0|||
27610615|NCT04488003|80415740|FG000|Assessed for Eligibility|Adverse Event|1|||
27610616|NCT04488003|80415741|FG001|Assessed for Eligibility|Adverse Event|0|||
27610617|NCT04488003|80415742|FG002|Assessed for Eligibility|Adverse Event|0|||
27610618|NCT04488003|80415740|FG000|Assessed for Eligibility|Death|1|||
27610619|NCT04488003|80415741|FG001|Assessed for Eligibility|Death|0|||
27610620|NCT04488003|80415742|FG002|Assessed for Eligibility|Death|0|||
27610621|NCT04488003|80415740|FG000|Assessed for Eligibility|Physician Decision|1|||
27610622|NCT04488003|80415741|FG001|Assessed for Eligibility|Physician Decision|0|||
27610623|NCT04488003|80415742|FG002|Assessed for Eligibility|Physician Decision|0|||
27610624|NCT04488003|80415740|FG000|Allocated to Treatment|Progressive Disease|51|||
27610625|NCT04488003|80415741|FG001|Allocated to Treatment|Progressive Disease|0|||
27721688|NCT01582308|80815239|FG004|Period 1|Withdrawal by Subject|0|||
27721689|NCT01582308|80815240|FG005|Period 1|Withdrawal by Subject|0|||
27610626|NCT04488003|80415742|FG002|Allocated to Treatment|Progressive Disease|0|||
27610627|NCT04488003|80415740|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
27610628|NCT04488003|80415741|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
27610629|NCT04488003|80415742|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
27610630|NCT04488003|80415740|FG000|Allocated to Treatment|Adverse Event|6|||
27891397|NCT04143594|81437268|FG003|Overall Study|Withdrew consent|1|||
27501485|NCT01074970|80030283|FG002|Overall Study|Withdrawal by Subject|6|||
27501486|NCT01074970|80030284|FG003|Overall Study|Withdrawal by Subject|4|||
27840302|NCT01115933|81245003|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
27610631|NCT04488003|80415741|FG001|Allocated to Treatment|Adverse Event|0|||
27610632|NCT04488003|80415742|FG002|Allocated to Treatment|Adverse Event|0|||
27610633|NCT04488003|80415740|FG000|Allocated to Treatment|Other|5|||
27610634|NCT04488003|80415741|FG001|Allocated to Treatment|Other|0|||
27610635|NCT04488003|80415742|FG002|Allocated to Treatment|Other|0|||
27610636|NCT04488003|80415740|FG000|Allocated to Treatment|Physician Decision|4|||
27610637|NCT04488003|80415741|FG001|Allocated to Treatment|Physician Decision|0|||
27610638|NCT04488003|80415742|FG002|Allocated to Treatment|Physician Decision|0|||
27610639|NCT04488003|80415740|FG000|Allocated to Treatment|Death|4|||
27610640|NCT04488003|80415741|FG001|Allocated to Treatment|Death|0|||
27610641|NCT04488003|80415742|FG002|Allocated to Treatment|Death|0|||
27610642|NCT01536145|80415743|FG000|Overall Study|Progressive disease|3|||
27610643|NCT01536145|80415744|FG001|Overall Study|Progressive disease|4|||
27610644|NCT01536145|80415745|FG002|Overall Study|Progressive disease|1|||
27610645|NCT01536145|80415746|FG003|Overall Study|Progressive disease|2|||
27610646|NCT01536145|80415747|FG004|Overall Study|Progressive disease|1|||
27610647|NCT01536145|80415748|FG005|Overall Study|Progressive disease|2|||
27610648|NCT01536145|80415749|FG006|Overall Study|Progressive disease|1|||
27610649|NCT01536145|80415750|FG007|Overall Study|Progressive disease|2|||
27610650|NCT01536145|80415751|FG008|Overall Study|Progressive disease|1|||
27610651|NCT01536145|80415752|FG009|Overall Study|Progressive disease|3|||
27610652|NCT01536145|80415753|FG010|Overall Study|Progressive disease|3|||
27610653|NCT01536145|80415743|FG000|Overall Study|Withdrawal by Subject|0|||
27610654|NCT01536145|80415744|FG001|Overall Study|Withdrawal by Subject|0|||
27610655|NCT01536145|80415745|FG002|Overall Study|Withdrawal by Subject|1|||
27610656|NCT01536145|80415746|FG003|Overall Study|Withdrawal by Subject|0|||
27610657|NCT01536145|80415747|FG004|Overall Study|Withdrawal by Subject|0|||
27610658|NCT01536145|80415748|FG005|Overall Study|Withdrawal by Subject|1|||
27840303|NCT04640194|81245004|FG000|Overall Study|Adverse Event|3|||
27840304|NCT04640194|81245005|FG001|Overall Study|Adverse Event|7|||
27840305|NCT04640194|81245006|FG002|Overall Study|Adverse Event|0|||
27840306|NCT04640194|81245007|FG003|Overall Study|Adverse Event|5|||
27840307|NCT04640194|81245008|FG004|Overall Study|Adverse Event|0|||
27840308|NCT04640194|81245009|FG005|Overall Study|Adverse Event|4|||
27840309|NCT04640194|81245010|FG006|Overall Study|Adverse Event|0|||
27840310|NCT04640194|81245004|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
27840311|NCT04640194|81245005|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
27501487|NCT03497676|80030285|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
27501488|NCT03497676|80030286|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
27501489|NCT03497676|80030287|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
27501490|NCT03497676|80030288|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
27721690|NCT01582308|80815241|FG006|Period 1|Withdrawal by Subject|1|||
27501491|NCT03497676|80030285|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
27610659|NCT01536145|80415749|FG006|Overall Study|Withdrawal by Subject|0|||
27610660|NCT01536145|80415750|FG007|Overall Study|Withdrawal by Subject|0|||
27610661|NCT01536145|80415751|FG008|Overall Study|Withdrawal by Subject|2|||
27610662|NCT01536145|80415752|FG009|Overall Study|Withdrawal by Subject|0|||
27840312|NCT04640194|81245006|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
27840313|NCT04640194|81245007|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
27840314|NCT04640194|81245008|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
27840315|NCT04640194|81245009|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
27610663|NCT01536145|80415753|FG010|Overall Study|Withdrawal by Subject|2|||
27891398|NCT04143594|81437265|FG000|Overall Study|Lost to Follow-up|3|||
27891399|NCT04143594|81437266|FG001|Overall Study|Lost to Follow-up|5|||
27891400|NCT04143594|81437267|FG002|Overall Study|Lost to Follow-up|11|||
27891401|NCT04143594|81437268|FG003|Overall Study|Lost to Follow-up|0|||
27891402|NCT04143594|81437265|FG000|Overall Study|Investigator's discretion|2|||
27891403|NCT04143594|81437266|FG001|Overall Study|Investigator's discretion|2|||
27891404|NCT04143594|81437267|FG002|Overall Study|Investigator's discretion|0|||
27891405|NCT04143594|81437268|FG003|Overall Study|Investigator's discretion|0|||
27891406|NCT04143594|81437265|FG000|Overall Study|Randomized but never treated|0|||
27891407|NCT04143594|81437266|FG001|Overall Study|Randomized but never treated|0|||
27891408|NCT04143594|81437267|FG002|Overall Study|Randomized but never treated|0|||
27891409|NCT04143594|81437268|FG003|Overall Study|Randomized but never treated|1|||
27891410|NCT04143594|81437265|FG000|Overall Study|Death|1|||
27891411|NCT04143594|81437266|FG001|Overall Study|Death|0|||
27610664|NCT01536145|80415743|FG000|Overall Study|Other|0|||
27610665|NCT01536145|80415744|FG001|Overall Study|Other|0|||
27610666|NCT01536145|80415745|FG002|Overall Study|Other|0|||
27610667|NCT01536145|80415746|FG003|Overall Study|Other|0|||
27840316|NCT04640194|81245010|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
27840317|NCT04640194|81245004|FG000|Overall Study|fibrinogen level too low|0|||
27840318|NCT04640194|81245005|FG001|Overall Study|fibrinogen level too low|0|||
27840319|NCT04640194|81245006|FG002|Overall Study|fibrinogen level too low|0|||
27891412|NCT04143594|81437267|FG002|Overall Study|Death|1|||
27891413|NCT04143594|81437268|FG003|Overall Study|Death|0|||
27891414|NCT04143594|81437265|FG000|Overall Study|Adverse Event|1|||
27891415|NCT04143594|81437266|FG001|Overall Study|Adverse Event|0|||
27891416|NCT04143594|81437267|FG002|Overall Study|Adverse Event|0|||
27891417|NCT04143594|81437268|FG003|Overall Study|Adverse Event|0|||
27891418|NCT04143594|81437265|FG000|Overall Study|Pregnancy|0|||
27891419|NCT04143594|81437266|FG001|Overall Study|Pregnancy|0|||
27891420|NCT04143594|81437267|FG002|Overall Study|Pregnancy|1|||
27891421|NCT04143594|81437268|FG003|Overall Study|Pregnancy|0|||
27891422|NCT04143594|81437265|FG000|Overall Study|Lack of Efficacy|1|||
27891423|NCT04143594|81437266|FG001|Overall Study|Lack of Efficacy|1|||
27891424|NCT04143594|81437267|FG002|Overall Study|Lack of Efficacy|0|||
27891425|NCT04143594|81437268|FG003|Overall Study|Lack of Efficacy|0|||
27891426|NCT04114357|81437269|FG000|Baseline-Randomization|Adverse Event|2|||
27891427|NCT04114357|81437270|FG001|Baseline-Randomization|Adverse Event|1|||
27891428|NCT04114357|81437269|FG000|Baseline-Randomization|Lost to Follow-up|1|||
27891429|NCT04114357|81437270|FG001|Baseline-Randomization|Lost to Follow-up|1|||
27891430|NCT04114357|81437269|FG000|Cross-over|Adverse Event|0|||
27840320|NCT04640194|81245007|FG003|Overall Study|fibrinogen level too low|1|||
27840321|NCT04640194|81245008|FG004|Overall Study|fibrinogen level too low|0|||
27840322|NCT04640194|81245009|FG005|Overall Study|fibrinogen level too low|0|||
27840323|NCT04640194|81245010|FG006|Overall Study|fibrinogen level too low|0|||
27840324|NCT04640194|81245004|FG000|Overall Study|mild bleeding|0|||
27840325|NCT04640194|81245005|FG001|Overall Study|mild bleeding|0|||
27840326|NCT04640194|81245006|FG002|Overall Study|mild bleeding|0|||
27840327|NCT04640194|81245007|FG003|Overall Study|mild bleeding|1|||
27891431|NCT04114357|81437270|FG001|Cross-over|Adverse Event|1|||
27501492|NCT03497676|80030286|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
27501493|NCT03497676|80030287|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
27610668|NCT01536145|80415747|FG004|Overall Study|Other|1|||
27610669|NCT01536145|80415748|FG005|Overall Study|Other|0|||
27891432|NCT00191282|81437272|FG000|Overall Study|Adverse Event|5|||
27891433|NCT00191282|81437273|FG001|Overall Study|Adverse Event|6|||
27891434|NCT00191282|81437272|FG000|Overall Study|Death|51|||
27891435|NCT00191282|81437273|FG001|Overall Study|Death|51|||
27891436|NCT00191282|81437272|FG000|Overall Study|Lack of Efficacy|11|||
27891437|NCT00191282|81437273|FG001|Overall Study|Lack of Efficacy|6|||
27891438|NCT00191282|81437272|FG000|Overall Study|Noncompliance|14|||
27610670|NCT01536145|80415749|FG006|Overall Study|Other|0|||
27840328|NCT04640194|81245008|FG004|Overall Study|mild bleeding|0|||
27840329|NCT04640194|81245009|FG005|Overall Study|mild bleeding|0|||
27840330|NCT04640194|81245010|FG006|Overall Study|mild bleeding|0|||
27891439|NCT00191282|81437273|FG001|Overall Study|Noncompliance|17|||
27610671|NCT01536145|80415750|FG007|Overall Study|Other|0|||
27891440|NCT00191282|81437272|FG000|Overall Study|Patient moved|11|||
27891441|NCT00191282|81437273|FG001|Overall Study|Patient moved|14|||
27610672|NCT01536145|80415751|FG008|Overall Study|Other|0|||
27610673|NCT01536145|80415752|FG009|Overall Study|Other|3|||
27610674|NCT01536145|80415753|FG010|Overall Study|Other|2|||
27610675|NCT01536145|80415743|FG000|Overall Study|Death|0|||
27610676|NCT01536145|80415744|FG001|Overall Study|Death|0|||
27610677|NCT01536145|80415745|FG002|Overall Study|Death|0|||
27610678|NCT01536145|80415746|FG003|Overall Study|Death|0|||
27610679|NCT01536145|80415747|FG004|Overall Study|Death|0|||
27610680|NCT01536145|80415748|FG005|Overall Study|Death|0|||
27610681|NCT01536145|80415749|FG006|Overall Study|Death|1|||
27610682|NCT01536145|80415750|FG007|Overall Study|Death|0|||
27610683|NCT01536145|80415751|FG008|Overall Study|Death|0|||
27610684|NCT01536145|80415752|FG009|Overall Study|Death|0|||
27610685|NCT01536145|80415753|FG010|Overall Study|Death|0|||
27610686|NCT01536145|80415743|FG000|Overall Study|Adverse Event|0|||
27610687|NCT01536145|80415744|FG001|Overall Study|Adverse Event|0|||
27610688|NCT01536145|80415745|FG002|Overall Study|Adverse Event|0|||
27610689|NCT01536145|80415746|FG003|Overall Study|Adverse Event|0|||
27610690|NCT01536145|80415747|FG004|Overall Study|Adverse Event|0|||
27610691|NCT01536145|80415748|FG005|Overall Study|Adverse Event|0|||
27610692|NCT01536145|80415749|FG006|Overall Study|Adverse Event|0|||
27610693|NCT01536145|80415750|FG007|Overall Study|Adverse Event|2|||
27610694|NCT01536145|80415751|FG008|Overall Study|Adverse Event|0|||
27610695|NCT01536145|80415752|FG009|Overall Study|Adverse Event|0|||
27610696|NCT01536145|80415753|FG010|Overall Study|Adverse Event|3|||
27610697|NCT01806740|80415758|FG000|Overall Study|Withdrawal by Subject|4|||
27610698|NCT01806740|80415758|FG000|Overall Study|Physician Decision|1|||
27610699|NCT01806740|80415758|FG000|Overall Study|Patient's refusal of treatment|1|||
27610700|NCT01478113|80415761|FG000|Overall Study|Withdrawal by Subject|0|||
27501494|NCT03497676|80030288|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
27501495|NCT03497676|80030285|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
27501496|NCT03497676|80030286|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
27501497|NCT03497676|80030287|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
27501498|NCT03497676|80030288|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
27501499|NCT03497676|80030285|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
27501500|NCT03497676|80030286|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
27501501|NCT03497676|80030287|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
27501502|NCT03497676|80030288|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
27501503|NCT03497676|80030285|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
27501504|NCT03497676|80030286|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
27501505|NCT03497676|80030287|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
27501506|NCT03497676|80030288|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
27501507|NCT03497676|80030285|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
27501508|NCT03497676|80030286|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
27501509|NCT03497676|80030287|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
27501510|NCT03497676|80030288|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
27501511|NCT03497676|80030285|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
27501512|NCT03497676|80030286|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
27501513|NCT03497676|80030287|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
27501514|NCT03497676|80030288|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
27501515|NCT03497676|80030285|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
27501516|NCT03497676|80030286|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
27501517|NCT03497676|80030287|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
27501518|NCT03497676|80030288|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
27501519|NCT01383928|80030291|FG000|Overall Study|Initiation of ASCT|2|||
27501520|NCT01383928|80030292|FG001|Overall Study|Initiation of ASCT|1|||
27501521|NCT01383928|80030293|FG002|Overall Study|Initiation of ASCT|18|||
27501522|NCT01383928|80030291|FG000|Overall Study|Adverse Event|1|||
27501523|NCT01383928|80030292|FG001|Overall Study|Adverse Event|2|||
27501524|NCT01383928|80030293|FG002|Overall Study|Adverse Event|8|||
27501525|NCT01383928|80030291|FG000|Overall Study|Other|1|||
27840331|NCT04640194|81245004|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
27501526|NCT01383928|80030292|FG001|Overall Study|Other|3|||
27610701|NCT01478113|80415762|FG001|Overall Study|Withdrawal by Subject|1|||
27610702|NCT01478113|80415761|FG000|Overall Study|Physician Decision|1|||
27610703|NCT01478113|80415762|FG001|Overall Study|Physician Decision|0|||
27610704|NCT02247804|80415769|FG000|Treatment Period 1|Adverse Event|9|||
27610705|NCT02247804|80415770|FG001|Treatment Period 1|Adverse Event|2|||
27610706|NCT02247804|80415771|FG002|Treatment Period 1|Adverse Event|0|||
27610707|NCT02247804|80415769|FG000|Treatment Period 1|Lack of Efficacy|0|||
27610708|NCT02247804|80415770|FG001|Treatment Period 1|Lack of Efficacy|0|||
27840332|NCT04640194|81245005|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
27840333|NCT04640194|81245006|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
27891442|NCT00191282|81437272|FG000|Overall Study|Withdrawal by Subject|59|||
27891443|NCT00191282|81437273|FG001|Overall Study|Withdrawal by Subject|44|||
27891444|NCT00191282|81437272|FG000|Overall Study|Physician Decision|18|||
27891445|NCT00191282|81437273|FG001|Overall Study|Physician Decision|15|||
27891446|NCT00191282|81437272|FG000|Overall Study|Protocol entry criteria not met|14|||
27891447|NCT00191282|81437273|FG001|Overall Study|Protocol entry criteria not met|9|||
27891448|NCT00191282|81437272|FG000|Overall Study|Protocol Violation|9|||
27891449|NCT00191282|81437273|FG001|Overall Study|Protocol Violation|12|||
27891450|NCT00191282|81437272|FG000|Overall Study|Severity of outcome|2|||
27840334|NCT04640194|81245007|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
27840335|NCT04640194|81245008|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
27840336|NCT04640194|81245009|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
27840337|NCT04640194|81245010|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
27840338|NCT01685216|81245012|FG000|Overall Study|Did not receive study drug|1|||
27840339|NCT03253744|81245020|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
27840340|NCT03253744|81245021|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
27840341|NCT03253744|81245022|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
27840342|NCT03253744|81245023|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
27840343|NCT01175473|81245024|FG000|Overall Study|Adverse Event|2|||
27840344|NCT01175473|81245025|FG001|Overall Study|Adverse Event|2|||
27840345|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
27840346|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
27721691|NCT01582308|80815242|FG007|Period 1|Withdrawal by Subject|0|||
27840347|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
27840348|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
27840349|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
27840350|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
27840351|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
27840352|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
27840353|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
27891451|NCT00191282|81437273|FG001|Overall Study|Severity of outcome|5|||
27891452|NCT00191282|81437272|FG000|Overall Study|Sponsor's decision|2|||
27891453|NCT00191282|81437273|FG001|Overall Study|Sponsor's decision|2|||
27891454|NCT00191282|81437272|FG000|Overall Study|Lost to Follow-up|24|||
27891455|NCT00191282|81437273|FG001|Overall Study|Lost to Follow-up|31|||
27891456|NCT00725608|81437278|FG000|Overall Study|Lost to Follow-up|60|||
27891457|NCT00725608|81437278|FG000|Overall Study|Adverse Event|14|||
27891458|NCT00725608|81437278|FG000|Overall Study|Individual reasons|86|||
27891459|NCT00725608|81437278|FG000|Overall Study|Other|7|||
27891460|NCT01936181|81437279|FG000|Randomised, Double-blind|Adverse Event|27|||
27891461|NCT01936181|81437280|FG001|Randomised, Double-blind|Adverse Event|21|||
27891462|NCT01936181|81437281|FG002|Randomised, Double-blind|Adverse Event|0|||
27891463|NCT01936181|81437282|FG003|Randomised, Double-blind|Adverse Event|0|||
27891464|NCT01936181|81437279|FG000|Randomised, Double-blind|Protocol Violation|1|||
27891465|NCT01936181|81437280|FG001|Randomised, Double-blind|Protocol Violation|5|||
27891466|NCT01936181|81437281|FG002|Randomised, Double-blind|Protocol Violation|0|||
27891467|NCT01936181|81437282|FG003|Randomised, Double-blind|Protocol Violation|0|||
27891468|NCT01936181|81437279|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
27891469|NCT01936181|81437280|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
27891470|NCT01936181|81437281|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
27891471|NCT01936181|81437282|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
27840354|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
27721692|NCT01582308|80815243|FG008|Period 1|Withdrawal by Subject|0|||
27840355|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
27840356|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
27891472|NCT01936181|81437279|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
27721693|NCT01582308|80815244|FG009|Period 1|Withdrawal by Subject|0|||
27721694|NCT01582308|80815235|FG000|10-day Washout Following Period 1|Physician Decision|0|||
27721695|NCT01582308|80815236|FG001|10-day Washout Following Period 1|Physician Decision|0|||
27721696|NCT01582308|80815237|FG002|10-day Washout Following Period 1|Physician Decision|0|||
27721697|NCT01582308|80815238|FG003|10-day Washout Following Period 1|Physician Decision|0|||
27721698|NCT01582308|80815239|FG004|10-day Washout Following Period 1|Physician Decision|1|||
27721699|NCT01582308|80815240|FG005|10-day Washout Following Period 1|Physician Decision|0|||
27721700|NCT01582308|80815241|FG006|10-day Washout Following Period 1|Physician Decision|0|||
27891473|NCT01936181|81437280|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
27891474|NCT01936181|81437281|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
27891475|NCT01936181|81437282|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
27891476|NCT01936181|81437279|FG000|Randomised, Double-blind|Pregnancy|0|||
27891477|NCT01936181|81437280|FG001|Randomised, Double-blind|Pregnancy|1|||
27891478|NCT01936181|81437281|FG002|Randomised, Double-blind|Pregnancy|0|||
27891479|NCT01936181|81437282|FG003|Randomised, Double-blind|Pregnancy|0|||
27891480|NCT01936181|81437279|FG000|Randomised, Double-blind|Physician Decision|4|||
27891481|NCT01936181|81437280|FG001|Randomised, Double-blind|Physician Decision|4|||
27721701|NCT01582308|80815242|FG007|10-day Washout Following Period 1|Physician Decision|0|||
27721702|NCT01582308|80815243|FG008|10-day Washout Following Period 1|Physician Decision|0|||
27721703|NCT01582308|80815244|FG009|10-day Washout Following Period 1|Physician Decision|0|||
27721704|NCT01582308|80815235|FG000|Period 4|Physician Decision|1|||
27721705|NCT01582308|80815236|FG001|Period 4|Physician Decision|0|||
27721706|NCT01582308|80815237|FG002|Period 4|Physician Decision|0|||
27721707|NCT01582308|80815238|FG003|Period 4|Physician Decision|0|||
27721708|NCT01582308|80815239|FG004|Period 4|Physician Decision|0|||
27721709|NCT01582308|80815240|FG005|Period 4|Physician Decision|1|||
27891482|NCT01936181|81437281|FG002|Randomised, Double-blind|Physician Decision|0|||
27891483|NCT01936181|81437282|FG003|Randomised, Double-blind|Physician Decision|0|||
27721710|NCT01582308|80815241|FG006|Period 4|Physician Decision|0|||
27721711|NCT01582308|80815242|FG007|Period 4|Physician Decision|0|||
27721712|NCT01582308|80815243|FG008|Period 4|Physician Decision|0|||
27891484|NCT01936181|81437279|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
27721713|NCT01582308|80815244|FG009|Period 4|Physician Decision|1|||
27721714|NCT01157078|80815247|FG000|Overall Study|Withdrawal by Subject|12|||
27721715|NCT01157078|80815248|FG001|Overall Study|Withdrawal by Subject|14|||
27721716|NCT01157078|80815247|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27721717|NCT01157078|80815248|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27721718|NCT01157078|80815247|FG000|Overall Study|Adverse Event|6|||
27721719|NCT01157078|80815248|FG001|Overall Study|Adverse Event|6|||
27721720|NCT01157078|80815247|FG000|Overall Study|Severe non-compliance to protocol|2|||
27721721|NCT01157078|80815248|FG001|Overall Study|Severe non-compliance to protocol|4|||
27721722|NCT01157078|80815247|FG000|Overall Study|Condition under investigation worsened|0|||
27721723|NCT01157078|80815248|FG001|Overall Study|Condition under investigation worsened|1|||
27721724|NCT01157078|80815247|FG000|Overall Study|Lack of Efficacy|2|||
27721725|NCT01157078|80815248|FG001|Overall Study|Lack of Efficacy|0|||
27721726|NCT01157078|80815247|FG000|Overall Study|Study-specific withdrawal criteria|2|||
27721727|NCT01157078|80815248|FG001|Overall Study|Study-specific withdrawal criteria|2|||
27721728|NCT01157078|80815247|FG000|Overall Study|Lost to Follow-up|7|||
27721729|NCT01157078|80815248|FG001|Overall Study|Lost to Follow-up|5|||
27721730|NCT01157078|80815247|FG000|Overall Study|Other|2|||
27721731|NCT01157078|80815248|FG001|Overall Study|Other|4|||
27721732|NCT03694925|80815249|FG000|Overall Study|Inadequate laboratory testing|0|||
27721733|NCT03694925|80815250|FG001|Overall Study|Inadequate laboratory testing|3|||
27721734|NCT03694925|80815251|FG002|Overall Study|Inadequate laboratory testing|0|||
27721735|NCT01142726|80815257|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
27721736|NCT01142726|80815258|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
27721737|NCT01142726|80815259|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
27721738|NCT01142726|80815257|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
27721739|NCT01142726|80815258|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
27721740|NCT01142726|80815259|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
27721741|NCT01142726|80815257|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
27721742|NCT01142726|80815258|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
27721743|NCT01142726|80815259|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
27721744|NCT01142726|80815257|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
27721745|NCT01142726|80815258|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
27721746|NCT01142726|80815259|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
27721747|NCT01142726|80815257|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
27721748|NCT01142726|80815258|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
27721749|NCT01142726|80815259|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
27721750|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
27721751|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
27721752|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
27721753|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
27721754|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
27721755|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
27891485|NCT01936181|81437280|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
27891486|NCT01936181|81437281|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
27891487|NCT01936181|81437282|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
27891488|NCT01936181|81437279|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
27891489|NCT01936181|81437280|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
27891490|NCT01936181|81437281|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
27891491|NCT01936181|81437282|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
27891492|NCT01936181|81437279|FG000|Transition-extension|Adverse Event|3|||
27891493|NCT01936181|81437280|FG001|Transition-extension|Adverse Event|0|||
27891494|NCT01936181|81437281|FG002|Transition-extension|Adverse Event|3|||
27891495|NCT01936181|81437282|FG003|Transition-extension|Adverse Event|1|||
27840357|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
27840358|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
27840359|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
27840360|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
27840361|NCT01067521|81245026|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
27840362|NCT01067521|81245027|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
27840363|NCT01067521|81245026|FG000|Open-Label Period|Death|3|||
27501527|NCT01383928|80030293|FG002|Overall Study|Other|4|||
27501528|NCT01383928|80030291|FG000|Overall Study|Progressive Disease|1|||
27501529|NCT01383928|80030292|FG001|Overall Study|Progressive Disease|1|||
27501530|NCT01383928|80030293|FG002|Overall Study|Progressive Disease|5|||
27501531|NCT01383928|80030291|FG000|Overall Study|Withdrawal by Subject|0|||
27501532|NCT01383928|80030292|FG001|Overall Study|Withdrawal by Subject|0|||
27501533|NCT01383928|80030293|FG002|Overall Study|Withdrawal by Subject|4|||
27610709|NCT02247804|80415771|FG002|Treatment Period 1|Lack of Efficacy|2|||
27610710|NCT02247804|80415769|FG000|Treatment Period 1|Lost to Follow-up|1|||
27610711|NCT02247804|80415770|FG001|Treatment Period 1|Lost to Follow-up|0|||
27610712|NCT02247804|80415771|FG002|Treatment Period 1|Lost to Follow-up|2|||
27610713|NCT02247804|80415769|FG000|Treatment Period 1|Personal Reasons|7|||
27501534|NCT01383928|80030291|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
27501535|NCT01383928|80030292|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
27610714|NCT02247804|80415770|FG001|Treatment Period 1|Personal Reasons|1|||
27610715|NCT02247804|80415771|FG002|Treatment Period 1|Personal Reasons|2|||
27840364|NCT01067521|81245027|FG001|Open-Label Period|Death|1|||
27840365|NCT01067521|81245026|FG000|Open-Label Period|Adverse Event|30|||
27840366|NCT01067521|81245027|FG001|Open-Label Period|Adverse Event|28|||
27840367|NCT01067521|81245026|FG000|Open-Label Period|Withdrawal by Subject|160|||
27840368|NCT01067521|81245027|FG001|Open-Label Period|Withdrawal by Subject|88|||
27840369|NCT01067521|81245026|FG000|Open-Label Period|Physician Decision|13|||
27840370|NCT01067521|81245027|FG001|Open-Label Period|Physician Decision|11|||
27840371|NCT01067521|81245026|FG000|Open-Label Period|Non-compliance with study drug|5|||
27840372|NCT01067521|81245027|FG001|Open-Label Period|Non-compliance with study drug|0|||
27840373|NCT01067521|81245026|FG000|Open-Label Period|Protocol Violation|3|||
27840374|NCT01067521|81245027|FG001|Open-Label Period|Protocol Violation|0|||
27840375|NCT01067521|81245026|FG000|Open-Label Period|Pregnancy|14|||
27840376|NCT01067521|81245027|FG001|Open-Label Period|Pregnancy|8|||
27840377|NCT01067521|81245026|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
27840378|NCT01067521|81245027|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
27840379|NCT01067521|81245026|FG000|Open-Label Period|Lost to Follow-up|21|||
27840380|NCT01067521|81245027|FG001|Open-Label Period|Lost to Follow-up|20|||
27840381|NCT02075840|81245028|FG000|Overall Study|Withdrawal by Subject|13|||
27840382|NCT02075840|81245029|FG001|Overall Study|Withdrawal by Subject|22|||
27840383|NCT02075840|81245028|FG000|Overall Study|Reason not specified|1|||
27840384|NCT02075840|81245029|FG001|Overall Study|Reason not specified|0|||
27840385|NCT02075840|81245028|FG000|Overall Study|Adverse Event|0|||
27840386|NCT02075840|81245029|FG001|Overall Study|Adverse Event|2|||
27840387|NCT02075840|81245028|FG000|Overall Study|Death|35|||
27840388|NCT02075840|81245029|FG001|Overall Study|Death|40|||
27840389|NCT02075840|81245028|FG000|Overall Study|Lost to Follow-up|3|||
27840390|NCT02075840|81245029|FG001|Overall Study|Lost to Follow-up|2|||
27840391|NCT02075840|81245028|FG000|Overall Study|Physician Decision|1|||
27840392|NCT02075840|81245029|FG001|Overall Study|Physician Decision|3|||
27840393|NCT02075840|81245028|FG000|Overall Study|Ongoing at CCOD|99|||
27840394|NCT02075840|81245029|FG001|Overall Study|Ongoing at CCOD|82|||
27721756|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
27721757|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
27721758|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
27721759|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
27721760|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
27721761|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
27501536|NCT01383928|80030293|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
27501537|NCT01339832|80030294|FG000|Overall Study|Lost to Follow-up|3|||
27501538|NCT01339832|80030294|FG000|Overall Study|Death|11|||
27501539|NCT01502293|80030295|FG000|Overall Study|Progressive Disease|20|||
27501540|NCT01502293|80030296|FG001|Overall Study|Progressive Disease|12|||
27501541|NCT01502293|80030297|FG002|Overall Study|Progressive Disease|2|||
27501542|NCT01502293|80030295|FG000|Overall Study|Withdrawal by Subject|3|||
27501543|NCT01502293|80030296|FG001|Overall Study|Withdrawal by Subject|3|||
27501544|NCT01502293|80030297|FG002|Overall Study|Withdrawal by Subject|1|||
27721762|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
27721763|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
27721764|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
27721765|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
27721766|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
27721767|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
27721768|NCT01142726|80815257|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
27721769|NCT01142726|80815258|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
27721770|NCT01142726|80815259|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
27721771|NCT01142726|80815257|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
27721772|NCT01142726|80815258|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
27721773|NCT01142726|80815259|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
27721774|NCT01142726|80815257|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
27721775|NCT01142726|80815258|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
27721776|NCT01142726|80815259|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
27721777|NCT01142726|80815257|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
27721778|NCT01142726|80815258|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
27721779|NCT01142726|80815259|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
27721780|NCT01142726|80815257|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
27721781|NCT01142726|80815258|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
27721782|NCT01142726|80815259|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
27721783|NCT02799069|80815260|FG000|Overall Study|Adverse Event|0|||
27721784|NCT02799069|80815261|FG001|Overall Study|Adverse Event|2|||
27721785|NCT02799069|80815262|FG002|Overall Study|Adverse Event|2|||
27721786|NCT02799069|80815260|FG000|Overall Study|Lack of Efficacy|2|||
27721787|NCT02799069|80815261|FG001|Overall Study|Lack of Efficacy|0|||
27721788|NCT02799069|80815262|FG002|Overall Study|Lack of Efficacy|0|||
27721789|NCT02799069|80815260|FG000|Overall Study|Lost to Follow-up|1|||
27721790|NCT02799069|80815261|FG001|Overall Study|Lost to Follow-up|1|||
27721791|NCT02799069|80815262|FG002|Overall Study|Lost to Follow-up|0|||
27721792|NCT02799069|80815260|FG000|Overall Study|Withdrawal by Subject|4|||
27721793|NCT02799069|80815261|FG001|Overall Study|Withdrawal by Subject|4|||
27721794|NCT02799069|80815262|FG002|Overall Study|Withdrawal by Subject|3|||
27721795|NCT02799069|80815260|FG000|Overall Study|Protocol Violation|1|||
27721796|NCT02799069|80815261|FG001|Overall Study|Protocol Violation|0|||
27840395|NCT02911935|81245031|FG000|Overall Study|Lost to Follow-up|5|||
27840396|NCT02911935|81245032|FG001|Overall Study|Lost to Follow-up|7|||
27721797|NCT02799069|80815262|FG002|Overall Study|Protocol Violation|2|||
27721798|NCT02513329|80815263|FG000|Overall Study|Lost to Follow-up|5|||
27721799|NCT02513329|80815264|FG001|Overall Study|Lost to Follow-up|2|||
27840397|NCT04994431|81245033|FG000|Overall Study|Adverse Event|1|||
27501545|NCT01502293|80030295|FG000|Overall Study|Adverse Event|0|||
27840398|NCT04994431|81245034|FG001|Overall Study|Adverse Event|0|||
27501546|NCT01502293|80030296|FG001|Overall Study|Adverse Event|2|||
27501547|NCT01502293|80030297|FG002|Overall Study|Adverse Event|0|||
27721800|NCT00725075|80815265|FG000|Overall Study|Use of Excluded Medication|0|||
27721801|NCT00725075|80815266|FG001|Overall Study|Use of Excluded Medication|1|||
27721802|NCT00725075|80815267|FG002|Overall Study|Use of Excluded Medication|0|||
27721803|NCT00725075|80815265|FG000|Overall Study|Protocol Violation|0|||
27721804|NCT00725075|80815266|FG001|Overall Study|Protocol Violation|0|||
27721805|NCT00725075|80815267|FG002|Overall Study|Protocol Violation|1|||
27721806|NCT00725075|80815265|FG000|Overall Study|Lost to Follow-up|1|||
27721807|NCT00725075|80815266|FG001|Overall Study|Lost to Follow-up|0|||
27721808|NCT00725075|80815267|FG002|Overall Study|Lost to Follow-up|0|||
27721809|NCT00725075|80815265|FG000|Overall Study|Withdrawal by Subject|4|||
27721810|NCT00725075|80815266|FG001|Overall Study|Withdrawal by Subject|5|||
27721811|NCT00725075|80815267|FG002|Overall Study|Withdrawal by Subject|4|||
27721812|NCT00725075|80815265|FG000|Overall Study|Adverse Event|2|||
27721813|NCT00725075|80815266|FG001|Overall Study|Adverse Event|1|||
27721814|NCT00725075|80815267|FG002|Overall Study|Adverse Event|1|||
27721815|NCT00725075|80815265|FG000|Overall Study|Worsening of Disease|2|||
27721816|NCT00725075|80815266|FG001|Overall Study|Worsening of Disease|1|||
27721817|NCT00725075|80815267|FG002|Overall Study|Worsening of Disease|2|||
27721818|NCT00725075|80815265|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
27721819|NCT00725075|80815266|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
27721820|NCT00725075|80815267|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
27721821|NCT00725075|80815265|FG000|Overall Study|Other|1|||
27721822|NCT00725075|80815266|FG001|Overall Study|Other|0|||
27721823|NCT00725075|80815267|FG002|Overall Study|Other|0|||
27721824|NCT00044512|80815270|FG000|Follow Up|Lost to Follow-up|2|||
27721825|NCT01512264|80815271|FG000|Overall Study|Lost to Follow-up|0|||
27721826|NCT01512264|80815272|FG001|Overall Study|Lost to Follow-up|0|||
27721827|NCT01512264|80815273|FG002|Overall Study|Lost to Follow-up|0|||
27721828|NCT01512264|80815274|FG003|Overall Study|Lost to Follow-up|1|||
27721829|NCT03984305|80815275|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
27721830|NCT03984305|80815276|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
27721831|NCT03984305|80815275|FG000|Overall Study|Withdrawal by Subject|3|||
27721832|NCT03984305|80815276|FG001|Overall Study|Withdrawal by Subject|3|||
27840399|NCT04233216|81245040|FG000|Overall Study|Lost to Follow-up|1|||
27501548|NCT01502293|80030295|FG000|Overall Study|Reason Not Specified|2|||
27501549|NCT01502293|80030296|FG001|Overall Study|Reason Not Specified|0|||
27721833|NCT03984305|80815275|FG000|Overall Study|Lost to Follow-up|1|||
27721834|NCT03984305|80815276|FG001|Overall Study|Lost to Follow-up|0|||
27721835|NCT02508194|80815279|FG000|Overall Study|Death|5|||
27721836|NCT02508194|80815280|FG001|Overall Study|Death|3|||
27721837|NCT02508194|80815279|FG000|Overall Study|Lost to Follow-up|25|||
27840400|NCT04233216|81245041|FG001|Overall Study|Lost to Follow-up|0|||
27840401|NCT04233216|81245042|FG002|Overall Study|Lost to Follow-up|2|||
27840402|NCT04233216|81245043|FG003|Overall Study|Lost to Follow-up|0|||
27840403|NCT04233216|81245040|FG000|Overall Study|Physician Decision|0|||
27840404|NCT04233216|81245041|FG001|Overall Study|Physician Decision|3|||
27721838|NCT02508194|80815280|FG001|Overall Study|Lost to Follow-up|18|||
27501550|NCT01502293|80030297|FG002|Overall Study|Reason Not Specified|0|||
27721839|NCT02508194|80815279|FG000|Overall Study|Withdrawal by Subject|20|||
27721840|NCT02508194|80815280|FG001|Overall Study|Withdrawal by Subject|18|||
27721841|NCT02508194|80815279|FG000|Overall Study|Error in Randomization|1|||
27721842|NCT02508194|80815280|FG001|Overall Study|Error in Randomization|3|||
27840405|NCT04233216|81245042|FG002|Overall Study|Physician Decision|0|||
27840406|NCT04233216|81245043|FG003|Overall Study|Physician Decision|2|||
27840407|NCT04233216|81245040|FG000|Overall Study|Withdrawal by Subject|0|||
27840408|NCT04233216|81245041|FG001|Overall Study|Withdrawal by Subject|2|||
27840409|NCT04233216|81245042|FG002|Overall Study|Withdrawal by Subject|1|||
27840410|NCT04233216|81245043|FG003|Overall Study|Withdrawal by Subject|0|||
27840411|NCT00559637|81245047|FG000|Overall Study|Adverse Event|22|||
27840412|NCT00559637|81245047|FG000|Overall Study|Withdrawal by Subject|4|||
27840413|NCT00559637|81245047|FG000|Overall Study|Protocol Violation|6|||
27840414|NCT00559637|81245047|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
27840415|NCT00559637|81245047|FG000|Overall Study|Failure to return|6|||
27840416|NCT00559637|81245047|FG000|Overall Study|Insufficient response|3|||
27840417|NCT00559637|81245047|FG000|Overall Study|Started requiring dialysis after month 7|2|||
27891496|NCT01936181|81437279|FG000|Transition-extension|Lost to Follow-up|3|||
27891497|NCT01936181|81437280|FG001|Transition-extension|Lost to Follow-up|0|||
27501551|NCT01502293|80030295|FG000|Overall Study|Physician Decision|0|||
27840418|NCT00559637|81245047|FG000|Overall Study|Suspected lung cancer|1|||
27891498|NCT01936181|81437281|FG002|Transition-extension|Lost to Follow-up|1|||
27891499|NCT01936181|81437282|FG003|Transition-extension|Lost to Follow-up|2|||
27891500|NCT01936181|81437279|FG000|Transition-extension|Physician Decision|2|||
27891501|NCT01936181|81437280|FG001|Transition-extension|Physician Decision|0|||
27840419|NCT00559637|81245047|FG000|Overall Study|Participation in another study|1|||
27840420|NCT00559637|81245047|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
27891502|NCT01936181|81437281|FG002|Transition-extension|Physician Decision|0|||
27891503|NCT01936181|81437282|FG003|Transition-extension|Physician Decision|1|||
27891504|NCT01936181|81437279|FG000|Transition-extension|Withdrawal by Subject|7|||
27891505|NCT01936181|81437280|FG001|Transition-extension|Withdrawal by Subject|0|||
27891506|NCT01936181|81437281|FG002|Transition-extension|Withdrawal by Subject|2|||
27891507|NCT01936181|81437282|FG003|Transition-extension|Withdrawal by Subject|1|||
27891508|NCT05239494|81437289|FG000|Overall Study|Lost to Follow-up|1|||
27891509|NCT05174949|81437296|FG000|Overall Study|Physician Decision|1|||
27891510|NCT05174949|81437297|FG001|Overall Study|Physician Decision|2|||
27891511|NCT05174949|81437298|FG002|Overall Study|Physician Decision|0|||
27501552|NCT01502293|80030296|FG001|Overall Study|Physician Decision|0|||
27891512|NCT05174949|81437299|FG003|Overall Study|Physician Decision|1|||
27891513|NCT05174949|81437300|FG004|Overall Study|Physician Decision|0|||
27891514|NCT05174949|81437301|FG005|Overall Study|Physician Decision|0|||
27891515|NCT05174949|81437296|FG000|Overall Study|Withdrawal by Subject|0|||
27891516|NCT05174949|81437297|FG001|Overall Study|Withdrawal by Subject|1|||
27891517|NCT05174949|81437298|FG002|Overall Study|Withdrawal by Subject|0|||
27891518|NCT05174949|81437299|FG003|Overall Study|Withdrawal by Subject|0|||
27891519|NCT05174949|81437300|FG004|Overall Study|Withdrawal by Subject|0|||
27891520|NCT05174949|81437301|FG005|Overall Study|Withdrawal by Subject|0|||
27891521|NCT05174949|81437296|FG000|Overall Study|Lost to Follow-up|0|||
27891522|NCT05174949|81437297|FG001|Overall Study|Lost to Follow-up|0|||
27891523|NCT05174949|81437298|FG002|Overall Study|Lost to Follow-up|0|||
27891524|NCT05174949|81437299|FG003|Overall Study|Lost to Follow-up|1|||
27891525|NCT05174949|81437300|FG004|Overall Study|Lost to Follow-up|0|||
27891526|NCT05174949|81437301|FG005|Overall Study|Lost to Follow-up|0|||
27891527|NCT03499899|81437304|FG000|Overall Study|Adverse Event|2|||
27891528|NCT03499899|81437305|FG001|Overall Study|Adverse Event|3|||
27891529|NCT03499899|81437306|FG002|Overall Study|Adverse Event|3|||
27891530|NCT03499899|81437304|FG000|Overall Study|Death|0|||
27891531|NCT03499899|81437305|FG001|Overall Study|Death|0|||
27891532|NCT03499899|81437306|FG002|Overall Study|Death|1|||
27891533|NCT03499899|81437304|FG000|Overall Study|Physician Decision|3|||
27891534|NCT03499899|81437305|FG001|Overall Study|Physician Decision|6|||
27891535|NCT03499899|81437306|FG002|Overall Study|Physician Decision|6|||
27891536|NCT03499899|81437304|FG000|Overall Study|Progressive disease|15|||
27891537|NCT03499899|81437305|FG001|Overall Study|Progressive disease|23|||
27891538|NCT03499899|81437306|FG002|Overall Study|Progressive disease|23|||
27891539|NCT03499899|81437304|FG000|Overall Study|Patient decision|0|||
27891540|NCT03499899|81437305|FG001|Overall Study|Patient decision|1|||
27610716|NCT02247804|80415769|FG000|Treatment Period 1|Protocol Deviation|0|||
27610717|NCT02247804|80415770|FG001|Treatment Period 1|Protocol Deviation|0|||
27610718|NCT02247804|80415771|FG002|Treatment Period 1|Protocol Deviation|1|||
27610719|NCT02247804|80415769|FG000|Treatment Period 1|Randomized but not Treated|5|||
27610720|NCT02247804|80415770|FG001|Treatment Period 1|Randomized but not Treated|1|||
27610721|NCT02247804|80415771|FG002|Treatment Period 1|Randomized but not Treated|1|||
27610722|NCT02247804|80415769|FG000|Treatment Period 2|Adverse Event|6|||
27610723|NCT02247804|80415770|FG001|Treatment Period 2|Adverse Event|3|||
27610724|NCT02247804|80415771|FG002|Treatment Period 2|Adverse Event|3|||
27610725|NCT02247804|80415769|FG000|Treatment Period 2|Lack of Efficacy|0|||
27610726|NCT02247804|80415770|FG001|Treatment Period 2|Lack of Efficacy|0|||
27610727|NCT02247804|80415771|FG002|Treatment Period 2|Lack of Efficacy|1|||
27610728|NCT02247804|80415769|FG000|Treatment Period 2|Lost to Follow-up|0|||
27610729|NCT02247804|80415770|FG001|Treatment Period 2|Lost to Follow-up|1|||
27610730|NCT02247804|80415771|FG002|Treatment Period 2|Lost to Follow-up|1|||
27610731|NCT02247804|80415769|FG000|Treatment Period 2|Personal Reasons|2|||
27610732|NCT02247804|80415770|FG001|Treatment Period 2|Personal Reasons|1|||
27610733|NCT02247804|80415771|FG002|Treatment Period 2|Personal Reasons|1|||
27610734|NCT02247804|80415769|FG000|Treatment Period 2|Reason not Specified|0|||
27610735|NCT02247804|80415770|FG001|Treatment Period 2|Reason not Specified|0|||
27610736|NCT02247804|80415771|FG002|Treatment Period 2|Reason not Specified|2|||
27610737|NCT02247804|80415769|FG000|Treatment Period 3|Adverse Event|4|||
27610738|NCT02247804|80415770|FG001|Treatment Period 3|Adverse Event|3|||
27610739|NCT02247804|80415771|FG002|Treatment Period 3|Adverse Event|3|||
27610740|NCT02247804|80415769|FG000|Treatment Period 3|Lack of Efficacy|0|||
27610741|NCT02247804|80415770|FG001|Treatment Period 3|Lack of Efficacy|1|||
27610742|NCT02247804|80415771|FG002|Treatment Period 3|Lack of Efficacy|0|||
27610743|NCT02247804|80415769|FG000|Treatment Period 3|Lost to Follow-up|1|||
27610744|NCT02247804|80415770|FG001|Treatment Period 3|Lost to Follow-up|2|||
27610745|NCT02247804|80415771|FG002|Treatment Period 3|Lost to Follow-up|2|||
27610746|NCT02247804|80415769|FG000|Treatment Period 3|Personal Reasons|4|||
27840421|NCT00559637|81245047|FG000|Overall Study|Change of center|1|||
27840422|NCT00559637|81245047|FG000|Overall Study|Change of home|1|||
27840423|NCT00559637|81245047|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
27840424|NCT01560819|81245048|FG000|Overall Study|Physician Decision|1|||
27840425|NCT01560819|81245049|FG001|Overall Study|Physician Decision|0|||
27840426|NCT01923311|81245050|FG000|Overall Study|Pregnancy|1|||
27840427|NCT01923311|81245051|FG001|Overall Study|Pregnancy|0|||
27840428|NCT01923311|81245050|FG000|Overall Study|Investigator's Discretion|1|||
27840429|NCT01923311|81245051|FG001|Overall Study|Investigator's Discretion|0|||
27840430|NCT01923311|81245050|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27891541|NCT03499899|81437306|FG002|Overall Study|Patient decision|1|||
27840431|NCT01923311|81245051|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27840432|NCT01923311|81245050|FG000|Overall Study|Withdrew Consent|1|||
27891542|NCT03499899|81437304|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
27891543|NCT03499899|81437305|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
27891544|NCT03499899|81437306|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
27891545|NCT03430895|81437307|FG000|Overall Study|Not Treated|2|||
27610747|NCT02247804|80415770|FG001|Treatment Period 3|Personal Reasons|3|||
27610748|NCT02247804|80415771|FG002|Treatment Period 3|Personal Reasons|2|||
27610749|NCT02247804|80415769|FG000|Treatment Period 3|Reason not Specified|2|||
27610750|NCT02247804|80415770|FG001|Treatment Period 3|Reason not Specified|1|||
27610751|NCT02247804|80415771|FG002|Treatment Period 3|Reason not Specified|3|||
27610752|NCT00562978|80415772|FG000|Overall Study|Patient had imaging dose only|1|||
27610753|NCT00562978|80415773|FG001|Overall Study|Patient had imaging dose only|11|||
27610754|NCT00936221|80415774|FG000|Overall Study|Withdrawal by Subject|1|||
27610755|NCT00936221|80415775|FG001|Overall Study|Withdrawal by Subject|1|||
27610756|NCT00068380|80415776|FG000|Overall Study|Withdrawal by Subject|3|||
27610757|NCT00068380|80415776|FG000|Overall Study|Adverse Event|2|||
27610758|NCT03358329|80415777|FG000|Overall Study|Lost to Follow-up|2|||
27610759|NCT03358329|80415777|FG000|Overall Study|Withdrawal by Subject|2|||
27610760|NCT02494921|80415779|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
27610761|NCT02494921|80415780|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
27610762|NCT02494921|80415781|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
27610763|NCT02494921|80415782|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
27610764|NCT02494921|80415783|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
27610765|NCT02494921|80415779|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
27610766|NCT02494921|80415780|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
27610767|NCT02494921|80415781|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
27610768|NCT02494921|80415782|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
27610769|NCT02494921|80415783|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
27610770|NCT02494921|80415779|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
27610771|NCT02494921|80415780|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
27610772|NCT02494921|80415781|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
27610773|NCT02494921|80415782|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
27610774|NCT02494921|80415783|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
27610775|NCT01051063|80415784|FG000|Overall Study|Death|2|||
27610776|NCT01051063|80415785|FG001|Overall Study|Death|2|||
27610777|NCT01051063|80415784|FG000|Overall Study|Withdrawal by Subject|1|||
27610778|NCT01051063|80415785|FG001|Overall Study|Withdrawal by Subject|1|||
27610779|NCT01051063|80415784|FG000|Overall Study|Termination of the study|5|||
27610780|NCT01051063|80415785|FG001|Overall Study|Termination of the study|0|||
27610781|NCT01051063|80415784|FG000|Overall Study|Moved from the study site area|1|||
27610782|NCT01051063|80415785|FG001|Overall Study|Moved from the study site area|0|||
27610783|NCT01051063|80415784|FG000|Overall Study|Other|1|||
27610784|NCT01051063|80415785|FG001|Overall Study|Other|0|||
27610785|NCT01051063|80415784|FG000|Overall Study|Lost to Follow-up|0|||
27610786|NCT01051063|80415785|FG001|Overall Study|Lost to Follow-up|1|||
27610787|NCT01984424|80415791|FG000|Overall Study|Withdrawal by Subject|3|||
27610788|NCT01984424|80415792|FG001|Overall Study|Withdrawal by Subject|5|||
27610789|NCT01984424|80415791|FG000|Overall Study|Sponsor Decision|0|||
27610790|NCT01984424|80415792|FG001|Overall Study|Sponsor Decision|1|||
27610791|NCT01984424|80415791|FG000|Overall Study|Lost to Follow-up|0|||
27610792|NCT01984424|80415792|FG001|Overall Study|Lost to Follow-up|1|||
27891546|NCT04083235|81437308|FG000|Overall Study|Death|252|||
27891547|NCT04083235|81437309|FG001|Overall Study|Death|277|||
27891548|NCT04083235|81437308|FG000|Overall Study|Withdrawal by Subject|13|||
27891549|NCT04083235|81437309|FG001|Overall Study|Withdrawal by Subject|17|||
27891550|NCT04083235|81437308|FG000|Overall Study|Lost to Follow-up|1|||
27891551|NCT04083235|81437309|FG001|Overall Study|Lost to Follow-up|1|||
27891552|NCT04083235|81437308|FG000|Overall Study|Does not meet entry criteria|1|||
27891553|NCT04083235|81437309|FG001|Overall Study|Does not meet entry criteria|0|||
27891554|NCT04083235|81437308|FG000|Overall Study|Did not receive treatment|13|||
27610793|NCT02998021|80415793|FG000|Overall Study|Withdrawal by Subject|3|||
27610794|NCT02998021|80415794|FG001|Overall Study|Withdrawal by Subject|1|||
27610795|NCT02998021|80415793|FG000|Overall Study|unsafe home|0|||
27891555|NCT04083235|81437309|FG001|Overall Study|Did not receive treatment|8|||
27610796|NCT02998021|80415794|FG001|Overall Study|unsafe home|1|||
27610797|NCT02291432|80415799|FG000|Overall Study|Withdrawal by Subject|2|||
27610798|NCT00545363|80415800|FG000|Overall Study|Adverse Event|6|||
27891556|NCT04083235|81437308|FG000|Overall Study|Ongoing at the time of DCO|44|||
27501553|NCT01502293|80030297|FG002|Overall Study|Physician Decision|1|||
27501554|NCT03361137|80030299|FG000|Overall Study|Reason not specified|1|||
27501555|NCT03361137|80030300|FG001|Overall Study|Reason not specified|0|||
27501556|NCT03361137|80030301|FG002|Overall Study|Reason not specified|0|||
27501557|NCT03361137|80030302|FG003|Overall Study|Reason not specified|0|||
27501558|NCT03361137|80030303|FG004|Overall Study|Reason not specified|0|||
27501559|NCT00107198|80030306|FG000|Overall Study|Lack of Efficacy|28|||
27501560|NCT00107198|80030306|FG000|Overall Study|Lost to Follow-up|12|||
27501561|NCT00107198|80030306|FG000|Overall Study|Protocol Violation|1|||
27501562|NCT00107198|80030306|FG000|Overall Study|Withdrawal by Subject|6|||
27501563|NCT00107198|80030306|FG000|Overall Study|Ineligible|5|||
27501564|NCT03598036|80030313|FG000|Overall Study|Withdrawal by Subject|1|||
27501565|NCT03598036|80030314|FG001|Overall Study|Withdrawal by Subject|0|||
27501566|NCT01280903|80030317|FG000|Overall Study|Lost to Follow-up|23|||
27501567|NCT01280903|80030318|FG001|Overall Study|Lost to Follow-up|16|||
27501568|NCT02783690|80030325|FG000|Overall Study|Withdrawal by Subject|3|||
27501569|NCT02783690|80030326|FG001|Overall Study|Withdrawal by Subject|3|||
27501570|NCT04973449|80030327|FG000|Overall Study|Withdrawal by Subject|3|||
27501571|NCT04973449|80030328|FG001|Overall Study|Withdrawal by Subject|3|||
27501572|NCT04973449|80030329|FG002|Overall Study|Withdrawal by Subject|2|||
27501573|NCT04973449|80030330|FG003|Overall Study|Withdrawal by Subject|5|||
27501574|NCT04973449|80030331|FG004|Overall Study|Withdrawal by Subject|5|||
27501575|NCT04973449|80030332|FG005|Overall Study|Withdrawal by Subject|4|||
27501576|NCT04973449|80030333|FG006|Overall Study|Withdrawal by Subject|7|||
27501577|NCT04973449|80030334|FG007|Overall Study|Withdrawal by Subject|5|||
27501578|NCT04973449|80030327|FG000|Overall Study|Lost to Follow-up|15|||
27501579|NCT04973449|80030328|FG001|Overall Study|Lost to Follow-up|16|||
27501580|NCT04973449|80030329|FG002|Overall Study|Lost to Follow-up|16|||
27501581|NCT04973449|80030330|FG003|Overall Study|Lost to Follow-up|13|||
27501582|NCT04973449|80030331|FG004|Overall Study|Lost to Follow-up|5|||
27840433|NCT01923311|81245051|FG001|Overall Study|Withdrew Consent|0|||
27840434|NCT01923311|81245050|FG000|Overall Study|Study Terminated by Sponsor|12|||
27840435|NCT01923311|81245051|FG001|Overall Study|Study Terminated by Sponsor|0|||
27958598|NCT01791517|81680058|FG000|Phase II|Lack of Efficacy|0|||
27501583|NCT04973449|80030332|FG005|Overall Study|Lost to Follow-up|6|||
27501584|NCT04973449|80030333|FG006|Overall Study|Lost to Follow-up|10|||
27501585|NCT04973449|80030334|FG007|Overall Study|Lost to Follow-up|6|||
27840436|NCT01207492|81245076|FG000|Overall Study|Still on study|1|||
27840437|NCT01207492|81245076|FG000|Overall Study|Withdrawal by Subject|9|||
27840438|NCT01207492|81245076|FG000|Overall Study|Physician Decision|1|||
27840439|NCT01207492|81245076|FG000|Overall Study|Progressive disease|3|||
27840440|NCT01207492|81245076|FG000|Overall Study|Toxicity|1|||
27840441|NCT01808248|81245077|FG000|Overall Study|Lack of Efficacy|3|||
27840442|NCT01808248|81245077|FG000|Overall Study|Withdrawal by Subject|1|||
27840443|NCT01808248|81245077|FG000|Overall Study|Lost to Follow-up|1|||
27840444|NCT05103657|81245082|FG000|Overall Study|Other reasons than listed|9|||
27840445|NCT05103657|81245083|FG001|Overall Study|Other reasons than listed|8|||
27840446|NCT05103657|81245082|FG000|Overall Study|Protocol deviation|2|||
27840447|NCT05103657|81245083|FG001|Overall Study|Protocol deviation|2|||
27840448|NCT05103657|81245082|FG000|Overall Study|No reason available|5|||
27840449|NCT05103657|81245083|FG001|Overall Study|No reason available|4|||
27840450|NCT05103657|81245082|FG000|Overall Study|Burden of study procedures|3|||
27840451|NCT05103657|81245083|FG001|Overall Study|Burden of study procedures|1|||
27501586|NCT04973449|80030327|FG000|Overall Study|Death|1|||
27501587|NCT04973449|80030328|FG001|Overall Study|Death|0|||
27501588|NCT04973449|80030329|FG002|Overall Study|Death|0|||
27501589|NCT04973449|80030330|FG003|Overall Study|Death|0|||
27501590|NCT04973449|80030331|FG004|Overall Study|Death|0|||
27501591|NCT04973449|80030332|FG005|Overall Study|Death|1|||
27501592|NCT04973449|80030333|FG006|Overall Study|Death|0|||
27501593|NCT04973449|80030334|FG007|Overall Study|Death|0|||
27501594|NCT04973449|80030327|FG000|Overall Study|Other|1|||
27501595|NCT04973449|80030328|FG001|Overall Study|Other|1|||
27501596|NCT04973449|80030329|FG002|Overall Study|Other|2|||
27501597|NCT04973449|80030330|FG003|Overall Study|Other|1|||
27501598|NCT04973449|80030331|FG004|Overall Study|Other|4|||
27501599|NCT04973449|80030332|FG005|Overall Study|Other|0|||
27501600|NCT04973449|80030333|FG006|Overall Study|Other|2|||
27501601|NCT04973449|80030334|FG007|Overall Study|Other|2|||
27501602|NCT04025710|80030335|FG000|Overall Study|Death|3|||
27501603|NCT04025710|80030335|FG000|Overall Study|Lost to Follow-up|5|||
27501604|NCT04025710|80030335|FG000|Overall Study|Withdrawal by Subject|1|||
27501605|NCT04025710|80030335|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
27501606|NCT04025710|80030335|FG000|Overall Study|Drop-out according to protocol|34|||
27501607|NCT05523089|80030343|FG000|Overall Study|Withdrawal by Subject|1|||
27501608|NCT05523089|80030344|FG001|Overall Study|Withdrawal by Subject|0|||
27501609|NCT05523089|80030345|FG002|Overall Study|Withdrawal by Subject|0|||
27501610|NCT05523089|80030343|FG000|Overall Study|Lost to Follow-up|1|||
27501611|NCT05523089|80030344|FG001|Overall Study|Lost to Follow-up|0|||
27501612|NCT05523089|80030345|FG002|Overall Study|Lost to Follow-up|0|||
27501613|NCT01838395|80030348|FG000|Overall Study|Withdrawal by Subject|0|||
27501614|NCT01838395|80030349|FG001|Overall Study|Withdrawal by Subject|0|||
27501615|NCT01838395|80030350|FG002|Overall Study|Withdrawal by Subject|0|||
27501616|NCT01838395|80030351|FG003|Overall Study|Withdrawal by Subject|0|||
27501617|NCT01838395|80030352|FG004|Overall Study|Withdrawal by Subject|1|||
27501618|NCT01838395|80030353|FG005|Overall Study|Withdrawal by Subject|0|||
27501619|NCT01838395|80030348|FG000|Overall Study|Death|0|||
27501620|NCT01838395|80030349|FG001|Overall Study|Death|0|||
27501621|NCT01838395|80030350|FG002|Overall Study|Death|1|||
27501622|NCT01838395|80030351|FG003|Overall Study|Death|0|||
27501623|NCT01838395|80030352|FG004|Overall Study|Death|0|||
27501624|NCT01838395|80030353|FG005|Overall Study|Death|0|||
27501625|NCT01838395|80030348|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
27501626|NCT01838395|80030349|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
27501627|NCT01838395|80030350|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
27501628|NCT01838395|80030351|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
27501629|NCT01838395|80030352|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
27501630|NCT01838395|80030353|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
27501631|NCT04583618|80030354|FG000|Overall Study|Adverse Event|0|||
27501632|NCT04583618|80030355|FG001|Overall Study|Adverse Event|0|||
27501633|NCT04583618|80030356|FG002|Overall Study|Adverse Event|1|||
27501634|NCT04583618|80030357|FG003|Overall Study|Adverse Event|0|||
27501635|NCT04583618|80030358|FG004|Overall Study|Adverse Event|0|||
27501636|NCT04583618|80030354|FG000|Overall Study|Protocol deviation|1|||
27501637|NCT04583618|80030355|FG001|Overall Study|Protocol deviation|1|||
27501638|NCT04583618|80030356|FG002|Overall Study|Protocol deviation|1|||
27501639|NCT04583618|80030357|FG003|Overall Study|Protocol deviation|0|||
27501640|NCT04583618|80030358|FG004|Overall Study|Protocol deviation|0|||
27501641|NCT04583618|80030354|FG000|Overall Study|Withdrawal by Subject|2|||
27501642|NCT04583618|80030355|FG001|Overall Study|Withdrawal by Subject|1|||
27501643|NCT04583618|80030356|FG002|Overall Study|Withdrawal by Subject|3|||
27501644|NCT04583618|80030357|FG003|Overall Study|Withdrawal by Subject|1|||
27501645|NCT04583618|80030358|FG004|Overall Study|Withdrawal by Subject|1|||
27501646|NCT04583618|80030354|FG000|Overall Study|Lost to Follow-up|0|||
27501647|NCT04583618|80030355|FG001|Overall Study|Lost to Follow-up|1|||
27501648|NCT04583618|80030356|FG002|Overall Study|Lost to Follow-up|3|||
27501649|NCT04583618|80030357|FG003|Overall Study|Lost to Follow-up|1|||
27610799|NCT00545363|80415801|FG001|Overall Study|Adverse Event|7|||
27610800|NCT00545363|80415800|FG000|Overall Study|Withdrawal by Subject|6|||
27610801|NCT00545363|80415801|FG001|Overall Study|Withdrawal by Subject|5|||
27610802|NCT00545363|80415800|FG000|Overall Study|Non-compliance|3|||
27721843|NCT02508194|80815279|FG000|Overall Study|Principal Investigator Decision|1|||
27840452|NCT05103657|81245082|FG000|Overall Study|Perceived lack of efficacy|1|||
27840453|NCT05103657|81245083|FG001|Overall Study|Perceived lack of efficacy|1|||
27501650|NCT04583618|80030358|FG004|Overall Study|Lost to Follow-up|1|||
27501651|NCT04272242|80030366|FG000|Overall Study|Withdrawal by Subject|3|||
27501652|NCT04272242|80030366|FG000|Overall Study|Lost to Follow-up|1|||
27501653|NCT04272242|80030366|FG000|Overall Study|Adverse Event|1|||
27501654|NCT04659044|80030367|FG000|Induction|Physician Decision|1|||
27501655|NCT04659044|80030367|FG000|Induction|Adverse Event|2|||
27610803|NCT00545363|80415801|FG001|Overall Study|Non-compliance|1|||
27610804|NCT00545363|80415800|FG000|Overall Study|Did not meet entry criteria|1|||
27610805|NCT00545363|80415801|FG001|Overall Study|Did not meet entry criteria|1|||
27610806|NCT00545363|80415800|FG000|Overall Study|Lost to Follow-up|2|||
27610807|NCT00545363|80415801|FG001|Overall Study|Lost to Follow-up|0|||
27610808|NCT00545363|80415800|FG000|Overall Study|Other|1|||
27610809|NCT00545363|80415801|FG001|Overall Study|Other|1|||
27501656|NCT04905134|80030373|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
27501657|NCT04905134|80030373|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
27501658|NCT03317405|80030374|FG000|Overall Study|Withdrawal by Subject|1|||
27501659|NCT03317405|80030375|FG001|Overall Study|Withdrawal by Subject|0|||
27501660|NCT03317405|80030376|FG002|Overall Study|Withdrawal by Subject|0|||
27501661|NCT03317405|80030374|FG000|Overall Study|Physician Decision|0|||
27501662|NCT03317405|80030375|FG001|Overall Study|Physician Decision|0|||
27501663|NCT03317405|80030376|FG002|Overall Study|Physician Decision|1|||
27501664|NCT03317405|80030374|FG000|Overall Study|Surgery Rescheduled|0|||
27501665|NCT03317405|80030375|FG001|Overall Study|Surgery Rescheduled|1|||
27501666|NCT03317405|80030376|FG002|Overall Study|Surgery Rescheduled|0|||
27501667|NCT01652235|80030377|FG000|Overall Study|Death|9|||
27501668|NCT01652235|80030377|FG000|Overall Study|Lost to Follow-up|5|||
27501669|NCT01652235|80030377|FG000|Overall Study|Withdrawal by Subject|2|||
27501670|NCT01473134|80030378|FG000|Overall Study|Lost to Follow-up|21|||
27501671|NCT01473134|80030379|FG001|Overall Study|Lost to Follow-up|13|||
27501672|NCT01473134|80030378|FG000|Overall Study|Protocol Violation|32|||
27501673|NCT01473134|80030379|FG001|Overall Study|Protocol Violation|19|||
27501674|NCT01473134|80030378|FG000|Overall Study|Withdrawal by Subject|1|||
27501675|NCT01473134|80030379|FG001|Overall Study|Withdrawal by Subject|2|||
27501676|NCT01473134|80030378|FG000|Overall Study|Death|0|||
27501677|NCT01473134|80030379|FG001|Overall Study|Death|1|||
27501678|NCT01473134|80030378|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
27501679|NCT01473134|80030379|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
27501680|NCT04629508|80030380|FG000|Overall Study|Adverse Event|1|||
27501681|NCT04629508|80030380|FG000|Overall Study|Death|2|||
27501682|NCT04629508|80030380|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
27501683|NCT01864018|80030381|FG000|Overall Study|Ineligible|3|||
27501684|NCT01864018|80030382|FG001|Overall Study|Ineligible|1|||
27501685|NCT03675126|80030383|FG000|Overall Study|Study Terminated by Sponsor|9|||
27501686|NCT03675126|80030383|FG000|Overall Study|Death|2|||
27501687|NCT03675126|80030383|FG000|Overall Study|Withdrawal by Subject|4|||
27501688|NCT03453164|80030384|FG000|Overall Study|Lack of Efficacy|16|||
27501689|NCT03453164|80030384|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
27501690|NCT02002598|80030385|FG000|Dose Level 1|Withdrawal by Subject|1|||
27501691|NCT02002598|80030386|FG001|Dose Level 1|Withdrawal by Subject|0|||
27501692|NCT02002598|80030387|FG002|Dose Level 1|Withdrawal by Subject|0|||
27501693|NCT02002598|80030388|FG003|Dose Level 1|Withdrawal by Subject|0|||
27501694|NCT02002598|80030389|FG004|Dose Level 1|Withdrawal by Subject|0|||
27501695|NCT00400179|80030390|FG000|Overall Study|Adverse Event|2|||
27501696|NCT00400179|80030391|FG001|Overall Study|Adverse Event|2|||
27501697|NCT00400179|80030390|FG000|Overall Study|Death|1|||
27501698|NCT00400179|80030391|FG001|Overall Study|Death|2|||
27501699|NCT00400179|80030390|FG000|Overall Study|Withdrew Consent|1|||
27501700|NCT00400179|80030391|FG001|Overall Study|Withdrew Consent|5|||
27501701|NCT00400179|80030390|FG000|Overall Study|Disease progression|1|||
27501702|NCT00400179|80030391|FG001|Overall Study|Disease progression|1|||
27501703|NCT00400179|80030390|FG000|Overall Study|Intercurrent illness|0|||
27501704|NCT00400179|80030391|FG001|Overall Study|Intercurrent illness|1|||
27501705|NCT00400179|80030390|FG000|Overall Study|Investigator judgment|0|||
27501706|NCT00400179|80030391|FG001|Overall Study|Investigator judgment|1|||
27501707|NCT00400179|80030390|FG000|Overall Study|Randomization error/patient ineligible|1|||
27501708|NCT00400179|80030391|FG001|Overall Study|Randomization error/patient ineligible|6|||
27501709|NCT04825678|80030392|FG000|Overall Study|Decision by Sponsor|2|||
27501710|NCT04825678|80030393|FG001|Overall Study|Decision by Sponsor|3|||
27501711|NCT04825678|80030392|FG000|Overall Study|Withdrawal of Consent From Study|7|||
27501712|NCT04825678|80030393|FG001|Overall Study|Withdrawal of Consent From Study|9|||
27501713|NCT04825678|80030392|FG000|Overall Study|Lost to Follow-up|3|||
27501714|NCT04825678|80030393|FG001|Overall Study|Lost to Follow-up|4|||
27501715|NCT04825678|80030392|FG000|Overall Study|Never Received Investigational Product|1|||
27501716|NCT04825678|80030393|FG001|Overall Study|Never Received Investigational Product|1|||
27501717|NCT00870740|80030394|FG000|Overall Study|Adverse Event|2|||
27501718|NCT00870740|80030395|FG001|Overall Study|Adverse Event|1|||
27610810|NCT02340520|80415802|FG000|Overall Study|Lost to Follow-up|1|||
27891557|NCT04083235|81437309|FG001|Overall Study|Ongoing at the time of DCO|7|||
27891558|NCT01084668|81437315|FG000|Overall Study|Lack of Efficacy|5|||
27501719|NCT00870740|80030396|FG002|Overall Study|Adverse Event|3|||
27501720|NCT00870740|80030397|FG003|Overall Study|Adverse Event|2|||
27501721|NCT00870740|80030398|FG004|Overall Study|Adverse Event|1|||
27891559|NCT01084668|81437315|FG000|Overall Study|Withdrawal by Subject|2|||
27501722|NCT00870740|80030399|FG005|Overall Study|Adverse Event|6|||
27501723|NCT00870740|80030394|FG000|Overall Study|Consent Withdrawn|6|||
27501724|NCT00870740|80030395|FG001|Overall Study|Consent Withdrawn|3|||
27501725|NCT00870740|80030396|FG002|Overall Study|Consent Withdrawn|4|||
27501726|NCT00870740|80030397|FG003|Overall Study|Consent Withdrawn|6|||
27501727|NCT00870740|80030398|FG004|Overall Study|Consent Withdrawn|6|||
27501728|NCT00870740|80030399|FG005|Overall Study|Consent Withdrawn|5|||
27501729|NCT00870740|80030394|FG000|Overall Study|Investigator Decision|2|||
27501730|NCT00870740|80030395|FG001|Overall Study|Investigator Decision|0|||
27501731|NCT00870740|80030396|FG002|Overall Study|Investigator Decision|1|||
27501732|NCT00870740|80030397|FG003|Overall Study|Investigator Decision|0|||
27501733|NCT00870740|80030398|FG004|Overall Study|Investigator Decision|0|||
27501734|NCT00870740|80030399|FG005|Overall Study|Investigator Decision|0|||
27501735|NCT00870740|80030394|FG000|Overall Study|Subject Non-compliance|0|||
27501736|NCT00870740|80030395|FG001|Overall Study|Subject Non-compliance|0|||
27501737|NCT00870740|80030396|FG002|Overall Study|Subject Non-compliance|0|||
27501738|NCT00870740|80030397|FG003|Overall Study|Subject Non-compliance|0|||
27610811|NCT02340520|80415802|FG000|Overall Study|Patient did not take drug as specified|1|||
27610812|NCT02340520|80415802|FG000|Overall Study|Withdrawal by Subject|1|||
27610813|NCT00152971|80415804|FG000|Overall Study|Adverse Event|12|||
27610814|NCT00152971|80415805|FG001|Overall Study|Adverse Event|10|||
27610815|NCT00152971|80415806|FG002|Overall Study|Adverse Event|9|||
27501739|NCT00870740|80030398|FG004|Overall Study|Subject Non-compliance|0|||
27501740|NCT00870740|80030399|FG005|Overall Study|Subject Non-compliance|1|||
27501741|NCT00870740|80030394|FG000|Overall Study|Death|0|||
27501742|NCT00870740|80030395|FG001|Overall Study|Death|0|||
27610816|NCT00152971|80415804|FG000|Overall Study|Protocol Violation|10|||
27610817|NCT00152971|80415805|FG001|Overall Study|Protocol Violation|11|||
27610818|NCT00152971|80415806|FG002|Overall Study|Protocol Violation|8|||
27610819|NCT00152971|80415804|FG000|Overall Study|Lost to Follow-up|17|||
27610820|NCT00152971|80415805|FG001|Overall Study|Lost to Follow-up|14|||
27610821|NCT00152971|80415806|FG002|Overall Study|Lost to Follow-up|13|||
27610822|NCT00152971|80415804|FG000|Overall Study|Withdrawal by Subject|9|||
27610823|NCT00152971|80415805|FG001|Overall Study|Withdrawal by Subject|8|||
27610824|NCT00152971|80415806|FG002|Overall Study|Withdrawal by Subject|14|||
27610825|NCT00152971|80415804|FG000|Overall Study|Other|3|||
27610826|NCT00152971|80415805|FG001|Overall Study|Other|5|||
27610827|NCT00152971|80415806|FG002|Overall Study|Other|5|||
27610828|NCT00152971|80415804|FG000|Treatment|Adverse Event|49|||
27610829|NCT00152971|80415805|FG001|Treatment|Adverse Event|40|||
27610830|NCT00152971|80415806|FG002|Treatment|Adverse Event|54|||
27610831|NCT00152971|80415804|FG000|Treatment|Protocol Violation|8|||
27610832|NCT00152971|80415805|FG001|Treatment|Protocol Violation|6|||
27610833|NCT00152971|80415806|FG002|Treatment|Protocol Violation|10|||
27610834|NCT00152971|80415804|FG000|Treatment|Lost to Follow-up|1|||
27610835|NCT00152971|80415805|FG001|Treatment|Lost to Follow-up|2|||
27610836|NCT00152971|80415806|FG002|Treatment|Lost to Follow-up|1|||
27610837|NCT00152971|80415804|FG000|Treatment|Withdrawal by Subject|4|||
27610838|NCT00152971|80415805|FG001|Treatment|Withdrawal by Subject|4|||
27610839|NCT00152971|80415806|FG002|Treatment|Withdrawal by Subject|5|||
27610840|NCT00152971|80415804|FG000|Treatment|Other|9|||
27610841|NCT00152971|80415805|FG001|Treatment|Other|11|||
27610842|NCT00152971|80415806|FG002|Treatment|Other|10|||
27610843|NCT00734214|80415807|FG000|Overall Study|Withdrawal by Subject|3|||
27610844|NCT00734214|80415808|FG001|Overall Study|Withdrawal by Subject|4|||
27501743|NCT00870740|80030396|FG002|Overall Study|Death|0|||
27501744|NCT00870740|80030397|FG003|Overall Study|Death|0|||
27501745|NCT00870740|80030398|FG004|Overall Study|Death|1|||
27501746|NCT00870740|80030399|FG005|Overall Study|Death|0|||
27501747|NCT00870740|80030394|FG000|Overall Study|Other|2|||
27501748|NCT00870740|80030395|FG001|Overall Study|Other|5|||
27610845|NCT00734214|80415807|FG000|Overall Study|MD withdrawal|1|||
27610846|NCT00734214|80415808|FG001|Overall Study|MD withdrawal|0|||
27610847|NCT01863043|80415814|FG000|Overall Study|Death|6|||
27610848|NCT01863043|80415815|FG001|Overall Study|Death|1|||
27610849|NCT01863043|80415814|FG000|Overall Study|Withdrawal by Subject|0|||
27610850|NCT01863043|80415815|FG001|Overall Study|Withdrawal by Subject|2|||
27501749|NCT00870740|80030396|FG002|Overall Study|Other|2|||
27501750|NCT00870740|80030397|FG003|Overall Study|Other|4|||
27501751|NCT00870740|80030398|FG004|Overall Study|Other|3|||
27501752|NCT00870740|80030399|FG005|Overall Study|Other|5|||
27501753|NCT03668873|80030403|FG000|Overall Study|Lost to Follow-up|6|||
27501754|NCT03668873|80030404|FG001|Overall Study|Lost to Follow-up|3|||
27501755|NCT04532528|80030405|FG000|Overall Study|Adverse Event|12|||
27610851|NCT01863043|80415814|FG000|Overall Study|Adverse Event|7|||
27610852|NCT01863043|80415815|FG001|Overall Study|Adverse Event|8|||
27610853|NCT01863043|80415814|FG000|Overall Study|exclusion criteria found after enrollment|0|||
27610854|NCT01863043|80415815|FG001|Overall Study|exclusion criteria found after enrollment|1|||
27501756|NCT04532528|80030406|FG001|Overall Study|Adverse Event|17|||
27610855|NCT01112514|80415816|FG000|Overall Study|Lost to Follow-up|1|||
27610856|NCT01960790|80415817|FG000|Overall Study|Survey forms could not be recovered|3|||
27501757|NCT04532528|80030405|FG000|Overall Study|Withdrawal of consent|16|||
27501758|NCT04532528|80030406|FG001|Overall Study|Withdrawal of consent|17|||
27501759|NCT04532528|80030405|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
27610857|NCT01960790|80415817|FG000|Overall Study|Treat with Humira outside survey period|3|||
27610858|NCT01960790|80415817|FG000|Overall Study|Transferred to another hospital|4|||
27610859|NCT01960790|80415817|FG000|Overall Study|Unevaluable for safety|1|||
27610860|NCT05284019|80415818|FG000|Overall Study|Study terminated|2|||
27610861|NCT05284019|80415819|FG001|Overall Study|Study terminated|2|||
27610862|NCT05284019|80415820|FG002|Overall Study|Study terminated|2|||
27610863|NCT05284019|80415821|FG003|Overall Study|Study terminated|5|||
27610864|NCT05284019|80415822|FG004|Overall Study|Study terminated|15|||
27610865|NCT05284019|80415818|FG000|Overall Study|Withdrawal by Subject|0|||
27610866|NCT05284019|80415819|FG001|Overall Study|Withdrawal by Subject|0|||
27610867|NCT05284019|80415820|FG002|Overall Study|Withdrawal by Subject|0|||
27610868|NCT05284019|80415821|FG003|Overall Study|Withdrawal by Subject|1|||
27610869|NCT05284019|80415822|FG004|Overall Study|Withdrawal by Subject|1|||
27610870|NCT05284019|80415818|FG000|Overall Study|Lost to Follow-up|1|||
27610871|NCT05284019|80415819|FG001|Overall Study|Lost to Follow-up|0|||
27610872|NCT05284019|80415820|FG002|Overall Study|Lost to Follow-up|0|||
27610873|NCT05284019|80415821|FG003|Overall Study|Lost to Follow-up|2|||
27610874|NCT05284019|80415822|FG004|Overall Study|Lost to Follow-up|1|||
27610875|NCT03734991|80415826|FG000|Overall Study|Adverse Event|4|||
27610876|NCT03734991|80415827|FG001|Overall Study|Adverse Event|0|||
27610877|NCT03734991|80415826|FG000|Overall Study|Lost to Follow-up|4|||
27610878|NCT03734991|80415827|FG001|Overall Study|Lost to Follow-up|0|||
27610879|NCT03734991|80415826|FG000|Overall Study|Physician Decision|0|||
27840454|NCT05103657|81245082|FG000|Overall Study|Adverse Event|6|||
27501760|NCT04532528|80030406|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
27501761|NCT04532528|80030405|FG000|Overall Study|Lost to Follow-up|69|||
27501762|NCT04532528|80030406|FG001|Overall Study|Lost to Follow-up|68|||
27501763|NCT04532528|80030405|FG000|Overall Study|Administrative problems|12|||
27501764|NCT04532528|80030406|FG001|Overall Study|Administrative problems|14|||
27501765|NCT04532528|80030405|FG000|Overall Study|Death|3|||
27501766|NCT04532528|80030406|FG001|Overall Study|Death|3|||
27501767|NCT04532528|80030405|FG000|Overall Study|Other|38|||
27501768|NCT04532528|80030406|FG001|Overall Study|Other|46|||
27501769|NCT01527149|80030413|FG000|Overall Study|Death|2|||
27501770|NCT00537394|80030417|FG000|First Year of Follow-up|Death|7|||
27501771|NCT00537394|80030418|FG001|First Year of Follow-up|Death|0|||
27501772|NCT00537394|80030419|FG002|First Year of Follow-up|Death|0|||
27501773|NCT00537394|80030417|FG000|First Year of Follow-up|Severe debilitation|1|||
27501774|NCT00537394|80030418|FG001|First Year of Follow-up|Severe debilitation|0|||
27501775|NCT00537394|80030419|FG002|First Year of Follow-up|Severe debilitation|1|||
27501776|NCT00537394|80030417|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
27501777|NCT00537394|80030418|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
27501778|NCT00537394|80030419|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
27501779|NCT00537394|80030417|FG000|First Year of Follow-up|Lost to Follow-up|1|||
27501780|NCT00537394|80030418|FG001|First Year of Follow-up|Lost to Follow-up|5|||
27501781|NCT00537394|80030419|FG002|First Year of Follow-up|Lost to Follow-up|1|||
27501782|NCT00537394|80030417|FG000|2nd Year of Follow-up|Death|4|||
27501783|NCT00537394|80030418|FG001|2nd Year of Follow-up|Death|1|||
27501784|NCT00537394|80030419|FG002|2nd Year of Follow-up|Death|2|||
27501785|NCT00537394|80030417|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
27501786|NCT00537394|80030418|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
27501787|NCT00537394|80030419|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
27501788|NCT00537394|80030417|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
27501789|NCT00537394|80030418|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
27501790|NCT00537394|80030419|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
27501791|NCT00537394|80030417|FG000|2nd Year of Follow-up|Clinic site closure|1|||
27501792|NCT00537394|80030418|FG001|2nd Year of Follow-up|Clinic site closure|0|||
27501793|NCT00537394|80030419|FG002|2nd Year of Follow-up|Clinic site closure|0|||
27501794|NCT01772472|80030420|FG000|Overall Study|Death|56|||
27501795|NCT01772472|80030421|FG001|Overall Study|Death|42|||
27610880|NCT03734991|80415827|FG001|Overall Study|Physician Decision|1|||
27610881|NCT03734991|80415826|FG000|Overall Study|Pregnancy|1|||
27610882|NCT03734991|80415827|FG001|Overall Study|Pregnancy|0|||
27610883|NCT03734991|80415826|FG000|Overall Study|Withdrawal by Subject|6|||
27501796|NCT01772472|80030420|FG000|Overall Study|Physician Decision|1|||
27501797|NCT01772472|80030421|FG001|Overall Study|Physician Decision|3|||
27610884|NCT03734991|80415827|FG001|Overall Study|Withdrawal by Subject|3|||
27610885|NCT03734991|80415826|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
27501798|NCT01772472|80030420|FG000|Overall Study|Other|5|||
27501799|NCT01772472|80030421|FG001|Overall Study|Other|5|||
27501800|NCT01772472|80030420|FG000|Overall Study|Lost to Follow-up|12|||
27501801|NCT01772472|80030421|FG001|Overall Study|Lost to Follow-up|8|||
27501802|NCT01772472|80030420|FG000|Overall Study|Withdrawal by Subject|72|||
27610886|NCT03734991|80415827|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
27610887|NCT03734991|80415826|FG000|Overall Study|Other|2|||
27610888|NCT03734991|80415827|FG001|Overall Study|Other|2|||
27891560|NCT01084668|81437315|FG000|Overall Study|Pregnancy|1|||
27891561|NCT01084668|81437315|FG000|Overall Study|Non-compliance|1|||
27891562|NCT03193801|81437316|FG000|Overall Study|Physician Decision|2|||
27891563|NCT03193801|81437316|FG000|Overall Study|Withdrawal by Subject|1|||
27891564|NCT04778059|81437317|FG000|Overall Study|Death|2|||
27891565|NCT04778059|81437318|FG001|Overall Study|Death|2|||
27891566|NCT04778059|81437319|FG002|Overall Study|Death|1|||
27891567|NCT04778059|81437320|FG003|Overall Study|Death|1|||
27891568|NCT04778059|81437321|FG004|Overall Study|Death|1|||
27891569|NCT04778059|81437317|FG000|Overall Study|Lost to Follow-up|0|||
27891570|NCT04778059|81437318|FG001|Overall Study|Lost to Follow-up|0|||
27891571|NCT04778059|81437319|FG002|Overall Study|Lost to Follow-up|0|||
27891572|NCT04778059|81437320|FG003|Overall Study|Lost to Follow-up|0|||
27891573|NCT04778059|81437321|FG004|Overall Study|Lost to Follow-up|1|||
27891574|NCT04778059|81437317|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
27891575|NCT04778059|81437318|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
27891576|NCT04778059|81437319|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
27891577|NCT04778059|81437320|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
27891578|NCT04778059|81437321|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
27891579|NCT00514904|81437322|FG000|Overall Study|Withdrawal by Subject|3|||
27891580|NCT00514904|81437323|FG001|Overall Study|Withdrawal by Subject|2|||
27610889|NCT00675506|80415828|FG000|Overall Study|Lost to Follow-up|1|||
27610890|NCT00675506|80415829|FG001|Overall Study|Lost to Follow-up|5|||
27610891|NCT00675506|80415828|FG000|Overall Study|Lost interest|3|||
27610892|NCT00675506|80415829|FG001|Overall Study|Lost interest|5|||
27610893|NCT00675506|80415828|FG000|Overall Study|Elevated fasting glucose|2|||
27501803|NCT01772472|80030421|FG001|Overall Study|Withdrawal by Subject|50|||
27501804|NCT01772472|80030420|FG000|Overall Study|Ongoing|597|||
27501805|NCT01772472|80030421|FG001|Overall Study|Ongoing|635|||
27501806|NCT04613362|80030422|FG000|3 Month Follow-up|Lost to Follow-up|1|||
27501807|NCT04613362|80030423|FG001|3 Month Follow-up|Lost to Follow-up|2|||
27501808|NCT04613362|80030422|FG000|6 Month Follow-up|Lost to Follow-up|0|||
27501809|NCT04613362|80030423|FG001|6 Month Follow-up|Lost to Follow-up|1|||
27610894|NCT00675506|80415829|FG001|Overall Study|Elevated fasting glucose|1|||
27610895|NCT00675506|80415828|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
27610896|NCT00675506|80415829|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
27610897|NCT00675506|80415828|FG000|Overall Study|Elevated IGF-1|2|||
27610898|NCT00675506|80415829|FG001|Overall Study|Elevated IGF-1|0|||
27610899|NCT00675506|80415828|FG000|Overall Study|Hypersensitivity Reaction|1|||
27501810|NCT02060721|80030424|FG000|Overall Study|Lost to Follow-up|1|||
27610900|NCT00675506|80415829|FG001|Overall Study|Hypersensitivity Reaction|0|||
27501811|NCT02060721|80030424|FG000|Overall Study|Physician Decision|2|||
27610901|NCT00675506|80415828|FG000|Overall Study|Disclosed history of cancer|1|||
27610902|NCT00675506|80415829|FG001|Overall Study|Disclosed history of cancer|0|||
27610903|NCT00675506|80415828|FG000|Overall Study|Declined participation|1|||
27610904|NCT00675506|80415829|FG001|Overall Study|Declined participation|0|||
27501812|NCT02060721|80030424|FG000|Overall Study|Death|14|||
27501813|NCT02060721|80030424|FG000|Overall Study|Withdrawal by Subject|2|||
27610905|NCT00675506|80415828|FG000|Overall Study|Schedule conflict|0|||
27891581|NCT00514904|81437322|FG000|Overall Study|Lost to Follow-up|21|||
27891582|NCT00514904|81437323|FG001|Overall Study|Lost to Follow-up|3|||
27891583|NCT00791661|81437329|FG000|7 Day Wash-out|Adverse Event|0|||
27891584|NCT00791661|81437330|FG001|7 Day Wash-out|Adverse Event|0|||
27891585|NCT00791661|81437331|FG002|7 Day Wash-out|Adverse Event|1|||
27501814|NCT02060721|80030424|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
27501815|NCT01648751|80030425|FG000|Overall Study|Withdrawal by Subject|2|||
27501816|NCT01648751|80030426|FG001|Overall Study|Withdrawal by Subject|3|||
27501817|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
27501818|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
27501819|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
27501820|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
27721844|NCT02508194|80815280|FG001|Overall Study|Principal Investigator Decision|2|||
27721845|NCT00704964|80815281|FG000|Overall Study|Not completed on time|328|||
27721846|NCT01486199|80815286|FG000|Two Year Period Between Study Days|Physician Decision|1|||
27721847|NCT01486199|80815287|FG001|Two Year Period Between Study Days|Physician Decision|0|||
27721848|NCT02049944|80815288|FG000|Overall Study|Protocol Violation|2|||
27721849|NCT01783678|80815291|FG000|Overall Study|Randomized but Not Treated|0|||
27721850|NCT01783678|80815292|FG001|Overall Study|Randomized but Not Treated|0|||
27721851|NCT01783678|80815293|FG002|Overall Study|Randomized but Not Treated|0|||
27721852|NCT01783678|80815294|FG003|Overall Study|Randomized but Not Treated|1|||
27721853|NCT01783678|80815295|FG004|Overall Study|Randomized but Not Treated|0|||
27721854|NCT01783678|80815296|FG005|Overall Study|Randomized but Not Treated|0|||
27721855|NCT01783678|80815291|FG000|Overall Study|Lack of Efficacy|1|||
27721856|NCT01783678|80815292|FG001|Overall Study|Lack of Efficacy|13|||
27721857|NCT01783678|80815293|FG002|Overall Study|Lack of Efficacy|1|||
27721858|NCT01783678|80815294|FG003|Overall Study|Lack of Efficacy|3|||
27721859|NCT01783678|80815295|FG004|Overall Study|Lack of Efficacy|6|||
27721860|NCT01783678|80815296|FG005|Overall Study|Lack of Efficacy|5|||
27721861|NCT01783678|80815291|FG000|Overall Study|Lost to Follow-up|0|||
27721862|NCT01783678|80815292|FG001|Overall Study|Lost to Follow-up|4|||
27721863|NCT01783678|80815293|FG002|Overall Study|Lost to Follow-up|0|||
27721864|NCT01783678|80815294|FG003|Overall Study|Lost to Follow-up|2|||
27721865|NCT01783678|80815295|FG004|Overall Study|Lost to Follow-up|1|||
27721866|NCT01783678|80815296|FG005|Overall Study|Lost to Follow-up|0|||
27721867|NCT01783678|80815291|FG000|Overall Study|Withdrew Consent|1|||
27721868|NCT01783678|80815292|FG001|Overall Study|Withdrew Consent|1|||
27721869|NCT01783678|80815293|FG002|Overall Study|Withdrew Consent|0|||
27721870|NCT01783678|80815294|FG003|Overall Study|Withdrew Consent|2|||
27721871|NCT01783678|80815295|FG004|Overall Study|Withdrew Consent|0|||
27721872|NCT01783678|80815296|FG005|Overall Study|Withdrew Consent|0|||
27721873|NCT01791855|80815298|FG000|Overall Study|Adverse Event|0|||
27721874|NCT01791855|80815299|FG001|Overall Study|Adverse Event|0|||
27721875|NCT01791855|80815300|FG002|Overall Study|Adverse Event|0|||
27721876|NCT01791855|80815301|FG003|Overall Study|Adverse Event|1|||
27721877|NCT01791855|80815298|FG000|Overall Study|Randomized, not treated|0|||
27721878|NCT01791855|80815299|FG001|Overall Study|Randomized, not treated|1|||
27721879|NCT01791855|80815300|FG002|Overall Study|Randomized, not treated|0|||
27721880|NCT01791855|80815301|FG003|Overall Study|Randomized, not treated|0|||
27721881|NCT02319044|80815303|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
27721882|NCT02319044|80815304|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
27721883|NCT02319044|80815305|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
27721884|NCT02319044|80815303|FG000|Overall Study|Withdrawal by Subject|3|||
27721885|NCT02319044|80815304|FG001|Overall Study|Withdrawal by Subject|3|||
27721886|NCT02319044|80815305|FG002|Overall Study|Withdrawal by Subject|6|||
27721887|NCT02319044|80815303|FG000|Overall Study|Condition under investigation worsened|100|||
27501821|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
27501822|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
27501823|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
27501824|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
27501825|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
27721888|NCT02319044|80815304|FG001|Overall Study|Condition under investigation worsened|50|||
27721889|NCT02319044|80815305|FG002|Overall Study|Condition under investigation worsened|46|||
27721890|NCT02319044|80815303|FG000|Overall Study|Adverse Event|17|||
27721891|NCT02319044|80815304|FG001|Overall Study|Adverse Event|2|||
27721892|NCT02319044|80815305|FG002|Overall Study|Adverse Event|8|||
27721893|NCT02319044|80815303|FG000|Overall Study|Study specific discontinuation criteria|2|||
27721894|NCT02319044|80815304|FG001|Overall Study|Study specific discontinuation criteria|2|||
27721895|NCT02319044|80815305|FG002|Overall Study|Study specific discontinuation criteria|1|||
27721896|NCT02319044|80815303|FG000|Overall Study|Not treated|0|||
27721897|NCT02319044|80815304|FG001|Overall Study|Not treated|2|||
27721898|NCT02319044|80815305|FG002|Overall Study|Not treated|2|||
27721899|NCT04607733|80815306|FG000|Overall Study|Lost to Follow-up|1|||
27721900|NCT04607733|80815307|FG001|Overall Study|Lost to Follow-up|0|||
27721901|NCT04607733|80815308|FG002|Overall Study|Lost to Follow-up|0|||
27721902|NCT04607733|80815309|FG003|Overall Study|Lost to Follow-up|1|||
27721903|NCT04607733|80815310|FG004|Overall Study|Lost to Follow-up|1|||
27721904|NCT04607733|80815311|FG005|Overall Study|Lost to Follow-up|0|||
27721905|NCT04607733|80815306|FG000|Overall Study|Withdrawal by Subject|0|||
27721906|NCT04607733|80815307|FG001|Overall Study|Withdrawal by Subject|0|||
27721907|NCT04607733|80815308|FG002|Overall Study|Withdrawal by Subject|0|||
27721908|NCT04607733|80815309|FG003|Overall Study|Withdrawal by Subject|0|||
27721909|NCT04607733|80815310|FG004|Overall Study|Withdrawal by Subject|1|||
27721910|NCT04607733|80815311|FG005|Overall Study|Withdrawal by Subject|0|||
27721911|NCT02867995|80815312|FG000|Overall Study|Withdrawal by Subject|0|||
27721912|NCT02867995|80815313|FG001|Overall Study|Withdrawal by Subject|1|||
27721913|NCT02867995|80815312|FG000|Overall Study|Lost to Follow-up|0|||
27721914|NCT02867995|80815313|FG001|Overall Study|Lost to Follow-up|2|||
27721915|NCT04002310|80815314|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
27721916|NCT04002310|80815315|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
27721917|NCT04002310|80815316|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
27721918|NCT04002310|80815317|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
27610906|NCT00675506|80415829|FG001|Overall Study|Schedule conflict|1|||
27721919|NCT04002310|80815318|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
27721920|NCT03806127|80815320|FG000|Overall Study|Withdrawal by Subject|4|||
27721921|NCT03806127|80815321|FG001|Overall Study|Withdrawal by Subject|5|||
27721922|NCT03806127|80815320|FG000|Overall Study|Protocol Violation|3|||
27721923|NCT03806127|80815321|FG001|Overall Study|Protocol Violation|1|||
27721924|NCT03806127|80815320|FG000|Overall Study|Adverse Event|3|||
27721925|NCT03806127|80815321|FG001|Overall Study|Adverse Event|0|||
27721926|NCT03806127|80815320|FG000|Overall Study|Unable to Complete Procedures|0|||
27721927|NCT03806127|80815321|FG001|Overall Study|Unable to Complete Procedures|1|||
27721928|NCT03806127|80815320|FG000|Overall Study|Pregnancy|0|||
27721929|NCT03806127|80815321|FG001|Overall Study|Pregnancy|1|||
27721930|NCT03806127|80815320|FG000|Overall Study|Lost to Follow-up|5|||
27721931|NCT03806127|80815321|FG001|Overall Study|Lost to Follow-up|1|||
27721932|NCT03806127|80815320|FG000|Overall Study|Physician Decision|1|||
27721933|NCT03806127|80815321|FG001|Overall Study|Physician Decision|1|||
27721934|NCT03806127|80815320|FG000|Overall Study|Could Not Come Due to Covid|1|||
27721935|NCT03806127|80815321|FG001|Overall Study|Could Not Come Due to Covid|0|||
27721936|NCT03806127|80815320|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
27721937|NCT03806127|80815321|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
27721938|NCT03806127|80815320|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
27721939|NCT03806127|80815321|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
27721940|NCT03806127|80815320|FG000|Overall Study|Covid 19 Restrictions|2|||
27721941|NCT03806127|80815321|FG001|Overall Study|Covid 19 Restrictions|0|||
27721942|NCT03806127|80815320|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
27721943|NCT03806127|80815321|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
27721944|NCT03806127|80815320|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
27721945|NCT03806127|80815321|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
27610907|NCT02285595|80415830|FG000|Overall Study|Lost to Follow-up|14|||
27610908|NCT02285595|80415830|FG000|Overall Study|Withdrawal by Subject|1|||
27610909|NCT04076020|80415831|FG000|Overall Study|Death|4|||
27610910|NCT04076020|80415832|FG001|Overall Study|Death|6|||
27610911|NCT04076020|80415831|FG000|Overall Study|Withdrawal by Subject|12|||
27610912|NCT04076020|80415832|FG001|Overall Study|Withdrawal by Subject|8|||
27610913|NCT02145078|80415833|FG000|Overall Study|Death|1|||
27610914|NCT02145078|80415833|FG000|Overall Study|Reason not given|3|||
27721946|NCT00648167|80815323|FG000|Overall Study|Adverse Event|6|||
27721947|NCT00648167|80815323|FG000|Overall Study|unable to swallow tablets|1|||
27610915|NCT01868035|80415834|FG000|Overall Study|Lost to Follow-up|3|||
27610916|NCT01868035|80415834|FG000|Overall Study|Withdrawal by Subject|1|||
27501826|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
27721948|NCT00105443|80815326|FG000|Double-Blind Treatment|Adverse Event|1|||
27721949|NCT00105443|80815327|FG001|Double-Blind Treatment|Adverse Event|0|||
27721950|NCT00105443|80815328|FG002|Double-Blind Treatment|Adverse Event|0|||
27721951|NCT00105443|80815329|FG003|Double-Blind Treatment|Adverse Event|0|||
27721952|NCT00105443|80815326|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
27721953|NCT00105443|80815327|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
27721954|NCT00105443|80815328|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
27721955|NCT00105443|80815329|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
27721956|NCT00105443|80815326|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
27721957|NCT00105443|80815327|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
27721958|NCT00105443|80815328|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
27721959|NCT00105443|80815329|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
27721960|NCT00105443|80815326|FG000|Double-Blind Treatment|Physician Decision|1|||
27721961|NCT00105443|80815327|FG001|Double-Blind Treatment|Physician Decision|0|||
27721962|NCT00105443|80815328|FG002|Double-Blind Treatment|Physician Decision|2|||
27721963|NCT00105443|80815329|FG003|Double-Blind Treatment|Physician Decision|0|||
27721964|NCT00105443|80815326|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
27721965|NCT00105443|80815327|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
27721966|NCT00105443|80815328|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
27721967|NCT00105443|80815329|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
27721968|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
27721969|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
27501827|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
27501828|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
27721970|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
27721971|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
27721972|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
27721973|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
27721974|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
27721975|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
27721976|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
27721977|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
27721978|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
27721979|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
27721980|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
27721981|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
27721982|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
27721983|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
27721984|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
27721985|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
27721986|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
27721987|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
27721988|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
27721989|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
27721990|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
27721991|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
27721992|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
27721993|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
27721994|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
27721995|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
27721996|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
27840455|NCT05103657|81245083|FG001|Overall Study|Adverse Event|14|||
27721997|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
27721998|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
27721999|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
27722000|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
27722001|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
27722002|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
27722003|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
27722004|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
27722005|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
27722006|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
27722007|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
27722008|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
27722009|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
27722010|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
27722011|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
27722012|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
27722013|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
27722014|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
27722015|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
27722016|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
27722017|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
27722018|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
27722019|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
27722020|NCT00105443|80815326|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
27722021|NCT00105443|80815327|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
27722022|NCT00105443|80815328|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
27722023|NCT00105443|80815329|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
27722024|NCT04429061|80815330|FG000|Overall Study|Lost to Follow-up|62|||
27722025|NCT04429061|80815331|FG001|Overall Study|Lost to Follow-up|87|||
27722026|NCT04429061|80815330|FG000|Overall Study|Withdrawal by Subject|3|||
27722027|NCT04429061|80815331|FG001|Overall Study|Withdrawal by Subject|4|||
27840456|NCT05103657|81245082|FG000|Overall Study|Not Treated|1|||
27840457|NCT05103657|81245083|FG001|Overall Study|Not Treated|1|||
27840458|NCT00329160|81245084|FG000|Overall Study|Adverse Event|27|||
27840459|NCT00329160|81245084|FG000|Overall Study|Withdrawal by Subject|13|||
27840460|NCT00329160|81245084|FG000|Overall Study|Protocol Violation|2|||
27840461|NCT00329160|81245084|FG000|Overall Study|Did not Receive Study Drug|1|||
27840462|NCT00329160|81245084|FG000|Overall Study|Incomplete IVUS|45|||
27840463|NCT04330157|81245085|FG000|Overall Study|Protocol Violation|4|||
27840464|NCT04330157|81245085|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
27840465|NCT01186016|81245086|FG000|Overall Study|Withdrawal by Subject|46|||
27840466|NCT01186016|81245087|FG001|Overall Study|Withdrawal by Subject|29|||
27840467|NCT04220775|81245092|FG000|Overall Study|Adverse Event|1|||
27840468|NCT04220775|81245093|FG001|Overall Study|Adverse Event|0|||
27840469|NCT04220775|81245092|FG000|Overall Study|Disease Progression|1|||
27840470|NCT04220775|81245093|FG001|Overall Study|Disease Progression|0|||
27840471|NCT02094261|81245100|FG000|Overall Study|Death|24|||
27840472|NCT02094261|81245100|FG000|Overall Study|Lost to Follow-up|1|||
27840473|NCT02094261|81245100|FG000|Overall Study|Withdrawal by Subject|4|||
27840474|NCT02094261|81245100|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
27840475|NCT00676650|81245101|FG000|Overall Study|Death|45|||
27840476|NCT00676650|81245102|FG001|Overall Study|Death|14|||
27840477|NCT00676650|81245101|FG000|Overall Study|Adverse Event|159|||
27840478|NCT00676650|81245102|FG001|Overall Study|Adverse Event|21|||
27840479|NCT00676650|81245101|FG000|Overall Study|Global deterioration of health status|66|||
27840480|NCT00676650|81245102|FG001|Overall Study|Global deterioration of health status|31|||
27840481|NCT00676650|81245101|FG000|Overall Study|Lost to Follow-up|0|||
27840482|NCT00676650|81245102|FG001|Overall Study|Lost to Follow-up|1|||
27840483|NCT00676650|81245101|FG000|Overall Study|Objective progression or relapse|189|||
27840484|NCT00676650|81245102|FG001|Overall Study|Objective progression or relapse|140|||
27840485|NCT00676650|81245101|FG000|Overall Study|Other|14|||
27840486|NCT00676650|81245102|FG001|Overall Study|Other|10|||
27840487|NCT00676650|81245101|FG000|Overall Study|Protocol Violation|3|||
27840488|NCT00676650|81245102|FG001|Overall Study|Protocol Violation|1|||
27840489|NCT00676650|81245101|FG000|Overall Study|Study terminated by sponsor|57|||
27610917|NCT01868035|80415834|FG000|Overall Study|Progressive Disease|2|||
27840490|NCT00676650|81245102|FG001|Overall Study|Study terminated by sponsor|43|||
27840491|NCT00676650|81245101|FG000|Overall Study|Withdrawal by Subject|48|||
27610918|NCT01868035|80415834|FG000|Overall Study|Non-compliance|1|||
27840492|NCT00676650|81245102|FG001|Overall Study|Withdrawal by Subject|24|||
27840493|NCT00676650|81245101|FG000|Overall Study|Randomized but not treated|3|||
27722028|NCT04316585|80815332|FG000|Overall Study|Adverse Event|2|||
27722029|NCT04316585|80815333|FG001|Overall Study|Adverse Event|1|||
27722030|NCT04316585|80815332|FG000|Overall Study|Lost to Follow-up|1|||
27722031|NCT04316585|80815333|FG001|Overall Study|Lost to Follow-up|0|||
27722032|NCT04316585|80815332|FG000|Overall Study|Withdrawal by Subject|2|||
27722033|NCT04316585|80815333|FG001|Overall Study|Withdrawal by Subject|3|||
27722034|NCT04316585|80815332|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
27722035|NCT04316585|80815333|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
27722036|NCT04316585|80815332|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
27722037|NCT04316585|80815333|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
27722038|NCT01665807|80815334|FG000|Overall Study|Withdrawal by Subject|2|||
27722039|NCT01665807|80815335|FG001|Overall Study|Withdrawal by Subject|0|||
27722040|NCT01665807|80815336|FG002|Overall Study|Withdrawal by Subject|1|||
27722041|NCT02004873|80815337|FG000|Overall Study|Implant unsuccessful|6|||
27722042|NCT02004873|80815337|FG000|Overall Study|Awaiting 6-month visit|390|||
27722043|NCT02004873|80815337|FG000|Overall Study|Missed 6-month visit|4|||
27722044|NCT02004873|80815337|FG000|Overall Study|Death|23|||
27722045|NCT02004873|80815337|FG000|Overall Study|Withdrawal by Subject|1|||
27722046|NCT01465659|80815339|FG000|Completed 1 Cycle of Treatment|Death|0|||
27722047|NCT01465659|80815340|FG001|Completed 1 Cycle of Treatment|Death|1|||
27722048|NCT01465659|80815341|FG002|Completed 1 Cycle of Treatment|Death|0|||
27722049|NCT01465659|80815342|FG003|Completed 1 Cycle of Treatment|Death|0|||
27722050|NCT01465659|80815339|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
27722051|NCT01465659|80815340|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
27722052|NCT01465659|80815341|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
27722053|NCT01465659|80815342|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
27722054|NCT01465659|80815339|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
27722055|NCT01465659|80815340|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
27722056|NCT01465659|80815341|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
27722057|NCT01465659|80815342|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
27722058|NCT01465659|80815339|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
27722059|NCT01465659|80815340|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
27722060|NCT01465659|80815341|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
27722061|NCT01465659|80815342|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
27722062|NCT01465659|80815339|FG000|Completed Follow for 1 Year|Death|6|||
27722063|NCT01465659|80815340|FG001|Completed Follow for 1 Year|Death|3|||
27722064|NCT01465659|80815341|FG002|Completed Follow for 1 Year|Death|2|||
27722065|NCT01465659|80815342|FG003|Completed Follow for 1 Year|Death|4|||
27610919|NCT00735644|80415835|FG000|Overall Study|Did not receive study vaccine|0|||
27610920|NCT00735644|80415836|FG001|Overall Study|Did not receive study vaccine|1|||
27610921|NCT00735644|80415837|FG002|Overall Study|Did not receive study vaccine|0|||
27610922|NCT00735644|80415838|FG003|Overall Study|Did not receive study vaccine|0|||
27610923|NCT00735644|80415839|FG004|Overall Study|Did not receive study vaccine|0|||
27610924|NCT00735644|80415835|FG000|Overall Study|Withdrawal by Subject|0|||
27610925|NCT00735644|80415836|FG001|Overall Study|Withdrawal by Subject|1|||
27610926|NCT00735644|80415837|FG002|Overall Study|Withdrawal by Subject|1|||
27722066|NCT01445769|80815343|FG000|Overall Study|Consent Withdrawn|2|||
27722067|NCT01445769|80815343|FG000|Overall Study|Disease Progression|1|||
27722068|NCT01445769|80815343|FG000|Overall Study|Lost to Follow-up|5|||
27722069|NCT03434379|80815344|FG000|Global Period|Lost to Follow-up|3|||
27840494|NCT00676650|81245102|FG001|Overall Study|Randomized but not treated|4|||
27840495|NCT02726386|81245107|FG000|Overall Study|Adverse Event|17|||
27840496|NCT02726386|81245108|FG001|Overall Study|Adverse Event|20|||
27840497|NCT02726386|81245107|FG000|Overall Study|Withdrawal by Subject|14|||
27840498|NCT02726386|81245108|FG001|Overall Study|Withdrawal by Subject|28|||
27840499|NCT02726386|81245107|FG000|Overall Study|Other reasons|7|||
27722070|NCT03434379|80815345|FG001|Global Period|Lost to Follow-up|6|||
27722071|NCT03434379|80815346|FG002|Global Period|Lost to Follow-up|0|||
27722072|NCT03434379|80815347|FG003|Global Period|Lost to Follow-up|0|||
27891586|NCT00791661|81437329|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
27891587|NCT00791661|81437330|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
27891588|NCT00791661|81437331|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
27891589|NCT00723255|81437340|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
27610927|NCT00735644|80415838|FG003|Overall Study|Withdrawal by Subject|1|||
27722073|NCT03434379|80815344|FG000|Global Period|Death|115|||
27722074|NCT03434379|80815345|FG001|Global Period|Death|228|||
27722075|NCT03434379|80815346|FG002|Global Period|Death|0|||
27722076|NCT03434379|80815347|FG003|Global Period|Death|0|||
27722077|NCT03434379|80815344|FG000|Global Period|Withdrawal by Subject|20|||
27722078|NCT03434379|80815345|FG001|Global Period|Withdrawal by Subject|21|||
27722079|NCT03434379|80815346|FG002|Global Period|Withdrawal by Subject|0|||
27840500|NCT02726386|81245108|FG001|Overall Study|Other reasons|8|||
27840501|NCT02795676|81245109|FG000|Overall Study|Adverse Event|2|||
27840502|NCT02795676|81245110|FG001|Overall Study|Adverse Event|0|||
27840503|NCT02795676|81245109|FG000|Overall Study|Withdrawal by Subject|3|||
27840504|NCT02795676|81245110|FG001|Overall Study|Withdrawal by Subject|1|||
27840505|NCT02875028|81245120|FG000|Washout Period|Withdrawal by Subject|0|||
27840506|NCT02875028|81245121|FG001|Washout Period|Withdrawal by Subject|1|||
27840507|NCT01876368|81245124|FG000|Overall Study|Adverse Event|2|||
27840508|NCT01876368|81245125|FG001|Overall Study|Adverse Event|5|||
27840509|NCT01876368|81245124|FG000|Overall Study|Lack of Efficacy|1|||
27840510|NCT01876368|81245125|FG001|Overall Study|Lack of Efficacy|0|||
27840511|NCT01876368|81245124|FG000|Overall Study|Lost to Follow-up|0|||
27840512|NCT01876368|81245125|FG001|Overall Study|Lost to Follow-up|1|||
27891590|NCT00723255|81437340|FG000|Overall Study|Ineligible: Second primary|1|||
27891591|NCT00723255|81437340|FG000|Overall Study|Ineligible: Wrong Primary|2|||
27891592|NCT02738879|81437343|FG000|Overall Study|Adverse Event|1|||
27840513|NCT01876368|81245124|FG000|Overall Study|Non-compliance with study treatment|0|||
27840514|NCT01876368|81245125|FG001|Overall Study|Non-compliance with study treatment|1|||
27840515|NCT01876368|81245124|FG000|Overall Study|Physician Decision|0|||
27840516|NCT01876368|81245125|FG001|Overall Study|Physician Decision|2|||
27840517|NCT01876368|81245124|FG000|Overall Study|Protocol deviation|3|||
27840518|NCT01876368|81245125|FG001|Overall Study|Protocol deviation|3|||
27840519|NCT01876368|81245124|FG000|Overall Study|Subject/guardian decision|3|||
27840520|NCT01876368|81245125|FG001|Overall Study|Subject/guardian decision|1|||
27840521|NCT00183196|81245133|FG000|Overall Study|Withdrawal by Subject|18|||
27840522|NCT00183196|81245134|FG001|Overall Study|Withdrawal by Subject|11|||
27840523|NCT00183196|81245135|FG002|Overall Study|Withdrawal by Subject|13|||
27840524|NCT00183196|81245133|FG000|Overall Study|Adverse Event|1|||
27840525|NCT00183196|81245134|FG001|Overall Study|Adverse Event|2|||
27840526|NCT00183196|81245135|FG002|Overall Study|Adverse Event|2|||
27840527|NCT00183196|81245133|FG000|Overall Study|Legal event|1|||
27840528|NCT00183196|81245134|FG001|Overall Study|Legal event|1|||
27840529|NCT00183196|81245135|FG002|Overall Study|Legal event|1|||
27840530|NCT00183196|81245133|FG000|Overall Study|Required more intensive care|0|||
27840531|NCT00183196|81245134|FG001|Overall Study|Required more intensive care|1|||
27840532|NCT00183196|81245135|FG002|Overall Study|Required more intensive care|2|||
27840533|NCT02654015|81245138|FG000|Overall Study|Death|12|||
27840534|NCT02654015|81245138|FG000|Overall Study|Lost to Follow-up|3|||
27840535|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
27840536|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
27840537|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
27840538|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
27840539|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
27840540|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
27840541|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
27840542|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
27840543|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
27840544|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
27840545|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
27840546|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
27840547|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
27840548|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
27840549|NCT04592419|81245139|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
27840550|NCT04592419|81245140|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
27840551|NCT04592419|81245139|FG000|Open-Label Extension Period|Adverse Event|1|||
27840552|NCT04592419|81245140|FG001|Open-Label Extension Period|Adverse Event|2|||
27840553|NCT04592419|81245139|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
27840554|NCT04592419|81245140|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
27840555|NCT04592419|81245139|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
27840556|NCT04592419|81245140|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
27840557|NCT04592419|81245139|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
27840558|NCT04592419|81245140|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
27840559|NCT04592419|81245139|FG000|Open-Label Extension Period|Sponsor Request|73|||
27840560|NCT04592419|81245140|FG001|Open-Label Extension Period|Sponsor Request|84|||
27840561|NCT05444543|81245141|FG000|Overall Study|Withdrawal by Subject|1|||
27840562|NCT05444543|81245142|FG001|Overall Study|Withdrawal by Subject|0|||
27840563|NCT05444543|81245141|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
27840564|NCT05444543|81245142|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
27840565|NCT05444543|81245141|FG000|Overall Study|Adverse Event|0|||
27840566|NCT05444543|81245142|FG001|Overall Study|Adverse Event|1|||
27840567|NCT05444543|81245141|FG000|Overall Study|Family relocating at a distance from study site|0|||
27840568|NCT05444543|81245142|FG001|Overall Study|Family relocating at a distance from study site|1|||
27840569|NCT02938442|81245143|FG000|Overall Study|Death|0|||
27840570|NCT02938442|81245144|FG001|Overall Study|Death|1|||
27840571|NCT02938442|81245143|FG000|Overall Study|Lost to Follow-up|0|||
27840572|NCT02938442|81245144|FG001|Overall Study|Lost to Follow-up|1|||
27840573|NCT02938442|81245143|FG000|Overall Study|Physician Decision|0|||
27840574|NCT02938442|81245144|FG001|Overall Study|Physician Decision|1|||
27840575|NCT02938442|81245143|FG000|Overall Study|Withdrawal by Subject|2|||
27840576|NCT02938442|81245144|FG001|Overall Study|Withdrawal by Subject|0|||
27840577|NCT03969641|81245145|FG000|Overall Study|Lost to Follow-up|5|||
27840578|NCT03969641|81245146|FG001|Overall Study|Lost to Follow-up|3|||
27840579|NCT03969641|81245145|FG000|Overall Study|Withdrawal by Subject|1|||
27840580|NCT03969641|81245146|FG001|Overall Study|Withdrawal by Subject|2|||
27840581|NCT03969641|81245145|FG000|Overall Study|Found to be ineligible|1|||
27840582|NCT03969641|81245146|FG001|Overall Study|Found to be ineligible|1|||
27840583|NCT03969641|81245145|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
27840584|NCT03969641|81245146|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
27840585|NCT03969641|81245145|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
27840586|NCT03969641|81245146|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
27840587|NCT03969641|81245145|FG000|Overall Study|Elective termination|0|||
27840588|NCT03969641|81245146|FG001|Overall Study|Elective termination|1|||
27840589|NCT00360490|81245147|FG000|Overall Study|Adverse Event|4|||
27840590|NCT00360490|81245148|FG001|Overall Study|Adverse Event|2|||
27840591|NCT00360490|81245147|FG000|Overall Study|Lost to Follow-up|2|||
27840592|NCT00360490|81245148|FG001|Overall Study|Lost to Follow-up|1|||
27840593|NCT00360490|81245147|FG000|Overall Study|Physician Decision|2|||
27840594|NCT00360490|81245148|FG001|Overall Study|Physician Decision|1|||
27840595|NCT00360490|81245147|FG000|Overall Study|Protocol Violation|0|||
27840596|NCT00360490|81245148|FG001|Overall Study|Protocol Violation|4|||
27840597|NCT00360490|81245147|FG000|Overall Study|Withdrawal by Subject|1|||
27840598|NCT00360490|81245148|FG001|Overall Study|Withdrawal by Subject|3|||
27840599|NCT02539368|81245151|FG000|Overall Study|Death|4|||
27840600|NCT02539368|81245152|FG001|Overall Study|Death|2|||
27840601|NCT02539368|81245153|FG002|Overall Study|Death|1|||
27840602|NCT02539368|81245154|FG003|Overall Study|Death|0|||
27840603|NCT02539368|81245155|FG004|Overall Study|Death|0|||
27840604|NCT02539368|81245151|FG000|Overall Study|Withdrawal by Subject|44|||
27840605|NCT02539368|81245152|FG001|Overall Study|Withdrawal by Subject|35|||
27840606|NCT02539368|81245153|FG002|Overall Study|Withdrawal by Subject|9|||
27840607|NCT02539368|81245154|FG003|Overall Study|Withdrawal by Subject|1|||
27840608|NCT02539368|81245155|FG004|Overall Study|Withdrawal by Subject|3|||
27840609|NCT02539368|81245151|FG000|Overall Study|Physician Decision|49|||
27840610|NCT02539368|81245152|FG001|Overall Study|Physician Decision|15|||
27840611|NCT02539368|81245153|FG002|Overall Study|Physician Decision|7|||
27840612|NCT02539368|81245154|FG003|Overall Study|Physician Decision|0|||
27840613|NCT02539368|81245155|FG004|Overall Study|Physician Decision|2|||
27840614|NCT02539368|81245151|FG000|Overall Study|Lost to Follow-up|96|||
27840615|NCT02539368|81245152|FG001|Overall Study|Lost to Follow-up|21|||
27891593|NCT02738879|81437344|FG001|Overall Study|Adverse Event|1|||
27891594|NCT02738879|81437343|FG000|Overall Study|Death|0|||
27891595|NCT02738879|81437344|FG001|Overall Study|Death|2|||
27891596|NCT02738879|81437343|FG000|Overall Study|Lost to Follow-up|1|||
27891597|NCT02738879|81437344|FG001|Overall Study|Lost to Follow-up|5|||
27891598|NCT02738879|81437343|FG000|Overall Study|Protocol Violation|1|||
27891599|NCT02738879|81437344|FG001|Overall Study|Protocol Violation|3|||
27891600|NCT02738879|81437343|FG000|Overall Study|Physician Decision|3|||
27891601|NCT02738879|81437344|FG001|Overall Study|Physician Decision|4|||
27891602|NCT02738879|81437343|FG000|Overall Study|Pregnancy|0|||
27891603|NCT02738879|81437344|FG001|Overall Study|Pregnancy|1|||
27891604|NCT02738879|81437343|FG000|Overall Study|Screen Failure|1|||
27891605|NCT02738879|81437344|FG001|Overall Study|Screen Failure|2|||
27891606|NCT02738879|81437343|FG000|Overall Study|Site Discontinued Study Participation|1|||
27891607|NCT02738879|81437344|FG001|Overall Study|Site Discontinued Study Participation|0|||
27891608|NCT02738879|81437343|FG000|Overall Study|Withdrawal by Subject|5|||
27891609|NCT02738879|81437344|FG001|Overall Study|Withdrawal by Subject|7|||
27840616|NCT02539368|81245153|FG002|Overall Study|Lost to Follow-up|16|||
27840617|NCT02539368|81245154|FG003|Overall Study|Lost to Follow-up|4|||
27840618|NCT02539368|81245155|FG004|Overall Study|Lost to Follow-up|3|||
27840619|NCT02539368|81245151|FG000|Overall Study|Adverse Event|44|||
27840620|NCT02539368|81245152|FG001|Overall Study|Adverse Event|5|||
27840621|NCT02539368|81245153|FG002|Overall Study|Adverse Event|9|||
27840622|NCT02539368|81245154|FG003|Overall Study|Adverse Event|0|||
27840623|NCT02539368|81245155|FG004|Overall Study|Adverse Event|3|||
27840624|NCT02539368|81245151|FG000|Overall Study|Participant Non-compliant|13|||
27840625|NCT02539368|81245152|FG001|Overall Study|Participant Non-compliant|2|||
27840626|NCT02539368|81245153|FG002|Overall Study|Participant Non-compliant|1|||
27891610|NCT03721835|81437349|FG000|Overall Study|Participant not able to return|1|||
27891611|NCT03721835|81437349|FG000|Overall Study|Lost to Follow-up|1|||
27891612|NCT03721835|81437349|FG000|Overall Study|Revision of the components of the study device|2|||
27891613|NCT03721835|81437349|FG000|Overall Study|Sponsor terminated study|6|||
27891614|NCT03721835|81437349|FG000|Overall Study|Death|1|||
27501829|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
27501830|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
27501831|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
27501832|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
27501833|NCT03773978|80030427|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
27501834|NCT03773978|80030428|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
27501835|NCT03773978|80030427|FG000|DBW Period|Adverse Event|2|||
27501836|NCT03773978|80030428|FG001|DBW Period|Adverse Event|2|||
27501837|NCT03773978|80030427|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
27501838|NCT03773978|80030428|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
27501839|NCT03773978|80030427|FG000|DBW Period|Withdrawal by Subject|2|||
27501840|NCT03773978|80030428|FG001|DBW Period|Withdrawal by Subject|1|||
27610928|NCT00735644|80415839|FG004|Overall Study|Withdrawal by Subject|0|||
27610929|NCT00951509|80415846|FG000|Overall Study|Withdrawal by Subject|2|||
27610930|NCT03893825|80418944|FG000|Overall Study|Death|2|||
27610931|NCT03893825|80418945|FG001|Overall Study|Death|1|||
27610932|NCT03893825|80418944|FG000|Overall Study|Adverse Event|0|||
27610933|NCT03893825|80418945|FG001|Overall Study|Adverse Event|2|||
27610934|NCT03893825|80418944|FG000|Overall Study|Withdrawal by Subject|19|||
27610935|NCT03893825|80418945|FG001|Overall Study|Withdrawal by Subject|21|||
27610936|NCT03893825|80418944|FG000|Overall Study|Protocol deviation|1|||
27610937|NCT03893825|80418945|FG001|Overall Study|Protocol deviation|0|||
27610938|NCT03893825|80418944|FG000|Overall Study|Lost to Follow-up|10|||
27610939|NCT03893825|80418945|FG001|Overall Study|Lost to Follow-up|10|||
27610940|NCT03893825|80418944|FG000|Overall Study|Other than specified|7|||
27610941|NCT03893825|80418945|FG001|Overall Study|Other than specified|6|||
27610942|NCT03125941|80418950|FG000|Overall Study|did not receive intervention|1|||
27610943|NCT03125941|80418951|FG001|Overall Study|did not receive intervention|2|||
27610944|NCT00130793|80418952|FG000|Overall Study|Lost to Follow-up|1|||
27610945|NCT00130793|80418953|FG001|Overall Study|Lost to Follow-up|4|||
27610946|NCT00130793|80418952|FG000|Overall Study|Withdrew consent|2|||
27610947|NCT00130793|80418953|FG001|Overall Study|Withdrew consent|0|||
27610948|NCT02440594|80418958|FG000|Overall Study|Lost to Follow-up|34|||
27610949|NCT02440594|80418959|FG001|Overall Study|Lost to Follow-up|33|||
27840627|NCT02539368|81245154|FG003|Overall Study|Participant Non-compliant|1|||
27840628|NCT02539368|81245155|FG004|Overall Study|Participant Non-compliant|0|||
27501841|NCT03773978|80030427|FG000|DBW Period|Due to epidemic or pandemic|5|||
27501842|NCT03773978|80030428|FG001|DBW Period|Due to epidemic or pandemic|6|||
27501843|NCT03773978|80030427|FG000|DBW Period|Study team decision|1|||
27501844|NCT03773978|80030428|FG001|DBW Period|Study team decision|0|||
27501845|NCT04245111|80030432|FG000|Overall Study|Lost to Follow-up|5|||
27501846|NCT04245111|80030433|FG001|Overall Study|Lost to Follow-up|1|||
27501847|NCT04245111|80030434|FG002|Overall Study|Lost to Follow-up|1|||
27501848|NCT05176314|80030435|FG000|Overall Study|Lost to Follow-up|2|||
27501849|NCT05176314|80030435|FG000|Overall Study|Physician Decision|1|||
27501850|NCT05176314|80030435|FG000|Overall Study|Adverse Event|1|||
27501851|NCT03104868|80030436|FG000|6 Week Follow up|Lost to Follow-up|5|||
27501852|NCT03104868|80030437|FG001|6 Week Follow up|Lost to Follow-up|8|||
27610950|NCT02440594|80418960|FG002|Overall Study|Lost to Follow-up|54|||
27610951|NCT02440594|80418961|FG003|Overall Study|Lost to Follow-up|47|||
27840629|NCT02539368|81245151|FG000|Overall Study|Other|145|||
27840630|NCT02539368|81245152|FG001|Overall Study|Other|18|||
27840631|NCT02539368|81245153|FG002|Overall Study|Other|24|||
27840632|NCT02539368|81245154|FG003|Overall Study|Other|1|||
27840633|NCT02539368|81245155|FG004|Overall Study|Other|3|||
27501853|NCT03104868|80030436|FG000|6 Week Follow up|Death|1|||
27610952|NCT02440594|80418962|FG004|Overall Study|Lost to Follow-up|5|||
27610953|NCT02440594|80418963|FG005|Overall Study|Lost to Follow-up|4|||
27610954|NCT02440594|80418964|FG006|Overall Study|Lost to Follow-up|28|||
27610955|NCT02440594|80418965|FG007|Overall Study|Lost to Follow-up|48|||
27610956|NCT02440594|80418958|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
27610957|NCT02440594|80418959|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
27610958|NCT02440594|80418960|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
27840634|NCT02539368|81245151|FG000|Overall Study|Missing|10|||
27501854|NCT03104868|80030437|FG001|6 Week Follow up|Death|1|||
27501855|NCT03104868|80030436|FG000|6 Week Follow up|Withdrawal by Subject|7|||
27891615|NCT03721835|81437349|FG000|Overall Study|Sponsor decision|1|||
27891616|NCT00174967|81437350|FG000|Overall Study|Adverse Event|1|||
27891617|NCT00174967|81437351|FG001|Overall Study|Adverse Event|2|||
27891618|NCT00174967|81437352|FG002|Overall Study|Adverse Event|2|||
27891619|NCT00174967|81437353|FG003|Overall Study|Adverse Event|1|||
27891620|NCT00174967|81437350|FG000|Overall Study|Gout Flare|0|||
27891621|NCT00174967|81437351|FG001|Overall Study|Gout Flare|0|||
27501856|NCT03104868|80030437|FG001|6 Week Follow up|Withdrawal by Subject|6|||
27501857|NCT03104868|80030436|FG000|6 Week Follow up|Completed Later Timepoint|24|||
27610959|NCT02440594|80418961|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
27610960|NCT02440594|80418962|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
27610961|NCT02440594|80418963|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
27610962|NCT02440594|80418964|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
27610963|NCT02440594|80418965|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
27610964|NCT02440594|80418958|FG000|Overall Study|Withdrawal by Subject|81|||
27840635|NCT02539368|81245152|FG001|Overall Study|Missing|3|||
27840636|NCT02539368|81245153|FG002|Overall Study|Missing|0|||
27501858|NCT03104868|80030437|FG001|6 Week Follow up|Completed Later Timepoint|22|||
27501859|NCT03104868|80030436|FG000|6 Month Follow up|Lost to Follow-up|2|||
27501860|NCT03104868|80030437|FG001|6 Month Follow up|Lost to Follow-up|2|||
27501861|NCT03104868|80030436|FG000|6 Month Follow up|Death|0|||
27501862|NCT03104868|80030437|FG001|6 Month Follow up|Death|1|||
27501863|NCT03104868|80030436|FG000|6 Month Follow up|Completed Later Timepoint|22|||
27501864|NCT03104868|80030437|FG001|6 Month Follow up|Completed Later Timepoint|32|||
27501865|NCT03104868|80030436|FG000|12 Month Follow up|Lost to Follow-up|1|||
27501866|NCT03104868|80030437|FG001|12 Month Follow up|Lost to Follow-up|2|||
27501867|NCT03104868|80030436|FG000|12 Month Follow up|Death|0|||
27501868|NCT03104868|80030437|FG001|12 Month Follow up|Death|1|||
27501869|NCT03104868|80030436|FG000|12 Month Follow up|Withdrawal by Subject|0|||
27501870|NCT03104868|80030437|FG001|12 Month Follow up|Withdrawal by Subject|3|||
27501871|NCT03104868|80030436|FG000|12 Month Follow up|Completed Later Timepoint|32|||
27501872|NCT03104868|80030437|FG001|12 Month Follow up|Completed Later Timepoint|29|||
27501873|NCT03104868|80030436|FG000|18 Month Follow up|Lost to Follow-up|7|||
27501874|NCT03104868|80030437|FG001|18 Month Follow up|Lost to Follow-up|11|||
27501875|NCT03104868|80030436|FG000|18 Month Follow up|Death|2|||
27610965|NCT02440594|80418959|FG001|Overall Study|Withdrawal by Subject|67|||
27840637|NCT02539368|81245154|FG003|Overall Study|Missing|0|||
27840638|NCT02539368|81245155|FG004|Overall Study|Missing|0|||
27840639|NCT05135273|81245156|FG000|Overall Study|Recruited into the army|0|||
27840640|NCT05135273|81245157|FG001|Overall Study|Recruited into the army|0|||
27840641|NCT05135273|81245158|FG002|Overall Study|Recruited into the army|0|||
27840642|NCT05135273|81245159|FG003|Overall Study|Recruited into the army|0|||
27891622|NCT00174967|81437352|FG002|Overall Study|Gout Flare|0|||
27891623|NCT00174967|81437353|FG003|Overall Study|Gout Flare|1|||
27840643|NCT05135273|81245160|FG004|Overall Study|Recruited into the army|1|||
27891624|NCT00174967|81437350|FG000|Overall Study|Other|0|||
27501876|NCT03104868|80030437|FG001|18 Month Follow up|Death|1|||
27501877|NCT03104868|80030436|FG000|18 Month Follow up|Withdrawal by Subject|1|||
27501878|NCT03104868|80030437|FG001|18 Month Follow up|Withdrawal by Subject|2|||
27891625|NCT00174967|81437351|FG001|Overall Study|Other|1|||
27891626|NCT00174967|81437352|FG002|Overall Study|Other|0|||
27891627|NCT00174967|81437353|FG003|Overall Study|Other|0|||
27891628|NCT02836236|81437354|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
27891629|NCT02836236|81437355|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
27891630|NCT02836236|81437356|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
27891631|NCT02836236|81437357|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
27958599|NCT01791517|81680059|FG001|Phase II|Lack of Efficacy|0|||
27501879|NCT03104868|80030436|FG000|18 Month Follow up|Graft Loss|1|||
27501880|NCT03104868|80030437|FG001|18 Month Follow up|Graft Loss|1|||
27501881|NCT03104868|80030436|FG000|18 Month Follow up|Completed Later Timepoint|19|||
27501882|NCT03104868|80030437|FG001|18 Month Follow up|Completed Later Timepoint|20|||
27501883|NCT03104868|80030436|FG000|24 Month Follow up|Lost to Follow-up|15|||
27501884|NCT03104868|80030437|FG001|24 Month Follow up|Lost to Follow-up|16|||
27501885|NCT03104868|80030436|FG000|24 Month Follow up|Death|3|||
27501886|NCT03104868|80030437|FG001|24 Month Follow up|Death|2|||
27501887|NCT03104868|80030436|FG000|24 Month Follow up|Withdrawal by Subject|1|||
27501888|NCT03104868|80030437|FG001|24 Month Follow up|Withdrawal by Subject|0|||
27610966|NCT02440594|80418960|FG002|Overall Study|Withdrawal by Subject|59|||
27610967|NCT02440594|80418961|FG003|Overall Study|Withdrawal by Subject|38|||
27610968|NCT02440594|80418962|FG004|Overall Study|Withdrawal by Subject|2|||
27610969|NCT02440594|80418963|FG005|Overall Study|Withdrawal by Subject|2|||
27610970|NCT02440594|80418964|FG006|Overall Study|Withdrawal by Subject|7|||
27610971|NCT02440594|80418965|FG007|Overall Study|Withdrawal by Subject|7|||
27610972|NCT02440594|80418958|FG000|Overall Study|Administratively w/drawn|3|||
27610973|NCT02440594|80418959|FG001|Overall Study|Administratively w/drawn|2|||
27610974|NCT02440594|80418960|FG002|Overall Study|Administratively w/drawn|0|||
27610975|NCT02440594|80418961|FG003|Overall Study|Administratively w/drawn|0|||
27610976|NCT02440594|80418962|FG004|Overall Study|Administratively w/drawn|0|||
27610977|NCT02440594|80418963|FG005|Overall Study|Administratively w/drawn|0|||
27610978|NCT02440594|80418964|FG006|Overall Study|Administratively w/drawn|2|||
27610979|NCT02440594|80418965|FG007|Overall Study|Administratively w/drawn|1|||
27610980|NCT00579982|80418970|FG000|Overall Study|Adverse Event|4|||
27610981|NCT00579982|80418970|FG000|Overall Study|Protocol Violation|4|||
27610982|NCT00957931|80418971|FG000|Overall Study|Death|4|||
27610983|NCT00845871|80418972|FG000|Assessment Period|Adverse Event|2|||
27610984|NCT00845871|80418972|FG000|Assessment Period|Abnormal laboratory values|1|||
27610985|NCT00845871|80418972|FG000|Assessment Period|Abnormal test procedure results|1|||
27610986|NCT00845871|80418972|FG000|Assessment Period|Patient withdrew consent|3|||
27610987|NCT03225846|80418975|FG000|Overall Study|Adverse Event|0|||
27610988|NCT03225846|80418976|FG001|Overall Study|Adverse Event|0|||
27610989|NCT03225846|80418977|FG002|Overall Study|Adverse Event|0|||
27610990|NCT03225846|80418978|FG003|Overall Study|Adverse Event|0|||
27610991|NCT03225846|80418979|FG004|Overall Study|Adverse Event|0|||
27610992|NCT03225846|80418980|FG005|Overall Study|Adverse Event|0|||
27610993|NCT03225846|80418981|FG006|Overall Study|Adverse Event|6|||
27610994|NCT03225846|80418975|FG000|Overall Study|Withdrawal by Subject|0|||
27610995|NCT03225846|80418976|FG001|Overall Study|Withdrawal by Subject|1|||
27610996|NCT03225846|80418977|FG002|Overall Study|Withdrawal by Subject|0|||
27610997|NCT03225846|80418978|FG003|Overall Study|Withdrawal by Subject|0|||
27610998|NCT03225846|80418979|FG004|Overall Study|Withdrawal by Subject|0|||
27610999|NCT03225846|80418980|FG005|Overall Study|Withdrawal by Subject|0|||
27611000|NCT03225846|80418981|FG006|Overall Study|Withdrawal by Subject|0|||
27611001|NCT03225846|80418975|FG000|Overall Study|Death|0|||
27611002|NCT03225846|80418976|FG001|Overall Study|Death|1|||
27611003|NCT03225846|80418977|FG002|Overall Study|Death|0|||
27611004|NCT03225846|80418978|FG003|Overall Study|Death|0|||
27611005|NCT03225846|80418979|FG004|Overall Study|Death|0|||
27611006|NCT03225846|80418980|FG005|Overall Study|Death|0|||
27611007|NCT03225846|80418981|FG006|Overall Study|Death|0|||
27611008|NCT03225846|80418975|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
27611009|NCT03225846|80418976|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
27611010|NCT03225846|80418977|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
27611011|NCT03225846|80418978|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
27611012|NCT03225846|80418979|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
27611013|NCT03225846|80418980|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
27611014|NCT03225846|80418981|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
27501889|NCT03104868|80030436|FG000|24 Month Follow up|Graft Loss|2|||
27501890|NCT03104868|80030437|FG001|24 Month Follow up|Graft Loss|0|||
27611015|NCT03225846|80418975|FG000|Overall Study|Patient decision|0|||
27611016|NCT03225846|80418976|FG001|Overall Study|Patient decision|0|||
27611017|NCT03225846|80418977|FG002|Overall Study|Patient decision|0|||
27611018|NCT03225846|80418978|FG003|Overall Study|Patient decision|0|||
27611019|NCT03225846|80418979|FG004|Overall Study|Patient decision|0|||
27501891|NCT02546609|80030443|FG000|Overall Study|Withdrawal by Subject|0|||
27501892|NCT02546609|80030444|FG001|Overall Study|Withdrawal by Subject|1|||
27611020|NCT03225846|80418980|FG005|Overall Study|Patient decision|0|||
27611021|NCT03225846|80418981|FG006|Overall Study|Patient decision|1|||
27611022|NCT00594906|80418985|FG000|Overall Study|Physician Decision|1|||
27611023|NCT00594906|80418986|FG001|Overall Study|Physician Decision|0|||
27501893|NCT02546609|80030445|FG002|Overall Study|Withdrawal by Subject|2|||
27501894|NCT02546609|80030443|FG000|Overall Study|Adverse Event|0|||
27501895|NCT02546609|80030444|FG001|Overall Study|Adverse Event|6|||
27501896|NCT02546609|80030445|FG002|Overall Study|Adverse Event|1|||
27501897|NCT02546609|80030443|FG000|Overall Study|Protocol Violation|0|||
27501898|NCT02546609|80030444|FG001|Overall Study|Protocol Violation|1|||
27501899|NCT02546609|80030445|FG002|Overall Study|Protocol Violation|1|||
27501900|NCT02546609|80030443|FG000|Overall Study|Lost to Follow-up|2|||
27501901|NCT02546609|80030444|FG001|Overall Study|Lost to Follow-up|3|||
27501902|NCT02546609|80030445|FG002|Overall Study|Lost to Follow-up|1|||
27501903|NCT02546609|80030443|FG000|Overall Study|travel or work schedule restriction|0|||
27501904|NCT02546609|80030444|FG001|Overall Study|travel or work schedule restriction|0|||
27501905|NCT02546609|80030445|FG002|Overall Study|travel or work schedule restriction|2|||
27501906|NCT02242942|80030446|FG000|Overall Study|Death|17|||
27501907|NCT02242942|80030447|FG001|Overall Study|Death|20|||
27501908|NCT02242942|80030448|FG002|Overall Study|Death|2|||
27501909|NCT02242942|80030446|FG000|Overall Study|Physician Decision|1|||
27501910|NCT02242942|80030447|FG001|Overall Study|Physician Decision|0|||
27501911|NCT02242942|80030448|FG002|Overall Study|Physician Decision|0|||
27501912|NCT02242942|80030446|FG000|Overall Study|Withdrawal by Subject|8|||
27501913|NCT02242942|80030447|FG001|Overall Study|Withdrawal by Subject|10|||
27501914|NCT02242942|80030448|FG002|Overall Study|Withdrawal by Subject|0|||
27891632|NCT02836236|81437354|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
27891633|NCT02836236|81437355|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
27891634|NCT02836236|81437356|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
27501915|NCT02242942|80030446|FG000|Overall Study|On-going in Study|190|||
27611024|NCT00594906|80418985|FG000|Overall Study|Physician Decision|0|||
27611025|NCT00594906|80418986|FG001|Overall Study|Physician Decision|1|||
27611026|NCT00594906|80418985|FG000|Overall Study|Death|0|||
27611027|NCT00594906|80418986|FG001|Overall Study|Death|1|||
27611028|NCT02693834|80418989|FG000|Baseline Measurement|Withdrawal by Subject|1|||
27840644|NCT05135273|81245161|FG005|Overall Study|Recruited into the army|0|||
27840645|NCT05135273|81245162|FG006|Overall Study|Recruited into the army|0|||
27891635|NCT02836236|81437357|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
27891636|NCT02836236|81437354|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
27891637|NCT02836236|81437355|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
27891638|NCT02836236|81437356|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
27891639|NCT02836236|81437357|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
27891640|NCT02836236|81437354|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
27891641|NCT02836236|81437355|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
27891642|NCT02836236|81437356|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
27501916|NCT02242942|80030447|FG001|Overall Study|On-going in Study|186|||
27501917|NCT02242942|80030448|FG002|Overall Study|On-going in Study|11|||
27611029|NCT02693834|80418990|FG001|Baseline Measurement|Withdrawal by Subject|0|||
27611030|NCT02693834|80418989|FG000|Baseline Measurement|Adverse Event|1|||
27611031|NCT02693834|80418990|FG001|Baseline Measurement|Adverse Event|0|||
27840646|NCT05135273|81245163|FG007|Overall Study|Recruited into the army|0|||
27840647|NCT05135273|81245156|FG000|Overall Study|Moved away from study site|0|||
27840648|NCT05135273|81245157|FG001|Overall Study|Moved away from study site|0|||
27840649|NCT05135273|81245158|FG002|Overall Study|Moved away from study site|0|||
27840650|NCT05135273|81245159|FG003|Overall Study|Moved away from study site|0|||
27840651|NCT05135273|81245160|FG004|Overall Study|Moved away from study site|0|||
27840652|NCT05135273|81245161|FG005|Overall Study|Moved away from study site|1|||
27840653|NCT05135273|81245162|FG006|Overall Study|Moved away from study site|1|||
27840654|NCT05135273|81245163|FG007|Overall Study|Moved away from study site|0|||
27840655|NCT05135273|81245156|FG000|Overall Study|Travel|0|||
27840656|NCT05135273|81245157|FG001|Overall Study|Travel|0|||
27840657|NCT05135273|81245158|FG002|Overall Study|Travel|0|||
27840658|NCT05135273|81245159|FG003|Overall Study|Travel|0|||
27840659|NCT05135273|81245160|FG004|Overall Study|Travel|0|||
27840660|NCT05135273|81245161|FG005|Overall Study|Travel|0|||
27840661|NCT05135273|81245162|FG006|Overall Study|Travel|0|||
27611032|NCT02693834|80418989|FG000|Week 2 Practice|Adverse Event|0|||
27611033|NCT02693834|80418990|FG001|Week 2 Practice|Adverse Event|1|||
27611034|NCT01515189|80418991|FG000|Induction|Disease Progression|109|||
27611035|NCT01515189|80418992|FG001|Induction|Disease Progression|155|||
27611036|NCT01515189|80418991|FG000|Induction|Study drug toxicity|86|||
27501918|NCT05316597|80032491|FG000|First Session|Withdrawal by Subject|0|||
27501919|NCT05316597|80032492|FG001|First Session|Withdrawal by Subject|1|||
27501920|NCT05316597|80032491|FG000|Washout Period|Lost to Follow-up|1|||
27501921|NCT05316597|80032492|FG001|Washout Period|Lost to Follow-up|2|||
27501922|NCT05316597|80032491|FG000|Washout Period|Physician Decision|1|||
27501923|NCT05316597|80032492|FG001|Washout Period|Physician Decision|1|||
27501924|NCT05316597|80032491|FG000|Washout Period|Excluded before second session|1|||
27501925|NCT05316597|80032492|FG001|Washout Period|Excluded before second session|1|||
27501926|NCT05316597|80032491|FG000|Washout Period|Withdrawal by Subject|0|||
27501927|NCT05316597|80032492|FG001|Washout Period|Withdrawal by Subject|4|||
27501928|NCT02023086|80032495|FG000|Overall Study|Withdrawal by Subject|2|||
27501929|NCT02023086|80032496|FG001|Overall Study|Withdrawal by Subject|0|||
27501930|NCT02052778|80032498|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
27501931|NCT02052778|80032499|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
27501932|NCT02052778|80032500|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
27501933|NCT02052778|80032501|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
27501934|NCT02052778|80032502|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
27501935|NCT02052778|80032503|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
27501936|NCT02052778|80032504|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501937|NCT02052778|80032505|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
27501938|NCT02052778|80032506|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
27501939|NCT02052778|80032507|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
27501940|NCT02052778|80032508|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
27501941|NCT02052778|80032509|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
27501942|NCT02052778|80032510|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
27501943|NCT02052778|80032511|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
27501944|NCT02052778|80032512|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501945|NCT02052778|80032513|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501946|NCT02052778|80032514|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501947|NCT02052778|80032515|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501948|NCT02052778|80032516|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501949|NCT02052778|80032517|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501950|NCT02052778|80032518|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501951|NCT02052778|80032519|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501952|NCT02052778|80032520|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
27501953|NCT02052778|80032498|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
27501954|NCT02052778|80032499|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
27501955|NCT02052778|80032500|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
27501956|NCT02052778|80032501|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
27501957|NCT02052778|80032502|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
27501958|NCT02052778|80032503|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
27501959|NCT02052778|80032504|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
27501960|NCT02052778|80032505|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
27501961|NCT02052778|80032506|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
27501962|NCT02052778|80032507|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501963|NCT02052778|80032508|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501964|NCT02052778|80032509|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
27501965|NCT02052778|80032510|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
27501966|NCT02052778|80032511|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
27501967|NCT02052778|80032512|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501968|NCT02052778|80032513|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501969|NCT02052778|80032514|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501970|NCT02052778|80032515|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501971|NCT02052778|80032516|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501972|NCT02052778|80032517|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501973|NCT02052778|80032518|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501974|NCT02052778|80032519|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501975|NCT02052778|80032520|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
27501976|NCT02052778|80032498|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501977|NCT02052778|80032499|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501978|NCT02052778|80032500|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501979|NCT02052778|80032501|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501980|NCT02052778|80032502|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27611037|NCT01515189|80418992|FG001|Induction|Study drug toxicity|36|||
27611038|NCT01515189|80418991|FG000|Induction|Death|24|||
27611039|NCT01515189|80418992|FG001|Induction|Death|17|||
27611040|NCT01515189|80418991|FG000|Induction|Adverse Event|14|||
27611041|NCT01515189|80418992|FG001|Induction|Adverse Event|9|||
27611042|NCT01515189|80418991|FG000|Induction|Withdrawal by Subject|3|||
27611043|NCT01515189|80418992|FG001|Induction|Withdrawal by Subject|9|||
27611044|NCT01515189|80418991|FG000|Induction|No longer meets study criteria|0|||
27611045|NCT01515189|80418992|FG001|Induction|No longer meets study criteria|2|||
27611046|NCT01515189|80418991|FG000|Induction|Lost to Follow-up|1|||
27611047|NCT01515189|80418992|FG001|Induction|Lost to Follow-up|0|||
27611048|NCT01515189|80418991|FG000|Induction|Other|0|||
27611049|NCT01515189|80418992|FG001|Induction|Other|4|||
27611050|NCT01515189|80418991|FG000|First Re-Induction Phase|Disease progression|6|||
27611051|NCT01515189|80418992|FG001|First Re-Induction Phase|Disease progression|14|||
27611052|NCT01515189|80418991|FG000|First Re-Induction Phase|Study drug toxicity|5|||
27611053|NCT01515189|80418992|FG001|First Re-Induction Phase|Study drug toxicity|0|||
27611054|NCT01515189|80418991|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
27611055|NCT01515189|80418992|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
27611056|NCT01515189|80418991|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
27611057|NCT01515189|80418992|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
27611058|NCT01515189|80418991|FG000|First Re-Induction Phase|Other|1|||
27611059|NCT01515189|80418992|FG001|First Re-Induction Phase|Other|0|||
27611060|NCT00582491|80418993|FG000|Overall Study|Withdrawal by Subject|1|||
27611061|NCT00582491|80418994|FG001|Overall Study|Withdrawal by Subject|0|||
27611062|NCT01617005|80418997|FG000|Overall Study|Pregnancy|1|||
27611063|NCT01617005|80418997|FG000|Overall Study|Lack of motivation for treatment|1|||
27611064|NCT00474929|80418998|FG000|Overall Study|Withdrawal by Subject|0|||
27611065|NCT00474929|80418999|FG001|Overall Study|Withdrawal by Subject|1|||
27611066|NCT00474929|80419000|FG002|Overall Study|Withdrawal by Subject|0|||
27611067|NCT00474929|80419001|FG003|Overall Study|Withdrawal by Subject|0|||
27611068|NCT00474929|80419002|FG004|Overall Study|Withdrawal by Subject|0|||
27611069|NCT00474929|80418998|FG000|Overall Study|Unrelated medical condition|0|||
27611070|NCT00474929|80418999|FG001|Overall Study|Unrelated medical condition|0|||
27611071|NCT00474929|80419000|FG002|Overall Study|Unrelated medical condition|1|||
27840662|NCT05135273|81245163|FG007|Overall Study|Travel|1|||
27840663|NCT00593827|81245167|FG000|Overall Study|On Active Treatment/Pending|0|||
27840664|NCT00593827|81245168|FG001|Overall Study|On Active Treatment/Pending|2|||
27840665|NCT01332968|81245169|FG000|Induction Period|Adverse Event|23|||
27840666|NCT01332968|81245170|FG001|Induction Period|Adverse Event|26|||
27722080|NCT03434379|80815347|FG003|Global Period|Withdrawal by Subject|0|||
27722081|NCT03434379|80815344|FG000|Global Period|Reason Unspecified|0|||
27611072|NCT00474929|80419001|FG003|Overall Study|Unrelated medical condition|0|||
27611073|NCT00474929|80419002|FG004|Overall Study|Unrelated medical condition|0|||
27611074|NCT00474929|80418998|FG000|Overall Study|Physician Decision|0|||
27611075|NCT00474929|80418999|FG001|Overall Study|Physician Decision|0|||
27611076|NCT00474929|80419000|FG002|Overall Study|Physician Decision|1|||
27611077|NCT00474929|80419001|FG003|Overall Study|Physician Decision|2|||
27611078|NCT00474929|80419002|FG004|Overall Study|Physician Decision|0|||
27611079|NCT03661996|80419003|FG000|Overall Study|Adverse Event|0|||
27611080|NCT03661996|80419004|FG001|Overall Study|Adverse Event|0|||
27611081|NCT03661996|80419005|FG002|Overall Study|Adverse Event|1|||
27611082|NCT03661996|80419006|FG003|Overall Study|Adverse Event|1|||
27611083|NCT03661996|80419007|FG004|Overall Study|Adverse Event|0|||
27611084|NCT03661996|80419003|FG000|Overall Study|Lost to Follow-up|5|||
27611085|NCT03661996|80419004|FG001|Overall Study|Lost to Follow-up|1|||
27611086|NCT03661996|80419005|FG002|Overall Study|Lost to Follow-up|2|||
27611087|NCT03661996|80419006|FG003|Overall Study|Lost to Follow-up|2|||
27611088|NCT03661996|80419007|FG004|Overall Study|Lost to Follow-up|6|||
27611089|NCT03661996|80419003|FG000|Overall Study|Physician Decision|1|||
27611090|NCT03661996|80419004|FG001|Overall Study|Physician Decision|1|||
27611091|NCT03661996|80419005|FG002|Overall Study|Physician Decision|1|||
27611092|NCT03661996|80419006|FG003|Overall Study|Physician Decision|2|||
27891643|NCT02836236|81437357|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
27891644|NCT02836236|81437354|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
27891645|NCT02836236|81437355|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
27891646|NCT02836236|81437356|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
27891647|NCT02836236|81437357|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
27891648|NCT02836236|81437354|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
27501981|NCT02052778|80032503|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501982|NCT02052778|80032504|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501983|NCT02052778|80032505|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501984|NCT02052778|80032506|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501985|NCT02052778|80032507|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501986|NCT02052778|80032508|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501987|NCT02052778|80032509|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501988|NCT02052778|80032510|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501989|NCT02052778|80032511|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
27501990|NCT02052778|80032512|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501991|NCT02052778|80032513|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501992|NCT02052778|80032514|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501993|NCT02052778|80032515|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501994|NCT02052778|80032516|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501995|NCT02052778|80032517|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501996|NCT02052778|80032518|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501997|NCT02052778|80032519|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501998|NCT02052778|80032520|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
27501999|NCT02052778|80032498|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
27502000|NCT02052778|80032499|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
27502001|NCT02052778|80032500|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
27502002|NCT02052778|80032501|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
27502003|NCT02052778|80032502|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
27502004|NCT02052778|80032503|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
27502005|NCT02052778|80032504|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
27502006|NCT02052778|80032505|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
27502007|NCT02052778|80032506|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
27502008|NCT02052778|80032507|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
27502009|NCT02052778|80032508|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
27891649|NCT02836236|81437355|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
27891650|NCT02836236|81437356|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
27891651|NCT02836236|81437357|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
27891652|NCT02836236|81437354|FG000|Open-Label TAF Treatment Phase|Death|0|||
27891653|NCT02836236|81437355|FG001|Open-Label TAF Treatment Phase|Death|0|||
27891654|NCT02836236|81437356|FG002|Open-Label TAF Treatment Phase|Death|1|||
27891655|NCT02836236|81437357|FG003|Open-Label TAF Treatment Phase|Death|1|||
27891656|NCT02836236|81437354|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
27891657|NCT02836236|81437355|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
27891658|NCT02836236|81437356|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
27891659|NCT02836236|81437357|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
27891660|NCT00425061|81437360|FG000|Overall Study|Adverse Event|1|||
27891661|NCT00425061|81437361|FG001|Overall Study|Adverse Event|0|||
27502010|NCT02052778|80032509|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
27502011|NCT02052778|80032510|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
27891662|NCT00425061|81437362|FG002|Overall Study|Adverse Event|0|||
27891663|NCT00425061|81437363|FG003|Overall Study|Adverse Event|2|||
27502012|NCT02052778|80032511|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
27611093|NCT03661996|80419007|FG004|Overall Study|Physician Decision|0|||
27611094|NCT03661996|80419003|FG000|Overall Study|Protocol Violation|0|||
27611095|NCT03661996|80419004|FG001|Overall Study|Protocol Violation|0|||
27611096|NCT03661996|80419005|FG002|Overall Study|Protocol Violation|0|||
27611097|NCT03661996|80419006|FG003|Overall Study|Protocol Violation|0|||
27891664|NCT00425061|81437364|FG004|Overall Study|Adverse Event|2|||
27891665|NCT00425061|81437365|FG005|Overall Study|Adverse Event|0|||
27891666|NCT00425061|81437366|FG006|Overall Study|Adverse Event|0|||
27891667|NCT00425061|81437360|FG000|Overall Study|Lost to Follow-up|0|||
27891668|NCT00425061|81437361|FG001|Overall Study|Lost to Follow-up|1|||
27891669|NCT00425061|81437362|FG002|Overall Study|Lost to Follow-up|0|||
27891670|NCT00425061|81437363|FG003|Overall Study|Lost to Follow-up|0|||
27891671|NCT00425061|81437364|FG004|Overall Study|Lost to Follow-up|0|||
27891672|NCT00425061|81437365|FG005|Overall Study|Lost to Follow-up|0|||
27891673|NCT00425061|81437366|FG006|Overall Study|Lost to Follow-up|0|||
27891674|NCT00425061|81437360|FG000|Overall Study|Protocol Violation|1|||
27891675|NCT00425061|81437361|FG001|Overall Study|Protocol Violation|0|||
27891676|NCT00425061|81437362|FG002|Overall Study|Protocol Violation|0|||
27891677|NCT00425061|81437363|FG003|Overall Study|Protocol Violation|0|||
27891678|NCT00425061|81437364|FG004|Overall Study|Protocol Violation|0|||
27891679|NCT00425061|81437365|FG005|Overall Study|Protocol Violation|0|||
27891680|NCT00425061|81437366|FG006|Overall Study|Protocol Violation|0|||
27891681|NCT00425061|81437360|FG000|Overall Study|Withdrawal by Subject|0|||
27891682|NCT00425061|81437361|FG001|Overall Study|Withdrawal by Subject|1|||
27891683|NCT00425061|81437362|FG002|Overall Study|Withdrawal by Subject|0|||
27891684|NCT00425061|81437363|FG003|Overall Study|Withdrawal by Subject|0|||
27891685|NCT00425061|81437364|FG004|Overall Study|Withdrawal by Subject|1|||
27891686|NCT00425061|81437365|FG005|Overall Study|Withdrawal by Subject|0|||
27891687|NCT00425061|81437366|FG006|Overall Study|Withdrawal by Subject|3|||
27891688|NCT00425061|81437360|FG000|Overall Study|Sponsor's request|0|||
27891689|NCT00425061|81437361|FG001|Overall Study|Sponsor's request|0|||
27891690|NCT00425061|81437362|FG002|Overall Study|Sponsor's request|0|||
27891691|NCT00425061|81437363|FG003|Overall Study|Sponsor's request|0|||
27891692|NCT00425061|81437364|FG004|Overall Study|Sponsor's request|19|||
27891693|NCT00425061|81437365|FG005|Overall Study|Sponsor's request|4|||
27891694|NCT00425061|81437366|FG006|Overall Study|Sponsor's request|15|||
27891695|NCT00425061|81437360|FG000|Overall Study|Physician Decision|0|||
27891696|NCT00425061|81437361|FG001|Overall Study|Physician Decision|0|||
27891697|NCT00425061|81437362|FG002|Overall Study|Physician Decision|0|||
27891698|NCT00425061|81437363|FG003|Overall Study|Physician Decision|0|||
27891699|NCT00425061|81437364|FG004|Overall Study|Physician Decision|1|||
27891700|NCT00425061|81437365|FG005|Overall Study|Physician Decision|0|||
27891701|NCT00425061|81437366|FG006|Overall Study|Physician Decision|0|||
27891702|NCT00425061|81437360|FG000|Overall Study|Other|0|||
27891703|NCT00425061|81437361|FG001|Overall Study|Other|0|||
27891704|NCT00425061|81437362|FG002|Overall Study|Other|0|||
27891705|NCT00425061|81437363|FG003|Overall Study|Other|0|||
27502013|NCT02052778|80032512|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
27502014|NCT02052778|80032513|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
27502015|NCT02052778|80032514|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
27502016|NCT02052778|80032515|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
27891706|NCT00425061|81437364|FG004|Overall Study|Other|3|||
27891707|NCT00425061|81437365|FG005|Overall Study|Other|0|||
27891708|NCT00425061|81437366|FG006|Overall Study|Other|1|||
27891709|NCT02655016|81437368|FG000|Overall Study|Disease progression|6|||
27891710|NCT02655016|81437369|FG001|Overall Study|Disease progression|4|||
27502017|NCT02052778|80032516|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
27502018|NCT02052778|80032517|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
27502019|NCT02052778|80032518|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
27891711|NCT02655016|81437368|FG000|Overall Study|Site closed|0|||
27891712|NCT02655016|81437369|FG001|Overall Study|Site closed|1|||
27611098|NCT03661996|80419007|FG004|Overall Study|Protocol Violation|1|||
27891713|NCT02655016|81437368|FG000|Overall Study|Death|30|||
27891714|NCT02655016|81437369|FG001|Overall Study|Death|48|||
27891715|NCT02655016|81437368|FG000|Overall Study|Lost to Follow-up|1|||
27891716|NCT02655016|81437369|FG001|Overall Study|Lost to Follow-up|1|||
27891717|NCT02655016|81437368|FG000|Overall Study|Withdrawal by Subject|18|||
27891718|NCT02655016|81437369|FG001|Overall Study|Withdrawal by Subject|36|||
27891719|NCT03385304|81437370|FG000|Overall Study|Death|19|||
27891720|NCT03385304|81437371|FG001|Overall Study|Death|7|||
27891721|NCT03385304|81437370|FG000|Overall Study|Lost to Follow-up|17|||
27891722|NCT03385304|81437371|FG001|Overall Study|Lost to Follow-up|14|||
27891723|NCT03385304|81437370|FG000|Overall Study|Withdrawal by Subject|3|||
27891724|NCT03385304|81437371|FG001|Overall Study|Withdrawal by Subject|2|||
27891725|NCT03385304|81437370|FG000|Overall Study|Incarceration|2|||
27891726|NCT03385304|81437371|FG001|Overall Study|Incarceration|3|||
27502020|NCT02052778|80032519|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
27502021|NCT02052778|80032520|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
27722082|NCT03434379|80815345|FG001|Global Period|Reason Unspecified|1|||
27722083|NCT03434379|80815346|FG002|Global Period|Reason Unspecified|0|||
27722084|NCT03434379|80815347|FG003|Global Period|Reason Unspecified|0|||
27722085|NCT03434379|80815344|FG000|Global Period|Study Ended by Sponsor|26|||
27722086|NCT03434379|80815345|FG001|Global Period|Study Ended by Sponsor|80|||
27722087|NCT03434379|80815346|FG002|Global Period|Study Ended by Sponsor|0|||
27722088|NCT03434379|80815347|FG003|Global Period|Study Ended by Sponsor|0|||
27722089|NCT03434379|80815344|FG000|Global Period|Physician Decision|1|||
27722090|NCT03434379|80815345|FG001|Global Period|Physician Decision|0|||
27722091|NCT03434379|80815346|FG002|Global Period|Physician Decision|0|||
27722092|NCT03434379|80815347|FG003|Global Period|Physician Decision|0|||
27611099|NCT03661996|80419003|FG000|Overall Study|Withdrawal by Subject|3|||
27611100|NCT03661996|80419004|FG001|Overall Study|Withdrawal by Subject|5|||
27722093|NCT03434379|80815344|FG000|China Extension Period|Lost to Follow-up|0|||
27722094|NCT03434379|80815345|FG001|China Extension Period|Lost to Follow-up|0|||
27722095|NCT03434379|80815346|FG002|China Extension Period|Lost to Follow-up|2|||
27722096|NCT03434379|80815347|FG003|China Extension Period|Lost to Follow-up|3|||
27722097|NCT03434379|80815344|FG000|China Extension Period|Death|0|||
27722098|NCT03434379|80815345|FG001|China Extension Period|Death|0|||
27722099|NCT03434379|80815346|FG002|China Extension Period|Death|46|||
27722100|NCT03434379|80815347|FG003|China Extension Period|Death|88|||
27722101|NCT03434379|80815344|FG000|China Extension Period|Withdrawal by Subject|0|||
27722102|NCT03434379|80815345|FG001|China Extension Period|Withdrawal by Subject|0|||
27722103|NCT03434379|80815346|FG002|China Extension Period|Withdrawal by Subject|8|||
27722104|NCT03434379|80815347|FG003|China Extension Period|Withdrawal by Subject|6|||
27722105|NCT03434379|80815344|FG000|China Extension Period|Study Ended by Sponsor|0|||
27722106|NCT03434379|80815345|FG001|China Extension Period|Study Ended by Sponsor|0|||
27722107|NCT03434379|80815346|FG002|China Extension Period|Study Ended by Sponsor|5|||
27722108|NCT03434379|80815347|FG003|China Extension Period|Study Ended by Sponsor|36|||
27722109|NCT01857869|80815354|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
27722110|NCT01857869|80815355|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
27722111|NCT01857869|80815356|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
27722112|NCT01857869|80815357|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
27722113|NCT01857869|80815358|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
27722114|NCT01857869|80815359|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
27722115|NCT01857869|80815360|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
27722116|NCT01857869|80815361|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
27722117|NCT01857869|80815362|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
27722118|NCT01857869|80815363|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
27722119|NCT01857869|80815354|FG000|Primary/Challenge Phase|Pregnancy|1|||
27722120|NCT01857869|80815355|FG001|Primary/Challenge Phase|Pregnancy|0|||
27722121|NCT01857869|80815356|FG002|Primary/Challenge Phase|Pregnancy|0|||
27722122|NCT01857869|80815357|FG003|Primary/Challenge Phase|Pregnancy|0|||
27722123|NCT01857869|80815358|FG004|Primary/Challenge Phase|Pregnancy|0|||
27722124|NCT01857869|80815359|FG005|Primary/Challenge Phase|Pregnancy|0|||
27722125|NCT01857869|80815360|FG006|Primary/Challenge Phase|Pregnancy|0|||
27722126|NCT01857869|80815361|FG007|Primary/Challenge Phase|Pregnancy|0|||
27722127|NCT01857869|80815362|FG008|Primary/Challenge Phase|Pregnancy|0|||
27722128|NCT01857869|80815363|FG009|Primary/Challenge Phase|Pregnancy|0|||
27722129|NCT01857869|80815354|FG000|Primary/Challenge Phase|Protocol Violation|1|||
27722130|NCT01857869|80815355|FG001|Primary/Challenge Phase|Protocol Violation|0|||
27722131|NCT01857869|80815356|FG002|Primary/Challenge Phase|Protocol Violation|0|||
27722132|NCT01857869|80815357|FG003|Primary/Challenge Phase|Protocol Violation|0|||
27722133|NCT01857869|80815358|FG004|Primary/Challenge Phase|Protocol Violation|0|||
27722134|NCT01857869|80815359|FG005|Primary/Challenge Phase|Protocol Violation|0|||
27722135|NCT01857869|80815360|FG006|Primary/Challenge Phase|Protocol Violation|0|||
27722136|NCT01857869|80815361|FG007|Primary/Challenge Phase|Protocol Violation|0|||
27722137|NCT01857869|80815362|FG008|Primary/Challenge Phase|Protocol Violation|0|||
27722138|NCT01857869|80815363|FG009|Primary/Challenge Phase|Protocol Violation|0|||
27722139|NCT01857869|80815354|FG000|Primary/Challenge Phase|Other|1|||
27722140|NCT01857869|80815355|FG001|Primary/Challenge Phase|Other|1|||
27722141|NCT01857869|80815356|FG002|Primary/Challenge Phase|Other|0|||
27611101|NCT03661996|80419005|FG002|Overall Study|Withdrawal by Subject|1|||
27722142|NCT01857869|80815357|FG003|Primary/Challenge Phase|Other|0|||
27722143|NCT01857869|80815358|FG004|Primary/Challenge Phase|Other|0|||
27722144|NCT01857869|80815359|FG005|Primary/Challenge Phase|Other|0|||
27722145|NCT01857869|80815360|FG006|Primary/Challenge Phase|Other|0|||
27722146|NCT01857869|80815361|FG007|Primary/Challenge Phase|Other|0|||
27722147|NCT01857869|80815362|FG008|Primary/Challenge Phase|Other|0|||
27611102|NCT03661996|80419006|FG003|Overall Study|Withdrawal by Subject|7|||
27611103|NCT03661996|80419007|FG004|Overall Study|Withdrawal by Subject|7|||
27722148|NCT01857869|80815363|FG009|Primary/Challenge Phase|Other|0|||
27722149|NCT01857869|80815354|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722150|NCT01857869|80815355|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722151|NCT01857869|80815356|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722152|NCT01857869|80815357|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
27722153|NCT01857869|80815358|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722154|NCT01857869|80815359|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722155|NCT01857869|80815360|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722156|NCT01857869|80815361|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722157|NCT01857869|80815362|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27722158|NCT01857869|80815363|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
27840667|NCT01332968|81245171|FG002|Induction Period|Adverse Event|0|||
27840668|NCT01332968|81245172|FG003|Induction Period|Adverse Event|0|||
27840669|NCT01332968|81245173|FG004|Induction Period|Adverse Event|0|||
27840670|NCT01332968|81245174|FG005|Induction Period|Adverse Event|0|||
27840671|NCT01332968|81245175|FG006|Induction Period|Adverse Event|0|||
27840672|NCT01332968|81245176|FG007|Induction Period|Adverse Event|0|||
27840673|NCT01332968|81245169|FG000|Induction Period|Death|1|||
27840674|NCT01332968|81245170|FG001|Induction Period|Death|4|||
27840675|NCT01332968|81245171|FG002|Induction Period|Death|0|||
27840676|NCT01332968|81245172|FG003|Induction Period|Death|0|||
27840677|NCT01332968|81245173|FG004|Induction Period|Death|0|||
27840678|NCT01332968|81245174|FG005|Induction Period|Death|0|||
27840679|NCT01332968|81245175|FG006|Induction Period|Death|0|||
27840680|NCT01332968|81245176|FG007|Induction Period|Death|0|||
27840681|NCT01332968|81245169|FG000|Induction Period|Non-compliance|1|||
27840682|NCT01332968|81245170|FG001|Induction Period|Non-compliance|0|||
27840683|NCT01332968|81245171|FG002|Induction Period|Non-compliance|0|||
27840684|NCT01332968|81245172|FG003|Induction Period|Non-compliance|0|||
27840685|NCT01332968|81245173|FG004|Induction Period|Non-compliance|0|||
27840686|NCT01332968|81245174|FG005|Induction Period|Non-compliance|0|||
27840687|NCT01332968|81245175|FG006|Induction Period|Non-compliance|0|||
27840688|NCT01332968|81245176|FG007|Induction Period|Non-compliance|0|||
27840689|NCT01332968|81245169|FG000|Induction Period|Other|2|||
27840690|NCT01332968|81245170|FG001|Induction Period|Other|2|||
27840691|NCT01332968|81245171|FG002|Induction Period|Other|0|||
27840692|NCT01332968|81245172|FG003|Induction Period|Other|0|||
27840693|NCT01332968|81245173|FG004|Induction Period|Other|0|||
27840694|NCT01332968|81245174|FG005|Induction Period|Other|0|||
27840695|NCT01332968|81245175|FG006|Induction Period|Other|0|||
27840696|NCT01332968|81245176|FG007|Induction Period|Other|0|||
27840697|NCT01332968|81245169|FG000|Induction Period|Physician Decision|6|||
27840698|NCT01332968|81245170|FG001|Induction Period|Physician Decision|1|||
27840699|NCT01332968|81245171|FG002|Induction Period|Physician Decision|0|||
27840700|NCT01332968|81245172|FG003|Induction Period|Physician Decision|0|||
27840701|NCT01332968|81245173|FG004|Induction Period|Physician Decision|0|||
27840702|NCT01332968|81245174|FG005|Induction Period|Physician Decision|0|||
27840703|NCT01332968|81245175|FG006|Induction Period|Physician Decision|0|||
27840704|NCT01332968|81245176|FG007|Induction Period|Physician Decision|0|||
27840705|NCT01332968|81245169|FG000|Induction Period|Progressive Disease|15|||
27840706|NCT01332968|81245170|FG001|Induction Period|Progressive Disease|7|||
27840707|NCT01332968|81245171|FG002|Induction Period|Progressive Disease|0|||
27840708|NCT01332968|81245172|FG003|Induction Period|Progressive Disease|0|||
27840709|NCT01332968|81245173|FG004|Induction Period|Progressive Disease|0|||
27891727|NCT01901653|81437372|FG000|Overall Study|Death|2|||
27891728|NCT01901653|81437373|FG001|Overall Study|Death|1|||
27891729|NCT01901653|81437374|FG002|Overall Study|Death|8|||
27891730|NCT01901653|81437375|FG003|Overall Study|Death|3|||
27891731|NCT01901653|81437376|FG004|Overall Study|Death|2|||
27891732|NCT01901653|81437377|FG005|Overall Study|Death|2|||
27891733|NCT01901653|81437378|FG006|Overall Study|Death|6|||
27891734|NCT01901653|81437379|FG007|Overall Study|Death|9|||
27891735|NCT01901653|81437380|FG008|Overall Study|Death|1|||
27891736|NCT01901653|81437381|FG009|Overall Study|Death|16|||
27502022|NCT02052778|80032498|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27722159|NCT01857869|80815354|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722160|NCT01857869|80815355|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27840710|NCT01332968|81245174|FG005|Induction Period|Progressive Disease|0|||
27840711|NCT01332968|81245175|FG006|Induction Period|Progressive Disease|0|||
27840712|NCT01332968|81245176|FG007|Induction Period|Progressive Disease|0|||
27840713|NCT01332968|81245169|FG000|Induction Period|Protocol Violation|3|||
27840714|NCT01332968|81245170|FG001|Induction Period|Protocol Violation|4|||
27840715|NCT01332968|81245171|FG002|Induction Period|Protocol Violation|0|||
27840716|NCT01332968|81245172|FG003|Induction Period|Protocol Violation|0|||
27840717|NCT01332968|81245173|FG004|Induction Period|Protocol Violation|0|||
27840718|NCT01332968|81245174|FG005|Induction Period|Protocol Violation|0|||
27840719|NCT01332968|81245175|FG006|Induction Period|Protocol Violation|0|||
27840720|NCT01332968|81245176|FG007|Induction Period|Protocol Violation|0|||
27840721|NCT01332968|81245169|FG000|Induction Period|Withdrawal by Subject|3|||
27891737|NCT01901653|81437382|FG010|Overall Study|Death|2|||
27891738|NCT01901653|81437383|FG011|Overall Study|Death|15|||
27722161|NCT01857869|80815356|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722162|NCT01857869|80815357|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
27722163|NCT01857869|80815358|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722164|NCT01857869|80815359|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722165|NCT01857869|80815360|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722166|NCT01857869|80815361|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722167|NCT01857869|80815362|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722168|NCT01857869|80815363|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
27722169|NCT01668654|80815368|FG000|Overall Study|Study Closed/Terminated|3|||
27722170|NCT01668654|80815368|FG000|Overall Study|Withdrawal by Subject|1|||
27722171|NCT00070941|80815369|FG000|Overall Study|Adverse Event|10|||
27722172|NCT00070941|80815370|FG001|Overall Study|Adverse Event|8|||
27722173|NCT00070941|80815371|FG002|Overall Study|Adverse Event|4|||
27722174|NCT01972074|80815372|FG000|Overall Study|Adverse Event|4|||
27722175|NCT01972074|80815373|FG001|Overall Study|Adverse Event|1|||
27722176|NCT01972074|80815374|FG002|Overall Study|Adverse Event|0|||
27722177|NCT01972074|80815372|FG000|Overall Study|Lack of Efficacy|1|||
27722178|NCT01972074|80815373|FG001|Overall Study|Lack of Efficacy|1|||
27722179|NCT01972074|80815374|FG002|Overall Study|Lack of Efficacy|0|||
27722180|NCT01972074|80815372|FG000|Overall Study|Lost to Follow-up|0|||
27722181|NCT01972074|80815373|FG001|Overall Study|Lost to Follow-up|1|||
27722182|NCT01972074|80815374|FG002|Overall Study|Lost to Follow-up|1|||
27722183|NCT01972074|80815372|FG000|Overall Study|Withdrawal by Subject|1|||
27722184|NCT01972074|80815373|FG001|Overall Study|Withdrawal by Subject|1|||
27722185|NCT01972074|80815374|FG002|Overall Study|Withdrawal by Subject|1|||
27502023|NCT02052778|80032499|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502024|NCT02052778|80032500|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502025|NCT02052778|80032501|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502026|NCT02052778|80032502|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502027|NCT02052778|80032503|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502028|NCT02052778|80032504|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502029|NCT02052778|80032505|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502030|NCT02052778|80032506|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
27502031|NCT02052778|80032507|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502032|NCT02052778|80032508|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27722186|NCT01972074|80815372|FG000|Overall Study|Scanner Unavailable|0|||
27722187|NCT01972074|80815373|FG001|Overall Study|Scanner Unavailable|0|||
27722188|NCT01972074|80815374|FG002|Overall Study|Scanner Unavailable|1|||
27840722|NCT01332968|81245170|FG001|Induction Period|Withdrawal by Subject|5|||
27502033|NCT02052778|80032509|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27722189|NCT00634569|80815377|FG000|Overall Study|Withdrawal by Subject|0|||
27722190|NCT00634569|80815378|FG001|Overall Study|Withdrawal by Subject|4|||
27840723|NCT01332968|81245171|FG002|Induction Period|Withdrawal by Subject|0|||
27840724|NCT01332968|81245172|FG003|Induction Period|Withdrawal by Subject|0|||
27722191|NCT00634569|80815377|FG000|Overall Study|Physician Decision|0|||
27611104|NCT03661996|80419003|FG000|Overall Study|Sponsors Decision|2|||
27840725|NCT01332968|81245173|FG004|Induction Period|Withdrawal by Subject|0|||
27840726|NCT01332968|81245174|FG005|Induction Period|Withdrawal by Subject|0|||
27840727|NCT01332968|81245175|FG006|Induction Period|Withdrawal by Subject|0|||
27840728|NCT01332968|81245176|FG007|Induction Period|Withdrawal by Subject|0|||
27722192|NCT00634569|80815378|FG001|Overall Study|Physician Decision|1|||
27722193|NCT01459614|80815379|FG000|Overall Study|Adverse Event|1|||
27722194|NCT01459614|80815380|FG001|Overall Study|Adverse Event|0|||
27722195|NCT02810964|80815381|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
27722196|NCT02810964|80815382|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
27722197|NCT02810964|80815381|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
27722198|NCT02810964|80815382|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
27722199|NCT02810964|80815381|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
27722200|NCT02810964|80815382|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
27722201|NCT02810964|80815381|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
27722202|NCT02810964|80815382|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
27722203|NCT01700192|80815383|FG000|Overall Study|Adverse Event|73|||
27722204|NCT01700192|80815384|FG001|Overall Study|Adverse Event|18|||
27722205|NCT01700192|80815383|FG000|Overall Study|Lack of Efficacy|1|||
27722206|NCT01700192|80815384|FG001|Overall Study|Lack of Efficacy|0|||
27722207|NCT01700192|80815383|FG000|Overall Study|Lost to Follow-up|42|||
27722208|NCT01700192|80815384|FG001|Overall Study|Lost to Follow-up|29|||
27722209|NCT01700192|80815383|FG000|Overall Study|Noncompliance with study drug|0|||
27722210|NCT01700192|80815384|FG001|Overall Study|Noncompliance with study drug|5|||
27722211|NCT01700192|80815383|FG000|Overall Study|Physician Decision|2|||
27722212|NCT01700192|80815384|FG001|Overall Study|Physician Decision|3|||
27722213|NCT01700192|80815383|FG000|Overall Study|Pregnancy|1|||
27722214|NCT01700192|80815384|FG001|Overall Study|Pregnancy|4|||
27722215|NCT01700192|80815383|FG000|Overall Study|Progressive disease|1|||
27722216|NCT01700192|80815384|FG001|Overall Study|Progressive disease|0|||
27722217|NCT01700192|80815383|FG000|Overall Study|Protocol Violation|3|||
27722218|NCT01700192|80815384|FG001|Overall Study|Protocol Violation|4|||
27722219|NCT01700192|80815383|FG000|Overall Study|Technical problems|0|||
27722220|NCT01700192|80815384|FG001|Overall Study|Technical problems|1|||
27722221|NCT01700192|80815383|FG000|Overall Study|Withdrawal by Subject|56|||
27722222|NCT01700192|80815384|FG001|Overall Study|Withdrawal by Subject|64|||
27722223|NCT01700192|80815383|FG000|Overall Study|Never received study drug|1|||
27722224|NCT01700192|80815384|FG001|Overall Study|Never received study drug|0|||
27722225|NCT03870555|80815387|FG000|Period 3 (2 Days)|Adverse Event|1|||
27722226|NCT03870555|80815388|FG001|Period 3 (2 Days)|Adverse Event|0|||
27722227|NCT03870555|80815389|FG002|Period 3 (2 Days)|Adverse Event|0|||
27722228|NCT00477165|80815390|FG000|Overall Study|Adverse Event|7|||
27722229|NCT00477165|80815391|FG001|Overall Study|Adverse Event|2|||
27722230|NCT00343512|80815400|FG000|Overall Study|Withdrawal by Subject|2|||
27722231|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
27722232|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
27722233|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
27722234|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27722235|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27722236|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27722237|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27722238|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27722239|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
27722240|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
27722241|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
27722242|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
27722243|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27722244|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27722245|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27722246|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27722247|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27840729|NCT01332968|81245169|FG000|Induction Period|Randomised but not treated|4|||
27840730|NCT01332968|81245170|FG001|Induction Period|Randomised but not treated|7|||
27840731|NCT01332968|81245171|FG002|Induction Period|Randomised but not treated|0|||
27840732|NCT01332968|81245172|FG003|Induction Period|Randomised but not treated|0|||
27722248|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
27722249|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
27840733|NCT01332968|81245173|FG004|Induction Period|Randomised but not treated|0|||
27840734|NCT01332968|81245174|FG005|Induction Period|Randomised but not treated|0|||
27840735|NCT01332968|81245175|FG006|Induction Period|Randomised but not treated|0|||
27840736|NCT01332968|81245176|FG007|Induction Period|Randomised but not treated|0|||
27611105|NCT03661996|80419004|FG001|Overall Study|Sponsors Decision|0|||
27840737|NCT01332968|81245169|FG000|Maintenance/Observation Period|Adverse Event|0|||
27722250|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
27722251|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722252|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722253|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722254|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722255|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722256|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722257|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
27722258|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
27722259|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
27722260|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
27722261|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27722262|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27722263|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27722264|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27722265|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27722266|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
27722267|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
27722268|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
27722269|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722270|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722271|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722272|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722273|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722274|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722275|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
27722276|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722277|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722278|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
27722279|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722280|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722281|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722282|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27891739|NCT01901653|81437384|FG012|Overall Study|Death|4|||
27891740|NCT01901653|81437372|FG000|Overall Study|Lost to Follow-up|1|||
27891741|NCT01901653|81437373|FG001|Overall Study|Lost to Follow-up|0|||
27891742|NCT01901653|81437374|FG002|Overall Study|Lost to Follow-up|2|||
27891743|NCT01901653|81437375|FG003|Overall Study|Lost to Follow-up|0|||
27891744|NCT01901653|81437376|FG004|Overall Study|Lost to Follow-up|0|||
27891745|NCT01901653|81437377|FG005|Overall Study|Lost to Follow-up|1|||
27891746|NCT01901653|81437378|FG006|Overall Study|Lost to Follow-up|0|||
27891747|NCT01901653|81437379|FG007|Overall Study|Lost to Follow-up|1|||
27891748|NCT01901653|81437380|FG008|Overall Study|Lost to Follow-up|0|||
27891749|NCT01901653|81437381|FG009|Overall Study|Lost to Follow-up|0|||
27891750|NCT01901653|81437382|FG010|Overall Study|Lost to Follow-up|0|||
27891751|NCT01901653|81437383|FG011|Overall Study|Lost to Follow-up|0|||
27891752|NCT01901653|81437384|FG012|Overall Study|Lost to Follow-up|0|||
27891753|NCT01901653|81437372|FG000|Overall Study|Withdrawal by Subject|0|||
27891754|NCT01901653|81437373|FG001|Overall Study|Withdrawal by Subject|0|||
27891755|NCT01901653|81437374|FG002|Overall Study|Withdrawal by Subject|0|||
27891756|NCT01901653|81437375|FG003|Overall Study|Withdrawal by Subject|0|||
27891757|NCT01901653|81437376|FG004|Overall Study|Withdrawal by Subject|0|||
27891758|NCT01901653|81437377|FG005|Overall Study|Withdrawal by Subject|0|||
27891759|NCT01901653|81437378|FG006|Overall Study|Withdrawal by Subject|1|||
27722283|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722284|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
27722285|NCT01583374|80815401|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722286|NCT01583374|80815402|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
27722287|NCT01583374|80815403|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722288|NCT01583374|80815404|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722289|NCT01583374|80815405|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722290|NCT01583374|80815406|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722291|NCT01583374|80815407|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722292|NCT01583374|80815408|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
27891760|NCT01901653|81437379|FG007|Overall Study|Withdrawal by Subject|0|||
27891761|NCT01901653|81437380|FG008|Overall Study|Withdrawal by Subject|0|||
27891762|NCT01901653|81437381|FG009|Overall Study|Withdrawal by Subject|0|||
27891763|NCT01901653|81437382|FG010|Overall Study|Withdrawal by Subject|0|||
27891764|NCT01901653|81437383|FG011|Overall Study|Withdrawal by Subject|0|||
27722293|NCT01583374|80815409|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
27722294|NCT01583374|80815401|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722295|NCT01583374|80815402|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722296|NCT01583374|80815403|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722297|NCT01583374|80815404|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722298|NCT01583374|80815405|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722299|NCT01583374|80815406|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722300|NCT01583374|80815407|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722301|NCT01583374|80815408|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
27722302|NCT01583374|80815409|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
27722303|NCT01583374|80815401|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27722304|NCT01583374|80815402|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27722305|NCT01583374|80815403|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
27722306|NCT01583374|80815404|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27722307|NCT01583374|80815405|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27722308|NCT01583374|80815406|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27722309|NCT01583374|80815407|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27722310|NCT01583374|80815408|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
27722311|NCT01583374|80815409|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
27722312|NCT01583374|80815401|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
27722313|NCT01583374|80815402|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
27722314|NCT01583374|80815403|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
27722315|NCT01583374|80815404|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
27722316|NCT01583374|80815405|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
27722317|NCT01583374|80815406|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
27722318|NCT01583374|80815407|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
27722319|NCT01583374|80815408|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
27722320|NCT01583374|80815409|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
27722321|NCT01583374|80815401|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27611106|NCT03661996|80419005|FG002|Overall Study|Sponsors Decision|0|||
27611107|NCT03661996|80419006|FG003|Overall Study|Sponsors Decision|0|||
27611108|NCT03661996|80419007|FG004|Overall Study|Sponsors Decision|0|||
27611109|NCT03661996|80419003|FG000|Overall Study|Other|1|||
27611110|NCT03661996|80419004|FG001|Overall Study|Other|1|||
27722322|NCT01583374|80815402|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
27840738|NCT01332968|81245170|FG001|Maintenance/Observation Period|Adverse Event|0|||
27840739|NCT01332968|81245171|FG002|Maintenance/Observation Period|Adverse Event|53|||
27611111|NCT03661996|80419005|FG002|Overall Study|Other|1|||
27891765|NCT01901653|81437384|FG012|Overall Study|Withdrawal by Subject|0|||
27891766|NCT01901653|81437372|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
27891767|NCT01901653|81437373|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
27891768|NCT01901653|81437374|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
27891769|NCT01901653|81437375|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
27891770|NCT01901653|81437376|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
27891771|NCT01901653|81437377|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
27891772|NCT01901653|81437378|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
27891773|NCT01901653|81437379|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
27891774|NCT01901653|81437380|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
27891775|NCT01901653|81437381|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
27891776|NCT01901653|81437382|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
27891777|NCT01901653|81437383|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
27891778|NCT01901653|81437384|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
27891779|NCT01032239|81437390|FG000|Overall Study|Lost to Follow-up|3|||
27891780|NCT01032239|81437391|FG001|Overall Study|Lost to Follow-up|2|||
27891781|NCT01032239|81437390|FG000|Overall Study|Withdrawal by Subject|2|||
27891782|NCT01032239|81437391|FG001|Overall Study|Withdrawal by Subject|3|||
27891783|NCT01032239|81437390|FG000|Overall Study|Death|1|||
27891784|NCT01032239|81437391|FG001|Overall Study|Death|0|||
27891785|NCT01032239|81437390|FG000|Overall Study|Protocol Violation|1|||
27891786|NCT01032239|81437391|FG001|Overall Study|Protocol Violation|0|||
27891787|NCT04712019|81437394|FG000|Overall Study|Withdrawal by Subject|2|||
27891788|NCT04712019|81437395|FG001|Overall Study|Withdrawal by Subject|2|||
27891789|NCT04712019|81437394|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
27891790|NCT04712019|81437395|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
27891791|NCT02832375|81437397|FG000|Overall Study|Lost to Follow-up|1|||
27891792|NCT02832375|81437398|FG001|Overall Study|Lost to Follow-up|0|||
27891793|NCT02832375|81437397|FG000|Overall Study|Withdrawal of Consent|1|||
27611112|NCT03661996|80419006|FG003|Overall Study|Other|1|||
27891794|NCT02832375|81437398|FG001|Overall Study|Withdrawal of Consent|0|||
27611113|NCT03661996|80419007|FG004|Overall Study|Other|0|||
27891795|NCT04756154|81437401|FG000|Overall Study|Did not meet treatment day baseline|30|||
27891796|NCT04756154|81437402|FG001|Overall Study|Did not meet treatment day baseline|28|||
27891797|NCT04756154|81437403|FG002|Overall Study|Did not meet treatment day baseline|7|||
27891798|NCT04756154|81437401|FG000|Overall Study|Did not return for final sample collection|1|||
27891799|NCT04756154|81437402|FG001|Overall Study|Did not return for final sample collection|1|||
27891800|NCT04756154|81437403|FG002|Overall Study|Did not return for final sample collection|0|||
27891801|NCT01966068|81437406|FG000|Overall Study|Withdrawal by Subject|57|||
27891802|NCT01966068|81437406|FG000|Overall Study|Lost to Follow-up|81|||
27891803|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Adverse Event|6|||
27891804|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Adverse Event|14|||
27611114|NCT03377790|80419008|FG000|Overall Study|Withdrawal by Subject|1|||
27611115|NCT03377790|80419009|FG001|Overall Study|Withdrawal by Subject|0|||
27611116|NCT03377790|80419008|FG000|Overall Study|Adverse Event|1|||
27611117|NCT03377790|80419009|FG001|Overall Study|Adverse Event|0|||
27611118|NCT03377790|80419008|FG000|Overall Study|Lost to Follow-up|0|||
27611119|NCT03377790|80419009|FG001|Overall Study|Lost to Follow-up|2|||
27611120|NCT03377790|80419008|FG000|Overall Study|Randomized but not treated|1|||
27611121|NCT03377790|80419009|FG001|Overall Study|Randomized but not treated|0|||
27611122|NCT03377790|80419008|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
27611123|NCT03377790|80419009|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
27611124|NCT04789577|80419012|FG000|Overall Study|Withdrawal by Subject|1|||
27611125|NCT04789577|80419013|FG001|Overall Study|Withdrawal by Subject|1|||
27611126|NCT04789577|80419014|FG002|Overall Study|Withdrawal by Subject|1|||
27611127|NCT04789577|80419015|FG003|Overall Study|Withdrawal by Subject|3|||
27611128|NCT04789577|80419016|FG004|Overall Study|Withdrawal by Subject|1|||
27611129|NCT04789577|80419017|FG005|Overall Study|Withdrawal by Subject|7|||
27611130|NCT04789577|80419018|FG006|Overall Study|Withdrawal by Subject|1|||
27611131|NCT04789577|80419012|FG000|Overall Study|Lost to Follow-up|7|||
27611132|NCT04789577|80419013|FG001|Overall Study|Lost to Follow-up|12|||
27611133|NCT04789577|80419014|FG002|Overall Study|Lost to Follow-up|7|||
27611134|NCT04789577|80419015|FG003|Overall Study|Lost to Follow-up|10|||
27611135|NCT04789577|80419016|FG004|Overall Study|Lost to Follow-up|8|||
27611136|NCT04789577|80419017|FG005|Overall Study|Lost to Follow-up|6|||
27611137|NCT04789577|80419018|FG006|Overall Study|Lost to Follow-up|10|||
27611138|NCT04789577|80419012|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
27611139|NCT04789577|80419013|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
27611140|NCT04789577|80419014|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
27611141|NCT04789577|80419015|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
27611142|NCT04789577|80419016|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
27611143|NCT04789577|80419017|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
27611144|NCT04789577|80419018|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
27611145|NCT04789577|80419012|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
27611146|NCT04789577|80419013|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
27611147|NCT04789577|80419014|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
27611148|NCT04789577|80419015|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
27611149|NCT04789577|80419016|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
27611150|NCT04789577|80419017|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
27611151|NCT04789577|80419018|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
27722323|NCT01583374|80815403|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
27502034|NCT02052778|80032510|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27611152|NCT00539643|80419020|FG000|Overall Study|Adverse Event|1|||
27611153|NCT00539643|80419021|FG001|Overall Study|Adverse Event|0|||
27611154|NCT00539643|80419020|FG000|Overall Study|Death|2|||
27611155|NCT00539643|80419021|FG001|Overall Study|Death|1|||
27611156|NCT00539643|80419020|FG000|Overall Study|Physician Decision|3|||
27611157|NCT00539643|80419021|FG001|Overall Study|Physician Decision|1|||
27611158|NCT00539643|80419020|FG000|Overall Study|Withdrawal by Subject|0|||
27891805|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Death|3|||
27891806|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Death|1|||
27891807|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
27891808|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
27891809|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
27891810|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
27891811|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
27891812|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
27891813|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
27891814|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
27891815|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
27891816|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
27891817|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Physician Decision|2|||
27891818|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Physician Decision|4|||
27891819|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Pregnancy|2|||
27891820|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Pregnancy|1|||
27891821|NCT02275780|81437407|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
27891822|NCT02275780|81437408|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
27891823|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
27891824|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
27891825|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
27891826|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
27891827|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
27891828|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
27891829|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
27891830|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
27891831|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
27891832|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
27891833|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
27891834|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
27891835|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
27891836|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
27891837|NCT02275780|81437407|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
27891838|NCT02275780|81437408|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
27891839|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
27891840|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
27891841|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
27891842|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
27891843|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
27891844|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
27891845|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
27891846|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
27891847|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
27891848|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
27891849|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
27891850|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
27891851|NCT02275780|81437407|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
27891852|NCT02275780|81437408|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
27891853|NCT02275780|81437407|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
27891854|NCT02275780|81437408|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
27891855|NCT02275780|81437407|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
27891856|NCT02275780|81437408|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
27891857|NCT02275780|81437407|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
27891858|NCT02275780|81437408|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
27891859|NCT02275780|81437407|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
27891860|NCT02275780|81437408|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
27891861|NCT02275780|81437407|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
27891862|NCT02275780|81437408|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
27891863|NCT02275780|81437407|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
27891864|NCT02275780|81437408|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
27891865|NCT02777970|81437409|FG000|Overall Study|Lost to Follow-up|0|||
27891866|NCT02777970|81437410|FG001|Overall Study|Lost to Follow-up|1|||
27891867|NCT02777970|81437411|FG002|Overall Study|Lost to Follow-up|0|||
27891868|NCT02777970|81437409|FG000|Overall Study|Protocol Violation|1|||
27722324|NCT01583374|80815404|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27891869|NCT02777970|81437410|FG001|Overall Study|Protocol Violation|0|||
27891870|NCT02777970|81437411|FG002|Overall Study|Protocol Violation|0|||
27891871|NCT02253316|81437419|FG000|Consolidation|Progression|4|||
27891872|NCT02253316|81437420|FG001|Consolidation|Progression|0|||
27891873|NCT02253316|81437421|FG002|Consolidation|Progression|0|||
27891874|NCT02253316|81437419|FG000|Consolidation|Non-Compliance|1|||
27891875|NCT02253316|81437420|FG001|Consolidation|Non-Compliance|0|||
27891876|NCT02253316|81437421|FG002|Consolidation|Non-Compliance|0|||
27891877|NCT02253316|81437419|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
27891878|NCT02253316|81437420|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
27891879|NCT02253316|81437421|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
27891880|NCT02253316|81437419|FG000|Consolidation|Secondary Malignancy|2|||
27891881|NCT02253316|81437420|FG001|Consolidation|Secondary Malignancy|0|||
27891882|NCT02253316|81437421|FG002|Consolidation|Secondary Malignancy|0|||
27891883|NCT02253316|81437419|FG000|Consolidation|Adverse Event|7|||
27891884|NCT02253316|81437420|FG001|Consolidation|Adverse Event|0|||
27891885|NCT02253316|81437421|FG002|Consolidation|Adverse Event|0|||
27891886|NCT02253316|81437419|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
27891887|NCT02253316|81437420|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
27891888|NCT02253316|81437421|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
27891889|NCT02253316|81437419|FG000|Maintenance|Physician Decision|0|||
27891890|NCT02253316|81437420|FG001|Maintenance|Physician Decision|7|||
27891891|NCT02253316|81437421|FG002|Maintenance|Physician Decision|16|||
27891892|NCT02253316|81437419|FG000|Maintenance|Non-Compliance|0|||
27891893|NCT02253316|81437420|FG001|Maintenance|Non-Compliance|1|||
27891894|NCT02253316|81437421|FG002|Maintenance|Non-Compliance|1|||
27891895|NCT02253316|81437419|FG000|Maintenance|Secondary Malignancy|0|||
27891896|NCT02253316|81437420|FG001|Maintenance|Secondary Malignancy|2|||
27891897|NCT02253316|81437421|FG002|Maintenance|Secondary Malignancy|6|||
27891898|NCT02253316|81437419|FG000|Maintenance|Adverse Event|0|||
27891899|NCT02253316|81437420|FG001|Maintenance|Adverse Event|8|||
27891900|NCT02253316|81437421|FG002|Maintenance|Adverse Event|12|||
27891901|NCT02253316|81437419|FG000|Maintenance|Still receiving active treatment|0|||
27891902|NCT02253316|81437420|FG001|Maintenance|Still receiving active treatment|5|||
27891903|NCT02253316|81437421|FG002|Maintenance|Still receiving active treatment|0|||
27891904|NCT00808639|81437431|FG000|Overall Study|Disease progression before surgery.|1|||
27891905|NCT04776018|81437432|FG000|Overall Study|Death|0|||
27891906|NCT04776018|81437433|FG001|Overall Study|Death|1|||
27891907|NCT04776018|81437434|FG002|Overall Study|Death|4|||
27891908|NCT04776018|81437435|FG003|Overall Study|Death|1|||
27891909|NCT04776018|81437436|FG004|Overall Study|Death|4|||
27891910|NCT04776018|81437437|FG005|Overall Study|Death|0|||
27891911|NCT04776018|81437438|FG006|Overall Study|Death|0|||
27891912|NCT04776018|81437432|FG000|Overall Study|Study terminated by sponsor|2|||
27891913|NCT04776018|81437433|FG001|Overall Study|Study terminated by sponsor|1|||
27891914|NCT04776018|81437434|FG002|Overall Study|Study terminated by sponsor|4|||
27891915|NCT04776018|81437435|FG003|Overall Study|Study terminated by sponsor|0|||
27891916|NCT04776018|81437436|FG004|Overall Study|Study terminated by sponsor|3|||
27891917|NCT04776018|81437437|FG005|Overall Study|Study terminated by sponsor|0|||
27891918|NCT04776018|81437438|FG006|Overall Study|Study terminated by sponsor|0|||
27722325|NCT01583374|80815405|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
27722326|NCT01583374|80815406|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27722327|NCT01583374|80815407|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27722328|NCT01583374|80815408|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27722329|NCT01583374|80815409|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
27722330|NCT01583374|80815401|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27722331|NCT01583374|80815402|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27722332|NCT01583374|80815403|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
27722333|NCT01583374|80815404|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27722334|NCT01583374|80815405|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
27722335|NCT01583374|80815406|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
27891919|NCT04776018|81437432|FG000|Overall Study|Withdrawal by Subject|1|||
27891920|NCT04776018|81437433|FG001|Overall Study|Withdrawal by Subject|0|||
27891921|NCT04776018|81437434|FG002|Overall Study|Withdrawal by Subject|0|||
27891922|NCT04776018|81437435|FG003|Overall Study|Withdrawal by Subject|2|||
27891923|NCT04776018|81437436|FG004|Overall Study|Withdrawal by Subject|1|||
27891924|NCT04776018|81437437|FG005|Overall Study|Withdrawal by Subject|0|||
27891925|NCT04776018|81437438|FG006|Overall Study|Withdrawal by Subject|0|||
27891926|NCT04776018|81437432|FG000|Overall Study|Other|0|||
27502035|NCT02052778|80032511|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
27502036|NCT02052778|80032512|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502037|NCT02052778|80032513|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502038|NCT02052778|80032514|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502039|NCT02052778|80032515|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502040|NCT02052778|80032516|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502041|NCT02052778|80032517|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502042|NCT02052778|80032518|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502043|NCT02052778|80032519|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502044|NCT02052778|80032520|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
27502045|NCT02052778|80032498|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502046|NCT02052778|80032499|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502047|NCT02052778|80032500|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502048|NCT02052778|80032501|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502049|NCT02052778|80032502|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502050|NCT02052778|80032503|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
27502051|NCT02052778|80032504|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502052|NCT02052778|80032505|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502053|NCT02052778|80032506|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502054|NCT02052778|80032507|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27891927|NCT04776018|81437433|FG001|Overall Study|Other|1|||
27891928|NCT04776018|81437434|FG002|Overall Study|Other|1|||
27891929|NCT04776018|81437435|FG003|Overall Study|Other|0|||
27891930|NCT04776018|81437436|FG004|Overall Study|Other|0|||
27891931|NCT04776018|81437437|FG005|Overall Study|Other|0|||
27891932|NCT04776018|81437438|FG006|Overall Study|Other|0|||
27891933|NCT04776018|81437432|FG000|Overall Study|Lost to Follow-up|0|||
27891934|NCT04776018|81437433|FG001|Overall Study|Lost to Follow-up|0|||
27891935|NCT04776018|81437434|FG002|Overall Study|Lost to Follow-up|1|||
27891936|NCT04776018|81437435|FG003|Overall Study|Lost to Follow-up|0|||
27502055|NCT02052778|80032508|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502056|NCT02052778|80032509|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502057|NCT02052778|80032510|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
27502058|NCT02052778|80032511|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502059|NCT02052778|80032512|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502060|NCT02052778|80032513|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502061|NCT02052778|80032514|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27611159|NCT00539643|80419021|FG001|Overall Study|Withdrawal by Subject|1|||
27611160|NCT02307513|80419022|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
27611161|NCT02307513|80419023|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
27722336|NCT01583374|80815407|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27891937|NCT04776018|81437436|FG004|Overall Study|Lost to Follow-up|0|||
27891938|NCT04776018|81437437|FG005|Overall Study|Lost to Follow-up|0|||
27891939|NCT04776018|81437438|FG006|Overall Study|Lost to Follow-up|0|||
27891940|NCT00519428|81437448|FG000|Overall Study|Adverse Event|5|||
27891941|NCT00519428|81437449|FG001|Overall Study|Adverse Event|2|||
27891942|NCT00519428|81437450|FG002|Overall Study|Adverse Event|10|||
27722337|NCT01583374|80815408|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27722338|NCT01583374|80815409|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
27502062|NCT02052778|80032515|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502063|NCT02052778|80032516|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502064|NCT02052778|80032517|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502065|NCT02052778|80032518|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502066|NCT02052778|80032519|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502067|NCT02052778|80032520|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
27502068|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502069|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502070|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502071|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502072|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502073|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502074|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502075|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502076|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502077|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502078|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502079|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27722339|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
27722340|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
27891943|NCT00519428|81437448|FG000|Overall Study|Lost to Follow-up|7|||
27891944|NCT00519428|81437449|FG001|Overall Study|Lost to Follow-up|7|||
27891945|NCT00519428|81437450|FG002|Overall Study|Lost to Follow-up|6|||
27891946|NCT00519428|81437448|FG000|Overall Study|Withdrawal by Subject|8|||
27891947|NCT00519428|81437449|FG001|Overall Study|Withdrawal by Subject|3|||
27891948|NCT00519428|81437450|FG002|Overall Study|Withdrawal by Subject|7|||
27891949|NCT00519428|81437448|FG000|Overall Study|unstated|1|||
27891950|NCT00519428|81437449|FG001|Overall Study|unstated|3|||
27891951|NCT00519428|81437450|FG002|Overall Study|unstated|2|||
27891952|NCT01970475|81437451|FG000|Overall Study|Withdrawal by Subject|11|||
27891953|NCT01970475|81437452|FG001|Overall Study|Withdrawal by Subject|6|||
27891954|NCT01970475|81437451|FG000|Overall Study|Adverse Event|7|||
27891955|NCT01970475|81437452|FG001|Overall Study|Adverse Event|3|||
27891956|NCT01970475|81437451|FG000|Overall Study|Lost to Follow-up|2|||
27891957|NCT01970475|81437452|FG001|Overall Study|Lost to Follow-up|2|||
27891958|NCT01970475|81437451|FG000|Overall Study|Protocol Violation|1|||
27891959|NCT01970475|81437452|FG001|Overall Study|Protocol Violation|0|||
27722341|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27840740|NCT01332968|81245172|FG003|Maintenance/Observation Period|Adverse Event|66|||
27840741|NCT01332968|81245173|FG004|Maintenance/Observation Period|Adverse Event|0|||
27840742|NCT01332968|81245174|FG005|Maintenance/Observation Period|Adverse Event|0|||
27840743|NCT01332968|81245175|FG006|Maintenance/Observation Period|Adverse Event|0|||
27840744|NCT01332968|81245176|FG007|Maintenance/Observation Period|Adverse Event|0|||
27840745|NCT01332968|81245169|FG000|Maintenance/Observation Period|Death|0|||
27840746|NCT01332968|81245170|FG001|Maintenance/Observation Period|Death|0|||
27840747|NCT01332968|81245171|FG002|Maintenance/Observation Period|Death|5|||
27722342|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27722343|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
27722344|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27722345|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
27722346|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
27722347|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
27722348|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
27722349|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
27722350|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
27722351|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
27722352|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
27722353|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
27722354|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
27722355|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
27722356|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
27840748|NCT01332968|81245172|FG003|Maintenance/Observation Period|Death|6|||
27840749|NCT01332968|81245173|FG004|Maintenance/Observation Period|Death|0|||
27840750|NCT01332968|81245174|FG005|Maintenance/Observation Period|Death|0|||
27891960|NCT01582178|81437453|FG000|Overall Study|Physician Decision|6|||
27891961|NCT01582178|81437454|FG001|Overall Study|Physician Decision|5|||
27891962|NCT02000622|81437458|FG000|Overall Study|Withdrawal by Subject|5|||
27891963|NCT02000622|81437459|FG001|Overall Study|Withdrawal by Subject|7|||
27502080|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502081|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502082|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
27502083|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
27502084|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
27502085|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
27502086|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
27502087|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
27502088|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
27502089|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
27502090|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
27502091|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502092|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502093|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502094|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502095|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502096|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502097|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502098|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502099|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502100|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502101|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502102|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502103|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502104|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502105|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
27502106|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
27502107|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502108|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
27502109|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
27502110|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
27502111|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
27502112|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
27502113|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
27502114|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502115|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502116|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502117|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27840751|NCT01332968|81245175|FG006|Maintenance/Observation Period|Death|0|||
27840752|NCT01332968|81245176|FG007|Maintenance/Observation Period|Death|0|||
27840753|NCT01332968|81245169|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
27840754|NCT01332968|81245170|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
27840755|NCT01332968|81245171|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
27840756|NCT01332968|81245172|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
27840757|NCT01332968|81245173|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
27840758|NCT01332968|81245174|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
27840759|NCT01332968|81245175|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
27840760|NCT01332968|81245176|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
27840761|NCT01332968|81245169|FG000|Maintenance/Observation Period|Non-compliance|0|||
27840762|NCT01332968|81245170|FG001|Maintenance/Observation Period|Non-compliance|0|||
27840763|NCT01332968|81245171|FG002|Maintenance/Observation Period|Non-compliance|4|||
27840764|NCT01332968|81245172|FG003|Maintenance/Observation Period|Non-compliance|3|||
27840765|NCT01332968|81245173|FG004|Maintenance/Observation Period|Non-compliance|0|||
27840766|NCT01332968|81245174|FG005|Maintenance/Observation Period|Non-compliance|0|||
27840767|NCT01332968|81245175|FG006|Maintenance/Observation Period|Non-compliance|0|||
27840768|NCT01332968|81245176|FG007|Maintenance/Observation Period|Non-compliance|0|||
27840769|NCT01332968|81245169|FG000|Maintenance/Observation Period|Other|0|||
27840770|NCT01332968|81245170|FG001|Maintenance/Observation Period|Other|0|||
27840771|NCT01332968|81245171|FG002|Maintenance/Observation Period|Other|4|||
27840772|NCT01332968|81245172|FG003|Maintenance/Observation Period|Other|7|||
27840773|NCT01332968|81245173|FG004|Maintenance/Observation Period|Other|0|||
27840774|NCT01332968|81245174|FG005|Maintenance/Observation Period|Other|0|||
27840775|NCT01332968|81245175|FG006|Maintenance/Observation Period|Other|0|||
27611162|NCT02307513|80419022|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
27611163|NCT02307513|80419023|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
27611164|NCT02307513|80419022|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
27611165|NCT02307513|80419023|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
27611166|NCT02307513|80419022|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
27611167|NCT02307513|80419023|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
27611168|NCT02307513|80419022|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
27611169|NCT02307513|80419023|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
27611170|NCT02307513|80419022|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
27611171|NCT02307513|80419023|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
27611172|NCT02307513|80419022|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
27611173|NCT02307513|80419023|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
27611174|NCT02307513|80419022|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
27611175|NCT02307513|80419023|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
27611176|NCT02307513|80419022|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
27611177|NCT02307513|80419023|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
27611178|NCT02307513|80419022|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
27611179|NCT02307513|80419023|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
27611180|NCT02307513|80419022|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
27611181|NCT02307513|80419023|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
27611182|NCT02307513|80419022|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
27611183|NCT02307513|80419023|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
27611184|NCT02307513|80419022|FG000|Long-term Extension|Physician Decision|1|||
27611185|NCT02307513|80419023|FG001|Long-term Extension|Physician Decision|0|||
27611186|NCT01346514|80419024|FG000|Overall Study|Lost to Follow-up|19|||
27611187|NCT01346514|80419025|FG001|Overall Study|Lost to Follow-up|30|||
27611188|NCT01346514|80419024|FG000|Overall Study|Withdrawal by Subject|7|||
27611189|NCT01346514|80419025|FG001|Overall Study|Withdrawal by Subject|3|||
27611190|NCT01346514|80419024|FG000|Overall Study|Death|3|||
27611191|NCT01346514|80419025|FG001|Overall Study|Death|4|||
27502118|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502119|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27611192|NCT00932646|80419026|FG000|Overall Study|Adverse Event|2|||
27611193|NCT00932646|80419027|FG001|Overall Study|Adverse Event|1|||
27611194|NCT00932646|80419028|FG002|Overall Study|Adverse Event|1|||
27611195|NCT00932646|80419029|FG003|Overall Study|Adverse Event|1|||
27611196|NCT00932646|80419026|FG000|Overall Study|Lost to Follow-up|2|||
27611197|NCT00932646|80419027|FG001|Overall Study|Lost to Follow-up|1|||
27611198|NCT00932646|80419028|FG002|Overall Study|Lost to Follow-up|0|||
27840776|NCT01332968|81245176|FG007|Maintenance/Observation Period|Other|0|||
27840777|NCT01332968|81245169|FG000|Maintenance/Observation Period|Physician Decision|0|||
27502120|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502121|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502122|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502123|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502124|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502125|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502126|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502127|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502128|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
27502129|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
27502130|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
27502131|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502132|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
27502133|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
27502134|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502135|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27611199|NCT00932646|80419029|FG003|Overall Study|Lost to Follow-up|0|||
27611200|NCT00932646|80419026|FG000|Overall Study|Withdrawal by Subject|1|||
27611201|NCT00932646|80419027|FG001|Overall Study|Withdrawal by Subject|1|||
27611202|NCT00932646|80419028|FG002|Overall Study|Withdrawal by Subject|3|||
27611203|NCT00932646|80419029|FG003|Overall Study|Withdrawal by Subject|0|||
27611204|NCT02550873|80419030|FG000|Randomized Double Blind|Adverse Event|3|||
27891964|NCT02000622|81437458|FG000|Overall Study|Lost to Follow-up|4|||
27611205|NCT02550873|80419031|FG001|Randomized Double Blind|Adverse Event|1|||
27611206|NCT02550873|80419032|FG002|Randomized Double Blind|Adverse Event|0|||
27611207|NCT02550873|80419030|FG000|Randomized Double Blind|Disease progression|1|||
27611208|NCT02550873|80419031|FG001|Randomized Double Blind|Disease progression|1|||
27611209|NCT02550873|80419032|FG002|Randomized Double Blind|Disease progression|0|||
27611210|NCT02550873|80419030|FG000|Open Label Extension|Study ongoing|0|||
27722357|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27722358|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27722359|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27722360|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27722361|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
27722362|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27722363|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
27722364|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
27722365|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
27722366|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
27840778|NCT01332968|81245170|FG001|Maintenance/Observation Period|Physician Decision|0|||
27840779|NCT01332968|81245171|FG002|Maintenance/Observation Period|Physician Decision|14|||
27840780|NCT01332968|81245172|FG003|Maintenance/Observation Period|Physician Decision|19|||
27722367|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
27840781|NCT01332968|81245173|FG004|Maintenance/Observation Period|Physician Decision|0|||
27840782|NCT01332968|81245174|FG005|Maintenance/Observation Period|Physician Decision|1|||
27840783|NCT01332968|81245175|FG006|Maintenance/Observation Period|Physician Decision|0|||
27840784|NCT01332968|81245176|FG007|Maintenance/Observation Period|Physician Decision|0|||
27840785|NCT01332968|81245169|FG000|Maintenance/Observation Period|Progressive Disease|0|||
27840786|NCT01332968|81245170|FG001|Maintenance/Observation Period|Progressive Disease|0|||
27502136|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
27502137|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502138|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502139|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502140|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27722368|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
27722369|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
27722370|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
27722371|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
27722372|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
27840787|NCT01332968|81245171|FG002|Maintenance/Observation Period|Progressive Disease|72|||
27840788|NCT01332968|81245172|FG003|Maintenance/Observation Period|Progressive Disease|40|||
27840789|NCT01332968|81245173|FG004|Maintenance/Observation Period|Progressive Disease|0|||
27840790|NCT01332968|81245174|FG005|Maintenance/Observation Period|Progressive Disease|0|||
27840791|NCT01332968|81245175|FG006|Maintenance/Observation Period|Progressive Disease|0|||
27840792|NCT01332968|81245176|FG007|Maintenance/Observation Period|Progressive Disease|0|||
27840793|NCT01332968|81245169|FG000|Maintenance/Observation Period|Protocol Violation|0|||
27840794|NCT01332968|81245170|FG001|Maintenance/Observation Period|Protocol Violation|0|||
27840795|NCT01332968|81245171|FG002|Maintenance/Observation Period|Protocol Violation|1|||
27840796|NCT01332968|81245172|FG003|Maintenance/Observation Period|Protocol Violation|1|||
27840797|NCT01332968|81245173|FG004|Maintenance/Observation Period|Protocol Violation|0|||
27840798|NCT01332968|81245174|FG005|Maintenance/Observation Period|Protocol Violation|0|||
27840799|NCT01332968|81245175|FG006|Maintenance/Observation Period|Protocol Violation|0|||
27502141|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27840800|NCT01332968|81245176|FG007|Maintenance/Observation Period|Protocol Violation|0|||
27611211|NCT02550873|80419031|FG001|Open Label Extension|Study ongoing|0|||
27611212|NCT02550873|80419032|FG002|Open Label Extension|Study ongoing|111|||
27611213|NCT00366301|80419033|FG000|Overall Study|Lost to Follow-up|4|||
27611214|NCT00366301|80419034|FG001|Overall Study|Lost to Follow-up|4|||
27611215|NCT00366301|80419035|FG002|Overall Study|Lost to Follow-up|3|||
27611216|NCT00366301|80419036|FG003|Overall Study|Lost to Follow-up|7|||
27611217|NCT00366301|80419033|FG000|Overall Study|Withdrawal by Subject|4|||
27611218|NCT00366301|80419034|FG001|Overall Study|Withdrawal by Subject|2|||
27611219|NCT00366301|80419035|FG002|Overall Study|Withdrawal by Subject|1|||
27611220|NCT00366301|80419036|FG003|Overall Study|Withdrawal by Subject|1|||
27611221|NCT03119610|80419043|FG000|Overall Study|Adverse Event|1|||
27611222|NCT03119610|80419044|FG001|Overall Study|Adverse Event|0|||
27611223|NCT03119610|80419043|FG000|Overall Study|Lost to Follow-up|0|||
27611224|NCT03119610|80419044|FG001|Overall Study|Lost to Follow-up|1|||
27611225|NCT01216293|80419045|FG000|Main Study|Adverse Event|1|||
27722373|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
27502142|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502143|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502144|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502145|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502146|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502147|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502148|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502149|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502150|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502151|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
27502152|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
27502153|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502154|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502155|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502156|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502157|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502158|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502159|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
27502160|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502161|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502162|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502163|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502164|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27611226|NCT01216293|80419046|FG001|Main Study|Adverse Event|4|||
27891965|NCT02000622|81437459|FG001|Overall Study|Lost to Follow-up|0|||
27502165|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27611227|NCT01216293|80419047|FG002|Main Study|Adverse Event|2|||
27891966|NCT02000622|81437458|FG000|Overall Study|Death|159|||
27611228|NCT01216293|80419045|FG000|Main Study|Major Protocol Deviation|1|||
27611229|NCT01216293|80419046|FG001|Main Study|Major Protocol Deviation|0|||
27891967|NCT02000622|81437459|FG001|Overall Study|Death|73|||
27891968|NCT02000622|81437458|FG000|Overall Study|Withdrawn due to site closure|1|||
27891969|NCT02000622|81437459|FG001|Overall Study|Withdrawn due to site closure|0|||
27502166|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502167|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502168|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502169|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502170|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502171|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502172|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502173|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502174|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
27502175|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
27502176|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502177|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502178|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502179|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
27502180|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502181|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502182|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
27502183|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
27502184|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
27502185|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
27502186|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
27502187|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
27502188|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
27502189|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
27502190|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
27502191|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
27502192|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
27502193|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
27502194|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
27502195|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
27502196|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
27502197|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
27502198|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
27502199|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
27502200|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
27502201|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
27502202|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
27502203|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
27502204|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
27502205|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
27722374|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
27722375|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
27891970|NCT00738881|81437460|FG000|Overall Study|Withdrawal by Subject|0|||
27611230|NCT01216293|80419047|FG002|Main Study|Major Protocol Deviation|1|||
27611231|NCT01216293|80419045|FG000|Main Study|Lost to Follow-up|3|||
27611232|NCT01216293|80419046|FG001|Main Study|Lost to Follow-up|1|||
27611233|NCT01216293|80419047|FG002|Main Study|Lost to Follow-up|0|||
27611234|NCT01216293|80419045|FG000|Main Study|Voluntary Withdrawal|2|||
27611235|NCT01216293|80419046|FG001|Main Study|Voluntary Withdrawal|2|||
27611236|NCT01216293|80419047|FG002|Main Study|Voluntary Withdrawal|2|||
27611237|NCT01216293|80419045|FG000|Main Study|Other Reason Not Specified|0|||
27611238|NCT01216293|80419046|FG001|Main Study|Other Reason Not Specified|1|||
27611239|NCT01216293|80419047|FG002|Main Study|Other Reason Not Specified|1|||
27611240|NCT01216293|80419045|FG000|Main Study|Randomized, Not Treated|1|||
27611241|NCT01216293|80419046|FG001|Main Study|Randomized, Not Treated|0|||
27611242|NCT01216293|80419047|FG002|Main Study|Randomized, Not Treated|0|||
27611243|NCT01216293|80419045|FG000|Calcium Absorption Substudy|Adverse Event|0|||
27611244|NCT01216293|80419046|FG001|Calcium Absorption Substudy|Adverse Event|2|||
27891971|NCT00738881|81437461|FG001|Overall Study|Withdrawal by Subject|2|||
27891972|NCT00614120|81437467|FG000|Overall Study|Adverse Event|9|||
27891973|NCT00614120|81437468|FG001|Overall Study|Adverse Event|22|||
27891974|NCT00614120|81437469|FG002|Overall Study|Adverse Event|30|||
27891975|NCT00614120|81437470|FG003|Overall Study|Adverse Event|3|||
27891976|NCT00614120|81437467|FG000|Overall Study|Lack of Efficacy|3|||
27891977|NCT00614120|81437468|FG001|Overall Study|Lack of Efficacy|3|||
27891978|NCT00614120|81437469|FG002|Overall Study|Lack of Efficacy|2|||
27611245|NCT01216293|80419047|FG002|Calcium Absorption Substudy|Adverse Event|0|||
27611246|NCT01216293|80419045|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
27722376|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
27722377|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
27722378|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
27722379|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
27722380|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
27722381|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
27722382|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
27722383|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
27722384|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27722385|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27891979|NCT00614120|81437470|FG003|Overall Study|Lack of Efficacy|2|||
27891980|NCT00614120|81437467|FG000|Overall Study|Protocol Violation|2|||
27891981|NCT00614120|81437468|FG001|Overall Study|Protocol Violation|5|||
27891982|NCT00614120|81437469|FG002|Overall Study|Protocol Violation|3|||
27891983|NCT00614120|81437470|FG003|Overall Study|Protocol Violation|1|||
27891984|NCT00614120|81437467|FG000|Overall Study|Withdrawal criteria|1|||
27891985|NCT00614120|81437468|FG001|Overall Study|Withdrawal criteria|0|||
27891986|NCT00614120|81437469|FG002|Overall Study|Withdrawal criteria|0|||
27891987|NCT00614120|81437470|FG003|Overall Study|Withdrawal criteria|0|||
27891988|NCT00614120|81437467|FG000|Overall Study|Withdrawal by Subject|9|||
27891989|NCT00614120|81437468|FG001|Overall Study|Withdrawal by Subject|10|||
27891990|NCT00614120|81437469|FG002|Overall Study|Withdrawal by Subject|16|||
27891991|NCT00614120|81437470|FG003|Overall Study|Withdrawal by Subject|3|||
27611247|NCT01216293|80419046|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
27611248|NCT01216293|80419047|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
27611249|NCT01216293|80419045|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
27611250|NCT01216293|80419046|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
27891992|NCT00614120|81437467|FG000|Overall Study|Did not meet trial criteria|0|||
27891993|NCT00614120|81437468|FG001|Overall Study|Did not meet trial criteria|1|||
27891994|NCT00614120|81437469|FG002|Overall Study|Did not meet trial criteria|1|||
27891995|NCT00614120|81437470|FG003|Overall Study|Did not meet trial criteria|1|||
27611251|NCT01216293|80419047|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
27611252|NCT00839917|80419048|FG000|Overall Study|Lost to Follow-up|1|||
27502206|NCT02052778|80032498|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502207|NCT02052778|80032499|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27722386|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27722387|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27722388|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27722389|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27722390|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
27722391|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27722392|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
27722393|NCT01583374|80815401|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
27722394|NCT01583374|80815402|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
27722395|NCT01583374|80815403|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
27722396|NCT01583374|80815404|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
27722397|NCT01583374|80815405|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
27722398|NCT01583374|80815406|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
27722399|NCT01583374|80815407|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
27722400|NCT01583374|80815408|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
27722401|NCT01583374|80815409|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
27722402|NCT02167945|80815410|FG000|Overall Study|Adverse Event|16|||
27722403|NCT02167945|80815410|FG000|Overall Study|Withdrew Consent|42|||
27722404|NCT02167945|80815410|FG000|Overall Study|Lost to Follow-up|122|||
27722405|NCT02167945|80815410|FG000|Overall Study|COVID-19 logistical restrictions|6|||
27722406|NCT02167945|80815410|FG000|Overall Study|Other, not specified|63|||
27502208|NCT02052778|80032500|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502209|NCT02052778|80032501|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502210|NCT02052778|80032502|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502211|NCT02052778|80032503|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27722407|NCT00684515|80815413|FG000|Overall Study|Adverse Event|3|||
27722408|NCT00684515|80815414|FG001|Overall Study|Adverse Event|3|||
27722409|NCT00684515|80815415|FG002|Overall Study|Adverse Event|1|||
27722410|NCT00684515|80815413|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
27722411|NCT00684515|80815414|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
27722412|NCT00684515|80815415|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
27722413|NCT02356562|80815416|FG000|Overall Study|Withdrawal by Subject|0|||
27502212|NCT02052778|80032504|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502213|NCT02052778|80032505|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502214|NCT02052778|80032506|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502215|NCT02052778|80032507|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502216|NCT02052778|80032508|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502217|NCT02052778|80032509|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502218|NCT02052778|80032510|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502219|NCT02052778|80032511|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502220|NCT02052778|80032512|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
27502221|NCT02052778|80032513|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
27502222|NCT02052778|80032514|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
27502223|NCT02052778|80032515|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502224|NCT02052778|80032516|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
27611253|NCT00839917|80419049|FG001|Overall Study|Lost to Follow-up|0|||
27611254|NCT00839917|80419048|FG000|Overall Study|Did not receive vaccine|0|||
27722414|NCT02356562|80815417|FG001|Overall Study|Withdrawal by Subject|1|||
27722415|NCT02356562|80815416|FG000|Overall Study|Re-entered treatment in a previous study|1|||
27722416|NCT02356562|80815417|FG001|Overall Study|Re-entered treatment in a previous study|0|||
27722417|NCT02356562|80815416|FG000|Overall Study|site closure|1|||
27722418|NCT02356562|80815417|FG001|Overall Study|site closure|0|||
27722419|NCT04142983|80815418|FG000|Overall Study|Lost to Follow-up|73|||
27891996|NCT00614120|81437467|FG000|Overall Study|hCG positive (not pregnant)|0|||
27891997|NCT00614120|81437468|FG001|Overall Study|hCG positive (not pregnant)|0|||
27891998|NCT00614120|81437469|FG002|Overall Study|hCG positive (not pregnant)|1|||
27891999|NCT00614120|81437470|FG003|Overall Study|hCG positive (not pregnant)|0|||
27722420|NCT04142983|80815418|FG000|Overall Study|Withdrawal by Subject|10|||
27892000|NCT00614120|81437467|FG000|Overall Study|Hypoglycaemia|0|||
27722421|NCT04142983|80815418|FG000|Overall Study|Physician Decision|1|||
27722422|NCT04142983|80815418|FG000|Overall Study|Adverse Event|1|||
27722423|NCT04142983|80815418|FG000|Overall Study|No longer eligible|4|||
27722424|NCT04142983|80815418|FG000|Overall Study|Screen Failure|10|||
27722425|NCT00763321|80815419|FG000|Open-label Period|Adverse Event|24|||
27722426|NCT00763321|80815420|FG001|Open-label Period|Adverse Event|0|||
27722427|NCT00763321|80815421|FG002|Open-label Period|Adverse Event|0|||
27502225|NCT02052778|80032517|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502226|NCT02052778|80032518|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502227|NCT02052778|80032519|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502228|NCT02052778|80032520|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
27502229|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502230|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502231|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502232|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502233|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502234|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502235|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502236|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502237|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502238|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502239|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502240|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502241|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502242|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502243|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502244|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502245|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502246|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502247|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502248|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502249|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502250|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
27502251|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
27502252|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502253|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502254|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502255|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502256|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502257|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502258|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502259|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502260|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502261|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502262|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502263|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27722428|NCT00763321|80815419|FG000|Open-label Period|Lost to Follow-up|14|||
27840801|NCT01332968|81245169|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
27840802|NCT01332968|81245170|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
27840803|NCT01332968|81245171|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
27840804|NCT01332968|81245172|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
27840805|NCT01332968|81245173|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
27840806|NCT01332968|81245174|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
27840807|NCT01332968|81245175|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
27840808|NCT01332968|81245176|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
27892001|NCT00614120|81437468|FG001|Overall Study|Hypoglycaemia|0|||
27722429|NCT00763321|80815420|FG001|Open-label Period|Lost to Follow-up|0|||
27722430|NCT00763321|80815421|FG002|Open-label Period|Lost to Follow-up|0|||
27722431|NCT00763321|80815419|FG000|Open-label Period|Withdrawal by Subject|7|||
27722432|NCT00763321|80815420|FG001|Open-label Period|Withdrawal by Subject|0|||
27722433|NCT00763321|80815421|FG002|Open-label Period|Withdrawal by Subject|0|||
27722434|NCT00763321|80815419|FG000|Open-label Period|Subject noncompliant|7|||
27722435|NCT00763321|80815420|FG001|Open-label Period|Subject noncompliant|0|||
27722436|NCT00763321|80815421|FG002|Open-label Period|Subject noncompliant|0|||
27722437|NCT00763321|80815419|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
27722438|NCT00763321|80815420|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
27722439|NCT00763321|80815421|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
27611255|NCT00839917|80419049|FG001|Overall Study|Did not receive vaccine|1|||
27611256|NCT01734434|80419053|FG000|Overall Study|Death Infant|3|||
27611257|NCT01734434|80419054|FG001|Overall Study|Death Infant|1|||
27611258|NCT01734434|80419055|FG002|Overall Study|Death Infant|17|||
27611259|NCT01734434|80419056|FG003|Overall Study|Death Infant|5|||
27611260|NCT01734434|80419053|FG000|Overall Study|Lost to Follow-up|2|||
27611261|NCT01734434|80419054|FG001|Overall Study|Lost to Follow-up|9|||
27611262|NCT01734434|80419055|FG002|Overall Study|Lost to Follow-up|67|||
27611263|NCT01734434|80419056|FG003|Overall Study|Lost to Follow-up|11|||
27722440|NCT00763321|80815419|FG000|Open-label Period|Lack of Efficacy|2|||
27722441|NCT00763321|80815420|FG001|Open-label Period|Lack of Efficacy|0|||
27722442|NCT00763321|80815421|FG002|Open-label Period|Lack of Efficacy|0|||
27722443|NCT00763321|80815419|FG000|Open-label Period|Other|4|||
27722444|NCT00763321|80815420|FG001|Open-label Period|Other|0|||
27722445|NCT00763321|80815421|FG002|Open-label Period|Other|0|||
27722446|NCT00763321|80815419|FG000|Double-blind Period|Lack of Efficacy|0|||
27722447|NCT00763321|80815420|FG001|Double-blind Period|Lack of Efficacy|9|||
27722448|NCT00763321|80815421|FG002|Double-blind Period|Lack of Efficacy|17|||
27722449|NCT00763321|80815419|FG000|Double-blind Period|Adverse Event|0|||
27722450|NCT00763321|80815420|FG001|Double-blind Period|Adverse Event|4|||
27722451|NCT00763321|80815421|FG002|Double-blind Period|Adverse Event|4|||
27722452|NCT00763321|80815419|FG000|Double-blind Period|Lost to Follow-up|0|||
27722453|NCT00763321|80815420|FG001|Double-blind Period|Lost to Follow-up|4|||
27722454|NCT00763321|80815421|FG002|Double-blind Period|Lost to Follow-up|2|||
27722455|NCT00763321|80815419|FG000|Double-blind Period|Withdrawal by Subject|0|||
27722456|NCT00763321|80815420|FG001|Double-blind Period|Withdrawal by Subject|2|||
27722457|NCT00763321|80815421|FG002|Double-blind Period|Withdrawal by Subject|3|||
27722458|NCT00763321|80815419|FG000|Double-blind Period|Other|0|||
27722459|NCT00763321|80815420|FG001|Double-blind Period|Other|2|||
27722460|NCT00763321|80815421|FG002|Double-blind Period|Other|3|||
27722461|NCT01363986|80815422|FG000|Overall Study|Disease progression|1|||
27722462|NCT01986062|80815431|FG000|Overall Study|Lost to Follow-up|1|||
27722463|NCT01986062|80815432|FG001|Overall Study|Lost to Follow-up|0|||
27722464|NCT01986062|80815431|FG000|Overall Study|Withdrawal by Subject|0|||
27722465|NCT01986062|80815432|FG001|Overall Study|Withdrawal by Subject|1|||
27722466|NCT00624520|80815434|FG000|Overall Study|Withdrawal by Subject|12|||
27722467|NCT00624520|80815435|FG001|Overall Study|Withdrawal by Subject|7|||
27722468|NCT00624520|80815434|FG000|Overall Study|Death|0|||
27722469|NCT00624520|80815435|FG001|Overall Study|Death|1|||
27722470|NCT05099640|80815436|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
27722471|NCT05099640|80815437|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
27722472|NCT05099640|80815438|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
27722473|NCT05099640|80815436|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
27611264|NCT01734434|80419053|FG000|Overall Study|No Live Birth|1|||
27611265|NCT01734434|80419054|FG001|Overall Study|No Live Birth|2|||
27722474|NCT05099640|80815437|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
27722475|NCT05099640|80815438|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
27722476|NCT05099640|80815436|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
27722477|NCT05099640|80815437|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
27722478|NCT05099640|80815438|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
27722479|NCT05099640|80815436|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
27722480|NCT05099640|80815437|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
27722481|NCT05099640|80815438|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
27722482|NCT05099640|80815436|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
27722483|NCT05099640|80815437|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
27722484|NCT05099640|80815438|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
27722485|NCT05099640|80815436|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
27722486|NCT05099640|80815437|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
27722487|NCT05099640|80815438|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
27722488|NCT01557166|80815445|FG000|Overall Study|Adverse Event|20|||
27722489|NCT01557166|80815446|FG001|Overall Study|Adverse Event|6|||
27722490|NCT01557166|80815445|FG000|Overall Study|Lack of Efficacy|2|||
27722491|NCT01557166|80815446|FG001|Overall Study|Lack of Efficacy|1|||
27722492|NCT01557166|80815445|FG000|Overall Study|Protocol Violation|8|||
27722493|NCT01557166|80815446|FG001|Overall Study|Protocol Violation|5|||
27722494|NCT01557166|80815445|FG000|Overall Study|Withdrawn consent|12|||
27722495|NCT01557166|80815446|FG001|Overall Study|Withdrawn consent|20|||
27722496|NCT01557166|80815445|FG000|Overall Study|Target dose not tolerated|1|||
27722497|NCT01557166|80815446|FG001|Overall Study|Target dose not tolerated|0|||
27722498|NCT01557166|80815445|FG000|Overall Study|Psychiatric disorder|1|||
27722499|NCT01557166|80815446|FG001|Overall Study|Psychiatric disorder|0|||
27722500|NCT01557166|80815445|FG000|Overall Study|Unclassified|2|||
27722501|NCT01557166|80815446|FG001|Overall Study|Unclassified|5|||
27722502|NCT01164722|80815447|FG000|Overall Study|Adverse Event|0|||
27722503|NCT01164722|80815448|FG001|Overall Study|Adverse Event|1|||
27722504|NCT01164722|80815447|FG000|Overall Study|Withdrawal by Subject|3|||
27722505|NCT01164722|80815448|FG001|Overall Study|Withdrawal by Subject|4|||
27722506|NCT01164722|80815447|FG000|Overall Study|Lost to Follow-up|3|||
27722507|NCT01164722|80815448|FG001|Overall Study|Lost to Follow-up|6|||
27722508|NCT01164722|80815447|FG000|Overall Study|met protocol criteria for non-treatment|11|||
27722509|NCT01164722|80815448|FG001|Overall Study|met protocol criteria for non-treatment|1|||
27722510|NCT01164722|80815447|FG000|Overall Study|enrolled on other study, concomitant med|1|||
27722511|NCT01164722|80815448|FG001|Overall Study|enrolled on other study, concomitant med|3|||
27722512|NCT04823949|80815449|FG000|Overall Study|Withdrawal by Subject|0|||
27722513|NCT04823949|80815450|FG001|Overall Study|Withdrawal by Subject|4|||
27722514|NCT04823949|80815449|FG000|Overall Study|Physician Decision|0|||
27722515|NCT04823949|80815450|FG001|Overall Study|Physician Decision|1|||
27722516|NCT01580397|80815451|FG000|Overall Study|Lack of Efficacy|14|||
27722517|NCT02083380|80815453|FG000|Overall Study|Lack of Efficacy|68|||
27722518|NCT02083380|80815454|FG001|Overall Study|Lack of Efficacy|79|||
27722519|NCT02083380|80815455|FG002|Overall Study|Lack of Efficacy|64|||
27722520|NCT02083380|80815453|FG000|Overall Study|Withdrawal by Subject|9|||
27722521|NCT02083380|80815454|FG001|Overall Study|Withdrawal by Subject|3|||
27722522|NCT02083380|80815455|FG002|Overall Study|Withdrawal by Subject|7|||
27840809|NCT01332968|81245169|FG000|Follow-Up Period|Adverse Event|0|||
27502264|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502265|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502266|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502267|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502268|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502269|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502270|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502271|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502272|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502273|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
27502274|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
27502275|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502276|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502277|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502278|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27611266|NCT01734434|80419055|FG002|Overall Study|No Live Birth|32|||
27611267|NCT01734434|80419056|FG003|Overall Study|No Live Birth|6|||
27611268|NCT01734434|80419053|FG000|Overall Study|Withdrawal by Subject|4|||
27722523|NCT02083380|80815453|FG000|Overall Study|Physician Decision|1|||
27722524|NCT02083380|80815454|FG001|Overall Study|Physician Decision|6|||
27722525|NCT02083380|80815455|FG002|Overall Study|Physician Decision|3|||
27722526|NCT02083380|80815453|FG000|Overall Study|Adverse Event|0|||
27722527|NCT02083380|80815454|FG001|Overall Study|Adverse Event|0|||
27722528|NCT02083380|80815455|FG002|Overall Study|Adverse Event|1|||
27722529|NCT02083380|80815453|FG000|Overall Study|Lost to Follow-up|5|||
27502279|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502280|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502281|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502282|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502283|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502284|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502285|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502286|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502287|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502288|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502289|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502290|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502291|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502292|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502293|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502294|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502295|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502296|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
27502297|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
27502298|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502299|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502300|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502301|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502302|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502303|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502304|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502305|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27840810|NCT01332968|81245170|FG001|Follow-Up Period|Adverse Event|0|||
27840811|NCT01332968|81245171|FG002|Follow-Up Period|Adverse Event|0|||
27840812|NCT01332968|81245172|FG003|Follow-Up Period|Adverse Event|0|||
27840813|NCT01332968|81245173|FG004|Follow-Up Period|Adverse Event|0|||
27840814|NCT01332968|81245174|FG005|Follow-Up Period|Adverse Event|0|||
27840815|NCT01332968|81245175|FG006|Follow-Up Period|Adverse Event|0|||
27840816|NCT01332968|81245176|FG007|Follow-Up Period|Adverse Event|4|||
27840817|NCT01332968|81245169|FG000|Follow-Up Period|Death|0|||
27840818|NCT01332968|81245170|FG001|Follow-Up Period|Death|0|||
27840819|NCT01332968|81245171|FG002|Follow-Up Period|Death|0|||
27840820|NCT01332968|81245172|FG003|Follow-Up Period|Death|0|||
27502306|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502307|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502308|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27611269|NCT01734434|80419054|FG001|Overall Study|Withdrawal by Subject|0|||
27722530|NCT02083380|80815454|FG001|Overall Study|Lost to Follow-up|3|||
27722531|NCT02083380|80815455|FG002|Overall Study|Lost to Follow-up|3|||
27722532|NCT02083380|80815453|FG000|Overall Study|Other|8|||
27722533|NCT02083380|80815454|FG001|Overall Study|Other|4|||
27722534|NCT02083380|80815455|FG002|Overall Study|Other|6|||
27722535|NCT01882907|80815458|FG000|Overall Study|Adverse Event|3|||
27722536|NCT01882907|80815459|FG001|Overall Study|Adverse Event|1|||
27722537|NCT01882907|80815458|FG000|Overall Study|Lack of Efficacy|0|||
27722538|NCT01882907|80815459|FG001|Overall Study|Lack of Efficacy|3|||
27722539|NCT01882907|80815458|FG000|Overall Study|Lost to Follow-up|1|||
27722540|NCT01882907|80815459|FG001|Overall Study|Lost to Follow-up|4|||
27722541|NCT01882907|80815458|FG000|Overall Study|Protocol Violation|10|||
27722542|NCT01882907|80815459|FG001|Overall Study|Protocol Violation|14|||
27722543|NCT01882907|80815458|FG000|Overall Study|Withdrawal by Subject|0|||
27722544|NCT01882907|80815459|FG001|Overall Study|Withdrawal by Subject|6|||
27840821|NCT01332968|81245173|FG004|Follow-Up Period|Death|0|||
27840822|NCT01332968|81245174|FG005|Follow-Up Period|Death|0|||
27502309|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502310|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27611270|NCT01734434|80419055|FG002|Overall Study|Withdrawal by Subject|8|||
27722545|NCT02026063|80815460|FG000|Overall Study|Physician Decision|0|||
27722546|NCT02026063|80815461|FG001|Overall Study|Physician Decision|10|||
27722547|NCT02026063|80815460|FG000|Overall Study|Noncompliance with Study Drug|1|||
27722548|NCT02026063|80815461|FG001|Overall Study|Noncompliance with Study Drug|1|||
27722549|NCT02026063|80815460|FG000|Overall Study|Withdrawal of Consent|1|||
27840823|NCT01332968|81245175|FG006|Follow-Up Period|Death|27|||
27840824|NCT01332968|81245176|FG007|Follow-Up Period|Death|30|||
27840825|NCT01332968|81245169|FG000|Follow-Up Period|Lost to Follow-up|0|||
27840826|NCT01332968|81245170|FG001|Follow-Up Period|Lost to Follow-up|0|||
27722550|NCT02026063|80815461|FG001|Overall Study|Withdrawal of Consent|6|||
27722551|NCT02026063|80815460|FG000|Overall Study|Adverse Event|5|||
27722552|NCT02026063|80815461|FG001|Overall Study|Adverse Event|20|||
27722553|NCT02026063|80815460|FG000|Overall Study|Lack of Efficacy|0|||
27722554|NCT02026063|80815461|FG001|Overall Study|Lack of Efficacy|4|||
27722555|NCT02026063|80815460|FG000|Overall Study|Lost to Follow-up|0|||
27722556|NCT02026063|80815461|FG001|Overall Study|Lost to Follow-up|1|||
27722557|NCT02026063|80815460|FG000|Overall Study|Reason not Specified|2|||
27722558|NCT02026063|80815461|FG001|Overall Study|Reason not Specified|7|||
27722559|NCT02658812|80815464|FG000|Overall Study|Disease Progression|7|||
27722560|NCT02658812|80815464|FG000|Overall Study|Unrelated to study treatment|1|||
27840827|NCT01332968|81245171|FG002|Follow-Up Period|Lost to Follow-up|0|||
27840828|NCT01332968|81245172|FG003|Follow-Up Period|Lost to Follow-up|0|||
27840829|NCT01332968|81245173|FG004|Follow-Up Period|Lost to Follow-up|0|||
27840830|NCT01332968|81245174|FG005|Follow-Up Period|Lost to Follow-up|0|||
27840831|NCT01332968|81245175|FG006|Follow-Up Period|Lost to Follow-up|11|||
27840832|NCT01332968|81245176|FG007|Follow-Up Period|Lost to Follow-up|15|||
27840833|NCT01332968|81245169|FG000|Follow-Up Period|Non-compliance|0|||
27840834|NCT01332968|81245170|FG001|Follow-Up Period|Non-compliance|0|||
27840835|NCT01332968|81245171|FG002|Follow-Up Period|Non-compliance|0|||
27840836|NCT01332968|81245172|FG003|Follow-Up Period|Non-compliance|0|||
27840837|NCT01332968|81245173|FG004|Follow-Up Period|Non-compliance|0|||
27840838|NCT01332968|81245174|FG005|Follow-Up Period|Non-compliance|0|||
27840839|NCT01332968|81245175|FG006|Follow-Up Period|Non-compliance|4|||
27840840|NCT01332968|81245176|FG007|Follow-Up Period|Non-compliance|9|||
27840841|NCT01332968|81245169|FG000|Follow-Up Period|Other|0|||
27840842|NCT01332968|81245170|FG001|Follow-Up Period|Other|0|||
27840843|NCT01332968|81245171|FG002|Follow-Up Period|Other|0|||
27840844|NCT01332968|81245172|FG003|Follow-Up Period|Other|0|||
27840845|NCT01332968|81245173|FG004|Follow-Up Period|Other|0|||
27840846|NCT01332968|81245174|FG005|Follow-Up Period|Other|0|||
27840847|NCT01332968|81245175|FG006|Follow-Up Period|Other|18|||
27840848|NCT01332968|81245176|FG007|Follow-Up Period|Other|21|||
27840849|NCT01332968|81245169|FG000|Follow-Up Period|Physician Decision|0|||
27840850|NCT01332968|81245170|FG001|Follow-Up Period|Physician Decision|0|||
27840851|NCT01332968|81245171|FG002|Follow-Up Period|Physician Decision|0|||
27840852|NCT01332968|81245172|FG003|Follow-Up Period|Physician Decision|0|||
27840853|NCT01332968|81245173|FG004|Follow-Up Period|Physician Decision|0|||
27840854|NCT01332968|81245174|FG005|Follow-Up Period|Physician Decision|0|||
27840855|NCT01332968|81245175|FG006|Follow-Up Period|Physician Decision|12|||
27840856|NCT01332968|81245176|FG007|Follow-Up Period|Physician Decision|15|||
27840857|NCT01332968|81245169|FG000|Follow-Up Period|Progressive Disease|0|||
27840858|NCT01332968|81245170|FG001|Follow-Up Period|Progressive Disease|0|||
27840859|NCT01332968|81245171|FG002|Follow-Up Period|Progressive Disease|0|||
27840860|NCT01332968|81245172|FG003|Follow-Up Period|Progressive Disease|0|||
27840861|NCT01332968|81245173|FG004|Follow-Up Period|Progressive Disease|0|||
27840862|NCT01332968|81245174|FG005|Follow-Up Period|Progressive Disease|0|||
27840863|NCT01332968|81245175|FG006|Follow-Up Period|Progressive Disease|126|||
27840864|NCT01332968|81245176|FG007|Follow-Up Period|Progressive Disease|106|||
27840865|NCT01332968|81245169|FG000|Follow-Up Period|Protocol Violation|0|||
27840866|NCT01332968|81245170|FG001|Follow-Up Period|Protocol Violation|0|||
27840867|NCT01332968|81245171|FG002|Follow-Up Period|Protocol Violation|0|||
27840868|NCT01332968|81245172|FG003|Follow-Up Period|Protocol Violation|0|||
27892002|NCT00614120|81437469|FG002|Overall Study|Hypoglycaemia|0|||
27722561|NCT02658812|80815464|FG000|Overall Study|Adverse Event|1|||
27840869|NCT01332968|81245173|FG004|Follow-Up Period|Protocol Violation|0|||
27840870|NCT01332968|81245174|FG005|Follow-Up Period|Protocol Violation|0|||
27840871|NCT01332968|81245175|FG006|Follow-Up Period|Protocol Violation|1|||
27722562|NCT01116544|80815469|FG000|Overall Study|Protocol Violation|1|||
27722563|NCT01116544|80815470|FG001|Overall Study|Protocol Violation|0|||
27722564|NCT01116544|80815469|FG000|Overall Study|Withdrawal by Subject|1|||
27840872|NCT01332968|81245176|FG007|Follow-Up Period|Protocol Violation|0|||
27840873|NCT01332968|81245169|FG000|Follow-Up Period|Withdrawal by Subject|0|||
27892003|NCT00614120|81437470|FG003|Overall Study|Hypoglycaemia|1|||
27722565|NCT01116544|80815470|FG001|Overall Study|Withdrawal by Subject|1|||
27722566|NCT02161562|80815477|FG000|Overall Study|Withdrawal by Subject|5|||
27722567|NCT02161562|80815478|FG001|Overall Study|Withdrawal by Subject|8|||
27722568|NCT02161562|80815477|FG000|Overall Study|Protocol Violation|9|||
27722569|NCT02161562|80815478|FG001|Overall Study|Protocol Violation|4|||
27722570|NCT02161562|80815477|FG000|Overall Study|Pregnancy|1|||
27722571|NCT02161562|80815478|FG001|Overall Study|Pregnancy|2|||
27722572|NCT02161562|80815477|FG000|Overall Study|Lost to Follow-up|3|||
27722573|NCT02161562|80815478|FG001|Overall Study|Lost to Follow-up|1|||
27722574|NCT02161562|80815477|FG000|Overall Study|Lack of Efficacy|4|||
27722575|NCT02161562|80815478|FG001|Overall Study|Lack of Efficacy|1|||
27722576|NCT02161562|80815477|FG000|Overall Study|Adverse Event|1|||
27722577|NCT02161562|80815478|FG001|Overall Study|Adverse Event|1|||
27722578|NCT02161562|80815477|FG000|Overall Study|Participant moved back to home country|1|||
27722579|NCT02161562|80815478|FG001|Overall Study|Participant moved back to home country|0|||
27722580|NCT02161562|80815477|FG000|Overall Study|Withdrew due to being out of the country|1|||
27722581|NCT02161562|80815478|FG001|Overall Study|Withdrew due to being out of the country|0|||
27722582|NCT02161562|80815477|FG000|Overall Study|Participant moved out of province|1|||
27722583|NCT02161562|80815478|FG001|Overall Study|Participant moved out of province|0|||
27722584|NCT02623335|80815479|FG000|Overall Study|Death|8|||
27722585|NCT02623335|80815480|FG001|Overall Study|Death|7|||
27722586|NCT02623335|80815479|FG000|Overall Study|Lost to Follow-up|15|||
27722587|NCT02623335|80815480|FG001|Overall Study|Lost to Follow-up|23|||
27722588|NCT02623335|80815479|FG000|Overall Study|Withdrawal by Subject|2|||
27722589|NCT02623335|80815480|FG001|Overall Study|Withdrawal by Subject|5|||
27722590|NCT02623335|80815479|FG000|Overall Study|Protocol Violation|2|||
27722591|NCT02623335|80815480|FG001|Overall Study|Protocol Violation|1|||
27722592|NCT00328627|80815482|FG000|Overall Study|Hyperglycemic Rescue|41|||
27722593|NCT00328627|80815483|FG001|Overall Study|Hyperglycemic Rescue|18|||
27722594|NCT00328627|80815484|FG002|Overall Study|Hyperglycemic Rescue|16|||
27722595|NCT00328627|80815485|FG003|Overall Study|Hyperglycemic Rescue|13|||
27722596|NCT00328627|80815486|FG004|Overall Study|Hyperglycemic Rescue|6|||
27722597|NCT00328627|80815487|FG005|Overall Study|Hyperglycemic Rescue|5|||
27722598|NCT00328627|80815488|FG006|Overall Study|Hyperglycemic Rescue|19|||
27722599|NCT00328627|80815489|FG007|Overall Study|Hyperglycemic Rescue|6|||
27722600|NCT00328627|80815490|FG008|Overall Study|Hyperglycemic Rescue|6|||
27722601|NCT00328627|80815491|FG009|Overall Study|Hyperglycemic Rescue|11|||
27722602|NCT00328627|80815492|FG010|Overall Study|Hyperglycemic Rescue|3|||
27722603|NCT00328627|80815493|FG011|Overall Study|Hyperglycemic Rescue|2|||
27722604|NCT00328627|80815482|FG000|Overall Study|Adverse Event|3|||
27722605|NCT00328627|80815483|FG001|Overall Study|Adverse Event|1|||
27722606|NCT00328627|80815484|FG002|Overall Study|Adverse Event|2|||
27722607|NCT00328627|80815485|FG003|Overall Study|Adverse Event|3|||
27722608|NCT00328627|80815486|FG004|Overall Study|Adverse Event|1|||
27722609|NCT00328627|80815487|FG005|Overall Study|Adverse Event|2|||
27722610|NCT00328627|80815488|FG006|Overall Study|Adverse Event|1|||
27722611|NCT00328627|80815489|FG007|Overall Study|Adverse Event|2|||
27722612|NCT00328627|80815490|FG008|Overall Study|Adverse Event|0|||
27722613|NCT00328627|80815491|FG009|Overall Study|Adverse Event|7|||
27722614|NCT00328627|80815492|FG010|Overall Study|Adverse Event|5|||
27722615|NCT00328627|80815493|FG011|Overall Study|Adverse Event|4|||
27722616|NCT00328627|80815482|FG000|Overall Study|Protocol Violation|2|||
27722617|NCT00328627|80815483|FG001|Overall Study|Protocol Violation|2|||
27722618|NCT00328627|80815484|FG002|Overall Study|Protocol Violation|2|||
27722619|NCT00328627|80815485|FG003|Overall Study|Protocol Violation|8|||
27840874|NCT01332968|81245170|FG001|Follow-Up Period|Withdrawal by Subject|0|||
27840875|NCT01332968|81245171|FG002|Follow-Up Period|Withdrawal by Subject|0|||
27840876|NCT01332968|81245172|FG003|Follow-Up Period|Withdrawal by Subject|0|||
27722620|NCT00328627|80815486|FG004|Overall Study|Protocol Violation|5|||
27722621|NCT00328627|80815487|FG005|Overall Study|Protocol Violation|5|||
27722622|NCT00328627|80815488|FG006|Overall Study|Protocol Violation|6|||
27722623|NCT00328627|80815489|FG007|Overall Study|Protocol Violation|2|||
27722624|NCT00328627|80815490|FG008|Overall Study|Protocol Violation|1|||
27722625|NCT00328627|80815491|FG009|Overall Study|Protocol Violation|4|||
27722626|NCT00328627|80815492|FG010|Overall Study|Protocol Violation|6|||
27722627|NCT00328627|80815493|FG011|Overall Study|Protocol Violation|2|||
27722628|NCT00328627|80815482|FG000|Overall Study|Lost to Follow-up|4|||
27722629|NCT00328627|80815483|FG001|Overall Study|Lost to Follow-up|2|||
27722630|NCT00328627|80815484|FG002|Overall Study|Lost to Follow-up|2|||
27722631|NCT00328627|80815485|FG003|Overall Study|Lost to Follow-up|4|||
27722632|NCT00328627|80815486|FG004|Overall Study|Lost to Follow-up|0|||
27722633|NCT00328627|80815487|FG005|Overall Study|Lost to Follow-up|2|||
27840877|NCT01332968|81245173|FG004|Follow-Up Period|Withdrawal by Subject|0|||
27722634|NCT00328627|80815488|FG006|Overall Study|Lost to Follow-up|3|||
27722635|NCT00328627|80815489|FG007|Overall Study|Lost to Follow-up|0|||
27722636|NCT00328627|80815490|FG008|Overall Study|Lost to Follow-up|3|||
27722637|NCT00328627|80815491|FG009|Overall Study|Lost to Follow-up|2|||
27722638|NCT00328627|80815492|FG010|Overall Study|Lost to Follow-up|0|||
27722639|NCT00328627|80815493|FG011|Overall Study|Lost to Follow-up|1|||
27722640|NCT00328627|80815482|FG000|Overall Study|Withdrawal by Subject|5|||
27722641|NCT00328627|80815483|FG001|Overall Study|Withdrawal by Subject|4|||
27722642|NCT00328627|80815484|FG002|Overall Study|Withdrawal by Subject|5|||
27722643|NCT00328627|80815485|FG003|Overall Study|Withdrawal by Subject|6|||
27722644|NCT00328627|80815486|FG004|Overall Study|Withdrawal by Subject|2|||
27722645|NCT00328627|80815487|FG005|Overall Study|Withdrawal by Subject|5|||
27722646|NCT00328627|80815488|FG006|Overall Study|Withdrawal by Subject|4|||
27722647|NCT00328627|80815489|FG007|Overall Study|Withdrawal by Subject|4|||
27722648|NCT00328627|80815490|FG008|Overall Study|Withdrawal by Subject|4|||
27502311|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502312|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502313|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27722649|NCT00328627|80815491|FG009|Overall Study|Withdrawal by Subject|5|||
27722650|NCT00328627|80815492|FG010|Overall Study|Withdrawal by Subject|2|||
27722651|NCT00328627|80815493|FG011|Overall Study|Withdrawal by Subject|7|||
27722652|NCT00328627|80815482|FG000|Overall Study|Pregnancy|0|||
27722653|NCT00328627|80815483|FG001|Overall Study|Pregnancy|1|||
27840878|NCT01332968|81245174|FG005|Follow-Up Period|Withdrawal by Subject|0|||
27840879|NCT01332968|81245175|FG006|Follow-Up Period|Withdrawal by Subject|29|||
27840880|NCT01332968|81245176|FG007|Follow-Up Period|Withdrawal by Subject|32|||
27840881|NCT01332968|81245169|FG000|Follow-Up Period|No reason provided|0|||
27840882|NCT01332968|81245170|FG001|Follow-Up Period|No reason provided|0|||
27840883|NCT01332968|81245171|FG002|Follow-Up Period|No reason provided|0|||
27840884|NCT01332968|81245172|FG003|Follow-Up Period|No reason provided|0|||
27840885|NCT01332968|81245173|FG004|Follow-Up Period|No reason provided|0|||
27840886|NCT01332968|81245174|FG005|Follow-Up Period|No reason provided|0|||
27840887|NCT01332968|81245175|FG006|Follow-Up Period|No reason provided|2|||
27840888|NCT01332968|81245176|FG007|Follow-Up Period|No reason provided|3|||
27840889|NCT01579006|81245181|FG000|Overall Study|Lack of Efficacy|10|||
27840890|NCT01579006|81245181|FG000|Overall Study|Adverse Event|13|||
27840891|NCT01579006|81245181|FG000|Overall Study|Withdrawal by Subject|5|||
27840892|NCT01579006|81245181|FG000|Overall Study|Non-compliance|3|||
27840893|NCT01579006|81245181|FG000|Overall Study|Due to participant's health fund|1|||
27840894|NCT01579006|81245181|FG000|Overall Study|Scheduled surgery|1|||
27840895|NCT00605176|81245183|FG000|Overall Study|Adverse Event|2|||
27840896|NCT00605176|81245184|FG001|Overall Study|Adverse Event|1|||
27840897|NCT00605176|81245185|FG002|Overall Study|Adverse Event|3|||
27840898|NCT00605176|81245183|FG000|Overall Study|Withdrawal by Subject|4|||
27840899|NCT00605176|81245184|FG001|Overall Study|Withdrawal by Subject|2|||
27840900|NCT00605176|81245185|FG002|Overall Study|Withdrawal by Subject|4|||
27840901|NCT00605176|81245183|FG000|Overall Study|Lost to Follow-up|2|||
27840902|NCT00605176|81245184|FG001|Overall Study|Lost to Follow-up|2|||
27840903|NCT00605176|81245185|FG002|Overall Study|Lost to Follow-up|1|||
27840904|NCT00605176|81245183|FG000|Overall Study|Non-complicance with study procedures|1|||
27840905|NCT00605176|81245184|FG001|Overall Study|Non-complicance with study procedures|0|||
27502314|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502315|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27722654|NCT00328627|80815484|FG002|Overall Study|Pregnancy|0|||
27722655|NCT00328627|80815485|FG003|Overall Study|Pregnancy|0|||
27840906|NCT00605176|81245185|FG002|Overall Study|Non-complicance with study procedures|0|||
27840907|NCT00605176|81245183|FG000|Overall Study|Use of concomitant therapy|1|||
27840908|NCT00605176|81245184|FG001|Overall Study|Use of concomitant therapy|0|||
27840909|NCT00605176|81245185|FG002|Overall Study|Use of concomitant therapy|1|||
27840910|NCT00605176|81245183|FG000|Overall Study|Other (not due to AE)|1|||
27722656|NCT00328627|80815486|FG004|Overall Study|Pregnancy|0|||
27722657|NCT00328627|80815487|FG005|Overall Study|Pregnancy|0|||
27840911|NCT00605176|81245184|FG001|Overall Study|Other (not due to AE)|1|||
27722658|NCT00328627|80815488|FG006|Overall Study|Pregnancy|0|||
27722659|NCT00328627|80815489|FG007|Overall Study|Pregnancy|0|||
27722660|NCT00328627|80815490|FG008|Overall Study|Pregnancy|0|||
27502316|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27611271|NCT01734434|80419056|FG003|Overall Study|Withdrawal by Subject|1|||
27611272|NCT01734434|80419053|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
27611273|NCT01734434|80419054|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
27611274|NCT01734434|80419055|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
27611275|NCT01734434|80419056|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
27611276|NCT01734434|80419053|FG000|Overall Study|Subject Not Reachable|0|||
27611277|NCT01734434|80419054|FG001|Overall Study|Subject Not Reachable|0|||
27611278|NCT01734434|80419055|FG002|Overall Study|Subject Not Reachable|1|||
27611279|NCT01734434|80419056|FG003|Overall Study|Subject Not Reachable|0|||
27611280|NCT01734434|80419053|FG000|Overall Study|Treatment Defaulter|0|||
27611281|NCT01734434|80419054|FG001|Overall Study|Treatment Defaulter|0|||
27611282|NCT01734434|80419055|FG002|Overall Study|Treatment Defaulter|1|||
27892004|NCT00614120|81437467|FG000|Overall Study|Lack of trial product|3|||
27892005|NCT00614120|81437468|FG001|Overall Study|Lack of trial product|3|||
27892006|NCT00614120|81437469|FG002|Overall Study|Lack of trial product|2|||
27892007|NCT00614120|81437470|FG003|Overall Study|Lack of trial product|0|||
27892008|NCT00614120|81437467|FG000|Overall Study|Late syphilis, latent|1|||
27502317|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502318|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502319|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
27502320|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
27502321|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502322|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502323|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502324|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502325|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502326|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502327|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502328|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502329|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502330|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502331|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502332|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502333|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502334|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502335|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502336|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502337|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502338|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502339|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502340|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502341|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502342|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
27502343|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
27502344|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
27502345|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
27502346|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
27502347|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
27502348|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
27502349|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
27502350|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
27502351|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
27502352|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
27502353|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
27502354|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
27502355|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
27502356|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
27502357|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
27502358|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
27502359|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
27502360|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
27502361|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
27502362|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
27611283|NCT01734434|80419056|FG003|Overall Study|Treatment Defaulter|0|||
27611284|NCT01734434|80419053|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
27611285|NCT01734434|80419054|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
27611286|NCT01734434|80419055|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
27892009|NCT00614120|81437468|FG001|Overall Study|Late syphilis, latent|0|||
27892010|NCT00614120|81437469|FG002|Overall Study|Late syphilis, latent|0|||
27611287|NCT01734434|80419056|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
27611288|NCT01734434|80419053|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
27611289|NCT01734434|80419054|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
27611290|NCT01734434|80419055|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
27611291|NCT01734434|80419056|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
27611292|NCT02337478|80419059|FG000|Overall Study|Lack of Efficacy|5|||
27611293|NCT00064025|80419060|FG000|Overall Study|Ineligible|4|||
27611294|NCT00064025|80419060|FG000|Overall Study|Inevaluable|3|||
27611295|NCT00147225|80419072|FG000|Overall Study|Withdrawal by Subject|1|||
27611296|NCT00147225|80419073|FG001|Overall Study|Withdrawal by Subject|0|||
27611297|NCT00147225|80419074|FG002|Overall Study|Withdrawal by Subject|1|||
27611298|NCT00147225|80419075|FG003|Overall Study|Withdrawal by Subject|0|||
27611299|NCT00147225|80419076|FG004|Overall Study|Withdrawal by Subject|0|||
27611300|NCT00147225|80419077|FG005|Overall Study|Withdrawal by Subject|1|||
27611301|NCT00147225|80419072|FG000|Overall Study|Adverse Event|0|||
27611302|NCT00147225|80419073|FG001|Overall Study|Adverse Event|0|||
27611303|NCT00147225|80419074|FG002|Overall Study|Adverse Event|1|||
27611304|NCT00147225|80419075|FG003|Overall Study|Adverse Event|1|||
27611305|NCT00147225|80419076|FG004|Overall Study|Adverse Event|0|||
27611306|NCT00147225|80419077|FG005|Overall Study|Adverse Event|0|||
27611307|NCT00147225|80419072|FG000|Overall Study|Screen Failure|0|||
27611308|NCT00147225|80419073|FG001|Overall Study|Screen Failure|0|||
27611309|NCT00147225|80419074|FG002|Overall Study|Screen Failure|0|||
27611310|NCT00147225|80419075|FG003|Overall Study|Screen Failure|0|||
27611311|NCT00147225|80419076|FG004|Overall Study|Screen Failure|1|||
27611312|NCT00147225|80419077|FG005|Overall Study|Screen Failure|0|||
27611313|NCT00147225|80419072|FG000|Overall Study|Chemotherapy Changed|0|||
27611314|NCT00147225|80419073|FG001|Overall Study|Chemotherapy Changed|0|||
27611315|NCT00147225|80419074|FG002|Overall Study|Chemotherapy Changed|0|||
27611316|NCT00147225|80419075|FG003|Overall Study|Chemotherapy Changed|0|||
27502363|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
27502364|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
27502365|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
27502366|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
27502367|NCT02052778|80032498|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502368|NCT02052778|80032499|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502369|NCT02052778|80032500|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502370|NCT02052778|80032501|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502371|NCT02052778|80032502|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502372|NCT02052778|80032503|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502373|NCT02052778|80032504|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502374|NCT02052778|80032505|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502375|NCT02052778|80032506|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502376|NCT02052778|80032507|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502377|NCT02052778|80032508|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502378|NCT02052778|80032509|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502379|NCT02052778|80032510|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502380|NCT02052778|80032511|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502381|NCT02052778|80032512|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502382|NCT02052778|80032513|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502383|NCT02052778|80032514|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502384|NCT02052778|80032515|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502385|NCT02052778|80032516|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502386|NCT02052778|80032517|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502387|NCT02052778|80032518|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502388|NCT02052778|80032519|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
27502389|NCT02052778|80032520|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
27840912|NCT00605176|81245185|FG002|Overall Study|Other (not due to AE)|0|||
27840913|NCT03712124|81248099|FG000|Overall Study|Protocol Violation|1|||
27840914|NCT03712124|81248100|FG001|Overall Study|Protocol Violation|0|||
27840915|NCT00480324|81248105|FG000|Overall Study|Adverse Event|1|||
27840916|NCT00480324|81248106|FG001|Overall Study|Adverse Event|1|||
27502390|NCT02006472|80032527|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
27502391|NCT02006472|80032528|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
27502392|NCT02006472|80032529|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
27502393|NCT02006472|80032530|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
27611317|NCT00147225|80419076|FG004|Overall Study|Chemotherapy Changed|0|||
27611318|NCT00147225|80419077|FG005|Overall Study|Chemotherapy Changed|1|||
27611319|NCT01588990|80419078|FG000|Phase A|Withdrawal by Subject|5|||
27611320|NCT01588990|80419078|FG000|Phase A|Physician Decision|11|||
27611321|NCT01588990|80419078|FG000|Phase A|Other|14|||
27611322|NCT01588990|80419078|FG000|Phase A|Lost to Follow-up|1|||
27611323|NCT01588990|80419078|FG000|Phase A|Death|5|||
27611324|NCT01588990|80419078|FG000|Phase A|Adverse Event|28|||
27840917|NCT00480324|81248105|FG000|Overall Study|Protocol Violation|0|||
27502394|NCT02006472|80032531|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
27502395|NCT02006472|80032527|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27502396|NCT02006472|80032528|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27502397|NCT02006472|80032529|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
27502398|NCT02006472|80032530|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27502399|NCT02006472|80032531|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
27502400|NCT02006472|80032527|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
27502401|NCT02006472|80032528|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
27502402|NCT02006472|80032529|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
27502403|NCT02006472|80032530|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
27502404|NCT02006472|80032531|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
27502405|NCT02006472|80032527|FG000|Period 1 (Through Week 26)|Other|1|||
27502406|NCT02006472|80032528|FG001|Period 1 (Through Week 26)|Other|5|||
27502407|NCT02006472|80032529|FG002|Period 1 (Through Week 26)|Other|0|||
27502408|NCT02006472|80032530|FG003|Period 1 (Through Week 26)|Other|2|||
27502409|NCT02006472|80032531|FG004|Period 1 (Through Week 26)|Other|3|||
27502410|NCT02006472|80032527|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
27502411|NCT02006472|80032528|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
27502412|NCT02006472|80032529|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
27502413|NCT02006472|80032530|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
27502414|NCT02006472|80032531|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
27502415|NCT02006472|80032527|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
27502416|NCT02006472|80032528|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
27502417|NCT02006472|80032529|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
27502418|NCT02006472|80032530|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
27502419|NCT02006472|80032531|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
27502420|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
27502421|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
27502422|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
27502423|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
27502424|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
27502425|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
27502426|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
27502427|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
27502428|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
27502429|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
27502430|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
27502431|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
27502432|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
27502433|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
27502434|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
27502435|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Other|0|||
27502436|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Other|1|||
27502437|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Other|0|||
27502438|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Other|1|||
27502439|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Other|0|||
27502440|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Not treated|0|||
27502441|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Not treated|0|||
27502442|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Not treated|2|||
27502443|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Not treated|0|||
27502444|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Not treated|0|||
27502445|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
27502446|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
27502447|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
27502448|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
27502449|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
27502450|NCT02006472|80032527|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
27502451|NCT02006472|80032528|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
27502452|NCT02006472|80032529|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
27502453|NCT02006472|80032530|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
27502454|NCT02006472|80032531|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
27502455|NCT04914364|80032535|FG000|Overall Study|No longer eligible for study|1|||
27502456|NCT04914364|80032535|FG000|Overall Study|Lost to Follow-up|2|||
27502457|NCT02992288|80032540|FG000|Overall Study|Adverse Event|8|||
27502458|NCT02992288|80032541|FG001|Overall Study|Adverse Event|2|||
27502459|NCT02992288|80032542|FG002|Overall Study|Adverse Event|2|||
27502460|NCT02992288|80032543|FG003|Overall Study|Adverse Event|2|||
27502461|NCT02992288|80032544|FG004|Overall Study|Adverse Event|2|||
27502462|NCT02992288|80032545|FG005|Overall Study|Adverse Event|7|||
27502463|NCT02992288|80032540|FG000|Overall Study|Non-compliance with study drug|0|||
27502464|NCT02992288|80032541|FG001|Overall Study|Non-compliance with study drug|1|||
27502465|NCT02992288|80032542|FG002|Overall Study|Non-compliance with study drug|1|||
27502466|NCT02992288|80032543|FG003|Overall Study|Non-compliance with study drug|0|||
27840918|NCT00480324|81248106|FG001|Overall Study|Protocol Violation|1|||
27611325|NCT01588990|80419078|FG000|Phase A|Still on therapy at end of study|6|||
27611326|NCT01588990|80419078|FG000|Phase B|Adverse Event|2|||
27611327|NCT01588990|80419078|FG000|Phase B|Still on therapy at end of study|5|||
27611328|NCT01588990|80419078|FG000|Phase B|Withdrawal by Subject|3|||
27611329|NCT01588990|80419078|FG000|Phase B|Physician Decision|4|||
27611330|NCT01588990|80419078|FG000|Phase B|Other|2|||
27892011|NCT00614120|81437470|FG003|Overall Study|Late syphilis, latent|0|||
27892012|NCT00614120|81437467|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
27892013|NCT00614120|81437468|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
27892014|NCT00614120|81437469|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
27892015|NCT00614120|81437470|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
27892016|NCT00614120|81437467|FG000|Overall Study|Lost to Follow-up|1|||
27892017|NCT00614120|81437468|FG001|Overall Study|Lost to Follow-up|2|||
27892018|NCT00614120|81437469|FG002|Overall Study|Lost to Follow-up|3|||
27892019|NCT00614120|81437470|FG003|Overall Study|Lost to Follow-up|4|||
27892020|NCT03020199|81437471|FG000|Treatment Period|Adverse Event|0|||
27892021|NCT03020199|81437472|FG001|Treatment Period|Adverse Event|2|||
27892022|NCT03020199|81437471|FG000|Treatment Period|Lack of Efficacy|1|||
27892023|NCT03020199|81437472|FG001|Treatment Period|Lack of Efficacy|6|||
27892024|NCT03020199|81437471|FG000|Treatment Period|Lost to Follow-up|1|||
27892025|NCT03020199|81437472|FG001|Treatment Period|Lost to Follow-up|6|||
27892026|NCT03020199|81437471|FG000|Treatment Period|Physician Decision|0|||
27892027|NCT03020199|81437472|FG001|Treatment Period|Physician Decision|1|||
27892028|NCT03020199|81437471|FG000|Treatment Period|Subject/guardian decision|8|||
27892029|NCT03020199|81437472|FG001|Treatment Period|Subject/guardian decision|15|||
27502467|NCT02992288|80032544|FG004|Overall Study|Non-compliance with study drug|1|||
27502468|NCT02992288|80032545|FG005|Overall Study|Non-compliance with study drug|0|||
27502469|NCT02992288|80032540|FG000|Overall Study|Physician Decision|3|||
27502470|NCT02992288|80032541|FG001|Overall Study|Physician Decision|0|||
27502471|NCT02992288|80032542|FG002|Overall Study|Physician Decision|1|||
27502472|NCT02992288|80032543|FG003|Overall Study|Physician Decision|0|||
27502473|NCT02992288|80032544|FG004|Overall Study|Physician Decision|0|||
27502474|NCT02992288|80032545|FG005|Overall Study|Physician Decision|1|||
27502475|NCT02992288|80032540|FG000|Overall Study|Death|2|||
27502476|NCT02992288|80032541|FG001|Overall Study|Death|0|||
27502477|NCT02992288|80032542|FG002|Overall Study|Death|2|||
27502478|NCT02992288|80032543|FG003|Overall Study|Death|1|||
27502479|NCT02992288|80032544|FG004|Overall Study|Death|2|||
27502480|NCT02992288|80032545|FG005|Overall Study|Death|0|||
27502481|NCT02992288|80032540|FG000|Overall Study|Lost to Follow-up|0|||
27502482|NCT02992288|80032541|FG001|Overall Study|Lost to Follow-up|0|||
27502483|NCT02992288|80032542|FG002|Overall Study|Lost to Follow-up|0|||
27502484|NCT02992288|80032543|FG003|Overall Study|Lost to Follow-up|1|||
27502485|NCT02992288|80032544|FG004|Overall Study|Lost to Follow-up|0|||
27502486|NCT02992288|80032545|FG005|Overall Study|Lost to Follow-up|0|||
27502487|NCT02992288|80032540|FG000|Overall Study|Protocol Violation|0|||
27502488|NCT02992288|80032541|FG001|Overall Study|Protocol Violation|0|||
27502489|NCT02992288|80032542|FG002|Overall Study|Protocol Violation|0|||
27502490|NCT02992288|80032543|FG003|Overall Study|Protocol Violation|0|||
27502491|NCT02992288|80032544|FG004|Overall Study|Protocol Violation|0|||
27502492|NCT02992288|80032545|FG005|Overall Study|Protocol Violation|1|||
27502493|NCT02992288|80032540|FG000|Overall Study|Withdrawal by Subject|4|||
27502494|NCT02992288|80032541|FG001|Overall Study|Withdrawal by Subject|2|||
27502495|NCT02992288|80032542|FG002|Overall Study|Withdrawal by Subject|1|||
27502496|NCT02992288|80032543|FG003|Overall Study|Withdrawal by Subject|5|||
27502497|NCT02992288|80032544|FG004|Overall Study|Withdrawal by Subject|3|||
27611331|NCT00871351|80419081|FG000|Overall Study|Withdrawal by Subject|1|||
27892030|NCT03020199|81437471|FG000|Treatment Period|Subjects not treated|3|||
27892031|NCT03020199|81437472|FG001|Treatment Period|Subjects not treated|4|||
27892032|NCT03020199|81437471|FG000|Follow-up Period|Disease relapse|32|||
27892033|NCT03020199|81437472|FG001|Follow-up Period|Disease relapse|7|||
27502498|NCT02992288|80032545|FG005|Overall Study|Withdrawal by Subject|4|||
27502499|NCT03435211|80032546|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
27502500|NCT03164616|80032547|FG000|Overall Study|Death|250|||
27502501|NCT03164616|80032548|FG001|Overall Study|Death|264|||
27502502|NCT03164616|80032549|FG002|Overall Study|Death|279|||
27502503|NCT03164616|80032547|FG000|Overall Study|Lost to Follow-up|2|||
27502504|NCT03164616|80032548|FG001|Overall Study|Lost to Follow-up|2|||
27502505|NCT03164616|80032549|FG002|Overall Study|Lost to Follow-up|2|||
27502506|NCT03164616|80032547|FG000|Overall Study|Withdrawal by Subject|6|||
27502507|NCT03164616|80032548|FG001|Overall Study|Withdrawal by Subject|7|||
27502508|NCT03164616|80032549|FG002|Overall Study|Withdrawal by Subject|16|||
27502509|NCT02085460|80032552|FG000|Overall Study|Adverse Event|2|||
27502510|NCT02085460|80032553|FG001|Overall Study|Adverse Event|2|||
27502511|NCT02085460|80032554|FG002|Overall Study|Adverse Event|1|||
27502512|NCT02085460|80032552|FG000|Overall Study|Physician Decision|1|||
27502513|NCT02085460|80032553|FG001|Overall Study|Physician Decision|1|||
27502514|NCT02085460|80032554|FG002|Overall Study|Physician Decision|2|||
27502515|NCT02085460|80032552|FG000|Overall Study|Withdrawal by Subject|11|||
27502516|NCT02085460|80032553|FG001|Overall Study|Withdrawal by Subject|5|||
27502517|NCT02085460|80032554|FG002|Overall Study|Withdrawal by Subject|7|||
27502518|NCT00541658|80032556|FG000|Overall Study|Adverse Event|28|||
27502519|NCT00541658|80032557|FG001|Overall Study|Adverse Event|37|||
27502520|NCT00541658|80032558|FG002|Overall Study|Adverse Event|25|||
27502521|NCT00541658|80032556|FG000|Overall Study|Physician Decision|0|||
27502522|NCT00541658|80032557|FG001|Overall Study|Physician Decision|0|||
27502523|NCT00541658|80032558|FG002|Overall Study|Physician Decision|4|||
27502524|NCT00541658|80032556|FG000|Overall Study|Lost to Follow-up|3|||
27502525|NCT00541658|80032557|FG001|Overall Study|Lost to Follow-up|3|||
27502526|NCT00541658|80032558|FG002|Overall Study|Lost to Follow-up|6|||
27502527|NCT00541658|80032556|FG000|Overall Study|Protocol Violation|0|||
27502528|NCT00541658|80032557|FG001|Overall Study|Protocol Violation|1|||
27502529|NCT00541658|80032558|FG002|Overall Study|Protocol Violation|1|||
27502530|NCT00541658|80032556|FG000|Overall Study|Withdrawal by Subject|28|||
27502531|NCT00541658|80032557|FG001|Overall Study|Withdrawal by Subject|32|||
27502532|NCT00541658|80032558|FG002|Overall Study|Withdrawal by Subject|32|||
27502533|NCT00541658|80032556|FG000|Overall Study|Took No Study Drug|1|||
27502534|NCT00541658|80032557|FG001|Overall Study|Took No Study Drug|0|||
27502535|NCT00541658|80032558|FG002|Overall Study|Took No Study Drug|0|||
27502536|NCT04288089|80032559|FG000|Overall Study|Ongoing Treatment|2|||
27502537|NCT04288089|80032560|FG001|Overall Study|Ongoing Treatment|1|||
27502538|NCT04288089|80032561|FG002|Overall Study|Ongoing Treatment|1|||
27502539|NCT04288089|80032562|FG003|Overall Study|Ongoing Treatment|4|||
27502540|NCT05249582|80032567|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
27502541|NCT05249582|80032568|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
27502542|NCT05249582|80032567|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
27502543|NCT05249582|80032568|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
27502544|NCT05249582|80032567|FG000|Overall Study|Declined to use virtual reality headset|1|||
27722661|NCT00328627|80815491|FG009|Overall Study|Pregnancy|0|||
27722662|NCT00328627|80815492|FG010|Overall Study|Pregnancy|0|||
27722663|NCT00328627|80815493|FG011|Overall Study|Pregnancy|0|||
27722664|NCT00328627|80815482|FG000|Overall Study|Physician Decision|4|||
27722665|NCT00328627|80815483|FG001|Overall Study|Physician Decision|3|||
27722666|NCT00328627|80815484|FG002|Overall Study|Physician Decision|1|||
27722667|NCT00328627|80815485|FG003|Overall Study|Physician Decision|2|||
27840919|NCT00480324|81248105|FG000|Overall Study|Withdrawal by Subject|14|||
27840920|NCT00480324|81248106|FG001|Overall Study|Withdrawal by Subject|5|||
27840921|NCT00480324|81248105|FG000|Overall Study|Lost to Follow-up|17|||
27840922|NCT00480324|81248106|FG001|Overall Study|Lost to Follow-up|8|||
27840923|NCT00480324|81248105|FG000|Overall Study|Subject's mother pregnant|0|||
27840924|NCT00480324|81248106|FG001|Overall Study|Subject's mother pregnant|1|||
27840925|NCT03941834|81248107|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
27840926|NCT03941834|81248108|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
27840927|NCT03941834|81248109|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
27840928|NCT03941834|81248107|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
27840929|NCT03941834|81248108|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
27840930|NCT03941834|81248109|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
27840931|NCT03941834|81248107|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
27840932|NCT03941834|81248108|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
27840933|NCT03941834|81248109|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
27840934|NCT03941834|81248107|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
27840935|NCT03941834|81248108|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
27840936|NCT03941834|81248109|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
27840937|NCT03941834|81248107|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
27840938|NCT03941834|81248108|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
27840939|NCT03941834|81248109|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
27840940|NCT03941834|81248107|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
27892034|NCT03020199|81437471|FG000|Follow-up Period|Lack of Efficacy|1|||
27892035|NCT03020199|81437472|FG001|Follow-up Period|Lack of Efficacy|2|||
27502545|NCT05249582|80032568|FG001|Overall Study|Declined to use virtual reality headset|0|||
27502546|NCT01394016|80032569|FG000|Overall Study|Progressive Disease|2|||
27502547|NCT01394016|80032570|FG001|Overall Study|Progressive Disease|0|||
27840941|NCT03941834|81248108|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
27840942|NCT03941834|81248109|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
27840943|NCT03480022|81248110|FG000|Overall Study|Pregnancy|2|||
27840944|NCT03480022|81248111|FG001|Overall Study|Pregnancy|0|||
27611332|NCT00871351|80419082|FG001|Overall Study|Withdrawal by Subject|0|||
27611333|NCT00871351|80419083|FG002|Overall Study|Withdrawal by Subject|0|||
27722668|NCT00328627|80815486|FG004|Overall Study|Physician Decision|1|||
27722669|NCT00328627|80815487|FG005|Overall Study|Physician Decision|1|||
27722670|NCT00328627|80815488|FG006|Overall Study|Physician Decision|1|||
27722671|NCT00328627|80815489|FG007|Overall Study|Physician Decision|0|||
27722672|NCT00328627|80815490|FG008|Overall Study|Physician Decision|3|||
27722673|NCT00328627|80815491|FG009|Overall Study|Physician Decision|2|||
27722674|NCT00328627|80815492|FG010|Overall Study|Physician Decision|1|||
27722675|NCT00328627|80815493|FG011|Overall Study|Physician Decision|0|||
27722676|NCT00328627|80815482|FG000|Overall Study|Other|0|||
27722677|NCT00328627|80815483|FG001|Overall Study|Other|0|||
27502548|NCT01394016|80032571|FG002|Overall Study|Progressive Disease|0|||
27502549|NCT01394016|80032572|FG003|Overall Study|Progressive Disease|0|||
27502550|NCT01394016|80032573|FG004|Overall Study|Progressive Disease|0|||
27502551|NCT01394016|80032574|FG005|Overall Study|Progressive Disease|0|||
27502552|NCT01394016|80032575|FG006|Overall Study|Progressive Disease|0|||
27722678|NCT00328627|80815484|FG002|Overall Study|Other|0|||
27722679|NCT00328627|80815485|FG003|Overall Study|Other|1|||
27840945|NCT03480022|81248110|FG000|Overall Study|Adverse Event|6|||
27840946|NCT03480022|81248111|FG001|Overall Study|Adverse Event|0|||
27502553|NCT01394016|80032576|FG007|Overall Study|Progressive Disease|0|||
27502554|NCT01394016|80032577|FG008|Overall Study|Progressive Disease|0|||
27502555|NCT01394016|80032578|FG009|Overall Study|Progressive Disease|0|||
27502556|NCT01394016|80032579|FG010|Overall Study|Progressive Disease|0|||
27502557|NCT01394016|80032580|FG011|Overall Study|Progressive Disease|0|||
27502558|NCT01394016|80032581|FG012|Overall Study|Progressive Disease|0|||
27502559|NCT01394016|80032582|FG013|Overall Study|Progressive Disease|0|||
27502560|NCT01394016|80032583|FG014|Overall Study|Progressive Disease|0|||
27502561|NCT01394016|80032584|FG015|Overall Study|Progressive Disease|0|||
27502562|NCT01394016|80032585|FG016|Overall Study|Progressive Disease|0|||
27502563|NCT01394016|80032586|FG017|Overall Study|Progressive Disease|0|||
27502564|NCT01394016|80032587|FG018|Overall Study|Progressive Disease|0|||
27502565|NCT01394016|80032569|FG000|Overall Study|Withdrawal by Subject|0|||
27502566|NCT01394016|80032570|FG001|Overall Study|Withdrawal by Subject|0|||
27502567|NCT01394016|80032571|FG002|Overall Study|Withdrawal by Subject|0|||
27502568|NCT01394016|80032572|FG003|Overall Study|Withdrawal by Subject|0|||
27502569|NCT01394016|80032573|FG004|Overall Study|Withdrawal by Subject|0|||
27502570|NCT01394016|80032574|FG005|Overall Study|Withdrawal by Subject|0|||
27502571|NCT01394016|80032575|FG006|Overall Study|Withdrawal by Subject|0|||
27502572|NCT01394016|80032576|FG007|Overall Study|Withdrawal by Subject|1|||
27502573|NCT01394016|80032577|FG008|Overall Study|Withdrawal by Subject|1|||
27502574|NCT01394016|80032578|FG009|Overall Study|Withdrawal by Subject|1|||
27502575|NCT01394016|80032579|FG010|Overall Study|Withdrawal by Subject|4|||
27611334|NCT00871351|80419081|FG000|Overall Study|Adverse Event|3|||
27611335|NCT00871351|80419082|FG001|Overall Study|Adverse Event|1|||
27840947|NCT03480022|81248110|FG000|Overall Study|Lack of Efficacy|0|||
27840948|NCT03480022|81248111|FG001|Overall Study|Lack of Efficacy|2|||
27840949|NCT03480022|81248110|FG000|Overall Study|Physician Decision|0|||
27840950|NCT03480022|81248111|FG001|Overall Study|Physician Decision|1|||
27892036|NCT03020199|81437471|FG000|Follow-up Period|Lost to Follow-up|4|||
27892037|NCT03020199|81437472|FG001|Follow-up Period|Lost to Follow-up|6|||
27502576|NCT01394016|80032580|FG011|Overall Study|Withdrawal by Subject|0|||
27502577|NCT01394016|80032581|FG012|Overall Study|Withdrawal by Subject|0|||
27722680|NCT00328627|80815486|FG004|Overall Study|Other|0|||
27722681|NCT00328627|80815487|FG005|Overall Study|Other|0|||
27722682|NCT00328627|80815488|FG006|Overall Study|Other|1|||
27722683|NCT00328627|80815489|FG007|Overall Study|Other|0|||
27722684|NCT00328627|80815490|FG008|Overall Study|Other|0|||
27840951|NCT03480022|81248110|FG000|Overall Study|Withdrawal by Subject|2|||
27840952|NCT03480022|81248111|FG001|Overall Study|Withdrawal by Subject|0|||
27840953|NCT03480022|81248110|FG000|Overall Study|Medication concerns|1|||
27611336|NCT00871351|80419083|FG002|Overall Study|Adverse Event|0|||
27611337|NCT04192630|80419084|FG000|Overall Study|Discontinued before surgery|2|||
27611338|NCT04192630|80419085|FG001|Overall Study|Discontinued before surgery|0|||
27611339|NCT04192630|80419084|FG000|Overall Study|Discontinued after surgery|5|||
27611340|NCT04192630|80419085|FG001|Overall Study|Discontinued after surgery|3|||
27611341|NCT00098254|80419090|FG000|Overall Study|Adverse Event|2|||
27611342|NCT00098254|80419090|FG000|Overall Study|Death|1|||
27611343|NCT02045433|80419091|FG000|Overall Study|Withdrawal by Subject|1|||
27611344|NCT00519636|80419092|FG000|Treatment Period 1|Adverse Event|1|||
27611345|NCT00519636|80419093|FG001|Treatment Period 1|Adverse Event|0|||
27611346|NCT00519636|80419094|FG002|Treatment Period 1|Adverse Event|1|||
27611347|NCT00519636|80419095|FG003|Treatment Period 1|Adverse Event|0|||
27611348|NCT00519636|80419092|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
27611349|NCT00519636|80419093|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
27611350|NCT00519636|80419094|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
27611351|NCT00519636|80419095|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
27611352|NCT00519636|80419092|FG000|Washout Period|Adverse Event|2|||
27611353|NCT00519636|80419093|FG001|Washout Period|Adverse Event|1|||
27611354|NCT00519636|80419094|FG002|Washout Period|Adverse Event|1|||
27611355|NCT00519636|80419095|FG003|Washout Period|Adverse Event|0|||
27611356|NCT00519636|80419092|FG000|Washout Period|Lost to Follow-up|1|||
27611357|NCT00519636|80419093|FG001|Washout Period|Lost to Follow-up|0|||
27611358|NCT00519636|80419094|FG002|Washout Period|Lost to Follow-up|0|||
27611359|NCT00519636|80419095|FG003|Washout Period|Lost to Follow-up|0|||
27611360|NCT00519636|80419092|FG000|Washout Period|Protocol Violation|0|||
27611361|NCT00519636|80419093|FG001|Washout Period|Protocol Violation|0|||
27611362|NCT00519636|80419094|FG002|Washout Period|Protocol Violation|1|||
27611363|NCT00519636|80419095|FG003|Washout Period|Protocol Violation|2|||
27611364|NCT00519636|80419092|FG000|Washout Period|Withdrawal by Subject|1|||
27611365|NCT00519636|80419093|FG001|Washout Period|Withdrawal by Subject|0|||
27611366|NCT00519636|80419094|FG002|Washout Period|Withdrawal by Subject|1|||
27611367|NCT00519636|80419095|FG003|Washout Period|Withdrawal by Subject|0|||
27611368|NCT00519636|80419092|FG000|Washout Period|Failed to meet continuation criteria|14|||
27611369|NCT00519636|80419093|FG001|Washout Period|Failed to meet continuation criteria|11|||
27611370|NCT00519636|80419094|FG002|Washout Period|Failed to meet continuation criteria|9|||
27611371|NCT00519636|80419095|FG003|Washout Period|Failed to meet continuation criteria|3|||
27611372|NCT00519636|80419092|FG000|Washout Period|Out of pollen area > 48 hours|1|||
27611373|NCT00519636|80419093|FG001|Washout Period|Out of pollen area > 48 hours|0|||
27840954|NCT03480022|81248111|FG001|Overall Study|Medication concerns|0|||
27611374|NCT00519636|80419094|FG002|Washout Period|Out of pollen area > 48 hours|0|||
27611375|NCT00519636|80419095|FG003|Washout Period|Out of pollen area > 48 hours|0|||
27611376|NCT00519636|80419092|FG000|Washout Period|Participating in study at another site|1|||
27611377|NCT00519636|80419093|FG001|Washout Period|Participating in study at another site|0|||
27611378|NCT00519636|80419094|FG002|Washout Period|Participating in study at another site|0|||
27611379|NCT00519636|80419095|FG003|Washout Period|Participating in study at another site|0|||
27611380|NCT00519636|80419092|FG000|Washout Period|Non-compliant|0|||
27611381|NCT00519636|80419093|FG001|Washout Period|Non-compliant|1|||
27611382|NCT00519636|80419094|FG002|Washout Period|Non-compliant|0|||
27611383|NCT00519636|80419095|FG003|Washout Period|Non-compliant|0|||
27611384|NCT00519636|80419092|FG000|Washout Period|Per doctors request|0|||
27611385|NCT00519636|80419093|FG001|Washout Period|Per doctors request|1|||
27611386|NCT00519636|80419094|FG002|Washout Period|Per doctors request|0|||
27611387|NCT00519636|80419095|FG003|Washout Period|Per doctors request|0|||
27611388|NCT00519636|80419092|FG000|Washout Period|Subject randomized in error|0|||
27611389|NCT00519636|80419093|FG001|Washout Period|Subject randomized in error|0|||
27611390|NCT00519636|80419094|FG002|Washout Period|Subject randomized in error|1|||
27611391|NCT00519636|80419095|FG003|Washout Period|Subject randomized in error|0|||
27611392|NCT00519636|80419092|FG000|Washout Period|Prohibited medications|0|||
27611393|NCT00519636|80419093|FG001|Washout Period|Prohibited medications|0|||
27611394|NCT00519636|80419094|FG002|Washout Period|Prohibited medications|1|||
27611395|NCT00519636|80419095|FG003|Washout Period|Prohibited medications|0|||
27611396|NCT00519636|80419092|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
27611397|NCT00519636|80419093|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
27502578|NCT01394016|80032582|FG013|Overall Study|Withdrawal by Subject|3|||
27502579|NCT01394016|80032583|FG014|Overall Study|Withdrawal by Subject|1|||
27502580|NCT01394016|80032584|FG015|Overall Study|Withdrawal by Subject|3|||
27502581|NCT01394016|80032585|FG016|Overall Study|Withdrawal by Subject|1|||
27502582|NCT01394016|80032586|FG017|Overall Study|Withdrawal by Subject|1|||
27502583|NCT01394016|80032587|FG018|Overall Study|Withdrawal by Subject|2|||
27502584|NCT01394016|80032569|FG000|Overall Study|Adverse Event|0|||
27502585|NCT01394016|80032570|FG001|Overall Study|Adverse Event|0|||
27611398|NCT00519636|80419094|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
27611399|NCT00519636|80419095|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
27611400|NCT00519636|80419092|FG000|Treatment Period 2|Subject randomized in error|0|||
27611401|NCT00519636|80419093|FG001|Treatment Period 2|Subject randomized in error|1|||
27611402|NCT00519636|80419094|FG002|Treatment Period 2|Subject randomized in error|0|||
27611403|NCT00519636|80419095|FG003|Treatment Period 2|Subject randomized in error|0|||
27611404|NCT00519636|80419092|FG000|Treatment Period 2|Per doctors request|0|||
27611405|NCT00519636|80419093|FG001|Treatment Period 2|Per doctors request|0|||
27611406|NCT00519636|80419094|FG002|Treatment Period 2|Per doctors request|1|||
27611407|NCT00519636|80419095|FG003|Treatment Period 2|Per doctors request|0|||
27611408|NCT00519636|80419092|FG000|Treatment Period 2|Subject misrandomized|0|||
27611409|NCT00519636|80419093|FG001|Treatment Period 2|Subject misrandomized|0|||
27502586|NCT01394016|80032571|FG002|Overall Study|Adverse Event|0|||
27502587|NCT01394016|80032572|FG003|Overall Study|Adverse Event|0|||
27502588|NCT01394016|80032573|FG004|Overall Study|Adverse Event|0|||
27502589|NCT01394016|80032574|FG005|Overall Study|Adverse Event|0|||
27502590|NCT01394016|80032575|FG006|Overall Study|Adverse Event|0|||
27502591|NCT01394016|80032576|FG007|Overall Study|Adverse Event|0|||
27502592|NCT01394016|80032577|FG008|Overall Study|Adverse Event|0|||
27502593|NCT01394016|80032578|FG009|Overall Study|Adverse Event|1|||
27502594|NCT01394016|80032579|FG010|Overall Study|Adverse Event|0|||
27502595|NCT01394016|80032580|FG011|Overall Study|Adverse Event|0|||
27502596|NCT01394016|80032581|FG012|Overall Study|Adverse Event|0|||
27502597|NCT01394016|80032582|FG013|Overall Study|Adverse Event|0|||
27502598|NCT01394016|80032583|FG014|Overall Study|Adverse Event|0|||
27502599|NCT01394016|80032584|FG015|Overall Study|Adverse Event|0|||
27502600|NCT01394016|80032585|FG016|Overall Study|Adverse Event|1|||
27502601|NCT01394016|80032586|FG017|Overall Study|Adverse Event|1|||
27502602|NCT01394016|80032587|FG018|Overall Study|Adverse Event|0|||
27611410|NCT00519636|80419094|FG002|Treatment Period 2|Subject misrandomized|0|||
27611411|NCT00519636|80419095|FG003|Treatment Period 2|Subject misrandomized|1|||
27611412|NCT00519636|80419092|FG000|Post Study Period|Subject randomized in error|0|||
27611413|NCT00519636|80419093|FG001|Post Study Period|Subject randomized in error|0|||
27611414|NCT00519636|80419094|FG002|Post Study Period|Subject randomized in error|0|||
27611415|NCT00519636|80419095|FG003|Post Study Period|Subject randomized in error|1|||
27611416|NCT02684903|80419097|FG000|Overall Study|COVID-19 shutdown of lab|4|||
27611417|NCT02684903|80419098|FG001|Overall Study|COVID-19 shutdown of lab|6|||
27840955|NCT03480022|81248110|FG000|Overall Study|Family member COVID exposure|0|||
27840956|NCT03480022|81248111|FG001|Overall Study|Family member COVID exposure|1|||
27840957|NCT04214288|81248112|FG000|Overall Study|Ongoing in the study|41|||
27502603|NCT01394016|80032569|FG000|Overall Study|Sponsor Decision|0|||
27502604|NCT01394016|80032570|FG001|Overall Study|Sponsor Decision|0|||
27502605|NCT01394016|80032571|FG002|Overall Study|Sponsor Decision|0|||
27502606|NCT01394016|80032572|FG003|Overall Study|Sponsor Decision|0|||
27502607|NCT01394016|80032573|FG004|Overall Study|Sponsor Decision|0|||
27502608|NCT01394016|80032574|FG005|Overall Study|Sponsor Decision|0|||
27502609|NCT01394016|80032575|FG006|Overall Study|Sponsor Decision|0|||
27722685|NCT00328627|80815491|FG009|Overall Study|Other|1|||
27722686|NCT00328627|80815492|FG010|Overall Study|Other|1|||
27722687|NCT00328627|80815493|FG011|Overall Study|Other|0|||
27722688|NCT01623271|80815494|FG000|Overall Study|Withdrawal by Subject|2|||
27722689|NCT00662792|80815495|FG000|Period 1|Personal Reasons|0|||
27722690|NCT00662792|80815496|FG001|Period 1|Personal Reasons|0|||
27722691|NCT00662792|80815497|FG002|Period 1|Personal Reasons|1|||
27722692|NCT00662792|80815498|FG003|Period 1|Personal Reasons|0|||
27722693|NCT00662792|80815495|FG000|Period 1|Refused continuing medication|0|||
27722694|NCT00662792|80815496|FG001|Period 1|Refused continuing medication|1|||
27722695|NCT00662792|80815497|FG002|Period 1|Refused continuing medication|1|||
27722696|NCT00662792|80815498|FG003|Period 1|Refused continuing medication|0|||
27722697|NCT00662792|80815495|FG000|Period 1|Lost to Follow-up|1|||
27722698|NCT00662792|80815496|FG001|Period 1|Lost to Follow-up|0|||
27722699|NCT00662792|80815497|FG002|Period 1|Lost to Follow-up|0|||
27722700|NCT00662792|80815498|FG003|Period 1|Lost to Follow-up|0|||
27722701|NCT00662792|80815495|FG000|Period 1|Other adverse event (AE)|0|||
27722702|NCT00662792|80815496|FG001|Period 1|Other adverse event (AE)|2|||
27722703|NCT00662792|80815497|FG002|Period 1|Other adverse event (AE)|0|||
27840958|NCT04214288|81248113|FG001|Overall Study|Ongoing in the study|51|||
27840959|NCT04214288|81248114|FG002|Overall Study|Ongoing in the study|12|||
27840960|NCT04214288|81248115|FG003|Overall Study|Ongoing in the study|39|||
27892038|NCT03020199|81437471|FG000|Follow-up Period|Physician Decision|2|||
27892039|NCT03020199|81437472|FG001|Follow-up Period|Physician Decision|2|||
27502610|NCT01394016|80032576|FG007|Overall Study|Sponsor Decision|0|||
27502611|NCT01394016|80032577|FG008|Overall Study|Sponsor Decision|0|||
27502612|NCT01394016|80032578|FG009|Overall Study|Sponsor Decision|0|||
27502613|NCT01394016|80032579|FG010|Overall Study|Sponsor Decision|0|||
27502614|NCT01394016|80032580|FG011|Overall Study|Sponsor Decision|0|||
27502615|NCT01394016|80032581|FG012|Overall Study|Sponsor Decision|1|||
27502616|NCT01394016|80032582|FG013|Overall Study|Sponsor Decision|0|||
27502617|NCT01394016|80032583|FG014|Overall Study|Sponsor Decision|0|||
27502618|NCT01394016|80032584|FG015|Overall Study|Sponsor Decision|0|||
27502619|NCT01394016|80032585|FG016|Overall Study|Sponsor Decision|0|||
27502620|NCT01394016|80032586|FG017|Overall Study|Sponsor Decision|0|||
27502621|NCT01394016|80032587|FG018|Overall Study|Sponsor Decision|0|||
27502622|NCT01394016|80032569|FG000|Overall Study|Lost to Follow-up|0|||
27502623|NCT01394016|80032570|FG001|Overall Study|Lost to Follow-up|0|||
27502624|NCT01394016|80032571|FG002|Overall Study|Lost to Follow-up|0|||
27502625|NCT01394016|80032572|FG003|Overall Study|Lost to Follow-up|0|||
27502626|NCT01394016|80032573|FG004|Overall Study|Lost to Follow-up|0|||
27502627|NCT01394016|80032574|FG005|Overall Study|Lost to Follow-up|0|||
27502628|NCT01394016|80032575|FG006|Overall Study|Lost to Follow-up|0|||
27502629|NCT01394016|80032576|FG007|Overall Study|Lost to Follow-up|0|||
27502630|NCT01394016|80032577|FG008|Overall Study|Lost to Follow-up|0|||
27502631|NCT01394016|80032578|FG009|Overall Study|Lost to Follow-up|0|||
27502632|NCT01394016|80032579|FG010|Overall Study|Lost to Follow-up|0|||
27502633|NCT01394016|80032580|FG011|Overall Study|Lost to Follow-up|0|||
27502634|NCT01394016|80032581|FG012|Overall Study|Lost to Follow-up|0|||
27502635|NCT01394016|80032582|FG013|Overall Study|Lost to Follow-up|0|||
27502636|NCT01394016|80032583|FG014|Overall Study|Lost to Follow-up|0|||
27502637|NCT01394016|80032584|FG015|Overall Study|Lost to Follow-up|0|||
27502638|NCT01394016|80032585|FG016|Overall Study|Lost to Follow-up|0|||
27722704|NCT00662792|80815498|FG003|Period 1|Other adverse event (AE)|0|||
27840961|NCT04214288|81248112|FG000|Overall Study|Adverse Event|1|||
27840962|NCT04214288|81248113|FG001|Overall Study|Adverse Event|0|||
27840963|NCT04214288|81248114|FG002|Overall Study|Adverse Event|0|||
27840964|NCT04214288|81248115|FG003|Overall Study|Adverse Event|0|||
27840965|NCT04214288|81248112|FG000|Overall Study|Death|22|||
27840966|NCT04214288|81248113|FG001|Overall Study|Death|13|||
27840967|NCT04214288|81248114|FG002|Overall Study|Death|7|||
27840968|NCT04214288|81248115|FG003|Overall Study|Death|19|||
27840969|NCT04214288|81248112|FG000|Overall Study|Lost to Follow-up|1|||
27840970|NCT04214288|81248113|FG001|Overall Study|Lost to Follow-up|2|||
27840971|NCT04214288|81248114|FG002|Overall Study|Lost to Follow-up|1|||
27722705|NCT00662792|80815495|FG000|Period 1|Worsening of disease under study (AE)|1|||
27722706|NCT00662792|80815496|FG001|Period 1|Worsening of disease under study (AE)|3|||
27722707|NCT00662792|80815497|FG002|Period 1|Worsening of disease under study (AE)|2|||
27722708|NCT00662792|80815498|FG003|Period 1|Worsening of disease under study (AE)|0|||
27892040|NCT03020199|81437471|FG000|Follow-up Period|Protocol Violation|1|||
27502639|NCT01394016|80032586|FG017|Overall Study|Lost to Follow-up|0|||
27502640|NCT01394016|80032587|FG018|Overall Study|Lost to Follow-up|1|||
27502641|NCT01419236|80032588|FG000|Overall Study|Adverse Event|1|||
27502642|NCT01419236|80032589|FG001|Overall Study|Adverse Event|0|||
27502643|NCT01419236|80032588|FG000|Overall Study|Lack of Efficacy|0|||
27502644|NCT01419236|80032589|FG001|Overall Study|Lack of Efficacy|1|||
27502645|NCT01419236|80032588|FG000|Overall Study|Lost to Follow-up|1|||
27722709|NCT00662792|80815495|FG000|Period 1|Not treated|0|||
27722710|NCT00662792|80815496|FG001|Period 1|Not treated|1|||
27722711|NCT00662792|80815497|FG002|Period 1|Not treated|0|||
27722712|NCT00662792|80815498|FG003|Period 1|Not treated|0|||
27502646|NCT01419236|80032589|FG001|Overall Study|Lost to Follow-up|0|||
27502647|NCT01419236|80032588|FG000|Overall Study|Physician Decision|1|||
27502648|NCT01419236|80032589|FG001|Overall Study|Physician Decision|0|||
27502649|NCT01419236|80032588|FG000|Overall Study|Withdrawal by Subject|1|||
27502650|NCT01419236|80032589|FG001|Overall Study|Withdrawal by Subject|4|||
27502651|NCT01419236|80032588|FG000|Overall Study|Entry Criteria Not Met|1|||
27502652|NCT01419236|80032589|FG001|Overall Study|Entry Criteria Not Met|0|||
27502653|NCT04163341|80032590|FG000|Overall Study|Withdrawal by Subject|2|||
27502654|NCT04163341|80032591|FG001|Overall Study|Withdrawal by Subject|0|||
27502655|NCT04163341|80032590|FG000|Overall Study|Lost to Follow-up|3|||
27502656|NCT04163341|80032591|FG001|Overall Study|Lost to Follow-up|4|||
27502657|NCT01263769|80032592|FG000|Overall Study|Non-Compliant with treatment|1|||
27502658|NCT01285557|80032595|FG000|Overall Study|Death|173|||
27611418|NCT02684903|80419097|FG000|Overall Study|Lost to Follow-up|31|||
27611419|NCT02684903|80419098|FG001|Overall Study|Lost to Follow-up|41|||
27611420|NCT02058290|80419099|FG000|Overall Study|Protocol Violation|2|||
27611421|NCT02058290|80419100|FG001|Overall Study|Protocol Violation|1|||
27611422|NCT02058290|80419099|FG000|Overall Study|Physician Decision|1|||
27611423|NCT02058290|80419100|FG001|Overall Study|Physician Decision|0|||
27611424|NCT02058290|80419099|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
27611425|NCT02058290|80419100|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
27611426|NCT02058290|80419099|FG000|Overall Study|Withdrawal by Subject|0|||
27611427|NCT02058290|80419100|FG001|Overall Study|Withdrawal by Subject|1|||
27611428|NCT01317875|80419101|FG000|Overall Study|Other|0|||
27611429|NCT01317875|80419102|FG001|Overall Study|Other|0|||
27611430|NCT01317875|80419103|FG002|Overall Study|Other|1|||
27611431|NCT01317875|80419104|FG003|Overall Study|Other|0|||
27611432|NCT01317875|80419105|FG004|Overall Study|Other|0|||
27611433|NCT01317875|80419106|FG005|Overall Study|Other|0|||
27611434|NCT01317875|80419107|FG006|Overall Study|Other|0|||
27611435|NCT01317875|80419108|FG007|Overall Study|Other|0|||
27611436|NCT01317875|80419109|FG008|Overall Study|Other|0|||
27611437|NCT01317875|80419110|FG009|Overall Study|Other|0|||
27611438|NCT01317875|80419101|FG000|Overall Study|Noncompliance with study drug|0|||
27611439|NCT01317875|80419102|FG001|Overall Study|Noncompliance with study drug|0|||
27611440|NCT01317875|80419103|FG002|Overall Study|Noncompliance with study drug|1|||
27611441|NCT01317875|80419104|FG003|Overall Study|Noncompliance with study drug|0|||
27611442|NCT01317875|80419105|FG004|Overall Study|Noncompliance with study drug|0|||
27611443|NCT01317875|80419106|FG005|Overall Study|Noncompliance with study drug|0|||
27611444|NCT01317875|80419107|FG006|Overall Study|Noncompliance with study drug|0|||
27611445|NCT01317875|80419108|FG007|Overall Study|Noncompliance with study drug|0|||
27611446|NCT01317875|80419109|FG008|Overall Study|Noncompliance with study drug|0|||
27611447|NCT01317875|80419110|FG009|Overall Study|Noncompliance with study drug|0|||
27611448|NCT01317875|80419101|FG000|Overall Study|Progressive Disease|1|||
27892041|NCT03020199|81437472|FG001|Follow-up Period|Protocol Violation|2|||
27892042|NCT03020199|81437471|FG000|Follow-up Period|Study terminated by Sponsor|6|||
27892043|NCT03020199|81437472|FG001|Follow-up Period|Study terminated by Sponsor|3|||
27892044|NCT03020199|81437471|FG000|Follow-up Period|Subject/guardian decision|14|||
27892045|NCT03020199|81437472|FG001|Follow-up Period|Subject/guardian decision|9|||
27892046|NCT04161079|81437473|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
27892047|NCT03201874|81437477|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
27892048|NCT03201874|81437478|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
27892049|NCT03201874|81437477|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
27892050|NCT03201874|81437478|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
27892051|NCT01123941|81437479|FG000|Overall Study|Lost to Follow-up|2|||
27892052|NCT01123941|81437480|FG001|Overall Study|Lost to Follow-up|1|||
27892053|NCT02447497|81437481|FG000|Overall Study|Did not meet treatment day baseline.|6|||
27892054|NCT02447497|81437482|FG001|Overall Study|Did not meet treatment day baseline.|5|||
27892055|NCT02447497|81437483|FG002|Overall Study|Did not meet treatment day baseline.|2|||
27892056|NCT02447497|81437484|FG003|Overall Study|Did not meet treatment day baseline.|2|||
27892057|NCT02447497|81437481|FG000|Overall Study|Dressing was compromised|0|||
27892058|NCT02447497|81437482|FG001|Overall Study|Dressing was compromised|1|||
27611449|NCT01317875|80419102|FG001|Overall Study|Progressive Disease|0|||
27611450|NCT01317875|80419103|FG002|Overall Study|Progressive Disease|2|||
27611451|NCT01317875|80419104|FG003|Overall Study|Progressive Disease|0|||
27611452|NCT01317875|80419105|FG004|Overall Study|Progressive Disease|1|||
27611453|NCT01317875|80419106|FG005|Overall Study|Progressive Disease|0|||
27722713|NCT00662792|80815495|FG000|Period 2|Worsening of disease under study|1|||
27502659|NCT01285557|80032596|FG001|Overall Study|Death|90|||
27502660|NCT01285557|80032595|FG000|Overall Study|Lost to Follow-up|6|||
27502661|NCT01285557|80032596|FG001|Overall Study|Lost to Follow-up|2|||
27502662|NCT01285557|80032595|FG000|Overall Study|Withdrew Consent|6|||
27502663|NCT01285557|80032596|FG001|Overall Study|Withdrew Consent|1|||
27502664|NCT01285557|80032595|FG000|Overall Study|Sponsor Study Termination|23|||
27502665|NCT01285557|80032596|FG001|Overall Study|Sponsor Study Termination|13|||
27722714|NCT00662792|80815496|FG001|Period 2|Worsening of disease under study|0|||
27722715|NCT00662792|80815497|FG002|Period 2|Worsening of disease under study|0|||
27722716|NCT00662792|80815498|FG003|Period 2|Worsening of disease under study|3|||
27722717|NCT00662792|80815495|FG000|Period 3|Refused continuing medication|1|||
27722718|NCT00662792|80815496|FG001|Period 3|Refused continuing medication|0|||
27722719|NCT00662792|80815497|FG002|Period 3|Refused continuing medication|1|||
27722720|NCT00662792|80815498|FG003|Period 3|Refused continuing medication|0|||
27722721|NCT00662792|80815495|FG000|Period 3|Other adverse event (AE)|0|||
27722722|NCT00662792|80815496|FG001|Period 3|Other adverse event (AE)|0|||
27722723|NCT00662792|80815497|FG002|Period 3|Other adverse event (AE)|1|||
27722724|NCT00662792|80815498|FG003|Period 3|Other adverse event (AE)|1|||
27722725|NCT00662792|80815495|FG000|Period 4|Refused continuing medication|0|||
27722726|NCT00662792|80815496|FG001|Period 4|Refused continuing medication|1|||
27722727|NCT00662792|80815497|FG002|Period 4|Refused continuing medication|0|||
27722728|NCT00662792|80815498|FG003|Period 4|Refused continuing medication|0|||
27722729|NCT00662792|80815495|FG000|Period 4|Other adverse event (AE)|1|||
27722730|NCT00662792|80815496|FG001|Period 4|Other adverse event (AE)|0|||
27722731|NCT00662792|80815497|FG002|Period 4|Other adverse event (AE)|0|||
27722732|NCT00662792|80815498|FG003|Period 4|Other adverse event (AE)|0|||
27722733|NCT00662792|80815495|FG000|Period 4|Worsening of disease under study (AE)|0|||
27722734|NCT00662792|80815496|FG001|Period 4|Worsening of disease under study (AE)|0|||
27722735|NCT00662792|80815497|FG002|Period 4|Worsening of disease under study (AE)|0|||
27722736|NCT00662792|80815498|FG003|Period 4|Worsening of disease under study (AE)|1|||
27722737|NCT00217087|80815499|FG000|Overall Study|decided to have esophagectomy|1|||
27722738|NCT00217087|80815500|FG001|Overall Study|decided to have esophagectomy|2|||
27722739|NCT00217087|80815499|FG000|Overall Study|completed less than 12 months return|10|||
27722740|NCT00217087|80815500|FG001|Overall Study|completed less than 12 months return|18|||
27722741|NCT04682405|80815501|FG000|Overall Study|Adverse Event|0|||
27722742|NCT04682405|80815502|FG001|Overall Study|Adverse Event|1|||
27722743|NCT01920711|80815503|FG000|Overall Study|Death|347|||
27722744|NCT01920711|80815504|FG001|Overall Study|Death|356|||
27722745|NCT01920711|80815503|FG000|Overall Study|Lost to Follow-up|13|||
27722746|NCT01920711|80815504|FG001|Overall Study|Lost to Follow-up|14|||
27722747|NCT01920711|80815503|FG000|Overall Study|Withdrawal by Subject|4|||
27722748|NCT01920711|80815504|FG001|Overall Study|Withdrawal by Subject|3|||
27722749|NCT01688050|80815505|FG000|Overall Study|Death|7|||
27722750|NCT01688050|80815505|FG000|Overall Study|Conversion to open repair|1|||
27722751|NCT01688050|80815505|FG000|Overall Study|Lost to Follow-up|13|||
27722752|NCT01688050|80815505|FG000|Overall Study|Withdrawal by Subject|10|||
27722753|NCT02894840|80815509|FG000|Overall Study|Lost to Follow-up|1|||
27722754|NCT02894840|80815510|FG001|Overall Study|Lost to Follow-up|0|||
27722755|NCT02894840|80815511|FG002|Overall Study|Lost to Follow-up|3|||
27722756|NCT02894840|80815512|FG003|Overall Study|Lost to Follow-up|0|||
27722757|NCT02296242|80815513|FG000|Overall Study|Death|1|||
27722758|NCT02296242|80815514|FG001|Overall Study|Death|1|||
27722759|NCT02296242|80815515|FG002|Overall Study|Death|1|||
27722760|NCT02296242|80815516|FG003|Overall Study|Death|1|||
27722761|NCT02296242|80815517|FG004|Overall Study|Death|1|||
27722762|NCT02296242|80815513|FG000|Overall Study|Withdrawal by Subject|0|||
27722763|NCT02296242|80815514|FG001|Overall Study|Withdrawal by Subject|0|||
27722764|NCT02296242|80815515|FG002|Overall Study|Withdrawal by Subject|1|||
27722765|NCT02296242|80815516|FG003|Overall Study|Withdrawal by Subject|1|||
27722766|NCT02296242|80815517|FG004|Overall Study|Withdrawal by Subject|3|||
27722767|NCT02296242|80815513|FG000|Overall Study|Disease Progression|1|||
27722768|NCT02296242|80815514|FG001|Overall Study|Disease Progression|3|||
27722769|NCT02296242|80815515|FG002|Overall Study|Disease Progression|2|||
27722770|NCT02296242|80815516|FG003|Overall Study|Disease Progression|8|||
27722771|NCT02296242|80815517|FG004|Overall Study|Disease Progression|11|||
27722772|NCT02296242|80815513|FG000|Overall Study|Unacceptable Toxicity|0|||
27722773|NCT02296242|80815514|FG001|Overall Study|Unacceptable Toxicity|0|||
27722774|NCT02296242|80815515|FG002|Overall Study|Unacceptable Toxicity|0|||
27722775|NCT02296242|80815516|FG003|Overall Study|Unacceptable Toxicity|0|||
27840972|NCT04214288|81248115|FG003|Overall Study|Lost to Follow-up|0|||
27722776|NCT02296242|80815517|FG004|Overall Study|Unacceptable Toxicity|1|||
27722777|NCT02296242|80815513|FG000|Overall Study|Patient Condition Changed|0|||
27722778|NCT02296242|80815514|FG001|Overall Study|Patient Condition Changed|0|||
27722779|NCT02296242|80815515|FG002|Overall Study|Patient Condition Changed|2|||
27722780|NCT02296242|80815516|FG003|Overall Study|Patient Condition Changed|0|||
27722781|NCT02296242|80815517|FG004|Overall Study|Patient Condition Changed|1|||
27722782|NCT02296242|80815513|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
27722783|NCT02296242|80815514|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
27722784|NCT02296242|80815515|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
27840973|NCT04214288|81248112|FG000|Overall Study|Other|1|||
27840974|NCT04214288|81248113|FG001|Overall Study|Other|2|||
27722785|NCT02296242|80815516|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
27722786|NCT02296242|80815517|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
27722787|NCT02296242|80815513|FG000|Overall Study|Lost to Follow-up|1|||
27722788|NCT02296242|80815514|FG001|Overall Study|Lost to Follow-up|0|||
27722789|NCT02296242|80815515|FG002|Overall Study|Lost to Follow-up|0|||
27722790|NCT02296242|80815516|FG003|Overall Study|Lost to Follow-up|0|||
27722791|NCT02296242|80815517|FG004|Overall Study|Lost to Follow-up|0|||
27722792|NCT02296242|80815513|FG000|Overall Study|Need for Hydroxyurea|2|||
27722793|NCT02296242|80815514|FG001|Overall Study|Need for Hydroxyurea|0|||
27722794|NCT02296242|80815515|FG002|Overall Study|Need for Hydroxyurea|0|||
27722795|NCT02296242|80815516|FG003|Overall Study|Need for Hydroxyurea|0|||
27722796|NCT02296242|80815517|FG004|Overall Study|Need for Hydroxyurea|0|||
27722797|NCT02296242|80815513|FG000|Overall Study|Screened for Other Protocol|0|||
27722798|NCT02296242|80815514|FG001|Overall Study|Screened for Other Protocol|1|||
27722799|NCT02296242|80815515|FG002|Overall Study|Screened for Other Protocol|0|||
27722800|NCT02296242|80815516|FG003|Overall Study|Screened for Other Protocol|0|||
27722801|NCT02296242|80815517|FG004|Overall Study|Screened for Other Protocol|0|||
27722802|NCT02296242|80815513|FG000|Overall Study|Physician Decision|0|||
27722803|NCT02296242|80815514|FG001|Overall Study|Physician Decision|1|||
27722804|NCT02296242|80815515|FG002|Overall Study|Physician Decision|0|||
27722805|NCT02296242|80815516|FG003|Overall Study|Physician Decision|1|||
27722806|NCT02296242|80815517|FG004|Overall Study|Physician Decision|0|||
27722807|NCT02296242|80815513|FG000|Overall Study|Alternative Treatment|0|||
27722808|NCT02296242|80815514|FG001|Overall Study|Alternative Treatment|0|||
27722809|NCT02296242|80815515|FG002|Overall Study|Alternative Treatment|0|||
27722810|NCT02296242|80815516|FG003|Overall Study|Alternative Treatment|1|||
27722811|NCT02296242|80815517|FG004|Overall Study|Alternative Treatment|0|||
27722812|NCT02296242|80815513|FG000|Overall Study|Adverse Event|0|||
27722813|NCT02296242|80815514|FG001|Overall Study|Adverse Event|0|||
27722814|NCT02296242|80815515|FG002|Overall Study|Adverse Event|0|||
27722815|NCT02296242|80815516|FG003|Overall Study|Adverse Event|1|||
27722816|NCT02296242|80815517|FG004|Overall Study|Adverse Event|0|||
27722817|NCT02296242|80815513|FG000|Overall Study|Lack of Efficacy|0|||
27722818|NCT02296242|80815514|FG001|Overall Study|Lack of Efficacy|0|||
27722819|NCT02296242|80815515|FG002|Overall Study|Lack of Efficacy|0|||
27722820|NCT02296242|80815516|FG003|Overall Study|Lack of Efficacy|0|||
27722821|NCT02296242|80815517|FG004|Overall Study|Lack of Efficacy|3|||
27722822|NCT00428597|80815518|FG000|Overall Study|Randomized but not treated|3|||
27722823|NCT00428597|80815519|FG001|Overall Study|Randomized but not treated|3|||
27722824|NCT00428597|80815518|FG000|Overall Study|Objective Progression or Relapse|19|||
27722825|NCT00428597|80815519|FG001|Overall Study|Objective Progression or Relapse|47|||
27722826|NCT00428597|80815518|FG000|Overall Study|Study Terminated by Sponsor|41|||
27722827|NCT00428597|80815519|FG001|Overall Study|Study Terminated by Sponsor|16|||
27722828|NCT00428597|80815518|FG000|Overall Study|Adverse Event|15|||
27722829|NCT00428597|80815519|FG001|Overall Study|Adverse Event|7|||
27722830|NCT00428597|80815518|FG000|Overall Study|Global Deterioration of Health Status|1|||
27722831|NCT00428597|80815519|FG001|Overall Study|Global Deterioration of Health Status|5|||
27722832|NCT00428597|80815518|FG000|Overall Study|Protocol Violation|2|||
27722833|NCT00428597|80815519|FG001|Overall Study|Protocol Violation|1|||
27722834|NCT00428597|80815518|FG000|Overall Study|Withdrawal by Subject|2|||
27722835|NCT00428597|80815519|FG001|Overall Study|Withdrawal by Subject|1|||
27722836|NCT00428597|80815518|FG000|Overall Study|Other|1|||
27722837|NCT00428597|80815519|FG001|Overall Study|Other|1|||
27722838|NCT00428597|80815518|FG000|Overall Study|Lost to Follow-up|0|||
27722839|NCT00428597|80815519|FG001|Overall Study|Lost to Follow-up|1|||
27722840|NCT00428597|80815518|FG000|Overall Study|Pregnancy|1|||
27722841|NCT00428597|80815519|FG001|Overall Study|Pregnancy|0|||
27722842|NCT00428597|80815518|FG000|Overall Study|Death|1|||
27722843|NCT00428597|80815519|FG001|Overall Study|Death|3|||
27722844|NCT01100944|80815522|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
27722845|NCT01100944|80815523|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
27722846|NCT01100944|80815524|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
27722847|NCT01100944|80815522|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
27722848|NCT01100944|80815523|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
27892059|NCT02447497|81437483|FG002|Overall Study|Dressing was compromised|0|||
27892060|NCT02447497|81437484|FG003|Overall Study|Dressing was compromised|0|||
27722849|NCT01100944|80815524|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
27722850|NCT01100944|80815522|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
27722851|NCT01100944|80815523|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
27722852|NCT01100944|80815524|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
27722853|NCT01100944|80815522|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
27722854|NCT01100944|80815523|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
27722855|NCT01100944|80815524|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
27722856|NCT02979431|80815528|FG000|Overall Study|Parent/guardian withdrew consent|2|||
27722857|NCT02979431|80815529|FG001|Overall Study|Parent/guardian withdrew consent|1|||
27722858|NCT02979431|80815530|FG002|Overall Study|Parent/guardian withdrew consent|1|||
27722859|NCT02979431|80815531|FG003|Overall Study|Parent/guardian withdrew consent|1|||
27722860|NCT02979431|80815528|FG000|Overall Study|Randomized but received no study drug|1|||
27722861|NCT02979431|80815529|FG001|Overall Study|Randomized but received no study drug|1|||
27722862|NCT02979431|80815530|FG002|Overall Study|Randomized but received no study drug|0|||
27722863|NCT02979431|80815531|FG003|Overall Study|Randomized but received no study drug|0|||
27722864|NCT02979431|80815528|FG000|Overall Study|Adverse Event|0|||
27722865|NCT02979431|80815529|FG001|Overall Study|Adverse Event|0|||
27722866|NCT02979431|80815530|FG002|Overall Study|Adverse Event|1|||
27722867|NCT02979431|80815531|FG003|Overall Study|Adverse Event|0|||
27722868|NCT02979431|80815528|FG000|Overall Study|Subject left country after Day14|1|||
27722869|NCT02979431|80815529|FG001|Overall Study|Subject left country after Day14|0|||
27722870|NCT02979431|80815530|FG002|Overall Study|Subject left country after Day14|0|||
27722871|NCT02979431|80815531|FG003|Overall Study|Subject left country after Day14|0|||
27722872|NCT00379795|80815532|FG000|Overall Study|Death|31|||
27722873|NCT00379795|80815533|FG001|Overall Study|Death|8|||
27722874|NCT00379795|80815534|FG002|Overall Study|Death|6|||
27722875|NCT00379795|80815535|FG003|Overall Study|Death|4|||
27722876|NCT00379795|80815536|FG004|Overall Study|Death|7|||
27722877|NCT00379795|80815532|FG000|Overall Study|Adverse Event|17|||
27722878|NCT00379795|80815533|FG001|Overall Study|Adverse Event|3|||
27722879|NCT00379795|80815534|FG002|Overall Study|Adverse Event|3|||
27722880|NCT00379795|80815535|FG003|Overall Study|Adverse Event|1|||
27722881|NCT00379795|80815536|FG004|Overall Study|Adverse Event|4|||
27722882|NCT00379795|80815532|FG000|Overall Study|Lost to Follow-up|8|||
27722883|NCT00379795|80815533|FG001|Overall Study|Lost to Follow-up|1|||
27722884|NCT00379795|80815534|FG002|Overall Study|Lost to Follow-up|2|||
27722885|NCT00379795|80815535|FG003|Overall Study|Lost to Follow-up|1|||
27722886|NCT00379795|80815536|FG004|Overall Study|Lost to Follow-up|4|||
27722887|NCT00379795|80815532|FG000|Overall Study|Physician Decision|25|||
27722888|NCT00379795|80815533|FG001|Overall Study|Physician Decision|0|||
27722889|NCT00379795|80815534|FG002|Overall Study|Physician Decision|2|||
27722890|NCT00379795|80815535|FG003|Overall Study|Physician Decision|2|||
27722891|NCT00379795|80815536|FG004|Overall Study|Physician Decision|2|||
27722892|NCT00379795|80815532|FG000|Overall Study|Withdrawal by Subject|94|||
27722893|NCT00379795|80815533|FG001|Overall Study|Withdrawal by Subject|11|||
27502666|NCT01285557|80032595|FG000|Overall Study|Randomized but not treated|1|||
27502667|NCT01285557|80032596|FG001|Overall Study|Randomized but not treated|1|||
27502668|NCT01285557|80032595|FG000|Overall Study|Study follow-up ongoing|28|||
27502669|NCT01285557|80032596|FG001|Overall Study|Study follow-up ongoing|14|||
27722894|NCT00379795|80815534|FG002|Overall Study|Withdrawal by Subject|19|||
27892061|NCT04934189|81437485|FG000|Overall Study|Lost to Follow-up|4|||
27892062|NCT04934189|81437485|FG000|Overall Study|Withdrawal by Subject|17|||
27722895|NCT00379795|80815535|FG003|Overall Study|Withdrawal by Subject|7|||
27722896|NCT00379795|80815536|FG004|Overall Study|Withdrawal by Subject|14|||
27722897|NCT00379795|80815532|FG000|Overall Study|Subject non-compliance|7|||
27722898|NCT00379795|80815533|FG001|Overall Study|Subject non-compliance|2|||
27722899|NCT00379795|80815534|FG002|Overall Study|Subject non-compliance|0|||
27722900|NCT00379795|80815535|FG003|Overall Study|Subject non-compliance|0|||
27722901|NCT00379795|80815536|FG004|Overall Study|Subject non-compliance|1|||
27722902|NCT00379795|80815532|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
27722903|NCT00379795|80815533|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
27722904|NCT00379795|80815534|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
27502670|NCT01285557|80032595|FG000|Overall Study|Sponsor Decision|2|||
27722905|NCT00379795|80815535|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
27722906|NCT00379795|80815536|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
27722907|NCT00379795|80815532|FG000|Overall Study|Subjects condition mandated intervention|34|||
27722908|NCT00379795|80815533|FG001|Overall Study|Subjects condition mandated intervention|9|||
27722909|NCT00379795|80815534|FG002|Overall Study|Subjects condition mandated intervention|7|||
27722910|NCT00379795|80815535|FG003|Overall Study|Subjects condition mandated intervention|5|||
27722911|NCT00379795|80815536|FG004|Overall Study|Subjects condition mandated intervention|7|||
27502671|NCT01285557|80032596|FG001|Overall Study|Sponsor Decision|1|||
27502672|NCT03119259|80032600|FG000|Overall Study|Withdrawn as no longer eligible|1|||
27722912|NCT00379795|80815532|FG000|Overall Study|Sponsor's decision|257|||
27722913|NCT00379795|80815533|FG001|Overall Study|Sponsor's decision|17|||
27722914|NCT00379795|80815534|FG002|Overall Study|Sponsor's decision|54|||
27722915|NCT00379795|80815535|FG003|Overall Study|Sponsor's decision|47|||
27722916|NCT00379795|80815536|FG004|Overall Study|Sponsor's decision|10|||
27722917|NCT01827384|80815537|FG000|Overall Study|Switched to alternative treatment|0|||
27722918|NCT01827384|80815538|FG001|Overall Study|Switched to alternative treatment|0|||
27722919|NCT01827384|80815539|FG002|Overall Study|Switched to alternative treatment|0|||
27722920|NCT01827384|80815540|FG003|Overall Study|Switched to alternative treatment|0|||
27722921|NCT01827384|80815541|FG004|Overall Study|Switched to alternative treatment|0|||
27722922|NCT01827384|80815542|FG005|Overall Study|Switched to alternative treatment|0|||
27722923|NCT01827384|80815543|FG006|Overall Study|Switched to alternative treatment|0|||
27722924|NCT01827384|80815544|FG007|Overall Study|Switched to alternative treatment|0|||
27722925|NCT01827384|80815545|FG008|Overall Study|Switched to alternative treatment|0|||
27722926|NCT01827384|80815546|FG009|Overall Study|Switched to alternative treatment|0|||
27722927|NCT01827384|80815547|FG010|Overall Study|Switched to alternative treatment|0|||
27722928|NCT01827384|80815548|FG011|Overall Study|Switched to alternative treatment|0|||
27722929|NCT01827384|80815549|FG012|Overall Study|Switched to alternative treatment|0|||
27722930|NCT01827384|80815550|FG013|Overall Study|Switched to alternative treatment|2|||
27722931|NCT01827384|80815537|FG000|Overall Study|Disease progression before treatment|0|||
27722932|NCT01827384|80815538|FG001|Overall Study|Disease progression before treatment|0|||
27722933|NCT01827384|80815539|FG002|Overall Study|Disease progression before treatment|0|||
27722934|NCT01827384|80815540|FG003|Overall Study|Disease progression before treatment|0|||
27722935|NCT01827384|80815541|FG004|Overall Study|Disease progression before treatment|0|||
27722936|NCT01827384|80815542|FG005|Overall Study|Disease progression before treatment|0|||
27722937|NCT01827384|80815543|FG006|Overall Study|Disease progression before treatment|0|||
27722938|NCT01827384|80815544|FG007|Overall Study|Disease progression before treatment|0|||
27722939|NCT01827384|80815545|FG008|Overall Study|Disease progression before treatment|0|||
27722940|NCT01827384|80815546|FG009|Overall Study|Disease progression before treatment|0|||
27722941|NCT01827384|80815547|FG010|Overall Study|Disease progression before treatment|0|||
27722942|NCT01827384|80815548|FG011|Overall Study|Disease progression before treatment|0|||
27722943|NCT01827384|80815549|FG012|Overall Study|Disease progression before treatment|0|||
27722944|NCT01827384|80815550|FG013|Overall Study|Disease progression before treatment|4|||
27722945|NCT01827384|80815537|FG000|Overall Study|Ineligible|0|||
27722946|NCT01827384|80815538|FG001|Overall Study|Ineligible|0|||
27722947|NCT01827384|80815539|FG002|Overall Study|Ineligible|0|||
27722948|NCT01827384|80815540|FG003|Overall Study|Ineligible|0|||
27722949|NCT01827384|80815541|FG004|Overall Study|Ineligible|0|||
27722950|NCT01827384|80815542|FG005|Overall Study|Ineligible|0|||
27722951|NCT01827384|80815543|FG006|Overall Study|Ineligible|0|||
27722952|NCT01827384|80815544|FG007|Overall Study|Ineligible|0|||
27722953|NCT01827384|80815545|FG008|Overall Study|Ineligible|0|||
27722954|NCT01827384|80815546|FG009|Overall Study|Ineligible|0|||
27722955|NCT01827384|80815547|FG010|Overall Study|Ineligible|0|||
27722956|NCT01827384|80815548|FG011|Overall Study|Ineligible|0|||
27722957|NCT01827384|80815549|FG012|Overall Study|Ineligible|0|||
27722958|NCT01827384|80815550|FG013|Overall Study|Ineligible|19|||
27722959|NCT01827384|80815537|FG000|Overall Study|Participant died before treatment|0|||
27722960|NCT01827384|80815538|FG001|Overall Study|Participant died before treatment|0|||
27722961|NCT01827384|80815539|FG002|Overall Study|Participant died before treatment|0|||
27722962|NCT01827384|80815540|FG003|Overall Study|Participant died before treatment|0|||
27722963|NCT01827384|80815541|FG004|Overall Study|Participant died before treatment|0|||
27722964|NCT01827384|80815542|FG005|Overall Study|Participant died before treatment|0|||
27722965|NCT01827384|80815543|FG006|Overall Study|Participant died before treatment|0|||
27722966|NCT01827384|80815544|FG007|Overall Study|Participant died before treatment|0|||
27722967|NCT01827384|80815545|FG008|Overall Study|Participant died before treatment|0|||
27722968|NCT01827384|80815546|FG009|Overall Study|Participant died before treatment|0|||
27722969|NCT01827384|80815547|FG010|Overall Study|Participant died before treatment|0|||
27722970|NCT01827384|80815548|FG011|Overall Study|Participant died before treatment|0|||
27722971|NCT01827384|80815549|FG012|Overall Study|Participant died before treatment|0|||
27722972|NCT01827384|80815550|FG013|Overall Study|Participant died before treatment|5|||
27722973|NCT01827384|80815537|FG000|Overall Study|Insufficient tumor cells|0|||
27722974|NCT01827384|80815538|FG001|Overall Study|Insufficient tumor cells|0|||
27722975|NCT01827384|80815539|FG002|Overall Study|Insufficient tumor cells|0|||
27722976|NCT01827384|80815540|FG003|Overall Study|Insufficient tumor cells|0|||
27722977|NCT01827384|80815541|FG004|Overall Study|Insufficient tumor cells|0|||
27722978|NCT01827384|80815542|FG005|Overall Study|Insufficient tumor cells|0|||
27722979|NCT01827384|80815543|FG006|Overall Study|Insufficient tumor cells|0|||
27722980|NCT01827384|80815544|FG007|Overall Study|Insufficient tumor cells|0|||
27722981|NCT01827384|80815545|FG008|Overall Study|Insufficient tumor cells|0|||
27722982|NCT01827384|80815546|FG009|Overall Study|Insufficient tumor cells|0|||
27722983|NCT01827384|80815547|FG010|Overall Study|Insufficient tumor cells|0|||
27722984|NCT01827384|80815548|FG011|Overall Study|Insufficient tumor cells|0|||
27611454|NCT01317875|80419107|FG006|Overall Study|Progressive Disease|0|||
27840975|NCT04214288|81248114|FG002|Overall Study|Other|0|||
27722985|NCT01827384|80815549|FG012|Overall Study|Insufficient tumor cells|0|||
27722986|NCT01827384|80815550|FG013|Overall Study|Insufficient tumor cells|13|||
27722987|NCT01827384|80815537|FG000|Overall Study|No actionable mutation|0|||
27722988|NCT01827384|80815538|FG001|Overall Study|No actionable mutation|0|||
27722989|NCT01827384|80815539|FG002|Overall Study|No actionable mutation|0|||
27722990|NCT01827384|80815540|FG003|Overall Study|No actionable mutation|0|||
27722991|NCT01827384|80815541|FG004|Overall Study|No actionable mutation|0|||
27722992|NCT01827384|80815542|FG005|Overall Study|No actionable mutation|0|||
27722993|NCT01827384|80815543|FG006|Overall Study|No actionable mutation|0|||
27722994|NCT01827384|80815544|FG007|Overall Study|No actionable mutation|0|||
27722995|NCT01827384|80815545|FG008|Overall Study|No actionable mutation|0|||
27722996|NCT01827384|80815546|FG009|Overall Study|No actionable mutation|0|||
27722997|NCT01827384|80815547|FG010|Overall Study|No actionable mutation|0|||
27722998|NCT01827384|80815548|FG011|Overall Study|No actionable mutation|0|||
27722999|NCT01827384|80815549|FG012|Overall Study|No actionable mutation|0|||
27502673|NCT03119259|80032601|FG001|Overall Study|Withdrawn as no longer eligible|0|||
27502674|NCT03119259|80032600|FG000|Overall Study|Withdrawal by Subject|4|||
27502675|NCT03119259|80032601|FG001|Overall Study|Withdrawal by Subject|2|||
27502676|NCT03119259|80032600|FG000|Overall Study|Lost to Follow-up|0|||
27502677|NCT03119259|80032601|FG001|Overall Study|Lost to Follow-up|1|||
27502678|NCT03173560|80032602|FG000|Overall Study|Ongoing on Treatment|38|||
27502679|NCT03173560|80032603|FG001|Overall Study|Ongoing on Treatment|50|||
27502680|NCT03173560|80032602|FG000|Overall Study|Ongoing Survival Follow-up|56|||
27502681|NCT03173560|80032603|FG001|Overall Study|Ongoing Survival Follow-up|57|||
27502682|NCT03173560|80032602|FG000|Overall Study|Lost to Follow-up|1|||
27502683|NCT03173560|80032603|FG001|Overall Study|Lost to Follow-up|4|||
27502684|NCT03173560|80032602|FG000|Overall Study|Withdrawal by Subject|10|||
27502685|NCT03173560|80032603|FG001|Overall Study|Withdrawal by Subject|5|||
27502686|NCT03173560|80032602|FG000|Overall Study|Other|0|||
27502687|NCT03173560|80032603|FG001|Overall Study|Other|1|||
27502688|NCT04298697|80032606|FG000|Overall Study|Lost to Follow-up|5|||
27502689|NCT04298697|80032607|FG001|Overall Study|Lost to Follow-up|5|||
27502690|NCT04298697|80032608|FG002|Overall Study|Lost to Follow-up|1|||
27502691|NCT04298697|80032609|FG003|Overall Study|Lost to Follow-up|0|||
27611455|NCT01317875|80419108|FG007|Overall Study|Progressive Disease|1|||
27723000|NCT01827384|80815550|FG013|Overall Study|No actionable mutation|73|||
27723001|NCT01827384|80815537|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
27723002|NCT01827384|80815538|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
27723003|NCT01827384|80815539|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
27723004|NCT01827384|80815540|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
27723005|NCT01827384|80815541|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
27723006|NCT01827384|80815542|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
27723007|NCT01827384|80815543|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
27723008|NCT01827384|80815544|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
27723009|NCT01827384|80815545|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
27723010|NCT01827384|80815546|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
27723011|NCT01827384|80815547|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
27723012|NCT01827384|80815548|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
27723013|NCT01827384|80815549|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
27723014|NCT01827384|80815550|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
27723015|NCT01422239|80815551|FG000|Overall Study|Lost to Follow-up|4|||
27723016|NCT01422239|80815552|FG001|Overall Study|Lost to Follow-up|3|||
27723017|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
27723018|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
27840976|NCT04214288|81248115|FG003|Overall Study|Other|6|||
27502692|NCT04298697|80032606|FG000|Overall Study|Withdrawal by Subject|0|||
27502693|NCT04298697|80032607|FG001|Overall Study|Withdrawal by Subject|3|||
27502694|NCT04298697|80032608|FG002|Overall Study|Withdrawal by Subject|2|||
27611456|NCT01317875|80419109|FG008|Overall Study|Progressive Disease|0|||
27723019|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
27840977|NCT04214288|81248112|FG000|Overall Study|Protocol Violation|0|||
27502695|NCT04298697|80032609|FG003|Overall Study|Withdrawal by Subject|3|||
27502696|NCT05135767|80032614|FG000|Baseline|Lost to Follow-up|1|||
27723020|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Death|28|||
27723021|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Death|0|||
27723022|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Death|0|||
27723023|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
27723024|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
27723025|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
27723026|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
27502697|NCT05135767|80032615|FG001|Baseline|Lost to Follow-up|1|||
27502698|NCT05135767|80032614|FG000|Baseline|Withdrawal by Subject|0|||
27502699|NCT05135767|80032615|FG001|Baseline|Withdrawal by Subject|2|||
27502700|NCT05135767|80032614|FG000|Active Study Phase|Lost to Follow-up|2|||
27723027|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
27723028|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
27723029|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
27723030|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
27723031|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
27723032|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
27723033|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
27723034|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
27723035|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
27723036|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
27723037|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
27723038|NCT00820755|80815554|FG000|Period 1: Combination Therapy Phase|Other|11|||
27723039|NCT00820755|80815555|FG001|Period 1: Combination Therapy Phase|Other|0|||
27723040|NCT00820755|80815556|FG002|Period 1: Combination Therapy Phase|Other|0|||
27723041|NCT00820755|80815554|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
27723042|NCT00820755|80815555|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
27723043|NCT00820755|80815556|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
27723044|NCT00584870|80815557|FG000|Overall Study|Adverse Event|4|||
27723045|NCT00584870|80815558|FG001|Overall Study|Adverse Event|3|||
27723046|NCT00584870|80815559|FG002|Overall Study|Adverse Event|2|||
27723047|NCT00584870|80815557|FG000|Overall Study|Lost to Follow-up|4|||
27723048|NCT00584870|80815558|FG001|Overall Study|Lost to Follow-up|1|||
27723049|NCT00584870|80815559|FG002|Overall Study|Lost to Follow-up|1|||
27723050|NCT00584870|80815557|FG000|Overall Study|Lack of Efficacy|7|||
27723051|NCT00584870|80815558|FG001|Overall Study|Lack of Efficacy|14|||
27723052|NCT00584870|80815559|FG002|Overall Study|Lack of Efficacy|8|||
27723053|NCT00584870|80815557|FG000|Overall Study|Withdrawal by Subject|10|||
27723054|NCT00584870|80815558|FG001|Overall Study|Withdrawal by Subject|5|||
27723055|NCT00584870|80815559|FG002|Overall Study|Withdrawal by Subject|3|||
27723056|NCT00584870|80815557|FG000|Overall Study|Protocol Violation|1|||
27723057|NCT00584870|80815558|FG001|Overall Study|Protocol Violation|1|||
27502701|NCT05135767|80032615|FG001|Active Study Phase|Lost to Follow-up|0|||
27611457|NCT01317875|80419110|FG009|Overall Study|Progressive Disease|0|||
27611458|NCT01317875|80419101|FG000|Overall Study|Withdrawal by Subject|0|||
27611459|NCT01317875|80419102|FG001|Overall Study|Withdrawal by Subject|0|||
27723058|NCT00584870|80815559|FG002|Overall Study|Protocol Violation|2|||
27723059|NCT00584870|80815557|FG000|Overall Study|Did not met entrance criteria|1|||
27723060|NCT00584870|80815558|FG001|Overall Study|Did not met entrance criteria|0|||
27723061|NCT00584870|80815559|FG002|Overall Study|Did not met entrance criteria|0|||
27723062|NCT00584870|80815557|FG000|Overall Study|Other|2|||
27723063|NCT00584870|80815558|FG001|Overall Study|Other|0|||
27723064|NCT00584870|80815559|FG002|Overall Study|Other|0|||
27723065|NCT00584870|80815557|FG000|Overall Study|Randomized but not treated|0|||
27840978|NCT04214288|81248113|FG001|Overall Study|Protocol Violation|1|||
27840979|NCT04214288|81248114|FG002|Overall Study|Protocol Violation|0|||
27840980|NCT04214288|81248115|FG003|Overall Study|Protocol Violation|0|||
27840981|NCT04214288|81248112|FG000|Overall Study|Withdrawal by Subject|8|||
27840982|NCT04214288|81248113|FG001|Overall Study|Withdrawal by Subject|4|||
27840983|NCT04214288|81248114|FG002|Overall Study|Withdrawal by Subject|0|||
27840984|NCT04214288|81248115|FG003|Overall Study|Withdrawal by Subject|9|||
27840985|NCT01266603|81248116|FG000|Overall Study|Adverse Event|1|||
27840986|NCT01266603|81248116|FG000|Overall Study|Lack of Efficacy|14|||
27840987|NCT01266603|81248116|FG000|Overall Study|Withdrawal by Subject|1|||
27840988|NCT01266603|81248116|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
27840989|NCT02462486|81248122|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27840990|NCT02462486|81248123|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
27840991|NCT02462486|81248124|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
27840992|NCT02462486|81248122|FG000|Overall Study|Adverse Event|53|||
27502702|NCT03221556|80032618|FG000|Allocation|post-randomization exclusion|0|||
27502703|NCT03221556|80032619|FG001|Allocation|post-randomization exclusion|1|||
27840993|NCT02462486|81248123|FG001|Overall Study|Adverse Event|48|||
27840994|NCT02462486|81248124|FG002|Overall Study|Adverse Event|21|||
27840995|NCT02462486|81248122|FG000|Overall Study|Lack of Efficacy|6|||
27840996|NCT02462486|81248123|FG001|Overall Study|Lack of Efficacy|12|||
27840997|NCT02462486|81248124|FG002|Overall Study|Lack of Efficacy|3|||
27840998|NCT02462486|81248122|FG000|Overall Study|Lost to Follow-up|3|||
27840999|NCT02462486|81248123|FG001|Overall Study|Lost to Follow-up|4|||
27841000|NCT02462486|81248124|FG002|Overall Study|Lost to Follow-up|2|||
27841001|NCT02462486|81248122|FG000|Overall Study|Withdrawal by Subject|25|||
27841002|NCT02462486|81248123|FG001|Overall Study|Withdrawal by Subject|22|||
27841003|NCT02462486|81248124|FG002|Overall Study|Withdrawal by Subject|19|||
27841004|NCT02462486|81248122|FG000|Overall Study|Protocol Violation|3|||
27841005|NCT02462486|81248123|FG001|Overall Study|Protocol Violation|1|||
27841006|NCT02462486|81248124|FG002|Overall Study|Protocol Violation|1|||
27841007|NCT02462486|81248122|FG000|Overall Study|Reason not Specified|3|||
27841008|NCT02462486|81248123|FG001|Overall Study|Reason not Specified|4|||
27841009|NCT02462486|81248124|FG002|Overall Study|Reason not Specified|3|||
27841010|NCT03139240|81248138|FG000|Overall Study|Lost to Follow-up|0|||
27841011|NCT03139240|81248139|FG001|Overall Study|Lost to Follow-up|1|||
27841012|NCT03139240|81248140|FG002|Overall Study|Lost to Follow-up|1|||
27841013|NCT03139240|81248141|FG003|Overall Study|Lost to Follow-up|0|||
27841014|NCT05692154|81248145|FG000|Overall Study|Adverse Event|0|||
27841015|NCT05692154|81248146|FG001|Overall Study|Adverse Event|1|||
27502704|NCT03221556|80032618|FG000|Follow-Up|Withdrawal by Subject|0|||
27502705|NCT03221556|80032619|FG001|Follow-Up|Withdrawal by Subject|1|||
27502706|NCT01474317|80032621|FG000|Overall Study|Adverse Event|1|||
27502707|NCT01474317|80032621|FG000|Overall Study|Subject ineligible for study|1|||
27502708|NCT04500158|80032624|FG000|Overall Study|Physician Decision|17|||
27502709|NCT04500158|80032625|FG001|Overall Study|Physician Decision|11|||
27502710|NCT03043794|80032626|FG000|Overall Study|Lost to Follow-up|1|||
27502711|NCT02476617|80032629|FG000|Overall Study|Adverse Event|1|||
27502712|NCT02476617|80032629|FG000|Overall Study|Lost to Follow-up|1|||
27841016|NCT00927251|81248150|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
27841017|NCT04590781|81248153|FG000|Overall Study|Death|0|||
27841018|NCT04590781|81248154|FG001|Overall Study|Death|2|||
27841019|NCT04590781|81248153|FG000|Overall Study|Withdrawal by Subject|2|||
27502713|NCT04218240|80032635|FG000|Overall Study|Withdrawal by Subject|6|||
27502714|NCT04218240|80032636|FG001|Overall Study|Withdrawal by Subject|0|||
27841020|NCT04590781|81248154|FG001|Overall Study|Withdrawal by Subject|0|||
27841021|NCT03365791|81248159|FG000|Overall Study|Adverse Event|5|||
27841022|NCT03365791|81248159|FG000|Overall Study|Death|1|||
27502715|NCT04218240|80032635|FG000|Overall Study|Lack of Efficacy|24|||
27502716|NCT04218240|80032636|FG001|Overall Study|Lack of Efficacy|19|||
27841023|NCT03365791|81248159|FG000|Overall Study|Lost to Follow-up|1|||
27841024|NCT03365791|81248159|FG000|Overall Study|Physician Decision|9|||
27841025|NCT03365791|81248159|FG000|Overall Study|Progressive disease|51|||
27841026|NCT03365791|81248159|FG000|Overall Study|Subject/guardian decision|5|||
27841027|NCT01157234|81248160|FG000|Overall Study|Withdrawal by Subject|1|||
27841028|NCT01157234|81248161|FG001|Overall Study|Withdrawal by Subject|0|||
27841029|NCT03507686|81248162|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
27841030|NCT03507686|81248163|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
27841031|NCT03507686|81248162|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
27841032|NCT03507686|81248163|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
27841033|NCT03507686|81248162|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
27841034|NCT03507686|81248163|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
27841035|NCT03507686|81248162|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
27841036|NCT03507686|81248163|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
27841037|NCT03507686|81248162|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
27841038|NCT03507686|81248163|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
27841039|NCT03507686|81248162|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
27892063|NCT05249127|81437486|FG000|Overall Study|Protocol Violation|13|||
27502717|NCT04218240|80032635|FG000|Overall Study|Physician Decision|0|||
27892064|NCT05249127|81437486|FG000|Overall Study|Physician Decision|4|||
27892065|NCT05249127|81437486|FG000|Overall Study|Withdrawal by Subject|2|||
27892066|NCT05249127|81437486|FG000|Overall Study|Participant Non-compliance|1|||
27892067|NCT03403751|81437489|FG000|Overall Study|Death|5|||
27892068|NCT03403751|81437490|FG001|Overall Study|Death|6|||
27892069|NCT03403751|81437489|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
27892070|NCT03403751|81437490|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
27502718|NCT04218240|80032636|FG001|Overall Study|Physician Decision|1|||
27502719|NCT04218240|80032635|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
27502720|NCT04218240|80032636|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
27502721|NCT03103542|80032644|FG000|Overall Study|Physician Decision|2|||
27502722|NCT03103542|80032644|FG000|Overall Study|Adverse Event|2|||
27502723|NCT03103542|80032644|FG000|Overall Study|Other|2|||
27502724|NCT03103542|80032644|FG000|Overall Study|Withdrawal by Subject|1|||
27502725|NCT03448406|80032648|FG000|Overall Study|Noncompliance of scheduled visits|1|||
27502726|NCT03448406|80032649|FG001|Overall Study|Noncompliance of scheduled visits|2|||
27502727|NCT03448406|80032648|FG000|Overall Study|Withdrawal by Subject|1|||
27892071|NCT02347891|81437491|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
27892072|NCT02347891|81437492|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
27892073|NCT02347891|81437491|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
27892074|NCT02347891|81437492|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
27892075|NCT04725812|81441149|FG000|Overall Study|Withdrawal by Subject|1|||
27892076|NCT00834639|81441150|FG000|Second Intervention|Physician Decision|0|||
27892077|NCT00834639|81441151|FG001|Second Intervention|Physician Decision|2|||
27892078|NCT02567435|81441152|FG000|Overall Study|Death|1|||
27892079|NCT02567435|81441153|FG001|Overall Study|Death|1|||
27892080|NCT02567435|81441154|FG002|Overall Study|Death|0|||
27892081|NCT02567435|81441155|FG003|Overall Study|Death|0|||
27892082|NCT02567435|81441152|FG000|Overall Study|Ineligible|1|||
27892083|NCT02567435|81441153|FG001|Overall Study|Ineligible|3|||
27892084|NCT02567435|81441154|FG002|Overall Study|Ineligible|0|||
27892085|NCT02567435|81441155|FG003|Overall Study|Ineligible|0|||
27892086|NCT02567435|81441152|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
27892087|NCT02567435|81441153|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
27502728|NCT03448406|80032649|FG001|Overall Study|Withdrawal by Subject|2|||
27502729|NCT03448406|80032648|FG000|Overall Study|Protocol Violation|1|||
27502730|NCT03448406|80032649|FG001|Overall Study|Protocol Violation|0|||
27502731|NCT03448406|80032648|FG000|Overall Study|Adverse Event|8|||
27502732|NCT03448406|80032649|FG001|Overall Study|Adverse Event|9|||
27502733|NCT03205423|80032650|FG000|Overall Study|Personal|1|||
27502734|NCT03205423|80032651|FG001|Overall Study|Personal|1|||
27502735|NCT03205423|80032650|FG000|Overall Study|Physician Decision|0|||
27502736|NCT03205423|80032651|FG001|Overall Study|Physician Decision|2|||
27502737|NCT02205736|80032668|FG000|Overall Study|Lost to Follow-up|106|||
27841040|NCT03507686|81248163|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
27841041|NCT01117987|81248166|FG000|Overall Study|Protocol deviation|0|||
27841042|NCT01117987|81248167|FG001|Overall Study|Protocol deviation|1|||
27892088|NCT02567435|81441154|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
27892089|NCT02567435|81441155|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
27502738|NCT02003924|80032671|FG000|Double-blind Phase|Lost to Follow-up|2|||
27502739|NCT02003924|80032672|FG001|Double-blind Phase|Lost to Follow-up|1|||
27502740|NCT02003924|80032673|FG002|Double-blind Phase|Lost to Follow-up|0|||
27892090|NCT02822573|81441163|FG000|Overall Study|Lost to Follow-up|5|||
27502741|NCT02003924|80032671|FG000|Double-blind Phase|Protocol Violation|1|||
27892091|NCT02822573|81441164|FG001|Overall Study|Lost to Follow-up|3|||
27892092|NCT02822573|81441163|FG000|Overall Study|Physician Decision|1|||
27892093|NCT02822573|81441164|FG001|Overall Study|Physician Decision|1|||
27892094|NCT02822573|81441163|FG000|Overall Study|Withdrawal by Subject|9|||
27892095|NCT02822573|81441164|FG001|Overall Study|Withdrawal by Subject|5|||
27892096|NCT02822573|81441163|FG000|Overall Study|Protocol Violation|6|||
27892097|NCT02822573|81441164|FG001|Overall Study|Protocol Violation|4|||
27892098|NCT02822573|81441163|FG000|Overall Study|Too sick or ill|2|||
27892099|NCT02822573|81441164|FG001|Overall Study|Too sick or ill|1|||
27892100|NCT02822573|81441163|FG000|Overall Study|Disease Progression|1|||
27892101|NCT02822573|81441164|FG001|Overall Study|Disease Progression|1|||
27892102|NCT02822573|81441163|FG000|Overall Study|No reason given|6|||
27892103|NCT02822573|81441164|FG001|Overall Study|No reason given|4|||
27892104|NCT00459706|81441165|FG000|Overall Study|Adverse Event|19|||
27892105|NCT00459706|81441166|FG001|Overall Study|Adverse Event|13|||
27892106|NCT00459706|81441165|FG000|Overall Study|Withdrawal by Subject|1|||
27892107|NCT00459706|81441166|FG001|Overall Study|Withdrawal by Subject|6|||
27892108|NCT00459706|81441165|FG000|Overall Study|Physician Decision|2|||
27892109|NCT00459706|81441166|FG001|Overall Study|Physician Decision|0|||
27892110|NCT00459706|81441165|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
27892111|NCT00459706|81441166|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27892112|NCT00459706|81441165|FG000|Overall Study|Protocol Violation|2|||
27892113|NCT00459706|81441166|FG001|Overall Study|Protocol Violation|1|||
27892114|NCT00459706|81441165|FG000|Overall Study|Failed to Return|1|||
27892115|NCT00459706|81441166|FG001|Overall Study|Failed to Return|0|||
27892116|NCT00459706|81441165|FG000|Overall Study|Other|0|||
27892117|NCT00459706|81441166|FG001|Overall Study|Other|1|||
27892118|NCT01943851|81441167|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892119|NCT01943851|81441168|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892120|NCT01943851|81441169|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892121|NCT01943851|81441170|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27892122|NCT01943851|81441171|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892123|NCT01943851|81441172|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892124|NCT01943851|81441173|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27892125|NCT01943851|81441174|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27892126|NCT01943851|81441175|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
27892127|NCT01943851|81441176|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892128|NCT01943851|81441177|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892129|NCT01943851|81441178|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892130|NCT01943851|81441179|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892131|NCT01943851|81441180|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892132|NCT01943851|81441181|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892133|NCT01943851|81441182|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892134|NCT01943851|81441183|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892135|NCT01943851|81441184|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
27892136|NCT01943851|81441167|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892137|NCT01943851|81441168|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892138|NCT01943851|81441169|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27611460|NCT01317875|80419103|FG002|Overall Study|Withdrawal by Subject|0|||
27611461|NCT01317875|80419104|FG003|Overall Study|Withdrawal by Subject|0|||
27611462|NCT01317875|80419105|FG004|Overall Study|Withdrawal by Subject|1|||
27611463|NCT01317875|80419106|FG005|Overall Study|Withdrawal by Subject|0|||
27611464|NCT01317875|80419107|FG006|Overall Study|Withdrawal by Subject|0|||
27611465|NCT01317875|80419108|FG007|Overall Study|Withdrawal by Subject|3|||
27611466|NCT01317875|80419109|FG008|Overall Study|Withdrawal by Subject|0|||
27611467|NCT01317875|80419110|FG009|Overall Study|Withdrawal by Subject|0|||
27611468|NCT01317875|80419101|FG000|Overall Study|Physician Decision|0|||
27611469|NCT01317875|80419102|FG001|Overall Study|Physician Decision|1|||
27611470|NCT01317875|80419103|FG002|Overall Study|Physician Decision|1|||
27611471|NCT01317875|80419104|FG003|Overall Study|Physician Decision|0|||
27611472|NCT01317875|80419105|FG004|Overall Study|Physician Decision|2|||
27611473|NCT01317875|80419106|FG005|Overall Study|Physician Decision|0|||
27611474|NCT01317875|80419107|FG006|Overall Study|Physician Decision|0|||
27723066|NCT00584870|80815558|FG001|Overall Study|Randomized but not treated|1|||
27723067|NCT00584870|80815559|FG002|Overall Study|Randomized but not treated|2|||
27892139|NCT01943851|81441170|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892140|NCT01943851|81441171|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
27892141|NCT01943851|81441172|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892142|NCT01943851|81441173|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892143|NCT01943851|81441174|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
27892144|NCT01943851|81441175|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892145|NCT01943851|81441176|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892146|NCT01943851|81441177|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892147|NCT01943851|81441178|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892148|NCT01943851|81441179|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27611475|NCT01317875|80419108|FG007|Overall Study|Physician Decision|2|||
27611476|NCT01317875|80419109|FG008|Overall Study|Physician Decision|0|||
27611477|NCT01317875|80419110|FG009|Overall Study|Physician Decision|0|||
27502742|NCT02003924|80032672|FG001|Double-blind Phase|Protocol Violation|2|||
27502743|NCT02003924|80032673|FG002|Double-blind Phase|Protocol Violation|0|||
27502744|NCT02003924|80032671|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
27502745|NCT02003924|80032672|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
27502746|NCT02003924|80032673|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
27502747|NCT02003924|80032671|FG000|Double-blind Phase|Disease Progression|229|||
27502748|NCT02003924|80032672|FG001|Double-blind Phase|Disease Progression|247|||
27502749|NCT02003924|80032673|FG002|Double-blind Phase|Disease Progression|0|||
27502750|NCT02003924|80032671|FG000|Double-blind Phase|Adverse Event|120|||
27502751|NCT02003924|80032672|FG001|Double-blind Phase|Adverse Event|31|||
27502752|NCT02003924|80032673|FG002|Double-blind Phase|Adverse Event|0|||
27502753|NCT02003924|80032671|FG000|Double-blind Phase|Randomized But not Treated|3|||
27502754|NCT02003924|80032672|FG001|Double-blind Phase|Randomized But not Treated|3|||
27502755|NCT02003924|80032673|FG002|Double-blind Phase|Randomized But not Treated|0|||
27502756|NCT02003924|80032671|FG000|Double-blind Phase|Other|29|||
27502757|NCT02003924|80032672|FG001|Double-blind Phase|Other|50|||
27502758|NCT02003924|80032673|FG002|Double-blind Phase|Other|0|||
27502759|NCT02003924|80032671|FG000|Open-label Phase|Lost to Follow-up|0|||
27502760|NCT02003924|80032672|FG001|Open-label Phase|Lost to Follow-up|0|||
27502761|NCT02003924|80032673|FG002|Open-label Phase|Lost to Follow-up|1|||
27502762|NCT02003924|80032671|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
27502763|NCT02003924|80032672|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
27502764|NCT02003924|80032673|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
27502765|NCT02003924|80032671|FG000|Open-label Phase|Disease Progression|59|||
27502766|NCT02003924|80032672|FG001|Open-label Phase|Disease Progression|0|||
27502767|NCT02003924|80032673|FG002|Open-label Phase|Disease Progression|5|||
27502768|NCT02003924|80032671|FG000|Open-label Phase|Adverse Event|25|||
27502769|NCT02003924|80032672|FG001|Open-label Phase|Adverse Event|0|||
27502770|NCT02003924|80032673|FG002|Open-label Phase|Adverse Event|10|||
27502771|NCT02003924|80032671|FG000|Open-label Phase|Other|7|||
27502772|NCT02003924|80032672|FG001|Open-label Phase|Other|0|||
27502773|NCT02003924|80032673|FG002|Open-label Phase|Other|0|||
27502774|NCT02003924|80032671|FG000|Long-term Follow-up Phase|Death|288|||
27502775|NCT02003924|80032672|FG001|Long-term Follow-up Phase|Death|174|||
27841043|NCT01117987|81248166|FG000|Overall Study|Subject no longer requires study drug|1|||
27841044|NCT01117987|81248167|FG001|Overall Study|Subject no longer requires study drug|0|||
27841045|NCT01117987|81248166|FG000|Overall Study|Lost to Follow-up|1|||
27841046|NCT01117987|81248167|FG001|Overall Study|Lost to Follow-up|1|||
27841047|NCT01117987|81248166|FG000|Overall Study|Abnormal test procedure result|2|||
27841048|NCT01117987|81248167|FG001|Overall Study|Abnormal test procedure result|0|||
27841049|NCT01117987|81248166|FG000|Overall Study|Lack of Efficacy|3|||
27841050|NCT01117987|81248167|FG001|Overall Study|Lack of Efficacy|4|||
27841051|NCT01117987|81248166|FG000|Overall Study|Death|5|||
27841052|NCT01117987|81248167|FG001|Overall Study|Death|10|||
27841053|NCT01117987|81248166|FG000|Overall Study|Withdrawal by Subject|5|||
27502776|NCT02003924|80032673|FG002|Long-term Follow-up Phase|Death|4|||
27502777|NCT02003924|80032671|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
27502778|NCT02003924|80032672|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
27502779|NCT02003924|80032673|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
27502780|NCT02003924|80032671|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
27502781|NCT02003924|80032672|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
27502782|NCT02003924|80032673|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
27502783|NCT02003924|80032671|FG000|Long-term Follow-up Phase|Other|5|||
27502784|NCT02003924|80032672|FG001|Long-term Follow-up Phase|Other|2|||
27502785|NCT02003924|80032673|FG002|Long-term Follow-up Phase|Other|1|||
27611478|NCT01317875|80419101|FG000|Overall Study|Death|0|||
27611479|NCT01317875|80419102|FG001|Overall Study|Death|0|||
27611480|NCT01317875|80419103|FG002|Overall Study|Death|2|||
27611481|NCT01317875|80419104|FG003|Overall Study|Death|1|||
27841054|NCT01117987|81248167|FG001|Overall Study|Withdrawal by Subject|10|||
27502786|NCT03204188|80032674|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
27502787|NCT03204188|80032674|FG000|Immunotherapy Phase (1 Year)|Death|1|||
27502788|NCT03204188|80032674|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
27502789|NCT03204188|80032674|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
27502790|NCT02946580|80032675|FG000|Overall Study|Withdrawal by Subject|1|||
27502791|NCT02946580|80032676|FG001|Overall Study|Withdrawal by Subject|2|||
27502792|NCT02946580|80032675|FG000|Overall Study|Adverse Event|0|||
27502793|NCT02946580|80032676|FG001|Overall Study|Adverse Event|2|||
27611482|NCT01317875|80419105|FG004|Overall Study|Death|0|||
27611483|NCT01317875|80419106|FG005|Overall Study|Death|1|||
27611484|NCT01317875|80419107|FG006|Overall Study|Death|0|||
27611485|NCT01317875|80419108|FG007|Overall Study|Death|4|||
27611486|NCT01317875|80419109|FG008|Overall Study|Death|0|||
27611487|NCT01317875|80419110|FG009|Overall Study|Death|0|||
27611488|NCT01317875|80419101|FG000|Overall Study|Adverse Event|2|||
27611489|NCT01317875|80419102|FG001|Overall Study|Adverse Event|1|||
27611490|NCT01317875|80419103|FG002|Overall Study|Adverse Event|2|||
27611491|NCT01317875|80419104|FG003|Overall Study|Adverse Event|1|||
27611492|NCT01317875|80419105|FG004|Overall Study|Adverse Event|5|||
27611493|NCT01317875|80419106|FG005|Overall Study|Adverse Event|1|||
27611494|NCT01317875|80419107|FG006|Overall Study|Adverse Event|2|||
27611495|NCT01317875|80419108|FG007|Overall Study|Adverse Event|5|||
27611496|NCT01317875|80419109|FG008|Overall Study|Adverse Event|0|||
27611497|NCT01317875|80419110|FG009|Overall Study|Adverse Event|0|||
27502794|NCT02946580|80032675|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
27502795|NCT02946580|80032676|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
27502796|NCT05228470|80032681|FG000|Overall Study|Death|6|||
27502797|NCT05228470|80032682|FG001|Overall Study|Death|11|||
27502798|NCT05228470|80032681|FG000|Overall Study|Withdrawal by Subject|1|||
27502799|NCT05228470|80032682|FG001|Overall Study|Withdrawal by Subject|8|||
27502800|NCT05228470|80032681|FG000|Overall Study|Ongoing|1|||
27502801|NCT05228470|80032682|FG001|Overall Study|Ongoing|11|||
27502802|NCT05615922|80032683|FG000|Overall Study|Lost to Follow-up|1|||
27502803|NCT02864394|80032685|FG000|Overall Study|Death|184|||
27502804|NCT02864394|80032686|FG001|Overall Study|Death|189|||
27502805|NCT02864394|80032685|FG000|Overall Study|Lost to Follow-up|0|||
27502806|NCT02864394|80032686|FG001|Overall Study|Lost to Follow-up|2|||
27502807|NCT02864394|80032685|FG000|Overall Study|Sponsor Decision|26|||
27502808|NCT02864394|80032686|FG001|Overall Study|Sponsor Decision|11|||
27502809|NCT02864394|80032685|FG000|Overall Study|Withdrawal by Subject|3|||
27502810|NCT02864394|80032686|FG001|Overall Study|Withdrawal by Subject|10|||
27502811|NCT00412984|80032687|FG000|Overall Study|Death|331|||
27502812|NCT00412984|80032688|FG001|Overall Study|Death|349|||
27502813|NCT00412984|80032687|FG000|Overall Study|Adverse Event|679|||
27502814|NCT00412984|80032688|FG001|Overall Study|Adverse Event|738|||
27502815|NCT00412984|80032687|FG000|Overall Study|Withdrawal by Subject|921|||
27502816|NCT00412984|80032688|FG001|Overall Study|Withdrawal by Subject|989|||
27502817|NCT00412984|80032687|FG000|Overall Study|Lost to Follow-up|51|||
27502818|NCT00412984|80032688|FG001|Overall Study|Lost to Follow-up|39|||
27502819|NCT00412984|80032687|FG000|Overall Study|Poor/Noncompliance|57|||
27502820|NCT00412984|80032688|FG001|Overall Study|Poor/Noncompliance|77|||
27611498|NCT00572624|80419111|FG000|Overall Study|Lost to Follow-up|10|||
27611499|NCT00572624|80419112|FG001|Overall Study|Lost to Follow-up|4|||
27611500|NCT00572624|80419111|FG000|Overall Study|Wanted to do a different diet program|1|||
27502821|NCT00412984|80032687|FG000|Overall Study|Pregnancy|1|||
27502822|NCT00412984|80032688|FG001|Overall Study|Pregnancy|0|||
27502823|NCT00412984|80032687|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
27502824|NCT00412984|80032688|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
27611501|NCT00572624|80419112|FG001|Overall Study|Wanted to do a different diet program|0|||
27611502|NCT00572624|80419111|FG000|Overall Study|Medication change|1|||
27502825|NCT00412984|80032687|FG000|Overall Study|Administrative Reason by Sponsor|11|||
27611503|NCT00572624|80419112|FG001|Overall Study|Medication change|0|||
27611504|NCT00572624|80419111|FG000|Overall Study|Started a new job-- no time for study|1|||
27611505|NCT00572624|80419112|FG001|Overall Study|Started a new job-- no time for study|0|||
27611506|NCT00572624|80419111|FG000|Overall Study|Admitted to being a smoker|1|||
27611507|NCT00572624|80419112|FG001|Overall Study|Admitted to being a smoker|0|||
27611508|NCT00572624|80419111|FG000|Overall Study|Refused to do the stress test|1|||
27611509|NCT00572624|80419112|FG001|Overall Study|Refused to do the stress test|0|||
27611510|NCT00572624|80419111|FG000|Overall Study|Problem with vascular access|1|||
27611511|NCT00572624|80419112|FG001|Overall Study|Problem with vascular access|0|||
27611512|NCT00572624|80419111|FG000|Overall Study|Health issues unrelated to the study|1|||
27611513|NCT00572624|80419112|FG001|Overall Study|Health issues unrelated to the study|0|||
27611514|NCT01290822|80419117|FG000|Overall Study|Withdrawal by Subject|1|||
27611515|NCT01290822|80419117|FG000|Overall Study|Physician Decision|10|||
27611516|NCT02635724|80419118|FG000|Overall Study|Withdrawal by Subject|0|||
27611517|NCT02635724|80419119|FG001|Overall Study|Withdrawal by Subject|1|||
27502826|NCT00412984|80032688|FG001|Overall Study|Administrative Reason by Sponsor|8|||
27502827|NCT00412984|80032687|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
27502828|NCT00412984|80032688|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
27502829|NCT00412984|80032687|FG000|Overall Study|Other Reason|80|||
27502830|NCT00412984|80032688|FG001|Overall Study|Other Reason|92|||
27502831|NCT00412984|80032687|FG000|Overall Study|Not Reported|11|||
27502832|NCT00412984|80032688|FG001|Overall Study|Not Reported|12|||
27502833|NCT02197234|80032689|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
27502834|NCT02197234|80032689|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
27502835|NCT02197234|80032689|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
27502836|NCT02197234|80032689|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
27502837|NCT02197234|80032689|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
27502838|NCT02197234|80032689|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
27502839|NCT02681523|80032691|FG000|Overall Study|Adverse Event|1|||
27502840|NCT02681523|80032691|FG000|Overall Study|Patient Non-compliance|1|||
27502841|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
27502842|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
27502843|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
27502844|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
27502845|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Adverse Event|2|||
27502846|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Adverse Event|5|||
27502847|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Adverse Event|1|||
27502848|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Adverse Event|2|||
27502849|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Death|13|||
27502850|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Death|17|||
27502851|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Death|1|||
27502852|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Death|0|||
27502853|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
27502854|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
27502855|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
27502856|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
27502857|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Disease Progression|2|||
27502858|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Disease Progression|0|||
27502859|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Disease Progression|0|||
27502860|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Disease Progression|0|||
27502861|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
27502862|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
27502863|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
27502864|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
27502865|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
27502866|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
27502867|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
27502868|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
27502869|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
27502870|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
27502871|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
27502872|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
27502873|NCT03955146|80032694|FG000|DB Period (48 Weeks)|Participant Decision|9|||
27502874|NCT03955146|80032695|FG001|DB Period (48 Weeks)|Participant Decision|12|||
27502875|NCT03955146|80032696|FG002|DB Period (48 Weeks)|Participant Decision|1|||
27502876|NCT03955146|80032697|FG003|DB Period (48 Weeks)|Participant Decision|1|||
27502877|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
27502878|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
27502879|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
27502880|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
27611518|NCT02635724|80419120|FG002|Overall Study|Withdrawal by Subject|0|||
27611519|NCT00423293|80419122|FG000|Overall Study|Ineligible / No protocol treatment|11|||
27611520|NCT01213173|80419123|FG000|Overall Study|Protocol Violation|2|||
27502881|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
27611521|NCT01213173|80419124|FG001|Overall Study|Protocol Violation|0|||
27611522|NCT01213173|80419123|FG000|Overall Study|Adverse Event|4|||
27611523|NCT01213173|80419124|FG001|Overall Study|Adverse Event|8|||
27611524|NCT01213173|80419123|FG000|Overall Study|Withdrawal by Subject|5|||
27611525|NCT01213173|80419124|FG001|Overall Study|Withdrawal by Subject|5|||
27611526|NCT01213173|80419123|FG000|Overall Study|Incorrect Enrollment|1|||
27611527|NCT01213173|80419124|FG001|Overall Study|Incorrect Enrollment|3|||
27611528|NCT01987596|80419125|FG000|Overall Study|Physician Decision|1|||
27502882|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
27502883|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
27502884|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
27502885|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
27502886|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
27502887|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
27502888|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
27502889|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
27502890|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
27502891|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
27502892|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
27502893|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
27502894|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
27502895|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
27502896|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
27502897|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
27502898|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
27502899|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
27502900|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
27502901|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
27502902|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
27502903|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
27502904|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
27502905|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
27502906|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
27502907|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
27502908|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
27502909|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
27502910|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
27502911|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
27502912|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
27502913|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
27502914|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
27611529|NCT01987596|80419126|FG001|Overall Study|Physician Decision|0|||
27611530|NCT01987596|80419125|FG000|Overall Study|Progressive Disease; missing all period|0|||
27611531|NCT01987596|80419126|FG001|Overall Study|Progressive Disease; missing all period|1|||
27611532|NCT04091360|80419129|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611533|NCT04091360|80419130|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611534|NCT04091360|80419131|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611535|NCT04091360|80419132|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611536|NCT04091360|80419133|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611537|NCT04091360|80419134|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611538|NCT04091360|80419135|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611539|NCT04091360|80419136|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
27611540|NCT04091360|80419137|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
27611541|NCT04091360|80419138|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
27611542|NCT04091360|80419129|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611543|NCT04091360|80419130|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611544|NCT04091360|80419131|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611545|NCT04091360|80419132|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611546|NCT04091360|80419133|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611547|NCT04091360|80419134|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27841055|NCT01117987|81248166|FG000|Overall Study|Adverse Event|19|||
27841056|NCT01117987|81248167|FG001|Overall Study|Adverse Event|26|||
27502915|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
27502916|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
27502917|NCT03955146|80032694|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
27502918|NCT03955146|80032695|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
27611548|NCT04091360|80419135|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
27502919|NCT03955146|80032696|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
27502920|NCT03955146|80032697|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
27502921|NCT02603146|80032698|FG000|Overall Study|Lost to Follow-up|5|||
27611549|NCT04091360|80419136|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
27611550|NCT04091360|80419137|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611551|NCT04091360|80419138|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
27611552|NCT04091360|80419129|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611553|NCT04091360|80419130|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611554|NCT04091360|80419131|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611555|NCT04091360|80419132|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611556|NCT04091360|80419133|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611557|NCT04091360|80419134|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27841057|NCT01117987|81248166|FG000|Overall Study|Administrative problems|25|||
27502922|NCT02603146|80032699|FG001|Overall Study|Lost to Follow-up|6|||
27502923|NCT02603146|80032698|FG000|Overall Study|Withdrawal by Subject|8|||
27502924|NCT02603146|80032699|FG001|Overall Study|Withdrawal by Subject|10|||
27502925|NCT02603146|80032698|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
27502926|NCT02603146|80032699|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
27502927|NCT02603146|80032698|FG000|Overall Study|Participant moved|2|||
27502928|NCT02603146|80032699|FG001|Overall Study|Participant moved|0|||
27502929|NCT02603146|80032698|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
27502930|NCT02603146|80032699|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
27502931|NCT04558125|80032700|FG000|Overall Study|Death|1|||
27502932|NCT03755934|80032701|FG000|Overall Study|Adverse Event|4|||
27502933|NCT03755934|80032702|FG001|Overall Study|Adverse Event|1|||
27502934|NCT03755934|80032703|FG002|Overall Study|Adverse Event|1|||
27502935|NCT03755934|80032704|FG003|Overall Study|Adverse Event|3|||
27502936|NCT03755934|80032701|FG000|Overall Study|Physician Decision|2|||
27502937|NCT03755934|80032702|FG001|Overall Study|Physician Decision|0|||
27502938|NCT03755934|80032703|FG002|Overall Study|Physician Decision|0|||
27502939|NCT03755934|80032704|FG003|Overall Study|Physician Decision|1|||
27502940|NCT03755934|80032701|FG000|Overall Study|Withdrawal by Subject|5|||
27502941|NCT03755934|80032702|FG001|Overall Study|Withdrawal by Subject|0|||
27502942|NCT03755934|80032703|FG002|Overall Study|Withdrawal by Subject|0|||
27502943|NCT03755934|80032704|FG003|Overall Study|Withdrawal by Subject|1|||
27502944|NCT03755934|80032701|FG000|Overall Study|Other|3|||
27502945|NCT03755934|80032702|FG001|Overall Study|Other|1|||
27502946|NCT03755934|80032703|FG002|Overall Study|Other|3|||
27502947|NCT03755934|80032704|FG003|Overall Study|Other|1|||
27502948|NCT03279081|80034947|FG000|Overall Study|Withdrawal by Subject|12|||
27502949|NCT03279081|80034948|FG001|Overall Study|Withdrawal by Subject|20|||
27502950|NCT03279081|80034947|FG000|Overall Study|Physician Decision|4|||
27502951|NCT03279081|80034948|FG001|Overall Study|Physician Decision|1|||
27502952|NCT03279081|80034947|FG000|Overall Study|Lost to Follow-up|8|||
27502953|NCT03279081|80034948|FG001|Overall Study|Lost to Follow-up|8|||
27502954|NCT03279081|80034947|FG000|Overall Study|Death|0|||
27502955|NCT03279081|80034948|FG001|Overall Study|Death|1|||
27502956|NCT03279081|80034947|FG000|Overall Study|Adverse Event|1|||
27502957|NCT03279081|80034948|FG001|Overall Study|Adverse Event|0|||
27841058|NCT01117987|81248167|FG001|Overall Study|Administrative problems|22|||
27502958|NCT03279081|80034947|FG000|Overall Study|Reason not Specified|14|||
27502959|NCT03279081|80034948|FG001|Overall Study|Reason not Specified|4|||
27502960|NCT05408429|80034949|FG000|Overall Study|Lost to Follow-up|1|||
27502961|NCT05408429|80034950|FG001|Overall Study|Lost to Follow-up|1|||
27502962|NCT05408429|80034951|FG002|Overall Study|Lost to Follow-up|0|||
27502963|NCT05408429|80034949|FG000|Overall Study|Withdrawal by Subject|5|||
27502964|NCT05408429|80034950|FG001|Overall Study|Withdrawal by Subject|0|||
27502965|NCT05408429|80034951|FG002|Overall Study|Withdrawal by Subject|1|||
27502966|NCT04179500|80034954|FG000|Treatment|Withdrawal by Subject|1|||
27502967|NCT04179500|80034954|FG000|Treatment|Adverse Event|2|||
27611558|NCT04091360|80419135|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
27611559|NCT04091360|80419136|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611560|NCT04091360|80419137|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
27611561|NCT04091360|80419138|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
27611562|NCT03285295|80419139|FG000|Alinity s HBsAg|Protocol Violation|11|||
27611563|NCT03285295|80419140|FG001|Alinity s HBsAg|Protocol Violation|0|||
27611564|NCT03285295|80419141|FG002|Alinity s HBsAg|Protocol Violation|0|||
27611565|NCT03285295|80419142|FG003|Alinity s HBsAg|Protocol Violation|0|||
27611566|NCT03285295|80419143|FG004|Alinity s HBsAg|Protocol Violation|0|||
27611567|NCT03285295|80419139|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
27611568|NCT03285295|80419140|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
27611569|NCT03285295|80419141|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
27611570|NCT03285295|80419142|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
27611571|NCT03285295|80419143|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
27611572|NCT03285295|80419139|FG000|Alinity s HBsAg|No Results Generated|74|||
27892149|NCT01943851|81441180|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892150|NCT01943851|81441181|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892151|NCT01943851|81441182|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892152|NCT01943851|81441183|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892153|NCT01943851|81441184|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
27892154|NCT01943851|81441167|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892155|NCT01943851|81441168|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892156|NCT01943851|81441169|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892157|NCT01943851|81441170|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892158|NCT01943851|81441171|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892159|NCT01943851|81441172|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892160|NCT01943851|81441173|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892161|NCT01943851|81441174|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892162|NCT01943851|81441175|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892163|NCT01943851|81441176|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892164|NCT01943851|81441177|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892165|NCT01943851|81441178|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892166|NCT01943851|81441179|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892167|NCT01943851|81441180|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
27892168|NCT01943851|81441181|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892169|NCT01943851|81441182|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892170|NCT01943851|81441183|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27502968|NCT04179500|80034954|FG000|Treatment|pyrazinamide resistance|1|||
27502969|NCT02694185|80034955|FG000|Overall Study|Withdrawal by Subject|45|||
27502970|NCT02694185|80034956|FG001|Overall Study|Withdrawal by Subject|0|||
27502971|NCT05417438|80034957|FG000|Overall Study|Withdrawal by Subject|3|||
27502972|NCT02903771|80034958|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
27502973|NCT02903771|80034959|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
27502974|NCT02903771|80034960|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
27611573|NCT03285295|80419140|FG001|Alinity s HBsAg|No Results Generated|6|||
27611574|NCT03285295|80419141|FG002|Alinity s HBsAg|No Results Generated|0|||
27611575|NCT03285295|80419142|FG003|Alinity s HBsAg|No Results Generated|0|||
27611576|NCT03285295|80419143|FG004|Alinity s HBsAg|No Results Generated|0|||
27611577|NCT03285295|80419139|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
27841059|NCT00024258|81248168|FG000|Overall Study|Withdrawal by Subject|1|||
27841060|NCT00024258|81248168|FG000|Overall Study|Disease Progression|8|||
27841061|NCT05766787|81248169|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
27841062|NCT05766787|81248170|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
27841063|NCT05766787|81248169|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
27841064|NCT05766787|81248170|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
27841065|NCT05766787|81248169|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
27841066|NCT05766787|81248170|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
27502975|NCT02903771|80034961|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
27502976|NCT02903771|80034962|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
27502977|NCT02903771|80034963|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
27502978|NCT02903771|80034964|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
27502979|NCT02903771|80034958|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
27502980|NCT02903771|80034959|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
27502981|NCT02903771|80034960|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
27502982|NCT02903771|80034961|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
27502983|NCT02903771|80034962|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
27502984|NCT02903771|80034963|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
27502985|NCT02903771|80034964|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
27502986|NCT02903771|80034958|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
27502987|NCT02903771|80034959|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
27502988|NCT02903771|80034960|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
27502989|NCT02903771|80034961|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
27502990|NCT02903771|80034962|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
27502991|NCT02903771|80034963|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
27502992|NCT02903771|80034964|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
27502993|NCT02903771|80034958|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
27502994|NCT02903771|80034959|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
27502995|NCT02903771|80034960|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
27502996|NCT02903771|80034961|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
27502997|NCT02903771|80034962|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
27502998|NCT02903771|80034963|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
27502999|NCT02903771|80034964|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
27503000|NCT02903771|80034958|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
27503001|NCT02903771|80034959|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
27503002|NCT02903771|80034960|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
27503003|NCT02903771|80034961|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
27503004|NCT02903771|80034962|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
27503005|NCT02903771|80034963|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
27503006|NCT02903771|80034964|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
27503007|NCT02903771|80034958|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
27503008|NCT02903771|80034959|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
27503009|NCT02903771|80034960|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
27503010|NCT02903771|80034961|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
27503011|NCT02903771|80034962|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
27503012|NCT02903771|80034963|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
27503013|NCT02903771|80034964|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
27723068|NCT00482014|80815560|FG000|Overall Study|Withdrawal by Subject|1|||
27723069|NCT00482014|80815561|FG001|Overall Study|Withdrawal by Subject|2|||
27841067|NCT01213836|81248171|FG000|Period 1, First Intervention|Adverse Event|2|||
27841068|NCT01213836|81248172|FG001|Period 1, First Intervention|Adverse Event|1|||
27841069|NCT01213836|81248171|FG000|Period 1, First Intervention|Protocol Violation|0|||
27841070|NCT01213836|81248172|FG001|Period 1, First Intervention|Protocol Violation|1|||
27841071|NCT01213836|81248171|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
27841072|NCT01213836|81248172|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
27841073|NCT02488824|81248182|FG000|Overall Study|Adverse Event|1|||
27841074|NCT02488824|81248183|FG001|Overall Study|Adverse Event|1|||
27841075|NCT00983528|81248185|FG000|Overall Study|Death|4|||
27841076|NCT00983528|81248185|FG000|Overall Study|Lost to Follow-up|1|||
27841077|NCT00983528|81248185|FG000|Overall Study|Study Terminated|1|||
27841078|NCT01192399|81248186|FG000|Overall Study|Lack of Efficacy|2|||
27841079|NCT02302716|81248189|FG000|Overall Study|Adverse Event|1|||
27841080|NCT02302716|81248190|FG001|Overall Study|Adverse Event|1|||
27841081|NCT02302716|81248189|FG000|Overall Study|Death|0|||
27841082|NCT02302716|81248190|FG001|Overall Study|Death|1|||
27841083|NCT02302716|81248189|FG000|Overall Study|Lack of Efficacy|0|||
27841084|NCT02302716|81248190|FG001|Overall Study|Lack of Efficacy|1|||
27841085|NCT02302716|81248189|FG000|Overall Study|Lost to Follow-up|2|||
27841086|NCT02302716|81248190|FG001|Overall Study|Lost to Follow-up|4|||
27841087|NCT02302716|81248189|FG000|Overall Study|Physician Decision|3|||
27841088|NCT02302716|81248190|FG001|Overall Study|Physician Decision|4|||
27841089|NCT02302716|81248189|FG000|Overall Study|Withdrawal by Subject|13|||
27841090|NCT02302716|81248190|FG001|Overall Study|Withdrawal by Subject|7|||
27841091|NCT02302716|81248189|FG000|Overall Study|Protocol Violation|0|||
27841092|NCT02302716|81248190|FG001|Overall Study|Protocol Violation|1|||
27841093|NCT00124462|81248191|FG000|Overall Study|Lost to Follow-up|3|||
27841094|NCT00124462|81248192|FG001|Overall Study|Lost to Follow-up|3|||
27841095|NCT00124462|81248191|FG000|Overall Study|Physician Decision|3|||
27841096|NCT00124462|81248192|FG001|Overall Study|Physician Decision|4|||
27841097|NCT00124462|81248191|FG000|Overall Study|Withdrawal by Subject|4|||
27958600|NCT01791517|81680060|FG002|Phase II|Lack of Efficacy|0|||
27503014|NCT02903771|80034958|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
27503015|NCT02903771|80034959|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
27503016|NCT02903771|80034960|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
27503017|NCT02903771|80034961|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
27503018|NCT02903771|80034962|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
27503019|NCT02903771|80034963|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
27503020|NCT02903771|80034964|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
27503021|NCT02903771|80034958|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
27503022|NCT02903771|80034959|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
27503023|NCT02903771|80034960|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
27503024|NCT02903771|80034961|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
27503025|NCT02903771|80034962|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
27503026|NCT02903771|80034963|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
27503027|NCT02903771|80034964|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
27503028|NCT02903771|80034958|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
27503029|NCT02903771|80034959|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
27611578|NCT03285295|80419140|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
27611579|NCT03285295|80419141|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
27611580|NCT03285295|80419142|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
27841098|NCT00124462|81248192|FG001|Overall Study|Withdrawal by Subject|5|||
27503030|NCT02903771|80034960|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
27503031|NCT02903771|80034961|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
27503032|NCT02903771|80034962|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
27503033|NCT02903771|80034963|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
27503034|NCT02903771|80034964|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
27503035|NCT02903771|80034958|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
27503036|NCT02903771|80034959|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
27503037|NCT02903771|80034960|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
27503038|NCT02903771|80034961|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
27503039|NCT02903771|80034962|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
27611581|NCT03285295|80419143|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
27611582|NCT03285295|80419139|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
27611583|NCT03285295|80419140|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
27841099|NCT00124462|81248191|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
27841100|NCT00124462|81248192|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
27611584|NCT03285295|80419141|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
27611585|NCT03285295|80419142|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
27611586|NCT03285295|80419143|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
27611587|NCT03285295|80419139|FG000|Alinity s HTLV I/II|No Results Generated|70|||
27611588|NCT03285295|80419140|FG001|Alinity s HTLV I/II|No Results Generated|0|||
27611589|NCT03285295|80419141|FG002|Alinity s HTLV I/II|No Results Generated|0|||
27611590|NCT03285295|80419142|FG003|Alinity s HTLV I/II|No Results Generated|0|||
27611591|NCT03285295|80419143|FG004|Alinity s HTLV I/II|No Results Generated|0|||
27611592|NCT03285295|80419139|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
27611593|NCT03285295|80419140|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
27611594|NCT03285295|80419141|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
27611595|NCT03285295|80419142|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
27611596|NCT03285295|80419143|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
27611597|NCT03285295|80419139|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
27611598|NCT03285295|80419140|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
27611599|NCT03285295|80419141|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
27611600|NCT03285295|80419142|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
27611601|NCT03285295|80419143|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
27611602|NCT03285295|80419139|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
27611603|NCT03285295|80419140|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
27611604|NCT03285295|80419141|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
27611605|NCT03285295|80419142|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
27611606|NCT03285295|80419143|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
27611607|NCT03285295|80419139|FG000|Alinity s Anti-HCV|No Results Generated|71|||
27611608|NCT03285295|80419140|FG001|Alinity s Anti-HCV|No Results Generated|0|||
27611609|NCT03285295|80419141|FG002|Alinity s Anti-HCV|No Results Generated|0|||
27611610|NCT03285295|80419142|FG003|Alinity s Anti-HCV|No Results Generated|0|||
27611611|NCT03285295|80419143|FG004|Alinity s Anti-HCV|No Results Generated|0|||
27723070|NCT00482014|80815562|FG002|Overall Study|Withdrawal by Subject|3|||
27723071|NCT00482014|80815563|FG003|Overall Study|Withdrawal by Subject|4|||
27723072|NCT00482014|80815560|FG000|Overall Study|Adverse Event|3|||
27723073|NCT00482014|80815561|FG001|Overall Study|Adverse Event|0|||
27723074|NCT00482014|80815562|FG002|Overall Study|Adverse Event|2|||
27723075|NCT00482014|80815563|FG003|Overall Study|Adverse Event|8|||
27723076|NCT00482014|80815560|FG000|Overall Study|Death|1|||
27723077|NCT00482014|80815561|FG001|Overall Study|Death|2|||
27723078|NCT00482014|80815562|FG002|Overall Study|Death|1|||
27723079|NCT00482014|80815563|FG003|Overall Study|Death|4|||
27723080|NCT00482014|80815560|FG000|Overall Study|Lack of Efficacy|1|||
27723081|NCT00482014|80815561|FG001|Overall Study|Lack of Efficacy|0|||
27723082|NCT00482014|80815562|FG002|Overall Study|Lack of Efficacy|4|||
27723083|NCT00482014|80815563|FG003|Overall Study|Lack of Efficacy|6|||
27723084|NCT00482014|80815560|FG000|Overall Study|Sponsor Decision|1|||
27723085|NCT00482014|80815561|FG001|Overall Study|Sponsor Decision|2|||
27723086|NCT00482014|80815562|FG002|Overall Study|Sponsor Decision|1|||
27723087|NCT00482014|80815563|FG003|Overall Study|Sponsor Decision|1|||
27723088|NCT00559507|80815564|FG000|Overall Study|Not treated, patient ineligible|3|||
27723089|NCT00493038|80815565|FG000|Treatment|Adverse Event|8|||
27723090|NCT00493038|80815566|FG001|Treatment|Adverse Event|4|||
27723091|NCT00493038|80815565|FG000|Treatment|Lost to Follow-up|5|||
27723092|NCT00493038|80815566|FG001|Treatment|Lost to Follow-up|3|||
27841101|NCT01644149|81248193|FG000|Overall Study|Withdrawal by Subject|1|||
27841102|NCT01644149|81248194|FG001|Overall Study|Withdrawal by Subject|0|||
27841103|NCT01644149|81248193|FG000|Overall Study|Lost to Follow-up|3|||
27841104|NCT01644149|81248194|FG001|Overall Study|Lost to Follow-up|1|||
27841105|NCT04205162|81248195|FG000|Overall Study|Lost to Follow-up|1|||
27841106|NCT04205162|81248196|FG001|Overall Study|Lost to Follow-up|0|||
27841107|NCT04205162|81248195|FG000|Overall Study|Withdrawal by Subject|2|||
27841108|NCT04205162|81248196|FG001|Overall Study|Withdrawal by Subject|0|||
27841109|NCT04205162|81248195|FG000|Overall Study|University closure due to COVID-19|1|||
27841110|NCT04205162|81248196|FG001|Overall Study|University closure due to COVID-19|0|||
27841111|NCT05467982|81248199|FG000|Overall Study|Death|0|||
27841112|NCT05467982|81248200|FG001|Overall Study|Death|1|||
27841113|NCT05467982|81248199|FG000|Overall Study|Lost to Follow-up|3|||
27611612|NCT03285295|80419139|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
27611613|NCT03285295|80419140|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
27611614|NCT03285295|80419141|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
27611615|NCT03285295|80419142|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
27611616|NCT03285295|80419143|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
27723093|NCT00493038|80815565|FG000|Treatment|Withdrawal by Subject|11|||
27723094|NCT00493038|80815566|FG001|Treatment|Withdrawal by Subject|12|||
27723095|NCT00493038|80815565|FG000|Treatment|Other|0|||
27723096|NCT00493038|80815566|FG001|Treatment|Other|1|||
27723097|NCT00493038|80815565|FG000|Follow-up|Lost to Follow-up|1|||
27723098|NCT00493038|80815566|FG001|Follow-up|Lost to Follow-up|0|||
27723099|NCT02154087|80819401|FG000|Overall Study|Study Termination|1|||
27841114|NCT05467982|81248200|FG001|Overall Study|Lost to Follow-up|1|||
27723100|NCT03099707|80819402|FG000|Overall Study|Withdrawal by Subject|0|||
27723101|NCT03099707|80819403|FG001|Overall Study|Withdrawal by Subject|3|||
27723102|NCT03099707|80819402|FG000|Overall Study|Lost to Follow-up|0|||
27723103|NCT03099707|80819403|FG001|Overall Study|Lost to Follow-up|1|||
27723104|NCT01430442|80819404|FG000|Overall Study|Subject Withdrew Consent|3|||
27723105|NCT01430442|80819405|FG001|Overall Study|Subject Withdrew Consent|0|||
27723106|NCT01430442|80819406|FG002|Overall Study|Subject Withdrew Consent|1|||
27723107|NCT01430442|80819407|FG003|Overall Study|Subject Withdrew Consent|0|||
27723108|NCT01430442|80819408|FG004|Overall Study|Subject Withdrew Consent|2|||
27723109|NCT01430442|80819409|FG005|Overall Study|Subject Withdrew Consent|1|||
27723110|NCT01430442|80819410|FG006|Overall Study|Subject Withdrew Consent|5|||
27723111|NCT01430442|80819411|FG007|Overall Study|Subject Withdrew Consent|2|||
27723112|NCT01430442|80819404|FG000|Overall Study|Lost to Follow-up|2|||
27723113|NCT01430442|80819405|FG001|Overall Study|Lost to Follow-up|0|||
27723114|NCT01430442|80819406|FG002|Overall Study|Lost to Follow-up|1|||
27723115|NCT01430442|80819407|FG003|Overall Study|Lost to Follow-up|2|||
27723116|NCT01430442|80819408|FG004|Overall Study|Lost to Follow-up|2|||
27723117|NCT01430442|80819409|FG005|Overall Study|Lost to Follow-up|1|||
27723118|NCT01430442|80819410|FG006|Overall Study|Lost to Follow-up|5|||
27723119|NCT01430442|80819411|FG007|Overall Study|Lost to Follow-up|1|||
27723120|NCT01430442|80819404|FG000|Overall Study|Pregnancy|1|||
27723121|NCT01430442|80819405|FG001|Overall Study|Pregnancy|0|||
27723122|NCT01430442|80819406|FG002|Overall Study|Pregnancy|0|||
27723123|NCT01430442|80819407|FG003|Overall Study|Pregnancy|0|||
27723124|NCT01430442|80819408|FG004|Overall Study|Pregnancy|0|||
27723125|NCT01430442|80819409|FG005|Overall Study|Pregnancy|1|||
27723126|NCT01430442|80819410|FG006|Overall Study|Pregnancy|0|||
27723127|NCT01430442|80819411|FG007|Overall Study|Pregnancy|0|||
27723128|NCT01430442|80819404|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
27723129|NCT01430442|80819405|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
27723130|NCT01430442|80819406|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
27723131|NCT01430442|80819407|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
27723132|NCT01430442|80819408|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
27723133|NCT01430442|80819409|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
27723134|NCT01430442|80819410|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
27723135|NCT01430442|80819411|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
27723136|NCT03538743|80819412|FG000|Overall Study|Adverse Event|0|||
27723137|NCT03538743|80819413|FG001|Overall Study|Adverse Event|0|||
27723138|NCT03538743|80819414|FG002|Overall Study|Adverse Event|1|||
27723139|NCT03538743|80819415|FG003|Overall Study|Adverse Event|1|||
27723140|NCT03538743|80819416|FG004|Overall Study|Adverse Event|0|||
27723141|NCT03538743|80819417|FG005|Overall Study|Adverse Event|0|||
27723142|NCT03538743|80819418|FG006|Overall Study|Adverse Event|0|||
27723143|NCT03538743|80819419|FG007|Overall Study|Adverse Event|0|||
27723144|NCT03538743|80819420|FG008|Overall Study|Adverse Event|0|||
27723145|NCT03538743|80819412|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
27723146|NCT03538743|80819413|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
27723147|NCT03538743|80819414|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
27723148|NCT03538743|80819415|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
27723149|NCT03538743|80819416|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
27723150|NCT03538743|80819417|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
27723151|NCT03538743|80819418|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
27723152|NCT03538743|80819419|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
27723153|NCT03538743|80819420|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
27723154|NCT03538743|80819412|FG000|Overall Study|Withdrawal by Subject|0|||
27723155|NCT03538743|80819413|FG001|Overall Study|Withdrawal by Subject|0|||
27723156|NCT03538743|80819414|FG002|Overall Study|Withdrawal by Subject|0|||
27723157|NCT03538743|80819415|FG003|Overall Study|Withdrawal by Subject|1|||
27723158|NCT03538743|80819416|FG004|Overall Study|Withdrawal by Subject|0|||
27892171|NCT01943851|81441184|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
27892172|NCT01943851|81441167|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892173|NCT01943851|81441168|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27611617|NCT03285295|80419139|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
27723159|NCT03538743|80819417|FG005|Overall Study|Withdrawal by Subject|0|||
27723160|NCT03538743|80819418|FG006|Overall Study|Withdrawal by Subject|0|||
27723161|NCT03538743|80819419|FG007|Overall Study|Withdrawal by Subject|0|||
27723162|NCT03538743|80819420|FG008|Overall Study|Withdrawal by Subject|0|||
27723163|NCT02239263|80819421|FG000|Overall Study|Protocol Violation|6|||
27723164|NCT01031446|80819422|FG000|Overall Study|Disease Progression|38|||
27723165|NCT01031446|80819422|FG000|Overall Study|Adverse Event|9|||
27723166|NCT01031446|80819422|FG000|Overall Study|Physician Decision|4|||
27723167|NCT01031446|80819422|FG000|Overall Study|Withdrawal by Subject|3|||
27723168|NCT01031446|80819422|FG000|Overall Study|Still on treatment|1|||
27723169|NCT03980938|80819438|FG000|Treatment Period 1|Study Terminated|1|||
27723170|NCT03980938|80819439|FG001|Treatment Period 1|Study Terminated|1|||
27892174|NCT01943851|81441169|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27723171|NCT03980938|80819438|FG000|Treatment Period 2|Study Terminated|2|||
27723172|NCT03980938|80819439|FG001|Treatment Period 2|Study Terminated|2|||
27723173|NCT00382993|80819440|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
27723174|NCT00382993|80819441|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
27723175|NCT00382993|80819440|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
27723176|NCT00382993|80819441|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
27723177|NCT00382993|80819440|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
27723178|NCT00382993|80819441|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
27723179|NCT00382993|80819440|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
27723180|NCT00382993|80819441|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
27723181|NCT00382993|80819440|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
27723182|NCT00382993|80819441|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
27723183|NCT00382993|80819440|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
27723184|NCT00382993|80819441|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
27723185|NCT00382993|80819440|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
27723186|NCT00382993|80819441|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
27723187|NCT00382993|80819440|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
27723188|NCT00382993|80819441|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
27723189|NCT00382993|80819440|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
27723190|NCT00382993|80819441|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
27723191|NCT00382993|80819440|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
27723192|NCT00382993|80819441|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
27723193|NCT01764633|80819446|FG000|Overall Study|Withdrawal by Subject|105|||
27723194|NCT01764633|80819447|FG001|Overall Study|Withdrawal by Subject|88|||
27723195|NCT01764633|80819446|FG000|Overall Study|Lost to Follow-up|13|||
27723196|NCT01764633|80819447|FG001|Overall Study|Lost to Follow-up|5|||
27723197|NCT00666926|80819448|FG000|Overall Study|Adverse Event|0|||
27723198|NCT00666926|80819449|FG001|Overall Study|Adverse Event|0|||
27723199|NCT00666926|80819450|FG002|Overall Study|Adverse Event|0|||
27723200|NCT00666926|80819451|FG003|Overall Study|Adverse Event|0|||
27723201|NCT00666926|80819452|FG004|Overall Study|Adverse Event|0|||
27723202|NCT00666926|80819453|FG005|Overall Study|Adverse Event|0|||
27723203|NCT00666926|80819454|FG006|Overall Study|Adverse Event|0|||
27723204|NCT00666926|80819455|FG007|Overall Study|Adverse Event|0|||
27723205|NCT00666926|80819456|FG008|Overall Study|Adverse Event|0|||
27723206|NCT00666926|80819457|FG009|Overall Study|Adverse Event|2|||
27723207|NCT00666926|80819458|FG010|Overall Study|Adverse Event|2|||
27723208|NCT00666926|80819459|FG011|Overall Study|Adverse Event|2|||
27723209|NCT00666926|80819460|FG012|Overall Study|Adverse Event|0|||
27723210|NCT00666926|80819461|FG013|Overall Study|Adverse Event|1|||
27723211|NCT00666926|80819462|FG014|Overall Study|Adverse Event|0|||
27723212|NCT00666926|80819463|FG015|Overall Study|Adverse Event|0|||
27723213|NCT00666926|80819448|FG000|Overall Study|Laboratory abnormality|0|||
27723214|NCT00666926|80819449|FG001|Overall Study|Laboratory abnormality|0|||
27723215|NCT00666926|80819450|FG002|Overall Study|Laboratory abnormality|0|||
27723216|NCT00666926|80819451|FG003|Overall Study|Laboratory abnormality|0|||
27723217|NCT00666926|80819452|FG004|Overall Study|Laboratory abnormality|0|||
27723218|NCT00666926|80819453|FG005|Overall Study|Laboratory abnormality|0|||
27723219|NCT00666926|80819454|FG006|Overall Study|Laboratory abnormality|0|||
27723220|NCT00666926|80819455|FG007|Overall Study|Laboratory abnormality|0|||
27723221|NCT00666926|80819456|FG008|Overall Study|Laboratory abnormality|0|||
27723222|NCT00666926|80819457|FG009|Overall Study|Laboratory abnormality|0|||
27723223|NCT00666926|80819458|FG010|Overall Study|Laboratory abnormality|1|||
27723224|NCT00666926|80819459|FG011|Overall Study|Laboratory abnormality|0|||
27723225|NCT00666926|80819460|FG012|Overall Study|Laboratory abnormality|0|||
27723226|NCT00666926|80819461|FG013|Overall Study|Laboratory abnormality|0|||
27723227|NCT00666926|80819462|FG014|Overall Study|Laboratory abnormality|0|||
27723228|NCT00666926|80819463|FG015|Overall Study|Laboratory abnormality|1|||
27723229|NCT00666926|80819448|FG000|Overall Study|Lack of Efficacy|0|||
27723230|NCT00666926|80819449|FG001|Overall Study|Lack of Efficacy|0|||
27723231|NCT00666926|80819450|FG002|Overall Study|Lack of Efficacy|0|||
27723232|NCT00666926|80819451|FG003|Overall Study|Lack of Efficacy|0|||
27723233|NCT00666926|80819452|FG004|Overall Study|Lack of Efficacy|0|||
27841115|NCT01294449|81248201|FG000|Overall Study|Death|11|||
27841116|NCT01294449|81248202|FG001|Overall Study|Death|12|||
27503040|NCT02903771|80034963|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
27611618|NCT03285295|80419140|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
27723234|NCT00666926|80819453|FG005|Overall Study|Lack of Efficacy|1|||
27723235|NCT00666926|80819454|FG006|Overall Study|Lack of Efficacy|0|||
27723236|NCT00666926|80819455|FG007|Overall Study|Lack of Efficacy|0|||
27723237|NCT00666926|80819456|FG008|Overall Study|Lack of Efficacy|0|||
27611619|NCT03285295|80419141|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
27723238|NCT00666926|80819457|FG009|Overall Study|Lack of Efficacy|0|||
27723239|NCT00666926|80819458|FG010|Overall Study|Lack of Efficacy|0|||
27723240|NCT00666926|80819459|FG011|Overall Study|Lack of Efficacy|1|||
27723241|NCT00666926|80819460|FG012|Overall Study|Lack of Efficacy|0|||
27841117|NCT01294449|81248201|FG000|Overall Study|Withdrawal by Subject|1|||
27841118|NCT01294449|81248202|FG001|Overall Study|Withdrawal by Subject|3|||
27841119|NCT04100096|81248205|FG000|Overall Study|Adverse Event|19|||
27841120|NCT04100096|81248206|FG001|Overall Study|Adverse Event|7|||
27841121|NCT04100096|81248205|FG000|Overall Study|Lack of Efficacy|0|||
27841122|NCT04100096|81248206|FG001|Overall Study|Lack of Efficacy|1|||
27841123|NCT04100096|81248205|FG000|Overall Study|Lost to Follow-up|13|||
27841124|NCT04100096|81248206|FG001|Overall Study|Lost to Follow-up|11|||
27841125|NCT04100096|81248205|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27841126|NCT04100096|81248206|FG001|Overall Study|Non-Compliance With Study Drug|3|||
27841127|NCT04100096|81248205|FG000|Overall Study|Protocol Deviation|1|||
27841128|NCT04100096|81248206|FG001|Overall Study|Protocol Deviation|1|||
27841129|NCT04100096|81248205|FG000|Overall Study|Withdrawal by Participant|13|||
27841130|NCT04100096|81248206|FG001|Overall Study|Withdrawal by Participant|15|||
27841131|NCT03904693|81248207|FG000|Overall Study|Death|0|||
27841132|NCT03904693|81248208|FG001|Overall Study|Death|0|||
27841133|NCT03904693|81248209|FG002|Overall Study|Death|3|||
27841134|NCT03904693|81248207|FG000|Overall Study|Physician Decision|0|||
27841135|NCT03904693|81248208|FG001|Overall Study|Physician Decision|0|||
27723242|NCT00666926|80819461|FG013|Overall Study|Lack of Efficacy|0|||
27723243|NCT00666926|80819462|FG014|Overall Study|Lack of Efficacy|0|||
27723244|NCT00666926|80819463|FG015|Overall Study|Lack of Efficacy|0|||
27723245|NCT00666926|80819448|FG000|Overall Study|Lost to Follow-up|0|||
27723246|NCT00666926|80819449|FG001|Overall Study|Lost to Follow-up|0|||
27723247|NCT00666926|80819450|FG002|Overall Study|Lost to Follow-up|0|||
27723248|NCT00666926|80819451|FG003|Overall Study|Lost to Follow-up|1|||
27723249|NCT00666926|80819452|FG004|Overall Study|Lost to Follow-up|0|||
27723250|NCT00666926|80819453|FG005|Overall Study|Lost to Follow-up|0|||
27723251|NCT00666926|80819454|FG006|Overall Study|Lost to Follow-up|0|||
27723252|NCT00666926|80819455|FG007|Overall Study|Lost to Follow-up|0|||
27723253|NCT00666926|80819456|FG008|Overall Study|Lost to Follow-up|0|||
27723254|NCT00666926|80819457|FG009|Overall Study|Lost to Follow-up|0|||
27723255|NCT00666926|80819458|FG010|Overall Study|Lost to Follow-up|0|||
27723256|NCT00666926|80819459|FG011|Overall Study|Lost to Follow-up|0|||
27723257|NCT00666926|80819460|FG012|Overall Study|Lost to Follow-up|0|||
27723258|NCT00666926|80819461|FG013|Overall Study|Lost to Follow-up|0|||
27723259|NCT00666926|80819462|FG014|Overall Study|Lost to Follow-up|0|||
27723260|NCT00666926|80819463|FG015|Overall Study|Lost to Follow-up|0|||
27723261|NCT00666926|80819448|FG000|Overall Study|Other|2|||
27723262|NCT00666926|80819449|FG001|Overall Study|Other|4|||
27723263|NCT00666926|80819450|FG002|Overall Study|Other|3|||
27723264|NCT00666926|80819451|FG003|Overall Study|Other|3|||
27723265|NCT00666926|80819452|FG004|Overall Study|Other|3|||
27723266|NCT00666926|80819453|FG005|Overall Study|Other|3|||
27723267|NCT00666926|80819454|FG006|Overall Study|Other|4|||
27723268|NCT00666926|80819455|FG007|Overall Study|Other|0|||
27723269|NCT00666926|80819456|FG008|Overall Study|Other|3|||
27723270|NCT00666926|80819457|FG009|Overall Study|Other|5|||
27723271|NCT00666926|80819458|FG010|Overall Study|Other|3|||
27723272|NCT00666926|80819459|FG011|Overall Study|Other|26|||
27723273|NCT00666926|80819460|FG012|Overall Study|Other|3|||
27723274|NCT00666926|80819461|FG013|Overall Study|Other|2|||
27723275|NCT00666926|80819462|FG014|Overall Study|Other|4|||
27723276|NCT00666926|80819463|FG015|Overall Study|Other|4|||
27723277|NCT00666926|80819448|FG000|Overall Study|Withdrawal by Subject|0|||
27723278|NCT00666926|80819449|FG001|Overall Study|Withdrawal by Subject|0|||
27892175|NCT01943851|81441170|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27723279|NCT00666926|80819450|FG002|Overall Study|Withdrawal by Subject|0|||
27723280|NCT00666926|80819451|FG003|Overall Study|Withdrawal by Subject|0|||
27723281|NCT00666926|80819452|FG004|Overall Study|Withdrawal by Subject|0|||
27723282|NCT00666926|80819453|FG005|Overall Study|Withdrawal by Subject|0|||
27723283|NCT00666926|80819454|FG006|Overall Study|Withdrawal by Subject|0|||
27723284|NCT00666926|80819455|FG007|Overall Study|Withdrawal by Subject|1|||
27723285|NCT00666926|80819456|FG008|Overall Study|Withdrawal by Subject|0|||
27841136|NCT03904693|81248209|FG002|Overall Study|Physician Decision|2|||
27723286|NCT00666926|80819457|FG009|Overall Study|Withdrawal by Subject|3|||
27841137|NCT03904693|81248207|FG000|Overall Study|Withdrawal by Subject|0|||
27841138|NCT03904693|81248208|FG001|Overall Study|Withdrawal by Subject|1|||
27841139|NCT03904693|81248209|FG002|Overall Study|Withdrawal by Subject|4|||
27958601|NCT01791517|81680061|FG003|Phase II|Lack of Efficacy|0|||
27723287|NCT00666926|80819458|FG010|Overall Study|Withdrawal by Subject|0|||
27723288|NCT00666926|80819459|FG011|Overall Study|Withdrawal by Subject|3|||
27723289|NCT00666926|80819460|FG012|Overall Study|Withdrawal by Subject|0|||
27723290|NCT00666926|80819461|FG013|Overall Study|Withdrawal by Subject|1|||
27841140|NCT02940522|81248212|FG000|Overall Study|Lost to Follow-up|1|||
27841141|NCT02940522|81248213|FG001|Overall Study|Lost to Follow-up|2|||
27841142|NCT02940522|81248212|FG000|Overall Study|Withdrawal by Subject|1|||
27841143|NCT02940522|81248213|FG001|Overall Study|Withdrawal by Subject|0|||
27841144|NCT02246764|81248214|FG000|Overall Study|Adverse Event|15|||
27841145|NCT02246764|81248215|FG001|Overall Study|Adverse Event|29|||
27841146|NCT02246764|81248216|FG002|Overall Study|Adverse Event|1|||
27841147|NCT02246764|81248214|FG000|Overall Study|Withdrawal by Subject|0|||
27841148|NCT02246764|81248215|FG001|Overall Study|Withdrawal by Subject|0|||
27841149|NCT02246764|81248216|FG002|Overall Study|Withdrawal by Subject|1|||
27841150|NCT02246764|81248214|FG000|Overall Study|Disallowed Concomitant Medication|1|||
27841151|NCT02246764|81248215|FG001|Overall Study|Disallowed Concomitant Medication|0|||
27841152|NCT02246764|81248216|FG002|Overall Study|Disallowed Concomitant Medication|0|||
27841153|NCT02246764|81248214|FG000|Overall Study|Physician Decision|0|||
27841154|NCT02246764|81248215|FG001|Overall Study|Physician Decision|2|||
27841155|NCT02246764|81248216|FG002|Overall Study|Physician Decision|1|||
27841156|NCT02246764|81248214|FG000|Overall Study|Protocol Violation|2|||
27841157|NCT02246764|81248215|FG001|Overall Study|Protocol Violation|1|||
27841158|NCT02246764|81248216|FG002|Overall Study|Protocol Violation|1|||
27841159|NCT02293460|81248219|FG000|Overall Study|Protocol Violation|1|||
27841160|NCT02293460|81248219|FG000|Overall Study|Lack of Efficacy|2|||
27841161|NCT02293460|81248219|FG000|Overall Study|Adverse Event|2|||
27503041|NCT02903771|80034964|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
27503042|NCT02903771|80034958|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
27611620|NCT03285295|80419142|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
27611621|NCT03285295|80419143|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
27611622|NCT03285295|80419139|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
27611623|NCT03285295|80419140|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
27611624|NCT03285295|80419141|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
27611625|NCT03285295|80419142|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
27611626|NCT03285295|80419143|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
27611627|NCT03285295|80419139|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
27611628|NCT03285295|80419140|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
27611629|NCT03285295|80419141|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
27611630|NCT03285295|80419142|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
27611631|NCT03285295|80419143|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
27611632|NCT03285295|80419139|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
27611633|NCT03285295|80419140|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
27611634|NCT03285295|80419141|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
27611635|NCT03285295|80419142|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
27611636|NCT03285295|80419143|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
27611637|NCT03285295|80419139|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
27611638|NCT03285295|80419140|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
27611639|NCT03285295|80419141|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
27611640|NCT03285295|80419142|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
27611641|NCT03285295|80419143|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
27611642|NCT03285295|80419139|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
27611643|NCT03285295|80419140|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
27611644|NCT03285295|80419141|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
27611645|NCT03285295|80419142|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
27611646|NCT03285295|80419143|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
27611647|NCT03285295|80419139|FG000|Alinity s Anti-HBc|No Results Generated|70|||
27611648|NCT03285295|80419140|FG001|Alinity s Anti-HBc|No Results Generated|0|||
27611649|NCT03285295|80419141|FG002|Alinity s Anti-HBc|No Results Generated|0|||
27611650|NCT03285295|80419142|FG003|Alinity s Anti-HBc|No Results Generated|0|||
27611651|NCT03285295|80419143|FG004|Alinity s Anti-HBc|No Results Generated|0|||
27611652|NCT03285295|80419139|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
27611653|NCT03285295|80419140|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
27611654|NCT03285295|80419141|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
27611655|NCT03285295|80419142|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
27611656|NCT03285295|80419143|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
27841162|NCT02293460|81248219|FG000|Overall Study|Withdrawal by Subject|1|||
27841163|NCT04439110|81248220|FG000|Overall Study|Ineligible|2|||
27841164|NCT04439110|81248220|FG000|Overall Study|Adverse Event|4|||
27841165|NCT04439110|81248220|FG000|Overall Study|Death|2|||
27841166|NCT04439110|81248220|FG000|Overall Study|Disease proression|25|||
27841167|NCT04439110|81248220|FG000|Overall Study|Withdrawal by Subject|1|||
27841168|NCT04439110|81248220|FG000|Overall Study|Alternative therapy|1|||
27841169|NCT04439110|81248220|FG000|Overall Study|Other complicating disease|1|||
27841170|NCT04439110|81248220|FG000|Overall Study|Personal reasons|1|||
27841171|NCT04439110|81248220|FG000|Overall Study|Still on treatment|1|||
27841172|NCT01755975|81248226|FG000|Overall Study|Adverse Event|0|||
27841173|NCT01755975|81248227|FG001|Overall Study|Adverse Event|0|||
27841174|NCT01755975|81248228|FG002|Overall Study|Adverse Event|1|||
27841175|NCT01755975|81248229|FG003|Overall Study|Adverse Event|0|||
27841176|NCT01755975|81248230|FG004|Overall Study|Adverse Event|2|||
27841177|NCT01588548|81248231|FG000|Overall Study|Withdrawal by Subject|0|||
27723291|NCT00666926|80819462|FG014|Overall Study|Withdrawal by Subject|3|||
27723292|NCT00666926|80819463|FG015|Overall Study|Withdrawal by Subject|3|||
27723293|NCT00666926|80819448|FG000|Overall Study|Death|0|||
27723294|NCT00666926|80819449|FG001|Overall Study|Death|0|||
27723295|NCT00666926|80819450|FG002|Overall Study|Death|0|||
27723296|NCT00666926|80819451|FG003|Overall Study|Death|0|||
27723297|NCT00666926|80819452|FG004|Overall Study|Death|0|||
27723298|NCT00666926|80819453|FG005|Overall Study|Death|0|||
27723299|NCT00666926|80819454|FG006|Overall Study|Death|0|||
27723300|NCT00666926|80819455|FG007|Overall Study|Death|0|||
27723301|NCT00666926|80819456|FG008|Overall Study|Death|0|||
27723302|NCT00666926|80819457|FG009|Overall Study|Death|0|||
27723303|NCT00666926|80819458|FG010|Overall Study|Death|0|||
27723304|NCT00666926|80819459|FG011|Overall Study|Death|1|||
27723305|NCT00666926|80819460|FG012|Overall Study|Death|0|||
27723306|NCT00666926|80819461|FG013|Overall Study|Death|0|||
27723307|NCT00666926|80819462|FG014|Overall Study|Death|0|||
27723308|NCT00666926|80819463|FG015|Overall Study|Death|0|||
27723309|NCT00494091|80819465|FG000|Overall Study|Death|5|||
27723310|NCT00494091|80819466|FG001|Overall Study|Death|54|||
27723311|NCT00494091|80819465|FG000|Overall Study|Lost to Follow-up|0|||
27723312|NCT00494091|80819466|FG001|Overall Study|Lost to Follow-up|4|||
27723313|NCT00494091|80819465|FG000|Overall Study|Other|1|||
27723314|NCT00494091|80819466|FG001|Overall Study|Other|11|||
27723315|NCT00494091|80819465|FG000|Overall Study|Withdrawal by Subject|0|||
27723316|NCT00494091|80819466|FG001|Overall Study|Withdrawal by Subject|7|||
27723317|NCT01847885|80819475|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
27723318|NCT01847885|80819476|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
27723319|NCT01847885|80819477|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
27723320|NCT01847885|80819475|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
27723321|NCT01847885|80819476|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
27723322|NCT01847885|80819477|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
27723323|NCT01847885|80819475|FG000|Initial Enrollment (Consented)|Screen failure|39|||
27723324|NCT01847885|80819476|FG001|Initial Enrollment (Consented)|Screen failure|0|||
27723325|NCT01847885|80819477|FG002|Initial Enrollment (Consented)|Screen failure|0|||
27723326|NCT01847885|80819475|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
27723327|NCT01847885|80819476|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
27841178|NCT01588548|81248232|FG001|Overall Study|Withdrawal by Subject|1|||
27723328|NCT01847885|80819477|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
27892176|NCT01943851|81441171|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892177|NCT01943851|81441172|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27723329|NCT01847885|80819475|FG000|Randomization|Protocol Violation|0|||
27723330|NCT01847885|80819476|FG001|Randomization|Protocol Violation|1|||
27723331|NCT01847885|80819477|FG002|Randomization|Protocol Violation|0|||
27723332|NCT01847885|80819475|FG000|Randomization|Withdrawal by Subject|0|||
27723333|NCT01847885|80819476|FG001|Randomization|Withdrawal by Subject|0|||
27841179|NCT01588548|81248233|FG002|Overall Study|Withdrawal by Subject|1|||
27841180|NCT01588548|81248234|FG003|Overall Study|Withdrawal by Subject|1|||
27841181|NCT01588548|81248235|FG004|Overall Study|Withdrawal by Subject|2|||
27841182|NCT01588548|81248236|FG005|Overall Study|Withdrawal by Subject|3|||
27841183|NCT01588548|81248231|FG000|Overall Study|Adverse Event|0|||
27841184|NCT01588548|81248232|FG001|Overall Study|Adverse Event|0|||
27503043|NCT02903771|80034959|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
27503044|NCT02903771|80034960|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
27503045|NCT02903771|80034961|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
27503046|NCT02903771|80034962|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
27503047|NCT02903771|80034963|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
27503048|NCT02903771|80034964|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
27503049|NCT03425643|80034968|FG000|Overall Study|Withdrawal by Subject|10|||
27503050|NCT03425643|80034969|FG001|Overall Study|Withdrawal by Subject|12|||
27503051|NCT03425643|80034968|FG000|Overall Study|Lost to Follow-up|2|||
27503052|NCT03425643|80034969|FG001|Overall Study|Lost to Follow-up|0|||
27503053|NCT03425643|80034968|FG000|Overall Study|Death|109|||
27503054|NCT03425643|80034969|FG001|Overall Study|Death|141|||
27841185|NCT01588548|81248233|FG002|Overall Study|Adverse Event|1|||
27503055|NCT03425643|80034968|FG000|Overall Study|Ongoing in study|276|||
27503056|NCT03425643|80034969|FG001|Overall Study|Ongoing in study|247|||
27503057|NCT03173248|80034970|FG000|Overall Study|Death|28|||
27503058|NCT03173248|80034971|FG001|Overall Study|Death|46|||
27503059|NCT03173248|80034970|FG000|Overall Study|Lost to Follow-up|0|||
27503060|NCT03173248|80034971|FG001|Overall Study|Lost to Follow-up|1|||
27611657|NCT03285295|80419139|FG000|Alinity s Chagas|Protocol Violation|76|||
27611658|NCT03285295|80419140|FG001|Alinity s Chagas|Protocol Violation|0|||
27611659|NCT03285295|80419141|FG002|Alinity s Chagas|Protocol Violation|0|||
27611660|NCT03285295|80419142|FG003|Alinity s Chagas|Protocol Violation|0|||
27611661|NCT03285295|80419143|FG004|Alinity s Chagas|Protocol Violation|0|||
27611662|NCT03285295|80419139|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
27611663|NCT03285295|80419140|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
27611664|NCT03285295|80419141|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
27611665|NCT03285295|80419142|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
27611666|NCT03285295|80419143|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
27611667|NCT03285295|80419139|FG000|Alinity s Chagas|No Results Generated|105|||
27611668|NCT03285295|80419140|FG001|Alinity s Chagas|No Results Generated|0|||
27611669|NCT03285295|80419141|FG002|Alinity s Chagas|No Results Generated|0|||
27611670|NCT03285295|80419142|FG003|Alinity s Chagas|No Results Generated|0|||
27611671|NCT03285295|80419143|FG004|Alinity s Chagas|No Results Generated|0|||
27611672|NCT03285295|80419139|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
27611673|NCT03285295|80419140|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
27723334|NCT01847885|80819477|FG002|Randomization|Withdrawal by Subject|2|||
27723335|NCT01847885|80819475|FG000|Randomization|Screen Failure|0|||
27723336|NCT01847885|80819476|FG001|Randomization|Screen Failure|3|||
27723337|NCT01847885|80819477|FG002|Randomization|Screen Failure|0|||
27723338|NCT01703858|80819478|FG000|Overall Study|Withdrawal by Subject|0|||
27723339|NCT01703858|80819479|FG001|Overall Study|Withdrawal by Subject|1|||
27723340|NCT01703858|80819480|FG002|Overall Study|Withdrawal by Subject|0|||
27723341|NCT02475655|80819481|FG000|Overall Study|Lost to Follow-up|0|||
27723342|NCT02475655|80819482|FG001|Overall Study|Lost to Follow-up|1|||
27723343|NCT00332709|80819483|FG000|Overall Study|Adverse Event|11|||
27723344|NCT00332709|80819484|FG001|Overall Study|Adverse Event|14|||
27723345|NCT00332709|80819483|FG000|Overall Study|Withdrawal by Subject|2|||
27723346|NCT00332709|80819484|FG001|Overall Study|Withdrawal by Subject|3|||
27723347|NCT00332709|80819483|FG000|Overall Study|Lost to Follow-up|2|||
27723348|NCT00332709|80819484|FG001|Overall Study|Lost to Follow-up|0|||
27723349|NCT00332709|80819483|FG000|Overall Study|Administrative Problems|0|||
27723350|NCT00332709|80819484|FG001|Overall Study|Administrative Problems|3|||
27723351|NCT00332709|80819483|FG000|Overall Study|Abnormal test procedure result|1|||
27723352|NCT00332709|80819484|FG001|Overall Study|Abnormal test procedure result|0|||
27723353|NCT00364689|80819485|FG000|Overall Study|Lost to Follow-up|1|||
27723354|NCT02796755|80819487|FG000|Overall Study|Adverse Event|2|||
27723355|NCT02796755|80819488|FG001|Overall Study|Adverse Event|0|||
27723356|NCT05020899|80819489|FG000|8 Week Follow-up|Lost to Follow-up|3|||
27723357|NCT05020899|80819490|FG001|8 Week Follow-up|Lost to Follow-up|6|||
27723358|NCT05020899|80819489|FG000|12 Week Follow-up|Lost to Follow-up|1|||
27503061|NCT03173248|80034970|FG000|Overall Study|Withdrawal by Subject|6|||
27503062|NCT03173248|80034971|FG001|Overall Study|Withdrawal by Subject|4|||
27503063|NCT03173248|80034970|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
27503064|NCT03173248|80034971|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
27503065|NCT05058365|80034976|FG000|Overall Study|Migration|1|||
27503066|NCT05058365|80034977|FG001|Overall Study|Migration|1|||
27503067|NCT01099267|80034978|FG000|MDS-003 Study|Adverse Event|37|||
27503068|NCT01099267|80034978|FG000|MDS-003 Study|Lack of Efficacy|52|||
27503069|NCT01099267|80034978|FG000|MDS-003 Study|Withdrawal by Subject|8|||
27503070|NCT01099267|80034978|FG000|MDS-003 Study|Lost to Follow-up|1|||
27503071|NCT01099267|80034978|FG000|MDS-003 Study|Death|11|||
27503072|NCT01099267|80034978|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
27503073|NCT01099267|80034978|FG000|MDS-003 Study|Disease Progression|7|||
27503074|NCT01099267|80034978|FG000|MDS-003 Study|Investigator Decision|2|||
27723359|NCT05020899|80819490|FG001|12 Week Follow-up|Lost to Follow-up|0|||
27723360|NCT05020899|80819489|FG000|12 Week Follow-up|Death|0|||
27723361|NCT05020899|80819490|FG001|12 Week Follow-up|Death|1|||
27723362|NCT05098041|80819494|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
27503075|NCT01099267|80034978|FG000|MDS-003 Study|Non-Compliance|2|||
27503076|NCT01099267|80034978|FG000|MDS-003 Study|Loss of Response|1|||
27611674|NCT03285295|80419141|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
27611675|NCT03285295|80419142|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
27723363|NCT01239160|80819495|FG000|Overall Study|Lost to Follow-up|3|||
27503077|NCT01099267|80034978|FG000|MDS-003 Study|Secondary Malign Disease|1|||
27503078|NCT03674411|80034979|FG000|Overall Study|Non-treatment|4|||
27503079|NCT00762164|80034980|FG000|Overall Study|Lost to Follow-up|1|||
27723364|NCT01239160|80819496|FG001|Overall Study|Lost to Follow-up|5|||
27723365|NCT01239160|80819497|FG002|Overall Study|Lost to Follow-up|0|||
27723366|NCT01239160|80819495|FG000|Overall Study|Withdrawal by Subject|17|||
27611676|NCT03285295|80419143|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
27611677|NCT00409786|80419144|FG000|Overall Study|Withdrawal by Subject|3|||
27611678|NCT01544582|80419145|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
27611679|NCT01544582|80419146|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
27611680|NCT01544582|80419147|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
27611681|NCT01544582|80419148|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
27611682|NCT01544582|80419145|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
27611683|NCT01544582|80419146|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
27611684|NCT01544582|80419147|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
27611685|NCT01544582|80419148|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
27611686|NCT01544582|80419145|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
27611687|NCT01544582|80419146|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
27611688|NCT01544582|80419147|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
27611689|NCT01544582|80419148|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
27611690|NCT01544582|80419145|FG000|Analysis Population|Physician Decision|0|||
27611691|NCT01544582|80419146|FG001|Analysis Population|Physician Decision|13|||
27611692|NCT01544582|80419147|FG002|Analysis Population|Physician Decision|10|||
27611693|NCT01544582|80419148|FG003|Analysis Population|Physician Decision|9|||
27611694|NCT01544582|80419145|FG000|Analysis Population|Safety Reason|0|||
27611695|NCT01544582|80419146|FG001|Analysis Population|Safety Reason|33|||
27611696|NCT01544582|80419147|FG002|Analysis Population|Safety Reason|31|||
27611697|NCT01544582|80419148|FG003|Analysis Population|Safety Reason|8|||
27611698|NCT01544582|80419145|FG000|Analysis Population|Effectiveness Reason|0|||
27611699|NCT01544582|80419146|FG001|Analysis Population|Effectiveness Reason|48|||
27611700|NCT01544582|80419147|FG002|Analysis Population|Effectiveness Reason|29|||
27503080|NCT00762164|80034981|FG001|Overall Study|Lost to Follow-up|1|||
27503081|NCT00762164|80034980|FG000|Overall Study|Discontinued medication|2|||
27503082|NCT00762164|80034981|FG001|Overall Study|Discontinued medication|0|||
27503083|NCT00762164|80034980|FG000|Overall Study|Withdrawal by Subject|0|||
27503084|NCT00762164|80034981|FG001|Overall Study|Withdrawal by Subject|1|||
27503085|NCT03312231|80034982|FG000|Overall Study|Lost to Follow-up|2|||
27503086|NCT03312231|80034983|FG001|Overall Study|Lost to Follow-up|6|||
27503087|NCT03312231|80034984|FG002|Overall Study|Lost to Follow-up|1|||
27503088|NCT03312231|80034985|FG003|Overall Study|Lost to Follow-up|3|||
27503089|NCT03312231|80034986|FG004|Overall Study|Lost to Follow-up|1|||
27503090|NCT03312231|80034982|FG000|Overall Study|Withdrawal by Subject|0|||
27503091|NCT03312231|80034983|FG001|Overall Study|Withdrawal by Subject|3|||
27503092|NCT03312231|80034984|FG002|Overall Study|Withdrawal by Subject|1|||
27503093|NCT03312231|80034985|FG003|Overall Study|Withdrawal by Subject|0|||
27503094|NCT03312231|80034986|FG004|Overall Study|Withdrawal by Subject|0|||
27503095|NCT03312231|80034982|FG000|Overall Study|Death|0|||
27503096|NCT03312231|80034983|FG001|Overall Study|Death|1|||
27503097|NCT03312231|80034984|FG002|Overall Study|Death|1|||
27503098|NCT03312231|80034985|FG003|Overall Study|Death|0|||
27503099|NCT03312231|80034986|FG004|Overall Study|Death|0|||
27503100|NCT03312231|80034982|FG000|Overall Study|Study Vaccination not Received|1|||
27503101|NCT03312231|80034983|FG001|Overall Study|Study Vaccination not Received|1|||
27503102|NCT03312231|80034984|FG002|Overall Study|Study Vaccination not Received|1|||
27503103|NCT03312231|80034985|FG003|Overall Study|Study Vaccination not Received|0|||
27503104|NCT03312231|80034986|FG004|Overall Study|Study Vaccination not Received|0|||
27503105|NCT01084655|80034987|FG000|Overall Study|Radiographic disease progression|3|||
27503106|NCT01084655|80034988|FG001|Overall Study|Radiographic disease progression|2|||
27503107|NCT01084655|80034989|FG002|Overall Study|Radiographic disease progression|8|||
27503108|NCT01084655|80034987|FG000|Overall Study|Withdrawal by Subject|1|||
27503109|NCT01084655|80034988|FG001|Overall Study|Withdrawal by Subject|0|||
27503110|NCT01084655|80034989|FG002|Overall Study|Withdrawal by Subject|4|||
27503111|NCT01084655|80034987|FG000|Overall Study|Adverse Event|2|||
27503112|NCT01084655|80034988|FG001|Overall Study|Adverse Event|1|||
27503113|NCT01084655|80034989|FG002|Overall Study|Adverse Event|2|||
27503114|NCT01084655|80034987|FG000|Overall Study|Other|0|||
27503115|NCT01084655|80034988|FG001|Overall Study|Other|3|||
27503116|NCT01084655|80034989|FG002|Overall Study|Other|2|||
27503117|NCT01084655|80034987|FG000|Overall Study|Symptomatic deterioration|0|||
27503118|NCT01084655|80034988|FG001|Overall Study|Symptomatic deterioration|0|||
27503119|NCT01084655|80034989|FG002|Overall Study|Symptomatic deterioration|2|||
27611701|NCT01544582|80419148|FG003|Analysis Population|Effectiveness Reason|12|||
27503120|NCT01084655|80034987|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
27503121|NCT01084655|80034988|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
27503122|NCT01084655|80034989|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
27503123|NCT04439539|80034991|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
27503124|NCT04439539|80034992|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
27503125|NCT04439539|80034993|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
27503126|NCT04439539|80034991|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
27503127|NCT04439539|80034992|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
27611702|NCT01544582|80419145|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
27611703|NCT01544582|80419146|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
27611704|NCT01544582|80419147|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
27611705|NCT01544582|80419148|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
27611706|NCT01544582|80419145|FG000|Analysis Population|Lost to Follow-up|0|||
27611707|NCT01544582|80419146|FG001|Analysis Population|Lost to Follow-up|6|||
27611708|NCT01544582|80419147|FG002|Analysis Population|Lost to Follow-up|6|||
27611709|NCT01544582|80419148|FG003|Analysis Population|Lost to Follow-up|5|||
27611710|NCT01544582|80419145|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
27611711|NCT01544582|80419146|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
27611712|NCT01544582|80419147|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
27611713|NCT01544582|80419148|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
27611714|NCT01544582|80419145|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
27611715|NCT01544582|80419146|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
27611716|NCT01544582|80419147|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
27611717|NCT01544582|80419148|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
27611718|NCT01544582|80419145|FG000|Analysis Population|Intolerance|0|||
27611719|NCT01544582|80419146|FG001|Analysis Population|Intolerance|1|||
27611720|NCT01544582|80419147|FG002|Analysis Population|Intolerance|0|||
27611721|NCT01544582|80419148|FG003|Analysis Population|Intolerance|0|||
27611722|NCT01544582|80419145|FG000|Analysis Population|Liver Transplantation|0|||
27611723|NCT01544582|80419146|FG001|Analysis Population|Liver Transplantation|0|||
27611724|NCT01544582|80419147|FG002|Analysis Population|Liver Transplantation|1|||
27503128|NCT04439539|80034993|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
27503129|NCT04439539|80034991|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
27611725|NCT01544582|80419148|FG003|Analysis Population|Liver Transplantation|0|||
27611726|NCT01544582|80419145|FG000|Analysis Population|No Social Insurance|0|||
27611727|NCT01544582|80419146|FG001|Analysis Population|No Social Insurance|0|||
27611728|NCT01544582|80419147|FG002|Analysis Population|No Social Insurance|1|||
27841186|NCT01588548|81248234|FG003|Overall Study|Adverse Event|2|||
27841187|NCT01588548|81248235|FG004|Overall Study|Adverse Event|1|||
27841188|NCT01588548|81248236|FG005|Overall Study|Adverse Event|0|||
27841189|NCT01588548|81248231|FG000|Overall Study|Condition Under Investigation Worsened|3|||
27611729|NCT01544582|80419148|FG003|Analysis Population|No Social Insurance|0|||
27611730|NCT01544582|80419145|FG000|Analysis Population|Poor Adherence|0|||
27611731|NCT01544582|80419146|FG001|Analysis Population|Poor Adherence|0|||
27611732|NCT01544582|80419147|FG002|Analysis Population|Poor Adherence|1|||
27841190|NCT01588548|81248232|FG001|Overall Study|Condition Under Investigation Worsened|6|||
27841191|NCT01588548|81248233|FG002|Overall Study|Condition Under Investigation Worsened|4|||
27841192|NCT01588548|81248234|FG003|Overall Study|Condition Under Investigation Worsened|4|||
27841193|NCT01588548|81248235|FG004|Overall Study|Condition Under Investigation Worsened|3|||
27841194|NCT01588548|81248236|FG005|Overall Study|Condition Under Investigation Worsened|3|||
27611733|NCT01544582|80419148|FG003|Analysis Population|Poor Adherence|0|||
27611734|NCT01544582|80419145|FG000|Analysis Population|Poor Participant Compliance|0|||
27611735|NCT01544582|80419146|FG001|Analysis Population|Poor Participant Compliance|1|||
27611736|NCT01544582|80419147|FG002|Analysis Population|Poor Participant Compliance|0|||
27611737|NCT01544582|80419148|FG003|Analysis Population|Poor Participant Compliance|0|||
27611738|NCT01544582|80419145|FG000|Analysis Population|Programmed Surgery|0|||
27611739|NCT01544582|80419146|FG001|Analysis Population|Programmed Surgery|1|||
27611740|NCT01544582|80419147|FG002|Analysis Population|Programmed Surgery|0|||
27611741|NCT01544582|80419148|FG003|Analysis Population|Programmed Surgery|0|||
27611742|NCT01544582|80419145|FG000|Analysis Population|Participant in Jail|0|||
27611743|NCT01544582|80419146|FG001|Analysis Population|Participant in Jail|0|||
27723367|NCT01239160|80819496|FG001|Overall Study|Withdrawal by Subject|6|||
27723368|NCT01239160|80819497|FG002|Overall Study|Withdrawal by Subject|2|||
27723369|NCT01239160|80819495|FG000|Overall Study|Physician Decision|5|||
27723370|NCT01239160|80819496|FG001|Overall Study|Physician Decision|7|||
27723371|NCT01239160|80819497|FG002|Overall Study|Physician Decision|2|||
27841195|NCT01999894|81248237|FG000|Overall Study|Adverse Event|9|||
27611744|NCT01544582|80419147|FG002|Analysis Population|Participant in Jail|1|||
27723372|NCT01239160|80819495|FG000|Overall Study|Early Termination Due to Study Closure|0|||
27841196|NCT01999894|81248237|FG000|Overall Study|Lack of Efficacy|5|||
27611745|NCT01544582|80419148|FG003|Analysis Population|Participant in Jail|0|||
27611746|NCT01737996|80419149|FG000|Overall Study|Adverse Event|0|||
27611747|NCT01737996|80419150|FG001|Overall Study|Adverse Event|1|||
27611748|NCT01737996|80419151|FG002|Overall Study|Adverse Event|1|||
27611749|NCT01737996|80419149|FG000|Overall Study|Withdrawal by Subject|0|||
27611750|NCT01737996|80419150|FG001|Overall Study|Withdrawal by Subject|0|||
27841197|NCT01999894|81248237|FG000|Overall Study|Protocol Violation|1|||
27841198|NCT01999894|81248237|FG000|Overall Study|Withdrawal by Subject|7|||
27841199|NCT01999894|81248237|FG000|Overall Study|Lost to Follow-up|10|||
27841200|NCT01999894|81248237|FG000|Overall Study|Other Reason|3|||
27841201|NCT01999894|81248237|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
27841202|NCT03310619|81248238|FG000|Pre-Treatment Period|Death|1|||
27841203|NCT03310619|81248239|FG001|Pre-Treatment Period|Death|0|||
27611751|NCT01737996|80419151|FG002|Overall Study|Withdrawal by Subject|1|||
27611752|NCT03898180|80419152|FG000|Overall Study|Ongoing in Study|133|||
27611753|NCT03898180|80419153|FG001|Overall Study|Ongoing in Study|134|||
27611754|NCT03898180|80419152|FG000|Overall Study|Withdrawal by Subject|3|||
27611755|NCT03898180|80419153|FG001|Overall Study|Withdrawal by Subject|2|||
27611756|NCT03898180|80419152|FG000|Overall Study|Death|109|||
27611757|NCT03898180|80419153|FG001|Overall Study|Death|106|||
27611758|NCT02388074|80419156|FG000|Overall Study|Lost in Transit|2|||
27611759|NCT02388074|80419156|FG000|Overall Study|Sample Not Returned|1|||
27611760|NCT01848834|80419157|FG000|Overall Study|Adverse Event|3|||
27611761|NCT01848834|80419158|FG001|Overall Study|Adverse Event|11|||
27611762|NCT01848834|80419159|FG002|Overall Study|Adverse Event|3|||
27611763|NCT01848834|80419160|FG003|Overall Study|Adverse Event|5|||
27611764|NCT01848834|80419161|FG004|Overall Study|Adverse Event|9|||
27611765|NCT01848834|80419157|FG000|Overall Study|Death|2|||
27611766|NCT01848834|80419158|FG001|Overall Study|Death|11|||
27611767|NCT01848834|80419159|FG002|Overall Study|Death|1|||
27611768|NCT01848834|80419160|FG003|Overall Study|Death|8|||
27611769|NCT01848834|80419161|FG004|Overall Study|Death|27|||
27611770|NCT01848834|80419157|FG000|Overall Study|Excluded Medication|5|||
27611771|NCT01848834|80419158|FG001|Overall Study|Excluded Medication|4|||
27611772|NCT01848834|80419159|FG002|Overall Study|Excluded Medication|3|||
27611773|NCT01848834|80419160|FG003|Overall Study|Excluded Medication|6|||
27611774|NCT01848834|80419161|FG004|Overall Study|Excluded Medication|6|||
27611775|NCT01848834|80419157|FG000|Overall Study|Lost to Follow-up|5|||
27611776|NCT01848834|80419158|FG001|Overall Study|Lost to Follow-up|5|||
27611777|NCT01848834|80419159|FG002|Overall Study|Lost to Follow-up|3|||
27611778|NCT01848834|80419160|FG003|Overall Study|Lost to Follow-up|0|||
27611779|NCT01848834|80419161|FG004|Overall Study|Lost to Follow-up|3|||
27611780|NCT01848834|80419157|FG000|Overall Study|Physician Decision|1|||
27611781|NCT01848834|80419158|FG001|Overall Study|Physician Decision|3|||
27611782|NCT01848834|80419159|FG002|Overall Study|Physician Decision|4|||
27611783|NCT01848834|80419160|FG003|Overall Study|Physician Decision|0|||
27611784|NCT01848834|80419161|FG004|Overall Study|Physician Decision|11|||
27611785|NCT01848834|80419157|FG000|Overall Study|Protocol Violation|0|||
27611786|NCT01848834|80419158|FG001|Overall Study|Protocol Violation|0|||
27611787|NCT01848834|80419159|FG002|Overall Study|Protocol Violation|0|||
27611788|NCT01848834|80419160|FG003|Overall Study|Protocol Violation|0|||
27611789|NCT01848834|80419161|FG004|Overall Study|Protocol Violation|1|||
27611790|NCT01848834|80419157|FG000|Overall Study|Sponsor Decision|1|||
27611791|NCT01848834|80419158|FG001|Overall Study|Sponsor Decision|1|||
27611792|NCT01848834|80419159|FG002|Overall Study|Sponsor Decision|0|||
27611793|NCT01848834|80419160|FG003|Overall Study|Sponsor Decision|1|||
27611794|NCT01848834|80419161|FG004|Overall Study|Sponsor Decision|1|||
27611795|NCT01848834|80419157|FG000|Overall Study|Withdrawal by Subject|2|||
27611796|NCT01848834|80419158|FG001|Overall Study|Withdrawal by Subject|13|||
27611797|NCT01848834|80419159|FG002|Overall Study|Withdrawal by Subject|10|||
27611798|NCT01848834|80419160|FG003|Overall Study|Withdrawal by Subject|6|||
27611799|NCT01848834|80419161|FG004|Overall Study|Withdrawal by Subject|36|||
27841204|NCT03310619|81248240|FG002|Pre-Treatment Period|Death|0|||
27841205|NCT03310619|81248241|FG003|Pre-Treatment Period|Death|0|||
27841206|NCT03310619|81248242|FG004|Pre-Treatment Period|Death|1|||
27611800|NCT02133924|80419163|FG000|Overall Study|Death|38|||
27611801|NCT02133924|80419163|FG000|Overall Study|Physician Decision|1|||
27611802|NCT02133924|80419163|FG000|Overall Study|Withdrawal by Subject|3|||
27611803|NCT03857841|80419169|FG000|Overall Study|Death|1|||
27611804|NCT03857841|80419170|FG001|Overall Study|Death|0|||
27611805|NCT03857841|80419171|FG002|Overall Study|Death|0|||
27611806|NCT03857841|80419172|FG003|Overall Study|Death|0|||
27611807|NCT03857841|80419169|FG000|Overall Study|Study Terminated by Sponsor|1|||
27611808|NCT03857841|80419170|FG001|Overall Study|Study Terminated by Sponsor|0|||
27611809|NCT03857841|80419171|FG002|Overall Study|Study Terminated by Sponsor|0|||
27611810|NCT03857841|80419172|FG003|Overall Study|Study Terminated by Sponsor|0|||
27611811|NCT02318719|80419173|FG000|Double-blind Phase|Adverse Event|7|||
27611812|NCT02318719|80419174|FG001|Double-blind Phase|Adverse Event|6|||
27841207|NCT03310619|81248243|FG005|Pre-Treatment Period|Death|0|||
27841208|NCT03310619|81248244|FG006|Pre-Treatment Period|Death|0|||
27841209|NCT03310619|81248245|FG007|Pre-Treatment Period|Death|0|||
27611813|NCT02318719|80419175|FG002|Double-blind Phase|Adverse Event|12|||
27611814|NCT02318719|80419176|FG003|Double-blind Phase|Adverse Event|4|||
27611815|NCT02318719|80419177|FG004|Double-blind Phase|Adverse Event|0|||
27611816|NCT02318719|80419173|FG000|Double-blind Phase|Lack of Efficacy|5|||
27611817|NCT02318719|80419174|FG001|Double-blind Phase|Lack of Efficacy|0|||
27611818|NCT02318719|80419175|FG002|Double-blind Phase|Lack of Efficacy|1|||
27611819|NCT02318719|80419176|FG003|Double-blind Phase|Lack of Efficacy|1|||
27611820|NCT02318719|80419177|FG004|Double-blind Phase|Lack of Efficacy|0|||
27611821|NCT02318719|80419173|FG000|Double-blind Phase|Protocol Violation|0|||
27611822|NCT02318719|80419174|FG001|Double-blind Phase|Protocol Violation|1|||
27611823|NCT02318719|80419175|FG002|Double-blind Phase|Protocol Violation|3|||
27611824|NCT02318719|80419176|FG003|Double-blind Phase|Protocol Violation|0|||
27611825|NCT02318719|80419177|FG004|Double-blind Phase|Protocol Violation|0|||
27611826|NCT02318719|80419173|FG000|Double-blind Phase|Withdrawal by Subject|25|||
27611827|NCT02318719|80419174|FG001|Double-blind Phase|Withdrawal by Subject|7|||
27503130|NCT04439539|80034992|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
27503131|NCT04439539|80034993|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
27611828|NCT02318719|80419175|FG002|Double-blind Phase|Withdrawal by Subject|9|||
27611829|NCT02318719|80419176|FG003|Double-blind Phase|Withdrawal by Subject|10|||
27611830|NCT02318719|80419177|FG004|Double-blind Phase|Withdrawal by Subject|0|||
27611831|NCT02318719|80419173|FG000|Double-blind Phase|Other|1|||
27503132|NCT01761877|80034994|FG000|Overall Study|Adverse Event|7|||
27503133|NCT01761877|80034995|FG001|Overall Study|Adverse Event|0|||
27503134|NCT01761877|80034994|FG000|Overall Study|Withdrawal by Subject|6|||
27503135|NCT01761877|80034995|FG001|Overall Study|Withdrawal by Subject|4|||
27503136|NCT01761877|80034994|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
27503137|NCT01761877|80034995|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
27503138|NCT01761877|80034994|FG000|Overall Study|Death|0|||
27503139|NCT01761877|80034995|FG001|Overall Study|Death|1|||
27503140|NCT01761877|80034994|FG000|Overall Study|MRI intolerant|1|||
27503141|NCT01761877|80034995|FG001|Overall Study|MRI intolerant|6|||
27503142|NCT01709721|80034997|FG000|Open Label Phase|Withdrawal by Subject|0|||
27503143|NCT01709721|80034998|FG001|Open Label Phase|Withdrawal by Subject|0|||
27503144|NCT01709721|80034999|FG002|Open Label Phase|Withdrawal by Subject|5|||
27503145|NCT01709721|80034997|FG000|Open Label Phase|Adverse Event|0|||
27503146|NCT01709721|80034998|FG001|Open Label Phase|Adverse Event|0|||
27503147|NCT01709721|80034999|FG002|Open Label Phase|Adverse Event|8|||
27503148|NCT01709721|80034997|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
27503149|NCT01709721|80034998|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
27503150|NCT01709721|80034999|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
27503151|NCT01709721|80034997|FG000|Open Label Phase|Investigator Decision|0|||
27503152|NCT01709721|80034998|FG001|Open Label Phase|Investigator Decision|0|||
27503153|NCT01709721|80034999|FG002|Open Label Phase|Investigator Decision|1|||
27503154|NCT01709721|80034997|FG000|Open Label Phase|Sponsor Decision|0|||
27503155|NCT01709721|80034998|FG001|Open Label Phase|Sponsor Decision|0|||
27503156|NCT01709721|80034999|FG002|Open Label Phase|Sponsor Decision|2|||
27503157|NCT01709721|80034997|FG000|Open Label Phase|Protocol Violation|0|||
27503158|NCT01709721|80034998|FG001|Open Label Phase|Protocol Violation|0|||
27503159|NCT01709721|80034999|FG002|Open Label Phase|Protocol Violation|1|||
27503160|NCT01709721|80034997|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
27503161|NCT01709721|80034998|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
27503162|NCT01709721|80034999|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
27503163|NCT01709721|80034997|FG000|Open Label Phase|Inadequate Pain Control|0|||
27503164|NCT01709721|80034998|FG001|Open Label Phase|Inadequate Pain Control|0|||
27503165|NCT01709721|80034999|FG002|Open Label Phase|Inadequate Pain Control|37|||
27503166|NCT01709721|80034997|FG000|Open Label Phase|Other, Specify in text field in database|0|||
27503167|NCT01709721|80034998|FG001|Open Label Phase|Other, Specify in text field in database|0|||
27503168|NCT01709721|80034999|FG002|Open Label Phase|Other, Specify in text field in database|14|||
27503169|NCT01709721|80034997|FG000|Randomized Phase|Adverse Event|0|||
27611832|NCT02318719|80419174|FG001|Double-blind Phase|Other|2|||
27611833|NCT02318719|80419175|FG002|Double-blind Phase|Other|0|||
27611834|NCT02318719|80419176|FG003|Double-blind Phase|Other|0|||
27611835|NCT02318719|80419177|FG004|Double-blind Phase|Other|0|||
27611836|NCT02318719|80419173|FG000|Open-label Extension Phase|Adverse Event|0|||
27611837|NCT02318719|80419174|FG001|Open-label Extension Phase|Adverse Event|0|||
27503170|NCT01709721|80034998|FG001|Randomized Phase|Adverse Event|1|||
27503171|NCT01709721|80034999|FG002|Randomized Phase|Adverse Event|0|||
27503172|NCT01709721|80034997|FG000|Randomized Phase|Lost to Follow-up|1|||
27503173|NCT01709721|80034998|FG001|Randomized Phase|Lost to Follow-up|0|||
27503174|NCT01709721|80034999|FG002|Randomized Phase|Lost to Follow-up|0|||
27503175|NCT01709721|80034997|FG000|Randomized Phase|Inadequate Pain Control|1|||
27611838|NCT02318719|80419175|FG002|Open-label Extension Phase|Adverse Event|0|||
27611839|NCT02318719|80419176|FG003|Open-label Extension Phase|Adverse Event|0|||
27611840|NCT02318719|80419177|FG004|Open-label Extension Phase|Adverse Event|15|||
27611841|NCT02318719|80419173|FG000|Open-label Extension Phase|Death|0|||
27723373|NCT01239160|80819496|FG001|Overall Study|Early Termination Due to Study Closure|1|||
27723374|NCT01239160|80819497|FG002|Overall Study|Early Termination Due to Study Closure|6|||
27723375|NCT03056573|80819498|FG000|Overall Study|Death|2|||
27723376|NCT03056573|80819499|FG001|Overall Study|Death|4|||
27723377|NCT03056573|80819498|FG000|Overall Study|Withdrawal by Subject|2|||
27723378|NCT03056573|80819499|FG001|Overall Study|Withdrawal by Subject|0|||
27723379|NCT03056573|80819498|FG000|Overall Study|Lost to Follow-up|1|||
27723380|NCT03056573|80819499|FG001|Overall Study|Lost to Follow-up|1|||
27892178|NCT01943851|81441173|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892179|NCT01943851|81441174|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892180|NCT01943851|81441175|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27503176|NCT01709721|80034998|FG001|Randomized Phase|Inadequate Pain Control|2|||
27723381|NCT00090545|80819500|FG000|Overall Study|Disease progression on study|21|||
27841210|NCT03310619|81248238|FG000|Pre-Treatment Period|Other reasons|2|||
27841211|NCT03310619|81248239|FG001|Pre-Treatment Period|Other reasons|1|||
27841212|NCT03310619|81248240|FG002|Pre-Treatment Period|Other reasons|2|||
27841213|NCT03310619|81248241|FG003|Pre-Treatment Period|Other reasons|0|||
27841214|NCT03310619|81248242|FG004|Pre-Treatment Period|Other reasons|0|||
27841215|NCT03310619|81248243|FG005|Pre-Treatment Period|Other reasons|0|||
27841216|NCT03310619|81248244|FG006|Pre-Treatment Period|Other reasons|2|||
27841217|NCT03310619|81248245|FG007|Pre-Treatment Period|Other reasons|0|||
27841218|NCT03310619|81248238|FG000|Treatment Period|Death|1|||
27841219|NCT03310619|81248239|FG001|Treatment Period|Death|2|||
27841220|NCT03310619|81248240|FG002|Treatment Period|Death|0|||
27841221|NCT03310619|81248241|FG003|Treatment Period|Death|0|||
27841222|NCT03310619|81248242|FG004|Treatment Period|Death|1|||
27841223|NCT03310619|81248243|FG005|Treatment Period|Death|0|||
27841224|NCT03310619|81248244|FG006|Treatment Period|Death|2|||
27841225|NCT03310619|81248245|FG007|Treatment Period|Death|0|||
27841226|NCT03310619|81248238|FG000|Treatment Period|Adverse Event|0|||
27841227|NCT03310619|81248239|FG001|Treatment Period|Adverse Event|1|||
27841228|NCT03310619|81248240|FG002|Treatment Period|Adverse Event|4|||
27841229|NCT03310619|81248241|FG003|Treatment Period|Adverse Event|1|||
27841230|NCT03310619|81248242|FG004|Treatment Period|Adverse Event|0|||
27841231|NCT03310619|81248243|FG005|Treatment Period|Adverse Event|0|||
27841232|NCT03310619|81248244|FG006|Treatment Period|Adverse Event|0|||
27841233|NCT03310619|81248245|FG007|Treatment Period|Adverse Event|0|||
27841234|NCT03310619|81248238|FG000|Treatment Period|Withdrawal by participant|0|||
27841235|NCT03310619|81248239|FG001|Treatment Period|Withdrawal by participant|0|||
27841236|NCT03310619|81248240|FG002|Treatment Period|Withdrawal by participant|1|||
27841237|NCT03310619|81248241|FG003|Treatment Period|Withdrawal by participant|0|||
27841238|NCT03310619|81248242|FG004|Treatment Period|Withdrawal by participant|0|||
27841239|NCT03310619|81248243|FG005|Treatment Period|Withdrawal by participant|0|||
27841240|NCT03310619|81248244|FG006|Treatment Period|Withdrawal by participant|0|||
27503177|NCT01709721|80034999|FG002|Randomized Phase|Inadequate Pain Control|0|||
27503178|NCT01709721|80034997|FG000|Randomized Phase|Other, Specify text field in database|1|||
27503179|NCT01709721|80034998|FG001|Randomized Phase|Other, Specify text field in database|3|||
27503180|NCT01709721|80034999|FG002|Randomized Phase|Other, Specify text field in database|0|||
27841241|NCT03310619|81248245|FG007|Treatment Period|Withdrawal by participant|0|||
27841242|NCT03310619|81248238|FG000|Treatment Period|Lost to Follow-up|0|||
27841243|NCT03310619|81248239|FG001|Treatment Period|Lost to Follow-up|0|||
27841244|NCT03310619|81248240|FG002|Treatment Period|Lost to Follow-up|0|||
27841245|NCT03310619|81248241|FG003|Treatment Period|Lost to Follow-up|0|||
27841246|NCT03310619|81248242|FG004|Treatment Period|Lost to Follow-up|0|||
27841247|NCT03310619|81248243|FG005|Treatment Period|Lost to Follow-up|0|||
27841248|NCT03310619|81248244|FG006|Treatment Period|Lost to Follow-up|0|||
27841249|NCT03310619|81248245|FG007|Treatment Period|Lost to Follow-up|1|||
27841250|NCT03310619|81248238|FG000|Treatment Period|Study terminated by sponsor|0|||
27841251|NCT03310619|81248239|FG001|Treatment Period|Study terminated by sponsor|0|||
27841252|NCT03310619|81248240|FG002|Treatment Period|Study terminated by sponsor|0|||
27841253|NCT03310619|81248241|FG003|Treatment Period|Study terminated by sponsor|0|||
27841254|NCT03310619|81248242|FG004|Treatment Period|Study terminated by sponsor|0|||
27841255|NCT03310619|81248243|FG005|Treatment Period|Study terminated by sponsor|0|||
27841256|NCT03310619|81248244|FG006|Treatment Period|Study terminated by sponsor|0|||
27841257|NCT03310619|81248245|FG007|Treatment Period|Study terminated by sponsor|1|||
27841258|NCT03310619|81248238|FG000|Treatment Period|Physician Decision|0|||
27841259|NCT03310619|81248239|FG001|Treatment Period|Physician Decision|0|||
27841260|NCT03310619|81248240|FG002|Treatment Period|Physician Decision|0|||
27841261|NCT03310619|81248241|FG003|Treatment Period|Physician Decision|0|||
27841262|NCT03310619|81248242|FG004|Treatment Period|Physician Decision|3|||
27841263|NCT03310619|81248243|FG005|Treatment Period|Physician Decision|0|||
27892181|NCT01943851|81441176|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27503181|NCT04576988|80035003|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
27723382|NCT00090545|80819501|FG001|Overall Study|Disease progression on study|17|||
27723383|NCT00090545|80819500|FG000|Overall Study|Refused further treatment|1|||
27611842|NCT02318719|80419174|FG001|Open-label Extension Phase|Death|0|||
27611843|NCT02318719|80419175|FG002|Open-label Extension Phase|Death|0|||
27611844|NCT02318719|80419176|FG003|Open-label Extension Phase|Death|0|||
27611845|NCT02318719|80419177|FG004|Open-label Extension Phase|Death|1|||
27611846|NCT02318719|80419173|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
27611847|NCT02318719|80419174|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
27611848|NCT02318719|80419175|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
27611849|NCT02318719|80419176|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
27611850|NCT02318719|80419177|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
27611851|NCT02318719|80419173|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
27611852|NCT02318719|80419174|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
27611853|NCT02318719|80419175|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
27611854|NCT02318719|80419176|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
27611855|NCT02318719|80419177|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
27611856|NCT02318719|80419173|FG000|Open-label Extension Phase|Other|0|||
27611857|NCT02318719|80419174|FG001|Open-label Extension Phase|Other|0|||
27503182|NCT04576988|80035004|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
27503183|NCT04576988|80035003|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
27503184|NCT04576988|80035004|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
27503185|NCT04576988|80035003|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
27503186|NCT04576988|80035004|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
27503187|NCT04576988|80035003|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
27503188|NCT04576988|80035004|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
27503189|NCT04576988|80035003|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
27503190|NCT04576988|80035004|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
27503191|NCT04576988|80035003|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
27503192|NCT04576988|80035004|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
27503193|NCT04576988|80035003|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
27503194|NCT04576988|80035004|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
27503195|NCT04576988|80035003|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
27611858|NCT02318719|80419175|FG002|Open-label Extension Phase|Other|0|||
27611859|NCT02318719|80419176|FG003|Open-label Extension Phase|Other|0|||
27611860|NCT02318719|80419177|FG004|Open-label Extension Phase|Other|7|||
27611861|NCT01794117|80419178|FG000|Overall Study|Adverse Event|1|||
27611862|NCT01794117|80419179|FG001|Overall Study|Adverse Event|0|||
27611863|NCT01794117|80419180|FG002|Overall Study|Adverse Event|0|||
27611864|NCT01794117|80419181|FG003|Overall Study|Adverse Event|0|||
27611865|NCT01794117|80419178|FG000|Overall Study|Participant noncompliance|0|||
27611866|NCT01794117|80419179|FG001|Overall Study|Participant noncompliance|1|||
27611867|NCT01794117|80419180|FG002|Overall Study|Participant noncompliance|0|||
27611868|NCT01794117|80419181|FG003|Overall Study|Participant noncompliance|0|||
27611869|NCT01794117|80419178|FG000|Overall Study|Refused further treatment|0|||
27611870|NCT01794117|80419179|FG001|Overall Study|Refused further treatment|2|||
27611871|NCT01794117|80419180|FG002|Overall Study|Refused further treatment|0|||
27611872|NCT01794117|80419181|FG003|Overall Study|Refused further treatment|0|||
27611873|NCT00744237|80419182|FG000|Overall Study|Lack of Efficacy|1|||
27611874|NCT00744237|80419183|FG001|Overall Study|Lack of Efficacy|1|||
27611875|NCT00744237|80419184|FG002|Overall Study|Lack of Efficacy|0|||
27611876|NCT00744237|80419182|FG000|Overall Study|Withdrawal by Subject|9|||
27611877|NCT00744237|80419183|FG001|Overall Study|Withdrawal by Subject|5|||
27611878|NCT00744237|80419184|FG002|Overall Study|Withdrawal by Subject|3|||
27611879|NCT00744237|80419182|FG000|Overall Study|Lost to Follow-up|1|||
27611880|NCT00744237|80419183|FG001|Overall Study|Lost to Follow-up|1|||
27611881|NCT00744237|80419184|FG002|Overall Study|Lost to Follow-up|1|||
27611882|NCT00744237|80419182|FG000|Overall Study|Protocol Violation|3|||
27611883|NCT00744237|80419183|FG001|Overall Study|Protocol Violation|4|||
27611884|NCT00744237|80419184|FG002|Overall Study|Protocol Violation|3|||
27611885|NCT00744237|80419182|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
27611886|NCT00744237|80419183|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
27611887|NCT00744237|80419184|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
27611888|NCT00744237|80419182|FG000|Overall Study|Dosing Error|1|||
27611889|NCT00744237|80419183|FG001|Overall Study|Dosing Error|0|||
27611890|NCT00744237|80419184|FG002|Overall Study|Dosing Error|1|||
27611891|NCT00744237|80419182|FG000|Overall Study|Study Drug Error|1|||
27611892|NCT00744237|80419183|FG001|Overall Study|Study Drug Error|0|||
27611893|NCT00744237|80419184|FG002|Overall Study|Study Drug Error|0|||
27611894|NCT00744237|80419182|FG000|Overall Study|Prohibited Concomitant Medication|0|||
27611895|NCT00744237|80419183|FG001|Overall Study|Prohibited Concomitant Medication|0|||
27611896|NCT00744237|80419184|FG002|Overall Study|Prohibited Concomitant Medication|1|||
27611897|NCT00744237|80419182|FG000|Overall Study|Poor Compliance|0|||
27503196|NCT04576988|80035004|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
27503197|NCT04576988|80035003|FG000|Long Term Double Blind (LTDB)|Death|2|||
27611898|NCT00744237|80419183|FG001|Overall Study|Poor Compliance|2|||
27611899|NCT00744237|80419184|FG002|Overall Study|Poor Compliance|0|||
27611900|NCT00744237|80419182|FG000|Overall Study|Administrative. Site Closed|1|||
27611901|NCT00744237|80419183|FG001|Overall Study|Administrative. Site Closed|1|||
27611902|NCT00744237|80419184|FG002|Overall Study|Administrative. Site Closed|1|||
27611903|NCT00744237|80419182|FG000|Overall Study|Adverse Event|9|||
27611904|NCT00744237|80419183|FG001|Overall Study|Adverse Event|13|||
27611905|NCT00744237|80419184|FG002|Overall Study|Adverse Event|5|||
27611906|NCT02009696|80419185|FG000|Overall Study|Withdrawal by Subject|2|||
27611907|NCT02757521|80419188|FG000|Overall Study|Adverse Event|1|||
27611908|NCT02757521|80419189|FG001|Overall Study|Adverse Event|0|||
27611909|NCT01539863|80419190|FG000|Overall Study|Lost to Follow-up|5|||
27611910|NCT01539863|80419191|FG001|Overall Study|Lost to Follow-up|4|||
27611911|NCT01107743|80419192|FG000|Overall Study|Protocol Violation|46|||
27611912|NCT01563978|80419193|FG000|Overall Study|Physician Decision|1|||
27611913|NCT01563978|80419194|FG001|Overall Study|Physician Decision|0|||
27611914|NCT01563978|80419193|FG000|Overall Study|Lost to Follow-up|1|||
27611915|NCT01563978|80419194|FG001|Overall Study|Lost to Follow-up|0|||
27611916|NCT01563978|80419193|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
27611917|NCT01563978|80419194|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
27611918|NCT01563978|80419193|FG000|Overall Study|Adverse Event|1|||
27611919|NCT01563978|80419194|FG001|Overall Study|Adverse Event|2|||
27611920|NCT01320735|80419195|FG000|Overall Study|Adverse Event|3|||
27611921|NCT01320735|80419195|FG000|Overall Study|Withdrawal by Subject|3|||
27611922|NCT01320735|80419195|FG000|Overall Study|Lost to Follow-up|13|||
27611923|NCT01320735|80419195|FG000|Overall Study|Administrative Reason|6|||
27611924|NCT01320735|80419195|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
27611925|NCT01320735|80419195|FG000|Overall Study|Protocol Violation|1|||
27611926|NCT01320735|80419195|FG000|Overall Study|Other|1|||
27611927|NCT01320735|80419195|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
27611928|NCT01320735|80419195|FG000|Overall Study|Investigator Unable to be Contacted|17|||
27611929|NCT02366936|80419199|FG000|Overall Study|Withdrawal by Subject|2|||
27611930|NCT02366936|80419199|FG000|Overall Study|Lost to Follow-up|4|||
27611931|NCT02366936|80419199|FG000|Overall Study|Physician Decision|2|||
27611932|NCT02638623|80419208|FG000|Overall Study|Surgery timing|5|||
27611933|NCT02638623|80419209|FG001|Overall Study|Surgery timing|6|||
27611934|NCT02638623|80419208|FG000|Overall Study|Not given intervention|2|||
27611935|NCT02638623|80419209|FG001|Overall Study|Not given intervention|0|||
27611936|NCT01590771|80419211|FG000|Overall Study|Other Protocol Specified Criteria|5|||
27611937|NCT01590771|80419212|FG001|Overall Study|Other Protocol Specified Criteria|14|||
27611938|NCT01590771|80419211|FG000|Overall Study|Withdrawal by Subject|8|||
27611939|NCT01590771|80419212|FG001|Overall Study|Withdrawal by Subject|15|||
27611940|NCT01590771|80419211|FG000|Overall Study|Protocol Violation|1|||
27892182|NCT01943851|81441177|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27503198|NCT04576988|80035004|FG001|Long Term Double Blind (LTDB)|Death|1|||
27503199|NCT04576988|80035003|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
27503200|NCT04576988|80035004|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
27503201|NCT01056822|80035008|FG000|Overall Study|Adverse Event|0|||
27503202|NCT01056822|80035009|FG001|Overall Study|Adverse Event|1|||
27503203|NCT01056822|80035008|FG000|Overall Study|Protocol Violation|6|||
27503204|NCT01056822|80035009|FG001|Overall Study|Protocol Violation|5|||
27503205|NCT01056822|80035008|FG000|Overall Study|Withdrawal by Subject|1|||
27503206|NCT01056822|80035009|FG001|Overall Study|Withdrawal by Subject|1|||
27503207|NCT01056822|80035008|FG000|Overall Study|Lost to Follow-up|1|||
27503208|NCT01056822|80035009|FG001|Overall Study|Lost to Follow-up|0|||
27503209|NCT05530252|80035013|FG000|Overall Study|Lost to Follow-up|1|||
27503210|NCT05530252|80035014|FG001|Overall Study|Lost to Follow-up|1|||
27503211|NCT05530252|80035015|FG002|Overall Study|Lost to Follow-up|1|||
27503212|NCT00551642|80035016|FG000|Treatment Period|Protocol Deviation|6|||
27503213|NCT00551642|80035017|FG001|Treatment Period|Protocol Deviation|11|||
27503214|NCT00551642|80035016|FG000|Treatment Period|Delivery device failure|1|||
27503215|NCT00551642|80035017|FG001|Treatment Period|Delivery device failure|3|||
27503216|NCT00551642|80035016|FG000|Treatment Period|Physician Decision|0|||
27503217|NCT00551642|80035017|FG001|Treatment Period|Physician Decision|1|||
27503218|NCT00551642|80035016|FG000|Treatment Period|Death|33|||
27611941|NCT01590771|80419212|FG001|Overall Study|Protocol Violation|2|||
27611942|NCT01590771|80419211|FG000|Overall Study|Lost to Follow-up|1|||
27611943|NCT01590771|80419212|FG001|Overall Study|Lost to Follow-up|1|||
27611944|NCT01590771|80419211|FG000|Overall Study|Lack of Efficacy|1|||
27611945|NCT01590771|80419212|FG001|Overall Study|Lack of Efficacy|0|||
27611946|NCT01590771|80419211|FG000|Overall Study|Adverse Event|3|||
27611947|NCT01590771|80419212|FG001|Overall Study|Adverse Event|7|||
27611948|NCT03679767|80419213|FG000|Overall Study|Death|16|||
27611949|NCT03679767|80419214|FG001|Overall Study|Death|11|||
27611950|NCT03679767|80419215|FG002|Overall Study|Death|17|||
27611951|NCT03679767|80419216|FG003|Overall Study|Death|10|||
27503219|NCT00551642|80035017|FG001|Treatment Period|Death|31|||
27503220|NCT00551642|80035016|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
27503221|NCT00551642|80035017|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
27503222|NCT00551642|80035016|FG000|Treatment Period|Adverse Event|15|||
27611952|NCT03679767|80419213|FG000|Overall Study|Lost to Follow-up|1|||
27611953|NCT03679767|80419214|FG001|Overall Study|Lost to Follow-up|1|||
27611954|NCT03679767|80419215|FG002|Overall Study|Lost to Follow-up|1|||
27611955|NCT03679767|80419216|FG003|Overall Study|Lost to Follow-up|1|||
27611956|NCT03679767|80419213|FG000|Overall Study|Withdrawal by Subject|0|||
27611957|NCT03679767|80419214|FG001|Overall Study|Withdrawal by Subject|0|||
27611958|NCT03679767|80419215|FG002|Overall Study|Withdrawal by Subject|0|||
27611959|NCT03679767|80419216|FG003|Overall Study|Withdrawal by Subject|1|||
27611960|NCT03679767|80419213|FG000|Overall Study|Follow-up Completed|18|||
27611961|NCT03679767|80419214|FG001|Overall Study|Follow-up Completed|11|||
27611962|NCT03679767|80419215|FG002|Overall Study|Follow-up Completed|11|||
27503223|NCT00551642|80035017|FG001|Treatment Period|Adverse Event|12|||
27503224|NCT00551642|80035016|FG000|Treatment Period|Withdrawal by Subject|2|||
27503225|NCT00551642|80035017|FG001|Treatment Period|Withdrawal by Subject|1|||
27503226|NCT04106557|80035019|FG000|Overall Study|Physician Decision|0|||
27503227|NCT04106557|80035020|FG001|Overall Study|Physician Decision|1|||
27503228|NCT04106557|80035021|FG002|Overall Study|Physician Decision|0|||
27503229|NCT04106557|80035019|FG000|Overall Study|Protocol Violation|0|||
27503230|NCT04106557|80035020|FG001|Overall Study|Protocol Violation|1|||
27503231|NCT04106557|80035021|FG002|Overall Study|Protocol Violation|0|||
27503232|NCT04966013|80035029|FG000|Overall Study|Withdrawal by Subject|0|||
27503233|NCT04966013|80035030|FG001|Overall Study|Withdrawal by Subject|2|||
27503234|NCT04966013|80035031|FG002|Overall Study|Withdrawal by Subject|1|||
27503235|NCT04966013|80035029|FG000|Overall Study|Adverse Event|2|||
27503236|NCT04966013|80035030|FG001|Overall Study|Adverse Event|1|||
27503237|NCT04966013|80035031|FG002|Overall Study|Adverse Event|1|||
27503238|NCT02420717|80035034|FG000|Overall Study|Did not receive all study medication|2|||
27503239|NCT02420717|80035035|FG001|Overall Study|Did not receive all study medication|0|||
27503240|NCT02420717|80035036|FG002|Overall Study|Did not receive all study medication|0|||
27503241|NCT02484391|80035037|FG000|Overall Study|Lack of Efficacy|15|||
27503242|NCT02484391|80035038|FG001|Overall Study|Lack of Efficacy|14|||
27503243|NCT02484391|80035039|FG002|Overall Study|Lack of Efficacy|3|||
27611963|NCT03679767|80419216|FG003|Overall Study|Follow-up Completed|20|||
27611964|NCT03679767|80419213|FG000|Overall Study|Entered Hospice Care|0|||
27611965|NCT03679767|80419214|FG001|Overall Study|Entered Hospice Care|0|||
27611966|NCT03679767|80419215|FG002|Overall Study|Entered Hospice Care|0|||
27611967|NCT03679767|80419216|FG003|Overall Study|Entered Hospice Care|1|||
27611968|NCT03679767|80419213|FG000|Overall Study|Progressive Disease|0|||
27611969|NCT03679767|80419214|FG001|Overall Study|Progressive Disease|0|||
27611970|NCT03679767|80419215|FG002|Overall Study|Progressive Disease|0|||
27611971|NCT03679767|80419216|FG003|Overall Study|Progressive Disease|1|||
27611972|NCT04182880|80419221|FG000|Overall Study|Pregnancy|1|||
27611973|NCT04182880|80419222|FG001|Overall Study|Pregnancy|0|||
27611974|NCT00318149|80419223|FG000|Overall Study|Adverse Event|0|||
27611975|NCT00318149|80419224|FG001|Overall Study|Adverse Event|0|||
27611976|NCT00318149|80419225|FG002|Overall Study|Adverse Event|0|||
27611977|NCT00318149|80419226|FG003|Overall Study|Adverse Event|0|||
27611978|NCT00318149|80419227|FG004|Overall Study|Adverse Event|0|||
27611979|NCT00318149|80419228|FG005|Overall Study|Adverse Event|2|||
27611980|NCT01155661|80419229|FG000|Overall Study|Adverse Event|101|||
27611981|NCT01155661|80419229|FG000|Overall Study|Death|1|||
27611982|NCT01155661|80419229|FG000|Overall Study|Lack of Efficacy|32|||
27611983|NCT01155661|80419229|FG000|Overall Study|Lost to Follow-up|22|||
27611984|NCT01155661|80419229|FG000|Overall Study|Physician Decision|3|||
27841264|NCT03310619|81248244|FG006|Treatment Period|Physician Decision|0|||
27841265|NCT03310619|81248245|FG007|Treatment Period|Physician Decision|0|||
27841266|NCT03310619|81248238|FG000|Treatment Period|Other reasons|1|||
27841267|NCT03310619|81248239|FG001|Treatment Period|Other reasons|0|||
27841268|NCT03310619|81248240|FG002|Treatment Period|Other reasons|2|||
27841269|NCT03310619|81248241|FG003|Treatment Period|Other reasons|0|||
27841270|NCT03310619|81248242|FG004|Treatment Period|Other reasons|0|||
27841271|NCT03310619|81248243|FG005|Treatment Period|Other reasons|0|||
27892183|NCT01943851|81441178|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27611985|NCT01155661|80419229|FG000|Overall Study|Protocol Violation|35|||
27611986|NCT01155661|80419229|FG000|Overall Study|Withdrawal by Subject|73|||
27611987|NCT01155661|80419229|FG000|Overall Study|Sponsor Decision|13|||
27611988|NCT00592319|80419232|FG000|Overall Study|Lost to Follow-up|0|||
27841272|NCT03310619|81248244|FG006|Treatment Period|Other reasons|0|||
27611989|NCT00592319|80419233|FG001|Overall Study|Lost to Follow-up|3|||
27611990|NCT01348776|80419234|FG000|Overall Study|Lost to Follow-up|3|||
27841273|NCT03310619|81248245|FG007|Treatment Period|Other reasons|0|||
27503244|NCT02484391|80035037|FG000|Overall Study|Lost to Follow-up|0|||
27503245|NCT02484391|80035038|FG001|Overall Study|Lost to Follow-up|0|||
27503246|NCT02484391|80035039|FG002|Overall Study|Lost to Follow-up|2|||
27503247|NCT02484391|80035037|FG000|Overall Study|Physician Decision|1|||
27503248|NCT02484391|80035038|FG001|Overall Study|Physician Decision|3|||
27503249|NCT02484391|80035039|FG002|Overall Study|Physician Decision|0|||
27503250|NCT02484391|80035037|FG000|Overall Study|Went to Transplant|5|||
27503251|NCT02484391|80035038|FG001|Overall Study|Went to Transplant|3|||
27892184|NCT01943851|81441179|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892185|NCT01943851|81441180|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27503252|NCT02484391|80035039|FG002|Overall Study|Went to Transplant|2|||
27503253|NCT02388269|80035040|FG000|Overall Study|Adverse Event|2|||
27611991|NCT01254890|80419251|FG000|Overall Study|Ineligible|0|||
27611992|NCT01254890|80419252|FG001|Overall Study|Ineligible|3|||
27611993|NCT01254890|80419251|FG000|Overall Study|Withdrawal by Subject|1|||
27611994|NCT01254890|80419252|FG001|Overall Study|Withdrawal by Subject|2|||
27611995|NCT01254890|80419251|FG000|Overall Study|Disease Progression|0|||
27611996|NCT01254890|80419252|FG001|Overall Study|Disease Progression|5|||
27611997|NCT00553202|80419255|FG000|Overall Study|Death|16|||
27611998|NCT00553202|80419255|FG000|Overall Study|Lost to Follow-up|1|||
27611999|NCT00553202|80419255|FG000|Overall Study|Physician Decision|28|||
27612000|NCT00553202|80419255|FG000|Overall Study|Withdrawal by Subject|1|||
27612001|NCT00553202|80419255|FG000|Overall Study|No donor identified|16|||
27612002|NCT00553202|80419255|FG000|Overall Study|Fails to meet organ function|6|||
27612003|NCT00210119|80419256|FG000|Overall Study|Protocol Violation|1|||
27612004|NCT00210119|80419256|FG000|Overall Study|Withdrawal by Subject|1|||
27612005|NCT02611830|80419257|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
27503254|NCT02388269|80035041|FG001|Overall Study|Adverse Event|0|||
27503255|NCT02388269|80035042|FG002|Overall Study|Adverse Event|0|||
27503256|NCT02388269|80035040|FG000|Overall Study|Withdrawal by Subject|1|||
27503257|NCT02388269|80035041|FG001|Overall Study|Withdrawal by Subject|2|||
27503258|NCT02388269|80035042|FG002|Overall Study|Withdrawal by Subject|0|||
27503259|NCT02388269|80035040|FG000|Overall Study|less than 50% stimulations|1|||
27503260|NCT02388269|80035041|FG001|Overall Study|less than 50% stimulations|0|||
27503261|NCT02388269|80035042|FG002|Overall Study|less than 50% stimulations|0|||
27503262|NCT02388269|80035040|FG000|Overall Study|no diary data|3|||
27503263|NCT02388269|80035041|FG001|Overall Study|no diary data|0|||
27503264|NCT02388269|80035042|FG002|Overall Study|no diary data|0|||
27503265|NCT02388269|80035040|FG000|Overall Study|Protocol Violation|2|||
27503266|NCT02388269|80035041|FG001|Overall Study|Protocol Violation|0|||
27503267|NCT02388269|80035042|FG002|Overall Study|Protocol Violation|0|||
27503268|NCT02388269|80035040|FG000|Overall Study|Screen Failure|0|||
27503269|NCT02388269|80035041|FG001|Overall Study|Screen Failure|0|||
27503270|NCT02388269|80035042|FG002|Overall Study|Screen Failure|10|||
27503271|NCT01600326|80035043|FG000|Overall Study|Lost to Follow-up|1|||
27503272|NCT01600326|80035044|FG001|Overall Study|Lost to Follow-up|1|||
27503273|NCT02230410|80035047|FG000|Overall Study|Screen Failure|3|||
27503274|NCT01285323|80035048|FG000|Overall Study|Adverse Event|9|||
27503275|NCT01285323|80035049|FG001|Overall Study|Adverse Event|8|||
27503276|NCT01285323|80035048|FG000|Overall Study|Lack of Efficacy|4|||
27503277|NCT01285323|80035049|FG001|Overall Study|Lack of Efficacy|2|||
27503278|NCT01285323|80035048|FG000|Overall Study|Withdrawal by Subject|15|||
27503279|NCT01285323|80035049|FG001|Overall Study|Withdrawal by Subject|11|||
27503280|NCT01285323|80035048|FG000|Overall Study|Protocol Violation|1|||
27503281|NCT01285323|80035049|FG001|Overall Study|Protocol Violation|2|||
27503282|NCT01285323|80035048|FG000|Overall Study|Non-compliance with study procedures|2|||
27503283|NCT01285323|80035049|FG001|Overall Study|Non-compliance with study procedures|3|||
27503284|NCT01285323|80035048|FG000|Overall Study|Lost to Follow-up|1|||
27503285|NCT01285323|80035049|FG001|Overall Study|Lost to Follow-up|1|||
27503286|NCT01285323|80035048|FG000|Overall Study|Other|1|||
27503287|NCT01285323|80035049|FG001|Overall Study|Other|3|||
27503288|NCT04467905|80035057|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
27503289|NCT04467905|80035058|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
27503290|NCT04467905|80035059|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
27503291|NCT04467905|80035057|FG000|Overall Study|Conversion to SR|0|||
27503292|NCT04467905|80035058|FG001|Overall Study|Conversion to SR|0|||
27503293|NCT04467905|80035059|FG002|Overall Study|Conversion to SR|3|||
27503294|NCT04467905|80035057|FG000|Overall Study|Technical issue with Holter ECG|0|||
27503295|NCT04467905|80035058|FG001|Overall Study|Technical issue with Holter ECG|0|||
27723384|NCT00090545|80819501|FG001|Overall Study|Refused further treatment|4|||
27723385|NCT00090545|80819500|FG000|Overall Study|Death|0|||
27503296|NCT04467905|80035059|FG002|Overall Study|Technical issue with Holter ECG|3|||
27503297|NCT04467905|80035057|FG000|Overall Study|Hemodynamic instability|0|||
27612006|NCT02611830|80419258|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
27612007|NCT02611830|80419259|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
27503298|NCT04467905|80035058|FG001|Overall Study|Hemodynamic instability|0|||
27503299|NCT04467905|80035059|FG002|Overall Study|Hemodynamic instability|1|||
27503300|NCT04467905|80035057|FG000|Overall Study|Site misinterpretation of protocol|0|||
27503301|NCT04467905|80035058|FG001|Overall Study|Site misinterpretation of protocol|0|||
27503302|NCT04467905|80035059|FG002|Overall Study|Site misinterpretation of protocol|1|||
27503303|NCT01210313|80035060|FG000|Overall Study|Withdrawal by Subject|3|||
27503304|NCT01210313|80035060|FG000|Overall Study|Adverse Event|2|||
27503305|NCT01210313|80035060|FG000|Overall Study|Distant recurrence|4|||
27503306|NCT01210313|80035060|FG000|Overall Study|Non-compliance|7|||
27503307|NCT04109547|80035061|FG000|Overall Study|Withdrawal by Subject|3|||
27612008|NCT02611830|80419260|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
27612009|NCT02611830|80419257|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
27612010|NCT02611830|80419258|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
27612011|NCT02611830|80419259|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
27612012|NCT02611830|80419260|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
27612013|NCT02611830|80419257|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
27612014|NCT02611830|80419258|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
27612015|NCT02611830|80419259|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
27612016|NCT02611830|80419260|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
27612017|NCT02611830|80419257|FG000|OL Induction Phase|Lack of Efficacy|9|||
27612018|NCT02611830|80419258|FG001|OL Induction Phase|Lack of Efficacy|0|||
27612019|NCT02611830|80419259|FG002|OL Induction Phase|Lack of Efficacy|0|||
27612020|NCT02611830|80419260|FG003|OL Induction Phase|Lack of Efficacy|0|||
27612021|NCT02611830|80419257|FG000|OL Induction Phase|Reason not specified|3|||
27612022|NCT02611830|80419258|FG001|OL Induction Phase|Reason not specified|0|||
27612023|NCT02611830|80419259|FG002|OL Induction Phase|Reason not specified|0|||
27503308|NCT04109547|80035062|FG001|Overall Study|Withdrawal by Subject|2|||
27503309|NCT04109547|80035063|FG002|Overall Study|Withdrawal by Subject|6|||
27503310|NCT04109547|80035064|FG003|Overall Study|Withdrawal by Subject|6|||
27503311|NCT04109547|80035061|FG000|Overall Study|Lost to Follow-up|0|||
27503312|NCT04109547|80035062|FG001|Overall Study|Lost to Follow-up|0|||
27503313|NCT04109547|80035063|FG002|Overall Study|Lost to Follow-up|0|||
27503314|NCT04109547|80035064|FG003|Overall Study|Lost to Follow-up|1|||
27503315|NCT04109547|80035061|FG000|Overall Study|Physician Decision|1|||
27503316|NCT04109547|80035062|FG001|Overall Study|Physician Decision|2|||
27503317|NCT04109547|80035063|FG002|Overall Study|Physician Decision|0|||
27503318|NCT04109547|80035064|FG003|Overall Study|Physician Decision|0|||
27503319|NCT03882021|80035065|FG000|Enrollment|Procedure aborted/cancelled|2|||
27503320|NCT03882021|80035065|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
27503321|NCT03882021|80035065|FG000|Enrollment to 3-Month|Death|1|||
27503322|NCT03882021|80035065|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
27503323|NCT03882021|80035065|FG000|Enrollment to 3-Month|Missed Visit|4|||
27503324|NCT03882021|80035065|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
27503325|NCT03882021|80035065|FG000|6-Month to 12-Month Visit|Death|1|||
27503326|NCT03882021|80035065|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
27503327|NCT02954536|80035069|FG000|Overall Study|Adverse Event|2|||
27503328|NCT02954536|80035069|FG000|Overall Study|Death|12|||
27503329|NCT00385671|80035070|FG000|Overall Study|Adverse Event|14|||
27503330|NCT00385671|80035071|FG001|Overall Study|Adverse Event|27|||
27503331|NCT00385671|80035072|FG002|Overall Study|Adverse Event|18|||
27503332|NCT00385671|80035070|FG000|Overall Study|Lack of Efficacy|5|||
27503333|NCT00385671|80035071|FG001|Overall Study|Lack of Efficacy|9|||
27503334|NCT00385671|80035072|FG002|Overall Study|Lack of Efficacy|5|||
27503335|NCT00385671|80035070|FG000|Overall Study|Lost to Follow-up|6|||
27503336|NCT00385671|80035071|FG001|Overall Study|Lost to Follow-up|6|||
27503337|NCT00385671|80035072|FG002|Overall Study|Lost to Follow-up|5|||
27612024|NCT02611830|80419260|FG003|OL Induction Phase|Reason not specified|0|||
27612025|NCT02611830|80419257|FG000|Maintenance Phase|Lack of Efficacy|0|||
27723386|NCT00090545|80819501|FG001|Overall Study|Death|1|||
27841274|NCT03847974|81248246|FG000|Overall Study|relocated out of region|3|||
27841275|NCT03847974|81248246|FG000|Overall Study|Withdrawal by Subject|2|||
27841276|NCT03847974|81248246|FG000|Overall Study|Adverse Event|1|||
27841277|NCT02460835|81248249|FG000|Overall Study|Disease progression prior to treatment|3|||
27841278|NCT02460835|81248249|FG000|Overall Study|Unable to complete planning scans|2|||
27841279|NCT02460835|81248249|FG000|Overall Study|Decrease in performance status|1|||
27841280|NCT02460835|81248249|FG000|Overall Study|Withdrawal by Subject|3|||
27841281|NCT02460835|81248249|FG000|Overall Study|Underwent fractionated RT|10|||
27841282|NCT02460835|81248249|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
27503338|NCT00385671|80035070|FG000|Overall Study|Physician Decision|2|||
27612026|NCT02611830|80419258|FG001|Maintenance Phase|Lack of Efficacy|29|||
27503339|NCT00385671|80035071|FG001|Overall Study|Physician Decision|1|||
27612027|NCT02611830|80419259|FG002|Maintenance Phase|Lack of Efficacy|18|||
27612028|NCT02611830|80419260|FG003|Maintenance Phase|Lack of Efficacy|6|||
27503340|NCT00385671|80035072|FG002|Overall Study|Physician Decision|2|||
27612029|NCT02611830|80419257|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27612030|NCT02611830|80419258|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
27612031|NCT02611830|80419259|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
27612032|NCT02611830|80419260|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
27612033|NCT02611830|80419257|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
27612034|NCT02611830|80419258|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
27612035|NCT02611830|80419259|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
27612036|NCT02611830|80419260|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
27612037|NCT02611830|80419257|FG000|Maintenance Phase|Lost to Follow-up|0|||
27612038|NCT02611830|80419258|FG001|Maintenance Phase|Lost to Follow-up|0|||
27612039|NCT02611830|80419259|FG002|Maintenance Phase|Lost to Follow-up|0|||
27612040|NCT02611830|80419260|FG003|Maintenance Phase|Lost to Follow-up|1|||
27612041|NCT02611830|80419257|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
27612042|NCT02611830|80419258|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
27612043|NCT02611830|80419259|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
27612044|NCT02611830|80419260|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
27612045|NCT02611830|80419257|FG000|Maintenance Phase|Pregnancy|0|||
27612046|NCT02611830|80419258|FG001|Maintenance Phase|Pregnancy|0|||
27612047|NCT02611830|80419259|FG002|Maintenance Phase|Pregnancy|1|||
27892186|NCT01943851|81441181|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892187|NCT01943851|81441182|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
27892188|NCT01943851|81441183|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892189|NCT01943851|81441184|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
27892190|NCT01943851|81441167|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892191|NCT01943851|81441168|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892192|NCT01943851|81441169|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892193|NCT01943851|81441170|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27612048|NCT02611830|80419260|FG003|Maintenance Phase|Pregnancy|0|||
27612049|NCT02611830|80419257|FG000|Maintenance Phase|Reason not specified|0|||
27612050|NCT02611830|80419258|FG001|Maintenance Phase|Reason not specified|1|||
27612051|NCT02611830|80419259|FG002|Maintenance Phase|Reason not specified|4|||
27612052|NCT02611830|80419260|FG003|Maintenance Phase|Reason not specified|0|||
27612053|NCT01827254|80419261|FG000|Overall Study|Death|10|||
27612054|NCT01827254|80419261|FG000|Overall Study|Case report form not completed|4|||
27612055|NCT01827254|80419261|FG000|Overall Study|Invalidated centre|3|||
27612056|NCT01827254|80419261|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
27612057|NCT01827254|80419261|FG000|Overall Study|Did not complete re-challenge|1|||
27612058|NCT01827254|80419261|FG000|Overall Study|Disease progression|36|||
27612059|NCT01827254|80419261|FG000|Overall Study|Intolerance to treatment|4|||
27892194|NCT01943851|81441171|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892195|NCT01943851|81441172|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892196|NCT01943851|81441173|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892197|NCT01943851|81441174|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892198|NCT01943851|81441175|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892199|NCT01943851|81441176|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892200|NCT01943851|81441177|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892201|NCT01943851|81441178|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892202|NCT01943851|81441179|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27892203|NCT01943851|81441180|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27503341|NCT00385671|80035070|FG000|Overall Study|Protocol Violation|5|||
27612060|NCT00641186|80419262|FG000|Overall Study|Adverse Event|3|||
27612061|NCT00358150|80419263|FG000|Overall Study|Adverse Event|3|||
27612062|NCT00358150|80419263|FG000|Overall Study|Withdrawal by Subject|1|||
27612063|NCT00358150|80419263|FG000|Overall Study|Undefined|3|||
27612064|NCT00924560|80419274|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
27612065|NCT00924560|80419275|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
27612066|NCT00924560|80419276|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
27612067|NCT00924560|80419274|FG000|Overall Study|Non Compliance with the Protocol|20|||
27612068|NCT00924560|80419275|FG001|Overall Study|Non Compliance with the Protocol|15|||
27612069|NCT00924560|80419276|FG002|Overall Study|Non Compliance with the Protocol|4|||
27612070|NCT00924560|80419274|FG000|Overall Study|Physician Decision|2|||
27503342|NCT00385671|80035071|FG001|Overall Study|Protocol Violation|2|||
27612071|NCT00924560|80419275|FG001|Overall Study|Physician Decision|3|||
27723387|NCT00090545|80819500|FG000|Overall Study|Adverse Event|0|||
27892204|NCT01943851|81441181|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
27723388|NCT00090545|80819501|FG001|Overall Study|Adverse Event|2|||
27723389|NCT02499029|80819504|FG000|Overall Study|Lost to Follow-up|2|||
27723390|NCT02499029|80819505|FG001|Overall Study|Lost to Follow-up|2|||
27723391|NCT02499029|80819504|FG000|Overall Study|Physician Decision|2|||
27723392|NCT02499029|80819505|FG001|Overall Study|Physician Decision|1|||
27723393|NCT02499029|80819504|FG000|Overall Study|Death|1|||
27723394|NCT02499029|80819505|FG001|Overall Study|Death|0|||
27723395|NCT03213366|80819510|FG000|Overall Study|Lost to Follow-up|9|||
27723396|NCT03213366|80819511|FG001|Overall Study|Lost to Follow-up|4|||
27723397|NCT00643994|80819512|FG000|Overall Study|Death|24|||
27723398|NCT00643994|80819512|FG000|Overall Study|Lost to Follow-up|72|||
27723399|NCT02549339|80819513|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
27723400|NCT02549339|80819514|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
27723401|NCT02549339|80819513|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
27723402|NCT02549339|80819514|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
27723403|NCT02549339|80819513|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
27723404|NCT02549339|80819514|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
27723405|NCT02549339|80819513|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
27723406|NCT02549339|80819514|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
27723407|NCT02549339|80819513|FG000|12-month Follow-up|Lack of Efficacy|0|||
27723408|NCT02549339|80819514|FG001|12-month Follow-up|Lack of Efficacy|2|||
27723409|NCT02549339|80819513|FG000|12-month Follow-up|Withdrawal by Subject|8|||
27723410|NCT02549339|80819514|FG001|12-month Follow-up|Withdrawal by Subject|3|||
27892205|NCT01943851|81441182|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
27892206|NCT01943851|81441183|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
27892207|NCT01943851|81441184|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
27892208|NCT02637895|81441185|FG000|Overall Study|Lost to Follow-up|4|||
27892209|NCT02637895|81441186|FG001|Overall Study|Lost to Follow-up|0|||
27892210|NCT02637895|81441185|FG000|Overall Study|Protocol Violation|0|||
27892211|NCT02637895|81441186|FG001|Overall Study|Protocol Violation|1|||
27892212|NCT02637895|81441185|FG000|Overall Study|Lack of Efficacy|1|||
27892213|NCT02637895|81441186|FG001|Overall Study|Lack of Efficacy|0|||
27892214|NCT02637895|81441185|FG000|Overall Study|Withdrawal by Subject|1|||
27892215|NCT02637895|81441186|FG001|Overall Study|Withdrawal by Subject|1|||
27892216|NCT02637895|81441185|FG000|Overall Study|Abnormal baseline lab|0|||
27892217|NCT02637895|81441186|FG001|Overall Study|Abnormal baseline lab|1|||
27892218|NCT01424514|81441187|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
27892219|NCT01424514|81441188|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
27892220|NCT01424514|81441187|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
27892221|NCT01424514|81441188|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
27892222|NCT04450407|81441198|FG000|Overall Study|Withdrawal by Subject|10|||
27892223|NCT04450407|81441199|FG001|Overall Study|Withdrawal by Subject|1|||
27892224|NCT04450407|81441200|FG002|Overall Study|Withdrawal by Subject|4|||
27892225|NCT04450407|81441198|FG000|Overall Study|Adverse Event|0|||
27892226|NCT04450407|81441199|FG001|Overall Study|Adverse Event|0|||
27892227|NCT04450407|81441200|FG002|Overall Study|Adverse Event|1|||
27892228|NCT04450407|81441198|FG000|Overall Study|Lost to Follow-up|1|||
27892229|NCT04450407|81441199|FG001|Overall Study|Lost to Follow-up|0|||
27892230|NCT04450407|81441200|FG002|Overall Study|Lost to Follow-up|0|||
27892231|NCT04450407|81441198|FG000|Overall Study|Physician Decision|0|||
27892232|NCT04450407|81441199|FG001|Overall Study|Physician Decision|0|||
27892233|NCT04450407|81441200|FG002|Overall Study|Physician Decision|1|||
27892234|NCT04450407|81441198|FG000|Overall Study|Pregnancy|1|||
27892235|NCT04450407|81441199|FG001|Overall Study|Pregnancy|0|||
27892236|NCT04450407|81441200|FG002|Overall Study|Pregnancy|0|||
27892237|NCT04450407|81441198|FG000|Overall Study|Protocol Violation|2|||
27892238|NCT04450407|81441199|FG001|Overall Study|Protocol Violation|0|||
27892239|NCT04450407|81441200|FG002|Overall Study|Protocol Violation|0|||
27892240|NCT04450407|81441198|FG000|Overall Study|Investigational site terminated by sponsor|3|||
27503343|NCT00385671|80035072|FG002|Overall Study|Protocol Violation|1|||
27503344|NCT00385671|80035070|FG000|Overall Study|Sponsor Decision|2|||
27723411|NCT02549339|80819513|FG000|12-month Follow-up|Lost to Follow-up|1|||
27723412|NCT02549339|80819514|FG001|12-month Follow-up|Lost to Follow-up|3|||
27892241|NCT04450407|81441199|FG001|Overall Study|Investigational site terminated by sponsor|0|||
27892242|NCT04450407|81441200|FG002|Overall Study|Investigational site terminated by sponsor|2|||
27892243|NCT03962790|81441201|FG000|Period 1|Adverse Event|0|||
27892244|NCT03962790|81441202|FG001|Period 1|Adverse Event|1|||
27892245|NCT03962790|81441201|FG000|Period 1|Failed to meet all eligibility criteria|1|||
27892246|NCT03962790|81441202|FG001|Period 1|Failed to meet all eligibility criteria|1|||
27892247|NCT03962790|81441201|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
27892248|NCT03962790|81441202|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
27503345|NCT00385671|80035071|FG001|Overall Study|Sponsor Decision|2|||
27723413|NCT02549339|80819513|FG000|12-month Follow-up|Other|0|||
27723414|NCT02549339|80819514|FG001|12-month Follow-up|Other|3|||
27892249|NCT03962790|81441201|FG000|Period 1|Withdrawal by Subject|1|||
27892250|NCT03962790|81441202|FG001|Period 1|Withdrawal by Subject|0|||
27723415|NCT01818297|80819515|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
27723416|NCT01818297|80819516|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
27723417|NCT01818297|80819515|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
27723418|NCT01818297|80819516|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
27723419|NCT01818297|80819515|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
27723420|NCT01818297|80819516|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
27723421|NCT02450487|80819518|FG000|Overall Study|Lost to Follow-up|3|||
27723422|NCT01813890|80819519|FG000|Overall Study|Adverse Event|0|||
27723423|NCT01813890|80819520|FG001|Overall Study|Adverse Event|3|||
27723424|NCT01813890|80819521|FG002|Overall Study|Adverse Event|4|||
27723425|NCT01813890|80819519|FG000|Overall Study|Lack of Efficacy|9|||
27723426|NCT01813890|80819520|FG001|Overall Study|Lack of Efficacy|1|||
27723427|NCT01813890|80819521|FG002|Overall Study|Lack of Efficacy|2|||
27723428|NCT00454805|80819522|FG000|Overall Study|Withdrawal by Subject|9|||
27723429|NCT00454805|80819523|FG001|Overall Study|Withdrawal by Subject|2|||
27723430|NCT00454805|80819522|FG000|Overall Study|Death|0|||
27723431|NCT00454805|80819523|FG001|Overall Study|Death|2|||
27723432|NCT00454805|80819522|FG000|Overall Study|Disease progression|16|||
27723433|NCT00454805|80819523|FG001|Overall Study|Disease progression|19|||
27723434|NCT00454805|80819522|FG000|Overall Study|In order to begin radiotherapy|1|||
27723435|NCT00454805|80819523|FG001|Overall Study|In order to begin radiotherapy|0|||
27723436|NCT00352105|80819524|FG000|Overall Study|Death|5|||
27723437|NCT00352105|80819524|FG000|Overall Study|Withdrawal by Subject|5|||
27723438|NCT00352105|80819524|FG000|Overall Study|Lack of Efficacy|9|||
27723439|NCT00352105|80819524|FG000|Overall Study|Adverse Event|19|||
27723440|NCT00352105|80819524|FG000|Overall Study|Protocol Violation|2|||
27723441|NCT02787850|80819525|FG000|Overall Study|Withdrawal by Subject|0|||
27723442|NCT02787850|80819526|FG001|Overall Study|Withdrawal by Subject|1|||
27723443|NCT01627860|80819528|FG000|Overall Study|Adverse Event|9|||
27723444|NCT01627860|80819529|FG001|Overall Study|Adverse Event|4|||
27723445|NCT01627860|80819528|FG000|Overall Study|Withdrawal by Subject|2|||
27723446|NCT01627860|80819529|FG001|Overall Study|Withdrawal by Subject|1|||
27723447|NCT01627860|80819528|FG000|Overall Study|Seizure frequency doubled|0|||
27723448|NCT01627860|80819529|FG001|Overall Study|Seizure frequency doubled|1|||
27723449|NCT01627860|80819528|FG000|Overall Study|Protocol Violation|1|||
27723450|NCT01627860|80819529|FG001|Overall Study|Protocol Violation|0|||
27723451|NCT00463476|80819530|FG000|Overall Study|Withdrawal by Subject|1|||
27723452|NCT00463476|80819531|FG001|Overall Study|Withdrawal by Subject|2|||
27723453|NCT00463476|80819530|FG000|Overall Study|Lost to Follow-up|1|||
27723454|NCT00463476|80819531|FG001|Overall Study|Lost to Follow-up|1|||
27723455|NCT01014585|80819535|FG000|Overall Study|Adverse Event|0|||
27723456|NCT01014585|80819536|FG001|Overall Study|Adverse Event|2|||
27723457|NCT01014585|80819537|FG002|Overall Study|Adverse Event|0|||
27723458|NCT01014585|80819538|FG003|Overall Study|Adverse Event|3|||
27723459|NCT01014585|80819535|FG000|Overall Study|Withdrawal by Subject|2|||
27723460|NCT01014585|80819536|FG001|Overall Study|Withdrawal by Subject|0|||
27723461|NCT01014585|80819537|FG002|Overall Study|Withdrawal by Subject|1|||
27723462|NCT01014585|80819538|FG003|Overall Study|Withdrawal by Subject|3|||
27723463|NCT01014585|80819535|FG000|Overall Study|Lost to Follow-up|0|||
27723464|NCT01014585|80819536|FG001|Overall Study|Lost to Follow-up|0|||
27723465|NCT01014585|80819537|FG002|Overall Study|Lost to Follow-up|0|||
27723466|NCT01014585|80819538|FG003|Overall Study|Lost to Follow-up|2|||
27723467|NCT01014585|80819535|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
27723468|NCT01014585|80819536|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
27723469|NCT01014585|80819537|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
27723470|NCT01014585|80819538|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
27723471|NCT03705793|80819539|FG000|Overall Study|Lost to Follow-up|3|||
27723472|NCT03705793|80819540|FG001|Overall Study|Lost to Follow-up|4|||
27723473|NCT03705793|80819539|FG000|Overall Study|Withdrawal by Subject|2|||
27723474|NCT03705793|80819540|FG001|Overall Study|Withdrawal by Subject|1|||
27723475|NCT01761266|80819541|FG000|Overall Study|Death|415|||
27723476|NCT01761266|80819542|FG001|Overall Study|Death|402|||
27723477|NCT01761266|80819541|FG000|Overall Study|Lost to Follow-up|8|||
27723478|NCT01761266|80819542|FG001|Overall Study|Lost to Follow-up|12|||
27723479|NCT01761266|80819541|FG000|Overall Study|Withdrawal by Subject|14|||
27723480|NCT01761266|80819542|FG001|Overall Study|Withdrawal by Subject|10|||
27723481|NCT01761266|80819541|FG000|Overall Study|Sponsor Decision|41|||
27723482|NCT01761266|80819542|FG001|Overall Study|Sponsor Decision|52|||
27841283|NCT01517867|81248250|FG000|Overall Study|never started treatment|29|||
27841284|NCT01517867|81248251|FG001|Overall Study|never started treatment|32|||
27841285|NCT01517867|81248250|FG000|Overall Study|Withdrawal by Subject|34|||
27841286|NCT01517867|81248251|FG001|Overall Study|Withdrawal by Subject|30|||
27841287|NCT01517867|81248250|FG000|Overall Study|Still in treatment at study end|0|||
27841288|NCT01517867|81248251|FG001|Overall Study|Still in treatment at study end|3|||
27841289|NCT02310763|81248256|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
27841290|NCT02310763|81248257|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
27723483|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
27723484|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
27723485|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
27723486|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
27723487|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
27892251|NCT04743804|81441203|FG000|Overall Study|Other|1|||
27892252|NCT04743804|81441204|FG001|Overall Study|Other|0|||
27892253|NCT04743804|81441203|FG000|Overall Study|Withdrawal by Subject|0|||
27612072|NCT00924560|80419276|FG002|Overall Study|Physician Decision|4|||
27892254|NCT04743804|81441204|FG001|Overall Study|Withdrawal by Subject|1|||
27892255|NCT04743804|81441203|FG000|Overall Study|Study Terminated by Sponsor|1|||
27892256|NCT04743804|81441204|FG001|Overall Study|Study Terminated by Sponsor|4|||
27892257|NCT04743804|81441203|FG000|Overall Study|Physician Decision|0|||
27892258|NCT04743804|81441204|FG001|Overall Study|Physician Decision|1|||
27892259|NCT04743804|81441203|FG000|Overall Study|Death|3|||
27892260|NCT04743804|81441204|FG001|Overall Study|Death|0|||
27892261|NCT00381238|81441205|FG000|Overall Study|Adverse Event|3|||
27892262|NCT00381238|81441205|FG000|Overall Study|Protocol Violation|1|||
27892263|NCT00381238|81441205|FG000|Overall Study|Withdrawal by Subject|4|||
27892264|NCT00381238|81441205|FG000|Overall Study|Lack of Efficacy|2|||
27892265|NCT00381238|81441205|FG000|Overall Study|Withdrew by physician|1|||
27892266|NCT00381238|81441205|FG000|Overall Study|Disease progression|1|||
27892267|NCT04050124|81441206|FG000|Overall Study|Death|1|||
27892268|NCT04050124|81441207|FG001|Overall Study|Death|0|||
27892269|NCT03155997|81441208|FG000|Overall Study|Withdrawal by Subject|119|||
27892270|NCT03155997|81441209|FG001|Overall Study|Withdrawal by Subject|134|||
27892271|NCT03155997|81441208|FG000|Overall Study|Lost to Follow-up|12|||
27892272|NCT03155997|81441209|FG001|Overall Study|Lost to Follow-up|13|||
27892273|NCT03155997|81441208|FG000|Overall Study|Missing disposition data|0|||
27892274|NCT03155997|81441209|FG001|Overall Study|Missing disposition data|1|||
27892275|NCT03155997|81441208|FG000|Overall Study|On study treatment|2027|||
27892276|NCT03155997|81441209|FG001|Overall Study|On study treatment|2074|||
27892277|NCT02520427|81441212|FG000|Overall Study|Decision by sponsor|0|||
27892278|NCT02520427|81441213|FG001|Overall Study|Decision by sponsor|0|||
27892279|NCT02520427|81441214|FG002|Overall Study|Decision by sponsor|0|||
27892280|NCT02520427|81441215|FG003|Overall Study|Decision by sponsor|0|||
27892281|NCT02520427|81441216|FG004|Overall Study|Decision by sponsor|0|||
27892282|NCT02520427|81441217|FG005|Overall Study|Decision by sponsor|0|||
27892283|NCT02520427|81441218|FG006|Overall Study|Decision by sponsor|0|||
27892284|NCT02520427|81441219|FG007|Overall Study|Decision by sponsor|0|||
27892285|NCT02520427|81441220|FG008|Overall Study|Decision by sponsor|1|||
27892286|NCT02520427|81441221|FG009|Overall Study|Decision by sponsor|1|||
27892287|NCT02520427|81441222|FG010|Overall Study|Decision by sponsor|0|||
27892288|NCT02520427|81441223|FG011|Overall Study|Decision by sponsor|0|||
27892289|NCT02520427|81441224|FG012|Overall Study|Decision by sponsor|0|||
27892290|NCT02520427|81441225|FG013|Overall Study|Decision by sponsor|0|||
27892291|NCT02520427|81441226|FG014|Overall Study|Decision by sponsor|0|||
27892292|NCT02520427|81441227|FG015|Overall Study|Decision by sponsor|0|||
27892293|NCT02520427|81441228|FG016|Overall Study|Decision by sponsor|0|||
27892294|NCT02520427|81441229|FG017|Overall Study|Decision by sponsor|0|||
27892295|NCT02520427|81441230|FG018|Overall Study|Decision by sponsor|0|||
27892296|NCT02520427|81441231|FG019|Overall Study|Decision by sponsor|0|||
27892297|NCT02520427|81441232|FG020|Overall Study|Decision by sponsor|0|||
27892298|NCT02520427|81441233|FG021|Overall Study|Decision by sponsor|0|||
27892299|NCT02520427|81441234|FG022|Overall Study|Decision by sponsor|0|||
27892300|NCT02520427|81441235|FG023|Overall Study|Decision by sponsor|0|||
27892301|NCT02520427|81441236|FG024|Overall Study|Decision by sponsor|0|||
27892302|NCT02520427|81441237|FG025|Overall Study|Decision by sponsor|0|||
27892303|NCT02520427|81441212|FG000|Overall Study|Withdrawal by Subject|0|||
27892304|NCT02520427|81441213|FG001|Overall Study|Withdrawal by Subject|0|||
27892305|NCT02520427|81441214|FG002|Overall Study|Withdrawal by Subject|1|||
27892306|NCT02520427|81441215|FG003|Overall Study|Withdrawal by Subject|0|||
27892307|NCT02520427|81441216|FG004|Overall Study|Withdrawal by Subject|0|||
27892308|NCT02520427|81441217|FG005|Overall Study|Withdrawal by Subject|0|||
27892309|NCT02520427|81441218|FG006|Overall Study|Withdrawal by Subject|0|||
27892310|NCT02520427|81441219|FG007|Overall Study|Withdrawal by Subject|0|||
27892311|NCT02520427|81441220|FG008|Overall Study|Withdrawal by Subject|0|||
27892312|NCT02520427|81441221|FG009|Overall Study|Withdrawal by Subject|0|||
27892313|NCT02520427|81441222|FG010|Overall Study|Withdrawal by Subject|0|||
27892314|NCT02520427|81441223|FG011|Overall Study|Withdrawal by Subject|0|||
27892315|NCT02520427|81441224|FG012|Overall Study|Withdrawal by Subject|1|||
27841291|NCT02310763|81248258|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
27841292|NCT02310763|81248256|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
27841293|NCT02310763|81248257|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
27841294|NCT02310763|81248258|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
27841295|NCT02310763|81248256|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
27841296|NCT02310763|81248257|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
27841297|NCT02310763|81248258|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
27841298|NCT02310763|81248256|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
27841299|NCT02310763|81248257|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
27841300|NCT02310763|81248258|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
27841301|NCT02310763|81248256|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
27841302|NCT02310763|81248257|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
27841303|NCT02310763|81248258|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
27841304|NCT01436643|81248261|FG000|2-week Pre-treatment|Abnormal test result|0|||
27841305|NCT01436643|81248262|FG001|2-week Pre-treatment|Abnormal test result|0|||
27841306|NCT01436643|81248263|FG002|2-week Pre-treatment|Abnormal test result|0|||
27841307|NCT01436643|81248264|FG003|2-week Pre-treatment|Abnormal test result|1|||
27841308|NCT01436643|81248261|FG000|2-week Pre-treatment|Adverse Event|0|||
27841309|NCT01436643|81248262|FG001|2-week Pre-treatment|Adverse Event|0|||
27841310|NCT01436643|81248263|FG002|2-week Pre-treatment|Adverse Event|0|||
27841311|NCT01436643|81248264|FG003|2-week Pre-treatment|Adverse Event|5|||
27841312|NCT01436643|81248261|FG000|2-week Pre-treatment|Protocol Violation|0|||
27841313|NCT01436643|81248262|FG001|2-week Pre-treatment|Protocol Violation|0|||
27841314|NCT01436643|81248263|FG002|2-week Pre-treatment|Protocol Violation|0|||
27841315|NCT01436643|81248264|FG003|2-week Pre-treatment|Protocol Violation|4|||
27841316|NCT01436643|81248261|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
27841317|NCT01436643|81248262|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
27841318|NCT01436643|81248263|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
27892316|NCT02520427|81441225|FG013|Overall Study|Withdrawal by Subject|1|||
27892317|NCT02520427|81441226|FG014|Overall Study|Withdrawal by Subject|1|||
27892318|NCT02520427|81441227|FG015|Overall Study|Withdrawal by Subject|0|||
27892319|NCT02520427|81441228|FG016|Overall Study|Withdrawal by Subject|1|||
27892320|NCT02520427|81441229|FG017|Overall Study|Withdrawal by Subject|0|||
27612073|NCT00924560|80419274|FG000|Overall Study|Withdrawal by Subject|50|||
27612074|NCT00924560|80419275|FG001|Overall Study|Withdrawal by Subject|44|||
27612075|NCT00924560|80419276|FG002|Overall Study|Withdrawal by Subject|18|||
27612076|NCT00924560|80419274|FG000|Overall Study|Adverse Event|39|||
27612077|NCT00924560|80419275|FG001|Overall Study|Adverse Event|33|||
27612078|NCT00924560|80419276|FG002|Overall Study|Adverse Event|0|||
27612079|NCT00924560|80419274|FG000|Overall Study|Pregnancy|5|||
27612080|NCT00924560|80419275|FG001|Overall Study|Pregnancy|7|||
27612081|NCT00924560|80419276|FG002|Overall Study|Pregnancy|1|||
27612082|NCT00924560|80419274|FG000|Overall Study|Lost to Follow-up|78|||
27612083|NCT00924560|80419275|FG001|Overall Study|Lost to Follow-up|94|||
27612084|NCT00924560|80419276|FG002|Overall Study|Lost to Follow-up|45|||
27612085|NCT00924560|80419274|FG000|Overall Study|Miscellaneous Reasons|13|||
27612086|NCT00924560|80419275|FG001|Overall Study|Miscellaneous Reasons|10|||
27612087|NCT00924560|80419276|FG002|Overall Study|Miscellaneous Reasons|10|||
27612088|NCT00758160|80419281|FG000|Overall Study|No Longer Requires Study Medication|4|||
27612089|NCT00758160|80419281|FG000|Overall Study|Administration Problems|3|||
27612090|NCT00758160|80419281|FG000|Overall Study|Adverse Event|15|||
27612091|NCT00758160|80419281|FG000|Overall Study|Lack of Efficacy|10|||
27612092|NCT00758160|80419281|FG000|Overall Study|Lost to Follow-up|14|||
27612093|NCT00758160|80419281|FG000|Overall Study|Protocol Violation|12|||
27612094|NCT00758160|80419281|FG000|Overall Study|Withdrawal by Subject|8|||
27612095|NCT01987830|80423159|FG000|Overall Study|Never received baseline scan|1|||
27612096|NCT01146574|80423160|FG000|Overall Study|Death|0|||
27612097|NCT01146574|80423161|FG001|Overall Study|Death|1|||
27612098|NCT01146574|80423162|FG002|Overall Study|Death|1|||
27612099|NCT01146574|80423163|FG003|Overall Study|Death|0|||
27612100|NCT01146574|80423164|FG004|Overall Study|Death|0|||
27612101|NCT01146574|80423165|FG005|Overall Study|Death|0|||
27612102|NCT01146574|80423166|FG006|Overall Study|Death|0|||
27612103|NCT01146574|80423160|FG000|Overall Study|Other reasons|0|||
27841319|NCT01436643|81248264|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
27892321|NCT02520427|81441230|FG018|Overall Study|Withdrawal by Subject|0|||
27612104|NCT01146574|80423161|FG001|Overall Study|Other reasons|0|||
27612105|NCT01146574|80423162|FG002|Overall Study|Other reasons|3|||
27612106|NCT01146574|80423163|FG003|Overall Study|Other reasons|0|||
27841320|NCT01436643|81248261|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
27841321|NCT01436643|81248262|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
27841322|NCT01436643|81248263|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
27892322|NCT02520427|81441231|FG019|Overall Study|Withdrawal by Subject|3|||
27612107|NCT01146574|80423164|FG004|Overall Study|Other reasons|0|||
27612108|NCT01146574|80423165|FG005|Overall Study|Other reasons|0|||
27892323|NCT02520427|81441232|FG020|Overall Study|Withdrawal by Subject|2|||
27841323|NCT01436643|81248264|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
27841324|NCT01436643|81248261|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
27841325|NCT01436643|81248262|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
27841326|NCT01436643|81248263|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
27841327|NCT01436643|81248264|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
27841328|NCT00603512|81248265|FG000|Overall Study|Adverse Event|0|||
27841329|NCT00603512|81248266|FG001|Overall Study|Adverse Event|2|||
27841330|NCT00603512|81248267|FG002|Overall Study|Adverse Event|4|||
27841331|NCT00603512|81248268|FG003|Overall Study|Adverse Event|4|||
27841332|NCT00603512|81248269|FG004|Overall Study|Adverse Event|2|||
27841333|NCT00603512|81248265|FG000|Overall Study|Lack of Efficacy|0|||
27841334|NCT00603512|81248266|FG001|Overall Study|Lack of Efficacy|1|||
27841335|NCT00603512|81248267|FG002|Overall Study|Lack of Efficacy|0|||
27841336|NCT00603512|81248268|FG003|Overall Study|Lack of Efficacy|0|||
27841337|NCT00603512|81248269|FG004|Overall Study|Lack of Efficacy|1|||
27841338|NCT00603512|81248265|FG000|Overall Study|Other|2|||
27841339|NCT00603512|81248266|FG001|Overall Study|Other|1|||
27841340|NCT00603512|81248267|FG002|Overall Study|Other|0|||
27841341|NCT00603512|81248268|FG003|Overall Study|Other|1|||
27841342|NCT00603512|81248269|FG004|Overall Study|Other|1|||
27841343|NCT00603512|81248265|FG000|Overall Study|Withdrawal by Subject|0|||
27841344|NCT00603512|81248266|FG001|Overall Study|Withdrawal by Subject|0|||
27841345|NCT00603512|81248267|FG002|Overall Study|Withdrawal by Subject|0|||
27841346|NCT00603512|81248268|FG003|Overall Study|Withdrawal by Subject|0|||
27841347|NCT00603512|81248269|FG004|Overall Study|Withdrawal by Subject|1|||
27841348|NCT00603512|81248265|FG000|Overall Study|Randomized but not treated|0|||
27841349|NCT00603512|81248266|FG001|Overall Study|Randomized but not treated|1|||
27841350|NCT00603512|81248267|FG002|Overall Study|Randomized but not treated|1|||
27841351|NCT00603512|81248268|FG003|Overall Study|Randomized but not treated|2|||
27841352|NCT00603512|81248269|FG004|Overall Study|Randomized but not treated|0|||
27841353|NCT02488109|81248270|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
27841354|NCT02488109|81248271|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
27841355|NCT02488109|81248270|FG000|12-month Follow-Up|Lost to Follow-up|4|||
27841356|NCT02488109|81248271|FG001|12-month Follow-Up|Lost to Follow-up|7|||
27841357|NCT00380588|81248272|FG000|Overall Study|Unequivocal Disease Progression|25|||
27841358|NCT00380588|81248273|FG001|Overall Study|Unequivocal Disease Progression|34|||
27841359|NCT00380588|81248272|FG000|Overall Study|Next Cycle Not Started|4|||
27754867|NCT02065622|80929632|FG002|Induction Study|Withdrawal by Subject|0|||
27841360|NCT00380588|81248273|FG001|Overall Study|Next Cycle Not Started|0|||
27841361|NCT00380588|81248272|FG000|Overall Study|Adverse Event|7|||
27503346|NCT00385671|80035072|FG002|Overall Study|Sponsor Decision|1|||
27754868|NCT02065622|80929633|FG003|Induction Study|Withdrawal by Subject|0|||
27754869|NCT02065622|80929634|FG004|Induction Study|Withdrawal by Subject|0|||
27841362|NCT00380588|81248273|FG001|Overall Study|Adverse Event|3|||
27841363|NCT00380588|81248272|FG000|Overall Study|Withdrawal by Subject|1|||
27841364|NCT00380588|81248273|FG001|Overall Study|Withdrawal by Subject|3|||
27841365|NCT00380588|81248272|FG000|Overall Study|Physician Decision|2|||
27841366|NCT00380588|81248273|FG001|Overall Study|Physician Decision|0|||
27892324|NCT02520427|81441233|FG021|Overall Study|Withdrawal by Subject|0|||
27892325|NCT02520427|81441234|FG022|Overall Study|Withdrawal by Subject|0|||
27892326|NCT02520427|81441235|FG023|Overall Study|Withdrawal by Subject|0|||
27892327|NCT02520427|81441236|FG024|Overall Study|Withdrawal by Subject|0|||
27892328|NCT02520427|81441237|FG025|Overall Study|Withdrawal by Subject|0|||
27892329|NCT02520427|81441212|FG000|Overall Study|Death|1|||
27892330|NCT02520427|81441213|FG001|Overall Study|Death|0|||
27612109|NCT01146574|80423166|FG006|Overall Study|Other reasons|0|||
27612110|NCT01146574|80423160|FG000|Overall Study|Kidney transplant|0|||
27612111|NCT01146574|80423161|FG001|Overall Study|Kidney transplant|0|||
27612112|NCT01146574|80423162|FG002|Overall Study|Kidney transplant|1|||
27612113|NCT01146574|80423163|FG003|Overall Study|Kidney transplant|1|||
27612114|NCT01146574|80423164|FG004|Overall Study|Kidney transplant|0|||
27612115|NCT01146574|80423165|FG005|Overall Study|Kidney transplant|0|||
27612116|NCT01146574|80423166|FG006|Overall Study|Kidney transplant|0|||
27612117|NCT01146574|80423160|FG000|Overall Study|Withdrew consent|0|||
27612118|NCT01146574|80423161|FG001|Overall Study|Withdrew consent|0|||
27612119|NCT01146574|80423162|FG002|Overall Study|Withdrew consent|1|||
27612120|NCT01146574|80423163|FG003|Overall Study|Withdrew consent|1|||
27612121|NCT01146574|80423164|FG004|Overall Study|Withdrew consent|2|||
27612122|NCT01146574|80423165|FG005|Overall Study|Withdrew consent|1|||
27841367|NCT02329431|81248274|FG000|Overall Study|Lost to Follow-up|20|||
27841368|NCT02329431|81248275|FG001|Overall Study|Lost to Follow-up|13|||
27841369|NCT01628549|81248276|FG000|Overall Study|Adverse Event|1|||
27841370|NCT01628549|81248277|FG001|Overall Study|Adverse Event|1|||
27841371|NCT01628549|81248278|FG002|Overall Study|Adverse Event|0|||
27841372|NCT01628549|81248279|FG003|Overall Study|Adverse Event|4|||
27841373|NCT01628549|81248276|FG000|Overall Study|Lost to Follow-up|3|||
27841374|NCT01628549|81248277|FG001|Overall Study|Lost to Follow-up|4|||
27841375|NCT01628549|81248278|FG002|Overall Study|Lost to Follow-up|3|||
27841376|NCT01628549|81248279|FG003|Overall Study|Lost to Follow-up|3|||
27841377|NCT01628549|81248276|FG000|Overall Study|Withdrawal by Subject|3|||
27841378|NCT01628549|81248277|FG001|Overall Study|Withdrawal by Subject|4|||
27841379|NCT01628549|81248278|FG002|Overall Study|Withdrawal by Subject|4|||
27841380|NCT01628549|81248279|FG003|Overall Study|Withdrawal by Subject|1|||
27841381|NCT01628549|81248276|FG000|Overall Study|Protocol Violation|2|||
27841382|NCT01628549|81248277|FG001|Overall Study|Protocol Violation|1|||
27841383|NCT01628549|81248278|FG002|Overall Study|Protocol Violation|1|||
27841384|NCT01628549|81248279|FG003|Overall Study|Protocol Violation|0|||
27841385|NCT01628549|81248276|FG000|Overall Study|withdrawn for noncompliance|0|||
27841386|NCT01628549|81248277|FG001|Overall Study|withdrawn for noncompliance|2|||
27841387|NCT01628549|81248278|FG002|Overall Study|withdrawn for noncompliance|1|||
27841388|NCT01628549|81248279|FG003|Overall Study|withdrawn for noncompliance|0|||
27841389|NCT01628549|81248276|FG000|Overall Study|abnormal laboratory test results|0|||
27841390|NCT01628549|81248277|FG001|Overall Study|abnormal laboratory test results|0|||
27841391|NCT01628549|81248278|FG002|Overall Study|abnormal laboratory test results|1|||
27841392|NCT01628549|81248279|FG003|Overall Study|abnormal laboratory test results|0|||
27841393|NCT01628549|81248276|FG000|Overall Study|positive pregnancy test|0|||
27841394|NCT01628549|81248277|FG001|Overall Study|positive pregnancy test|0|||
27841395|NCT01628549|81248278|FG002|Overall Study|positive pregnancy test|0|||
27841396|NCT01628549|81248279|FG003|Overall Study|positive pregnancy test|1|||
27841397|NCT00263887|81248280|FG000|Overall Study|Withdrawal by Subject|1|||
27841398|NCT00263887|81248281|FG001|Overall Study|Withdrawal by Subject|1|||
27841399|NCT00263887|81248280|FG000|Overall Study|Lung transplantation|1|||
27841400|NCT00263887|81248281|FG001|Overall Study|Lung transplantation|2|||
27841401|NCT00263887|81248280|FG000|Overall Study|Too ill to attend visit|1|||
27841402|NCT00263887|81248281|FG001|Overall Study|Too ill to attend visit|0|||
27841403|NCT00263887|81248280|FG000|Overall Study|Adverse Event|0|||
27841404|NCT00263887|81248281|FG001|Overall Study|Adverse Event|2|||
27841405|NCT00263887|81248280|FG000|Overall Study|Disease progression|0|||
27841406|NCT00263887|81248281|FG001|Overall Study|Disease progression|1|||
27841407|NCT00263887|81248280|FG000|Overall Study|Lack of Efficacy|0|||
27841408|NCT00263887|81248281|FG001|Overall Study|Lack of Efficacy|1|||
27892331|NCT02520427|81441214|FG002|Overall Study|Death|0|||
27892332|NCT02520427|81441215|FG003|Overall Study|Death|0|||
27612123|NCT01146574|80423166|FG006|Overall Study|Withdrew consent|1|||
27612124|NCT03853317|80423167|FG000|Overall Study|Progressive Disease|5|||
27841409|NCT01098851|81248283|FG000|Overall Study|Equipment failure|1|||
27841410|NCT01098851|81248284|FG001|Overall Study|Equipment failure|0|||
27841411|NCT04556734|81248285|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
27841412|NCT04556734|81248286|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
27841413|NCT04556734|81248287|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
27892333|NCT02520427|81441216|FG004|Overall Study|Death|0|||
27892334|NCT02520427|81441217|FG005|Overall Study|Death|0|||
27612125|NCT03853317|80423167|FG000|Overall Study|Adverse Event|1|||
27841414|NCT04556734|81248288|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27892335|NCT02520427|81441218|FG006|Overall Study|Death|0|||
27892336|NCT02520427|81441219|FG007|Overall Study|Death|0|||
27892337|NCT02520427|81441220|FG008|Overall Study|Death|0|||
27892338|NCT02520427|81441221|FG009|Overall Study|Death|0|||
27892339|NCT02520427|81441222|FG010|Overall Study|Death|0|||
27892340|NCT02520427|81441223|FG011|Overall Study|Death|0|||
27892341|NCT02520427|81441224|FG012|Overall Study|Death|0|||
27892342|NCT02520427|81441225|FG013|Overall Study|Death|0|||
27892343|NCT02520427|81441226|FG014|Overall Study|Death|0|||
27892344|NCT02520427|81441227|FG015|Overall Study|Death|0|||
27892345|NCT02520427|81441228|FG016|Overall Study|Death|2|||
27892346|NCT02520427|81441229|FG017|Overall Study|Death|1|||
27892347|NCT02520427|81441230|FG018|Overall Study|Death|3|||
27892348|NCT02520427|81441231|FG019|Overall Study|Death|2|||
27892349|NCT02520427|81441232|FG020|Overall Study|Death|0|||
27892350|NCT02520427|81441233|FG021|Overall Study|Death|0|||
27892351|NCT02520427|81441234|FG022|Overall Study|Death|1|||
27892352|NCT02520427|81441235|FG023|Overall Study|Death|0|||
27892353|NCT02520427|81441236|FG024|Overall Study|Death|1|||
27892354|NCT02520427|81441237|FG025|Overall Study|Death|0|||
27892355|NCT02662764|81441238|FG000|Overall Study|Adverse Event|6|||
27892356|NCT02662764|81441238|FG000|Overall Study|Lack of Efficacy|8|||
27892357|NCT02662764|81441238|FG000|Overall Study|Protocol Violation|1|||
27892358|NCT02662764|81441238|FG000|Overall Study|Withdrawal by Subject|5|||
27892359|NCT02662764|81441238|FG000|Overall Study|Device failure|4|||
27892360|NCT02662764|81441238|FG000|Overall Study|Patient changed treatment|1|||
27612126|NCT03853317|80423167|FG000|Overall Study|Death|1|||
27612127|NCT03853317|80423167|FG000|Overall Study|other event|2|||
27612128|NCT01382940|80423170|FG000|Overall Study|Adverse Event|19|||
27612129|NCT01382940|80423170|FG000|Overall Study|Lost to Follow-up|4|||
27612130|NCT01382940|80423170|FG000|Overall Study|Physician Decision|7|||
27612131|NCT01382940|80423170|FG000|Overall Study|Withdrawal by Subject|23|||
27612132|NCT01382940|80423170|FG000|Overall Study|Protocol Violation|20|||
27612133|NCT01976364|80423171|FG000|Main Study (36 Months)|Adverse Event|63|||
27612134|NCT01976364|80423172|FG001|Main Study (36 Months)|Adverse Event|0|||
27612135|NCT01976364|80423173|FG002|Main Study (36 Months)|Adverse Event|0|||
27612136|NCT01976364|80423171|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
27612137|NCT01976364|80423172|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
27612138|NCT01976364|80423173|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
27612139|NCT01976364|80423171|FG000|Main Study (36 Months)|Other|13|||
27612140|NCT01976364|80423172|FG001|Main Study (36 Months)|Other|0|||
27612141|NCT01976364|80423173|FG002|Main Study (36 Months)|Other|0|||
27612142|NCT01976364|80423171|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
27612143|NCT01976364|80423172|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
27612144|NCT01976364|80423173|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
27612145|NCT01976364|80423171|FG000|Main Study (36 Months)|Medication error|1|||
27612146|NCT01976364|80423172|FG001|Main Study (36 Months)|Medication error|0|||
27612147|NCT01976364|80423173|FG002|Main Study (36 Months)|Medication error|0|||
27612148|NCT01976364|80423171|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
27612149|NCT01976364|80423172|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
27612150|NCT01976364|80423173|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
27612151|NCT01976364|80423171|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
27612152|NCT01976364|80423172|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
27612153|NCT01976364|80423173|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
27612154|NCT01976364|80423171|FG000|Main Study (36 Months)|Protocol Violation|13|||
27612155|NCT01976364|80423172|FG001|Main Study (36 Months)|Protocol Violation|0|||
27612156|NCT01976364|80423173|FG002|Main Study (36 Months)|Protocol Violation|0|||
27612157|NCT01976364|80423171|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
27612158|NCT01976364|80423172|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
27612159|NCT01976364|80423173|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
27612160|NCT01976364|80423171|FG000|Main Study (36 Months)|Death|5|||
27612161|NCT01976364|80423172|FG001|Main Study (36 Months)|Death|0|||
27612162|NCT01976364|80423173|FG002|Main Study (36 Months)|Death|0|||
27612163|NCT01976364|80423171|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
27612164|NCT01976364|80423172|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
27612165|NCT01976364|80423173|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
27612166|NCT01976364|80423171|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
27612167|NCT01976364|80423172|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
27892361|NCT02662764|81441238|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
27892362|NCT04323306|81441240|FG000|Overall Study|Physician Decision|1|||
27892363|NCT04323306|81441241|FG001|Overall Study|Physician Decision|0|||
27892364|NCT04323306|81441242|FG002|Overall Study|Physician Decision|0|||
27892365|NCT04323306|81441243|FG003|Overall Study|Physician Decision|0|||
27892366|NCT04323306|81441244|FG004|Overall Study|Physician Decision|0|||
27892367|NCT04323306|81441245|FG005|Overall Study|Physician Decision|0|||
27892368|NCT04323306|81441246|FG006|Overall Study|Physician Decision|0|||
27892369|NCT04323306|81441247|FG007|Overall Study|Physician Decision|0|||
27612168|NCT01976364|80423173|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
27612169|NCT01976364|80423171|FG000|Sub-study (12 Months)|Protocol Violation|0|||
27612170|NCT01976364|80423172|FG001|Sub-study (12 Months)|Protocol Violation|1|||
27612171|NCT01976364|80423173|FG002|Sub-study (12 Months)|Protocol Violation|1|||
27612172|NCT01976364|80423171|FG000|Sub-study (12 Months)|Adverse Event|0|||
27612173|NCT01976364|80423172|FG001|Sub-study (12 Months)|Adverse Event|4|||
27612174|NCT01976364|80423173|FG002|Sub-study (12 Months)|Adverse Event|3|||
27612175|NCT01231503|80423182|FG000|Overall Study|Adverse Event|0|||
27612176|NCT01231503|80423183|FG001|Overall Study|Adverse Event|0|||
27612177|NCT01231503|80423184|FG002|Overall Study|Adverse Event|0|||
27612178|NCT01231503|80423185|FG003|Overall Study|Adverse Event|0|||
27612179|NCT01231503|80423186|FG004|Overall Study|Adverse Event|0|||
27612180|NCT01231503|80423187|FG005|Overall Study|Adverse Event|1|||
27612181|NCT01231503|80423188|FG006|Overall Study|Adverse Event|0|||
27612182|NCT01231503|80423189|FG007|Overall Study|Adverse Event|0|||
27612183|NCT01231503|80423182|FG000|Overall Study|Adverse event, serious fatal|0|||
27612184|NCT01231503|80423183|FG001|Overall Study|Adverse event, serious fatal|0|||
27612185|NCT01231503|80423184|FG002|Overall Study|Adverse event, serious fatal|1|||
27612186|NCT01231503|80423185|FG003|Overall Study|Adverse event, serious fatal|1|||
27612187|NCT01231503|80423186|FG004|Overall Study|Adverse event, serious fatal|0|||
27612188|NCT01231503|80423187|FG005|Overall Study|Adverse event, serious fatal|1|||
27612189|NCT01231503|80423188|FG006|Overall Study|Adverse event, serious fatal|0|||
27612190|NCT01231503|80423189|FG007|Overall Study|Adverse event, serious fatal|0|||
27612191|NCT01231503|80423182|FG000|Overall Study|Withdrawal by Subject|6|||
27612192|NCT01231503|80423183|FG001|Overall Study|Withdrawal by Subject|3|||
27612193|NCT01231503|80423184|FG002|Overall Study|Withdrawal by Subject|3|||
27841415|NCT04556734|81248289|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27841416|NCT04556734|81248290|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27841417|NCT04556734|81248291|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27841418|NCT04556734|81248292|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27841419|NCT04556734|81248285|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
27841420|NCT04556734|81248286|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841421|NCT04556734|81248287|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841422|NCT04556734|81248288|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841423|NCT04556734|81248289|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841424|NCT04556734|81248290|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841425|NCT04556734|81248291|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841426|NCT04556734|81248292|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27841427|NCT04556734|81248285|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27841428|NCT04556734|81248286|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27841429|NCT04556734|81248287|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
27841430|NCT04556734|81248288|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27841431|NCT04556734|81248289|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27841432|NCT04556734|81248290|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27841433|NCT04556734|81248291|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27841434|NCT04556734|81248292|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
27841435|NCT04556734|81248285|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
27841436|NCT04556734|81248286|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841437|NCT04556734|81248287|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841438|NCT04556734|81248288|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841439|NCT04556734|81248289|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841440|NCT04556734|81248290|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841441|NCT04556734|81248291|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841442|NCT04556734|81248292|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27841443|NCT04556734|81248285|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841444|NCT04556734|81248286|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841445|NCT04556734|81248287|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
27841446|NCT04556734|81248288|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841447|NCT04556734|81248289|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841448|NCT04556734|81248290|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841449|NCT04556734|81248291|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841450|NCT04556734|81248292|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
27841451|NCT04556734|81248285|FG000|OLE Period (28 Weeks)|Not reported|0|||
27841452|NCT04556734|81248286|FG001|OLE Period (28 Weeks)|Not reported|0|||
27841453|NCT04556734|81248287|FG002|OLE Period (28 Weeks)|Not reported|0|||
27612194|NCT01231503|80423185|FG003|Overall Study|Withdrawal by Subject|1|||
27612195|NCT01231503|80423186|FG004|Overall Study|Withdrawal by Subject|3|||
27612196|NCT01231503|80423187|FG005|Overall Study|Withdrawal by Subject|5|||
27841454|NCT04556734|81248288|FG003|OLE Period (28 Weeks)|Not reported|0|||
27841455|NCT04556734|81248289|FG004|OLE Period (28 Weeks)|Not reported|0|||
27892370|NCT04323306|81441248|FG008|Overall Study|Physician Decision|0|||
27892371|NCT04323306|81441240|FG000|Overall Study|Withdrawal by Subject|0|||
27612197|NCT01231503|80423188|FG006|Overall Study|Withdrawal by Subject|1|||
27612198|NCT01231503|80423189|FG007|Overall Study|Withdrawal by Subject|2|||
27612199|NCT01231503|80423182|FG000|Overall Study|Lost to Follow-up|8|||
27612200|NCT01231503|80423183|FG001|Overall Study|Lost to Follow-up|10|||
27612201|NCT01231503|80423184|FG002|Overall Study|Lost to Follow-up|8|||
27612202|NCT01231503|80423185|FG003|Overall Study|Lost to Follow-up|5|||
27612203|NCT01231503|80423186|FG004|Overall Study|Lost to Follow-up|7|||
27612204|NCT01231503|80423187|FG005|Overall Study|Lost to Follow-up|9|||
27612205|NCT01231503|80423188|FG006|Overall Study|Lost to Follow-up|6|||
27612206|NCT01231503|80423189|FG007|Overall Study|Lost to Follow-up|6|||
27612207|NCT01231503|80423182|FG000|Overall Study|Protocol Violation|0|||
27841456|NCT04556734|81248290|FG005|OLE Period (28 Weeks)|Not reported|1|||
27841457|NCT04556734|81248291|FG006|OLE Period (28 Weeks)|Not reported|0|||
27503347|NCT00385671|80035070|FG000|Overall Study|Withdrawal by Subject|4|||
27503348|NCT00385671|80035071|FG001|Overall Study|Withdrawal by Subject|4|||
27503349|NCT00385671|80035072|FG002|Overall Study|Withdrawal by Subject|4|||
27503350|NCT01521117|80035073|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
27503351|NCT01521117|80035074|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27503352|NCT01521117|80035073|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
27612208|NCT01231503|80423183|FG001|Overall Study|Protocol Violation|0|||
27612209|NCT01231503|80423184|FG002|Overall Study|Protocol Violation|0|||
27503353|NCT01521117|80035074|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
27612210|NCT01231503|80423185|FG003|Overall Study|Protocol Violation|1|||
27612211|NCT01231503|80423186|FG004|Overall Study|Protocol Violation|0|||
27612212|NCT01231503|80423187|FG005|Overall Study|Protocol Violation|0|||
27841458|NCT04556734|81248292|FG007|OLE Period (28 Weeks)|Not reported|0|||
27612213|NCT01231503|80423188|FG006|Overall Study|Protocol Violation|0|||
27841459|NCT04556734|81248285|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27892372|NCT04323306|81441241|FG001|Overall Study|Withdrawal by Subject|0|||
27892373|NCT04323306|81441242|FG002|Overall Study|Withdrawal by Subject|0|||
27892374|NCT04323306|81441243|FG003|Overall Study|Withdrawal by Subject|0|||
27892375|NCT04323306|81441244|FG004|Overall Study|Withdrawal by Subject|0|||
27892376|NCT04323306|81441245|FG005|Overall Study|Withdrawal by Subject|1|||
27892377|NCT04323306|81441246|FG006|Overall Study|Withdrawal by Subject|3|||
27892378|NCT04323306|81441247|FG007|Overall Study|Withdrawal by Subject|0|||
27892379|NCT04323306|81441248|FG008|Overall Study|Withdrawal by Subject|1|||
27892380|NCT00567489|81441249|FG000|Overall Study|Adverse Event|6|||
27503354|NCT01521117|80035073|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27612214|NCT01231503|80423189|FG007|Overall Study|Protocol Violation|0|||
27892381|NCT00567489|81441250|FG001|Overall Study|Adverse Event|14|||
27892382|NCT00567489|81441249|FG000|Overall Study|Physician Decision|0|||
27503355|NCT01521117|80035074|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
27892383|NCT00567489|81441250|FG001|Overall Study|Physician Decision|4|||
27503356|NCT04456504|80035084|FG000|Overall Study|Lost to Follow-up|2|||
27503357|NCT03777982|80035085|FG000|Overall Study|Physician Decision|0|||
27503358|NCT03777982|80035086|FG001|Overall Study|Physician Decision|1|||
27503359|NCT02081677|80035092|FG000|Overall Study|Adverse Event|0|||
27503360|NCT02081677|80035093|FG001|Overall Study|Adverse Event|0|||
27503361|NCT02081677|80035094|FG002|Overall Study|Adverse Event|1|||
27503362|NCT02081677|80035095|FG003|Overall Study|Adverse Event|0|||
27503363|NCT02081677|80035092|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27503364|NCT02081677|80035093|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27503365|NCT02081677|80035094|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
27503366|NCT02081677|80035095|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
27503367|NCT02081677|80035092|FG000|Overall Study|Not comfortable with lens care system|1|||
27503368|NCT02081677|80035093|FG001|Overall Study|Not comfortable with lens care system|0|||
27503369|NCT02081677|80035094|FG002|Overall Study|Not comfortable with lens care system|0|||
27503370|NCT02081677|80035095|FG003|Overall Study|Not comfortable with lens care system|0|||
27503371|NCT02081677|80035092|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
27723488|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
27503372|NCT02081677|80035093|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27723489|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
27723490|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
27723491|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
27723492|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
27723493|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
27723494|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
27841460|NCT04556734|81248286|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27841461|NCT04556734|81248287|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27503373|NCT02081677|80035094|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
27503374|NCT02081677|80035095|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
27503375|NCT01614249|80035096|FG000|Overall Study|Lost to Follow-up|11|||
27723495|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
27723496|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
27723497|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
27841462|NCT04556734|81248288|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27841463|NCT04556734|81248289|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27841464|NCT04556734|81248290|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27841465|NCT04556734|81248291|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
27841466|NCT04556734|81248292|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
27503376|NCT01614249|80035097|FG001|Overall Study|Lost to Follow-up|23|||
27503377|NCT03558737|80035098|FG000|Overall Study|Death|1|||
27503378|NCT03558737|80035099|FG001|Overall Study|Death|1|||
27503379|NCT02991768|80035100|FG000|Overall Study|Physician Decision|4|||
27892384|NCT00567489|81441249|FG000|Overall Study|Withdrawal by Subject|0|||
27892385|NCT00567489|81441250|FG001|Overall Study|Withdrawal by Subject|2|||
27892386|NCT00567489|81441249|FG000|Overall Study|Renal Transplantation|0|||
27892387|NCT00567489|81441250|FG001|Overall Study|Renal Transplantation|3|||
27503380|NCT01724346|80035102|FG000|Overall Study|Death|42|||
27503381|NCT01724346|80035103|FG001|Overall Study|Death|42|||
27503382|NCT01724346|80035102|FG000|Overall Study|Lost to Follow-up|5|||
27503383|NCT01724346|80035103|FG001|Overall Study|Lost to Follow-up|1|||
27503384|NCT01724346|80035102|FG000|Overall Study|Withdrawal by Subject|27|||
27503385|NCT01724346|80035103|FG001|Overall Study|Withdrawal by Subject|19|||
27503386|NCT01724346|80035102|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
27503387|NCT01724346|80035103|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
27723498|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
27503388|NCT00307801|80035104|FG000|Overall Study|Adverse Event|12|||
27892388|NCT00567489|81441249|FG000|Overall Study|Other|1|||
27503389|NCT00307801|80035105|FG001|Overall Study|Adverse Event|4|||
27503390|NCT00307801|80035104|FG000|Overall Study|Withdrawal by Subject|9|||
27503391|NCT00307801|80035105|FG001|Overall Study|Withdrawal by Subject|4|||
27892389|NCT00567489|81441250|FG001|Overall Study|Other|0|||
27892390|NCT00546117|81441251|FG000|Overall Study|Withdrawal by Subject|3|||
27892391|NCT00546117|81441252|FG001|Overall Study|Withdrawal by Subject|0|||
27892392|NCT00546117|81441251|FG000|Overall Study|Inability to schedule follow-up visit|1|||
27892393|NCT00546117|81441252|FG001|Overall Study|Inability to schedule follow-up visit|0|||
27892394|NCT01154296|81441253|FG000|Randomization and Intervention|Decided to decline|1|||
27892395|NCT01154296|81441254|FG001|Randomization and Intervention|Decided to decline|1|||
27892396|NCT01154296|81441253|FG000|Randomization and Intervention|Declined by staff|1|||
27892397|NCT01154296|81441254|FG001|Randomization and Intervention|Declined by staff|0|||
27892398|NCT01154296|81441253|FG000|Randomization and Intervention|Did not return|1|||
27892399|NCT01154296|81441254|FG001|Randomization and Intervention|Did not return|0|||
27892400|NCT01154296|81441253|FG000|Randomization and Intervention|Left before test|0|||
27892401|NCT01154296|81441254|FG001|Randomization and Intervention|Left before test|1|||
27892402|NCT01154296|81441253|FG000|Randomization and Intervention|Left clinic early|2|||
27892403|NCT01154296|81441254|FG001|Randomization and Intervention|Left clinic early|0|||
27892404|NCT01154296|81441253|FG000|6-month Follow-up|Lost contact|269|||
27892405|NCT01154296|81441254|FG001|6-month Follow-up|Lost contact|275|||
27892406|NCT01154296|81441253|FG000|6-month Follow-up|Incarcerated|37|||
27892407|NCT01154296|81441254|FG001|6-month Follow-up|Incarcerated|32|||
27892408|NCT01154296|81441253|FG000|6-month Follow-up|Withdrew consent|14|||
27892409|NCT01154296|81441254|FG001|6-month Follow-up|Withdrew consent|15|||
27892410|NCT01154296|81441253|FG000|6-month Follow-up|Death|3|||
27892411|NCT01154296|81441254|FG001|6-month Follow-up|Death|2|||
27892412|NCT01154296|81441253|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
27892413|NCT01154296|81441254|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
27892414|NCT01698879|81441256|FG000|Overall Study|Withdrawal by Subject|1|||
27892415|NCT01698879|81441257|FG001|Overall Study|Withdrawal by Subject|0|||
27892416|NCT01698879|81441258|FG002|Overall Study|Withdrawal by Subject|0|||
27892417|NCT01984892|81441260|FG000|Overall Study|Progressive disease|7|||
27892418|NCT01254318|81441261|FG000|Overall Study|Lost to Follow-up|5|||
27892419|NCT01254318|81441261|FG000|Overall Study|Death|47|||
27892420|NCT04216589|81441262|FG000|Overall Study|Withdrawal by Subject|2|||
27892421|NCT04216589|81441262|FG000|Overall Study|Protocol Violation|1|||
27892422|NCT04216589|81441262|FG000|Overall Study|Incarceration|1|||
27892423|NCT04017832|81441263|FG000|Overall Study|Withdrawal by Subject|13|||
27892424|NCT04017832|81441264|FG001|Overall Study|Withdrawal by Subject|12|||
27892425|NCT04017832|81441265|FG002|Overall Study|Withdrawal by Subject|21|||
27892426|NCT04017832|81441266|FG003|Overall Study|Withdrawal by Subject|7|||
27892427|NCT04017832|81441263|FG000|Overall Study|Lost to Follow-up|0|||
27892428|NCT04017832|81441264|FG001|Overall Study|Lost to Follow-up|3|||
27892429|NCT04017832|81441265|FG002|Overall Study|Lost to Follow-up|3|||
27892430|NCT04017832|81441266|FG003|Overall Study|Lost to Follow-up|1|||
27892431|NCT04017832|81441263|FG000|Overall Study|Physician Decision|1|||
27892432|NCT04017832|81441264|FG001|Overall Study|Physician Decision|1|||
27892433|NCT04017832|81441265|FG002|Overall Study|Physician Decision|1|||
27892434|NCT04017832|81441266|FG003|Overall Study|Physician Decision|1|||
27892435|NCT04017832|81441263|FG000|Overall Study|Death|2|||
27892436|NCT04017832|81441264|FG001|Overall Study|Death|2|||
27892437|NCT04017832|81441265|FG002|Overall Study|Death|1|||
27892438|NCT04017832|81441266|FG003|Overall Study|Death|0|||
27892439|NCT00749684|81441267|FG000|Overall Study|Death|1|||
27892440|NCT00749684|81441267|FG000|Overall Study|Adverse Event|27|||
27892441|NCT00749684|81441267|FG000|Overall Study|Participant's Wish|10|||
27892442|NCT00749684|81441267|FG000|Overall Study|Not Documented|1|||
27892443|NCT00749684|81441267|FG000|Overall Study|Progressive Desease|31|||
27892444|NCT00749684|81441267|FG000|Overall Study|Therapy according to protocol + AE|2|||
27892445|NCT00749684|81441267|FG000|Overall Study|AE+discontinuation on participants wish|1|||
27892446|NCT00749684|81441267|FG000|Overall Study|Missing|9|||
27892447|NCT04351373|81441268|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
27892448|NCT03315754|81441274|FG000|Overall Study|COVID-19 complications leading to death|1|||
27892449|NCT03315754|81441274|FG000|Overall Study|insurance coverage issue|1|||
27892450|NCT02276053|81441275|FG000|Overall Study|Death|2|||
27892451|NCT02276053|81441275|FG000|Overall Study|Adverse Event|5|||
27892452|NCT02276053|81441275|FG000|Overall Study|Lack of Efficacy|2|||
27892453|NCT02276053|81441275|FG000|Overall Study|Withdrawal by Subject|1|||
27892454|NCT02276053|81441275|FG000|Overall Study|Patient does not meet selection criteria|3|||
27892455|NCT02276053|81441275|FG000|Overall Study|Patient needs to increase baseline AED|1|||
27892456|NCT02733185|81441279|FG000|Overall Study|Withdrawal by Subject|12|||
27892457|NCT02733185|81441280|FG001|Overall Study|Withdrawal by Subject|10|||
27503392|NCT00307801|80035104|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
27503393|NCT00307801|80035105|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
27503394|NCT00307801|80035104|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
27503395|NCT00307801|80035105|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
27503396|NCT00307801|80035104|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
27503397|NCT00307801|80035105|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
27503398|NCT00307801|80035104|FG000|Overall Study|Wrong Randomization|1|||
27503399|NCT00307801|80035105|FG001|Overall Study|Wrong Randomization|0|||
27503400|NCT00307801|80035104|FG000|Overall Study|Lack of Efficacy|0|||
27503401|NCT00307801|80035105|FG001|Overall Study|Lack of Efficacy|2|||
27612215|NCT00423852|80423196|FG000|Overall Study|Removed pior to the high-dose portion|3|||
27612216|NCT02138747|80423198|FG000|Treatment Period 1|Adverse Event|10|||
27612217|NCT02138747|80423199|FG001|Treatment Period 1|Adverse Event|14|||
27612218|NCT02138747|80423200|FG002|Treatment Period 1|Adverse Event|2|||
27612219|NCT02138747|80423201|FG003|Treatment Period 1|Adverse Event|1|||
27612220|NCT02138747|80423198|FG000|Treatment Period 1|Lost to Follow-up|0|||
27612221|NCT02138747|80423199|FG001|Treatment Period 1|Lost to Follow-up|1|||
27612222|NCT02138747|80423200|FG002|Treatment Period 1|Lost to Follow-up|1|||
27612223|NCT02138747|80423201|FG003|Treatment Period 1|Lost to Follow-up|0|||
27612224|NCT02138747|80423198|FG000|Treatment Period 1|Protocol Violation|0|||
27612225|NCT02138747|80423199|FG001|Treatment Period 1|Protocol Violation|2|||
27612226|NCT02138747|80423200|FG002|Treatment Period 1|Protocol Violation|0|||
27841467|NCT04556734|81248285|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
27841468|NCT04556734|81248286|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
27841469|NCT04556734|81248287|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
27503402|NCT00307801|80035104|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
27503403|NCT00307801|80035105|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
27503404|NCT00307801|80035104|FG000|Overall Study|Frustration with e-diary|1|||
27503405|NCT00307801|80035105|FG001|Overall Study|Frustration with e-diary|0|||
27612227|NCT02138747|80423201|FG003|Treatment Period 1|Protocol Violation|0|||
27841470|NCT04556734|81248288|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
27841471|NCT04556734|81248289|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
27841472|NCT04556734|81248290|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
27841473|NCT04556734|81248291|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
27841474|NCT04556734|81248292|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
27841475|NCT04556734|81248285|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27841476|NCT04556734|81248286|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27723499|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
27723500|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
27723501|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
27723502|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
27723503|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
27723504|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
27723505|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
27723506|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
27723507|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Death|2|||
27723508|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Death|1|||
27723509|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Death|2|||
27723510|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Graft loss|0|||
27723511|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Graft loss|2|||
27723512|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Graft loss|0|||
27723513|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
27723514|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
27723515|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
27723516|NCT01114529|80819545|FG000|Completed Study Medication at Month 24|Missing|2|||
27723517|NCT01114529|80819546|FG001|Completed Study Medication at Month 24|Missing|0|||
27841477|NCT04556734|81248287|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27841478|NCT04556734|81248288|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
27841479|NCT04556734|81248289|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
27503406|NCT00307801|80035104|FG000|Overall Study|Protocol Violation|3|||
27503407|NCT00307801|80035105|FG001|Overall Study|Protocol Violation|2|||
27503408|NCT00307801|80035104|FG000|Overall Study|No reason specified|2|||
27503409|NCT00307801|80035105|FG001|Overall Study|No reason specified|0|||
27503410|NCT00307801|80035104|FG000|Overall Study|Pregnancy|0|||
27503411|NCT00307801|80035105|FG001|Overall Study|Pregnancy|1|||
27503412|NCT04929249|80035106|FG000|Overall Study|Adverse Event|2|||
27503413|NCT04929249|80035107|FG001|Overall Study|Adverse Event|1|||
27503414|NCT04929249|80035106|FG000|Overall Study|Death|2|||
27503415|NCT04929249|80035107|FG001|Overall Study|Death|1|||
27503416|NCT04929249|80035106|FG000|Overall Study|Lost to Follow-up|3|||
27503417|NCT04929249|80035107|FG001|Overall Study|Lost to Follow-up|11|||
27503418|NCT04929249|80035106|FG000|Overall Study|Technical problems|0|||
27503419|NCT04929249|80035107|FG001|Overall Study|Technical problems|1|||
27503420|NCT04929249|80035106|FG000|Overall Study|Subject decision|6|||
27503421|NCT04929249|80035107|FG001|Overall Study|Subject decision|8|||
27503422|NCT04929249|80035106|FG000|Overall Study|Withdrew consent|0|||
27503423|NCT04929249|80035107|FG001|Overall Study|Withdrew consent|8|||
27503424|NCT03175367|80037768|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27503425|NCT03175367|80037769|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27503426|NCT03175367|80037770|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
27503427|NCT03175367|80037771|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
27503428|NCT03175367|80037772|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27503429|NCT03175367|80037773|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
27841480|NCT04556734|81248290|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
27841481|NCT04556734|81248291|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
27841482|NCT04556734|81248292|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
27841483|NCT01557920|81248295|FG000|Overall Study|Withdrawal by Subject|2|||
27841484|NCT01557920|81248296|FG001|Overall Study|Withdrawal by Subject|3|||
27723518|NCT01114529|80819547|FG002|Completed Study Medication at Month 24|Missing|0|||
27841485|NCT01557920|81248295|FG000|Overall Study|Lack of Efficacy|1|||
27503430|NCT03175367|80037774|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
27503431|NCT03175367|80037768|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27503432|NCT03175367|80037769|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27503433|NCT03175367|80037770|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
27503434|NCT03175367|80037771|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
27892458|NCT02733185|81441281|FG002|Overall Study|Withdrawal by Subject|17|||
27892459|NCT02733185|81441282|FG003|Overall Study|Withdrawal by Subject|21|||
27892460|NCT02733185|81441279|FG000|Overall Study|Death|46|||
27892461|NCT02733185|81441280|FG001|Overall Study|Death|34|||
27892462|NCT02733185|81441281|FG002|Overall Study|Death|35|||
27892463|NCT02733185|81441282|FG003|Overall Study|Death|43|||
27892464|NCT02733185|81441279|FG000|Overall Study|Lost to Follow-up|17|||
27892465|NCT02733185|81441280|FG001|Overall Study|Lost to Follow-up|18|||
27892466|NCT02733185|81441281|FG002|Overall Study|Lost to Follow-up|16|||
27892467|NCT02733185|81441282|FG003|Overall Study|Lost to Follow-up|11|||
27892468|NCT01905553|81441283|FG000|Period 2|Adverse Event|1|||
27892469|NCT01905553|81441284|FG001|Period 2|Adverse Event|0|||
27892470|NCT00654875|81441285|FG000|Overall Study|Adverse Event|5|||
27892471|NCT00654875|81441286|FG001|Overall Study|Adverse Event|5|||
27892472|NCT00654875|81441285|FG000|Overall Study|Withdrawal by Subject|4|||
27892473|NCT00654875|81441286|FG001|Overall Study|Withdrawal by Subject|4|||
27892474|NCT00654875|81441285|FG000|Overall Study|Protocol Violation|3|||
27503435|NCT03175367|80037772|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
27503436|NCT03175367|80037773|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27503437|NCT03175367|80037774|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27503438|NCT03175367|80037768|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27503439|NCT03175367|80037769|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27503440|NCT03175367|80037770|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
27503441|NCT03175367|80037771|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
27503442|NCT03175367|80037772|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27503443|NCT03175367|80037773|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27503444|NCT03175367|80037774|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27503445|NCT03175367|80037768|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
27723519|NCT01114529|80819545|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
27723520|NCT01114529|80819546|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
27841486|NCT01557920|81248296|FG001|Overall Study|Lack of Efficacy|0|||
27841487|NCT01717040|81248297|FG000|Overall Study|Lost to Follow-up|2|||
27841488|NCT01717040|81248298|FG001|Overall Study|Lost to Follow-up|3|||
27841489|NCT01717040|81248297|FG000|Overall Study|Lack of Efficacy|1|||
27841490|NCT01717040|81248298|FG001|Overall Study|Lack of Efficacy|1|||
27841491|NCT01717040|81248297|FG000|Overall Study|Adverse Event|1|||
27841492|NCT01717040|81248298|FG001|Overall Study|Adverse Event|0|||
27841493|NCT01717040|81248297|FG000|Overall Study|Required Medication Change|0|||
27841494|NCT01717040|81248298|FG001|Overall Study|Required Medication Change|1|||
27841495|NCT01717040|81248297|FG000|Overall Study|New Substance Use Disorder|1|||
27841496|NCT01717040|81248298|FG001|Overall Study|New Substance Use Disorder|0|||
27841497|NCT01917084|81248299|FG000|Overall Study|Withdrawal by Subject|1|||
27841498|NCT01142661|81248300|FG000|Overall Study|Adverse Event|2|||
27841499|NCT01142661|81248300|FG000|Overall Study|Withdrawal by Subject|1|||
27841500|NCT01142661|81248300|FG000|Overall Study|Physician Decision|1|||
27841501|NCT02688387|81248308|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841502|NCT02688387|81248309|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841503|NCT02688387|81248310|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
27841504|NCT02688387|81248311|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841505|NCT02688387|81248312|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841506|NCT02688387|81248313|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841507|NCT02688387|81248314|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841508|NCT02688387|81248315|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841509|NCT02688387|81248316|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841510|NCT02688387|81248317|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841511|NCT02688387|81248318|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841512|NCT02688387|81248319|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841513|NCT02688387|81248320|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841514|NCT02688387|81248321|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841515|NCT02688387|81248322|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841516|NCT02688387|81248323|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841517|NCT02688387|81248324|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841518|NCT02688387|81248325|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841519|NCT02688387|81248326|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841520|NCT02688387|81248327|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27841521|NCT02688387|81248328|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27892475|NCT00654875|81441286|FG001|Overall Study|Protocol Violation|3|||
27892476|NCT00654875|81441285|FG000|Overall Study|Lack of Efficacy|2|||
27892477|NCT00654875|81441286|FG001|Overall Study|Lack of Efficacy|2|||
27892478|NCT00654875|81441285|FG000|Overall Study|Lost to Follow-up|1|||
27892479|NCT00654875|81441286|FG001|Overall Study|Lost to Follow-up|3|||
27892480|NCT00654875|81441285|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
27892481|NCT00654875|81441286|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27503446|NCT03175367|80037769|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
27503447|NCT03175367|80037770|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
27503448|NCT03175367|80037771|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
27503449|NCT03175367|80037772|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27503450|NCT03175367|80037773|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27503451|NCT03175367|80037774|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27503452|NCT03175367|80037768|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27503453|NCT03175367|80037769|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27503454|NCT03175367|80037770|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
27503455|NCT03175367|80037771|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27503456|NCT03175367|80037772|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
27503457|NCT03175367|80037773|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27503458|NCT03175367|80037774|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27503459|NCT03175367|80037768|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27503460|NCT03175367|80037769|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27503461|NCT03175367|80037770|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27503462|NCT03175367|80037771|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27503463|NCT03175367|80037772|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27503464|NCT03175367|80037773|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
27503465|NCT03175367|80037774|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
27503466|NCT03175367|80037768|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27503467|NCT03175367|80037769|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27503468|NCT03175367|80037770|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27503469|NCT03175367|80037771|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27503470|NCT03175367|80037772|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27503471|NCT03175367|80037773|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
27503472|NCT03175367|80037774|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
27503473|NCT00561925|80037776|FG000|14 Day Lead-In Period|Adverse Event|38|||
27503474|NCT00561925|80037777|FG001|14 Day Lead-In Period|Adverse Event|0|||
27503475|NCT00561925|80037778|FG002|14 Day Lead-In Period|Adverse Event|0|||
27503476|NCT00561925|80037779|FG003|14 Day Lead-In Period|Adverse Event|0|||
27503477|NCT00561925|80037780|FG004|14 Day Lead-In Period|Adverse Event|0|||
27723521|NCT01114529|80819547|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
27892482|NCT00654875|81441285|FG000|Overall Study|Administrative Problems|1|||
27892483|NCT00654875|81441286|FG001|Overall Study|Administrative Problems|0|||
27892484|NCT05397171|81441287|FG000|Overall Study|Death|2|||
27892485|NCT05397171|81441288|FG001|Overall Study|Death|3|||
27892486|NCT05397171|81441289|FG002|Overall Study|Death|3|||
27892487|NCT05397171|81441287|FG000|Overall Study|Study Terminated By Sponsor|1|||
27892488|NCT05397171|81441288|FG001|Overall Study|Study Terminated By Sponsor|2|||
27892489|NCT05397171|81441289|FG002|Overall Study|Study Terminated By Sponsor|3|||
27892490|NCT05397171|81441287|FG000|Overall Study|Withdrawal by Subject|0|||
27892491|NCT05397171|81441288|FG001|Overall Study|Withdrawal by Subject|1|||
27892492|NCT05397171|81441289|FG002|Overall Study|Withdrawal by Subject|1|||
27892493|NCT02487771|81441294|FG000|Overall Study|Lost to Follow-up|2|||
27892494|NCT02487771|81441295|FG001|Overall Study|Lost to Follow-up|3|||
27892495|NCT02487771|81441294|FG000|Overall Study|Moved out of area|5|||
27892496|NCT02487771|81441295|FG001|Overall Study|Moved out of area|6|||
27892497|NCT02487771|81441294|FG000|Overall Study|Withdrawal by Subject|3|||
27892498|NCT02487771|81441295|FG001|Overall Study|Withdrawal by Subject|5|||
27892499|NCT03589976|81441296|FG000|Overall Study|Death|5|||
27892500|NCT03589976|81441297|FG001|Overall Study|Death|1|||
27892501|NCT03589976|81441296|FG000|Overall Study|Adverse Event|5|||
27892502|NCT03589976|81441297|FG001|Overall Study|Adverse Event|1|||
27892503|NCT03589976|81441296|FG000|Overall Study|Withdrawal by Subject|4|||
27892504|NCT03589976|81441297|FG001|Overall Study|Withdrawal by Subject|1|||
27892505|NCT03589976|81441296|FG000|Overall Study|Lost to Follow-up|1|||
27892506|NCT03589976|81441297|FG001|Overall Study|Lost to Follow-up|0|||
27723522|NCT01114529|80819545|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
27892507|NCT03589976|81441296|FG000|Overall Study|Other|4|||
27892508|NCT03589976|81441297|FG001|Overall Study|Other|3|||
27892509|NCT05087966|81441298|FG000|Overall Study|Lost to Follow-up|1|||
27892510|NCT05087966|81441298|FG000|Overall Study|Withdrawal by Subject|5|||
27892511|NCT01500187|81441299|FG000|Overall Study|Lost to Follow-up|6|||
27892512|NCT01500187|81441300|FG001|Overall Study|Lost to Follow-up|0|||
27892513|NCT00978250|81441301|FG000|Overall Study|Late determination of ineligibility|0|||
27723523|NCT01114529|80819546|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
27723524|NCT01114529|80819547|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
27723525|NCT01114529|80819545|FG000|Completed Study Phase at Month 24|Death|8|||
27723526|NCT01114529|80819546|FG001|Completed Study Phase at Month 24|Death|5|||
27723527|NCT01114529|80819547|FG002|Completed Study Phase at Month 24|Death|4|||
27723528|NCT01114529|80819545|FG000|Completed Study Phase at Month 24|Other|2|||
27723529|NCT01114529|80819546|FG001|Completed Study Phase at Month 24|Other|0|||
27723530|NCT01114529|80819547|FG002|Completed Study Phase at Month 24|Other|0|||
27723531|NCT01114529|80819545|FG000|Completed Study Phase at Month 24|Missing|2|||
27723532|NCT01114529|80819546|FG001|Completed Study Phase at Month 24|Missing|0|||
27723533|NCT01114529|80819547|FG002|Completed Study Phase at Month 24|Missing|0|||
27723534|NCT02944448|80819548|FG000|Overall Study|Adverse Event|37|||
27723535|NCT02944448|80819549|FG001|Overall Study|Adverse Event|6|||
27723536|NCT02944448|80819548|FG000|Overall Study|Lack of Efficacy|8|||
27723537|NCT02944448|80819549|FG001|Overall Study|Lack of Efficacy|5|||
27723538|NCT02944448|80819548|FG000|Overall Study|Lost to Follow-up|3|||
27723539|NCT02944448|80819549|FG001|Overall Study|Lost to Follow-up|1|||
27723540|NCT02944448|80819548|FG000|Overall Study|Protocol Violation|25|||
27723541|NCT02944448|80819549|FG001|Overall Study|Protocol Violation|7|||
27723542|NCT02944448|80819548|FG000|Overall Study|Withdrawal by Subject|14|||
27723543|NCT02944448|80819549|FG001|Overall Study|Withdrawal by Subject|4|||
27723544|NCT02944448|80819548|FG000|Overall Study|Sponsor did not supply drug in time|0|||
27723545|NCT02944448|80819549|FG001|Overall Study|Sponsor did not supply drug in time|1|||
27723546|NCT02944448|80819548|FG000|Overall Study|Noncompliant with dosing|1|||
27723547|NCT02944448|80819549|FG001|Overall Study|Noncompliant with dosing|0|||
27723548|NCT02944448|80819548|FG000|Overall Study|Abnormal laboratory values|1|||
27723549|NCT02944448|80819549|FG001|Overall Study|Abnormal laboratory values|0|||
27723550|NCT03472560|80819550|FG000|Overall Study|Subject transfer to continuation protocol|0|||
27723551|NCT03472560|80819551|FG001|Overall Study|Subject transfer to continuation protocol|1|||
27612228|NCT02138747|80423198|FG000|Treatment Period 1|Withdrawal by Subject|8|||
27612229|NCT02138747|80423199|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27612230|NCT02138747|80423200|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27612231|NCT02138747|80423201|FG003|Treatment Period 1|Withdrawal by Subject|3|||
27612232|NCT02138747|80423198|FG000|Treatment Period 1|Other - Miscellaneous|2|||
27612233|NCT02138747|80423199|FG001|Treatment Period 1|Other - Miscellaneous|4|||
27612234|NCT02138747|80423200|FG002|Treatment Period 1|Other - Miscellaneous|0|||
27612235|NCT02138747|80423201|FG003|Treatment Period 1|Other - Miscellaneous|0|||
27612236|NCT02138747|80423198|FG000|Treatment Period 2|Adverse Event|6|||
27723552|NCT03472560|80819550|FG000|Overall Study|Withdrawal by Subject|4|||
27723553|NCT03472560|80819551|FG001|Overall Study|Withdrawal by Subject|0|||
27723554|NCT03472560|80819550|FG000|Overall Study|Progressive disease|24|||
27723555|NCT03472560|80819551|FG001|Overall Study|Progressive disease|8|||
27723556|NCT03472560|80819550|FG000|Overall Study|Physician Decision|1|||
27723557|NCT03472560|80819551|FG001|Overall Study|Physician Decision|0|||
27723558|NCT03472560|80819550|FG000|Overall Study|Death|7|||
27723559|NCT03472560|80819551|FG001|Overall Study|Death|4|||
27723560|NCT03472560|80819550|FG000|Overall Study|Adverse Event|5|||
27723561|NCT03472560|80819551|FG001|Overall Study|Adverse Event|3|||
27612237|NCT02138747|80423199|FG001|Treatment Period 2|Adverse Event|3|||
27612238|NCT02138747|80423200|FG002|Treatment Period 2|Adverse Event|1|||
27612239|NCT02138747|80423201|FG003|Treatment Period 2|Adverse Event|1|||
27612240|NCT02138747|80423198|FG000|Treatment Period 2|Lost to Follow-up|2|||
27612241|NCT02138747|80423199|FG001|Treatment Period 2|Lost to Follow-up|0|||
27612242|NCT02138747|80423200|FG002|Treatment Period 2|Lost to Follow-up|0|||
27612243|NCT02138747|80423201|FG003|Treatment Period 2|Lost to Follow-up|0|||
27612244|NCT02138747|80423198|FG000|Treatment Period 2|Protocol Violation|1|||
27612245|NCT02138747|80423199|FG001|Treatment Period 2|Protocol Violation|0|||
27612246|NCT02138747|80423200|FG002|Treatment Period 2|Protocol Violation|0|||
27612247|NCT02138747|80423201|FG003|Treatment Period 2|Protocol Violation|0|||
27723562|NCT03472560|80819550|FG000|Overall Study|Global deterioration of health status|0|||
27723563|NCT03472560|80819551|FG001|Overall Study|Global deterioration of health status|4|||
27723564|NCT03555266|80819552|FG000|Overall Study|Protocol Violation|6|||
27723565|NCT03555266|80819553|FG001|Overall Study|Protocol Violation|4|||
27723566|NCT03167073|80819554|FG000|Overall Study|Stillbirth|1|||
27723567|NCT03167073|80819555|FG001|Overall Study|Stillbirth|0|||
27723568|NCT00087646|80819556|FG000|Overall Study|Adverse Event|37|||
27723569|NCT00087646|80819557|FG001|Overall Study|Adverse Event|6|||
27723570|NCT00087646|80819558|FG002|Overall Study|Adverse Event|18|||
27723571|NCT00087646|80819559|FG003|Overall Study|Adverse Event|20|||
27723572|NCT00087646|80819556|FG000|Overall Study|Death|0|||
27612248|NCT02138747|80423198|FG000|Treatment Period 2|Withdrawal by Subject|5|||
27612249|NCT02138747|80423199|FG001|Treatment Period 2|Withdrawal by Subject|4|||
27723573|NCT00087646|80819557|FG001|Overall Study|Death|1|||
27723574|NCT00087646|80819558|FG002|Overall Study|Death|0|||
27841522|NCT02688387|81248329|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
27723575|NCT00087646|80819559|FG003|Overall Study|Death|0|||
27612250|NCT02138747|80423200|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27723576|NCT00087646|80819556|FG000|Overall Study|Withdrawal by Subject|6|||
27723577|NCT00087646|80819557|FG001|Overall Study|Withdrawal by Subject|1|||
27723578|NCT00087646|80819558|FG002|Overall Study|Withdrawal by Subject|2|||
27723579|NCT00087646|80819559|FG003|Overall Study|Withdrawal by Subject|2|||
27723580|NCT00087646|80819556|FG000|Overall Study|Insufficient therapeutic response|64|||
27723581|NCT00087646|80819557|FG001|Overall Study|Insufficient therapeutic response|24|||
27723582|NCT00087646|80819558|FG002|Overall Study|Insufficient therapeutic response|38|||
27723583|NCT00087646|80819559|FG003|Overall Study|Insufficient therapeutic response|51|||
27723584|NCT00087646|80819556|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
27723585|NCT00087646|80819557|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
27841523|NCT02688387|81248308|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841524|NCT02688387|81248309|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841525|NCT02688387|81248310|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841526|NCT02688387|81248311|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
27841527|NCT02688387|81248312|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841528|NCT02688387|81248313|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841529|NCT02688387|81248314|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27723586|NCT00087646|80819558|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
27723587|NCT00087646|80819559|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
27723588|NCT00087646|80819556|FG000|Overall Study|Failure to Return|5|||
27723589|NCT00087646|80819557|FG001|Overall Study|Failure to Return|2|||
27723590|NCT00087646|80819558|FG002|Overall Study|Failure to Return|2|||
27723591|NCT00087646|80819559|FG003|Overall Study|Failure to Return|3|||
27723592|NCT00087646|80819556|FG000|Overall Study|Administrative/Other|6|||
27723593|NCT00087646|80819557|FG001|Overall Study|Administrative/Other|1|||
27723594|NCT00087646|80819558|FG002|Overall Study|Administrative/Other|1|||
27723595|NCT00087646|80819559|FG003|Overall Study|Administrative/Other|2|||
27723596|NCT00087646|80819556|FG000|Overall Study|Other Protocol Violation|3|||
27723597|NCT00087646|80819557|FG001|Overall Study|Other Protocol Violation|1|||
27723598|NCT00087646|80819558|FG002|Overall Study|Other Protocol Violation|0|||
27723599|NCT00087646|80819559|FG003|Overall Study|Other Protocol Violation|0|||
27723600|NCT00087646|80819556|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27723601|NCT00087646|80819557|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27723602|NCT00087646|80819558|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
27723603|NCT00087646|80819559|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
27723604|NCT02154425|80819564|FG000|Screening Period|Adverse Event|1|||
27723605|NCT00469612|80819565|FG000|Overall Study|Study terminated before data collected|2|||
27723606|NCT00469612|80819566|FG001|Overall Study|Study terminated before data collected|0|||
27841530|NCT02688387|81248315|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841531|NCT02688387|81248316|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841532|NCT02688387|81248317|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841533|NCT02688387|81248318|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841534|NCT02688387|81248319|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841535|NCT02688387|81248320|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841536|NCT02688387|81248321|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841537|NCT02688387|81248322|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841538|NCT02688387|81248323|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841539|NCT02688387|81248324|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841540|NCT02688387|81248325|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841541|NCT02688387|81248326|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841542|NCT02688387|81248327|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841543|NCT02688387|81248328|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841544|NCT02688387|81248329|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841545|NCT02688387|81248308|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841546|NCT02688387|81248309|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
27841547|NCT02688387|81248310|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841548|NCT02688387|81248311|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841549|NCT02688387|81248312|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841550|NCT02688387|81248313|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841551|NCT02688387|81248314|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841552|NCT02688387|81248315|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841553|NCT02688387|81248316|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27958602|NCT01791517|81680062|FG004|Phase II|Lack of Efficacy|1|||
27723607|NCT02631200|80819567|FG000|First Period|Death|1|||
27723608|NCT02631200|80819568|FG001|First Period|Death|2|||
27723609|NCT02631200|80819567|FG000|First Period|Patient ill-health|2|||
27723610|NCT02631200|80819568|FG001|First Period|Patient ill-health|4|||
27723611|NCT02631200|80819567|FG000|First Period|Withdrawal by Subject|4|||
27723612|NCT02631200|80819568|FG001|First Period|Withdrawal by Subject|1|||
27723613|NCT02631200|80819567|FG000|Deferred Period|Death|0|||
27723614|NCT02631200|80819568|FG001|Deferred Period|Death|1|||
27723615|NCT02631200|80819567|FG000|Deferred Period|Received kidney transplant|0|||
27723616|NCT02631200|80819568|FG001|Deferred Period|Received kidney transplant|1|||
27723617|NCT02631200|80819567|FG000|Deferred Period|Withdrawal by Subject|0|||
27723618|NCT02631200|80819568|FG001|Deferred Period|Withdrawal by Subject|2|||
27723619|NCT02631200|80819567|FG000|Deferred Period|Lost to Follow-up|0|||
27723620|NCT02631200|80819568|FG001|Deferred Period|Lost to Follow-up|1|||
27723621|NCT01602341|80819572|FG000|Overall Study|Adverse Event|0|||
27723622|NCT01602341|80819573|FG001|Overall Study|Adverse Event|1|||
27723623|NCT02574637|80819574|FG000|Double-blind Period|Adverse Event|1|||
27723624|NCT02574637|80819575|FG001|Double-blind Period|Adverse Event|0|||
27723625|NCT02574637|80819576|FG002|Double-blind Period|Adverse Event|0|||
27723626|NCT02574637|80819577|FG003|Double-blind Period|Adverse Event|0|||
27723627|NCT02574637|80819578|FG004|Double-blind Period|Adverse Event|0|||
27723628|NCT02574637|80819579|FG005|Double-blind Period|Adverse Event|0|||
27723629|NCT02574637|80819580|FG006|Double-blind Period|Adverse Event|0|||
27723630|NCT02574637|80819581|FG007|Double-blind Period|Adverse Event|0|||
27723631|NCT02574637|80819582|FG008|Double-blind Period|Adverse Event|0|||
27723632|NCT02574637|80819583|FG009|Double-blind Period|Adverse Event|0|||
27723633|NCT02574637|80819574|FG000|Double-blind Period|Lack of Efficacy|0|||
27723634|NCT02574637|80819575|FG001|Double-blind Period|Lack of Efficacy|0|||
27723635|NCT02574637|80819576|FG002|Double-blind Period|Lack of Efficacy|2|||
27723636|NCT02574637|80819577|FG003|Double-blind Period|Lack of Efficacy|0|||
27723637|NCT02574637|80819578|FG004|Double-blind Period|Lack of Efficacy|0|||
27723638|NCT02574637|80819579|FG005|Double-blind Period|Lack of Efficacy|0|||
27723639|NCT02574637|80819580|FG006|Double-blind Period|Lack of Efficacy|0|||
27723640|NCT02574637|80819581|FG007|Double-blind Period|Lack of Efficacy|0|||
27723641|NCT02574637|80819582|FG008|Double-blind Period|Lack of Efficacy|0|||
27723642|NCT02574637|80819583|FG009|Double-blind Period|Lack of Efficacy|0|||
27723643|NCT02574637|80819574|FG000|Double-blind Period|Protocol Deviation|1|||
27723644|NCT02574637|80819575|FG001|Double-blind Period|Protocol Deviation|0|||
27723645|NCT02574637|80819576|FG002|Double-blind Period|Protocol Deviation|0|||
27723646|NCT02574637|80819577|FG003|Double-blind Period|Protocol Deviation|0|||
27723647|NCT02574637|80819578|FG004|Double-blind Period|Protocol Deviation|0|||
27723648|NCT02574637|80819579|FG005|Double-blind Period|Protocol Deviation|0|||
27723649|NCT02574637|80819580|FG006|Double-blind Period|Protocol Deviation|0|||
27723650|NCT02574637|80819581|FG007|Double-blind Period|Protocol Deviation|0|||
27723651|NCT02574637|80819582|FG008|Double-blind Period|Protocol Deviation|0|||
27958603|NCT01791517|81680063|FG005|Phase II|Lack of Efficacy|0|||
27723652|NCT02574637|80819583|FG009|Double-blind Period|Protocol Deviation|0|||
27723653|NCT02574637|80819574|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
27723654|NCT02574637|80819575|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
27723655|NCT02574637|80819576|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
27841554|NCT02688387|81248317|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841555|NCT02688387|81248318|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841556|NCT02688387|81248319|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841557|NCT02688387|81248320|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841558|NCT02688387|81248321|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841559|NCT02688387|81248322|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841560|NCT02688387|81248323|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841561|NCT02688387|81248324|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841562|NCT02688387|81248325|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841563|NCT02688387|81248326|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841564|NCT02688387|81248327|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27723656|NCT02574637|80819577|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
27723657|NCT02574637|80819578|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
27723658|NCT02574637|80819579|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
27723659|NCT02574637|80819580|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
27723660|NCT02574637|80819581|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
27723661|NCT02574637|80819582|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
27723662|NCT02574637|80819583|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
27723663|NCT02574637|80819574|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
27723664|NCT02574637|80819575|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
27723665|NCT02574637|80819576|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
27841565|NCT02688387|81248328|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841566|NCT02688387|81248329|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
27841567|NCT02688387|81248308|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841568|NCT02688387|81248309|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841569|NCT02688387|81248310|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
27841570|NCT02688387|81248311|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841571|NCT02688387|81248312|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
27841572|NCT02688387|81248313|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841573|NCT02688387|81248314|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841574|NCT02688387|81248315|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841575|NCT02688387|81248316|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841576|NCT02688387|81248317|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841577|NCT02688387|81248318|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841578|NCT02688387|81248319|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841579|NCT02688387|81248320|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841580|NCT02688387|81248321|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841581|NCT02688387|81248322|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841582|NCT02688387|81248323|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841583|NCT02688387|81248324|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841584|NCT02688387|81248325|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841585|NCT02688387|81248326|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841586|NCT02688387|81248327|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841587|NCT02688387|81248328|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841588|NCT02688387|81248329|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
27841589|NCT02688387|81248308|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
27841590|NCT02688387|81248309|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27892514|NCT00978250|81441302|FG001|Overall Study|Late determination of ineligibility|1|||
27892515|NCT00978250|81441303|FG002|Overall Study|Late determination of ineligibility|0|||
27892516|NCT00978250|81441304|FG003|Overall Study|Late determination of ineligibility|1|||
27892517|NCT02680834|81441305|FG000|Overall Study|Physician Decision|5|||
27612251|NCT02138747|80423201|FG003|Treatment Period 2|Withdrawal by Subject|2|||
27612252|NCT02138747|80423198|FG000|Treatment Period 2|Other - Miscellaneous|3|||
27841591|NCT02688387|81248310|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27612253|NCT02138747|80423199|FG001|Treatment Period 2|Other - Miscellaneous|0|||
27612254|NCT02138747|80423200|FG002|Treatment Period 2|Other - Miscellaneous|0|||
27612255|NCT02138747|80423201|FG003|Treatment Period 2|Other - Miscellaneous|0|||
27612256|NCT02036515|80423202|FG000|Overall Study|Adverse Event|1|||
27612257|NCT02036515|80423203|FG001|Overall Study|Adverse Event|1|||
27612258|NCT02036515|80423204|FG002|Overall Study|Adverse Event|2|||
27612259|NCT02036515|80423202|FG000|Overall Study|Lost to Follow-up|0|||
27612260|NCT02036515|80423203|FG001|Overall Study|Lost to Follow-up|2|||
27612261|NCT02036515|80423204|FG002|Overall Study|Lost to Follow-up|0|||
27612262|NCT02036515|80423202|FG000|Overall Study|Non-compliance with study drug|0|||
27612263|NCT02036515|80423203|FG001|Overall Study|Non-compliance with study drug|0|||
27612264|NCT02036515|80423204|FG002|Overall Study|Non-compliance with study drug|2|||
27612265|NCT02036515|80423202|FG000|Overall Study|Screen failure|0|||
27612266|NCT02036515|80423203|FG001|Overall Study|Screen failure|2|||
27612267|NCT02036515|80423204|FG002|Overall Study|Screen failure|0|||
27612268|NCT02036515|80423202|FG000|Overall Study|Withdrawal by Subject|4|||
27723666|NCT02574637|80819577|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
27841592|NCT02688387|81248311|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841593|NCT02688387|81248312|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841594|NCT02688387|81248313|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27612269|NCT02036515|80423203|FG001|Overall Study|Withdrawal by Subject|7|||
27612270|NCT02036515|80423204|FG002|Overall Study|Withdrawal by Subject|9|||
27723667|NCT02574637|80819578|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
27723668|NCT02574637|80819579|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
27723669|NCT02574637|80819580|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
27612271|NCT02036515|80423202|FG000|Overall Study|Hyperglycemia|0|||
27723670|NCT02574637|80819581|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
27723671|NCT02574637|80819582|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
27723672|NCT02574637|80819583|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
27723673|NCT02574637|80819574|FG000|Double-blind Period|Reason Not Specified|0|||
27723674|NCT02574637|80819575|FG001|Double-blind Period|Reason Not Specified|0|||
27723675|NCT02574637|80819576|FG002|Double-blind Period|Reason Not Specified|0|||
27723676|NCT02574637|80819577|FG003|Double-blind Period|Reason Not Specified|1|||
27723677|NCT02574637|80819578|FG004|Double-blind Period|Reason Not Specified|0|||
27612272|NCT02036515|80423203|FG001|Overall Study|Hyperglycemia|0|||
27612273|NCT02036515|80423204|FG002|Overall Study|Hyperglycemia|1|||
27723678|NCT02574637|80819579|FG005|Double-blind Period|Reason Not Specified|0|||
27723679|NCT02574637|80819580|FG006|Double-blind Period|Reason Not Specified|0|||
27723680|NCT02574637|80819581|FG007|Double-blind Period|Reason Not Specified|0|||
27723681|NCT02574637|80819582|FG008|Double-blind Period|Reason Not Specified|0|||
27723682|NCT02574637|80819583|FG009|Double-blind Period|Reason Not Specified|0|||
27723683|NCT02574637|80819574|FG000|Open-label (OL) Period|Adverse Event|0|||
27723684|NCT02574637|80819575|FG001|Open-label (OL) Period|Adverse Event|0|||
27723685|NCT02574637|80819576|FG002|Open-label (OL) Period|Adverse Event|0|||
27723686|NCT02574637|80819577|FG003|Open-label (OL) Period|Adverse Event|0|||
27723687|NCT02574637|80819578|FG004|Open-label (OL) Period|Adverse Event|0|||
27723688|NCT02574637|80819579|FG005|Open-label (OL) Period|Adverse Event|0|||
27723689|NCT02574637|80819580|FG006|Open-label (OL) Period|Adverse Event|0|||
27723690|NCT02574637|80819581|FG007|Open-label (OL) Period|Adverse Event|0|||
27723691|NCT02574637|80819582|FG008|Open-label (OL) Period|Adverse Event|1|||
27723692|NCT02574637|80819583|FG009|Open-label (OL) Period|Adverse Event|0|||
27723693|NCT02574637|80819574|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
27723694|NCT02574637|80819575|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
27612274|NCT04296890|80423206|FG000|Overall Study|Withdrawal by Subject|1|||
27612275|NCT04296890|80423206|FG000|Overall Study|Death|62|||
27612276|NCT04296890|80423206|FG000|Overall Study|Lost to Follow-up|3|||
27612277|NCT04296890|80423206|FG000|Overall Study|Other than specified|2|||
27612278|NCT04248465|80423207|FG000|Randomized-Controlled Period|Death|12|||
27612279|NCT04248465|80423208|FG001|Randomized-Controlled Period|Death|5|||
27612280|NCT04248465|80423207|FG000|Randomized-Controlled Period|Adverse Event|2|||
27612281|NCT04248465|80423208|FG001|Randomized-Controlled Period|Adverse Event|0|||
27612282|NCT04248465|80423207|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
27612283|NCT04248465|80423208|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
27612284|NCT04248465|80423207|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
27612285|NCT04248465|80423208|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
27612286|NCT04248465|80423207|FG000|Randomized-Controlled Period|Physician Decision|1|||
27612287|NCT04248465|80423208|FG001|Randomized-Controlled Period|Physician Decision|1|||
27612288|NCT04248465|80423207|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
27612289|NCT04248465|80423208|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
27612290|NCT04248465|80423207|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
27612291|NCT04248465|80423208|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
27612292|NCT04248465|80423207|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
27612293|NCT04248465|80423208|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
27612294|NCT01533714|80423218|FG000|Overall Study|Adverse Event|0|||
27612295|NCT01533714|80423219|FG001|Overall Study|Adverse Event|1|||
27723695|NCT02574637|80819576|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
27723696|NCT02574637|80819577|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
27723697|NCT02574637|80819578|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
27723698|NCT02574637|80819579|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
27723699|NCT02574637|80819580|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
27723700|NCT02574637|80819581|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
27723701|NCT02574637|80819582|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
27723702|NCT02574637|80819583|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
27723703|NCT02574637|80819574|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27723704|NCT02574637|80819575|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27723705|NCT02574637|80819576|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27612296|NCT01533714|80423220|FG002|Overall Study|Adverse Event|2|||
27612297|NCT01533714|80423221|FG003|Overall Study|Adverse Event|2|||
27723706|NCT02574637|80819577|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27723707|NCT02574637|80819578|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27723708|NCT02574637|80819579|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
27723709|NCT02574637|80819580|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
27723710|NCT02574637|80819581|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
27723711|NCT02574637|80819582|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
27612298|NCT01533714|80423222|FG004|Overall Study|Adverse Event|2|||
27612299|NCT01533714|80423223|FG005|Overall Study|Adverse Event|1|||
27612300|NCT01533714|80423218|FG000|Overall Study|Lack of Efficacy|0|||
27612301|NCT01533714|80423219|FG001|Overall Study|Lack of Efficacy|0|||
27612302|NCT01533714|80423220|FG002|Overall Study|Lack of Efficacy|0|||
27612303|NCT01533714|80423221|FG003|Overall Study|Lack of Efficacy|0|||
27612304|NCT01533714|80423222|FG004|Overall Study|Lack of Efficacy|0|||
27612305|NCT01533714|80423223|FG005|Overall Study|Lack of Efficacy|1|||
27612306|NCT01533714|80423218|FG000|Overall Study|Withdrawal by Subject|0|||
27612307|NCT01533714|80423219|FG001|Overall Study|Withdrawal by Subject|1|||
27612308|NCT01533714|80423220|FG002|Overall Study|Withdrawal by Subject|0|||
27612309|NCT01533714|80423221|FG003|Overall Study|Withdrawal by Subject|1|||
27612310|NCT01533714|80423222|FG004|Overall Study|Withdrawal by Subject|1|||
27612311|NCT01533714|80423223|FG005|Overall Study|Withdrawal by Subject|0|||
27612312|NCT01533714|80423218|FG000|Overall Study|Exclusion criteria|0|||
27612313|NCT01533714|80423219|FG001|Overall Study|Exclusion criteria|1|||
27612314|NCT01533714|80423220|FG002|Overall Study|Exclusion criteria|0|||
27612315|NCT01533714|80423221|FG003|Overall Study|Exclusion criteria|0|||
27612316|NCT01533714|80423222|FG004|Overall Study|Exclusion criteria|0|||
27612317|NCT01533714|80423223|FG005|Overall Study|Exclusion criteria|0|||
27612318|NCT01533714|80423218|FG000|Overall Study|Positive for purified protein derivative|0|||
27612319|NCT01533714|80423219|FG001|Overall Study|Positive for purified protein derivative|0|||
27612320|NCT01533714|80423220|FG002|Overall Study|Positive for purified protein derivative|1|||
27612321|NCT01533714|80423221|FG003|Overall Study|Positive for purified protein derivative|0|||
27612322|NCT01533714|80423222|FG004|Overall Study|Positive for purified protein derivative|1|||
27612323|NCT01533714|80423223|FG005|Overall Study|Positive for purified protein derivative|0|||
27612324|NCT01533714|80423218|FG000|Overall Study|Withdrawal criteria|0|||
27612325|NCT01533714|80423219|FG001|Overall Study|Withdrawal criteria|0|||
27612326|NCT01533714|80423220|FG002|Overall Study|Withdrawal criteria|1|||
27612327|NCT01533714|80423221|FG003|Overall Study|Withdrawal criteria|0|||
27612328|NCT01533714|80423222|FG004|Overall Study|Withdrawal criteria|3|||
27612329|NCT01533714|80423223|FG005|Overall Study|Withdrawal criteria|1|||
27612330|NCT01533714|80423218|FG000|Overall Study|Ineligibility reason|0|||
27612331|NCT01533714|80423219|FG001|Overall Study|Ineligibility reason|0|||
27612332|NCT01533714|80423220|FG002|Overall Study|Ineligibility reason|0|||
27612333|NCT01533714|80423221|FG003|Overall Study|Ineligibility reason|1|||
27612334|NCT01533714|80423222|FG004|Overall Study|Ineligibility reason|0|||
27612335|NCT01533714|80423223|FG005|Overall Study|Ineligibility reason|0|||
27612336|NCT02917265|80423227|FG000|Overall Study|Physician Decision|1|||
27612337|NCT02917265|80423228|FG001|Overall Study|Physician Decision|0|||
27612338|NCT02917265|80423227|FG000|Overall Study|Withdrawal by Subject|1|||
27612339|NCT02917265|80423228|FG001|Overall Study|Withdrawal by Subject|0|||
27612340|NCT00472186|80423238|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
27612341|NCT00472186|80423239|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
27612342|NCT00453310|80423240|FG000|Overall Study|Progression of Disease|10|||
27723712|NCT02574637|80819583|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
27723713|NCT00500682|80819584|FG000|Overall Study|Adverse Event|37|||
27723714|NCT00500682|80819585|FG001|Overall Study|Adverse Event|29|||
27723715|NCT00500682|80819584|FG000|Overall Study|Death|25|||
27723716|NCT00500682|80819585|FG001|Overall Study|Death|16|||
27723717|NCT00500682|80819584|FG000|Overall Study|Lost to Follow-up|11|||
27723718|NCT00500682|80819585|FG001|Overall Study|Lost to Follow-up|11|||
27723719|NCT00500682|80819584|FG000|Overall Study|Physician Decision|6|||
27723720|NCT00500682|80819585|FG001|Overall Study|Physician Decision|10|||
27723721|NCT00500682|80819584|FG000|Overall Study|Pregnancy|2|||
27723722|NCT00500682|80819585|FG001|Overall Study|Pregnancy|0|||
27723723|NCT00500682|80819584|FG000|Overall Study|Protocol Violation|1|||
27723724|NCT00500682|80819585|FG001|Overall Study|Protocol Violation|3|||
27723725|NCT00500682|80819584|FG000|Overall Study|Withdrawal by Subject|80|||
27723726|NCT00500682|80819585|FG001|Overall Study|Withdrawal by Subject|74|||
27723727|NCT00500682|80819584|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
27723728|NCT00500682|80819585|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
27723729|NCT02629159|80819586|FG000|Overall Study|Adverse Event|17|||
27723730|NCT02629159|80819587|FG001|Overall Study|Adverse Event|20|||
27612343|NCT01284140|80423256|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
27612344|NCT01284140|80423257|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
27612345|NCT01284140|80423256|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
27612346|NCT01284140|80423257|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
27612347|NCT00514046|80423258|FG000|Overall Study|transferred to another protocol|2|||
27612348|NCT00514046|80423259|FG001|Overall Study|transferred to another protocol|1|||
27723731|NCT02629159|80819588|FG002|Overall Study|Adverse Event|22|||
27723732|NCT02629159|80819586|FG000|Overall Study|Withdrawal by Subject|22|||
27723733|NCT02629159|80819587|FG001|Overall Study|Withdrawal by Subject|11|||
27723734|NCT02629159|80819588|FG002|Overall Study|Withdrawal by Subject|15|||
27723735|NCT02629159|80819586|FG000|Overall Study|Lost to Follow-up|7|||
27723736|NCT02629159|80819587|FG001|Overall Study|Lost to Follow-up|4|||
27723737|NCT02629159|80819588|FG002|Overall Study|Lost to Follow-up|5|||
27723738|NCT02629159|80819586|FG000|Overall Study|Lack of Efficacy|4|||
27723739|NCT02629159|80819587|FG001|Overall Study|Lack of Efficacy|0|||
27723740|NCT02629159|80819588|FG002|Overall Study|Lack of Efficacy|1|||
27723741|NCT02629159|80819586|FG000|Overall Study|Other|6|||
27723742|NCT02629159|80819587|FG001|Overall Study|Other|4|||
27723743|NCT02629159|80819588|FG002|Overall Study|Other|8|||
27723744|NCT00400400|80819594|FG000|Overall Study|Adverse Event|9|||
27723745|NCT00400400|80819595|FG001|Overall Study|Adverse Event|8|||
27723746|NCT00400400|80819594|FG000|Overall Study|Protocol Violation|2|||
27723747|NCT00400400|80819595|FG001|Overall Study|Protocol Violation|0|||
27723748|NCT00400400|80819594|FG000|Overall Study|Withdrawal by Subject|1|||
27723749|NCT00400400|80819595|FG001|Overall Study|Withdrawal by Subject|3|||
27723750|NCT00400400|80819594|FG000|Overall Study|Administrative Problem|1|||
27723751|NCT00400400|80819595|FG001|Overall Study|Administrative Problem|0|||
27723752|NCT00400400|80819594|FG000|Overall Study|Lost to Follow-up|0|||
27723753|NCT00400400|80819595|FG001|Overall Study|Lost to Follow-up|1|||
27723754|NCT00400400|80819594|FG000|Overall Study|Did not receive study drug|1|||
27723755|NCT00400400|80819595|FG001|Overall Study|Did not receive study drug|3|||
27723756|NCT00654498|80819596|FG000|Overall Study|Not Treated|1|||
27723757|NCT00654498|80819597|FG001|Overall Study|Not Treated|0|||
27723758|NCT00654498|80819596|FG000|Overall Study|Adverse Event|6|||
27723759|NCT00654498|80819597|FG001|Overall Study|Adverse Event|1|||
27723760|NCT00654498|80819596|FG000|Overall Study|Protocol Violation|1|||
27723761|NCT00654498|80819597|FG001|Overall Study|Protocol Violation|1|||
27723762|NCT00654498|80819596|FG000|Overall Study|Lost to Follow-up|1|||
27723763|NCT00654498|80819597|FG001|Overall Study|Lost to Follow-up|5|||
27723764|NCT00654498|80819596|FG000|Overall Study|Withdrawal by Subject|1|||
27723765|NCT00654498|80819597|FG001|Overall Study|Withdrawal by Subject|0|||
27723766|NCT00654498|80819596|FG000|Overall Study|Other reason not defined above|4|||
27723767|NCT00654498|80819597|FG001|Overall Study|Other reason not defined above|5|||
27723768|NCT00257010|80819598|FG000|Overall Study|Lack of Efficacy|11|||
27723769|NCT00257010|80819598|FG000|Overall Study|Lost to Follow-up|53|||
27723770|NCT00257010|80819598|FG000|Overall Study|Withdrawal by Subject|34|||
27723771|NCT00257010|80819598|FG000|Overall Study|Adverse Event|10|||
27723772|NCT00257010|80819598|FG000|Overall Study|various|11|||
27723773|NCT00257010|80819598|FG000|Overall Study|no headache reported|9|||
27723774|NCT04269395|80819599|FG000|Overall Study|Lost to Follow-up|1|||
27723775|NCT04269395|80819600|FG001|Overall Study|Lost to Follow-up|0|||
27723776|NCT04269395|80819599|FG000|Overall Study|Study terminated by Sponsor|13|||
27723777|NCT04269395|80819600|FG001|Overall Study|Study terminated by Sponsor|10|||
27723778|NCT01408147|80819601|FG000|Overall Study|Withdrawal by Subject|0|||
27723779|NCT01408147|80819602|FG001|Overall Study|Withdrawal by Subject|1|||
27723780|NCT01235962|80819606|FG000|Overall Study|Withdrawal by Subject|20|||
27723781|NCT01235962|80819607|FG001|Overall Study|Withdrawal by Subject|19|||
27723782|NCT01235962|80819608|FG002|Overall Study|Withdrawal by Subject|62|||
27723783|NCT01235962|80819609|FG003|Overall Study|Withdrawal by Subject|49|||
27723784|NCT01235962|80819606|FG000|Overall Study|Lost to Follow-up|21|||
27723785|NCT01235962|80819607|FG001|Overall Study|Lost to Follow-up|16|||
27723786|NCT01235962|80819608|FG002|Overall Study|Lost to Follow-up|47|||
27723787|NCT01235962|80819609|FG003|Overall Study|Lost to Follow-up|32|||
27723788|NCT01235962|80819606|FG000|Overall Study|Physician Decision|5|||
27723789|NCT01235962|80819607|FG001|Overall Study|Physician Decision|0|||
27723790|NCT01235962|80819608|FG002|Overall Study|Physician Decision|9|||
27723791|NCT01235962|80819609|FG003|Overall Study|Physician Decision|5|||
27723792|NCT00880256|80819613|FG000|Overall Study|Lost to Follow-up|28|||
27723793|NCT00769119|80819617|FG000|Overall Study|Voluntary discontinuation|0|||
27723794|NCT00769119|80819618|FG001|Overall Study|Voluntary discontinuation|2|||
27723795|NCT00769119|80819617|FG000|Overall Study|Adverse Event|1|||
27723796|NCT00769119|80819618|FG001|Overall Study|Adverse Event|1|||
27723797|NCT00769119|80819617|FG000|Overall Study|Disallowed medication|1|||
27723798|NCT00769119|80819618|FG001|Overall Study|Disallowed medication|0|||
27723799|NCT03575104|80819619|FG000|Overall Study|Adverse Event|4|||
27723800|NCT03575104|80819620|FG001|Overall Study|Adverse Event|3|||
27723801|NCT03575104|80819621|FG002|Overall Study|Adverse Event|4|||
27723802|NCT03575104|80819619|FG000|Overall Study|Withdrawal by Subject|13|||
27723803|NCT03575104|80819620|FG001|Overall Study|Withdrawal by Subject|16|||
27841595|NCT02688387|81248314|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27723804|NCT03575104|80819621|FG002|Overall Study|Withdrawal by Subject|11|||
27723805|NCT03575104|80819619|FG000|Overall Study|Other reasons|6|||
27723806|NCT03575104|80819620|FG001|Overall Study|Other reasons|8|||
27723807|NCT03575104|80819621|FG002|Overall Study|Other reasons|6|||
27723808|NCT03575104|80819619|FG000|Overall Study|Lost to Follow-up|1|||
27723809|NCT03575104|80819620|FG001|Overall Study|Lost to Follow-up|2|||
27723810|NCT03575104|80819621|FG002|Overall Study|Lost to Follow-up|1|||
27723811|NCT00264004|80819628|FG000|Overall Study|Adverse Event|2|||
27723812|NCT00264004|80819629|FG001|Overall Study|Adverse Event|3|||
27723813|NCT00264004|80819630|FG002|Overall Study|Adverse Event|6|||
27612349|NCT00514046|80423260|FG002|Overall Study|transferred to another protocol|3|||
27612350|NCT00514046|80423261|FG003|Overall Study|transferred to another protocol|0|||
27612351|NCT00514046|80423262|FG004|Overall Study|transferred to another protocol|1|||
27612352|NCT00514046|80423263|FG005|Overall Study|transferred to another protocol|0|||
27612353|NCT00514046|80423264|FG006|Overall Study|transferred to another protocol|0|||
27612354|NCT00514046|80423265|FG007|Overall Study|transferred to another protocol|0|||
27612355|NCT00514046|80423266|FG008|Overall Study|transferred to another protocol|0|||
27612356|NCT00514046|80423258|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
27612357|NCT00514046|80423259|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
27612358|NCT00514046|80423260|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
27612359|NCT00514046|80423261|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
27612360|NCT00514046|80423262|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
27612361|NCT00514046|80423263|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
27612362|NCT00514046|80423264|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
27612363|NCT00514046|80423265|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
27612364|NCT00514046|80423266|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
27612365|NCT00514046|80423258|FG000|Overall Study|Disease progression on study|0|||
27612366|NCT00514046|80423259|FG001|Overall Study|Disease progression on study|0|||
27612367|NCT00514046|80423260|FG002|Overall Study|Disease progression on study|2|||
27612368|NCT00514046|80423261|FG003|Overall Study|Disease progression on study|0|||
27612369|NCT00514046|80423262|FG004|Overall Study|Disease progression on study|0|||
27612370|NCT00514046|80423263|FG005|Overall Study|Disease progression on study|1|||
27612371|NCT00514046|80423264|FG006|Overall Study|Disease progression on study|0|||
27612372|NCT00514046|80423265|FG007|Overall Study|Disease progression on study|0|||
27612373|NCT00514046|80423266|FG008|Overall Study|Disease progression on study|0|||
27612374|NCT03075501|80423269|FG000|Overall Study|Scheduling difficulties|15|||
27612375|NCT03075501|80423270|FG001|Overall Study|Scheduling difficulties|9|||
27612376|NCT03154359|80423273|FG000|Overall Study|Adverse Event|1|||
27612377|NCT03154359|80423273|FG000|Overall Study|Lack of Efficacy|2|||
27612378|NCT03154359|80423273|FG000|Overall Study|Lost to Follow-up|3|||
27612379|NCT03154359|80423273|FG000|Overall Study|Physician Decision|3|||
27612380|NCT03154359|80423273|FG000|Overall Study|Protocol Violation|4|||
27612381|NCT03154359|80423273|FG000|Overall Study|Withdrawal by Subject|5|||
27612382|NCT03154359|80423273|FG000|Overall Study|Disruption of study due to COVID-19|4|||
27612383|NCT02609659|80423277|FG000|Overall Study|Adverse Event|1|||
27612384|NCT02609659|80423277|FG000|Overall Study|Lost to Follow-up|6|||
27612385|NCT02609659|80423277|FG000|Overall Study|Other|1|||
27612386|NCT01923428|80423282|FG000|Overall Study|Adverse Event|8|||
27612387|NCT01923428|80423283|FG001|Overall Study|Adverse Event|6|||
27612388|NCT01923428|80423284|FG002|Overall Study|Adverse Event|3|||
27612389|NCT01923428|80423285|FG003|Overall Study|Adverse Event|3|||
27612390|NCT01923428|80423282|FG000|Overall Study|Withdrawal by Subject|5|||
27612391|NCT01923428|80423283|FG001|Overall Study|Withdrawal by Subject|3|||
27612392|NCT01923428|80423284|FG002|Overall Study|Withdrawal by Subject|0|||
27612393|NCT01923428|80423285|FG003|Overall Study|Withdrawal by Subject|4|||
27612394|NCT01923428|80423282|FG000|Overall Study|Lost to Follow-up|2|||
27612395|NCT01923428|80423283|FG001|Overall Study|Lost to Follow-up|1|||
27612396|NCT01923428|80423284|FG002|Overall Study|Lost to Follow-up|5|||
27612397|NCT01923428|80423285|FG003|Overall Study|Lost to Follow-up|0|||
27612398|NCT01923428|80423282|FG000|Overall Study|Protocol Violation|3|||
27612399|NCT01923428|80423283|FG001|Overall Study|Protocol Violation|0|||
27612400|NCT01923428|80423284|FG002|Overall Study|Protocol Violation|2|||
27612401|NCT01923428|80423285|FG003|Overall Study|Protocol Violation|1|||
27612402|NCT01923428|80423282|FG000|Overall Study|Non Compliance to treatment|1|||
27612403|NCT01923428|80423283|FG001|Overall Study|Non Compliance to treatment|2|||
27612404|NCT01923428|80423284|FG002|Overall Study|Non Compliance to treatment|0|||
27612405|NCT01923428|80423285|FG003|Overall Study|Non Compliance to treatment|1|||
27612406|NCT01923428|80423282|FG000|Overall Study|Lack of Efficacy|0|||
27612407|NCT01923428|80423283|FG001|Overall Study|Lack of Efficacy|0|||
27612408|NCT01923428|80423284|FG002|Overall Study|Lack of Efficacy|1|||
27612409|NCT01923428|80423285|FG003|Overall Study|Lack of Efficacy|1|||
27612410|NCT01370603|80423286|FG000|Period 1|Adverse Event|5|||
27612411|NCT01370603|80423287|FG001|Period 1|Adverse Event|3|||
27612412|NCT01370603|80423286|FG000|Period 1|Lost to Follow-up|2|||
27612413|NCT01370603|80423287|FG001|Period 1|Lost to Follow-up|0|||
27612414|NCT01370603|80423286|FG000|Period 1|Protocol Violation|2|||
27612415|NCT01370603|80423287|FG001|Period 1|Protocol Violation|2|||
27612416|NCT01370603|80423286|FG000|Period 1|Withdrawal by Subject|5|||
27612417|NCT01370603|80423287|FG001|Period 1|Withdrawal by Subject|5|||
27841596|NCT02688387|81248315|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27612418|NCT01370603|80423286|FG000|Crossover Washout|Adverse Event|2|||
27612419|NCT01370603|80423287|FG001|Crossover Washout|Adverse Event|1|||
27612420|NCT01370603|80423286|FG000|Crossover Washout|Lost to Follow-up|2|||
27612421|NCT01370603|80423287|FG001|Crossover Washout|Lost to Follow-up|0|||
27841597|NCT02688387|81248316|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27612422|NCT01370603|80423286|FG000|Crossover Washout|Protocol Violation|1|||
27612423|NCT01370603|80423287|FG001|Crossover Washout|Protocol Violation|0|||
27612424|NCT01370603|80423286|FG000|Crossover Washout|Withdrawal by Subject|4|||
27612425|NCT01370603|80423287|FG001|Crossover Washout|Withdrawal by Subject|1|||
27612426|NCT01370603|80423286|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
27612427|NCT01370603|80423287|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
27612428|NCT01370603|80423286|FG000|Period 2|Adverse Event|1|||
27612429|NCT01370603|80423287|FG001|Period 2|Adverse Event|4|||
27612430|NCT01370603|80423286|FG000|Period 2|Lost to Follow-up|1|||
27612431|NCT01370603|80423287|FG001|Period 2|Lost to Follow-up|0|||
27612432|NCT01370603|80423286|FG000|Period 2|Withdrawal by Subject|1|||
27612433|NCT01370603|80423287|FG001|Period 2|Withdrawal by Subject|0|||
27612434|NCT00235443|80423294|FG000|Overall Study|Adverse Event|4|||
27612435|NCT00235443|80423295|FG001|Overall Study|Adverse Event|12|||
27612436|NCT00235443|80423296|FG002|Overall Study|Adverse Event|17|||
27841598|NCT02688387|81248317|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841599|NCT02688387|81248318|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841600|NCT02688387|81248319|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841601|NCT02688387|81248320|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841602|NCT02688387|81248321|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841603|NCT02688387|81248322|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27723814|NCT00264004|80819631|FG003|Overall Study|Adverse Event|4|||
27723815|NCT00264004|80819628|FG000|Overall Study|Withdrawal by Subject|0|||
27723816|NCT00264004|80819629|FG001|Overall Study|Withdrawal by Subject|1|||
27723817|NCT00264004|80819630|FG002|Overall Study|Withdrawal by Subject|2|||
27723818|NCT00264004|80819631|FG003|Overall Study|Withdrawal by Subject|2|||
27723819|NCT00264004|80819628|FG000|Overall Study|Other|2|||
27723820|NCT00264004|80819629|FG001|Overall Study|Other|2|||
27723821|NCT00264004|80819630|FG002|Overall Study|Other|0|||
27612437|NCT00235443|80423297|FG003|Overall Study|Adverse Event|44|||
27612438|NCT00235443|80423298|FG004|Overall Study|Adverse Event|10|||
27612439|NCT00235443|80423299|FG005|Overall Study|Adverse Event|15|||
27612440|NCT00235443|80423294|FG000|Overall Study|Lack of Efficacy|0|||
27612441|NCT00235443|80423295|FG001|Overall Study|Lack of Efficacy|1|||
27612442|NCT00235443|80423296|FG002|Overall Study|Lack of Efficacy|5|||
27612443|NCT00235443|80423297|FG003|Overall Study|Lack of Efficacy|12|||
27612444|NCT00235443|80423298|FG004|Overall Study|Lack of Efficacy|2|||
27612445|NCT00235443|80423299|FG005|Overall Study|Lack of Efficacy|9|||
27612446|NCT00235443|80423294|FG000|Overall Study|Withdrawal by Subject|3|||
27612447|NCT00235443|80423295|FG001|Overall Study|Withdrawal by Subject|9|||
27612448|NCT00235443|80423296|FG002|Overall Study|Withdrawal by Subject|25|||
27612449|NCT00235443|80423297|FG003|Overall Study|Withdrawal by Subject|24|||
27612450|NCT00235443|80423298|FG004|Overall Study|Withdrawal by Subject|10|||
27612451|NCT00235443|80423299|FG005|Overall Study|Withdrawal by Subject|12|||
27612452|NCT00235443|80423294|FG000|Overall Study|Lost to Follow-up|0|||
27612453|NCT00235443|80423295|FG001|Overall Study|Lost to Follow-up|8|||
27612454|NCT00235443|80423296|FG002|Overall Study|Lost to Follow-up|6|||
27612455|NCT00235443|80423297|FG003|Overall Study|Lost to Follow-up|6|||
27612456|NCT00235443|80423298|FG004|Overall Study|Lost to Follow-up|4|||
27612457|NCT00235443|80423299|FG005|Overall Study|Lost to Follow-up|3|||
27612458|NCT00235443|80423294|FG000|Overall Study|Unsatisfactory compliance|0|||
27723822|NCT00264004|80819631|FG003|Overall Study|Other|3|||
27723823|NCT00264004|80819628|FG000|Overall Study|Development study specific disc. crit.|1|||
27723824|NCT00264004|80819629|FG001|Overall Study|Development study specific disc. crit.|0|||
27841604|NCT02688387|81248323|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841605|NCT02688387|81248324|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841606|NCT02688387|81248325|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841607|NCT02688387|81248326|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27503478|NCT00561925|80037776|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
27503479|NCT00561925|80037777|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
27503480|NCT00561925|80037778|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
27841608|NCT02688387|81248327|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27892518|NCT02680834|81441306|FG001|Overall Study|Physician Decision|2|||
27503481|NCT00561925|80037779|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
27612459|NCT00235443|80423295|FG001|Overall Study|Unsatisfactory compliance|2|||
27612460|NCT00235443|80423296|FG002|Overall Study|Unsatisfactory compliance|3|||
27612461|NCT00235443|80423297|FG003|Overall Study|Unsatisfactory compliance|4|||
27612462|NCT00235443|80423298|FG004|Overall Study|Unsatisfactory compliance|1|||
27612463|NCT00235443|80423299|FG005|Overall Study|Unsatisfactory compliance|0|||
27612464|NCT00235443|80423294|FG000|Overall Study|Other reasons for premature termination|1|||
27612465|NCT00235443|80423295|FG001|Overall Study|Other reasons for premature termination|6|||
27612466|NCT00235443|80423296|FG002|Overall Study|Other reasons for premature termination|6|||
27723825|NCT00264004|80819630|FG002|Overall Study|Development study specific disc. crit.|1|||
27723826|NCT00264004|80819631|FG003|Overall Study|Development study specific disc. crit.|0|||
27723827|NCT00264004|80819628|FG000|Overall Study|Cond. under inv. worsened|9|||
27503482|NCT00561925|80037780|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
27503483|NCT00561925|80037776|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
27503484|NCT00561925|80037777|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
27503485|NCT00561925|80037778|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
27503486|NCT00561925|80037779|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
27503487|NCT00561925|80037780|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
27503488|NCT00561925|80037776|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
27503489|NCT00561925|80037777|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
27503490|NCT00561925|80037778|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
27503491|NCT00561925|80037779|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
27503492|NCT00561925|80037780|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
27503493|NCT00561925|80037776|FG000|14 Day Lead-In Period|Other|5|||
27503494|NCT00561925|80037777|FG001|14 Day Lead-In Period|Other|0|||
27503495|NCT00561925|80037778|FG002|14 Day Lead-In Period|Other|0|||
27503496|NCT00561925|80037779|FG003|14 Day Lead-In Period|Other|0|||
27503497|NCT00561925|80037780|FG004|14 Day Lead-In Period|Other|0|||
27612467|NCT00235443|80423297|FG003|Overall Study|Other reasons for premature termination|7|||
27612468|NCT00235443|80423298|FG004|Overall Study|Other reasons for premature termination|3|||
27612469|NCT00235443|80423299|FG005|Overall Study|Other reasons for premature termination|6|||
27612470|NCT01679236|80423300|FG000|Overall Study|Lost to Follow-up|15|||
27612471|NCT01679236|80423301|FG001|Overall Study|Lost to Follow-up|15|||
27612472|NCT01582789|80423304|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27612473|NCT01582789|80423305|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27612474|NCT01018563|80423308|FG000|Overall Study|Termination of the study by Sponsor|2|||
27612475|NCT01018563|80423309|FG001|Overall Study|Termination of the study by Sponsor|1|||
27612476|NCT00708305|80423310|FG000|Period 1|Protocol Violation|1|||
27612477|NCT00708305|80423311|FG001|Period 1|Protocol Violation|0|||
27612478|NCT00708305|80423312|FG002|Period 1|Protocol Violation|1|||
27612479|NCT00708305|80423313|FG003|Period 1|Protocol Violation|0|||
27612480|NCT00708305|80423310|FG000|Period 1|Other Reason|0|||
27612481|NCT00708305|80423311|FG001|Period 1|Other Reason|0|||
27612482|NCT00708305|80423312|FG002|Period 1|Other Reason|0|||
27612483|NCT00708305|80423313|FG003|Period 1|Other Reason|2|||
27612484|NCT00708305|80423310|FG000|Period 2|Lost to Follow-up|0|||
27612485|NCT00708305|80423311|FG001|Period 2|Lost to Follow-up|1|||
27612486|NCT00708305|80423312|FG002|Period 2|Lost to Follow-up|0|||
27612487|NCT00708305|80423313|FG003|Period 2|Lost to Follow-up|0|||
27612488|NCT00708305|80423310|FG000|Period 2|Protocol Violation|0|||
27612489|NCT00708305|80423311|FG001|Period 2|Protocol Violation|1|||
27612490|NCT00708305|80423312|FG002|Period 2|Protocol Violation|0|||
27612491|NCT00708305|80423313|FG003|Period 2|Protocol Violation|0|||
27612492|NCT00708305|80423310|FG000|Period 2|Other Reason|1|||
27612493|NCT00708305|80423311|FG001|Period 2|Other Reason|0|||
27612494|NCT00708305|80423312|FG002|Period 2|Other Reason|0|||
27612495|NCT00708305|80423313|FG003|Period 2|Other Reason|1|||
27612496|NCT00708305|80423310|FG000|Period 3|Protocol Violation|0|||
27612497|NCT00708305|80423311|FG001|Period 3|Protocol Violation|2|||
27612498|NCT00708305|80423312|FG002|Period 3|Protocol Violation|0|||
27612499|NCT00708305|80423313|FG003|Period 3|Protocol Violation|0|||
27612500|NCT00708305|80423310|FG000|Period 3|Other Reason|1|||
27612501|NCT00708305|80423311|FG001|Period 3|Other Reason|0|||
27612502|NCT00708305|80423312|FG002|Period 3|Other Reason|0|||
27612503|NCT00708305|80423313|FG003|Period 3|Other Reason|0|||
27612504|NCT03321513|80423314|FG000|Overall Study|Death|11|||
27612505|NCT03321513|80423315|FG001|Overall Study|Death|5|||
27612506|NCT03321513|80423314|FG000|Overall Study|Withdrawal by Subject|5|||
27612507|NCT03321513|80423315|FG001|Overall Study|Withdrawal by Subject|10|||
27612508|NCT03321513|80423314|FG000|Overall Study|Lost to Follow-up|10|||
27612509|NCT03321513|80423315|FG001|Overall Study|Lost to Follow-up|11|||
27612510|NCT00065468|80423322|FG000|Overall Study|Death|172|||
27723828|NCT00264004|80819629|FG001|Overall Study|Cond. under inv. worsened|5|||
27723829|NCT00264004|80819630|FG002|Overall Study|Cond. under inv. worsened|3|||
27723830|NCT00264004|80819631|FG003|Overall Study|Cond. under inv. worsened|4|||
27723831|NCT00264004|80819628|FG000|Overall Study|Not treated|3|||
27723832|NCT00264004|80819629|FG001|Overall Study|Not treated|0|||
27723833|NCT00264004|80819630|FG002|Overall Study|Not treated|2|||
27723834|NCT00264004|80819631|FG003|Overall Study|Not treated|2|||
27723835|NCT03336502|80819635|FG000|Overall Study|Physician Decision|0|||
27723836|NCT03336502|80819636|FG001|Overall Study|Physician Decision|1|||
27723837|NCT03336502|80819635|FG000|Overall Study|Prohibited Drugs|1|||
27723838|NCT03336502|80819636|FG001|Overall Study|Prohibited Drugs|1|||
27723839|NCT03336502|80819635|FG000|Overall Study|Death|1|||
27723840|NCT03336502|80819636|FG001|Overall Study|Death|2|||
27723841|NCT03336502|80819635|FG000|Overall Study|Adverse Event|2|||
27723842|NCT03336502|80819636|FG001|Overall Study|Adverse Event|5|||
27723843|NCT03902080|80819643|FG000|Overall Study|Adverse Event|17|||
27723844|NCT03902080|80819644|FG001|Overall Study|Adverse Event|15|||
27723845|NCT03902080|80819643|FG000|Overall Study|Withdrawal by Subject|28|||
27723846|NCT03902080|80819644|FG001|Overall Study|Withdrawal by Subject|35|||
27723847|NCT03902080|80819643|FG000|Overall Study|Lost to Follow-up|6|||
27723848|NCT03902080|80819644|FG001|Overall Study|Lost to Follow-up|7|||
27723849|NCT03902080|80819643|FG000|Overall Study|Other|3|||
27723850|NCT03902080|80819644|FG001|Overall Study|Other|5|||
27723851|NCT03902080|80819643|FG000|Overall Study|Non compliance|4|||
27723852|NCT03902080|80819644|FG001|Overall Study|Non compliance|3|||
27723853|NCT03902080|80819643|FG000|Overall Study|Physician Decision|5|||
27723854|NCT03902080|80819644|FG001|Overall Study|Physician Decision|1|||
27723855|NCT03902080|80819643|FG000|Overall Study|Protocol Violation|3|||
27723856|NCT03902080|80819644|FG001|Overall Study|Protocol Violation|3|||
27723857|NCT03902080|80819643|FG000|Overall Study|Lack of Efficacy|1|||
27723858|NCT03902080|80819644|FG001|Overall Study|Lack of Efficacy|3|||
27723859|NCT03902080|80819643|FG000|Overall Study|Withdrawn prior to dosing|0|||
27723860|NCT03902080|80819644|FG001|Overall Study|Withdrawn prior to dosing|1|||
27723861|NCT00168831|80819645|FG000|Overall Study|Adverse Event|36|||
27723862|NCT00168831|80819646|FG001|Overall Study|Adverse Event|47|||
27723863|NCT00168831|80819647|FG002|Overall Study|Adverse Event|74|||
27723864|NCT00168831|80819645|FG000|Overall Study|Lost to Follow-up|5|||
27723865|NCT00168831|80819646|FG001|Overall Study|Lost to Follow-up|6|||
27723866|NCT00168831|80819647|FG002|Overall Study|Lost to Follow-up|4|||
27723867|NCT00168831|80819645|FG000|Overall Study|Withdrawal by Subject|7|||
27723868|NCT00168831|80819646|FG001|Overall Study|Withdrawal by Subject|14|||
27723869|NCT00168831|80819647|FG002|Overall Study|Withdrawal by Subject|19|||
27723870|NCT00168831|80819645|FG000|Overall Study|Protocol Violation|6|||
27723871|NCT00168831|80819646|FG001|Overall Study|Protocol Violation|11|||
27723872|NCT00168831|80819647|FG002|Overall Study|Protocol Violation|11|||
27723873|NCT00168831|80819645|FG000|Overall Study|Other|6|||
27723874|NCT00168831|80819646|FG001|Overall Study|Other|3|||
27723875|NCT00168831|80819647|FG002|Overall Study|Other|6|||
27723876|NCT00413959|80819651|FG000|Overall Study|Pt had only one cycle.|1|||
27723877|NCT01015833|80819655|FG000|Overall Study|Death|1|||
27723878|NCT01015833|80819656|FG001|Overall Study|Death|0|||
27723879|NCT01015833|80819655|FG000|Overall Study|Withdrawal by Subject|3|||
27723880|NCT01015833|80819656|FG001|Overall Study|Withdrawal by Subject|2|||
27723881|NCT01015833|80819655|FG000|Overall Study|Adverse Event|0|||
27723882|NCT01015833|80819656|FG001|Overall Study|Adverse Event|1|||
27723883|NCT01015833|80819655|FG000|Overall Study|Physician Decision|2|||
27723884|NCT01015833|80819656|FG001|Overall Study|Physician Decision|0|||
27723885|NCT01015833|80819655|FG000|Overall Study|Symptomatic deterioration|0|||
27892519|NCT02680834|81441305|FG000|Overall Study|Withdrawal by Subject|6|||
27892520|NCT02680834|81441306|FG001|Overall Study|Withdrawal by Subject|0|||
27723886|NCT01015833|80819656|FG001|Overall Study|Symptomatic deterioration|1|||
27723887|NCT01015833|80819655|FG000|Overall Study|Other|5|||
27723888|NCT01015833|80819656|FG001|Overall Study|Other|1|||
27723889|NCT01015833|80819655|FG000|Overall Study|Motor Vehicle Accidents|1|||
27723890|NCT01015833|80819656|FG001|Overall Study|Motor Vehicle Accidents|0|||
27723891|NCT01015833|80819655|FG000|Overall Study|Did not start treatment|1|||
27723892|NCT01015833|80819656|FG001|Overall Study|Did not start treatment|0|||
27723893|NCT01613326|80819659|FG000|Overall Study|Adverse Event|7|||
27723894|NCT01613326|80819660|FG001|Overall Study|Adverse Event|5|||
27723895|NCT01613326|80819659|FG000|Overall Study|Withdrawal by Subject|3|||
27892521|NCT02680834|81441305|FG000|Overall Study|Lost to Follow-up|0|||
27892522|NCT02680834|81441306|FG001|Overall Study|Lost to Follow-up|1|||
27723896|NCT01613326|80819660|FG001|Overall Study|Withdrawal by Subject|4|||
27723897|NCT01613326|80819659|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27723898|NCT01613326|80819660|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27723899|NCT01613326|80819659|FG000|Overall Study|inability to use device|1|||
27723900|NCT01613326|80819660|FG001|Overall Study|inability to use device|0|||
27723901|NCT01613326|80819659|FG000|Overall Study|Lack of Efficacy|0|||
27723902|NCT01613326|80819660|FG001|Overall Study|Lack of Efficacy|1|||
27723903|NCT01613326|80819659|FG000|Overall Study|Lost to Follow-up|0|||
27612511|NCT00065468|80423323|FG001|Overall Study|Death|169|||
27612512|NCT00065468|80423324|FG002|Overall Study|Death|171|||
27612513|NCT00065468|80423322|FG000|Overall Study|Withdrawal by Subject|3|||
27612514|NCT00065468|80423323|FG001|Overall Study|Withdrawal by Subject|4|||
27612515|NCT00065468|80423324|FG002|Overall Study|Withdrawal by Subject|5|||
27612516|NCT00065468|80423322|FG000|Overall Study|Lost to Follow-up|5|||
27612517|NCT00065468|80423323|FG001|Overall Study|Lost to Follow-up|3|||
27612518|NCT00065468|80423324|FG002|Overall Study|Lost to Follow-up|2|||
27612519|NCT00065468|80423322|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
27612520|NCT00065468|80423323|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
27612521|NCT00065468|80423324|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
27612522|NCT00065468|80423322|FG000|Overall Study|Disease progression|0|||
27612523|NCT00065468|80423323|FG001|Overall Study|Disease progression|0|||
27612524|NCT00065468|80423324|FG002|Overall Study|Disease progression|1|||
27612525|NCT00065468|80423322|FG000|Overall Study|Other|14|||
27612526|NCT00065468|80423323|FG001|Overall Study|Other|24|||
27612527|NCT00065468|80423324|FG002|Overall Study|Other|18|||
27612528|NCT01671748|80423325|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
27612529|NCT01671748|80423326|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
27612530|NCT01671748|80423325|FG000|4 Week run-in Phase|Adverse Event|1|||
27612531|NCT01671748|80423326|FG001|4 Week run-in Phase|Adverse Event|0|||
27612532|NCT01671748|80423325|FG000|4 Week run-in Phase|Not eligible|9|||
27612533|NCT01671748|80423326|FG001|4 Week run-in Phase|Not eligible|0|||
27503498|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
27503499|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
27503500|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
27612534|NCT00258440|80423329|FG000|Overall Study|Withdrawal by Subject|0|||
27612535|NCT00258440|80423330|FG001|Overall Study|Withdrawal by Subject|0|||
27612536|NCT00258440|80423331|FG002|Overall Study|Withdrawal by Subject|1|||
27612537|NCT03354637|80423332|FG000|Double-blind Period|Protocol Violation|2|||
27612538|NCT03354637|80423333|FG001|Double-blind Period|Protocol Violation|0|||
27612539|NCT03354637|80423334|FG002|Double-blind Period|Protocol Violation|0|||
27612540|NCT03354637|80423332|FG000|Double-blind Period|Adverse Event|1|||
27612541|NCT03354637|80423333|FG001|Double-blind Period|Adverse Event|2|||
27723904|NCT01613326|80819660|FG001|Overall Study|Lost to Follow-up|1|||
27723905|NCT01613326|80819659|FG000|Overall Study|Administrative|0|||
27723906|NCT01613326|80819660|FG001|Overall Study|Administrative|2|||
27723907|NCT01613326|80819659|FG000|Overall Study|Protocol Violation|0|||
27723908|NCT01613326|80819660|FG001|Overall Study|Protocol Violation|1|||
27723909|NCT03094195|80819661|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
27723910|NCT03094195|80819662|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
27723911|NCT03094195|80819663|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
27723912|NCT03094195|80819664|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27723913|NCT03094195|80819665|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27723914|NCT03094195|80819666|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27723915|NCT03094195|80819667|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27723916|NCT03094195|80819668|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27723917|NCT03094195|80819661|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
27723918|NCT03094195|80819662|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
27723919|NCT03094195|80819663|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
27723920|NCT03094195|80819664|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27723921|NCT03094195|80819665|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27723922|NCT03094195|80819666|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27723923|NCT03094195|80819667|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27723924|NCT03094195|80819668|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27723925|NCT03094195|80819661|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27723926|NCT03094195|80819662|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27723927|NCT03094195|80819663|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
27723928|NCT03094195|80819664|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27723929|NCT03094195|80819665|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27723930|NCT03094195|80819666|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27723931|NCT03094195|80819667|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27503501|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
27723932|NCT03094195|80819668|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27503502|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
27612542|NCT03354637|80423334|FG002|Double-blind Period|Adverse Event|0|||
27612543|NCT03354637|80423332|FG000|Double-blind Period|Lost to Follow-up|3|||
27612544|NCT03354637|80423333|FG001|Double-blind Period|Lost to Follow-up|4|||
27612545|NCT03354637|80423334|FG002|Double-blind Period|Lost to Follow-up|3|||
27723933|NCT03094195|80819661|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27612546|NCT03354637|80423332|FG000|Double-blind Period|Withdrawal by Subject|10|||
27612547|NCT03354637|80423333|FG001|Double-blind Period|Withdrawal by Subject|6|||
27612548|NCT03354637|80423334|FG002|Double-blind Period|Withdrawal by Subject|4|||
27612549|NCT03354637|80423332|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
27612550|NCT03354637|80423333|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
27612551|NCT03354637|80423334|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
27612552|NCT03354637|80423332|FG000|Open Label Extension|Adverse Event|0|||
27612553|NCT03354637|80423333|FG001|Open Label Extension|Adverse Event|0|||
27612554|NCT03354637|80423334|FG002|Open Label Extension|Adverse Event|1|||
27612555|NCT03354637|80423332|FG000|Open Label Extension|Lost to Follow-up|0|||
27612556|NCT03354637|80423333|FG001|Open Label Extension|Lost to Follow-up|0|||
27723934|NCT03094195|80819662|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
27723935|NCT03094195|80819663|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
27723936|NCT03094195|80819664|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27723937|NCT03094195|80819665|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27723938|NCT03094195|80819666|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27723939|NCT03094195|80819667|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27723940|NCT03094195|80819668|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27723941|NCT03474679|80819673|FG000|Overall Study|Death|7|||
27723942|NCT03474679|80819673|FG000|Overall Study|Withdrawal by Subject|1|||
27723943|NCT02771522|80819674|FG000|Overall Study|Lost to Follow-up|3|||
27723944|NCT02771522|80819674|FG000|Overall Study|Withdrawal by Subject|2|||
27723945|NCT02771522|80819674|FG000|Overall Study|No white spot lesions|3|||
27723946|NCT00486278|80819675|FG000|Overall Study|Adverse Event|5|||
27723947|NCT00486278|80819675|FG000|Overall Study|Withdrawal by Subject|2|||
27723948|NCT00486278|80819675|FG000|Overall Study|Physician Decision|2|||
27723949|NCT02404103|80819679|FG000|Overall Study|Adverse Event|1|||
27723950|NCT02404103|80819680|FG001|Overall Study|Adverse Event|0|||
27723951|NCT02404103|80819679|FG000|Overall Study|Lost to Follow-up|3|||
27723952|NCT02404103|80819680|FG001|Overall Study|Lost to Follow-up|3|||
27723953|NCT01441063|80819681|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
27723954|NCT01441063|80819681|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
27723955|NCT01318122|80819682|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27723956|NCT01318122|80819683|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27723957|NCT01318122|80819684|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
27723958|NCT01318122|80819685|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
27723959|NCT01318122|80819682|FG000|Enrolled - Long-Term Extension Study|Other|1|||
27723960|NCT01318122|80819683|FG001|Enrolled - Long-Term Extension Study|Other|0|||
27723961|NCT01318122|80819684|FG002|Enrolled - Long-Term Extension Study|Other|0|||
27723962|NCT01318122|80819685|FG003|Enrolled - Long-Term Extension Study|Other|0|||
27723963|NCT01318122|80819682|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
27723964|NCT01318122|80819683|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
27723965|NCT01318122|80819684|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
27723966|NCT01318122|80819685|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
27723967|NCT01318122|80819682|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
27723968|NCT01318122|80819683|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27723969|NCT01318122|80819684|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27723970|NCT01318122|80819685|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27723971|NCT01318122|80819682|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27723972|NCT01318122|80819683|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
27503503|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
27723973|NCT01318122|80819684|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27723974|NCT01318122|80819685|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27723975|NCT01318122|80819682|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27723976|NCT01318122|80819683|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
27723977|NCT01318122|80819684|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
27723978|NCT01318122|80819685|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27723979|NCT03624946|80819686|FG000|Overall Study|Lost to Follow-up|0|||
27723980|NCT03624946|80819687|FG001|Overall Study|Lost to Follow-up|1|||
27723981|NCT03686969|80819688|FG000|Overall Study|Study terminated|1|||
27723982|NCT03686969|80819689|FG001|Overall Study|Study terminated|0|||
27723983|NCT02847598|80819690|FG000|Overall Study|Adverse Event|0|||
27723984|NCT02847598|80819691|FG001|Overall Study|Adverse Event|0|||
27892523|NCT00157248|81441308|FG000|Overall Study|Adverse Event|36|||
27892524|NCT00157248|81441309|FG001|Overall Study|Adverse Event|25|||
27892525|NCT00157248|81441310|FG002|Overall Study|Adverse Event|13|||
27892526|NCT00157248|81441311|FG003|Overall Study|Adverse Event|33|||
27723985|NCT02847598|80819692|FG002|Overall Study|Adverse Event|0|||
27723986|NCT02847598|80819693|FG003|Overall Study|Adverse Event|0|||
27723987|NCT02847598|80819694|FG004|Overall Study|Adverse Event|0|||
27723988|NCT02847598|80819695|FG005|Overall Study|Adverse Event|0|||
27723989|NCT02847598|80819696|FG006|Overall Study|Adverse Event|0|||
27892527|NCT00157248|81441308|FG000|Overall Study|Protocol Violation|4|||
27612557|NCT03354637|80423334|FG002|Open Label Extension|Lost to Follow-up|2|||
27723990|NCT02847598|80819697|FG007|Overall Study|Adverse Event|1|||
27723991|NCT02847598|80819690|FG000|Overall Study|Consent withdrawn|2|||
27723992|NCT02847598|80819691|FG001|Overall Study|Consent withdrawn|0|||
27723993|NCT02847598|80819692|FG002|Overall Study|Consent withdrawn|0|||
27723994|NCT02847598|80819693|FG003|Overall Study|Consent withdrawn|4|||
27723995|NCT02847598|80819694|FG004|Overall Study|Consent withdrawn|3|||
27723996|NCT02847598|80819695|FG005|Overall Study|Consent withdrawn|2|||
27723997|NCT02847598|80819696|FG006|Overall Study|Consent withdrawn|1|||
27503504|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
27503505|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
27503506|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
27503507|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
27612558|NCT03354637|80423332|FG000|Open Label Extension|Withdrawal by Subject|0|||
27612559|NCT03354637|80423333|FG001|Open Label Extension|Withdrawal by Subject|0|||
27612560|NCT03354637|80423334|FG002|Open Label Extension|Withdrawal by Subject|5|||
27612561|NCT03354637|80423332|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
27612562|NCT03354637|80423333|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
27612563|NCT03354637|80423334|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
27612564|NCT03354637|80423332|FG000|Open Label Extension|Subject Noncompliance|0|||
27612565|NCT03354637|80423333|FG001|Open Label Extension|Subject Noncompliance|0|||
27612566|NCT03354637|80423334|FG002|Open Label Extension|Subject Noncompliance|1|||
27612567|NCT03354637|80423332|FG000|Open Label Extension|Lack of Efficacy|0|||
27612568|NCT03354637|80423333|FG001|Open Label Extension|Lack of Efficacy|0|||
27612569|NCT03354637|80423334|FG002|Open Label Extension|Lack of Efficacy|1|||
27612570|NCT03354637|80423332|FG000|Open Label Extension|Physician Decision|0|||
27612571|NCT03354637|80423333|FG001|Open Label Extension|Physician Decision|0|||
27612572|NCT03354637|80423334|FG002|Open Label Extension|Physician Decision|1|||
27612573|NCT03029247|80423335|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
27612574|NCT03029247|80423336|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
27612575|NCT03029247|80423335|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
27612576|NCT03029247|80423336|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
27612577|NCT03029247|80423335|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
27612578|NCT03029247|80423336|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
27612579|NCT03029247|80423335|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
27612580|NCT03029247|80423336|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
27612581|NCT00630058|80423338|FG000|Overall Study|Adverse Event|1|||
27612582|NCT00630058|80423339|FG001|Overall Study|Adverse Event|1|||
27612583|NCT00630058|80423338|FG000|Overall Study|Withdrawal by Subject|0|||
27612584|NCT00630058|80423339|FG001|Overall Study|Withdrawal by Subject|1|||
27612585|NCT00630058|80423338|FG000|Overall Study|stopping criteria|3|||
27612586|NCT00630058|80423339|FG001|Overall Study|stopping criteria|2|||
27612587|NCT00655551|80423340|FG000|All Periods Combined|Adverse Event|0|||
27612588|NCT00655551|80423341|FG001|All Periods Combined|Adverse Event|3|||
27612589|NCT00655551|80423342|FG002|All Periods Combined|Adverse Event|4|||
27612590|NCT00655551|80423340|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
27612591|NCT00655551|80423341|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
27612592|NCT00655551|80423342|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
27612593|NCT00655551|80423340|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
27612594|NCT00655551|80423341|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
27612595|NCT00655551|80423342|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
27612596|NCT00655551|80423340|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
27723998|NCT02847598|80819697|FG007|Overall Study|Consent withdrawn|3|||
27723999|NCT02847598|80819690|FG000|Overall Study|Death|3|||
27724000|NCT02847598|80819691|FG001|Overall Study|Death|0|||
27724001|NCT02847598|80819692|FG002|Overall Study|Death|0|||
27724002|NCT02847598|80819693|FG003|Overall Study|Death|0|||
27724003|NCT02847598|80819694|FG004|Overall Study|Death|0|||
27724004|NCT02847598|80819695|FG005|Overall Study|Death|0|||
27503508|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
27503509|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
27503510|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
27503511|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
27503512|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
27503513|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
27503514|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
27503515|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
27503516|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
27503517|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
27503518|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
27503519|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
27503520|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
27503521|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
27503522|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
27503523|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
27503524|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
27503525|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
27503526|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
27724005|NCT02847598|80819696|FG006|Overall Study|Death|0|||
27724006|NCT02847598|80819697|FG007|Overall Study|Death|0|||
27724007|NCT02847598|80819690|FG000|Overall Study|Lost to Follow-up|0|||
27724008|NCT02847598|80819691|FG001|Overall Study|Lost to Follow-up|0|||
27724009|NCT02847598|80819692|FG002|Overall Study|Lost to Follow-up|0|||
27724010|NCT02847598|80819693|FG003|Overall Study|Lost to Follow-up|0|||
27724011|NCT02847598|80819694|FG004|Overall Study|Lost to Follow-up|0|||
27724012|NCT02847598|80819695|FG005|Overall Study|Lost to Follow-up|1|||
27724013|NCT02847598|80819696|FG006|Overall Study|Lost to Follow-up|1|||
27724014|NCT02847598|80819697|FG007|Overall Study|Lost to Follow-up|0|||
27724015|NCT00197054|80819698|FG000|Overall Study|Withdrawal by Subject|9|||
27892528|NCT00157248|81441309|FG001|Overall Study|Protocol Violation|0|||
27724016|NCT00197054|80819699|FG001|Overall Study|Withdrawal by Subject|3|||
27724017|NCT00197054|80819700|FG002|Overall Study|Withdrawal by Subject|3|||
27724018|NCT00197054|80819698|FG000|Overall Study|Moved from area|7|||
27724019|NCT00197054|80819699|FG001|Overall Study|Moved from area|14|||
27724020|NCT00197054|80819700|FG002|Overall Study|Moved from area|9|||
27724021|NCT00197054|80819698|FG000|Overall Study|Lost to Follow-up|1|||
27724022|NCT00197054|80819699|FG001|Overall Study|Lost to Follow-up|4|||
27724023|NCT00197054|80819700|FG002|Overall Study|Lost to Follow-up|0|||
27724024|NCT01528787|80819701|FG000|Overall Study|Withdrawal by Subject|0|||
27724025|NCT01528787|80819702|FG001|Overall Study|Withdrawal by Subject|0|||
27724026|NCT01528787|80819703|FG002|Overall Study|Withdrawal by Subject|0|||
27724027|NCT01528787|80819704|FG003|Overall Study|Withdrawal by Subject|1|||
27724028|NCT01528787|80819701|FG000|Overall Study|Family Emergency|0|||
27724029|NCT01528787|80819702|FG001|Overall Study|Family Emergency|0|||
27724030|NCT01528787|80819703|FG002|Overall Study|Family Emergency|1|||
27724031|NCT01528787|80819704|FG003|Overall Study|Family Emergency|0|||
27724032|NCT00167245|80819705|FG000|Overall Study|Lost to Follow-up|20|||
27724033|NCT00167245|80819706|FG001|Overall Study|Lost to Follow-up|31|||
27724034|NCT00167245|80819705|FG000|Overall Study|Withdrawal by Subject|5|||
27724035|NCT00167245|80819706|FG001|Overall Study|Withdrawal by Subject|8|||
27724036|NCT00167245|80819705|FG000|Overall Study|Incarcerated|3|||
27841609|NCT02688387|81248328|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841610|NCT02688387|81248329|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
27841611|NCT02688387|81248308|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841612|NCT02688387|81248309|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841613|NCT02688387|81248310|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841614|NCT02688387|81248311|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841615|NCT02688387|81248312|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841616|NCT02688387|81248313|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841617|NCT02688387|81248314|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841618|NCT02688387|81248315|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841619|NCT02688387|81248316|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841620|NCT02688387|81248317|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841621|NCT02688387|81248318|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
27841622|NCT02688387|81248319|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841623|NCT02688387|81248320|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841624|NCT02688387|81248321|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841625|NCT02688387|81248322|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841626|NCT02688387|81248323|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27892529|NCT00157248|81441310|FG002|Overall Study|Protocol Violation|2|||
27892530|NCT00157248|81441311|FG003|Overall Study|Protocol Violation|2|||
27892531|NCT00157248|81441308|FG000|Overall Study|Lost to Follow-up|0|||
27892532|NCT00157248|81441309|FG001|Overall Study|Lost to Follow-up|1|||
27892533|NCT00157248|81441310|FG002|Overall Study|Lost to Follow-up|0|||
27892534|NCT00157248|81441311|FG003|Overall Study|Lost to Follow-up|0|||
27892535|NCT00157248|81441308|FG000|Overall Study|Withdrawal by Subject|1|||
27892536|NCT00157248|81441309|FG001|Overall Study|Withdrawal by Subject|4|||
27892537|NCT00157248|81441310|FG002|Overall Study|Withdrawal by Subject|3|||
27892538|NCT00157248|81441311|FG003|Overall Study|Withdrawal by Subject|3|||
27892539|NCT00157248|81441308|FG000|Overall Study|site closures, subject moving|7|||
27892540|NCT00157248|81441309|FG001|Overall Study|site closures, subject moving|7|||
27841627|NCT02688387|81248324|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841628|NCT02688387|81248325|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27892541|NCT00157248|81441310|FG002|Overall Study|site closures, subject moving|3|||
27892542|NCT00157248|81441311|FG003|Overall Study|site closures, subject moving|9|||
27892543|NCT04034251|81441315|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
27724037|NCT00167245|80819706|FG001|Overall Study|Incarcerated|2|||
27724038|NCT00167245|80819705|FG000|Overall Study|Drowsy|1|||
27724039|NCT00167245|80819706|FG001|Overall Study|Drowsy|0|||
27724040|NCT03687502|80819707|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
27724041|NCT03687502|80819707|FG000|Overall Study|Lumason not available|1|||
27724042|NCT02471716|80822889|FG000|Overall Study|Withdrawal by Subject|0|||
27724043|NCT02471716|80822890|FG001|Overall Study|Withdrawal by Subject|1|||
27724044|NCT02471716|80822891|FG002|Overall Study|Withdrawal by Subject|0|||
27724045|NCT02471716|80822892|FG003|Overall Study|Withdrawal by Subject|2|||
27724046|NCT02471716|80822893|FG004|Overall Study|Withdrawal by Subject|5|||
27892544|NCT04034251|81441316|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
27892545|NCT04034251|81441317|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
27892546|NCT01967706|81441318|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
27892547|NCT01967706|81441319|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
27892548|NCT01967706|81441320|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
27892549|NCT01967706|81441321|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
27892550|NCT03981900|81441322|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
27892551|NCT03981900|81441322|FG000|Overall Study|Adverse Event|5|||
27892552|NCT03981900|81441322|FG000|Overall Study|Protocol Violation|1|||
27892553|NCT03981900|81441322|FG000|Overall Study|Withdrawal by Subject|7|||
27892554|NCT03981900|81441322|FG000|Overall Study|Lost to Follow-up|46|||
27892555|NCT03981900|81441322|FG000|Overall Study|Decision of the researcher|3|||
27892556|NCT03981900|81441322|FG000|Overall Study|Death|3|||
27892557|NCT03981900|81441322|FG000|Overall Study|Other|5|||
27892558|NCT01740128|81441323|FG000|Overall Study|Pregnancy|0|||
27892559|NCT01740128|81441324|FG001|Overall Study|Pregnancy|1|||
27892560|NCT01740128|81441323|FG000|Overall Study|Protocol Violation|1|||
27892561|NCT01740128|81441324|FG001|Overall Study|Protocol Violation|2|||
27892562|NCT01740128|81441323|FG000|Overall Study|Lost to Follow-up|2|||
27892563|NCT01740128|81441324|FG001|Overall Study|Lost to Follow-up|2|||
27892564|NCT01740128|81441323|FG000|Overall Study|Withdrawal by Subject|1|||
27892565|NCT01740128|81441324|FG001|Overall Study|Withdrawal by Subject|0|||
27892566|NCT01740128|81441323|FG000|Overall Study|Insufficient protocol compliance|2|||
27892567|NCT01740128|81441324|FG001|Overall Study|Insufficient protocol compliance|2|||
27892568|NCT01968707|81441325|FG000|Overall Study|Did not meet treatment day baseline|49|||
27892569|NCT01968707|81441326|FG001|Overall Study|Did not meet treatment day baseline|12|||
27892570|NCT01968707|81441327|FG002|Overall Study|Did not meet treatment day baseline|41|||
27892571|NCT01968707|81441328|FG003|Overall Study|Did not meet treatment day baseline|44|||
27892572|NCT01968707|81441329|FG004|Overall Study|Did not meet treatment day baseline|36|||
27892573|NCT01968707|81441330|FG005|Overall Study|Did not meet treatment day baseline|11|||
27892574|NCT01968707|81441331|FG006|Overall Study|Did not meet treatment day baseline|34|||
27892575|NCT01968707|81441332|FG007|Overall Study|Did not meet treatment day baseline|35|||
27892576|NCT03814720|81441333|FG000|Overall Study|Lost to Follow-up|0|||
27892577|NCT03814720|81441334|FG001|Overall Study|Lost to Follow-up|1|||
27892578|NCT03814720|81441335|FG002|Overall Study|Lost to Follow-up|0|||
27892579|NCT03814720|81441336|FG003|Overall Study|Lost to Follow-up|0|||
27892580|NCT03814720|81441337|FG004|Overall Study|Lost to Follow-up|0|||
27503527|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
27724047|NCT02471716|80822889|FG000|Overall Study|Study Terminiated by sponsor|0|||
27724048|NCT02471716|80822890|FG001|Overall Study|Study Terminiated by sponsor|0|||
27724049|NCT02471716|80822891|FG002|Overall Study|Study Terminiated by sponsor|0|||
27724050|NCT02471716|80822892|FG003|Overall Study|Study Terminiated by sponsor|1|||
27724051|NCT02471716|80822893|FG004|Overall Study|Study Terminiated by sponsor|0|||
27724052|NCT02471716|80822889|FG000|Overall Study|Lost to Follow-up|0|||
27724053|NCT02471716|80822890|FG001|Overall Study|Lost to Follow-up|0|||
27724054|NCT02471716|80822891|FG002|Overall Study|Lost to Follow-up|0|||
27724055|NCT02471716|80822892|FG003|Overall Study|Lost to Follow-up|3|||
27724056|NCT02471716|80822893|FG004|Overall Study|Lost to Follow-up|2|||
27724057|NCT02471716|80822889|FG000|Overall Study|Death|0|||
27841629|NCT02688387|81248326|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841630|NCT02688387|81248327|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841631|NCT02688387|81248328|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841632|NCT02688387|81248329|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
27841633|NCT02688387|81248308|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841634|NCT02688387|81248309|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841635|NCT02688387|81248310|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841636|NCT02688387|81248311|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841637|NCT02688387|81248312|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841638|NCT02688387|81248313|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841639|NCT02688387|81248314|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841640|NCT02688387|81248315|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841641|NCT02688387|81248316|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27892581|NCT00759785|81441338|FG000|Overall Study|Participant sample not evaluable|11|||
27724058|NCT02471716|80822890|FG001|Overall Study|Death|0|||
27503528|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Death|0|||
27503529|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Death|6|||
27503530|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Death|3|||
27503531|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Death|0|||
27503532|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Death|0|||
27503533|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27503534|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
27503535|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27503536|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27503537|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
27503538|NCT00561925|80037776|FG000|144-week Double-blind, Double-dummy|Other|0|||
27503539|NCT00561925|80037777|FG001|144-week Double-blind, Double-dummy|Other|8|||
27503540|NCT00561925|80037778|FG002|144-week Double-blind, Double-dummy|Other|11|||
27503541|NCT00561925|80037779|FG003|144-week Double-blind, Double-dummy|Other|0|||
27503542|NCT00561925|80037780|FG004|144-week Double-blind, Double-dummy|Other|0|||
27503543|NCT00561925|80037776|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
27503544|NCT00561925|80037777|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
27503545|NCT00561925|80037778|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
27503546|NCT00561925|80037779|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
27503547|NCT00561925|80037780|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
27503548|NCT05767749|80037781|FG000|Overall Study|Withdrawal by Subject|0|||
27503549|NCT05767749|80037782|FG001|Overall Study|Withdrawal by Subject|0|||
27503550|NCT05767749|80037783|FG002|Overall Study|Withdrawal by Subject|2|||
27503551|NCT05767749|80037784|FG003|Overall Study|Withdrawal by Subject|2|||
27503552|NCT05767749|80037785|FG004|Overall Study|Withdrawal by Subject|2|||
27503553|NCT05767749|80037786|FG005|Overall Study|Withdrawal by Subject|2|||
27503554|NCT03264404|80037787|FG000|Overall Study|Death|2|||
27503555|NCT03264404|80037787|FG000|Overall Study|Physician Decision|1|||
27503556|NCT03264404|80037787|FG000|Overall Study|Disease Progression|28|||
27503557|NCT03264404|80037787|FG000|Overall Study|Adverse Event|1|||
27503558|NCT03264404|80037787|FG000|Overall Study|Off study prior to treatment|2|||
27503559|NCT03938259|80037793|FG000|Overall Study|unable to establish baseline for ventilation|1|||
27503560|NCT03938259|80037794|FG001|Overall Study|unable to establish baseline for ventilation|1|||
27503561|NCT04102098|80037797|FG000|Main Study Period|Ongoing in study|302|||
27503562|NCT04102098|80037798|FG001|Main Study Period|Ongoing in study|291|||
27503563|NCT04102098|80037797|FG000|Main Study Period|Death|20|||
27503564|NCT04102098|80037798|FG001|Main Study Period|Death|27|||
27503565|NCT04102098|80037797|FG000|Main Study Period|Lost to Follow-up|1|||
27503566|NCT04102098|80037798|FG001|Main Study Period|Lost to Follow-up|1|||
27503567|NCT04102098|80037797|FG000|Main Study Period|Physician Decision|0|||
27503568|NCT04102098|80037798|FG001|Main Study Period|Physician Decision|1|||
27503569|NCT04102098|80037797|FG000|Main Study Period|Withdrawal by Subject|11|||
27503570|NCT04102098|80037798|FG001|Main Study Period|Withdrawal by Subject|14|||
27503571|NCT04102098|80037797|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
27503572|NCT04102098|80037798|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
27503573|NCT04102098|80037797|FG000|Crossover: AS Who Crossed Over|Death|11|||
27503574|NCT04102098|80037798|FG001|Crossover: AS Who Crossed Over|Death|0|||
27503575|NCT04102098|80037797|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
27503576|NCT04102098|80037798|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
27503577|NCT00906204|80037799|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
27503578|NCT00906204|80037800|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
27503579|NCT00906204|80037799|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
27503580|NCT00906204|80037800|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
27503581|NCT00906204|80037799|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
27503582|NCT00906204|80037800|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
27503583|NCT00906204|80037799|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
27503584|NCT00906204|80037800|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
27612597|NCT00655551|80423341|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
27612598|NCT00655551|80423342|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
27724059|NCT02471716|80822891|FG002|Overall Study|Death|0|||
27958604|NCT01791517|81680064|FG006|Phase II|Lack of Efficacy|0|||
27503585|NCT00906204|80037799|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
27503586|NCT00906204|80037800|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
27503587|NCT01710501|80037801|FG000|Overall Study|Lost to Follow-up|2|||
27503588|NCT01710501|80037802|FG001|Overall Study|Lost to Follow-up|0|||
27503589|NCT01710501|80037803|FG002|Overall Study|Lost to Follow-up|0|||
27503590|NCT02589938|80037804|FG000|Overall Study|Withdrawal by Subject|11|||
27503591|NCT02589938|80037805|FG001|Overall Study|Withdrawal by Subject|5|||
27503592|NCT02589938|80037806|FG002|Overall Study|Withdrawal by Subject|6|||
27503593|NCT02589938|80037804|FG000|Overall Study|Lost to Follow-up|3|||
27503594|NCT02589938|80037805|FG001|Overall Study|Lost to Follow-up|3|||
27612599|NCT00195715|80423344|FG000|Overall Study|Adverse Event|122|||
27503595|NCT02589938|80037806|FG002|Overall Study|Lost to Follow-up|3|||
27503596|NCT02589938|80037804|FG000|Overall Study|Death|1|||
27503597|NCT02589938|80037805|FG001|Overall Study|Death|0|||
27503598|NCT02589938|80037806|FG002|Overall Study|Death|1|||
27503599|NCT02589938|80037804|FG000|Overall Study|Protocol Violation|6|||
27503600|NCT02589938|80037805|FG001|Overall Study|Protocol Violation|2|||
27503601|NCT02589938|80037806|FG002|Overall Study|Protocol Violation|3|||
27503602|NCT02589938|80037804|FG000|Overall Study|Physician Decision|1|||
27503603|NCT02589938|80037805|FG001|Overall Study|Physician Decision|0|||
27503604|NCT02589938|80037806|FG002|Overall Study|Physician Decision|0|||
27503605|NCT02589938|80037804|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
27503606|NCT02589938|80037805|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
27503607|NCT02589938|80037806|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
27503608|NCT05232682|80037816|FG000|Overall Study|Lost to Follow-up|2|||
27503609|NCT01283139|80037817|FG000|Overall Study|Lost to Follow-up|5|||
27503610|NCT01283139|80037818|FG001|Overall Study|Lost to Follow-up|2|||
27503611|NCT01283139|80037819|FG002|Overall Study|Lost to Follow-up|3|||
27503612|NCT01283139|80037820|FG003|Overall Study|Lost to Follow-up|1|||
27503613|NCT01283139|80037817|FG000|Overall Study|Withdrawal by Subject|8|||
27503614|NCT01283139|80037818|FG001|Overall Study|Withdrawal by Subject|8|||
27612600|NCT00195715|80423344|FG000|Overall Study|Withdrawal by Subject|58|||
27612601|NCT00195715|80423344|FG000|Overall Study|Lost to Follow-up|27|||
27612602|NCT00195715|80423344|FG000|Overall Study|Protocol Violation|13|||
27612603|NCT00195715|80423344|FG000|Overall Study|Lack of Efficacy|93|||
27612604|NCT00195715|80423344|FG000|Overall Study|Pregnancy|14|||
27612605|NCT00195715|80423344|FG000|Overall Study|Investigative site closure|8|||
27612606|NCT00195715|80423344|FG000|Overall Study|Subject moved/relocated|7|||
27612607|NCT00195715|80423344|FG000|Overall Study|Subject non-compliance|6|||
27612608|NCT00195715|80423344|FG000|Overall Study|Subject started commercial Humira|5|||
27612609|NCT00195715|80423344|FG000|Overall Study|Subject choice|3|||
27612610|NCT00195715|80423344|FG000|Overall Study|Loss of response/no improvement|3|||
27612611|NCT00195715|80423344|FG000|Overall Study|Sponsor stopped study|1|||
27612612|NCT00195715|80423344|FG000|Overall Study|Administrative reasons|2|||
27612613|NCT00195715|80423344|FG000|Overall Study|Investigator's decision|2|||
27612614|NCT00195715|80423344|FG000|Overall Study|Subject wants to get pregnant|4|||
27612615|NCT00195715|80423344|FG000|Overall Study|Use of prohibited medication|2|||
27612616|NCT00195715|80423344|FG000|Overall Study|Planned surgery|2|||
27612617|NCT00195715|80423344|FG000|Overall Study|Increased infection rate|1|||
27612618|NCT00195715|80423344|FG000|Overall Study|Ineligible|1|||
27612619|NCT00195715|80423344|FG000|Overall Study|Colonic stricture|1|||
27503615|NCT01283139|80037819|FG002|Overall Study|Withdrawal by Subject|6|||
27503616|NCT01283139|80037820|FG003|Overall Study|Withdrawal by Subject|8|||
27503617|NCT01283139|80037817|FG000|Overall Study|Death|2|||
27503618|NCT01283139|80037818|FG001|Overall Study|Death|0|||
27612620|NCT00195715|80423344|FG000|Overall Study|Sponsor discontinued trial|1|||
27612621|NCT00195715|80423344|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
27612622|NCT03008122|80423348|FG000|Overall Study|Physician Decision|3|||
27612623|NCT03008122|80423349|FG001|Overall Study|Physician Decision|2|||
27612624|NCT03008122|80423350|FG002|Overall Study|Physician Decision|0|||
27612625|NCT03008122|80423348|FG000|Overall Study|Withdrawal by Subject|1|||
27612626|NCT03008122|80423349|FG001|Overall Study|Withdrawal by Subject|3|||
27612627|NCT03008122|80423350|FG002|Overall Study|Withdrawal by Subject|0|||
27612628|NCT03008122|80423348|FG000|Overall Study|Lost to Follow-up|4|||
27612629|NCT03008122|80423349|FG001|Overall Study|Lost to Follow-up|8|||
27612630|NCT03008122|80423350|FG002|Overall Study|Lost to Follow-up|3|||
27612631|NCT03008122|80423348|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
27612632|NCT03008122|80423349|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
27612633|NCT03008122|80423350|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
27612634|NCT03008122|80423348|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
27612635|NCT03008122|80423349|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
27612636|NCT03008122|80423350|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
27612637|NCT03008122|80423348|FG000|Overall Study|Death|0|||
27612638|NCT03008122|80423349|FG001|Overall Study|Death|0|||
27724060|NCT02471716|80822892|FG003|Overall Study|Death|1|||
27724061|NCT02471716|80822893|FG004|Overall Study|Death|0|||
27503619|NCT01283139|80037819|FG002|Overall Study|Death|2|||
27724062|NCT02471716|80822889|FG000|Overall Study|Other|0|||
27503620|NCT01283139|80037820|FG003|Overall Study|Death|2|||
27503621|NCT01283139|80037817|FG000|Overall Study|Lack of Efficacy|1|||
27503622|NCT01283139|80037818|FG001|Overall Study|Lack of Efficacy|2|||
27503623|NCT01283139|80037819|FG002|Overall Study|Lack of Efficacy|2|||
27503624|NCT01283139|80037820|FG003|Overall Study|Lack of Efficacy|1|||
27503625|NCT01283139|80037817|FG000|Overall Study|Early termination due to AE/SAE|1|||
27503626|NCT01283139|80037818|FG001|Overall Study|Early termination due to AE/SAE|1|||
27503627|NCT01283139|80037819|FG002|Overall Study|Early termination due to AE/SAE|0|||
27503628|NCT01283139|80037820|FG003|Overall Study|Early termination due to AE/SAE|0|||
27503629|NCT01283139|80037817|FG000|Overall Study|Participant's refusal to continue|0|||
27503630|NCT01283139|80037818|FG001|Overall Study|Participant's refusal to continue|3|||
27503631|NCT01283139|80037819|FG002|Overall Study|Participant's refusal to continue|1|||
27503632|NCT01283139|80037820|FG003|Overall Study|Participant's refusal to continue|1|||
27503633|NCT01283139|80037817|FG000|Overall Study|Pregnancy|0|||
27503634|NCT01283139|80037818|FG001|Overall Study|Pregnancy|1|||
27503635|NCT01283139|80037819|FG002|Overall Study|Pregnancy|1|||
27503636|NCT01283139|80037820|FG003|Overall Study|Pregnancy|0|||
27503637|NCT01283139|80037817|FG000|Overall Study|Missed follow-up visit|0|||
27503638|NCT01283139|80037818|FG001|Overall Study|Missed follow-up visit|1|||
27503639|NCT01283139|80037819|FG002|Overall Study|Missed follow-up visit|2|||
27503640|NCT01283139|80037820|FG003|Overall Study|Missed follow-up visit|2|||
27503641|NCT01283139|80037817|FG000|Overall Study|Participant randomized in error|0|||
27503642|NCT01283139|80037818|FG001|Overall Study|Participant randomized in error|0|||
27503643|NCT01283139|80037819|FG002|Overall Study|Participant randomized in error|1|||
27503644|NCT01283139|80037820|FG003|Overall Study|Participant randomized in error|0|||
27612639|NCT03008122|80423350|FG002|Overall Study|Death|1|||
27612640|NCT02032173|80423351|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
27724063|NCT02471716|80822890|FG001|Overall Study|Other|0|||
27503645|NCT00536744|80037821|FG000|Overall Study|Adverse Event|13|||
27892582|NCT00759785|81441339|FG001|Overall Study|Participant sample not evaluable|2|||
27892583|NCT00759785|81441338|FG000|Overall Study|Participant sample lost|0|||
27892584|NCT00759785|81441339|FG001|Overall Study|Participant sample lost|1|||
27892585|NCT00759785|81441338|FG000|Overall Study|Protocol Violation|1|||
27892586|NCT00759785|81441339|FG001|Overall Study|Protocol Violation|0|||
27892587|NCT00759785|81441338|FG000|Overall Study|Physician Decision|0|||
27892588|NCT00759785|81441339|FG001|Overall Study|Physician Decision|1|||
27892589|NCT00759785|81441338|FG000|Overall Study|Withdrawal by Subject|0|||
27892590|NCT00759785|81441339|FG001|Overall Study|Withdrawal by Subject|1|||
27892591|NCT00637000|81441340|FG000|Overall Study|Withdrawal by Subject|4|||
27892592|NCT00637000|81441341|FG001|Overall Study|Withdrawal by Subject|3|||
27892593|NCT02855359|81441342|FG000|Overall Study|Death|2|||
27892594|NCT02855359|81441343|FG001|Overall Study|Death|2|||
27892595|NCT02855359|81441344|FG002|Overall Study|Death|0|||
27892596|NCT02855359|81441345|FG003|Overall Study|Death|0|||
27892597|NCT02855359|81441342|FG000|Overall Study|Study Termination by Sponsor|9|||
27892598|NCT02855359|81441343|FG001|Overall Study|Study Termination by Sponsor|11|||
27892599|NCT02855359|81441344|FG002|Overall Study|Study Termination by Sponsor|0|||
27503646|NCT00536744|80037822|FG001|Overall Study|Adverse Event|10|||
27503647|NCT00536744|80037821|FG000|Overall Study|Death|2|||
27503648|NCT00536744|80037822|FG001|Overall Study|Death|1|||
27503649|NCT00536744|80037821|FG000|Overall Study|Physician Decision|3|||
27503650|NCT00536744|80037822|FG001|Overall Study|Physician Decision|1|||
27503651|NCT00536744|80037821|FG000|Overall Study|Lost to Follow-up|3|||
27503652|NCT00536744|80037822|FG001|Overall Study|Lost to Follow-up|5|||
27503653|NCT00536744|80037821|FG000|Overall Study|Withdrawal by Subject|7|||
27503654|NCT00536744|80037822|FG001|Overall Study|Withdrawal by Subject|8|||
27503655|NCT00536744|80037821|FG000|Overall Study|PI tried alternative treatment|1|||
27724064|NCT02471716|80822891|FG002|Overall Study|Other|0|||
27841642|NCT02688387|81248317|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841643|NCT02688387|81248318|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841644|NCT02688387|81248319|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841645|NCT02688387|81248320|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841646|NCT02688387|81248321|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841647|NCT02688387|81248322|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
27841648|NCT02688387|81248323|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841649|NCT02688387|81248324|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841650|NCT02688387|81248325|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841651|NCT02688387|81248326|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841652|NCT02688387|81248327|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841653|NCT02688387|81248328|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841654|NCT02688387|81248329|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
27841655|NCT02688387|81248308|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841656|NCT02688387|81248309|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841657|NCT02688387|81248310|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841658|NCT02688387|81248311|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841659|NCT02688387|81248312|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841660|NCT02688387|81248313|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841661|NCT02688387|81248314|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841662|NCT02688387|81248315|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841663|NCT02688387|81248316|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841664|NCT02688387|81248317|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841665|NCT02688387|81248318|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841666|NCT02688387|81248319|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841667|NCT02688387|81248320|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841668|NCT02688387|81248321|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841669|NCT02688387|81248322|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841670|NCT02688387|81248323|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27503656|NCT00536744|80037822|FG001|Overall Study|PI tried alternative treatment|3|||
27503657|NCT03962491|80037823|FG000|Overall Study|Lost to Follow-up|4|||
27503658|NCT03962491|80037824|FG001|Overall Study|Lost to Follow-up|5|||
27612641|NCT00452413|80423352|FG000|Overall Study|Progressive Disease|4|||
27612642|NCT00452413|80423353|FG001|Overall Study|Progressive Disease|11|||
27612643|NCT00452413|80423354|FG002|Overall Study|Progressive Disease|30|||
27612644|NCT00452413|80423352|FG000|Overall Study|Withdrawal by Subject|0|||
27612645|NCT00452413|80423353|FG001|Overall Study|Withdrawal by Subject|1|||
27612646|NCT00452413|80423354|FG002|Overall Study|Withdrawal by Subject|4|||
27612647|NCT00452413|80423352|FG000|Overall Study|Adverse Event|0|||
27612648|NCT00452413|80423353|FG001|Overall Study|Adverse Event|0|||
27612649|NCT00452413|80423354|FG002|Overall Study|Adverse Event|5|||
27612650|NCT00452413|80423352|FG000|Overall Study|Physician Decision|0|||
27612651|NCT00452413|80423353|FG001|Overall Study|Physician Decision|0|||
27612652|NCT00452413|80423354|FG002|Overall Study|Physician Decision|4|||
27612653|NCT00452413|80423352|FG000|Overall Study|Death due to study disease|0|||
27612654|NCT00452413|80423353|FG001|Overall Study|Death due to study disease|0|||
27612655|NCT00452413|80423354|FG002|Overall Study|Death due to study disease|2|||
27612656|NCT00452413|80423352|FG000|Overall Study|Death due to adverse event (AE)|0|||
27612657|NCT00452413|80423353|FG001|Overall Study|Death due to adverse event (AE)|0|||
27612658|NCT00452413|80423354|FG002|Overall Study|Death due to adverse event (AE)|1|||
27612659|NCT00452413|80423352|FG000|Overall Study|On treatment|0|||
27612660|NCT00452413|80423353|FG001|Overall Study|On treatment|0|||
27612661|NCT00452413|80423354|FG002|Overall Study|On treatment|3|||
27612662|NCT02887989|80423358|FG000|Overall Study|Withdrawal by Subject|8|||
27612663|NCT02887989|80423359|FG001|Overall Study|Withdrawal by Subject|11|||
27612664|NCT02887989|80423358|FG000|Overall Study|Death|1|||
27612665|NCT02887989|80423359|FG001|Overall Study|Death|0|||
27612666|NCT00383240|80423360|FG000|Overall Study|Adverse Event|4|||
27841671|NCT02688387|81248324|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27612667|NCT00383240|80423361|FG001|Overall Study|Adverse Event|6|||
27612668|NCT00383240|80423362|FG002|Overall Study|Adverse Event|9|||
27612669|NCT00383240|80423363|FG003|Overall Study|Adverse Event|7|||
27612670|NCT00383240|80423360|FG000|Overall Study|Treatment Failure|8|||
27612671|NCT00383240|80423361|FG001|Overall Study|Treatment Failure|13|||
27612672|NCT00383240|80423362|FG002|Overall Study|Treatment Failure|47|||
27612673|NCT00383240|80423363|FG003|Overall Study|Treatment Failure|46|||
27612674|NCT00383240|80423360|FG000|Overall Study|Lost to Follow-up|3|||
27612675|NCT00383240|80423361|FG001|Overall Study|Lost to Follow-up|0|||
27612676|NCT00383240|80423362|FG002|Overall Study|Lost to Follow-up|0|||
27612677|NCT00383240|80423363|FG003|Overall Study|Lost to Follow-up|2|||
27612678|NCT00383240|80423360|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
27612679|NCT00383240|80423361|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
27612680|NCT00383240|80423362|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
27612681|NCT00383240|80423363|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
27612682|NCT00383240|80423360|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
27612683|NCT00383240|80423361|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
27612684|NCT00383240|80423362|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
27612685|NCT00383240|80423363|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
27612686|NCT00383240|80423360|FG000|Overall Study|Protocol Violation|4|||
27612687|NCT00383240|80423361|FG001|Overall Study|Protocol Violation|5|||
27612688|NCT00383240|80423362|FG002|Overall Study|Protocol Violation|9|||
27612689|NCT00383240|80423363|FG003|Overall Study|Protocol Violation|6|||
27612690|NCT00383240|80423360|FG000|Overall Study|Did not meet protocol eligibility|9|||
27612691|NCT00383240|80423361|FG001|Overall Study|Did not meet protocol eligibility|4|||
27612692|NCT00383240|80423362|FG002|Overall Study|Did not meet protocol eligibility|9|||
27612693|NCT00383240|80423363|FG003|Overall Study|Did not meet protocol eligibility|3|||
27612694|NCT00383240|80423360|FG000|Overall Study|Administrative|1|||
27612695|NCT00383240|80423361|FG001|Overall Study|Administrative|1|||
27612696|NCT00383240|80423362|FG002|Overall Study|Administrative|0|||
27612697|NCT00383240|80423363|FG003|Overall Study|Administrative|0|||
27612698|NCT02105636|80423366|FG000|Pre-Treatment|Disease Progression|1|||
27612699|NCT02105636|80423367|FG001|Pre-Treatment|Disease Progression|0|||
27612700|NCT02105636|80423366|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
27612701|NCT02105636|80423367|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
27612702|NCT02105636|80423366|FG000|Pre-Treatment|Participant withdrew consent|0|||
27612703|NCT02105636|80423367|FG001|Pre-Treatment|Participant withdrew consent|6|||
27612704|NCT02105636|80423366|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
27612705|NCT02105636|80423367|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
27612706|NCT02105636|80423366|FG000|Treatment|Study Drug Toxicity|14|||
27612707|NCT02105636|80423367|FG001|Treatment|Study Drug Toxicity|10|||
27612708|NCT02105636|80423366|FG000|Treatment|Adverse event unrelated to study drug|19|||
27612709|NCT02105636|80423367|FG001|Treatment|Adverse event unrelated to study drug|3|||
27612710|NCT02105636|80423366|FG000|Treatment|Participant request to discontinue study treatment|8|||
27612711|NCT02105636|80423367|FG001|Treatment|Participant request to discontinue study treatment|6|||
27724065|NCT02471716|80822892|FG003|Overall Study|Other|8|||
27724066|NCT02471716|80822893|FG004|Overall Study|Other|9|||
27841672|NCT02688387|81248325|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27612712|NCT02105636|80423366|FG000|Treatment|Participant withdrew consent|5|||
27612713|NCT02105636|80423367|FG001|Treatment|Participant withdrew consent|1|||
27612714|NCT02105636|80423366|FG000|Treatment|Lost to Follow-up|1|||
27612715|NCT02105636|80423367|FG001|Treatment|Lost to Follow-up|0|||
27892600|NCT02855359|81441345|FG003|Overall Study|Study Termination by Sponsor|0|||
27892601|NCT01565668|81441347|FG000|Overall Study|Death|2|||
27892602|NCT01565668|81441348|FG001|Overall Study|Death|1|||
27892603|NCT01565668|81441347|FG000|Overall Study|Lack of Efficacy|4|||
27892604|NCT01565668|81441348|FG001|Overall Study|Lack of Efficacy|2|||
27503659|NCT04323124|80037825|FG000|Overall Study|Adverse Event|0|||
27503660|NCT04323124|80037826|FG001|Overall Study|Adverse Event|0|||
27503661|NCT04323124|80037827|FG002|Overall Study|Adverse Event|0|||
27503662|NCT04323124|80037828|FG003|Overall Study|Adverse Event|0|||
27503663|NCT04323124|80037829|FG004|Overall Study|Adverse Event|0|||
27503664|NCT04323124|80037830|FG005|Overall Study|Adverse Event|1|||
27503665|NCT04323124|80037831|FG006|Overall Study|Adverse Event|0|||
27503666|NCT04323124|80037832|FG007|Overall Study|Adverse Event|1|||
27612716|NCT02105636|80423366|FG000|Treatment|Maximum Clinical Benefit|1|||
27612717|NCT02105636|80423367|FG001|Treatment|Maximum Clinical Benefit|3|||
27612718|NCT02105636|80423366|FG000|Treatment|Poor/Non-compliance|0|||
27612719|NCT02105636|80423367|FG001|Treatment|Poor/Non-compliance|1|||
27612720|NCT02105636|80423366|FG000|Treatment|Participant no longer meets study criteria|1|||
27612721|NCT02105636|80423367|FG001|Treatment|Participant no longer meets study criteria|0|||
27612722|NCT02105636|80423366|FG000|Treatment|Other reasons|1|||
27612723|NCT02105636|80423367|FG001|Treatment|Other reasons|0|||
27612724|NCT02105636|80423366|FG000|Treatment|Disease Progression|185|||
27612725|NCT02105636|80423367|FG001|Treatment|Disease Progression|87|||
27612726|NCT00152763|80423370|FG000|Overall Study|Death|4|||
27612727|NCT00152763|80423371|FG001|Overall Study|Death|1|||
27612728|NCT00152763|80423372|FG002|Overall Study|Death|2|||
27612729|NCT00152763|80423373|FG003|Overall Study|Death|1|||
27612730|NCT00152763|80423370|FG000|Overall Study|Lost to Follow-up|6|||
27612731|NCT00152763|80423371|FG001|Overall Study|Lost to Follow-up|4|||
27612732|NCT00152763|80423372|FG002|Overall Study|Lost to Follow-up|2|||
27612733|NCT00152763|80423373|FG003|Overall Study|Lost to Follow-up|13|||
27612734|NCT01406717|80423374|FG000|Overall Study|Subject non-compliance|4|||
27612735|NCT01406717|80423375|FG001|Overall Study|Subject non-compliance|3|||
27612736|NCT01406717|80423374|FG000|Overall Study|Protocol Violation|5|||
27612737|NCT01406717|80423375|FG001|Overall Study|Protocol Violation|1|||
27612738|NCT01406717|80423374|FG000|Overall Study|Lost to Follow-up|14|||
27612739|NCT01406717|80423375|FG001|Overall Study|Lost to Follow-up|8|||
27612740|NCT01406717|80423374|FG000|Overall Study|Withdrawal by Subject|19|||
27612741|NCT01406717|80423375|FG001|Overall Study|Withdrawal by Subject|15|||
27612742|NCT01406717|80423374|FG000|Overall Study|Adverse Event|1|||
27612743|NCT01406717|80423375|FG001|Overall Study|Adverse Event|2|||
27612744|NCT01406717|80423374|FG000|Overall Study|Lack of Efficacy|0|||
27612745|NCT01406717|80423375|FG001|Overall Study|Lack of Efficacy|1|||
27612746|NCT01406717|80423374|FG000|Overall Study|Non-completion of visit activity|0|||
27612747|NCT01406717|80423375|FG001|Overall Study|Non-completion of visit activity|1|||
27612748|NCT00519896|80423379|FG000|Overall Study|Protocol Violation|1|||
27841673|NCT02688387|81248326|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841674|NCT02688387|81248327|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841675|NCT02688387|81248328|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
27841676|NCT02688387|81248329|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
27841677|NCT02688387|81248308|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841678|NCT02688387|81248309|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841679|NCT02688387|81248310|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27503667|NCT04323124|80037833|FG008|Overall Study|Adverse Event|1|||
27612749|NCT00519896|80423379|FG000|Overall Study|Adverse Event|1|||
27612750|NCT05593211|80423382|FG000|Overall Study|Withdrawal by Subject|1|||
27612751|NCT01108510|80423392|FG000|Overall Study|Randomized but Not Treated|5|||
27612752|NCT01108510|80423393|FG001|Overall Study|Randomized but Not Treated|1|||
27612753|NCT01108510|80423392|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
27612754|NCT01108510|80423393|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
27612755|NCT01108510|80423392|FG000|Overall Study|Adverse Event|26|||
27612756|NCT01108510|80423393|FG001|Overall Study|Adverse Event|19|||
27841680|NCT02688387|81248311|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841681|NCT02688387|81248312|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27612757|NCT01108510|80423392|FG000|Overall Study|Lost to Follow-up|20|||
27612758|NCT01108510|80423393|FG001|Overall Study|Lost to Follow-up|17|||
27612759|NCT01108510|80423392|FG000|Overall Study|Withdrew Consent|21|||
27892605|NCT01565668|81441347|FG000|Overall Study|Participant went on Hospice Care|1|||
27841682|NCT02688387|81248313|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841683|NCT02688387|81248314|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841684|NCT02688387|81248315|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841685|NCT02688387|81248316|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841686|NCT02688387|81248317|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841687|NCT02688387|81248318|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27503668|NCT04323124|80037834|FG009|Overall Study|Adverse Event|0|||
27503669|NCT04323124|80037835|FG010|Overall Study|Adverse Event|0|||
27503670|NCT04323124|80037836|FG011|Overall Study|Adverse Event|0|||
27503671|NCT04323124|80037837|FG012|Overall Study|Adverse Event|0|||
27503672|NCT04323124|80037838|FG013|Overall Study|Adverse Event|0|||
27503673|NCT04323124|80037839|FG014|Overall Study|Adverse Event|0|||
27503674|NCT04323124|80037825|FG000|Overall Study|Other|0|||
27503675|NCT04323124|80037826|FG001|Overall Study|Other|0|||
27503676|NCT04323124|80037827|FG002|Overall Study|Other|0|||
27503677|NCT04323124|80037828|FG003|Overall Study|Other|0|||
27503678|NCT04323124|80037829|FG004|Overall Study|Other|1|||
27503679|NCT04323124|80037830|FG005|Overall Study|Other|0|||
27503680|NCT04323124|80037831|FG006|Overall Study|Other|0|||
27503681|NCT04323124|80037832|FG007|Overall Study|Other|0|||
27503682|NCT04323124|80037833|FG008|Overall Study|Other|1|||
27503683|NCT04323124|80037834|FG009|Overall Study|Other|0|||
27503684|NCT04323124|80037835|FG010|Overall Study|Other|0|||
27503685|NCT04323124|80037836|FG011|Overall Study|Other|0|||
27503686|NCT04323124|80037837|FG012|Overall Study|Other|0|||
27503687|NCT04323124|80037838|FG013|Overall Study|Other|0|||
27503688|NCT04323124|80037839|FG014|Overall Study|Other|0|||
27503689|NCT04323124|80037825|FG000|Overall Study|Coming from a red zone (COVID)|0|||
27503690|NCT04323124|80037826|FG001|Overall Study|Coming from a red zone (COVID)|0|||
27503691|NCT04323124|80037827|FG002|Overall Study|Coming from a red zone (COVID)|0|||
27503692|NCT04323124|80037828|FG003|Overall Study|Coming from a red zone (COVID)|0|||
27503693|NCT04323124|80037829|FG004|Overall Study|Coming from a red zone (COVID)|1|||
27503694|NCT04323124|80037830|FG005|Overall Study|Coming from a red zone (COVID)|1|||
27503695|NCT04323124|80037831|FG006|Overall Study|Coming from a red zone (COVID)|0|||
27503696|NCT04323124|80037832|FG007|Overall Study|Coming from a red zone (COVID)|0|||
27841688|NCT02688387|81248319|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841689|NCT02688387|81248320|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27612760|NCT01108510|80423393|FG001|Overall Study|Withdrew Consent|15|||
27612761|NCT01108510|80423392|FG000|Overall Study|Investigator's Discretion|12|||
27612762|NCT01108510|80423393|FG001|Overall Study|Investigator's Discretion|10|||
27612763|NCT01108510|80423392|FG000|Overall Study|Participant Noncompliance|5|||
27612764|NCT01108510|80423393|FG001|Overall Study|Participant Noncompliance|7|||
27612765|NCT01108510|80423392|FG000|Overall Study|Lack of Efficacy|3|||
27612766|NCT01108510|80423393|FG001|Overall Study|Lack of Efficacy|0|||
27612767|NCT01108510|80423392|FG000|Overall Study|Pregnancy|0|||
27612768|NCT01108510|80423393|FG001|Overall Study|Pregnancy|3|||
27612769|NCT01108510|80423392|FG000|Overall Study|Death|1|||
27612770|NCT01108510|80423393|FG001|Overall Study|Death|1|||
27612771|NCT00924469|80423394|FG000|Overall Study|Adverse Event|2|||
27612772|NCT00924469|80423395|FG001|Overall Study|Adverse Event|0|||
27612773|NCT00924469|80423394|FG000|Overall Study|Withdrawal by Subject|0|||
27612774|NCT00924469|80423395|FG001|Overall Study|Withdrawal by Subject|1|||
27612775|NCT00924469|80423394|FG000|Overall Study|Lost to Follow-up|0|||
27612776|NCT00924469|80423395|FG001|Overall Study|Lost to Follow-up|1|||
27612777|NCT00904150|80423396|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
27612778|NCT00904150|80423397|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
27612779|NCT00904150|80423396|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
27612780|NCT00904150|80423397|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
27503697|NCT04323124|80037833|FG008|Overall Study|Coming from a red zone (COVID)|0|||
27503698|NCT04323124|80037834|FG009|Overall Study|Coming from a red zone (COVID)|0|||
27503699|NCT04323124|80037835|FG010|Overall Study|Coming from a red zone (COVID)|0|||
27503700|NCT04323124|80037836|FG011|Overall Study|Coming from a red zone (COVID)|0|||
27503701|NCT04323124|80037837|FG012|Overall Study|Coming from a red zone (COVID)|0|||
27503702|NCT04323124|80037838|FG013|Overall Study|Coming from a red zone (COVID)|0|||
27724067|NCT00809328|80822896|FG000|Overall Study|Lack of Efficacy|18|||
27724068|NCT00809328|80822896|FG000|Overall Study|Adverse Event|6|||
27724069|NCT00809328|80822896|FG000|Overall Study|Protocol Violation|3|||
27503703|NCT04323124|80037839|FG014|Overall Study|Coming from a red zone (COVID)|0|||
27503704|NCT04323124|80037825|FG000|Overall Study|No longer meets eligibility criteria|0|||
27503705|NCT04323124|80037826|FG001|Overall Study|No longer meets eligibility criteria|0|||
27503706|NCT04323124|80037827|FG002|Overall Study|No longer meets eligibility criteria|0|||
27503707|NCT04323124|80037828|FG003|Overall Study|No longer meets eligibility criteria|0|||
27503708|NCT04323124|80037829|FG004|Overall Study|No longer meets eligibility criteria|0|||
27503709|NCT04323124|80037830|FG005|Overall Study|No longer meets eligibility criteria|0|||
27612781|NCT01087723|80423400|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
27612782|NCT01087723|80423401|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
27724070|NCT00809328|80822896|FG000|Overall Study|Withdrawal by Subject|2|||
27724071|NCT04082663|80822899|FG000|Overall Study|Adverse Event|6|||
27724072|NCT04082663|80822899|FG000|Overall Study|Lost to Follow-up|1|||
27724073|NCT02425098|80822901|FG000|Overall Study|Lost to Follow-up|7|||
27503710|NCT04323124|80037831|FG006|Overall Study|No longer meets eligibility criteria|0|||
27612783|NCT01087723|80423400|FG000|Overall Study|Withdrawal by Subject|10|||
27612784|NCT01087723|80423401|FG001|Overall Study|Withdrawal by Subject|13|||
27612785|NCT01087723|80423400|FG000|Overall Study|Physician Decision|2|||
27612786|NCT01087723|80423401|FG001|Overall Study|Physician Decision|0|||
27724074|NCT02425098|80822902|FG001|Overall Study|Lost to Follow-up|7|||
27724075|NCT02425098|80822901|FG000|Overall Study|Withdrawal by Subject|4|||
27724076|NCT02425098|80822902|FG001|Overall Study|Withdrawal by Subject|8|||
27724077|NCT02425098|80822901|FG000|Overall Study|Pregnancy|2|||
27724078|NCT02425098|80822902|FG001|Overall Study|Pregnancy|0|||
27724079|NCT02425098|80822901|FG000|Overall Study|Reason not Specified|0|||
27724080|NCT02425098|80822902|FG001|Overall Study|Reason not Specified|1|||
27724081|NCT01651780|80822907|FG000|Overall Study|Physician decision: No 30-day visit|2|||
27724082|NCT01651780|80822908|FG001|Overall Study|Physician decision: No 30-day visit|1|||
27724083|NCT01651780|80822907|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
27724084|NCT01651780|80822908|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
27724085|NCT01651780|80822907|FG000|Overall Study|Withdrawal by Subject|2|||
27724086|NCT01651780|80822908|FG001|Overall Study|Withdrawal by Subject|0|||
27724087|NCT01651780|80822907|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
27724088|NCT01651780|80822908|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27724089|NCT01651780|80822907|FG000|Overall Study|Lost to Follow-up|1|||
27724090|NCT01651780|80822908|FG001|Overall Study|Lost to Follow-up|2|||
27724091|NCT01651780|80822907|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
27724092|NCT01651780|80822908|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
27724093|NCT00756938|80822911|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
27724094|NCT00756938|80822912|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
27724095|NCT00756938|80822913|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
27724096|NCT00756938|80822914|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
27724097|NCT00756938|80822911|FG000|12-week Base Study|Protocol Violation|0|||
27724098|NCT00756938|80822912|FG001|12-week Base Study|Protocol Violation|0|||
27724099|NCT00756938|80822913|FG002|12-week Base Study|Protocol Violation|1|||
27724100|NCT00756938|80822914|FG003|12-week Base Study|Protocol Violation|0|||
27724101|NCT00756938|80822911|FG000|12-week Base Study|Lost to Follow-up|1|||
27724102|NCT00756938|80822912|FG001|12-week Base Study|Lost to Follow-up|0|||
27724103|NCT00756938|80822913|FG002|12-week Base Study|Lost to Follow-up|0|||
27724104|NCT00756938|80822914|FG003|12-week Base Study|Lost to Follow-up|0|||
27724105|NCT00756938|80822911|FG000|Optional Extension|Lack of Efficacy|0|||
27724106|NCT00756938|80822912|FG001|Optional Extension|Lack of Efficacy|0|||
27724107|NCT00756938|80822913|FG002|Optional Extension|Lack of Efficacy|0|||
27958605|NCT01791517|81680065|FG007|Phase II|Lack of Efficacy|0|||
27503711|NCT04323124|80037832|FG007|Overall Study|No longer meets eligibility criteria|1|||
27503712|NCT04323124|80037833|FG008|Overall Study|No longer meets eligibility criteria|0|||
27503713|NCT04323124|80037834|FG009|Overall Study|No longer meets eligibility criteria|0|||
27503714|NCT04323124|80037835|FG010|Overall Study|No longer meets eligibility criteria|0|||
27503715|NCT04323124|80037836|FG011|Overall Study|No longer meets eligibility criteria|0|||
27503716|NCT04323124|80037837|FG012|Overall Study|No longer meets eligibility criteria|0|||
27503717|NCT04323124|80037838|FG013|Overall Study|No longer meets eligibility criteria|1|||
27503718|NCT04323124|80037839|FG014|Overall Study|No longer meets eligibility criteria|1|||
27503719|NCT04323124|80037825|FG000|Overall Study|Study terminated by sponsor|0|||
27503720|NCT04323124|80037826|FG001|Overall Study|Study terminated by sponsor|0|||
27503721|NCT04323124|80037827|FG002|Overall Study|Study terminated by sponsor|0|||
27503722|NCT04323124|80037828|FG003|Overall Study|Study terminated by sponsor|0|||
27503723|NCT04323124|80037829|FG004|Overall Study|Study terminated by sponsor|0|||
27503724|NCT04323124|80037830|FG005|Overall Study|Study terminated by sponsor|0|||
27724108|NCT00756938|80822914|FG003|Optional Extension|Lack of Efficacy|1|||
27724109|NCT00756938|80822911|FG000|Optional Extension|End of Study|0|||
27724110|NCT00756938|80822912|FG001|Optional Extension|End of Study|0|||
27724111|NCT00756938|80822913|FG002|Optional Extension|End of Study|0|||
27724112|NCT00756938|80822914|FG003|Optional Extension|End of Study|11|||
27503725|NCT04323124|80037831|FG006|Overall Study|Study terminated by sponsor|0|||
27724113|NCT00756938|80822911|FG000|Optional Extension|Protocol-specific criteria met|0|||
27724114|NCT00756938|80822912|FG001|Optional Extension|Protocol-specific criteria met|0|||
27724115|NCT00756938|80822913|FG002|Optional Extension|Protocol-specific criteria met|0|||
27612787|NCT01087723|80423400|FG000|Overall Study|Lost to Follow-up|1|||
27754870|NCT02065622|80929630|FG000|Induction Study|Lost to Follow-up|1|||
27724116|NCT00756938|80822914|FG003|Optional Extension|Protocol-specific criteria met|9|||
27724117|NCT00756938|80822911|FG000|Optional Extension|Physician Decision|0|||
27724118|NCT00756938|80822912|FG001|Optional Extension|Physician Decision|0|||
27724119|NCT00756938|80822913|FG002|Optional Extension|Physician Decision|0|||
27724120|NCT00756938|80822914|FG003|Optional Extension|Physician Decision|3|||
27724121|NCT00756938|80822911|FG000|Optional Extension|Lost to Follow-up|0|||
27724122|NCT00756938|80822912|FG001|Optional Extension|Lost to Follow-up|0|||
27724123|NCT00756938|80822913|FG002|Optional Extension|Lost to Follow-up|0|||
27724124|NCT00756938|80822914|FG003|Optional Extension|Lost to Follow-up|1|||
27724125|NCT00756938|80822911|FG000|Optional Extension|Protocol Violation|0|||
27724126|NCT00756938|80822912|FG001|Optional Extension|Protocol Violation|0|||
27724127|NCT00756938|80822913|FG002|Optional Extension|Protocol Violation|0|||
27724128|NCT00756938|80822914|FG003|Optional Extension|Protocol Violation|1|||
27724129|NCT00756938|80822911|FG000|Optional Extension|Withdrawal by Subject|0|||
27724130|NCT00756938|80822912|FG001|Optional Extension|Withdrawal by Subject|0|||
27724131|NCT00756938|80822913|FG002|Optional Extension|Withdrawal by Subject|0|||
27503726|NCT04323124|80037832|FG007|Overall Study|Study terminated by sponsor|0|||
27724132|NCT00756938|80822914|FG003|Optional Extension|Withdrawal by Subject|10|||
27724133|NCT00756938|80822911|FG000|Optional Extension|Adverse Event|0|||
27724134|NCT00756938|80822912|FG001|Optional Extension|Adverse Event|0|||
27841690|NCT02688387|81248321|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841691|NCT02688387|81248322|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841692|NCT02688387|81248323|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841693|NCT02688387|81248324|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841694|NCT02688387|81248325|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841695|NCT02688387|81248326|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
27841696|NCT02688387|81248327|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841697|NCT02688387|81248328|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
27841698|NCT02688387|81248329|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
27841699|NCT02688387|81248308|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841700|NCT02688387|81248309|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841701|NCT02688387|81248310|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841702|NCT02688387|81248311|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841703|NCT02688387|81248312|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27892606|NCT01565668|81441348|FG001|Overall Study|Participant went on Hospice Care|0|||
27892607|NCT01565668|81441347|FG000|Overall Study|Adverse Event|6|||
27892608|NCT01565668|81441348|FG001|Overall Study|Adverse Event|1|||
27892609|NCT01565668|81441347|FG000|Overall Study|Randomized, but never received drug|0|||
27724135|NCT00756938|80822913|FG002|Optional Extension|Adverse Event|0|||
27724136|NCT00756938|80822914|FG003|Optional Extension|Adverse Event|1|||
27724137|NCT00661271|80822915|FG000|Overall Study|Lost to Follow-up|28|||
27724138|NCT00661271|80822916|FG001|Overall Study|Lost to Follow-up|25|||
27892610|NCT01565668|81441348|FG001|Overall Study|Randomized, but never received drug|2|||
27892611|NCT01565668|81441347|FG000|Overall Study|Progressive disease|13|||
27724139|NCT01737931|80822925|FG000|Overall Study|Withdrawal by Subject|0|||
27724140|NCT01737931|80822926|FG001|Overall Study|Withdrawal by Subject|1|||
27724141|NCT01737931|80822927|FG002|Overall Study|Withdrawal by Subject|1|||
27724142|NCT01737931|80822925|FG000|Overall Study|Physician Decision|0|||
27724143|NCT01737931|80822926|FG001|Overall Study|Physician Decision|1|||
27724144|NCT01737931|80822927|FG002|Overall Study|Physician Decision|0|||
27724145|NCT01323478|80822928|FG000|Overall Study|Adverse Event|7|||
27724146|NCT01323478|80822928|FG000|Overall Study|Lack of Efficacy|4|||
27724147|NCT01323478|80822928|FG000|Overall Study|Non-compliance With Study Product|3|||
27724148|NCT01323478|80822928|FG000|Overall Study|Protocol Violation|1|||
27724149|NCT01323478|80822928|FG000|Overall Study|Withdrawal of Consent|1|||
27724150|NCT01323478|80822928|FG000|Overall Study|Administrative or Other Reasons|8|||
27724151|NCT00946309|80822929|FG000|Overall Study|Protocol Violation|1|||
27724152|NCT00946309|80822930|FG001|Overall Study|Protocol Violation|0|||
27724153|NCT00946309|80822929|FG000|Overall Study|Lost to Follow-up|0|||
27724154|NCT00946309|80822930|FG001|Overall Study|Lost to Follow-up|1|||
27724155|NCT00946309|80822929|FG000|Overall Study|Procedure cancelled/discontinued|0|||
27724156|NCT00946309|80822930|FG001|Overall Study|Procedure cancelled/discontinued|3|||
27724157|NCT02452762|80822931|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
27724158|NCT02452762|80822932|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
27724159|NCT02452762|80822931|FG000|Overall Study|Withdrawal by Subject|1|||
27724160|NCT02452762|80822932|FG001|Overall Study|Withdrawal by Subject|0|||
27724161|NCT02322710|80822934|FG000|Overall Study|No efficacy assessment post-baseline|0|||
27724162|NCT02322710|80822935|FG001|Overall Study|No efficacy assessment post-baseline|1|||
27724163|NCT02322710|80822934|FG000|Overall Study|Protocol Violation|20|||
27724164|NCT02322710|80822935|FG001|Overall Study|Protocol Violation|25|||
27724165|NCT00074958|80822946|FG000|Overall Study|Adverse Event|1|||
27724166|NCT03183128|80822952|FG000|Overall Study|Adverse Event|1|||
27724167|NCT03183128|80822953|FG001|Overall Study|Adverse Event|2|||
27724168|NCT03183128|80822952|FG000|Overall Study|Withdrawal by Subject|1|||
27724169|NCT03183128|80822953|FG001|Overall Study|Withdrawal by Subject|8|||
27724170|NCT03183128|80822952|FG000|Overall Study|Protocol Violation|2|||
27724171|NCT03183128|80822953|FG001|Overall Study|Protocol Violation|0|||
27724172|NCT03183128|80822952|FG000|Overall Study|Lack of Efficacy|4|||
27724173|NCT03183128|80822953|FG001|Overall Study|Lack of Efficacy|27|||
27724174|NCT03183128|80822952|FG000|Overall Study|Lost to Follow-up|1|||
27724175|NCT03183128|80822953|FG001|Overall Study|Lost to Follow-up|0|||
27724176|NCT03183128|80822952|FG000|Overall Study|Death|2|||
27724177|NCT03183128|80822953|FG001|Overall Study|Death|0|||
27724178|NCT03183128|80822952|FG000|Overall Study|Physician Decision|1|||
27724179|NCT03183128|80822953|FG001|Overall Study|Physician Decision|0|||
27724180|NCT04428411|80822954|FG000|Overall Study|Lost to Follow-up|114|||
27841704|NCT02688387|81248313|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841705|NCT02688387|81248314|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841706|NCT02688387|81248315|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841707|NCT02688387|81248316|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841708|NCT02688387|81248317|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841709|NCT02688387|81248318|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27503727|NCT04323124|80037833|FG008|Overall Study|Study terminated by sponsor|0|||
27503728|NCT04323124|80037834|FG009|Overall Study|Study terminated by sponsor|0|||
27503729|NCT04323124|80037835|FG010|Overall Study|Study terminated by sponsor|0|||
27503730|NCT04323124|80037836|FG011|Overall Study|Study terminated by sponsor|2|||
27503731|NCT04323124|80037837|FG012|Overall Study|Study terminated by sponsor|1|||
27503732|NCT04323124|80037838|FG013|Overall Study|Study terminated by sponsor|0|||
27503733|NCT04323124|80037839|FG014|Overall Study|Study terminated by sponsor|0|||
27503734|NCT01668784|80037840|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
27503735|NCT01668784|80037841|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
27841710|NCT02688387|81248319|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841711|NCT02688387|81248320|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841712|NCT02688387|81248321|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27892612|NCT01565668|81441348|FG001|Overall Study|Progressive disease|14|||
27892613|NCT01565668|81441347|FG000|Overall Study|Withdrawal by Subject|1|||
27503736|NCT01668784|80037840|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
27503737|NCT01668784|80037841|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
27724181|NCT03222349|80822956|FG000|Overall Study|Treatment B not done|5|||
27841713|NCT02688387|81248322|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27503738|NCT01668784|80037840|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
27724182|NCT03222349|80822957|FG001|Overall Study|Treatment B not done|0|||
27724183|NCT03222349|80822956|FG000|Overall Study|Lost to Follow-up|1|||
27724184|NCT03222349|80822957|FG001|Overall Study|Lost to Follow-up|2|||
27724185|NCT03222349|80822956|FG000|Overall Study|Withdrawal by Subject|1|||
27724186|NCT03222349|80822957|FG001|Overall Study|Withdrawal by Subject|0|||
27724187|NCT03222349|80822956|FG000|Overall Study|Treatment A not done|0|||
27724188|NCT03222349|80822957|FG001|Overall Study|Treatment A not done|5|||
27724189|NCT03222349|80822956|FG000|Overall Study|Study terminated by sponsor|1|||
27892614|NCT01565668|81441348|FG001|Overall Study|Withdrawal by Subject|3|||
27503739|NCT01668784|80037841|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
27841714|NCT02688387|81248323|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841715|NCT02688387|81248324|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841716|NCT02688387|81248325|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841717|NCT02688387|81248326|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841718|NCT02688387|81248327|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
27841719|NCT02688387|81248328|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841720|NCT02688387|81248329|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
27841721|NCT02998541|81248332|FG000|Overall Study|Adverse Event|4|||
27841722|NCT02998541|81248333|FG001|Overall Study|Adverse Event|5|||
27841723|NCT02998541|81248334|FG002|Overall Study|Adverse Event|1|||
27841724|NCT02998541|81248332|FG000|Overall Study|Protocol Violation|1|||
27841725|NCT02998541|81248333|FG001|Overall Study|Protocol Violation|0|||
27841726|NCT02998541|81248334|FG002|Overall Study|Protocol Violation|0|||
27841727|NCT02998541|81248332|FG000|Overall Study|Withdrawal by Subject|3|||
27892615|NCT01565668|81441347|FG000|Overall Study|HSCT Transplant|11|||
27892616|NCT01565668|81441348|FG001|Overall Study|HSCT Transplant|15|||
27892617|NCT05523323|81441352|FG000|Overall Study|Death|26|||
27892618|NCT05523323|81441353|FG001|Overall Study|Death|21|||
27892619|NCT05523323|81441352|FG000|Overall Study|Ongoing participants|35|||
27892620|NCT05523323|81441353|FG001|Overall Study|Ongoing participants|30|||
27892621|NCT03602391|81441356|FG000|Overall Study|COVID-19|7|||
27892622|NCT03602391|81441357|FG001|Overall Study|COVID-19|6|||
27892623|NCT05177354|81441358|FG000|Implant to 30-day Visit|Physician Decision|1|||
27892624|NCT05177354|81441358|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
27892625|NCT05177354|81441358|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
27892626|NCT05177354|81441358|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
27892627|NCT05835011|81441361|FG000|Overall Study|Study Terminated by the Sponsor|1|||
27892628|NCT05835011|81441361|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
27892629|NCT00348790|81441362|FG000|Completed Treatment|Withdrawal by Subject|4|||
27892630|NCT00348790|81441362|FG000|Completed Treatment|Disease progression|14|||
27892631|NCT00348790|81441362|FG000|Completed Treatment|Adverse Event|4|||
27892632|NCT00348790|81441362|FG000|Completed Treatment|Required surgery|2|||
27892633|NCT00348790|81441362|FG000|Completed Treatment|Unable to travel to study site|1|||
27892634|NCT03917472|81441363|FG000|Overall Study|Physician Decision|4|||
27841728|NCT02998541|81248333|FG001|Overall Study|Withdrawal by Subject|1|||
27841729|NCT02998541|81248334|FG002|Overall Study|Withdrawal by Subject|0|||
27841730|NCT02998541|81248332|FG000|Overall Study|Lost to Follow-up|0|||
27841731|NCT02998541|81248333|FG001|Overall Study|Lost to Follow-up|3|||
27841732|NCT02998541|81248334|FG002|Overall Study|Lost to Follow-up|1|||
27892635|NCT03917472|81441364|FG001|Overall Study|Physician Decision|0|||
27892636|NCT03917472|81441363|FG000|Overall Study|Adverse Event|3|||
27892637|NCT03917472|81441364|FG001|Overall Study|Adverse Event|1|||
27892638|NCT03917472|81441363|FG000|Overall Study|Death|7|||
27892639|NCT03917472|81441364|FG001|Overall Study|Death|5|||
27892640|NCT03917472|81441363|FG000|Overall Study|Withdrawal by Subject|11|||
27892641|NCT03917472|81441364|FG001|Overall Study|Withdrawal by Subject|4|||
27892642|NCT03917472|81441363|FG000|Overall Study|Lost to Follow-up|10|||
27892643|NCT03917472|81441364|FG001|Overall Study|Lost to Follow-up|5|||
27892644|NCT00970632|81441365|FG000|Overall Study|Adverse Event|2|||
27892645|NCT00970632|81441366|FG001|Overall Study|Adverse Event|2|||
27892646|NCT00970632|81441367|FG002|Overall Study|Adverse Event|1|||
27892647|NCT00970632|81441365|FG000|Overall Study|Lack of Efficacy|3|||
27892648|NCT00970632|81441366|FG001|Overall Study|Lack of Efficacy|0|||
27892649|NCT00970632|81441367|FG002|Overall Study|Lack of Efficacy|0|||
27892650|NCT00970632|81441365|FG000|Overall Study|Lost to Follow-up|3|||
27892651|NCT00970632|81441366|FG001|Overall Study|Lost to Follow-up|0|||
27892652|NCT00970632|81441367|FG002|Overall Study|Lost to Follow-up|2|||
27841733|NCT02998541|81248332|FG000|Overall Study|Physician Decision|0|||
27841734|NCT02998541|81248333|FG001|Overall Study|Physician Decision|0|||
27841735|NCT02998541|81248334|FG002|Overall Study|Physician Decision|3|||
27841736|NCT02998541|81248332|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27841737|NCT02998541|81248333|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27892653|NCT00970632|81441365|FG000|Overall Study|Protocol Violation|8|||
27892654|NCT00970632|81441366|FG001|Overall Study|Protocol Violation|5|||
27892655|NCT00970632|81441367|FG002|Overall Study|Protocol Violation|8|||
27892656|NCT00970632|81441365|FG000|Overall Study|Withdrawal by Subject|7|||
27892657|NCT00970632|81441366|FG001|Overall Study|Withdrawal by Subject|6|||
27892658|NCT00970632|81441367|FG002|Overall Study|Withdrawal by Subject|4|||
27958606|NCT01791517|81680066|FG008|Phase II|Lack of Efficacy|0|||
27841738|NCT02998541|81248334|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
27841739|NCT02655224|81248337|FG000|Overall Study|Adverse Event|1|||
27841740|NCT02655224|81248338|FG001|Overall Study|Adverse Event|1|||
27841741|NCT02274558|81248340|FG000|Overall Study|Adverse Event|2|||
27841742|NCT02274558|81248341|FG001|Overall Study|Adverse Event|4|||
27841743|NCT02274558|81248342|FG002|Overall Study|Adverse Event|2|||
27841744|NCT02274558|81248340|FG000|Overall Study|Non-compliance|2|||
27841745|NCT02274558|81248341|FG001|Overall Study|Non-compliance|1|||
27841746|NCT02274558|81248342|FG002|Overall Study|Non-compliance|0|||
27841747|NCT02274558|81248340|FG000|Overall Study|Withdrawal by Subject|1|||
27841748|NCT02274558|81248341|FG001|Overall Study|Withdrawal by Subject|5|||
27841749|NCT02274558|81248342|FG002|Overall Study|Withdrawal by Subject|4|||
27841750|NCT02274558|81248340|FG000|Overall Study|Death|0|||
27841751|NCT02274558|81248341|FG001|Overall Study|Death|0|||
27841752|NCT02274558|81248342|FG002|Overall Study|Death|1|||
27841753|NCT02274558|81248340|FG000|Overall Study|Lost to Follow-up|2|||
27841754|NCT02274558|81248341|FG001|Overall Study|Lost to Follow-up|1|||
27841755|NCT02274558|81248342|FG002|Overall Study|Lost to Follow-up|1|||
27841756|NCT02274558|81248340|FG000|Overall Study|Physician Decision|0|||
27841757|NCT02274558|81248341|FG001|Overall Study|Physician Decision|2|||
27841758|NCT02274558|81248342|FG002|Overall Study|Physician Decision|1|||
27841759|NCT02297841|81248343|FG000|Overall Study|Withdrawal by Subject|1|||
27841760|NCT02297841|81248343|FG000|Overall Study|Protocol Violation|7|||
27841761|NCT04149535|81248344|FG000|Overall Study|Death|11|||
27841762|NCT04149535|81248345|FG001|Overall Study|Death|7|||
27841763|NCT04149535|81248344|FG000|Overall Study|Physician Decision|10|||
27841764|NCT04149535|81248345|FG001|Overall Study|Physician Decision|4|||
27841765|NCT04149535|81248344|FG000|Overall Study|Withdrawal by Subject|6|||
27841766|NCT04149535|81248345|FG001|Overall Study|Withdrawal by Subject|7|||
27841767|NCT04149535|81248344|FG000|Overall Study|Not described|2|||
27841768|NCT04149535|81248345|FG001|Overall Study|Not described|0|||
27841769|NCT01483625|81248346|FG000|Overall Study|Adverse Event|1|||
27841770|NCT01483625|81248347|FG001|Overall Study|Adverse Event|1|||
27841771|NCT01483625|81248346|FG000|Overall Study|Refused to continue medication|2|||
27841772|NCT01483625|81248347|FG001|Overall Study|Refused to continue medication|1|||
27841773|NCT01483625|81248346|FG000|Overall Study|Due to other reason|1|||
27841774|NCT01483625|81248347|FG001|Overall Study|Due to other reason|0|||
27841775|NCT02327325|81248348|FG000|Overall Study|Withdrawal by Subject|1|||
27841776|NCT02327325|81248349|FG001|Overall Study|Withdrawal by Subject|4|||
27841777|NCT02327325|81248350|FG002|Overall Study|Withdrawal by Subject|4|||
27841778|NCT02327325|81248348|FG000|Overall Study|Excluded by Study Team|0|||
27841779|NCT02327325|81248349|FG001|Overall Study|Excluded by Study Team|0|||
27841780|NCT02327325|81248350|FG002|Overall Study|Excluded by Study Team|1|||
27841781|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
27612788|NCT01087723|80423401|FG001|Overall Study|Lost to Follow-up|4|||
27612789|NCT01087723|80423400|FG000|Overall Study|Reason Not Specified|1|||
27612790|NCT01087723|80423401|FG001|Overall Study|Reason Not Specified|2|||
27841782|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
27841783|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
27841784|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
27841785|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
27841786|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
27841787|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
27841788|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
27841789|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
27841790|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
27841791|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
27841792|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
27612791|NCT01992549|80423402|FG000|Overall Study|Lost to Follow-up|2|||
27612792|NCT01992549|80423402|FG000|Overall Study|Serious Adverse Event|1|||
27841793|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Death|0|||
27841794|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Death|1|||
27841795|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Death|0|||
27841796|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Death|0|||
27841797|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
27841798|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
27841799|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
27841800|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
27841801|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
27841802|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
27841803|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
27841804|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
27841805|NCT00545688|81248354|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
27841806|NCT00545688|81248355|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
27841807|NCT00545688|81248356|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
27612793|NCT01992549|80423402|FG000|Overall Study|Product Switch to Extend Half Life|1|||
27612794|NCT01004250|80423404|FG000|Induction Therapy Period|Adverse Event|10|||
27612795|NCT01004250|80423404|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
27612796|NCT01004250|80423404|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
27612797|NCT01004250|80423404|FG000|Induction Therapy Period|Physician Decision|2|||
27612798|NCT01004250|80423404|FG000|Maintenance Therapy Period|Adverse Event|15|||
27612799|NCT01004250|80423404|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
27612800|NCT01004250|80423404|FG000|Maintenance Therapy Period|Protocol Violation|1|||
27612801|NCT01004250|80423404|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
27612802|NCT01004250|80423404|FG000|Maintenance Therapy Period|Physician Decision|4|||
27612803|NCT01004250|80423404|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
27612804|NCT02788006|80423405|FG000|Overall Study|Patient not treated|1|||
27612805|NCT02293837|80423408|FG000|Overall Study|Lost to Follow-up|0|||
27612806|NCT02293837|80423409|FG001|Overall Study|Lost to Follow-up|2|||
27612807|NCT02293837|80423410|FG002|Overall Study|Lost to Follow-up|1|||
27612808|NCT02293837|80423411|FG003|Overall Study|Lost to Follow-up|0|||
27612809|NCT02293837|80423408|FG000|Overall Study|Withdrawal by Subject|2|||
27612810|NCT02293837|80423409|FG001|Overall Study|Withdrawal by Subject|1|||
27612811|NCT02293837|80423410|FG002|Overall Study|Withdrawal by Subject|2|||
27612812|NCT02293837|80423411|FG003|Overall Study|Withdrawal by Subject|1|||
27612813|NCT02293837|80423408|FG000|Overall Study|COVID-19 Related|1|||
27612814|NCT02293837|80423409|FG001|Overall Study|COVID-19 Related|1|||
27612815|NCT02293837|80423410|FG002|Overall Study|COVID-19 Related|0|||
27612816|NCT02293837|80423411|FG003|Overall Study|COVID-19 Related|0|||
27612817|NCT02293837|80423408|FG000|Overall Study|Participant ill and could not be infused|0|||
27612818|NCT02293837|80423409|FG001|Overall Study|Participant ill and could not be infused|0|||
27612819|NCT02293837|80423410|FG002|Overall Study|Participant ill and could not be infused|1|||
27612820|NCT02293837|80423411|FG003|Overall Study|Participant ill and could not be infused|0|||
27612821|NCT01630590|80423415|FG000|Overall Study|Adverse Event|9|||
27612822|NCT01630590|80423415|FG000|Overall Study|Lack of Efficacy|37|||
27612823|NCT01630590|80423415|FG000|Overall Study|Withdrawal by Subject|4|||
27612824|NCT01630590|80423415|FG000|Overall Study|2nd primary tumor|2|||
27612825|NCT01630590|80423415|FG000|Overall Study|Automobile accident|1|||
27612826|NCT01630590|80423415|FG000|Overall Study|Maximum benefit|4|||
27612827|NCT01591460|80423416|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
27612828|NCT01591460|80423416|FG000|Overall Study|Futility Rule (Week 12)|7|||
27612829|NCT01591460|80423416|FG000|Overall Study|Futility Rule (Week 24)|3|||
27612830|NCT01591460|80423416|FG000|Overall Study|Rebound or Breakthrough|3|||
27612831|NCT01591460|80423416|FG000|Overall Study|Treatment Discontinued by Error|1|||
27612832|NCT01591460|80423416|FG000|Overall Study|Lost to Follow-up|1|||
27612833|NCT01591460|80423416|FG000|Overall Study|Noncompliance|1|||
27612834|NCT01591460|80423416|FG000|Overall Study|Participant Refusal|3|||
27612835|NCT01591460|80423416|FG000|Overall Study|Withdrawal by Subject|1|||
27612836|NCT01591460|80423416|FG000|Overall Study|Protocol Violation|1|||
27612837|NCT02855164|80423417|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
27612838|NCT02855164|80423418|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
27612839|NCT02855164|80423419|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
27612840|NCT02855164|80423420|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
27612841|NCT02855164|80423421|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
27612842|NCT02855164|80423422|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
27612843|NCT02855164|80423423|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
27892659|NCT00970632|81441365|FG000|Overall Study|Entry criteria not met|0|||
27892660|NCT00970632|81441366|FG001|Overall Study|Entry criteria not met|2|||
27892661|NCT00970632|81441367|FG002|Overall Study|Entry criteria not met|2|||
27892662|NCT00970632|81441365|FG000|Overall Study|Sponsor decision|1|||
27892663|NCT00970632|81441366|FG001|Overall Study|Sponsor decision|0|||
27892664|NCT00970632|81441367|FG002|Overall Study|Sponsor decision|1|||
27892665|NCT00614523|81441372|FG000|Overall Study|Adverse Event|4|||
27892666|NCT00614523|81441373|FG001|Overall Study|Adverse Event|20|||
27892667|NCT00614523|81441372|FG000|Overall Study|Death|5|||
27892668|NCT00614523|81441373|FG001|Overall Study|Death|8|||
27892669|NCT00614523|81441372|FG000|Overall Study|Lack of Efficacy|9|||
27612844|NCT02855164|80423424|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
27612845|NCT02855164|80423417|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
27612846|NCT02855164|80423418|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
27612847|NCT02855164|80423419|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
27612848|NCT02855164|80423420|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
27612849|NCT02855164|80423421|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
27612850|NCT02855164|80423422|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
27612851|NCT02855164|80423423|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
27612852|NCT02855164|80423424|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
27612853|NCT02855164|80423417|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
27892670|NCT00614523|81441373|FG001|Overall Study|Lack of Efficacy|11|||
27892671|NCT00614523|81441372|FG000|Overall Study|Lost to Follow-up|0|||
27841808|NCT00545688|81248357|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
27841809|NCT00545688|81248354|FG000|Adjuvant Treatment Period|Disease Progression|3|||
27841810|NCT00545688|81248355|FG001|Adjuvant Treatment Period|Disease Progression|3|||
27841811|NCT00545688|81248356|FG002|Adjuvant Treatment Period|Disease Progression|0|||
27841812|NCT00545688|81248357|FG003|Adjuvant Treatment Period|Disease Progression|7|||
27841813|NCT00545688|81248354|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
27841814|NCT00545688|81248355|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
27841815|NCT00545688|81248356|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
27841816|NCT00545688|81248357|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
27841817|NCT00545688|81248354|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
27841818|NCT00545688|81248355|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
27841819|NCT00545688|81248356|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
27841820|NCT00545688|81248357|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
27841821|NCT00545688|81248354|FG000|Adjuvant Treatment Period|Adverse Event|0|||
27841822|NCT00545688|81248355|FG001|Adjuvant Treatment Period|Adverse Event|3|||
27841823|NCT00545688|81248356|FG002|Adjuvant Treatment Period|Adverse Event|2|||
27841824|NCT00545688|81248357|FG003|Adjuvant Treatment Period|Adverse Event|2|||
27841825|NCT00545688|81248354|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
27841826|NCT00545688|81248355|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
27841827|NCT00545688|81248356|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
27841828|NCT00545688|81248357|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
27841829|NCT00545688|81248354|FG000|Follow-Up Period|Death|4|||
27841830|NCT00545688|81248355|FG001|Follow-Up Period|Death|2|||
27841831|NCT00545688|81248356|FG002|Follow-Up Period|Death|2|||
27841832|NCT00545688|81248357|FG003|Follow-Up Period|Death|6|||
27841833|NCT00545688|81248354|FG000|Follow-Up Period|Disease Progression|6|||
27841834|NCT00545688|81248355|FG001|Follow-Up Period|Disease Progression|5|||
27841835|NCT00545688|81248356|FG002|Follow-Up Period|Disease Progression|9|||
27841836|NCT00545688|81248357|FG003|Follow-Up Period|Disease Progression|9|||
27841837|NCT00545688|81248354|FG000|Follow-Up Period|Refused Treatment|6|||
27841838|NCT00545688|81248355|FG001|Follow-Up Period|Refused Treatment|2|||
27841839|NCT00545688|81248356|FG002|Follow-Up Period|Refused Treatment|0|||
27841840|NCT00545688|81248357|FG003|Follow-Up Period|Refused Treatment|2|||
27841841|NCT00545688|81248354|FG000|Follow-Up Period|Lost to Follow-up|3|||
27841842|NCT00545688|81248355|FG001|Follow-Up Period|Lost to Follow-up|3|||
27841843|NCT00545688|81248356|FG002|Follow-Up Period|Lost to Follow-up|3|||
27841844|NCT00545688|81248357|FG003|Follow-Up Period|Lost to Follow-up|1|||
27841845|NCT00545688|81248354|FG000|Follow-Up Period|Unspecified Reason|2|||
27841846|NCT00545688|81248355|FG001|Follow-Up Period|Unspecified Reason|5|||
27841847|NCT00545688|81248356|FG002|Follow-Up Period|Unspecified Reason|6|||
27841848|NCT00545688|81248357|FG003|Follow-Up Period|Unspecified Reason|8|||
27841849|NCT00545688|81248354|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
27841850|NCT00545688|81248355|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
27841851|NCT00545688|81248356|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
27841852|NCT00545688|81248357|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
27841853|NCT00708682|81248368|FG000|Infant Series|Adverse Event|1|||
27841854|NCT00708682|81248368|FG000|Infant Series|Lost to Follow-up|4|||
27841855|NCT00708682|81248368|FG000|Infant Series|Protocol Violation|1|||
27841856|NCT00708682|81248368|FG000|Infant Series|Parent/legal guardian request|6|||
27841857|NCT00708682|81248368|FG000|Infant Series|Failed to return|2|||
27841858|NCT00708682|81248368|FG000|Infant Series|Other|19|||
27841859|NCT00708682|81248368|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
27841860|NCT00708682|81248368|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
27841861|NCT00708682|81248368|FG000|Toddler Dose|Lost to Follow-up|3|||
27841862|NCT00708682|81248368|FG000|Toddler Dose|Failed to Return|4|||
27841863|NCT00537017|81248378|FG000|Treatment Phase|Adverse Event|19|||
27841864|NCT00537017|81248378|FG000|Treatment Phase|Withdrawal by Subject|13|||
27841865|NCT00537017|81248378|FG000|Treatment Phase|Protocol Violation|2|||
27841866|NCT00537017|81248378|FG000|Follow-up Phase|Withdrawal by Subject|9|||
27841867|NCT01040793|81248379|FG000|Overall Study|Adverse Event|5|||
27841868|NCT01040793|81248380|FG001|Overall Study|Adverse Event|3|||
27841869|NCT01040793|81248381|FG002|Overall Study|Adverse Event|0|||
27841870|NCT01040793|81248382|FG003|Overall Study|Adverse Event|2|||
27841871|NCT01040793|81248383|FG004|Overall Study|Adverse Event|2|||
27841872|NCT01040793|81248384|FG005|Overall Study|Adverse Event|1|||
27841873|NCT01040793|81248379|FG000|Overall Study|Protocol Violation|1|||
27841874|NCT01040793|81248380|FG001|Overall Study|Protocol Violation|1|||
27841875|NCT01040793|81248381|FG002|Overall Study|Protocol Violation|1|||
27841876|NCT01040793|81248382|FG003|Overall Study|Protocol Violation|0|||
27841877|NCT01040793|81248383|FG004|Overall Study|Protocol Violation|1|||
27841878|NCT01040793|81248384|FG005|Overall Study|Protocol Violation|0|||
27841879|NCT01040793|81248379|FG000|Overall Study|Lost to Follow-up|0|||
27841880|NCT01040793|81248380|FG001|Overall Study|Lost to Follow-up|1|||
27841881|NCT01040793|81248381|FG002|Overall Study|Lost to Follow-up|1|||
27841882|NCT01040793|81248382|FG003|Overall Study|Lost to Follow-up|0|||
27841883|NCT01040793|81248383|FG004|Overall Study|Lost to Follow-up|0|||
27892672|NCT00614523|81441373|FG001|Overall Study|Lost to Follow-up|1|||
27892673|NCT00614523|81441372|FG000|Overall Study|Protocol Violation|3|||
27892674|NCT00614523|81441373|FG001|Overall Study|Protocol Violation|2|||
27892675|NCT00614523|81441372|FG000|Overall Study|Withdrawal by Subject|12|||
27892676|NCT00614523|81441373|FG001|Overall Study|Withdrawal by Subject|22|||
27892677|NCT00614523|81441372|FG000|Overall Study|Other|6|||
27892678|NCT00614523|81441373|FG001|Overall Study|Other|11|||
27892679|NCT00614523|81441372|FG000|Overall Study|Ineligibility Determined|1|||
27892680|NCT00614523|81441373|FG001|Overall Study|Ineligibility Determined|2|||
27892681|NCT00614523|81441372|FG000|Overall Study|Disease Progression|0|||
27892682|NCT00614523|81441373|FG001|Overall Study|Disease Progression|8|||
27612854|NCT02855164|80423418|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
27724190|NCT03222349|80822957|FG001|Overall Study|Study terminated by sponsor|0|||
27724191|NCT02814565|80822958|FG000|Overall Study|Lack of Efficacy|0|||
27724192|NCT02814565|80822959|FG001|Overall Study|Lack of Efficacy|1|||
27724193|NCT02814565|80822958|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
27724194|NCT02814565|80822959|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
27724195|NCT02354703|80822960|FG000|Overall Study|Withdrawal by Subject|1|||
27724196|NCT02354703|80822961|FG001|Overall Study|Withdrawal by Subject|1|||
27724197|NCT02354703|80822962|FG002|Overall Study|Withdrawal by Subject|1|||
27724198|NCT02354703|80822963|FG003|Overall Study|Withdrawal by Subject|1|||
27724199|NCT02354703|80822960|FG000|Overall Study|Lost to Follow-up|2|||
27724200|NCT02354703|80822961|FG001|Overall Study|Lost to Follow-up|7|||
27724201|NCT02354703|80822962|FG002|Overall Study|Lost to Follow-up|9|||
27724202|NCT02354703|80822963|FG003|Overall Study|Lost to Follow-up|2|||
27724203|NCT02354703|80822960|FG000|Overall Study|Adverse Event|0|||
27724204|NCT02354703|80822961|FG001|Overall Study|Adverse Event|0|||
27724205|NCT02354703|80822962|FG002|Overall Study|Adverse Event|1|||
27724206|NCT02354703|80822963|FG003|Overall Study|Adverse Event|0|||
27724207|NCT03433781|80822964|FG000|Overall Study|Progression of Disease|1|||
27724208|NCT03433781|80822965|FG001|Overall Study|Progression of Disease|0|||
27724209|NCT03433781|80822966|FG002|Overall Study|Progression of Disease|0|||
27724210|NCT03433781|80822964|FG000|Overall Study|Physician Decision|0|||
27724211|NCT03433781|80822965|FG001|Overall Study|Physician Decision|1|||
27724212|NCT03433781|80822966|FG002|Overall Study|Physician Decision|0|||
27724213|NCT01725750|80822967|FG000|Overall Study|Adverse Event|1|||
27724214|NCT01725750|80822968|FG001|Overall Study|Adverse Event|0|||
27724215|NCT01725750|80822967|FG000|Overall Study|Lost to Follow-up|1|||
27724216|NCT01725750|80822968|FG001|Overall Study|Lost to Follow-up|1|||
27724217|NCT01725750|80822967|FG000|Overall Study|Withdrawal by Subject|0|||
27724218|NCT01725750|80822968|FG001|Overall Study|Withdrawal by Subject|9|||
27724219|NCT01078805|80822969|FG000|Overall Study|Clinically significant abnormal lab|5|||
27724220|NCT01078805|80822969|FG000|Overall Study|Death|134|||
27724221|NCT01078805|80822969|FG000|Overall Study|Lost to Follow-up|676|||
27724222|NCT01078805|80822969|FG000|Overall Study|Physician Decision|169|||
27724223|NCT01078805|80822969|FG000|Overall Study|Serious adverse event|26|||
27724224|NCT01078805|80822969|FG000|Overall Study|Sponsor decision|46|||
27724225|NCT01078805|80822969|FG000|Overall Study|Withdrawal by Subject|739|||
27724226|NCT01078805|80822969|FG000|Overall Study|Other|173|||
27724227|NCT01078805|80822969|FG000|Overall Study|Didn't take study drug|82|||
27724228|NCT01724528|80822970|FG000|Overall Study|Death|3|||
27724229|NCT01724528|80822971|FG001|Overall Study|Death|0|||
27724230|NCT01724528|80822970|FG000|Overall Study|Withdrawal by Subject|0|||
27724231|NCT01724528|80822971|FG001|Overall Study|Withdrawal by Subject|2|||
27724232|NCT01724528|80822970|FG000|Overall Study|Protocol Violation|0|||
27724233|NCT01724528|80822971|FG001|Overall Study|Protocol Violation|1|||
27724234|NCT01724528|80822970|FG000|Overall Study|Patient refused to attend last visit|1|||
27724235|NCT01724528|80822971|FG001|Overall Study|Patient refused to attend last visit|0|||
27724236|NCT01276236|80822972|FG000|Overall Study|Lack of Efficacy|2|||
27724237|NCT01276236|80822972|FG000|Overall Study|Withdrawal by Subject|4|||
27724238|NCT03887130|80822973|FG000|Overall Study|Progressive disease|23|||
27724239|NCT03887130|80822974|FG001|Overall Study|Progressive disease|14|||
27724240|NCT03887130|80822975|FG002|Overall Study|Progressive disease|7|||
27724241|NCT03887130|80822973|FG000|Overall Study|Protocol Violation|3|||
27724242|NCT03887130|80822974|FG001|Overall Study|Protocol Violation|1|||
27724243|NCT03887130|80822975|FG002|Overall Study|Protocol Violation|2|||
27724244|NCT03887130|80822973|FG000|Overall Study|Drug related toxicity|7|||
27724245|NCT03887130|80822974|FG001|Overall Study|Drug related toxicity|7|||
27724246|NCT03887130|80822975|FG002|Overall Study|Drug related toxicity|13|||
27724247|NCT03887130|80822973|FG000|Overall Study|Non drug related toxicity|3|||
27724248|NCT03887130|80822974|FG001|Overall Study|Non drug related toxicity|0|||
27724249|NCT03887130|80822975|FG002|Overall Study|Non drug related toxicity|0|||
27724250|NCT03887130|80822973|FG000|Overall Study|Death|2|||
27724251|NCT03887130|80822974|FG001|Overall Study|Death|2|||
27892683|NCT00614523|81441372|FG000|Overall Study|Administrative Decision|23|||
27892684|NCT00614523|81441373|FG001|Overall Study|Administrative Decision|46|||
27841884|NCT01040793|81248384|FG005|Overall Study|Lost to Follow-up|0|||
27841885|NCT01040793|81248379|FG000|Overall Study|Withdrawal by Subject|0|||
27841886|NCT01040793|81248380|FG001|Overall Study|Withdrawal by Subject|0|||
27841887|NCT01040793|81248381|FG002|Overall Study|Withdrawal by Subject|0|||
27841888|NCT01040793|81248382|FG003|Overall Study|Withdrawal by Subject|2|||
27841889|NCT01040793|81248383|FG004|Overall Study|Withdrawal by Subject|0|||
27841890|NCT01040793|81248384|FG005|Overall Study|Withdrawal by Subject|0|||
27841891|NCT01040793|81248379|FG000|Overall Study|Other reasons not listed above|0|||
27841892|NCT01040793|81248380|FG001|Overall Study|Other reasons not listed above|0|||
27841893|NCT01040793|81248381|FG002|Overall Study|Other reasons not listed above|1|||
27841894|NCT01040793|81248382|FG003|Overall Study|Other reasons not listed above|0|||
27841895|NCT01040793|81248383|FG004|Overall Study|Other reasons not listed above|1|||
27841896|NCT01040793|81248384|FG005|Overall Study|Other reasons not listed above|0|||
27841897|NCT00585312|81248387|FG000|Overall Study|Adverse Event|3|||
27841898|NCT00585312|81248388|FG001|Overall Study|Adverse Event|0|||
27841899|NCT00585312|81248387|FG000|Overall Study|Lack of Efficacy|6|||
27841900|NCT00585312|81248388|FG001|Overall Study|Lack of Efficacy|11|||
27841901|NCT00585312|81248387|FG000|Overall Study|Lost to Follow-up|1|||
27841902|NCT00585312|81248388|FG001|Overall Study|Lost to Follow-up|1|||
27841903|NCT00585312|81248387|FG000|Overall Study|Reason not specified|2|||
27841904|NCT00585312|81248388|FG001|Overall Study|Reason not specified|0|||
27841905|NCT00585312|81248387|FG000|Overall Study|Withdrawal by Subject|5|||
27841906|NCT00585312|81248388|FG001|Overall Study|Withdrawal by Subject|1|||
27841907|NCT00585312|81248387|FG000|Overall Study|Study terminated by the sponsor|34|||
27841908|NCT00585312|81248388|FG001|Overall Study|Study terminated by the sponsor|31|||
27841909|NCT01362296|81248394|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
27841910|NCT01362296|81248395|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
27841911|NCT01362296|81248396|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
27841912|NCT01362296|81248397|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
27841913|NCT01362296|81248394|FG000|Randomized Phase (RP)|Physician Decision|1|||
27841914|NCT01362296|81248395|FG001|Randomized Phase (RP)|Physician Decision|9|||
27841915|NCT01362296|81248396|FG002|Randomized Phase (RP)|Physician Decision|0|||
27841916|NCT01362296|81248397|FG003|Randomized Phase (RP)|Physician Decision|0|||
27841917|NCT01362296|81248394|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
27841918|NCT01362296|81248395|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
27841919|NCT01362296|81248396|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
27841920|NCT01362296|81248397|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
27841921|NCT01362296|81248394|FG000|Randomized Phase (RP)|Adverse Event|20|||
27841922|NCT01362296|81248395|FG001|Randomized Phase (RP)|Adverse Event|4|||
27841923|NCT01362296|81248396|FG002|Randomized Phase (RP)|Adverse Event|0|||
27841924|NCT01362296|81248397|FG003|Randomized Phase (RP)|Adverse Event|0|||
27841925|NCT01362296|81248394|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
27841926|NCT01362296|81248395|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
27841927|NCT01362296|81248396|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
27841928|NCT01362296|81248397|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
27841929|NCT01362296|81248394|FG000|Crossover Phase|PD including Death due to PD|0|||
27841930|NCT01362296|81248395|FG001|Crossover Phase|PD including Death due to PD|0|||
27841931|NCT01362296|81248396|FG002|Crossover Phase|PD including Death due to PD|16|||
27841932|NCT01362296|81248397|FG003|Crossover Phase|PD including Death due to PD|1|||
27841933|NCT01362296|81248394|FG000|Crossover Phase|Withdrawal by Subject|0|||
27841934|NCT01362296|81248395|FG001|Crossover Phase|Withdrawal by Subject|0|||
27841935|NCT01362296|81248396|FG002|Crossover Phase|Withdrawal by Subject|2|||
27841936|NCT01362296|81248397|FG003|Crossover Phase|Withdrawal by Subject|1|||
27841937|NCT01362296|81248394|FG000|Crossover Phase|Adverse Event|0|||
27841938|NCT01362296|81248395|FG001|Crossover Phase|Adverse Event|0|||
27841939|NCT01362296|81248396|FG002|Crossover Phase|Adverse Event|4|||
27841940|NCT01362296|81248397|FG003|Crossover Phase|Adverse Event|0|||
27841941|NCT01362296|81248394|FG000|Crossover Phase|Study Closed/Terminated|0|||
27841942|NCT01362296|81248395|FG001|Crossover Phase|Study Closed/Terminated|0|||
27841943|NCT01362296|81248396|FG002|Crossover Phase|Study Closed/Terminated|1|||
27841944|NCT01362296|81248397|FG003|Crossover Phase|Study Closed/Terminated|0|||
27841945|NCT03203642|81248400|FG000|Overall Study|Adverse Event|3|||
27841946|NCT03203642|81248401|FG001|Overall Study|Adverse Event|1|||
27841947|NCT03203642|81248400|FG000|Overall Study|Withdrawal by Subject|6|||
27841948|NCT03203642|81248401|FG001|Overall Study|Withdrawal by Subject|6|||
27841949|NCT03203642|81248400|FG000|Overall Study|Lost to Follow-up|2|||
27841950|NCT03203642|81248401|FG001|Overall Study|Lost to Follow-up|1|||
27841951|NCT03203642|81248400|FG000|Overall Study|Termination of the study by sponsor|1|||
27841952|NCT03203642|81248401|FG001|Overall Study|Termination of the study by sponsor|1|||
27841953|NCT03203642|81248400|FG000|Overall Study|Participant moved|0|||
27841954|NCT03203642|81248401|FG001|Overall Study|Participant moved|1|||
27841955|NCT03203642|81248400|FG000|Overall Study|Investigator's decision|3|||
27892685|NCT01171898|81441374|FG000|Overall Study|Death|0|||
27892686|NCT01171898|81441375|FG001|Overall Study|Death|0|||
27612855|NCT02855164|80423419|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
27612856|NCT02855164|80423420|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
27892687|NCT01171898|81441376|FG002|Overall Study|Death|2|||
27892688|NCT01171898|81441377|FG003|Overall Study|Death|0|||
27892689|NCT01171898|81441374|FG000|Overall Study|Lost to Follow-up|0|||
27612857|NCT02855164|80423421|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
27612858|NCT02855164|80423422|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
27892690|NCT01171898|81441375|FG001|Overall Study|Lost to Follow-up|1|||
27892691|NCT01171898|81441376|FG002|Overall Study|Lost to Follow-up|1|||
27892692|NCT01171898|81441377|FG003|Overall Study|Lost to Follow-up|1|||
27612859|NCT02855164|80423423|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
27612860|NCT02855164|80423424|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
27892693|NCT01171898|81441374|FG000|Overall Study|Withdrawal by Subject|1|||
27892694|NCT01171898|81441375|FG001|Overall Study|Withdrawal by Subject|4|||
27892695|NCT01171898|81441376|FG002|Overall Study|Withdrawal by Subject|6|||
27892696|NCT01171898|81441377|FG003|Overall Study|Withdrawal by Subject|3|||
27892697|NCT01171898|81441374|FG000|Overall Study|Terminated by Sponsor|1|||
27892698|NCT01171898|81441375|FG001|Overall Study|Terminated by Sponsor|0|||
27892699|NCT01171898|81441376|FG002|Overall Study|Terminated by Sponsor|0|||
27612861|NCT02855164|80423417|FG000|Part C (Randomized Set)|Adverse Event|0|||
27612862|NCT02855164|80423418|FG001|Part C (Randomized Set)|Adverse Event|0|||
27612863|NCT02855164|80423419|FG002|Part C (Randomized Set)|Adverse Event|0|||
27612864|NCT02855164|80423420|FG003|Part C (Randomized Set)|Adverse Event|0|||
27841956|NCT03203642|81248401|FG001|Overall Study|Investigator's decision|0|||
27841957|NCT03203642|81248400|FG000|Overall Study|Other than above specified|0|||
27892700|NCT01171898|81441377|FG003|Overall Study|Terminated by Sponsor|0|||
27892701|NCT01171898|81441374|FG000|Overall Study|Ongoing|1|||
27892702|NCT01171898|81441375|FG001|Overall Study|Ongoing|9|||
27892703|NCT01171898|81441376|FG002|Overall Study|Ongoing|3|||
27892704|NCT01171898|81441377|FG003|Overall Study|Ongoing|0|||
27892705|NCT01171898|81441374|FG000|Overall Study|Other|1|||
27892706|NCT01171898|81441375|FG001|Overall Study|Other|5|||
27892707|NCT01171898|81441376|FG002|Overall Study|Other|0|||
27892708|NCT01171898|81441377|FG003|Overall Study|Other|2|||
27892709|NCT02499146|81441378|FG000|Overall Study|Lost to Follow-up|1|||
27892710|NCT02499146|81441378|FG000|Overall Study|Withdrawal by Subject|1|||
27503740|NCT01668784|80037840|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
27612865|NCT02855164|80423421|FG004|Part C (Randomized Set)|Adverse Event|0|||
27841958|NCT03203642|81248401|FG001|Overall Study|Other than above specified|1|||
27892711|NCT02499146|81441378|FG000|Overall Study|Other|2|||
27612866|NCT02855164|80423422|FG005|Part C (Randomized Set)|Adverse Event|5|||
27612867|NCT02855164|80423423|FG006|Part C (Randomized Set)|Adverse Event|9|||
27892712|NCT02499146|81441378|FG000|Overall Study|Ongoing at date of cut-off|9|||
27892713|NCT02499146|81441378|FG000|Overall Study|Began other treatment/therapy|13|||
27892714|NCT02375555|81441379|FG000|Induction Period|Adverse Event|7|||
27892715|NCT02375555|81441379|FG000|Induction Period|Withdrawal by Subject|2|||
27892716|NCT02375555|81441379|FG000|Induction Period|Other|1|||
27892717|NCT02375555|81441379|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
27892718|NCT02375555|81441379|FG000|Maintenance Period|Adverse Event|2|||
27892719|NCT02375555|81441379|FG000|Maintenance Period|Withdrawal by Subject|4|||
27612868|NCT02855164|80423424|FG007|Part C (Randomized Set)|Adverse Event|2|||
27612869|NCT02855164|80423417|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
27612870|NCT02855164|80423418|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
27612871|NCT02855164|80423419|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
27612872|NCT02855164|80423420|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
27612873|NCT02855164|80423421|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
27612874|NCT02855164|80423422|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
27612875|NCT02855164|80423423|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
27612876|NCT02855164|80423424|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
27612877|NCT02855164|80423417|FG000|Part C (Randomized Set)|Physician Decision|0|||
27612878|NCT02855164|80423418|FG001|Part C (Randomized Set)|Physician Decision|0|||
27612879|NCT02855164|80423419|FG002|Part C (Randomized Set)|Physician Decision|0|||
27612880|NCT02855164|80423420|FG003|Part C (Randomized Set)|Physician Decision|0|||
27612881|NCT02855164|80423421|FG004|Part C (Randomized Set)|Physician Decision|0|||
27612882|NCT02855164|80423422|FG005|Part C (Randomized Set)|Physician Decision|1|||
27612883|NCT02855164|80423423|FG006|Part C (Randomized Set)|Physician Decision|0|||
27612884|NCT02855164|80423424|FG007|Part C (Randomized Set)|Physician Decision|1|||
27612885|NCT02855164|80423417|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
27612886|NCT02855164|80423418|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
27612887|NCT02855164|80423419|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
27612888|NCT02855164|80423420|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
27612889|NCT02855164|80423421|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
27612890|NCT02855164|80423422|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
27612891|NCT02855164|80423423|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
27612892|NCT02855164|80423424|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
27612893|NCT01342887|80423425|FG000|Overall Study|Death|2|||
27612894|NCT04880161|80423431|FG000|Overall Study|Withdrawal by Subject|1|||
27612895|NCT04880161|80423432|FG001|Overall Study|Withdrawal by Subject|0|||
27612896|NCT04880161|80423431|FG000|Overall Study|Lack of Compliance|1|||
27612897|NCT04880161|80423432|FG001|Overall Study|Lack of Compliance|1|||
27612898|NCT04880161|80423431|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
27612899|NCT04880161|80423432|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
27612900|NCT04880161|80423431|FG000|Overall Study|Screen Failure|0|||
27612901|NCT04880161|80423432|FG001|Overall Study|Screen Failure|1|||
27612902|NCT01258660|80423433|FG000|Overall Study|Adverse Event|2|||
27612903|NCT01258660|80423434|FG001|Overall Study|Adverse Event|4|||
27612904|NCT01258660|80423433|FG000|Overall Study|Withdrawal by Subject|3|||
27612905|NCT01258660|80423434|FG001|Overall Study|Withdrawal by Subject|0|||
27612906|NCT01258660|80423433|FG000|Overall Study|due to relocation|2|||
27612907|NCT01258660|80423434|FG001|Overall Study|due to relocation|0|||
27612908|NCT01258660|80423433|FG000|Overall Study|Protocol Violation|0|||
27612909|NCT01258660|80423434|FG001|Overall Study|Protocol Violation|1|||
27612910|NCT01258660|80423433|FG000|Overall Study|Invalid for primary analysis data set|4|||
27612911|NCT01258660|80423434|FG001|Overall Study|Invalid for primary analysis data set|6|||
27612912|NCT03621982|80423435|FG000|Overall Study|Withdrawal by Subject|1|||
27612913|NCT03621982|80423436|FG001|Overall Study|Withdrawal by Subject|0|||
27612914|NCT03621982|80423437|FG002|Overall Study|Withdrawal by Subject|0|||
27612915|NCT03621982|80423438|FG003|Overall Study|Withdrawal by Subject|1|||
27612916|NCT03621982|80423439|FG004|Overall Study|Withdrawal by Subject|0|||
27612917|NCT03621982|80423440|FG005|Overall Study|Withdrawal by Subject|1|||
27612918|NCT03621982|80423441|FG006|Overall Study|Withdrawal by Subject|1|||
27612919|NCT03621982|80423442|FG007|Overall Study|Withdrawal by Subject|0|||
27612920|NCT03621982|80423443|FG008|Overall Study|Withdrawal by Subject|1|||
27612921|NCT03621982|80423444|FG009|Overall Study|Withdrawal by Subject|0|||
27612922|NCT03621982|80423445|FG010|Overall Study|Withdrawal by Subject|2|||
27724252|NCT03887130|80822975|FG002|Overall Study|Death|1|||
27724253|NCT03887130|80822973|FG000|Overall Study|Withdrawal by Subject|7|||
27724254|NCT03887130|80822974|FG001|Overall Study|Withdrawal by Subject|6|||
27724255|NCT03887130|80822975|FG002|Overall Study|Withdrawal by Subject|11|||
27724256|NCT03887130|80822973|FG000|Overall Study|other reason|6|||
27892720|NCT02375555|81441379|FG000|Maintenance Period|Death|1|||
27892721|NCT02375555|81441379|FG000|Maintenance Period|Disease Progression|5|||
27892722|NCT02375555|81441379|FG000|Maintenance Period|Patient Non-compliance|1|||
27892723|NCT02375555|81441379|FG000|Maintenance Period|Still on maintenance|16|||
27612923|NCT03621982|80423446|FG011|Overall Study|Withdrawal by Subject|1|||
27612924|NCT03621982|80423447|FG012|Overall Study|Withdrawal by Subject|2|||
27724257|NCT03887130|80822974|FG001|Overall Study|other reason|20|||
27724258|NCT03887130|80822975|FG002|Overall Study|other reason|17|||
27612925|NCT03621982|80423448|FG013|Overall Study|Withdrawal by Subject|2|||
27612926|NCT03621982|80423435|FG000|Overall Study|Investigator/Sponsor decision|0|||
27612927|NCT03621982|80423436|FG001|Overall Study|Investigator/Sponsor decision|0|||
27612928|NCT03621982|80423437|FG002|Overall Study|Investigator/Sponsor decision|0|||
27612929|NCT03621982|80423438|FG003|Overall Study|Investigator/Sponsor decision|0|||
27612930|NCT03621982|80423439|FG004|Overall Study|Investigator/Sponsor decision|0|||
27503741|NCT01668784|80037841|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
27892724|NCT02677038|81441380|FG000|Overall Study|Physician Decision|1|||
27892725|NCT02677038|81441380|FG000|Overall Study|Withdrawal by Subject|1|||
27892726|NCT05178641|81441381|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
27892727|NCT05178641|81441382|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
27892728|NCT05178641|81441381|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
27892729|NCT05178641|81441382|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
27892730|NCT04464720|81441386|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
27892731|NCT04186806|81441387|FG000|Period 1: 7 Days|Adverse Event|1|||
27892732|NCT04186806|81441388|FG001|Period 1: 7 Days|Adverse Event|0|||
27892733|NCT05500274|81441389|FG000|Overall Study|Not able to complete the session and follow-up visits.|2|||
27892734|NCT05500274|81441390|FG001|Overall Study|Not able to complete the session and follow-up visits.|0|||
27892735|NCT05500274|81441389|FG000|Overall Study|Lost to Follow-up|86|||
27892736|NCT05500274|81441390|FG001|Overall Study|Lost to Follow-up|93|||
27892737|NCT01661933|81441397|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
27892738|NCT01661933|81441397|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
27892739|NCT01867294|81441398|FG000|Overall Study|Withdrawal by Subject|1|||
27892740|NCT01867294|81441399|FG001|Overall Study|Withdrawal by Subject|1|||
27892741|NCT01867294|81441400|FG002|Overall Study|Withdrawal by Subject|0|||
27892742|NCT01867294|81441401|FG003|Overall Study|Withdrawal by Subject|0|||
27892743|NCT03533114|81441402|FG000|Overall|Adverse Event|16|||
27892744|NCT03533114|81441403|FG001|Overall|Adverse Event|11|||
27892745|NCT03533114|81441402|FG000|Overall|Consent Withdrawal by Participant|7|||
27892746|NCT03533114|81441403|FG001|Overall|Consent Withdrawal by Participant|6|||
27892747|NCT03533114|81441402|FG000|Overall|Lack of Efficacy|5|||
27892748|NCT03533114|81441403|FG001|Overall|Lack of Efficacy|3|||
27892749|NCT03533114|81441402|FG000|Overall|Lost to Follow-up|1|||
27892750|NCT03533114|81441403|FG001|Overall|Lost to Follow-up|1|||
27892751|NCT03533114|81441402|FG000|Overall|Physician Decision|0|||
27892752|NCT03533114|81441403|FG001|Overall|Physician Decision|2|||
27892753|NCT03533114|81441402|FG000|Overall|Protocol deviation|1|||
27892754|NCT03533114|81441403|FG001|Overall|Protocol deviation|1|||
27892755|NCT03533114|81441402|FG000|Overall|Failure to meet randomization criteria|1|||
27892756|NCT03533114|81441403|FG001|Overall|Failure to meet randomization criteria|2|||
27892757|NCT03533114|81441402|FG000|Overall|Non-Compliance with study drug|0|||
27892758|NCT03533114|81441403|FG001|Overall|Non-Compliance with study drug|1|||
27892759|NCT03533114|81441402|FG000|Overall|Other|0|||
27892760|NCT03533114|81441403|FG001|Overall|Other|1|||
27892761|NCT03533114|81441402|FG000|Open Label Titration and Optimization|Adverse Event|11|||
27892762|NCT03533114|81441403|FG001|Open Label Titration and Optimization|Adverse Event|8|||
27892763|NCT03533114|81441402|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
27892764|NCT03533114|81441403|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
27892765|NCT03533114|81441402|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
27892766|NCT03533114|81441403|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
27892767|NCT03533114|81441402|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
27892768|NCT03533114|81441403|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
27892769|NCT03533114|81441402|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
27892770|NCT03533114|81441403|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
27892771|NCT03533114|81441402|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
27892772|NCT03533114|81441403|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
27892773|NCT03533114|81441402|FG000|Stable Dose|Adverse Event|0|||
27892774|NCT03533114|81441403|FG001|Stable Dose|Adverse Event|2|||
27503742|NCT01668784|80037840|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
27503743|NCT01668784|80037841|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
27503744|NCT01668784|80037840|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
27612931|NCT03621982|80423440|FG005|Overall Study|Investigator/Sponsor decision|0|||
27612932|NCT03621982|80423441|FG006|Overall Study|Investigator/Sponsor decision|0|||
27724259|NCT01171820|80822976|FG000|Overall Study|Death|3|||
27724260|NCT01171820|80822977|FG001|Overall Study|Death|3|||
27724261|NCT01171820|80822976|FG000|Overall Study|Lost to Follow-up|0|||
27724262|NCT01171820|80822977|FG001|Overall Study|Lost to Follow-up|1|||
27724263|NCT01171820|80822976|FG000|Overall Study|Withdrawal by Subject|2|||
27724264|NCT01171820|80822977|FG001|Overall Study|Withdrawal by Subject|0|||
27724265|NCT01171820|80822976|FG000|Overall Study|Physician Decision|0|||
27724266|NCT01171820|80822977|FG001|Overall Study|Physician Decision|1|||
27724267|NCT01171820|80822976|FG000|Overall Study|1-Year Missed Visit|1|||
27724268|NCT01171820|80822977|FG001|Overall Study|1-Year Missed Visit|1|||
27724269|NCT02600507|80822978|FG000|Overall Study|Adverse Event|3|||
27892775|NCT03533114|81441402|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
27892776|NCT03533114|81441403|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
27892777|NCT03533114|81441402|FG000|Stable Dose|Lack of Efficacy|1|||
27892778|NCT03533114|81441403|FG001|Stable Dose|Lack of Efficacy|0|||
27892779|NCT03533114|81441402|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
27503745|NCT01668784|80037841|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
27503746|NCT01668784|80037840|FG000|Treatment Period|Disease Progression|316|||
27503747|NCT01668784|80037841|FG001|Treatment Period|Disease Progression|293|||
27503748|NCT01668784|80037840|FG000|Treatment Period|Study Drug Toxicity|46|||
27503749|NCT01668784|80037841|FG001|Treatment Period|Study Drug Toxicity|53|||
27503750|NCT01668784|80037840|FG000|Treatment Period|Death|1|||
27503751|NCT01668784|80037841|FG001|Treatment Period|Death|1|||
27503752|NCT01668784|80037840|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
27503753|NCT01668784|80037841|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
27612933|NCT03621982|80423442|FG007|Overall Study|Investigator/Sponsor decision|0|||
27612934|NCT03621982|80423443|FG008|Overall Study|Investigator/Sponsor decision|0|||
27892780|NCT03533114|81441403|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
27892781|NCT03533114|81441402|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
27892782|NCT03533114|81441403|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
27892783|NCT03533114|81441402|FG000|Open-Label Safety Extension|Adverse Event|3|||
27892784|NCT03533114|81441403|FG001|Open-Label Safety Extension|Adverse Event|0|||
27892785|NCT03533114|81441402|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
27612935|NCT03621982|80423444|FG009|Overall Study|Investigator/Sponsor decision|0|||
27612936|NCT03621982|80423445|FG010|Overall Study|Investigator/Sponsor decision|0|||
27612937|NCT03621982|80423446|FG011|Overall Study|Investigator/Sponsor decision|4|||
27892786|NCT03533114|81441403|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
27612938|NCT03621982|80423447|FG012|Overall Study|Investigator/Sponsor decision|0|||
27612939|NCT03621982|80423448|FG013|Overall Study|Investigator/Sponsor decision|2|||
27612940|NCT03621982|80423435|FG000|Overall Study|Death|2|||
27612941|NCT03621982|80423436|FG001|Overall Study|Death|4|||
27612942|NCT03621982|80423437|FG002|Overall Study|Death|4|||
27612943|NCT03621982|80423438|FG003|Overall Study|Death|3|||
27612944|NCT03621982|80423439|FG004|Overall Study|Death|8|||
27612945|NCT03621982|80423440|FG005|Overall Study|Death|4|||
27612946|NCT03621982|80423441|FG006|Overall Study|Death|6|||
27612947|NCT03621982|80423442|FG007|Overall Study|Death|3|||
27612948|NCT03621982|80423443|FG008|Overall Study|Death|0|||
27612949|NCT03621982|80423444|FG009|Overall Study|Death|3|||
27612950|NCT03621982|80423445|FG010|Overall Study|Death|8|||
27612951|NCT03621982|80423446|FG011|Overall Study|Death|4|||
27612952|NCT03621982|80423447|FG012|Overall Study|Death|2|||
27612953|NCT03621982|80423448|FG013|Overall Study|Death|2|||
27612954|NCT03621982|80423435|FG000|Overall Study|Lost to Follow-up|0|||
27612955|NCT03621982|80423436|FG001|Overall Study|Lost to Follow-up|0|||
27612956|NCT03621982|80423437|FG002|Overall Study|Lost to Follow-up|1|||
27612957|NCT03621982|80423438|FG003|Overall Study|Lost to Follow-up|0|||
27612958|NCT03621982|80423439|FG004|Overall Study|Lost to Follow-up|0|||
27612959|NCT03621982|80423440|FG005|Overall Study|Lost to Follow-up|0|||
27612960|NCT03621982|80423441|FG006|Overall Study|Lost to Follow-up|1|||
27612961|NCT03621982|80423442|FG007|Overall Study|Lost to Follow-up|0|||
27612962|NCT03621982|80423443|FG008|Overall Study|Lost to Follow-up|0|||
27612963|NCT03621982|80423444|FG009|Overall Study|Lost to Follow-up|1|||
27612964|NCT03621982|80423445|FG010|Overall Study|Lost to Follow-up|0|||
27612965|NCT03621982|80423446|FG011|Overall Study|Lost to Follow-up|0|||
27612966|NCT03621982|80423447|FG012|Overall Study|Lost to Follow-up|0|||
27612967|NCT03621982|80423448|FG013|Overall Study|Lost to Follow-up|0|||
27612968|NCT01680458|80423449|FG000|Overall Study|Protocol Violation|3|||
27612969|NCT01744782|80423450|FG000|Overall Study|Death|1|||
27612970|NCT02441946|80423453|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
27612971|NCT02441946|80423454|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
27612972|NCT02441946|80423455|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
27612973|NCT02441946|80423453|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
27612974|NCT02441946|80423454|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
27612975|NCT02441946|80423455|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
27892787|NCT03533114|81441402|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
27612976|NCT02441946|80423453|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27612977|NCT02441946|80423454|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
27612978|NCT02441946|80423455|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27612979|NCT02441946|80423453|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
27612980|NCT02441946|80423454|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
27612981|NCT02441946|80423455|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
27612982|NCT02441946|80423453|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
27612983|NCT02441946|80423454|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
27503754|NCT01668784|80037840|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
27503755|NCT01668784|80037841|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
27612984|NCT02441946|80423455|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
27612985|NCT02441946|80423453|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
27612986|NCT02441946|80423454|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
27724270|NCT02600507|80822979|FG001|Overall Study|Adverse Event|15|||
27612987|NCT02441946|80423455|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
27612988|NCT02441946|80423453|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
27612989|NCT02441946|80423454|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
27612990|NCT02441946|80423455|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
27612991|NCT02441946|80423453|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
27612992|NCT02441946|80423454|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
27612993|NCT02441946|80423455|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
27612994|NCT02441946|80423453|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
27612995|NCT02441946|80423454|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
27612996|NCT02441946|80423455|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
27612997|NCT02441946|80423453|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
27612998|NCT02441946|80423454|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
27612999|NCT02441946|80423455|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
27613000|NCT02441946|80423453|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
27613001|NCT02441946|80423454|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27613002|NCT02441946|80423455|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
27613003|NCT02500979|80423456|FG000|Period 1|Hyperglycemia|1|||
27613004|NCT02500979|80423457|FG001|Period 1|Hyperglycemia|0|||
27892788|NCT03533114|81441403|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
27892789|NCT03533114|81441402|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
27892790|NCT03533114|81441403|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
27892791|NCT03533114|81441402|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
27892792|NCT03533114|81441403|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
27892793|NCT02658734|81441404|FG000|Overall Study|Adverse Event|2|||
27892794|NCT02658734|81441404|FG000|Overall Study|Death|4|||
27892795|NCT02658734|81441404|FG000|Overall Study|Lost to Follow-up|7|||
27892796|NCT02658734|81441404|FG000|Overall Study|Withdrawal of Consent|16|||
27503756|NCT01668784|80037840|FG000|Treatment Period|Withdrawal by Subject|5|||
27503757|NCT01668784|80037841|FG001|Treatment Period|Withdrawal by Subject|3|||
27503758|NCT01668784|80037840|FG000|Treatment Period|Maximal Clinical Benefit|3|||
27503759|NCT01668784|80037841|FG001|Treatment Period|Maximal Clinical Benefit|3|||
27613005|NCT02500979|80423456|FG000|Period 1|Severe non-compliance to protocol|0|||
27613006|NCT02500979|80423457|FG001|Period 1|Severe non-compliance to protocol|1|||
27613007|NCT02500979|80423456|FG000|Period 1|Adverse Event|1|||
27613008|NCT02500979|80423457|FG001|Period 1|Adverse Event|0|||
27892797|NCT02658734|81441404|FG000|Overall Study|Disease Progression|28|||
27892798|NCT01647516|81441407|FG000|Induction Period (IP)|Physician Decision|2|||
27892799|NCT01647516|81441408|FG001|Induction Period (IP)|Physician Decision|0|||
27892800|NCT01647516|81441409|FG002|Induction Period (IP)|Physician Decision|0|||
27892801|NCT01647516|81441410|FG003|Induction Period (IP)|Physician Decision|0|||
27892802|NCT01647516|81441411|FG004|Induction Period (IP)|Physician Decision|0|||
27892803|NCT01647516|81441412|FG005|Induction Period (IP)|Physician Decision|0|||
27892804|NCT01647516|81441407|FG000|Induction Period (IP)|Adverse Event|1|||
27892805|NCT01647516|81441408|FG001|Induction Period (IP)|Adverse Event|2|||
27892806|NCT01647516|81441409|FG002|Induction Period (IP)|Adverse Event|0|||
27892807|NCT01647516|81441410|FG003|Induction Period (IP)|Adverse Event|0|||
27892808|NCT01647516|81441411|FG004|Induction Period (IP)|Adverse Event|0|||
27892809|NCT01647516|81441412|FG005|Induction Period (IP)|Adverse Event|0|||
27892810|NCT01647516|81441407|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
27503760|NCT01668784|80037840|FG000|Treatment Period|Other|2|||
27503761|NCT01668784|80037841|FG001|Treatment Period|Other|8|||
27503762|NCT01668784|80037840|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
27503763|NCT01668784|80037841|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
27503764|NCT00734149|80037843|FG000|Overall Study|Withdrawal by Subject|1|||
27503765|NCT02017405|80037844|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
27503766|NCT02017405|80037845|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
27503767|NCT02017405|80037846|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
27503768|NCT02017405|80037847|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
27613009|NCT02500979|80423456|FG000|Period 1|Subject decision|2|||
27613010|NCT02500979|80423457|FG001|Period 1|Subject decision|0|||
27613011|NCT02500979|80423456|FG000|Period 2|Change in risk|1|||
27613012|NCT02500979|80423457|FG001|Period 2|Change in risk|0|||
27613013|NCT00661258|80423458|FG000|Overall Study|Death|1|||
27613014|NCT00661258|80423459|FG001|Overall Study|Death|0|||
27613015|NCT00661258|80423458|FG000|Overall Study|caught by police and in detox center|2|||
27613016|NCT00661258|80423459|FG001|Overall Study|caught by police and in detox center|1|||
27613017|NCT00569803|80423460|FG000|Overall Study|Lost to Follow-up|1|||
27613018|NCT00569803|80423461|FG001|Overall Study|Lost to Follow-up|0|||
27613019|NCT00569803|80423462|FG002|Overall Study|Lost to Follow-up|0|||
27613020|NCT00569803|80423463|FG003|Overall Study|Lost to Follow-up|0|||
27613021|NCT00569803|80423464|FG004|Overall Study|Lost to Follow-up|0|||
27613022|NCT00569803|80423465|FG005|Overall Study|Lost to Follow-up|0|||
27613023|NCT00569803|80423466|FG006|Overall Study|Lost to Follow-up|0|||
27613024|NCT00569803|80423467|FG007|Overall Study|Lost to Follow-up|0|||
27613025|NCT00569803|80423460|FG000|Overall Study|injection syringe leaked during dosing|0|||
27613026|NCT00569803|80423461|FG001|Overall Study|injection syringe leaked during dosing|0|||
27613027|NCT00569803|80423462|FG002|Overall Study|injection syringe leaked during dosing|0|||
27613028|NCT00569803|80423463|FG003|Overall Study|injection syringe leaked during dosing|1|||
27613029|NCT00569803|80423464|FG004|Overall Study|injection syringe leaked during dosing|0|||
27613030|NCT00569803|80423465|FG005|Overall Study|injection syringe leaked during dosing|0|||
27613031|NCT00569803|80423466|FG006|Overall Study|injection syringe leaked during dosing|0|||
27613032|NCT00569803|80423467|FG007|Overall Study|injection syringe leaked during dosing|0|||
27613033|NCT00569803|80423460|FG000|Overall Study|Withdrawal by Subject|0|||
27613034|NCT00569803|80423461|FG001|Overall Study|Withdrawal by Subject|0|||
27613035|NCT00569803|80423462|FG002|Overall Study|Withdrawal by Subject|0|||
27613036|NCT00569803|80423463|FG003|Overall Study|Withdrawal by Subject|0|||
27613037|NCT00569803|80423464|FG004|Overall Study|Withdrawal by Subject|0|||
27613038|NCT00569803|80423465|FG005|Overall Study|Withdrawal by Subject|0|||
27613039|NCT00569803|80423466|FG006|Overall Study|Withdrawal by Subject|0|||
27613040|NCT00569803|80423467|FG007|Overall Study|Withdrawal by Subject|1|||
27613041|NCT00597714|80423468|FG000|Overall Study|Death|56|||
27613042|NCT00597714|80423469|FG001|Overall Study|Death|46|||
27613043|NCT00597714|80423470|FG002|Overall Study|Death|0|||
27613044|NCT00597714|80423468|FG000|Overall Study|Recipient death|0|||
27613045|NCT00597714|80423469|FG001|Overall Study|Recipient death|0|||
27613046|NCT00597714|80423470|FG002|Overall Study|Recipient death|10|||
27613047|NCT00402337|80423471|FG000|Overall Study|Adverse Event|0|||
27613048|NCT00402337|80423472|FG001|Overall Study|Adverse Event|2|||
27613049|NCT00402337|80423473|FG002|Overall Study|Adverse Event|2|||
27613050|NCT00402337|80423474|FG003|Overall Study|Adverse Event|3|||
27613051|NCT00402337|80423475|FG004|Overall Study|Adverse Event|2|||
27613052|NCT00402337|80423471|FG000|Overall Study|Noncompliance|0|||
27613053|NCT00402337|80423472|FG001|Overall Study|Noncompliance|0|||
27613054|NCT00402337|80423473|FG002|Overall Study|Noncompliance|0|||
27613055|NCT00402337|80423474|FG003|Overall Study|Noncompliance|0|||
27613056|NCT00402337|80423475|FG004|Overall Study|Noncompliance|2|||
27613057|NCT00402337|80423471|FG000|Overall Study|Withdrawal by Subject|5|||
27613058|NCT00402337|80423472|FG001|Overall Study|Withdrawal by Subject|3|||
27613059|NCT00402337|80423473|FG002|Overall Study|Withdrawal by Subject|1|||
27613060|NCT00402337|80423474|FG003|Overall Study|Withdrawal by Subject|6|||
27613061|NCT00402337|80423475|FG004|Overall Study|Withdrawal by Subject|4|||
27613062|NCT00402337|80423471|FG000|Overall Study|Lost to Follow-up|0|||
27613063|NCT00402337|80423472|FG001|Overall Study|Lost to Follow-up|0|||
27613064|NCT00402337|80423473|FG002|Overall Study|Lost to Follow-up|1|||
27724271|NCT02600507|80822980|FG002|Overall Study|Adverse Event|5|||
27503769|NCT02017405|80037848|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
27613065|NCT00402337|80423474|FG003|Overall Study|Lost to Follow-up|2|||
27613066|NCT00402337|80423475|FG004|Overall Study|Lost to Follow-up|0|||
27613067|NCT00402337|80423471|FG000|Overall Study|Physician Decision|0|||
27613068|NCT00402337|80423472|FG001|Overall Study|Physician Decision|0|||
27724272|NCT02600507|80822978|FG000|Overall Study|Lack of Efficacy|3|||
27613069|NCT00402337|80423473|FG002|Overall Study|Physician Decision|0|||
27613070|NCT00402337|80423474|FG003|Overall Study|Physician Decision|1|||
27613071|NCT00402337|80423475|FG004|Overall Study|Physician Decision|0|||
27613072|NCT00402337|80423471|FG000|Overall Study|Other Reason|0|||
27724273|NCT02600507|80822979|FG001|Overall Study|Lack of Efficacy|8|||
27613073|NCT00402337|80423472|FG001|Overall Study|Other Reason|1|||
27613074|NCT00402337|80423473|FG002|Overall Study|Other Reason|0|||
27613075|NCT00402337|80423474|FG003|Overall Study|Other Reason|0|||
27613076|NCT00402337|80423475|FG004|Overall Study|Other Reason|0|||
27613077|NCT02353832|80426529|FG000|Overall Study|Ineligible after enrollment|1|||
27613078|NCT02353832|80426529|FG000|Overall Study|Lost to Follow-up|1|||
27613079|NCT00547911|80426530|FG000|Overall Study|Adverse Event|0|||
27613080|NCT00547911|80426531|FG001|Overall Study|Adverse Event|0|||
27613081|NCT00547911|80426532|FG002|Overall Study|Adverse Event|0|||
27613082|NCT00547911|80426533|FG003|Overall Study|Adverse Event|1|||
27613083|NCT00547911|80426534|FG004|Overall Study|Adverse Event|0|||
27613084|NCT00547911|80426535|FG005|Overall Study|Adverse Event|0|||
27613085|NCT02310126|80426540|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
27613086|NCT02310126|80426541|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
27613087|NCT02310126|80426540|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
27613088|NCT02310126|80426541|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
27613089|NCT01267825|80426542|FG000|Overall Study|study terminated. no data collected.|1|||
27613090|NCT01267825|80426543|FG001|Overall Study|study terminated. no data collected.|0|||
27613091|NCT03662997|80426550|FG000|Overall Study|Adverse Event|0|||
27613092|NCT03662997|80426551|FG001|Overall Study|Adverse Event|2|||
27613093|NCT03662997|80426552|FG002|Overall Study|Adverse Event|0|||
27613094|NCT03662997|80426553|FG003|Overall Study|Adverse Event|0|||
27613095|NCT01291225|80426554|FG000|Overall Study|Lost to Follow-up|85|||
27613096|NCT01291225|80426555|FG001|Overall Study|Lost to Follow-up|39|||
27613097|NCT04170296|80426556|FG000|Overall Study|Adverse Event|1|||
27613098|NCT04170296|80426557|FG001|Overall Study|Adverse Event|0|||
27613099|NCT04170296|80426556|FG000|Overall Study|Withdrawal by Subject|3|||
27613100|NCT04170296|80426557|FG001|Overall Study|Withdrawal by Subject|2|||
27613101|NCT04170296|80426556|FG000|Overall Study|Lost to Follow-up|4|||
27613102|NCT04170296|80426557|FG001|Overall Study|Lost to Follow-up|2|||
27613103|NCT03580356|80426558|FG000|Treatment Period|Withdrawal by Subject|13|||
27613104|NCT03580356|80426559|FG001|Treatment Period|Withdrawal by Subject|0|||
27613105|NCT03580356|80426560|FG002|Treatment Period|Withdrawal by Subject|13|||
27613106|NCT03580356|80426561|FG003|Treatment Period|Withdrawal by Subject|1|||
27613107|NCT03580356|80426562|FG004|Treatment Period|Withdrawal by Subject|17|||
27613108|NCT03580356|80426563|FG005|Treatment Period|Withdrawal by Subject|0|||
27613109|NCT03580356|80426564|FG006|Treatment Period|Withdrawal by Subject|5|||
27613110|NCT03580356|80426565|FG007|Treatment Period|Withdrawal by Subject|0|||
27613111|NCT03580356|80426558|FG000|Treatment Period|Adverse Event|10|||
27613112|NCT03580356|80426559|FG001|Treatment Period|Adverse Event|0|||
27613113|NCT03580356|80426560|FG002|Treatment Period|Adverse Event|13|||
27613114|NCT03580356|80426561|FG003|Treatment Period|Adverse Event|0|||
27613115|NCT03580356|80426562|FG004|Treatment Period|Adverse Event|5|||
27503770|NCT02017405|80037849|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
27503771|NCT02017405|80037844|FG000|Open-label Phase|Adverse Event|1|||
27503772|NCT02017405|80037845|FG001|Open-label Phase|Adverse Event|1|||
27503773|NCT02017405|80037846|FG002|Open-label Phase|Adverse Event|0|||
27503774|NCT02017405|80037847|FG003|Open-label Phase|Adverse Event|0|||
27503775|NCT02017405|80037848|FG004|Open-label Phase|Adverse Event|0|||
27503776|NCT02017405|80037849|FG005|Open-label Phase|Adverse Event|0|||
27503777|NCT02351817|80037854|FG000|Period 1|Adverse Event|1|||
27503778|NCT02351817|80037855|FG001|Period 1|Adverse Event|2|||
27503779|NCT02351817|80037854|FG000|Period 1|Lack of Efficacy|0|||
27503780|NCT02351817|80037855|FG001|Period 1|Lack of Efficacy|1|||
27503781|NCT02351817|80037854|FG000|Period 2|Adverse Event|0|||
27503782|NCT02351817|80037855|FG001|Period 2|Adverse Event|2|||
27503783|NCT02351817|80037854|FG000|Period 2|Protocol Violation|1|||
27503784|NCT02351817|80037855|FG001|Period 2|Protocol Violation|0|||
27503785|NCT03094416|80037865|FG000|Run-in|Screening failure|8|||
27503786|NCT03094416|80037865|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
27503787|NCT03094416|80037865|FG000|Run-in|Withdrawal by Subject|3|||
27503788|NCT03094416|80037865|FG000|Treatment Period|Withdrawal by Subject|2|||
27503789|NCT02855125|80037866|FG000|Overall Study|Withdrawal by Subject|2|||
27503790|NCT02855125|80037867|FG001|Overall Study|Withdrawal by Subject|2|||
27503791|NCT02855125|80037866|FG000|Overall Study|Clinical Disease Progression|5|||
27503792|NCT02855125|80037867|FG001|Overall Study|Clinical Disease Progression|4|||
27503793|NCT02855125|80037866|FG000|Overall Study|Radiologic Disease Progression|36|||
27613116|NCT03580356|80426563|FG005|Treatment Period|Adverse Event|0|||
27613117|NCT03580356|80426564|FG006|Treatment Period|Adverse Event|8|||
27613118|NCT03580356|80426565|FG007|Treatment Period|Adverse Event|0|||
27613119|NCT03580356|80426558|FG000|Treatment Period|Protocol Violation|5|||
27613120|NCT03580356|80426559|FG001|Treatment Period|Protocol Violation|0|||
27613121|NCT03580356|80426560|FG002|Treatment Period|Protocol Violation|6|||
27613122|NCT03580356|80426561|FG003|Treatment Period|Protocol Violation|1|||
27613123|NCT03580356|80426562|FG004|Treatment Period|Protocol Violation|9|||
27503794|NCT02855125|80037867|FG001|Overall Study|Radiologic Disease Progression|39|||
27503795|NCT02855125|80037866|FG000|Overall Study|Adverse Event|11|||
27613124|NCT03580356|80426563|FG005|Treatment Period|Protocol Violation|1|||
27613125|NCT03580356|80426564|FG006|Treatment Period|Protocol Violation|1|||
27613126|NCT03580356|80426565|FG007|Treatment Period|Protocol Violation|0|||
27613127|NCT03580356|80426558|FG000|Treatment Period|Lack of Efficacy|6|||
27613128|NCT03580356|80426559|FG001|Treatment Period|Lack of Efficacy|0|||
27613129|NCT03580356|80426560|FG002|Treatment Period|Lack of Efficacy|2|||
27613130|NCT03580356|80426561|FG003|Treatment Period|Lack of Efficacy|0|||
27613131|NCT03580356|80426562|FG004|Treatment Period|Lack of Efficacy|3|||
27613132|NCT03580356|80426563|FG005|Treatment Period|Lack of Efficacy|0|||
27613133|NCT03580356|80426564|FG006|Treatment Period|Lack of Efficacy|3|||
27613134|NCT03580356|80426565|FG007|Treatment Period|Lack of Efficacy|0|||
27613135|NCT03580356|80426558|FG000|Treatment Period|Pregnancy|1|||
27613136|NCT03580356|80426559|FG001|Treatment Period|Pregnancy|0|||
27613137|NCT03580356|80426560|FG002|Treatment Period|Pregnancy|7|||
27613138|NCT03580356|80426561|FG003|Treatment Period|Pregnancy|0|||
27613139|NCT03580356|80426562|FG004|Treatment Period|Pregnancy|2|||
27613140|NCT03580356|80426563|FG005|Treatment Period|Pregnancy|0|||
27613141|NCT03580356|80426564|FG006|Treatment Period|Pregnancy|1|||
27613142|NCT03580356|80426565|FG007|Treatment Period|Pregnancy|0|||
27613143|NCT03580356|80426558|FG000|Treatment Period|Physician Decision|2|||
27613144|NCT03580356|80426559|FG001|Treatment Period|Physician Decision|0|||
27613145|NCT03580356|80426560|FG002|Treatment Period|Physician Decision|1|||
27613146|NCT03580356|80426561|FG003|Treatment Period|Physician Decision|0|||
27613147|NCT03580356|80426562|FG004|Treatment Period|Physician Decision|4|||
27613148|NCT03580356|80426563|FG005|Treatment Period|Physician Decision|0|||
27613149|NCT03580356|80426564|FG006|Treatment Period|Physician Decision|2|||
27613150|NCT03580356|80426565|FG007|Treatment Period|Physician Decision|0|||
27613151|NCT03580356|80426558|FG000|Treatment Period|Lost to Follow-up|1|||
27613152|NCT03580356|80426559|FG001|Treatment Period|Lost to Follow-up|1|||
27892811|NCT01647516|81441408|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
27892812|NCT01647516|81441409|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
27892813|NCT01647516|81441410|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
27892814|NCT01647516|81441411|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
27892815|NCT01647516|81441412|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
27892816|NCT01647516|81441407|FG000|Induction Period (IP)|Participant Choice|0|||
27892817|NCT01647516|81441408|FG001|Induction Period (IP)|Participant Choice|0|||
27892818|NCT01647516|81441409|FG002|Induction Period (IP)|Participant Choice|1|||
27613153|NCT03580356|80426560|FG002|Treatment Period|Lost to Follow-up|1|||
27613154|NCT03580356|80426561|FG003|Treatment Period|Lost to Follow-up|0|||
27724274|NCT02600507|80822980|FG002|Overall Study|Lack of Efficacy|5|||
27724275|NCT02600507|80822978|FG000|Overall Study|Lost to Follow-up|3|||
27841959|NCT04599166|81248404|FG000|Overall Study|Technological failure connecting to study app|80|||
27841960|NCT01466036|81248405|FG000|Overall Study|Death|1|||
27841961|NCT01466036|81248406|FG001|Overall Study|Death|1|||
27841962|NCT01466036|81248405|FG000|Overall Study|Physician Decision|0|||
27841963|NCT01466036|81248406|FG001|Overall Study|Physician Decision|4|||
27841964|NCT01466036|81248405|FG000|Overall Study|Adverse Event|2|||
27841965|NCT01466036|81248406|FG001|Overall Study|Adverse Event|6|||
27841966|NCT01466036|81248405|FG000|Overall Study|Withdrawal by Subject|2|||
27841967|NCT01466036|81248406|FG001|Overall Study|Withdrawal by Subject|8|||
27841968|NCT01466036|81248405|FG000|Overall Study|progression/relapse|14|||
27841969|NCT01466036|81248406|FG001|Overall Study|progression/relapse|21|||
27841970|NCT01466036|81248405|FG000|Overall Study|prolonged treatment delay|1|||
27892819|NCT01647516|81441410|FG003|Induction Period (IP)|Participant Choice|0|||
27841971|NCT01466036|81248406|FG001|Overall Study|prolonged treatment delay|1|||
27841972|NCT01029392|81248407|FG000|Overall Study|Withdrawal by Subject|18|||
27841973|NCT01029392|81248408|FG001|Overall Study|Withdrawal by Subject|11|||
27841974|NCT01029392|81248407|FG000|Overall Study|Physician Decision|2|||
27841975|NCT01029392|81248408|FG001|Overall Study|Physician Decision|0|||
27841976|NCT01341587|81248409|FG000|Overall Study|Lost to Follow-up|2|||
27841977|NCT01341587|81248410|FG001|Overall Study|Lost to Follow-up|0|||
27841978|NCT01341587|81248409|FG000|Overall Study|stopped using the meters|2|||
27841979|NCT01341587|81248410|FG001|Overall Study|stopped using the meters|10|||
27841980|NCT02300987|81248411|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
27841981|NCT02300987|81248412|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
27841982|NCT02300987|81248411|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
27892820|NCT01647516|81441411|FG004|Induction Period (IP)|Participant Choice|0|||
27613155|NCT03580356|80426562|FG004|Treatment Period|Lost to Follow-up|3|||
27613156|NCT03580356|80426563|FG005|Treatment Period|Lost to Follow-up|0|||
27613157|NCT03580356|80426564|FG006|Treatment Period|Lost to Follow-up|1|||
27613158|NCT03580356|80426565|FG007|Treatment Period|Lost to Follow-up|0|||
27613159|NCT03580356|80426558|FG000|Treatment Period|Death|0|||
27613160|NCT03580356|80426559|FG001|Treatment Period|Death|0|||
27613161|NCT03580356|80426560|FG002|Treatment Period|Death|1|||
27613162|NCT03580356|80426561|FG003|Treatment Period|Death|0|||
27613163|NCT03580356|80426562|FG004|Treatment Period|Death|0|||
27613164|NCT03580356|80426563|FG005|Treatment Period|Death|0|||
27841983|NCT02300987|81248412|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
27892821|NCT01647516|81441412|FG005|Induction Period (IP)|Participant Choice|0|||
27892822|NCT01647516|81441407|FG000|Induction Period (IP)|Lack of Efficacy|1|||
27892823|NCT01647516|81441408|FG001|Induction Period (IP)|Lack of Efficacy|0|||
27892824|NCT01647516|81441409|FG002|Induction Period (IP)|Lack of Efficacy|0|||
27892825|NCT01647516|81441410|FG003|Induction Period (IP)|Lack of Efficacy|0|||
27892826|NCT01647516|81441411|FG004|Induction Period (IP)|Lack of Efficacy|0|||
27892827|NCT01647516|81441412|FG005|Induction Period (IP)|Lack of Efficacy|0|||
27892828|NCT01647516|81441407|FG000|Induction Period (IP)|No study drug received|1|||
27892829|NCT01647516|81441408|FG001|Induction Period (IP)|No study drug received|1|||
27892830|NCT01647516|81441409|FG002|Induction Period (IP)|No study drug received|0|||
27892831|NCT01647516|81441410|FG003|Induction Period (IP)|No study drug received|0|||
27892832|NCT01647516|81441411|FG004|Induction Period (IP)|No study drug received|0|||
27892833|NCT01647516|81441412|FG005|Induction Period (IP)|No study drug received|0|||
27892834|NCT01647516|81441407|FG000|Maintenance Period (MP)|Adverse Event|2|||
27892835|NCT01647516|81441408|FG001|Maintenance Period (MP)|Adverse Event|1|||
27892836|NCT01647516|81441409|FG002|Maintenance Period (MP)|Adverse Event|0|||
27892837|NCT01647516|81441410|FG003|Maintenance Period (MP)|Adverse Event|0|||
27892838|NCT01647516|81441411|FG004|Maintenance Period (MP)|Adverse Event|0|||
27892839|NCT01647516|81441412|FG005|Maintenance Period (MP)|Adverse Event|0|||
27892840|NCT01647516|81441407|FG000|Maintenance Period (MP)|Non-compliance|1|||
27892841|NCT01647516|81441408|FG001|Maintenance Period (MP)|Non-compliance|0|||
27892842|NCT01647516|81441409|FG002|Maintenance Period (MP)|Non-compliance|0|||
27892843|NCT01647516|81441410|FG003|Maintenance Period (MP)|Non-compliance|0|||
27892844|NCT01647516|81441411|FG004|Maintenance Period (MP)|Non-compliance|0|||
27892845|NCT01647516|81441412|FG005|Maintenance Period (MP)|Non-compliance|0|||
27892846|NCT01647516|81441407|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
27892847|NCT01647516|81441408|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
27892848|NCT01647516|81441409|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
27892849|NCT01647516|81441410|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
27892850|NCT01647516|81441411|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
27503796|NCT02855125|80037867|FG001|Overall Study|Adverse Event|7|||
27503797|NCT02855125|80037866|FG000|Overall Study|Physician Decision|1|||
27503798|NCT02855125|80037867|FG001|Overall Study|Physician Decision|0|||
27503799|NCT02855125|80037866|FG000|Overall Study|On Treatment|9|||
27503800|NCT02855125|80037867|FG001|Overall Study|On Treatment|11|||
27503801|NCT02855125|80037866|FG000|Overall Study|Randomized but not treated|0|||
27503802|NCT02855125|80037867|FG001|Overall Study|Randomized but not treated|1|||
27503803|NCT04639245|80037870|FG000|Overall Study|Death|1|||
27503804|NCT00791934|80037871|FG000|Overall Study|Withdrawal by Subject|2|||
27503805|NCT00791934|80037871|FG000|Overall Study|Did not consent for extended follow-up|13|||
27503806|NCT02638220|80037874|FG000|Overall Study|Lost to Follow-up|6|||
27503807|NCT02638220|80037874|FG000|Overall Study|Withdrawal by Subject|3|||
27503808|NCT02638220|80037874|FG000|Overall Study|Physician Decision|1|||
27503809|NCT02638220|80037874|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
27503810|NCT02796170|80037875|FG000|Overall Study|Lost to Follow-up|3|||
27503811|NCT02796170|80037876|FG001|Overall Study|Lost to Follow-up|0|||
27503812|NCT00456846|80037877|FG000|Overall Study|Adverse Event|2|||
27503813|NCT00456846|80037878|FG001|Overall Study|Adverse Event|15|||
27503814|NCT00456846|80037877|FG000|Overall Study|Physician Decision|11|||
27503815|NCT00456846|80037878|FG001|Overall Study|Physician Decision|6|||
27503816|NCT00456846|80037877|FG000|Overall Study|Protocol Deviation|2|||
27503817|NCT00456846|80037878|FG001|Overall Study|Protocol Deviation|0|||
27503818|NCT00456846|80037877|FG000|Overall Study|Participant Discretion|1|||
27503819|NCT00456846|80037878|FG001|Overall Study|Participant Discretion|5|||
27503820|NCT00456846|80037877|FG000|Overall Study|Other|0|||
27503821|NCT00456846|80037878|FG001|Overall Study|Other|2|||
27503822|NCT02514083|80037881|FG000|Overall Study|Adverse Event|1|||
27503823|NCT04177823|80037882|FG000|Overall Study|Physician Decision|1|||
27503824|NCT04177823|80037882|FG000|Overall Study|Withdrawal by Subject|1|||
27503825|NCT01256788|80037885|FG000|Overall Study|Lost to Follow-up|5|||
27503826|NCT01256788|80037886|FG001|Overall Study|Lost to Follow-up|8|||
27503827|NCT01256788|80037887|FG002|Overall Study|Lost to Follow-up|3|||
27503828|NCT01149096|80037890|FG000|Overall Study|Lost to Follow-up|0|||
27503829|NCT01149096|80037891|FG001|Overall Study|Lost to Follow-up|1|||
27503830|NCT03815929|80037892|FG000|Overall Study|Lost to Follow-up|2|||
27892851|NCT01647516|81441412|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
27503831|NCT03815929|80037893|FG001|Overall Study|Lost to Follow-up|1|||
27503832|NCT03815929|80037894|FG002|Overall Study|Lost to Follow-up|0|||
27503833|NCT03815929|80037892|FG000|Overall Study|Physician Decision|2|||
27503834|NCT03815929|80037893|FG001|Overall Study|Physician Decision|2|||
27503835|NCT03815929|80037894|FG002|Overall Study|Physician Decision|0|||
27841984|NCT02300987|81248411|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
27841985|NCT02300987|81248412|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
27841986|NCT02300987|81248411|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
27841987|NCT02300987|81248412|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
27841988|NCT02300987|81248411|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
27841989|NCT02300987|81248412|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
27841990|NCT04523480|81248413|FG000|Overall Study|Lost to Follow-up|30|||
27841991|NCT04523480|81248414|FG001|Overall Study|Lost to Follow-up|35|||
27841992|NCT04523480|81248415|FG002|Overall Study|Lost to Follow-up|0|||
27841993|NCT01801917|81248420|FG000|Period 1 - Randomized|Adverse Event|1|||
27841994|NCT01801917|81248421|FG001|Period 1 - Randomized|Adverse Event|0|||
27841995|NCT01801917|81248422|FG002|Period 1 - Randomized|Adverse Event|1|||
27841996|NCT01801917|81248423|FG003|Period 1 - Randomized|Adverse Event|0|||
27841997|NCT03686215|81248425|FG000|Overall Study|Adverse Event|0|||
27841998|NCT03686215|81248426|FG001|Overall Study|Adverse Event|0|||
27841999|NCT03686215|81248427|FG002|Overall Study|Adverse Event|7|||
27842000|NCT03686215|81248425|FG000|Overall Study|Physician Decision|0|||
27842001|NCT03686215|81248426|FG001|Overall Study|Physician Decision|0|||
27892852|NCT01647516|81441407|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
27892853|NCT01647516|81441408|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
27892854|NCT01647516|81441409|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
27842002|NCT03686215|81248427|FG002|Overall Study|Physician Decision|1|||
27842003|NCT03686215|81248425|FG000|Overall Study|Protocol Violation|0|||
27842004|NCT03686215|81248426|FG001|Overall Study|Protocol Violation|0|||
27842005|NCT03686215|81248427|FG002|Overall Study|Protocol Violation|4|||
27842006|NCT03686215|81248425|FG000|Overall Study|Device issue|1|||
27842007|NCT03686215|81248426|FG001|Overall Study|Device issue|0|||
27842008|NCT03686215|81248427|FG002|Overall Study|Device issue|2|||
27842009|NCT02722616|81248430|FG000|Overall Study|Sponsor closed study after one month|2|||
27842010|NCT02722616|81248431|FG001|Overall Study|Sponsor closed study after one month|0|||
27842011|NCT02722616|81248432|FG002|Overall Study|Sponsor closed study after one month|0|||
27842012|NCT01263561|81248433|FG000|Overall Study|Death|1|||
27842013|NCT01263561|81248434|FG001|Overall Study|Death|2|||
27842014|NCT01857973|81248435|FG000|Overall Study|Subject did not meet required BG range|3|||
27842015|NCT01857973|81248435|FG000|Overall Study|drop out after 3 failed attempts|1|||
27842016|NCT01857973|81248435|FG000|Overall Study|Physician Decision|1|||
27842017|NCT00109850|81251200|FG000|Overall Study|Adverse Event|1|||
27842018|NCT00109850|81251200|FG000|Overall Study|Death|2|||
27842019|NCT00109850|81251200|FG000|Overall Study|Ineligible|1|||
27842020|NCT01662024|81251202|FG000|Overall Study|Pregnancy|2|||
27842021|NCT01662024|81251202|FG000|Overall Study|Withdrawal by Subject|3|||
27842022|NCT01849458|81251206|FG000|Overall Study|Lost to Follow-up|4|||
27842023|NCT04823130|81251207|FG000|Overall Study|Withdrawal by Subject|2|||
27842024|NCT04823130|81251208|FG001|Overall Study|Withdrawal by Subject|3|||
27842025|NCT04823130|81251207|FG000|Overall Study|Failure to meet inclusion criteria|6|||
27842026|NCT04823130|81251208|FG001|Overall Study|Failure to meet inclusion criteria|4|||
27842027|NCT04823130|81251207|FG000|Overall Study|Other-unspecified|1|||
27842028|NCT04823130|81251208|FG001|Overall Study|Other-unspecified|0|||
27842029|NCT00683787|81251209|FG000|Overall Study|Progression|3|||
27842030|NCT00683787|81251210|FG001|Overall Study|Progression|3|||
27842031|NCT00683787|81251211|FG002|Overall Study|Progression|0|||
27842032|NCT00683787|81251209|FG000|Overall Study|Adverse Event|0|||
27842033|NCT00683787|81251210|FG001|Overall Study|Adverse Event|0|||
27892855|NCT01647516|81441410|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
27892856|NCT01647516|81441411|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
27613165|NCT03580356|80426564|FG006|Treatment Period|Death|0|||
27613166|NCT03580356|80426565|FG007|Treatment Period|Death|0|||
27613167|NCT03580356|80426558|FG000|Treatment Period|Technical problems|0|||
27613168|NCT03580356|80426559|FG001|Treatment Period|Technical problems|0|||
27724276|NCT02600507|80822979|FG001|Overall Study|Lost to Follow-up|5|||
27842034|NCT00683787|81251211|FG002|Overall Study|Adverse Event|2|||
27842035|NCT03438006|81251212|FG000|Overall Study|Adverse Event|1|||
27842036|NCT03438006|81251212|FG000|Overall Study|Lost to Follow-up|67|||
27842037|NCT03438006|81251212|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
27842038|NCT03438006|81251212|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
27842039|NCT03761056|81251213|FG000|Overall Study|Still on Study|34|||
27842040|NCT03761056|81251213|FG000|Overall Study|Death|6|||
27613169|NCT03580356|80426560|FG002|Treatment Period|Technical problems|0|||
27613170|NCT03580356|80426561|FG003|Treatment Period|Technical problems|0|||
27613171|NCT03580356|80426562|FG004|Treatment Period|Technical problems|1|||
27613172|NCT03580356|80426563|FG005|Treatment Period|Technical problems|0|||
27613173|NCT03580356|80426564|FG006|Treatment Period|Technical problems|0|||
27613174|NCT03580356|80426565|FG007|Treatment Period|Technical problems|0|||
27613175|NCT03580356|80426558|FG000|Treatment Period|Misrandomized, no treatment|0|||
27613176|NCT03580356|80426559|FG001|Treatment Period|Misrandomized, no treatment|0|||
27613177|NCT03580356|80426560|FG002|Treatment Period|Misrandomized, no treatment|1|||
27613178|NCT03580356|80426561|FG003|Treatment Period|Misrandomized, no treatment|0|||
27613179|NCT03580356|80426562|FG004|Treatment Period|Misrandomized, no treatment|2|||
27613180|NCT03580356|80426563|FG005|Treatment Period|Misrandomized, no treatment|0|||
27724277|NCT02600507|80822980|FG002|Overall Study|Lost to Follow-up|2|||
27724278|NCT02600507|80822978|FG000|Overall Study|Protocol Violation|12|||
27724279|NCT02600507|80822979|FG001|Overall Study|Protocol Violation|4|||
27724280|NCT02600507|80822980|FG002|Overall Study|Protocol Violation|4|||
27503836|NCT03815929|80037892|FG000|Overall Study|Withdrawal by Subject|0|||
27503837|NCT03815929|80037893|FG001|Overall Study|Withdrawal by Subject|0|||
27503838|NCT03815929|80037894|FG002|Overall Study|Withdrawal by Subject|1|||
27503839|NCT02443688|80037895|FG000|Overall Study|Adverse Event|2|||
27503840|NCT02443688|80037896|FG001|Overall Study|Adverse Event|3|||
27503841|NCT02443688|80037897|FG002|Overall Study|Adverse Event|2|||
27503842|NCT02443688|80037895|FG000|Overall Study|Lost to Follow-up|1|||
27503843|NCT02443688|80037896|FG001|Overall Study|Lost to Follow-up|0|||
27503844|NCT02443688|80037897|FG002|Overall Study|Lost to Follow-up|0|||
27724281|NCT02600507|80822978|FG000|Overall Study|Physician Decision|1|||
27724282|NCT02600507|80822979|FG001|Overall Study|Physician Decision|0|||
27724283|NCT02600507|80822980|FG002|Overall Study|Physician Decision|1|||
27724284|NCT02600507|80822978|FG000|Overall Study|Withdrawal by Subject|7|||
27724285|NCT02600507|80822979|FG001|Overall Study|Withdrawal by Subject|11|||
27724286|NCT02600507|80822980|FG002|Overall Study|Withdrawal by Subject|7|||
27724287|NCT02600507|80822978|FG000|Overall Study|Other|0|||
27724288|NCT02600507|80822979|FG001|Overall Study|Other|1|||
27724289|NCT02600507|80822980|FG002|Overall Study|Other|1|||
27724290|NCT01592760|80822981|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
27724291|NCT01592760|80822982|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
27724292|NCT01592760|80822983|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
27724293|NCT03446885|80822984|FG000|Overall Study|Lost to Follow-up|1|||
27724294|NCT03446885|80822985|FG001|Overall Study|Lost to Follow-up|0|||
27724295|NCT03446885|80822984|FG000|Overall Study|Did not complete entire visit|1|||
27724296|NCT03446885|80822985|FG001|Overall Study|Did not complete entire visit|0|||
27724297|NCT00132041|80822986|FG000|Baseline|Ineligible|6|||
27724298|NCT00132041|80822986|FG000|3 Months Post Ablation|Transplant|1|||
27724299|NCT00132041|80822986|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
27724300|NCT00132041|80822986|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
27503845|NCT02443688|80037895|FG000|Overall Study|Physician Decision|3|||
27503846|NCT02443688|80037896|FG001|Overall Study|Physician Decision|0|||
27503847|NCT02443688|80037897|FG002|Overall Study|Physician Decision|1|||
27503848|NCT02443688|80037895|FG000|Overall Study|Pregnancy|0|||
27724301|NCT00132041|80822986|FG000|6 Months Post Ablation|Death|2|||
27724302|NCT00132041|80822986|FG000|6 Months Post Ablation|Transplant|6|||
27724303|NCT00132041|80822986|FG000|9 Months Post Ablation|Death|1|||
27724304|NCT00132041|80822986|FG000|9 Months Post Ablation|Transplant|1|||
27724305|NCT00132041|80822986|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
27724306|NCT00132041|80822986|FG000|12 Months Post Ablation|Death|1|||
27724307|NCT00132041|80822986|FG000|12 Months Post Ablation|Transplant|1|||
27724308|NCT00132041|80822986|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
27724309|NCT00132041|80822986|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
27724310|NCT00132041|80822986|FG000|15 Months Post Ablation|Death|1|||
27754871|NCT02065622|80929631|FG001|Induction Study|Lost to Follow-up|0|||
27503849|NCT02443688|80037896|FG001|Overall Study|Pregnancy|0|||
27613181|NCT03580356|80426564|FG006|Treatment Period|Misrandomized, no treatment|0|||
27613182|NCT03580356|80426565|FG007|Treatment Period|Misrandomized, no treatment|0|||
27724311|NCT00132041|80822986|FG000|15 Months Post Ablation|Transplant|5|||
27724312|NCT00132041|80822986|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
27724313|NCT00132041|80822986|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
27724314|NCT00132041|80822986|FG000|18 Months Post Ablation|Transplant|1|||
27724315|NCT00132041|80822986|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
27724316|NCT00132041|80822986|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
27724317|NCT01960855|80822988|FG000|Overall Study|Subject noncompliant|1|||
27724318|NCT01960855|80822989|FG001|Overall Study|Subject noncompliant|0|||
27724319|NCT01960855|80822990|FG002|Overall Study|Subject noncompliant|0|||
27724320|NCT01960855|80822991|FG003|Overall Study|Subject noncompliant|0|||
27724321|NCT01960855|80822992|FG004|Overall Study|Subject noncompliant|0|||
27503850|NCT02443688|80037897|FG002|Overall Study|Pregnancy|1|||
27503851|NCT02443688|80037895|FG000|Overall Study|Withdrawal by Subject|3|||
27503852|NCT02443688|80037896|FG001|Overall Study|Withdrawal by Subject|3|||
27503853|NCT02443688|80037897|FG002|Overall Study|Withdrawal by Subject|4|||
27503854|NCT02443688|80037895|FG000|Overall Study|Non-compliance with study drug|1|||
27503855|NCT02443688|80037896|FG001|Overall Study|Non-compliance with study drug|2|||
27503856|NCT02443688|80037897|FG002|Overall Study|Non-compliance with study drug|4|||
27724322|NCT01960855|80822988|FG000|Overall Study|Adverse Event|2|||
27503857|NCT02443688|80037895|FG000|Overall Study|Sponsor Request|2|||
27724323|NCT01960855|80822989|FG001|Overall Study|Adverse Event|0|||
27724324|NCT01960855|80822990|FG002|Overall Study|Adverse Event|6|||
27724325|NCT01960855|80822991|FG003|Overall Study|Adverse Event|2|||
27724326|NCT01960855|80822992|FG004|Overall Study|Adverse Event|2|||
27724327|NCT01960855|80822988|FG000|Overall Study|Lack of Efficacy|1|||
27842041|NCT03761056|81251213|FG000|Overall Study|Investigator Decision|1|||
27842042|NCT03761056|81251213|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
27842043|NCT01937351|81251215|FG000|Overall Study|Withdrawal by Subject|4|||
27842044|NCT01937351|81251216|FG001|Overall Study|Withdrawal by Subject|2|||
27842045|NCT01937351|81251215|FG000|Overall Study|Death|1|||
27842046|NCT01937351|81251216|FG001|Overall Study|Death|0|||
27842047|NCT01937351|81251215|FG000|Overall Study|Not treated w device, per protocol fail|4|||
27842048|NCT01937351|81251216|FG001|Overall Study|Not treated w device, per protocol fail|0|||
27842049|NCT01264835|81251219|FG000|Overall Study|Lost to Follow-up|1|||
27842050|NCT00588731|81251221|FG000|Overall Study|Withdrawal by Subject|3|||
27842051|NCT00588731|81251222|FG001|Overall Study|Withdrawal by Subject|2|||
27842052|NCT01719562|81251223|FG000|Overall Study|Lost to Follow-up|1|||
27892857|NCT01647516|81441412|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
27503858|NCT02443688|80037896|FG001|Overall Study|Sponsor Request|1|||
27724328|NCT01960855|80822989|FG001|Overall Study|Lack of Efficacy|1|||
27724329|NCT01960855|80822990|FG002|Overall Study|Lack of Efficacy|0|||
27842053|NCT01719562|81251224|FG001|Overall Study|Lost to Follow-up|0|||
27842054|NCT01719562|81251223|FG000|Overall Study|Death|1|||
27842055|NCT01719562|81251224|FG001|Overall Study|Death|0|||
27892858|NCT01647516|81441407|FG000|Open-Label Period|Adverse Event|0|||
27503859|NCT02443688|80037897|FG002|Overall Study|Sponsor Request|0|||
27724330|NCT01960855|80822991|FG003|Overall Study|Lack of Efficacy|0|||
27724331|NCT01960855|80822992|FG004|Overall Study|Lack of Efficacy|0|||
27724332|NCT01960855|80822988|FG000|Overall Study|Other|2|||
27724333|NCT01960855|80822989|FG001|Overall Study|Other|1|||
27892859|NCT01647516|81441408|FG001|Open-Label Period|Adverse Event|0|||
27892860|NCT01647516|81441409|FG002|Open-Label Period|Adverse Event|0|||
27892861|NCT01647516|81441410|FG003|Open-Label Period|Adverse Event|5|||
27892862|NCT01647516|81441411|FG004|Open-Label Period|Adverse Event|6|||
27892863|NCT01647516|81441412|FG005|Open-Label Period|Adverse Event|3|||
27892864|NCT01647516|81441407|FG000|Open-Label Period|Pregnancy|0|||
27892865|NCT01647516|81441408|FG001|Open-Label Period|Pregnancy|0|||
27892866|NCT01647516|81441409|FG002|Open-Label Period|Pregnancy|0|||
27892867|NCT01647516|81441410|FG003|Open-Label Period|Pregnancy|0|||
27613183|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
27613184|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
27613185|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
27613186|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
27613187|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
27613188|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
27613189|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
27613190|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
27613191|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
27613192|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
27613193|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
27613194|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
27613195|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
27613196|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
27613197|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
27613198|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
27892868|NCT01647516|81441411|FG004|Open-Label Period|Pregnancy|0|||
27892869|NCT01647516|81441412|FG005|Open-Label Period|Pregnancy|1|||
27892870|NCT01647516|81441407|FG000|Open-Label Period|Non-compliance|0|||
27892871|NCT01647516|81441408|FG001|Open-Label Period|Non-compliance|0|||
27892872|NCT01647516|81441409|FG002|Open-Label Period|Non-compliance|0|||
27892873|NCT01647516|81441410|FG003|Open-Label Period|Non-compliance|1|||
27892874|NCT01647516|81441411|FG004|Open-Label Period|Non-compliance|0|||
27613199|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
27613200|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
27613201|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
27613202|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
27613203|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
27613204|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
27613205|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
27613206|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
27613207|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
27613208|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
27613209|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
27613210|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
27724334|NCT01960855|80822990|FG002|Overall Study|Other|1|||
27724335|NCT01960855|80822991|FG003|Overall Study|Other|1|||
27613211|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
27613212|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
27724336|NCT01960855|80822992|FG004|Overall Study|Other|0|||
27724337|NCT01960855|80822988|FG000|Overall Study|Consent withdrawn by subject|3|||
27724338|NCT01960855|80822989|FG001|Overall Study|Consent withdrawn by subject|1|||
27892875|NCT01647516|81441412|FG005|Open-Label Period|Non-compliance|1|||
27892876|NCT01647516|81441407|FG000|Open-Label Period|Physician Decision|0|||
27754872|NCT02065622|80929632|FG002|Induction Study|Lost to Follow-up|0|||
27892877|NCT01647516|81441408|FG001|Open-Label Period|Physician Decision|0|||
27892878|NCT01647516|81441409|FG002|Open-Label Period|Physician Decision|0|||
27754873|NCT02065622|80929633|FG003|Induction Study|Lost to Follow-up|0|||
27842056|NCT01719562|81251223|FG000|Overall Study|New cancer diagnosis|1|||
27842057|NCT01719562|81251224|FG001|Overall Study|New cancer diagnosis|0|||
27842058|NCT00388037|81251225|FG000|Overall Study|Protocol Violation|1|||
27842059|NCT01011556|81251226|FG000|Overall Study|Adverse Event|1|||
27842060|NCT01011556|81251227|FG001|Overall Study|Adverse Event|3|||
27842061|NCT01011556|81251228|FG002|Overall Study|Adverse Event|2|||
27842062|NCT01011556|81251229|FG003|Overall Study|Adverse Event|1|||
27842063|NCT01011556|81251226|FG000|Overall Study|Lost to Follow-up|1|||
27842064|NCT01011556|81251227|FG001|Overall Study|Lost to Follow-up|0|||
27842065|NCT01011556|81251228|FG002|Overall Study|Lost to Follow-up|0|||
27842066|NCT01011556|81251229|FG003|Overall Study|Lost to Follow-up|0|||
27842067|NCT01011556|81251226|FG000|Overall Study|Physician Decision|1|||
27842068|NCT01011556|81251227|FG001|Overall Study|Physician Decision|0|||
27842069|NCT01011556|81251228|FG002|Overall Study|Physician Decision|0|||
27842070|NCT01011556|81251229|FG003|Overall Study|Physician Decision|1|||
27842071|NCT01011556|81251226|FG000|Overall Study|Protocol Violation|0|||
27842072|NCT01011556|81251227|FG001|Overall Study|Protocol Violation|1|||
27842073|NCT01011556|81251228|FG002|Overall Study|Protocol Violation|0|||
27842074|NCT01011556|81251229|FG003|Overall Study|Protocol Violation|0|||
27842075|NCT01011556|81251226|FG000|Overall Study|Withdrawal by Subject|1|||
27842076|NCT01011556|81251227|FG001|Overall Study|Withdrawal by Subject|2|||
27842077|NCT01011556|81251228|FG002|Overall Study|Withdrawal by Subject|4|||
27754874|NCT02065622|80929634|FG004|Induction Study|Lost to Follow-up|0|||
27754875|NCT02065622|80929630|FG000|Induction Study|Lack of Efficacy|22|||
27754876|NCT02065622|80929631|FG001|Induction Study|Lack of Efficacy|27|||
27754877|NCT02065622|80929632|FG002|Induction Study|Lack of Efficacy|0|||
27754878|NCT02065622|80929633|FG003|Induction Study|Lack of Efficacy|0|||
27754879|NCT02065622|80929634|FG004|Induction Study|Lack of Efficacy|0|||
27754880|NCT02065622|80929630|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
27754881|NCT02065622|80929631|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
27754882|NCT02065622|80929632|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
27754883|NCT02065622|80929633|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
27754884|NCT02065622|80929634|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
27754885|NCT02065622|80929630|FG000|Induction Study|Subject Noncompliance|1|||
27754886|NCT02065622|80929631|FG001|Induction Study|Subject Noncompliance|1|||
27754887|NCT02065622|80929632|FG002|Induction Study|Subject Noncompliance|0|||
27754888|NCT02065622|80929633|FG003|Induction Study|Subject Noncompliance|0|||
27754889|NCT02065622|80929634|FG004|Induction Study|Subject Noncompliance|0|||
27754890|NCT02065622|80929630|FG000|Induction Study|Other, Not Specified|3|||
27754891|NCT02065622|80929631|FG001|Induction Study|Other, Not Specified|2|||
27754892|NCT02065622|80929632|FG002|Induction Study|Other, Not Specified|0|||
27754893|NCT02065622|80929633|FG003|Induction Study|Other, Not Specified|0|||
27842078|NCT01011556|81251229|FG003|Overall Study|Withdrawal by Subject|4|||
27842079|NCT01011556|81251226|FG000|Overall Study|Sponsor decision|0|||
27842080|NCT01011556|81251227|FG001|Overall Study|Sponsor decision|1|||
27842081|NCT01011556|81251228|FG002|Overall Study|Sponsor decision|1|||
27842082|NCT01011556|81251229|FG003|Overall Study|Sponsor decision|2|||
27842083|NCT01011556|81251226|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
27842084|NCT01011556|81251227|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
27842085|NCT01011556|81251228|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
27842086|NCT01011556|81251229|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
27842087|NCT01989676|81251234|FG000|Overall Study|Death|52|||
27842088|NCT01989676|81251235|FG001|Overall Study|Death|60|||
27842089|NCT01989676|81251234|FG000|Overall Study|Protocol Violation|2|||
27842090|NCT01989676|81251235|FG001|Overall Study|Protocol Violation|1|||
27503860|NCT01033019|80037898|FG000|Overall Study|Withdrawal by Subject|1|||
27503861|NCT01033019|80037899|FG001|Overall Study|Withdrawal by Subject|0|||
27503862|NCT01967238|80037900|FG000|Overall Study|Adverse Event|1|||
27613213|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
27503863|NCT01967238|80037901|FG001|Overall Study|Adverse Event|1|||
27503864|NCT01967238|80037902|FG002|Overall Study|Adverse Event|0|||
27503865|NCT01967238|80037900|FG000|Overall Study|Lost to Follow-up|1|||
27503866|NCT01967238|80037901|FG001|Overall Study|Lost to Follow-up|0|||
27503867|NCT01967238|80037902|FG002|Overall Study|Lost to Follow-up|1|||
27503868|NCT01967238|80037900|FG000|Overall Study|Withdrawal by Subject|0|||
27503869|NCT01967238|80037901|FG001|Overall Study|Withdrawal by Subject|0|||
27503870|NCT01967238|80037902|FG002|Overall Study|Withdrawal by Subject|1|||
27503871|NCT01001221|80037903|FG000|Overall Study|Adverse Event|1|||
27503872|NCT01001221|80037904|FG001|Overall Study|Adverse Event|2|||
27503873|NCT01001221|80037905|FG002|Overall Study|Adverse Event|0|||
27503874|NCT01001221|80037906|FG003|Overall Study|Adverse Event|2|||
27503875|NCT01001221|80037907|FG004|Overall Study|Adverse Event|0|||
27503876|NCT01001221|80037903|FG000|Overall Study|Disease progression|3|||
27503877|NCT01001221|80037904|FG001|Overall Study|Disease progression|2|||
27724339|NCT01960855|80822990|FG002|Overall Study|Consent withdrawn by subject|2|||
27724340|NCT01960855|80822991|FG003|Overall Study|Consent withdrawn by subject|1|||
27724341|NCT01960855|80822992|FG004|Overall Study|Consent withdrawn by subject|1|||
27724342|NCT01960855|80822988|FG000|Overall Study|Lost to Follow-up|2|||
27724343|NCT01960855|80822989|FG001|Overall Study|Lost to Follow-up|1|||
27724344|NCT01960855|80822990|FG002|Overall Study|Lost to Follow-up|0|||
27724345|NCT01960855|80822991|FG003|Overall Study|Lost to Follow-up|0|||
27724346|NCT01960855|80822992|FG004|Overall Study|Lost to Follow-up|2|||
27724347|NCT02292771|80822993|FG000|Overall Study|Withdrawal by Subject|2|||
27724348|NCT02292771|80822994|FG001|Overall Study|Withdrawal by Subject|1|||
27724349|NCT02292771|80822993|FG000|Overall Study|Lost to Follow-up|2|||
27842091|NCT01989676|81251234|FG000|Overall Study|Lost to Follow-up|8|||
27842092|NCT01989676|81251235|FG001|Overall Study|Lost to Follow-up|18|||
27842093|NCT01989676|81251234|FG000|Overall Study|No longer willing to participate in study|26|||
27842094|NCT01989676|81251235|FG001|Overall Study|No longer willing to participate in study|26|||
27842095|NCT01989676|81251234|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
27842096|NCT01989676|81251235|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
27842097|NCT01989676|81251234|FG000|Overall Study|Other|4|||
27503878|NCT01001221|80037905|FG002|Overall Study|Disease progression|2|||
27503879|NCT01001221|80037906|FG003|Overall Study|Disease progression|4|||
27503880|NCT01001221|80037907|FG004|Overall Study|Disease progression|0|||
27503881|NCT01001221|80037903|FG000|Overall Study|Other|1|||
27503882|NCT01001221|80037904|FG001|Overall Study|Other|1|||
27503883|NCT01001221|80037905|FG002|Overall Study|Other|0|||
27503884|NCT01001221|80037906|FG003|Overall Study|Other|0|||
27503885|NCT01001221|80037907|FG004|Overall Study|Other|0|||
27503886|NCT01001221|80037903|FG000|Overall Study|Not treated; protocol exclusion|0|||
27503887|NCT01001221|80037904|FG001|Overall Study|Not treated; protocol exclusion|0|||
27503888|NCT01001221|80037905|FG002|Overall Study|Not treated; protocol exclusion|1|||
27503889|NCT01001221|80037906|FG003|Overall Study|Not treated; protocol exclusion|0|||
27503890|NCT01001221|80037907|FG004|Overall Study|Not treated; protocol exclusion|0|||
27503891|NCT03067077|80037908|FG000|Overall Study|Did not receive surgery|4|||
27503892|NCT03067077|80037909|FG001|Overall Study|Did not receive surgery|5|||
27503893|NCT03067077|80037908|FG000|Overall Study|Lost to Follow-up|3|||
27503894|NCT03067077|80037909|FG001|Overall Study|Lost to Follow-up|2|||
27503895|NCT01959503|80037910|FG000|Overall Study|Death|2|||
27724350|NCT02292771|80822994|FG001|Overall Study|Lost to Follow-up|1|||
27724351|NCT00763009|80822995|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
27724352|NCT03757988|80822996|FG000|Overall Study|Withdrawal by Subject|1|||
27503896|NCT01959503|80037911|FG001|Overall Study|Death|1|||
27503897|NCT01959503|80037910|FG000|Overall Study|Randomized but not treated|1|||
27724353|NCT01790503|80822997|FG000|Overall Study|Adverse Event|1|||
27842098|NCT01989676|81251235|FG001|Overall Study|Other|3|||
27503898|NCT01959503|80037911|FG001|Overall Study|Randomized but not treated|1|||
27503899|NCT02488915|80037912|FG000|Overall Study|Death|21|||
27503900|NCT02488915|80037912|FG000|Overall Study|Lost to Follow-up|4|||
27503901|NCT02488915|80037912|FG000|Overall Study|Withdrawal by Subject|1|||
27503902|NCT01292486|80037919|FG000|Overall Study|Protocol Violation|2|||
27503903|NCT01292486|80037919|FG000|Overall Study|Did not meet screening criteria|2|||
27503904|NCT01292486|80037919|FG000|Overall Study|Adverse Event|1|||
27842099|NCT00784979|81251237|FG000|Overall Study|incomplete data|6|||
27842100|NCT03069417|81251239|FG000|Overall Study|Lost to Follow-up|2|||
27842101|NCT03069417|81251240|FG001|Overall Study|Lost to Follow-up|0|||
27842102|NCT03069417|81251239|FG000|Overall Study|Reason Unknown|4|||
27842103|NCT03069417|81251240|FG001|Overall Study|Reason Unknown|7|||
27842104|NCT00199901|81251241|FG000|Overall Study|Protocol Violation|2|||
27842105|NCT00199901|81251242|FG001|Overall Study|Protocol Violation|0|||
27842106|NCT00199901|81251241|FG000|Overall Study|Withdrawal by Subject|1|||
27842107|NCT00199901|81251242|FG001|Overall Study|Withdrawal by Subject|0|||
27842108|NCT00199901|81251241|FG000|Overall Study|Progressive Disease|24|||
27842109|NCT00199901|81251242|FG001|Overall Study|Progressive Disease|24|||
27842110|NCT02522780|81251243|FG000|Overall Study|Consent withdrawn by subject|5|||
27842111|NCT02522780|81251244|FG001|Overall Study|Consent withdrawn by subject|7|||
27842112|NCT02522780|81251243|FG000|Overall Study|Protocol deviation|1|||
27842113|NCT02522780|81251244|FG001|Overall Study|Protocol deviation|3|||
27842114|NCT02522780|81251243|FG000|Overall Study|Subject refused endoscopic procedure|0|||
27842115|NCT02522780|81251244|FG001|Overall Study|Subject refused endoscopic procedure|1|||
27842116|NCT02522780|81251243|FG000|Overall Study|Adverse event, non-fatal|11|||
27842117|NCT02522780|81251244|FG001|Overall Study|Adverse event, non-fatal|16|||
27842118|NCT00756717|81251247|FG000|Overall Study|Withdrawal by Subject|2|||
27842119|NCT01376037|81251248|FG000|Overall Study|Lost to Follow-up|0|||
27842120|NCT01376037|81251249|FG001|Overall Study|Lost to Follow-up|2|||
27842121|NCT00438659|81251259|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
27842122|NCT00438659|81251260|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
27842123|NCT00438659|81251259|FG000|Overall Study|Cancel|5|||
27842124|NCT00438659|81251260|FG001|Overall Study|Cancel|2|||
27842125|NCT03877926|81251261|FG000|Overall Study|Adverse Event|1|||
27842126|NCT03877926|81251262|FG001|Overall Study|Adverse Event|0|||
27842127|NCT03877926|81251263|FG002|Overall Study|Adverse Event|0|||
27842128|NCT03877926|81251264|FG003|Overall Study|Adverse Event|0|||
27842129|NCT03877926|81251261|FG000|Overall Study|Death|2|||
27842130|NCT03877926|81251262|FG001|Overall Study|Death|2|||
27842131|NCT03877926|81251263|FG002|Overall Study|Death|2|||
27842132|NCT03877926|81251264|FG003|Overall Study|Death|0|||
27842133|NCT03877926|81251261|FG000|Overall Study|Lost to Follow-up|41|||
27842134|NCT03877926|81251262|FG001|Overall Study|Lost to Follow-up|52|||
27842135|NCT03877926|81251263|FG002|Overall Study|Lost to Follow-up|45|||
27842136|NCT03877926|81251264|FG003|Overall Study|Lost to Follow-up|17|||
27842137|NCT03877926|81251261|FG000|Overall Study|Physician Decision|2|||
27842138|NCT03877926|81251262|FG001|Overall Study|Physician Decision|0|||
27842139|NCT03877926|81251263|FG002|Overall Study|Physician Decision|2|||
27842140|NCT03877926|81251264|FG003|Overall Study|Physician Decision|0|||
27842141|NCT03877926|81251261|FG000|Overall Study|Withdrawal by Subject|18|||
27842142|NCT03877926|81251262|FG001|Overall Study|Withdrawal by Subject|21|||
27842143|NCT03877926|81251263|FG002|Overall Study|Withdrawal by Subject|12|||
27842144|NCT03877926|81251264|FG003|Overall Study|Withdrawal by Subject|4|||
27842145|NCT03877926|81251261|FG000|Overall Study|Other - Various|4|||
27842146|NCT03877926|81251262|FG001|Overall Study|Other - Various|1|||
27842147|NCT03877926|81251263|FG002|Overall Study|Other - Various|1|||
27842148|NCT03877926|81251264|FG003|Overall Study|Other - Various|0|||
27842149|NCT03877926|81251261|FG000|Overall Study|Not Treated|3|||
27842150|NCT03877926|81251262|FG001|Overall Study|Not Treated|1|||
27842151|NCT03877926|81251263|FG002|Overall Study|Not Treated|1|||
27842152|NCT03877926|81251264|FG003|Overall Study|Not Treated|0|||
27842153|NCT02224053|81251266|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
27842154|NCT02224053|81251266|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
27842155|NCT02224053|81251266|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
27842156|NCT02224053|81251266|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
27842157|NCT02224053|81251266|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
27842158|NCT01188226|81251267|FG000|Overall Study|Withdrawal by Subject|4|||
27842159|NCT02658019|81251270|FG000|Overall Study|Adverse Event|1|||
27842160|NCT02927834|81251271|FG000|Overall Study|Lost to Follow-up|1|||
27842161|NCT02927834|81251272|FG001|Overall Study|Lost to Follow-up|2|||
27842162|NCT02927834|81251273|FG002|Overall Study|Lost to Follow-up|2|||
27842163|NCT04980456|81251274|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
27842164|NCT04980456|81251275|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
27842165|NCT04980456|81251274|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
27842166|NCT04980456|81251275|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
27842167|NCT04980456|81251274|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
27842168|NCT04980456|81251275|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
27842169|NCT04980456|81251274|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
27842170|NCT04980456|81251275|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
27842171|NCT02510261|81251276|FG000|Overall Study|Adverse Event|5|||
27842172|NCT02510261|81251277|FG001|Overall Study|Adverse Event|8|||
27842173|NCT02510261|81251278|FG002|Overall Study|Adverse Event|0|||
27842174|NCT02510261|81251276|FG000|Overall Study|Physician Decision|1|||
27842175|NCT02510261|81251277|FG001|Overall Study|Physician Decision|5|||
27842176|NCT02510261|81251278|FG002|Overall Study|Physician Decision|0|||
27842177|NCT02510261|81251276|FG000|Overall Study|Death|19|||
27842178|NCT02510261|81251277|FG001|Overall Study|Death|19|||
27842179|NCT02510261|81251278|FG002|Overall Study|Death|0|||
27842180|NCT02510261|81251276|FG000|Overall Study|Withdrawal by Subject|3|||
27842181|NCT02510261|81251277|FG001|Overall Study|Withdrawal by Subject|10|||
27842182|NCT02510261|81251278|FG002|Overall Study|Withdrawal by Subject|3|||
27842183|NCT01894230|81251281|FG000|Overall Study|Lost to Follow-up|2|||
27842184|NCT01894230|81251282|FG001|Overall Study|Lost to Follow-up|2|||
27842185|NCT01894230|81251281|FG000|Overall Study|Withdrawal by Subject|4|||
27842186|NCT01894230|81251282|FG001|Overall Study|Withdrawal by Subject|4|||
27842187|NCT01894230|81251281|FG000|Overall Study|Non-adherent|0|||
27842188|NCT01894230|81251282|FG001|Overall Study|Non-adherent|1|||
27842189|NCT01894230|81251281|FG000|Overall Study|Death|1|||
27842190|NCT01894230|81251282|FG001|Overall Study|Death|0|||
27842191|NCT01475786|81251283|FG000|Overall Study|Adverse Event|0|||
27842192|NCT01475786|81251284|FG001|Overall Study|Adverse Event|1|||
27842193|NCT01475786|81251285|FG002|Overall Study|Adverse Event|0|||
27842194|NCT01475786|81251283|FG000|Overall Study|Lost to Follow-up|1|||
27842195|NCT01475786|81251284|FG001|Overall Study|Lost to Follow-up|2|||
27842196|NCT01475786|81251285|FG002|Overall Study|Lost to Follow-up|1|||
27842197|NCT01475786|81251283|FG000|Overall Study|Withdrawal by Subject|0|||
27842198|NCT01475786|81251284|FG001|Overall Study|Withdrawal by Subject|1|||
27842199|NCT01475786|81251285|FG002|Overall Study|Withdrawal by Subject|1|||
27842200|NCT01475786|81251283|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
27842201|NCT01475786|81251284|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
27842202|NCT01475786|81251285|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
27842203|NCT03785145|81251286|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
27842204|NCT03785145|81251287|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
27842205|NCT03785145|81251286|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
27842206|NCT03785145|81251287|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
27842207|NCT03785145|81251286|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
27842208|NCT03785145|81251287|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
27842209|NCT03785145|81251286|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
27842210|NCT03785145|81251287|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
27842211|NCT03785145|81251286|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
27842212|NCT03785145|81251287|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
27842213|NCT03785145|81251286|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
27842214|NCT03785145|81251287|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
27842215|NCT03785145|81251286|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
27842216|NCT03785145|81251287|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
27842217|NCT03785145|81251286|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
27842218|NCT03785145|81251287|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
27842219|NCT03785145|81251286|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
27842220|NCT03785145|81251287|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
27842221|NCT03785145|81251286|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
27842222|NCT03785145|81251287|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
27842223|NCT03785145|81251286|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
27842224|NCT03785145|81251287|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
27842225|NCT00351351|81251288|FG000|Overall Study|surgical access pbs; device issues|9|||
27842226|NCT00351351|81251289|FG001|Overall Study|surgical access pbs; device issues|4|||
27842227|NCT00224484|81251290|FG000|Overall Study|Serious Adverse Event|1|||
27842228|NCT00224484|81251291|FG001|Overall Study|Serious Adverse Event|1|||
27842229|NCT00224484|81251292|FG002|Overall Study|Serious Adverse Event|0|||
27842230|NCT00224484|81251290|FG000|Overall Study|Non-Serious Adverse Event|5|||
27842231|NCT00224484|81251291|FG001|Overall Study|Non-Serious Adverse Event|7|||
27842232|NCT00224484|81251292|FG002|Overall Study|Non-Serious Adverse Event|3|||
27842233|NCT00224484|81251290|FG000|Overall Study|Protocol Violation|2|||
27842234|NCT00224484|81251291|FG001|Overall Study|Protocol Violation|2|||
27842235|NCT00224484|81251292|FG002|Overall Study|Protocol Violation|0|||
27842236|NCT00224484|81251290|FG000|Overall Study|Withdrawal by Subject|49|||
27842237|NCT00224484|81251291|FG001|Overall Study|Withdrawal by Subject|18|||
27842238|NCT00224484|81251292|FG002|Overall Study|Withdrawal by Subject|16|||
27842239|NCT00224484|81251290|FG000|Overall Study|Migrated/moved from study area|18|||
27842240|NCT00224484|81251291|FG001|Overall Study|Migrated/moved from study area|5|||
27892879|NCT01647516|81441410|FG003|Open-Label Period|Physician Decision|1|||
27842241|NCT00224484|81251292|FG002|Overall Study|Migrated/moved from study area|5|||
27842242|NCT00224484|81251290|FG000|Overall Study|Lost to Follow-up|66|||
27892880|NCT01647516|81441411|FG004|Open-Label Period|Physician Decision|1|||
27842243|NCT00224484|81251291|FG001|Overall Study|Lost to Follow-up|28|||
27842244|NCT00224484|81251292|FG002|Overall Study|Lost to Follow-up|36|||
27842245|NCT00224484|81251290|FG000|Overall Study|Reason not specified|5|||
27842246|NCT00224484|81251291|FG001|Overall Study|Reason not specified|4|||
27842247|NCT00224484|81251292|FG002|Overall Study|Reason not specified|2|||
27842248|NCT03442569|81251293|FG000|Overall Study|Subject was ineligible after enrollment|1|||
27842249|NCT00726895|81251297|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27842250|NCT00726895|81251298|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27842251|NCT03180528|81251300|FG000|Overall Study|Adverse Event|1|||
27842252|NCT03180528|81251300|FG000|Overall Study|Withdrawal by Subject|1|||
27842253|NCT03180528|81251300|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
27842254|NCT01520987|81251301|FG000|Overall Study|Withdrawal by Subject|1|||
27842255|NCT01520987|81251302|FG001|Overall Study|Withdrawal by Subject|0|||
27842256|NCT01520987|81251303|FG002|Overall Study|Withdrawal by Subject|0|||
27842257|NCT01520987|81251304|FG003|Overall Study|Withdrawal by Subject|0|||
27842258|NCT01520987|81251305|FG004|Overall Study|Withdrawal by Subject|0|||
27842259|NCT01520987|81251306|FG005|Overall Study|Withdrawal by Subject|1|||
27842260|NCT01520987|81251307|FG006|Overall Study|Withdrawal by Subject|0|||
27842261|NCT01520987|81251308|FG007|Overall Study|Withdrawal by Subject|0|||
27842262|NCT02289820|81251315|FG000|Overall Study|Withdrawal by Subject|2|||
27842263|NCT02289820|81251316|FG001|Overall Study|Withdrawal by Subject|1|||
27842264|NCT02289820|81251317|FG002|Overall Study|Withdrawal by Subject|2|||
27842265|NCT02289820|81251318|FG003|Overall Study|Withdrawal by Subject|1|||
27842266|NCT02289820|81251319|FG004|Overall Study|Withdrawal by Subject|0|||
27842267|NCT02289820|81251320|FG005|Overall Study|Withdrawal by Subject|0|||
27842268|NCT02289820|81251321|FG006|Overall Study|Withdrawal by Subject|1|||
27842269|NCT02289820|81251315|FG000|Overall Study|Death|0|||
27842270|NCT02289820|81251316|FG001|Overall Study|Death|0|||
27842271|NCT02289820|81251317|FG002|Overall Study|Death|1|||
27842272|NCT02289820|81251318|FG003|Overall Study|Death|0|||
27842273|NCT02289820|81251319|FG004|Overall Study|Death|0|||
27842274|NCT02289820|81251320|FG005|Overall Study|Death|0|||
27842275|NCT02289820|81251321|FG006|Overall Study|Death|0|||
27503905|NCT01292486|80037919|FG000|Overall Study|Physician Decision|1|||
27613214|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
27613215|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
27613216|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
27613217|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
27613218|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
27613219|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
27613220|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
27613221|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
27613222|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
27613223|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
27613224|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
27613225|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
27613226|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
27613227|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
27613228|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
27613229|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
27613230|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
27613231|NCT03580356|80426558|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
27613232|NCT03580356|80426559|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
27613233|NCT03580356|80426560|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
27842276|NCT02289820|81251315|FG000|Overall Study|Lost to Follow-up|0|||
27842277|NCT02289820|81251316|FG001|Overall Study|Lost to Follow-up|0|||
27842278|NCT02289820|81251317|FG002|Overall Study|Lost to Follow-up|3|||
27842279|NCT02289820|81251318|FG003|Overall Study|Lost to Follow-up|1|||
27842280|NCT02289820|81251319|FG004|Overall Study|Lost to Follow-up|0|||
27842281|NCT02289820|81251320|FG005|Overall Study|Lost to Follow-up|1|||
27842282|NCT02289820|81251321|FG006|Overall Study|Lost to Follow-up|1|||
27842283|NCT02289820|81251315|FG000|Overall Study|withdrawal of consent|0|||
27613234|NCT03580356|80426561|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
27613235|NCT03580356|80426562|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
27613236|NCT03580356|80426563|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
27613237|NCT03580356|80426564|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
27613238|NCT03580356|80426565|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
27613239|NCT02066532|80426567|FG000|Phase II|Withdrawal by Subject|1|||
27613240|NCT02066532|80426568|FG001|Phase II|Withdrawal by Subject|0|||
27613241|NCT02066532|80426569|FG002|Phase II|Withdrawal by Subject|0|||
27613242|NCT02066532|80426570|FG003|Phase II|Withdrawal by Subject|0|||
27613243|NCT01368211|80426571|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
27613244|NCT01368211|80426572|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
27613245|NCT01822353|80426575|FG000|Overall Study|Adverse Event|1|||
27613246|NCT01822353|80426576|FG001|Overall Study|Adverse Event|3|||
27613247|NCT01822353|80426577|FG002|Overall Study|Adverse Event|1|||
27613248|NCT01822353|80426575|FG000|Overall Study|Pregnancy|0|||
27503906|NCT03467750|80037923|FG000|Overall Study|Surgery canceled|1|||
27503907|NCT03467750|80037924|FG001|Overall Study|Surgery canceled|0|||
27503908|NCT03467750|80037923|FG000|Overall Study|Protocol Violation|1|||
27503909|NCT03467750|80037924|FG001|Overall Study|Protocol Violation|1|||
27503910|NCT03467750|80037923|FG000|Overall Study|Withdrawal by Subject|0|||
27503911|NCT03467750|80037924|FG001|Overall Study|Withdrawal by Subject|1|||
27503912|NCT02374450|80037927|FG000|Overall Study|Protocol Violation|0|||
27503913|NCT02374450|80037928|FG001|Overall Study|Protocol Violation|1|||
27503914|NCT02374450|80037929|FG002|Overall Study|Protocol Violation|0|||
27503915|NCT02374450|80037927|FG000|Overall Study|Withdrawal by Subject|91|||
27503916|NCT02374450|80037928|FG001|Overall Study|Withdrawal by Subject|110|||
27503917|NCT02374450|80037929|FG002|Overall Study|Withdrawal by Subject|4|||
27503918|NCT02374450|80037927|FG000|Overall Study|Lost to Follow-up|168|||
27503919|NCT02374450|80037928|FG001|Overall Study|Lost to Follow-up|194|||
27503920|NCT02374450|80037929|FG002|Overall Study|Lost to Follow-up|138|||
27503921|NCT02374450|80037927|FG000|Overall Study|Death|173|||
27503922|NCT02374450|80037928|FG001|Overall Study|Death|185|||
27503923|NCT02374450|80037929|FG002|Overall Study|Death|81|||
27503924|NCT02374450|80037927|FG000|Overall Study|Migrated from the study area|538|||
27503925|NCT02374450|80037928|FG001|Overall Study|Migrated from the study area|648|||
27503926|NCT02374450|80037929|FG002|Overall Study|Migrated from the study area|181|||
27503927|NCT02374450|80037927|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
27503928|NCT02374450|80037928|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
27503929|NCT02374450|80037929|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
27503930|NCT02374450|80037927|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
27503931|NCT02374450|80037928|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
27503932|NCT02374450|80037929|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
27503933|NCT02374450|80037927|FG000|Overall Study|Other|0|||
27503934|NCT02374450|80037928|FG001|Overall Study|Other|21|||
27503935|NCT02374450|80037929|FG002|Overall Study|Other|79|||
27503936|NCT01748292|80037934|FG000|Overall Study|Adverse Event|2|||
27503937|NCT01748292|80037935|FG001|Overall Study|Adverse Event|4|||
27503938|NCT01748292|80037934|FG000|Overall Study|Lost to Follow-up|0|||
27503939|NCT01748292|80037935|FG001|Overall Study|Lost to Follow-up|3|||
27503940|NCT01748292|80037934|FG000|Overall Study|Death|0|||
27503941|NCT01748292|80037935|FG001|Overall Study|Death|3|||
27503942|NCT01748292|80037934|FG000|Overall Study|Withdrawal by Subject|0|||
27503943|NCT01748292|80037935|FG001|Overall Study|Withdrawal by Subject|2|||
27503944|NCT00751296|80037936|FG000|Overall Study|Adverse Event|2|||
27503945|NCT02749422|80037937|FG000|Overall Study|Lost to Follow-up|0|||
27503946|NCT02749422|80037938|FG001|Overall Study|Lost to Follow-up|2|||
27503947|NCT02749422|80037937|FG000|Overall Study|Ineligible|0|||
27503948|NCT02749422|80037938|FG001|Overall Study|Ineligible|1|||
27503949|NCT03722238|80037939|FG000|Overall Study|Protocol Violation|1|||
27503950|NCT03722238|80037940|FG001|Overall Study|Protocol Violation|0|||
27503951|NCT03722238|80037939|FG000|Overall Study|Physician Decision|1|||
27503952|NCT03722238|80037940|FG001|Overall Study|Physician Decision|0|||
27503953|NCT03722238|80037939|FG000|Overall Study|Death|1|||
27503954|NCT03722238|80037940|FG001|Overall Study|Death|0|||
27503955|NCT03722238|80037939|FG000|Overall Study|Lost to Follow-up|6|||
27503956|NCT03722238|80037940|FG001|Overall Study|Lost to Follow-up|0|||
27503957|NCT03722238|80037939|FG000|Overall Study|Partial missing data|44|||
27503958|NCT03722238|80037940|FG001|Overall Study|Partial missing data|1|||
27503959|NCT03722238|80037939|FG000|Overall Study|Withdrawal by Subject|2|||
27503960|NCT03722238|80037940|FG001|Overall Study|Withdrawal by Subject|0|||
27613249|NCT01822353|80426576|FG001|Overall Study|Pregnancy|1|||
27613250|NCT01822353|80426577|FG002|Overall Study|Pregnancy|0|||
27613251|NCT01822353|80426575|FG000|Overall Study|Withdrawal by Subject|3|||
27613252|NCT01822353|80426576|FG001|Overall Study|Withdrawal by Subject|1|||
27613253|NCT01822353|80426577|FG002|Overall Study|Withdrawal by Subject|0|||
27613254|NCT03306043|80426578|FG000|Overall Study|Adverse Event|1|||
27503961|NCT03722238|80037939|FG000|Overall Study|Other|4|||
27503962|NCT03722238|80037940|FG001|Overall Study|Other|0|||
27613255|NCT03306043|80426578|FG000|Overall Study|Lost to Follow-up|1|||
27842284|NCT02289820|81251316|FG001|Overall Study|withdrawal of consent|1|||
27842285|NCT02289820|81251317|FG002|Overall Study|withdrawal of consent|0|||
27842286|NCT02289820|81251318|FG003|Overall Study|withdrawal of consent|0|||
27842287|NCT02289820|81251319|FG004|Overall Study|withdrawal of consent|0|||
27842288|NCT02289820|81251320|FG005|Overall Study|withdrawal of consent|0|||
27842289|NCT02289820|81251321|FG006|Overall Study|withdrawal of consent|0|||
27892881|NCT01647516|81441412|FG005|Open-Label Period|Physician Decision|0|||
27892882|NCT01647516|81441407|FG000|Open-Label Period|Withdrawal by Subject|0|||
27892883|NCT01647516|81441408|FG001|Open-Label Period|Withdrawal by Subject|0|||
27892884|NCT01647516|81441409|FG002|Open-Label Period|Withdrawal by Subject|0|||
27503963|NCT03722238|80037939|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
27503964|NCT03722238|80037940|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
27503965|NCT03722238|80037939|FG000|Overall Study|Did not meet risk classification group criteria|90|||
27503966|NCT03722238|80037940|FG001|Overall Study|Did not meet risk classification group criteria|0|||
27503967|NCT03722238|80037939|FG000|Overall Study|Did not sign consent|17|||
27503968|NCT03722238|80037940|FG001|Overall Study|Did not sign consent|0|||
27503969|NCT03722238|80037939|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
27503970|NCT03722238|80037940|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
27503971|NCT03722238|80037939|FG000|Overall Study|Not willing to purchase study medication|142|||
27503972|NCT03722238|80037940|FG001|Overall Study|Not willing to purchase study medication|0|||
27503973|NCT03722238|80037939|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
27503974|NCT03722238|80037940|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
27503975|NCT00687193|80037943|FG000|Overall Study|Adverse Event|0|||
27503976|NCT00687193|80037944|FG001|Overall Study|Adverse Event|1|||
27503977|NCT00687193|80037945|FG002|Overall Study|Adverse Event|2|||
27503978|NCT00687193|80037946|FG003|Overall Study|Adverse Event|3|||
27503979|NCT00687193|80037947|FG004|Overall Study|Adverse Event|0|||
27503980|NCT00687193|80037948|FG005|Overall Study|Adverse Event|2|||
27503981|NCT00687193|80037943|FG000|Overall Study|Lack of Efficacy|1|||
27503982|NCT00687193|80037944|FG001|Overall Study|Lack of Efficacy|1|||
27503983|NCT00687193|80037945|FG002|Overall Study|Lack of Efficacy|0|||
27503984|NCT00687193|80037946|FG003|Overall Study|Lack of Efficacy|0|||
27503985|NCT00687193|80037947|FG004|Overall Study|Lack of Efficacy|0|||
27613256|NCT03306043|80426578|FG000|Overall Study|Withdrawal by Subject|2|||
27842290|NCT01899326|81251322|FG000|Overall Study|Withdrawal by Subject|1|||
27842291|NCT01899326|81251322|FG000|Overall Study|Adverse Event|2|||
27842292|NCT01899326|81251322|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
27503986|NCT00687193|80037948|FG005|Overall Study|Lack of Efficacy|2|||
27842293|NCT04099641|81251327|FG000|Overall Study|Death|46|||
27842294|NCT04099641|81251328|FG001|Overall Study|Death|12|||
27842295|NCT04099641|81251327|FG000|Overall Study|Lost to Follow-up|1|||
27842296|NCT04099641|81251328|FG001|Overall Study|Lost to Follow-up|0|||
27842297|NCT04099641|81251327|FG000|Overall Study|Withdrawal by Subject|2|||
27842298|NCT04099641|81251328|FG001|Overall Study|Withdrawal by Subject|0|||
27842299|NCT00271024|81251329|FG000|Overall Study|Lost Interest|3|||
27842300|NCT00271024|81251330|FG001|Overall Study|Lost Interest|4|||
27842301|NCT00271024|81251331|FG002|Overall Study|Lost Interest|2|||
27503987|NCT00687193|80037943|FG000|Overall Study|Protocol Violation|1|||
27503988|NCT00687193|80037944|FG001|Overall Study|Protocol Violation|2|||
27503989|NCT00687193|80037945|FG002|Overall Study|Protocol Violation|0|||
27503990|NCT00687193|80037946|FG003|Overall Study|Protocol Violation|1|||
27503991|NCT00687193|80037947|FG004|Overall Study|Protocol Violation|2|||
27503992|NCT00687193|80037948|FG005|Overall Study|Protocol Violation|0|||
27503993|NCT00425269|80037949|FG000|Overall Study|Pregnancy|5|||
27503994|NCT00425269|80037950|FG001|Overall Study|Pregnancy|7|||
27613257|NCT00993317|80426579|FG000|Overall Study|Adverse Event|2|||
27613258|NCT00993317|80426580|FG001|Overall Study|Adverse Event|4|||
27613259|NCT00993317|80426579|FG000|Overall Study|Lack of Efficacy|18|||
27613260|NCT00993317|80426580|FG001|Overall Study|Lack of Efficacy|18|||
27503995|NCT00425269|80037949|FG000|Overall Study|Lost to Follow-up|9|||
27503996|NCT00425269|80037950|FG001|Overall Study|Lost to Follow-up|9|||
27503997|NCT00425269|80037949|FG000|Overall Study|moved or medical reason|5|||
27503998|NCT00425269|80037950|FG001|Overall Study|moved or medical reason|4|||
27503999|NCT02345070|80037951|FG000|Overall Study|Adverse Event|12|||
27504000|NCT02345070|80037952|FG001|Overall Study|Adverse Event|8|||
27504001|NCT02345070|80037953|FG002|Overall Study|Adverse Event|16|||
27504002|NCT02345070|80037951|FG000|Overall Study|Poor compliance to protocol|2|||
27504003|NCT02345070|80037952|FG001|Overall Study|Poor compliance to protocol|0|||
27504004|NCT02345070|80037953|FG002|Overall Study|Poor compliance to protocol|0|||
27504005|NCT02345070|80037951|FG000|Overall Study|Other than specified above|6|||
27504006|NCT02345070|80037952|FG001|Overall Study|Other than specified above|3|||
27504007|NCT02345070|80037953|FG002|Overall Study|Other than specified above|7|||
27504008|NCT00089297|80037962|FG000|Overall Study|Adverse Event|9|||
27504009|NCT00089297|80037962|FG000|Overall Study|Death|1|||
27504010|NCT00089297|80037962|FG000|Overall Study|Withdrawal by Subject|12|||
27504011|NCT00089297|80037962|FG000|Overall Study|Disease progression|2|||
27504012|NCT00089297|80037962|FG000|Overall Study|Ineligible|11|||
27504013|NCT00089297|80037962|FG000|Overall Study|Secondary malignancy|1|||
27504014|NCT00089297|80037962|FG000|Overall Study|IRB approval not ready|1|||
27504015|NCT00089297|80037962|FG000|Overall Study|Non-compliance|1|||
27613261|NCT00993317|80426579|FG000|Overall Study|Withdrawal by Subject|0|||
27613262|NCT00993317|80426580|FG001|Overall Study|Withdrawal by Subject|2|||
27613263|NCT00993317|80426579|FG000|Overall Study|Investigator's opinion|0|||
27613264|NCT00993317|80426580|FG001|Overall Study|Investigator's opinion|1|||
27613265|NCT00993317|80426579|FG000|Overall Study|Early study termination at the site|1|||
27613266|NCT00993317|80426580|FG001|Overall Study|Early study termination at the site|0|||
27613267|NCT02572817|80426602|FG000|Overall Study|Death|6|||
27613268|NCT02572817|80426603|FG001|Overall Study|Death|3|||
27613269|NCT02572817|80426602|FG000|Overall Study|Lost to Follow-up|3|||
27613270|NCT02572817|80426603|FG001|Overall Study|Lost to Follow-up|3|||
27613271|NCT01830881|80426604|FG000|Overall Study|Changed decision to have an abortion|0|||
27613272|NCT01830881|80426605|FG001|Overall Study|Changed decision to have an abortion|1|||
27613273|NCT01448044|80426606|FG000|Treatment Period|Adverse Event|4|||
27613274|NCT01448044|80426607|FG001|Treatment Period|Adverse Event|3|||
27613275|NCT01448044|80426606|FG000|Treatment Period|Lack of Efficacy|5|||
27613276|NCT01448044|80426607|FG001|Treatment Period|Lack of Efficacy|12|||
27504016|NCT01131507|80037967|FG000|Overall Study|Adverse Event|1|||
27504017|NCT01131507|80037967|FG000|Overall Study|Lost to Follow-up|1|||
27504018|NCT01131507|80037967|FG000|Overall Study|Withdrawal by Subject|1|||
27504019|NCT03413891|80037972|FG000|Overall Study|Lost to Follow-up|2|||
27613277|NCT01448044|80426606|FG000|Treatment Period|Subject requested discontinue study drug|1|||
27613278|NCT01448044|80426607|FG001|Treatment Period|Subject requested discontinue study drug|0|||
27613279|NCT01448044|80426606|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
27724354|NCT01790503|80822998|FG001|Overall Study|Adverse Event|0|||
27842302|NCT00271024|81251332|FG003|Overall Study|Lost Interest|3|||
27504020|NCT03413891|80037973|FG001|Overall Study|Lost to Follow-up|1|||
27842303|NCT00271024|81251329|FG000|Overall Study|Unknown/Unspecified|11|||
27842304|NCT00271024|81251330|FG001|Overall Study|Unknown/Unspecified|11|||
27842305|NCT00271024|81251331|FG002|Overall Study|Unknown/Unspecified|8|||
27842306|NCT00271024|81251332|FG003|Overall Study|Unknown/Unspecified|4|||
27842307|NCT00271024|81251329|FG000|Overall Study|Protocol Violation|1|||
27842308|NCT00271024|81251330|FG001|Overall Study|Protocol Violation|6|||
27842309|NCT00271024|81251331|FG002|Overall Study|Protocol Violation|5|||
27842310|NCT00271024|81251332|FG003|Overall Study|Protocol Violation|11|||
27842311|NCT00271024|81251329|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
27842312|NCT00271024|81251330|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
27842313|NCT00271024|81251331|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
27842314|NCT00271024|81251332|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
27842315|NCT00271024|81251329|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
27842316|NCT00271024|81251330|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
27842317|NCT00271024|81251331|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
27842318|NCT00271024|81251332|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
27842319|NCT01463982|81251337|FG000|Overall Study|Withdrawal by Subject|0|||
27504021|NCT03413891|80037972|FG000|Overall Study|Protocol Violation|0|||
27504022|NCT03413891|80037973|FG001|Overall Study|Protocol Violation|1|||
27504023|NCT04314284|80037974|FG000|Overall Study|Withdrawal by Subject|4|||
27724355|NCT01790503|80822999|FG002|Overall Study|Adverse Event|0|||
27724356|NCT01790503|80823000|FG003|Overall Study|Adverse Event|0|||
27724357|NCT01790503|80823001|FG004|Overall Study|Adverse Event|0|||
27724358|NCT01790503|80823002|FG005|Overall Study|Adverse Event|2|||
27724359|NCT01790503|80823003|FG006|Overall Study|Adverse Event|0|||
27724360|NCT01790503|80823004|FG007|Overall Study|Adverse Event|0|||
27724361|NCT01790503|80823005|FG008|Overall Study|Adverse Event|2|||
27724362|NCT01790503|80823006|FG009|Overall Study|Adverse Event|4|||
27724363|NCT01790503|80823007|FG010|Overall Study|Adverse Event|7|||
27724364|NCT01790503|80822997|FG000|Overall Study|Withdrawal by Subject|0|||
27724365|NCT01790503|80822998|FG001|Overall Study|Withdrawal by Subject|0|||
27724366|NCT01790503|80822999|FG002|Overall Study|Withdrawal by Subject|1|||
27724367|NCT01790503|80823000|FG003|Overall Study|Withdrawal by Subject|1|||
27724368|NCT01790503|80823001|FG004|Overall Study|Withdrawal by Subject|1|||
27724369|NCT01790503|80823002|FG005|Overall Study|Withdrawal by Subject|2|||
27724370|NCT01790503|80823003|FG006|Overall Study|Withdrawal by Subject|1|||
27724371|NCT01790503|80823004|FG007|Overall Study|Withdrawal by Subject|0|||
27724372|NCT01790503|80823005|FG008|Overall Study|Withdrawal by Subject|0|||
27724373|NCT01790503|80823006|FG009|Overall Study|Withdrawal by Subject|0|||
27724374|NCT01790503|80823007|FG010|Overall Study|Withdrawal by Subject|1|||
27724375|NCT01790503|80822997|FG000|Overall Study|Disease progression|2|||
27724376|NCT01790503|80822998|FG001|Overall Study|Disease progression|1|||
27724377|NCT01790503|80822999|FG002|Overall Study|Disease progression|0|||
27724378|NCT01790503|80823000|FG003|Overall Study|Disease progression|1|||
27724379|NCT01790503|80823001|FG004|Overall Study|Disease progression|2|||
27724380|NCT01790503|80823002|FG005|Overall Study|Disease progression|1|||
27724381|NCT01790503|80823003|FG006|Overall Study|Disease progression|0|||
27724382|NCT01790503|80823004|FG007|Overall Study|Disease progression|1|||
27724383|NCT01790503|80823005|FG008|Overall Study|Disease progression|0|||
27724384|NCT01790503|80823006|FG009|Overall Study|Disease progression|17|||
27724385|NCT01790503|80823007|FG010|Overall Study|Disease progression|7|||
27724386|NCT01790503|80822997|FG000|Overall Study|Protocol Violation|0|||
27504024|NCT04314284|80037975|FG001|Overall Study|Withdrawal by Subject|7|||
27504025|NCT04314284|80037974|FG000|Overall Study|Consented but did not complete survey|0|||
27504026|NCT04314284|80037975|FG001|Overall Study|Consented but did not complete survey|6|||
27504027|NCT00394095|80037978|FG000|Overall Study|Adverse Event|1|||
27504028|NCT00394095|80037979|FG001|Overall Study|Adverse Event|0|||
27504029|NCT01063751|80037980|FG000|Overall Study|Site terminated|45|||
27504030|NCT01063751|80037980|FG000|Overall Study|Lost to Follow-up|28|||
27504031|NCT01063751|80037980|FG000|Overall Study|Withdrawal by Subject|25|||
27504032|NCT01063751|80037980|FG000|Overall Study|Revision|6|||
27504033|NCT01063751|80037980|FG000|Overall Study|Death|12|||
27504034|NCT01063751|80037980|FG000|Overall Study|Physician Decision|4|||
27504035|NCT01063751|80037980|FG000|Overall Study|Active|91|||
27504036|NCT01980017|80037984|FG000|Overall Study|Lost to Follow-up|30|||
27504037|NCT01980017|80037985|FG001|Overall Study|Lost to Follow-up|21|||
27504038|NCT01980017|80037984|FG000|Overall Study|Death|0|||
27504039|NCT01980017|80037985|FG001|Overall Study|Death|1|||
27504040|NCT00453206|80037986|FG000|Overall Study|Death|1|||
27504041|NCT00904982|80037998|FG000|Overall Study|Withdrawal by Subject|2|||
27504042|NCT00904982|80037999|FG001|Overall Study|Withdrawal by Subject|0|||
27504043|NCT00904982|80038000|FG002|Overall Study|Withdrawal by Subject|0|||
27504044|NCT00904982|80038001|FG003|Overall Study|Withdrawal by Subject|0|||
27504045|NCT00966654|80038002|FG000|Overall Study|Study was terminated,PI left institution|12|||
27504046|NCT01499940|80038003|FG000|Overall Study|Study was withdrawn before completion.|9|||
27504047|NCT00926237|80038009|FG000|Overall Study|Withdrawal by Subject|2|||
27613280|NCT01448044|80426607|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
27613281|NCT01448044|80426606|FG000|Treatment Period|Participant does not meet study criteria|1|||
27613282|NCT01448044|80426607|FG001|Treatment Period|Participant does not meet study criteria|0|||
27613283|NCT01448044|80426606|FG000|Treatment Period|Lost to Follow-up|2|||
27613284|NCT01448044|80426607|FG001|Treatment Period|Lost to Follow-up|1|||
27613285|NCT01448044|80426606|FG000|Treatment Period|Other reason|2|||
27613286|NCT01448044|80426607|FG001|Treatment Period|Other reason|0|||
27613287|NCT01448044|80426606|FG000|Follow Up Period|Withdrawal by Subject|1|||
27613288|NCT01448044|80426607|FG001|Follow Up Period|Withdrawal by Subject|1|||
27613289|NCT01448044|80426606|FG000|Follow Up Period|Lost to Follow-up|6|||
27613290|NCT01448044|80426607|FG001|Follow Up Period|Lost to Follow-up|2|||
27613291|NCT01448044|80426606|FG000|Follow Up Period|Other|5|||
27613292|NCT01448044|80426607|FG001|Follow Up Period|Other|11|||
27613293|NCT01077362|80426608|FG000|Overall Study|Lack of Efficacy|13|||
27613294|NCT01077362|80426609|FG001|Overall Study|Lack of Efficacy|8|||
27613295|NCT01077362|80426610|FG002|Overall Study|Lack of Efficacy|10|||
27892885|NCT01647516|81441410|FG003|Open-Label Period|Withdrawal by Subject|9|||
27504048|NCT00926237|80038010|FG001|Overall Study|Withdrawal by Subject|1|||
27504049|NCT00910650|80038011|FG000|Overall Study|Death|2|||
27613296|NCT01077362|80426608|FG000|Overall Study|Lost to Follow-up|1|||
27613297|NCT01077362|80426609|FG001|Overall Study|Lost to Follow-up|0|||
27613298|NCT01077362|80426610|FG002|Overall Study|Lost to Follow-up|3|||
27613299|NCT01077362|80426608|FG000|Overall Study|Adverse Event|12|||
27613300|NCT01077362|80426609|FG001|Overall Study|Adverse Event|7|||
27613301|NCT01077362|80426610|FG002|Overall Study|Adverse Event|4|||
27613302|NCT01077362|80426608|FG000|Overall Study|Withdrawal by Subject|5|||
27613303|NCT01077362|80426609|FG001|Overall Study|Withdrawal by Subject|3|||
27613304|NCT01077362|80426610|FG002|Overall Study|Withdrawal by Subject|5|||
27724387|NCT01790503|80822998|FG001|Overall Study|Protocol Violation|0|||
27842320|NCT01463982|81251338|FG001|Overall Study|Withdrawal by Subject|1|||
27842321|NCT01463982|81251339|FG002|Overall Study|Withdrawal by Subject|1|||
27842322|NCT01463982|81251340|FG003|Overall Study|Withdrawal by Subject|0|||
27842323|NCT01463982|81251337|FG000|Overall Study|Treatment delay over 5 week|0|||
27842324|NCT01463982|81251338|FG001|Overall Study|Treatment delay over 5 week|0|||
27842325|NCT01463982|81251339|FG002|Overall Study|Treatment delay over 5 week|1|||
27842326|NCT01463982|81251340|FG003|Overall Study|Treatment delay over 5 week|0|||
27842327|NCT00749411|81251341|FG000|Overall Study|Adverse Event|0|||
27842328|NCT00749411|81251342|FG001|Overall Study|Adverse Event|2|||
27842329|NCT00749411|81251341|FG000|Overall Study|Lack of Efficacy|0|||
27842330|NCT00749411|81251342|FG001|Overall Study|Lack of Efficacy|1|||
27842331|NCT00749411|81251341|FG000|Overall Study|Protocol Violation|1|||
27842332|NCT00749411|81251342|FG001|Overall Study|Protocol Violation|1|||
27842333|NCT00749411|81251341|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27842334|NCT00749411|81251342|FG001|Overall Study|Protocol-defined stopping criteria|1|||
27842335|NCT01896505|81251343|FG000|Overall Study|Adverse Event|1|||
27842336|NCT01896505|81251344|FG001|Overall Study|Adverse Event|0|||
27842337|NCT01896505|81251345|FG002|Overall Study|Adverse Event|2|||
27613305|NCT01077362|80426608|FG000|Overall Study|Other|0|||
27613306|NCT01077362|80426609|FG001|Overall Study|Other|1|||
27613307|NCT01077362|80426610|FG002|Overall Study|Other|2|||
27613308|NCT00557622|80426611|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
27842338|NCT01896505|81251346|FG003|Overall Study|Adverse Event|1|||
27504050|NCT00914849|80038012|FG000|Overall Study|Withdrawal by Subject|1|||
27724388|NCT01790503|80822999|FG002|Overall Study|Protocol Violation|0|||
27724389|NCT01790503|80823000|FG003|Overall Study|Protocol Violation|0|||
27724390|NCT01790503|80823001|FG004|Overall Study|Protocol Violation|0|||
27724391|NCT01790503|80823002|FG005|Overall Study|Protocol Violation|0|||
27724392|NCT01790503|80823003|FG006|Overall Study|Protocol Violation|0|||
27724393|NCT01790503|80823004|FG007|Overall Study|Protocol Violation|0|||
27724394|NCT01790503|80823005|FG008|Overall Study|Protocol Violation|0|||
27724395|NCT01790503|80823006|FG009|Overall Study|Protocol Violation|1|||
27724396|NCT01790503|80823007|FG010|Overall Study|Protocol Violation|0|||
27724397|NCT01790503|80822997|FG000|Overall Study|Physician Decision|0|||
27724398|NCT01790503|80822998|FG001|Overall Study|Physician Decision|0|||
27724399|NCT01790503|80822999|FG002|Overall Study|Physician Decision|0|||
27504051|NCT00914849|80038013|FG001|Overall Study|Withdrawal by Subject|0|||
27504052|NCT00914849|80038012|FG000|Overall Study|Not eligible|0|||
27504053|NCT00914849|80038013|FG001|Overall Study|Not eligible|1|||
27504054|NCT04385277|80038014|FG000|Overall Study|Physician Decision|2|||
27504055|NCT04385277|80038014|FG000|Overall Study|Ineligible|1|||
27842339|NCT01896505|81251347|FG004|Overall Study|Adverse Event|1|||
27842340|NCT01896505|81251348|FG005|Overall Study|Adverse Event|0|||
27842341|NCT01896505|81251343|FG000|Overall Study|Physician Decision|1|||
27842342|NCT01896505|81251344|FG001|Overall Study|Physician Decision|3|||
27842343|NCT01896505|81251345|FG002|Overall Study|Physician Decision|2|||
27842344|NCT01896505|81251346|FG003|Overall Study|Physician Decision|0|||
27842345|NCT01896505|81251347|FG004|Overall Study|Physician Decision|0|||
27842346|NCT01896505|81251348|FG005|Overall Study|Physician Decision|1|||
27842347|NCT01896505|81251343|FG000|Overall Study|Withdrawal by Subject|1|||
27842348|NCT01896505|81251344|FG001|Overall Study|Withdrawal by Subject|0|||
27842349|NCT01896505|81251345|FG002|Overall Study|Withdrawal by Subject|3|||
27842350|NCT01896505|81251346|FG003|Overall Study|Withdrawal by Subject|1|||
27842351|NCT01896505|81251347|FG004|Overall Study|Withdrawal by Subject|0|||
27842352|NCT01896505|81251348|FG005|Overall Study|Withdrawal by Subject|0|||
27892886|NCT01647516|81441411|FG004|Open-Label Period|Withdrawal by Subject|11|||
27892887|NCT01647516|81441412|FG005|Open-Label Period|Withdrawal by Subject|6|||
27892888|NCT01647516|81441407|FG000|Open-Label Period|Lost to Follow-up|0|||
27892889|NCT01647516|81441408|FG001|Open-Label Period|Lost to Follow-up|0|||
27892890|NCT01647516|81441409|FG002|Open-Label Period|Lost to Follow-up|0|||
27504056|NCT04385277|80038014|FG000|Overall Study|Patient/Parent Refusal|2|||
27724400|NCT01790503|80823000|FG003|Overall Study|Physician Decision|0|||
27842353|NCT01896505|81251343|FG000|Overall Study|Disease Progression|7|||
27842354|NCT01896505|81251344|FG001|Overall Study|Disease Progression|5|||
27892891|NCT01647516|81441410|FG003|Open-Label Period|Lost to Follow-up|1|||
27504057|NCT00283296|80038026|FG000|Overall Study|in-home trial not completed|5|||
27504058|NCT01527370|80038027|FG000|Overall Study|Withdrawal by Subject|4|||
27504059|NCT01527370|80038027|FG000|Overall Study|Physician Decision|1|||
27504060|NCT01527370|80038027|FG000|Overall Study|Death|1|||
27504061|NCT04123470|80040701|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
27504062|NCT04123470|80040702|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
27504063|NCT04123470|80040701|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
27504064|NCT04123470|80040702|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
27613309|NCT00557622|80426612|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
27504065|NCT04123470|80040701|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
27842355|NCT01896505|81251345|FG002|Overall Study|Disease Progression|8|||
27842356|NCT01896505|81251346|FG003|Overall Study|Disease Progression|4|||
27842357|NCT01896505|81251347|FG004|Overall Study|Disease Progression|4|||
27842358|NCT01896505|81251348|FG005|Overall Study|Disease Progression|4|||
27892892|NCT01647516|81441411|FG004|Open-Label Period|Lost to Follow-up|0|||
27613310|NCT00557622|80426611|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
27724401|NCT01790503|80823001|FG004|Overall Study|Physician Decision|0|||
27724402|NCT01790503|80823002|FG005|Overall Study|Physician Decision|0|||
27724403|NCT01790503|80823003|FG006|Overall Study|Physician Decision|0|||
27613311|NCT00557622|80426612|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
27613312|NCT00557622|80426611|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
27613313|NCT00557622|80426612|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
27613314|NCT00003458|80426613|FG000|Overall Study|Not evaluable|4|||
27613315|NCT03918239|80426614|FG000|Overall Study|Lost to Follow-up|3|||
27613316|NCT03918239|80426615|FG001|Overall Study|Lost to Follow-up|1|||
27724404|NCT01790503|80823004|FG007|Overall Study|Physician Decision|0|||
27724405|NCT01790503|80823005|FG008|Overall Study|Physician Decision|0|||
27504066|NCT04123470|80040702|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
27504067|NCT04123470|80040701|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
27504068|NCT04123470|80040702|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
27504069|NCT02129699|80040703|FG000|Overall Study|Did not start treatment|3|||
27504070|NCT02129699|80040704|FG001|Overall Study|Did not start treatment|2|||
27504071|NCT00651742|80040707|FG000|Overall Study|Objective Disease Progression|22|||
27504072|NCT00651742|80040707|FG000|Overall Study|Toxicity|3|||
27504073|NCT00651742|80040707|FG000|Overall Study|Investigator Judgment|1|||
27504074|NCT00651742|80040707|FG000|Overall Study|Withdrawal of Consent|1|||
27504075|NCT00651742|80040707|FG000|Overall Study|Enrolled but not treated|1|||
27504076|NCT02151058|80040708|FG000|Overall Study|Withdrawal by Subject|1|||
27504077|NCT02151058|80040709|FG001|Overall Study|Withdrawal by Subject|1|||
27504078|NCT02151058|80040710|FG002|Overall Study|Withdrawal by Subject|3|||
27504079|NCT02151058|80040708|FG000|Overall Study|Lost to Follow-up|1|||
27504080|NCT02151058|80040709|FG001|Overall Study|Lost to Follow-up|0|||
27504081|NCT02151058|80040710|FG002|Overall Study|Lost to Follow-up|2|||
27504082|NCT00911170|80040711|FG000|Treatment Period|Randomized in error|1|||
27504083|NCT00911170|80040712|FG001|Treatment Period|Randomized in error|1|||
27504084|NCT00911170|80040711|FG000|Treatment Period|Ineligibility determined|1|||
27724406|NCT01790503|80823006|FG009|Overall Study|Physician Decision|1|||
27504085|NCT00911170|80040712|FG001|Treatment Period|Ineligibility determined|3|||
27504086|NCT00911170|80040711|FG000|Treatment Period|Protocol deviation|1|||
27504087|NCT00911170|80040712|FG001|Treatment Period|Protocol deviation|2|||
27613317|NCT03918239|80426614|FG000|Overall Study|Pregnancy|0|||
27613318|NCT03918239|80426615|FG001|Overall Study|Pregnancy|2|||
27724407|NCT01790503|80823007|FG010|Overall Study|Physician Decision|1|||
27842359|NCT01896505|81251343|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
27842360|NCT01896505|81251344|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
27842361|NCT01896505|81251345|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
27842362|NCT01896505|81251346|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
27842363|NCT01896505|81251347|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
27842364|NCT01896505|81251348|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
27842365|NCT01896505|81251343|FG000|Overall Study|Intercurrent illness|0|||
27842366|NCT01896505|81251344|FG001|Overall Study|Intercurrent illness|1|||
27842367|NCT01896505|81251345|FG002|Overall Study|Intercurrent illness|0|||
27842368|NCT01896505|81251346|FG003|Overall Study|Intercurrent illness|0|||
27842369|NCT01896505|81251347|FG004|Overall Study|Intercurrent illness|0|||
27842370|NCT01896505|81251348|FG005|Overall Study|Intercurrent illness|0|||
27842371|NCT01896505|81251343|FG000|Overall Study|Death|0|||
27842372|NCT01896505|81251344|FG001|Overall Study|Death|0|||
27842373|NCT01896505|81251345|FG002|Overall Study|Death|1|||
27842374|NCT01896505|81251346|FG003|Overall Study|Death|1|||
27842375|NCT01896505|81251347|FG004|Overall Study|Death|0|||
27842376|NCT01896505|81251348|FG005|Overall Study|Death|1|||
27842377|NCT00557245|81251350|FG000|Overall Study|Lost to Follow-up|7|||
27613319|NCT03918239|80426614|FG000|Overall Study|Withdrawal by Subject|3|||
27613320|NCT03918239|80426615|FG001|Overall Study|Withdrawal by Subject|3|||
27613321|NCT03918239|80426614|FG000|Overall Study|positive urine drug screening results|4|||
27613322|NCT03918239|80426615|FG001|Overall Study|positive urine drug screening results|1|||
27613323|NCT01130883|80426616|FG000|Overall Study|Patient Noncompliance|6|||
27613324|NCT01130883|80426616|FG000|Overall Study|Reason Unknown|1|||
27724408|NCT01790503|80822997|FG000|Overall Study|Death|0|||
27724409|NCT01790503|80822998|FG001|Overall Study|Death|0|||
27842378|NCT00557245|81251351|FG001|Overall Study|Lost to Follow-up|8|||
27842379|NCT00557245|81251352|FG002|Overall Study|Lost to Follow-up|10|||
27842380|NCT00557245|81251350|FG000|Overall Study|Ineligible|5|||
27842381|NCT00557245|81251351|FG001|Overall Study|Ineligible|4|||
27842382|NCT00557245|81251352|FG002|Overall Study|Ineligible|2|||
27842383|NCT02260635|81251353|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
27842384|NCT02260635|81251354|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
27842385|NCT02260635|81251353|FG000|Open-Label Extension|Study Termination|25|||
27842386|NCT02260635|81251354|FG001|Open-Label Extension|Study Termination|25|||
27842387|NCT02260635|81251353|FG000|Open-Label Extension|Withdrawal by Subject|1|||
27613325|NCT01130883|80426616|FG000|Overall Study|Adverse Event|3|||
27613326|NCT00917267|80426617|FG000|Overall Study|Adverse Event|15|||
27613327|NCT00917267|80426618|FG001|Overall Study|Adverse Event|36|||
27613328|NCT00917267|80426617|FG000|Overall Study|Physician Decision|2|||
27613329|NCT00917267|80426618|FG001|Overall Study|Physician Decision|4|||
27613330|NCT00917267|80426617|FG000|Overall Study|Protocol Violation|9|||
27613331|NCT00917267|80426618|FG001|Overall Study|Protocol Violation|18|||
27613332|NCT00917267|80426617|FG000|Overall Study|Withdrawal by Subject|5|||
27842388|NCT02260635|81251354|FG001|Open-Label Extension|Withdrawal by Subject|0|||
27842389|NCT01439724|81251355|FG000|Overall Study|missing consultation|9|||
27842390|NCT01439724|81251356|FG001|Overall Study|missing consultation|8|||
27842391|NCT01622660|81251357|FG000|Overall Study|Adverse Event|1|||
27842392|NCT00857818|81251364|FG000|Overall Study|Lack of Efficacy|1|||
27842393|NCT00857818|81251365|FG001|Overall Study|Lack of Efficacy|0|||
27613333|NCT00917267|80426618|FG001|Overall Study|Withdrawal by Subject|12|||
27724410|NCT01790503|80822999|FG002|Overall Study|Death|0|||
27842394|NCT00857818|81251364|FG000|Overall Study|Adverse Event|3|||
27842395|NCT00857818|81251365|FG001|Overall Study|Adverse Event|0|||
27842396|NCT00857818|81251364|FG000|Overall Study|Withdrawal by Subject|0|||
27842397|NCT00857818|81251365|FG001|Overall Study|Withdrawal by Subject|4|||
27842398|NCT00857818|81251364|FG000|Overall Study|Sponsor terminated study|6|||
27504088|NCT00911170|80040711|FG000|Treatment Period|Adverse Event|9|||
27504089|NCT00911170|80040712|FG001|Treatment Period|Adverse Event|10|||
27504090|NCT00911170|80040711|FG000|Treatment Period|Withdrawal by Subject|4|||
27504091|NCT00911170|80040712|FG001|Treatment Period|Withdrawal by Subject|4|||
27504092|NCT00911170|80040711|FG000|Treatment Period|Disease progression|0|||
27504093|NCT00911170|80040712|FG001|Treatment Period|Disease progression|2|||
27504094|NCT00911170|80040711|FG000|Treatment Period|Physician Decision|5|||
27504095|NCT00911170|80040712|FG001|Treatment Period|Physician Decision|5|||
27504096|NCT00911170|80040711|FG000|Treatment Period|Lost to Follow-up|0|||
27504097|NCT00911170|80040712|FG001|Treatment Period|Lost to Follow-up|1|||
27504098|NCT00911170|80040711|FG000|Treatment Period|Death|6|||
27504099|NCT00911170|80040712|FG001|Treatment Period|Death|9|||
27504100|NCT00911170|80040711|FG000|Long Term Follow-Up|Continuing in study|274|||
27504101|NCT00911170|80040712|FG001|Long Term Follow-Up|Continuing in study|269|||
27504102|NCT00911170|80040711|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
27504103|NCT00911170|80040712|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
27504104|NCT00911170|80040711|FG000|Long Term Follow-Up|Physician Decision|5|||
27504105|NCT00911170|80040712|FG001|Long Term Follow-Up|Physician Decision|4|||
27504106|NCT00911170|80040711|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
27504107|NCT00911170|80040712|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
27504108|NCT00911170|80040711|FG000|Long Term Follow-Up|Death|116|||
27504109|NCT00911170|80040712|FG001|Long Term Follow-Up|Death|121|||
27504110|NCT01615939|80040715|FG000|Overall Study|Lost to Follow-up|5|||
27504111|NCT01615939|80040716|FG001|Overall Study|Lost to Follow-up|0|||
27504112|NCT03011099|80040717|FG000|Overall Study|Withdrawal by Subject|0|||
27504113|NCT03011099|80040718|FG001|Overall Study|Withdrawal by Subject|2|||
27504114|NCT02072668|80040719|FG000|Second Intervention|Lost to Follow-up|1|||
27504115|NCT02072668|80040720|FG001|Second Intervention|Lost to Follow-up|0|||
27504116|NCT00474487|80040721|FG000|Overall Study|Withdrawal by Subject|6|||
27504117|NCT00474487|80040722|FG001|Overall Study|Withdrawal by Subject|0|||
27842399|NCT00857818|81251365|FG001|Overall Study|Sponsor terminated study|4|||
27842400|NCT00857818|81251364|FG000|Overall Study|Investigator decision|1|||
27842401|NCT00857818|81251365|FG001|Overall Study|Investigator decision|0|||
27842402|NCT02999984|81251366|FG000|Overall Study|Treatment Failure|1|||
27842403|NCT02966340|81251367|FG000|Overall Study|Adverse Event|0|||
27842404|NCT02966340|81251368|FG001|Overall Study|Adverse Event|1|||
27842405|NCT02966340|81251367|FG000|Overall Study|Lost to Follow-up|0|||
27842406|NCT02966340|81251368|FG001|Overall Study|Lost to Follow-up|1|||
27842407|NCT02966340|81251367|FG000|Overall Study|Withdrawal by Subject|1|||
27504118|NCT00474487|80040723|FG002|Overall Study|Withdrawal by Subject|0|||
27504119|NCT00474487|80040724|FG003|Overall Study|Withdrawal by Subject|0|||
27504120|NCT00474487|80040721|FG000|Overall Study|Lost to Follow-up|20|||
27504121|NCT00474487|80040722|FG001|Overall Study|Lost to Follow-up|1|||
27504122|NCT00474487|80040723|FG002|Overall Study|Lost to Follow-up|7|||
27504123|NCT00474487|80040724|FG003|Overall Study|Lost to Follow-up|0|||
27504124|NCT00474487|80040721|FG000|Overall Study|Inappropriate enrollment|4|||
27842408|NCT02966340|81251368|FG001|Overall Study|Withdrawal by Subject|0|||
27842409|NCT02966340|81251367|FG000|Overall Study|data acquisition error|1|||
27842410|NCT02966340|81251368|FG001|Overall Study|data acquisition error|0|||
27842411|NCT02966340|81251367|FG000|Overall Study|startle non-responder|1|||
27842412|NCT02966340|81251368|FG001|Overall Study|startle non-responder|1|||
27842413|NCT02093923|81251369|FG000|Overall Study|Lost to Follow-up|0|||
27842414|NCT02093923|81251370|FG001|Overall Study|Lost to Follow-up|0|||
27842415|NCT02093923|81251371|FG002|Overall Study|Lost to Follow-up|0|||
27613334|NCT00917267|80426617|FG000|Overall Study|Lost to follow up|0|||
27613335|NCT00917267|80426618|FG001|Overall Study|Lost to follow up|2|||
27613336|NCT00917267|80426617|FG000|Overall Study|Entry Criteria Not Met|1|||
27613337|NCT00917267|80426618|FG001|Overall Study|Entry Criteria Not Met|0|||
27613338|NCT00917267|80426617|FG000|Overall Study|Sponsor Decision|5|||
27613339|NCT00917267|80426618|FG001|Overall Study|Sponsor Decision|5|||
27613340|NCT00917267|80426617|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
27613341|NCT00917267|80426618|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
27613342|NCT02038764|80426619|FG000|Overall Study|Adverse Event|0|||
27613343|NCT02038764|80426620|FG001|Overall Study|Adverse Event|0|||
27613344|NCT02038764|80426621|FG002|Overall Study|Adverse Event|1|||
27613345|NCT02038764|80426622|FG003|Overall Study|Adverse Event|0|||
27613346|NCT02038764|80426623|FG004|Overall Study|Adverse Event|0|||
27613347|NCT02038764|80426619|FG000|Overall Study|Lost to Follow-up|0|||
27613348|NCT02038764|80426620|FG001|Overall Study|Lost to Follow-up|1|||
27613349|NCT02038764|80426621|FG002|Overall Study|Lost to Follow-up|0|||
27613350|NCT02038764|80426622|FG003|Overall Study|Lost to Follow-up|0|||
27613351|NCT02038764|80426623|FG004|Overall Study|Lost to Follow-up|0|||
27613352|NCT02038764|80426619|FG000|Overall Study|Withdrawal by Subject|0|||
27613353|NCT02038764|80426620|FG001|Overall Study|Withdrawal by Subject|0|||
27613354|NCT02038764|80426621|FG002|Overall Study|Withdrawal by Subject|0|||
27613355|NCT02038764|80426622|FG003|Overall Study|Withdrawal by Subject|0|||
27613356|NCT02038764|80426623|FG004|Overall Study|Withdrawal by Subject|1|||
27613357|NCT02038764|80426619|FG000|Overall Study|Other|1|||
27613358|NCT02038764|80426620|FG001|Overall Study|Other|0|||
27613359|NCT02038764|80426621|FG002|Overall Study|Other|1|||
27613360|NCT02038764|80426622|FG003|Overall Study|Other|0|||
27613361|NCT02038764|80426623|FG004|Overall Study|Other|0|||
27613362|NCT03204695|80426626|FG000|Overall Study|Death|1|||
27613363|NCT03204695|80426626|FG000|Overall Study|Participant was treated with another device|1|||
27613364|NCT03204695|80426626|FG000|Overall Study|Physician Decision|2|||
27613365|NCT00867490|80426630|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
27613366|NCT00867490|80426630|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
27613367|NCT00867490|80426630|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
27613368|NCT00867490|80426630|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
27613369|NCT00867490|80426630|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
27613370|NCT05764239|80426641|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
27613371|NCT05764239|80426641|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
27613372|NCT05764239|80426641|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
27613373|NCT05764239|80426641|FG000|DEP (Part 1)|Adverse Event|1|||
27613374|NCT05764239|80426641|FG000|DEP (Part 1)|Lost to Follow-up|1|||
27613375|NCT05764239|80426641|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
27613376|NCT05764239|80426641|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
27613377|NCT05764239|80426641|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
27613378|NCT05764239|80426641|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
27613379|NCT01651936|80426642|FG000|Base Study|Adverse Event|3|||
27613380|NCT01651936|80426643|FG001|Base Study|Adverse Event|0|||
27613381|NCT01651936|80426644|FG002|Base Study|Adverse Event|0|||
27613382|NCT01651936|80426642|FG000|Base Study|Withdrawal by Subject|1|||
27613383|NCT01651936|80426643|FG001|Base Study|Withdrawal by Subject|1|||
27613384|NCT01651936|80426644|FG002|Base Study|Withdrawal by Subject|0|||
27613385|NCT01651936|80426642|FG000|Base Study|Early Escape|2|||
27613386|NCT01651936|80426643|FG001|Base Study|Early Escape|8|||
27842416|NCT02093923|81251372|FG003|Overall Study|Lost to Follow-up|1|||
27613387|NCT01651936|80426644|FG002|Base Study|Early Escape|0|||
27613388|NCT01651936|80426642|FG000|Base Study|Study terminated by sponsor|21|||
27613389|NCT01651936|80426643|FG001|Base Study|Study terminated by sponsor|16|||
27842417|NCT02093923|81251373|FG004|Overall Study|Lost to Follow-up|0|||
27613390|NCT01651936|80426644|FG002|Base Study|Study terminated by sponsor|0|||
27613391|NCT01651936|80426642|FG000|Extension Study|Lack of Efficacy|0|||
27613392|NCT01651936|80426643|FG001|Extension Study|Lack of Efficacy|0|||
27613393|NCT01651936|80426644|FG002|Extension Study|Lack of Efficacy|1|||
27613394|NCT01651936|80426642|FG000|Extension Study|Study terminated by sponsor|0|||
27613395|NCT01651936|80426643|FG001|Extension Study|Study terminated by sponsor|0|||
27724411|NCT01790503|80823000|FG003|Overall Study|Death|0|||
27892893|NCT01647516|81441412|FG005|Open-Label Period|Lost to Follow-up|1|||
27892894|NCT01647516|81441407|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
27892895|NCT01647516|81441408|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
27892896|NCT01647516|81441409|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
27892897|NCT01647516|81441410|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
27892898|NCT01647516|81441411|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
27892899|NCT01647516|81441412|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
27892900|NCT01647516|81441407|FG000|Open-Label Period|Lack of Efficacy|0|||
27892901|NCT01647516|81441408|FG001|Open-Label Period|Lack of Efficacy|0|||
27892902|NCT01647516|81441409|FG002|Open-Label Period|Lack of Efficacy|0|||
27892903|NCT01647516|81441410|FG003|Open-Label Period|Lack of Efficacy|7|||
27892904|NCT01647516|81441411|FG004|Open-Label Period|Lack of Efficacy|9|||
27892905|NCT01647516|81441412|FG005|Open-Label Period|Lack of Efficacy|10|||
27892906|NCT01647516|81441407|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
27892907|NCT01647516|81441408|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
27892908|NCT01647516|81441409|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
27892909|NCT01647516|81441410|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
27892910|NCT01647516|81441411|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
27892911|NCT01647516|81441412|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
27892912|NCT01647516|81441407|FG000|Open-Label Period|No completion / discontinuation visit|0|||
27504125|NCT00474487|80040722|FG001|Overall Study|Inappropriate enrollment|0|||
27504126|NCT00474487|80040723|FG002|Overall Study|Inappropriate enrollment|7|||
27504127|NCT00474487|80040724|FG003|Overall Study|Inappropriate enrollment|0|||
27504128|NCT00474487|80040721|FG000|Overall Study|Death|0|||
27504129|NCT00474487|80040722|FG001|Overall Study|Death|1|||
27504130|NCT00474487|80040723|FG002|Overall Study|Death|0|||
27504131|NCT00474487|80040724|FG003|Overall Study|Death|0|||
27504132|NCT00371150|80040728|FG000|Overall Study|Lost to Follow-up|3|||
27504133|NCT00371150|80040729|FG001|Overall Study|Lost to Follow-up|2|||
27504134|NCT00830440|80040730|FG000|Overall Study|Protocol Violation|1|||
27504135|NCT00830440|80040731|FG001|Overall Study|Protocol Violation|0|||
27504136|NCT00830440|80040730|FG000|Overall Study|Withdrawal by Subject|1|||
27504137|NCT00830440|80040731|FG001|Overall Study|Withdrawal by Subject|0|||
27504138|NCT00830440|80040730|FG000|Overall Study|unsuccessful procedure|4|||
27504139|NCT00830440|80040731|FG001|Overall Study|unsuccessful procedure|0|||
27504140|NCT00830440|80040730|FG000|Overall Study|Adverse Event|2|||
27504141|NCT00830440|80040731|FG001|Overall Study|Adverse Event|0|||
27504142|NCT04201262|80040732|FG000|Overall Study|Adverse Event|1|||
27504143|NCT04201262|80040733|FG001|Overall Study|Adverse Event|2|||
27504144|NCT04201262|80040732|FG000|Overall Study|Continuing in the study|57|||
27504145|NCT04201262|80040733|FG001|Overall Study|Continuing in the study|0|||
27504146|NCT04201262|80040732|FG000|Overall Study|Withdrawal by Subject|0|||
27504147|NCT04201262|80040733|FG001|Overall Study|Withdrawal by Subject|1|||
27504148|NCT03521570|80040736|FG000|Overall Study|Not eligible|11|||
27504149|NCT00004563|80040737|FG000|Overall Study|Withdrawal by Subject|20|||
27504150|NCT00004563|80040738|FG001|Overall Study|Withdrawal by Subject|16|||
27504151|NCT00004563|80040737|FG000|Overall Study|Lack of Efficacy|3|||
27504152|NCT00004563|80040738|FG001|Overall Study|Lack of Efficacy|5|||
27504153|NCT00004563|80040737|FG000|Overall Study|Death|2|||
27504154|NCT00004563|80040738|FG001|Overall Study|Death|3|||
27504155|NCT00389610|80040743|FG000|Overall Study|Disease Progression|0|||
27504156|NCT00389610|80040744|FG001|Overall Study|Disease Progression|19|||
27504157|NCT00389610|80040743|FG000|Overall Study|Death|0|||
27504158|NCT00389610|80040744|FG001|Overall Study|Death|1|||
27504159|NCT00389610|80040743|FG000|Overall Study|Physician Decision|0|||
27504160|NCT00389610|80040744|FG001|Overall Study|Physician Decision|1|||
27504161|NCT00389610|80040743|FG000|Overall Study|Withdrawal by Subject|0|||
27504162|NCT00389610|80040744|FG001|Overall Study|Withdrawal by Subject|1|||
27504163|NCT04945733|80040746|FG000|Overall Study|Physician Decision|1|||
27504164|NCT04945733|80040747|FG001|Overall Study|Physician Decision|3|||
27504165|NCT04945733|80040748|FG002|Overall Study|Physician Decision|0|||
27504166|NCT04945733|80040746|FG000|Overall Study|Withdrawal by Subject|3|||
27504167|NCT04945733|80040747|FG001|Overall Study|Withdrawal by Subject|3|||
27504168|NCT04945733|80040748|FG002|Overall Study|Withdrawal by Subject|0|||
27504169|NCT04030143|80040751|FG000|Overall Study|Adverse Event|5|||
27504170|NCT04030143|80040752|FG001|Overall Study|Adverse Event|10|||
27504171|NCT04030143|80040751|FG000|Overall Study|Lost to Follow-up|3|||
27504172|NCT04030143|80040752|FG001|Overall Study|Lost to Follow-up|7|||
27504173|NCT04030143|80040751|FG000|Overall Study|Protocol Deviation|2|||
27504174|NCT04030143|80040752|FG001|Overall Study|Protocol Deviation|2|||
27892913|NCT01647516|81441408|FG001|Open-Label Period|No completion / discontinuation visit|0|||
27892914|NCT01647516|81441409|FG002|Open-Label Period|No completion / discontinuation visit|0|||
27892915|NCT01647516|81441410|FG003|Open-Label Period|No completion / discontinuation visit|0|||
27892916|NCT01647516|81441411|FG004|Open-Label Period|No completion / discontinuation visit|2|||
27504175|NCT04030143|80040751|FG000|Overall Study|Withdrawal by Subject|16|||
27613396|NCT01651936|80426644|FG002|Extension Study|Study terminated by sponsor|13|||
27613397|NCT02443103|80426645|FG000|Overall Study|Adverse Event|2|||
27613398|NCT02443103|80426645|FG000|Overall Study|Noncompliance|1|||
27613399|NCT04297241|80426646|FG000|Overall Study|Withdrawal by Subject|1|||
27613400|NCT04297241|80426646|FG000|Overall Study|Adverse Event|1|||
27613401|NCT04297241|80426646|FG000|Overall Study|Physician Decision|3|||
27613402|NCT00895843|80426647|FG000|Overall Study|Protocol Violation|12|||
27613403|NCT00895843|80426648|FG001|Overall Study|Protocol Violation|12|||
27613404|NCT03317379|80426649|FG000|Overall Study|Lost to Follow-up|0|||
27613405|NCT03317379|80426650|FG001|Overall Study|Lost to Follow-up|3|||
27613406|NCT03317379|80426651|FG002|Overall Study|Lost to Follow-up|2|||
27613407|NCT04445155|80426652|FG000|Overall Study|Lost to Follow-up|11|||
27613408|NCT04445155|80426653|FG001|Overall Study|Lost to Follow-up|2|||
27613409|NCT04445155|80426654|FG002|Overall Study|Lost to Follow-up|3|||
27613410|NCT04445155|80426655|FG003|Overall Study|Lost to Follow-up|0|||
27613411|NCT04445155|80426652|FG000|Overall Study|Withdrawal by Subject|8|||
27613412|NCT04445155|80426653|FG001|Overall Study|Withdrawal by Subject|0|||
27613413|NCT04445155|80426654|FG002|Overall Study|Withdrawal by Subject|0|||
27613414|NCT04445155|80426655|FG003|Overall Study|Withdrawal by Subject|0|||
27613415|NCT04445155|80426652|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
27613416|NCT04445155|80426653|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
27613417|NCT04445155|80426654|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
27613418|NCT04445155|80426655|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
27613419|NCT04445155|80426652|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
27613420|NCT04445155|80426653|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
27613421|NCT04445155|80426654|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
27613422|NCT04445155|80426655|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
27613423|NCT02753530|80426658|FG000|Overall Study|Adverse Event|7|||
27613424|NCT02753530|80426659|FG001|Overall Study|Adverse Event|1|||
27613425|NCT02753530|80426658|FG000|Overall Study|Death|0|||
27613426|NCT02753530|80426659|FG001|Overall Study|Death|1|||
27613427|NCT02753530|80426658|FG000|Overall Study|Physician Decision|0|||
27613428|NCT02753530|80426659|FG001|Overall Study|Physician Decision|1|||
27613429|NCT02753530|80426658|FG000|Overall Study|Protocol Violation|1|||
27613430|NCT02753530|80426659|FG001|Overall Study|Protocol Violation|0|||
27613431|NCT02753530|80426658|FG000|Overall Study|Withdrawal by Subject|4|||
27613432|NCT02753530|80426659|FG001|Overall Study|Withdrawal by Subject|3|||
27613433|NCT01807221|80426662|FG000|Overall Study|Progressive disease|1|||
27613434|NCT01807221|80426663|FG001|Overall Study|Progressive disease|0|||
27613435|NCT01807221|80426664|FG002|Overall Study|Progressive disease|1|||
27613436|NCT01807221|80426665|FG003|Overall Study|Progressive disease|0|||
27613437|NCT01807221|80426666|FG004|Overall Study|Progressive disease|0|||
27613438|NCT01807221|80426667|FG005|Overall Study|Progressive disease|0|||
27613439|NCT01807221|80426662|FG000|Overall Study|Death|7|||
27613440|NCT01807221|80426663|FG001|Overall Study|Death|9|||
27613441|NCT01807221|80426664|FG002|Overall Study|Death|4|||
27613442|NCT01807221|80426665|FG003|Overall Study|Death|2|||
27613443|NCT01807221|80426666|FG004|Overall Study|Death|1|||
27613444|NCT01807221|80426667|FG005|Overall Study|Death|6|||
27613445|NCT01807221|80426662|FG000|Overall Study|Physician Decision|2|||
27613446|NCT01807221|80426663|FG001|Overall Study|Physician Decision|1|||
27613447|NCT01807221|80426664|FG002|Overall Study|Physician Decision|0|||
27613448|NCT01807221|80426665|FG003|Overall Study|Physician Decision|0|||
27613449|NCT01807221|80426666|FG004|Overall Study|Physician Decision|0|||
27613450|NCT01807221|80426667|FG005|Overall Study|Physician Decision|0|||
27613451|NCT01807221|80426662|FG000|Overall Study|Adverse Event|33|||
27613452|NCT01807221|80426663|FG001|Overall Study|Adverse Event|22|||
27613453|NCT01807221|80426664|FG002|Overall Study|Adverse Event|26|||
27613454|NCT01807221|80426665|FG003|Overall Study|Adverse Event|25|||
27613455|NCT01807221|80426666|FG004|Overall Study|Adverse Event|18|||
27613456|NCT01807221|80426667|FG005|Overall Study|Adverse Event|21|||
27613457|NCT01807221|80426662|FG000|Overall Study|Protocol Violation|0|||
27613458|NCT01807221|80426663|FG001|Overall Study|Protocol Violation|2|||
27613459|NCT01807221|80426664|FG002|Overall Study|Protocol Violation|1|||
27613460|NCT01807221|80426665|FG003|Overall Study|Protocol Violation|2|||
27613461|NCT01807221|80426666|FG004|Overall Study|Protocol Violation|0|||
27613462|NCT01807221|80426667|FG005|Overall Study|Protocol Violation|1|||
27613463|NCT01807221|80426662|FG000|Overall Study|Non-compliance|1|||
27613464|NCT01807221|80426663|FG001|Overall Study|Non-compliance|2|||
27613465|NCT01807221|80426664|FG002|Overall Study|Non-compliance|0|||
27613466|NCT01807221|80426665|FG003|Overall Study|Non-compliance|1|||
27613467|NCT01807221|80426666|FG004|Overall Study|Non-compliance|0|||
27613468|NCT01807221|80426667|FG005|Overall Study|Non-compliance|0|||
27613469|NCT01807221|80426662|FG000|Overall Study|Logistical difficulties|0|||
27613470|NCT01807221|80426663|FG001|Overall Study|Logistical difficulties|1|||
27842418|NCT02093923|81251369|FG000|Overall Study|Screen failure after randomization|0|||
27842419|NCT02093923|81251370|FG001|Overall Study|Screen failure after randomization|0|||
27842420|NCT02093923|81251371|FG002|Overall Study|Screen failure after randomization|0|||
27842421|NCT02093923|81251372|FG003|Overall Study|Screen failure after randomization|1|||
27842422|NCT02093923|81251373|FG004|Overall Study|Screen failure after randomization|0|||
27842423|NCT02762994|81251374|FG000|Overall Study|Withdrawal by Subject|0|||
27842424|NCT02762994|81251375|FG001|Overall Study|Withdrawal by Subject|1|||
27842425|NCT02762994|81251376|FG002|Overall Study|Withdrawal by Subject|2|||
27842426|NCT02762994|81251377|FG003|Overall Study|Withdrawal by Subject|0|||
27842427|NCT02762994|81251374|FG000|Overall Study|Protocol Violation|1|||
27842428|NCT02762994|81251375|FG001|Overall Study|Protocol Violation|0|||
27842429|NCT02762994|81251376|FG002|Overall Study|Protocol Violation|0|||
27842430|NCT02762994|81251377|FG003|Overall Study|Protocol Violation|2|||
27842431|NCT04253236|81251380|FG000|Overall Study|Adverse Event|1|||
27842432|NCT04253236|81251381|FG001|Overall Study|Adverse Event|0|||
27842433|NCT04253236|81251380|FG000|Overall Study|Safety Concerns|1|||
27842434|NCT04253236|81251381|FG001|Overall Study|Safety Concerns|0|||
27842435|NCT04253236|81251380|FG000|Overall Study|Study Terminated by Sponsor|1|||
27842436|NCT04253236|81251381|FG001|Overall Study|Study Terminated by Sponsor|0|||
27842437|NCT00220727|81251382|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
27842438|NCT00220727|81251383|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
27842439|NCT02820740|81251384|FG000|Overall Study|Did not have procedure|2|||
27842440|NCT03635983|81251387|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
27842441|NCT03635983|81251388|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
27842442|NCT03635983|81251387|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
27842443|NCT03635983|81251388|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
27842444|NCT03635983|81251387|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27842445|NCT03635983|81251388|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27842446|NCT03635983|81251387|FG000|Pre-Treatment Period|Other reasons|1|||
27842447|NCT03635983|81251388|FG001|Pre-Treatment Period|Other reasons|2|||
27842448|NCT03635983|81251387|FG000|Pre-Treatment Period|Disease Progression|0|||
27842449|NCT03635983|81251388|FG001|Pre-Treatment Period|Disease Progression|1|||
27842450|NCT03635983|81251387|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
27842451|NCT03635983|81251388|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
27842452|NCT03635983|81251387|FG000|Treatment Period|Completed treatment period|13|||
27842453|NCT03635983|81251388|FG001|Treatment Period|Completed treatment period|20|||
27842454|NCT03635983|81251387|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
27842455|NCT03635983|81251388|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
27842456|NCT03635983|81251387|FG000|Treatment Period|Withdrawal by Subject|2|||
27842457|NCT03635983|81251388|FG001|Treatment Period|Withdrawal by Subject|4|||
27842458|NCT03635983|81251387|FG000|Treatment Period|Death|3|||
27842459|NCT03635983|81251388|FG001|Treatment Period|Death|4|||
27842460|NCT03635983|81251387|FG000|Treatment Period|Poor/Non-compliance|1|||
27842461|NCT03635983|81251388|FG001|Treatment Period|Poor/Non-compliance|0|||
27842462|NCT03635983|81251387|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
27842463|NCT03635983|81251388|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
27842464|NCT03635983|81251387|FG000|Treatment Period|Other reasons|5|||
27842465|NCT03635983|81251388|FG001|Treatment Period|Other reasons|2|||
27842466|NCT03635983|81251387|FG000|Treatment Period|Disease progression|184|||
27842467|NCT03635983|81251388|FG001|Treatment Period|Disease progression|168|||
27724412|NCT01790503|80823001|FG004|Overall Study|Death|0|||
27724413|NCT01790503|80823002|FG005|Overall Study|Death|0|||
27842468|NCT03635983|81251387|FG000|Treatment Period|Study drug toxicity|26|||
27842469|NCT03635983|81251388|FG001|Treatment Period|Study drug toxicity|29|||
27842470|NCT03635983|81251387|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
27842471|NCT03635983|81251388|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
27842472|NCT03635983|81251387|FG000|Treatment Period|Maximum clinical benefit|3|||
27842473|NCT03635983|81251388|FG001|Treatment Period|Maximum clinical benefit|2|||
27842474|NCT02063217|81251389|FG000|Overall Study|Withdrawal by Subject|1|||
27842475|NCT02063217|81251390|FG001|Overall Study|Withdrawal by Subject|0|||
27842476|NCT02063217|81251391|FG002|Overall Study|Withdrawal by Subject|0|||
27613471|NCT01807221|80426664|FG002|Overall Study|Logistical difficulties|0|||
27724414|NCT01790503|80823003|FG006|Overall Study|Death|0|||
27842477|NCT00460109|81251398|FG000|Overall Study|Death|1|||
27842478|NCT00676494|81251399|FG000|Overall Study|Missed Visit|8|||
27842479|NCT00676494|81251399|FG000|Overall Study|Withdrawal by Subject|6|||
27613472|NCT01807221|80426665|FG003|Overall Study|Logistical difficulties|0|||
27724415|NCT01790503|80823004|FG007|Overall Study|Death|0|||
27842480|NCT02351167|81251401|FG000|Overall Study|Withdrawal by Subject|19|||
27842481|NCT02351167|81251402|FG001|Overall Study|Withdrawal by Subject|18|||
27842482|NCT02351167|81251403|FG002|Overall Study|Withdrawal by Subject|21|||
27724416|NCT01790503|80823005|FG008|Overall Study|Death|0|||
27724417|NCT01790503|80823006|FG009|Overall Study|Death|1|||
27842483|NCT00517192|81251404|FG000|Overall Study|Adverse Event|1|||
27842484|NCT00517192|81251405|FG001|Overall Study|Adverse Event|1|||
27842485|NCT00517192|81251404|FG000|Overall Study|Lost to Follow-up|1|||
27842486|NCT00517192|81251405|FG001|Overall Study|Lost to Follow-up|1|||
27842487|NCT00517192|81251404|FG000|Overall Study|Withdrawal by Subject|1|||
27842488|NCT00517192|81251405|FG001|Overall Study|Withdrawal by Subject|0|||
27842489|NCT00517192|81251404|FG000|Overall Study|Early termination of the trial|16|||
27842490|NCT00517192|81251405|FG001|Overall Study|Early termination of the trial|18|||
27842491|NCT03840382|81251406|FG000|Overall Study|Lost to Follow-up|11|||
27842492|NCT03135899|81251407|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842493|NCT03135899|81251408|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842494|NCT03135899|81251409|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842495|NCT03135899|81251410|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842496|NCT03135899|81251411|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842497|NCT03135899|81251412|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842498|NCT03135899|81251413|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
27842499|NCT03135899|81251414|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
27842500|NCT03135899|81251407|FG000|Overall Study|Withdrawal by Subject|0|||
27842501|NCT03135899|81251408|FG001|Overall Study|Withdrawal by Subject|0|||
27842502|NCT03135899|81251409|FG002|Overall Study|Withdrawal by Subject|0|||
27842503|NCT03135899|81251410|FG003|Overall Study|Withdrawal by Subject|0|||
27842504|NCT03135899|81251411|FG004|Overall Study|Withdrawal by Subject|0|||
27842505|NCT03135899|81251412|FG005|Overall Study|Withdrawal by Subject|2|||
27842506|NCT03135899|81251413|FG006|Overall Study|Withdrawal by Subject|0|||
27842507|NCT03135899|81251414|FG007|Overall Study|Withdrawal by Subject|0|||
27842508|NCT04106817|81251417|FG000|Overall Study|Lost to Follow-up|1|||
27842509|NCT04106817|81251418|FG001|Overall Study|Lost to Follow-up|0|||
27842510|NCT04106817|81251419|FG002|Overall Study|Lost to Follow-up|0|||
27842511|NCT00754052|81251425|FG000|Overall Study|Study terminated by Sponsor|5|||
27842512|NCT00754052|81251426|FG001|Overall Study|Study terminated by Sponsor|3|||
27842513|NCT02148445|81251427|FG000|Overall Study|Death|1|||
27842514|NCT02148445|81251428|FG001|Overall Study|Death|3|||
27842515|NCT01848210|81251429|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
27842516|NCT01848210|81251430|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
27613473|NCT01807221|80426666|FG004|Overall Study|Logistical difficulties|1|||
27613474|NCT01807221|80426667|FG005|Overall Study|Logistical difficulties|0|||
27613475|NCT01807221|80426662|FG000|Overall Study|Withdrawal by Subject|33|||
27842517|NCT01848210|81251429|FG000|Overall Study|Lost to Follow-up|24|||
27842518|NCT01848210|81251430|FG001|Overall Study|Lost to Follow-up|12|||
27842519|NCT01848210|81251429|FG000|Overall Study|Protocol Violation|3|||
27613476|NCT01807221|80426663|FG001|Overall Study|Withdrawal by Subject|15|||
27613477|NCT01807221|80426664|FG002|Overall Study|Withdrawal by Subject|8|||
27613478|NCT01807221|80426665|FG003|Overall Study|Withdrawal by Subject|14|||
27613479|NCT01807221|80426666|FG004|Overall Study|Withdrawal by Subject|16|||
27613480|NCT01807221|80426667|FG005|Overall Study|Withdrawal by Subject|13|||
27613481|NCT01807221|80426662|FG000|Overall Study|Sponsor decision|2|||
27613482|NCT01807221|80426663|FG001|Overall Study|Sponsor decision|0|||
27613483|NCT01807221|80426664|FG002|Overall Study|Sponsor decision|1|||
27613484|NCT01807221|80426665|FG003|Overall Study|Sponsor decision|1|||
27613485|NCT01807221|80426666|FG004|Overall Study|Sponsor decision|0|||
27724418|NCT01790503|80823007|FG010|Overall Study|Death|0|||
27724419|NCT01790503|80822997|FG000|Overall Study|Non Compliance|0|||
27613486|NCT01807221|80426667|FG005|Overall Study|Sponsor decision|0|||
27613487|NCT01807221|80426662|FG000|Overall Study|Lost to Follow-up|1|||
27724420|NCT01790503|80822998|FG001|Overall Study|Non Compliance|0|||
27842520|NCT01848210|81251430|FG001|Overall Study|Protocol Violation|5|||
27613488|NCT01807221|80426663|FG001|Overall Study|Lost to Follow-up|0|||
27613489|NCT01807221|80426664|FG002|Overall Study|Lost to Follow-up|2|||
27613490|NCT01807221|80426665|FG003|Overall Study|Lost to Follow-up|1|||
27613491|NCT01807221|80426666|FG004|Overall Study|Lost to Follow-up|0|||
27613492|NCT01807221|80426667|FG005|Overall Study|Lost to Follow-up|0|||
27613493|NCT00363896|80426668|FG000|Overall Study|Withdrawal by Subject|29|||
27958607|NCT01791517|81680067|FG009|Phase II|Lack of Efficacy|0|||
27613494|NCT00363896|80426669|FG001|Overall Study|Withdrawal by Subject|16|||
27724421|NCT01790503|80822999|FG002|Overall Study|Non Compliance|0|||
27842521|NCT01848210|81251429|FG000|Overall Study|Use of Forbidden Drugs|9|||
27842522|NCT01848210|81251430|FG001|Overall Study|Use of Forbidden Drugs|10|||
27842523|NCT01848210|81251429|FG000|Overall Study|Impedition Condition|5|||
27842524|NCT01848210|81251430|FG001|Overall Study|Impedition Condition|9|||
27842525|NCT01848210|81251429|FG000|Overall Study|Adverse Event|7|||
27842526|NCT01848210|81251430|FG001|Overall Study|Adverse Event|9|||
27613495|NCT00363896|80426668|FG000|Overall Study|Adverse Event|24|||
27613496|NCT00363896|80426669|FG001|Overall Study|Adverse Event|13|||
27613497|NCT00363896|80426668|FG000|Overall Study|COPD exacerbation|13|||
27613498|NCT00363896|80426669|FG001|Overall Study|COPD exacerbation|7|||
27613499|NCT00363896|80426668|FG000|Overall Study|Lack of Efficacy|12|||
27724422|NCT01790503|80823000|FG003|Overall Study|Non Compliance|0|||
27842527|NCT01848210|81251429|FG000|Overall Study|Discontinuation Criterion|5|||
27842528|NCT01848210|81251430|FG001|Overall Study|Discontinuation Criterion|7|||
27842529|NCT01848210|81251429|FG000|Overall Study|Hypesensitivity|1|||
27842530|NCT01848210|81251430|FG001|Overall Study|Hypesensitivity|0|||
27842531|NCT01848210|81251429|FG000|Overall Study|Hepatic Function Alteration|4|||
27842532|NCT01848210|81251430|FG001|Overall Study|Hepatic Function Alteration|0|||
27842533|NCT01848210|81251429|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
27842534|NCT01848210|81251430|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
27842535|NCT01848210|81251429|FG000|Overall Study|Administrative|1|||
27842536|NCT01848210|81251430|FG001|Overall Study|Administrative|0|||
27842537|NCT00612677|81251434|FG000|Overall Study|study closed before treatment started|1|||
27842538|NCT00889252|81251435|FG000|Overall Study|Adverse Event|2|||
27842539|NCT00889252|81251436|FG001|Overall Study|Adverse Event|4|||
27842540|NCT00889252|81251435|FG000|Overall Study|Withdrawal by Subject|3|||
27842541|NCT00889252|81251436|FG001|Overall Study|Withdrawal by Subject|0|||
27842542|NCT00889252|81251435|FG000|Overall Study|Protocol Violation|2|||
27842543|NCT00889252|81251436|FG001|Overall Study|Protocol Violation|0|||
27842544|NCT01501110|81251447|FG000|Overall Study|Death|0|||
27842545|NCT01501110|81251448|FG001|Overall Study|Death|1|||
27842546|NCT00631007|81251453|FG000|Overall Study|Adverse Event|0|||
27842547|NCT00631007|81251454|FG001|Overall Study|Adverse Event|2|||
27842548|NCT00631007|81251455|FG002|Overall Study|Adverse Event|0|||
27842549|NCT00631007|81251456|FG003|Overall Study|Adverse Event|2|||
27842550|NCT00631007|81251457|FG004|Overall Study|Adverse Event|3|||
27842551|NCT00631007|81251458|FG005|Overall Study|Adverse Event|2|||
27842552|NCT00631007|81251453|FG000|Overall Study|Lost to Follow-up|2|||
27842553|NCT00631007|81251454|FG001|Overall Study|Lost to Follow-up|1|||
27842554|NCT00631007|81251455|FG002|Overall Study|Lost to Follow-up|2|||
27842555|NCT00631007|81251456|FG003|Overall Study|Lost to Follow-up|4|||
27842556|NCT00631007|81251457|FG004|Overall Study|Lost to Follow-up|5|||
27842557|NCT00631007|81251458|FG005|Overall Study|Lost to Follow-up|3|||
27842558|NCT00631007|81251453|FG000|Overall Study|Physician Decision|1|||
27842559|NCT00631007|81251454|FG001|Overall Study|Physician Decision|0|||
27842560|NCT00631007|81251455|FG002|Overall Study|Physician Decision|1|||
27842561|NCT00631007|81251456|FG003|Overall Study|Physician Decision|0|||
27842562|NCT00631007|81251457|FG004|Overall Study|Physician Decision|0|||
27842563|NCT00631007|81251458|FG005|Overall Study|Physician Decision|2|||
27842564|NCT00631007|81251453|FG000|Overall Study|Persistent Hyperglycemia|2|||
27842565|NCT00631007|81251454|FG001|Overall Study|Persistent Hyperglycemia|2|||
27842566|NCT00631007|81251455|FG002|Overall Study|Persistent Hyperglycemia|5|||
27842567|NCT00631007|81251456|FG003|Overall Study|Persistent Hyperglycemia|1|||
27842568|NCT00631007|81251457|FG004|Overall Study|Persistent Hyperglycemia|2|||
27842569|NCT00631007|81251458|FG005|Overall Study|Persistent Hyperglycemia|5|||
27842570|NCT00631007|81251453|FG000|Overall Study|Withdrawal by Subject|4|||
27842571|NCT00631007|81251454|FG001|Overall Study|Withdrawal by Subject|5|||
27842572|NCT00631007|81251455|FG002|Overall Study|Withdrawal by Subject|2|||
27842573|NCT00631007|81251456|FG003|Overall Study|Withdrawal by Subject|2|||
27842574|NCT00631007|81251457|FG004|Overall Study|Withdrawal by Subject|1|||
27842575|NCT00631007|81251458|FG005|Overall Study|Withdrawal by Subject|3|||
27842576|NCT00631007|81251453|FG000|Overall Study|Other|2|||
27842577|NCT00631007|81251454|FG001|Overall Study|Other|1|||
27842578|NCT00631007|81251455|FG002|Overall Study|Other|0|||
27842579|NCT00631007|81251456|FG003|Overall Study|Other|0|||
27842580|NCT00631007|81251457|FG004|Overall Study|Other|1|||
27842581|NCT00631007|81251458|FG005|Overall Study|Other|0|||
27842582|NCT03431337|81251459|FG000|Overall Study|Lost to Follow-up|21|||
27842583|NCT03431337|81251460|FG001|Overall Study|Lost to Follow-up|19|||
27842584|NCT03431337|81251459|FG000|Overall Study|Withdrawal by Subject|8|||
27842585|NCT03431337|81251460|FG001|Overall Study|Withdrawal by Subject|3|||
27842586|NCT00576303|81251469|FG000|Dose Titration Period|Early withdrawal|17|||
27842587|NCT00576303|81251469|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
27504176|NCT04030143|80040752|FG001|Overall Study|Withdrawal by Subject|18|||
27504177|NCT04030143|80040751|FG000|Overall Study|Physician Decision|1|||
27504178|NCT04030143|80040752|FG001|Overall Study|Physician Decision|1|||
27842588|NCT00576303|81251469|FG000|Long Term Safety Period|Early withdrawal|16|||
27842589|NCT02608476|81254237|FG000|Overall Study|Withdrawal by Subject|30|||
27842590|NCT02608476|81254238|FG001|Overall Study|Withdrawal by Subject|37|||
27842591|NCT02608476|81254237|FG000|Overall Study|Lost to Follow-up|24|||
27842592|NCT02608476|81254238|FG001|Overall Study|Lost to Follow-up|24|||
27842593|NCT02608476|81254237|FG000|Overall Study|Adverse Event|2|||
27842594|NCT02608476|81254238|FG001|Overall Study|Adverse Event|8|||
27842595|NCT02608476|81254237|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
27842596|NCT02608476|81254238|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
27842597|NCT02608476|81254237|FG000|Overall Study|Noncompliance with treatment|1|||
27842598|NCT02608476|81254238|FG001|Overall Study|Noncompliance with treatment|5|||
27842599|NCT02608476|81254237|FG000|Overall Study|Lack of Efficacy|3|||
27842600|NCT02608476|81254238|FG001|Overall Study|Lack of Efficacy|1|||
27842601|NCT02608476|81254237|FG000|Overall Study|Other|0|||
27842602|NCT02608476|81254238|FG001|Overall Study|Other|1|||
27842603|NCT02608476|81254237|FG000|Overall Study|Physician Decision|1|||
27892917|NCT01647516|81441412|FG005|Open-Label Period|No completion / discontinuation visit|1|||
27892918|NCT00380081|81441413|FG000|Overall Study|Withdrawal by Subject|0|||
27892919|NCT00380081|81441414|FG001|Overall Study|Withdrawal by Subject|0|||
27892920|NCT00380081|81441415|FG002|Overall Study|Withdrawal by Subject|0|||
27892921|NCT00380081|81441416|FG003|Overall Study|Withdrawal by Subject|0|||
27892922|NCT00380081|81441417|FG004|Overall Study|Withdrawal by Subject|1|||
27892923|NCT00380081|81441418|FG005|Overall Study|Withdrawal by Subject|0|||
27892924|NCT00380081|81441413|FG000|Overall Study|Family Emergency|0|||
27892925|NCT00380081|81441414|FG001|Overall Study|Family Emergency|0|||
27892926|NCT00380081|81441415|FG002|Overall Study|Family Emergency|0|||
27892927|NCT00380081|81441416|FG003|Overall Study|Family Emergency|0|||
27892928|NCT00380081|81441417|FG004|Overall Study|Family Emergency|0|||
27892929|NCT00380081|81441418|FG005|Overall Study|Family Emergency|1|||
27724423|NCT01790503|80823001|FG004|Overall Study|Non Compliance|1|||
27724424|NCT01790503|80823002|FG005|Overall Study|Non Compliance|0|||
27724425|NCT01790503|80823003|FG006|Overall Study|Non Compliance|0|||
27724426|NCT01790503|80823004|FG007|Overall Study|Non Compliance|0|||
27724427|NCT01790503|80823005|FG008|Overall Study|Non Compliance|0|||
27724428|NCT01790503|80823006|FG009|Overall Study|Non Compliance|0|||
27724429|NCT01790503|80823007|FG010|Overall Study|Non Compliance|0|||
27842604|NCT02608476|81254238|FG001|Overall Study|Physician Decision|0|||
27842605|NCT02608476|81254237|FG000|Overall Study|Pregnancy|0|||
27842606|NCT02608476|81254238|FG001|Overall Study|Pregnancy|1|||
27842607|NCT02608476|81254237|FG000|Overall Study|Progressive disease|1|||
27842608|NCT02608476|81254238|FG001|Overall Study|Progressive disease|0|||
27842609|NCT01680016|81254239|FG000|Overall Study|Adverse Event|0|||
27842610|NCT01680016|81254240|FG001|Overall Study|Adverse Event|0|||
27842611|NCT01680016|81254241|FG002|Overall Study|Adverse Event|1|||
27842612|NCT01680016|81254242|FG003|Overall Study|Adverse Event|4|||
27842613|NCT01680016|81254239|FG000|Overall Study|The Subject went out of The Trial|1|||
27842614|NCT01680016|81254240|FG001|Overall Study|The Subject went out of The Trial|0|||
27842615|NCT01680016|81254241|FG002|Overall Study|The Subject went out of The Trial|3|||
27842616|NCT01680016|81254242|FG003|Overall Study|The Subject went out of The Trial|0|||
27842617|NCT01680016|81254239|FG000|Overall Study|Protocol Violation|0|||
27842618|NCT01680016|81254240|FG001|Overall Study|Protocol Violation|1|||
27842619|NCT01680016|81254241|FG002|Overall Study|Protocol Violation|0|||
27842620|NCT01680016|81254242|FG003|Overall Study|Protocol Violation|0|||
27892930|NCT00782184|81441419|FG000|Overall Study|Adverse Event|1|||
27892931|NCT00782184|81441420|FG001|Overall Study|Adverse Event|2|||
27892932|NCT00782184|81441419|FG000|Overall Study|Protocol Violation|0|||
27892933|NCT00782184|81441420|FG001|Overall Study|Protocol Violation|1|||
27892934|NCT00782184|81441419|FG000|Overall Study|Withdrawal by Subject|3|||
27724430|NCT01790503|80822997|FG000|Overall Study|Other|0|||
27724431|NCT01790503|80822998|FG001|Overall Study|Other|0|||
27724432|NCT01790503|80822999|FG002|Overall Study|Other|0|||
27724433|NCT01790503|80823000|FG003|Overall Study|Other|0|||
27724434|NCT01790503|80823001|FG004|Overall Study|Other|1|||
27724435|NCT01790503|80823002|FG005|Overall Study|Other|0|||
27724436|NCT01790503|80823003|FG006|Overall Study|Other|0|||
27724437|NCT01790503|80823004|FG007|Overall Study|Other|0|||
27724438|NCT01790503|80823005|FG008|Overall Study|Other|1|||
27724439|NCT01790503|80823006|FG009|Overall Study|Other|2|||
27724440|NCT01790503|80823007|FG010|Overall Study|Other|0|||
27842621|NCT01680016|81254239|FG000|Overall Study|Withdrawal by Subject|5|||
27504179|NCT04030143|80040751|FG000|Overall Study|Due to Covid-19|2|||
27504180|NCT04030143|80040752|FG001|Overall Study|Due to Covid-19|3|||
27504181|NCT04030143|80040751|FG000|Overall Study|Not Due to Covid-19|1|||
27504182|NCT04030143|80040752|FG001|Overall Study|Not Due to Covid-19|1|||
27504183|NCT01458392|80040753|FG000|Overall Study|Death|2|||
27504184|NCT01458392|80040754|FG001|Overall Study|Death|11|||
27504185|NCT01458392|80040755|FG002|Overall Study|Death|22|||
27504186|NCT01458392|80040753|FG000|Overall Study|At the discretion of the sponsor|0|||
27504187|NCT01458392|80040754|FG001|Overall Study|At the discretion of the sponsor|2|||
27504188|NCT01458392|80040755|FG002|Overall Study|At the discretion of the sponsor|7|||
27504189|NCT01458392|80040753|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
27504190|NCT01458392|80040754|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
27504191|NCT01458392|80040755|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
27504192|NCT01194830|80040756|FG000|Overall Study|Adverse Event|3|||
27504193|NCT01194830|80040757|FG001|Overall Study|Adverse Event|2|||
27504194|NCT01194830|80040756|FG000|Overall Study|Protocol Violation|5|||
27504195|NCT01194830|80040757|FG001|Overall Study|Protocol Violation|4|||
27504196|NCT01194830|80040756|FG000|Overall Study|Lost to Follow-up|9|||
27504197|NCT01194830|80040757|FG001|Overall Study|Lost to Follow-up|7|||
27504198|NCT01194830|80040756|FG000|Overall Study|Withdrawal by Subject|2|||
27504199|NCT01194830|80040757|FG001|Overall Study|Withdrawal by Subject|1|||
27504200|NCT01194830|80040756|FG000|Overall Study|Lack of Efficacy|1|||
27504201|NCT01194830|80040757|FG001|Overall Study|Lack of Efficacy|1|||
27504202|NCT01194830|80040756|FG000|Overall Study|Non-compliance issues|4|||
27842622|NCT01680016|81254240|FG001|Overall Study|Withdrawal by Subject|7|||
27842623|NCT01680016|81254241|FG002|Overall Study|Withdrawal by Subject|1|||
27842624|NCT01680016|81254242|FG003|Overall Study|Withdrawal by Subject|1|||
27842625|NCT00831233|81254251|FG000|Overall Study|Adverse Event|0|||
27842626|NCT00831233|81254252|FG001|Overall Study|Adverse Event|1|||
27842627|NCT00831233|81254251|FG000|Overall Study|Protocol Violation|1|||
27842628|NCT00831233|81254252|FG001|Overall Study|Protocol Violation|0|||
27842629|NCT00831233|81254251|FG000|Overall Study|Selection Criteria Not Met|2|||
27842630|NCT00831233|81254252|FG001|Overall Study|Selection Criteria Not Met|0|||
27842631|NCT00035555|81254253|FG000|Overall Study|Adverse Event|5|||
27842632|NCT00035555|81254254|FG001|Overall Study|Adverse Event|8|||
27842633|NCT00035555|81254255|FG002|Overall Study|Adverse Event|9|||
27842634|NCT00035555|81254253|FG000|Overall Study|Allograft loss|1|||
27842635|NCT00035555|81254254|FG001|Overall Study|Allograft loss|1|||
27842636|NCT00035555|81254255|FG002|Overall Study|Allograft loss|2|||
27842637|NCT00035555|81254253|FG000|Overall Study|Death|0|||
27842638|NCT00035555|81254254|FG001|Overall Study|Death|0|||
27842639|NCT00035555|81254255|FG002|Overall Study|Death|2|||
27842640|NCT00035555|81254253|FG000|Overall Study|Lost to Follow-up|0|||
27842641|NCT00035555|81254254|FG001|Overall Study|Lost to Follow-up|0|||
27842642|NCT00035555|81254255|FG002|Overall Study|Lost to Follow-up|1|||
27842643|NCT00035555|81254253|FG000|Overall Study|Noncompliance|0|||
27842644|NCT00035555|81254254|FG001|Overall Study|Noncompliance|1|||
27842645|NCT00035555|81254255|FG002|Overall Study|Noncompliance|1|||
27842646|NCT00035555|81254253|FG000|Overall Study|Prohibited medication|1|||
27842647|NCT00035555|81254254|FG001|Overall Study|Prohibited medication|1|||
27842648|NCT00035555|81254255|FG002|Overall Study|Prohibited medication|0|||
27842649|NCT00035555|81254253|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
27842650|NCT00035555|81254254|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
27842651|NCT00035555|81254255|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
27842652|NCT00035555|81254253|FG000|Overall Study|Withdrawal by Subject|2|||
27842653|NCT00035555|81254254|FG001|Overall Study|Withdrawal by Subject|0|||
27842654|NCT00035555|81254255|FG002|Overall Study|Withdrawal by Subject|2|||
27842655|NCT00035555|81254253|FG000|Overall Study|Investigator deemed not a good candidate|0|||
27842656|NCT00035555|81254254|FG001|Overall Study|Investigator deemed not a good candidate|0|||
27842657|NCT00035555|81254255|FG002|Overall Study|Investigator deemed not a good candidate|1|||
27842658|NCT00035555|81254253|FG000|Overall Study|Received cyclosporin in error|0|||
27842659|NCT00035555|81254254|FG001|Overall Study|Received cyclosporin in error|0|||
27842660|NCT00035555|81254255|FG002|Overall Study|Received cyclosporin in error|1|||
27842661|NCT01592721|81254259|FG000|Long-term Follow-up|Death|1|||
27842662|NCT00063258|81254260|FG000|Overall Study|Physician Decision|2|||
27842663|NCT00063258|81254261|FG001|Overall Study|Physician Decision|0|||
27842664|NCT00063258|81254260|FG000|Overall Study|Lack of Efficacy|2|||
27842665|NCT00063258|81254261|FG001|Overall Study|Lack of Efficacy|0|||
27842666|NCT02363439|81254262|FG000|Overall Study|Lack of Efficacy|4|||
27842667|NCT02056652|81254263|FG000|Overall Study|Withdrawal by Subject|1|||
27842668|NCT02056652|81254264|FG001|Overall Study|Withdrawal by Subject|0|||
27842669|NCT02056652|81254263|FG000|Overall Study|Lost to Follow-up|0|||
27842670|NCT02056652|81254264|FG001|Overall Study|Lost to Follow-up|3|||
27842671|NCT01235442|81254265|FG000|Overall Study|Lost to Follow-up|12|||
27842672|NCT01235442|81254266|FG001|Overall Study|Lost to Follow-up|10|||
27842673|NCT01235442|81254265|FG000|Overall Study|Death|0|||
27842674|NCT01235442|81254266|FG001|Overall Study|Death|2|||
27842675|NCT01235442|81254265|FG000|Overall Study|Pregnancy|1|||
27842676|NCT01235442|81254266|FG001|Overall Study|Pregnancy|1|||
27842677|NCT01235442|81254265|FG000|Overall Study|Ineligibility determined|5|||
27842678|NCT01235442|81254266|FG001|Overall Study|Ineligibility determined|4|||
27842679|NCT01235442|81254265|FG000|Overall Study|Protocol Violation|3|||
27842680|NCT01235442|81254266|FG001|Overall Study|Protocol Violation|3|||
27842681|NCT01235442|81254265|FG000|Overall Study|Adverse Event|4|||
27842682|NCT01235442|81254266|FG001|Overall Study|Adverse Event|6|||
27842683|NCT01235442|81254265|FG000|Overall Study|Withdrawal by Subject|15|||
27842684|NCT01235442|81254266|FG001|Overall Study|Withdrawal by Subject|9|||
27842685|NCT01235442|81254265|FG000|Overall Study|Lack of Efficacy|1|||
27842686|NCT01235442|81254266|FG001|Overall Study|Lack of Efficacy|3|||
27842687|NCT01235442|81254265|FG000|Overall Study|Noncompliance|1|||
27842688|NCT01235442|81254266|FG001|Overall Study|Noncompliance|2|||
27504203|NCT01194830|80040757|FG001|Overall Study|Non-compliance issues|4|||
27842689|NCT01235442|81254265|FG000|Overall Study|Administrative decision|1|||
27504204|NCT01194830|80040756|FG000|Overall Study|Other Reason|12|||
27842690|NCT01235442|81254266|FG001|Overall Study|Administrative decision|2|||
27842691|NCT01235442|81254265|FG000|Overall Study|Other unspecified|1|||
27842692|NCT01235442|81254266|FG001|Overall Study|Other unspecified|2|||
27842693|NCT03223909|81254267|FG000|Overall Study|Protocol Violation|48|||
27842694|NCT03223909|81254268|FG001|Overall Study|Protocol Violation|45|||
27842695|NCT03223909|81254269|FG002|Overall Study|Protocol Violation|16|||
27842696|NCT00979212|81254270|FG000|Overall Study|Protocol Violation|1|||
27842697|NCT00979212|81254271|FG001|Overall Study|Protocol Violation|8|||
27958608|NCT01791517|81680068|FG010|Phase II|Lack of Efficacy|0|||
27842698|NCT00979212|81254270|FG000|Overall Study|No protocol therapy received|1|||
27842699|NCT00979212|81254271|FG001|Overall Study|No protocol therapy received|0|||
27842700|NCT01908205|81254272|FG000|Overall Study|Lost to Follow-up|2|||
27842701|NCT01908205|81254273|FG001|Overall Study|Lost to Follow-up|0|||
27842702|NCT01908205|81254272|FG000|Overall Study|Withdrawal by Subject|3|||
27842703|NCT01908205|81254273|FG001|Overall Study|Withdrawal by Subject|1|||
27842704|NCT04167618|81254277|FG000|Overall Study|Trial terminated by sponsor|1|||
27842705|NCT04167618|81254278|FG001|Overall Study|Trial terminated by sponsor|1|||
27842706|NCT04703855|81254279|FG000|Overall Study|Heart Transplant|1|||
27842707|NCT04252287|81254280|FG000|Overall Study|Death|5|||
27842708|NCT04252287|81254281|FG001|Overall Study|Death|3|||
27842709|NCT04252287|81254280|FG000|Overall Study|Lost to Follow-up|4|||
27842710|NCT04252287|81254281|FG001|Overall Study|Lost to Follow-up|6|||
27842711|NCT04252287|81254280|FG000|Overall Study|Withdrawal by Subject|19|||
27842712|NCT04252287|81254281|FG001|Overall Study|Withdrawal by Subject|16|||
27842713|NCT04252287|81254280|FG000|Overall Study|Protocol Violation|3|||
27842714|NCT04252287|81254281|FG001|Overall Study|Protocol Violation|4|||
27842715|NCT02124902|81254285|FG000|Overall Study|Adverse Event|7|||
27842716|NCT02124902|81254286|FG001|Overall Study|Adverse Event|2|||
27842717|NCT02124902|81254285|FG000|Overall Study|Went to alternative treatment|4|||
27842718|NCT02124902|81254286|FG001|Overall Study|Went to alternative treatment|0|||
27842719|NCT02124902|81254285|FG000|Overall Study|Withdrawal by Subject|2|||
27842720|NCT02124902|81254286|FG001|Overall Study|Withdrawal by Subject|1|||
27842721|NCT02124902|81254285|FG000|Overall Study|Physician Decision|2|||
27842722|NCT02124902|81254286|FG001|Overall Study|Physician Decision|0|||
27842723|NCT02124902|81254285|FG000|Overall Study|Not eligible|1|||
27842724|NCT02124902|81254286|FG001|Overall Study|Not eligible|0|||
27842725|NCT02124902|81254285|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
27842726|NCT02124902|81254286|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
27842727|NCT01731886|81254289|FG000|Overall Study|Death|1|||
27842728|NCT01731886|81254290|FG001|Overall Study|Death|0|||
27842729|NCT01731886|81254289|FG000|Overall Study|Never started treatment|0|||
27842730|NCT01731886|81254290|FG001|Overall Study|Never started treatment|1|||
27842731|NCT01731886|81254289|FG000|Overall Study|Non-compliant|1|||
27842732|NCT01731886|81254290|FG001|Overall Study|Non-compliant|0|||
27842733|NCT03847194|81254292|FG000|Overall Study|Lost to Follow-up|2|||
27842734|NCT03847194|81254293|FG001|Overall Study|Lost to Follow-up|5|||
27842735|NCT03847194|81254292|FG000|Overall Study|Withdrawal by Subject|1|||
27842736|NCT03847194|81254293|FG001|Overall Study|Withdrawal by Subject|2|||
27842737|NCT03847194|81254292|FG000|Overall Study|Death|0|||
27842738|NCT03847194|81254293|FG001|Overall Study|Death|1|||
27842739|NCT01813435|81254294|FG000|Overall Study|did not finish experimental regimen|1902|||
27842740|NCT01813435|81254295|FG001|Overall Study|did not finish experimental regimen|770|||
27842741|NCT01813435|81254294|FG000|Overall Study|Lost to Follow-up|268|||
27842742|NCT01813435|81254295|FG001|Overall Study|Lost to Follow-up|237|||
27842743|NCT00108628|81254300|FG000|Overall Study|Withdrawal by Subject|17|||
27842744|NCT00108628|81254301|FG001|Overall Study|Withdrawal by Subject|9|||
27724441|NCT02769624|80823008|FG000|Overall Study|Lost to Follow-up|0|||
27724442|NCT02769624|80823009|FG001|Overall Study|Lost to Follow-up|1|||
27724443|NCT03543410|80823022|FG000|Overall Study|Adverse Event|10|||
27724444|NCT03543410|80823023|FG001|Overall Study|Adverse Event|8|||
27724445|NCT03543410|80823024|FG002|Overall Study|Adverse Event|2|||
27724446|NCT03543410|80823022|FG000|Overall Study|Lack of Efficacy|0|||
27724447|NCT03543410|80823023|FG001|Overall Study|Lack of Efficacy|1|||
27724448|NCT03543410|80823024|FG002|Overall Study|Lack of Efficacy|0|||
27724449|NCT03543410|80823022|FG000|Overall Study|Lost to Follow-up|0|||
27724450|NCT03543410|80823023|FG001|Overall Study|Lost to Follow-up|1|||
27724451|NCT03543410|80823024|FG002|Overall Study|Lost to Follow-up|0|||
27724452|NCT03543410|80823022|FG000|Overall Study|Withdrawal by Subject|5|||
27724453|NCT03543410|80823023|FG001|Overall Study|Withdrawal by Subject|2|||
27724454|NCT03543410|80823024|FG002|Overall Study|Withdrawal by Subject|8|||
27724455|NCT03543410|80823022|FG000|Overall Study|Protocol Violation|0|||
27724456|NCT03543410|80823023|FG001|Overall Study|Protocol Violation|1|||
27724457|NCT03543410|80823024|FG002|Overall Study|Protocol Violation|0|||
27724458|NCT03543410|80823022|FG000|Overall Study|Due to COVID-19|4|||
27724459|NCT03543410|80823023|FG001|Overall Study|Due to COVID-19|0|||
27724460|NCT03543410|80823024|FG002|Overall Study|Due to COVID-19|2|||
27842745|NCT00108628|81254300|FG000|Overall Study|Lack of Efficacy|2|||
27842746|NCT00108628|81254301|FG001|Overall Study|Lack of Efficacy|1|||
27842747|NCT00108628|81254300|FG000|Overall Study|Death|1|||
27842748|NCT00108628|81254301|FG001|Overall Study|Death|0|||
27842749|NCT01011335|81254302|FG000|Overall Study|Lost to Follow-up|0|||
27842750|NCT01011335|81254303|FG001|Overall Study|Lost to Follow-up|0|||
27842751|NCT01011335|81254304|FG002|Overall Study|Lost to Follow-up|1|||
27724461|NCT03543410|80823022|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
27842752|NCT01011335|81254305|FG003|Overall Study|Lost to Follow-up|1|||
27842753|NCT01011335|81254306|FG004|Overall Study|Lost to Follow-up|1|||
27842754|NCT01011335|81254307|FG005|Overall Study|Lost to Follow-up|1|||
27842755|NCT01011335|81254308|FG006|Overall Study|Lost to Follow-up|2|||
27842756|NCT01011335|81254309|FG007|Overall Study|Lost to Follow-up|2|||
27842757|NCT01011335|81254310|FG008|Overall Study|Lost to Follow-up|1|||
27842758|NCT01011335|81254311|FG009|Overall Study|Lost to Follow-up|0|||
27842759|NCT01011335|81254312|FG010|Overall Study|Lost to Follow-up|0|||
27842760|NCT01011335|81254313|FG011|Overall Study|Lost to Follow-up|1|||
27842761|NCT01011335|81254314|FG012|Overall Study|Lost to Follow-up|2|||
27842762|NCT01011335|81254302|FG000|Overall Study|Protocol Violation|0|||
27842763|NCT01011335|81254303|FG001|Overall Study|Protocol Violation|1|||
27842764|NCT01011335|81254304|FG002|Overall Study|Protocol Violation|0|||
27842765|NCT01011335|81254305|FG003|Overall Study|Protocol Violation|0|||
27842766|NCT01011335|81254306|FG004|Overall Study|Protocol Violation|0|||
27842767|NCT01011335|81254307|FG005|Overall Study|Protocol Violation|0|||
27842768|NCT01011335|81254308|FG006|Overall Study|Protocol Violation|0|||
27842769|NCT01011335|81254309|FG007|Overall Study|Protocol Violation|0|||
27842770|NCT01011335|81254310|FG008|Overall Study|Protocol Violation|0|||
27842771|NCT01011335|81254311|FG009|Overall Study|Protocol Violation|0|||
27842772|NCT01011335|81254312|FG010|Overall Study|Protocol Violation|0|||
27842773|NCT01011335|81254313|FG011|Overall Study|Protocol Violation|0|||
27842774|NCT01011335|81254314|FG012|Overall Study|Protocol Violation|0|||
27842775|NCT01011335|81254302|FG000|Overall Study|Moved/deployed or no booster|1|||
27842776|NCT01011335|81254303|FG001|Overall Study|Moved/deployed or no booster|0|||
27842777|NCT01011335|81254304|FG002|Overall Study|Moved/deployed or no booster|0|||
27842778|NCT01011335|81254305|FG003|Overall Study|Moved/deployed or no booster|1|||
27842779|NCT01011335|81254306|FG004|Overall Study|Moved/deployed or no booster|0|||
27842780|NCT01011335|81254307|FG005|Overall Study|Moved/deployed or no booster|0|||
27842781|NCT01011335|81254308|FG006|Overall Study|Moved/deployed or no booster|1|||
27842782|NCT01011335|81254309|FG007|Overall Study|Moved/deployed or no booster|0|||
27842783|NCT01011335|81254310|FG008|Overall Study|Moved/deployed or no booster|1|||
27842784|NCT01011335|81254311|FG009|Overall Study|Moved/deployed or no booster|0|||
27842785|NCT01011335|81254312|FG010|Overall Study|Moved/deployed or no booster|2|||
27842786|NCT01011335|81254313|FG011|Overall Study|Moved/deployed or no booster|0|||
27842787|NCT01011335|81254314|FG012|Overall Study|Moved/deployed or no booster|0|||
27842788|NCT01011335|81254302|FG000|Overall Study|Adverse Event|0|||
27842789|NCT01011335|81254303|FG001|Overall Study|Adverse Event|0|||
27842790|NCT01011335|81254304|FG002|Overall Study|Adverse Event|0|||
27842791|NCT01011335|81254305|FG003|Overall Study|Adverse Event|0|||
27842792|NCT01011335|81254306|FG004|Overall Study|Adverse Event|0|||
27842793|NCT01011335|81254307|FG005|Overall Study|Adverse Event|0|||
27842794|NCT01011335|81254308|FG006|Overall Study|Adverse Event|0|||
27842795|NCT01011335|81254309|FG007|Overall Study|Adverse Event|0|||
27842796|NCT01011335|81254310|FG008|Overall Study|Adverse Event|0|||
27842797|NCT01011335|81254311|FG009|Overall Study|Adverse Event|0|||
27842798|NCT01011335|81254312|FG010|Overall Study|Adverse Event|4|||
27842799|NCT01011335|81254313|FG011|Overall Study|Adverse Event|0|||
27842800|NCT01011335|81254314|FG012|Overall Study|Adverse Event|1|||
27842801|NCT03573817|81254316|FG000|Overall Study|Adverse Event|0|||
27842802|NCT03573817|81254317|FG001|Overall Study|Adverse Event|2|||
27842803|NCT03573817|81254316|FG000|Overall Study|Protocol Violation|0|||
27842804|NCT03573817|81254317|FG001|Overall Study|Protocol Violation|1|||
27842805|NCT03573817|81254316|FG000|Overall Study|Withdrawal by Subject|1|||
27842806|NCT03573817|81254317|FG001|Overall Study|Withdrawal by Subject|1|||
27842807|NCT03547635|81254323|FG000|Overall Study|Adverse Event|5|||
27842808|NCT03547635|81254324|FG001|Overall Study|Adverse Event|2|||
27842809|NCT03547635|81254325|FG002|Overall Study|Adverse Event|3|||
27842810|NCT03547635|81254323|FG000|Overall Study|Lost to Follow-up|1|||
27842811|NCT03547635|81254324|FG001|Overall Study|Lost to Follow-up|3|||
27842812|NCT03547635|81254325|FG002|Overall Study|Lost to Follow-up|4|||
27842813|NCT03547635|81254323|FG000|Overall Study|Withdrawal by Subject|1|||
27842814|NCT03547635|81254324|FG001|Overall Study|Withdrawal by Subject|0|||
27842815|NCT03547635|81254325|FG002|Overall Study|Withdrawal by Subject|0|||
27842816|NCT03547635|81254323|FG000|Overall Study|Withdrawal By PI|0|||
27842817|NCT03547635|81254324|FG001|Overall Study|Withdrawal By PI|1|||
27842818|NCT03547635|81254325|FG002|Overall Study|Withdrawal By PI|0|||
27842819|NCT03547635|81254323|FG000|Overall Study|Withdrawal by Sponsor|0|||
27842820|NCT03547635|81254324|FG001|Overall Study|Withdrawal by Sponsor|0|||
27842821|NCT03547635|81254325|FG002|Overall Study|Withdrawal by Sponsor|1|||
27842822|NCT03547635|81254323|FG000|Overall Study|Errant Randomization before Treatment|0|||
27842823|NCT03547635|81254324|FG001|Overall Study|Errant Randomization before Treatment|1|||
27842824|NCT03547635|81254325|FG002|Overall Study|Errant Randomization before Treatment|0|||
27842825|NCT03547635|81254323|FG000|Overall Study|Withdrawal by Subject|1|||
27842826|NCT03547635|81254324|FG001|Overall Study|Withdrawal by Subject|0|||
27842827|NCT03547635|81254325|FG002|Overall Study|Withdrawal by Subject|0|||
27842828|NCT00761176|81254326|FG000|Overall Study|Death|1|||
27842829|NCT00761176|81254327|FG001|Overall Study|Death|0|||
27842830|NCT00761176|81254326|FG000|Overall Study|Withdrawal by Subject|1|||
27842831|NCT00761176|81254327|FG001|Overall Study|Withdrawal by Subject|1|||
27842832|NCT03756883|81254328|FG000|Overall Study|Adverse Event|2|||
27842833|NCT03756883|81254329|FG001|Overall Study|Adverse Event|2|||
27842834|NCT03756883|81254330|FG002|Overall Study|Adverse Event|2|||
27842835|NCT03756883|81254328|FG000|Overall Study|Lack of Efficacy|0|||
27842836|NCT03756883|81254329|FG001|Overall Study|Lack of Efficacy|1|||
27842837|NCT03756883|81254330|FG002|Overall Study|Lack of Efficacy|2|||
27842838|NCT03756883|81254328|FG000|Overall Study|Lost to Follow-up|3|||
27842839|NCT03756883|81254329|FG001|Overall Study|Lost to Follow-up|3|||
27842840|NCT03756883|81254330|FG002|Overall Study|Lost to Follow-up|0|||
27842841|NCT03756883|81254328|FG000|Overall Study|Protocol Violation|2|||
27842842|NCT03756883|81254329|FG001|Overall Study|Protocol Violation|0|||
27842843|NCT03756883|81254330|FG002|Overall Study|Protocol Violation|1|||
27842844|NCT03756883|81254328|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
27842845|NCT03756883|81254329|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
27842846|NCT03756883|81254330|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
27842847|NCT03756883|81254328|FG000|Overall Study|Withdrawal by Subject|4|||
27842848|NCT03756883|81254329|FG001|Overall Study|Withdrawal by Subject|1|||
27504205|NCT01194830|80040757|FG001|Overall Study|Other Reason|8|||
27724462|NCT03543410|80823023|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
27724463|NCT03543410|80823024|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
27724464|NCT03543410|80823022|FG000|Overall Study|Not Due to COVID-19|2|||
27724465|NCT03543410|80823023|FG001|Overall Study|Not Due to COVID-19|0|||
27724466|NCT03543410|80823024|FG002|Overall Study|Not Due to COVID-19|1|||
27724467|NCT03634800|80823025|FG000|Overall Study|Adverse Event|1|||
27724468|NCT03634800|80823025|FG000|Overall Study|Disease Progression|4|||
27724469|NCT03634800|80823025|FG000|Overall Study|Withdrawal by Subject|1|||
27724470|NCT00647556|80823028|FG000|Overall Study|Adverse Event|0|||
27724471|NCT00647556|80823029|FG001|Overall Study|Adverse Event|1|||
27724472|NCT00647556|80823028|FG000|Overall Study|Lost to Follow-up|1|||
27724473|NCT00647556|80823029|FG001|Overall Study|Lost to Follow-up|0|||
27724474|NCT00647556|80823028|FG000|Overall Study|Protocol Violation|0|||
27842849|NCT03756883|81254330|FG002|Overall Study|Withdrawal by Subject|0|||
27842850|NCT03756883|81254328|FG000|Overall Study|Other Reasons|2|||
27504206|NCT03493464|80040758|FG000|Overall Study|Surgery not performed|1|||
27724475|NCT00647556|80823029|FG001|Overall Study|Protocol Violation|1|||
27724476|NCT00647556|80823028|FG000|Overall Study|Withdrawal by Subject|1|||
27724477|NCT00647556|80823029|FG001|Overall Study|Withdrawal by Subject|0|||
27842851|NCT03756883|81254329|FG001|Overall Study|Other Reasons|4|||
27842852|NCT03756883|81254330|FG002|Overall Study|Other Reasons|0|||
27842853|NCT02426541|81254331|FG000|Overall Study|Protocol Violation|1|||
27842854|NCT02426541|81254332|FG001|Overall Study|Protocol Violation|0|||
27842855|NCT02408120|81254333|FG000|Overall Study|Withdrawal by Subject|0|||
27842856|NCT02408120|81254334|FG001|Overall Study|Withdrawal by Subject|1|||
27842857|NCT02408120|81254333|FG000|Overall Study|Treatment Refusal|1|||
27842858|NCT02408120|81254334|FG001|Overall Study|Treatment Refusal|0|||
27842859|NCT02408120|81254333|FG000|Overall Study|Received Steroids|1|||
27842860|NCT02408120|81254334|FG001|Overall Study|Received Steroids|1|||
27842861|NCT02408120|81254333|FG000|Overall Study|Discharged same day|1|||
27842862|NCT02408120|81254334|FG001|Overall Study|Discharged same day|1|||
27842863|NCT02408120|81254333|FG000|Overall Study|Did not receive insulin|1|||
27842864|NCT02408120|81254334|FG001|Overall Study|Did not receive insulin|2|||
27842865|NCT01470417|81254337|FG000|Overall Study|Disease progression|0|||
27842866|NCT01470417|81254338|FG001|Overall Study|Disease progression|2|||
27842867|NCT01619579|81254339|FG000|Overall Study|Withdrawal by Subject|0|||
27842868|NCT01619579|81254340|FG001|Overall Study|Withdrawal by Subject|3|||
27842869|NCT01134627|81254341|FG000|Overall Study|Adverse Event|47|||
27842870|NCT01134627|81254342|FG001|Overall Study|Adverse Event|31|||
27842871|NCT01134627|81254341|FG000|Overall Study|Lost to Follow-up|1|||
27842872|NCT01134627|81254342|FG001|Overall Study|Lost to Follow-up|2|||
27842873|NCT01134627|81254341|FG000|Overall Study|Protocol Violation|3|||
27842874|NCT01134627|81254342|FG001|Overall Study|Protocol Violation|5|||
27842875|NCT01134627|81254341|FG000|Overall Study|Lack of Efficacy|2|||
27842876|NCT01134627|81254342|FG001|Overall Study|Lack of Efficacy|12|||
27842877|NCT01134627|81254341|FG000|Overall Study|Withdrawal by Subject|4|||
27842878|NCT01134627|81254342|FG001|Overall Study|Withdrawal by Subject|3|||
27842879|NCT01134627|81254341|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
27842880|NCT01134627|81254342|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
27842881|NCT01134627|81254341|FG000|Overall Study|Other|11|||
27842882|NCT01134627|81254342|FG001|Overall Study|Other|14|||
27842883|NCT04542694|81254343|FG000|Overall Study|The need for prohibited therapy|2|||
27842884|NCT04542694|81254344|FG001|Overall Study|The need for prohibited therapy|0|||
27842885|NCT04542694|81254343|FG000|Overall Study|Adverse Event|1|||
27842886|NCT04542694|81254344|FG001|Overall Study|Adverse Event|0|||
27842887|NCT04542694|81254343|FG000|Overall Study|Protocol Violation|1|||
27842888|NCT04542694|81254344|FG001|Overall Study|Protocol Violation|0|||
27842889|NCT03136406|81254348|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
27842890|NCT01231373|81254349|FG000|Overall Study|Withdrew consent prior to randomization|2|||
27842891|NCT01231373|81254350|FG001|Overall Study|Withdrew consent prior to randomization|1|||
27842892|NCT01231373|81254351|FG002|Overall Study|Withdrew consent prior to randomization|0|||
27842893|NCT01231373|81254352|FG003|Overall Study|Withdrew consent prior to randomization|0|||
27842894|NCT01231373|81254349|FG000|Overall Study|Lost to Follow-up|0|||
27842895|NCT01231373|81254350|FG001|Overall Study|Lost to Follow-up|0|||
27842896|NCT01231373|81254351|FG002|Overall Study|Lost to Follow-up|0|||
27613500|NCT00363896|80426669|FG001|Overall Study|Lack of Efficacy|8|||
27724478|NCT00647556|80823028|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
27842897|NCT01231373|81254352|FG003|Overall Study|Lost to Follow-up|1|||
27842898|NCT01231373|81254349|FG000|Overall Study|Withdrew Consent|1|||
27842899|NCT01231373|81254350|FG001|Overall Study|Withdrew Consent|0|||
27724479|NCT00647556|80823029|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
27842900|NCT01231373|81254351|FG002|Overall Study|Withdrew Consent|0|||
27842901|NCT01231373|81254352|FG003|Overall Study|Withdrew Consent|0|||
27842902|NCT01321697|81254353|FG000|Overall Study|Study Terminated|7|||
27842903|NCT00595335|81254354|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
27842904|NCT00595335|81254355|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
27504207|NCT05567783|80040759|FG000|Overall Study|Death|2|||
27842905|NCT00595335|81254354|FG000|Baseline to Six Months|Disease Progression|1|||
27842906|NCT00595335|81254355|FG001|Baseline to Six Months|Disease Progression|1|||
27842907|NCT00595335|81254354|FG000|Baseline to Six Months|Adverse Event|1|||
27842908|NCT00595335|81254355|FG001|Baseline to Six Months|Adverse Event|0|||
27842909|NCT00595335|81254354|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
27504208|NCT05567783|80040760|FG001|Overall Study|Death|3|||
27504209|NCT05567783|80040761|FG002|Overall Study|Death|0|||
27504210|NCT05567783|80040759|FG000|Overall Study|Lost to Follow-up|25|||
27504211|NCT05567783|80040760|FG001|Overall Study|Lost to Follow-up|19|||
27504212|NCT05567783|80040761|FG002|Overall Study|Lost to Follow-up|17|||
27504213|NCT05567783|80040759|FG000|Overall Study|Physician Decision|10|||
27613501|NCT00363896|80426668|FG000|Overall Study|Protocol Violation|6|||
27613502|NCT00363896|80426669|FG001|Overall Study|Protocol Violation|1|||
27613503|NCT00363896|80426668|FG000|Overall Study|Lost to Follow-up|3|||
27613504|NCT00363896|80426669|FG001|Overall Study|Lost to Follow-up|0|||
27613505|NCT00363896|80426668|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
27613506|NCT00363896|80426669|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
27613507|NCT00363896|80426668|FG000|Overall Study|Other|1|||
27613508|NCT00363896|80426669|FG001|Overall Study|Other|2|||
27613509|NCT01556763|80426670|FG000|Overall Study|Withdrawal by Subject|0|||
27613510|NCT01556763|80426671|FG001|Overall Study|Withdrawal by Subject|1|||
27613511|NCT01556763|80426672|FG002|Overall Study|Withdrawal by Subject|0|||
27613512|NCT01928225|80426673|FG000|Overall Study|Pregnancy|1|||
27613513|NCT01928225|80426674|FG001|Overall Study|Pregnancy|0|||
27613514|NCT01928225|80426673|FG000|Overall Study|basaloid cervical cancer|1|||
27613515|NCT01928225|80426674|FG001|Overall Study|basaloid cervical cancer|0|||
27613516|NCT01928225|80426673|FG000|Overall Study|Lost to Follow-up|1|||
27613517|NCT01928225|80426674|FG001|Overall Study|Lost to Follow-up|3|||
27842910|NCT00595335|81254355|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
27504214|NCT05567783|80040760|FG001|Overall Study|Physician Decision|7|||
27504215|NCT05567783|80040761|FG002|Overall Study|Physician Decision|9|||
27504216|NCT05567783|80040759|FG000|Overall Study|Study Terminated by Sponsor|924|||
27613518|NCT03075904|80426675|FG000|Overall Study|Physician Decision|3|||
27613519|NCT03075904|80426675|FG000|Overall Study|Need for Medication not Permitted|1|||
27613520|NCT00794820|80426676|FG000|Overall Study|Adverse Event|11|||
27613521|NCT00794820|80426676|FG000|Overall Study|Secondary Malignancies|2|||
27613522|NCT00794820|80426676|FG000|Overall Study|Resistant Disease|2|||
27842911|NCT00595335|81254354|FG000|Six Months to Twelve Months|Disease Progression|1|||
27842912|NCT00595335|81254355|FG001|Six Months to Twelve Months|Disease Progression|0|||
27842913|NCT03078478|81254365|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
27842914|NCT03078478|81254366|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
27842915|NCT03078478|81254365|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
27842916|NCT03078478|81254366|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
27842917|NCT03078478|81254365|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
27842918|NCT03078478|81254366|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
27842919|NCT03078478|81254365|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
27842920|NCT03078478|81254366|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
27842921|NCT03078478|81254365|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
27842922|NCT03078478|81254366|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
27842923|NCT03078478|81254365|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
27842924|NCT03078478|81254366|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
27842925|NCT03078478|81254365|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
27842926|NCT03078478|81254366|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
27842927|NCT03078478|81254365|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
27842928|NCT03078478|81254366|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
27842929|NCT00784134|81254370|FG000|Overall Study|Lost to Follow-up|3|||
27842930|NCT00784134|81254371|FG001|Overall Study|Lost to Follow-up|6|||
27842931|NCT01867606|81254372|FG000|Overall Study|Withdrawal by Subject|10|||
27842932|NCT01867606|81254373|FG001|Overall Study|Withdrawal by Subject|14|||
27842933|NCT01867606|81254372|FG000|Overall Study|Protocol Violation|0|||
27842934|NCT01867606|81254373|FG001|Overall Study|Protocol Violation|1|||
27842935|NCT00413218|81254374|FG000|Overall Study|Randomized but didn't receive study drug|2|||
27842936|NCT00413218|81254375|FG001|Overall Study|Randomized but didn't receive study drug|8|||
27842937|NCT00413218|81254374|FG000|Overall Study|Death|57|||
27842938|NCT00413218|81254375|FG001|Overall Study|Death|56|||
27842939|NCT00413218|81254374|FG000|Overall Study|Lost to Follow-up|14|||
27842940|NCT00413218|81254375|FG001|Overall Study|Lost to Follow-up|17|||
27842941|NCT00413218|81254374|FG000|Overall Study|Admin|20|||
27842942|NCT00413218|81254375|FG001|Overall Study|Admin|14|||
27842943|NCT00413218|81254374|FG000|Overall Study|Missing|1|||
27842944|NCT00413218|81254375|FG001|Overall Study|Missing|0|||
27842945|NCT00413218|81254374|FG000|Overall Study|Withdrawal by Subject|9|||
27842946|NCT00413218|81254375|FG001|Overall Study|Withdrawal by Subject|1|||
27842947|NCT02447887|81254377|FG000|Overall Study|Study was terminated|3|||
27842948|NCT02972515|81254378|FG000|Overall Study|Lost to Follow-up|78|||
27842949|NCT01785615|81254379|FG000|Dietary Phase|Lost to Follow-up|0|||
27842950|NCT01785615|81254380|FG001|Dietary Phase|Lost to Follow-up|0|||
27842951|NCT01785615|81254381|FG002|Dietary Phase|Lost to Follow-up|0|||
27842952|NCT01785615|81254382|FG003|Dietary Phase|Lost to Follow-up|24|||
27842953|NCT03558139|81254383|FG000|Overall Study|Consent Withdrawn|1|||
27842954|NCT03558139|81254384|FG001|Overall Study|Consent Withdrawn|1|||
27842955|NCT03558139|81254385|FG002|Overall Study|Consent Withdrawn|4|||
27842956|NCT03558139|81254383|FG000|Overall Study|Death|5|||
27842957|NCT03558139|81254384|FG001|Overall Study|Death|3|||
27842958|NCT03558139|81254385|FG002|Overall Study|Death|8|||
27842959|NCT03558139|81254383|FG000|Overall Study|Lost to Follow-up|0|||
27842960|NCT03558139|81254384|FG001|Overall Study|Lost to Follow-up|0|||
27842961|NCT03558139|81254385|FG002|Overall Study|Lost to Follow-up|3|||
27842962|NCT03558139|81254383|FG000|Overall Study|Study Ended Per Protocol|0|||
27842963|NCT03558139|81254384|FG001|Overall Study|Study Ended Per Protocol|3|||
27842964|NCT03558139|81254385|FG002|Overall Study|Study Ended Per Protocol|6|||
27842965|NCT01074008|81254386|FG000|Overall Study|Adverse Event|0|||
27842966|NCT01074008|81254387|FG001|Overall Study|Adverse Event|1|||
27842967|NCT01074008|81254388|FG002|Overall Study|Adverse Event|0|||
27842968|NCT01074008|81254389|FG003|Overall Study|Adverse Event|0|||
27842969|NCT01074008|81254390|FG004|Overall Study|Adverse Event|0|||
27842970|NCT01074008|81254391|FG005|Overall Study|Adverse Event|0|||
27842971|NCT01074008|81254392|FG006|Overall Study|Adverse Event|0|||
27842972|NCT01074008|81254393|FG007|Overall Study|Adverse Event|0|||
27842973|NCT01074008|81254394|FG008|Overall Study|Adverse Event|0|||
27842974|NCT01074008|81254386|FG000|Overall Study|Withdrawal by Subject|1|||
27842975|NCT01074008|81254387|FG001|Overall Study|Withdrawal by Subject|1|||
27842976|NCT01074008|81254388|FG002|Overall Study|Withdrawal by Subject|1|||
27842977|NCT01074008|81254389|FG003|Overall Study|Withdrawal by Subject|0|||
27842978|NCT01074008|81254390|FG004|Overall Study|Withdrawal by Subject|1|||
27504217|NCT05567783|80040760|FG001|Overall Study|Study Terminated by Sponsor|937|||
27842979|NCT01074008|81254391|FG005|Overall Study|Withdrawal by Subject|0|||
27842980|NCT01074008|81254392|FG006|Overall Study|Withdrawal by Subject|0|||
27842981|NCT01074008|81254393|FG007|Overall Study|Withdrawal by Subject|0|||
27842982|NCT01074008|81254394|FG008|Overall Study|Withdrawal by Subject|0|||
27842983|NCT01074008|81254386|FG000|Overall Study|Lost to Follow-up|0|||
27842984|NCT01074008|81254387|FG001|Overall Study|Lost to Follow-up|1|||
27842985|NCT01074008|81254388|FG002|Overall Study|Lost to Follow-up|1|||
27842986|NCT01074008|81254389|FG003|Overall Study|Lost to Follow-up|1|||
27842987|NCT01074008|81254390|FG004|Overall Study|Lost to Follow-up|1|||
27842988|NCT01074008|81254391|FG005|Overall Study|Lost to Follow-up|0|||
27842989|NCT01074008|81254392|FG006|Overall Study|Lost to Follow-up|1|||
27842990|NCT01074008|81254393|FG007|Overall Study|Lost to Follow-up|0|||
27842991|NCT01074008|81254394|FG008|Overall Study|Lost to Follow-up|4|||
27842992|NCT03566238|81254395|FG000|Overall Study|Adverse Event|0|||
27842993|NCT03566238|81254396|FG001|Overall Study|Adverse Event|1|||
27842994|NCT03566238|81254397|FG002|Overall Study|Adverse Event|0|||
27842995|NCT03566238|81254395|FG000|Overall Study|Lack of Efficacy|4|||
27842996|NCT03566238|81254396|FG001|Overall Study|Lack of Efficacy|2|||
27842997|NCT03566238|81254397|FG002|Overall Study|Lack of Efficacy|5|||
27842998|NCT03566238|81254395|FG000|Overall Study|Other|1|||
27842999|NCT03566238|81254396|FG001|Overall Study|Other|0|||
27843000|NCT03566238|81254397|FG002|Overall Study|Other|0|||
27843001|NCT04046549|81254398|FG000|Overall Study|Adverse Event|1|||
27843002|NCT04046549|81254398|FG000|Overall Study|Physician Decision|1|||
27843003|NCT04046549|81254398|FG000|Overall Study|Withdrawal by Subject|3|||
27843004|NCT04046549|81254398|FG000|Overall Study|Other, Not Specified|5|||
27843005|NCT00089076|81254399|FG000|Overall Study|Alternate Therapy|1|||
27843006|NCT00089076|81254399|FG000|Overall Study|Withdrawal by Subject|2|||
27843007|NCT00089076|81254399|FG000|Overall Study|Progression|7|||
27843008|NCT02339090|81254400|FG000|Overall Study|Adverse Event|1|||
27843009|NCT02339090|81254401|FG001|Overall Study|Adverse Event|0|||
27843010|NCT02339090|81254400|FG000|Overall Study|Lost to Follow-up|0|||
27843011|NCT02339090|81254401|FG001|Overall Study|Lost to Follow-up|1|||
27843012|NCT02339090|81254400|FG000|Overall Study|Non-compliance With Study Drug|0|||
27843013|NCT02339090|81254401|FG001|Overall Study|Non-compliance With Study Drug|1|||
27843014|NCT02339090|81254400|FG000|Overall Study|Withdrawal by Subject|2|||
27843015|NCT02339090|81254401|FG001|Overall Study|Withdrawal by Subject|1|||
27843016|NCT02339090|81254400|FG000|Overall Study|Poor Growth|3|||
27843017|NCT02339090|81254401|FG001|Overall Study|Poor Growth|0|||
27843018|NCT02339090|81254400|FG000|Overall Study|Randomized but not treated|0|||
27843019|NCT02339090|81254401|FG001|Overall Study|Randomized but not treated|2|||
27843020|NCT03554317|81254402|FG000|Overall Study|Withdrawal by Subject|1|||
27843021|NCT03554317|81254402|FG000|Overall Study|PSA Progression|3|||
27843022|NCT03554317|81254402|FG000|Overall Study|Radiographic Progression|4|||
27843023|NCT01636934|81254405|FG000|Overall Study|Withdrawal by Subject|3|||
27843024|NCT01636934|81254406|FG001|Overall Study|Withdrawal by Subject|2|||
27843025|NCT01636934|81254405|FG000|Overall Study|Chemo cancel|1|||
27843026|NCT01636934|81254406|FG001|Overall Study|Chemo cancel|0|||
27843027|NCT01636934|81254405|FG000|Overall Study|Too ill to continue|1|||
27843028|NCT01636934|81254406|FG001|Overall Study|Too ill to continue|0|||
27843029|NCT01636934|81254405|FG000|Overall Study|Never started study medication|1|||
27843030|NCT01636934|81254406|FG001|Overall Study|Never started study medication|1|||
27843031|NCT03430011|81254410|FG000|Pre-Treatment|Death|1|||
27843032|NCT03430011|81254411|FG001|Pre-Treatment|Death|0|||
27843033|NCT03430011|81254412|FG002|Pre-Treatment|Death|0|||
27843034|NCT03430011|81254413|FG003|Pre-Treatment|Death|0|||
27843035|NCT03430011|81254414|FG004|Pre-Treatment|Death|1|||
27843036|NCT03430011|81254415|FG005|Pre-Treatment|Death|0|||
27843037|NCT03430011|81254416|FG006|Pre-Treatment|Death|1|||
27843038|NCT03430011|81254417|FG007|Pre-Treatment|Death|0|||
27843039|NCT03430011|81254410|FG000|Pre-Treatment|Screen Fail|0|||
27843040|NCT03430011|81254411|FG001|Pre-Treatment|Screen Fail|0|||
27843041|NCT03430011|81254412|FG002|Pre-Treatment|Screen Fail|0|||
27843042|NCT03430011|81254413|FG003|Pre-Treatment|Screen Fail|0|||
27843043|NCT03430011|81254414|FG004|Pre-Treatment|Screen Fail|1|||
27843044|NCT03430011|81254415|FG005|Pre-Treatment|Screen Fail|0|||
27843045|NCT03430011|81254416|FG006|Pre-Treatment|Screen Fail|0|||
27843046|NCT03430011|81254417|FG007|Pre-Treatment|Screen Fail|0|||
27843047|NCT03430011|81254410|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
27843048|NCT03430011|81254411|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
27843049|NCT03430011|81254412|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
27843050|NCT03430011|81254413|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
27843051|NCT03430011|81254414|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
27504218|NCT05567783|80040761|FG002|Overall Study|Study Terminated by Sponsor|941|||
27843052|NCT03430011|81254415|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
27843053|NCT03430011|81254416|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
27504219|NCT05567783|80040759|FG000|Overall Study|Withdrawal by Subject|23|||
27843054|NCT03430011|81254417|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
27843055|NCT03430011|81254410|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
27843056|NCT03430011|81254411|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
27843057|NCT03430011|81254412|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
27843058|NCT03430011|81254413|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
27843059|NCT03430011|81254414|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
27843060|NCT03430011|81254415|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
27843061|NCT03430011|81254416|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
27843062|NCT03430011|81254417|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
27843063|NCT03430011|81254410|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
27843064|NCT03430011|81254411|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
27843065|NCT03430011|81254412|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
27843066|NCT03430011|81254413|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
27843067|NCT03430011|81254414|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
27843068|NCT03430011|81254415|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
27843069|NCT03430011|81254416|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
27843070|NCT03430011|81254417|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
27843071|NCT03430011|81254410|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
27843072|NCT03430011|81254411|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
27843073|NCT03430011|81254412|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
27843074|NCT03430011|81254413|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
27843075|NCT03430011|81254414|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
27843076|NCT03430011|81254415|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
27843077|NCT03430011|81254416|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
27843078|NCT03430011|81254417|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
27843079|NCT03430011|81254410|FG000|JCARH125 Treatment|Death|4|||
27843080|NCT03430011|81254411|FG001|JCARH125 Treatment|Death|19|||
27843081|NCT03430011|81254412|FG002|JCARH125 Treatment|Death|10|||
27843082|NCT03430011|81254413|FG003|JCARH125 Treatment|Death|8|||
27843083|NCT03430011|81254414|FG004|JCARH125 Treatment|Death|5|||
27843084|NCT03430011|81254415|FG005|JCARH125 Treatment|Death|3|||
27843085|NCT03430011|81254416|FG006|JCARH125 Treatment|Death|4|||
27843086|NCT03430011|81254417|FG007|JCARH125 Treatment|Death|2|||
27843087|NCT03430011|81254410|FG000|JCARH125 Treatment|Other reasons|1|||
27843088|NCT03430011|81254411|FG001|JCARH125 Treatment|Other reasons|0|||
27843089|NCT03430011|81254412|FG002|JCARH125 Treatment|Other reasons|4|||
27843090|NCT03430011|81254413|FG003|JCARH125 Treatment|Other reasons|2|||
27843091|NCT03430011|81254414|FG004|JCARH125 Treatment|Other reasons|2|||
27843092|NCT03430011|81254415|FG005|JCARH125 Treatment|Other reasons|1|||
27843093|NCT03430011|81254416|FG006|JCARH125 Treatment|Other reasons|3|||
27843094|NCT03430011|81254417|FG007|JCARH125 Treatment|Other reasons|2|||
27843095|NCT00129116|81254418|FG000|Primary Phase|Lost to Follow-up|1|||
27843096|NCT00129116|81254419|FG001|Primary Phase|Lost to Follow-up|1|||
27843097|NCT00129116|81254420|FG002|Primary Phase|Lost to Follow-up|0|||
27843098|NCT00129116|81254421|FG003|Primary Phase|Lost to Follow-up|1|||
27843099|NCT00129116|81254422|FG004|Primary Phase|Lost to Follow-up|1|||
27843100|NCT00129116|81254418|FG000|Primary Phase|Protocol Violation|0|||
27843101|NCT00129116|81254419|FG001|Primary Phase|Protocol Violation|1|||
27843102|NCT00129116|81254420|FG002|Primary Phase|Protocol Violation|0|||
27843103|NCT00129116|81254421|FG003|Primary Phase|Protocol Violation|0|||
27843104|NCT00129116|81254422|FG004|Primary Phase|Protocol Violation|0|||
27843105|NCT00129116|81254418|FG000|Primary Phase|Adverse Event|1|||
27843106|NCT00129116|81254419|FG001|Primary Phase|Adverse Event|1|||
27843107|NCT00129116|81254420|FG002|Primary Phase|Adverse Event|0|||
27843108|NCT00129116|81254421|FG003|Primary Phase|Adverse Event|0|||
27504220|NCT05567783|80040760|FG001|Overall Study|Withdrawal by Subject|27|||
27504221|NCT05567783|80040761|FG002|Overall Study|Withdrawal by Subject|24|||
27504222|NCT05567783|80040759|FG000|Overall Study|Incarcerated|1|||
27504223|NCT05567783|80040760|FG001|Overall Study|Incarcerated|0|||
27504224|NCT05567783|80040761|FG002|Overall Study|Incarcerated|0|||
27843109|NCT00129116|81254422|FG004|Primary Phase|Adverse Event|0|||
27843110|NCT00129116|81254418|FG000|Primary Phase|Withdrawal by Subject|0|||
27843111|NCT00129116|81254419|FG001|Primary Phase|Withdrawal by Subject|1|||
27843112|NCT00129116|81254420|FG002|Primary Phase|Withdrawal by Subject|0|||
27843113|NCT00129116|81254421|FG003|Primary Phase|Withdrawal by Subject|0|||
27843114|NCT00129116|81254422|FG004|Primary Phase|Withdrawal by Subject|0|||
27843115|NCT00129116|81254418|FG000|Primary Phase|Other|0|||
27843116|NCT00129116|81254419|FG001|Primary Phase|Other|0|||
27843117|NCT00129116|81254420|FG002|Primary Phase|Other|1|||
27843118|NCT00129116|81254421|FG003|Primary Phase|Other|0|||
27843119|NCT00129116|81254422|FG004|Primary Phase|Other|0|||
27843120|NCT00129116|81254418|FG000|Booster Phase|Lost to Follow-up|2|||
27843121|NCT00129116|81254419|FG001|Booster Phase|Lost to Follow-up|0|||
27843122|NCT00129116|81254420|FG002|Booster Phase|Lost to Follow-up|0|||
27843123|NCT00129116|81254421|FG003|Booster Phase|Lost to Follow-up|0|||
27843124|NCT00129116|81254422|FG004|Booster Phase|Lost to Follow-up|1|||
27843125|NCT03259789|81254423|FG000|Overall Study|Adverse Event|3|||
27843126|NCT03259789|81254424|FG001|Overall Study|Adverse Event|2|||
27843127|NCT03259789|81254425|FG002|Overall Study|Adverse Event|1|||
27843128|NCT03259789|81254423|FG000|Overall Study|Withdrawal by Subject|9|||
27843129|NCT03259789|81254424|FG001|Overall Study|Withdrawal by Subject|5|||
27843130|NCT03259789|81254425|FG002|Overall Study|Withdrawal by Subject|1|||
27843131|NCT03259789|81254423|FG000|Overall Study|Lost to Follow-up|5|||
27843132|NCT03259789|81254424|FG001|Overall Study|Lost to Follow-up|9|||
27843133|NCT03259789|81254425|FG002|Overall Study|Lost to Follow-up|4|||
27843134|NCT03259789|81254423|FG000|Overall Study|Physician Decision|0|||
27843135|NCT03259789|81254424|FG001|Overall Study|Physician Decision|1|||
27843136|NCT03259789|81254425|FG002|Overall Study|Physician Decision|0|||
27843137|NCT00529217|81254426|FG000|Overall Study|Lack of Efficacy|2|||
27843138|NCT00529217|81254426|FG000|Overall Study|Unable to adhere to study schedule|2|||
27843139|NCT00179673|81254427|FG000|Overall Study|Adverse Event|7|||
27843140|NCT00179673|81254427|FG000|Overall Study|Lack of Efficacy|15|||
27843141|NCT00179673|81254427|FG000|Overall Study|Withdrawal by Subject|3|||
27843142|NCT00179673|81254427|FG000|Overall Study|Death|4|||
27843143|NCT00179673|81254427|FG000|Overall Study|Other Observations and options|14|||
27843144|NCT01546519|81254428|FG000|Overall Study|Adverse Event|0|||
27843145|NCT01546519|81254429|FG001|Overall Study|Adverse Event|0|||
27843146|NCT01546519|81254430|FG002|Overall Study|Adverse Event|1|||
27843147|NCT01546519|81254431|FG003|Overall Study|Adverse Event|1|||
27843148|NCT01546519|81254428|FG000|Overall Study|Death|0|||
27843149|NCT01546519|81254429|FG001|Overall Study|Death|1|||
27843150|NCT01546519|81254430|FG002|Overall Study|Death|3|||
27843151|NCT01546519|81254431|FG003|Overall Study|Death|1|||
27843152|NCT01546519|81254428|FG000|Overall Study|related to disease progression|2|||
27843153|NCT01546519|81254429|FG001|Overall Study|related to disease progression|2|||
27843154|NCT01546519|81254430|FG002|Overall Study|related to disease progression|2|||
27843155|NCT01546519|81254431|FG003|Overall Study|related to disease progression|1|||
27843156|NCT01546519|81254428|FG000|Overall Study|Physician Decision|6|||
27843157|NCT01546519|81254429|FG001|Overall Study|Physician Decision|5|||
27843158|NCT01546519|81254430|FG002|Overall Study|Physician Decision|2|||
27843159|NCT01546519|81254431|FG003|Overall Study|Physician Decision|3|||
27843160|NCT01546519|81254428|FG000|Overall Study|Withdrawal by Subject|1|||
27843161|NCT01546519|81254429|FG001|Overall Study|Withdrawal by Subject|0|||
27843162|NCT01546519|81254430|FG002|Overall Study|Withdrawal by Subject|0|||
27843163|NCT01546519|81254431|FG003|Overall Study|Withdrawal by Subject|0|||
27843164|NCT00575380|81254432|FG000|Overall Study|Withdrawal by Subject|1|||
27843165|NCT00575380|81254433|FG001|Overall Study|Withdrawal by Subject|0|||
27843166|NCT00575380|81254432|FG000|Overall Study|Adverse Event|0|||
27843167|NCT00575380|81254433|FG001|Overall Study|Adverse Event|1|||
27843168|NCT00575380|81254432|FG000|Overall Study|Various|0|||
27843169|NCT00575380|81254433|FG001|Overall Study|Various|2|||
27843170|NCT02413294|81254434|FG000|Overall Study|Withdrawal by Subject|1|||
27843171|NCT00587431|81254435|FG000|Overall Study|Adverse Event|1|||
27843172|NCT00587431|81254436|FG001|Overall Study|Adverse Event|0|||
27843173|NCT00587431|81254435|FG000|Overall Study|Withdrawal by Subject|0|||
27843174|NCT00587431|81254436|FG001|Overall Study|Withdrawal by Subject|1|||
27843175|NCT04406194|81254437|FG000|Period 1|Withdrawal by Subject|0|||
27892935|NCT00782184|81441420|FG001|Overall Study|Withdrawal by Subject|2|||
27892936|NCT04852679|81441421|FG000|Main Intervention Period|Withdrawal by Subject|3|||
27892937|NCT04852679|81441421|FG000|Main Intervention Period|Adverse Event|1|||
27892938|NCT04852679|81441421|FG000|Main Intervention Period|Progressive Disease|16|||
27892939|NCT04852679|81441421|FG000|Main Intervention Period|Refused study visit|1|||
27892940|NCT04852679|81441421|FG000|Independent Injection Period|Missed study visit|1|||
27892941|NCT02908672|81443850|FG000|Overall Study|Death|112|||
27892942|NCT02908672|81443851|FG001|Overall Study|Death|93|||
27892943|NCT02908672|81443850|FG000|Overall Study|Lost to Follow-up|3|||
27892944|NCT02908672|81443851|FG001|Overall Study|Lost to Follow-up|3|||
27892945|NCT02908672|81443850|FG000|Overall Study|Other|2|||
27892946|NCT02908672|81443851|FG001|Overall Study|Other|0|||
27892947|NCT02908672|81443850|FG000|Overall Study|Protocol Violation|1|||
27843176|NCT04406194|81254438|FG001|Period 1|Withdrawal by Subject|1|||
27843177|NCT04979858|81254439|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
27843178|NCT04979858|81254440|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
27843179|NCT01115855|81254441|FG000|Overall Study|Adverse Event|16|||
27843180|NCT01115855|81254442|FG001|Overall Study|Adverse Event|18|||
27843181|NCT01115855|81254441|FG000|Overall Study|Death|6|||
27843182|NCT01115855|81254442|FG001|Overall Study|Death|5|||
27892948|NCT02908672|81443851|FG001|Overall Study|Protocol Violation|1|||
27843183|NCT01115855|81254441|FG000|Overall Study|Lab Abnormality|1|||
27843184|NCT01115855|81254442|FG001|Overall Study|Lab Abnormality|1|||
27504225|NCT05567783|80040759|FG000|Overall Study|Participant randomized in error|4|||
27504226|NCT05567783|80040760|FG001|Overall Study|Participant randomized in error|2|||
27504227|NCT05567783|80040761|FG002|Overall Study|Participant randomized in error|2|||
27504228|NCT01046396|80040762|FG000|Overall Study|Withdrawal by Subject|5|||
27504229|NCT04949490|80040763|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
27504230|NCT04949490|80040764|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
27504231|NCT04949490|80040765|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
27504232|NCT04949490|80040766|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
27613523|NCT00794820|80426676|FG000|Overall Study|Ineligible/Screen Failure|1|||
27613524|NCT02111213|80426677|FG000|Overall Study|Withdrawal by Subject|3|||
27843185|NCT01115855|81254441|FG000|Overall Study|Protocol Violation|0|||
27843186|NCT01115855|81254442|FG001|Overall Study|Protocol Violation|1|||
27843187|NCT01115855|81254441|FG000|Overall Study|Withdrawal by Subject|5|||
27843188|NCT01115855|81254442|FG001|Overall Study|Withdrawal by Subject|5|||
27843189|NCT01115855|81254441|FG000|Overall Study|Other|8|||
27843190|NCT01115855|81254442|FG001|Overall Study|Other|6|||
27843191|NCT01009515|81254448|FG000|Overall Study|Withdrawal by Subject|3|||
27843192|NCT03086135|81254452|FG000|Overall Study|Adverse Event|1|||
27843193|NCT03086135|81254452|FG000|Overall Study|Lost to Follow-up|2|||
27843194|NCT03170869|81254455|FG000|Overall Study|Protocol Violation|5|||
27843195|NCT03170869|81254455|FG000|Overall Study|Early study termination|3|||
27843196|NCT01144403|81254456|FG000|Overall Study|Lost to Follow-up|3|||
27843197|NCT01144403|81254456|FG000|Overall Study|Death|1|||
27843198|NCT01144403|81254456|FG000|Overall Study|Adverse Event|1|||
27843199|NCT01705717|81254462|FG000|Overall Study|Adverse Event|2|||
27843200|NCT01705717|81254463|FG001|Overall Study|Adverse Event|2|||
27843201|NCT01705717|81254462|FG000|Overall Study|Lack of Efficacy|0|||
27613525|NCT02111213|80426678|FG001|Overall Study|Withdrawal by Subject|2|||
27613526|NCT02111213|80426677|FG000|Overall Study|Lost to Follow-up|3|||
27613527|NCT02111213|80426678|FG001|Overall Study|Lost to Follow-up|4|||
27613528|NCT02118714|80426679|FG000|Overall Study|Lost to Follow-up|2|||
27613529|NCT02118714|80426679|FG000|Overall Study|Protocol Violation|1|||
27613530|NCT03548064|80426680|FG000|Overall Study|Withdrawal by Subject|0|||
27613531|NCT03548064|80426681|FG001|Overall Study|Withdrawal by Subject|0|||
27613532|NCT03548064|80426682|FG002|Overall Study|Withdrawal by Subject|0|||
27613533|NCT03548064|80426683|FG003|Overall Study|Withdrawal by Subject|1|||
27613534|NCT03548064|80426684|FG004|Overall Study|Withdrawal by Subject|0|||
27613535|NCT03548064|80426685|FG005|Overall Study|Withdrawal by Subject|0|||
27613536|NCT03548064|80426686|FG006|Overall Study|Withdrawal by Subject|0|||
27613537|NCT03548064|80426687|FG007|Overall Study|Withdrawal by Subject|0|||
27613538|NCT03548064|80426680|FG000|Overall Study|Lost to Follow-up|0|||
27613539|NCT03548064|80426681|FG001|Overall Study|Lost to Follow-up|0|||
27613540|NCT03548064|80426682|FG002|Overall Study|Lost to Follow-up|0|||
27613541|NCT03548064|80426683|FG003|Overall Study|Lost to Follow-up|0|||
27613542|NCT03548064|80426684|FG004|Overall Study|Lost to Follow-up|2|||
27613543|NCT03548064|80426685|FG005|Overall Study|Lost to Follow-up|0|||
27613544|NCT03548064|80426686|FG006|Overall Study|Lost to Follow-up|0|||
27613545|NCT03548064|80426687|FG007|Overall Study|Lost to Follow-up|0|||
27613546|NCT03548064|80426680|FG000|Overall Study|Covid-19 Pandemic|0|||
27613547|NCT03548064|80426681|FG001|Overall Study|Covid-19 Pandemic|0|||
27613548|NCT03548064|80426682|FG002|Overall Study|Covid-19 Pandemic|0|||
27613549|NCT03548064|80426683|FG003|Overall Study|Covid-19 Pandemic|0|||
27613550|NCT03548064|80426684|FG004|Overall Study|Covid-19 Pandemic|10|||
27613551|NCT03548064|80426685|FG005|Overall Study|Covid-19 Pandemic|3|||
27613552|NCT03548064|80426686|FG006|Overall Study|Covid-19 Pandemic|0|||
27613553|NCT03548064|80426687|FG007|Overall Study|Covid-19 Pandemic|0|||
27613554|NCT01364727|80426692|FG000|Overall Study|Not Eligible|2|||
27724480|NCT03261531|80823032|FG000|Overall Study|Withdrawal by Subject|4|||
27843202|NCT01705717|81254463|FG001|Overall Study|Lack of Efficacy|1|||
27843203|NCT01705717|81254462|FG000|Overall Study|Other|0|||
27843204|NCT01705717|81254463|FG001|Overall Study|Other|2|||
27843205|NCT02618382|81254468|FG000|Overall Study|Physician Decision|1|||
27843206|NCT02618382|81254468|FG000|Overall Study|Withdrawal by Subject|1|||
27843207|NCT02618382|81254468|FG000|Overall Study|Protocol Violation|1|||
27892949|NCT02908672|81443850|FG000|Overall Study|Withdrawal by Subject|13|||
27892950|NCT02908672|81443851|FG001|Overall Study|Withdrawal by Subject|18|||
27613555|NCT01254305|80426693|FG000|Overall Study|Adverse Event|6|||
27843208|NCT04117945|81254470|FG000|Overall Study|Death|1|||
27843209|NCT04117945|81254471|FG001|Overall Study|Death|0|||
27613556|NCT01254305|80426694|FG001|Overall Study|Adverse Event|3|||
27613557|NCT01254305|80426695|FG002|Overall Study|Adverse Event|2|||
27613558|NCT01254305|80426693|FG000|Overall Study|Lack of Efficacy|1|||
27613559|NCT01254305|80426694|FG001|Overall Study|Lack of Efficacy|0|||
27613560|NCT01254305|80426695|FG002|Overall Study|Lack of Efficacy|1|||
27613561|NCT01254305|80426693|FG000|Overall Study|Protocol Violation|1|||
27613562|NCT01254305|80426694|FG001|Overall Study|Protocol Violation|7|||
27843210|NCT04117945|81254470|FG000|Overall Study|Withdrawal by Subject|3|||
27843211|NCT04117945|81254471|FG001|Overall Study|Withdrawal by Subject|1|||
27892951|NCT02908672|81443850|FG000|Overall Study|Study is ongoing|124|||
27843212|NCT04117945|81254470|FG000|Overall Study|Disease Progression|0|||
27843213|NCT04117945|81254471|FG001|Overall Study|Disease Progression|2|||
27843214|NCT04117945|81254470|FG000|Overall Study|Ineligible|8|||
27843215|NCT04117945|81254471|FG001|Overall Study|Ineligible|7|||
27843216|NCT04211766|81254472|FG000|Overall Study|Withdrawal by Subject|5|||
27843217|NCT04211766|81254473|FG001|Overall Study|Withdrawal by Subject|1|||
27843218|NCT00442351|81254474|FG000|Overall Study|Administrative|6|||
27843219|NCT00442351|81254475|FG001|Overall Study|Administrative|5|||
27843220|NCT00442351|81254474|FG000|Overall Study|Did not meet protocol eligibility|1|||
27843221|NCT00442351|81254475|FG001|Overall Study|Did not meet protocol eligibility|0|||
27843222|NCT00442351|81254474|FG000|Overall Study|Other|0|||
27843223|NCT00442351|81254475|FG001|Overall Study|Other|1|||
27843224|NCT00559364|81254476|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
27843225|NCT00559364|81254477|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
27843226|NCT00685035|81254478|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
27843227|NCT00685035|81254479|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
27843228|NCT00732160|81254481|FG000|Overall Study|Adverse Event|1|||
27843229|NCT00732160|81254482|FG001|Overall Study|Adverse Event|0|||
27843230|NCT00732160|81254483|FG002|Overall Study|Adverse Event|1|||
27843231|NCT00732160|81254484|FG003|Overall Study|Adverse Event|1|||
27843232|NCT00732160|81254481|FG000|Overall Study|scheduling|4|||
27843233|NCT00732160|81254482|FG001|Overall Study|scheduling|4|||
27843234|NCT00732160|81254483|FG002|Overall Study|scheduling|2|||
27843235|NCT00732160|81254484|FG003|Overall Study|scheduling|1|||
27843236|NCT00500318|81254487|FG000|Overall Study|Adverse Event|3|||
27843237|NCT00500318|81254488|FG001|Overall Study|Adverse Event|8|||
27843238|NCT00500318|81254487|FG000|Overall Study|Protocol Violation|1|||
27843239|NCT00500318|81254488|FG001|Overall Study|Protocol Violation|3|||
27843240|NCT00500318|81254487|FG000|Overall Study|Withdrawal by Subject|1|||
27843241|NCT00500318|81254488|FG001|Overall Study|Withdrawal by Subject|2|||
27843242|NCT00500318|81254487|FG000|Overall Study|Lack of Efficacy|0|||
27843243|NCT00500318|81254488|FG001|Overall Study|Lack of Efficacy|3|||
27843244|NCT00500318|81254487|FG000|Overall Study|Other Reason|0|||
27843245|NCT00500318|81254488|FG001|Overall Study|Other Reason|1|||
27843246|NCT01857206|81254489|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
27843247|NCT01857206|81254490|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
27843248|NCT01857206|81254489|FG000|Overall Study|Lost to Follow-up|9|||
27843249|NCT01857206|81254490|FG001|Overall Study|Lost to Follow-up|6|||
27843250|NCT01857206|81254489|FG000|Overall Study|Unclassified|3|||
27843251|NCT01857206|81254490|FG001|Overall Study|Unclassified|3|||
27843252|NCT01857206|81254489|FG000|Overall Study|Withdrawal by Subject|1|||
27843253|NCT01857206|81254490|FG001|Overall Study|Withdrawal by Subject|0|||
27843254|NCT02466386|81254491|FG000|Overall Study|Adverse Event|5|||
27843255|NCT02466386|81254491|FG000|Overall Study|Protocol Violation|2|||
27843256|NCT02466386|81254491|FG000|Overall Study|Withdrawal by Subject|14|||
27843257|NCT02466386|81254491|FG000|Overall Study|Lost to Follow-up|5|||
27843258|NCT02466386|81254491|FG000|Overall Study|Lack of Efficacy|8|||
27843259|NCT02466386|81254491|FG000|Overall Study|Other|10|||
27843260|NCT02280187|81254492|FG000|Overall Study|Lost to Follow-up|218|||
27843261|NCT01020526|81254493|FG000|Overall Study|Withdrawal by Subject|5|||
27843262|NCT01020526|81254493|FG000|Overall Study|Other reasons|3|||
27843263|NCT01020526|81254493|FG000|Overall Study|Insufficient clinical response|3|||
27843264|NCT01020526|81254493|FG000|Overall Study|Lost to Follow-up|1|||
27843265|NCT01020526|81254493|FG000|Overall Study|Adverse Event|2|||
27843266|NCT01438476|81254494|FG000|Overall Study|Protocol Violation|1|||
27504233|NCT04949490|80040767|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
27504234|NCT04949490|80040768|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
27504235|NCT04949490|80040763|FG000|Group A and Group B|Withdrawal by Subject|0|||
27504236|NCT04949490|80040764|FG001|Group A and Group B|Withdrawal by Subject|0|||
27504237|NCT04949490|80040765|FG002|Group A and Group B|Withdrawal by Subject|1|||
27613563|NCT01254305|80426695|FG002|Overall Study|Protocol Violation|3|||
27843267|NCT01438476|81254495|FG001|Overall Study|Protocol Violation|0|||
27843268|NCT01438476|81254494|FG000|Overall Study|Withdrawal by Subject|1|||
27843269|NCT01438476|81254495|FG001|Overall Study|Withdrawal by Subject|0|||
27843270|NCT01438476|81254494|FG000|Overall Study|No Surgery- Disease|8|||
27843271|NCT01438476|81254495|FG001|Overall Study|No Surgery- Disease|10|||
27843272|NCT01438476|81254494|FG000|Overall Study|Communication barrier|0|||
27843273|NCT01438476|81254495|FG001|Overall Study|Communication barrier|1|||
27843274|NCT02756637|81254499|FG000|Overall Study|Not eligible for initial SWOG study|10|||
27843275|NCT02756637|81254500|FG001|Overall Study|Not eligible for initial SWOG study|10|||
27504238|NCT04949490|80040766|FG003|Group A and Group B|Withdrawal by Subject|0|||
27843276|NCT02756637|81254499|FG000|Overall Study|No available NLR value|44|||
27843277|NCT02756637|81254500|FG001|Overall Study|No available NLR value|44|||
27843278|NCT02756637|81254499|FG000|Overall Study|Did not complete curative therapy|33|||
27843279|NCT02756637|81254500|FG001|Overall Study|Did not complete curative therapy|0|||
27843280|NCT00775528|81254501|FG000|Overall Study|Protocol Violation|1|||
27843281|NCT04569786|81254502|FG000|Overall Study|Lost to Follow-up|1|||
27504239|NCT04949490|80040767|FG004|Group A and Group B|Withdrawal by Subject|0|||
27504240|NCT04949490|80040768|FG005|Group A and Group B|Withdrawal by Subject|0|||
27504241|NCT04949490|80040763|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
27724481|NCT01162421|80823033|FG000|Overall Study|Did not receive study drug|2|||
27724482|NCT01162421|80823034|FG001|Overall Study|Did not receive study drug|1|||
27724483|NCT01162421|80823033|FG000|Overall Study|Adverse Event|2|||
27892952|NCT02908672|81443851|FG001|Overall Study|Study is ongoing|141|||
27892953|NCT02908672|81443850|FG000|Overall Study|Discontinued the study during run-in|3|||
27892954|NCT02908672|81443851|FG001|Overall Study|Discontinued the study during run-in|0|||
27892955|NCT04325698|81443856|FG000|Overall Study|Study Terminated By Sponsor|1|||
27504242|NCT04949490|80040764|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
27504243|NCT04949490|80040765|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
27504244|NCT04949490|80040766|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
27892956|NCT04325698|81443857|FG001|Overall Study|Study Terminated By Sponsor|1|||
27892957|NCT04325698|81443856|FG000|Overall Study|Withdrawal by Subject|0|||
27892958|NCT04325698|81443857|FG001|Overall Study|Withdrawal by Subject|2|||
27504245|NCT04949490|80040767|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
27504246|NCT04949490|80040768|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
27504247|NCT04949490|80040763|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
27504248|NCT04949490|80040764|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
27504249|NCT04949490|80040765|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
27504250|NCT04949490|80040766|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
27504251|NCT04949490|80040767|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
27724484|NCT01162421|80823034|FG001|Overall Study|Adverse Event|5|||
27724485|NCT01162421|80823033|FG000|Overall Study|Lost to Follow-up|0|||
27843282|NCT04569786|81254503|FG001|Overall Study|Lost to Follow-up|0|||
27843283|NCT04569786|81254504|FG002|Overall Study|Lost to Follow-up|4|||
27843284|NCT04569786|81254505|FG003|Overall Study|Lost to Follow-up|1|||
27843285|NCT04569786|81254506|FG004|Overall Study|Lost to Follow-up|0|||
27843286|NCT04569786|81254502|FG000|Overall Study|Withdrawal by Subject|0|||
27843287|NCT04569786|81254503|FG001|Overall Study|Withdrawal by Subject|0|||
27843288|NCT04569786|81254504|FG002|Overall Study|Withdrawal by Subject|0|||
27843289|NCT04569786|81254505|FG003|Overall Study|Withdrawal by Subject|5|||
27843290|NCT04569786|81254506|FG004|Overall Study|Withdrawal by Subject|1|||
27843291|NCT04569786|81254502|FG000|Overall Study|Physician Decision|0|||
27843292|NCT04569786|81254503|FG001|Overall Study|Physician Decision|0|||
27843293|NCT04569786|81254504|FG002|Overall Study|Physician Decision|0|||
27843294|NCT04569786|81254505|FG003|Overall Study|Physician Decision|1|||
27843295|NCT04569786|81254506|FG004|Overall Study|Physician Decision|0|||
27843296|NCT03546647|81254513|FG000|Overall Study|Adverse Event|1|||
27843297|NCT03546647|81254514|FG001|Overall Study|Adverse Event|0|||
27892959|NCT03091192|81443858|FG000|Overall Study|Study terminated by sponsor|21|||
27724486|NCT01162421|80823034|FG001|Overall Study|Lost to Follow-up|2|||
27724487|NCT01162421|80823033|FG000|Overall Study|Lack of Efficacy|2|||
27724488|NCT01162421|80823034|FG001|Overall Study|Lack of Efficacy|2|||
27724489|NCT01162421|80823033|FG000|Overall Study|Other|2|||
27724490|NCT01162421|80823034|FG001|Overall Study|Other|3|||
27724491|NCT01565980|80823035|FG000|Overall Study|Death|1|||
27724492|NCT01565980|80823036|FG001|Overall Study|Death|0|||
27724493|NCT01565980|80823035|FG000|Overall Study|Lost to Follow-up|1|||
27724494|NCT01565980|80823036|FG001|Overall Study|Lost to Follow-up|0|||
27724495|NCT01565980|80823035|FG000|Overall Study|health complications|1|||
27724496|NCT01565980|80823036|FG001|Overall Study|health complications|1|||
27724497|NCT01565980|80823035|FG000|Overall Study|stopped medical treatment|1|||
27724498|NCT01565980|80823036|FG001|Overall Study|stopped medical treatment|0|||
27724499|NCT01565980|80823035|FG000|Overall Study|Withdrawal by Subject|0|||
27724500|NCT01565980|80823036|FG001|Overall Study|Withdrawal by Subject|3|||
27724501|NCT01988090|80823037|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
27724502|NCT01988090|80823038|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
27724503|NCT01988090|80823037|FG000|Start Treament After Randomization|Protocol Violation|0|||
27724504|NCT01988090|80823038|FG001|Start Treament After Randomization|Protocol Violation|1|||
27724505|NCT01988090|80823037|FG000|Complete Study After Start|Withdrawal by Subject|2|||
27724506|NCT01988090|80823038|FG001|Complete Study After Start|Withdrawal by Subject|0|||
27724507|NCT01988090|80823037|FG000|Complete Study After Start|Protocol Violation|1|||
27724508|NCT01988090|80823038|FG001|Complete Study After Start|Protocol Violation|1|||
27724509|NCT00448708|80823039|FG000|Overall Study|Death|21|||
27724510|NCT00448708|80823040|FG001|Overall Study|Death|17|||
27724511|NCT00448708|80823039|FG000|Overall Study|Withdrawal by Subject|8|||
27724512|NCT00448708|80823040|FG001|Overall Study|Withdrawal by Subject|4|||
27724513|NCT00448708|80823039|FG000|Overall Study|Lost to Follow-up|6|||
27724514|NCT00448708|80823040|FG001|Overall Study|Lost to Follow-up|8|||
27724515|NCT00448708|80823039|FG000|Overall Study|not listed|0|||
27724516|NCT00448708|80823040|FG001|Overall Study|not listed|2|||
27724517|NCT03118297|80823041|FG000|Overall Study|Lost to Follow-up|0|||
27724518|NCT03118297|80823042|FG001|Overall Study|Lost to Follow-up|2|||
27724519|NCT01407926|80823043|FG000|Overall Study|Lost to Follow-up|55|||
27724520|NCT04162210|80823044|FG000|Overall Study|Lost to Follow-up|4|||
27724521|NCT04162210|80823045|FG001|Overall Study|Lost to Follow-up|1|||
27724522|NCT04162210|80823044|FG000|Overall Study|Withdrawal by Subject|17|||
27724523|NCT04162210|80823045|FG001|Overall Study|Withdrawal by Subject|9|||
27724524|NCT04162210|80823044|FG000|Overall Study|Ongoing|113|||
27724525|NCT04162210|80823045|FG001|Overall Study|Ongoing|59|||
27724526|NCT02908880|80823046|FG000|Overall Study|Lost to Follow-up|4|||
27724527|NCT02908880|80823046|FG000|Overall Study|Explantation of the device|1|||
27724528|NCT02908880|80823046|FG000|Overall Study|Withdrawal by Subject|17|||
27724529|NCT02908880|80823046|FG000|Overall Study|Death|5|||
27724530|NCT02690194|80823047|FG000|Overall Study|Withdrawal by Subject|1|||
27724531|NCT02690194|80823048|FG001|Overall Study|Withdrawal by Subject|4|||
27724532|NCT02690194|80823049|FG002|Overall Study|Withdrawal by Subject|0|||
27724533|NCT03683394|80823050|FG000|Overall Study|Withdrawal by Subject|4|||
27724534|NCT03683394|80823051|FG001|Overall Study|Withdrawal by Subject|8|||
27724535|NCT03683394|80823050|FG000|Overall Study|Lost to Follow-up|7|||
27724536|NCT03683394|80823051|FG001|Overall Study|Lost to Follow-up|0|||
27724537|NCT03683394|80823050|FG000|Overall Study|Death|3|||
27724538|NCT03683394|80823051|FG001|Overall Study|Death|1|||
27724539|NCT00330187|80823052|FG000|Overall Study|Lost to Follow-up|12|||
27724540|NCT00330187|80823053|FG001|Overall Study|Lost to Follow-up|13|||
27724541|NCT00330187|80823054|FG002|Overall Study|Lost to Follow-up|14|||
27724542|NCT00330187|80823055|FG003|Overall Study|Lost to Follow-up|10|||
27724543|NCT00330187|80823052|FG000|Overall Study|Withdrawal by Subject|8|||
27724544|NCT00330187|80823053|FG001|Overall Study|Withdrawal by Subject|5|||
27724545|NCT00330187|80823054|FG002|Overall Study|Withdrawal by Subject|4|||
27724546|NCT00330187|80823055|FG003|Overall Study|Withdrawal by Subject|4|||
27724547|NCT02024971|80823056|FG000|Overall Study|Data Not Available|30|||
27724548|NCT02024971|80823056|FG000|Overall Study|Lost to Follow-up|6|||
27724549|NCT02675075|80823059|FG000|Overall Study|Lost to Follow-up|3|||
27724550|NCT02675075|80823060|FG001|Overall Study|Lost to Follow-up|0|||
27724551|NCT01481896|80823061|FG000|Overall Study|Lost to Follow-up|12|||
27892960|NCT03091192|81443859|FG001|Overall Study|Study terminated by sponsor|14|||
27724552|NCT00440726|80823062|FG000|Phase 1|Dose-Limiting Toxicity|0|||
27724553|NCT00440726|80823063|FG001|Phase 1|Dose-Limiting Toxicity|1|||
27724554|NCT00440726|80823064|FG002|Phase 1|Dose-Limiting Toxicity|0|||
27724555|NCT00440726|80823062|FG000|Phase 1|Physician Decision|1|||
27724556|NCT00440726|80823063|FG001|Phase 1|Physician Decision|0|||
27724557|NCT00440726|80823064|FG002|Phase 1|Physician Decision|0|||
27724558|NCT00440726|80823062|FG000|Phase 2|Death|0|||
27724559|NCT00440726|80823063|FG001|Phase 2|Death|0|||
27843298|NCT00202839|81254515|FG000|Overall Study|Adverse Event|1|||
27843299|NCT00202839|81254516|FG001|Overall Study|Adverse Event|5|||
27843300|NCT00202839|81254515|FG000|Overall Study|Physician Decision|12|||
27843301|NCT00202839|81254516|FG001|Overall Study|Physician Decision|0|||
27843302|NCT00202839|81254515|FG000|Overall Study|Withdrawal by Subject|6|||
27843303|NCT00202839|81254516|FG001|Overall Study|Withdrawal by Subject|2|||
27843304|NCT00202839|81254515|FG000|Overall Study|Protocol Violation|2|||
27843305|NCT00202839|81254516|FG001|Overall Study|Protocol Violation|1|||
27843306|NCT00202839|81254515|FG000|Overall Study|Lost to Follow-up|3|||
27843307|NCT00202839|81254516|FG001|Overall Study|Lost to Follow-up|2|||
27613564|NCT01254305|80426693|FG000|Overall Study|Withdrawal by Subject|4|||
27613565|NCT01254305|80426694|FG001|Overall Study|Withdrawal by Subject|2|||
27613566|NCT01254305|80426695|FG002|Overall Study|Withdrawal by Subject|4|||
27613567|NCT01254305|80426693|FG000|Overall Study|Lost to Follow-up|10|||
27613568|NCT01254305|80426694|FG001|Overall Study|Lost to Follow-up|6|||
27613569|NCT01254305|80426695|FG002|Overall Study|Lost to Follow-up|5|||
27613570|NCT01254305|80426693|FG000|Overall Study|Other Reasons|0|||
27613571|NCT01254305|80426694|FG001|Overall Study|Other Reasons|0|||
27613572|NCT01254305|80426695|FG002|Overall Study|Other Reasons|2|||
27613573|NCT02406261|80426698|FG000|Period 1|Lost to Follow-up|2|||
27613574|NCT02406261|80426699|FG001|Period 1|Lost to Follow-up|0|||
27613575|NCT02406261|80426698|FG000|Period 1|Adverse Event|1|||
27613576|NCT02406261|80426699|FG001|Period 1|Adverse Event|0|||
27843308|NCT00401245|81254522|FG000|Double Blind Titration Phase|Adverse Event|3|||
27843309|NCT00401245|81254523|FG001|Double Blind Titration Phase|Adverse Event|2|||
27843310|NCT00401245|81254524|FG002|Double Blind Titration Phase|Adverse Event|5|||
27843311|NCT00401245|81254525|FG003|Double Blind Titration Phase|Adverse Event|12|||
27843312|NCT00401245|81254526|FG004|Double Blind Titration Phase|Adverse Event|0|||
27843313|NCT00401245|81254527|FG005|Double Blind Titration Phase|Adverse Event|0|||
27843314|NCT00401245|81254528|FG006|Double Blind Titration Phase|Adverse Event|0|||
27843315|NCT00401245|81254529|FG007|Double Blind Titration Phase|Adverse Event|0|||
27843316|NCT00401245|81254522|FG000|Double Blind Titration Phase|Other|0|||
27843317|NCT00401245|81254523|FG001|Double Blind Titration Phase|Other|0|||
27843318|NCT00401245|81254524|FG002|Double Blind Titration Phase|Other|1|||
27843319|NCT00401245|81254525|FG003|Double Blind Titration Phase|Other|0|||
27843320|NCT00401245|81254526|FG004|Double Blind Titration Phase|Other|0|||
27843321|NCT00401245|81254527|FG005|Double Blind Titration Phase|Other|0|||
27843322|NCT00401245|81254528|FG006|Double Blind Titration Phase|Other|0|||
27843323|NCT00401245|81254529|FG007|Double Blind Titration Phase|Other|0|||
27843324|NCT00401245|81254522|FG000|Double Blind Titration Phase|Protocol Violation|0|||
27843325|NCT00401245|81254523|FG001|Double Blind Titration Phase|Protocol Violation|0|||
27843326|NCT00401245|81254524|FG002|Double Blind Titration Phase|Protocol Violation|0|||
27843327|NCT00401245|81254525|FG003|Double Blind Titration Phase|Protocol Violation|1|||
27843328|NCT00401245|81254526|FG004|Double Blind Titration Phase|Protocol Violation|0|||
27843329|NCT00401245|81254527|FG005|Double Blind Titration Phase|Protocol Violation|0|||
27843330|NCT00401245|81254528|FG006|Double Blind Titration Phase|Protocol Violation|0|||
27843331|NCT00401245|81254529|FG007|Double Blind Titration Phase|Protocol Violation|0|||
27843332|NCT00401245|81254522|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
27843333|NCT00401245|81254523|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
27613577|NCT02406261|80426698|FG000|Period 2|Physician Decision|0|||
27613578|NCT02406261|80426699|FG001|Period 2|Physician Decision|1|||
27613579|NCT02406261|80426698|FG000|Period 2|Protocol Violation|0|||
27613580|NCT02406261|80426699|FG001|Period 2|Protocol Violation|1|||
27613581|NCT02406261|80426698|FG000|Period 2|Withdrawal by Subject|0|||
27613582|NCT02406261|80426699|FG001|Period 2|Withdrawal by Subject|1|||
27843334|NCT00401245|81254524|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
27843335|NCT00401245|81254525|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
27843336|NCT00401245|81254526|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
27843337|NCT00401245|81254527|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
27843338|NCT00401245|81254528|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
27843339|NCT00401245|81254529|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
27843340|NCT00401245|81254522|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
27843341|NCT00401245|81254523|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
27843342|NCT00401245|81254524|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
27843343|NCT00401245|81254525|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
27843344|NCT00401245|81254526|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
27843345|NCT00401245|81254527|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
27843346|NCT00401245|81254528|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
27843347|NCT00401245|81254529|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
27843348|NCT00401245|81254522|FG000|Open Label Phase|Adverse Event|5|||
27843349|NCT00401245|81254523|FG001|Open Label Phase|Adverse Event|14|||
27843350|NCT00401245|81254524|FG002|Open Label Phase|Adverse Event|6|||
27843351|NCT00401245|81254525|FG003|Open Label Phase|Adverse Event|7|||
27843352|NCT00401245|81254526|FG004|Open Label Phase|Adverse Event|0|||
27843353|NCT00401245|81254527|FG005|Open Label Phase|Adverse Event|0|||
27843354|NCT00401245|81254528|FG006|Open Label Phase|Adverse Event|0|||
27843355|NCT00401245|81254529|FG007|Open Label Phase|Adverse Event|0|||
27843356|NCT00401245|81254522|FG000|Open Label Phase|Lost to Follow-up|5|||
27843357|NCT00401245|81254523|FG001|Open Label Phase|Lost to Follow-up|7|||
27504252|NCT04949490|80040768|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
27504253|NCT02113982|80040769|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
27504254|NCT02113982|80040770|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
27504255|NCT02113982|80040771|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
27504256|NCT02113982|80040772|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
27724560|NCT00440726|80823064|FG002|Phase 2|Death|1|||
27724561|NCT00440726|80823062|FG000|Phase 2|Adverse Event|0|||
27724562|NCT00440726|80823063|FG001|Phase 2|Adverse Event|0|||
27724563|NCT00440726|80823064|FG002|Phase 2|Adverse Event|1|||
27724564|NCT02307682|80823066|FG000|Overall Study|Adverse Event|9|||
27724565|NCT02307682|80823067|FG001|Overall Study|Adverse Event|8|||
27724566|NCT02307682|80823068|FG002|Overall Study|Adverse Event|12|||
27724567|NCT02307682|80823066|FG000|Overall Study|Lack of Efficacy|1|||
27724568|NCT02307682|80823067|FG001|Overall Study|Lack of Efficacy|0|||
27724569|NCT02307682|80823068|FG002|Overall Study|Lack of Efficacy|1|||
27724570|NCT02307682|80823066|FG000|Overall Study|Physician Decision|2|||
27724571|NCT02307682|80823067|FG001|Overall Study|Physician Decision|2|||
27724572|NCT02307682|80823068|FG002|Overall Study|Physician Decision|8|||
27724573|NCT02307682|80823066|FG000|Overall Study|Progressive Disease|1|||
27724574|NCT02307682|80823067|FG001|Overall Study|Progressive Disease|0|||
27724575|NCT02307682|80823068|FG002|Overall Study|Progressive Disease|0|||
27724576|NCT02307682|80823066|FG000|Overall Study|Withdrawal by Subject|26|||
27724577|NCT02307682|80823067|FG001|Overall Study|Withdrawal by Subject|34|||
27724578|NCT02307682|80823068|FG002|Overall Study|Withdrawal by Subject|23|||
27724579|NCT02307682|80823066|FG000|Overall Study|Death|9|||
27724580|NCT02307682|80823067|FG001|Overall Study|Death|7|||
27724581|NCT02307682|80823068|FG002|Overall Study|Death|12|||
27724582|NCT02307682|80823066|FG000|Overall Study|Lost to Follow-up|1|||
27724583|NCT02307682|80823067|FG001|Overall Study|Lost to Follow-up|5|||
27724584|NCT02307682|80823068|FG002|Overall Study|Lost to Follow-up|6|||
27724585|NCT02307682|80823066|FG000|Overall Study|Protocol Deviation|0|||
27724586|NCT02307682|80823067|FG001|Overall Study|Protocol Deviation|0|||
27724587|NCT02307682|80823068|FG002|Overall Study|Protocol Deviation|2|||
27724588|NCT02307682|80823066|FG000|Overall Study|Other|1|||
27724589|NCT02307682|80823067|FG001|Overall Study|Other|1|||
27724590|NCT02307682|80823068|FG002|Overall Study|Other|0|||
27724591|NCT00568555|80823071|FG000|Overall Study|Withdrawal by Subject|1|||
27724592|NCT00568555|80823072|FG001|Overall Study|Withdrawal by Subject|1|||
27724593|NCT00112905|80823075|FG000|Overall Study|Adverse Event|4|||
27724594|NCT00112905|80823075|FG000|Overall Study|Death|1|||
27724595|NCT00112905|80823075|FG000|Overall Study|Ineligibility|5|||
27724596|NCT00112905|80823075|FG000|Overall Study|Alternative treatment|1|||
27724597|NCT00112905|80823075|FG000|Overall Study|performance status was deteiorating|1|||
27724598|NCT04557384|80823085|FG000|Overall Study|Study Terminated by Sponsor|1|||
27724599|NCT04557384|80823085|FG000|Overall Study|Death|1|||
27724600|NCT00354601|80823086|FG000|Overall Study|Protocol Violation|1|||
27724601|NCT00354601|80823086|FG000|Overall Study|progression|1|||
27724602|NCT01656434|80823090|FG000|Overall Study|Adverse Event|199|||
27724603|NCT01656434|80823091|FG001|Overall Study|Adverse Event|63|||
27724604|NCT01656434|80823090|FG000|Overall Study|Enrollment terminated at trial site|2|||
27504257|NCT02113982|80040773|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
27504258|NCT02113982|80040774|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
27504259|NCT02113982|80040775|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
27504260|NCT02113982|80040776|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
27504261|NCT02113982|80040777|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
27504262|NCT02113982|80040778|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
27504263|NCT02113982|80040779|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
27504264|NCT02113982|80040780|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
27504265|NCT02113982|80040781|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
27504266|NCT02113982|80040782|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
27504267|NCT02113982|80040769|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
27504268|NCT02113982|80040770|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
27504269|NCT02113982|80040771|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
27504270|NCT02113982|80040772|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
27724605|NCT01656434|80823091|FG001|Overall Study|Enrollment terminated at trial site|0|||
27724606|NCT01656434|80823090|FG000|Overall Study|Lost to Follow-up|309|||
27724607|NCT01656434|80823091|FG001|Overall Study|Lost to Follow-up|76|||
27724608|NCT01656434|80823090|FG000|Overall Study|Site discontinued study participation|24|||
27724609|NCT01656434|80823091|FG001|Overall Study|Site discontinued study participation|9|||
27724610|NCT01656434|80823090|FG000|Overall Study|Screen failure|2|||
27724611|NCT01656434|80823091|FG001|Overall Study|Screen failure|0|||
27724612|NCT01656434|80823090|FG000|Overall Study|Protocol Violation|7|||
27724613|NCT01656434|80823091|FG001|Overall Study|Protocol Violation|0|||
27724614|NCT01656434|80823090|FG000|Overall Study|Pregnancy wish|18|||
27724615|NCT01656434|80823091|FG001|Overall Study|Pregnancy wish|6|||
27724616|NCT01656434|80823090|FG000|Overall Study|Pregnancy|45|||
27724617|NCT01656434|80823091|FG001|Overall Study|Pregnancy|10|||
27724618|NCT01656434|80823090|FG000|Overall Study|Physician Decision|7|||
27724619|NCT01656434|80823091|FG001|Overall Study|Physician Decision|2|||
27724620|NCT01656434|80823090|FG000|Overall Study|Non-compliance with study drug|48|||
27724621|NCT01656434|80823091|FG001|Overall Study|Non-compliance with study drug|9|||
27724622|NCT01656434|80823090|FG000|Overall Study|Study terminated by sponsor|1501|||
27724623|NCT01656434|80823091|FG001|Overall Study|Study terminated by sponsor|348|||
27724624|NCT01656434|80823090|FG000|Overall Study|Participant discontinued; drug related|13|||
27724625|NCT01656434|80823091|FG001|Overall Study|Participant discontinued; drug related|4|||
27724626|NCT01656434|80823090|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
27724627|NCT01656434|80823091|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
27724628|NCT01656434|80823090|FG000|Overall Study|Non-compliance with protocol|39|||
27724629|NCT01656434|80823091|FG001|Overall Study|Non-compliance with protocol|15|||
27724630|NCT01656434|80823090|FG000|Overall Study|Participant moved|40|||
27724631|NCT01656434|80823091|FG001|Overall Study|Participant moved|12|||
27724632|NCT01656434|80823090|FG000|Overall Study|Participant withdrew consent|28|||
27724633|NCT01656434|80823091|FG001|Overall Study|Participant withdrew consent|9|||
27724634|NCT01656434|80823090|FG000|Overall Study|Withdrawal by Subject|64|||
27724635|NCT01656434|80823091|FG001|Overall Study|Withdrawal by Subject|7|||
27724636|NCT01790048|80823093|FG000|Overall Study|Incorrect Age|9|||
27724637|NCT01790048|80823094|FG001|Overall Study|Incorrect Age|14|||
27724638|NCT01790048|80823093|FG000|Overall Study|data entry error|0|||
27724639|NCT01790048|80823094|FG001|Overall Study|data entry error|1|||
27724640|NCT01790048|80823093|FG000|Overall Study|Other|0|||
27724641|NCT01790048|80823094|FG001|Overall Study|Other|2|||
27724642|NCT01790048|80823093|FG000|Overall Study|SAM at Enrollment|2|||
27724643|NCT01790048|80823094|FG001|Overall Study|SAM at Enrollment|0|||
27724644|NCT01790048|80823093|FG000|Overall Study|Measurement error|1|||
27724645|NCT01790048|80823094|FG001|Overall Study|Measurement error|0|||
27724646|NCT02624492|80823101|FG000|Overall Study|Adverse Event|2|||
27724647|NCT02624492|80823102|FG001|Overall Study|Adverse Event|2|||
27724648|NCT02624492|80823103|FG002|Overall Study|Adverse Event|2|||
27724649|NCT02624492|80823101|FG000|Overall Study|Progressive disease|0|||
27724650|NCT02624492|80823102|FG001|Overall Study|Progressive disease|2|||
27724651|NCT02624492|80823103|FG002|Overall Study|Progressive disease|3|||
27724652|NCT03898063|80823104|FG000|Overall Study|Withdrawal by Subject|10|||
27724653|NCT03898063|80823105|FG001|Overall Study|Withdrawal by Subject|8|||
27724654|NCT00821678|80823106|FG000|Overall Study|Withdrawal by Subject|8|||
27504271|NCT02113982|80040773|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
27504272|NCT02113982|80040774|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
27504273|NCT02113982|80040775|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
27724655|NCT00821678|80823107|FG001|Overall Study|Withdrawal by Subject|0|||
27724656|NCT00821678|80823106|FG000|Overall Study|Lost to Follow-up|13|||
27724657|NCT00821678|80823107|FG001|Overall Study|Lost to Follow-up|12|||
27724658|NCT00821678|80823106|FG000|Overall Study|Death|0|||
27724659|NCT00821678|80823107|FG001|Overall Study|Death|2|||
27724660|NCT01848145|80823110|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
27724661|NCT01848145|80823110|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
27724662|NCT01848145|80823110|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
27724663|NCT01848145|80823110|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
27843358|NCT00401245|81254524|FG002|Open Label Phase|Lost to Follow-up|5|||
27843359|NCT00401245|81254525|FG003|Open Label Phase|Lost to Follow-up|4|||
27843360|NCT00401245|81254526|FG004|Open Label Phase|Lost to Follow-up|0|||
27843361|NCT00401245|81254527|FG005|Open Label Phase|Lost to Follow-up|0|||
27843362|NCT00401245|81254528|FG006|Open Label Phase|Lost to Follow-up|0|||
27843363|NCT00401245|81254529|FG007|Open Label Phase|Lost to Follow-up|0|||
27843364|NCT00401245|81254522|FG000|Open Label Phase|Other|4|||
27843365|NCT00401245|81254523|FG001|Open Label Phase|Other|8|||
27843366|NCT00401245|81254524|FG002|Open Label Phase|Other|7|||
27843367|NCT00401245|81254525|FG003|Open Label Phase|Other|8|||
27843368|NCT00401245|81254526|FG004|Open Label Phase|Other|0|||
27843369|NCT00401245|81254527|FG005|Open Label Phase|Other|0|||
27843370|NCT00401245|81254528|FG006|Open Label Phase|Other|0|||
27843371|NCT00401245|81254529|FG007|Open Label Phase|Other|0|||
27843372|NCT00401245|81254522|FG000|Open Label Phase|Protocol Violation|0|||
27843373|NCT00401245|81254523|FG001|Open Label Phase|Protocol Violation|1|||
27843374|NCT00401245|81254524|FG002|Open Label Phase|Protocol Violation|0|||
27843375|NCT00401245|81254525|FG003|Open Label Phase|Protocol Violation|1|||
27843376|NCT00401245|81254526|FG004|Open Label Phase|Protocol Violation|0|||
27843377|NCT00401245|81254527|FG005|Open Label Phase|Protocol Violation|0|||
27843378|NCT00401245|81254528|FG006|Open Label Phase|Protocol Violation|0|||
27843379|NCT00401245|81254529|FG007|Open Label Phase|Protocol Violation|0|||
27843380|NCT00401245|81254522|FG000|Open Label Phase|Withdrawal by Subject|3|||
27843381|NCT00401245|81254523|FG001|Open Label Phase|Withdrawal by Subject|3|||
27843382|NCT00401245|81254524|FG002|Open Label Phase|Withdrawal by Subject|2|||
27843383|NCT00401245|81254525|FG003|Open Label Phase|Withdrawal by Subject|1|||
27843384|NCT00401245|81254526|FG004|Open Label Phase|Withdrawal by Subject|0|||
27843385|NCT00401245|81254527|FG005|Open Label Phase|Withdrawal by Subject|0|||
27843386|NCT00401245|81254528|FG006|Open Label Phase|Withdrawal by Subject|0|||
27843387|NCT00401245|81254529|FG007|Open Label Phase|Withdrawal by Subject|0|||
27843388|NCT00401245|81254522|FG000|Open Label Phase|Lack of Efficacy|4|||
27843389|NCT00401245|81254523|FG001|Open Label Phase|Lack of Efficacy|2|||
27843390|NCT00401245|81254524|FG002|Open Label Phase|Lack of Efficacy|3|||
27843391|NCT00401245|81254525|FG003|Open Label Phase|Lack of Efficacy|0|||
27843392|NCT00401245|81254526|FG004|Open Label Phase|Lack of Efficacy|0|||
27843393|NCT00401245|81254527|FG005|Open Label Phase|Lack of Efficacy|0|||
27843394|NCT00401245|81254528|FG006|Open Label Phase|Lack of Efficacy|0|||
27843395|NCT00401245|81254529|FG007|Open Label Phase|Lack of Efficacy|0|||
27843396|NCT00401245|81254522|FG000|Double Blind Tapering Phase|Adverse Event|0|||
27843397|NCT00401245|81254523|FG001|Double Blind Tapering Phase|Adverse Event|0|||
27843398|NCT00401245|81254524|FG002|Double Blind Tapering Phase|Adverse Event|0|||
27843399|NCT00401245|81254525|FG003|Double Blind Tapering Phase|Adverse Event|0|||
27843400|NCT00401245|81254526|FG004|Double Blind Tapering Phase|Adverse Event|1|||
27843401|NCT00401245|81254527|FG005|Double Blind Tapering Phase|Adverse Event|1|||
27843402|NCT00401245|81254528|FG006|Double Blind Tapering Phase|Adverse Event|2|||
27843403|NCT00401245|81254529|FG007|Double Blind Tapering Phase|Adverse Event|4|||
27843404|NCT00401245|81254522|FG000|Double Blind Tapering Phase|Investigator request|0|||
27892961|NCT03091192|81443858|FG000|Overall Study|Death|9|||
27724664|NCT01848145|80823110|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
27892962|NCT03091192|81443859|FG001|Overall Study|Death|13|||
27892963|NCT03091192|81443858|FG000|Overall Study|Withdrawal by Subject|2|||
27892964|NCT03091192|81443859|FG001|Overall Study|Withdrawal by Subject|0|||
27892965|NCT03091192|81443858|FG000|Overall Study|Lost to Follow-up|1|||
27892966|NCT03091192|81443859|FG001|Overall Study|Lost to Follow-up|0|||
27892967|NCT00504725|81443860|FG000|Overall Study|Protocol Violation|1|||
27892968|NCT00504725|81443861|FG001|Overall Study|Protocol Violation|0|||
27892969|NCT03652636|81443862|FG000|Overall Study|Withdrawal by Subject|7|||
27892970|NCT03205761|81443863|FG000|Overall Study|Withdrawal by Subject|1|||
27892971|NCT03205761|81443863|FG000|Overall Study|Progressive Disease|10|||
27892972|NCT01806961|81443864|FG000|Overall Study|sponsor decision|16|||
27892973|NCT02963558|81443869|FG000|Overall Study|Withdrawn by investigator|1|||
27892974|NCT02963558|81443870|FG001|Overall Study|Withdrawn by investigator|0|||
27892975|NCT02963558|81443869|FG000|Overall Study|Withdrawal by Subject|0|||
27892976|NCT02963558|81443870|FG001|Overall Study|Withdrawal by Subject|1|||
27892977|NCT02779855|81443871|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
27892978|NCT02779855|81443872|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
27843405|NCT00401245|81254523|FG001|Double Blind Tapering Phase|Investigator request|0|||
27843406|NCT00401245|81254524|FG002|Double Blind Tapering Phase|Investigator request|0|||
27843407|NCT00401245|81254525|FG003|Double Blind Tapering Phase|Investigator request|0|||
27843408|NCT00401245|81254526|FG004|Double Blind Tapering Phase|Investigator request|0|||
27843409|NCT00401245|81254527|FG005|Double Blind Tapering Phase|Investigator request|0|||
27892979|NCT02779855|81443873|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
27892980|NCT01895608|81443875|FG000|Overall Study|change in health status|0|||
27892981|NCT01895608|81443876|FG001|Overall Study|change in health status|1|||
27843410|NCT00401245|81254528|FG006|Double Blind Tapering Phase|Investigator request|0|||
27892982|NCT01895608|81443877|FG002|Overall Study|change in health status|1|||
27892983|NCT01895608|81443878|FG003|Overall Study|change in health status|0|||
27724665|NCT01848145|80823110|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
27724666|NCT01848145|80823110|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
27724667|NCT02058147|80823113|FG000|Overall Study|Randomized but not treated|0|||
27724668|NCT02058147|80823114|FG001|Overall Study|Randomized but not treated|0|||
27724669|NCT02058147|80823115|FG002|Overall Study|Randomized but not treated|1|||
27724670|NCT02058147|80823113|FG000|Overall Study|Adverse Event|12|||
27724671|NCT02058147|80823114|FG001|Overall Study|Adverse Event|9|||
27724672|NCT02058147|80823115|FG002|Overall Study|Adverse Event|21|||
27724673|NCT02058147|80823113|FG000|Overall Study|Lack of Efficacy|1|||
27724674|NCT02058147|80823114|FG001|Overall Study|Lack of Efficacy|0|||
27724675|NCT02058147|80823115|FG002|Overall Study|Lack of Efficacy|3|||
27724676|NCT02058147|80823113|FG000|Overall Study|Poor compliance to protocol|8|||
27724677|NCT02058147|80823114|FG001|Overall Study|Poor compliance to protocol|9|||
27724678|NCT02058147|80823115|FG002|Overall Study|Poor compliance to protocol|4|||
27724679|NCT02058147|80823113|FG000|Overall Study|Other than specified|8|||
27724680|NCT02058147|80823114|FG001|Overall Study|Other than specified|9|||
27724681|NCT02058147|80823115|FG002|Overall Study|Other than specified|0|||
27724682|NCT02363478|80823116|FG000|Overall Study|Lost to Follow-up|4|||
27724683|NCT02363478|80823116|FG000|Overall Study|Adverse Event|4|||
27724684|NCT00529958|80823117|FG000|2-Year Follow-up|Lost to Follow-up|1|||
27724685|NCT00529958|80823118|FG001|2-Year Follow-up|Lost to Follow-up|2|||
27724686|NCT00529958|80823119|FG002|2-Year Follow-up|Lost to Follow-up|2|||
27724687|NCT00529958|80823117|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
27724688|NCT00529958|80823118|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
27724689|NCT00529958|80823119|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
27724690|NCT00529958|80823117|FG000|5-Year Follow-up|Lost to Follow-up|2|||
27724691|NCT00529958|80823118|FG001|5-Year Follow-up|Lost to Follow-up|3|||
27724692|NCT00529958|80823119|FG002|5-Year Follow-up|Lost to Follow-up|1|||
27724693|NCT00529958|80823117|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
27724694|NCT00529958|80823118|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
27724695|NCT00529958|80823119|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
27724696|NCT03682120|80823120|FG000|Overall Study|Lost to Follow-up|11|||
27724697|NCT03682120|80823121|FG001|Overall Study|Lost to Follow-up|4|||
27724698|NCT03682120|80823122|FG002|Overall Study|Lost to Follow-up|5|||
27724699|NCT03682120|80823123|FG003|Overall Study|Lost to Follow-up|2|||
27724700|NCT03682120|80823120|FG000|Overall Study|Physician Decision|1|||
27724701|NCT03682120|80823121|FG001|Overall Study|Physician Decision|0|||
27724702|NCT03682120|80823122|FG002|Overall Study|Physician Decision|0|||
27724703|NCT03682120|80823123|FG003|Overall Study|Physician Decision|0|||
27724704|NCT03682120|80823120|FG000|Overall Study|Withdrawal by Subject|1|||
27724705|NCT03682120|80823121|FG001|Overall Study|Withdrawal by Subject|2|||
27724706|NCT03682120|80823122|FG002|Overall Study|Withdrawal by Subject|3|||
27724707|NCT03682120|80823123|FG003|Overall Study|Withdrawal by Subject|0|||
27724708|NCT03682120|80823120|FG000|Overall Study|Death|0|||
27724709|NCT03682120|80823121|FG001|Overall Study|Death|1|||
27724710|NCT03682120|80823122|FG002|Overall Study|Death|0|||
27724711|NCT03682120|80823123|FG003|Overall Study|Death|0|||
27724712|NCT03682120|80823120|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
27724713|NCT03682120|80823121|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
27724714|NCT03682120|80823122|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
27724715|NCT03682120|80823123|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
27724716|NCT03064490|80823124|FG000|Overall Study|Physician Decision|5|||
27724717|NCT03313050|80823125|FG000|Stage 2: 12 Months|Adverse Event|0|||
27724718|NCT03313050|80823126|FG001|Stage 2: 12 Months|Adverse Event|0|||
27724719|NCT03313050|80823127|FG002|Stage 2: 12 Months|Adverse Event|0|||
27724720|NCT03313050|80823128|FG003|Stage 2: 12 Months|Adverse Event|1|||
27724721|NCT03313050|80823125|FG000|Stage 2: 12 Months|Death|0|||
27724722|NCT03313050|80823126|FG001|Stage 2: 12 Months|Death|0|||
27843411|NCT00401245|81254529|FG007|Double Blind Tapering Phase|Investigator request|1|||
27843412|NCT00401245|81254522|FG000|Double Blind Tapering Phase|Other|0|||
27843413|NCT00401245|81254523|FG001|Double Blind Tapering Phase|Other|0|||
27843414|NCT00401245|81254524|FG002|Double Blind Tapering Phase|Other|0|||
27724723|NCT03313050|80823127|FG002|Stage 2: 12 Months|Death|3|||
27724724|NCT03313050|80823128|FG003|Stage 2: 12 Months|Death|0|||
27724725|NCT03313050|80823125|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
27724726|NCT03313050|80823126|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
27724727|NCT03313050|80823127|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
27724728|NCT03313050|80823128|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
27724729|NCT03313050|80823125|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
27724730|NCT03313050|80823126|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
27724731|NCT03313050|80823127|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
27724732|NCT03313050|80823128|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
27724733|NCT03313050|80823125|FG000|Stage 2: 12 Months|Protocol deviation|0|||
27724734|NCT03313050|80823126|FG001|Stage 2: 12 Months|Protocol deviation|0|||
27843415|NCT00401245|81254525|FG003|Double Blind Tapering Phase|Other|0|||
27724735|NCT03313050|80823127|FG002|Stage 2: 12 Months|Protocol deviation|7|||
27724736|NCT03313050|80823128|FG003|Stage 2: 12 Months|Protocol deviation|7|||
27843416|NCT00401245|81254526|FG004|Double Blind Tapering Phase|Other|1|||
27843417|NCT00401245|81254527|FG005|Double Blind Tapering Phase|Other|0|||
27843418|NCT00401245|81254528|FG006|Double Blind Tapering Phase|Other|2|||
27843419|NCT00401245|81254529|FG007|Double Blind Tapering Phase|Other|2|||
27843420|NCT00401245|81254522|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
27843421|NCT00401245|81254523|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
27843422|NCT00401245|81254524|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
27843423|NCT00401245|81254525|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
27843424|NCT00401245|81254526|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
27843425|NCT00401245|81254527|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
27843426|NCT00401245|81254528|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
27843427|NCT00401245|81254529|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
27843428|NCT00401245|81254522|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843429|NCT00401245|81254523|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843430|NCT00401245|81254524|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843431|NCT00401245|81254525|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843432|NCT00401245|81254526|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843433|NCT00401245|81254527|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
27843434|NCT00401245|81254528|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843435|NCT00401245|81254529|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
27843436|NCT00985231|81254530|FG000|Overall Study|ineligible|1|||
27843437|NCT00985231|81254531|FG001|Overall Study|ineligible|0|||
27843438|NCT00985231|81254530|FG000|Overall Study|Protocol Violation|1|||
27843439|NCT00985231|81254531|FG001|Overall Study|Protocol Violation|0|||
27843440|NCT00985231|81254530|FG000|Overall Study|Withdrawal by Subject|1|||
27843441|NCT00985231|81254531|FG001|Overall Study|Withdrawal by Subject|0|||
27843442|NCT00985231|81254530|FG000|Overall Study|Lost to Follow-up|0|||
27843443|NCT00985231|81254531|FG001|Overall Study|Lost to Follow-up|1|||
27843444|NCT00985231|81254530|FG000|Overall Study|Study related symptoms & complaints|0|||
27843445|NCT00985231|81254531|FG001|Overall Study|Study related symptoms & complaints|2|||
27843446|NCT01301482|81254532|FG000|Overall Study|Withdrawal by Subject|1|||
27843447|NCT00819767|81254533|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27843448|NCT00819767|81254534|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27504274|NCT02113982|80040776|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
27504275|NCT02113982|80040777|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
27504276|NCT02113982|80040778|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
27504277|NCT02113982|80040779|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
27504278|NCT02113982|80040780|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
27504279|NCT02113982|80040781|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
27504280|NCT02113982|80040782|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
27843449|NCT01363011|81257690|FG000|Main Study|Adverse Event|2|||
27843450|NCT01363011|81257691|FG001|Main Study|Adverse Event|3|||
27843451|NCT01363011|81257690|FG000|Main Study|Investigator's Discretion|1|||
27843452|NCT01363011|81257691|FG001|Main Study|Investigator's Discretion|1|||
27843453|NCT01363011|81257690|FG000|Main Study|Withdrew Consent|1|||
27843454|NCT01363011|81257691|FG001|Main Study|Withdrew Consent|4|||
27843455|NCT01363011|81257690|FG000|Main Study|Protocol Violation|0|||
27843456|NCT01363011|81257691|FG001|Main Study|Protocol Violation|1|||
27843457|NCT01363011|81257690|FG000|Extension Phase|Adverse Event|1|||
27843458|NCT01363011|81257691|FG001|Extension Phase|Adverse Event|1|||
27843459|NCT01363011|81257690|FG000|Extension Phase|Lack of Efficacy|0|||
27843460|NCT01363011|81257691|FG001|Extension Phase|Lack of Efficacy|1|||
27843461|NCT01363011|81257690|FG000|Extension Phase|Investigator's Discretion|2|||
27843462|NCT01363011|81257691|FG001|Extension Phase|Investigator's Discretion|2|||
27843463|NCT01363011|81257690|FG000|Extension Phase|Withdrew Consent|0|||
27843464|NCT01363011|81257691|FG001|Extension Phase|Withdrew Consent|1|||
27843465|NCT01363011|81257690|FG000|Extension Phase|Lost to Follow-up|0|||
27843466|NCT01363011|81257691|FG001|Extension Phase|Lost to Follow-up|2|||
27843467|NCT01363011|81257690|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
27843468|NCT01363011|81257691|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
27843469|NCT03689894|81257693|FG000|Overall Study|Adverse Event|1|||
27843470|NCT00810602|81257696|FG000|Overall Study|Withdrawal by Subject|8|||
27504281|NCT02113982|80040769|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504282|NCT02113982|80040770|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504283|NCT02113982|80040771|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27843471|NCT00810602|81257697|FG001|Overall Study|Withdrawal by Subject|3|||
27843472|NCT00983476|81257698|FG000|Overall Study|Did not receive intervention|17|||
27843473|NCT00983476|81257699|FG001|Overall Study|Did not receive intervention|22|||
27843474|NCT00983476|81257700|FG002|Overall Study|Did not receive intervention|0|||
27843475|NCT00084799|81257701|FG000|Overall Study|Disease Progression|1|||
27843476|NCT00084799|81257702|FG001|Overall Study|Disease Progression|0|||
27843477|NCT01754376|81257703|FG000|Overall Study|Adverse Event|1|||
27843478|NCT01754376|81257703|FG000|Overall Study|Lack of Efficacy|2|||
27843479|NCT00171340|81257704|FG000|Overall Study|Adverse Event|46|||
27843480|NCT00171340|81257705|FG001|Overall Study|Adverse Event|42|||
27843481|NCT00171340|81257704|FG000|Overall Study|Lack of Efficacy|29|||
27843482|NCT00171340|81257705|FG001|Overall Study|Lack of Efficacy|41|||
27843483|NCT00171340|81257704|FG000|Overall Study|Protocol Violation|7|||
27843484|NCT00171340|81257705|FG001|Overall Study|Protocol Violation|8|||
27843485|NCT00171340|81257704|FG000|Overall Study|Withdrawal by Subject|22|||
27504284|NCT02113982|80040772|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504285|NCT02113982|80040773|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504286|NCT02113982|80040774|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504287|NCT02113982|80040775|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
27504288|NCT02113982|80040776|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504289|NCT02113982|80040777|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504290|NCT02113982|80040778|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504291|NCT02113982|80040779|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504292|NCT02113982|80040780|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504293|NCT02113982|80040781|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504294|NCT02113982|80040782|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
27504295|NCT02113982|80040769|FG000|Stage 1: Dose Escalation|Transplant|0|||
27504296|NCT02113982|80040770|FG001|Stage 1: Dose Escalation|Transplant|1|||
27843486|NCT00171340|81257705|FG001|Overall Study|Withdrawal by Subject|19|||
27843487|NCT00171340|81257704|FG000|Overall Study|Lost to Follow-up|0|||
27843488|NCT00171340|81257705|FG001|Overall Study|Lost to Follow-up|5|||
27843489|NCT00171340|81257704|FG000|Overall Study|Abnormal Laboratory Results|2|||
27843490|NCT00171340|81257705|FG001|Overall Study|Abnormal Laboratory Results|0|||
27843491|NCT00171340|81257704|FG000|Overall Study|Abnormal Test Procedure Results|6|||
27843492|NCT00171340|81257705|FG001|Overall Study|Abnormal Test Procedure Results|11|||
27843493|NCT00171340|81257704|FG000|Overall Study|No Longer Required Study Drug|1|||
27843494|NCT00171340|81257705|FG001|Overall Study|No Longer Required Study Drug|1|||
27843495|NCT00171340|81257704|FG000|Overall Study|Administrative Problems|5|||
27843496|NCT00171340|81257705|FG001|Overall Study|Administrative Problems|2|||
27843497|NCT00171340|81257704|FG000|Overall Study|Death|6|||
27843498|NCT00171340|81257705|FG001|Overall Study|Death|6|||
27843499|NCT02020967|81257706|FG000|Overall Study|Withdrawal by Subject|51|||
27843500|NCT04405739|81257707|FG000|Overall Study|Adverse Event|0|||
27843501|NCT04405739|81257708|FG001|Overall Study|Adverse Event|1|||
27843502|NCT04405739|81257709|FG002|Overall Study|Adverse Event|0|||
27843503|NCT04405739|81257710|FG003|Overall Study|Adverse Event|0|||
27843504|NCT04405739|81257707|FG000|Overall Study|Lost to Follow-up|0|||
27843505|NCT04405739|81257708|FG001|Overall Study|Lost to Follow-up|2|||
27843506|NCT04405739|81257709|FG002|Overall Study|Lost to Follow-up|1|||
27843507|NCT04405739|81257710|FG003|Overall Study|Lost to Follow-up|3|||
27843508|NCT04405739|81257707|FG000|Overall Study|Withdrawal by Subject|0|||
27843509|NCT04405739|81257708|FG001|Overall Study|Withdrawal by Subject|2|||
27843510|NCT04405739|81257709|FG002|Overall Study|Withdrawal by Subject|1|||
27843511|NCT04405739|81257710|FG003|Overall Study|Withdrawal by Subject|1|||
27843512|NCT04405739|81257707|FG000|Overall Study|Death|0|||
27843513|NCT04405739|81257708|FG001|Overall Study|Death|0|||
27843514|NCT04405739|81257709|FG002|Overall Study|Death|1|||
27843515|NCT04405739|81257710|FG003|Overall Study|Death|0|||
27843516|NCT04405739|81257707|FG000|Overall Study|Transferred to rehab|0|||
27843517|NCT04405739|81257708|FG001|Overall Study|Transferred to rehab|0|||
27843518|NCT04405739|81257709|FG002|Overall Study|Transferred to rehab|0|||
27843519|NCT04405739|81257710|FG003|Overall Study|Transferred to rehab|1|||
27843520|NCT04405739|81257707|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
27843521|NCT04405739|81257708|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
27843522|NCT04405739|81257709|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
27843523|NCT04405739|81257710|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
27843524|NCT01740791|81257714|FG000|Overall Study|Randomized but never treated|5|||
27843525|NCT01740791|81257715|FG001|Overall Study|Randomized but never treated|3|||
27843526|NCT01740791|81257716|FG002|Overall Study|Randomized but never treated|2|||
27843527|NCT01740791|81257717|FG003|Overall Study|Randomized but never treated|2|||
27892984|NCT01895608|81443875|FG000|Overall Study|Withdrawal by Subject|0|||
27892985|NCT01895608|81443876|FG001|Overall Study|Withdrawal by Subject|0|||
27892986|NCT01895608|81443877|FG002|Overall Study|Withdrawal by Subject|2|||
27892987|NCT01895608|81443878|FG003|Overall Study|Withdrawal by Subject|0|||
27504297|NCT02113982|80040771|FG002|Stage 1: Dose Escalation|Transplant|0|||
27504298|NCT02113982|80040772|FG003|Stage 1: Dose Escalation|Transplant|0|||
27504299|NCT02113982|80040773|FG004|Stage 1: Dose Escalation|Transplant|0|||
27843528|NCT01740791|81257718|FG004|Overall Study|Randomized but never treated|1|||
27843529|NCT01740791|81257719|FG005|Overall Study|Randomized but never treated|3|||
27843530|NCT01740791|81257714|FG000|Overall Study|Lost to Follow-up|2|||
27843531|NCT01740791|81257715|FG001|Overall Study|Lost to Follow-up|0|||
27843532|NCT01740791|81257716|FG002|Overall Study|Lost to Follow-up|2|||
27843533|NCT01740791|81257717|FG003|Overall Study|Lost to Follow-up|3|||
27843534|NCT01740791|81257718|FG004|Overall Study|Lost to Follow-up|2|||
27892988|NCT03409107|81443879|FG000|Overall Study|Withdrawal by Subject|4|||
27843535|NCT01740791|81257719|FG005|Overall Study|Lost to Follow-up|3|||
27843536|NCT01740791|81257714|FG000|Overall Study|Withdrew Consent|4|||
27843537|NCT01740791|81257715|FG001|Overall Study|Withdrew Consent|0|||
27843538|NCT01740791|81257716|FG002|Overall Study|Withdrew Consent|1|||
27843539|NCT01740791|81257717|FG003|Overall Study|Withdrew Consent|2|||
27843540|NCT01740791|81257718|FG004|Overall Study|Withdrew Consent|0|||
27843541|NCT01740791|81257719|FG005|Overall Study|Withdrew Consent|3|||
27843542|NCT01740791|81257714|FG000|Overall Study|Investigator's discretion|1|||
27843543|NCT01740791|81257715|FG001|Overall Study|Investigator's discretion|0|||
27843544|NCT01740791|81257716|FG002|Overall Study|Investigator's discretion|1|||
27843545|NCT01740791|81257717|FG003|Overall Study|Investigator's discretion|0|||
27843546|NCT01740791|81257718|FG004|Overall Study|Investigator's discretion|0|||
27843547|NCT01740791|81257719|FG005|Overall Study|Investigator's discretion|1|||
27843548|NCT01740791|81257714|FG000|Overall Study|Adverse Event|0|||
27843549|NCT01740791|81257715|FG001|Overall Study|Adverse Event|0|||
27843550|NCT01740791|81257716|FG002|Overall Study|Adverse Event|0|||
27843551|NCT01740791|81257717|FG003|Overall Study|Adverse Event|0|||
27843552|NCT01740791|81257718|FG004|Overall Study|Adverse Event|0|||
27843553|NCT01740791|81257719|FG005|Overall Study|Adverse Event|1|||
27843554|NCT01957150|81257721|FG000|Overall Study|Adverse Event|23|||
27843555|NCT01957150|81257722|FG001|Overall Study|Adverse Event|20|||
27843556|NCT01957150|81257721|FG000|Overall Study|Withdrawal by Subject|13|||
27843557|NCT01957150|81257722|FG001|Overall Study|Withdrawal by Subject|17|||
27843558|NCT01957150|81257721|FG000|Overall Study|Physician Decision|3|||
27843559|NCT01957150|81257722|FG001|Overall Study|Physician Decision|6|||
27843560|NCT01957150|81257721|FG000|Overall Study|Lost to Follow-up|4|||
27843561|NCT01957150|81257722|FG001|Overall Study|Lost to Follow-up|4|||
27843562|NCT01957150|81257721|FG000|Overall Study|Protocol Violation|1|||
27843563|NCT01957150|81257722|FG001|Overall Study|Protocol Violation|0|||
27843564|NCT01957150|81257721|FG000|Overall Study|Lack of Efficacy|11|||
27843565|NCT01957150|81257722|FG001|Overall Study|Lack of Efficacy|11|||
27843566|NCT02839798|81257723|FG000|Overall Study|Withdrawal by Subject|2|||
27843567|NCT00399893|81257724|FG000|Overall Study|Withdrawal by Subject|1|||
27724737|NCT03313050|80823125|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
27724738|NCT03313050|80823126|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
27724739|NCT03313050|80823127|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
27724740|NCT03313050|80823128|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
27724741|NCT03313050|80823125|FG000|Stage 2: 12 Months|Other|0|||
27724742|NCT03313050|80823126|FG001|Stage 2: 12 Months|Other|0|||
27724743|NCT03313050|80823127|FG002|Stage 2: 12 Months|Other|0|||
27724744|NCT03313050|80823128|FG003|Stage 2: 12 Months|Other|1|||
27724745|NCT01931059|80823129|FG000|Day 1|Pregnancy|0|||
27724746|NCT01931059|80823130|FG001|Day 1|Pregnancy|1|||
27724747|NCT01931059|80823129|FG000|Day3|Lost to Follow-up|1|||
27724748|NCT01931059|80823130|FG001|Day3|Lost to Follow-up|0|||
27843568|NCT00399893|81257725|FG001|Overall Study|Withdrawal by Subject|0|||
27843569|NCT02190279|81257741|FG000|Overall Study|Withdrawal consent|1|||
27843570|NCT02190279|81257742|FG001|Overall Study|Withdrawal consent|0|||
27843571|NCT02190279|81257743|FG002|Overall Study|Withdrawal consent|1|||
27843572|NCT02190279|81257741|FG000|Overall Study|Lost to Follow-up|2|||
27892989|NCT03409107|81443880|FG001|Overall Study|Withdrawal by Subject|2|||
27724749|NCT02440581|80823131|FG000|Overall Study|Death|0|||
27843573|NCT02190279|81257742|FG001|Overall Study|Lost to Follow-up|0|||
27724750|NCT02440581|80823132|FG001|Overall Study|Death|0|||
27724751|NCT02440581|80823133|FG002|Overall Study|Death|7|||
27724752|NCT02440581|80823134|FG003|Overall Study|Death|5|||
27724753|NCT02440581|80823131|FG000|Overall Study|Transplanted|1|||
27724754|NCT02440581|80823132|FG001|Overall Study|Transplanted|0|||
27724755|NCT02440581|80823133|FG002|Overall Study|Transplanted|3|||
27724756|NCT02440581|80823134|FG003|Overall Study|Transplanted|2|||
27724757|NCT02440581|80823131|FG000|Overall Study|Withdrawal by Subject|4|||
27843574|NCT02190279|81257743|FG002|Overall Study|Lost to Follow-up|0|||
27843575|NCT02190279|81257741|FG000|Overall Study|Refused further treatment|0|||
27504300|NCT02113982|80040774|FG005|Stage 1: Dose Escalation|Transplant|1|||
27504301|NCT02113982|80040775|FG006|Stage 1: Dose Escalation|Transplant|0|||
27504302|NCT02113982|80040776|FG007|Stage 1: Dose Escalation|Transplant|0|||
27504303|NCT02113982|80040777|FG008|Stage 1: Dose Escalation|Transplant|0|||
27504304|NCT02113982|80040778|FG009|Stage 1: Dose Escalation|Transplant|0|||
27504305|NCT02113982|80040779|FG010|Stage 1: Dose Escalation|Transplant|0|||
27504306|NCT02113982|80040780|FG011|Stage 1: Dose Escalation|Transplant|0|||
27504307|NCT02113982|80040781|FG012|Stage 1: Dose Escalation|Transplant|0|||
27504308|NCT02113982|80040782|FG013|Stage 1: Dose Escalation|Transplant|0|||
27504309|NCT02113982|80040769|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
27843576|NCT02190279|81257742|FG001|Overall Study|Refused further treatment|0|||
27843577|NCT02190279|81257743|FG002|Overall Study|Refused further treatment|1|||
27843578|NCT02190279|81257741|FG000|Overall Study|Screening failure|0|||
27843579|NCT02190279|81257742|FG001|Overall Study|Screening failure|0|||
27843580|NCT02190279|81257743|FG002|Overall Study|Screening failure|1|||
27843581|NCT02096588|81257744|FG000|Overall Study|Lack of Efficacy|2|||
27843582|NCT02096588|81257745|FG001|Overall Study|Lack of Efficacy|0|||
27843583|NCT02096588|81257744|FG000|Overall Study|Withdrawal by Subject|0|||
27843584|NCT02096588|81257745|FG001|Overall Study|Withdrawal by Subject|1|||
27843585|NCT02070757|81257747|FG000|Overall Study|Adverse Event|107|||
27843586|NCT02070757|81257748|FG001|Overall Study|Adverse Event|99|||
27843587|NCT02070757|81257747|FG000|Overall Study|Lost to Follow-up|7|||
27843588|NCT02070757|81257748|FG001|Overall Study|Lost to Follow-up|4|||
27843589|NCT02070757|81257747|FG000|Overall Study|Protocol Violation|0|||
27843590|NCT02070757|81257748|FG001|Overall Study|Protocol Violation|4|||
27843591|NCT02070757|81257747|FG000|Overall Study|Withdrawal by Subject|1|||
27843592|NCT02070757|81257748|FG001|Overall Study|Withdrawal by Subject|3|||
27843593|NCT02070757|81257747|FG000|Overall Study|Investigator Decision|0|||
27843594|NCT02070757|81257748|FG001|Overall Study|Investigator Decision|2|||
27843595|NCT02070757|81257747|FG000|Overall Study|Discharged from Study Hospital|2|||
27843596|NCT02070757|81257748|FG001|Overall Study|Discharged from Study Hospital|2|||
27843597|NCT01647958|81257749|FG000|Initial Study|Lost to Follow-up|2|||
27843598|NCT01647958|81257750|FG001|Initial Study|Lost to Follow-up|3|||
27843599|NCT01647958|81257749|FG000|Continuation Phase|treatment received during Overall Study|39|||
27843600|NCT01647958|81257750|FG001|Continuation Phase|treatment received during Overall Study|0|||
27843601|NCT01647958|81257749|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
27843602|NCT01647958|81257750|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
27843603|NCT00779402|81257751|FG000|Treatment Phase 1|Disease Progression|1|||
27843604|NCT00779402|81257752|FG001|Treatment Phase 1|Disease Progression|0|||
27843605|NCT00779402|81257751|FG000|Treatment Phase 1|Adverse Event|2|||
27843606|NCT00779402|81257752|FG001|Treatment Phase 1|Adverse Event|0|||
27843607|NCT00779402|81257751|FG000|Treatment Phase 1|Protocol Violation|1|||
27843608|NCT00779402|81257752|FG001|Treatment Phase 1|Protocol Violation|0|||
27843609|NCT00779402|81257751|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
27504310|NCT02113982|80040770|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
27504311|NCT02113982|80040771|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
27843610|NCT00779402|81257752|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
27843611|NCT00779402|81257751|FG000|Treatment Phase 1|Lost to Follow-up|0|||
27843612|NCT00779402|81257752|FG001|Treatment Phase 1|Lost to Follow-up|1|||
27843613|NCT00779402|81257751|FG000|Treatment Phase 1|Death|0|||
27843614|NCT00779402|81257752|FG001|Treatment Phase 1|Death|1|||
27843615|NCT00779402|81257751|FG000|Treatment Phase 1|Intercurrent Illness|1|||
27843616|NCT00779402|81257752|FG001|Treatment Phase 1|Intercurrent Illness|1|||
27843617|NCT00779402|81257751|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
27843618|NCT00779402|81257752|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
27843619|NCT00779402|81257751|FG000|Treatment Phase 1|Other|4|||
27843620|NCT00779402|81257752|FG001|Treatment Phase 1|Other|2|||
27843621|NCT00779402|81257751|FG000|Treatment Phase 1|Closure of Study|3|||
27504312|NCT02113982|80040772|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
27504313|NCT02113982|80040773|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
27504314|NCT02113982|80040774|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
27843622|NCT00779402|81257752|FG001|Treatment Phase 1|Closure of Study|2|||
27843623|NCT00779402|81257751|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
27843624|NCT00779402|81257752|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
27504315|NCT02113982|80040775|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
27504316|NCT02113982|80040776|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
27504317|NCT02113982|80040777|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
27504318|NCT02113982|80040778|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
27843625|NCT00779402|81257751|FG000|Surveillance Phase|Protocol Violation|0|||
27843626|NCT00779402|81257752|FG001|Surveillance Phase|Protocol Violation|1|||
27843627|NCT00779402|81257751|FG000|Surveillance Phase|Patient refused to continue|22|||
27843628|NCT00779402|81257752|FG001|Surveillance Phase|Patient refused to continue|14|||
27843629|NCT00779402|81257751|FG000|Surveillance Phase|Lost to Follow-up|2|||
27843630|NCT00779402|81257752|FG001|Surveillance Phase|Lost to Follow-up|1|||
27843631|NCT00779402|81257751|FG000|Surveillance Phase|Death|0|||
27843632|NCT00779402|81257752|FG001|Surveillance Phase|Death|1|||
27843633|NCT00779402|81257751|FG000|Surveillance Phase|Intercurrent Illness|2|||
27843634|NCT00779402|81257752|FG001|Surveillance Phase|Intercurrent Illness|0|||
27843635|NCT00779402|81257751|FG000|Surveillance Phase|Other|5|||
27843636|NCT00779402|81257752|FG001|Surveillance Phase|Other|5|||
27843637|NCT00779402|81257751|FG000|Surveillance Phase|Withdrawal by Subject|4|||
27843638|NCT00779402|81257752|FG001|Surveillance Phase|Withdrawal by Subject|1|||
27843639|NCT00779402|81257751|FG000|Surveillance Phase|Closure of study|5|||
27843640|NCT00779402|81257752|FG001|Surveillance Phase|Closure of study|6|||
27843641|NCT00779402|81257751|FG000|Surveillance Phase|Completed Protocol Visits|3|||
27843642|NCT00779402|81257752|FG001|Surveillance Phase|Completed Protocol Visits|2|||
27843643|NCT00779402|81257751|FG000|Long-term Follow-up|Patient refused to continue|2|||
27843644|NCT00779402|81257752|FG001|Long-term Follow-up|Patient refused to continue|0|||
27843645|NCT00779402|81257751|FG000|Long-term Follow-up|Other|5|||
27843646|NCT00779402|81257752|FG001|Long-term Follow-up|Other|0|||
27843647|NCT00779402|81257751|FG000|Long-term Follow-up|Closure of Study|8|||
27843648|NCT00779402|81257752|FG001|Long-term Follow-up|Closure of Study|4|||
27843649|NCT00779402|81257751|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
27843650|NCT00779402|81257752|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
27843651|NCT02419573|81257753|FG000|Overall Study|Lost to Follow-up|3|||
27843652|NCT02419573|81257754|FG001|Overall Study|Lost to Follow-up|0|||
27843653|NCT02419573|81257753|FG000|Overall Study|Withdrawal by Subject|1|||
27843654|NCT02419573|81257754|FG001|Overall Study|Withdrawal by Subject|0|||
27843655|NCT01392326|81257768|FG000|Overall Study|Death|2|||
27843656|NCT01392326|81257769|FG001|Overall Study|Death|0|||
27843657|NCT01392326|81257770|FG002|Overall Study|Death|0|||
27843658|NCT01392326|81257768|FG000|Overall Study|Withdrawal by Subject|12|||
27843659|NCT01392326|81257769|FG001|Overall Study|Withdrawal by Subject|11|||
27843660|NCT01392326|81257770|FG002|Overall Study|Withdrawal by Subject|15|||
27843661|NCT01392326|81257768|FG000|Overall Study|Protocol Violation|2|||
27843662|NCT01392326|81257769|FG001|Overall Study|Protocol Violation|0|||
27843663|NCT01392326|81257770|FG002|Overall Study|Protocol Violation|0|||
27843664|NCT01392326|81257768|FG000|Overall Study|Pregnancy|0|||
27843665|NCT01392326|81257769|FG001|Overall Study|Pregnancy|0|||
27843666|NCT01392326|81257770|FG002|Overall Study|Pregnancy|1|||
27843667|NCT01392326|81257768|FG000|Overall Study|Physician Decision|7|||
27843668|NCT01392326|81257769|FG001|Overall Study|Physician Decision|5|||
27843669|NCT01392326|81257770|FG002|Overall Study|Physician Decision|2|||
27843670|NCT01392326|81257768|FG000|Overall Study|Lost to Follow-up|1|||
27843671|NCT01392326|81257769|FG001|Overall Study|Lost to Follow-up|3|||
27843672|NCT01392326|81257770|FG002|Overall Study|Lost to Follow-up|4|||
27843673|NCT01392326|81257768|FG000|Overall Study|Lack of Efficacy|14|||
27843674|NCT01392326|81257769|FG001|Overall Study|Lack of Efficacy|10|||
27843675|NCT01392326|81257770|FG002|Overall Study|Lack of Efficacy|15|||
27843676|NCT01392326|81257768|FG000|Overall Study|Adverse Event|9|||
27843677|NCT01392326|81257769|FG001|Overall Study|Adverse Event|6|||
27843678|NCT01392326|81257770|FG002|Overall Study|Adverse Event|11|||
27843679|NCT00544817|81257772|FG000|Combined Modality|Lack of Efficacy|2|||
27843680|NCT00544817|81257772|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
27843681|NCT00544817|81257772|FG000|Combined Modality|Adverse Event|2|||
27843682|NCT00544817|81257772|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
27843683|NCT00544817|81257772|FG000|No Treatment Interval|Lack of Efficacy|8|||
27843684|NCT00544817|81257772|FG000|No Treatment Interval|Physician Decision|3|||
27843685|NCT00544817|81257772|FG000|No Treatment Interval|Adverse Event|1|||
27504319|NCT02113982|80040779|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
27504320|NCT02113982|80040780|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
27504321|NCT02113982|80040781|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
27504322|NCT02113982|80040782|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
27504323|NCT02113982|80040769|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
27504324|NCT02113982|80040770|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
27504325|NCT02113982|80040771|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
27843686|NCT00544817|81257772|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
27843687|NCT00544817|81257772|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
27843688|NCT00544817|81257772|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
27843689|NCT00602537|81257773|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
27843690|NCT00602537|81257774|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
27843691|NCT00602537|81257773|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
27843692|NCT00602537|81257774|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
27843693|NCT00602537|81257773|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
27504326|NCT02113982|80040772|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
27504327|NCT02113982|80040773|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
27892990|NCT03409107|81443879|FG000|Overall Study|Physician Decision|1|||
27843694|NCT00602537|81257774|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
27843695|NCT00602537|81257773|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
27843696|NCT00602537|81257774|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
27843697|NCT00602537|81257773|FG000|Follow Up Study Comparison|Adverse Event|1|||
27843698|NCT00602537|81257774|FG001|Follow Up Study Comparison|Adverse Event|0|||
27504328|NCT02113982|80040774|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
27504329|NCT02113982|80040775|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
27504330|NCT02113982|80040776|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
27504331|NCT02113982|80040777|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
27504332|NCT02113982|80040778|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
27504333|NCT02113982|80040779|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
27504334|NCT02113982|80040780|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
27843699|NCT00602537|81257773|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
27843700|NCT00602537|81257774|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
27843701|NCT00602537|81257773|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
27843702|NCT00602537|81257774|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
27843703|NCT01714739|81257784|FG000|Overall Study|Disease progression|3|||
27843704|NCT01714739|81257785|FG001|Overall Study|Disease progression|5|||
27843705|NCT01714739|81257786|FG002|Overall Study|Disease progression|5|||
27843706|NCT01714739|81257787|FG003|Overall Study|Disease progression|204|||
27843707|NCT01714739|81257788|FG004|Overall Study|Disease progression|1|||
27843708|NCT01714739|81257789|FG005|Overall Study|Disease progression|3|||
27843709|NCT01714739|81257790|FG006|Overall Study|Disease progression|5|||
27843710|NCT01714739|81257784|FG000|Overall Study|Study drug toxicity|1|||
27843711|NCT01714739|81257785|FG001|Overall Study|Study drug toxicity|1|||
27843712|NCT01714739|81257786|FG002|Overall Study|Study drug toxicity|1|||
27843713|NCT01714739|81257787|FG003|Overall Study|Study drug toxicity|15|||
27843714|NCT01714739|81257788|FG004|Overall Study|Study drug toxicity|0|||
27843715|NCT01714739|81257789|FG005|Overall Study|Study drug toxicity|0|||
27843716|NCT01714739|81257790|FG006|Overall Study|Study drug toxicity|5|||
27843717|NCT01714739|81257784|FG000|Overall Study|Death|0|||
27843718|NCT01714739|81257785|FG001|Overall Study|Death|0|||
27843719|NCT01714739|81257786|FG002|Overall Study|Death|0|||
27843720|NCT01714739|81257787|FG003|Overall Study|Death|1|||
27892991|NCT03409107|81443880|FG001|Overall Study|Physician Decision|0|||
27892992|NCT03409107|81443879|FG000|Overall Study|Lost to Follow-up|7|||
27892993|NCT03409107|81443880|FG001|Overall Study|Lost to Follow-up|2|||
27892994|NCT03409107|81443879|FG000|Overall Study|Adverse Event|5|||
27892995|NCT03409107|81443880|FG001|Overall Study|Adverse Event|3|||
27892996|NCT04507256|81443881|FG000|Overall Study|Withdrawal by Subject|1|||
27892997|NCT04507256|81443882|FG001|Overall Study|Withdrawal by Subject|0|||
27892998|NCT04507256|81443883|FG002|Overall Study|Withdrawal by Subject|0|||
27892999|NCT04507256|81443884|FG003|Overall Study|Withdrawal by Subject|1|||
27504335|NCT02113982|80040781|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
27613583|NCT02746575|80426700|FG000|Overall Study|Surgery cancelled or time chaned|13|||
27504336|NCT02113982|80040782|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
27613584|NCT02746575|80426700|FG000|Overall Study|Received epidural|10|||
27843721|NCT01714739|81257788|FG004|Overall Study|Death|0|||
27843722|NCT01714739|81257789|FG005|Overall Study|Death|0|||
27843723|NCT01714739|81257790|FG006|Overall Study|Death|0|||
27843724|NCT01714739|81257784|FG000|Overall Study|Adverse Event unrelated to drug|0|||
27843725|NCT01714739|81257785|FG001|Overall Study|Adverse Event unrelated to drug|0|||
27893000|NCT04507256|81443885|FG004|Overall Study|Withdrawal by Subject|0|||
27893001|NCT04507256|81443886|FG005|Overall Study|Withdrawal by Subject|0|||
27843726|NCT01714739|81257786|FG002|Overall Study|Adverse Event unrelated to drug|3|||
27893002|NCT02589522|81443892|FG000|Overall Study|Physician Decision|1|||
27843727|NCT01714739|81257787|FG003|Overall Study|Adverse Event unrelated to drug|21|||
27504337|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
27504338|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
27724758|NCT02440581|80823132|FG001|Overall Study|Withdrawal by Subject|11|||
27724759|NCT02440581|80823133|FG002|Overall Study|Withdrawal by Subject|3|||
27724760|NCT02440581|80823134|FG003|Overall Study|Withdrawal by Subject|7|||
27724761|NCT00491179|80823143|FG000|Overall Study|Adverse Event|5|||
27724762|NCT00491179|80823144|FG001|Overall Study|Adverse Event|1|||
27724763|NCT00491179|80823143|FG000|Overall Study|Withdrawal by Subject|2|||
27724764|NCT00491179|80823144|FG001|Overall Study|Withdrawal by Subject|1|||
27724765|NCT01337973|80823147|FG000|Overall Study|Lost to Follow-up|2|||
27724766|NCT01337973|80823148|FG001|Overall Study|Lost to Follow-up|4|||
27724767|NCT01337973|80823149|FG002|Overall Study|Lost to Follow-up|3|||
27724768|NCT01337973|80823147|FG000|Overall Study|Death|1|||
27724769|NCT01337973|80823148|FG001|Overall Study|Death|2|||
27724770|NCT01337973|80823149|FG002|Overall Study|Death|1|||
27724771|NCT01337973|80823147|FG000|Overall Study|Withdrawal by Subject|10|||
27724772|NCT01337973|80823148|FG001|Overall Study|Withdrawal by Subject|8|||
27724773|NCT01337973|80823149|FG002|Overall Study|Withdrawal by Subject|4|||
27724774|NCT01337973|80823147|FG000|Overall Study|missing data on primary outcome|3|||
27724775|NCT01337973|80823148|FG001|Overall Study|missing data on primary outcome|1|||
27843728|NCT01714739|81257788|FG004|Overall Study|Adverse Event unrelated to drug|0|||
27843729|NCT01714739|81257789|FG005|Overall Study|Adverse Event unrelated to drug|0|||
27843730|NCT01714739|81257790|FG006|Overall Study|Adverse Event unrelated to drug|0|||
27843731|NCT01714739|81257784|FG000|Overall Study|Participant request to stop therapy|0|||
27843732|NCT01714739|81257785|FG001|Overall Study|Participant request to stop therapy|1|||
27843733|NCT01714739|81257786|FG002|Overall Study|Participant request to stop therapy|0|||
27843734|NCT01714739|81257787|FG003|Overall Study|Participant request to stop therapy|6|||
27843735|NCT01714739|81257788|FG004|Overall Study|Participant request to stop therapy|0|||
27843736|NCT01714739|81257789|FG005|Overall Study|Participant request to stop therapy|0|||
27843737|NCT01714739|81257790|FG006|Overall Study|Participant request to stop therapy|0|||
27843738|NCT01714739|81257784|FG000|Overall Study|Participant withdrew consent|0|||
27893003|NCT02589522|81443893|FG001|Overall Study|Physician Decision|2|||
27504339|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
27504340|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
27504341|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
27504342|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
27504343|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
27504344|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
27504345|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
27504346|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
27504347|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
27504348|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
27504349|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
27504350|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
27504351|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
27504352|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
27504353|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
27504354|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
27504355|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
27504356|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
27504357|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
27504358|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
27504359|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
27504360|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
27504361|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
27504362|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
27504363|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
27504364|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
27504365|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504366|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
27724776|NCT01337973|80823149|FG002|Overall Study|missing data on primary outcome|3|||
27724777|NCT02883244|80823150|FG000|Overall Study|Lost to Follow-up|0|||
27724778|NCT02883244|80823151|FG001|Overall Study|Lost to Follow-up|1|||
27724779|NCT02809833|80823152|FG000|Overall Study|Death|3|||
27724780|NCT02809833|80823152|FG000|Overall Study|Intolerance|54|||
27843739|NCT01714739|81257785|FG001|Overall Study|Participant withdrew consent|1|||
27843740|NCT01714739|81257786|FG002|Overall Study|Participant withdrew consent|0|||
27504367|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504368|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
27724781|NCT02809833|80823152|FG000|Overall Study|Lack of Efficacy|89|||
27724782|NCT02809833|80823152|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
27724783|NCT02809833|80823152|FG000|Overall Study|Noncompliance|1|||
27724784|NCT02809833|80823152|FG000|Overall Study|Withdrawal by Subject|34|||
27724785|NCT02809833|80823152|FG000|Overall Study|Lost to Follow-up|35|||
27724786|NCT02809833|80823152|FG000|Overall Study|Adverse Event (AE)|24|||
27724787|NCT02809833|80823152|FG000|Overall Study|Other|5|||
27724788|NCT02809833|80823152|FG000|Overall Study|Missing Information|52|||
27724789|NCT03468309|80823158|FG000|Overall Study|Lost to Follow-up|4|||
27724790|NCT03468309|80823158|FG000|Overall Study|Withdrawal by Subject|2|||
27724791|NCT03345472|80823159|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
27724792|NCT03345472|80823159|FG000|Implant to 3 Months|Physician Decision|1|||
27724793|NCT03345472|80823159|FG000|Implant to 3 Months|Adverse Event|1|||
27724794|NCT03345472|80823159|FG000|3 Months to 12 Months|Physician Decision|3|||
27724795|NCT03345472|80823159|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
27724796|NCT03345472|80823159|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
27724797|NCT03345472|80823159|FG000|3 Months to 12 Months|Adverse Event|1|||
27724798|NCT03345472|80823159|FG000|3 Months to 12 Months|Death|1|||
27724799|NCT00860158|80823165|FG000|Overall Study|Study Terminated|1|||
27724800|NCT02817087|80823176|FG000|Overall Study|Withdrawal by Subject|2|||
27724801|NCT02817087|80823177|FG001|Overall Study|Withdrawal by Subject|0|||
27724802|NCT02479802|80823178|FG000|Overall Study|Lost to Follow-up|1|||
27724803|NCT02479802|80823178|FG000|Overall Study|Adverse Event|1|||
27724804|NCT02546986|80823179|FG000|Treatment Period|Progressive Disease|20|||
27724805|NCT02546986|80823180|FG001|Treatment Period|Progressive Disease|22|||
27724806|NCT02546986|80823179|FG000|Treatment Period|Adverse Event|14|||
27724807|NCT02546986|80823180|FG001|Treatment Period|Adverse Event|6|||
27724808|NCT02546986|80823179|FG000|Treatment Period|Symptomatic Deterioration|4|||
27504369|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504370|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504371|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504372|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
27504373|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
27724809|NCT02546986|80823180|FG001|Treatment Period|Symptomatic Deterioration|3|||
27724810|NCT02546986|80823179|FG000|Treatment Period|Death|3|||
27724811|NCT02546986|80823180|FG001|Treatment Period|Death|4|||
27724812|NCT02546986|80823179|FG000|Treatment Period|Physician Decision|1|||
27724813|NCT02546986|80823180|FG001|Treatment Period|Physician Decision|2|||
27724814|NCT02546986|80823179|FG000|Treatment Period|Protocol Violation|1|||
27724815|NCT02546986|80823180|FG001|Treatment Period|Protocol Violation|0|||
27724816|NCT02546986|80823179|FG000|Treatment Period|Withdrawal by Subject|1|||
27724817|NCT02546986|80823180|FG001|Treatment Period|Withdrawal by Subject|1|||
27724818|NCT02546986|80823179|FG000|Treatment Period|Non-compliance with Study Drug|0|||
27724819|NCT02546986|80823180|FG001|Treatment Period|Non-compliance with Study Drug|1|||
27724820|NCT02546986|80823179|FG000|Treatment Period|Study Terminated by Sponsor|0|||
27724821|NCT02546986|80823180|FG001|Treatment Period|Study Terminated by Sponsor|1|||
27724822|NCT02546986|80823179|FG000|Treatment Period|Miscellaneous|7|||
27724823|NCT02546986|80823180|FG001|Treatment Period|Miscellaneous|9|||
27724824|NCT02546986|80823179|FG000|Survival Follow-Up Phase|Missing Status|3|||
27724825|NCT02546986|80823180|FG001|Survival Follow-Up Phase|Missing Status|5|||
27724826|NCT02546986|80823179|FG000|Survival Follow-Up Phase|Death|18|||
27724827|NCT02546986|80823180|FG001|Survival Follow-Up Phase|Death|12|||
27724828|NCT02546986|80823179|FG000|Survival Follow-Up Phase|Alive|13|||
27893004|NCT02589522|81443894|FG002|Overall Study|Physician Decision|0|||
27504374|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
27504375|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
27504376|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504377|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
27724829|NCT02546986|80823180|FG001|Survival Follow-Up Phase|Alive|16|||
27724830|NCT02546986|80823179|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
27724831|NCT02546986|80823180|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
27724832|NCT01554579|80823186|FG000|Overall Study|Adverse Event|6|||
27724833|NCT01554579|80823187|FG001|Overall Study|Adverse Event|25|||
27724834|NCT01554579|80823186|FG000|Overall Study|Lack of Efficacy|2|||
27724835|NCT01554579|80823187|FG001|Overall Study|Lack of Efficacy|1|||
27893005|NCT02589522|81443892|FG000|Overall Study|Did not start treatment|1|||
27724836|NCT01554579|80823186|FG000|Overall Study|Withdrawal by Subject|2|||
27724837|NCT01554579|80823187|FG001|Overall Study|Withdrawal by Subject|1|||
27724838|NCT01354028|80823188|FG000|Overall Study|Physician Decision|0|||
27843741|NCT01714739|81257787|FG003|Overall Study|Participant withdrew consent|8|||
27843742|NCT01714739|81257788|FG004|Overall Study|Participant withdrew consent|0|||
27843743|NCT01714739|81257789|FG005|Overall Study|Participant withdrew consent|0|||
27843744|NCT01714739|81257790|FG006|Overall Study|Participant withdrew consent|0|||
27843745|NCT01714739|81257784|FG000|Overall Study|Lost to Follow-up|0|||
27843746|NCT01714739|81257785|FG001|Overall Study|Lost to Follow-up|0|||
27843747|NCT01714739|81257786|FG002|Overall Study|Lost to Follow-up|0|||
27843748|NCT01714739|81257787|FG003|Overall Study|Lost to Follow-up|1|||
27843749|NCT01714739|81257788|FG004|Overall Study|Lost to Follow-up|0|||
27843750|NCT01714739|81257789|FG005|Overall Study|Lost to Follow-up|0|||
27843751|NCT01714739|81257790|FG006|Overall Study|Lost to Follow-up|0|||
27843752|NCT01714739|81257784|FG000|Overall Study|Maximum clinical benefit|0|||
27843753|NCT01714739|81257785|FG001|Overall Study|Maximum clinical benefit|1|||
27843754|NCT01714739|81257786|FG002|Overall Study|Maximum clinical benefit|1|||
27843755|NCT01714739|81257787|FG003|Overall Study|Maximum clinical benefit|3|||
27843756|NCT01714739|81257788|FG004|Overall Study|Maximum clinical benefit|0|||
27843757|NCT01714739|81257789|FG005|Overall Study|Maximum clinical benefit|0|||
27843758|NCT01714739|81257790|FG006|Overall Study|Maximum clinical benefit|0|||
27843759|NCT01714739|81257784|FG000|Overall Study|Poor/non-comliance|0|||
27843760|NCT01714739|81257785|FG001|Overall Study|Poor/non-comliance|1|||
27843761|NCT01714739|81257786|FG002|Overall Study|Poor/non-comliance|0|||
27504378|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
27504379|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504380|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504381|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504382|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504383|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504384|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27843762|NCT01714739|81257787|FG003|Overall Study|Poor/non-comliance|1|||
27843763|NCT01714739|81257788|FG004|Overall Study|Poor/non-comliance|0|||
27843764|NCT01714739|81257789|FG005|Overall Study|Poor/non-comliance|0|||
27843765|NCT01714739|81257790|FG006|Overall Study|Poor/non-comliance|0|||
27843766|NCT01714739|81257784|FG000|Overall Study|No longer meets study criteria|0|||
27724839|NCT01354028|80823189|FG001|Overall Study|Physician Decision|2|||
27724840|NCT01354028|80823188|FG000|Overall Study|Discharged before study start|2|||
27724841|NCT01354028|80823189|FG001|Overall Study|Discharged before study start|2|||
27724842|NCT01354028|80823188|FG000|Overall Study|No quiet alert state|0|||
27724843|NCT01354028|80823189|FG001|Overall Study|No quiet alert state|1|||
27724844|NCT04957290|80823195|FG000|Overall Study|Progressive disease|3|||
27843767|NCT01714739|81257785|FG001|Overall Study|No longer meets study criteria|0|||
27843768|NCT01714739|81257786|FG002|Overall Study|No longer meets study criteria|0|||
27843769|NCT01714739|81257787|FG003|Overall Study|No longer meets study criteria|1|||
27843770|NCT01714739|81257788|FG004|Overall Study|No longer meets study criteria|0|||
27843771|NCT01714739|81257789|FG005|Overall Study|No longer meets study criteria|0|||
27843772|NCT01714739|81257790|FG006|Overall Study|No longer meets study criteria|0|||
27843773|NCT01714739|81257784|FG000|Overall Study|Other reason|0|||
27843774|NCT01714739|81257785|FG001|Overall Study|Other reason|0|||
27843775|NCT01714739|81257786|FG002|Overall Study|Other reason|0|||
27843776|NCT01714739|81257787|FG003|Overall Study|Other reason|3|||
27843777|NCT01714739|81257788|FG004|Overall Study|Other reason|1|||
27724845|NCT04957290|80823196|FG001|Overall Study|Progressive disease|3|||
27724846|NCT04957290|80823197|FG002|Overall Study|Progressive disease|2|||
27724847|NCT04957290|80823198|FG003|Overall Study|Progressive disease|0|||
27724848|NCT04957290|80823199|FG004|Overall Study|Progressive disease|0|||
27724849|NCT04957290|80823200|FG005|Overall Study|Progressive disease|0|||
27724850|NCT04957290|80823195|FG000|Overall Study|Withdrawal by Subject|1|||
27724851|NCT04957290|80823196|FG001|Overall Study|Withdrawal by Subject|0|||
27724852|NCT04957290|80823197|FG002|Overall Study|Withdrawal by Subject|1|||
27724853|NCT04957290|80823198|FG003|Overall Study|Withdrawal by Subject|0|||
27843778|NCT01714739|81257789|FG005|Overall Study|Other reason|0|||
27843779|NCT01714739|81257790|FG006|Overall Study|Other reason|0|||
27843780|NCT02443324|81257791|FG000|Overall Study|Death|4|||
27843781|NCT02443324|81257792|FG001|Overall Study|Death|1|||
27843782|NCT02443324|81257793|FG002|Overall Study|Death|0|||
27843783|NCT02443324|81257794|FG003|Overall Study|Death|3|||
27843784|NCT02443324|81257795|FG004|Overall Study|Death|1|||
27843785|NCT02443324|81257796|FG005|Overall Study|Death|3|||
27843786|NCT02443324|81257797|FG006|Overall Study|Death|2|||
27843787|NCT02443324|81257791|FG000|Overall Study|Lost to Follow-up|0|||
27843788|NCT02443324|81257792|FG001|Overall Study|Lost to Follow-up|0|||
27843789|NCT02443324|81257793|FG002|Overall Study|Lost to Follow-up|0|||
27724854|NCT04957290|80823199|FG004|Overall Study|Withdrawal by Subject|0|||
27724855|NCT04957290|80823200|FG005|Overall Study|Withdrawal by Subject|0|||
27724856|NCT04957290|80823195|FG000|Overall Study|Death|0|||
27843790|NCT02443324|81257794|FG003|Overall Study|Lost to Follow-up|1|||
27843791|NCT02443324|81257795|FG004|Overall Study|Lost to Follow-up|0|||
27843792|NCT02443324|81257796|FG005|Overall Study|Lost to Follow-up|1|||
27843793|NCT02443324|81257797|FG006|Overall Study|Lost to Follow-up|0|||
27843794|NCT02443324|81257791|FG000|Overall Study|Physician Decision|0|||
27843795|NCT02443324|81257792|FG001|Overall Study|Physician Decision|3|||
27843796|NCT02443324|81257793|FG002|Overall Study|Physician Decision|5|||
27843797|NCT02443324|81257794|FG003|Overall Study|Physician Decision|1|||
27843798|NCT02443324|81257795|FG004|Overall Study|Physician Decision|1|||
27843799|NCT02443324|81257796|FG005|Overall Study|Physician Decision|0|||
27843800|NCT02443324|81257797|FG006|Overall Study|Physician Decision|2|||
27843801|NCT02443324|81257791|FG000|Overall Study|Progressive Disease|20|||
27843802|NCT02443324|81257792|FG001|Overall Study|Progressive Disease|20|||
27843803|NCT02443324|81257793|FG002|Overall Study|Progressive Disease|13|||
27843804|NCT02443324|81257794|FG003|Overall Study|Progressive Disease|10|||
27843805|NCT02443324|81257795|FG004|Overall Study|Progressive Disease|13|||
27843806|NCT02443324|81257796|FG005|Overall Study|Progressive Disease|17|||
27843807|NCT02443324|81257797|FG006|Overall Study|Progressive Disease|10|||
27843808|NCT02443324|81257791|FG000|Overall Study|Withdrawal by Subject|0|||
27843809|NCT02443324|81257792|FG001|Overall Study|Withdrawal by Subject|0|||
27843810|NCT02443324|81257793|FG002|Overall Study|Withdrawal by Subject|3|||
27843811|NCT02443324|81257794|FG003|Overall Study|Withdrawal by Subject|1|||
27843812|NCT02443324|81257795|FG004|Overall Study|Withdrawal by Subject|1|||
27843813|NCT02443324|81257796|FG005|Overall Study|Withdrawal by Subject|0|||
27843814|NCT02443324|81257797|FG006|Overall Study|Withdrawal by Subject|1|||
27843815|NCT02443324|81257791|FG000|Overall Study|Adverse Event|0|||
27843816|NCT02443324|81257792|FG001|Overall Study|Adverse Event|1|||
27843817|NCT02443324|81257793|FG002|Overall Study|Adverse Event|3|||
27843818|NCT02443324|81257794|FG003|Overall Study|Adverse Event|0|||
27843819|NCT02443324|81257795|FG004|Overall Study|Adverse Event|4|||
27843820|NCT02443324|81257796|FG005|Overall Study|Adverse Event|3|||
27843821|NCT02443324|81257797|FG006|Overall Study|Adverse Event|3|||
27843822|NCT02443324|81257791|FG000|Overall Study|Enrolled but Never Treated|0|||
27843823|NCT02443324|81257792|FG001|Overall Study|Enrolled but Never Treated|0|||
27843824|NCT02443324|81257793|FG002|Overall Study|Enrolled but Never Treated|1|||
27843825|NCT02443324|81257794|FG003|Overall Study|Enrolled but Never Treated|0|||
27843826|NCT02443324|81257795|FG004|Overall Study|Enrolled but Never Treated|1|||
27843827|NCT02443324|81257796|FG005|Overall Study|Enrolled but Never Treated|0|||
27843828|NCT02443324|81257797|FG006|Overall Study|Enrolled but Never Treated|1|||
27843829|NCT01235715|81257801|FG000|Overall Study|Physician Decision|0|||
27843830|NCT01235715|81257802|FG001|Overall Study|Physician Decision|2|||
27843831|NCT02274948|81257803|FG000|Overall Study|Lost to Follow-up|28|||
27843832|NCT02274948|81257804|FG001|Overall Study|Lost to Follow-up|25|||
27843833|NCT02274948|81257803|FG000|Overall Study|Withdrawal by Subject|64|||
27843834|NCT02274948|81257804|FG001|Overall Study|Withdrawal by Subject|58|||
27843835|NCT02274948|81257803|FG000|Overall Study|Stopped on family Practitioner advice|2|||
27843836|NCT02274948|81257804|FG001|Overall Study|Stopped on family Practitioner advice|5|||
27843837|NCT02274948|81257803|FG000|Overall Study|Left the area|4|||
27843838|NCT02274948|81257804|FG001|Overall Study|Left the area|3|||
27843839|NCT02039063|81257805|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
27843840|NCT02039063|81257806|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
27843841|NCT02039063|81257807|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
27724857|NCT04957290|80823196|FG001|Overall Study|Death|2|||
27724858|NCT04957290|80823197|FG002|Overall Study|Death|1|||
27724859|NCT04957290|80823198|FG003|Overall Study|Death|0|||
27724860|NCT04957290|80823199|FG004|Overall Study|Death|0|||
27724861|NCT04957290|80823200|FG005|Overall Study|Death|0|||
27724862|NCT04957290|80823195|FG000|Overall Study|non compliance with study drug|0|||
27724863|NCT04957290|80823196|FG001|Overall Study|non compliance with study drug|1|||
27843842|NCT02039063|81257808|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
27843843|NCT02039063|81257805|FG000|Treatment Phase|Progression of disease|0|||
27843844|NCT02039063|81257806|FG001|Treatment Phase|Progression of disease|0|||
27843845|NCT02039063|81257807|FG002|Treatment Phase|Progression of disease|1|||
27843846|NCT02039063|81257808|FG003|Treatment Phase|Progression of disease|1|||
27843847|NCT02039063|81257805|FG000|Extension Phase|Inadequate therapeutic effect|0|||
27843848|NCT02039063|81257806|FG001|Extension Phase|Inadequate therapeutic effect|1|||
27843849|NCT02039063|81257807|FG002|Extension Phase|Inadequate therapeutic effect|2|||
27843850|NCT02039063|81257808|FG003|Extension Phase|Inadequate therapeutic effect|0|||
27893006|NCT02589522|81443893|FG001|Overall Study|Did not start treatment|0|||
27893007|NCT02589522|81443894|FG002|Overall Study|Did not start treatment|0|||
27843851|NCT02039063|81257805|FG000|Extension Phase|Progression of disease|0|||
27843852|NCT02039063|81257806|FG001|Extension Phase|Progression of disease|0|||
27843853|NCT02039063|81257807|FG002|Extension Phase|Progression of disease|0|||
27843854|NCT02039063|81257808|FG003|Extension Phase|Progression of disease|1|||
27843855|NCT02039063|81257805|FG000|Extension Phase|Adverse Event|0|||
27843856|NCT02039063|81257806|FG001|Extension Phase|Adverse Event|0|||
27724864|NCT04957290|80823197|FG002|Overall Study|non compliance with study drug|0|||
27724865|NCT04957290|80823198|FG003|Overall Study|non compliance with study drug|0|||
27843857|NCT02039063|81257807|FG002|Extension Phase|Adverse Event|1|||
27893008|NCT03861273|81443904|FG000|Screening Phase (3 Weeks)|Other|1|||
27843858|NCT02039063|81257808|FG003|Extension Phase|Adverse Event|0|||
27843859|NCT00981799|81257817|FG000|Overall Study|Adverse Event|1|||
27843860|NCT00981799|81257818|FG001|Overall Study|Adverse Event|1|||
27843861|NCT00981799|81257819|FG002|Overall Study|Adverse Event|0|||
27843862|NCT00981799|81257820|FG003|Overall Study|Adverse Event|0|||
27843863|NCT01606228|81257823|FG000|Overall Study|Lost to Follow-up|20|||
27843864|NCT01606228|81257823|FG000|Overall Study|Withdrawal by Subject|3|||
27843865|NCT01606228|81257823|FG000|Overall Study|Non-compliant|3|||
27843866|NCT01606228|81257823|FG000|Overall Study|Lack of Efficacy|2|||
27843867|NCT01606228|81257823|FG000|Overall Study|Adverse Event|1|||
27843868|NCT03381196|81257824|FG000|Overall Study|Withdrawal by Subject|7|||
27843869|NCT03381196|81257825|FG001|Overall Study|Withdrawal by Subject|7|||
27843870|NCT03381196|81257824|FG000|Overall Study|Other|0|||
27843871|NCT03381196|81257825|FG001|Overall Study|Other|1|||
27843872|NCT03381196|81257824|FG000|Overall Study|Lost to Follow-up|5|||
27843873|NCT03381196|81257825|FG001|Overall Study|Lost to Follow-up|4|||
27843874|NCT03381196|81257824|FG000|Overall Study|Death|0|||
27843875|NCT03381196|81257825|FG001|Overall Study|Death|1|||
27843876|NCT03381196|81257824|FG000|Overall Study|Adverse Event|1|||
27843877|NCT03381196|81257825|FG001|Overall Study|Adverse Event|0|||
27843878|NCT03381196|81257824|FG000|Overall Study|Randomized, not treated|3|||
27843879|NCT03381196|81257825|FG001|Overall Study|Randomized, not treated|6|||
27843880|NCT00700817|81257826|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
27843881|NCT00700817|81257827|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
27843882|NCT00700817|81257828|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
27843883|NCT00700817|81257829|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
27843884|NCT00700817|81257830|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
27843885|NCT00700817|81257826|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
27843886|NCT00700817|81257827|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
27504385|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504386|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
27504387|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504388|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
27504389|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504390|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504391|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27504392|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
27724866|NCT04957290|80823199|FG004|Overall Study|non compliance with study drug|0|||
27724867|NCT04957290|80823200|FG005|Overall Study|non compliance with study drug|0|||
27724868|NCT04957290|80823195|FG000|Overall Study|none specified.|0|||
27724869|NCT04957290|80823196|FG001|Overall Study|none specified.|1|||
27724870|NCT04957290|80823197|FG002|Overall Study|none specified.|2|||
27724871|NCT04957290|80823198|FG003|Overall Study|none specified.|0|||
27724872|NCT04957290|80823199|FG004|Overall Study|none specified.|0|||
27724873|NCT04957290|80823200|FG005|Overall Study|none specified.|0|||
27724874|NCT04957290|80823195|FG000|Overall Study|unacceptable toxicity|0|||
27724875|NCT04957290|80823196|FG001|Overall Study|unacceptable toxicity|0|||
27724876|NCT04957290|80823197|FG002|Overall Study|unacceptable toxicity|1|||
27724877|NCT04957290|80823198|FG003|Overall Study|unacceptable toxicity|0|||
27724878|NCT04957290|80823199|FG004|Overall Study|unacceptable toxicity|0|||
27724879|NCT04957290|80823200|FG005|Overall Study|unacceptable toxicity|0|||
27724880|NCT04957290|80823195|FG000|Overall Study|Adverse Event|0|||
27724881|NCT04957290|80823196|FG001|Overall Study|Adverse Event|0|||
27724882|NCT04957290|80823197|FG002|Overall Study|Adverse Event|1|||
27724883|NCT04957290|80823198|FG003|Overall Study|Adverse Event|0|||
27843887|NCT00700817|81257828|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
27843888|NCT00700817|81257829|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
27843889|NCT00700817|81257830|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
27843890|NCT00700817|81257826|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
27843891|NCT00700817|81257827|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
27724884|NCT04957290|80823199|FG004|Overall Study|Adverse Event|0|||
27724885|NCT04957290|80823200|FG005|Overall Study|Adverse Event|0|||
27724886|NCT04957290|80823195|FG000|Overall Study|study terminated by sponsor|0|||
27724887|NCT04957290|80823196|FG001|Overall Study|study terminated by sponsor|0|||
27724888|NCT04957290|80823197|FG002|Overall Study|study terminated by sponsor|2|||
27724889|NCT04957290|80823198|FG003|Overall Study|study terminated by sponsor|0|||
27724890|NCT04957290|80823199|FG004|Overall Study|study terminated by sponsor|0|||
27724891|NCT04957290|80823200|FG005|Overall Study|study terminated by sponsor|0|||
27724892|NCT02688647|80823201|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
27724893|NCT02688647|80823202|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
27843892|NCT00700817|81257828|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
27843893|NCT00700817|81257829|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
27843894|NCT00700817|81257830|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
27843895|NCT00700817|81257826|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
27843896|NCT00700817|81257827|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
27843897|NCT00700817|81257828|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
27843898|NCT00700817|81257829|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
27843899|NCT00700817|81257830|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
27843900|NCT00700817|81257826|FG000|Week 0-26 (Main Period)|Unclassified|14|||
27843901|NCT00700817|81257827|FG001|Week 0-26 (Main Period)|Unclassified|4|||
27843902|NCT00700817|81257828|FG002|Week 0-26 (Main Period)|Unclassified|8|||
27843903|NCT00700817|81257829|FG003|Week 0-26 (Main Period)|Unclassified|0|||
27843904|NCT00700817|81257830|FG004|Week 0-26 (Main Period)|Unclassified|0|||
27843905|NCT00700817|81257826|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
27843906|NCT00700817|81257827|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
27843907|NCT00700817|81257828|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
27843908|NCT00700817|81257829|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
27843909|NCT00700817|81257830|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
27843910|NCT00700817|81257826|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
27843911|NCT00700817|81257827|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
27843912|NCT00700817|81257828|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
27843913|NCT00700817|81257829|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
27843914|NCT00700817|81257830|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
27843915|NCT00700817|81257826|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
27843916|NCT00700817|81257827|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
27843917|NCT00700817|81257828|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
27843918|NCT00700817|81257829|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
27843919|NCT00700817|81257830|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
27843920|NCT00700817|81257826|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
27843921|NCT00700817|81257827|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
27843922|NCT00700817|81257828|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
27843923|NCT00700817|81257829|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
27843924|NCT00700817|81257830|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
27843925|NCT00700817|81257826|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
27843926|NCT00700817|81257827|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
27843927|NCT00700817|81257828|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
27843928|NCT00700817|81257829|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
27843929|NCT00700817|81257830|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
27724894|NCT02688647|80823201|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
27724895|NCT02688647|80823202|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
27724896|NCT02688647|80823201|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
27724897|NCT02688647|80823202|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
27724898|NCT02688647|80823201|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
27724899|NCT02688647|80823202|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
27724900|NCT02688647|80823201|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
27724901|NCT02688647|80823202|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
27724902|NCT02688647|80823201|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
27724903|NCT02688647|80823202|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
27724904|NCT02688647|80823201|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
27724905|NCT02688647|80823202|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
27724906|NCT02605642|80823203|FG000|Overall Study|Other|11|||
27724907|NCT02605642|80823204|FG001|Overall Study|Other|1|||
27724908|NCT02605642|80823203|FG000|Overall Study|Participant non-compliance|2|||
27724909|NCT02605642|80823204|FG001|Overall Study|Participant non-compliance|4|||
27724910|NCT02605642|80823203|FG000|Overall Study|Physician Decision|10|||
27724911|NCT02605642|80823204|FG001|Overall Study|Physician Decision|0|||
27724912|NCT02605642|80823203|FG000|Overall Study|Lost to Follow-up|12|||
27724913|NCT02605642|80823204|FG001|Overall Study|Lost to Follow-up|1|||
27724914|NCT02605642|80823203|FG000|Overall Study|Adverse Event|14|||
27724915|NCT02605642|80823204|FG001|Overall Study|Adverse Event|2|||
27724916|NCT02605642|80823203|FG000|Overall Study|Withdrawal by Subject|23|||
27724917|NCT02605642|80823204|FG001|Overall Study|Withdrawal by Subject|2|||
27724918|NCT02605642|80823203|FG000|Overall Study|Lack of response|24|||
27724919|NCT02605642|80823204|FG001|Overall Study|Lack of response|11|||
27724920|NCT00441545|80823209|FG000|First Intervention|Adverse Event|6|||
27843930|NCT00700817|81257826|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
27843931|NCT00700817|81257827|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
27724921|NCT00441545|80823210|FG001|First Intervention|Adverse Event|5|||
27843932|NCT00700817|81257828|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
27724922|NCT00441545|80823209|FG000|First Intervention|Protocol Violation|2|||
27843933|NCT00700817|81257829|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
27843934|NCT00700817|81257830|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
27724923|NCT00441545|80823210|FG001|First Intervention|Protocol Violation|2|||
27724924|NCT00441545|80823209|FG000|First Intervention|Withdrawal by Subject|3|||
27843935|NCT00700817|81257826|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
27843936|NCT00700817|81257827|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
27843937|NCT00700817|81257828|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
27843938|NCT00700817|81257829|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
27843939|NCT00700817|81257830|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
27843940|NCT00700817|81257826|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
27843941|NCT00700817|81257827|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
27724925|NCT00441545|80823210|FG001|First Intervention|Withdrawal by Subject|3|||
27724926|NCT00441545|80823209|FG000|First Intervention|Kidney transplant|1|||
27724927|NCT00441545|80823210|FG001|First Intervention|Kidney transplant|1|||
27724928|NCT00441545|80823209|FG000|First Intervention|Lack of Efficacy|2|||
27724929|NCT00441545|80823210|FG001|First Intervention|Lack of Efficacy|0|||
27724930|NCT00441545|80823209|FG000|First Intervention|Subject exceeded safety criteria|0|||
27724931|NCT00441545|80823210|FG001|First Intervention|Subject exceeded safety criteria|1|||
27724932|NCT00441545|80823209|FG000|First Intervention|Subject met an exclusionary criteria|1|||
27724933|NCT00441545|80823210|FG001|First Intervention|Subject met an exclusionary criteria|0|||
27724934|NCT00441545|80823209|FG000|First Intervention|Extended hospitalization|1|||
27724935|NCT00441545|80823210|FG001|First Intervention|Extended hospitalization|0|||
27724936|NCT00441545|80823209|FG000|First Intervention|Site error|1|||
27724937|NCT00441545|80823210|FG001|First Intervention|Site error|0|||
27724938|NCT00441545|80823209|FG000|First Intervention|Sponsor's request|1|||
27724939|NCT00441545|80823210|FG001|First Intervention|Sponsor's request|0|||
27724940|NCT00441545|80823209|FG000|Second Intervention|Adverse Event|5|||
27724941|NCT00441545|80823210|FG001|Second Intervention|Adverse Event|2|||
27724942|NCT00441545|80823209|FG000|Second Intervention|Protocol Violation|4|||
27724943|NCT00441545|80823210|FG001|Second Intervention|Protocol Violation|1|||
27724944|NCT00441545|80823209|FG000|Second Intervention|Withdrawal by Subject|1|||
27724945|NCT00441545|80823210|FG001|Second Intervention|Withdrawal by Subject|1|||
27724946|NCT00441545|80823209|FG000|Second Intervention|Kidney Transplant|1|||
27724947|NCT00441545|80823210|FG001|Second Intervention|Kidney Transplant|1|||
27724948|NCT00441545|80823209|FG000|Second Intervention|Lack of Efficacy|0|||
27724949|NCT00441545|80823210|FG001|Second Intervention|Lack of Efficacy|1|||
27724950|NCT00441545|80823209|FG000|Second Intervention|Subject exceeded safety criteria|1|||
27724951|NCT00441545|80823210|FG001|Second Intervention|Subject exceeded safety criteria|0|||
27724952|NCT00441545|80823209|FG000|Second Intervention|Subject moved|0|||
27724953|NCT00441545|80823210|FG001|Second Intervention|Subject moved|1|||
27724954|NCT03208231|80823214|FG000|Overall Study|Death|1|||
27724955|NCT03208231|80823215|FG001|Overall Study|Death|2|||
27724956|NCT03208231|80823214|FG000|Overall Study|Moved and unable to get to clinic|1|||
27504393|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27724957|NCT03208231|80823215|FG001|Overall Study|Moved and unable to get to clinic|0|||
27724958|NCT03208231|80823214|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
27724959|NCT03208231|80823215|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
27724960|NCT03430986|80823216|FG000|24-week Control Period|Adverse Event|1|||
27724961|NCT03430986|80823217|FG001|24-week Control Period|Adverse Event|0|||
27724962|NCT03430986|80823216|FG000|24-week Control Period|Lost to Follow-up|2|||
27724963|NCT03430986|80823217|FG001|24-week Control Period|Lost to Follow-up|2|||
27724964|NCT03430986|80823216|FG000|24-week Control Period|Withdrawal by Participant|5|||
27724965|NCT03430986|80823217|FG001|24-week Control Period|Withdrawal by Participant|0|||
27724966|NCT03430986|80823216|FG000|24-week Control Period|Protocol Deviation|0|||
27724967|NCT03430986|80823217|FG001|24-week Control Period|Protocol Deviation|2|||
27724968|NCT03430986|80823216|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
27724969|NCT03430986|80823217|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
27724970|NCT03430986|80823216|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
27613585|NCT02746575|80426700|FG000|Overall Study|Withdrawal by Subject|3|||
27724971|NCT03430986|80823217|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
27724972|NCT02419508|80823218|FG000|Overall Study|Adverse Event|9|||
27724973|NCT02419508|80823219|FG001|Overall Study|Adverse Event|3|||
27724974|NCT02419508|80823218|FG000|Overall Study|Withdrawal by Subject|1|||
27724975|NCT02419508|80823219|FG001|Overall Study|Withdrawal by Subject|0|||
27724976|NCT02419508|80823218|FG000|Overall Study|Other - Reason not specified|0|||
27724977|NCT02419508|80823219|FG001|Overall Study|Other - Reason not specified|1|||
27724978|NCT01925209|80823226|FG000|Treatment Epoch|Physician Decision|1|||
27724979|NCT01925209|80823227|FG001|Treatment Epoch|Physician Decision|0|||
27724980|NCT01925209|80823228|FG002|Treatment Epoch|Physician Decision|0|||
27504394|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27893009|NCT03861273|81443904|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
27893010|NCT03861273|81443904|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
27893011|NCT03861273|81443904|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
27893012|NCT03861273|81443904|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
27893013|NCT03696108|81443905|FG000|Overall Study|Physician Decision|1|||
27893014|NCT03696108|81443906|FG001|Overall Study|Physician Decision|0|||
27893015|NCT03696108|81443905|FG000|Overall Study|Withdrawal by Subject|3|||
27893016|NCT03696108|81443906|FG001|Overall Study|Withdrawal by Subject|6|||
27893017|NCT04852276|81443907|FG000|Overall Study|Death|2|||
27893018|NCT04852276|81443908|FG001|Overall Study|Death|0|||
27893019|NCT04852276|81443907|FG000|Overall Study|Lost to Follow-up|15|||
27893020|NCT04852276|81443908|FG001|Overall Study|Lost to Follow-up|9|||
27893021|NCT04852276|81443907|FG000|Overall Study|Withdrawal by Subject|26|||
27893022|NCT04852276|81443908|FG001|Overall Study|Withdrawal by Subject|6|||
27893023|NCT03361865|81443910|FG000|Overall Study|Death|17|||
27504395|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504396|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27893024|NCT03361865|81443911|FG001|Overall Study|Death|18|||
27893025|NCT03361865|81443910|FG000|Overall Study|Physician Decision|1|||
27893026|NCT03361865|81443911|FG001|Overall Study|Physician Decision|9|||
27893027|NCT03361865|81443910|FG000|Overall Study|Withdrawal by Subject|1|||
27893028|NCT03361865|81443911|FG001|Overall Study|Withdrawal by Subject|0|||
27893029|NCT04506905|81443913|FG000|Overall Study|Lost to Follow-up|1|||
27893030|NCT04506905|81443914|FG001|Overall Study|Lost to Follow-up|0|||
27893031|NCT04506905|81443915|FG002|Overall Study|Lost to Follow-up|0|||
27893032|NCT04506905|81443916|FG003|Overall Study|Lost to Follow-up|1|||
27893033|NCT04506905|81443917|FG004|Overall Study|Lost to Follow-up|0|||
27893034|NCT04506905|81443918|FG005|Overall Study|Lost to Follow-up|0|||
27893035|NCT04506905|81443919|FG006|Overall Study|Lost to Follow-up|0|||
27893036|NCT04506905|81443920|FG007|Overall Study|Lost to Follow-up|0|||
27893037|NCT04506905|81443921|FG008|Overall Study|Lost to Follow-up|0|||
27893038|NCT04506905|81443913|FG000|Overall Study|Withdrawal by Subject|0|||
27893039|NCT04506905|81443914|FG001|Overall Study|Withdrawal by Subject|0|||
27893040|NCT04506905|81443915|FG002|Overall Study|Withdrawal by Subject|0|||
27893041|NCT04506905|81443916|FG003|Overall Study|Withdrawal by Subject|2|||
27893042|NCT04506905|81443917|FG004|Overall Study|Withdrawal by Subject|0|||
27893043|NCT04506905|81443918|FG005|Overall Study|Withdrawal by Subject|0|||
27504397|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504398|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27724981|NCT01925209|80823229|FG003|Treatment Epoch|Physician Decision|0|||
27724982|NCT01925209|80823226|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
27724983|NCT01925209|80823227|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
27724984|NCT01925209|80823228|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
27724985|NCT01925209|80823229|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
27724986|NCT01925209|80823226|FG000|Treatment Epoch|Death|1|||
27724987|NCT01925209|80823227|FG001|Treatment Epoch|Death|0|||
27724988|NCT01925209|80823228|FG002|Treatment Epoch|Death|0|||
27724989|NCT01925209|80823229|FG003|Treatment Epoch|Death|0|||
27724990|NCT01925209|80823226|FG000|Treatment Epoch|Protocol deviation|0|||
27724991|NCT01925209|80823227|FG001|Treatment Epoch|Protocol deviation|0|||
27724992|NCT01925209|80823228|FG002|Treatment Epoch|Protocol deviation|1|||
27724993|NCT01925209|80823229|FG003|Treatment Epoch|Protocol deviation|1|||
27724994|NCT01925209|80823226|FG000|Treatment Epoch|Withdrawal by Subject|4|||
27724995|NCT01925209|80823227|FG001|Treatment Epoch|Withdrawal by Subject|3|||
27724996|NCT01925209|80823228|FG002|Treatment Epoch|Withdrawal by Subject|3|||
27724997|NCT01925209|80823229|FG003|Treatment Epoch|Withdrawal by Subject|2|||
27724998|NCT01925209|80823226|FG000|Treatment Epoch|Adverse Event|3|||
27724999|NCT01925209|80823227|FG001|Treatment Epoch|Adverse Event|5|||
27725000|NCT01925209|80823228|FG002|Treatment Epoch|Adverse Event|3|||
27725001|NCT01925209|80823229|FG003|Treatment Epoch|Adverse Event|1|||
27725002|NCT01925209|80823226|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
27725003|NCT01925209|80823227|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
27725004|NCT01925209|80823228|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
27725005|NCT01925209|80823229|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
27725006|NCT01925209|80823226|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
27893044|NCT04506905|81443919|FG006|Overall Study|Withdrawal by Subject|0|||
27504399|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27725007|NCT01925209|80823227|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
27725008|NCT01925209|80823228|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
27725009|NCT01925209|80823229|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
27893045|NCT04506905|81443920|FG007|Overall Study|Withdrawal by Subject|0|||
27893046|NCT04506905|81443921|FG008|Overall Study|Withdrawal by Subject|0|||
27893047|NCT03990571|81443922|FG000|Overall Study|Withdrawal by Subject|1|||
27893048|NCT03990571|81443922|FG000|Overall Study|Insurance Issues|3|||
27893049|NCT03990571|81443922|FG000|Overall Study|Covid Restrictions|2|||
27725010|NCT01925209|80823226|FG000|Follow-up|Adverse Event|1|||
27725011|NCT01925209|80823227|FG001|Follow-up|Adverse Event|4|||
27725012|NCT01925209|80823228|FG002|Follow-up|Adverse Event|0|||
27725013|NCT01925209|80823229|FG003|Follow-up|Adverse Event|1|||
27725014|NCT01925209|80823226|FG000|Follow-up|Physician Decision|0|||
27725015|NCT01925209|80823227|FG001|Follow-up|Physician Decision|0|||
27725016|NCT01925209|80823228|FG002|Follow-up|Physician Decision|1|||
27725017|NCT01925209|80823229|FG003|Follow-up|Physician Decision|0|||
27725018|NCT01925209|80823226|FG000|Follow-up|Non-compliance with study treatment|0|||
27725019|NCT01925209|80823227|FG001|Follow-up|Non-compliance with study treatment|0|||
27893050|NCT00655733|81443923|FG000|Overall Study|Lost to Follow-up|2|||
27893051|NCT00655733|81443924|FG001|Overall Study|Lost to Follow-up|2|||
27893052|NCT00655733|81443923|FG000|Overall Study|Adverse Event|2|||
27893053|NCT00655733|81443924|FG001|Overall Study|Adverse Event|2|||
27893054|NCT00655733|81443923|FG000|Overall Study|Withdrawal by Subject|3|||
27893055|NCT00655733|81443924|FG001|Overall Study|Withdrawal by Subject|3|||
27893056|NCT00655733|81443923|FG000|Overall Study|Physician Decision|0|||
27893057|NCT00655733|81443924|FG001|Overall Study|Physician Decision|1|||
27893058|NCT01093326|81443937|FG000|Overall Study|Death|0|||
27893059|NCT01093326|81443938|FG001|Overall Study|Death|1|||
27893060|NCT01093326|81443939|FG002|Overall Study|Death|0|||
27504400|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
27504401|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504402|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504403|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504404|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504405|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504406|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
27504407|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Transplant|0|||
27504408|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Transplant|0|||
27504409|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Transplant|0|||
27504410|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Transplant|0|||
27504411|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Transplant|0|||
27504412|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Transplant|0|||
27504413|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Transplant|0|||
27504414|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Transplant|0|||
27504415|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Transplant|0|||
27504416|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Transplant|4|||
27504417|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Transplant|2|||
27504418|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Transplant|0|||
27504419|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Transplant|0|||
27504420|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Transplant|0|||
27504421|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
27504422|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
27504423|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
27504424|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
27504425|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
27504426|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
27504427|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
27504428|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
27504429|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
27504430|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
27504431|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
27504432|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
27504433|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
27613586|NCT02746575|80426700|FG000|Overall Study|Bradycardia/hypotension|9|||
27613587|NCT02746575|80426700|FG000|Overall Study|Study paused|8|||
27725020|NCT01925209|80823228|FG002|Follow-up|Non-compliance with study treatment|0|||
27893061|NCT01093326|81443937|FG000|Overall Study|Lack of Efficacy|7|||
27893062|NCT01093326|81443938|FG001|Overall Study|Lack of Efficacy|6|||
27504434|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
27843942|NCT00700817|81257828|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
27843943|NCT00700817|81257829|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
27843944|NCT00700817|81257830|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
27843945|NCT00700817|81257826|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
27843946|NCT00700817|81257827|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
27843947|NCT00700817|81257828|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
27843948|NCT00700817|81257829|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
27504435|NCT02113982|80040769|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
27504436|NCT02113982|80040770|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
27504437|NCT02113982|80040771|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
27504438|NCT02113982|80040772|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
27504439|NCT02113982|80040773|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
27504440|NCT02113982|80040774|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
27504441|NCT02113982|80040775|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
27504442|NCT02113982|80040776|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
27504443|NCT02113982|80040777|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
27504444|NCT02113982|80040778|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
27504445|NCT02113982|80040779|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
27504446|NCT02113982|80040780|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
27504447|NCT02113982|80040781|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
27504448|NCT02113982|80040782|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
27504449|NCT02113982|80040769|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504450|NCT02113982|80040770|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504451|NCT02113982|80040771|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
27613588|NCT02746575|80426700|FG000|Overall Study|put on beta-blocker|3|||
27613589|NCT02746575|80426700|FG000|Overall Study|type of surgery|1|||
27613590|NCT02746575|80426700|FG000|Overall Study|typ of surgery|1|||
27725021|NCT01925209|80823229|FG003|Follow-up|Non-compliance with study treatment|1|||
27725022|NCT01925209|80823226|FG000|Follow-up|Withdrawal by Subject|0|||
27725023|NCT01925209|80823227|FG001|Follow-up|Withdrawal by Subject|2|||
27725024|NCT01925209|80823228|FG002|Follow-up|Withdrawal by Subject|0|||
27843949|NCT00700817|81257830|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
27843950|NCT00700817|81257826|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
27893063|NCT01093326|81443939|FG002|Overall Study|Lack of Efficacy|3|||
27893064|NCT01093326|81443937|FG000|Overall Study|Lost to Follow-up|2|||
27504452|NCT02113982|80040772|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504453|NCT02113982|80040773|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504454|NCT02113982|80040774|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504455|NCT02113982|80040775|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
27613591|NCT02746575|80426700|FG000|Overall Study|PI unavailable|1|||
27613592|NCT02746575|80426700|FG000|Overall Study|Unknown history of CVA|1|||
27725025|NCT01925209|80823229|FG003|Follow-up|Withdrawal by Subject|2|||
27843951|NCT00700817|81257827|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
27843952|NCT00700817|81257828|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
27843953|NCT00700817|81257829|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
27843954|NCT00700817|81257830|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
27843955|NCT04314843|81257831|FG000|Overall Study|Death|2|||
27843956|NCT04314843|81257832|FG001|Overall Study|Death|2|||
27843957|NCT04314843|81257831|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
27504456|NCT02113982|80040776|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504457|NCT02113982|80040777|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504458|NCT02113982|80040778|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504459|NCT02113982|80040779|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504460|NCT02113982|80040780|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
27504461|NCT02113982|80040781|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504462|NCT02113982|80040782|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
27504463|NCT02113982|80040769|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504464|NCT02113982|80040770|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504465|NCT02113982|80040771|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504466|NCT02113982|80040772|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504467|NCT02113982|80040773|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504468|NCT02113982|80040774|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504469|NCT02113982|80040775|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504470|NCT02113982|80040776|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504471|NCT02113982|80040777|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504472|NCT02113982|80040778|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504473|NCT02113982|80040779|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504474|NCT02113982|80040780|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
27504475|NCT02113982|80040781|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504476|NCT02113982|80040782|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
27504477|NCT02113982|80040769|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504478|NCT02113982|80040770|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504479|NCT02113982|80040771|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504480|NCT02113982|80040772|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504481|NCT02113982|80040773|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504482|NCT02113982|80040774|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504483|NCT02113982|80040775|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504484|NCT02113982|80040776|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504485|NCT02113982|80040777|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504486|NCT02113982|80040778|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504487|NCT02113982|80040779|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504488|NCT02113982|80040780|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
27504489|NCT02113982|80040781|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504490|NCT02113982|80040782|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
27504491|NCT02113982|80040769|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
27725026|NCT00631137|80823230|FG000|Overall Study|Withdrawal by Subject|1|||
27725027|NCT00631137|80823231|FG001|Overall Study|Withdrawal by Subject|0|||
27725028|NCT03269344|80823232|FG000|Overall Study|Protocol Violation|4|||
27725029|NCT03269344|80823233|FG001|Overall Study|Protocol Violation|3|||
27725030|NCT03609619|80823234|FG000|Overall Study|Adverse Event|1|||
27725031|NCT03609619|80823235|FG001|Overall Study|Adverse Event|0|||
27725032|NCT03609619|80823234|FG000|Overall Study|Lack of Efficacy|1|||
27725033|NCT03609619|80823235|FG001|Overall Study|Lack of Efficacy|2|||
27725034|NCT03609619|80823234|FG000|Overall Study|Protocol Violation|5|||
27725035|NCT03609619|80823235|FG001|Overall Study|Protocol Violation|0|||
27725036|NCT03609619|80823234|FG000|Overall Study|Withdrawal by Subject|2|||
27725037|NCT03609619|80823235|FG001|Overall Study|Withdrawal by Subject|3|||
27843958|NCT04314843|81257832|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
27843959|NCT05317195|81257835|FG000|Randomization|Withdrawal by Subject|1|||
27843960|NCT05317195|81257835|FG000|Randomization|Discontinued|6|||
27843961|NCT05317195|81257835|FG000|Admission|Withdrawal by Subject|2|||
27843962|NCT02010255|81257836|FG000|Overall Study|Death|0|||
27843963|NCT02010255|81257837|FG001|Overall Study|Death|1|||
27843964|NCT02010255|81257838|FG002|Overall Study|Death|4|||
27843965|NCT02010255|81257839|FG003|Overall Study|Death|4|||
27504492|NCT02113982|80040770|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
27504493|NCT02113982|80040771|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
27504494|NCT02113982|80040772|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
27504495|NCT02113982|80040773|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
27504496|NCT02113982|80040774|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
27843966|NCT02010255|81257840|FG004|Overall Study|Death|2|||
27843967|NCT02010255|81257841|FG005|Overall Study|Death|0|||
27843968|NCT02010255|81257842|FG006|Overall Study|Death|1|||
27843969|NCT02010255|81257843|FG007|Overall Study|Death|1|||
27843970|NCT02010255|81257844|FG008|Overall Study|Death|1|||
27843971|NCT02010255|81257845|FG009|Overall Study|Death|0|||
27843972|NCT02010255|81257846|FG010|Overall Study|Death|1|||
27843973|NCT02010255|81257847|FG011|Overall Study|Death|1|||
27843974|NCT02010255|81257848|FG012|Overall Study|Death|0|||
27843975|NCT02010255|81257849|FG013|Overall Study|Death|0|||
27843976|NCT02010255|81257836|FG000|Overall Study|Lack of Efficacy|4|||
27843977|NCT02010255|81257837|FG001|Overall Study|Lack of Efficacy|1|||
27843978|NCT02010255|81257838|FG002|Overall Study|Lack of Efficacy|2|||
27843979|NCT02010255|81257839|FG003|Overall Study|Lack of Efficacy|1|||
27843980|NCT02010255|81257840|FG004|Overall Study|Lack of Efficacy|1|||
27843981|NCT02010255|81257841|FG005|Overall Study|Lack of Efficacy|0|||
27843982|NCT02010255|81257842|FG006|Overall Study|Lack of Efficacy|0|||
27843983|NCT02010255|81257843|FG007|Overall Study|Lack of Efficacy|0|||
27843984|NCT02010255|81257844|FG008|Overall Study|Lack of Efficacy|0|||
27843985|NCT02010255|81257845|FG009|Overall Study|Lack of Efficacy|0|||
27843986|NCT02010255|81257846|FG010|Overall Study|Lack of Efficacy|1|||
27843987|NCT02010255|81257847|FG011|Overall Study|Lack of Efficacy|0|||
27843988|NCT02010255|81257848|FG012|Overall Study|Lack of Efficacy|0|||
27843989|NCT02010255|81257849|FG013|Overall Study|Lack of Efficacy|0|||
27843990|NCT02010255|81257836|FG000|Overall Study|Withdrew Consent|1|||
27843991|NCT02010255|81257837|FG001|Overall Study|Withdrew Consent|0|||
27843992|NCT02010255|81257838|FG002|Overall Study|Withdrew Consent|0|||
27843993|NCT02010255|81257839|FG003|Overall Study|Withdrew Consent|1|||
27843994|NCT02010255|81257840|FG004|Overall Study|Withdrew Consent|0|||
27843995|NCT02010255|81257841|FG005|Overall Study|Withdrew Consent|0|||
27843996|NCT02010255|81257842|FG006|Overall Study|Withdrew Consent|0|||
27843997|NCT02010255|81257843|FG007|Overall Study|Withdrew Consent|0|||
27843998|NCT02010255|81257844|FG008|Overall Study|Withdrew Consent|0|||
27843999|NCT02010255|81257845|FG009|Overall Study|Withdrew Consent|0|||
27844000|NCT02010255|81257846|FG010|Overall Study|Withdrew Consent|0|||
27844001|NCT02010255|81257847|FG011|Overall Study|Withdrew Consent|0|||
27844002|NCT02010255|81257848|FG012|Overall Study|Withdrew Consent|0|||
27844003|NCT02010255|81257849|FG013|Overall Study|Withdrew Consent|0|||
27844004|NCT02010255|81257836|FG000|Overall Study|Adverse Event|1|||
27844005|NCT02010255|81257837|FG001|Overall Study|Adverse Event|0|||
27844006|NCT02010255|81257838|FG002|Overall Study|Adverse Event|0|||
27844007|NCT02010255|81257839|FG003|Overall Study|Adverse Event|0|||
27844008|NCT02010255|81257840|FG004|Overall Study|Adverse Event|0|||
27844009|NCT02010255|81257841|FG005|Overall Study|Adverse Event|0|||
27844010|NCT02010255|81257842|FG006|Overall Study|Adverse Event|0|||
27844011|NCT02010255|81257843|FG007|Overall Study|Adverse Event|0|||
27844012|NCT02010255|81257844|FG008|Overall Study|Adverse Event|0|||
27844013|NCT02010255|81257845|FG009|Overall Study|Adverse Event|0|||
27844014|NCT02010255|81257846|FG010|Overall Study|Adverse Event|0|||
27844015|NCT02010255|81257847|FG011|Overall Study|Adverse Event|0|||
27893065|NCT01093326|81443938|FG001|Overall Study|Lost to Follow-up|5|||
27893066|NCT01093326|81443939|FG002|Overall Study|Lost to Follow-up|4|||
27893067|NCT01093326|81443937|FG000|Overall Study|Physician Decision|3|||
27893068|NCT01093326|81443938|FG001|Overall Study|Physician Decision|1|||
27893069|NCT01093326|81443939|FG002|Overall Study|Physician Decision|3|||
27893070|NCT01093326|81443937|FG000|Overall Study|Withdrawal by Subject|30|||
27893071|NCT01093326|81443938|FG001|Overall Study|Withdrawal by Subject|27|||
27893072|NCT01093326|81443939|FG002|Overall Study|Withdrawal by Subject|26|||
27844016|NCT02010255|81257848|FG012|Overall Study|Adverse Event|0|||
27844017|NCT02010255|81257849|FG013|Overall Study|Adverse Event|0|||
27844018|NCT02010255|81257836|FG000|Overall Study|Lost to Follow-up|0|||
27844019|NCT02010255|81257837|FG001|Overall Study|Lost to Follow-up|0|||
27844020|NCT02010255|81257838|FG002|Overall Study|Lost to Follow-up|1|||
27893073|NCT01093326|81443937|FG000|Overall Study|Adverse Event|2|||
27504497|NCT02113982|80040775|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
27504498|NCT02113982|80040776|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
27504499|NCT02113982|80040777|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
27504500|NCT02113982|80040778|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
27504501|NCT02113982|80040779|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
27504502|NCT02113982|80040780|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
27504503|NCT02113982|80040781|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
27504504|NCT02113982|80040782|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
27504505|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504506|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504507|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504508|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504509|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504510|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504511|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504512|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504513|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27844021|NCT02010255|81257839|FG003|Overall Study|Lost to Follow-up|0|||
27504514|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504515|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504516|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504517|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
27613593|NCT04022889|80426701|FG000|Stage 1: Period 1|Adverse Event|1|||
27504518|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
27504519|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504520|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27844022|NCT02010255|81257840|FG004|Overall Study|Lost to Follow-up|1|||
27844023|NCT02010255|81257841|FG005|Overall Study|Lost to Follow-up|0|||
27844024|NCT02010255|81257842|FG006|Overall Study|Lost to Follow-up|0|||
27844025|NCT02010255|81257843|FG007|Overall Study|Lost to Follow-up|0|||
27844026|NCT02010255|81257844|FG008|Overall Study|Lost to Follow-up|0|||
27844027|NCT02010255|81257845|FG009|Overall Study|Lost to Follow-up|0|||
27844028|NCT02010255|81257846|FG010|Overall Study|Lost to Follow-up|0|||
27844029|NCT02010255|81257847|FG011|Overall Study|Lost to Follow-up|0|||
27844030|NCT02010255|81257848|FG012|Overall Study|Lost to Follow-up|0|||
27844031|NCT02010255|81257849|FG013|Overall Study|Lost to Follow-up|0|||
27844032|NCT02010255|81257836|FG000|Overall Study|Randomized but Not Treated|0|||
27844033|NCT02010255|81257837|FG001|Overall Study|Randomized but Not Treated|0|||
27844034|NCT02010255|81257838|FG002|Overall Study|Randomized but Not Treated|0|||
27844035|NCT02010255|81257839|FG003|Overall Study|Randomized but Not Treated|0|||
27504521|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504522|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504523|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504524|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504525|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504526|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504527|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27725038|NCT03609619|80823234|FG000|Overall Study|Lost to Follow-up|1|||
27844036|NCT02010255|81257840|FG004|Overall Study|Randomized but Not Treated|0|||
27844037|NCT02010255|81257841|FG005|Overall Study|Randomized but Not Treated|0|||
27613594|NCT04022889|80426702|FG001|Stage 1: Period 1|Adverse Event|0|||
27844038|NCT02010255|81257842|FG006|Overall Study|Randomized but Not Treated|0|||
27844039|NCT02010255|81257843|FG007|Overall Study|Randomized but Not Treated|0|||
27844040|NCT02010255|81257844|FG008|Overall Study|Randomized but Not Treated|0|||
27844041|NCT02010255|81257845|FG009|Overall Study|Randomized but Not Treated|0|||
27504528|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504529|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504530|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
27504531|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
27504532|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
27504533|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504534|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504535|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504536|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27613595|NCT04022889|80426703|FG002|Stage 1: Period 1|Adverse Event|0|||
27613596|NCT04022889|80426701|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
27613597|NCT04022889|80426702|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
27844042|NCT02010255|81257846|FG010|Overall Study|Randomized but Not Treated|0|||
27844043|NCT02010255|81257847|FG011|Overall Study|Randomized but Not Treated|0|||
27844044|NCT02010255|81257848|FG012|Overall Study|Randomized but Not Treated|0|||
27844045|NCT02010255|81257849|FG013|Overall Study|Randomized but Not Treated|1|||
27844046|NCT02576717|81257850|FG000|Overall Study|Other Reasons|16|||
27844047|NCT02576717|81257851|FG001|Overall Study|Other Reasons|18|||
27844048|NCT02576717|81257852|FG002|Overall Study|Other Reasons|15|||
27844049|NCT02576717|81257850|FG000|Overall Study|Covid-19 Pandemic|0|||
27844050|NCT02576717|81257851|FG001|Overall Study|Covid-19 Pandemic|1|||
27844051|NCT02576717|81257852|FG002|Overall Study|Covid-19 Pandemic|1|||
27844052|NCT02576717|81257850|FG000|Overall Study|Sponsor Decision|0|||
27844053|NCT02576717|81257851|FG001|Overall Study|Sponsor Decision|0|||
27844054|NCT02576717|81257852|FG002|Overall Study|Sponsor Decision|1|||
27844055|NCT02576717|81257850|FG000|Overall Study|Physician Decision|3|||
27844056|NCT02576717|81257851|FG001|Overall Study|Physician Decision|8|||
27844057|NCT02576717|81257852|FG002|Overall Study|Physician Decision|9|||
27844058|NCT02576717|81257850|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
27844059|NCT02576717|81257851|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
27844060|NCT02576717|81257852|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
27844061|NCT02576717|81257850|FG000|Overall Study|Death|3|||
27844062|NCT02576717|81257851|FG001|Overall Study|Death|5|||
27844063|NCT02576717|81257852|FG002|Overall Study|Death|3|||
27844064|NCT02576717|81257850|FG000|Overall Study|Lost to Follow-up|9|||
27844065|NCT02576717|81257851|FG001|Overall Study|Lost to Follow-up|10|||
27844066|NCT02576717|81257852|FG002|Overall Study|Lost to Follow-up|19|||
27844067|NCT02576717|81257850|FG000|Overall Study|Protocol Violation|4|||
27844068|NCT02576717|81257851|FG001|Overall Study|Protocol Violation|0|||
27844069|NCT02576717|81257852|FG002|Overall Study|Protocol Violation|5|||
27844070|NCT02576717|81257850|FG000|Overall Study|Lack of Efficacy|24|||
27844071|NCT02576717|81257851|FG001|Overall Study|Lack of Efficacy|28|||
27844072|NCT02576717|81257852|FG002|Overall Study|Lack of Efficacy|20|||
27844073|NCT02576717|81257850|FG000|Overall Study|Adverse Event|26|||
27844074|NCT02576717|81257851|FG001|Overall Study|Adverse Event|32|||
27844075|NCT02576717|81257852|FG002|Overall Study|Adverse Event|26|||
27844076|NCT00823199|81257853|FG000|Overall Study|Withdrawal by Subject|2|||
27844077|NCT02031237|81257854|FG000|Overall Study|Death|1|||
27844078|NCT02031237|81257855|FG001|Overall Study|Death|5|||
27844079|NCT02031237|81257856|FG002|Overall Study|Death|0|||
27844080|NCT02031237|81257854|FG000|Overall Study|Physician Decision|0|||
27844081|NCT02031237|81257855|FG001|Overall Study|Physician Decision|1|||
27844082|NCT02031237|81257856|FG002|Overall Study|Physician Decision|0|||
27844083|NCT02031237|81257854|FG000|Overall Study|Withdrawal by Subject|2|||
27844084|NCT02031237|81257855|FG001|Overall Study|Withdrawal by Subject|2|||
27844085|NCT02031237|81257856|FG002|Overall Study|Withdrawal by Subject|0|||
27844086|NCT02031237|81257854|FG000|Overall Study|Protocol Violation|2|||
27844087|NCT02031237|81257855|FG001|Overall Study|Protocol Violation|6|||
27844088|NCT02031237|81257856|FG002|Overall Study|Protocol Violation|0|||
27844089|NCT02031237|81257854|FG000|Overall Study|Alternate Treatment Given|0|||
27844090|NCT02031237|81257855|FG001|Overall Study|Alternate Treatment Given|0|||
27844091|NCT02031237|81257856|FG002|Overall Study|Alternate Treatment Given|3|||
27844092|NCT01315028|81257857|FG000|Overall Study|Lost to Follow-up|1|||
27844093|NCT01315028|81257858|FG001|Overall Study|Lost to Follow-up|0|||
27844094|NCT01315028|81257857|FG000|Overall Study|Death|0|||
27844095|NCT01315028|81257858|FG001|Overall Study|Death|1|||
27844096|NCT00255151|81257875|FG000|Overall Study|Adverse Event|10|||
27844097|NCT00255151|81257876|FG001|Overall Study|Adverse Event|6|||
27844098|NCT00255151|81257877|FG002|Overall Study|Adverse Event|9|||
27844099|NCT00255151|81257875|FG000|Overall Study|Lost to Follow-up|4|||
27844100|NCT00255151|81257876|FG001|Overall Study|Lost to Follow-up|3|||
27844101|NCT00255151|81257877|FG002|Overall Study|Lost to Follow-up|4|||
27844102|NCT00255151|81257875|FG000|Overall Study|Withdrawal by Subject|18|||
27844103|NCT00255151|81257876|FG001|Overall Study|Withdrawal by Subject|17|||
27844104|NCT00255151|81257877|FG002|Overall Study|Withdrawal by Subject|8|||
27504537|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504538|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504539|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504540|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504541|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504542|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27844105|NCT00255151|81257875|FG000|Overall Study|Noncompliance|0|||
27844106|NCT00255151|81257876|FG001|Overall Study|Noncompliance|1|||
27844107|NCT00255151|81257877|FG002|Overall Study|Noncompliance|2|||
27844108|NCT00255151|81257875|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
27844109|NCT00255151|81257876|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
27844110|NCT00255151|81257877|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
27844111|NCT00255151|81257875|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
27844112|NCT00255151|81257876|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
27844113|NCT00255151|81257877|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
27844114|NCT00255151|81257875|FG000|Overall Study|Possible Barrett's Esophagus|1|||
27844115|NCT00255151|81257876|FG001|Overall Study|Possible Barrett's Esophagus|3|||
27844116|NCT00255151|81257877|FG002|Overall Study|Possible Barrett's Esophagus|8|||
27844117|NCT00255151|81257875|FG000|Overall Study|Esophageal Stricture|0|||
27844118|NCT00255151|81257876|FG001|Overall Study|Esophageal Stricture|0|||
27844119|NCT00255151|81257877|FG002|Overall Study|Esophageal Stricture|1|||
27844120|NCT00255151|81257875|FG000|Overall Study|Therapeutic Failure|11|||
27844121|NCT00255151|81257876|FG001|Overall Study|Therapeutic Failure|2|||
27844122|NCT00255151|81257877|FG002|Overall Study|Therapeutic Failure|3|||
27844123|NCT03648879|81257878|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
27844124|NCT00931463|81257886|FG000|Overall Study|Death|8|||
27844125|NCT00931463|81257887|FG001|Overall Study|Death|4|||
27844126|NCT00931463|81257886|FG000|Overall Study|Withdrawal by Subject|5|||
27844127|NCT00931463|81257887|FG001|Overall Study|Withdrawal by Subject|0|||
27844128|NCT00931463|81257886|FG000|Overall Study|Lost to Follow-up|4|||
27844129|NCT00931463|81257887|FG001|Overall Study|Lost to Follow-up|1|||
27504543|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27844130|NCT02710214|81257889|FG000|Overall Study|Lost to Follow-up|1|||
27844131|NCT02710214|81257890|FG001|Overall Study|Lost to Follow-up|0|||
27844132|NCT02710214|81257889|FG000|Overall Study|Lack of Efficacy|0|||
27844133|NCT02710214|81257890|FG001|Overall Study|Lack of Efficacy|1|||
27844134|NCT02710214|81257889|FG000|Overall Study|Death|0|||
27844135|NCT02710214|81257890|FG001|Overall Study|Death|1|||
27844136|NCT03429049|81257893|FG000|Overall Study|Adverse Event|2|||
27844137|NCT03429049|81257894|FG001|Overall Study|Adverse Event|3|||
27844138|NCT03429049|81257893|FG000|Overall Study|Death|0|||
27844139|NCT03429049|81257894|FG001|Overall Study|Death|1|||
27844140|NCT03429049|81257893|FG000|Overall Study|Lack of Efficacy|4|||
27844141|NCT03429049|81257894|FG001|Overall Study|Lack of Efficacy|2|||
27844142|NCT03429049|81257893|FG000|Overall Study|Lost to Follow-up|9|||
27844143|NCT03429049|81257894|FG001|Overall Study|Lost to Follow-up|8|||
27844144|NCT03429049|81257893|FG000|Overall Study|Physician Decision|1|||
27844145|NCT03429049|81257894|FG001|Overall Study|Physician Decision|0|||
27844146|NCT03429049|81257893|FG000|Overall Study|Protocol Violation|3|||
27844147|NCT03429049|81257894|FG001|Overall Study|Protocol Violation|0|||
27844148|NCT03429049|81257893|FG000|Overall Study|Sponsor Decision|2|||
27844149|NCT03429049|81257894|FG001|Overall Study|Sponsor Decision|0|||
27844150|NCT03429049|81257893|FG000|Overall Study|Withdrawal by Subject|4|||
27844151|NCT03429049|81257894|FG001|Overall Study|Withdrawal by Subject|20|||
27844152|NCT03429049|81257893|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
27844153|NCT03429049|81257894|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
27844154|NCT00895037|81257895|FG000|Overall Study|Death|0|||
27844155|NCT00895037|81257896|FG001|Overall Study|Death|2|||
27844156|NCT00895037|81257897|FG002|Overall Study|Death|1|||
27844157|NCT00763555|81257898|FG000|Overall Study|Adverse Event|2|||
27844158|NCT00763555|81257899|FG001|Overall Study|Adverse Event|1|||
27844159|NCT00763555|81257898|FG000|Overall Study|Withdrawal by Subject|2|||
27844160|NCT00763555|81257899|FG001|Overall Study|Withdrawal by Subject|6|||
27844161|NCT00763555|81257898|FG000|Overall Study|Lost to Follow-up|0|||
27844162|NCT00763555|81257899|FG001|Overall Study|Lost to Follow-up|3|||
27504544|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
27504545|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
27725039|NCT03609619|80823235|FG001|Overall Study|Lost to Follow-up|1|||
27725040|NCT00713219|80823237|FG000|Overall Study|Death|1|||
27725041|NCT00713219|80823237|FG000|Overall Study|Protocol Violation|1|||
27725042|NCT02911688|80826498|FG000|Washout|Lost to Follow-up|1|||
27725043|NCT02911688|80826499|FG001|Washout|Lost to Follow-up|1|||
27725044|NCT02911688|80826498|FG000|Washout|Withdrawal by Subject|0|||
27725045|NCT02911688|80826499|FG001|Washout|Withdrawal by Subject|1|||
27725046|NCT03786432|80826503|FG000|Overall Study|Screen Failure after consent|1|||
27725047|NCT03786432|80826503|FG000|Overall Study|Lost to Follow-up|4|||
27725048|NCT03786432|80826503|FG000|Overall Study|did not complete 12 month CT scan|1|||
27725049|NCT00655928|80826506|FG000|Overall Study|Withdrawal by Subject|2|||
27725050|NCT00655928|80826507|FG001|Overall Study|Withdrawal by Subject|1|||
27725051|NCT00655928|80826506|FG000|Overall Study|Physician Decision|1|||
27725052|NCT00655928|80826507|FG001|Overall Study|Physician Decision|1|||
27725053|NCT01225562|80826508|FG000|Overall Study|Withdrawal by Subject|52|||
27725054|NCT01225562|80826509|FG001|Overall Study|Withdrawal by Subject|50|||
27725055|NCT01225562|80826510|FG002|Overall Study|Withdrawal by Subject|52|||
27725056|NCT01225562|80826508|FG000|Overall Study|Lost to Follow-up|3|||
27725057|NCT01225562|80826509|FG001|Overall Study|Lost to Follow-up|6|||
27725058|NCT01225562|80826510|FG002|Overall Study|Lost to Follow-up|1|||
27725059|NCT01885000|80826511|FG000|Overall Study|Adverse Event|1|||
27725060|NCT01885000|80826512|FG001|Overall Study|Adverse Event|0|||
27725061|NCT01885000|80826511|FG000|Overall Study|Withdrawal by Subject|1|||
27725062|NCT01885000|80826512|FG001|Overall Study|Withdrawal by Subject|1|||
27725063|NCT01885000|80826511|FG000|Overall Study|Protocol Violation|0|||
27725064|NCT01885000|80826512|FG001|Overall Study|Protocol Violation|1|||
27725065|NCT00272987|80826513|FG000|Overall Study|Adverse Event|1|||
27725066|NCT00272987|80826514|FG001|Overall Study|Adverse Event|0|||
27725067|NCT00272987|80826515|FG002|Overall Study|Adverse Event|0|||
27725068|NCT00272987|80826513|FG000|Overall Study|Lost to Follow-up|3|||
27725069|NCT00272987|80826514|FG001|Overall Study|Lost to Follow-up|1|||
27725070|NCT00272987|80826515|FG002|Overall Study|Lost to Follow-up|1|||
27725071|NCT00272987|80826513|FG000|Overall Study|Withdrawal by Subject|1|||
27725072|NCT00272987|80826514|FG001|Overall Study|Withdrawal by Subject|0|||
27844163|NCT01955044|81257906|FG000|Overall Study|Death|1|||
27844164|NCT01955044|81257907|FG001|Overall Study|Death|1|||
27844165|NCT01955044|81257908|FG002|Overall Study|Death|0|||
27844166|NCT01662362|81257918|FG000|Overall Study|Lost to Follow-up|38|||
27844167|NCT03701763|81257921|FG000|Placebo-controlled Phase|Adverse Event|1|||
27844168|NCT03701763|81257922|FG001|Placebo-controlled Phase|Adverse Event|5|||
27844169|NCT03701763|81257923|FG002|Placebo-controlled Phase|Adverse Event|0|||
27844170|NCT03701763|81257924|FG003|Placebo-controlled Phase|Adverse Event|0|||
27844171|NCT03701763|81257921|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
27844172|NCT03701763|81257922|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
27844173|NCT03701763|81257923|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
27844174|NCT03701763|81257924|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
27844175|NCT03701763|81257921|FG000|Placebo-controlled Phase|Miscellaneous|2|||
27844176|NCT03701763|81257922|FG001|Placebo-controlled Phase|Miscellaneous|0|||
27844177|NCT03701763|81257923|FG002|Placebo-controlled Phase|Miscellaneous|0|||
27844178|NCT03701763|81257924|FG003|Placebo-controlled Phase|Miscellaneous|0|||
27844179|NCT03701763|81257921|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
27844180|NCT03701763|81257922|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
27844181|NCT03701763|81257923|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
27844182|NCT03701763|81257924|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
27844183|NCT03701763|81257921|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
27844184|NCT03701763|81257922|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
27844185|NCT03701763|81257923|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
27844186|NCT03701763|81257924|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
27844187|NCT03701763|81257921|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
27844188|NCT03701763|81257922|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
27844189|NCT03701763|81257923|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
27844190|NCT03701763|81257924|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
27844191|NCT03701763|81257921|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
27844192|NCT03701763|81257922|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
27844193|NCT03701763|81257923|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
27844194|NCT03701763|81257924|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
27844195|NCT03701763|81257921|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
27844196|NCT03701763|81257922|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
27844197|NCT03701763|81257923|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
27844198|NCT03701763|81257924|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
27844199|NCT03701763|81257921|FG000|Apremilast Extension Phase|Adverse Event|0|||
27844200|NCT03701763|81257922|FG001|Apremilast Extension Phase|Adverse Event|0|||
27844201|NCT03701763|81257923|FG002|Apremilast Extension Phase|Adverse Event|3|||
27844202|NCT03701763|81257924|FG003|Apremilast Extension Phase|Adverse Event|1|||
27844203|NCT03701763|81257921|FG000|Apremilast Extension Phase|Miscellaneous|0|||
27844204|NCT03701763|81257922|FG001|Apremilast Extension Phase|Miscellaneous|0|||
27844205|NCT03701763|81257923|FG002|Apremilast Extension Phase|Miscellaneous|2|||
27844206|NCT03701763|81257924|FG003|Apremilast Extension Phase|Miscellaneous|1|||
27844207|NCT03701763|81257921|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
27844208|NCT03701763|81257922|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
27844209|NCT03701763|81257923|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
27844210|NCT03701763|81257924|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
27844211|NCT03701763|81257921|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
27844212|NCT03701763|81257922|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
27844213|NCT03701763|81257923|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
27844214|NCT03701763|81257924|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
27844215|NCT03701763|81257921|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
27844216|NCT03701763|81257922|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
27844217|NCT03701763|81257923|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
27844218|NCT03701763|81257924|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
27844219|NCT03701763|81257921|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
27844220|NCT03701763|81257922|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
27844221|NCT03701763|81257923|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
27844222|NCT03701763|81257924|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
27844223|NCT03701763|81257921|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
27844224|NCT03701763|81257922|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
27844225|NCT03701763|81257923|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
27844226|NCT03701763|81257924|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
27844227|NCT03701763|81257921|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
27844228|NCT03701763|81257922|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
27844229|NCT03701763|81257923|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
27844230|NCT03701763|81257924|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
27893074|NCT01093326|81443938|FG001|Overall Study|Adverse Event|1|||
27725073|NCT00272987|80826515|FG002|Overall Study|Withdrawal by Subject|3|||
27844231|NCT03701763|81257921|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
27844232|NCT03701763|81257922|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
27844233|NCT03701763|81257923|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
27844234|NCT03701763|81257924|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
27844235|NCT03701763|81257921|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
27844236|NCT03701763|81257922|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
27844237|NCT03701763|81257923|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
27844238|NCT03701763|81257924|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
27844239|NCT03417830|81257925|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
27844240|NCT03417830|81257926|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
27844241|NCT00546910|81257927|FG000|Overall Study|Adverse Event|2|||
27844242|NCT00546910|81257928|FG001|Overall Study|Adverse Event|3|||
27844243|NCT00546910|81257927|FG000|Overall Study|Lack of Efficacy|5|||
27844244|NCT00546910|81257928|FG001|Overall Study|Lack of Efficacy|7|||
27844245|NCT00546910|81257927|FG000|Overall Study|Physician Decision|0|||
27844246|NCT00546910|81257928|FG001|Overall Study|Physician Decision|1|||
27844247|NCT00546910|81257927|FG000|Overall Study|Withdrawal by Subject|2|||
27844248|NCT00546910|81257928|FG001|Overall Study|Withdrawal by Subject|0|||
27844249|NCT01765270|81257929|FG000|Overall Study|Physician Decision|1|||
27844250|NCT01765270|81257930|FG001|Overall Study|Physician Decision|0|||
27844251|NCT01765270|81257929|FG000|Overall Study|Withdrawal by Subject|0|||
27844252|NCT01765270|81257930|FG001|Overall Study|Withdrawal by Subject|1|||
27844253|NCT00653159|81257931|FG000|Overall Study|Adverse Event|4|||
27844254|NCT00653159|81257932|FG001|Overall Study|Adverse Event|1|||
27844255|NCT00653159|81257931|FG000|Overall Study|Lost to Follow-up|1|||
27844256|NCT00653159|81257932|FG001|Overall Study|Lost to Follow-up|2|||
27844257|NCT04675775|81257933|FG000|Overall Study|Withdrawal by Subject|7|||
27844258|NCT00493779|81257942|FG000|Overall Study|Logistical issue at site|1|||
27844259|NCT02219308|81257944|FG000|Overall Study|Withdrawal by Subject|1|||
27844260|NCT02219308|81257945|FG001|Overall Study|Withdrawal by Subject|2|||
27844261|NCT00939627|81257946|FG000|Overall Study|Disease Progression|16|||
27844262|NCT00939627|81257947|FG001|Overall Study|Disease Progression|12|||
27844263|NCT00939627|81257948|FG002|Overall Study|Disease Progression|0|||
27844264|NCT00939627|81257946|FG000|Overall Study|Adverse Event|6|||
27844265|NCT00939627|81257947|FG001|Overall Study|Adverse Event|7|||
27844266|NCT00939627|81257948|FG002|Overall Study|Adverse Event|0|||
27844267|NCT00939627|81257946|FG000|Overall Study|Death|0|||
27844268|NCT00939627|81257947|FG001|Overall Study|Death|2|||
27844269|NCT00939627|81257948|FG002|Overall Study|Death|0|||
27844270|NCT00939627|81257946|FG000|Overall Study|Withdrawal by Subject|2|||
27844271|NCT00939627|81257947|FG001|Overall Study|Withdrawal by Subject|4|||
27844272|NCT00939627|81257948|FG002|Overall Study|Withdrawal by Subject|0|||
27844273|NCT00939627|81257946|FG000|Overall Study|Other complicating disease|1|||
27844274|NCT00939627|81257947|FG001|Overall Study|Other complicating disease|1|||
27844275|NCT00939627|81257948|FG002|Overall Study|Other complicating disease|0|||
27844276|NCT00939627|81257946|FG000|Overall Study|Not compliant|2|||
27844277|NCT00939627|81257947|FG001|Overall Study|Not compliant|0|||
27844278|NCT00939627|81257948|FG002|Overall Study|Not compliant|0|||
27844279|NCT00939627|81257946|FG000|Overall Study|No off-tx reason given|0|||
27844280|NCT00939627|81257947|FG001|Overall Study|No off-tx reason given|2|||
27844281|NCT00939627|81257948|FG002|Overall Study|No off-tx reason given|0|||
27844282|NCT02013531|81257949|FG000|Overall Study|Lost to Follow-up|3|||
27844283|NCT02013531|81257949|FG000|Overall Study|Met Withdrawal Criteria|1|||
27844284|NCT02013531|81257949|FG000|Overall Study|Withdrawal by Subject|1|||
27844285|NCT02344745|81257952|FG000|Overall Study|Data collection sheets were lost|2|||
27844286|NCT02344745|81257953|FG001|Overall Study|Data collection sheets were lost|0|||
27844287|NCT01350934|81257960|FG000|Base Study|Adverse Event|6|||
27844288|NCT01350934|81257961|FG001|Base Study|Adverse Event|0|||
27844289|NCT01350934|81257960|FG000|Base Study|Lost to Follow-up|1|||
27844290|NCT01350934|81257961|FG001|Base Study|Lost to Follow-up|0|||
27844291|NCT01350934|81257960|FG000|Base Study|Protocol Violation|1|||
27844292|NCT01350934|81257961|FG001|Base Study|Protocol Violation|1|||
27844293|NCT01350934|81257960|FG000|Base Study|Withdrawal by Subject|1|||
27844294|NCT01350934|81257961|FG001|Base Study|Withdrawal by Subject|2|||
27893075|NCT01093326|81443939|FG002|Overall Study|Adverse Event|4|||
27844295|NCT01350934|81257960|FG000|Base Study|Non-Compliance With Study Drug|2|||
27844296|NCT01350934|81257961|FG001|Base Study|Non-Compliance With Study Drug|0|||
27844297|NCT01350934|81257960|FG000|Extension Study|Adverse Event|2|||
27844298|NCT01350934|81257961|FG001|Extension Study|Adverse Event|1|||
27844299|NCT01350934|81257960|FG000|Extension Study|Lost to Follow-up|2|||
27844300|NCT01350934|81257961|FG001|Extension Study|Lost to Follow-up|0|||
27844301|NCT01350934|81257960|FG000|Extension Study|Protocol Violation|1|||
27844302|NCT01350934|81257961|FG001|Extension Study|Protocol Violation|1|||
27844303|NCT01350934|81257960|FG000|Extension Study|Lack of Efficacy|0|||
27844304|NCT01350934|81257961|FG001|Extension Study|Lack of Efficacy|1|||
27844305|NCT01350934|81257960|FG000|Extension Study|Withdrawal by Subject|0|||
27844306|NCT01350934|81257961|FG001|Extension Study|Withdrawal by Subject|1|||
27844307|NCT02654587|81260593|FG000|Overall Study|patient alive at end of study|22|||
27844308|NCT02654587|81260594|FG001|Overall Study|patient alive at end of study|8|||
27725074|NCT00272987|80826513|FG000|Overall Study|Sponsor Terminated study|0|||
27725075|NCT00272987|80826514|FG001|Overall Study|Sponsor Terminated study|1|||
27725076|NCT00272987|80826515|FG002|Overall Study|Sponsor Terminated study|1|||
27725077|NCT00272987|80826513|FG000|Overall Study|Disease progression|1|||
27725078|NCT00272987|80826514|FG001|Overall Study|Disease progression|1|||
27725079|NCT00272987|80826515|FG002|Overall Study|Disease progression|2|||
27725080|NCT00272987|80826513|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
27725081|NCT00272987|80826514|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
27725082|NCT00272987|80826515|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
27725083|NCT00272987|80826513|FG000|Overall Study|Death|1|||
27725084|NCT00272987|80826514|FG001|Overall Study|Death|0|||
27725085|NCT00272987|80826515|FG002|Overall Study|Death|0|||
27725086|NCT02117687|80826517|FG000|Overall Study|Lost to Follow-up|0|||
27725087|NCT02117687|80826518|FG001|Overall Study|Lost to Follow-up|1|||
27725088|NCT02117687|80826517|FG000|Overall Study|Adverse Event|0|||
27725089|NCT02117687|80826518|FG001|Overall Study|Adverse Event|2|||
27725090|NCT02117687|80826517|FG000|Overall Study|Other Reasons|1|||
27725091|NCT02117687|80826518|FG001|Overall Study|Other Reasons|1|||
27725092|NCT04303000|80826519|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
27725093|NCT04303000|80826520|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
27725094|NCT04303000|80826521|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
27725095|NCT04178772|80826522|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
27725096|NCT04178772|80826522|FG000|Overall Study|study terminated early due to COVID-19|7|||
27725097|NCT01449708|80826525|FG000|Overall Study|Protocol Violation|0|||
27725098|NCT01449708|80826526|FG001|Overall Study|Protocol Violation|1|||
27725099|NCT01449708|80826525|FG000|Overall Study|surgical complication|1|||
27725100|NCT01449708|80826526|FG001|Overall Study|surgical complication|2|||
27725101|NCT01449708|80826525|FG000|Overall Study|respiratory failure|1|||
27725102|NCT01449708|80826526|FG001|Overall Study|respiratory failure|0|||
27725103|NCT05425563|80826529|FG000|Overall Study|Withdrawal by Subject|17|||
27725104|NCT02654002|80826538|FG000|Overall Study|Adverse Event|0|||
27725105|NCT02654002|80826539|FG001|Overall Study|Adverse Event|0|||
27725106|NCT02654002|80826540|FG002|Overall Study|Adverse Event|0|||
27725107|NCT02654002|80826541|FG003|Overall Study|Adverse Event|0|||
27725108|NCT02654002|80826542|FG004|Overall Study|Adverse Event|0|||
27844309|NCT02654587|81260593|FG000|Overall Study|Withdrawal by Subject|1|||
27844310|NCT02654587|81260594|FG001|Overall Study|Withdrawal by Subject|7|||
27844311|NCT01355302|81260595|FG000|Phase 1b|Death|4|||
27844312|NCT01355302|81260596|FG001|Phase 1b|Death|0|||
27844313|NCT01355302|81260597|FG002|Phase 1b|Death|0|||
27844314|NCT01355302|81260595|FG000|Phase 1b|Study terminated by sponsor|2|||
27844315|NCT01355302|81260596|FG001|Phase 1b|Study terminated by sponsor|0|||
27844316|NCT01355302|81260597|FG002|Phase 1b|Study terminated by sponsor|0|||
27844317|NCT02001051|81260600|FG000|Overall Study|Deemed not eligible following enrollment|0|||
27844318|NCT02001051|81260601|FG001|Overall Study|Deemed not eligible following enrollment|1|||
27844319|NCT01961687|81260602|FG000|Overall Study|Lost to Follow-up|19|||
27844320|NCT01961687|81260602|FG000|Overall Study|Re-operation|17|||
27844321|NCT01961687|81260602|FG000|Overall Study|Death|7|||
27844322|NCT01961687|81260602|FG000|Overall Study|Withdrawal by Subject|6|||
27844323|NCT01961687|81260602|FG000|Overall Study|Adverse Event|6|||
27844324|NCT01961687|81260602|FG000|Overall Study|Moved to area without study site|2|||
27844325|NCT01961687|81260602|FG000|Overall Study|Sponsor decision|2|||
27844326|NCT01961687|81260602|FG000|Overall Study|Physician Decision|1|||
27844327|NCT01961687|81260602|FG000|Overall Study|Unable to meet follow-up requirements|1|||
27844328|NCT00348816|81260603|FG000|Overall Study|Noncompliance with radiation treatment|1|||
27844329|NCT00418522|81260604|FG000|Overall Study|Adverse Event|7|||
27844330|NCT00418522|81260605|FG001|Overall Study|Adverse Event|1|||
27844331|NCT00418522|81260604|FG000|Overall Study|Lack of Efficacy|1|||
27725109|NCT02654002|80826543|FG005|Overall Study|Adverse Event|0|||
27844332|NCT00418522|81260605|FG001|Overall Study|Lack of Efficacy|3|||
27844333|NCT00418522|81260604|FG000|Overall Study|Lost to Follow-up|10|||
27844334|NCT00418522|81260605|FG001|Overall Study|Lost to Follow-up|4|||
27725110|NCT02654002|80826544|FG006|Overall Study|Adverse Event|1|||
27725111|NCT02654002|80826545|FG007|Overall Study|Adverse Event|0|||
27725112|NCT02654002|80826546|FG008|Overall Study|Adverse Event|0|||
27725113|NCT02654002|80826538|FG000|Overall Study|Withdrew Consent|0|||
27725114|NCT02654002|80826539|FG001|Overall Study|Withdrew Consent|0|||
27725115|NCT02654002|80826540|FG002|Overall Study|Withdrew Consent|0|||
27844335|NCT00418522|81260604|FG000|Overall Study|Withdrawal by Subject|31|||
27725116|NCT02654002|80826541|FG003|Overall Study|Withdrew Consent|0|||
27725117|NCT02654002|80826542|FG004|Overall Study|Withdrew Consent|0|||
27725118|NCT02654002|80826543|FG005|Overall Study|Withdrew Consent|1|||
27725119|NCT02654002|80826544|FG006|Overall Study|Withdrew Consent|0|||
27725120|NCT02654002|80826545|FG007|Overall Study|Withdrew Consent|1|||
27844336|NCT00418522|81260605|FG001|Overall Study|Withdrawal by Subject|7|||
27844337|NCT00418522|81260604|FG000|Overall Study|Other|27|||
27844338|NCT00418522|81260605|FG001|Overall Study|Other|23|||
27844339|NCT00418522|81260604|FG000|Overall Study|Randomized but did not receive treatment|7|||
27844340|NCT00418522|81260605|FG001|Overall Study|Randomized but did not receive treatment|4|||
27844341|NCT01270620|81260606|FG000|Overall Study|Withdrawal by Subject|1|||
27844342|NCT01270620|81260607|FG001|Overall Study|Withdrawal by Subject|3|||
27844343|NCT02808819|81260608|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
27844344|NCT02808819|81260609|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
27844345|NCT02808819|81260608|FG000|Overall Study|Withdrawal by Subject|10|||
27844346|NCT02808819|81260609|FG001|Overall Study|Withdrawal by Subject|13|||
27844347|NCT02808819|81260608|FG000|Overall Study|Site terminated by sponsor|2|||
27844348|NCT02808819|81260609|FG001|Overall Study|Site terminated by sponsor|0|||
27844349|NCT02808819|81260608|FG000|Overall Study|Pregnancy|1|||
27844350|NCT02808819|81260609|FG001|Overall Study|Pregnancy|0|||
27844351|NCT02808819|81260608|FG000|Overall Study|Lost to Follow-up|1|||
27844352|NCT02808819|81260609|FG001|Overall Study|Lost to Follow-up|6|||
27844353|NCT02808819|81260608|FG000|Overall Study|Protocol Violation|0|||
27844354|NCT02808819|81260609|FG001|Overall Study|Protocol Violation|1|||
27844355|NCT02808819|81260608|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
27844356|NCT02808819|81260609|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
27844357|NCT02808819|81260608|FG000|Overall Study|Death|1|||
27844358|NCT02808819|81260609|FG001|Overall Study|Death|0|||
27844359|NCT02808819|81260608|FG000|Overall Study|Adverse Event|3|||
27844360|NCT02808819|81260609|FG001|Overall Study|Adverse Event|4|||
27844361|NCT04287868|81260610|FG000|Overall Study|Screening fail|1|||
27844362|NCT04287868|81260611|FG001|Overall Study|Screening fail|0|||
27844363|NCT02751827|81260612|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
27844364|NCT02751827|81260613|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
27844365|NCT02751827|81260614|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
27844366|NCT01223235|81260615|FG000|Overall Study|Withdrawal by Subject|1|||
27844367|NCT00860743|81260616|FG000|Overall Study|Withdrawal by Subject|3|||
27844368|NCT00860743|81260617|FG001|Overall Study|Withdrawal by Subject|0|||
27844369|NCT03823287|81260618|FG000|Overall Study|Withdrawal by Subject|25|||
27844370|NCT03823287|81260619|FG001|Overall Study|Withdrawal by Subject|17|||
27844371|NCT03823287|81260618|FG000|Overall Study|Death|13|||
27844372|NCT03823287|81260619|FG001|Overall Study|Death|7|||
27844373|NCT03823287|81260618|FG000|Overall Study|Lost to Follow-up|7|||
27844374|NCT03823287|81260619|FG001|Overall Study|Lost to Follow-up|8|||
27844375|NCT03823287|81260618|FG000|Overall Study|Adverse Event|6|||
27844376|NCT03823287|81260619|FG001|Overall Study|Adverse Event|8|||
27844377|NCT03823287|81260618|FG000|Overall Study|Physician Decision|5|||
27844378|NCT03823287|81260619|FG001|Overall Study|Physician Decision|2|||
27844379|NCT03823287|81260618|FG000|Overall Study|Lack of Efficacy|2|||
27844380|NCT03823287|81260619|FG001|Overall Study|Lack of Efficacy|0|||
27844381|NCT03823287|81260618|FG000|Overall Study|Other|2|||
27844382|NCT03823287|81260619|FG001|Overall Study|Other|4|||
27844383|NCT03176784|81260620|FG000|Overall Study|Lost to Follow-up|77|||
27844384|NCT03176784|81260621|FG001|Overall Study|Lost to Follow-up|79|||
27844385|NCT03176784|81260622|FG002|Overall Study|Lost to Follow-up|79|||
27844386|NCT03176784|81260623|FG003|Overall Study|Lost to Follow-up|49|||
27844387|NCT03176784|81260620|FG000|Overall Study|Withdrawal by Subject|28|||
27844388|NCT03176784|81260621|FG001|Overall Study|Withdrawal by Subject|34|||
27844389|NCT03176784|81260622|FG002|Overall Study|Withdrawal by Subject|34|||
27844390|NCT03176784|81260623|FG003|Overall Study|Withdrawal by Subject|21|||
27844391|NCT03702049|81260625|FG000|Overall Study|Lost to Follow-up|4|||
27844392|NCT03702049|81260625|FG000|Overall Study|Physician Decision|1|||
27844393|NCT01257581|81260626|FG000|Overall Study|Early Termination|3|||
27844394|NCT01257581|81260627|FG001|Overall Study|Early Termination|1|||
27844395|NCT01257581|81260628|FG002|Overall Study|Early Termination|2|||
27844396|NCT01257581|81260626|FG000|Overall Study|Death|2|||
27844397|NCT01257581|81260627|FG001|Overall Study|Death|2|||
27844398|NCT01257581|81260628|FG002|Overall Study|Death|4|||
27844399|NCT01701973|81260629|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844400|NCT01701973|81260630|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
27844401|NCT01701973|81260631|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844402|NCT01701973|81260632|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844403|NCT01701973|81260633|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844404|NCT01701973|81260634|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844405|NCT01701973|81260635|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844406|NCT01701973|81260636|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
27844407|NCT04403399|81260642|FG000|Period 2|Physician Decision|0|||
27844408|NCT04403399|81260643|FG001|Period 2|Physician Decision|1|||
27844409|NCT03449199|81260651|FG000|Overall Study|Lost to Follow-up|1|||
27844410|NCT03449199|81260652|FG001|Overall Study|Lost to Follow-up|1|||
27844411|NCT03449199|81260653|FG002|Overall Study|Lost to Follow-up|0|||
27844412|NCT03449199|81260651|FG000|Overall Study|Protocol Deviation|0|||
27844413|NCT03449199|81260652|FG001|Overall Study|Protocol Deviation|0|||
27844414|NCT03449199|81260653|FG002|Overall Study|Protocol Deviation|1|||
27844415|NCT03449199|81260651|FG000|Overall Study|Withdrawal by Subject|0|||
27844416|NCT03449199|81260652|FG001|Overall Study|Withdrawal by Subject|0|||
27844417|NCT03449199|81260653|FG002|Overall Study|Withdrawal by Subject|1|||
27844418|NCT02776553|81260654|FG000|Overall Study|Lost to Follow-up|1|||
27844419|NCT02776553|81260655|FG001|Overall Study|Lost to Follow-up|0|||
27844420|NCT02776553|81260654|FG000|Overall Study|got liver transplant|1|||
27844421|NCT02776553|81260655|FG001|Overall Study|got liver transplant|2|||
27844422|NCT02776553|81260654|FG000|Overall Study|had other surgery|1|||
27844423|NCT02776553|81260655|FG001|Overall Study|had other surgery|0|||
27844424|NCT02776553|81260654|FG000|Overall Study|Protocol Violation|0|||
27844425|NCT02776553|81260655|FG001|Overall Study|Protocol Violation|1|||
27844426|NCT04126343|81260656|FG000|Overall Study|Adverse Event|0|||
27844427|NCT04126343|81260657|FG001|Overall Study|Adverse Event|0|||
27844428|NCT04126343|81260658|FG002|Overall Study|Adverse Event|0|||
27844429|NCT04126343|81260659|FG003|Overall Study|Adverse Event|0|||
27844430|NCT04126343|81260660|FG004|Overall Study|Adverse Event|0|||
27844431|NCT04126343|81260661|FG005|Overall Study|Adverse Event|1|||
27844432|NCT04126343|81260656|FG000|Overall Study|Withdrawal by Subject|0|||
27844433|NCT04126343|81260657|FG001|Overall Study|Withdrawal by Subject|0|||
27844434|NCT04126343|81260658|FG002|Overall Study|Withdrawal by Subject|0|||
27844435|NCT04126343|81260659|FG003|Overall Study|Withdrawal by Subject|1|||
27844436|NCT04126343|81260660|FG004|Overall Study|Withdrawal by Subject|0|||
27844437|NCT04126343|81260661|FG005|Overall Study|Withdrawal by Subject|0|||
27844438|NCT04126343|81260656|FG000|Overall Study|Related to COVID-19 pandemic|3|||
27844439|NCT04126343|81260657|FG001|Overall Study|Related to COVID-19 pandemic|4|||
27844440|NCT04126343|81260658|FG002|Overall Study|Related to COVID-19 pandemic|3|||
27844441|NCT04126343|81260659|FG003|Overall Study|Related to COVID-19 pandemic|3|||
27844442|NCT04126343|81260660|FG004|Overall Study|Related to COVID-19 pandemic|3|||
27844443|NCT04126343|81260661|FG005|Overall Study|Related to COVID-19 pandemic|3|||
27844444|NCT00830167|81260666|FG000|Overall Study|Lack of Efficacy|26|||
27844445|NCT00830167|81260667|FG001|Overall Study|Lack of Efficacy|10|||
27844446|NCT00830167|81260666|FG000|Overall Study|Adverse Event|8|||
27844447|NCT00830167|81260667|FG001|Overall Study|Adverse Event|24|||
27844448|NCT00830167|81260666|FG000|Overall Study|Not meeting entrance criteria|2|||
27844449|NCT00830167|81260667|FG001|Overall Study|Not meeting entrance criteria|5|||
27844450|NCT00830167|81260666|FG000|Overall Study|Withdrawal by Subject|2|||
27844451|NCT00830167|81260667|FG001|Overall Study|Withdrawal by Subject|0|||
27844452|NCT00830167|81260666|FG000|Overall Study|Lost to Follow-up|0|||
27844453|NCT00830167|81260667|FG001|Overall Study|Lost to Follow-up|1|||
27844454|NCT00830167|81260666|FG000|Overall Study|Protocol Violation|0|||
27893076|NCT01093326|81443937|FG000|Overall Study|Other|0|||
27893077|NCT01093326|81443938|FG001|Overall Study|Other|0|||
27893078|NCT01093326|81443939|FG002|Overall Study|Other|1|||
27725121|NCT02654002|80826546|FG008|Overall Study|Withdrew Consent|0|||
27844455|NCT00830167|81260667|FG001|Overall Study|Protocol Violation|1|||
27844456|NCT00830167|81260666|FG000|Overall Study|Other|2|||
27844457|NCT00830167|81260667|FG001|Overall Study|Other|2|||
27844458|NCT04234464|81260672|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
27844459|NCT04234464|81260673|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
27958609|NCT01791517|81680069|FG011|Phase II|Lack of Efficacy|0|||
27844460|NCT01729026|81260674|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
27844461|NCT01729026|81260675|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
27844462|NCT01729026|81260674|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
27844463|NCT01729026|81260675|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
27844464|NCT04102345|81260676|FG000|Overall Study|Withdrawal by Subject|1|||
27844465|NCT04102345|81260677|FG001|Overall Study|Withdrawal by Subject|0|||
27844466|NCT00476593|81260678|FG000|Overall Study|Lost to Follow-up|10|||
27844467|NCT00476593|81260679|FG001|Overall Study|Lost to Follow-up|2|||
27844468|NCT00476593|81260680|FG002|Overall Study|Lost to Follow-up|8|||
27844469|NCT00476593|81260681|FG003|Overall Study|Lost to Follow-up|22|||
27844470|NCT01825837|81260691|FG000|PART I|Withdrawal by Subject|0|||
27844471|NCT01825837|81260692|FG001|PART I|Withdrawal by Subject|0|||
27844472|NCT01825837|81260693|FG002|PART I|Withdrawal by Subject|0|||
27844473|NCT01825837|81260694|FG003|PART I|Withdrawal by Subject|6|||
27844474|NCT01825837|81260691|FG000|PART I|Patient non-compliance|0|||
27844475|NCT01825837|81260692|FG001|PART I|Patient non-compliance|0|||
27844476|NCT01825837|81260693|FG002|PART I|Patient non-compliance|0|||
27844477|NCT01825837|81260694|FG003|PART I|Patient non-compliance|1|||
27844478|NCT01825837|81260691|FG000|PART I|Treatment failure|0|||
27844479|NCT01825837|81260692|FG001|PART I|Treatment failure|0|||
27844480|NCT01825837|81260693|FG002|PART I|Treatment failure|0|||
27844481|NCT01825837|81260694|FG003|PART I|Treatment failure|7|||
27844482|NCT01825837|81260691|FG000|PART I|reason unspecified|0|||
27844483|NCT01825837|81260692|FG001|PART I|reason unspecified|0|||
27844484|NCT01825837|81260693|FG002|PART I|reason unspecified|0|||
27844485|NCT01825837|81260694|FG003|PART I|reason unspecified|3|||
27844486|NCT01825837|81260691|FG000|PART II|Withdrawal by Subject|3|||
27844487|NCT01825837|81260692|FG001|PART II|Withdrawal by Subject|3|||
27844488|NCT01825837|81260693|FG002|PART II|Withdrawal by Subject|7|||
27844489|NCT01825837|81260694|FG003|PART II|Withdrawal by Subject|0|||
27844490|NCT01825837|81260691|FG000|PART II|Patient non-compliance|5|||
27844491|NCT01825837|81260692|FG001|PART II|Patient non-compliance|2|||
27844492|NCT01825837|81260693|FG002|PART II|Patient non-compliance|4|||
27844493|NCT01825837|81260694|FG003|PART II|Patient non-compliance|0|||
27844494|NCT01825837|81260691|FG000|PART II|Adverse Event|3|||
27844495|NCT01825837|81260692|FG001|PART II|Adverse Event|3|||
27844496|NCT01825837|81260693|FG002|PART II|Adverse Event|1|||
27844497|NCT01825837|81260694|FG003|PART II|Adverse Event|0|||
27844498|NCT01825837|81260691|FG000|PART II|Treatment failure|6|||
27844499|NCT01825837|81260692|FG001|PART II|Treatment failure|4|||
27844500|NCT01825837|81260693|FG002|PART II|Treatment failure|5|||
27844501|NCT01825837|81260694|FG003|PART II|Treatment failure|0|||
27844502|NCT01825837|81260691|FG000|PART II|reason unspecified|2|||
27844503|NCT01825837|81260692|FG001|PART II|reason unspecified|2|||
27725122|NCT00888238|80826547|FG000|Washout Period After Period 2|Adverse Event|0|||
27725123|NCT00888238|80826548|FG001|Washout Period After Period 2|Adverse Event|0|||
27725124|NCT00888238|80826549|FG002|Washout Period After Period 2|Adverse Event|1|||
27725125|NCT00741819|80826550|FG000|Overall Study|Adverse Event|3|||
27725126|NCT00741819|80826550|FG000|Overall Study|Withdrawal by Subject|3|||
27725127|NCT00741819|80826550|FG000|Overall Study|Death|1|||
27725128|NCT00741819|80826550|FG000|Overall Study|Disease progression|1|||
27725129|NCT01671280|80826551|FG000|Overall Study|Withdrawal by Subject|2|||
27725130|NCT03603652|80826552|FG000|Overall Study|Death|2|||
27725131|NCT00768898|80826553|FG000|Overall Study|Unrelated injury|1|||
27725132|NCT00768898|80826553|FG000|Overall Study|Headache|1|||
27725133|NCT00542997|80826555|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
27725134|NCT00542997|80826555|FG000|Wash in / Wash Out Period|Adverse Event|3|||
27725135|NCT00542997|80826555|FG000|Efficacy Period|Adverse Event|3|||
27725136|NCT01291017|80826556|FG000|Overall Study|Lost to Follow-up|2|||
27725137|NCT01291017|80826556|FG000|Overall Study|Withdrawal by Subject|3|||
27725138|NCT01178138|80826559|FG000|Overall Study|Lost to Follow-up|8|||
27844504|NCT01825837|81260693|FG002|PART II|reason unspecified|2|||
27844505|NCT01825837|81260694|FG003|PART II|reason unspecified|0|||
27725139|NCT01178138|80826559|FG000|Overall Study|Withdrawal by Subject|7|||
27725140|NCT01178138|80826559|FG000|Overall Study|Physician Decision|8|||
27725141|NCT01001702|80826566|FG000|Overall Study|Lost to Follow-up|7|||
27725142|NCT01001702|80826566|FG000|Overall Study|Adverse Event|7|||
27844506|NCT02244424|81260695|FG000|Overall Study|Lost to Follow-up|20|||
27844507|NCT02244424|81260696|FG001|Overall Study|Lost to Follow-up|10|||
27844508|NCT05816200|81260699|FG000|Overall Study|Lost to Follow-up|2|||
27844509|NCT05816200|81260700|FG001|Overall Study|Lost to Follow-up|1|||
27844510|NCT03253094|81260701|FG000|Overall Study|Adverse Event|2|||
27844511|NCT03253094|81260702|FG001|Overall Study|Adverse Event|0|||
27844512|NCT03253094|81260703|FG002|Overall Study|Adverse Event|0|||
27844513|NCT03253094|81260704|FG003|Overall Study|Adverse Event|0|||
27844514|NCT03253094|81260705|FG004|Overall Study|Adverse Event|0|||
27725143|NCT01001702|80826566|FG000|Overall Study|Sponsor Discontinued Study|4|||
27725144|NCT01001702|80826566|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
27725145|NCT01001702|80826566|FG000|Overall Study|Investigator withdrew Subject|10|||
27725146|NCT01001702|80826566|FG000|Overall Study|Withdrawal by Subject|19|||
27725147|NCT01001702|80826566|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
27725148|NCT01957137|80826567|FG000|Randomized Portion|Adverse Event|1|||
27725149|NCT01957137|80826567|FG000|Randomized Portion|Withdrawal by Subject|1|||
27725150|NCT04067518|80826572|FG000|Overall Study|Adverse Event|1|||
27725151|NCT04067518|80826573|FG001|Overall Study|Adverse Event|3|||
27725152|NCT04067518|80826572|FG000|Overall Study|Screen failures|0|||
27725153|NCT04067518|80826573|FG001|Overall Study|Screen failures|1|||
27725154|NCT04067518|80826572|FG000|Overall Study|Enrolled but not treated|0|||
27725155|NCT04067518|80826573|FG001|Overall Study|Enrolled but not treated|1|||
27725156|NCT03905863|80826574|FG000|Overall Study|Adverse Event|2|||
27725157|NCT03905863|80826575|FG001|Overall Study|Adverse Event|4|||
27725158|NCT03905863|80826574|FG000|Overall Study|Withdrawal by Subject|2|||
27725159|NCT03905863|80826575|FG001|Overall Study|Withdrawal by Subject|2|||
27725160|NCT03905863|80826574|FG000|Overall Study|Physician Decision|0|||
27725161|NCT03905863|80826575|FG001|Overall Study|Physician Decision|3|||
27725162|NCT03905863|80826574|FG000|Overall Study|Lost to Follow-up|1|||
27725163|NCT03905863|80826575|FG001|Overall Study|Lost to Follow-up|0|||
27725164|NCT03905863|80826574|FG000|Overall Study|Protocol Violation|0|||
27725165|NCT03905863|80826575|FG001|Overall Study|Protocol Violation|2|||
27725166|NCT03905863|80826574|FG000|Overall Study|Death|0|||
27725167|NCT03905863|80826575|FG001|Overall Study|Death|1|||
27725168|NCT01262976|80826576|FG000|Up to Month 2|Serious Adverse Event|0|||
27725169|NCT01262976|80826577|FG001|Up to Month 2|Serious Adverse Event|0|||
27725170|NCT01262976|80826578|FG002|Up to Month 2|Serious Adverse Event|1|||
27725171|NCT01262976|80826579|FG003|Up to Month 2|Serious Adverse Event|0|||
27725172|NCT01262976|80826580|FG004|Up to Month 2|Serious Adverse Event|0|||
27725173|NCT01262976|80826581|FG005|Up to Month 2|Serious Adverse Event|0|||
27725174|NCT01262976|80826576|FG000|Up to Month 2|Withdrawal by Subject|1|||
27725175|NCT01262976|80826577|FG001|Up to Month 2|Withdrawal by Subject|0|||
27725176|NCT01262976|80826578|FG002|Up to Month 2|Withdrawal by Subject|0|||
27725177|NCT01262976|80826579|FG003|Up to Month 2|Withdrawal by Subject|0|||
27725178|NCT01262976|80826580|FG004|Up to Month 2|Withdrawal by Subject|0|||
27725179|NCT01262976|80826581|FG005|Up to Month 2|Withdrawal by Subject|0|||
27725180|NCT01262976|80826576|FG000|Up to Month 2|Migrated/moved from study area|0|||
27725181|NCT01262976|80826577|FG001|Up to Month 2|Migrated/moved from study area|1|||
27725182|NCT01262976|80826578|FG002|Up to Month 2|Migrated/moved from study area|0|||
27725183|NCT01262976|80826579|FG003|Up to Month 2|Migrated/moved from study area|0|||
27844515|NCT03253094|81260706|FG005|Overall Study|Adverse Event|0|||
27844516|NCT03253094|81260701|FG000|Overall Study|Lack of Efficacy|0|||
27844517|NCT03253094|81260702|FG001|Overall Study|Lack of Efficacy|0|||
27844518|NCT03253094|81260703|FG002|Overall Study|Lack of Efficacy|2|||
27844519|NCT03253094|81260704|FG003|Overall Study|Lack of Efficacy|1|||
27844520|NCT03253094|81260705|FG004|Overall Study|Lack of Efficacy|2|||
27844521|NCT03253094|81260706|FG005|Overall Study|Lack of Efficacy|1|||
27844522|NCT03253094|81260701|FG000|Overall Study|Lost to Follow-up|0|||
27844523|NCT03253094|81260702|FG001|Overall Study|Lost to Follow-up|0|||
27844524|NCT03253094|81260703|FG002|Overall Study|Lost to Follow-up|1|||
27844525|NCT03253094|81260704|FG003|Overall Study|Lost to Follow-up|1|||
27844526|NCT03253094|81260705|FG004|Overall Study|Lost to Follow-up|0|||
27844527|NCT03253094|81260706|FG005|Overall Study|Lost to Follow-up|1|||
27844528|NCT03253094|81260701|FG000|Overall Study|Physician Decision|1|||
27844529|NCT03253094|81260702|FG001|Overall Study|Physician Decision|0|||
27844530|NCT03253094|81260703|FG002|Overall Study|Physician Decision|0|||
27844531|NCT03253094|81260704|FG003|Overall Study|Physician Decision|1|||
27844532|NCT03253094|81260705|FG004|Overall Study|Physician Decision|0|||
27844533|NCT03253094|81260706|FG005|Overall Study|Physician Decision|2|||
27844534|NCT03253094|81260701|FG000|Overall Study|Withdrawal by Subject|1|||
27844535|NCT03253094|81260702|FG001|Overall Study|Withdrawal by Subject|2|||
27844536|NCT03253094|81260703|FG002|Overall Study|Withdrawal by Subject|1|||
27844537|NCT03253094|81260704|FG003|Overall Study|Withdrawal by Subject|0|||
27844538|NCT03253094|81260705|FG004|Overall Study|Withdrawal by Subject|3|||
27844539|NCT03253094|81260706|FG005|Overall Study|Withdrawal by Subject|0|||
27504546|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
27844540|NCT03253094|81260701|FG000|Overall Study|Other|0|||
27844541|NCT03253094|81260702|FG001|Overall Study|Other|1|||
27844542|NCT03253094|81260703|FG002|Overall Study|Other|2|||
27844543|NCT03253094|81260704|FG003|Overall Study|Other|1|||
27844544|NCT03253094|81260705|FG004|Overall Study|Other|0|||
27958610|NCT01791517|81680058|FG000|Phase II|Adverse Event|0|||
27504547|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27844545|NCT03253094|81260706|FG005|Overall Study|Other|0|||
27958611|NCT01791517|81680059|FG001|Phase II|Adverse Event|0|||
27958612|NCT01791517|81680060|FG002|Phase II|Adverse Event|0|||
27958613|NCT01791517|81680061|FG003|Phase II|Adverse Event|0|||
27958614|NCT01791517|81680062|FG004|Phase II|Adverse Event|0|||
27958615|NCT01791517|81680063|FG005|Phase II|Adverse Event|0|||
27958616|NCT01791517|81680064|FG006|Phase II|Adverse Event|2|||
27958617|NCT01791517|81680065|FG007|Phase II|Adverse Event|1|||
27958618|NCT01791517|81680066|FG008|Phase II|Adverse Event|0|||
27958619|NCT01791517|81680067|FG009|Phase II|Adverse Event|1|||
27504548|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27844546|NCT04768296|81260707|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
27844547|NCT04768296|81260708|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
27844548|NCT01553747|81260713|FG000|Overall Study|Protocol Violation|0|||
27844549|NCT01553747|81260714|FG001|Overall Study|Protocol Violation|2|||
27844550|NCT01553747|81260715|FG002|Overall Study|Protocol Violation|0|||
27844551|NCT01553747|81260713|FG000|Overall Study|Voluntarily withdrew|70|||
27844552|NCT01553747|81260714|FG001|Overall Study|Voluntarily withdrew|66|||
27844553|NCT01553747|81260715|FG002|Overall Study|Voluntarily withdrew|74|||
27893079|NCT01077739|81443944|FG000|Overall Study|Premature withdrawal|1|||
27893080|NCT01077739|81443945|FG001|Overall Study|Premature withdrawal|3|||
27893081|NCT01077739|81443944|FG000|Overall Study|Withdrawal by Subject|1|||
27893082|NCT01077739|81443945|FG001|Overall Study|Withdrawal by Subject|0|||
27893083|NCT01077739|81443944|FG000|Overall Study|Death|0|||
27893084|NCT01077739|81443945|FG001|Overall Study|Death|3|||
27893085|NCT01077739|81443944|FG000|Overall Study|Unacceptable toxicity|1|||
27893086|NCT01077739|81443945|FG001|Overall Study|Unacceptable toxicity|2|||
27893087|NCT01077739|81443944|FG000|Overall Study|Other|2|||
27893088|NCT01077739|81443945|FG001|Overall Study|Other|2|||
27893089|NCT03634033|81443949|FG000|Overall Study|Did not have a post-assessment|384|||
27893090|NCT03634033|81443950|FG001|Overall Study|Did not have a post-assessment|291|||
27893091|NCT03634033|81443951|FG002|Overall Study|Did not have a post-assessment|114|||
27893092|NCT03634033|81443952|FG003|Overall Study|Did not have a post-assessment|161|||
27893093|NCT03634033|81443953|FG004|Overall Study|Did not have a post-assessment|5|||
27893094|NCT03634033|81443954|FG005|Overall Study|Did not have a post-assessment|0|||
27893095|NCT03634033|81443955|FG006|Overall Study|Did not have a post-assessment|0|||
27893096|NCT03634033|81443949|FG000|Overall Study|Death|0|||
27893097|NCT03634033|81443950|FG001|Overall Study|Death|0|||
27893098|NCT03634033|81443951|FG002|Overall Study|Death|0|||
27893099|NCT03634033|81443952|FG003|Overall Study|Death|0|||
27893100|NCT03634033|81443953|FG004|Overall Study|Death|0|||
27893101|NCT03634033|81443954|FG005|Overall Study|Death|7|||
27893102|NCT03634033|81443955|FG006|Overall Study|Death|7|||
27893103|NCT03634033|81443949|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
27893104|NCT03634033|81443950|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
27893105|NCT03634033|81443951|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
27893106|NCT03634033|81443952|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
27893107|NCT03634033|81443953|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
27893108|NCT03634033|81443954|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
27893109|NCT03634033|81443955|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
27893110|NCT03634033|81443949|FG000|Overall Study|Lost to Follow-up|0|||
27725184|NCT01262976|80826580|FG004|Up to Month 2|Migrated/moved from study area|1|||
27504549|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27844554|NCT01553747|81260713|FG000|Overall Study|Adverse event or SAE|32|||
27893111|NCT03634033|81443950|FG001|Overall Study|Lost to Follow-up|0|||
27893112|NCT03634033|81443951|FG002|Overall Study|Lost to Follow-up|0|||
27893113|NCT03634033|81443952|FG003|Overall Study|Lost to Follow-up|0|||
27893114|NCT03634033|81443953|FG004|Overall Study|Lost to Follow-up|0|||
27893115|NCT03634033|81443954|FG005|Overall Study|Lost to Follow-up|1|||
27893116|NCT03634033|81443955|FG006|Overall Study|Lost to Follow-up|2|||
27844555|NCT01553747|81260714|FG001|Overall Study|Adverse event or SAE|28|||
27844556|NCT01553747|81260715|FG002|Overall Study|Adverse event or SAE|19|||
27844557|NCT01553747|81260713|FG000|Overall Study|Physician decision: other|10|||
27844558|NCT01553747|81260714|FG001|Overall Study|Physician decision: other|8|||
27844559|NCT01553747|81260715|FG002|Overall Study|Physician decision: other|7|||
27844560|NCT01553747|81260713|FG000|Overall Study|Lost to Follow-up|11|||
27844561|NCT01553747|81260714|FG001|Overall Study|Lost to Follow-up|5|||
27844562|NCT01553747|81260715|FG002|Overall Study|Lost to Follow-up|6|||
27844563|NCT01553747|81260713|FG000|Overall Study|Sponsor decision, specify|7|||
27844564|NCT01553747|81260714|FG001|Overall Study|Sponsor decision, specify|5|||
27844565|NCT01553747|81260715|FG002|Overall Study|Sponsor decision, specify|0|||
27844566|NCT01553747|81260713|FG000|Overall Study|Physician decision: lack of efficacy|1|||
27893117|NCT03634033|81443949|FG000|Overall Study|Withdrawal by Subject|0|||
27893118|NCT03634033|81443950|FG001|Overall Study|Withdrawal by Subject|0|||
27893119|NCT03634033|81443951|FG002|Overall Study|Withdrawal by Subject|0|||
27893120|NCT03634033|81443952|FG003|Overall Study|Withdrawal by Subject|0|||
27893121|NCT03634033|81443953|FG004|Overall Study|Withdrawal by Subject|0|||
27893122|NCT03634033|81443954|FG005|Overall Study|Withdrawal by Subject|0|||
27893123|NCT03634033|81443955|FG006|Overall Study|Withdrawal by Subject|1|||
27893124|NCT02100670|81443960|FG000|Overall Study|Adverse Event|10|||
27893125|NCT02100670|81443961|FG001|Overall Study|Adverse Event|3|||
27893126|NCT02100670|81443962|FG002|Overall Study|Adverse Event|3|||
27893127|NCT02100670|81443963|FG003|Overall Study|Adverse Event|0|||
27893128|NCT02100670|81443960|FG000|Overall Study|Lost to Follow-up|1|||
27893129|NCT02100670|81443961|FG001|Overall Study|Lost to Follow-up|0|||
27893130|NCT02100670|81443962|FG002|Overall Study|Lost to Follow-up|0|||
27893131|NCT02100670|81443963|FG003|Overall Study|Lost to Follow-up|0|||
27893132|NCT02100670|81443960|FG000|Overall Study|Protocol Violation|0|||
27893133|NCT02100670|81443961|FG001|Overall Study|Protocol Violation|1|||
27893134|NCT02100670|81443962|FG002|Overall Study|Protocol Violation|0|||
27893135|NCT02100670|81443963|FG003|Overall Study|Protocol Violation|1|||
27893136|NCT02100670|81443960|FG000|Overall Study|Withdrawal of Consent|0|||
27893137|NCT02100670|81443961|FG001|Overall Study|Withdrawal of Consent|1|||
27893138|NCT02100670|81443962|FG002|Overall Study|Withdrawal of Consent|1|||
27504550|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504551|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504552|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504553|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504554|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504555|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504556|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504557|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504558|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
27504559|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
27504560|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
27844567|NCT01553747|81260714|FG001|Overall Study|Physician decision: lack of efficacy|5|||
27844568|NCT01553747|81260715|FG002|Overall Study|Physician decision: lack of efficacy|3|||
27893139|NCT02100670|81443963|FG003|Overall Study|Withdrawal of Consent|0|||
27893140|NCT02100670|81443960|FG000|Overall Study|No swelling no pain|1|||
27893141|NCT02100670|81443961|FG001|Overall Study|No swelling no pain|0|||
27893142|NCT02100670|81443962|FG002|Overall Study|No swelling no pain|0|||
27725185|NCT01262976|80826581|FG005|Up to Month 2|Migrated/moved from study area|1|||
27725186|NCT01262976|80826576|FG000|Up to Month 2|Lost to Follow-up|1|||
27725187|NCT01262976|80826577|FG001|Up to Month 2|Lost to Follow-up|0|||
27725188|NCT01262976|80826578|FG002|Up to Month 2|Lost to Follow-up|0|||
27725189|NCT01262976|80826579|FG003|Up to Month 2|Lost to Follow-up|1|||
27725190|NCT01262976|80826580|FG004|Up to Month 2|Lost to Follow-up|1|||
27725191|NCT01262976|80826581|FG005|Up to Month 2|Lost to Follow-up|1|||
27725192|NCT01262976|80826576|FG000|Up to Month 2|Other|1|||
27725193|NCT01262976|80826577|FG001|Up to Month 2|Other|0|||
27725194|NCT01262976|80826578|FG002|Up to Month 2|Other|0|||
27725195|NCT01262976|80826579|FG003|Up to Month 2|Other|1|||
27725196|NCT01262976|80826580|FG004|Up to Month 2|Other|0|||
27725197|NCT01262976|80826581|FG005|Up to Month 2|Other|2|||
27725198|NCT01262976|80826576|FG000|Up to Month 7|Serious Adverse Event|0|||
27725199|NCT01262976|80826577|FG001|Up to Month 7|Serious Adverse Event|0|||
27725200|NCT01262976|80826578|FG002|Up to Month 7|Serious Adverse Event|2|||
27725201|NCT01262976|80826579|FG003|Up to Month 7|Serious Adverse Event|0|||
27725202|NCT01262976|80826580|FG004|Up to Month 7|Serious Adverse Event|0|||
27725203|NCT01262976|80826581|FG005|Up to Month 7|Serious Adverse Event|0|||
27725204|NCT01262976|80826576|FG000|Up to Month 7|Withdrawal by Subject|1|||
27725205|NCT01262976|80826577|FG001|Up to Month 7|Withdrawal by Subject|0|||
27725206|NCT01262976|80826578|FG002|Up to Month 7|Withdrawal by Subject|0|||
27725207|NCT01262976|80826579|FG003|Up to Month 7|Withdrawal by Subject|0|||
27725208|NCT01262976|80826580|FG004|Up to Month 7|Withdrawal by Subject|0|||
27725209|NCT01262976|80826581|FG005|Up to Month 7|Withdrawal by Subject|0|||
27725210|NCT01262976|80826576|FG000|Up to Month 7|Migrated/moved from study area|0|||
27725211|NCT01262976|80826577|FG001|Up to Month 7|Migrated/moved from study area|0|||
27725212|NCT01262976|80826578|FG002|Up to Month 7|Migrated/moved from study area|1|||
27725213|NCT01262976|80826579|FG003|Up to Month 7|Migrated/moved from study area|3|||
27725214|NCT01262976|80826580|FG004|Up to Month 7|Migrated/moved from study area|1|||
27725215|NCT01262976|80826581|FG005|Up to Month 7|Migrated/moved from study area|1|||
27725216|NCT01262976|80826576|FG000|Up to Month 7|Lost to Follow-up|1|||
27725217|NCT01262976|80826577|FG001|Up to Month 7|Lost to Follow-up|0|||
27725218|NCT01262976|80826578|FG002|Up to Month 7|Lost to Follow-up|1|||
27725219|NCT01262976|80826579|FG003|Up to Month 7|Lost to Follow-up|3|||
27725220|NCT01262976|80826580|FG004|Up to Month 7|Lost to Follow-up|1|||
27725221|NCT01262976|80826581|FG005|Up to Month 7|Lost to Follow-up|3|||
27725222|NCT01262976|80826576|FG000|Up to Month 7|Other|3|||
27725223|NCT01262976|80826577|FG001|Up to Month 7|Other|0|||
27725224|NCT01262976|80826578|FG002|Up to Month 7|Other|2|||
27725225|NCT01262976|80826579|FG003|Up to Month 7|Other|0|||
27725226|NCT01262976|80826580|FG004|Up to Month 7|Other|0|||
27725227|NCT01262976|80826581|FG005|Up to Month 7|Other|0|||
27725228|NCT01262976|80826576|FG000|Up to Year 1|Serious Adverse Event|0|||
27725229|NCT01262976|80826577|FG001|Up to Year 1|Serious Adverse Event|0|||
27725230|NCT01262976|80826578|FG002|Up to Year 1|Serious Adverse Event|2|||
27725231|NCT01262976|80826579|FG003|Up to Year 1|Serious Adverse Event|0|||
27725232|NCT01262976|80826580|FG004|Up to Year 1|Serious Adverse Event|0|||
27725233|NCT01262976|80826581|FG005|Up to Year 1|Serious Adverse Event|0|||
27725234|NCT01262976|80826576|FG000|Up to Year 1|Withdrawal by Subject|1|||
27725235|NCT01262976|80826577|FG001|Up to Year 1|Withdrawal by Subject|0|||
27725236|NCT01262976|80826578|FG002|Up to Year 1|Withdrawal by Subject|0|||
27504561|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27725237|NCT01262976|80826579|FG003|Up to Year 1|Withdrawal by Subject|0|||
27844569|NCT00251316|81260716|FG000|Overall Study|Physician Decision|2|||
27844570|NCT00251316|81260717|FG001|Overall Study|Physician Decision|3|||
27725238|NCT01262976|80826580|FG004|Up to Year 1|Withdrawal by Subject|0|||
27725239|NCT01262976|80826581|FG005|Up to Year 1|Withdrawal by Subject|0|||
27725240|NCT01262976|80826576|FG000|Up to Year 1|Migrated/moved from study area|1|||
27725241|NCT01262976|80826577|FG001|Up to Year 1|Migrated/moved from study area|0|||
27504562|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27725242|NCT01262976|80826578|FG002|Up to Year 1|Migrated/moved from study area|0|||
27725243|NCT01262976|80826579|FG003|Up to Year 1|Migrated/moved from study area|3|||
27725244|NCT01262976|80826580|FG004|Up to Year 1|Migrated/moved from study area|3|||
27725245|NCT01262976|80826581|FG005|Up to Year 1|Migrated/moved from study area|2|||
27725246|NCT01262976|80826576|FG000|Up to Year 1|Lost to Follow-up|4|||
27504563|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504564|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504565|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504566|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504567|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504568|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504569|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504570|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504571|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504572|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504573|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
27504574|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
27504575|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504576|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504577|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504578|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504579|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504580|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504581|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504582|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504583|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504584|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504585|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504586|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504587|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
27504588|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
27504589|NCT02113982|80040769|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504590|NCT02113982|80040770|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504591|NCT02113982|80040771|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504592|NCT02113982|80040772|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504593|NCT02113982|80040773|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504594|NCT02113982|80040774|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504595|NCT02113982|80040775|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504596|NCT02113982|80040776|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504597|NCT02113982|80040777|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504598|NCT02113982|80040778|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504599|NCT02113982|80040779|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504600|NCT02113982|80040780|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504601|NCT02113982|80040781|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
27504602|NCT02113982|80040782|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
27504603|NCT03198715|80040783|FG000|Overall Study|Death|0|||
27504604|NCT03198715|80040784|FG001|Overall Study|Death|0|||
27504605|NCT03198715|80040785|FG002|Overall Study|Death|1|||
27504606|NCT03198715|80040786|FG003|Overall Study|Death|0|||
27504607|NCT03198715|80040787|FG004|Overall Study|Death|2|||
27504608|NCT03198715|80040783|FG000|Overall Study|Other|0|||
27504609|NCT03198715|80040784|FG001|Overall Study|Other|1|||
27504610|NCT03198715|80040785|FG002|Overall Study|Other|1|||
27504611|NCT03198715|80040786|FG003|Overall Study|Other|0|||
27504612|NCT03198715|80040787|FG004|Overall Study|Other|0|||
27504613|NCT01553084|80040793|FG000|Overall Study|Withdrawal by Subject|15|||
27504614|NCT01553084|80040794|FG001|Overall Study|Withdrawal by Subject|13|||
27504615|NCT01553084|80040795|FG002|Overall Study|Withdrawal by Subject|35|||
27504616|NCT00538902|80040803|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
27504617|NCT00538902|80040804|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
27504618|NCT00538902|80040805|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
27504619|NCT00538902|80040803|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
27504620|NCT00538902|80040804|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
27504621|NCT00538902|80040805|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
27504622|NCT00538902|80040803|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
27504623|NCT00538902|80040804|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
27504624|NCT00538902|80040805|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
27504625|NCT00538902|80040803|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
27504626|NCT00538902|80040804|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
27504627|NCT00538902|80040805|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
27504628|NCT00538902|80040803|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
27504629|NCT00538902|80040804|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
27504630|NCT00538902|80040805|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
27504631|NCT00538902|80040803|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
27504632|NCT00538902|80040804|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
27504633|NCT00538902|80040805|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
27504634|NCT00538902|80040803|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
27504635|NCT00538902|80040804|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
27844571|NCT00551616|81260718|FG000|Overall Study|Lost to Follow-up|48|||
27844572|NCT00551616|81260719|FG001|Overall Study|Lost to Follow-up|40|||
27844573|NCT00508027|81260722|FG000|Dose Level 1|Lost to Follow-up|4|||
27844574|NCT00508027|81260722|FG000|Dose Level 1|Withdrawal by Subject|2|||
27504636|NCT00538902|80040805|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
27504637|NCT00538902|80040803|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
27725247|NCT01262976|80826577|FG001|Up to Year 1|Lost to Follow-up|0|||
27725248|NCT01262976|80826578|FG002|Up to Year 1|Lost to Follow-up|0|||
27844575|NCT00508027|81260722|FG000|Dose Level 1|Physician Decision|2|||
27844576|NCT00508027|81260722|FG000|Dose Level 2|Lost to Follow-up|2|||
27844577|NCT00508027|81260722|FG000|Dose Level 2|Withdrawal by Subject|2|||
27844578|NCT00194792|81260726|FG000|Overall Study|Withdrawal by Subject|1|||
27844579|NCT01523587|81260727|FG000|Overall Study|Other than listed|5|||
27844580|NCT01523587|81260728|FG001|Overall Study|Other than listed|5|||
27844581|NCT01523587|81260727|FG000|Overall Study|Worsening of underlying cancer disease|19|||
27844582|NCT01523587|81260728|FG001|Overall Study|Worsening of underlying cancer disease|34|||
27844583|NCT01523587|81260727|FG000|Overall Study|Adverse Event|68|||
27844584|NCT01523587|81260728|FG001|Overall Study|Adverse Event|52|||
27844585|NCT01523587|81260727|FG000|Overall Study|Protocol Violation|5|||
27844586|NCT01523587|81260728|FG001|Overall Study|Protocol Violation|3|||
27844587|NCT01523587|81260727|FG000|Overall Study|Lost to Follow-up|2|||
27844588|NCT01523587|81260728|FG001|Overall Study|Lost to Follow-up|2|||
27844589|NCT01523587|81260727|FG000|Overall Study|Withdrawal by Subject|28|||
27844590|NCT01523587|81260728|FG001|Overall Study|Withdrawal by Subject|20|||
27844591|NCT01523587|81260727|FG000|Overall Study|Withdrew due to Progressive disease|265|||
27844592|NCT01523587|81260728|FG001|Overall Study|Withdrew due to Progressive disease|279|||
27844593|NCT01523587|81260727|FG000|Overall Study|Randomised but bot treated|6|||
27844594|NCT01523587|81260728|FG001|Overall Study|Randomised but bot treated|2|||
27844595|NCT01640184|81260729|FG000|Overall Study|Death|1|||
27844596|NCT01640184|81260730|FG001|Overall Study|Death|0|||
27844597|NCT01640184|81260731|FG002|Overall Study|Death|0|||
27844598|NCT01640184|81260729|FG000|Overall Study|Lost to Follow-up|4|||
27844599|NCT01640184|81260730|FG001|Overall Study|Lost to Follow-up|1|||
27844600|NCT01640184|81260731|FG002|Overall Study|Lost to Follow-up|0|||
27844601|NCT01640184|81260729|FG000|Overall Study|Physician Decision|3|||
27893143|NCT02100670|81443963|FG003|Overall Study|No swelling no pain|0|||
27725249|NCT01262976|80826579|FG003|Up to Year 1|Lost to Follow-up|1|||
27725250|NCT01262976|80826580|FG004|Up to Year 1|Lost to Follow-up|6|||
27725251|NCT01262976|80826581|FG005|Up to Year 1|Lost to Follow-up|5|||
27725252|NCT01262976|80826576|FG000|Up to Year 1|Other|3|||
27725253|NCT01262976|80826577|FG001|Up to Year 1|Other|1|||
27725254|NCT01262976|80826578|FG002|Up to Year 1|Other|0|||
27725255|NCT01262976|80826579|FG003|Up to Year 1|Other|0|||
27725256|NCT01262976|80826580|FG004|Up to Year 1|Other|2|||
27725257|NCT01262976|80826581|FG005|Up to Year 1|Other|1|||
27725258|NCT01262976|80826576|FG000|Up to Year 1|Subjects with unknown completion status|0|||
27725259|NCT01262976|80826577|FG001|Up to Year 1|Subjects with unknown completion status|0|||
27725260|NCT01262976|80826578|FG002|Up to Year 1|Subjects with unknown completion status|1|||
27725261|NCT01262976|80826579|FG003|Up to Year 1|Subjects with unknown completion status|0|||
27725262|NCT01262976|80826580|FG004|Up to Year 1|Subjects with unknown completion status|0|||
27725263|NCT01262976|80826581|FG005|Up to Year 1|Subjects with unknown completion status|1|||
27725264|NCT01262976|80826576|FG000|Up to Year 2|Serious Adverse Event|0|||
27725265|NCT01262976|80826577|FG001|Up to Year 2|Serious Adverse Event|0|||
27725266|NCT01262976|80826578|FG002|Up to Year 2|Serious Adverse Event|2|||
27725267|NCT01262976|80826579|FG003|Up to Year 2|Serious Adverse Event|0|||
27725268|NCT01262976|80826580|FG004|Up to Year 2|Serious Adverse Event|0|||
27725269|NCT01262976|80826581|FG005|Up to Year 2|Serious Adverse Event|0|||
27725270|NCT01262976|80826576|FG000|Up to Year 2|Withdrawal by Subject|1|||
27725271|NCT01262976|80826577|FG001|Up to Year 2|Withdrawal by Subject|0|||
27725272|NCT01262976|80826578|FG002|Up to Year 2|Withdrawal by Subject|0|||
27725273|NCT01262976|80826579|FG003|Up to Year 2|Withdrawal by Subject|0|||
27725274|NCT01262976|80826580|FG004|Up to Year 2|Withdrawal by Subject|0|||
27725275|NCT01262976|80826581|FG005|Up to Year 2|Withdrawal by Subject|0|||
27725276|NCT01262976|80826576|FG000|Up to Year 2|Migrated/moved from study area|0|||
27725277|NCT01262976|80826577|FG001|Up to Year 2|Migrated/moved from study area|0|||
27725278|NCT01262976|80826578|FG002|Up to Year 2|Migrated/moved from study area|0|||
27725279|NCT01262976|80826579|FG003|Up to Year 2|Migrated/moved from study area|2|||
27725280|NCT01262976|80826580|FG004|Up to Year 2|Migrated/moved from study area|1|||
27725281|NCT01262976|80826581|FG005|Up to Year 2|Migrated/moved from study area|2|||
27844602|NCT01640184|81260730|FG001|Overall Study|Physician Decision|0|||
27844603|NCT01640184|81260731|FG002|Overall Study|Physician Decision|0|||
27844604|NCT01640184|81260729|FG000|Overall Study|Withdrawal by Subject|0|||
27844605|NCT01640184|81260730|FG001|Overall Study|Withdrawal by Subject|1|||
27725282|NCT01262976|80826576|FG000|Up to Year 2|Lost to Follow-up|1|||
27725283|NCT01262976|80826577|FG001|Up to Year 2|Lost to Follow-up|1|||
27725284|NCT01262976|80826578|FG002|Up to Year 2|Lost to Follow-up|2|||
27844606|NCT01640184|81260731|FG002|Overall Study|Withdrawal by Subject|1|||
27844607|NCT01640184|81260729|FG000|Overall Study|Protocol Violation|0|||
27844608|NCT01640184|81260730|FG001|Overall Study|Protocol Violation|0|||
27844609|NCT01640184|81260731|FG002|Overall Study|Protocol Violation|1|||
27844610|NCT01841073|81260740|FG000|Overall Study|Adverse Event|1|||
27844611|NCT01841073|81260741|FG001|Overall Study|Adverse Event|1|||
27844612|NCT01841073|81260740|FG000|Overall Study|Physician Decision|1|||
27844613|NCT01841073|81260741|FG001|Overall Study|Physician Decision|0|||
27844614|NCT01841073|81260740|FG000|Overall Study|Lost to Follow-up|0|||
27844615|NCT01841073|81260741|FG001|Overall Study|Lost to Follow-up|2|||
27844616|NCT01765751|81260742|FG000|Overall Study|Lost to Follow-up|0|||
27844617|NCT01765751|81260743|FG001|Overall Study|Lost to Follow-up|2|||
27844618|NCT01765751|81260744|FG002|Overall Study|Lost to Follow-up|1|||
27844619|NCT03401073|81260749|FG000|Overall Study|Lost to Follow-up|1|||
27844620|NCT03401073|81260750|FG001|Overall Study|Lost to Follow-up|2|||
27844621|NCT02792218|81260756|FG000|Overall Study|Patient/guardian decision|15|||
27844622|NCT02792218|81260757|FG001|Overall Study|Patient/guardian decision|42|||
27893144|NCT02100670|81443960|FG000|Overall Study|Poor Efficacy|0|||
27893145|NCT02100670|81443961|FG001|Overall Study|Poor Efficacy|1|||
27893146|NCT02100670|81443962|FG002|Overall Study|Poor Efficacy|0|||
27893147|NCT02100670|81443963|FG003|Overall Study|Poor Efficacy|0|||
27893148|NCT02100670|81443960|FG000|Overall Study|Physician Decision|0|||
27893149|NCT02100670|81443961|FG001|Overall Study|Physician Decision|1|||
27893150|NCT02100670|81443962|FG002|Overall Study|Physician Decision|0|||
27893151|NCT02100670|81443963|FG003|Overall Study|Physician Decision|0|||
27893152|NCT02100670|81443960|FG000|Overall Study|Withdrawal by Subject|1|||
27893153|NCT02100670|81443961|FG001|Overall Study|Withdrawal by Subject|0|||
27893154|NCT02100670|81443962|FG002|Overall Study|Withdrawal by Subject|0|||
27893155|NCT02100670|81443963|FG003|Overall Study|Withdrawal by Subject|0|||
27893156|NCT03698994|81443965|FG000|Overall Study|Adverse Event|2|||
27893157|NCT03698994|81443965|FG000|Overall Study|Death|1|||
27893158|NCT03698994|81443965|FG000|Overall Study|Physician Decision|1|||
27893159|NCT03698994|81443965|FG000|Overall Study|Withdrawal by Subject|3|||
27893160|NCT03698994|81443965|FG000|Overall Study|Progressive Disease|12|||
27844623|NCT02792218|81260756|FG000|Overall Study|Adverse Event|15|||
27844624|NCT02792218|81260757|FG001|Overall Study|Adverse Event|14|||
27844625|NCT02792218|81260756|FG000|Overall Study|Lost to Follow-up|10|||
27844626|NCT02792218|81260757|FG001|Overall Study|Lost to Follow-up|5|||
27844627|NCT02792218|81260756|FG000|Overall Study|Lack of Efficacy|1|||
27844628|NCT02792218|81260757|FG001|Overall Study|Lack of Efficacy|12|||
27844629|NCT02792218|81260756|FG000|Overall Study|Physician Decision|4|||
27844630|NCT02792218|81260757|FG001|Overall Study|Physician Decision|4|||
27844631|NCT02792218|81260756|FG000|Overall Study|Protocol deviation|3|||
27844632|NCT02792218|81260757|FG001|Overall Study|Protocol deviation|2|||
27844633|NCT02792218|81260756|FG000|Overall Study|New therapy for study indication|0|||
27893161|NCT01096589|81443966|FG000|Overall Study|Adverse Event|2|||
27844634|NCT02792218|81260757|FG001|Overall Study|New therapy for study indication|1|||
27893162|NCT01096589|81443967|FG001|Overall Study|Adverse Event|1|||
27844635|NCT02792218|81260756|FG000|Overall Study|Non-compliance with study treatment|0|||
27844636|NCT02792218|81260757|FG001|Overall Study|Non-compliance with study treatment|1|||
27893163|NCT01096589|81443968|FG002|Overall Study|Adverse Event|2|||
27893164|NCT01096589|81443969|FG003|Overall Study|Adverse Event|1|||
27893165|NCT01096589|81443966|FG000|Overall Study|Withdrawal by Subject|2|||
27844637|NCT02792218|81260756|FG000|Overall Study|Pregnancy|1|||
27844638|NCT02792218|81260757|FG001|Overall Study|Pregnancy|0|||
27844639|NCT02485158|81260761|FG000|Overall Study|Withdrawal by Subject|3|||
27844640|NCT02485158|81260761|FG000|Overall Study|expected drug side effect|1|||
27844641|NCT00941720|81260764|FG000|Overall Study|Withdrawal by Subject|1|||
27844642|NCT00941720|81260764|FG000|Overall Study|Insurance denied participation|11|||
27844643|NCT00941720|81260764|FG000|Overall Study|ineligible|2|||
27844644|NCT02788513|81260765|FG000|Overall Study|Withdrawal by Subject|3|||
27844645|NCT02788513|81260766|FG001|Overall Study|Withdrawal by Subject|0|||
27844646|NCT02788513|81260767|FG002|Overall Study|Withdrawal by Subject|2|||
27844647|NCT02788513|81260768|FG003|Overall Study|Withdrawal by Subject|3|||
27844648|NCT02788513|81260769|FG004|Overall Study|Withdrawal by Subject|1|||
27844649|NCT02788513|81260765|FG000|Overall Study|Lost to Follow-up|1|||
27844650|NCT02788513|81260766|FG001|Overall Study|Lost to Follow-up|0|||
27844651|NCT02788513|81260767|FG002|Overall Study|Lost to Follow-up|0|||
27844652|NCT02788513|81260768|FG003|Overall Study|Lost to Follow-up|0|||
27844653|NCT02788513|81260769|FG004|Overall Study|Lost to Follow-up|1|||
27844654|NCT02788513|81260765|FG000|Overall Study|Adverse Event|5|||
27844655|NCT02788513|81260766|FG001|Overall Study|Adverse Event|8|||
27844656|NCT02788513|81260767|FG002|Overall Study|Adverse Event|4|||
27844657|NCT02788513|81260768|FG003|Overall Study|Adverse Event|2|||
27844658|NCT02788513|81260769|FG004|Overall Study|Adverse Event|2|||
27844659|NCT02788513|81260765|FG000|Overall Study|Protocol Violation|0|||
27844660|NCT02788513|81260766|FG001|Overall Study|Protocol Violation|0|||
27893166|NCT01096589|81443967|FG001|Overall Study|Withdrawal by Subject|1|||
27893167|NCT01096589|81443968|FG002|Overall Study|Withdrawal by Subject|1|||
27893168|NCT01096589|81443969|FG003|Overall Study|Withdrawal by Subject|1|||
27893169|NCT01096589|81443966|FG000|Overall Study|Compliance with protocol|0|||
27893170|NCT01096589|81443967|FG001|Overall Study|Compliance with protocol|0|||
27893171|NCT01096589|81443968|FG002|Overall Study|Compliance with protocol|1|||
27844661|NCT02788513|81260767|FG002|Overall Study|Protocol Violation|1|||
27844662|NCT02788513|81260768|FG003|Overall Study|Protocol Violation|1|||
27844663|NCT02788513|81260769|FG004|Overall Study|Protocol Violation|0|||
27844664|NCT02788513|81260765|FG000|Overall Study|Subject decided to stop taking treatment|0|||
27844665|NCT02788513|81260766|FG001|Overall Study|Subject decided to stop taking treatment|0|||
27844666|NCT02788513|81260767|FG002|Overall Study|Subject decided to stop taking treatment|1|||
27844667|NCT02788513|81260768|FG003|Overall Study|Subject decided to stop taking treatment|0|||
27844668|NCT02788513|81260769|FG004|Overall Study|Subject decided to stop taking treatment|0|||
27844669|NCT02788513|81260765|FG000|Overall Study|Decision by the study team|0|||
27844670|NCT02788513|81260766|FG001|Overall Study|Decision by the study team|0|||
27844671|NCT02788513|81260767|FG002|Overall Study|Decision by the study team|0|||
27844672|NCT02788513|81260768|FG003|Overall Study|Decision by the study team|0|||
27844673|NCT02788513|81260769|FG004|Overall Study|Decision by the study team|1|||
27844674|NCT01552369|81260770|FG000|Overall Study|Did not consent to extended follow up|8|||
27844675|NCT01552369|81260771|FG001|Overall Study|Did not consent to extended follow up|9|||
27844676|NCT00869440|81260773|FG000|Overall Study|Withdrawal by Subject|1|||
27844677|NCT00869440|81260774|FG001|Overall Study|Withdrawal by Subject|0|||
27844678|NCT00869440|81260775|FG002|Overall Study|Withdrawal by Subject|0|||
27844679|NCT00869440|81260776|FG003|Overall Study|Withdrawal by Subject|0|||
27844680|NCT00869440|81260773|FG000|Overall Study|Physician Decision|1|||
27844681|NCT00869440|81260774|FG001|Overall Study|Physician Decision|1|||
27844682|NCT00869440|81260775|FG002|Overall Study|Physician Decision|0|||
27893172|NCT01096589|81443969|FG003|Overall Study|Compliance with protocol|0|||
27844683|NCT00869440|81260776|FG003|Overall Study|Physician Decision|0|||
27893173|NCT01096589|81443966|FG000|Overall Study|found treatment exhausting|0|||
27893174|NCT01096589|81443967|FG001|Overall Study|found treatment exhausting|0|||
27844684|NCT01660022|81260780|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
27844685|NCT01660022|81260781|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
27844686|NCT01660022|81260782|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
27844687|NCT01660022|81260783|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
27893175|NCT01096589|81443968|FG002|Overall Study|found treatment exhausting|0|||
27725285|NCT01262976|80826579|FG003|Up to Year 2|Lost to Follow-up|2|||
27725286|NCT01262976|80826580|FG004|Up to Year 2|Lost to Follow-up|3|||
27725287|NCT01262976|80826581|FG005|Up to Year 2|Lost to Follow-up|3|||
27725288|NCT01262976|80826576|FG000|Up to Year 2|Subjects with unknown completion status|0|||
27725289|NCT01262976|80826577|FG001|Up to Year 2|Subjects with unknown completion status|0|||
27725290|NCT01262976|80826578|FG002|Up to Year 2|Subjects with unknown completion status|1|||
27725291|NCT01262976|80826579|FG003|Up to Year 2|Subjects with unknown completion status|0|||
27725292|NCT01262976|80826580|FG004|Up to Year 2|Subjects with unknown completion status|0|||
27725293|NCT01262976|80826581|FG005|Up to Year 2|Subjects with unknown completion status|0|||
27725294|NCT01262976|80826576|FG000|Up to Year 2|Other|3|||
27725295|NCT01262976|80826577|FG001|Up to Year 2|Other|0|||
27504638|NCT00538902|80040804|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
27504639|NCT00538902|80040805|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
27504640|NCT01409707|80040806|FG000|Overall Study|Withdrawal by Subject|5|||
27504641|NCT01409707|80040807|FG001|Overall Study|Withdrawal by Subject|17|||
27504642|NCT01409707|80040808|FG002|Overall Study|Withdrawal by Subject|16|||
27504643|NCT02691507|80040809|FG000|Overall Study|Missed Visit 3|0|||
27725296|NCT01262976|80826578|FG002|Up to Year 2|Other|0|||
27725297|NCT01262976|80826579|FG003|Up to Year 2|Other|0|||
27725298|NCT01262976|80826580|FG004|Up to Year 2|Other|0|||
27725299|NCT01262976|80826581|FG005|Up to Year 2|Other|0|||
27725300|NCT01262976|80826576|FG000|Up to Year 3|Serious Adverse Event|0|||
27725301|NCT01262976|80826577|FG001|Up to Year 3|Serious Adverse Event|0|||
27725302|NCT01262976|80826578|FG002|Up to Year 3|Serious Adverse Event|2|||
27725303|NCT01262976|80826579|FG003|Up to Year 3|Serious Adverse Event|0|||
27725304|NCT01262976|80826580|FG004|Up to Year 3|Serious Adverse Event|0|||
27725305|NCT01262976|80826581|FG005|Up to Year 3|Serious Adverse Event|0|||
27725306|NCT01262976|80826576|FG000|Up to Year 3|Withdrawal by Subject|1|||
27725307|NCT01262976|80826577|FG001|Up to Year 3|Withdrawal by Subject|0|||
27725308|NCT01262976|80826578|FG002|Up to Year 3|Withdrawal by Subject|0|||
27725309|NCT01262976|80826579|FG003|Up to Year 3|Withdrawal by Subject|0|||
27725310|NCT01262976|80826580|FG004|Up to Year 3|Withdrawal by Subject|0|||
27725311|NCT01262976|80826581|FG005|Up to Year 3|Withdrawal by Subject|0|||
27725312|NCT01262976|80826576|FG000|Up to Year 3|Migrated/moved from study area|0|||
27725313|NCT01262976|80826577|FG001|Up to Year 3|Migrated/moved from study area|0|||
27725314|NCT01262976|80826578|FG002|Up to Year 3|Migrated/moved from study area|0|||
27725315|NCT01262976|80826579|FG003|Up to Year 3|Migrated/moved from study area|2|||
27725316|NCT01262976|80826580|FG004|Up to Year 3|Migrated/moved from study area|1|||
27725317|NCT01262976|80826581|FG005|Up to Year 3|Migrated/moved from study area|1|||
27725318|NCT01262976|80826576|FG000|Up to Year 3|Lost to Follow-up|2|||
27725319|NCT01262976|80826577|FG001|Up to Year 3|Lost to Follow-up|2|||
27725320|NCT01262976|80826578|FG002|Up to Year 3|Lost to Follow-up|4|||
27725321|NCT01262976|80826579|FG003|Up to Year 3|Lost to Follow-up|3|||
27725322|NCT01262976|80826580|FG004|Up to Year 3|Lost to Follow-up|1|||
27725323|NCT01262976|80826581|FG005|Up to Year 3|Lost to Follow-up|3|||
27725324|NCT01262976|80826576|FG000|Up to Year 3|Subjects with unknown completion status|0|||
27725325|NCT01262976|80826577|FG001|Up to Year 3|Subjects with unknown completion status|0|||
27725326|NCT01262976|80826578|FG002|Up to Year 3|Subjects with unknown completion status|1|||
27725327|NCT01262976|80826579|FG003|Up to Year 3|Subjects with unknown completion status|0|||
27725328|NCT01262976|80826580|FG004|Up to Year 3|Subjects with unknown completion status|0|||
27725329|NCT01262976|80826581|FG005|Up to Year 3|Subjects with unknown completion status|0|||
27725330|NCT01262976|80826576|FG000|Up to Year 3|Other|3|||
27725331|NCT01262976|80826577|FG001|Up to Year 3|Other|0|||
27504644|NCT02691507|80040810|FG001|Overall Study|Missed Visit 3|1|||
27725332|NCT01262976|80826578|FG002|Up to Year 3|Other|0|||
27725333|NCT01262976|80826579|FG003|Up to Year 3|Other|0|||
27725334|NCT01262976|80826580|FG004|Up to Year 3|Other|0|||
27725335|NCT01262976|80826581|FG005|Up to Year 3|Other|0|||
27725336|NCT01046695|80826582|FG000|Overall Study|Subject had a pacemaker|0|||
27725337|NCT01046695|80826583|FG001|Overall Study|Subject had a pacemaker|1|||
27725338|NCT01046695|80826582|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
27725339|NCT01046695|80826583|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
27504645|NCT00696072|80040811|FG000|Overall Study|continuing active treatment|10|||
27504646|NCT00696072|80040812|FG001|Overall Study|continuing active treatment|13|||
27725340|NCT00705263|80826584|FG000|Overall Study|Withdrawal by Subject|2|||
27725341|NCT00996203|80826585|FG000|Overall Study|Adverse Event|3|||
27725342|NCT00996203|80826585|FG000|Overall Study|Lost to Follow-up|1|||
27725343|NCT00996203|80826585|FG000|Overall Study|Lack of Efficacy|1|||
27725344|NCT00996203|80826585|FG000|Overall Study|Protocol Violation|2|||
27504647|NCT00696072|80040811|FG000|Overall Study|Adverse Event|10|||
27504648|NCT00696072|80040812|FG001|Overall Study|Adverse Event|6|||
27725345|NCT00927368|80826586|FG000|Overall Study|enrollment in another study|1|||
27725346|NCT00927368|80826587|FG001|Overall Study|enrollment in another study|1|||
27504649|NCT00696072|80040811|FG000|Overall Study|Patient Request|3|||
27504650|NCT00696072|80040812|FG001|Overall Study|Patient Request|7|||
27504651|NCT00696072|80040811|FG000|Overall Study|Investigator Request|1|||
27504652|NCT00696072|80040812|FG001|Overall Study|Investigator Request|4|||
27504653|NCT00696072|80040811|FG000|Overall Study|Sponsor Request|0|||
27504654|NCT00696072|80040812|FG001|Overall Study|Sponsor Request|1|||
27725347|NCT00927368|80826588|FG002|Overall Study|enrollment in another study|2|||
27725348|NCT00927368|80826586|FG000|Overall Study|Lost to Follow-up|4|||
27725349|NCT00927368|80826587|FG001|Overall Study|Lost to Follow-up|0|||
27725350|NCT00927368|80826588|FG002|Overall Study|Lost to Follow-up|0|||
27725351|NCT00927368|80826586|FG000|Overall Study|equipment failure|1|||
27725352|NCT00927368|80826587|FG001|Overall Study|equipment failure|0|||
27725353|NCT00927368|80826588|FG002|Overall Study|equipment failure|0|||
27725354|NCT00927368|80826586|FG000|Overall Study|ineligible post randomization|0|||
27725355|NCT00927368|80826587|FG001|Overall Study|ineligible post randomization|3|||
27504655|NCT00696072|80040811|FG000|Overall Study|Disease Progression|32|||
27504656|NCT00696072|80040812|FG001|Overall Study|Disease Progression|30|||
27844688|NCT01660022|81260784|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
27725356|NCT00927368|80826588|FG002|Overall Study|ineligible post randomization|1|||
27725357|NCT00927368|80826586|FG000|Overall Study|cancellation of surgery|0|||
27844689|NCT01660022|81260785|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
27844690|NCT01660022|81260780|FG000|First Sequence (7 Days)|Adverse Event|0|||
27504657|NCT00696072|80040811|FG000|Overall Study|Non-specified|1|||
27504658|NCT00696072|80040812|FG001|Overall Study|Non-specified|2|||
27504659|NCT01972217|80040813|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
27504660|NCT01972217|80040814|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
27844691|NCT01660022|81260781|FG001|First Sequence (7 Days)|Adverse Event|0|||
27844692|NCT01660022|81260782|FG002|First Sequence (7 Days)|Adverse Event|0|||
27844693|NCT01660022|81260783|FG003|First Sequence (7 Days)|Adverse Event|0|||
27844694|NCT01660022|81260784|FG004|First Sequence (7 Days)|Adverse Event|1|||
27844695|NCT01660022|81260785|FG005|First Sequence (7 Days)|Adverse Event|3|||
27844696|NCT01660022|81260780|FG000|First Sequence (7 Days)|Protocol Violation|0|||
27844697|NCT01660022|81260781|FG001|First Sequence (7 Days)|Protocol Violation|0|||
27844698|NCT01660022|81260782|FG002|First Sequence (7 Days)|Protocol Violation|0|||
27844699|NCT01660022|81260783|FG003|First Sequence (7 Days)|Protocol Violation|0|||
27844700|NCT01660022|81260784|FG004|First Sequence (7 Days)|Protocol Violation|0|||
27844701|NCT01660022|81260785|FG005|First Sequence (7 Days)|Protocol Violation|1|||
27844702|NCT00996437|81260793|FG000|Overall Study|Death|1|||
27844703|NCT00996437|81260794|FG001|Overall Study|Death|0|||
27844704|NCT00996437|81260793|FG000|Overall Study|Dropped|2|||
27844705|NCT00996437|81260794|FG001|Overall Study|Dropped|2|||
27844706|NCT00996437|81260793|FG000|Overall Study|Missed|2|||
27844707|NCT00996437|81260794|FG001|Overall Study|Missed|5|||
27844708|NCT02415387|81260797|FG000|Overall Study|Withdrawal by Subject|6|||
27844709|NCT02415387|81260798|FG001|Overall Study|Withdrawal by Subject|1|||
27844710|NCT02415387|81260797|FG000|Overall Study|blood draw problem|0|||
27844711|NCT02415387|81260798|FG001|Overall Study|blood draw problem|1|||
27844712|NCT02415387|81260797|FG000|Overall Study|Protocol Violation|1|||
27844713|NCT02415387|81260798|FG001|Overall Study|Protocol Violation|0|||
27844714|NCT01083680|81260799|FG000|Overall Study|Lost to Follow-up|2758|||
27844715|NCT01083680|81260799|FG000|Overall Study|Withdrawal by Subject|1086|||
27844716|NCT02674633|81260803|FG000|Overall Study|Lost to Follow-up|3|||
27844717|NCT02674633|81260804|FG001|Overall Study|Lost to Follow-up|2|||
27844718|NCT02674633|81260803|FG000|Overall Study|Physician Decision|1|||
27844719|NCT02674633|81260804|FG001|Overall Study|Physician Decision|0|||
27844720|NCT02674633|81260803|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27844721|NCT02674633|81260804|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27844722|NCT00894933|81260805|FG000|Overall Study|Lost to Follow-up|2|||
27844723|NCT00894933|81260805|FG000|Overall Study|Cancelled Procedure|1|||
27844724|NCT00894933|81260805|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
27844725|NCT00605917|81260806|FG000|Overall Study|Protocol Violation|79|||
27844726|NCT00685802|81260809|FG000|Washout Period of 7 Days|Protocol Violation|2|||
27844727|NCT00685802|81260810|FG001|Washout Period of 7 Days|Protocol Violation|0|||
27844728|NCT00685802|81260809|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27844729|NCT00685802|81260810|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27844730|NCT00104247|81260816|FG000|Overall Study|Withdrawal by Subject|1|||
27844731|NCT00104247|81260817|FG001|Overall Study|Withdrawal by Subject|0|||
27844732|NCT00104247|81260816|FG000|Overall Study|Noncompliant with dosing|0|||
27844733|NCT00104247|81260817|FG001|Overall Study|Noncompliant with dosing|1|||
27844734|NCT00707434|81260818|FG000|Overall Study|Adverse Event|1|||
27844735|NCT04276935|81260819|FG000|Overall Study|Lost to Follow-up|3|||
27844736|NCT02278718|81260825|FG000|Overall Study|Adverse Event|1|||
27844737|NCT02278718|81260826|FG001|Overall Study|Adverse Event|0|||
27844738|NCT02278718|81260825|FG000|Overall Study|Lost to Follow-up|2|||
27844739|NCT02278718|81260826|FG001|Overall Study|Lost to Follow-up|4|||
27844740|NCT02278718|81260825|FG000|Overall Study|Withdrawal by Subject|1|||
27844741|NCT02278718|81260826|FG001|Overall Study|Withdrawal by Subject|4|||
27844742|NCT02278718|81260825|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
27844743|NCT02278718|81260826|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
27844744|NCT02278718|81260825|FG000|Overall Study|Missing|0|||
27844745|NCT02278718|81260826|FG001|Overall Study|Missing|1|||
27844746|NCT00567476|81260827|FG000|Overall Study|Adverse Event|2|||
27844747|NCT00567476|81260828|FG001|Overall Study|Adverse Event|0|||
27844748|NCT00567476|81260827|FG000|Overall Study|Pregnancy|1|||
27844749|NCT00567476|81260828|FG001|Overall Study|Pregnancy|0|||
27844750|NCT00567476|81260827|FG000|Overall Study|Protocol Violation|4|||
27844751|NCT00567476|81260828|FG001|Overall Study|Protocol Violation|1|||
27844752|NCT00567476|81260827|FG000|Overall Study|Lost to Follow-up|0|||
27844753|NCT00567476|81260828|FG001|Overall Study|Lost to Follow-up|1|||
27844754|NCT00567476|81260827|FG000|Overall Study|Administrative issues|1|||
27844755|NCT00567476|81260828|FG001|Overall Study|Administrative issues|0|||
27844756|NCT00567476|81260827|FG000|Overall Study|Medical Decision|0|||
27844757|NCT00567476|81260828|FG001|Overall Study|Medical Decision|1|||
27844758|NCT00567476|81260827|FG000|Overall Study|Non-adherence to protocol|0|||
27844759|NCT00567476|81260828|FG001|Overall Study|Non-adherence to protocol|1|||
27844760|NCT02508116|81260829|FG000|Overall Study|Lost to Follow-up|2|||
27844761|NCT02508116|81260830|FG001|Overall Study|Lost to Follow-up|3|||
27844762|NCT02508116|81260829|FG000|Overall Study|Withdrawal by Subject|3|||
27844763|NCT02508116|81260830|FG001|Overall Study|Withdrawal by Subject|2|||
27844764|NCT02508116|81260829|FG000|Overall Study|Protocol Violation|1|||
27844765|NCT02508116|81260830|FG001|Overall Study|Protocol Violation|2|||
27844766|NCT02508116|81260829|FG000|Overall Study|Physician Decision|2|||
27844767|NCT02508116|81260830|FG001|Overall Study|Physician Decision|0|||
27844768|NCT00942331|81260831|FG000|Overall Study|Did not start treatment|15|||
27844769|NCT00942331|81260832|FG001|Overall Study|Did not start treatment|22|||
27844770|NCT01961882|81260833|FG000|Overall Study|Adverse Event|3|||
27844771|NCT01961882|81260834|FG001|Overall Study|Adverse Event|2|||
27504661|NCT01972217|80040815|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
27504662|NCT01972217|80040816|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
27504663|NCT01972217|80040813|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
27504664|NCT01972217|80040814|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
27504665|NCT01972217|80040815|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
27504666|NCT01972217|80040816|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
27504667|NCT01972217|80040813|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
27504668|NCT01972217|80040814|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
27504669|NCT01972217|80040815|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
27504670|NCT01972217|80040816|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
27504671|NCT01972217|80040813|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
27504672|NCT01972217|80040814|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
27504673|NCT01972217|80040815|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
27725358|NCT00927368|80826587|FG001|Overall Study|cancellation of surgery|1|||
27725359|NCT00927368|80826588|FG002|Overall Study|cancellation of surgery|2|||
27725360|NCT02848833|80826589|FG000|Overall Study|subject who are duplicated|1|||
27504674|NCT01972217|80040816|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
27725361|NCT02848833|80826589|FG000|Overall Study|have not taken the study drug|11|||
27725362|NCT02848833|80826589|FG000|Overall Study|follow-up failure|6|||
27504675|NCT01972217|80040813|FG000|Part B Double-blind, Randomised Period|Death|0|||
27504676|NCT01972217|80040814|FG001|Part B Double-blind, Randomised Period|Death|0|||
27725363|NCT02848833|80826589|FG000|Overall Study|Protocol Violation|119|||
27844772|NCT01961882|81260833|FG000|Overall Study|Physician Decision|1|||
27844773|NCT01961882|81260834|FG001|Overall Study|Physician Decision|0|||
27844774|NCT01961882|81260833|FG000|Overall Study|Withdrawal by Subject|4|||
27844775|NCT01961882|81260834|FG001|Overall Study|Withdrawal by Subject|1|||
27844776|NCT01961882|81260833|FG000|Overall Study|Relapse of AML|39|||
27844777|NCT01961882|81260834|FG001|Overall Study|Relapse of AML|37|||
27844778|NCT01961882|81260833|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
27844779|NCT01961882|81260834|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
27844780|NCT01961882|81260833|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
27844781|NCT01961882|81260834|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
27844782|NCT01915940|81260835|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
27844783|NCT01915940|81260836|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
27844784|NCT01915940|81260837|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
27844785|NCT01915940|81260835|FG000|Treatment Period|Decision of Participant|0|||
27844786|NCT01915940|81260836|FG001|Treatment Period|Decision of Participant|1|||
27844787|NCT01915940|81260837|FG002|Treatment Period|Decision of Participant|3|||
27844788|NCT01915940|81260835|FG000|Treatment Period|Adverse Event|0|||
27844789|NCT01915940|81260836|FG001|Treatment Period|Adverse Event|9|||
27844790|NCT01915940|81260837|FG002|Treatment Period|Adverse Event|1|||
27844791|NCT01915940|81260835|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
27844792|NCT01915940|81260836|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
27844793|NCT01915940|81260837|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
27844794|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
27844795|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844796|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844797|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844798|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844799|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844800|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844801|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844802|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
27844803|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
27844804|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844805|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844806|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844807|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844808|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844809|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844810|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844811|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
27844812|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
27844813|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844814|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844815|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844816|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844817|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844818|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844819|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844820|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
27844821|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
27844822|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844823|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844824|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844825|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844826|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844827|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844828|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844829|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
27844830|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
27844831|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844832|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844833|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844834|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844835|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844836|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844837|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844838|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
27844839|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
27844840|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844841|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844842|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844843|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844844|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844845|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844846|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844847|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
27844848|NCT00739973|81260840|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
27844849|NCT00739973|81260841|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844850|NCT00739973|81260842|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844851|NCT00739973|81260843|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844852|NCT00739973|81260844|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844853|NCT00739973|81260845|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844854|NCT00739973|81260846|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844855|NCT00739973|81260847|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844856|NCT00739973|81260848|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
27844857|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
27844858|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
27844859|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
27844860|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
27844861|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
27844862|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
27844863|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
27844864|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
27844865|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
27844866|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27844867|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27844868|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27844869|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27844870|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
27844871|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27893176|NCT01096589|81443969|FG003|Overall Study|found treatment exhausting|1|||
27893177|NCT02600845|81443970|FG000|Overall Study|Reason Not Specified|3|||
27893178|NCT02600845|81443970|FG000|Overall Study|Non-compliance with Study Procedures|10|||
27893179|NCT02600845|81443970|FG000|Overall Study|Consent Withdrawal|5|||
27893180|NCT00386425|81443973|FG000|Overall Study|Physician Decision|3|||
27893181|NCT00386425|81443974|FG001|Overall Study|Physician Decision|0|||
27504677|NCT01972217|80040815|FG002|Part B Double-blind, Randomised Period|Death|43|||
27504678|NCT01972217|80040816|FG003|Part B Double-blind, Randomised Period|Death|44|||
27504679|NCT01972217|80040813|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
27504680|NCT01972217|80040814|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
27504681|NCT01972217|80040815|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
27504682|NCT01972217|80040816|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
27504683|NCT01972217|80040813|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
27504684|NCT01972217|80040814|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
27504685|NCT01972217|80040815|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
27504686|NCT01972217|80040816|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
27504687|NCT01972217|80040813|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
27504688|NCT01972217|80040814|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
27504689|NCT01972217|80040815|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
27504690|NCT01972217|80040816|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
27504691|NCT01972217|80040813|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
27504692|NCT01972217|80040814|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
27504693|NCT01972217|80040815|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
27504694|NCT01972217|80040816|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
27725364|NCT00110019|80826590|FG000|Overall Study|Lack of Efficacy|253|||
27725365|NCT00110019|80826591|FG001|Overall Study|Lack of Efficacy|285|||
27725366|NCT00110019|80826590|FG000|Overall Study|Adverse Event|61|||
27725367|NCT00110019|80826591|FG001|Overall Study|Adverse Event|40|||
27725368|NCT00110019|80826590|FG000|Overall Study|Death|13|||
27893182|NCT00386425|81443975|FG002|Overall Study|Physician Decision|0|||
27893183|NCT00386425|81443973|FG000|Overall Study|Withdrawal by Subject|0|||
27725369|NCT00110019|80826591|FG001|Overall Study|Death|15|||
27725370|NCT00110019|80826590|FG000|Overall Study|Withdrawal by Subject|21|||
27725371|NCT00110019|80826591|FG001|Overall Study|Withdrawal by Subject|9|||
27725372|NCT00110019|80826590|FG000|Overall Study|alternative therapy|5|||
27725373|NCT00110019|80826591|FG001|Overall Study|alternative therapy|1|||
27725374|NCT00110019|80826590|FG000|Overall Study|complicating disease|1|||
27725375|NCT00110019|80826591|FG001|Overall Study|complicating disease|1|||
27725376|NCT00110019|80826590|FG000|Overall Study|symptom deterioration|13|||
27725377|NCT00110019|80826591|FG001|Overall Study|symptom deterioration|16|||
27725378|NCT00110019|80826590|FG000|Overall Study|Not start protocol therapy|17|||
27725379|NCT00110019|80826591|FG001|Overall Study|Not start protocol therapy|16|||
27504695|NCT01838694|80040819|FG000|Overall Study|Adverse Event|0|||
27725380|NCT00110019|80826590|FG000|Overall Study|other reasons|22|||
27725381|NCT00110019|80826591|FG001|Overall Study|other reasons|30|||
27725382|NCT00956943|80826592|FG000|Overall Study|Lost to Follow-up|9|||
27725383|NCT00956943|80826593|FG001|Overall Study|Lost to Follow-up|10|||
27725384|NCT03093155|80826594|FG000|Overall Study|Not Eligible|1|||
27725385|NCT03093155|80826595|FG001|Overall Study|Not Eligible|0|||
27725386|NCT03093155|80826594|FG000|Overall Study|Withdrawal by Subject|0|||
27725387|NCT03093155|80826595|FG001|Overall Study|Withdrawal by Subject|1|||
27725388|NCT02723201|80826599|FG000|Second Intervention Period|Protocol Violation|1|||
27725389|NCT02723201|80826600|FG001|Second Intervention Period|Protocol Violation|0|||
27725390|NCT02723201|80826601|FG002|Second Intervention Period|Protocol Violation|0|||
27725391|NCT02723201|80826599|FG000|Second Intervention Period|Adverse Event|1|||
27725392|NCT02723201|80826600|FG001|Second Intervention Period|Adverse Event|0|||
27725393|NCT02723201|80826601|FG002|Second Intervention Period|Adverse Event|0|||
27725394|NCT03653390|80826602|FG000|Overall Study|Lost to Follow-up|12|||
27725395|NCT03653390|80826603|FG001|Overall Study|Lost to Follow-up|8|||
27725396|NCT03653390|80826604|FG002|Overall Study|Lost to Follow-up|7|||
27725397|NCT03653390|80826602|FG000|Overall Study|Withdrawal by Subject|6|||
27725398|NCT03653390|80826603|FG001|Overall Study|Withdrawal by Subject|1|||
27725399|NCT03653390|80826604|FG002|Overall Study|Withdrawal by Subject|1|||
27725400|NCT03653390|80826602|FG000|Overall Study|Death|1|||
27725401|NCT03653390|80826603|FG001|Overall Study|Death|0|||
27725402|NCT03653390|80826604|FG002|Overall Study|Death|0|||
27725403|NCT03653390|80826602|FG000|Overall Study|Paper Survey Lost|1|||
27844872|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27844873|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
27844874|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
27844875|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
27844876|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
27844877|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844878|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844879|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844880|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844881|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844882|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844883|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
27844884|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
27844885|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
27844886|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
27844887|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
27844888|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
27893184|NCT00386425|81443974|FG001|Overall Study|Withdrawal by Subject|1|||
27893185|NCT00386425|81443975|FG002|Overall Study|Withdrawal by Subject|0|||
27893186|NCT00474786|81443976|FG000|Overall Study|Not Meeting Study Criteria|0|||
27893187|NCT00474786|81443977|FG001|Overall Study|Not Meeting Study Criteria|1|||
27893188|NCT00474786|81443976|FG000|Overall Study|Investigator Request|2|||
27893189|NCT00474786|81443977|FG001|Overall Study|Investigator Request|1|||
27893190|NCT00474786|81443976|FG000|Overall Study|Death|189|||
27893191|NCT00474786|81443977|FG001|Overall Study|Death|170|||
27893192|NCT00474786|81443976|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
27893193|NCT00474786|81443977|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
27893194|NCT00474786|81443976|FG000|Overall Study|Lost to Follow-up|4|||
27893195|NCT00474786|81443977|FG001|Overall Study|Lost to Follow-up|7|||
27893196|NCT00474786|81443976|FG000|Overall Study|Protocol Violation|2|||
27893197|NCT00474786|81443977|FG001|Overall Study|Protocol Violation|0|||
27893198|NCT00474786|81443976|FG000|Overall Study|Withdrawal by Subject|15|||
27893199|NCT00474786|81443977|FG001|Overall Study|Withdrawal by Subject|15|||
27893200|NCT00474786|81443976|FG000|Overall Study|Other|5|||
27893201|NCT00474786|81443977|FG001|Overall Study|Other|0|||
27893202|NCT02017912|81443983|FG000|Overall Study|Withdrawal by Subject|2|||
27725404|NCT03653390|80826603|FG001|Overall Study|Paper Survey Lost|0|||
27725405|NCT03653390|80826604|FG002|Overall Study|Paper Survey Lost|0|||
27725406|NCT00706030|80826605|FG000|Overall Study|Disease Progression|4|||
27725407|NCT00706030|80826606|FG001|Overall Study|Disease Progression|6|||
27725408|NCT00706030|80826607|FG002|Overall Study|Disease Progression|46|||
27725409|NCT00706030|80826608|FG003|Overall Study|Disease Progression|12|||
27844889|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
27893203|NCT02017912|81443984|FG001|Overall Study|Withdrawal by Subject|1|||
27893204|NCT02017912|81443983|FG000|Overall Study|miscellaneous|1|||
27725410|NCT00706030|80826605|FG000|Overall Study|Adverse Event|1|||
27725411|NCT00706030|80826606|FG001|Overall Study|Adverse Event|0|||
27504696|NCT01838694|80040820|FG001|Overall Study|Adverse Event|1|||
27504697|NCT03085095|80040824|FG000|Overall Study|Adverse Event|23|||
27504698|NCT03085095|80040825|FG001|Overall Study|Adverse Event|8|||
27504699|NCT03085095|80040824|FG000|Overall Study|Protocol Violation|0|||
27504700|NCT03085095|80040825|FG001|Overall Study|Protocol Violation|1|||
27504701|NCT03085095|80040824|FG000|Overall Study|Lost to Follow-up|2|||
27504702|NCT03085095|80040825|FG001|Overall Study|Lost to Follow-up|1|||
27504703|NCT03085095|80040824|FG000|Overall Study|Withdrawal by Subject|17|||
27504704|NCT03085095|80040825|FG001|Overall Study|Withdrawal by Subject|6|||
27504705|NCT03085095|80040824|FG000|Overall Study|Physician Decision|9|||
27504706|NCT03085095|80040825|FG001|Overall Study|Physician Decision|3|||
27504707|NCT03085095|80040824|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
27504708|NCT03085095|80040825|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
27504709|NCT03085095|80040824|FG000|Overall Study|Did not Receive Study Drug|2|||
27504710|NCT03085095|80040825|FG001|Overall Study|Did not Receive Study Drug|2|||
27504711|NCT03085095|80040824|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
27504712|NCT03085095|80040825|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
27504713|NCT00248625|80040830|FG000|Overall Study|Withdrawal by Subject|0|||
27504714|NCT00248625|80040831|FG001|Overall Study|Withdrawal by Subject|2|||
27504715|NCT04730804|80040834|FG000|Overall Study|Physician Decision|0|||
27504716|NCT04730804|80040835|FG001|Overall Study|Physician Decision|0|||
27504717|NCT04730804|80040836|FG002|Overall Study|Physician Decision|0|||
27504718|NCT04730804|80040837|FG003|Overall Study|Physician Decision|0|||
27504719|NCT04730804|80040838|FG004|Overall Study|Physician Decision|0|||
27504720|NCT04730804|80040839|FG005|Overall Study|Physician Decision|1|||
27504721|NCT04730804|80040834|FG000|Overall Study|Withdrawal by Subject|0|||
27504722|NCT04730804|80040835|FG001|Overall Study|Withdrawal by Subject|0|||
27504723|NCT04730804|80040836|FG002|Overall Study|Withdrawal by Subject|0|||
27504724|NCT04730804|80040837|FG003|Overall Study|Withdrawal by Subject|0|||
27504725|NCT04730804|80040838|FG004|Overall Study|Withdrawal by Subject|1|||
27504726|NCT04730804|80040839|FG005|Overall Study|Withdrawal by Subject|2|||
27504727|NCT01586364|80040840|FG000|Overall Study|Withdrawal by Subject|40|||
27504728|NCT01586364|80040840|FG000|Overall Study|Adverse Event|37|||
27504729|NCT01586364|80040840|FG000|Overall Study|Lost to Follow-up|17|||
27504730|NCT01586364|80040840|FG000|Overall Study|Protocol Violation|16|||
27504731|NCT01586364|80040840|FG000|Overall Study|Lack of Efficacy|1|||
27504732|NCT01586364|80040840|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
27504733|NCT01586364|80040840|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
27504734|NCT01586364|80040840|FG000|Overall Study|Other-Site closure due to PI illness|1|||
27504735|NCT01586364|80040840|FG000|Overall Study|Other-PI discretion, site closing|2|||
27504736|NCT01586364|80040840|FG000|Overall Study|Other-Not specified|1|||
27504737|NCT04774094|80040843|FG000|Overall Study|Other|2|||
27504738|NCT04774094|80040843|FG000|Overall Study|Withdrawal by Subject|9|||
27504739|NCT04774094|80040843|FG000|Overall Study|Lost to Follow-up|7|||
27504740|NCT04774094|80040843|FG000|Overall Study|Lack of Efficacy|5|||
27504741|NCT04774094|80040843|FG000|Overall Study|Death|17|||
27504742|NCT04774094|80040843|FG000|Overall Study|Adverse Event|4|||
27504743|NCT03895203|80040847|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
27504744|NCT03895203|80040848|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
27504745|NCT03895203|80040849|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
27504746|NCT03895203|80040850|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
27504747|NCT03895203|80040851|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
27504748|NCT03895203|80040852|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
27504749|NCT03895203|80040847|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
27504750|NCT03895203|80040848|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
27504751|NCT03895203|80040849|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
27504752|NCT03895203|80040850|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
27504753|NCT03895203|80040851|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
27504754|NCT03895203|80040852|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
27504755|NCT03895203|80040847|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
27504756|NCT03895203|80040848|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
27504757|NCT03895203|80040849|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
27504758|NCT03895203|80040850|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
27844890|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
27504759|NCT03895203|80040851|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
27504760|NCT03895203|80040852|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
27504761|NCT03895203|80040847|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
27504762|NCT03895203|80040848|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
27504763|NCT03895203|80040849|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
27504764|NCT03895203|80040850|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
27504765|NCT03895203|80040851|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
27844891|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
27725412|NCT00706030|80826607|FG002|Overall Study|Adverse Event|4|||
27725413|NCT00706030|80826608|FG003|Overall Study|Adverse Event|2|||
27725414|NCT00706030|80826605|FG000|Overall Study|Withdrawal by Subject|1|||
27725415|NCT00706030|80826606|FG001|Overall Study|Withdrawal by Subject|0|||
27504766|NCT03895203|80040852|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
27504767|NCT03895203|80040847|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
27725416|NCT00706030|80826607|FG002|Overall Study|Withdrawal by Subject|2|||
27725417|NCT00706030|80826608|FG003|Overall Study|Withdrawal by Subject|0|||
27725418|NCT00706030|80826605|FG000|Overall Study|Physician Decision|0|||
27725419|NCT00706030|80826606|FG001|Overall Study|Physician Decision|0|||
27725420|NCT00706030|80826607|FG002|Overall Study|Physician Decision|2|||
27725421|NCT00706030|80826608|FG003|Overall Study|Physician Decision|0|||
27725422|NCT00706030|80826605|FG000|Overall Study|Not recorded|0|||
27725423|NCT00706030|80826606|FG001|Overall Study|Not recorded|0|||
27725424|NCT00706030|80826607|FG002|Overall Study|Not recorded|2|||
27725425|NCT00706030|80826608|FG003|Overall Study|Not recorded|0|||
27725426|NCT00706030|80826605|FG000|Overall Study|Protocol Violation|0|||
27725427|NCT00706030|80826606|FG001|Overall Study|Protocol Violation|0|||
27725428|NCT00706030|80826607|FG002|Overall Study|Protocol Violation|1|||
27725429|NCT00706030|80826608|FG003|Overall Study|Protocol Violation|1|||
27725430|NCT00706030|80826605|FG000|Overall Study|Failed to return|0|||
27725431|NCT00706030|80826606|FG001|Overall Study|Failed to return|0|||
27725432|NCT00706030|80826607|FG002|Overall Study|Failed to return|1|||
27725433|NCT00706030|80826608|FG003|Overall Study|Failed to return|0|||
27725434|NCT00706030|80826605|FG000|Overall Study|Symptomatic Deterioration|0|||
27725435|NCT00706030|80826606|FG001|Overall Study|Symptomatic Deterioration|0|||
27725436|NCT00706030|80826607|FG002|Overall Study|Symptomatic Deterioration|1|||
27725437|NCT00706030|80826608|FG003|Overall Study|Symptomatic Deterioration|0|||
27725438|NCT00706030|80826605|FG000|Overall Study|No treatment received|0|||
27725439|NCT00706030|80826606|FG001|Overall Study|No treatment received|0|||
27725440|NCT00706030|80826607|FG002|Overall Study|No treatment received|0|||
27725441|NCT00706030|80826608|FG003|Overall Study|No treatment received|1|||
27725442|NCT00706030|80826605|FG000|Overall Study|Death|0|||
27725443|NCT00706030|80826606|FG001|Overall Study|Death|0|||
27725444|NCT00706030|80826607|FG002|Overall Study|Death|1|||
27725445|NCT00706030|80826608|FG003|Overall Study|Death|0|||
27725446|NCT00630331|80826609|FG000|Overall Study|Death|2|||
27725447|NCT00630331|80826610|FG001|Overall Study|Death|1|||
27725448|NCT00630331|80826611|FG002|Overall Study|Death|1|||
27725449|NCT00630331|80826609|FG000|Overall Study|Adverse Event|1|||
27725450|NCT00630331|80826610|FG001|Overall Study|Adverse Event|0|||
27725451|NCT00630331|80826611|FG002|Overall Study|Adverse Event|0|||
27725452|NCT00630331|80826609|FG000|Overall Study|Withdrawal by Subject|12|||
27725453|NCT00630331|80826610|FG001|Overall Study|Withdrawal by Subject|7|||
27725454|NCT00630331|80826611|FG002|Overall Study|Withdrawal by Subject|5|||
27725455|NCT00630331|80826609|FG000|Overall Study|Lost to Follow-up|175|||
27725456|NCT00630331|80826610|FG001|Overall Study|Lost to Follow-up|143|||
27725457|NCT00630331|80826611|FG002|Overall Study|Lost to Follow-up|170|||
27725458|NCT00630331|80826609|FG000|Overall Study|Inappropriate enrollment|3|||
27725459|NCT00630331|80826610|FG001|Overall Study|Inappropriate enrollment|6|||
27725460|NCT00630331|80826611|FG002|Overall Study|Inappropriate enrollment|3|||
27725461|NCT00630331|80826609|FG000|Overall Study|Unable to classify|9|||
27725462|NCT00630331|80826610|FG001|Overall Study|Unable to classify|4|||
27725463|NCT00630331|80826611|FG002|Overall Study|Unable to classify|3|||
27725464|NCT00630331|80826609|FG000|Overall Study|Protocol Violation|4|||
27725465|NCT00630331|80826610|FG001|Overall Study|Protocol Violation|5|||
27725466|NCT00630331|80826611|FG002|Overall Study|Protocol Violation|6|||
27725467|NCT02899156|80826612|FG000|Overall Study|Death|1|||
27725468|NCT02899156|80826613|FG001|Overall Study|Death|0|||
27725469|NCT02899156|80826612|FG000|Overall Study|Physician Decision|0|||
27725470|NCT02899156|80826613|FG001|Overall Study|Physician Decision|1|||
27725471|NCT01194440|80826614|FG000|Baseline (First Dose)|Reason not specified|4|||
27893205|NCT02017912|81443984|FG001|Overall Study|miscellaneous|1|||
27893206|NCT02703272|81443985|FG000|Overall Study|Death|4|||
27725472|NCT01194440|80826614|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
27725473|NCT01194440|80826614|FG000|Baseline (First Dose)|Change in therapy|1|||
27725474|NCT01194440|80826614|FG000|Baseline (First Dose)|Adverse Event|1|||
27725475|NCT01194440|80826614|FG000|6-months (2nd Dose)|Change in therapy|4|||
27725476|NCT00234039|80826618|FG000|Overall Study|Adverse Event|2|||
27725477|NCT00234039|80826618|FG000|Overall Study|Progression/relapse|34|||
27725478|NCT00234039|80826618|FG000|Overall Study|Other - Not Protocol Specified|3|||
27725479|NCT00234039|80826618|FG000|Overall Study|Ineligible|9|||
27725480|NCT00234039|80826618|FG000|Overall Study|No Protocol Treatment Received|2|||
27725481|NCT04640766|80826619|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
27725482|NCT01327651|80826620|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
27725483|NCT01327651|80826621|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
27725484|NCT01327651|80826622|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
27725485|NCT01327651|80826623|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
27504768|NCT03895203|80040848|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
27504769|NCT03895203|80040849|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
27613598|NCT04022889|80426703|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
27844892|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
27844893|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844894|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844895|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
27844896|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844897|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844898|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844899|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844900|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844901|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
27844902|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
27844903|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
27844904|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
27844905|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
27844906|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
27844907|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
27844908|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
27844909|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
27893207|NCT02703272|81443986|FG001|Overall Study|Death|9|||
27893208|NCT02703272|81443987|FG002|Overall Study|Death|19|||
27893209|NCT02703272|81443988|FG003|Overall Study|Death|10|||
27893210|NCT02703272|81443985|FG000|Overall Study|Withdrawal by Subject|0|||
27893211|NCT02703272|81443986|FG001|Overall Study|Withdrawal by Subject|0|||
27893212|NCT02703272|81443987|FG002|Overall Study|Withdrawal by Subject|4|||
27893213|NCT02703272|81443988|FG003|Overall Study|Withdrawal by Subject|2|||
27613599|NCT04022889|80426701|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
27613600|NCT04022889|80426702|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
27893214|NCT02703272|81443985|FG000|Overall Study|Study Terminated by Sponsor|6|||
27893215|NCT02703272|81443986|FG001|Overall Study|Study Terminated by Sponsor|1|||
27893216|NCT02703272|81443987|FG002|Overall Study|Study Terminated by Sponsor|12|||
27893217|NCT02703272|81443988|FG003|Overall Study|Study Terminated by Sponsor|4|||
27893218|NCT02703272|81443985|FG000|Overall Study|Other|1|||
27893219|NCT02703272|81443986|FG001|Overall Study|Other|0|||
27893220|NCT02703272|81443987|FG002|Overall Study|Other|0|||
27893221|NCT02703272|81443988|FG003|Overall Study|Other|0|||
27893222|NCT03687372|81443994|FG000|Overall Study|Lost to Follow-up|12|||
27893223|NCT03687372|81443995|FG001|Overall Study|Lost to Follow-up|21|||
27893224|NCT03687372|81443994|FG000|Overall Study|Withdrawal by Subject|4|||
27893225|NCT03687372|81443995|FG001|Overall Study|Withdrawal by Subject|17|||
27893226|NCT03687372|81443994|FG000|Overall Study|Investigator Decision|1|||
27893227|NCT03687372|81443995|FG001|Overall Study|Investigator Decision|1|||
27893228|NCT03729570|81443996|FG000|Overall Study|Lost to Follow-up|16|||
27893229|NCT03729570|81443997|FG001|Overall Study|Lost to Follow-up|20|||
27893230|NCT03729570|81443996|FG000|Overall Study|Seroconversion|5|||
27893231|NCT03729570|81443997|FG001|Overall Study|Seroconversion|0|||
27504770|NCT03895203|80040850|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
27504771|NCT03895203|80040851|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
27725486|NCT01327651|80826624|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
27725487|NCT01327651|80826625|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
27725488|NCT01327651|80826626|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
27725489|NCT01327651|80826627|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
27725490|NCT01327651|80826628|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
27725491|NCT01327651|80826620|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
27725492|NCT01327651|80826621|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725493|NCT01327651|80826622|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725494|NCT01327651|80826623|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725495|NCT01327651|80826624|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725496|NCT01327651|80826625|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725497|NCT01327651|80826626|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725498|NCT01327651|80826627|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725499|NCT01327651|80826628|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
27725500|NCT01327651|80826620|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
27725501|NCT01327651|80826621|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
27725502|NCT01327651|80826622|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
27725503|NCT01327651|80826623|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
27725504|NCT01327651|80826624|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
27725505|NCT01327651|80826625|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
27725506|NCT01327651|80826626|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
27725507|NCT01327651|80826627|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
27725508|NCT01327651|80826628|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
27725509|NCT01327651|80826620|FG000|Post Study Follow-up|Lost to Follow-up|0|||
27725510|NCT01327651|80826621|FG001|Post Study Follow-up|Lost to Follow-up|1|||
27725511|NCT01327651|80826622|FG002|Post Study Follow-up|Lost to Follow-up|1|||
27725512|NCT01327651|80826623|FG003|Post Study Follow-up|Lost to Follow-up|0|||
27725513|NCT01327651|80826624|FG004|Post Study Follow-up|Lost to Follow-up|0|||
27725514|NCT01327651|80826625|FG005|Post Study Follow-up|Lost to Follow-up|0|||
27725515|NCT01327651|80826626|FG006|Post Study Follow-up|Lost to Follow-up|4|||
27725516|NCT01327651|80826627|FG007|Post Study Follow-up|Lost to Follow-up|1|||
27725517|NCT01327651|80826628|FG008|Post Study Follow-up|Lost to Follow-up|2|||
27725518|NCT00236080|80826629|FG000|Overall Study|Adverse Event|0|||
27725519|NCT00236080|80826630|FG001|Overall Study|Adverse Event|0|||
27725520|NCT00236080|80826631|FG002|Overall Study|Adverse Event|3|||
27725521|NCT00236080|80826632|FG003|Overall Study|Adverse Event|1|||
27725522|NCT00236080|80826633|FG004|Overall Study|Adverse Event|0|||
27725523|NCT00236080|80826629|FG000|Overall Study|Lost to Follow-up|0|||
27725524|NCT00236080|80826630|FG001|Overall Study|Lost to Follow-up|1|||
27725525|NCT00236080|80826631|FG002|Overall Study|Lost to Follow-up|0|||
27725526|NCT00236080|80826632|FG003|Overall Study|Lost to Follow-up|0|||
27725527|NCT00236080|80826633|FG004|Overall Study|Lost to Follow-up|0|||
27725528|NCT00236080|80826629|FG000|Overall Study|Physician Decision|1|||
27725529|NCT00236080|80826630|FG001|Overall Study|Physician Decision|0|||
27725530|NCT00236080|80826631|FG002|Overall Study|Physician Decision|1|||
27725531|NCT00236080|80826632|FG003|Overall Study|Physician Decision|1|||
27725532|NCT00236080|80826633|FG004|Overall Study|Physician Decision|1|||
27725533|NCT00236080|80826629|FG000|Overall Study|Withdrawal by Subject|1|||
27725534|NCT00236080|80826630|FG001|Overall Study|Withdrawal by Subject|0|||
27725535|NCT00236080|80826631|FG002|Overall Study|Withdrawal by Subject|0|||
27725536|NCT00236080|80826632|FG003|Overall Study|Withdrawal by Subject|0|||
27725537|NCT00236080|80826633|FG004|Overall Study|Withdrawal by Subject|0|||
27725538|NCT00236080|80826629|FG000|Overall Study|Miscellaneous|0|||
27725539|NCT00236080|80826630|FG001|Overall Study|Miscellaneous|0|||
27725540|NCT00236080|80826631|FG002|Overall Study|Miscellaneous|1|||
27725541|NCT00236080|80826632|FG003|Overall Study|Miscellaneous|0|||
27725542|NCT00236080|80826633|FG004|Overall Study|Miscellaneous|0|||
27725543|NCT02183519|80826636|FG000|Overall Study|computer error|3|||
27725544|NCT02183519|80826637|FG001|Overall Study|computer error|0|||
27725545|NCT02183519|80826636|FG000|Overall Study|Did not respond to cough inducter|0|||
27725546|NCT02183519|80826637|FG001|Overall Study|Did not respond to cough inducter|3|||
27725547|NCT02597062|80826638|FG000|Overall Study|Ineligible|1|||
27725548|NCT00130286|80826646|FG000|Overall Study|Withdrawal by Subject|0|||
27725549|NCT00130286|80826647|FG001|Overall Study|Withdrawal by Subject|1|||
27725550|NCT00130286|80826648|FG002|Overall Study|Withdrawal by Subject|2|||
27725551|NCT00130286|80826649|FG003|Overall Study|Withdrawal by Subject|2|||
27725552|NCT00130286|80826646|FG000|Overall Study|Adverse Event|0|||
27725553|NCT00130286|80826647|FG001|Overall Study|Adverse Event|0|||
27844910|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
27844911|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
27613601|NCT04022889|80426703|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
27725554|NCT00130286|80826648|FG002|Overall Study|Adverse Event|2|||
27958620|NCT01791517|81680068|FG010|Phase II|Adverse Event|0|||
27893232|NCT03729570|81443996|FG000|Overall Study|Moved out of the city|1|||
27893233|NCT03729570|81443997|FG001|Overall Study|Moved out of the city|0|||
27893234|NCT03729570|81443996|FG000|Overall Study|Time Conflict|1|||
27893235|NCT03729570|81443997|FG001|Overall Study|Time Conflict|0|||
27893236|NCT03729570|81443996|FG000|Overall Study|Time Commitment|2|||
27893237|NCT03729570|81443997|FG001|Overall Study|Time Commitment|0|||
27893238|NCT03729570|81443996|FG000|Overall Study|Bad Experience|0|||
27893239|NCT03729570|81443997|FG001|Overall Study|Bad Experience|1|||
27893240|NCT03729570|81443996|FG000|Overall Study|No reason provided|2|||
27893241|NCT03729570|81443997|FG001|Overall Study|No reason provided|1|||
27893242|NCT03729570|81443996|FG000|Overall Study|Family Conflict|0|||
27893243|NCT03729570|81443997|FG001|Overall Study|Family Conflict|1|||
27893244|NCT03729570|81443996|FG000|Overall Study|Did not want to continue taking medications|0|||
27893245|NCT03729570|81443997|FG001|Overall Study|Did not want to continue taking medications|1|||
27893246|NCT03729570|81443996|FG000|Overall Study|Found another PrEP provider|1|||
27893247|NCT03729570|81443997|FG001|Overall Study|Found another PrEP provider|0|||
27893248|NCT03729570|81443996|FG000|Overall Study|Did not enjoy being in the control group|0|||
27893249|NCT03729570|81443997|FG001|Overall Study|Did not enjoy being in the control group|1|||
27893250|NCT05072964|81443998|FG000|Overall Study|Withdrawal by Subject|4|||
27893251|NCT05072964|81443998|FG000|Overall Study|Death|1|||
27893252|NCT03467763|81443999|FG000|Overall Study|Lost to Follow-up|1|||
27893253|NCT03467763|81443999|FG000|Overall Study|Protocol Violation|2|||
27893254|NCT03191864|81444000|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
27893255|NCT03191864|81444001|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
27893256|NCT03191864|81444002|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
27893257|NCT03191864|81444003|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
27893258|NCT03191864|81444004|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
27893259|NCT03191864|81444005|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
27893260|NCT03191864|81444000|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27893261|NCT03191864|81444001|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27893262|NCT03191864|81444002|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27893263|NCT03191864|81444003|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27893264|NCT03191864|81444004|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
27893265|NCT03191864|81444005|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
27893266|NCT03191864|81444000|FG000|Baseline Symptom Assessment|Adverse Event|0|||
27893267|NCT03191864|81444001|FG001|Baseline Symptom Assessment|Adverse Event|0|||
27893268|NCT03191864|81444002|FG002|Baseline Symptom Assessment|Adverse Event|0|||
27893269|NCT03191864|81444003|FG003|Baseline Symptom Assessment|Adverse Event|0|||
27893270|NCT03191864|81444004|FG004|Baseline Symptom Assessment|Adverse Event|0|||
27893271|NCT03191864|81444005|FG005|Baseline Symptom Assessment|Adverse Event|2|||
27893272|NCT03191864|81444000|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27893273|NCT03191864|81444001|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27893274|NCT03191864|81444002|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27613602|NCT04022889|80426701|FG000|Stage 2|Screen Failure|0|||
27893275|NCT03191864|81444003|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27893276|NCT03191864|81444004|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
27893277|NCT03191864|81444005|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
27893278|NCT03191864|81444000|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27893279|NCT03191864|81444001|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27893280|NCT03191864|81444002|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27893281|NCT03191864|81444003|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27893282|NCT03191864|81444004|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
27893283|NCT03191864|81444005|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
27893284|NCT03191864|81444000|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27893285|NCT03191864|81444001|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27893286|NCT03191864|81444002|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
27893287|NCT03191864|81444003|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27893288|NCT03191864|81444004|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
27893289|NCT03191864|81444005|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
27893290|NCT03191864|81444000|FG000|Part 1 - Induction|Adverse Event|0|||
27893291|NCT03191864|81444001|FG001|Part 1 - Induction|Adverse Event|2|||
27893292|NCT03191864|81444002|FG002|Part 1 - Induction|Adverse Event|0|||
27893293|NCT03191864|81444003|FG003|Part 1 - Induction|Adverse Event|1|||
27893294|NCT03191864|81444004|FG004|Part 1 - Induction|Adverse Event|0|||
27893295|NCT03191864|81444005|FG005|Part 1 - Induction|Adverse Event|2|||
27893296|NCT03191864|81444000|FG000|Part 1 - Induction|Randomized but never dosed|0|||
27893297|NCT03191864|81444001|FG001|Part 1 - Induction|Randomized but never dosed|0|||
27893298|NCT03191864|81444002|FG002|Part 1 - Induction|Randomized but never dosed|1|||
27893299|NCT03191864|81444003|FG003|Part 1 - Induction|Randomized but never dosed|0|||
27893300|NCT03191864|81444004|FG004|Part 1 - Induction|Randomized but never dosed|0|||
27893301|NCT03191864|81444005|FG005|Part 1 - Induction|Randomized but never dosed|0|||
27893302|NCT03191864|81444000|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
27893303|NCT03191864|81444001|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
27893304|NCT03191864|81444002|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
27893305|NCT03191864|81444003|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
27893306|NCT03191864|81444004|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
27893307|NCT03191864|81444005|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
27893308|NCT03191864|81444000|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27893309|NCT03191864|81444001|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27893310|NCT03191864|81444002|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
27893311|NCT03191864|81444003|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27893312|NCT03191864|81444004|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27893313|NCT03191864|81444005|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
27893314|NCT03191864|81444000|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
27893315|NCT03191864|81444001|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27893316|NCT03191864|81444002|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27893317|NCT03191864|81444003|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27893318|NCT03191864|81444004|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27893319|NCT03191864|81444005|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
27893320|NCT03191864|81444000|FG000|Part 2 - Maintenance|Physician Decision|1|||
27893321|NCT03191864|81444001|FG001|Part 2 - Maintenance|Physician Decision|0|||
27893322|NCT03191864|81444002|FG002|Part 2 - Maintenance|Physician Decision|0|||
27893323|NCT03191864|81444003|FG003|Part 2 - Maintenance|Physician Decision|0|||
27893324|NCT03191864|81444004|FG004|Part 2 - Maintenance|Physician Decision|0|||
27893325|NCT03191864|81444005|FG005|Part 2 - Maintenance|Physician Decision|0|||
27893326|NCT03191864|81444000|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
27893327|NCT03191864|81444001|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
27893328|NCT03191864|81444002|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
27893329|NCT03191864|81444003|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
27893330|NCT03191864|81444004|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
27893331|NCT03191864|81444005|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
27893332|NCT03191864|81444000|FG000|Part 2 - Maintenance|Adverse Event|0|||
27893333|NCT03191864|81444001|FG001|Part 2 - Maintenance|Adverse Event|0|||
27893334|NCT03191864|81444002|FG002|Part 2 - Maintenance|Adverse Event|0|||
27893335|NCT03191864|81444003|FG003|Part 2 - Maintenance|Adverse Event|0|||
27613603|NCT04022889|80426702|FG001|Stage 2|Screen Failure|0|||
27844912|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
27844913|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
27844914|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
27844915|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
27844916|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
27844917|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
27844918|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
27844919|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
27844920|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844921|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844922|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27893336|NCT03191864|81444004|FG004|Part 2 - Maintenance|Adverse Event|1|||
27893337|NCT03191864|81444005|FG005|Part 2 - Maintenance|Adverse Event|0|||
27893338|NCT03191864|81444000|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
27893339|NCT03191864|81444001|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
27893340|NCT03191864|81444002|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
27893341|NCT03191864|81444003|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
27893342|NCT03191864|81444004|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
27893343|NCT03191864|81444005|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
27613604|NCT04022889|80426703|FG002|Stage 2|Screen Failure|3|||
27893344|NCT03191864|81444000|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27613605|NCT04022889|80426701|FG000|Stage 2|Ineligible for apheresis donation|0|||
27893345|NCT03191864|81444001|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27725555|NCT00130286|80826649|FG003|Overall Study|Adverse Event|0|||
27725556|NCT00130286|80826646|FG000|Overall Study|Missing lab specimens|0|||
27725557|NCT00130286|80826647|FG001|Overall Study|Missing lab specimens|2|||
27725558|NCT00130286|80826648|FG002|Overall Study|Missing lab specimens|0|||
27725559|NCT00130286|80826649|FG003|Overall Study|Missing lab specimens|0|||
27725560|NCT02614079|80826650|FG000|Overall Study|Withdrawal by Subject|1|||
27725561|NCT02542267|80826652|FG000|Overall Study|Withdrawal by Subject|10|||
27725562|NCT02542267|80826652|FG000|Overall Study|Physician Decision|6|||
27725563|NCT02542267|80826652|FG000|Overall Study|Lost to Follow-up|4|||
27725564|NCT02542267|80826652|FG000|Overall Study|Death|13|||
27725565|NCT02542267|80826652|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
27725566|NCT02542267|80826652|FG000|Overall Study|Other|9|||
27725567|NCT01360645|80826662|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
27725568|NCT01360645|80826663|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
27725569|NCT01360645|80826664|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
27725570|NCT01360645|80826665|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
27725571|NCT01360645|80826662|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
27725572|NCT01360645|80826663|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
27725573|NCT01360645|80826664|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
27725574|NCT01360645|80826665|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
27725575|NCT01360645|80826662|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
27725576|NCT01360645|80826663|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
27725577|NCT01360645|80826664|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
27725578|NCT01360645|80826665|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
27725579|NCT01360645|80826662|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
27725580|NCT01360645|80826663|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
27725581|NCT01360645|80826664|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
27725582|NCT01360645|80826665|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
27725583|NCT01360645|80826662|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
27725584|NCT01360645|80826663|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
27725585|NCT01360645|80826664|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
27725586|NCT01360645|80826665|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
27725587|NCT01360645|80826662|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
27725588|NCT01360645|80826663|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
27725589|NCT01360645|80826664|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
27725590|NCT01360645|80826665|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
27725591|NCT01360645|80826662|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
27725592|NCT01360645|80826663|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
27725593|NCT01360645|80826664|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
27725594|NCT01360645|80826665|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
27725595|NCT01360645|80826662|FG000|Phase B (6 Weeks)|Adverse Event|0|||
27725596|NCT01360645|80826663|FG001|Phase B (6 Weeks)|Adverse Event|6|||
27725597|NCT01360645|80826664|FG002|Phase B (6 Weeks)|Adverse Event|0|||
27725598|NCT01360645|80826665|FG003|Phase B (6 Weeks)|Adverse Event|0|||
27725599|NCT01360645|80826662|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27725600|NCT01360645|80826663|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
27725601|NCT01360645|80826664|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
27725602|NCT01360645|80826665|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
27725603|NCT01360645|80826662|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27725604|NCT01360645|80826663|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
27725605|NCT01360645|80826664|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
27725606|NCT01360645|80826665|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
27725607|NCT01360645|80826662|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
27725608|NCT01360645|80826663|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
27725609|NCT01360645|80826664|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
27725610|NCT01360645|80826665|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
27725611|NCT01360645|80826662|FG000|Phase A+|Lost to Follow-up|0|||
27725612|NCT01360645|80826663|FG001|Phase A+|Lost to Follow-up|0|||
27613606|NCT04022889|80426702|FG001|Stage 2|Ineligible for apheresis donation|0|||
27725613|NCT01360645|80826664|FG002|Phase A+|Lost to Follow-up|0|||
27725614|NCT01360645|80826665|FG003|Phase A+|Lost to Follow-up|7|||
27725615|NCT01360645|80826662|FG000|Phase A+|Adverse Event|0|||
27725616|NCT01360645|80826663|FG001|Phase A+|Adverse Event|0|||
27725617|NCT01360645|80826664|FG002|Phase A+|Adverse Event|0|||
27725618|NCT01360645|80826665|FG003|Phase A+|Adverse Event|2|||
27725619|NCT01360645|80826662|FG000|Phase A+|Met Withdrawal Criteria|0|||
27725620|NCT01360645|80826663|FG001|Phase A+|Met Withdrawal Criteria|0|||
27725621|NCT01360645|80826664|FG002|Phase A+|Met Withdrawal Criteria|0|||
27725622|NCT01360645|80826665|FG003|Phase A+|Met Withdrawal Criteria|4|||
27725623|NCT01360645|80826662|FG000|Phase A+|Physician Decision|0|||
27613607|NCT04022889|80426703|FG002|Stage 2|Ineligible for apheresis donation|2|||
27893346|NCT03191864|81444002|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27893347|NCT03191864|81444003|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27893348|NCT03191864|81444004|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
27893349|NCT03191864|81444005|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
27893350|NCT01794793|81444009|FG000|Treatment Period|Withdrawal by Subject|24|||
27893351|NCT01794793|81444009|FG000|Treatment Period|Lack of Efficacy|22|||
27893352|NCT01794793|81444009|FG000|Treatment Period|Adverse Event|17|||
27893353|NCT01794793|81444009|FG000|Treatment Period|Physician Decision|14|||
27893354|NCT01794793|81444009|FG000|Treatment Period|Lost to Follow-up|7|||
27893355|NCT01794793|81444009|FG000|Treatment Period|Death|6|||
27893356|NCT01794793|81444009|FG000|Treatment Period|Protocol Violation|5|||
27844923|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844924|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844925|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844926|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
27844927|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844928|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
27844929|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
27844930|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
27844931|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
27844932|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
27844933|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
27844934|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
27844935|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
27844936|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
27844937|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
27844938|NCT00739973|81260840|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844939|NCT00739973|81260841|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
27844940|NCT00739973|81260842|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844941|NCT00739973|81260843|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844942|NCT00739973|81260844|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844943|NCT00739973|81260845|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844944|NCT00739973|81260846|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
27844945|NCT00739973|81260847|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844946|NCT00739973|81260848|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
27844947|NCT00346164|81260849|FG000|Overall Study|Adverse Event|0|||
27844948|NCT00346164|81260850|FG001|Overall Study|Adverse Event|0|||
27844949|NCT00346164|81260851|FG002|Overall Study|Adverse Event|0|||
27844950|NCT00346164|81260852|FG003|Overall Study|Adverse Event|1|||
27844951|NCT00346164|81260849|FG000|Overall Study|Lack of Efficacy|0|||
27893357|NCT01794793|81444009|FG000|Treatment Period|administrative problem|3|||
27893358|NCT01794793|81444009|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
27893359|NCT01794793|81444009|FG000|Post-treatment Follow-up|Adverse Event|8|||
27893360|NCT01794793|81444009|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
27893361|NCT01794793|81444009|FG000|Post-treatment Follow-up|administrative problem|5|||
27893362|NCT01794793|81444009|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
27893363|NCT01794793|81444009|FG000|Post-treatment Follow-up|Protocol Violation|3|||
27893364|NCT04598451|81444010|FG000|Overall Study|Adverse Event|3|||
27893365|NCT04598451|81444011|FG001|Overall Study|Adverse Event|2|||
27893366|NCT04598451|81444010|FG000|Overall Study|Withdrawal by Subject|3|||
27893367|NCT04598451|81444011|FG001|Overall Study|Withdrawal by Subject|7|||
27893368|NCT04598451|81444010|FG000|Overall Study|Lost to Follow-up|2|||
27893369|NCT04598451|81444011|FG001|Overall Study|Lost to Follow-up|0|||
27893370|NCT04598451|81444010|FG000|Overall Study|Physician Decision|4|||
27893371|NCT04598451|81444011|FG001|Overall Study|Physician Decision|1|||
27893372|NCT04598451|81444010|FG000|Overall Study|Requires Prohibited Medication|1|||
27893373|NCT04598451|81444011|FG001|Overall Study|Requires Prohibited Medication|0|||
27893374|NCT04598451|81444010|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
27893375|NCT04598451|81444011|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
27893376|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
27893377|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
27893378|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
27893379|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
27893380|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
27893381|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
27893382|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
27893383|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
27893384|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Death|0|||
27893385|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Death|1|||
27893386|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
27893387|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
27893388|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
27893389|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
27893390|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
27893391|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
27893392|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
27893393|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
27893394|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
27893395|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
27893396|NCT00394836|81444014|FG000|Teatment or Follow-up Phase|Non compliance|0|||
27893397|NCT00394836|81444015|FG001|Teatment or Follow-up Phase|Non compliance|1|||
27893398|NCT00394836|81444014|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
27893399|NCT00394836|81444015|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
27893400|NCT00394836|81444014|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
27893401|NCT00394836|81444015|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
27893402|NCT00394836|81444014|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
27613608|NCT04022889|80426701|FG000|Stage 2|Adverse Event|0|||
27725624|NCT01360645|80826663|FG001|Phase A+|Physician Decision|0|||
27844952|NCT00346164|81260850|FG001|Overall Study|Lack of Efficacy|1|||
27844953|NCT00346164|81260851|FG002|Overall Study|Lack of Efficacy|7|||
27844954|NCT00346164|81260852|FG003|Overall Study|Lack of Efficacy|25|||
27844955|NCT00346164|81260849|FG000|Overall Study|Physician Decision|0|||
27844956|NCT00346164|81260850|FG001|Overall Study|Physician Decision|1|||
27844957|NCT00346164|81260851|FG002|Overall Study|Physician Decision|2|||
27844958|NCT00346164|81260852|FG003|Overall Study|Physician Decision|27|||
27844959|NCT00346164|81260849|FG000|Overall Study|Protocol Violation|6|||
27844960|NCT00346164|81260850|FG001|Overall Study|Protocol Violation|2|||
27844961|NCT00346164|81260851|FG002|Overall Study|Protocol Violation|10|||
27844962|NCT00346164|81260852|FG003|Overall Study|Protocol Violation|4|||
27844963|NCT00346164|81260849|FG000|Overall Study|Withdrawal by Subject|0|||
27844964|NCT00346164|81260850|FG001|Overall Study|Withdrawal by Subject|0|||
27844965|NCT00346164|81260851|FG002|Overall Study|Withdrawal by Subject|2|||
27844966|NCT00346164|81260852|FG003|Overall Study|Withdrawal by Subject|0|||
27844967|NCT00346164|81260849|FG000|Overall Study|Ineligible|11|||
27844968|NCT00346164|81260850|FG001|Overall Study|Ineligible|2|||
27844969|NCT00346164|81260851|FG002|Overall Study|Ineligible|2|||
27844970|NCT00346164|81260852|FG003|Overall Study|Ineligible|23|||
27844971|NCT00346164|81260849|FG000|Overall Study|Refusal of further protocol therapy|0|||
27844972|NCT00346164|81260850|FG001|Overall Study|Refusal of further protocol therapy|1|||
27844973|NCT00346164|81260851|FG002|Overall Study|Refusal of further protocol therapy|3|||
27844974|NCT00346164|81260852|FG003|Overall Study|Refusal of further protocol therapy|15|||
27844975|NCT00346164|81260849|FG000|Overall Study|Inability to start week 16 tx on time|0|||
27844976|NCT00346164|81260850|FG001|Overall Study|Inability to start week 16 tx on time|0|||
27844977|NCT00346164|81260851|FG002|Overall Study|Inability to start week 16 tx on time|0|||
27844978|NCT00346164|81260852|FG003|Overall Study|Inability to start week 16 tx on time|11|||
27844979|NCT01118117|81260856|FG000|Overall Study|Death|8|||
27725625|NCT01360645|80826664|FG002|Phase A+|Physician Decision|0|||
27844980|NCT01118117|81260857|FG001|Overall Study|Death|0|||
27844981|NCT01118117|81260856|FG000|Overall Study|Lost to Follow-up|6|||
27844982|NCT01118117|81260857|FG001|Overall Study|Lost to Follow-up|0|||
27725626|NCT01360645|80826665|FG003|Phase A+|Physician Decision|2|||
27844983|NCT01118117|81260856|FG000|Overall Study|Missed 12 Month Visit|7|||
27844984|NCT01118117|81260857|FG001|Overall Study|Missed 12 Month Visit|0|||
27844985|NCT02012452|81260863|FG000|Overall Study|Lost to Follow-up|2|||
27844986|NCT02012452|81260864|FG001|Overall Study|Lost to Follow-up|1|||
27844987|NCT02012452|81260863|FG000|Overall Study|Withdrawal by Subject|4|||
27844988|NCT02012452|81260864|FG001|Overall Study|Withdrawal by Subject|0|||
27844989|NCT04974619|81260865|FG000|Overall Study|Lost to Follow-up|0|||
27844990|NCT04974619|81260866|FG001|Overall Study|Lost to Follow-up|0|||
27844991|NCT04974619|81260867|FG002|Overall Study|Lost to Follow-up|1|||
27844992|NCT04974619|81260865|FG000|Overall Study|Withdrawal by Subject|0|||
27844993|NCT04974619|81260866|FG001|Overall Study|Withdrawal by Subject|0|||
27844994|NCT04974619|81260867|FG002|Overall Study|Withdrawal by Subject|1|||
27844995|NCT04974619|81260865|FG000|Overall Study|Protocol Violation|0|||
27844996|NCT04974619|81260866|FG001|Overall Study|Protocol Violation|1|||
27844997|NCT04974619|81260867|FG002|Overall Study|Protocol Violation|0|||
27844998|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
27844999|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
27845000|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
27845001|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
27845002|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
27893403|NCT00394836|81444015|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
27893404|NCT00394836|81444014|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
27893405|NCT00394836|81444015|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
27893406|NCT06137703|81444018|FG000|Overall Study|Other|0|||
27893407|NCT06137703|81444019|FG001|Overall Study|Other|1|||
27893408|NCT06137703|81444020|FG002|Overall Study|Other|0|||
27845003|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
27845004|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
27845005|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
27845006|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
27845007|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
27845008|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
27845009|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
27845010|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
27845011|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
27845012|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
27845013|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
27893409|NCT06137703|81444021|FG003|Overall Study|Other|0|||
27893410|NCT06137703|81444018|FG000|Overall Study|Adverse Event|0|||
27893411|NCT06137703|81444019|FG001|Overall Study|Adverse Event|0|||
27893412|NCT06137703|81444020|FG002|Overall Study|Adverse Event|1|||
27893413|NCT06137703|81444021|FG003|Overall Study|Adverse Event|0|||
27504772|NCT03895203|80040852|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
27504773|NCT03895203|80040847|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
27504774|NCT03895203|80040848|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
27504775|NCT03895203|80040849|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
27504776|NCT03895203|80040850|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
27504777|NCT03895203|80040851|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
27504778|NCT03895203|80040852|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
27504779|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
27504780|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
27504781|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
27504782|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
27504783|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
27504784|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
27504785|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
27504786|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
27845014|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
27893414|NCT01328548|81444022|FG000|Overall Study|Death|3|||
27504787|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
27504788|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
27893415|NCT01328548|81444023|FG001|Overall Study|Death|0|||
27893416|NCT01328548|81444022|FG000|Overall Study|Protocol Violation|1|||
27893417|NCT01328548|81444023|FG001|Overall Study|Protocol Violation|0|||
27893418|NCT00477750|81444024|FG000|Overall Study|Currently Receiving Treatment|11|||
27893419|NCT02396420|81444027|FG000|Overall Study|Death|1|||
27504789|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
27504790|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
27504791|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
27504792|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
27504793|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
27504794|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
27504795|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
27504796|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
27504797|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
27504798|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
27504799|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
27504800|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
27504801|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
27504802|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
27725627|NCT01360645|80826662|FG000|Phase A+|Withdrawal by Subject|0|||
27725628|NCT01360645|80826663|FG001|Phase A+|Withdrawal by Subject|0|||
27725629|NCT01360645|80826664|FG002|Phase A+|Withdrawal by Subject|0|||
27725630|NCT01360645|80826665|FG003|Phase A+|Withdrawal by Subject|5|||
27725631|NCT01360645|80826662|FG000|Phase A+|Protocol Deviation|0|||
27845015|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
27845016|NCT00384293|81260868|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
27845017|NCT00384293|81260869|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
27845018|NCT00384293|81260870|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
27845019|NCT00384293|81260868|FG000|Post-randomization Period|Adverse Event|0|||
27845020|NCT00384293|81260869|FG001|Post-randomization Period|Adverse Event|23|||
27845021|NCT00384293|81260870|FG002|Post-randomization Period|Adverse Event|7|||
27845022|NCT00384293|81260868|FG000|Post-randomization Period|Lost to Follow-up|0|||
27845023|NCT00384293|81260869|FG001|Post-randomization Period|Lost to Follow-up|2|||
27845024|NCT00384293|81260870|FG002|Post-randomization Period|Lost to Follow-up|1|||
27845025|NCT00384293|81260868|FG000|Post-randomization Period|Protocol Violation|0|||
27845026|NCT00384293|81260869|FG001|Post-randomization Period|Protocol Violation|1|||
27845027|NCT00384293|81260870|FG002|Post-randomization Period|Protocol Violation|0|||
27845028|NCT00384293|81260868|FG000|Post-randomization Period|Withdrawal by Subject|0|||
27845029|NCT00384293|81260869|FG001|Post-randomization Period|Withdrawal by Subject|8|||
27845030|NCT00384293|81260870|FG002|Post-randomization Period|Withdrawal by Subject|6|||
27845031|NCT00384293|81260868|FG000|Post-randomization Period|Trial Termination|0|||
27845032|NCT00384293|81260869|FG001|Post-randomization Period|Trial Termination|180|||
27845033|NCT00384293|81260870|FG002|Post-randomization Period|Trial Termination|204|||
27845034|NCT00384293|81260868|FG000|Post-randomization Period|Patient Randomized in Error|0|||
27845035|NCT00384293|81260869|FG001|Post-randomization Period|Patient Randomized in Error|0|||
27845036|NCT00384293|81260870|FG002|Post-randomization Period|Patient Randomized in Error|1|||
27845037|NCT02563769|81260871|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
27845038|NCT02563769|81260872|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
27845039|NCT02563769|81260873|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
27845040|NCT05158140|81260876|FG000|Overall Study|Death|0|||
27845041|NCT05158140|81260877|FG001|Overall Study|Death|0|||
27845042|NCT05158140|81260878|FG002|Overall Study|Death|0|||
27845043|NCT05158140|81260879|FG003|Overall Study|Death|1|||
27845044|NCT05158140|81260876|FG000|Overall Study|Lost to Follow-up|3|||
27845045|NCT05158140|81260877|FG001|Overall Study|Lost to Follow-up|6|||
27845046|NCT05158140|81260878|FG002|Overall Study|Lost to Follow-up|4|||
27845047|NCT05158140|81260879|FG003|Overall Study|Lost to Follow-up|3|||
27845048|NCT05158140|81260876|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27845049|NCT05158140|81260877|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27845050|NCT05158140|81260878|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
27845051|NCT05158140|81260879|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
27845052|NCT05158140|81260876|FG000|Overall Study|Withdrawal by Subject|3|||
27845053|NCT05158140|81260877|FG001|Overall Study|Withdrawal by Subject|7|||
27845054|NCT05158140|81260878|FG002|Overall Study|Withdrawal by Subject|3|||
27845055|NCT05158140|81260879|FG003|Overall Study|Withdrawal by Subject|7|||
27893420|NCT01362244|81444028|FG000|Overall Study|Adverse Event|3|||
27504803|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
27504804|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
27504805|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
27725632|NCT01360645|80826663|FG001|Phase A+|Protocol Deviation|0|||
27725633|NCT01360645|80826664|FG002|Phase A+|Protocol Deviation|0|||
27725634|NCT01360645|80826665|FG003|Phase A+|Protocol Deviation|4|||
27725635|NCT02597855|80826686|FG000|Overall Study|Lost to Follow-up|2|||
27725636|NCT02597855|80826687|FG001|Overall Study|Lost to Follow-up|1|||
27845056|NCT02487082|81260880|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
27845057|NCT02487082|81260881|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
27845058|NCT02487082|81260880|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
27845059|NCT02487082|81260881|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
27845060|NCT00802178|81260882|FG000|Overall Study|Lack of Efficacy|36|||
27845061|NCT00802178|81260882|FG000|Overall Study|Insufficient tolerability (IT)|17|||
27845062|NCT00802178|81260882|FG000|Overall Study|Withdrawal by Subject|18|||
27845063|NCT00802178|81260882|FG000|Overall Study|Other|32|||
27845064|NCT00802178|81260882|FG000|Overall Study|Lack of efficacy and patient wish|1|||
27845065|NCT00802178|81260882|FG000|Overall Study|IT and patient wish|8|||
27845066|NCT00802178|81260882|FG000|Overall Study|Patients wish and other reason|1|||
27845067|NCT00298740|81260883|FG000|Overall Study|Lack of Efficacy|6|||
27845068|NCT00298740|81260883|FG000|Overall Study|Withdrawal by Subject|3|||
27845069|NCT00977431|81260885|FG000|Overall Study|Other than listed|1|||
27845070|NCT00977431|81260886|FG001|Overall Study|Other than listed|0|||
27845071|NCT00977431|81260887|FG002|Overall Study|Other than listed|0|||
27845072|NCT00977431|81260888|FG003|Overall Study|Other than listed|0|||
27845073|NCT00977431|81260889|FG004|Overall Study|Other than listed|2|||
27845074|NCT00977431|81260885|FG000|Overall Study|Protocol Violation|0|||
27845075|NCT00977431|81260886|FG001|Overall Study|Protocol Violation|0|||
27845076|NCT00977431|81260887|FG002|Overall Study|Protocol Violation|1|||
27845077|NCT00977431|81260888|FG003|Overall Study|Protocol Violation|0|||
27845078|NCT00977431|81260889|FG004|Overall Study|Protocol Violation|0|||
27845079|NCT00977431|81260885|FG000|Overall Study|Adverse Event|3|||
27845080|NCT00977431|81260886|FG001|Overall Study|Adverse Event|0|||
27845081|NCT00977431|81260887|FG002|Overall Study|Adverse Event|4|||
27845082|NCT00977431|81260888|FG003|Overall Study|Adverse Event|0|||
27845083|NCT00977431|81260889|FG004|Overall Study|Adverse Event|6|||
27845084|NCT00977431|81260885|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
27845085|NCT00977431|81260886|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
27845086|NCT00977431|81260887|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
27845087|NCT00977431|81260888|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
27845088|NCT00977431|81260889|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
27845089|NCT00977431|81260885|FG000|Overall Study|Progressive disease|2|||
27845090|NCT00977431|81260886|FG001|Overall Study|Progressive disease|6|||
27845091|NCT00977431|81260887|FG002|Overall Study|Progressive disease|1|||
27845092|NCT00977431|81260888|FG003|Overall Study|Progressive disease|3|||
27845093|NCT00977431|81260889|FG004|Overall Study|Progressive disease|5|||
27504806|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
27725637|NCT02292212|80826688|FG000|ViE Phase|Withdrawal by Subject|1|||
27725638|NCT02292212|80826688|FG000|ViE Phase|Protocol Violation|2|||
27725639|NCT00481065|80826691|FG000|Overall Study|Adverse event or death|1|||
27725640|NCT00481065|80826692|FG001|Overall Study|Adverse event or death|1|||
27725641|NCT00481065|80826693|FG002|Overall Study|Adverse event or death|3|||
27725642|NCT00481065|80826694|FG003|Overall Study|Adverse event or death|0|||
27725643|NCT00481065|80826695|FG004|Overall Study|Adverse event or death|2|||
27725644|NCT00481065|80826696|FG005|Overall Study|Adverse event or death|0|||
27725645|NCT00481065|80826697|FG006|Overall Study|Adverse event or death|1|||
27725646|NCT00481065|80826698|FG007|Overall Study|Adverse event or death|1|||
27725647|NCT00481065|80826691|FG000|Overall Study|Withdrawal by Subject|11|||
27725648|NCT00481065|80826692|FG001|Overall Study|Withdrawal by Subject|12|||
27725649|NCT00481065|80826693|FG002|Overall Study|Withdrawal by Subject|7|||
27725650|NCT00481065|80826694|FG003|Overall Study|Withdrawal by Subject|11|||
27725651|NCT00481065|80826695|FG004|Overall Study|Withdrawal by Subject|13|||
27725652|NCT00481065|80826696|FG005|Overall Study|Withdrawal by Subject|12|||
27725653|NCT00481065|80826697|FG006|Overall Study|Withdrawal by Subject|9|||
27725654|NCT00481065|80826698|FG007|Overall Study|Withdrawal by Subject|10|||
27725655|NCT00481065|80826691|FG000|Overall Study|Lost to Follow-up|4|||
27725656|NCT00481065|80826692|FG001|Overall Study|Lost to Follow-up|2|||
27725657|NCT00481065|80826693|FG002|Overall Study|Lost to Follow-up|4|||
27725658|NCT00481065|80826694|FG003|Overall Study|Lost to Follow-up|3|||
27725659|NCT00481065|80826695|FG004|Overall Study|Lost to Follow-up|3|||
27725660|NCT00481065|80826696|FG005|Overall Study|Lost to Follow-up|3|||
27725661|NCT00481065|80826697|FG006|Overall Study|Lost to Follow-up|2|||
27725662|NCT00481065|80826698|FG007|Overall Study|Lost to Follow-up|5|||
27725663|NCT00481065|80826691|FG000|Overall Study|Inappropriate enrollment|4|||
27845094|NCT01563237|81260892|FG000|Overall Study|Lost to Follow-up|6|||
27845095|NCT01563237|81260893|FG001|Overall Study|Lost to Follow-up|0|||
27845096|NCT01563237|81260892|FG000|Overall Study|Withdrawal by Subject|1|||
27845097|NCT01563237|81260893|FG001|Overall Study|Withdrawal by Subject|0|||
27725664|NCT00481065|80826692|FG001|Overall Study|Inappropriate enrollment|0|||
27725665|NCT00481065|80826693|FG002|Overall Study|Inappropriate enrollment|2|||
27725666|NCT00481065|80826694|FG003|Overall Study|Inappropriate enrollment|0|||
27725667|NCT00481065|80826695|FG004|Overall Study|Inappropriate enrollment|2|||
27845098|NCT01563237|81260892|FG000|Overall Study|Adverse Event|1|||
27845099|NCT01563237|81260893|FG001|Overall Study|Adverse Event|0|||
27845100|NCT01563237|81260892|FG000|Overall Study|Medical Reasons|1|||
27845101|NCT01563237|81260893|FG001|Overall Study|Medical Reasons|0|||
27845102|NCT01563237|81260892|FG000|Overall Study|Death|1|||
27845103|NCT01563237|81260893|FG001|Overall Study|Death|0|||
27845104|NCT00708708|81265176|FG000|Overall Study|Another therapy instead of Enbrel|141|||
27845105|NCT00708708|81265176|FG000|Overall Study|Lost to Follow-up|52|||
27845106|NCT00708708|81265176|FG000|Overall Study|Withdrawal by Subject|51|||
27845107|NCT00708708|81265176|FG000|Overall Study|Intolerance|42|||
27845108|NCT00708708|81265176|FG000|Overall Study|Another therapy along with Enbrel|15|||
27845109|NCT00708708|81265176|FG000|Overall Study|Other unspecified|11|||
27845110|NCT00708708|81265176|FG000|Overall Study|Good effectiveness|9|||
27845111|NCT00708708|81265176|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
27845112|NCT00708708|81265176|FG000|Overall Study|Administrative reasons|7|||
27845113|NCT00708708|81265176|FG000|Overall Study|Lack of effectiveness|4|||
27845114|NCT00708708|81265176|FG000|Overall Study|Lack of compliance|3|||
27845115|NCT00708708|81265176|FG000|Overall Study|Pregnancy|3|||
27845116|NCT00708708|81265176|FG000|Overall Study|Adverse Event|3|||
27845117|NCT00708708|81265176|FG000|Overall Study|Missing values|392|||
27845118|NCT01803269|81265177|FG000|Overall Study|Withdrawal by Subject|3|||
27845119|NCT01803269|81265178|FG001|Overall Study|Withdrawal by Subject|0|||
27845120|NCT01803269|81265179|FG002|Overall Study|Withdrawal by Subject|0|||
27845121|NCT00407745|81265180|FG000|Overall Study|Lack of Efficacy|1|||
27845122|NCT00407745|81265181|FG001|Overall Study|Lack of Efficacy|2|||
27845123|NCT00407745|81265180|FG000|Overall Study|Withdrawal by Subject|3|||
27845124|NCT00407745|81265181|FG001|Overall Study|Withdrawal by Subject|3|||
27845125|NCT00407745|81265180|FG000|Overall Study|Protocol Violation|5|||
27845126|NCT00407745|81265181|FG001|Overall Study|Protocol Violation|3|||
27845127|NCT00407745|81265180|FG000|Overall Study|Adverse Event|8|||
27845128|NCT00407745|81265181|FG001|Overall Study|Adverse Event|8|||
27845129|NCT00407745|81265180|FG000|Overall Study|Other|2|||
27845130|NCT00407745|81265181|FG001|Overall Study|Other|0|||
27845131|NCT00407745|81265180|FG000|Overall Study|Randomized, unknown if treated|0|||
27845132|NCT00407745|81265181|FG001|Overall Study|Randomized, unknown if treated|1|||
27845133|NCT02418455|81265182|FG000|48-Week Treatment Period|Other- Not Specified|1|||
27845134|NCT02418455|81265182|FG000|Continuation Period|Sponsor Decision|7|||
27845135|NCT02846883|81265187|FG000|Overall Study|Death|0|||
27845136|NCT02846883|81265188|FG001|Overall Study|Death|1|||
27845137|NCT02846883|81265189|FG002|Overall Study|Death|1|||
27845138|NCT02846883|81265187|FG000|Overall Study|Lost to Follow-up|0|||
27845139|NCT02846883|81265188|FG001|Overall Study|Lost to Follow-up|0|||
27845140|NCT02846883|81265189|FG002|Overall Study|Lost to Follow-up|1|||
27845141|NCT02846883|81265187|FG000|Overall Study|Withdrawal by Subject|1|||
27845142|NCT02846883|81265188|FG001|Overall Study|Withdrawal by Subject|0|||
27845143|NCT02846883|81265189|FG002|Overall Study|Withdrawal by Subject|0|||
27845144|NCT02846883|81265187|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
27845145|NCT02846883|81265188|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
27845146|NCT02846883|81265189|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
27845147|NCT02846883|81265187|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
27845148|NCT02846883|81265188|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
27845149|NCT02846883|81265189|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
27845150|NCT02631876|81265206|FG000|Overall Study|Death|96|||
27845151|NCT02631876|81265207|FG001|Overall Study|Death|50|||
27845152|NCT02631876|81265206|FG000|Overall Study|Investigator's discretion|1|||
27845153|NCT02631876|81265207|FG001|Overall Study|Investigator's discretion|0|||
27845154|NCT02631876|81265206|FG000|Overall Study|Lost to Follow-up|2|||
27845155|NCT02631876|81265207|FG001|Overall Study|Lost to Follow-up|0|||
27845156|NCT02631876|81265206|FG000|Overall Study|Withdrawal by Subject|16|||
27845157|NCT02631876|81265207|FG001|Overall Study|Withdrawal by Subject|9|||
27845158|NCT02631876|81265206|FG000|Overall Study|Other than specified|4|||
27845159|NCT02631876|81265207|FG001|Overall Study|Other than specified|4|||
27845160|NCT02733627|81265211|FG000|Overall Study|Adverse Event|0|||
27845161|NCT02733627|81265212|FG001|Overall Study|Adverse Event|1|||
27845162|NCT02733627|81265213|FG002|Overall Study|Adverse Event|1|||
27845163|NCT02733627|81265214|FG003|Overall Study|Adverse Event|0|||
27845164|NCT02733627|81265211|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
27613609|NCT04022889|80426702|FG001|Stage 2|Adverse Event|0|||
27845165|NCT02733627|81265212|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
27845166|NCT02733627|81265213|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
27845167|NCT02733627|81265214|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
27845168|NCT01220609|81265215|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
27845169|NCT01220609|81265215|FG000|Overall Study|Ineligible- Wrong cell type|1|||
27845170|NCT01220609|81265215|FG000|Overall Study|Ineligible-Never treated|1|||
27845171|NCT01909934|81265218|FG000|Overall Study|Ongoing|23|||
27845172|NCT01909934|81265218|FG000|Overall Study|Withdrawal by Subject|3|||
27893421|NCT01362244|81444029|FG001|Overall Study|Adverse Event|5|||
27845173|NCT01909934|81265218|FG000|Overall Study|Lost to Follow-up|1|||
27845174|NCT01909934|81265218|FG000|Overall Study|Withdrawal of Informed Consent|1|||
27845175|NCT01909934|81265218|FG000|Overall Study|Death|22|||
27845176|NCT03395639|81265222|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
27845177|NCT03395639|81265223|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
27845178|NCT03395639|81265224|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
27845179|NCT03395639|81265222|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
27845180|NCT03395639|81265223|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
27845181|NCT03395639|81265224|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
27845182|NCT03395639|81265222|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
27845183|NCT03395639|81265223|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
27845184|NCT03395639|81265224|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
27845185|NCT03395639|81265222|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
27845186|NCT03395639|81265223|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
27845187|NCT03395639|81265224|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
27845188|NCT03395639|81265222|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
27845189|NCT03395639|81265223|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
27845190|NCT03395639|81265224|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
27845191|NCT01239472|81265225|FG000|Overall Study|Withdrawal by Subject|5|||
27845192|NCT01239472|81265226|FG001|Overall Study|Withdrawal by Subject|1|||
27845193|NCT01239472|81265225|FG000|Overall Study|Adverse Event|0|||
27845194|NCT01239472|81265226|FG001|Overall Study|Adverse Event|1|||
27845195|NCT01239472|81265225|FG000|Overall Study|Lack of Efficacy|0|||
27845196|NCT01239472|81265226|FG001|Overall Study|Lack of Efficacy|1|||
27845197|NCT02858726|81265227|FG000|Overall Study|Adverse Event|4|||
27845198|NCT02858726|81265228|FG001|Overall Study|Adverse Event|4|||
27845199|NCT02858726|81265229|FG002|Overall Study|Adverse Event|9|||
27845200|NCT02858726|81265230|FG003|Overall Study|Adverse Event|1|||
27845201|NCT02858726|81265227|FG000|Overall Study|Physician Decision|0|||
27845202|NCT02858726|81265228|FG001|Overall Study|Physician Decision|0|||
27845203|NCT02858726|81265229|FG002|Overall Study|Physician Decision|1|||
27845204|NCT02858726|81265230|FG003|Overall Study|Physician Decision|0|||
27845205|NCT02858726|81265227|FG000|Overall Study|Protocol Violation|0|||
27845206|NCT02858726|81265228|FG001|Overall Study|Protocol Violation|0|||
27845207|NCT02858726|81265229|FG002|Overall Study|Protocol Violation|0|||
27845208|NCT02858726|81265230|FG003|Overall Study|Protocol Violation|1|||
27845209|NCT02858726|81265227|FG000|Overall Study|Study Terminated by Sponsor|0|||
27845210|NCT02858726|81265228|FG001|Overall Study|Study Terminated by Sponsor|0|||
27845211|NCT02858726|81265229|FG002|Overall Study|Study Terminated by Sponsor|0|||
27845212|NCT02858726|81265230|FG003|Overall Study|Study Terminated by Sponsor|1|||
27845213|NCT02858726|81265227|FG000|Overall Study|Withdrawal by Subject|1|||
27845214|NCT02858726|81265228|FG001|Overall Study|Withdrawal by Subject|2|||
27845215|NCT02858726|81265229|FG002|Overall Study|Withdrawal by Subject|1|||
27845216|NCT02858726|81265230|FG003|Overall Study|Withdrawal by Subject|0|||
27845217|NCT02858726|81265227|FG000|Overall Study|Noncompliance|0|||
27845218|NCT02858726|81265228|FG001|Overall Study|Noncompliance|1|||
27845219|NCT02858726|81265229|FG002|Overall Study|Noncompliance|0|||
27845220|NCT02858726|81265230|FG003|Overall Study|Noncompliance|0|||
27845221|NCT01684878|81265231|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
27845222|NCT01684878|81265232|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
27845223|NCT01684878|81265233|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
27845224|NCT01684878|81265234|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
27845225|NCT01684878|81265231|FG000|Part 1: Safety Run in Phase|Death|15|||
27845226|NCT01684878|81265232|FG001|Part 1: Safety Run in Phase|Death|20|||
27845227|NCT01684878|81265233|FG002|Part 1: Safety Run in Phase|Death|0|||
27845228|NCT01684878|81265234|FG003|Part 1: Safety Run in Phase|Death|0|||
27845229|NCT01684878|81265231|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
27845230|NCT01684878|81265232|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
27845231|NCT01684878|81265233|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
27845232|NCT01684878|81265234|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
27845233|NCT01684878|81265231|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
27845234|NCT01684878|81265232|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
27845235|NCT01684878|81265233|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
27845236|NCT01684878|81265234|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
27845237|NCT01684878|81265231|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
27845238|NCT01684878|81265232|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
27845239|NCT01684878|81265233|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
27845240|NCT01684878|81265234|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
27845241|NCT01684878|81265231|FG000|Part 2: Randomized Phase|Death|0|||
27845242|NCT01684878|81265232|FG001|Part 2: Randomized Phase|Death|0|||
27845243|NCT01684878|81265233|FG002|Part 2: Randomized Phase|Death|62|||
27845244|NCT01684878|81265234|FG003|Part 2: Randomized Phase|Death|68|||
27845245|NCT01684878|81265231|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
27845246|NCT01684878|81265232|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
27845247|NCT01684878|81265233|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
27845248|NCT01684878|81265234|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
27845249|NCT01684878|81265231|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
27845250|NCT01684878|81265232|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
27845251|NCT01684878|81265233|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
27845252|NCT01684878|81265234|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
27845253|NCT00702208|81265235|FG000|Overall Study|Lost to Follow-up|28|||
27845254|NCT00702208|81265235|FG000|Overall Study|Did not self-lavage|1|||
27845255|NCT00702208|81265235|FG000|Overall Study|Unsatisfactory colposcopy|2|||
27845256|NCT01396421|81265236|FG000|Overall Study|Lost to Follow-up|0|||
27845257|NCT01396421|81265237|FG001|Overall Study|Lost to Follow-up|0|||
27845258|NCT01396421|81265238|FG002|Overall Study|Lost to Follow-up|0|||
27845259|NCT01396421|81265239|FG003|Overall Study|Lost to Follow-up|1|||
27845260|NCT01396421|81265236|FG000|Overall Study|Adverse Event|17|||
27845261|NCT01396421|81265237|FG001|Overall Study|Adverse Event|15|||
27845262|NCT01396421|81265238|FG002|Overall Study|Adverse Event|12|||
27845263|NCT01396421|81265239|FG003|Overall Study|Adverse Event|32|||
27845264|NCT01396421|81265236|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
27845265|NCT01396421|81265237|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
27845266|NCT01396421|81265238|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
27845267|NCT01396421|81265239|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
27845268|NCT01396421|81265236|FG000|Overall Study|Physician Decision|1|||
27845269|NCT01396421|81265237|FG001|Overall Study|Physician Decision|1|||
27845270|NCT01396421|81265238|FG002|Overall Study|Physician Decision|0|||
27845271|NCT01396421|81265239|FG003|Overall Study|Physician Decision|3|||
27845272|NCT01396421|81265236|FG000|Overall Study|Withdrawal by Subject|31|||
27845273|NCT01396421|81265237|FG001|Overall Study|Withdrawal by Subject|24|||
27845274|NCT01396421|81265238|FG002|Overall Study|Withdrawal by Subject|13|||
27845275|NCT01396421|81265239|FG003|Overall Study|Withdrawal by Subject|21|||
27845276|NCT01396421|81265236|FG000|Overall Study|Protocol Deviation|2|||
27845277|NCT01396421|81265237|FG001|Overall Study|Protocol Deviation|1|||
27845278|NCT01396421|81265238|FG002|Overall Study|Protocol Deviation|1|||
27845279|NCT01396421|81265239|FG003|Overall Study|Protocol Deviation|0|||
27845280|NCT01396421|81265236|FG000|Overall Study|Lack of Efficacy|7|||
27845281|NCT01396421|81265237|FG001|Overall Study|Lack of Efficacy|17|||
27845282|NCT01396421|81265238|FG002|Overall Study|Lack of Efficacy|7|||
27845283|NCT01396421|81265239|FG003|Overall Study|Lack of Efficacy|18|||
27845284|NCT01813071|81265240|FG000|Overall Study|Protocol Violation|0|||
27845285|NCT01813071|81265241|FG001|Overall Study|Protocol Violation|0|||
27845286|NCT01813071|81265242|FG002|Overall Study|Protocol Violation|0|||
27845287|NCT01813071|81265243|FG003|Overall Study|Protocol Violation|0|||
27845288|NCT01813071|81265244|FG004|Overall Study|Protocol Violation|1|||
27845289|NCT01813071|81265245|FG005|Overall Study|Protocol Violation|4|||
27845290|NCT01813071|81265246|FG006|Overall Study|Protocol Violation|2|||
27845291|NCT01813071|81265247|FG007|Overall Study|Protocol Violation|4|||
27845292|NCT01813071|81265248|FG008|Overall Study|Protocol Violation|2|||
27845293|NCT01813071|81265240|FG000|Overall Study|Withdrawal by Subject|0|||
27845294|NCT01813071|81265241|FG001|Overall Study|Withdrawal by Subject|0|||
27845295|NCT01813071|81265242|FG002|Overall Study|Withdrawal by Subject|0|||
27845296|NCT01813071|81265243|FG003|Overall Study|Withdrawal by Subject|0|||
27845297|NCT01813071|81265244|FG004|Overall Study|Withdrawal by Subject|0|||
27845298|NCT01813071|81265245|FG005|Overall Study|Withdrawal by Subject|1|||
27845299|NCT01813071|81265246|FG006|Overall Study|Withdrawal by Subject|0|||
27845300|NCT01813071|81265247|FG007|Overall Study|Withdrawal by Subject|0|||
27845301|NCT01813071|81265248|FG008|Overall Study|Withdrawal by Subject|0|||
27845302|NCT01813071|81265240|FG000|Overall Study|Adverse Event|0|||
27845303|NCT01813071|81265241|FG001|Overall Study|Adverse Event|0|||
27845304|NCT01813071|81265242|FG002|Overall Study|Adverse Event|0|||
27845305|NCT01813071|81265243|FG003|Overall Study|Adverse Event|0|||
27845306|NCT01813071|81265244|FG004|Overall Study|Adverse Event|0|||
27613610|NCT04022889|80426703|FG002|Stage 2|Adverse Event|2|||
27845307|NCT01813071|81265245|FG005|Overall Study|Adverse Event|1|||
27845308|NCT01813071|81265246|FG006|Overall Study|Adverse Event|0|||
27845309|NCT01813071|81265247|FG007|Overall Study|Adverse Event|0|||
27845310|NCT01813071|81265248|FG008|Overall Study|Adverse Event|0|||
27845311|NCT01813071|81265240|FG000|Overall Study|Physician Decision|0|||
27845312|NCT01813071|81265241|FG001|Overall Study|Physician Decision|0|||
27845313|NCT01813071|81265242|FG002|Overall Study|Physician Decision|0|||
27845314|NCT01813071|81265243|FG003|Overall Study|Physician Decision|0|||
27845315|NCT01813071|81265244|FG004|Overall Study|Physician Decision|0|||
27845316|NCT01813071|81265245|FG005|Overall Study|Physician Decision|0|||
27845317|NCT01813071|81265246|FG006|Overall Study|Physician Decision|1|||
27845318|NCT01813071|81265247|FG007|Overall Study|Physician Decision|0|||
27845319|NCT01813071|81265248|FG008|Overall Study|Physician Decision|0|||
27845320|NCT01813071|81265240|FG000|Overall Study|Met inc/exc criteria|0|||
27845321|NCT01813071|81265241|FG001|Overall Study|Met inc/exc criteria|0|||
27845322|NCT01813071|81265242|FG002|Overall Study|Met inc/exc criteria|0|||
27845323|NCT01813071|81265243|FG003|Overall Study|Met inc/exc criteria|0|||
27845324|NCT01813071|81265244|FG004|Overall Study|Met inc/exc criteria|0|||
27845325|NCT01813071|81265245|FG005|Overall Study|Met inc/exc criteria|1|||
27845326|NCT01813071|81265246|FG006|Overall Study|Met inc/exc criteria|0|||
27845327|NCT01813071|81265247|FG007|Overall Study|Met inc/exc criteria|1|||
27845328|NCT01813071|81265248|FG008|Overall Study|Met inc/exc criteria|1|||
27845329|NCT03653026|81265252|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
27845330|NCT03653026|81265253|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
27845331|NCT03653026|81265254|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
27845332|NCT03653026|81265255|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
27845333|NCT03653026|81265252|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
27845334|NCT03653026|81265253|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
27845335|NCT03653026|81265254|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27845336|NCT03653026|81265255|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
27845337|NCT03653026|81265252|FG000|Part 1: Placebo-controlled Period|Other|0|||
27845338|NCT03653026|81265253|FG001|Part 1: Placebo-controlled Period|Other|3|||
27845339|NCT03653026|81265254|FG002|Part 1: Placebo-controlled Period|Other|0|||
27845340|NCT03653026|81265255|FG003|Part 1: Placebo-controlled Period|Other|0|||
27845341|NCT03653026|81265252|FG000|Part 2: Open-label Extension|Adverse Event|0|||
27845342|NCT03653026|81265253|FG001|Part 2: Open-label Extension|Adverse Event|0|||
27845343|NCT03653026|81265254|FG002|Part 2: Open-label Extension|Adverse Event|1|||
27845344|NCT03653026|81265255|FG003|Part 2: Open-label Extension|Adverse Event|1|||
27845345|NCT03653026|81265252|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
27845346|NCT03653026|81265253|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
27845347|NCT03653026|81265254|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
27845348|NCT03653026|81265255|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
27845349|NCT03653026|81265252|FG000|Part 2: Open-label Extension|Other|0|||
27845350|NCT03653026|81265253|FG001|Part 2: Open-label Extension|Other|0|||
27845351|NCT03653026|81265254|FG002|Part 2: Open-label Extension|Other|1|||
27845352|NCT03653026|81265255|FG003|Part 2: Open-label Extension|Other|2|||
27845353|NCT00885677|81265265|FG000|Overall Study|Death|40|||
27845354|NCT00885677|81265266|FG001|Overall Study|Death|34|||
27845355|NCT00885677|81265265|FG000|Overall Study|Lost to Follow-up|15|||
27845356|NCT00885677|81265266|FG001|Overall Study|Lost to Follow-up|13|||
27845357|NCT00885677|81265265|FG000|Overall Study|Protocol Violation|54|||
27845358|NCT00885677|81265266|FG001|Overall Study|Protocol Violation|54|||
27845359|NCT00885677|81265265|FG000|Overall Study|premature study closure|41|||
27845360|NCT00885677|81265266|FG001|Overall Study|premature study closure|44|||
27845361|NCT00885677|81265265|FG000|Overall Study|device/lead revision or replacement|7|||
27845362|NCT00885677|81265266|FG001|Overall Study|device/lead revision or replacement|6|||
27845363|NCT00885677|81265265|FG000|Overall Study|Heart transplantation|1|||
27845364|NCT00885677|81265266|FG001|Overall Study|Heart transplantation|0|||
27845365|NCT00885677|81265265|FG000|Overall Study|Inclusion/exclusion not met|25|||
27845366|NCT00885677|81265266|FG001|Overall Study|Inclusion/exclusion not met|27|||
27845367|NCT00063882|81265267|FG000|Overall Study|Protocol Violation|3|||
27845368|NCT00063882|81265268|FG001|Overall Study|Protocol Violation|3|||
27845369|NCT00063882|81265267|FG000|Overall Study|Withdrawal by Subject|2|||
27845370|NCT00063882|81265268|FG001|Overall Study|Withdrawal by Subject|1|||
27845371|NCT02457611|81265269|FG000|Overall Study|Lost to Follow-up|3|||
27845372|NCT00873119|81265270|FG000|Overall Study|Patient request|4|||
27845373|NCT00873119|81265271|FG001|Overall Study|Patient request|2|||
27845374|NCT00873119|81265270|FG000|Overall Study|Adverse Event|8|||
27845375|NCT00873119|81265271|FG001|Overall Study|Adverse Event|0|||
27845376|NCT00873119|81265270|FG000|Overall Study|Progressive disease|26|||
27845377|NCT00873119|81265271|FG001|Overall Study|Progressive disease|18|||
27845378|NCT00873119|81265270|FG000|Overall Study|Death|2|||
27845379|NCT00873119|81265271|FG001|Overall Study|Death|1|||
27845380|NCT00873119|81265270|FG000|Overall Study|Other|2|||
27845381|NCT00873119|81265271|FG001|Overall Study|Other|5|||
27845382|NCT00873119|81265270|FG000|Overall Study|Not treated|2|||
27845383|NCT00873119|81265271|FG001|Overall Study|Not treated|0|||
27504807|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
27845384|NCT00097786|81265272|FG000|Overall Study|lost to follow-up for all-cause death|296|||
27845385|NCT00097786|81265273|FG001|Overall Study|lost to follow-up for all-cause death|292|||
27845386|NCT00097786|81265274|FG002|Overall Study|lost to follow-up for all-cause death|313|||
27845387|NCT00097786|81265275|FG003|Overall Study|lost to follow-up for all-cause death|310|||
27845388|NCT02400476|81265276|FG000|Overall Study|Adverse Event|57|||
27845389|NCT02400476|81265277|FG001|Overall Study|Adverse Event|10|||
27893422|NCT01362244|81444028|FG000|Overall Study|Lack of Efficacy|5|||
27893423|NCT01362244|81444029|FG001|Overall Study|Lack of Efficacy|11|||
27893424|NCT01362244|81444028|FG000|Overall Study|Lost to Follow-up|0|||
27893425|NCT01362244|81444029|FG001|Overall Study|Lost to Follow-up|2|||
27893426|NCT01362244|81444028|FG000|Overall Study|Protocol Violation|5|||
27893427|NCT01362244|81444029|FG001|Overall Study|Protocol Violation|1|||
27893428|NCT01362244|81444028|FG000|Overall Study|Withdrawal by Subject|2|||
27893429|NCT01362244|81444029|FG001|Overall Study|Withdrawal by Subject|1|||
27893430|NCT01362244|81444028|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
27893431|NCT01362244|81444029|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
27893432|NCT01362244|81444028|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
27893433|NCT01362244|81444029|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
27893434|NCT04683939|81444032|FG000|Overall Study|Study termination by the sponsor|0|||
27893435|NCT04683939|81444033|FG001|Overall Study|Study termination by the sponsor|1|||
27893436|NCT04683939|81444034|FG002|Overall Study|Study termination by the sponsor|2|||
27893437|NCT04683939|81444035|FG003|Overall Study|Study termination by the sponsor|2|||
27893438|NCT04683939|81444032|FG000|Overall Study|Death|1|||
27893439|NCT04683939|81444033|FG001|Overall Study|Death|1|||
27893440|NCT04683939|81444034|FG002|Overall Study|Death|2|||
27893441|NCT04683939|81444035|FG003|Overall Study|Death|1|||
27893442|NCT04683939|81444032|FG000|Overall Study|Withdrawal by Subject|1|||
27893443|NCT04683939|81444033|FG001|Overall Study|Withdrawal by Subject|0|||
27893444|NCT04683939|81444034|FG002|Overall Study|Withdrawal by Subject|0|||
27504808|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
27504809|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
27504810|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
27845390|NCT02400476|81265278|FG002|Overall Study|Adverse Event|22|||
27845391|NCT02400476|81265279|FG003|Overall Study|Adverse Event|19|||
27845392|NCT02400476|81265280|FG004|Overall Study|Adverse Event|5|||
27845393|NCT02400476|81265281|FG005|Overall Study|Adverse Event|8|||
27845394|NCT02400476|81265276|FG000|Overall Study|Withdrawal by Subject|4|||
27845395|NCT02400476|81265277|FG001|Overall Study|Withdrawal by Subject|1|||
27845396|NCT02400476|81265278|FG002|Overall Study|Withdrawal by Subject|12|||
27845397|NCT02400476|81265279|FG003|Overall Study|Withdrawal by Subject|7|||
27845398|NCT02400476|81265280|FG004|Overall Study|Withdrawal by Subject|5|||
27845399|NCT02400476|81265281|FG005|Overall Study|Withdrawal by Subject|5|||
27845400|NCT02400476|81265276|FG000|Overall Study|Lost to Follow-up|0|||
27845401|NCT02400476|81265277|FG001|Overall Study|Lost to Follow-up|0|||
27845402|NCT02400476|81265278|FG002|Overall Study|Lost to Follow-up|0|||
27845403|NCT02400476|81265279|FG003|Overall Study|Lost to Follow-up|1|||
27845404|NCT02400476|81265280|FG004|Overall Study|Lost to Follow-up|3|||
27845405|NCT02400476|81265281|FG005|Overall Study|Lost to Follow-up|1|||
27845406|NCT02400476|81265276|FG000|Overall Study|Physician Decision|0|||
27845407|NCT02400476|81265277|FG001|Overall Study|Physician Decision|0|||
27845408|NCT02400476|81265278|FG002|Overall Study|Physician Decision|1|||
27845409|NCT02400476|81265279|FG003|Overall Study|Physician Decision|1|||
27845410|NCT02400476|81265280|FG004|Overall Study|Physician Decision|0|||
27845411|NCT02400476|81265281|FG005|Overall Study|Physician Decision|1|||
27845412|NCT02400476|81265276|FG000|Overall Study|Other, Disease Progression|0|||
27845413|NCT02400476|81265277|FG001|Overall Study|Other, Disease Progression|1|||
27845414|NCT02400476|81265278|FG002|Overall Study|Other, Disease Progression|2|||
27845415|NCT02400476|81265279|FG003|Overall Study|Other, Disease Progression|1|||
27845416|NCT02400476|81265280|FG004|Overall Study|Other, Disease Progression|2|||
27845417|NCT02400476|81265281|FG005|Overall Study|Other, Disease Progression|1|||
27845418|NCT02400476|81265276|FG000|Overall Study|Other, Decreased Quality of Life|0|||
27845419|NCT02400476|81265277|FG001|Overall Study|Other, Decreased Quality of Life|0|||
27845420|NCT02400476|81265278|FG002|Overall Study|Other, Decreased Quality of Life|2|||
27845421|NCT02400476|81265279|FG003|Overall Study|Other, Decreased Quality of Life|0|||
27845422|NCT02400476|81265280|FG004|Overall Study|Other, Decreased Quality of Life|0|||
27845423|NCT02400476|81265281|FG005|Overall Study|Other, Decreased Quality of Life|0|||
27845424|NCT02400476|81265276|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27893445|NCT04683939|81444035|FG003|Overall Study|Withdrawal by Subject|0|||
27893446|NCT04683939|81444032|FG000|Overall Study|Physician Decision|1|||
27893447|NCT04683939|81444033|FG001|Overall Study|Physician Decision|0|||
27893448|NCT04683939|81444034|FG002|Overall Study|Physician Decision|0|||
27504811|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
27845425|NCT02400476|81265277|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27845426|NCT02400476|81265278|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
27845427|NCT02400476|81265279|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
27845428|NCT02400476|81265280|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27845429|NCT02400476|81265281|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
27845430|NCT01286558|81265300|FG000|Overall Study|Adverse Event|1|||
27845431|NCT01286558|81265301|FG001|Overall Study|Adverse Event|1|||
27893449|NCT04683939|81444035|FG003|Overall Study|Physician Decision|0|||
27845432|NCT01286558|81265300|FG000|Overall Study|Withdrawal by Subject|0|||
27845433|NCT01286558|81265301|FG001|Overall Study|Withdrawal by Subject|1|||
27845434|NCT04291508|81265302|FG000|Overall Study|Withdrawal by Subject|1|||
27845435|NCT04291508|81265303|FG001|Overall Study|Withdrawal by Subject|0|||
27845436|NCT04291508|81265304|FG002|Overall Study|Withdrawal by Subject|1|||
27845437|NCT04291508|81265305|FG003|Overall Study|Withdrawal by Subject|0|||
27845438|NCT04291508|81265302|FG000|Overall Study|lost to follow up|4|||
27845439|NCT04291508|81265303|FG001|Overall Study|lost to follow up|0|||
27845440|NCT04291508|81265304|FG002|Overall Study|lost to follow up|1|||
27845441|NCT04291508|81265305|FG003|Overall Study|lost to follow up|0|||
27845442|NCT00892281|81265308|FG000|Overall Study|Adverse Event|65|||
27845443|NCT00892281|81265309|FG001|Overall Study|Adverse Event|8|||
27845444|NCT00892281|81265308|FG000|Overall Study|Lost to Follow-up|81|||
27845445|NCT00892281|81265309|FG001|Overall Study|Lost to Follow-up|8|||
27845446|NCT00892281|81265308|FG000|Overall Study|Pregnancy|1|||
27845447|NCT00892281|81265309|FG001|Overall Study|Pregnancy|0|||
27845448|NCT00892281|81265308|FG000|Overall Study|Protocol Violation|7|||
27845449|NCT00892281|81265309|FG001|Overall Study|Protocol Violation|2|||
27845450|NCT00892281|81265308|FG000|Overall Study|Withdrawal by Subject|86|||
27845451|NCT00892281|81265309|FG001|Overall Study|Withdrawal by Subject|14|||
27845452|NCT00892281|81265308|FG000|Overall Study|Subject failed to return for final visit|2|||
27845453|NCT00892281|81265309|FG001|Overall Study|Subject failed to return for final visit|0|||
27845454|NCT00892281|81265308|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
27845455|NCT00892281|81265309|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
27845456|NCT00892281|81265308|FG000|Overall Study|Final visit completed 4 weeks late|0|||
27845457|NCT00892281|81265309|FG001|Overall Study|Final visit completed 4 weeks late|1|||
27845458|NCT00892281|81265308|FG000|Overall Study|Subject completed day after study closed|1|||
27845459|NCT00892281|81265309|FG001|Overall Study|Subject completed day after study closed|0|||
27845460|NCT00892281|81265308|FG000|Overall Study|Family emergency|1|||
27845461|NCT00892281|81265309|FG001|Overall Study|Family emergency|0|||
27845462|NCT00892281|81265308|FG000|Overall Study|Last visit not done - death in family|1|||
27845463|NCT00892281|81265309|FG001|Overall Study|Last visit not done - death in family|0|||
27845464|NCT00892281|81265308|FG000|Overall Study|Did not meet incl/excl criteria|1|||
27845465|NCT00892281|81265309|FG001|Overall Study|Did not meet incl/excl criteria|0|||
27845466|NCT00892281|81265308|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
27845467|NCT00892281|81265309|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
27845468|NCT00892281|81265308|FG000|Overall Study|Unable to redeem the drug voucher|1|||
27845469|NCT00892281|81265309|FG001|Overall Study|Unable to redeem the drug voucher|0|||
27845470|NCT00892281|81265308|FG000|Overall Study|Subject not good candidate for study|1|||
27845471|NCT00892281|81265309|FG001|Overall Study|Subject not good candidate for study|0|||
27845472|NCT00892281|81265308|FG000|Overall Study|Subject did not return for any visits|1|||
27845473|NCT00892281|81265309|FG001|Overall Study|Subject did not return for any visits|0|||
27845474|NCT00892281|81265308|FG000|Overall Study|Subject missed several visits/lost meds|1|||
27845475|NCT00892281|81265309|FG001|Overall Study|Subject missed several visits/lost meds|0|||
27845476|NCT00892281|81265308|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
27845477|NCT00892281|81265309|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
27845478|NCT00892281|81265308|FG000|Overall Study|Scheduled for knee replacement|0|||
27845479|NCT00892281|81265309|FG001|Overall Study|Scheduled for knee replacement|1|||
27845480|NCT00892281|81265308|FG000|Overall Study|PI complained of inadequate compensation|3|||
27845481|NCT00892281|81265309|FG001|Overall Study|PI complained of inadequate compensation|0|||
27845482|NCT00892281|81265308|FG000|Overall Study|Subject lost interest in program|0|||
27845483|NCT00892281|81265309|FG001|Overall Study|Subject lost interest in program|1|||
27845484|NCT00892281|81265308|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
27845485|NCT00892281|81265309|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
27845486|NCT00892281|81265308|FG000|Overall Study|Death in family|1|||
27845487|NCT00892281|81265309|FG001|Overall Study|Death in family|0|||
27845488|NCT00892281|81265308|FG000|Overall Study|Lack of efficacy of study product|2|||
27845489|NCT00892281|81265309|FG001|Overall Study|Lack of efficacy of study product|0|||
27845490|NCT00892281|81265308|FG000|Overall Study|Subject not seen by PI at final visit|1|||
27845491|NCT00892281|81265309|FG001|Overall Study|Subject not seen by PI at final visit|0|||
27845492|NCT00892281|81265308|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
27845493|NCT00892281|81265309|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
27845494|NCT00892281|81265308|FG000|Overall Study|Missed multiple visits|1|||
27845495|NCT00892281|81265309|FG001|Overall Study|Missed multiple visits|0|||
27845496|NCT00892281|81265308|FG000|Overall Study|Missed visits rescheduled out of window|1|||
27845497|NCT00892281|81265309|FG001|Overall Study|Missed visits rescheduled out of window|0|||
27845498|NCT00892281|81265308|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
27845499|NCT00892281|81265309|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
27845500|NCT00892281|81265308|FG000|Overall Study|Subject had history of drug abuse|1|||
27725668|NCT00481065|80826696|FG005|Overall Study|Inappropriate enrollment|1|||
27893450|NCT04683939|81444032|FG000|Overall Study|Lost to Follow-up|0|||
27893451|NCT04683939|81444033|FG001|Overall Study|Lost to Follow-up|1|||
27893452|NCT04683939|81444034|FG002|Overall Study|Lost to Follow-up|0|||
27893453|NCT04683939|81444035|FG003|Overall Study|Lost to Follow-up|0|||
27893454|NCT00432276|81444036|FG000|Overall Study|Hyperglycemic Rescue|44|||
27845501|NCT00892281|81265309|FG001|Overall Study|Subject had history of drug abuse|0|||
27845502|NCT00892281|81265308|FG000|Overall Study|Rash on hand|1|||
27845503|NCT00892281|81265309|FG001|Overall Study|Rash on hand|0|||
27845504|NCT00892281|81265308|FG000|Overall Study|Visit 4 date out of window|1|||
27845505|NCT00892281|81265309|FG001|Overall Study|Visit 4 date out of window|0|||
27845506|NCT03005067|81265310|FG000|Overall Study|Withdrawal by Subject|3|||
27845507|NCT03005067|81265311|FG001|Overall Study|Withdrawal by Subject|2|||
27845508|NCT03005067|81265310|FG000|Overall Study|Adverse Event|4|||
27845509|NCT03005067|81265311|FG001|Overall Study|Adverse Event|3|||
27845510|NCT03005067|81265310|FG000|Overall Study|Other (reason not specified)|3|||
27845511|NCT03005067|81265311|FG001|Overall Study|Other (reason not specified)|1|||
27893455|NCT00432276|81444037|FG001|Overall Study|Hyperglycemic Rescue|87|||
27893456|NCT00432276|81444036|FG000|Overall Study|Adverse Event|13|||
27893457|NCT00432276|81444037|FG001|Overall Study|Adverse Event|16|||
27893458|NCT00432276|81444036|FG000|Overall Study|Protocol Violation|25|||
27893459|NCT00432276|81444037|FG001|Overall Study|Protocol Violation|20|||
27893460|NCT00432276|81444036|FG000|Overall Study|Lost to Follow-up|6|||
27893461|NCT00432276|81444037|FG001|Overall Study|Lost to Follow-up|2|||
27893462|NCT00432276|81444036|FG000|Overall Study|Withdrawal by Subject|25|||
27893463|NCT00432276|81444037|FG001|Overall Study|Withdrawal by Subject|20|||
27893464|NCT00432276|81444036|FG000|Overall Study|Physician Decision|6|||
27893465|NCT00432276|81444037|FG001|Overall Study|Physician Decision|8|||
27893466|NCT00432276|81444036|FG000|Overall Study|Other|2|||
27893467|NCT00432276|81444037|FG001|Overall Study|Other|3|||
27893468|NCT00308087|81444042|FG000|Overall Study|Progressive Disease|19|||
27893469|NCT00308087|81444043|FG001|Overall Study|Progressive Disease|21|||
27893470|NCT00308087|81444042|FG000|Overall Study|Study Closure|11|||
27893471|NCT00308087|81444043|FG001|Overall Study|Study Closure|12|||
27893472|NCT00308087|81444042|FG000|Overall Study|Withdrawal by Subject|2|||
27893473|NCT00308087|81444043|FG001|Overall Study|Withdrawal by Subject|1|||
27893474|NCT00308087|81444042|FG000|Overall Study|Other|4|||
27893475|NCT00308087|81444043|FG001|Overall Study|Other|3|||
27893476|NCT01300338|81444044|FG000|Overall Study|Lost to Follow-up|5|||
27893477|NCT01300338|81444045|FG001|Overall Study|Lost to Follow-up|0|||
27893478|NCT02951533|81444046|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
27893479|NCT02951533|81444047|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
27893480|NCT02951533|81444048|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
27725669|NCT00481065|80826697|FG006|Overall Study|Inappropriate enrollment|0|||
27725670|NCT00481065|80826698|FG007|Overall Study|Inappropriate enrollment|1|||
27725671|NCT00481065|80826691|FG000|Overall Study|Administrative reason|0|||
27725672|NCT00481065|80826692|FG001|Overall Study|Administrative reason|0|||
27725673|NCT00481065|80826693|FG002|Overall Study|Administrative reason|0|||
27725674|NCT00481065|80826694|FG003|Overall Study|Administrative reason|0|||
27845512|NCT03005067|81265310|FG000|Overall Study|Protocol Violation|0|||
27845513|NCT03005067|81265311|FG001|Overall Study|Protocol Violation|1|||
27845514|NCT00865098|81265312|FG000|Overall Study|Progressive disease|1|||
27893481|NCT02951533|81444046|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
27893482|NCT02951533|81444047|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
27893483|NCT02951533|81444048|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
27893484|NCT02951533|81444046|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
27893485|NCT02951533|81444047|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
27893486|NCT02951533|81444048|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
27893487|NCT02951533|81444046|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
27845515|NCT02457819|81265313|FG000|Overall Study|reason not given|8|||
27958621|NCT01791517|81680069|FG011|Phase II|Adverse Event|0|||
27845516|NCT02457819|81265313|FG000|Overall Study|Withdrawal by Subject|24|||
27845517|NCT02457819|81265313|FG000|Overall Study|Protocol Violation|1|||
27845518|NCT02457819|81265313|FG000|Overall Study|non compliance with study drug|4|||
27845519|NCT02457819|81265313|FG000|Overall Study|Lost to Follow-up|10|||
27845520|NCT02457819|81265313|FG000|Overall Study|Lack of Efficacy|19|||
27845521|NCT02457819|81265313|FG000|Overall Study|Adverse Event|33|||
27845522|NCT02220725|81265314|FG000|Overall Study|Lost to Follow-up|0|||
27845523|NCT02220725|81265315|FG001|Overall Study|Lost to Follow-up|0|||
27845524|NCT02220725|81265316|FG002|Overall Study|Lost to Follow-up|0|||
27845525|NCT02220725|81265317|FG003|Overall Study|Lost to Follow-up|1|||
27845526|NCT02220725|81265314|FG000|Overall Study|Withdrawal by Subject|0|||
27845527|NCT02220725|81265315|FG001|Overall Study|Withdrawal by Subject|0|||
27845528|NCT02220725|81265316|FG002|Overall Study|Withdrawal by Subject|0|||
27845529|NCT02220725|81265317|FG003|Overall Study|Withdrawal by Subject|1|||
27845530|NCT01297322|81265318|FG000|Overall Study|Lost to Follow-up|1|||
27845531|NCT01297322|81265319|FG001|Overall Study|Lost to Follow-up|0|||
27845532|NCT01297322|81265318|FG000|Overall Study|Withdrawal by Subject|0|||
27845533|NCT01297322|81265319|FG001|Overall Study|Withdrawal by Subject|1|||
27845534|NCT01297322|81265318|FG000|Overall Study|Protocol Violation|0|||
27845535|NCT01297322|81265319|FG001|Overall Study|Protocol Violation|3|||
27845536|NCT01559935|81265328|FG000|Car Phase|Toxicity|4|||
27845537|NCT01559935|81265328|FG000|Car Phase|Death|1|||
27845538|NCT01559935|81265328|FG000|Car Phase|Lack of Efficacy|2|||
27845539|NCT01559935|81265328|FG000|Car Phase|Lost to Follow-up|1|||
27845540|NCT01559935|81265328|FG000|Car Phase|Physician Decision|1|||
27845541|NCT01559935|81265328|FG000|Car Phase|Withdrawal by Subject|2|||
27845542|NCT01559935|81265328|FG000|Car Phase|Per protocol|1|||
27845543|NCT01559935|81265328|FG000|Car Phase|Insurance|1|||
27845544|NCT01559935|81265328|FG000|Car Phase|non-compliance|1|||
27845545|NCT01559935|81265328|FG000|BiRD Phase|Toxicity|1|||
27845546|NCT01559935|81265328|FG000|BiRD Phase|Lack of Efficacy|1|||
27845547|NCT01559935|81265328|FG000|BiRD Phase|Withdrawal by Subject|2|||
27845548|NCT01559935|81265328|FG000|Maintenance Phase|Remains on study|28|||
27845549|NCT01559935|81265328|FG000|Maintenance Phase|Toxicity|1|||
27845550|NCT01559935|81265328|FG000|Maintenance Phase|Lack of Efficacy|18|||
27845551|NCT01559935|81265328|FG000|Maintenance Phase|Withdrawal by Subject|5|||
27845552|NCT01559935|81265328|FG000|Maintenance Phase|Non-compliance|2|||
27845553|NCT04025684|81265329|FG000|Overall Study|Withdrawal by Subject|1|||
27845554|NCT04025684|81265330|FG001|Overall Study|Withdrawal by Subject|1|||
27845555|NCT04025684|81265331|FG002|Overall Study|Withdrawal by Subject|0|||
27845556|NCT04025684|81265332|FG003|Overall Study|Withdrawal by Subject|0|||
27845557|NCT04025684|81265329|FG000|Overall Study|Multiple reasons|1|||
27845558|NCT04025684|81265330|FG001|Overall Study|Multiple reasons|3|||
27845559|NCT04025684|81265331|FG002|Overall Study|Multiple reasons|0|||
27845560|NCT04025684|81265332|FG003|Overall Study|Multiple reasons|1|||
27845561|NCT00099268|81265335|FG000|Overall Study|Withdrawal by Subject|46|||
27845562|NCT00099268|81265336|FG001|Overall Study|Withdrawal by Subject|28|||
27845563|NCT00099268|81265335|FG000|Overall Study|Adverse Event|19|||
27845564|NCT00099268|81265336|FG001|Overall Study|Adverse Event|19|||
27845565|NCT00099268|81265335|FG000|Overall Study|Protocol Violation|9|||
27845566|NCT00099268|81265336|FG001|Overall Study|Protocol Violation|8|||
27845567|NCT00099268|81265335|FG000|Overall Study|Lost to Follow-up|6|||
27845568|NCT00099268|81265336|FG001|Overall Study|Lost to Follow-up|4|||
27845569|NCT00099268|81265335|FG000|Overall Study|Lack of Efficacy|5|||
27845570|NCT00099268|81265336|FG001|Overall Study|Lack of Efficacy|18|||
27845571|NCT00099268|81265335|FG000|Overall Study|Administrative problems|4|||
27845572|NCT00099268|81265336|FG001|Overall Study|Administrative problems|4|||
27845573|NCT00099268|81265335|FG000|Overall Study|Death|3|||
27845574|NCT00099268|81265336|FG001|Overall Study|Death|1|||
27845575|NCT01796964|81265337|FG000|Overall Study|Adverse Event|1|||
27845576|NCT01796964|81265338|FG001|Overall Study|Adverse Event|1|||
27845577|NCT01796964|81265337|FG000|Overall Study|Death|1|||
27845578|NCT01796964|81265338|FG001|Overall Study|Death|0|||
27845579|NCT01796964|81265337|FG000|Overall Study|Protocol Violation|0|||
27845580|NCT01796964|81265338|FG001|Overall Study|Protocol Violation|1|||
27845581|NCT01796964|81265337|FG000|Overall Study|Withdrawal by Subject|1|||
27845582|NCT01796964|81265338|FG001|Overall Study|Withdrawal by Subject|1|||
27845583|NCT00442546|81265342|FG000|Overall Study|Adverse Event|11|||
27845584|NCT00442546|81265343|FG001|Overall Study|Adverse Event|17|||
27845585|NCT00442546|81265344|FG002|Overall Study|Adverse Event|13|||
27845586|NCT00442546|81265342|FG000|Overall Study|Lost to Follow-up|1|||
27845587|NCT00442546|81265343|FG001|Overall Study|Lost to Follow-up|2|||
27845588|NCT00442546|81265344|FG002|Overall Study|Lost to Follow-up|1|||
27845589|NCT00442546|81265342|FG000|Overall Study|Other|4|||
27845590|NCT00442546|81265343|FG001|Overall Study|Other|9|||
27845591|NCT00442546|81265344|FG002|Overall Study|Other|6|||
27845592|NCT00442546|81265342|FG000|Overall Study|Withdrawal by Subject|5|||
27845593|NCT00442546|81265343|FG001|Overall Study|Withdrawal by Subject|5|||
27845594|NCT00442546|81265344|FG002|Overall Study|Withdrawal by Subject|7|||
27504812|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
27504813|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
27504814|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
27504815|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
27504816|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
27504817|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
27613611|NCT04022889|80426701|FG000|Stage 2|Protocol Violation|0|||
27725675|NCT00481065|80826695|FG004|Overall Study|Administrative reason|0|||
27725676|NCT00481065|80826696|FG005|Overall Study|Administrative reason|2|||
27725677|NCT00481065|80826697|FG006|Overall Study|Administrative reason|1|||
27725678|NCT00481065|80826698|FG007|Overall Study|Administrative reason|0|||
27725679|NCT00481065|80826691|FG000|Overall Study|Protocol Violation|2|||
27725680|NCT00481065|80826692|FG001|Overall Study|Protocol Violation|1|||
27725681|NCT00481065|80826693|FG002|Overall Study|Protocol Violation|1|||
27725682|NCT00481065|80826694|FG003|Overall Study|Protocol Violation|1|||
27725683|NCT00481065|80826695|FG004|Overall Study|Protocol Violation|2|||
27725684|NCT00481065|80826696|FG005|Overall Study|Protocol Violation|6|||
27725685|NCT00481065|80826697|FG006|Overall Study|Protocol Violation|3|||
27725686|NCT00481065|80826698|FG007|Overall Study|Protocol Violation|2|||
27725687|NCT00481065|80826691|FG000|Overall Study|Unable to classify|0|||
27725688|NCT00481065|80826692|FG001|Overall Study|Unable to classify|1|||
27725689|NCT00481065|80826693|FG002|Overall Study|Unable to classify|2|||
27725690|NCT00481065|80826694|FG003|Overall Study|Unable to classify|0|||
27725691|NCT00481065|80826695|FG004|Overall Study|Unable to classify|1|||
27725692|NCT00481065|80826696|FG005|Overall Study|Unable to classify|0|||
27725693|NCT00481065|80826697|FG006|Overall Study|Unable to classify|0|||
27725694|NCT00481065|80826698|FG007|Overall Study|Unable to classify|0|||
27725695|NCT04541004|80826700|FG000|Overall Study|Adverse Event|2|||
27725696|NCT01959165|80826701|FG000|Overall Study|Adverse Event|0|||
27725697|NCT01959165|80826702|FG001|Overall Study|Adverse Event|0|||
27725698|NCT01959165|80826703|FG002|Overall Study|Adverse Event|0|||
27725699|NCT01959165|80826704|FG003|Overall Study|Adverse Event|1|||
27725700|NCT01959165|80826701|FG000|Overall Study|Lack of Efficacy|1|||
27725701|NCT01959165|80826702|FG001|Overall Study|Lack of Efficacy|0|||
27725702|NCT01959165|80826703|FG002|Overall Study|Lack of Efficacy|0|||
27725703|NCT01959165|80826704|FG003|Overall Study|Lack of Efficacy|0|||
27725704|NCT01959165|80826701|FG000|Overall Study|overdose|0|||
27725705|NCT01959165|80826702|FG001|Overall Study|overdose|0|||
27725706|NCT01959165|80826703|FG002|Overall Study|overdose|0|||
27725707|NCT01959165|80826704|FG003|Overall Study|overdose|1|||
27725708|NCT01959165|80826701|FG000|Overall Study|Welfare recipient|0|||
27725709|NCT01959165|80826702|FG001|Overall Study|Welfare recipient|1|||
27725710|NCT01959165|80826703|FG002|Overall Study|Welfare recipient|0|||
27725711|NCT01959165|80826704|FG003|Overall Study|Welfare recipient|0|||
27725712|NCT01299766|80826705|FG000|Overall Study|Death|5|||
27725713|NCT01299766|80826706|FG001|Overall Study|Death|4|||
27725714|NCT01299766|80826705|FG000|Overall Study|Withdrawal by Subject|29|||
27725715|NCT01299766|80826706|FG001|Overall Study|Withdrawal by Subject|19|||
27725716|NCT01679002|80826707|FG000|Overall Study|Adverse Event|1|||
27725717|NCT01679002|80826708|FG001|Overall Study|Adverse Event|1|||
27725718|NCT01679002|80826709|FG002|Overall Study|Adverse Event|0|||
27725719|NCT01987908|80826710|FG000|Placebo Lead-in Period|Adverse Event|2|||
27725720|NCT01987908|80826711|FG001|Placebo Lead-in Period|Adverse Event|0|||
27725721|NCT01987908|80826712|FG002|Placebo Lead-in Period|Adverse Event|0|||
27725722|NCT01987908|80826710|FG000|Placebo Lead-in Period|Physician Decision|2|||
27725723|NCT01987908|80826711|FG001|Placebo Lead-in Period|Physician Decision|0|||
27725724|NCT01987908|80826712|FG002|Placebo Lead-in Period|Physician Decision|0|||
27725725|NCT01987908|80826710|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
27725726|NCT01987908|80826711|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
27725727|NCT01987908|80826712|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
27725728|NCT01987908|80826710|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
27725729|NCT01987908|80826711|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
27725730|NCT01987908|80826712|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
27725731|NCT01987908|80826710|FG000|Treatment Period|Adverse Event|0|||
27725732|NCT01987908|80826711|FG001|Treatment Period|Adverse Event|1|||
27725733|NCT01987908|80826712|FG002|Treatment Period|Adverse Event|1|||
27725734|NCT01987908|80826710|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
27725735|NCT01987908|80826711|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
27725736|NCT01987908|80826712|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
27725737|NCT01987908|80826710|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
27725738|NCT01987908|80826711|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
27725739|NCT01987908|80826712|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
27725740|NCT00560755|80826713|FG000|Overall Study|Protocol Violation|15|||
27725741|NCT00560755|80826713|FG000|Overall Study|Withdrawal by Subject|26|||
27845595|NCT00442546|81265342|FG000|Overall Study|Randomized But Not Treated|5|||
27845596|NCT00442546|81265343|FG001|Overall Study|Randomized But Not Treated|4|||
27845597|NCT00442546|81265344|FG002|Overall Study|Randomized But Not Treated|6|||
27845598|NCT01949116|81265345|FG000|Overall Study|Death|2|||
27845599|NCT01949116|81265346|FG001|Overall Study|Death|0|||
27845600|NCT01949116|81265345|FG000|Overall Study|Lost to Follow-up|1|||
27845601|NCT01949116|81265346|FG001|Overall Study|Lost to Follow-up|3|||
27845602|NCT01949116|81265345|FG000|Overall Study|Withdrawal by Subject|5|||
27845603|NCT01949116|81265346|FG001|Overall Study|Withdrawal by Subject|3|||
27845604|NCT04213209|81265348|FG000|Overall Study|Protocol Violation|1|||
27845605|NCT04213209|81265349|FG001|Overall Study|Protocol Violation|0|||
27845606|NCT04213209|81265350|FG002|Overall Study|Protocol Violation|0|||
27845607|NCT04213209|81265351|FG003|Overall Study|Protocol Violation|0|||
27845608|NCT04213209|81265352|FG004|Overall Study|Protocol Violation|0|||
27845609|NCT04213209|81265353|FG005|Overall Study|Protocol Violation|0|||
27845610|NCT00436917|81265354|FG000|Overall Study|Withdrawal by Subject|13|||
27845611|NCT00436917|81265354|FG000|Overall Study|Adverse Event|2|||
27845612|NCT00436917|81265354|FG000|Overall Study|Physician Decision|1|||
27845613|NCT00436917|81265354|FG000|Overall Study|Death|1|||
27845614|NCT00436917|81265354|FG000|Overall Study|Lost to Follow-up|1|||
27845615|NCT00436917|81265354|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
27845616|NCT00436917|81265354|FG000|Overall Study|Increased creatinine|1|||
27845617|NCT00436917|81265354|FG000|Overall Study|Personal conflicts of patient|1|||
27845618|NCT00319046|81265355|FG000|Overall Study|withdrawal of subject's consent|7|||
27845619|NCT00319046|81265355|FG000|Overall Study|administrative reason|1|||
27845620|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
27845621|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
27845622|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
27845623|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
27845624|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
27845625|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
27845626|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
27845627|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
27845628|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
27845629|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
27845630|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Subject decision|1|||
27845631|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Subject decision|1|||
27845632|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
27845633|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
27845634|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
27845635|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
27845636|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
27845637|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
27845638|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
27845639|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
27845640|NCT00518882|81265356|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
27845641|NCT00518882|81265357|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
27845642|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
27845643|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
27845644|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
27845645|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
27845646|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
27845647|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
27845648|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
27845649|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
27845650|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
27845651|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
27845652|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
27845653|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
27613612|NCT04022889|80426702|FG001|Stage 2|Protocol Violation|0|||
27613613|NCT04022889|80426703|FG002|Stage 2|Protocol Violation|1|||
27845654|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
27845655|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
27845656|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
27845657|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
27845658|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
27845659|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
27613614|NCT04022889|80426701|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
27845660|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
27845661|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
27845662|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
27845663|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
27845664|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
27725742|NCT00560755|80826713|FG000|Overall Study|Lost to Follow-up|9|||
27725743|NCT00560755|80826713|FG000|Overall Study|Adverse Event|8|||
27725744|NCT00560755|80826713|FG000|Overall Study|Physician Decision|2|||
27725745|NCT01273064|80826714|FG000|Overall Study|Adverse Event|5|||
27725746|NCT01273064|80826715|FG001|Overall Study|Adverse Event|1|||
27725747|NCT01273064|80826716|FG002|Overall Study|Adverse Event|3|||
27725748|NCT01273064|80826717|FG003|Overall Study|Adverse Event|2|||
27725749|NCT01273064|80826718|FG004|Overall Study|Adverse Event|1|||
27725750|NCT01273064|80826714|FG000|Overall Study|Withdrawal by Subject|4|||
27725751|NCT01273064|80826715|FG001|Overall Study|Withdrawal by Subject|2|||
27725752|NCT01273064|80826716|FG002|Overall Study|Withdrawal by Subject|2|||
27725753|NCT01273064|80826717|FG003|Overall Study|Withdrawal by Subject|2|||
27845665|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
27845666|NCT00518882|81265356|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
27845667|NCT00518882|81265357|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
27845668|NCT01103479|81265359|FG000|Overall Study|Up to date with CRC screening|1|||
27845669|NCT01103479|81265360|FG001|Overall Study|Up to date with CRC screening|9|||
27845670|NCT01103479|81265361|FG002|Overall Study|Up to date with CRC screening|12|||
27893488|NCT02951533|81444047|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
27893489|NCT02951533|81444048|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
27893490|NCT02951533|81444046|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
27893491|NCT02951533|81444047|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
27893492|NCT02951533|81444048|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
27893493|NCT02951533|81444046|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
27893494|NCT02951533|81444047|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
27893495|NCT02951533|81444048|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
27893496|NCT02951533|81444046|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
27893497|NCT02951533|81444047|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
27893498|NCT02951533|81444048|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
27893499|NCT02951533|81444046|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
27893500|NCT02951533|81444047|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
27893501|NCT02951533|81444048|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
27893502|NCT02951533|81444046|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
27893503|NCT02951533|81444047|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
27725754|NCT01273064|80826718|FG004|Overall Study|Withdrawal by Subject|0|||
27725755|NCT01273064|80826714|FG000|Overall Study|Study Termination|13|||
27845671|NCT01103479|81265359|FG000|Overall Study|Family history of CRC|1|||
27845672|NCT01103479|81265360|FG001|Overall Study|Family history of CRC|0|||
27845673|NCT01103479|81265361|FG002|Overall Study|Family history of CRC|2|||
27845674|NCT01103479|81265359|FG000|Overall Study|Active cancer|1|||
27845675|NCT01103479|81265360|FG001|Overall Study|Active cancer|0|||
27845676|NCT01103479|81265361|FG002|Overall Study|Active cancer|0|||
27845677|NCT01103479|81265359|FG000|Overall Study|Saw non-study physician|2|||
27845678|NCT01103479|81265360|FG001|Overall Study|Saw non-study physician|0|||
27845679|NCT01103479|81265361|FG002|Overall Study|Saw non-study physician|0|||
27845680|NCT02147587|81265364|FG000|Overall Study|Adverse Event|9|||
27845681|NCT02147587|81265365|FG001|Overall Study|Adverse Event|4|||
27845682|NCT02147587|81265364|FG000|Overall Study|Lack of Efficacy|2|||
27845683|NCT02147587|81265365|FG001|Overall Study|Lack of Efficacy|1|||
27845684|NCT01253317|81265366|FG000|Overall Study|Adverse Event|2|||
27845685|NCT00987831|81265367|FG000|Overall Study|Never flared in 12 months|1|||
27845686|NCT00987831|81265368|FG001|Overall Study|Never flared in 12 months|0|||
27845687|NCT00987831|81265369|FG002|Overall Study|Never flared in 12 months|0|||
27845688|NCT00987831|81265367|FG000|Overall Study|Lost to Follow-up|0|||
27845689|NCT00987831|81265368|FG001|Overall Study|Lost to Follow-up|3|||
27845690|NCT00987831|81265369|FG002|Overall Study|Lost to Follow-up|0|||
27845691|NCT00792623|81265375|FG000|Overall Study|Adverse Event|2|||
27845692|NCT00792623|81265375|FG000|Overall Study|Withdrawal by Subject|5|||
27845693|NCT02181296|81265382|FG000|Overall Study|Lost to Follow-up|7|||
27845694|NCT02181296|81265383|FG001|Overall Study|Lost to Follow-up|6|||
27845695|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
27725756|NCT01273064|80826715|FG001|Overall Study|Study Termination|27|||
27725757|NCT01273064|80826716|FG002|Overall Study|Study Termination|26|||
27725758|NCT01273064|80826717|FG003|Overall Study|Study Termination|16|||
27504818|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
27504819|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
27504820|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
27504821|NCT03895203|80040847|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
27504822|NCT03895203|80040848|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
27504823|NCT03895203|80040849|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
27725759|NCT01273064|80826718|FG004|Overall Study|Study Termination|8|||
27725760|NCT01273064|80826714|FG000|Overall Study|Lost to Follow-up|1|||
27725761|NCT01273064|80826715|FG001|Overall Study|Lost to Follow-up|0|||
27725762|NCT01273064|80826716|FG002|Overall Study|Lost to Follow-up|0|||
27725763|NCT01273064|80826717|FG003|Overall Study|Lost to Follow-up|0|||
27725764|NCT01273064|80826718|FG004|Overall Study|Lost to Follow-up|0|||
27725765|NCT01273064|80826714|FG000|Overall Study|Physician Decision|0|||
27725766|NCT01273064|80826715|FG001|Overall Study|Physician Decision|0|||
27893504|NCT02951533|81444048|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
27893505|NCT02951533|81444046|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
27893506|NCT02951533|81444047|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
27893507|NCT02951533|81444048|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
27893508|NCT02951533|81444046|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
27845696|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
27845697|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
27845698|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
27845699|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
27845700|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
27845701|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
27845702|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
27845703|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
27845704|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
27845705|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
27845706|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
27845707|NCT03321526|81265384|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
27845708|NCT03321526|81265385|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
27845709|NCT03321526|81265384|FG000|Follow-up Phase (2 Weeks)|Other|24|||
27845710|NCT03321526|81265385|FG001|Follow-up Phase (2 Weeks)|Other|24|||
27845711|NCT02000531|81265386|FG000|Overall Study|Lost to Follow-up|1|||
27845712|NCT02000531|81265387|FG001|Overall Study|Lost to Follow-up|0|||
27845713|NCT02000531|81265386|FG000|Overall Study|Discontinued due to data cut-off|3|||
27845714|NCT02000531|81265387|FG001|Overall Study|Discontinued due to data cut-off|8|||
27845715|NCT02752802|81265389|FG000|Overall Study|Contrast Volume Not Collected|1|||
27845716|NCT02752802|81265390|FG001|Overall Study|Contrast Volume Not Collected|0|||
27845717|NCT00918463|81265391|FG000|Overall Study|Death|1|||
27845718|NCT00918463|81265391|FG000|Overall Study|Lack of Efficacy|1|||
27845719|NCT01507090|81265392|FG000|Overall Study|incomplete dataset|18|||
27725767|NCT01273064|80826716|FG002|Overall Study|Physician Decision|0|||
27845720|NCT02310789|81265396|FG000|Overall Study|Adverse Event|1|||
27845721|NCT02994394|81265397|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
27845722|NCT02994394|81265398|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
27845723|NCT02994394|81265399|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
27845724|NCT02994394|81265400|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
27845725|NCT02994394|81265401|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
27845726|NCT02994394|81265402|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
27845727|NCT02994394|81265397|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
27845728|NCT02994394|81265398|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
27845729|NCT02994394|81265399|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
27845730|NCT02994394|81265400|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
27845731|NCT02994394|81265401|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
27845732|NCT02994394|81265402|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
27845733|NCT00483548|81265403|FG000|Overall Study|Randomized; not treated with study drug|1|||
27845734|NCT00483548|81265404|FG001|Overall Study|Randomized; not treated with study drug|3|||
27845735|NCT00483548|81265403|FG000|Overall Study|Adverse Event|25|||
27845736|NCT00483548|81265404|FG001|Overall Study|Adverse Event|14|||
27504824|NCT03895203|80040850|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
27504825|NCT03895203|80040851|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
27845737|NCT00483548|81265403|FG000|Overall Study|Laboratory abnormality|1|||
27893509|NCT02951533|81444047|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
27893510|NCT02951533|81444048|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
27893511|NCT02052596|81444049|FG000|Active Phase|Adverse Event|3|||
27893512|NCT02052596|81444050|FG001|Active Phase|Adverse Event|2|||
27845738|NCT00483548|81265404|FG001|Overall Study|Laboratory abnormality|2|||
27845739|NCT00483548|81265403|FG000|Overall Study|Lack of Efficacy|4|||
27845740|NCT00483548|81265404|FG001|Overall Study|Lack of Efficacy|8|||
27845741|NCT00483548|81265403|FG000|Overall Study|Protocol Violation|11|||
27845742|NCT00483548|81265404|FG001|Overall Study|Protocol Violation|7|||
27845743|NCT00483548|81265403|FG000|Overall Study|Pregnancy|1|||
27845744|NCT00483548|81265404|FG001|Overall Study|Pregnancy|0|||
27845745|NCT00483548|81265403|FG000|Overall Study|Protocol required discontinuation|6|||
27845746|NCT00483548|81265404|FG001|Overall Study|Protocol required discontinuation|6|||
27845747|NCT00483548|81265403|FG000|Overall Study|Unable to comply with protocol schedule|1|||
27845748|NCT00483548|81265404|FG001|Overall Study|Unable to comply with protocol schedule|0|||
27845749|NCT00483548|81265403|FG000|Overall Study|Non-compliance with medication|2|||
27845750|NCT00483548|81265404|FG001|Overall Study|Non-compliance with medication|0|||
27845751|NCT00483548|81265403|FG000|Overall Study|Lost to Follow-up|3|||
27845752|NCT00483548|81265404|FG001|Overall Study|Lost to Follow-up|4|||
27845753|NCT00483548|81265403|FG000|Overall Study|Withdrawal by Subject|5|||
27845754|NCT00483548|81265404|FG001|Overall Study|Withdrawal by Subject|2|||
27845755|NCT02014441|81265405|FG000|Overall Study|Withdrawal by Subject|12|||
27845756|NCT00094094|81265406|FG000|Overall Study|Death|2|||
27845757|NCT00094094|81265406|FG000|Overall Study|Lack of Efficacy|23|||
27845758|NCT00094094|81265406|FG000|Overall Study|Adverse Event|7|||
27845759|NCT02284347|81265409|FG000|Overall Study|Lost to Follow-up|2|||
27845760|NCT02284347|81265409|FG000|Overall Study|Withdrawn prior to treatment|1|||
27845761|NCT00966381|81265410|FG000|Overall Study|Withdrawal by Subject|2|||
27845762|NCT00966381|81265411|FG001|Overall Study|Withdrawal by Subject|2|||
27845763|NCT01684215|81265412|FG000|Phase 1, Part 1|Adverse Event|1|||
27845764|NCT01684215|81265413|FG001|Phase 1, Part 1|Adverse Event|0|||
27845765|NCT01684215|81265414|FG002|Phase 1, Part 1|Adverse Event|0|||
27845766|NCT01684215|81265415|FG003|Phase 1, Part 1|Adverse Event|0|||
27845767|NCT01684215|81265412|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
27845768|NCT01684215|81265413|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
27845769|NCT01684215|81265414|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
27845770|NCT01684215|81265415|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
27845771|NCT01684215|81265412|FG000|Phase 1, Part 2|Adverse Event|0|||
27845772|NCT01684215|81265413|FG001|Phase 1, Part 2|Adverse Event|0|||
27845773|NCT01684215|81265414|FG002|Phase 1, Part 2|Adverse Event|1|||
27893513|NCT02052596|81444049|FG000|Active Phase|Lost to Follow-up|8|||
27893514|NCT02052596|81444050|FG001|Active Phase|Lost to Follow-up|11|||
27893515|NCT02052596|81444049|FG000|Active Phase|Protocol Violation|1|||
27504826|NCT03895203|80040852|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
27845774|NCT01684215|81265415|FG003|Phase 1, Part 2|Adverse Event|0|||
27845775|NCT01684215|81265412|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
27845776|NCT01684215|81265413|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
27845777|NCT01684215|81265414|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
27845778|NCT01684215|81265415|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
27845779|NCT01684215|81265412|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
27845780|NCT01684215|81265413|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
27845781|NCT01684215|81265414|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
27845782|NCT01684215|81265415|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
27845783|NCT01684215|81265412|FG000|Phase 2|Death|0|||
27893516|NCT02052596|81444050|FG001|Active Phase|Protocol Violation|2|||
27845784|NCT01684215|81265413|FG001|Phase 2|Death|0|||
27845785|NCT01684215|81265414|FG002|Phase 2|Death|0|||
27845786|NCT01684215|81265415|FG003|Phase 2|Death|8|||
27845787|NCT01684215|81265412|FG000|Phase 2|Study terminated by sponsor|0|||
27845788|NCT01684215|81265413|FG001|Phase 2|Study terminated by sponsor|0|||
27845789|NCT01684215|81265414|FG002|Phase 2|Study terminated by sponsor|0|||
27845790|NCT01684215|81265415|FG003|Phase 2|Study terminated by sponsor|30|||
27845791|NCT01684215|81265412|FG000|Phase 2|Enrolled but not treated|0|||
27845792|NCT01684215|81265413|FG001|Phase 2|Enrolled but not treated|0|||
27845793|NCT01684215|81265414|FG002|Phase 2|Enrolled but not treated|0|||
27845794|NCT01684215|81265415|FG003|Phase 2|Enrolled but not treated|1|||
27845795|NCT01684215|81265412|FG000|Phase 2|Lost to Follow-up|0|||
27845796|NCT01684215|81265413|FG001|Phase 2|Lost to Follow-up|0|||
27845797|NCT01684215|81265414|FG002|Phase 2|Lost to Follow-up|0|||
27845798|NCT01684215|81265415|FG003|Phase 2|Lost to Follow-up|4|||
27845799|NCT03297294|81265416|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
27845800|NCT03297294|81265417|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
27845801|NCT03297294|81265418|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27845802|NCT03297294|81265419|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27845803|NCT03297294|81265420|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
27893517|NCT02052596|81444049|FG000|Active Phase|Withdrawal by Subject|3|||
27893518|NCT02052596|81444050|FG001|Active Phase|Withdrawal by Subject|4|||
27893519|NCT02052596|81444049|FG000|Active Phase|Enrolled in error|1|||
27893520|NCT02052596|81444050|FG001|Active Phase|Enrolled in error|0|||
27893521|NCT02052596|81444049|FG000|Active Phase|Lost due to Crohn's disease|0|||
27893522|NCT02052596|81444050|FG001|Active Phase|Lost due to Crohn's disease|1|||
27893523|NCT02052596|81444049|FG000|Safety Phase|Adverse Event|6|||
27893524|NCT02052596|81444050|FG001|Safety Phase|Adverse Event|3|||
27893525|NCT02052596|81444049|FG000|Safety Phase|Lost to Follow-up|11|||
27893526|NCT02052596|81444050|FG001|Safety Phase|Lost to Follow-up|18|||
27893527|NCT02052596|81444049|FG000|Safety Phase|Protocol Violation|1|||
27893528|NCT02052596|81444050|FG001|Safety Phase|Protocol Violation|2|||
27893529|NCT02052596|81444049|FG000|Safety Phase|Withdrawal by Subject|8|||
27893530|NCT02052596|81444050|FG001|Safety Phase|Withdrawal by Subject|11|||
27893531|NCT02052596|81444049|FG000|Safety Phase|Enrolled in error|1|||
27893532|NCT02052596|81444050|FG001|Safety Phase|Enrolled in error|0|||
27893533|NCT02052596|81444049|FG000|Safety Phase|Lost due to Crohn's disease|0|||
27893534|NCT02052596|81444050|FG001|Safety Phase|Lost due to Crohn's disease|1|||
27893535|NCT03535740|81444053|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
27893536|NCT03535740|81444053|FG000|Overall Study|Death|34|||
27893537|NCT03535740|81444053|FG000|Overall Study|Lost to Follow-up|1|||
27893538|NCT03535740|81444053|FG000|Overall Study|Withdrawal by Subject|13|||
27893539|NCT02091986|81444056|FG000|Overall Study|7 rand in error 1 patient decision|2|||
27893540|NCT02091986|81444057|FG001|Overall Study|7 rand in error 1 patient decision|3|||
27893541|NCT02091986|81444058|FG002|Overall Study|7 rand in error 1 patient decision|3|||
27893542|NCT02091986|81444056|FG000|Overall Study|Lost to Follow-up|1|||
27893543|NCT02091986|81444057|FG001|Overall Study|Lost to Follow-up|0|||
27893544|NCT02091986|81444058|FG002|Overall Study|Lost to Follow-up|0|||
27893545|NCT02091986|81444056|FG000|Overall Study|Withdrawal by Subject|4|||
27893546|NCT02091986|81444057|FG001|Overall Study|Withdrawal by Subject|8|||
27893547|NCT02091986|81444058|FG002|Overall Study|Withdrawal by Subject|3|||
27893548|NCT02091986|81444056|FG000|Overall Study|Adverse Event|0|||
27893549|NCT02091986|81444057|FG001|Overall Study|Adverse Event|0|||
27893550|NCT02091986|81444058|FG002|Overall Study|Adverse Event|2|||
27893551|NCT02344290|81447117|FG000|Overall Study|Withdrawal by Subject|315|||
27893552|NCT02344290|81447118|FG001|Overall Study|Withdrawal by Subject|324|||
27893553|NCT02344290|81447117|FG000|Overall Study|Lost to Follow-up|258|||
27893554|NCT02344290|81447118|FG001|Overall Study|Lost to Follow-up|249|||
27893555|NCT02344290|81447117|FG000|Overall Study|Unable to get to clinic|69|||
27893556|NCT02344290|81447118|FG001|Overall Study|Unable to get to clinic|60|||
27893557|NCT02344290|81447117|FG000|Overall Study|Physician Decision|25|||
27893558|NCT02344290|81447118|FG001|Overall Study|Physician Decision|25|||
27893559|NCT02344290|81447117|FG000|Overall Study|Site Closure|15|||
27893560|NCT02344290|81447118|FG001|Overall Study|Site Closure|19|||
27893561|NCT02344290|81447117|FG000|Overall Study|Other|5|||
27893562|NCT02344290|81447118|FG001|Overall Study|Other|3|||
27845804|NCT03297294|81265416|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
27893563|NCT04972968|81447119|FG000|Overall Study|Adverse Event|3|||
27893564|NCT04972968|81447120|FG001|Overall Study|Adverse Event|1|||
27845805|NCT03297294|81265417|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
27893565|NCT04972968|81447121|FG002|Overall Study|Adverse Event|1|||
27893566|NCT04972968|81447122|FG003|Overall Study|Adverse Event|7|||
27893567|NCT04972968|81447119|FG000|Overall Study|Lack of Efficacy|2|||
27504827|NCT00888173|80040853|FG000|Overall Study|Wrong Primary|1|||
27893568|NCT04972968|81447120|FG001|Overall Study|Lack of Efficacy|1|||
27893569|NCT04972968|81447121|FG002|Overall Study|Lack of Efficacy|0|||
27845806|NCT03297294|81265418|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27845807|NCT03297294|81265419|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27893570|NCT04972968|81447122|FG003|Overall Study|Lack of Efficacy|0|||
27893571|NCT04972968|81447119|FG000|Overall Study|Withdrawal by Subject|7|||
27893572|NCT04972968|81447120|FG001|Overall Study|Withdrawal by Subject|4|||
27893573|NCT04972968|81447121|FG002|Overall Study|Withdrawal by Subject|3|||
27893574|NCT04972968|81447122|FG003|Overall Study|Withdrawal by Subject|2|||
27893575|NCT04972968|81447119|FG000|Overall Study|Study Terminated by Sponsor|25|||
27893576|NCT04972968|81447120|FG001|Overall Study|Study Terminated by Sponsor|28|||
27893577|NCT04972968|81447121|FG002|Overall Study|Study Terminated by Sponsor|32|||
27893578|NCT04972968|81447122|FG003|Overall Study|Study Terminated by Sponsor|27|||
27893579|NCT04972968|81447119|FG000|Overall Study|Other|1|||
27893580|NCT04972968|81447120|FG001|Overall Study|Other|0|||
27893581|NCT04972968|81447121|FG002|Overall Study|Other|1|||
27893582|NCT04972968|81447122|FG003|Overall Study|Other|1|||
27893583|NCT00131365|81447125|FG000|Overall Study|Withdrawal by Subject|1|||
27893584|NCT00131365|81447125|FG000|Overall Study|Alternative treatment|3|||
27893585|NCT01482962|81447132|FG000|Overall Study|Progressive Disease|65|||
27893586|NCT01482962|81447133|FG001|Overall Study|Progressive Disease|53|||
27893587|NCT01482962|81447132|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
27893588|NCT01482962|81447133|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
27893589|NCT01482962|81447132|FG000|Overall Study|Adverse Event|18|||
27893590|NCT01482962|81447133|FG001|Overall Study|Adverse Event|22|||
27893591|NCT01482962|81447132|FG000|Overall Study|Withdrawal by Participant|8|||
27893592|NCT01482962|81447133|FG001|Overall Study|Withdrawal by Participant|13|||
27893593|NCT01482962|81447132|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
27893594|NCT01482962|81447133|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
27893595|NCT01482962|81447132|FG000|Overall Study|Other Reason|1|||
27893596|NCT01482962|81447133|FG001|Overall Study|Other Reason|5|||
27893597|NCT01482962|81447132|FG000|Overall Study|Study Terminated by Sponsor|5|||
27893598|NCT01482962|81447133|FG001|Overall Study|Study Terminated by Sponsor|2|||
27893599|NCT01482962|81447132|FG000|Overall Study|Did not Receive Study Drug|1|||
27893600|NCT01482962|81447133|FG001|Overall Study|Did not Receive Study Drug|6|||
27893601|NCT05153148|81447134|FG000|Overall Study|Adverse Event|1|||
27893602|NCT05153148|81447135|FG001|Overall Study|Adverse Event|0|||
27893603|NCT05153148|81447136|FG002|Overall Study|Adverse Event|3|||
27893604|NCT05153148|81447137|FG003|Overall Study|Adverse Event|5|||
27893605|NCT05153148|81447134|FG000|Overall Study|Lost to Follow-up|1|||
27893606|NCT05153148|81447135|FG001|Overall Study|Lost to Follow-up|1|||
27893607|NCT05153148|81447136|FG002|Overall Study|Lost to Follow-up|2|||
27893608|NCT05153148|81447137|FG003|Overall Study|Lost to Follow-up|0|||
27893609|NCT05153148|81447134|FG000|Overall Study|Withdrawal by Subject|6|||
27893610|NCT05153148|81447135|FG001|Overall Study|Withdrawal by Subject|8|||
27893611|NCT05153148|81447136|FG002|Overall Study|Withdrawal by Subject|6|||
27893612|NCT05153148|81447137|FG003|Overall Study|Withdrawal by Subject|8|||
27893613|NCT05153148|81447134|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
27893614|NCT05153148|81447135|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
27893615|NCT05153148|81447136|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
27893616|NCT05153148|81447137|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
27893617|NCT05153148|81447134|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
27893618|NCT05153148|81447135|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
27845808|NCT03297294|81265420|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
27845809|NCT03297294|81265416|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
27845810|NCT03297294|81265417|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
27845811|NCT03297294|81265418|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27845812|NCT03297294|81265419|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27845813|NCT03297294|81265420|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
27845814|NCT03297294|81265416|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
27845815|NCT03297294|81265417|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
27845816|NCT03297294|81265418|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27845817|NCT03297294|81265419|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27845818|NCT03297294|81265420|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
27845819|NCT03297294|81265416|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
27893619|NCT05153148|81447136|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
27893620|NCT05153148|81447137|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
27893621|NCT05153148|81447134|FG000|Overall Study|Reason not Specified|1|||
27504828|NCT00888173|80040853|FG000|Overall Study|Ineligible: required test not done|1|||
27893622|NCT05153148|81447135|FG001|Overall Study|Reason not Specified|1|||
27893623|NCT05153148|81447136|FG002|Overall Study|Reason not Specified|1|||
27893624|NCT05153148|81447137|FG003|Overall Study|Reason not Specified|1|||
27504829|NCT01217229|80040854|FG000|Overall Study|Adverse Event|1|||
27893625|NCT00784550|81447141|FG000|Overall Study|Adverse Event|12|||
27893626|NCT00784550|81447142|FG001|Overall Study|Adverse Event|10|||
27893627|NCT00784550|81447141|FG000|Overall Study|Lack of Efficacy|0|||
27504830|NCT01217229|80040854|FG000|Overall Study|Disease progression, deterioration|2|||
27845820|NCT03297294|81265417|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
27845821|NCT03297294|81265418|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
27845822|NCT03297294|81265419|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
27845823|NCT03297294|81265420|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
27845824|NCT01730040|81265421|FG000|Overall Study|Randomized but not treated|0|||
27845825|NCT01730040|81265422|FG001|Overall Study|Randomized but not treated|0|||
27845826|NCT01730040|81265423|FG002|Overall Study|Randomized but not treated|0|||
27845827|NCT01730040|81265424|FG003|Overall Study|Randomized but not treated|0|||
27845828|NCT01730040|81265425|FG004|Overall Study|Randomized but not treated|0|||
27845829|NCT01730040|81265426|FG005|Overall Study|Randomized but not treated|1|||
27845830|NCT01730040|81265427|FG006|Overall Study|Randomized but not treated|0|||
27845831|NCT01730040|81265421|FG000|Overall Study|Subject moved|0|||
27845832|NCT01730040|81265422|FG001|Overall Study|Subject moved|0|||
27845833|NCT01730040|81265423|FG002|Overall Study|Subject moved|1|||
27845834|NCT01730040|81265424|FG003|Overall Study|Subject moved|0|||
27845835|NCT01730040|81265425|FG004|Overall Study|Subject moved|0|||
27845836|NCT01730040|81265426|FG005|Overall Study|Subject moved|0|||
27845837|NCT01730040|81265427|FG006|Overall Study|Subject moved|1|||
27845838|NCT01730040|81265421|FG000|Overall Study|Physician Decision|0|||
27845839|NCT01730040|81265422|FG001|Overall Study|Physician Decision|0|||
27845840|NCT01730040|81265423|FG002|Overall Study|Physician Decision|0|||
27845841|NCT01730040|81265424|FG003|Overall Study|Physician Decision|0|||
27845842|NCT01730040|81265425|FG004|Overall Study|Physician Decision|0|||
27845843|NCT01730040|81265426|FG005|Overall Study|Physician Decision|1|||
27845844|NCT01730040|81265427|FG006|Overall Study|Physician Decision|1|||
27893628|NCT00784550|81447142|FG001|Overall Study|Lack of Efficacy|1|||
27893629|NCT00784550|81447141|FG000|Overall Study|Protocol Violation|10|||
27845845|NCT01730040|81265421|FG000|Overall Study|Other than specified|7|||
27845846|NCT01730040|81265422|FG001|Overall Study|Other than specified|8|||
27845847|NCT01730040|81265423|FG002|Overall Study|Other than specified|5|||
27845848|NCT01730040|81265424|FG003|Overall Study|Other than specified|5|||
27845849|NCT01730040|81265425|FG004|Overall Study|Other than specified|5|||
27845850|NCT01730040|81265426|FG005|Overall Study|Other than specified|4|||
27845851|NCT01730040|81265427|FG006|Overall Study|Other than specified|4|||
27845852|NCT01730040|81265421|FG000|Overall Study|Adverse Event|4|||
27845853|NCT01730040|81265422|FG001|Overall Study|Adverse Event|3|||
27845854|NCT01730040|81265423|FG002|Overall Study|Adverse Event|5|||
27845855|NCT01730040|81265424|FG003|Overall Study|Adverse Event|3|||
27845856|NCT01730040|81265425|FG004|Overall Study|Adverse Event|1|||
27845857|NCT01730040|81265426|FG005|Overall Study|Adverse Event|1|||
27845858|NCT01730040|81265427|FG006|Overall Study|Adverse Event|2|||
27845859|NCT01730040|81265421|FG000|Overall Study|Poor compliance to protocol|2|||
27845860|NCT01730040|81265422|FG001|Overall Study|Poor compliance to protocol|4|||
27845861|NCT01730040|81265423|FG002|Overall Study|Poor compliance to protocol|0|||
27845862|NCT01730040|81265424|FG003|Overall Study|Poor compliance to protocol|0|||
27845863|NCT01730040|81265425|FG004|Overall Study|Poor compliance to protocol|0|||
27845864|NCT01730040|81265426|FG005|Overall Study|Poor compliance to protocol|0|||
27845865|NCT01730040|81265427|FG006|Overall Study|Poor compliance to protocol|1|||
27845866|NCT04034355|81265428|FG000|Overall Study|Study terminated by Sponsor|10|||
27845867|NCT04034355|81265429|FG001|Overall Study|Study terminated by Sponsor|17|||
27845868|NCT04034355|81265428|FG000|Overall Study|Withdrawal by Subject|12|||
27845869|NCT04034355|81265429|FG001|Overall Study|Withdrawal by Subject|11|||
27845870|NCT04034355|81265428|FG000|Overall Study|Site terminated by Sponsor|4|||
27845871|NCT04034355|81265429|FG001|Overall Study|Site terminated by Sponsor|5|||
27845872|NCT04034355|81265428|FG000|Overall Study|Adverse Event|2|||
27845873|NCT04034355|81265429|FG001|Overall Study|Adverse Event|0|||
27845874|NCT04034355|81265428|FG000|Overall Study|Death|1|||
27845875|NCT04034355|81265429|FG001|Overall Study|Death|1|||
27845876|NCT04034355|81265428|FG000|Overall Study|Not reported|2|||
27845877|NCT04034355|81265429|FG001|Overall Study|Not reported|0|||
27845878|NCT04034355|81265428|FG000|Overall Study|Lost to Follow-up|1|||
27845879|NCT04034355|81265429|FG001|Overall Study|Lost to Follow-up|0|||
27845880|NCT04034355|81265428|FG000|Overall Study|Physician Decision|1|||
27845881|NCT04034355|81265429|FG001|Overall Study|Physician Decision|0|||
27845882|NCT04034355|81265428|FG000|Overall Study|Protocol Violation|0|||
27845883|NCT04034355|81265429|FG001|Overall Study|Protocol Violation|1|||
27845884|NCT04034355|81265428|FG000|Overall Study|Progressive disease|1|||
27893630|NCT00784550|81447142|FG001|Overall Study|Protocol Violation|10|||
27893631|NCT00784550|81447141|FG000|Overall Study|Lost to Follow-up|8|||
27725768|NCT01273064|80826717|FG003|Overall Study|Physician Decision|0|||
27845885|NCT04034355|81265429|FG001|Overall Study|Progressive disease|0|||
27845886|NCT00515034|81265430|FG000|Overall Study|Adverse Event|2|||
27893632|NCT00784550|81447142|FG001|Overall Study|Lost to Follow-up|5|||
27845887|NCT00515034|81265431|FG001|Overall Study|Adverse Event|0|||
27845888|NCT00515034|81265432|FG002|Overall Study|Adverse Event|1|||
27893633|NCT00784550|81447141|FG000|Overall Study|Physician Decision|2|||
27845889|NCT00515034|81265433|FG003|Overall Study|Adverse Event|0|||
27845890|NCT00515034|81265430|FG000|Overall Study|Death|4|||
27845891|NCT00515034|81265431|FG001|Overall Study|Death|2|||
27845892|NCT00515034|81265432|FG002|Overall Study|Death|1|||
27845893|NCT00515034|81265433|FG003|Overall Study|Death|3|||
27845894|NCT00515034|81265430|FG000|Overall Study|Withdrawal by Subject|1|||
27845895|NCT00515034|81265431|FG001|Overall Study|Withdrawal by Subject|0|||
27845896|NCT00515034|81265432|FG002|Overall Study|Withdrawal by Subject|3|||
27845897|NCT00515034|81265433|FG003|Overall Study|Withdrawal by Subject|0|||
27845898|NCT00515034|81265430|FG000|Overall Study|Physician Decision|0|||
27845899|NCT00515034|81265431|FG001|Overall Study|Physician Decision|0|||
27845900|NCT00515034|81265432|FG002|Overall Study|Physician Decision|1|||
27845901|NCT00515034|81265433|FG003|Overall Study|Physician Decision|1|||
27845902|NCT00515034|81265430|FG000|Overall Study|Other|1|||
27845903|NCT00515034|81265431|FG001|Overall Study|Other|0|||
27845904|NCT00515034|81265432|FG002|Overall Study|Other|2|||
27845905|NCT00515034|81265433|FG003|Overall Study|Other|1|||
27845906|NCT00848042|81265434|FG000|Overall Study|Death|1|||
27893634|NCT00784550|81447142|FG001|Overall Study|Physician Decision|3|||
27893635|NCT00784550|81447141|FG000|Overall Study|Withdrawal by Subject|4|||
27893636|NCT00784550|81447142|FG001|Overall Study|Withdrawal by Subject|13|||
27893637|NCT03320850|81447143|FG000|Overall Study|Lost to Follow-up|0|||
27893638|NCT03320850|81447144|FG001|Overall Study|Lost to Follow-up|0|||
27893639|NCT03320850|81447145|FG002|Overall Study|Lost to Follow-up|0|||
27893640|NCT03320850|81447146|FG003|Overall Study|Lost to Follow-up|0|||
27893641|NCT03320850|81447147|FG004|Overall Study|Lost to Follow-up|1|||
27893642|NCT03320850|81447148|FG005|Overall Study|Lost to Follow-up|2|||
27893643|NCT03320850|81447149|FG006|Overall Study|Lost to Follow-up|2|||
27893644|NCT03320850|81447150|FG007|Overall Study|Lost to Follow-up|0|||
27893645|NCT03320850|81447151|FG008|Overall Study|Lost to Follow-up|6|||
27893646|NCT03320850|81447152|FG009|Overall Study|Lost to Follow-up|4|||
27893647|NCT03320850|81447143|FG000|Overall Study|Withdrawal by Subject|0|||
27893648|NCT03320850|81447144|FG001|Overall Study|Withdrawal by Subject|0|||
27845907|NCT00848042|81265435|FG001|Overall Study|Death|2|||
27845908|NCT00848042|81265436|FG002|Overall Study|Death|0|||
27845909|NCT00848042|81265434|FG000|Overall Study|Other Therapy|3|||
27845910|NCT00848042|81265435|FG001|Overall Study|Other Therapy|0|||
27845911|NCT00848042|81265436|FG002|Overall Study|Other Therapy|0|||
27845912|NCT00808509|81265437|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
27845913|NCT00808509|81265438|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
27845914|NCT00808509|81265437|FG000|Randomized Phase|Reduced methotrexate dose|1|||
27845915|NCT00808509|81265438|FG001|Randomized Phase|Reduced methotrexate dose|2|||
27845916|NCT00808509|81265437|FG000|Randomized Phase|Patient refused rescue therapy|0|||
27845917|NCT00808509|81265438|FG001|Randomized Phase|Patient refused rescue therapy|3|||
27845918|NCT00988208|81265441|FG000|Overall Study|Adverse Event|71|||
27845919|NCT00988208|81265442|FG001|Overall Study|Adverse Event|122|||
27845920|NCT00988208|81265441|FG000|Overall Study|Disease Progression|103|||
27845921|NCT00988208|81265442|FG001|Overall Study|Disease Progression|89|||
27845922|NCT00988208|81265441|FG000|Overall Study|Withdrawal by Subject|50|||
27845923|NCT00988208|81265442|FG001|Overall Study|Withdrawal by Subject|57|||
27845924|NCT00988208|81265441|FG000|Overall Study|Death|9|||
27845925|NCT00988208|81265442|FG001|Overall Study|Death|15|||
27845926|NCT00988208|81265441|FG000|Overall Study|Lost to Follow-up|2|||
27845927|NCT00988208|81265442|FG001|Overall Study|Lost to Follow-up|3|||
27845928|NCT00988208|81265441|FG000|Overall Study|Protocol Violation|9|||
27845929|NCT00988208|81265442|FG001|Overall Study|Protocol Violation|2|||
27845930|NCT00988208|81265441|FG000|Overall Study|Sponsor Decision|102|||
27845931|NCT00988208|81265442|FG001|Overall Study|Sponsor Decision|78|||
27893649|NCT03320850|81447145|FG002|Overall Study|Withdrawal by Subject|0|||
27893650|NCT03320850|81447146|FG003|Overall Study|Withdrawal by Subject|0|||
27845932|NCT00988208|81265441|FG000|Overall Study|Clinical Progression|17|||
27845933|NCT00988208|81265442|FG001|Overall Study|Clinical Progression|16|||
27893651|NCT03320850|81447147|FG004|Overall Study|Withdrawal by Subject|1|||
27845934|NCT00988208|81265441|FG000|Overall Study|Biochemical Progression|21|||
27845935|NCT00988208|81265442|FG001|Overall Study|Biochemical Progression|7|||
27845936|NCT00988208|81265441|FG000|Overall Study|Clinical Deterioration|7|||
27845937|NCT00988208|81265442|FG001|Overall Study|Clinical Deterioration|14|||
27845938|NCT00988208|81265441|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
27893652|NCT03320850|81447148|FG005|Overall Study|Withdrawal by Subject|2|||
27893653|NCT03320850|81447149|FG006|Overall Study|Withdrawal by Subject|4|||
27893654|NCT03320850|81447150|FG007|Overall Study|Withdrawal by Subject|5|||
27893655|NCT03320850|81447151|FG008|Overall Study|Withdrawal by Subject|2|||
27893656|NCT03320850|81447152|FG009|Overall Study|Withdrawal by Subject|1|||
27893657|NCT03320850|81447143|FG000|Overall Study|Lack of Efficacy|0|||
27893658|NCT03320850|81447144|FG001|Overall Study|Lack of Efficacy|0|||
27893659|NCT03320850|81447145|FG002|Overall Study|Lack of Efficacy|0|||
27893660|NCT03320850|81447146|FG003|Overall Study|Lack of Efficacy|1|||
27893661|NCT03320850|81447147|FG004|Overall Study|Lack of Efficacy|0|||
27504831|NCT01217229|80040854|FG000|Overall Study|Disease progression, Cheson criteria|14|||
27893662|NCT03320850|81447148|FG005|Overall Study|Lack of Efficacy|1|||
27893663|NCT03320850|81447149|FG006|Overall Study|Lack of Efficacy|0|||
27893664|NCT03320850|81447150|FG007|Overall Study|Lack of Efficacy|2|||
27893665|NCT03320850|81447151|FG008|Overall Study|Lack of Efficacy|0|||
27893666|NCT03320850|81447152|FG009|Overall Study|Lack of Efficacy|3|||
27845939|NCT00988208|81265442|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
27845940|NCT00988208|81265441|FG000|Overall Study|Other|8|||
27845941|NCT00988208|81265442|FG001|Overall Study|Other|3|||
27845942|NCT02427984|81265443|FG000|Overall Study|Lost to Follow-up|13|||
27845943|NCT02427984|81265444|FG001|Overall Study|Lost to Follow-up|5|||
27845944|NCT02427984|81265445|FG002|Overall Study|Lost to Follow-up|18|||
27845945|NCT01647711|81265447|FG000|Overall Study|Progressive disease|6|||
27845946|NCT01647711|81265448|FG001|Overall Study|Progressive disease|2|||
27845947|NCT01647711|81265449|FG002|Overall Study|Progressive disease|6|||
27845948|NCT01647711|81265450|FG003|Overall Study|Progressive disease|8|||
27893667|NCT03320850|81447143|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
27893668|NCT03320850|81447144|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
27893669|NCT03320850|81447145|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
27893670|NCT03320850|81447146|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
27893671|NCT03320850|81447147|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
27893672|NCT03320850|81447148|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
27893673|NCT03320850|81447149|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
27893674|NCT03320850|81447150|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
27893675|NCT03320850|81447151|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
27893676|NCT03320850|81447152|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
27893677|NCT03320850|81447143|FG000|Overall Study|Adverse Event|0|||
27893678|NCT03320850|81447144|FG001|Overall Study|Adverse Event|0|||
27845949|NCT01647711|81265451|FG004|Overall Study|Progressive disease|2|||
27845950|NCT01647711|81265447|FG000|Overall Study|Other adverse event|0|||
27845951|NCT01647711|81265448|FG001|Overall Study|Other adverse event|0|||
27845952|NCT01647711|81265449|FG002|Overall Study|Other adverse event|2|||
27845953|NCT01647711|81265450|FG003|Overall Study|Other adverse event|0|||
27845954|NCT01647711|81265451|FG004|Overall Study|Other adverse event|2|||
27845955|NCT01647711|81265447|FG000|Overall Study|Protocol Violation|0|||
27845956|NCT01647711|81265448|FG001|Overall Study|Protocol Violation|0|||
27845957|NCT01647711|81265449|FG002|Overall Study|Protocol Violation|0|||
27845958|NCT01647711|81265450|FG003|Overall Study|Protocol Violation|0|||
27845959|NCT01647711|81265451|FG004|Overall Study|Protocol Violation|1|||
27845960|NCT01647711|81265447|FG000|Overall Study|Refused to continue taking medication|0|||
27893679|NCT03320850|81447145|FG002|Overall Study|Adverse Event|0|||
27893680|NCT03320850|81447146|FG003|Overall Study|Adverse Event|0|||
27893681|NCT03320850|81447147|FG004|Overall Study|Adverse Event|0|||
27893682|NCT03320850|81447148|FG005|Overall Study|Adverse Event|2|||
27893683|NCT03320850|81447149|FG006|Overall Study|Adverse Event|1|||
27893684|NCT03320850|81447150|FG007|Overall Study|Adverse Event|0|||
27893685|NCT03320850|81447151|FG008|Overall Study|Adverse Event|2|||
27504832|NCT01217229|80040854|FG000|Overall Study|Protocol Violation|1|||
27504833|NCT01217229|80040854|FG000|Overall Study|Disease progression not confirmed|2|||
27504834|NCT02158546|80040857|FG000|Overall Study|Physician Decision|0|||
27845961|NCT01647711|81265448|FG001|Overall Study|Refused to continue taking medication|0|||
27845962|NCT01647711|81265449|FG002|Overall Study|Refused to continue taking medication|0|||
27845963|NCT01647711|81265450|FG003|Overall Study|Refused to continue taking medication|2|||
27893686|NCT03320850|81447152|FG009|Overall Study|Adverse Event|0|||
27893687|NCT03320850|81447143|FG000|Overall Study|Reason Not Specified|0|||
27893688|NCT03320850|81447144|FG001|Overall Study|Reason Not Specified|0|||
27893689|NCT03320850|81447145|FG002|Overall Study|Reason Not Specified|0|||
27893690|NCT03320850|81447146|FG003|Overall Study|Reason Not Specified|0|||
27893691|NCT03320850|81447147|FG004|Overall Study|Reason Not Specified|0|||
27504835|NCT02158546|80040858|FG001|Overall Study|Physician Decision|1|||
27845964|NCT01647711|81265451|FG004|Overall Study|Refused to continue taking medication|1|||
27893692|NCT03320850|81447148|FG005|Overall Study|Reason Not Specified|1|||
27504836|NCT02158546|80040859|FG002|Overall Study|Physician Decision|0|||
27845965|NCT01647711|81265447|FG000|Overall Study|Other reason not defined|0|||
27845966|NCT01647711|81265448|FG001|Overall Study|Other reason not defined|1|||
27845967|NCT01647711|81265449|FG002|Overall Study|Other reason not defined|1|||
27893693|NCT03320850|81447149|FG006|Overall Study|Reason Not Specified|0|||
27893694|NCT03320850|81447150|FG007|Overall Study|Reason Not Specified|0|||
27893695|NCT03320850|81447151|FG008|Overall Study|Reason Not Specified|0|||
27893696|NCT03320850|81447152|FG009|Overall Study|Reason Not Specified|1|||
27893697|NCT00270231|81447157|FG000|First Intervention|Lost to Follow-up|1|||
27893698|NCT00270231|81447158|FG001|First Intervention|Lost to Follow-up|1|||
27893699|NCT00270231|81447157|FG000|Washout Period|Lost to Follow-up|1|||
27893700|NCT00270231|81447158|FG001|Washout Period|Lost to Follow-up|0|||
27893701|NCT00270231|81447157|FG000|Second Intervention|Lost to Follow-up|0|||
27893702|NCT00270231|81447158|FG001|Second Intervention|Lost to Follow-up|1|||
27893703|NCT01104246|81447162|FG000|Overall Study|Withdrawal by Subject|1|||
27725769|NCT01273064|80826718|FG004|Overall Study|Physician Decision|1|||
27725770|NCT00930059|80826722|FG000|Overall Study|Death|1|||
27725771|NCT00930059|80826723|FG001|Overall Study|Death|0|||
27725772|NCT00930059|80826722|FG000|Overall Study|Did not meet entrance criteria|1|||
27725773|NCT00930059|80826723|FG001|Overall Study|Did not meet entrance criteria|1|||
27725774|NCT00930059|80826722|FG000|Overall Study|Withdrawal by Subject|3|||
27725775|NCT00930059|80826723|FG001|Overall Study|Withdrawal by Subject|4|||
27725776|NCT00930059|80826722|FG000|Overall Study|Other|1|||
27725777|NCT00930059|80826723|FG001|Overall Study|Other|0|||
27725778|NCT00930059|80826722|FG000|Overall Study|1 site terminated by sponsor|1|||
27725779|NCT00930059|80826723|FG001|Overall Study|1 site terminated by sponsor|1|||
27725780|NCT00930059|80826722|FG000|Overall Study|Adverse Event|1|||
27725781|NCT00930059|80826723|FG001|Overall Study|Adverse Event|6|||
27725782|NCT01622569|80826725|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
27725783|NCT01622569|80826726|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
27725784|NCT01622569|80826727|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
27725785|NCT01622569|80826728|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
27725786|NCT01622569|80826725|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
27725787|NCT01622569|80826726|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
27725788|NCT01622569|80826727|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
27725789|NCT01622569|80826728|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
27725790|NCT01622569|80826725|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
27725791|NCT01622569|80826726|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
27725792|NCT01622569|80826727|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
27725793|NCT01622569|80826728|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
27725794|NCT01622569|80826725|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27725795|NCT01622569|80826726|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
27845968|NCT01647711|81265450|FG003|Overall Study|Other reason not defined|1|||
27845969|NCT01647711|81265451|FG004|Overall Study|Other reason not defined|0|||
27845970|NCT00108082|81265454|FG000|Overall Study|Adverse Event|14|||
27845971|NCT00108082|81265455|FG001|Overall Study|Adverse Event|12|||
27845972|NCT00108082|81265456|FG002|Overall Study|Adverse Event|17|||
27845973|NCT00108082|81265454|FG000|Overall Study|Lost to Follow-up|6|||
27845974|NCT00108082|81265455|FG001|Overall Study|Lost to Follow-up|3|||
27845975|NCT00108082|81265456|FG002|Overall Study|Lost to Follow-up|7|||
27845976|NCT00108082|81265454|FG000|Overall Study|Consent Withdrawn|3|||
27845977|NCT00108082|81265455|FG001|Overall Study|Consent Withdrawn|3|||
27845978|NCT00108082|81265456|FG002|Overall Study|Consent Withdrawn|5|||
27845979|NCT00108082|81265454|FG000|Overall Study|Protocol Violation|1|||
27893704|NCT01104246|81447162|FG000|Overall Study|did not meet inclusion criteria|4|||
27893705|NCT00976209|81447163|FG000|Treatment Period 1|Protocol Violation|1|||
27725796|NCT01622569|80826727|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
27845980|NCT00108082|81265455|FG001|Overall Study|Protocol Violation|2|||
27845981|NCT00108082|81265456|FG002|Overall Study|Protocol Violation|0|||
27845982|NCT00108082|81265454|FG000|Overall Study|Lack of Efficacy|3|||
27893706|NCT00976209|81447164|FG001|Treatment Period 1|Protocol Violation|0|||
27893707|NCT00976209|81447163|FG000|Treatment Period 1|Lost to Follow-up|2|||
27845983|NCT00108082|81265455|FG001|Overall Study|Lack of Efficacy|1|||
27845984|NCT00108082|81265456|FG002|Overall Study|Lack of Efficacy|2|||
27845985|NCT00108082|81265454|FG000|Overall Study|Amendment 4: > Month 12|5|||
27845986|NCT00108082|81265455|FG001|Overall Study|Amendment 4: > Month 12|7|||
27845987|NCT00108082|81265456|FG002|Overall Study|Amendment 4: > Month 12|5|||
27845988|NCT00108082|81265454|FG000|Overall Study|Woman of Child-bearing Potential|2|||
27845989|NCT00108082|81265455|FG001|Overall Study|Woman of Child-bearing Potential|0|||
27845990|NCT00108082|81265456|FG002|Overall Study|Woman of Child-bearing Potential|2|||
27845991|NCT00108082|81265454|FG000|Overall Study|Incorrectly Randomized|0|||
27845992|NCT00108082|81265455|FG001|Overall Study|Incorrectly Randomized|0|||
27845993|NCT00108082|81265456|FG002|Overall Study|Incorrectly Randomized|2|||
27845994|NCT00108082|81265454|FG000|Overall Study|Non-compliance|1|||
27845995|NCT00108082|81265455|FG001|Overall Study|Non-compliance|0|||
27845996|NCT00108082|81265456|FG002|Overall Study|Non-compliance|2|||
27845997|NCT00108082|81265454|FG000|Overall Study|Stopped Study Medication|0|||
27845998|NCT00108082|81265455|FG001|Overall Study|Stopped Study Medication|0|||
27845999|NCT00108082|81265456|FG002|Overall Study|Stopped Study Medication|1|||
27846000|NCT00108082|81265454|FG000|Overall Study|Site Closed Study|0|||
27846001|NCT00108082|81265455|FG001|Overall Study|Site Closed Study|2|||
27846002|NCT00108082|81265456|FG002|Overall Study|Site Closed Study|0|||
27846003|NCT00108082|81265454|FG000|Overall Study|Protocol Amendment|0|||
27846004|NCT00108082|81265455|FG001|Overall Study|Protocol Amendment|1|||
27846005|NCT00108082|81265456|FG002|Overall Study|Protocol Amendment|0|||
27846006|NCT00108082|81265454|FG000|Overall Study|Study Medication Not Tapered|0|||
27846007|NCT00108082|81265455|FG001|Overall Study|Study Medication Not Tapered|1|||
27846008|NCT00108082|81265456|FG002|Overall Study|Study Medication Not Tapered|0|||
27846009|NCT00108082|81265454|FG000|Overall Study|Subject Left Site Location|1|||
27846010|NCT00108082|81265455|FG001|Overall Study|Subject Left Site Location|0|||
27846011|NCT00108082|81265456|FG002|Overall Study|Subject Left Site Location|0|||
27846012|NCT00108082|81265454|FG000|Overall Study|Investigator Not at Site|1|||
27846013|NCT00108082|81265455|FG001|Overall Study|Investigator Not at Site|0|||
27846014|NCT00108082|81265456|FG002|Overall Study|Investigator Not at Site|0|||
27846015|NCT00108082|81265454|FG000|Overall Study|Blood Pressure Not Controlled|1|||
27846016|NCT00108082|81265455|FG001|Overall Study|Blood Pressure Not Controlled|0|||
27846017|NCT00108082|81265456|FG002|Overall Study|Blood Pressure Not Controlled|0|||
27846018|NCT00303667|81265462|FG000|Overall Study|Death|0|||
27846019|NCT00303667|81265463|FG001|Overall Study|Death|4|||
27893708|NCT00976209|81447164|FG001|Treatment Period 1|Lost to Follow-up|0|||
27893709|NCT00976209|81447163|FG000|Treatment Period 1|Other|0|||
27893710|NCT00976209|81447164|FG001|Treatment Period 1|Other|1|||
27893711|NCT00976209|81447163|FG000|Wash-out Period|Adverse Event|1|||
27893712|NCT00976209|81447164|FG001|Wash-out Period|Adverse Event|2|||
27893713|NCT00976209|81447163|FG000|Wash-out Period|Lost to Follow-up|1|||
27613615|NCT04022889|80426702|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
27613616|NCT04022889|80426703|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
27846020|NCT01467479|81265464|FG000|Overall Study|No Study Medication|1|||
27846021|NCT01467479|81265465|FG001|Overall Study|No Study Medication|0|||
27846022|NCT01467479|81265466|FG002|Overall Study|No Study Medication|2|||
27846023|NCT01467479|81265464|FG000|Overall Study|Adverse Event|1|||
27846024|NCT01467479|81265465|FG001|Overall Study|Adverse Event|2|||
27846025|NCT01467479|81265466|FG002|Overall Study|Adverse Event|0|||
27846026|NCT01467479|81265464|FG000|Overall Study|Death|0|||
27846027|NCT01467479|81265465|FG001|Overall Study|Death|0|||
27893714|NCT00976209|81447164|FG001|Wash-out Period|Lost to Follow-up|0|||
27893715|NCT00976209|81447163|FG000|Wash-out Period|Protocol Violation|1|||
27893716|NCT00976209|81447164|FG001|Wash-out Period|Protocol Violation|0|||
27893717|NCT00976209|81447163|FG000|Wash-out Period|Other|1|||
27893718|NCT00976209|81447164|FG001|Wash-out Period|Other|0|||
27846028|NCT01467479|81265466|FG002|Overall Study|Death|1|||
27846029|NCT01467479|81265464|FG000|Overall Study|Lost to Follow-up|2|||
27846030|NCT01467479|81265465|FG001|Overall Study|Lost to Follow-up|5|||
27846031|NCT01467479|81265466|FG002|Overall Study|Lost to Follow-up|3|||
27846032|NCT01467479|81265464|FG000|Overall Study|Withdrawal of Consent|3|||
27846033|NCT01467479|81265465|FG001|Overall Study|Withdrawal of Consent|7|||
27893719|NCT00976209|81447163|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27893720|NCT00976209|81447164|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27893721|NCT00976209|81447163|FG000|Treatment Period 2|Lost to Follow-up|0|||
27893722|NCT00976209|81447164|FG001|Treatment Period 2|Lost to Follow-up|1|||
27893723|NCT01871402|81447172|FG000|Overall Study|Lost to Follow-up|1|||
27893724|NCT01871402|81447173|FG001|Overall Study|Lost to Follow-up|0|||
27504837|NCT02158546|80040860|FG003|Overall Study|Physician Decision|0|||
27504838|NCT02158546|80040857|FG000|Overall Study|Non-compliance|0|||
27504839|NCT02158546|80040858|FG001|Overall Study|Non-compliance|1|||
27504840|NCT02158546|80040859|FG002|Overall Study|Non-compliance|0|||
27504841|NCT02158546|80040860|FG003|Overall Study|Non-compliance|1|||
27846034|NCT01467479|81265466|FG002|Overall Study|Withdrawal of Consent|7|||
27846035|NCT01467479|81265464|FG000|Overall Study|Study Terminated by Sponsor|1|||
27846036|NCT01467479|81265465|FG001|Overall Study|Study Terminated by Sponsor|3|||
27846037|NCT01467479|81265466|FG002|Overall Study|Study Terminated by Sponsor|3|||
27846038|NCT01467479|81265464|FG000|Overall Study|Other|1|||
27846039|NCT01467479|81265465|FG001|Overall Study|Other|0|||
27846040|NCT01467479|81265466|FG002|Overall Study|Other|0|||
27846041|NCT02985398|81265469|FG000|Overall Study|Adverse Event|1|||
27846042|NCT02985398|81265469|FG000|Overall Study|Lost to Follow-up|4|||
27846043|NCT02985398|81265469|FG000|Overall Study|Withdrawal by Subject|8|||
27846044|NCT02985398|81265469|FG000|Overall Study|Study Burden|9|||
27846045|NCT01453153|81265470|FG000|Overall Study|Physician Decision|0|||
27846046|NCT01453153|81265471|FG001|Overall Study|Physician Decision|0|||
27846047|NCT01453153|81265472|FG002|Overall Study|Physician Decision|1|||
27846048|NCT01453153|81265470|FG000|Overall Study|Progressive Disease|3|||
27846049|NCT01453153|81265471|FG001|Overall Study|Progressive Disease|2|||
27846050|NCT01453153|81265472|FG002|Overall Study|Progressive Disease|16|||
27846051|NCT01453153|81265470|FG000|Overall Study|Withdrawal by Subject|0|||
27846052|NCT01453153|81265471|FG001|Overall Study|Withdrawal by Subject|1|||
27846053|NCT01453153|81265472|FG002|Overall Study|Withdrawal by Subject|2|||
27846054|NCT01453153|81265470|FG000|Overall Study|Adverse Event|1|||
27846055|NCT01453153|81265471|FG001|Overall Study|Adverse Event|1|||
27846056|NCT01453153|81265472|FG002|Overall Study|Adverse Event|1|||
27846057|NCT03718117|81265473|FG000|Overall Study|Death|12|||
27846058|NCT03718117|81265474|FG001|Overall Study|Death|11|||
27846059|NCT03718117|81265475|FG002|Overall Study|Death|0|||
27846060|NCT03718117|81265473|FG000|Overall Study|Other|0|||
27846061|NCT03718117|81265474|FG001|Overall Study|Other|1|||
27846062|NCT03718117|81265475|FG002|Overall Study|Other|0|||
27846063|NCT03718117|81265473|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
27846064|NCT03718117|81265474|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
27504842|NCT02158546|80040857|FG000|Overall Study|Failure to meet eligibility criteria|0|||
27504843|NCT02158546|80040858|FG001|Overall Study|Failure to meet eligibility criteria|1|||
27504844|NCT02158546|80040859|FG002|Overall Study|Failure to meet eligibility criteria|0|||
27504845|NCT02158546|80040860|FG003|Overall Study|Failure to meet eligibility criteria|0|||
27846065|NCT03718117|81265475|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
27846066|NCT03718117|81265473|FG000|Overall Study|Participant not met eligibility criteria|0|||
27846067|NCT03718117|81265474|FG001|Overall Study|Participant not met eligibility criteria|0|||
27846068|NCT03718117|81265475|FG002|Overall Study|Participant not met eligibility criteria|2|||
27846069|NCT01610063|81265476|FG000|Overall Study|Lost to Follow-up|42|||
27846070|NCT01610063|81265477|FG001|Overall Study|Lost to Follow-up|20|||
27846071|NCT03166124|81265478|FG000|Treatment Period 1|Adverse Event|0|||
27846072|NCT03166124|81265479|FG001|Treatment Period 1|Adverse Event|0|||
27846073|NCT03166124|81265480|FG002|Treatment Period 1|Adverse Event|1|||
27893725|NCT01871402|81447172|FG000|Overall Study|Withdrawal by Subject|0|||
27893726|NCT01871402|81447173|FG001|Overall Study|Withdrawal by Subject|2|||
27504846|NCT02158546|80040857|FG000|Overall Study|Lack of Efficacy|1|||
27504847|NCT02158546|80040858|FG001|Overall Study|Lack of Efficacy|1|||
27504848|NCT02158546|80040859|FG002|Overall Study|Lack of Efficacy|0|||
27504849|NCT02158546|80040860|FG003|Overall Study|Lack of Efficacy|0|||
27504850|NCT02158546|80040857|FG000|Overall Study|Adverse Event|2|||
27504851|NCT02158546|80040858|FG001|Overall Study|Adverse Event|2|||
27504852|NCT02158546|80040859|FG002|Overall Study|Adverse Event|0|||
27504853|NCT02158546|80040860|FG003|Overall Study|Adverse Event|0|||
27504854|NCT02158546|80040857|FG000|Overall Study|Withdrawal by Subject|6|||
27504855|NCT02158546|80040858|FG001|Overall Study|Withdrawal by Subject|2|||
27504856|NCT02158546|80040859|FG002|Overall Study|Withdrawal by Subject|1|||
27504857|NCT02158546|80040860|FG003|Overall Study|Withdrawal by Subject|0|||
27504858|NCT02158546|80040857|FG000|Overall Study|Lost to Follow-up|5|||
27504859|NCT02158546|80040858|FG001|Overall Study|Lost to Follow-up|4|||
27504860|NCT02158546|80040859|FG002|Overall Study|Lost to Follow-up|0|||
27504861|NCT02158546|80040860|FG003|Overall Study|Lost to Follow-up|1|||
27504862|NCT02158546|80040857|FG000|Overall Study|Site Excluded|5|||
27504863|NCT02158546|80040858|FG001|Overall Study|Site Excluded|5|||
27504864|NCT02158546|80040859|FG002|Overall Study|Site Excluded|3|||
27504865|NCT02158546|80040860|FG003|Overall Study|Site Excluded|4|||
27504866|NCT03043872|80040861|FG000|Overall Study|Withdrawal by Subject|6|||
27504867|NCT03043872|80040862|FG001|Overall Study|Withdrawal by Subject|6|||
27504868|NCT03043872|80040863|FG002|Overall Study|Withdrawal by Subject|15|||
27504869|NCT03043872|80040861|FG000|Overall Study|Lost to Follow-up|2|||
27504870|NCT03043872|80040862|FG001|Overall Study|Lost to Follow-up|1|||
27504871|NCT03043872|80040863|FG002|Overall Study|Lost to Follow-up|1|||
27504872|NCT03043872|80040861|FG000|Overall Study|Death|270|||
27504873|NCT03043872|80040862|FG001|Overall Study|Death|269|||
27504874|NCT03043872|80040863|FG002|Overall Study|Death|296|||
27504875|NCT01213472|80040867|FG000|Overall Study|Recurrence/Progressive disease|25|||
27504876|NCT01213472|80040867|FG000|Overall Study|Withdrawal by Subject|1|||
27504877|NCT01213472|80040867|FG000|Overall Study|Physician Decision|1|||
27504878|NCT01353898|80040868|FG000|Overall Study|Study site terminated|0|||
27504879|NCT01353898|80040869|FG001|Overall Study|Study site terminated|0|||
27504880|NCT01353898|80040870|FG002|Overall Study|Study site terminated|0|||
27504881|NCT01353898|80040871|FG003|Overall Study|Study site terminated|0|||
27504882|NCT01353898|80040872|FG004|Overall Study|Study site terminated|0|||
27504883|NCT01353898|80040873|FG005|Overall Study|Study site terminated|1|||
27504884|NCT01294553|80040874|FG000|Overall Study|Duplicated Participants|1|||
27504885|NCT01294553|80040874|FG000|Overall Study|Protocol Violation|268|||
27504886|NCT00887809|80040879|FG000|Overall Study|Patient Not Treated|3|||
27504887|NCT00887809|80040880|FG001|Overall Study|Patient Not Treated|0|||
27504888|NCT00887809|80040879|FG000|Overall Study|Death|1|||
27504889|NCT00887809|80040880|FG001|Overall Study|Death|0|||
27504890|NCT03592186|80040881|FG000|Overall Study|Withdrawal by Subject|1|||
27893727|NCT01871402|81447172|FG000|Overall Study|Non-compliance|0|||
27504891|NCT03592186|80040882|FG001|Overall Study|Withdrawal by Subject|0|||
27504892|NCT03592186|80040881|FG000|Overall Study|Lost to Follow-up|16|||
27504893|NCT03592186|80040882|FG001|Overall Study|Lost to Follow-up|11|||
27504894|NCT04596267|80040884|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
27504895|NCT04596267|80040885|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
27504896|NCT04596267|80040884|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
27504897|NCT04596267|80040885|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
27504898|NCT00303069|80040888|FG000|Overall Study|Lost to Follow-up|1|||
27504899|NCT00303069|80040889|FG001|Overall Study|Lost to Follow-up|0|||
27504900|NCT00303069|80040890|FG002|Overall Study|Lost to Follow-up|0|||
27504901|NCT00303069|80040891|FG003|Overall Study|Lost to Follow-up|2|||
27613617|NCT04078035|80426704|FG000|Session 2|Lost to Follow-up|3|||
27846074|NCT03166124|81265481|FG003|Treatment Period 1|Adverse Event|0|||
27846075|NCT03166124|81265478|FG000|Wash-out Period|Withdrawal by Subject|0|||
27846076|NCT03166124|81265479|FG001|Wash-out Period|Withdrawal by Subject|1|||
27846077|NCT03166124|81265480|FG002|Wash-out Period|Withdrawal by Subject|0|||
27846078|NCT03166124|81265481|FG003|Wash-out Period|Withdrawal by Subject|1|||
27846079|NCT03166124|81265478|FG000|Wash-out Period|Adverse Event|0|||
27846080|NCT03166124|81265479|FG001|Wash-out Period|Adverse Event|1|||
27846081|NCT03166124|81265480|FG002|Wash-out Period|Adverse Event|1|||
27893728|NCT01871402|81447173|FG001|Overall Study|Non-compliance|1|||
27893729|NCT00972816|81447174|FG000|Overall Study|Adverse Event|0|||
27504902|NCT00303069|80040888|FG000|Overall Study|subject moved|1|||
27504903|NCT00303069|80040889|FG001|Overall Study|subject moved|0|||
27504904|NCT00303069|80040890|FG002|Overall Study|subject moved|0|||
27504905|NCT00303069|80040891|FG003|Overall Study|subject moved|0|||
27504906|NCT00303069|80040888|FG000|Overall Study|Recruitment into Army Reserves|0|||
27504907|NCT00303069|80040889|FG001|Overall Study|Recruitment into Army Reserves|0|||
27504908|NCT00303069|80040890|FG002|Overall Study|Recruitment into Army Reserves|1|||
27846082|NCT03166124|81265481|FG003|Wash-out Period|Adverse Event|0|||
27846083|NCT01230892|81265482|FG000|Overall Study|Withdrawal by Subject|1|||
27846084|NCT01230892|81265483|FG001|Overall Study|Withdrawal by Subject|1|||
27846085|NCT01230892|81265482|FG000|Overall Study|Lost to Follow-up|2|||
27846086|NCT01230892|81265483|FG001|Overall Study|Lost to Follow-up|0|||
27846087|NCT00114231|81265484|FG000|Overall Study|No consent|2|||
27846088|NCT00114231|81265485|FG001|Overall Study|No consent|0|||
27846089|NCT00114231|81265484|FG000|Overall Study|QARC requirement not met|1|||
27846090|NCT00114231|81265485|FG001|Overall Study|QARC requirement not met|0|||
27846091|NCT00114231|81265484|FG000|Overall Study|Suspected metastatic disease|1|||
27846092|NCT00114231|81265485|FG001|Overall Study|Suspected metastatic disease|0|||
27846093|NCT00114231|81265484|FG000|Overall Study|No adenocarcinoma|1|||
27846094|NCT00114231|81265485|FG001|Overall Study|No adenocarcinoma|0|||
27846095|NCT00114231|81265484|FG000|Overall Study|Low creatinine clearance|0|||
27846096|NCT00114231|81265485|FG001|Overall Study|Low creatinine clearance|1|||
27846097|NCT00114231|81265484|FG000|Overall Study|Tumor size > 4cm|1|||
27846098|NCT00114231|81265485|FG001|Overall Study|Tumor size > 4cm|0|||
27846099|NCT00114231|81265484|FG000|Overall Study|Tumor fixed on digital exam|0|||
27846100|NCT00114231|81265485|FG001|Overall Study|Tumor fixed on digital exam|1|||
27846101|NCT00114231|81265484|FG000|Overall Study|No Absolute Neutrophil Count|2|||
27846102|NCT00114231|81265485|FG001|Overall Study|No Absolute Neutrophil Count|0|||
27846103|NCT00114231|81265484|FG000|Overall Study|Biopsy done after registration|1|||
27846104|NCT00114231|81265485|FG001|Overall Study|Biopsy done after registration|0|||
27846105|NCT04776746|81265488|FG000|Overall Study|Study terminated by sponsor|61|||
27846106|NCT04776746|81265488|FG000|Overall Study|Adverse Event|5|||
27846107|NCT04776746|81265488|FG000|Overall Study|Death|4|||
27846108|NCT04776746|81265488|FG000|Overall Study|Lack of Efficacy|3|||
27846109|NCT04776746|81265488|FG000|Overall Study|Noncompliance with study drug|2|||
27846110|NCT04776746|81265488|FG000|Overall Study|Not related to COVID-19|2|||
27846111|NCT02575339|81265492|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
27846112|NCT02575339|81265493|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
27613618|NCT04078035|80426705|FG001|Session 2|Lost to Follow-up|1|||
27846113|NCT02575339|81265494|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
27846114|NCT02575339|81265492|FG000|Study Treatment|Disease Progression|5|||
27846115|NCT02575339|81265493|FG001|Study Treatment|Disease Progression|2|||
27846116|NCT02575339|81265494|FG002|Study Treatment|Disease Progression|0|||
27846117|NCT02575339|81265492|FG000|Study Treatment|Adverse Event|1|||
27846118|NCT02575339|81265493|FG001|Study Treatment|Adverse Event|2|||
27504909|NCT00303069|80040891|FG003|Overall Study|Recruitment into Army Reserves|0|||
27504910|NCT00836693|80040897|FG000|Overall Study|Adverse Event|4|||
27504911|NCT00836693|80040898|FG001|Overall Study|Adverse Event|1|||
27504912|NCT00836693|80040897|FG000|Overall Study|Sponsor Decision|0|||
27504913|NCT00836693|80040898|FG001|Overall Study|Sponsor Decision|1|||
27504914|NCT00836693|80040897|FG000|Overall Study|Physician Decision|2|||
27504915|NCT00836693|80040898|FG001|Overall Study|Physician Decision|0|||
27504916|NCT00836693|80040897|FG000|Overall Study|Withdrawal by Subject|9|||
27504917|NCT00836693|80040898|FG001|Overall Study|Withdrawal by Subject|4|||
27504918|NCT00836693|80040897|FG000|Overall Study|Protocol Violation|1|||
27504919|NCT00836693|80040898|FG001|Overall Study|Protocol Violation|0|||
27846119|NCT02575339|81265494|FG002|Study Treatment|Adverse Event|0|||
27846120|NCT02575339|81265492|FG000|Follow up|Death|6|||
27846121|NCT02575339|81265493|FG001|Follow up|Death|2|||
27846122|NCT02575339|81265494|FG002|Follow up|Death|0|||
27846123|NCT02575339|81265492|FG000|Follow up|Study Terminated|0|||
27846124|NCT02575339|81265493|FG001|Follow up|Study Terminated|2|||
27846125|NCT02575339|81265494|FG002|Follow up|Study Terminated|0|||
27893730|NCT00972816|81447175|FG001|Overall Study|Adverse Event|0|||
27504920|NCT00836693|80040897|FG000|Overall Study|Lost to Follow-up|1|||
27504921|NCT00836693|80040898|FG001|Overall Study|Lost to Follow-up|0|||
27504922|NCT02379728|80040904|FG000|Overall Study|Lost to Follow-up|1|||
27504923|NCT02379728|80040905|FG001|Overall Study|Lost to Follow-up|0|||
27725797|NCT01622569|80826728|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
27725798|NCT01622569|80826725|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
27725799|NCT01622569|80826726|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
27725800|NCT01622569|80826727|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
27725801|NCT01622569|80826728|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
27725802|NCT01622569|80826725|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
27725803|NCT01622569|80826726|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
27725804|NCT01622569|80826727|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
27725805|NCT01622569|80826728|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
27725806|NCT01622569|80826725|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
27725807|NCT01622569|80826726|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
27725808|NCT01622569|80826727|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
27725809|NCT01622569|80826728|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
27725810|NCT01622569|80826725|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27725811|NCT01622569|80826726|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27725812|NCT01622569|80826727|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
27725813|NCT01622569|80826728|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
27725814|NCT02324270|80826730|FG000|Overall Study|Withdrawal by Subject|0|||
27725815|NCT02324270|80826731|FG001|Overall Study|Withdrawal by Subject|1|||
27725816|NCT02324270|80826732|FG002|Overall Study|Withdrawal by Subject|0|||
27725817|NCT02324270|80826730|FG000|Overall Study|Lost to Follow-up|4|||
27725818|NCT02324270|80826731|FG001|Overall Study|Lost to Follow-up|3|||
27725819|NCT02324270|80826732|FG002|Overall Study|Lost to Follow-up|4|||
27725820|NCT02324270|80826730|FG000|Overall Study|Protocol Violation|0|||
27725821|NCT02324270|80826731|FG001|Overall Study|Protocol Violation|1|||
27725822|NCT02324270|80826732|FG002|Overall Study|Protocol Violation|1|||
27725823|NCT02324270|80826730|FG000|Overall Study|Non Compliance with Study Drug|1|||
27725824|NCT02324270|80826731|FG001|Overall Study|Non Compliance with Study Drug|2|||
27725825|NCT02324270|80826732|FG002|Overall Study|Non Compliance with Study Drug|0|||
27725826|NCT01497262|80826733|FG000|Overall Study|Abnormal Lab Values|4|||
27725827|NCT01497262|80826733|FG000|Overall Study|Abnormal Test Procedure Result|1|||
27725828|NCT01497262|80826733|FG000|Overall Study|Physician Decision|1|||
27725829|NCT01497262|80826733|FG000|Overall Study|Withdrawal by Subject|2|||
27725830|NCT01497262|80826733|FG000|Overall Study|Adverse Event|2|||
27725831|NCT01497262|80826733|FG000|Overall Study|Protocol Violation|1|||
27725832|NCT00944034|80826734|FG000|Overall Study|Inappropriate enrollment|0|||
27725833|NCT00944034|80826735|FG001|Overall Study|Inappropriate enrollment|1|||
27725834|NCT00944034|80826736|FG002|Overall Study|Inappropriate enrollment|0|||
27725835|NCT00944034|80826737|FG003|Overall Study|Inappropriate enrollment|1|||
27725836|NCT00944034|80826738|FG004|Overall Study|Inappropriate enrollment|2|||
27504924|NCT02379728|80040906|FG002|Overall Study|Lost to Follow-up|3|||
27504925|NCT02379728|80040907|FG003|Overall Study|Lost to Follow-up|0|||
27504926|NCT02379728|80040904|FG000|Overall Study|Withdrawal by Subject|5|||
27725837|NCT00944034|80826739|FG005|Overall Study|Inappropriate enrollment|1|||
27725838|NCT00944034|80826740|FG006|Overall Study|Inappropriate enrollment|0|||
27725839|NCT00944034|80826741|FG007|Overall Study|Inappropriate enrollment|0|||
27725840|NCT00944034|80826742|FG008|Overall Study|Inappropriate enrollment|1|||
27725841|NCT00944034|80826743|FG009|Overall Study|Inappropriate enrollment|1|||
27846126|NCT02575339|81265492|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
27893731|NCT00972816|81447176|FG002|Overall Study|Adverse Event|1|||
27504927|NCT02379728|80040905|FG001|Overall Study|Withdrawal by Subject|0|||
27725842|NCT00944034|80826744|FG010|Overall Study|Inappropriate enrollment|0|||
27725843|NCT00944034|80826745|FG011|Overall Study|Inappropriate enrollment|0|||
27725844|NCT00944034|80826734|FG000|Overall Study|Withdrawal by Subject|3|||
27725845|NCT00944034|80826735|FG001|Overall Study|Withdrawal by Subject|2|||
27725846|NCT00944034|80826736|FG002|Overall Study|Withdrawal by Subject|6|||
27725847|NCT00944034|80826737|FG003|Overall Study|Withdrawal by Subject|2|||
27725848|NCT00944034|80826738|FG004|Overall Study|Withdrawal by Subject|5|||
27725849|NCT00944034|80826739|FG005|Overall Study|Withdrawal by Subject|8|||
27725850|NCT00944034|80826740|FG006|Overall Study|Withdrawal by Subject|2|||
27725851|NCT00944034|80826741|FG007|Overall Study|Withdrawal by Subject|2|||
27725852|NCT00944034|80826742|FG008|Overall Study|Withdrawal by Subject|3|||
27725853|NCT00944034|80826743|FG009|Overall Study|Withdrawal by Subject|4|||
27725854|NCT00944034|80826744|FG010|Overall Study|Withdrawal by Subject|0|||
27725855|NCT00944034|80826745|FG011|Overall Study|Withdrawal by Subject|4|||
27725856|NCT00944034|80826734|FG000|Overall Study|Lost to Follow-up|0|||
27725857|NCT00944034|80826735|FG001|Overall Study|Lost to Follow-up|4|||
27725858|NCT00944034|80826736|FG002|Overall Study|Lost to Follow-up|2|||
27725859|NCT00944034|80826737|FG003|Overall Study|Lost to Follow-up|0|||
27725860|NCT00944034|80826738|FG004|Overall Study|Lost to Follow-up|5|||
27725861|NCT00944034|80826739|FG005|Overall Study|Lost to Follow-up|7|||
27725862|NCT00944034|80826740|FG006|Overall Study|Lost to Follow-up|0|||
27725863|NCT00944034|80826741|FG007|Overall Study|Lost to Follow-up|1|||
27725864|NCT00944034|80826742|FG008|Overall Study|Lost to Follow-up|5|||
27725865|NCT00944034|80826743|FG009|Overall Study|Lost to Follow-up|1|||
27725866|NCT00944034|80826744|FG010|Overall Study|Lost to Follow-up|1|||
27725867|NCT00944034|80826745|FG011|Overall Study|Lost to Follow-up|0|||
27725868|NCT00944034|80826734|FG000|Overall Study|Death|0|||
27725869|NCT00944034|80826735|FG001|Overall Study|Death|0|||
27725870|NCT00944034|80826736|FG002|Overall Study|Death|1|||
27725871|NCT00944034|80826737|FG003|Overall Study|Death|0|||
27725872|NCT00944034|80826738|FG004|Overall Study|Death|0|||
27725873|NCT00944034|80826739|FG005|Overall Study|Death|0|||
27725874|NCT00944034|80826740|FG006|Overall Study|Death|0|||
27725875|NCT00944034|80826741|FG007|Overall Study|Death|0|||
27725876|NCT00944034|80826742|FG008|Overall Study|Death|0|||
27725877|NCT00944034|80826743|FG009|Overall Study|Death|0|||
27725878|NCT00944034|80826744|FG010|Overall Study|Death|0|||
27725879|NCT00944034|80826745|FG011|Overall Study|Death|0|||
27725880|NCT00944034|80826734|FG000|Overall Study|Protocol Violation|2|||
27725881|NCT00944034|80826735|FG001|Overall Study|Protocol Violation|0|||
27725882|NCT00944034|80826736|FG002|Overall Study|Protocol Violation|0|||
27725883|NCT00944034|80826737|FG003|Overall Study|Protocol Violation|1|||
27725884|NCT00944034|80826738|FG004|Overall Study|Protocol Violation|2|||
27725885|NCT00944034|80826739|FG005|Overall Study|Protocol Violation|3|||
27725886|NCT00944034|80826740|FG006|Overall Study|Protocol Violation|0|||
27725887|NCT00944034|80826741|FG007|Overall Study|Protocol Violation|1|||
27725888|NCT00944034|80826742|FG008|Overall Study|Protocol Violation|1|||
27725889|NCT00944034|80826743|FG009|Overall Study|Protocol Violation|4|||
27725890|NCT00944034|80826744|FG010|Overall Study|Protocol Violation|0|||
27725891|NCT00944034|80826745|FG011|Overall Study|Protocol Violation|0|||
27725892|NCT00944034|80826734|FG000|Overall Study|Unable to classify|0|||
27725893|NCT00944034|80826735|FG001|Overall Study|Unable to classify|0|||
27725894|NCT00944034|80826736|FG002|Overall Study|Unable to classify|0|||
27846127|NCT02575339|81265493|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
27846128|NCT02575339|81265494|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
27504928|NCT02379728|80040906|FG002|Overall Study|Withdrawal by Subject|5|||
27504929|NCT02379728|80040907|FG003|Overall Study|Withdrawal by Subject|3|||
27504930|NCT02379728|80040904|FG000|Overall Study|Protocol Violation|0|||
27504931|NCT02379728|80040905|FG001|Overall Study|Protocol Violation|0|||
27504932|NCT02379728|80040906|FG002|Overall Study|Protocol Violation|2|||
27504933|NCT02379728|80040907|FG003|Overall Study|Protocol Violation|0|||
27504934|NCT02807402|80040908|FG000|Overall Study|Failure to Return|1|||
27725895|NCT00944034|80826737|FG003|Overall Study|Unable to classify|0|||
27725896|NCT00944034|80826738|FG004|Overall Study|Unable to classify|0|||
27613619|NCT04078035|80426704|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
27725897|NCT00944034|80826739|FG005|Overall Study|Unable to classify|1|||
27504935|NCT02807402|80040908|FG000|Overall Study|Death|3|||
27504936|NCT02807402|80040908|FG000|Overall Study|Other|2|||
27613620|NCT04078035|80426705|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
27725898|NCT00944034|80826740|FG006|Overall Study|Unable to classify|1|||
27725899|NCT00944034|80826741|FG007|Overall Study|Unable to classify|1|||
27725900|NCT00944034|80826742|FG008|Overall Study|Unable to classify|0|||
27725901|NCT00944034|80826743|FG009|Overall Study|Unable to classify|0|||
27725902|NCT00944034|80826744|FG010|Overall Study|Unable to classify|0|||
27725903|NCT00944034|80826745|FG011|Overall Study|Unable to classify|0|||
27725904|NCT00944034|80826734|FG000|Overall Study|Administrative reason|0|||
27725905|NCT00944034|80826735|FG001|Overall Study|Administrative reason|0|||
27725906|NCT00944034|80826736|FG002|Overall Study|Administrative reason|0|||
27725907|NCT00944034|80826737|FG003|Overall Study|Administrative reason|0|||
27846129|NCT00206102|81265495|FG000|Overall Study|Adverse Event|119|||
27846130|NCT00206102|81265496|FG001|Overall Study|Adverse Event|82|||
27846131|NCT00206102|81265495|FG000|Overall Study|Protocol Violation|0|||
27846132|NCT00206102|81265496|FG001|Overall Study|Protocol Violation|2|||
27846133|NCT00206102|81265495|FG000|Overall Study|Lack of therapeutic response|16|||
27846134|NCT00206102|81265496|FG001|Overall Study|Lack of therapeutic response|11|||
27846135|NCT00206102|81265495|FG000|Overall Study|Lost to Follow-up|95|||
27846136|NCT00206102|81265496|FG001|Overall Study|Lost to Follow-up|66|||
27846137|NCT00206102|81265495|FG000|Overall Study|Withdrawal by Subject|118|||
27846138|NCT00206102|81265496|FG001|Overall Study|Withdrawal by Subject|101|||
27846139|NCT00206102|81265495|FG000|Overall Study|Study-specific discontinuation criteria|18|||
27846140|NCT00206102|81265496|FG001|Overall Study|Study-specific discontinuation criteria|17|||
27893732|NCT00972816|81447177|FG003|Overall Study|Adverse Event|0|||
27893733|NCT00972816|81447178|FG004|Overall Study|Adverse Event|0|||
27893734|NCT00972816|81447179|FG005|Overall Study|Adverse Event|0|||
27893735|NCT00972816|81447180|FG006|Overall Study|Adverse Event|0|||
27893736|NCT00972816|81447181|FG007|Overall Study|Adverse Event|0|||
27893737|NCT00972816|81447174|FG000|Overall Study|Withdrawal by Subject|4|||
27893738|NCT00972816|81447175|FG001|Overall Study|Withdrawal by Subject|2|||
27893739|NCT00972816|81447176|FG002|Overall Study|Withdrawal by Subject|1|||
27846141|NCT00206102|81265495|FG000|Overall Study|None of those categories|42|||
27846142|NCT00206102|81265496|FG001|Overall Study|None of those categories|36|||
27846143|NCT00766831|81265497|FG000|Overall Study|Withdrawal by Subject|4|||
27846144|NCT00766831|81265497|FG000|Overall Study|Lost to Follow-up|3|||
27846145|NCT00766831|81265497|FG000|Overall Study|Adverse Event|20|||
27846146|NCT00766831|81265497|FG000|Overall Study|Protocol Violation|15|||
27846147|NCT00766831|81265497|FG000|Overall Study|Physician Decision|5|||
27846148|NCT00766831|81265497|FG000|Overall Study|Withdrawal of consent|26|||
27846149|NCT00766831|81265497|FG000|Overall Study|Non cooperation by participants|14|||
27846150|NCT00766831|81265497|FG000|Overall Study|Other|28|||
27846151|NCT01258101|81265498|FG000|Overall Study|Adverse Event|5|||
27846152|NCT01258101|81265499|FG001|Overall Study|Adverse Event|6|||
27846153|NCT01258101|81265500|FG002|Overall Study|Adverse Event|0|||
27846154|NCT01258101|81265501|FG003|Overall Study|Adverse Event|0|||
27846155|NCT01258101|81265498|FG000|Overall Study|Extra exclusion criterion amended|2|||
27893740|NCT00972816|81447177|FG003|Overall Study|Withdrawal by Subject|3|||
27846156|NCT01258101|81265499|FG001|Overall Study|Extra exclusion criterion amended|1|||
27846157|NCT01258101|81265500|FG002|Overall Study|Extra exclusion criterion amended|1|||
27846158|NCT01258101|81265501|FG003|Overall Study|Extra exclusion criterion amended|1|||
27846159|NCT01258101|81265498|FG000|Overall Study|Informed consent has been withdrawn|2|||
27846160|NCT01258101|81265499|FG001|Overall Study|Informed consent has been withdrawn|2|||
27893741|NCT00972816|81447178|FG004|Overall Study|Withdrawal by Subject|0|||
27504937|NCT00726063|80040909|FG000|Overall Study|Adverse Event|9|||
27504938|NCT00726063|80040910|FG001|Overall Study|Adverse Event|7|||
27504939|NCT02606643|80040913|FG000|Overall Study|did not meet inclusion criteria|1|||
27504940|NCT02606643|80040914|FG001|Overall Study|did not meet inclusion criteria|3|||
27504941|NCT04163016|80040915|FG000|Enrollment|Adverse Event|1|||
27504942|NCT04163016|80040916|FG001|Enrollment|Adverse Event|0|||
27504943|NCT04163016|80040917|FG002|Enrollment|Adverse Event|0|||
27504944|NCT04163016|80040918|FG003|Enrollment|Adverse Event|0|||
27504945|NCT04163016|80040915|FG000|Treatment|Adverse Event|0|||
27504946|NCT04163016|80040916|FG001|Treatment|Adverse Event|1|||
27504947|NCT04163016|80040917|FG002|Treatment|Adverse Event|0|||
27504948|NCT04163016|80040918|FG003|Treatment|Adverse Event|0|||
27893742|NCT00972816|81447179|FG005|Overall Study|Withdrawal by Subject|1|||
27893743|NCT00972816|81447180|FG006|Overall Study|Withdrawal by Subject|1|||
27504949|NCT04163016|80040915|FG000|Treatment|Withdrawal by Subject|0|||
27504950|NCT04163016|80040916|FG001|Treatment|Withdrawal by Subject|2|||
27504951|NCT04163016|80040917|FG002|Treatment|Withdrawal by Subject|0|||
27504952|NCT04163016|80040918|FG003|Treatment|Withdrawal by Subject|0|||
27504953|NCT04163016|80040915|FG000|Treatment|Indeterminate TB-test|0|||
27504954|NCT04163016|80040916|FG001|Treatment|Indeterminate TB-test|0|||
27893744|NCT00972816|81447181|FG007|Overall Study|Withdrawal by Subject|2|||
27893745|NCT00972816|81447174|FG000|Overall Study|Lost to Follow-up|11|||
27504955|NCT04163016|80040917|FG002|Treatment|Indeterminate TB-test|0|||
27504956|NCT04163016|80040918|FG003|Treatment|Indeterminate TB-test|1|||
27504957|NCT04163016|80040915|FG000|Treatment|Participant did not want to continue in study|0|||
27504958|NCT04163016|80040916|FG001|Treatment|Participant did not want to continue in study|0|||
27504959|NCT04163016|80040917|FG002|Treatment|Participant did not want to continue in study|0|||
27504960|NCT04163016|80040918|FG003|Treatment|Participant did not want to continue in study|1|||
27846161|NCT01258101|81265500|FG002|Overall Study|Informed consent has been withdrawn|1|||
27846162|NCT01258101|81265501|FG003|Overall Study|Informed consent has been withdrawn|1|||
27846163|NCT01258101|81265498|FG000|Overall Study|Patient is not able to attend visits|8|||
27893746|NCT00972816|81447175|FG001|Overall Study|Lost to Follow-up|9|||
27893747|NCT00972816|81447176|FG002|Overall Study|Lost to Follow-up|7|||
27846164|NCT01258101|81265499|FG001|Overall Study|Patient is not able to attend visits|9|||
27846165|NCT01258101|81265500|FG002|Overall Study|Patient is not able to attend visits|7|||
27846166|NCT01258101|81265501|FG003|Overall Study|Patient is not able to attend visits|6|||
27846167|NCT01258101|81265498|FG000|Overall Study|Patient´s compliance|4|||
27846168|NCT01258101|81265499|FG001|Overall Study|Patient´s compliance|3|||
27846169|NCT01258101|81265500|FG002|Overall Study|Patient´s compliance|1|||
27846170|NCT01258101|81265501|FG003|Overall Study|Patient´s compliance|2|||
27846171|NCT01258101|81265498|FG000|Overall Study|Lost to Follow-up|5|||
27846172|NCT01258101|81265499|FG001|Overall Study|Lost to Follow-up|5|||
27846173|NCT01258101|81265500|FG002|Overall Study|Lost to Follow-up|0|||
27846174|NCT01258101|81265501|FG003|Overall Study|Lost to Follow-up|6|||
27846175|NCT01258101|81265498|FG000|Overall Study|PCR positive at week 24|0|||
27846176|NCT01258101|81265499|FG001|Overall Study|PCR positive at week 24|0|||
27846177|NCT01258101|81265500|FG002|Overall Study|PCR positive at week 24|0|||
27846178|NCT01258101|81265501|FG003|Overall Study|PCR positive at week 24|1|||
27846179|NCT01258101|81265498|FG000|Overall Study|Other reason|7|||
27846180|NCT01258101|81265499|FG001|Overall Study|Other reason|8|||
27893748|NCT00972816|81447177|FG003|Overall Study|Lost to Follow-up|5|||
27893749|NCT00972816|81447178|FG004|Overall Study|Lost to Follow-up|11|||
27893750|NCT00972816|81447179|FG005|Overall Study|Lost to Follow-up|10|||
27893751|NCT00972816|81447180|FG006|Overall Study|Lost to Follow-up|7|||
27893752|NCT00972816|81447181|FG007|Overall Study|Lost to Follow-up|7|||
27893753|NCT00972816|81447174|FG000|Overall Study|Inappropriate enrolment|0|||
27893754|NCT00972816|81447175|FG001|Overall Study|Inappropriate enrolment|0|||
27893755|NCT00972816|81447176|FG002|Overall Study|Inappropriate enrolment|0|||
27893756|NCT00972816|81447177|FG003|Overall Study|Inappropriate enrolment|0|||
27893757|NCT00972816|81447178|FG004|Overall Study|Inappropriate enrolment|0|||
27846181|NCT01258101|81265500|FG002|Overall Study|Other reason|1|||
27846182|NCT01258101|81265501|FG003|Overall Study|Other reason|8|||
27846183|NCT00003531|81265506|FG000|Overall Study|Not evaluable|10|||
27846184|NCT01010750|81268149|FG000|Second Intervention|Adverse Event|0|||
27846185|NCT01010750|81268150|FG001|Second Intervention|Adverse Event|1|||
27846186|NCT01010750|81268151|FG002|Second Intervention|Adverse Event|0|||
27846187|NCT01010750|81268152|FG003|Second Intervention|Adverse Event|0|||
27846188|NCT01010750|81268153|FG004|Second Intervention|Adverse Event|0|||
27846189|NCT01010750|81268154|FG005|Second Intervention|Adverse Event|0|||
27846190|NCT00412737|81268157|FG000|Overall Study|Death|1|||
27846191|NCT00412737|81268158|FG001|Overall Study|Death|0|||
27846192|NCT00412737|81268157|FG000|Overall Study|Adverse Event|3|||
27846193|NCT00412737|81268158|FG001|Overall Study|Adverse Event|2|||
27846194|NCT00412737|81268157|FG000|Overall Study|Refused Treatment|6|||
27846195|NCT00412737|81268158|FG001|Overall Study|Refused Treatment|2|||
27846196|NCT00412737|81268157|FG000|Overall Study|Failure to Return|6|||
27846197|NCT00412737|81268158|FG001|Overall Study|Failure to Return|2|||
27846198|NCT04403763|81268162|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
27846199|NCT04403763|81268163|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
27846200|NCT04403763|81268164|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
27846201|NCT04403763|81268165|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
27846202|NCT04403763|81268166|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
27846203|NCT04403763|81268167|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
27846204|NCT04403763|81268168|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
27846205|NCT04403763|81268162|FG000|Stage 1|Early termination due to PK tube failure|0|||
27846206|NCT04403763|81268163|FG001|Stage 1|Early termination due to PK tube failure|0|||
27846207|NCT04403763|81268164|FG002|Stage 1|Early termination due to PK tube failure|1|||
27846208|NCT04403763|81268165|FG003|Stage 1|Early termination due to PK tube failure|0|||
27846209|NCT04403763|81268166|FG004|Stage 1|Early termination due to PK tube failure|0|||
27846210|NCT04403763|81268167|FG005|Stage 1|Early termination due to PK tube failure|0|||
27846211|NCT04403763|81268168|FG006|Stage 1|Early termination due to PK tube failure|0|||
27846212|NCT04403763|81268162|FG000|Stage 2A|Adverse Event|0|||
27893758|NCT00972816|81447179|FG005|Overall Study|Inappropriate enrolment|0|||
27893759|NCT00972816|81447180|FG006|Overall Study|Inappropriate enrolment|2|||
27846213|NCT04403763|81268163|FG001|Stage 2A|Adverse Event|0|||
27846214|NCT04403763|81268164|FG002|Stage 2A|Adverse Event|0|||
27846215|NCT04403763|81268165|FG003|Stage 2A|Adverse Event|0|||
27893760|NCT00972816|81447181|FG007|Overall Study|Inappropriate enrolment|0|||
27893761|NCT00972816|81447174|FG000|Overall Study|Unable to classify|2|||
27893762|NCT00972816|81447175|FG001|Overall Study|Unable to classify|0|||
27893763|NCT00972816|81447176|FG002|Overall Study|Unable to classify|0|||
27846216|NCT04403763|81268166|FG004|Stage 2A|Adverse Event|0|||
27846217|NCT04403763|81268167|FG005|Stage 2A|Adverse Event|0|||
27846218|NCT04403763|81268168|FG006|Stage 2A|Adverse Event|1|||
27846219|NCT00094458|81268170|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
27846220|NCT00094458|81268171|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
27846221|NCT00094458|81268172|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
27846222|NCT00094458|81268173|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
27846223|NCT00094458|81268174|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
27846224|NCT00094458|81268175|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
27846225|NCT00094458|81268170|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
27846226|NCT00094458|81268171|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
27846227|NCT00094458|81268172|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
27846228|NCT00094458|81268173|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
27893764|NCT00972816|81447177|FG003|Overall Study|Unable to classify|0|||
27893765|NCT00972816|81447178|FG004|Overall Study|Unable to classify|1|||
27893766|NCT00972816|81447179|FG005|Overall Study|Unable to classify|0|||
27893767|NCT00972816|81447180|FG006|Overall Study|Unable to classify|0|||
27893768|NCT00972816|81447181|FG007|Overall Study|Unable to classify|0|||
27846229|NCT00094458|81268174|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
27846230|NCT00094458|81268175|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
27846231|NCT00094458|81268170|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
27846232|NCT00094458|81268171|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
27846233|NCT00094458|81268172|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
27846234|NCT00094458|81268173|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
27846235|NCT00094458|81268174|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
27846236|NCT00094458|81268175|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
27846237|NCT00094458|81268170|FG000|Main Study: Through Week 30|Adverse Event|38|||
27846238|NCT00094458|81268171|FG001|Main Study: Through Week 30|Adverse Event|20|||
27893769|NCT03692325|81447182|FG000|Overall Study|Adverse Event|2|||
27893770|NCT03692325|81447182|FG000|Overall Study|Progression/Recurrence|2|||
27893771|NCT00900731|81447184|FG000|Overall Study|Adverse Event|31|||
27893772|NCT00900731|81447185|FG001|Overall Study|Adverse Event|27|||
27893773|NCT00900731|81447184|FG000|Overall Study|Withdrawal by Subject|8|||
27893774|NCT00900731|81447185|FG001|Overall Study|Withdrawal by Subject|7|||
27893775|NCT00900731|81447184|FG000|Overall Study|Protocol Deviation|8|||
27893776|NCT00900731|81447185|FG001|Overall Study|Protocol Deviation|11|||
27893777|NCT00900731|81447184|FG000|Overall Study|Administrative Problems|5|||
27893778|NCT00900731|81447185|FG001|Overall Study|Administrative Problems|4|||
27893779|NCT00900731|81447184|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
27893780|NCT00900731|81447185|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27504961|NCT00174187|80040919|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
27504962|NCT00174187|80040920|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
27504963|NCT00174187|80040921|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
27504964|NCT00174187|80040919|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
27504965|NCT00174187|80040920|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
27504966|NCT00174187|80040921|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
27504967|NCT00174187|80040919|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
27504968|NCT00174187|80040920|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
27846239|NCT00094458|81268172|FG002|Main Study: Through Week 30|Adverse Event|28|||
27846240|NCT00094458|81268173|FG003|Main Study: Through Week 30|Adverse Event|0|||
27846241|NCT00094458|81268174|FG004|Main Study: Through Week 30|Adverse Event|0|||
27846242|NCT00094458|81268175|FG005|Main Study: Through Week 30|Adverse Event|0|||
27846243|NCT00094458|81268170|FG000|Main Study: Through Week 30|Death|1|||
27846244|NCT00094458|81268171|FG001|Main Study: Through Week 30|Death|0|||
27846245|NCT00094458|81268172|FG002|Main Study: Through Week 30|Death|0|||
27846246|NCT00094458|81268173|FG003|Main Study: Through Week 30|Death|0|||
27846247|NCT00094458|81268174|FG004|Main Study: Through Week 30|Death|0|||
27846248|NCT00094458|81268175|FG005|Main Study: Through Week 30|Death|0|||
27893781|NCT00900731|81447184|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
27893782|NCT00900731|81447185|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
27893783|NCT00900731|81447184|FG000|Overall Study|Lost to Follow-up|2|||
27893784|NCT00900731|81447185|FG001|Overall Study|Lost to Follow-up|3|||
27504969|NCT00174187|80040921|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
27504970|NCT00174187|80040919|FG000|Period 1 (up to 3 Years)|Other|0|||
27504971|NCT00174187|80040920|FG001|Period 1 (up to 3 Years)|Other|1|||
27504972|NCT00174187|80040921|FG002|Period 1 (up to 3 Years)|Other|0|||
27504973|NCT00174187|80040919|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
27504974|NCT00174187|80040920|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
27846249|NCT00094458|81268170|FG000|Main Study: Through Week 30|Other|19|||
27846250|NCT00094458|81268171|FG001|Main Study: Through Week 30|Other|16|||
27846251|NCT00094458|81268172|FG002|Main Study: Through Week 30|Other|9|||
27846252|NCT00094458|81268173|FG003|Main Study: Through Week 30|Other|0|||
27893785|NCT00900731|81447184|FG000|Overall Study|Lack of Efficacy|1|||
27504975|NCT00174187|80040921|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
27504976|NCT00174187|80040919|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
27613621|NCT02204293|80426706|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
27846253|NCT00094458|81268174|FG004|Main Study: Through Week 30|Other|0|||
27846254|NCT00094458|81268175|FG005|Main Study: Through Week 30|Other|0|||
27846255|NCT00094458|81268170|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
27846256|NCT00094458|81268171|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
27846257|NCT00094458|81268172|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
27893786|NCT00900731|81447185|FG001|Overall Study|Lack of Efficacy|3|||
27893787|NCT00900731|81447184|FG000|Overall Study|Death|0|||
27893788|NCT00900731|81447185|FG001|Overall Study|Death|2|||
27846258|NCT00094458|81268173|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
27846259|NCT00094458|81268174|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
27846260|NCT00094458|81268175|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
27846261|NCT00094458|81268170|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
27846262|NCT00094458|81268171|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
27846263|NCT00094458|81268172|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
27846264|NCT00094458|81268173|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
27846265|NCT00094458|81268174|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
27846266|NCT00094458|81268175|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
27846267|NCT00094458|81268170|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
27846268|NCT00094458|81268171|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
27893789|NCT00452673|81447193|FG000|Dose Escalation Period|Disease Progression|6|||
27893790|NCT00452673|81447194|FG001|Dose Escalation Period|Disease Progression|6|||
27893791|NCT00452673|81447195|FG002|Dose Escalation Period|Disease Progression|2|||
27893792|NCT00452673|81447196|FG003|Dose Escalation Period|Disease Progression|6|||
27893793|NCT00452673|81447197|FG004|Dose Escalation Period|Disease Progression|0|||
27893794|NCT00452673|81447193|FG000|Dose Escalation Period|study drug toxicity|1|||
27893795|NCT00452673|81447194|FG001|Dose Escalation Period|study drug toxicity|3|||
27893796|NCT00452673|81447195|FG002|Dose Escalation Period|study drug toxicity|3|||
27893797|NCT00452673|81447196|FG003|Dose Escalation Period|study drug toxicity|1|||
27893798|NCT00452673|81447197|FG004|Dose Escalation Period|study drug toxicity|0|||
27893799|NCT00452673|81447193|FG000|Dose Escalation Period|Other|0|||
27893800|NCT00452673|81447194|FG001|Dose Escalation Period|Other|0|||
27893801|NCT00452673|81447195|FG002|Dose Escalation Period|Other|1|||
27893802|NCT00452673|81447196|FG003|Dose Escalation Period|Other|0|||
27893803|NCT00452673|81447197|FG004|Dose Escalation Period|Other|0|||
27893804|NCT00452673|81447193|FG000|Dose Escalation Period|Adverse Event|0|||
27893805|NCT00452673|81447194|FG001|Dose Escalation Period|Adverse Event|0|||
27893806|NCT00452673|81447195|FG002|Dose Escalation Period|Adverse Event|0|||
27893807|NCT00452673|81447196|FG003|Dose Escalation Period|Adverse Event|1|||
27893808|NCT00452673|81447197|FG004|Dose Escalation Period|Adverse Event|0|||
27893809|NCT00452673|81447193|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
27893810|NCT00452673|81447194|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
27893811|NCT00452673|81447195|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
27893812|NCT00452673|81447196|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
27893813|NCT00452673|81447197|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
27893814|NCT00452673|81447193|FG000|Dose Expansion Period|Disease Progression|0|||
27893815|NCT00452673|81447194|FG001|Dose Expansion Period|Disease Progression|0|||
27893816|NCT00452673|81447195|FG002|Dose Expansion Period|Disease Progression|0|||
27893817|NCT00452673|81447196|FG003|Dose Expansion Period|Disease Progression|0|||
27893818|NCT00452673|81447197|FG004|Dose Expansion Period|Disease Progression|19|||
27893819|NCT00452673|81447193|FG000|Dose Expansion Period|Other|0|||
27893820|NCT00452673|81447194|FG001|Dose Expansion Period|Other|0|||
27893821|NCT00452673|81447195|FG002|Dose Expansion Period|Other|0|||
27893822|NCT00452673|81447196|FG003|Dose Expansion Period|Other|0|||
27893823|NCT00452673|81447197|FG004|Dose Expansion Period|Other|2|||
27893824|NCT01088243|81447200|FG000|Overall Study|Adverse Event|1|||
27893825|NCT01088243|81447201|FG001|Overall Study|Adverse Event|0|||
27893826|NCT01286168|81447202|FG000|Overall Study|Withdrawal by Subject|1|||
27893827|NCT01286168|81447202|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
27893828|NCT02203851|81447203|FG000|Overall Study|Lost to Follow-up|4|||
27893829|NCT02203851|81447203|FG000|Overall Study|Withdrawal by Subject|6|||
27893830|NCT02203851|81447203|FG000|Overall Study|Other|1|||
27893831|NCT03875092|81447205|FG000|Overall Study|Adverse Event|2|||
27893832|NCT03875092|81447206|FG001|Overall Study|Adverse Event|5|||
27893833|NCT03875092|81447205|FG000|Overall Study|Death|44|||
27893834|NCT03875092|81447206|FG001|Overall Study|Death|51|||
27893835|NCT03875092|81447205|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
27893836|NCT03875092|81447206|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
27893837|NCT00520481|81447207|FG000|Overall Study|Adverse Event|4|||
27893838|NCT00520481|81447208|FG001|Overall Study|Adverse Event|1|||
27893839|NCT00520481|81447207|FG000|Overall Study|Withdrawal by Subject|3|||
27893840|NCT00520481|81447208|FG001|Overall Study|Withdrawal by Subject|0|||
27893841|NCT04569968|81447209|FG000|Overall Study|Lost to Follow-up|2|||
27893842|NCT04569968|81447210|FG001|Overall Study|Lost to Follow-up|5|||
27893843|NCT04569968|81447209|FG000|Overall Study|Story of head and/or neck surgery|2|||
27893844|NCT04569968|81447210|FG001|Overall Study|Story of head and/or neck surgery|2|||
27893845|NCT04569968|81447209|FG000|Overall Study|Time of stroke onset|8|||
27893846|NCT04569968|81447210|FG001|Overall Study|Time of stroke onset|7|||
27893847|NCT04569968|81447209|FG000|Overall Study|Type of strokr|12|||
27893848|NCT04569968|81447210|FG001|Overall Study|Type of strokr|8|||
27893849|NCT04569968|81447209|FG000|Overall Study|Cooperation|8|||
27893850|NCT04569968|81447210|FG001|Overall Study|Cooperation|8|||
27893851|NCT04569968|81447209|FG000|Overall Study|Age interval|17|||
27893852|NCT04569968|81447210|FG001|Overall Study|Age interval|6|||
27893853|NCT04569968|81447209|FG000|Overall Study|Denial of participation to the study|0|||
27893854|NCT04569968|81447210|FG001|Overall Study|Denial of participation to the study|3|||
27893855|NCT04569968|81447209|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
27893856|NCT04569968|81447210|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
27893857|NCT04569968|81447209|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
27893858|NCT04569968|81447210|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
27893859|NCT04569968|81447209|FG000|Overall Study|Quarantine|1|||
27893860|NCT04569968|81447210|FG001|Overall Study|Quarantine|0|||
27893861|NCT04569968|81447209|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
27893862|NCT04569968|81447210|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
27893863|NCT04569968|81447209|FG000|Overall Study|Repetitive stroke|8|||
27893864|NCT04569968|81447210|FG001|Overall Study|Repetitive stroke|0|||
27893865|NCT04569968|81447209|FG000|Overall Study|Insufficient mastication|1|||
27846269|NCT00094458|81268172|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
27846270|NCT00094458|81268173|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
27846271|NCT00094458|81268174|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
27846272|NCT00094458|81268175|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
27846273|NCT00094458|81268170|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
27846274|NCT00094458|81268171|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
27846275|NCT00094458|81268172|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
27846276|NCT00094458|81268173|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
27846277|NCT00094458|81268174|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
27846278|NCT00094458|81268175|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
27846279|NCT00094458|81268170|FG000|OLE: Open-Label Extension|Adverse Event|0|||
27846280|NCT00094458|81268171|FG001|OLE: Open-Label Extension|Adverse Event|0|||
27846281|NCT00094458|81268172|FG002|OLE: Open-Label Extension|Adverse Event|0|||
27846282|NCT00094458|81268173|FG003|OLE: Open-Label Extension|Adverse Event|0|||
27846283|NCT00094458|81268174|FG004|OLE: Open-Label Extension|Adverse Event|3|||
27846284|NCT00094458|81268175|FG005|OLE: Open-Label Extension|Adverse Event|4|||
27846285|NCT00094458|81268170|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27846286|NCT00094458|81268171|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27846287|NCT00094458|81268172|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27846288|NCT00094458|81268173|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
27846289|NCT00094458|81268174|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
27846290|NCT00094458|81268175|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
27846291|NCT00094458|81268170|FG000|OLE: Open-Label Extension|Patient decision|0|||
27846292|NCT00094458|81268171|FG001|OLE: Open-Label Extension|Patient decision|0|||
27846293|NCT00094458|81268172|FG002|OLE: Open-Label Extension|Patient decision|0|||
27846294|NCT00094458|81268173|FG003|OLE: Open-Label Extension|Patient decision|0|||
27846295|NCT00094458|81268174|FG004|OLE: Open-Label Extension|Patient decision|1|||
27846296|NCT00094458|81268175|FG005|OLE: Open-Label Extension|Patient decision|0|||
27846297|NCT01615263|81268176|FG000|Overall Study|Post-randomization exclusion|0|||
27846298|NCT01615263|81268177|FG001|Overall Study|Post-randomization exclusion|2|||
27846299|NCT02087176|81268178|FG000|Overall Study|Withdrawal by Subject|1|||
27846300|NCT02087176|81268178|FG000|Overall Study|Death|10|||
27846301|NCT02087176|81268178|FG000|Overall Study|Censored|19|||
27846302|NCT02087176|81268178|FG000|Overall Study|Study Terminated by Sponsor|2|||
27846303|NCT01478828|81268182|FG000|Overall Study|Adverse Event|1|||
27846304|NCT00733369|81268183|FG000|Overall Study|Lost to Follow-up|2|||
27846305|NCT00733369|81268184|FG001|Overall Study|Lost to Follow-up|1|||
27846306|NCT00733369|81268183|FG000|Overall Study|Adverse Event|4|||
27846307|NCT00733369|81268184|FG001|Overall Study|Adverse Event|4|||
27846308|NCT00733369|81268183|FG000|Overall Study|Protocol Violation|4|||
27846309|NCT00733369|81268184|FG001|Overall Study|Protocol Violation|4|||
27846310|NCT01189500|81268185|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
27846311|NCT01189500|81268185|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
27846312|NCT01546142|81268187|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
27846313|NCT01546142|81268188|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
27846314|NCT01546142|81268187|FG000|Overall Study|Subject Noncompliance|1|||
27846315|NCT01546142|81268188|FG001|Overall Study|Subject Noncompliance|1|||
27725908|NCT00944034|80826738|FG004|Overall Study|Administrative reason|0|||
27725909|NCT00944034|80826739|FG005|Overall Study|Administrative reason|0|||
27846316|NCT01546142|81268187|FG000|Overall Study|Adverse Event|6|||
27846317|NCT01546142|81268188|FG001|Overall Study|Adverse Event|3|||
27846318|NCT01546142|81268187|FG000|Overall Study|Lost to Follow-up|20|||
27846319|NCT01546142|81268188|FG001|Overall Study|Lost to Follow-up|15|||
27846320|NCT01546142|81268187|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
27846321|NCT01546142|81268188|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
27893866|NCT04569968|81447210|FG001|Overall Study|Insufficient mastication|0|||
27893867|NCT04569968|81447209|FG000|Overall Study|Infection|1|||
27893868|NCT04569968|81447210|FG001|Overall Study|Infection|0|||
27893869|NCT04299048|81447211|FG000|Overall Study|Death|1|||
27846322|NCT01546142|81268187|FG000|Overall Study|Subject Randomized but Not Treated|1|||
27846323|NCT01546142|81268188|FG001|Overall Study|Subject Randomized but Not Treated|0|||
27846324|NCT02843659|81268193|FG000|Overall Study|Subject Withdrew Consent|0|||
27846325|NCT02843659|81268194|FG001|Overall Study|Subject Withdrew Consent|0|||
27846326|NCT02843659|81268195|FG002|Overall Study|Subject Withdrew Consent|1|||
27846327|NCT02843659|81268193|FG000|Overall Study|Administrative Reason by Sponsor|4|||
27846328|NCT02843659|81268194|FG001|Overall Study|Administrative Reason by Sponsor|5|||
27846329|NCT02843659|81268195|FG002|Overall Study|Administrative Reason by Sponsor|4|||
27846330|NCT02843659|81268193|FG000|Overall Study|Adverse Event|0|||
27846331|NCT02843659|81268194|FG001|Overall Study|Adverse Event|1|||
27846332|NCT02843659|81268195|FG002|Overall Study|Adverse Event|0|||
27846333|NCT04932941|81268200|FG000|Overall Study|Lost to Follow-up|3|||
27846334|NCT04932941|81268201|FG001|Overall Study|Lost to Follow-up|1|||
27846335|NCT04932941|81268200|FG000|Overall Study|Withdrawal by Subject|7|||
27846336|NCT04932941|81268201|FG001|Overall Study|Withdrawal by Subject|4|||
27846337|NCT04932941|81268200|FG000|Overall Study|Other|4|||
27893870|NCT04299048|81447211|FG000|Overall Study|Global deterioration of health status|2|||
27893871|NCT04299048|81447211|FG000|Overall Study|Enrolled and not treated|1|||
27893872|NCT01149421|81447212|FG000|Overall Study|Adverse Event|22|||
27893873|NCT01149421|81447213|FG001|Overall Study|Adverse Event|6|||
27893874|NCT01149421|81447214|FG002|Overall Study|Adverse Event|11|||
27893875|NCT01149421|81447212|FG000|Overall Study|Withdrawal by Subject|20|||
27893876|NCT01149421|81447213|FG001|Overall Study|Withdrawal by Subject|12|||
27893877|NCT01149421|81447214|FG002|Overall Study|Withdrawal by Subject|13|||
27893878|NCT01149421|81447212|FG000|Overall Study|Sponsor Decision|0|||
27893879|NCT01149421|81447213|FG001|Overall Study|Sponsor Decision|1|||
27893880|NCT01149421|81447214|FG002|Overall Study|Sponsor Decision|1|||
27893881|NCT01149421|81447212|FG000|Overall Study|Lost to Follow-up|2|||
27893882|NCT01149421|81447213|FG001|Overall Study|Lost to Follow-up|4|||
27893883|NCT01149421|81447214|FG002|Overall Study|Lost to Follow-up|5|||
27846338|NCT04932941|81268201|FG001|Overall Study|Other|2|||
27846339|NCT02737592|81268202|FG000|Overall Study|Withdrawal by Subject|1|||
27846340|NCT03212794|81268203|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
27846341|NCT03212794|81268204|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
27846342|NCT03212794|81268203|FG000|Overall Study|Lost to Follow-up|5|||
27893884|NCT01149421|81447212|FG000|Overall Study|Physician Decision|5|||
27893885|NCT01149421|81447213|FG001|Overall Study|Physician Decision|3|||
27893886|NCT01149421|81447214|FG002|Overall Study|Physician Decision|6|||
27893887|NCT01149421|81447212|FG000|Overall Study|Entry Criteria Not Met|1|||
27893888|NCT01149421|81447213|FG001|Overall Study|Entry Criteria Not Met|1|||
27893889|NCT01149421|81447214|FG002|Overall Study|Entry Criteria Not Met|2|||
27893890|NCT01149421|81447212|FG000|Overall Study|Protocol Violation|2|||
27893891|NCT01149421|81447213|FG001|Overall Study|Protocol Violation|2|||
27893892|NCT01149421|81447214|FG002|Overall Study|Protocol Violation|6|||
27893893|NCT02278367|81447215|FG000|Overall Study|Physician Decision|5|||
27893894|NCT02278367|81447216|FG001|Overall Study|Physician Decision|0|||
27893895|NCT02278367|81447215|FG000|Overall Study|Withdrawal by Subject|5|||
27893896|NCT02278367|81447216|FG001|Overall Study|Withdrawal by Subject|0|||
27893897|NCT00373958|81447217|FG000|Infant Series|Withdrawal by Subject|13|||
27893898|NCT00373958|81447218|FG001|Infant Series|Withdrawal by Subject|15|||
27504977|NCT00174187|80040920|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
27846343|NCT03212794|81268204|FG001|Overall Study|Lost to Follow-up|6|||
27846344|NCT03212794|81268203|FG000|Overall Study|Incarcerated; unable to participate|2|||
27893899|NCT00373958|81447217|FG000|Infant Series|Failed to return|8|||
27893900|NCT00373958|81447218|FG001|Infant Series|Failed to return|13|||
27893901|NCT00373958|81447217|FG000|Infant Series|Lost to Follow-up|6|||
27846345|NCT03212794|81268204|FG001|Overall Study|Incarcerated; unable to participate|0|||
27893902|NCT00373958|81447218|FG001|Infant Series|Lost to Follow-up|5|||
27893903|NCT00373958|81447217|FG000|Infant Series|Protocol Violation|3|||
27893904|NCT00373958|81447218|FG001|Infant Series|Protocol Violation|7|||
27893905|NCT00373958|81447217|FG000|Infant Series|Lost Kaiser coverage|4|||
27846346|NCT03212794|81268203|FG000|Overall Study|Withdrawal by Subject|1|||
27846347|NCT03212794|81268204|FG001|Overall Study|Withdrawal by Subject|0|||
27846348|NCT03212794|81268203|FG000|Overall Study|Death|0|||
27846349|NCT03212794|81268204|FG001|Overall Study|Death|1|||
27846350|NCT03212794|81268203|FG000|Overall Study|Found to be ineligible after allocation|0|||
27846351|NCT03212794|81268204|FG001|Overall Study|Found to be ineligible after allocation|1|||
27846352|NCT03212794|81268203|FG000|Overall Study|Relocated out of area|2|||
27846353|NCT03212794|81268204|FG001|Overall Study|Relocated out of area|0|||
27846354|NCT01546922|81268205|FG000|First Period of 10 Weeks|Protocol Violation|3|||
27846355|NCT01546922|81268206|FG001|First Period of 10 Weeks|Protocol Violation|1|||
27846356|NCT01546922|81268205|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
27846357|NCT01546922|81268206|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
27846358|NCT01546922|81268205|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
27846359|NCT01546922|81268206|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
27846360|NCT01546922|81268205|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
27846361|NCT01546922|81268206|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
27846362|NCT01546922|81268205|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
27846363|NCT01546922|81268206|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
27846364|NCT01640873|81268209|FG000|Overall Study|Protocol Violation|2|||
27846365|NCT01640873|81268210|FG001|Overall Study|Protocol Violation|1|||
27846366|NCT01522950|81268211|FG000|Overall Study|Withdrawal by Subject|3|||
27846367|NCT01522950|81268212|FG001|Overall Study|Withdrawal by Subject|2|||
27846368|NCT01522950|81268213|FG002|Overall Study|Withdrawal by Subject|1|||
27846369|NCT01522950|81268211|FG000|Overall Study|Adverse Event|3|||
27846370|NCT01522950|81268212|FG001|Overall Study|Adverse Event|1|||
27846371|NCT01522950|81268213|FG002|Overall Study|Adverse Event|1|||
27846372|NCT01522950|81268211|FG000|Overall Study|Protocol Violation|0|||
27846373|NCT01522950|81268212|FG001|Overall Study|Protocol Violation|0|||
27846374|NCT01522950|81268213|FG002|Overall Study|Protocol Violation|2|||
27846375|NCT01522950|81268211|FG000|Overall Study|Death|0|||
27846376|NCT01522950|81268212|FG001|Overall Study|Death|1|||
27846377|NCT01522950|81268213|FG002|Overall Study|Death|1|||
27846378|NCT01522950|81268211|FG000|Overall Study|Study Medication Sensitivity|0|||
27846379|NCT01522950|81268212|FG001|Overall Study|Study Medication Sensitivity|1|||
27846380|NCT01522950|81268213|FG002|Overall Study|Study Medication Sensitivity|0|||
27846381|NCT00268892|81268223|FG000|Overall Study|Adverse Event|14|||
27846382|NCT00268892|81268224|FG001|Overall Study|Adverse Event|17|||
27846383|NCT00268892|81268225|FG002|Overall Study|Adverse Event|20|||
27846384|NCT00268892|81268223|FG000|Overall Study|Lack of Efficacy|1|||
27846385|NCT00268892|81268224|FG001|Overall Study|Lack of Efficacy|3|||
27846386|NCT00268892|81268225|FG002|Overall Study|Lack of Efficacy|0|||
27846387|NCT00268892|81268223|FG000|Overall Study|Withdrawal by Subject|14|||
27846388|NCT00268892|81268224|FG001|Overall Study|Withdrawal by Subject|15|||
27846389|NCT00268892|81268225|FG002|Overall Study|Withdrawal by Subject|13|||
27846390|NCT00268892|81268223|FG000|Overall Study|Physician Decision|0|||
27846391|NCT00268892|81268224|FG001|Overall Study|Physician Decision|1|||
27846392|NCT00268892|81268225|FG002|Overall Study|Physician Decision|0|||
27846393|NCT00268892|81268223|FG000|Overall Study|Lost to Follow-up|5|||
27846394|NCT00268892|81268224|FG001|Overall Study|Lost to Follow-up|2|||
27846395|NCT00268892|81268225|FG002|Overall Study|Lost to Follow-up|4|||
27846396|NCT00268892|81268223|FG000|Overall Study|Protocol Violation|0|||
27846397|NCT00268892|81268224|FG001|Overall Study|Protocol Violation|1|||
27846398|NCT00268892|81268225|FG002|Overall Study|Protocol Violation|0|||
27504978|NCT00174187|80040921|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
27504979|NCT00174187|80040919|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
27504980|NCT00174187|80040920|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
27504981|NCT00174187|80040921|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
27504982|NCT00174187|80040919|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
27504983|NCT00174187|80040920|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
27504984|NCT00174187|80040921|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
27504985|NCT00174187|80040919|FG000|Period 2 (After 3 Years)|Other|0|||
27504986|NCT00174187|80040920|FG001|Period 2 (After 3 Years)|Other|0|||
27504987|NCT00174187|80040921|FG002|Period 2 (After 3 Years)|Other|5|||
27504988|NCT03299166|80040924|FG000|Overall Study|Adverse Event|9|||
27846399|NCT00268892|81268223|FG000|Overall Study|Disease Progression|1|||
27846400|NCT00268892|81268224|FG001|Overall Study|Disease Progression|1|||
27846401|NCT00268892|81268225|FG002|Overall Study|Disease Progression|0|||
27504989|NCT03299166|80040925|FG001|Overall Study|Adverse Event|4|||
27504990|NCT03299166|80040924|FG000|Overall Study|Withdrawal by Subject|6|||
27846402|NCT00268892|81268223|FG000|Overall Study|Trial Site Closed|4|||
27846403|NCT00268892|81268224|FG001|Overall Study|Trial Site Closed|2|||
27846404|NCT00268892|81268225|FG002|Overall Study|Trial Site Closed|2|||
27846405|NCT00743509|81268227|FG000|Overall Study|Withdrawal by Subject|2|||
27846406|NCT01567826|81268228|FG000|Overall Study|Lost to Follow-up|3|||
27846407|NCT01567826|81268229|FG001|Overall Study|Lost to Follow-up|2|||
27846408|NCT01885182|81268230|FG000|Overall Study|Adverse Event|11|||
27846409|NCT01885182|81268231|FG001|Overall Study|Adverse Event|13|||
27846410|NCT01885182|81268230|FG000|Overall Study|Withdrawal by Subject|13|||
27846411|NCT01885182|81268231|FG001|Overall Study|Withdrawal by Subject|6|||
27846412|NCT01885182|81268230|FG000|Overall Study|Lost to Follow-up|2|||
27846413|NCT01885182|81268231|FG001|Overall Study|Lost to Follow-up|2|||
27846414|NCT01885182|81268230|FG000|Overall Study|Lack of Efficacy|8|||
27846415|NCT01885182|81268231|FG001|Overall Study|Lack of Efficacy|1|||
27846416|NCT00285584|81268245|FG000|Month 3|Lost to Follow-up|3|||
27846417|NCT00285584|81268246|FG001|Month 3|Lost to Follow-up|3|||
27846418|NCT00285584|81268245|FG000|Month 3|Withdrawal by Subject|1|||
27846419|NCT00285584|81268246|FG001|Month 3|Withdrawal by Subject|0|||
27846420|NCT00285584|81268245|FG000|Month 6|Lost to Follow-up|0|||
27846421|NCT00285584|81268246|FG001|Month 6|Lost to Follow-up|1|||
27846422|NCT00854373|81268249|FG000|Overall Study|Withdrawal by Subject|1|||
27846423|NCT00854373|81268250|FG001|Overall Study|Withdrawal by Subject|3|||
27846424|NCT00854373|81268249|FG000|Overall Study|Forgot to take study drug|1|||
27846425|NCT00854373|81268250|FG001|Overall Study|Forgot to take study drug|1|||
27846426|NCT01132664|81268251|FG000|Phase lb|Adverse Event|0|||
27893906|NCT00373958|81447218|FG001|Infant Series|Lost Kaiser coverage|0|||
27893907|NCT00373958|81447217|FG000|Infant Series|Child relocated|1|||
27893908|NCT00373958|81447218|FG001|Infant Series|Child relocated|0|||
27893909|NCT00373958|81447217|FG000|Infant Series|Consent was not received|1|||
27893910|NCT00373958|81447218|FG001|Infant Series|Consent was not received|0|||
27893911|NCT00373958|81447217|FG000|Infant Series|Adverse Event|3|||
27893912|NCT00373958|81447218|FG001|Infant Series|Adverse Event|1|||
27893913|NCT00373958|81447217|FG000|Infant Series|Physician Decision|1|||
27893914|NCT00373958|81447218|FG001|Infant Series|Physician Decision|1|||
27504991|NCT03299166|80040925|FG001|Overall Study|Withdrawal by Subject|5|||
27504992|NCT03299166|80040924|FG000|Overall Study|Physician Decision|1|||
27846427|NCT01132664|81268252|FG001|Phase lb|Adverse Event|1|||
27846428|NCT01132664|81268253|FG002|Phase lb|Adverse Event|0|||
27846429|NCT01132664|81268254|FG003|Phase lb|Adverse Event|0|||
27846430|NCT01132664|81268255|FG004|Phase lb|Adverse Event|0|||
27846431|NCT01132664|81268251|FG000|Phase lb|Withdrawal by Subject|1|||
27846432|NCT01132664|81268252|FG001|Phase lb|Withdrawal by Subject|2|||
27846433|NCT01132664|81268253|FG002|Phase lb|Withdrawal by Subject|0|||
27846434|NCT01132664|81268254|FG003|Phase lb|Withdrawal by Subject|0|||
27846435|NCT01132664|81268255|FG004|Phase lb|Withdrawal by Subject|0|||
27846436|NCT01132664|81268251|FG000|Phase lb|Disease Progression|4|||
27846437|NCT01132664|81268252|FG001|Phase lb|Disease Progression|9|||
27846438|NCT01132664|81268253|FG002|Phase lb|Disease Progression|0|||
27846439|NCT01132664|81268254|FG003|Phase lb|Disease Progression|0|||
27846440|NCT01132664|81268255|FG004|Phase lb|Disease Progression|0|||
27846441|NCT01132664|81268251|FG000|Phase ll|Death|0|||
27846442|NCT01132664|81268252|FG001|Phase ll|Death|0|||
27846443|NCT01132664|81268253|FG002|Phase ll|Death|2|||
27846444|NCT01132664|81268254|FG003|Phase ll|Death|0|||
27846445|NCT01132664|81268255|FG004|Phase ll|Death|0|||
27846446|NCT01132664|81268251|FG000|Phase ll|Adverse Event|0|||
27846447|NCT01132664|81268252|FG001|Phase ll|Adverse Event|0|||
27846448|NCT01132664|81268253|FG002|Phase ll|Adverse Event|10|||
27846449|NCT01132664|81268254|FG003|Phase ll|Adverse Event|0|||
27846450|NCT01132664|81268255|FG004|Phase ll|Adverse Event|0|||
27846451|NCT01132664|81268251|FG000|Phase ll|Withdrawal by Subject|0|||
27846452|NCT01132664|81268252|FG001|Phase ll|Withdrawal by Subject|0|||
27846453|NCT01132664|81268253|FG002|Phase ll|Withdrawal by Subject|3|||
27846454|NCT01132664|81268254|FG003|Phase ll|Withdrawal by Subject|0|||
27846455|NCT01132664|81268255|FG004|Phase ll|Withdrawal by Subject|0|||
27846456|NCT01132664|81268251|FG000|Phase ll|Disease progression|0|||
27846457|NCT01132664|81268252|FG001|Phase ll|Disease progression|0|||
27846458|NCT01132664|81268253|FG002|Phase ll|Disease progression|35|||
27504993|NCT03299166|80040925|FG001|Overall Study|Physician Decision|1|||
27504994|NCT03299166|80040924|FG000|Overall Study|Sponsor Decision|3|||
27846459|NCT01132664|81268254|FG003|Phase ll|Disease progression|0|||
27846460|NCT01132664|81268255|FG004|Phase ll|Disease progression|0|||
27846461|NCT01132664|81268251|FG000|BM Cohort|Disease progression|0|||
27846462|NCT01132664|81268252|FG001|BM Cohort|Disease progression|0|||
27846463|NCT01132664|81268253|FG002|BM Cohort|Disease progression|0|||
27893915|NCT00373958|81447217|FG000|Toddler Dose|Lost to Follow-up|5|||
27893916|NCT00373958|81447218|FG001|Toddler Dose|Lost to Follow-up|8|||
27893917|NCT00373958|81447217|FG000|Toddler Dose|Withdrawal by Subject|2|||
27504995|NCT03299166|80040925|FG001|Overall Study|Sponsor Decision|0|||
27846464|NCT01132664|81268254|FG003|BM Cohort|Disease progression|3|||
27846465|NCT01132664|81268255|FG004|BM Cohort|Disease progression|4|||
27846466|NCT01132664|81268251|FG000|BM Cohort|Adverse Event|0|||
27893918|NCT00373958|81447218|FG001|Toddler Dose|Withdrawal by Subject|2|||
27504996|NCT03299166|80040924|FG000|Overall Study|Lost to Follow-up|2|||
27504997|NCT03299166|80040925|FG001|Overall Study|Lost to Follow-up|4|||
27504998|NCT03299166|80040924|FG000|Overall Study|Randomization Error|0|||
27846467|NCT01132664|81268252|FG001|BM Cohort|Adverse Event|0|||
27846468|NCT01132664|81268253|FG002|BM Cohort|Adverse Event|0|||
27846469|NCT01132664|81268254|FG003|BM Cohort|Adverse Event|0|||
27846470|NCT01132664|81268255|FG004|BM Cohort|Adverse Event|1|||
27846471|NCT01132664|81268251|FG000|BM Cohort|Withdrawal by Subject|0|||
27846472|NCT01132664|81268252|FG001|BM Cohort|Withdrawal by Subject|0|||
27893919|NCT00373958|81447217|FG000|Toddler Dose|Failed to return|1|||
27893920|NCT00373958|81447218|FG001|Toddler Dose|Failed to return|2|||
27504999|NCT03299166|80040925|FG001|Overall Study|Randomization Error|1|||
27505000|NCT03299166|80040924|FG000|Overall Study|Subject unable to return due to COVID|1|||
27505001|NCT03299166|80040925|FG001|Overall Study|Subject unable to return due to COVID|0|||
27505002|NCT03299166|80040924|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
27846473|NCT01132664|81268253|FG002|BM Cohort|Withdrawal by Subject|0|||
27846474|NCT01132664|81268254|FG003|BM Cohort|Withdrawal by Subject|0|||
27846475|NCT01132664|81268255|FG004|BM Cohort|Withdrawal by Subject|1|||
27846476|NCT02663882|81268256|FG000|Overall Study|Lost to Follow-up|4|||
27846477|NCT02663882|81268257|FG001|Overall Study|Lost to Follow-up|2|||
27846478|NCT01098110|81268262|FG000|Overall Study|Withdrawal by Subject|14|||
27846479|NCT01098110|81268263|FG001|Overall Study|Withdrawal by Subject|24|||
27846480|NCT01098110|81268264|FG002|Overall Study|Withdrawal by Subject|19|||
27846481|NCT01098110|81268262|FG000|Overall Study|Adverse Event|30|||
27846482|NCT01098110|81268263|FG001|Overall Study|Adverse Event|32|||
27846483|NCT01098110|81268264|FG002|Overall Study|Adverse Event|43|||
27846484|NCT01098110|81268262|FG000|Overall Study|Lack of Efficacy|13|||
27505003|NCT03299166|80040925|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
27505004|NCT02536976|80040926|FG000|Overall Study|Physician Decision|0|||
27505005|NCT02536976|80040927|FG001|Overall Study|Physician Decision|1|||
27505006|NCT02059278|80040929|FG000|Overall Study|Adverse Event|1|||
27505007|NCT02059278|80040930|FG001|Overall Study|Adverse Event|1|||
27505008|NCT02059278|80040929|FG000|Overall Study|Lost to Follow-up|1|||
27505009|NCT02059278|80040930|FG001|Overall Study|Lost to Follow-up|0|||
27505010|NCT02059278|80040929|FG000|Overall Study|Withdrawal by Subject|0|||
27505011|NCT02059278|80040930|FG001|Overall Study|Withdrawal by Subject|3|||
27505012|NCT02059278|80040929|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
27505013|NCT02059278|80040930|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
27505014|NCT01207414|80040931|FG000|Overall Study|Adverse Event|25|||
27505015|NCT01207414|80040932|FG001|Overall Study|Adverse Event|39|||
27505016|NCT01207414|80040931|FG000|Overall Study|Abnormal test procedure results|0|||
27505017|NCT01207414|80040932|FG001|Overall Study|Abnormal test procedure results|1|||
27505018|NCT01207414|80040931|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27505019|NCT01207414|80040932|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27505020|NCT01207414|80040931|FG000|Overall Study|Patient withdrew consent|14|||
27505021|NCT01207414|80040932|FG001|Overall Study|Patient withdrew consent|11|||
27505022|NCT01207414|80040931|FG000|Overall Study|Lost to Follow-up|15|||
27846485|NCT01098110|81268263|FG001|Overall Study|Lack of Efficacy|9|||
27846486|NCT01098110|81268264|FG002|Overall Study|Lack of Efficacy|27|||
27846487|NCT01098110|81268262|FG000|Overall Study|Other|4|||
27846488|NCT01098110|81268263|FG001|Overall Study|Other|7|||
27846489|NCT01098110|81268264|FG002|Overall Study|Other|5|||
27846490|NCT01098110|81268262|FG000|Overall Study|Untreated|1|||
27846491|NCT01098110|81268263|FG001|Overall Study|Untreated|1|||
27846492|NCT01098110|81268264|FG002|Overall Study|Untreated|0|||
27846493|NCT01207440|81268268|FG000|Overall Study|Adverse Event|46|||
27846494|NCT01207440|81268269|FG001|Overall Study|Adverse Event|11|||
27846495|NCT01207440|81268270|FG002|Overall Study|Adverse Event|7|||
27846496|NCT01207440|81268271|FG003|Overall Study|Adverse Event|2|||
27846497|NCT01207440|81268272|FG004|Overall Study|Adverse Event|6|||
27846498|NCT01207440|81268273|FG005|Overall Study|Adverse Event|6|||
27846499|NCT01207440|81268274|FG006|Overall Study|Adverse Event|2|||
27846500|NCT01207440|81268268|FG000|Overall Study|Death|6|||
27846501|NCT01207440|81268269|FG001|Overall Study|Death|3|||
27846502|NCT01207440|81268270|FG002|Overall Study|Death|2|||
27846503|NCT01207440|81268271|FG003|Overall Study|Death|2|||
27505023|NCT01207414|80040932|FG001|Overall Study|Lost to Follow-up|17|||
27846504|NCT01207440|81268272|FG004|Overall Study|Death|7|||
27846505|NCT01207440|81268273|FG005|Overall Study|Death|5|||
27846506|NCT01207440|81268274|FG006|Overall Study|Death|1|||
27846507|NCT01207440|81268268|FG000|Overall Study|Lack of Efficacy|13|||
27846508|NCT01207440|81268269|FG001|Overall Study|Lack of Efficacy|2|||
27846509|NCT01207440|81268270|FG002|Overall Study|Lack of Efficacy|5|||
27893921|NCT00373958|81447217|FG000|Toddler Dose|Protocol Violation|0|||
27505024|NCT01207414|80040931|FG000|Overall Study|Administrative problems|1|||
27505025|NCT01207414|80040932|FG001|Overall Study|Administrative problems|1|||
27505026|NCT01207414|80040931|FG000|Overall Study|Protocol deviation|12|||
27846510|NCT01207440|81268271|FG003|Overall Study|Lack of Efficacy|1|||
27846511|NCT01207440|81268272|FG004|Overall Study|Lack of Efficacy|2|||
27846512|NCT01207440|81268273|FG005|Overall Study|Lack of Efficacy|3|||
27846513|NCT01207440|81268274|FG006|Overall Study|Lack of Efficacy|0|||
27846514|NCT01207440|81268268|FG000|Overall Study|Lost to Follow-up|0|||
27846515|NCT01207440|81268269|FG001|Overall Study|Lost to Follow-up|0|||
27846516|NCT01207440|81268270|FG002|Overall Study|Lost to Follow-up|2|||
27846517|NCT01207440|81268271|FG003|Overall Study|Lost to Follow-up|1|||
27846518|NCT01207440|81268272|FG004|Overall Study|Lost to Follow-up|0|||
27846519|NCT01207440|81268273|FG005|Overall Study|Lost to Follow-up|0|||
27846520|NCT01207440|81268274|FG006|Overall Study|Lost to Follow-up|0|||
27846521|NCT01207440|81268268|FG000|Overall Study|Non-compliance with Study Drug|3|||
27846522|NCT01207440|81268269|FG001|Overall Study|Non-compliance with Study Drug|0|||
27846523|NCT01207440|81268270|FG002|Overall Study|Non-compliance with Study Drug|1|||
27846524|NCT01207440|81268271|FG003|Overall Study|Non-compliance with Study Drug|0|||
27893922|NCT00373958|81447218|FG001|Toddler Dose|Protocol Violation|1|||
27893923|NCT00373958|81447217|FG000|Toddler Dose|Withdrawn after infant series|22|||
27893924|NCT00373958|81447218|FG001|Toddler Dose|Withdrawn after infant series|25|||
27893925|NCT03605862|81447221|FG000|Overall Study|Withdrawal by Subject|12|||
27893926|NCT03605862|81447222|FG001|Overall Study|Withdrawal by Subject|9|||
27893927|NCT03605862|81447221|FG000|Overall Study|Adverse Event|2|||
27893928|NCT03605862|81447222|FG001|Overall Study|Adverse Event|1|||
27893929|NCT03605862|81447221|FG000|Overall Study|Physician Decision|3|||
27846525|NCT01207440|81268272|FG004|Overall Study|Non-compliance with Study Drug|0|||
27846526|NCT01207440|81268273|FG005|Overall Study|Non-compliance with Study Drug|0|||
27846527|NCT01207440|81268274|FG006|Overall Study|Non-compliance with Study Drug|0|||
27846528|NCT01207440|81268268|FG000|Overall Study|Physician Decision|6|||
27846529|NCT01207440|81268269|FG001|Overall Study|Physician Decision|5|||
27846530|NCT01207440|81268270|FG002|Overall Study|Physician Decision|5|||
27846531|NCT01207440|81268271|FG003|Overall Study|Physician Decision|0|||
27846532|NCT01207440|81268272|FG004|Overall Study|Physician Decision|1|||
27846533|NCT01207440|81268273|FG005|Overall Study|Physician Decision|0|||
27846534|NCT01207440|81268274|FG006|Overall Study|Physician Decision|0|||
27846535|NCT01207440|81268268|FG000|Overall Study|Progressive Disease|19|||
27846536|NCT01207440|81268269|FG001|Overall Study|Progressive Disease|10|||
27846537|NCT01207440|81268270|FG002|Overall Study|Progressive Disease|19|||
27846538|NCT01207440|81268271|FG003|Overall Study|Progressive Disease|7|||
27846539|NCT01207440|81268272|FG004|Overall Study|Progressive Disease|23|||
27846540|NCT01207440|81268273|FG005|Overall Study|Progressive Disease|27|||
27846541|NCT01207440|81268274|FG006|Overall Study|Progressive Disease|0|||
27846542|NCT01207440|81268268|FG000|Overall Study|Protocol Violation|2|||
27846543|NCT01207440|81268269|FG001|Overall Study|Protocol Violation|0|||
27846544|NCT01207440|81268270|FG002|Overall Study|Protocol Violation|0|||
27846545|NCT01207440|81268271|FG003|Overall Study|Protocol Violation|0|||
27846546|NCT01207440|81268272|FG004|Overall Study|Protocol Violation|0|||
27846547|NCT01207440|81268273|FG005|Overall Study|Protocol Violation|0|||
27893930|NCT03605862|81447222|FG001|Overall Study|Physician Decision|1|||
27893931|NCT03605862|81447221|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
27893932|NCT03605862|81447222|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
27893933|NCT01446237|81447233|FG000|Overall Study|Adverse Event|1|||
27893934|NCT01446237|81447233|FG000|Overall Study|Lost to Follow-up|2|||
27893935|NCT01446237|81447233|FG000|Overall Study|Withdrawal by Subject|7|||
27893936|NCT02429310|81447234|FG000|Overall Study|Lost to Follow-up|1|||
27505027|NCT01207414|80040932|FG001|Overall Study|Protocol deviation|9|||
27505028|NCT01207414|80040931|FG000|Overall Study|Randomized in error|1|||
27505029|NCT01207414|80040932|FG001|Overall Study|Randomized in error|0|||
27505030|NCT00535496|80040933|FG000|Overall Study|Lost to Follow-up|0|||
27505031|NCT00535496|80040934|FG001|Overall Study|Lost to Follow-up|1|||
27505032|NCT00535496|80040935|FG002|Overall Study|Lost to Follow-up|0|||
27505033|NCT00535496|80040936|FG003|Overall Study|Lost to Follow-up|0|||
27505034|NCT00535496|80040933|FG000|Overall Study|Not treated with sugammadex|0|||
27505035|NCT00535496|80040934|FG001|Overall Study|Not treated with sugammadex|1|||
27505036|NCT00535496|80040935|FG002|Overall Study|Not treated with sugammadex|0|||
27505037|NCT00535496|80040936|FG003|Overall Study|Not treated with sugammadex|0|||
27505038|NCT02120898|80040937|FG000|Overall Study|Withdrawal by Subject|4|||
27505039|NCT02120898|80040938|FG001|Overall Study|Withdrawal by Subject|2|||
27505040|NCT02120898|80040939|FG002|Overall Study|Withdrawal by Subject|2|||
27846548|NCT01207440|81268274|FG006|Overall Study|Protocol Violation|0|||
27846549|NCT01207440|81268268|FG000|Overall Study|Site Terminated by Sponsor|69|||
27846550|NCT01207440|81268269|FG001|Overall Study|Site Terminated by Sponsor|19|||
27846551|NCT01207440|81268270|FG002|Overall Study|Site Terminated by Sponsor|12|||
27505041|NCT02120898|80040937|FG000|Overall Study|Non-compliance with study drug|3|||
27505042|NCT02120898|80040938|FG001|Overall Study|Non-compliance with study drug|0|||
27505043|NCT02120898|80040939|FG002|Overall Study|Non-compliance with study drug|0|||
27505044|NCT02120898|80040937|FG000|Overall Study|Adverse Event|1|||
27846552|NCT01207440|81268271|FG003|Overall Study|Site Terminated by Sponsor|2|||
27846553|NCT01207440|81268272|FG004|Overall Study|Site Terminated by Sponsor|3|||
27846554|NCT01207440|81268273|FG005|Overall Study|Site Terminated by Sponsor|0|||
27505045|NCT02120898|80040938|FG001|Overall Study|Adverse Event|2|||
27846555|NCT01207440|81268274|FG006|Overall Study|Site Terminated by Sponsor|2|||
27893937|NCT02429310|81447235|FG001|Overall Study|Lost to Follow-up|2|||
27846556|NCT01207440|81268268|FG000|Overall Study|Withdrawal by Subject|29|||
27505046|NCT02120898|80040939|FG002|Overall Study|Adverse Event|1|||
27505047|NCT02120898|80040937|FG000|Overall Study|Protocol Violation|1|||
27505048|NCT02120898|80040938|FG001|Overall Study|Protocol Violation|2|||
27505049|NCT02120898|80040939|FG002|Overall Study|Protocol Violation|0|||
27846557|NCT01207440|81268269|FG001|Overall Study|Withdrawal by Subject|4|||
27846558|NCT01207440|81268270|FG002|Overall Study|Withdrawal by Subject|5|||
27846559|NCT01207440|81268271|FG003|Overall Study|Withdrawal by Subject|3|||
27846560|NCT01207440|81268272|FG004|Overall Study|Withdrawal by Subject|2|||
27846561|NCT01207440|81268273|FG005|Overall Study|Withdrawal by Subject|2|||
27846562|NCT01207440|81268274|FG006|Overall Study|Withdrawal by Subject|0|||
27846563|NCT01207440|81268268|FG000|Overall Study|Reason Not Specified|10|||
27846564|NCT01207440|81268269|FG001|Overall Study|Reason Not Specified|10|||
27846565|NCT01207440|81268270|FG002|Overall Study|Reason Not Specified|7|||
27846566|NCT01207440|81268271|FG003|Overall Study|Reason Not Specified|0|||
27846567|NCT01207440|81268272|FG004|Overall Study|Reason Not Specified|4|||
27846568|NCT01207440|81268273|FG005|Overall Study|Reason Not Specified|3|||
27846569|NCT01207440|81268274|FG006|Overall Study|Reason Not Specified|0|||
27846570|NCT05069155|81268275|FG000|Overall Study|Withdrawal by Subject|1|||
27846571|NCT05069155|81268276|FG001|Overall Study|Withdrawal by Subject|3|||
27846572|NCT04241133|81268278|FG000|Overall Study|COVID19 Precautions|14|||
27846573|NCT04241133|81268279|FG001|Overall Study|COVID19 Precautions|34|||
27846574|NCT00794417|81268280|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
27846575|NCT00794417|81268281|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
27846576|NCT00794417|81268282|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
27846577|NCT00794417|81268283|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
27846578|NCT00794417|81268280|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
27846579|NCT00794417|81268281|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
27846580|NCT00794417|81268282|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
27846581|NCT00794417|81268283|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
27846582|NCT00794417|81268280|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
27846583|NCT00794417|81268281|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
27846584|NCT00794417|81268282|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
27846585|NCT00794417|81268283|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
27846586|NCT00794417|81268280|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
27846587|NCT00794417|81268281|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
27846588|NCT00794417|81268282|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
27846589|NCT00794417|81268283|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
27846590|NCT00794417|81268280|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
27846591|NCT00794417|81268281|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
27846592|NCT00794417|81268282|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
27846593|NCT00794417|81268283|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
27846594|NCT00794417|81268280|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
27846595|NCT00794417|81268281|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
27846596|NCT00794417|81268282|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
27846597|NCT00794417|81268283|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
27846598|NCT02924376|81268284|FG000|Overall Study|Progressive Disease|4|||
27846599|NCT02924376|81268285|FG001|Overall Study|Progressive Disease|0|||
27846600|NCT02924376|81268286|FG002|Overall Study|Progressive Disease|1|||
27846601|NCT02924376|81268287|FG003|Overall Study|Progressive Disease|0|||
27846602|NCT02924376|81268284|FG000|Overall Study|Death|73|||
27846603|NCT02924376|81268285|FG001|Overall Study|Death|18|||
27846604|NCT02924376|81268286|FG002|Overall Study|Death|15|||
27846605|NCT02924376|81268287|FG003|Overall Study|Death|2|||
27846606|NCT02924376|81268284|FG000|Overall Study|Lost to Follow-up|3|||
27846607|NCT02924376|81268285|FG001|Overall Study|Lost to Follow-up|0|||
27846608|NCT02924376|81268286|FG002|Overall Study|Lost to Follow-up|0|||
27846609|NCT02924376|81268287|FG003|Overall Study|Lost to Follow-up|0|||
27846610|NCT02924376|81268284|FG000|Overall Study|Study Terminated by Sponsor|19|||
27846611|NCT02924376|81268285|FG001|Overall Study|Study Terminated by Sponsor|0|||
27846612|NCT02924376|81268286|FG002|Overall Study|Study Terminated by Sponsor|0|||
27846613|NCT02924376|81268287|FG003|Overall Study|Study Terminated by Sponsor|0|||
27505050|NCT02120898|80040937|FG000|Overall Study|Lost to Follow-up|0|||
27505051|NCT02120898|80040938|FG001|Overall Study|Lost to Follow-up|0|||
27505052|NCT02120898|80040939|FG002|Overall Study|Lost to Follow-up|1|||
27613622|NCT02204293|80426707|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
27846614|NCT02924376|81268284|FG000|Overall Study|Physician Decision|1|||
27846615|NCT02924376|81268285|FG001|Overall Study|Physician Decision|0|||
27846616|NCT02924376|81268286|FG002|Overall Study|Physician Decision|0|||
27846617|NCT02924376|81268287|FG003|Overall Study|Physician Decision|0|||
27846618|NCT02924376|81268284|FG000|Overall Study|Withdrawal by Subject|7|||
27846619|NCT02924376|81268285|FG001|Overall Study|Withdrawal by Subject|2|||
27846620|NCT02924376|81268286|FG002|Overall Study|Withdrawal by Subject|1|||
27846621|NCT02924376|81268287|FG003|Overall Study|Withdrawal by Subject|0|||
27846622|NCT02924376|81268284|FG000|Overall Study|Rolled Over to Another Study|1|||
27846623|NCT02924376|81268285|FG001|Overall Study|Rolled Over to Another Study|0|||
27846624|NCT02924376|81268286|FG002|Overall Study|Rolled Over to Another Study|0|||
27846625|NCT02924376|81268287|FG003|Overall Study|Rolled Over to Another Study|0|||
27846626|NCT01221090|81268300|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
27846627|NCT01221090|81268301|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
27846628|NCT01221090|81268302|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
27846629|NCT01221090|81268303|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
27846630|NCT01221090|81268300|FG000|Overall Study|Withdrawal by Subject|0|||
27846631|NCT01221090|81268301|FG001|Overall Study|Withdrawal by Subject|22|||
27846632|NCT01221090|81268302|FG002|Overall Study|Withdrawal by Subject|27|||
27846633|NCT01221090|81268303|FG003|Overall Study|Withdrawal by Subject|2|||
27846634|NCT02104817|81268304|FG000|Overall Study|Death|363|||
27846635|NCT02104817|81268305|FG001|Overall Study|Death|330|||
27846636|NCT02104817|81268304|FG000|Overall Study|Lost to Follow-up|3|||
27846637|NCT02104817|81268305|FG001|Overall Study|Lost to Follow-up|2|||
27846638|NCT02104817|81268304|FG000|Overall Study|Protocol Violation|0|||
27846639|NCT02104817|81268305|FG001|Overall Study|Protocol Violation|1|||
27846640|NCT02104817|81268304|FG000|Overall Study|Study terminated by sponsor|5854|||
27846641|NCT02104817|81268305|FG001|Overall Study|Study terminated by sponsor|5901|||
27846642|NCT02104817|81268304|FG000|Overall Study|Withdrawal by Subject|111|||
27846643|NCT02104817|81268305|FG001|Overall Study|Withdrawal by Subject|78|||
27846644|NCT02104817|81268304|FG000|Overall Study|Other reasons|128|||
27846645|NCT02104817|81268305|FG001|Overall Study|Other reasons|135|||
27846646|NCT00373425|81268306|FG000|Overall Study|Relapse of NSCLC|116|||
27846647|NCT00373425|81268307|FG001|Overall Study|Relapse of NSCLC|104|||
27846648|NCT00373425|81268308|FG002|Overall Study|Relapse of NSCLC|19|||
27846649|NCT00373425|81268309|FG003|Overall Study|Relapse of NSCLC|2|||
27846650|NCT00373425|81268310|FG004|Overall Study|Relapse of NSCLC|26|||
27846651|NCT00373425|81268306|FG000|Overall Study|Adverse Event|191|||
27846652|NCT00373425|81268307|FG001|Overall Study|Adverse Event|22|||
27846653|NCT00373425|81268308|FG002|Overall Study|Adverse Event|59|||
27846654|NCT00373425|81268309|FG003|Overall Study|Adverse Event|0|||
27846655|NCT00373425|81268310|FG004|Overall Study|Adverse Event|34|||
27893938|NCT02429310|81447234|FG000|Overall Study|Protocol Violation|1|||
27893939|NCT02429310|81447235|FG001|Overall Study|Protocol Violation|1|||
27893940|NCT02474589|81447238|FG000|Overall Study|Adverse Event|6|||
27893941|NCT02474589|81447239|FG001|Overall Study|Adverse Event|2|||
27893942|NCT02474589|81447238|FG000|Overall Study|Lost to Follow-up|6|||
27893943|NCT02474589|81447239|FG001|Overall Study|Lost to Follow-up|1|||
27893944|NCT02474589|81447238|FG000|Overall Study|Protocol Violation|4|||
27893945|NCT02474589|81447239|FG001|Overall Study|Protocol Violation|1|||
27893946|NCT02474589|81447238|FG000|Overall Study|Withdrawal by Subject|4|||
27893947|NCT02474589|81447239|FG001|Overall Study|Withdrawal by Subject|0|||
27893948|NCT02474589|81447238|FG000|Overall Study|Inability to complete study procedures|5|||
27893949|NCT02474589|81447239|FG001|Overall Study|Inability to complete study procedures|1|||
27893950|NCT02850016|81447240|FG000|Overall Study|Withdrawal by Subject|1|||
27893951|NCT02850016|81447241|FG001|Overall Study|Withdrawal by Subject|2|||
27893952|NCT04253782|81447242|FG000|Overall Study|Death|2|||
27893953|NCT04253782|81447243|FG001|Overall Study|Death|0|||
27893954|NCT00843037|81447249|FG000|Overall Study|Lost to Follow-up|1|||
27893955|NCT00189306|81447263|FG000|Treatment Period|Withdrawal by Subject|2|||
27893956|NCT00189306|81447263|FG000|Treatment Period|Adverse Event|2|||
27893957|NCT00189306|81447263|FG000|Treatment Period|Protocol Violation|1|||
27893958|NCT00189306|81447263|FG000|Posttreatment Period|Death|1|||
27893959|NCT00189306|81447263|FG000|Posttreatment Period|Withdrawal by Subject|2|||
27893960|NCT00189306|81447263|FG000|Posttreatment Period|Noncompliance|1|||
27893961|NCT00189306|81447263|FG000|Posttreatment Period|Target lesion excised|1|||
27893962|NCT00189306|81447263|FG000|Posttreatment Period|Protocol Violation|1|||
27893963|NCT00189306|81447263|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
27893964|NCT00189306|81447263|FG000|Posttreatment Period|Local skin reaction/sign|1|||
27893965|NCT00189306|81447263|FG000|Long-Term Follow-up|Adverse Event|2|||
27893966|NCT00189306|81447263|FG000|Long-Term Follow-up|Death|4|||
27893967|NCT00189306|81447263|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
27505053|NCT02612779|80040940|FG000|Overall Study|Administrative reason by sponsor|4|||
27505054|NCT02612779|80040941|FG001|Overall Study|Administrative reason by sponsor|1|||
27613623|NCT02204293|80426708|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
27613624|NCT02204293|80426709|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
27846656|NCT00373425|81268306|FG000|Overall Study|Patient request|35|||
27846657|NCT00373425|81268307|FG001|Overall Study|Patient request|18|||
27893968|NCT00189306|81447263|FG000|Long-Term Follow-up|Intercurrent disease|2|||
27893969|NCT00189306|81447263|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
27893970|NCT00189306|81447263|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
27893971|NCT04521621|81447269|FG000|Overall Study|Death|17|||
27846658|NCT00373425|81268308|FG002|Overall Study|Patient request|43|||
27846659|NCT00373425|81268309|FG003|Overall Study|Patient request|6|||
27846660|NCT00373425|81268310|FG004|Overall Study|Patient request|7|||
27893972|NCT04521621|81447270|FG001|Overall Study|Death|8|||
27505055|NCT02612779|80040940|FG000|Overall Study|No longer meet study criteria|0|||
27505056|NCT02612779|80040941|FG001|Overall Study|No longer meet study criteria|1|||
27505057|NCT02612779|80040940|FG000|Overall Study|Disease progression|29|||
27505058|NCT02612779|80040941|FG001|Overall Study|Disease progression|2|||
27505059|NCT02612779|80040940|FG000|Overall Study|Study drug toxicity|10|||
27725910|NCT00944034|80826740|FG006|Overall Study|Administrative reason|1|||
27725911|NCT00944034|80826741|FG007|Overall Study|Administrative reason|0|||
27725912|NCT00944034|80826742|FG008|Overall Study|Administrative reason|0|||
27725913|NCT00944034|80826743|FG009|Overall Study|Administrative reason|0|||
27725914|NCT00944034|80826744|FG010|Overall Study|Administrative reason|0|||
27725915|NCT00944034|80826745|FG011|Overall Study|Administrative reason|0|||
27725916|NCT04270760|80826748|FG000|Overall Study|Withdrawal by Subject|0|||
27725917|NCT04270760|80826749|FG001|Overall Study|Withdrawal by Subject|1|||
27725918|NCT04270760|80826750|FG002|Overall Study|Withdrawal by Subject|3|||
27725919|NCT04270760|80826751|FG003|Overall Study|Withdrawal by Subject|0|||
27725920|NCT04270760|80826752|FG004|Overall Study|Withdrawal by Subject|0|||
27725921|NCT04270760|80826748|FG000|Overall Study|Lost to Follow-up|1|||
27725922|NCT04270760|80826749|FG001|Overall Study|Lost to Follow-up|2|||
27725923|NCT04270760|80826750|FG002|Overall Study|Lost to Follow-up|1|||
27725924|NCT04270760|80826751|FG003|Overall Study|Lost to Follow-up|0|||
27725925|NCT04270760|80826752|FG004|Overall Study|Lost to Follow-up|0|||
27725926|NCT04270760|80826748|FG000|Overall Study|Death|0|||
27725927|NCT04270760|80826749|FG001|Overall Study|Death|0|||
27725928|NCT04270760|80826750|FG002|Overall Study|Death|0|||
27725929|NCT04270760|80826751|FG003|Overall Study|Death|0|||
27725930|NCT04270760|80826752|FG004|Overall Study|Death|1|||
27725931|NCT01871090|80826753|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
27725932|NCT01871090|80826754|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
27725933|NCT01871090|80826753|FG000|Overall Study|Interrogation not completed correctly|1|||
27725934|NCT01871090|80826754|FG001|Overall Study|Interrogation not completed correctly|0|||
27725935|NCT01871090|80826753|FG000|Overall Study|Subject Non-Compliance|0|||
27725936|NCT01871090|80826754|FG001|Overall Study|Subject Non-Compliance|1|||
27846661|NCT00373425|81268306|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
27846662|NCT00373425|81268307|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
27846663|NCT00373425|81268308|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
27846664|NCT00373425|81268309|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
27846665|NCT00373425|81268310|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
27846666|NCT00373425|81268306|FG000|Overall Study|Death|7|||
27846667|NCT00373425|81268307|FG001|Overall Study|Death|0|||
27846668|NCT00373425|81268308|FG002|Overall Study|Death|3|||
27846669|NCT00373425|81268309|FG003|Overall Study|Death|1|||
27846670|NCT00373425|81268310|FG004|Overall Study|Death|0|||
27846671|NCT00330460|81268316|FG000|Overall Study|Physician Decision|1|||
27846672|NCT00330460|81268317|FG001|Overall Study|Physician Decision|0|||
27846673|NCT00330460|81268316|FG000|Overall Study|Adverse Event|10|||
27846674|NCT00330460|81268317|FG001|Overall Study|Adverse Event|8|||
27846675|NCT00330460|81268316|FG000|Overall Study|Withdrawal by Subject|18|||
27846676|NCT00330460|81268317|FG001|Overall Study|Withdrawal by Subject|17|||
27846677|NCT00330460|81268316|FG000|Overall Study|Death|1|||
27846678|NCT00330460|81268317|FG001|Overall Study|Death|1|||
27846679|NCT00330460|81268316|FG000|Overall Study|Ineligibility determined|1|||
27846680|NCT00330460|81268317|FG001|Overall Study|Ineligibility determined|3|||
27846681|NCT00330460|81268316|FG000|Overall Study|Lost to Follow-up|8|||
27846682|NCT00330460|81268317|FG001|Overall Study|Lost to Follow-up|3|||
27846683|NCT00330460|81268316|FG000|Overall Study|Noncompliance|2|||
27846684|NCT00330460|81268317|FG001|Overall Study|Noncompliance|1|||
27846685|NCT00330460|81268316|FG000|Overall Study|Other|1|||
27846686|NCT00330460|81268317|FG001|Overall Study|Other|0|||
27893973|NCT04521621|81447271|FG002|Overall Study|Death|8|||
27505060|NCT02612779|80040941|FG001|Overall Study|Study drug toxicity|1|||
27725937|NCT00939692|80826755|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
27725938|NCT00939692|80826756|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
27725939|NCT00939692|80826755|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
27725940|NCT00939692|80826756|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
27725941|NCT03739528|80826760|FG000|Overall Study|Not treated|8|||
27725942|NCT03739528|80826761|FG001|Overall Study|Not treated|12|||
27725943|NCT03739528|80826760|FG000|Overall Study|Treatment and study discontinued|6|||
27725944|NCT03739528|80826761|FG001|Overall Study|Treatment and study discontinued|2|||
27846687|NCT03336242|81268320|FG000|Overall Study|Adverse Event|0|||
27846688|NCT03336242|81268321|FG001|Overall Study|Adverse Event|1|||
27846689|NCT00537199|81268323|FG000|Overall Study|Study Terminated|1|||
27846690|NCT03891329|81268324|FG000|Overall Study|Death|5|||
27846691|NCT03891329|81268324|FG000|Overall Study|Lost to Follow-up|4|||
27846692|NCT03891329|81268324|FG000|Overall Study|Physician Decision|4|||
27846693|NCT03891329|81268324|FG000|Overall Study|Device explanted|3|||
27846694|NCT03891329|81268324|FG000|Overall Study|No study device implanted|3|||
27846695|NCT01557582|81268325|FG000|Overall Study|Protocol Violation|4|||
27893974|NCT04521621|81447272|FG003|Overall Study|Death|5|||
27893975|NCT04521621|81447273|FG004|Overall Study|Death|2|||
27893976|NCT04521621|81447274|FG005|Overall Study|Death|7|||
27893977|NCT04521621|81447275|FG006|Overall Study|Death|0|||
27893978|NCT04521621|81447276|FG007|Overall Study|Death|0|||
27893979|NCT04521621|81447269|FG000|Overall Study|Study Terminated by Sponsor|4|||
27893980|NCT04521621|81447270|FG001|Overall Study|Study Terminated by Sponsor|6|||
27893981|NCT04521621|81447271|FG002|Overall Study|Study Terminated by Sponsor|8|||
27893982|NCT04521621|81447272|FG003|Overall Study|Study Terminated by Sponsor|0|||
27893983|NCT04521621|81447273|FG004|Overall Study|Study Terminated by Sponsor|1|||
27893984|NCT04521621|81447274|FG005|Overall Study|Study Terminated by Sponsor|7|||
27893985|NCT04521621|81447275|FG006|Overall Study|Study Terminated by Sponsor|0|||
27893986|NCT04521621|81447276|FG007|Overall Study|Study Terminated by Sponsor|0|||
27893987|NCT04521621|81447269|FG000|Overall Study|Withdrawal by Subject|0|||
27893988|NCT04521621|81447270|FG001|Overall Study|Withdrawal by Subject|0|||
27893989|NCT04521621|81447271|FG002|Overall Study|Withdrawal by Subject|1|||
27893990|NCT04521621|81447272|FG003|Overall Study|Withdrawal by Subject|1|||
27893991|NCT04521621|81447273|FG004|Overall Study|Withdrawal by Subject|0|||
27893992|NCT04521621|81447274|FG005|Overall Study|Withdrawal by Subject|0|||
27893993|NCT04521621|81447275|FG006|Overall Study|Withdrawal by Subject|0|||
27893994|NCT04521621|81447276|FG007|Overall Study|Withdrawal by Subject|0|||
27893995|NCT04521621|81447269|FG000|Overall Study|Allocated in error without study intervention|1|||
27893996|NCT04521621|81447270|FG001|Overall Study|Allocated in error without study intervention|0|||
27893997|NCT04521621|81447271|FG002|Overall Study|Allocated in error without study intervention|0|||
27893998|NCT04521621|81447272|FG003|Overall Study|Allocated in error without study intervention|0|||
27846696|NCT01557582|81268325|FG000|Overall Study|Operator error|2|||
27846697|NCT01832402|81268333|FG000|Overall Study|Lost to Follow-up|2|||
27846698|NCT01832402|81268334|FG001|Overall Study|Lost to Follow-up|0|||
27846699|NCT01832402|81268333|FG000|Overall Study|Withdrawal by Subject|3|||
27846700|NCT01832402|81268334|FG001|Overall Study|Withdrawal by Subject|3|||
27846701|NCT01832402|81268333|FG000|Overall Study|Declining Performance status|2|||
27846702|NCT01832402|81268334|FG001|Overall Study|Declining Performance status|1|||
27846703|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
27846704|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
27846705|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
27505061|NCT02612779|80040940|FG000|Overall Study|Death|1|||
27505062|NCT02612779|80040941|FG001|Overall Study|Death|0|||
27505063|NCT02612779|80040940|FG000|Overall Study|Adverse event unrelated to study drug|5|||
27846706|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
27846707|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
27846708|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
27846709|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
27846710|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
27846711|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
27846712|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
27846713|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
27846714|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
27846715|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27846716|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27893999|NCT04521621|81447273|FG004|Overall Study|Allocated in error without study intervention|0|||
27505064|NCT02612779|80040941|FG001|Overall Study|Adverse event unrelated to study drug|0|||
27505065|NCT02612779|80040940|FG000|Overall Study|Participant withdrew consent|4|||
27846717|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27846718|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27846719|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
27846720|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
27846721|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
27846722|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
27846723|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
27894000|NCT04521621|81447274|FG005|Overall Study|Allocated in error without study intervention|0|||
27894001|NCT04521621|81447275|FG006|Overall Study|Allocated in error without study intervention|0|||
27894002|NCT04521621|81447276|FG007|Overall Study|Allocated in error without study intervention|0|||
27894003|NCT00412217|81447279|FG000|Overall Study|Insufficient Data Available|8|||
27894004|NCT00412217|81447280|FG001|Overall Study|Insufficient Data Available|3|||
27894005|NCT00412217|81447279|FG000|Overall Study|Death|5|||
27894006|NCT00412217|81447280|FG001|Overall Study|Death|4|||
27846724|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
27846725|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
27846726|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
27846727|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
27846728|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
27846729|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
27846730|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
27846731|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Death|0|||
27846732|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Death|1|||
27846733|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Death|0|||
27846734|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Death|0|||
27846735|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
27846736|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
27846737|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
27846738|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
27894007|NCT00412217|81447279|FG000|Overall Study|Disease Progression|2|||
27505066|NCT02612779|80040941|FG001|Overall Study|Participant withdrew consent|0|||
27505067|NCT02612779|80040940|FG000|Overall Study|Lost to Follow-up|1|||
27505068|NCT02612779|80040941|FG001|Overall Study|Lost to Follow-up|0|||
27505069|NCT02612779|80040940|FG000|Overall Study|Maximum clinical benefit|10|||
27505070|NCT02612779|80040941|FG001|Overall Study|Maximum clinical benefit|1|||
27505071|NCT02612779|80040940|FG000|Overall Study|Other reasons|4|||
27505072|NCT02612779|80040941|FG001|Overall Study|Other reasons|0|||
27505073|NCT02603887|80040942|FG000|Stage 1|Adverse Event|4|||
27505074|NCT02603887|80040942|FG000|Stage 1|Disease progression|1|||
27505075|NCT02603887|80040942|FG000|Stage 2|FDA guidance|1|||
27505076|NCT02491684|80040944|FG000|Treatment Phase|Adverse Event|2|||
27505077|NCT02491684|80040945|FG001|Treatment Phase|Adverse Event|2|||
27505078|NCT02491684|80040944|FG000|Treatment Phase|Incorrect randomisation|1|||
27505079|NCT02491684|80040945|FG001|Treatment Phase|Incorrect randomisation|0|||
27505080|NCT02491684|80040944|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
27505081|NCT02491684|80040945|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
27505082|NCT01907854|80040948|FG000|Overall Study|Protocol Violation|1|||
27505083|NCT01907854|80040949|FG001|Overall Study|Protocol Violation|1|||
27505084|NCT01907854|80040948|FG000|Overall Study|Withdrawal by Subject|9|||
27505085|NCT01907854|80040949|FG001|Overall Study|Withdrawal by Subject|7|||
27505086|NCT01907854|80040948|FG000|Overall Study|Lost to Follow-up|2|||
27505087|NCT01907854|80040949|FG001|Overall Study|Lost to Follow-up|2|||
27505088|NCT01907854|80040948|FG000|Overall Study|Unclassified|4|||
27505089|NCT01907854|80040949|FG001|Overall Study|Unclassified|3|||
27505090|NCT00905164|80040950|FG000|Period 1|Protocol Violation|0|||
27505091|NCT00905164|80040951|FG001|Period 1|Protocol Violation|1|||
27505092|NCT04139798|80040952|FG000|Overall Study|Withdrawal by Subject|6|||
27505093|NCT04139798|80040953|FG001|Overall Study|Withdrawal by Subject|5|||
27505094|NCT04139798|80040952|FG000|Overall Study|Lost to Follow-up|2|||
27505095|NCT04139798|80040953|FG001|Overall Study|Lost to Follow-up|5|||
27505096|NCT04139798|80040952|FG000|Overall Study|Discontinued|4|||
27505097|NCT04139798|80040953|FG001|Overall Study|Discontinued|2|||
27505098|NCT04139798|80040952|FG000|Overall Study|Adverse Event|1|||
27505099|NCT04139798|80040953|FG001|Overall Study|Adverse Event|3|||
27505100|NCT04139798|80040952|FG000|Overall Study|Protocol Violation|1|||
27505101|NCT04139798|80040953|FG001|Overall Study|Protocol Violation|0|||
27505102|NCT03873116|80040957|FG000|Part 1|Study drug discontinuation due to rash|0|||
27505103|NCT03873116|80040958|FG001|Part 1|Study drug discontinuation due to rash|0|||
27505104|NCT03873116|80040959|FG002|Part 1|Study drug discontinuation due to rash|0|||
27505105|NCT03873116|80040960|FG003|Part 1|Study drug discontinuation due to rash|0|||
27505106|NCT03873116|80040961|FG004|Part 1|Study drug discontinuation due to rash|0|||
27505107|NCT03873116|80040962|FG005|Part 1|Study drug discontinuation due to rash|1|||
27505108|NCT03873116|80040957|FG000|Part 2|Withdrawal by Subject|0|||
27505109|NCT03873116|80040958|FG001|Part 2|Withdrawal by Subject|0|||
27505110|NCT03873116|80040959|FG002|Part 2|Withdrawal by Subject|1|||
27505111|NCT03873116|80040960|FG003|Part 2|Withdrawal by Subject|0|||
27846739|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
27505112|NCT03873116|80040961|FG004|Part 2|Withdrawal by Subject|0|||
27505113|NCT03873116|80040962|FG005|Part 2|Withdrawal by Subject|0|||
27505114|NCT03873116|80040957|FG000|Part 2|Lab abnormality or AE|0|||
27505115|NCT03873116|80040958|FG001|Part 2|Lab abnormality or AE|0|||
27846740|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
27505116|NCT03873116|80040959|FG002|Part 2|Lab abnormality or AE|0|||
27505117|NCT03873116|80040960|FG003|Part 2|Lab abnormality or AE|0|||
27505118|NCT03873116|80040961|FG004|Part 2|Lab abnormality or AE|1|||
27505119|NCT03873116|80040962|FG005|Part 2|Lab abnormality or AE|0|||
27505120|NCT03873116|80040957|FG000|Part 3|Withdrawal by Subject|0|||
27505121|NCT03873116|80040958|FG001|Part 3|Withdrawal by Subject|0|||
27613625|NCT02204293|80426710|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
27613626|NCT02204293|80426711|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
27613627|NCT02204293|80426706|FG000|Core Study Part I|Adverse Event|1|||
27613628|NCT02204293|80426707|FG001|Core Study Part I|Adverse Event|0|||
27613629|NCT02204293|80426708|FG002|Core Study Part I|Adverse Event|0|||
27613630|NCT02204293|80426709|FG003|Core Study Part I|Adverse Event|0|||
27613631|NCT02204293|80426710|FG004|Core Study Part I|Adverse Event|0|||
27613632|NCT02204293|80426711|FG005|Core Study Part I|Adverse Event|0|||
27613633|NCT02204293|80426706|FG000|Core Study Part I|Physician Decision|0|||
27613634|NCT02204293|80426707|FG001|Core Study Part I|Physician Decision|3|||
27613635|NCT02204293|80426708|FG002|Core Study Part I|Physician Decision|0|||
27613636|NCT02204293|80426709|FG003|Core Study Part I|Physician Decision|0|||
27613637|NCT02204293|80426710|FG004|Core Study Part I|Physician Decision|0|||
27613638|NCT02204293|80426711|FG005|Core Study Part I|Physician Decision|0|||
27505122|NCT03873116|80040959|FG002|Part 3|Withdrawal by Subject|0|||
27505123|NCT03873116|80040960|FG003|Part 3|Withdrawal by Subject|0|||
27613639|NCT02204293|80426706|FG000|LTE Phase|Study Suspended|0|||
27613640|NCT02204293|80426707|FG001|LTE Phase|Study Suspended|0|||
27613641|NCT02204293|80426708|FG002|LTE Phase|Study Suspended|0|||
27613642|NCT02204293|80426709|FG003|LTE Phase|Study Suspended|0|||
27613643|NCT02204293|80426710|FG004|LTE Phase|Study Suspended|0|||
27613644|NCT02204293|80426711|FG005|LTE Phase|Study Suspended|7|||
27613645|NCT04362137|80426712|FG000|Overall Study|Death|9|||
27613646|NCT04362137|80426713|FG001|Overall Study|Death|3|||
27894008|NCT00412217|81447280|FG001|Overall Study|Disease Progression|3|||
27846741|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
27846742|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
27846743|NCT02990806|81268335|FG000|Stage 1 (22 Weeks)|Other|1|||
27846744|NCT02990806|81268336|FG001|Stage 1 (22 Weeks)|Other|3|||
27846745|NCT02990806|81268337|FG002|Stage 1 (22 Weeks)|Other|0|||
27613647|NCT04362137|80426712|FG000|Overall Study|Patient decision|6|||
27613648|NCT04362137|80426713|FG001|Overall Study|Patient decision|3|||
27613649|NCT04362137|80426712|FG000|Overall Study|Adverse Event|1|||
27613650|NCT04362137|80426713|FG001|Overall Study|Adverse Event|0|||
27613651|NCT04362137|80426712|FG000|Overall Study|Lost to Follow-up|1|||
27613652|NCT04362137|80426713|FG001|Overall Study|Lost to Follow-up|0|||
27613653|NCT04362137|80426712|FG000|Overall Study|Protocol deviation|1|||
27613654|NCT04362137|80426713|FG001|Overall Study|Protocol deviation|0|||
27846746|NCT02990806|81268338|FG003|Stage 1 (22 Weeks)|Other|0|||
27846747|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
27846748|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
27846749|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
27894009|NCT00412217|81447279|FG000|Overall Study|Investigator Decision|1|||
27894010|NCT00412217|81447280|FG001|Overall Study|Investigator Decision|0|||
27894011|NCT00412217|81447279|FG000|Overall Study|Withdrawal by Subject|2|||
27894012|NCT00412217|81447280|FG001|Overall Study|Withdrawal by Subject|0|||
27894013|NCT00412217|81447279|FG000|Overall Study|Lost to Follow-up|1|||
27894014|NCT00412217|81447280|FG001|Overall Study|Lost to Follow-up|4|||
27894015|NCT00412217|81447279|FG000|Overall Study|Study Terminated by Sponsor|26|||
27894016|NCT00412217|81447280|FG001|Overall Study|Study Terminated by Sponsor|33|||
27894017|NCT00412217|81447279|FG000|Overall Study|Other|1|||
27894018|NCT00412217|81447280|FG001|Overall Study|Other|1|||
27894019|NCT02089334|81447281|FG000|Overall Study|Withdrawal by Subject|0|||
27894020|NCT02089334|81447282|FG001|Overall Study|Withdrawal by Subject|0|||
27894021|NCT02089334|81447283|FG002|Overall Study|Withdrawal by Subject|0|||
27894022|NCT02089334|81447284|FG003|Overall Study|Withdrawal by Subject|2|||
27894023|NCT02089334|81447281|FG000|Overall Study|Adverse Event|0|||
27894024|NCT02089334|81447282|FG001|Overall Study|Adverse Event|0|||
27894025|NCT02089334|81447283|FG002|Overall Study|Adverse Event|0|||
27894026|NCT02089334|81447284|FG003|Overall Study|Adverse Event|2|||
27894027|NCT02089334|81447281|FG000|Overall Study|Progressive disease|0|||
27894028|NCT02089334|81447282|FG001|Overall Study|Progressive disease|0|||
27613655|NCT02790073|80426714|FG000|Overall Study|Death|1|||
27846750|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
27846751|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Death|1|||
27846752|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Death|0|||
27846753|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Death|0|||
27846754|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Death|0|||
27894029|NCT02089334|81447283|FG002|Overall Study|Progressive disease|0|||
27894030|NCT02089334|81447284|FG003|Overall Study|Progressive disease|2|||
27894031|NCT02089334|81447281|FG000|Overall Study|Physician Decision|0|||
27894032|NCT02089334|81447282|FG001|Overall Study|Physician Decision|0|||
27894033|NCT02089334|81447283|FG002|Overall Study|Physician Decision|1|||
27894034|NCT02089334|81447284|FG003|Overall Study|Physician Decision|1|||
27894035|NCT04696861|81447287|FG000|Overall Study|Death|1|||
27894036|NCT04696861|81447288|FG001|Overall Study|Death|0|||
27613656|NCT02790073|80426714|FG000|Overall Study|Withdrawal from HD|1|||
27613657|NCT02790073|80426714|FG000|Overall Study|Withdrawal by Subject|1|||
27613658|NCT04666922|80426717|FG000|Overall Study|Withdrawal by Subject|1|||
27846755|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
27846756|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
27846757|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
27846758|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
27846759|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
27894037|NCT04696861|81447287|FG000|Overall Study|Lost to Follow-up|3|||
27894038|NCT04696861|81447288|FG001|Overall Study|Lost to Follow-up|0|||
27894039|NCT03126019|81447290|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
27894040|NCT03126019|81447291|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
27894041|NCT03126019|81447290|FG000|Overall Study|Death|2|||
27894042|NCT03126019|81447291|FG001|Overall Study|Death|7|||
27894043|NCT03126019|81447290|FG000|Overall Study|Lost to Follow-up|2|||
27894044|NCT03126019|81447291|FG001|Overall Study|Lost to Follow-up|3|||
27894045|NCT03126019|81447290|FG000|Overall Study|Withdrawal by Participant|1|||
27613659|NCT04666922|80426718|FG001|Overall Study|Withdrawal by Subject|0|||
27613660|NCT04666922|80426719|FG002|Overall Study|Withdrawal by Subject|0|||
27846760|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
27846761|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
27846762|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
27846763|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
27846764|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
27846765|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
27846766|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
27894046|NCT03126019|81447291|FG001|Overall Study|Withdrawal by Participant|3|||
27894047|NCT03126019|81447290|FG000|Overall Study|Reason not Specified|1|||
27894048|NCT03126019|81447291|FG001|Overall Study|Reason not Specified|3|||
27894049|NCT03671564|81447294|FG000|Overall Study|Progressive Disease|3|||
27894050|NCT03671564|81447295|FG001|Overall Study|Progressive Disease|5|||
27894051|NCT03671564|81447296|FG002|Overall Study|Progressive Disease|3|||
27894052|NCT03671564|81447294|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
27894053|NCT03671564|81447295|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
27725945|NCT03739528|80826760|FG000|Overall Study|Treatment discontinued + study completed|1|||
27725946|NCT03739528|80826761|FG001|Overall Study|Treatment discontinued + study completed|3|||
27725947|NCT00159432|80826762|FG000|Overall Study|Adverse Event|1|||
27725948|NCT00159432|80826762|FG000|Overall Study|Death|1|||
27725949|NCT00159432|80826762|FG000|Overall Study|Lack of Efficacy|8|||
27725950|NCT00621504|80826765|FG000|Overall Study|Adverse Event|1|||
27725951|NCT00621504|80826766|FG001|Overall Study|Adverse Event|3|||
27725952|NCT00621504|80826765|FG000|Overall Study|At the request of sponsor/investigator|1|||
27725953|NCT00621504|80826766|FG001|Overall Study|At the request of sponsor/investigator|0|||
27725954|NCT00621504|80826765|FG000|Overall Study|Withdrew consent|9|||
27725955|NCT00621504|80826766|FG001|Overall Study|Withdrew consent|6|||
27725956|NCT00621504|80826765|FG000|Overall Study|Lost to Follow-up|8|||
27725957|NCT00621504|80826766|FG001|Overall Study|Lost to Follow-up|10|||
27725958|NCT00621504|80826765|FG000|Overall Study|Other|1|||
27725959|NCT00621504|80826766|FG001|Overall Study|Other|0|||
27725960|NCT00621504|80826765|FG000|Overall Study|Death|6|||
27725961|NCT00621504|80826766|FG001|Overall Study|Death|6|||
27725962|NCT00508391|80826767|FG000|First Treatment|Withdrawal by Subject|6|||
27725963|NCT00508391|80826768|FG001|First Treatment|Withdrawal by Subject|3|||
27725964|NCT00508391|80826767|FG000|Second Treatment|Withdrawal by Subject|2|||
27725965|NCT00508391|80826768|FG001|Second Treatment|Withdrawal by Subject|0|||
27725966|NCT03072160|80826769|FG000|Overall Study|Adverse Event|3|||
27725967|NCT03072160|80826770|FG001|Overall Study|Adverse Event|1|||
27725968|NCT03072160|80826769|FG000|Overall Study|Refused further treatment|6|||
27725969|NCT03072160|80826770|FG001|Overall Study|Refused further treatment|1|||
27725970|NCT03072160|80826769|FG000|Overall Study|Physician Decision|1|||
27725971|NCT03072160|80826770|FG001|Overall Study|Physician Decision|0|||
27725972|NCT03072160|80826769|FG000|Overall Study|Disease progression on study|1|||
27725973|NCT03072160|80826770|FG001|Overall Study|Disease progression on study|1|||
27846767|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
27846768|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
27846769|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
27846770|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
27846771|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27725974|NCT03072160|80826769|FG000|Overall Study|No contact|0|||
27725975|NCT03072160|80826770|FG001|Overall Study|No contact|1|||
27846772|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27894054|NCT03671564|81447296|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
27894055|NCT03671564|81447294|FG000|Overall Study|Withdrawal by Subject|1|||
27894056|NCT03671564|81447295|FG001|Overall Study|Withdrawal by Subject|1|||
27894057|NCT03671564|81447296|FG002|Overall Study|Withdrawal by Subject|0|||
27725976|NCT01662440|80826771|FG000|Overall Study|Adverse Event|1|||
27725977|NCT01662440|80826772|FG001|Overall Study|Adverse Event|0|||
27725978|NCT01662440|80826773|FG002|Overall Study|Adverse Event|0|||
27725979|NCT01662440|80826774|FG003|Overall Study|Adverse Event|1|||
27725980|NCT01662440|80826771|FG000|Overall Study|Death|0|||
27505124|NCT03873116|80040961|FG004|Part 3|Withdrawal by Subject|1|||
27846773|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
27846774|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
27846775|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
27505125|NCT03873116|80040962|FG005|Part 3|Withdrawal by Subject|0|||
27846776|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
27846777|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
27846778|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
27846779|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
27846780|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
27846781|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
27846782|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
27846783|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
27846784|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
27846785|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
27846786|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
27846787|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
27846788|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
27846789|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
27846790|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
27846791|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Other|3|||
27846792|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Other|0|||
27846793|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Other|4|||
27846794|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Other|1|||
27846795|NCT02990806|81268335|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
27846796|NCT02990806|81268336|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
27846797|NCT02990806|81268337|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
27846798|NCT02990806|81268338|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
27846799|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
27846800|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
27846801|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
27846802|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
27846803|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
27846804|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
27846805|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
27846806|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
27846807|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27846808|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
27846809|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27846810|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
27846811|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
27846812|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
27846813|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
27846814|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
27846815|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
27846816|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
27846817|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
27846818|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
27894058|NCT04250350|81447297|FG000|Overall Study|Withdrawal by Subject|13|||
27894059|NCT04250350|81447297|FG000|Overall Study|Lost to Follow-up|8|||
27894060|NCT04250350|81447297|FG000|Overall Study|Adverse Event|5|||
27894061|NCT04250350|81447297|FG000|Overall Study|Lack of Efficacy|4|||
27613661|NCT04666922|80426720|FG003|Overall Study|Withdrawal by Subject|0|||
27613662|NCT04666922|80426721|FG004|Overall Study|Withdrawal by Subject|0|||
27613663|NCT04666922|80426722|FG005|Overall Study|Withdrawal by Subject|0|||
27613664|NCT04666922|80426723|FG006|Overall Study|Withdrawal by Subject|0|||
27613665|NCT03462706|80426726|FG000|Overall Study|Polyp was pedunculated|1|||
27613666|NCT03462706|80426727|FG001|Overall Study|Polyp was pedunculated|0|||
27613667|NCT03462706|80426728|FG002|Overall Study|Polyp was pedunculated|1|||
27613668|NCT03462706|80426729|FG003|Overall Study|Polyp was pedunculated|0|||
27613669|NCT03462706|80426726|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
27725981|NCT01662440|80826772|FG001|Overall Study|Death|1|||
27725982|NCT01662440|80826773|FG002|Overall Study|Death|0|||
27725983|NCT01662440|80826774|FG003|Overall Study|Death|0|||
27725984|NCT01662440|80826771|FG000|Overall Study|Lost to Follow-up|2|||
27725985|NCT01662440|80826772|FG001|Overall Study|Lost to Follow-up|2|||
27725986|NCT01662440|80826773|FG002|Overall Study|Lost to Follow-up|4|||
27725987|NCT01662440|80826774|FG003|Overall Study|Lost to Follow-up|1|||
27725988|NCT01662440|80826771|FG000|Overall Study|Subject moved to another country.|0|||
27725989|NCT01662440|80826772|FG001|Overall Study|Subject moved to another country.|1|||
27725990|NCT01662440|80826773|FG002|Overall Study|Subject moved to another country.|0|||
27725991|NCT01662440|80826774|FG003|Overall Study|Subject moved to another country.|0|||
27725992|NCT01662440|80826771|FG000|Overall Study|Protocol Violation|1|||
27725993|NCT01662440|80826772|FG001|Overall Study|Protocol Violation|0|||
27725994|NCT01662440|80826773|FG002|Overall Study|Protocol Violation|0|||
27725995|NCT01662440|80826774|FG003|Overall Study|Protocol Violation|0|||
27725996|NCT01662440|80826771|FG000|Overall Study|Withdrawal by Subject|5|||
27725997|NCT01662440|80826772|FG001|Overall Study|Withdrawal by Subject|2|||
27725998|NCT01662440|80826773|FG002|Overall Study|Withdrawal by Subject|2|||
27725999|NCT01662440|80826774|FG003|Overall Study|Withdrawal by Subject|2|||
27726000|NCT01671345|80826775|FG000|Overall Study|Lost to Follow-up|10|||
27726001|NCT01671345|80826776|FG001|Overall Study|Lost to Follow-up|6|||
27726002|NCT01671345|80826775|FG000|Overall Study|visit with non-participating physician|3|||
27726003|NCT01671345|80826776|FG001|Overall Study|visit with non-participating physician|3|||
27726004|NCT00578643|80826777|FG000|Overall Study|Death|1|||
27726005|NCT00578643|80826777|FG000|Overall Study|Lost to Follow-up|1|||
27726006|NCT02901431|80826778|FG000|PK Part|Adverse Event|0|||
27726007|NCT02901431|80826779|FG001|PK Part|Adverse Event|1|||
27613670|NCT03462706|80426727|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
27846819|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
27846820|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
27846821|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
27846822|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
27846823|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
27846824|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
27846825|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
27846826|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
27894062|NCT04250350|81447297|FG000|Overall Study|Physician Decision|1|||
27894063|NCT04250350|81447297|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
27894064|NCT02062944|81447298|FG000|Overall Study|Lost to Follow-up|1|||
27613671|NCT03462706|80426728|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
27613672|NCT03462706|80426729|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
27613673|NCT03567993|80426731|FG000|Overall Study|Lost to Follow-up|4|||
27613674|NCT03567993|80426732|FG001|Overall Study|Lost to Follow-up|2|||
27613675|NCT03567993|80426731|FG000|Overall Study|Death|1|||
27613676|NCT03567993|80426732|FG001|Overall Study|Death|1|||
27613677|NCT03567993|80426731|FG000|Overall Study|Withdrawal by Subject|1|||
27613678|NCT03567993|80426732|FG001|Overall Study|Withdrawal by Subject|0|||
27613679|NCT01973491|80426738|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
27613680|NCT01973491|80426738|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
27613681|NCT01973491|80426738|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
27613682|NCT01275196|80426739|FG000|Overall Study|Adverse Event|3|||
27613683|NCT01275196|80426740|FG001|Overall Study|Adverse Event|5|||
27613684|NCT01275196|80426739|FG000|Overall Study|Withdrawal by Subject|4|||
27613685|NCT01275196|80426740|FG001|Overall Study|Withdrawal by Subject|5|||
27613686|NCT01275196|80426739|FG000|Overall Study|Lost to Follow-up|1|||
27613687|NCT01275196|80426740|FG001|Overall Study|Lost to Follow-up|0|||
27613688|NCT01275196|80426739|FG000|Overall Study|Disease Progression|6|||
27613689|NCT01275196|80426740|FG001|Overall Study|Disease Progression|5|||
27613690|NCT01275196|80426739|FG000|Overall Study|Protocol Violation|1|||
27613691|NCT01275196|80426740|FG001|Overall Study|Protocol Violation|0|||
27613692|NCT01275196|80426739|FG000|Overall Study|Suboptimal response/treatment failure|5|||
27613693|NCT01275196|80426740|FG001|Overall Study|Suboptimal response/treatment failure|6|||
27613694|NCT00432835|80426741|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
27613695|NCT00432835|80426742|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
27613696|NCT01289041|80426747|FG000|Overall Study|Adverse Event|24|||
27613697|NCT01289041|80426747|FG000|Overall Study|Physician Decision|1|||
27613698|NCT01289041|80426747|FG000|Overall Study|Progressive Disease|41|||
27613699|NCT01289041|80426747|FG000|Overall Study|Withdrawal by Subject|3|||
27613700|NCT01289041|80426747|FG000|Overall Study|Death|1|||
27613701|NCT03017235|80426753|FG000|Overall Study|Withdrawal by Subject|4|||
27613702|NCT03017235|80426754|FG001|Overall Study|Withdrawal by Subject|3|||
27613703|NCT03017235|80426753|FG000|Overall Study|Lost to Follow-up|2|||
27613704|NCT03017235|80426754|FG001|Overall Study|Lost to Follow-up|7|||
27613705|NCT03017235|80426753|FG000|Overall Study|Adverse Event|0|||
27613706|NCT03017235|80426754|FG001|Overall Study|Adverse Event|1|||
27613707|NCT03017235|80426753|FG000|Overall Study|Protocol Violation|2|||
27613708|NCT03017235|80426754|FG001|Overall Study|Protocol Violation|1|||
27613709|NCT03017235|80426753|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
27613710|NCT03017235|80426754|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
27613711|NCT00785538|80426759|FG000|Treatment Period|Adverse Event|1|||
27613712|NCT00785538|80426760|FG001|Treatment Period|Adverse Event|2|||
27613713|NCT00785538|80426761|FG002|Treatment Period|Adverse Event|2|||
27613714|NCT00785538|80426762|FG003|Treatment Period|Adverse Event|0|||
27613715|NCT00785538|80426759|FG000|Treatment Period|Withdrawal by Subject|0|||
27613716|NCT00785538|80426760|FG001|Treatment Period|Withdrawal by Subject|0|||
27613717|NCT00785538|80426761|FG002|Treatment Period|Withdrawal by Subject|0|||
27613718|NCT00785538|80426762|FG003|Treatment Period|Withdrawal by Subject|1|||
27613719|NCT02023879|80426766|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
27613720|NCT02023879|80426767|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
27846827|NCT02990806|81268335|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
27894065|NCT02062944|81447298|FG000|Overall Study|New hemotological disorder identified|1|||
27846828|NCT02990806|81268336|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
27894066|NCT02062944|81447298|FG000|Overall Study|Uncontrolled Hypertension|1|||
27613721|NCT02023879|80426768|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
27613722|NCT02023879|80426766|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
27613723|NCT02023879|80426767|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
27613724|NCT02023879|80426768|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
27613725|NCT02023879|80426766|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
27613726|NCT02023879|80426767|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
27894067|NCT02062944|81447298|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
27894068|NCT01552915|81447301|FG000|Overall Study|Adverse Event|3|||
27894069|NCT01552915|81447302|FG001|Overall Study|Adverse Event|14|||
27894070|NCT01552915|81447303|FG002|Overall Study|Adverse Event|3|||
27894071|NCT01552915|81447301|FG000|Overall Study|Lost to Follow-up|4|||
27894072|NCT01552915|81447302|FG001|Overall Study|Lost to Follow-up|6|||
27894073|NCT01552915|81447303|FG002|Overall Study|Lost to Follow-up|5|||
27846829|NCT02990806|81268337|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
27846830|NCT02990806|81268338|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
27846831|NCT02674386|81268339|FG000|Overall Study|Lost to Follow-up|0|||
27846832|NCT02674386|81268340|FG001|Overall Study|Lost to Follow-up|1|||
27846833|NCT02674386|81268341|FG002|Overall Study|Lost to Follow-up|1|||
27846834|NCT02674386|81268339|FG000|Overall Study|Withdrawal by Subject|0|||
27846835|NCT02674386|81268340|FG001|Overall Study|Withdrawal by Subject|4|||
27846836|NCT02674386|81268341|FG002|Overall Study|Withdrawal by Subject|0|||
27846837|NCT02674386|81268339|FG000|Overall Study|Other|0|||
27846838|NCT02674386|81268340|FG001|Overall Study|Other|1|||
27846839|NCT02674386|81268341|FG002|Overall Study|Other|0|||
27846840|NCT02674386|81268339|FG000|Overall Study|Enrolled but not evaluated|0|||
27846841|NCT02674386|81268340|FG001|Overall Study|Enrolled but not evaluated|4|||
27846842|NCT02674386|81268341|FG002|Overall Study|Enrolled but not evaluated|0|||
27846843|NCT04223778|81268342|FG000|Overall Study|Ongoing|322|||
27846844|NCT04223778|81268343|FG001|Overall Study|Ongoing|326|||
27846845|NCT04223778|81268342|FG000|Overall Study|Death|0|||
27846846|NCT04223778|81268343|FG001|Overall Study|Death|1|||
27846847|NCT04223778|81268342|FG000|Overall Study|Lost to Follow-up|1|||
27846848|NCT04223778|81268343|FG001|Overall Study|Lost to Follow-up|5|||
27846849|NCT04223778|81268342|FG000|Overall Study|Physician Decision|3|||
27846850|NCT04223778|81268343|FG001|Overall Study|Physician Decision|1|||
27846851|NCT04223778|81268342|FG000|Overall Study|Withdrawal by Subject|10|||
27846852|NCT04223778|81268343|FG001|Overall Study|Withdrawal by Subject|1|||
27846853|NCT04223778|81268342|FG000|Overall Study|Lack of Efficacy|0|||
27846854|NCT04223778|81268343|FG001|Overall Study|Lack of Efficacy|2|||
27846855|NCT00402025|81268344|FG000|Overall Study|Adverse Event|0|||
27846856|NCT00402025|81268345|FG001|Overall Study|Adverse Event|0|||
27846857|NCT00402025|81268346|FG002|Overall Study|Adverse Event|2|||
27846858|NCT00402025|81268344|FG000|Overall Study|Death|0|||
27846859|NCT00402025|81268345|FG001|Overall Study|Death|1|||
27846860|NCT00402025|81268346|FG002|Overall Study|Death|5|||
27846861|NCT00402025|81268344|FG000|Overall Study|Disease Progression|1|||
27846862|NCT00402025|81268345|FG001|Overall Study|Disease Progression|1|||
27846863|NCT00402025|81268346|FG002|Overall Study|Disease Progression|2|||
27846864|NCT00402025|81268344|FG000|Overall Study|Physician Decision|1|||
27846865|NCT00402025|81268345|FG001|Overall Study|Physician Decision|1|||
27846866|NCT00402025|81268346|FG002|Overall Study|Physician Decision|0|||
27846867|NCT00402025|81268344|FG000|Overall Study|Participant Decision|0|||
27846868|NCT00402025|81268345|FG001|Overall Study|Participant Decision|0|||
27846869|NCT00402025|81268346|FG002|Overall Study|Participant Decision|1|||
27846870|NCT02340221|81268347|FG000|Overall Study|Death|100|||
27846871|NCT02340221|81268348|FG001|Overall Study|Death|197|||
27846872|NCT02340221|81268347|FG000|Overall Study|Withdrawal by Participant|24|||
27846873|NCT02340221|81268348|FG001|Overall Study|Withdrawal by Participant|37|||
27846874|NCT02340221|81268347|FG000|Overall Study|Lost to Follow-up|4|||
27846875|NCT02340221|81268348|FG001|Overall Study|Lost to Follow-up|15|||
27846876|NCT02340221|81268347|FG000|Overall Study|Reason Not Specified|85|||
27846877|NCT02340221|81268348|FG001|Overall Study|Reason Not Specified|165|||
27846878|NCT02340221|81268347|FG000|Overall Study|Study Terminated by Sponsor|1|||
27894074|NCT01552915|81447301|FG000|Overall Study|Withdrawal by Subject|6|||
27846879|NCT02340221|81268348|FG001|Overall Study|Study Terminated by Sponsor|3|||
27846880|NCT03451006|81268351|FG000|Overall Study|Withdrawal by Subject|2|||
27846881|NCT03451006|81268352|FG001|Overall Study|Withdrawal by Subject|2|||
27894075|NCT01552915|81447302|FG001|Overall Study|Withdrawal by Subject|4|||
27894076|NCT01552915|81447303|FG002|Overall Study|Withdrawal by Subject|5|||
27846882|NCT00058214|81268355|FG000|Overall Study|Adverse Event|1|||
27846883|NCT01933919|81268356|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
27846884|NCT01933919|81268357|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
27846885|NCT01933919|81268356|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
27846886|NCT01933919|81268357|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
27846887|NCT01933919|81268356|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
27846888|NCT01933919|81268357|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
27846889|NCT01933919|81268356|FG000|Open-label Long-term Phase|Adverse Event|2|||
27846890|NCT01933919|81268357|FG001|Open-label Long-term Phase|Adverse Event|0|||
27846891|NCT01933919|81268356|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
27846892|NCT01933919|81268357|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
27894077|NCT01552915|81447301|FG000|Overall Study|Protocol Violation|0|||
27846893|NCT01933919|81268356|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
27846894|NCT01933919|81268357|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
27846895|NCT01933919|81268356|FG000|Open-label Long-term Phase|Other|1|||
27846896|NCT01933919|81268357|FG001|Open-label Long-term Phase|Other|2|||
27846897|NCT02676284|81268358|FG000|Overall Study|Withdrawal by Subject|1|||
27846898|NCT02746627|81268364|FG000|Overall Study|Withdrawal by Subject|1|||
27846899|NCT02746627|81268365|FG001|Overall Study|Withdrawal by Subject|1|||
27846900|NCT02746627|81268366|FG002|Overall Study|Withdrawal by Subject|1|||
27846901|NCT00897949|81268367|FG000|Overall Study|Adverse Event|1|||
27846902|NCT00897949|81268368|FG001|Overall Study|Adverse Event|1|||
27846903|NCT00897949|81268369|FG002|Overall Study|Adverse Event|0|||
27846904|NCT00897949|81268367|FG000|Overall Study|Lost to Follow-up|0|||
27846905|NCT00897949|81268368|FG001|Overall Study|Lost to Follow-up|2|||
27846906|NCT00897949|81268369|FG002|Overall Study|Lost to Follow-up|1|||
27846907|NCT00897949|81268367|FG000|Overall Study|Protocol Violation|6|||
27846908|NCT00897949|81268368|FG001|Overall Study|Protocol Violation|3|||
27846909|NCT00897949|81268369|FG002|Overall Study|Protocol Violation|1|||
27846910|NCT00897949|81268367|FG000|Overall Study|Withdrawal by Subject|1|||
27846911|NCT00897949|81268368|FG001|Overall Study|Withdrawal by Subject|2|||
27846912|NCT00897949|81268369|FG002|Overall Study|Withdrawal by Subject|0|||
27846913|NCT00897949|81268367|FG000|Overall Study|Patient Uncoorperative|0|||
27846914|NCT00897949|81268368|FG001|Overall Study|Patient Uncoorperative|2|||
27846915|NCT00897949|81268369|FG002|Overall Study|Patient Uncoorperative|1|||
27846916|NCT00897949|81268367|FG000|Overall Study|Lost to Follow-up|30|||
27846917|NCT00897949|81268368|FG001|Overall Study|Lost to Follow-up|23|||
27846918|NCT00897949|81268369|FG002|Overall Study|Lost to Follow-up|17|||
27846919|NCT00897949|81268367|FG000|Overall Study|Withdrawal by Subject|24|||
27846920|NCT00897949|81268368|FG001|Overall Study|Withdrawal by Subject|31|||
27846921|NCT00897949|81268369|FG002|Overall Study|Withdrawal by Subject|17|||
27846922|NCT00897949|81268367|FG000|Overall Study|Abnormal Prestudy Labs|2|||
27846923|NCT00897949|81268368|FG001|Overall Study|Abnormal Prestudy Labs|3|||
27846924|NCT00897949|81268369|FG002|Overall Study|Abnormal Prestudy Labs|4|||
27846925|NCT00897949|81268367|FG000|Overall Study|Abnormal Baseline ECG|2|||
27846926|NCT00897949|81268368|FG001|Overall Study|Abnormal Baseline ECG|2|||
27846927|NCT00897949|81268369|FG002|Overall Study|Abnormal Baseline ECG|4|||
27846928|NCT00897949|81268367|FG000|Overall Study|Need for Concom. Med.|0|||
27846929|NCT00897949|81268368|FG001|Overall Study|Need for Concom. Med.|1|||
27846930|NCT00897949|81268369|FG002|Overall Study|Need for Concom. Med.|1|||
27894078|NCT01552915|81447302|FG001|Overall Study|Protocol Violation|4|||
27894079|NCT01552915|81447303|FG002|Overall Study|Protocol Violation|4|||
27894080|NCT01552915|81447301|FG000|Overall Study|Lack of Efficacy|8|||
27894081|NCT01552915|81447302|FG001|Overall Study|Lack of Efficacy|1|||
27894082|NCT01552915|81447303|FG002|Overall Study|Lack of Efficacy|4|||
27894083|NCT01552915|81447301|FG000|Overall Study|Other|2|||
27894084|NCT01552915|81447302|FG001|Overall Study|Other|0|||
27894085|NCT01552915|81447303|FG002|Overall Study|Other|6|||
27894086|NCT00710684|81447305|FG000|Overall Study|Adverse Event|11|||
27894087|NCT00710684|81447306|FG001|Overall Study|Adverse Event|19|||
27846931|NCT00897949|81268367|FG000|Overall Study|Lack of Migraine Attack|29|||
27846932|NCT00897949|81268368|FG001|Overall Study|Lack of Migraine Attack|30|||
27846933|NCT00897949|81268369|FG002|Overall Study|Lack of Migraine Attack|19|||
27846934|NCT00897949|81268367|FG000|Overall Study|Did not take study drug|9|||
27846935|NCT00897949|81268368|FG001|Overall Study|Did not take study drug|3|||
27846936|NCT00897949|81268369|FG002|Overall Study|Did not take study drug|4|||
27846937|NCT03581188|81268370|FG000|Overall Study|Inclusion criteria not met|3|||
27846938|NCT03581188|81268371|FG001|Overall Study|Inclusion criteria not met|2|||
27846939|NCT03581188|81268370|FG000|Overall Study|Lost to Follow-up|5|||
27846940|NCT03581188|81268371|FG001|Overall Study|Lost to Follow-up|5|||
27846941|NCT03581188|81268370|FG000|Overall Study|Discontinued intervention|11|||
27846942|NCT03581188|81268371|FG001|Overall Study|Discontinued intervention|8|||
27846943|NCT03087786|81268372|FG000|Overall Study|Withdrawal by Subject|2|||
27846944|NCT03087786|81268373|FG001|Overall Study|Withdrawal by Subject|0|||
27846945|NCT04553913|81268376|FG000|Overall Study|patient's block resolved prior to PACU|1|||
27846946|NCT04553913|81268376|FG000|Overall Study|did not use the device properly|5|||
27894088|NCT00710684|81447307|FG002|Overall Study|Adverse Event|16|||
27894089|NCT00710684|81447305|FG000|Overall Study|Lack of Efficacy|4|||
27894090|NCT00710684|81447306|FG001|Overall Study|Lack of Efficacy|3|||
27846947|NCT00880087|81268377|FG000|Overall Study|Lost to Follow-up|0|||
27846948|NCT00880087|81268378|FG001|Overall Study|Lost to Follow-up|2|||
27846949|NCT01998243|81268384|FG000|Overall Study|Pregnancy|0|||
27846950|NCT01998243|81268385|FG001|Overall Study|Pregnancy|1|||
27846951|NCT01998243|81268384|FG000|Overall Study|Protocol Violation|5|||
27894091|NCT00710684|81447307|FG002|Overall Study|Lack of Efficacy|5|||
27505126|NCT02121535|80040963|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
27846952|NCT01998243|81268385|FG001|Overall Study|Protocol Violation|2|||
27505127|NCT02121535|80040964|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
27846953|NCT01998243|81268384|FG000|Overall Study|Withdrawal by Subject|3|||
27846954|NCT01998243|81268385|FG001|Overall Study|Withdrawal by Subject|4|||
27894092|NCT00710684|81447305|FG000|Overall Study|Protocol Violation|5|||
27894093|NCT00710684|81447306|FG001|Overall Study|Protocol Violation|5|||
27846955|NCT02953678|81268387|FG000|Overall Study|Adverse Event|20|||
27846956|NCT02953678|81268387|FG000|Overall Study|Death|7|||
27846957|NCT02953678|81268387|FG000|Overall Study|Physician Decision|23|||
27846958|NCT02953678|81268387|FG000|Overall Study|Progressive Disease of GVHD|7|||
27846959|NCT02953678|81268387|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
27846960|NCT02953678|81268387|FG000|Overall Study|Withdrawal by participant|3|||
27846961|NCT02953678|81268387|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
27726008|NCT02901431|80826780|FG002|PK Part|Adverse Event|0|||
27726009|NCT02901431|80826781|FG003|PK Part|Adverse Event|0|||
27726010|NCT02901431|80826782|FG004|PK Part|Adverse Event|0|||
27726011|NCT02901431|80826783|FG005|PK Part|Adverse Event|0|||
27726012|NCT02901431|80826784|FG006|PK Part|Adverse Event|0|||
27726013|NCT02901431|80826785|FG007|PK Part|Adverse Event|0|||
27726014|NCT02901431|80826786|FG008|PK Part|Adverse Event|0|||
27726015|NCT02901431|80826787|FG009|PK Part|Adverse Event|0|||
27726016|NCT02901431|80826788|FG010|PK Part|Adverse Event|0|||
27726017|NCT02901431|80826789|FG011|PK Part|Adverse Event|0|||
27726018|NCT02901431|80826790|FG012|PK Part|Adverse Event|0|||
27726019|NCT02901431|80826778|FG000|PK Part|Lost to Follow-up|0|||
27726020|NCT02901431|80826779|FG001|PK Part|Lost to Follow-up|0|||
27726021|NCT02901431|80826780|FG002|PK Part|Lost to Follow-up|1|||
27726022|NCT02901431|80826781|FG003|PK Part|Lost to Follow-up|0|||
27726023|NCT02901431|80826782|FG004|PK Part|Lost to Follow-up|0|||
27726024|NCT02901431|80826783|FG005|PK Part|Lost to Follow-up|0|||
27726025|NCT02901431|80826784|FG006|PK Part|Lost to Follow-up|0|||
27726026|NCT02901431|80826785|FG007|PK Part|Lost to Follow-up|0|||
27726027|NCT02901431|80826786|FG008|PK Part|Lost to Follow-up|0|||
27726028|NCT02901431|80826787|FG009|PK Part|Lost to Follow-up|0|||
27726029|NCT02901431|80826788|FG010|PK Part|Lost to Follow-up|0|||
27726030|NCT02901431|80826789|FG011|PK Part|Lost to Follow-up|0|||
27726031|NCT02901431|80826790|FG012|PK Part|Lost to Follow-up|0|||
27726032|NCT02901431|80826778|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
27726033|NCT02901431|80826779|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726034|NCT02901431|80826780|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726035|NCT02901431|80826781|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726036|NCT02901431|80826782|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726037|NCT02901431|80826783|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726038|NCT02901431|80826784|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726039|NCT02901431|80826785|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726040|NCT02901431|80826786|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726041|NCT02901431|80826787|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726042|NCT02901431|80826788|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726043|NCT02901431|80826789|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726044|NCT02901431|80826790|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
27726045|NCT02901431|80826778|FG000|PK Part|Pending dose confirmation|0|||
27726046|NCT02901431|80826779|FG001|PK Part|Pending dose confirmation|1|||
27726047|NCT02901431|80826780|FG002|PK Part|Pending dose confirmation|0|||
27726048|NCT02901431|80826781|FG003|PK Part|Pending dose confirmation|0|||
27726049|NCT02901431|80826782|FG004|PK Part|Pending dose confirmation|0|||
27726050|NCT02901431|80826783|FG005|PK Part|Pending dose confirmation|0|||
27726051|NCT02901431|80826784|FG006|PK Part|Pending dose confirmation|0|||
27726052|NCT02901431|80826785|FG007|PK Part|Pending dose confirmation|0|||
27726053|NCT02901431|80826786|FG008|PK Part|Pending dose confirmation|0|||
27726054|NCT02901431|80826787|FG009|PK Part|Pending dose confirmation|0|||
27726055|NCT02901431|80826788|FG010|PK Part|Pending dose confirmation|0|||
27726056|NCT02901431|80826789|FG011|PK Part|Pending dose confirmation|0|||
27726057|NCT02901431|80826790|FG012|PK Part|Pending dose confirmation|0|||
27726058|NCT02901431|80826778|FG000|PK Part|8 weeks of treatment ran out|2|||
27726059|NCT02901431|80826779|FG001|PK Part|8 weeks of treatment ran out|0|||
27726060|NCT02901431|80826780|FG002|PK Part|8 weeks of treatment ran out|0|||
27726061|NCT02901431|80826781|FG003|PK Part|8 weeks of treatment ran out|0|||
27726062|NCT02901431|80826782|FG004|PK Part|8 weeks of treatment ran out|0|||
27726063|NCT02901431|80826783|FG005|PK Part|8 weeks of treatment ran out|0|||
27726064|NCT02901431|80826784|FG006|PK Part|8 weeks of treatment ran out|0|||
27846962|NCT02953678|81268387|FG000|Overall Study|Participants were transferred to commercial product.|3|||
27846963|NCT00991510|81268388|FG000|Period I (Days 1-14)|Adverse Event|1|||
27846964|NCT00991510|81268389|FG001|Period I (Days 1-14)|Adverse Event|0|||
27846965|NCT00991510|81268388|FG000|Period III (Days 29-112)|Adverse Event|1|||
27726065|NCT02901431|80826785|FG007|PK Part|8 weeks of treatment ran out|0|||
27726066|NCT02901431|80826786|FG008|PK Part|8 weeks of treatment ran out|0|||
27726067|NCT02901431|80826787|FG009|PK Part|8 weeks of treatment ran out|0|||
27726068|NCT02901431|80826788|FG010|PK Part|8 weeks of treatment ran out|0|||
27726069|NCT02901431|80826789|FG011|PK Part|8 weeks of treatment ran out|0|||
27846966|NCT00991510|81268389|FG001|Period III (Days 29-112)|Adverse Event|1|||
27726070|NCT02901431|80826790|FG012|PK Part|8 weeks of treatment ran out|0|||
27726071|NCT02901431|80826778|FG000|PK Part|Stopped treatment after 8 weeks|1|||
27726072|NCT02901431|80826779|FG001|PK Part|Stopped treatment after 8 weeks|0|||
27726073|NCT02901431|80826780|FG002|PK Part|Stopped treatment after 8 weeks|1|||
27726074|NCT02901431|80826781|FG003|PK Part|Stopped treatment after 8 weeks|0|||
27846967|NCT02695719|81268390|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
27846968|NCT02695719|81268391|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
27846969|NCT02695719|81268390|FG000|Overall Study|Significant Protocol Deviation|0|||
27846970|NCT02695719|81268391|FG001|Overall Study|Significant Protocol Deviation|1|||
27846971|NCT02695719|81268390|FG000|Overall Study|Voluntary Withdrawal|1|||
27846972|NCT02695719|81268391|FG001|Overall Study|Voluntary Withdrawal|0|||
27846973|NCT02459418|81268395|FG000|Overall Study|Exclusion Criteria|4|||
27846974|NCT02459418|81268396|FG001|Overall Study|Exclusion Criteria|0|||
27846975|NCT02459418|81268395|FG000|Overall Study|Protocol Violation|0|||
27846976|NCT02459418|81268396|FG001|Overall Study|Protocol Violation|2|||
27846977|NCT02459418|81268395|FG000|Overall Study|Physician Decision|0|||
27846978|NCT02459418|81268396|FG001|Overall Study|Physician Decision|2|||
27846979|NCT02459418|81268395|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
27846980|NCT02459418|81268396|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
27846981|NCT02459418|81268395|FG000|Overall Study|Adverse Event|0|||
27846982|NCT02459418|81268396|FG001|Overall Study|Adverse Event|1|||
27846983|NCT02459418|81268395|FG000|Overall Study|Withdrawal by Subject|1|||
27846984|NCT02459418|81268396|FG001|Overall Study|Withdrawal by Subject|1|||
27846985|NCT02459418|81268395|FG000|Overall Study|Elevated Creatine Kinase|1|||
27846986|NCT02459418|81268396|FG001|Overall Study|Elevated Creatine Kinase|0|||
27846987|NCT02459418|81268395|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
27846988|NCT02459418|81268396|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
27846989|NCT02148913|81271935|FG000|Overall Study|Death|0|||
27846990|NCT02148913|81271936|FG001|Overall Study|Death|1|||
27846991|NCT02148913|81271937|FG002|Overall Study|Death|0|||
27846992|NCT02148913|81271938|FG003|Overall Study|Death|0|||
27846993|NCT02470091|81271939|FG000|Overall Study|Withdrawal by Subject|1|||
27846994|NCT02470091|81271940|FG001|Overall Study|Withdrawal by Subject|0|||
27846995|NCT02470091|81271939|FG000|Overall Study|Ineligible|0|||
27846996|NCT02470091|81271940|FG001|Overall Study|Ineligible|2|||
27846997|NCT00493454|81271946|FG000|Overall Study|Withdrawal by Subject|1|||
27846998|NCT01564459|81271947|FG000|Run-In|Adverse Event|7|||
27726075|NCT02901431|80826782|FG004|PK Part|Stopped treatment after 8 weeks|0|||
27726076|NCT02901431|80826783|FG005|PK Part|Stopped treatment after 8 weeks|0|||
27726077|NCT02901431|80826784|FG006|PK Part|Stopped treatment after 8 weeks|0|||
27726078|NCT02901431|80826785|FG007|PK Part|Stopped treatment after 8 weeks|0|||
27726079|NCT02901431|80826786|FG008|PK Part|Stopped treatment after 8 weeks|0|||
27726080|NCT02901431|80826787|FG009|PK Part|Stopped treatment after 8 weeks|0|||
27726081|NCT02901431|80826788|FG010|PK Part|Stopped treatment after 8 weeks|0|||
27726082|NCT02901431|80826789|FG011|PK Part|Stopped treatment after 8 weeks|0|||
27726083|NCT02901431|80826790|FG012|PK Part|Stopped treatment after 8 weeks|0|||
27726084|NCT02901431|80826778|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
27726085|NCT02901431|80826779|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726086|NCT02901431|80826780|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
27726087|NCT02901431|80826781|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726088|NCT02901431|80826782|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726089|NCT02901431|80826783|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726090|NCT02901431|80826784|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726091|NCT02901431|80826785|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726092|NCT02901431|80826786|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726093|NCT02901431|80826787|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726094|NCT02901431|80826788|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726095|NCT02901431|80826789|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726096|NCT02901431|80826790|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
27726097|NCT02901431|80826778|FG000|PK Part|Discontinued per Sponsor|0|||
27726098|NCT02901431|80826779|FG001|PK Part|Discontinued per Sponsor|3|||
27726099|NCT02901431|80826780|FG002|PK Part|Discontinued per Sponsor|0|||
27726100|NCT02901431|80826781|FG003|PK Part|Discontinued per Sponsor|0|||
27846999|NCT01564459|81271948|FG001|Run-In|Adverse Event|0|||
27847000|NCT01564459|81271949|FG002|Run-In|Adverse Event|0|||
27726101|NCT02901431|80826782|FG004|PK Part|Discontinued per Sponsor|0|||
27726102|NCT02901431|80826783|FG005|PK Part|Discontinued per Sponsor|0|||
27847001|NCT01564459|81271947|FG000|Run-In|Lost to Follow-up|1|||
27847002|NCT01564459|81271948|FG001|Run-In|Lost to Follow-up|0|||
27847003|NCT01564459|81271949|FG002|Run-In|Lost to Follow-up|0|||
27847004|NCT01564459|81271947|FG000|Run-In|Non-compliance with study drug|2|||
27847005|NCT01564459|81271948|FG001|Run-In|Non-compliance with study drug|0|||
27847006|NCT01564459|81271949|FG002|Run-In|Non-compliance with study drug|0|||
27847007|NCT01564459|81271947|FG000|Run-In|Protocol Violation|1|||
27847008|NCT01564459|81271948|FG001|Run-In|Protocol Violation|0|||
27726103|NCT02901431|80826784|FG006|PK Part|Discontinued per Sponsor|0|||
27847009|NCT01564459|81271949|FG002|Run-In|Protocol Violation|0|||
27847010|NCT01564459|81271947|FG000|Run-In|Withdrawal by Subject|1|||
27726104|NCT02901431|80826785|FG007|PK Part|Discontinued per Sponsor|0|||
27726105|NCT02901431|80826786|FG008|PK Part|Discontinued per Sponsor|0|||
27726106|NCT02901431|80826787|FG009|PK Part|Discontinued per Sponsor|0|||
27726107|NCT02901431|80826788|FG010|PK Part|Discontinued per Sponsor|0|||
27726108|NCT02901431|80826789|FG011|PK Part|Discontinued per Sponsor|0|||
27726109|NCT02901431|80826790|FG012|PK Part|Discontinued per Sponsor|0|||
27726110|NCT02901431|80826778|FG000|PK Part|Withdrawal by Subject|1|||
27726111|NCT02901431|80826779|FG001|PK Part|Withdrawal by Subject|1|||
27726112|NCT02901431|80826780|FG002|PK Part|Withdrawal by Subject|3|||
27726113|NCT02901431|80826781|FG003|PK Part|Withdrawal by Subject|0|||
27726114|NCT02901431|80826782|FG004|PK Part|Withdrawal by Subject|0|||
27726115|NCT02901431|80826783|FG005|PK Part|Withdrawal by Subject|0|||
27726116|NCT02901431|80826784|FG006|PK Part|Withdrawal by Subject|0|||
27726117|NCT02901431|80826785|FG007|PK Part|Withdrawal by Subject|0|||
27726118|NCT02901431|80826786|FG008|PK Part|Withdrawal by Subject|0|||
27726119|NCT02901431|80826787|FG009|PK Part|Withdrawal by Subject|0|||
27726120|NCT02901431|80826788|FG010|PK Part|Withdrawal by Subject|0|||
27726121|NCT02901431|80826789|FG011|PK Part|Withdrawal by Subject|0|||
27726122|NCT02901431|80826790|FG012|PK Part|Withdrawal by Subject|0|||
27726123|NCT02901431|80826778|FG000|Main Treatment Part|Adverse Event|0|||
27726124|NCT02901431|80826779|FG001|Main Treatment Part|Adverse Event|0|||
27726125|NCT02901431|80826780|FG002|Main Treatment Part|Adverse Event|0|||
27726126|NCT02901431|80826781|FG003|Main Treatment Part|Adverse Event|3|||
27726127|NCT02901431|80826782|FG004|Main Treatment Part|Adverse Event|3|||
27726128|NCT02901431|80826783|FG005|Main Treatment Part|Adverse Event|4|||
27726129|NCT02901431|80826784|FG006|Main Treatment Part|Adverse Event|1|||
27726130|NCT02901431|80826785|FG007|Main Treatment Part|Adverse Event|0|||
27726131|NCT02901431|80826786|FG008|Main Treatment Part|Adverse Event|0|||
27847011|NCT01564459|81271948|FG001|Run-In|Withdrawal by Subject|0|||
27847012|NCT01564459|81271949|FG002|Run-In|Withdrawal by Subject|0|||
27847013|NCT01564459|81271947|FG000|Double-blind Treatment|Adverse Event|0|||
27847014|NCT01564459|81271948|FG001|Double-blind Treatment|Adverse Event|0|||
27847015|NCT01564459|81271949|FG002|Double-blind Treatment|Adverse Event|1|||
27847016|NCT01929395|81271950|FG000|Overall Study|Did not complete - non-related toxicity|1|||
27847017|NCT01929395|81271951|FG001|Overall Study|Did not complete - non-related toxicity|0|||
27847018|NCT01929395|81271952|FG002|Overall Study|Did not complete - non-related toxicity|0|||
27847019|NCT01929395|81271950|FG000|Overall Study|Withdrawal by Subject|0|||
27847020|NCT01929395|81271951|FG001|Overall Study|Withdrawal by Subject|1|||
27847021|NCT01929395|81271952|FG002|Overall Study|Withdrawal by Subject|0|||
27847022|NCT01929395|81271950|FG000|Overall Study|Screen Fail|0|||
27847023|NCT01929395|81271951|FG001|Overall Study|Screen Fail|0|||
27847024|NCT01929395|81271952|FG002|Overall Study|Screen Fail|1|||
27847025|NCT01010126|81271953|FG000|Overall Study|Withdrawal by Subject|1|||
27847026|NCT01010126|81271954|FG001|Overall Study|Withdrawal by Subject|0|||
27847027|NCT01010126|81271955|FG002|Overall Study|Withdrawal by Subject|1|||
27847028|NCT01010126|81271956|FG003|Overall Study|Withdrawal by Subject|0|||
27847029|NCT01010126|81271957|FG004|Overall Study|Withdrawal by Subject|3|||
27847030|NCT01010126|81271958|FG005|Overall Study|Withdrawal by Subject|0|||
27847031|NCT03545191|81271959|FG000|Overall Study|Death|1|||
27847032|NCT03545191|81271960|FG001|Overall Study|Death|0|||
27847033|NCT03545191|81271961|FG002|Overall Study|Death|0|||
27894094|NCT00710684|81447307|FG002|Overall Study|Protocol Violation|5|||
27894095|NCT00710684|81447305|FG000|Overall Study|Lost to Follow-up|4|||
27894096|NCT00710684|81447306|FG001|Overall Study|Lost to Follow-up|6|||
27894097|NCT00710684|81447307|FG002|Overall Study|Lost to Follow-up|7|||
27894098|NCT00710684|81447305|FG000|Overall Study|Physician Decision|0|||
27894099|NCT00710684|81447306|FG001|Overall Study|Physician Decision|2|||
27894100|NCT00710684|81447307|FG002|Overall Study|Physician Decision|4|||
27505128|NCT02121535|80040963|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
27505129|NCT02121535|80040964|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
27505130|NCT03051178|80044045|FG000|Overall Study|Withdrawal by Subject|5|||
27505131|NCT04498832|80044048|FG000|Overall Study|Adverse Event|1|||
27726132|NCT02901431|80826787|FG009|Main Treatment Part|Adverse Event|0|||
27726133|NCT02901431|80826788|FG010|Main Treatment Part|Adverse Event|0|||
27726134|NCT02901431|80826789|FG011|Main Treatment Part|Adverse Event|0|||
27726135|NCT02901431|80826790|FG012|Main Treatment Part|Adverse Event|0|||
27726136|NCT02901431|80826778|FG000|Main Treatment Part|Lack of Efficacy|0|||
27847034|NCT03545191|81271959|FG000|Overall Study|Adverse Event|4|||
27847035|NCT03545191|81271960|FG001|Overall Study|Adverse Event|2|||
27847036|NCT03545191|81271961|FG002|Overall Study|Adverse Event|7|||
27847037|NCT03545191|81271959|FG000|Overall Study|Other reasons|3|||
27726137|NCT02901431|80826779|FG001|Main Treatment Part|Lack of Efficacy|0|||
27726138|NCT02901431|80826780|FG002|Main Treatment Part|Lack of Efficacy|0|||
27726139|NCT02901431|80826781|FG003|Main Treatment Part|Lack of Efficacy|1|||
27726140|NCT02901431|80826782|FG004|Main Treatment Part|Lack of Efficacy|0|||
27726141|NCT02901431|80826783|FG005|Main Treatment Part|Lack of Efficacy|0|||
27847038|NCT03545191|81271960|FG001|Overall Study|Other reasons|11|||
27847039|NCT03545191|81271961|FG002|Overall Study|Other reasons|8|||
27894101|NCT00710684|81447305|FG000|Overall Study|Withdrawal by Subject|24|||
27505132|NCT04498832|80044049|FG001|Overall Study|Adverse Event|3|||
27505133|NCT04498832|80044048|FG000|Overall Study|Withdrawal by Subject|0|||
27505134|NCT04498832|80044049|FG001|Overall Study|Withdrawal by Subject|1|||
27505135|NCT00313014|80044054|FG000|Overall Study|Withdrawal by Subject|11|||
27505136|NCT00313014|80044055|FG001|Overall Study|Withdrawal by Subject|7|||
27847040|NCT03545191|81271959|FG000|Overall Study|Withdrawal by Subject|13|||
27847041|NCT03545191|81271960|FG001|Overall Study|Withdrawal by Subject|10|||
27847042|NCT03545191|81271961|FG002|Overall Study|Withdrawal by Subject|12|||
27847043|NCT03545191|81271959|FG000|Overall Study|Lost to Follow-up|1|||
27847044|NCT03545191|81271960|FG001|Overall Study|Lost to Follow-up|2|||
27847045|NCT03545191|81271961|FG002|Overall Study|Lost to Follow-up|3|||
27847046|NCT01316419|81271964|FG000|Overall Study|Not treated|103|||
27847047|NCT01316419|81271964|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
27847048|NCT01316419|81271964|FG000|Overall Study|Lost to Follow-up|19|||
27847049|NCT03629028|81271966|FG000|Overall Study|Lost to Follow-up|26|||
27847050|NCT03629028|81271967|FG001|Overall Study|Lost to Follow-up|23|||
27847051|NCT03629028|81271966|FG000|Overall Study|Pregnancy|4|||
27847052|NCT03629028|81271967|FG001|Overall Study|Pregnancy|2|||
27847053|NCT03629028|81271966|FG000|Overall Study|intolerance to examination|2|||
27847054|NCT03629028|81271967|FG001|Overall Study|intolerance to examination|0|||
27847055|NCT01345318|81271968|FG000|Overall Study|Adverse Event|16|||
27847056|NCT01345318|81271968|FG000|Overall Study|Lack of Efficacy|17|||
27505137|NCT00313014|80044056|FG002|Overall Study|Withdrawal by Subject|5|||
27613727|NCT02023879|80426768|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
27613728|NCT02023879|80426766|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
27847057|NCT01345318|81271968|FG000|Overall Study|Lost to Follow-up|2|||
27847058|NCT01345318|81271968|FG000|Overall Study|Protocol Violation|1|||
27847059|NCT01345318|81271968|FG000|Overall Study|Withdrawal by Subject|41|||
27847060|NCT01345318|81271968|FG000|Overall Study|Other|3|||
27847061|NCT01844531|81271971|FG000|Overall Study|Withdrawal by Subject|0|||
27847062|NCT01844531|81271972|FG001|Overall Study|Withdrawal by Subject|1|||
27894102|NCT00710684|81447306|FG001|Overall Study|Withdrawal by Subject|18|||
27505138|NCT00313014|80044054|FG000|Overall Study|Adverse Event|14|||
27726142|NCT02901431|80826784|FG006|Main Treatment Part|Lack of Efficacy|0|||
27726143|NCT02901431|80826785|FG007|Main Treatment Part|Lack of Efficacy|0|||
27726144|NCT02901431|80826786|FG008|Main Treatment Part|Lack of Efficacy|0|||
27726145|NCT02901431|80826787|FG009|Main Treatment Part|Lack of Efficacy|0|||
27726146|NCT02901431|80826788|FG010|Main Treatment Part|Lack of Efficacy|0|||
27726147|NCT02901431|80826789|FG011|Main Treatment Part|Lack of Efficacy|0|||
27726148|NCT02901431|80826790|FG012|Main Treatment Part|Lack of Efficacy|0|||
27505139|NCT00313014|80044055|FG001|Overall Study|Adverse Event|29|||
27505140|NCT00313014|80044056|FG002|Overall Study|Adverse Event|16|||
27505141|NCT00313014|80044054|FG000|Overall Study|Lost to Follow-up|7|||
27505142|NCT00313014|80044055|FG001|Overall Study|Lost to Follow-up|6|||
27505143|NCT00313014|80044056|FG002|Overall Study|Lost to Follow-up|10|||
27505144|NCT00313014|80044054|FG000|Overall Study|Administrative|9|||
27505145|NCT00313014|80044055|FG001|Overall Study|Administrative|6|||
27505146|NCT00313014|80044056|FG002|Overall Study|Administrative|14|||
27505147|NCT00313014|80044054|FG000|Overall Study|Lack of Efficacy|52|||
27505148|NCT00313014|80044055|FG001|Overall Study|Lack of Efficacy|25|||
27505149|NCT00313014|80044056|FG002|Overall Study|Lack of Efficacy|16|||
27505150|NCT04682366|80044057|FG000|Overall Study|Lost to Follow-up|1|||
27505151|NCT04682366|80044058|FG001|Overall Study|Lost to Follow-up|1|||
27505152|NCT01352793|80044059|FG000|Overall Study|Lost to Follow-up|289|||
27505153|NCT01352793|80044060|FG001|Overall Study|Lost to Follow-up|125|||
27505154|NCT01352793|80044059|FG000|Overall Study|Withdrawal by Subject|120|||
27505155|NCT01352793|80044060|FG001|Overall Study|Withdrawal by Subject|55|||
27505156|NCT01352793|80044059|FG000|Overall Study|Protocol Violation|44|||
27505157|NCT01352793|80044060|FG001|Overall Study|Protocol Violation|23|||
27505158|NCT01352793|80044059|FG000|Overall Study|Adverse Event|44|||
27505159|NCT01352793|80044060|FG001|Overall Study|Adverse Event|10|||
27505160|NCT01352793|80044059|FG000|Overall Study|Physician Decision|1|||
27505161|NCT01352793|80044060|FG001|Overall Study|Physician Decision|0|||
27505162|NCT01352793|80044059|FG000|Overall Study|Pregnancy|26|||
27505163|NCT01352793|80044060|FG001|Overall Study|Pregnancy|8|||
27505164|NCT01352793|80044059|FG000|Overall Study|Other|25|||
27505165|NCT01352793|80044060|FG001|Overall Study|Other|7|||
27505166|NCT01352793|80044059|FG000|Overall Study|Medication error|2|||
27505167|NCT01352793|80044060|FG001|Overall Study|Medication error|2|||
27505168|NCT01352793|80044059|FG000|Overall Study|Death|1|||
27505169|NCT01352793|80044060|FG001|Overall Study|Death|0|||
27505170|NCT01352793|80044059|FG000|Overall Study|Randomized but not vaccinated|8|||
27505171|NCT01352793|80044060|FG001|Overall Study|Randomized but not vaccinated|0|||
27505172|NCT01352793|80044059|FG000|Overall Study|No longer meets eligibility criteria|25|||
27505173|NCT01352793|80044060|FG001|Overall Study|No longer meets eligibility criteria|15|||
27505174|NCT01910298|80044061|FG000|Overall Study|Adverse Event|1|||
27505175|NCT01910298|80044062|FG001|Overall Study|Adverse Event|0|||
27505176|NCT01910298|80044061|FG000|Overall Study|Withdrawal by Subject|2|||
27505177|NCT01910298|80044062|FG001|Overall Study|Withdrawal by Subject|7|||
27726149|NCT02901431|80826778|FG000|Main Treatment Part|Lost to Follow-up|0|||
27726150|NCT02901431|80826779|FG001|Main Treatment Part|Lost to Follow-up|0|||
27505178|NCT01910298|80044061|FG000|Overall Study|Protocol Deviation|0|||
27505179|NCT01910298|80044062|FG001|Overall Study|Protocol Deviation|5|||
27505180|NCT01910298|80044061|FG000|Overall Study|Lost to Follow-up|1|||
27505181|NCT01910298|80044062|FG001|Overall Study|Lost to Follow-up|1|||
27505182|NCT01910298|80044061|FG000|Overall Study|Study Terminated by Sponsor|1|||
27505183|NCT01910298|80044062|FG001|Overall Study|Study Terminated by Sponsor|17|||
27505184|NCT01910298|80044061|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27847063|NCT01844531|81271973|FG002|Overall Study|Withdrawal by Subject|0|||
27847064|NCT01844531|81271974|FG003|Overall Study|Withdrawal by Subject|0|||
27847065|NCT00710749|81271975|FG000|First Intervention|Withdrawal by Subject|1|||
27847066|NCT00710749|81271976|FG001|First Intervention|Withdrawal by Subject|0|||
27847067|NCT00606502|81271977|FG000|Randomization|Randomized but not treated|3|||
27847068|NCT00606502|81271978|FG001|Randomization|Randomized but not treated|0|||
27847069|NCT00606502|81271977|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
27847070|NCT00606502|81271978|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
27847071|NCT02954159|81271980|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
27847072|NCT02954159|81271981|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
27847073|NCT02954159|81271980|FG000|Overall Study|Withdrawal by Subject|0|||
27847074|NCT02954159|81271981|FG001|Overall Study|Withdrawal by Subject|1|||
27847075|NCT00725621|81271982|FG000|Overall Study|Adverse Event|25|||
27847076|NCT00725621|81271982|FG000|Overall Study|Lack of Efficacy|46|||
27847077|NCT00725621|81271982|FG000|Overall Study|Withdrawal by Subject|57|||
27847078|NCT00725621|81271982|FG000|Overall Study|Physician Decision|19|||
27847079|NCT00725621|81271982|FG000|Overall Study|Lost to Follow-up|52|||
27847080|NCT00725621|81271982|FG000|Overall Study|Non-compliance|8|||
27847081|NCT00725621|81271982|FG000|Overall Study|Continued treatment by other physician|6|||
27847082|NCT00725621|81271982|FG000|Overall Study|Switched to other study|1|||
27847083|NCT00725621|81271982|FG000|Overall Study|Switched to other drug|1|||
27847084|NCT00725621|81271982|FG000|Overall Study|Prepared for elective surgery|1|||
27847085|NCT00725621|81271982|FG000|Overall Study|Reason not specified|55|||
27847086|NCT00369382|81271983|FG000|Overall Study|Death|0|||
27847087|NCT00369382|81271984|FG001|Overall Study|Death|2|||
27847088|NCT00369382|81271983|FG000|Overall Study|Physician Decision|2|||
27847089|NCT00369382|81271984|FG001|Overall Study|Physician Decision|1|||
27847090|NCT00369382|81271983|FG000|Overall Study|Withdrawal by Subject|5|||
27847091|NCT00369382|81271984|FG001|Overall Study|Withdrawal by Subject|0|||
27847092|NCT00369382|81271983|FG000|Overall Study|Randomized, not treated|2|||
27847093|NCT00369382|81271984|FG001|Overall Study|Randomized, not treated|0|||
27847094|NCT00369382|81271983|FG000|Overall Study|Other|1|||
27847095|NCT00369382|81271984|FG001|Overall Study|Other|0|||
27847096|NCT00767520|81271985|FG000|Overall Study|Participants still on treatment|11|||
27847097|NCT00767520|81271986|FG001|Overall Study|Participants still on treatment|15|||
27847098|NCT00767520|81271985|FG000|Overall Study|Randomized in error and Never treated|0|||
27847099|NCT00767520|81271986|FG001|Overall Study|Randomized in error and Never treated|2|||
27847100|NCT01884688|81271987|FG000|Overall Study|Screen Failure|2|||
27847101|NCT00706992|81271988|FG000|Overall Study|Study termination|5|||
27847102|NCT00706992|81271989|FG001|Overall Study|Study termination|5|||
27847103|NCT00706992|81271990|FG002|Overall Study|Study termination|6|||
27847104|NCT00706992|81271991|FG003|Overall Study|Study termination|2|||
27847105|NCT00706992|81271992|FG004|Overall Study|Study termination|3|||
27847106|NCT00706992|81271993|FG005|Overall Study|Study termination|2|||
27847107|NCT00706992|81271994|FG006|Overall Study|Study termination|3|||
27847108|NCT00706992|81271988|FG000|Overall Study|Disease progression before treatment|0|||
27847109|NCT00706992|81271989|FG001|Overall Study|Disease progression before treatment|0|||
27847110|NCT00706992|81271990|FG002|Overall Study|Disease progression before treatment|0|||
27847111|NCT00706992|81271991|FG003|Overall Study|Disease progression before treatment|0|||
27847112|NCT00706992|81271992|FG004|Overall Study|Disease progression before treatment|1|||
27847113|NCT00706992|81271993|FG005|Overall Study|Disease progression before treatment|0|||
27847114|NCT00706992|81271994|FG006|Overall Study|Disease progression before treatment|0|||
27847115|NCT03123783|81271999|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
27847116|NCT03123783|81272000|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
27847117|NCT03123783|81272001|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
27847118|NCT03123783|81272002|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
27847119|NCT03123783|81272003|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
27847120|NCT03123783|81272004|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
27847121|NCT03123783|81272005|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
27847122|NCT03123783|81271999|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
27847123|NCT03123783|81272000|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
27847124|NCT03123783|81272001|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
27847125|NCT03123783|81272002|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
27847126|NCT03123783|81272003|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
27847127|NCT03123783|81272004|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
27613729|NCT02023879|80426767|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
27847128|NCT03123783|81272005|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
27847129|NCT03123783|81271999|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
27847130|NCT03123783|81272000|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
27847131|NCT03123783|81272001|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
27847132|NCT03123783|81272002|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
27847133|NCT03123783|81272003|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
27847134|NCT03123783|81272004|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
27847135|NCT03123783|81272005|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
27847136|NCT03123783|81271999|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
27847137|NCT03123783|81272000|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
27847138|NCT03123783|81272001|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
27847139|NCT03123783|81272002|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
27847140|NCT03123783|81272003|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
27847141|NCT03123783|81272004|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
27847142|NCT03123783|81272005|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
27847143|NCT01201759|81272006|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
27847144|NCT01201759|81272007|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
27847145|NCT01201759|81272006|FG000|Visit 3 - Washout|Adverse Event|0|||
27847146|NCT01201759|81272007|FG001|Visit 3 - Washout|Adverse Event|3|||
27847147|NCT01201759|81272006|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
27847148|NCT01201759|81272007|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
27847149|NCT01201759|81272006|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
27505185|NCT01910298|80044062|FG001|Overall Study|Other Miscellaneous Reasons|2|||
27505186|NCT01317472|80044063|FG000|Overall Study|Withdrawal by Subject|1|||
27505187|NCT01317472|80044064|FG001|Overall Study|Withdrawal by Subject|0|||
27505188|NCT01317472|80044063|FG000|Overall Study|Unrelated hospitalization|1|||
27505189|NCT01317472|80044064|FG001|Overall Study|Unrelated hospitalization|0|||
27505190|NCT00003475|80044065|FG000|Overall Study|Not evaluable|13|||
27847150|NCT01201759|81272007|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
27847151|NCT03042468|81272008|FG000|Overall Study|Death|0|||
27847152|NCT03042468|81272009|FG001|Overall Study|Death|1|||
27847153|NCT03042468|81272010|FG002|Overall Study|Death|1|||
27847154|NCT03042468|81272011|FG003|Overall Study|Death|0|||
27505191|NCT02195518|80044068|FG000|Overall Study|Adverse Event|1|||
27505192|NCT02195518|80044068|FG000|Overall Study|Protocol Violation|4|||
27505193|NCT02195518|80044068|FG000|Overall Study|Pregnancy|2|||
27505194|NCT02195518|80044068|FG000|Overall Study|Withdrawal by Subject|1|||
27505195|NCT02195518|80044068|FG000|Overall Study|Lost to Follow-up|1|||
27505196|NCT01815918|80044071|FG000|Overall Study|Patient samples not analyzable|3|||
27505197|NCT01815918|80044072|FG001|Overall Study|Patient samples not analyzable|4|||
27505198|NCT01815918|80044071|FG000|Overall Study|Lack of Efficacy|15|||
27505199|NCT01815918|80044072|FG001|Overall Study|Lack of Efficacy|15|||
27505200|NCT02220920|80044074|FG000|Overall Study|Adverse Event|1|||
27847155|NCT03042468|81272012|FG004|Overall Study|Death|0|||
27894103|NCT00710684|81447307|FG002|Overall Study|Withdrawal by Subject|11|||
27894104|NCT00710684|81447305|FG000|Overall Study|Missing|1|||
27894105|NCT00710684|81447306|FG001|Overall Study|Missing|0|||
27894106|NCT00710684|81447307|FG002|Overall Study|Missing|0|||
27894107|NCT00710684|81447305|FG000|Overall Study|Did not continue after week 24|25|||
27847156|NCT03042468|81272013|FG005|Overall Study|Death|0|||
27847157|NCT03042468|81272008|FG000|Overall Study|Withdrawal by Subject|0|||
27847158|NCT03042468|81272009|FG001|Overall Study|Withdrawal by Subject|0|||
27894108|NCT00710684|81447306|FG001|Overall Study|Did not continue after week 24|21|||
27894109|NCT00710684|81447307|FG002|Overall Study|Did not continue after week 24|16|||
27505201|NCT02220920|80044075|FG001|Overall Study|Adverse Event|0|||
27505202|NCT02220920|80044074|FG000|Overall Study|Lack of Efficacy|0|||
27505203|NCT02220920|80044075|FG001|Overall Study|Lack of Efficacy|1|||
27847159|NCT03042468|81272010|FG002|Overall Study|Withdrawal by Subject|0|||
27894110|NCT01282164|81447308|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
27894111|NCT01282164|81447309|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
27894112|NCT02407457|81447310|FG000|1 Month|Death|3|||
27894113|NCT02407457|81447311|FG001|1 Month|Death|0|||
27894114|NCT02407457|81447310|FG000|1 Month|Lost to Follow-up|1|||
27847160|NCT03042468|81272011|FG003|Overall Study|Withdrawal by Subject|0|||
27847161|NCT03042468|81272012|FG004|Overall Study|Withdrawal by Subject|0|||
27847162|NCT03042468|81272013|FG005|Overall Study|Withdrawal by Subject|1|||
27847163|NCT03042468|81272008|FG000|Overall Study|Lost to Follow-up|0|||
27847164|NCT03042468|81272009|FG001|Overall Study|Lost to Follow-up|0|||
27847165|NCT03042468|81272010|FG002|Overall Study|Lost to Follow-up|0|||
27847166|NCT03042468|81272011|FG003|Overall Study|Lost to Follow-up|0|||
27847167|NCT03042468|81272012|FG004|Overall Study|Lost to Follow-up|1|||
27847168|NCT03042468|81272013|FG005|Overall Study|Lost to Follow-up|1|||
27847169|NCT03870477|81272016|FG000|Overall Study|Early Study Termination|1|||
27847170|NCT04039919|81272017|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27847171|NCT04039919|81272018|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27847172|NCT04039919|81272019|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27847173|NCT04039919|81272020|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27847174|NCT04039919|81272021|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27847175|NCT04039919|81272017|FG000|Treatment Period 1|Sponsor's decision|0|||
27847176|NCT04039919|81272018|FG001|Treatment Period 1|Sponsor's decision|0|||
27847177|NCT04039919|81272019|FG002|Treatment Period 1|Sponsor's decision|0|||
27847178|NCT04039919|81272020|FG003|Treatment Period 1|Sponsor's decision|0|||
27847179|NCT04039919|81272021|FG004|Treatment Period 1|Sponsor's decision|16|||
27847180|NCT04039919|81272017|FG000|Treatment Period 5|Withdrawal by Subject|1|||
27847181|NCT04039919|81272018|FG001|Treatment Period 5|Withdrawal by Subject|0|||
27847182|NCT04039919|81272019|FG002|Treatment Period 5|Withdrawal by Subject|0|||
27847183|NCT04039919|81272020|FG003|Treatment Period 5|Withdrawal by Subject|0|||
27847184|NCT04039919|81272021|FG004|Treatment Period 5|Withdrawal by Subject|0|||
27847185|NCT00466726|81272022|FG000|Overall Study|Not evaluable for response|14|||
27847186|NCT00731549|81272025|FG000|Overall Study|Lost to Follow-up|19|||
27847187|NCT00731549|81272025|FG000|Overall Study|Met withdrawal criteria|24|||
27847188|NCT00731549|81272025|FG000|Overall Study|Physician Decision|16|||
27847189|NCT00731549|81272025|FG000|Overall Study|Withdrawal by Subject|89|||
27847190|NCT00731549|81272025|FG000|Overall Study|Protocol deviation|1|||
27847191|NCT00731549|81272025|FG000|Overall Study|Adverse Event|31|||
27847192|NCT00731549|81272025|FG000|Overall Study|Lack of efficacy with AE|37|||
27847193|NCT00731549|81272025|FG000|Overall Study|Lack of efficacy without AE|6|||
27847194|NCT00611884|81272026|FG000|Overall Study|Adverse Event|1|||
27847195|NCT00611884|81272027|FG001|Overall Study|Adverse Event|0|||
27847196|NCT00611884|81272028|FG002|Overall Study|Adverse Event|0|||
27847197|NCT00611884|81272029|FG003|Overall Study|Adverse Event|1|||
27847198|NCT00611884|81272026|FG000|Overall Study|Non-Compliance|1|||
27847199|NCT00611884|81272027|FG001|Overall Study|Non-Compliance|4|||
27847200|NCT00611884|81272028|FG002|Overall Study|Non-Compliance|2|||
27847201|NCT00611884|81272029|FG003|Overall Study|Non-Compliance|2|||
27847202|NCT00611884|81272026|FG000|Overall Study|Lack of Efficacy|0|||
27847203|NCT00611884|81272027|FG001|Overall Study|Lack of Efficacy|1|||
27847204|NCT00611884|81272028|FG002|Overall Study|Lack of Efficacy|0|||
27847205|NCT00611884|81272029|FG003|Overall Study|Lack of Efficacy|0|||
27847206|NCT00611884|81272026|FG000|Overall Study|Unclassified|7|||
27847207|NCT00611884|81272027|FG001|Overall Study|Unclassified|4|||
27847208|NCT00611884|81272028|FG002|Overall Study|Unclassified|2|||
27847209|NCT00611884|81272029|FG003|Overall Study|Unclassified|3|||
27847210|NCT01807117|81272030|FG000|Overall Study|Physician Decision|2|||
27847211|NCT01807117|81272030|FG000|Overall Study|Disease diagnosis not a study disease|1|||
27847212|NCT04633642|81272032|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
27847213|NCT04633642|81272033|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
27847214|NCT01652729|81272037|FG000|Overall Study|Withdrawal by Subject|14|||
27505204|NCT02220920|80044074|FG000|Overall Study|Withdrawal by Subject|1|||
27505205|NCT02220920|80044075|FG001|Overall Study|Withdrawal by Subject|0|||
27505206|NCT02220920|80044074|FG000|Overall Study|Conflict with the stopping criteria|1|||
27505207|NCT02220920|80044075|FG001|Overall Study|Conflict with the stopping criteria|2|||
27847215|NCT01652729|81272038|FG001|Overall Study|Withdrawal by Subject|7|||
27847216|NCT01652729|81272039|FG002|Overall Study|Withdrawal by Subject|7|||
27847217|NCT01652729|81272037|FG000|Overall Study|Adverse Event|4|||
27847218|NCT01652729|81272038|FG001|Overall Study|Adverse Event|0|||
27847219|NCT01652729|81272039|FG002|Overall Study|Adverse Event|3|||
27847220|NCT01652729|81272037|FG000|Overall Study|Physician Decision|1|||
27847221|NCT01652729|81272038|FG001|Overall Study|Physician Decision|0|||
27894115|NCT02407457|81447311|FG001|1 Month|Lost to Follow-up|1|||
27847222|NCT01652729|81272039|FG002|Overall Study|Physician Decision|1|||
27847223|NCT01652729|81272037|FG000|Overall Study|Protocol Violation|1|||
27847224|NCT01652729|81272038|FG001|Overall Study|Protocol Violation|0|||
27894116|NCT02407457|81447310|FG000|1 Month|missed visit|2|||
27894117|NCT02407457|81447311|FG001|1 Month|missed visit|5|||
27726151|NCT02901431|80826780|FG002|Main Treatment Part|Lost to Follow-up|0|||
27726152|NCT02901431|80826781|FG003|Main Treatment Part|Lost to Follow-up|3|||
27726153|NCT02901431|80826782|FG004|Main Treatment Part|Lost to Follow-up|1|||
27726154|NCT02901431|80826783|FG005|Main Treatment Part|Lost to Follow-up|2|||
27726155|NCT02901431|80826784|FG006|Main Treatment Part|Lost to Follow-up|3|||
27726156|NCT02901431|80826785|FG007|Main Treatment Part|Lost to Follow-up|0|||
27726157|NCT02901431|80826786|FG008|Main Treatment Part|Lost to Follow-up|0|||
27726158|NCT02901431|80826787|FG009|Main Treatment Part|Lost to Follow-up|0|||
27726159|NCT02901431|80826788|FG010|Main Treatment Part|Lost to Follow-up|0|||
27726160|NCT02901431|80826789|FG011|Main Treatment Part|Lost to Follow-up|0|||
27726161|NCT02901431|80826790|FG012|Main Treatment Part|Lost to Follow-up|0|||
27726162|NCT02901431|80826778|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
27726163|NCT02901431|80826779|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
27726164|NCT02901431|80826780|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
27726165|NCT02901431|80826781|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
27726166|NCT02901431|80826782|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
27726167|NCT02901431|80826783|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
27726168|NCT02901431|80826784|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
27726169|NCT02901431|80826785|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
27726170|NCT02901431|80826786|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
27726171|NCT02901431|80826787|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
27726172|NCT02901431|80826788|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
27726173|NCT02901431|80826789|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
27726174|NCT02901431|80826790|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
27726175|NCT02901431|80826778|FG000|Main Treatment Part|Physician Decision|0|||
27726176|NCT02901431|80826779|FG001|Main Treatment Part|Physician Decision|0|||
27726177|NCT02901431|80826780|FG002|Main Treatment Part|Physician Decision|0|||
27726178|NCT02901431|80826781|FG003|Main Treatment Part|Physician Decision|1|||
27726179|NCT02901431|80826782|FG004|Main Treatment Part|Physician Decision|0|||
27726180|NCT02901431|80826783|FG005|Main Treatment Part|Physician Decision|0|||
27726181|NCT02901431|80826784|FG006|Main Treatment Part|Physician Decision|1|||
27726182|NCT02901431|80826785|FG007|Main Treatment Part|Physician Decision|0|||
27726183|NCT02901431|80826786|FG008|Main Treatment Part|Physician Decision|0|||
27726184|NCT02901431|80826787|FG009|Main Treatment Part|Physician Decision|0|||
27726185|NCT02901431|80826788|FG010|Main Treatment Part|Physician Decision|0|||
27726186|NCT02901431|80826789|FG011|Main Treatment Part|Physician Decision|0|||
27726187|NCT02901431|80826790|FG012|Main Treatment Part|Physician Decision|0|||
27726188|NCT02901431|80826778|FG000|Main Treatment Part|Withdrawal by Subject|0|||
27726189|NCT02901431|80826779|FG001|Main Treatment Part|Withdrawal by Subject|0|||
27726190|NCT02901431|80826780|FG002|Main Treatment Part|Withdrawal by Subject|0|||
27726191|NCT02901431|80826781|FG003|Main Treatment Part|Withdrawal by Subject|18|||
27726192|NCT02901431|80826782|FG004|Main Treatment Part|Withdrawal by Subject|3|||
27726193|NCT02901431|80826783|FG005|Main Treatment Part|Withdrawal by Subject|5|||
27726194|NCT02901431|80826784|FG006|Main Treatment Part|Withdrawal by Subject|6|||
27726195|NCT02901431|80826785|FG007|Main Treatment Part|Withdrawal by Subject|0|||
27726196|NCT02901431|80826786|FG008|Main Treatment Part|Withdrawal by Subject|0|||
27726197|NCT02901431|80826787|FG009|Main Treatment Part|Withdrawal by Subject|0|||
27726198|NCT02901431|80826788|FG010|Main Treatment Part|Withdrawal by Subject|0|||
27726199|NCT02901431|80826789|FG011|Main Treatment Part|Withdrawal by Subject|0|||
27726200|NCT02901431|80826790|FG012|Main Treatment Part|Withdrawal by Subject|0|||
27726201|NCT02901431|80826778|FG000|Open Label Part|Adverse Event|0|||
27726202|NCT02901431|80826779|FG001|Open Label Part|Adverse Event|0|||
27726203|NCT02901431|80826780|FG002|Open Label Part|Adverse Event|0|||
27726204|NCT02901431|80826781|FG003|Open Label Part|Adverse Event|0|||
27726205|NCT02901431|80826782|FG004|Open Label Part|Adverse Event|0|||
27726206|NCT02901431|80826783|FG005|Open Label Part|Adverse Event|0|||
27726207|NCT02901431|80826784|FG006|Open Label Part|Adverse Event|0|||
27726208|NCT02901431|80826785|FG007|Open Label Part|Adverse Event|0|||
27726209|NCT02901431|80826786|FG008|Open Label Part|Adverse Event|4|||
27726210|NCT02901431|80826787|FG009|Open Label Part|Adverse Event|4|||
27726211|NCT02901431|80826788|FG010|Open Label Part|Adverse Event|0|||
27726212|NCT02901431|80826789|FG011|Open Label Part|Adverse Event|4|||
27726213|NCT02901431|80826790|FG012|Open Label Part|Adverse Event|1|||
27726214|NCT02901431|80826778|FG000|Open Label Part|Lost to Follow-up|0|||
27726215|NCT02901431|80826779|FG001|Open Label Part|Lost to Follow-up|0|||
27726216|NCT02901431|80826780|FG002|Open Label Part|Lost to Follow-up|0|||
27726217|NCT02901431|80826781|FG003|Open Label Part|Lost to Follow-up|0|||
27726218|NCT02901431|80826782|FG004|Open Label Part|Lost to Follow-up|0|||
27726219|NCT02901431|80826783|FG005|Open Label Part|Lost to Follow-up|0|||
27726220|NCT02901431|80826784|FG006|Open Label Part|Lost to Follow-up|0|||
27726221|NCT02901431|80826785|FG007|Open Label Part|Lost to Follow-up|0|||
27726222|NCT02901431|80826786|FG008|Open Label Part|Lost to Follow-up|2|||
27726223|NCT02901431|80826787|FG009|Open Label Part|Lost to Follow-up|2|||
27726224|NCT02901431|80826788|FG010|Open Label Part|Lost to Follow-up|1|||
27726225|NCT02901431|80826789|FG011|Open Label Part|Lost to Follow-up|1|||
27726226|NCT02901431|80826790|FG012|Open Label Part|Lost to Follow-up|1|||
27847225|NCT01652729|81272039|FG002|Overall Study|Protocol Violation|0|||
27847226|NCT01652729|81272037|FG000|Overall Study|Lost to Follow-up|6|||
27847227|NCT01652729|81272038|FG001|Overall Study|Lost to Follow-up|6|||
27847228|NCT01652729|81272039|FG002|Overall Study|Lost to Follow-up|3|||
27847229|NCT01652729|81272037|FG000|Overall Study|Administrative|1|||
27847230|NCT01652729|81272038|FG001|Overall Study|Administrative|0|||
27847231|NCT01652729|81272039|FG002|Overall Study|Administrative|0|||
27847232|NCT03978091|81272040|FG000|Overall Study|Lost to Follow-up|0|||
27847233|NCT03978091|81272041|FG001|Overall Study|Lost to Follow-up|0|||
27847234|NCT03978091|81272042|FG002|Overall Study|Lost to Follow-up|1|||
27847235|NCT03978091|81272043|FG003|Overall Study|Lost to Follow-up|0|||
27847236|NCT03978091|81272044|FG004|Overall Study|Lost to Follow-up|0|||
27847237|NCT03978091|81272045|FG005|Overall Study|Lost to Follow-up|0|||
27847238|NCT03978091|81272040|FG000|Overall Study|Withdrawal by Subject|0|||
27847239|NCT03978091|81272041|FG001|Overall Study|Withdrawal by Subject|0|||
27847240|NCT03978091|81272042|FG002|Overall Study|Withdrawal by Subject|0|||
27847241|NCT03978091|81272043|FG003|Overall Study|Withdrawal by Subject|1|||
27847242|NCT03978091|81272044|FG004|Overall Study|Withdrawal by Subject|1|||
27847243|NCT03978091|81272045|FG005|Overall Study|Withdrawal by Subject|0|||
27505208|NCT02158442|80044077|FG000|Overall Study|Withdrawal by Subject|1|||
27505209|NCT02158442|80044078|FG001|Overall Study|Withdrawal by Subject|0|||
27505210|NCT02158442|80044077|FG000|Overall Study|Perfusion staff not available|1|||
27505211|NCT02158442|80044078|FG001|Overall Study|Perfusion staff not available|0|||
27505212|NCT00992108|80044079|FG000|Overall Study|Lost to Follow-up|0|||
27505213|NCT00992108|80044080|FG001|Overall Study|Lost to Follow-up|1|||
27505214|NCT00087152|80044081|FG000|Overall Study|Ineligible|6|||
27505215|NCT04986904|80044082|FG000|Overall Study|Lost to Follow-up|11|||
27505216|NCT04986904|80044082|FG000|Overall Study|Withdrawal by Subject|1|||
27505217|NCT00853307|80044084|FG000|Overall Study|Adverse Event|1|||
27505218|NCT00853307|80044085|FG001|Overall Study|Adverse Event|2|||
27505219|NCT00853307|80044084|FG000|Overall Study|Withdrawal by Subject|1|||
27505220|NCT00853307|80044085|FG001|Overall Study|Withdrawal by Subject|2|||
27505221|NCT00853307|80044084|FG000|Overall Study|Reason Not Specified|0|||
27505222|NCT00853307|80044085|FG001|Overall Study|Reason Not Specified|1|||
27505223|NCT01550003|80044090|FG000|Overall Study|Adverse Event|0|||
27505224|NCT01550003|80044091|FG001|Overall Study|Adverse Event|9|||
27505225|NCT01550003|80044092|FG002|Overall Study|Adverse Event|15|||
27505226|NCT01550003|80044090|FG000|Overall Study|Lack of Efficacy|4|||
27505227|NCT01550003|80044091|FG001|Overall Study|Lack of Efficacy|11|||
27505228|NCT01550003|80044092|FG002|Overall Study|Lack of Efficacy|15|||
27726227|NCT02901431|80826778|FG000|Open Label Part|Physician Decision|0|||
27847244|NCT05506358|81272046|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
27847245|NCT05506358|81272047|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
27847246|NCT05506358|81272048|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
27847247|NCT05506358|81272049|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
27847248|NCT05506358|81272050|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
27847249|NCT05506358|81272046|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
27847250|NCT05506358|81272047|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
27847251|NCT05506358|81272048|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
27847252|NCT05506358|81272049|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
27847253|NCT05506358|81272050|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
27847254|NCT05506358|81272046|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
27847255|NCT05506358|81272047|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
27847256|NCT05506358|81272048|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
27847257|NCT05506358|81272049|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
27847258|NCT05506358|81272050|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
27847259|NCT05506358|81272046|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
27847260|NCT05506358|81272047|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
27847261|NCT05506358|81272048|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
27847262|NCT05506358|81272049|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
27847263|NCT05506358|81272050|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
27847264|NCT05506358|81272046|FG000|Overall Study|HbE trait|0|||
27847265|NCT05506358|81272047|FG001|Overall Study|HbE trait|0|||
27847266|NCT05506358|81272048|FG002|Overall Study|HbE trait|0|||
27847267|NCT05506358|81272049|FG003|Overall Study|HbE trait|1|||
27847268|NCT05506358|81272050|FG004|Overall Study|HbE trait|0|||
27847269|NCT04059549|81272051|FG000|Overall Study|Withdrawal by Subject|2|||
27847270|NCT04059549|81272052|FG001|Overall Study|Withdrawal by Subject|0|||
27847271|NCT04364737|81272053|FG000|Overall Study|Withdrawal by Subject|4|||
27847272|NCT04364737|81272054|FG001|Overall Study|Withdrawal by Subject|9|||
27847273|NCT04364737|81272053|FG000|Overall Study|Lost to Follow-up|1|||
27847274|NCT04364737|81272054|FG001|Overall Study|Lost to Follow-up|1|||
27847275|NCT00140413|81272055|FG000|Overall Study|Lost to Follow-up|1|||
27847276|NCT00140413|81272056|FG001|Overall Study|Lost to Follow-up|0|||
27847277|NCT00140413|81272055|FG000|Overall Study|Withdrawal by Subject|2|||
27847278|NCT00140413|81272056|FG001|Overall Study|Withdrawal by Subject|0|||
27847279|NCT03165955|81272057|FG000|Treatment|Withdrawal by Subject|3|||
27847280|NCT03165955|81272057|FG000|Treatment|Death|1|||
27847281|NCT03165955|81272057|FG000|Treatment|Adverse Event|1|||
27847282|NCT03165955|81272057|FG000|Treatment|Progressive disease|3|||
27847283|NCT03864042|81272065|FG000|DDI Phase|Adverse Event|2|||
27847284|NCT03864042|81272066|FG001|DDI Phase|Adverse Event|0|||
27847285|NCT03864042|81272067|FG002|DDI Phase|Adverse Event|0|||
27847286|NCT03864042|81272065|FG000|DDI Phase|Physician Decision|1|||
27847287|NCT03864042|81272066|FG001|DDI Phase|Physician Decision|0|||
27847288|NCT03864042|81272067|FG002|DDI Phase|Physician Decision|0|||
27847289|NCT03864042|81272065|FG000|DDI Phase|Progressive Disease|1|||
27847290|NCT03864042|81272066|FG001|DDI Phase|Progressive Disease|0|||
27847291|NCT03864042|81272067|FG002|DDI Phase|Progressive Disease|0|||
27847292|NCT03864042|81272065|FG000|Post-DDI Phase|Adverse Event|5|||
27847293|NCT03864042|81272066|FG001|Post-DDI Phase|Adverse Event|3|||
27847294|NCT03864042|81272067|FG002|Post-DDI Phase|Adverse Event|2|||
27847295|NCT03864042|81272065|FG000|Post-DDI Phase|Progressive Disease|11|||
27847296|NCT03864042|81272066|FG001|Post-DDI Phase|Progressive Disease|6|||
27847297|NCT03864042|81272067|FG002|Post-DDI Phase|Progressive Disease|13|||
27847298|NCT03864042|81272065|FG000|Post-DDI Phase|Discretion of investigator|1|||
27847299|NCT03864042|81272066|FG001|Post-DDI Phase|Discretion of investigator|1|||
27847300|NCT03864042|81272067|FG002|Post-DDI Phase|Discretion of investigator|0|||
27847301|NCT03864042|81272065|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
27847302|NCT03864042|81272066|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
27847303|NCT03864042|81272067|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
27847304|NCT03864042|81272065|FG000|Post-DDI Phase|Withdrawal of consent|1|||
27847305|NCT03864042|81272066|FG001|Post-DDI Phase|Withdrawal of consent|2|||
27847306|NCT03864042|81272067|FG002|Post-DDI Phase|Withdrawal of consent|0|||
27505229|NCT01550003|80044090|FG000|Overall Study|Protocol Violation|0|||
27505230|NCT01550003|80044091|FG001|Overall Study|Protocol Violation|3|||
27505231|NCT01550003|80044092|FG002|Overall Study|Protocol Violation|2|||
27505232|NCT01550003|80044090|FG000|Overall Study|Lost to Follow-up|1|||
27505233|NCT01550003|80044091|FG001|Overall Study|Lost to Follow-up|4|||
27505234|NCT01550003|80044092|FG002|Overall Study|Lost to Follow-up|8|||
27505235|NCT01550003|80044090|FG000|Overall Study|Consent withdrawn|2|||
27505236|NCT01550003|80044091|FG001|Overall Study|Consent withdrawn|11|||
27505237|NCT01550003|80044092|FG002|Overall Study|Consent withdrawn|23|||
27505238|NCT01550003|80044090|FG000|Overall Study|Missing|1|||
27505239|NCT01550003|80044091|FG001|Overall Study|Missing|0|||
27505240|NCT01550003|80044092|FG002|Overall Study|Missing|2|||
27505241|NCT01550003|80044090|FG000|Overall Study|Study closure as announced by sponsor|7|||
27505242|NCT01550003|80044091|FG001|Overall Study|Study closure as announced by sponsor|6|||
27847307|NCT01333072|81272068|FG000|Overall Study|Lost to Follow-up|3|||
27847308|NCT01333072|81272069|FG001|Overall Study|Lost to Follow-up|0|||
27847309|NCT01333072|81272068|FG000|Overall Study|Adverse Event|2|||
27847310|NCT01333072|81272069|FG001|Overall Study|Adverse Event|4|||
27847311|NCT01333072|81272068|FG000|Overall Study|Physician Decision|1|||
27847312|NCT01333072|81272069|FG001|Overall Study|Physician Decision|0|||
27847313|NCT03341000|81272070|FG000|Overall Study|Adverse Event|1|||
27505243|NCT01550003|80044092|FG002|Overall Study|Study closure as announced by sponsor|24|||
27847314|NCT02744755|81272073|FG000|Study Period 1|Protocol Violation|2|||
27847315|NCT02744755|81272074|FG001|Study Period 1|Protocol Violation|1|||
27847316|NCT02744755|81272073|FG000|Study Period 1|not defined|0|||
27847317|NCT02744755|81272074|FG001|Study Period 1|not defined|1|||
27847318|NCT02744755|81272073|FG000|Study Period 1|Pregnancy|1|||
27505244|NCT01550003|80044090|FG000|Overall Study|Protocol Noncompliance|1|||
27505245|NCT01550003|80044091|FG001|Overall Study|Protocol Noncompliance|0|||
27505246|NCT01550003|80044092|FG002|Overall Study|Protocol Noncompliance|0|||
27505247|NCT01550003|80044090|FG000|Overall Study|Study closure|0|||
27505248|NCT01550003|80044091|FG001|Overall Study|Study closure|1|||
27505249|NCT01550003|80044092|FG002|Overall Study|Study closure|1|||
27505250|NCT01550003|80044090|FG000|Overall Study|Patient reached adulthood|0|||
27505251|NCT01550003|80044091|FG001|Overall Study|Patient reached adulthood|1|||
27505252|NCT01550003|80044092|FG002|Overall Study|Patient reached adulthood|0|||
27505253|NCT01550003|80044090|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
27505254|NCT01550003|80044091|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
27505255|NCT01550003|80044092|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
27505256|NCT01550003|80044090|FG000|Overall Study|Sponsor's order|0|||
27505257|NCT01550003|80044091|FG001|Overall Study|Sponsor's order|3|||
27505258|NCT01550003|80044092|FG002|Overall Study|Sponsor's order|3|||
27505259|NCT01550003|80044090|FG000|Overall Study|Sponsor's decision|1|||
27505260|NCT01550003|80044091|FG001|Overall Study|Sponsor's decision|5|||
27505261|NCT01550003|80044092|FG002|Overall Study|Sponsor's decision|4|||
27505262|NCT01550003|80044090|FG000|Overall Study|Subject mother passed away|0|||
27505263|NCT01550003|80044091|FG001|Overall Study|Subject mother passed away|1|||
27505264|NCT01550003|80044092|FG002|Overall Study|Subject mother passed away|0|||
27505265|NCT01550003|80044090|FG000|Overall Study|Discontinuation|0|||
27505266|NCT01550003|80044091|FG001|Overall Study|Discontinuation|1|||
27505267|NCT01550003|80044092|FG002|Overall Study|Discontinuation|0|||
27505268|NCT01550003|80044090|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
27505269|NCT01550003|80044091|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
27505270|NCT01550003|80044092|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
27505271|NCT01550003|80044090|FG000|Overall Study|Site closure|0|||
27505272|NCT01550003|80044091|FG001|Overall Study|Site closure|2|||
27505273|NCT01550003|80044092|FG002|Overall Study|Site closure|0|||
27505274|NCT01550003|80044090|FG000|Overall Study|Pregnancy|0|||
27505275|NCT01550003|80044091|FG001|Overall Study|Pregnancy|1|||
27505276|NCT01550003|80044092|FG002|Overall Study|Pregnancy|0|||
27505277|NCT01550003|80044090|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
27505278|NCT01550003|80044091|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
27505279|NCT01550003|80044092|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
27505280|NCT01550003|80044090|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
27505281|NCT01550003|80044091|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
27505282|NCT01550003|80044092|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
27505283|NCT01550003|80044090|FG000|Overall Study|Switching to adult rheumatologist|0|||
27505284|NCT01550003|80044091|FG001|Overall Study|Switching to adult rheumatologist|0|||
27505285|NCT01550003|80044092|FG002|Overall Study|Switching to adult rheumatologist|1|||
27505286|NCT01550003|80044090|FG000|Overall Study|Patient transition to adult care|0|||
27505287|NCT01550003|80044091|FG001|Overall Study|Patient transition to adult care|0|||
27505288|NCT01550003|80044092|FG002|Overall Study|Patient transition to adult care|1|||
27505289|NCT01550003|80044090|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
27505290|NCT01550003|80044091|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
27505291|NCT01550003|80044092|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
27505292|NCT01550003|80044090|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
27505293|NCT01550003|80044091|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
27505294|NCT01550003|80044092|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
27505295|NCT01550003|80044090|FG000|Overall Study|Per Sponsor request|1|||
27505296|NCT01550003|80044091|FG001|Overall Study|Per Sponsor request|0|||
27505297|NCT01550003|80044092|FG002|Overall Study|Per Sponsor request|1|||
27505298|NCT01550003|80044090|FG000|Overall Study|Patient not compliance|0|||
27505299|NCT01550003|80044091|FG001|Overall Study|Patient not compliance|0|||
27505300|NCT01550003|80044092|FG002|Overall Study|Patient not compliance|1|||
27505301|NCT01550003|80044090|FG000|Overall Study|Non-compliance|0|||
27505302|NCT01550003|80044091|FG001|Overall Study|Non-compliance|0|||
27505303|NCT01550003|80044092|FG002|Overall Study|Non-compliance|1|||
27505304|NCT01550003|80044090|FG000|Overall Study|Study closed|0|||
27505305|NCT01550003|80044091|FG001|Overall Study|Study closed|1|||
27505306|NCT01550003|80044092|FG002|Overall Study|Study closed|0|||
27505307|NCT01550003|80044090|FG000|Overall Study|Transitioned to adult rheumatology|0|||
27505308|NCT01550003|80044091|FG001|Overall Study|Transitioned to adult rheumatology|0|||
27505309|NCT01550003|80044092|FG002|Overall Study|Transitioned to adult rheumatology|1|||
27505310|NCT00092417|80044093|FG000|Overall Study|Lost to Follow-up|2|||
27505311|NCT00092417|80044094|FG001|Overall Study|Lost to Follow-up|0|||
27505312|NCT00092417|80044093|FG000|Overall Study|Withdrawal by Subject|2|||
27613730|NCT02023879|80426768|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
27847319|NCT02744755|81272074|FG001|Study Period 1|Pregnancy|0|||
27505313|NCT00092417|80044094|FG001|Overall Study|Withdrawal by Subject|1|||
27847320|NCT02744755|81272073|FG000|Study Period 1|Adverse Event|1|||
27505314|NCT00092417|80044093|FG000|Overall Study|Other|1|||
27505315|NCT00092417|80044094|FG001|Overall Study|Other|0|||
27505316|NCT00632229|80044095|FG000|Overall Study|Adverse Event|6|||
27505317|NCT00632229|80044096|FG001|Overall Study|Adverse Event|0|||
27505318|NCT00632229|80044095|FG000|Overall Study|Lost to Follow-up|0|||
27505319|NCT00632229|80044096|FG001|Overall Study|Lost to Follow-up|3|||
27505320|NCT00632229|80044095|FG000|Overall Study|Lack of Efficacy|0|||
27505321|NCT00632229|80044096|FG001|Overall Study|Lack of Efficacy|2|||
27505322|NCT00632229|80044095|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
27505323|NCT00632229|80044096|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
27505324|NCT00656513|80044099|FG000|Overall Study|Protocol Violation|1|||
27505325|NCT00656513|80044100|FG001|Overall Study|Protocol Violation|0|||
27505326|NCT00656513|80044101|FG002|Overall Study|Protocol Violation|2|||
27505327|NCT00656513|80044099|FG000|Overall Study|Withdrawal by Subject|0|||
27505328|NCT00656513|80044100|FG001|Overall Study|Withdrawal by Subject|11|||
27505329|NCT00656513|80044101|FG002|Overall Study|Withdrawal by Subject|4|||
27505330|NCT00656513|80044099|FG000|Overall Study|Death|0|||
27505331|NCT00656513|80044100|FG001|Overall Study|Death|0|||
27505332|NCT00656513|80044101|FG002|Overall Study|Death|1|||
27505333|NCT00656513|80044099|FG000|Overall Study|Missing data|0|||
27505334|NCT00656513|80044100|FG001|Overall Study|Missing data|11|||
27505335|NCT00656513|80044101|FG002|Overall Study|Missing data|9|||
27505336|NCT00656513|80044099|FG000|Overall Study|Incomplete treatment|3|||
27505337|NCT00656513|80044100|FG001|Overall Study|Incomplete treatment|0|||
27505338|NCT00656513|80044101|FG002|Overall Study|Incomplete treatment|0|||
27505339|NCT00656513|80044099|FG000|Overall Study|Treatment completed outside of timeframe|0|||
27505340|NCT00656513|80044100|FG001|Overall Study|Treatment completed outside of timeframe|3|||
27505341|NCT00656513|80044101|FG002|Overall Study|Treatment completed outside of timeframe|1|||
27505342|NCT00656513|80044099|FG000|Overall Study|Missing baseline form|0|||
27505343|NCT00656513|80044100|FG001|Overall Study|Missing baseline form|5|||
27505344|NCT00656513|80044101|FG002|Overall Study|Missing baseline form|5|||
27505345|NCT05786651|80044102|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
27505346|NCT03096288|80044105|FG000|Overall Study|Withdrawal by Subject|0|||
27505347|NCT03096288|80044106|FG001|Overall Study|Withdrawal by Subject|1|||
27505348|NCT03096288|80044107|FG002|Overall Study|Withdrawal by Subject|0|||
27505349|NCT03096288|80044108|FG003|Overall Study|Withdrawal by Subject|1|||
27505350|NCT02703597|80044109|FG000|Assignment to Baseline|Lost to Follow-up|17|||
27505351|NCT02703597|80044110|FG001|Assignment to Baseline|Lost to Follow-up|16|||
27505352|NCT02703597|80044109|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
27505353|NCT02703597|80044110|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
27505354|NCT02703597|80044109|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
27505355|NCT02703597|80044110|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
27505356|NCT02703597|80044109|FG000|First Post-test to First Follow-up|Site drop out|0|||
27505357|NCT02703597|80044110|FG001|First Post-test to First Follow-up|Site drop out|58|||
27505358|NCT02703597|80044109|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
27505359|NCT02703597|80044110|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
27505360|NCT02703597|80044109|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
27505361|NCT02703597|80044110|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
27505362|NCT02703597|80044109|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
27505363|NCT02703597|80044110|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
27847321|NCT02744755|81272074|FG001|Study Period 1|Adverse Event|1|||
27847322|NCT02744755|81272073|FG000|Study Period 1|Lost to Follow-up|1|||
27847323|NCT02744755|81272074|FG001|Study Period 1|Lost to Follow-up|1|||
27847324|NCT02744755|81272073|FG000|Study Period 1|Lack of Efficacy|1|||
27505364|NCT00124943|80044111|FG000|Phase II|Adverse Event|0|||
27505365|NCT00124943|80044112|FG001|Phase II|Adverse Event|2|||
27505366|NCT00124943|80044113|FG002|Phase II|Adverse Event|0|||
27505367|NCT00124943|80044114|FG003|Phase II|Adverse Event|1|||
27505368|NCT00124943|80044111|FG000|Phase II|Protocol Violation|0|||
27847325|NCT02744755|81272074|FG001|Study Period 1|Lack of Efficacy|0|||
27505369|NCT00124943|80044112|FG001|Phase II|Protocol Violation|0|||
27505370|NCT00124943|80044113|FG002|Phase II|Protocol Violation|0|||
27847326|NCT02744755|81272073|FG000|Study Period 1|Withdrawal by Subject|8|||
27847327|NCT02744755|81272074|FG001|Study Period 1|Withdrawal by Subject|4|||
27847328|NCT02744755|81272073|FG000|Study Period 2|Adverse Event|5|||
27847329|NCT02744755|81272074|FG001|Study Period 2|Adverse Event|0|||
27847330|NCT02744755|81272073|FG000|Study Period 2|Protocol Violation|1|||
27505371|NCT00124943|80044114|FG003|Phase II|Protocol Violation|1|||
27505372|NCT00124943|80044111|FG000|Phase II|Lost to Follow-up|0|||
27505373|NCT00124943|80044112|FG001|Phase II|Lost to Follow-up|0|||
27613731|NCT02023879|80426766|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
27613732|NCT02023879|80426767|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
27847331|NCT02744755|81272074|FG001|Study Period 2|Protocol Violation|0|||
27847332|NCT02744755|81272073|FG000|Study Period 2|not defined|3|||
27847333|NCT02744755|81272074|FG001|Study Period 2|not defined|2|||
27847334|NCT02744755|81272073|FG000|Study Period 2|Lost to Follow-up|0|||
27847335|NCT02744755|81272074|FG001|Study Period 2|Lost to Follow-up|2|||
27847336|NCT02744755|81272073|FG000|Study Period 2|Withdrawal by Subject|2|||
27847337|NCT02744755|81272074|FG001|Study Period 2|Withdrawal by Subject|2|||
27847338|NCT02744755|81272073|FG000|Study Period 2|Lack of Efficacy|3|||
27847339|NCT02744755|81272074|FG001|Study Period 2|Lack of Efficacy|2|||
27847340|NCT02619682|81272075|FG000|Overall Study|Withdrawal by Subject|3|||
27847341|NCT02619682|81272075|FG000|Overall Study|Lack of Efficacy|8|||
27847342|NCT02619682|81272075|FG000|Overall Study|new secondary cancer|1|||
27847343|NCT02619682|81272075|FG000|Overall Study|post surgery complications|2|||
27847344|NCT02315066|81272076|FG000|Overall Study|Lost to Follow-up|0|||
27847345|NCT02315066|81272077|FG001|Overall Study|Lost to Follow-up|1|||
27847346|NCT02315066|81272078|FG002|Overall Study|Lost to Follow-up|1|||
27847347|NCT02315066|81272079|FG003|Overall Study|Lost to Follow-up|0|||
27847348|NCT02315066|81272080|FG004|Overall Study|Lost to Follow-up|1|||
27847349|NCT02315066|81272081|FG005|Overall Study|Lost to Follow-up|0|||
27847350|NCT02315066|81272082|FG006|Overall Study|Lost to Follow-up|2|||
27847351|NCT02315066|81272083|FG007|Overall Study|Lost to Follow-up|1|||
27847352|NCT02315066|81272084|FG008|Overall Study|Lost to Follow-up|0|||
27847353|NCT02315066|81272085|FG009|Overall Study|Lost to Follow-up|0|||
27847354|NCT02315066|81272086|FG010|Overall Study|Lost to Follow-up|1|||
27847355|NCT02315066|81272087|FG011|Overall Study|Lost to Follow-up|2|||
27847356|NCT02315066|81272088|FG012|Overall Study|Lost to Follow-up|0|||
27847357|NCT02315066|81272089|FG013|Overall Study|Lost to Follow-up|4|||
27847358|NCT02315066|81272076|FG000|Overall Study|Death|2|||
27847359|NCT02315066|81272077|FG001|Overall Study|Death|7|||
27847360|NCT02315066|81272078|FG002|Overall Study|Death|6|||
27847361|NCT02315066|81272079|FG003|Overall Study|Death|11|||
27847362|NCT02315066|81272080|FG004|Overall Study|Death|10|||
27847363|NCT02315066|81272081|FG005|Overall Study|Death|3|||
27847364|NCT02315066|81272082|FG006|Overall Study|Death|9|||
27847365|NCT02315066|81272083|FG007|Overall Study|Death|9|||
27847366|NCT02315066|81272084|FG008|Overall Study|Death|10|||
27847367|NCT02315066|81272085|FG009|Overall Study|Death|8|||
27847368|NCT02315066|81272086|FG010|Overall Study|Death|10|||
27847369|NCT02315066|81272087|FG011|Overall Study|Death|7|||
27847370|NCT02315066|81272088|FG012|Overall Study|Death|8|||
27847371|NCT02315066|81272089|FG013|Overall Study|Death|21|||
27847372|NCT02315066|81272076|FG000|Overall Study|Other|0|||
27613733|NCT02023879|80426768|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
27613734|NCT02023879|80426766|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
27613735|NCT02023879|80426767|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
27613736|NCT02023879|80426768|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
27613737|NCT02023879|80426766|FG000|Extension Open Label Treatment|Adverse Event|1|||
27613738|NCT02023879|80426767|FG001|Extension Open Label Treatment|Adverse Event|7|||
27613739|NCT02023879|80426768|FG002|Extension Open Label Treatment|Adverse Event|3|||
27613740|NCT02023879|80426766|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
27613741|NCT02023879|80426767|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
27613742|NCT02023879|80426768|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
27613743|NCT02023879|80426766|FG000|Extension Open Label Treatment|Participant moved|1|||
27613744|NCT02023879|80426767|FG001|Extension Open Label Treatment|Participant moved|2|||
27847373|NCT02315066|81272077|FG001|Overall Study|Other|0|||
27847374|NCT02315066|81272078|FG002|Overall Study|Other|0|||
27847375|NCT02315066|81272079|FG003|Overall Study|Other|0|||
27847376|NCT02315066|81272080|FG004|Overall Study|Other|0|||
27847377|NCT02315066|81272081|FG005|Overall Study|Other|0|||
27847378|NCT02315066|81272082|FG006|Overall Study|Other|0|||
27847379|NCT02315066|81272083|FG007|Overall Study|Other|1|||
27847380|NCT02315066|81272084|FG008|Overall Study|Other|1|||
27613745|NCT02023879|80426768|FG002|Extension Open Label Treatment|Participant moved|0|||
27613746|NCT02023879|80426766|FG000|Extension Open Label Treatment|Other than specified above|2|||
27847381|NCT02315066|81272085|FG009|Overall Study|Other|2|||
27847382|NCT02315066|81272086|FG010|Overall Study|Other|0|||
27847383|NCT02315066|81272087|FG011|Overall Study|Other|0|||
27847384|NCT02315066|81272088|FG012|Overall Study|Other|0|||
27847385|NCT02315066|81272089|FG013|Overall Study|Other|0|||
27847386|NCT02315066|81272076|FG000|Overall Study|Subject refused further follow-up|0|||
27847387|NCT02315066|81272077|FG001|Overall Study|Subject refused further follow-up|2|||
27847388|NCT02315066|81272078|FG002|Overall Study|Subject refused further follow-up|2|||
27847389|NCT02315066|81272079|FG003|Overall Study|Subject refused further follow-up|0|||
27847390|NCT02315066|81272080|FG004|Overall Study|Subject refused further follow-up|0|||
27847391|NCT02315066|81272081|FG005|Overall Study|Subject refused further follow-up|0|||
27847392|NCT02315066|81272082|FG006|Overall Study|Subject refused further follow-up|2|||
27847393|NCT02315066|81272083|FG007|Overall Study|Subject refused further follow-up|3|||
27847394|NCT02315066|81272084|FG008|Overall Study|Subject refused further follow-up|0|||
27847395|NCT02315066|81272085|FG009|Overall Study|Subject refused further follow-up|1|||
27726228|NCT02901431|80826779|FG001|Open Label Part|Physician Decision|0|||
27726229|NCT02901431|80826780|FG002|Open Label Part|Physician Decision|0|||
27726230|NCT02901431|80826781|FG003|Open Label Part|Physician Decision|0|||
27726231|NCT02901431|80826782|FG004|Open Label Part|Physician Decision|0|||
27726232|NCT02901431|80826783|FG005|Open Label Part|Physician Decision|0|||
27726233|NCT02901431|80826784|FG006|Open Label Part|Physician Decision|0|||
27726234|NCT02901431|80826785|FG007|Open Label Part|Physician Decision|0|||
27726235|NCT02901431|80826786|FG008|Open Label Part|Physician Decision|1|||
27726236|NCT02901431|80826787|FG009|Open Label Part|Physician Decision|1|||
27726237|NCT02901431|80826788|FG010|Open Label Part|Physician Decision|0|||
27726238|NCT02901431|80826789|FG011|Open Label Part|Physician Decision|0|||
27726239|NCT02901431|80826790|FG012|Open Label Part|Physician Decision|0|||
27726240|NCT02901431|80826778|FG000|Open Label Part|Study Terminated By Sponsor|0|||
27726241|NCT02901431|80826779|FG001|Open Label Part|Study Terminated By Sponsor|0|||
27726242|NCT02901431|80826780|FG002|Open Label Part|Study Terminated By Sponsor|0|||
27726243|NCT02901431|80826781|FG003|Open Label Part|Study Terminated By Sponsor|0|||
27726244|NCT02901431|80826782|FG004|Open Label Part|Study Terminated By Sponsor|0|||
27726245|NCT02901431|80826783|FG005|Open Label Part|Study Terminated By Sponsor|0|||
27726246|NCT02901431|80826784|FG006|Open Label Part|Study Terminated By Sponsor|0|||
27726247|NCT02901431|80826785|FG007|Open Label Part|Study Terminated By Sponsor|0|||
27726248|NCT02901431|80826786|FG008|Open Label Part|Study Terminated By Sponsor|35|||
27726249|NCT02901431|80826787|FG009|Open Label Part|Study Terminated By Sponsor|12|||
27726250|NCT02901431|80826788|FG010|Open Label Part|Study Terminated By Sponsor|21|||
27726251|NCT02901431|80826789|FG011|Open Label Part|Study Terminated By Sponsor|31|||
27726252|NCT02901431|80826790|FG012|Open Label Part|Study Terminated By Sponsor|0|||
27726253|NCT02901431|80826778|FG000|Open Label Part|Withdrawal by Subject|0|||
27726254|NCT02901431|80826779|FG001|Open Label Part|Withdrawal by Subject|0|||
27726255|NCT02901431|80826780|FG002|Open Label Part|Withdrawal by Subject|0|||
27726256|NCT02901431|80826781|FG003|Open Label Part|Withdrawal by Subject|0|||
27726257|NCT02901431|80826782|FG004|Open Label Part|Withdrawal by Subject|0|||
27726258|NCT02901431|80826783|FG005|Open Label Part|Withdrawal by Subject|0|||
27726259|NCT02901431|80826784|FG006|Open Label Part|Withdrawal by Subject|0|||
27726260|NCT02901431|80826785|FG007|Open Label Part|Withdrawal by Subject|0|||
27726261|NCT02901431|80826786|FG008|Open Label Part|Withdrawal by Subject|6|||
27726262|NCT02901431|80826787|FG009|Open Label Part|Withdrawal by Subject|5|||
27726263|NCT02901431|80826788|FG010|Open Label Part|Withdrawal by Subject|7|||
27726264|NCT02901431|80826789|FG011|Open Label Part|Withdrawal by Subject|3|||
27726265|NCT02901431|80826790|FG012|Open Label Part|Withdrawal by Subject|1|||
27726266|NCT02494596|80826791|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27726267|NCT02494596|80826792|FG001|Overall Study|Insufficient Therapeutic Response|3|||
27726268|NCT02494596|80826793|FG002|Overall Study|Insufficient Therapeutic Response|1|||
27726269|NCT02494596|80826791|FG000|Overall Study|Adverse Event|0|||
27726270|NCT02494596|80826792|FG001|Overall Study|Adverse Event|1|||
27726271|NCT02494596|80826793|FG002|Overall Study|Adverse Event|0|||
27726272|NCT02494596|80826791|FG000|Overall Study|Refused Treatment|0|||
27726273|NCT02494596|80826792|FG001|Overall Study|Refused Treatment|1|||
27726274|NCT02494596|80826793|FG002|Overall Study|Refused Treatment|0|||
27726275|NCT02320487|80826794|FG000|Overall Study|Reason not Specified|1|||
27726276|NCT02320487|80826794|FG000|Overall Study|Physician Decision|5|||
27726277|NCT02320487|80826794|FG000|Overall Study|Withdrawal by Subject|1|||
27726278|NCT02320487|80826794|FG000|Overall Study|Death|3|||
27726279|NCT02320487|80826794|FG000|Overall Study|Adverse Event|11|||
27726280|NCT00556426|80826795|FG000|Overall Study|Withdrawal by Subject|3|||
27726281|NCT00556426|80826795|FG000|Overall Study|Death|6|||
27726282|NCT01777763|80826796|FG000|Overall Study|Adverse Event|2|||
27726283|NCT01777763|80826797|FG001|Overall Study|Adverse Event|32|||
27726284|NCT01777763|80826796|FG000|Overall Study|Protocol Violation|1|||
27726285|NCT01777763|80826797|FG001|Overall Study|Protocol Violation|7|||
27726286|NCT01777763|80826796|FG000|Overall Study|Withdrawal by Subject|0|||
27726287|NCT01777763|80826797|FG001|Overall Study|Withdrawal by Subject|2|||
27726288|NCT01777763|80826796|FG000|Overall Study|Treatment Failure|1|||
27726289|NCT01777763|80826797|FG001|Overall Study|Treatment Failure|6|||
27726290|NCT00699348|80826799|FG000|Overall Study|Death|6|||
27613747|NCT02023879|80426767|FG001|Extension Open Label Treatment|Other than specified above|7|||
27726291|NCT00699348|80826799|FG000|Overall Study|Adverse Event|15|||
27847396|NCT02315066|81272086|FG010|Overall Study|Subject refused further follow-up|1|||
27726292|NCT00699348|80826799|FG000|Overall Study|Withdrawal by Subject|11|||
27726293|NCT00699348|80826799|FG000|Overall Study|Protocol Violation|10|||
27726294|NCT00699348|80826799|FG000|Overall Study|Lack of Efficacy|8|||
27726295|NCT00699348|80826799|FG000|Overall Study|Failure to return|1|||
27613748|NCT02023879|80426768|FG002|Extension Open Label Treatment|Other than specified above|2|||
27726296|NCT00699348|80826799|FG000|Overall Study|Blood transfusion|24|||
27726297|NCT00699348|80826799|FG000|Overall Study|Renal transplantation|10|||
27726298|NCT00699348|80826799|FG000|Overall Study|Other|5|||
27613749|NCT01003184|80426769|FG000|Overall Study|Adverse Event|12|||
27726299|NCT04451330|80826800|FG000|Overall Study|Adverse Event|1|||
27505374|NCT00124943|80044113|FG002|Phase II|Lost to Follow-up|0|||
27505375|NCT00124943|80044114|FG003|Phase II|Lost to Follow-up|1|||
27505376|NCT00124943|80044111|FG000|Phase II|Withdrawal by Subject|0|||
27505377|NCT00124943|80044112|FG001|Phase II|Withdrawal by Subject|0|||
27505378|NCT00124943|80044113|FG002|Phase II|Withdrawal by Subject|0|||
27505379|NCT00124943|80044114|FG003|Phase II|Withdrawal by Subject|2|||
27505380|NCT03405792|80044119|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
27505381|NCT03405792|80044120|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
27505382|NCT03405792|80044119|FG000|Overall Study|o Did not receive pembrolizumab|1|||
27505383|NCT03405792|80044120|FG001|Overall Study|o Did not receive pembrolizumab|0|||
27726300|NCT04451330|80826801|FG001|Overall Study|Adverse Event|2|||
27894118|NCT02407457|81447310|FG000|6-Month|Death|2|||
27894119|NCT02407457|81447311|FG001|6-Month|Death|8|||
27894120|NCT02407457|81447310|FG000|6-Month|Lost to Follow-up|2|||
27894121|NCT02407457|81447311|FG001|6-Month|Lost to Follow-up|2|||
27894122|NCT02407457|81447310|FG000|6-Month|missed visit|16|||
27894123|NCT02407457|81447311|FG001|6-Month|missed visit|14|||
27894124|NCT02407457|81447310|FG000|6-Month|Open Repair|0|||
27894125|NCT02407457|81447311|FG001|6-Month|Open Repair|1|||
27894126|NCT02407457|81447310|FG000|1 Year|Death|6|||
27894127|NCT02407457|81447311|FG001|1 Year|Death|11|||
27894128|NCT02407457|81447310|FG000|1 Year|Lost to Follow-up|3|||
27894129|NCT02407457|81447311|FG001|1 Year|Lost to Follow-up|2|||
27894130|NCT02407457|81447310|FG000|1 Year|Missed Visit|24|||
27894131|NCT02407457|81447311|FG001|1 Year|Missed Visit|14|||
27894132|NCT02407457|81447310|FG000|1 Year|Open Repair|0|||
27894133|NCT02407457|81447311|FG001|1 Year|Open Repair|1|||
27894134|NCT02407457|81447310|FG000|2-year|Death|14|||
27894135|NCT02407457|81447311|FG001|2-year|Death|8|||
27894136|NCT02407457|81447310|FG000|2-year|Lost to Follow-up|7|||
27894137|NCT02407457|81447311|FG001|2-year|Lost to Follow-up|10|||
27847397|NCT02315066|81272087|FG011|Overall Study|Subject refused further follow-up|2|||
27847398|NCT02315066|81272088|FG012|Overall Study|Subject refused further follow-up|2|||
27847399|NCT02315066|81272089|FG013|Overall Study|Subject refused further follow-up|4|||
27847400|NCT02315066|81272076|FG000|Overall Study|Study ongoing at date of cut-off|0|||
27847401|NCT02315066|81272077|FG001|Overall Study|Study ongoing at date of cut-off|0|||
27847402|NCT02315066|81272078|FG002|Overall Study|Study ongoing at date of cut-off|0|||
27847403|NCT02315066|81272079|FG003|Overall Study|Study ongoing at date of cut-off|0|||
27847404|NCT02315066|81272080|FG004|Overall Study|Study ongoing at date of cut-off|0|||
27847405|NCT02315066|81272081|FG005|Overall Study|Study ongoing at date of cut-off|0|||
27847406|NCT02315066|81272082|FG006|Overall Study|Study ongoing at date of cut-off|0|||
27894138|NCT02407457|81447310|FG000|2-year|Missed Visit|13|||
27894139|NCT02407457|81447311|FG001|2-year|Missed Visit|15|||
27894140|NCT02407457|81447310|FG000|2-year|Open Repair|0|||
27894141|NCT02407457|81447311|FG001|2-year|Open Repair|2|||
27894142|NCT02407457|81447310|FG000|3-year|Death|11|||
27894143|NCT02407457|81447311|FG001|3-year|Death|10|||
27847407|NCT02315066|81272083|FG007|Overall Study|Study ongoing at date of cut-off|0|||
27726301|NCT04451330|80826800|FG000|Overall Study|Lost to Follow-up|5|||
27726302|NCT04451330|80826801|FG001|Overall Study|Lost to Follow-up|0|||
27726303|NCT04451330|80826800|FG000|Overall Study|Withdrawal by Subject|3|||
27847408|NCT02315066|81272084|FG008|Overall Study|Study ongoing at date of cut-off|0|||
27847409|NCT02315066|81272085|FG009|Overall Study|Study ongoing at date of cut-off|0|||
27847410|NCT02315066|81272086|FG010|Overall Study|Study ongoing at date of cut-off|0|||
27847411|NCT02315066|81272087|FG011|Overall Study|Study ongoing at date of cut-off|0|||
27847412|NCT02315066|81272088|FG012|Overall Study|Study ongoing at date of cut-off|0|||
27847413|NCT02315066|81272089|FG013|Overall Study|Study ongoing at date of cut-off|1|||
27847414|NCT00890552|81272090|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
27847415|NCT00890552|81272090|FG000|On-treatment|Early prog disease/ death|10|||
27847416|NCT00949988|81272100|FG000|Overall Study|Withdrawal by Subject|3|||
27847417|NCT01049412|81272105|FG000|Period I|Withdrawal by Subject|4|||
27847418|NCT01049412|81272106|FG001|Period I|Withdrawal by Subject|6|||
27847419|NCT01049412|81272105|FG000|Period I|Lost to Follow-up|2|||
27847420|NCT01049412|81272106|FG001|Period I|Lost to Follow-up|2|||
27847421|NCT01049412|81272105|FG000|Period I|Physician Decision|0|||
27847422|NCT01049412|81272106|FG001|Period I|Physician Decision|3|||
27894144|NCT02407457|81447310|FG000|3-year|Lost to Follow-up|9|||
27894145|NCT02407457|81447311|FG001|3-year|Lost to Follow-up|10|||
27894146|NCT02407457|81447310|FG000|3-year|Missed Visit|19|||
27894147|NCT02407457|81447311|FG001|3-year|Missed Visit|16|||
27894148|NCT02407457|81447310|FG000|4-year|Death|18|||
27894149|NCT02407457|81447311|FG001|4-year|Death|10|||
27847423|NCT01049412|81272105|FG000|Period I|Protocol Violation|1|||
27894150|NCT02407457|81447310|FG000|4-year|Lost to Follow-up|10|||
27847424|NCT01049412|81272106|FG001|Period I|Protocol Violation|2|||
27894151|NCT02407457|81447311|FG001|4-year|Lost to Follow-up|12|||
27894152|NCT02407457|81447310|FG000|4-year|Missed Visit|18|||
27894153|NCT02407457|81447311|FG001|4-year|Missed Visit|16|||
27894154|NCT02407457|81447310|FG000|5-year|Death|10|||
27894155|NCT02407457|81447311|FG001|5-year|Death|3|||
27847425|NCT01049412|81272105|FG000|Period I|Adverse Event|1|||
27847426|NCT01049412|81272106|FG001|Period I|Adverse Event|0|||
27847427|NCT01049412|81272105|FG000|Period II|Withdrawal by Subject|2|||
27847428|NCT01049412|81272106|FG001|Period II|Withdrawal by Subject|3|||
27847429|NCT01049412|81272105|FG000|Period II|Adverse Event|1|||
27847430|NCT01049412|81272106|FG001|Period II|Adverse Event|0|||
27847431|NCT01049412|81272105|FG000|Period II|Lost to Follow-up|1|||
27847432|NCT01049412|81272106|FG001|Period II|Lost to Follow-up|0|||
27847433|NCT01682148|81272107|FG000|Overall Study|Withdrawal by Subject|2|||
27847434|NCT01682148|81272108|FG001|Overall Study|Withdrawal by Subject|0|||
27847435|NCT01682148|81272107|FG000|Overall Study|Lost to Follow-up|1|||
27847436|NCT01682148|81272108|FG001|Overall Study|Lost to Follow-up|2|||
27847437|NCT01682148|81272107|FG000|Overall Study|Protocol Violation|1|||
27847438|NCT01682148|81272108|FG001|Overall Study|Protocol Violation|1|||
27847439|NCT01546649|81272109|FG000|Overall Study|Adverse Event|4|||
27847440|NCT01546649|81272110|FG001|Overall Study|Adverse Event|5|||
27847441|NCT01546649|81272109|FG000|Overall Study|Protocol Violation|1|||
27847442|NCT01546649|81272110|FG001|Overall Study|Protocol Violation|0|||
27847443|NCT01546649|81272109|FG000|Overall Study|Lack of Efficacy|1|||
27847444|NCT01546649|81272110|FG001|Overall Study|Lack of Efficacy|0|||
27847445|NCT01546649|81272109|FG000|Overall Study|Recurrence|1|||
27847446|NCT01546649|81272110|FG001|Overall Study|Recurrence|1|||
27847447|NCT01546649|81272109|FG000|Overall Study|Discovery of secondary cancer|0|||
27847448|NCT01546649|81272110|FG001|Overall Study|Discovery of secondary cancer|1|||
27847449|NCT01546649|81272109|FG000|Overall Study|Withdrawal by Subject|1|||
27847450|NCT01546649|81272110|FG001|Overall Study|Withdrawal by Subject|2|||
27847451|NCT01131299|81272115|FG000|Overall Study|Withdrawal by Subject|4|||
27847452|NCT01131299|81272116|FG001|Overall Study|Withdrawal by Subject|7|||
27847453|NCT00824369|81272119|FG000|Overall Study|Nolonger willing to participate in study|1|||
27847454|NCT00824369|81272120|FG001|Overall Study|Nolonger willing to participate in study|0|||
27894156|NCT02407457|81447310|FG000|5-year|Lost to Follow-up|22|||
27894157|NCT02407457|81447311|FG001|5-year|Lost to Follow-up|13|||
27894158|NCT02407457|81447310|FG000|5-year|Missed Visit|9|||
27894159|NCT02407457|81447311|FG001|5-year|Missed Visit|1|||
27894160|NCT02889835|81447312|FG000|Overall Study|Lost to Follow-up|13|||
27894161|NCT02889835|81447313|FG001|Overall Study|Lost to Follow-up|13|||
27894162|NCT02889835|81447314|FG002|Overall Study|Lost to Follow-up|13|||
27894163|NCT02889835|81447312|FG000|Overall Study|Withdrawal by Subject|2|||
27894164|NCT02889835|81447313|FG001|Overall Study|Withdrawal by Subject|2|||
27894165|NCT02889835|81447314|FG002|Overall Study|Withdrawal by Subject|2|||
27894166|NCT02889835|81447312|FG000|Overall Study|Protocol Violation|1|||
27894167|NCT02889835|81447313|FG001|Overall Study|Protocol Violation|1|||
27894168|NCT02889835|81447314|FG002|Overall Study|Protocol Violation|1|||
27894169|NCT02889835|81447312|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
27894170|NCT02889835|81447313|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
27894171|NCT02889835|81447314|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
27894172|NCT02889835|81447312|FG000|Overall Study|Death|1|||
27894173|NCT02889835|81447313|FG001|Overall Study|Death|1|||
27894174|NCT02889835|81447314|FG002|Overall Study|Death|1|||
27894175|NCT03614078|81447315|FG000|Overall Study|Withdrawal by Subject|2|||
27894176|NCT03614078|81447316|FG001|Overall Study|Withdrawal by Subject|2|||
27894177|NCT03614078|81447317|FG002|Overall Study|Withdrawal by Subject|3|||
27894178|NCT03614078|81447315|FG000|Overall Study|Participant Did Not Return for Visit|0|||
27894179|NCT03614078|81447316|FG001|Overall Study|Participant Did Not Return for Visit|1|||
27894180|NCT03614078|81447317|FG002|Overall Study|Participant Did Not Return for Visit|0|||
27894181|NCT03614078|81447315|FG000|Overall Study|High Neutrophils|0|||
27894182|NCT03614078|81447316|FG001|Overall Study|High Neutrophils|0|||
27894183|NCT03614078|81447317|FG002|Overall Study|High Neutrophils|2|||
27894184|NCT03614078|81447315|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
27894185|NCT03614078|81447316|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
27847455|NCT00824369|81272121|FG002|Overall Study|Nolonger willing to participate in study|1|||
27847456|NCT00824369|81272122|FG003|Overall Study|Nolonger willing to participate in study|2|||
27847457|NCT00824369|81272123|FG004|Overall Study|Nolonger willing to participate in study|0|||
27847458|NCT00824369|81272124|FG005|Overall Study|Nolonger willing to participate in study|1|||
27894186|NCT03614078|81447317|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
27894187|NCT03614078|81447315|FG000|Overall Study|Exacerbation of Psoriasis|0|||
27894188|NCT03614078|81447316|FG001|Overall Study|Exacerbation of Psoriasis|1|||
27894189|NCT03614078|81447317|FG002|Overall Study|Exacerbation of Psoriasis|0|||
27505384|NCT00423579|80044121|FG000|Overall Study|Lost to Follow-up|3|||
27847459|NCT00824369|81272119|FG000|Overall Study|Lost to Follow-up|0|||
27847460|NCT00824369|81272120|FG001|Overall Study|Lost to Follow-up|0|||
27847461|NCT00824369|81272121|FG002|Overall Study|Lost to Follow-up|0|||
27847462|NCT00824369|81272122|FG003|Overall Study|Lost to Follow-up|0|||
27847463|NCT00824369|81272123|FG004|Overall Study|Lost to Follow-up|1|||
27847464|NCT00824369|81272124|FG005|Overall Study|Lost to Follow-up|0|||
27847465|NCT01302847|81272125|FG000|Overall Study|Ongoing|0|||
27847466|NCT01302847|81272126|FG001|Overall Study|Ongoing|0|||
27726304|NCT04451330|80826801|FG001|Overall Study|Withdrawal by Subject|1|||
27726305|NCT04451330|80826800|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27726306|NCT04451330|80826801|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27726307|NCT04451330|80826800|FG000|Overall Study|Other than specified|0|||
27726308|NCT04451330|80826801|FG001|Overall Study|Other than specified|1|||
27726309|NCT04373460|80826802|FG000|Overall Study|Did not receive tranfusion|18|||
27726310|NCT04373460|80826803|FG001|Overall Study|Did not receive tranfusion|26|||
27726311|NCT00214461|80826804|FG000|Overall Study|Adverse Event|0|||
27726312|NCT00214461|80826805|FG001|Overall Study|Adverse Event|0|||
27726313|NCT00214461|80826806|FG002|Overall Study|Adverse Event|1|||
27726314|NCT00214461|80826807|FG003|Overall Study|Adverse Event|1|||
27726315|NCT00214461|80826804|FG000|Overall Study|Withdrawal by Subject|0|||
27726316|NCT00214461|80826805|FG001|Overall Study|Withdrawal by Subject|0|||
27726317|NCT00214461|80826806|FG002|Overall Study|Withdrawal by Subject|1|||
27726318|NCT00214461|80826807|FG003|Overall Study|Withdrawal by Subject|0|||
27726319|NCT02266433|80826812|FG000|Overall Study|Lost to Follow-up|54|||
27726320|NCT02266433|80826813|FG001|Overall Study|Lost to Follow-up|46|||
27726321|NCT02266433|80826812|FG000|Overall Study|Withdrawal by Subject|5|||
27726322|NCT02266433|80826813|FG001|Overall Study|Withdrawal by Subject|7|||
27726323|NCT01256177|80826814|FG000|Overall Study|Withdrawal by Subject|23|||
27726324|NCT01256177|80826815|FG001|Overall Study|Withdrawal by Subject|22|||
27726325|NCT01256177|80826814|FG000|Overall Study|Lost to Follow-up|2|||
27726326|NCT01256177|80826815|FG001|Overall Study|Lost to Follow-up|2|||
27726327|NCT01256177|80826814|FG000|Overall Study|Adverse Event|8|||
27726328|NCT01256177|80826815|FG001|Overall Study|Adverse Event|9|||
27726329|NCT01256177|80826814|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
27726330|NCT01256177|80826815|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27726331|NCT01256177|80826814|FG000|Overall Study|Condition under Investigation Worsened|1|||
27726332|NCT01256177|80826815|FG001|Overall Study|Condition under Investigation Worsened|0|||
27726333|NCT01256177|80826814|FG000|Overall Study|Lack of Efficacy|11|||
27726334|NCT01256177|80826815|FG001|Overall Study|Lack of Efficacy|2|||
27726335|NCT01256177|80826814|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
27726336|NCT01256177|80826815|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
27726337|NCT00200850|80826827|FG000|Overall Study|relocation|1|||
27726338|NCT00200850|80826828|FG001|Overall Study|relocation|0|||
27726339|NCT00200850|80826829|FG002|Overall Study|relocation|1|||
27726340|NCT00200850|80826827|FG000|Overall Study|too busy|1|||
27726341|NCT00200850|80826828|FG001|Overall Study|too busy|0|||
27726342|NCT00200850|80826829|FG002|Overall Study|too busy|0|||
27726343|NCT00200850|80826827|FG000|Overall Study|Pregnancy|0|||
27726344|NCT00200850|80826828|FG001|Overall Study|Pregnancy|0|||
27726345|NCT00200850|80826829|FG002|Overall Study|Pregnancy|1|||
27726346|NCT00200850|80826827|FG000|Overall Study|Poor adherence|0|||
27726347|NCT00200850|80826828|FG001|Overall Study|Poor adherence|0|||
27726348|NCT00200850|80826829|FG002|Overall Study|Poor adherence|1|||
27726349|NCT00200850|80826827|FG000|Overall Study|optic neuritis|0|||
27726350|NCT00200850|80826828|FG001|Overall Study|optic neuritis|0|||
27726351|NCT00200850|80826829|FG002|Overall Study|optic neuritis|1|||
27726352|NCT00200850|80826827|FG000|Overall Study|Adverse Event|1|||
27726353|NCT00200850|80826828|FG001|Overall Study|Adverse Event|1|||
27726354|NCT00200850|80826829|FG002|Overall Study|Adverse Event|2|||
27726355|NCT00709956|80830040|FG000|Overall Study|Withdrawal by Subject|1|||
27726356|NCT00709956|80830041|FG001|Overall Study|Withdrawal by Subject|1|||
27726357|NCT00709956|80830040|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
27726358|NCT00709956|80830041|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
27726359|NCT02400255|80830044|FG000|Overall Study|Relapse|4|||
27726360|NCT02400255|80830045|FG001|Overall Study|Relapse|1|||
27726361|NCT02400255|80830046|FG002|Overall Study|Relapse|1|||
27726362|NCT02400255|80830047|FG003|Overall Study|Relapse|2|||
27726363|NCT02400255|80830044|FG000|Overall Study|Adverse Event|6|||
27726364|NCT02400255|80830045|FG001|Overall Study|Adverse Event|3|||
27726365|NCT02400255|80830046|FG002|Overall Study|Adverse Event|0|||
27726366|NCT02400255|80830047|FG003|Overall Study|Adverse Event|0|||
27726367|NCT02400255|80830044|FG000|Overall Study|Physician Decision|6|||
27726368|NCT02400255|80830045|FG001|Overall Study|Physician Decision|0|||
27726369|NCT02400255|80830046|FG002|Overall Study|Physician Decision|0|||
27726370|NCT02400255|80830047|FG003|Overall Study|Physician Decision|0|||
27726371|NCT02400255|80830044|FG000|Overall Study|Loss of insurance|1|||
27847467|NCT01302847|81272127|FG002|Overall Study|Ongoing|0|||
27726372|NCT02400255|80830045|FG001|Overall Study|Loss of insurance|0|||
27726373|NCT02400255|80830046|FG002|Overall Study|Loss of insurance|0|||
27726374|NCT02400255|80830047|FG003|Overall Study|Loss of insurance|0|||
27726375|NCT01072344|80830048|FG000|Overall Study|Relasped-reached end point|7|||
27726376|NCT01072344|80830049|FG001|Overall Study|Relasped-reached end point|12|||
27726377|NCT01072344|80830048|FG000|Overall Study|Protocol Violation|1|||
27726378|NCT01072344|80830049|FG001|Overall Study|Protocol Violation|2|||
27726379|NCT01072344|80830048|FG000|Overall Study|Lost to Follow-up|3|||
27505385|NCT00423579|80044122|FG001|Overall Study|Lost to Follow-up|0|||
27726380|NCT01072344|80830049|FG001|Overall Study|Lost to Follow-up|4|||
27847468|NCT01302847|81272128|FG003|Overall Study|Ongoing|0|||
27847469|NCT01302847|81272129|FG004|Overall Study|Ongoing|0|||
27847470|NCT01302847|81272130|FG005|Overall Study|Ongoing|27|||
27847471|NCT01302847|81272131|FG006|Overall Study|Ongoing|22|||
27847472|NCT01302847|81272132|FG007|Overall Study|Ongoing|17|||
27847473|NCT01302847|81272125|FG000|Overall Study|Death|0|||
27505386|NCT00423579|80044121|FG000|Overall Study|Protocol Violation|1|||
27505387|NCT00423579|80044122|FG001|Overall Study|Protocol Violation|3|||
27505388|NCT00423579|80044121|FG000|Overall Study|Diagnosis of diabetes|0|||
27505389|NCT00423579|80044122|FG001|Overall Study|Diagnosis of diabetes|1|||
27505390|NCT02863419|80044123|FG000|Overall Study|Lost to Follow-up|0|||
27505391|NCT02863419|80044124|FG001|Overall Study|Lost to Follow-up|1|||
27505392|NCT02863419|80044125|FG002|Overall Study|Lost to Follow-up|4|||
27505393|NCT02863419|80044123|FG000|Overall Study|Withdrawal by Subject|5|||
27505394|NCT02863419|80044124|FG001|Overall Study|Withdrawal by Subject|5|||
27505395|NCT02863419|80044125|FG002|Overall Study|Withdrawal by Subject|3|||
27505396|NCT02863419|80044123|FG000|Overall Study|Died|3|||
27847474|NCT01302847|81272126|FG001|Overall Study|Death|1|||
27847475|NCT01302847|81272127|FG002|Overall Study|Death|0|||
27847476|NCT01302847|81272128|FG003|Overall Study|Death|0|||
27847477|NCT01302847|81272129|FG004|Overall Study|Death|0|||
27847478|NCT01302847|81272130|FG005|Overall Study|Death|1|||
27847479|NCT01302847|81272131|FG006|Overall Study|Death|1|||
27847480|NCT01302847|81272132|FG007|Overall Study|Death|0|||
27847481|NCT01302847|81272125|FG000|Overall Study|Pregnancy|2|||
27847482|NCT01302847|81272126|FG001|Overall Study|Pregnancy|0|||
27847483|NCT01302847|81272127|FG002|Overall Study|Pregnancy|0|||
27847484|NCT01302847|81272128|FG003|Overall Study|Pregnancy|0|||
27847485|NCT01302847|81272129|FG004|Overall Study|Pregnancy|0|||
27847486|NCT01302847|81272130|FG005|Overall Study|Pregnancy|0|||
27847487|NCT01302847|81272131|FG006|Overall Study|Pregnancy|0|||
27847488|NCT01302847|81272132|FG007|Overall Study|Pregnancy|0|||
27847489|NCT01302847|81272125|FG000|Overall Study|Virologic failure|0|||
27847490|NCT01302847|81272126|FG001|Overall Study|Virologic failure|2|||
27847491|NCT01302847|81272127|FG002|Overall Study|Virologic failure|2|||
27847492|NCT01302847|81272128|FG003|Overall Study|Virologic failure|0|||
27847493|NCT01302847|81272129|FG004|Overall Study|Virologic failure|1|||
27847494|NCT01302847|81272130|FG005|Overall Study|Virologic failure|1|||
27847495|NCT01302847|81272131|FG006|Overall Study|Virologic failure|0|||
27847496|NCT01302847|81272132|FG007|Overall Study|Virologic failure|2|||
27847497|NCT01302847|81272125|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27847498|NCT01302847|81272126|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27847499|NCT01302847|81272127|FG002|Overall Study|Severe debilitation, unable to continue|0|||
27847500|NCT01302847|81272128|FG003|Overall Study|Severe debilitation, unable to continue|0|||
27847501|NCT01302847|81272129|FG004|Overall Study|Severe debilitation, unable to continue|0|||
27847502|NCT01302847|81272130|FG005|Overall Study|Severe debilitation, unable to continue|1|||
27847503|NCT01302847|81272131|FG006|Overall Study|Severe debilitation, unable to continue|1|||
27847504|NCT01302847|81272132|FG007|Overall Study|Severe debilitation, unable to continue|0|||
27847505|NCT01302847|81272125|FG000|Overall Study|Not able to get to clinic|1|||
27847506|NCT01302847|81272126|FG001|Overall Study|Not able to get to clinic|1|||
27847507|NCT01302847|81272127|FG002|Overall Study|Not able to get to clinic|0|||
27847508|NCT01302847|81272128|FG003|Overall Study|Not able to get to clinic|0|||
27847509|NCT01302847|81272129|FG004|Overall Study|Not able to get to clinic|0|||
27847510|NCT01302847|81272130|FG005|Overall Study|Not able to get to clinic|0|||
27847511|NCT01302847|81272131|FG006|Overall Study|Not able to get to clinic|0|||
27847512|NCT01302847|81272132|FG007|Overall Study|Not able to get to clinic|0|||
27847513|NCT01302847|81272125|FG000|Overall Study|Site closing|2|||
27847514|NCT01302847|81272126|FG001|Overall Study|Site closing|2|||
27847515|NCT01302847|81272127|FG002|Overall Study|Site closing|0|||
27847516|NCT01302847|81272128|FG003|Overall Study|Site closing|0|||
27847517|NCT01302847|81272129|FG004|Overall Study|Site closing|0|||
27505397|NCT02863419|80044124|FG001|Overall Study|Died|4|||
27847518|NCT01302847|81272130|FG005|Overall Study|Site closing|0|||
27847519|NCT01302847|81272131|FG006|Overall Study|Site closing|0|||
27847520|NCT01302847|81272132|FG007|Overall Study|Site closing|0|||
27847521|NCT01302847|81272125|FG000|Overall Study|Withdrawal by Subject|1|||
27847522|NCT01302847|81272126|FG001|Overall Study|Withdrawal by Subject|0|||
27847523|NCT01302847|81272127|FG002|Overall Study|Withdrawal by Subject|0|||
27847524|NCT01302847|81272128|FG003|Overall Study|Withdrawal by Subject|0|||
27847525|NCT01302847|81272129|FG004|Overall Study|Withdrawal by Subject|1|||
27847526|NCT01302847|81272130|FG005|Overall Study|Withdrawal by Subject|0|||
27505398|NCT02863419|80044125|FG002|Overall Study|Died|1|||
27847527|NCT01302847|81272131|FG006|Overall Study|Withdrawal by Subject|0|||
27505399|NCT01347112|80044127|FG000|Overall Study|Withdrawal by Subject|1|||
27505400|NCT01347112|80044128|FG001|Overall Study|Withdrawal by Subject|7|||
27505401|NCT01347112|80044127|FG000|Overall Study|Lost to Follow-up|3|||
27505402|NCT01347112|80044128|FG001|Overall Study|Lost to Follow-up|5|||
27505403|NCT01310777|80044129|FG000|Overall Study|Adverse Event|23|||
27505404|NCT01310777|80044130|FG001|Overall Study|Adverse Event|1|||
27505405|NCT01310777|80044131|FG002|Overall Study|Adverse Event|15|||
27505406|NCT01310777|80044129|FG000|Overall Study|Lost to Follow-up|0|||
27505407|NCT01310777|80044130|FG001|Overall Study|Lost to Follow-up|4|||
27505408|NCT01310777|80044131|FG002|Overall Study|Lost to Follow-up|1|||
27505409|NCT01310777|80044129|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
27847528|NCT01302847|81272132|FG007|Overall Study|Withdrawal by Subject|1|||
27847529|NCT01302847|81272125|FG000|Overall Study|Not willing to adhere to requirements|5|||
27847530|NCT01302847|81272126|FG001|Overall Study|Not willing to adhere to requirements|0|||
27847531|NCT01302847|81272127|FG002|Overall Study|Not willing to adhere to requirements|0|||
27847532|NCT01302847|81272128|FG003|Overall Study|Not willing to adhere to requirements|1|||
27847533|NCT01302847|81272129|FG004|Overall Study|Not willing to adhere to requirements|0|||
27847534|NCT01302847|81272130|FG005|Overall Study|Not willing to adhere to requirements|0|||
27894190|NCT03614078|81447315|FG000|Overall Study|Adverse Event|0|||
27894191|NCT03614078|81447316|FG001|Overall Study|Adverse Event|2|||
27894192|NCT03614078|81447317|FG002|Overall Study|Adverse Event|0|||
27894193|NCT03614078|81447315|FG000|Overall Study|Dizziness and Rash|0|||
27894194|NCT03614078|81447316|FG001|Overall Study|Dizziness and Rash|1|||
27505410|NCT01310777|80044130|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
27505411|NCT01310777|80044131|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
27847535|NCT01302847|81272131|FG006|Overall Study|Not willing to adhere to requirements|0|||
27894195|NCT03614078|81447317|FG002|Overall Study|Dizziness and Rash|0|||
27894196|NCT00336024|81447318|FG000|Overall Study|Death|2|||
27894197|NCT00336024|81447319|FG001|Overall Study|Death|1|||
27894198|NCT00336024|81447318|FG000|Overall Study|Physician Decision|4|||
27894199|NCT00336024|81447319|FG001|Overall Study|Physician Decision|1|||
27894200|NCT00336024|81447318|FG000|Overall Study|Protocol Violation|1|||
27894201|NCT00336024|81447319|FG001|Overall Study|Protocol Violation|0|||
27894202|NCT00336024|81447318|FG000|Overall Study|Withdrawal by Subject|1|||
27894203|NCT00336024|81447319|FG001|Overall Study|Withdrawal by Subject|2|||
27894204|NCT00336024|81447318|FG000|Overall Study|Failure to fulfill consolidation|1|||
27894205|NCT00336024|81447319|FG001|Overall Study|Failure to fulfill consolidation|1|||
27894206|NCT00336024|81447318|FG000|Overall Study|Progressive Disease|4|||
27894207|NCT00336024|81447319|FG001|Overall Study|Progressive Disease|7|||
27894208|NCT00336024|81447318|FG000|Overall Study|Ineligible|7|||
27894209|NCT00336024|81447319|FG001|Overall Study|Ineligible|7|||
27894210|NCT02091375|81447322|FG000|Overall Study|Adverse Event|8|||
27894211|NCT02091375|81447323|FG001|Overall Study|Adverse Event|1|||
27894212|NCT02091375|81447322|FG000|Overall Study|Lost to Follow-up|0|||
27847536|NCT01302847|81272132|FG007|Overall Study|Not willing to adhere to requirements|2|||
27847537|NCT01302847|81272125|FG000|Overall Study|Site unable to contact participant|2|||
27847538|NCT01302847|81272126|FG001|Overall Study|Site unable to contact participant|1|||
27847539|NCT01302847|81272127|FG002|Overall Study|Site unable to contact participant|0|||
27894213|NCT02091375|81447323|FG001|Overall Study|Lost to Follow-up|1|||
27894214|NCT02091375|81447322|FG000|Overall Study|Withdrawal by Subject|0|||
27894215|NCT02091375|81447323|FG001|Overall Study|Withdrawal by Subject|1|||
27894216|NCT02091375|81447322|FG000|Overall Study|Withdrawn by the investigator|1|||
27894217|NCT02091375|81447323|FG001|Overall Study|Withdrawn by the investigator|0|||
27894218|NCT04258254|81447326|FG000|Overall Study|Withdrawal by Subject|0|||
27894219|NCT04258254|81447327|FG001|Overall Study|Withdrawal by Subject|1|||
27894220|NCT04258254|81447328|FG002|Overall Study|Withdrawal by Subject|0|||
27894221|NCT05323994|81447329|FG000|Overall Study|Protocol Violation|1|||
27505412|NCT01310777|80044129|FG000|Overall Study|Inadequate Control of IOP|5|||
27894222|NCT01854879|81447351|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
27894223|NCT01854879|81447351|FG000|Overall Study|screen fail|3|||
27894224|NCT01854879|81447351|FG000|Overall Study|incomplete data set|1|||
27894225|NCT02817516|81447352|FG000|Overall Study|Other|0|||
27894226|NCT02817516|81447353|FG001|Overall Study|Other|0|||
27894227|NCT02817516|81447354|FG002|Overall Study|Other|1|||
27894228|NCT02817516|81447355|FG003|Overall Study|Other|0|||
27726381|NCT01808612|80830052|FG000|Treatment Period|Adverse Event|8|||
27726382|NCT01808612|80830053|FG001|Treatment Period|Adverse Event|4|||
27613750|NCT01003184|80426770|FG001|Overall Study|Adverse Event|5|||
27613751|NCT01003184|80426769|FG000|Overall Study|Lost to Follow-up|1|||
27613752|NCT01003184|80426770|FG001|Overall Study|Lost to Follow-up|0|||
27613753|NCT01003184|80426769|FG000|Overall Study|Loss of glucose control|1|||
27613754|NCT01003184|80426770|FG001|Overall Study|Loss of glucose control|1|||
27613755|NCT01003184|80426769|FG000|Overall Study|Protocol Violation|3|||
27613756|NCT01003184|80426770|FG001|Overall Study|Protocol Violation|0|||
27613757|NCT01003184|80426769|FG000|Overall Study|Withdrawal by Subject|1|||
27613758|NCT01003184|80426770|FG001|Overall Study|Withdrawal by Subject|6|||
27726383|NCT01808612|80830054|FG002|Treatment Period|Adverse Event|3|||
27726384|NCT01808612|80830052|FG000|Treatment Period|Lost to Follow-up|2|||
27847540|NCT01302847|81272128|FG003|Overall Study|Site unable to contact participant|0|||
27847541|NCT01302847|81272129|FG004|Overall Study|Site unable to contact participant|0|||
27847542|NCT01302847|81272130|FG005|Overall Study|Site unable to contact participant|0|||
27894229|NCT01892085|81447360|FG000|Overall Study|Death|4|||
27726385|NCT01808612|80830053|FG001|Treatment Period|Lost to Follow-up|2|||
27894230|NCT01892085|81447361|FG001|Overall Study|Death|1|||
27894231|NCT01892085|81447362|FG002|Overall Study|Death|3|||
27894232|NCT01892085|81447360|FG000|Overall Study|Withdrawal by Subject|2|||
27894233|NCT01892085|81447361|FG001|Overall Study|Withdrawal by Subject|0|||
27894234|NCT01892085|81447362|FG002|Overall Study|Withdrawal by Subject|2|||
27894235|NCT02829723|81447364|FG000|Overall Study|Adverse Event|0|||
27894236|NCT02829723|81447365|FG001|Overall Study|Adverse Event|0|||
27894237|NCT02829723|81447366|FG002|Overall Study|Adverse Event|1|||
27505413|NCT01310777|80044130|FG001|Overall Study|Inadequate Control of IOP|7|||
27847543|NCT01302847|81272131|FG006|Overall Study|Site unable to contact participant|2|||
27505414|NCT01310777|80044131|FG002|Overall Study|Inadequate Control of IOP|10|||
27505415|NCT01310777|80044129|FG000|Overall Study|Other|4|||
27505416|NCT01310777|80044130|FG001|Overall Study|Other|1|||
27505417|NCT01310777|80044131|FG002|Overall Study|Other|2|||
27505418|NCT01002339|80044132|FG000|Overall Study|Withdrawal by Subject|0|||
27847544|NCT01302847|81272132|FG007|Overall Study|Site unable to contact participant|0|||
27847545|NCT01787279|81272136|FG000|Overall Study|Lost to Follow-up|2|||
27847546|NCT01787279|81272136|FG000|Overall Study|Lack of Efficacy|1|||
27847547|NCT01048502|81272137|FG000|Overall Study|Lost to Follow-up|2|||
27847548|NCT01048502|81272138|FG001|Overall Study|Lost to Follow-up|0|||
27847549|NCT01048502|81272139|FG002|Overall Study|Lost to Follow-up|0|||
27847550|NCT01048502|81272140|FG003|Overall Study|Lost to Follow-up|0|||
27847551|NCT01048502|81272137|FG000|Overall Study|Adverse Event|1|||
27847552|NCT01048502|81272138|FG001|Overall Study|Adverse Event|0|||
27847553|NCT01048502|81272139|FG002|Overall Study|Adverse Event|0|||
27847554|NCT01048502|81272140|FG003|Overall Study|Adverse Event|0|||
27847555|NCT01048502|81272137|FG000|Overall Study|Withdrawal by Subject|1|||
27847556|NCT01048502|81272138|FG001|Overall Study|Withdrawal by Subject|4|||
27847557|NCT01048502|81272139|FG002|Overall Study|Withdrawal by Subject|5|||
27847558|NCT01048502|81272140|FG003|Overall Study|Withdrawal by Subject|3|||
27847559|NCT01048502|81272137|FG000|Overall Study|Physician Decision|0|||
27847560|NCT01048502|81272138|FG001|Overall Study|Physician Decision|3|||
27847561|NCT01048502|81272139|FG002|Overall Study|Physician Decision|0|||
27847562|NCT01048502|81272140|FG003|Overall Study|Physician Decision|1|||
27847563|NCT04798482|81272141|FG000|Overall Study|Physician Decision|1|||
27847564|NCT04798482|81272141|FG000|Overall Study|Lost eligibility|1|||
27847565|NCT01045707|81272142|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
27847566|NCT01045707|81272143|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
27847567|NCT01045707|81272142|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
27847568|NCT01045707|81272143|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
27847569|NCT01045707|81272142|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
27847570|NCT01045707|81272143|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
27847571|NCT01045707|81272142|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
27847572|NCT01045707|81272143|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
27847573|NCT01045707|81272142|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
27847574|NCT01045707|81272143|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
27847575|NCT01045707|81272142|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
27847576|NCT01045707|81272143|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
27847577|NCT01045707|81272142|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
27847578|NCT01045707|81272143|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
27505419|NCT01002339|80044133|FG001|Overall Study|Withdrawal by Subject|1|||
27505420|NCT01002339|80044134|FG002|Overall Study|Withdrawal by Subject|0|||
27505421|NCT01002339|80044132|FG000|Overall Study|Incorrect treatment assignment|0|||
27505422|NCT01002339|80044133|FG001|Overall Study|Incorrect treatment assignment|0|||
27847579|NCT01045707|81272142|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
27847580|NCT01045707|81272143|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
27847581|NCT01045707|81272142|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
27847582|NCT01045707|81272143|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
27847583|NCT00977548|81272146|FG000|Overall Study|Ineligible|4|||
27847584|NCT00977548|81272146|FG000|Overall Study|Adverse Event|8|||
27847585|NCT00977548|81272146|FG000|Overall Study|Withdrawal by Subject|1|||
27894238|NCT02829723|81447367|FG003|Overall Study|Adverse Event|1|||
27894239|NCT02829723|81447368|FG004|Overall Study|Adverse Event|0|||
27847586|NCT02502734|81272151|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
27847587|NCT02502734|81272152|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
27847588|NCT02502734|81272151|FG000|Washout Period|Adverse Event|1|||
27847589|NCT02502734|81272152|FG001|Washout Period|Adverse Event|0|||
27847590|NCT00467831|81272153|FG000|Overall Study|Death|2|||
27847591|NCT00467831|81272153|FG000|Overall Study|Withdrawal by Subject|1|||
27847592|NCT00573170|81272154|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
27847593|NCT00573170|81272155|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
27847594|NCT00573170|81272156|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
27847595|NCT00573170|81272157|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
27847596|NCT00573170|81272158|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
27847597|NCT00573170|81272159|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
27847598|NCT00573170|81272154|FG000|First Washout Period|Adverse Event|1|||
27847599|NCT00573170|81272155|FG001|First Washout Period|Adverse Event|1|||
27847600|NCT00573170|81272156|FG002|First Washout Period|Adverse Event|0|||
27847601|NCT00573170|81272157|FG003|First Washout Period|Adverse Event|0|||
27847602|NCT00573170|81272158|FG004|First Washout Period|Adverse Event|0|||
27847603|NCT00573170|81272159|FG005|First Washout Period|Adverse Event|1|||
27847604|NCT00573170|81272154|FG000|First Washout Period|Lack of Efficacy|0|||
27847605|NCT00573170|81272155|FG001|First Washout Period|Lack of Efficacy|0|||
27847606|NCT00573170|81272156|FG002|First Washout Period|Lack of Efficacy|0|||
27847607|NCT00573170|81272157|FG003|First Washout Period|Lack of Efficacy|0|||
27847608|NCT00573170|81272158|FG004|First Washout Period|Lack of Efficacy|0|||
27847609|NCT00573170|81272159|FG005|First Washout Period|Lack of Efficacy|1|||
27847610|NCT00573170|81272154|FG000|First Washout Period|Lost to Follow-up|1|||
27847611|NCT00573170|81272155|FG001|First Washout Period|Lost to Follow-up|1|||
27847612|NCT00573170|81272156|FG002|First Washout Period|Lost to Follow-up|0|||
27847613|NCT00573170|81272157|FG003|First Washout Period|Lost to Follow-up|2|||
27847614|NCT00573170|81272158|FG004|First Washout Period|Lost to Follow-up|0|||
27847615|NCT00573170|81272159|FG005|First Washout Period|Lost to Follow-up|2|||
27847616|NCT00573170|81272154|FG000|First Washout Period|Withdrawal by Subject|2|||
27847617|NCT00573170|81272155|FG001|First Washout Period|Withdrawal by Subject|0|||
27505423|NCT01002339|80044134|FG002|Overall Study|Incorrect treatment assignment|1|||
27505424|NCT01002339|80044132|FG000|Overall Study|Protocol Violation|0|||
27505425|NCT01002339|80044133|FG001|Overall Study|Protocol Violation|0|||
27505426|NCT01002339|80044134|FG002|Overall Study|Protocol Violation|2|||
27505427|NCT01002339|80044132|FG000|Overall Study|Lung cancer detected before transplant|0|||
27505428|NCT01002339|80044133|FG001|Overall Study|Lung cancer detected before transplant|0|||
27505429|NCT01002339|80044134|FG002|Overall Study|Lung cancer detected before transplant|1|||
27505430|NCT01002339|80044132|FG000|Overall Study|Randomized. Not transplanted|0|||
27505431|NCT01002339|80044133|FG001|Overall Study|Randomized. Not transplanted|0|||
27505432|NCT01002339|80044134|FG002|Overall Study|Randomized. Not transplanted|1|||
27505433|NCT00907335|80044135|FG000|Overall Study|Withdrawal by Subject|2|||
27505434|NCT00907335|80044136|FG001|Overall Study|Withdrawal by Subject|0|||
27505435|NCT00907335|80044135|FG000|Overall Study|Adverse Event|4|||
27847618|NCT00573170|81272156|FG002|First Washout Period|Withdrawal by Subject|0|||
27847619|NCT00573170|81272157|FG003|First Washout Period|Withdrawal by Subject|2|||
27847620|NCT00573170|81272158|FG004|First Washout Period|Withdrawal by Subject|3|||
27847621|NCT00573170|81272159|FG005|First Washout Period|Withdrawal by Subject|3|||
27847622|NCT00573170|81272154|FG000|First Washout Period|Other|4|||
27847623|NCT00573170|81272155|FG001|First Washout Period|Other|0|||
27847624|NCT00573170|81272156|FG002|First Washout Period|Other|1|||
27847625|NCT00573170|81272157|FG003|First Washout Period|Other|1|||
27847626|NCT00573170|81272158|FG004|First Washout Period|Other|0|||
27847627|NCT00573170|81272159|FG005|First Washout Period|Other|0|||
27847628|NCT00573170|81272154|FG000|Second Washout Period|Adverse Event|1|||
27847629|NCT00573170|81272155|FG001|Second Washout Period|Adverse Event|0|||
27847630|NCT00573170|81272156|FG002|Second Washout Period|Adverse Event|0|||
27847631|NCT00573170|81272157|FG003|Second Washout Period|Adverse Event|0|||
27847632|NCT00573170|81272158|FG004|Second Washout Period|Adverse Event|1|||
27847633|NCT00573170|81272159|FG005|Second Washout Period|Adverse Event|0|||
27847634|NCT00573170|81272154|FG000|Second Washout Period|Protocol Violation|2|||
27847635|NCT00573170|81272155|FG001|Second Washout Period|Protocol Violation|1|||
27847636|NCT00573170|81272156|FG002|Second Washout Period|Protocol Violation|1|||
27847637|NCT00573170|81272157|FG003|Second Washout Period|Protocol Violation|0|||
27847638|NCT00573170|81272158|FG004|Second Washout Period|Protocol Violation|0|||
27847639|NCT00573170|81272159|FG005|Second Washout Period|Protocol Violation|0|||
27847640|NCT00573170|81272154|FG000|Second Washout Period|Withdrawal by Subject|1|||
27847641|NCT00573170|81272155|FG001|Second Washout Period|Withdrawal by Subject|1|||
27847642|NCT00573170|81272156|FG002|Second Washout Period|Withdrawal by Subject|2|||
27847643|NCT00573170|81272157|FG003|Second Washout Period|Withdrawal by Subject|0|||
27847644|NCT00573170|81272158|FG004|Second Washout Period|Withdrawal by Subject|1|||
27847645|NCT00573170|81272159|FG005|Second Washout Period|Withdrawal by Subject|0|||
27505436|NCT00907335|80044136|FG001|Overall Study|Adverse Event|1|||
27726386|NCT01808612|80830054|FG002|Treatment Period|Lost to Follow-up|1|||
27726387|NCT01808612|80830052|FG000|Treatment Period|Protocol Violation|1|||
27726388|NCT01808612|80830053|FG001|Treatment Period|Protocol Violation|0|||
27726389|NCT01808612|80830054|FG002|Treatment Period|Protocol Violation|0|||
27726390|NCT01808612|80830052|FG000|Treatment Period|Withdrawal by Subject|1|||
27726391|NCT01808612|80830053|FG001|Treatment Period|Withdrawal by Subject|0|||
27726392|NCT01808612|80830054|FG002|Treatment Period|Withdrawal by Subject|4|||
27726393|NCT01808612|80830052|FG000|Treatment Period|Physician Decision|1|||
27726394|NCT01808612|80830053|FG001|Treatment Period|Physician Decision|0|||
27726395|NCT01808612|80830054|FG002|Treatment Period|Physician Decision|4|||
27726396|NCT01808612|80830052|FG000|Treatment Period|Sponsor Decision|1|||
27726397|NCT01808612|80830053|FG001|Treatment Period|Sponsor Decision|0|||
27726398|NCT01808612|80830054|FG002|Treatment Period|Sponsor Decision|0|||
27726399|NCT01808612|80830052|FG000|Treatment Period|Lack of Efficacy|1|||
27726400|NCT01808612|80830053|FG001|Treatment Period|Lack of Efficacy|1|||
27726401|NCT01808612|80830054|FG002|Treatment Period|Lack of Efficacy|2|||
27726402|NCT01808612|80830052|FG000|Discontinuation Period|Adverse Event|1|||
27726403|NCT01808612|80830053|FG001|Discontinuation Period|Adverse Event|0|||
27726404|NCT01808612|80830054|FG002|Discontinuation Period|Adverse Event|0|||
27726405|NCT01808612|80830052|FG000|Discontinuation Period|Physician Decision|1|||
27726406|NCT01808612|80830053|FG001|Discontinuation Period|Physician Decision|0|||
27726407|NCT01808612|80830054|FG002|Discontinuation Period|Physician Decision|0|||
27726408|NCT01808612|80830052|FG000|Discontinuation Period|Lost to Follow-up|0|||
27726409|NCT01808612|80830053|FG001|Discontinuation Period|Lost to Follow-up|1|||
27726410|NCT01808612|80830054|FG002|Discontinuation Period|Lost to Follow-up|0|||
27726411|NCT02222714|80830055|FG000|Overall Study|Death|0|||
27726412|NCT02222714|80830056|FG001|Overall Study|Death|2|||
27894240|NCT02829723|81447369|FG005|Overall Study|Adverse Event|0|||
27894241|NCT02829723|81447370|FG006|Overall Study|Adverse Event|0|||
27894242|NCT02829723|81447371|FG007|Overall Study|Adverse Event|1|||
27894243|NCT02829723|81447372|FG008|Overall Study|Adverse Event|0|||
27894244|NCT02829723|81447373|FG009|Overall Study|Adverse Event|0|||
27894245|NCT02829723|81447374|FG010|Overall Study|Adverse Event|0|||
27894246|NCT02829723|81447375|FG011|Overall Study|Adverse Event|0|||
27894247|NCT02829723|81447376|FG012|Overall Study|Adverse Event|0|||
27894248|NCT02829723|81447377|FG013|Overall Study|Adverse Event|0|||
27894249|NCT02829723|81447378|FG014|Overall Study|Adverse Event|1|||
27894250|NCT02829723|81447379|FG015|Overall Study|Adverse Event|1|||
27894251|NCT02829723|81447380|FG016|Overall Study|Adverse Event|1|||
27894252|NCT02829723|81447381|FG017|Overall Study|Adverse Event|2|||
27894253|NCT02829723|81447382|FG018|Overall Study|Adverse Event|1|||
27894254|NCT02829723|81447383|FG019|Overall Study|Adverse Event|1|||
27894255|NCT02829723|81447384|FG020|Overall Study|Adverse Event|3|||
27894256|NCT02829723|81447385|FG021|Overall Study|Adverse Event|0|||
27894257|NCT02829723|81447386|FG022|Overall Study|Adverse Event|0|||
27894258|NCT02829723|81447387|FG023|Overall Study|Adverse Event|1|||
27894259|NCT02829723|81447388|FG024|Overall Study|Adverse Event|1|||
27894260|NCT02829723|81447389|FG025|Overall Study|Adverse Event|3|||
27505437|NCT00907335|80044135|FG000|Overall Study|Lost to Follow-up|2|||
27726413|NCT02222714|80830057|FG002|Overall Study|Death|3|||
27726414|NCT02222714|80830058|FG003|Overall Study|Death|4|||
27726415|NCT02222714|80830059|FG004|Overall Study|Death|6|||
27726416|NCT02222714|80830055|FG000|Overall Study|Withdrawal by Subject|0|||
27726417|NCT02222714|80830056|FG001|Overall Study|Withdrawal by Subject|0|||
27726418|NCT02222714|80830057|FG002|Overall Study|Withdrawal by Subject|1|||
27726419|NCT02222714|80830058|FG003|Overall Study|Withdrawal by Subject|0|||
27726420|NCT02222714|80830059|FG004|Overall Study|Withdrawal by Subject|1|||
27894261|NCT02829723|81447390|FG026|Overall Study|Adverse Event|5|||
27894262|NCT02829723|81447364|FG000|Overall Study|Death|1|||
27894263|NCT02829723|81447365|FG001|Overall Study|Death|0|||
27894264|NCT02829723|81447366|FG002|Overall Study|Death|1|||
27894265|NCT02829723|81447367|FG003|Overall Study|Death|1|||
27894266|NCT02829723|81447368|FG004|Overall Study|Death|0|||
27894267|NCT02829723|81447369|FG005|Overall Study|Death|0|||
27894268|NCT02829723|81447370|FG006|Overall Study|Death|2|||
27894269|NCT02829723|81447371|FG007|Overall Study|Death|0|||
27894270|NCT02829723|81447372|FG008|Overall Study|Death|1|||
27726421|NCT01916980|80830063|FG000|Overall Study|Adverse Event|4|||
27726422|NCT01916980|80830064|FG001|Overall Study|Adverse Event|2|||
27726423|NCT01916980|80830063|FG000|Overall Study|Lack of Efficacy|2|||
27726424|NCT01916980|80830064|FG001|Overall Study|Lack of Efficacy|2|||
27894271|NCT02829723|81447373|FG009|Overall Study|Death|0|||
27726425|NCT01916980|80830063|FG000|Overall Study|Withdrawal by Subject|1|||
27894272|NCT02829723|81447374|FG010|Overall Study|Death|0|||
27726426|NCT01916980|80830064|FG001|Overall Study|Withdrawal by Subject|0|||
27726427|NCT01506882|80830069|FG000|Overall Study|Lack of Efficacy|4|||
27894273|NCT02829723|81447375|FG011|Overall Study|Death|0|||
27894274|NCT02829723|81447376|FG012|Overall Study|Death|2|||
27847646|NCT00573170|81272154|FG000|Second Washout Period|Lost to Follow-up|0|||
27847647|NCT00573170|81272155|FG001|Second Washout Period|Lost to Follow-up|0|||
27847648|NCT00573170|81272156|FG002|Second Washout Period|Lost to Follow-up|0|||
27847649|NCT00573170|81272157|FG003|Second Washout Period|Lost to Follow-up|1|||
27847650|NCT00573170|81272158|FG004|Second Washout Period|Lost to Follow-up|0|||
27847651|NCT00573170|81272159|FG005|Second Washout Period|Lost to Follow-up|0|||
27847652|NCT00573170|81272154|FG000|Second Washout Period|Other|1|||
27847653|NCT00573170|81272155|FG001|Second Washout Period|Other|2|||
27847654|NCT00573170|81272156|FG002|Second Washout Period|Other|1|||
27847655|NCT00573170|81272157|FG003|Second Washout Period|Other|4|||
27847656|NCT00573170|81272158|FG004|Second Washout Period|Other|6|||
27847657|NCT00573170|81272159|FG005|Second Washout Period|Other|2|||
27847658|NCT00573170|81272154|FG000|Third Treatment Period|Withdrawal by Subject|1|||
27847659|NCT00573170|81272155|FG001|Third Treatment Period|Withdrawal by Subject|0|||
27847660|NCT00573170|81272156|FG002|Third Treatment Period|Withdrawal by Subject|0|||
27847661|NCT00573170|81272157|FG003|Third Treatment Period|Withdrawal by Subject|0|||
27847662|NCT00573170|81272158|FG004|Third Treatment Period|Withdrawal by Subject|0|||
27847663|NCT00573170|81272159|FG005|Third Treatment Period|Withdrawal by Subject|0|||
27847664|NCT00573170|81272154|FG000|Third Treatment Period|Lost to Follow-up|0|||
27613759|NCT01003184|80426769|FG000|Overall Study|Physician Decision|1|||
27613760|NCT01003184|80426770|FG001|Overall Study|Physician Decision|0|||
27613761|NCT02494206|80426771|FG000|Overall Study|Adverse Event|1|||
27613762|NCT02494206|80426771|FG000|Overall Study|Disease Progression|1|||
27613763|NCT01266993|80426772|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
27613764|NCT01266993|80426773|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
27613765|NCT01266993|80426772|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
27847665|NCT00573170|81272155|FG001|Third Treatment Period|Lost to Follow-up|0|||
27847666|NCT00573170|81272156|FG002|Third Treatment Period|Lost to Follow-up|0|||
27847667|NCT00573170|81272157|FG003|Third Treatment Period|Lost to Follow-up|0|||
27847668|NCT00573170|81272158|FG004|Third Treatment Period|Lost to Follow-up|0|||
27847669|NCT00573170|81272159|FG005|Third Treatment Period|Lost to Follow-up|2|||
27613766|NCT01266993|80426773|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
27613767|NCT02065570|80426783|FG000|Induction Study|Adverse Event|5|||
27613768|NCT02065570|80426784|FG001|Induction Study|Adverse Event|12|||
27613769|NCT02065570|80426785|FG002|Induction Study|Adverse Event|0|||
27613770|NCT02065570|80426786|FG003|Induction Study|Adverse Event|0|||
27613771|NCT02065570|80426783|FG000|Induction Study|Withdrawal by Subject|2|||
27726428|NCT01506882|80830070|FG001|Overall Study|Lack of Efficacy|3|||
27726429|NCT01506882|80830069|FG000|Overall Study|Lost to Follow-up|1|||
27726430|NCT01506882|80830070|FG001|Overall Study|Lost to Follow-up|0|||
27726431|NCT01506882|80830069|FG000|Overall Study|Withdrawal by Subject|9|||
27726432|NCT01506882|80830070|FG001|Overall Study|Withdrawal by Subject|3|||
27726433|NCT01506882|80830069|FG000|Overall Study|SAE, non-fatal|2|||
27726434|NCT01506882|80830070|FG001|Overall Study|SAE, non-fatal|0|||
27726435|NCT01506882|80830069|FG000|Overall Study|AE, non-serious non-fatal|3|||
27726436|NCT01506882|80830070|FG001|Overall Study|AE, non-serious non-fatal|1|||
27726437|NCT01506882|80830069|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
27726438|NCT01506882|80830070|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27726439|NCT01506882|80830069|FG000|Overall Study|Other Reason|2|||
27726440|NCT01506882|80830070|FG001|Overall Study|Other Reason|0|||
27726441|NCT04684420|80830073|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27726442|NCT04684420|80830074|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27726443|NCT04684420|80830075|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
27726444|NCT04684420|80830076|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
27726445|NCT04684420|80830073|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
27726446|NCT04684420|80830074|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
27726447|NCT04684420|80830075|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
27726448|NCT04684420|80830076|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
27726449|NCT00772447|80830077|FG000|Overall Study|Withdrawal by Subject|9|||
27847670|NCT02075606|81272160|FG000|Overall Study|Adverse Event|5|||
27726450|NCT00772447|80830078|FG001|Overall Study|Withdrawal by Subject|5|||
27726451|NCT00772447|80830077|FG000|Overall Study|Physician Decision|4|||
27847671|NCT02075606|81272160|FG000|Overall Study|Withdrawal by Subject|1|||
27505438|NCT00907335|80044136|FG001|Overall Study|Lost to Follow-up|0|||
27726452|NCT00772447|80830078|FG001|Overall Study|Physician Decision|8|||
27726453|NCT00772447|80830077|FG000|Overall Study|Lost to Follow-up|2|||
27847672|NCT02075606|81272160|FG000|Overall Study|Death|1|||
27847673|NCT02075606|81272160|FG000|Overall Study|Investigator's decision|1|||
27613772|NCT02065570|80426784|FG001|Induction Study|Withdrawal by Subject|3|||
27847674|NCT02075606|81272160|FG000|Overall Study|Symptom management|1|||
27613773|NCT02065570|80426785|FG002|Induction Study|Withdrawal by Subject|0|||
27613774|NCT02065570|80426786|FG003|Induction Study|Withdrawal by Subject|0|||
27613775|NCT02065570|80426783|FG000|Induction Study|Lost to Follow-up|1|||
27613776|NCT02065570|80426784|FG001|Induction Study|Lost to Follow-up|1|||
27613777|NCT02065570|80426785|FG002|Induction Study|Lost to Follow-up|0|||
27613778|NCT02065570|80426786|FG003|Induction Study|Lost to Follow-up|0|||
27613779|NCT02065570|80426783|FG000|Induction Study|Other, Not Specified|6|||
27613780|NCT02065570|80426784|FG001|Induction Study|Other, Not Specified|5|||
27613781|NCT02065570|80426785|FG002|Induction Study|Other, Not Specified|0|||
27613782|NCT02065570|80426786|FG003|Induction Study|Other, Not Specified|0|||
27613783|NCT02065570|80426783|FG000|Maintenance Study|Adverse Event|0|||
27613784|NCT02065570|80426784|FG001|Maintenance Study|Adverse Event|0|||
27613785|NCT02065570|80426785|FG002|Maintenance Study|Adverse Event|8|||
27847675|NCT02075606|81272160|FG000|Overall Study|Increasing Symptoms|1|||
27505439|NCT02900378|80044137|FG000|Randomization (Visit 2)|Adverse Event|14|||
27505440|NCT02900378|80044138|FG001|Randomization (Visit 2)|Adverse Event|11|||
27505441|NCT02900378|80044137|FG000|Randomization (Visit 2)|Death|1|||
27505442|NCT02900378|80044138|FG001|Randomization (Visit 2)|Death|4|||
27505443|NCT02900378|80044137|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
27505444|NCT02900378|80044138|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
27505445|NCT02900378|80044137|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
27505446|NCT02900378|80044138|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
27505447|NCT02900378|80044137|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
27505448|NCT02900378|80044138|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
27505449|NCT02900378|80044137|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
27505450|NCT02900378|80044138|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
27505451|NCT02900378|80044137|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
27505452|NCT02900378|80044138|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
27505453|NCT04944992|80044139|FG000|Overall Study|Lost to Follow-up|1|||
27505454|NCT04944992|80044140|FG001|Overall Study|Lost to Follow-up|1|||
27505455|NCT04944992|80044139|FG000|Overall Study|Physician Decision|1|||
27505456|NCT04944992|80044140|FG001|Overall Study|Physician Decision|0|||
27505457|NCT04944992|80044139|FG000|Overall Study|Withdrawal by Subject|6|||
27505458|NCT04944992|80044140|FG001|Overall Study|Withdrawal by Subject|1|||
27613786|NCT02065570|80426786|FG003|Maintenance Study|Adverse Event|8|||
27613787|NCT02065570|80426783|FG000|Maintenance Study|Withdrawal by Subject|0|||
27613788|NCT02065570|80426784|FG001|Maintenance Study|Withdrawal by Subject|0|||
27613789|NCT02065570|80426785|FG002|Maintenance Study|Withdrawal by Subject|1|||
27613790|NCT02065570|80426786|FG003|Maintenance Study|Withdrawal by Subject|4|||
27613791|NCT02065570|80426783|FG000|Maintenance Study|Lost to Follow-up|0|||
27613792|NCT02065570|80426784|FG001|Maintenance Study|Lost to Follow-up|0|||
27726454|NCT00772447|80830078|FG001|Overall Study|Lost to Follow-up|4|||
27847676|NCT01613378|81272161|FG000|Overall Study|Lack of Efficacy|13|||
27847677|NCT01613378|81272161|FG000|Overall Study|Adverse Event|11|||
27847678|NCT01613378|81272161|FG000|Overall Study|Withdrawal by Subject|8|||
27847679|NCT01613378|81272161|FG000|Overall Study|Death|2|||
27847680|NCT01613378|81272161|FG000|Overall Study|Lost to Follow-up|1|||
27847681|NCT01613378|81272161|FG000|Overall Study|Other Reason|4|||
27847682|NCT01790113|81272162|FG000|Overall Study|Adverse Event|2|||
27847683|NCT01790113|81272163|FG001|Overall Study|Adverse Event|7|||
27847684|NCT01790113|81272162|FG000|Overall Study|Study ended due to FDA clearance|1|||
27847685|NCT01790113|81272163|FG001|Overall Study|Study ended due to FDA clearance|68|||
27847686|NCT00227266|81272164|FG000|Overall Study|Withdrawal by Subject|0|||
27847687|NCT00227266|81272165|FG001|Overall Study|Withdrawal by Subject|0|||
27847688|NCT00227266|81272166|FG002|Overall Study|Withdrawal by Subject|1|||
27847689|NCT00227266|81272164|FG000|Overall Study|Protocol Violation|1|||
27847690|NCT00227266|81272165|FG001|Overall Study|Protocol Violation|0|||
27847691|NCT00227266|81272166|FG002|Overall Study|Protocol Violation|1|||
27847692|NCT00227266|81272164|FG000|Overall Study|Excessive weight gain|0|||
27847693|NCT00227266|81272165|FG001|Overall Study|Excessive weight gain|0|||
27847694|NCT00227266|81272166|FG002|Overall Study|Excessive weight gain|2|||
27847695|NCT04233879|81272167|FG000|Overall Study|Death|2|||
27847696|NCT04233879|81272168|FG001|Overall Study|Death|0|||
27847697|NCT04233879|81272167|FG000|Overall Study|Lost to Follow-up|3|||
27847698|NCT04233879|81272168|FG001|Overall Study|Lost to Follow-up|8|||
27847699|NCT04233879|81272167|FG000|Overall Study|Physician Decision|4|||
27847700|NCT04233879|81272168|FG001|Overall Study|Physician Decision|4|||
27847701|NCT04233879|81272167|FG000|Overall Study|Withdrawal by Subject|7|||
27847702|NCT04233879|81272168|FG001|Overall Study|Withdrawal by Subject|10|||
27894275|NCT02829723|81447377|FG013|Overall Study|Death|1|||
27894276|NCT02829723|81447378|FG014|Overall Study|Death|0|||
27894277|NCT02829723|81447379|FG015|Overall Study|Death|0|||
27894278|NCT02829723|81447380|FG016|Overall Study|Death|0|||
27894279|NCT02829723|81447381|FG017|Overall Study|Death|0|||
27894280|NCT02829723|81447382|FG018|Overall Study|Death|0|||
27894281|NCT02829723|81447383|FG019|Overall Study|Death|0|||
27894282|NCT02829723|81447384|FG020|Overall Study|Death|0|||
27894283|NCT02829723|81447385|FG021|Overall Study|Death|2|||
27894284|NCT02829723|81447386|FG022|Overall Study|Death|0|||
27894285|NCT02829723|81447387|FG023|Overall Study|Death|0|||
27894286|NCT02829723|81447388|FG024|Overall Study|Death|0|||
27894287|NCT02829723|81447389|FG025|Overall Study|Death|1|||
27894288|NCT02829723|81447390|FG026|Overall Study|Death|2|||
27894289|NCT02829723|81447364|FG000|Overall Study|Physician Decision|0|||
27894290|NCT02829723|81447365|FG001|Overall Study|Physician Decision|0|||
27847703|NCT04233879|81272167|FG000|Overall Study|Other|281|||
27847704|NCT04233879|81272168|FG001|Overall Study|Other|279|||
27847705|NCT00233987|81272169|FG000|Overall Study|Withdrawal by Subject|1|||
27847706|NCT00233987|81272169|FG000|Overall Study|Lack of Efficacy|2|||
27847707|NCT00233987|81272169|FG000|Overall Study|Reason Under Review|1|||
27847708|NCT00233987|81272169|FG000|Overall Study|Other - Not Protocol Specified|5|||
27847709|NCT00233987|81272169|FG000|Overall Study|Eligible but No Treatment Received|2|||
27847710|NCT00233987|81272169|FG000|Overall Study|Ineligible|4|||
27847711|NCT00706355|81272170|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
27847712|NCT00706355|81272171|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
27847713|NCT00706355|81272172|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
27847714|NCT00706355|81272173|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
27894291|NCT02829723|81447366|FG002|Overall Study|Physician Decision|0|||
27894292|NCT02829723|81447367|FG003|Overall Study|Physician Decision|0|||
27894293|NCT02829723|81447368|FG004|Overall Study|Physician Decision|0|||
27894294|NCT02829723|81447369|FG005|Overall Study|Physician Decision|0|||
27894295|NCT02829723|81447370|FG006|Overall Study|Physician Decision|0|||
27894296|NCT02829723|81447371|FG007|Overall Study|Physician Decision|0|||
27894297|NCT02829723|81447372|FG008|Overall Study|Physician Decision|0|||
27894298|NCT02829723|81447373|FG009|Overall Study|Physician Decision|1|||
27613793|NCT02065570|80426785|FG002|Maintenance Study|Lost to Follow-up|2|||
27613794|NCT02065570|80426786|FG003|Maintenance Study|Lost to Follow-up|2|||
27613795|NCT02065570|80426783|FG000|Maintenance Study|Other, Not Specified|0|||
27613796|NCT02065570|80426784|FG001|Maintenance Study|Other, Not Specified|0|||
27613797|NCT02065570|80426785|FG002|Maintenance Study|Other, Not Specified|11|||
27613798|NCT02065570|80426786|FG003|Maintenance Study|Other, Not Specified|5|||
27613799|NCT00556374|80426791|FG000|Overall Study|Withdrawal by Subject|235|||
27613800|NCT00556374|80426792|FG001|Overall Study|Withdrawal by Subject|205|||
27894299|NCT02829723|81447374|FG010|Overall Study|Physician Decision|1|||
27894300|NCT02829723|81447375|FG011|Overall Study|Physician Decision|0|||
27894301|NCT02829723|81447376|FG012|Overall Study|Physician Decision|0|||
27894302|NCT02829723|81447377|FG013|Overall Study|Physician Decision|1|||
27726455|NCT00772447|80830077|FG000|Overall Study|incorrect enrolment|3|||
27726456|NCT00772447|80830078|FG001|Overall Study|incorrect enrolment|4|||
27847715|NCT00706355|81272170|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
27847716|NCT00706355|81272171|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
27894303|NCT02829723|81447378|FG014|Overall Study|Physician Decision|0|||
27894304|NCT02829723|81447379|FG015|Overall Study|Physician Decision|0|||
27894305|NCT02829723|81447380|FG016|Overall Study|Physician Decision|2|||
27894306|NCT02829723|81447381|FG017|Overall Study|Physician Decision|0|||
27894307|NCT02829723|81447382|FG018|Overall Study|Physician Decision|0|||
27894308|NCT02829723|81447383|FG019|Overall Study|Physician Decision|0|||
27894309|NCT02829723|81447384|FG020|Overall Study|Physician Decision|0|||
27894310|NCT02829723|81447385|FG021|Overall Study|Physician Decision|0|||
27726457|NCT00772447|80830077|FG000|Overall Study|Protocol Violation|0|||
27726458|NCT00772447|80830078|FG001|Overall Study|Protocol Violation|1|||
27847717|NCT00706355|81272172|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
27847718|NCT00706355|81272173|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
27894311|NCT02829723|81447386|FG022|Overall Study|Physician Decision|1|||
27894312|NCT02829723|81447387|FG023|Overall Study|Physician Decision|1|||
27894313|NCT02829723|81447388|FG024|Overall Study|Physician Decision|1|||
27894314|NCT02829723|81447389|FG025|Overall Study|Physician Decision|1|||
27894315|NCT02829723|81447390|FG026|Overall Study|Physician Decision|3|||
27894316|NCT02829723|81447364|FG000|Overall Study|Progressive disease|4|||
27847719|NCT00706355|81272170|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
27847720|NCT00706355|81272171|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
27847721|NCT00706355|81272172|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
27847722|NCT00706355|81272173|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
27847723|NCT00706355|81272170|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
27847724|NCT00706355|81272171|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
27847725|NCT00706355|81272172|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
27847726|NCT00706355|81272173|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
27847727|NCT00706355|81272170|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
27847728|NCT00706355|81272171|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
27847729|NCT00706355|81272172|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
27847730|NCT00706355|81272173|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
27847731|NCT00706355|81272170|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
27847732|NCT00706355|81272171|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
27847733|NCT00706355|81272172|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
27847734|NCT00706355|81272173|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
27847735|NCT00706355|81272170|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
27847736|NCT00706355|81272171|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
27847737|NCT00706355|81272172|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
27847738|NCT00706355|81272173|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
27847739|NCT00706355|81272170|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
27847740|NCT00706355|81272171|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
27847741|NCT00706355|81272172|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
27847742|NCT00706355|81272173|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
27847743|NCT00706355|81272170|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
27726459|NCT00772447|80830077|FG000|Overall Study|all others|2|||
27726460|NCT00772447|80830078|FG001|Overall Study|all others|2|||
27726461|NCT00598975|80830081|FG000|Overall Study|Adverse Event|1|||
27726462|NCT00598975|80830082|FG001|Overall Study|Adverse Event|1|||
27847744|NCT00706355|81272171|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
27847745|NCT00706355|81272172|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
27847746|NCT00706355|81272173|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
27847747|NCT02694549|81272183|FG000|Overall Study|screen failures|2|||
27847748|NCT02377921|81272184|FG000|Overall Study|Subject non-compliance|1|||
27847749|NCT02377921|81272185|FG001|Overall Study|Subject non-compliance|1|||
27847750|NCT03921151|81272186|FG000|Overall Study|Withdrawal by Subject|11|||
27847751|NCT03921151|81272187|FG001|Overall Study|Withdrawal by Subject|16|||
27847752|NCT01688726|81272188|FG000|Overall Study|Adverse Event|1|||
27847753|NCT01688726|81272189|FG001|Overall Study|Adverse Event|0|||
27847754|NCT01688726|81272188|FG000|Overall Study|Relocated abroad|0|||
27847755|NCT01688726|81272189|FG001|Overall Study|Relocated abroad|1|||
27847756|NCT01534078|81272198|FG000|Overall Study|Death|1|||
27847757|NCT01534078|81272198|FG000|Overall Study|Withdrawal by Subject|1|||
27847758|NCT01376310|81272199|FG000|Overall Study|Study closed/terminated|1|||
27847759|NCT01376310|81272200|FG001|Overall Study|Study closed/terminated|2|||
27847760|NCT01376310|81272199|FG000|Overall Study|Withdrawal by Subject|8|||
27847761|NCT01376310|81272200|FG001|Overall Study|Withdrawal by Subject|2|||
27847762|NCT01376310|81272199|FG000|Overall Study|Physician Decision|26|||
27847763|NCT01376310|81272200|FG001|Overall Study|Physician Decision|7|||
27847764|NCT01376310|81272199|FG000|Overall Study|Lost to Follow-up|1|||
27847765|NCT01376310|81272200|FG001|Overall Study|Lost to Follow-up|0|||
27847766|NCT02938520|81272201|FG000|Overall Study|On-going at the time of analysis|258|||
27847767|NCT02938520|81272202|FG001|Overall Study|On-going at the time of analysis|261|||
27847768|NCT02938520|81272201|FG000|Overall Study|Physician Decision|2|||
27894317|NCT02829723|81447365|FG001|Overall Study|Progressive disease|6|||
27894318|NCT02829723|81447366|FG002|Overall Study|Progressive disease|3|||
27894319|NCT02829723|81447367|FG003|Overall Study|Progressive disease|3|||
27894320|NCT02829723|81447368|FG004|Overall Study|Progressive disease|3|||
27894321|NCT02829723|81447369|FG005|Overall Study|Progressive disease|5|||
27847769|NCT02938520|81272202|FG001|Overall Study|Physician Decision|5|||
27894322|NCT02829723|81447370|FG006|Overall Study|Progressive disease|4|||
27894323|NCT02829723|81447371|FG007|Overall Study|Progressive disease|6|||
27894324|NCT02829723|81447372|FG008|Overall Study|Progressive disease|8|||
27894325|NCT02829723|81447373|FG009|Overall Study|Progressive disease|4|||
27894326|NCT02829723|81447374|FG010|Overall Study|Progressive disease|9|||
27847770|NCT02938520|81272201|FG000|Overall Study|Lost to Follow-up|2|||
27847771|NCT02938520|81272202|FG001|Overall Study|Lost to Follow-up|2|||
27847772|NCT02938520|81272201|FG000|Overall Study|Withdrawal by Subject|7|||
27894327|NCT02829723|81447375|FG011|Overall Study|Progressive disease|0|||
27894328|NCT02829723|81447376|FG012|Overall Study|Progressive disease|3|||
27894329|NCT02829723|81447377|FG013|Overall Study|Progressive disease|4|||
27894330|NCT02829723|81447378|FG014|Overall Study|Progressive disease|2|||
27726463|NCT00598975|80830081|FG000|Overall Study|Brain metastases|1|||
27847773|NCT02938520|81272202|FG001|Overall Study|Withdrawal by Subject|7|||
27847774|NCT02938520|81272201|FG000|Overall Study|Protocol Violation|0|||
27505459|NCT00098475|80044147|FG000|Step 1|Progressive disease|33|||
27505460|NCT00098475|80044148|FG001|Step 1|Progressive disease|35|||
27505461|NCT00098475|80044149|FG002|Step 1|Progressive disease|2|||
27505462|NCT00098475|80044150|FG003|Step 1|Progressive disease|1|||
27505463|NCT00098475|80044147|FG000|Step 1|Adverse Event|56|||
27505464|NCT00098475|80044148|FG001|Step 1|Adverse Event|37|||
27505465|NCT00098475|80044149|FG002|Step 1|Adverse Event|0|||
27505466|NCT00098475|80044150|FG003|Step 1|Adverse Event|1|||
27505467|NCT00098475|80044147|FG000|Step 1|Death|8|||
27505468|NCT00098475|80044148|FG001|Step 1|Death|5|||
27505469|NCT00098475|80044149|FG002|Step 1|Death|0|||
27505470|NCT00098475|80044150|FG003|Step 1|Death|1|||
27505471|NCT00098475|80044147|FG000|Step 1|Withdrawal by Subject|14|||
27505472|NCT00098475|80044148|FG001|Step 1|Withdrawal by Subject|11|||
27505473|NCT00098475|80044149|FG002|Step 1|Withdrawal by Subject|0|||
27505474|NCT00098475|80044150|FG003|Step 1|Withdrawal by Subject|0|||
27505475|NCT00098475|80044147|FG000|Step 1|Physician Decision|5|||
27505476|NCT00098475|80044148|FG001|Step 1|Physician Decision|2|||
27505477|NCT00098475|80044149|FG002|Step 1|Physician Decision|0|||
27505478|NCT00098475|80044150|FG003|Step 1|Physician Decision|0|||
27505479|NCT00098475|80044147|FG000|Step 1|Alternative therapy|31|||
27505480|NCT00098475|80044148|FG001|Step 1|Alternative therapy|43|||
27505481|NCT00098475|80044149|FG002|Step 1|Alternative therapy|1|||
27505482|NCT00098475|80044150|FG003|Step 1|Alternative therapy|0|||
27505483|NCT00098475|80044147|FG000|Step 1|Other disease|2|||
27505484|NCT00098475|80044148|FG001|Step 1|Other disease|1|||
27505485|NCT00098475|80044149|FG002|Step 1|Other disease|1|||
27505486|NCT00098475|80044150|FG003|Step 1|Other disease|0|||
27505487|NCT00098475|80044147|FG000|Step 1|Never started treatment|0|||
27505488|NCT00098475|80044148|FG001|Step 1|Never started treatment|2|||
27505489|NCT00098475|80044149|FG002|Step 1|Never started treatment|0|||
27505490|NCT00098475|80044150|FG003|Step 1|Never started treatment|0|||
27505491|NCT00098475|80044147|FG000|Step 1|Still on treatment as of this analysis|14|||
27847775|NCT02938520|81272202|FG001|Overall Study|Protocol Violation|1|||
27847776|NCT02938520|81272201|FG000|Overall Study|Lack of Efficacy|5|||
27847777|NCT02938520|81272202|FG001|Overall Study|Lack of Efficacy|3|||
27847778|NCT02938520|81272201|FG000|Overall Study|Adverse Event|9|||
27847779|NCT02938520|81272202|FG001|Overall Study|Adverse Event|4|||
27847780|NCT00359788|81272203|FG000|Overall Study|Adverse Event|11|||
27847781|NCT00359788|81272204|FG001|Overall Study|Adverse Event|10|||
27847782|NCT00359788|81272203|FG000|Overall Study|Lack of Efficacy|1|||
27847783|NCT00359788|81272204|FG001|Overall Study|Lack of Efficacy|2|||
27894331|NCT02829723|81447379|FG015|Overall Study|Progressive disease|4|||
27894332|NCT02829723|81447380|FG016|Overall Study|Progressive disease|5|||
27894333|NCT02829723|81447381|FG017|Overall Study|Progressive disease|3|||
27894334|NCT02829723|81447382|FG018|Overall Study|Progressive disease|4|||
27894335|NCT02829723|81447383|FG019|Overall Study|Progressive disease|4|||
27894336|NCT02829723|81447384|FG020|Overall Study|Progressive disease|7|||
27894337|NCT02829723|81447385|FG021|Overall Study|Progressive disease|6|||
27505492|NCT00098475|80044148|FG001|Step 1|Still on treatment as of this analysis|27|||
27505493|NCT00098475|80044149|FG002|Step 1|Still on treatment as of this analysis|0|||
27505494|NCT00098475|80044150|FG003|Step 1|Still on treatment as of this analysis|0|||
27505495|NCT00098475|80044147|FG000|Step 1|Knee surgery|1|||
27847784|NCT00359788|81272203|FG000|Overall Study|Lost to Follow-up|3|||
27847785|NCT00359788|81272204|FG001|Overall Study|Lost to Follow-up|2|||
27847786|NCT00359788|81272203|FG000|Overall Study|Withdrawal by Subject|4|||
27847787|NCT00359788|81272204|FG001|Overall Study|Withdrawal by Subject|1|||
27847788|NCT00359788|81272203|FG000|Overall Study|Protocol Violation|4|||
27847789|NCT00359788|81272204|FG001|Overall Study|Protocol Violation|2|||
27847790|NCT03407118|81272205|FG000|Period 2|Withdrawal by Subject|1|||
27847791|NCT03407118|81272206|FG001|Period 2|Withdrawal by Subject|0|||
27847792|NCT04086641|81272209|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
27847793|NCT04086641|81272210|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
27847794|NCT02531594|81272211|FG000|Overall Study|Withdrawal by Subject|7|||
27847795|NCT02531594|81272212|FG001|Overall Study|Withdrawal by Subject|8|||
27505496|NCT00098475|80044148|FG001|Step 1|Knee surgery|0|||
27505497|NCT00098475|80044149|FG002|Step 1|Knee surgery|0|||
27847796|NCT00904748|81272213|FG000|Overall Study|Withdrawal by Subject|1|||
27847797|NCT00904748|81272214|FG001|Overall Study|Withdrawal by Subject|1|||
27505498|NCT00098475|80044150|FG003|Step 1|Knee surgery|0|||
27847798|NCT00904748|81272215|FG002|Overall Study|Withdrawal by Subject|1|||
27847799|NCT00904748|81272216|FG003|Overall Study|Withdrawal by Subject|2|||
27894338|NCT02829723|81447386|FG022|Overall Study|Progressive disease|3|||
27894339|NCT02829723|81447387|FG023|Overall Study|Progressive disease|3|||
27505499|NCT00098475|80044147|FG000|Step 1|Complications|1|||
27505500|NCT00098475|80044148|FG001|Step 1|Complications|0|||
27505501|NCT00098475|80044149|FG002|Step 1|Complications|0|||
27847800|NCT00904748|81272217|FG004|Overall Study|Withdrawal by Subject|0|||
27847801|NCT00904748|81272218|FG005|Overall Study|Withdrawal by Subject|0|||
27894340|NCT02829723|81447388|FG024|Overall Study|Progressive disease|3|||
27847802|NCT00904748|81272213|FG000|Overall Study|Adverse Event|0|||
27847803|NCT00904748|81272214|FG001|Overall Study|Adverse Event|0|||
27847804|NCT00904748|81272215|FG002|Overall Study|Adverse Event|0|||
27505502|NCT00098475|80044150|FG003|Step 1|Complications|0|||
27847805|NCT00904748|81272216|FG003|Overall Study|Adverse Event|0|||
27847806|NCT00904748|81272217|FG004|Overall Study|Adverse Event|1|||
27847807|NCT00904748|81272218|FG005|Overall Study|Adverse Event|0|||
27847808|NCT03180801|81272227|FG000|Overall Study|Physician Decision|3|||
27847809|NCT03180801|81272228|FG001|Overall Study|Physician Decision|3|||
27847810|NCT03180801|81272229|FG002|Overall Study|Physician Decision|1|||
27847811|NCT03180801|81272227|FG000|Overall Study|Non-compliance|1|||
27847812|NCT03180801|81272228|FG001|Overall Study|Non-compliance|4|||
27847813|NCT03180801|81272229|FG002|Overall Study|Non-compliance|0|||
27847814|NCT03180801|81272227|FG000|Overall Study|Inoculation Target Reached|1|||
27847815|NCT03180801|81272228|FG001|Overall Study|Inoculation Target Reached|1|||
27847816|NCT03180801|81272229|FG002|Overall Study|Inoculation Target Reached|3|||
27847817|NCT03180801|81272227|FG000|Overall Study|Adverse Event|1|||
27847818|NCT03180801|81272228|FG001|Overall Study|Adverse Event|0|||
27847819|NCT03180801|81272229|FG002|Overall Study|Adverse Event|2|||
27847820|NCT03180801|81272227|FG000|Overall Study|Withdrawal by Subject|2|||
27847821|NCT03180801|81272228|FG001|Overall Study|Withdrawal by Subject|2|||
27847822|NCT03180801|81272229|FG002|Overall Study|Withdrawal by Subject|1|||
27847823|NCT03180801|81272227|FG000|Overall Study|Lost to Follow-up|0|||
27847824|NCT03180801|81272228|FG001|Overall Study|Lost to Follow-up|2|||
27847825|NCT03180801|81272229|FG002|Overall Study|Lost to Follow-up|3|||
27847826|NCT01901848|81272230|FG000|Randomized and Treated|Lost to Follow-up|3|||
27847827|NCT01901848|81272231|FG001|Randomized and Treated|Lost to Follow-up|6|||
27847828|NCT01901848|81272230|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
27847829|NCT01901848|81272231|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
27847830|NCT01042535|81272234|FG000|Overall Study|disease progression prior to treatment|3|||
27847831|NCT01042535|81272234|FG000|Overall Study|disease progression during treatment|3|||
27847832|NCT01042535|81272234|FG000|Overall Study|complications from other disease|2|||
27847833|NCT00307931|81272237|FG000|Overall Study|Adverse Event|1|||
27847834|NCT02443545|81272240|FG000|Overall Study|Adverse Event|1|||
27847835|NCT02443545|81272241|FG001|Overall Study|Adverse Event|1|||
27847836|NCT02443545|81272240|FG000|Overall Study|Lost to Follow-up|0|||
27847837|NCT02443545|81272241|FG001|Overall Study|Lost to Follow-up|2|||
27847838|NCT02443545|81272240|FG000|Overall Study|Physician Decision|3|||
27847839|NCT02443545|81272241|FG001|Overall Study|Physician Decision|0|||
27847840|NCT02443545|81272240|FG000|Overall Study|Protocol Violation|8|||
27847841|NCT02443545|81272241|FG001|Overall Study|Protocol Violation|1|||
27847842|NCT02443545|81272240|FG000|Overall Study|Pregnancy|1|||
27847843|NCT02443545|81272241|FG001|Overall Study|Pregnancy|1|||
27847844|NCT02443545|81272240|FG000|Overall Study|Withdrawal by Subject|6|||
27847845|NCT02443545|81272241|FG001|Overall Study|Withdrawal by Subject|3|||
27847846|NCT02443545|81272240|FG000|Overall Study|Termination of study|20|||
27847847|NCT02443545|81272241|FG001|Overall Study|Termination of study|11|||
27847848|NCT03827018|81275602|FG000|Overall Study|Adverse Event|1|||
27847849|NCT03827018|81275603|FG001|Overall Study|Adverse Event|0|||
27847850|NCT03827018|81275602|FG000|Overall Study|Withdrawal by Subject|2|||
27847851|NCT03827018|81275603|FG001|Overall Study|Withdrawal by Subject|2|||
27847852|NCT03827018|81275602|FG000|Overall Study|Lack of Efficacy|0|||
27847853|NCT03827018|81275603|FG001|Overall Study|Lack of Efficacy|1|||
27847854|NCT00479388|81275604|FG000|Overall Study|Adverse Event|90|||
27847855|NCT00479388|81275605|FG001|Overall Study|Adverse Event|45|||
27847856|NCT00479388|81275604|FG000|Overall Study|Lost to Follow-up|0|||
27847857|NCT00479388|81275605|FG001|Overall Study|Lost to Follow-up|2|||
27847858|NCT00479388|81275604|FG000|Overall Study|Protocol Violation|10|||
27847859|NCT00479388|81275605|FG001|Overall Study|Protocol Violation|9|||
27847860|NCT00479388|81275604|FG000|Overall Study|Withdrawal by Subject|32|||
27847861|NCT00479388|81275605|FG001|Overall Study|Withdrawal by Subject|17|||
27847862|NCT04412057|81275606|FG000|Overall Study|Death|3|||
27847863|NCT04412057|81275607|FG001|Overall Study|Death|7|||
27505503|NCT00098475|80044147|FG000|Step 1|Cannot comply due to other tx|0|||
27847864|NCT04412057|81275606|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
27847865|NCT04412057|81275607|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
27847866|NCT02492841|81275608|FG000|Overall Study|Lost to Follow-up|34|||
27847867|NCT02492841|81275609|FG001|Overall Study|Lost to Follow-up|31|||
27847868|NCT02492841|81275610|FG002|Overall Study|Lost to Follow-up|35|||
27505504|NCT00098475|80044148|FG001|Step 1|Cannot comply due to other tx|1|||
27847869|NCT02450526|81275611|FG000|DB Period (Cycle 1)|Adverse Event|0|||
27847870|NCT02450526|81275612|FG001|DB Period (Cycle 1)|Adverse Event|0|||
27847871|NCT02450526|81275613|FG002|DB Period (Cycle 1)|Adverse Event|2|||
27847872|NCT02450526|81275614|FG003|DB Period (Cycle 1)|Adverse Event|0|||
27847873|NCT02450526|81275615|FG004|DB Period (Cycle 1)|Adverse Event|0|||
27847874|NCT02450526|81275611|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
27847875|NCT02450526|81275612|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
27847876|NCT02450526|81275613|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
27505505|NCT00098475|80044149|FG002|Step 1|Cannot comply due to other tx|0|||
27505506|NCT00098475|80044150|FG003|Step 1|Cannot comply due to other tx|0|||
27505507|NCT00098475|80044147|FG000|Step 1|Both patient and physician's decision|2|||
27505508|NCT00098475|80044148|FG001|Step 1|Both patient and physician's decision|1|||
27505509|NCT00098475|80044149|FG002|Step 1|Both patient and physician's decision|0|||
27505510|NCT00098475|80044150|FG003|Step 1|Both patient and physician's decision|0|||
27505511|NCT00098475|80044147|FG000|Step 1|Incorrect disease assessment|2|||
27505512|NCT00098475|80044148|FG001|Step 1|Incorrect disease assessment|0|||
27505513|NCT00098475|80044149|FG002|Step 1|Incorrect disease assessment|0|||
27505514|NCT00098475|80044150|FG003|Step 1|Incorrect disease assessment|0|||
27847877|NCT02450526|81275614|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
27847878|NCT02450526|81275615|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
27847879|NCT02450526|81275611|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
27894341|NCT02829723|81447389|FG025|Overall Study|Progressive disease|16|||
27894342|NCT02829723|81447390|FG026|Overall Study|Progressive disease|10|||
27894343|NCT02829723|81447364|FG000|Overall Study|Subject/guardian decision|0|||
27894344|NCT02829723|81447365|FG001|Overall Study|Subject/guardian decision|1|||
27894345|NCT02829723|81447366|FG002|Overall Study|Subject/guardian decision|0|||
27894346|NCT02829723|81447367|FG003|Overall Study|Subject/guardian decision|1|||
27894347|NCT02829723|81447368|FG004|Overall Study|Subject/guardian decision|0|||
27894348|NCT02829723|81447369|FG005|Overall Study|Subject/guardian decision|0|||
27894349|NCT02829723|81447370|FG006|Overall Study|Subject/guardian decision|0|||
27894350|NCT02829723|81447371|FG007|Overall Study|Subject/guardian decision|1|||
27894351|NCT02829723|81447372|FG008|Overall Study|Subject/guardian decision|0|||
27894352|NCT02829723|81447373|FG009|Overall Study|Subject/guardian decision|0|||
27894353|NCT02829723|81447374|FG010|Overall Study|Subject/guardian decision|0|||
27894354|NCT02829723|81447375|FG011|Overall Study|Subject/guardian decision|0|||
27894355|NCT02829723|81447376|FG012|Overall Study|Subject/guardian decision|0|||
27894356|NCT02829723|81447377|FG013|Overall Study|Subject/guardian decision|0|||
27894357|NCT02829723|81447378|FG014|Overall Study|Subject/guardian decision|1|||
27894358|NCT02829723|81447379|FG015|Overall Study|Subject/guardian decision|0|||
27894359|NCT02829723|81447380|FG016|Overall Study|Subject/guardian decision|1|||
27894360|NCT02829723|81447381|FG017|Overall Study|Subject/guardian decision|0|||
27894361|NCT02829723|81447382|FG018|Overall Study|Subject/guardian decision|1|||
27894362|NCT02829723|81447383|FG019|Overall Study|Subject/guardian decision|0|||
27847880|NCT02450526|81275612|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
27894363|NCT02829723|81447384|FG020|Overall Study|Subject/guardian decision|1|||
27894364|NCT02829723|81447385|FG021|Overall Study|Subject/guardian decision|0|||
27894365|NCT02829723|81447386|FG022|Overall Study|Subject/guardian decision|0|||
27894366|NCT02829723|81447387|FG023|Overall Study|Subject/guardian decision|1|||
27894367|NCT02829723|81447388|FG024|Overall Study|Subject/guardian decision|0|||
27894368|NCT02829723|81447389|FG025|Overall Study|Subject/guardian decision|1|||
27894369|NCT02829723|81447390|FG026|Overall Study|Subject/guardian decision|1|||
27894370|NCT02829723|81447364|FG000|Overall Study|Study terminated by sponsor|0|||
27894371|NCT02829723|81447365|FG001|Overall Study|Study terminated by sponsor|0|||
27847881|NCT02450526|81275613|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
27847882|NCT02450526|81275614|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
27847883|NCT02450526|81275615|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
27847884|NCT02450526|81275611|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
27847885|NCT02450526|81275612|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
27847886|NCT02450526|81275613|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
27847887|NCT02450526|81275614|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
27847888|NCT02450526|81275615|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
27847889|NCT02450526|81275611|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
27847890|NCT02450526|81275612|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
27847891|NCT02450526|81275613|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
27847892|NCT02450526|81275614|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
27894372|NCT02829723|81447366|FG002|Overall Study|Study terminated by sponsor|0|||
27894373|NCT02829723|81447367|FG003|Overall Study|Study terminated by sponsor|0|||
27894374|NCT02829723|81447368|FG004|Overall Study|Study terminated by sponsor|0|||
27505515|NCT00098475|80044147|FG000|Step 1|Off treatment for > specified timeframe|1|||
27505516|NCT00098475|80044148|FG001|Step 1|Off treatment for > specified timeframe|1|||
27505517|NCT00098475|80044149|FG002|Step 1|Off treatment for > specified timeframe|0|||
27847893|NCT02450526|81275615|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
27847894|NCT02450526|81275611|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27847895|NCT02450526|81275612|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27847896|NCT02450526|81275613|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27847897|NCT02450526|81275614|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
27847898|NCT02450526|81275615|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
27847899|NCT02450526|81275611|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27847900|NCT02450526|81275612|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27894375|NCT02829723|81447369|FG005|Overall Study|Study terminated by sponsor|0|||
27894376|NCT02829723|81447370|FG006|Overall Study|Study terminated by sponsor|0|||
27894377|NCT02829723|81447371|FG007|Overall Study|Study terminated by sponsor|0|||
27847901|NCT02450526|81275613|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27847902|NCT02450526|81275614|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
27847903|NCT02450526|81275615|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
27847904|NCT02450526|81275611|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
27847905|NCT02450526|81275612|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
27847906|NCT02450526|81275613|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
27847907|NCT02450526|81275614|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
27847908|NCT02450526|81275615|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
27847909|NCT01232491|81275616|FG000|Overall Study|Adverse Event|13|||
27847910|NCT01232491|81275617|FG001|Overall Study|Adverse Event|8|||
27847911|NCT01232491|81275616|FG000|Overall Study|Lack of Efficacy|1|||
27847912|NCT01232491|81275617|FG001|Overall Study|Lack of Efficacy|5|||
27847913|NCT01232491|81275616|FG000|Overall Study|Protocol Violation|13|||
27847914|NCT01232491|81275617|FG001|Overall Study|Protocol Violation|11|||
27847915|NCT01232491|81275616|FG000|Overall Study|Withdrawal Criteria|12|||
27847916|NCT01232491|81275617|FG001|Overall Study|Withdrawal Criteria|21|||
27847917|NCT01232491|81275616|FG000|Overall Study|Other|21|||
27847918|NCT01232491|81275617|FG001|Overall Study|Other|18|||
27847919|NCT00684567|81275618|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
27847920|NCT00684567|81275618|FG000|Monotherapy Period|Adverse Event|2|||
27894378|NCT02829723|81447372|FG008|Overall Study|Study terminated by sponsor|0|||
27894379|NCT02829723|81447373|FG009|Overall Study|Study terminated by sponsor|0|||
27505518|NCT00098475|80044150|FG003|Step 1|Off treatment for > specified timeframe|0|||
27505519|NCT00098475|80044147|FG000|Step 1|Declining performance status|0|||
27505520|NCT00098475|80044148|FG001|Step 1|Declining performance status|1|||
27505521|NCT00098475|80044149|FG002|Step 1|Declining performance status|0|||
27505522|NCT00098475|80044150|FG003|Step 1|Declining performance status|0|||
27505523|NCT00098475|80044147|FG000|Step 1|Insurance issue|0|||
27505524|NCT00098475|80044148|FG001|Step 1|Insurance issue|1|||
27505525|NCT00098475|80044149|FG002|Step 1|Insurance issue|0|||
27505526|NCT00098475|80044150|FG003|Step 1|Insurance issue|0|||
27505527|NCT00098475|80044147|FG000|Step 1|Rising paraprotein|0|||
27726464|NCT00598975|80830082|FG001|Overall Study|Brain metastases|0|||
27726465|NCT00598975|80830081|FG000|Overall Study|Withdrawal by Subject|1|||
27726466|NCT00598975|80830082|FG001|Overall Study|Withdrawal by Subject|1|||
27847921|NCT00684567|81275618|FG000|Monotherapy Period|Death|1|||
27847922|NCT00684567|81275618|FG000|Monotherapy Period|Progression of primary disease|11|||
27847923|NCT00865514|81275619|FG000|Overall Study|Infusion cost exceeded funding|2|||
27894380|NCT02829723|81447374|FG010|Overall Study|Study terminated by sponsor|0|||
27894381|NCT02829723|81447375|FG011|Overall Study|Study terminated by sponsor|0|||
27894382|NCT02829723|81447376|FG012|Overall Study|Study terminated by sponsor|0|||
27894383|NCT02829723|81447377|FG013|Overall Study|Study terminated by sponsor|0|||
27894384|NCT02829723|81447378|FG014|Overall Study|Study terminated by sponsor|0|||
27894385|NCT02829723|81447379|FG015|Overall Study|Study terminated by sponsor|0|||
27894386|NCT02829723|81447380|FG016|Overall Study|Study terminated by sponsor|0|||
27847924|NCT00775606|81275620|FG000|Overall Study|Study sponsor terminated funding|3|||
27505528|NCT00098475|80044148|FG001|Step 1|Rising paraprotein|1|||
27505529|NCT00098475|80044149|FG002|Step 1|Rising paraprotein|0|||
27505530|NCT00098475|80044150|FG003|Step 1|Rising paraprotein|0|||
27847925|NCT00775606|81275621|FG001|Overall Study|Study sponsor terminated funding|0|||
27847926|NCT00337428|81275622|FG000|Overall Study|Withdrawal by Subject|1|||
27847927|NCT00337428|81275623|FG001|Overall Study|Withdrawal by Subject|2|||
27847928|NCT00337428|81275622|FG000|Overall Study|Lack of Time|1|||
27847929|NCT00337428|81275623|FG001|Overall Study|Lack of Time|1|||
27894387|NCT02829723|81447381|FG017|Overall Study|Study terminated by sponsor|0|||
27847930|NCT00337428|81275622|FG000|Overall Study|Unwilling to Continue|1|||
27847931|NCT00337428|81275623|FG001|Overall Study|Unwilling to Continue|0|||
27894388|NCT02829723|81447382|FG018|Overall Study|Study terminated by sponsor|0|||
27894389|NCT02829723|81447383|FG019|Overall Study|Study terminated by sponsor|0|||
27894390|NCT02829723|81447384|FG020|Overall Study|Study terminated by sponsor|0|||
27894391|NCT02829723|81447385|FG021|Overall Study|Study terminated by sponsor|1|||
27894392|NCT02829723|81447386|FG022|Overall Study|Study terminated by sponsor|0|||
27894393|NCT02829723|81447387|FG023|Overall Study|Study terminated by sponsor|0|||
27894394|NCT02829723|81447388|FG024|Overall Study|Study terminated by sponsor|0|||
27894395|NCT02829723|81447389|FG025|Overall Study|Study terminated by sponsor|0|||
27894396|NCT02829723|81447390|FG026|Overall Study|Study terminated by sponsor|0|||
27894397|NCT04420585|81450232|FG000|Overall Study|Adverse Event|1|||
27894398|NCT04420585|81450232|FG000|Overall Study|Never initiated medication|2|||
27894399|NCT02267135|81450233|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
27894400|NCT02267135|81450234|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
27894401|NCT02267135|81450233|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
27894402|NCT02267135|81450234|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
27894403|NCT02267135|81450233|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
27894404|NCT02267135|81450234|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
27894405|NCT02267135|81450233|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
27894406|NCT02267135|81450234|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
27894407|NCT02267135|81450233|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
27894408|NCT02267135|81450234|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
27894409|NCT00348595|81450235|FG000|Overall Study|Adverse Event|5|||
27894410|NCT00348595|81450236|FG001|Overall Study|Adverse Event|8|||
27894411|NCT03045276|81450237|FG000|Intervention Phase|Withdrawal by Subject|7|||
27894412|NCT03045276|81450238|FG001|Intervention Phase|Withdrawal by Subject|2|||
27894413|NCT03045276|81450239|FG002|Intervention Phase|Withdrawal by Subject|3|||
27894414|NCT03045276|81450240|FG003|Intervention Phase|Withdrawal by Subject|7|||
27894415|NCT03045276|81450237|FG000|Intervention Phase|Developed exclusionary criteria|3|||
27894416|NCT03045276|81450238|FG001|Intervention Phase|Developed exclusionary criteria|3|||
27894417|NCT03045276|81450239|FG002|Intervention Phase|Developed exclusionary criteria|0|||
27894418|NCT03045276|81450240|FG003|Intervention Phase|Developed exclusionary criteria|0|||
27894419|NCT03045276|81450237|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
27894420|NCT03045276|81450238|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
27894421|NCT03045276|81450239|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
27894422|NCT03045276|81450240|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
27894423|NCT03045276|81450237|FG000|Follow-Up Phase|Lost to Follow-up|0|||
27894424|NCT03045276|81450238|FG001|Follow-Up Phase|Lost to Follow-up|1|||
27894425|NCT03045276|81450239|FG002|Follow-Up Phase|Lost to Follow-up|0|||
27894426|NCT03045276|81450240|FG003|Follow-Up Phase|Lost to Follow-up|1|||
27894427|NCT03045276|81450237|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
27894428|NCT03045276|81450238|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
27894429|NCT03045276|81450239|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
27894430|NCT03045276|81450240|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
27894431|NCT00878969|81450241|FG000|Overall Study|Physician Decision|5|||
27894432|NCT00878969|81450242|FG001|Overall Study|Physician Decision|3|||
27894433|NCT00878969|81450243|FG002|Overall Study|Physician Decision|2|||
27894434|NCT00878969|81450241|FG000|Overall Study|Withdrawal by Subject|1|||
27894435|NCT00878969|81450242|FG001|Overall Study|Withdrawal by Subject|6|||
27894436|NCT00878969|81450243|FG002|Overall Study|Withdrawal by Subject|3|||
27894437|NCT00878969|81450241|FG000|Overall Study|kidney transplant|2|||
27894438|NCT00878969|81450242|FG001|Overall Study|kidney transplant|3|||
27894439|NCT00878969|81450243|FG002|Overall Study|kidney transplant|2|||
27894440|NCT00878969|81450241|FG000|Overall Study|Adverse Event|3|||
27894441|NCT00878969|81450242|FG001|Overall Study|Adverse Event|1|||
27894442|NCT00878969|81450243|FG002|Overall Study|Adverse Event|2|||
27894443|NCT00878969|81450241|FG000|Overall Study|Lost to Follow-up|2|||
27847932|NCT00337428|81275622|FG000|Overall Study|Anorexia|1|||
27847933|NCT00337428|81275623|FG001|Overall Study|Anorexia|0|||
27847934|NCT01355159|81275624|FG000|Overall Study|Withdrew consent|39|||
27847935|NCT01355159|81275625|FG001|Overall Study|Withdrew consent|47|||
27847936|NCT01355159|81275624|FG000|Overall Study|No primary outcome data|17|||
27847937|NCT01355159|81275625|FG001|Overall Study|No primary outcome data|11|||
27847938|NCT01355159|81275624|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
27894444|NCT00878969|81450242|FG001|Overall Study|Lost to Follow-up|1|||
27894445|NCT00878969|81450243|FG002|Overall Study|Lost to Follow-up|0|||
27847939|NCT01355159|81275625|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
27847940|NCT01355159|81275624|FG000|Overall Study|Early intrauterine fetal death|6|||
27894446|NCT00878969|81450241|FG000|Overall Study|Protocol Violation|2|||
27894447|NCT00878969|81450242|FG001|Overall Study|Protocol Violation|0|||
27894448|NCT00878969|81450243|FG002|Overall Study|Protocol Violation|0|||
27894449|NCT00878969|81450241|FG000|Overall Study|Death|0|||
27894450|NCT00878969|81450242|FG001|Overall Study|Death|0|||
27894451|NCT00878969|81450243|FG002|Overall Study|Death|2|||
27894452|NCT00878969|81450241|FG000|Overall Study|Pregnancy|0|||
27726467|NCT00598975|80830081|FG000|Overall Study|Withdrawal of consent|0|||
27726468|NCT00598975|80830082|FG001|Overall Study|Withdrawal of consent|1|||
27726469|NCT00598975|80830081|FG000|Overall Study|Disease progression|8|||
27726470|NCT00598975|80830082|FG001|Overall Study|Disease progression|3|||
27726471|NCT00598975|80830081|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
27726472|NCT00598975|80830082|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
27726473|NCT05655377|80830083|FG000|Overall Study|Withdrawal by Subject|2|||
27726474|NCT02149810|80830084|FG000|Overall Study|Physician Decision|1|||
27726475|NCT02149810|80830085|FG001|Overall Study|Physician Decision|2|||
27726476|NCT02149810|80830084|FG000|Overall Study|Lost to Follow-up|2|||
27726477|NCT02149810|80830085|FG001|Overall Study|Lost to Follow-up|1|||
27726478|NCT02149810|80830084|FG000|Overall Study|Withdrawal by Subject|5|||
27726479|NCT02149810|80830085|FG001|Overall Study|Withdrawal by Subject|1|||
27726480|NCT03158220|80830086|FG000|Overall Study|Screen Failure|0|||
27726481|NCT03158220|80830087|FG001|Overall Study|Screen Failure|1|||
27726482|NCT03158220|80830086|FG000|Overall Study|Withdrawal by Subject|8|||
27726483|NCT03158220|80830087|FG001|Overall Study|Withdrawal by Subject|9|||
27726484|NCT03158220|80830086|FG000|Overall Study|Status unknown|0|||
27726485|NCT03158220|80830087|FG001|Overall Study|Status unknown|1|||
27726486|NCT03158220|80830086|FG000|Overall Study|Lost to Follow-up|8|||
27726487|NCT03158220|80830087|FG001|Overall Study|Lost to Follow-up|5|||
27726488|NCT03158220|80830086|FG000|Overall Study|Physician Decision|1|||
27726489|NCT03158220|80830087|FG001|Overall Study|Physician Decision|0|||
27726490|NCT01439945|80830088|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
27726491|NCT01439945|80830089|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
27726492|NCT01439945|80830090|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
27726493|NCT01439945|80830091|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
27726494|NCT01439945|80830088|FG000|Double-Blind Treatment Phase|Ineligible|1|||
27726495|NCT01439945|80830089|FG001|Double-Blind Treatment Phase|Ineligible|2|||
27726496|NCT01439945|80830090|FG002|Double-Blind Treatment Phase|Ineligible|0|||
27726497|NCT01439945|80830091|FG003|Double-Blind Treatment Phase|Ineligible|1|||
27726498|NCT03372941|80830110|FG000|Overall Study|Lost to Follow-up|2|||
27726499|NCT03372941|80830111|FG001|Overall Study|Lost to Follow-up|4|||
27726500|NCT02078219|80830112|FG000|Overall Study|Other|2|||
27726501|NCT02078219|80830113|FG001|Overall Study|Other|2|||
27726502|NCT02078219|80830114|FG002|Overall Study|Other|3|||
27726503|NCT02078219|80830115|FG003|Overall Study|Other|0|||
27726504|NCT02078219|80830116|FG004|Overall Study|Other|1|||
27726505|NCT02078219|80830112|FG000|Overall Study|Withdrawal by Subject|0|||
27726506|NCT02078219|80830113|FG001|Overall Study|Withdrawal by Subject|1|||
27726507|NCT02078219|80830114|FG002|Overall Study|Withdrawal by Subject|0|||
27726508|NCT02078219|80830115|FG003|Overall Study|Withdrawal by Subject|1|||
27726509|NCT02078219|80830116|FG004|Overall Study|Withdrawal by Subject|1|||
27726510|NCT02078219|80830112|FG000|Overall Study|Protocol Violation|0|||
27726511|NCT02078219|80830113|FG001|Overall Study|Protocol Violation|0|||
27726512|NCT02078219|80830114|FG002|Overall Study|Protocol Violation|0|||
27726513|NCT02078219|80830115|FG003|Overall Study|Protocol Violation|1|||
27726514|NCT02078219|80830116|FG004|Overall Study|Protocol Violation|0|||
27726515|NCT02078219|80830112|FG000|Overall Study|Death|0|||
27726516|NCT02078219|80830113|FG001|Overall Study|Death|0|||
27726517|NCT02078219|80830114|FG002|Overall Study|Death|0|||
27726518|NCT02078219|80830115|FG003|Overall Study|Death|1|||
27726519|NCT02078219|80830116|FG004|Overall Study|Death|0|||
27726520|NCT02078219|80830112|FG000|Overall Study|Adverse Event|1|||
27726521|NCT02078219|80830113|FG001|Overall Study|Adverse Event|1|||
27726522|NCT02078219|80830114|FG002|Overall Study|Adverse Event|3|||
27726523|NCT02078219|80830115|FG003|Overall Study|Adverse Event|1|||
27726524|NCT02078219|80830116|FG004|Overall Study|Adverse Event|0|||
27726525|NCT00984204|80830117|FG000|Overall Study|Death|1|||
27726526|NCT00984204|80830117|FG000|Overall Study|Lost to Follow-up|4|||
27894453|NCT00878969|81450242|FG001|Overall Study|Pregnancy|1|||
27894454|NCT00878969|81450243|FG002|Overall Study|Pregnancy|0|||
27726527|NCT00984204|80830117|FG000|Overall Study|Lack of Efficacy|10|||
27726528|NCT01926626|80830121|FG000|Overall Study|Withdrawal by Subject|15|||
27726529|NCT01926626|80830121|FG000|Overall Study|Lost to Follow-up|7|||
27726530|NCT00802360|80830122|FG000|Overall Study|Stimulation failure|4|||
27726531|NCT00802360|80830123|FG001|Overall Study|Stimulation failure|0|||
27726532|NCT00802360|80830124|FG002|Overall Study|Stimulation failure|3|||
27726533|NCT00802360|80830125|FG003|Overall Study|Stimulation failure|3|||
27726534|NCT00802360|80830122|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
27726535|NCT00802360|80830123|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
27726536|NCT00802360|80830124|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
27726537|NCT00802360|80830125|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
27726538|NCT00802360|80830122|FG000|Overall Study|Cycle cancelled|0|||
27613801|NCT00556374|80426791|FG000|Overall Study|Death|158|||
27726539|NCT00802360|80830123|FG001|Overall Study|Cycle cancelled|1|||
27726540|NCT00802360|80830124|FG002|Overall Study|Cycle cancelled|1|||
27726541|NCT00802360|80830125|FG003|Overall Study|Cycle cancelled|1|||
27894455|NCT00875433|81450244|FG000|Overall Study|Progressive disease|41|||
27847941|NCT01355159|81275625|FG001|Overall Study|Early intrauterine fetal death|6|||
27894456|NCT00875433|81450244|FG000|Overall Study|Other Adverse Event|14|||
27894457|NCT00875433|81450244|FG000|Overall Study|Withdrawal by Subject|2|||
27894458|NCT00875433|81450244|FG000|Overall Study|Other|3|||
27505531|NCT00098475|80044147|FG000|Step 1|Referred to other physicians|0|||
27505532|NCT00098475|80044148|FG001|Step 1|Referred to other physicians|1|||
27505533|NCT00098475|80044149|FG002|Step 1|Referred to other physicians|0|||
27505534|NCT00098475|80044150|FG003|Step 1|Referred to other physicians|0|||
27505535|NCT00098475|80044147|FG000|Step 1|Criteria to continue treatment not met|0|||
27505536|NCT00098475|80044148|FG001|Step 1|Criteria to continue treatment not met|1|||
27505537|NCT00098475|80044149|FG002|Step 1|Criteria to continue treatment not met|0|||
27847942|NCT01272921|81275626|FG000|Overall Study|Protocol Violation|2|||
27847943|NCT01272921|81275627|FG001|Overall Study|Protocol Violation|1|||
27847944|NCT00115934|81275631|FG000|Overall Study|Lost to Follow-up|1|||
27505538|NCT00098475|80044150|FG003|Step 1|Criteria to continue treatment not met|0|||
27505539|NCT00098475|80044147|FG000|Step 1|Misinterpretation of lab data|0|||
27505540|NCT00098475|80044148|FG001|Step 1|Misinterpretation of lab data|1|||
27505541|NCT00098475|80044149|FG002|Step 1|Misinterpretation of lab data|0|||
27505542|NCT00098475|80044150|FG003|Step 1|Misinterpretation of lab data|0|||
27505543|NCT00098475|80044147|FG000|Step 1|Patient fell with fracture|1|||
27505544|NCT00098475|80044148|FG001|Step 1|Patient fell with fracture|0|||
27505545|NCT00098475|80044149|FG002|Step 1|Patient fell with fracture|0|||
27505546|NCT00098475|80044150|FG003|Step 1|Patient fell with fracture|0|||
27505547|NCT00098475|80044147|FG000|Step 1|Not documented|0|||
27505548|NCT00098475|80044148|FG001|Step 1|Not documented|1|||
27505549|NCT00098475|80044149|FG002|Step 1|Not documented|0|||
27505550|NCT00098475|80044150|FG003|Step 1|Not documented|0|||
27505551|NCT00098475|80044147|FG000|Step 2|Disease progression|1|||
27847945|NCT00115934|81275632|FG001|Overall Study|Lost to Follow-up|0|||
27847946|NCT00115934|81275631|FG000|Overall Study|Did not receive intervention|3|||
27847947|NCT00115934|81275632|FG001|Overall Study|Did not receive intervention|2|||
27847948|NCT00852917|81275637|FG000|Overall Study|Adverse Event|13|||
27847949|NCT00852917|81275638|FG001|Overall Study|Adverse Event|20|||
27847950|NCT00852917|81275639|FG002|Overall Study|Adverse Event|35|||
27847951|NCT00852917|81275640|FG003|Overall Study|Adverse Event|17|||
27847952|NCT00852917|81275637|FG000|Overall Study|Lack of Efficacy|21|||
27847953|NCT00852917|81275638|FG001|Overall Study|Lack of Efficacy|11|||
27847954|NCT00852917|81275639|FG002|Overall Study|Lack of Efficacy|11|||
27847955|NCT00852917|81275640|FG003|Overall Study|Lack of Efficacy|47|||
27847956|NCT00852917|81275637|FG000|Overall Study|Withdrawal by Subject|4|||
27847957|NCT00852917|81275638|FG001|Overall Study|Withdrawal by Subject|8|||
27847958|NCT00852917|81275639|FG002|Overall Study|Withdrawal by Subject|10|||
27847959|NCT00852917|81275640|FG003|Overall Study|Withdrawal by Subject|9|||
27847960|NCT00852917|81275637|FG000|Overall Study|Physician Decision|6|||
27847961|NCT00852917|81275638|FG001|Overall Study|Physician Decision|7|||
27847962|NCT00852917|81275639|FG002|Overall Study|Physician Decision|2|||
27847963|NCT00852917|81275640|FG003|Overall Study|Physician Decision|19|||
27847964|NCT00852917|81275637|FG000|Overall Study|Death|0|||
27847965|NCT00852917|81275638|FG001|Overall Study|Death|0|||
27847966|NCT00852917|81275639|FG002|Overall Study|Death|0|||
27847967|NCT00852917|81275640|FG003|Overall Study|Death|1|||
27847968|NCT02696031|81275645|FG000|Up to Week 24|Adverse Event|2|||
27847969|NCT02696031|81275646|FG001|Up to Week 24|Adverse Event|4|||
27847970|NCT02696031|81275647|FG002|Up to Week 24|Adverse Event|2|||
27847971|NCT02696031|81275648|FG003|Up to Week 24|Adverse Event|0|||
27847972|NCT02696031|81275649|FG004|Up to Week 24|Adverse Event|0|||
27847973|NCT02696031|81275650|FG005|Up to Week 24|Adverse Event|0|||
27847974|NCT02696031|81275645|FG000|Up to Week 24|Lack of Efficacy|2|||
27847975|NCT02696031|81275646|FG001|Up to Week 24|Lack of Efficacy|1|||
27847976|NCT02696031|81275647|FG002|Up to Week 24|Lack of Efficacy|2|||
27847977|NCT02696031|81275648|FG003|Up to Week 24|Lack of Efficacy|0|||
27847978|NCT02696031|81275649|FG004|Up to Week 24|Lack of Efficacy|0|||
27847979|NCT02696031|81275650|FG005|Up to Week 24|Lack of Efficacy|0|||
27505552|NCT00098475|80044148|FG001|Step 2|Disease progression|4|||
27505553|NCT00098475|80044149|FG002|Step 2|Disease progression|0|||
27847980|NCT02696031|81275645|FG000|Up to Week 24|Lost to Follow-up|0|||
27847981|NCT02696031|81275646|FG001|Up to Week 24|Lost to Follow-up|1|||
27847982|NCT02696031|81275647|FG002|Up to Week 24|Lost to Follow-up|1|||
27847983|NCT02696031|81275648|FG003|Up to Week 24|Lost to Follow-up|0|||
27847984|NCT02696031|81275649|FG004|Up to Week 24|Lost to Follow-up|0|||
27505554|NCT00098475|80044150|FG003|Step 2|Disease progression|0|||
27505555|NCT00098475|80044147|FG000|Step 2|Adverse Event|2|||
27505556|NCT00098475|80044148|FG001|Step 2|Adverse Event|0|||
27505557|NCT00098475|80044149|FG002|Step 2|Adverse Event|0|||
27847985|NCT02696031|81275650|FG005|Up to Week 24|Lost to Follow-up|0|||
27847986|NCT02696031|81275645|FG000|Up to Week 24|Physician Decision|1|||
27847987|NCT02696031|81275646|FG001|Up to Week 24|Physician Decision|0|||
27847988|NCT02696031|81275647|FG002|Up to Week 24|Physician Decision|1|||
27847989|NCT02696031|81275648|FG003|Up to Week 24|Physician Decision|0|||
27847990|NCT02696031|81275649|FG004|Up to Week 24|Physician Decision|0|||
27847991|NCT02696031|81275650|FG005|Up to Week 24|Physician Decision|0|||
27847992|NCT02696031|81275645|FG000|Up to Week 24|Protocol Violation|1|||
27847993|NCT02696031|81275646|FG001|Up to Week 24|Protocol Violation|0|||
27847994|NCT02696031|81275647|FG002|Up to Week 24|Protocol Violation|0|||
27847995|NCT02696031|81275648|FG003|Up to Week 24|Protocol Violation|0|||
27847996|NCT02696031|81275649|FG004|Up to Week 24|Protocol Violation|0|||
27847997|NCT02696031|81275650|FG005|Up to Week 24|Protocol Violation|0|||
27847998|NCT02696031|81275645|FG000|Up to Week 24|Withdrawal by Subject|4|||
27847999|NCT02696031|81275646|FG001|Up to Week 24|Withdrawal by Subject|1|||
27848000|NCT02696031|81275647|FG002|Up to Week 24|Withdrawal by Subject|5|||
27848001|NCT02696031|81275648|FG003|Up to Week 24|Withdrawal by Subject|0|||
27848002|NCT02696031|81275649|FG004|Up to Week 24|Withdrawal by Subject|0|||
27848003|NCT02696031|81275650|FG005|Up to Week 24|Withdrawal by Subject|0|||
27848004|NCT02696031|81275645|FG000|Up to Week 52|Adverse Event|4|||
27848005|NCT02696031|81275646|FG001|Up to Week 52|Adverse Event|5|||
27848006|NCT02696031|81275647|FG002|Up to Week 52|Adverse Event|3|||
27848007|NCT02696031|81275648|FG003|Up to Week 52|Adverse Event|0|||
27848008|NCT02696031|81275649|FG004|Up to Week 52|Adverse Event|0|||
27848009|NCT02696031|81275650|FG005|Up to Week 52|Adverse Event|0|||
27848010|NCT02696031|81275645|FG000|Up to Week 52|Lack of Efficacy|10|||
27848011|NCT02696031|81275646|FG001|Up to Week 52|Lack of Efficacy|7|||
27848012|NCT02696031|81275647|FG002|Up to Week 52|Lack of Efficacy|11|||
27848013|NCT02696031|81275648|FG003|Up to Week 52|Lack of Efficacy|0|||
27848014|NCT02696031|81275649|FG004|Up to Week 52|Lack of Efficacy|0|||
27848015|NCT02696031|81275650|FG005|Up to Week 52|Lack of Efficacy|0|||
27848016|NCT02696031|81275645|FG000|Up to Week 52|Lost to Follow-up|1|||
27848017|NCT02696031|81275646|FG001|Up to Week 52|Lost to Follow-up|1|||
27848018|NCT02696031|81275647|FG002|Up to Week 52|Lost to Follow-up|1|||
27505558|NCT00098475|80044150|FG003|Step 2|Adverse Event|0|||
27505559|NCT00098475|80044147|FG000|Step 2|Withdrawal by Subject|0|||
27505560|NCT00098475|80044148|FG001|Step 2|Withdrawal by Subject|2|||
27505561|NCT00098475|80044149|FG002|Step 2|Withdrawal by Subject|0|||
27505562|NCT00098475|80044150|FG003|Step 2|Withdrawal by Subject|0|||
27505563|NCT00098475|80044147|FG000|Step 2|Physician Decision|0|||
27505564|NCT00098475|80044148|FG001|Step 2|Physician Decision|1|||
27505565|NCT00098475|80044149|FG002|Step 2|Physician Decision|0|||
27505566|NCT00098475|80044150|FG003|Step 2|Physician Decision|0|||
27505567|NCT00098475|80044147|FG000|Step 2|Alternative therapy|1|||
27505568|NCT00098475|80044148|FG001|Step 2|Alternative therapy|2|||
27505569|NCT00098475|80044149|FG002|Step 2|Alternative therapy|0|||
27505570|NCT00098475|80044150|FG003|Step 2|Alternative therapy|0|||
27505571|NCT00098475|80044147|FG000|Step 2|Never started treatment|1|||
27505572|NCT00098475|80044148|FG001|Step 2|Never started treatment|1|||
27505573|NCT00098475|80044149|FG002|Step 2|Never started treatment|0|||
27505574|NCT00098475|80044150|FG003|Step 2|Never started treatment|0|||
27505575|NCT00630838|80044153|FG000|Overall Study|Death|0|||
27848019|NCT02696031|81275648|FG003|Up to Week 52|Lost to Follow-up|0|||
27848020|NCT02696031|81275649|FG004|Up to Week 52|Lost to Follow-up|0|||
27848021|NCT02696031|81275650|FG005|Up to Week 52|Lost to Follow-up|0|||
27848022|NCT02696031|81275645|FG000|Up to Week 52|Physician Decision|1|||
27848023|NCT02696031|81275646|FG001|Up to Week 52|Physician Decision|1|||
27848024|NCT02696031|81275647|FG002|Up to Week 52|Physician Decision|2|||
27848025|NCT02696031|81275648|FG003|Up to Week 52|Physician Decision|0|||
27848026|NCT02696031|81275649|FG004|Up to Week 52|Physician Decision|0|||
27505576|NCT00630838|80044154|FG001|Overall Study|Death|1|||
27505577|NCT00630838|80044153|FG000|Overall Study|Lost to Follow-up|0|||
27505578|NCT00630838|80044154|FG001|Overall Study|Lost to Follow-up|1|||
27848027|NCT02696031|81275650|FG005|Up to Week 52|Physician Decision|0|||
27848028|NCT02696031|81275645|FG000|Up to Week 52|Pregnancy|0|||
27848029|NCT02696031|81275646|FG001|Up to Week 52|Pregnancy|2|||
27848030|NCT02696031|81275647|FG002|Up to Week 52|Pregnancy|0|||
27848031|NCT02696031|81275648|FG003|Up to Week 52|Pregnancy|0|||
27848032|NCT02696031|81275649|FG004|Up to Week 52|Pregnancy|0|||
27848033|NCT02696031|81275650|FG005|Up to Week 52|Pregnancy|0|||
27848034|NCT02696031|81275645|FG000|Up to Week 52|Protocol Violation|1|||
27848035|NCT02696031|81275646|FG001|Up to Week 52|Protocol Violation|0|||
27848036|NCT02696031|81275647|FG002|Up to Week 52|Protocol Violation|0|||
27848037|NCT02696031|81275648|FG003|Up to Week 52|Protocol Violation|0|||
27848038|NCT02696031|81275649|FG004|Up to Week 52|Protocol Violation|0|||
27848039|NCT02696031|81275650|FG005|Up to Week 52|Protocol Violation|0|||
27848040|NCT02696031|81275645|FG000|Up to Week 52|Withdrawal by Subject|12|||
27848041|NCT02696031|81275646|FG001|Up to Week 52|Withdrawal by Subject|3|||
27505579|NCT01598532|80044155|FG000|Overall Study|Lost to Follow-up|3|||
27505580|NCT01598532|80044155|FG000|Overall Study|Did not meet inclusion criteria|8|||
27505581|NCT03213691|80044157|FG000|Overall Study|Adverse Event|2|||
27505582|NCT03213691|80044157|FG000|Overall Study|Death|3|||
27505583|NCT03213691|80044157|FG000|Overall Study|Physician Decision|1|||
27505584|NCT03213691|80044157|FG000|Overall Study|Progressive Disease|14|||
27505585|NCT03213691|80044157|FG000|Overall Study|Ineligible|1|||
27726542|NCT00802360|80830122|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
27726543|NCT00802360|80830123|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
27726544|NCT00802360|80830124|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
27726545|NCT00802360|80830125|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
27726546|NCT00802360|80830122|FG000|Overall Study|No positive serum pregnancy|17|||
27894459|NCT01664949|81450247|FG000|Overall Study|Adverse Event|11|||
27894460|NCT01664949|81450248|FG001|Overall Study|Adverse Event|12|||
27894461|NCT01664949|81450247|FG000|Overall Study|Lack of Efficacy|1|||
27894462|NCT01664949|81450248|FG001|Overall Study|Lack of Efficacy|1|||
27894463|NCT01664949|81450247|FG000|Overall Study|Lost to Follow-up|1|||
27894464|NCT01664949|81450248|FG001|Overall Study|Lost to Follow-up|2|||
27894465|NCT01664949|81450247|FG000|Overall Study|Personal Reasons|3|||
27894466|NCT01664949|81450248|FG001|Overall Study|Personal Reasons|4|||
27894467|NCT01664949|81450247|FG000|Overall Study|Protocol Violation|5|||
27894468|NCT01664949|81450248|FG001|Overall Study|Protocol Violation|5|||
27894469|NCT01664949|81450247|FG000|Overall Study|Other Miscellaneous Reasons|3|||
27894470|NCT01664949|81450248|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27894471|NCT00732758|81450249|FG000|Overall Study|Lost to Follow-up|8|||
27726547|NCT00802360|80830123|FG001|Overall Study|No positive serum pregnancy|20|||
27726548|NCT00802360|80830124|FG002|Overall Study|No positive serum pregnancy|14|||
27726549|NCT00802360|80830125|FG003|Overall Study|No positive serum pregnancy|10|||
27726550|NCT00802360|80830122|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
27505586|NCT02420821|80044160|FG000|Overall Study|Lost to Follow-up|6|||
27726551|NCT00802360|80830123|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27726552|NCT00802360|80830124|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
27726553|NCT00802360|80830125|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
27726554|NCT00802360|80830122|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
27726555|NCT00802360|80830123|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
27726556|NCT00802360|80830124|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
27726557|NCT00802360|80830125|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
27726558|NCT00802360|80830122|FG000|Overall Study|Other|2|||
27726559|NCT00802360|80830123|FG001|Overall Study|Other|3|||
27726560|NCT00802360|80830124|FG002|Overall Study|Other|6|||
27726561|NCT00802360|80830125|FG003|Overall Study|Other|3|||
27726562|NCT03828487|80830126|FG000|Overall Study|Physician Decision|1|||
27726563|NCT02542072|80830127|FG000|First Intervention (1 Month)|Adverse Event|1|||
27726564|NCT02542072|80830128|FG001|First Intervention (1 Month)|Adverse Event|1|||
27726565|NCT02542072|80830127|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
27726566|NCT02542072|80830128|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
27726567|NCT02542072|80830127|FG000|First Intervention (1 Month)|Lens discomfort|1|||
27726568|NCT02542072|80830128|FG001|First Intervention (1 Month)|Lens discomfort|2|||
27726569|NCT02542072|80830127|FG000|First Intervention (1 Month)|Protocol Violation|1|||
27726570|NCT02542072|80830128|FG001|First Intervention (1 Month)|Protocol Violation|0|||
27726571|NCT02542072|80830127|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
27726572|NCT02542072|80830128|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
27726573|NCT02542072|80830127|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
27726574|NCT02542072|80830128|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
27726575|NCT01275222|80830132|FG000|Phase l by Treatment|Adverse Event|1|||
27726576|NCT01275222|80830133|FG001|Phase l by Treatment|Adverse Event|4|||
27726577|NCT01275222|80830134|FG002|Phase l by Treatment|Adverse Event|2|||
27848042|NCT02696031|81275647|FG002|Up to Week 52|Withdrawal by Subject|9|||
27848043|NCT02696031|81275648|FG003|Up to Week 52|Withdrawal by Subject|0|||
27726578|NCT01275222|80830135|FG003|Phase l by Treatment|Adverse Event|3|||
27726579|NCT01275222|80830136|FG004|Phase l by Treatment|Adverse Event|0|||
27894472|NCT00732758|81450250|FG001|Overall Study|Lost to Follow-up|16|||
27894473|NCT02998476|81450252|FG000|Overall Study|Lost to Follow-up|1|||
27505587|NCT02420821|80044161|FG001|Overall Study|Lost to Follow-up|6|||
27726580|NCT01275222|80830137|FG005|Phase l by Treatment|Adverse Event|0|||
27848044|NCT02696031|81275649|FG004|Up to Week 52|Withdrawal by Subject|0|||
27848045|NCT02696031|81275650|FG005|Up to Week 52|Withdrawal by Subject|0|||
27848046|NCT02696031|81275645|FG000|Up to Week 104|Pregnancy|0|||
27894474|NCT02998476|81450253|FG001|Overall Study|Lost to Follow-up|0|||
27848047|NCT02696031|81275646|FG001|Up to Week 104|Pregnancy|2|||
27848048|NCT02696031|81275647|FG002|Up to Week 104|Pregnancy|1|||
27848049|NCT02696031|81275648|FG003|Up to Week 104|Pregnancy|0|||
27848050|NCT02696031|81275649|FG004|Up to Week 104|Pregnancy|0|||
27848051|NCT02696031|81275650|FG005|Up to Week 104|Pregnancy|0|||
27848052|NCT02696031|81275645|FG000|Up to Week 104|Withdrawal by Subject|15|||
27848053|NCT02696031|81275646|FG001|Up to Week 104|Withdrawal by Subject|10|||
27848054|NCT02696031|81275647|FG002|Up to Week 104|Withdrawal by Subject|16|||
27848055|NCT02696031|81275648|FG003|Up to Week 104|Withdrawal by Subject|0|||
27848056|NCT02696031|81275649|FG004|Up to Week 104|Withdrawal by Subject|0|||
27848057|NCT02696031|81275650|FG005|Up to Week 104|Withdrawal by Subject|0|||
27848058|NCT02696031|81275645|FG000|Up to Week 104|Protocol Violation|1|||
27848059|NCT02696031|81275646|FG001|Up to Week 104|Protocol Violation|0|||
27848060|NCT02696031|81275647|FG002|Up to Week 104|Protocol Violation|0|||
27848061|NCT02696031|81275648|FG003|Up to Week 104|Protocol Violation|0|||
27848062|NCT02696031|81275649|FG004|Up to Week 104|Protocol Violation|0|||
27848063|NCT02696031|81275650|FG005|Up to Week 104|Protocol Violation|0|||
27848064|NCT02696031|81275645|FG000|Up to Week 104|Physician Decision|1|||
27848065|NCT02696031|81275646|FG001|Up to Week 104|Physician Decision|2|||
27848066|NCT02696031|81275647|FG002|Up to Week 104|Physician Decision|3|||
27848067|NCT02696031|81275648|FG003|Up to Week 104|Physician Decision|0|||
27848068|NCT02696031|81275649|FG004|Up to Week 104|Physician Decision|0|||
27848069|NCT02696031|81275650|FG005|Up to Week 104|Physician Decision|0|||
27848070|NCT02696031|81275645|FG000|Up to Week 104|Lost to Follow-up|2|||
27848071|NCT02696031|81275646|FG001|Up to Week 104|Lost to Follow-up|3|||
27848072|NCT02696031|81275647|FG002|Up to Week 104|Lost to Follow-up|1|||
27848073|NCT02696031|81275648|FG003|Up to Week 104|Lost to Follow-up|0|||
27848074|NCT02696031|81275649|FG004|Up to Week 104|Lost to Follow-up|0|||
27848075|NCT02696031|81275650|FG005|Up to Week 104|Lost to Follow-up|0|||
27848076|NCT02696031|81275645|FG000|Up to Week 104|Lack of Efficacy|13|||
27848077|NCT02696031|81275646|FG001|Up to Week 104|Lack of Efficacy|12|||
27848078|NCT02696031|81275647|FG002|Up to Week 104|Lack of Efficacy|11|||
27848079|NCT02696031|81275648|FG003|Up to Week 104|Lack of Efficacy|0|||
27848080|NCT02696031|81275649|FG004|Up to Week 104|Lack of Efficacy|0|||
27848081|NCT02696031|81275650|FG005|Up to Week 104|Lack of Efficacy|0|||
27848082|NCT02696031|81275645|FG000|Up to Week 104|Adverse Event|7|||
27848083|NCT02696031|81275646|FG001|Up to Week 104|Adverse Event|11|||
27848084|NCT02696031|81275647|FG002|Up to Week 104|Adverse Event|5|||
27848085|NCT02696031|81275648|FG003|Up to Week 104|Adverse Event|0|||
27848086|NCT02696031|81275649|FG004|Up to Week 104|Adverse Event|0|||
27848087|NCT02696031|81275650|FG005|Up to Week 104|Adverse Event|0|||
27848088|NCT02696031|81275645|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
27848089|NCT02696031|81275646|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
27848090|NCT02696031|81275647|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
27848091|NCT02696031|81275648|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
27848092|NCT02696031|81275649|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
27848093|NCT02696031|81275650|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
27848094|NCT02696031|81275645|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
27848095|NCT02696031|81275646|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
27848096|NCT02696031|81275647|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
27848097|NCT02696031|81275648|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
27848098|NCT02696031|81275649|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
27848099|NCT02696031|81275650|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
27848100|NCT02696031|81275645|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
27848101|NCT02696031|81275646|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
27848102|NCT02696031|81275647|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
27848103|NCT02696031|81275648|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
27848104|NCT02696031|81275649|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
27848105|NCT02696031|81275650|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
27848106|NCT02696031|81275645|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
27848107|NCT02696031|81275646|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
27848108|NCT02696031|81275647|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
27848109|NCT02696031|81275648|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
27848110|NCT02696031|81275649|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
27848111|NCT02696031|81275650|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
27848112|NCT02696031|81275645|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
27848113|NCT02696031|81275646|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
27848114|NCT02696031|81275647|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
27848115|NCT02696031|81275648|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
27848116|NCT02696031|81275649|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
27848117|NCT02696031|81275650|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
27848118|NCT02696031|81275645|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
27848119|NCT02696031|81275646|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
27848120|NCT02696031|81275647|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
27848121|NCT02696031|81275648|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
27848122|NCT02696031|81275649|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
27848123|NCT02696031|81275650|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
27848124|NCT02696031|81275645|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
27848125|NCT02696031|81275646|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
27848126|NCT02696031|81275647|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
27848127|NCT02696031|81275648|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
27848128|NCT02696031|81275649|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
27848129|NCT02696031|81275650|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
27848130|NCT02384850|81275651|FG000|Overall Study|Withdrawal by Subject|2|||
27848131|NCT02384850|81275652|FG001|Overall Study|Withdrawal by Subject|2|||
27848132|NCT01976728|81275653|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
27848133|NCT01976728|81275654|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
27848134|NCT01976728|81275655|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
27848135|NCT01976728|81275656|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
27848136|NCT00754442|81275657|FG000|Overall Study|Withdrawal by Subject|5|||
27848137|NCT00754442|81275658|FG001|Overall Study|Withdrawal by Subject|3|||
27848138|NCT01298778|81275660|FG000|Overall Study|Lost to Follow-up|2|||
27848139|NCT01298778|81275661|FG001|Overall Study|Lost to Follow-up|3|||
27848140|NCT01298778|81275660|FG000|Overall Study|Incorrect use of VAS|1|||
27848141|NCT01298778|81275661|FG001|Overall Study|Incorrect use of VAS|0|||
27848142|NCT01298778|81275660|FG000|Overall Study|Withdrawal by Subject|0|||
27848143|NCT01298778|81275661|FG001|Overall Study|Withdrawal by Subject|1|||
27848144|NCT01298778|81275660|FG000|Overall Study|Protocol Violation|0|||
27848145|NCT01298778|81275661|FG001|Overall Study|Protocol Violation|1|||
27848146|NCT01298778|81275660|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
27848147|NCT01298778|81275661|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
27848148|NCT00518622|81275663|FG000|Overall Study|Lost to Follow-up|0|||
27848149|NCT00518622|81275664|FG001|Overall Study|Lost to Follow-up|0|||
27848150|NCT00518622|81275665|FG002|Overall Study|Lost to Follow-up|1|||
27848151|NCT00518622|81275666|FG003|Overall Study|Lost to Follow-up|0|||
27848152|NCT00518622|81275667|FG004|Overall Study|Lost to Follow-up|0|||
27848153|NCT00518622|81275668|FG005|Overall Study|Lost to Follow-up|0|||
27848154|NCT00518622|81275669|FG006|Overall Study|Lost to Follow-up|0|||
27848155|NCT00518622|81275670|FG007|Overall Study|Lost to Follow-up|0|||
27848156|NCT00518622|81275663|FG000|Overall Study|Study medication taken incorrectly|0|||
27848157|NCT00518622|81275664|FG001|Overall Study|Study medication taken incorrectly|1|||
27848158|NCT00518622|81275665|FG002|Overall Study|Study medication taken incorrectly|0|||
27848159|NCT00518622|81275666|FG003|Overall Study|Study medication taken incorrectly|0|||
27848160|NCT00518622|81275667|FG004|Overall Study|Study medication taken incorrectly|0|||
27848161|NCT00518622|81275668|FG005|Overall Study|Study medication taken incorrectly|0|||
27848162|NCT00518622|81275669|FG006|Overall Study|Study medication taken incorrectly|0|||
27848163|NCT00518622|81275670|FG007|Overall Study|Study medication taken incorrectly|0|||
27848164|NCT02985879|81275671|FG000|Overall Study|Adverse Event|7|||
27848165|NCT02985879|81275672|FG001|Overall Study|Adverse Event|9|||
27848166|NCT02985879|81275673|FG002|Overall Study|Adverse Event|7|||
27848167|NCT02985879|81275671|FG000|Overall Study|Withdrew consent|6|||
27848168|NCT02985879|81275672|FG001|Overall Study|Withdrew consent|8|||
27848169|NCT02985879|81275673|FG002|Overall Study|Withdrew consent|10|||
27848170|NCT02985879|81275671|FG000|Overall Study|Lost to Follow-up|1|||
27848171|NCT02985879|81275672|FG001|Overall Study|Lost to Follow-up|0|||
27848172|NCT02985879|81275673|FG002|Overall Study|Lost to Follow-up|2|||
27848173|NCT02985879|81275671|FG000|Overall Study|Other, not specified|62|||
27848174|NCT02985879|81275672|FG001|Overall Study|Other, not specified|58|||
27848175|NCT02985879|81275673|FG002|Overall Study|Other, not specified|58|||
27848176|NCT02747004|81275674|FG000|Overall Study|Withdrawal by Subject|8|||
27848177|NCT02747004|81275675|FG001|Overall Study|Withdrawal by Subject|5|||
27848178|NCT02747004|81275676|FG002|Overall Study|Withdrawal by Subject|4|||
27848179|NCT02747004|81275674|FG000|Overall Study|Lost to Follow-up|1|||
27848180|NCT02747004|81275675|FG001|Overall Study|Lost to Follow-up|2|||
27848181|NCT02747004|81275676|FG002|Overall Study|Lost to Follow-up|2|||
27848182|NCT02747004|81275674|FG000|Overall Study|on study treatment/follow-up|48|||
27848183|NCT02747004|81275675|FG001|Overall Study|on study treatment/follow-up|42|||
27848184|NCT02747004|81275676|FG002|Overall Study|on study treatment/follow-up|41|||
27848185|NCT00396331|81275679|FG000|Overall Study|Failed to mobilize - no transplant|8|||
27848186|NCT00396331|81275679|FG000|Overall Study|Did not go on to transplant|5|||
27848187|NCT00396331|81275679|FG000|Overall Study|Lost to Follow-up|3|||
27848188|NCT00396331|81275679|FG000|Overall Study|Death|16|||
27848189|NCT01673698|81275680|FG000|Overall Study|Lost to Follow-up|51|||
27505588|NCT02420821|80044160|FG000|Overall Study|Non-compliance|0|||
27848190|NCT01673698|81275681|FG001|Overall Study|Lost to Follow-up|13|||
27848191|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
27848192|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
27848193|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
27848194|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
27848195|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
27848196|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
27848197|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
27848198|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
27848199|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
27848200|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
27848201|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
27848202|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
27848203|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
27848204|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27848205|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27848206|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27848207|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
27848208|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
27848209|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
27848210|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
27848211|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
27848212|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
27848213|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
27848214|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
27848215|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
27848216|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
27848217|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
27848218|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
27848219|NCT03227224|81275682|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
27848220|NCT03227224|81275683|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
27848221|NCT03227224|81275684|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
27848222|NCT03227224|81275685|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
27848223|NCT03227224|81275682|FG000|Follow-up Phase (2 Weeks)|Other|4|||
27848224|NCT03227224|81275683|FG001|Follow-up Phase (2 Weeks)|Other|4|||
27848225|NCT03227224|81275684|FG002|Follow-up Phase (2 Weeks)|Other|6|||
27848226|NCT03227224|81275685|FG003|Follow-up Phase (2 Weeks)|Other|3|||
27848227|NCT01014624|81275686|FG000|Overall Study|Adverse Event|0|||
27848228|NCT01014624|81275687|FG001|Overall Study|Adverse Event|1|||
27848229|NCT01014624|81275686|FG000|Overall Study|Protocol Violation|1|||
27848230|NCT01014624|81275687|FG001|Overall Study|Protocol Violation|0|||
27848231|NCT01014624|81275686|FG000|Overall Study|Withdrawal by Subject|1|||
27848232|NCT01014624|81275687|FG001|Overall Study|Withdrawal by Subject|0|||
27848233|NCT03903159|81275689|FG000|Overall Study|Discharged with Staff Approval|2|||
27848234|NCT03903159|81275689|FG000|Overall Study|Discharged at Staff Request|2|||
27848235|NCT03903159|81275689|FG000|Overall Study|Discharged Against Staff Advice|1|||
27848236|NCT01568866|81275690|FG000|Overall Study|Disease Progression|208|||
27848237|NCT01568866|81275691|FG001|Overall Study|Disease Progression|183|||
27848238|NCT01568866|81275690|FG000|Overall Study|Adverse Event|94|||
27848239|NCT01568866|81275691|FG001|Overall Study|Adverse Event|96|||
27848240|NCT01568866|81275690|FG000|Overall Study|Patient Request|55|||
27848241|NCT01568866|81275691|FG001|Overall Study|Patient Request|71|||
27848242|NCT01568866|81275690|FG000|Overall Study|Physician Decision|40|||
27848243|NCT01568866|81275691|FG001|Overall Study|Physician Decision|32|||
27848244|NCT01568866|81275690|FG000|Overall Study|Withdrawal by Subject|19|||
27848245|NCT01568866|81275691|FG001|Overall Study|Withdrawal by Subject|11|||
27848246|NCT01568866|81275690|FG000|Overall Study|Death|10|||
27848247|NCT01568866|81275691|FG001|Overall Study|Death|18|||
27848248|NCT01568866|81275690|FG000|Overall Study|Protocol Non-compliance|2|||
27894475|NCT02998476|81450252|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
27505589|NCT02420821|80044161|FG001|Overall Study|Non-compliance|2|||
27848249|NCT01568866|81275691|FG001|Overall Study|Protocol Non-compliance|4|||
27848250|NCT01568866|81275690|FG000|Overall Study|Lost to Follow-up|1|||
27848251|NCT01568866|81275691|FG001|Overall Study|Lost to Follow-up|0|||
27848252|NCT01568866|81275690|FG000|Overall Study|Randomized but Not Dosed|9|||
27848253|NCT01568866|81275691|FG001|Overall Study|Randomized but Not Dosed|1|||
27848254|NCT04440449|81275692|FG000|Overall Study|Lost to Follow-up|2|||
27848255|NCT04440449|81275693|FG001|Overall Study|Lost to Follow-up|0|||
27848256|NCT00112294|81275694|FG000|Overall Study|Still on study|5|||
27505590|NCT02420821|80044160|FG000|Overall Study|Physician Decision|6|||
27848257|NCT00112294|81275695|FG001|Overall Study|Still on study|0|||
27848258|NCT00724373|81275696|FG000|Overall Study|Adverse Event|41|||
27848259|NCT00724373|81275696|FG000|Overall Study|Lack of Efficacy|82|||
27848260|NCT00724373|81275696|FG000|Overall Study|Lost to Follow-up|7|||
27848261|NCT00724373|81275696|FG000|Overall Study|Non-compliance|2|||
27848262|NCT00724373|81275696|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
27848263|NCT00724373|81275696|FG000|Overall Study|Participant moved away|1|||
27848264|NCT00724373|81275696|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
27848265|NCT00724373|81275696|FG000|Overall Study|Only to have 24 week regimen|1|||
27848266|NCT00724373|81275696|FG000|Overall Study|Viral Relapse|1|||
27848267|NCT00724373|81275696|FG000|Overall Study|Acute HCV infection|1|||
27848268|NCT00724373|81275696|FG000|Overall Study|Drug Relapse|1|||
27848269|NCT00724373|81275696|FG000|Overall Study|Tolerability|23|||
27848270|NCT00493246|81275697|FG000|Overall Study|Withdrawal by Subject|0|||
27848271|NCT00493246|81275698|FG001|Overall Study|Withdrawal by Subject|0|||
27848272|NCT00493246|81275699|FG002|Overall Study|Withdrawal by Subject|0|||
27848273|NCT00493246|81275700|FG003|Overall Study|Withdrawal by Subject|0|||
27848274|NCT00493246|81275701|FG004|Overall Study|Withdrawal by Subject|1|||
27848275|NCT00493246|81275702|FG005|Overall Study|Withdrawal by Subject|0|||
27848276|NCT00493246|81275703|FG006|Overall Study|Withdrawal by Subject|0|||
27848277|NCT00493246|81275704|FG007|Overall Study|Withdrawal by Subject|0|||
27848278|NCT00493246|81275697|FG000|Overall Study|No access to draw blood|0|||
27848279|NCT00493246|81275698|FG001|Overall Study|No access to draw blood|0|||
27848280|NCT00493246|81275699|FG002|Overall Study|No access to draw blood|0|||
27848281|NCT00493246|81275700|FG003|Overall Study|No access to draw blood|0|||
27848282|NCT00493246|81275701|FG004|Overall Study|No access to draw blood|0|||
27848283|NCT00493246|81275702|FG005|Overall Study|No access to draw blood|1|||
27848284|NCT00493246|81275703|FG006|Overall Study|No access to draw blood|0|||
27848285|NCT00493246|81275704|FG007|Overall Study|No access to draw blood|0|||
27848286|NCT00493246|81275697|FG000|Overall Study|Lost to Follow-up|0|||
27848287|NCT00493246|81275698|FG001|Overall Study|Lost to Follow-up|0|||
27848288|NCT00493246|81275699|FG002|Overall Study|Lost to Follow-up|0|||
27848289|NCT00493246|81275700|FG003|Overall Study|Lost to Follow-up|0|||
27848290|NCT00493246|81275701|FG004|Overall Study|Lost to Follow-up|0|||
27848291|NCT00493246|81275702|FG005|Overall Study|Lost to Follow-up|0|||
27848292|NCT00493246|81275703|FG006|Overall Study|Lost to Follow-up|1|||
27848293|NCT00493246|81275704|FG007|Overall Study|Lost to Follow-up|0|||
27848294|NCT00868296|81275708|FG000|Overall Study|Adverse Event|0|||
27848295|NCT00868296|81275709|FG001|Overall Study|Adverse Event|2|||
27848296|NCT00868296|81275708|FG000|Overall Study|Withdrawal by Subject|0|||
27848297|NCT00868296|81275709|FG001|Overall Study|Withdrawal by Subject|1|||
27848298|NCT01194973|81275718|FG000|Screening Period|Screen Failure|3|||
27848299|NCT01194973|81275718|FG000|26 Week Treatment Period|Adverse Event|1|||
27848300|NCT01194973|81275718|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
27848301|NCT01194973|81275718|FG000|26 Week Treatment Period|Pregnancy|1|||
27848302|NCT01583218|81275721|FG000|Overall Study|Withdrawal by Subject|43|||
27848303|NCT01583218|81275722|FG001|Overall Study|Withdrawal by Subject|29|||
27848304|NCT01583218|81275721|FG000|Overall Study|Death|206|||
27848305|NCT01583218|81275722|FG001|Overall Study|Death|211|||
27848306|NCT01583218|81275721|FG000|Overall Study|Lost to Follow-up|11|||
27848307|NCT01583218|81275722|FG001|Overall Study|Lost to Follow-up|17|||
27848308|NCT01583218|81275721|FG000|Overall Study|Adverse event or serious adverse event|3|||
27848309|NCT01583218|81275722|FG001|Overall Study|Adverse event or serious adverse event|3|||
27848310|NCT01583218|81275721|FG000|Overall Study|Patient /Family decision|3|||
27848311|NCT01583218|81275722|FG001|Overall Study|Patient /Family decision|0|||
27894476|NCT02998476|81450253|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
27894477|NCT02998476|81450252|FG000|Overall Study|Withdrawal by Subject|1|||
27894478|NCT02998476|81450253|FG001|Overall Study|Withdrawal by Subject|2|||
27894479|NCT02998476|81450252|FG000|Overall Study|Death|45|||
27848312|NCT01583218|81275721|FG000|Overall Study|Cannot contact patient directly|1|||
27848313|NCT01583218|81275722|FG001|Overall Study|Cannot contact patient directly|2|||
27848314|NCT01583218|81275721|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
27848315|NCT01583218|81275722|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
27848316|NCT01583218|81275721|FG000|Overall Study|Patient did not wish to attend visits|0|||
27848317|NCT01583218|81275722|FG001|Overall Study|Patient did not wish to attend visits|1|||
27848318|NCT01583218|81275721|FG000|Overall Study|Patient randomized but not dosed|17|||
27848319|NCT01583218|81275722|FG001|Overall Study|Patient randomized but not dosed|16|||
27848320|NCT01583218|81275721|FG000|Overall Study|Patient was assessed via phone in person|1|||
27848321|NCT01583218|81275722|FG001|Overall Study|Patient was assessed via phone in person|0|||
27848322|NCT01583218|81275721|FG000|Overall Study|Patient deemed ineligible after random|2|||
27848323|NCT01583218|81275722|FG001|Overall Study|Patient deemed ineligible after random|0|||
27848324|NCT01583218|81275721|FG000|Overall Study|Patient was early terminated from study|0|||
27848325|NCT01583218|81275722|FG001|Overall Study|Patient was early terminated from study|1|||
27848326|NCT01583218|81275721|FG000|Overall Study|Patient was randomized due to mistake|1|||
27894480|NCT02998476|81450253|FG001|Overall Study|Death|2|||
27848327|NCT01583218|81275722|FG001|Overall Study|Patient was randomized due to mistake|0|||
27848328|NCT01583218|81275721|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
27848329|NCT01583218|81275722|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
27848330|NCT01583218|81275721|FG000|Overall Study|Withdraw of consent on day of random|1|||
27848331|NCT01583218|81275722|FG001|Overall Study|Withdraw of consent on day of random|0|||
27848332|NCT01491035|81275725|FG000|Overall Study|Lost to Follow-up|0|||
27848333|NCT01491035|81275726|FG001|Overall Study|Lost to Follow-up|0|||
27505591|NCT02420821|80044161|FG001|Overall Study|Physician Decision|2|||
27505592|NCT02420821|80044160|FG000|Overall Study|Withdrawal by Subject|32|||
27505593|NCT02420821|80044161|FG001|Overall Study|Withdrawal by Subject|25|||
27505594|NCT02420821|80044160|FG000|Overall Study|Death|270|||
27505595|NCT02420821|80044161|FG001|Overall Study|Death|263|||
27505596|NCT02420821|80044160|FG000|Overall Study|Study Terminated By Sponsor|145|||
27848334|NCT01491035|81275727|FG002|Overall Study|Lost to Follow-up|0|||
27848335|NCT01491035|81275728|FG003|Overall Study|Lost to Follow-up|0|||
27848336|NCT01491035|81275729|FG004|Overall Study|Lost to Follow-up|1|||
27848337|NCT01491035|81275730|FG005|Overall Study|Lost to Follow-up|0|||
27848338|NCT01491035|81275731|FG006|Overall Study|Lost to Follow-up|0|||
27848339|NCT01491035|81275732|FG007|Overall Study|Lost to Follow-up|0|||
27848340|NCT00613834|81275733|FG000|Overall Study|Withdrawal by Subject|0|||
27848341|NCT00613834|81275734|FG001|Overall Study|Withdrawal by Subject|3|||
27848342|NCT00251641|81275735|FG000|Overall Study|Adverse Event|80|||
27848343|NCT00251641|81275736|FG001|Overall Study|Adverse Event|8|||
27848344|NCT00251641|81275735|FG000|Overall Study|Lack of Efficacy|2|||
27848345|NCT00251641|81275736|FG001|Overall Study|Lack of Efficacy|1|||
27848346|NCT00251641|81275735|FG000|Overall Study|Progression of Disease|0|||
27848347|NCT00251641|81275736|FG001|Overall Study|Progression of Disease|2|||
27848348|NCT00251641|81275735|FG000|Overall Study|Lost to Follow-up|3|||
27848349|NCT00251641|81275736|FG001|Overall Study|Lost to Follow-up|3|||
27848350|NCT00251641|81275735|FG000|Overall Study|Withdrawal by Subject|6|||
27848351|NCT00251641|81275736|FG001|Overall Study|Withdrawal by Subject|8|||
27848352|NCT00251641|81275735|FG000|Overall Study|Protocol Violation|10|||
27848353|NCT00251641|81275736|FG001|Overall Study|Protocol Violation|2|||
27848354|NCT00251641|81275735|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
27848355|NCT00251641|81275736|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
27848356|NCT00251641|81275735|FG000|Overall Study|Switched Treatment|9|||
27848357|NCT00251641|81275736|FG001|Overall Study|Switched Treatment|63|||
27848358|NCT00103402|81275737|FG000|Overall Study|Adverse Event|3|||
27848359|NCT00103402|81275738|FG001|Overall Study|Adverse Event|4|||
27848360|NCT00103402|81275737|FG000|Overall Study|Lost to Follow-up|8|||
27848361|NCT00103402|81275738|FG001|Overall Study|Lost to Follow-up|7|||
27848362|NCT00103402|81275737|FG000|Overall Study|Dissatisfied/No longer interested|6|||
27848363|NCT00103402|81275738|FG001|Overall Study|Dissatisfied/No longer interested|6|||
27848364|NCT00103402|81275737|FG000|Overall Study|Personal constraints/Other|5|||
27848365|NCT00103402|81275738|FG001|Overall Study|Personal constraints/Other|0|||
27848366|NCT02039414|81275739|FG000|Overall Study|Delivered|1|||
27848367|NCT02039414|81275740|FG001|Overall Study|Delivered|1|||
27848368|NCT02039414|81275739|FG000|Overall Study|Lost to Follow-up|2|||
27848369|NCT02039414|81275740|FG001|Overall Study|Lost to Follow-up|0|||
27848370|NCT02039414|81275739|FG000|Overall Study|Protocol Violation|3|||
27848371|NCT02039414|81275740|FG001|Overall Study|Protocol Violation|1|||
27848372|NCT05016622|81275741|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
27894481|NCT02998476|81450252|FG000|Overall Study|Other|6|||
27894482|NCT02998476|81450253|FG001|Overall Study|Other|1|||
27894483|NCT00784238|81450258|FG000|Overall Study|Adverse Event|14|||
27894484|NCT00784238|81450258|FG000|Overall Study|Death|2|||
27894485|NCT00784238|81450258|FG000|Overall Study|Lack of Efficacy|33|||
27894486|NCT00784238|81450258|FG000|Overall Study|Lost to Follow-up|29|||
27894487|NCT00784238|81450258|FG000|Overall Study|Pregnancy|1|||
27894488|NCT00784238|81450258|FG000|Overall Study|Withdrawal by Subject|26|||
27894489|NCT00784238|81450258|FG000|Overall Study|Other|14|||
27894490|NCT01097421|81450259|FG000|Overall Study|Adverse Event|8|||
27894491|NCT01097421|81450259|FG000|Overall Study|Protocol Violation|2|||
27894492|NCT01097421|81450259|FG000|Overall Study|Lost to Follow-up|1|||
27894493|NCT01097421|81450259|FG000|Overall Study|Withdrawal by Subject|3|||
27894494|NCT01459718|81450262|FG000|Overall Study|Physician Decision|1|||
27894495|NCT01459718|81450262|FG000|Overall Study|Lost to Follow-up|1|||
27894496|NCT01459718|81450262|FG000|Overall Study|Adverse Event|1|||
27848373|NCT05016622|81275741|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
27848374|NCT00290251|81275742|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27848375|NCT00290251|81275743|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27848376|NCT00290251|81275744|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27848377|NCT00290251|81275745|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27848378|NCT00290251|81275746|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
27848379|NCT00290251|81275747|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
27894497|NCT02143791|81450274|FG000|Enrolled|Withdrawal by Subject|4|||
27505597|NCT02420821|80044161|FG001|Overall Study|Study Terminated By Sponsor|149|||
27894498|NCT02143791|81450274|FG000|Trial Stimulation|Lack of Efficacy|21|||
27894499|NCT02143791|81450274|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
27894500|NCT02143791|81450274|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
27894501|NCT02143791|81450274|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
27894502|NCT02143791|81450274|FG000|Any Programming (3-6 Months)|Missing Data|1|||
27894503|NCT02143791|81450274|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
27894504|NCT03769675|81450275|FG000|Overall Study|Lost to Follow-up|1|||
27894505|NCT01037127|81450276|FG000|Overall Study|Lost to Follow-up|2|||
27894506|NCT01037127|81450277|FG001|Overall Study|Lost to Follow-up|4|||
27613802|NCT00556374|80426792|FG001|Overall Study|Death|127|||
27613803|NCT00556374|80426791|FG000|Overall Study|Lost to Follow-up|24|||
27613804|NCT00556374|80426792|FG001|Overall Study|Lost to Follow-up|17|||
27613805|NCT00556374|80426791|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
27613806|NCT00556374|80426792|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
27613807|NCT00663962|80426793|FG000|Overall Study|somnolence|1|||
27613808|NCT00663962|80426794|FG001|Overall Study|somnolence|0|||
27613809|NCT03545113|80426795|FG000|Overall Study|Surgery Cancelled|1|||
27613810|NCT03545113|80426796|FG001|Overall Study|Surgery Cancelled|0|||
27613811|NCT03545113|80426795|FG000|Overall Study|Death|1|||
27613812|NCT03545113|80426796|FG001|Overall Study|Death|0|||
27613813|NCT03545113|80426795|FG000|Overall Study|Adverse Event|2|||
27613814|NCT03545113|80426796|FG001|Overall Study|Adverse Event|0|||
27613815|NCT03545113|80426795|FG000|Overall Study|Received different surgery|1|||
27613816|NCT03545113|80426796|FG001|Overall Study|Received different surgery|0|||
27613817|NCT01775930|80426798|FG000|Overall Study|Futility stopping boundary met|1|||
27613818|NCT01003639|80426799|FG000|Overall Study|Lost to Follow-up|6|||
27613819|NCT01003639|80426800|FG001|Overall Study|Lost to Follow-up|9|||
27613820|NCT01003639|80426799|FG000|Overall Study|Withdrawal by Subject|9|||
27613821|NCT01003639|80426800|FG001|Overall Study|Withdrawal by Subject|5|||
27613822|NCT01003639|80426799|FG000|Overall Study|Lack of Efficacy|1|||
27505598|NCT02420821|80044160|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
27505599|NCT02420821|80044161|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
27505600|NCT02420821|80044160|FG000|Overall Study|Adverse Event|0|||
27613823|NCT01003639|80426800|FG001|Overall Study|Lack of Efficacy|6|||
27613824|NCT01003639|80426799|FG000|Overall Study|Adverse Event|0|||
27613825|NCT01003639|80426800|FG001|Overall Study|Adverse Event|1|||
27613826|NCT01003639|80426799|FG000|Overall Study|Protocol Violation|0|||
27613827|NCT01003639|80426800|FG001|Overall Study|Protocol Violation|1|||
27613828|NCT01003639|80426799|FG000|Overall Study|Physician Decision|1|||
27613829|NCT01003639|80426800|FG001|Overall Study|Physician Decision|0|||
27613830|NCT01193582|80426801|FG000|Vaccination Series|Withdrawal by Subject|11|||
27613831|NCT01193582|80426802|FG001|Vaccination Series|Withdrawal by Subject|13|||
27613832|NCT01193582|80426803|FG002|Vaccination Series|Withdrawal by Subject|8|||
27613833|NCT01193582|80426804|FG003|Vaccination Series|Withdrawal by Subject|3|||
27613834|NCT01193582|80426801|FG000|12 Month Follow-up|Death|0|||
27613835|NCT01193582|80426802|FG001|12 Month Follow-up|Death|0|||
27613836|NCT01193582|80426803|FG002|12 Month Follow-up|Death|1|||
27613837|NCT01193582|80426804|FG003|12 Month Follow-up|Death|0|||
27613838|NCT01193582|80426801|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
27613839|NCT01193582|80426802|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
27613840|NCT01193582|80426803|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
27613841|NCT01193582|80426804|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
27613842|NCT02207374|80426805|FG000|Overall Study|Withdrawal by Subject|5|||
27726581|NCT01275222|80830132|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27894507|NCT01037127|81450276|FG000|Overall Study|Physician Decision|1|||
27894508|NCT01037127|81450277|FG001|Overall Study|Physician Decision|0|||
27894509|NCT01037127|81450276|FG000|Overall Study|Study Closed Terminated|2|||
27894510|NCT01037127|81450277|FG001|Overall Study|Study Closed Terminated|17|||
27505601|NCT02420821|80044161|FG001|Overall Study|Adverse Event|1|||
27613843|NCT02207374|80426806|FG001|Overall Study|Withdrawal by Subject|9|||
27613844|NCT02207374|80426807|FG002|Overall Study|Withdrawal by Subject|4|||
27613845|NCT02207374|80426805|FG000|Overall Study|Death|1|||
27726582|NCT01275222|80830133|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27613846|NCT02207374|80426806|FG001|Overall Study|Death|0|||
27613847|NCT02207374|80426807|FG002|Overall Study|Death|1|||
27613848|NCT02207374|80426805|FG000|Overall Study|Missing follow-up information|0|||
27613849|NCT02207374|80426806|FG001|Overall Study|Missing follow-up information|1|||
27613850|NCT02207374|80426807|FG002|Overall Study|Missing follow-up information|1|||
27894511|NCT00501059|81450278|FG000|Overall Study|Protocol Violation|80|||
27894512|NCT00501059|81450279|FG001|Overall Study|Protocol Violation|69|||
27726583|NCT01275222|80830134|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
27726584|NCT01275222|80830135|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27848380|NCT00290251|81275742|FG000|Treatment 1 (Months 2-4)|headache|0|||
27848381|NCT00290251|81275743|FG001|Treatment 1 (Months 2-4)|headache|0|||
27848382|NCT00290251|81275744|FG002|Treatment 1 (Months 2-4)|headache|0|||
27848383|NCT00290251|81275745|FG003|Treatment 1 (Months 2-4)|headache|0|||
27848384|NCT00290251|81275746|FG004|Treatment 1 (Months 2-4)|headache|1|||
27848385|NCT00290251|81275747|FG005|Treatment 1 (Months 2-4)|headache|0|||
27848386|NCT00290251|81275742|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
27848387|NCT00290251|81275743|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
27848388|NCT00290251|81275744|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
27848389|NCT00290251|81275745|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
27848390|NCT00290251|81275746|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
27848391|NCT00290251|81275747|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
27848392|NCT01124695|81275748|FG000|Overall Study|Disease progression|77|||
27848393|NCT01124695|81275748|FG000|Overall Study|Adverse Event|11|||
27848394|NCT01124695|81275748|FG000|Overall Study|Death|1|||
27848395|NCT01124695|81275748|FG000|Overall Study|Withdrawal by Subject|7|||
27848396|NCT01124695|81275748|FG000|Overall Study|Physician Decision|3|||
27848397|NCT01124695|81275748|FG000|Overall Study|Alternative therapy|9|||
27848398|NCT01124695|81275748|FG000|Overall Study|No documentation that patient went off treatment|4|||
27848399|NCT01124695|81275748|FG000|Overall Study|Ineligible|9|||
27848400|NCT01124695|81275748|FG000|Overall Study|Ineligible and never start treatment|2|||
27848401|NCT03499119|81275749|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
27848402|NCT03499119|81275750|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
27848403|NCT03499119|81275751|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
27848404|NCT03499119|81275752|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
27848405|NCT03499119|81275749|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
27848406|NCT03499119|81275750|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
27848407|NCT03499119|81275751|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
27848408|NCT03499119|81275752|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
27848409|NCT03499119|81275749|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
27848410|NCT03499119|81275750|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
27848411|NCT03499119|81275751|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
27848412|NCT03499119|81275752|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
27848413|NCT03499119|81275749|FG000|Optional Extension Phase|Lost to Follow-up|0|||
27848414|NCT03499119|81275750|FG001|Optional Extension Phase|Lost to Follow-up|0|||
27848415|NCT03499119|81275751|FG002|Optional Extension Phase|Lost to Follow-up|0|||
27848416|NCT03499119|81275752|FG003|Optional Extension Phase|Lost to Follow-up|1|||
27848417|NCT03499119|81275749|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
27848418|NCT03499119|81275750|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
27848419|NCT03499119|81275751|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
27848420|NCT03499119|81275752|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
27848421|NCT03499119|81275749|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
27848422|NCT03499119|81275750|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
27848423|NCT03499119|81275751|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
27848424|NCT03499119|81275752|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
27848425|NCT03433755|81275761|FG000|Overall Study|Lost to Follow-up|1|||
27848426|NCT03433755|81275762|FG001|Overall Study|Lost to Follow-up|0|||
27848427|NCT03433755|81275763|FG002|Overall Study|Lost to Follow-up|0|||
27848428|NCT03433755|81275764|FG003|Overall Study|Lost to Follow-up|0|||
27848429|NCT03433755|81275761|FG000|Overall Study|Decision by Sponsor|1|||
27848430|NCT03433755|81275762|FG001|Overall Study|Decision by Sponsor|0|||
27848431|NCT03433755|81275763|FG002|Overall Study|Decision by Sponsor|0|||
27848432|NCT03433755|81275764|FG003|Overall Study|Decision by Sponsor|0|||
27848433|NCT01056640|81275765|FG000|Overall Study|Withdrawal by Subject|11|||
27848434|NCT01056640|81275766|FG001|Overall Study|Withdrawal by Subject|8|||
27848435|NCT01056640|81275765|FG000|Overall Study|Death|15|||
27894513|NCT00501059|81450278|FG000|Overall Study|Death|140|||
27894514|NCT00501059|81450279|FG001|Overall Study|Death|137|||
27848436|NCT01056640|81275766|FG001|Overall Study|Death|4|||
27848437|NCT00653991|81275767|FG000|3 Month Follow-up|Participant would not respond|150|||
27848438|NCT00653991|81275768|FG001|3 Month Follow-up|Participant would not respond|157|||
27848439|NCT00653991|81275767|FG000|6 Month Follow-up|Participant would not respond|133|||
27848440|NCT00653991|81275768|FG001|6 Month Follow-up|Participant would not respond|141|||
27848441|NCT00502801|81275769|FG000|Treatment Period|Withdrawal by Subject|3|||
27848442|NCT00502801|81275769|FG000|Treatment Period|Adverse Event|7|||
27848443|NCT00502801|81275769|FG000|Treatment Period|Death|14|||
27848444|NCT00502801|81275769|FG000|Treatment Period|OTHER|30|||
27848445|NCT00502801|81275769|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
27848446|NCT00502801|81275769|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
27848447|NCT00502801|81275769|FG000|End of Therapy to Test of Cure|Death|3|||
27894515|NCT00501059|81450278|FG000|Overall Study|Other|236|||
27894516|NCT00501059|81450279|FG001|Overall Study|Other|239|||
27894517|NCT00501059|81450278|FG000|Overall Study|Missing end-of-study page|91|||
27894518|NCT00501059|81450279|FG001|Overall Study|Missing end-of-study page|92|||
27894519|NCT00501059|81450278|FG000|Overall Study|Clinical endpoint reached|110|||
27894520|NCT00501059|81450279|FG001|Overall Study|Clinical endpoint reached|123|||
27894521|NCT00501059|81450278|FG000|Overall Study|Insufficient therapeutic effect|4|||
27894522|NCT00501059|81450279|FG001|Overall Study|Insufficient therapeutic effect|5|||
27613851|NCT00127413|80426808|FG000|Overall Study|Lost to Follow-up|6|||
27613852|NCT00127413|80426809|FG001|Overall Study|Lost to Follow-up|4|||
27613853|NCT00127413|80426810|FG002|Overall Study|Lost to Follow-up|8|||
27613854|NCT00127413|80426811|FG003|Overall Study|Lost to Follow-up|2|||
27613855|NCT04848662|80426812|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
27894523|NCT00501059|81450278|FG000|Overall Study|Consent withdrawn by subject|817|||
27894524|NCT00501059|81450279|FG001|Overall Study|Consent withdrawn by subject|873|||
27894525|NCT00501059|81450278|FG000|Overall Study|Non-compliant with study treatment|23|||
27894526|NCT00501059|81450279|FG001|Overall Study|Non-compliant with study treatment|16|||
27894527|NCT00501059|81450278|FG000|Overall Study|Reason not given|3|||
27894528|NCT00501059|81450279|FG001|Overall Study|Reason not given|1|||
27894529|NCT00501059|81450278|FG000|Overall Study|Adverse Event|129|||
27894530|NCT00501059|81450279|FG001|Overall Study|Adverse Event|122|||
27505602|NCT02420821|80044160|FG000|Overall Study|Protinuria|0|||
27505603|NCT02420821|80044161|FG001|Overall Study|Protinuria|1|||
27505604|NCT02420821|80044160|FG000|Overall Study|Progressive Disease|1|||
27505605|NCT02420821|80044161|FG001|Overall Study|Progressive Disease|1|||
27505606|NCT02420821|80044160|FG000|Overall Study|Disease Progression|0|||
27505607|NCT02420821|80044161|FG001|Overall Study|Disease Progression|1|||
27505608|NCT02420821|80044160|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
27505609|NCT02420821|80044161|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
27505610|NCT03591406|80044162|FG000|Overall Study|Adverse Event|5|||
27505611|NCT03591406|80044163|FG001|Overall Study|Adverse Event|3|||
27505612|NCT03591406|80044162|FG000|Overall Study|Protocol Violation|2|||
27505613|NCT03591406|80044163|FG001|Overall Study|Protocol Violation|1|||
27505614|NCT03591406|80044162|FG000|Overall Study|Withdrawal by Subject|0|||
27505615|NCT03591406|80044163|FG001|Overall Study|Withdrawal by Subject|5|||
27505616|NCT02458313|80044164|FG000|Overall Study|Withdrawal by Subject|6|||
27505617|NCT02458313|80044165|FG001|Overall Study|Withdrawal by Subject|8|||
27505618|NCT02458313|80044164|FG000|Overall Study|Excluded for motion during MRI|1|||
27505619|NCT02458313|80044165|FG001|Overall Study|Excluded for motion during MRI|2|||
27505620|NCT01352715|80044166|FG000|Overall Study|Death|3|||
27505621|NCT01352715|80044167|FG001|Overall Study|Death|3|||
27505622|NCT01352715|80044166|FG000|Overall Study|Lost to Follow-up|5|||
27613856|NCT04848662|80426813|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
27613857|NCT01254565|80426819|FG000|Overall Study|Non-compliance to Study Procedures|0|||
27613858|NCT01254565|80426820|FG001|Overall Study|Non-compliance to Study Procedures|0|||
27848448|NCT00502801|81275769|FG000|End of Therapy to Test of Cure|OTHER|2|||
27848449|NCT01715896|81275772|FG000|Overall Study|Lost to Follow-up|0|||
27848450|NCT01715896|81275773|FG001|Overall Study|Lost to Follow-up|2|||
27848451|NCT01715896|81275772|FG000|Overall Study|Withdrawal by Subject|1|||
27848452|NCT01715896|81275773|FG001|Overall Study|Withdrawal by Subject|4|||
27848453|NCT01715896|81275772|FG000|Overall Study|Other|2|||
27848454|NCT01715896|81275773|FG001|Overall Study|Other|5|||
27848455|NCT00430950|81275774|FG000|Overall Study|Adverse Event|7|||
27848456|NCT00430950|81275775|FG001|Overall Study|Adverse Event|6|||
27848457|NCT00430950|81275774|FG000|Overall Study|Withdrawal by Subject|1|||
27848458|NCT00430950|81275775|FG001|Overall Study|Withdrawal by Subject|0|||
27848459|NCT00430950|81275774|FG000|Overall Study|concomitant medication,etc.|5|||
27848460|NCT00430950|81275775|FG001|Overall Study|concomitant medication,etc.|7|||
27848461|NCT01311557|81275778|FG000|Overall Study|Serious adverse event|0|||
27848462|NCT01311557|81275779|FG001|Overall Study|Serious adverse event|1|||
27848463|NCT01311557|81275778|FG000|Overall Study|Protocol Violation|4|||
27848464|NCT01311557|81275779|FG001|Overall Study|Protocol Violation|2|||
27894531|NCT00501059|81450278|FG000|Overall Study|Lost to Follow-up|210|||
27894532|NCT00501059|81450279|FG001|Overall Study|Lost to Follow-up|198|||
27894533|NCT00501059|81450278|FG000|Overall Study|Not treated|25|||
27505623|NCT01352715|80044167|FG001|Overall Study|Lost to Follow-up|7|||
27894534|NCT00501059|81450279|FG001|Overall Study|Not treated|17|||
27505624|NCT01352715|80044166|FG000|Overall Study|Withdrawal by Subject|4|||
27505625|NCT01352715|80044167|FG001|Overall Study|Withdrawal by Subject|8|||
27505626|NCT01352715|80044166|FG000|Overall Study|site closure|16|||
27726585|NCT01275222|80830136|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27848465|NCT01311557|81275778|FG000|Overall Study|Lost to Follow-up|0|||
27848466|NCT01311557|81275779|FG001|Overall Study|Lost to Follow-up|1|||
27848467|NCT01311557|81275778|FG000|Overall Study|Withdrawal by Subject|1|||
27613859|NCT01254565|80426821|FG002|Overall Study|Non-compliance to Study Procedures|0|||
27894535|NCT03244618|81450280|FG000|Overall Study|Lost to Follow-up|3|||
27894536|NCT03244618|81450281|FG001|Overall Study|Lost to Follow-up|4|||
27848468|NCT01311557|81275779|FG001|Overall Study|Withdrawal by Subject|2|||
27848469|NCT01091103|81275786|FG000|Overall Study|Adverse Event|1|||
27848470|NCT01091103|81275786|FG000|Overall Study|Progressive Disease|3|||
27848471|NCT03832738|81275787|FG000|Overall Study|Withdrawal by Subject|6|||
27894537|NCT03244618|81450280|FG000|Overall Study|Protocol Violation|4|||
27894538|NCT03244618|81450281|FG001|Overall Study|Protocol Violation|3|||
27894539|NCT03244618|81450280|FG000|Overall Study|Withdrawal by Subject|0|||
27894540|NCT03244618|81450281|FG001|Overall Study|Withdrawal by Subject|2|||
27894541|NCT04325828|81450288|FG000|Overall Study|Ongoing|26|||
27894542|NCT01044290|81450289|FG000|Follow-up 1|Death|3|||
27613860|NCT01254565|80426822|FG003|Overall Study|Non-compliance to Study Procedures|0|||
27848472|NCT03832738|81275788|FG001|Overall Study|Withdrawal by Subject|7|||
27848473|NCT03832738|81275789|FG002|Overall Study|Withdrawal by Subject|16|||
27848474|NCT03832738|81275787|FG000|Overall Study|Physician Decision|0|||
27848475|NCT03832738|81275788|FG001|Overall Study|Physician Decision|1|||
27848476|NCT03832738|81275789|FG002|Overall Study|Physician Decision|2|||
27848477|NCT03832738|81275787|FG000|Overall Study|Adverse Event|2|||
27848478|NCT03832738|81275788|FG001|Overall Study|Adverse Event|3|||
27848479|NCT03832738|81275789|FG002|Overall Study|Adverse Event|1|||
27848480|NCT03832738|81275787|FG000|Overall Study|Pregnancy|0|||
27848481|NCT03832738|81275788|FG001|Overall Study|Pregnancy|1|||
27848482|NCT03832738|81275789|FG002|Overall Study|Pregnancy|0|||
27848483|NCT04142242|81275792|FG000|Stage I|Non-compliance with the protocol|1|||
27848484|NCT04142242|81275793|FG001|Stage I|Non-compliance with the protocol|0|||
27848485|NCT04142242|81275794|FG002|Stage I|Non-compliance with the protocol|0|||
27848486|NCT04142242|81275795|FG003|Stage I|Non-compliance with the protocol|0|||
27848487|NCT04142242|81275796|FG004|Stage I|Non-compliance with the protocol|0|||
27848488|NCT04142242|81275797|FG005|Stage I|Non-compliance with the protocol|1|||
27848489|NCT04142242|81275792|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
27848490|NCT04142242|81275793|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
27848491|NCT04142242|81275794|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
27848492|NCT04142242|81275795|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
27848493|NCT04142242|81275796|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
27848494|NCT04142242|81275797|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
27848495|NCT04142242|81275792|FG000|Stage II|Non-compliance with the protocol|0|||
27848496|NCT04142242|81275793|FG001|Stage II|Non-compliance with the protocol|0|||
27848497|NCT04142242|81275794|FG002|Stage II|Non-compliance with the protocol|0|||
27848498|NCT04142242|81275795|FG003|Stage II|Non-compliance with the protocol|2|||
27848499|NCT04142242|81275796|FG004|Stage II|Non-compliance with the protocol|0|||
27848500|NCT04142242|81275797|FG005|Stage II|Non-compliance with the protocol|0|||
27848501|NCT04142242|81275792|FG000|Stage II|Lost to Follow-up|0|||
27848502|NCT04142242|81275793|FG001|Stage II|Lost to Follow-up|0|||
27848503|NCT04142242|81275794|FG002|Stage II|Lost to Follow-up|1|||
27848504|NCT04142242|81275795|FG003|Stage II|Lost to Follow-up|2|||
27848505|NCT04142242|81275796|FG004|Stage II|Lost to Follow-up|0|||
27848506|NCT04142242|81275797|FG005|Stage II|Lost to Follow-up|0|||
27848507|NCT04142242|81275792|FG000|Stage II|Withdrawal by Subject|0|||
27848508|NCT04142242|81275793|FG001|Stage II|Withdrawal by Subject|0|||
27848509|NCT04142242|81275794|FG002|Stage II|Withdrawal by Subject|5|||
27848510|NCT04142242|81275795|FG003|Stage II|Withdrawal by Subject|9|||
27848511|NCT04142242|81275796|FG004|Stage II|Withdrawal by Subject|0|||
27848512|NCT04142242|81275797|FG005|Stage II|Withdrawal by Subject|0|||
27848513|NCT00955721|81275804|FG000|Overall Study|Physician Decision|1|||
27848514|NCT00955721|81275805|FG001|Overall Study|Physician Decision|0|||
27848515|NCT00955721|81275804|FG000|Overall Study|Death|1|||
27848516|NCT00955721|81275805|FG001|Overall Study|Death|0|||
27848517|NCT00955721|81275804|FG000|Overall Study|Withdrawal by Subject|1|||
27848518|NCT00955721|81275805|FG001|Overall Study|Withdrawal by Subject|0|||
27848519|NCT03235479|81275806|FG000|Overall Study|Lost to Follow-up|8|||
27848520|NCT03235479|81275807|FG001|Overall Study|Lost to Follow-up|11|||
27848521|NCT03235479|81275806|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
27848522|NCT03235479|81275807|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
27848523|NCT03235479|81275806|FG000|Overall Study|Pregnancy|1|||
27848524|NCT03235479|81275807|FG001|Overall Study|Pregnancy|0|||
27505627|NCT01352715|80044167|FG001|Overall Study|site closure|15|||
27613861|NCT01254565|80426823|FG004|Overall Study|Non-compliance to Study Procedures|1|||
27613862|NCT01254565|80426824|FG005|Overall Study|Non-compliance to Study Procedures|0|||
27848525|NCT03235479|81275806|FG000|Overall Study|Protocol Deviation|1|||
27894543|NCT01044290|81450290|FG001|Follow-up 1|Death|3|||
27726586|NCT01275222|80830137|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
27848526|NCT03235479|81275807|FG001|Overall Study|Protocol Deviation|3|||
27848527|NCT03235479|81275806|FG000|Overall Study|Technical Problems|3|||
27848528|NCT03235479|81275807|FG001|Overall Study|Technical Problems|2|||
27848529|NCT03235479|81275806|FG000|Overall Study|Withdrawal by Subject|2|||
27848530|NCT03235479|81275807|FG001|Overall Study|Withdrawal by Subject|2|||
27848531|NCT03235479|81275806|FG000|Overall Study|Other Reasons|3|||
27505628|NCT01352715|80044166|FG000|Overall Study|no final visit in closeout period|15|||
27505629|NCT01352715|80044167|FG001|Overall Study|no final visit in closeout period|12|||
27505630|NCT01352715|80044166|FG000|Overall Study|major ineligibility|2|||
27505631|NCT01352715|80044167|FG001|Overall Study|major ineligibility|1|||
27505632|NCT03100149|80044168|FG000|Overall Study|Adverse Event|0|||
27505633|NCT03100149|80044169|FG001|Overall Study|Adverse Event|1|||
27505634|NCT03100149|80044170|FG002|Overall Study|Adverse Event|0|||
27505635|NCT03100149|80044168|FG000|Overall Study|Participant Moved out of Country|0|||
27505636|NCT03100149|80044169|FG001|Overall Study|Participant Moved out of Country|0|||
27505637|NCT03100149|80044170|FG002|Overall Study|Participant Moved out of Country|1|||
27505638|NCT03100149|80044168|FG000|Overall Study|Withdrawal by Subject|0|||
27505639|NCT03100149|80044169|FG001|Overall Study|Withdrawal by Subject|3|||
27505640|NCT03100149|80044170|FG002|Overall Study|Withdrawal by Subject|1|||
27505641|NCT00361296|80044171|FG000|Overall Study|Physician Decision|1|||
27505642|NCT00361296|80044171|FG000|Overall Study|Lack of Efficacy|2|||
27505643|NCT00321620|80044173|FG000|Overall Study|Death|269|||
27505644|NCT00321620|80044174|FG001|Overall Study|Death|294|||
27505645|NCT00321620|80044173|FG000|Overall Study|Withdrawal by Subject|164|||
27505646|NCT00321620|80044174|FG001|Overall Study|Withdrawal by Subject|147|||
27505647|NCT00321620|80044173|FG000|Overall Study|Disease progression|113|||
27505648|NCT00321620|80044174|FG001|Overall Study|Disease progression|117|||
27505649|NCT00321620|80044173|FG000|Overall Study|Adverse Event|43|||
27505650|NCT00321620|80044174|FG001|Overall Study|Adverse Event|56|||
27505651|NCT00321620|80044173|FG000|Overall Study|Lost to Follow-up|13|||
27505652|NCT00321620|80044174|FG001|Overall Study|Lost to Follow-up|9|||
27505653|NCT00321620|80044173|FG000|Overall Study|Physician Decision|4|||
27505654|NCT00321620|80044174|FG001|Overall Study|Physician Decision|1|||
27505655|NCT00321620|80044173|FG000|Overall Study|Noncompliance|14|||
27505656|NCT00321620|80044174|FG001|Overall Study|Noncompliance|7|||
27505657|NCT00321620|80044173|FG000|Overall Study|Protocol deviation|4|||
27505658|NCT00321620|80044174|FG001|Overall Study|Protocol deviation|3|||
27505659|NCT00321620|80044173|FG000|Overall Study|Ineligibility determined|2|||
27505660|NCT00321620|80044174|FG001|Overall Study|Ineligibility determined|3|||
27505661|NCT00321620|80044173|FG000|Overall Study|Participant request|75|||
27505662|NCT00321620|80044174|FG001|Overall Study|Participant request|52|||
27505663|NCT00321620|80044173|FG000|Overall Study|Other|42|||
27505664|NCT00321620|80044174|FG001|Overall Study|Other|33|||
27505665|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
27505666|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
27505667|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
27726587|NCT01275222|80830132|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27726588|NCT01275222|80830133|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27726589|NCT01275222|80830134|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27726590|NCT01275222|80830135|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
27726591|NCT01275222|80830136|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27726592|NCT01275222|80830137|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
27726593|NCT01275222|80830132|FG000|Phase l by Treatment|Disease progression|12|||
27726594|NCT01275222|80830133|FG001|Phase l by Treatment|Disease progression|8|||
27726595|NCT01275222|80830134|FG002|Phase l by Treatment|Disease progression|2|||
27726596|NCT01275222|80830135|FG003|Phase l by Treatment|Disease progression|5|||
27726597|NCT01275222|80830136|FG004|Phase l by Treatment|Disease progression|0|||
27726598|NCT01275222|80830137|FG005|Phase l by Treatment|Disease progression|0|||
27726599|NCT01275222|80830132|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
27726600|NCT01275222|80830133|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
27726601|NCT01275222|80830134|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
27726602|NCT01275222|80830135|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
27726603|NCT01275222|80830136|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
27726604|NCT01275222|80830137|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
27726605|NCT01275222|80830132|FG000|Phase l by Treatment|Death|0|||
27726606|NCT01275222|80830133|FG001|Phase l by Treatment|Death|1|||
27726607|NCT01275222|80830134|FG002|Phase l by Treatment|Death|0|||
27726608|NCT01275222|80830135|FG003|Phase l by Treatment|Death|1|||
27726609|NCT01275222|80830136|FG004|Phase l by Treatment|Death|0|||
27726610|NCT01275222|80830137|FG005|Phase l by Treatment|Death|0|||
27726611|NCT01275222|80830132|FG000|Phase ll by Stratum|Adverse Event|0|||
27726612|NCT01275222|80830133|FG001|Phase ll by Stratum|Adverse Event|0|||
27726613|NCT01275222|80830134|FG002|Phase ll by Stratum|Adverse Event|0|||
27726614|NCT01275222|80830135|FG003|Phase ll by Stratum|Adverse Event|0|||
27726615|NCT01275222|80830136|FG004|Phase ll by Stratum|Adverse Event|2|||
27726616|NCT01275222|80830137|FG005|Phase ll by Stratum|Adverse Event|10|||
27726617|NCT01275222|80830132|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
27848532|NCT03235479|81275807|FG001|Overall Study|Other Reasons|5|||
27848533|NCT00842530|81275808|FG000|Overall Study|Serious adverse event|0|||
27505668|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
27848534|NCT00842530|81275809|FG001|Overall Study|Serious adverse event|6|||
27505669|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
27726618|NCT01275222|80830133|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
27726619|NCT01275222|80830134|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
27726620|NCT01275222|80830135|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
27726621|NCT01275222|80830136|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
27726622|NCT01275222|80830137|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
27726623|NCT01275222|80830132|FG000|Phase ll by Stratum|Disease progression|0|||
27726624|NCT01275222|80830133|FG001|Phase ll by Stratum|Disease progression|0|||
27726625|NCT01275222|80830134|FG002|Phase ll by Stratum|Disease progression|0|||
27726626|NCT01275222|80830135|FG003|Phase ll by Stratum|Disease progression|0|||
27726627|NCT01275222|80830136|FG004|Phase ll by Stratum|Disease progression|23|||
27726628|NCT01275222|80830137|FG005|Phase ll by Stratum|Disease progression|31|||
27726629|NCT01275222|80830132|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
27726630|NCT01275222|80830133|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
27726631|NCT01275222|80830134|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
27726632|NCT01275222|80830135|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
27726633|NCT01275222|80830136|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
27726634|NCT01275222|80830137|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
27726635|NCT01275222|80830132|FG000|Phase ll by Stratum|Death|0|||
27726636|NCT01275222|80830133|FG001|Phase ll by Stratum|Death|0|||
27726637|NCT01275222|80830134|FG002|Phase ll by Stratum|Death|0|||
27726638|NCT01275222|80830135|FG003|Phase ll by Stratum|Death|0|||
27726639|NCT01275222|80830136|FG004|Phase ll by Stratum|Death|1|||
27726640|NCT01275222|80830137|FG005|Phase ll by Stratum|Death|1|||
27726641|NCT01084551|80830138|FG000|Overall Study|Adverse Event|2|||
27726642|NCT01084551|80830139|FG001|Overall Study|Adverse Event|9|||
27726643|NCT01084551|80830140|FG002|Overall Study|Adverse Event|4|||
27726644|NCT01084551|80830138|FG000|Overall Study|Lack of Efficacy|2|||
27726645|NCT01084551|80830139|FG001|Overall Study|Lack of Efficacy|0|||
27726646|NCT01084551|80830140|FG002|Overall Study|Lack of Efficacy|1|||
27726647|NCT01084551|80830138|FG000|Overall Study|Withdrawal by Subject|2|||
27726648|NCT01084551|80830139|FG001|Overall Study|Withdrawal by Subject|1|||
27726649|NCT01084551|80830140|FG002|Overall Study|Withdrawal by Subject|0|||
27726650|NCT01084551|80830138|FG000|Overall Study|Protocol Violation|2|||
27726651|NCT01084551|80830139|FG001|Overall Study|Protocol Violation|4|||
27726652|NCT01084551|80830140|FG002|Overall Study|Protocol Violation|0|||
27726653|NCT01084551|80830138|FG000|Overall Study|Lost to Follow-up|0|||
27726654|NCT01084551|80830139|FG001|Overall Study|Lost to Follow-up|0|||
27726655|NCT01084551|80830140|FG002|Overall Study|Lost to Follow-up|3|||
27726656|NCT01084551|80830138|FG000|Overall Study|Physician Decision|1|||
27726657|NCT01084551|80830139|FG001|Overall Study|Physician Decision|0|||
27726658|NCT01084551|80830140|FG002|Overall Study|Physician Decision|0|||
27726659|NCT01583179|80830141|FG000|Overall Study|Screen failure|1|||
27726660|NCT01583179|80830142|FG001|Overall Study|Screen failure|2|||
27726661|NCT03446456|80830146|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
27726662|NCT03446456|80830147|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
27726663|NCT03446456|80830146|FG000|Overall Study|Lost to Follow-up|1|||
27726664|NCT03446456|80830147|FG001|Overall Study|Lost to Follow-up|3|||
27726665|NCT03446456|80830146|FG000|Overall Study|Participant failed the toxicology test|1|||
27726666|NCT03446456|80830147|FG001|Overall Study|Participant failed the toxicology test|0|||
27726667|NCT03446456|80830146|FG000|Overall Study|Break down of the experimental equipment|1|||
27726668|NCT03446456|80830147|FG001|Overall Study|Break down of the experimental equipment|0|||
27726669|NCT02421887|80830149|FG000|Overall Study|Lost to Follow-up|5|||
27726670|NCT02421887|80830150|FG001|Overall Study|Lost to Follow-up|0|||
27726671|NCT02421887|80830149|FG000|Overall Study|Withdrawal by Subject|8|||
27726672|NCT02421887|80830150|FG001|Overall Study|Withdrawal by Subject|5|||
27726673|NCT02421887|80830149|FG000|Overall Study|Physician Decision|2|||
27726674|NCT02421887|80830150|FG001|Overall Study|Physician Decision|4|||
27726675|NCT02421887|80830149|FG000|Overall Study|Adverse Event|2|||
27726676|NCT02421887|80830150|FG001|Overall Study|Adverse Event|0|||
27726677|NCT01109940|80830157|FG000|Overall Study|Administrative problems|2|||
27848535|NCT00842530|81275808|FG000|Overall Study|Other adverse event|6|||
27848536|NCT00842530|81275809|FG001|Overall Study|Other adverse event|1|||
27848537|NCT00842530|81275808|FG000|Overall Study|Protocol Violation|32|||
27848538|NCT00842530|81275809|FG001|Overall Study|Protocol Violation|14|||
27848539|NCT00842530|81275808|FG000|Overall Study|Lost to Follow-up|6|||
27505670|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
27726678|NCT01109940|80830158|FG001|Overall Study|Administrative problems|0|||
27726679|NCT01109940|80830159|FG002|Overall Study|Administrative problems|0|||
27726680|NCT01109940|80830160|FG003|Overall Study|Administrative problems|0|||
27726681|NCT01109940|80830157|FG000|Overall Study|Serious Adverse Event|2|||
27726682|NCT01109940|80830158|FG001|Overall Study|Serious Adverse Event|1|||
27726683|NCT01109940|80830159|FG002|Overall Study|Serious Adverse Event|0|||
27726684|NCT01109940|80830160|FG003|Overall Study|Serious Adverse Event|0|||
27726685|NCT01109940|80830157|FG000|Overall Study|Lost to Follow-up|1|||
27726686|NCT01109940|80830158|FG001|Overall Study|Lost to Follow-up|0|||
27848540|NCT00842530|81275809|FG001|Overall Study|Lost to Follow-up|8|||
27894544|NCT01044290|81450291|FG002|Follow-up 1|Death|1|||
27505671|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
27505672|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
27848541|NCT00842530|81275808|FG000|Overall Study|Withdrawal by Subject|73|||
27848542|NCT00842530|81275809|FG001|Overall Study|Withdrawal by Subject|28|||
27505673|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
27848543|NCT00690482|81275810|FG000|Overall Study|Adverse Event|2|||
27848544|NCT00690482|81275811|FG001|Overall Study|Adverse Event|1|||
27848545|NCT00690482|81275810|FG000|Overall Study|Incorrect enrolment|0|||
27848546|NCT00690482|81275811|FG001|Overall Study|Incorrect enrolment|1|||
27848547|NCT00690482|81275810|FG000|Overall Study|Study-specific discontinuation criteria|1|||
27848548|NCT00690482|81275811|FG001|Overall Study|Study-specific discontinuation criteria|0|||
27848549|NCT00690482|81275810|FG000|Overall Study|Intake of prohibited medicine|1|||
27848550|NCT00690482|81275811|FG001|Overall Study|Intake of prohibited medicine|0|||
27894545|NCT01044290|81450289|FG000|Follow-up 1|Withdrawal by Subject|2|||
27894546|NCT01044290|81450290|FG001|Follow-up 1|Withdrawal by Subject|2|||
27894547|NCT01044290|81450291|FG002|Follow-up 1|Withdrawal by Subject|0|||
27894548|NCT01044290|81450289|FG000|Follow-Up 2|Death|0|||
27894549|NCT01044290|81450290|FG001|Follow-Up 2|Death|1|||
27894550|NCT01044290|81450291|FG002|Follow-Up 2|Death|1|||
27894551|NCT01044290|81450289|FG000|Follow-Up 2|Withdrawal by Subject|0|||
27894552|NCT01044290|81450290|FG001|Follow-Up 2|Withdrawal by Subject|1|||
27894553|NCT01044290|81450291|FG002|Follow-Up 2|Withdrawal by Subject|1|||
27894554|NCT05619536|81450292|FG000|Overall Study|Withdrawal by Subject|0|||
27894555|NCT05619536|81450293|FG001|Overall Study|Withdrawal by Subject|1|||
27894556|NCT05619536|81450294|FG002|Overall Study|Withdrawal by Subject|0|||
27894557|NCT05619536|81450295|FG003|Overall Study|Withdrawal by Subject|1|||
27894558|NCT05619536|81450292|FG000|Overall Study|Lost to Follow-up|0|||
27505674|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
27505675|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
27505676|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
27505677|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
27505678|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
27848551|NCT00690482|81275810|FG000|Overall Study|withdrew consent at rand.day|0|||
27848552|NCT00690482|81275811|FG001|Overall Study|withdrew consent at rand.day|1|||
27848553|NCT03330236|81275812|FG000|Overall Study|Death|2|||
27848554|NCT03330236|81275813|FG001|Overall Study|Death|1|||
27894559|NCT05619536|81450293|FG001|Overall Study|Lost to Follow-up|1|||
27894560|NCT05619536|81450294|FG002|Overall Study|Lost to Follow-up|1|||
27894561|NCT05619536|81450295|FG003|Overall Study|Lost to Follow-up|0|||
27894562|NCT00712881|81450299|FG000|Overall Study|Adverse Event|3|||
27894563|NCT00712881|81450300|FG001|Overall Study|Adverse Event|3|||
27894564|NCT00712881|81450299|FG000|Overall Study|Withdrawal by Subject|1|||
27894565|NCT00712881|81450300|FG001|Overall Study|Withdrawal by Subject|1|||
27894566|NCT00712881|81450299|FG000|Overall Study|Disease Progression|2|||
27894567|NCT00712881|81450300|FG001|Overall Study|Disease Progression|1|||
27894568|NCT00712881|81450299|FG000|Overall Study|Lost to Follow-up|1|||
27894569|NCT00712881|81450300|FG001|Overall Study|Lost to Follow-up|1|||
27894570|NCT00712881|81450299|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
27894571|NCT00712881|81450300|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
27894572|NCT00712881|81450299|FG000|Overall Study|Protocol Violation|1|||
27894573|NCT00712881|81450300|FG001|Overall Study|Protocol Violation|1|||
27894574|NCT00712881|81450299|FG000|Overall Study|Randomized but not treated|1|||
27894575|NCT00712881|81450300|FG001|Overall Study|Randomized but not treated|0|||
27894576|NCT02294175|81450305|FG000|Overall Study|Withdrawal by Subject|1|||
27894577|NCT02294175|81450306|FG001|Overall Study|Withdrawal by Subject|2|||
27894578|NCT02294175|81450305|FG000|Overall Study|pt taking excluded medication|3|||
27894579|NCT02294175|81450306|FG001|Overall Study|pt taking excluded medication|1|||
27894580|NCT02294175|81450305|FG000|Overall Study|Protocol Violation|1|||
27894581|NCT02294175|81450306|FG001|Overall Study|Protocol Violation|0|||
27894582|NCT02294175|81450305|FG000|Overall Study|Lost to Follow-up|0|||
27894583|NCT02294175|81450306|FG001|Overall Study|Lost to Follow-up|1|||
27894584|NCT02294175|81450305|FG000|Overall Study|wound healed|0|||
27894585|NCT02294175|81450306|FG001|Overall Study|wound healed|2|||
27894586|NCT01258075|81450307|FG000|Overall Study|Adverse Event|8|||
27894587|NCT01258075|81450308|FG001|Overall Study|Adverse Event|3|||
27894588|NCT01258075|81450307|FG000|Overall Study|Lost to Follow-up|11|||
27894589|NCT01258075|81450308|FG001|Overall Study|Lost to Follow-up|6|||
27894590|NCT01258075|81450307|FG000|Overall Study|Withdrawal by Subject|10|||
27894591|NCT01258075|81450308|FG001|Overall Study|Withdrawal by Subject|7|||
27894592|NCT01258075|81450307|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
27894593|NCT01258075|81450308|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
27894594|NCT01258075|81450307|FG000|Overall Study|Other|12|||
27894595|NCT01258075|81450308|FG001|Overall Study|Other|5|||
27894596|NCT03673345|81450309|FG000|Overall Study|Lost to Follow-up|1|||
27894597|NCT03673345|81450310|FG001|Overall Study|Lost to Follow-up|0|||
27894598|NCT03673345|81450311|FG002|Overall Study|Lost to Follow-up|3|||
27894599|NCT03673345|81450312|FG003|Overall Study|Lost to Follow-up|3|||
27894600|NCT03673345|81450313|FG004|Overall Study|Lost to Follow-up|2|||
27894601|NCT03673345|81450314|FG005|Overall Study|Lost to Follow-up|1|||
27894602|NCT03673345|81450315|FG006|Overall Study|Lost to Follow-up|0|||
27894603|NCT03673345|81450316|FG007|Overall Study|Lost to Follow-up|0|||
27894604|NCT03673345|81450309|FG000|Overall Study|Withdrawal by Subject|1|||
27894605|NCT03673345|81450310|FG001|Overall Study|Withdrawal by Subject|0|||
27894606|NCT03673345|81450311|FG002|Overall Study|Withdrawal by Subject|4|||
27894607|NCT03673345|81450312|FG003|Overall Study|Withdrawal by Subject|2|||
27894608|NCT03673345|81450313|FG004|Overall Study|Withdrawal by Subject|0|||
27894609|NCT03673345|81450314|FG005|Overall Study|Withdrawal by Subject|0|||
27894610|NCT03673345|81450315|FG006|Overall Study|Withdrawal by Subject|0|||
27894611|NCT03673345|81450316|FG007|Overall Study|Withdrawal by Subject|0|||
27894612|NCT03673345|81450309|FG000|Overall Study|Physician Decision|0|||
27894613|NCT03673345|81450310|FG001|Overall Study|Physician Decision|0|||
27894614|NCT03673345|81450311|FG002|Overall Study|Physician Decision|2|||
27894615|NCT03673345|81450312|FG003|Overall Study|Physician Decision|0|||
27894616|NCT03673345|81450313|FG004|Overall Study|Physician Decision|0|||
27894617|NCT03673345|81450314|FG005|Overall Study|Physician Decision|0|||
27894618|NCT03673345|81450315|FG006|Overall Study|Physician Decision|0|||
27894619|NCT03673345|81450316|FG007|Overall Study|Physician Decision|0|||
27894620|NCT01546168|81450317|FG000|Overall Study|Lost to Follow-up|1|||
27894621|NCT01546168|81450318|FG001|Overall Study|Lost to Follow-up|0|||
27505679|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
27505680|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
27505681|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
27505682|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
27848555|NCT03330236|81275812|FG000|Overall Study|Withdrawal by Subject|2|||
27848556|NCT03330236|81275813|FG001|Overall Study|Withdrawal by Subject|4|||
27848557|NCT03330236|81275812|FG000|Overall Study|Lost to Follow-up|0|||
27848558|NCT03330236|81275813|FG001|Overall Study|Lost to Follow-up|2|||
27848559|NCT03330236|81275812|FG000|Overall Study|Physician Decision|2|||
27848560|NCT03330236|81275813|FG001|Overall Study|Physician Decision|0|||
27848561|NCT03330236|81275812|FG000|Overall Study|Protocol Violation|4|||
27848562|NCT03330236|81275813|FG001|Overall Study|Protocol Violation|3|||
27848563|NCT03330236|81275812|FG000|Overall Study|SedLine malfunction/blinding|19|||
27848564|NCT03330236|81275813|FG001|Overall Study|SedLine malfunction/blinding|14|||
27848565|NCT03330236|81275812|FG000|Overall Study|Volatile anesthetics used|11|||
27848566|NCT03330236|81275813|FG001|Overall Study|Volatile anesthetics used|8|||
27848567|NCT03330236|81275812|FG000|Overall Study|Surgery aborted/converted to open|60|||
27848568|NCT03330236|81275813|FG001|Overall Study|Surgery aborted/converted to open|52|||
27848569|NCT00296491|81275814|FG000|Overall Study|Low Pollen Counts|18|||
27848570|NCT00296491|81275815|FG001|Overall Study|Low Pollen Counts|26|||
27848571|NCT00296491|81275816|FG002|Overall Study|Low Pollen Counts|25|||
27848572|NCT00296491|81275817|FG003|Overall Study|Low Pollen Counts|16|||
27848573|NCT00296491|81275814|FG000|Overall Study|Protocol Violation|4|||
27848574|NCT00296491|81275815|FG001|Overall Study|Protocol Violation|6|||
27894622|NCT01546168|81450317|FG000|Overall Study|Withdrawal by Subject|1|||
27894623|NCT01546168|81450318|FG001|Overall Study|Withdrawal by Subject|0|||
27894624|NCT01546168|81450317|FG000|Overall Study|ineligible after signing consent|2|||
27894625|NCT01546168|81450318|FG001|Overall Study|ineligible after signing consent|0|||
27505683|NCT02952820|80044176|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
27505684|NCT02952820|80044177|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
27505685|NCT02952820|80044178|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
27894626|NCT01668966|81450319|FG000|Overall Study|Withdrawal by Subject|1|||
27894627|NCT01668966|81450319|FG000|Overall Study|Death|1|||
27894628|NCT01668966|81450319|FG000|Overall Study|Not treated|2|||
27894629|NCT04489381|81450320|FG000|Overall Study|Lost to Follow-up|2|||
27894630|NCT04489381|81450321|FG001|Overall Study|Lost to Follow-up|3|||
27894631|NCT04489381|81450320|FG000|Overall Study|Withdrawal by Subject|1|||
27505686|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
27848575|NCT00296491|81275816|FG002|Overall Study|Protocol Violation|2|||
27848576|NCT00296491|81275817|FG003|Overall Study|Protocol Violation|3|||
27848577|NCT00296491|81275814|FG000|Overall Study|Adverse Event|1|||
27848578|NCT00296491|81275815|FG001|Overall Study|Adverse Event|3|||
27613863|NCT01254565|80426819|FG000|Overall Study|Did not Receive Treatment|1|||
27613864|NCT01254565|80426820|FG001|Overall Study|Did not Receive Treatment|1|||
27613865|NCT01254565|80426821|FG002|Overall Study|Did not Receive Treatment|0|||
27613866|NCT01254565|80426822|FG003|Overall Study|Did not Receive Treatment|0|||
27613867|NCT01254565|80426823|FG004|Overall Study|Did not Receive Treatment|3|||
27613868|NCT01254565|80426824|FG005|Overall Study|Did not Receive Treatment|4|||
27613869|NCT01254565|80426819|FG000|Overall Study|Other|0|||
27613870|NCT01254565|80426820|FG001|Overall Study|Other|0|||
27613871|NCT01254565|80426821|FG002|Overall Study|Other|0|||
27613872|NCT01254565|80426822|FG003|Overall Study|Other|1|||
27613873|NCT01254565|80426823|FG004|Overall Study|Other|0|||
27613874|NCT01254565|80426824|FG005|Overall Study|Other|0|||
27613875|NCT00649389|80426831|FG000|Overall Study|Adverse Event|22|||
27613876|NCT00649389|80426832|FG001|Overall Study|Adverse Event|46|||
27613877|NCT00649389|80426833|FG002|Overall Study|Adverse Event|38|||
27613878|NCT00649389|80426834|FG003|Overall Study|Adverse Event|48|||
27613879|NCT00649389|80426831|FG000|Overall Study|Lost to Follow-up|15|||
27613880|NCT00649389|80426832|FG001|Overall Study|Lost to Follow-up|17|||
27613881|NCT00649389|80426833|FG002|Overall Study|Lost to Follow-up|21|||
27613882|NCT00649389|80426834|FG003|Overall Study|Lost to Follow-up|26|||
27613883|NCT00649389|80426831|FG000|Overall Study|Protocol Violation|11|||
27613884|NCT00649389|80426832|FG001|Overall Study|Protocol Violation|13|||
27613885|NCT00649389|80426833|FG002|Overall Study|Protocol Violation|9|||
27613886|NCT00649389|80426834|FG003|Overall Study|Protocol Violation|8|||
27613887|NCT00649389|80426831|FG000|Overall Study|Withdrawal by Subject|20|||
27613888|NCT00649389|80426832|FG001|Overall Study|Withdrawal by Subject|21|||
27613889|NCT00649389|80426833|FG002|Overall Study|Withdrawal by Subject|19|||
27613890|NCT00649389|80426834|FG003|Overall Study|Withdrawal by Subject|23|||
27613891|NCT00649389|80426831|FG000|Overall Study|Other|3|||
27613892|NCT00649389|80426832|FG001|Overall Study|Other|9|||
27613893|NCT00649389|80426833|FG002|Overall Study|Other|1|||
27613894|NCT00649389|80426834|FG003|Overall Study|Other|6|||
27613895|NCT01586338|80426835|FG000|Overall Study|Adverse Event|3|||
27613896|NCT01586338|80426835|FG000|Overall Study|Lost to Follow-up|1|||
27613897|NCT01586338|80426835|FG000|Overall Study|Withdrawal by participant|3|||
27613898|NCT01586338|80426835|FG000|Overall Study|Other|1|||
27613899|NCT01234649|80426840|FG000|Overall Study|Withdrawal by Subject|32|||
27613900|NCT01234649|80426841|FG001|Overall Study|Withdrawal by Subject|26|||
27613901|NCT01234649|80426840|FG000|Overall Study|Pregnancy|6|||
27613902|NCT01234649|80426841|FG001|Overall Study|Pregnancy|6|||
27613903|NCT01234649|80426840|FG000|Overall Study|intolerant to side effects|4|||
27613904|NCT01234649|80426841|FG001|Overall Study|intolerant to side effects|3|||
27613905|NCT01234649|80426840|FG000|Overall Study|Allergic reaction|1|||
27726687|NCT01109940|80830159|FG002|Overall Study|Lost to Follow-up|0|||
27505687|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
27613906|NCT01234649|80426841|FG001|Overall Study|Allergic reaction|0|||
27613907|NCT01234649|80426840|FG000|Overall Study|Lack of Efficacy|0|||
27613908|NCT01234649|80426841|FG001|Overall Study|Lack of Efficacy|3|||
27613909|NCT01912222|80426849|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
27613910|NCT01912222|80426850|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
27613911|NCT01912222|80426851|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
27613912|NCT01912222|80426849|FG000|Part B: Treatment Period|Progressive disease|10|||
27613913|NCT01912222|80426850|FG001|Part B: Treatment Period|Progressive disease|12|||
27613914|NCT01912222|80426851|FG002|Part B: Treatment Period|Progressive disease|15|||
27613915|NCT01912222|80426849|FG000|Part B: Treatment Period|Adverse Event|1|||
27505688|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
27505689|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
27505690|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
27505691|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
27505692|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
27505693|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
27894632|NCT04489381|81450321|FG001|Overall Study|Withdrawal by Subject|0|||
27894633|NCT02543892|81450322|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
27894634|NCT02543892|81450323|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
27894635|NCT02543892|81450324|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
27894636|NCT02543892|81450325|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
27894637|NCT02543892|81450326|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
27894638|NCT02543892|81450327|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
27894639|NCT02543892|81450328|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
27894640|NCT02543892|81450329|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
27894641|NCT02543892|81450322|FG000|Received Vaccination 2|Physician Decision|0|||
27894642|NCT02543892|81450323|FG001|Received Vaccination 2|Physician Decision|0|||
27894643|NCT02543892|81450324|FG002|Received Vaccination 2|Physician Decision|0|||
27894644|NCT02543892|81450325|FG003|Received Vaccination 2|Physician Decision|0|||
27894645|NCT02543892|81450326|FG004|Received Vaccination 2|Physician Decision|0|||
27894646|NCT02543892|81450327|FG005|Received Vaccination 2|Physician Decision|1|||
27894647|NCT02543892|81450328|FG006|Received Vaccination 2|Physician Decision|0|||
27894648|NCT02543892|81450329|FG007|Received Vaccination 2|Physician Decision|0|||
27894649|NCT02543892|81450322|FG000|Received Vaccination 2|Adverse Event|0|||
27894650|NCT02543892|81450323|FG001|Received Vaccination 2|Adverse Event|1|||
27894651|NCT02543892|81450324|FG002|Received Vaccination 2|Adverse Event|0|||
27894652|NCT02543892|81450325|FG003|Received Vaccination 2|Adverse Event|0|||
27894653|NCT02543892|81450326|FG004|Received Vaccination 2|Adverse Event|0|||
27894654|NCT02543892|81450327|FG005|Received Vaccination 2|Adverse Event|0|||
27894655|NCT02543892|81450328|FG006|Received Vaccination 2|Adverse Event|0|||
27894656|NCT02543892|81450329|FG007|Received Vaccination 2|Adverse Event|0|||
27894657|NCT02543892|81450322|FG000|Had Immunology Data|Withdrawal by Subject|0|||
27894658|NCT02543892|81450323|FG001|Had Immunology Data|Withdrawal by Subject|0|||
27894659|NCT02543892|81450324|FG002|Had Immunology Data|Withdrawal by Subject|0|||
27894660|NCT02543892|81450325|FG003|Had Immunology Data|Withdrawal by Subject|0|||
27894661|NCT02543892|81450326|FG004|Had Immunology Data|Withdrawal by Subject|0|||
27894662|NCT02543892|81450327|FG005|Had Immunology Data|Withdrawal by Subject|0|||
27894663|NCT02543892|81450328|FG006|Had Immunology Data|Withdrawal by Subject|1|||
27848579|NCT00296491|81275816|FG002|Overall Study|Adverse Event|1|||
27848580|NCT00296491|81275817|FG003|Overall Study|Adverse Event|4|||
27848581|NCT00296491|81275814|FG000|Overall Study|Withdrawn due to Asthma|0|||
27848582|NCT00296491|81275815|FG001|Overall Study|Withdrawn due to Asthma|0|||
27848583|NCT00296491|81275816|FG002|Overall Study|Withdrawn due to Asthma|0|||
27848584|NCT00296491|81275817|FG003|Overall Study|Withdrawn due to Asthma|4|||
27848585|NCT00296491|81275814|FG000|Overall Study|Withdrawal by Subject|7|||
27848586|NCT00296491|81275815|FG001|Overall Study|Withdrawal by Subject|3|||
27848587|NCT00296491|81275816|FG002|Overall Study|Withdrawal by Subject|3|||
27848588|NCT00296491|81275817|FG003|Overall Study|Withdrawal by Subject|2|||
27848589|NCT00296491|81275814|FG000|Overall Study|Non-Compliance|12|||
27848590|NCT00296491|81275815|FG001|Overall Study|Non-Compliance|13|||
27848591|NCT00296491|81275816|FG002|Overall Study|Non-Compliance|10|||
27848592|NCT00296491|81275817|FG003|Overall Study|Non-Compliance|14|||
27848593|NCT00296491|81275814|FG000|Overall Study|Lost to Follow-up|0|||
27848594|NCT00296491|81275815|FG001|Overall Study|Lost to Follow-up|2|||
27848595|NCT00296491|81275816|FG002|Overall Study|Lost to Follow-up|2|||
27848596|NCT00296491|81275817|FG003|Overall Study|Lost to Follow-up|0|||
27848597|NCT02556307|81275818|FG000|Overall Study|Premature treatment interruption|11|||
27848598|NCT02556307|81275818|FG000|Overall Study|Lost to Follow-up|36|||
27505694|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
27505695|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
27505696|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
27505697|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
27505698|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
27848599|NCT02556307|81275818|FG000|Overall Study|Change to triple therapy|4|||
27894664|NCT02543892|81450329|FG007|Had Immunology Data|Withdrawal by Subject|0|||
27894665|NCT00176644|81450333|FG000|Overall Study|Withdrawal by Subject|1|||
27894666|NCT03104400|81450336|FG000|Overall Study|Adverse Event|5|||
27894667|NCT03104400|81450337|FG001|Overall Study|Adverse Event|7|||
27894668|NCT03104400|81450338|FG002|Overall Study|Adverse Event|11|||
27505699|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
27848600|NCT02556307|81275818|FG000|Overall Study|Enrolled but not treated|2|||
27848601|NCT01560507|81275819|FG000|Overall Study|Lost to Follow-up|3|||
27848602|NCT01560507|81275820|FG001|Overall Study|Lost to Follow-up|1|||
27848603|NCT01560507|81275821|FG002|Overall Study|Lost to Follow-up|2|||
27894669|NCT03104400|81450339|FG003|Overall Study|Adverse Event|9|||
27894670|NCT03104400|81450340|FG004|Overall Study|Adverse Event|21|||
27894671|NCT03104400|81450336|FG000|Overall Study|Withdrawal by Subject|17|||
27894672|NCT03104400|81450337|FG001|Overall Study|Withdrawal by Subject|19|||
27894673|NCT03104400|81450338|FG002|Overall Study|Withdrawal by Subject|29|||
27894674|NCT03104400|81450339|FG003|Overall Study|Withdrawal by Subject|25|||
27894675|NCT03104400|81450340|FG004|Overall Study|Withdrawal by Subject|24|||
27894676|NCT03104400|81450336|FG000|Overall Study|Lost to Follow-up|4|||
27894677|NCT03104400|81450337|FG001|Overall Study|Lost to Follow-up|1|||
27894678|NCT03104400|81450338|FG002|Overall Study|Lost to Follow-up|4|||
27894679|NCT03104400|81450339|FG003|Overall Study|Lost to Follow-up|8|||
27894680|NCT03104400|81450340|FG004|Overall Study|Lost to Follow-up|7|||
27894681|NCT03104400|81450336|FG000|Overall Study|Lack of Efficacy|6|||
27894682|NCT03104400|81450337|FG001|Overall Study|Lack of Efficacy|3|||
27894683|NCT03104400|81450338|FG002|Overall Study|Lack of Efficacy|8|||
27894684|NCT03104400|81450339|FG003|Overall Study|Lack of Efficacy|2|||
27894685|NCT03104400|81450340|FG004|Overall Study|Lack of Efficacy|1|||
27894686|NCT03104400|81450336|FG000|Overall Study|COVID Logistical Restrictions|0|||
27894687|NCT03104400|81450337|FG001|Overall Study|COVID Logistical Restrictions|0|||
27894688|NCT03104400|81450338|FG002|Overall Study|COVID Logistical Restrictions|0|||
27894689|NCT03104400|81450339|FG003|Overall Study|COVID Logistical Restrictions|1|||
27894690|NCT03104400|81450340|FG004|Overall Study|COVID Logistical Restrictions|0|||
27894691|NCT03104400|81450336|FG000|Overall Study|Other|2|||
27894692|NCT03104400|81450337|FG001|Overall Study|Other|3|||
27894693|NCT03104400|81450338|FG002|Overall Study|Other|7|||
27894694|NCT03104400|81450339|FG003|Overall Study|Other|6|||
27894695|NCT03104400|81450340|FG004|Overall Study|Other|4|||
27894696|NCT03104400|81450336|FG000|Overall Study|Other|0|||
27894697|NCT03104400|81450337|FG001|Overall Study|Other|1|||
27894698|NCT03104400|81450338|FG002|Overall Study|Other|0|||
27894699|NCT03104400|81450339|FG003|Overall Study|Other|0|||
27894700|NCT03104400|81450340|FG004|Overall Study|Other|0|||
27894701|NCT00115037|81450343|FG000|Phase1|Lost to Follow-up|16|||
27894702|NCT00115037|81450344|FG001|Phase1|Lost to Follow-up|23|||
27894703|NCT00115037|81450345|FG002|Phase1|Lost to Follow-up|0|||
27894704|NCT00115037|81450346|FG003|Phase1|Lost to Follow-up|0|||
27894705|NCT00115037|81450347|FG004|Phase1|Lost to Follow-up|0|||
27894706|NCT00115037|81450348|FG005|Phase1|Lost to Follow-up|0|||
27894707|NCT00115037|81450343|FG000|Phase1|Withdrawal by Subject|9|||
27894708|NCT00115037|81450344|FG001|Phase1|Withdrawal by Subject|4|||
27894709|NCT00115037|81450345|FG002|Phase1|Withdrawal by Subject|0|||
27894710|NCT00115037|81450346|FG003|Phase1|Withdrawal by Subject|0|||
27894711|NCT00115037|81450347|FG004|Phase1|Withdrawal by Subject|0|||
27894712|NCT00115037|81450348|FG005|Phase1|Withdrawal by Subject|0|||
27894713|NCT00115037|81450343|FG000|Phase2|Death|0|||
27894714|NCT00115037|81450344|FG001|Phase2|Death|0|||
27894715|NCT00115037|81450345|FG002|Phase2|Death|1|||
27894716|NCT00115037|81450346|FG003|Phase2|Death|0|||
27894717|NCT00115037|81450347|FG004|Phase2|Death|0|||
27894718|NCT00115037|81450348|FG005|Phase2|Death|1|||
27894719|NCT00115037|81450343|FG000|Phase2|Withdrawal by Subject|0|||
27894720|NCT00115037|81450344|FG001|Phase2|Withdrawal by Subject|0|||
27894721|NCT00115037|81450345|FG002|Phase2|Withdrawal by Subject|2|||
27894722|NCT00115037|81450346|FG003|Phase2|Withdrawal by Subject|1|||
27894723|NCT00115037|81450347|FG004|Phase2|Withdrawal by Subject|2|||
27894724|NCT00115037|81450348|FG005|Phase2|Withdrawal by Subject|1|||
27894725|NCT00115037|81450343|FG000|Phase2|Lost to Follow-up|0|||
27894726|NCT00115037|81450344|FG001|Phase2|Lost to Follow-up|0|||
27894727|NCT00115037|81450345|FG002|Phase2|Lost to Follow-up|12|||
27894728|NCT00115037|81450346|FG003|Phase2|Lost to Follow-up|14|||
27894729|NCT00115037|81450347|FG004|Phase2|Lost to Follow-up|4|||
27894730|NCT00115037|81450348|FG005|Phase2|Lost to Follow-up|10|||
27894731|NCT02553499|81450349|FG000|Overall Study|Adverse Event|0|||
27894732|NCT02553499|81450350|FG001|Overall Study|Adverse Event|0|||
27894733|NCT02553499|81450351|FG002|Overall Study|Adverse Event|0|||
27505700|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
27894734|NCT02553499|81450352|FG003|Overall Study|Adverse Event|0|||
27894735|NCT02553499|81450353|FG004|Overall Study|Adverse Event|0|||
27894736|NCT02553499|81450354|FG005|Overall Study|Adverse Event|0|||
27894737|NCT02553499|81450355|FG006|Overall Study|Adverse Event|1|||
27894738|NCT02553499|81450356|FG007|Overall Study|Adverse Event|1|||
27894739|NCT02553499|81450357|FG008|Overall Study|Adverse Event|0|||
27894740|NCT02553499|81450358|FG009|Overall Study|Adverse Event|0|||
27894741|NCT02553499|81450359|FG010|Overall Study|Adverse Event|0|||
27894742|NCT02553499|81450360|FG011|Overall Study|Adverse Event|0|||
27894743|NCT02553499|81450361|FG012|Overall Study|Adverse Event|0|||
27894744|NCT02553499|81450362|FG013|Overall Study|Adverse Event|1|||
27894745|NCT02553499|81450349|FG000|Overall Study|Death|0|||
27894746|NCT02553499|81450350|FG001|Overall Study|Death|1|||
27894747|NCT02553499|81450351|FG002|Overall Study|Death|1|||
27894748|NCT02553499|81450352|FG003|Overall Study|Death|0|||
27894749|NCT02553499|81450353|FG004|Overall Study|Death|1|||
27894750|NCT02553499|81450354|FG005|Overall Study|Death|2|||
27894751|NCT02553499|81450355|FG006|Overall Study|Death|0|||
27894752|NCT02553499|81450356|FG007|Overall Study|Death|0|||
27894753|NCT02553499|81450357|FG008|Overall Study|Death|0|||
27894754|NCT02553499|81450358|FG009|Overall Study|Death|0|||
27894755|NCT02553499|81450359|FG010|Overall Study|Death|1|||
27894756|NCT02553499|81450360|FG011|Overall Study|Death|0|||
27894757|NCT02553499|81450361|FG012|Overall Study|Death|0|||
27894758|NCT02553499|81450362|FG013|Overall Study|Death|0|||
27894759|NCT02553499|81450349|FG000|Overall Study|Lost to Follow-up|0|||
27894760|NCT02553499|81450350|FG001|Overall Study|Lost to Follow-up|0|||
27894761|NCT02553499|81450351|FG002|Overall Study|Lost to Follow-up|0|||
27894762|NCT02553499|81450352|FG003|Overall Study|Lost to Follow-up|0|||
27894763|NCT02553499|81450353|FG004|Overall Study|Lost to Follow-up|0|||
27894764|NCT02553499|81450354|FG005|Overall Study|Lost to Follow-up|0|||
27894765|NCT02553499|81450355|FG006|Overall Study|Lost to Follow-up|1|||
27894766|NCT02553499|81450356|FG007|Overall Study|Lost to Follow-up|0|||
27894767|NCT02553499|81450357|FG008|Overall Study|Lost to Follow-up|0|||
27894768|NCT02553499|81450358|FG009|Overall Study|Lost to Follow-up|0|||
27894769|NCT02553499|81450359|FG010|Overall Study|Lost to Follow-up|0|||
27894770|NCT02553499|81450360|FG011|Overall Study|Lost to Follow-up|0|||
27894771|NCT02553499|81450361|FG012|Overall Study|Lost to Follow-up|0|||
27894772|NCT02553499|81450362|FG013|Overall Study|Lost to Follow-up|0|||
27894773|NCT02553499|81450349|FG000|Overall Study|Physician Decision|0|||
27894774|NCT02553499|81450350|FG001|Overall Study|Physician Decision|1|||
27894775|NCT02553499|81450351|FG002|Overall Study|Physician Decision|1|||
27894776|NCT02553499|81450352|FG003|Overall Study|Physician Decision|0|||
27894777|NCT02553499|81450353|FG004|Overall Study|Physician Decision|1|||
27894778|NCT02553499|81450354|FG005|Overall Study|Physician Decision|0|||
27894779|NCT02553499|81450355|FG006|Overall Study|Physician Decision|0|||
27894780|NCT02553499|81450356|FG007|Overall Study|Physician Decision|1|||
27894781|NCT02553499|81450357|FG008|Overall Study|Physician Decision|1|||
27894782|NCT02553499|81450358|FG009|Overall Study|Physician Decision|2|||
27894783|NCT02553499|81450359|FG010|Overall Study|Physician Decision|1|||
27894784|NCT02553499|81450360|FG011|Overall Study|Physician Decision|3|||
27894785|NCT02553499|81450361|FG012|Overall Study|Physician Decision|1|||
27894786|NCT02553499|81450362|FG013|Overall Study|Physician Decision|0|||
27894787|NCT02553499|81450349|FG000|Overall Study|Progressive Disease|0|||
27894788|NCT02553499|81450350|FG001|Overall Study|Progressive Disease|0|||
27894789|NCT02553499|81450351|FG002|Overall Study|Progressive Disease|0|||
27894790|NCT02553499|81450352|FG003|Overall Study|Progressive Disease|2|||
27894791|NCT02553499|81450353|FG004|Overall Study|Progressive Disease|1|||
27894792|NCT02553499|81450354|FG005|Overall Study|Progressive Disease|1|||
27894793|NCT02553499|81450355|FG006|Overall Study|Progressive Disease|1|||
27894794|NCT02553499|81450356|FG007|Overall Study|Progressive Disease|0|||
27894795|NCT02553499|81450357|FG008|Overall Study|Progressive Disease|0|||
27894796|NCT02553499|81450358|FG009|Overall Study|Progressive Disease|1|||
27894797|NCT02553499|81450359|FG010|Overall Study|Progressive Disease|0|||
27894798|NCT02553499|81450360|FG011|Overall Study|Progressive Disease|0|||
27894799|NCT02553499|81450361|FG012|Overall Study|Progressive Disease|2|||
27894800|NCT02553499|81450362|FG013|Overall Study|Progressive Disease|1|||
27894801|NCT02553499|81450349|FG000|Overall Study|Study Terminated by Sponsor|0|||
27894802|NCT02553499|81450350|FG001|Overall Study|Study Terminated by Sponsor|0|||
27726688|NCT01109940|80830160|FG003|Overall Study|Lost to Follow-up|0|||
27726689|NCT01109940|80830157|FG000|Overall Study|Patient withdrew consent|1|||
27726690|NCT01109940|80830158|FG001|Overall Study|Patient withdrew consent|1|||
27726691|NCT01109940|80830159|FG002|Overall Study|Patient withdrew consent|0|||
27726692|NCT01109940|80830160|FG003|Overall Study|Patient withdrew consent|0|||
27726693|NCT01109940|80830157|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27726694|NCT01109940|80830158|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27726695|NCT01109940|80830159|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27726696|NCT01109940|80830160|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27726697|NCT03064763|80830161|FG000|Overall Study|Lost to Follow-up|1|||
27726698|NCT03064763|80830161|FG000|Overall Study|Death|8|||
27726699|NCT00805740|80830168|FG000|Overall Study|Death|7|||
27726700|NCT00805740|80830169|FG001|Overall Study|Death|4|||
27726701|NCT00805740|80830168|FG000|Overall Study|Withdrawal by Subject|1|||
27726702|NCT00805740|80830169|FG001|Overall Study|Withdrawal by Subject|0|||
27726703|NCT00805740|80830168|FG000|Overall Study|Lost to Follow-up|1|||
27726704|NCT00805740|80830169|FG001|Overall Study|Lost to Follow-up|0|||
27726705|NCT00805740|80830168|FG000|Overall Study|Randomized, but not treated|2|||
27726706|NCT00805740|80830169|FG001|Overall Study|Randomized, but not treated|0|||
27726707|NCT03118947|80830171|FG000|Overall Study|Adverse Event|7|||
27726708|NCT03118947|80830171|FG000|Overall Study|Death|3|||
27726709|NCT03118947|80830171|FG000|Overall Study|Lack of Efficacy|4|||
27726710|NCT03118947|80830171|FG000|Overall Study|Non-compliance with study drug|1|||
27726711|NCT03118947|80830171|FG000|Overall Study|Protocol Violation|2|||
27894803|NCT02553499|81450351|FG002|Overall Study|Study Terminated by Sponsor|0|||
27894804|NCT02553499|81450352|FG003|Overall Study|Study Terminated by Sponsor|0|||
27894805|NCT02553499|81450353|FG004|Overall Study|Study Terminated by Sponsor|0|||
27894806|NCT02553499|81450354|FG005|Overall Study|Study Terminated by Sponsor|0|||
27894807|NCT02553499|81450355|FG006|Overall Study|Study Terminated by Sponsor|0|||
27894808|NCT02553499|81450356|FG007|Overall Study|Study Terminated by Sponsor|0|||
27894809|NCT02553499|81450357|FG008|Overall Study|Study Terminated by Sponsor|1|||
27894810|NCT02553499|81450358|FG009|Overall Study|Study Terminated by Sponsor|0|||
27894811|NCT02553499|81450359|FG010|Overall Study|Study Terminated by Sponsor|0|||
27894812|NCT02553499|81450360|FG011|Overall Study|Study Terminated by Sponsor|0|||
27894813|NCT02553499|81450361|FG012|Overall Study|Study Terminated by Sponsor|0|||
27894814|NCT02553499|81450362|FG013|Overall Study|Study Terminated by Sponsor|0|||
27894815|NCT02553499|81450349|FG000|Overall Study|Withdrawal by Subject|2|||
27894816|NCT02553499|81450350|FG001|Overall Study|Withdrawal by Subject|0|||
27894817|NCT02553499|81450351|FG002|Overall Study|Withdrawal by Subject|0|||
27894818|NCT02553499|81450352|FG003|Overall Study|Withdrawal by Subject|0|||
27894819|NCT02553499|81450353|FG004|Overall Study|Withdrawal by Subject|0|||
27894820|NCT02553499|81450354|FG005|Overall Study|Withdrawal by Subject|0|||
27894821|NCT02553499|81450355|FG006|Overall Study|Withdrawal by Subject|0|||
27894822|NCT02553499|81450356|FG007|Overall Study|Withdrawal by Subject|1|||
27894823|NCT02553499|81450357|FG008|Overall Study|Withdrawal by Subject|1|||
27894824|NCT02553499|81450358|FG009|Overall Study|Withdrawal by Subject|0|||
27894825|NCT02553499|81450359|FG010|Overall Study|Withdrawal by Subject|1|||
27848604|NCT01560507|81275819|FG000|Overall Study|Withdrawal by Subject|1|||
27848605|NCT01560507|81275820|FG001|Overall Study|Withdrawal by Subject|1|||
27848606|NCT01560507|81275821|FG002|Overall Study|Withdrawal by Subject|0|||
27848607|NCT00969124|81275822|FG000|Overall Study|Protocol Violation|2|||
27848608|NCT00969124|81275822|FG000|Overall Study|Inadequate bowel preparation|15|||
27848609|NCT00969124|81275822|FG000|Overall Study|Inability to reach cecum|9|||
27848610|NCT00969124|81275822|FG000|Overall Study|Previously unrecognized disease|3|||
27848611|NCT00969124|81275822|FG000|Overall Study|Technical error|1|||
27848612|NCT03201211|81275823|FG000|Overall Study|Adverse Event|1|||
27848613|NCT03201211|81275824|FG001|Overall Study|Adverse Event|0|||
27848614|NCT03201211|81275825|FG002|Overall Study|Adverse Event|0|||
27848615|NCT03201211|81275823|FG000|Overall Study|Protocol Violation|1|||
27848616|NCT03201211|81275824|FG001|Overall Study|Protocol Violation|0|||
27848617|NCT03201211|81275825|FG002|Overall Study|Protocol Violation|0|||
27894826|NCT02553499|81450360|FG011|Overall Study|Withdrawal by Subject|0|||
27894827|NCT02553499|81450361|FG012|Overall Study|Withdrawal by Subject|0|||
27894828|NCT02553499|81450362|FG013|Overall Study|Withdrawal by Subject|0|||
27894829|NCT00937040|81450364|FG000|Overall Study|Adverse Event|5|||
27894830|NCT00937040|81450365|FG001|Overall Study|Adverse Event|8|||
27894831|NCT00937040|81450364|FG000|Overall Study|Lost to Follow-up|12|||
27894832|NCT00937040|81450365|FG001|Overall Study|Lost to Follow-up|12|||
27894833|NCT00937040|81450364|FG000|Overall Study|Protocol Violation|3|||
27894834|NCT00937040|81450365|FG001|Overall Study|Protocol Violation|0|||
27894835|NCT00937040|81450364|FG000|Overall Study|Withdrawal by Subject|13|||
27894836|NCT00937040|81450365|FG001|Overall Study|Withdrawal by Subject|7|||
27894837|NCT00937040|81450364|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
27894838|NCT00937040|81450365|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
27894839|NCT00937040|81450364|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
27848618|NCT03201211|81275823|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27894840|NCT00937040|81450365|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
27894841|NCT02691936|81450366|FG000|Overall Study|Withdrawal by Subject|2|||
27894842|NCT02691936|81450367|FG001|Overall Study|Withdrawal by Subject|5|||
27848619|NCT03201211|81275824|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27848620|NCT03201211|81275825|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
27894843|NCT01179737|81450368|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
27894844|NCT01179737|81450369|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
27894845|NCT01179737|81450370|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
27894846|NCT01179737|81450371|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
27894847|NCT01179737|81450368|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
27894848|NCT01179737|81450369|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
27894849|NCT01179737|81450370|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
27894850|NCT01179737|81450371|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
27894851|NCT01179737|81450368|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
27613916|NCT01912222|80426850|FG001|Part B: Treatment Period|Adverse Event|2|||
27613917|NCT01912222|80426851|FG002|Part B: Treatment Period|Adverse Event|3|||
27613918|NCT01912222|80426849|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
27613919|NCT01912222|80426850|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
27848621|NCT03201211|81275823|FG000|Overall Study|OTHER unknown reasons|0|||
27848622|NCT03201211|81275824|FG001|Overall Study|OTHER unknown reasons|1|||
27848623|NCT03201211|81275825|FG002|Overall Study|OTHER unknown reasons|0|||
27848624|NCT00484419|81275830|FG000|Overall Study|Adverse Event|3|||
27848625|NCT00484419|81275831|FG001|Overall Study|Adverse Event|0|||
27848626|NCT00484419|81275832|FG002|Overall Study|Adverse Event|0|||
27848627|NCT00484419|81275830|FG000|Overall Study|Lost to Follow-up|1|||
27848628|NCT00484419|81275831|FG001|Overall Study|Lost to Follow-up|0|||
27848629|NCT00484419|81275832|FG002|Overall Study|Lost to Follow-up|2|||
27848630|NCT00484419|81275830|FG000|Overall Study|Withdrawal by Subject|3|||
27848631|NCT00484419|81275831|FG001|Overall Study|Withdrawal by Subject|1|||
27848632|NCT00484419|81275832|FG002|Overall Study|Withdrawal by Subject|1|||
27848633|NCT00484419|81275830|FG000|Overall Study|subject met discontinuation criteria|2|||
27848634|NCT00484419|81275831|FG001|Overall Study|subject met discontinuation criteria|2|||
27848635|NCT00484419|81275832|FG002|Overall Study|subject met discontinuation criteria|4|||
27848636|NCT00484419|81275830|FG000|Overall Study|required restricted medication|1|||
27848637|NCT00484419|81275831|FG001|Overall Study|required restricted medication|0|||
27848638|NCT00484419|81275832|FG002|Overall Study|required restricted medication|1|||
27848639|NCT00484419|81275830|FG000|Overall Study|Physician Decision|1|||
27848640|NCT00484419|81275831|FG001|Overall Study|Physician Decision|1|||
27848641|NCT00484419|81275832|FG002|Overall Study|Physician Decision|1|||
27848642|NCT00484419|81275830|FG000|Overall Study|subject unable to receive medication|1|||
27848643|NCT00484419|81275831|FG001|Overall Study|subject unable to receive medication|0|||
27848644|NCT00484419|81275832|FG002|Overall Study|subject unable to receive medication|0|||
27848645|NCT00484419|81275830|FG000|Overall Study|subject relocated|0|||
27848646|NCT00484419|81275831|FG001|Overall Study|subject relocated|1|||
27848647|NCT00484419|81275832|FG002|Overall Study|subject relocated|0|||
27848648|NCT00484419|81275830|FG000|Overall Study|sponsor decision, randomized in error|0|||
27848649|NCT00484419|81275831|FG001|Overall Study|sponsor decision, randomized in error|0|||
27848650|NCT00484419|81275832|FG002|Overall Study|sponsor decision, randomized in error|2|||
27848651|NCT02458092|81275833|FG000|Overall Study|Withdrawal by Subject|1|||
27848652|NCT02458092|81275834|FG001|Overall Study|Withdrawal by Subject|0|||
27848653|NCT02610816|81275838|FG000|Phase 1|Withdrawal by Subject|2|||
27848654|NCT02610816|81275839|FG001|Phase 1|Withdrawal by Subject|6|||
27848655|NCT02610816|81275840|FG002|Phase 1|Withdrawal by Subject|0|||
27848656|NCT02610816|81275841|FG003|Phase 1|Withdrawal by Subject|0|||
27848657|NCT02610816|81275838|FG000|Phase 1|Lost to Follow-up|2|||
27848658|NCT02610816|81275839|FG001|Phase 1|Lost to Follow-up|1|||
27848659|NCT02610816|81275840|FG002|Phase 1|Lost to Follow-up|0|||
27848660|NCT02610816|81275841|FG003|Phase 1|Lost to Follow-up|0|||
27848661|NCT02610816|81275838|FG000|Phase 1|Physician Decision|0|||
27848662|NCT02610816|81275839|FG001|Phase 1|Physician Decision|1|||
27848663|NCT02610816|81275840|FG002|Phase 1|Physician Decision|0|||
27848664|NCT02610816|81275841|FG003|Phase 1|Physician Decision|0|||
27848665|NCT02610816|81275838|FG000|Phase 2|Withdrawal by Subject|0|||
27848666|NCT02610816|81275839|FG001|Phase 2|Withdrawal by Subject|0|||
27848667|NCT02610816|81275840|FG002|Phase 2|Withdrawal by Subject|9|||
27613920|NCT01912222|80426851|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
27613921|NCT02491892|80430075|FG000|Overall Study|Adverse Event|1|||
27848668|NCT02610816|81275841|FG003|Phase 2|Withdrawal by Subject|3|||
27848669|NCT02610816|81275838|FG000|Phase 2|Lost to Follow-up|0|||
27848670|NCT02610816|81275839|FG001|Phase 2|Lost to Follow-up|0|||
27894852|NCT01179737|81450369|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
27894853|NCT01179737|81450370|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
27848671|NCT02610816|81275840|FG002|Phase 2|Lost to Follow-up|2|||
27848672|NCT02610816|81275841|FG003|Phase 2|Lost to Follow-up|0|||
27848673|NCT02610816|81275838|FG000|Phase 2|Physician Decision|0|||
27848674|NCT02610816|81275839|FG001|Phase 2|Physician Decision|0|||
27848675|NCT02610816|81275840|FG002|Phase 2|Physician Decision|0|||
27848676|NCT02610816|81275841|FG003|Phase 2|Physician Decision|2|||
27848677|NCT02610816|81275838|FG000|Phase 2|Pregnancy|0|||
27848678|NCT02610816|81275839|FG001|Phase 2|Pregnancy|0|||
27848679|NCT02610816|81275840|FG002|Phase 2|Pregnancy|0|||
27848680|NCT02610816|81275841|FG003|Phase 2|Pregnancy|1|||
27894854|NCT01179737|81450371|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
27894855|NCT01179737|81450368|FG000|Cohort 1 & Cohort 2|Death|0|||
27894856|NCT01179737|81450369|FG001|Cohort 1 & Cohort 2|Death|0|||
27894857|NCT01179737|81450370|FG002|Cohort 1 & Cohort 2|Death|1|||
27894858|NCT01179737|81450371|FG003|Cohort 1 & Cohort 2|Death|0|||
27894859|NCT01179737|81450368|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
27894860|NCT01179737|81450369|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
27894861|NCT01179737|81450370|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
27894862|NCT01179737|81450371|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
27894863|NCT01179737|81450368|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
27894864|NCT01179737|81450369|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
27894865|NCT01179737|81450370|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
27894866|NCT01179737|81450371|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
27894867|NCT01179737|81450368|FG000|Extension|The study was terminated|3|||
27894868|NCT01179737|81450369|FG001|Extension|The study was terminated|0|||
27894869|NCT01179737|81450370|FG002|Extension|The study was terminated|0|||
27894870|NCT01179737|81450371|FG003|Extension|The study was terminated|0|||
27894871|NCT03417024|81450377|FG000|Overall Study|Study Termination prior to follow-up|11|||
27894872|NCT03417024|81450377|FG000|Overall Study|Physician Decision|2|||
27894873|NCT00705718|81450378|FG000|Overall Study|Death|6|||
27894874|NCT00705718|81450379|FG001|Overall Study|Death|6|||
27894875|NCT00705718|81450378|FG000|Overall Study|Not due for Visit|0|||
27894876|NCT00705718|81450379|FG001|Overall Study|Not due for Visit|12|||
27894877|NCT00705718|81450378|FG000|Overall Study|Follow up not done|1|||
27894878|NCT00705718|81450379|FG001|Overall Study|Follow up not done|4|||
27894879|NCT00595517|81450380|FG000|Overall Study|Adverse Event|6|||
27894880|NCT00595517|81450380|FG000|Overall Study|Withdrawal by Subject|4|||
27894881|NCT00595517|81450380|FG000|Overall Study|Protocol Violation|2|||
27894882|NCT00595517|81450380|FG000|Overall Study|Recurrence of ulcer|5|||
27894883|NCT00595517|81450380|FG000|Overall Study|usage of prohibited treatment|1|||
27894884|NCT00595517|81450380|FG000|Overall Study|No intention to attend regularly|1|||
27505701|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
27505702|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
27505703|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
27505704|NCT02952820|80044176|FG000|Active Treatment Period (6 Months)|Not treated|0|||
27848681|NCT02083926|81275842|FG000|Overall Study|Withdrawal by Subject|1|||
27848682|NCT02083926|81275843|FG001|Overall Study|Withdrawal by Subject|0|||
27848683|NCT02201290|81275848|FG000|Overall Study|Withdrawal by Subject|2|||
27848684|NCT02201290|81275848|FG000|Overall Study|Lack of Efficacy|2|||
27848685|NCT02201290|81275848|FG000|Overall Study|Adverse Event|1|||
27848686|NCT03856593|81275849|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
27848687|NCT03856593|81275850|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
27848688|NCT02243293|81275851|FG000|Overall Study|Adverse Event|1|||
27848689|NCT02243293|81275852|FG001|Overall Study|Adverse Event|0|||
27848690|NCT02243293|81275853|FG002|Overall Study|Adverse Event|0|||
27848691|NCT02243293|81275854|FG003|Overall Study|Adverse Event|0|||
27848692|NCT02243293|81275855|FG004|Overall Study|Adverse Event|0|||
27848693|NCT02243293|81275856|FG005|Overall Study|Adverse Event|0|||
27848694|NCT02243293|81275857|FG006|Overall Study|Adverse Event|0|||
27848695|NCT02243293|81275858|FG007|Overall Study|Adverse Event|0|||
27848696|NCT02243293|81275859|FG008|Overall Study|Adverse Event|0|||
27848697|NCT02243293|81275860|FG009|Overall Study|Adverse Event|0|||
27848698|NCT02243293|81275861|FG010|Overall Study|Adverse Event|0|||
27848699|NCT02243293|81275862|FG011|Overall Study|Adverse Event|0|||
27848700|NCT02243293|81275863|FG012|Overall Study|Adverse Event|0|||
27848701|NCT02243293|81275864|FG013|Overall Study|Adverse Event|0|||
27848702|NCT02243293|81275865|FG014|Overall Study|Adverse Event|0|||
27848703|NCT02243293|81275866|FG015|Overall Study|Adverse Event|1|||
27848704|NCT02243293|81275867|FG016|Overall Study|Adverse Event|0|||
27848705|NCT02243293|81275868|FG017|Overall Study|Adverse Event|0|||
27848706|NCT02243293|81275869|FG018|Overall Study|Adverse Event|0|||
27848707|NCT02243293|81275870|FG019|Overall Study|Adverse Event|0|||
27848708|NCT02243293|81275871|FG020|Overall Study|Adverse Event|1|||
27848709|NCT02243293|81275872|FG021|Overall Study|Adverse Event|0|||
27848710|NCT02243293|81275851|FG000|Overall Study|Withdrawal by Subject|1|||
27848711|NCT02243293|81275852|FG001|Overall Study|Withdrawal by Subject|0|||
27848712|NCT02243293|81275853|FG002|Overall Study|Withdrawal by Subject|0|||
27848713|NCT02243293|81275854|FG003|Overall Study|Withdrawal by Subject|0|||
27848714|NCT02243293|81275855|FG004|Overall Study|Withdrawal by Subject|0|||
27848715|NCT02243293|81275856|FG005|Overall Study|Withdrawal by Subject|0|||
27894885|NCT00819780|81450381|FG000|Overall Study|Did not receive study drug|3|||
27894886|NCT00819780|81450382|FG001|Overall Study|Did not receive study drug|4|||
27894887|NCT00819780|81450381|FG000|Overall Study|Still in treatment|25|||
27894888|NCT00819780|81450382|FG001|Overall Study|Still in treatment|17|||
27894889|NCT02706886|81450386|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
27894890|NCT02706886|81450387|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
27848716|NCT02243293|81275857|FG006|Overall Study|Withdrawal by Subject|0|||
27848717|NCT02243293|81275858|FG007|Overall Study|Withdrawal by Subject|0|||
27848718|NCT02243293|81275859|FG008|Overall Study|Withdrawal by Subject|0|||
27848719|NCT02243293|81275860|FG009|Overall Study|Withdrawal by Subject|1|||
27848720|NCT02243293|81275861|FG010|Overall Study|Withdrawal by Subject|0|||
27848721|NCT02243293|81275862|FG011|Overall Study|Withdrawal by Subject|1|||
27848722|NCT02243293|81275863|FG012|Overall Study|Withdrawal by Subject|0|||
27848723|NCT02243293|81275864|FG013|Overall Study|Withdrawal by Subject|0|||
27848724|NCT02243293|81275865|FG014|Overall Study|Withdrawal by Subject|0|||
27848725|NCT02243293|81275866|FG015|Overall Study|Withdrawal by Subject|0|||
27848726|NCT02243293|81275867|FG016|Overall Study|Withdrawal by Subject|0|||
27848727|NCT02243293|81275868|FG017|Overall Study|Withdrawal by Subject|0|||
27848728|NCT02243293|81275869|FG018|Overall Study|Withdrawal by Subject|0|||
27848729|NCT02243293|81275870|FG019|Overall Study|Withdrawal by Subject|0|||
27848730|NCT02243293|81275871|FG020|Overall Study|Withdrawal by Subject|0|||
27848731|NCT02243293|81275872|FG021|Overall Study|Withdrawal by Subject|1|||
27848732|NCT02243293|81275851|FG000|Overall Study|Lost to Follow-up|0|||
27848733|NCT02243293|81275852|FG001|Overall Study|Lost to Follow-up|1|||
27848734|NCT02243293|81275853|FG002|Overall Study|Lost to Follow-up|1|||
27848735|NCT02243293|81275854|FG003|Overall Study|Lost to Follow-up|1|||
27848736|NCT02243293|81275855|FG004|Overall Study|Lost to Follow-up|0|||
27848737|NCT02243293|81275856|FG005|Overall Study|Lost to Follow-up|0|||
27848738|NCT02243293|81275857|FG006|Overall Study|Lost to Follow-up|3|||
27894891|NCT02706886|81450388|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
27613922|NCT02491892|80430076|FG001|Overall Study|Adverse Event|1|||
27894892|NCT02706886|81450389|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
27894893|NCT02706886|81450390|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
27894894|NCT02706886|81450391|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
27894895|NCT02706886|81450392|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
27894896|NCT02706886|81450393|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
27894897|NCT02706886|81450394|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
27894898|NCT00866333|81450395|FG000|Overall Study|Withdrawal of consent|0|||
27894899|NCT00866333|81450396|FG001|Overall Study|Withdrawal of consent|1|||
27894900|NCT00866333|81450397|FG002|Overall Study|Withdrawal of consent|2|||
27894901|NCT00866333|81450395|FG000|Overall Study|Reason not Specified|3|||
27894902|NCT00866333|81450396|FG001|Overall Study|Reason not Specified|1|||
27894903|NCT00866333|81450397|FG002|Overall Study|Reason not Specified|1|||
27894904|NCT00866333|81450395|FG000|Overall Study|Study Terminated by Sponsor|2|||
27894905|NCT00866333|81450396|FG001|Overall Study|Study Terminated by Sponsor|5|||
27894906|NCT00866333|81450397|FG002|Overall Study|Study Terminated by Sponsor|9|||
27894907|NCT01732471|81450398|FG000|Overall Study|Withdrawal by Subject|1|||
27894908|NCT00199797|81450399|FG000|Overall Study|Progressive Disease|1|||
27894909|NCT00199797|81450399|FG000|Overall Study|Adverse Event|1|||
27894910|NCT00199797|81450399|FG000|Overall Study|Physician Decision|1|||
27894911|NCT00664859|81450400|FG000|Overall Study|Adverse Event|2|||
27894912|NCT00664859|81450401|FG001|Overall Study|Adverse Event|1|||
27894913|NCT00664859|81450402|FG002|Overall Study|Adverse Event|3|||
27894914|NCT00664859|81450400|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
27894915|NCT00664859|81450401|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
27894916|NCT00664859|81450402|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
27894917|NCT00664859|81450400|FG000|Overall Study|Noncompliance with protocol|1|||
27894918|NCT00664859|81450401|FG001|Overall Study|Noncompliance with protocol|0|||
27894919|NCT00664859|81450402|FG002|Overall Study|Noncompliance with protocol|4|||
27894920|NCT00664859|81450400|FG000|Overall Study|Laboratory abnormality|2|||
27894921|NCT00664859|81450401|FG001|Overall Study|Laboratory abnormality|1|||
27894922|NCT00664859|81450402|FG002|Overall Study|Laboratory abnormality|4|||
27894923|NCT00664859|81450400|FG000|Overall Study|Withdrawal by Subject|4|||
27894924|NCT00664859|81450401|FG001|Overall Study|Withdrawal by Subject|1|||
27848739|NCT02243293|81275858|FG007|Overall Study|Lost to Follow-up|0|||
27894925|NCT00664859|81450402|FG002|Overall Study|Withdrawal by Subject|3|||
27894926|NCT00664859|81450400|FG000|Overall Study|Lost to Follow-up|2|||
27848740|NCT02243293|81275859|FG008|Overall Study|Lost to Follow-up|0|||
27848741|NCT02243293|81275860|FG009|Overall Study|Lost to Follow-up|0|||
27848742|NCT02243293|81275861|FG010|Overall Study|Lost to Follow-up|0|||
27848743|NCT02243293|81275862|FG011|Overall Study|Lost to Follow-up|2|||
27848744|NCT02243293|81275863|FG012|Overall Study|Lost to Follow-up|0|||
27894927|NCT00664859|81450401|FG001|Overall Study|Lost to Follow-up|2|||
27894928|NCT00664859|81450402|FG002|Overall Study|Lost to Follow-up|1|||
27894929|NCT00664859|81450400|FG000|Overall Study|Other|0|||
27505705|NCT02952820|80044177|FG001|Active Treatment Period (6 Months)|Not treated|0|||
27505706|NCT02952820|80044178|FG002|Active Treatment Period (6 Months)|Not treated|1|||
27505707|NCT00807911|80044179|FG000|Overall Study|Withdrawal by Subject|12|||
27505708|NCT00807911|80044180|FG001|Overall Study|Withdrawal by Subject|10|||
27505709|NCT00807911|80044179|FG000|Overall Study|Ineligible|0|||
27505710|NCT00807911|80044180|FG001|Overall Study|Ineligible|4|||
27505711|NCT00325897|80044181|FG000|Overall Study|Lost to Follow-up|12|||
27505712|NCT00325897|80044182|FG001|Overall Study|Lost to Follow-up|13|||
27505713|NCT02201953|80044185|FG000|Overall Study|Randomized but Never Treated|1|||
27505714|NCT02201953|80044186|FG001|Overall Study|Randomized but Never Treated|5|||
27505715|NCT02201953|80044185|FG000|Overall Study|Lack of Efficacy|9|||
27505716|NCT02201953|80044186|FG001|Overall Study|Lack of Efficacy|30|||
27505717|NCT02201953|80044185|FG000|Overall Study|Lost to Follow-up|8|||
27505718|NCT02201953|80044186|FG001|Overall Study|Lost to Follow-up|8|||
27505719|NCT02201953|80044185|FG000|Overall Study|Withdrew Consent|2|||
27505720|NCT02201953|80044186|FG001|Overall Study|Withdrew Consent|5|||
27505721|NCT02201953|80044185|FG000|Overall Study|Adverse Event|0|||
27505722|NCT02201953|80044186|FG001|Overall Study|Adverse Event|5|||
27505723|NCT02201953|80044185|FG000|Overall Study|Death|0|||
27505724|NCT02201953|80044186|FG001|Overall Study|Death|3|||
27505725|NCT04119414|80044190|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
27505726|NCT03780244|80044191|FG000|Overall Study|Lost to Follow-up|1|||
27505727|NCT03780244|80044192|FG001|Overall Study|Lost to Follow-up|0|||
27505728|NCT02326155|80044193|FG000|Overall Study|Adverse Event|21|||
27505729|NCT02326155|80044194|FG001|Overall Study|Adverse Event|5|||
27505730|NCT02326155|80044193|FG000|Overall Study|Death|3|||
27505731|NCT02326155|80044194|FG001|Overall Study|Death|0|||
27505732|NCT02326155|80044193|FG000|Overall Study|Lack of Efficacy|49|||
27505733|NCT02326155|80044194|FG001|Overall Study|Lack of Efficacy|5|||
27505734|NCT02326155|80044193|FG000|Overall Study|Lost to Follow-up|14|||
27505735|NCT02326155|80044194|FG001|Overall Study|Lost to Follow-up|3|||
27505736|NCT02326155|80044193|FG000|Overall Study|Protocol Violation|2|||
27505737|NCT02326155|80044194|FG001|Overall Study|Protocol Violation|0|||
27505738|NCT02326155|80044193|FG000|Overall Study|Withdrawal by Subject|34|||
27505739|NCT02326155|80044194|FG001|Overall Study|Withdrawal by Subject|11|||
27505740|NCT02326155|80044193|FG000|Overall Study|Disease progression|37|||
27505741|NCT02326155|80044194|FG001|Overall Study|Disease progression|4|||
27505742|NCT02326155|80044193|FG000|Overall Study|Study close|188|||
27505743|NCT02326155|80044194|FG001|Overall Study|Study close|21|||
27505744|NCT02326155|80044193|FG000|Overall Study|except for study close|46|||
27505745|NCT02326155|80044194|FG001|Overall Study|except for study close|13|||
27505746|NCT02383576|80044195|FG000|Overall Study|Death|53|||
27505747|NCT02383576|80044196|FG001|Overall Study|Death|33|||
27505748|NCT02383576|80044195|FG000|Overall Study|Lost to Follow-up|7|||
27505749|NCT02383576|80044196|FG001|Overall Study|Lost to Follow-up|1|||
27613923|NCT02491892|80430075|FG000|Overall Study|Death|1|||
27613924|NCT02491892|80430076|FG001|Overall Study|Death|1|||
27505750|NCT02383576|80044195|FG000|Overall Study|Withdrew Consent|1|||
27505751|NCT02383576|80044196|FG001|Overall Study|Withdrew Consent|6|||
27505752|NCT02383576|80044195|FG000|Overall Study|Investigator's Decision|0|||
27505753|NCT02383576|80044196|FG001|Overall Study|Investigator's Decision|1|||
27848745|NCT02243293|81275864|FG013|Overall Study|Lost to Follow-up|0|||
27505754|NCT02383576|80044195|FG000|Overall Study|Administrative/Other|2|||
27505755|NCT02383576|80044196|FG001|Overall Study|Administrative/Other|4|||
27613925|NCT02491892|80430075|FG000|Overall Study|Lack of Efficacy|37|||
27848746|NCT02243293|81275865|FG014|Overall Study|Lost to Follow-up|0|||
27848747|NCT02243293|81275866|FG015|Overall Study|Lost to Follow-up|0|||
27848748|NCT02243293|81275867|FG016|Overall Study|Lost to Follow-up|3|||
27848749|NCT02243293|81275868|FG017|Overall Study|Lost to Follow-up|1|||
27848750|NCT02243293|81275869|FG018|Overall Study|Lost to Follow-up|0|||
27848751|NCT02243293|81275870|FG019|Overall Study|Lost to Follow-up|0|||
27848752|NCT02243293|81275871|FG020|Overall Study|Lost to Follow-up|1|||
27848753|NCT02243293|81275872|FG021|Overall Study|Lost to Follow-up|2|||
27848754|NCT02243293|81275851|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
27848755|NCT02243293|81275852|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
27848756|NCT02243293|81275853|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
27848757|NCT02243293|81275854|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
27848758|NCT02243293|81275855|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
27848759|NCT02243293|81275856|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
27848760|NCT02243293|81275857|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
27848761|NCT02243293|81275858|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
27848762|NCT02243293|81275859|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
27848763|NCT02243293|81275860|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
27848764|NCT02243293|81275861|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
27848765|NCT02243293|81275862|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
27848766|NCT02243293|81275863|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
27848767|NCT02243293|81275864|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
27894930|NCT00664859|81450401|FG001|Overall Study|Other|1|||
27894931|NCT00664859|81450402|FG002|Overall Study|Other|2|||
27894932|NCT01730534|81450403|FG000|Overall Study|Withdrawal by Subject|97|||
27894933|NCT01730534|81450404|FG001|Overall Study|Withdrawal by Subject|127|||
27894934|NCT01730534|81450403|FG000|Overall Study|Lost to Follow-up|12|||
27894935|NCT01730534|81450404|FG001|Overall Study|Lost to Follow-up|18|||
27894936|NCT01143064|81450405|FG000|Overall Study|Death|109|||
27894937|NCT01143064|81450406|FG001|Overall Study|Death|91|||
27894938|NCT01143064|81450405|FG000|Overall Study|Adverse Event|0|||
27894939|NCT01143064|81450406|FG001|Overall Study|Adverse Event|1|||
27894940|NCT01143064|81450405|FG000|Overall Study|Withdrawal by Subject|7|||
27894941|NCT01143064|81450406|FG001|Overall Study|Withdrawal by Subject|5|||
27894942|NCT01143064|81450405|FG000|Overall Study|Lost to Follow-up|17|||
27894943|NCT01143064|81450406|FG001|Overall Study|Lost to Follow-up|14|||
27894944|NCT01143064|81450405|FG000|Overall Study|Physician Decision|0|||
27894945|NCT01143064|81450406|FG001|Overall Study|Physician Decision|4|||
27894946|NCT01217385|81450409|FG000|Overall Study|Withdrawal by Subject|3|||
27894947|NCT01217385|81450409|FG000|Overall Study|DOSI not performed/not eval|12|||
27894948|NCT01217385|81450409|FG000|Overall Study|Central Path not Available|1|||
27894949|NCT01217385|81450409|FG000|Overall Study|Normal Breast TOI not available|10|||
27894950|NCT04416737|81450410|FG000|Week 1 (First Injection)|Physician Decision|0|||
27894951|NCT04416737|81450411|FG001|Week 1 (First Injection)|Physician Decision|1|||
27894952|NCT01306045|81450412|FG000|Met General Eligibility Criteria|Screen failures|193|||
27894953|NCT01306045|81450413|FG001|Met General Eligibility Criteria|Screen failures|11|||
27894954|NCT01306045|81450414|FG002|Met General Eligibility Criteria|Screen failures|8|||
27894955|NCT03627416|81450415|FG000|Overall Study|Adverse Event|0|||
27894956|NCT03627416|81450416|FG001|Overall Study|Adverse Event|1|||
27894957|NCT02255552|81450417|FG000|Overall Study|Participants enrolled into another study|0|||
27894958|NCT02255552|81450418|FG001|Overall Study|Participants enrolled into another study|11|||
27894959|NCT02255552|81450417|FG000|Overall Study|Withdrawal by Subject|1|||
27894960|NCT02255552|81450418|FG001|Overall Study|Withdrawal by Subject|4|||
27894961|NCT01384019|81450419|FG000|Overall Study|Withdrawal by Subject|3|||
27894962|NCT01384019|81450420|FG001|Overall Study|Withdrawal by Subject|0|||
27894963|NCT01384019|81450419|FG000|Overall Study|Death|1|||
27894964|NCT01384019|81450420|FG001|Overall Study|Death|0|||
27894965|NCT01384019|81450419|FG000|Overall Study|MRI refusal|6|||
27894966|NCT01384019|81450420|FG001|Overall Study|MRI refusal|6|||
27894967|NCT02342548|81450423|FG000|Overall Study|Adverse Event|12|||
27894968|NCT02342548|81450424|FG001|Overall Study|Adverse Event|17|||
27894969|NCT02342548|81450425|FG002|Overall Study|Adverse Event|13|||
27894970|NCT02342548|81450423|FG000|Overall Study|Lost to Follow-up|0|||
27894971|NCT02342548|81450424|FG001|Overall Study|Lost to Follow-up|1|||
27894972|NCT02342548|81450425|FG002|Overall Study|Lost to Follow-up|0|||
27894973|NCT02342548|81450423|FG000|Overall Study|Study terminated by sponsor|20|||
27894974|NCT02342548|81450424|FG001|Overall Study|Study terminated by sponsor|39|||
27894975|NCT02342548|81450425|FG002|Overall Study|Study terminated by sponsor|25|||
27894976|NCT02342548|81450423|FG000|Overall Study|Protocol Violation|0|||
27894977|NCT02342548|81450424|FG001|Overall Study|Protocol Violation|1|||
27894978|NCT02342548|81450425|FG002|Overall Study|Protocol Violation|0|||
27894979|NCT02342548|81450423|FG000|Overall Study|Withdrawal by Subject|1|||
27894980|NCT02342548|81450424|FG001|Overall Study|Withdrawal by Subject|3|||
27894981|NCT02342548|81450425|FG002|Overall Study|Withdrawal by Subject|4|||
27894982|NCT02342548|81450423|FG000|Overall Study|Other|1|||
27894983|NCT02342548|81450424|FG001|Overall Study|Other|1|||
27894984|NCT02342548|81450425|FG002|Overall Study|Other|1|||
27894985|NCT00990665|81450426|FG000|Overall Study|Unsuccessful Implant|8|||
27505756|NCT03697252|80044199|FG000|Overall Study|Adverse Event|3|||
27505757|NCT03697252|80044200|FG001|Overall Study|Adverse Event|2|||
27505758|NCT03697252|80044199|FG000|Overall Study|Withdrawal by Subject|14|||
27894986|NCT00990665|81450426|FG000|Overall Study|Death|29|||
27894987|NCT00990665|81450426|FG000|Overall Study|Heart Transplant|1|||
27894988|NCT00990665|81450426|FG000|Overall Study|Withdrawal by Subject|6|||
27894989|NCT00990665|81450426|FG000|Overall Study|Lost to Follow-up|1|||
27894990|NCT00990665|81450426|FG000|Overall Study|System Explant|3|||
27894991|NCT01796197|81450427|FG000|Overall Study|Lost to Follow-up|1|||
27894992|NCT01796197|81450427|FG000|Overall Study|Lack of Efficacy|1|||
27613926|NCT02491892|80430076|FG001|Overall Study|Lack of Efficacy|36|||
27613927|NCT02491892|80430075|FG000|Overall Study|Refused Treatment|1|||
27613928|NCT02491892|80430076|FG001|Overall Study|Refused Treatment|0|||
27613929|NCT02491892|80430075|FG000|Overall Study|Lost to Follow-up|1|||
27894993|NCT02407054|81450428|FG000|Overall Study|Adverse Event|1|||
27894994|NCT02407054|81450429|FG001|Overall Study|Adverse Event|4|||
27894995|NCT02407054|81450430|FG002|Overall Study|Adverse Event|1|||
27505759|NCT03697252|80044200|FG001|Overall Study|Withdrawal by Subject|14|||
27894996|NCT02407054|81450428|FG000|Overall Study|Non-compliance with Study|0|||
27894997|NCT02407054|81450429|FG001|Overall Study|Non-compliance with Study|2|||
27894998|NCT02407054|81450430|FG002|Overall Study|Non-compliance with Study|1|||
27894999|NCT02407054|81450428|FG000|Overall Study|Physician Decision|1|||
27895000|NCT02407054|81450429|FG001|Overall Study|Physician Decision|3|||
27895001|NCT02407054|81450430|FG002|Overall Study|Physician Decision|3|||
27895002|NCT02407054|81450428|FG000|Overall Study|Withdrawal by Subject|5|||
27895003|NCT02407054|81450429|FG001|Overall Study|Withdrawal by Subject|9|||
27895004|NCT02407054|81450430|FG002|Overall Study|Withdrawal by Subject|2|||
27895005|NCT01632904|81450431|FG000|Overall Study|Adverse Event|4|||
27895006|NCT01632904|81450432|FG001|Overall Study|Adverse Event|1|||
27895007|NCT01632904|81450431|FG000|Overall Study|Physician Decision|0|||
27895008|NCT01632904|81450432|FG001|Overall Study|Physician Decision|1|||
27895009|NCT01632904|81450431|FG000|Overall Study|Subject decision|3|||
27895010|NCT01632904|81450432|FG001|Overall Study|Subject decision|2|||
27895011|NCT01632904|81450431|FG000|Overall Study|Disease Progression|0|||
27895012|NCT01632904|81450432|FG001|Overall Study|Disease Progression|1|||
27895013|NCT01632904|81450431|FG000|Overall Study|Reason for discontinuation not available|0|||
27895014|NCT01632904|81450432|FG001|Overall Study|Reason for discontinuation not available|1|||
27895015|NCT01173055|81450433|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
27895016|NCT01173055|81450434|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
27895017|NCT01173055|81450433|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
27895018|NCT01173055|81450434|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
27895019|NCT00535847|81450435|FG000|Overall Study|Adverse Event|5|||
27895020|NCT00535847|81450436|FG001|Overall Study|Adverse Event|3|||
27895021|NCT00535847|81450437|FG002|Overall Study|Adverse Event|2|||
27895022|NCT00535847|81450435|FG000|Overall Study|Non compliance|1|||
27895023|NCT00535847|81450436|FG001|Overall Study|Non compliance|1|||
27895024|NCT00535847|81450437|FG002|Overall Study|Non compliance|0|||
27895025|NCT00535847|81450435|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
27895026|NCT00535847|81450436|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
27895027|NCT00535847|81450437|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
27895028|NCT04068688|81450438|FG000|Overall Study|Lost to Follow-up|1|||
27895029|NCT04068688|81450439|FG001|Overall Study|Lost to Follow-up|1|||
27895030|NCT04068688|81450440|FG002|Overall Study|Lost to Follow-up|0|||
27895031|NCT04068688|81450441|FG003|Overall Study|Lost to Follow-up|0|||
27895032|NCT04068688|81450442|FG004|Overall Study|Lost to Follow-up|5|||
27505760|NCT03697252|80044199|FG000|Overall Study|Lost to Follow-up|0|||
27895033|NCT04068688|81450443|FG005|Overall Study|Lost to Follow-up|5|||
27895034|NCT04068688|81450444|FG006|Overall Study|Lost to Follow-up|0|||
27895035|NCT04068688|81450445|FG007|Overall Study|Lost to Follow-up|0|||
27895036|NCT04068688|81450446|FG008|Overall Study|Lost to Follow-up|1|||
27895037|NCT04068688|81450447|FG009|Overall Study|Lost to Follow-up|0|||
27895038|NCT04068688|81450438|FG000|Overall Study|Withdrawal by Subject|1|||
27895039|NCT04068688|81450439|FG001|Overall Study|Withdrawal by Subject|1|||
27895040|NCT04068688|81450440|FG002|Overall Study|Withdrawal by Subject|0|||
27895041|NCT04068688|81450441|FG003|Overall Study|Withdrawal by Subject|0|||
27895042|NCT04068688|81450442|FG004|Overall Study|Withdrawal by Subject|0|||
27895043|NCT04068688|81450443|FG005|Overall Study|Withdrawal by Subject|0|||
27895044|NCT04068688|81450444|FG006|Overall Study|Withdrawal by Subject|0|||
27895045|NCT04068688|81450445|FG007|Overall Study|Withdrawal by Subject|0|||
27895046|NCT04068688|81450446|FG008|Overall Study|Withdrawal by Subject|0|||
27895047|NCT04068688|81450447|FG009|Overall Study|Withdrawal by Subject|0|||
27895048|NCT04068688|81450438|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
27895049|NCT04068688|81450439|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
27895050|NCT04068688|81450440|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895051|NCT04068688|81450441|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895052|NCT04068688|81450442|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895053|NCT04068688|81450443|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895054|NCT04068688|81450444|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895055|NCT04068688|81450445|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895056|NCT04068688|81450446|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895057|NCT04068688|81450447|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
27895058|NCT00387010|81450448|FG000|Dose Titration Period|Adverse Event|12|||
27895059|NCT00387010|81450448|FG000|Dose Titration Period|Lack of Efficacy|5|||
27895060|NCT00387010|81450448|FG000|Dose Titration Period|Withdrawal by Subject|3|||
27895061|NCT00387010|81450448|FG000|Dose Titration Period|Protocol Violation|1|||
27895062|NCT00387010|81450448|FG000|Dose Titration Period|Lost to Follow-up|2|||
27895063|NCT00387010|81450448|FG000|Dose Titration Period|Noncompliance with study medication|8|||
27895064|NCT00387010|81450448|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
27895065|NCT00387010|81450448|FG000|Treatment Period|Adverse Event|4|||
27895066|NCT00387010|81450448|FG000|Treatment Period|Withdrawal by Subject|1|||
27895067|NCT00387010|81450448|FG000|Treatment Period|Noncompliance with study medication|2|||
27895068|NCT00387010|81450448|FG000|Treatment Period|Noncompliance with study procedures|3|||
27895069|NCT00387010|81450448|FG000|Treatment Period|Participant reported study drug stolen|1|||
27895070|NCT03521817|81450449|FG000|Overall Study|Protocol Violation|0|||
27895071|NCT03521817|81450450|FG001|Overall Study|Protocol Violation|1|||
27895072|NCT01801358|81450451|FG000|Overall Study|Adverse Event|0|||
27895073|NCT01801358|81450452|FG001|Overall Study|Adverse Event|2|||
27895074|NCT01801358|81450453|FG002|Overall Study|Adverse Event|1|||
27895075|NCT01801358|81450454|FG003|Overall Study|Adverse Event|0|||
27895076|NCT01801358|81450455|FG004|Overall Study|Adverse Event|0|||
27895077|NCT01801358|81450456|FG005|Overall Study|Adverse Event|1|||
27895078|NCT01801358|81450451|FG000|Overall Study|Physician Decision|0|||
27895079|NCT01801358|81450452|FG001|Overall Study|Physician Decision|0|||
27895080|NCT01801358|81450453|FG002|Overall Study|Physician Decision|1|||
27895081|NCT01801358|81450454|FG003|Overall Study|Physician Decision|0|||
27895082|NCT01801358|81450455|FG004|Overall Study|Physician Decision|0|||
27895083|NCT01801358|81450456|FG005|Overall Study|Physician Decision|0|||
27895084|NCT01801358|81450451|FG000|Overall Study|Progressive Disease|6|||
27895085|NCT01801358|81450452|FG001|Overall Study|Progressive Disease|4|||
27895086|NCT01801358|81450453|FG002|Overall Study|Progressive Disease|4|||
27895087|NCT01801358|81450454|FG003|Overall Study|Progressive Disease|5|||
27895088|NCT01801358|81450455|FG004|Overall Study|Progressive Disease|6|||
27895089|NCT01801358|81450456|FG005|Overall Study|Progressive Disease|5|||
27895090|NCT01801358|81450451|FG000|Overall Study|Withdrawal by Subject|0|||
27895091|NCT01801358|81450452|FG001|Overall Study|Withdrawal by Subject|0|||
27895092|NCT01801358|81450453|FG002|Overall Study|Withdrawal by Subject|0|||
27895093|NCT01801358|81450454|FG003|Overall Study|Withdrawal by Subject|1|||
27895094|NCT01801358|81450455|FG004|Overall Study|Withdrawal by Subject|0|||
27895095|NCT01801358|81450456|FG005|Overall Study|Withdrawal by Subject|2|||
27895096|NCT03782974|81450457|FG000|Overall Study|Withdrawal by Subject|7|||
27895097|NCT03782974|81450458|FG001|Overall Study|Withdrawal by Subject|7|||
27895098|NCT03782974|81450457|FG000|Overall Study|Pregnancy|1|||
27895099|NCT03782974|81450458|FG001|Overall Study|Pregnancy|0|||
27895100|NCT02484651|81450459|FG000|Overall Study|Patients' data files were corrupted.|1|||
27895101|NCT02484651|81450460|FG001|Overall Study|Patients' data files were corrupted.|1|||
27613930|NCT02491892|80430076|FG001|Overall Study|Lost to Follow-up|0|||
27613931|NCT02597933|80430077|FG000|Overall Study|Withdrawal by Subject|7|||
27613932|NCT02597933|80430078|FG001|Overall Study|Withdrawal by Subject|5|||
27613933|NCT02597933|80430077|FG000|Overall Study|Protocol Violation|2|||
27895102|NCT02484651|81450459|FG000|Overall Study|BIS monitoring failed.|1|||
27895103|NCT02484651|81450460|FG001|Overall Study|BIS monitoring failed.|1|||
27848768|NCT02243293|81275865|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
27848769|NCT02243293|81275866|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
27848770|NCT02243293|81275867|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
27848771|NCT02243293|81275868|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
27848772|NCT02243293|81275869|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
27848773|NCT02243293|81275870|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
27848774|NCT02243293|81275871|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
27848775|NCT02243293|81275872|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
27848776|NCT02243293|81275851|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
27848777|NCT02243293|81275852|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
27848778|NCT02243293|81275853|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
27848779|NCT02243293|81275854|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
27848780|NCT02243293|81275855|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
27848781|NCT02243293|81275856|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
27848782|NCT02243293|81275857|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
27848783|NCT02243293|81275858|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
27848784|NCT02243293|81275859|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
27848785|NCT02243293|81275860|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
27848786|NCT02243293|81275861|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
27848787|NCT02243293|81275862|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
27848788|NCT02243293|81275863|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
27848789|NCT02243293|81275864|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
27848790|NCT02243293|81275865|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
27848791|NCT02243293|81275866|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
27848792|NCT02243293|81275867|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
27848793|NCT02243293|81275868|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
27848794|NCT02243293|81275869|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
27848795|NCT02243293|81275870|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
27848796|NCT02243293|81275871|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
27848797|NCT02243293|81275872|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
27848798|NCT03977701|81275875|FG000|Overall Study|COVID-19 pandemic|0|||
27848799|NCT03977701|81275876|FG001|Overall Study|COVID-19 pandemic|0|||
27848800|NCT03977701|81275877|FG002|Overall Study|COVID-19 pandemic|0|||
27848801|NCT03977701|81275878|FG003|Overall Study|COVID-19 pandemic|0|||
27848802|NCT03977701|81275879|FG004|Overall Study|COVID-19 pandemic|0|||
27848803|NCT03977701|81275880|FG005|Overall Study|COVID-19 pandemic|1|||
27848804|NCT03977701|81275881|FG006|Overall Study|COVID-19 pandemic|0|||
27848805|NCT03977701|81275882|FG007|Overall Study|COVID-19 pandemic|1|||
27848806|NCT03977701|81275883|FG008|Overall Study|COVID-19 pandemic|0|||
27848807|NCT03977701|81275884|FG009|Overall Study|COVID-19 pandemic|0|||
27848808|NCT02211014|81275885|FG000|Overall Study|Adverse Event|0|||
27848809|NCT02211014|81275886|FG001|Overall Study|Adverse Event|2|||
27848810|NCT02211014|81275885|FG000|Overall Study|Physician Decision|1|||
27848811|NCT02211014|81275886|FG001|Overall Study|Physician Decision|2|||
27848812|NCT02211014|81275885|FG000|Overall Study|Started another cancer therapy|1|||
27848813|NCT02211014|81275886|FG001|Overall Study|Started another cancer therapy|0|||
27848814|NCT02211014|81275885|FG000|Overall Study|Withdrawal by Subject|0|||
27848815|NCT02211014|81275886|FG001|Overall Study|Withdrawal by Subject|1|||
27848816|NCT02211014|81275885|FG000|Overall Study|In agreement with patient, no benefit|0|||
27848817|NCT02211014|81275886|FG001|Overall Study|In agreement with patient, no benefit|1|||
27848818|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
27848819|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
27848820|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
27848821|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
27848822|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
27848823|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
27848824|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
27848825|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
27848826|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
27848827|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
27848828|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
27848829|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
27848830|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
27848831|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
27848832|NCT04740931|81275887|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
27848833|NCT04740931|81275888|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
27848834|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
27848835|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
27848836|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
27848837|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
27895104|NCT02484651|81450459|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
27895105|NCT02484651|81450460|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
27895106|NCT01764997|81450461|FG000|Run-in Period|Adverse Event|15|||
27895107|NCT01764997|81450462|FG001|Run-in Period|Adverse Event|0|||
27895108|NCT01764997|81450463|FG002|Run-in Period|Adverse Event|0|||
27895109|NCT01764997|81450464|FG003|Run-in Period|Adverse Event|0|||
27895110|NCT01764997|81450465|FG004|Run-in Period|Adverse Event|0|||
27895111|NCT01764997|81450461|FG000|Run-in Period|Lack of Efficacy|5|||
27895112|NCT01764997|81450462|FG001|Run-in Period|Lack of Efficacy|0|||
27895113|NCT01764997|81450463|FG002|Run-in Period|Lack of Efficacy|0|||
27895114|NCT01764997|81450464|FG003|Run-in Period|Lack of Efficacy|0|||
27895115|NCT01764997|81450465|FG004|Run-in Period|Lack of Efficacy|0|||
27895116|NCT01764997|81450461|FG000|Run-in Period|Poor compliance to protocol|1|||
27895117|NCT01764997|81450462|FG001|Run-in Period|Poor compliance to protocol|0|||
27895118|NCT01764997|81450463|FG002|Run-in Period|Poor compliance to protocol|0|||
27895119|NCT01764997|81450464|FG003|Run-in Period|Poor compliance to protocol|0|||
27895120|NCT01764997|81450465|FG004|Run-in Period|Poor compliance to protocol|0|||
27895121|NCT01764997|81450461|FG000|Run-in Period|Other than specified above|17|||
27895122|NCT01764997|81450462|FG001|Run-in Period|Other than specified above|0|||
27895123|NCT01764997|81450463|FG002|Run-in Period|Other than specified above|0|||
27895124|NCT01764997|81450464|FG003|Run-in Period|Other than specified above|0|||
27895125|NCT01764997|81450465|FG004|Run-in Period|Other than specified above|0|||
27895126|NCT01764997|81450461|FG000|Study Drug Treatment Period|Adverse Event|0|||
27895127|NCT01764997|81450462|FG001|Study Drug Treatment Period|Adverse Event|1|||
27895128|NCT01764997|81450463|FG002|Study Drug Treatment Period|Adverse Event|0|||
27895129|NCT01764997|81450464|FG003|Study Drug Treatment Period|Adverse Event|0|||
27505761|NCT03697252|80044200|FG001|Overall Study|Lost to Follow-up|1|||
27505762|NCT03697252|80044199|FG000|Overall Study|Physician Decision|1|||
27505763|NCT03697252|80044200|FG001|Overall Study|Physician Decision|1|||
27505764|NCT03697252|80044199|FG000|Overall Study|Other|0|||
27505765|NCT03697252|80044200|FG001|Overall Study|Other|1|||
27505766|NCT02963506|80044202|FG000|Double-Blind Period|Adverse Event|0|||
27505767|NCT02963506|80044203|FG001|Double-Blind Period|Adverse Event|0|||
27505768|NCT02963506|80044204|FG002|Double-Blind Period|Adverse Event|1|||
27505769|NCT02963506|80044205|FG003|Double-Blind Period|Adverse Event|0|||
27505770|NCT02963506|80044206|FG004|Double-Blind Period|Adverse Event|0|||
27505771|NCT02963506|80044207|FG005|Double-Blind Period|Adverse Event|0|||
27505772|NCT02963506|80044208|FG006|Double-Blind Period|Adverse Event|0|||
27505773|NCT02963506|80044209|FG007|Double-Blind Period|Adverse Event|0|||
27505774|NCT02963506|80044210|FG008|Double-Blind Period|Adverse Event|0|||
27505775|NCT02963506|80044211|FG009|Double-Blind Period|Adverse Event|0|||
27505776|NCT02963506|80044212|FG010|Double-Blind Period|Adverse Event|0|||
27505777|NCT02963506|80044213|FG011|Double-Blind Period|Adverse Event|0|||
27505778|NCT02963506|80044214|FG012|Double-Blind Period|Adverse Event|0|||
27505779|NCT02963506|80044202|FG000|Double-Blind Period|Death|0|||
27505780|NCT02963506|80044203|FG001|Double-Blind Period|Death|0|||
27505781|NCT02963506|80044204|FG002|Double-Blind Period|Death|0|||
27505782|NCT02963506|80044205|FG003|Double-Blind Period|Death|1|||
27505783|NCT02963506|80044206|FG004|Double-Blind Period|Death|0|||
27505784|NCT02963506|80044207|FG005|Double-Blind Period|Death|0|||
27505785|NCT02963506|80044208|FG006|Double-Blind Period|Death|0|||
27505786|NCT02963506|80044209|FG007|Double-Blind Period|Death|0|||
27505787|NCT02963506|80044210|FG008|Double-Blind Period|Death|0|||
27505788|NCT02963506|80044211|FG009|Double-Blind Period|Death|0|||
27505789|NCT02963506|80044212|FG010|Double-Blind Period|Death|0|||
27505790|NCT02963506|80044213|FG011|Double-Blind Period|Death|0|||
27505791|NCT02963506|80044214|FG012|Double-Blind Period|Death|0|||
27505792|NCT02963506|80044202|FG000|Double-Blind Period|Lost to Follow-up|0|||
27505793|NCT02963506|80044203|FG001|Double-Blind Period|Lost to Follow-up|1|||
27505794|NCT02963506|80044204|FG002|Double-Blind Period|Lost to Follow-up|0|||
27505795|NCT02963506|80044205|FG003|Double-Blind Period|Lost to Follow-up|0|||
27895130|NCT01764997|81450465|FG004|Study Drug Treatment Period|Adverse Event|24|||
27895131|NCT01764997|81450461|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
27895132|NCT01764997|81450462|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
27895133|NCT01764997|81450463|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
27895134|NCT01764997|81450464|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
27895135|NCT01764997|81450465|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
27895136|NCT01764997|81450461|FG000|Study Drug Treatment Period|Other than specified above|0|||
27895137|NCT01764997|81450462|FG001|Study Drug Treatment Period|Other than specified above|0|||
27505796|NCT02963506|80044206|FG004|Double-Blind Period|Lost to Follow-up|0|||
27505797|NCT02963506|80044207|FG005|Double-Blind Period|Lost to Follow-up|0|||
27505798|NCT02963506|80044208|FG006|Double-Blind Period|Lost to Follow-up|0|||
27613934|NCT02597933|80430078|FG001|Overall Study|Protocol Violation|2|||
27895138|NCT01764997|81450463|FG002|Study Drug Treatment Period|Other than specified above|0|||
27895139|NCT01764997|81450464|FG003|Study Drug Treatment Period|Other than specified above|0|||
27895140|NCT01764997|81450465|FG004|Study Drug Treatment Period|Other than specified above|10|||
27895141|NCT02461524|81450468|FG000|Overall Study|Death|16|||
27895142|NCT02461524|81450468|FG000|Overall Study|Withdrawal by Subject|4|||
27895143|NCT02461524|81450468|FG000|Overall Study|Device Explanted|5|||
27895144|NCT02461524|81450468|FG000|Overall Study|Missed Visit|6|||
27895145|NCT01573767|81450469|FG000|Overall Study|Adverse Event|0|||
27895146|NCT01573767|81450470|FG001|Overall Study|Adverse Event|1|||
27895147|NCT01573767|81450471|FG002|Overall Study|Adverse Event|0|||
27895148|NCT01573767|81450472|FG003|Overall Study|Adverse Event|1|||
27895149|NCT01573767|81450469|FG000|Overall Study|Lack of Efficacy|18|||
27895150|NCT01573767|81450470|FG001|Overall Study|Lack of Efficacy|15|||
27895151|NCT01573767|81450471|FG002|Overall Study|Lack of Efficacy|12|||
27895152|NCT01573767|81450472|FG003|Overall Study|Lack of Efficacy|17|||
27895153|NCT01573767|81450469|FG000|Overall Study|Protocol Violation|3|||
27895154|NCT01573767|81450470|FG001|Overall Study|Protocol Violation|1|||
27895155|NCT01573767|81450471|FG002|Overall Study|Protocol Violation|1|||
27895156|NCT01573767|81450472|FG003|Overall Study|Protocol Violation|3|||
27505799|NCT02963506|80044209|FG007|Double-Blind Period|Lost to Follow-up|0|||
27505800|NCT02963506|80044210|FG008|Double-Blind Period|Lost to Follow-up|0|||
27505801|NCT02963506|80044211|FG009|Double-Blind Period|Lost to Follow-up|0|||
27505802|NCT02963506|80044212|FG010|Double-Blind Period|Lost to Follow-up|0|||
27505803|NCT02963506|80044213|FG011|Double-Blind Period|Lost to Follow-up|0|||
27505804|NCT02963506|80044214|FG012|Double-Blind Period|Lost to Follow-up|0|||
27895157|NCT01573767|81450469|FG000|Overall Study|Lost to Follow-up|0|||
27895158|NCT01573767|81450470|FG001|Overall Study|Lost to Follow-up|1|||
27895159|NCT01573767|81450471|FG002|Overall Study|Lost to Follow-up|1|||
27895160|NCT01573767|81450472|FG003|Overall Study|Lost to Follow-up|1|||
27895161|NCT01573767|81450469|FG000|Overall Study|Physician Decision|1|||
27895162|NCT01573767|81450470|FG001|Overall Study|Physician Decision|2|||
27505805|NCT02963506|80044202|FG000|Double-Blind Period|Withdrawal by Subject|0|||
27505806|NCT02963506|80044203|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27505807|NCT02963506|80044204|FG002|Double-Blind Period|Withdrawal by Subject|1|||
27505808|NCT02963506|80044205|FG003|Double-Blind Period|Withdrawal by Subject|1|||
27505809|NCT02963506|80044206|FG004|Double-Blind Period|Withdrawal by Subject|0|||
27505810|NCT02963506|80044207|FG005|Double-Blind Period|Withdrawal by Subject|0|||
27505811|NCT02963506|80044208|FG006|Double-Blind Period|Withdrawal by Subject|0|||
27895163|NCT01573767|81450471|FG002|Overall Study|Physician Decision|0|||
27895164|NCT01573767|81450472|FG003|Overall Study|Physician Decision|2|||
27895165|NCT01573767|81450469|FG000|Overall Study|Withdrawal by Subject|0|||
27895166|NCT01573767|81450470|FG001|Overall Study|Withdrawal by Subject|1|||
27505812|NCT02963506|80044209|FG007|Double-Blind Period|Withdrawal by Subject|0|||
27895167|NCT01573767|81450471|FG002|Overall Study|Withdrawal by Subject|0|||
27895168|NCT01573767|81450472|FG003|Overall Study|Withdrawal by Subject|0|||
27895169|NCT04331067|81450473|FG000|Overall Study|Adverse Event|1|||
27895170|NCT04331067|81450474|FG001|Overall Study|Adverse Event|3|||
27895171|NCT04331067|81450475|FG002|Overall Study|Adverse Event|1|||
27895172|NCT04331067|81450473|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
27895173|NCT04331067|81450474|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
27895174|NCT04331067|81450475|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
27895175|NCT02987972|81450476|FG000|Overall Study|Adverse Event|1|||
27505813|NCT02963506|80044210|FG008|Double-Blind Period|Withdrawal by Subject|0|||
27505814|NCT02963506|80044211|FG009|Double-Blind Period|Withdrawal by Subject|0|||
27505815|NCT02963506|80044212|FG010|Double-Blind Period|Withdrawal by Subject|0|||
27505816|NCT02963506|80044213|FG011|Double-Blind Period|Withdrawal by Subject|0|||
27505817|NCT02963506|80044214|FG012|Double-Blind Period|Withdrawal by Subject|0|||
27505818|NCT02963506|80044202|FG000|Double-Blind Period|No compliance|0|||
27505819|NCT02963506|80044203|FG001|Double-Blind Period|No compliance|1|||
27505820|NCT02963506|80044204|FG002|Double-Blind Period|No compliance|0|||
27505821|NCT02963506|80044205|FG003|Double-Blind Period|No compliance|0|||
27726712|NCT03118947|80830171|FG000|Overall Study|Withdrawal by Subject|3|||
27726713|NCT03118947|80830171|FG000|Overall Study|Withdrawal by caregiver|3|||
27505822|NCT02963506|80044206|FG004|Double-Blind Period|No compliance|0|||
27505823|NCT02963506|80044207|FG005|Double-Blind Period|No compliance|0|||
27505824|NCT02963506|80044208|FG006|Double-Blind Period|No compliance|0|||
27505825|NCT02963506|80044209|FG007|Double-Blind Period|No compliance|0|||
27505826|NCT02963506|80044210|FG008|Double-Blind Period|No compliance|0|||
27505827|NCT02963506|80044211|FG009|Double-Blind Period|No compliance|0|||
27505828|NCT02963506|80044212|FG010|Double-Blind Period|No compliance|0|||
27505829|NCT02963506|80044213|FG011|Double-Blind Period|No compliance|0|||
27505830|NCT02963506|80044214|FG012|Double-Blind Period|No compliance|0|||
27505831|NCT02963506|80044202|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505832|NCT02963506|80044203|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
27505833|NCT02963506|80044204|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505834|NCT02963506|80044205|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505835|NCT02963506|80044206|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505836|NCT02963506|80044207|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505837|NCT02963506|80044208|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505838|NCT02963506|80044209|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505839|NCT02963506|80044210|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505840|NCT02963506|80044211|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505841|NCT02963506|80044212|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505842|NCT02963506|80044213|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27726714|NCT03118947|80830171|FG000|Overall Study|Change in patient's living situation|4|||
27726715|NCT03118947|80830171|FG000|Overall Study|Lost to Follow-up|2|||
27726716|NCT03663166|80830174|FG000|Overall Study|Withdrawal by Subject|1|||
27726717|NCT00132730|80830175|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
27726718|NCT00132730|80830176|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
27726719|NCT00132730|80830177|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
27726720|NCT00132730|80830178|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
27726721|NCT00132730|80830179|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
27505843|NCT02963506|80044214|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
27505844|NCT02963506|80044202|FG000|Dose-Blind Period|Adverse Event|0|||
27505845|NCT02963506|80044203|FG001|Dose-Blind Period|Adverse Event|0|||
27505846|NCT02963506|80044204|FG002|Dose-Blind Period|Adverse Event|0|||
27505847|NCT02963506|80044205|FG003|Dose-Blind Period|Adverse Event|0|||
27505848|NCT02963506|80044206|FG004|Dose-Blind Period|Adverse Event|0|||
27726722|NCT00132730|80830180|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
27505849|NCT02963506|80044207|FG005|Dose-Blind Period|Adverse Event|1|||
27505850|NCT02963506|80044208|FG006|Dose-Blind Period|Adverse Event|3|||
27505851|NCT02963506|80044209|FG007|Dose-Blind Period|Adverse Event|2|||
27505852|NCT02963506|80044210|FG008|Dose-Blind Period|Adverse Event|2|||
27505853|NCT02963506|80044211|FG009|Dose-Blind Period|Adverse Event|2|||
27505854|NCT02963506|80044212|FG010|Dose-Blind Period|Adverse Event|1|||
27505855|NCT02963506|80044213|FG011|Dose-Blind Period|Adverse Event|1|||
27505856|NCT02963506|80044214|FG012|Dose-Blind Period|Adverse Event|6|||
27505857|NCT02963506|80044202|FG000|Dose-Blind Period|Lack of Efficacy|0|||
27505858|NCT02963506|80044203|FG001|Dose-Blind Period|Lack of Efficacy|0|||
27505859|NCT02963506|80044204|FG002|Dose-Blind Period|Lack of Efficacy|0|||
27505860|NCT02963506|80044205|FG003|Dose-Blind Period|Lack of Efficacy|0|||
27505861|NCT02963506|80044206|FG004|Dose-Blind Period|Lack of Efficacy|0|||
27505862|NCT02963506|80044207|FG005|Dose-Blind Period|Lack of Efficacy|0|||
27505863|NCT02963506|80044208|FG006|Dose-Blind Period|Lack of Efficacy|0|||
27505864|NCT02963506|80044209|FG007|Dose-Blind Period|Lack of Efficacy|1|||
27613935|NCT02597933|80430077|FG000|Overall Study|Adverse Event|20|||
27848838|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
27848839|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
27505865|NCT02963506|80044210|FG008|Dose-Blind Period|Lack of Efficacy|0|||
27505866|NCT02963506|80044211|FG009|Dose-Blind Period|Lack of Efficacy|1|||
27505867|NCT02963506|80044212|FG010|Dose-Blind Period|Lack of Efficacy|0|||
27505868|NCT02963506|80044213|FG011|Dose-Blind Period|Lack of Efficacy|0|||
27505869|NCT02963506|80044214|FG012|Dose-Blind Period|Lack of Efficacy|0|||
27505870|NCT02963506|80044202|FG000|Dose-Blind Period|Lost to Follow-up|0|||
27505871|NCT02963506|80044203|FG001|Dose-Blind Period|Lost to Follow-up|0|||
27505872|NCT02963506|80044204|FG002|Dose-Blind Period|Lost to Follow-up|0|||
27505873|NCT02963506|80044205|FG003|Dose-Blind Period|Lost to Follow-up|0|||
27505874|NCT02963506|80044206|FG004|Dose-Blind Period|Lost to Follow-up|0|||
27505875|NCT02963506|80044207|FG005|Dose-Blind Period|Lost to Follow-up|1|||
27505876|NCT02963506|80044208|FG006|Dose-Blind Period|Lost to Follow-up|0|||
27505877|NCT02963506|80044209|FG007|Dose-Blind Period|Lost to Follow-up|0|||
27505878|NCT02963506|80044210|FG008|Dose-Blind Period|Lost to Follow-up|1|||
27505879|NCT02963506|80044211|FG009|Dose-Blind Period|Lost to Follow-up|0|||
27505880|NCT02963506|80044212|FG010|Dose-Blind Period|Lost to Follow-up|0|||
27505881|NCT02963506|80044213|FG011|Dose-Blind Period|Lost to Follow-up|1|||
27505882|NCT02963506|80044214|FG012|Dose-Blind Period|Lost to Follow-up|0|||
27505883|NCT02963506|80044202|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
27505884|NCT02963506|80044203|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
27505885|NCT02963506|80044204|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
27505886|NCT02963506|80044205|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
27726723|NCT00132730|80830175|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
27726724|NCT00132730|80830176|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
27505887|NCT02963506|80044206|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
27505888|NCT02963506|80044207|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
27726725|NCT00132730|80830177|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
27726726|NCT00132730|80830178|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
27726727|NCT00132730|80830179|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
27848840|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
27848841|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
27848842|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
27848843|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
27848844|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
27848845|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
27848846|NCT04740931|81275887|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
27848847|NCT04740931|81275888|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
27848848|NCT01506908|81275892|FG000|Overall Study|Adverse Event|1|||
27848849|NCT01506908|81275893|FG001|Overall Study|Adverse Event|0|||
27848850|NCT00834899|81275894|FG000|Overall Study|Withdrawal by Subject|1|||
27848851|NCT00834899|81275895|FG001|Overall Study|Withdrawal by Subject|1|||
27848852|NCT00536484|81275896|FG000|Overall Study|Adverse Event|21|||
27848853|NCT00536484|81275897|FG001|Overall Study|Adverse Event|34|||
27848854|NCT00536484|81275896|FG000|Overall Study|Withdrawal by Subject|11|||
27848855|NCT00536484|81275897|FG001|Overall Study|Withdrawal by Subject|11|||
27848856|NCT00536484|81275896|FG000|Overall Study|Lost to Follow-up|8|||
27848857|NCT00536484|81275897|FG001|Overall Study|Lost to Follow-up|6|||
27848858|NCT00536484|81275896|FG000|Overall Study|Lack of Efficacy|16|||
27848859|NCT00536484|81275897|FG001|Overall Study|Lack of Efficacy|5|||
27848860|NCT00536484|81275896|FG000|Overall Study|Other|4|||
27848861|NCT00536484|81275897|FG001|Overall Study|Other|0|||
27848862|NCT01917968|81275898|FG000|Overall Study|Death|3|||
27848863|NCT01917968|81275899|FG001|Overall Study|Death|2|||
27848864|NCT01917968|81275898|FG000|Overall Study|Lost to Follow-up|21|||
27848865|NCT01917968|81275899|FG001|Overall Study|Lost to Follow-up|39|||
27848866|NCT01917968|81275898|FG000|Overall Study|Physician Decision|1|||
27848867|NCT01917968|81275899|FG001|Overall Study|Physician Decision|2|||
27848868|NCT01917968|81275898|FG000|Overall Study|Withdrawal by Subject|20|||
27848869|NCT01917968|81275899|FG001|Overall Study|Withdrawal by Subject|35|||
27848870|NCT01917968|81275898|FG000|Overall Study|Subject Relocation|5|||
27848871|NCT01917968|81275899|FG001|Overall Study|Subject Relocation|1|||
27848872|NCT01917968|81275898|FG000|Overall Study|36M Missed Visit|3|||
27848873|NCT01917968|81275899|FG001|Overall Study|36M Missed Visit|2|||
27848874|NCT01917968|81275898|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
27848875|NCT01917968|81275899|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
27848876|NCT01917968|81275898|FG000|Overall Study|Change in Family Circumstances|0|||
27848877|NCT01917968|81275899|FG001|Overall Study|Change in Family Circumstances|1|||
27848878|NCT01917968|81275898|FG000|Overall Study|No Data Available|0|||
27848879|NCT01917968|81275899|FG001|Overall Study|No Data Available|2|||
27848880|NCT01351350|81275900|FG000|Overall Study|Disease Progression|5|||
27895176|NCT02987972|81450477|FG001|Overall Study|Adverse Event|1|||
27895177|NCT02987972|81450478|FG002|Overall Study|Adverse Event|0|||
27895178|NCT02987972|81450476|FG000|Overall Study|Death|1|||
27895179|NCT02987972|81450477|FG001|Overall Study|Death|0|||
27895180|NCT02987972|81450478|FG002|Overall Study|Death|0|||
27895181|NCT02987972|81450476|FG000|Overall Study|Lack of Efficacy|9|||
27895182|NCT02987972|81450477|FG001|Overall Study|Lack of Efficacy|12|||
27895183|NCT02987972|81450478|FG002|Overall Study|Lack of Efficacy|12|||
27895184|NCT02987972|81450476|FG000|Overall Study|Lost to Follow-up|7|||
27895185|NCT02987972|81450477|FG001|Overall Study|Lost to Follow-up|8|||
27895186|NCT02987972|81450478|FG002|Overall Study|Lost to Follow-up|4|||
27895187|NCT02987972|81450476|FG000|Overall Study|Physician Decision|1|||
27895188|NCT02987972|81450477|FG001|Overall Study|Physician Decision|6|||
27895189|NCT02987972|81450478|FG002|Overall Study|Physician Decision|0|||
27895190|NCT02987972|81450476|FG000|Overall Study|Protocol Violation|2|||
27895191|NCT02987972|81450477|FG001|Overall Study|Protocol Violation|1|||
27895192|NCT02987972|81450478|FG002|Overall Study|Protocol Violation|5|||
27895193|NCT02987972|81450476|FG000|Overall Study|Withdrawal by Subject|22|||
27895194|NCT02987972|81450477|FG001|Overall Study|Withdrawal by Subject|17|||
27895195|NCT02987972|81450478|FG002|Overall Study|Withdrawal by Subject|21|||
27895196|NCT00916344|81450485|FG000|Overall Study|Death|2|||
27895197|NCT00916344|81450485|FG000|Overall Study|ICD upgrade|1|||
27895198|NCT00916344|81450485|FG000|Overall Study|Drop-out|5|||
27895199|NCT05108922|81450486|FG000|Overall Study|Adverse Event|0|||
27895200|NCT05108922|81450487|FG001|Overall Study|Adverse Event|1|||
27895201|NCT05108922|81450486|FG000|Overall Study|Physician Decision|1|||
27895202|NCT05108922|81450487|FG001|Overall Study|Physician Decision|1|||
27895203|NCT05108922|81450486|FG000|Overall Study|Screen Failure|1|||
27895204|NCT05108922|81450487|FG001|Overall Study|Screen Failure|1|||
27895205|NCT05108922|81450486|FG000|Overall Study|Withdrawal by Subject|7|||
27895206|NCT05108922|81450487|FG001|Overall Study|Withdrawal by Subject|4|||
27895207|NCT04601103|81450488|FG000|Overall Study|Needed crown & cleaning|0|||
27895208|NCT04601103|81450489|FG001|Overall Study|Needed crown & cleaning|0|||
27895209|NCT04601103|81450490|FG002|Overall Study|Needed crown & cleaning|1|||
27895210|NCT04601103|81450488|FG000|Overall Study|study was terminated|18|||
27895211|NCT04601103|81450489|FG001|Overall Study|study was terminated|18|||
27895212|NCT04601103|81450490|FG002|Overall Study|study was terminated|16|||
27895213|NCT01447927|81450491|FG000|Overall Study|Adverse Event|4|||
27895214|NCT01447927|81450492|FG001|Overall Study|Adverse Event|3|||
27895215|NCT01447927|81450491|FG000|Overall Study|Withdrawal by Subject|1|||
27895216|NCT01447927|81450492|FG001|Overall Study|Withdrawal by Subject|0|||
27895217|NCT00550862|81450497|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
27895218|NCT00550862|81450498|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
27895219|NCT00550862|81450499|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
27895220|NCT00550862|81450500|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
27895221|NCT00550862|81450501|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
27895222|NCT00550862|81450497|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
27895223|NCT00550862|81450498|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
27895224|NCT00550862|81450499|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
27895225|NCT00550862|81450500|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
27895226|NCT00550862|81450501|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
27895227|NCT00550862|81450497|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
27895228|NCT00550862|81450498|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
27895229|NCT00550862|81450499|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
27895230|NCT00550862|81450500|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
27895231|NCT00550862|81450501|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
27895232|NCT00550862|81450497|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
27895233|NCT00550862|81450498|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
27895234|NCT00550862|81450499|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
27895235|NCT00550862|81450500|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
27895236|NCT00550862|81450501|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
27895237|NCT00550862|81450497|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
27895238|NCT00550862|81450498|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
27895239|NCT00550862|81450499|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
27895240|NCT00550862|81450500|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
27895241|NCT00550862|81450501|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
27895242|NCT00550862|81450497|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
27895243|NCT00550862|81450498|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
27895244|NCT00550862|81450499|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
27895245|NCT00550862|81450500|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
27895246|NCT00550862|81450501|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
27895247|NCT00550862|81450497|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
27895248|NCT00550862|81450498|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
27895249|NCT00550862|81450499|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
27895250|NCT00550862|81450500|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
27895251|NCT00550862|81450501|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
27895252|NCT00550862|81450497|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
27895253|NCT00550862|81450498|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
27895254|NCT00550862|81450499|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
27895255|NCT00550862|81450500|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
27895256|NCT00550862|81450501|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
27895257|NCT00550862|81450497|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
27895258|NCT00550862|81450498|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
27895259|NCT00550862|81450499|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
27895260|NCT00550862|81450500|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
27895261|NCT00550862|81450501|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
27895262|NCT00550862|81450497|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
27895263|NCT00550862|81450498|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
27895264|NCT00550862|81450499|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
27895265|NCT00550862|81450500|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
27895266|NCT00550862|81450501|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
27895267|NCT01777295|81450502|FG000|Overall Study|Withdrawal by Subject|2|||
27895268|NCT01777295|81450503|FG001|Overall Study|Withdrawal by Subject|2|||
27895269|NCT01777295|81450502|FG000|Overall Study|Pregnancy|0|||
27895270|NCT01777295|81450503|FG001|Overall Study|Pregnancy|1|||
27895271|NCT01777295|81450502|FG000|Overall Study|Personal problem|1|||
27895272|NCT01777295|81450503|FG001|Overall Study|Personal problem|0|||
27895273|NCT01777295|81450502|FG000|Overall Study|Investigator call for AEs check|1|||
27895274|NCT01777295|81450503|FG001|Overall Study|Investigator call for AEs check|0|||
27895275|NCT02954653|81450504|FG000|Overall Study|Death|3|||
27895276|NCT02954653|81450505|FG001|Overall Study|Death|1|||
27895277|NCT02954653|81450506|FG002|Overall Study|Death|0|||
27895278|NCT02954653|81450507|FG003|Overall Study|Death|0|||
27895279|NCT02954653|81450508|FG004|Overall Study|Death|0|||
27895280|NCT02954653|81450509|FG005|Overall Study|Death|0|||
27895281|NCT02954653|81450510|FG006|Overall Study|Death|0|||
27895282|NCT02954653|81450511|FG007|Overall Study|Death|0|||
27895283|NCT02954653|81450512|FG008|Overall Study|Death|0|||
27895284|NCT02954653|81450504|FG000|Overall Study|Randomized but did not receive treatment|1|||
27895285|NCT02954653|81450505|FG001|Overall Study|Randomized but did not receive treatment|0|||
27895286|NCT02954653|81450506|FG002|Overall Study|Randomized but did not receive treatment|0|||
27895287|NCT02954653|81450507|FG003|Overall Study|Randomized but did not receive treatment|0|||
27895288|NCT02954653|81450508|FG004|Overall Study|Randomized but did not receive treatment|0|||
27895289|NCT02954653|81450509|FG005|Overall Study|Randomized but did not receive treatment|0|||
27895290|NCT02954653|81450510|FG006|Overall Study|Randomized but did not receive treatment|0|||
27895291|NCT02954653|81450511|FG007|Overall Study|Randomized but did not receive treatment|0|||
27895292|NCT02954653|81450512|FG008|Overall Study|Randomized but did not receive treatment|0|||
27895293|NCT02954653|81450504|FG000|Overall Study|Started another anti-cancer therapy|0|||
27895294|NCT02954653|81450505|FG001|Overall Study|Started another anti-cancer therapy|1|||
27895295|NCT02954653|81450506|FG002|Overall Study|Started another anti-cancer therapy|0|||
27895296|NCT02954653|81450507|FG003|Overall Study|Started another anti-cancer therapy|0|||
27895297|NCT02954653|81450508|FG004|Overall Study|Started another anti-cancer therapy|0|||
27895298|NCT02954653|81450509|FG005|Overall Study|Started another anti-cancer therapy|0|||
27895299|NCT02954653|81450510|FG006|Overall Study|Started another anti-cancer therapy|0|||
27895300|NCT02954653|81450511|FG007|Overall Study|Started another anti-cancer therapy|0|||
27895301|NCT02954653|81450512|FG008|Overall Study|Started another anti-cancer therapy|0|||
27895302|NCT02954653|81450504|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
27895303|NCT02954653|81450505|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
27895304|NCT02954653|81450506|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
27895305|NCT02954653|81450507|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
27895306|NCT02954653|81450508|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
27895307|NCT02954653|81450509|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
27895308|NCT02954653|81450510|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
27726728|NCT00132730|80830180|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
27895309|NCT02954653|81450511|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
27895310|NCT02954653|81450512|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
27895311|NCT02620384|81450515|FG000|Overall Study|Adverse Event|2|||
27895312|NCT02620384|81450516|FG001|Overall Study|Adverse Event|1|||
27895313|NCT02620384|81450515|FG000|Overall Study|Discharged prior to 2nd dose|2|||
27895314|NCT02620384|81450516|FG001|Overall Study|Discharged prior to 2nd dose|5|||
27895315|NCT02620384|81450515|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
27895316|NCT02620384|81450516|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
27895317|NCT04829331|81450517|FG000|Overall Study|Lost to Follow-up|1|||
27848881|NCT01351350|81275901|FG001|Overall Study|Disease Progression|13|||
27848882|NCT01351350|81275902|FG002|Overall Study|Disease Progression|6|||
27848883|NCT01351350|81275903|FG003|Overall Study|Disease Progression|8|||
27848884|NCT01351350|81275904|FG004|Overall Study|Disease Progression|5|||
27848885|NCT01351350|81275900|FG000|Overall Study|Adverse Event|1|||
27848886|NCT01351350|81275901|FG001|Overall Study|Adverse Event|10|||
27848887|NCT01351350|81275902|FG002|Overall Study|Adverse Event|1|||
27848888|NCT01351350|81275903|FG003|Overall Study|Adverse Event|2|||
27848889|NCT01351350|81275904|FG004|Overall Study|Adverse Event|0|||
27848890|NCT01351350|81275900|FG000|Overall Study|Participant Decision|2|||
27848891|NCT01351350|81275901|FG001|Overall Study|Participant Decision|6|||
27848892|NCT01351350|81275902|FG002|Overall Study|Participant Decision|3|||
27848893|NCT01351350|81275903|FG003|Overall Study|Participant Decision|3|||
27848894|NCT01351350|81275904|FG004|Overall Study|Participant Decision|2|||
27848895|NCT01351350|81275900|FG000|Overall Study|Enrolled but not Treated|0|||
27848896|NCT01351350|81275901|FG001|Overall Study|Enrolled but not Treated|0|||
27848897|NCT01351350|81275902|FG002|Overall Study|Enrolled but not Treated|1|||
27848898|NCT01351350|81275903|FG003|Overall Study|Enrolled but not Treated|0|||
27848899|NCT01351350|81275904|FG004|Overall Study|Enrolled but not Treated|0|||
27848900|NCT00456495|81275905|FG000|Overall Study|Physician Decision|2|||
27848901|NCT03585959|81275910|FG000|Overall Study|Physician Decision|1|||
27848902|NCT03585959|81275910|FG000|Overall Study|Unsuccessful Procedure|2|||
27848903|NCT01663727|81275911|FG000|Overall Study|Death|161|||
27848904|NCT01663727|81275912|FG001|Overall Study|Death|155|||
27848905|NCT01663727|81275911|FG000|Overall Study|Lost to Follow-up|10|||
27848906|NCT01663727|81275912|FG001|Overall Study|Lost to Follow-up|8|||
27848907|NCT01663727|81275911|FG000|Overall Study|Withdrawal by Subject|18|||
27848908|NCT01663727|81275912|FG001|Overall Study|Withdrawal by Subject|25|||
27848909|NCT01663727|81275911|FG000|Overall Study|Study Terminated|51|||
27848910|NCT01663727|81275912|FG001|Overall Study|Study Terminated|50|||
27848911|NCT01663727|81275911|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
27848912|NCT01663727|81275912|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
27848913|NCT01663727|81275911|FG000|Overall Study|Withdrawal prior to dosing.|1|||
27848914|NCT01663727|81275912|FG001|Overall Study|Withdrawal prior to dosing.|0|||
27848915|NCT01366443|81275913|FG000|Overall Study|Lost to Follow-up|2|||
27848916|NCT01366443|81275913|FG000|Overall Study|Under 18 yo|1|||
27848917|NCT03710590|81275914|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
27848918|NCT03710590|81275915|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
27848919|NCT02326974|81275916|FG000|Overall Study|Withdrawal by Subject|2|||
27848920|NCT02326974|81275916|FG000|Overall Study|failed heterogenity evaluation|5|||
27848921|NCT00293202|81275917|FG000|Overall Study|Withdrawal by Subject|1|||
27848922|NCT00293202|81275918|FG001|Overall Study|Withdrawal by Subject|2|||
27848923|NCT00293202|81275917|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
27848924|NCT00293202|81275918|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
27848925|NCT00293202|81275917|FG000|Overall Study|on-hold due to fistula maturation time|1|||
27848926|NCT00293202|81275918|FG001|Overall Study|on-hold due to fistula maturation time|0|||
27848927|NCT00995085|81275919|FG000|Overall Study|Withdrawal by Subject|5|||
27848928|NCT02903238|81275920|FG000|Overall Study|Lost to Follow-up|4|||
27848929|NCT02777918|81275921|FG000|Overall Study|Medical reasons|1|||
27848930|NCT02777918|81275922|FG001|Overall Study|Medical reasons|2|||
27848931|NCT02777918|81275921|FG000|Overall Study|Too busy / stressed|1|||
27848932|NCT02777918|81275922|FG001|Overall Study|Too busy / stressed|1|||
27848933|NCT02777918|81275921|FG000|Overall Study|Withdrawal by Subject|1|||
27848934|NCT02777918|81275922|FG001|Overall Study|Withdrawal by Subject|1|||
27848935|NCT03919448|81275925|FG000|Overall Study|Withdrawal by Subject|1|||
27848936|NCT03919448|81275926|FG001|Overall Study|Withdrawal by Subject|0|||
27848937|NCT03919448|81275927|FG002|Overall Study|Withdrawal by Subject|0|||
27848938|NCT00257920|81275936|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
27848939|NCT00257920|81275937|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
27848940|NCT00257920|81275936|FG000|Period: Second Intervention|Other|2|||
27895318|NCT04829331|81450518|FG001|Overall Study|Lost to Follow-up|0|||
27848941|NCT00257920|81275937|FG001|Period: Second Intervention|Other|1|||
27848942|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
27848943|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
27848944|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
27895319|NCT01001598|81450523|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
27848945|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
27848946|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
27848947|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
27895320|NCT01001598|81450523|FG000|Overall Study|Adverse Event|1|||
27895321|NCT00636194|81450524|FG000|Overall Study|Study related symptoms and complaints|1|||
27895322|NCT00636194|81450525|FG001|Overall Study|Study related symptoms and complaints|0|||
27895323|NCT00636194|81450524|FG000|Overall Study|Protocol Violation|2|||
27895324|NCT00636194|81450525|FG001|Overall Study|Protocol Violation|0|||
27895325|NCT01783821|81450526|FG000|Overall Study|Screen Failure|1|||
27895326|NCT01783821|81450527|FG001|Overall Study|Screen Failure|1|||
27895327|NCT02892513|81450528|FG000|Overall Study|Withdrawal by Subject|0|||
27895328|NCT02892513|81450529|FG001|Overall Study|Withdrawal by Subject|1|||
27895329|NCT00090987|81450530|FG000|Overall Study|Adverse Event|5|||
27895330|NCT00090987|81450530|FG000|Overall Study|Lack of Efficacy|7|||
27895331|NCT00090987|81450530|FG000|Overall Study|Withdrawal by Subject|3|||
27895332|NCT00090987|81450530|FG000|Overall Study|alternative therapy|1|||
27895333|NCT00090987|81450530|FG000|Overall Study|Non-compliance|4|||
27895334|NCT00090987|81450530|FG000|Overall Study|Incarcerated|1|||
27895335|NCT00955968|81450531|FG000|Overall Study|Death|2|||
27895336|NCT00955968|81450532|FG001|Overall Study|Death|4|||
27895337|NCT00955968|81450531|FG000|Overall Study|Withdrawal by Subject|35|||
27895338|NCT00955968|81450532|FG001|Overall Study|Withdrawal by Subject|31|||
27895339|NCT00955968|81450531|FG000|Overall Study|Lost to Follow-up|45|||
27895340|NCT00955968|81450532|FG001|Overall Study|Lost to Follow-up|39|||
27895341|NCT00955968|81450531|FG000|Overall Study|Site closed|55|||
27895342|NCT00955968|81450532|FG001|Overall Study|Site closed|52|||
27895343|NCT01706575|81450533|FG000|Overall Study|Participant Withdrew Consent|4|||
27895344|NCT01706575|81450533|FG000|Overall Study|Lost to Follow-up|2|||
27895345|NCT01706575|81450533|FG000|Overall Study|Started but not Treated|6|||
27895346|NCT00460265|81450534|FG000|Overall Study|Lost to Follow-up|14|||
27895347|NCT00460265|81450535|FG001|Overall Study|Lost to Follow-up|15|||
27895348|NCT00460265|81450534|FG000|Overall Study|Physician Decision|1|||
27895349|NCT00460265|81450535|FG001|Overall Study|Physician Decision|2|||
27895350|NCT00460265|81450534|FG000|Overall Study|Withdrawal by Subject|10|||
27895351|NCT00460265|81450535|FG001|Overall Study|Withdrawal by Subject|25|||
27895352|NCT00460265|81450534|FG000|Overall Study|Ongoing|60|||
27895353|NCT00460265|81450535|FG001|Overall Study|Ongoing|47|||
27895354|NCT02879994|81450536|FG000|Overall Study|off treatment early|7|||
27895355|NCT02879994|81450536|FG000|Overall Study|Adverse Event|2|||
27895356|NCT02879994|81450536|FG000|Overall Study|Death|2|||
27895357|NCT06011161|81453643|FG000|Overall Study|Withdrawal by Subject|2|||
27895358|NCT06011161|81453643|FG000|Overall Study|Lost to Follow-up|5|||
27895359|NCT02284568|81453648|FG000|Overall Study|Adverse Event|2|||
27895360|NCT02284568|81453649|FG001|Overall Study|Adverse Event|9|||
27895361|NCT02284568|81453650|FG002|Overall Study|Adverse Event|4|||
27895362|NCT02284568|81453648|FG000|Overall Study|Withdrawal by Subject|22|||
27895363|NCT02284568|81453649|FG001|Overall Study|Withdrawal by Subject|21|||
27895364|NCT02284568|81453650|FG002|Overall Study|Withdrawal by Subject|1|||
27895365|NCT02284568|81453648|FG000|Overall Study|Noncompliance with study drug admin|1|||
27895366|NCT02284568|81453649|FG001|Overall Study|Noncompliance with study drug admin|2|||
27895367|NCT02284568|81453650|FG002|Overall Study|Noncompliance with study drug admin|0|||
27895368|NCT02284568|81453648|FG000|Overall Study|Noncompliance|1|||
27895369|NCT02284568|81453649|FG001|Overall Study|Noncompliance|0|||
27895370|NCT02284568|81453650|FG002|Overall Study|Noncompliance|0|||
27895371|NCT02284568|81453648|FG000|Overall Study|Protocol Violation|0|||
27895372|NCT02284568|81453649|FG001|Overall Study|Protocol Violation|1|||
27895373|NCT02284568|81453650|FG002|Overall Study|Protocol Violation|0|||
27895374|NCT02284568|81453648|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
27895375|NCT02284568|81453649|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
27895376|NCT02284568|81453650|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
27895377|NCT02284568|81453648|FG000|Overall Study|Lost to Follow-up|0|||
27895378|NCT02284568|81453649|FG001|Overall Study|Lost to Follow-up|3|||
27895379|NCT02284568|81453650|FG002|Overall Study|Lost to Follow-up|0|||
27895380|NCT02284568|81453648|FG000|Overall Study|Lack of Efficacy|4|||
27895381|NCT02284568|81453649|FG001|Overall Study|Lack of Efficacy|7|||
27895382|NCT02284568|81453650|FG002|Overall Study|Lack of Efficacy|0|||
27895383|NCT02284568|81453648|FG000|Overall Study|Other|1|||
27895384|NCT02284568|81453649|FG001|Overall Study|Other|2|||
27895385|NCT02284568|81453650|FG002|Overall Study|Other|0|||
27895386|NCT02284568|81453648|FG000|Overall Study|Withdrew before taking study drug|0|||
27895387|NCT02284568|81453649|FG001|Overall Study|Withdrew before taking study drug|1|||
27895388|NCT02284568|81453650|FG002|Overall Study|Withdrew before taking study drug|0|||
27895389|NCT00984061|81453651|FG000|Clarithromycin Alone|Protocol Violation|1|||
27895390|NCT02122770|81453658|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
27895391|NCT02122770|81453659|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
27895392|NCT02122770|81453660|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
27895393|NCT02122770|81453661|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
27895394|NCT02122770|81453662|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
27895395|NCT02122770|81453663|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
27895396|NCT02122770|81453658|FG000|Part A: Drug-drug Interaction 2|Other|0|||
27895397|NCT02122770|81453659|FG001|Part A: Drug-drug Interaction 2|Other|0|||
27505889|NCT02963506|80044208|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
27505890|NCT02963506|80044209|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
27505891|NCT02963506|80044210|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
27505892|NCT02963506|80044211|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
27505893|NCT02963506|80044212|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
27505894|NCT02963506|80044213|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
27505895|NCT02963506|80044214|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
27505896|NCT02963506|80044202|FG000|Dose-Blind Period|Sponsor decision|0|||
27505897|NCT02963506|80044203|FG001|Dose-Blind Period|Sponsor decision|0|||
27505898|NCT02963506|80044204|FG002|Dose-Blind Period|Sponsor decision|0|||
27505899|NCT02963506|80044205|FG003|Dose-Blind Period|Sponsor decision|0|||
27505900|NCT02963506|80044206|FG004|Dose-Blind Period|Sponsor decision|0|||
27505901|NCT02963506|80044207|FG005|Dose-Blind Period|Sponsor decision|1|||
27505902|NCT02963506|80044208|FG006|Dose-Blind Period|Sponsor decision|0|||
27505903|NCT02963506|80044209|FG007|Dose-Blind Period|Sponsor decision|0|||
27505904|NCT02963506|80044210|FG008|Dose-Blind Period|Sponsor decision|0|||
27505905|NCT02963506|80044211|FG009|Dose-Blind Period|Sponsor decision|0|||
27505906|NCT02963506|80044212|FG010|Dose-Blind Period|Sponsor decision|0|||
27505907|NCT02963506|80044213|FG011|Dose-Blind Period|Sponsor decision|0|||
27505908|NCT02963506|80044214|FG012|Dose-Blind Period|Sponsor decision|0|||
27505909|NCT02963506|80044202|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505910|NCT02963506|80044203|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505911|NCT02963506|80044204|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27895398|NCT02122770|81453660|FG002|Part A: Drug-drug Interaction 2|Other|1|||
27895399|NCT02122770|81453661|FG003|Part A: Drug-drug Interaction 2|Other|0|||
27895400|NCT02122770|81453662|FG004|Part A: Drug-drug Interaction 2|Other|0|||
27895401|NCT02122770|81453663|FG005|Part A: Drug-drug Interaction 2|Other|0|||
27895402|NCT02122770|81453658|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27895403|NCT02122770|81453659|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
27895404|NCT02122770|81453660|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27895405|NCT02122770|81453661|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27895406|NCT02122770|81453662|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27895407|NCT02122770|81453663|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
27895408|NCT02122770|81453658|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
27895409|NCT02122770|81453659|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
27895410|NCT02122770|81453660|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
27895411|NCT02122770|81453661|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
27895412|NCT02122770|81453662|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
27895413|NCT02122770|81453663|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
27895414|NCT02122770|81453658|FG000|Part B: Standard of Care|Adverse Event|0|||
27895415|NCT02122770|81453659|FG001|Part B: Standard of Care|Adverse Event|0|||
27895416|NCT02122770|81453660|FG002|Part B: Standard of Care|Adverse Event|0|||
27895417|NCT02122770|81453661|FG003|Part B: Standard of Care|Adverse Event|0|||
27895418|NCT02122770|81453662|FG004|Part B: Standard of Care|Adverse Event|4|||
27895419|NCT02122770|81453663|FG005|Part B: Standard of Care|Adverse Event|1|||
27895420|NCT02122770|81453658|FG000|Part B: Standard of Care|Other|0|||
27895421|NCT02122770|81453659|FG001|Part B: Standard of Care|Other|0|||
27895422|NCT02122770|81453660|FG002|Part B: Standard of Care|Other|0|||
27895423|NCT02122770|81453661|FG003|Part B: Standard of Care|Other|0|||
27895424|NCT02122770|81453662|FG004|Part B: Standard of Care|Other|0|||
27895425|NCT02122770|81453663|FG005|Part B: Standard of Care|Other|2|||
27895426|NCT02122770|81453658|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
27895427|NCT02122770|81453659|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
27895428|NCT02122770|81453660|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
27895429|NCT02122770|81453661|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
27895430|NCT02122770|81453662|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
27895431|NCT02122770|81453663|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
27895432|NCT02122770|81453658|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
27895433|NCT02122770|81453659|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
27895434|NCT02122770|81453660|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
27895435|NCT02122770|81453661|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
27895436|NCT02122770|81453662|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
27895437|NCT02122770|81453663|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
27895438|NCT02122770|81453658|FG000|Part B: Standard of Care|Progressive Disease|0|||
27505912|NCT02963506|80044205|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505913|NCT02963506|80044206|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505914|NCT02963506|80044207|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505915|NCT02963506|80044208|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505916|NCT02963506|80044209|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505917|NCT02963506|80044210|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505918|NCT02963506|80044211|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27613936|NCT02597933|80430078|FG001|Overall Study|Adverse Event|28|||
27613937|NCT02597933|80430077|FG000|Overall Study|Not treated|2|||
27848948|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
27895439|NCT02122770|81453659|FG001|Part B: Standard of Care|Progressive Disease|0|||
27895440|NCT02122770|81453660|FG002|Part B: Standard of Care|Progressive Disease|0|||
27895441|NCT02122770|81453661|FG003|Part B: Standard of Care|Progressive Disease|0|||
27895442|NCT02122770|81453662|FG004|Part B: Standard of Care|Progressive Disease|10|||
27895443|NCT02122770|81453663|FG005|Part B: Standard of Care|Progressive Disease|8|||
27895444|NCT00401544|81453664|FG000|Overall Study|Adverse Event|5|||
27895445|NCT00401544|81453665|FG001|Overall Study|Adverse Event|1|||
27895446|NCT00401544|81453666|FG002|Overall Study|Adverse Event|1|||
27895447|NCT00401544|81453667|FG003|Overall Study|Adverse Event|1|||
27895448|NCT00401544|81453664|FG000|Overall Study|Death|3|||
27895449|NCT00401544|81453665|FG001|Overall Study|Death|6|||
27895450|NCT00401544|81453666|FG002|Overall Study|Death|2|||
27895451|NCT00401544|81453667|FG003|Overall Study|Death|5|||
27895452|NCT00401544|81453664|FG000|Overall Study|Lost to Follow-up|2|||
27895453|NCT00401544|81453665|FG001|Overall Study|Lost to Follow-up|0|||
27895454|NCT00401544|81453666|FG002|Overall Study|Lost to Follow-up|1|||
27895455|NCT00401544|81453667|FG003|Overall Study|Lost to Follow-up|1|||
27895456|NCT00401544|81453664|FG000|Overall Study|Withdrawal by Subject|7|||
27895457|NCT00401544|81453665|FG001|Overall Study|Withdrawal by Subject|6|||
27895458|NCT00401544|81453666|FG002|Overall Study|Withdrawal by Subject|6|||
27895459|NCT00401544|81453667|FG003|Overall Study|Withdrawal by Subject|5|||
27895460|NCT00401544|81453664|FG000|Overall Study|Physician Decision|1|||
27895461|NCT00401544|81453665|FG001|Overall Study|Physician Decision|3|||
27895462|NCT00401544|81453666|FG002|Overall Study|Physician Decision|0|||
27895463|NCT00401544|81453667|FG003|Overall Study|Physician Decision|0|||
27895464|NCT00401544|81453664|FG000|Overall Study|Ineligibility determined|0|||
27895465|NCT00401544|81453665|FG001|Overall Study|Ineligibility determined|1|||
27895466|NCT00401544|81453666|FG002|Overall Study|Ineligibility determined|0|||
27613938|NCT02597933|80430078|FG001|Overall Study|Not treated|2|||
27613939|NCT02597933|80430077|FG000|Overall Study|Other than stated above|7|||
27848949|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
27848950|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
27848951|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
27848952|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
27848953|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
27848954|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
27848955|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
27848956|NCT02510014|81275938|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
27848957|NCT02510014|81275939|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
27848958|NCT02510014|81275938|FG000|Treatment Period|Adverse Event|11|||
27848959|NCT02510014|81275939|FG001|Treatment Period|Adverse Event|4|||
27848960|NCT02510014|81275938|FG000|Treatment Period|Withdrawal symptoms|3|||
27848961|NCT02510014|81275939|FG001|Treatment Period|Withdrawal symptoms|0|||
27848962|NCT02510014|81275938|FG000|Treatment Period|Lost to Follow-up|80|||
27848963|NCT02510014|81275939|FG001|Treatment Period|Lost to Follow-up|19|||
27848964|NCT02510014|81275938|FG000|Treatment Period|Physician Decision|5|||
27848965|NCT02510014|81275939|FG001|Treatment Period|Physician Decision|0|||
27848966|NCT02510014|81275938|FG000|Treatment Period|Withdrawal by Subject|67|||
27848967|NCT02510014|81275939|FG001|Treatment Period|Withdrawal by Subject|24|||
27848968|NCT02510014|81275938|FG000|Treatment Period|Withdrawn by the investigator|7|||
27848969|NCT02510014|81275939|FG001|Treatment Period|Withdrawn by the investigator|1|||
27848970|NCT02510014|81275938|FG000|Treatment Period|Protocol Violation|4|||
27848971|NCT02510014|81275939|FG001|Treatment Period|Protocol Violation|4|||
27848972|NCT02510014|81275938|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
27848973|NCT02510014|81275939|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
27848974|NCT00062751|81278966|FG000|Overall Study|Disease progression|24|||
27848975|NCT00062751|81278967|FG001|Overall Study|Disease progression|17|||
27848976|NCT00062751|81278968|FG002|Overall Study|Disease progression|24|||
27848977|NCT00062751|81278969|FG003|Overall Study|Disease progression|2|||
27848978|NCT00062751|81278970|FG004|Overall Study|Disease progression|2|||
27848979|NCT00062751|81278966|FG000|Overall Study|Adverse Event|4|||
27848980|NCT00062751|81278967|FG001|Overall Study|Adverse Event|7|||
27848981|NCT00062751|81278968|FG002|Overall Study|Adverse Event|2|||
27848982|NCT00062751|81278969|FG003|Overall Study|Adverse Event|2|||
27848983|NCT00062751|81278970|FG004|Overall Study|Adverse Event|2|||
27895467|NCT00401544|81453667|FG003|Overall Study|Ineligibility determined|2|||
27895468|NCT00401544|81453664|FG000|Overall Study|Disease progression|0|||
27895469|NCT00401544|81453665|FG001|Overall Study|Disease progression|1|||
27613940|NCT02597933|80430078|FG001|Overall Study|Other than stated above|14|||
27613941|NCT00786474|80430082|FG000|Overall Study|Death|5|||
27848984|NCT00062751|81278966|FG000|Overall Study|Other|2|||
27848985|NCT00062751|81278967|FG001|Overall Study|Other|3|||
27895470|NCT00401544|81453666|FG002|Overall Study|Disease progression|0|||
27895471|NCT00401544|81453667|FG003|Overall Study|Disease progression|0|||
27895472|NCT00401544|81453664|FG000|Overall Study|Other|0|||
27895473|NCT00401544|81453665|FG001|Overall Study|Other|0|||
27895474|NCT00401544|81453666|FG002|Overall Study|Other|2|||
27895475|NCT00401544|81453667|FG003|Overall Study|Other|2|||
27895476|NCT02607306|81453668|FG000|Overall Study|Adverse Event|8|||
27895477|NCT02607306|81453669|FG001|Overall Study|Adverse Event|6|||
27895478|NCT02607306|81453670|FG002|Overall Study|Adverse Event|6|||
27895479|NCT02607306|81453668|FG000|Overall Study|Unclassified|1|||
27895480|NCT02607306|81453669|FG001|Overall Study|Unclassified|4|||
27895481|NCT02607306|81453670|FG002|Overall Study|Unclassified|0|||
27895482|NCT02607306|81453668|FG000|Overall Study|Withdrawal by Subject|8|||
27895483|NCT02607306|81453669|FG001|Overall Study|Withdrawal by Subject|10|||
27895484|NCT02607306|81453670|FG002|Overall Study|Withdrawal by Subject|2|||
27895485|NCT02607306|81453668|FG000|Overall Study|Lack of Efficacy|0|||
27895486|NCT02607306|81453669|FG001|Overall Study|Lack of Efficacy|1|||
27895487|NCT02607306|81453670|FG002|Overall Study|Lack of Efficacy|1|||
27895488|NCT02607306|81453668|FG000|Overall Study|Protocol Violation|4|||
27895489|NCT02607306|81453669|FG001|Overall Study|Protocol Violation|2|||
27895490|NCT02607306|81453670|FG002|Overall Study|Protocol Violation|1|||
27895491|NCT00829829|81453673|FG000|Overall Study|Protocol Violation|0|||
27895492|NCT00829829|81453674|FG001|Overall Study|Protocol Violation|3|||
27895493|NCT00829829|81453675|FG002|Overall Study|Protocol Violation|0|||
27895494|NCT00829829|81453673|FG000|Overall Study|Adverse Event|4|||
27895495|NCT00829829|81453674|FG001|Overall Study|Adverse Event|4|||
27895496|NCT00829829|81453675|FG002|Overall Study|Adverse Event|3|||
27895497|NCT00829829|81453673|FG000|Overall Study|Withdrawal by Subject|8|||
27895498|NCT00829829|81453674|FG001|Overall Study|Withdrawal by Subject|4|||
27895499|NCT00829829|81453675|FG002|Overall Study|Withdrawal by Subject|2|||
27895500|NCT00829829|81453673|FG000|Overall Study|Decision by the Sponsor|1|||
27895501|NCT00829829|81453674|FG001|Overall Study|Decision by the Sponsor|0|||
27895502|NCT00829829|81453675|FG002|Overall Study|Decision by the Sponsor|2|||
27895503|NCT00829829|81453673|FG000|Overall Study|Lost to Follow-up|7|||
27895504|NCT00829829|81453674|FG001|Overall Study|Lost to Follow-up|3|||
27895505|NCT00829829|81453675|FG002|Overall Study|Lost to Follow-up|3|||
27895506|NCT00829829|81453673|FG000|Overall Study|Other than specified above|2|||
27895507|NCT00829829|81453674|FG001|Overall Study|Other than specified above|2|||
27895508|NCT00829829|81453675|FG002|Overall Study|Other than specified above|1|||
27895509|NCT01317797|81453676|FG000|Overall Study|Other|0|||
27895510|NCT01317797|81453677|FG001|Overall Study|Other|1|||
27895511|NCT01317797|81453678|FG002|Overall Study|Other|0|||
27895512|NCT01317797|81453676|FG000|Overall Study|Withdrawal of Patient|0|||
27895513|NCT01317797|81453677|FG001|Overall Study|Withdrawal of Patient|0|||
27895514|NCT01317797|81453678|FG002|Overall Study|Withdrawal of Patient|1|||
27895515|NCT03435224|81453679|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
27895516|NCT02333383|81453680|FG000|Overall Study|Adalimumab discontinuation|21|||
27895517|NCT02333383|81453680|FG000|Overall Study|Lost to Follow-up|15|||
27895518|NCT02333383|81453680|FG000|Overall Study|Withdrawal by Subject|3|||
27895519|NCT02333383|81453680|FG000|Overall Study|Transfer to another hospital|2|||
27895520|NCT00177307|81453681|FG000|Overall Study|Withdrawal by Subject|1|||
27895521|NCT02956057|81453682|FG000|Overall Study|Discontinued intervention|14|||
27895522|NCT02956057|81453683|FG001|Overall Study|Discontinued intervention|10|||
27895523|NCT02956057|81453684|FG002|Overall Study|Discontinued intervention|7|||
27895524|NCT02956057|81453685|FG003|Overall Study|Discontinued intervention|14|||
27895525|NCT02956057|81453686|FG004|Overall Study|Discontinued intervention|4|||
27895526|NCT02956057|81453687|FG005|Overall Study|Discontinued intervention|17|||
27895527|NCT02956057|81453682|FG000|Overall Study|Lost to Follow-up|0|||
27895528|NCT02956057|81453683|FG001|Overall Study|Lost to Follow-up|2|||
27895529|NCT02956057|81453684|FG002|Overall Study|Lost to Follow-up|1|||
27895530|NCT02956057|81453685|FG003|Overall Study|Lost to Follow-up|1|||
27895531|NCT02956057|81453686|FG004|Overall Study|Lost to Follow-up|1|||
27895532|NCT02956057|81453687|FG005|Overall Study|Lost to Follow-up|0|||
27895533|NCT00278148|81453688|FG000|Phase II - Expansion Phase|Disease progression|0|||
27895534|NCT00278148|81453689|FG001|Phase II - Expansion Phase|Disease progression|0|||
27895535|NCT00278148|81453690|FG002|Phase II - Expansion Phase|Disease progression|4|||
27895536|NCT00278148|81453688|FG000|Phase II - Expansion Phase|Adverse Event|0|||
27895537|NCT00278148|81453689|FG001|Phase II - Expansion Phase|Adverse Event|0|||
27613942|NCT00786474|80430083|FG001|Overall Study|Death|4|||
27895538|NCT00278148|81453690|FG002|Phase II - Expansion Phase|Adverse Event|2|||
27895539|NCT00980174|81453691|FG000|Overall Study|Withdrawal by Subject|1|||
27895540|NCT00980174|81453692|FG001|Overall Study|Withdrawal by Subject|4|||
27895541|NCT00980174|81453691|FG000|Overall Study|Adverse Event|0|||
27895542|NCT00980174|81453692|FG001|Overall Study|Adverse Event|3|||
27895543|NCT00980174|81453691|FG000|Overall Study|Ineligibility determined|2|||
27895544|NCT00980174|81453692|FG001|Overall Study|Ineligibility determined|1|||
27895545|NCT00980174|81453691|FG000|Overall Study|Death|1|||
27895546|NCT00980174|81453692|FG001|Overall Study|Death|1|||
27895547|NCT00980174|81453691|FG000|Overall Study|Other|0|||
27895548|NCT00980174|81453692|FG001|Overall Study|Other|1|||
27895549|NCT00558896|81453693|FG000|Overall Study|Adverse Event|1|||
27895550|NCT00558896|81453694|FG001|Overall Study|Adverse Event|1|||
27895551|NCT00558896|81453695|FG002|Overall Study|Adverse Event|1|||
27895552|NCT00558896|81453696|FG003|Overall Study|Adverse Event|3|||
27895553|NCT00558896|81453697|FG004|Overall Study|Adverse Event|4|||
27895554|NCT00558896|81453698|FG005|Overall Study|Adverse Event|10|||
27895555|NCT00558896|81453699|FG006|Overall Study|Adverse Event|3|||
27895556|NCT00558896|81453693|FG000|Overall Study|Death|3|||
27895557|NCT00558896|81453694|FG001|Overall Study|Death|0|||
27895558|NCT00558896|81453695|FG002|Overall Study|Death|2|||
27895559|NCT00558896|81453696|FG003|Overall Study|Death|3|||
27895560|NCT00558896|81453697|FG004|Overall Study|Death|2|||
27895561|NCT00558896|81453698|FG005|Overall Study|Death|2|||
27895562|NCT00558896|81453699|FG006|Overall Study|Death|6|||
27895563|NCT00558896|81453693|FG000|Overall Study|Withdrawal by Subject|2|||
27895564|NCT00558896|81453694|FG001|Overall Study|Withdrawal by Subject|1|||
27895565|NCT00558896|81453695|FG002|Overall Study|Withdrawal by Subject|1|||
27895566|NCT00558896|81453696|FG003|Overall Study|Withdrawal by Subject|1|||
27895567|NCT00558896|81453697|FG004|Overall Study|Withdrawal by Subject|1|||
27895568|NCT00558896|81453698|FG005|Overall Study|Withdrawal by Subject|5|||
27895569|NCT00558896|81453699|FG006|Overall Study|Withdrawal by Subject|5|||
27895570|NCT00558896|81453693|FG000|Overall Study|Alternative Treatment|2|||
27895571|NCT00558896|81453694|FG001|Overall Study|Alternative Treatment|2|||
27895572|NCT00558896|81453695|FG002|Overall Study|Alternative Treatment|0|||
27895573|NCT00558896|81453696|FG003|Overall Study|Alternative Treatment|2|||
27895574|NCT00558896|81453697|FG004|Overall Study|Alternative Treatment|6|||
27895575|NCT00558896|81453698|FG005|Overall Study|Alternative Treatment|7|||
27895576|NCT00558896|81453699|FG006|Overall Study|Alternative Treatment|1|||
27895577|NCT00558896|81453693|FG000|Overall Study|Physician discretion|3|||
27895578|NCT00558896|81453694|FG001|Overall Study|Physician discretion|2|||
27895579|NCT00558896|81453695|FG002|Overall Study|Physician discretion|1|||
27895580|NCT00558896|81453696|FG003|Overall Study|Physician discretion|2|||
27895581|NCT00558896|81453697|FG004|Overall Study|Physician discretion|1|||
27895582|NCT00558896|81453698|FG005|Overall Study|Physician discretion|3|||
27895583|NCT00558896|81453699|FG006|Overall Study|Physician discretion|3|||
27895584|NCT00558896|81453693|FG000|Overall Study|Continues on treatment|10|||
27895585|NCT00558896|81453694|FG001|Overall Study|Continues on treatment|1|||
27895586|NCT00558896|81453695|FG002|Overall Study|Continues on treatment|0|||
27895587|NCT00558896|81453696|FG003|Overall Study|Continues on treatment|1|||
27895588|NCT00558896|81453697|FG004|Overall Study|Continues on treatment|9|||
27895589|NCT00558896|81453698|FG005|Overall Study|Continues on treatment|25|||
27895590|NCT00558896|81453699|FG006|Overall Study|Continues on treatment|6|||
27895591|NCT04608344|81453706|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
27895592|NCT04608344|81453707|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
27895593|NCT04608344|81453706|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
27895594|NCT04608344|81453707|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
27895595|NCT01846221|81453708|FG000|Overall Study|Catheter Failure|2|||
27895596|NCT01846221|81453709|FG001|Overall Study|Catheter Failure|0|||
27895597|NCT01846221|81453708|FG000|Overall Study|Age Exclusion|1|||
27895598|NCT01846221|81453709|FG001|Overall Study|Age Exclusion|0|||
27895599|NCT02083185|81453710|FG000|Overall Study|Lost to Follow-up|0|||
27895600|NCT02083185|81453711|FG001|Overall Study|Lost to Follow-up|3|||
27895601|NCT02083185|81453712|FG002|Overall Study|Lost to Follow-up|0|||
27895602|NCT02083185|81453710|FG000|Overall Study|Withdrawal by Subject|9|||
27895603|NCT02083185|81453711|FG001|Overall Study|Withdrawal by Subject|15|||
27895604|NCT02083185|81453712|FG002|Overall Study|Withdrawal by Subject|1|||
27895605|NCT02083185|81453710|FG000|Overall Study|Death|2|||
27895606|NCT02083185|81453711|FG001|Overall Study|Death|2|||
27895607|NCT02083185|81453712|FG002|Overall Study|Death|1|||
27895608|NCT02083185|81453710|FG000|Overall Study|Reason not Specified|9|||
27895609|NCT02083185|81453711|FG001|Overall Study|Reason not Specified|6|||
27895610|NCT02083185|81453712|FG002|Overall Study|Reason not Specified|5|||
27895611|NCT02083185|81453710|FG000|Overall Study|Study Terminated by Sponsor|0|||
27895612|NCT02083185|81453711|FG001|Overall Study|Study Terminated by Sponsor|1|||
27895613|NCT02083185|81453712|FG002|Overall Study|Study Terminated by Sponsor|0|||
27895614|NCT02083185|81453710|FG000|Overall Study|Did not Receive Study Drug|0|||
27895615|NCT02083185|81453711|FG001|Overall Study|Did not Receive Study Drug|2|||
27895616|NCT02083185|81453712|FG002|Overall Study|Did not Receive Study Drug|0|||
27895617|NCT00932698|81453713|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
27895618|NCT00932698|81453714|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
27895619|NCT00932698|81453715|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
27895620|NCT00932698|81453716|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
27895621|NCT00932698|81453717|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
27895622|NCT00932698|81453718|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
27895623|NCT00932698|81453719|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
27895624|NCT00932698|81453720|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
27895625|NCT00932698|81453721|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
27895626|NCT00932698|81453722|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
27895627|NCT00932698|81453723|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
27895628|NCT00932698|81453713|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895629|NCT00932698|81453714|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27895630|NCT00932698|81453715|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895631|NCT00932698|81453716|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27895632|NCT00932698|81453717|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895633|NCT00932698|81453718|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27895634|NCT00932698|81453719|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
27895635|NCT00932698|81453720|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895636|NCT00932698|81453721|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895637|NCT00932698|81453722|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895638|NCT00932698|81453723|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
27895639|NCT00932698|81453713|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
27895640|NCT00932698|81453714|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
27895641|NCT00932698|81453715|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
27895642|NCT00932698|81453716|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
27895643|NCT00932698|81453717|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
27895644|NCT00932698|81453718|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
27895645|NCT00932698|81453719|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
27895646|NCT00932698|81453720|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
27895647|NCT00932698|81453721|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
27895648|NCT00932698|81453722|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
27895649|NCT00932698|81453723|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
27895650|NCT00932698|81453713|FG000|Part 1 (Dose Escalation)|Other|0|||
27613943|NCT00786474|80430082|FG000|Overall Study|Withdrawal by Subject|23|||
27848986|NCT00062751|81278968|FG002|Overall Study|Other|1|||
27848987|NCT00062751|81278969|FG003|Overall Study|Other|0|||
27848988|NCT00062751|81278970|FG004|Overall Study|Other|1|||
27848989|NCT00062751|81278966|FG000|Overall Study|Withdrawal by Subject|1|||
27848990|NCT00062751|81278967|FG001|Overall Study|Withdrawal by Subject|2|||
27848991|NCT00062751|81278968|FG002|Overall Study|Withdrawal by Subject|2|||
27848992|NCT00062751|81278969|FG003|Overall Study|Withdrawal by Subject|1|||
27848993|NCT00062751|81278970|FG004|Overall Study|Withdrawal by Subject|0|||
27848994|NCT00062751|81278966|FG000|Overall Study|Symptomatic deterioration|1|||
27848995|NCT00062751|81278967|FG001|Overall Study|Symptomatic deterioration|1|||
27848996|NCT00062751|81278968|FG002|Overall Study|Symptomatic deterioration|0|||
27848997|NCT00062751|81278969|FG003|Overall Study|Symptomatic deterioration|0|||
27848998|NCT00062751|81278970|FG004|Overall Study|Symptomatic deterioration|1|||
27848999|NCT00062751|81278966|FG000|Overall Study|Death|1|||
27849000|NCT00062751|81278967|FG001|Overall Study|Death|0|||
27849001|NCT00062751|81278968|FG002|Overall Study|Death|1|||
27849002|NCT00062751|81278969|FG003|Overall Study|Death|0|||
27849003|NCT00062751|81278970|FG004|Overall Study|Death|0|||
27849004|NCT00619359|81278978|FG000|Overall Study|Adverse Event|32|||
27849005|NCT00619359|81278979|FG001|Overall Study|Adverse Event|36|||
27849006|NCT00619359|81278978|FG000|Overall Study|Lost to Follow-up|12|||
27849007|NCT00619359|81278979|FG001|Overall Study|Lost to Follow-up|16|||
27849008|NCT00619359|81278978|FG000|Overall Study|Physician Decision|0|||
27849009|NCT00619359|81278979|FG001|Overall Study|Physician Decision|7|||
27849010|NCT00619359|81278978|FG000|Overall Study|Protocol Violation|1|||
27849011|NCT00619359|81278979|FG001|Overall Study|Protocol Violation|1|||
27849012|NCT00619359|81278978|FG000|Overall Study|Withdrawal by Subject|19|||
27613944|NCT00786474|80430083|FG001|Overall Study|Withdrawal by Subject|31|||
27849013|NCT00619359|81278979|FG001|Overall Study|Withdrawal by Subject|20|||
27849014|NCT00619359|81278978|FG000|Overall Study|Progressive Disease|3|||
27849015|NCT00619359|81278979|FG001|Overall Study|Progressive Disease|1|||
27849016|NCT03487848|81278980|FG000|Overall Study|Lost to Follow-up|1|||
27849017|NCT04349631|81278981|FG000|Overall Study|Lost to Follow-up|3|||
27849018|NCT04349631|81278981|FG000|Overall Study|Withdrawal by Subject|7|||
27895651|NCT00932698|81453714|FG001|Part 1 (Dose Escalation)|Other|0|||
27849019|NCT02065713|81278982|FG000|Overall Study|Adverse Event|0|||
27849020|NCT02065713|81278983|FG001|Overall Study|Adverse Event|1|||
27849021|NCT02065713|81278982|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27849022|NCT02065713|81278983|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27849023|NCT02522403|81278984|FG000|Overall Study|Lost to Follow-up|2|||
27849024|NCT02522403|81278985|FG001|Overall Study|Lost to Follow-up|2|||
27849025|NCT02522403|81278984|FG000|Overall Study|Withdrawal by Subject|2|||
27849026|NCT02522403|81278985|FG001|Overall Study|Withdrawal by Subject|4|||
27849027|NCT01138826|81278989|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
27895652|NCT00932698|81453715|FG002|Part 1 (Dose Escalation)|Other|1|||
27895653|NCT00932698|81453716|FG003|Part 1 (Dose Escalation)|Other|0|||
27895654|NCT00932698|81453717|FG004|Part 1 (Dose Escalation)|Other|0|||
27895655|NCT00932698|81453718|FG005|Part 1 (Dose Escalation)|Other|0|||
27895656|NCT00932698|81453719|FG006|Part 1 (Dose Escalation)|Other|1|||
27895657|NCT00932698|81453720|FG007|Part 1 (Dose Escalation)|Other|0|||
27895658|NCT00932698|81453721|FG008|Part 1 (Dose Escalation)|Other|0|||
27895659|NCT00932698|81453722|FG009|Part 1 (Dose Escalation)|Other|0|||
27895660|NCT00932698|81453723|FG010|Part 1 (Dose Escalation)|Other|0|||
27895661|NCT00932698|81453713|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895662|NCT00932698|81453714|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895663|NCT00932698|81453715|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895664|NCT00932698|81453716|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895665|NCT00932698|81453717|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895666|NCT00932698|81453718|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895667|NCT00932698|81453719|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
27895668|NCT00932698|81453720|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
27895669|NCT00932698|81453721|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
27895670|NCT00932698|81453722|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
27895671|NCT00932698|81453723|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
27895672|NCT00932698|81453713|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895673|NCT00932698|81453714|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895674|NCT00932698|81453715|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895675|NCT00932698|81453716|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895676|NCT00932698|81453717|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895677|NCT00932698|81453718|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895678|NCT00932698|81453719|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895679|NCT00932698|81453720|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
27895680|NCT00932698|81453721|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
27895681|NCT00932698|81453722|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
27895682|NCT00932698|81453723|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
27895683|NCT00932698|81453713|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
27895684|NCT00932698|81453714|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
27895685|NCT00932698|81453715|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
27895686|NCT00932698|81453716|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
27895687|NCT00932698|81453717|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
27895688|NCT00932698|81453718|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
27895689|NCT00932698|81453719|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
27895690|NCT00932698|81453720|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
27895691|NCT00932698|81453721|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
27895692|NCT00932698|81453722|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
27895693|NCT00932698|81453723|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
27895694|NCT02339155|81453724|FG000|Overall Study|Adverse Event|0|||
27895695|NCT02339155|81453725|FG001|Overall Study|Adverse Event|6|||
27895696|NCT02339155|81453724|FG000|Overall Study|Death|1|||
27895697|NCT02339155|81453725|FG001|Overall Study|Death|1|||
27895698|NCT02339155|81453724|FG000|Overall Study|Lost to Follow-up|8|||
27895699|NCT02339155|81453725|FG001|Overall Study|Lost to Follow-up|9|||
27895700|NCT02339155|81453724|FG000|Overall Study|Physician Decision|2|||
27895701|NCT02339155|81453725|FG001|Overall Study|Physician Decision|1|||
27895702|NCT02339155|81453724|FG000|Overall Study|Withdrawal by Subject|4|||
27895703|NCT02339155|81453725|FG001|Overall Study|Withdrawal by Subject|4|||
27895704|NCT00616603|81453726|FG000|Overall Study|Physician Decision|2|||
27895705|NCT00616603|81453727|FG001|Overall Study|Physician Decision|0|||
27895706|NCT00616603|81453728|FG002|Overall Study|Physician Decision|2|||
27895707|NCT00454818|81453732|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
27895708|NCT00454818|81453733|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
27895709|NCT00454818|81453734|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
27895710|NCT00454818|81453735|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
27895711|NCT00454818|81453736|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
27895712|NCT00454818|81453732|FG000|Phase I: Open-label Dose-escalation|Death|0|||
27895713|NCT00454818|81453733|FG001|Phase I: Open-label Dose-escalation|Death|1|||
27895714|NCT00454818|81453734|FG002|Phase I: Open-label Dose-escalation|Death|0|||
27895715|NCT00454818|81453735|FG003|Phase I: Open-label Dose-escalation|Death|0|||
27895716|NCT00454818|81453736|FG004|Phase I: Open-label Dose-escalation|Death|0|||
27895717|NCT00454818|81453732|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
27895718|NCT00454818|81453733|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
27895719|NCT00454818|81453734|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
27895720|NCT00454818|81453735|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
27895721|NCT00454818|81453736|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
27895722|NCT00454818|81453732|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
27613945|NCT00786474|80430082|FG000|Overall Study|Lost to Follow-up|3|||
27726729|NCT00132730|80830175|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
27726730|NCT00132730|80830176|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
27726731|NCT00132730|80830177|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
27726732|NCT00132730|80830178|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
27726733|NCT00132730|80830179|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
27726734|NCT00132730|80830180|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
27726735|NCT00132730|80830175|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
27726736|NCT00132730|80830176|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
27726737|NCT00132730|80830177|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
27726738|NCT00132730|80830178|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
27726739|NCT00132730|80830179|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
27726740|NCT00132730|80830180|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
27726741|NCT00132730|80830175|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
27726742|NCT00132730|80830176|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
27726743|NCT00132730|80830177|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
27726744|NCT00132730|80830178|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
27726745|NCT00132730|80830179|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
27726746|NCT00132730|80830180|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
27726747|NCT00132730|80830175|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
27726748|NCT00132730|80830176|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
27726749|NCT00132730|80830177|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
27726750|NCT00132730|80830178|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
27726751|NCT00132730|80830179|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
27726752|NCT00132730|80830180|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
27726753|NCT00132730|80830175|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
27726754|NCT00132730|80830176|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
27726755|NCT00132730|80830177|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
27726756|NCT00132730|80830178|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
27726757|NCT00132730|80830179|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
27726758|NCT00132730|80830180|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
27726759|NCT00132730|80830175|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
27726760|NCT00132730|80830176|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
27726761|NCT00132730|80830177|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
27726762|NCT00132730|80830178|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
27726763|NCT00132730|80830179|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
27726764|NCT00132730|80830180|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
27726765|NCT00132730|80830175|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
27726766|NCT00132730|80830176|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
27726767|NCT00132730|80830177|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
27726768|NCT00132730|80830178|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
27726769|NCT00132730|80830179|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
27726770|NCT00132730|80830180|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
27726771|NCT00132730|80830175|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
27726772|NCT00132730|80830176|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
27726773|NCT00132730|80830177|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
27726774|NCT00132730|80830178|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
27726775|NCT00132730|80830179|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
27726776|NCT00132730|80830180|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
27726777|NCT00132730|80830175|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
27726778|NCT00132730|80830176|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
27726779|NCT00132730|80830177|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
27726780|NCT00132730|80830178|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
27726781|NCT00132730|80830179|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
27726782|NCT00132730|80830180|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
27726783|NCT00132730|80830175|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
27726784|NCT00132730|80830176|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
27849028|NCT01138826|81278990|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
27849029|NCT01138826|81278991|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
27849030|NCT01138826|81278992|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
27849031|NCT01138826|81278993|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
27849032|NCT01138826|81278994|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
27613946|NCT00786474|80430083|FG001|Overall Study|Lost to Follow-up|3|||
27613947|NCT00786474|80430082|FG000|Overall Study|Physician Decision|2|||
27613948|NCT00786474|80430083|FG001|Overall Study|Physician Decision|1|||
27613949|NCT00786474|80430082|FG000|Overall Study|Other|4|||
27613950|NCT00786474|80430083|FG001|Overall Study|Other|4|||
27613951|NCT00840996|80430086|FG000|Overall Study|Withdrawal by Subject|1|||
27613952|NCT00840996|80430087|FG001|Overall Study|Withdrawal by Subject|0|||
27613953|NCT01622348|80430094|FG000|Overall Study|Withdrawal by Subject|1|||
27613954|NCT01622348|80430095|FG001|Overall Study|Withdrawal by Subject|0|||
27613955|NCT01622348|80430096|FG002|Overall Study|Withdrawal by Subject|1|||
27613956|NCT03881059|80430097|FG000|Treatment Period - Part A|Adverse Event|1|||
27613957|NCT03881059|80430098|FG001|Treatment Period - Part A|Adverse Event|3|||
27613958|NCT03881059|80430099|FG002|Treatment Period - Part A|Adverse Event|4|||
27613959|NCT03881059|80430097|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
27613960|NCT03881059|80430098|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
27613961|NCT03881059|80430099|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
27613962|NCT03881059|80430097|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
27613963|NCT03881059|80430098|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
27613964|NCT03881059|80430099|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
27613965|NCT03881059|80430097|FG000|Treatment Period - Part A|Other reasons|2|||
27613966|NCT03881059|80430098|FG001|Treatment Period - Part A|Other reasons|1|||
27613967|NCT03881059|80430099|FG002|Treatment Period - Part A|Other reasons|0|||
27613968|NCT03881059|80430097|FG000|Treatment Period - Part B|Adverse Event|0|||
27613969|NCT03881059|80430098|FG001|Treatment Period - Part B|Adverse Event|0|||
27613970|NCT03881059|80430099|FG002|Treatment Period - Part B|Adverse Event|3|||
27613971|NCT03881059|80430097|FG000|Treatment Period - Part B|Death|0|||
27613972|NCT03881059|80430098|FG001|Treatment Period - Part B|Death|1|||
27613973|NCT03881059|80430099|FG002|Treatment Period - Part B|Death|1|||
27613974|NCT03881059|80430097|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
27613975|NCT03881059|80430098|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
27613976|NCT03881059|80430099|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
27613977|NCT03881059|80430097|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
27613978|NCT03881059|80430098|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
27613979|NCT03881059|80430099|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
27613980|NCT03881059|80430097|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
27613981|NCT03881059|80430098|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
27613982|NCT03881059|80430099|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
27613983|NCT03881059|80430097|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
27613984|NCT03881059|80430098|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
27613985|NCT03881059|80430099|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
27613986|NCT03881059|80430097|FG000|Treatment Period - Part B|Other reasons|4|||
27613987|NCT03881059|80430098|FG001|Treatment Period - Part B|Other reasons|3|||
27613988|NCT03881059|80430099|FG002|Treatment Period - Part B|Other reasons|3|||
27613989|NCT05033743|80430100|FG000|Overall Study|Lost to Follow-up|1|||
27613990|NCT05033743|80430100|FG000|Overall Study|Protocol Violation|2|||
27613991|NCT05033743|80430100|FG000|Overall Study|Withdrawal by Subject|1|||
27613992|NCT01313182|80430101|FG000|Overall Study|Protocol Violation|66|||
27613993|NCT01313182|80430102|FG001|Overall Study|Protocol Violation|92|||
27613994|NCT01785628|80430105|FG000|Overall Study|Lost to Follow-up|2|||
27613995|NCT01785628|80430106|FG001|Overall Study|Lost to Follow-up|3|||
27613996|NCT01000376|80430107|FG000|Cycle 1 Day 1|Adverse Event|1|||
27613997|NCT01000376|80430108|FG001|Cycle 1 Day 1|Adverse Event|0|||
27613998|NCT01000376|80430107|FG000|Cycle 1 Day 1|Progressive Disease|1|||
27613999|NCT01000376|80430108|FG001|Cycle 1 Day 1|Progressive Disease|0|||
27726785|NCT00132730|80830177|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
27726786|NCT00132730|80830178|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
27726787|NCT00132730|80830179|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
27726788|NCT00132730|80830180|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
27726789|NCT00110994|80830181|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
27614000|NCT01208415|80430109|FG000|Overall Study|Death|1|||
27614001|NCT01208415|80430109|FG000|Overall Study|Lost to Follow-up|2|||
27614002|NCT01208415|80430109|FG000|Overall Study|Withdrawal by Subject|3|||
27614003|NCT01208415|80430109|FG000|Overall Study|Device not placed|1|||
27614004|NCT01208415|80430109|FG000|Overall Study|Still be eligible for follow-up|33|||
27614005|NCT01189890|80430115|FG000|Overall Study|Adverse Event|3|||
27614006|NCT01189890|80430116|FG001|Overall Study|Adverse Event|4|||
27614007|NCT01189890|80430115|FG000|Overall Study|Lack of Efficacy|7|||
27614008|NCT01189890|80430116|FG001|Overall Study|Lack of Efficacy|2|||
27614009|NCT01189890|80430115|FG000|Overall Study|Lost to Follow-up|1|||
27614010|NCT01189890|80430116|FG001|Overall Study|Lost to Follow-up|7|||
27849033|NCT01425723|81278995|FG000|Overall Study|Lack of Efficacy|0|||
27849034|NCT01425723|81278996|FG001|Overall Study|Lack of Efficacy|1|||
27849035|NCT01425723|81278995|FG000|Overall Study|Withdrawal by Subject|1|||
27895723|NCT00454818|81453733|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
27895724|NCT00454818|81453734|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
27895725|NCT00454818|81453735|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
27895726|NCT00454818|81453736|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
27895727|NCT00454818|81453732|FG000|Phase 2: Randomized Double-blind|Death|0|||
27895728|NCT00454818|81453733|FG001|Phase 2: Randomized Double-blind|Death|1|||
27895729|NCT00454818|81453734|FG002|Phase 2: Randomized Double-blind|Death|0|||
27895730|NCT00454818|81453735|FG003|Phase 2: Randomized Double-blind|Death|0|||
27895731|NCT00454818|81453736|FG004|Phase 2: Randomized Double-blind|Death|1|||
27895732|NCT00454818|81453732|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
27895733|NCT00454818|81453733|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
27895734|NCT00454818|81453734|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
27895735|NCT00454818|81453735|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
27895736|NCT00454818|81453736|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
27895737|NCT00454818|81453732|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
27895738|NCT00454818|81453733|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
27895739|NCT00454818|81453734|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
27895740|NCT00454818|81453735|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
27895741|NCT00454818|81453736|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
27895742|NCT01935700|81453741|FG000|Overall Study|Withdrawal by Subject|1|||
27895743|NCT01935700|81453742|FG001|Overall Study|Withdrawal by Subject|0|||
27895744|NCT01935700|81453741|FG000|Overall Study|Physician Decision|4|||
27895745|NCT01935700|81453742|FG001|Overall Study|Physician Decision|0|||
27895746|NCT03199612|81453743|FG000|Overall Study|Adverse Event|1|||
27895747|NCT03199612|81453744|FG001|Overall Study|Adverse Event|0|||
27895748|NCT01041976|81453746|FG000|Overall Study|Withdrawal by Subject|3|||
27895749|NCT01041976|81453747|FG001|Overall Study|Withdrawal by Subject|0|||
27895750|NCT01041976|81453746|FG000|Overall Study|Incarceration|2|||
27895751|NCT01041976|81453747|FG001|Overall Study|Incarceration|0|||
27895752|NCT01041976|81453746|FG000|Overall Study|Death|0|||
27895753|NCT01041976|81453747|FG001|Overall Study|Death|4|||
27895754|NCT01629823|81453763|FG000|Trial Period|Missed visit|11|||
27895755|NCT01629823|81453764|FG001|Trial Period|Missed visit|9|||
27895756|NCT01629823|81453765|FG002|Trial Period|Missed visit|8|||
27895757|NCT01629823|81453763|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
27895758|NCT01629823|81453764|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
27895759|NCT01629823|81453765|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
27895760|NCT01629823|81453763|FG000|Trial Period|Pregnancy|1|||
27895761|NCT01629823|81453764|FG001|Trial Period|Pregnancy|0|||
27895762|NCT01629823|81453765|FG002|Trial Period|Pregnancy|0|||
27895763|NCT01629823|81453763|FG000|Trial Period|Adverse Event|0|||
27895764|NCT01629823|81453764|FG001|Trial Period|Adverse Event|1|||
27895765|NCT01629823|81453765|FG002|Trial Period|Adverse Event|0|||
27895766|NCT01629823|81453763|FG000|Trial Period|Out-of-window visit|0|||
27895767|NCT01629823|81453764|FG001|Trial Period|Out-of-window visit|2|||
27895768|NCT01629823|81453765|FG002|Trial Period|Out-of-window visit|0|||
27895769|NCT01629823|81453763|FG000|Trial Period|Failed to hold medication|0|||
27895770|NCT01629823|81453764|FG001|Trial Period|Failed to hold medication|0|||
27895771|NCT01629823|81453765|FG002|Trial Period|Failed to hold medication|1|||
27895772|NCT01629823|81453763|FG000|Washout Period|Safety|2|||
27895773|NCT01629823|81453764|FG001|Washout Period|Safety|5|||
27895774|NCT01629823|81453765|FG002|Washout Period|Safety|0|||
27895775|NCT01629823|81453763|FG000|Washout Period|Pregnancy|1|||
27895776|NCT01629823|81453764|FG001|Washout Period|Pregnancy|0|||
27895777|NCT01629823|81453765|FG002|Washout Period|Pregnancy|0|||
27895778|NCT01629823|81453763|FG000|Washout Period|Protocol Violation|0|||
27895779|NCT01629823|81453764|FG001|Washout Period|Protocol Violation|1|||
27895780|NCT01629823|81453765|FG002|Washout Period|Protocol Violation|0|||
27895781|NCT01404208|81453766|FG000|Overall Study|Discontinued|3|||
27895782|NCT01404208|81453767|FG001|Overall Study|Discontinued|0|||
27895783|NCT01500213|81453770|FG000|Overall Study|Adverse Event|35|||
27895784|NCT01500213|81453771|FG001|Overall Study|Adverse Event|35|||
27895785|NCT01500213|81453770|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
27895786|NCT01500213|81453771|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
27895787|NCT01500213|81453770|FG000|Overall Study|Withdrawal by Subject|28|||
27895788|NCT01500213|81453771|FG001|Overall Study|Withdrawal by Subject|37|||
27895789|NCT01500213|81453770|FG000|Overall Study|Death|7|||
27895790|NCT01500213|81453771|FG001|Overall Study|Death|3|||
27895791|NCT01500213|81453770|FG000|Overall Study|Disease Progression|13|||
27895792|NCT01500213|81453771|FG001|Overall Study|Disease Progression|21|||
27895793|NCT01500213|81453770|FG000|Overall Study|Protocol Violation|19|||
27895794|NCT01500213|81453771|FG001|Overall Study|Protocol Violation|19|||
27895795|NCT01500213|81453770|FG000|Overall Study|Physician Decision|12|||
27895796|NCT01500213|81453771|FG001|Overall Study|Physician Decision|10|||
27895797|NCT01500213|81453770|FG000|Overall Study|Lack of Efficacy|9|||
27895798|NCT01500213|81453771|FG001|Overall Study|Lack of Efficacy|7|||
27895799|NCT01500213|81453770|FG000|Overall Study|Lost to Follow-up|3|||
27895800|NCT01500213|81453771|FG001|Overall Study|Lost to Follow-up|6|||
27895801|NCT01500213|81453770|FG000|Overall Study|Other Reasons|7|||
27895802|NCT01500213|81453771|FG001|Overall Study|Other Reasons|5|||
27895803|NCT03802565|81453775|FG000|Overall Study|Adverse Event|0|||
27895804|NCT03802565|81453776|FG001|Overall Study|Adverse Event|1|||
27895805|NCT03802565|81453777|FG002|Overall Study|Adverse Event|2|||
27895806|NCT03802565|81453778|FG003|Overall Study|Adverse Event|1|||
27895807|NCT03802565|81453779|FG004|Overall Study|Adverse Event|1|||
27895808|NCT03802565|81453775|FG000|Overall Study|Withdrawal by Subject|2|||
27895809|NCT03802565|81453776|FG001|Overall Study|Withdrawal by Subject|2|||
27895810|NCT03802565|81453777|FG002|Overall Study|Withdrawal by Subject|2|||
27895811|NCT03802565|81453778|FG003|Overall Study|Withdrawal by Subject|0|||
27895812|NCT03802565|81453779|FG004|Overall Study|Withdrawal by Subject|1|||
27895813|NCT03802565|81453775|FG000|Overall Study|Protocol Violation|2|||
27895814|NCT03802565|81453776|FG001|Overall Study|Protocol Violation|1|||
27895815|NCT03802565|81453777|FG002|Overall Study|Protocol Violation|4|||
27895816|NCT03802565|81453778|FG003|Overall Study|Protocol Violation|5|||
27895817|NCT03802565|81453779|FG004|Overall Study|Protocol Violation|1|||
27895818|NCT03802565|81453775|FG000|Overall Study|Lost to Follow-up|0|||
27895819|NCT03802565|81453776|FG001|Overall Study|Lost to Follow-up|0|||
27895820|NCT03802565|81453777|FG002|Overall Study|Lost to Follow-up|1|||
27895821|NCT03802565|81453778|FG003|Overall Study|Lost to Follow-up|0|||
27895822|NCT03802565|81453779|FG004|Overall Study|Lost to Follow-up|0|||
27895823|NCT03802565|81453775|FG000|Overall Study|Subjects Related to Each Other|1|||
27895824|NCT03802565|81453776|FG001|Overall Study|Subjects Related to Each Other|0|||
27895825|NCT03802565|81453777|FG002|Overall Study|Subjects Related to Each Other|0|||
27895826|NCT03802565|81453778|FG003|Overall Study|Subjects Related to Each Other|2|||
27895827|NCT03802565|81453779|FG004|Overall Study|Subjects Related to Each Other|1|||
27895828|NCT03802565|81453775|FG000|Overall Study|Elevated Enzymes|0|||
27895829|NCT03802565|81453776|FG001|Overall Study|Elevated Enzymes|0|||
27895830|NCT03802565|81453777|FG002|Overall Study|Elevated Enzymes|0|||
27895831|NCT03802565|81453778|FG003|Overall Study|Elevated Enzymes|0|||
27895832|NCT03802565|81453779|FG004|Overall Study|Elevated Enzymes|2|||
27726790|NCT00110994|80830182|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
27726791|NCT00110994|80830181|FG000|Double-blind (DB) Treatment|Death|1|||
27849036|NCT01425723|81278996|FG001|Overall Study|Withdrawal by Subject|4|||
27849037|NCT01425723|81278995|FG000|Overall Study|Lost to Follow-up|0|||
27849038|NCT01425723|81278996|FG001|Overall Study|Lost to Follow-up|3|||
27849039|NCT01425723|81278995|FG000|Overall Study|Physician Decision|2|||
27849040|NCT01425723|81278996|FG001|Overall Study|Physician Decision|0|||
27849041|NCT01425723|81278995|FG000|Overall Study|Other|1|||
27849042|NCT01425723|81278996|FG001|Overall Study|Other|10|||
27849043|NCT01360866|81279009|FG000|Overall Study|Lost to Follow-up|11|||
27849044|NCT01360866|81279010|FG001|Overall Study|Lost to Follow-up|28|||
27849045|NCT01360866|81279011|FG002|Overall Study|Lost to Follow-up|41|||
27849046|NCT01360866|81279012|FG003|Overall Study|Lost to Follow-up|0|||
27849047|NCT01360866|81279009|FG000|Overall Study|Adverse Event|56|||
27849048|NCT01360866|81279010|FG001|Overall Study|Adverse Event|61|||
27849049|NCT01360866|81279011|FG002|Overall Study|Adverse Event|134|||
27849050|NCT01360866|81279012|FG003|Overall Study|Adverse Event|6|||
27849051|NCT01360866|81279009|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
27849052|NCT01360866|81279010|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
27849053|NCT01360866|81279011|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
27849054|NCT01360866|81279012|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
27849055|NCT01360866|81279009|FG000|Overall Study|Withdrawn by Investigator|9|||
27849056|NCT01360866|81279010|FG001|Overall Study|Withdrawn by Investigator|8|||
27849057|NCT01360866|81279011|FG002|Overall Study|Withdrawn by Investigator|31|||
27849058|NCT01360866|81279012|FG003|Overall Study|Withdrawn by Investigator|2|||
27849059|NCT01360866|81279009|FG000|Overall Study|Withdrawal by participant|79|||
27849060|NCT01360866|81279010|FG001|Overall Study|Withdrawal by participant|89|||
27849061|NCT01360866|81279011|FG002|Overall Study|Withdrawal by participant|168|||
27849062|NCT01360866|81279012|FG003|Overall Study|Withdrawal by participant|8|||
27849063|NCT01360866|81279009|FG000|Overall Study|Protocol Deviation|25|||
27849064|NCT01360866|81279010|FG001|Overall Study|Protocol Deviation|33|||
27849065|NCT01360866|81279011|FG002|Overall Study|Protocol Deviation|61|||
27849066|NCT01360866|81279012|FG003|Overall Study|Protocol Deviation|2|||
27849067|NCT01360866|81279009|FG000|Overall Study|Lack of Efficacy|30|||
27849068|NCT01360866|81279010|FG001|Overall Study|Lack of Efficacy|40|||
27849069|NCT01360866|81279011|FG002|Overall Study|Lack of Efficacy|30|||
27849070|NCT01360866|81279012|FG003|Overall Study|Lack of Efficacy|4|||
27849071|NCT02960438|81279013|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
27849072|NCT02960438|81279014|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
27849073|NCT02960438|81279015|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
27895833|NCT04063657|81453782|FG000|Overall Study|Lost to Follow-up|1|||
27895834|NCT04063657|81453783|FG001|Overall Study|Lost to Follow-up|0|||
27849074|NCT02960438|81279016|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
27895835|NCT02604550|81453788|FG000|Overall Study|Lost to Follow-up|7|||
27895836|NCT02604550|81453789|FG001|Overall Study|Lost to Follow-up|6|||
27895837|NCT02604550|81453788|FG000|Overall Study|Withdrawal by Subject|0|||
27895838|NCT02604550|81453789|FG001|Overall Study|Withdrawal by Subject|1|||
27849075|NCT02960438|81279013|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
27849076|NCT02960438|81279014|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
27849077|NCT02960438|81279015|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
27849078|NCT02960438|81279016|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
27849079|NCT02960438|81279013|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
27849080|NCT02960438|81279014|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
27849081|NCT02960438|81279015|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
27849082|NCT02960438|81279016|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
27849083|NCT02960438|81279013|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
27849084|NCT02960438|81279014|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
27849085|NCT02960438|81279015|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
27849086|NCT02960438|81279016|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
27849087|NCT02960438|81279013|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
27849088|NCT02960438|81279014|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
27849089|NCT02960438|81279015|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
27849090|NCT02960438|81279016|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
27849091|NCT02960438|81279013|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
27849092|NCT02960438|81279014|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
27849093|NCT02960438|81279015|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
27849094|NCT02960438|81279016|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
27849095|NCT02960438|81279013|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
27849096|NCT02960438|81279014|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
27849097|NCT02960438|81279015|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
27849098|NCT02960438|81279016|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
27849099|NCT02960438|81279013|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
27849100|NCT02960438|81279014|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
27849101|NCT02960438|81279015|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
27849102|NCT02960438|81279016|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
27849103|NCT02960438|81279013|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
27849104|NCT02960438|81279014|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
27849105|NCT02960438|81279015|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
27849106|NCT02960438|81279016|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
27849107|NCT02960438|81279013|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
27849108|NCT02960438|81279014|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
27849109|NCT02960438|81279015|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
27849110|NCT02960438|81279016|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
27849111|NCT02960438|81279013|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
27849112|NCT02960438|81279014|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
27849113|NCT02960438|81279015|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
27849114|NCT02960438|81279016|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
27849115|NCT02960438|81279013|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
27849116|NCT02960438|81279014|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
27849117|NCT02960438|81279015|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
27849118|NCT02960438|81279016|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
27849119|NCT00831623|81279022|FG000|Overall Study|Withdrawal by Subject|9|||
27849120|NCT00831623|81279022|FG000|Overall Study|Lost to Follow-up|1|||
27849121|NCT00831623|81279022|FG000|Overall Study|Not 2 years post-treatment|12|||
27849122|NCT00720226|81279023|FG000|Overall Study|Withdrawal by Subject|7|||
27849123|NCT00720226|81279024|FG001|Overall Study|Withdrawal by Subject|4|||
27849124|NCT00869024|81279027|FG000|Overall Study|Death|2|||
27849125|NCT00869024|81279028|FG001|Overall Study|Death|3|||
27849126|NCT00869024|81279027|FG000|Overall Study|Lost to Follow-up|0|||
27849127|NCT00869024|81279028|FG001|Overall Study|Lost to Follow-up|1|||
27849128|NCT00869024|81279027|FG000|Overall Study|Protocol Violation|0|||
27849129|NCT00869024|81279028|FG001|Overall Study|Protocol Violation|1|||
27849130|NCT02459665|81279030|FG000|Overall Study|Withdrawal by Subject|0|||
27849131|NCT02459665|81279031|FG001|Overall Study|Withdrawal by Subject|1|||
27849132|NCT02459665|81279032|FG002|Overall Study|Withdrawal by Subject|1|||
27895839|NCT02604550|81453788|FG000|Overall Study|Incomplete data using paper journal|18|||
27895840|NCT02604550|81453789|FG001|Overall Study|Incomplete data using paper journal|19|||
27895841|NCT02386345|81453790|FG000|Overall Study|Not treated|14|||
27614011|NCT01189890|80430115|FG000|Overall Study|Protocol Violation|1|||
27895842|NCT02386345|81453790|FG000|Overall Study|Lost to Follow-up|1|||
27895843|NCT02386345|81453790|FG000|Overall Study|Adverse Event|5|||
27895844|NCT02386345|81453790|FG000|Overall Study|Repeat Procedure|10|||
27895845|NCT02386345|81453790|FG000|Overall Study|Did not complete 12-month follow-up|72|||
27895846|NCT03047720|81453793|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
27895847|NCT03047720|81453794|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
27895848|NCT00778102|81453795|FG000|Overall Study|Adverse Event|8|||
27895849|NCT00778102|81453796|FG001|Overall Study|Adverse Event|5|||
27895850|NCT00778102|81453795|FG000|Overall Study|Death|1|||
27895851|NCT00778102|81453796|FG001|Overall Study|Death|1|||
27895852|NCT00778102|81453795|FG000|Overall Study|Lost to Follow-up|1|||
27895853|NCT00778102|81453796|FG001|Overall Study|Lost to Follow-up|0|||
27895854|NCT00778102|81453795|FG000|Overall Study|Violation of Selection Criteria|1|||
27895855|NCT00778102|81453796|FG001|Overall Study|Violation of Selection Criteria|1|||
27895856|NCT00778102|81453795|FG000|Overall Study|Protocol Violation|0|||
27895857|NCT00778102|81453796|FG001|Overall Study|Protocol Violation|1|||
27895858|NCT00778102|81453795|FG000|Overall Study|Refused Treatment|2|||
27895859|NCT00778102|81453796|FG001|Overall Study|Refused Treatment|3|||
27895860|NCT00778102|81453795|FG000|Overall Study|Withdrawal by Subject|1|||
27895861|NCT00778102|81453796|FG001|Overall Study|Withdrawal by Subject|1|||
27895862|NCT00778102|81453795|FG000|Overall Study|Administrative Reason|7|||
27895863|NCT00778102|81453796|FG001|Overall Study|Administrative Reason|10|||
27895864|NCT04329091|81453797|FG000|Overall Study|Physician Decision|5|||
27895865|NCT02847182|81453798|FG000|Overall Study|Withdrawal by Subject|0|||
27895866|NCT02847182|81453799|FG001|Overall Study|Withdrawal by Subject|1|||
27895867|NCT02002533|81453800|FG000|Overall Study|Withdrawal by Subject|6|||
27895868|NCT02002533|81453801|FG001|Overall Study|Withdrawal by Subject|13|||
27895869|NCT02002533|81453800|FG000|Overall Study|Protocol Violation|0|||
27895870|NCT02002533|81453801|FG001|Overall Study|Protocol Violation|1|||
27895871|NCT02002533|81453800|FG000|Overall Study|Adverse Event|0|||
27895872|NCT02002533|81453801|FG001|Overall Study|Adverse Event|3|||
27895873|NCT02002533|81453800|FG000|Overall Study|Lost to Follow-up|0|||
27895874|NCT02002533|81453801|FG001|Overall Study|Lost to Follow-up|1|||
27895875|NCT02609724|81453802|FG000|Overall Study|Death|2|||
27895876|NCT02609724|81453803|FG001|Overall Study|Death|0|||
27895877|NCT02609724|81453804|FG002|Overall Study|Death|1|||
27895878|NCT02609724|81453802|FG000|Overall Study|Withdrawal by Subject|1|||
27895879|NCT02609724|81453803|FG001|Overall Study|Withdrawal by Subject|2|||
27895880|NCT02609724|81453804|FG002|Overall Study|Withdrawal by Subject|3|||
27895881|NCT02609724|81453802|FG000|Overall Study|Illness|2|||
27895882|NCT02609724|81453803|FG001|Overall Study|Illness|1|||
27895883|NCT02609724|81453804|FG002|Overall Study|Illness|0|||
27895884|NCT00467961|81453809|FG000|Overall Study|Technical Failures|5|||
27895885|NCT00467961|81453809|FG000|Overall Study|Disease Progression|2|||
27895886|NCT03605849|81453810|FG000|Overall Study|Adverse Event|20|||
27895887|NCT03605849|81453811|FG001|Overall Study|Adverse Event|21|||
27895888|NCT03605849|81453812|FG002|Overall Study|Adverse Event|29|||
27895889|NCT03605849|81453813|FG003|Overall Study|Adverse Event|11|||
27895890|NCT03605849|81453810|FG000|Overall Study|Lack of Efficacy|4|||
27895891|NCT03605849|81453811|FG001|Overall Study|Lack of Efficacy|7|||
27895892|NCT03605849|81453812|FG002|Overall Study|Lack of Efficacy|9|||
27895893|NCT03605849|81453813|FG003|Overall Study|Lack of Efficacy|2|||
27895894|NCT03605849|81453810|FG000|Overall Study|Lost to Follow-up|8|||
27895895|NCT03605849|81453811|FG001|Overall Study|Lost to Follow-up|8|||
27895896|NCT03605849|81453812|FG002|Overall Study|Lost to Follow-up|14|||
27895897|NCT03605849|81453813|FG003|Overall Study|Lost to Follow-up|11|||
27895898|NCT03605849|81453810|FG000|Overall Study|Non-compliance With IMP|6|||
27895899|NCT03605849|81453811|FG001|Overall Study|Non-compliance With IMP|5|||
27895900|NCT03605849|81453812|FG002|Overall Study|Non-compliance With IMP|2|||
27895901|NCT03605849|81453813|FG003|Overall Study|Non-compliance With IMP|1|||
27895902|NCT03605849|81453810|FG000|Overall Study|Protocol Deviation|1|||
27895903|NCT03605849|81453811|FG001|Overall Study|Protocol Deviation|2|||
27895904|NCT03605849|81453812|FG002|Overall Study|Protocol Deviation|1|||
27895905|NCT03605849|81453813|FG003|Overall Study|Protocol Deviation|3|||
27895906|NCT03605849|81453810|FG000|Overall Study|Withdrawal by Subject|33|||
27895907|NCT03605849|81453811|FG001|Overall Study|Withdrawal by Subject|28|||
27895908|NCT03605849|81453812|FG002|Overall Study|Withdrawal by Subject|30|||
27895909|NCT03605849|81453813|FG003|Overall Study|Withdrawal by Subject|28|||
27895910|NCT03605849|81453810|FG000|Overall Study|Site Terminated by Sponsor|0|||
27895911|NCT03605849|81453811|FG001|Overall Study|Site Terminated by Sponsor|0|||
27895912|NCT03605849|81453812|FG002|Overall Study|Site Terminated by Sponsor|0|||
27895913|NCT03605849|81453813|FG003|Overall Study|Site Terminated by Sponsor|1|||
27895914|NCT03605849|81453810|FG000|Overall Study|Physician Decision|2|||
27895915|NCT03605849|81453811|FG001|Overall Study|Physician Decision|1|||
27895916|NCT03605849|81453812|FG002|Overall Study|Physician Decision|2|||
27895917|NCT03605849|81453813|FG003|Overall Study|Physician Decision|1|||
27895918|NCT03605849|81453810|FG000|Overall Study|Enrolled, but not Treated|2|||
27895919|NCT03605849|81453811|FG001|Overall Study|Enrolled, but not Treated|2|||
27895920|NCT03605849|81453812|FG002|Overall Study|Enrolled, but not Treated|3|||
27895921|NCT03605849|81453813|FG003|Overall Study|Enrolled, but not Treated|2|||
27895922|NCT03605849|81453810|FG000|Overall Study|Other (COVID-19 Related)|0|||
27895923|NCT03605849|81453811|FG001|Overall Study|Other (COVID-19 Related)|1|||
27895924|NCT03605849|81453812|FG002|Overall Study|Other (COVID-19 Related)|1|||
27895925|NCT03605849|81453813|FG003|Overall Study|Other (COVID-19 Related)|0|||
27895926|NCT03605849|81453810|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
27895927|NCT03605849|81453811|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
27895928|NCT03605849|81453812|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
27895929|NCT03605849|81453813|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
27895930|NCT00860249|81453815|FG000|Overall Study|trial was terminated prior to completion|21|||
27895931|NCT00860249|81453816|FG001|Overall Study|trial was terminated prior to completion|18|||
27895932|NCT00860249|81453817|FG002|Overall Study|trial was terminated prior to completion|21|||
27895933|NCT00835679|81453818|FG000|Overall Study|Withdrawal by Subject|1|||
27895934|NCT00835679|81453819|FG001|Overall Study|Withdrawal by Subject|0|||
27895935|NCT00835679|81453820|FG002|Overall Study|Withdrawal by Subject|0|||
27895936|NCT00835679|81453821|FG003|Overall Study|Withdrawal by Subject|0|||
27895937|NCT02071706|81453822|FG000|Overall Study|Adverse Event|1|||
27895938|NCT02071706|81453822|FG000|Overall Study|Withdrawal by Subject|2|||
27895939|NCT02306694|81453823|FG000|Overall Study|Withdrawal by Subject|3|||
27895940|NCT02306694|81453823|FG000|Overall Study|Lost to Follow-up|1|||
27895941|NCT03197870|81453827|FG000|Overall Study|Adverse Event|9|||
27895942|NCT03197870|81453828|FG001|Overall Study|Adverse Event|4|||
27895943|NCT03197870|81453829|FG002|Overall Study|Adverse Event|6|||
27895944|NCT03197870|81453827|FG000|Overall Study|Withdrawal by Subject|2|||
27895945|NCT03197870|81453828|FG001|Overall Study|Withdrawal by Subject|3|||
27895946|NCT03197870|81453829|FG002|Overall Study|Withdrawal by Subject|0|||
27895947|NCT03197870|81453827|FG000|Overall Study|Lost to Follow-up|2|||
27614012|NCT01189890|80430116|FG001|Overall Study|Protocol Violation|5|||
27614013|NCT01189890|80430115|FG000|Overall Study|Withdrawal by Subject|15|||
27614014|NCT01189890|80430116|FG001|Overall Study|Withdrawal by Subject|11|||
27726792|NCT00110994|80830182|FG001|Double-blind (DB) Treatment|Death|0|||
27726793|NCT00110994|80830181|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
27726794|NCT00110994|80830182|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
27726795|NCT00110994|80830181|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
27726796|NCT00110994|80830182|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
27726797|NCT00110994|80830181|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
27726798|NCT00110994|80830182|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
27726799|NCT00110994|80830181|FG000|Double-blind (DB) Treatment|other reasons|2|||
27726800|NCT00110994|80830182|FG001|Double-blind (DB) Treatment|other reasons|3|||
27726801|NCT00110994|80830181|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
27726802|NCT00110994|80830182|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
27726803|NCT00110994|80830181|FG000|Active Follow-up|Other reasons|0|||
27726804|NCT00110994|80830182|FG001|Active Follow-up|Other reasons|2|||
27726805|NCT00110994|80830181|FG000|Long Term Follow-up|Death|19|||
27726806|NCT00110994|80830182|FG001|Long Term Follow-up|Death|17|||
27726807|NCT04173741|80830186|FG000|Overall Study|IVC measurement cannot be done|1|||
27726808|NCT04173741|80830187|FG001|Overall Study|IVC measurement cannot be done|1|||
27726809|NCT00605267|80830188|FG000|Overall Study|Adverse Event|0|||
27726810|NCT00605267|80830189|FG001|Overall Study|Adverse Event|1|||
27726811|NCT00605267|80830188|FG000|Overall Study|Lack of Efficacy|1|||
27726812|NCT00605267|80830189|FG001|Overall Study|Lack of Efficacy|5|||
27726813|NCT00605267|80830188|FG000|Overall Study|Withdrawal by Subject|2|||
27726814|NCT00605267|80830189|FG001|Overall Study|Withdrawal by Subject|3|||
27726815|NCT01445535|80830190|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
27726816|NCT01445535|80830191|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
27726817|NCT01445535|80830192|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
27849133|NCT02459665|81279033|FG003|Overall Study|Withdrawal by Subject|2|||
27849134|NCT03812991|81279034|FG000|Overall Study|Lost to Follow-up|3|||
27849135|NCT03812991|81279035|FG001|Overall Study|Lost to Follow-up|1|||
27849136|NCT02356211|81279040|FG000|Overall Study|Withdrawal by Subject|2|||
27849137|NCT02356211|81279041|FG001|Overall Study|Withdrawal by Subject|2|||
27849138|NCT02356211|81279040|FG000|Overall Study|ineligible|1|||
27849139|NCT02356211|81279041|FG001|Overall Study|ineligible|8|||
27849140|NCT01674647|81279044|FG000|Treatment Period|Death|4|||
27849141|NCT01674647|81279045|FG001|Treatment Period|Death|1|||
27849142|NCT01674647|81279044|FG000|Treatment Period|Efficacy outcome reached|0|||
27849143|NCT01674647|81279045|FG001|Treatment Period|Efficacy outcome reached|1|||
27849144|NCT01674647|81279044|FG000|Treatment Period|Physician Decision|3|||
27849145|NCT01674647|81279045|FG001|Treatment Period|Physician Decision|1|||
27849146|NCT01674647|81279044|FG000|Treatment Period|Adverse Event|60|||
27849147|NCT01674647|81279045|FG001|Treatment Period|Adverse Event|22|||
27849148|NCT01674647|81279044|FG000|Treatment Period|Non-compliance with study drug|3|||
27849149|NCT01674647|81279045|FG001|Treatment Period|Non-compliance with study drug|0|||
27849150|NCT01674647|81279044|FG000|Treatment Period|Lost to Follow-up|1|||
27849151|NCT01674647|81279045|FG001|Treatment Period|Lost to Follow-up|1|||
27849152|NCT01674647|81279044|FG000|Treatment Period|Withdrawal by Subject|19|||
27895948|NCT03197870|81453828|FG001|Overall Study|Lost to Follow-up|2|||
27895949|NCT03197870|81453829|FG002|Overall Study|Lost to Follow-up|0|||
27895950|NCT03197870|81453827|FG000|Overall Study|data not available|1|||
27895951|NCT03197870|81453828|FG001|Overall Study|data not available|1|||
27895952|NCT03197870|81453829|FG002|Overall Study|data not available|0|||
27895953|NCT00157820|81453830|FG000|Randomized|Physician Decision|4|||
27895954|NCT00157820|81453831|FG001|Randomized|Physician Decision|2|||
27895955|NCT00157820|81453832|FG002|Randomized|Physician Decision|3|||
27895956|NCT00157820|81453830|FG000|Randomized|Withdrawal by Subject|1|||
27895957|NCT00157820|81453831|FG001|Randomized|Withdrawal by Subject|2|||
27895958|NCT00157820|81453832|FG002|Randomized|Withdrawal by Subject|3|||
27895959|NCT00157820|81453830|FG000|Randomized|Protocol Violation|2|||
27895960|NCT00157820|81453831|FG001|Randomized|Protocol Violation|1|||
27895961|NCT00157820|81453832|FG002|Randomized|Protocol Violation|2|||
27895962|NCT00157820|81453830|FG000|1st 8 Month|Death|7|||
27895963|NCT00157820|81453831|FG001|1st 8 Month|Death|8|||
27895964|NCT00157820|81453832|FG002|1st 8 Month|Death|3|||
27895965|NCT00157820|81453830|FG000|1st 8 Month|Lost to Follow-up|1|||
27895966|NCT00157820|81453831|FG001|1st 8 Month|Lost to Follow-up|2|||
27895967|NCT00157820|81453832|FG002|1st 8 Month|Lost to Follow-up|1|||
27895968|NCT00157820|81453830|FG000|1st 8 Month|Premature cross-over|0|||
27895969|NCT00157820|81453831|FG001|1st 8 Month|Premature cross-over|2|||
27895970|NCT00157820|81453832|FG002|1st 8 Month|Premature cross-over|2|||
27895971|NCT00157820|81453830|FG000|2nd 8 Months|Death|3|||
27895972|NCT00157820|81453831|FG001|2nd 8 Months|Death|1|||
27895973|NCT00157820|81453832|FG002|2nd 8 Months|Death|3|||
27895974|NCT00157820|81453830|FG000|2nd 8 Months|Lost to Follow-up|1|||
27895975|NCT00157820|81453831|FG001|2nd 8 Months|Lost to Follow-up|5|||
27895976|NCT00157820|81453832|FG002|2nd 8 Months|Lost to Follow-up|2|||
27895977|NCT00157820|81453830|FG000|2nd 8 Months|Premature cross-over|1|||
27895978|NCT00157820|81453831|FG001|2nd 8 Months|Premature cross-over|7|||
27895979|NCT00157820|81453832|FG002|2nd 8 Months|Premature cross-over|9|||
27895980|NCT00623597|81453834|FG000|Overall Study|Failed to return|1|||
27895981|NCT00623597|81453835|FG001|Overall Study|Failed to return|0|||
27895982|NCT00070018|81453836|FG000|Overall Study|Adverse Event|2|||
27895983|NCT00070018|81453836|FG000|Overall Study|Lack of Efficacy|1|||
27895984|NCT00070018|81453836|FG000|Overall Study|Withdrawal by Subject|1|||
27505919|NCT02963506|80044212|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505920|NCT02963506|80044213|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
27505921|NCT02963506|80044214|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
27505922|NCT00744497|80044217|FG000|Overall Study|Withdrawal by Subject|21|||
27895985|NCT03379792|81453844|FG000|Overall Study|Physician Decision|0|||
27895986|NCT03379792|81453845|FG001|Overall Study|Physician Decision|0|||
27895987|NCT03379792|81453846|FG002|Overall Study|Physician Decision|0|||
27895988|NCT03379792|81453847|FG003|Overall Study|Physician Decision|1|||
27895989|NCT03379792|81453848|FG004|Overall Study|Physician Decision|0|||
27895990|NCT03379792|81453849|FG005|Overall Study|Physician Decision|0|||
27895991|NCT03379792|81453844|FG000|Overall Study|Withdrawal by Subject|0|||
27895992|NCT03379792|81453845|FG001|Overall Study|Withdrawal by Subject|0|||
27895993|NCT03379792|81453846|FG002|Overall Study|Withdrawal by Subject|0|||
27895994|NCT03379792|81453847|FG003|Overall Study|Withdrawal by Subject|0|||
27895995|NCT03379792|81453848|FG004|Overall Study|Withdrawal by Subject|1|||
27895996|NCT03379792|81453849|FG005|Overall Study|Withdrawal by Subject|1|||
27895997|NCT02186847|81453850|FG000|Overall Study|Protocol Violation|3|||
27895998|NCT02186847|81453851|FG001|Overall Study|Protocol Violation|0|||
27895999|NCT01841567|81453852|FG000|Overall Study|Adverse Event|3|||
27896000|NCT01430624|81453857|FG000|Overall Study|Lost to Follow-up|23|||
27896001|NCT01430624|81453858|FG001|Overall Study|Lost to Follow-up|29|||
27896002|NCT01430624|81453859|FG002|Overall Study|Lost to Follow-up|27|||
27896003|NCT01430624|81453857|FG000|Overall Study|technical or eligibility|5|||
27896004|NCT01430624|81453858|FG001|Overall Study|technical or eligibility|5|||
27896005|NCT01430624|81453859|FG002|Overall Study|technical or eligibility|2|||
27505923|NCT00744497|80044218|FG001|Overall Study|Withdrawal by Subject|18|||
27896006|NCT01397786|81453860|FG000|Phase A|Lost to Follow-up|0|||
27896007|NCT01397786|81453861|FG001|Phase A|Lost to Follow-up|0|||
27896008|NCT01397786|81453862|FG002|Phase A|Lost to Follow-up|6|||
27896009|NCT01397786|81453860|FG000|Phase A|Adverse Event|0|||
27896010|NCT01397786|81453861|FG001|Phase A|Adverse Event|0|||
27896011|NCT01397786|81453862|FG002|Phase A|Adverse Event|8|||
27896012|NCT01397786|81453860|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
27896013|NCT01397786|81453861|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
27896014|NCT01397786|81453862|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
27896015|NCT01397786|81453860|FG000|Phase A|Physician Decision|0|||
27896016|NCT01397786|81453861|FG001|Phase A|Physician Decision|0|||
27505924|NCT00744497|80044217|FG000|Overall Study|Death|11|||
27896017|NCT01397786|81453862|FG002|Phase A|Physician Decision|1|||
27896018|NCT01397786|81453860|FG000|Phase A|Withdrawal by Subject|0|||
27896019|NCT01397786|81453861|FG001|Phase A|Withdrawal by Subject|0|||
27896020|NCT01397786|81453862|FG002|Phase A|Withdrawal by Subject|5|||
27896021|NCT01397786|81453860|FG000|Phase A|Lack of Efficacy|0|||
27896022|NCT01397786|81453861|FG001|Phase A|Lack of Efficacy|0|||
27849153|NCT01674647|81279045|FG001|Treatment Period|Withdrawal by Subject|16|||
27849154|NCT01674647|81279044|FG000|Treatment Period|Switching to other therapy|5|||
27849155|NCT01674647|81279045|FG001|Treatment Period|Switching to other therapy|2|||
27849156|NCT01674647|81279044|FG000|Treatment Period|Logistical difficulties|5|||
27849157|NCT01674647|81279045|FG001|Treatment Period|Logistical difficulties|8|||
27849158|NCT01674647|81279044|FG000|Treatment Period|Treatment failure|0|||
27849159|NCT01674647|81279045|FG001|Treatment Period|Treatment failure|14|||
27849160|NCT01674647|81279044|FG000|Treatment Period|Protocol Violation|56|||
27849161|NCT01674647|81279045|FG001|Treatment Period|Protocol Violation|36|||
27849162|NCT01674647|81279044|FG000|30-day Safety Follow-up Period|Death|3|||
27849163|NCT01674647|81279045|FG001|30-day Safety Follow-up Period|Death|2|||
27849164|NCT01674647|81279044|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
27849165|NCT01674647|81279045|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
27849166|NCT01674647|81279044|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
27849167|NCT01674647|81279045|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
27849168|NCT01674647|81279044|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
27849169|NCT01674647|81279045|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
27849170|NCT01674647|81279044|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
27849171|NCT01674647|81279045|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
27849172|NCT01674647|81279044|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
27849173|NCT01674647|81279045|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
27849174|NCT00614822|81279046|FG000|Overall Study|Adverse Event|3|||
27849175|NCT03078582|81279047|FG000|Overall Study|Adverse Event|0|||
27849176|NCT03078582|81279048|FG001|Overall Study|Adverse Event|8|||
27849177|NCT02692482|81279051|FG000|Overall Study|Death|2|||
27849178|NCT02692482|81279052|FG001|Overall Study|Death|2|||
27849179|NCT02692482|81279051|FG000|Overall Study|Withdrawal by Subject|1|||
27849180|NCT02692482|81279052|FG001|Overall Study|Withdrawal by Subject|2|||
27849181|NCT00107042|81279053|FG000|Overall Study|Lost to Follow-up|9|||
27849182|NCT00107042|81279054|FG001|Overall Study|Lost to Follow-up|7|||
27849183|NCT00107042|81279053|FG000|Overall Study|Withdrawal by Subject|6|||
27849184|NCT00107042|81279054|FG001|Overall Study|Withdrawal by Subject|1|||
27849185|NCT00107042|81279053|FG000|Overall Study|Moved out of area|5|||
27849186|NCT00107042|81279054|FG001|Overall Study|Moved out of area|3|||
27849187|NCT00107042|81279053|FG000|Overall Study|Pregnancy|1|||
27849188|NCT00107042|81279054|FG001|Overall Study|Pregnancy|1|||
27849189|NCT00107042|81279053|FG000|Overall Study|Inadvertent enrollment|0|||
27849190|NCT00107042|81279054|FG001|Overall Study|Inadvertent enrollment|1|||
27849191|NCT00107042|81279053|FG000|Overall Study|vaccinated outside window|1|||
27849192|NCT00107042|81279054|FG001|Overall Study|vaccinated outside window|1|||
27849193|NCT00107042|81279053|FG000|Overall Study|Disallowed medications|0|||
27849194|NCT00107042|81279054|FG001|Overall Study|Disallowed medications|2|||
27849195|NCT03686150|81279055|FG000|Overall Study|Withdrawal by Subject|1|||
27849196|NCT03686150|81279056|FG001|Overall Study|Withdrawal by Subject|1|||
27849197|NCT03686150|81279057|FG002|Overall Study|Withdrawal by Subject|1|||
27849198|NCT03686150|81279058|FG003|Overall Study|Withdrawal by Subject|0|||
27849199|NCT03686150|81279059|FG004|Overall Study|Withdrawal by Subject|1|||
27849200|NCT03686150|81279060|FG005|Overall Study|Withdrawal by Subject|2|||
27849201|NCT03686150|81279055|FG000|Overall Study|Physician Decision|1|||
27849202|NCT03686150|81279056|FG001|Overall Study|Physician Decision|0|||
27849203|NCT03686150|81279057|FG002|Overall Study|Physician Decision|0|||
27849204|NCT03686150|81279058|FG003|Overall Study|Physician Decision|0|||
27849205|NCT03686150|81279059|FG004|Overall Study|Physician Decision|0|||
27849206|NCT03686150|81279060|FG005|Overall Study|Physician Decision|1|||
27849207|NCT03686150|81279055|FG000|Overall Study|Lost to Follow-up|0|||
27849208|NCT03686150|81279056|FG001|Overall Study|Lost to Follow-up|1|||
27849209|NCT03686150|81279057|FG002|Overall Study|Lost to Follow-up|0|||
27849210|NCT03686150|81279058|FG003|Overall Study|Lost to Follow-up|0|||
27849211|NCT03686150|81279059|FG004|Overall Study|Lost to Follow-up|0|||
27849212|NCT03686150|81279060|FG005|Overall Study|Lost to Follow-up|0|||
27849213|NCT01557842|81279061|FG000|Overall Study|Lost to Follow-up|0|||
27849214|NCT01557842|81279062|FG001|Overall Study|Lost to Follow-up|1|||
27849215|NCT01557842|81279061|FG000|Overall Study|Death|1|||
27849216|NCT01557842|81279062|FG001|Overall Study|Death|0|||
27849217|NCT01557842|81279061|FG000|Overall Study|Lack of Efficacy|0|||
27849218|NCT01557842|81279062|FG001|Overall Study|Lack of Efficacy|1|||
27849219|NCT01557842|81279061|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
27849220|NCT01557842|81279062|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
27849221|NCT01557842|81279061|FG000|Overall Study|Study Terminated by Sponsor|3|||
27849222|NCT01557842|81279062|FG001|Overall Study|Study Terminated by Sponsor|4|||
27849223|NCT01557842|81279061|FG000|Overall Study|Not Ablated|2|||
27849224|NCT01557842|81279062|FG001|Overall Study|Not Ablated|0|||
27849225|NCT01846273|81279063|FG000|Overall Study|Adverse Event|9|||
27849226|NCT01846273|81279064|FG001|Overall Study|Adverse Event|7|||
27849227|NCT01846273|81279065|FG002|Overall Study|Adverse Event|0|||
27849228|NCT01846273|81279063|FG000|Overall Study|Subject withdrew consent|5|||
27896023|NCT01397786|81453862|FG002|Phase A|Lack of Efficacy|1|||
27726818|NCT01445535|80830193|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
27726819|NCT01445535|80830190|FG000|Overall Study|Disease progression|1|||
27726820|NCT01445535|80830191|FG001|Overall Study|Disease progression|0|||
27726821|NCT01445535|80830192|FG002|Overall Study|Disease progression|1|||
27726822|NCT01445535|80830193|FG003|Overall Study|Disease progression|0|||
27726823|NCT01445535|80830190|FG000|Overall Study|PI discretion|0|||
27726824|NCT01445535|80830191|FG001|Overall Study|PI discretion|0|||
27726825|NCT01445535|80830192|FG002|Overall Study|PI discretion|0|||
27726826|NCT01445535|80830193|FG003|Overall Study|PI discretion|1|||
27726827|NCT03308188|80830196|FG000|Overall Study|Withdrawal by Subject|0|||
27726828|NCT03308188|80830197|FG001|Overall Study|Withdrawal by Subject|3|||
27726829|NCT03308188|80830196|FG000|Overall Study|Death|0|||
27726830|NCT03308188|80830197|FG001|Overall Study|Death|1|||
27726831|NCT00094757|80830199|FG000|Overall Study|Adverse Event|11|||
27726832|NCT00094757|80830200|FG001|Overall Study|Adverse Event|9|||
27726833|NCT00094757|80830201|FG002|Overall Study|Adverse Event|6|||
27726834|NCT00094757|80830199|FG000|Overall Study|Lack of Efficacy|11|||
27726835|NCT00094757|80830200|FG001|Overall Study|Lack of Efficacy|15|||
27726836|NCT00094757|80830201|FG002|Overall Study|Lack of Efficacy|8|||
27726837|NCT00094757|80830199|FG000|Overall Study|Lost to Follow-up|3|||
27726838|NCT00094757|80830200|FG001|Overall Study|Lost to Follow-up|5|||
27726839|NCT00094757|80830201|FG002|Overall Study|Lost to Follow-up|6|||
27726840|NCT00094757|80830199|FG000|Overall Study|Patient Moved|2|||
27726841|NCT00094757|80830200|FG001|Overall Study|Patient Moved|1|||
27726842|NCT00094757|80830201|FG002|Overall Study|Patient Moved|1|||
27726843|NCT00094757|80830199|FG000|Overall Study|Protocol Violation|8|||
27726844|NCT00094757|80830200|FG001|Overall Study|Protocol Violation|5|||
27726845|NCT00094757|80830201|FG002|Overall Study|Protocol Violation|3|||
27726846|NCT00094757|80830199|FG000|Overall Study|Withdrawal by Subject|14|||
27726847|NCT00094757|80830200|FG001|Overall Study|Withdrawal by Subject|21|||
27726848|NCT00094757|80830201|FG002|Overall Study|Withdrawal by Subject|5|||
27726849|NCT00094757|80830199|FG000|Overall Study|Other|3|||
27614015|NCT01189890|80430115|FG000|Overall Study|Non Compliance|0|||
27614016|NCT01189890|80430116|FG001|Overall Study|Non Compliance|1|||
27726850|NCT00094757|80830200|FG001|Overall Study|Other|3|||
27726851|NCT00094757|80830201|FG002|Overall Study|Other|1|||
27726852|NCT00094757|80830199|FG000|Overall Study|Protocol specified discontinuation|1|||
27726853|NCT00094757|80830200|FG001|Overall Study|Protocol specified discontinuation|3|||
27726854|NCT00094757|80830201|FG002|Overall Study|Protocol specified discontinuation|0|||
27726855|NCT01773421|80830202|FG000|Treatment Phase|Other|0|||
27849229|NCT01846273|81279064|FG001|Overall Study|Subject withdrew consent|8|||
27849230|NCT01846273|81279065|FG002|Overall Study|Subject withdrew consent|0|||
27849231|NCT01846273|81279063|FG000|Overall Study|Lost to Follow-up|2|||
27849232|NCT01846273|81279064|FG001|Overall Study|Lost to Follow-up|1|||
27726856|NCT01773421|80830203|FG001|Treatment Phase|Other|0|||
27726857|NCT01773421|80830204|FG002|Treatment Phase|Other|2|||
27726858|NCT01773421|80830205|FG003|Treatment Phase|Other|0|||
27726859|NCT01773421|80830206|FG004|Treatment Phase|Other|0|||
27726860|NCT01773421|80830207|FG005|Treatment Phase|Other|0|||
27726861|NCT01773421|80830208|FG006|Treatment Phase|Other|0|||
27726862|NCT01773421|80830202|FG000|Treatment Phase|Adverse Event|0|||
27726863|NCT01773421|80830203|FG001|Treatment Phase|Adverse Event|0|||
27849233|NCT01846273|81279065|FG002|Overall Study|Lost to Follow-up|0|||
27849234|NCT01846273|81279063|FG000|Overall Study|Administrative problems|1|||
27849235|NCT01846273|81279064|FG001|Overall Study|Administrative problems|0|||
27849236|NCT01846273|81279065|FG002|Overall Study|Administrative problems|0|||
27849237|NCT01846273|81279063|FG000|Overall Study|Death|2|||
27849238|NCT01846273|81279064|FG001|Overall Study|Death|1|||
27849239|NCT01846273|81279065|FG002|Overall Study|Death|0|||
27849240|NCT01846273|81279063|FG000|Overall Study|Disease Progression|0|||
27849241|NCT01846273|81279064|FG001|Overall Study|Disease Progression|4|||
27849242|NCT01846273|81279065|FG002|Overall Study|Disease Progression|0|||
27849243|NCT01846273|81279063|FG000|Overall Study|Protocol Deviation|2|||
27849244|NCT01846273|81279064|FG001|Overall Study|Protocol Deviation|3|||
27849245|NCT01846273|81279065|FG002|Overall Study|Protocol Deviation|0|||
27849246|NCT01846273|81279063|FG000|Overall Study|Physician Decision|1|||
27849247|NCT01846273|81279064|FG001|Overall Study|Physician Decision|2|||
27849248|NCT01846273|81279065|FG002|Overall Study|Physician Decision|0|||
27849249|NCT03463993|81279066|FG000|Overall Study|Lost to Follow-up|7|||
27849250|NCT03463993|81279067|FG001|Overall Study|Lost to Follow-up|8|||
27849251|NCT03463993|81279066|FG000|Overall Study|Withdrawal by Subject|2|||
27849252|NCT03463993|81279067|FG001|Overall Study|Withdrawal by Subject|0|||
27849253|NCT03463993|81279066|FG000|Overall Study|Protocol Violation|4|||
27849254|NCT03463993|81279067|FG001|Overall Study|Protocol Violation|1|||
27849255|NCT03463993|81279066|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
27849256|NCT03463993|81279067|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
27849257|NCT03463993|81279066|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
27849258|NCT03463993|81279067|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
27896024|NCT01397786|81453860|FG000|Phase B|Lost to Follow-up|22|||
27505925|NCT00744497|80044218|FG001|Overall Study|Death|9|||
27505926|NCT00744497|80044217|FG000|Overall Study|Lost to Follow-up|4|||
27505927|NCT00744497|80044218|FG001|Overall Study|Lost to Follow-up|2|||
27505928|NCT00744497|80044217|FG000|Overall Study|Poor compliance/noncompliance|9|||
27505929|NCT00744497|80044218|FG001|Overall Study|Poor compliance/noncompliance|5|||
27726864|NCT01773421|80830204|FG002|Treatment Phase|Adverse Event|3|||
27726865|NCT01773421|80830205|FG003|Treatment Phase|Adverse Event|1|||
27726866|NCT01773421|80830206|FG004|Treatment Phase|Adverse Event|0|||
27726867|NCT01773421|80830207|FG005|Treatment Phase|Adverse Event|0|||
27726868|NCT01773421|80830208|FG006|Treatment Phase|Adverse Event|0|||
27726869|NCT01773421|80830202|FG000|Treatment Phase|Withdrawal by Subject|0|||
27726870|NCT01773421|80830203|FG001|Treatment Phase|Withdrawal by Subject|0|||
27849259|NCT01202877|81279068|FG000|Overall Study|Disease Progression|0|||
27849260|NCT01202877|81279069|FG001|Overall Study|Disease Progression|1|||
27849261|NCT01202877|81279070|FG002|Overall Study|Disease Progression|2|||
27849262|NCT01202877|81279068|FG000|Overall Study|Adverse Event|0|||
27849263|NCT01202877|81279069|FG001|Overall Study|Adverse Event|0|||
27849264|NCT01202877|81279070|FG002|Overall Study|Adverse Event|2|||
27849265|NCT01202877|81279068|FG000|Overall Study|Withdrawal by Subject|0|||
27849266|NCT01202877|81279069|FG001|Overall Study|Withdrawal by Subject|0|||
27849267|NCT01202877|81279070|FG002|Overall Study|Withdrawal by Subject|1|||
27849268|NCT01202877|81279068|FG000|Overall Study|Death|0|||
27849269|NCT01202877|81279069|FG001|Overall Study|Death|0|||
27849270|NCT01202877|81279070|FG002|Overall Study|Death|1|||
27849271|NCT00788593|81279073|FG000|Placebo Run-in Phase|Adverse Event|2|||
27849272|NCT00788593|81279074|FG001|Placebo Run-in Phase|Adverse Event|0|||
27849273|NCT00788593|81279075|FG002|Placebo Run-in Phase|Adverse Event|0|||
27849274|NCT00788593|81279073|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
27849275|NCT00788593|81279074|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
27849276|NCT00788593|81279075|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
27849277|NCT00788593|81279073|FG000|Placebo Run-in Phase|Protocol Violation|2|||
27849278|NCT00788593|81279074|FG001|Placebo Run-in Phase|Protocol Violation|0|||
27849279|NCT00788593|81279075|FG002|Placebo Run-in Phase|Protocol Violation|0|||
27849280|NCT00788593|81279073|FG000|First Intervention Period|Adverse Event|0|||
27849281|NCT00788593|81279074|FG001|First Intervention Period|Adverse Event|1|||
27849282|NCT00788593|81279075|FG002|First Intervention Period|Adverse Event|0|||
27849283|NCT00788593|81279073|FG000|Second Intervention Period|Lost to Follow-up|0|||
27849284|NCT00788593|81279074|FG001|Second Intervention Period|Lost to Follow-up|1|||
27849285|NCT00788593|81279075|FG002|Second Intervention Period|Lost to Follow-up|0|||
27849286|NCT00788593|81279073|FG000|Second Intervention Period|Other|0|||
27849287|NCT00788593|81279074|FG001|Second Intervention Period|Other|0|||
27849288|NCT00788593|81279075|FG002|Second Intervention Period|Other|1|||
27849289|NCT00952276|81279080|FG000|Overall Study|Withdrawal by Subject|1|||
27849290|NCT00952276|81279081|FG001|Overall Study|Withdrawal by Subject|0|||
27849291|NCT00952276|81279082|FG002|Overall Study|Withdrawal by Subject|0|||
27849292|NCT00952276|81279083|FG003|Overall Study|Withdrawal by Subject|1|||
27849293|NCT00952276|81279084|FG004|Overall Study|Withdrawal by Subject|0|||
27849294|NCT02701413|81279087|FG000|Overall Study|Withdrawal by Subject|7|||
27849295|NCT02701413|81279088|FG001|Overall Study|Withdrawal by Subject|11|||
27849296|NCT02972502|81279091|FG000|Overall Study|Lost to Follow-up|3|||
27849297|NCT02972502|81279092|FG001|Overall Study|Lost to Follow-up|1|||
27849298|NCT02972502|81279091|FG000|Overall Study|Withdrawal by Subject|1|||
27849299|NCT02972502|81279092|FG001|Overall Study|Withdrawal by Subject|1|||
27849300|NCT00693225|81279093|FG000|Overall Study|Lost to Follow-up|1|||
27849301|NCT00693225|81279094|FG001|Overall Study|Lost to Follow-up|2|||
27849302|NCT00693225|81279093|FG000|Overall Study|Adverse Event|1|||
27849303|NCT00693225|81279094|FG001|Overall Study|Adverse Event|3|||
27849304|NCT03604341|81279097|FG000|Overall Study|Withdrawal by Subject|1|||
27849305|NCT03604341|81279098|FG001|Overall Study|Withdrawal by Subject|1|||
27849306|NCT03604341|81279097|FG000|Overall Study|Adverse Event|1|||
27849307|NCT03604341|81279098|FG001|Overall Study|Adverse Event|0|||
27849308|NCT03604341|81279097|FG000|Overall Study|Protocol Violation|0|||
27849309|NCT03604341|81279098|FG001|Overall Study|Protocol Violation|1|||
27896025|NCT01397786|81453861|FG001|Phase B|Lost to Follow-up|12|||
27849310|NCT03276780|81279099|FG000|Overall Study|Withdrawal by Subject|5|||
27849311|NCT03276780|81279100|FG001|Overall Study|Withdrawal by Subject|3|||
27849312|NCT03276780|81279099|FG000|Overall Study|Lost to Follow-up|3|||
27849313|NCT03276780|81279100|FG001|Overall Study|Lost to Follow-up|5|||
27849314|NCT03276780|81279099|FG000|Overall Study|Moved out of state|1|||
27849315|NCT03276780|81279100|FG001|Overall Study|Moved out of state|1|||
27849316|NCT03276780|81279099|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
27849317|NCT03276780|81279100|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
27849318|NCT03276780|81279099|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
27505930|NCT00744497|80044217|FG000|Overall Study|No longer meets study criteria|7|||
27505931|NCT00744497|80044218|FG001|Overall Study|No longer meets study criteria|3|||
27896026|NCT01397786|81453862|FG002|Phase B|Lost to Follow-up|22|||
27896027|NCT01397786|81453860|FG000|Phase B|Adverse Event|109|||
27896028|NCT01397786|81453861|FG001|Phase B|Adverse Event|23|||
27896029|NCT01397786|81453862|FG002|Phase B|Adverse Event|27|||
27896030|NCT01397786|81453860|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
27896031|NCT01397786|81453861|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
27896032|NCT01397786|81453862|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
27896033|NCT01397786|81453860|FG000|Phase B|Physician Decision|9|||
27896034|NCT01397786|81453861|FG001|Phase B|Physician Decision|1|||
27896035|NCT01397786|81453862|FG002|Phase B|Physician Decision|3|||
27896036|NCT01397786|81453860|FG000|Phase B|Withdrawal by Subject|102|||
27896037|NCT01397786|81453861|FG001|Phase B|Withdrawal by Subject|45|||
27896038|NCT01397786|81453862|FG002|Phase B|Withdrawal by Subject|30|||
27896039|NCT01397786|81453860|FG000|Phase B|Protocol Deviation|1|||
27896040|NCT01397786|81453861|FG001|Phase B|Protocol Deviation|2|||
27896041|NCT01397786|81453862|FG002|Phase B|Protocol Deviation|4|||
27896042|NCT01397786|81453860|FG000|Phase B|Lack of Efficacy|22|||
27896043|NCT01397786|81453861|FG001|Phase B|Lack of Efficacy|7|||
27896044|NCT01397786|81453862|FG002|Phase B|Lack of Efficacy|14|||
27896045|NCT00329641|81453863|FG000|Overall Study|Did not start treatment|1|||
27896046|NCT00329641|81453863|FG000|Overall Study|Not eligible|1|||
27896047|NCT00329641|81453863|FG000|Overall Study|Adverse Event|3|||
27896048|NCT00329641|81453863|FG000|Overall Study|Other reason, not protocol specified|1|||
27896049|NCT02607280|81453864|FG000|Overall Study|Adverse Event|4|||
27896050|NCT02607280|81453865|FG001|Overall Study|Adverse Event|0|||
27896051|NCT02607280|81453864|FG000|Overall Study|Decrease in CrCl <15|0|||
27896052|NCT02607280|81453865|FG001|Overall Study|Decrease in CrCl <15|1|||
27726871|NCT01773421|80830204|FG002|Treatment Phase|Withdrawal by Subject|1|||
27726872|NCT01773421|80830205|FG003|Treatment Phase|Withdrawal by Subject|1|||
27896053|NCT00334802|81453866|FG000|Overall Study|Progressive Disease|2|||
27896054|NCT00334802|81453867|FG001|Overall Study|Progressive Disease|24|||
27896055|NCT00334802|81453866|FG000|Overall Study|Toxicity|1|||
27896056|NCT00334802|81453867|FG001|Overall Study|Toxicity|5|||
27896057|NCT00334802|81453866|FG000|Overall Study|Lack of Efficacy|1|||
27896058|NCT00334802|81453867|FG001|Overall Study|Lack of Efficacy|3|||
27896059|NCT00334802|81453866|FG000|Overall Study|Patient Condition Aggrevated|1|||
27896060|NCT00334802|81453867|FG001|Overall Study|Patient Condition Aggrevated|0|||
27896061|NCT00334802|81453866|FG000|Overall Study|Physician Decision|1|||
27896062|NCT00334802|81453867|FG001|Overall Study|Physician Decision|0|||
27896063|NCT00334802|81453866|FG000|Overall Study|Withdrawal by Subject|0|||
27896064|NCT00334802|81453867|FG001|Overall Study|Withdrawal by Subject|4|||
27896065|NCT00334802|81453866|FG000|Overall Study|Adverse Event|0|||
27896066|NCT00334802|81453867|FG001|Overall Study|Adverse Event|3|||
27505932|NCT00744497|80044217|FG000|Overall Study|Administrative Reason By Sponsor|25|||
27726873|NCT01773421|80830206|FG004|Treatment Phase|Withdrawal by Subject|0|||
27726874|NCT01773421|80830207|FG005|Treatment Phase|Withdrawal by Subject|0|||
27726875|NCT01773421|80830208|FG006|Treatment Phase|Withdrawal by Subject|0|||
27726876|NCT01773421|80830202|FG000|Extension Phase|Other|0|||
27726877|NCT01773421|80830203|FG001|Extension Phase|Other|0|||
27726878|NCT01773421|80830204|FG002|Extension Phase|Other|0|||
27726879|NCT01773421|80830205|FG003|Extension Phase|Other|0|||
27726880|NCT01773421|80830206|FG004|Extension Phase|Other|1|||
27849319|NCT03276780|81279100|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
27849320|NCT02333487|81279103|FG000|Overall Study|Adverse Event|0|||
27849321|NCT02333487|81279104|FG001|Overall Study|Adverse Event|2|||
27849322|NCT02333487|81279105|FG002|Overall Study|Adverse Event|0|||
27849323|NCT02549573|81279106|FG000|Overall Study|Withdrawal by Subject|0|||
27849324|NCT02549573|81279107|FG001|Overall Study|Withdrawal by Subject|2|||
27849325|NCT02549573|81279106|FG000|Overall Study|Protocol Violation|0|||
27849326|NCT02549573|81279107|FG001|Overall Study|Protocol Violation|1|||
27849327|NCT02224573|81279108|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
27849328|NCT02224573|81279109|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
27849329|NCT02224573|81279108|FG000|Treatment Phase|Started on Other IMP|1|||
27849330|NCT02224573|81279109|FG001|Treatment Phase|Started on Other IMP|0|||
27849331|NCT02224573|81279108|FG000|Treatment Phase|Participant Discontinued IMP|0|||
27849332|NCT02224573|81279109|FG001|Treatment Phase|Participant Discontinued IMP|1|||
27849333|NCT02224573|81279108|FG000|Treatment Phase|Lack of Efficacy|15|||
27849334|NCT02224573|81279109|FG001|Treatment Phase|Lack of Efficacy|8|||
27849335|NCT02224573|81279108|FG000|Treatment Phase|Began Commercial Product|1|||
27849336|NCT02224573|81279109|FG001|Treatment Phase|Began Commercial Product|0|||
27849337|NCT02224573|81279108|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
27896067|NCT00334802|81453866|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
27896068|NCT00334802|81453867|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
27726881|NCT01773421|80830207|FG005|Extension Phase|Other|2|||
27896069|NCT01793688|81453868|FG000|Overall Study|Protocol Violation|2|||
27896070|NCT00894790|81453869|FG000|Overall Study|Protocol Violation|0|||
27896071|NCT00894790|81453870|FG001|Overall Study|Protocol Violation|1|||
27896072|NCT00894790|81453869|FG000|Overall Study|Lost to Follow-up|0|||
27896073|NCT00894790|81453870|FG001|Overall Study|Lost to Follow-up|1|||
27896074|NCT00894790|81453869|FG000|Overall Study|Did not meet entrance criteria|1|||
27896075|NCT00894790|81453870|FG001|Overall Study|Did not meet entrance criteria|0|||
27896076|NCT00766467|81453874|FG000|Overall Study|Withdrawal by Subject|7|||
27896077|NCT00766467|81453875|FG001|Overall Study|Withdrawal by Subject|2|||
27896078|NCT00766467|81453874|FG000|Overall Study|Adverse Event|1|||
27896079|NCT00766467|81453875|FG001|Overall Study|Adverse Event|1|||
27896080|NCT00766467|81453874|FG000|Overall Study|Protocol Violation|2|||
27896081|NCT00766467|81453875|FG001|Overall Study|Protocol Violation|4|||
27896082|NCT00766467|81453874|FG000|Overall Study|Tumor Progression on Study|0|||
27896083|NCT00766467|81453875|FG001|Overall Study|Tumor Progression on Study|1|||
27896084|NCT00766467|81453874|FG000|Overall Study|Physician Decision|1|||
27614017|NCT01189890|80430115|FG000|Overall Study|Physician Decision|5|||
27614018|NCT01189890|80430116|FG001|Overall Study|Physician Decision|4|||
27614019|NCT01189890|80430115|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
27614020|NCT01189890|80430116|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
27614021|NCT02374593|80430117|FG000|Overall Study|non-compliant|2|||
27614022|NCT02374593|80430118|FG001|Overall Study|non-compliant|0|||
27614023|NCT00453102|80430119|FG000|Overall Study|Withdrawal by Subject|2|||
27614024|NCT00154063|80430121|FG000|Overall Study|Adverse Event|4|||
27614025|NCT00154063|80430122|FG001|Overall Study|Adverse Event|8|||
27896085|NCT00766467|81453875|FG001|Overall Study|Physician Decision|0|||
27896086|NCT02035748|81453877|FG000|Overall Study|Adverse Event|5|||
27896087|NCT02035748|81453877|FG000|Overall Study|Death|3|||
27896088|NCT02035748|81453877|FG000|Overall Study|Lost to Follow-up|2|||
27896089|NCT02035748|81453877|FG000|Overall Study|Physician Decision|3|||
27896090|NCT02035748|81453877|FG000|Overall Study|Withdrawal by Subject|6|||
27896091|NCT02035748|81453877|FG000|Overall Study|Progressive Disease|1|||
27896092|NCT00793546|81453878|FG000|Overall Study|Death|3|||
27896093|NCT00793546|81453879|FG001|Overall Study|Death|0|||
27896094|NCT00793546|81453878|FG000|Overall Study|Lost to Follow-up|1|||
27896095|NCT00793546|81453879|FG001|Overall Study|Lost to Follow-up|0|||
27896096|NCT00793546|81453878|FG000|Overall Study|Withdrawal by Subject|1|||
27896097|NCT00793546|81453879|FG001|Overall Study|Withdrawal by Subject|1|||
27896098|NCT00793546|81453878|FG000|Overall Study|Study Terminated by Sponsor|8|||
27896099|NCT00793546|81453879|FG001|Overall Study|Study Terminated by Sponsor|27|||
27896100|NCT00793546|81453878|FG000|Overall Study|Other|1|||
27896101|NCT00793546|81453879|FG001|Overall Study|Other|0|||
27896102|NCT01549041|81453884|FG000|Overall Study|Lack of Efficacy|2|||
27896103|NCT01549041|81453885|FG001|Overall Study|Lack of Efficacy|4|||
27896104|NCT01549041|81453884|FG000|Overall Study|Adverse Event|0|||
27896105|NCT01549041|81453885|FG001|Overall Study|Adverse Event|4|||
27896106|NCT02515994|81453888|FG000|Overall Study|Protocol Violation|3|||
27896107|NCT02515994|81453889|FG001|Overall Study|Protocol Violation|5|||
27896108|NCT02515994|81453888|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
27896109|NCT02515994|81453889|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
27896110|NCT02515994|81453888|FG000|Overall Study|Adverse Event|3|||
27896111|NCT02515994|81453889|FG001|Overall Study|Adverse Event|1|||
27896112|NCT02515994|81453888|FG000|Overall Study|Withdrawal by Subject|2|||
27896113|NCT02515994|81453889|FG001|Overall Study|Withdrawal by Subject|0|||
27896114|NCT02134353|81453890|FG000|Overall Study|Adverse Event|10|||
27896115|NCT02134353|81453891|FG001|Overall Study|Adverse Event|6|||
27896116|NCT02134353|81453890|FG000|Overall Study|Lost to Follow-up|1|||
27896117|NCT02134353|81453891|FG001|Overall Study|Lost to Follow-up|1|||
27896118|NCT02134353|81453890|FG000|Overall Study|Lack of Efficacy|2|||
27896119|NCT02134353|81453891|FG001|Overall Study|Lack of Efficacy|1|||
27896120|NCT02134353|81453890|FG000|Overall Study|Withdrawal by Subject|12|||
27896121|NCT02134353|81453891|FG001|Overall Study|Withdrawal by Subject|13|||
27614026|NCT00154063|80430121|FG000|Overall Study|Protocol Violation|1|||
27614027|NCT00154063|80430122|FG001|Overall Study|Protocol Violation|1|||
27849338|NCT02224573|81279109|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
27849339|NCT02224573|81279108|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
27849340|NCT02224573|81279109|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
27849341|NCT02224573|81279108|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
27849342|NCT02224573|81279109|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
27849343|NCT02224573|81279108|FG000|Treatment Phase|Continued Compassionate Use|1|||
27849344|NCT02224573|81279109|FG001|Treatment Phase|Continued Compassionate Use|0|||
27849345|NCT02224573|81279108|FG000|Treatment Phase|Lack of Efficiency|2|||
27896122|NCT02134353|81453890|FG000|Overall Study|Death|0|||
27614028|NCT00154063|80430121|FG000|Overall Study|Investigator or Sponsor Request|0|||
27614029|NCT00154063|80430122|FG001|Overall Study|Investigator or Sponsor Request|1|||
27614030|NCT00154063|80430121|FG000|Overall Study|Withdrawal by Subject|4|||
27896123|NCT02134353|81453891|FG001|Overall Study|Death|1|||
27896124|NCT02134353|81453890|FG000|Overall Study|Pregnancy|0|||
27896125|NCT02134353|81453891|FG001|Overall Study|Pregnancy|1|||
27896126|NCT02134353|81453890|FG000|Overall Study|Relocation|1|||
27896127|NCT02134353|81453891|FG001|Overall Study|Relocation|0|||
27896128|NCT02134353|81453890|FG000|Overall Study|Other - Patient's Choice|0|||
27896129|NCT02134353|81453891|FG001|Overall Study|Other - Patient's Choice|1|||
27896130|NCT00723190|81453892|FG000|Overall Study|Withdrawal by Subject|45|||
27896131|NCT00723190|81453892|FG000|Overall Study|Lost to Follow-up|37|||
27896132|NCT00723190|81453892|FG000|Overall Study|Adverse Event|18|||
27896133|NCT00723190|81453892|FG000|Overall Study|Lack of Efficacy|16|||
27896134|NCT00723190|81453892|FG000|Overall Study|Protocol Violation|15|||
27896135|NCT00723190|81453892|FG000|Overall Study|Other-Premature Discontinuation|9|||
27896136|NCT00723190|81453892|FG000|Overall Study|Other-Not included in safety population|2|||
27896137|NCT00769067|81453893|FG000|Overall Study|Death|89|||
27896138|NCT00769067|81453894|FG001|Overall Study|Death|86|||
27896139|NCT00769067|81453893|FG000|Overall Study|Lost to Follow-up|3|||
27896140|NCT00769067|81453894|FG001|Overall Study|Lost to Follow-up|1|||
27896141|NCT00769067|81453893|FG000|Overall Study|Study terminated by sponsor|1|||
27896142|NCT00769067|81453894|FG001|Overall Study|Study terminated by sponsor|3|||
27896143|NCT00769067|81453893|FG000|Overall Study|Other|1|||
27896144|NCT00769067|81453894|FG001|Overall Study|Other|3|||
27896145|NCT00769067|81453893|FG000|Overall Study|Withdrawal by Subject|0|||
27896146|NCT00769067|81453894|FG001|Overall Study|Withdrawal by Subject|1|||
27896147|NCT01877382|81453895|FG000|Dose Escalation|Progressive disease|2|||
27896148|NCT01877382|81453896|FG001|Dose Escalation|Progressive disease|0|||
27896149|NCT01877382|81453897|FG002|Dose Escalation|Progressive disease|1|||
27896150|NCT01877382|81453898|FG003|Dose Escalation|Progressive disease|6|||
27896151|NCT01877382|81453899|FG004|Dose Escalation|Progressive disease|1|||
27896152|NCT01877382|81453900|FG005|Dose Escalation|Progressive disease|0|||
27896153|NCT01877382|81453901|FG006|Dose Escalation|Progressive disease|3|||
27896154|NCT01877382|81453902|FG007|Dose Escalation|Progressive disease|10|||
27896155|NCT01877382|81453903|FG008|Dose Escalation|Progressive disease|4|||
27896156|NCT01877382|81453904|FG009|Dose Escalation|Progressive disease|2|||
27896157|NCT01877382|81453905|FG010|Dose Escalation|Progressive disease|3|||
27896158|NCT01877382|81453906|FG011|Dose Escalation|Progressive disease|3|||
27896159|NCT01877382|81453907|FG012|Dose Escalation|Progressive disease|13|||
27896160|NCT01877382|81453908|FG013|Dose Escalation|Progressive disease|1|||
27896161|NCT01877382|81453909|FG014|Dose Escalation|Progressive disease|0|||
27896162|NCT01877382|81453895|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
27896163|NCT01877382|81453896|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896164|NCT01877382|81453897|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896165|NCT01877382|81453898|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
27896166|NCT01877382|81453899|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896167|NCT01877382|81453900|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896168|NCT01877382|81453901|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
27896169|NCT01877382|81453902|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896170|NCT01877382|81453903|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896171|NCT01877382|81453904|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896172|NCT01877382|81453905|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896173|NCT01877382|81453906|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896174|NCT01877382|81453907|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896175|NCT01877382|81453908|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896176|NCT01877382|81453909|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896177|NCT01877382|81453895|FG000|Dose Escalation|Clinical progression|0|||
27896178|NCT01877382|81453896|FG001|Dose Escalation|Clinical progression|1|||
27896179|NCT01877382|81453897|FG002|Dose Escalation|Clinical progression|0|||
27896180|NCT01877382|81453898|FG003|Dose Escalation|Clinical progression|2|||
27896181|NCT01877382|81453899|FG004|Dose Escalation|Clinical progression|0|||
27896182|NCT01877382|81453900|FG005|Dose Escalation|Clinical progression|0|||
27896183|NCT01877382|81453901|FG006|Dose Escalation|Clinical progression|1|||
27896184|NCT01877382|81453902|FG007|Dose Escalation|Clinical progression|0|||
27896185|NCT01877382|81453903|FG008|Dose Escalation|Clinical progression|0|||
27896186|NCT01877382|81453904|FG009|Dose Escalation|Clinical progression|1|||
27896187|NCT01877382|81453905|FG010|Dose Escalation|Clinical progression|0|||
27896188|NCT01877382|81453906|FG011|Dose Escalation|Clinical progression|0|||
27896189|NCT01877382|81453907|FG012|Dose Escalation|Clinical progression|2|||
27896190|NCT01877382|81453908|FG013|Dose Escalation|Clinical progression|1|||
27896191|NCT01877382|81453909|FG014|Dose Escalation|Clinical progression|0|||
27896192|NCT01877382|81453895|FG000|Dose Escalation|Adverse Event|0|||
27896193|NCT01877382|81453896|FG001|Dose Escalation|Adverse Event|0|||
27896194|NCT01877382|81453897|FG002|Dose Escalation|Adverse Event|0|||
27896195|NCT01877382|81453898|FG003|Dose Escalation|Adverse Event|4|||
27896196|NCT01877382|81453899|FG004|Dose Escalation|Adverse Event|1|||
27896197|NCT01877382|81453900|FG005|Dose Escalation|Adverse Event|2|||
27896198|NCT01877382|81453901|FG006|Dose Escalation|Adverse Event|1|||
27896199|NCT01877382|81453902|FG007|Dose Escalation|Adverse Event|2|||
27896200|NCT01877382|81453903|FG008|Dose Escalation|Adverse Event|0|||
27896201|NCT01877382|81453904|FG009|Dose Escalation|Adverse Event|0|||
27896202|NCT01877382|81453905|FG010|Dose Escalation|Adverse Event|0|||
27896203|NCT01877382|81453906|FG011|Dose Escalation|Adverse Event|0|||
27896204|NCT01877382|81453907|FG012|Dose Escalation|Adverse Event|1|||
27896205|NCT01877382|81453908|FG013|Dose Escalation|Adverse Event|0|||
27896206|NCT01877382|81453909|FG014|Dose Escalation|Adverse Event|0|||
27896207|NCT01877382|81453895|FG000|Dose Escalation|Withdrawal by Subject|0|||
27896208|NCT01877382|81453896|FG001|Dose Escalation|Withdrawal by Subject|0|||
27896209|NCT01877382|81453897|FG002|Dose Escalation|Withdrawal by Subject|0|||
27896210|NCT01877382|81453898|FG003|Dose Escalation|Withdrawal by Subject|0|||
27896211|NCT01877382|81453899|FG004|Dose Escalation|Withdrawal by Subject|0|||
27896212|NCT01877382|81453900|FG005|Dose Escalation|Withdrawal by Subject|3|||
27896213|NCT01877382|81453901|FG006|Dose Escalation|Withdrawal by Subject|2|||
27896214|NCT01877382|81453902|FG007|Dose Escalation|Withdrawal by Subject|1|||
27896215|NCT01877382|81453903|FG008|Dose Escalation|Withdrawal by Subject|1|||
27896216|NCT01877382|81453904|FG009|Dose Escalation|Withdrawal by Subject|0|||
27896217|NCT01877382|81453905|FG010|Dose Escalation|Withdrawal by Subject|0|||
27896218|NCT01877382|81453906|FG011|Dose Escalation|Withdrawal by Subject|0|||
27896219|NCT01877382|81453907|FG012|Dose Escalation|Withdrawal by Subject|0|||
27896220|NCT01877382|81453908|FG013|Dose Escalation|Withdrawal by Subject|0|||
27896221|NCT01877382|81453909|FG014|Dose Escalation|Withdrawal by Subject|0|||
27896222|NCT01877382|81453895|FG000|Dose Escalation|Protocol Violation|0|||
27896223|NCT01877382|81453896|FG001|Dose Escalation|Protocol Violation|0|||
27896224|NCT01877382|81453897|FG002|Dose Escalation|Protocol Violation|0|||
27896225|NCT01877382|81453898|FG003|Dose Escalation|Protocol Violation|0|||
27896226|NCT01877382|81453899|FG004|Dose Escalation|Protocol Violation|0|||
27896227|NCT01877382|81453900|FG005|Dose Escalation|Protocol Violation|0|||
27896228|NCT01877382|81453901|FG006|Dose Escalation|Protocol Violation|1|||
27896229|NCT01877382|81453902|FG007|Dose Escalation|Protocol Violation|0|||
27896230|NCT01877382|81453903|FG008|Dose Escalation|Protocol Violation|0|||
27896231|NCT01877382|81453904|FG009|Dose Escalation|Protocol Violation|0|||
27896232|NCT01877382|81453905|FG010|Dose Escalation|Protocol Violation|0|||
27896233|NCT01877382|81453906|FG011|Dose Escalation|Protocol Violation|0|||
27896234|NCT01877382|81453907|FG012|Dose Escalation|Protocol Violation|0|||
27896235|NCT01877382|81453908|FG013|Dose Escalation|Protocol Violation|0|||
27896236|NCT01877382|81453909|FG014|Dose Escalation|Protocol Violation|0|||
27896237|NCT01877382|81453895|FG000|Dose Escalation|Study terminated by sponsor|0|||
27896238|NCT01877382|81453896|FG001|Dose Escalation|Study terminated by sponsor|0|||
27896239|NCT01877382|81453897|FG002|Dose Escalation|Study terminated by sponsor|0|||
27896240|NCT01877382|81453898|FG003|Dose Escalation|Study terminated by sponsor|0|||
27896241|NCT01877382|81453899|FG004|Dose Escalation|Study terminated by sponsor|0|||
27896242|NCT01877382|81453900|FG005|Dose Escalation|Study terminated by sponsor|0|||
27896243|NCT01877382|81453901|FG006|Dose Escalation|Study terminated by sponsor|0|||
27896244|NCT01877382|81453902|FG007|Dose Escalation|Study terminated by sponsor|1|||
27896245|NCT01877382|81453903|FG008|Dose Escalation|Study terminated by sponsor|1|||
27896246|NCT01877382|81453904|FG009|Dose Escalation|Study terminated by sponsor|0|||
27896247|NCT01877382|81453905|FG010|Dose Escalation|Study terminated by sponsor|0|||
27896248|NCT01877382|81453906|FG011|Dose Escalation|Study terminated by sponsor|0|||
27896249|NCT01877382|81453907|FG012|Dose Escalation|Study terminated by sponsor|3|||
27896250|NCT01877382|81453908|FG013|Dose Escalation|Study terminated by sponsor|0|||
27896251|NCT01877382|81453909|FG014|Dose Escalation|Study terminated by sponsor|0|||
27896252|NCT01877382|81453895|FG000|Dose Escalation|Death|0|||
27896253|NCT01877382|81453896|FG001|Dose Escalation|Death|0|||
27896254|NCT01877382|81453897|FG002|Dose Escalation|Death|0|||
27896255|NCT01877382|81453898|FG003|Dose Escalation|Death|0|||
27896256|NCT01877382|81453899|FG004|Dose Escalation|Death|0|||
27896257|NCT01877382|81453900|FG005|Dose Escalation|Death|0|||
27896258|NCT01877382|81453901|FG006|Dose Escalation|Death|0|||
27896259|NCT01877382|81453902|FG007|Dose Escalation|Death|1|||
27896260|NCT01877382|81453903|FG008|Dose Escalation|Death|0|||
27896261|NCT01877382|81453904|FG009|Dose Escalation|Death|0|||
27896262|NCT01877382|81453905|FG010|Dose Escalation|Death|0|||
27896263|NCT01877382|81453906|FG011|Dose Escalation|Death|0|||
27505933|NCT00744497|80044218|FG001|Overall Study|Administrative Reason By Sponsor|8|||
27896264|NCT01877382|81453907|FG012|Dose Escalation|Death|1|||
27896265|NCT01877382|81453908|FG013|Dose Escalation|Death|1|||
27896266|NCT01877382|81453909|FG014|Dose Escalation|Death|0|||
27896267|NCT01877382|81453895|FG000|Dose Expansion|Progressive disease|0|||
27896268|NCT01877382|81453896|FG001|Dose Expansion|Progressive disease|0|||
27505934|NCT00744497|80044217|FG000|Overall Study|Disease progression|312|||
27896269|NCT01877382|81453897|FG002|Dose Expansion|Progressive disease|0|||
27896270|NCT01877382|81453898|FG003|Dose Expansion|Progressive disease|0|||
27896271|NCT01877382|81453899|FG004|Dose Expansion|Progressive disease|0|||
27896272|NCT01877382|81453900|FG005|Dose Expansion|Progressive disease|0|||
27896273|NCT01877382|81453901|FG006|Dose Expansion|Progressive disease|0|||
27896274|NCT01877382|81453902|FG007|Dose Expansion|Progressive disease|0|||
27896275|NCT01877382|81453903|FG008|Dose Expansion|Progressive disease|0|||
27896276|NCT01877382|81453904|FG009|Dose Expansion|Progressive disease|0|||
27896277|NCT01877382|81453905|FG010|Dose Expansion|Progressive disease|0|||
27896278|NCT01877382|81453906|FG011|Dose Expansion|Progressive disease|0|||
27896279|NCT01877382|81453907|FG012|Dose Expansion|Progressive disease|0|||
27896280|NCT01877382|81453908|FG013|Dose Expansion|Progressive disease|0|||
27896281|NCT01877382|81453909|FG014|Dose Expansion|Progressive disease|11|||
27896282|NCT01877382|81453895|FG000|Dose Expansion|Clinical progression|0|||
27896283|NCT01877382|81453896|FG001|Dose Expansion|Clinical progression|0|||
27896284|NCT01877382|81453897|FG002|Dose Expansion|Clinical progression|0|||
27896285|NCT01877382|81453898|FG003|Dose Expansion|Clinical progression|0|||
27896286|NCT01877382|81453899|FG004|Dose Expansion|Clinical progression|0|||
27896287|NCT01877382|81453900|FG005|Dose Expansion|Clinical progression|0|||
27896288|NCT01877382|81453901|FG006|Dose Expansion|Clinical progression|0|||
27896289|NCT01877382|81453902|FG007|Dose Expansion|Clinical progression|0|||
27896290|NCT01877382|81453903|FG008|Dose Expansion|Clinical progression|0|||
27896291|NCT01877382|81453904|FG009|Dose Expansion|Clinical progression|0|||
27896292|NCT01877382|81453905|FG010|Dose Expansion|Clinical progression|0|||
27896293|NCT01877382|81453906|FG011|Dose Expansion|Clinical progression|0|||
27896294|NCT01877382|81453907|FG012|Dose Expansion|Clinical progression|0|||
27896295|NCT01877382|81453908|FG013|Dose Expansion|Clinical progression|0|||
27896296|NCT01877382|81453909|FG014|Dose Expansion|Clinical progression|6|||
27896297|NCT01877382|81453895|FG000|Dose Expansion|Adverse Event|0|||
27896298|NCT01877382|81453896|FG001|Dose Expansion|Adverse Event|0|||
27896299|NCT01877382|81453897|FG002|Dose Expansion|Adverse Event|0|||
27896300|NCT01877382|81453898|FG003|Dose Expansion|Adverse Event|0|||
27896301|NCT01877382|81453899|FG004|Dose Expansion|Adverse Event|0|||
27896302|NCT01877382|81453900|FG005|Dose Expansion|Adverse Event|0|||
27896303|NCT01877382|81453901|FG006|Dose Expansion|Adverse Event|0|||
27896304|NCT01877382|81453902|FG007|Dose Expansion|Adverse Event|0|||
27896305|NCT01877382|81453903|FG008|Dose Expansion|Adverse Event|0|||
27896306|NCT01877382|81453904|FG009|Dose Expansion|Adverse Event|0|||
27896307|NCT01877382|81453905|FG010|Dose Expansion|Adverse Event|0|||
27896308|NCT01877382|81453906|FG011|Dose Expansion|Adverse Event|0|||
27896309|NCT01877382|81453907|FG012|Dose Expansion|Adverse Event|0|||
27896310|NCT01877382|81453908|FG013|Dose Expansion|Adverse Event|0|||
27896311|NCT01877382|81453909|FG014|Dose Expansion|Adverse Event|1|||
27896312|NCT01877382|81453895|FG000|Dose Expansion|Death|0|||
27896313|NCT01877382|81453896|FG001|Dose Expansion|Death|0|||
27896314|NCT01877382|81453897|FG002|Dose Expansion|Death|0|||
27896315|NCT01877382|81453898|FG003|Dose Expansion|Death|0|||
27896316|NCT01877382|81453899|FG004|Dose Expansion|Death|0|||
27896317|NCT01877382|81453900|FG005|Dose Expansion|Death|0|||
27896318|NCT01877382|81453901|FG006|Dose Expansion|Death|0|||
27896319|NCT01877382|81453902|FG007|Dose Expansion|Death|0|||
27896320|NCT01877382|81453903|FG008|Dose Expansion|Death|0|||
27896321|NCT01877382|81453904|FG009|Dose Expansion|Death|0|||
27896322|NCT01877382|81453905|FG010|Dose Expansion|Death|0|||
27896323|NCT01877382|81453906|FG011|Dose Expansion|Death|0|||
27896324|NCT01877382|81453907|FG012|Dose Expansion|Death|0|||
27896325|NCT01877382|81453908|FG013|Dose Expansion|Death|0|||
27896326|NCT01877382|81453909|FG014|Dose Expansion|Death|1|||
27896327|NCT01877382|81453895|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896328|NCT01877382|81453896|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896329|NCT01877382|81453897|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896330|NCT01877382|81453898|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896331|NCT01877382|81453899|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896332|NCT01877382|81453900|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896333|NCT01877382|81453901|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896334|NCT01877382|81453902|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896335|NCT01877382|81453903|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896336|NCT01877382|81453904|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896337|NCT01877382|81453905|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896338|NCT01877382|81453906|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896339|NCT01877382|81453907|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896340|NCT01877382|81453908|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
27896341|NCT01877382|81453909|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
27896342|NCT01797081|81453912|FG000|Overall Study|Adverse Event|1|||
27896343|NCT01797081|81453913|FG001|Overall Study|Adverse Event|0|||
27896344|NCT01797081|81453914|FG002|Overall Study|Adverse Event|1|||
27896345|NCT01797081|81453915|FG003|Overall Study|Adverse Event|0|||
27896346|NCT01797081|81453912|FG000|Overall Study|Pregnancy|1|||
27896347|NCT01797081|81453913|FG001|Overall Study|Pregnancy|0|||
27896348|NCT01797081|81453914|FG002|Overall Study|Pregnancy|0|||
27896349|NCT01797081|81453915|FG003|Overall Study|Pregnancy|0|||
27896350|NCT01797081|81453912|FG000|Overall Study|Personal Reasons|12|||
27896351|NCT01797081|81453913|FG001|Overall Study|Personal Reasons|4|||
27896352|NCT01797081|81453914|FG002|Overall Study|Personal Reasons|4|||
27896353|NCT01797081|81453915|FG003|Overall Study|Personal Reasons|8|||
27896354|NCT01797081|81453912|FG000|Overall Study|Protocol Violation|0|||
27896355|NCT01797081|81453913|FG001|Overall Study|Protocol Violation|0|||
27896356|NCT01797081|81453914|FG002|Overall Study|Protocol Violation|0|||
27896357|NCT01797081|81453915|FG003|Overall Study|Protocol Violation|1|||
27896358|NCT03578146|81453921|FG000|Overall Study|Did Not Receive Treatment|1|||
27896359|NCT03578146|81453922|FG001|Overall Study|Did Not Receive Treatment|0|||
27896360|NCT03578146|81453923|FG002|Overall Study|Did Not Receive Treatment|0|||
27896361|NCT03578146|81453924|FG003|Overall Study|Did Not Receive Treatment|0|||
27896362|NCT03578146|81453925|FG004|Overall Study|Did Not Receive Treatment|0|||
27896363|NCT03578146|81453926|FG005|Overall Study|Did Not Receive Treatment|2|||
27896364|NCT03578146|81453921|FG000|Overall Study|Lost to Follow-up|0|||
27896365|NCT03578146|81453922|FG001|Overall Study|Lost to Follow-up|1|||
27896366|NCT03578146|81453923|FG002|Overall Study|Lost to Follow-up|1|||
27896367|NCT03578146|81453924|FG003|Overall Study|Lost to Follow-up|0|||
27896368|NCT03578146|81453925|FG004|Overall Study|Lost to Follow-up|0|||
27896369|NCT03578146|81453926|FG005|Overall Study|Lost to Follow-up|1|||
27896370|NCT00232596|81453927|FG000|6-Week Titration Phase|Adverse Event|6|||
27896371|NCT00232596|81453928|FG001|6-Week Titration Phase|Adverse Event|19|||
27896372|NCT00232596|81453927|FG000|6-Week Titration Phase|Failed to Return|2|||
27896373|NCT00232596|81453928|FG001|6-Week Titration Phase|Failed to Return|1|||
27896374|NCT00232596|81453927|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
27896375|NCT00232596|81453928|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
27896376|NCT00232596|81453927|FG000|6-Week Titration Phase|Protocol Violation|1|||
27896377|NCT00232596|81453928|FG001|6-Week Titration Phase|Protocol Violation|3|||
27896378|NCT00232596|81453927|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
27896379|NCT00232596|81453928|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
27896380|NCT00232596|81453927|FG000|6-Week Titration Phase|Other|3|||
27896381|NCT00232596|81453928|FG001|6-Week Titration Phase|Other|3|||
27896382|NCT00232596|81453927|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
27896383|NCT00232596|81453928|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
27896384|NCT00232596|81453927|FG000|12-Week Maintenance Phase|Adverse Event|7|||
27896385|NCT00232596|81453928|FG001|12-Week Maintenance Phase|Adverse Event|22|||
27896386|NCT00232596|81453927|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
27896387|NCT00232596|81453928|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
27896388|NCT00232596|81453927|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
27896389|NCT00232596|81453928|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
27896390|NCT00232596|81453927|FG000|12-Week Maintenance Phase|Other|1|||
27896391|NCT00232596|81453928|FG001|12-Week Maintenance Phase|Other|3|||
27896392|NCT00367484|81453929|FG000|Overall Study|Adverse Event|7|||
27896393|NCT00367484|81453929|FG000|Overall Study|Withdrew informed consent|5|||
27896394|NCT00367484|81453929|FG000|Overall Study|Travel to USA|1|||
27896395|NCT00367484|81453929|FG000|Overall Study|Lost to Follow-up|1|||
27896396|NCT00367484|81453929|FG000|Overall Study|Protocol Violation|1|||
27896397|NCT00367484|81453929|FG000|Overall Study|The choice of the patient|1|||
27896398|NCT00367484|81453929|FG000|Overall Study|Lack of Efficacy|1|||
27896399|NCT04481191|81453930|FG000|Overall Study|Withdrawn by parent/guardian|15|||
27896400|NCT04481191|81453931|FG001|Overall Study|Withdrawn by parent/guardian|10|||
27896401|NCT00108485|81453932|FG000|Overall Study|Withdrawal by Subject|3|||
27896402|NCT00108485|81453933|FG001|Overall Study|Withdrawal by Subject|0|||
27896403|NCT00108485|81453932|FG000|Overall Study|Lost to Follow-up|0|||
27896404|NCT00108485|81453933|FG001|Overall Study|Lost to Follow-up|2|||
27896405|NCT02653170|81453936|FG000|Overall Study|Withdrawal by Subject|3|||
27896406|NCT02653170|81453937|FG001|Overall Study|Withdrawal by Subject|8|||
27896407|NCT02653170|81453938|FG002|Overall Study|Withdrawal by Subject|3|||
27896408|NCT02653170|81453936|FG000|Overall Study|withdrawn by study team|2|||
27896409|NCT02653170|81453937|FG001|Overall Study|withdrawn by study team|4|||
27896410|NCT02653170|81453938|FG002|Overall Study|withdrawn by study team|5|||
27896411|NCT02653170|81453936|FG000|Overall Study|Lost to Follow-up|12|||
27896412|NCT02653170|81453937|FG001|Overall Study|Lost to Follow-up|4|||
27896413|NCT02653170|81453938|FG002|Overall Study|Lost to Follow-up|10|||
27896414|NCT03419598|81453940|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
27896415|NCT04984681|81453941|FG000|Overall Study|Lost to Follow-up|3|||
27896416|NCT04984681|81453942|FG001|Overall Study|Lost to Follow-up|1|||
27896417|NCT00787917|81453943|FG000|Blinded Treatment|Adverse Event|1|||
27896418|NCT00787917|81453944|FG001|Blinded Treatment|Adverse Event|0|||
27896419|NCT00787917|81453943|FG000|Blinded Treatment|Lack of Efficacy|1|||
27896420|NCT00787917|81453944|FG001|Blinded Treatment|Lack of Efficacy|0|||
27896421|NCT00787917|81453943|FG000|Blinded Treatment|Administrative problems|3|||
27896422|NCT00787917|81453944|FG001|Blinded Treatment|Administrative problems|2|||
27896423|NCT00787917|81453943|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
27896424|NCT00787917|81453944|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
27896425|NCT00787917|81453943|FG000|Open Label|Administrative problems|3|||
27896426|NCT00787917|81453944|FG001|Open Label|Administrative problems|0|||
27896427|NCT00655681|81453947|FG000|Overall Study|Lost to Follow-up|1|||
27896428|NCT00655681|81453948|FG001|Overall Study|Lost to Follow-up|1|||
27896429|NCT01004406|81453949|FG000|Overall Study|Withdrawal by Subject|2|||
27505935|NCT00744497|80044218|FG001|Overall Study|Disease progression|219|||
27505936|NCT00744497|80044217|FG000|Overall Study|Study drug toxicity|68|||
27505937|NCT00744497|80044218|FG001|Overall Study|Study drug toxicity|141|||
27505938|NCT00744497|80044217|FG000|Overall Study|Adverse event unrelated to study drug|78|||
27505939|NCT00744497|80044218|FG001|Overall Study|Adverse event unrelated to study drug|122|||
27505940|NCT00744497|80044217|FG000|Overall Study|Patient requested to stop study drug|65|||
27505941|NCT00744497|80044218|FG001|Overall Study|Patient requested to stop study drug|80|||
27505942|NCT00744497|80044217|FG000|Overall Study|Maximum clinical benefit|141|||
27505943|NCT00744497|80044218|FG001|Overall Study|Maximum clinical benefit|142|||
27505944|NCT00744497|80044217|FG000|Overall Study|Not defined|19|||
27505945|NCT00744497|80044218|FG001|Overall Study|Not defined|13|||
27726882|NCT01773421|80830208|FG006|Extension Phase|Other|0|||
27726883|NCT01773421|80830202|FG000|Extension Phase|Adverse Event|0|||
27726884|NCT01773421|80830203|FG001|Extension Phase|Adverse Event|0|||
27726885|NCT01773421|80830204|FG002|Extension Phase|Adverse Event|0|||
27726886|NCT01773421|80830205|FG003|Extension Phase|Adverse Event|0|||
27726887|NCT01773421|80830206|FG004|Extension Phase|Adverse Event|2|||
27726888|NCT01773421|80830207|FG005|Extension Phase|Adverse Event|0|||
27896430|NCT01004406|81453950|FG001|Overall Study|Withdrawal by Subject|0|||
27896431|NCT01004406|81453949|FG000|Overall Study|Lost to Follow-up|1|||
27896432|NCT01004406|81453950|FG001|Overall Study|Lost to Follow-up|0|||
27896433|NCT00358956|81453956|FG000|Overall Study|Adverse Event|3|||
27896434|NCT00358956|81453956|FG000|Overall Study|condition under investigation worsened|4|||
27896435|NCT00358956|81453956|FG000|Overall Study|Withdrawal by Subject|1|||
27896436|NCT00084318|81453957|FG000|Overall Study|Withdrawal by Subject|5|||
27896437|NCT00084318|81453958|FG001|Overall Study|Withdrawal by Subject|2|||
27896438|NCT00084318|81453957|FG000|Overall Study|Protocol Violation|15|||
27896439|NCT00084318|81453958|FG001|Overall Study|Protocol Violation|11|||
27896440|NCT00084318|81453957|FG000|Overall Study|No protocol treatment|2|||
27896441|NCT00084318|81453958|FG001|Overall Study|No protocol treatment|0|||
27896442|NCT00672841|81453959|FG000|Overall Study|Comfort care|1|||
27896443|NCT00672841|81453960|FG001|Overall Study|Comfort care|4|||
27896444|NCT00672841|81453959|FG000|Overall Study|icteric specimens|0|||
27896445|NCT00672841|81453960|FG001|Overall Study|icteric specimens|3|||
27896446|NCT00672841|81453959|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
27896447|NCT00672841|81453960|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
27896448|NCT00672841|81453959|FG000|Overall Study|Adverse Event|0|||
27896449|NCT00672841|81453960|FG001|Overall Study|Adverse Event|3|||
27896450|NCT00672841|81453959|FG000|Overall Study|Pregnancy|0|||
27896451|NCT00672841|81453960|FG001|Overall Study|Pregnancy|1|||
27896452|NCT00094536|81453961|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
27896453|NCT00094536|81453961|FG000|Treatment and Follow-up|Adverse Event|4|||
27896454|NCT00094536|81453961|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
27896455|NCT00094536|81453961|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
27896456|NCT00094536|81453961|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
27896457|NCT00094536|81453961|FG000|Treatment and Follow-up|Subject non-compliance|9|||
27896458|NCT00094536|81453961|FG000|Treatment and Follow-up|Unable to attend visits|1|||
27505946|NCT03829228|80044219|FG000|Overall Study|Protocol Violation|1|||
27505947|NCT00459316|80044222|FG000|Steps 1 & 2|Other eligibility failure|1|||
27505948|NCT00459316|80044223|FG001|Steps 1 & 2|Other eligibility failure|1|||
27505949|NCT00459316|80044224|FG002|Steps 1 & 2|Other eligibility failure|0|||
27896459|NCT02908074|81453964|FG000|Overall Study|sponsor/ICON decision|0|||
27896460|NCT02908074|81453965|FG001|Overall Study|sponsor/ICON decision|0|||
27896461|NCT02908074|81453966|FG002|Overall Study|sponsor/ICON decision|1|||
27896462|NCT02908074|81453967|FG003|Overall Study|sponsor/ICON decision|0|||
27505950|NCT00459316|80044222|FG000|Steps 1 & 2|Death|1|||
27505951|NCT00459316|80044223|FG001|Steps 1 & 2|Death|1|||
27505952|NCT00459316|80044224|FG002|Steps 1 & 2|Death|0|||
27505953|NCT00459316|80044222|FG000|Steps 1 & 2|Not able to get to clinic|7|||
27505954|NCT00459316|80044223|FG001|Steps 1 & 2|Not able to get to clinic|4|||
27896463|NCT02908074|81453968|FG004|Overall Study|sponsor/ICON decision|0|||
27896464|NCT02908074|81453969|FG005|Overall Study|sponsor/ICON decision|0|||
27896465|NCT02908074|81453964|FG000|Overall Study|Protocol Violation|0|||
27896466|NCT02908074|81453965|FG001|Overall Study|Protocol Violation|1|||
27896467|NCT02908074|81453966|FG002|Overall Study|Protocol Violation|0|||
27896468|NCT02908074|81453967|FG003|Overall Study|Protocol Violation|0|||
27505955|NCT00459316|80044224|FG002|Steps 1 & 2|Not able to get to clinic|0|||
27505956|NCT00459316|80044222|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
27849346|NCT02224573|81279109|FG001|Treatment Phase|Lack of Efficiency|1|||
27849347|NCT02224573|81279108|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
27849348|NCT02224573|81279109|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
27849349|NCT02224573|81279108|FG000|Treatment Phase|Participant Moved|2|||
27849350|NCT02224573|81279109|FG001|Treatment Phase|Participant Moved|0|||
27849351|NCT02224573|81279108|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
27849352|NCT02224573|81279109|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
27849353|NCT02224573|81279108|FG000|Treatment Phase|Refused Medication|1|||
27849354|NCT02224573|81279109|FG001|Treatment Phase|Refused Medication|1|||
27849355|NCT02224573|81279108|FG000|Treatment Phase|Adverse Event|26|||
27849356|NCT02224573|81279109|FG001|Treatment Phase|Adverse Event|38|||
27849357|NCT02224573|81279108|FG000|Treatment Phase|Placed in Group Home|0|||
27849358|NCT02224573|81279109|FG001|Treatment Phase|Placed in Group Home|1|||
27849359|NCT02224573|81279108|FG000|Treatment Phase|Pursued Other Trials|1|||
27849360|NCT02224573|81279109|FG001|Treatment Phase|Pursued Other Trials|0|||
27849361|NCT02224573|81279108|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
27849362|NCT02224573|81279109|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
27849363|NCT02224573|81279108|FG000|Treatment Phase|Lost to Follow-up|2|||
27849364|NCT02224573|81279109|FG001|Treatment Phase|Lost to Follow-up|1|||
27849365|NCT02224573|81279108|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
27849366|NCT02224573|81279109|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
27849367|NCT02224573|81279108|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
27849368|NCT02224573|81279109|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
27849369|NCT02224573|81279108|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
27849370|NCT02224573|81279109|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
27849371|NCT02224573|81279108|FG000|Taper Phase|Adverse Event|1|||
27849372|NCT02224573|81279109|FG001|Taper Phase|Adverse Event|1|||
27849373|NCT02691741|81279110|FG000|Overall Study|Adverse Event|0|||
27849374|NCT02691741|81279111|FG001|Overall Study|Adverse Event|2|||
27849375|NCT02691741|81279110|FG000|Overall Study|Lost to Follow-up|1|||
27849376|NCT02691741|81279111|FG001|Overall Study|Lost to Follow-up|0|||
27849377|NCT02691741|81279110|FG000|Overall Study|Physician Decision|0|||
27849378|NCT02691741|81279111|FG001|Overall Study|Physician Decision|1|||
27849379|NCT02691741|81279110|FG000|Overall Study|Withdrawal by Subject|0|||
27849380|NCT02691741|81279111|FG001|Overall Study|Withdrawal by Subject|4|||
27849381|NCT02037165|81279112|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27849382|NCT02037165|81279113|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27849383|NCT02037165|81279114|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27849384|NCT02037165|81279115|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
27849385|NCT02037165|81279116|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
27849386|NCT00407758|81279117|FG000|Overall Study|ineligible -improper prior treatment|1|||
27849387|NCT00248170|81279118|FG000|Overall Study|Withdrawal by Subject|71|||
27849388|NCT00248170|81279119|FG001|Overall Study|Withdrawal by Subject|79|||
27849389|NCT00248170|81279118|FG000|Overall Study|Protocol Violation|35|||
27849390|NCT00248170|81279119|FG001|Overall Study|Protocol Violation|30|||
27849391|NCT00248170|81279118|FG000|Overall Study|Lost to Follow-up|28|||
27849392|NCT00248170|81279119|FG001|Overall Study|Lost to Follow-up|35|||
27849393|NCT00248170|81279118|FG000|Overall Study|Disease progression|196|||
27849394|NCT00248170|81279119|FG001|Overall Study|Disease progression|216|||
27849395|NCT00248170|81279118|FG000|Overall Study|Death|28|||
27849396|NCT00248170|81279119|FG001|Overall Study|Death|47|||
27849397|NCT00248170|81279118|FG000|Overall Study|Adverse Event|311|||
27849398|NCT00248170|81279119|FG001|Overall Study|Adverse Event|296|||
27849399|NCT00248170|81279118|FG000|Overall Study|Administrative problems|22|||
27849400|NCT00248170|81279119|FG001|Overall Study|Administrative problems|25|||
27896469|NCT02908074|81453968|FG004|Overall Study|Protocol Violation|0|||
27896470|NCT02908074|81453969|FG005|Overall Study|Protocol Violation|0|||
27505957|NCT00459316|80044223|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
27849401|NCT00248170|81279118|FG000|Overall Study|Abnormal test procedure(s) result|49|||
27849402|NCT00248170|81279119|FG001|Overall Study|Abnormal test procedure(s) result|61|||
27849403|NCT00248170|81279118|FG000|Overall Study|Abnormal laboratory values|4|||
27849404|NCT00248170|81279119|FG001|Overall Study|Abnormal laboratory values|0|||
27849405|NCT00248170|81279118|FG000|Overall Study|Protocol deviation|17|||
27849406|NCT00248170|81279119|FG001|Overall Study|Protocol deviation|19|||
27849407|NCT01045421|81279120|FG000|Phase 1|Progressive Disease|0|||
27849408|NCT01045421|81279121|FG001|Phase 1|Progressive Disease|0|||
27849409|NCT01045421|81279122|FG002|Phase 1|Progressive Disease|0|||
27849410|NCT01045421|81279123|FG003|Phase 1|Progressive Disease|0|||
27849411|NCT01045421|81279124|FG004|Phase 1|Progressive Disease|1|||
27849412|NCT01045421|81279125|FG005|Phase 1|Progressive Disease|0|||
27896471|NCT02908074|81453964|FG000|Overall Study|Adverse Event|5|||
27896472|NCT02908074|81453965|FG001|Overall Study|Adverse Event|2|||
27896473|NCT02908074|81453966|FG002|Overall Study|Adverse Event|0|||
27896474|NCT02908074|81453967|FG003|Overall Study|Adverse Event|0|||
27896475|NCT02908074|81453968|FG004|Overall Study|Adverse Event|1|||
27896476|NCT02908074|81453969|FG005|Overall Study|Adverse Event|0|||
27896477|NCT02908074|81453964|FG000|Overall Study|AESI|1|||
27896478|NCT02908074|81453965|FG001|Overall Study|AESI|0|||
27896479|NCT02908074|81453966|FG002|Overall Study|AESI|1|||
27896480|NCT02908074|81453967|FG003|Overall Study|AESI|0|||
27896481|NCT02908074|81453968|FG004|Overall Study|AESI|1|||
27896482|NCT02908074|81453969|FG005|Overall Study|AESI|0|||
27896483|NCT02908074|81453964|FG000|Overall Study|Discontinuation criteria per protocol|0|||
27896484|NCT02908074|81453965|FG001|Overall Study|Discontinuation criteria per protocol|0|||
27896485|NCT02908074|81453966|FG002|Overall Study|Discontinuation criteria per protocol|1|||
27896486|NCT02908074|81453967|FG003|Overall Study|Discontinuation criteria per protocol|0|||
27896487|NCT02908074|81453968|FG004|Overall Study|Discontinuation criteria per protocol|0|||
27896488|NCT02908074|81453969|FG005|Overall Study|Discontinuation criteria per protocol|1|||
27896489|NCT02908074|81453964|FG000|Overall Study|Withdrawal by Subject|3|||
27896490|NCT02908074|81453965|FG001|Overall Study|Withdrawal by Subject|2|||
27896491|NCT02908074|81453966|FG002|Overall Study|Withdrawal by Subject|2|||
27896492|NCT02908074|81453967|FG003|Overall Study|Withdrawal by Subject|2|||
27896493|NCT02908074|81453968|FG004|Overall Study|Withdrawal by Subject|2|||
27896494|NCT02908074|81453969|FG005|Overall Study|Withdrawal by Subject|2|||
27896495|NCT02908074|81453964|FG000|Overall Study|Lost to Follow-up|0|||
27896496|NCT02908074|81453965|FG001|Overall Study|Lost to Follow-up|1|||
27896497|NCT02908074|81453966|FG002|Overall Study|Lost to Follow-up|1|||
27896498|NCT02908074|81453967|FG003|Overall Study|Lost to Follow-up|1|||
27896499|NCT02908074|81453968|FG004|Overall Study|Lost to Follow-up|0|||
27896500|NCT02908074|81453969|FG005|Overall Study|Lost to Follow-up|1|||
27896501|NCT00767039|81453970|FG000|Overall Study|Death|5|||
27896502|NCT00767039|81453971|FG001|Overall Study|Death|2|||
27896503|NCT04007107|81453972|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
27896504|NCT04007107|81453973|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
27896505|NCT04007107|81453974|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
27896506|NCT04007107|81453975|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
27726889|NCT01773421|80830208|FG006|Extension Phase|Adverse Event|0|||
27726890|NCT00552110|80830209|FG000|Overall Study|Serious or Life-Threatening AE|0|||
27726891|NCT00552110|80830210|FG001|Overall Study|Serious or Life-Threatening AE|0|||
27726892|NCT00552110|80830211|FG002|Overall Study|Serious or Life-Threatening AE|1|||
27726893|NCT00552110|80830212|FG003|Overall Study|Serious or Life-Threatening AE|0|||
27726894|NCT00552110|80830213|FG004|Overall Study|Serious or Life-Threatening AE|0|||
27726895|NCT00552110|80830209|FG000|Overall Study|Lack of Efficacy|1|||
27726896|NCT00552110|80830210|FG001|Overall Study|Lack of Efficacy|0|||
27726897|NCT00552110|80830211|FG002|Overall Study|Lack of Efficacy|0|||
27896507|NCT01322035|81453976|FG000|Overall Study|Lost to Follow-up|8|||
27896508|NCT01322035|81453977|FG001|Overall Study|Lost to Follow-up|3|||
27896509|NCT02614131|81457013|FG000|Overall Study|Withdrawal by Subject|1|||
27726898|NCT00552110|80830212|FG003|Overall Study|Lack of Efficacy|1|||
27726899|NCT00552110|80830213|FG004|Overall Study|Lack of Efficacy|4|||
27726900|NCT00552110|80830209|FG000|Overall Study|Withdrawal by Subject|0|||
27896510|NCT02614131|81457014|FG001|Overall Study|Withdrawal by Subject|0|||
27896511|NCT02614131|81457015|FG002|Overall Study|Withdrawal by Subject|0|||
27896512|NCT02614131|81457016|FG003|Overall Study|Withdrawal by Subject|0|||
27896513|NCT02614131|81457017|FG004|Overall Study|Withdrawal by Subject|0|||
27896514|NCT02614131|81457018|FG005|Overall Study|Withdrawal by Subject|0|||
27896515|NCT02614131|81457019|FG006|Overall Study|Withdrawal by Subject|0|||
27896516|NCT02614131|81457013|FG000|Overall Study|Adverse Event|0|||
27896517|NCT02614131|81457014|FG001|Overall Study|Adverse Event|0|||
27896518|NCT02614131|81457015|FG002|Overall Study|Adverse Event|0|||
27896519|NCT02614131|81457016|FG003|Overall Study|Adverse Event|0|||
27896520|NCT02614131|81457017|FG004|Overall Study|Adverse Event|0|||
27896521|NCT02614131|81457018|FG005|Overall Study|Adverse Event|0|||
27896522|NCT02614131|81457019|FG006|Overall Study|Adverse Event|1|||
27896523|NCT00314132|81457020|FG000|Overall Study|Lost to Follow-up|3|||
27896524|NCT00314132|81457021|FG001|Overall Study|Lost to Follow-up|13|||
27896525|NCT00314132|81457020|FG000|Overall Study|Withdrawal by Subject|3|||
27896526|NCT00314132|81457021|FG001|Overall Study|Withdrawal by Subject|5|||
27896527|NCT00314132|81457020|FG000|Overall Study|Adverse Event|1|||
27896528|NCT00314132|81457021|FG001|Overall Study|Adverse Event|0|||
27896529|NCT00314132|81457020|FG000|Overall Study|Physician Decision|1|||
27896530|NCT00314132|81457021|FG001|Overall Study|Physician Decision|0|||
27896531|NCT01472965|81457025|FG000|Overall Study|Withdrawal by Subject|1|||
27896532|NCT01472965|81457026|FG001|Overall Study|Withdrawal by Subject|0|||
27896533|NCT02450552|81457027|FG000|Overall Study|Withdrawal by Subject|4|||
27896534|NCT02450552|81457028|FG001|Overall Study|Withdrawal by Subject|0|||
27896535|NCT02450552|81457029|FG002|Overall Study|Withdrawal by Subject|4|||
27896536|NCT02450552|81457027|FG000|Overall Study|Physician Decision|1|||
27896537|NCT02450552|81457028|FG001|Overall Study|Physician Decision|0|||
27896538|NCT02450552|81457029|FG002|Overall Study|Physician Decision|1|||
27896539|NCT00081731|81457030|FG000|Overall Study|scientific integrity issue|8|||
27896540|NCT00081731|81457031|FG001|Overall Study|scientific integrity issue|8|||
27896541|NCT03495154|81457034|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
27896542|NCT03495154|81457034|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
27896543|NCT03495154|81457034|FG000|Overall Study|Screen Failures During Surgery|6|||
27896544|NCT03495154|81457034|FG000|Overall Study|Death|2|||
27896545|NCT03495154|81457034|FG000|Overall Study|Lost to Follow-up|16|||
27896546|NCT03495154|81457034|FG000|Overall Study|Withdrawal by Subject|2|||
27896547|NCT03495154|81457034|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
27896548|NCT01712334|81457038|FG000|Treatment Period 1|Randomized in Error|0|||
27896549|NCT01712334|81457039|FG001|Treatment Period 1|Randomized in Error|2|||
27896550|NCT00477607|81457044|FG000|Overall Study|Lost to Follow-up|7|||
27896551|NCT00477607|81457045|FG001|Overall Study|Lost to Follow-up|7|||
27896552|NCT04392167|81457046|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
27896553|NCT03956615|81457047|FG000|Overall Study|No multiple myeloma confirmed|2|||
27896554|NCT03956615|81457047|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
27896555|NCT03956615|81457047|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
27896556|NCT03956615|81457047|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
27896557|NCT01195844|81457049|FG000|Overall Study|Fecal sample not collected|40|||
27896558|NCT02195427|81457050|FG000|Overall Study|Did not consent to study extension|13|||
27896559|NCT02195427|81457051|FG001|Overall Study|Did not consent to study extension|9|||
27896560|NCT02195427|81457050|FG000|Overall Study|Withdrawal by Subject|4|||
27896561|NCT02195427|81457051|FG001|Overall Study|Withdrawal by Subject|2|||
27896562|NCT02195427|81457050|FG000|Overall Study|Lost to Follow-up|0|||
27896563|NCT02195427|81457051|FG001|Overall Study|Lost to Follow-up|1|||
27896564|NCT02195427|81457050|FG000|Overall Study|Protocol Violation|7|||
27896565|NCT02195427|81457051|FG001|Overall Study|Protocol Violation|14|||
27896566|NCT02195427|81457050|FG000|Overall Study|Conditional re-treatment at W52|2|||
27896567|NCT02195427|81457051|FG001|Overall Study|Conditional re-treatment at W52|1|||
27896568|NCT01298141|81457052|FG000|Overall Study|Adverse Event|3|||
27896569|NCT01298141|81457052|FG000|Overall Study|Refusal of Required Study Procedures|1|||
27896570|NCT01298141|81457052|FG000|Overall Study|Withdrawal by Subject|6|||
27896571|NCT01298141|81457052|FG000|Overall Study|Termination of Study by the Investigator|5|||
27896572|NCT01298141|81457052|FG000|Overall Study|Other|5|||
27896573|NCT01298141|81457052|FG000|Overall Study|Lost to Follow-up|1|||
27896574|NCT01298141|81457052|FG000|Overall Study|Death|6|||
27896575|NCT01298141|81457052|FG000|Overall Study|Not treated|4|||
27896576|NCT03408444|81457053|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
27896577|NCT03408444|81457054|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27896578|NCT03408444|81457055|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27896579|NCT03408444|81457056|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27896580|NCT03408444|81457053|FG000|Overall Study|Lens Discomfort|0|||
27896581|NCT03408444|81457054|FG001|Overall Study|Lens Discomfort|1|||
27896582|NCT03408444|81457055|FG002|Overall Study|Lens Discomfort|0|||
27896583|NCT03408444|81457056|FG003|Overall Study|Lens Discomfort|0|||
27896584|NCT03408444|81457053|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
27505958|NCT00459316|80044224|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
27849413|NCT01045421|81279126|FG006|Phase 1|Progressive Disease|0|||
27505959|NCT00459316|80044222|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
27849414|NCT01045421|81279127|FG007|Phase 1|Progressive Disease|0|||
27849415|NCT01045421|81279128|FG008|Phase 1|Progressive Disease|0|||
27849416|NCT01045421|81279129|FG009|Phase 1|Progressive Disease|0|||
27849417|NCT01045421|81279130|FG010|Phase 1|Progressive Disease|0|||
27849418|NCT01045421|81279120|FG000|Phase 1|Withdrawal by Subject|0|||
27849419|NCT01045421|81279121|FG001|Phase 1|Withdrawal by Subject|0|||
27849420|NCT01045421|81279122|FG002|Phase 1|Withdrawal by Subject|0|||
27849421|NCT01045421|81279123|FG003|Phase 1|Withdrawal by Subject|1|||
27849422|NCT01045421|81279124|FG004|Phase 1|Withdrawal by Subject|0|||
27505960|NCT00459316|80044223|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
27505961|NCT00459316|80044224|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
27896585|NCT03408444|81457054|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
27896586|NCT03408444|81457055|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
27896587|NCT03408444|81457056|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
27896588|NCT03408444|81457053|FG000|Overall Study|Withdrawal by Subject|0|||
27896589|NCT03408444|81457054|FG001|Overall Study|Withdrawal by Subject|2|||
27896590|NCT03408444|81457055|FG002|Overall Study|Withdrawal by Subject|3|||
27896591|NCT03408444|81457056|FG003|Overall Study|Withdrawal by Subject|0|||
27896592|NCT03408444|81457053|FG000|Overall Study|Lost to Follow-up|0|||
27896593|NCT03408444|81457054|FG001|Overall Study|Lost to Follow-up|0|||
27896594|NCT03408444|81457055|FG002|Overall Study|Lost to Follow-up|1|||
27896595|NCT03408444|81457056|FG003|Overall Study|Lost to Follow-up|0|||
27896596|NCT03408444|81457053|FG000|Overall Study|Adverse Event|0|||
27896597|NCT03408444|81457054|FG001|Overall Study|Adverse Event|0|||
27896598|NCT03408444|81457055|FG002|Overall Study|Adverse Event|0|||
27896599|NCT03408444|81457056|FG003|Overall Study|Adverse Event|1|||
27896600|NCT03408444|81457053|FG000|Overall Study|Lens Handling Difficulties|0|||
27896601|NCT03408444|81457054|FG001|Overall Study|Lens Handling Difficulties|0|||
27896602|NCT03408444|81457055|FG002|Overall Study|Lens Handling Difficulties|1|||
27896603|NCT03408444|81457056|FG003|Overall Study|Lens Handling Difficulties|0|||
27896604|NCT03408444|81457053|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
27896605|NCT03408444|81457054|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
27896606|NCT03408444|81457055|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
27896607|NCT03408444|81457056|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
27896608|NCT00742508|81457057|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
27896609|NCT00742508|81457058|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
27896610|NCT00742508|81457057|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
27896611|NCT00742508|81457058|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
27896612|NCT00742508|81457057|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
27896613|NCT00742508|81457058|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
27896614|NCT00742508|81457057|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
27896615|NCT00742508|81457058|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
27896616|NCT00742508|81457057|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
27896617|NCT00742508|81457058|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
27896618|NCT00197002|81457061|FG000|Overall Study|Adverse Event|0|||
27896619|NCT00197002|81457062|FG001|Overall Study|Adverse Event|1|||
27896620|NCT00197002|81457063|FG002|Overall Study|Adverse Event|0|||
27896621|NCT00197002|81457061|FG000|Overall Study|Protocol Violation|1|||
27896622|NCT00197002|81457062|FG001|Overall Study|Protocol Violation|0|||
27896623|NCT00197002|81457063|FG002|Overall Study|Protocol Violation|2|||
27896624|NCT00197002|81457061|FG000|Overall Study|Withdrawal by Subject|9|||
27896625|NCT00197002|81457062|FG001|Overall Study|Withdrawal by Subject|5|||
27896626|NCT00197002|81457063|FG002|Overall Study|Withdrawal by Subject|7|||
27896627|NCT00197002|81457061|FG000|Overall Study|Migrated/moved from study area|3|||
27896628|NCT00197002|81457062|FG001|Overall Study|Migrated/moved from study area|5|||
27896629|NCT00197002|81457063|FG002|Overall Study|Migrated/moved from study area|1|||
27896630|NCT00197002|81457061|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
27896631|NCT00197002|81457062|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
27896632|NCT00197002|81457063|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
27896633|NCT00197002|81457061|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
27896634|NCT00197002|81457062|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
27896635|NCT00197002|81457063|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
27896636|NCT00197002|81457061|FG000|Overall Study|Others|3|||
27896637|NCT00197002|81457062|FG001|Overall Study|Others|1|||
27896638|NCT00197002|81457063|FG002|Overall Study|Others|1|||
27896639|NCT03054064|81457065|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
27896640|NCT03054064|81457065|FG000|Overall Study|Investigator Decision|2|||
27896641|NCT03054064|81457065|FG000|Overall Study|Bladder Issue|1|||
27896642|NCT03054064|81457065|FG000|Overall Study|High Blood Pressure|1|||
27896643|NCT03054064|81457065|FG000|Overall Study|Change in Status|1|||
27614031|NCT00154063|80430122|FG001|Overall Study|Withdrawal by Subject|9|||
27614032|NCT00154063|80430121|FG000|Overall Study|Other|3|||
27505962|NCT00459316|80044222|FG000|Steps 1 & 2|Lost to Follow-up|5|||
27614033|NCT00154063|80430122|FG001|Overall Study|Other|3|||
27896644|NCT02071082|81457066|FG000|Overall Study|Enrolled and Never Treated|1|||
27896645|NCT02071082|81457067|FG001|Overall Study|Enrolled and Never Treated|1|||
27896646|NCT02071082|81457066|FG000|Overall Study|Adverse Event|0|||
27896647|NCT02071082|81457067|FG001|Overall Study|Adverse Event|1|||
27896648|NCT02071082|81457066|FG000|Overall Study|Withdrew Consent|0|||
27505963|NCT00459316|80044223|FG001|Steps 1 & 2|Lost to Follow-up|0|||
27614034|NCT01700348|80430123|FG000|Overall Study|Withdrawal by Subject|22|||
27614035|NCT01700348|80430123|FG000|Overall Study|Lost to Follow-up|1|||
27896649|NCT02071082|81457067|FG001|Overall Study|Withdrew Consent|4|||
27896650|NCT02071082|81457066|FG000|Overall Study|Lost to Follow-up|1|||
27896651|NCT02071082|81457067|FG001|Overall Study|Lost to Follow-up|1|||
27896652|NCT01371877|81457068|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
27896653|NCT01371877|81457069|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
27896654|NCT03168919|81457070|FG000|Overall Study|Withdrawal by Subject|2|||
27896655|NCT01844505|81457075|FG000|Overall Study|Disease progression|170|||
27896656|NCT01844505|81457076|FG001|Overall Study|Disease progression|88|||
27896657|NCT01844505|81457077|FG002|Overall Study|Disease progression|224|||
27896658|NCT01844505|81457075|FG000|Overall Study|Study drug toxicity|40|||
27896659|NCT01844505|81457076|FG001|Overall Study|Study drug toxicity|131|||
27896660|NCT01844505|81457077|FG002|Overall Study|Study drug toxicity|50|||
27896661|NCT01844505|81457075|FG000|Overall Study|Death|1|||
27896662|NCT01844505|81457076|FG001|Overall Study|Death|3|||
27896663|NCT01844505|81457077|FG002|Overall Study|Death|1|||
27896664|NCT01844505|81457075|FG000|Overall Study|Adverse event unrelated to study drug|7|||
27896665|NCT01844505|81457076|FG001|Overall Study|Adverse event unrelated to study drug|15|||
27896666|NCT01844505|81457077|FG002|Overall Study|Adverse event unrelated to study drug|6|||
27896667|NCT01844505|81457075|FG000|Overall Study|Subject request discontinue treatment|17|||
27896668|NCT01844505|81457076|FG001|Overall Study|Subject request discontinue treatment|14|||
27896669|NCT01844505|81457077|FG002|Overall Study|Subject request discontinue treatment|8|||
27896670|NCT01844505|81457075|FG000|Overall Study|Withdrawal by Subject|0|||
27896671|NCT01844505|81457076|FG001|Overall Study|Withdrawal by Subject|3|||
27896672|NCT01844505|81457077|FG002|Overall Study|Withdrawal by Subject|0|||
27896673|NCT01844505|81457075|FG000|Overall Study|Lost to Follow-up|1|||
27896674|NCT01844505|81457076|FG001|Overall Study|Lost to Follow-up|0|||
27896675|NCT01844505|81457077|FG002|Overall Study|Lost to Follow-up|0|||
27896676|NCT01844505|81457075|FG000|Overall Study|Maximum clinical benefit|8|||
27896677|NCT01844505|81457076|FG001|Overall Study|Maximum clinical benefit|11|||
27896678|NCT01844505|81457077|FG002|Overall Study|Maximum clinical benefit|2|||
27896679|NCT01844505|81457075|FG000|Overall Study|Poor/non-compliance|1|||
27896680|NCT01844505|81457076|FG001|Overall Study|Poor/non-compliance|1|||
27896681|NCT01844505|81457077|FG002|Overall Study|Poor/non-compliance|1|||
27896682|NCT01844505|81457075|FG000|Overall Study|Subject no longer meets criteria|0|||
27896683|NCT01844505|81457076|FG001|Overall Study|Subject no longer meets criteria|1|||
27896684|NCT01844505|81457077|FG002|Overall Study|Subject no longer meets criteria|0|||
27896685|NCT01844505|81457075|FG000|Overall Study|Other Reasons|4|||
27896686|NCT01844505|81457076|FG001|Overall Study|Other Reasons|2|||
27896687|NCT01844505|81457077|FG002|Overall Study|Other Reasons|2|||
27896688|NCT01844505|81457075|FG000|Overall Study|Not Reported|0|||
27896689|NCT01844505|81457076|FG001|Overall Study|Not Reported|0|||
27896690|NCT01844505|81457077|FG002|Overall Study|Not Reported|1|||
27896691|NCT00622336|81457079|FG000|Treatment Phase|Progression of Disease|181|||
27896692|NCT00622336|81457079|FG000|Treatment Phase|Adverse Event|46|||
27896693|NCT00622336|81457079|FG000|Treatment Phase|Other|40|||
27896694|NCT00622336|81457079|FG000|Treatment Phase|Death|14|||
27896695|NCT00622336|81457079|FG000|Treatment Phase|Lack of therapeutic effect|13|||
27896696|NCT00622336|81457079|FG000|Treatment Phase|Withdrawal by Subject|13|||
27726901|NCT00552110|80830210|FG001|Overall Study|Withdrawal by Subject|2|||
27726902|NCT00552110|80830211|FG002|Overall Study|Withdrawal by Subject|0|||
27726903|NCT00552110|80830212|FG003|Overall Study|Withdrawal by Subject|3|||
27726904|NCT00552110|80830213|FG004|Overall Study|Withdrawal by Subject|2|||
27726905|NCT00552110|80830209|FG000|Overall Study|Lost to Follow-up|0|||
27896697|NCT00622336|81457079|FG000|Treatment Phase|Lost to Follow-up|2|||
27896698|NCT00622336|81457079|FG000|Extension Phase|Adverse Event|2|||
27896699|NCT00622336|81457079|FG000|Extension Phase|Progressive Disease|6|||
27896700|NCT00622336|81457079|FG000|Extension Phase|Lack of therapeutic effect|2|||
27896701|NCT00622336|81457079|FG000|Extension Phase|Withdrawal by Subject|1|||
27896702|NCT00622336|81457079|FG000|Extension Phase|Lost to Follow-up|1|||
27896703|NCT00622336|81457079|FG000|Extension Phase|Other|9|||
27896704|NCT03646305|81457081|FG000|Overall Study|Lost to Follow-up|4|||
27896705|NCT03646305|81457082|FG001|Overall Study|Lost to Follow-up|2|||
27896706|NCT03646305|81457083|FG002|Overall Study|Lost to Follow-up|2|||
27726906|NCT00552110|80830210|FG001|Overall Study|Lost to Follow-up|0|||
27896707|NCT03646305|81457084|FG003|Overall Study|Lost to Follow-up|1|||
27896708|NCT03646305|81457081|FG000|Overall Study|Withdrawal by Subject|1|||
27505964|NCT00459316|80044224|FG002|Steps 1 & 2|Lost to Follow-up|2|||
27505965|NCT00459316|80044222|FG000|Step 3|Withdrawal by Subject|3|||
27505966|NCT00459316|80044223|FG001|Step 3|Withdrawal by Subject|0|||
27896709|NCT03646305|81457082|FG001|Overall Study|Withdrawal by Subject|0|||
27896710|NCT03646305|81457083|FG002|Overall Study|Withdrawal by Subject|0|||
27896711|NCT03646305|81457084|FG003|Overall Study|Withdrawal by Subject|1|||
27896712|NCT01603407|81457085|FG000|Overall Study|Adverse Event|1|||
27896713|NCT01603407|81457086|FG001|Overall Study|Adverse Event|1|||
27896714|NCT01603407|81457087|FG002|Overall Study|Adverse Event|1|||
27896715|NCT01603407|81457085|FG000|Overall Study|Protocol Violation|2|||
27896716|NCT01603407|81457086|FG001|Overall Study|Protocol Violation|2|||
27896717|NCT01603407|81457087|FG002|Overall Study|Protocol Violation|0|||
27896718|NCT01603407|81457085|FG000|Overall Study|Withdrawal by Subject|8|||
27896719|NCT01603407|81457086|FG001|Overall Study|Withdrawal by Subject|5|||
27896720|NCT01603407|81457087|FG002|Overall Study|Withdrawal by Subject|7|||
27896721|NCT01603407|81457085|FG000|Overall Study|Lost to Follow-up|0|||
27896722|NCT01603407|81457086|FG001|Overall Study|Lost to Follow-up|3|||
27896723|NCT01603407|81457087|FG002|Overall Study|Lost to Follow-up|2|||
27896724|NCT00435019|81457090|FG000|Overall Study|Adverse Event|1|||
27896725|NCT00435019|81457091|FG001|Overall Study|Adverse Event|0|||
27896726|NCT00435019|81457090|FG000|Overall Study|Lack of Efficacy|1|||
27896727|NCT00435019|81457091|FG001|Overall Study|Lack of Efficacy|2|||
27896728|NCT00435019|81457090|FG000|Overall Study|Protocol Violation|3|||
27896729|NCT00435019|81457091|FG001|Overall Study|Protocol Violation|1|||
27896730|NCT00435019|81457090|FG000|Overall Study|Personal reasons for withdrawal|8|||
27896731|NCT00435019|81457091|FG001|Overall Study|Personal reasons for withdrawal|7|||
27896732|NCT02919267|81457092|FG000|Overall Study|Protocol Violation|0|||
27896733|NCT02919267|81457093|FG001|Overall Study|Protocol Violation|3|||
27896734|NCT02919267|81457094|FG002|Overall Study|Protocol Violation|3|||
27896735|NCT02919267|81457095|FG003|Overall Study|Protocol Violation|4|||
27896736|NCT02912455|81457096|FG000|Overall Study|Withdrawal by Subject|0|||
27896737|NCT02912455|81457097|FG001|Overall Study|Withdrawal by Subject|1|||
27896738|NCT02912455|81457096|FG000|Overall Study|Lack of Efficacy|0|||
27896739|NCT02912455|81457097|FG001|Overall Study|Lack of Efficacy|1|||
27896740|NCT02912455|81457096|FG000|Overall Study|Lost to Follow-up|2|||
27896741|NCT02912455|81457097|FG001|Overall Study|Lost to Follow-up|1|||
27896742|NCT01472757|81457098|FG000|Overall Study|Withdrawal by Subject|1|||
27896743|NCT01472757|81457099|FG001|Overall Study|Withdrawal by Subject|2|||
27896744|NCT01472757|81457100|FG002|Overall Study|Withdrawal by Subject|2|||
27896745|NCT01472757|81457101|FG003|Overall Study|Withdrawal by Subject|0|||
27896746|NCT01472757|81457098|FG000|Overall Study|Asthma exacerbation|4|||
27896747|NCT01472757|81457099|FG001|Overall Study|Asthma exacerbation|1|||
27896748|NCT01472757|81457100|FG002|Overall Study|Asthma exacerbation|2|||
27896749|NCT01472757|81457101|FG003|Overall Study|Asthma exacerbation|1|||
27896750|NCT01472757|81457098|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
27896751|NCT01472757|81457099|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
27896752|NCT01472757|81457100|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
27896753|NCT01472757|81457101|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
27896754|NCT01472757|81457098|FG000|Overall Study|Protocol Violation|3|||
27896755|NCT01472757|81457099|FG001|Overall Study|Protocol Violation|2|||
27896756|NCT01472757|81457100|FG002|Overall Study|Protocol Violation|4|||
27896757|NCT01472757|81457101|FG003|Overall Study|Protocol Violation|4|||
27896758|NCT01472757|81457098|FG000|Overall Study|Other reasons|1|||
27896759|NCT01472757|81457099|FG001|Overall Study|Other reasons|0|||
27896760|NCT01472757|81457100|FG002|Overall Study|Other reasons|2|||
27896761|NCT01472757|81457101|FG003|Overall Study|Other reasons|2|||
27896762|NCT01279070|81457102|FG000|Overall Study|Withdrawal by Subject|2|||
27896763|NCT01279070|81457103|FG001|Overall Study|Withdrawal by Subject|3|||
27896764|NCT01279070|81457102|FG000|Overall Study|Acute exacerbation|3|||
27896765|NCT01279070|81457103|FG001|Overall Study|Acute exacerbation|1|||
27896766|NCT04459598|81457104|FG000|Overall Study|Adverse Event|1|||
27896767|NCT04459598|81457105|FG001|Overall Study|Adverse Event|1|||
27896768|NCT01527487|81457121|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
27896769|NCT01527487|81457122|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
27896770|NCT01527487|81457121|FG000|Overall Study|Disease Progression|4|||
27896771|NCT01527487|81457122|FG001|Overall Study|Disease Progression|1|||
27896772|NCT01527487|81457121|FG000|Overall Study|Adverse Event|1|||
27849423|NCT01045421|81279125|FG005|Phase 1|Withdrawal by Subject|0|||
27849424|NCT01045421|81279126|FG006|Phase 1|Withdrawal by Subject|0|||
27849425|NCT01045421|81279127|FG007|Phase 1|Withdrawal by Subject|0|||
27849426|NCT01045421|81279128|FG008|Phase 1|Withdrawal by Subject|0|||
27849427|NCT01045421|81279129|FG009|Phase 1|Withdrawal by Subject|0|||
27849428|NCT01045421|81279130|FG010|Phase 1|Withdrawal by Subject|0|||
27849429|NCT01045421|81279120|FG000|Phase 2|Progressive Disease|0|||
27896773|NCT01527487|81457122|FG001|Overall Study|Adverse Event|1|||
27896774|NCT01527487|81457121|FG000|Overall Study|Death|0|||
27896775|NCT01527487|81457122|FG001|Overall Study|Death|1|||
27896776|NCT02054910|81457123|FG000|Overall Study|Lost to Follow-up|4|||
27896777|NCT02054910|81457124|FG001|Overall Study|Lost to Follow-up|1|||
27896778|NCT01995175|81457125|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
27896779|NCT01995175|81457125|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
27896780|NCT01995175|81457125|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
27896781|NCT01995175|81457125|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
27849430|NCT01045421|81279121|FG001|Phase 2|Progressive Disease|0|||
27849431|NCT01045421|81279122|FG002|Phase 2|Progressive Disease|0|||
27849432|NCT01045421|81279123|FG003|Phase 2|Progressive Disease|0|||
27896782|NCT01995175|81457125|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
27896783|NCT01995175|81457125|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
27896784|NCT01995175|81457125|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
27896785|NCT01995175|81457125|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
27896786|NCT01995175|81457125|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
27896787|NCT01917344|81457126|FG000|Overall Study|Withdrawal by Subject|1|||
27896788|NCT01382225|81457127|FG000|Overall Study|Adverse Event|3|||
27896789|NCT01382225|81457128|FG001|Overall Study|Adverse Event|2|||
27896790|NCT01382225|81457127|FG000|Overall Study|Protocol Violation|2|||
27896791|NCT01382225|81457128|FG001|Overall Study|Protocol Violation|1|||
27896792|NCT01382225|81457127|FG000|Overall Study|Subject Withdrew Consent|5|||
27896793|NCT01382225|81457128|FG001|Overall Study|Subject Withdrew Consent|2|||
27896794|NCT01382225|81457127|FG000|Overall Study|Other|4|||
27896795|NCT01382225|81457128|FG001|Overall Study|Other|2|||
27896796|NCT01420679|81457130|FG000|Overall Study|Disease Progression|3|||
27896797|NCT01420679|81457131|FG001|Overall Study|Disease Progression|2|||
27896798|NCT01420679|81457130|FG000|Overall Study|Adverse Event|4|||
27896799|NCT01420679|81457131|FG001|Overall Study|Adverse Event|0|||
27896800|NCT01420679|81457130|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
27896801|NCT01420679|81457131|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
27896802|NCT01420679|81457130|FG000|Overall Study|Patient Decision|1|||
27896803|NCT01420679|81457131|FG001|Overall Study|Patient Decision|0|||
27896804|NCT01420679|81457130|FG000|Overall Study|Investigator Decision|1|||
27896805|NCT01420679|81457131|FG001|Overall Study|Investigator Decision|2|||
27896806|NCT01420679|81457130|FG000|Overall Study|Sponsor Decision|3|||
27896807|NCT01420679|81457131|FG001|Overall Study|Sponsor Decision|3|||
27896808|NCT01420679|81457130|FG000|Overall Study|Other|1|||
27896809|NCT01420679|81457131|FG001|Overall Study|Other|0|||
27896810|NCT01214252|81457134|FG000|Overall Study|Not eligible per protocol|82|||
27896811|NCT00985959|81457140|FG000|Overall Study|Adverse Event|0|||
27896812|NCT00985959|81457141|FG001|Overall Study|Adverse Event|0|||
27896813|NCT00985959|81457142|FG002|Overall Study|Adverse Event|19|||
27896814|NCT00985959|81457140|FG000|Overall Study|Withdrawal by Subject|0|||
27896815|NCT00985959|81457141|FG001|Overall Study|Withdrawal by Subject|0|||
27896816|NCT00985959|81457142|FG002|Overall Study|Withdrawal by Subject|8|||
27896817|NCT00985959|81457140|FG000|Overall Study|Progressive disease|1|||
27896818|NCT00985959|81457141|FG001|Overall Study|Progressive disease|2|||
27896819|NCT00985959|81457142|FG002|Overall Study|Progressive disease|8|||
27896820|NCT00985959|81457140|FG000|Overall Study|Unrecovered toxicity|0|||
27896821|NCT00985959|81457141|FG001|Overall Study|Unrecovered toxicity|0|||
27896822|NCT00985959|81457142|FG002|Overall Study|Unrecovered toxicity|7|||
27896823|NCT00985959|81457140|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
27896824|NCT00985959|81457141|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
27896825|NCT00985959|81457142|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
27896826|NCT00985959|81457140|FG000|Overall Study|Complete response observed over 2 cycles|0|||
27896827|NCT00985959|81457141|FG001|Overall Study|Complete response observed over 2 cycles|1|||
27896828|NCT00985959|81457142|FG002|Overall Study|Complete response observed over 2 cycles|4|||
27896829|NCT00985959|81457140|FG000|Overall Study|Other|0|||
27896830|NCT00985959|81457141|FG001|Overall Study|Other|0|||
27896831|NCT00985959|81457142|FG002|Overall Study|Other|11|||
27896832|NCT00785213|81457143|FG000|Quinine Sulfate Alone|Adverse Event|4|||
27896833|NCT00785213|81457143|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
27896834|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
27896835|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
27896836|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
27896837|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
27896838|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|Death|1|||
27896839|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|Death|1|||
27896840|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
27896841|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
27896842|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
27614036|NCT03051659|80430124|FG000|Treatment Period|Withdrawal by Subject|0|||
27614037|NCT03051659|80430125|FG001|Treatment Period|Withdrawal by Subject|2|||
27896843|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
27896844|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
27896845|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
27896846|NCT00033657|81457149|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
27896847|NCT00033657|81457150|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
27896848|NCT00033657|81457149|FG000|Surgical Resection|not complete resection|0|||
27896849|NCT00033657|81457150|FG001|Surgical Resection|not complete resection|3|||
27896850|NCT00033657|81457149|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
27896851|NCT00033657|81457150|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
27896852|NCT00033657|81457149|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
27896853|NCT00033657|81457150|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
27896854|NCT00033657|81457149|FG000|Adjuvant Chemotherapy|Death|2|||
27896855|NCT00033657|81457150|FG001|Adjuvant Chemotherapy|Death|1|||
27896856|NCT00033657|81457149|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
27896857|NCT00033657|81457150|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
27896858|NCT00033657|81457149|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
27896859|NCT00033657|81457150|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
27896860|NCT00033657|81457149|FG000|Adjuvant Chemotherapy|Other|0|||
27896861|NCT00033657|81457150|FG001|Adjuvant Chemotherapy|Other|2|||
27896862|NCT00347919|81457151|FG000|Overall Study|Lost to Follow-up|11|||
27896863|NCT00347919|81457152|FG001|Overall Study|Lost to Follow-up|13|||
27896864|NCT00347919|81457153|FG002|Overall Study|Lost to Follow-up|0|||
27896865|NCT00347919|81457151|FG000|Overall Study|Withdrawal by Subject|6|||
27896866|NCT00347919|81457152|FG001|Overall Study|Withdrawal by Subject|8|||
27896867|NCT00347919|81457153|FG002|Overall Study|Withdrawal by Subject|0|||
27896868|NCT00347919|81457151|FG000|Overall Study|Physician Decision|1|||
27896869|NCT00347919|81457152|FG001|Overall Study|Physician Decision|1|||
27896870|NCT00347919|81457153|FG002|Overall Study|Physician Decision|0|||
27896871|NCT00347919|81457151|FG000|Overall Study|Sponsor terminated study|15|||
27896872|NCT00347919|81457152|FG001|Overall Study|Sponsor terminated study|10|||
27896873|NCT00347919|81457153|FG002|Overall Study|Sponsor terminated study|16|||
27896874|NCT00347919|81457151|FG000|Overall Study|Death|35|||
27896875|NCT00347919|81457152|FG001|Overall Study|Death|42|||
27896876|NCT00347919|81457153|FG002|Overall Study|Death|19|||
27896877|NCT00347919|81457151|FG000|Overall Study|Par. Started Other Treatment|1|||
27896878|NCT00347919|81457152|FG001|Overall Study|Par. Started Other Treatment|1|||
27896879|NCT00347919|81457153|FG002|Overall Study|Par. Started Other Treatment|1|||
27896880|NCT00347919|81457151|FG000|Overall Study|Missing|2|||
27896881|NCT00347919|81457152|FG001|Overall Study|Missing|1|||
27896882|NCT00347919|81457153|FG002|Overall Study|Missing|2|||
27896883|NCT02073565|81457156|FG000|Cohort A|Withdrawal by Subject|1|||
27896884|NCT02073565|81457157|FG001|Cohort A|Withdrawal by Subject|0|||
27896885|NCT02073565|81457156|FG000|Cohort B|Withdrawal by Subject|1|||
27896886|NCT02073565|81457157|FG001|Cohort B|Withdrawal by Subject|2|||
27896887|NCT02073565|81457156|FG000|Cohort C|Withdrawal by Subject|0|||
27849433|NCT01045421|81279124|FG004|Phase 2|Progressive Disease|0|||
27849434|NCT01045421|81279125|FG005|Phase 2|Progressive Disease|0|||
27849435|NCT01045421|81279126|FG006|Phase 2|Progressive Disease|0|||
27849436|NCT01045421|81279127|FG007|Phase 2|Progressive Disease|1|||
27849437|NCT01045421|81279128|FG008|Phase 2|Progressive Disease|1|||
27849438|NCT01045421|81279129|FG009|Phase 2|Progressive Disease|1|||
27849439|NCT01045421|81279130|FG010|Phase 2|Progressive Disease|1|||
27849440|NCT01045421|81279120|FG000|Phase 2|Death|0|||
27849441|NCT01045421|81279121|FG001|Phase 2|Death|0|||
27849442|NCT01045421|81279122|FG002|Phase 2|Death|0|||
27849443|NCT01045421|81279123|FG003|Phase 2|Death|0|||
27849444|NCT01045421|81279124|FG004|Phase 2|Death|0|||
27849445|NCT01045421|81279125|FG005|Phase 2|Death|0|||
27896888|NCT02073565|81457157|FG001|Cohort C|Withdrawal by Subject|2|||
27896889|NCT02073565|81457156|FG000|Cohort C|Lost to Follow-up|0|||
27849446|NCT01045421|81279126|FG006|Phase 2|Death|0|||
27849447|NCT01045421|81279127|FG007|Phase 2|Death|1|||
27849448|NCT01045421|81279128|FG008|Phase 2|Death|1|||
27896890|NCT02073565|81457157|FG001|Cohort C|Lost to Follow-up|2|||
27896891|NCT02678000|81457158|FG000|PART 2|Adverse Event|0|||
27896892|NCT02678000|81457159|FG001|PART 2|Adverse Event|0|||
27896893|NCT02678000|81457160|FG002|PART 2|Adverse Event|2|||
27896894|NCT02678000|81457161|FG003|PART 2|Adverse Event|1|||
27896895|NCT02678000|81457162|FG004|PART 2|Adverse Event|0|||
27896896|NCT02678000|81457158|FG000|PART 2|Withdrawal by Subject|0|||
27896897|NCT02678000|81457159|FG001|PART 2|Withdrawal by Subject|0|||
27896898|NCT02678000|81457160|FG002|PART 2|Withdrawal by Subject|1|||
27896899|NCT02678000|81457161|FG003|PART 2|Withdrawal by Subject|0|||
27896900|NCT02678000|81457162|FG004|PART 2|Withdrawal by Subject|0|||
27896901|NCT02079636|81457163|FG000|Overall Study|Death|2|||
27896902|NCT02079636|81457164|FG001|Overall Study|Death|1|||
27896903|NCT02079636|81457165|FG002|Overall Study|Death|0|||
27896904|NCT02079636|81457166|FG003|Overall Study|Death|5|||
27896905|NCT02079636|81457167|FG004|Overall Study|Death|1|||
27896906|NCT02079636|81457168|FG005|Overall Study|Death|2|||
27896907|NCT02079636|81457169|FG006|Overall Study|Death|1|||
27896908|NCT02079636|81457170|FG007|Overall Study|Death|0|||
27896909|NCT02079636|81457171|FG008|Overall Study|Death|0|||
27896910|NCT02079636|81457172|FG009|Overall Study|Death|0|||
27896911|NCT02079636|81457173|FG010|Overall Study|Death|0|||
27896912|NCT02079636|81457174|FG011|Overall Study|Death|1|||
27896913|NCT02079636|81457175|FG012|Overall Study|Death|1|||
27896914|NCT02079636|81457176|FG013|Overall Study|Death|0|||
27896915|NCT02079636|81457177|FG014|Overall Study|Death|2|||
27896916|NCT02079636|81457163|FG000|Overall Study|Adverse Event|1|||
27896917|NCT02079636|81457164|FG001|Overall Study|Adverse Event|1|||
27896918|NCT02079636|81457165|FG002|Overall Study|Adverse Event|0|||
27896919|NCT02079636|81457166|FG003|Overall Study|Adverse Event|1|||
27896920|NCT02079636|81457167|FG004|Overall Study|Adverse Event|1|||
27896921|NCT02079636|81457168|FG005|Overall Study|Adverse Event|2|||
27896922|NCT02079636|81457169|FG006|Overall Study|Adverse Event|0|||
27896923|NCT02079636|81457170|FG007|Overall Study|Adverse Event|0|||
27896924|NCT02079636|81457171|FG008|Overall Study|Adverse Event|0|||
27896925|NCT02079636|81457172|FG009|Overall Study|Adverse Event|0|||
27896926|NCT02079636|81457173|FG010|Overall Study|Adverse Event|0|||
27896927|NCT02079636|81457174|FG011|Overall Study|Adverse Event|0|||
27896928|NCT02079636|81457175|FG012|Overall Study|Adverse Event|0|||
27896929|NCT02079636|81457176|FG013|Overall Study|Adverse Event|0|||
27896930|NCT02079636|81457177|FG014|Overall Study|Adverse Event|0|||
27896931|NCT02079636|81457163|FG000|Overall Study|Progressive disease|0|||
27896932|NCT02079636|81457164|FG001|Overall Study|Progressive disease|0|||
27896933|NCT02079636|81457165|FG002|Overall Study|Progressive disease|0|||
27896934|NCT02079636|81457166|FG003|Overall Study|Progressive disease|2|||
27896935|NCT02079636|81457167|FG004|Overall Study|Progressive disease|0|||
27896936|NCT02079636|81457168|FG005|Overall Study|Progressive disease|0|||
27896937|NCT02079636|81457169|FG006|Overall Study|Progressive disease|0|||
27896938|NCT02079636|81457170|FG007|Overall Study|Progressive disease|0|||
27896939|NCT02079636|81457171|FG008|Overall Study|Progressive disease|0|||
27849449|NCT01045421|81279129|FG009|Phase 2|Death|2|||
27849450|NCT01045421|81279130|FG010|Phase 2|Death|0|||
27849451|NCT01045421|81279120|FG000|Phase 2|Other|0|||
27849452|NCT01045421|81279121|FG001|Phase 2|Other|0|||
27849453|NCT01045421|81279122|FG002|Phase 2|Other|0|||
27849454|NCT01045421|81279123|FG003|Phase 2|Other|0|||
27849455|NCT01045421|81279124|FG004|Phase 2|Other|0|||
27849456|NCT01045421|81279125|FG005|Phase 2|Other|0|||
27849457|NCT01045421|81279126|FG006|Phase 2|Other|0|||
27849458|NCT01045421|81279127|FG007|Phase 2|Other|3|||
27849459|NCT01045421|81279128|FG008|Phase 2|Other|0|||
27849460|NCT01045421|81279129|FG009|Phase 2|Other|0|||
27849461|NCT01045421|81279130|FG010|Phase 2|Other|1|||
27849462|NCT01791153|81279131|FG000|Part 1: Blinded Period|Adverse Event|7|||
27849463|NCT01791153|81279132|FG001|Part 1: Blinded Period|Adverse Event|3|||
27849464|NCT01791153|81279133|FG002|Part 1: Blinded Period|Adverse Event|2|||
27849465|NCT01791153|81279134|FG003|Part 1: Blinded Period|Adverse Event|0|||
27849466|NCT01791153|81279135|FG004|Part 1: Blinded Period|Adverse Event|0|||
27849467|NCT01791153|81279136|FG005|Part 1: Blinded Period|Adverse Event|0|||
27849468|NCT01791153|81279137|FG006|Part 1: Blinded Period|Adverse Event|0|||
27849469|NCT01791153|81279138|FG007|Part 1: Blinded Period|Adverse Event|0|||
27849470|NCT01791153|81279131|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
27849471|NCT01791153|81279132|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
27896940|NCT02079636|81457172|FG009|Overall Study|Progressive disease|0|||
27896941|NCT02079636|81457173|FG010|Overall Study|Progressive disease|0|||
27896942|NCT02079636|81457174|FG011|Overall Study|Progressive disease|0|||
27896943|NCT02079636|81457175|FG012|Overall Study|Progressive disease|1|||
27896944|NCT02079636|81457176|FG013|Overall Study|Progressive disease|0|||
27896945|NCT02079636|81457177|FG014|Overall Study|Progressive disease|0|||
27896946|NCT02079636|81457163|FG000|Overall Study|Withdrawal by Subject|0|||
27896947|NCT02079636|81457164|FG001|Overall Study|Withdrawal by Subject|0|||
27896948|NCT02079636|81457165|FG002|Overall Study|Withdrawal by Subject|0|||
27896949|NCT02079636|81457166|FG003|Overall Study|Withdrawal by Subject|4|||
27896950|NCT02079636|81457167|FG004|Overall Study|Withdrawal by Subject|0|||
27896951|NCT02079636|81457168|FG005|Overall Study|Withdrawal by Subject|1|||
27896952|NCT02079636|81457169|FG006|Overall Study|Withdrawal by Subject|0|||
27896953|NCT02079636|81457170|FG007|Overall Study|Withdrawal by Subject|0|||
27896954|NCT02079636|81457171|FG008|Overall Study|Withdrawal by Subject|0|||
27896955|NCT02079636|81457172|FG009|Overall Study|Withdrawal by Subject|2|||
27896956|NCT02079636|81457173|FG010|Overall Study|Withdrawal by Subject|1|||
27896957|NCT02079636|81457174|FG011|Overall Study|Withdrawal by Subject|1|||
27726907|NCT00552110|80830211|FG002|Overall Study|Lost to Follow-up|0|||
27726908|NCT00552110|80830212|FG003|Overall Study|Lost to Follow-up|1|||
27726909|NCT00552110|80830213|FG004|Overall Study|Lost to Follow-up|1|||
27726910|NCT00552110|80830209|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
27726911|NCT00552110|80830210|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
27726912|NCT00552110|80830211|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
27726913|NCT00552110|80830212|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
27726914|NCT00552110|80830213|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
27726915|NCT00552110|80830209|FG000|Overall Study|Withdrawn per Sponsor|0|||
27726916|NCT00552110|80830210|FG001|Overall Study|Withdrawn per Sponsor|1|||
27726917|NCT00552110|80830211|FG002|Overall Study|Withdrawn per Sponsor|0|||
27726918|NCT00552110|80830212|FG003|Overall Study|Withdrawn per Sponsor|0|||
27726919|NCT00552110|80830213|FG004|Overall Study|Withdrawn per Sponsor|1|||
27726920|NCT00552110|80830209|FG000|Overall Study|Use of Prohibited Medication|1|||
27726921|NCT00552110|80830210|FG001|Overall Study|Use of Prohibited Medication|1|||
27726922|NCT00552110|80830211|FG002|Overall Study|Use of Prohibited Medication|0|||
27726923|NCT00552110|80830212|FG003|Overall Study|Use of Prohibited Medication|0|||
27726924|NCT00552110|80830213|FG004|Overall Study|Use of Prohibited Medication|0|||
27726925|NCT00552110|80830209|FG000|Overall Study|Delay of Study due to Relabeling|0|||
27726926|NCT00552110|80830210|FG001|Overall Study|Delay of Study due to Relabeling|0|||
27726927|NCT00552110|80830211|FG002|Overall Study|Delay of Study due to Relabeling|0|||
27726928|NCT00552110|80830212|FG003|Overall Study|Delay of Study due to Relabeling|1|||
27726929|NCT00552110|80830213|FG004|Overall Study|Delay of Study due to Relabeling|0|||
27726930|NCT00552110|80830209|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
27726931|NCT00552110|80830210|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
27726932|NCT00552110|80830211|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
27726933|NCT00552110|80830212|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
27726934|NCT00552110|80830213|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
27726935|NCT00552110|80830209|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
27726936|NCT00552110|80830210|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
27726937|NCT00552110|80830211|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
27726938|NCT00552110|80830212|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
27726939|NCT00552110|80830213|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
27726940|NCT02700984|80830214|FG000|Overall Study|Death|2|||
27726941|NCT02700984|80830215|FG001|Overall Study|Death|1|||
27726942|NCT02700984|80830214|FG000|Overall Study|Lost to Follow-up|2|||
27726943|NCT02700984|80830215|FG001|Overall Study|Lost to Follow-up|1|||
27726944|NCT02700984|80830214|FG000|Overall Study|Physician Decision|0|||
27726945|NCT02700984|80830215|FG001|Overall Study|Physician Decision|1|||
27726946|NCT02700984|80830214|FG000|Overall Study|Withdrawal by Subject|8|||
27726947|NCT02700984|80830215|FG001|Overall Study|Withdrawal by Subject|9|||
27726948|NCT02700984|80830214|FG000|Overall Study|Reason not specified|3|||
27726949|NCT02700984|80830215|FG001|Overall Study|Reason not specified|2|||
27505967|NCT00459316|80044224|FG002|Step 3|Withdrawal by Subject|1|||
27505968|NCT05101122|80044228|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
27505969|NCT05101122|80044228|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
27505970|NCT05101122|80044228|FG000|AD313 80/5|Withdrawal by Subject|1|||
27505971|NCT05101122|80044228|FG000|AD313 80/10|Physician Decision|1|||
27505972|NCT00260533|80044229|FG000|Overall Study|Other|3|||
27505973|NCT00260533|80044230|FG001|Overall Study|Other|3|||
27505974|NCT00577889|80044231|FG000|Overall Study|Withdrawal by Subject|1|||
27505975|NCT00577889|80044232|FG001|Overall Study|Withdrawal by Subject|0|||
27505976|NCT00577889|80044233|FG002|Overall Study|Withdrawal by Subject|0|||
27505977|NCT00935584|80044235|FG000|Overall Study|Withdrawal by Subject|9|||
27505978|NCT00935584|80044236|FG001|Overall Study|Withdrawal by Subject|0|||
27505979|NCT00935584|80044235|FG000|Overall Study|Death|3|||
27505980|NCT00935584|80044236|FG001|Overall Study|Death|0|||
27505981|NCT00935584|80044235|FG000|Overall Study|Lost to Follow-up|8|||
27505982|NCT00935584|80044236|FG001|Overall Study|Lost to Follow-up|0|||
27505983|NCT00935584|80044235|FG000|Overall Study|No show|9|||
27505984|NCT00935584|80044236|FG001|Overall Study|No show|0|||
27614038|NCT03051659|80430124|FG000|Survival Follow-up|Lost to Follow-up|23|||
27726950|NCT01467492|80830219|FG000|Overall Study|Withdrawal by Subject|6|||
27726951|NCT01467492|80830220|FG001|Overall Study|Withdrawal by Subject|4|||
27726952|NCT01467492|80830219|FG000|Overall Study|Study Terminated by Sponsor|6|||
27726953|NCT01467492|80830220|FG001|Overall Study|Study Terminated by Sponsor|4|||
27896958|NCT02079636|81457175|FG012|Overall Study|Withdrawal by Subject|1|||
27896959|NCT02079636|81457176|FG013|Overall Study|Withdrawal by Subject|0|||
27505985|NCT00935584|80044235|FG000|Overall Study|Relocated|3|||
27614039|NCT03051659|80430125|FG001|Survival Follow-up|Lost to Follow-up|22|||
27505986|NCT00935584|80044236|FG001|Overall Study|Relocated|0|||
27505987|NCT00935584|80044235|FG000|Overall Study|Patient changed provider|3|||
27505988|NCT00935584|80044236|FG001|Overall Study|Patient changed provider|0|||
27505989|NCT00935584|80044235|FG000|Overall Study|Provider dropped out of study|14|||
27614040|NCT02262260|80430126|FG000|Overall Study|Adverse Event|4|||
27896960|NCT02079636|81457177|FG014|Overall Study|Withdrawal by Subject|2|||
27896961|NCT02079636|81457163|FG000|Overall Study|Physician Decision|0|||
27896962|NCT02079636|81457164|FG001|Overall Study|Physician Decision|0|||
27896963|NCT02079636|81457165|FG002|Overall Study|Physician Decision|0|||
27896964|NCT02079636|81457166|FG003|Overall Study|Physician Decision|0|||
27896965|NCT02079636|81457167|FG004|Overall Study|Physician Decision|0|||
27896966|NCT02079636|81457168|FG005|Overall Study|Physician Decision|1|||
27896967|NCT02079636|81457169|FG006|Overall Study|Physician Decision|0|||
27896968|NCT02079636|81457170|FG007|Overall Study|Physician Decision|0|||
27896969|NCT02079636|81457171|FG008|Overall Study|Physician Decision|0|||
27896970|NCT02079636|81457172|FG009|Overall Study|Physician Decision|1|||
27896971|NCT02079636|81457173|FG010|Overall Study|Physician Decision|1|||
27896972|NCT02079636|81457174|FG011|Overall Study|Physician Decision|0|||
27896973|NCT02079636|81457175|FG012|Overall Study|Physician Decision|0|||
27896974|NCT02079636|81457176|FG013|Overall Study|Physician Decision|0|||
27896975|NCT02079636|81457177|FG014|Overall Study|Physician Decision|1|||
27896976|NCT02079636|81457163|FG000|Overall Study|Lost to Follow-up|0|||
27896977|NCT02079636|81457164|FG001|Overall Study|Lost to Follow-up|0|||
27896978|NCT02079636|81457165|FG002|Overall Study|Lost to Follow-up|0|||
27896979|NCT02079636|81457166|FG003|Overall Study|Lost to Follow-up|0|||
27896980|NCT02079636|81457167|FG004|Overall Study|Lost to Follow-up|0|||
27896981|NCT02079636|81457168|FG005|Overall Study|Lost to Follow-up|0|||
27896982|NCT02079636|81457169|FG006|Overall Study|Lost to Follow-up|0|||
27896983|NCT02079636|81457170|FG007|Overall Study|Lost to Follow-up|1|||
27896984|NCT02079636|81457171|FG008|Overall Study|Lost to Follow-up|0|||
27896985|NCT02079636|81457172|FG009|Overall Study|Lost to Follow-up|0|||
27896986|NCT02079636|81457173|FG010|Overall Study|Lost to Follow-up|0|||
27896987|NCT02079636|81457174|FG011|Overall Study|Lost to Follow-up|0|||
27896988|NCT02079636|81457175|FG012|Overall Study|Lost to Follow-up|0|||
27896989|NCT02079636|81457176|FG013|Overall Study|Lost to Follow-up|0|||
27896990|NCT02079636|81457177|FG014|Overall Study|Lost to Follow-up|0|||
27896991|NCT03181503|81457178|FG000|Overall Study|Adverse Event|2|||
27896992|NCT03181503|81457179|FG001|Overall Study|Adverse Event|2|||
27896993|NCT03181503|81457178|FG000|Overall Study|Protocol Violation|1|||
27896994|NCT03181503|81457179|FG001|Overall Study|Protocol Violation|0|||
27896995|NCT03181503|81457178|FG000|Overall Study|Withdrawal by Subject|3|||
27896996|NCT03181503|81457179|FG001|Overall Study|Withdrawal by Subject|0|||
27896997|NCT03181503|81457178|FG000|Overall Study|Lost to Follow-up|1|||
27896998|NCT03181503|81457179|FG001|Overall Study|Lost to Follow-up|1|||
27896999|NCT03738800|81457180|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
27897000|NCT03738800|81457181|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27897001|NCT03738800|81457182|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27897002|NCT03738800|81457180|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
27897003|NCT03738800|81457181|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
27897004|NCT03738800|81457182|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
27897005|NCT03738800|81457180|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
27897006|NCT03738800|81457181|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
27897007|NCT03738800|81457182|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
27897008|NCT03325894|81457186|FG000|Overall Study|Adverse Event|2|||
27897009|NCT03325894|81457187|FG001|Overall Study|Adverse Event|3|||
27897010|NCT03325894|81457186|FG000|Overall Study|Protocol Violation|1|||
27897011|NCT03325894|81457187|FG001|Overall Study|Protocol Violation|2|||
27897012|NCT03325894|81457186|FG000|Overall Study|Withdrawal by Subject|10|||
27505990|NCT00935584|80044236|FG001|Overall Study|Provider dropped out of study|4|||
27505991|NCT04393454|80044239|FG000|Overall Study|Death|1|||
27505992|NCT04393454|80044239|FG000|Overall Study|Lost to Follow-up|1|||
27897013|NCT03325894|81457187|FG001|Overall Study|Withdrawal by Subject|6|||
27897014|NCT03325894|81457186|FG000|Overall Study|Lost to Follow-up|4|||
27897015|NCT03325894|81457187|FG001|Overall Study|Lost to Follow-up|9|||
27897016|NCT03325894|81457186|FG000|Overall Study|Lack of Efficacy|8|||
27897017|NCT03325894|81457187|FG001|Overall Study|Lack of Efficacy|14|||
27505993|NCT03414983|80044240|FG000|Pre-Treatment|Other reasons|1|||
27505994|NCT03414983|80044241|FG001|Pre-Treatment|Other reasons|0|||
27505995|NCT03414983|80044240|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
27505996|NCT03414983|80044241|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
27505997|NCT03414983|80044240|FG000|Pre-Treatment|Participant withdrew consent|1|||
27897018|NCT03325894|81457186|FG000|Overall Study|Study Terminated by Sponsor|38|||
27897019|NCT03325894|81457187|FG001|Overall Study|Study Terminated by Sponsor|43|||
27897020|NCT03325894|81457186|FG000|Overall Study|Other (Not received Treatment)|1|||
27897021|NCT03325894|81457187|FG001|Overall Study|Other (Not received Treatment)|0|||
27897022|NCT01524783|81457188|FG000|Blinded Period|Adverse Event|64|||
27897023|NCT01524783|81457189|FG001|Blinded Period|Adverse Event|7|||
27897024|NCT01524783|81457190|FG002|Blinded Period|Adverse Event|0|||
27897025|NCT01524783|81457188|FG000|Blinded Period|Disease Progression|89|||
27897026|NCT01524783|81457189|FG001|Blinded Period|Disease Progression|75|||
27897027|NCT01524783|81457190|FG002|Blinded Period|Disease Progression|0|||
27897028|NCT01524783|81457188|FG000|Blinded Period|Withdrawal by Subject|19|||
27897029|NCT01524783|81457189|FG001|Blinded Period|Withdrawal by Subject|6|||
27897030|NCT01524783|81457190|FG002|Blinded Period|Withdrawal by Subject|0|||
27897031|NCT01524783|81457188|FG000|Blinded Period|Protocol deviation|2|||
27897032|NCT01524783|81457189|FG001|Blinded Period|Protocol deviation|1|||
27897033|NCT01524783|81457190|FG002|Blinded Period|Protocol deviation|0|||
27897034|NCT01524783|81457188|FG000|Blinded Period|Death|5|||
27897035|NCT01524783|81457189|FG001|Blinded Period|Death|2|||
27897036|NCT01524783|81457190|FG002|Blinded Period|Death|0|||
27897037|NCT01524783|81457188|FG000|Open-label Period|Disease progression|13|||
27897038|NCT01524783|81457189|FG001|Open-label Period|Disease progression|0|||
27897039|NCT01524783|81457190|FG002|Open-label Period|Disease progression|2|||
27897040|NCT01524783|81457188|FG000|Open-label Period|Administrative problems|5|||
27897041|NCT01524783|81457189|FG001|Open-label Period|Administrative problems|0|||
27897042|NCT01524783|81457190|FG002|Open-label Period|Administrative problems|2|||
27897043|NCT01524783|81457188|FG000|Open-label Period|Adverse Event|5|||
27897044|NCT01524783|81457189|FG001|Open-label Period|Adverse Event|0|||
27897045|NCT01524783|81457190|FG002|Open-label Period|Adverse Event|1|||
27897046|NCT01524783|81457188|FG000|Open-label Period|Withdrawal by Subject|2|||
27897047|NCT01524783|81457189|FG001|Open-label Period|Withdrawal by Subject|0|||
27897048|NCT01524783|81457190|FG002|Open-label Period|Withdrawal by Subject|1|||
27897049|NCT01524783|81457188|FG000|Open-label Period|Protocol deviation|1|||
27897050|NCT01524783|81457189|FG001|Open-label Period|Protocol deviation|0|||
27897051|NCT01524783|81457190|FG002|Open-label Period|Protocol deviation|0|||
27897052|NCT02258334|81457191|FG000|Overall Study|Adverse Event|1|||
27897053|NCT02258334|81457192|FG001|Overall Study|Adverse Event|0|||
27897054|NCT02258334|81457193|FG002|Overall Study|Adverse Event|0|||
27897055|NCT02258334|81457194|FG003|Overall Study|Adverse Event|0|||
27897056|NCT02791438|81457195|FG000|Treatment Period|Adverse Event|1|||
27897057|NCT02791438|81457196|FG001|Treatment Period|Adverse Event|0|||
27897058|NCT02791438|81457195|FG000|Treatment Period|Withdrawal by Subject|0|||
27897059|NCT02791438|81457196|FG001|Treatment Period|Withdrawal by Subject|1|||
27897060|NCT02791438|81457195|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
27897061|NCT02791438|81457196|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
27897062|NCT02638259|81457197|FG000|Treatment Period 1|Adverse Event|1|||
27897063|NCT02638259|81457198|FG001|Treatment Period 1|Adverse Event|5|||
27897064|NCT02638259|81457197|FG000|Treatment Period 1|Death|0|||
27897065|NCT02638259|81457198|FG001|Treatment Period 1|Death|1|||
27897066|NCT02638259|81457197|FG000|Treatment Period 1|Lack of Efficacy|0|||
27897067|NCT02638259|81457198|FG001|Treatment Period 1|Lack of Efficacy|1|||
27897068|NCT02638259|81457197|FG000|Treatment Period 1|Protocol Violation|0|||
27897069|NCT02638259|81457198|FG001|Treatment Period 1|Protocol Violation|3|||
27897070|NCT02638259|81457197|FG000|Treatment Period 1|Withdrawal by Subject|4|||
27897071|NCT02638259|81457198|FG001|Treatment Period 1|Withdrawal by Subject|6|||
27897072|NCT02638259|81457197|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
27897073|NCT02638259|81457198|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
27897074|NCT02638259|81457197|FG000|Treatment Period 2|Adverse Event|5|||
27897075|NCT02638259|81457198|FG001|Treatment Period 2|Adverse Event|4|||
27897076|NCT02638259|81457197|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27897077|NCT02638259|81457198|FG001|Treatment Period 2|Withdrawal by Subject|7|||
27897078|NCT02928770|81457199|FG000|Overall Study|Withdrawal by Subject|2|||
27897079|NCT01944670|81457200|FG000|Overall Study|Lost to Follow-up|2|||
27897080|NCT00962091|81457201|FG000|Overall Study|Withdrawal by Subject|1|||
27897081|NCT00962091|81457202|FG001|Overall Study|Withdrawal by Subject|2|||
27897082|NCT00962091|81457203|FG002|Overall Study|Withdrawal by Subject|1|||
27897083|NCT00962091|81457204|FG003|Overall Study|Withdrawal by Subject|1|||
27897084|NCT00962091|81457205|FG004|Overall Study|Withdrawal by Subject|0|||
27897085|NCT00962091|81457206|FG005|Overall Study|Withdrawal by Subject|1|||
27897086|NCT00962091|81457207|FG006|Overall Study|Withdrawal by Subject|0|||
27897087|NCT00962091|81457201|FG000|Overall Study|Adverse Event|0|||
27897088|NCT00962091|81457202|FG001|Overall Study|Adverse Event|0|||
27897089|NCT00962091|81457203|FG002|Overall Study|Adverse Event|0|||
27897090|NCT00962091|81457204|FG003|Overall Study|Adverse Event|0|||
27897091|NCT00962091|81457205|FG004|Overall Study|Adverse Event|0|||
27897092|NCT00962091|81457206|FG005|Overall Study|Adverse Event|0|||
27897093|NCT00962091|81457207|FG006|Overall Study|Adverse Event|1|||
27897094|NCT01534208|81457208|FG000|Overall Study|Lost to Follow-up|19|||
27897095|NCT01534208|81457209|FG001|Overall Study|Lost to Follow-up|14|||
27897096|NCT01534208|81457208|FG000|Overall Study|Withdrawal by Subject|6|||
27897097|NCT01534208|81457209|FG001|Overall Study|Withdrawal by Subject|20|||
27897098|NCT01534208|81457208|FG000|Overall Study|Adverse Event|15|||
27897099|NCT01534208|81457209|FG001|Overall Study|Adverse Event|8|||
27897100|NCT01534208|81457208|FG000|Overall Study|Physician Decision|2|||
27897101|NCT01534208|81457209|FG001|Overall Study|Physician Decision|0|||
27897102|NCT01534208|81457208|FG000|Overall Study|Lack of Efficacy|0|||
27897103|NCT01534208|81457209|FG001|Overall Study|Lack of Efficacy|3|||
27897104|NCT01534208|81457208|FG000|Overall Study|Protocol Violation|2|||
27897105|NCT01534208|81457209|FG001|Overall Study|Protocol Violation|2|||
27897106|NCT01534208|81457208|FG000|Overall Study|Sponsor decision|4|||
27897107|NCT01534208|81457209|FG001|Overall Study|Sponsor decision|1|||
27897108|NCT01534208|81457208|FG000|Overall Study|Subject relocation|2|||
27897109|NCT01534208|81457209|FG001|Overall Study|Subject relocation|0|||
27897110|NCT01534208|81457208|FG000|Overall Study|Lab assessment|2|||
27897111|NCT01534208|81457209|FG001|Overall Study|Lab assessment|1|||
27897112|NCT01534208|81457208|FG000|Overall Study|Eligibility error|3|||
27897113|NCT01534208|81457209|FG001|Overall Study|Eligibility error|0|||
27897114|NCT01534208|81457208|FG000|Overall Study|PCP decision|1|||
27897115|NCT01534208|81457209|FG001|Overall Study|PCP decision|0|||
27897116|NCT01534208|81457208|FG000|Overall Study|Needed prohibited meds|1|||
27897117|NCT01534208|81457209|FG001|Overall Study|Needed prohibited meds|0|||
27897118|NCT01283334|81457213|FG000|Overall Study|Withdrawal by Subject|1|||
27897119|NCT01283334|81457213|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
27897120|NCT01283334|81457213|FG000|Overall Study|Adverse Event|4|||
27897121|NCT01283334|81457213|FG000|Overall Study|Physician Decision|1|||
27897122|NCT02669082|81457214|FG000|Overall Study|Adverse Event|1|||
27897123|NCT00430352|81457217|FG000|Overall Study|Disease progression|58|||
27897124|NCT00430352|81457217|FG000|Overall Study|Withdrawal by Subject|11|||
27897125|NCT00430352|81457217|FG000|Overall Study|Adverse Event|16|||
27897126|NCT00430352|81457217|FG000|Overall Study|Death|5|||
27897127|NCT00430352|81457217|FG000|Overall Study|Other|48|||
27897128|NCT02638129|81457218|FG000|Overall Study|Study terminated|28|||
27897129|NCT02638129|81457219|FG001|Overall Study|Study terminated|30|||
27897130|NCT01952080|81457220|FG000|Overall Study|Withdrawal by Subject|0|||
27897131|NCT01952080|81457221|FG001|Overall Study|Withdrawal by Subject|0|||
27897132|NCT01952080|81457222|FG002|Overall Study|Withdrawal by Subject|0|||
27897133|NCT01952080|81457223|FG003|Overall Study|Withdrawal by Subject|1|||
27897134|NCT01952080|81457220|FG000|Overall Study|Protocol Non-compliance|0|||
27897135|NCT01952080|81457221|FG001|Overall Study|Protocol Non-compliance|1|||
27897136|NCT01952080|81457222|FG002|Overall Study|Protocol Non-compliance|0|||
27897137|NCT01952080|81457223|FG003|Overall Study|Protocol Non-compliance|0|||
27897138|NCT02332239|81457224|FG000|Overall Study|Lost to Follow-up|4|||
27897139|NCT02332239|81457225|FG001|Overall Study|Lost to Follow-up|6|||
27897140|NCT03570554|81457228|FG000|Overall Study|Non-compliance with study drug|0|||
27897141|NCT03570554|81457229|FG001|Overall Study|Non-compliance with study drug|0|||
27897142|NCT03570554|81457230|FG002|Overall Study|Non-compliance with study drug|1|||
27897143|NCT03570554|81457231|FG003|Overall Study|Non-compliance with study drug|0|||
27897144|NCT03570554|81457228|FG000|Overall Study|Adverse Event|0|||
27897145|NCT03570554|81457229|FG001|Overall Study|Adverse Event|0|||
27897146|NCT03570554|81457230|FG002|Overall Study|Adverse Event|0|||
27897147|NCT03570554|81457231|FG003|Overall Study|Adverse Event|1|||
27897148|NCT04599933|81457232|FG000|Overall Study|Adverse Event|4|||
27897149|NCT04599933|81457233|FG001|Overall Study|Adverse Event|1|||
27897150|NCT04599933|81457232|FG000|Overall Study|Withdrawal by Subject|4|||
27897151|NCT04599933|81457233|FG001|Overall Study|Withdrawal by Subject|2|||
27897152|NCT04599933|81457232|FG000|Overall Study|Lost to Follow-up|0|||
27726954|NCT01467492|80830219|FG000|Overall Study|Adverse Event|4|||
27726955|NCT01467492|80830220|FG001|Overall Study|Adverse Event|3|||
27726956|NCT01467492|80830219|FG000|Overall Study|Lost to Follow-up|3|||
27726957|NCT01467492|80830220|FG001|Overall Study|Lost to Follow-up|2|||
27726958|NCT01467492|80830219|FG000|Overall Study|Undefined|2|||
27849472|NCT01791153|81279133|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
27849473|NCT01791153|81279134|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
27849474|NCT01791153|81279135|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
27849475|NCT01791153|81279136|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
27849476|NCT01791153|81279137|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
27849477|NCT01791153|81279138|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
27849478|NCT01791153|81279131|FG000|Part 1: Blinded Period|Non-Compliance|1|||
27849479|NCT01791153|81279132|FG001|Part 1: Blinded Period|Non-Compliance|0|||
27849480|NCT01791153|81279133|FG002|Part 1: Blinded Period|Non-Compliance|0|||
27849481|NCT01791153|81279134|FG003|Part 1: Blinded Period|Non-Compliance|0|||
27849482|NCT01791153|81279135|FG004|Part 1: Blinded Period|Non-Compliance|0|||
27849483|NCT01791153|81279136|FG005|Part 1: Blinded Period|Non-Compliance|0|||
27849484|NCT01791153|81279137|FG006|Part 1: Blinded Period|Non-Compliance|0|||
27849485|NCT01791153|81279138|FG007|Part 1: Blinded Period|Non-Compliance|0|||
27849486|NCT01791153|81279131|FG000|Part 1: Blinded Period|Physician Decision|0|||
27849487|NCT01791153|81279132|FG001|Part 1: Blinded Period|Physician Decision|0|||
27849488|NCT01791153|81279133|FG002|Part 1: Blinded Period|Physician Decision|0|||
27849489|NCT01791153|81279134|FG003|Part 1: Blinded Period|Physician Decision|1|||
27849490|NCT01791153|81279135|FG004|Part 1: Blinded Period|Physician Decision|0|||
27897153|NCT04599933|81457233|FG001|Overall Study|Lost to Follow-up|1|||
27726959|NCT01467492|80830220|FG001|Overall Study|Undefined|0|||
27726960|NCT01467492|80830219|FG000|Overall Study|Enrolled But Not Treated|1|||
27897154|NCT04599933|81457232|FG000|Overall Study|Physician Decision|0|||
27849491|NCT01791153|81279136|FG005|Part 1: Blinded Period|Physician Decision|0|||
27849492|NCT01791153|81279137|FG006|Part 1: Blinded Period|Physician Decision|0|||
27897155|NCT04599933|81457233|FG001|Overall Study|Physician Decision|1|||
27897156|NCT04599933|81457232|FG000|Overall Study|Screen Failure|1|||
27897157|NCT04599933|81457233|FG001|Overall Study|Screen Failure|2|||
27897158|NCT01907217|81457234|FG000|Overall Study|Withdrawal by Subject|0|||
27897159|NCT01907217|81457235|FG001|Overall Study|Withdrawal by Subject|2|||
27897160|NCT02505334|81457238|FG000|Main Treatment Period|Adverse Event|3|||
27897161|NCT02505334|81457239|FG001|Main Treatment Period|Adverse Event|3|||
27897162|NCT02505334|81457238|FG000|Main Treatment Period|Lack of Efficacy|7|||
27897163|NCT02505334|81457239|FG001|Main Treatment Period|Lack of Efficacy|17|||
27897164|NCT02505334|81457238|FG000|Main Treatment Period|Protocol Violation|0|||
27897165|NCT02505334|81457239|FG001|Main Treatment Period|Protocol Violation|1|||
27897166|NCT02505334|81457238|FG000|Main Treatment Period|Withdrawal by Subject|1|||
27897167|NCT02505334|81457239|FG001|Main Treatment Period|Withdrawal by Subject|8|||
27897168|NCT02505334|81457238|FG000|Main Treatment Period|Unclassified|4|||
27897169|NCT02505334|81457239|FG001|Main Treatment Period|Unclassified|10|||
27897170|NCT02505334|81457238|FG000|Extension Treatment Period|Adverse Event|5|||
27897171|NCT02505334|81457239|FG001|Extension Treatment Period|Adverse Event|0|||
27897172|NCT02505334|81457238|FG000|Extension Treatment Period|Lack of Efficacy|4|||
27897173|NCT02505334|81457239|FG001|Extension Treatment Period|Lack of Efficacy|0|||
27897174|NCT02505334|81457238|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
27897175|NCT02505334|81457239|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27897176|NCT02505334|81457238|FG000|Extension Treatment Period|Unclassified|3|||
27897177|NCT02505334|81457239|FG001|Extension Treatment Period|Unclassified|0|||
27897178|NCT01826370|81457240|FG000|Overall Study|Protocol Violation|6|||
27897179|NCT01826370|81457240|FG000|Overall Study|Lost to Follow-up|12|||
27897180|NCT01826370|81457240|FG000|Overall Study|Other reason not defined above|2|||
27897181|NCT00415597|81457245|FG000|Enrollment|Withdrawal by Subject|1|||
27897182|NCT00415597|81457245|FG000|Enrollment|Protocol Violation|1|||
27897183|NCT00415597|81457245|FG000|Treatment|Adverse Event|110|||
27897184|NCT00415597|81457245|FG000|Treatment|Lack of Efficacy|39|||
27897185|NCT00415597|81457245|FG000|Treatment|Protocol Violation|67|||
27897186|NCT00415597|81457245|FG000|Treatment|Physician Decision|3|||
27897187|NCT00415597|81457245|FG000|Treatment|Withdrawal by Subject|51|||
27897188|NCT00415597|81457245|FG000|Treatment|Lost to Follow-up|28|||
27897189|NCT00415597|81457245|FG000|Treatment|Drug Screen|2|||
27897190|NCT00415597|81457245|FG000|Treatment|Administrative|3|||
27897191|NCT00415597|81457245|FG000|Treatment|Sponsor Decision|1|||
27897192|NCT00415597|81457245|FG000|Treatment|Multiple Reasons|1|||
27897193|NCT01955109|81457246|FG000|Overall Study|Adverse Event|2|||
27897194|NCT01955109|81457247|FG001|Overall Study|Adverse Event|0|||
27897195|NCT01955109|81457246|FG000|Overall Study|Participant unwilling to continue|35|||
27897196|NCT01955109|81457247|FG001|Overall Study|Participant unwilling to continue|7|||
27897197|NCT01955109|81457246|FG000|Overall Study|Physician Decision|2|||
27897198|NCT01955109|81457247|FG001|Overall Study|Physician Decision|0|||
27897199|NCT01955109|81457246|FG000|Overall Study|Lost to Follow-up|3|||
27897200|NCT01955109|81457247|FG001|Overall Study|Lost to Follow-up|1|||
27897201|NCT01955109|81457246|FG000|Overall Study|Non-compliance|3|||
27897202|NCT01955109|81457247|FG001|Overall Study|Non-compliance|1|||
27897203|NCT01294371|81457248|FG000|Overall Study|Adverse Event|1|||
27897204|NCT01294371|81457248|FG000|Overall Study|Withdrawal by Subject|12|||
27897205|NCT01294371|81457248|FG000|Overall Study|Lost to Follow-up|6|||
27897206|NCT01294371|81457248|FG000|Overall Study|Administrative Reason|1|||
27897207|NCT01294371|81457248|FG000|Overall Study|Other|14|||
27897208|NCT01801280|81457249|FG000|Period 1|Withdrawal by Subject|0|||
27897209|NCT01801280|81457250|FG001|Period 1|Withdrawal by Subject|1|||
27897210|NCT01801280|81457251|FG002|Period 1|Withdrawal by Subject|0|||
27897211|NCT01801280|81457252|FG003|Period 1|Withdrawal by Subject|0|||
27897212|NCT01801280|81457249|FG000|Period 2|Withdrawal by Subject|1|||
27897213|NCT01801280|81457250|FG001|Period 2|Withdrawal by Subject|0|||
27897214|NCT01801280|81457251|FG002|Period 2|Withdrawal by Subject|0|||
27897215|NCT01801280|81457252|FG003|Period 2|Withdrawal by Subject|0|||
27897216|NCT01801280|81457249|FG000|Period 4|Protocol Violation|0|||
27897217|NCT01801280|81457250|FG001|Period 4|Protocol Violation|0|||
27897218|NCT01801280|81457251|FG002|Period 4|Protocol Violation|1|||
27897219|NCT01801280|81457252|FG003|Period 4|Protocol Violation|0|||
27897220|NCT00480493|81457253|FG000|Overall Study|moved|2|||
27897221|NCT00480493|81457254|FG001|Overall Study|moved|7|||
27897222|NCT00328094|81457260|FG000|Overall Study|Physician Decision|3|||
27897223|NCT00328094|81457261|FG001|Overall Study|Physician Decision|3|||
27897224|NCT01416155|81457265|FG000|Overall Study|Adverse Event|8|||
27897225|NCT01416155|81457265|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
27897226|NCT01416155|81457265|FG000|Overall Study|Withdrawal by Subject|33|||
27897227|NCT01416155|81457265|FG000|Overall Study|Investigator decision|8|||
27614041|NCT02262260|80430127|FG001|Overall Study|Adverse Event|1|||
27614042|NCT02262260|80430126|FG000|Overall Study|Withdrawal of consent|4|||
27614043|NCT02262260|80430127|FG001|Overall Study|Withdrawal of consent|2|||
27897228|NCT01416155|81457265|FG000|Overall Study|Other|7|||
27897229|NCT02101359|81457266|FG000|Overall Study|Not included|23|||
27897230|NCT02101359|81457267|FG001|Overall Study|Not included|13|||
27897231|NCT02101359|81457266|FG000|Overall Study|Withdrawal by Subject|5|||
27505998|NCT03414983|80044241|FG001|Pre-Treatment|Participant withdrew consent|3|||
27505999|NCT03414983|80044240|FG000|Treatment|Participant withdrew consent|4|||
27506000|NCT03414983|80044241|FG001|Treatment|Participant withdrew consent|3|||
27506001|NCT03414983|80044240|FG000|Treatment|Participant request to discontinue study treatment|8|||
27506002|NCT03414983|80044241|FG001|Treatment|Participant request to discontinue study treatment|10|||
27506003|NCT03414983|80044240|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
27506004|NCT03414983|80044241|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
27506005|NCT03414983|80044240|FG000|Treatment|Death|0|||
27726961|NCT01467492|80830220|FG001|Overall Study|Enrolled But Not Treated|0|||
27506006|NCT03414983|80044241|FG001|Treatment|Death|1|||
27506007|NCT03414983|80044240|FG000|Treatment|Study Drug Toxicity|10|||
27506008|NCT03414983|80044241|FG001|Treatment|Study Drug Toxicity|5|||
27506009|NCT03414983|80044240|FG000|Treatment|Disease Progression|75|||
27506010|NCT03414983|80044241|FG001|Treatment|Disease Progression|29|||
27506011|NCT03414983|80044240|FG000|Treatment|Not reported|1|||
27506012|NCT03414983|80044241|FG001|Treatment|Not reported|0|||
27506013|NCT03414983|80044240|FG000|Treatment|Other reasons|3|||
27506014|NCT03414983|80044241|FG001|Treatment|Other reasons|2|||
27506015|NCT03414983|80044240|FG000|Treatment|Poor/non-compliance|2|||
27506016|NCT03414983|80044241|FG001|Treatment|Poor/non-compliance|0|||
27506017|NCT03414983|80044240|FG000|Treatment|Maximum clinical benefit|5|||
27506018|NCT03414983|80044241|FG001|Treatment|Maximum clinical benefit|9|||
27506019|NCT03414983|80044240|FG000|Treatment|Lost to Follow-up|0|||
27506020|NCT03414983|80044241|FG001|Treatment|Lost to Follow-up|1|||
27726962|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726963|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726964|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726965|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
27726966|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726967|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
27726968|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726969|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726970|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726971|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726972|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726973|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726974|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726975|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726976|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726977|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726978|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726979|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726980|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726981|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726982|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726983|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726984|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
27726985|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27726986|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
27726987|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27849493|NCT01791153|81279138|FG007|Part 1: Blinded Period|Physician Decision|0|||
27849494|NCT01791153|81279131|FG000|Part 1: Blinded Period|Protocol Violation|0|||
27849495|NCT01791153|81279132|FG001|Part 1: Blinded Period|Protocol Violation|0|||
27849496|NCT01791153|81279133|FG002|Part 1: Blinded Period|Protocol Violation|0|||
27849497|NCT01791153|81279134|FG003|Part 1: Blinded Period|Protocol Violation|1|||
27849498|NCT01791153|81279135|FG004|Part 1: Blinded Period|Protocol Violation|0|||
27849499|NCT01791153|81279136|FG005|Part 1: Blinded Period|Protocol Violation|0|||
27849500|NCT01791153|81279137|FG006|Part 1: Blinded Period|Protocol Violation|0|||
27849501|NCT01791153|81279138|FG007|Part 1: Blinded Period|Protocol Violation|0|||
27849502|NCT01791153|81279131|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
27849503|NCT01791153|81279132|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
27849504|NCT01791153|81279133|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
27849505|NCT01791153|81279134|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
27506021|NCT03414983|80044240|FG000|Treatment|Administrative reasons by sponsor|1|||
27506022|NCT03414983|80044241|FG001|Treatment|Administrative reasons by sponsor|0|||
27506023|NCT01488890|80044244|FG000|Overall Study|Serious adverse event|2|||
27506024|NCT01488890|80044245|FG001|Overall Study|Serious adverse event|0|||
27506025|NCT01488890|80044246|FG002|Overall Study|Serious adverse event|0|||
27506026|NCT01488890|80044247|FG003|Overall Study|Serious adverse event|0|||
27506027|NCT01488890|80044244|FG000|Overall Study|Protocol Violation|3|||
27897232|NCT02101359|81457267|FG001|Overall Study|Withdrawal by Subject|4|||
27897233|NCT02101359|81457266|FG000|Overall Study|Lost to Follow-up|1|||
27897234|NCT02101359|81457267|FG001|Overall Study|Lost to Follow-up|0|||
27897235|NCT02101359|81457266|FG000|Overall Study|Protocol Violation|0|||
27897236|NCT02101359|81457267|FG001|Overall Study|Protocol Violation|2|||
27897237|NCT00561470|81457268|FG000|Overall Study|Adverse Event|74|||
27897238|NCT00561470|81457269|FG001|Overall Study|Adverse Event|163|||
27897239|NCT00561470|81457268|FG000|Overall Study|Disease progression|437|||
27897240|NCT00561470|81457269|FG001|Overall Study|Disease progression|305|||
27897241|NCT00561470|81457268|FG000|Overall Study|poor compliance to protocol|4|||
27897242|NCT00561470|81457269|FG001|Overall Study|poor compliance to protocol|4|||
27897243|NCT00561470|81457268|FG000|Overall Study|Lost to Follow-up|2|||
27506028|NCT01488890|80044245|FG001|Overall Study|Protocol Violation|0|||
27506029|NCT01488890|80044246|FG002|Overall Study|Protocol Violation|4|||
27506030|NCT01488890|80044247|FG003|Overall Study|Protocol Violation|0|||
27506031|NCT01488890|80044244|FG000|Overall Study|Lost to Follow-up|13|||
27506032|NCT01488890|80044245|FG001|Overall Study|Lost to Follow-up|10|||
27506033|NCT01488890|80044246|FG002|Overall Study|Lost to Follow-up|20|||
27506034|NCT01488890|80044247|FG003|Overall Study|Lost to Follow-up|3|||
27506035|NCT01488890|80044244|FG000|Overall Study|Withdrawal by Subject|14|||
27506036|NCT01488890|80044245|FG001|Overall Study|Withdrawal by Subject|10|||
27506037|NCT01488890|80044246|FG002|Overall Study|Withdrawal by Subject|11|||
27506038|NCT01488890|80044247|FG003|Overall Study|Withdrawal by Subject|2|||
27506039|NCT04225897|80044250|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506040|NCT04225897|80044251|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
27506041|NCT04225897|80044252|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506042|NCT04225897|80044253|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506043|NCT04225897|80044254|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506044|NCT04225897|80044255|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506045|NCT04225897|80044256|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506046|NCT04225897|80044257|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506047|NCT04225897|80044258|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506048|NCT04225897|80044259|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506049|NCT04225897|80044260|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506050|NCT04225897|80044261|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
27506051|NCT04225897|80044250|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506052|NCT04225897|80044251|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506053|NCT04225897|80044252|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
27726988|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
27726989|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27726990|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27726991|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
27726992|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27726993|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27726994|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27726995|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27726996|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27849506|NCT01791153|81279135|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
27849507|NCT01791153|81279136|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
27849508|NCT01791153|81279137|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
27849509|NCT01791153|81279138|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
27849510|NCT01791153|81279131|FG000|Part 2: Open-label Period|Adverse Event|0|||
27849511|NCT01791153|81279132|FG001|Part 2: Open-label Period|Adverse Event|0|||
27849512|NCT01791153|81279133|FG002|Part 2: Open-label Period|Adverse Event|0|||
27849513|NCT01791153|81279134|FG003|Part 2: Open-label Period|Adverse Event|0|||
27849514|NCT01791153|81279135|FG004|Part 2: Open-label Period|Adverse Event|0|||
27849515|NCT01791153|81279136|FG005|Part 2: Open-label Period|Adverse Event|1|||
27849516|NCT01791153|81279137|FG006|Part 2: Open-label Period|Adverse Event|1|||
27849517|NCT01791153|81279138|FG007|Part 2: Open-label Period|Adverse Event|2|||
27849518|NCT01791153|81279131|FG000|Part 2: Open-label Period|Death|0|||
27849519|NCT01791153|81279132|FG001|Part 2: Open-label Period|Death|0|||
27849520|NCT01791153|81279133|FG002|Part 2: Open-label Period|Death|0|||
27849521|NCT01791153|81279134|FG003|Part 2: Open-label Period|Death|0|||
27849522|NCT01791153|81279135|FG004|Part 2: Open-label Period|Death|0|||
27849523|NCT01791153|81279136|FG005|Part 2: Open-label Period|Death|1|||
27849524|NCT01791153|81279137|FG006|Part 2: Open-label Period|Death|1|||
27849525|NCT01791153|81279138|FG007|Part 2: Open-label Period|Death|1|||
27849526|NCT01791153|81279131|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
27849527|NCT01791153|81279132|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
27897244|NCT00561470|81457269|FG001|Overall Study|Lost to Follow-up|0|||
27506054|NCT04225897|80044253|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506055|NCT04225897|80044254|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506056|NCT04225897|80044255|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27897245|NCT00561470|81457268|FG000|Overall Study|Physician Decision|21|||
27897246|NCT00561470|81457269|FG001|Overall Study|Physician Decision|20|||
27897247|NCT00561470|81457268|FG000|Overall Study|Consent Withdrawn|2|||
27897248|NCT00561470|81457269|FG001|Overall Study|Consent Withdrawn|6|||
27897249|NCT00561470|81457268|FG000|Overall Study|Subject request|43|||
27897250|NCT00561470|81457269|FG001|Overall Study|Subject request|77|||
27897251|NCT00561470|81457268|FG000|Overall Study|Metastatic surgery|10|||
27897252|NCT00561470|81457269|FG001|Overall Study|Metastatic surgery|12|||
27897253|NCT00561470|81457268|FG000|Overall Study|Unauthorized procedure|3|||
27897254|NCT00561470|81457269|FG001|Overall Study|Unauthorized procedure|1|||
27897255|NCT00561470|81457268|FG000|Overall Study|Randomized but not treated|5|||
27897256|NCT00561470|81457269|FG001|Overall Study|Randomized but not treated|5|||
27897257|NCT00561470|81457268|FG000|Overall Study|Missed visit window|1|||
27897258|NCT00561470|81457269|FG001|Overall Study|Missed visit window|4|||
27897259|NCT00561470|81457268|FG000|Overall Study|Planning surgery|1|||
27897260|NCT00561470|81457269|FG001|Overall Study|Planning surgery|1|||
27897261|NCT00561470|81457268|FG000|Overall Study|Ongoing Treatment|11|||
27897262|NCT00561470|81457269|FG001|Overall Study|Ongoing Treatment|14|||
27897263|NCT02044874|81457272|FG000|Overall Study|Adverse Event|5|||
27897264|NCT02044874|81457273|FG001|Overall Study|Adverse Event|6|||
27897265|NCT02044874|81457274|FG002|Overall Study|Adverse Event|6|||
27897266|NCT02044874|81457272|FG000|Overall Study|Withdrawal by Subject|8|||
27897267|NCT02044874|81457273|FG001|Overall Study|Withdrawal by Subject|16|||
27897268|NCT02044874|81457274|FG002|Overall Study|Withdrawal by Subject|23|||
27897269|NCT02044874|81457272|FG000|Overall Study|Physician Decision|0|||
27897270|NCT02044874|81457273|FG001|Overall Study|Physician Decision|2|||
27897271|NCT02044874|81457274|FG002|Overall Study|Physician Decision|1|||
27897272|NCT02044874|81457272|FG000|Overall Study|Lost to Follow-up|10|||
27897273|NCT02044874|81457273|FG001|Overall Study|Lost to Follow-up|27|||
27897274|NCT02044874|81457274|FG002|Overall Study|Lost to Follow-up|21|||
27897275|NCT02044874|81457272|FG000|Overall Study|Sponsor Decision|0|||
27897276|NCT02044874|81457273|FG001|Overall Study|Sponsor Decision|1|||
27897277|NCT02044874|81457274|FG002|Overall Study|Sponsor Decision|1|||
27897278|NCT02044874|81457272|FG000|Overall Study|Other|7|||
27897279|NCT02044874|81457273|FG001|Overall Study|Other|3|||
27897280|NCT02044874|81457274|FG002|Overall Study|Other|8|||
27897281|NCT00401960|81457277|FG000|Overall Study|Lost to Follow-up|3|||
27897282|NCT00401960|81457278|FG001|Overall Study|Lost to Follow-up|0|||
27897283|NCT00401960|81457277|FG000|Overall Study|Death|2|||
27897284|NCT00401960|81457278|FG001|Overall Study|Death|0|||
27897285|NCT00090584|81457279|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
27897286|NCT00090584|81457280|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
27897287|NCT00090584|81457279|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
27897288|NCT00090584|81457280|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
27897289|NCT00717275|81457281|FG000|Overall Study|Premature study termination.|3|||
27897290|NCT01378975|81457283|FG000|Overall Study|Death|77|||
27897291|NCT01378975|81457284|FG001|Overall Study|Death|46|||
27897292|NCT01378975|81457283|FG000|Overall Study|Investigator Request|1|||
27726997|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27726998|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27726999|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727000|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727001|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727002|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727003|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727004|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727005|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27897293|NCT01378975|81457284|FG001|Overall Study|Investigator Request|0|||
27897294|NCT01378975|81457283|FG000|Overall Study|Lost to Follow-up|4|||
27897295|NCT01378975|81457284|FG001|Overall Study|Lost to Follow-up|1|||
27897296|NCT01378975|81457283|FG000|Overall Study|Withdrew Consent|4|||
27897297|NCT01378975|81457284|FG001|Overall Study|Withdrew Consent|3|||
27897298|NCT01904903|81457285|FG000|Overall Study|Withdrawal by Subject|1|||
27897299|NCT03434249|81457286|FG000|Overall Study|Adverse Event|1|||
27897300|NCT03434249|81457287|FG001|Overall Study|Adverse Event|0|||
27727006|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27727007|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
27897301|NCT03434249|81457286|FG000|Overall Study|Lost to Follow-up|0|||
27897302|NCT03434249|81457287|FG001|Overall Study|Lost to Follow-up|1|||
27897303|NCT03434249|81457286|FG000|Overall Study|Non-compliance of family|2|||
27897304|NCT03434249|81457287|FG001|Overall Study|Non-compliance of family|1|||
27897305|NCT03434249|81457286|FG000|Overall Study|Difficulties in completing daily diary|2|||
27897306|NCT03434249|81457287|FG001|Overall Study|Difficulties in completing daily diary|1|||
27897307|NCT01490697|81457290|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
27614044|NCT02262260|80430126|FG000|Overall Study|Lost to Follow-up|1|||
27614045|NCT02262260|80430127|FG001|Overall Study|Lost to Follow-up|2|||
27897308|NCT01490697|81457291|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
27897309|NCT02939716|81457292|FG000|Overall Study|scanner failure|0|||
27897310|NCT02939716|81457293|FG001|Overall Study|scanner failure|0|||
27897311|NCT02939716|81457294|FG002|Overall Study|scanner failure|0|||
27897312|NCT02939716|81457295|FG003|Overall Study|scanner failure|1|||
27897313|NCT02939716|81457296|FG004|Overall Study|scanner failure|1|||
27897314|NCT02939716|81457297|FG005|Overall Study|scanner failure|1|||
27897315|NCT00335959|81457298|FG000|Overall Study|Adverse Event|2|||
27897316|NCT00335959|81457298|FG000|Overall Study|Ineligible|1|||
27897317|NCT03085238|81457299|FG000|Overall Study|Adverse Event|2|||
27897318|NCT03085238|81457299|FG000|Overall Study|Death|2|||
27897319|NCT00725101|81457300|FG000|Overall Study|Death|3|||
27897320|NCT00725101|81457300|FG000|Overall Study|Lost to Follow-up|353|||
27897321|NCT00725101|81457300|FG000|Overall Study|Protocol Violation|1|||
27897322|NCT00725101|81457300|FG000|Overall Study|Withdrawal by Subject|127|||
27897323|NCT00725101|81457300|FG000|Overall Study|not specified/no reason given|11|||
27897324|NCT01537068|81457301|FG000|Overall Study|Lost to Follow-up|2|||
27897325|NCT01537068|81457302|FG001|Overall Study|Lost to Follow-up|1|||
27897326|NCT01537068|81457301|FG000|Overall Study|Adverse Event|0|||
27897327|NCT01537068|81457302|FG001|Overall Study|Adverse Event|1|||
27897328|NCT01537068|81457301|FG000|Overall Study|Withdrawal by Subject|1|||
27897329|NCT01537068|81457302|FG001|Overall Study|Withdrawal by Subject|1|||
27897330|NCT01537068|81457301|FG000|Overall Study|Lack of Efficacy|1|||
27897331|NCT01537068|81457302|FG001|Overall Study|Lack of Efficacy|0|||
27897332|NCT02631746|81457311|FG000|Overall Study|Lack of Efficacy|3|||
27897333|NCT02923245|81457312|FG000|Overall Study|ultrasound order was cancelled|2|||
27897334|NCT02923245|81457313|FG001|Overall Study|ultrasound order was cancelled|1|||
27897335|NCT00306787|81457314|FG000|Overall Study|Discontinued without taking study drug|208|||
27897336|NCT00306787|81457315|FG001|Overall Study|Discontinued without taking study drug|215|||
27897337|NCT00306787|81457314|FG000|Overall Study|Adverse Event|1|||
27897338|NCT00306787|81457315|FG001|Overall Study|Adverse Event|1|||
27897339|NCT00306787|81457314|FG000|Overall Study|Lack of Efficacy|1|||
27897340|NCT00306787|81457315|FG001|Overall Study|Lack of Efficacy|0|||
27897341|NCT00306787|81457314|FG000|Overall Study|Protocol Violation|8|||
27897342|NCT00306787|81457315|FG001|Overall Study|Protocol Violation|10|||
27897343|NCT00306787|81457314|FG000|Overall Study|Withdrawal by Subject|2|||
27897344|NCT00306787|81457315|FG001|Overall Study|Withdrawal by Subject|9|||
27897345|NCT00306787|81457314|FG000|Overall Study|Lost to Follow-up|9|||
27897346|NCT00306787|81457315|FG001|Overall Study|Lost to Follow-up|6|||
27897347|NCT00306787|81457314|FG000|Overall Study|Administrative problems|4|||
27897348|NCT00306787|81457315|FG001|Overall Study|Administrative problems|0|||
27897349|NCT00306787|81457314|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27897350|NCT00306787|81457315|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27897351|NCT00574795|81457316|FG000|Infant Series|Withdrawal by Subject|2|||
27897352|NCT00574795|81457316|FG000|Infant Series|Protocol Violation|2|||
27897353|NCT00574795|81457316|FG000|Infant Series|Adverse Event|1|||
27897354|NCT00574795|81457316|FG000|After Infant Series|Withdrawal by Subject|1|||
27897355|NCT00574795|81457316|FG000|After Infant Series|Adverse Event|2|||
27897356|NCT00574795|81457316|FG000|Toddler Dose|Withdrawal by Subject|1|||
27897357|NCT02637713|81457318|FG000|Overall Study|Screen Failure|2|||
27897358|NCT03026530|81457323|FG000|Overall Study|Lost to Follow-up|19|||
27897359|NCT03026530|81457324|FG001|Overall Study|Lost to Follow-up|24|||
27897360|NCT03026530|81457323|FG000|Overall Study|Protocol Violation|2|||
27897361|NCT03026530|81457324|FG001|Overall Study|Protocol Violation|5|||
27897362|NCT03488225|81457325|FG000|Overall Study|Off Protocol Therapy|2|||
27897363|NCT03488225|81457325|FG000|Overall Study|Stem Cell Transplant|2|||
27897364|NCT01592292|81457328|FG000|Overall Study|Follow-up loss|3|||
27897365|NCT01592292|81457329|FG001|Overall Study|Follow-up loss|3|||
27506057|NCT04225897|80044256|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27614046|NCT02262260|80430126|FG000|Overall Study|Protocol deviation|2|||
27897366|NCT01592292|81457330|FG002|Overall Study|Follow-up loss|1|||
27897367|NCT01592292|81457331|FG003|Overall Study|Follow-up loss|0|||
27897368|NCT01592292|81457328|FG000|Overall Study|Withdrew consent|2|||
27897369|NCT01592292|81457329|FG001|Overall Study|Withdrew consent|1|||
27897370|NCT01592292|81457330|FG002|Overall Study|Withdrew consent|0|||
27897371|NCT01592292|81457331|FG003|Overall Study|Withdrew consent|0|||
27897372|NCT01592292|81457328|FG000|Overall Study|Other|1|||
27897373|NCT01592292|81457329|FG001|Overall Study|Other|1|||
27897374|NCT01592292|81457330|FG002|Overall Study|Other|2|||
27897375|NCT01592292|81457331|FG003|Overall Study|Other|1|||
27897376|NCT02918552|81460871|FG000|Overall Study|Failed Pharmacokinetics|1|||
27897377|NCT02918552|81460872|FG001|Overall Study|Failed Pharmacokinetics|0|||
27897378|NCT02918552|81460871|FG000|Overall Study|Withdrawal by Subject|0|||
27897379|NCT02918552|81460872|FG001|Overall Study|Withdrawal by Subject|1|||
27897380|NCT02918552|81460871|FG000|Overall Study|Lost to Follow-up|0|||
27727008|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27727009|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
27727010|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27727011|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
27727012|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
27727013|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
27727014|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27727015|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
27727016|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727017|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727018|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727019|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727020|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727021|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727022|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727023|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727024|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727025|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727026|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727027|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727028|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727029|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727030|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
27727031|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727032|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727033|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
27727034|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727035|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
27727036|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727037|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727038|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727039|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727040|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727041|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727042|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727043|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727044|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727045|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727046|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727047|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727048|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727049|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727050|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727051|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727052|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727053|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
27727054|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
27727055|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727056|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727057|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
27727058|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727059|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727060|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727061|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727062|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727063|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727064|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727065|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27849528|NCT01791153|81279133|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
27506058|NCT04225897|80044257|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506059|NCT04225897|80044258|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27614047|NCT02262260|80430127|FG001|Overall Study|Protocol deviation|5|||
27897381|NCT02918552|81460872|FG001|Overall Study|Lost to Follow-up|1|||
27897382|NCT00207727|81460873|FG000|Overall Study|Withdrawal by Subject|0|||
27897383|NCT00207727|81460874|FG001|Overall Study|Withdrawal by Subject|0|||
27897384|NCT00207727|81460875|FG002|Overall Study|Withdrawal by Subject|0|||
27897385|NCT00207727|81460876|FG003|Overall Study|Withdrawal by Subject|0|||
27897386|NCT00207727|81460877|FG004|Overall Study|Withdrawal by Subject|1|||
27897387|NCT00207727|81460873|FG000|Overall Study|Lost to Follow-up|0|||
27897388|NCT00207727|81460874|FG001|Overall Study|Lost to Follow-up|1|||
27897389|NCT00207727|81460875|FG002|Overall Study|Lost to Follow-up|0|||
27897390|NCT00207727|81460876|FG003|Overall Study|Lost to Follow-up|0|||
27897391|NCT00207727|81460877|FG004|Overall Study|Lost to Follow-up|0|||
27897392|NCT00207727|81460873|FG000|Overall Study|Other|38|||
27897393|NCT00207727|81460874|FG001|Overall Study|Other|41|||
27897394|NCT00207727|81460875|FG002|Overall Study|Other|41|||
27897395|NCT00207727|81460876|FG003|Overall Study|Other|37|||
27897396|NCT00207727|81460877|FG004|Overall Study|Other|33|||
27897397|NCT02360475|81460878|FG000|Overall Study|Lost to Follow-up|4|||
27897398|NCT02360475|81460879|FG001|Overall Study|Lost to Follow-up|12|||
27897399|NCT02360475|81460880|FG002|Overall Study|Lost to Follow-up|6|||
27897400|NCT02360475|81460881|FG003|Overall Study|Lost to Follow-up|4|||
27897401|NCT02360475|81460878|FG000|Overall Study|Withdrawal by Subject|0|||
27897402|NCT02360475|81460879|FG001|Overall Study|Withdrawal by Subject|1|||
27897403|NCT02360475|81460880|FG002|Overall Study|Withdrawal by Subject|2|||
27897404|NCT02360475|81460881|FG003|Overall Study|Withdrawal by Subject|0|||
27897405|NCT02360475|81460878|FG000|Overall Study|Migrated/moved from study area|0|||
27897406|NCT02360475|81460879|FG001|Overall Study|Migrated/moved from study area|0|||
27897407|NCT02360475|81460880|FG002|Overall Study|Migrated/moved from study area|0|||
27897408|NCT02360475|81460881|FG003|Overall Study|Migrated/moved from study area|1|||
27897409|NCT02124759|81460883|FG000|Overall Study|Withdrawal by Subject|3|||
27897410|NCT02124759|81460884|FG001|Overall Study|Withdrawal by Subject|1|||
27897411|NCT02124759|81460885|FG002|Overall Study|Withdrawal by Subject|1|||
27897412|NCT02124759|81460883|FG000|Overall Study|Screen Fail|2|||
27897413|NCT02124759|81460884|FG001|Overall Study|Screen Fail|2|||
27897414|NCT02124759|81460885|FG002|Overall Study|Screen Fail|3|||
27897415|NCT01876979|81460889|FG000|Overall Study|Physician Decision|2|||
27897416|NCT01876979|81460890|FG001|Overall Study|Physician Decision|3|||
27897417|NCT02945254|81460891|FG000|Overall Study|Lost to Follow-up|1|||
27897418|NCT02945254|81460892|FG001|Overall Study|Lost to Follow-up|0|||
27897419|NCT02945254|81460891|FG000|Overall Study|Withdrawal by Subject|1|||
27897420|NCT02945254|81460892|FG001|Overall Study|Withdrawal by Subject|0|||
27897421|NCT02258542|81460898|FG000|Overall Study|eg. not made to the visit|7|||
27897422|NCT02258542|81460899|FG001|Overall Study|eg. not made to the visit|4|||
27897423|NCT02258542|81460900|FG002|Overall Study|eg. not made to the visit|0|||
27897424|NCT02258542|81460901|FG003|Overall Study|eg. not made to the visit|1|||
27897425|NCT02258542|81460898|FG000|Overall Study|study specific discount. criteria|1|||
27897426|NCT02258542|81460899|FG001|Overall Study|study specific discount. criteria|1|||
27897427|NCT02258542|81460900|FG002|Overall Study|study specific discount. criteria|0|||
27897428|NCT02258542|81460901|FG003|Overall Study|study specific discount. criteria|0|||
27897429|NCT02258542|81460898|FG000|Overall Study|Withdrawal by Subject|20|||
27897430|NCT02258542|81460899|FG001|Overall Study|Withdrawal by Subject|20|||
27897431|NCT02258542|81460900|FG002|Overall Study|Withdrawal by Subject|7|||
27897432|NCT02258542|81460901|FG003|Overall Study|Withdrawal by Subject|1|||
27897433|NCT02258542|81460898|FG000|Overall Study|Lost to Follow-up|5|||
27897434|NCT02258542|81460899|FG001|Overall Study|Lost to Follow-up|12|||
27897435|NCT02258542|81460900|FG002|Overall Study|Lost to Follow-up|1|||
27897436|NCT02258542|81460901|FG003|Overall Study|Lost to Follow-up|2|||
27897437|NCT02258542|81460898|FG000|Overall Study|Death|5|||
27897438|NCT02258542|81460899|FG001|Overall Study|Death|4|||
27897439|NCT02258542|81460900|FG002|Overall Study|Death|0|||
27897440|NCT02258542|81460901|FG003|Overall Study|Death|1|||
27897441|NCT02258542|81460898|FG000|Overall Study|Adverse Event|3|||
27897442|NCT02258542|81460899|FG001|Overall Study|Adverse Event|4|||
27897443|NCT02258542|81460900|FG002|Overall Study|Adverse Event|0|||
27897444|NCT02258542|81460901|FG003|Overall Study|Adverse Event|0|||
27897445|NCT02258542|81460898|FG000|Overall Study|Protocol Violation|1|||
27897446|NCT02258542|81460899|FG001|Overall Study|Protocol Violation|2|||
27897447|NCT02258542|81460900|FG002|Overall Study|Protocol Violation|0|||
27506060|NCT04225897|80044259|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27727066|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27897448|NCT02258542|81460901|FG003|Overall Study|Protocol Violation|0|||
27897449|NCT02258542|81460898|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27897450|NCT02258542|81460899|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
27897451|NCT02258542|81460900|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
27897452|NCT02258542|81460901|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
27727067|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27897453|NCT03332628|81460904|FG000|Overall Study|Physician Decision|2|||
27897454|NCT02223819|81460905|FG000|Overall Study|Lost to Follow-up|2|||
27897455|NCT03672461|81460908|FG000|Overall Study|COVID Related|4|||
27897456|NCT03672461|81460909|FG001|Overall Study|COVID Related|2|||
27897457|NCT03672461|81460908|FG000|Overall Study|Adverse Event|2|||
27897458|NCT03672461|81460909|FG001|Overall Study|Adverse Event|0|||
27897459|NCT03672461|81460908|FG000|Overall Study|Serious Adverse Event|0|||
27897460|NCT03672461|81460909|FG001|Overall Study|Serious Adverse Event|1|||
27897461|NCT03672461|81460908|FG000|Overall Study|Too Busy|3|||
27897462|NCT03672461|81460909|FG001|Overall Study|Too Busy|1|||
27897463|NCT03672461|81460908|FG000|Overall Study|Lost to Follow-up|1|||
27897464|NCT03672461|81460909|FG001|Overall Study|Lost to Follow-up|2|||
27897465|NCT03672461|81460908|FG000|Overall Study|Family|2|||
27897466|NCT03672461|81460909|FG001|Overall Study|Family|2|||
27897467|NCT03672461|81460908|FG000|Overall Study|No remote technology access|0|||
27897468|NCT03672461|81460909|FG001|Overall Study|No remote technology access|1|||
27897469|NCT03672461|81460908|FG000|Overall Study|Withdrawal by Subject|1|||
27897470|NCT03672461|81460909|FG001|Overall Study|Withdrawal by Subject|0|||
27897471|NCT03672461|81460908|FG000|Overall Study|Cannot tolerate intervention|1|||
27897472|NCT03672461|81460909|FG001|Overall Study|Cannot tolerate intervention|0|||
27897473|NCT03672461|81460908|FG000|Overall Study|Incomplete outcome data|6|||
27897474|NCT03672461|81460909|FG001|Overall Study|Incomplete outcome data|1|||
27897475|NCT02858180|81460910|FG000|Overall Study|Lost to Follow-up|0|||
27897476|NCT02858180|81460911|FG001|Overall Study|Lost to Follow-up|2|||
27897477|NCT00380718|81460912|FG000|Overall Study|Adverse Event|1|||
27897478|NCT00380718|81460912|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
27897479|NCT02603562|81460915|FG000|Overall Study|Lost to Follow-up|1|||
27897480|NCT03427268|81460918|FG000|Overall Study|Progressive disease|25|||
27897481|NCT03427268|81460918|FG000|Overall Study|Never treated|2|||
27897482|NCT03427268|81460918|FG000|Overall Study|Compassionate use|1|||
27897483|NCT03427268|81460918|FG000|Overall Study|Withdrawal by Subject|1|||
27897484|NCT03427268|81460918|FG000|Overall Study|Adverse Event|3|||
27897485|NCT02370667|81460919|FG000|Overall Study|Lost to Follow-up|0|||
27897486|NCT02370667|81460920|FG001|Overall Study|Lost to Follow-up|1|||
27897487|NCT02370667|81460921|FG002|Overall Study|Lost to Follow-up|0|||
27897488|NCT00980018|81460922|FG000|Overall Study|Adverse Event|8|||
27897489|NCT00980018|81460922|FG000|Overall Study|Patient withdrew consent|3|||
27897490|NCT00980018|81460922|FG000|Overall Study|Lost to Follow-up|1|||
27897491|NCT00394433|81460935|FG000|Overall Study|Adverse Event|2|||
27897492|NCT00394433|81460935|FG000|Overall Study|Alternative Therapy|1|||
27897493|NCT03806231|81460938|FG000|Overall Study|Physician Decision|1|||
27897494|NCT03806231|81460939|FG001|Overall Study|Physician Decision|0|||
27897495|NCT03806231|81460938|FG000|Overall Study|Withdrawal by Subject|1|||
27897496|NCT03806231|81460939|FG001|Overall Study|Withdrawal by Subject|0|||
27897497|NCT00603382|81460945|FG000|Overall Study|Adverse Event|0|||
27897498|NCT00603382|81460946|FG001|Overall Study|Adverse Event|1|||
27897499|NCT00603382|81460947|FG002|Overall Study|Adverse Event|1|||
27897500|NCT00603382|81460948|FG003|Overall Study|Adverse Event|2|||
27897501|NCT00603382|81460949|FG004|Overall Study|Adverse Event|1|||
27897502|NCT00603382|81460950|FG005|Overall Study|Adverse Event|2|||
27897503|NCT00603382|81460945|FG000|Overall Study|Lack of Efficacy|14|||
27897504|NCT00603382|81460946|FG001|Overall Study|Lack of Efficacy|9|||
27897505|NCT00603382|81460947|FG002|Overall Study|Lack of Efficacy|3|||
27897506|NCT00603382|81460948|FG003|Overall Study|Lack of Efficacy|6|||
27897507|NCT00603382|81460949|FG004|Overall Study|Lack of Efficacy|6|||
27897508|NCT00603382|81460950|FG005|Overall Study|Lack of Efficacy|11|||
27897509|NCT00603382|81460945|FG000|Overall Study|Protocol Violation|1|||
27897510|NCT00603382|81460946|FG001|Overall Study|Protocol Violation|0|||
27897511|NCT00603382|81460947|FG002|Overall Study|Protocol Violation|1|||
27897512|NCT00603382|81460948|FG003|Overall Study|Protocol Violation|2|||
27897513|NCT00603382|81460949|FG004|Overall Study|Protocol Violation|1|||
27897514|NCT00603382|81460950|FG005|Overall Study|Protocol Violation|0|||
27897515|NCT00603382|81460945|FG000|Overall Study|Lost to Follow-up|0|||
27897516|NCT00603382|81460946|FG001|Overall Study|Lost to Follow-up|1|||
27897517|NCT00603382|81460947|FG002|Overall Study|Lost to Follow-up|1|||
27897518|NCT00603382|81460948|FG003|Overall Study|Lost to Follow-up|1|||
27897519|NCT00603382|81460949|FG004|Overall Study|Lost to Follow-up|0|||
27897520|NCT00603382|81460950|FG005|Overall Study|Lost to Follow-up|1|||
27897521|NCT00603382|81460945|FG000|Overall Study|Physician Decision|0|||
27897522|NCT00603382|81460946|FG001|Overall Study|Physician Decision|0|||
27897523|NCT00603382|81460947|FG002|Overall Study|Physician Decision|2|||
27897524|NCT00603382|81460948|FG003|Overall Study|Physician Decision|0|||
27506061|NCT04225897|80044260|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506062|NCT04225897|80044261|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
27506063|NCT04225897|80044250|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27897525|NCT00603382|81460949|FG004|Overall Study|Physician Decision|1|||
27897526|NCT00603382|81460950|FG005|Overall Study|Physician Decision|3|||
27897527|NCT00603382|81460945|FG000|Overall Study|Withdrawal by Subject|3|||
27897528|NCT00603382|81460946|FG001|Overall Study|Withdrawal by Subject|3|||
27897529|NCT00603382|81460947|FG002|Overall Study|Withdrawal by Subject|1|||
27897530|NCT00603382|81460948|FG003|Overall Study|Withdrawal by Subject|1|||
27897531|NCT00603382|81460949|FG004|Overall Study|Withdrawal by Subject|0|||
27849529|NCT01791153|81279134|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
27849530|NCT01791153|81279135|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
27849531|NCT01791153|81279136|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
27849532|NCT01791153|81279137|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
27849533|NCT01791153|81279138|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
27849534|NCT01791153|81279131|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
27849535|NCT01791153|81279132|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
27849536|NCT01791153|81279133|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
27849537|NCT01791153|81279134|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
27849538|NCT01791153|81279135|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
27849539|NCT01791153|81279136|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
27849540|NCT01791153|81279137|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
27849541|NCT01791153|81279138|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
27849542|NCT01791153|81279131|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
27849543|NCT01791153|81279132|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
27849544|NCT01791153|81279133|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
27849545|NCT01791153|81279134|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
27849546|NCT01791153|81279135|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
27849547|NCT01791153|81279136|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
27849548|NCT01791153|81279137|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
27849549|NCT01791153|81279138|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
27849550|NCT01791153|81279131|FG000|Part 2: Open-label Period|Physician Decision|0|||
27849551|NCT01791153|81279132|FG001|Part 2: Open-label Period|Physician Decision|0|||
27849552|NCT01791153|81279133|FG002|Part 2: Open-label Period|Physician Decision|0|||
27849553|NCT01791153|81279134|FG003|Part 2: Open-label Period|Physician Decision|0|||
27849554|NCT01791153|81279135|FG004|Part 2: Open-label Period|Physician Decision|1|||
27849555|NCT01791153|81279136|FG005|Part 2: Open-label Period|Physician Decision|1|||
27849556|NCT01791153|81279137|FG006|Part 2: Open-label Period|Physician Decision|0|||
27849557|NCT01791153|81279138|FG007|Part 2: Open-label Period|Physician Decision|0|||
27849558|NCT01005329|81279139|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
27849559|NCT00355472|81279142|FG000|Overall Study|Physician Decision|1|||
27849560|NCT00126126|81279143|FG000|Overall Study|Lost to Follow-up|0|||
27849561|NCT00126126|81279144|FG001|Overall Study|Lost to Follow-up|2|||
27849562|NCT00059787|81279149|FG000|Overall Study|Adverse Event|13|||
27849563|NCT00059787|81279149|FG000|Overall Study|disease progression|2|||
27849564|NCT00059787|81279149|FG000|Overall Study|ineligible|1|||
27849565|NCT00059787|81279149|FG000|Overall Study|Other|4|||
27849566|NCT01299805|81279150|FG000|Overall Study|Adverse Event|2|||
27849567|NCT01299805|81279151|FG001|Overall Study|Adverse Event|0|||
27849568|NCT01000610|81279152|FG000|Overall Study|Adverse Event|1|||
27849569|NCT01000610|81279152|FG000|Overall Study|Lost to Follow-up|4|||
27849570|NCT01000610|81279152|FG000|Overall Study|Treatment failure|1|||
27849571|NCT00532935|81279155|FG000|Overall Study|Adverse Event|11|||
27849572|NCT00532935|81279156|FG001|Overall Study|Adverse Event|12|||
27849573|NCT00532935|81279155|FG000|Overall Study|Lack of Efficacy|0|||
27849574|NCT00532935|81279156|FG001|Overall Study|Lack of Efficacy|3|||
27849575|NCT00532935|81279155|FG000|Overall Study|Lost to Follow-up|10|||
27849576|NCT00532935|81279156|FG001|Overall Study|Lost to Follow-up|6|||
27849577|NCT00532935|81279155|FG000|Overall Study|Physician Decision|4|||
27849578|NCT00532935|81279156|FG001|Overall Study|Physician Decision|5|||
27849579|NCT00532935|81279155|FG000|Overall Study|Pregnancy|1|||
27849580|NCT00532935|81279156|FG001|Overall Study|Pregnancy|0|||
27849581|NCT00532935|81279155|FG000|Overall Study|Protocol Violation|4|||
27849582|NCT00532935|81279156|FG001|Overall Study|Protocol Violation|2|||
27849583|NCT00532935|81279155|FG000|Overall Study|Withdrawal by Subject|10|||
27849584|NCT00532935|81279156|FG001|Overall Study|Withdrawal by Subject|9|||
27849585|NCT00532935|81279155|FG000|Overall Study|Protocol Specific Criteria|11|||
27849586|NCT00532935|81279156|FG001|Overall Study|Protocol Specific Criteria|15|||
27849587|NCT03739138|81279157|FG000|Overall Study|Death|0|||
27849588|NCT03739138|81279158|FG001|Overall Study|Death|7|||
27849589|NCT03739138|81279159|FG002|Overall Study|Death|4|||
27849590|NCT03739138|81279160|FG003|Overall Study|Death|13|||
27849591|NCT03739138|81279161|FG004|Overall Study|Death|0|||
27849592|NCT03739138|81279157|FG000|Overall Study|Lost to Follow-up|0|||
27849593|NCT03739138|81279158|FG001|Overall Study|Lost to Follow-up|0|||
27849594|NCT03739138|81279159|FG002|Overall Study|Lost to Follow-up|1|||
27849595|NCT03739138|81279160|FG003|Overall Study|Lost to Follow-up|0|||
27849596|NCT03739138|81279161|FG004|Overall Study|Lost to Follow-up|0|||
27849597|NCT03739138|81279157|FG000|Overall Study|Study Terminated By Sponsor|0|||
27849598|NCT03739138|81279158|FG001|Overall Study|Study Terminated By Sponsor|0|||
27897532|NCT00603382|81460950|FG005|Overall Study|Withdrawal by Subject|1|||
27849599|NCT03739138|81279159|FG002|Overall Study|Study Terminated By Sponsor|0|||
27849600|NCT03739138|81279160|FG003|Overall Study|Study Terminated By Sponsor|4|||
27849601|NCT03739138|81279161|FG004|Overall Study|Study Terminated By Sponsor|0|||
27849602|NCT03739138|81279157|FG000|Overall Study|Withdrawal by Subject|0|||
27849603|NCT03739138|81279158|FG001|Overall Study|Withdrawal by Subject|0|||
27727068|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727069|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727070|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727071|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727072|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727073|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727074|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727075|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727076|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
27727077|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727078|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727079|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
27727080|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727081|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727082|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727083|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727084|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727085|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727086|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727087|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727088|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727089|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727090|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727091|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727092|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727093|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727094|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727095|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727096|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727097|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727098|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727099|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
27727100|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727101|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727102|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
27727103|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727104|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727105|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727106|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727107|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727108|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727109|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727110|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727111|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727112|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727113|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727114|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727115|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727116|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727117|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727118|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727119|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727120|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727121|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27727122|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
27614048|NCT04320615|80430128|FG000|Overall Study|Withdrawal by Subject|4|||
27614049|NCT04320615|80430129|FG001|Overall Study|Withdrawal by Subject|10|||
27897533|NCT04495816|81460951|FG000|Overall Study|Lost to Follow-up|10|||
27897534|NCT04495816|81460952|FG001|Overall Study|Lost to Follow-up|4|||
27727123|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727124|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727125|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727126|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
27727127|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727128|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727129|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727130|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727131|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727132|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727133|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727134|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727135|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727136|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727137|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727138|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27897535|NCT04495816|81460951|FG000|Overall Study|Withdrawal by Subject|3|||
27897536|NCT04495816|81460952|FG001|Overall Study|Withdrawal by Subject|5|||
27897537|NCT02655419|81460953|FG000|Overall Study|Enrolled but not treated|1|||
27897538|NCT02655419|81460954|FG001|Overall Study|Enrolled but not treated|5|||
27897539|NCT02655419|81460953|FG000|Overall Study|Withdrawal by Subject|4|||
27897540|NCT02655419|81460954|FG001|Overall Study|Withdrawal by Subject|1|||
27897541|NCT02655419|81460953|FG000|Overall Study|Other|0|||
27897542|NCT02655419|81460954|FG001|Overall Study|Other|1|||
27897543|NCT00636636|81460955|FG000|Overall Study|Other reason|4|||
27897544|NCT00636636|81460956|FG001|Overall Study|Other reason|6|||
27897545|NCT00636636|81460955|FG000|Overall Study|Adverse Event|19|||
27897546|NCT00636636|81460956|FG001|Overall Study|Adverse Event|8|||
27897547|NCT00636636|81460955|FG000|Overall Study|Lack of Efficacy|7|||
27897548|NCT00636636|81460956|FG001|Overall Study|Lack of Efficacy|12|||
27897549|NCT00636636|81460955|FG000|Overall Study|Protocol Violation|2|||
27897550|NCT00636636|81460956|FG001|Overall Study|Protocol Violation|2|||
27897551|NCT00636636|81460955|FG000|Overall Study|Lost to Follow-up|0|||
27897552|NCT00636636|81460956|FG001|Overall Study|Lost to Follow-up|1|||
27897553|NCT00636636|81460955|FG000|Overall Study|Death|0|||
27897554|NCT00636636|81460956|FG001|Overall Study|Death|1|||
27897555|NCT00636636|81460955|FG000|Overall Study|Withdrawal by Subject|4|||
27897556|NCT00636636|81460956|FG001|Overall Study|Withdrawal by Subject|9|||
27897557|NCT01210144|81460958|FG000|Overall Study|Lack of ovarian response|1|||
27897558|NCT01210144|81460959|FG001|Overall Study|Lack of ovarian response|0|||
27897559|NCT01210144|81460958|FG000|Overall Study|No fertilization|1|||
27897560|NCT01210144|81460959|FG001|Overall Study|No fertilization|0|||
27897561|NCT01210144|81460958|FG000|Overall Study|No transfer|1|||
27897562|NCT01210144|81460959|FG001|Overall Study|No transfer|0|||
27897563|NCT03426436|81460960|FG000|Overall Study|Incorrect lead placement|12|||
27897564|NCT03426436|81460960|FG000|Overall Study|Withdrawal by Subject|2|||
27897565|NCT03426436|81460960|FG000|Overall Study|Consent issue|1|||
27897566|NCT03426436|81460960|FG000|Overall Study|ECGs not saved|4|||
27897567|NCT01085136|81460961|FG000|Part A|Other Adverse event|223|||
27897568|NCT01085136|81460962|FG001|Part A|Other Adverse event|0|||
27897569|NCT01085136|81460963|FG002|Part A|Other Adverse event|0|||
27897570|NCT01085136|81460961|FG000|Part A|Protocol Violation|3|||
27897571|NCT01085136|81460962|FG001|Part A|Protocol Violation|0|||
27897572|NCT01085136|81460963|FG002|Part A|Protocol Violation|0|||
27897573|NCT01085136|81460961|FG000|Part A|Lost to Follow-up|3|||
27897574|NCT01085136|81460962|FG001|Part A|Lost to Follow-up|0|||
27897575|NCT01085136|81460963|FG002|Part A|Lost to Follow-up|0|||
27897576|NCT01085136|81460961|FG000|Part A|Refusal to continue trial medication|64|||
27897577|NCT01085136|81460962|FG001|Part A|Refusal to continue trial medication|0|||
27897578|NCT01085136|81460963|FG002|Part A|Refusal to continue trial medication|0|||
27897579|NCT01085136|81460961|FG000|Part A|Other reason not defined above|30|||
27506064|NCT04225897|80044251|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27727139|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27897580|NCT01085136|81460962|FG001|Part A|Other reason not defined above|0|||
27897581|NCT01085136|81460963|FG002|Part A|Other reason not defined above|0|||
27897582|NCT01085136|81460961|FG000|Part B|Other AE|0|||
27897583|NCT01085136|81460962|FG001|Part B|Other AE|29|||
27897584|NCT01085136|81460963|FG002|Part B|Other AE|8|||
27897585|NCT01085136|81460961|FG000|Part B|Refusal to continue trial medication|0|||
27897586|NCT01085136|81460962|FG001|Part B|Refusal to continue trial medication|12|||
27897587|NCT01085136|81460963|FG002|Part B|Refusal to continue trial medication|7|||
27897588|NCT01085136|81460961|FG000|Part B|Not treated|0|||
27897589|NCT01085136|81460962|FG001|Part B|Not treated|4|||
27897590|NCT01085136|81460963|FG002|Part B|Not treated|8|||
27897591|NCT01085136|81460961|FG000|Part B|Other reason not defined above|0|||
27897592|NCT01085136|81460962|FG001|Part B|Other reason not defined above|6|||
27897593|NCT01085136|81460963|FG002|Part B|Other reason not defined above|3|||
27897594|NCT01440569|81460964|FG000|Main Study|Enrolled but not treated|1|||
27897595|NCT01440569|81460965|FG001|Main Study|Enrolled but not treated|0|||
27897596|NCT01440569|81460964|FG000|Main Study|Adverse Event|9|||
27897597|NCT01440569|81460965|FG001|Main Study|Adverse Event|0|||
27897598|NCT01440569|81460964|FG000|Main Study|Pregnancy|1|||
27897599|NCT01440569|81460965|FG001|Main Study|Pregnancy|0|||
27897600|NCT01440569|81460964|FG000|Main Study|Investigator's Discretion|1|||
27897601|NCT01440569|81460965|FG001|Main Study|Investigator's Discretion|1|||
27897602|NCT01440569|81460964|FG000|Main Study|Withdrew Consent|7|||
27897603|NCT01440569|81460965|FG001|Main Study|Withdrew Consent|1|||
27897604|NCT01440569|81460964|FG000|Main Study|Lost to Follow-up|13|||
27897605|NCT01440569|81460965|FG001|Main Study|Lost to Follow-up|2|||
27897606|NCT01440569|81460964|FG000|Main Study|Subject Non-Compliance|3|||
27897607|NCT01440569|81460965|FG001|Main Study|Subject Non-Compliance|0|||
27897608|NCT01440569|81460964|FG000|Main Study|Protocol Violation|1|||
27897609|NCT01440569|81460965|FG001|Main Study|Protocol Violation|0|||
27897610|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Adverse Event|3|||
27897611|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Adverse Event|0|||
27897612|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Pregnancy|1|||
27897613|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Pregnancy|0|||
27897614|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
27897615|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
27897616|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
27897617|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
27897618|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
27897619|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
27897620|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
27897621|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
27897622|NCT01440569|81460964|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
27897623|NCT01440569|81460965|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
27897624|NCT00628095|81460967|FG000|Overall Study|Adverse Event|5|||
27897625|NCT00628095|81460968|FG001|Overall Study|Adverse Event|3|||
27897626|NCT00628095|81460967|FG000|Overall Study|Lack of Efficacy|0|||
27897627|NCT00628095|81460968|FG001|Overall Study|Lack of Efficacy|3|||
27897628|NCT00628095|81460967|FG000|Overall Study|Withdrawal by Subject|2|||
27897629|NCT00628095|81460968|FG001|Overall Study|Withdrawal by Subject|0|||
27897630|NCT00628095|81460967|FG000|Overall Study|Other|0|||
27897631|NCT00628095|81460968|FG001|Overall Study|Other|1|||
27897632|NCT00900757|81460973|FG000|Overall Study|screen failure|19|||
27897633|NCT04907227|81460974|FG000|Overall Study|Death|12|||
27897634|NCT04907227|81460975|FG001|Overall Study|Death|8|||
27897635|NCT04907227|81460974|FG000|Overall Study|Withdrawal by Subject|2|||
27897636|NCT04907227|81460975|FG001|Overall Study|Withdrawal by Subject|2|||
27897637|NCT04907227|81460974|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
27897638|NCT04907227|81460975|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
27897639|NCT04907227|81460974|FG000|Overall Study|Sponsor Decision|25|||
27897640|NCT04907227|81460975|FG001|Overall Study|Sponsor Decision|30|||
27897641|NCT04907227|81460974|FG000|Overall Study|Physician Decision|1|||
27897642|NCT04907227|81460975|FG001|Overall Study|Physician Decision|0|||
27897643|NCT00844480|81460978|FG000|Overall Study|Withdrawal by Subject|2|||
27897644|NCT00844480|81460979|FG001|Overall Study|Withdrawal by Subject|3|||
27897645|NCT01167634|81460980|FG000|Overall Study|Lost to Follow-up|1|||
27897646|NCT01167634|81460981|FG001|Overall Study|Lost to Follow-up|3|||
27727140|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727141|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27897647|NCT01167634|81460982|FG002|Overall Study|Lost to Follow-up|3|||
27897648|NCT01167634|81460983|FG003|Overall Study|Lost to Follow-up|4|||
27897649|NCT01167634|81460980|FG000|Overall Study|Withdrawal by Subject|1|||
27897650|NCT01167634|81460981|FG001|Overall Study|Withdrawal by Subject|1|||
27897651|NCT01167634|81460982|FG002|Overall Study|Withdrawal by Subject|0|||
27897652|NCT01167634|81460983|FG003|Overall Study|Withdrawal by Subject|0|||
27897653|NCT03787303|81460986|FG000|Overall Study|Death|1|||
27897654|NCT03787303|81460986|FG000|Overall Study|Premature Termination of Study|1|||
27897655|NCT00741091|81460987|FG000|Overall Study|Death|13|||
27897656|NCT00741091|81460987|FG000|Overall Study|Lost to Follow-up|16|||
27897657|NCT00741091|81460987|FG000|Overall Study|Withdrawal by Subject|6|||
27897658|NCT00741091|81460987|FG000|Overall Study|Missed Visit|22|||
27897659|NCT02059434|81460988|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
27897660|NCT02059434|81460989|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
27897661|NCT02059434|81460990|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
27897662|NCT02059434|81460991|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
27897663|NCT02059434|81460992|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
27897664|NCT02059434|81460993|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
27897665|NCT02059434|81460994|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
27897666|NCT02059434|81460995|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
27897667|NCT02059434|81460996|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
27897668|NCT02059434|81460988|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
27897669|NCT02059434|81460989|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
27897670|NCT02059434|81460990|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
27897671|NCT02059434|81460991|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
27897672|NCT02059434|81460992|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
27897673|NCT02059434|81460993|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
27897674|NCT02059434|81460994|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
27897675|NCT02059434|81460995|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
27897676|NCT02059434|81460996|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
27897677|NCT02059434|81460988|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
27897678|NCT02059434|81460989|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
27897679|NCT02059434|81460990|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
27897680|NCT02059434|81460991|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
27897681|NCT02059434|81460992|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
27897682|NCT02059434|81460993|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
27897683|NCT02059434|81460994|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
27897684|NCT02059434|81460995|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
27897685|NCT02059434|81460996|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
27897686|NCT02059434|81460988|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
27897687|NCT02059434|81460989|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
27897688|NCT02059434|81460990|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
27897689|NCT02059434|81460991|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
27897690|NCT02059434|81460992|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
27897691|NCT02059434|81460993|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
27897692|NCT02059434|81460994|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
27897693|NCT02059434|81460995|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
27897694|NCT02059434|81460996|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
27897695|NCT02059434|81460988|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897696|NCT02059434|81460989|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897697|NCT02059434|81460990|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897698|NCT02059434|81460991|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897699|NCT02059434|81460992|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897700|NCT02059434|81460993|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897701|NCT02059434|81460994|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897702|NCT02059434|81460995|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
27897703|NCT02059434|81460996|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
27897704|NCT02686658|81460997|FG000|Overall Study|Adverse Event|0|||
27897705|NCT02686658|81460998|FG001|Overall Study|Adverse Event|0|||
27897706|NCT02686658|81460999|FG002|Overall Study|Adverse Event|1|||
27897707|NCT02686658|81461000|FG003|Overall Study|Adverse Event|1|||
27897708|NCT02686658|81461001|FG004|Overall Study|Adverse Event|2|||
27897709|NCT02686658|81461002|FG005|Overall Study|Adverse Event|1|||
27897710|NCT02686658|81460997|FG000|Overall Study|Investigator decision|0|||
27897711|NCT02686658|81460998|FG001|Overall Study|Investigator decision|0|||
27897712|NCT02686658|81460999|FG002|Overall Study|Investigator decision|0|||
27897713|NCT02686658|81461000|FG003|Overall Study|Investigator decision|1|||
27897714|NCT02686658|81461001|FG004|Overall Study|Investigator decision|2|||
27897715|NCT02686658|81461002|FG005|Overall Study|Investigator decision|1|||
27897716|NCT02686658|81460997|FG000|Overall Study|Sponsor decision|1|||
27897717|NCT02686658|81460998|FG001|Overall Study|Sponsor decision|2|||
27614050|NCT04320615|80430128|FG000|Overall Study|Physician Decision|2|||
27614051|NCT04320615|80430129|FG001|Overall Study|Physician Decision|0|||
27614052|NCT04320615|80430128|FG000|Overall Study|Other|2|||
27614053|NCT04320615|80430129|FG001|Overall Study|Other|0|||
27614054|NCT04320615|80430128|FG000|Overall Study|Lost to Follow-up|5|||
27614055|NCT04320615|80430129|FG001|Overall Study|Lost to Follow-up|23|||
27614056|NCT04320615|80430128|FG000|Overall Study|Death|35|||
27614057|NCT04320615|80430129|FG001|Overall Study|Death|71|||
27614058|NCT02726399|80430132|FG000|Overall Study|Participant Non-Compliance|1|||
27897718|NCT02686658|81460999|FG002|Overall Study|Sponsor decision|1|||
27897719|NCT02686658|81461000|FG003|Overall Study|Sponsor decision|5|||
27897720|NCT02686658|81461001|FG004|Overall Study|Sponsor decision|13|||
27614059|NCT02726399|80430132|FG000|Overall Study|Adverse Event|2|||
27614060|NCT02726399|80430132|FG000|Overall Study|Progression of disease|4|||
27897721|NCT02686658|81461002|FG005|Overall Study|Sponsor decision|2|||
27897722|NCT02686658|81460997|FG000|Overall Study|Lost to Follow-up|0|||
27897723|NCT02686658|81460998|FG001|Overall Study|Lost to Follow-up|0|||
27897724|NCT02686658|81460999|FG002|Overall Study|Lost to Follow-up|2|||
27897725|NCT02686658|81461000|FG003|Overall Study|Lost to Follow-up|0|||
27897726|NCT02686658|81461001|FG004|Overall Study|Lost to Follow-up|0|||
27897727|NCT02686658|81461002|FG005|Overall Study|Lost to Follow-up|1|||
27897728|NCT02686658|81460997|FG000|Overall Study|Death|1|||
27897729|NCT02686658|81460998|FG001|Overall Study|Death|0|||
27897730|NCT02686658|81460999|FG002|Overall Study|Death|0|||
27897731|NCT02686658|81461000|FG003|Overall Study|Death|1|||
27506065|NCT04225897|80044252|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
27754894|NCT02065622|80929634|FG004|Induction Study|Other, Not Specified|0|||
27897732|NCT02686658|81461001|FG004|Overall Study|Death|1|||
27897733|NCT02686658|81461002|FG005|Overall Study|Death|1|||
27897734|NCT02686658|81460997|FG000|Overall Study|Withdrawal by Subject|2|||
27897735|NCT02686658|81460998|FG001|Overall Study|Withdrawal by Subject|5|||
27897736|NCT02686658|81460999|FG002|Overall Study|Withdrawal by Subject|4|||
27897737|NCT02686658|81461000|FG003|Overall Study|Withdrawal by Subject|4|||
27897738|NCT02686658|81461001|FG004|Overall Study|Withdrawal by Subject|17|||
27897739|NCT02686658|81461002|FG005|Overall Study|Withdrawal by Subject|8|||
27897740|NCT02686658|81460997|FG000|Overall Study|Placed in hospice care|0|||
27897741|NCT02686658|81460998|FG001|Overall Study|Placed in hospice care|0|||
27897742|NCT02686658|81460999|FG002|Overall Study|Placed in hospice care|1|||
27897743|NCT02686658|81461000|FG003|Overall Study|Placed in hospice care|0|||
27897744|NCT02686658|81461001|FG004|Overall Study|Placed in hospice care|0|||
27897745|NCT02686658|81461002|FG005|Overall Study|Placed in hospice care|0|||
27897746|NCT02686658|81460997|FG000|Overall Study|Participant non-compliance|0|||
27897747|NCT02686658|81460998|FG001|Overall Study|Participant non-compliance|0|||
27897748|NCT02686658|81460999|FG002|Overall Study|Participant non-compliance|0|||
27897749|NCT02686658|81461000|FG003|Overall Study|Participant non-compliance|0|||
27897750|NCT02686658|81461001|FG004|Overall Study|Participant non-compliance|0|||
27897751|NCT02686658|81461002|FG005|Overall Study|Participant non-compliance|1|||
27897752|NCT02686658|81460997|FG000|Overall Study|Concern over coronavirus disease care|0|||
27897753|NCT02686658|81460998|FG001|Overall Study|Concern over coronavirus disease care|0|||
27897754|NCT02686658|81460999|FG002|Overall Study|Concern over coronavirus disease care|0|||
27897755|NCT02686658|81461000|FG003|Overall Study|Concern over coronavirus disease care|0|||
27897756|NCT02686658|81461001|FG004|Overall Study|Concern over coronavirus disease care|2|||
27897757|NCT02686658|81461002|FG005|Overall Study|Concern over coronavirus disease care|1|||
27897758|NCT00932451|81461010|FG000|Overall Study|Withdrawal by Subject|69|||
27897759|NCT00932451|81461010|FG000|Overall Study|Lost to Follow-up|22|||
27897760|NCT00932451|81461010|FG000|Overall Study|Death|726|||
27897761|NCT00932451|81461010|FG000|Overall Study|Other reasons|5|||
27897762|NCT01047332|81461012|FG000|Overall Study|SEMS Obstruction|11|||
27897763|NCT01047332|81461013|FG001|Overall Study|SEMS Obstruction|20|||
27897764|NCT01047332|81461012|FG000|Overall Study|Died Unobstructed|38|||
27897765|NCT01047332|81461013|FG001|Overall Study|Died Unobstructed|41|||
27897766|NCT01047332|81461012|FG000|Overall Study|Lost to Follow-up|8|||
27897767|NCT01047332|81461013|FG001|Overall Study|Lost to Follow-up|3|||
27897768|NCT00597012|81461016|FG000|Overall Study|Death|1|||
27897769|NCT00597012|81461017|FG001|Overall Study|Death|1|||
27897770|NCT00597012|81461016|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
27897771|NCT00597012|81461017|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
27897772|NCT00597012|81461016|FG000|Overall Study|Withdrawal by Subject|7|||
27506066|NCT04225897|80044253|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27897773|NCT00597012|81461017|FG001|Overall Study|Withdrawal by Subject|4|||
27897774|NCT00597012|81461016|FG000|Overall Study|Ineligible|2|||
27897775|NCT00597012|81461017|FG001|Overall Study|Ineligible|0|||
27897776|NCT00597012|81461016|FG000|Overall Study|Lost to Follow-up|0|||
27897777|NCT00597012|81461017|FG001|Overall Study|Lost to Follow-up|2|||
27897778|NCT01432275|81461018|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
27897779|NCT01432275|81461019|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
27897780|NCT01432275|81461018|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
27897781|NCT01432275|81461019|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
27897782|NCT01432275|81461018|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
27897783|NCT01432275|81461019|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
27897784|NCT01432275|81461018|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
27897785|NCT01432275|81461019|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
27897786|NCT01432275|81461018|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
27897787|NCT01432275|81461019|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
27897788|NCT01432275|81461018|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
27897789|NCT01432275|81461019|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
27897790|NCT01432275|81461018|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
27897791|NCT01432275|81461019|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
27897792|NCT01432275|81461018|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
27897793|NCT01432275|81461019|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
27897794|NCT01432275|81461018|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
27897795|NCT01432275|81461019|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
27897796|NCT01210495|81461020|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
27897797|NCT01210495|81461021|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
27897798|NCT01210495|81461022|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
27897799|NCT01210495|81461023|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
27897800|NCT01210495|81461020|FG000|Overall Study|Death|14|||
27897801|NCT01210495|81461021|FG001|Overall Study|Death|7|||
27897802|NCT01210495|81461022|FG002|Overall Study|Death|112|||
27897803|NCT01210495|81461023|FG003|Overall Study|Death|54|||
27897804|NCT01210495|81461020|FG000|Overall Study|Study Terminated by Sponsor|0|||
27897805|NCT01210495|81461021|FG001|Overall Study|Study Terminated by Sponsor|0|||
27897806|NCT01210495|81461022|FG002|Overall Study|Study Terminated by Sponsor|4|||
27897807|NCT01210495|81461023|FG003|Overall Study|Study Terminated by Sponsor|11|||
27897808|NCT01210495|81461020|FG000|Overall Study|Lost to Follow-up|0|||
27897809|NCT01210495|81461021|FG001|Overall Study|Lost to Follow-up|0|||
27897810|NCT01210495|81461022|FG002|Overall Study|Lost to Follow-up|1|||
27897811|NCT01210495|81461023|FG003|Overall Study|Lost to Follow-up|1|||
27897812|NCT01210495|81461020|FG000|Overall Study|Other unspecified|0|||
27897813|NCT01210495|81461021|FG001|Overall Study|Other unspecified|0|||
27897814|NCT01210495|81461022|FG002|Overall Study|Other unspecified|6|||
27897815|NCT01210495|81461023|FG003|Overall Study|Other unspecified|0|||
27897816|NCT01043705|81461024|FG000|Overall Study|Death|28|||
27897817|NCT01043705|81461025|FG001|Overall Study|Death|60|||
27897818|NCT01043705|81461026|FG002|Overall Study|Death|26|||
27897819|NCT01043705|81461024|FG000|Overall Study|Lost to Follow-up|27|||
27897820|NCT01043705|81461025|FG001|Overall Study|Lost to Follow-up|12|||
27897821|NCT01043705|81461026|FG002|Overall Study|Lost to Follow-up|0|||
27897822|NCT01043705|81461024|FG000|Overall Study|Multiple Reasons|4|||
27849604|NCT03739138|81279159|FG002|Overall Study|Withdrawal by Subject|0|||
27849605|NCT03739138|81279160|FG003|Overall Study|Withdrawal by Subject|1|||
27849606|NCT03739138|81279161|FG004|Overall Study|Withdrawal by Subject|0|||
27849607|NCT02668822|81279164|FG000|Overall Study|Protocol Violation|2|||
27849608|NCT02668822|81279165|FG001|Overall Study|Protocol Violation|0|||
27849609|NCT02668822|81279164|FG000|Overall Study|Study Terminated by Sponsor|7|||
27849610|NCT02668822|81279165|FG001|Overall Study|Study Terminated by Sponsor|9|||
27849611|NCT03465436|81279166|FG000|Period 1|Protocol Violation|0|||
27897823|NCT01043705|81461025|FG001|Overall Study|Multiple Reasons|7|||
27897824|NCT01043705|81461026|FG002|Overall Study|Multiple Reasons|0|||
27897825|NCT01043705|81461024|FG000|Overall Study|Protocol Violation|2|||
27897826|NCT01043705|81461025|FG001|Overall Study|Protocol Violation|1|||
27897827|NCT01043705|81461026|FG002|Overall Study|Protocol Violation|0|||
27897828|NCT01043705|81461024|FG000|Overall Study|Withdrawal by Subject|8|||
27897829|NCT01043705|81461025|FG001|Overall Study|Withdrawal by Subject|6|||
27849612|NCT03465436|81279167|FG001|Period 1|Protocol Violation|0|||
27849613|NCT03465436|81279168|FG002|Period 1|Protocol Violation|1|||
27897830|NCT01043705|81461026|FG002|Overall Study|Withdrawal by Subject|0|||
27897831|NCT01043705|81461024|FG000|Overall Study|Site Closure|8|||
27897832|NCT01043705|81461025|FG001|Overall Study|Site Closure|0|||
27897833|NCT01043705|81461026|FG002|Overall Study|Site Closure|0|||
27897834|NCT01043705|81461024|FG000|Overall Study|Subsequent Procedure|9|||
27897835|NCT01043705|81461025|FG001|Overall Study|Subsequent Procedure|24|||
27897836|NCT01043705|81461026|FG002|Overall Study|Subsequent Procedure|29|||
27897837|NCT01043705|81461024|FG000|Overall Study|Adverse Event|0|||
27897838|NCT01043705|81461025|FG001|Overall Study|Adverse Event|2|||
27897839|NCT01043705|81461026|FG002|Overall Study|Adverse Event|0|||
27897840|NCT01043705|81461024|FG000|Overall Study|Screen Fail|21|||
27849614|NCT03465436|81279169|FG003|Period 1|Protocol Violation|0|||
27849615|NCT03465436|81279166|FG000|Period 2|Protocol Violation|0|||
27849616|NCT03465436|81279167|FG001|Period 2|Protocol Violation|1|||
27849617|NCT03465436|81279168|FG002|Period 2|Protocol Violation|0|||
27849618|NCT03465436|81279169|FG003|Period 2|Protocol Violation|0|||
27849619|NCT03465436|81279166|FG000|Period 3|Protocol Violation|1|||
27849620|NCT03465436|81279167|FG001|Period 3|Protocol Violation|1|||
27849621|NCT03465436|81279168|FG002|Period 3|Protocol Violation|0|||
27849622|NCT03465436|81279169|FG003|Period 3|Protocol Violation|0|||
27849623|NCT03465436|81279166|FG000|Period 4|Protocol Violation|0|||
27849624|NCT03465436|81279167|FG001|Period 4|Protocol Violation|0|||
27849625|NCT03465436|81279168|FG002|Period 4|Protocol Violation|1|||
27849626|NCT03465436|81279169|FG003|Period 4|Protocol Violation|0|||
27849627|NCT03827564|81279173|FG000|Overall Study|Discontinued due to Study Termination|1|||
27849628|NCT03827564|81279174|FG001|Overall Study|Discontinued due to Study Termination|0|||
27849629|NCT02133001|81279184|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
27849630|NCT02133001|81279185|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
27849631|NCT02133001|81279184|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
27849632|NCT02133001|81279185|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
27849633|NCT02133001|81279184|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
27849634|NCT02133001|81279185|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
27849635|NCT02133001|81279184|FG000|Double Blind (Day 1-25)|Other|2|||
27849636|NCT02133001|81279185|FG001|Double Blind (Day 1-25)|Other|2|||
27849637|NCT02133001|81279184|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
27849638|NCT02133001|81279185|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
27849639|NCT02133001|81279184|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
27849640|NCT02133001|81279185|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
27849641|NCT02133001|81279184|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
27849642|NCT02133001|81279185|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
27849643|NCT02133001|81279184|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
27849644|NCT02133001|81279185|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
27849645|NCT02370914|81279186|FG000|Overall Study|Protocol Violation|2|||
27849646|NCT02357342|81279187|FG000|First 6 Months|Death|2|||
27849647|NCT02357342|81279188|FG001|First 6 Months|Death|0|||
27849648|NCT01475253|81279192|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
27849649|NCT01475253|81279193|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
27849650|NCT01475253|81279194|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
27849651|NCT01475253|81279195|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
27849652|NCT01475253|81279192|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
27849653|NCT01475253|81279193|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
27849654|NCT01475253|81279194|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
27849655|NCT01475253|81279195|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
27849656|NCT02225665|81279196|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
27849657|NCT02225665|81279197|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
27849658|NCT02225665|81279196|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
27849659|NCT02225665|81279197|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
27849660|NCT00389831|81279200|FG000|Overall Study|Lack of Efficacy|0|||
27849661|NCT00389831|81279201|FG001|Overall Study|Lack of Efficacy|2|||
27849662|NCT00389831|81279200|FG000|Overall Study|Did not receive treatment.|0|||
27849663|NCT00389831|81279201|FG001|Overall Study|Did not receive treatment.|2|||
27849664|NCT00389831|81279200|FG000|Overall Study|Other reasons|0|||
27849665|NCT00389831|81279201|FG001|Overall Study|Other reasons|2|||
27849666|NCT00389831|81279200|FG000|Overall Study|Lost to Follow-up|0|||
27849667|NCT00389831|81279201|FG001|Overall Study|Lost to Follow-up|1|||
27849668|NCT03852459|81279202|FG000|Overall Study|Adverse Event|2|||
27849669|NCT03852459|81279203|FG001|Overall Study|Adverse Event|2|||
27849670|NCT03852459|81279202|FG000|Overall Study|Withdrawal by Subject|1|||
27849671|NCT03852459|81279203|FG001|Overall Study|Withdrawal by Subject|1|||
27849672|NCT01930175|81279206|FG000|Core Study|Lost to Follow-up|0|||
27849673|NCT01930175|81279207|FG001|Core Study|Lost to Follow-up|1|||
27849674|NCT01930175|81279208|FG002|Core Study|Lost to Follow-up|0|||
27849675|NCT01930175|81279206|FG000|Core Study|Adverse Event|0|||
27849676|NCT01930175|81279207|FG001|Core Study|Adverse Event|0|||
27849677|NCT01930175|81279208|FG002|Core Study|Adverse Event|1|||
27897841|NCT01043705|81461025|FG001|Overall Study|Screen Fail|0|||
27897842|NCT01043705|81461026|FG002|Overall Study|Screen Fail|0|||
27897843|NCT01043705|81461024|FG000|Overall Study|Other|0|||
27849678|NCT00513682|81279209|FG000|Washout Phase|Adverse Event|2|||
27849679|NCT02221037|81279210|FG000|Overall Study|Physician Decision|0|||
27849680|NCT02221037|81279211|FG001|Overall Study|Physician Decision|0|||
27849681|NCT02221037|81279212|FG002|Overall Study|Physician Decision|1|||
27849682|NCT02221037|81279213|FG003|Overall Study|Physician Decision|0|||
27897844|NCT01043705|81461025|FG001|Overall Study|Other|19|||
27849683|NCT00804141|81279214|FG000|Overall Study|Adverse Event|157|||
27849684|NCT00804141|81279214|FG000|Overall Study|Death|4|||
27849685|NCT00804141|81279214|FG000|Overall Study|Failed to return|96|||
27849686|NCT00804141|81279214|FG000|Overall Study|Investigator request|8|||
27849687|NCT00804141|81279214|FG000|Overall Study|Protocol Violation|85|||
27849688|NCT00804141|81279214|FG000|Overall Study|Withdrawal by Subject|131|||
27849689|NCT00804141|81279214|FG000|Overall Study|Lack of Efficacy|46|||
27849690|NCT00804141|81279214|FG000|Overall Study|Other than specified|30|||
27849691|NCT00804141|81279214|FG000|Overall Study|Enrolled but not treated|6|||
27849692|NCT02940730|81279218|FG000|Intervention 2|Physician Decision|7|||
27849693|NCT02940730|81279219|FG001|Intervention 2|Physician Decision|0|||
27849694|NCT01843348|81279220|FG000|Overall Study|Withdrawal by Subject|4|||
27849695|NCT01843348|81279221|FG001|Overall Study|Withdrawal by Subject|16|||
27849696|NCT01843348|81279222|FG002|Overall Study|Withdrawal by Subject|18|||
27849697|NCT01843348|81279220|FG000|Overall Study|Lost to Follow-up|5|||
27849698|NCT01843348|81279221|FG001|Overall Study|Lost to Follow-up|4|||
27849699|NCT01843348|81279222|FG002|Overall Study|Lost to Follow-up|2|||
27849700|NCT01843348|81279220|FG000|Overall Study|Death|5|||
27849701|NCT01843348|81279221|FG001|Overall Study|Death|3|||
27849702|NCT01843348|81279222|FG002|Overall Study|Death|4|||
27849703|NCT01843348|81279220|FG000|Overall Study|Graft loss/retransplantation|5|||
27849704|NCT01843348|81279221|FG001|Overall Study|Graft loss/retransplantation|8|||
27849705|NCT01843348|81279222|FG002|Overall Study|Graft loss/retransplantation|11|||
27849706|NCT01843348|81279220|FG000|Overall Study|Various reasons|4|||
27849707|NCT01843348|81279221|FG001|Overall Study|Various reasons|9|||
27849708|NCT01843348|81279222|FG002|Overall Study|Various reasons|6|||
27849709|NCT01382251|81279223|FG000|Overall Study|Surgeries cancelled or delayed|16|||
27849710|NCT01382251|81279224|FG001|Overall Study|Surgeries cancelled or delayed|16|||
27849711|NCT01382251|81279223|FG000|Overall Study|Lost to Follow-up|4|||
27849712|NCT01382251|81279224|FG001|Overall Study|Lost to Follow-up|4|||
27849713|NCT01382251|81279223|FG000|Overall Study|Contacted after study closed|1|||
27849714|NCT01382251|81279224|FG001|Overall Study|Contacted after study closed|1|||
27849715|NCT00359632|81279225|FG000|Overall Study|Death|2|||
27849716|NCT00359632|81279226|FG001|Overall Study|Death|0|||
27849717|NCT00359632|81279225|FG000|Overall Study|Adverse Event|1|||
27849718|NCT00359632|81279226|FG001|Overall Study|Adverse Event|0|||
27849719|NCT00359632|81279225|FG000|Overall Study|Non-compliance with visit schedule|1|||
27849720|NCT00359632|81279226|FG001|Overall Study|Non-compliance with visit schedule|0|||
27849721|NCT00983918|81279227|FG000|Overall Study|conversion to open cholecystectomy|0|||
27849722|NCT00983918|81279228|FG001|Overall Study|conversion to open cholecystectomy|2|||
27849723|NCT00983918|81279229|FG002|Overall Study|conversion to open cholecystectomy|2|||
27849724|NCT00983918|81279230|FG003|Overall Study|conversion to open cholecystectomy|2|||
27849725|NCT00375492|81279235|FG000|Overall Study|Adverse Event|4|||
27849726|NCT00375492|81279236|FG001|Overall Study|Adverse Event|5|||
27849727|NCT00375492|81279235|FG000|Overall Study|Entry Criteria Not Met|0|||
27849728|NCT00375492|81279236|FG001|Overall Study|Entry Criteria Not Met|1|||
27849729|NCT00375492|81279235|FG000|Overall Study|Loss of Glucose Control|0|||
27849730|NCT00375492|81279236|FG001|Overall Study|Loss of Glucose Control|1|||
27849731|NCT00375492|81279235|FG000|Overall Study|Lost to Follow-up|10|||
27849732|NCT00375492|81279236|FG001|Overall Study|Lost to Follow-up|5|||
27849733|NCT00375492|81279235|FG000|Overall Study|Physician Decision|0|||
27849734|NCT00375492|81279236|FG001|Overall Study|Physician Decision|4|||
27849735|NCT00375492|81279235|FG000|Overall Study|Protocol Violation|6|||
27849736|NCT00375492|81279236|FG001|Overall Study|Protocol Violation|3|||
27849737|NCT00375492|81279235|FG000|Overall Study|Sponsor Decision|0|||
27849738|NCT00375492|81279236|FG001|Overall Study|Sponsor Decision|1|||
27849739|NCT00375492|81279235|FG000|Overall Study|Withdrawal by Subject|6|||
27849740|NCT00375492|81279236|FG001|Overall Study|Withdrawal by Subject|6|||
27849741|NCT02100319|81279240|FG000|Overall Study|Case Report Forms Uncollected|11|||
27849742|NCT02100319|81279240|FG000|Overall Study|Protocol Deviation|5|||
27849743|NCT05132569|81279244|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
27849744|NCT05132569|81279245|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
27849745|NCT05132569|81279244|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
27849746|NCT05132569|81279245|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
27849747|NCT05132569|81279244|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
27849748|NCT05132569|81279245|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
27897845|NCT01043705|81461026|FG002|Overall Study|Other|25|||
27897846|NCT03673501|81461027|FG000|Overall Study|Participants ongoing.|36|||
27897847|NCT03673501|81461028|FG001|Overall Study|Participants ongoing.|24|||
27849749|NCT03097588|81279248|FG000|Overall Study|Adverse Event|1|||
27849750|NCT03351231|81279250|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
27849751|NCT03351231|81279250|FG000|Combination Therapy Period|Disease progression|2|||
27897848|NCT04326439|81461029|FG000|Overall Study|Withdrawal by Subject|1|||
27897849|NCT04326439|81461030|FG001|Overall Study|Withdrawal by Subject|0|||
27897850|NCT04326439|81461029|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
27897851|NCT04326439|81461030|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
27897852|NCT04326439|81461029|FG000|Overall Study|Relapse after Induction 2|0|||
27897853|NCT04326439|81461030|FG001|Overall Study|Relapse after Induction 2|1|||
27897854|NCT04326439|81461029|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
27897855|NCT04326439|81461030|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
27897856|NCT01625689|81461031|FG000|Overall Study|Migration|2|||
27897857|NCT01625689|81461032|FG001|Overall Study|Migration|1|||
27897858|NCT00526331|81461033|FG000|Overall Study|Sponsor Termination|55|||
27897859|NCT01185509|81461037|FG000|Overall Study|Progression/Relapse|9|||
27897860|NCT01185509|81461038|FG001|Overall Study|Progression/Relapse|15|||
27897861|NCT01185509|81461037|FG000|Overall Study|Physician Decision|2|||
27897862|NCT01185509|81461038|FG001|Overall Study|Physician Decision|2|||
27897863|NCT01185509|81461037|FG000|Overall Study|Withdrawal by Subject|0|||
27897864|NCT01185509|81461038|FG001|Overall Study|Withdrawal by Subject|1|||
27897865|NCT01185509|81461037|FG000|Overall Study|Death|0|||
27897866|NCT01185509|81461038|FG001|Overall Study|Death|1|||
27897867|NCT01185509|81461037|FG000|Overall Study|Intercurrent Illness|0|||
27897868|NCT01185509|81461038|FG001|Overall Study|Intercurrent Illness|1|||
27897869|NCT00803205|81461039|FG000|Overall Study|Adverse Event|7|||
27897870|NCT00803205|81461040|FG001|Overall Study|Adverse Event|2|||
27506067|NCT04225897|80044254|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506068|NCT04225897|80044255|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506069|NCT04225897|80044256|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506070|NCT04225897|80044257|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506071|NCT04225897|80044258|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506072|NCT04225897|80044259|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506073|NCT04225897|80044260|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506074|NCT04225897|80044261|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
27506075|NCT04225897|80044250|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506076|NCT04225897|80044251|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506077|NCT04225897|80044252|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506078|NCT04225897|80044253|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506079|NCT04225897|80044254|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506080|NCT04225897|80044255|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506081|NCT04225897|80044256|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506082|NCT04225897|80044257|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
27506083|NCT04225897|80044258|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506084|NCT04225897|80044259|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506085|NCT04225897|80044260|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506086|NCT04225897|80044261|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
27506087|NCT01744977|80044262|FG000|Overall Study|Withdrawal by Subject|1|||
27506088|NCT01744977|80044263|FG001|Overall Study|Withdrawal by Subject|2|||
27506089|NCT01744977|80044262|FG000|Overall Study|Death|2|||
27614061|NCT03990363|80430133|FG000|Overall Study|Withdrawal by Subject|10|||
27727142|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727143|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727144|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727145|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
27727146|NCT00896532|80830221|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727147|NCT00896532|80830222|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
27727148|NCT00896532|80830223|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727149|NCT00896532|80830224|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
27727150|NCT00896532|80830225|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
27727151|NCT00896532|80830226|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727152|NCT00896532|80830227|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727153|NCT00896532|80830228|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727154|NCT00896532|80830229|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727155|NCT00896532|80830230|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727156|NCT00896532|80830231|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727157|NCT00896532|80830232|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727158|NCT00896532|80830233|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727159|NCT00896532|80830234|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727160|NCT00896532|80830235|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27897871|NCT00803205|81461039|FG000|Overall Study|Lost to Follow-up|1|||
27897872|NCT00803205|81461040|FG001|Overall Study|Lost to Follow-up|0|||
27506090|NCT01744977|80044263|FG001|Overall Study|Death|3|||
27506091|NCT01744977|80044262|FG000|Overall Study|Lost to Follow-up|2|||
27506092|NCT01744977|80044263|FG001|Overall Study|Lost to Follow-up|0|||
27506093|NCT01744977|80044262|FG000|Overall Study|No longer meets inclusion|6|||
27506094|NCT01744977|80044263|FG001|Overall Study|No longer meets inclusion|0|||
27506095|NCT02636595|80044266|FG000|Overall Study|Lost to Follow-up|1|||
27506096|NCT02636595|80044266|FG000|Overall Study|Other|1|||
27506097|NCT02153086|80044267|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
27506098|NCT02153086|80044267|FG000|Overall Study|Other|2|||
27506099|NCT00674817|80044268|FG000|Period 1|Withdrawal by Subject|2|||
27506100|NCT00674817|80044268|FG000|Period 1|Protocol Violation|1|||
27506101|NCT00674817|80044268|FG000|Period 3|Adverse Event|1|||
27897873|NCT00803205|81461039|FG000|Overall Study|Withdrawal by Subject|9|||
27897874|NCT00803205|81461040|FG001|Overall Study|Withdrawal by Subject|9|||
27897875|NCT00803205|81461039|FG000|Overall Study|Physician Decision|1|||
27897876|NCT00803205|81461040|FG001|Overall Study|Physician Decision|0|||
27897877|NCT00803205|81461039|FG000|Overall Study|Protocol Violation|1|||
27897878|NCT00803205|81461040|FG001|Overall Study|Protocol Violation|1|||
27897879|NCT00803205|81461039|FG000|Overall Study|Medical Monitor Decision|1|||
27897880|NCT00803205|81461040|FG001|Overall Study|Medical Monitor Decision|0|||
27897881|NCT00803205|81461039|FG000|Overall Study|Acquired a Lung Infection|0|||
27897882|NCT00803205|81461040|FG001|Overall Study|Acquired a Lung Infection|1|||
27897883|NCT00803205|81461039|FG000|Overall Study|Sponsor Decision|0|||
27897884|NCT00803205|81461040|FG001|Overall Study|Sponsor Decision|1|||
27897885|NCT02240069|81461041|FG000|Overall Study|Withdrawal by Subject|5|||
27897886|NCT02240069|81461042|FG001|Overall Study|Withdrawal by Subject|5|||
27897887|NCT02240069|81461043|FG002|Overall Study|Withdrawal by Subject|2|||
27897888|NCT01790516|81461046|FG000|Overall Study|Physician Decision|1|||
27897889|NCT01790516|81461047|FG001|Overall Study|Physician Decision|0|||
27897890|NCT01346540|81461048|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
27897891|NCT01346540|81461049|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
27897892|NCT01346540|81461048|FG000|Overall Study|Adverse Event|0|||
27897893|NCT01346540|81461049|FG001|Overall Study|Adverse Event|4|||
27897894|NCT01314105|81461050|FG000|Overall Study|Progressive Disease|6|||
27506102|NCT00674817|80044268|FG000|Period 3|Protocol Violation|1|||
27506103|NCT00674817|80044268|FG000|Period 4|Adverse Event|1|||
27614062|NCT03990363|80430134|FG001|Overall Study|Withdrawal by Subject|9|||
27897895|NCT01314105|81461051|FG001|Overall Study|Progressive Disease|10|||
27506104|NCT01614886|80044272|FG000|Overall Study|Adverse Event|15|||
27506105|NCT01614886|80044273|FG001|Overall Study|Adverse Event|20|||
27506106|NCT01614886|80044272|FG000|Overall Study|Withdrawal by Subject|4|||
27506107|NCT01614886|80044273|FG001|Overall Study|Withdrawal by Subject|4|||
27506108|NCT01614886|80044272|FG000|Overall Study|Death|1|||
27897896|NCT01314105|81461050|FG000|Overall Study|Refused to continue taking medication|0|||
27897897|NCT01314105|81461051|FG001|Overall Study|Refused to continue taking medication|1|||
27897898|NCT01314105|81461050|FG000|Overall Study|Other Adverse Event|1|||
27897899|NCT01314105|81461051|FG001|Overall Study|Other Adverse Event|1|||
27897900|NCT00943670|81461052|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
27897901|NCT00943670|81461052|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
27897902|NCT00943670|81461052|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
27897903|NCT00943670|81461052|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
27897904|NCT00943670|81461052|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
27897905|NCT00943670|81461052|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
27897906|NCT00943670|81461052|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
27897907|NCT00943670|81461052|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
27897908|NCT00943670|81461052|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
27897909|NCT00943670|81461052|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
27897910|NCT02719353|81461059|FG000|First Intervention|Physician Decision|0|||
27897911|NCT02719353|81461060|FG001|First Intervention|Physician Decision|1|||
27897912|NCT02667626|81461061|FG000|Overall Study|Withdrawal by Subject|0|||
27897913|NCT02667626|81461062|FG001|Overall Study|Withdrawal by Subject|1|||
27897914|NCT01472939|81461063|FG000|Overall Study|Adverse Event|3|||
27897915|NCT01472939|81461064|FG001|Overall Study|Adverse Event|7|||
27897916|NCT01472939|81461065|FG002|Overall Study|Adverse Event|7|||
27897917|NCT01472939|81461066|FG003|Overall Study|Adverse Event|14|||
27897918|NCT01472939|81461063|FG000|Overall Study|Lack of Efficacy|1|||
27897919|NCT01472939|81461064|FG001|Overall Study|Lack of Efficacy|0|||
27897920|NCT01472939|81461065|FG002|Overall Study|Lack of Efficacy|0|||
27849752|NCT03351231|81279250|FG000|Combination Therapy Period|Study drug toxicity|1|||
27849753|NCT03351231|81279250|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
27849754|NCT03351231|81279250|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
27849755|NCT03351231|81279250|FG000|Safety Follow-Up Period|Other reason|2|||
27849756|NCT00857259|81279251|FG000|Overall Study|Protocol Violation|1|||
27849757|NCT00857259|81279252|FG001|Overall Study|Protocol Violation|0|||
27849758|NCT00857259|81279253|FG002|Overall Study|Protocol Violation|1|||
27897921|NCT01472939|81461066|FG003|Overall Study|Lack of Efficacy|1|||
27897922|NCT01472939|81461063|FG000|Overall Study|Lost to Follow-up|3|||
27897923|NCT01472939|81461064|FG001|Overall Study|Lost to Follow-up|0|||
27897924|NCT01472939|81461065|FG002|Overall Study|Lost to Follow-up|2|||
27897925|NCT01472939|81461066|FG003|Overall Study|Lost to Follow-up|0|||
27897926|NCT01472939|81461063|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
27897927|NCT01472939|81461064|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
27897928|NCT01472939|81461065|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
27897929|NCT01472939|81461066|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
27897930|NCT01472939|81461063|FG000|Overall Study|Prohibited Medication|0|||
27897931|NCT01472939|81461064|FG001|Overall Study|Prohibited Medication|1|||
27897932|NCT01472939|81461065|FG002|Overall Study|Prohibited Medication|0|||
27897933|NCT01472939|81461066|FG003|Overall Study|Prohibited Medication|0|||
27897934|NCT01472939|81461063|FG000|Overall Study|Withdrawal By PI|1|||
27897935|NCT01472939|81461064|FG001|Overall Study|Withdrawal By PI|0|||
27897936|NCT01472939|81461065|FG002|Overall Study|Withdrawal By PI|0|||
27897937|NCT01472939|81461066|FG003|Overall Study|Withdrawal By PI|0|||
27897938|NCT01472939|81461063|FG000|Overall Study|Protocol Violation|3|||
27897939|NCT01472939|81461064|FG001|Overall Study|Protocol Violation|3|||
27897940|NCT01472939|81461065|FG002|Overall Study|Protocol Violation|0|||
27897941|NCT01472939|81461066|FG003|Overall Study|Protocol Violation|1|||
27897942|NCT01472939|81461063|FG000|Overall Study|Withdrawal by Subject|9|||
27897943|NCT01472939|81461064|FG001|Overall Study|Withdrawal by Subject|3|||
27897944|NCT01472939|81461065|FG002|Overall Study|Withdrawal by Subject|1|||
27897945|NCT01472939|81461066|FG003|Overall Study|Withdrawal by Subject|4|||
27897946|NCT03535194|81461067|FG000|Induction Period|Adverse Event|2|||
27897947|NCT03535194|81461068|FG001|Induction Period|Adverse Event|2|||
27897948|NCT03535194|81461069|FG002|Induction Period|Adverse Event|1|||
27897949|NCT03535194|81461070|FG003|Induction Period|Adverse Event|3|||
27897950|NCT03535194|81461071|FG004|Induction Period|Adverse Event|0|||
27897951|NCT03535194|81461067|FG000|Induction Period|Death|0|||
27506109|NCT01614886|80044273|FG001|Overall Study|Death|0|||
27506110|NCT01614886|80044272|FG000|Overall Study|Protocol deviation|0|||
27849759|NCT00911807|81279254|FG000|Overall Study|Adverse Event|2|||
27849760|NCT00911807|81279255|FG001|Overall Study|Adverse Event|1|||
27849761|NCT00911807|81279256|FG002|Overall Study|Adverse Event|5|||
27897952|NCT03535194|81461068|FG001|Induction Period|Death|1|||
27897953|NCT03535194|81461069|FG002|Induction Period|Death|0|||
27897954|NCT03535194|81461070|FG003|Induction Period|Death|0|||
27897955|NCT03535194|81461071|FG004|Induction Period|Death|0|||
27897956|NCT03535194|81461067|FG000|Induction Period|Lack of Efficacy|1|||
27897957|NCT03535194|81461068|FG001|Induction Period|Lack of Efficacy|3|||
27897958|NCT03535194|81461069|FG002|Induction Period|Lack of Efficacy|2|||
27506111|NCT01614886|80044273|FG001|Overall Study|Protocol deviation|2|||
27897959|NCT03535194|81461070|FG003|Induction Period|Lack of Efficacy|2|||
27897960|NCT03535194|81461071|FG004|Induction Period|Lack of Efficacy|0|||
27897961|NCT03535194|81461067|FG000|Induction Period|Lost to Follow-up|3|||
27897962|NCT03535194|81461068|FG001|Induction Period|Lost to Follow-up|5|||
27897963|NCT03535194|81461069|FG002|Induction Period|Lost to Follow-up|2|||
27897964|NCT03535194|81461070|FG003|Induction Period|Lost to Follow-up|3|||
27897965|NCT03535194|81461071|FG004|Induction Period|Lost to Follow-up|0|||
27897966|NCT03535194|81461067|FG000|Induction Period|Physician Decision|1|||
27897967|NCT03535194|81461068|FG001|Induction Period|Physician Decision|1|||
27897968|NCT03535194|81461069|FG002|Induction Period|Physician Decision|0|||
27897969|NCT03535194|81461070|FG003|Induction Period|Physician Decision|0|||
27897970|NCT03535194|81461071|FG004|Induction Period|Physician Decision|0|||
27897971|NCT03535194|81461067|FG000|Induction Period|Protocol Violation|1|||
27897972|NCT03535194|81461068|FG001|Induction Period|Protocol Violation|0|||
27897973|NCT03535194|81461069|FG002|Induction Period|Protocol Violation|0|||
27897974|NCT03535194|81461070|FG003|Induction Period|Protocol Violation|1|||
27897975|NCT03535194|81461071|FG004|Induction Period|Protocol Violation|0|||
27897976|NCT03535194|81461067|FG000|Induction Period|Screen Failure|0|||
27897977|NCT03535194|81461068|FG001|Induction Period|Screen Failure|1|||
27897978|NCT03535194|81461069|FG002|Induction Period|Screen Failure|0|||
27897979|NCT03535194|81461070|FG003|Induction Period|Screen Failure|0|||
27897980|NCT03535194|81461071|FG004|Induction Period|Screen Failure|0|||
27897981|NCT03535194|81461067|FG000|Induction Period|Withdrawal by Subject|3|||
27897982|NCT03535194|81461068|FG001|Induction Period|Withdrawal by Subject|4|||
27897983|NCT03535194|81461069|FG002|Induction Period|Withdrawal by Subject|3|||
27897984|NCT03535194|81461070|FG003|Induction Period|Withdrawal by Subject|2|||
27897985|NCT03535194|81461071|FG004|Induction Period|Withdrawal by Subject|0|||
27897986|NCT03535194|81461067|FG000|Maintenance Period|Adverse Event|6|||
27897987|NCT03535194|81461068|FG001|Maintenance Period|Adverse Event|5|||
27897988|NCT03535194|81461069|FG002|Maintenance Period|Adverse Event|1|||
27897989|NCT03535194|81461070|FG003|Maintenance Period|Adverse Event|11|||
27897990|NCT03535194|81461071|FG004|Maintenance Period|Adverse Event|4|||
27897991|NCT03535194|81461067|FG000|Maintenance Period|Lack of Efficacy|3|||
27897992|NCT03535194|81461068|FG001|Maintenance Period|Lack of Efficacy|2|||
27897993|NCT03535194|81461069|FG002|Maintenance Period|Lack of Efficacy|5|||
27897994|NCT03535194|81461070|FG003|Maintenance Period|Lack of Efficacy|9|||
27897995|NCT03535194|81461071|FG004|Maintenance Period|Lack of Efficacy|0|||
27897996|NCT03535194|81461067|FG000|Maintenance Period|Lost to Follow-up|4|||
27897997|NCT03535194|81461068|FG001|Maintenance Period|Lost to Follow-up|2|||
27897998|NCT03535194|81461069|FG002|Maintenance Period|Lost to Follow-up|1|||
27897999|NCT03535194|81461070|FG003|Maintenance Period|Lost to Follow-up|5|||
27898000|NCT03535194|81461071|FG004|Maintenance Period|Lost to Follow-up|2|||
27898001|NCT03535194|81461067|FG000|Maintenance Period|Other|1|||
27898002|NCT03535194|81461068|FG001|Maintenance Period|Other|2|||
27898003|NCT03535194|81461069|FG002|Maintenance Period|Other|0|||
27898004|NCT03535194|81461070|FG003|Maintenance Period|Other|0|||
27898005|NCT03535194|81461071|FG004|Maintenance Period|Other|0|||
27898006|NCT03535194|81461067|FG000|Maintenance Period|Physician Decision|1|||
27898007|NCT03535194|81461068|FG001|Maintenance Period|Physician Decision|2|||
27898008|NCT03535194|81461069|FG002|Maintenance Period|Physician Decision|0|||
27898009|NCT03535194|81461070|FG003|Maintenance Period|Physician Decision|2|||
27898010|NCT03535194|81461071|FG004|Maintenance Period|Physician Decision|0|||
27898011|NCT03535194|81461067|FG000|Maintenance Period|Pregnancy|0|||
27898012|NCT03535194|81461068|FG001|Maintenance Period|Pregnancy|0|||
27898013|NCT03535194|81461069|FG002|Maintenance Period|Pregnancy|0|||
27898014|NCT03535194|81461070|FG003|Maintenance Period|Pregnancy|2|||
27898015|NCT03535194|81461071|FG004|Maintenance Period|Pregnancy|0|||
27898016|NCT03535194|81461067|FG000|Maintenance Period|Protocol Violation|0|||
27898017|NCT03535194|81461068|FG001|Maintenance Period|Protocol Violation|1|||
27898018|NCT03535194|81461069|FG002|Maintenance Period|Protocol Violation|0|||
27898019|NCT03535194|81461070|FG003|Maintenance Period|Protocol Violation|0|||
27898020|NCT03535194|81461071|FG004|Maintenance Period|Protocol Violation|0|||
27898021|NCT03535194|81461067|FG000|Maintenance Period|Withdrawal by Subject|7|||
27898022|NCT03535194|81461068|FG001|Maintenance Period|Withdrawal by Subject|2|||
27898023|NCT03535194|81461069|FG002|Maintenance Period|Withdrawal by Subject|1|||
27898024|NCT03535194|81461070|FG003|Maintenance Period|Withdrawal by Subject|8|||
27898025|NCT03535194|81461071|FG004|Maintenance Period|Withdrawal by Subject|0|||
27898026|NCT03535194|81461067|FG000|Post-Treatment Followup Period|Adverse Event|4|||
27898027|NCT03535194|81461068|FG001|Post-Treatment Followup Period|Adverse Event|5|||
27898028|NCT03535194|81461069|FG002|Post-Treatment Followup Period|Adverse Event|1|||
27898029|NCT03535194|81461070|FG003|Post-Treatment Followup Period|Adverse Event|8|||
27898030|NCT03535194|81461071|FG004|Post-Treatment Followup Period|Adverse Event|0|||
27898031|NCT03535194|81461067|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
27898032|NCT03535194|81461068|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
27898033|NCT03535194|81461069|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
27898034|NCT03535194|81461070|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
27898035|NCT03535194|81461071|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
27898036|NCT03535194|81461067|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
27898037|NCT03535194|81461068|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
27898038|NCT03535194|81461069|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
27898039|NCT03535194|81461070|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
27898040|NCT03535194|81461071|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
27898041|NCT03535194|81461067|FG000|Post-Treatment Followup Period|Other|1|||
27898042|NCT03535194|81461068|FG001|Post-Treatment Followup Period|Other|0|||
27898043|NCT03535194|81461069|FG002|Post-Treatment Followup Period|Other|0|||
27898044|NCT03535194|81461070|FG003|Post-Treatment Followup Period|Other|5|||
27898045|NCT03535194|81461071|FG004|Post-Treatment Followup Period|Other|0|||
27898046|NCT03535194|81461067|FG000|Post-Treatment Followup Period|Physician Decision|0|||
27898047|NCT03535194|81461068|FG001|Post-Treatment Followup Period|Physician Decision|2|||
27849762|NCT00911807|81279254|FG000|Overall Study|Death|0|||
27849763|NCT00911807|81279255|FG001|Overall Study|Death|0|||
27849764|NCT00911807|81279256|FG002|Overall Study|Death|1|||
27849765|NCT00911807|81279254|FG000|Overall Study|Protocol Violation|6|||
27849766|NCT00911807|81279255|FG001|Overall Study|Protocol Violation|4|||
27849767|NCT00911807|81279256|FG002|Overall Study|Protocol Violation|9|||
27849768|NCT00911807|81279254|FG000|Overall Study|Withdrawal by Subject|8|||
27849769|NCT00911807|81279255|FG001|Overall Study|Withdrawal by Subject|10|||
27849770|NCT00911807|81279256|FG002|Overall Study|Withdrawal by Subject|7|||
27849771|NCT00911807|81279254|FG000|Overall Study|Organizational reasons|1|||
27849772|NCT00911807|81279255|FG001|Overall Study|Organizational reasons|3|||
27849773|NCT00911807|81279256|FG002|Overall Study|Organizational reasons|1|||
27849774|NCT00109837|81279259|FG000|Overall Study|Adverse Event|2|||
27849775|NCT00109837|81279259|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
27849776|NCT00109837|81279259|FG000|Overall Study|Death|1|||
27849777|NCT00109837|81279259|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
27849778|NCT00109837|81279259|FG000|Overall Study|Not treated|1|||
27849779|NCT00109837|81279259|FG000|Overall Study|Ineligible|1|||
27849780|NCT01534637|81279260|FG000|Overall Study|Physician Decision|3|||
27849781|NCT01534637|81279260|FG000|Overall Study|Lack of Efficacy|3|||
27849782|NCT01534637|81279260|FG000|Overall Study|Withdrawal by Subject|1|||
27849783|NCT01534637|81279260|FG000|Overall Study|Adverse Event|1|||
27849784|NCT01534637|81279260|FG000|Overall Study|Liver Mets before treatment|1|||
27849785|NCT05855616|81279261|FG000|Overall Study|Lost to Follow-up|1|||
27849786|NCT05855616|81279262|FG001|Overall Study|Lost to Follow-up|2|||
27849787|NCT01020799|81279263|FG000|Overall Study|Adverse Event|4|||
27849788|NCT01020799|81279264|FG001|Overall Study|Adverse Event|3|||
27849789|NCT01020799|81279265|FG002|Overall Study|Adverse Event|2|||
27849790|NCT01020799|81279263|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
27849791|NCT01020799|81279264|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
27849792|NCT01020799|81279265|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
27849793|NCT01020799|81279263|FG000|Overall Study|Protocol Violation|3|||
27849794|NCT01020799|81279264|FG001|Overall Study|Protocol Violation|2|||
27849795|NCT01020799|81279265|FG002|Overall Study|Protocol Violation|0|||
27849796|NCT01020799|81279263|FG000|Overall Study|Withdrawal by Subject|2|||
27849797|NCT01020799|81279264|FG001|Overall Study|Withdrawal by Subject|2|||
27849798|NCT01020799|81279265|FG002|Overall Study|Withdrawal by Subject|3|||
27849799|NCT01020799|81279263|FG000|Overall Study|Lost to Follow-up|6|||
27849800|NCT01020799|81279264|FG001|Overall Study|Lost to Follow-up|4|||
27849801|NCT01020799|81279265|FG002|Overall Study|Lost to Follow-up|2|||
27849802|NCT00049842|81279266|FG000|Treatment Phase|Adverse Event|47|||
27849803|NCT00049842|81279267|FG001|Treatment Phase|Adverse Event|12|||
27849804|NCT00049842|81279266|FG000|Treatment Phase|Withdrawal by Subject|35|||
27849805|NCT00049842|81279267|FG001|Treatment Phase|Withdrawal by Subject|46|||
27849806|NCT00049842|81279266|FG000|Treatment Phase|Non-compliance with protocol|7|||
27849807|NCT00049842|81279267|FG001|Treatment Phase|Non-compliance with protocol|8|||
27849808|NCT00049842|81279266|FG000|Treatment Phase|Lost to Follow-up|4|||
27849809|NCT00049842|81279267|FG001|Treatment Phase|Lost to Follow-up|8|||
27849810|NCT00049842|81279266|FG000|Treatment Phase|Administrative|0|||
27849811|NCT00049842|81279267|FG001|Treatment Phase|Administrative|3|||
27849812|NCT00049842|81279266|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
27849813|NCT00049842|81279267|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
27849814|NCT00049842|81279266|FG000|Follow-up Phase|Adverse Event|6|||
27849815|NCT00049842|81279267|FG001|Follow-up Phase|Adverse Event|1|||
27849816|NCT00049842|81279266|FG000|Follow-up Phase|Other|1|||
27849817|NCT00049842|81279267|FG001|Follow-up Phase|Other|4|||
27849818|NCT00906373|81279268|FG000|Overall Study|Withdrawal by Subject|0|||
27849819|NCT00906373|81279269|FG001|Overall Study|Withdrawal by Subject|5|||
27849820|NCT00906373|81279268|FG000|Overall Study|Other|0|||
27849821|NCT00906373|81279269|FG001|Overall Study|Other|1|||
27898048|NCT03535194|81461069|FG002|Post-Treatment Followup Period|Physician Decision|1|||
27898049|NCT03535194|81461070|FG003|Post-Treatment Followup Period|Physician Decision|1|||
27849822|NCT00906373|81279268|FG000|Overall Study|Still on treatment at cutoff date|0|||
27727161|NCT00896532|80830236|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727162|NCT00896532|80830237|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727163|NCT00896532|80830238|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727164|NCT00896532|80830239|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727165|NCT00896532|80830240|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727166|NCT00896532|80830241|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727167|NCT00896532|80830242|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727168|NCT00896532|80830243|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
27727169|NCT00896532|80830221|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727170|NCT00896532|80830222|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727171|NCT00896532|80830223|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727172|NCT00896532|80830224|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727173|NCT00896532|80830225|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727174|NCT00896532|80830226|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727175|NCT00896532|80830227|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727176|NCT00896532|80830228|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727177|NCT00896532|80830229|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
27727178|NCT00896532|80830230|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727179|NCT00896532|80830231|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727180|NCT00896532|80830232|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727181|NCT00896532|80830233|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727182|NCT00896532|80830234|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727183|NCT00896532|80830235|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727184|NCT00896532|80830236|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727185|NCT00896532|80830237|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727186|NCT00896532|80830238|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727187|NCT00896532|80830239|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727188|NCT00896532|80830240|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727189|NCT00896532|80830241|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727190|NCT00896532|80830242|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727191|NCT00896532|80830243|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
27727192|NCT00896532|80830221|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727193|NCT00896532|80830222|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727194|NCT00896532|80830223|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727195|NCT00896532|80830224|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727196|NCT00896532|80830225|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727197|NCT00896532|80830226|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727198|NCT00896532|80830227|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727199|NCT00896532|80830228|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727200|NCT00896532|80830229|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27754895|NCT02065622|80929630|FG000|Maintenance Study|Adverse Event|0|||
27849823|NCT00906373|81279269|FG001|Overall Study|Still on treatment at cutoff date|2|||
27849824|NCT03656874|81279270|FG000|Overall Study|Lost to Follow-up|3|||
27849825|NCT03656874|81279271|FG001|Overall Study|Lost to Follow-up|17|||
27849826|NCT00925301|81279272|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
27849827|NCT00925301|81279273|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
27849828|NCT00925301|81279274|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
27849829|NCT00925301|81279275|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
27849830|NCT00925301|81279272|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
27849831|NCT00925301|81279273|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
27849832|NCT00925301|81279274|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
27849833|NCT00925301|81279275|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
27849834|NCT00925301|81279272|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
27849835|NCT00925301|81279273|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
27849836|NCT00925301|81279274|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
27849837|NCT00925301|81279275|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
27898050|NCT03535194|81461071|FG004|Post-Treatment Followup Period|Physician Decision|0|||
27898051|NCT03535194|81461067|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
27506112|NCT01188343|80044276|FG000|Overall Study|Not vaccinated|0|||
27506113|NCT01188343|80044277|FG001|Overall Study|Not vaccinated|2|||
27506114|NCT01188343|80044278|FG002|Overall Study|Not vaccinated|1|||
27506115|NCT01188343|80044276|FG000|Overall Study|Withdrawal by Subject|1|||
27506116|NCT01188343|80044277|FG001|Overall Study|Withdrawal by Subject|24|||
27506117|NCT01188343|80044278|FG002|Overall Study|Withdrawal by Subject|0|||
27506118|NCT02892344|80044279|FG000|Overall Study|Protocol deviation|3|||
27506119|NCT02892344|80044280|FG001|Overall Study|Protocol deviation|4|||
27849838|NCT00925301|81279272|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
27849839|NCT00925301|81279273|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
27849840|NCT00925301|81279274|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
27849841|NCT00925301|81279275|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
27849842|NCT00925301|81279272|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
27849843|NCT00925301|81279273|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
27849844|NCT00925301|81279274|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
27849845|NCT00925301|81279275|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
27849846|NCT00925301|81279272|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
27849847|NCT00925301|81279273|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
27849848|NCT00925301|81279274|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
27849849|NCT00925301|81279275|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
27849850|NCT00925301|81279272|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
27849851|NCT00925301|81279273|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
27849852|NCT00925301|81279274|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
27849853|NCT00925301|81279275|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
27849854|NCT01304693|81282729|FG000|Overall Study|Adverse Event|0|||
27849855|NCT01304693|81282730|FG001|Overall Study|Adverse Event|0|||
27849856|NCT01304693|81282731|FG002|Overall Study|Adverse Event|0|||
27849857|NCT01304693|81282732|FG003|Overall Study|Adverse Event|0|||
27849858|NCT01304693|81282733|FG004|Overall Study|Adverse Event|1|||
27849859|NCT01304693|81282729|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
27849860|NCT01304693|81282730|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
27849861|NCT01304693|81282731|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
27849862|NCT01304693|81282732|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
27849863|NCT01304693|81282733|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
27849864|NCT02792959|81282742|FG000|Overall Study|Protocol Violation|1|||
27849865|NCT01855048|81282743|FG000|Overall Study|Withdrawal by Subject|0|||
27849866|NCT01855048|81282744|FG001|Overall Study|Withdrawal by Subject|1|||
27849867|NCT01855048|81282745|FG002|Overall Study|Withdrawal by Subject|0|||
27849868|NCT01855048|81282746|FG003|Overall Study|Withdrawal by Subject|0|||
27849869|NCT01855048|81282747|FG004|Overall Study|Withdrawal by Subject|1|||
27849870|NCT01855048|81282748|FG005|Overall Study|Withdrawal by Subject|0|||
27849871|NCT04700280|81282749|FG000|Overall Study|Adverse Event|4|||
27849872|NCT04700280|81282750|FG001|Overall Study|Adverse Event|0|||
27849873|NCT04700280|81282749|FG000|Overall Study|Lack of Efficacy|1|||
27849874|NCT04700280|81282750|FG001|Overall Study|Lack of Efficacy|0|||
27849875|NCT04700280|81282749|FG000|Overall Study|Study terminated by sponsor|5|||
27849876|NCT04700280|81282750|FG001|Overall Study|Study terminated by sponsor|3|||
27849877|NCT04700280|81282749|FG000|Overall Study|Other than specified|1|||
27849878|NCT04700280|81282750|FG001|Overall Study|Other than specified|0|||
27849879|NCT02865395|81282753|FG000|Overall Study|Physician Decision|6|||
27898052|NCT03535194|81461068|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
27898053|NCT03535194|81461069|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
27898054|NCT03535194|81461070|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
27898055|NCT03535194|81461071|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
27898056|NCT01280682|81461074|FG000|Overall Study|Lost to Follow-up|0|||
27898057|NCT01280682|81461075|FG001|Overall Study|Lost to Follow-up|6|||
27898058|NCT01280682|81461074|FG000|Overall Study|Withdrawal by Subject|0|||
27898059|NCT01280682|81461075|FG001|Overall Study|Withdrawal by Subject|7|||
27898060|NCT01542034|81461076|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
27898061|NCT01542034|81461077|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
27898062|NCT01542034|81461076|FG000|Overall Study|Administrative decision|0|||
27898063|NCT01542034|81461077|FG001|Overall Study|Administrative decision|3|||
27898064|NCT01542034|81461076|FG000|Overall Study|Subject Noncompliance|1|||
27898065|NCT01542034|81461077|FG001|Overall Study|Subject Noncompliance|0|||
27898066|NCT01542034|81461076|FG000|Overall Study|Adverse Event|2|||
27898067|NCT01542034|81461077|FG001|Overall Study|Adverse Event|2|||
27898068|NCT01542034|81461076|FG000|Overall Study|Lost to Follow-up|7|||
27898069|NCT01542034|81461077|FG001|Overall Study|Lost to Follow-up|6|||
27898070|NCT02670382|81461078|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
27898071|NCT02670382|81461079|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
27898072|NCT00597506|81461089|FG000|Overall Study|Subject is being followed for survival|1|||
27898073|NCT05385224|81461093|FG000|Overall Study|Unable to swallow capsule|2|||
27898074|NCT05385224|81461093|FG000|Overall Study|Withdrawal by Subject|2|||
27898075|NCT05385224|81461093|FG000|Overall Study|Did not meet study criteria|1|||
27898076|NCT02470403|81461094|FG000|Overall Study|Adverse Event|1|||
27898077|NCT02470403|81461095|FG001|Overall Study|Adverse Event|0|||
27898078|NCT02470403|81461096|FG002|Overall Study|Adverse Event|0|||
27898079|NCT02470403|81461097|FG003|Overall Study|Adverse Event|0|||
27898080|NCT02470403|81461098|FG004|Overall Study|Adverse Event|0|||
27898081|NCT02470403|81461094|FG000|Overall Study|Lost to Follow-up|0|||
27898082|NCT02470403|81461095|FG001|Overall Study|Lost to Follow-up|1|||
27898083|NCT02470403|81461096|FG002|Overall Study|Lost to Follow-up|0|||
27898084|NCT02470403|81461097|FG003|Overall Study|Lost to Follow-up|0|||
27898085|NCT02470403|81461098|FG004|Overall Study|Lost to Follow-up|0|||
27898086|NCT02470403|81461094|FG000|Overall Study|Subject/guardian decision|1|||
27898087|NCT02470403|81461095|FG001|Overall Study|Subject/guardian decision|0|||
27898088|NCT02470403|81461096|FG002|Overall Study|Subject/guardian decision|0|||
27898089|NCT02470403|81461097|FG003|Overall Study|Subject/guardian decision|4|||
27898090|NCT02470403|81461098|FG004|Overall Study|Subject/guardian decision|0|||
27898091|NCT02083653|81461099|FG000|Overall Study|Randomized but not Treated|0|||
27898092|NCT02083653|81461100|FG001|Overall Study|Randomized but not Treated|2|||
27898093|NCT02083653|81461101|FG002|Overall Study|Randomized but not Treated|7|||
27898094|NCT02083653|81461099|FG000|Overall Study|Adverse Event|12|||
27898095|NCT02083653|81461100|FG001|Overall Study|Adverse Event|5|||
27898096|NCT02083653|81461101|FG002|Overall Study|Adverse Event|4|||
27898097|NCT02083653|81461099|FG000|Overall Study|Lost to Follow-up|1|||
27898098|NCT02083653|81461100|FG001|Overall Study|Lost to Follow-up|0|||
27898099|NCT02083653|81461101|FG002|Overall Study|Lost to Follow-up|0|||
27898100|NCT02083653|81461099|FG000|Overall Study|Death|2|||
27898101|NCT02083653|81461100|FG001|Overall Study|Death|2|||
27898102|NCT02083653|81461101|FG002|Overall Study|Death|2|||
27898103|NCT02083653|81461099|FG000|Overall Study|Progressive Disease|65|||
27898104|NCT02083653|81461100|FG001|Overall Study|Progressive Disease|73|||
27898105|NCT02083653|81461101|FG002|Overall Study|Progressive Disease|63|||
27898106|NCT02083653|81461099|FG000|Overall Study|Withdrawal by Subject|2|||
27898107|NCT02083653|81461100|FG001|Overall Study|Withdrawal by Subject|1|||
27898108|NCT02083653|81461101|FG002|Overall Study|Withdrawal by Subject|2|||
27898109|NCT02083653|81461099|FG000|Overall Study|Other Events|0|||
27898110|NCT02083653|81461100|FG001|Overall Study|Other Events|2|||
27898111|NCT02083653|81461101|FG002|Overall Study|Other Events|2|||
27898112|NCT02083653|81461099|FG000|Overall Study|Reason Missing|0|||
27898113|NCT02083653|81461100|FG001|Overall Study|Reason Missing|0|||
27898114|NCT02083653|81461101|FG002|Overall Study|Reason Missing|4|||
27898115|NCT03301740|81461106|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
27898116|NCT03301740|81461107|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
27898117|NCT03301740|81461106|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
27898118|NCT03301740|81461107|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
27898119|NCT00426660|81461108|FG000|Overall Study|Death|14|||
27898120|NCT00426660|81461108|FG000|Overall Study|Adverse Event|23|||
27898121|NCT00426660|81461108|FG000|Overall Study|Insufficient Clinical Response|22|||
27898122|NCT00426660|81461108|FG000|Overall Study|Lost to Follow-up|15|||
27898123|NCT00426660|81461108|FG000|Overall Study|Other|23|||
27898124|NCT00426660|81461108|FG000|Overall Study|Withdrawal by Subject|18|||
27898125|NCT00426660|81461108|FG000|Overall Study|Protocol Violation|1|||
27898126|NCT00426660|81461108|FG000|Overall Study|Enrolled Not Treated|15|||
27898127|NCT02906033|81461109|FG000|Baseline|Protocol Violation|37|||
27898128|NCT02906033|81461110|FG001|Baseline|Protocol Violation|33|||
27898129|NCT02906033|81461109|FG000|Follow-up|Lost to Follow-up|46|||
27898130|NCT02906033|81461110|FG001|Follow-up|Lost to Follow-up|62|||
27898131|NCT04594941|81461119|FG000|Overall Study|Other|0|||
27898132|NCT04594941|81461120|FG001|Overall Study|Other|3|||
27898133|NCT04594941|81461121|FG002|Overall Study|Other|1|||
27898134|NCT04594941|81461122|FG003|Overall Study|Other|0|||
27898135|NCT02474355|81461130|FG000|Overall Study|Other|43|||
27898136|NCT02474355|81461130|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
27898137|NCT02474355|81461130|FG000|Overall Study|Lost to Follow-up|98|||
27898138|NCT02474355|81461130|FG000|Overall Study|Withdrawal by Subject|124|||
27898139|NCT02474355|81461130|FG000|Overall Study|Death|1361|||
27898140|NCT01124292|81461137|FG000|Overall Study|Lost to Follow-up|2|||
27898141|NCT01124292|81461138|FG001|Overall Study|Lost to Follow-up|4|||
27898142|NCT01124292|81461139|FG002|Overall Study|Lost to Follow-up|3|||
27898143|NCT01124292|81461137|FG000|Overall Study|Physician Decision|0|||
27898144|NCT01124292|81461138|FG001|Overall Study|Physician Decision|3|||
27898145|NCT01124292|81461139|FG002|Overall Study|Physician Decision|2|||
27506120|NCT02892344|80044279|FG000|Overall Study|Adverse Event|1|||
27754896|NCT02065622|80929631|FG001|Maintenance Study|Adverse Event|0|||
27898146|NCT01124292|81461137|FG000|Overall Study|Withdrawal by Subject|0|||
27898147|NCT01124292|81461138|FG001|Overall Study|Withdrawal by Subject|6|||
27898148|NCT01124292|81461139|FG002|Overall Study|Withdrawal by Subject|2|||
27898149|NCT01124292|81461137|FG000|Overall Study|medical issue unrelated to the study|0|||
27898150|NCT01124292|81461138|FG001|Overall Study|medical issue unrelated to the study|0|||
27898151|NCT01124292|81461139|FG002|Overall Study|medical issue unrelated to the study|2|||
27898152|NCT01124292|81461137|FG000|Overall Study|piercing track closed|0|||
27898153|NCT01124292|81461138|FG001|Overall Study|piercing track closed|2|||
27898154|NCT01124292|81461139|FG002|Overall Study|piercing track closed|1|||
27898155|NCT01458951|81461140|FG000|Overall Study|Other|1|||
27898156|NCT01458951|81461141|FG001|Overall Study|Other|0|||
27898157|NCT01458951|81461142|FG002|Overall Study|Other|0|||
27898158|NCT01458951|81461140|FG000|Overall Study|Protocol Violation|5|||
27898159|NCT01458951|81461141|FG001|Overall Study|Protocol Violation|1|||
27898160|NCT01458951|81461142|FG002|Overall Study|Protocol Violation|0|||
27898161|NCT01458951|81461140|FG000|Overall Study|Withdrawal by Subject|2|||
27898162|NCT01458951|81461141|FG001|Overall Study|Withdrawal by Subject|0|||
27898163|NCT01458951|81461142|FG002|Overall Study|Withdrawal by Subject|2|||
27898164|NCT01458951|81461140|FG000|Overall Study|Adverse Event|7|||
27898165|NCT01458951|81461141|FG001|Overall Study|Adverse Event|0|||
27898166|NCT01458951|81461142|FG002|Overall Study|Adverse Event|2|||
27898167|NCT01458951|81461140|FG000|Overall Study|Insufficient Clinical Response|17|||
27898168|NCT01458951|81461141|FG001|Overall Study|Insufficient Clinical Response|0|||
27898169|NCT01458951|81461142|FG002|Overall Study|Insufficient Clinical Response|11|||
27898170|NCT03558152|81461147|FG000|Overall Study|Adverse Event|0|||
27898171|NCT03558152|81461148|FG001|Overall Study|Adverse Event|0|||
27898172|NCT03558152|81461149|FG002|Overall Study|Adverse Event|1|||
27898173|NCT03558152|81461150|FG003|Overall Study|Adverse Event|1|||
27898174|NCT03558152|81461151|FG004|Overall Study|Adverse Event|2|||
27898175|NCT03558152|81461152|FG005|Overall Study|Adverse Event|1|||
27898176|NCT03558152|81461153|FG006|Overall Study|Adverse Event|1|||
27898177|NCT03558152|81461154|FG007|Overall Study|Adverse Event|0|||
27898178|NCT03558152|81461147|FG000|Overall Study|Death|0|||
27898179|NCT03558152|81461148|FG001|Overall Study|Death|0|||
27898180|NCT03558152|81461149|FG002|Overall Study|Death|0|||
27898181|NCT03558152|81461150|FG003|Overall Study|Death|0|||
27898182|NCT03558152|81461151|FG004|Overall Study|Death|1|||
27898183|NCT03558152|81461152|FG005|Overall Study|Death|0|||
27898184|NCT03558152|81461153|FG006|Overall Study|Death|0|||
27898185|NCT03558152|81461154|FG007|Overall Study|Death|0|||
27898186|NCT03558152|81461147|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
27898187|NCT03558152|81461148|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898188|NCT03558152|81461149|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898189|NCT03558152|81461150|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898190|NCT03558152|81461151|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898191|NCT03558152|81461152|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898192|NCT03558152|81461153|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898193|NCT03558152|81461154|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
27898194|NCT03558152|81461147|FG000|Overall Study|Miscalculation in mmcs|0|||
27898195|NCT03558152|81461148|FG001|Overall Study|Miscalculation in mmcs|0|||
27898196|NCT03558152|81461149|FG002|Overall Study|Miscalculation in mmcs|0|||
27898197|NCT03558152|81461150|FG003|Overall Study|Miscalculation in mmcs|0|||
27898198|NCT03558152|81461151|FG004|Overall Study|Miscalculation in mmcs|0|||
27898199|NCT03558152|81461152|FG005|Overall Study|Miscalculation in mmcs|0|||
27898200|NCT03558152|81461153|FG006|Overall Study|Miscalculation in mmcs|1|||
27898201|NCT03558152|81461154|FG007|Overall Study|Miscalculation in mmcs|0|||
27898202|NCT03558152|81461147|FG000|Overall Study|Mistake in calculation|0|||
27898203|NCT03558152|81461148|FG001|Overall Study|Mistake in calculation|0|||
27898204|NCT03558152|81461149|FG002|Overall Study|Mistake in calculation|0|||
27898205|NCT03558152|81461150|FG003|Overall Study|Mistake in calculation|1|||
27898206|NCT03558152|81461151|FG004|Overall Study|Mistake in calculation|0|||
27898207|NCT03558152|81461152|FG005|Overall Study|Mistake in calculation|0|||
27898208|NCT03558152|81461153|FG006|Overall Study|Mistake in calculation|0|||
27898209|NCT03558152|81461154|FG007|Overall Study|Mistake in calculation|0|||
27898210|NCT03558152|81461147|FG000|Overall Study|Mistake in evaluation of disease status|0|||
27898211|NCT03558152|81461148|FG001|Overall Study|Mistake in evaluation of disease status|0|||
27898212|NCT03558152|81461149|FG002|Overall Study|Mistake in evaluation of disease status|0|||
27898213|NCT03558152|81461150|FG003|Overall Study|Mistake in evaluation of disease status|0|||
27898214|NCT03558152|81461151|FG004|Overall Study|Mistake in evaluation of disease status|0|||
27898215|NCT03558152|81461152|FG005|Overall Study|Mistake in evaluation of disease status|0|||
27898216|NCT03558152|81461153|FG006|Overall Study|Mistake in evaluation of disease status|0|||
27898217|NCT03558152|81461154|FG007|Overall Study|Mistake in evaluation of disease status|1|||
27898218|NCT03558152|81461147|FG000|Overall Study|Physician Decision|0|||
27898219|NCT03558152|81461148|FG001|Overall Study|Physician Decision|0|||
27898220|NCT03558152|81461149|FG002|Overall Study|Physician Decision|0|||
27898221|NCT03558152|81461150|FG003|Overall Study|Physician Decision|0|||
27898222|NCT03558152|81461151|FG004|Overall Study|Physician Decision|0|||
27898223|NCT03558152|81461152|FG005|Overall Study|Physician Decision|0|||
27898224|NCT03558152|81461153|FG006|Overall Study|Physician Decision|1|||
27898225|NCT03558152|81461154|FG007|Overall Study|Physician Decision|0|||
27898226|NCT03558152|81461147|FG000|Overall Study|Withdrawal by Subject|2|||
27898227|NCT03558152|81461148|FG001|Overall Study|Withdrawal by Subject|3|||
27898228|NCT03558152|81461149|FG002|Overall Study|Withdrawal by Subject|2|||
27898229|NCT03558152|81461150|FG003|Overall Study|Withdrawal by Subject|1|||
27898230|NCT03558152|81461151|FG004|Overall Study|Withdrawal by Subject|1|||
27898231|NCT03558152|81461152|FG005|Overall Study|Withdrawal by Subject|1|||
27506121|NCT02892344|80044280|FG001|Overall Study|Adverse Event|8|||
27506122|NCT02892344|80044279|FG000|Overall Study|Lost to Follow-up|0|||
27898232|NCT03558152|81461153|FG006|Overall Study|Withdrawal by Subject|3|||
27898233|NCT03558152|81461154|FG007|Overall Study|Withdrawal by Subject|2|||
27898234|NCT03558152|81461147|FG000|Overall Study|Lack of Efficacy|11|||
27898235|NCT03558152|81461148|FG001|Overall Study|Lack of Efficacy|11|||
27898236|NCT03558152|81461149|FG002|Overall Study|Lack of Efficacy|10|||
27898237|NCT03558152|81461150|FG003|Overall Study|Lack of Efficacy|11|||
27898238|NCT03558152|81461151|FG004|Overall Study|Lack of Efficacy|14|||
27898239|NCT03558152|81461152|FG005|Overall Study|Lack of Efficacy|12|||
27898240|NCT03558152|81461153|FG006|Overall Study|Lack of Efficacy|14|||
27898241|NCT03558152|81461154|FG007|Overall Study|Lack of Efficacy|13|||
27898242|NCT03558152|81461147|FG000|Overall Study|Protocol Violation|1|||
27898243|NCT03558152|81461148|FG001|Overall Study|Protocol Violation|1|||
27898244|NCT03558152|81461149|FG002|Overall Study|Protocol Violation|0|||
27898245|NCT03558152|81461150|FG003|Overall Study|Protocol Violation|1|||
27898246|NCT03558152|81461151|FG004|Overall Study|Protocol Violation|1|||
27898247|NCT03558152|81461152|FG005|Overall Study|Protocol Violation|0|||
27898248|NCT03558152|81461153|FG006|Overall Study|Protocol Violation|2|||
27898249|NCT03558152|81461154|FG007|Overall Study|Protocol Violation|0|||
27898250|NCT02248974|81461155|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
27898251|NCT02248974|81461156|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
27898252|NCT02248974|81461155|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
27898253|NCT02248974|81461156|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
27898254|NCT02248974|81461155|FG000|1-Day Follow-Up|Enrolled in another study|1|||
27898255|NCT02248974|81461156|FG001|1-Day Follow-Up|Enrolled in another study|0|||
27898256|NCT02248974|81461155|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
27898257|NCT02248974|81461156|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
27898258|NCT02248974|81461155|FG000|1-Week Follow-Up|Enrolled in another study|1|||
27898259|NCT02248974|81461156|FG001|1-Week Follow-Up|Enrolled in another study|1|||
27898260|NCT02248974|81461155|FG000|1-Week Follow-Up|Transferred to another facility|1|||
27898261|NCT02248974|81461156|FG001|1-Week Follow-Up|Transferred to another facility|0|||
27898262|NCT02248974|81461155|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
27898263|NCT02248974|81461156|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
27898264|NCT02248974|81461155|FG000|1-Week Follow-Up|Death|1|||
27898265|NCT02248974|81461156|FG001|1-Week Follow-Up|Death|1|||
27898266|NCT02248974|81461155|FG000|1-Week Follow-Up|Excluded because of age|0|||
27506123|NCT02892344|80044280|FG001|Overall Study|Lost to Follow-up|1|||
27506124|NCT02892344|80044279|FG000|Overall Study|Non-compliance with study treatment|0|||
27506125|NCT02892344|80044280|FG001|Overall Study|Non-compliance with study treatment|1|||
27506126|NCT02892344|80044279|FG000|Overall Study|Physician Decision|0|||
27506127|NCT02892344|80044280|FG001|Overall Study|Physician Decision|2|||
27506128|NCT02892344|80044279|FG000|Overall Study|Subject/guardian decision|0|||
27506129|NCT02892344|80044280|FG001|Overall Study|Subject/guardian decision|4|||
27506130|NCT02892344|80044279|FG000|Overall Study|Technical problems|0|||
27506131|NCT02892344|80044280|FG001|Overall Study|Technical problems|1|||
27506132|NCT01499355|80044285|FG000|Run-In Period|Study Termination|15|||
27506133|NCT01499355|80044286|FG001|Run-In Period|Study Termination|0|||
27506134|NCT01499355|80044287|FG002|Run-In Period|Study Termination|0|||
27506135|NCT01499355|80044288|FG003|Run-In Period|Study Termination|0|||
27506136|NCT01499355|80044285|FG000|Run-In Period|Other|3|||
27506137|NCT01499355|80044286|FG001|Run-In Period|Other|0|||
27506138|NCT01499355|80044287|FG002|Run-In Period|Other|0|||
27506139|NCT01499355|80044288|FG003|Run-In Period|Other|0|||
27898267|NCT02248974|81461156|FG001|1-Week Follow-Up|Excluded because of age|1|||
27898268|NCT02248974|81461155|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
27506140|NCT01499355|80044285|FG000|Run-In Period|Death|2|||
27506141|NCT01499355|80044286|FG001|Run-In Period|Death|0|||
27898269|NCT02248974|81461156|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
27898270|NCT02248974|81461155|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
27898271|NCT02248974|81461156|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
27898272|NCT02248974|81461155|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
27898273|NCT02248974|81461156|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
27898274|NCT02248974|81461155|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
27506142|NCT01499355|80044287|FG002|Run-In Period|Death|0|||
27506143|NCT01499355|80044288|FG003|Run-In Period|Death|0|||
27506144|NCT01499355|80044285|FG000|Run-In Period|Investigator Decision|2|||
27898275|NCT02248974|81461156|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
27898276|NCT02248974|81461155|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
27898277|NCT02248974|81461156|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
27898278|NCT00525902|81461159|FG000|Overall Study|Lack of Efficacy|1|||
27898279|NCT01069419|81461161|FG000|Overall Study|Adverse Event|233|||
27898280|NCT01069419|81461161|FG000|Overall Study|Lack of Efficacy|332|||
27898281|NCT01069419|81461161|FG000|Overall Study|Lost to Follow-up|49|||
27898282|NCT01069419|81461161|FG000|Overall Study|Remission of disease|11|||
27898283|NCT01069419|81461161|FG000|Overall Study|Withdrawal by Subject|34|||
27898284|NCT01069419|81461161|FG000|Overall Study|Other Reason|43|||
27898285|NCT01069419|81461161|FG000|Overall Study|Missing termination information|13|||
27849880|NCT02865395|81282754|FG001|Overall Study|Physician Decision|10|||
27849881|NCT02865395|81282755|FG002|Overall Study|Physician Decision|7|||
27849882|NCT00597116|81282756|FG000|Overall Study|Adverse Event|2|||
27849883|NCT00597116|81282757|FG001|Overall Study|Adverse Event|1|||
27849884|NCT00597116|81282756|FG000|Overall Study|Withdrawal by Subject|0|||
27849885|NCT00597116|81282757|FG001|Overall Study|Withdrawal by Subject|2|||
27849886|NCT00597116|81282756|FG000|Overall Study|Physician Decision|0|||
27849887|NCT00597116|81282757|FG001|Overall Study|Physician Decision|1|||
27849888|NCT00597116|81282756|FG000|Overall Study|Death|0|||
27849889|NCT00597116|81282757|FG001|Overall Study|Death|1|||
27849890|NCT00597116|81282756|FG000|Overall Study|Lost to Follow-up|1|||
27849891|NCT00597116|81282757|FG001|Overall Study|Lost to Follow-up|0|||
27849892|NCT00597116|81282756|FG000|Overall Study|Progressive disease|11|||
27849893|NCT00597116|81282757|FG001|Overall Study|Progressive disease|6|||
27849894|NCT00446199|81282758|FG000|Overall Study|Adverse Event|7|||
27849895|NCT00446199|81282759|FG001|Overall Study|Adverse Event|4|||
27849896|NCT00446199|81282760|FG002|Overall Study|Adverse Event|6|||
27849897|NCT00446199|81282761|FG003|Overall Study|Adverse Event|4|||
27849898|NCT00446199|81282758|FG000|Overall Study|Lost to Follow-up|4|||
27849899|NCT00446199|81282759|FG001|Overall Study|Lost to Follow-up|5|||
27849900|NCT00446199|81282760|FG002|Overall Study|Lost to Follow-up|2|||
27849901|NCT00446199|81282761|FG003|Overall Study|Lost to Follow-up|6|||
27849902|NCT00446199|81282758|FG000|Overall Study|Protocol Violation|1|||
27849903|NCT00446199|81282759|FG001|Overall Study|Protocol Violation|2|||
27849904|NCT00446199|81282760|FG002|Overall Study|Protocol Violation|1|||
27849905|NCT00446199|81282761|FG003|Overall Study|Protocol Violation|3|||
27849906|NCT00446199|81282758|FG000|Overall Study|Withdrawal by Subject|2|||
27849907|NCT00446199|81282759|FG001|Overall Study|Withdrawal by Subject|5|||
27849908|NCT00446199|81282760|FG002|Overall Study|Withdrawal by Subject|9|||
27849909|NCT00446199|81282761|FG003|Overall Study|Withdrawal by Subject|10|||
27849910|NCT00446199|81282758|FG000|Overall Study|Site termination|2|||
27849911|NCT00446199|81282759|FG001|Overall Study|Site termination|0|||
27849912|NCT00446199|81282760|FG002|Overall Study|Site termination|0|||
27849913|NCT00446199|81282761|FG003|Overall Study|Site termination|1|||
27849914|NCT00446199|81282758|FG000|Overall Study|Randomization in Error|2|||
27849915|NCT00446199|81282759|FG001|Overall Study|Randomization in Error|0|||
27849916|NCT00446199|81282760|FG002|Overall Study|Randomization in Error|1|||
27849917|NCT00446199|81282761|FG003|Overall Study|Randomization in Error|1|||
27849918|NCT00446199|81282758|FG000|Overall Study|Lack of Efficacy|1|||
27849919|NCT00446199|81282759|FG001|Overall Study|Lack of Efficacy|0|||
27849920|NCT00446199|81282760|FG002|Overall Study|Lack of Efficacy|0|||
27849921|NCT00446199|81282761|FG003|Overall Study|Lack of Efficacy|1|||
27849922|NCT00446199|81282758|FG000|Overall Study|Non-compliant with study drug|1|||
27849923|NCT00446199|81282759|FG001|Overall Study|Non-compliant with study drug|0|||
27849924|NCT00446199|81282760|FG002|Overall Study|Non-compliant with study drug|5|||
27849925|NCT00446199|81282761|FG003|Overall Study|Non-compliant with study drug|0|||
27849926|NCT00446199|81282758|FG000|Overall Study|Non-compliant with visit schedule|1|||
27849927|NCT00446199|81282759|FG001|Overall Study|Non-compliant with visit schedule|1|||
27849928|NCT00446199|81282760|FG002|Overall Study|Non-compliant with visit schedule|1|||
27849929|NCT00446199|81282761|FG003|Overall Study|Non-compliant with visit schedule|2|||
27849930|NCT00446199|81282758|FG000|Overall Study|Hormone fear|0|||
27849931|NCT00446199|81282759|FG001|Overall Study|Hormone fear|0|||
27849932|NCT00446199|81282760|FG002|Overall Study|Hormone fear|0|||
27849933|NCT00446199|81282761|FG003|Overall Study|Hormone fear|1|||
27849934|NCT00446199|81282758|FG000|Overall Study|Lost interest in study participation|0|||
27849935|NCT00446199|81282759|FG001|Overall Study|Lost interest in study participation|1|||
27849936|NCT00446199|81282760|FG002|Overall Study|Lost interest in study participation|0|||
27849937|NCT00446199|81282761|FG003|Overall Study|Lost interest in study participation|0|||
27898286|NCT04015518|81461162|FG000|Overall Study|Adverse Event|6|||
27898287|NCT04015518|81461163|FG001|Overall Study|Adverse Event|1|||
27614063|NCT03990363|80430135|FG002|Overall Study|Withdrawal by Subject|18|||
27898288|NCT04015518|81461164|FG002|Overall Study|Adverse Event|1|||
27614064|NCT03990363|80430136|FG003|Overall Study|Withdrawal by Subject|11|||
27614065|NCT03990363|80430137|FG004|Overall Study|Withdrawal by Subject|9|||
27849938|NCT00446199|81282758|FG000|Overall Study|In-/Exclusion criterion violated|2|||
27849939|NCT00446199|81282759|FG001|Overall Study|In-/Exclusion criterion violated|1|||
27849940|NCT00446199|81282760|FG002|Overall Study|In-/Exclusion criterion violated|2|||
27849941|NCT00446199|81282761|FG003|Overall Study|In-/Exclusion criterion violated|1|||
27849942|NCT00446199|81282758|FG000|Overall Study|Move|0|||
27849943|NCT00446199|81282759|FG001|Overall Study|Move|1|||
27849944|NCT00446199|81282760|FG002|Overall Study|Move|0|||
27849945|NCT00446199|81282761|FG003|Overall Study|Move|0|||
27849946|NCT00986570|81282762|FG000|Overall Study|Lost to Follow-up|6|||
27849947|NCT00986570|81282762|FG000|Overall Study|Potential bias for objective assessment|1|||
27849948|NCT00891371|81282763|FG000|Pre-assignment|Inclusion/exclusion|5|||
27849949|NCT00891371|81282763|FG000|Pre-assignment|Consent withdrawal|1|||
27849950|NCT00891371|81282763|FG000|Treatment|Lack of Efficacy|5|||
27849951|NCT00891371|81282763|FG000|Treatment|Adverse Event|2|||
27849952|NCT00891371|81282763|FG000|Treatment|Death|1|||
27849953|NCT00891371|81282763|FG000|Treatment|Lost to Follow-up|1|||
27849954|NCT00252174|81282764|FG000|Overall Study|Withdrawal by Subject|0|||
27849955|NCT00252174|81282765|FG001|Overall Study|Withdrawal by Subject|1|||
27849956|NCT00252174|81282766|FG002|Overall Study|Withdrawal by Subject|0|||
27849957|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
27849958|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
27849959|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
27849960|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
27849961|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
27849962|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
27849963|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
27849964|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
27849965|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
27849966|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
27849967|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
27849968|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
27898289|NCT04015518|81461165|FG003|Overall Study|Adverse Event|3|||
27898290|NCT04015518|81461166|FG004|Overall Study|Adverse Event|3|||
27898291|NCT04015518|81461162|FG000|Overall Study|Lack of Efficacy|1|||
27898292|NCT04015518|81461163|FG001|Overall Study|Lack of Efficacy|0|||
27898293|NCT04015518|81461164|FG002|Overall Study|Lack of Efficacy|1|||
27898294|NCT04015518|81461165|FG003|Overall Study|Lack of Efficacy|0|||
27898295|NCT04015518|81461166|FG004|Overall Study|Lack of Efficacy|4|||
27898296|NCT04015518|81461162|FG000|Overall Study|Lost to Follow-up|0|||
27898297|NCT04015518|81461163|FG001|Overall Study|Lost to Follow-up|0|||
27898298|NCT04015518|81461164|FG002|Overall Study|Lost to Follow-up|0|||
27898299|NCT04015518|81461165|FG003|Overall Study|Lost to Follow-up|0|||
27898300|NCT04015518|81461166|FG004|Overall Study|Lost to Follow-up|1|||
27849969|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
27849970|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
27849971|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
27849972|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
27849973|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
27849974|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
27898301|NCT04015518|81461162|FG000|Overall Study|Withdrawal by Subject|0|||
27898302|NCT04015518|81461163|FG001|Overall Study|Withdrawal by Subject|1|||
27898303|NCT04015518|81461164|FG002|Overall Study|Withdrawal by Subject|0|||
27898304|NCT04015518|81461165|FG003|Overall Study|Withdrawal by Subject|1|||
27898305|NCT04015518|81461166|FG004|Overall Study|Withdrawal by Subject|1|||
27898306|NCT04015518|81461162|FG000|Overall Study|Patient did not come for consecutive visits|0|||
27898307|NCT04015518|81461163|FG001|Overall Study|Patient did not come for consecutive visits|1|||
27898308|NCT04015518|81461164|FG002|Overall Study|Patient did not come for consecutive visits|0|||
27898309|NCT04015518|81461165|FG003|Overall Study|Patient did not come for consecutive visits|0|||
27898310|NCT04015518|81461166|FG004|Overall Study|Patient did not come for consecutive visits|0|||
27898311|NCT04015518|81461162|FG000|Overall Study|not willing to travel due to Covid-19|0|||
27898312|NCT04015518|81461163|FG001|Overall Study|not willing to travel due to Covid-19|0|||
27898313|NCT04015518|81461164|FG002|Overall Study|not willing to travel due to Covid-19|1|||
27898314|NCT04015518|81461165|FG003|Overall Study|not willing to travel due to Covid-19|0|||
27898315|NCT04015518|81461166|FG004|Overall Study|not willing to travel due to Covid-19|0|||
27898316|NCT04015518|81461162|FG000|Overall Study|Patient wants to discontinue treatment|0|||
27898317|NCT04015518|81461163|FG001|Overall Study|Patient wants to discontinue treatment|0|||
27898318|NCT04015518|81461164|FG002|Overall Study|Patient wants to discontinue treatment|0|||
27898319|NCT04015518|81461165|FG003|Overall Study|Patient wants to discontinue treatment|1|||
27898320|NCT04015518|81461166|FG004|Overall Study|Patient wants to discontinue treatment|0|||
27849975|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
27849976|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
27849977|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
27849978|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
27898321|NCT04015518|81461162|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
27898322|NCT04015518|81461163|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
27898323|NCT04015518|81461164|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
27898324|NCT04015518|81461165|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
27898325|NCT04015518|81461166|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
27898326|NCT04015518|81461162|FG000|Overall Study|Pregnancy|0|||
27898327|NCT04015518|81461163|FG001|Overall Study|Pregnancy|0|||
27898328|NCT04015518|81461164|FG002|Overall Study|Pregnancy|0|||
27898329|NCT04015518|81461165|FG003|Overall Study|Pregnancy|0|||
27898330|NCT04015518|81461166|FG004|Overall Study|Pregnancy|1|||
27898331|NCT04015518|81461162|FG000|Overall Study|Personal reasons|1|||
27898332|NCT04015518|81461163|FG001|Overall Study|Personal reasons|0|||
27898333|NCT04015518|81461164|FG002|Overall Study|Personal reasons|0|||
27898334|NCT04015518|81461165|FG003|Overall Study|Personal reasons|0|||
27898335|NCT04015518|81461166|FG004|Overall Study|Personal reasons|1|||
27898336|NCT04015518|81461162|FG000|Overall Study|Withdrew consent|1|||
27898337|NCT04015518|81461163|FG001|Overall Study|Withdrew consent|0|||
27898338|NCT04015518|81461164|FG002|Overall Study|Withdrew consent|0|||
27898339|NCT04015518|81461165|FG003|Overall Study|Withdrew consent|0|||
27898340|NCT04015518|81461166|FG004|Overall Study|Withdrew consent|0|||
27898341|NCT04015518|81461162|FG000|Overall Study|Prostate carcinoma|1|||
27898342|NCT04015518|81461163|FG001|Overall Study|Prostate carcinoma|0|||
27849979|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
27849980|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
27849981|NCT01421342|81282767|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
27849982|NCT01421342|81282768|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
27849983|NCT01421342|81282769|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
27849984|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
27849985|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
27849986|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
27849987|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
27849988|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
27849989|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
27849990|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
27849991|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
27849992|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
27849993|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
27849994|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
27849995|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
27849996|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
27849997|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
27849998|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
27849999|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
27850000|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
27850001|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
27850002|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
27850003|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
27850004|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
27850005|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
27850006|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
27850007|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
27850008|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
27850009|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
27850010|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
27850011|NCT01421342|81282767|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
27850012|NCT01421342|81282768|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
27850013|NCT01421342|81282769|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
27850014|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
27850015|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
27850016|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
27850017|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
27850018|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
27850019|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
27898343|NCT04015518|81461164|FG002|Overall Study|Prostate carcinoma|0|||
27898344|NCT04015518|81461165|FG003|Overall Study|Prostate carcinoma|0|||
27898345|NCT04015518|81461166|FG004|Overall Study|Prostate carcinoma|0|||
27898346|NCT04015518|81461162|FG000|Overall Study|Could not keep appointments due to work|1|||
27898347|NCT04015518|81461163|FG001|Overall Study|Could not keep appointments due to work|0|||
27850020|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
27850021|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
27850022|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
27850023|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
27850024|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
27850025|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
27850026|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
27850027|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
27850028|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
27850029|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
27850030|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
27850031|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
27850032|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
27850033|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
27850034|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
27850035|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
27850036|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
27850037|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
27850038|NCT01421342|81282767|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
27850039|NCT01421342|81282768|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
27850040|NCT01421342|81282769|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
27850041|NCT03212521|81282774|FG000|Overall Study|Adverse Event|1|||
27850042|NCT03212521|81282774|FG000|Overall Study|Lost to Follow-up|4|||
27850043|NCT03212521|81282774|FG000|Overall Study|Withdrawal by Subject|1|||
27850044|NCT03212521|81282774|FG000|Overall Study|Other|1|||
27850045|NCT00507546|81282775|FG000|Overall Study|Withdrawal by Subject|1|||
27850046|NCT00507546|81282776|FG001|Overall Study|Withdrawal by Subject|0|||
27850047|NCT00507546|81282775|FG000|Overall Study|Protocol Violation|1|||
27850048|NCT00507546|81282776|FG001|Overall Study|Protocol Violation|0|||
27850049|NCT00507546|81282775|FG000|Overall Study|Physician Decision|0|||
27850050|NCT00507546|81282776|FG001|Overall Study|Physician Decision|1|||
27850051|NCT03438227|81282777|FG000|Overall Study|Withdrawal by Subject|10|||
27850052|NCT03438227|81282778|FG001|Overall Study|Withdrawal by Subject|5|||
27850053|NCT02973321|81282781|FG000|Overall Study|Other than specified|0|||
27850054|NCT02973321|81282782|FG001|Overall Study|Other than specified|5|||
27850055|NCT02973321|81282783|FG002|Overall Study|Other than specified|3|||
27850056|NCT02973321|81282784|FG003|Overall Study|Other than specified|3|||
27850057|NCT02973321|81282785|FG004|Overall Study|Other than specified|1|||
27850058|NCT02973321|81282781|FG000|Overall Study|Lack of Efficacy|0|||
27850059|NCT02973321|81282782|FG001|Overall Study|Lack of Efficacy|0|||
27850060|NCT02973321|81282783|FG002|Overall Study|Lack of Efficacy|0|||
27850061|NCT02973321|81282784|FG003|Overall Study|Lack of Efficacy|0|||
27850062|NCT02973321|81282785|FG004|Overall Study|Lack of Efficacy|1|||
27850063|NCT02973321|81282781|FG000|Overall Study|Adverse Event|1|||
27850064|NCT02973321|81282782|FG001|Overall Study|Adverse Event|10|||
27850065|NCT02973321|81282783|FG002|Overall Study|Adverse Event|11|||
27850066|NCT02973321|81282784|FG003|Overall Study|Adverse Event|13|||
27850067|NCT02973321|81282785|FG004|Overall Study|Adverse Event|3|||
27850068|NCT00680186|81282787|FG000|Overall Study|Adverse Event|47|||
27850069|NCT00680186|81282788|FG001|Overall Study|Adverse Event|44|||
27850070|NCT00680186|81282787|FG000|Overall Study|Protocol Violation|31|||
27850071|NCT00680186|81282788|FG001|Overall Study|Protocol Violation|26|||
27850072|NCT00680186|81282787|FG000|Overall Study|Lost to Follow-up|11|||
27850073|NCT00680186|81282788|FG001|Overall Study|Lost to Follow-up|6|||
27850074|NCT00680186|81282787|FG000|Overall Study|Withdrawal by Subject|32|||
27850075|NCT00680186|81282788|FG001|Overall Study|Withdrawal by Subject|39|||
27850076|NCT00680186|81282787|FG000|Overall Study|Other|4|||
27850077|NCT00680186|81282788|FG001|Overall Study|Other|1|||
27850078|NCT03036839|81282789|FG000|Overall Study|Adverse Event|0|||
27850079|NCT03036839|81282790|FG001|Overall Study|Adverse Event|0|||
27850080|NCT03036839|81282791|FG002|Overall Study|Adverse Event|1|||
27850081|NCT03036839|81282789|FG000|Overall Study|Death|3|||
27506145|NCT01499355|80044286|FG001|Run-In Period|Investigator Decision|0|||
27506146|NCT01499355|80044287|FG002|Run-In Period|Investigator Decision|0|||
27850082|NCT03036839|81282790|FG001|Overall Study|Death|0|||
27850083|NCT03036839|81282791|FG002|Overall Study|Death|3|||
27850084|NCT03036839|81282789|FG000|Overall Study|Withdrew Consent|0|||
27850085|NCT03036839|81282790|FG001|Overall Study|Withdrew Consent|0|||
27850086|NCT03036839|81282791|FG002|Overall Study|Withdrew Consent|1|||
27850087|NCT00594646|81282793|FG000|Overall Study|Withdrawal by Subject|1|||
27850088|NCT00594646|81282793|FG000|Overall Study|Lost to Follow-up|15|||
27850089|NCT01435031|81282794|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
27898348|NCT04015518|81461164|FG002|Overall Study|Could not keep appointments due to work|0|||
27898349|NCT04015518|81461165|FG003|Overall Study|Could not keep appointments due to work|0|||
27898350|NCT04015518|81461166|FG004|Overall Study|Could not keep appointments due to work|0|||
27898351|NCT01886781|81461172|FG000|Overall Study|Protocol Violation|5|||
27898352|NCT01886781|81461173|FG001|Overall Study|Protocol Violation|0|||
27898353|NCT01886781|81461172|FG000|Overall Study|Adverse Event|1|||
27898354|NCT01886781|81461173|FG001|Overall Study|Adverse Event|0|||
27898355|NCT01886781|81461172|FG000|Overall Study|Lost to Follow-up|5|||
27506147|NCT01499355|80044288|FG003|Run-In Period|Investigator Decision|0|||
27506148|NCT01499355|80044285|FG000|Run-In Period|Consent Withdrawn|1|||
27898356|NCT01886781|81461173|FG001|Overall Study|Lost to Follow-up|0|||
27898357|NCT01886781|81461172|FG000|Overall Study|Withdrawal by Subject|2|||
27898358|NCT01886781|81461173|FG001|Overall Study|Withdrawal by Subject|1|||
27898359|NCT01886781|81461172|FG000|Overall Study|Worsening of symptoms|1|||
27898360|NCT01886781|81461173|FG001|Overall Study|Worsening of symptoms|1|||
27898361|NCT03840148|81461174|FG000|Study Drug Disposition|Adverse Event|13|||
27898362|NCT03840148|81461175|FG001|Study Drug Disposition|Adverse Event|2|||
27898363|NCT03840148|81461174|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
27898364|NCT03840148|81461175|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
27898365|NCT03840148|81461174|FG000|Study Drug Disposition|Lack of Efficacy|3|||
27898366|NCT03840148|81461175|FG001|Study Drug Disposition|Lack of Efficacy|0|||
27898367|NCT03840148|81461174|FG000|Study Drug Disposition|Physician Decision|2|||
27898368|NCT03840148|81461175|FG001|Study Drug Disposition|Physician Decision|0|||
27898369|NCT03840148|81461174|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
27898370|NCT03840148|81461175|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
27898371|NCT03840148|81461174|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
27898372|NCT03840148|81461175|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
27898373|NCT03840148|81461174|FG000|Study Completion Disposition|Physician Decision|2|||
27898374|NCT03840148|81461175|FG001|Study Completion Disposition|Physician Decision|0|||
27898375|NCT03840148|81461174|FG000|Study Completion Disposition|Covid-19 related|2|||
27898376|NCT03840148|81461175|FG001|Study Completion Disposition|Covid-19 related|0|||
27898377|NCT03840148|81461174|FG000|Study Completion Disposition|Lost to Follow-up|1|||
27898378|NCT03840148|81461175|FG001|Study Completion Disposition|Lost to Follow-up|1|||
27898379|NCT03840148|81461174|FG000|Study Completion Disposition|Death|1|||
27898380|NCT03840148|81461175|FG001|Study Completion Disposition|Death|0|||
27898381|NCT03840148|81461174|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
27898382|NCT03840148|81461175|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
27898383|NCT03304184|81461176|FG000|Overall Study|Withdrawal by Subject|1|||
27898384|NCT03304184|81461177|FG001|Overall Study|Withdrawal by Subject|2|||
27898385|NCT00979420|81461178|FG000|Overall Study|Adverse Event|1|||
27898386|NCT00979420|81461179|FG001|Overall Study|Adverse Event|0|||
27898387|NCT00979420|81461180|FG002|Overall Study|Adverse Event|0|||
27898388|NCT00979420|81461181|FG003|Overall Study|Adverse Event|0|||
27898389|NCT00979420|81461178|FG000|Overall Study|Lack of Efficacy|3|||
27898390|NCT00979420|81461179|FG001|Overall Study|Lack of Efficacy|0|||
27898391|NCT00979420|81461180|FG002|Overall Study|Lack of Efficacy|1|||
27898392|NCT00979420|81461181|FG003|Overall Study|Lack of Efficacy|1|||
27898393|NCT00979420|81461178|FG000|Overall Study|Other reasons not related to Viramune|3|||
27898394|NCT00979420|81461179|FG001|Overall Study|Other reasons not related to Viramune|0|||
27898395|NCT00979420|81461180|FG002|Overall Study|Other reasons not related to Viramune|0|||
27898396|NCT00979420|81461181|FG003|Overall Study|Other reasons not related to Viramune|1|||
27898397|NCT02921750|81461182|FG000|Overall Study|Adverse Event|1|||
27898398|NCT02921750|81461183|FG001|Overall Study|Adverse Event|2|||
27898399|NCT02921750|81461182|FG000|Overall Study|Withdrawal by Subject|1|||
27898400|NCT02921750|81461183|FG001|Overall Study|Withdrawal by Subject|1|||
27898401|NCT02921750|81461182|FG000|Overall Study|Lost to Follow-up|3|||
27898402|NCT02921750|81461183|FG001|Overall Study|Lost to Follow-up|3|||
27898403|NCT02921750|81461182|FG000|Overall Study|Wound healed|3|||
27898404|NCT02921750|81461183|FG001|Overall Study|Wound healed|3|||
27898405|NCT02921750|81461182|FG000|Overall Study|Serious Adverse Event|1|||
27898406|NCT02921750|81461183|FG001|Overall Study|Serious Adverse Event|2|||
27898407|NCT00248833|81461184|FG000|Overall Study|Adverse Event|2|||
27898408|NCT00248833|81461185|FG001|Overall Study|Adverse Event|0|||
27898409|NCT00248833|81461186|FG002|Overall Study|Adverse Event|0|||
27898410|NCT00248833|81461184|FG000|Overall Study|Withdrawal by Subject|0|||
27898411|NCT00248833|81461185|FG001|Overall Study|Withdrawal by Subject|1|||
27898412|NCT00248833|81461186|FG002|Overall Study|Withdrawal by Subject|1|||
27898413|NCT00248833|81461184|FG000|Overall Study|Lost to Follow-up|1|||
27898414|NCT00248833|81461185|FG001|Overall Study|Lost to Follow-up|1|||
27898415|NCT00248833|81461186|FG002|Overall Study|Lost to Follow-up|1|||
27898416|NCT00248833|81461184|FG000|Overall Study|Other|0|||
27898417|NCT00248833|81461185|FG001|Overall Study|Other|1|||
27898418|NCT00248833|81461186|FG002|Overall Study|Other|0|||
27898419|NCT02382796|81461187|FG000|Overall Study|Global deterioration of health status|1|||
27898420|NCT02382796|81461187|FG000|Overall Study|Objective progression or relapse|3|||
27898421|NCT02382796|81461187|FG000|Overall Study|Commercial dacomitinib became available|3|||
27898422|NCT04500769|81461188|FG000|Overall Study|Withdrawal by Subject|5|||
27898423|NCT03422159|81461193|FG000|Overall Study|Exclusion due to terminal disease|2|||
27898424|NCT03422159|81461194|FG001|Overall Study|Exclusion due to terminal disease|1|||
27898425|NCT01211483|81461197|FG000|Phase 1b|Death|6|||
27898426|NCT01211483|81461198|FG001|Phase 1b|Death|0|||
27898427|NCT01211483|81461199|FG002|Phase 1b|Death|0|||
27898428|NCT01211483|81461200|FG003|Phase 1b|Death|0|||
27898429|NCT01211483|81461197|FG000|Phase 1b|Withdrawal by Subject|1|||
27898430|NCT01211483|81461198|FG001|Phase 1b|Withdrawal by Subject|0|||
27898431|NCT01211483|81461199|FG002|Phase 1b|Withdrawal by Subject|0|||
27898432|NCT01211483|81461200|FG003|Phase 1b|Withdrawal by Subject|0|||
27898433|NCT01211483|81461197|FG000|Phase 2|Lost to Follow-up|0|||
27898434|NCT01211483|81461198|FG001|Phase 2|Lost to Follow-up|1|||
27898435|NCT01211483|81461199|FG002|Phase 2|Lost to Follow-up|1|||
27898436|NCT01211483|81461200|FG003|Phase 2|Lost to Follow-up|2|||
27898437|NCT01211483|81461197|FG000|Phase 2|Death|0|||
27898438|NCT01211483|81461198|FG001|Phase 2|Death|64|||
27898439|NCT01211483|81461199|FG002|Phase 2|Death|53|||
27898440|NCT01211483|81461200|FG003|Phase 2|Death|53|||
27898441|NCT01211483|81461197|FG000|Phase 2|Withdrawal by Subject|0|||
27898442|NCT01211483|81461198|FG001|Phase 2|Withdrawal by Subject|1|||
27898443|NCT01211483|81461199|FG002|Phase 2|Withdrawal by Subject|10|||
27898444|NCT01211483|81461200|FG003|Phase 2|Withdrawal by Subject|5|||
27898445|NCT01211483|81461197|FG000|Phase 2|Study terminated by Sponsor|0|||
27898446|NCT01211483|81461198|FG001|Phase 2|Study terminated by Sponsor|6|||
27898447|NCT01211483|81461199|FG002|Phase 2|Study terminated by Sponsor|8|||
27898448|NCT01211483|81461200|FG003|Phase 2|Study terminated by Sponsor|11|||
27898449|NCT01959698|81461201|FG000|Overall Study|Adverse Event|0|||
27898450|NCT01959698|81461202|FG001|Overall Study|Adverse Event|0|||
27898451|NCT01959698|81461203|FG002|Overall Study|Adverse Event|0|||
27898452|NCT01959698|81461204|FG003|Overall Study|Adverse Event|0|||
27898453|NCT01959698|81461205|FG004|Overall Study|Adverse Event|0|||
27898454|NCT01959698|81461206|FG005|Overall Study|Adverse Event|0|||
27898455|NCT01959698|81461207|FG006|Overall Study|Adverse Event|1|||
27898456|NCT01959698|81461201|FG000|Overall Study|Physician Decision|1|||
27898457|NCT01959698|81461202|FG001|Overall Study|Physician Decision|0|||
27898458|NCT01959698|81461203|FG002|Overall Study|Physician Decision|1|||
27898459|NCT01959698|81461204|FG003|Overall Study|Physician Decision|2|||
27898460|NCT01959698|81461205|FG004|Overall Study|Physician Decision|0|||
27898461|NCT01959698|81461206|FG005|Overall Study|Physician Decision|3|||
27898462|NCT01959698|81461207|FG006|Overall Study|Physician Decision|3|||
27898463|NCT01752634|81464880|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
27898464|NCT01752634|81464881|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
27898465|NCT01752634|81464882|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
27898466|NCT01752634|81464883|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
27898467|NCT01752634|81464884|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
27898468|NCT01752634|81464885|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
27898469|NCT01752634|81464880|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27898470|NCT01752634|81464881|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
27898471|NCT01752634|81464882|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27898472|NCT01752634|81464883|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27898473|NCT01752634|81464884|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27898474|NCT01752634|81464885|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
27898475|NCT01752634|81464880|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
27898476|NCT01752634|81464881|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
27898477|NCT01752634|81464882|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
27898478|NCT01752634|81464883|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
27898479|NCT01752634|81464884|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
27898480|NCT01752634|81464885|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
27898481|NCT01752634|81464880|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
27898482|NCT01752634|81464881|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
27898483|NCT01752634|81464882|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
27898484|NCT01752634|81464883|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
27898485|NCT01752634|81464884|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
27898486|NCT01752634|81464885|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
27898487|NCT01752634|81464880|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
27898488|NCT01752634|81464881|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
27898489|NCT01752634|81464882|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
27898490|NCT01752634|81464883|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
27898491|NCT01752634|81464884|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
27898492|NCT01752634|81464885|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
27898493|NCT01752634|81464880|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
27898494|NCT01752634|81464881|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
27898495|NCT01752634|81464882|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
27898496|NCT01752634|81464883|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
27898497|NCT01752634|81464884|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
27898498|NCT01752634|81464885|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
27898499|NCT01752634|81464880|FG000|Week 24 to Week 260|Physician Decision|1|||
27898500|NCT01752634|81464881|FG001|Week 24 to Week 260|Physician Decision|2|||
27898501|NCT01752634|81464882|FG002|Week 24 to Week 260|Physician Decision|4|||
27898502|NCT01752634|81464883|FG003|Week 24 to Week 260|Physician Decision|2|||
27898503|NCT01752634|81464884|FG004|Week 24 to Week 260|Physician Decision|1|||
27898504|NCT01752634|81464885|FG005|Week 24 to Week 260|Physician Decision|0|||
27898505|NCT01752634|81464880|FG000|Week 24 to Week 260|Death|0|||
27898506|NCT01752634|81464881|FG001|Week 24 to Week 260|Death|1|||
27898507|NCT01752634|81464882|FG002|Week 24 to Week 260|Death|0|||
27898508|NCT01752634|81464883|FG003|Week 24 to Week 260|Death|0|||
27898509|NCT01752634|81464884|FG004|Week 24 to Week 260|Death|0|||
27898510|NCT01752634|81464885|FG005|Week 24 to Week 260|Death|0|||
27898511|NCT01752634|81464880|FG000|Week 24 to Week 260|Pregnancy|0|||
27898512|NCT01752634|81464881|FG001|Week 24 to Week 260|Pregnancy|0|||
27898513|NCT01752634|81464882|FG002|Week 24 to Week 260|Pregnancy|1|||
27898514|NCT01752634|81464883|FG003|Week 24 to Week 260|Pregnancy|0|||
27898515|NCT01752634|81464884|FG004|Week 24 to Week 260|Pregnancy|0|||
27898516|NCT01752634|81464885|FG005|Week 24 to Week 260|Pregnancy|0|||
27898517|NCT01752634|81464880|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
27898518|NCT01752634|81464881|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
27898519|NCT01752634|81464882|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
27898520|NCT01752634|81464883|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
27898521|NCT01752634|81464884|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
27898522|NCT01752634|81464885|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
27898523|NCT01752634|81464880|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
27898524|NCT01752634|81464881|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
27898525|NCT01752634|81464882|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
27898526|NCT01752634|81464883|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
27898527|NCT01752634|81464884|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
27898528|NCT01752634|81464885|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
27898529|NCT01752634|81464880|FG000|Week 24 to Week 260|Adverse Event|4|||
27898530|NCT01752634|81464881|FG001|Week 24 to Week 260|Adverse Event|8|||
27898531|NCT01752634|81464882|FG002|Week 24 to Week 260|Adverse Event|8|||
27898532|NCT01752634|81464883|FG003|Week 24 to Week 260|Adverse Event|4|||
27898533|NCT01752634|81464884|FG004|Week 24 to Week 260|Adverse Event|2|||
27898534|NCT01752634|81464885|FG005|Week 24 to Week 260|Adverse Event|0|||
27898535|NCT01156051|81464886|FG000|Overall Study|Lost to Follow-up|1|||
27898536|NCT01156051|81464887|FG001|Overall Study|Lost to Follow-up|0|||
27898537|NCT01156051|81464886|FG000|Overall Study|patient not compliant with protocol|0|||
27898538|NCT01156051|81464887|FG001|Overall Study|patient not compliant with protocol|1|||
27898539|NCT03760458|81464888|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
27898540|NCT03760458|81464889|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
27898541|NCT03760458|81464890|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
27898542|NCT03760458|81464891|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
27898543|NCT03760458|81464892|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
27727201|NCT00896532|80830230|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27850090|NCT01435031|81282794|FG000|ITT at 1 Month|Death|1|||
27850091|NCT01435031|81282794|FG000|ITT at 1 Month|Lost to Follow-up|4|||
27850092|NCT01435031|81282794|FG000|ITT at 6 Months|Death|2|||
27850093|NCT01435031|81282794|FG000|ITT at 6 Months|Lost to Follow-up|3|||
27850094|NCT01435031|81282794|FG000|ITT at 1 Year|Death|1|||
27850095|NCT01435031|81282794|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
27850096|NCT01435031|81282794|FG000|ITT at 1 Year|Lost to Follow-up|6|||
27850097|NCT01435031|81282794|FG000|ITT at 2 Years|Death|7|||
27850098|NCT01435031|81282794|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
27850099|NCT01435031|81282794|FG000|ITT at 2 Years|Lost to Follow-up|4|||
27850100|NCT01435031|81282794|FG000|ITT at 3 Years|Death|5|||
27850101|NCT01435031|81282794|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
27850102|NCT01435031|81282794|FG000|ITT at 3 Years|Lost to Follow-up|4|||
27850103|NCT01435031|81282794|FG000|ITT at 4 Years|Death|4|||
27850104|NCT01435031|81282794|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
27850105|NCT01435031|81282794|FG000|ITT at 4 Years|Lost to Follow-up|1|||
27850106|NCT00186043|81282795|FG000|Overall Study|Lack of Efficacy|1|||
27850107|NCT00186043|81282796|FG001|Overall Study|Lack of Efficacy|3|||
27850108|NCT00186043|81282795|FG000|Overall Study|Lost to Follow-up|4|||
27850109|NCT00186043|81282796|FG001|Overall Study|Lost to Follow-up|6|||
27850110|NCT00186043|81282795|FG000|Overall Study|Withdrawal by Subject|1|||
27850111|NCT00186043|81282796|FG001|Overall Study|Withdrawal by Subject|0|||
27850112|NCT00186043|81282795|FG000|Overall Study|Adverse Event|7|||
27850113|NCT00186043|81282796|FG001|Overall Study|Adverse Event|3|||
27850114|NCT00186043|81282795|FG000|Overall Study|Protocol Violation|2|||
27850115|NCT00186043|81282796|FG001|Overall Study|Protocol Violation|1|||
27898544|NCT00308750|81464893|FG000|Overall Study|Adverse Event|9|||
27898545|NCT00308750|81464894|FG001|Overall Study|Adverse Event|9|||
27898546|NCT00308750|81464895|FG002|Overall Study|Adverse Event|13|||
27898547|NCT00308750|81464893|FG000|Overall Study|Withdrawal by Subject|6|||
27850116|NCT01000493|81282797|FG000|Overall Study|Adverse Event|3|||
27898548|NCT00308750|81464894|FG001|Overall Study|Withdrawal by Subject|2|||
27850117|NCT01000493|81282798|FG001|Overall Study|Adverse Event|6|||
27850118|NCT01000493|81282797|FG000|Overall Study|Lack of Efficacy|1|||
27850119|NCT01000493|81282798|FG001|Overall Study|Lack of Efficacy|1|||
27850120|NCT01000493|81282797|FG000|Overall Study|Protocol Violation|1|||
27850121|NCT01000493|81282798|FG001|Overall Study|Protocol Violation|8|||
27850122|NCT01000493|81282797|FG000|Overall Study|Study closed/terminated|25|||
27850123|NCT01000493|81282798|FG001|Overall Study|Study closed/terminated|23|||
27850124|NCT01000493|81282797|FG000|Overall Study|Lost to Follow-up|5|||
27850125|NCT01000493|81282798|FG001|Overall Study|Lost to Follow-up|9|||
27850126|NCT01000493|81282797|FG000|Overall Study|Physician Decision|1|||
27850127|NCT01000493|81282798|FG001|Overall Study|Physician Decision|1|||
27850128|NCT01000493|81282797|FG000|Overall Study|Withdrawal by Subject|3|||
27506149|NCT01499355|80044286|FG001|Run-In Period|Consent Withdrawn|0|||
27506150|NCT01499355|80044287|FG002|Run-In Period|Consent Withdrawn|0|||
27506151|NCT01499355|80044288|FG003|Run-In Period|Consent Withdrawn|0|||
27506152|NCT01499355|80044285|FG000|Run-In Period|Adverse Event|8|||
27506153|NCT01499355|80044286|FG001|Run-In Period|Adverse Event|0|||
27506154|NCT01499355|80044287|FG002|Run-In Period|Adverse Event|0|||
27506155|NCT01499355|80044288|FG003|Run-In Period|Adverse Event|0|||
27506156|NCT01499355|80044285|FG000|Double-Blind Period|Adverse Event|0|||
27506157|NCT01499355|80044286|FG001|Double-Blind Period|Adverse Event|2|||
27506158|NCT01499355|80044287|FG002|Double-Blind Period|Adverse Event|3|||
27506159|NCT01499355|80044288|FG003|Double-Blind Period|Adverse Event|2|||
27506160|NCT01499355|80044285|FG000|Double-Blind Period|Study Termination|0|||
27506161|NCT01499355|80044286|FG001|Double-Blind Period|Study Termination|18|||
27506162|NCT01499355|80044287|FG002|Double-Blind Period|Study Termination|16|||
27506163|NCT01499355|80044288|FG003|Double-Blind Period|Study Termination|14|||
27506164|NCT01499355|80044285|FG000|Double-Blind Period|Other|0|||
27614066|NCT03990363|80430133|FG000|Overall Study|Physician Decision|1|||
27614067|NCT03990363|80430134|FG001|Overall Study|Physician Decision|0|||
27614068|NCT03990363|80430135|FG002|Overall Study|Physician Decision|0|||
27614069|NCT03990363|80430136|FG003|Overall Study|Physician Decision|0|||
27850129|NCT01000493|81282798|FG001|Overall Study|Withdrawal by Subject|7|||
27850130|NCT01782482|81282803|FG000|Overall Study|Adverse Event|2|||
27850131|NCT01782482|81282804|FG001|Overall Study|Adverse Event|1|||
27850132|NCT01782482|81282803|FG000|Overall Study|Lost to Follow-up|2|||
27850133|NCT01782482|81282804|FG001|Overall Study|Lost to Follow-up|3|||
27850134|NCT01782482|81282803|FG000|Overall Study|Physician Decision|1|||
27850135|NCT01782482|81282804|FG001|Overall Study|Physician Decision|0|||
27850136|NCT01782482|81282803|FG000|Overall Study|Protocol Violation|1|||
27850137|NCT01782482|81282804|FG001|Overall Study|Protocol Violation|0|||
27850138|NCT01782482|81282803|FG000|Overall Study|Withdrawal by Subject|2|||
27898549|NCT00308750|81464895|FG002|Overall Study|Withdrawal by Subject|3|||
27614070|NCT03990363|80430137|FG004|Overall Study|Physician Decision|0|||
27614071|NCT03990363|80430133|FG000|Overall Study|Adverse Event|1|||
27614072|NCT03990363|80430134|FG001|Overall Study|Adverse Event|3|||
27614073|NCT03990363|80430135|FG002|Overall Study|Adverse Event|2|||
27614074|NCT03990363|80430136|FG003|Overall Study|Adverse Event|2|||
27614075|NCT03990363|80430137|FG004|Overall Study|Adverse Event|0|||
27614076|NCT03990363|80430133|FG000|Overall Study|Death|14|||
27614077|NCT03990363|80430134|FG001|Overall Study|Death|8|||
27614078|NCT03990363|80430135|FG002|Overall Study|Death|14|||
27614079|NCT03990363|80430136|FG003|Overall Study|Death|10|||
27614080|NCT03990363|80430137|FG004|Overall Study|Death|11|||
27614081|NCT03990363|80430133|FG000|Overall Study|Failure to meet randomization criteria|0|||
27614082|NCT03990363|80430134|FG001|Overall Study|Failure to meet randomization criteria|1|||
27614083|NCT03990363|80430135|FG002|Overall Study|Failure to meet randomization criteria|1|||
27614084|NCT03990363|80430136|FG003|Overall Study|Failure to meet randomization criteria|0|||
27614085|NCT03990363|80430137|FG004|Overall Study|Failure to meet randomization criteria|0|||
27850139|NCT01782482|81282804|FG001|Overall Study|Withdrawal by Subject|3|||
27850140|NCT01782482|81282803|FG000|Overall Study|Randomized in Error|2|||
27898550|NCT00308750|81464893|FG000|Overall Study|Physician Decision|3|||
27898551|NCT00308750|81464894|FG001|Overall Study|Physician Decision|4|||
27898552|NCT00308750|81464895|FG002|Overall Study|Physician Decision|3|||
27506165|NCT01499355|80044286|FG001|Double-Blind Period|Other|1|||
27850141|NCT01782482|81282804|FG001|Overall Study|Randomized in Error|2|||
27850142|NCT01782482|81282803|FG000|Overall Study|Habitually wearing toric lens OS|0|||
27850143|NCT01782482|81282804|FG001|Overall Study|Habitually wearing toric lens OS|1|||
27614086|NCT03990363|80430133|FG000|Overall Study|Lost to Follow-up|0|||
27614087|NCT03990363|80430134|FG001|Overall Study|Lost to Follow-up|0|||
27614088|NCT03990363|80430135|FG002|Overall Study|Lost to Follow-up|0|||
27614089|NCT03990363|80430136|FG003|Overall Study|Lost to Follow-up|1|||
27850144|NCT03407430|81282805|FG000|Washout|Protocol Violation|1|||
27898553|NCT00308750|81464893|FG000|Overall Study|Sponsor Decision|1|||
27506166|NCT01499355|80044287|FG002|Double-Blind Period|Other|2|||
27506167|NCT01499355|80044288|FG003|Double-Blind Period|Other|2|||
27506168|NCT01499355|80044285|FG000|Double-Blind Period|Death|0|||
27506169|NCT01499355|80044286|FG001|Double-Blind Period|Death|1|||
27850145|NCT03407430|81282806|FG001|Washout|Protocol Violation|0|||
27727202|NCT00896532|80830231|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727203|NCT00896532|80830232|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727204|NCT00896532|80830233|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
27727205|NCT00896532|80830234|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727206|NCT00896532|80830235|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727207|NCT00896532|80830236|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727208|NCT00896532|80830237|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727209|NCT00896532|80830238|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727210|NCT00896532|80830239|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727211|NCT00896532|80830240|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727212|NCT00896532|80830241|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727213|NCT00896532|80830242|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727214|NCT00896532|80830243|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
27727215|NCT00896532|80830221|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727216|NCT00896532|80830222|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727217|NCT00896532|80830223|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727218|NCT00896532|80830224|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727219|NCT00896532|80830225|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727220|NCT00896532|80830226|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727221|NCT00896532|80830227|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727222|NCT00896532|80830228|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727223|NCT00896532|80830229|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727224|NCT00896532|80830230|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727225|NCT00896532|80830231|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
27727226|NCT00896532|80830232|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727227|NCT00896532|80830233|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
27727228|NCT00896532|80830234|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727229|NCT00896532|80830235|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727230|NCT00896532|80830236|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727231|NCT00896532|80830237|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727232|NCT00896532|80830238|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727233|NCT00896532|80830239|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727234|NCT00896532|80830240|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727235|NCT00896532|80830241|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27898554|NCT00308750|81464894|FG001|Overall Study|Sponsor Decision|0|||
27898555|NCT00308750|81464895|FG002|Overall Study|Sponsor Decision|0|||
27727236|NCT00896532|80830242|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27727237|NCT00896532|80830243|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
27754897|NCT02065622|80929632|FG002|Maintenance Study|Adverse Event|25|||
27898556|NCT00308750|81464893|FG000|Overall Study|Disease Progression|47|||
27898557|NCT00308750|81464894|FG001|Overall Study|Disease Progression|24|||
27898558|NCT00308750|81464895|FG002|Overall Study|Disease Progression|28|||
27898559|NCT00308750|81464893|FG000|Overall Study|Unrelated Complication|3|||
27850146|NCT01300923|81282809|FG000|Overall Study|Physician Decision|0|||
27850147|NCT01300923|81282810|FG001|Overall Study|Physician Decision|2|||
27850148|NCT01138111|81282811|FG000|Overall Study|Withdrawal by Subject|5|||
27850149|NCT01138111|81282811|FG000|Overall Study|Adverse Event|1|||
27850150|NCT01138111|81282811|FG000|Overall Study|Death|1|||
27850151|NCT01138111|81282811|FG000|Overall Study|Lost to Follow-up|2|||
27850152|NCT03438539|81282819|FG000|Overall Study|Lost to Follow-up|8|||
27850153|NCT03438539|81282820|FG001|Overall Study|Lost to Follow-up|4|||
27850154|NCT03438539|81282821|FG002|Overall Study|Lost to Follow-up|10|||
27850155|NCT03438539|81282822|FG003|Overall Study|Lost to Follow-up|9|||
27850156|NCT03438539|81282823|FG004|Overall Study|Lost to Follow-up|3|||
27850157|NCT03438539|81282824|FG005|Overall Study|Lost to Follow-up|8|||
27850158|NCT01144364|81282825|FG000|Induction Phase|Disease progression|14|||
27850159|NCT01144364|81282826|FG001|Induction Phase|Disease progression|0|||
27850160|NCT01144364|81282827|FG002|Induction Phase|Disease progression|0|||
27850161|NCT01144364|81282825|FG000|Induction Phase|Adverse Event|9|||
27850162|NCT01144364|81282826|FG001|Induction Phase|Adverse Event|0|||
27850163|NCT01144364|81282827|FG002|Induction Phase|Adverse Event|0|||
27850164|NCT01144364|81282825|FG000|Induction Phase|Death|1|||
27850165|NCT01144364|81282826|FG001|Induction Phase|Death|0|||
27850166|NCT01144364|81282827|FG002|Induction Phase|Death|0|||
27850167|NCT01144364|81282825|FG000|Induction Phase|Withdrawal by Subject|1|||
27850168|NCT01144364|81282826|FG001|Induction Phase|Withdrawal by Subject|0|||
27850169|NCT01144364|81282827|FG002|Induction Phase|Withdrawal by Subject|0|||
27850170|NCT01144364|81282825|FG000|Induction Phase|Lost to Follow-up|2|||
27850171|NCT01144364|81282826|FG001|Induction Phase|Lost to Follow-up|0|||
27850172|NCT01144364|81282827|FG002|Induction Phase|Lost to Follow-up|0|||
27850173|NCT01144364|81282825|FG000|Induction Phase|Physician Decision|1|||
27850174|NCT01144364|81282826|FG001|Induction Phase|Physician Decision|0|||
27850175|NCT01144364|81282827|FG002|Induction Phase|Physician Decision|0|||
27850176|NCT01144364|81282825|FG000|Induction Phase|Stable disease|2|||
27850177|NCT01144364|81282826|FG001|Induction Phase|Stable disease|0|||
27850178|NCT01144364|81282827|FG002|Induction Phase|Stable disease|0|||
27850179|NCT01144364|81282825|FG000|Induction Phase|Secondary neoplasia|1|||
27850180|NCT01144364|81282826|FG001|Induction Phase|Secondary neoplasia|0|||
27850181|NCT01144364|81282827|FG002|Induction Phase|Secondary neoplasia|0|||
27850182|NCT01144364|81282825|FG000|Induction Phase|Protocol Violation|1|||
27850183|NCT01144364|81282826|FG001|Induction Phase|Protocol Violation|0|||
27850184|NCT01144364|81282827|FG002|Induction Phase|Protocol Violation|0|||
27850185|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
27850186|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
27850187|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
27850188|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
27850189|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
27850190|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
27850191|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Death|0|||
27850192|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Death|2|||
27850193|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Death|0|||
27850194|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
27850195|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
27850196|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
27850197|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
27850198|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
27850199|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
27850200|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
27850201|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
27850202|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
27850203|NCT01144364|81282825|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
27850204|NCT01144364|81282826|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
27850205|NCT01144364|81282827|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
27850206|NCT00655850|81282830|FG000|Overall Study|Death|2|||
27850207|NCT00655850|81282830|FG000|Overall Study|Withdrawal by Subject|1|||
27850208|NCT04965389|81282836|FG000|Overall Study|Other reasons|1|||
27850209|NCT04965389|81282837|FG001|Overall Study|Other reasons|0|||
27898560|NCT00308750|81464894|FG001|Overall Study|Unrelated Complication|0|||
27850210|NCT04965389|81282838|FG002|Overall Study|Other reasons|0|||
27850211|NCT04965389|81282839|FG003|Overall Study|Other reasons|0|||
27850212|NCT04965389|81282836|FG000|Overall Study|Participant withdrew consent|0|||
27850213|NCT04965389|81282837|FG001|Overall Study|Participant withdrew consent|1|||
27850214|NCT04965389|81282838|FG002|Overall Study|Participant withdrew consent|0|||
27850215|NCT04965389|81282839|FG003|Overall Study|Participant withdrew consent|0|||
27850216|NCT04965389|81282836|FG000|Overall Study|Poor/Non-compliance|0|||
27850217|NCT04965389|81282837|FG001|Overall Study|Poor/Non-compliance|1|||
27850218|NCT04965389|81282838|FG002|Overall Study|Poor/Non-compliance|0|||
27898561|NCT00308750|81464895|FG002|Overall Study|Unrelated Complication|1|||
27898562|NCT00308750|81464893|FG000|Overall Study|Death|1|||
27898563|NCT00308750|81464894|FG001|Overall Study|Death|0|||
27898564|NCT00308750|81464895|FG002|Overall Study|Death|1|||
27898565|NCT00308750|81464893|FG000|Overall Study|Protocol Violation|1|||
27898566|NCT00308750|81464894|FG001|Overall Study|Protocol Violation|0|||
27898567|NCT00308750|81464895|FG002|Overall Study|Protocol Violation|0|||
27898568|NCT00308750|81464893|FG000|Overall Study|New Primary Disease Identified|1|||
27898569|NCT00308750|81464894|FG001|Overall Study|New Primary Disease Identified|1|||
27898570|NCT00308750|81464895|FG002|Overall Study|New Primary Disease Identified|0|||
27898571|NCT00904839|81464896|FG000|Overall Study|Adverse Event|0|||
27727238|NCT00896532|80830221|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727239|NCT00896532|80830222|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727240|NCT00896532|80830223|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727241|NCT00896532|80830224|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727242|NCT00896532|80830225|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727243|NCT00896532|80830226|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727244|NCT00896532|80830227|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727245|NCT00896532|80830228|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27850219|NCT04965389|81282839|FG003|Overall Study|Poor/Non-compliance|0|||
27898572|NCT00904839|81464897|FG001|Overall Study|Adverse Event|5|||
27898573|NCT00904839|81464898|FG002|Overall Study|Adverse Event|4|||
27898574|NCT00904839|81464896|FG000|Overall Study|Protocol Violation|0|||
27898575|NCT00904839|81464897|FG001|Overall Study|Protocol Violation|1|||
27898576|NCT00904839|81464898|FG002|Overall Study|Protocol Violation|1|||
27898577|NCT00904839|81464896|FG000|Overall Study|Lost to Follow-up|0|||
27898578|NCT00904839|81464897|FG001|Overall Study|Lost to Follow-up|1|||
27898579|NCT00904839|81464898|FG002|Overall Study|Lost to Follow-up|2|||
27898580|NCT00904839|81464896|FG000|Overall Study|Withdrawal by Subject|0|||
27898581|NCT00904839|81464897|FG001|Overall Study|Withdrawal by Subject|2|||
27898582|NCT00904839|81464898|FG002|Overall Study|Withdrawal by Subject|0|||
27898583|NCT00904839|81464896|FG000|Overall Study|Not treated|1|||
27850220|NCT04647383|81282840|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
27850221|NCT04647383|81282841|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
27850222|NCT04647383|81282842|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
27850223|NCT04647383|81282843|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
27850224|NCT02813421|81282844|FG000|Overall Study|Withdrawal by Subject|1|||
27850225|NCT02813421|81282845|FG001|Overall Study|Withdrawal by Subject|2|||
27850226|NCT02813421|81282844|FG000|Overall Study|Lost to Follow-up|1|||
27850227|NCT02813421|81282845|FG001|Overall Study|Lost to Follow-up|1|||
27850228|NCT04551911|81282846|FG000|Overall Study|Lost to Follow-up|2|||
27850229|NCT04551911|81282847|FG001|Overall Study|Lost to Follow-up|1|||
27850230|NCT04551911|81282846|FG000|Overall Study|Withdrawal by Subject|10|||
27850231|NCT04551911|81282847|FG001|Overall Study|Withdrawal by Subject|10|||
27850232|NCT04551911|81282846|FG000|Overall Study|Did not receive the study drug|3|||
27850233|NCT04551911|81282847|FG001|Overall Study|Did not receive the study drug|4|||
27850234|NCT02698865|81282848|FG000|Overall Study|Other|11|||
27850235|NCT02698865|81282849|FG001|Overall Study|Other|11|||
27850236|NCT02698865|81282848|FG000|Overall Study|Withdrawal by Subject|20|||
27850237|NCT02698865|81282849|FG001|Overall Study|Withdrawal by Subject|16|||
27850238|NCT02698865|81282848|FG000|Overall Study|Physician Decision|0|||
27850239|NCT02698865|81282849|FG001|Overall Study|Physician Decision|4|||
27850240|NCT02698865|81282848|FG000|Overall Study|Lost to Follow-up|4|||
27850241|NCT02698865|81282849|FG001|Overall Study|Lost to Follow-up|2|||
27850242|NCT03001219|81282852|FG000|Proof of Concept|Study Termination by Sponsor|0|||
27850243|NCT03001219|81282853|FG001|Proof of Concept|Study Termination by Sponsor|1|||
27898584|NCT00904839|81464897|FG001|Overall Study|Not treated|0|||
27898585|NCT00904839|81464898|FG002|Overall Study|Not treated|1|||
27898586|NCT00904839|81464896|FG000|Overall Study|Other than above|0|||
27898587|NCT00904839|81464897|FG001|Overall Study|Other than above|9|||
27898588|NCT00904839|81464898|FG002|Overall Study|Other than above|7|||
27898589|NCT01717391|81464901|FG000|Overall Study|Withdrawal by Subject|5|||
27506170|NCT01499355|80044287|FG002|Double-Blind Period|Death|0|||
27727246|NCT00896532|80830229|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727247|NCT00896532|80830230|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727248|NCT00896532|80830231|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27850244|NCT03001219|81282852|FG000|Proof of Concept|Withdrawal by Subject|0|||
27850245|NCT03001219|81282853|FG001|Proof of Concept|Withdrawal by Subject|4|||
27850246|NCT03001219|81282852|FG000|Proof of Concept|Protocol Deviation|0|||
27898590|NCT01717391|81464901|FG000|Overall Study|Physician Decision|1|||
27898591|NCT01717391|81464901|FG000|Overall Study|FLT technical failure|3|||
27898592|NCT03536949|81464909|FG000|Overall Study|Adverse Event|4|||
27850247|NCT03001219|81282853|FG001|Proof of Concept|Protocol Deviation|1|||
27850248|NCT03001219|81282852|FG000|Proof of Concept|Adverse Event|1|||
27850249|NCT03001219|81282853|FG001|Proof of Concept|Adverse Event|1|||
27898593|NCT03536949|81464910|FG001|Overall Study|Adverse Event|0|||
27506171|NCT01499355|80044288|FG003|Double-Blind Period|Death|0|||
27727249|NCT00896532|80830232|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727250|NCT00896532|80830233|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
27727251|NCT00896532|80830234|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
27727252|NCT00896532|80830235|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727253|NCT00896532|80830236|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727254|NCT00896532|80830237|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727255|NCT00896532|80830238|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727256|NCT00896532|80830239|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727257|NCT00896532|80830240|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727258|NCT00896532|80830241|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727259|NCT00896532|80830242|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727260|NCT00896532|80830243|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
27727261|NCT00896532|80830221|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
27727262|NCT00896532|80830222|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
27727263|NCT00896532|80830223|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
27727264|NCT00896532|80830224|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
27506172|NCT01499355|80044285|FG000|Double-Blind Period|Investigator Decision|0|||
27506173|NCT01499355|80044286|FG001|Double-Blind Period|Investigator Decision|0|||
27506174|NCT01499355|80044287|FG002|Double-Blind Period|Investigator Decision|3|||
27506175|NCT01499355|80044288|FG003|Double-Blind Period|Investigator Decision|3|||
27727265|NCT00896532|80830225|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
27727266|NCT00896532|80830226|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
27727267|NCT00896532|80830227|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
27727268|NCT00896532|80830228|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
27727269|NCT00896532|80830229|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
27727270|NCT00896532|80830230|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
27727271|NCT00896532|80830231|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
27727272|NCT00896532|80830232|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
27727273|NCT00896532|80830233|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
27727274|NCT00896532|80830234|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
27727275|NCT00896532|80830235|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
27727276|NCT00896532|80830236|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
27727277|NCT00896532|80830237|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
27727278|NCT00896532|80830238|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
27727279|NCT00896532|80830239|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
27727280|NCT00896532|80830240|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
27727281|NCT00896532|80830241|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
27727282|NCT00896532|80830242|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
27506176|NCT01499355|80044285|FG000|Double-Blind Period|Consent Withdrawn|0|||
27506177|NCT01499355|80044286|FG001|Double-Blind Period|Consent Withdrawn|0|||
27506178|NCT01499355|80044287|FG002|Double-Blind Period|Consent Withdrawn|1|||
27506179|NCT01499355|80044288|FG003|Double-Blind Period|Consent Withdrawn|2|||
27506180|NCT01499355|80044285|FG000|Double-Blind Period|Lost to Follow-up|0|||
27506181|NCT01499355|80044286|FG001|Double-Blind Period|Lost to Follow-up|1|||
27506182|NCT01499355|80044287|FG002|Double-Blind Period|Lost to Follow-up|0|||
27506183|NCT01499355|80044288|FG003|Double-Blind Period|Lost to Follow-up|0|||
27506184|NCT03910244|80044289|FG000|Overall Study|Adverse Event|14|||
27506185|NCT03910244|80044290|FG001|Overall Study|Adverse Event|0|||
27506186|NCT03910244|80044289|FG000|Overall Study|Death|1|||
27506187|NCT03910244|80044290|FG001|Overall Study|Death|0|||
27506188|NCT03910244|80044289|FG000|Overall Study|Lost to Follow-up|0|||
27506189|NCT03910244|80044290|FG001|Overall Study|Lost to Follow-up|2|||
27727283|NCT00896532|80830243|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
27727284|NCT00896532|80830221|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727285|NCT00896532|80830222|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727286|NCT00896532|80830223|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27506190|NCT03910244|80044289|FG000|Overall Study|Joint withdrawal decision|1|||
27506191|NCT03910244|80044290|FG001|Overall Study|Joint withdrawal decision|0|||
27506192|NCT03910244|80044289|FG000|Overall Study|Study Terminated by Sponsor|7|||
27506193|NCT03910244|80044290|FG001|Overall Study|Study Terminated by Sponsor|4|||
27506194|NCT03910244|80044289|FG000|Overall Study|Physician Decision|1|||
27850250|NCT03001219|81282852|FG000|Proof of Concept|Physician Decision|1|||
27850251|NCT03001219|81282853|FG001|Proof of Concept|Physician Decision|0|||
27850252|NCT03001219|81282852|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
27850253|NCT03001219|81282853|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
27850254|NCT03001219|81282852|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
27850255|NCT03001219|81282853|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
27850256|NCT03001219|81282852|FG000|Extension Period Analysis|Physician Decision|0|||
27850257|NCT03001219|81282853|FG001|Extension Period Analysis|Physician Decision|1|||
27850258|NCT03001219|81282852|FG000|Extension Period Analysis|Adverse Event|1|||
27850259|NCT03001219|81282853|FG001|Extension Period Analysis|Adverse Event|1|||
27850260|NCT03001219|81282852|FG000|Extension Period Analysis|Protocol Deviation|0|||
27850261|NCT03001219|81282853|FG001|Extension Period Analysis|Protocol Deviation|1|||
27850262|NCT03001219|81282852|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
27850263|NCT03001219|81282853|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
27850264|NCT01277718|81282854|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
27850265|NCT01277718|81282855|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
27850266|NCT01277718|81282854|FG000|Period 2 - Second Intervention|Physician Decision|0|||
27850267|NCT01277718|81282855|FG001|Period 2 - Second Intervention|Physician Decision|2|||
27850268|NCT03176459|81282858|FG000|Overall Study|Lost to Follow-up|5|||
27850269|NCT03176459|81282859|FG001|Overall Study|Lost to Follow-up|7|||
27850270|NCT02622113|81282864|FG000|Overall Study|Adverse Event|4|||
27850271|NCT02622113|81282865|FG001|Overall Study|Adverse Event|4|||
27850272|NCT02622113|81282864|FG000|Overall Study|Physician Decision|0|||
27850273|NCT02622113|81282865|FG001|Overall Study|Physician Decision|1|||
27850274|NCT02622113|81282864|FG000|Overall Study|Withdrawal by Subject|0|||
27850275|NCT02622113|81282865|FG001|Overall Study|Withdrawal by Subject|2|||
27850276|NCT02622113|81282864|FG000|Overall Study|Stopping Criteria|1|||
27850277|NCT02622113|81282865|FG001|Overall Study|Stopping Criteria|3|||
27850278|NCT00958126|81282866|FG000|Overall Study|Serious Adverse Event|0|||
27850279|NCT00958126|81282867|FG001|Overall Study|Serious Adverse Event|2|||
27850280|NCT00958126|81282868|FG002|Overall Study|Serious Adverse Event|0|||
27850281|NCT00958126|81282869|FG003|Overall Study|Serious Adverse Event|0|||
27850282|NCT00958126|81282870|FG004|Overall Study|Serious Adverse Event|0|||
27850283|NCT00958126|81282871|FG005|Overall Study|Serious Adverse Event|0|||
27850284|NCT00958126|81282872|FG006|Overall Study|Serious Adverse Event|1|||
27850285|NCT00958126|81282873|FG007|Overall Study|Serious Adverse Event|0|||
27850286|NCT00958126|81282866|FG000|Overall Study|Withdrawal by Subject|0|||
27850287|NCT00958126|81282867|FG001|Overall Study|Withdrawal by Subject|2|||
27850288|NCT00958126|81282868|FG002|Overall Study|Withdrawal by Subject|0|||
27850289|NCT00958126|81282869|FG003|Overall Study|Withdrawal by Subject|0|||
27850290|NCT00958126|81282870|FG004|Overall Study|Withdrawal by Subject|0|||
27850291|NCT00958126|81282871|FG005|Overall Study|Withdrawal by Subject|0|||
27850292|NCT00958126|81282872|FG006|Overall Study|Withdrawal by Subject|0|||
27850293|NCT00958126|81282873|FG007|Overall Study|Withdrawal by Subject|0|||
27850294|NCT00958126|81282866|FG000|Overall Study|Moved away from study area|0|||
27850295|NCT00958126|81282867|FG001|Overall Study|Moved away from study area|0|||
27850296|NCT00958126|81282868|FG002|Overall Study|Moved away from study area|1|||
27850297|NCT00958126|81282869|FG003|Overall Study|Moved away from study area|1|||
27850298|NCT00958126|81282870|FG004|Overall Study|Moved away from study area|0|||
27850299|NCT00958126|81282871|FG005|Overall Study|Moved away from study area|0|||
27850300|NCT00958126|81282872|FG006|Overall Study|Moved away from study area|0|||
27850301|NCT00958126|81282873|FG007|Overall Study|Moved away from study area|0|||
27850302|NCT00958126|81282866|FG000|Overall Study|Lost to Follow-up|1|||
27850303|NCT00958126|81282867|FG001|Overall Study|Lost to Follow-up|5|||
27850304|NCT00958126|81282868|FG002|Overall Study|Lost to Follow-up|9|||
27850305|NCT00958126|81282869|FG003|Overall Study|Lost to Follow-up|8|||
27850306|NCT00958126|81282870|FG004|Overall Study|Lost to Follow-up|0|||
27850307|NCT00958126|81282871|FG005|Overall Study|Lost to Follow-up|0|||
27850308|NCT00958126|81282872|FG006|Overall Study|Lost to Follow-up|0|||
27850309|NCT00958126|81282873|FG007|Overall Study|Lost to Follow-up|0|||
27850310|NCT00958126|81282866|FG000|Overall Study|Sponsor/Investigator decision|0|||
27898594|NCT03536949|81464909|FG000|Overall Study|Lost to Follow-up|2|||
27898595|NCT03536949|81464910|FG001|Overall Study|Lost to Follow-up|1|||
27850311|NCT00958126|81282867|FG001|Overall Study|Sponsor/Investigator decision|0|||
27850312|NCT00958126|81282868|FG002|Overall Study|Sponsor/Investigator decision|0|||
27850313|NCT00958126|81282869|FG003|Overall Study|Sponsor/Investigator decision|1|||
27850314|NCT00958126|81282870|FG004|Overall Study|Sponsor/Investigator decision|0|||
27850315|NCT00958126|81282871|FG005|Overall Study|Sponsor/Investigator decision|0|||
27850316|NCT00958126|81282872|FG006|Overall Study|Sponsor/Investigator decision|0|||
27850317|NCT00958126|81282873|FG007|Overall Study|Sponsor/Investigator decision|0|||
27850318|NCT00958126|81282866|FG000|Overall Study|Other Reason|0|||
27850319|NCT00958126|81282867|FG001|Overall Study|Other Reason|0|||
27850320|NCT00958126|81282868|FG002|Overall Study|Other Reason|0|||
27850321|NCT00958126|81282869|FG003|Overall Study|Other Reason|1|||
27850322|NCT00958126|81282870|FG004|Overall Study|Other Reason|0|||
27850323|NCT00958126|81282871|FG005|Overall Study|Other Reason|1|||
27850324|NCT00958126|81282872|FG006|Overall Study|Other Reason|0|||
27850325|NCT00958126|81282873|FG007|Overall Study|Other Reason|0|||
27850326|NCT02080832|81282874|FG000|Overall Study|Excluded from analysis by MRI|9|||
27850327|NCT02080832|81282875|FG001|Overall Study|Excluded from analysis by MRI|10|||
27898596|NCT03536949|81464909|FG000|Overall Study|Withdrawal by Subject|6|||
27898597|NCT03536949|81464910|FG001|Overall Study|Withdrawal by Subject|0|||
27898598|NCT03536949|81464909|FG000|Overall Study|Non-compliance|2|||
27850328|NCT02080832|81282876|FG002|Overall Study|Excluded from analysis by MRI|14|||
27850329|NCT02080832|81282874|FG000|Overall Study|Lost to Follow-up|0|||
27850330|NCT02080832|81282875|FG001|Overall Study|Lost to Follow-up|2|||
27850331|NCT02080832|81282876|FG002|Overall Study|Lost to Follow-up|2|||
27850332|NCT04718194|81282880|FG000|Overall Study|Withdrawal by Subject|3|||
27850333|NCT04718194|81282881|FG001|Overall Study|Withdrawal by Subject|0|||
27850334|NCT04718194|81282880|FG000|Overall Study|Lost to Follow-up|3|||
27850335|NCT04718194|81282881|FG001|Overall Study|Lost to Follow-up|0|||
27850336|NCT01280617|81282884|FG000|Overall Study|Adverse Event|0|||
27850337|NCT01280617|81282885|FG001|Overall Study|Adverse Event|1|||
27850338|NCT01763918|81282886|FG000|Overall Study|Withdrawal by Subject|2|||
27850339|NCT01763918|81282887|FG001|Overall Study|Withdrawal by Subject|1|||
27850340|NCT01763918|81282888|FG002|Overall Study|Withdrawal by Subject|1|||
27850341|NCT01763918|81282889|FG003|Overall Study|Withdrawal by Subject|2|||
27850342|NCT01763918|81282886|FG000|Overall Study|Sponsor Decision|4|||
27850343|NCT01763918|81282887|FG001|Overall Study|Sponsor Decision|0|||
27850344|NCT01763918|81282888|FG002|Overall Study|Sponsor Decision|9|||
27850345|NCT01763918|81282889|FG003|Overall Study|Sponsor Decision|0|||
27850346|NCT00588640|81282894|FG000|Overall Study|Physician Decision|1|||
27850347|NCT00588640|81282894|FG000|Overall Study|Ineligible Patient|1|||
27850348|NCT03346070|81282895|FG000|Overall Study|Death|0|||
27850349|NCT03346070|81282896|FG001|Overall Study|Death|0|||
27850350|NCT03346070|81282897|FG002|Overall Study|Death|0|||
27850351|NCT03346070|81282898|FG003|Overall Study|Death|0|||
27850352|NCT03346070|81282899|FG004|Overall Study|Death|1|||
27850353|NCT03346070|81282895|FG000|Overall Study|Lost to Follow-up|0|||
27850354|NCT03346070|81282896|FG001|Overall Study|Lost to Follow-up|1|||
27850355|NCT03346070|81282897|FG002|Overall Study|Lost to Follow-up|2|||
27850356|NCT03346070|81282898|FG003|Overall Study|Lost to Follow-up|0|||
27850357|NCT03346070|81282899|FG004|Overall Study|Lost to Follow-up|0|||
27850358|NCT03346070|81282895|FG000|Overall Study|Physician Decision|0|||
27850359|NCT03346070|81282896|FG001|Overall Study|Physician Decision|0|||
27850360|NCT03346070|81282897|FG002|Overall Study|Physician Decision|0|||
27850361|NCT03346070|81282898|FG003|Overall Study|Physician Decision|1|||
27850362|NCT03346070|81282899|FG004|Overall Study|Physician Decision|1|||
27850363|NCT03346070|81282895|FG000|Overall Study|Withdrawal by Subject|1|||
27850364|NCT03346070|81282896|FG001|Overall Study|Withdrawal by Subject|0|||
27850365|NCT03346070|81282897|FG002|Overall Study|Withdrawal by Subject|0|||
27898599|NCT03536949|81464910|FG001|Overall Study|Non-compliance|1|||
27898600|NCT00908076|81464911|FG000|Overall Study|Lack of Efficacy|1|||
27898601|NCT00908076|81464912|FG001|Overall Study|Lack of Efficacy|1|||
27850366|NCT03346070|81282898|FG003|Overall Study|Withdrawal by Subject|1|||
27850367|NCT03346070|81282899|FG004|Overall Study|Withdrawal by Subject|0|||
27850368|NCT03346070|81282895|FG000|Overall Study|Study medication not received as planned|2|||
27850369|NCT03346070|81282896|FG001|Overall Study|Study medication not received as planned|3|||
27614090|NCT03990363|80430137|FG004|Overall Study|Lost to Follow-up|2|||
27727287|NCT00896532|80830224|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727288|NCT00896532|80830225|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727289|NCT00896532|80830226|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727290|NCT00896532|80830227|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727291|NCT00896532|80830228|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727292|NCT00896532|80830229|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727293|NCT00896532|80830230|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727294|NCT00896532|80830231|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727295|NCT00896532|80830232|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727296|NCT00896532|80830233|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727297|NCT00896532|80830234|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727298|NCT00896532|80830235|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727299|NCT00896532|80830236|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
27727300|NCT00896532|80830237|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
27727301|NCT00896532|80830238|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727302|NCT00896532|80830239|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727303|NCT00896532|80830240|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727304|NCT00896532|80830241|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727305|NCT00896532|80830242|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727306|NCT00896532|80830243|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
27727307|NCT00896532|80830221|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727308|NCT00896532|80830222|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727309|NCT00896532|80830223|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727310|NCT00896532|80830224|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727311|NCT00896532|80830225|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727312|NCT00896532|80830226|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727313|NCT00896532|80830227|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727314|NCT00896532|80830228|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727315|NCT00896532|80830229|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727316|NCT00896532|80830230|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727317|NCT00896532|80830231|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727318|NCT00896532|80830232|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727319|NCT00896532|80830233|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727320|NCT00896532|80830234|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727321|NCT00896532|80830235|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727322|NCT00896532|80830236|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
27727323|NCT00896532|80830237|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
27727324|NCT00896532|80830238|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
27727325|NCT00896532|80830239|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727326|NCT00896532|80830240|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727327|NCT00896532|80830241|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727328|NCT00896532|80830242|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727329|NCT00896532|80830243|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
27727330|NCT00896532|80830221|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727331|NCT00896532|80830222|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27754898|NCT02065622|80929633|FG003|Maintenance Study|Adverse Event|22|||
27850370|NCT03346070|81282897|FG002|Overall Study|Study medication not received as planned|2|||
27898602|NCT01606748|81464921|FG000|Overall Study|Adverse Event|1|||
27506195|NCT03910244|80044290|FG001|Overall Study|Physician Decision|0|||
27506196|NCT03910244|80044289|FG000|Overall Study|Protocol Violation|1|||
27506197|NCT03910244|80044290|FG001|Overall Study|Protocol Violation|0|||
27506198|NCT03910244|80044289|FG000|Overall Study|Withdrawal by Subject|7|||
27506199|NCT03910244|80044290|FG001|Overall Study|Withdrawal by Subject|2|||
27506200|NCT04322526|80044297|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
27506201|NCT04322526|80044298|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
27506202|NCT04322526|80044297|FG000|Washout (1 Week)|Lost to Follow-up|1|||
27506203|NCT04322526|80044298|FG001|Washout (1 Week)|Lost to Follow-up|2|||
27506204|NCT01967940|80044299|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
27506205|NCT01967940|80044300|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
27506206|NCT01967940|80044301|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
27506207|NCT01967940|80044302|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
27506208|NCT01967940|80044299|FG000|Part 2|Adverse Event|0|||
27614091|NCT03990363|80430133|FG000|Overall Study|Non-compliance with study drug|2|||
27506209|NCT01967940|80044300|FG001|Part 2|Adverse Event|0|||
27506210|NCT01967940|80044301|FG002|Part 2|Adverse Event|0|||
27506211|NCT01967940|80044302|FG003|Part 2|Adverse Event|1|||
27898603|NCT01606748|81464922|FG001|Overall Study|Adverse Event|0|||
27898604|NCT01606748|81464921|FG000|Overall Study|Progressive Disease|1|||
27898605|NCT01606748|81464922|FG001|Overall Study|Progressive Disease|0|||
27898606|NCT01606748|81464921|FG000|Overall Study|Withdrawal by Subject|1|||
27898607|NCT01606748|81464922|FG001|Overall Study|Withdrawal by Subject|0|||
27898608|NCT01199822|81464923|FG000|Overall Study|Investigator discontinued therapy|0|||
27898609|NCT01199822|81464924|FG001|Overall Study|Investigator discontinued therapy|1|||
27898610|NCT01199822|81464925|FG002|Overall Study|Investigator discontinued therapy|0|||
27898611|NCT00987402|81464930|FG000|Overall Study|Insufficient data entry|86|||
27898612|NCT00987402|81464931|FG001|Overall Study|Insufficient data entry|98|||
27898613|NCT00505661|81464932|FG000|Overall Study|Not Eligible|4|||
27898614|NCT00980655|81464936|FG000|Overall Study|Adverse Event|13|||
27898615|NCT00980655|81464937|FG001|Overall Study|Adverse Event|31|||
27898616|NCT00980655|81464936|FG000|Overall Study|Death|0|||
27898617|NCT00980655|81464937|FG001|Overall Study|Death|7|||
27898618|NCT00980655|81464936|FG000|Overall Study|Protocol Violation|2|||
27898619|NCT00980655|81464937|FG001|Overall Study|Protocol Violation|7|||
27898620|NCT00980655|81464936|FG000|Overall Study|Withdrawal by Subject|0|||
27898621|NCT00980655|81464937|FG001|Overall Study|Withdrawal by Subject|4|||
27898622|NCT00980655|81464936|FG000|Overall Study|Lost to Follow-up|0|||
27898623|NCT00980655|81464937|FG001|Overall Study|Lost to Follow-up|1|||
27898624|NCT00980655|81464936|FG000|Overall Study|Parent/legal guardian request|1|||
27898625|NCT00980655|81464937|FG001|Overall Study|Parent/legal guardian request|0|||
27898626|NCT00980655|81464936|FG000|Overall Study|Other|0|||
27898627|NCT00980655|81464937|FG001|Overall Study|Other|1|||
27898628|NCT03172364|81464938|FG000|Overall Study|Adverse Event|1|||
27898629|NCT03172364|81464939|FG001|Overall Study|Adverse Event|1|||
27898630|NCT03172364|81464938|FG000|Overall Study|Protocol Violation|1|||
27898631|NCT03172364|81464939|FG001|Overall Study|Protocol Violation|0|||
27898632|NCT01785849|81464942|FG000|Overall Study|Death|7|||
27898633|NCT01785849|81464943|FG001|Overall Study|Death|9|||
27898634|NCT01785849|81464942|FG000|Overall Study|Protocol Specified Criteria|29|||
27898635|NCT01785849|81464943|FG001|Overall Study|Protocol Specified Criteria|1|||
27898636|NCT01785849|81464942|FG000|Overall Study|Withdrawal by Subject|15|||
27898637|NCT01785849|81464943|FG001|Overall Study|Withdrawal by Subject|12|||
27898638|NCT01785849|81464942|FG000|Overall Study|Sponsor Decision|0|||
27898639|NCT01785849|81464943|FG001|Overall Study|Sponsor Decision|1|||
27898640|NCT01785849|81464942|FG000|Overall Study|Lost to Follow-up|10|||
27898641|NCT01785849|81464943|FG001|Overall Study|Lost to Follow-up|11|||
27898642|NCT00821015|81464944|FG000|Overall Study|Lost to Follow-up|12|||
27898643|NCT02774005|81464947|FG000|Overall Study|Adverse Event|8|||
27898644|NCT02774005|81464947|FG000|Overall Study|Withdrawal by Subject|23|||
27898645|NCT02774005|81464947|FG000|Overall Study|Lost to Follow-up|7|||
27898646|NCT02774005|81464947|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
27898647|NCT02774005|81464947|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
27898648|NCT02774005|81464947|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
27898649|NCT02774005|81464947|FG000|Overall Study|Death|1|||
27898650|NCT02774005|81464947|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
27898651|NCT02774005|81464947|FG000|Overall Study|Lack of compliance with study medication|4|||
27898652|NCT02774005|81464947|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
27898653|NCT02774005|81464947|FG000|Overall Study|another study|1|||
27898654|NCT02774005|81464947|FG000|Overall Study|cardiologist imposed travel restriction|1|||
27898655|NCT00106639|81464950|FG000|Overall Study|Adverse Event|3|||
27898656|NCT00106639|81464951|FG001|Overall Study|Adverse Event|4|||
27898657|NCT00106639|81464952|FG002|Overall Study|Adverse Event|1|||
27898658|NCT00106639|81464950|FG000|Overall Study|Protocol Violation|0|||
27898659|NCT00106639|81464951|FG001|Overall Study|Protocol Violation|1|||
27898660|NCT00106639|81464952|FG002|Overall Study|Protocol Violation|0|||
27898661|NCT00106639|81464950|FG000|Overall Study|Withdrawal by Subject|0|||
27898662|NCT00106639|81464951|FG001|Overall Study|Withdrawal by Subject|1|||
27898663|NCT00106639|81464952|FG002|Overall Study|Withdrawal by Subject|0|||
27898664|NCT00106639|81464950|FG000|Overall Study|Participant defaulted|0|||
27898665|NCT00106639|81464951|FG001|Overall Study|Participant defaulted|1|||
27898666|NCT00106639|81464952|FG002|Overall Study|Participant defaulted|1|||
27898667|NCT03004924|81464956|FG000|Overall Study|Adverse Event|6|||
27898668|NCT03004924|81464957|FG001|Overall Study|Adverse Event|5|||
27898669|NCT03004924|81464958|FG002|Overall Study|Adverse Event|10|||
27898670|NCT03004924|81464956|FG000|Overall Study|Protocol Violation|4|||
27898671|NCT03004924|81464957|FG001|Overall Study|Protocol Violation|0|||
27850371|NCT03346070|81282898|FG003|Overall Study|Study medication not received as planned|3|||
27850372|NCT03346070|81282899|FG004|Overall Study|Study medication not received as planned|2|||
27850373|NCT03346070|81282895|FG000|Overall Study|Screen Failure|0|||
27850374|NCT03346070|81282896|FG001|Overall Study|Screen Failure|0|||
27850375|NCT03346070|81282897|FG002|Overall Study|Screen Failure|0|||
27850376|NCT03346070|81282898|FG003|Overall Study|Screen Failure|1|||
27850377|NCT03346070|81282899|FG004|Overall Study|Screen Failure|1|||
27850378|NCT02429934|81282900|FG000|Overall Study|Withdrawal by Subject|0|||
27850379|NCT02429934|81282901|FG001|Overall Study|Withdrawal by Subject|2|||
27850380|NCT02429934|81282900|FG000|Overall Study|Adverse Event|2|||
27850381|NCT02429934|81282901|FG001|Overall Study|Adverse Event|0|||
27850382|NCT02429934|81282900|FG000|Overall Study|Lost to Follow-up|1|||
27850383|NCT02429934|81282901|FG001|Overall Study|Lost to Follow-up|1|||
27850384|NCT02429934|81282900|FG000|Overall Study|Physician Decision|1|||
27850385|NCT02429934|81282901|FG001|Overall Study|Physician Decision|0|||
27850386|NCT02547766|81282902|FG000|Overall Study|Withdrawal by Subject|1|||
27850387|NCT00262041|81282906|FG000|Overall Study|Withdrawal by Subject|0|||
27850388|NCT00262041|81282907|FG001|Overall Study|Withdrawal by Subject|3|||
27850389|NCT00262041|81282908|FG002|Overall Study|Withdrawal by Subject|1|||
27850390|NCT00262041|81282906|FG000|Overall Study|Lost to Follow-up|1|||
27850391|NCT00262041|81282907|FG001|Overall Study|Lost to Follow-up|1|||
27850392|NCT00262041|81282908|FG002|Overall Study|Lost to Follow-up|5|||
27850393|NCT00262041|81282906|FG000|Overall Study|Unable to classify|1|||
27850394|NCT00262041|81282907|FG001|Overall Study|Unable to classify|0|||
27850395|NCT00262041|81282908|FG002|Overall Study|Unable to classify|0|||
27850396|NCT03510182|81282909|FG000|Overall Study|Withdrawal by Subject|2|||
27850397|NCT02129647|81282910|FG000|Overall Study|Adverse Event|2|||
27850398|NCT02129647|81282910|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
27850399|NCT00292188|81282911|FG000|Single-Blind|Adverse Event|14|||
27850400|NCT00292188|81282912|FG001|Single-Blind|Adverse Event|0|||
27850401|NCT00292188|81282913|FG002|Single-Blind|Adverse Event|0|||
27850402|NCT00292188|81282911|FG000|Single-Blind|Lack of Efficacy|2|||
27850403|NCT00292188|81282912|FG001|Single-Blind|Lack of Efficacy|0|||
27898672|NCT03004924|81464958|FG002|Overall Study|Protocol Violation|1|||
27898673|NCT03004924|81464956|FG000|Overall Study|Withdrawal by Subject|5|||
27898674|NCT03004924|81464957|FG001|Overall Study|Withdrawal by Subject|3|||
27898675|NCT03004924|81464958|FG002|Overall Study|Withdrawal by Subject|5|||
27898676|NCT03004924|81464956|FG000|Overall Study|Lost to Follow-up|6|||
27898677|NCT03004924|81464957|FG001|Overall Study|Lost to Follow-up|1|||
27898678|NCT03004924|81464958|FG002|Overall Study|Lost to Follow-up|4|||
27898679|NCT03004924|81464956|FG000|Overall Study|Lack of Efficacy|2|||
27898680|NCT03004924|81464957|FG001|Overall Study|Lack of Efficacy|4|||
27898681|NCT03004924|81464958|FG002|Overall Study|Lack of Efficacy|2|||
27898682|NCT03004924|81464956|FG000|Overall Study|Physician Decision|1|||
27898683|NCT03004924|81464957|FG001|Overall Study|Physician Decision|0|||
27898684|NCT03004924|81464958|FG002|Overall Study|Physician Decision|1|||
27898685|NCT03004924|81464956|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27898686|NCT03004924|81464957|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27898687|NCT03004924|81464958|FG002|Overall Study|Withdrawal by parent/guardian|2|||
27898688|NCT03004924|81464956|FG000|Overall Study|Screen Failure|1|||
27898689|NCT03004924|81464957|FG001|Overall Study|Screen Failure|0|||
27898690|NCT03004924|81464958|FG002|Overall Study|Screen Failure|0|||
27898691|NCT03004924|81464956|FG000|Overall Study|Pregnancy|0|||
27898692|NCT03004924|81464957|FG001|Overall Study|Pregnancy|1|||
27898693|NCT03004924|81464958|FG002|Overall Study|Pregnancy|0|||
27898694|NCT03004924|81464956|FG000|Overall Study|Terminated by Sponsor|0|||
27898695|NCT03004924|81464957|FG001|Overall Study|Terminated by Sponsor|0|||
27898696|NCT03004924|81464958|FG002|Overall Study|Terminated by Sponsor|1|||
27898697|NCT03004924|81464956|FG000|Overall Study|Missed Study Visit|0|||
27898698|NCT03004924|81464957|FG001|Overall Study|Missed Study Visit|0|||
27898699|NCT03004924|81464958|FG002|Overall Study|Missed Study Visit|2|||
27898700|NCT03004924|81464956|FG000|Overall Study|HSV1 Positive|1|||
27898701|NCT03004924|81464957|FG001|Overall Study|HSV1 Positive|0|||
27898702|NCT03004924|81464958|FG002|Overall Study|HSV1 Positive|0|||
27898703|NCT03003000|81464959|FG000|Overall Study|Adverse Event|1|||
27898704|NCT03003000|81464960|FG001|Overall Study|Adverse Event|2|||
27898705|NCT03003000|81464961|FG002|Overall Study|Adverse Event|3|||
27898706|NCT03003000|81464959|FG000|Overall Study|Lack of Efficacy|1|||
27898707|NCT03003000|81464960|FG001|Overall Study|Lack of Efficacy|0|||
27898708|NCT03003000|81464961|FG002|Overall Study|Lack of Efficacy|0|||
27898709|NCT03003000|81464959|FG000|Overall Study|Non-compliant with protocol|0|||
27506212|NCT01967940|80044299|FG000|Part 2|Unknown Reason|0|||
27506213|NCT01967940|80044300|FG001|Part 2|Unknown Reason|0|||
27506214|NCT01967940|80044301|FG002|Part 2|Unknown Reason|0|||
27898710|NCT03003000|81464960|FG001|Overall Study|Non-compliant with protocol|1|||
27898711|NCT03003000|81464961|FG002|Overall Study|Non-compliant with protocol|1|||
27898712|NCT03003000|81464959|FG000|Overall Study|Refused to continue medication|2|||
27898713|NCT03003000|81464960|FG001|Overall Study|Refused to continue medication|0|||
27898714|NCT03003000|81464961|FG002|Overall Study|Refused to continue medication|0|||
27506215|NCT01967940|80044302|FG003|Part 2|Unknown Reason|1|||
27506216|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
27850404|NCT00292188|81282913|FG002|Single-Blind|Lack of Efficacy|0|||
27850405|NCT00292188|81282911|FG000|Single-Blind|Laboratory Abnormality|5|||
27898715|NCT03003000|81464959|FG000|Overall Study|Other than listed|1|||
27898716|NCT03003000|81464960|FG001|Overall Study|Other than listed|1|||
27898717|NCT03003000|81464961|FG002|Overall Study|Other than listed|1|||
27898718|NCT02179749|81464962|FG000|Overall Study|Adverse Event|0|||
27898719|NCT02179749|81464963|FG001|Overall Study|Adverse Event|0|||
27898720|NCT02179749|81464964|FG002|Overall Study|Adverse Event|1|||
27898721|NCT02179749|81464962|FG000|Overall Study|Withdrawal by Subject|0|||
27898722|NCT02179749|81464963|FG001|Overall Study|Withdrawal by Subject|0|||
27898723|NCT02179749|81464964|FG002|Overall Study|Withdrawal by Subject|1|||
27898724|NCT00503997|81464965|FG000|Overall Study|disease progression|1|||
27898725|NCT00503997|81464965|FG000|Overall Study|Adverse Event|5|||
27898726|NCT00503997|81464965|FG000|Overall Study|Death|1|||
27898727|NCT00503997|81464965|FG000|Overall Study|Withdrawal by Subject|1|||
27898728|NCT03515629|81464966|FG000|Overall Study|Death|0|||
27898729|NCT03515629|81464967|FG001|Overall Study|Death|1|||
27898730|NCT03515629|81464968|FG002|Overall Study|Death|1|||
27898731|NCT03515629|81464966|FG000|Overall Study|Progressive disease|0|||
27898732|NCT03515629|81464967|FG001|Overall Study|Progressive disease|1|||
27898733|NCT03515629|81464968|FG002|Overall Study|Progressive disease|0|||
27898734|NCT00250458|81464969|FG000|Overall Study|Lost to Follow-up|4|||
27898735|NCT00250458|81464970|FG001|Overall Study|Lost to Follow-up|2|||
27898736|NCT00250458|81464969|FG000|Overall Study|Protocol Violation|0|||
27898737|NCT00250458|81464970|FG001|Overall Study|Protocol Violation|1|||
27898738|NCT00250458|81464969|FG000|Overall Study|Withdrawal by Subject|4|||
27898739|NCT00250458|81464970|FG001|Overall Study|Withdrawal by Subject|2|||
27898740|NCT00250458|81464969|FG000|Overall Study|Lack of Migraine Attack|20|||
27898741|NCT00250458|81464970|FG001|Overall Study|Lack of Migraine Attack|9|||
27898742|NCT00250458|81464969|FG000|Overall Study|Qualifying migraine but did not treat|3|||
27898743|NCT00250458|81464970|FG001|Overall Study|Qualifying migraine but did not treat|3|||
27898744|NCT00250458|81464969|FG000|Overall Study|Other|1|||
27898745|NCT00250458|81464970|FG001|Overall Study|Other|0|||
27898746|NCT01741792|81464973|FG000|Overall Study|Death|6|||
27898747|NCT01741792|81464974|FG001|Overall Study|Death|1|||
27898748|NCT01741792|81464975|FG002|Overall Study|Death|12|||
27898749|NCT02457832|81464976|FG000|Training|Lost to Follow-up|10|||
27898750|NCT02457832|81464977|FG001|Training|Lost to Follow-up|6|||
27898751|NCT02457832|81464978|FG002|Training|Lost to Follow-up|3|||
27898752|NCT02457832|81464976|FG000|One Month Washout|Lost to Follow-up|0|||
27898753|NCT02457832|81464977|FG001|One Month Washout|Lost to Follow-up|1|||
27898754|NCT02457832|81464978|FG002|One Month Washout|Lost to Follow-up|1|||
27898755|NCT00424021|81464979|FG000|NCT00046319 Study Period|Adverse Event|1|||
27898756|NCT00424021|81464980|FG001|NCT00046319 Study Period|Adverse Event|0|||
27898757|NCT00424021|81464981|FG002|NCT00046319 Study Period|Adverse Event|1|||
27898758|NCT00424021|81464982|FG003|NCT00046319 Study Period|Adverse Event|1|||
27898759|NCT00424021|81464979|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
27898760|NCT00424021|81464980|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
27898761|NCT00424021|81464981|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
27898762|NCT00424021|81464982|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
27898763|NCT00424021|81464979|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
27898764|NCT00424021|81464980|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
27898765|NCT00424021|81464981|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
27898766|NCT00424021|81464982|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
27898767|NCT00424021|81464979|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
27898768|NCT00424021|81464980|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
27898769|NCT00424021|81464981|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
27898770|NCT00424021|81464982|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
27898771|NCT00424021|81464979|FG000|AMB-220-E Study Period|Adverse Event|1|||
27898772|NCT00424021|81464980|FG001|AMB-220-E Study Period|Adverse Event|1|||
27898773|NCT00424021|81464981|FG002|AMB-220-E Study Period|Adverse Event|3|||
27898774|NCT00424021|81464982|FG003|AMB-220-E Study Period|Adverse Event|7|||
27898775|NCT00424021|81464979|FG000|AMB-220-E Study Period|Death|0|||
27898776|NCT00424021|81464980|FG001|AMB-220-E Study Period|Death|0|||
27898777|NCT00424021|81464981|FG002|AMB-220-E Study Period|Death|1|||
27898778|NCT00424021|81464982|FG003|AMB-220-E Study Period|Death|1|||
27898779|NCT00424021|81464979|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
27898780|NCT00424021|81464980|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
27898781|NCT00424021|81464981|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
27898782|NCT00424021|81464982|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
27898783|NCT00424021|81464979|FG000|AMB-220-E Study Period|Physician Decision|0|||
27727332|NCT00896532|80830223|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27898784|NCT00424021|81464980|FG001|AMB-220-E Study Period|Physician Decision|0|||
27898785|NCT00424021|81464981|FG002|AMB-220-E Study Period|Physician Decision|0|||
27898786|NCT00424021|81464982|FG003|AMB-220-E Study Period|Physician Decision|1|||
27898787|NCT03597022|81464985|FG000|Overall Study|Premature termination of the study|7|||
27898788|NCT03597022|81464986|FG001|Overall Study|Premature termination of the study|7|||
27898789|NCT03597022|81464987|FG002|Overall Study|Premature termination of the study|8|||
27898790|NCT03597022|81464985|FG000|Overall Study|Serious adverse event|1|||
27898791|NCT03597022|81464986|FG001|Overall Study|Serious adverse event|1|||
27898792|NCT03597022|81464987|FG002|Overall Study|Serious adverse event|0|||
27898793|NCT03338569|81464988|FG000|Overall Study|Physician Decision|8|||
27898794|NCT03338569|81464989|FG001|Overall Study|Physician Decision|3|||
27898795|NCT03338569|81464988|FG000|Overall Study|Withdrawal by Subject|0|||
27898796|NCT03338569|81464989|FG001|Overall Study|Withdrawal by Subject|1|||
27898797|NCT03338569|81464988|FG000|Overall Study|Lost to Follow-up|0|||
27850406|NCT00292188|81282912|FG001|Single-Blind|Laboratory Abnormality|0|||
27850407|NCT00292188|81282913|FG002|Single-Blind|Laboratory Abnormality|0|||
27850408|NCT00292188|81282911|FG000|Single-Blind|Lost to Follow-up|3|||
27850409|NCT00292188|81282912|FG001|Single-Blind|Lost to Follow-up|0|||
27850410|NCT00292188|81282913|FG002|Single-Blind|Lost to Follow-up|0|||
27850411|NCT00292188|81282911|FG000|Single-Blind|Other|77|||
27850412|NCT00292188|81282912|FG001|Single-Blind|Other|0|||
27850413|NCT00292188|81282913|FG002|Single-Blind|Other|0|||
27850414|NCT00292188|81282911|FG000|Single-Blind|Withdrawal by Subject|12|||
27850415|NCT00292188|81282912|FG001|Single-Blind|Withdrawal by Subject|0|||
27850416|NCT00292188|81282913|FG002|Single-Blind|Withdrawal by Subject|0|||
27850417|NCT00292188|81282911|FG000|Single-Blind|Did not receive treatment|1|||
27850418|NCT00292188|81282912|FG001|Single-Blind|Did not receive treatment|0|||
27850419|NCT00292188|81282913|FG002|Single-Blind|Did not receive treatment|0|||
27850420|NCT00292188|81282911|FG000|Double-Blind|Adverse Event|0|||
27850421|NCT00292188|81282912|FG001|Double-Blind|Adverse Event|25|||
27850422|NCT00292188|81282913|FG002|Double-Blind|Adverse Event|9|||
27850423|NCT00292188|81282911|FG000|Double-Blind|Lack of Efficacy|0|||
27850424|NCT00292188|81282912|FG001|Double-Blind|Lack of Efficacy|2|||
27850425|NCT00292188|81282913|FG002|Double-Blind|Lack of Efficacy|12|||
27850426|NCT00292188|81282911|FG000|Double-Blind|Lost to Follow-up|0|||
27850427|NCT00292188|81282912|FG001|Double-Blind|Lost to Follow-up|1|||
27850428|NCT00292188|81282913|FG002|Double-Blind|Lost to Follow-up|0|||
27850429|NCT00292188|81282911|FG000|Double-Blind|Other|0|||
27850430|NCT00292188|81282912|FG001|Double-Blind|Other|3|||
27850431|NCT00292188|81282913|FG002|Double-Blind|Other|4|||
27850432|NCT00292188|81282911|FG000|Double-Blind|Withdrawal by Subject|0|||
27850433|NCT00292188|81282912|FG001|Double-Blind|Withdrawal by Subject|0|||
27850434|NCT00292188|81282913|FG002|Double-Blind|Withdrawal by Subject|3|||
27850435|NCT00292188|81282911|FG000|Double-Blind|Laboratory Abnormality|0|||
27850436|NCT00292188|81282912|FG001|Double-Blind|Laboratory Abnormality|0|||
27850437|NCT00292188|81282913|FG002|Double-Blind|Laboratory Abnormality|1|||
27850438|NCT04969861|81282915|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
27506217|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
27727333|NCT00896532|80830224|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727334|NCT00896532|80830225|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727335|NCT00896532|80830226|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727336|NCT00896532|80830227|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727337|NCT00896532|80830228|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727338|NCT00896532|80830229|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727339|NCT00896532|80830230|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727340|NCT00896532|80830231|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27850439|NCT04969861|81282916|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
27850440|NCT01370213|81282917|FG000|Overall Study|Early Death|1|||
27850441|NCT01370213|81282918|FG001|Overall Study|Early Death|0|||
27850442|NCT01370213|81282919|FG002|Overall Study|Early Death|0|||
27850443|NCT01370213|81282917|FG000|Overall Study|Not evaluable|0|||
27850444|NCT01370213|81282918|FG001|Overall Study|Not evaluable|2|||
27850445|NCT01370213|81282919|FG002|Overall Study|Not evaluable|0|||
27898798|NCT03338569|81464989|FG001|Overall Study|Lost to Follow-up|1|||
27850446|NCT03188718|81282920|FG000|Overall Study|Participant noncompliance|4|||
27898799|NCT04472026|81464995|FG000|Overall Study|Lost to Follow-up|5|||
27727341|NCT00896532|80830232|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727342|NCT00896532|80830233|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727343|NCT00896532|80830234|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27898800|NCT01606202|81464996|FG000|Overall Study|Adverse Event|5|||
27898801|NCT01606202|81464997|FG001|Overall Study|Adverse Event|0|||
27898802|NCT01606202|81464996|FG000|Overall Study|Withdrawal by Subject|2|||
27898803|NCT01606202|81464997|FG001|Overall Study|Withdrawal by Subject|1|||
27898804|NCT01606202|81464996|FG000|Overall Study|Personal problems|0|||
27898805|NCT01606202|81464997|FG001|Overall Study|Personal problems|1|||
27898806|NCT01606202|81464996|FG000|Overall Study|Problems with administration|0|||
27898807|NCT01606202|81464997|FG001|Overall Study|Problems with administration|1|||
27898808|NCT02494401|81465008|FG000|Overall Study|Lost to Follow-up|22|||
27898809|NCT02494401|81465009|FG001|Overall Study|Lost to Follow-up|25|||
27898810|NCT02494401|81465008|FG000|Overall Study|Withdrawal by Subject|3|||
27898811|NCT02494401|81465009|FG001|Overall Study|Withdrawal by Subject|2|||
27898812|NCT03235115|81465012|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
27898813|NCT03235115|81465013|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
27898814|NCT03235115|81465014|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
27898815|NCT03235115|81465015|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
27898816|NCT03235115|81465016|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
27898817|NCT03235115|81465017|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
27898818|NCT00659776|81465018|FG000|Overall Study|Withdrawal by Subject|12|||
27898819|NCT00659776|81465019|FG001|Overall Study|Withdrawal by Subject|2|||
27898820|NCT00659776|81465020|FG002|Overall Study|Withdrawal by Subject|0|||
27898821|NCT03077659|81465032|FG000|Overall Study|Withdrawal by Subject|0|||
27898822|NCT03077659|81465033|FG001|Overall Study|Withdrawal by Subject|0|||
27898823|NCT03077659|81465034|FG002|Overall Study|Withdrawal by Subject|1|||
27898824|NCT01764659|81465047|FG000|Overall Study|Death|1|||
27898825|NCT01764659|81465047|FG000|Overall Study|Physician Decision|1|||
27898826|NCT04811664|81465048|FG000|Overall Study|Lost to Follow-up|78|||
27898827|NCT04811664|81465049|FG001|Overall Study|Lost to Follow-up|125|||
27898828|NCT04811664|81465050|FG002|Overall Study|Lost to Follow-up|46|||
27898829|NCT04811664|81465048|FG000|Overall Study|Withdrawal by Subject|39|||
27898830|NCT04811664|81465049|FG001|Overall Study|Withdrawal by Subject|76|||
27898831|NCT04811664|81465050|FG002|Overall Study|Withdrawal by Subject|12|||
27898832|NCT04811664|81465048|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
27898833|NCT04811664|81465049|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
27898834|NCT04811664|81465050|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
27898835|NCT04811664|81465048|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
27898836|NCT04811664|81465049|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
27898837|NCT04811664|81465050|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
27898838|NCT04811664|81465048|FG000|Overall Study|Protocol Violation|0|||
27898839|NCT04811664|81465049|FG001|Overall Study|Protocol Violation|5|||
27898840|NCT04811664|81465050|FG002|Overall Study|Protocol Violation|11|||
27898841|NCT04811664|81465048|FG000|Overall Study|Study Terminated by Sponsor|4|||
27898842|NCT04811664|81465049|FG001|Overall Study|Study Terminated by Sponsor|3|||
27898843|NCT04811664|81465050|FG002|Overall Study|Study Terminated by Sponsor|34|||
27898844|NCT04811664|81465048|FG000|Overall Study|Early Study Closure|3|||
27898845|NCT04811664|81465049|FG001|Overall Study|Early Study Closure|7|||
27898846|NCT04811664|81465050|FG002|Overall Study|Early Study Closure|79|||
27506218|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
27506219|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
27727344|NCT00896532|80830235|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727345|NCT00896532|80830236|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727346|NCT00896532|80830237|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
27727347|NCT00896532|80830238|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727348|NCT00896532|80830239|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727349|NCT00896532|80830240|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727350|NCT00896532|80830241|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727351|NCT00896532|80830242|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727352|NCT00896532|80830243|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
27727353|NCT00896532|80830221|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
27727354|NCT00896532|80830222|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
27727355|NCT00896532|80830223|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
27727356|NCT00896532|80830224|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
27727357|NCT00896532|80830225|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
27727358|NCT00896532|80830226|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
27898847|NCT04811664|81465048|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
27898848|NCT04811664|81465049|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
27898849|NCT04811664|81465050|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
27898850|NCT00552032|81465051|FG000|Overall Study|Withdrawal by Subject|2|||
27898851|NCT00552032|81465052|FG001|Overall Study|Withdrawal by Subject|2|||
27898852|NCT00552032|81465051|FG000|Overall Study|Protocol Violation|7|||
27898853|NCT00552032|81465052|FG001|Overall Study|Protocol Violation|12|||
27898854|NCT00552032|81465051|FG000|Overall Study|Lost to Follow-up|8|||
27898855|NCT00552032|81465052|FG001|Overall Study|Lost to Follow-up|5|||
27898856|NCT02273908|81465057|FG000|Overall Study|Adverse Event|16|||
27898857|NCT02273908|81465058|FG001|Overall Study|Adverse Event|0|||
27898858|NCT02273908|81465057|FG000|Overall Study|Lost to Follow-up|10|||
27898859|NCT02273908|81465058|FG001|Overall Study|Lost to Follow-up|1|||
27898860|NCT02273908|81465057|FG000|Overall Study|Did not meet entrance criteria|3|||
27898861|NCT02273908|81465058|FG001|Overall Study|Did not meet entrance criteria|2|||
27898862|NCT02273908|81465057|FG000|Overall Study|Withdrawal by Subject|4|||
27898863|NCT02273908|81465058|FG001|Overall Study|Withdrawal by Subject|2|||
27898864|NCT00637806|81465059|FG000|Double-blind Phase|Study Discontinued|2|||
27898865|NCT00637806|81465060|FG001|Double-blind Phase|Study Discontinued|0|||
27898866|NCT00637806|81465061|FG002|Double-blind Phase|Study Discontinued|1|||
27898867|NCT00637806|81465062|FG003|Double-blind Phase|Study Discontinued|0|||
27898868|NCT00637806|81465059|FG000|Extension Phase|Study Discontinued|0|||
27898869|NCT00637806|81465060|FG001|Extension Phase|Study Discontinued|0|||
27898870|NCT00637806|81465061|FG002|Extension Phase|Study Discontinued|0|||
27898871|NCT00637806|81465062|FG003|Extension Phase|Study Discontinued|1|||
27898872|NCT01273155|81465063|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
27898873|NCT01273155|81465064|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
27898874|NCT01273155|81465065|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
27898875|NCT01273155|81465066|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
27898876|NCT01273155|81465067|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
27898877|NCT01273155|81465068|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
27898878|NCT01273155|81465069|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
27898879|NCT01273155|81465063|FG000|Overall Study|Change in liver function/no longer eval.|0|||
27898880|NCT01273155|81465064|FG001|Overall Study|Change in liver function/no longer eval.|1|||
27898881|NCT01273155|81465065|FG002|Overall Study|Change in liver function/no longer eval.|0|||
27898882|NCT01273155|81465066|FG003|Overall Study|Change in liver function/no longer eval.|0|||
27898883|NCT01273155|81465067|FG004|Overall Study|Change in liver function/no longer eval.|1|||
27898884|NCT01273155|81465068|FG005|Overall Study|Change in liver function/no longer eval.|0|||
27898885|NCT01273155|81465069|FG006|Overall Study|Change in liver function/no longer eval.|0|||
27898886|NCT01273155|81465063|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
27898887|NCT01273155|81465064|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
27898888|NCT01273155|81465065|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
27898889|NCT01273155|81465066|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
27898890|NCT01273155|81465067|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
27898891|NCT01273155|81465068|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
27898892|NCT01273155|81465069|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
27898893|NCT01273155|81465063|FG000|Overall Study|Died during Cycle 1|0|||
27898894|NCT01273155|81465064|FG001|Overall Study|Died during Cycle 1|0|||
27898895|NCT01273155|81465065|FG002|Overall Study|Died during Cycle 1|1|||
27898896|NCT01273155|81465066|FG003|Overall Study|Died during Cycle 1|1|||
27898897|NCT01273155|81465067|FG004|Overall Study|Died during Cycle 1|0|||
27898898|NCT01273155|81465068|FG005|Overall Study|Died during Cycle 1|2|||
27898899|NCT01273155|81465069|FG006|Overall Study|Died during Cycle 1|2|||
27898900|NCT01273155|81465063|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
27898901|NCT01273155|81465064|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
27898902|NCT01273155|81465065|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
27898903|NCT01273155|81465066|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
27898904|NCT01273155|81465067|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
27898905|NCT01273155|81465068|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
27898906|NCT01273155|81465069|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
27898907|NCT04529850|81465072|FG000|Overall Study|Death|2|||
27898908|NCT04529850|81465072|FG000|Overall Study|Physician Decision|1|||
27898909|NCT04529850|81465072|FG000|Overall Study|Withdrawal by Subject|2|||
27898910|NCT01573754|81465073|FG000|Overall Study|Noncompliance or remission not achieved|3|||
27898911|NCT01573754|81465074|FG001|Overall Study|Noncompliance or remission not achieved|15|||
27898912|NCT04679051|81465078|FG000|Overall Study|felt tired after restricted time in bed|3|||
27898913|NCT04679051|81465079|FG001|Overall Study|felt tired after restricted time in bed|0|||
27898914|NCT04679051|81465078|FG000|Overall Study|discomfort with blood pressure cuff|2|||
27898915|NCT04679051|81465079|FG001|Overall Study|discomfort with blood pressure cuff|0|||
27898916|NCT04679051|81465078|FG000|Overall Study|scheduling conflict|1|||
27898917|NCT04679051|81465079|FG001|Overall Study|scheduling conflict|1|||
27898918|NCT04679051|81465078|FG000|Overall Study|Protocol Violation|0|||
27898919|NCT04679051|81465079|FG001|Overall Study|Protocol Violation|4|||
27898920|NCT00423189|81465086|FG000|Overall Study|Death|0|||
27898921|NCT00423189|81465087|FG001|Overall Study|Death|1|||
27898922|NCT00423189|81465088|FG002|Overall Study|Death|0|||
27850447|NCT03188718|81282920|FG000|Overall Study|Withdrawal by Subject|1|||
27850448|NCT03188718|81282920|FG000|Overall Study|Device failure|3|||
27850449|NCT03064438|81282928|FG000|Overall Study|Lost to Follow-up|1|||
27850450|NCT03064438|81282929|FG001|Overall Study|Lost to Follow-up|0|||
27506220|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
27727359|NCT00896532|80830227|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
27727360|NCT00896532|80830228|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
27727361|NCT00896532|80830229|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
27727362|NCT00896532|80830230|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
27727363|NCT00896532|80830231|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
27727364|NCT00896532|80830232|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
27727365|NCT00896532|80830233|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
27727366|NCT00896532|80830234|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
27727367|NCT00896532|80830235|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
27727368|NCT00896532|80830236|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
27727369|NCT00896532|80830237|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
27727370|NCT00896532|80830238|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
27727371|NCT00896532|80830239|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
27727372|NCT00896532|80830240|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
27727373|NCT00896532|80830241|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
27727374|NCT00896532|80830242|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
27727375|NCT00896532|80830243|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
27727376|NCT00896532|80830221|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727377|NCT00896532|80830222|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727378|NCT00896532|80830223|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727379|NCT00896532|80830224|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727380|NCT00896532|80830225|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727381|NCT00896532|80830226|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727382|NCT00896532|80830227|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727383|NCT00896532|80830228|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727384|NCT00896532|80830229|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727385|NCT00896532|80830230|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727386|NCT00896532|80830231|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727387|NCT00896532|80830232|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727388|NCT00896532|80830233|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727389|NCT00896532|80830234|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727390|NCT00896532|80830235|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727391|NCT00896532|80830236|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727392|NCT00896532|80830237|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
27727393|NCT00896532|80830238|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727394|NCT00896532|80830239|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727395|NCT00896532|80830240|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727396|NCT00896532|80830241|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727397|NCT00896532|80830242|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727398|NCT00896532|80830243|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
27727399|NCT00896532|80830221|FG000|Months 48-72: Follow-on Phase|Death|0|||
27727400|NCT00896532|80830222|FG001|Months 48-72: Follow-on Phase|Death|0|||
27727401|NCT00896532|80830223|FG002|Months 48-72: Follow-on Phase|Death|0|||
27727402|NCT00896532|80830224|FG003|Months 48-72: Follow-on Phase|Death|0|||
27727403|NCT00896532|80830225|FG004|Months 48-72: Follow-on Phase|Death|0|||
27727404|NCT00896532|80830226|FG005|Months 48-72: Follow-on Phase|Death|0|||
27727405|NCT00896532|80830227|FG006|Months 48-72: Follow-on Phase|Death|0|||
27727406|NCT00896532|80830228|FG007|Months 48-72: Follow-on Phase|Death|0|||
27727407|NCT00896532|80830229|FG008|Months 48-72: Follow-on Phase|Death|0|||
27727408|NCT00896532|80830230|FG009|Months 48-72: Follow-on Phase|Death|0|||
27727409|NCT00896532|80830231|FG010|Months 48-72: Follow-on Phase|Death|0|||
27727410|NCT00896532|80830232|FG011|Months 48-72: Follow-on Phase|Death|0|||
27727411|NCT00896532|80830233|FG012|Months 48-72: Follow-on Phase|Death|0|||
27727412|NCT00896532|80830234|FG013|Months 48-72: Follow-on Phase|Death|0|||
27727413|NCT00896532|80830235|FG014|Months 48-72: Follow-on Phase|Death|0|||
27727414|NCT00896532|80830236|FG015|Months 48-72: Follow-on Phase|Death|0|||
27727415|NCT00896532|80830237|FG016|Months 48-72: Follow-on Phase|Death|0|||
27727416|NCT00896532|80830238|FG017|Months 48-72: Follow-on Phase|Death|0|||
27727417|NCT00896532|80830239|FG018|Months 48-72: Follow-on Phase|Death|1|||
27850451|NCT03064438|81282928|FG000|Overall Study|Withdrawal by Subject|0|||
27850452|NCT03064438|81282929|FG001|Overall Study|Withdrawal by Subject|1|||
27506221|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
27898923|NCT00581542|81465097|FG000|Overall Study|they met an exclusion criteria|2|||
27898924|NCT00581542|81465098|FG001|Overall Study|they met an exclusion criteria|2|||
27898925|NCT00581542|81465097|FG000|Overall Study|Lost to Follow-up|9|||
27898926|NCT00581542|81465098|FG001|Overall Study|Lost to Follow-up|21|||
27898927|NCT00948506|81465101|FG000|Overall Study|Withdrawal by Subject|3|||
27898928|NCT00948506|81465102|FG001|Overall Study|Withdrawal by Subject|1|||
27898929|NCT00114738|81465105|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
27898930|NCT00114738|81465106|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
27898931|NCT00114738|81465107|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
27898932|NCT00114738|81465105|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
27898933|NCT00114738|81465106|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
27898934|NCT00114738|81465107|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
27898935|NCT00114738|81465105|FG000|Screening for Randomization|Neuropathy|17|||
27898936|NCT00114738|81465106|FG001|Screening for Randomization|Neuropathy|0|||
27898937|NCT00114738|81465107|FG002|Screening for Randomization|Neuropathy|0|||
27898938|NCT00114738|81465105|FG000|Screening for Randomization|Progressive disease|2|||
27898939|NCT00114738|81465106|FG001|Screening for Randomization|Progressive disease|0|||
27898940|NCT00114738|81465107|FG002|Screening for Randomization|Progressive disease|0|||
27898941|NCT00114738|81465105|FG000|Screening for Randomization|CNS Hemorrhage|1|||
27898942|NCT00114738|81465106|FG001|Screening for Randomization|CNS Hemorrhage|0|||
27898943|NCT00114738|81465107|FG002|Screening for Randomization|CNS Hemorrhage|0|||
27898944|NCT00114738|81465105|FG000|Screening for Randomization|Other|1|||
27898945|NCT00114738|81465106|FG001|Screening for Randomization|Other|0|||
27898946|NCT00114738|81465107|FG002|Screening for Randomization|Other|0|||
27898947|NCT01362517|81465108|FG000|Overall Study|Protocol Violation|1|||
27898948|NCT01362517|81465108|FG000|Overall Study|Lost to Follow-up|1|||
27898949|NCT01675154|81465115|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
27898950|NCT01675154|81465116|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
27898951|NCT01675154|81465117|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
27898952|NCT01675154|81465118|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
27898953|NCT01643798|81465119|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
27898954|NCT01643798|81465120|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
27898955|NCT02418585|81465125|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
27898956|NCT02418585|81465126|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
27898957|NCT02418585|81465125|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
27898958|NCT02418585|81465126|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
27898959|NCT02418585|81465125|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
27898960|NCT02418585|81465126|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
27898961|NCT02418585|81465125|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
27898962|NCT02418585|81465126|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
27898963|NCT02418585|81465125|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
27898964|NCT02418585|81465126|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
27898965|NCT02418585|81465125|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
27898966|NCT02418585|81465126|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
27898967|NCT02418585|81465125|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
27898968|NCT02418585|81465126|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
27898969|NCT02418585|81465125|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
27898970|NCT02418585|81465126|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
27898971|NCT02418585|81465125|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
27898972|NCT02418585|81465126|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
27898973|NCT02418585|81465125|FG000|Follow-up Phase (24 Weeks)|Other|3|||
27898974|NCT02418585|81465126|FG001|Follow-up Phase (24 Weeks)|Other|2|||
27898975|NCT02326298|81465127|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898976|NCT02326298|81465128|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898977|NCT02326298|81465129|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
27898978|NCT02326298|81465130|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898979|NCT02326298|81465131|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898980|NCT02326298|81465132|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898981|NCT02326298|81465133|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898982|NCT02326298|81465134|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898983|NCT02326298|81465135|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898984|NCT02326298|81465136|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898985|NCT02326298|81465137|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898986|NCT02326298|81465138|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898987|NCT02326298|81465139|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898988|NCT02326298|81465140|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27898989|NCT02326298|81465127|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
27898990|NCT02326298|81465128|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27727418|NCT00896532|80830240|FG019|Months 48-72: Follow-on Phase|Death|0|||
27898991|NCT02326298|81465129|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898992|NCT02326298|81465130|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898993|NCT02326298|81465131|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898994|NCT02326298|81465132|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898995|NCT02326298|81465133|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898996|NCT02326298|81465134|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898997|NCT02326298|81465135|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898998|NCT02326298|81465136|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27898999|NCT02326298|81465137|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27899000|NCT02326298|81465138|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27850453|NCT01393730|81282934|FG000|Overall Study|Withdrawal by Subject|3|||
27850454|NCT01393730|81282934|FG000|Overall Study|Other|2|||
27850455|NCT01393730|81282934|FG000|Overall Study|Adverse Event|1|||
27850456|NCT03250299|81282935|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
27850457|NCT03250299|81282936|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
27850458|NCT03250299|81282937|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
27850459|NCT03250299|81282938|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
27850460|NCT03250299|81282939|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
27850461|NCT03250299|81282935|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
27850462|NCT03250299|81282936|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
27850463|NCT03250299|81282937|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
27850464|NCT03250299|81282938|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
27850465|NCT03250299|81282939|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
27850466|NCT03250299|81282935|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
27850467|NCT03250299|81282936|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
27850468|NCT03250299|81282937|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
27850469|NCT03250299|81282938|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
27850470|NCT03250299|81282939|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
27850471|NCT03250299|81282935|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
27850472|NCT03250299|81282936|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
27850473|NCT03250299|81282937|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
27850474|NCT03250299|81282938|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
27850475|NCT03250299|81282939|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
27850476|NCT00073021|81282940|FG000|Overall Study|Protocol Violation|2|||
27850477|NCT00073021|81282941|FG001|Overall Study|Protocol Violation|1|||
27850478|NCT00073021|81282940|FG000|Overall Study|Adverse Event|4|||
27850479|NCT00073021|81282941|FG001|Overall Study|Adverse Event|4|||
27850480|NCT00073021|81282940|FG000|Overall Study|Withdrawal by Subject|6|||
27850481|NCT00073021|81282941|FG001|Overall Study|Withdrawal by Subject|5|||
27850482|NCT00073021|81282940|FG000|Overall Study|Physician Decision|3|||
27850483|NCT00073021|81282941|FG001|Overall Study|Physician Decision|1|||
27850484|NCT00073021|81282940|FG000|Overall Study|Lack of Efficacy|11|||
27850485|NCT00073021|81282941|FG001|Overall Study|Lack of Efficacy|5|||
27850486|NCT04317599|81282942|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
27850487|NCT04317599|81282942|FG000|Overall Study|treatment outside standard of care|4|||
27850488|NCT00770692|81282949|FG000|Overall Study|Withdrawal by Subject|7|||
27850489|NCT00770692|81282950|FG001|Overall Study|Withdrawal by Subject|9|||
27850490|NCT00770692|81282951|FG002|Overall Study|Withdrawal by Subject|9|||
27850491|NCT00770692|81282952|FG003|Overall Study|Withdrawal by Subject|6|||
27850492|NCT00770692|81282949|FG000|Overall Study|Adverse Event|3|||
27850493|NCT00770692|81282950|FG001|Overall Study|Adverse Event|0|||
27850494|NCT00770692|81282951|FG002|Overall Study|Adverse Event|4|||
27850495|NCT00770692|81282952|FG003|Overall Study|Adverse Event|4|||
27850496|NCT00770692|81282949|FG000|Overall Study|Investigator judgment|2|||
27850497|NCT00770692|81282950|FG001|Overall Study|Investigator judgment|0|||
27850498|NCT00770692|81282951|FG002|Overall Study|Investigator judgment|1|||
27850499|NCT00770692|81282952|FG003|Overall Study|Investigator judgment|1|||
27850500|NCT02041091|81282953|FG000|Treatment|Adverse Event|3|||
27850501|NCT02041091|81282954|FG001|Treatment|Adverse Event|3|||
27850502|NCT02041091|81282953|FG000|Treatment|Withdrawal by Subject|2|||
27850503|NCT02041091|81282954|FG001|Treatment|Withdrawal by Subject|4|||
27850504|NCT02041091|81282953|FG000|Treatment|Physician Decision|1|||
27850505|NCT02041091|81282954|FG001|Treatment|Physician Decision|0|||
27850506|NCT02041091|81282953|FG000|Treatment|Sponsor Decision|15|||
27850507|NCT02041091|81282954|FG001|Treatment|Sponsor Decision|16|||
27850508|NCT02041091|81282953|FG000|Treatment|Lost to Follow-up|1|||
27850509|NCT02041091|81282954|FG001|Treatment|Lost to Follow-up|0|||
27850510|NCT02041091|81282953|FG000|Optional Safety Extension Period|Adverse Event|4|||
27850511|NCT02041091|81282954|FG001|Optional Safety Extension Period|Adverse Event|2|||
27850512|NCT02041091|81282953|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
27850513|NCT02041091|81282954|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
27850514|NCT02041091|81282953|FG000|Optional Safety Extension Period|Protocol Violation|2|||
27850515|NCT02041091|81282954|FG001|Optional Safety Extension Period|Protocol Violation|0|||
27899001|NCT02326298|81465139|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27899002|NCT02326298|81465140|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
27899003|NCT02326298|81465127|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
27899004|NCT02326298|81465128|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
27899005|NCT02326298|81465129|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899006|NCT02326298|81465130|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899007|NCT02326298|81465131|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899008|NCT02326298|81465132|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899009|NCT02326298|81465133|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899010|NCT02326298|81465134|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899011|NCT02326298|81465135|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899012|NCT02326298|81465136|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899013|NCT02326298|81465137|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899014|NCT02326298|81465138|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899015|NCT02326298|81465139|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27850516|NCT02041091|81282953|FG000|Optional Safety Extension Period|Physician Decision|2|||
27850517|NCT02041091|81282954|FG001|Optional Safety Extension Period|Physician Decision|1|||
27899016|NCT02326298|81465140|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27899017|NCT02326298|81465127|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
27899018|NCT02326298|81465128|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
27899019|NCT02326298|81465129|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899020|NCT02326298|81465130|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899021|NCT02326298|81465131|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899022|NCT02326298|81465132|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899023|NCT02326298|81465133|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899024|NCT02326298|81465134|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899025|NCT02326298|81465135|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899026|NCT02326298|81465136|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899027|NCT02326298|81465137|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899028|NCT02326298|81465138|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899029|NCT02326298|81465139|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899030|NCT02326298|81465140|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27899031|NCT02326298|81465127|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899032|NCT02326298|81465128|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899033|NCT02326298|81465129|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
27899034|NCT02326298|81465130|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899035|NCT02326298|81465131|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899036|NCT02326298|81465132|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899037|NCT02326298|81465133|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899038|NCT02326298|81465134|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899039|NCT02326298|81465135|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899040|NCT02326298|81465136|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27506222|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
27850518|NCT02041091|81282953|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
27850519|NCT02041091|81282954|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
27850520|NCT02041091|81282953|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
27850521|NCT02041091|81282954|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
27850522|NCT00350402|81282955|FG000|Overall Study|Lost to Follow-up|1|||
27850523|NCT00350402|81282956|FG001|Overall Study|Lost to Follow-up|1|||
27850524|NCT02206620|81282959|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27850525|NCT02206620|81282960|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
27850526|NCT02206620|81282959|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
27850527|NCT02206620|81282960|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
27850528|NCT02149121|81282961|FG000|Main Study Period|Lack of Efficacy|2|||
27850529|NCT02149121|81282962|FG001|Main Study Period|Lack of Efficacy|2|||
27850530|NCT02149121|81282963|FG002|Main Study Period|Lack of Efficacy|1|||
27850531|NCT02149121|81282964|FG003|Main Study Period|Lack of Efficacy|0|||
27850532|NCT02149121|81282965|FG004|Main Study Period|Lack of Efficacy|0|||
27850533|NCT02149121|81282966|FG005|Main Study Period|Lack of Efficacy|0|||
27754899|NCT02065622|80929634|FG004|Maintenance Study|Adverse Event|11|||
27754900|NCT02065622|80929630|FG000|Maintenance Study|Withdrawal by Subject|0|||
27754901|NCT02065622|80929631|FG001|Maintenance Study|Withdrawal by Subject|0|||
27754902|NCT02065622|80929632|FG002|Maintenance Study|Withdrawal by Subject|11|||
27754903|NCT02065622|80929633|FG003|Maintenance Study|Withdrawal by Subject|5|||
27899041|NCT02326298|81465137|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899042|NCT02326298|81465138|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899043|NCT02326298|81465139|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899044|NCT02326298|81465140|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
27899045|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899046|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899047|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899048|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899049|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899050|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27899051|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
27899052|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27899053|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27899054|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27899055|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899056|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899057|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899058|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27899059|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899060|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899061|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899062|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899063|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899064|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
27506223|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
27506224|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
27899065|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
27899066|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899067|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
27899068|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899069|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899070|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899071|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899072|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
27899073|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27506225|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
27850534|NCT02149121|81282967|FG006|Main Study Period|Lack of Efficacy|0|||
27850535|NCT02149121|81282961|FG000|Main Study Period|Withdrawal by Subject|9|||
27850536|NCT02149121|81282962|FG001|Main Study Period|Withdrawal by Subject|5|||
27850537|NCT02149121|81282963|FG002|Main Study Period|Withdrawal by Subject|1|||
27850538|NCT02149121|81282964|FG003|Main Study Period|Withdrawal by Subject|0|||
27850539|NCT02149121|81282965|FG004|Main Study Period|Withdrawal by Subject|0|||
27850540|NCT02149121|81282966|FG005|Main Study Period|Withdrawal by Subject|0|||
27850541|NCT02149121|81282967|FG006|Main Study Period|Withdrawal by Subject|0|||
27850542|NCT02149121|81282961|FG000|Main Study Period|Adverse Event|2|||
27850543|NCT02149121|81282962|FG001|Main Study Period|Adverse Event|5|||
27850544|NCT02149121|81282963|FG002|Main Study Period|Adverse Event|1|||
27850545|NCT02149121|81282964|FG003|Main Study Period|Adverse Event|0|||
27850546|NCT02149121|81282965|FG004|Main Study Period|Adverse Event|0|||
27850547|NCT02149121|81282966|FG005|Main Study Period|Adverse Event|0|||
27850548|NCT02149121|81282967|FG006|Main Study Period|Adverse Event|0|||
27850549|NCT02149121|81282961|FG000|Main Study Period|Protocol Violation|2|||
27850550|NCT02149121|81282962|FG001|Main Study Period|Protocol Violation|0|||
27850551|NCT02149121|81282963|FG002|Main Study Period|Protocol Violation|0|||
27850552|NCT02149121|81282964|FG003|Main Study Period|Protocol Violation|0|||
27850553|NCT02149121|81282965|FG004|Main Study Period|Protocol Violation|0|||
27850554|NCT02149121|81282966|FG005|Main Study Period|Protocol Violation|0|||
27850555|NCT02149121|81282967|FG006|Main Study Period|Protocol Violation|0|||
27850556|NCT02149121|81282961|FG000|Main Study Period|Lost to Follow-up|2|||
27850557|NCT02149121|81282962|FG001|Main Study Period|Lost to Follow-up|1|||
27850558|NCT02149121|81282963|FG002|Main Study Period|Lost to Follow-up|0|||
27850559|NCT02149121|81282964|FG003|Main Study Period|Lost to Follow-up|0|||
27850560|NCT02149121|81282965|FG004|Main Study Period|Lost to Follow-up|0|||
27850561|NCT02149121|81282966|FG005|Main Study Period|Lost to Follow-up|0|||
27899074|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899075|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899076|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899077|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899078|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
27899079|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899080|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899081|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899082|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899083|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899084|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899085|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899086|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
27899087|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899088|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899089|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899090|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899091|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899092|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899093|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
27899094|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899095|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899096|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899097|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27850562|NCT02149121|81282967|FG006|Main Study Period|Lost to Follow-up|0|||
27850563|NCT02149121|81282961|FG000|Main Study Period|Death|1|||
27850564|NCT02149121|81282962|FG001|Main Study Period|Death|0|||
27850565|NCT02149121|81282963|FG002|Main Study Period|Death|0|||
27850566|NCT02149121|81282964|FG003|Main Study Period|Death|0|||
27850567|NCT02149121|81282965|FG004|Main Study Period|Death|0|||
27850568|NCT02149121|81282966|FG005|Main Study Period|Death|0|||
27850569|NCT02149121|81282967|FG006|Main Study Period|Death|0|||
27850570|NCT02149121|81282961|FG000|Main Study Period|Physician Decision|1|||
27850571|NCT02149121|81282962|FG001|Main Study Period|Physician Decision|0|||
27850572|NCT02149121|81282963|FG002|Main Study Period|Physician Decision|0|||
27850573|NCT02149121|81282964|FG003|Main Study Period|Physician Decision|0|||
27850574|NCT02149121|81282965|FG004|Main Study Period|Physician Decision|0|||
27899098|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899099|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899100|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27899101|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899102|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899103|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899104|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27614092|NCT03990363|80430134|FG001|Overall Study|Non-compliance with study drug|1|||
27614093|NCT03990363|80430135|FG002|Overall Study|Non-compliance with study drug|2|||
27614094|NCT03990363|80430136|FG003|Overall Study|Non-compliance with study drug|0|||
27614095|NCT03990363|80430137|FG004|Overall Study|Non-compliance with study drug|0|||
27614096|NCT03990363|80430133|FG000|Overall Study|Study terminated by sponsor|0|||
27614097|NCT03990363|80430134|FG001|Overall Study|Study terminated by sponsor|1|||
27899105|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899106|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899107|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899108|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
27899109|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899110|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899111|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899112|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899113|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27506226|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
27506227|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
27506228|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
27850575|NCT02149121|81282966|FG005|Main Study Period|Physician Decision|0|||
27614098|NCT03990363|80430135|FG002|Overall Study|Study terminated by sponsor|0|||
27850576|NCT02149121|81282967|FG006|Main Study Period|Physician Decision|0|||
27850577|NCT02149121|81282961|FG000|Main Study Period|Developed any malignancy|0|||
27899114|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
27899115|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899116|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899117|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899118|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899119|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899120|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899121|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
27899122|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
27899123|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899124|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899125|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899126|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899127|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899128|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27899129|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899130|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899131|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899132|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899133|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899134|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899135|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899136|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27899137|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899138|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899139|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899140|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27506229|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
27506230|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
27850578|NCT02149121|81282962|FG001|Main Study Period|Developed any malignancy|1|||
27850579|NCT02149121|81282963|FG002|Main Study Period|Developed any malignancy|1|||
27850580|NCT02149121|81282964|FG003|Main Study Period|Developed any malignancy|0|||
27850581|NCT02149121|81282965|FG004|Main Study Period|Developed any malignancy|0|||
27850582|NCT02149121|81282966|FG005|Main Study Period|Developed any malignancy|0|||
27850583|NCT02149121|81282967|FG006|Main Study Period|Developed any malignancy|0|||
27850584|NCT02149121|81282961|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
27850585|NCT02149121|81282962|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
27850586|NCT02149121|81282963|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
27850587|NCT02149121|81282964|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
27850588|NCT02149121|81282965|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
27850589|NCT02149121|81282966|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
27850590|NCT02149121|81282967|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
27850591|NCT02149121|81282961|FG000|Main Study Period|Disease progression|0|||
27850592|NCT02149121|81282962|FG001|Main Study Period|Disease progression|1|||
27850593|NCT02149121|81282963|FG002|Main Study Period|Disease progression|0|||
27850594|NCT02149121|81282964|FG003|Main Study Period|Disease progression|0|||
27850595|NCT02149121|81282965|FG004|Main Study Period|Disease progression|0|||
27850596|NCT02149121|81282966|FG005|Main Study Period|Disease progression|0|||
27850597|NCT02149121|81282967|FG006|Main Study Period|Disease progression|0|||
27850598|NCT02149121|81282961|FG000|Extension Study Period|Withdrawal by Subject|0|||
27850599|NCT02149121|81282962|FG001|Extension Study Period|Withdrawal by Subject|0|||
27850600|NCT02149121|81282963|FG002|Extension Study Period|Withdrawal by Subject|0|||
27850601|NCT02149121|81282964|FG003|Extension Study Period|Withdrawal by Subject|1|||
27850602|NCT02149121|81282965|FG004|Extension Study Period|Withdrawal by Subject|0|||
27850603|NCT02149121|81282966|FG005|Extension Study Period|Withdrawal by Subject|2|||
27850604|NCT02149121|81282967|FG006|Extension Study Period|Withdrawal by Subject|0|||
27850605|NCT01597479|81282968|FG000|Overall Study|Protocol Violation|1|||
27850606|NCT01597479|81282969|FG001|Overall Study|Protocol Violation|0|||
27850607|NCT01597479|81282968|FG000|Overall Study|Lost to Follow-up|1|||
27850608|NCT01597479|81282969|FG001|Overall Study|Lost to Follow-up|0|||
27850609|NCT00317642|81282974|FG000|Overall Study|Not Received Either Study Drug|1|||
27850610|NCT00317642|81282975|FG001|Overall Study|Not Received Either Study Drug|3|||
27850611|NCT00317642|81282974|FG000|Overall Study|Physician Decision|15|||
27850612|NCT00317642|81282975|FG001|Overall Study|Physician Decision|7|||
27850613|NCT00317642|81282974|FG000|Overall Study|Participant declined treatment|14|||
27850614|NCT00317642|81282975|FG001|Overall Study|Participant declined treatment|3|||
27850615|NCT00317642|81282974|FG000|Overall Study|Adverse Event|17|||
27850616|NCT00317642|81282975|FG001|Overall Study|Adverse Event|5|||
27850617|NCT00317642|81282974|FG000|Overall Study|Treatment Failure|56|||
27899141|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899142|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27899143|NCT02326298|81465127|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899144|NCT02326298|81465128|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899145|NCT02326298|81465129|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899146|NCT02326298|81465130|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899147|NCT02326298|81465131|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899148|NCT02326298|81465132|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
27899149|NCT02326298|81465133|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899150|NCT02326298|81465134|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899151|NCT02326298|81465135|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899152|NCT02326298|81465136|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899153|NCT02326298|81465137|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27506231|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27506232|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27506233|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27506234|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
27506235|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27506236|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
27506237|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
27506238|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27506239|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
27506240|NCT01106690|80044306|FG000|Core Period: Baseline to Week 26|Other|10|||
27899154|NCT02326298|81465138|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899155|NCT02326298|81465139|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899156|NCT02326298|81465140|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
27899157|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
27899158|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
27899159|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
27899160|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
27899161|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
27899162|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
27899163|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
27899164|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
27899165|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
27899166|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
27899167|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
27899168|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
27899169|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
27899170|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
27899171|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899172|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899173|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899174|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899175|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899176|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899177|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899178|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899179|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899180|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899181|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899182|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
27899183|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
27899184|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27899185|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899186|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899187|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899188|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899189|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899190|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899191|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899192|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27506241|NCT01106690|80044307|FG001|Core Period: Baseline to Week 26|Other|2|||
27850618|NCT00317642|81282975|FG001|Overall Study|Treatment Failure|102|||
27850619|NCT00317642|81282974|FG000|Overall Study|Disease Recurrence|1|||
27850620|NCT00317642|81282975|FG001|Overall Study|Disease Recurrence|2|||
27850621|NCT00317642|81282974|FG000|Overall Study|Death|14|||
27850622|NCT00317642|81282975|FG001|Overall Study|Death|7|||
27850623|NCT00317642|81282974|FG000|Overall Study|Not Continue to Consolidation|2|||
27850624|NCT00317642|81282975|FG001|Overall Study|Not Continue to Consolidation|0|||
27850625|NCT00317642|81282974|FG000|Overall Study|Withdrawal by Subject|0|||
27850626|NCT00317642|81282975|FG001|Overall Study|Withdrawal by Subject|1|||
27850627|NCT00317642|81282974|FG000|Overall Study|Referred For Transplantation|1|||
27850628|NCT00317642|81282975|FG001|Overall Study|Referred For Transplantation|0|||
27850629|NCT00317642|81282974|FG000|Overall Study|AML Not Centrally Confirmed|1|||
27850630|NCT00317642|81282975|FG001|Overall Study|AML Not Centrally Confirmed|5|||
27850631|NCT03401450|81282976|FG000|Overall Study|Lost to Follow-up|4|||
27850632|NCT03401450|81282977|FG001|Overall Study|Lost to Follow-up|6|||
27850633|NCT03401450|81282976|FG000|Overall Study|Anesthesia plan changed|2|||
27850634|NCT03401450|81282977|FG001|Overall Study|Anesthesia plan changed|2|||
27850635|NCT03401450|81282976|FG000|Overall Study|Did not complete medication diary|4|||
27850636|NCT03401450|81282977|FG001|Overall Study|Did not complete medication diary|2|||
27850637|NCT03401450|81282976|FG000|Overall Study|post surgery medication change|2|||
27850638|NCT03401450|81282977|FG001|Overall Study|post surgery medication change|1|||
27850639|NCT03401450|81282976|FG000|Overall Study|Cancelled surgery|0|||
27850640|NCT03401450|81282977|FG001|Overall Study|Cancelled surgery|2|||
27850641|NCT01621191|81282978|FG000|Overall Study|Adverse Event|9|||
27850642|NCT01621191|81282978|FG000|Overall Study|Withdrawal by Subject|8|||
27850643|NCT01621191|81282978|FG000|Overall Study|Lack of Efficacy|6|||
27850644|NCT01621191|81282978|FG000|Overall Study|Lost to Follow-up|1|||
27850645|NCT01621191|81282978|FG000|Overall Study|Site Removed From Study|1|||
27850646|NCT02310646|81282979|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
27850647|NCT02310646|81282980|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
27850648|NCT02310646|81282979|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
27850649|NCT02310646|81282980|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
27850650|NCT00311311|81282981|FG000|Overall Study|Adverse Event|3|||
27850651|NCT00311311|81282982|FG001|Overall Study|Adverse Event|2|||
27850652|NCT00311311|81282981|FG000|Overall Study|Withdrawal by Subject|1|||
27850653|NCT00311311|81282982|FG001|Overall Study|Withdrawal by Subject|1|||
27850654|NCT00311311|81282981|FG000|Overall Study|Noncompliance|0|||
27850655|NCT00311311|81282982|FG001|Overall Study|Noncompliance|1|||
27850656|NCT00311311|81282981|FG000|Overall Study|Study Termination by Sponsor|3|||
27850657|NCT00311311|81282982|FG001|Overall Study|Study Termination by Sponsor|4|||
27850658|NCT00311311|81282981|FG000|Overall Study|Death|1|||
27850659|NCT00311311|81282982|FG001|Overall Study|Death|0|||
27850660|NCT00311311|81282981|FG000|Overall Study|Lack of ancillary assistance|0|||
27850661|NCT00311311|81282982|FG001|Overall Study|Lack of ancillary assistance|1|||
27850662|NCT01490866|81282983|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
27850663|NCT01490866|81282983|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
27850664|NCT01490866|81282983|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
27850665|NCT01490866|81282983|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
27850666|NCT01490866|81282983|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
27850667|NCT01490866|81282983|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
27850668|NCT01490866|81282983|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
27850669|NCT01490866|81282983|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
27850670|NCT01490866|81282983|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
27850671|NCT01490866|81282983|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
27850672|NCT01490866|81282983|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
27850673|NCT02621034|81282984|FG000|Overall Study|Lost to Follow-up|3|||
27850674|NCT02621034|81282985|FG001|Overall Study|Lost to Follow-up|2|||
27850675|NCT02621034|81282986|FG002|Overall Study|Lost to Follow-up|5|||
27850676|NCT01064531|81282987|FG000|Overall Study|Lost to Follow-up|0|||
27850677|NCT01064531|81282988|FG001|Overall Study|Lost to Follow-up|2|||
27850678|NCT01064531|81282987|FG000|Overall Study|Physician Decision|0|||
27850679|NCT01064531|81282988|FG001|Overall Study|Physician Decision|1|||
27850680|NCT01064531|81282987|FG000|Overall Study|Withdrawal by Subject|2|||
27850681|NCT01064531|81282988|FG001|Overall Study|Withdrawal by Subject|2|||
27850682|NCT01064531|81282987|FG000|Overall Study|Revision due to femoral stem loosening|1|||
27850683|NCT01064531|81282988|FG001|Overall Study|Revision due to femoral stem loosening|0|||
27850684|NCT01064531|81282987|FG000|Overall Study|Revision due to dislocation|0|||
27850685|NCT01064531|81282988|FG001|Overall Study|Revision due to dislocation|1|||
27850686|NCT01064531|81282987|FG000|Overall Study|Death|0|||
27850687|NCT01064531|81282988|FG001|Overall Study|Death|1|||
27850688|NCT00679913|81282989|FG000|Overall Study|Protocol Violation|18|||
27850689|NCT00679913|81282990|FG001|Overall Study|Protocol Violation|13|||
27850690|NCT02296684|81282993|FG000|Overall Study|Withdrawal by Subject|0|||
27850691|NCT02296684|81282994|FG001|Overall Study|Withdrawal by Subject|1|||
27850692|NCT02296684|81282995|FG002|Overall Study|Withdrawal by Subject|1|||
27899193|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899194|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899195|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899196|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27899197|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27899198|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27899199|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899200|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899201|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899202|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899203|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899204|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899205|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899206|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899207|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899208|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899209|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899210|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899211|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27899212|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
27899213|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27727419|NCT00896532|80830241|FG020|Months 48-72: Follow-on Phase|Death|0|||
27727420|NCT00896532|80830242|FG021|Months 48-72: Follow-on Phase|Death|0|||
27850693|NCT02296684|81282993|FG000|Overall Study|Death|2|||
27850694|NCT02296684|81282994|FG001|Overall Study|Death|0|||
27850695|NCT02296684|81282995|FG002|Overall Study|Death|0|||
27850696|NCT02939014|81282996|FG000|Overall Study|Lost to Follow-up|1|||
27850697|NCT02939014|81282997|FG001|Overall Study|Lost to Follow-up|0|||
27850698|NCT02939014|81282996|FG000|Overall Study|Death|4|||
27850699|NCT02939014|81282997|FG001|Overall Study|Death|3|||
27850700|NCT01698775|81283001|FG000|Phase A|Adverse Event|2|||
27850701|NCT01698775|81283002|FG001|Phase A|Adverse Event|1|||
27850702|NCT01698775|81283001|FG000|Phase A|Death|1|||
27850703|NCT01698775|81283002|FG001|Phase A|Death|1|||
27850704|NCT01698775|81283001|FG000|Phase A|Lack of Efficacy|1|||
27850705|NCT01698775|81283002|FG001|Phase A|Lack of Efficacy|0|||
27850706|NCT01698775|81283001|FG000|Phase A|Lost to Follow-up|1|||
27850707|NCT01698775|81283002|FG001|Phase A|Lost to Follow-up|2|||
27850708|NCT01698775|81283001|FG000|Phase A|Protocol Violation|1|||
27850709|NCT01698775|81283002|FG001|Phase A|Protocol Violation|0|||
27850710|NCT01698775|81283001|FG000|Phase A|Withdrawal by Subject|3|||
27850711|NCT01698775|81283002|FG001|Phase A|Withdrawal by Subject|4|||
27850712|NCT01698775|81283001|FG000|Phase A|Kidney [transplant]|0|||
27850713|NCT01698775|81283002|FG001|Phase A|Kidney [transplant]|1|||
27850714|NCT01698775|81283001|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
27850715|NCT01698775|81283002|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
27850716|NCT01698775|81283001|FG000|Phase B|Adverse Event|6|||
27850717|NCT01698775|81283002|FG001|Phase B|Adverse Event|3|||
27850718|NCT01698775|81283001|FG000|Phase B|Death|0|||
27850719|NCT01698775|81283002|FG001|Phase B|Death|1|||
27850720|NCT01698775|81283001|FG000|Phase B|Lack of Efficacy|0|||
27850721|NCT01698775|81283002|FG001|Phase B|Lack of Efficacy|1|||
27850722|NCT01698775|81283001|FG000|Phase B|Lost to Follow-up|0|||
27850723|NCT01698775|81283002|FG001|Phase B|Lost to Follow-up|1|||
27850724|NCT01698775|81283001|FG000|Phase B|Physician Decision|1|||
27850725|NCT01698775|81283002|FG001|Phase B|Physician Decision|1|||
27850726|NCT01698775|81283001|FG000|Phase B|Protocol Violation|1|||
27850727|NCT01698775|81283002|FG001|Phase B|Protocol Violation|1|||
27850728|NCT01698775|81283001|FG000|Phase B|Withdrawal by Subject|6|||
27850729|NCT01698775|81283002|FG001|Phase B|Withdrawal by Subject|2|||
27850730|NCT01432574|81283003|FG000|Overall Study|Moved|2|||
27850731|NCT01432574|81283003|FG000|Overall Study|Not interested|1|||
27850732|NCT01301508|81283004|FG000|Overall Study|Withdrawal by Subject|1|||
27850733|NCT01301508|81283005|FG001|Overall Study|Withdrawal by Subject|2|||
27850734|NCT01301508|81283004|FG000|Overall Study|Lost to Follow-up|0|||
27850735|NCT01301508|81283005|FG001|Overall Study|Lost to Follow-up|1|||
27850736|NCT00876018|81283011|FG000|Overall Study|Lost to Follow-up|0|||
27850737|NCT00876018|81283012|FG001|Overall Study|Lost to Follow-up|1|||
27850738|NCT00876018|81283013|FG002|Overall Study|Lost to Follow-up|1|||
27850739|NCT00876018|81283011|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
27850740|NCT00876018|81283012|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
27850741|NCT00876018|81283013|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
27850742|NCT00809159|81283014|FG000|Part 1|Adverse Event|1|||
27850743|NCT00809159|81283015|FG001|Part 1|Adverse Event|1|||
27850744|NCT00809159|81283016|FG002|Part 1|Adverse Event|0|||
27850745|NCT00809159|81283017|FG003|Part 1|Adverse Event|0|||
27899214|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899215|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899216|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899217|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899218|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899219|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899220|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899221|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899222|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899223|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27899224|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
27899225|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
27899226|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
27899227|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899228|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899229|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899230|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899231|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899232|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899233|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899234|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899235|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899236|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899237|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27899238|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
27899239|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
27899240|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
27899241|NCT02326298|81465127|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899242|NCT02326298|81465128|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899243|NCT02326298|81465129|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899244|NCT02326298|81465130|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899245|NCT02326298|81465131|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899246|NCT02326298|81465132|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899247|NCT02326298|81465133|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899248|NCT02326298|81465134|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899249|NCT02326298|81465135|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899250|NCT02326298|81465136|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899251|NCT02326298|81465137|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27899252|NCT02326298|81465138|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
27899253|NCT02326298|81465139|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
27899254|NCT02326298|81465140|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
27899255|NCT00551161|81465141|FG000|Overall Study|Withdrawal by Subject|1|||
27899256|NCT02772276|81465147|FG000|Overall Study|Lost to Follow-up|0|||
27899257|NCT02772276|81465148|FG001|Overall Study|Lost to Follow-up|0|||
27899258|NCT02772276|81465149|FG002|Overall Study|Lost to Follow-up|0|||
27899259|NCT02772276|81465150|FG003|Overall Study|Lost to Follow-up|0|||
27899260|NCT02772276|81465151|FG004|Overall Study|Lost to Follow-up|0|||
27899261|NCT02772276|81465152|FG005|Overall Study|Lost to Follow-up|0|||
27614099|NCT03990363|80430136|FG003|Overall Study|Study terminated by sponsor|0|||
27850746|NCT00809159|81283018|FG004|Part 1|Adverse Event|0|||
27850747|NCT00809159|81283019|FG005|Part 1|Adverse Event|0|||
27850748|NCT00809159|81283014|FG000|Part 1|Lost to Follow-up|1|||
27850749|NCT00809159|81283015|FG001|Part 1|Lost to Follow-up|0|||
27850750|NCT00809159|81283016|FG002|Part 1|Lost to Follow-up|0|||
27850751|NCT00809159|81283017|FG003|Part 1|Lost to Follow-up|0|||
27850752|NCT00809159|81283018|FG004|Part 1|Lost to Follow-up|0|||
27850753|NCT00809159|81283019|FG005|Part 1|Lost to Follow-up|0|||
27850754|NCT00809159|81283014|FG000|Part 1|Withdrawal by Subject|3|||
27850755|NCT00809159|81283015|FG001|Part 1|Withdrawal by Subject|1|||
27850756|NCT00809159|81283016|FG002|Part 1|Withdrawal by Subject|0|||
27850757|NCT00809159|81283017|FG003|Part 1|Withdrawal by Subject|0|||
27850758|NCT00809159|81283018|FG004|Part 1|Withdrawal by Subject|0|||
27850759|NCT00809159|81283019|FG005|Part 1|Withdrawal by Subject|0|||
27850760|NCT00809159|81283014|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
27614100|NCT03990363|80430137|FG004|Overall Study|Study terminated by sponsor|0|||
27614101|NCT03990363|80430133|FG000|Overall Study|Site terminated by sponsor|2|||
27850761|NCT00809159|81283015|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
27850762|NCT00809159|81283016|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
27850763|NCT00809159|81283017|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
27899262|NCT02772276|81465153|FG006|Overall Study|Lost to Follow-up|1|||
27899263|NCT02772276|81465154|FG007|Overall Study|Lost to Follow-up|0|||
27899264|NCT02772276|81465155|FG008|Overall Study|Lost to Follow-up|0|||
27899265|NCT02772276|81465156|FG009|Overall Study|Lost to Follow-up|0|||
27899266|NCT02772276|81465157|FG010|Overall Study|Lost to Follow-up|0|||
27899267|NCT02772276|81465158|FG011|Overall Study|Lost to Follow-up|0|||
27899268|NCT02772276|81465159|FG012|Overall Study|Lost to Follow-up|0|||
27899269|NCT02772276|81465147|FG000|Overall Study|Withdrew consent|0|||
27899270|NCT02772276|81465148|FG001|Overall Study|Withdrew consent|0|||
27899271|NCT02772276|81465149|FG002|Overall Study|Withdrew consent|0|||
27899272|NCT02772276|81465150|FG003|Overall Study|Withdrew consent|0|||
27899273|NCT02772276|81465151|FG004|Overall Study|Withdrew consent|0|||
27899274|NCT02772276|81465152|FG005|Overall Study|Withdrew consent|0|||
27899275|NCT02772276|81465153|FG006|Overall Study|Withdrew consent|0|||
27899276|NCT02772276|81465154|FG007|Overall Study|Withdrew consent|1|||
27899277|NCT02772276|81465155|FG008|Overall Study|Withdrew consent|0|||
27899278|NCT02772276|81465156|FG009|Overall Study|Withdrew consent|0|||
27899279|NCT02772276|81465157|FG010|Overall Study|Withdrew consent|0|||
27899280|NCT02772276|81465158|FG011|Overall Study|Withdrew consent|0|||
27899281|NCT02772276|81465159|FG012|Overall Study|Withdrew consent|0|||
27899282|NCT01068626|81465160|FG000|Overall Study|Adverse Event|3|||
27899283|NCT01068626|81465161|FG001|Overall Study|Adverse Event|0|||
27899284|NCT01068626|81465160|FG000|Overall Study|Withdrawal by Subject|0|||
27899285|NCT01068626|81465161|FG001|Overall Study|Withdrawal by Subject|2|||
27899286|NCT03611582|81465162|FG000|Overall Study|Adverse Event|26|||
27850764|NCT00809159|81283018|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
27850765|NCT00809159|81283019|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
27850766|NCT00809159|81283014|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
27850767|NCT00809159|81283015|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
27850768|NCT00809159|81283016|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
27850769|NCT00809159|81283017|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
27850770|NCT00809159|81283018|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
27850771|NCT00809159|81283019|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
27850772|NCT00809159|81283014|FG000|Part 1 and 2|Administrative problems|0|||
27850773|NCT00809159|81283015|FG001|Part 1 and 2|Administrative problems|0|||
27850774|NCT00809159|81283016|FG002|Part 1 and 2|Administrative problems|0|||
27899287|NCT03611582|81465163|FG001|Overall Study|Adverse Event|6|||
27899288|NCT03611582|81465162|FG000|Overall Study|Protocol Violation|0|||
27899289|NCT03611582|81465163|FG001|Overall Study|Protocol Violation|1|||
27899290|NCT03611582|81465162|FG000|Overall Study|Pregnancy|1|||
27899291|NCT03611582|81465163|FG001|Overall Study|Pregnancy|2|||
27899292|NCT03611582|81465162|FG000|Overall Study|Lack of Efficacy|0|||
27899293|NCT03611582|81465163|FG001|Overall Study|Lack of Efficacy|1|||
27899294|NCT03611582|81465162|FG000|Overall Study|At the discretion of the investigator|1|||
27899295|NCT03611582|81465163|FG001|Overall Study|At the discretion of the investigator|0|||
27899296|NCT03611582|81465162|FG000|Overall Study|Safety concern as judged by the investigator|1|||
27899297|NCT03611582|81465163|FG001|Overall Study|Safety concern as judged by the investigator|2|||
27899298|NCT03611582|81465162|FG000|Overall Study|Withdrawal by Subject|4|||
27899299|NCT03611582|81465163|FG001|Overall Study|Withdrawal by Subject|3|||
27899300|NCT03611582|81465162|FG000|Overall Study|Lost to Follow-up|18|||
27899301|NCT03611582|81465163|FG001|Overall Study|Lost to Follow-up|7|||
27899302|NCT03611582|81465162|FG000|Overall Study|other|17|||
27899303|NCT03611582|81465163|FG001|Overall Study|other|16|||
27899304|NCT00539032|81465165|FG000|Overall Study|Withdrawal by Subject|2|||
27899305|NCT00539032|81465166|FG001|Overall Study|Withdrawal by Subject|1|||
27850775|NCT00809159|81283017|FG003|Part 1 and 2|Administrative problems|1|||
27850776|NCT00809159|81283018|FG004|Part 1 and 2|Administrative problems|0|||
27850777|NCT00809159|81283019|FG005|Part 1 and 2|Administrative problems|0|||
27850778|NCT00809159|81283014|FG000|Part 1 and 2|Adverse Event|0|||
27899306|NCT02920177|81465167|FG000|Overall Study|Withdrawal by Subject|1|||
27899307|NCT02920177|81465168|FG001|Overall Study|Withdrawal by Subject|1|||
27899308|NCT02920177|81465167|FG000|Overall Study|Physician Decision|1|||
27899309|NCT02920177|81465168|FG001|Overall Study|Physician Decision|0|||
27899310|NCT02920177|81465167|FG000|Overall Study|Lost to Follow-up|0|||
27899311|NCT02920177|81465168|FG001|Overall Study|Lost to Follow-up|1|||
27899312|NCT02045732|81465169|FG000|Overall Study|At the discretion of the investigator|1|||
27899313|NCT02045732|81465170|FG001|Overall Study|At the discretion of the investigator|1|||
27899314|NCT02243046|81465178|FG000|Overall Study|Lost to Follow-up|1|||
27899315|NCT02243046|81465179|FG001|Overall Study|Lost to Follow-up|1|||
27899316|NCT02243046|81465180|FG002|Overall Study|Lost to Follow-up|4|||
27899317|NCT02093390|81465181|FG000|Overall Study|Withdrawal by Subject|0|||
27899318|NCT02093390|81465182|FG001|Overall Study|Withdrawal by Subject|1|||
27899319|NCT01078298|81465183|FG000|Overall Study|Lost to Follow-up|12|||
27850779|NCT00809159|81283015|FG001|Part 1 and 2|Adverse Event|0|||
27850780|NCT00809159|81283016|FG002|Part 1 and 2|Adverse Event|1|||
27899320|NCT01078298|81465184|FG001|Overall Study|Lost to Follow-up|13|||
27899321|NCT01078298|81465183|FG000|Overall Study|Withdrawal by Subject|31|||
27899322|NCT01078298|81465184|FG001|Overall Study|Withdrawal by Subject|33|||
27899323|NCT01078298|81465183|FG000|Overall Study|Protocol Violation|6|||
27899324|NCT01078298|81465184|FG001|Overall Study|Protocol Violation|6|||
27899325|NCT01078298|81465183|FG000|Overall Study|Adverse Event|6|||
27899326|NCT01078298|81465184|FG001|Overall Study|Adverse Event|5|||
27899327|NCT01078298|81465183|FG000|Overall Study|Death|2|||
27899328|NCT01078298|81465184|FG001|Overall Study|Death|0|||
27899329|NCT01078298|81465183|FG000|Overall Study|Did not meet entrance criteria|0|||
27899330|NCT01078298|81465184|FG001|Overall Study|Did not meet entrance criteria|1|||
27899331|NCT01078298|81465183|FG000|Overall Study|Other|24|||
27899332|NCT01078298|81465184|FG001|Overall Study|Other|32|||
27899333|NCT05007041|81465185|FG000|Overall Study|Missing Diary Entries|0|||
27899334|NCT05007041|81465186|FG001|Overall Study|Missing Diary Entries|1|||
27899335|NCT04045132|81465190|FG000|Overall Study|Lost to Follow-up|3|||
27899336|NCT04045132|81465191|FG001|Overall Study|Lost to Follow-up|6|||
27899337|NCT00481767|81465192|FG000|Overall Study|Withdrawal by Subject|16|||
27899338|NCT00481767|81465193|FG001|Overall Study|Withdrawal by Subject|11|||
27899339|NCT00481767|81465192|FG000|Overall Study|Lost to Follow-up|16|||
27899340|NCT00481767|81465193|FG001|Overall Study|Lost to Follow-up|10|||
27899341|NCT02117713|81465195|FG000|Week 48|Adverse Event|4|||
27899342|NCT02117713|81465195|FG000|Week 48|Withdrawal by caregiver|2|||
27899343|NCT02117713|81465195|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
27899344|NCT02117713|81465195|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
27899345|NCT02117713|81465195|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
27899346|NCT02117713|81465195|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
27899347|NCT01702532|81465205|FG000|Overall Study|Adverse Event|0|||
27899348|NCT01702532|81465206|FG001|Overall Study|Adverse Event|1|||
27899349|NCT02685072|81465207|FG000|Treatment Period|Lost to Follow-up|12|||
27899350|NCT02685072|81465208|FG001|Treatment Period|Lost to Follow-up|6|||
27899351|NCT02685072|81465207|FG000|Treatment Period|Withdrawal by Subject|1|||
27899352|NCT02685072|81465208|FG001|Treatment Period|Withdrawal by Subject|3|||
27899353|NCT02685072|81465207|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
27899354|NCT02685072|81465208|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
27899355|NCT00958412|81465211|FG000|Overall Study|Study prematurely terminated|18|||
27850781|NCT00809159|81283017|FG003|Part 1 and 2|Adverse Event|0|||
27850782|NCT00809159|81283018|FG004|Part 1 and 2|Adverse Event|1|||
27850783|NCT00809159|81283019|FG005|Part 1 and 2|Adverse Event|1|||
27850784|NCT00809159|81283014|FG000|Part 1 and 2|Lost to Follow-up|0|||
27850785|NCT00809159|81283015|FG001|Part 1 and 2|Lost to Follow-up|0|||
27850786|NCT00809159|81283016|FG002|Part 1 and 2|Lost to Follow-up|1|||
27850787|NCT00809159|81283017|FG003|Part 1 and 2|Lost to Follow-up|1|||
27850788|NCT00809159|81283018|FG004|Part 1 and 2|Lost to Follow-up|0|||
27850789|NCT00809159|81283019|FG005|Part 1 and 2|Lost to Follow-up|0|||
27850790|NCT00809159|81283014|FG000|Part 1 and 2|Withdrawal by Subject|0|||
27850791|NCT00809159|81283015|FG001|Part 1 and 2|Withdrawal by Subject|0|||
27850792|NCT00809159|81283016|FG002|Part 1 and 2|Withdrawal by Subject|4|||
27850793|NCT00809159|81283017|FG003|Part 1 and 2|Withdrawal by Subject|0|||
27850794|NCT00809159|81283018|FG004|Part 1 and 2|Withdrawal by Subject|0|||
27850795|NCT00809159|81283019|FG005|Part 1 and 2|Withdrawal by Subject|1|||
27899356|NCT00379808|81465213|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
27899357|NCT00379808|81465214|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
27899358|NCT02949908|81465215|FG000|Overall Study|Study termination|2|||
27899359|NCT01473394|81465220|FG000|Overall Study|Adverse Event|13|||
27899360|NCT01473394|81465221|FG001|Overall Study|Adverse Event|16|||
27899361|NCT01473394|81465220|FG000|Overall Study|Insufficient Therapeutic Response|4|||
27899362|NCT01473394|81465221|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27899363|NCT01473394|81465220|FG000|Overall Study|Protocol Violation|7|||
27899364|NCT01473394|81465221|FG001|Overall Study|Protocol Violation|5|||
27850796|NCT01079832|81283020|FG000|Overall Study|Withdrawal by Subject|1|||
27899365|NCT01473394|81465220|FG000|Overall Study|Withdrew Consent|12|||
27899366|NCT01473394|81465221|FG001|Overall Study|Withdrew Consent|10|||
27899367|NCT01473394|81465220|FG000|Overall Study|Lost to Follow-up|9|||
27899368|NCT01473394|81465221|FG001|Overall Study|Lost to Follow-up|11|||
27727421|NCT00896532|80830243|FG022|Months 48-72: Follow-on Phase|Death|0|||
27727422|NCT00896532|80830221|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727423|NCT00896532|80830222|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727424|NCT00896532|80830223|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727425|NCT00896532|80830224|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727426|NCT00896532|80830225|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727427|NCT00896532|80830226|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727428|NCT00896532|80830227|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727429|NCT00896532|80830228|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727430|NCT00896532|80830229|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727431|NCT00896532|80830230|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727432|NCT00896532|80830231|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727433|NCT00896532|80830232|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727434|NCT00896532|80830233|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727435|NCT00896532|80830234|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727436|NCT00896532|80830235|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727437|NCT00896532|80830236|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727438|NCT00896532|80830237|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727439|NCT00896532|80830238|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727440|NCT00896532|80830239|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727441|NCT00896532|80830240|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727442|NCT00896532|80830241|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727443|NCT00896532|80830242|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
27727444|NCT00896532|80830243|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
27727445|NCT00896532|80830221|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727446|NCT00896532|80830222|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727447|NCT00896532|80830223|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727448|NCT00896532|80830224|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727449|NCT00896532|80830225|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727450|NCT00896532|80830226|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727451|NCT00896532|80830227|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727452|NCT00896532|80830228|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727453|NCT00896532|80830229|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727454|NCT00896532|80830230|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727455|NCT00896532|80830231|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727456|NCT00896532|80830232|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727457|NCT00896532|80830233|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727458|NCT00896532|80830234|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727459|NCT00896532|80830235|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727460|NCT00896532|80830236|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727461|NCT00896532|80830237|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727462|NCT00896532|80830238|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727463|NCT00896532|80830239|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727464|NCT00896532|80830240|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727465|NCT00896532|80830241|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727466|NCT00896532|80830242|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
27727467|NCT00896532|80830243|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
27727468|NCT00045032|80830244|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
27727469|NCT00045032|80830245|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
27727470|NCT00045032|80830246|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
27727471|NCT00045032|80830244|FG000|Overall Study|Death|22|||
27727472|NCT00045032|80830245|FG001|Overall Study|Death|24|||
27727473|NCT00045032|80830246|FG002|Overall Study|Death|17|||
27850797|NCT02914236|81283021|FG000|Overall Study|Lost to Follow-up|1|||
27850798|NCT04322149|81283024|FG000|Overall Study|Adverse Event|1|||
27850799|NCT04322149|81283025|FG001|Overall Study|Adverse Event|1|||
27850800|NCT04322149|81283026|FG002|Overall Study|Adverse Event|0|||
27850801|NCT04322149|81283027|FG003|Overall Study|Adverse Event|0|||
27850802|NCT04322149|81283024|FG000|Overall Study|Withdrawal by Subject|0|||
27727474|NCT00045032|80830244|FG000|Overall Study|Insufficient Therapeutic Response|542|||
27850803|NCT04322149|81283025|FG001|Overall Study|Withdrawal by Subject|0|||
27850804|NCT04322149|81283026|FG002|Overall Study|Withdrawal by Subject|0|||
27850805|NCT04322149|81283027|FG003|Overall Study|Withdrawal by Subject|2|||
27899369|NCT04245202|81465226|FG000|Overall Study|Lack of Efficacy|10|||
27899370|NCT04245202|81465227|FG001|Overall Study|Lack of Efficacy|1|||
27899371|NCT00334295|81465228|FG000|Overall Study|Patients received fewer than 3 injection|5|||
27899372|NCT01618916|81465229|FG000|Overall Study|Adverse Event|1|||
27899373|NCT01618916|81465230|FG001|Overall Study|Adverse Event|0|||
27899374|NCT01618916|81465231|FG002|Overall Study|Adverse Event|0|||
27899375|NCT01618916|81465232|FG003|Overall Study|Adverse Event|0|||
27899376|NCT01618916|81465233|FG004|Overall Study|Adverse Event|0|||
27899377|NCT01618916|81465234|FG005|Overall Study|Adverse Event|0|||
27899378|NCT01618916|81465229|FG000|Overall Study|Withdrawal by Subject|0|||
27899379|NCT01618916|81465230|FG001|Overall Study|Withdrawal by Subject|1|||
27899380|NCT01618916|81465231|FG002|Overall Study|Withdrawal by Subject|1|||
27899381|NCT01618916|81465232|FG003|Overall Study|Withdrawal by Subject|0|||
27899382|NCT01618916|81465233|FG004|Overall Study|Withdrawal by Subject|1|||
27899383|NCT01618916|81465234|FG005|Overall Study|Withdrawal by Subject|0|||
27899384|NCT01618916|81465229|FG000|Overall Study|Lost to Follow-up|1|||
27899385|NCT01618916|81465230|FG001|Overall Study|Lost to Follow-up|0|||
27899386|NCT01618916|81465231|FG002|Overall Study|Lost to Follow-up|0|||
27899387|NCT01618916|81465232|FG003|Overall Study|Lost to Follow-up|2|||
27899388|NCT01618916|81465233|FG004|Overall Study|Lost to Follow-up|0|||
27614102|NCT03990363|80430134|FG001|Overall Study|Site terminated by sponsor|1|||
27614103|NCT03990363|80430135|FG002|Overall Study|Site terminated by sponsor|2|||
27614104|NCT03990363|80430136|FG003|Overall Study|Site terminated by sponsor|0|||
27614105|NCT03990363|80430137|FG004|Overall Study|Site terminated by sponsor|2|||
27850806|NCT04322149|81283024|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
27850807|NCT04322149|81283025|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
27850808|NCT04322149|81283026|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
27850809|NCT04322149|81283027|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
27850810|NCT04146363|81283028|FG000|Induction Period|Adverse Event|1|||
27850811|NCT04146363|81283029|FG001|Induction Period|Adverse Event|2|||
27850812|NCT04146363|81283030|FG002|Induction Period|Adverse Event|0|||
27850813|NCT04146363|81283031|FG003|Induction Period|Adverse Event|0|||
27850814|NCT04146363|81283032|FG004|Induction Period|Adverse Event|0|||
27850815|NCT04146363|81283033|FG005|Induction Period|Adverse Event|0|||
27850816|NCT04146363|81283034|FG006|Induction Period|Adverse Event|0|||
27850817|NCT04146363|81283035|FG007|Induction Period|Adverse Event|0|||
27850818|NCT04146363|81283036|FG008|Induction Period|Adverse Event|0|||
27850819|NCT04146363|81283037|FG009|Induction Period|Adverse Event|0|||
27850820|NCT04146363|81283038|FG010|Induction Period|Adverse Event|0|||
27850821|NCT04146363|81283028|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
27850822|NCT04146363|81283029|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
27850823|NCT04146363|81283030|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
27850824|NCT04146363|81283031|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
27850825|NCT04146363|81283032|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
27850826|NCT04146363|81283033|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
27850827|NCT04146363|81283034|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
27850828|NCT04146363|81283035|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
27850829|NCT04146363|81283036|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
27850830|NCT04146363|81283037|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
27850831|NCT04146363|81283038|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
27850832|NCT04146363|81283028|FG000|Induction Period|Lack of Efficacy|7|||
27850833|NCT04146363|81283029|FG001|Induction Period|Lack of Efficacy|2|||
27850834|NCT04146363|81283030|FG002|Induction Period|Lack of Efficacy|0|||
27850835|NCT04146363|81283031|FG003|Induction Period|Lack of Efficacy|0|||
27850836|NCT04146363|81283032|FG004|Induction Period|Lack of Efficacy|0|||
27850837|NCT04146363|81283033|FG005|Induction Period|Lack of Efficacy|0|||
27850838|NCT04146363|81283034|FG006|Induction Period|Lack of Efficacy|0|||
27850839|NCT04146363|81283035|FG007|Induction Period|Lack of Efficacy|0|||
27850840|NCT04146363|81283036|FG008|Induction Period|Lack of Efficacy|0|||
27850841|NCT04146363|81283037|FG009|Induction Period|Lack of Efficacy|0|||
27850842|NCT04146363|81283038|FG010|Induction Period|Lack of Efficacy|0|||
27850843|NCT04146363|81283028|FG000|Induction Period|Lost to Follow-up|1|||
27850844|NCT04146363|81283029|FG001|Induction Period|Lost to Follow-up|4|||
27850845|NCT04146363|81283030|FG002|Induction Period|Lost to Follow-up|0|||
27850846|NCT04146363|81283031|FG003|Induction Period|Lost to Follow-up|0|||
27850847|NCT04146363|81283032|FG004|Induction Period|Lost to Follow-up|0|||
27850848|NCT04146363|81283033|FG005|Induction Period|Lost to Follow-up|0|||
27850849|NCT04146363|81283034|FG006|Induction Period|Lost to Follow-up|0|||
27850850|NCT04146363|81283035|FG007|Induction Period|Lost to Follow-up|0|||
27899389|NCT01618916|81465234|FG005|Overall Study|Lost to Follow-up|0|||
27899390|NCT00662558|81465238|FG000|Overall Study|Adverse Event|21|||
27899391|NCT00662558|81465239|FG001|Overall Study|Adverse Event|59|||
27899392|NCT00662558|81465238|FG000|Overall Study|Lack of Efficacy|4|||
27899393|NCT00662558|81465239|FG001|Overall Study|Lack of Efficacy|7|||
27899394|NCT00662558|81465238|FG000|Overall Study|Lost to Follow-up|13|||
27899395|NCT00662558|81465239|FG001|Overall Study|Lost to Follow-up|10|||
27899396|NCT00662558|81465238|FG000|Overall Study|Other|9|||
27614106|NCT03990363|80430133|FG000|Overall Study|Not categorized|5|||
27614107|NCT03990363|80430134|FG001|Overall Study|Not categorized|5|||
27614108|NCT03990363|80430135|FG002|Overall Study|Not categorized|3|||
27614109|NCT03990363|80430136|FG003|Overall Study|Not categorized|2|||
27899397|NCT00662558|81465239|FG001|Overall Study|Other|14|||
27899398|NCT00662558|81465238|FG000|Overall Study|Withdrawal by Subject|7|||
27899399|NCT00662558|81465239|FG001|Overall Study|Withdrawal by Subject|12|||
27899400|NCT00662558|81465238|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
27899401|NCT00662558|81465239|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
27899402|NCT01267201|81465242|FG000|First Intervention Period|Withdrawal by Subject|1|||
27899403|NCT01267201|81465243|FG001|First Intervention Period|Withdrawal by Subject|0|||
27899404|NCT01267201|81465244|FG002|First Intervention Period|Withdrawal by Subject|0|||
27899405|NCT01267201|81465245|FG003|First Intervention Period|Withdrawal by Subject|0|||
27899406|NCT01267201|81465246|FG004|First Intervention Period|Withdrawal by Subject|0|||
27899407|NCT01267201|81465247|FG005|First Intervention Period|Withdrawal by Subject|0|||
27899408|NCT01267201|81465242|FG000|Second Intervention Period|Withdrawal by Subject|0|||
27899409|NCT01267201|81465243|FG001|Second Intervention Period|Withdrawal by Subject|1|||
27899410|NCT01267201|81465244|FG002|Second Intervention Period|Withdrawal by Subject|0|||
27899411|NCT01267201|81465245|FG003|Second Intervention Period|Withdrawal by Subject|0|||
27899412|NCT01267201|81465246|FG004|Second Intervention Period|Withdrawal by Subject|0|||
27899413|NCT01267201|81465247|FG005|Second Intervention Period|Withdrawal by Subject|0|||
27899414|NCT02631070|81469166|FG000|Overall Study|Withdrawal by Subject|35|||
27899415|NCT02631070|81469167|FG001|Overall Study|Withdrawal by Subject|13|||
27899416|NCT02631070|81469166|FG000|Overall Study|Death|45|||
27899417|NCT02631070|81469167|FG001|Overall Study|Death|24|||
27899418|NCT02631070|81469166|FG000|Overall Study|Lost to Follow-up|5|||
27899419|NCT02631070|81469167|FG001|Overall Study|Lost to Follow-up|1|||
27899420|NCT02631070|81469166|FG000|Overall Study|Transition to rollover protocol|52|||
27899421|NCT02631070|81469167|FG001|Overall Study|Transition to rollover protocol|21|||
27899422|NCT02631070|81469166|FG000|Overall Study|Other reasons|12|||
27899423|NCT02631070|81469167|FG001|Overall Study|Other reasons|5|||
27614110|NCT03990363|80430137|FG004|Overall Study|Not categorized|2|||
27850851|NCT04146363|81283036|FG008|Induction Period|Lost to Follow-up|0|||
27850852|NCT04146363|81283037|FG009|Induction Period|Lost to Follow-up|0|||
27850853|NCT04146363|81283038|FG010|Induction Period|Lost to Follow-up|0|||
27850854|NCT04146363|81283028|FG000|Induction Period|Positive quantiferon test|0|||
27850855|NCT04146363|81283029|FG001|Induction Period|Positive quantiferon test|1|||
27850856|NCT04146363|81283030|FG002|Induction Period|Positive quantiferon test|0|||
27850857|NCT04146363|81283031|FG003|Induction Period|Positive quantiferon test|0|||
27850858|NCT04146363|81283032|FG004|Induction Period|Positive quantiferon test|0|||
27850859|NCT04146363|81283033|FG005|Induction Period|Positive quantiferon test|0|||
27850860|NCT04146363|81283034|FG006|Induction Period|Positive quantiferon test|0|||
27850861|NCT04146363|81283035|FG007|Induction Period|Positive quantiferon test|0|||
27850862|NCT04146363|81283036|FG008|Induction Period|Positive quantiferon test|0|||
27850863|NCT04146363|81283037|FG009|Induction Period|Positive quantiferon test|0|||
27850864|NCT04146363|81283038|FG010|Induction Period|Positive quantiferon test|0|||
27850865|NCT04146363|81283028|FG000|Induction Period|Protocol Deviation|5|||
27850866|NCT04146363|81283029|FG001|Induction Period|Protocol Deviation|6|||
27850867|NCT04146363|81283030|FG002|Induction Period|Protocol Deviation|0|||
27850868|NCT04146363|81283031|FG003|Induction Period|Protocol Deviation|0|||
27850869|NCT04146363|81283032|FG004|Induction Period|Protocol Deviation|0|||
27850870|NCT04146363|81283033|FG005|Induction Period|Protocol Deviation|0|||
27850871|NCT04146363|81283034|FG006|Induction Period|Protocol Deviation|0|||
27850872|NCT04146363|81283035|FG007|Induction Period|Protocol Deviation|0|||
27850873|NCT04146363|81283036|FG008|Induction Period|Protocol Deviation|0|||
27850874|NCT04146363|81283037|FG009|Induction Period|Protocol Deviation|0|||
27850875|NCT04146363|81283038|FG010|Induction Period|Protocol Deviation|0|||
27850876|NCT04146363|81283028|FG000|Induction Period|Withdrawal by Subject|6|||
27850877|NCT04146363|81283029|FG001|Induction Period|Withdrawal by Subject|3|||
27850878|NCT04146363|81283030|FG002|Induction Period|Withdrawal by Subject|0|||
27850879|NCT04146363|81283031|FG003|Induction Period|Withdrawal by Subject|0|||
27850880|NCT04146363|81283032|FG004|Induction Period|Withdrawal by Subject|0|||
27850881|NCT04146363|81283033|FG005|Induction Period|Withdrawal by Subject|0|||
27850882|NCT04146363|81283034|FG006|Induction Period|Withdrawal by Subject|0|||
27850883|NCT04146363|81283035|FG007|Induction Period|Withdrawal by Subject|0|||
27899424|NCT00553358|81469174|FG000|Overall Study|Randomized but did not receive treatment|3|||
27899425|NCT00553358|81469175|FG001|Overall Study|Randomized but did not receive treatment|3|||
27614111|NCT01558674|80430138|FG000|Part 1|Study Terminated by Sponsor|10|||
27850884|NCT04146363|81283036|FG008|Induction Period|Withdrawal by Subject|0|||
27850885|NCT04146363|81283037|FG009|Induction Period|Withdrawal by Subject|0|||
27850886|NCT04146363|81283038|FG010|Induction Period|Withdrawal by Subject|0|||
27850887|NCT04146363|81283028|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850888|NCT04146363|81283029|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
27899426|NCT00553358|81469176|FG002|Overall Study|Randomized but did not receive treatment|1|||
27899427|NCT00553358|81469174|FG000|Overall Study|Lost to Follow-up|22|||
27899428|NCT00553358|81469175|FG001|Overall Study|Lost to Follow-up|26|||
27899429|NCT00553358|81469176|FG002|Overall Study|Lost to Follow-up|18|||
27899430|NCT00553358|81469174|FG000|Overall Study|Withdrew completely|23|||
27899431|NCT00553358|81469175|FG001|Overall Study|Withdrew completely|33|||
27899432|NCT00553358|81469176|FG002|Overall Study|Withdrew completely|34|||
27899433|NCT00553358|81469174|FG000|Overall Study|Died during clinical follow-up|25|||
27899434|NCT00553358|81469175|FG001|Overall Study|Died during clinical follow-up|29|||
27899435|NCT00553358|81469176|FG002|Overall Study|Died during clinical follow-up|32|||
27899436|NCT00553358|81469174|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
27899437|NCT00553358|81469175|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
27899438|NCT00553358|81469176|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
27899439|NCT00553358|81469174|FG000|Overall Study|Died after clinical follow-up ended|1|||
27899440|NCT00553358|81469175|FG001|Overall Study|Died after clinical follow-up ended|2|||
27899441|NCT00553358|81469176|FG002|Overall Study|Died after clinical follow-up ended|0|||
27899442|NCT00553358|81469174|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
27899443|NCT00553358|81469175|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
27899444|NCT00553358|81469176|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
27899445|NCT02073656|81469177|FG000|Primary Study|Lost to Follow-up|6|||
27899446|NCT02073656|81469177|FG000|Primary Study|Death|1|||
27899447|NCT02073656|81469177|FG000|Primary Study|Withdrew Consent|1|||
27899448|NCT02612610|81469178|FG000|Overall Study|Withdrawal by Subject|1|||
27899449|NCT02612610|81469179|FG001|Overall Study|Withdrawal by Subject|1|||
27899450|NCT02612610|81469180|FG002|Overall Study|Withdrawal by Subject|0|||
27899451|NCT02612610|81469181|FG003|Overall Study|Withdrawal by Subject|2|||
27899452|NCT02612610|81469178|FG000|Overall Study|Adverse Event|2|||
27899453|NCT02612610|81469179|FG001|Overall Study|Adverse Event|2|||
27899454|NCT02612610|81469180|FG002|Overall Study|Adverse Event|3|||
27899455|NCT02612610|81469181|FG003|Overall Study|Adverse Event|10|||
27899456|NCT02612610|81469178|FG000|Overall Study|Lost to Follow-up|0|||
27899457|NCT02612610|81469179|FG001|Overall Study|Lost to Follow-up|1|||
27899458|NCT02612610|81469180|FG002|Overall Study|Lost to Follow-up|0|||
27899459|NCT02612610|81469181|FG003|Overall Study|Lost to Follow-up|0|||
27899460|NCT02612610|81469178|FG000|Overall Study|Protocol Violation|0|||
27899461|NCT02612610|81469179|FG001|Overall Study|Protocol Violation|1|||
27899462|NCT02612610|81469180|FG002|Overall Study|Protocol Violation|1|||
27899463|NCT02612610|81469181|FG003|Overall Study|Protocol Violation|0|||
27899464|NCT02612610|81469178|FG000|Overall Study|Lack of Efficacy|1|||
27899465|NCT02612610|81469179|FG001|Overall Study|Lack of Efficacy|2|||
27899466|NCT02612610|81469180|FG002|Overall Study|Lack of Efficacy|0|||
27614112|NCT01558674|80430139|FG001|Part 1|Study Terminated by Sponsor|0|||
27614113|NCT01558674|80430138|FG000|Part 1|Withdrawal by Subject|1|||
27614114|NCT01558674|80430139|FG001|Part 1|Withdrawal by Subject|0|||
27614115|NCT01751113|80430140|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27614116|NCT01751113|80430141|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27614117|NCT01751113|80430142|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27614118|NCT01751113|80430143|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
27614119|NCT01751113|80430144|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
27614120|NCT01751113|80430145|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27614121|NCT01751113|80430140|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27614122|NCT01751113|80430141|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27614123|NCT01751113|80430142|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27614124|NCT01751113|80430143|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27614125|NCT01751113|80430144|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
27614126|NCT01751113|80430145|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
27614127|NCT02533258|80430146|FG000|Overall Study|Adverse Event|1|||
27614128|NCT02533258|80430146|FG000|Overall Study|Death|2|||
27614129|NCT02533258|80430146|FG000|Overall Study|Other|1|||
27614130|NCT02533258|80430146|FG000|Overall Study|Economic factor|1|||
27899467|NCT02612610|81469181|FG003|Overall Study|Lack of Efficacy|1|||
27614131|NCT02533258|80430146|FG000|Overall Study|Progression of pleural effusion|1|||
27614132|NCT02533258|80430146|FG000|Overall Study|Lack of Efficacy|2|||
27614133|NCT01592695|80430147|FG000|Overall Study|Lost to Follow-up|8|||
27899468|NCT02612610|81469178|FG000|Overall Study|Physician Decision|0|||
27899469|NCT02612610|81469179|FG001|Overall Study|Physician Decision|1|||
27899470|NCT02612610|81469180|FG002|Overall Study|Physician Decision|0|||
27899471|NCT02612610|81469181|FG003|Overall Study|Physician Decision|0|||
27899472|NCT02612610|81469178|FG000|Overall Study|Noncompliance|1|||
27899473|NCT02612610|81469179|FG001|Overall Study|Noncompliance|0|||
27899474|NCT02612610|81469180|FG002|Overall Study|Noncompliance|0|||
27899475|NCT02612610|81469181|FG003|Overall Study|Noncompliance|0|||
27899476|NCT02612610|81469178|FG000|Overall Study|Cough Improvement|0|||
27899477|NCT02612610|81469179|FG001|Overall Study|Cough Improvement|0|||
27899478|NCT02612610|81469180|FG002|Overall Study|Cough Improvement|1|||
27899479|NCT02612610|81469181|FG003|Overall Study|Cough Improvement|0|||
27899480|NCT01554176|81469182|FG000|Treatment Phase|Protocol Violation|1|||
27899481|NCT01554176|81469183|FG001|Treatment Phase|Protocol Violation|2|||
27899482|NCT01554176|81469184|FG002|Treatment Phase|Protocol Violation|0|||
27899483|NCT01554176|81469185|FG003|Treatment Phase|Protocol Violation|0|||
27899484|NCT01554176|81469186|FG004|Treatment Phase|Protocol Violation|0|||
27899485|NCT01554176|81469182|FG000|Treatment Phase|Physician Decision|1|||
27899486|NCT01554176|81469183|FG001|Treatment Phase|Physician Decision|1|||
27899487|NCT01554176|81469184|FG002|Treatment Phase|Physician Decision|0|||
27899488|NCT01554176|81469185|FG003|Treatment Phase|Physician Decision|0|||
27899489|NCT01554176|81469186|FG004|Treatment Phase|Physician Decision|0|||
27899490|NCT01554176|81469182|FG000|Treatment Phase|Lack of Efficacy|0|||
27899491|NCT01554176|81469183|FG001|Treatment Phase|Lack of Efficacy|1|||
27899492|NCT01554176|81469184|FG002|Treatment Phase|Lack of Efficacy|0|||
27899493|NCT01554176|81469185|FG003|Treatment Phase|Lack of Efficacy|0|||
27899494|NCT01554176|81469186|FG004|Treatment Phase|Lack of Efficacy|0|||
27899495|NCT01554176|81469182|FG000|Treatment Phase|Adverse event, non-fatal|1|||
27899496|NCT01554176|81469183|FG001|Treatment Phase|Adverse event, non-fatal|1|||
27899497|NCT01554176|81469184|FG002|Treatment Phase|Adverse event, non-fatal|0|||
27899498|NCT01554176|81469185|FG003|Treatment Phase|Adverse event, non-fatal|0|||
27899499|NCT01554176|81469186|FG004|Treatment Phase|Adverse event, non-fatal|0|||
27899500|NCT01554176|81469182|FG000|Treatment Phase|Non-compliance with study drug|1|||
27899501|NCT01554176|81469183|FG001|Treatment Phase|Non-compliance with study drug|0|||
27899502|NCT01554176|81469184|FG002|Treatment Phase|Non-compliance with study drug|0|||
27899503|NCT01554176|81469185|FG003|Treatment Phase|Non-compliance with study drug|0|||
27899504|NCT01554176|81469186|FG004|Treatment Phase|Non-compliance with study drug|0|||
27899505|NCT01554176|81469182|FG000|Treatment Phase|Withdrawal by Subject|1|||
27899506|NCT01554176|81469183|FG001|Treatment Phase|Withdrawal by Subject|0|||
27899507|NCT01554176|81469184|FG002|Treatment Phase|Withdrawal by Subject|0|||
27899508|NCT01554176|81469185|FG003|Treatment Phase|Withdrawal by Subject|0|||
27899509|NCT01554176|81469186|FG004|Treatment Phase|Withdrawal by Subject|0|||
27899510|NCT01554176|81469182|FG000|Treatment Phase|Lost to Follow-up|3|||
27899511|NCT01554176|81469183|FG001|Treatment Phase|Lost to Follow-up|0|||
27899512|NCT01554176|81469184|FG002|Treatment Phase|Lost to Follow-up|0|||
27899513|NCT01554176|81469185|FG003|Treatment Phase|Lost to Follow-up|0|||
27899514|NCT01554176|81469186|FG004|Treatment Phase|Lost to Follow-up|0|||
27899515|NCT01554176|81469182|FG000|Run-out Phase|Protocol Violation|0|||
27899516|NCT01554176|81469183|FG001|Run-out Phase|Protocol Violation|0|||
27899517|NCT01554176|81469184|FG002|Run-out Phase|Protocol Violation|0|||
27899518|NCT01554176|81469185|FG003|Run-out Phase|Protocol Violation|1|||
27899519|NCT01554176|81469186|FG004|Run-out Phase|Protocol Violation|0|||
27899520|NCT00312572|81469187|FG000|Overall Study|Adverse Event|10|||
27899521|NCT00312572|81469188|FG001|Overall Study|Adverse Event|16|||
27899522|NCT00312572|81469187|FG000|Overall Study|Lost to Follow-up|1|||
27899523|NCT00312572|81469188|FG001|Overall Study|Lost to Follow-up|1|||
27899524|NCT00312572|81469187|FG000|Overall Study|Administrative|4|||
27899525|NCT00312572|81469188|FG001|Overall Study|Administrative|2|||
27899526|NCT00312572|81469187|FG000|Overall Study|Lack of Efficacy|1|||
27899527|NCT00312572|81469188|FG001|Overall Study|Lack of Efficacy|2|||
27899528|NCT00738062|81469193|FG000|Open Label Treatment|Lack of Efficacy|5|||
27899529|NCT00738062|81469194|FG001|Open Label Treatment|Lack of Efficacy|0|||
27899530|NCT00738062|81469195|FG002|Open Label Treatment|Lack of Efficacy|0|||
27899531|NCT00738062|81469193|FG000|Open Label Treatment|Adverse Event|11|||
27899532|NCT00738062|81469194|FG001|Open Label Treatment|Adverse Event|0|||
27614134|NCT01592695|80430148|FG001|Overall Study|Lost to Follow-up|4|||
27614135|NCT02878213|80430149|FG000|Overall Study|Withdrawal by Subject|2|||
27727475|NCT00045032|80830245|FG001|Overall Study|Insufficient Therapeutic Response|437|||
27727476|NCT00045032|80830246|FG002|Overall Study|Insufficient Therapeutic Response|445|||
27614136|NCT02878213|80430149|FG000|Overall Study|Adverse Event|1|||
27899533|NCT00738062|81469195|FG002|Open Label Treatment|Adverse Event|0|||
27899534|NCT00738062|81469193|FG000|Open Label Treatment|Protocol Violation|2|||
27899535|NCT00738062|81469194|FG001|Open Label Treatment|Protocol Violation|0|||
27899536|NCT00738062|81469195|FG002|Open Label Treatment|Protocol Violation|0|||
27899537|NCT00738062|81469193|FG000|Open Label Treatment|Withdrawal by Subject|9|||
27899538|NCT00738062|81469194|FG001|Open Label Treatment|Withdrawal by Subject|0|||
27899539|NCT00738062|81469195|FG002|Open Label Treatment|Withdrawal by Subject|0|||
27899540|NCT00738062|81469193|FG000|Open Label Treatment|Investigator Decision|1|||
27899541|NCT00738062|81469194|FG001|Open Label Treatment|Investigator Decision|0|||
27899542|NCT00738062|81469195|FG002|Open Label Treatment|Investigator Decision|0|||
27899543|NCT00738062|81469193|FG000|Open-Label Extension|Adverse Event|5|||
27899544|NCT00738062|81469194|FG001|Open-Label Extension|Adverse Event|0|||
27899545|NCT00738062|81469195|FG002|Open-Label Extension|Adverse Event|0|||
27899546|NCT00738062|81469193|FG000|Open-Label Extension|Physician Decision|1|||
27899547|NCT00738062|81469194|FG001|Open-Label Extension|Physician Decision|0|||
27899548|NCT00738062|81469195|FG002|Open-Label Extension|Physician Decision|0|||
27899549|NCT00738062|81469193|FG000|Open-Label Extension|Lack of Efficacy|2|||
27899550|NCT00738062|81469194|FG001|Open-Label Extension|Lack of Efficacy|0|||
27899551|NCT00738062|81469195|FG002|Open-Label Extension|Lack of Efficacy|0|||
27899552|NCT00738062|81469193|FG000|Open-Label Extension|Withdrawal by Subject|6|||
27899553|NCT00738062|81469194|FG001|Open-Label Extension|Withdrawal by Subject|0|||
27899554|NCT00738062|81469195|FG002|Open-Label Extension|Withdrawal by Subject|0|||
27899555|NCT00738062|81469193|FG000|Open-Label Extension|Protocol Violation|1|||
27899556|NCT00738062|81469194|FG001|Open-Label Extension|Protocol Violation|0|||
27899557|NCT00738062|81469195|FG002|Open-Label Extension|Protocol Violation|0|||
27899558|NCT00738062|81469193|FG000|Open-Label Extension|Study Terminated|2|||
27899559|NCT00738062|81469194|FG001|Open-Label Extension|Study Terminated|0|||
27899560|NCT00738062|81469195|FG002|Open-Label Extension|Study Terminated|0|||
27899561|NCT03114657|81469196|FG000|Overall Study|Adverse Event|9|||
27899562|NCT03114657|81469197|FG001|Overall Study|Adverse Event|6|||
27899563|NCT03114657|81469196|FG000|Overall Study|Death|4|||
27899564|NCT03114657|81469197|FG001|Overall Study|Death|0|||
27899565|NCT03114657|81469196|FG000|Overall Study|Multiple Reasons|1|||
27899566|NCT03114657|81469197|FG001|Overall Study|Multiple Reasons|2|||
27899567|NCT03114657|81469196|FG000|Overall Study|Physician Decision|2|||
27899568|NCT03114657|81469197|FG001|Overall Study|Physician Decision|2|||
27899569|NCT03114657|81469196|FG000|Overall Study|Study Terminated By Sponsor|355|||
27899570|NCT03114657|81469197|FG001|Overall Study|Study Terminated By Sponsor|374|||
27899571|NCT03114657|81469196|FG000|Overall Study|Symptomatic Deterioration|0|||
27899572|NCT03114657|81469197|FG001|Overall Study|Symptomatic Deterioration|1|||
27899573|NCT03114657|81469196|FG000|Overall Study|Withdrawal by Subject|28|||
27899574|NCT03114657|81469197|FG001|Overall Study|Withdrawal by Subject|22|||
27899575|NCT03391232|81469200|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
27899576|NCT03391232|81469201|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
27899577|NCT03391232|81469200|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
27899578|NCT03391232|81469201|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
27899579|NCT01333956|81469204|FG000|Overall Study|Lost to Follow-up|1|||
27899580|NCT01333956|81469205|FG001|Overall Study|Lost to Follow-up|2|||
27899581|NCT01333956|81469206|FG002|Overall Study|Lost to Follow-up|0|||
27506242|NCT01106690|80044308|FG002|Core Period: Baseline to Week 26|Other|6|||
27506243|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27506244|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27506245|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
27506246|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27506247|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27899582|NCT01333956|81469207|FG003|Overall Study|Lost to Follow-up|1|||
27899583|NCT01333956|81469204|FG000|Overall Study|Unable to complete study procedure|1|||
27899584|NCT01333956|81469205|FG001|Overall Study|Unable to complete study procedure|0|||
27899585|NCT01333956|81469206|FG002|Overall Study|Unable to complete study procedure|0|||
27899586|NCT01333956|81469207|FG003|Overall Study|Unable to complete study procedure|1|||
27899587|NCT01333956|81469204|FG000|Overall Study|Withdrawal by Subject|0|||
27899588|NCT01333956|81469205|FG001|Overall Study|Withdrawal by Subject|2|||
27899589|NCT01333956|81469206|FG002|Overall Study|Withdrawal by Subject|1|||
27899590|NCT01333956|81469207|FG003|Overall Study|Withdrawal by Subject|0|||
27899591|NCT01632150|81469208|FG000|Overall Study|Disease progression|27|||
27899592|NCT01632150|81469208|FG000|Overall Study|Study drug toxicity|1|||
27899593|NCT01632150|81469208|FG000|Overall Study|Unrelated adverse event|7|||
27899594|NCT01632150|81469208|FG000|Overall Study|Withdrawal by Subject|2|||
27899595|NCT01632150|81469208|FG000|Overall Study|Patient underwent autologous transplant|1|||
27899596|NCT01632150|81469208|FG000|Overall Study|Moved to compassionate program|2|||
27899597|NCT01259375|81469211|FG000|Overall Study|Adverse Event|1|||
27899598|NCT01987232|81469212|FG000|Overall Study|Ongoing in Study|0|||
27899599|NCT01987232|81469213|FG001|Overall Study|Ongoing in Study|0|||
27899600|NCT01987232|81469214|FG002|Overall Study|Ongoing in Study|0|||
27506248|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27506249|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27899601|NCT01987232|81469215|FG003|Overall Study|Ongoing in Study|1|||
27899602|NCT01987232|81469216|FG004|Overall Study|Ongoing in Study|0|||
27899603|NCT02552888|81469219|FG000|Overall Study|Lost to Follow-up|1|||
27899604|NCT02552888|81469220|FG001|Overall Study|Lost to Follow-up|1|||
27899605|NCT05020366|81469223|FG000|Overall Study|Lost to Follow-up|2|||
27899606|NCT05020366|81469224|FG001|Overall Study|Lost to Follow-up|0|||
27899607|NCT05020366|81469223|FG000|Overall Study|Withdrawal by Subject|2|||
27899608|NCT05020366|81469224|FG001|Overall Study|Withdrawal by Subject|0|||
27899609|NCT00862459|81469226|FG000|Overall Study|Lost to Follow-up|1|||
27899610|NCT00862459|81469227|FG001|Overall Study|Lost to Follow-up|2|||
27899611|NCT00862459|81469228|FG002|Overall Study|Lost to Follow-up|2|||
27899612|NCT00862459|81469226|FG000|Overall Study|Protocol Violation|1|||
27899613|NCT00862459|81469227|FG001|Overall Study|Protocol Violation|0|||
27899614|NCT00862459|81469228|FG002|Overall Study|Protocol Violation|0|||
27899615|NCT00862459|81469226|FG000|Overall Study|Withdrawal by Subject|1|||
27899616|NCT00862459|81469227|FG001|Overall Study|Withdrawal by Subject|1|||
27899617|NCT00862459|81469228|FG002|Overall Study|Withdrawal by Subject|3|||
27899618|NCT00862459|81469226|FG000|Overall Study|Adverse Event|0|||
27899619|NCT00862459|81469227|FG001|Overall Study|Adverse Event|1|||
27727477|NCT00045032|80830244|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
27850889|NCT04146363|81283030|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850890|NCT04146363|81283031|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850891|NCT04146363|81283032|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850892|NCT04146363|81283033|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850893|NCT04146363|81283034|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
27850894|NCT04146363|81283035|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
27850895|NCT04146363|81283036|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850896|NCT04146363|81283037|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850897|NCT04146363|81283038|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
27850898|NCT04146363|81283028|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850899|NCT04146363|81283029|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850900|NCT04146363|81283030|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850901|NCT04146363|81283031|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850902|NCT04146363|81283032|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850903|NCT04146363|81283033|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850904|NCT04146363|81283034|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850905|NCT04146363|81283035|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
27850906|NCT04146363|81283036|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850907|NCT04146363|81283037|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850908|NCT04146363|81283038|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
27850909|NCT04146363|81283028|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850910|NCT04146363|81283029|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850911|NCT04146363|81283030|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850912|NCT04146363|81283031|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850913|NCT04146363|81283032|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850914|NCT04146363|81283033|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850915|NCT04146363|81283034|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
27850916|NCT04146363|81283035|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
27850917|NCT04146363|81283036|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850918|NCT04146363|81283037|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850919|NCT04146363|81283038|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
27850920|NCT04146363|81283028|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850921|NCT04146363|81283029|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850922|NCT04146363|81283030|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
27850923|NCT04146363|81283031|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850924|NCT04146363|81283032|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850925|NCT04146363|81283033|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
27850926|NCT04146363|81283034|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850927|NCT04146363|81283035|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850928|NCT04146363|81283036|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
27727478|NCT00045032|80830245|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
27899620|NCT00862459|81469228|FG002|Overall Study|Adverse Event|0|||
27899621|NCT00862459|81469226|FG000|Overall Study|Personal reasons|1|||
27899622|NCT00862459|81469227|FG001|Overall Study|Personal reasons|0|||
27899623|NCT00862459|81469228|FG002|Overall Study|Personal reasons|0|||
27899624|NCT00862459|81469226|FG000|Overall Study|Operation|1|||
27899625|NCT00862459|81469227|FG001|Overall Study|Operation|1|||
27899626|NCT00862459|81469228|FG002|Overall Study|Operation|0|||
27899627|NCT00862459|81469226|FG000|Overall Study|Intravenous (IV) site problems|1|||
27899628|NCT00862459|81469227|FG001|Overall Study|Intravenous (IV) site problems|0|||
27899629|NCT00862459|81469228|FG002|Overall Study|Intravenous (IV) site problems|1|||
27899630|NCT00862459|81469226|FG000|Overall Study|Unable to hold still for imaging|0|||
27899631|NCT00862459|81469227|FG001|Overall Study|Unable to hold still for imaging|1|||
27899632|NCT00862459|81469228|FG002|Overall Study|Unable to hold still for imaging|0|||
27899633|NCT00862459|81469226|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
27899634|NCT00862459|81469227|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
27899635|NCT00862459|81469228|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
27899636|NCT00862459|81469226|FG000|Overall Study|Administrative problems|0|||
27899637|NCT00862459|81469227|FG001|Overall Study|Administrative problems|1|||
27899638|NCT00862459|81469228|FG002|Overall Study|Administrative problems|0|||
27899639|NCT00568334|81469230|FG000|Overall Study|Withdrawal by Subject|0|||
27899640|NCT00568334|81469231|FG001|Overall Study|Withdrawal by Subject|1|||
27899641|NCT00568334|81469230|FG000|Overall Study|Lost to Follow-up|1|||
27899642|NCT00568334|81469231|FG001|Overall Study|Lost to Follow-up|0|||
27899643|NCT02539134|81469232|FG000|Overall Study|Lost to Follow-up|1|||
27899644|NCT02539134|81469233|FG001|Overall Study|Lost to Follow-up|0|||
27899645|NCT02539134|81469234|FG002|Overall Study|Lost to Follow-up|0|||
27899646|NCT02539134|81469235|FG003|Overall Study|Lost to Follow-up|0|||
27899647|NCT02539134|81469236|FG004|Overall Study|Lost to Follow-up|0|||
27899648|NCT02539134|81469237|FG005|Overall Study|Lost to Follow-up|0|||
27899649|NCT01969084|81469244|FG000|Overall Study|Adverse Event|0|||
27899650|NCT01969084|81469245|FG001|Overall Study|Adverse Event|1|||
27899651|NCT04686266|81469246|FG000|Overall Study|Withdrawal by Subject|0|||
27899652|NCT04686266|81469247|FG001|Overall Study|Withdrawal by Subject|1|||
27899653|NCT04150068|81469248|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
27899654|NCT04150068|81469249|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
27899655|NCT04150068|81469250|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
27899656|NCT04150068|81469248|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
27899657|NCT04150068|81469249|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
27899658|NCT04150068|81469250|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
27899659|NCT00337779|81469251|FG000|Overall Study|Withdrawal by Subject|10|||
27899660|NCT00337779|81469252|FG001|Overall Study|Withdrawal by Subject|12|||
27899661|NCT00337779|81469251|FG000|Overall Study|Sponsor decision|1|||
27899662|NCT00337779|81469252|FG001|Overall Study|Sponsor decision|1|||
27899663|NCT00337779|81469251|FG000|Overall Study|Physician Decision|3|||
27850929|NCT04146363|81283037|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850930|NCT04146363|81283038|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
27850931|NCT04146363|81283028|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850932|NCT04146363|81283029|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850933|NCT04146363|81283030|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850934|NCT04146363|81283031|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850935|NCT04146363|81283032|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
27850936|NCT04146363|81283033|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
27850937|NCT04146363|81283034|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
27850938|NCT04146363|81283035|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
27850939|NCT04146363|81283036|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850940|NCT04146363|81283037|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27850941|NCT04146363|81283038|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
27899664|NCT00337779|81469252|FG001|Overall Study|Physician Decision|6|||
27899665|NCT00337779|81469251|FG000|Overall Study|Protocol Violation|1|||
27899666|NCT00337779|81469252|FG001|Overall Study|Protocol Violation|1|||
27899667|NCT00337779|81469251|FG000|Overall Study|Lost to Follow-up|6|||
27899668|NCT00337779|81469252|FG001|Overall Study|Lost to Follow-up|5|||
27899669|NCT00337779|81469251|FG000|Overall Study|Adverse Event|28|||
27899670|NCT00337779|81469252|FG001|Overall Study|Adverse Event|51|||
27899671|NCT00337779|81469251|FG000|Overall Study|Pregnancy|3|||
27899672|NCT00337779|81469252|FG001|Overall Study|Pregnancy|2|||
27899673|NCT00337779|81469251|FG000|Overall Study|Death|0|||
27899674|NCT00337779|81469252|FG001|Overall Study|Death|1|||
27899675|NCT03617861|81469260|FG000|Second Intervention (1 Day)|Adverse Event|0|||
27899676|NCT03617861|81469261|FG001|Second Intervention (1 Day)|Adverse Event|0|||
27899677|NCT03617861|81469262|FG002|Second Intervention (1 Day)|Adverse Event|1|||
27899678|NCT03617861|81469263|FG003|Second Intervention (1 Day)|Adverse Event|0|||
27899679|NCT00783224|81469265|FG000|Overall Study|Adverse Event|0|||
27899680|NCT00783224|81469266|FG001|Overall Study|Adverse Event|0|||
27899681|NCT00783224|81469267|FG002|Overall Study|Adverse Event|1|||
27899682|NCT00783224|81469268|FG003|Overall Study|Adverse Event|0|||
27899683|NCT00783224|81469265|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
27899684|NCT00783224|81469266|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
27899685|NCT00783224|81469267|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
27899686|NCT00783224|81469268|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
27899687|NCT00783224|81469265|FG000|Overall Study|Inappropriate as a study subject|0|||
27899688|NCT00783224|81469266|FG001|Overall Study|Inappropriate as a study subject|0|||
27899689|NCT00783224|81469267|FG002|Overall Study|Inappropriate as a study subject|0|||
27899690|NCT00783224|81469268|FG003|Overall Study|Inappropriate as a study subject|1|||
27899691|NCT00904917|81469269|FG000|Overall Study|Lost to Follow-up|2|||
27899692|NCT00904917|81469270|FG001|Overall Study|Lost to Follow-up|2|||
27899693|NCT00904917|81469271|FG002|Overall Study|Lost to Follow-up|2|||
27899694|NCT00904917|81469272|FG003|Overall Study|Lost to Follow-up|2|||
27899695|NCT00085098|81469273|FG000|Overall Study|Withdrawal by Subject|0|||
27899696|NCT00085098|81469274|FG001|Overall Study|Withdrawal by Subject|1|||
27899697|NCT00085098|81469273|FG000|Overall Study|Ineligible|1|||
27899698|NCT00085098|81469274|FG001|Overall Study|Ineligible|1|||
27899699|NCT00986986|81469276|FG000|Overall Study|Lost to Follow-up|0|||
27899700|NCT00986986|81469277|FG001|Overall Study|Lost to Follow-up|1|||
27899701|NCT00743288|81469279|FG000|Overall Study|Adverse Event|1|||
27899702|NCT00743288|81469280|FG001|Overall Study|Adverse Event|1|||
27899703|NCT00743288|81469281|FG002|Overall Study|Adverse Event|2|||
27899704|NCT00743288|81469282|FG003|Overall Study|Adverse Event|2|||
27899705|NCT00743288|81469283|FG004|Overall Study|Adverse Event|1|||
27899706|NCT00743288|81469284|FG005|Overall Study|Adverse Event|1|||
27899707|NCT00743288|81469285|FG006|Overall Study|Adverse Event|2|||
27899708|NCT00743288|81469279|FG000|Overall Study|Withdrawal by Subject|0|||
27899709|NCT00743288|81469280|FG001|Overall Study|Withdrawal by Subject|0|||
27899710|NCT00743288|81469281|FG002|Overall Study|Withdrawal by Subject|1|||
27899711|NCT00743288|81469282|FG003|Overall Study|Withdrawal by Subject|0|||
27727479|NCT00045032|80830246|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
27727480|NCT00045032|80830244|FG000|Overall Study|Other Protocol Violation|2|||
27899712|NCT00743288|81469283|FG004|Overall Study|Withdrawal by Subject|0|||
27899713|NCT00743288|81469284|FG005|Overall Study|Withdrawal by Subject|1|||
27899714|NCT00743288|81469285|FG006|Overall Study|Withdrawal by Subject|1|||
27899715|NCT00743288|81469279|FG000|Overall Study|Progressive disease (PD)|2|||
27899716|NCT00743288|81469280|FG001|Overall Study|Progressive disease (PD)|0|||
27899717|NCT00743288|81469281|FG002|Overall Study|Progressive disease (PD)|1|||
27899718|NCT00743288|81469282|FG003|Overall Study|Progressive disease (PD)|4|||
27899719|NCT00743288|81469283|FG004|Overall Study|Progressive disease (PD)|5|||
27899720|NCT00743288|81469284|FG005|Overall Study|Progressive disease (PD)|3|||
27899721|NCT00743288|81469285|FG006|Overall Study|Progressive disease (PD)|6|||
27899722|NCT00743288|81469279|FG000|Overall Study|Worsening of condition (Not PD)|0|||
27899723|NCT00743288|81469280|FG001|Overall Study|Worsening of condition (Not PD)|2|||
27899724|NCT00743288|81469281|FG002|Overall Study|Worsening of condition (Not PD)|1|||
27899725|NCT00743288|81469282|FG003|Overall Study|Worsening of condition (Not PD)|1|||
27899726|NCT00743288|81469283|FG004|Overall Study|Worsening of condition (Not PD)|0|||
27899727|NCT00743288|81469284|FG005|Overall Study|Worsening of condition (Not PD)|0|||
27899728|NCT00743288|81469285|FG006|Overall Study|Worsening of condition (Not PD)|0|||
27899729|NCT01634659|81469288|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
27899730|NCT01634659|81469289|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
27899731|NCT01634659|81469288|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
27899732|NCT01634659|81469289|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
27899733|NCT01380691|81469290|FG000|Washout (7 Days)|Protocol Violation|0|||
27899734|NCT01380691|81469291|FG001|Washout (7 Days)|Protocol Violation|0|||
27899735|NCT01380691|81469292|FG002|Washout (7 Days)|Protocol Violation|0|||
27899736|NCT01380691|81469293|FG003|Washout (7 Days)|Protocol Violation|1|||
27899737|NCT01380691|81469290|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
27899738|NCT01380691|81469291|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
27899739|NCT01380691|81469292|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
27899740|NCT01380691|81469293|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
27899741|NCT03436199|81469299|FG000|Overall Study|Adverse Event|15|||
27899742|NCT03436199|81469300|FG001|Overall Study|Adverse Event|40|||
27899743|NCT03436199|81469301|FG002|Overall Study|Adverse Event|7|||
27899744|NCT03436199|81469299|FG000|Overall Study|Withdrawal by Subject|4|||
27899745|NCT03436199|81469300|FG001|Overall Study|Withdrawal by Subject|10|||
27899746|NCT03436199|81469301|FG002|Overall Study|Withdrawal by Subject|3|||
27899747|NCT03436199|81469299|FG000|Overall Study|Lost to Follow-up|1|||
27899748|NCT03436199|81469300|FG001|Overall Study|Lost to Follow-up|0|||
27899749|NCT03436199|81469301|FG002|Overall Study|Lost to Follow-up|2|||
27899750|NCT03436199|81469299|FG000|Overall Study|Protocol Violation|1|||
27899751|NCT03436199|81469300|FG001|Overall Study|Protocol Violation|1|||
27899752|NCT03436199|81469301|FG002|Overall Study|Protocol Violation|0|||
27899753|NCT03436199|81469299|FG000|Overall Study|Physician Decision|0|||
27899754|NCT03436199|81469300|FG001|Overall Study|Physician Decision|1|||
27899755|NCT03436199|81469301|FG002|Overall Study|Physician Decision|0|||
27899756|NCT03436199|81469299|FG000|Overall Study|Could not return to clinic|1|||
27899757|NCT03436199|81469300|FG001|Overall Study|Could not return to clinic|0|||
27899758|NCT03436199|81469301|FG002|Overall Study|Could not return to clinic|0|||
27899759|NCT03436199|81469299|FG000|Overall Study|Withdrawn per physician|0|||
27899760|NCT03436199|81469300|FG001|Overall Study|Withdrawn per physician|1|||
27899761|NCT03436199|81469301|FG002|Overall Study|Withdrawn per physician|0|||
27899762|NCT00524173|81469302|FG000|Overall Study|Lost to Follow-up|0|||
27899763|NCT00524173|81469303|FG001|Overall Study|Lost to Follow-up|1|||
27899764|NCT00524173|81469302|FG000|Overall Study|Death|1|||
27899765|NCT00524173|81469303|FG001|Overall Study|Death|0|||
27899766|NCT00524173|81469302|FG000|Overall Study|Had not reached endpoint at study close|4|||
27899767|NCT00524173|81469303|FG001|Overall Study|Had not reached endpoint at study close|1|||
27899768|NCT01714609|81469304|FG000|Overall Study|Protocol Violation|1|||
27899769|NCT01714609|81469305|FG001|Overall Study|Protocol Violation|0|||
27899770|NCT01900431|81469306|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
27899771|NCT01900431|81469307|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
27899772|NCT01900431|81469308|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
27899773|NCT01900431|81469306|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
27899774|NCT01900431|81469307|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
27899775|NCT01900431|81469308|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
27899776|NCT01900431|81469306|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
27899777|NCT01900431|81469307|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
27899778|NCT01900431|81469308|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
27899779|NCT01900431|81469306|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
27899780|NCT01900431|81469307|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
27899781|NCT01900431|81469308|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
27899782|NCT01900431|81469306|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
27899783|NCT01900431|81469307|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
27899784|NCT01900431|81469308|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
27899785|NCT01900431|81469306|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
27899786|NCT01900431|81469307|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
27899787|NCT01900431|81469308|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
27506250|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27506251|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
27506252|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
27506253|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
27506254|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
27506255|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27506256|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
27506257|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
27506258|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Other|8|||
27506259|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Other|3|||
27506260|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Other|4|||
27506261|NCT01106690|80044306|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
27506262|NCT01106690|80044307|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27506263|NCT01106690|80044308|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27506264|NCT04434937|80044309|FG000|Overall Study|Death|4|||
27506265|NCT04434937|80044309|FG000|Overall Study|Withdrawal by Subject|1|||
27850942|NCT04146363|81283028|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850943|NCT04146363|81283029|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850944|NCT04146363|81283030|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
27850945|NCT04146363|81283031|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850946|NCT04146363|81283032|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850947|NCT04146363|81283033|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
27850948|NCT04146363|81283034|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
27850949|NCT04146363|81283035|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
27850950|NCT04146363|81283036|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27899788|NCT01900431|81469306|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
27899789|NCT01900431|81469307|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
27899790|NCT01900431|81469308|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
27899791|NCT01900431|81469306|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
27899792|NCT01900431|81469307|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
27899793|NCT01900431|81469308|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
27899794|NCT01900431|81469306|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
27727481|NCT00045032|80830245|FG001|Overall Study|Other Protocol Violation|0|||
27727482|NCT00045032|80830246|FG002|Overall Study|Other Protocol Violation|1|||
27850951|NCT04146363|81283037|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850952|NCT04146363|81283038|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
27850953|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850954|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850955|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850956|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850957|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
27899795|NCT01900431|81469307|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
27506266|NCT04434937|80044309|FG000|Overall Study|Transitioned to Rollover Study|19|||
27506267|NCT04434937|80044309|FG000|Overall Study|Progressive Disease|18|||
27506268|NCT04971109|80044310|FG000|Overall Study|Adverse Event|4|||
27506269|NCT04971109|80044311|FG001|Overall Study|Adverse Event|3|||
27506270|NCT04971109|80044310|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
27506271|NCT04971109|80044311|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
27506272|NCT04971109|80044310|FG000|Overall Study|Lost to Follow-up|8|||
27614137|NCT01242176|80430150|FG000|Washout Period of 7 Days|Adverse Event|0|||
27614138|NCT01242176|80430151|FG001|Washout Period of 7 Days|Adverse Event|2|||
27614139|NCT01242176|80430150|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
27614140|NCT01242176|80430151|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
27614141|NCT00088205|80430152|FG000|Overall Study|Adverse Event|4|||
27614142|NCT00088205|80430152|FG000|Overall Study|Progressive Disease|51|||
27614143|NCT00088205|80430152|FG000|Overall Study|Physician Decision|1|||
27614144|NCT00088205|80430152|FG000|Overall Study|Death Due to Study Disease|4|||
27614145|NCT01340482|80430153|FG000|Overall Study|Adverse Event|2|||
27614146|NCT01340482|80430154|FG001|Overall Study|Adverse Event|0|||
27614147|NCT01340482|80430155|FG002|Overall Study|Adverse Event|0|||
27614148|NCT04267614|80430158|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
27614149|NCT04267614|80430158|FG000|Overall Study|Lost to Follow-up|115|||
27614150|NCT02670538|80430159|FG000|Overall Study|Withdrawal of Consent|8|||
27614151|NCT02670538|80430160|FG001|Overall Study|Withdrawal of Consent|6|||
27614152|NCT02670538|80430161|FG002|Overall Study|Withdrawal of Consent|5|||
27614153|NCT02670538|80430159|FG000|Overall Study|Lost to Follow-up|8|||
27614154|NCT02670538|80430160|FG001|Overall Study|Lost to Follow-up|12|||
27614155|NCT02670538|80430161|FG002|Overall Study|Lost to Follow-up|7|||
27614156|NCT02670538|80430159|FG000|Overall Study|Adverse Event|5|||
27614157|NCT02670538|80430160|FG001|Overall Study|Adverse Event|5|||
27614158|NCT02670538|80430161|FG002|Overall Study|Adverse Event|11|||
27614159|NCT02670538|80430159|FG000|Overall Study|Lack of Efficacy|7|||
27614160|NCT02670538|80430160|FG001|Overall Study|Lack of Efficacy|1|||
27614161|NCT02670538|80430161|FG002|Overall Study|Lack of Efficacy|2|||
27614162|NCT02670538|80430159|FG000|Overall Study|Protocol Violation|3|||
27614163|NCT02670538|80430160|FG001|Overall Study|Protocol Violation|4|||
27614164|NCT02670538|80430161|FG002|Overall Study|Protocol Violation|1|||
27614165|NCT02670538|80430159|FG000|Overall Study|Noncompliance with Study Drug|1|||
27614166|NCT02670538|80430160|FG001|Overall Study|Noncompliance with Study Drug|3|||
27614167|NCT02670538|80430161|FG002|Overall Study|Noncompliance with Study Drug|2|||
27614168|NCT02670538|80430159|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27614169|NCT02670538|80430160|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27614170|NCT02670538|80430161|FG002|Overall Study|Other Miscellaneous Reasons|2|||
27614171|NCT00806624|80430162|FG000|Overall Study|Adverse Event|2|||
27614172|NCT00806624|80430163|FG001|Overall Study|Adverse Event|8|||
27614173|NCT00806624|80430164|FG002|Overall Study|Adverse Event|0|||
27614174|NCT00806624|80430162|FG000|Overall Study|Death|0|||
27614175|NCT00806624|80430163|FG001|Overall Study|Death|1|||
27614176|NCT00806624|80430164|FG002|Overall Study|Death|1|||
27614177|NCT00806624|80430162|FG000|Overall Study|Lost to Follow-up|1|||
27506273|NCT04971109|80044311|FG001|Overall Study|Lost to Follow-up|2|||
27506274|NCT04971109|80044310|FG000|Overall Study|Physician Decision|5|||
27506275|NCT04971109|80044311|FG001|Overall Study|Physician Decision|0|||
27506276|NCT04971109|80044310|FG000|Overall Study|Protocol Violation|0|||
27506277|NCT04971109|80044311|FG001|Overall Study|Protocol Violation|1|||
27506278|NCT04971109|80044310|FG000|Overall Study|Withdrawal by Subject|18|||
27506279|NCT04971109|80044311|FG001|Overall Study|Withdrawal by Subject|3|||
27506280|NCT04971109|80044310|FG000|Overall Study|Subject was randomized in error|1|||
27614178|NCT00806624|80430163|FG001|Overall Study|Lost to Follow-up|0|||
27614179|NCT00806624|80430164|FG002|Overall Study|Lost to Follow-up|1|||
27614180|NCT00806624|80430162|FG000|Overall Study|Withdrawal by Subject|6|||
27614181|NCT00806624|80430163|FG001|Overall Study|Withdrawal by Subject|3|||
27614182|NCT00806624|80430164|FG002|Overall Study|Withdrawal by Subject|3|||
27506281|NCT04971109|80044311|FG001|Overall Study|Subject was randomized in error|0|||
27506282|NCT02516241|80044312|FG000|Overall Study|Death|255|||
27850958|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
27614183|NCT00806624|80430162|FG000|Overall Study|discontinued before start of treatment|0|||
27614184|NCT00806624|80430163|FG001|Overall Study|discontinued before start of treatment|0|||
27614185|NCT00806624|80430164|FG002|Overall Study|discontinued before start of treatment|1|||
27506283|NCT02516241|80044313|FG001|Overall Study|Death|262|||
27506284|NCT02516241|80044314|FG002|Overall Study|Death|270|||
27506285|NCT02516241|80044312|FG000|Overall Study|Lost to Follow-up|1|||
27506286|NCT02516241|80044313|FG001|Overall Study|Lost to Follow-up|1|||
27506287|NCT02516241|80044314|FG002|Overall Study|Lost to Follow-up|3|||
27506288|NCT02516241|80044312|FG000|Overall Study|Withdrawal by Subject|2|||
27506289|NCT02516241|80044313|FG001|Overall Study|Withdrawal by Subject|7|||
27506290|NCT02516241|80044314|FG002|Overall Study|Withdrawal by Subject|12|||
27506291|NCT02516241|80044312|FG000|Overall Study|participants ongoing at data cut-off|84|||
27506292|NCT02516241|80044313|FG001|Overall Study|participants ongoing at data cut-off|76|||
27506293|NCT02516241|80044314|FG002|Overall Study|participants ongoing at data cut-off|59|||
27506294|NCT03278249|80044315|FG000|Overall Study|Withdrawal by Subject|2|||
27506295|NCT03278249|80044315|FG000|Overall Study|Lost to Follow-up|1|||
27506296|NCT00702221|80044316|FG000|Overall Study|Adverse Event|4|||
27506297|NCT00702221|80044317|FG001|Overall Study|Adverse Event|3|||
27506298|NCT03610269|80047778|FG000|Overall Study|Physician Decision|10|||
27506299|NCT03610269|80047778|FG000|Overall Study|Protocol Violation|1|||
27506300|NCT03610269|80047778|FG000|Overall Study|Unable to draw blood|1|||
27506301|NCT03610269|80047778|FG000|Overall Study|Screen fail|4|||
27506302|NCT03387085|80047783|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
27506303|NCT00928408|80047784|FG000|Overall Study|Other|2|||
27506304|NCT00928408|80047784|FG000|Overall Study|Withdrawal by Subject|4|||
27506305|NCT00928408|80047784|FG000|Overall Study|Death|5|||
27506306|NCT00928408|80047784|FG000|Overall Study|Lost to Follow-up|12|||
27506307|NCT03044106|80047787|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
27506308|NCT03044106|80047788|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
27506309|NCT03112603|80047789|FG000|End of Randomization Period|Lost to Follow-up|3|||
27506310|NCT03112603|80047790|FG001|End of Randomization Period|Lost to Follow-up|0|||
27506311|NCT03112603|80047791|FG002|End of Randomization Period|Lost to Follow-up|0|||
27506312|NCT03112603|80047789|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
27506313|NCT03112603|80047790|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
27506314|NCT03112603|80047791|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
27506315|NCT03112603|80047789|FG000|End of Randomization Period|Physician Decision|43|||
27506316|NCT03112603|80047790|FG001|End of Randomization Period|Physician Decision|18|||
27506317|NCT03112603|80047791|FG002|End of Randomization Period|Physician Decision|0|||
27506318|NCT03112603|80047789|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
27506319|NCT03112603|80047790|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
27506320|NCT03112603|80047791|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
27506321|NCT03112603|80047789|FG000|End of Randomization Period|Death|10|||
27506322|NCT03112603|80047790|FG001|End of Randomization Period|Death|7|||
27506323|NCT03112603|80047791|FG002|End of Randomization Period|Death|0|||
27506324|NCT03112603|80047789|FG000|End of Randomization Period|Disease Relapse|12|||
27506325|NCT03112603|80047790|FG001|End of Randomization Period|Disease Relapse|7|||
27506326|NCT03112603|80047791|FG002|End of Randomization Period|Disease Relapse|0|||
27506327|NCT03112603|80047789|FG000|End of Randomization Period|Lack of Efficacy|25|||
27506328|NCT03112603|80047790|FG001|End of Randomization Period|Lack of Efficacy|77|||
27506329|NCT03112603|80047791|FG002|End of Randomization Period|Lack of Efficacy|0|||
27506330|NCT03112603|80047789|FG000|End of Randomization Period|Adverse Event|32|||
27614186|NCT00429494|80430167|FG000|Overall Study|Withdrawal by Subject|9|||
27614187|NCT00429494|80430167|FG000|Overall Study|Death|6|||
27614188|NCT02258464|80430171|FG000|Overall Study|Progressive disease (PD)|9|||
27614189|NCT02258464|80430172|FG001|Overall Study|Progressive disease (PD)|17|||
27614190|NCT02258464|80430171|FG000|Overall Study|Study drug never administered|1|||
27614191|NCT02258464|80430172|FG001|Overall Study|Study drug never administered|1|||
27614192|NCT02258464|80430171|FG000|Overall Study|AE not related to clinical PD|1|||
27614193|NCT02258464|80430172|FG001|Overall Study|AE not related to clinical PD|3|||
27614194|NCT02258464|80430171|FG000|Overall Study|Withdrawal by Subject|5|||
27614195|NCT02258464|80430172|FG001|Overall Study|Withdrawal by Subject|4|||
27614196|NCT02258464|80430171|FG000|Overall Study|AE related to clinical PD|1|||
27614197|NCT02258464|80430172|FG001|Overall Study|AE related to clinical PD|0|||
27614198|NCT03688711|80430173|FG000|Overall Study|Withdrawal by Subject|0|||
27614199|NCT03688711|80430174|FG001|Overall Study|Withdrawal by Subject|1|||
27614200|NCT01644474|80430175|FG000|Overall Study|Poor compliance to protocol|1|||
27614201|NCT01644474|80430176|FG001|Overall Study|Poor compliance to protocol|0|||
27614202|NCT01644474|80430175|FG000|Overall Study|Consent withdrawn by participant|0|||
27614203|NCT01644474|80430176|FG001|Overall Study|Consent withdrawn by participant|1|||
27506331|NCT03112603|80047790|FG001|End of Randomization Period|Adverse Event|12|||
27506332|NCT03112603|80047791|FG002|End of Randomization Period|Adverse Event|0|||
27506333|NCT03112603|80047789|FG000|End of Cross Over Period|Death|0|||
27506334|NCT03112603|80047790|FG001|End of Cross Over Period|Death|0|||
27506335|NCT03112603|80047791|FG002|End of Cross Over Period|Death|2|||
27506336|NCT03112603|80047789|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
27506337|NCT03112603|80047790|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
27506338|NCT03112603|80047791|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
27506339|NCT03112603|80047789|FG000|End of Cross Over Period|Physician Decision|0|||
27506340|NCT03112603|80047790|FG001|End of Cross Over Period|Physician Decision|0|||
27506341|NCT03112603|80047791|FG002|End of Cross Over Period|Physician Decision|29|||
27506342|NCT03112603|80047789|FG000|End of Cross Over Period|Lack of Efficacy|0|||
27506343|NCT03112603|80047790|FG001|End of Cross Over Period|Lack of Efficacy|0|||
27899796|NCT01900431|81469308|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
27899797|NCT01428115|81469310|FG000|Overall Study|Lack of Efficacy|3|||
27899798|NCT01428115|81469310|FG000|Overall Study|Lost to Follow-up|10|||
27899799|NCT01428115|81469310|FG000|Overall Study|Pregnancy|1|||
27899800|NCT01428115|81469310|FG000|Overall Study|Protocol Violation|3|||
27899801|NCT01428115|81469310|FG000|Overall Study|Withdrawal by Subject|4|||
27899802|NCT00388297|81469313|FG000|Overall Study|Lost to Follow-up|16|||
27899803|NCT00388297|81469314|FG001|Overall Study|Lost to Follow-up|12|||
27899804|NCT00388297|81469315|FG002|Overall Study|Lost to Follow-up|11|||
27899805|NCT00388297|81469316|FG003|Overall Study|Lost to Follow-up|8|||
27899806|NCT01651000|81469317|FG000|Overall Study|Adverse Event|2|||
27899807|NCT01651000|81469318|FG001|Overall Study|Adverse Event|8|||
27899808|NCT01651000|81469317|FG000|Overall Study|Lost to Follow-up|3|||
27899809|NCT01651000|81469318|FG001|Overall Study|Lost to Follow-up|2|||
27899810|NCT01651000|81469317|FG000|Overall Study|Protocol Violation|0|||
27899811|NCT01651000|81469318|FG001|Overall Study|Protocol Violation|3|||
27899812|NCT01651000|81469317|FG000|Overall Study|Withdrawal by Subject|2|||
27899813|NCT01651000|81469318|FG001|Overall Study|Withdrawal by Subject|10|||
27899814|NCT01651000|81469317|FG000|Overall Study|Subject noncompliance|0|||
27899815|NCT01651000|81469318|FG001|Overall Study|Subject noncompliance|3|||
27899816|NCT01651000|81469317|FG000|Overall Study|Lack of Efficacy|1|||
27899817|NCT01651000|81469318|FG001|Overall Study|Lack of Efficacy|1|||
27899818|NCT01651000|81469317|FG000|Overall Study|Physician Decision|1|||
27899819|NCT01651000|81469318|FG001|Overall Study|Physician Decision|0|||
27899820|NCT01651000|81469317|FG000|Overall Study|Administrative reason|1|||
27899821|NCT01651000|81469318|FG001|Overall Study|Administrative reason|0|||
27899822|NCT01651000|81469317|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
27899823|NCT01651000|81469318|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
27899824|NCT05940077|81469344|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
27899825|NCT00586898|81469345|FG000|Overall Study|Adverse Event|1|||
27899826|NCT00586898|81469345|FG000|Overall Study|Patiemt Non-compliance|1|||
27506344|NCT03112603|80047791|FG002|End of Cross Over Period|Lack of Efficacy|8|||
27506345|NCT03112603|80047789|FG000|End of Cross Over Period|Adverse Event|0|||
27614204|NCT01644474|80430175|FG000|Overall Study|Participant moved|0|||
27506346|NCT03112603|80047790|FG001|End of Cross Over Period|Adverse Event|0|||
27506347|NCT03112603|80047791|FG002|End of Cross Over Period|Adverse Event|6|||
27899827|NCT00586898|81469345|FG000|Overall Study|Evaluable for Toxicity Only|5|||
27899828|NCT01731470|81469346|FG000|Overall Study|Withdrawal by Subject|1|||
27899829|NCT01731470|81469346|FG000|Overall Study|Did not meet study criteria|1|||
27899830|NCT01627782|81469347|FG000|Overall Study|Adverse Event|1|||
27899831|NCT01627782|81469348|FG001|Overall Study|Adverse Event|2|||
27899832|NCT01627782|81469349|FG002|Overall Study|Adverse Event|0|||
27899833|NCT01627782|81469350|FG003|Overall Study|Adverse Event|1|||
27899834|NCT01627782|81469347|FG000|Overall Study|Lack of Efficacy|11|||
27899835|NCT01627782|81469348|FG001|Overall Study|Lack of Efficacy|1|||
27899836|NCT01627782|81469349|FG002|Overall Study|Lack of Efficacy|15|||
27899837|NCT01627782|81469350|FG003|Overall Study|Lack of Efficacy|2|||
27899838|NCT01627782|81469347|FG000|Overall Study|Protocol Violation|1|||
27899839|NCT01627782|81469348|FG001|Overall Study|Protocol Violation|0|||
27899840|NCT01627782|81469349|FG002|Overall Study|Protocol Violation|0|||
27899841|NCT01627782|81469350|FG003|Overall Study|Protocol Violation|0|||
27899842|NCT01627782|81469347|FG000|Overall Study|Withdrawal by Subject|2|||
27899843|NCT01627782|81469348|FG001|Overall Study|Withdrawal by Subject|1|||
27899844|NCT01627782|81469349|FG002|Overall Study|Withdrawal by Subject|0|||
27899845|NCT01627782|81469350|FG003|Overall Study|Withdrawal by Subject|0|||
27899846|NCT01627782|81469347|FG000|Overall Study|Other|0|||
27899847|NCT01627782|81469348|FG001|Overall Study|Other|2|||
27899848|NCT01627782|81469349|FG002|Overall Study|Other|0|||
27899849|NCT01627782|81469350|FG003|Overall Study|Other|3|||
27899850|NCT01627782|81469347|FG000|Overall Study|Randomized But Not Treated|1|||
27899851|NCT01627782|81469348|FG001|Overall Study|Randomized But Not Treated|0|||
27899852|NCT01627782|81469349|FG002|Overall Study|Randomized But Not Treated|0|||
27899853|NCT01627782|81469350|FG003|Overall Study|Randomized But Not Treated|0|||
27899854|NCT03448939|81469351|FG000|Overall Study|Adverse Event|5|||
27899855|NCT03448939|81469352|FG001|Overall Study|Adverse Event|1|||
27899856|NCT03448939|81469351|FG000|Overall Study|Lost to Follow-up|6|||
27899857|NCT03448939|81469352|FG001|Overall Study|Lost to Follow-up|6|||
27899858|NCT03448939|81469351|FG000|Overall Study|Pregnancy|1|||
27899859|NCT03448939|81469352|FG001|Overall Study|Pregnancy|1|||
27899860|NCT03448939|81469351|FG000|Overall Study|Withdrawal by Subject|9|||
27899861|NCT03448939|81469352|FG001|Overall Study|Withdrawal by Subject|3|||
27899862|NCT01398410|81469354|FG000|Overall Study|Adverse Event|12|||
27899863|NCT01398410|81469355|FG001|Overall Study|Adverse Event|16|||
27899864|NCT01398410|81469354|FG000|Overall Study|Participants Choice|8|||
27899865|NCT01398410|81469355|FG001|Overall Study|Participants Choice|11|||
27899866|NCT01398410|81469354|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
27899867|NCT01398410|81469355|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
27899868|NCT01398410|81469354|FG000|Overall Study|Other|36|||
27899869|NCT01398410|81469355|FG001|Overall Study|Other|29|||
27899870|NCT00574249|81469360|FG000|Overall Study|Adverse Event|6|||
27899871|NCT00574249|81469361|FG001|Overall Study|Adverse Event|18|||
27899872|NCT00574249|81469360|FG000|Overall Study|Lack of Efficacy|5|||
27899873|NCT00574249|81469361|FG001|Overall Study|Lack of Efficacy|3|||
27899874|NCT00574249|81469360|FG000|Overall Study|Lost to Follow-up|4|||
27899875|NCT00574249|81469361|FG001|Overall Study|Lost to Follow-up|3|||
27899876|NCT00574249|81469360|FG000|Overall Study|Protocol Violation|5|||
27899877|NCT00574249|81469361|FG001|Overall Study|Protocol Violation|2|||
27899878|NCT00574249|81469360|FG000|Overall Study|History of carcinoma|1|||
27899879|NCT00574249|81469361|FG001|Overall Study|History of carcinoma|0|||
27899880|NCT00574249|81469360|FG000|Overall Study|Withdrawal by Subject|3|||
27899881|NCT00574249|81469361|FG001|Overall Study|Withdrawal by Subject|0|||
27899882|NCT00574249|81469360|FG000|Overall Study|Physician Decision|1|||
27899883|NCT00574249|81469361|FG001|Overall Study|Physician Decision|0|||
27899884|NCT00574249|81469360|FG000|Overall Study|Pregnancy|1|||
27899885|NCT00574249|81469361|FG001|Overall Study|Pregnancy|0|||
27899886|NCT00574249|81469360|FG000|Overall Study|Excluded by company|0|||
27899887|NCT00574249|81469361|FG001|Overall Study|Excluded by company|1|||
27899888|NCT00574249|81469360|FG000|Overall Study|PPD test taken twice|0|||
27899889|NCT00574249|81469361|FG001|Overall Study|PPD test taken twice|1|||
27899890|NCT04643964|81469362|FG000|Overall Study|Lost to Follow-up|55|||
27899891|NCT04643964|81469363|FG001|Overall Study|Lost to Follow-up|59|||
27899892|NCT04643964|81469364|FG002|Overall Study|Lost to Follow-up|54|||
27899893|NCT04643964|81469365|FG003|Overall Study|Lost to Follow-up|129|||
27899894|NCT04643964|81469366|FG004|Overall Study|Lost to Follow-up|48|||
27899895|NCT04643964|81469362|FG000|Overall Study|Failed attention check|1|||
27899896|NCT04643964|81469363|FG001|Overall Study|Failed attention check|8|||
27899897|NCT04643964|81469364|FG002|Overall Study|Failed attention check|2|||
27899898|NCT04643964|81469365|FG003|Overall Study|Failed attention check|14|||
27899899|NCT04643964|81469366|FG004|Overall Study|Failed attention check|11|||
27899900|NCT03217968|81469367|FG000|Overall Study|Withdrawal by Subject|4|||
27899901|NCT03217968|81469367|FG000|Overall Study|Lost to Follow-up|1|||
27899902|NCT03217968|81469367|FG000|Overall Study|Protocol Violation|6|||
27899903|NCT00394771|81469368|FG000|Overall Study|Did not meet protocol requirements|1|||
27899904|NCT00394771|81469369|FG001|Overall Study|Did not meet protocol requirements|0|||
27899905|NCT00394771|81469370|FG002|Overall Study|Did not meet protocol requirements|2|||
27899906|NCT00394771|81469371|FG003|Overall Study|Did not meet protocol requirements|0|||
27899907|NCT00394771|81469368|FG000|Overall Study|Protocol Violation|2|||
27899908|NCT00394771|81469369|FG001|Overall Study|Protocol Violation|4|||
27899909|NCT00394771|81469370|FG002|Overall Study|Protocol Violation|9|||
27899910|NCT00394771|81469371|FG003|Overall Study|Protocol Violation|7|||
27899911|NCT00394771|81469368|FG000|Overall Study|Withdrawal by Subject|10|||
27899912|NCT00394771|81469369|FG001|Overall Study|Withdrawal by Subject|6|||
27899913|NCT00394771|81469370|FG002|Overall Study|Withdrawal by Subject|8|||
27899914|NCT00394771|81469371|FG003|Overall Study|Withdrawal by Subject|12|||
27899915|NCT00394771|81469368|FG000|Overall Study|Adverse Event|10|||
27899916|NCT00394771|81469369|FG001|Overall Study|Adverse Event|5|||
27899917|NCT00394771|81469370|FG002|Overall Study|Adverse Event|12|||
27899918|NCT00394771|81469371|FG003|Overall Study|Adverse Event|8|||
27899919|NCT00394771|81469368|FG000|Overall Study|Participant pregnant|0|||
27899920|NCT00394771|81469369|FG001|Overall Study|Participant pregnant|1|||
27899921|NCT00394771|81469370|FG002|Overall Study|Participant pregnant|2|||
27899922|NCT00394771|81469371|FG003|Overall Study|Participant pregnant|2|||
27899923|NCT00394771|81469368|FG000|Overall Study|Lost to Follow-up|15|||
27899924|NCT00394771|81469369|FG001|Overall Study|Lost to Follow-up|15|||
27899925|NCT00394771|81469370|FG002|Overall Study|Lost to Follow-up|13|||
27899926|NCT00394771|81469371|FG003|Overall Study|Lost to Follow-up|10|||
27899927|NCT00394771|81469368|FG000|Overall Study|Other|3|||
27899928|NCT00394771|81469369|FG001|Overall Study|Other|3|||
27899929|NCT00394771|81469370|FG002|Overall Study|Other|1|||
27899930|NCT00394771|81469371|FG003|Overall Study|Other|0|||
27899931|NCT00772005|81469372|FG000|Overall Study|Adverse Event|9|||
27899932|NCT00772005|81469373|FG001|Overall Study|Adverse Event|14|||
27899933|NCT00772005|81469374|FG002|Overall Study|Adverse Event|10|||
27899934|NCT00772005|81469375|FG003|Overall Study|Adverse Event|13|||
27899935|NCT00772005|81469372|FG000|Overall Study|Lack of Efficacy|0|||
27899936|NCT00772005|81469373|FG001|Overall Study|Lack of Efficacy|1|||
27899937|NCT00772005|81469374|FG002|Overall Study|Lack of Efficacy|0|||
27899938|NCT00772005|81469375|FG003|Overall Study|Lack of Efficacy|0|||
27899939|NCT00772005|81469372|FG000|Overall Study|Withdrawal by Subject|3|||
27899940|NCT00772005|81469373|FG001|Overall Study|Withdrawal by Subject|7|||
27899941|NCT00772005|81469374|FG002|Overall Study|Withdrawal by Subject|10|||
27899942|NCT00772005|81469375|FG003|Overall Study|Withdrawal by Subject|2|||
27899943|NCT00772005|81469372|FG000|Overall Study|Protocol Violation|2|||
27899944|NCT00772005|81469373|FG001|Overall Study|Protocol Violation|4|||
27899945|NCT00772005|81469374|FG002|Overall Study|Protocol Violation|1|||
27899946|NCT00772005|81469375|FG003|Overall Study|Protocol Violation|6|||
27899947|NCT00772005|81469372|FG000|Overall Study|Lost to Follow-up|7|||
27899948|NCT00772005|81469373|FG001|Overall Study|Lost to Follow-up|3|||
27899949|NCT00772005|81469374|FG002|Overall Study|Lost to Follow-up|6|||
27899950|NCT00772005|81469375|FG003|Overall Study|Lost to Follow-up|3|||
27899951|NCT00772005|81469372|FG000|Overall Study|Non-compliance with study procedures|1|||
27899952|NCT00772005|81469373|FG001|Overall Study|Non-compliance with study procedures|1|||
27899953|NCT00772005|81469374|FG002|Overall Study|Non-compliance with study procedures|0|||
27899954|NCT00772005|81469375|FG003|Overall Study|Non-compliance with study procedures|1|||
27899955|NCT00772005|81469372|FG000|Overall Study|Non-compliance with drug administration|3|||
27899956|NCT00772005|81469373|FG001|Overall Study|Non-compliance with drug administration|0|||
27899957|NCT00772005|81469374|FG002|Overall Study|Non-compliance with drug administration|1|||
27899958|NCT00772005|81469375|FG003|Overall Study|Non-compliance with drug administration|1|||
27899959|NCT01249833|81469376|FG000|Overall Study|Lost to Follow-up|0|||
27899960|NCT01249833|81469377|FG001|Overall Study|Lost to Follow-up|1|||
27899961|NCT02839876|81469382|FG000|Overall Study|Protocol Violation|10|||
27899962|NCT02839876|81469383|FG001|Overall Study|Protocol Violation|11|||
27899963|NCT02086448|81469384|FG000|Overall Study|Withdrawal by Subject|1|||
27899964|NCT02086448|81469385|FG001|Overall Study|Withdrawal by Subject|0|||
27899965|NCT02086448|81469386|FG002|Overall Study|Withdrawal by Subject|0|||
27899966|NCT02086448|81469387|FG003|Overall Study|Withdrawal by Subject|2|||
27899967|NCT03677934|81469389|FG000|Overall Study|Adverse Event|1|||
27899968|NCT03677934|81469390|FG001|Overall Study|Adverse Event|1|||
27899969|NCT03677934|81469389|FG000|Overall Study|Death|8|||
27899970|NCT03677934|81469390|FG001|Overall Study|Death|4|||
27899971|NCT03677934|81469389|FG000|Overall Study|Lost to Follow-up|3|||
27899972|NCT03677934|81469390|FG001|Overall Study|Lost to Follow-up|0|||
27899973|NCT03677934|81469389|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27899974|NCT03677934|81469390|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27899975|NCT03677934|81469389|FG000|Overall Study|Physician Decision|0|||
27506348|NCT03112603|80047789|FG000|End of Cross Over Period|Disease Relapse|0|||
27506349|NCT03112603|80047790|FG001|End of Cross Over Period|Disease Relapse|0|||
27899976|NCT03677934|81469390|FG001|Overall Study|Physician Decision|1|||
27899977|NCT03677934|81469389|FG000|Overall Study|Withdrawal by Subject|1|||
27899978|NCT03677934|81469390|FG001|Overall Study|Withdrawal by Subject|7|||
27899979|NCT00078949|81469391|FG000|Overall Study|No treated|4|||
27899980|NCT00078949|81469392|FG001|Overall Study|No treated|5|||
27899981|NCT00078949|81469393|FG002|Overall Study|No treated|3|||
27899982|NCT00078949|81469394|FG003|Overall Study|No treated|3|||
27899983|NCT01868165|81469395|FG000|Overall Study|Withdrawal by Subject|36|||
27899984|NCT01868165|81469395|FG000|Overall Study|Physician Decision|2|||
27899985|NCT01868165|81469395|FG000|Overall Study|Lost to Follow-up|3|||
27899986|NCT01868165|81469395|FG000|Overall Study|Death|4|||
27899987|NCT03970200|81469401|FG000|Overall Study|Death|2|||
27899988|NCT03970200|81469402|FG001|Overall Study|Death|2|||
27899989|NCT03970200|81469403|FG002|Overall Study|Death|1|||
27899990|NCT03970200|81469401|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
27899991|NCT03970200|81469402|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
27899992|NCT03970200|81469403|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
27899993|NCT02536781|81469404|FG000|Overall Study|Lost to Follow-up|2|||
27899994|NCT02536781|81469405|FG001|Overall Study|Lost to Follow-up|0|||
27899995|NCT02554318|81469410|FG000|Overall Study|Withdrawal by Subject|10|||
27899996|NCT02554318|81469411|FG001|Overall Study|Withdrawal by Subject|8|||
27899997|NCT00455520|81469412|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
27899998|NCT00455520|81469413|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
27899999|NCT00455520|81469412|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
27900000|NCT00455520|81469413|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
27900001|NCT00455520|81469412|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
27900002|NCT00455520|81469413|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
27900003|NCT00455520|81469412|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
27900004|NCT00455520|81469413|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
27900005|NCT00455520|81469412|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
27900006|NCT00455520|81469413|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
27900007|NCT00455520|81469412|FG000|Open Label Tapentadol Extended Release|All other|33|||
27900008|NCT00455520|81469413|FG001|Open Label Tapentadol Extended Release|All other|0|||
27900009|NCT00455520|81469412|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
27900010|NCT00455520|81469413|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
27900011|NCT00455520|81469412|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
27900012|NCT00455520|81469413|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
27900013|NCT00455520|81469412|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
27900014|NCT00455520|81469413|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
27900015|NCT00455520|81469412|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
27900016|NCT00455520|81469413|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
27900017|NCT00455520|81469412|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
27900018|NCT00455520|81469413|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
27900019|NCT00455520|81469412|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
27900020|NCT00455520|81469413|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
27900021|NCT01618019|81469414|FG000|Overall Study|Withdrawal by Subject|14|||
27900022|NCT01618019|81469415|FG001|Overall Study|Withdrawal by Subject|14|||
27900023|NCT02696434|81469418|FG000|Overall Study|Adverse Event|3|||
27900024|NCT02696434|81469419|FG001|Overall Study|Adverse Event|1|||
27900025|NCT02696434|81469418|FG000|Overall Study|Lost to Follow-up|5|||
27900026|NCT02696434|81469419|FG001|Overall Study|Lost to Follow-up|4|||
27900027|NCT02696434|81469418|FG000|Overall Study|Withdrawal by Subject|14|||
27900028|NCT02696434|81469419|FG001|Overall Study|Withdrawal by Subject|12|||
27900029|NCT02696434|81469418|FG000|Overall Study|Physician Decision|0|||
27900030|NCT02696434|81469419|FG001|Overall Study|Physician Decision|1|||
27900031|NCT00422292|81469421|FG000|Overall Study|Serious adverse events|1|||
27900032|NCT00422292|81469422|FG001|Overall Study|Serious adverse events|4|||
27900033|NCT00422292|81469423|FG002|Overall Study|Serious adverse events|0|||
27900034|NCT00422292|81469424|FG003|Overall Study|Serious adverse events|0|||
27900035|NCT00422292|81469421|FG000|Overall Study|Adverse Event|1|||
27900036|NCT00422292|81469422|FG001|Overall Study|Adverse Event|0|||
27900037|NCT00422292|81469423|FG002|Overall Study|Adverse Event|1|||
27900038|NCT00422292|81469424|FG003|Overall Study|Adverse Event|0|||
27900039|NCT00422292|81469421|FG000|Overall Study|Protocol Violation|4|||
27900040|NCT00422292|81469422|FG001|Overall Study|Protocol Violation|25|||
27900041|NCT00422292|81469423|FG002|Overall Study|Protocol Violation|8|||
27900042|NCT00422292|81469424|FG003|Overall Study|Protocol Violation|5|||
27900043|NCT00422292|81469421|FG000|Overall Study|Lost to Follow-up|6|||
27900044|NCT00422292|81469422|FG001|Overall Study|Lost to Follow-up|12|||
27900045|NCT00422292|81469423|FG002|Overall Study|Lost to Follow-up|6|||
27900046|NCT00422292|81469424|FG003|Overall Study|Lost to Follow-up|6|||
27900047|NCT00422292|81469421|FG000|Overall Study|Withdrawal by Subject|6|||
27900048|NCT00422292|81469422|FG001|Overall Study|Withdrawal by Subject|25|||
27900049|NCT00422292|81469423|FG002|Overall Study|Withdrawal by Subject|7|||
27900050|NCT00422292|81469424|FG003|Overall Study|Withdrawal by Subject|13|||
27900051|NCT02634983|81469425|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
27900052|NCT02634983|81469426|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
27900053|NCT02578940|81469427|FG000|Overall Study|Screening failure|5|||
27900054|NCT02578940|81469427|FG000|Overall Study|Lost to Follow-up|1|||
27900055|NCT03769194|81469428|FG000|Overall Study|Withdrawal by Subject|0|||
27900056|NCT03769194|81469429|FG001|Overall Study|Withdrawal by Subject|7|||
27900057|NCT03769194|81469430|FG002|Overall Study|Withdrawal by Subject|4|||
27900058|NCT03769194|81469431|FG003|Overall Study|Withdrawal by Subject|1|||
27900059|NCT03769194|81469428|FG000|Overall Study|moved from study area|0|||
27900060|NCT03769194|81469429|FG001|Overall Study|moved from study area|2|||
27900061|NCT03769194|81469430|FG002|Overall Study|moved from study area|1|||
27727483|NCT00045032|80830244|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
27727484|NCT00045032|80830245|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
27727485|NCT00045032|80830246|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
27727486|NCT00045032|80830244|FG000|Overall Study|Failure to Return|57|||
27727487|NCT00045032|80830245|FG001|Overall Study|Failure to Return|62|||
27727488|NCT00045032|80830246|FG002|Overall Study|Failure to Return|61|||
27727489|NCT00045032|80830244|FG000|Overall Study|Other|93|||
27727490|NCT00045032|80830245|FG001|Overall Study|Other|84|||
27727491|NCT00045032|80830246|FG002|Overall Study|Other|105|||
27727492|NCT02367521|80830250|FG000|Overall Study|severe headache after intervention|2|||
27727493|NCT02367521|80830251|FG001|Overall Study|severe headache after intervention|0|||
27727494|NCT02367521|80830250|FG000|Overall Study|unable to find transportation|2|||
27727495|NCT02367521|80830251|FG001|Overall Study|unable to find transportation|0|||
27727496|NCT01231555|80830252|FG000|Overall Study|Study terminated|8|||
27727497|NCT01231555|80830253|FG001|Overall Study|Study terminated|5|||
27727498|NCT01231555|80830254|FG002|Overall Study|Study terminated|8|||
27727499|NCT01231555|80830252|FG000|Overall Study|Withdrawal by Subject|0|||
27727500|NCT01231555|80830253|FG001|Overall Study|Withdrawal by Subject|2|||
27727501|NCT01231555|80830254|FG002|Overall Study|Withdrawal by Subject|0|||
27727502|NCT00849667|80830255|FG000|Overall Study|Withdrawal by Subject|16|||
27727503|NCT00849667|80830256|FG001|Overall Study|Withdrawal by Subject|33|||
27727504|NCT00849667|80830257|FG002|Overall Study|Withdrawal by Subject|35|||
27727505|NCT00849667|80830255|FG000|Overall Study|Lost to Follow-up|8|||
27727506|NCT00849667|80830256|FG001|Overall Study|Lost to Follow-up|8|||
27727507|NCT00849667|80830257|FG002|Overall Study|Lost to Follow-up|8|||
27727508|NCT00849667|80830255|FG000|Overall Study|Adverse Event|1|||
27727509|NCT00849667|80830256|FG001|Overall Study|Adverse Event|2|||
27727510|NCT00849667|80830257|FG002|Overall Study|Adverse Event|0|||
27727511|NCT00849667|80830255|FG000|Overall Study|Other|18|||
27727512|NCT00849667|80830256|FG001|Overall Study|Other|19|||
27727513|NCT00849667|80830257|FG002|Overall Study|Other|18|||
27727514|NCT00849667|80830255|FG000|Overall Study|Progressive disease|119|||
27727515|NCT00849667|80830256|FG001|Overall Study|Progressive disease|100|||
27727516|NCT00849667|80830257|FG002|Overall Study|Progressive disease|112|||
27727517|NCT00849667|80830255|FG000|Overall Study|Sponsor decision|208|||
27727518|NCT00849667|80830256|FG001|Overall Study|Sponsor decision|204|||
27727519|NCT00849667|80830257|FG002|Overall Study|Sponsor decision|190|||
27727520|NCT00849667|80830255|FG000|Overall Study|Investigator discretion|0|||
27727521|NCT00849667|80830256|FG001|Overall Study|Investigator discretion|0|||
27727522|NCT00849667|80830257|FG002|Overall Study|Investigator discretion|1|||
27727523|NCT02429856|80830258|FG000|Overall Study|Death|12|||
27727524|NCT02429856|80830259|FG001|Overall Study|Death|13|||
27727525|NCT02429856|80830258|FG000|Overall Study|Lost to Follow-up|6|||
27727526|NCT02429856|80830259|FG001|Overall Study|Lost to Follow-up|5|||
27727527|NCT02429856|80830258|FG000|Overall Study|Withdrawal by Subject|1|||
27727528|NCT02429856|80830259|FG001|Overall Study|Withdrawal by Subject|1|||
27727529|NCT00684177|80830262|FG000|Overall Study|Adverse Event|4|||
27727530|NCT00684177|80830263|FG001|Overall Study|Adverse Event|3|||
27727531|NCT00684177|80830262|FG000|Overall Study|Lack of Efficacy|10|||
27727532|NCT00684177|80830263|FG001|Overall Study|Lack of Efficacy|15|||
27727533|NCT00684177|80830262|FG000|Overall Study|Protocol Violation|1|||
27727534|NCT00684177|80830263|FG001|Overall Study|Protocol Violation|0|||
27727535|NCT00684177|80830262|FG000|Overall Study|Lost to Follow-up|2|||
27727536|NCT00684177|80830263|FG001|Overall Study|Lost to Follow-up|1|||
27727537|NCT00684177|80830262|FG000|Overall Study|Physician Decision|2|||
27727538|NCT00684177|80830263|FG001|Overall Study|Physician Decision|0|||
27727539|NCT00684177|80830262|FG000|Overall Study|Withdrawal by Subject|1|||
27727540|NCT00684177|80830263|FG001|Overall Study|Withdrawal by Subject|2|||
27727541|NCT00684177|80830262|FG000|Overall Study|Other|1|||
27506350|NCT03112603|80047791|FG002|End of Cross Over Period|Disease Relapse|2|||
27506351|NCT00787644|80047792|FG000|Overall Study|Lost to Follow-up|1|||
27727542|NCT00684177|80830263|FG001|Overall Study|Other|2|||
27727543|NCT04698525|80830265|FG000|Overall Study|Lost to Follow-up|1|||
27727544|NCT04698525|80830266|FG001|Overall Study|Lost to Follow-up|2|||
27727545|NCT04698525|80830265|FG000|Overall Study|Three suffered of Covid-19|2|||
27727546|NCT04698525|80830266|FG001|Overall Study|Three suffered of Covid-19|1|||
27727547|NCT04276207|80830267|FG000|Period 1|Withdrawal by Subject|0|||
27727548|NCT04276207|80830268|FG001|Period 1|Withdrawal by Subject|1|||
27727549|NCT02971202|80830271|FG000|Overall Study|Pregnancy|1|||
27614205|NCT01644474|80430176|FG001|Overall Study|Participant moved|1|||
27727550|NCT02971202|80830272|FG001|Overall Study|Pregnancy|0|||
27727551|NCT02971202|80830273|FG002|Overall Study|Pregnancy|0|||
27727552|NCT02971202|80830271|FG000|Overall Study|screen fail after consent|1|||
27727553|NCT02971202|80830272|FG001|Overall Study|screen fail after consent|0|||
27506352|NCT00787644|80047793|FG001|Overall Study|Lost to Follow-up|1|||
27727554|NCT02971202|80830273|FG002|Overall Study|screen fail after consent|1|||
27727555|NCT01670994|80830288|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
27727556|NCT01670994|80830289|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
27900062|NCT03769194|81469431|FG003|Overall Study|moved from study area|1|||
27900063|NCT03769194|81469428|FG000|Overall Study|Lost to Follow-up|3|||
27900064|NCT03769194|81469429|FG001|Overall Study|Lost to Follow-up|6|||
27900065|NCT03769194|81469430|FG002|Overall Study|Lost to Follow-up|3|||
27900066|NCT03769194|81469431|FG003|Overall Study|Lost to Follow-up|6|||
27900067|NCT03769194|81469428|FG000|Overall Study|other|1|||
27900068|NCT03769194|81469429|FG001|Overall Study|other|3|||
27900069|NCT03769194|81469430|FG002|Overall Study|other|0|||
27900070|NCT03769194|81469431|FG003|Overall Study|other|1|||
27900071|NCT00382109|81469432|FG000|Overall Study|Adverse Event|3|||
27900072|NCT00382109|81469433|FG001|Overall Study|Adverse Event|0|||
27900073|NCT00382109|81469432|FG000|Overall Study|Physician Decision|6|||
27900074|NCT00382109|81469433|FG001|Overall Study|Physician Decision|1|||
27900075|NCT00382109|81469432|FG000|Overall Study|Withdrawal by Subject|1|||
27900076|NCT00382109|81469433|FG001|Overall Study|Withdrawal by Subject|0|||
27900077|NCT00382109|81469432|FG000|Overall Study|ineligible|2|||
27900078|NCT00382109|81469433|FG001|Overall Study|ineligible|0|||
27900079|NCT00382109|81469432|FG000|Overall Study|Other|0|||
27900080|NCT00382109|81469433|FG001|Overall Study|Other|2|||
27900081|NCT00382109|81469432|FG000|Overall Study|consent withdrawal|0|||
27900082|NCT00382109|81469433|FG001|Overall Study|consent withdrawal|1|||
27506353|NCT00787644|80047792|FG000|Overall Study|Withdrawal by Subject|1|||
27506354|NCT00787644|80047793|FG001|Overall Study|Withdrawal by Subject|1|||
27506355|NCT00812708|80047794|FG000|Overall Study|Device could not be implanted|2|||
27850959|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850960|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850961|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
27850962|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
27850963|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
27850964|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850965|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850966|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850967|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850968|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850969|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850970|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850971|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27850972|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
27850973|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
27850974|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
27850975|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850976|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850977|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850978|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850979|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850980|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850981|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850982|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850983|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
27850984|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
27850985|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27850986|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850987|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850988|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850989|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850990|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850991|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850992|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850993|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850994|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
27850995|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
27850996|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
27850997|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27850998|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27900083|NCT01402986|81469434|FG000|Overall Study|Withdrawal by Subject|7|||
27900084|NCT01402986|81469435|FG001|Overall Study|Withdrawal by Subject|10|||
27900085|NCT01402986|81469436|FG002|Overall Study|Withdrawal by Subject|7|||
27900086|NCT01402986|81469437|FG003|Overall Study|Withdrawal by Subject|13|||
27900087|NCT01402986|81469434|FG000|Overall Study|Death|0|||
27900088|NCT01402986|81469435|FG001|Overall Study|Death|0|||
27900089|NCT01402986|81469436|FG002|Overall Study|Death|0|||
27506356|NCT00812708|80047794|FG000|Overall Study|Lack of medical insurance|1|||
27506357|NCT00812708|80047794|FG000|Overall Study|Switched to another study|1|||
27506358|NCT00812708|80047794|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
27506359|NCT00812708|80047794|FG000|Overall Study|Signed consent but later withdrew|3|||
27506360|NCT03126591|80047795|FG000|Overall Study|Death|6|||
27506361|NCT03126591|80047796|FG001|Overall Study|Death|3|||
27506362|NCT03126591|80047797|FG002|Overall Study|Death|17|||
27614206|NCT01644474|80430175|FG000|Overall Study|Adverse Event|4|||
27850999|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27851000|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27900090|NCT01402986|81469437|FG003|Overall Study|Death|2|||
27900091|NCT01402986|81469434|FG000|Overall Study|Lost to Follow-up|0|||
27900092|NCT01402986|81469435|FG001|Overall Study|Lost to Follow-up|0|||
27900093|NCT01402986|81469436|FG002|Overall Study|Lost to Follow-up|0|||
27900094|NCT01402986|81469437|FG003|Overall Study|Lost to Follow-up|1|||
27900095|NCT01402986|81469434|FG000|Overall Study|Other|2|||
27900096|NCT01402986|81469435|FG001|Overall Study|Other|5|||
27900097|NCT01402986|81469436|FG002|Overall Study|Other|1|||
27900098|NCT01402986|81469437|FG003|Overall Study|Other|6|||
27900099|NCT00628927|81469440|FG000|Overall Study|Problems performing blood draw|6|||
27900100|NCT00628927|81469441|FG001|Overall Study|Problems performing blood draw|0|||
27900101|NCT00628927|81469440|FG000|Overall Study|Lost to Follow-up|1|||
27900102|NCT00628927|81469441|FG001|Overall Study|Lost to Follow-up|0|||
27900103|NCT00628927|81469440|FG000|Overall Study|Equipment failure|1|||
27900104|NCT00628927|81469441|FG001|Overall Study|Equipment failure|0|||
27900105|NCT05095311|81469446|FG000|Overall Study|Lost to Follow-up|7|||
27900106|NCT05095311|81469447|FG001|Overall Study|Lost to Follow-up|0|||
27900107|NCT05095311|81469448|FG002|Overall Study|Lost to Follow-up|0|||
27900108|NCT00520767|81469449|FG000|Overall Study|Death|2|||
27900109|NCT00494221|81469450|FG000|Overall Study|Death|15|||
27900110|NCT00494221|81469451|FG001|Overall Study|Death|9|||
27900111|NCT00494221|81469452|FG002|Overall Study|Death|14|||
27900112|NCT00494221|81469450|FG000|Overall Study|Withdrawal by Subject|1|||
27900113|NCT00494221|81469451|FG001|Overall Study|Withdrawal by Subject|2|||
27900114|NCT00494221|81469452|FG002|Overall Study|Withdrawal by Subject|0|||
27900115|NCT00431067|81469456|FG000|Overall Study|Other Adverse Event|9|||
27900116|NCT00431067|81469456|FG000|Overall Study|Progressive disease|30|||
27900117|NCT00431067|81469456|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
27900118|NCT02636439|81469459|FG000|Overall Study|Adverse Event|2|||
27900119|NCT02636439|81469460|FG001|Overall Study|Adverse Event|2|||
27900120|NCT02636439|81469459|FG000|Overall Study|Lost to Follow-up|1|||
27900121|NCT02636439|81469460|FG001|Overall Study|Lost to Follow-up|0|||
27900122|NCT02636439|81469459|FG000|Overall Study|Non-compliance|1|||
27900123|NCT02636439|81469460|FG001|Overall Study|Non-compliance|1|||
27900124|NCT02636439|81469459|FG000|Overall Study|Personal reasons|2|||
27900125|NCT02636439|81469460|FG001|Overall Study|Personal reasons|0|||
27900126|NCT00236899|81469468|FG000|Overall Study|Adverse Event (Study Related)|1|||
27900127|NCT00236899|81469469|FG001|Overall Study|Adverse Event (Study Related)|1|||
27900128|NCT00236899|81469470|FG002|Overall Study|Adverse Event (Study Related)|2|||
27900129|NCT00236899|81469471|FG003|Overall Study|Adverse Event (Study Related)|1|||
27900130|NCT00236899|81469468|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
27900131|NCT00236899|81469469|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
27900132|NCT00236899|81469470|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
27900133|NCT00236899|81469471|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
27900134|NCT00236899|81469468|FG000|Overall Study|Death (Study Disease)|1|||
27900135|NCT00236899|81469469|FG001|Overall Study|Death (Study Disease)|4|||
27900136|NCT00236899|81469470|FG002|Overall Study|Death (Study Disease)|0|||
27900137|NCT00236899|81469471|FG003|Overall Study|Death (Study Disease)|0|||
27900138|NCT00236899|81469468|FG000|Overall Study|Death (Not Study Related)|2|||
27900139|NCT00236899|81469469|FG001|Overall Study|Death (Not Study Related)|0|||
27851001|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27851002|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27851003|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27851004|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27851005|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
27851006|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
27851007|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
27900140|NCT00236899|81469470|FG002|Overall Study|Death (Not Study Related)|0|||
27900141|NCT00236899|81469471|FG003|Overall Study|Death (Not Study Related)|0|||
27900142|NCT00236899|81469468|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
27900143|NCT00236899|81469469|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
27900144|NCT00236899|81469470|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
27900145|NCT00236899|81469471|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
27900146|NCT00236899|81469468|FG000|Overall Study|Lost to Follow-up|0|||
27900147|NCT00236899|81469469|FG001|Overall Study|Lost to Follow-up|1|||
27900148|NCT00236899|81469470|FG002|Overall Study|Lost to Follow-up|0|||
27900149|NCT00236899|81469471|FG003|Overall Study|Lost to Follow-up|0|||
27900150|NCT00236899|81469468|FG000|Overall Study|Entry Criteria Exclusion|0|||
27900151|NCT00236899|81469469|FG001|Overall Study|Entry Criteria Exclusion|1|||
27900152|NCT00236899|81469470|FG002|Overall Study|Entry Criteria Exclusion|1|||
27900153|NCT00236899|81469471|FG003|Overall Study|Entry Criteria Exclusion|0|||
27900154|NCT00236899|81469468|FG000|Overall Study|Protocol Violation|1|||
27900155|NCT00236899|81469469|FG001|Overall Study|Protocol Violation|0|||
27900156|NCT00236899|81469470|FG002|Overall Study|Protocol Violation|0|||
27900157|NCT00236899|81469471|FG003|Overall Study|Protocol Violation|0|||
27900158|NCT00236899|81469468|FG000|Overall Study|Withdrawal by Subject|6|||
27900159|NCT00236899|81469469|FG001|Overall Study|Withdrawal by Subject|4|||
27900160|NCT00236899|81469470|FG002|Overall Study|Withdrawal by Subject|5|||
27900161|NCT00236899|81469471|FG003|Overall Study|Withdrawal by Subject|2|||
27900162|NCT00236899|81469468|FG000|Overall Study|Physician Decision|7|||
27900163|NCT00236899|81469469|FG001|Overall Study|Physician Decision|8|||
27900164|NCT00236899|81469470|FG002|Overall Study|Physician Decision|7|||
27900165|NCT00236899|81469471|FG003|Overall Study|Physician Decision|6|||
27900166|NCT00236899|81469468|FG000|Overall Study|Satisfactory Response|2|||
27900167|NCT00236899|81469469|FG001|Overall Study|Satisfactory Response|0|||
27900168|NCT00236899|81469470|FG002|Overall Study|Satisfactory Response|0|||
27900169|NCT00236899|81469471|FG003|Overall Study|Satisfactory Response|1|||
27900170|NCT00236899|81469468|FG000|Overall Study|Lack of Efficacy|18|||
27900171|NCT00236899|81469469|FG001|Overall Study|Lack of Efficacy|18|||
27900172|NCT00236899|81469470|FG002|Overall Study|Lack of Efficacy|25|||
27900173|NCT00236899|81469471|FG003|Overall Study|Lack of Efficacy|23|||
27900174|NCT00792116|81469472|FG000|Overall Study|Lost to Follow-up|0|||
27900175|NCT00792116|81469473|FG001|Overall Study|Lost to Follow-up|1|||
27900176|NCT00792116|81469472|FG000|Overall Study|Discontnued intervention|1|||
27900177|NCT00792116|81469473|FG001|Overall Study|Discontnued intervention|0|||
27900178|NCT03309696|81469474|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
27900179|NCT03309696|81469475|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
27900180|NCT03309696|81469476|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
27900181|NCT03309696|81469477|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
27900182|NCT02305446|81469478|FG000|Overall Study|Adverse Event|1|||
27900183|NCT01877551|81469480|FG000|Overall Study|Physician Decision|0|||
27900184|NCT01877551|81469481|FG001|Overall Study|Physician Decision|1|||
27900185|NCT01926197|81469482|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
27900186|NCT01926197|81469483|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
27900187|NCT01926197|81469482|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
27900188|NCT01926197|81469483|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
27851008|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851009|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851010|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851011|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851012|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851013|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851014|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851015|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851016|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851017|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
27851018|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
27851019|NCT04146363|81283028|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851020|NCT04146363|81283029|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851021|NCT04146363|81283030|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851022|NCT04146363|81283031|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851023|NCT04146363|81283032|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851024|NCT04146363|81283033|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851025|NCT04146363|81283034|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851026|NCT04146363|81283035|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851027|NCT04146363|81283036|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851028|NCT04146363|81283037|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
27851029|NCT04146363|81283038|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
27851030|NCT02071849|81283039|FG000|6-month Primary Endpoint|Did not receive device|4|||
27851031|NCT02071849|81283039|FG000|6-month Primary Endpoint|Adverse Event|1|||
27851032|NCT02071849|81283039|FG000|2-year Extended Follow-up|Adverse Event|1|||
27900189|NCT01853696|81469486|FG000|Overall Study|Withdrawal by Subject|1|||
27900190|NCT01853696|81469487|FG001|Overall Study|Withdrawal by Subject|1|||
27900191|NCT01853696|81469486|FG000|Overall Study|Lost to Follow-up|5|||
27900192|NCT01853696|81469487|FG001|Overall Study|Lost to Follow-up|4|||
27900193|NCT03882957|81469491|FG000|Overall Study|Did not complete all three arms|1|||
27900194|NCT03099694|81472912|FG000|Overall Study|Withdrawal by Subject|11|||
27900195|NCT03099694|81472913|FG001|Overall Study|Withdrawal by Subject|13|||
27900196|NCT03099694|81472912|FG000|Overall Study|Lost to Follow-up|9|||
27900197|NCT03099694|81472913|FG001|Overall Study|Lost to Follow-up|5|||
27900198|NCT02172040|81472916|FG000|Overall Study|Adverse Event|0|||
27506363|NCT03126591|80047795|FG000|Overall Study|Progressive Disease|0|||
27506364|NCT03126591|80047796|FG001|Overall Study|Progressive Disease|1|||
27506365|NCT03126591|80047797|FG002|Overall Study|Progressive Disease|2|||
27506366|NCT03126591|80047795|FG000|Overall Study|Terminated by Sponsor|0|||
27506367|NCT03126591|80047796|FG001|Overall Study|Terminated by Sponsor|1|||
27506368|NCT03126591|80047797|FG002|Overall Study|Terminated by Sponsor|4|||
27506369|NCT03126591|80047795|FG000|Overall Study|Withdrawal by Subject|1|||
27506370|NCT03126591|80047796|FG001|Overall Study|Withdrawal by Subject|1|||
27506371|NCT03126591|80047797|FG002|Overall Study|Withdrawal by Subject|4|||
27506372|NCT04634253|80047798|FG000|Overall Study|Adverse Event|1|||
27506373|NCT04634253|80047799|FG001|Overall Study|Adverse Event|1|||
27506374|NCT04634253|80047800|FG002|Overall Study|Adverse Event|0|||
27506375|NCT04634253|80047798|FG000|Overall Study|Physician Decision|0|||
27506376|NCT04634253|80047799|FG001|Overall Study|Physician Decision|1|||
27506377|NCT04634253|80047800|FG002|Overall Study|Physician Decision|0|||
27506378|NCT04634253|80047798|FG000|Overall Study|Withdrawal by Subject|1|||
27506379|NCT04634253|80047799|FG001|Overall Study|Withdrawal by Subject|0|||
27506380|NCT04634253|80047800|FG002|Overall Study|Withdrawal by Subject|3|||
27506381|NCT01491607|80047801|FG000|Overall Study|Lost to Follow-up|7|||
27506382|NCT01491607|80047801|FG000|Overall Study|Withdrawal by Subject|3|||
27506383|NCT01721044|80047802|FG000|Treatment Period|Adverse Event|7|||
27506384|NCT01721044|80047803|FG001|Treatment Period|Adverse Event|7|||
27506385|NCT01721044|80047804|FG002|Treatment Period|Adverse Event|10|||
27506386|NCT01721044|80047802|FG000|Treatment Period|Death|0|||
27506387|NCT01721044|80047803|FG001|Treatment Period|Death|0|||
27506388|NCT01721044|80047804|FG002|Treatment Period|Death|1|||
27506389|NCT01721044|80047802|FG000|Treatment Period|Lack of Efficacy|16|||
27506390|NCT01721044|80047803|FG001|Treatment Period|Lack of Efficacy|4|||
27506391|NCT01721044|80047804|FG002|Treatment Period|Lack of Efficacy|4|||
27506392|NCT01721044|80047802|FG000|Treatment Period|Lost to Follow-up|0|||
27506393|NCT01721044|80047803|FG001|Treatment Period|Lost to Follow-up|0|||
27506394|NCT01721044|80047804|FG002|Treatment Period|Lost to Follow-up|1|||
27506395|NCT01721044|80047802|FG000|Treatment Period|Physician Decision|1|||
27506396|NCT01721044|80047803|FG001|Treatment Period|Physician Decision|0|||
27506397|NCT01721044|80047804|FG002|Treatment Period|Physician Decision|2|||
27506398|NCT01721044|80047802|FG000|Treatment Period|Protocol Violation|1|||
27506399|NCT01721044|80047803|FG001|Treatment Period|Protocol Violation|0|||
27506400|NCT01721044|80047804|FG002|Treatment Period|Protocol Violation|0|||
27506401|NCT01721044|80047802|FG000|Treatment Period|Withdrawal by Subject|7|||
27506402|NCT01721044|80047803|FG001|Treatment Period|Withdrawal by Subject|6|||
27506403|NCT01721044|80047804|FG002|Treatment Period|Withdrawal by Subject|1|||
27506404|NCT05050318|80047805|FG000|Overall Study|Protocol Deviation|1|||
27506405|NCT05050318|80047806|FG001|Overall Study|Protocol Deviation|0|||
27506406|NCT05050318|80047807|FG002|Overall Study|Protocol Deviation|0|||
27506407|NCT02083354|80047808|FG000|Overall Study|Withdrawal by Subject|9|||
27506408|NCT02083354|80047808|FG000|Overall Study|Lost to Follow-up|1|||
27506409|NCT02083354|80047808|FG000|Overall Study|Adverse Event|3|||
27727557|NCT01670994|80830288|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
27727558|NCT01670994|80830289|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
27727559|NCT01670994|80830288|FG000|Overall Study|Patient experienced DLT|0|||
27727560|NCT01670994|80830289|FG001|Overall Study|Patient experienced DLT|1|||
27727561|NCT02700451|80830290|FG000|Overall Study|Protocol Violation|2|||
27727562|NCT02700451|80830291|FG001|Overall Study|Protocol Violation|2|||
27727563|NCT02700451|80830292|FG002|Overall Study|Protocol Violation|3|||
27727564|NCT02700451|80830290|FG000|Overall Study|Discontinued intervention|14|||
27727565|NCT02700451|80830291|FG001|Overall Study|Discontinued intervention|15|||
27727566|NCT02700451|80830292|FG002|Overall Study|Discontinued intervention|14|||
27727567|NCT00848120|80830293|FG000|Overall Study|Adverse Event|1|||
27727568|NCT01468987|80830294|FG000|Overall Study|Adverse Event|12|||
27727569|NCT01468987|80830295|FG001|Overall Study|Adverse Event|9|||
27727570|NCT01468987|80830294|FG000|Overall Study|Death|4|||
27727571|NCT01468987|80830295|FG001|Overall Study|Death|1|||
27727572|NCT01468987|80830294|FG000|Overall Study|Lost to Follow-up|10|||
27506410|NCT02083354|80047808|FG000|Overall Study|Disease progression|46|||
27506411|NCT02083354|80047808|FG000|Overall Study|Study closed/terminated|5|||
27506412|NCT04313244|80047812|FG000|Overall Study|Withdrawal of Consent|3|||
27506413|NCT04313244|80047813|FG001|Overall Study|Withdrawal of Consent|3|||
27506414|NCT04313244|80047812|FG000|Overall Study|Met Exclusion Criteria|1|||
27506415|NCT04313244|80047813|FG001|Overall Study|Met Exclusion Criteria|0|||
27506416|NCT04313244|80047812|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
27727573|NCT01468987|80830295|FG001|Overall Study|Lost to Follow-up|5|||
27506417|NCT04313244|80047813|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
27506418|NCT02004093|80047814|FG000|Overall Study|Death|2|||
27727574|NCT01468987|80830294|FG000|Overall Study|Protocol Violation|8|||
27727575|NCT01468987|80830295|FG001|Overall Study|Protocol Violation|2|||
27506419|NCT02004093|80047815|FG001|Overall Study|Death|1|||
27727576|NCT01468987|80830294|FG000|Overall Study|Withdrawal by Subject|28|||
27727577|NCT01468987|80830295|FG001|Overall Study|Withdrawal by Subject|28|||
27900199|NCT02172040|81472917|FG001|Overall Study|Adverse Event|2|||
27900200|NCT02172040|81472918|FG002|Overall Study|Adverse Event|0|||
27900201|NCT02172040|81472919|FG003|Overall Study|Adverse Event|0|||
27900202|NCT02172040|81472916|FG000|Overall Study|Protocol Violation|0|||
27900203|NCT02172040|81472917|FG001|Overall Study|Protocol Violation|1|||
27900204|NCT02172040|81472918|FG002|Overall Study|Protocol Violation|0|||
27900205|NCT02172040|81472919|FG003|Overall Study|Protocol Violation|0|||
27900206|NCT02172040|81472916|FG000|Overall Study|Withdrawal by Subject|0|||
27900207|NCT02172040|81472917|FG001|Overall Study|Withdrawal by Subject|0|||
27900208|NCT02172040|81472918|FG002|Overall Study|Withdrawal by Subject|1|||
27900209|NCT02172040|81472919|FG003|Overall Study|Withdrawal by Subject|0|||
27900210|NCT02172040|81472916|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
27900211|NCT02172040|81472917|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
27900212|NCT02172040|81472918|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
27900213|NCT02172040|81472919|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
27900214|NCT02172040|81472916|FG000|Overall Study|Family emergency abroad|0|||
27900215|NCT02172040|81472917|FG001|Overall Study|Family emergency abroad|0|||
27900216|NCT02172040|81472918|FG002|Overall Study|Family emergency abroad|0|||
27900217|NCT02172040|81472919|FG003|Overall Study|Family emergency abroad|1|||
27900218|NCT00830518|81472925|FG000|Overall Study|Progressive Disease|18|||
27900219|NCT00830518|81472926|FG001|Overall Study|Progressive Disease|8|||
27900220|NCT00830518|81472925|FG000|Overall Study|Symptomatic Deterioration|4|||
27900221|NCT00830518|81472926|FG001|Overall Study|Symptomatic Deterioration|1|||
27900222|NCT00830518|81472925|FG000|Overall Study|Adverse Event|14|||
27900223|NCT00830518|81472926|FG001|Overall Study|Adverse Event|1|||
27900224|NCT00830518|81472925|FG000|Overall Study|Withdrawal by Patient|2|||
27900225|NCT00830518|81472926|FG001|Overall Study|Withdrawal by Patient|0|||
27900226|NCT00830518|81472925|FG000|Overall Study|Reason not Specified|8|||
27900227|NCT00830518|81472926|FG001|Overall Study|Reason not Specified|1|||
27900228|NCT04401202|81472927|FG000|Overall Study|Lost to Follow-up|2|||
27900229|NCT04401202|81472928|FG001|Overall Study|Lost to Follow-up|2|||
27900230|NCT04401202|81472927|FG000|Overall Study|Adverse Event|0|||
27900231|NCT04401202|81472928|FG001|Overall Study|Adverse Event|1|||
27900232|NCT04401202|81472927|FG000|Overall Study|Hospitalized|4|||
27900233|NCT04401202|81472928|FG001|Overall Study|Hospitalized|1|||
27900234|NCT02717442|81472929|FG000|Overall Study|Study Terminated by Sponsor|31|||
27900235|NCT02717442|81472930|FG001|Overall Study|Study Terminated by Sponsor|29|||
27900236|NCT02717442|81472929|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
27900237|NCT02717442|81472930|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
27900238|NCT02717442|81472929|FG000|Overall Study|Other - Not Specified|2|||
27900239|NCT02717442|81472930|FG001|Overall Study|Other - Not Specified|0|||
27900240|NCT01237327|81472931|FG000|Overall Study|Protocol Violation: Core Study|1|||
27900241|NCT01237327|81472932|FG001|Overall Study|Protocol Violation: Core Study|0|||
27900242|NCT01237327|81472931|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
27900243|NCT01237327|81472932|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
27900244|NCT01237327|81472931|FG000|Overall Study|Progression of Disease: Core Study|18|||
27900245|NCT01237327|81472932|FG001|Overall Study|Progression of Disease: Core Study|22|||
27900246|NCT01237327|81472931|FG000|Overall Study|Progression of Disease: Extension Study|15|||
27900247|NCT01237327|81472932|FG001|Overall Study|Progression of Disease: Extension Study|13|||
27900248|NCT01237327|81472931|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
27900249|NCT01237327|81472932|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
27900250|NCT01237327|81472931|FG000|Overall Study|Withdrawal by Subject|1|||
27900251|NCT01237327|81472932|FG001|Overall Study|Withdrawal by Subject|3|||
27900252|NCT01237327|81472931|FG000|Overall Study|Lost to Follow-up|3|||
27900253|NCT01237327|81472932|FG001|Overall Study|Lost to Follow-up|0|||
27900254|NCT02483572|81472933|FG000|Overall Study|Withdrawal by Subject|1|||
27900255|NCT02483572|81472934|FG001|Overall Study|Withdrawal by Subject|0|||
27900256|NCT02483572|81472933|FG000|Overall Study|Lost to Follow-up|1|||
27900257|NCT02483572|81472934|FG001|Overall Study|Lost to Follow-up|0|||
27900258|NCT02483572|81472933|FG000|Overall Study|Physician Decision|0|||
27900259|NCT02483572|81472934|FG001|Overall Study|Physician Decision|1|||
27900260|NCT00184093|81472935|FG000|Overall Study|Adverse Event|3|||
27900261|NCT00184093|81472935|FG000|Overall Study|Lost to Follow-up|3|||
27506420|NCT02004093|80047814|FG000|Overall Study|Lack of Efficacy|66|||
27900262|NCT00184093|81472935|FG000|Overall Study|Physician Decision|1|||
27900263|NCT00184093|81472935|FG000|Overall Study|Withdrawal by Subject|2|||
27900264|NCT02453256|81472936|FG000|Double Blind Period|Death|1|||
27900265|NCT02453256|81472937|FG001|Double Blind Period|Death|1|||
27900266|NCT02453256|81472936|FG000|Double Blind Period|Adverse Event|3|||
27900267|NCT02453256|81472937|FG001|Double Blind Period|Adverse Event|2|||
27900268|NCT02453256|81472936|FG000|Double Blind Period|Withdrawal by Subject|9|||
27900269|NCT02453256|81472937|FG001|Double Blind Period|Withdrawal by Subject|5|||
27900270|NCT02453256|81472936|FG000|Double Blind Period|Other|0|||
27900271|NCT02453256|81472937|FG001|Double Blind Period|Other|1|||
27900272|NCT02453256|81472936|FG000|Open Label Period|Adverse Event|1|||
27900273|NCT02453256|81472937|FG001|Open Label Period|Adverse Event|3|||
27900274|NCT02453256|81472936|FG000|Open Label Period|Death|0|||
27900275|NCT02453256|81472937|FG001|Open Label Period|Death|1|||
27900276|NCT02453256|81472936|FG000|Open Label Period|Lost to Follow-up|1|||
27900277|NCT02453256|81472937|FG001|Open Label Period|Lost to Follow-up|0|||
27900278|NCT02453256|81472936|FG000|Open Label Period|Other|0|||
27900279|NCT02453256|81472937|FG001|Open Label Period|Other|2|||
27900280|NCT02453256|81472936|FG000|Open Label Period|Withdrawal by Subject|5|||
27900281|NCT02453256|81472937|FG001|Open Label Period|Withdrawal by Subject|1|||
27900282|NCT04526574|81472940|FG000|Overall Study|Protocol Violation|3|||
27900283|NCT04526574|81472941|FG001|Overall Study|Protocol Violation|1|||
27900284|NCT04526574|81472940|FG000|Overall Study|Withdrawal by Subject|12|||
27900285|NCT04526574|81472941|FG001|Overall Study|Withdrawal by Subject|9|||
27900286|NCT04526574|81472940|FG000|Overall Study|Other|1|||
27900287|NCT04526574|81472941|FG001|Overall Study|Other|2|||
27900288|NCT04526574|81472940|FG000|Overall Study|Adverse Event|1|||
27900289|NCT04526574|81472941|FG001|Overall Study|Adverse Event|1|||
27900290|NCT04526574|81472940|FG000|Overall Study|Death|2|||
27900291|NCT04526574|81472941|FG001|Overall Study|Death|3|||
27900292|NCT04526574|81472940|FG000|Overall Study|Lost to Follow-up|9|||
27900293|NCT04526574|81472941|FG001|Overall Study|Lost to Follow-up|9|||
27900294|NCT04526574|81472940|FG000|Overall Study|No longer meets eligibility criteria|8|||
27900295|NCT04526574|81472941|FG001|Overall Study|No longer meets eligibility criteria|8|||
27900296|NCT00586508|81472944|FG000|Overall Study|Progressive disease|52|||
27900297|NCT00586508|81472945|FG001|Overall Study|Progressive disease|8|||
27900298|NCT00586508|81472944|FG000|Overall Study|Death|0|||
27727578|NCT01468987|80830294|FG000|Overall Study|Physician Decision|8|||
27727579|NCT01468987|80830295|FG001|Overall Study|Physician Decision|15|||
27727580|NCT01468987|80830294|FG000|Overall Study|Sponsor Decision|1|||
27727581|NCT01468987|80830295|FG001|Overall Study|Sponsor Decision|0|||
27727582|NCT02411747|80830300|FG000|Overall Study|Withdrawal by Subject|1|||
27727583|NCT02411747|80830301|FG001|Overall Study|Withdrawal by Subject|0|||
27727584|NCT02411747|80830300|FG000|Overall Study|Protocol Violation|2|||
27727585|NCT02411747|80830301|FG001|Overall Study|Protocol Violation|4|||
27727586|NCT02487108|80830302|FG000|Overall Study|Adverse Event|1|||
27727587|NCT02487108|80830303|FG001|Overall Study|Adverse Event|6|||
27727588|NCT02487108|80830304|FG002|Overall Study|Adverse Event|12|||
27727589|NCT02487108|80830305|FG003|Overall Study|Adverse Event|6|||
27727590|NCT02487108|80830302|FG000|Overall Study|Withdrawal by Subject|8|||
27727591|NCT02487108|80830303|FG001|Overall Study|Withdrawal by Subject|5|||
27727592|NCT02487108|80830304|FG002|Overall Study|Withdrawal by Subject|5|||
27727593|NCT02487108|80830305|FG003|Overall Study|Withdrawal by Subject|0|||
27900299|NCT00586508|81472945|FG001|Overall Study|Death|1|||
27900300|NCT00586508|81472944|FG000|Overall Study|Adverse Event|12|||
27900301|NCT00586508|81472945|FG001|Overall Study|Adverse Event|4|||
27900302|NCT00586508|81472944|FG000|Overall Study|Withdrawal by Subject|4|||
27900303|NCT00586508|81472945|FG001|Overall Study|Withdrawal by Subject|0|||
27900304|NCT01522235|81472947|FG000|Overall Study|Physician Decision|1|||
27727594|NCT02487108|80830302|FG000|Overall Study|Non-compliance to study medication|3|||
27727595|NCT02487108|80830303|FG001|Overall Study|Non-compliance to study medication|2|||
27727596|NCT02487108|80830304|FG002|Overall Study|Non-compliance to study medication|5|||
27727597|NCT02487108|80830305|FG003|Overall Study|Non-compliance to study medication|4|||
27727598|NCT02487108|80830302|FG000|Overall Study|Protocol Violation|1|||
27727599|NCT02487108|80830303|FG001|Overall Study|Protocol Violation|1|||
27727600|NCT02487108|80830304|FG002|Overall Study|Protocol Violation|2|||
27727601|NCT02487108|80830305|FG003|Overall Study|Protocol Violation|0|||
27727602|NCT02487108|80830302|FG000|Overall Study|Non-compliance to study procedures|0|||
27727603|NCT02487108|80830303|FG001|Overall Study|Non-compliance to study procedures|0|||
27727604|NCT02487108|80830304|FG002|Overall Study|Non-compliance to study procedures|0|||
27900305|NCT01522235|81472948|FG001|Overall Study|Physician Decision|1|||
27900306|NCT00369161|81472949|FG000|Overall Study|Adverse Event|15|||
27900307|NCT00369161|81472950|FG001|Overall Study|Adverse Event|13|||
27900308|NCT00369161|81472949|FG000|Overall Study|Abnormal laboratory value|0|||
27900309|NCT00369161|81472950|FG001|Overall Study|Abnormal laboratory value|1|||
27900310|NCT00369161|81472949|FG000|Overall Study|Lack of Efficacy|3|||
27900311|NCT00369161|81472950|FG001|Overall Study|Lack of Efficacy|1|||
27900312|NCT00369161|81472949|FG000|Overall Study|Protocol Violation|0|||
27900313|NCT00369161|81472950|FG001|Overall Study|Protocol Violation|2|||
27900314|NCT00369161|81472949|FG000|Overall Study|Withdrawal by Subject|2|||
27900315|NCT00369161|81472950|FG001|Overall Study|Withdrawal by Subject|3|||
27900316|NCT00369161|81472949|FG000|Overall Study|Death|1|||
27900317|NCT00369161|81472950|FG001|Overall Study|Death|2|||
27900318|NCT00369161|81472949|FG000|Overall Study|Graft loss|4|||
27506421|NCT02004093|80047815|FG001|Overall Study|Lack of Efficacy|62|||
27900319|NCT00369161|81472950|FG001|Overall Study|Graft loss|0|||
27900320|NCT00369161|81472949|FG000|Overall Study|Administrative Problem|2|||
27727605|NCT02487108|80830305|FG003|Overall Study|Non-compliance to study procedures|1|||
27727606|NCT02487108|80830302|FG000|Overall Study|Other than specified|3|||
27727607|NCT02487108|80830303|FG001|Overall Study|Other than specified|2|||
27727608|NCT02487108|80830304|FG002|Overall Study|Other than specified|2|||
27900321|NCT00369161|81472950|FG001|Overall Study|Administrative Problem|2|||
27900322|NCT00492232|81472951|FG000|Placebo Run-in|Adverse Event|0|||
27900323|NCT00492232|81472952|FG001|Placebo Run-in|Adverse Event|2|||
27900324|NCT00492232|81472951|FG000|Placebo Run-in|Protocol Violation|0|||
27900325|NCT00492232|81472952|FG001|Placebo Run-in|Protocol Violation|3|||
27900326|NCT00492232|81472951|FG000|Placebo Run-in|Lost to Follow-up|0|||
27900327|NCT00492232|81472952|FG001|Placebo Run-in|Lost to Follow-up|3|||
27900328|NCT00492232|81472951|FG000|Placebo Run-in|Withdrawal by Subject|0|||
27900329|NCT00492232|81472952|FG001|Placebo Run-in|Withdrawal by Subject|8|||
27900330|NCT00492232|81472951|FG000|Placebo Run-in|Pregnancy|0|||
27900331|NCT00492232|81472952|FG001|Placebo Run-in|Pregnancy|1|||
27900332|NCT00492232|81472951|FG000|Placebo Run-in|Entrance criteria not met|0|||
27900333|NCT00492232|81472952|FG001|Placebo Run-in|Entrance criteria not met|45|||
27900334|NCT00492232|81472951|FG000|Placebo Run-in|Other|0|||
27900335|NCT00492232|81472952|FG001|Placebo Run-in|Other|6|||
27900336|NCT00492232|81472951|FG000|Placebo Run-in|Missing|0|||
27900337|NCT00492232|81472952|FG001|Placebo Run-in|Missing|2|||
27900338|NCT00492232|81472951|FG000|Double-Blind Treatment|Adverse Event|1|||
27900339|NCT00492232|81472952|FG001|Double-Blind Treatment|Adverse Event|2|||
27900340|NCT00492232|81472951|FG000|Double-Blind Treatment|Protocol Violation|3|||
27900341|NCT00492232|81472952|FG001|Double-Blind Treatment|Protocol Violation|7|||
27900342|NCT00492232|81472951|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
27900343|NCT00492232|81472952|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
27900344|NCT00492232|81472951|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
27900345|NCT00492232|81472952|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
27900346|NCT00492232|81472951|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
27900347|NCT00492232|81472952|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
27900348|NCT00492232|81472951|FG000|Double-Blind Treatment|Other|6|||
27900349|NCT00492232|81472952|FG001|Double-Blind Treatment|Other|5|||
27900350|NCT00492232|81472951|FG000|Double-Blind Treatment|Randomized not treated|1|||
27900351|NCT00492232|81472952|FG001|Double-Blind Treatment|Randomized not treated|0|||
27900352|NCT00492232|81472951|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
27900353|NCT00492232|81472952|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
27900354|NCT02984267|81472953|FG000|Overall Study|Protocol Violation|1|||
27900355|NCT02984267|81472954|FG001|Overall Study|Protocol Violation|0|||
27900356|NCT02984267|81472953|FG000|Overall Study|Withdrawal by Subject|0|||
27900357|NCT02984267|81472954|FG001|Overall Study|Withdrawal by Subject|1|||
27900358|NCT00630747|81472955|FG000|Overall Study|Death|1|||
27900359|NCT00630747|81472955|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
27900360|NCT00630747|81472955|FG000|Overall Study|Returned to country of origin|1|||
27900361|NCT02661061|81472956|FG000|Overall Study|Lack of Efficacy|1|||
27900362|NCT02661061|81472957|FG001|Overall Study|Lack of Efficacy|1|||
27900363|NCT02661061|81472956|FG000|Overall Study|Withdrawal by Subject|1|||
27900364|NCT02661061|81472957|FG001|Overall Study|Withdrawal by Subject|1|||
27900365|NCT00636961|81472959|FG000|Period 1|Administrative problems|1|||
27900366|NCT00636961|81472960|FG001|Period 1|Administrative problems|1|||
27900367|NCT00636961|81472959|FG000|Period 2|Adverse Event|1|||
27900368|NCT00636961|81472960|FG001|Period 2|Adverse Event|0|||
27900369|NCT02787083|81472969|FG000|Overall Study|Adverse Event|1|||
27900370|NCT02787083|81472970|FG001|Overall Study|Adverse Event|0|||
27900371|NCT02787083|81472969|FG000|Overall Study|Withdrawal by Subject|2|||
27900372|NCT02787083|81472970|FG001|Overall Study|Withdrawal by Subject|2|||
27900373|NCT03403621|81472977|FG000|Overall Study|Withdrawal by Subject|2|||
27900374|NCT03403621|81472978|FG001|Overall Study|Withdrawal by Subject|2|||
27900375|NCT02147067|81472981|FG000|Overall Study|Withdrawal by Subject|2|||
27900376|NCT02147067|81472982|FG001|Overall Study|Withdrawal by Subject|2|||
27900377|NCT04093492|81472983|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
27900378|NCT04093492|81472984|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
27900379|NCT04093492|81472985|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
27900380|NCT04093492|81472986|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
27900381|NCT04093492|81472983|FG000|25 Weeks Gestational Age (GA)|No response|5|||
27900382|NCT04093492|81472984|FG001|25 Weeks Gestational Age (GA)|No response|5|||
27900383|NCT04093492|81472985|FG002|25 Weeks Gestational Age (GA)|No response|5|||
27900384|NCT04093492|81472986|FG003|25 Weeks Gestational Age (GA)|No response|2|||
27900385|NCT04093492|81472983|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
27900386|NCT04093492|81472984|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
27900387|NCT04093492|81472985|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
27900388|NCT04093492|81472986|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
27900389|NCT04093492|81472983|FG000|30 Weeks GA|Delivered before assessment|1|||
27900390|NCT04093492|81472984|FG001|30 Weeks GA|Delivered before assessment|2|||
27506422|NCT02004093|80047814|FG000|Overall Study|Protocol Violation|0|||
27614207|NCT01644474|80430176|FG001|Overall Study|Adverse Event|5|||
27900391|NCT04093492|81472985|FG002|30 Weeks GA|Delivered before assessment|0|||
27900392|NCT04093492|81472986|FG003|30 Weeks GA|Delivered before assessment|0|||
27900393|NCT04093492|81472983|FG000|30 Weeks GA|No response|7|||
27900394|NCT04093492|81472984|FG001|30 Weeks GA|No response|5|||
27900395|NCT04093492|81472985|FG002|30 Weeks GA|No response|5|||
27900396|NCT04093492|81472986|FG003|30 Weeks GA|No response|2|||
27900397|NCT04093492|81472983|FG000|30 Weeks GA|Lost to Follow-up|0|||
27900398|NCT04093492|81472984|FG001|30 Weeks GA|Lost to Follow-up|1|||
27900399|NCT04093492|81472985|FG002|30 Weeks GA|Lost to Follow-up|0|||
27900400|NCT04093492|81472986|FG003|30 Weeks GA|Lost to Follow-up|0|||
27900401|NCT04093492|81472983|FG000|34 Weeks GA|Delivered before assessment|6|||
27900402|NCT04093492|81472984|FG001|34 Weeks GA|Delivered before assessment|3|||
27900403|NCT04093492|81472985|FG002|34 Weeks GA|Delivered before assessment|0|||
27900404|NCT04093492|81472986|FG003|34 Weeks GA|Delivered before assessment|0|||
27900405|NCT04093492|81472983|FG000|34 Weeks GA|No response|0|||
27900406|NCT04093492|81472984|FG001|34 Weeks GA|No response|7|||
27900407|NCT04093492|81472985|FG002|34 Weeks GA|No response|5|||
27900408|NCT04093492|81472986|FG003|34 Weeks GA|No response|3|||
27900409|NCT04093492|81472983|FG000|34 Weeks GA|Lost to Follow-up|0|||
27900410|NCT04093492|81472984|FG001|34 Weeks GA|Lost to Follow-up|1|||
27900411|NCT04093492|81472985|FG002|34 Weeks GA|Lost to Follow-up|0|||
27900412|NCT04093492|81472986|FG003|34 Weeks GA|Lost to Follow-up|0|||
27900413|NCT00006305|81472987|FG000|Overall Study|Withdrawal by Subject|17|||
27900414|NCT00006305|81472988|FG001|Overall Study|Withdrawal by Subject|10|||
27900415|NCT00006305|81472989|FG002|Overall Study|Withdrawal by Subject|15|||
27900416|NCT00006305|81472990|FG003|Overall Study|Withdrawal by Subject|14|||
27900417|NCT00099632|81472993|FG000|Overall Study|Lost to Follow-up|1|||
27900418|NCT00099632|81472994|FG001|Overall Study|Lost to Follow-up|0|||
27900419|NCT00099632|81472995|FG002|Overall Study|Lost to Follow-up|3|||
27900420|NCT00099632|81472996|FG003|Overall Study|Lost to Follow-up|1|||
27900421|NCT00099632|81472997|FG004|Overall Study|Lost to Follow-up|1|||
27900422|NCT00099632|81472998|FG005|Overall Study|Lost to Follow-up|0|||
27900423|NCT00099632|81472993|FG000|Overall Study|Withdrawal by Subject|0|||
27900424|NCT00099632|81472994|FG001|Overall Study|Withdrawal by Subject|1|||
27900425|NCT00099632|81472995|FG002|Overall Study|Withdrawal by Subject|0|||
27900426|NCT00099632|81472996|FG003|Overall Study|Withdrawal by Subject|0|||
27900427|NCT00099632|81472997|FG004|Overall Study|Withdrawal by Subject|0|||
27900428|NCT00099632|81472998|FG005|Overall Study|Withdrawal by Subject|1|||
27900429|NCT00099632|81472993|FG000|Overall Study|Protocol Violation|0|||
27900430|NCT00099632|81472994|FG001|Overall Study|Protocol Violation|0|||
27900431|NCT00099632|81472995|FG002|Overall Study|Protocol Violation|0|||
27900432|NCT00099632|81472996|FG003|Overall Study|Protocol Violation|0|||
27900433|NCT00099632|81472997|FG004|Overall Study|Protocol Violation|0|||
27900434|NCT00099632|81472998|FG005|Overall Study|Protocol Violation|1|||
27900435|NCT00934856|81472999|FG000|Feasibility Part|Progressive disease|4|||
27900436|NCT00934856|81473000|FG001|Feasibility Part|Progressive disease|4|||
27900437|NCT00934856|81473001|FG002|Feasibility Part|Progressive disease|2|||
27900438|NCT00934856|81473002|FG003|Feasibility Part|Progressive disease|3|||
27900439|NCT00934856|81473003|FG004|Feasibility Part|Progressive disease|0|||
27900440|NCT00934856|81473004|FG005|Feasibility Part|Progressive disease|0|||
27900441|NCT00934856|81472999|FG000|Feasibility Part|Physician Decision|0|||
27900442|NCT00934856|81473000|FG001|Feasibility Part|Physician Decision|0|||
27900443|NCT00934856|81473001|FG002|Feasibility Part|Physician Decision|1|||
27900444|NCT00934856|81473002|FG003|Feasibility Part|Physician Decision|0|||
27900445|NCT00934856|81473003|FG004|Feasibility Part|Physician Decision|0|||
27506423|NCT02004093|80047815|FG001|Overall Study|Protocol Violation|1|||
27506424|NCT02004093|80047814|FG000|Overall Study|Lost to Follow-up|0|||
27506425|NCT02004093|80047815|FG001|Overall Study|Lost to Follow-up|1|||
27506426|NCT02004093|80047814|FG000|Overall Study|Withdrawal by Subject|3|||
27506427|NCT02004093|80047815|FG001|Overall Study|Withdrawal by Subject|7|||
27506428|NCT02004093|80047814|FG000|Overall Study|Other|3|||
27506429|NCT02004093|80047815|FG001|Overall Study|Other|1|||
27506430|NCT02976038|80047822|FG000|Overall Study|Physician Decision|22|||
27506431|NCT02976038|80047822|FG000|Overall Study|Withdrawal by Subject|3|||
27506432|NCT02976038|80047822|FG000|Overall Study|Lost to Follow-up|2|||
27506433|NCT02976038|80047822|FG000|Overall Study|Adverse Event|1|||
27727609|NCT02487108|80830305|FG003|Overall Study|Other than specified|0|||
27900446|NCT00934856|81473004|FG005|Feasibility Part|Physician Decision|0|||
27900447|NCT00934856|81472999|FG000|Feasibility Part|Adverse Event|1|||
27900448|NCT00934856|81473000|FG001|Feasibility Part|Adverse Event|1|||
27900449|NCT00934856|81473001|FG002|Feasibility Part|Adverse Event|0|||
27900450|NCT00934856|81473002|FG003|Feasibility Part|Adverse Event|1|||
27900451|NCT00934856|81473003|FG004|Feasibility Part|Adverse Event|0|||
27900452|NCT00934856|81473004|FG005|Feasibility Part|Adverse Event|2|||
27506434|NCT01055197|80047823|FG000|Overall Study|Protocol Violation|7|||
27900453|NCT00934856|81472999|FG000|Feasibility Part|Withdrawal by Subject|0|||
27900454|NCT00934856|81473000|FG001|Feasibility Part|Withdrawal by Subject|0|||
27900455|NCT00934856|81473001|FG002|Feasibility Part|Withdrawal by Subject|0|||
27900456|NCT00934856|81473002|FG003|Feasibility Part|Withdrawal by Subject|1|||
27900457|NCT00934856|81473003|FG004|Feasibility Part|Withdrawal by Subject|0|||
27900458|NCT00934856|81473004|FG005|Feasibility Part|Withdrawal by Subject|1|||
27900459|NCT00934856|81472999|FG000|Extension Part|Adverse Event|0|||
27900460|NCT00934856|81473000|FG001|Extension Part|Adverse Event|0|||
27727610|NCT04258579|80830306|FG000|Overall Study|Withdrawal by Subject|7|||
27727611|NCT04258579|80830306|FG000|Overall Study|Lost to Follow-up|3|||
27727612|NCT04258579|80830306|FG000|Overall Study|Protocol Violation|2|||
27727613|NCT04258579|80830306|FG000|Overall Study|Adverse Event|1|||
27851033|NCT00560937|81283042|FG000|Overall Study|Withdrawal by Subject|0|||
27851034|NCT00560937|81283043|FG001|Overall Study|Withdrawal by Subject|1|||
27851035|NCT00560937|81283042|FG000|Overall Study|Physician Decision|1|||
27851036|NCT00560937|81283043|FG001|Overall Study|Physician Decision|1|||
27851037|NCT02013375|81283044|FG000|Overall Study|Did not engraft|1|||
27851038|NCT02013375|81283044|FG000|Overall Study|Did not engraft|1|||
27851039|NCT02615171|81283045|FG000|Overall Study|Lost to Follow-up|2|||
27851040|NCT02615171|81283046|FG001|Overall Study|Lost to Follow-up|1|||
27851041|NCT04109313|81283047|FG000|Overall Study|Pregnancy|1|||
27851042|NCT04109313|81283047|FG000|Overall Study|Adverse Event|11|||
27851043|NCT04109313|81283047|FG000|Overall Study|Lack of Efficacy|11|||
27851044|NCT04109313|81283047|FG000|Overall Study|Lost to Follow-up|1|||
27851045|NCT04109313|81283047|FG000|Overall Study|Physician Decision|2|||
27851046|NCT04109313|81283047|FG000|Overall Study|Subject Decision|13|||
27851047|NCT04109313|81283047|FG000|Overall Study|Covid-19 situation|2|||
27851048|NCT01334710|81283048|FG000|Overall Study|Trial was terminated|3|||
27851049|NCT00605865|81283049|FG000|Overall Study|Protocol Violation|115|||
27851050|NCT04568031|81286947|FG000|Overall Study|Lost to Follow-up|1|||
27851051|NCT04568031|81286948|FG001|Overall Study|Lost to Follow-up|0|||
27851052|NCT04568031|81286949|FG002|Overall Study|Lost to Follow-up|0|||
27851053|NCT04568031|81286950|FG003|Overall Study|Lost to Follow-up|0|||
27851054|NCT04568031|81286947|FG000|Overall Study|Physician Decision|1|||
27851055|NCT04568031|81286948|FG001|Overall Study|Physician Decision|0|||
27851056|NCT04568031|81286949|FG002|Overall Study|Physician Decision|1|||
27851057|NCT04568031|81286950|FG003|Overall Study|Physician Decision|0|||
27851058|NCT04568031|81286947|FG000|Overall Study|Withdrawal by Subject|1|||
27851059|NCT04568031|81286948|FG001|Overall Study|Withdrawal by Subject|0|||
27851060|NCT04568031|81286949|FG002|Overall Study|Withdrawal by Subject|4|||
27851061|NCT04568031|81286950|FG003|Overall Study|Withdrawal by Subject|1|||
27851062|NCT03043560|81286951|FG000|Overall Study|Discontinued Intervention|1|||
27851063|NCT03043560|81286952|FG001|Overall Study|Discontinued Intervention|2|||
27506435|NCT01055197|80047824|FG001|Overall Study|Protocol Violation|2|||
27506436|NCT01055197|80047823|FG000|Overall Study|Withdrawal by Subject|2|||
27506437|NCT01055197|80047824|FG001|Overall Study|Withdrawal by Subject|0|||
27506438|NCT02419001|80047825|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
27506439|NCT02419001|80047826|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
27506440|NCT03857867|80047827|FG000|Overall Study|Physician Decision|1|||
27506441|NCT02556177|80047828|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
27851064|NCT03043560|81286951|FG000|Overall Study|Lost to Follow-up|0|||
27851065|NCT03043560|81286952|FG001|Overall Study|Lost to Follow-up|1|||
27851066|NCT01705236|81286955|FG000|Overall Study|Lost to Follow-up|1|||
27506442|NCT02556177|80047829|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
27506443|NCT03848728|80047837|FG000|Overall Study|Death|16|||
27851067|NCT01705236|81286955|FG000|Overall Study|Administrative problems|2|||
27851068|NCT01705236|81286955|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27851069|NCT01705236|81286955|FG000|Overall Study|Protocol Violation|3|||
27506444|NCT03848728|80047838|FG001|Overall Study|Death|13|||
27851070|NCT01705236|81286955|FG000|Overall Study|Abnormal test procedure result(s)|4|||
27851071|NCT01705236|81286955|FG000|Overall Study|Abnormal laboratory value(s)|4|||
27727614|NCT00559273|80830307|FG000|Correction Period (20 Weeks)|Death|3|||
27727615|NCT00559273|80830308|FG001|Correction Period (20 Weeks)|Death|4|||
27727616|NCT00559273|80830307|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
27727617|NCT00559273|80830308|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
27727618|NCT00559273|80830307|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
27727619|NCT00559273|80830308|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
27727620|NCT00559273|80830307|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
27727621|NCT00559273|80830308|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
27727622|NCT00559273|80830307|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
27727623|NCT00559273|80830308|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
27727624|NCT00559273|80830307|FG000|Evaluation Period (8 Weeks)|Death|1|||
27727625|NCT00559273|80830308|FG001|Evaluation Period (8 Weeks)|Death|3|||
27851072|NCT01705236|81286955|FG000|Overall Study|Withdrawal by Subject|5|||
27506445|NCT03848728|80047837|FG000|Overall Study|Outmigrated to non-study community|98|||
27506446|NCT03848728|80047838|FG001|Overall Study|Outmigrated to non-study community|106|||
27506447|NCT03848728|80047837|FG000|Overall Study|Transfered to non-study clinic|32|||
27851073|NCT01705236|81286955|FG000|Overall Study|Adverse Event|5|||
27851074|NCT01408563|81286956|FG000|Overall Study|Ineligible after consent/ registration|2|||
27851075|NCT00136318|81286959|FG000|Overall Study|Adverse Event|5|||
27506448|NCT03848728|80047838|FG001|Overall Study|Transfered to non-study clinic|48|||
27727626|NCT00559273|80830307|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
27851076|NCT00136318|81286960|FG001|Overall Study|Adverse Event|5|||
27506449|NCT03848728|80047837|FG000|Overall Study|Withdrawal by Subject|1|||
27506450|NCT03848728|80047838|FG001|Overall Study|Withdrawal by Subject|0|||
27900461|NCT00934856|81473001|FG002|Extension Part|Adverse Event|0|||
27900462|NCT00934856|81473002|FG003|Extension Part|Adverse Event|1|||
27900463|NCT00934856|81473003|FG004|Extension Part|Adverse Event|4|||
27900464|NCT00934856|81473004|FG005|Extension Part|Adverse Event|4|||
27900465|NCT00934856|81472999|FG000|Extension Part|Progressive disease|0|||
27900466|NCT00934856|81473000|FG001|Extension Part|Progressive disease|0|||
27900467|NCT00934856|81473001|FG002|Extension Part|Progressive disease|0|||
27900468|NCT00934856|81473002|FG003|Extension Part|Progressive disease|1|||
27900469|NCT00934856|81473003|FG004|Extension Part|Progressive disease|0|||
27900470|NCT00934856|81473004|FG005|Extension Part|Progressive disease|0|||
27900471|NCT00934856|81472999|FG000|Extension Part|Non-compliance with drug|0|||
27900472|NCT00934856|81473000|FG001|Extension Part|Non-compliance with drug|0|||
27900473|NCT00934856|81473001|FG002|Extension Part|Non-compliance with drug|0|||
27900474|NCT00934856|81473002|FG003|Extension Part|Non-compliance with drug|0|||
27900475|NCT00934856|81473003|FG004|Extension Part|Non-compliance with drug|0|||
27900476|NCT00934856|81473004|FG005|Extension Part|Non-compliance with drug|1|||
27900477|NCT02735096|81473005|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
27900478|NCT02943785|81473006|FG000|Overall Study|Adverse Event|112|||
27900479|NCT02943785|81473007|FG001|Overall Study|Adverse Event|97|||
27900480|NCT02943785|81473006|FG000|Overall Study|Withdrawal by Subject|63|||
27900481|NCT02943785|81473007|FG001|Overall Study|Withdrawal by Subject|126|||
27900482|NCT02943785|81473006|FG000|Overall Study|Physician Decision|23|||
27900483|NCT02943785|81473007|FG001|Overall Study|Physician Decision|47|||
27900484|NCT02943785|81473006|FG000|Overall Study|Death|46|||
27900485|NCT02943785|81473007|FG001|Overall Study|Death|46|||
27900486|NCT02943785|81473006|FG000|Overall Study|Lost to Follow-up|1|||
27900487|NCT02943785|81473007|FG001|Overall Study|Lost to Follow-up|0|||
27900488|NCT02943785|81473006|FG000|Overall Study|Other|16|||
27900489|NCT02943785|81473007|FG001|Overall Study|Other|19|||
27900490|NCT02943785|81473006|FG000|Overall Study|Did not receive any study medication|21|||
27900491|NCT02943785|81473007|FG001|Overall Study|Did not receive any study medication|28|||
27900492|NCT01492101|81473015|FG000|Overall Study|Death|323|||
27900493|NCT01492101|81473016|FG001|Overall Study|Death|322|||
27900494|NCT01492101|81473015|FG000|Overall Study|Withdrawal by Subject|14|||
27900495|NCT01492101|81473016|FG001|Overall Study|Withdrawal by Subject|18|||
27900496|NCT01492101|81473015|FG000|Overall Study|Lost to Follow-up|0|||
27900497|NCT01492101|81473016|FG001|Overall Study|Lost to Follow-up|2|||
27900498|NCT02427802|81473018|FG000|Overall Study|Adverse Event|11|||
27900499|NCT02427802|81473019|FG001|Overall Study|Adverse Event|3|||
27900500|NCT02427802|81473020|FG002|Overall Study|Adverse Event|7|||
27900501|NCT02427802|81473018|FG000|Overall Study|Death|0|||
27900502|NCT02427802|81473019|FG001|Overall Study|Death|4|||
27900503|NCT02427802|81473020|FG002|Overall Study|Death|1|||
27900504|NCT02427802|81473018|FG000|Overall Study|Lost to Follow-up|13|||
27900505|NCT02427802|81473019|FG001|Overall Study|Lost to Follow-up|8|||
27900506|NCT02427802|81473020|FG002|Overall Study|Lost to Follow-up|8|||
27900507|NCT02427802|81473018|FG000|Overall Study|Physician Decision|4|||
27900508|NCT02427802|81473019|FG001|Overall Study|Physician Decision|2|||
27900509|NCT02427802|81473020|FG002|Overall Study|Physician Decision|4|||
27900510|NCT02427802|81473018|FG000|Overall Study|Withdrawal by Subject|10|||
27900511|NCT02427802|81473019|FG001|Overall Study|Withdrawal by Subject|5|||
27900512|NCT02427802|81473020|FG002|Overall Study|Withdrawal by Subject|11|||
27900513|NCT02427802|81473018|FG000|Overall Study|Protocol Violation|3|||
27900514|NCT02427802|81473019|FG001|Overall Study|Protocol Violation|1|||
27900515|NCT02427802|81473020|FG002|Overall Study|Protocol Violation|1|||
27900516|NCT02427802|81473018|FG000|Overall Study|protocol specific treatment unrelated|18|||
27506451|NCT01456039|80047841|FG000|Phase 1 (First Step)|Disease Progression|1|||
27614208|NCT01644474|80430175|FG000|Overall Study|Site scheduling error|1|||
27614209|NCT01644474|80430176|FG001|Overall Study|Site scheduling error|1|||
27614210|NCT01644474|80430175|FG000|Overall Study|Protocol Violation|1|||
27614211|NCT01644474|80430176|FG001|Overall Study|Protocol Violation|0|||
27900517|NCT02427802|81473019|FG001|Overall Study|protocol specific treatment unrelated|11|||
27900518|NCT02427802|81473020|FG002|Overall Study|protocol specific treatment unrelated|11|||
27900519|NCT03871829|81473021|FG000|Overall Study|Lost to Follow-up|0|||
27900520|NCT03871829|81473022|FG001|Overall Study|Lost to Follow-up|1|||
27900521|NCT03871829|81473021|FG000|Overall Study|Withdrawal by Subject|1|||
27900522|NCT03871829|81473022|FG001|Overall Study|Withdrawal by Subject|1|||
27900523|NCT03871829|81473021|FG000|Overall Study|Death|12|||
27614212|NCT02102464|80430177|FG000|Randomized Study|Withdrawal by Subject|0|||
27900524|NCT03871829|81473022|FG001|Overall Study|Death|8|||
27900525|NCT03871829|81473021|FG000|Overall Study|Study terminated by sponsor|31|||
27900526|NCT03871829|81473022|FG001|Overall Study|Study terminated by sponsor|34|||
27900527|NCT01546038|81473023|FG000|Overall Study|Death|15|||
27900528|NCT01546038|81473024|FG001|Overall Study|Death|6|||
27900529|NCT01546038|81473025|FG002|Overall Study|Death|4|||
27900530|NCT01546038|81473026|FG003|Overall Study|Death|2|||
27900531|NCT01546038|81473027|FG004|Overall Study|Death|9|||
27727627|NCT00559273|80830308|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
27727628|NCT00559273|80830307|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
27727629|NCT00559273|80830308|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
27727630|NCT00559273|80830307|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
27727631|NCT00559273|80830308|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
27727632|NCT03075163|80830309|FG000|Overall Study|not eligible for treatment limb|138|||
27727633|NCT03075163|80830310|FG001|Overall Study|not eligible for treatment limb|138|||
27727634|NCT01570244|80830323|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
27727635|NCT01412957|80830325|FG000|Overall Study|Withdrawal by Subject|6|||
27727636|NCT01412957|80830326|FG001|Overall Study|Withdrawal by Subject|22|||
27727637|NCT01412957|80830325|FG000|Overall Study|Lost to Follow-up|7|||
27727638|NCT01412957|80830326|FG001|Overall Study|Lost to Follow-up|2|||
27727639|NCT01412957|80830325|FG000|Overall Study|Death|136|||
27727640|NCT01412957|80830326|FG001|Overall Study|Death|133|||
27727641|NCT00582556|80830327|FG000|Overall Study|Withdrawal by Subject|0|||
27727642|NCT00582556|80830328|FG001|Overall Study|Withdrawal by Subject|1|||
27727643|NCT00582556|80830329|FG002|Overall Study|Withdrawal by Subject|1|||
27727644|NCT00582556|80830327|FG000|Overall Study|Physician Decision|0|||
27727645|NCT00582556|80830328|FG001|Overall Study|Physician Decision|0|||
27727646|NCT00582556|80830329|FG002|Overall Study|Physician Decision|1|||
27727647|NCT00787787|80830332|FG000|Overall Study|Lack of Efficacy|4|||
27727648|NCT00787787|80830332|FG000|Overall Study|Adverse Event|3|||
27727649|NCT01934140|80830333|FG000|Persistence Phase (Year 6-10)|Other|24|||
27727650|NCT01934140|80830334|FG001|Persistence Phase (Year 6-10)|Other|6|||
27727651|NCT01934140|80830333|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
27727652|NCT01934140|80830334|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
27727653|NCT01934140|80830333|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
27727654|NCT01934140|80830334|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
27727655|NCT01934140|80830333|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
27727656|NCT01934140|80830334|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
27727657|NCT01934140|80830333|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
27727658|NCT01934140|80830334|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
27727659|NCT01934140|80830333|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
27727660|NCT01934140|80830334|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
27727661|NCT01934140|80830333|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
27727662|NCT01934140|80830334|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
27727663|NCT01934140|80830333|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
27727664|NCT01934140|80830334|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
27900532|NCT01546038|81473028|FG005|Overall Study|Death|3|||
27900533|NCT01546038|81473029|FG006|Overall Study|Death|46|||
27900534|NCT01546038|81473030|FG007|Overall Study|Death|76|||
27900535|NCT01546038|81473031|FG008|Overall Study|Death|39|||
27900536|NCT01546038|81473023|FG000|Overall Study|Lost to Follow-up|0|||
27900537|NCT01546038|81473024|FG001|Overall Study|Lost to Follow-up|0|||
27900538|NCT01546038|81473025|FG002|Overall Study|Lost to Follow-up|0|||
27727665|NCT02435914|80830335|FG000|Overall Study|Ocular Adverse Event|1|||
27727666|NCT02435914|80830336|FG001|Overall Study|Ocular Adverse Event|0|||
27727667|NCT02435914|80830337|FG002|Overall Study|Ocular Adverse Event|0|||
27900539|NCT01546038|81473026|FG003|Overall Study|Lost to Follow-up|0|||
27900540|NCT01546038|81473027|FG004|Overall Study|Lost to Follow-up|1|||
27900541|NCT01546038|81473028|FG005|Overall Study|Lost to Follow-up|0|||
27900542|NCT01546038|81473029|FG006|Overall Study|Lost to Follow-up|2|||
27900543|NCT01546038|81473030|FG007|Overall Study|Lost to Follow-up|1|||
27900544|NCT01546038|81473031|FG008|Overall Study|Lost to Follow-up|0|||
27900545|NCT01546038|81473023|FG000|Overall Study|Withdrawal by Subject|1|||
27900546|NCT01546038|81473024|FG001|Overall Study|Withdrawal by Subject|0|||
27900547|NCT01546038|81473025|FG002|Overall Study|Withdrawal by Subject|0|||
27900548|NCT01546038|81473026|FG003|Overall Study|Withdrawal by Subject|1|||
27900549|NCT01546038|81473027|FG004|Overall Study|Withdrawal by Subject|0|||
27900550|NCT01546038|81473028|FG005|Overall Study|Withdrawal by Subject|1|||
27900551|NCT01546038|81473029|FG006|Overall Study|Withdrawal by Subject|3|||
27900552|NCT01546038|81473030|FG007|Overall Study|Withdrawal by Subject|3|||
27900553|NCT01546038|81473031|FG008|Overall Study|Withdrawal by Subject|1|||
27900554|NCT01546038|81473023|FG000|Overall Study|: Randomized, not treated|0|||
27900555|NCT01546038|81473024|FG001|Overall Study|: Randomized, not treated|0|||
27900556|NCT01546038|81473025|FG002|Overall Study|: Randomized, not treated|0|||
27900557|NCT01546038|81473026|FG003|Overall Study|: Randomized, not treated|0|||
27900558|NCT01546038|81473027|FG004|Overall Study|: Randomized, not treated|0|||
27900559|NCT01546038|81473028|FG005|Overall Study|: Randomized, not treated|0|||
27900560|NCT01546038|81473029|FG006|Overall Study|: Randomized, not treated|2|||
27900561|NCT01546038|81473030|FG007|Overall Study|: Randomized, not treated|4|||
27727668|NCT02435914|80830338|FG003|Overall Study|Ocular Adverse Event|0|||
27851077|NCT00136318|81286959|FG000|Overall Study|Withdrawal by Subject|2|||
27851078|NCT00136318|81286960|FG001|Overall Study|Withdrawal by Subject|2|||
27851079|NCT03438396|81286961|FG000|Overall Study|Reason Not Specified|9|||
27851080|NCT03438396|81286961|FG000|Overall Study|Withdrawal by Subject|5|||
27851081|NCT03438396|81286961|FG000|Overall Study|Lost to Follow-up|2|||
27851082|NCT03438396|81286961|FG000|Overall Study|Death|85|||
27851083|NCT03438396|81286961|FG000|Overall Study|Not treated|1|||
27851084|NCT01660334|81286969|FG000|Overall Study|Lost to Follow-up|1|||
27851085|NCT00809965|81286970|FG000|Overall Study|Death|194|||
27851086|NCT00809965|81286971|FG001|Overall Study|Death|147|||
27851087|NCT00809965|81286972|FG002|Overall Study|Death|196|||
27851088|NCT00809965|81286970|FG000|Overall Study|Lost to Follow-up|17|||
27851089|NCT00809965|81286971|FG001|Overall Study|Lost to Follow-up|10|||
27851090|NCT00809965|81286972|FG002|Overall Study|Lost to Follow-up|18|||
27851091|NCT00809965|81286970|FG000|Overall Study|Withdrawal by Subject|405|||
27851092|NCT00809965|81286971|FG001|Overall Study|Withdrawal by Subject|448|||
27851093|NCT00809965|81286972|FG002|Overall Study|Withdrawal by Subject|441|||
27851094|NCT00809965|81286970|FG000|Overall Study|Other Reason|167|||
27851095|NCT00809965|81286971|FG001|Overall Study|Other Reason|170|||
27851096|NCT00809965|81286972|FG002|Overall Study|Other Reason|189|||
27851097|NCT01157897|81286973|FG000|Overall Study|Lost to Follow-up|2|||
27851098|NCT01157897|81286974|FG001|Overall Study|Lost to Follow-up|0|||
27851099|NCT01157897|81286975|FG002|Overall Study|Lost to Follow-up|0|||
27851100|NCT01157897|81286976|FG003|Overall Study|Lost to Follow-up|1|||
27851101|NCT01157897|81286973|FG000|Overall Study|Relocated|0|||
27851102|NCT01157897|81286974|FG001|Overall Study|Relocated|2|||
27851103|NCT01157897|81286975|FG002|Overall Study|Relocated|0|||
27851104|NCT01157897|81286976|FG003|Overall Study|Relocated|0|||
27851105|NCT02709486|81286977|FG000|Overall Study|Adverse Event|2|||
27851106|NCT02709486|81286978|FG001|Overall Study|Adverse Event|5|||
27851107|NCT02709486|81286979|FG002|Overall Study|Adverse Event|3|||
27851108|NCT02709486|81286977|FG000|Overall Study|Death|0|||
27851109|NCT02709486|81286978|FG001|Overall Study|Death|0|||
27851110|NCT02709486|81286979|FG002|Overall Study|Death|2|||
27851111|NCT02709486|81286977|FG000|Overall Study|Insufficient clinical response|7|||
27851112|NCT02709486|81286978|FG001|Overall Study|Insufficient clinical response|3|||
27851113|NCT02709486|81286979|FG002|Overall Study|Insufficient clinical response|3|||
27851114|NCT02709486|81286977|FG000|Overall Study|Lost to Follow-up|3|||
27851115|NCT02709486|81286978|FG001|Overall Study|Lost to Follow-up|2|||
27851116|NCT02709486|81286979|FG002|Overall Study|Lost to Follow-up|2|||
27851117|NCT02709486|81286977|FG000|Overall Study|Other|0|||
27851118|NCT02709486|81286978|FG001|Overall Study|Other|2|||
27851119|NCT02709486|81286979|FG002|Overall Study|Other|3|||
27851120|NCT02709486|81286977|FG000|Overall Study|Withdrawal by Subject|32|||
27851121|NCT02709486|81286978|FG001|Overall Study|Withdrawal by Subject|22|||
27851122|NCT02709486|81286979|FG002|Overall Study|Withdrawal by Subject|32|||
27851123|NCT02442271|81286980|FG000|Overall Study|Adverse Event|1|||
27851124|NCT02442271|81286980|FG000|Overall Study|Withdrew Consent|1|||
27851125|NCT02442271|81286980|FG000|Overall Study|Lost to Follow-up|1|||
27851126|NCT02442271|81286980|FG000|Overall Study|Other|1|||
27851127|NCT01641133|81286983|FG000|Overall Study|Protocol Violation|0|||
27851128|NCT01641133|81286984|FG001|Overall Study|Protocol Violation|1|||
27900562|NCT01546038|81473031|FG008|Overall Study|: Randomized, not treated|3|||
27900563|NCT00524680|81473032|FG000|Overall Study|progression|0|||
27900564|NCT00524680|81473033|FG001|Overall Study|progression|0|||
27900565|NCT00524680|81473034|FG002|Overall Study|progression|0|||
27900566|NCT00524680|81473035|FG003|Overall Study|progression|1|||
27900567|NCT00524680|81473032|FG000|Overall Study|Adverse Event|2|||
27900568|NCT00524680|81473033|FG001|Overall Study|Adverse Event|0|||
27900569|NCT00524680|81473034|FG002|Overall Study|Adverse Event|0|||
27900570|NCT00524680|81473035|FG003|Overall Study|Adverse Event|1|||
27900571|NCT00524680|81473032|FG000|Overall Study|Other|0|||
27900572|NCT00524680|81473033|FG001|Overall Study|Other|1|||
27900573|NCT00524680|81473034|FG002|Overall Study|Other|2|||
27900574|NCT00524680|81473035|FG003|Overall Study|Other|3|||
27727669|NCT02435914|80830335|FG000|Overall Study|Withdrawal by Subject|0|||
27727670|NCT02435914|80830336|FG001|Overall Study|Withdrawal by Subject|1|||
27727671|NCT02435914|80830337|FG002|Overall Study|Withdrawal by Subject|0|||
27506452|NCT01456039|80047842|FG001|Phase 1 (First Step)|Disease Progression|1|||
27506453|NCT01456039|80047843|FG002|Phase 1 (First Step)|Disease Progression|0|||
27506454|NCT01456039|80047841|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
27851129|NCT01641133|81286985|FG002|Overall Study|Protocol Violation|1|||
27851130|NCT01641133|81286983|FG000|Overall Study|Migrated/moved from study area|5|||
27851131|NCT01641133|81286984|FG001|Overall Study|Migrated/moved from study area|3|||
27851132|NCT01641133|81286985|FG002|Overall Study|Migrated/moved from study area|1|||
27851133|NCT01641133|81286983|FG000|Overall Study|Adverse Event|0|||
27851134|NCT01641133|81286984|FG001|Overall Study|Adverse Event|0|||
27851135|NCT01641133|81286985|FG002|Overall Study|Adverse Event|1|||
27851136|NCT01641133|81286983|FG000|Overall Study|Withdrawal by Subject|5|||
27851137|NCT01641133|81286984|FG001|Overall Study|Withdrawal by Subject|3|||
27851138|NCT01641133|81286985|FG002|Overall Study|Withdrawal by Subject|3|||
27851139|NCT01641133|81286983|FG000|Overall Study|Lost to Follow-up|0|||
27851140|NCT01641133|81286984|FG001|Overall Study|Lost to Follow-up|2|||
27851141|NCT01641133|81286985|FG002|Overall Study|Lost to Follow-up|2|||
27851142|NCT05212883|81286986|FG000|Overall Study|Invalid test result|125|||
27851143|NCT02025751|81286987|FG000|Overall Study|Lost to Follow-up|1|||
27851144|NCT02025751|81286988|FG001|Overall Study|Lost to Follow-up|0|||
27851145|NCT02025751|81286987|FG000|Overall Study|Adverse Event|0|||
27851146|NCT02025751|81286988|FG001|Overall Study|Adverse Event|1|||
27851147|NCT02025751|81286987|FG000|Overall Study|Physician Decision|0|||
27851148|NCT02025751|81286988|FG001|Overall Study|Physician Decision|1|||
27851149|NCT02025751|81286987|FG000|Overall Study|Withdrawal by Subject|0|||
27851150|NCT02025751|81286988|FG001|Overall Study|Withdrawal by Subject|1|||
27851151|NCT02132754|81286994|FG000|Overall Study|Adverse Event|0|||
27851152|NCT02132754|81286995|FG001|Overall Study|Adverse Event|0|||
27851153|NCT02132754|81286996|FG002|Overall Study|Adverse Event|0|||
27851154|NCT02132754|81286997|FG003|Overall Study|Adverse Event|0|||
27851155|NCT02132754|81286998|FG004|Overall Study|Adverse Event|0|||
27851156|NCT02132754|81286999|FG005|Overall Study|Adverse Event|0|||
27506455|NCT01456039|80047842|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
27851157|NCT02132754|81287000|FG006|Overall Study|Adverse Event|0|||
27851158|NCT02132754|81287001|FG007|Overall Study|Adverse Event|0|||
27851159|NCT02132754|81287002|FG008|Overall Study|Adverse Event|0|||
27851160|NCT02132754|81287003|FG009|Overall Study|Adverse Event|0|||
27900575|NCT00524680|81473032|FG000|Overall Study|Withdrawal by Subject|1|||
27900576|NCT00524680|81473033|FG001|Overall Study|Withdrawal by Subject|0|||
27614213|NCT02102464|80430178|FG001|Randomized Study|Withdrawal by Subject|1|||
27614214|NCT02102464|80430179|FG002|Randomized Study|Withdrawal by Subject|0|||
27614215|NCT02087150|80430180|FG000|Overall Study|Death|0|||
27614216|NCT02087150|80430181|FG001|Overall Study|Death|1|||
27614217|NCT02087150|80430182|FG002|Overall Study|Death|0|||
27851161|NCT02132754|81287004|FG010|Overall Study|Adverse Event|0|||
27851162|NCT02132754|81287005|FG011|Overall Study|Adverse Event|0|||
27851163|NCT02132754|81287006|FG012|Overall Study|Adverse Event|0|||
27851164|NCT02132754|81287007|FG013|Overall Study|Adverse Event|0|||
27851165|NCT02132754|81287008|FG014|Overall Study|Adverse Event|0|||
27851166|NCT02132754|81287009|FG015|Overall Study|Adverse Event|0|||
27851167|NCT02132754|81287010|FG016|Overall Study|Adverse Event|0|||
27851168|NCT02132754|81287011|FG017|Overall Study|Adverse Event|1|||
27851169|NCT02132754|81287012|FG018|Overall Study|Adverse Event|0|||
27851170|NCT02132754|81287013|FG019|Overall Study|Adverse Event|0|||
27851171|NCT02132754|81287014|FG020|Overall Study|Adverse Event|0|||
27851172|NCT02132754|81287015|FG021|Overall Study|Adverse Event|0|||
27851173|NCT02132754|81287016|FG022|Overall Study|Adverse Event|0|||
27851174|NCT02132754|81287017|FG023|Overall Study|Adverse Event|0|||
27851175|NCT02132754|81287018|FG024|Overall Study|Adverse Event|0|||
27851176|NCT02132754|81287019|FG025|Overall Study|Adverse Event|1|||
27851177|NCT02132754|81287020|FG026|Overall Study|Adverse Event|1|||
27851178|NCT02132754|81287021|FG027|Overall Study|Adverse Event|0|||
27851179|NCT02132754|81287022|FG028|Overall Study|Adverse Event|0|||
27851180|NCT02132754|81287023|FG029|Overall Study|Adverse Event|0|||
27851181|NCT02132754|81287024|FG030|Overall Study|Adverse Event|1|||
27851182|NCT02132754|81287025|FG031|Overall Study|Adverse Event|0|||
27506456|NCT01456039|80047843|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
27506457|NCT01456039|80047841|FG000|Phase 1 (First Step)|Adverse Event|0|||
27506458|NCT01456039|80047842|FG001|Phase 1 (First Step)|Adverse Event|3|||
27506459|NCT01456039|80047843|FG002|Phase 1 (First Step)|Adverse Event|0|||
27506460|NCT01456039|80047841|FG000|Phase 1 (First Step)|Other|0|||
27506461|NCT01456039|80047842|FG001|Phase 1 (First Step)|Other|1|||
27506462|NCT01456039|80047843|FG002|Phase 1 (First Step)|Other|0|||
27506463|NCT01456039|80047841|FG000|Phase 2 (Second Step)|Disease Progression|0|||
27506464|NCT01456039|80047842|FG001|Phase 2 (Second Step)|Disease Progression|0|||
27506465|NCT01456039|80047843|FG002|Phase 2 (Second Step)|Disease Progression|17|||
27506466|NCT01456039|80047841|FG000|Phase 2 (Second Step)|Adverse Event|0|||
27506467|NCT01456039|80047842|FG001|Phase 2 (Second Step)|Adverse Event|0|||
27506468|NCT01456039|80047843|FG002|Phase 2 (Second Step)|Adverse Event|10|||
27506469|NCT01456039|80047841|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
27614218|NCT02087150|80430180|FG000|Overall Study|Lost to Follow-up|6|||
27614219|NCT02087150|80430181|FG001|Overall Study|Lost to Follow-up|13|||
27851183|NCT02132754|81287026|FG032|Overall Study|Adverse Event|1|||
27851184|NCT02132754|81287027|FG033|Overall Study|Adverse Event|1|||
27851185|NCT02132754|81286994|FG000|Overall Study|Clinical Progression|0|||
27851186|NCT02132754|81286995|FG001|Overall Study|Clinical Progression|0|||
27851187|NCT02132754|81286996|FG002|Overall Study|Clinical Progression|0|||
27851188|NCT02132754|81286997|FG003|Overall Study|Clinical Progression|0|||
27851189|NCT02132754|81286998|FG004|Overall Study|Clinical Progression|0|||
27851190|NCT02132754|81286999|FG005|Overall Study|Clinical Progression|0|||
27851191|NCT02132754|81287000|FG006|Overall Study|Clinical Progression|0|||
27851192|NCT02132754|81287001|FG007|Overall Study|Clinical Progression|0|||
27851193|NCT02132754|81287002|FG008|Overall Study|Clinical Progression|0|||
27851194|NCT02132754|81287003|FG009|Overall Study|Clinical Progression|1|||
27851195|NCT02132754|81287004|FG010|Overall Study|Clinical Progression|0|||
27851196|NCT02132754|81287005|FG011|Overall Study|Clinical Progression|0|||
27851197|NCT02132754|81287006|FG012|Overall Study|Clinical Progression|0|||
27851198|NCT02132754|81287007|FG013|Overall Study|Clinical Progression|0|||
27851199|NCT02132754|81287008|FG014|Overall Study|Clinical Progression|0|||
27851200|NCT02132754|81287009|FG015|Overall Study|Clinical Progression|0|||
27851201|NCT02132754|81287010|FG016|Overall Study|Clinical Progression|1|||
27851202|NCT02132754|81287011|FG017|Overall Study|Clinical Progression|1|||
27851203|NCT02132754|81287012|FG018|Overall Study|Clinical Progression|0|||
27851204|NCT02132754|81287013|FG019|Overall Study|Clinical Progression|1|||
27851205|NCT02132754|81287014|FG020|Overall Study|Clinical Progression|0|||
27851206|NCT02132754|81287015|FG021|Overall Study|Clinical Progression|0|||
27614220|NCT02087150|80430182|FG002|Overall Study|Lost to Follow-up|7|||
27851207|NCT02132754|81287016|FG022|Overall Study|Clinical Progression|1|||
27851208|NCT02132754|81287017|FG023|Overall Study|Clinical Progression|0|||
27851209|NCT02132754|81287018|FG024|Overall Study|Clinical Progression|1|||
27851210|NCT02132754|81287019|FG025|Overall Study|Clinical Progression|1|||
27851211|NCT02132754|81287020|FG026|Overall Study|Clinical Progression|0|||
27851212|NCT02132754|81287021|FG027|Overall Study|Clinical Progression|1|||
27506470|NCT01456039|80047842|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
27506471|NCT01456039|80047843|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
27614221|NCT02087150|80430180|FG000|Overall Study|Withdrawal by Subject|2|||
27506472|NCT01456039|80047841|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
27506473|NCT01456039|80047842|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
27506474|NCT01456039|80047843|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
27727672|NCT02435914|80830338|FG003|Overall Study|Withdrawal by Subject|0|||
27727673|NCT02435914|80830335|FG000|Overall Study|Other Miscellaneous Reason|0|||
27727674|NCT02435914|80830336|FG001|Overall Study|Other Miscellaneous Reason|0|||
27727675|NCT02435914|80830337|FG002|Overall Study|Other Miscellaneous Reason|1|||
27727676|NCT02435914|80830338|FG003|Overall Study|Other Miscellaneous Reason|0|||
27727677|NCT00675597|80830339|FG000|Overall Study|Withdrawal by Subject|3|||
27727678|NCT04698629|80830340|FG000|Overall Study|Adverse Event|1|||
27727679|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Adverse Event|21|||
27727680|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Adverse Event|6|||
27727681|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
27727682|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
27727683|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
27727684|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
27727685|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
27727686|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
27727687|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Physician Decision|0|||
27727688|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Physician Decision|3|||
27727689|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
27727690|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
27727691|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
27727692|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
27727693|NCT00510276|80830341|FG000|Acute Double-Blind Phase|Subject Decision|26|||
27727694|NCT00510276|80830342|FG001|Acute Double-Blind Phase|Subject Decision|28|||
27727695|NCT00510276|80830341|FG000|Extension Open-Label Phase|Adverse Event|9|||
27727696|NCT00510276|80830342|FG001|Extension Open-Label Phase|Adverse Event|18|||
27727697|NCT00510276|80830341|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
27727698|NCT00510276|80830342|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
27727699|NCT00510276|80830341|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
27727700|NCT00510276|80830342|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
27727701|NCT00510276|80830341|FG000|Extension Open-Label Phase|Physician Decision|2|||
27727702|NCT00510276|80830342|FG001|Extension Open-Label Phase|Physician Decision|3|||
27727703|NCT00510276|80830341|FG000|Extension Open-Label Phase|Protocol Violation|0|||
27727704|NCT00510276|80830342|FG001|Extension Open-Label Phase|Protocol Violation|1|||
27727705|NCT00510276|80830341|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
27727706|NCT00510276|80830342|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
27727707|NCT00510276|80830341|FG000|Extension Open-Label Phase|Subject Decision|7|||
27727708|NCT00510276|80830342|FG001|Extension Open-Label Phase|Subject Decision|9|||
27727709|NCT01284114|80830347|FG000|Overall Study|viral infection|1|||
27727710|NCT01284114|80830347|FG000|Overall Study|From the results of ALLTITUDE study|1|||
27727711|NCT01284114|80830347|FG000|Overall Study|Symptomatic hypotension|1|||
27727712|NCT01284114|80830347|FG000|Overall Study|dizziness|1|||
27727713|NCT01573910|80830348|FG000|Overall Study|Adverse Event|4|||
27727714|NCT01573910|80830349|FG001|Overall Study|Adverse Event|4|||
27727715|NCT01573910|80830348|FG000|Overall Study|Lost to Follow-up|2|||
27727716|NCT01573910|80830349|FG001|Overall Study|Lost to Follow-up|1|||
27727717|NCT01573910|80830348|FG000|Overall Study|Withdrawal by Subject|0|||
27727718|NCT01573910|80830349|FG001|Overall Study|Withdrawal by Subject|1|||
27727719|NCT01573910|80830348|FG000|Overall Study|Protocol Violation|3|||
27851213|NCT02132754|81287022|FG028|Overall Study|Clinical Progression|1|||
27851214|NCT02132754|81287023|FG029|Overall Study|Clinical Progression|0|||
27851215|NCT02132754|81287024|FG030|Overall Study|Clinical Progression|1|||
27851216|NCT02132754|81287025|FG031|Overall Study|Clinical Progression|0|||
27851217|NCT02132754|81287026|FG032|Overall Study|Clinical Progression|0|||
27851218|NCT02132754|81287027|FG033|Overall Study|Clinical Progression|2|||
27851219|NCT02132754|81286994|FG000|Overall Study|Death|0|||
27851220|NCT02132754|81286995|FG001|Overall Study|Death|0|||
27851221|NCT02132754|81286996|FG002|Overall Study|Death|0|||
27851222|NCT02132754|81286997|FG003|Overall Study|Death|0|||
27851223|NCT02132754|81286998|FG004|Overall Study|Death|0|||
27851224|NCT02132754|81286999|FG005|Overall Study|Death|0|||
27851225|NCT02132754|81287000|FG006|Overall Study|Death|0|||
27851226|NCT02132754|81287001|FG007|Overall Study|Death|0|||
27851227|NCT02132754|81287002|FG008|Overall Study|Death|0|||
27851228|NCT02132754|81287003|FG009|Overall Study|Death|0|||
27851229|NCT02132754|81287004|FG010|Overall Study|Death|0|||
27851230|NCT02132754|81287005|FG011|Overall Study|Death|0|||
27727720|NCT01573910|80830349|FG001|Overall Study|Protocol Violation|0|||
27727721|NCT01573910|80830348|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
27851231|NCT02132754|81287006|FG012|Overall Study|Death|0|||
27851232|NCT02132754|81287007|FG013|Overall Study|Death|0|||
27506475|NCT01456039|80047841|FG000|Phase 2 (Second Step)|Other|0|||
27851233|NCT02132754|81287008|FG014|Overall Study|Death|0|||
27851234|NCT02132754|81287009|FG015|Overall Study|Death|1|||
27851235|NCT02132754|81287010|FG016|Overall Study|Death|0|||
27727722|NCT01573910|80830349|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
27727723|NCT02789657|80830351|FG000|Overall Study|Withdrawal by Subject|2|||
27727724|NCT02789657|80830352|FG001|Overall Study|Withdrawal by Subject|0|||
27727725|NCT02789657|80830353|FG002|Overall Study|Withdrawal by Subject|0|||
27727726|NCT02789657|80830354|FG003|Overall Study|Withdrawal by Subject|0|||
27727727|NCT01955707|80830355|FG000|Overall Study|Adverse Event|1|||
27727728|NCT01955707|80830356|FG001|Overall Study|Adverse Event|2|||
27727729|NCT01955707|80830355|FG000|Overall Study|Lost to Follow-up|2|||
27727730|NCT01955707|80830356|FG001|Overall Study|Lost to Follow-up|1|||
27727731|NCT01955707|80830355|FG000|Overall Study|Withdrawal by Subject|0|||
27727732|NCT01955707|80830356|FG001|Overall Study|Withdrawal by Subject|3|||
27727733|NCT01955707|80830355|FG000|Overall Study|Death|13|||
27727734|NCT01955707|80830356|FG001|Overall Study|Death|14|||
27727735|NCT01955707|80830355|FG000|Overall Study|Other|4|||
27727736|NCT01955707|80830356|FG001|Overall Study|Other|2|||
27727737|NCT02527707|80830357|FG000|Overall Study|Adverse Event|1|||
27727738|NCT02527707|80830357|FG000|Overall Study|Adverse Event|1|||
27727739|NCT01728779|80830359|FG000|Overall Study|Withdrawal by Subject|1|||
27727740|NCT01795547|80830360|FG000|Overall Study|Adverse Event|16|||
27727741|NCT01795547|80830361|FG001|Overall Study|Adverse Event|27|||
27727742|NCT01795547|80830360|FG000|Overall Study|Lack of Efficacy|8|||
27727743|NCT01795547|80830361|FG001|Overall Study|Lack of Efficacy|3|||
27727744|NCT01795547|80830360|FG000|Overall Study|Protocol Violation|6|||
27727745|NCT01795547|80830361|FG001|Overall Study|Protocol Violation|4|||
27727746|NCT01795547|80830360|FG000|Overall Study|Lost to Follow-up|2|||
27727747|NCT01795547|80830361|FG001|Overall Study|Lost to Follow-up|5|||
27727748|NCT01795547|80830360|FG000|Overall Study|Withdrawal of consent|7|||
27727749|NCT01795547|80830361|FG001|Overall Study|Withdrawal of consent|12|||
27727750|NCT01795547|80830360|FG000|Overall Study|Not Treated|4|||
27727751|NCT01795547|80830361|FG001|Overall Study|Not Treated|10|||
27727752|NCT01795547|80830360|FG000|Overall Study|Non-compliance with IMP|1|||
27727753|NCT01795547|80830361|FG001|Overall Study|Non-compliance with IMP|1|||
27727754|NCT01795547|80830360|FG000|Overall Study|Others|4|||
27727755|NCT01795547|80830361|FG001|Overall Study|Others|1|||
27727756|NCT01795547|80830360|FG000|Overall Study|Not stated|0|||
27727757|NCT01795547|80830361|FG001|Overall Study|Not stated|1|||
27900577|NCT00524680|81473034|FG002|Overall Study|Withdrawal by Subject|1|||
27727758|NCT00792298|80830362|FG000|Treatment Period 1|Adverse Event|0|||
27727759|NCT00792298|80830363|FG001|Treatment Period 1|Adverse Event|1|||
27727760|NCT00792298|80830364|FG002|Treatment Period 1|Adverse Event|0|||
27727761|NCT00792298|80830365|FG003|Treatment Period 1|Adverse Event|1|||
27727762|NCT00792298|80830366|FG004|Treatment Period 1|Adverse Event|0|||
27727763|NCT00792298|80830367|FG005|Treatment Period 1|Adverse Event|1|||
27727764|NCT00792298|80830368|FG006|Treatment Period 1|Adverse Event|1|||
27727765|NCT00792298|80830369|FG007|Treatment Period 1|Adverse Event|0|||
27727766|NCT00792298|80830362|FG000|Treatment Period 1|Lack of Efficacy|0|||
27727767|NCT00792298|80830363|FG001|Treatment Period 1|Lack of Efficacy|0|||
27851236|NCT02132754|81287011|FG017|Overall Study|Death|0|||
27727768|NCT00792298|80830364|FG002|Treatment Period 1|Lack of Efficacy|1|||
27727769|NCT00792298|80830365|FG003|Treatment Period 1|Lack of Efficacy|0|||
27727770|NCT00792298|80830366|FG004|Treatment Period 1|Lack of Efficacy|0|||
27727771|NCT00792298|80830367|FG005|Treatment Period 1|Lack of Efficacy|0|||
27727772|NCT00792298|80830368|FG006|Treatment Period 1|Lack of Efficacy|0|||
27727773|NCT00792298|80830369|FG007|Treatment Period 1|Lack of Efficacy|0|||
27727774|NCT00792298|80830362|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27727775|NCT00792298|80830363|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27727776|NCT00792298|80830364|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27727777|NCT00792298|80830365|FG003|Treatment Period 1|Withdrawal by Subject|2|||
27727778|NCT00792298|80830366|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27727779|NCT00792298|80830367|FG005|Treatment Period 1|Withdrawal by Subject|2|||
27727780|NCT00792298|80830368|FG006|Treatment Period 1|Withdrawal by Subject|1|||
27727781|NCT00792298|80830369|FG007|Treatment Period 1|Withdrawal by Subject|0|||
27727782|NCT00792298|80830362|FG000|Treatment Period 1|Lost to Follow-up|0|||
27727783|NCT00792298|80830363|FG001|Treatment Period 1|Lost to Follow-up|0|||
27727784|NCT00792298|80830364|FG002|Treatment Period 1|Lost to Follow-up|0|||
27727785|NCT00792298|80830365|FG003|Treatment Period 1|Lost to Follow-up|0|||
27727786|NCT00792298|80830366|FG004|Treatment Period 1|Lost to Follow-up|0|||
27727787|NCT00792298|80830367|FG005|Treatment Period 1|Lost to Follow-up|0|||
27727788|NCT00792298|80830368|FG006|Treatment Period 1|Lost to Follow-up|1|||
27727789|NCT00792298|80830369|FG007|Treatment Period 1|Lost to Follow-up|0|||
27727790|NCT00792298|80830362|FG000|Treatment Period 1|Physician Decision|0|||
27727791|NCT00792298|80830363|FG001|Treatment Period 1|Physician Decision|0|||
27727792|NCT00792298|80830364|FG002|Treatment Period 1|Physician Decision|0|||
27727793|NCT00792298|80830365|FG003|Treatment Period 1|Physician Decision|1|||
27727794|NCT00792298|80830366|FG004|Treatment Period 1|Physician Decision|0|||
27727795|NCT00792298|80830367|FG005|Treatment Period 1|Physician Decision|0|||
27727796|NCT00792298|80830368|FG006|Treatment Period 1|Physician Decision|1|||
27727797|NCT00792298|80830369|FG007|Treatment Period 1|Physician Decision|0|||
27727798|NCT00792298|80830362|FG000|Treatment Period 1|Protocol Violation|0|||
27900578|NCT00524680|81473035|FG003|Overall Study|Withdrawal by Subject|1|||
27900579|NCT01389258|81473036|FG000|Overall Study|Lost to Follow-up|5|||
27900580|NCT01451554|81473041|FG000|Overall Study|Withdrawal by Subject|14|||
27900581|NCT01451554|81473042|FG001|Overall Study|Withdrawal by Subject|9|||
27900582|NCT02603107|81473053|FG000|Randomized Phase|Withdrew consent|8|||
27506476|NCT01456039|80047842|FG001|Phase 2 (Second Step)|Other|0|||
27727799|NCT00792298|80830363|FG001|Treatment Period 1|Protocol Violation|0|||
27727800|NCT00792298|80830364|FG002|Treatment Period 1|Protocol Violation|0|||
27727801|NCT00792298|80830365|FG003|Treatment Period 1|Protocol Violation|0|||
27727802|NCT00792298|80830366|FG004|Treatment Period 1|Protocol Violation|0|||
27727803|NCT00792298|80830367|FG005|Treatment Period 1|Protocol Violation|0|||
27727804|NCT00792298|80830368|FG006|Treatment Period 1|Protocol Violation|0|||
27900583|NCT02603107|81473054|FG001|Randomized Phase|Withdrew consent|15|||
27900584|NCT02603107|81473053|FG000|Randomized Phase|Lost to Follow-up|1|||
27900585|NCT02603107|81473054|FG001|Randomized Phase|Lost to Follow-up|3|||
27900586|NCT02603107|81473053|FG000|Randomized Phase|Adverse Event|2|||
27900587|NCT02603107|81473054|FG001|Randomized Phase|Adverse Event|0|||
27900588|NCT02603107|81473053|FG000|Randomized Phase|Death|1|||
27900589|NCT02603107|81473054|FG001|Randomized Phase|Death|1|||
27900590|NCT02603107|81473053|FG000|Randomized Phase|Non-compliance with study drug|1|||
27900591|NCT02603107|81473054|FG001|Randomized Phase|Non-compliance with study drug|1|||
27900592|NCT02603107|81473053|FG000|Randomized Phase|Investigator's discretion|0|||
27900593|NCT02603107|81473054|FG001|Randomized Phase|Investigator's discretion|1|||
27900594|NCT02603107|81473053|FG000|Randomized Phase|Lack of Efficacy|1|||
27900595|NCT02603107|81473054|FG001|Randomized Phase|Lack of Efficacy|0|||
27900596|NCT02603107|81473053|FG000|Randomized Phase|Protocol Violation|1|||
27900597|NCT02603107|81473054|FG001|Randomized Phase|Protocol Violation|0|||
27900598|NCT02603107|81473053|FG000|Optional Extension Phase|Lost to Follow-up|3|||
27900599|NCT02603107|81473054|FG001|Optional Extension Phase|Lost to Follow-up|3|||
27900600|NCT02603107|81473053|FG000|Optional Extension Phase|Withdrew consent|3|||
27900601|NCT02603107|81473054|FG001|Optional Extension Phase|Withdrew consent|2|||
27900602|NCT02603107|81473053|FG000|Optional Extension Phase|Investigator's discretion|2|||
27900603|NCT02603107|81473054|FG001|Optional Extension Phase|Investigator's discretion|2|||
27900604|NCT02603107|81473053|FG000|Optional Extension Phase|Pregnancy|0|||
27900605|NCT02603107|81473054|FG001|Optional Extension Phase|Pregnancy|3|||
27900606|NCT02603107|81473053|FG000|Optional Extension Phase|Adverse Event|0|||
27900607|NCT02603107|81473054|FG001|Optional Extension Phase|Adverse Event|2|||
27900608|NCT02603107|81473053|FG000|Optional Extension Phase|Not treated in extension phase|0|||
27900609|NCT02603107|81473054|FG001|Optional Extension Phase|Not treated in extension phase|1|||
27900610|NCT02603107|81473053|FG000|Optional Extension Phase|Protocol Violation|1|||
27900611|NCT02603107|81473054|FG001|Optional Extension Phase|Protocol Violation|0|||
27900612|NCT01832818|81473057|FG000|Overall Study|Lost to Follow-up|6|||
27900613|NCT01672294|81473058|FG000|Overall Study|Withdrawal by Subject|4|||
27900614|NCT01672294|81473059|FG001|Overall Study|Withdrawal by Subject|4|||
27900615|NCT01672294|81473060|FG002|Overall Study|Withdrawal by Subject|4|||
27900616|NCT01672294|81473061|FG003|Overall Study|Withdrawal by Subject|4|||
27900617|NCT01672294|81473058|FG000|Overall Study|Excluded by study|1|||
27900618|NCT01672294|81473059|FG001|Overall Study|Excluded by study|1|||
27900619|NCT01672294|81473060|FG002|Overall Study|Excluded by study|0|||
27900620|NCT01672294|81473061|FG003|Overall Study|Excluded by study|0|||
27900621|NCT01672294|81473058|FG000|Overall Study|Lost to Follow-up|1|||
27900622|NCT01672294|81473059|FG001|Overall Study|Lost to Follow-up|16|||
27900623|NCT01672294|81473060|FG002|Overall Study|Lost to Follow-up|7|||
27900624|NCT01672294|81473061|FG003|Overall Study|Lost to Follow-up|9|||
27900625|NCT03885999|81473066|FG000|Overall Study|Adverse Event|1|||
27900626|NCT01285492|81473067|FG000|Overall Study|Adverse Event|11|||
27900627|NCT01285492|81473068|FG001|Overall Study|Adverse Event|0|||
27900628|NCT01285492|81473067|FG000|Overall Study|Protocol Violation|3|||
27900629|NCT01285492|81473068|FG001|Overall Study|Protocol Violation|0|||
27900630|NCT01285492|81473067|FG000|Overall Study|Withdrawal by Subject|2|||
27900631|NCT01285492|81473068|FG001|Overall Study|Withdrawal by Subject|1|||
27900632|NCT01285492|81473067|FG000|Overall Study|Death|1|||
27900633|NCT01285492|81473068|FG001|Overall Study|Death|0|||
27900634|NCT01857102|81473069|FG000|Period 1|No longer meets Eligibility Criteria|0|||
27900635|NCT01857102|81473070|FG001|Period 1|No longer meets Eligibility Criteria|2|||
27900636|NCT01857102|81473069|FG000|Period 1|Lost to Follow-up|0|||
27900637|NCT01857102|81473070|FG001|Period 1|Lost to Follow-up|3|||
27900638|NCT01857102|81473069|FG000|Period 1|Unsatisfactory Lens Fit|1|||
27900639|NCT01857102|81473070|FG001|Period 1|Unsatisfactory Lens Fit|0|||
27900640|NCT01857102|81473069|FG000|Period 1|Unsatisfactory Visual Response|1|||
27900641|NCT01857102|81473070|FG001|Period 1|Unsatisfactory Visual Response|0|||
27900642|NCT01857102|81473069|FG000|Period 1|Physician Decision|1|||
27900643|NCT01857102|81473070|FG001|Period 1|Physician Decision|0|||
27506477|NCT01456039|80047843|FG002|Phase 2 (Second Step)|Other|1|||
27506478|NCT02079246|80047845|FG000|OLEX|Withdrawal before treatment|1|||
27506479|NCT02079246|80047846|FG001|OLEX|Withdrawal before treatment|0|||
27900644|NCT01857102|81473069|FG000|Period 2|Lens Discomfort|1|||
27900645|NCT01857102|81473070|FG001|Period 2|Lens Discomfort|0|||
27900646|NCT01857102|81473069|FG000|Period 2|Unsatisfactory Lens Fit|1|||
27900647|NCT01857102|81473070|FG001|Period 2|Unsatisfactory Lens Fit|0|||
27900648|NCT00994214|81473076|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
27506480|NCT02079246|80047845|FG000|OLEX|Death|11|||
27900649|NCT00994214|81473077|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
27900650|NCT00994214|81473078|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
27900651|NCT00994214|81473079|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
27900652|NCT00994214|81473076|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
27900653|NCT00994214|81473077|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
27900654|NCT00994214|81473078|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
27900655|NCT00994214|81473079|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
27900656|NCT00994214|81473076|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
27900657|NCT00994214|81473077|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
27900658|NCT00994214|81473078|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
27900659|NCT00994214|81473079|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
27900660|NCT00994214|81473076|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
27900661|NCT00994214|81473077|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
27900662|NCT00994214|81473078|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
27900663|NCT00994214|81473079|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
27900664|NCT00994214|81473076|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
27900665|NCT00994214|81473077|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
27900666|NCT00994214|81473078|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
27900667|NCT00994214|81473079|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
27900668|NCT00994214|81473076|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
27900669|NCT00994214|81473077|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
27900670|NCT00994214|81473078|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
27900671|NCT00994214|81473079|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
27900672|NCT03747302|81473080|FG000|Overall Study|Withdrawal by Subject|1|||
27900673|NCT03747302|81473081|FG001|Overall Study|Withdrawal by Subject|2|||
27900674|NCT00427999|81473082|FG000|Overall Study|Adverse Event|6|||
27900675|NCT00427999|81473082|FG000|Overall Study|Abnormal laboratory values|1|||
27900676|NCT00427999|81473082|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
27900677|NCT00427999|81473082|FG000|Overall Study|Protocol Violation|2|||
27900678|NCT00427999|81473082|FG000|Overall Study|Withdrawal by Subject|9|||
27900679|NCT00427999|81473082|FG000|Overall Study|Death|1|||
27900680|NCT00359294|81473083|FG000|Overall Study|Progressive disease|1|||
27900681|NCT00359294|81473084|FG001|Overall Study|Progressive disease|1|||
27900682|NCT00359294|81473085|FG002|Overall Study|Progressive disease|2|||
27900683|NCT00359294|81473086|FG003|Overall Study|Progressive disease|3|||
27900684|NCT00359294|81473087|FG004|Overall Study|Progressive disease|2|||
27900685|NCT00359294|81473083|FG000|Overall Study|Withdrawal by Subject|0|||
27900686|NCT00359294|81473084|FG001|Overall Study|Withdrawal by Subject|0|||
27900687|NCT00359294|81473085|FG002|Overall Study|Withdrawal by Subject|0|||
27900688|NCT00359294|81473086|FG003|Overall Study|Withdrawal by Subject|0|||
27900689|NCT00359294|81473087|FG004|Overall Study|Withdrawal by Subject|1|||
27900690|NCT00359294|81473083|FG000|Overall Study|Not treated|0|||
27900691|NCT00359294|81473084|FG001|Overall Study|Not treated|0|||
27900692|NCT00359294|81473085|FG002|Overall Study|Not treated|0|||
27900693|NCT00359294|81473086|FG003|Overall Study|Not treated|1|||
27900694|NCT00359294|81473087|FG004|Overall Study|Not treated|0|||
27900695|NCT00359294|81473083|FG000|Overall Study|Physician Decision|0|||
27900696|NCT00359294|81473084|FG001|Overall Study|Physician Decision|0|||
27900697|NCT00359294|81473085|FG002|Overall Study|Physician Decision|1|||
27900698|NCT00359294|81473086|FG003|Overall Study|Physician Decision|0|||
27900699|NCT00359294|81473087|FG004|Overall Study|Physician Decision|0|||
27900700|NCT02362425|81473088|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
27900701|NCT02362425|81473089|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
27900702|NCT02362425|81473090|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
27900703|NCT02362425|81473091|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
27900704|NCT02362425|81473088|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
27900705|NCT02362425|81473089|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
27900706|NCT02362425|81473090|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
27900707|NCT02362425|81473091|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
27900708|NCT02362425|81473088|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
27900709|NCT02362425|81473089|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
27900710|NCT02362425|81473090|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
27900711|NCT02362425|81473091|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
27900712|NCT02362425|81473088|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
27900713|NCT02362425|81473089|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
27900714|NCT02362425|81473090|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
27900715|NCT02362425|81473091|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
27900716|NCT02362425|81473088|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
27900717|NCT02362425|81473089|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
27506481|NCT02079246|80047846|FG001|OLEX|Death|0|||
27506482|NCT02079246|80047845|FG000|OLEX|Adverse Event|66|||
27506483|NCT02079246|80047846|FG001|OLEX|Adverse Event|0|||
27506484|NCT02079246|80047845|FG000|OLEX|Withdrawal by Subject|60|||
27506485|NCT02079246|80047846|FG001|OLEX|Withdrawal by Subject|0|||
27506486|NCT02079246|80047845|FG000|OLEX|Lost to Follow-up|6|||
27900718|NCT02362425|81473090|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
27727805|NCT00792298|80830369|FG007|Treatment Period 1|Protocol Violation|1|||
27727806|NCT00792298|80830362|FG000|Washout|Adverse Event|0|||
27727807|NCT00792298|80830363|FG001|Washout|Adverse Event|0|||
27727808|NCT00792298|80830364|FG002|Washout|Adverse Event|0|||
27727809|NCT00792298|80830365|FG003|Washout|Adverse Event|0|||
27727810|NCT00792298|80830366|FG004|Washout|Adverse Event|0|||
27727811|NCT00792298|80830367|FG005|Washout|Adverse Event|1|||
27727812|NCT00792298|80830368|FG006|Washout|Adverse Event|0|||
27727813|NCT00792298|80830369|FG007|Washout|Adverse Event|0|||
27727814|NCT00792298|80830362|FG000|Washout|Withdrawal by Subject|0|||
27727815|NCT00792298|80830363|FG001|Washout|Withdrawal by Subject|0|||
27727816|NCT00792298|80830364|FG002|Washout|Withdrawal by Subject|1|||
27727817|NCT00792298|80830365|FG003|Washout|Withdrawal by Subject|0|||
27727818|NCT00792298|80830366|FG004|Washout|Withdrawal by Subject|0|||
27727819|NCT00792298|80830367|FG005|Washout|Withdrawal by Subject|1|||
27727820|NCT00792298|80830368|FG006|Washout|Withdrawal by Subject|0|||
27727821|NCT00792298|80830369|FG007|Washout|Withdrawal by Subject|0|||
27727822|NCT00792298|80830362|FG000|Treatment Period 2|Lack of Efficacy|0|||
27727823|NCT00792298|80830363|FG001|Treatment Period 2|Lack of Efficacy|0|||
27727824|NCT00792298|80830364|FG002|Treatment Period 2|Lack of Efficacy|0|||
27727825|NCT00792298|80830365|FG003|Treatment Period 2|Lack of Efficacy|0|||
27727826|NCT00792298|80830366|FG004|Treatment Period 2|Lack of Efficacy|1|||
27727827|NCT00792298|80830367|FG005|Treatment Period 2|Lack of Efficacy|0|||
27727828|NCT00792298|80830368|FG006|Treatment Period 2|Lack of Efficacy|0|||
27727829|NCT00792298|80830369|FG007|Treatment Period 2|Lack of Efficacy|0|||
27727830|NCT00792298|80830362|FG000|Treatment Period 2|Physician Decision|0|||
27727831|NCT00792298|80830363|FG001|Treatment Period 2|Physician Decision|0|||
27727832|NCT00792298|80830364|FG002|Treatment Period 2|Physician Decision|0|||
27727833|NCT00792298|80830365|FG003|Treatment Period 2|Physician Decision|0|||
27727834|NCT00792298|80830366|FG004|Treatment Period 2|Physician Decision|0|||
27727835|NCT00792298|80830367|FG005|Treatment Period 2|Physician Decision|0|||
27727836|NCT00792298|80830368|FG006|Treatment Period 2|Physician Decision|1|||
27727837|NCT00792298|80830369|FG007|Treatment Period 2|Physician Decision|0|||
27727838|NCT00792298|80830362|FG000|Treatment Period 2|Pregnancy|0|||
27727839|NCT00792298|80830363|FG001|Treatment Period 2|Pregnancy|0|||
27727840|NCT00792298|80830364|FG002|Treatment Period 2|Pregnancy|1|||
27727841|NCT00792298|80830365|FG003|Treatment Period 2|Pregnancy|0|||
27727842|NCT00792298|80830366|FG004|Treatment Period 2|Pregnancy|0|||
27727843|NCT00792298|80830367|FG005|Treatment Period 2|Pregnancy|0|||
27727844|NCT00792298|80830368|FG006|Treatment Period 2|Pregnancy|0|||
27727845|NCT00792298|80830369|FG007|Treatment Period 2|Pregnancy|0|||
27727846|NCT00792298|80830362|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27851237|NCT02132754|81287012|FG018|Overall Study|Death|0|||
27851238|NCT02132754|81287013|FG019|Overall Study|Death|1|||
27851239|NCT02132754|81287014|FG020|Overall Study|Death|0|||
27851240|NCT02132754|81287015|FG021|Overall Study|Death|1|||
27851241|NCT02132754|81287016|FG022|Overall Study|Death|0|||
27851242|NCT02132754|81287017|FG023|Overall Study|Death|0|||
27851243|NCT02132754|81287018|FG024|Overall Study|Death|0|||
27851244|NCT02132754|81287019|FG025|Overall Study|Death|0|||
27851245|NCT02132754|81287020|FG026|Overall Study|Death|1|||
27851246|NCT02132754|81287021|FG027|Overall Study|Death|0|||
27851247|NCT02132754|81287022|FG028|Overall Study|Death|0|||
27851248|NCT02132754|81287023|FG029|Overall Study|Death|0|||
27851249|NCT02132754|81287024|FG030|Overall Study|Death|0|||
27851250|NCT02132754|81287025|FG031|Overall Study|Death|0|||
27851251|NCT02132754|81287026|FG032|Overall Study|Death|0|||
27851252|NCT02132754|81287027|FG033|Overall Study|Death|2|||
27851253|NCT02132754|81286994|FG000|Overall Study|Excluded Medication|0|||
27851254|NCT02132754|81286995|FG001|Overall Study|Excluded Medication|0|||
27851255|NCT02132754|81286996|FG002|Overall Study|Excluded Medication|0|||
27851256|NCT02132754|81286997|FG003|Overall Study|Excluded Medication|0|||
27851257|NCT02132754|81286998|FG004|Overall Study|Excluded Medication|0|||
27851258|NCT02132754|81286999|FG005|Overall Study|Excluded Medication|0|||
27851259|NCT02132754|81287000|FG006|Overall Study|Excluded Medication|0|||
27851260|NCT02132754|81287001|FG007|Overall Study|Excluded Medication|0|||
27851261|NCT02132754|81287002|FG008|Overall Study|Excluded Medication|0|||
27851262|NCT02132754|81287003|FG009|Overall Study|Excluded Medication|0|||
27851263|NCT02132754|81287004|FG010|Overall Study|Excluded Medication|0|||
27851264|NCT02132754|81287005|FG011|Overall Study|Excluded Medication|0|||
27851265|NCT02132754|81287006|FG012|Overall Study|Excluded Medication|0|||
27851266|NCT02132754|81287007|FG013|Overall Study|Excluded Medication|0|||
27506487|NCT02079246|80047846|FG001|OLEX|Lost to Follow-up|0|||
27727847|NCT00792298|80830363|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27851267|NCT02132754|81287008|FG014|Overall Study|Excluded Medication|0|||
27851268|NCT02132754|81287009|FG015|Overall Study|Excluded Medication|0|||
27851269|NCT02132754|81287010|FG016|Overall Study|Excluded Medication|0|||
27851270|NCT02132754|81287011|FG017|Overall Study|Excluded Medication|0|||
27851271|NCT02132754|81287012|FG018|Overall Study|Excluded Medication|0|||
27900719|NCT02362425|81473091|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
27900720|NCT02362425|81473088|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
27900721|NCT02362425|81473089|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
27900722|NCT02362425|81473090|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
27900723|NCT02362425|81473091|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
27900724|NCT02362425|81473088|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
27900725|NCT02362425|81473089|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
27900726|NCT02362425|81473090|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
27900727|NCT02362425|81473091|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
27900728|NCT02362425|81473088|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
27900729|NCT02362425|81473089|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
27900730|NCT02362425|81473090|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
27900731|NCT02362425|81473091|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
27900732|NCT02440854|81473093|FG000|Overall Study|Relocation of patient|1|||
27900733|NCT02440854|81473093|FG000|Overall Study|Death|6|||
27900734|NCT02440854|81473093|FG000|Overall Study|Lost to Follow-up|10|||
27900735|NCT02440854|81473093|FG000|Overall Study|Afatinib discontinuation|46|||
27900736|NCT02440854|81473093|FG000|Overall Study|stopped study at earlier timepoint|14|||
27900737|NCT02440854|81473093|FG000|Overall Study|Study medication not received|1|||
27900738|NCT02440854|81473093|FG000|Overall Study|Violation of inclusion criteria|2|||
27900739|NCT01739764|81473094|FG000|Overall Study|Adverse Event|0|||
27900740|NCT01739764|81473095|FG001|Overall Study|Adverse Event|3|||
27900741|NCT01739764|81473096|FG002|Overall Study|Adverse Event|4|||
27900742|NCT01739764|81473094|FG000|Overall Study|Death|4|||
27900743|NCT01739764|81473095|FG001|Overall Study|Death|6|||
27900744|NCT01739764|81473096|FG002|Overall Study|Death|38|||
27900745|NCT01739764|81473094|FG000|Overall Study|Lost to Follow-up|0|||
27900746|NCT01739764|81473095|FG001|Overall Study|Lost to Follow-up|0|||
27900747|NCT01739764|81473096|FG002|Overall Study|Lost to Follow-up|5|||
27900748|NCT01739764|81473094|FG000|Overall Study|Non-Compliance|0|||
27900749|NCT01739764|81473095|FG001|Overall Study|Non-Compliance|0|||
27900750|NCT01739764|81473096|FG002|Overall Study|Non-Compliance|1|||
27900751|NCT01739764|81473094|FG000|Overall Study|Multiple Reasons|3|||
27900752|NCT01739764|81473095|FG001|Overall Study|Multiple Reasons|2|||
27900753|NCT01739764|81473096|FG002|Overall Study|Multiple Reasons|3|||
27900754|NCT01739764|81473094|FG000|Overall Study|Physician Decision|2|||
27900755|NCT01739764|81473095|FG001|Overall Study|Physician Decision|2|||
27900756|NCT01739764|81473096|FG002|Overall Study|Physician Decision|4|||
27900757|NCT01739764|81473094|FG000|Overall Study|Progressive Disease|3|||
27900758|NCT01739764|81473095|FG001|Overall Study|Progressive Disease|5|||
27900759|NCT01739764|81473096|FG002|Overall Study|Progressive Disease|16|||
27900760|NCT01739764|81473094|FG000|Overall Study|Protocol Violation|0|||
27900761|NCT01739764|81473095|FG001|Overall Study|Protocol Violation|0|||
27900762|NCT01739764|81473096|FG002|Overall Study|Protocol Violation|2|||
27900763|NCT01739764|81473094|FG000|Overall Study|Study Terminated by Sponsor|8|||
27900764|NCT01739764|81473095|FG001|Overall Study|Study Terminated by Sponsor|13|||
27900765|NCT01739764|81473096|FG002|Overall Study|Study Terminated by Sponsor|26|||
27900766|NCT01739764|81473094|FG000|Overall Study|Withdrawal by Subject|6|||
27900767|NCT01739764|81473095|FG001|Overall Study|Withdrawal by Subject|5|||
27900768|NCT01739764|81473096|FG002|Overall Study|Withdrawal by Subject|27|||
27900769|NCT02854605|81473097|FG000|Overall Study|Adverse Event|1|||
27900770|NCT02854605|81473098|FG001|Overall Study|Adverse Event|5|||
27900771|NCT02854605|81473099|FG002|Overall Study|Adverse Event|2|||
27900772|NCT02854605|81473097|FG000|Overall Study|Lost to Follow-up|0|||
27900773|NCT02854605|81473098|FG001|Overall Study|Lost to Follow-up|2|||
27900774|NCT02854605|81473099|FG002|Overall Study|Lost to Follow-up|0|||
27900775|NCT02854605|81473097|FG000|Overall Study|Withdrew Consent|1|||
27900776|NCT02854605|81473098|FG001|Overall Study|Withdrew Consent|0|||
27900777|NCT02854605|81473099|FG002|Overall Study|Withdrew Consent|1|||
27900778|NCT02854605|81473097|FG000|Overall Study|Investigator's Discretion|1|||
27900779|NCT02854605|81473098|FG001|Overall Study|Investigator's Discretion|0|||
27900780|NCT02854605|81473099|FG002|Overall Study|Investigator's Discretion|0|||
27900781|NCT02854605|81473097|FG000|Overall Study|Protocol Violation|0|||
27900782|NCT02854605|81473098|FG001|Overall Study|Protocol Violation|0|||
27900783|NCT02854605|81473099|FG002|Overall Study|Protocol Violation|1|||
27506488|NCT02079246|80047845|FG000|OLEX|Protocol Violation|6|||
27614222|NCT02087150|80430181|FG001|Overall Study|Withdrawal by Subject|5|||
27614223|NCT02087150|80430182|FG002|Overall Study|Withdrawal by Subject|3|||
27900784|NCT00856843|81473100|FG000|Overall Study|Withdrawal by Subject|1|||
27900785|NCT00856843|81473101|FG001|Overall Study|Withdrawal by Subject|5|||
27900786|NCT00856843|81473100|FG000|Overall Study|Lack of Efficacy|1|||
27900787|NCT00856843|81473101|FG001|Overall Study|Lack of Efficacy|0|||
27900788|NCT00438256|81473103|FG000|Overall Study|Ineligible for Resection|2|||
27900789|NCT00438256|81473104|FG001|Overall Study|Ineligible for Resection|1|||
27900790|NCT00438256|81473105|FG002|Overall Study|Ineligible for Resection|1|||
27900791|NCT00438256|81473106|FG003|Overall Study|Ineligible for Resection|7|||
27900792|NCT00438256|81473103|FG000|Overall Study|Excluded final Diagnosis|0|||
27900793|NCT00438256|81473104|FG001|Overall Study|Excluded final Diagnosis|0|||
27900794|NCT00438256|81473105|FG002|Overall Study|Excluded final Diagnosis|0|||
27900795|NCT00438256|81473106|FG003|Overall Study|Excluded final Diagnosis|2|||
27900796|NCT01941537|81473107|FG000|Overall Study|Lack of Efficacy|1|||
27900797|NCT01941537|81473108|FG001|Overall Study|Lack of Efficacy|2|||
27900798|NCT01941537|81473107|FG000|Overall Study|Lost to Follow-up|1|||
27900799|NCT01941537|81473108|FG001|Overall Study|Lost to Follow-up|0|||
27727848|NCT00792298|80830364|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27727849|NCT00792298|80830365|FG003|Treatment Period 2|Withdrawal by Subject|2|||
27727850|NCT00792298|80830366|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27727851|NCT00792298|80830367|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27727852|NCT00792298|80830368|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27727853|NCT00792298|80830369|FG007|Treatment Period 2|Withdrawal by Subject|2|||
27727854|NCT04167345|80830374|FG000|Overall Study|Other|1|||
27727855|NCT04167345|80830375|FG001|Overall Study|Other|1|||
27727856|NCT04167345|80830376|FG002|Overall Study|Other|0|||
27727857|NCT04167345|80830377|FG003|Overall Study|Other|0|||
27727858|NCT04167345|80830378|FG004|Overall Study|Other|0|||
27727859|NCT05172544|80830379|FG000|Overall Study|Withdrawal by Subject|1|||
27727860|NCT05172544|80830380|FG001|Overall Study|Withdrawal by Subject|0|||
27727861|NCT05172544|80830381|FG002|Overall Study|Withdrawal by Subject|0|||
27727862|NCT05172544|80830379|FG000|Overall Study|Physician Decision|0|||
27727863|NCT05172544|80830380|FG001|Overall Study|Physician Decision|0|||
27727864|NCT05172544|80830381|FG002|Overall Study|Physician Decision|1|||
27851272|NCT02132754|81287013|FG019|Overall Study|Excluded Medication|0|||
27727865|NCT03370770|80830382|FG000|Overall Study|Patient was followed in another hospital center|1|||
27727866|NCT03370770|80830382|FG000|Overall Study|Progressive Disease|98|||
27727867|NCT03370770|80830382|FG000|Overall Study|Adverse Event|2|||
27851273|NCT02132754|81287014|FG020|Overall Study|Excluded Medication|1|||
27851274|NCT02132754|81287015|FG021|Overall Study|Excluded Medication|0|||
27851275|NCT02132754|81287016|FG022|Overall Study|Excluded Medication|0|||
27851276|NCT02132754|81287017|FG023|Overall Study|Excluded Medication|0|||
27851277|NCT02132754|81287018|FG024|Overall Study|Excluded Medication|0|||
27851278|NCT02132754|81287019|FG025|Overall Study|Excluded Medication|0|||
27851279|NCT02132754|81287020|FG026|Overall Study|Excluded Medication|0|||
27900800|NCT01941537|81473107|FG000|Overall Study|Pregnancy|1|||
27727868|NCT03370770|80830382|FG000|Overall Study|Death|5|||
27727869|NCT02804763|80830383|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
27727870|NCT02804763|80830384|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
27851280|NCT02132754|81287021|FG027|Overall Study|Excluded Medication|0|||
27851281|NCT02132754|81287022|FG028|Overall Study|Excluded Medication|0|||
27851282|NCT02132754|81287023|FG029|Overall Study|Excluded Medication|0|||
27900801|NCT01941537|81473108|FG001|Overall Study|Pregnancy|0|||
27900802|NCT01941537|81473107|FG000|Overall Study|Adverse Event|1|||
27900803|NCT01941537|81473108|FG001|Overall Study|Adverse Event|0|||
27900804|NCT01941537|81473107|FG000|Overall Study|Withdrawal by Subject|0|||
27900805|NCT01941537|81473108|FG001|Overall Study|Withdrawal by Subject|1|||
27900806|NCT02000882|81473111|FG000|Overall Study|Adverse Event|3|||
27900807|NCT02000882|81473111|FG000|Overall Study|Physician Decision|2|||
27900808|NCT02000882|81473111|FG000|Overall Study|Withdrawal by Subject|1|||
27900809|NCT02368210|81473112|FG000|Overall Study|Withdrawal by Subject|1|||
27900810|NCT02368210|81473113|FG001|Overall Study|Withdrawal by Subject|0|||
27900811|NCT02368210|81473112|FG000|Overall Study|Adverse Event|0|||
27900812|NCT02368210|81473113|FG001|Overall Study|Adverse Event|1|||
27900813|NCT04908475|81473120|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
27900814|NCT04908475|81473121|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
27900815|NCT04908475|81473122|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
27900816|NCT04908475|81473123|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
27900817|NCT04908475|81473124|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
27900818|NCT04908475|81473125|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
27900819|NCT04908475|81473120|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
27900820|NCT04908475|81473121|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
27900821|NCT04908475|81473122|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
27900822|NCT04908475|81473123|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
27900823|NCT04908475|81473124|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
27900824|NCT04908475|81473125|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
27900825|NCT04908475|81473120|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
27900826|NCT04908475|81473121|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
27900827|NCT04908475|81473122|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
27900828|NCT04908475|81473123|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
27900829|NCT04908475|81473124|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
27900830|NCT04908475|81473125|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
27900831|NCT04908475|81473120|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27900832|NCT04908475|81473121|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
27900833|NCT04908475|81473122|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
27900834|NCT04908475|81473123|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
27900835|NCT04908475|81473124|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27900836|NCT04908475|81473125|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
27900837|NCT04908475|81473120|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
27900838|NCT04908475|81473121|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
27900839|NCT04908475|81473122|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
27900840|NCT04908475|81473123|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
27900841|NCT04908475|81473124|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
27900842|NCT04908475|81473125|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
27900843|NCT04908475|81473120|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
27900844|NCT04908475|81473121|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
27614224|NCT02087150|80430180|FG000|Overall Study|Physician Decision|0|||
27851283|NCT02132754|81287024|FG030|Overall Study|Excluded Medication|0|||
27851284|NCT02132754|81287025|FG031|Overall Study|Excluded Medication|0|||
27851285|NCT02132754|81287026|FG032|Overall Study|Excluded Medication|0|||
27851286|NCT02132754|81287027|FG033|Overall Study|Excluded Medication|1|||
27851287|NCT02132754|81286994|FG000|Overall Study|Physician Decision|0|||
27851288|NCT02132754|81286995|FG001|Overall Study|Physician Decision|0|||
27851289|NCT02132754|81286996|FG002|Overall Study|Physician Decision|0|||
27851290|NCT02132754|81286997|FG003|Overall Study|Physician Decision|0|||
27851291|NCT02132754|81286998|FG004|Overall Study|Physician Decision|0|||
27851292|NCT02132754|81286999|FG005|Overall Study|Physician Decision|0|||
27851293|NCT02132754|81287000|FG006|Overall Study|Physician Decision|0|||
27851294|NCT02132754|81287001|FG007|Overall Study|Physician Decision|0|||
27851295|NCT02132754|81287002|FG008|Overall Study|Physician Decision|0|||
27851296|NCT02132754|81287003|FG009|Overall Study|Physician Decision|1|||
27851297|NCT02132754|81287004|FG010|Overall Study|Physician Decision|0|||
27851298|NCT02132754|81287005|FG011|Overall Study|Physician Decision|1|||
27851299|NCT02132754|81287006|FG012|Overall Study|Physician Decision|1|||
27851300|NCT02132754|81287007|FG013|Overall Study|Physician Decision|0|||
27851301|NCT02132754|81287008|FG014|Overall Study|Physician Decision|0|||
27851302|NCT02132754|81287009|FG015|Overall Study|Physician Decision|1|||
27851303|NCT02132754|81287010|FG016|Overall Study|Physician Decision|0|||
27900845|NCT04908475|81473122|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
27851304|NCT02132754|81287011|FG017|Overall Study|Physician Decision|0|||
27851305|NCT02132754|81287012|FG018|Overall Study|Physician Decision|0|||
27851306|NCT02132754|81287013|FG019|Overall Study|Physician Decision|0|||
27851307|NCT02132754|81287014|FG020|Overall Study|Physician Decision|0|||
27851308|NCT02132754|81287015|FG021|Overall Study|Physician Decision|0|||
27851309|NCT02132754|81287016|FG022|Overall Study|Physician Decision|0|||
27851310|NCT02132754|81287017|FG023|Overall Study|Physician Decision|0|||
27900846|NCT04908475|81473123|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
27900847|NCT04908475|81473124|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
27900848|NCT04908475|81473125|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
27900849|NCT00483704|81473126|FG000|Randomization|Withdrawal by Subject|19|||
27900850|NCT00483704|81473127|FG001|Randomization|Withdrawal by Subject|28|||
27900851|NCT00483704|81473128|FG002|Randomization|Withdrawal by Subject|18|||
27900852|NCT00483704|81473126|FG000|Randomization|Protocol Violation|14|||
27900853|NCT00483704|81473127|FG001|Randomization|Protocol Violation|25|||
27506489|NCT02079246|80047846|FG001|OLEX|Protocol Violation|0|||
27506490|NCT02079246|80047845|FG000|OLEX|Lack of Efficacy|3|||
27506491|NCT02079246|80047846|FG001|OLEX|Lack of Efficacy|0|||
27506492|NCT02079246|80047845|FG000|OLEX|Results of the lead-in studies|58|||
27506493|NCT02079246|80047846|FG001|OLEX|Results of the lead-in studies|0|||
27506494|NCT02079246|80047845|FG000|OLEX|Other: Disallowed medication|8|||
27506495|NCT02079246|80047846|FG001|OLEX|Other: Disallowed medication|0|||
27506496|NCT02079246|80047845|FG000|OLEX|Other: Insufficient compliance|2|||
27506497|NCT02079246|80047846|FG001|OLEX|Other: Insufficient compliance|0|||
27506498|NCT02079246|80047845|FG000|OLEX|Other: Caregiver unavailable|3|||
27506499|NCT02079246|80047846|FG001|OLEX|Other: Caregiver unavailable|0|||
27506500|NCT02079246|80047845|FG000|OLEX|Other: Coordinator decision|1|||
27506501|NCT02079246|80047846|FG001|OLEX|Other: Coordinator decision|0|||
27506502|NCT02079246|80047845|FG000|OLEX|Other: Worsening of condition|1|||
27506503|NCT02079246|80047846|FG001|OLEX|Other: Worsening of condition|0|||
27900854|NCT00483704|81473128|FG002|Randomization|Protocol Violation|22|||
27900855|NCT00483704|81473126|FG000|Randomization|Lost to Follow-up|14|||
27900856|NCT00483704|81473127|FG001|Randomization|Lost to Follow-up|14|||
27900857|NCT00483704|81473128|FG002|Randomization|Lost to Follow-up|19|||
27900858|NCT00483704|81473126|FG000|Randomization|Pregnancy|1|||
27900859|NCT00483704|81473127|FG001|Randomization|Pregnancy|0|||
27900860|NCT00483704|81473128|FG002|Randomization|Pregnancy|0|||
27900861|NCT00483704|81473126|FG000|Randomization|Physician Decision|2|||
27900862|NCT00483704|81473127|FG001|Randomization|Physician Decision|4|||
27900863|NCT00483704|81473128|FG002|Randomization|Physician Decision|0|||
27900864|NCT00483704|81473126|FG000|Randomization|Progressive disease|0|||
27900865|NCT00483704|81473127|FG001|Randomization|Progressive disease|0|||
27900866|NCT00483704|81473128|FG002|Randomization|Progressive disease|1|||
27900867|NCT00483704|81473126|FG000|Randomization|Lack of qualifying migraines|21|||
27506504|NCT02079246|80047845|FG000|OLEX|Other: Moved to nursing home|1|||
27506505|NCT02079246|80047846|FG001|OLEX|Other: Moved to nursing home|0|||
27506506|NCT02079246|80047845|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
27614225|NCT02087150|80430181|FG001|Overall Study|Physician Decision|1|||
27614226|NCT02087150|80430182|FG002|Overall Study|Physician Decision|0|||
27614227|NCT02087150|80430180|FG000|Overall Study|Procedure not done|1|||
27900868|NCT00483704|81473127|FG001|Randomization|Lack of qualifying migraines|25|||
27614228|NCT02087150|80430181|FG001|Overall Study|Procedure not done|13|||
27614229|NCT02087150|80430182|FG002|Overall Study|Procedure not done|0|||
27614230|NCT02087150|80430180|FG000|Overall Study|F/U not completed w/in study window|0|||
27614231|NCT02087150|80430181|FG001|Overall Study|F/U not completed w/in study window|0|||
27900869|NCT00483704|81473128|FG002|Randomization|Lack of qualifying migraines|31|||
27900870|NCT00483704|81473126|FG000|Treatment|Lack of qualifying migraines|101|||
27900871|NCT00483704|81473127|FG001|Treatment|Lack of qualifying migraines|99|||
27900872|NCT00483704|81473128|FG002|Treatment|Lack of qualifying migraines|116|||
27614232|NCT02087150|80430182|FG002|Overall Study|F/U not completed w/in study window|1|||
27614233|NCT02087150|80430180|FG000|Overall Study|Other|1|||
27614234|NCT02087150|80430181|FG001|Overall Study|Other|0|||
27614235|NCT02087150|80430182|FG002|Overall Study|Other|0|||
27900873|NCT00483704|81473126|FG000|Treatment|Adverse Event|3|||
27506507|NCT02079246|80047846|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
27614236|NCT02087150|80430180|FG000|Overall Study|Pt moved out of town|0|||
27614237|NCT02087150|80430181|FG001|Overall Study|Pt moved out of town|1|||
27614238|NCT02087150|80430182|FG002|Overall Study|Pt moved out of town|0|||
27614239|NCT01115491|80430183|FG000|Overall Study|Death|22|||
27614240|NCT01115491|80430183|FG000|Overall Study|Adverse Event|3|||
27614241|NCT01115491|80430183|FG000|Overall Study|Lost to Follow-up|3|||
27614242|NCT01115491|80430183|FG000|Overall Study|Withdrawal by Subject|1|||
27506508|NCT02079246|80047845|FG000|OLEX-MEM|Adverse Event|0|||
27506509|NCT02079246|80047846|FG001|OLEX-MEM|Adverse Event|6|||
27506510|NCT02079246|80047845|FG000|OLEX-MEM|Withdrawal by Subject|0|||
27506511|NCT02079246|80047846|FG001|OLEX-MEM|Withdrawal by Subject|7|||
27614243|NCT01115491|80430183|FG000|Overall Study|Physician Decision|1|||
27614244|NCT00309608|80430191|FG000|Overall Study|Adverse Event|1|||
27614245|NCT00309608|80430192|FG001|Overall Study|Adverse Event|5|||
27614246|NCT00309608|80430193|FG002|Overall Study|Adverse Event|3|||
27900874|NCT00483704|81473127|FG001|Treatment|Adverse Event|5|||
27900875|NCT00483704|81473128|FG002|Treatment|Adverse Event|4|||
27506512|NCT02079246|80047845|FG000|OLEX-MEM|Protocol Violation|0|||
27614247|NCT00309608|80430194|FG003|Overall Study|Adverse Event|2|||
27614248|NCT00309608|80430195|FG004|Overall Study|Adverse Event|3|||
27900876|NCT00483704|81473126|FG000|Treatment|Withdrawal by Subject|16|||
27900877|NCT00483704|81473127|FG001|Treatment|Withdrawal by Subject|12|||
27900878|NCT00483704|81473128|FG002|Treatment|Withdrawal by Subject|21|||
27900879|NCT00483704|81473126|FG000|Treatment|Protocol Violation|6|||
27900880|NCT00483704|81473127|FG001|Treatment|Protocol Violation|3|||
27900881|NCT00483704|81473128|FG002|Treatment|Protocol Violation|5|||
27900882|NCT00483704|81473126|FG000|Treatment|Lost to Follow-up|2|||
27900883|NCT00483704|81473127|FG001|Treatment|Lost to Follow-up|7|||
27900884|NCT00483704|81473128|FG002|Treatment|Lost to Follow-up|5|||
27900885|NCT00483704|81473126|FG000|Treatment|Lack of Efficacy|1|||
27900886|NCT00483704|81473127|FG001|Treatment|Lack of Efficacy|1|||
27900887|NCT00483704|81473128|FG002|Treatment|Lack of Efficacy|1|||
27900888|NCT00483704|81473126|FG000|Treatment|Pregnancy|0|||
27900889|NCT00483704|81473127|FG001|Treatment|Pregnancy|1|||
27900890|NCT00483704|81473128|FG002|Treatment|Pregnancy|0|||
27900891|NCT00483704|81473126|FG000|Treatment|Physician Decision|0|||
27900892|NCT00483704|81473127|FG001|Treatment|Physician Decision|1|||
27900893|NCT00483704|81473128|FG002|Treatment|Physician Decision|4|||
27900894|NCT03877224|81473129|FG000|Overall Study|Death|3|||
27900895|NCT03877224|81473130|FG001|Overall Study|Death|2|||
27900896|NCT03877224|81473129|FG000|Overall Study|Withdrawal by Subject|1|||
27900897|NCT03877224|81473130|FG001|Overall Study|Withdrawal by Subject|6|||
27900898|NCT03877224|81473129|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
27900899|NCT03877224|81473130|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
27900900|NCT02732327|81473132|FG000|Overall Study|Protocol Violation|0|||
27900901|NCT02732327|81473133|FG001|Overall Study|Protocol Violation|1|||
27900902|NCT04933617|81473134|FG000|Dose Escalation|Early closure of study|0|||
27900903|NCT04933617|81473135|FG001|Dose Escalation|Early closure of study|3|||
27900904|NCT04933617|81473136|FG002|Dose Escalation|Early closure of study|0|||
27900905|NCT04933617|81473137|FG003|Dose Escalation|Early closure of study|0|||
27900906|NCT04933617|81473138|FG004|Dose Escalation|Early closure of study|0|||
27900907|NCT00583102|81473140|FG000|Overall Study|Adverse Event|3|||
27900908|NCT00269477|81473141|FG000|Overall Study|Protocol Violation|5|||
27900909|NCT00269477|81473142|FG001|Overall Study|Protocol Violation|5|||
27900910|NCT00269477|81473143|FG002|Overall Study|Protocol Violation|1|||
27900911|NCT00269477|81473144|FG003|Overall Study|Protocol Violation|0|||
27900912|NCT00269477|81473141|FG000|Overall Study|Missed post-vaccination blood draw|0|||
27900913|NCT00269477|81473142|FG001|Overall Study|Missed post-vaccination blood draw|1|||
27900914|NCT00269477|81473143|FG002|Overall Study|Missed post-vaccination blood draw|0|||
27900915|NCT00269477|81473144|FG003|Overall Study|Missed post-vaccination blood draw|0|||
27900916|NCT02971800|81473145|FG000|Overall Study|Protocol Violation|1|||
27900917|NCT02971800|81473145|FG000|Overall Study|Withdrawal by Subject|1|||
27900918|NCT02971800|81473145|FG000|Overall Study|Exclusion criteria prior intervention|1|||
27900919|NCT02971800|81473145|FG000|Overall Study|Number evaluable participant already reached|4|||
27900920|NCT02223364|81473152|FG000|Overall Study|Protocol Violation|3|||
27900921|NCT02223364|81473153|FG001|Overall Study|Protocol Violation|0|||
27900922|NCT02223364|81473154|FG002|Overall Study|Protocol Violation|3|||
27900923|NCT02223364|81473152|FG000|Overall Study|subject expired before surgery|1|||
27900924|NCT02223364|81473153|FG001|Overall Study|subject expired before surgery|0|||
27900925|NCT02223364|81473154|FG002|Overall Study|subject expired before surgery|0|||
27900926|NCT02223364|81473152|FG000|Overall Study|Physician Decision|1|||
27900927|NCT02223364|81473153|FG001|Overall Study|Physician Decision|0|||
27900928|NCT02223364|81473154|FG002|Overall Study|Physician Decision|0|||
27900929|NCT02772809|81473155|FG000|Overall Study|not completed some tasks|6|||
27900930|NCT03913104|81473157|FG000|Overall Study|Lost to Follow-up|20|||
27900931|NCT03913104|81473157|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
27900932|NCT03913104|81473157|FG000|Overall Study|Withdrawal by Subject|2|||
27900933|NCT01964716|81473158|FG000|Overall Study|Withdrawal by Subject|2|||
27900934|NCT01964716|81473159|FG001|Overall Study|Withdrawal by Subject|3|||
27900935|NCT01964716|81473158|FG000|Overall Study|Lost to Follow-up|1|||
27900936|NCT01964716|81473159|FG001|Overall Study|Lost to Follow-up|2|||
27900937|NCT01964716|81473158|FG000|Overall Study|No longer met eligibility criteria|1|||
27900938|NCT01964716|81473159|FG001|Overall Study|No longer met eligibility criteria|1|||
27900939|NCT01964716|81473158|FG000|Overall Study|Death|1|||
27900940|NCT01964716|81473159|FG001|Overall Study|Death|0|||
27900941|NCT01094782|81473166|FG000|Overall Study|Withdrawal by Subject|5|||
27900942|NCT01094782|81473167|FG001|Overall Study|Withdrawal by Subject|5|||
27900943|NCT01094782|81473168|FG002|Overall Study|Withdrawal by Subject|1|||
27900944|NCT01094782|81473169|FG003|Overall Study|Withdrawal by Subject|5|||
27900945|NCT01094782|81473170|FG004|Overall Study|Withdrawal by Subject|5|||
27900946|NCT01094782|81473171|FG005|Overall Study|Withdrawal by Subject|0|||
27900947|NCT01094782|81473166|FG000|Overall Study|Lost to Follow-up|1|||
27900948|NCT01094782|81473167|FG001|Overall Study|Lost to Follow-up|0|||
27900949|NCT01094782|81473168|FG002|Overall Study|Lost to Follow-up|0|||
27900950|NCT01094782|81473169|FG003|Overall Study|Lost to Follow-up|2|||
27900951|NCT01094782|81473170|FG004|Overall Study|Lost to Follow-up|1|||
27900952|NCT01094782|81473171|FG005|Overall Study|Lost to Follow-up|4|||
27900953|NCT01094782|81473166|FG000|Overall Study|Positive Drug Screen|2|||
27900954|NCT01094782|81473167|FG001|Overall Study|Positive Drug Screen|2|||
27900955|NCT01094782|81473168|FG002|Overall Study|Positive Drug Screen|1|||
27900956|NCT01094782|81473169|FG003|Overall Study|Positive Drug Screen|1|||
27900957|NCT01094782|81473170|FG004|Overall Study|Positive Drug Screen|3|||
27900958|NCT01094782|81473171|FG005|Overall Study|Positive Drug Screen|2|||
27900959|NCT01094782|81473166|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
27900960|NCT01094782|81473167|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
27900961|NCT01094782|81473168|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
27900962|NCT01094782|81473169|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
27900963|NCT01094782|81473170|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
27900964|NCT01094782|81473171|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
27900965|NCT01094782|81473166|FG000|Overall Study|Unable to Complete Questionnaires|0|||
27900966|NCT01094782|81473167|FG001|Overall Study|Unable to Complete Questionnaires|1|||
27900967|NCT01094782|81473168|FG002|Overall Study|Unable to Complete Questionnaires|0|||
27900968|NCT01094782|81473169|FG003|Overall Study|Unable to Complete Questionnaires|0|||
27900969|NCT01094782|81473170|FG004|Overall Study|Unable to Complete Questionnaires|0|||
27900970|NCT01094782|81473171|FG005|Overall Study|Unable to Complete Questionnaires|0|||
27900971|NCT01094782|81473166|FG000|Overall Study|Healthy Subject Had Pain|0|||
27900972|NCT01094782|81473167|FG001|Overall Study|Healthy Subject Had Pain|1|||
27900973|NCT01094782|81473168|FG002|Overall Study|Healthy Subject Had Pain|0|||
27900974|NCT01094782|81473169|FG003|Overall Study|Healthy Subject Had Pain|0|||
27900975|NCT01094782|81473170|FG004|Overall Study|Healthy Subject Had Pain|0|||
27900976|NCT01094782|81473171|FG005|Overall Study|Healthy Subject Had Pain|0|||
27900977|NCT01094782|81473166|FG000|Overall Study|Hypertension|0|||
27900978|NCT01094782|81473167|FG001|Overall Study|Hypertension|0|||
27900979|NCT01094782|81473168|FG002|Overall Study|Hypertension|1|||
27900980|NCT01094782|81473169|FG003|Overall Study|Hypertension|0|||
27900981|NCT01094782|81473170|FG004|Overall Study|Hypertension|0|||
27900982|NCT01094782|81473171|FG005|Overall Study|Hypertension|0|||
27900983|NCT01094782|81473166|FG000|Overall Study|Wrong Pain Condition|0|||
27900984|NCT01094782|81473167|FG001|Overall Study|Wrong Pain Condition|0|||
27900985|NCT01094782|81473168|FG002|Overall Study|Wrong Pain Condition|0|||
27900986|NCT01094782|81473169|FG003|Overall Study|Wrong Pain Condition|2|||
27900987|NCT01094782|81473170|FG004|Overall Study|Wrong Pain Condition|1|||
27900988|NCT01094782|81473171|FG005|Overall Study|Wrong Pain Condition|1|||
27900989|NCT01094782|81473166|FG000|Overall Study|Recent Interventional Injection|0|||
27900990|NCT01094782|81473167|FG001|Overall Study|Recent Interventional Injection|0|||
27900991|NCT01094782|81473168|FG002|Overall Study|Recent Interventional Injection|0|||
27900992|NCT01094782|81473169|FG003|Overall Study|Recent Interventional Injection|0|||
27900993|NCT01094782|81473170|FG004|Overall Study|Recent Interventional Injection|0|||
27900994|NCT01094782|81473171|FG005|Overall Study|Recent Interventional Injection|1|||
27900995|NCT01094782|81473166|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27900996|NCT01094782|81473167|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27900997|NCT01094782|81473168|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27900998|NCT01094782|81473169|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27900999|NCT01094782|81473170|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
27901000|NCT01094782|81473171|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
27901001|NCT01094782|81473166|FG000|Overall Study|Noncompliance With Study Schedule|0|||
27901002|NCT01094782|81473167|FG001|Overall Study|Noncompliance With Study Schedule|0|||
27901003|NCT01094782|81473168|FG002|Overall Study|Noncompliance With Study Schedule|0|||
27901004|NCT01094782|81473169|FG003|Overall Study|Noncompliance With Study Schedule|1|||
27901005|NCT01094782|81473170|FG004|Overall Study|Noncompliance With Study Schedule|0|||
27901006|NCT01094782|81473171|FG005|Overall Study|Noncompliance With Study Schedule|0|||
27901007|NCT05052697|81473172|FG000|Substudy A|Lost to Follow-up|0|||
27901008|NCT05052697|81473173|FG001|Substudy A|Lost to Follow-up|0|||
27901009|NCT05052697|81473174|FG002|Substudy A|Lost to Follow-up|0|||
27901010|NCT05052697|81473175|FG003|Substudy A|Lost to Follow-up|0|||
27901011|NCT05052697|81473176|FG004|Substudy A|Lost to Follow-up|0|||
27901012|NCT05052697|81473177|FG005|Substudy A|Lost to Follow-up|1|||
27901013|NCT05052697|81473178|FG006|Substudy A|Lost to Follow-up|0|||
27901014|NCT05052697|81473179|FG007|Substudy A|Lost to Follow-up|0|||
27901015|NCT05052697|81473180|FG008|Substudy A|Lost to Follow-up|0|||
27901016|NCT05052697|81473181|FG009|Substudy A|Lost to Follow-up|0|||
27901017|NCT05052697|81473182|FG010|Substudy A|Lost to Follow-up|0|||
27901018|NCT05052697|81473183|FG011|Substudy A|Lost to Follow-up|0|||
27901019|NCT05052697|81473184|FG012|Substudy A|Lost to Follow-up|0|||
27901020|NCT05052697|81473185|FG013|Substudy A|Lost to Follow-up|0|||
27901021|NCT05052697|81473186|FG014|Substudy A|Lost to Follow-up|0|||
27901022|NCT05052697|81473187|FG015|Substudy A|Lost to Follow-up|2|||
27901023|NCT05052697|81473188|FG016|Substudy A|Lost to Follow-up|0|||
27727871|NCT02804763|80830385|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
27901024|NCT05052697|81473189|FG017|Substudy A|Lost to Follow-up|0|||
27901025|NCT05052697|81473190|FG018|Substudy A|Lost to Follow-up|0|||
27901026|NCT05052697|81473191|FG019|Substudy A|Lost to Follow-up|0|||
27901027|NCT05052697|81473192|FG020|Substudy A|Lost to Follow-up|0|||
27506513|NCT02079246|80047846|FG001|OLEX-MEM|Protocol Violation|2|||
27506514|NCT02079246|80047845|FG000|OLEX-MEM|Lost to Follow-up|0|||
27506515|NCT02079246|80047846|FG001|OLEX-MEM|Lost to Follow-up|1|||
27506516|NCT02079246|80047845|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
27506517|NCT02079246|80047846|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
27506518|NCT00976560|80047853|FG000|Overall Study|Adverse Event|5|||
27506519|NCT00976560|80047854|FG001|Overall Study|Adverse Event|5|||
27506520|NCT00976560|80047853|FG000|Overall Study|Lack of Efficacy|3|||
27727872|NCT02804763|80830386|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
27727873|NCT02804763|80830383|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
27727874|NCT02804763|80830384|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
27727875|NCT02804763|80830385|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
27727876|NCT02804763|80830386|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
27727877|NCT02804763|80830383|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
27727878|NCT02804763|80830384|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
27727879|NCT02804763|80830385|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
27727880|NCT02804763|80830386|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
27727881|NCT02804763|80830383|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
27727882|NCT02804763|80830384|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
27727883|NCT02804763|80830385|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
27727884|NCT02804763|80830386|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
27727885|NCT02804763|80830383|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
27727886|NCT02804763|80830384|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
27727887|NCT02804763|80830385|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
27727888|NCT02804763|80830386|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
27727889|NCT02804763|80830383|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
27727890|NCT02804763|80830384|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
27727891|NCT02804763|80830385|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
27727892|NCT02804763|80830386|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
27727893|NCT02472847|80833062|FG000|Overall Study|Withdrawal by Subject|1|||
27727894|NCT02472847|80833063|FG001|Overall Study|Withdrawal by Subject|5|||
27727895|NCT00553462|80833067|FG000|Overall Study|Adverse Event|4|||
27727896|NCT00553462|80833067|FG000|Overall Study|Progression|4|||
27727897|NCT00553462|80833067|FG000|Overall Study|Withdrawal by Subject|5|||
27727898|NCT00553462|80833067|FG000|Overall Study|Physician Decision|1|||
27727899|NCT01220414|80833070|FG000|Overall Study|Withdrawal by Subject|1|||
27727900|NCT01220414|80833071|FG001|Overall Study|Withdrawal by Subject|0|||
27727901|NCT01220414|80833072|FG002|Overall Study|Withdrawal by Subject|0|||
27727902|NCT01220414|80833073|FG003|Overall Study|Withdrawal by Subject|1|||
27727903|NCT01163786|80833074|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
27727904|NCT01163786|80833074|FG000|Treatment With Bortezomib|Adverse Event|2|||
27727905|NCT01163786|80833074|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
27727906|NCT03136107|80833079|FG000|Overall Study|Other (Not specified)|1|||
27727907|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
27727908|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
27727909|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
27727910|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27727911|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27727912|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27727913|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27727914|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27727915|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
27727916|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
27727917|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
27727918|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27727919|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27506521|NCT00976560|80047854|FG001|Overall Study|Lack of Efficacy|5|||
27506522|NCT00976560|80047853|FG000|Overall Study|Protocol Violation|1|||
27506523|NCT00976560|80047854|FG001|Overall Study|Protocol Violation|0|||
27506524|NCT00976560|80047853|FG000|Overall Study|Lost to Follow-up|1|||
27506525|NCT00976560|80047854|FG001|Overall Study|Lost to Follow-up|0|||
27727920|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27727921|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27727922|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27727923|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
27727924|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
27506526|NCT00976560|80047853|FG000|Overall Study|Physician Decision|2|||
27506527|NCT00976560|80047854|FG001|Overall Study|Physician Decision|0|||
27901028|NCT05052697|81473193|FG021|Substudy A|Lost to Follow-up|0|||
27901029|NCT05052697|81473194|FG022|Substudy A|Lost to Follow-up|0|||
27901030|NCT05052697|81473195|FG023|Substudy A|Lost to Follow-up|0|||
27901031|NCT05052697|81473196|FG024|Substudy A|Lost to Follow-up|0|||
27901032|NCT05052697|81473197|FG025|Substudy A|Lost to Follow-up|0|||
27901033|NCT05052697|81473198|FG026|Substudy A|Lost to Follow-up|0|||
27901034|NCT05052697|81473199|FG027|Substudy A|Lost to Follow-up|0|||
27901035|NCT05052697|81473200|FG028|Substudy A|Lost to Follow-up|0|||
27901036|NCT05052697|81473201|FG029|Substudy A|Lost to Follow-up|0|||
27901037|NCT05052697|81473202|FG030|Substudy A|Lost to Follow-up|0|||
27901038|NCT05052697|81473203|FG031|Substudy A|Lost to Follow-up|0|||
27901039|NCT05052697|81473204|FG032|Substudy A|Lost to Follow-up|0|||
27901040|NCT05052697|81473205|FG033|Substudy A|Lost to Follow-up|0|||
27901041|NCT05052697|81473172|FG000|Substudy A|No longer met eligibility criteria|0|||
27901042|NCT05052697|81473173|FG001|Substudy A|No longer met eligibility criteria|0|||
27901043|NCT05052697|81473174|FG002|Substudy A|No longer met eligibility criteria|0|||
27901044|NCT05052697|81473175|FG003|Substudy A|No longer met eligibility criteria|0|||
27901045|NCT05052697|81473176|FG004|Substudy A|No longer met eligibility criteria|0|||
27901046|NCT05052697|81473177|FG005|Substudy A|No longer met eligibility criteria|0|||
27901047|NCT05052697|81473178|FG006|Substudy A|No longer met eligibility criteria|0|||
27901048|NCT05052697|81473179|FG007|Substudy A|No longer met eligibility criteria|0|||
27901049|NCT05052697|81473180|FG008|Substudy A|No longer met eligibility criteria|0|||
27901050|NCT05052697|81473181|FG009|Substudy A|No longer met eligibility criteria|0|||
27901051|NCT05052697|81473182|FG010|Substudy A|No longer met eligibility criteria|0|||
27901052|NCT05052697|81473183|FG011|Substudy A|No longer met eligibility criteria|0|||
27901053|NCT05052697|81473184|FG012|Substudy A|No longer met eligibility criteria|0|||
27901054|NCT05052697|81473185|FG013|Substudy A|No longer met eligibility criteria|1|||
27901055|NCT05052697|81473186|FG014|Substudy A|No longer met eligibility criteria|0|||
27901056|NCT05052697|81473187|FG015|Substudy A|No longer met eligibility criteria|0|||
27901057|NCT05052697|81473188|FG016|Substudy A|No longer met eligibility criteria|0|||
27901058|NCT05052697|81473189|FG017|Substudy A|No longer met eligibility criteria|0|||
27901059|NCT05052697|81473190|FG018|Substudy A|No longer met eligibility criteria|0|||
27901060|NCT05052697|81473191|FG019|Substudy A|No longer met eligibility criteria|0|||
27901061|NCT05052697|81473192|FG020|Substudy A|No longer met eligibility criteria|0|||
27901062|NCT05052697|81473193|FG021|Substudy A|No longer met eligibility criteria|0|||
27901063|NCT05052697|81473194|FG022|Substudy A|No longer met eligibility criteria|0|||
27901064|NCT05052697|81473195|FG023|Substudy A|No longer met eligibility criteria|0|||
27901065|NCT05052697|81473196|FG024|Substudy A|No longer met eligibility criteria|0|||
27901066|NCT05052697|81473197|FG025|Substudy A|No longer met eligibility criteria|0|||
27901067|NCT05052697|81473198|FG026|Substudy A|No longer met eligibility criteria|0|||
27901068|NCT05052697|81473199|FG027|Substudy A|No longer met eligibility criteria|0|||
27901069|NCT05052697|81473200|FG028|Substudy A|No longer met eligibility criteria|0|||
27901070|NCT05052697|81473201|FG029|Substudy A|No longer met eligibility criteria|0|||
27901071|NCT05052697|81473202|FG030|Substudy A|No longer met eligibility criteria|0|||
27901072|NCT05052697|81473203|FG031|Substudy A|No longer met eligibility criteria|0|||
27901073|NCT05052697|81473204|FG032|Substudy A|No longer met eligibility criteria|0|||
27901074|NCT05052697|81473205|FG033|Substudy A|No longer met eligibility criteria|0|||
27901075|NCT05052697|81473172|FG000|Substudy A|Not vaccinated|0|||
27901076|NCT05052697|81473173|FG001|Substudy A|Not vaccinated|0|||
27901077|NCT05052697|81473174|FG002|Substudy A|Not vaccinated|0|||
27901078|NCT05052697|81473175|FG003|Substudy A|Not vaccinated|1|||
27901079|NCT05052697|81473176|FG004|Substudy A|Not vaccinated|0|||
27901080|NCT05052697|81473177|FG005|Substudy A|Not vaccinated|0|||
27901081|NCT05052697|81473178|FG006|Substudy A|Not vaccinated|0|||
27901082|NCT05052697|81473179|FG007|Substudy A|Not vaccinated|0|||
27901083|NCT05052697|81473180|FG008|Substudy A|Not vaccinated|1|||
27901084|NCT05052697|81473181|FG009|Substudy A|Not vaccinated|0|||
27901085|NCT05052697|81473182|FG010|Substudy A|Not vaccinated|0|||
27901086|NCT05052697|81473183|FG011|Substudy A|Not vaccinated|0|||
27901087|NCT05052697|81473184|FG012|Substudy A|Not vaccinated|0|||
27901088|NCT05052697|81473185|FG013|Substudy A|Not vaccinated|0|||
27901089|NCT05052697|81473186|FG014|Substudy A|Not vaccinated|0|||
27901090|NCT05052697|81473187|FG015|Substudy A|Not vaccinated|0|||
27901091|NCT05052697|81473188|FG016|Substudy A|Not vaccinated|0|||
27901092|NCT05052697|81473189|FG017|Substudy A|Not vaccinated|0|||
27901093|NCT05052697|81473190|FG018|Substudy A|Not vaccinated|0|||
27901094|NCT05052697|81473191|FG019|Substudy A|Not vaccinated|0|||
27901095|NCT05052697|81473192|FG020|Substudy A|Not vaccinated|0|||
27901096|NCT05052697|81473193|FG021|Substudy A|Not vaccinated|0|||
27901097|NCT05052697|81473194|FG022|Substudy A|Not vaccinated|0|||
27901098|NCT05052697|81473195|FG023|Substudy A|Not vaccinated|0|||
27901099|NCT05052697|81473196|FG024|Substudy A|Not vaccinated|0|||
27901100|NCT05052697|81473197|FG025|Substudy A|Not vaccinated|0|||
27901101|NCT05052697|81473198|FG026|Substudy A|Not vaccinated|0|||
27901102|NCT05052697|81473199|FG027|Substudy A|Not vaccinated|0|||
27901103|NCT05052697|81473200|FG028|Substudy A|Not vaccinated|0|||
27901104|NCT05052697|81473201|FG029|Substudy A|Not vaccinated|0|||
27901105|NCT05052697|81473202|FG030|Substudy A|Not vaccinated|0|||
27901106|NCT05052697|81473203|FG031|Substudy A|Not vaccinated|0|||
27901107|NCT05052697|81473204|FG032|Substudy A|Not vaccinated|0|||
27901108|NCT05052697|81473205|FG033|Substudy A|Not vaccinated|0|||
27901109|NCT05052697|81473172|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901110|NCT05052697|81473173|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901111|NCT05052697|81473174|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901112|NCT05052697|81473175|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901113|NCT05052697|81473176|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901114|NCT05052697|81473177|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901115|NCT05052697|81473178|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901116|NCT05052697|81473179|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901117|NCT05052697|81473180|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901118|NCT05052697|81473181|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901119|NCT05052697|81473182|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901120|NCT05052697|81473183|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901121|NCT05052697|81473184|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901122|NCT05052697|81473185|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901123|NCT05052697|81473186|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901124|NCT05052697|81473187|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901125|NCT05052697|81473188|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901126|NCT05052697|81473189|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901127|NCT05052697|81473190|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
27901128|NCT05052697|81473191|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
27901129|NCT05052697|81473192|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901130|NCT05052697|81473193|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
27901131|NCT05052697|81473194|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
27901132|NCT05052697|81473195|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901133|NCT05052697|81473196|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901134|NCT05052697|81473197|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901135|NCT05052697|81473198|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901136|NCT05052697|81473199|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27506528|NCT00976560|80047853|FG000|Overall Study|Withdrawal by Subject|2|||
27506529|NCT00976560|80047854|FG001|Overall Study|Withdrawal by Subject|3|||
27506530|NCT02506244|80047855|FG000|Overall Study|Did not undergo active monitoring|458|||
27506531|NCT02506244|80047856|FG001|Overall Study|Did not undergo active monitoring|459|||
27506532|NCT02506244|80047857|FG002|Overall Study|Did not undergo active monitoring|0|||
27506533|NCT01597596|80047858|FG000|Overall Study|Study terminated by sponsor|1|||
27506534|NCT01597596|80047859|FG001|Overall Study|Study terminated by sponsor|0|||
27901137|NCT05052697|81473200|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901138|NCT05052697|81473201|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901139|NCT05052697|81473202|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901140|NCT05052697|81473203|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901141|NCT05052697|81473204|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901142|NCT05052697|81473205|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
27901143|NCT05052697|81473172|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901144|NCT05052697|81473173|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901145|NCT05052697|81473174|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901146|NCT05052697|81473175|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901147|NCT05052697|81473176|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901148|NCT05052697|81473177|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901149|NCT05052697|81473178|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901150|NCT05052697|81473179|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901151|NCT05052697|81473180|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901152|NCT05052697|81473181|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901153|NCT05052697|81473182|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901154|NCT05052697|81473183|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901155|NCT05052697|81473184|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901156|NCT05052697|81473185|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901157|NCT05052697|81473186|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
27506535|NCT01597596|80047858|FG000|Overall Study|Physician Decision|0|||
27614249|NCT00309608|80430191|FG000|Overall Study|Protocol Violation|2|||
27901158|NCT05052697|81473187|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901159|NCT05052697|81473188|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901160|NCT05052697|81473189|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
27901161|NCT05052697|81473190|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901162|NCT05052697|81473191|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901163|NCT05052697|81473192|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901164|NCT05052697|81473193|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
27506536|NCT01597596|80047859|FG001|Overall Study|Physician Decision|1|||
27727925|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
27727926|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27727927|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27727928|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27727929|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27727930|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27614250|NCT00309608|80430192|FG001|Overall Study|Protocol Violation|0|||
27614251|NCT00309608|80430193|FG002|Overall Study|Protocol Violation|0|||
27727931|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
27727932|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
27727933|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
27727934|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27727935|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27727936|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27727937|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27727938|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27727939|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
27727940|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
27727941|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
27727942|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27727943|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27727944|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27727945|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27727946|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27727947|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
27727948|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
27727949|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27727950|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27727951|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27727952|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27727953|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27614252|NCT00309608|80430194|FG003|Overall Study|Protocol Violation|0|||
27614253|NCT00309608|80430195|FG004|Overall Study|Protocol Violation|0|||
27614254|NCT00309608|80430191|FG000|Overall Study|Lost to Follow-up|0|||
27614255|NCT00309608|80430192|FG001|Overall Study|Lost to Follow-up|0|||
27614256|NCT00309608|80430193|FG002|Overall Study|Lost to Follow-up|2|||
27614257|NCT00309608|80430194|FG003|Overall Study|Lost to Follow-up|0|||
27614258|NCT00309608|80430195|FG004|Overall Study|Lost to Follow-up|1|||
27614259|NCT00309608|80430191|FG000|Overall Study|Withdrawal by Subject|1|||
27614260|NCT00309608|80430192|FG001|Overall Study|Withdrawal by Subject|4|||
27614261|NCT00309608|80430193|FG002|Overall Study|Withdrawal by Subject|2|||
27614262|NCT00309608|80430194|FG003|Overall Study|Withdrawal by Subject|0|||
27614263|NCT00309608|80430195|FG004|Overall Study|Withdrawal by Subject|0|||
27614264|NCT00309608|80430191|FG000|Overall Study|Other incl. Lack of efficacy|10|||
27614265|NCT00309608|80430192|FG001|Overall Study|Other incl. Lack of efficacy|4|||
27614266|NCT00309608|80430193|FG002|Overall Study|Other incl. Lack of efficacy|3|||
27614267|NCT00309608|80430194|FG003|Overall Study|Other incl. Lack of efficacy|4|||
27614268|NCT00309608|80430195|FG004|Overall Study|Other incl. Lack of efficacy|0|||
27614269|NCT00238420|80430201|FG000|Overall Study|Protocol Violation|1|||
27614270|NCT00238420|80430202|FG001|Overall Study|Protocol Violation|1|||
27614271|NCT01778062|80430203|FG000|Overall Study|Adverse Event|1|||
27614272|NCT01778062|80430204|FG001|Overall Study|Adverse Event|3|||
27614273|NCT01778062|80430203|FG000|Overall Study|Consent Withdrawal|1|||
27614274|NCT01778062|80430204|FG001|Overall Study|Consent Withdrawal|5|||
27614275|NCT01778062|80430203|FG000|Overall Study|major protocol deviation|4|||
27614276|NCT01778062|80430204|FG001|Overall Study|major protocol deviation|3|||
27614277|NCT00854295|80430205|FG000|Overall Study|Death|7|||
27614278|NCT00854295|80430206|FG001|Overall Study|Death|0|||
27614279|NCT00854295|80430207|FG002|Overall Study|Death|1|||
27614280|NCT00854295|80430208|FG003|Overall Study|Death|1|||
27727954|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27727955|NCT01097629|80833080|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
27727956|NCT01097629|80833081|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
27727957|NCT01097629|80833082|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
27727958|NCT01097629|80833083|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27851311|NCT02132754|81287018|FG024|Overall Study|Physician Decision|1|||
27851312|NCT02132754|81287019|FG025|Overall Study|Physician Decision|0|||
27614281|NCT00854295|80430205|FG000|Overall Study|Adverse Event|6|||
27614282|NCT00854295|80430206|FG001|Overall Study|Adverse Event|1|||
27614283|NCT00854295|80430207|FG002|Overall Study|Adverse Event|1|||
27614284|NCT00854295|80430208|FG003|Overall Study|Adverse Event|3|||
27506537|NCT01995838|80047864|FG000|Overall Study|Lost to Follow-up|0|||
27506538|NCT01995838|80047865|FG001|Overall Study|Lost to Follow-up|1|||
27506539|NCT01995838|80047866|FG002|Overall Study|Lost to Follow-up|0|||
27506540|NCT01995838|80047867|FG003|Overall Study|Lost to Follow-up|0|||
27506541|NCT01995838|80047868|FG004|Overall Study|Lost to Follow-up|0|||
27506542|NCT01995838|80047869|FG005|Overall Study|Lost to Follow-up|0|||
27506543|NCT01995838|80047870|FG006|Overall Study|Lost to Follow-up|1|||
27506544|NCT01995838|80047864|FG000|Overall Study|Participant choice|2|||
27506545|NCT01995838|80047865|FG001|Overall Study|Participant choice|0|||
27506546|NCT01995838|80047866|FG002|Overall Study|Participant choice|0|||
27506547|NCT01995838|80047867|FG003|Overall Study|Participant choice|0|||
27506548|NCT01995838|80047868|FG004|Overall Study|Participant choice|0|||
27506549|NCT01995838|80047869|FG005|Overall Study|Participant choice|1|||
27506550|NCT01995838|80047870|FG006|Overall Study|Participant choice|1|||
27506551|NCT01995838|80047864|FG000|Overall Study|Adverse Event|0|||
27506552|NCT01995838|80047865|FG001|Overall Study|Adverse Event|0|||
27506553|NCT01995838|80047866|FG002|Overall Study|Adverse Event|0|||
27506554|NCT01995838|80047867|FG003|Overall Study|Adverse Event|0|||
27506555|NCT01995838|80047868|FG004|Overall Study|Adverse Event|0|||
27506556|NCT01995838|80047869|FG005|Overall Study|Adverse Event|0|||
27506557|NCT01995838|80047870|FG006|Overall Study|Adverse Event|1|||
27506558|NCT01995838|80047864|FG000|Overall Study|Withdrawal by Subject|0|||
27506559|NCT01995838|80047865|FG001|Overall Study|Withdrawal by Subject|0|||
27506560|NCT01995838|80047866|FG002|Overall Study|Withdrawal by Subject|0|||
27506561|NCT01995838|80047867|FG003|Overall Study|Withdrawal by Subject|0|||
27506562|NCT01995838|80047868|FG004|Overall Study|Withdrawal by Subject|1|||
27506563|NCT01995838|80047869|FG005|Overall Study|Withdrawal by Subject|0|||
27506564|NCT01995838|80047870|FG006|Overall Study|Withdrawal by Subject|0|||
27506565|NCT01995838|80047864|FG000|Overall Study|Other|3|||
27506566|NCT01995838|80047865|FG001|Overall Study|Other|1|||
27506567|NCT01995838|80047866|FG002|Overall Study|Other|0|||
27506568|NCT01995838|80047867|FG003|Overall Study|Other|2|||
27506569|NCT01995838|80047868|FG004|Overall Study|Other|1|||
27506570|NCT01995838|80047869|FG005|Overall Study|Other|1|||
27506571|NCT01995838|80047870|FG006|Overall Study|Other|2|||
27506572|NCT04476797|80047871|FG000|Overall Study|Withdrawal by Subject|1|||
27506573|NCT04476797|80047872|FG001|Overall Study|Withdrawal by Subject|0|||
27506574|NCT04476797|80047873|FG002|Overall Study|Withdrawal by Subject|0|||
27506575|NCT04476797|80047871|FG000|Overall Study|Death|0|||
27506576|NCT04476797|80047872|FG001|Overall Study|Death|1|||
27506577|NCT04476797|80047873|FG002|Overall Study|Death|2|||
27506578|NCT04476797|80047871|FG000|Overall Study|Sponsor Terminated Study|0|||
27506579|NCT04476797|80047872|FG001|Overall Study|Sponsor Terminated Study|18|||
27506580|NCT04476797|80047873|FG002|Overall Study|Sponsor Terminated Study|17|||
27506581|NCT01337960|80047877|FG000|Overall Study|Lost to Follow-up|1|||
27506582|NCT01337960|80047878|FG001|Overall Study|Lost to Follow-up|0|||
27506583|NCT01337960|80047879|FG002|Overall Study|Lost to Follow-up|0|||
27506584|NCT01337960|80047877|FG000|Overall Study|Withdrawal by Subject|1|||
27506585|NCT01337960|80047878|FG001|Overall Study|Withdrawal by Subject|0|||
27506586|NCT01337960|80047879|FG002|Overall Study|Withdrawal by Subject|0|||
27506587|NCT00684021|80047880|FG000|Overall Study|MRI Contraindicated|1|||
27506588|NCT00684021|80047881|FG001|Overall Study|MRI Contraindicated|1|||
27506589|NCT00684021|80047882|FG002|Overall Study|MRI Contraindicated|1|||
27506590|NCT00684021|80047883|FG003|Overall Study|MRI Contraindicated|0|||
27506591|NCT00684021|80047880|FG000|Overall Study|MRI not performed|0|||
27506592|NCT00684021|80047881|FG001|Overall Study|MRI not performed|1|||
27506593|NCT00684021|80047882|FG002|Overall Study|MRI not performed|1|||
27506594|NCT00684021|80047883|FG003|Overall Study|MRI not performed|2|||
27506595|NCT00684021|80047880|FG000|Overall Study|Death|1|||
27506596|NCT00684021|80047881|FG001|Overall Study|Death|0|||
27506597|NCT00684021|80047882|FG002|Overall Study|Death|0|||
27614285|NCT00854295|80430205|FG000|Overall Study|Lost to Follow-up|18|||
27851313|NCT02132754|81287020|FG026|Overall Study|Physician Decision|0|||
27506598|NCT00684021|80047883|FG003|Overall Study|Death|0|||
27506599|NCT03137381|80047884|FG000|Overall Study|Adverse Event|3|||
27506600|NCT03137381|80047885|FG001|Overall Study|Adverse Event|0|||
27506601|NCT03137381|80047886|FG002|Overall Study|Adverse Event|2|||
27506602|NCT03137381|80047887|FG003|Overall Study|Adverse Event|0|||
27506603|NCT03137381|80047884|FG000|Overall Study|Lost to Follow-up|2|||
27614286|NCT00854295|80430206|FG001|Overall Study|Lost to Follow-up|5|||
27614287|NCT00854295|80430207|FG002|Overall Study|Lost to Follow-up|21|||
27614288|NCT00854295|80430208|FG003|Overall Study|Lost to Follow-up|21|||
27506604|NCT03137381|80047885|FG001|Overall Study|Lost to Follow-up|1|||
27506605|NCT03137381|80047886|FG002|Overall Study|Lost to Follow-up|1|||
27506606|NCT03137381|80047887|FG003|Overall Study|Lost to Follow-up|0|||
27506607|NCT03137381|80047884|FG000|Overall Study|Protocol deviation|1|||
27506608|NCT03137381|80047885|FG001|Overall Study|Protocol deviation|1|||
27614289|NCT00854295|80430205|FG000|Overall Study|Physician Decision|10|||
27506609|NCT03137381|80047886|FG002|Overall Study|Protocol deviation|0|||
27506610|NCT03137381|80047887|FG003|Overall Study|Protocol deviation|1|||
27506611|NCT03137381|80047884|FG000|Overall Study|Withdrawal by Investigator|0|||
27506612|NCT03137381|80047885|FG001|Overall Study|Withdrawal by Investigator|1|||
27506613|NCT03137381|80047886|FG002|Overall Study|Withdrawal by Investigator|1|||
27506614|NCT03137381|80047887|FG003|Overall Study|Withdrawal by Investigator|0|||
27506615|NCT03137381|80047884|FG000|Overall Study|Withdrawal by Subject|3|||
27506616|NCT03137381|80047885|FG001|Overall Study|Withdrawal by Subject|4|||
27614290|NCT00854295|80430206|FG001|Overall Study|Physician Decision|0|||
27851314|NCT02132754|81287021|FG027|Overall Study|Physician Decision|0|||
27851315|NCT02132754|81287022|FG028|Overall Study|Physician Decision|0|||
27851316|NCT02132754|81287023|FG029|Overall Study|Physician Decision|0|||
27901165|NCT05052697|81473194|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901166|NCT05052697|81473195|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901167|NCT05052697|81473196|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901168|NCT05052697|81473197|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901169|NCT05052697|81473198|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901170|NCT05052697|81473199|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901171|NCT05052697|81473200|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901172|NCT05052697|81473201|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901173|NCT05052697|81473202|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901174|NCT05052697|81473203|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901175|NCT05052697|81473204|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901176|NCT05052697|81473205|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
27901177|NCT05052697|81473172|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27506617|NCT03137381|80047886|FG002|Overall Study|Withdrawal by Subject|3|||
27851317|NCT02132754|81287024|FG030|Overall Study|Physician Decision|0|||
27851318|NCT02132754|81287025|FG031|Overall Study|Physician Decision|1|||
27851319|NCT02132754|81287026|FG032|Overall Study|Physician Decision|0|||
27851320|NCT02132754|81287027|FG033|Overall Study|Physician Decision|3|||
27851321|NCT02132754|81286994|FG000|Overall Study|Progressive Disease|1|||
27851322|NCT02132754|81286995|FG001|Overall Study|Progressive Disease|1|||
27851323|NCT02132754|81286996|FG002|Overall Study|Progressive Disease|1|||
27851324|NCT02132754|81286997|FG003|Overall Study|Progressive Disease|1|||
27851325|NCT02132754|81286998|FG004|Overall Study|Progressive Disease|1|||
27851326|NCT02132754|81286999|FG005|Overall Study|Progressive Disease|1|||
27851327|NCT02132754|81287000|FG006|Overall Study|Progressive Disease|1|||
27851328|NCT02132754|81287001|FG007|Overall Study|Progressive Disease|1|||
27851329|NCT02132754|81287002|FG008|Overall Study|Progressive Disease|1|||
27851330|NCT02132754|81287003|FG009|Overall Study|Progressive Disease|3|||
27851331|NCT02132754|81287004|FG010|Overall Study|Progressive Disease|3|||
27851332|NCT02132754|81287005|FG011|Overall Study|Progressive Disease|2|||
27851333|NCT02132754|81287006|FG012|Overall Study|Progressive Disease|2|||
27851334|NCT02132754|81287007|FG013|Overall Study|Progressive Disease|3|||
27851335|NCT02132754|81287008|FG014|Overall Study|Progressive Disease|2|||
27851336|NCT02132754|81287009|FG015|Overall Study|Progressive Disease|1|||
27851337|NCT02132754|81287010|FG016|Overall Study|Progressive Disease|2|||
27851338|NCT02132754|81287011|FG017|Overall Study|Progressive Disease|1|||
27851339|NCT02132754|81287012|FG018|Overall Study|Progressive Disease|3|||
27851340|NCT02132754|81287013|FG019|Overall Study|Progressive Disease|1|||
27851341|NCT02132754|81287014|FG020|Overall Study|Progressive Disease|1|||
27851342|NCT02132754|81287015|FG021|Overall Study|Progressive Disease|3|||
27851343|NCT02132754|81287016|FG022|Overall Study|Progressive Disease|2|||
27851344|NCT02132754|81287017|FG023|Overall Study|Progressive Disease|3|||
27851345|NCT02132754|81287018|FG024|Overall Study|Progressive Disease|0|||
27851346|NCT02132754|81287019|FG025|Overall Study|Progressive Disease|1|||
27851347|NCT02132754|81287020|FG026|Overall Study|Progressive Disease|2|||
27851348|NCT02132754|81287021|FG027|Overall Study|Progressive Disease|1|||
27851349|NCT02132754|81287022|FG028|Overall Study|Progressive Disease|2|||
27851350|NCT02132754|81287023|FG029|Overall Study|Progressive Disease|3|||
27851351|NCT02132754|81287024|FG030|Overall Study|Progressive Disease|1|||
27851352|NCT02132754|81287025|FG031|Overall Study|Progressive Disease|1|||
27851353|NCT02132754|81287026|FG032|Overall Study|Progressive Disease|3|||
27851354|NCT02132754|81287027|FG033|Overall Study|Progressive Disease|6|||
27851355|NCT02132754|81286994|FG000|Overall Study|Screen Failure|0|||
27851356|NCT02132754|81286995|FG001|Overall Study|Screen Failure|0|||
27851357|NCT02132754|81286996|FG002|Overall Study|Screen Failure|0|||
27851358|NCT02132754|81286997|FG003|Overall Study|Screen Failure|0|||
27851359|NCT02132754|81286998|FG004|Overall Study|Screen Failure|0|||
27851360|NCT02132754|81286999|FG005|Overall Study|Screen Failure|0|||
27901178|NCT05052697|81473173|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27506618|NCT03137381|80047887|FG003|Overall Study|Withdrawal by Subject|0|||
27851361|NCT02132754|81287000|FG006|Overall Study|Screen Failure|0|||
27851362|NCT02132754|81287001|FG007|Overall Study|Screen Failure|0|||
27851363|NCT02132754|81287002|FG008|Overall Study|Screen Failure|0|||
27851364|NCT02132754|81287003|FG009|Overall Study|Screen Failure|0|||
27851365|NCT02132754|81287004|FG010|Overall Study|Screen Failure|0|||
27851366|NCT02132754|81287005|FG011|Overall Study|Screen Failure|0|||
27851367|NCT02132754|81287006|FG012|Overall Study|Screen Failure|0|||
27901179|NCT05052697|81473174|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901180|NCT05052697|81473175|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901181|NCT05052697|81473176|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901182|NCT05052697|81473177|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901183|NCT05052697|81473178|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901184|NCT05052697|81473179|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901185|NCT05052697|81473180|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901186|NCT05052697|81473181|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901187|NCT05052697|81473182|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901188|NCT05052697|81473183|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901189|NCT05052697|81473184|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901190|NCT05052697|81473185|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901191|NCT05052697|81473186|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901192|NCT05052697|81473187|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901193|NCT05052697|81473188|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901194|NCT05052697|81473189|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901195|NCT05052697|81473190|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901196|NCT05052697|81473191|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
27901197|NCT05052697|81473192|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901198|NCT05052697|81473193|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901199|NCT05052697|81473194|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901200|NCT05052697|81473195|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901201|NCT05052697|81473196|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901202|NCT05052697|81473197|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901203|NCT05052697|81473198|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901204|NCT05052697|81473199|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901205|NCT05052697|81473200|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901206|NCT05052697|81473201|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901207|NCT05052697|81473202|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901208|NCT05052697|81473203|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901209|NCT05052697|81473204|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27901210|NCT05052697|81473205|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
27614291|NCT00854295|80430207|FG002|Overall Study|Physician Decision|0|||
27614292|NCT00854295|80430208|FG003|Overall Study|Physician Decision|0|||
27614293|NCT02791490|80430213|FG000|Overall Study|Lost to Follow-up|1|||
27614294|NCT02791490|80430214|FG001|Overall Study|Lost to Follow-up|2|||
27614295|NCT02791490|80430213|FG000|Overall Study|Withdrawal by Subject|2|||
27614296|NCT02791490|80430214|FG001|Overall Study|Withdrawal by Subject|6|||
27614297|NCT00287469|80430218|FG000|Overall Study|serious adverse event|1|||
27614298|NCT00287469|80430219|FG001|Overall Study|serious adverse event|6|||
27614299|NCT00287469|80430218|FG000|Overall Study|Adverse Event|1|||
27614300|NCT00287469|80430219|FG001|Overall Study|Adverse Event|1|||
27614301|NCT00287469|80430218|FG000|Overall Study|moved from area|144|||
27614302|NCT00287469|80430219|FG001|Overall Study|moved from area|138|||
27614303|NCT00287469|80430218|FG000|Overall Study|Lost to Follow-up|74|||
27614304|NCT00287469|80430219|FG001|Overall Study|Lost to Follow-up|69|||
27614305|NCT02141659|80430220|FG000|Overall Study|Major Protocol Deviation|0|||
27614306|NCT02141659|80430221|FG001|Overall Study|Major Protocol Deviation|1|||
27614307|NCT02141659|80430222|FG002|Overall Study|Major Protocol Deviation|0|||
27614308|NCT02141659|80430223|FG003|Overall Study|Major Protocol Deviation|0|||
27614309|NCT02141659|80430224|FG004|Overall Study|Major Protocol Deviation|0|||
27614310|NCT02141659|80430225|FG005|Overall Study|Major Protocol Deviation|0|||
27614311|NCT02141659|80430220|FG000|Overall Study|Lack of Efficacy|0|||
27614312|NCT02141659|80430221|FG001|Overall Study|Lack of Efficacy|0|||
27901211|NCT05052697|81473172|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901212|NCT05052697|81473173|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901213|NCT05052697|81473174|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901214|NCT05052697|81473175|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901215|NCT05052697|81473176|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901216|NCT05052697|81473177|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901217|NCT05052697|81473178|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27614313|NCT02141659|80430222|FG002|Overall Study|Lack of Efficacy|0|||
27614314|NCT02141659|80430223|FG003|Overall Study|Lack of Efficacy|0|||
27614315|NCT02141659|80430224|FG004|Overall Study|Lack of Efficacy|0|||
27614316|NCT02141659|80430225|FG005|Overall Study|Lack of Efficacy|1|||
27614317|NCT02141659|80430220|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
27901218|NCT05052697|81473179|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901219|NCT05052697|81473180|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27614318|NCT02141659|80430221|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
27614319|NCT02141659|80430222|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
27614320|NCT02141659|80430223|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
27614321|NCT02141659|80430224|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
27614322|NCT02141659|80430225|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
27614323|NCT01681368|80430226|FG000|Overall Study|Refused further treatment|1|||
27901220|NCT05052697|81473181|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27727959|NCT01097629|80833084|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27727960|NCT01097629|80833085|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27727961|NCT01097629|80833086|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27727962|NCT01097629|80833087|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27727963|NCT01097629|80833080|FG000|DB RO Phase|Withdrawal by Subject|0|||
27727964|NCT01097629|80833081|FG001|DB RO Phase|Withdrawal by Subject|0|||
27727965|NCT01097629|80833082|FG002|DB RO Phase|Withdrawal by Subject|0|||
27727966|NCT01097629|80833083|FG003|DB RO Phase|Withdrawal by Subject|0|||
27727967|NCT01097629|80833084|FG004|DB RO Phase|Withdrawal by Subject|0|||
27727968|NCT01097629|80833085|FG005|DB RO Phase|Withdrawal by Subject|0|||
27727969|NCT01097629|80833086|FG006|DB RO Phase|Withdrawal by Subject|0|||
27727970|NCT01097629|80833087|FG007|DB RO Phase|Withdrawal by Subject|1|||
27727971|NCT01097629|80833080|FG000|DB RO Phase|Protocol Violation|0|||
27727972|NCT01097629|80833081|FG001|DB RO Phase|Protocol Violation|0|||
27727973|NCT01097629|80833082|FG002|DB RO Phase|Protocol Violation|0|||
27727974|NCT01097629|80833083|FG003|DB RO Phase|Protocol Violation|1|||
27727975|NCT01097629|80833084|FG004|DB RO Phase|Protocol Violation|0|||
27727976|NCT01097629|80833085|FG005|DB RO Phase|Protocol Violation|1|||
27727977|NCT01097629|80833086|FG006|DB RO Phase|Protocol Violation|1|||
27727978|NCT01097629|80833087|FG007|DB RO Phase|Protocol Violation|0|||
27727979|NCT01097629|80833080|FG000|DB RO Phase|Lost to Follow-up|0|||
27727980|NCT01097629|80833081|FG001|DB RO Phase|Lost to Follow-up|0|||
27727981|NCT01097629|80833082|FG002|DB RO Phase|Lost to Follow-up|0|||
27727982|NCT01097629|80833083|FG003|DB RO Phase|Lost to Follow-up|0|||
27727983|NCT01097629|80833084|FG004|DB RO Phase|Lost to Follow-up|0|||
27727984|NCT01097629|80833085|FG005|DB RO Phase|Lost to Follow-up|0|||
27727985|NCT01097629|80833086|FG006|DB RO Phase|Lost to Follow-up|2|||
27727986|NCT01097629|80833087|FG007|DB RO Phase|Lost to Follow-up|0|||
27727987|NCT00454779|80833089|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
27727988|NCT00454779|80833090|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
27727989|NCT00454779|80833089|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
27727990|NCT00454779|80833090|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
27727991|NCT00454779|80833089|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
27727992|NCT00454779|80833090|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
27727993|NCT00454779|80833089|FG000|First-line Treatment Phase|Protocol Violation|0|||
27727994|NCT00454779|80833090|FG001|First-line Treatment Phase|Protocol Violation|1|||
27727995|NCT00454779|80833089|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
27727996|NCT00454779|80833090|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
27727997|NCT00454779|80833089|FG000|First-line Treatment Phase|Ongoing|1|||
27727998|NCT00454779|80833090|FG001|First-line Treatment Phase|Ongoing|0|||
27727999|NCT00454779|80833089|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
27728000|NCT00454779|80833090|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
27728001|NCT00454779|80833089|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
27728002|NCT00454779|80833090|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
27728003|NCT00454779|80833089|FG000|Second-line Treatment Phase|Ongoing|0|||
27728004|NCT00454779|80833090|FG001|Second-line Treatment Phase|Ongoing|1|||
27728005|NCT02009878|80833091|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
27728006|NCT02009878|80833092|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
27728007|NCT02009878|80833093|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
27728008|NCT03896295|80833096|FG000|Overall Study|Adverse Event|0|||
27728009|NCT03896295|80833097|FG001|Overall Study|Adverse Event|1|||
27728010|NCT03896295|80833096|FG000|Overall Study|COVID-19|7|||
27728011|NCT03896295|80833097|FG001|Overall Study|COVID-19|29|||
27728012|NCT01900002|80833098|FG000|Overall Study|Withdrawal by Subject|2|||
27728013|NCT01900002|80833098|FG000|Overall Study|ineligible for Y-90|4|||
27728014|NCT01662648|80833101|FG000|Overall Study|Death|1|||
27728015|NCT01662648|80833102|FG001|Overall Study|Death|3|||
27728016|NCT01662648|80833101|FG000|Overall Study|Adverse Event|40|||
27728017|NCT01662648|80833102|FG001|Overall Study|Adverse Event|37|||
27728018|NCT01662648|80833101|FG000|Overall Study|Lack of Efficacy|17|||
27728019|NCT01662648|80833102|FG001|Overall Study|Lack of Efficacy|16|||
27728020|NCT01662648|80833101|FG000|Overall Study|Participant ineligible to continue trial|1|||
27728021|NCT01662648|80833102|FG001|Overall Study|Participant ineligible to continue trial|1|||
27728022|NCT01662648|80833101|FG000|Overall Study|Lost to Follow-up|24|||
27901221|NCT05052697|81473182|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27728023|NCT01662648|80833102|FG001|Overall Study|Lost to Follow-up|36|||
27728024|NCT01662648|80833101|FG000|Overall Study|Withdrawal by Subject|36|||
27728025|NCT01662648|80833102|FG001|Overall Study|Withdrawal by Subject|53|||
27901222|NCT05052697|81473183|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27728026|NCT01662648|80833101|FG000|Overall Study|Participant non-compliant|16|||
27728027|NCT01662648|80833102|FG001|Overall Study|Participant non-compliant|20|||
27728028|NCT01662648|80833101|FG000|Overall Study|Other|8|||
27728029|NCT01662648|80833102|FG001|Overall Study|Other|11|||
27728030|NCT01662648|80833101|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
27728031|NCT01662648|80833102|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
27901223|NCT05052697|81473184|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901224|NCT05052697|81473185|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901225|NCT05052697|81473186|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901226|NCT05052697|81473187|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901227|NCT05052697|81473188|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901228|NCT05052697|81473189|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
27901229|NCT05052697|81473190|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901230|NCT05052697|81473191|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901231|NCT05052697|81473192|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901232|NCT05052697|81473193|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901233|NCT05052697|81473194|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901234|NCT05052697|81473195|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901235|NCT05052697|81473196|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901236|NCT05052697|81473197|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
27901237|NCT05052697|81473198|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901238|NCT05052697|81473199|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
27901239|NCT05052697|81473200|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901240|NCT05052697|81473201|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901241|NCT05052697|81473202|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901242|NCT05052697|81473203|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901243|NCT05052697|81473204|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901244|NCT05052697|81473205|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
27901245|NCT05052697|81473172|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901246|NCT05052697|81473173|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901247|NCT05052697|81473174|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901248|NCT05052697|81473175|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901249|NCT05052697|81473176|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901250|NCT05052697|81473177|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901251|NCT05052697|81473178|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901252|NCT05052697|81473179|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901253|NCT05052697|81473180|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901254|NCT05052697|81473181|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901255|NCT05052697|81473182|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901256|NCT05052697|81473183|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901257|NCT05052697|81473184|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901258|NCT05052697|81473185|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901259|NCT05052697|81473186|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901260|NCT05052697|81473187|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901261|NCT05052697|81473188|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901262|NCT05052697|81473189|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901263|NCT05052697|81473190|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901264|NCT05052697|81473191|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901265|NCT05052697|81473192|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901266|NCT05052697|81473193|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901267|NCT05052697|81473194|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901268|NCT05052697|81473195|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901269|NCT05052697|81473196|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901270|NCT05052697|81473197|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901271|NCT05052697|81473198|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901272|NCT05052697|81473199|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901273|NCT05052697|81473200|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
27901274|NCT05052697|81473201|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901275|NCT05052697|81473202|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
27901276|NCT05052697|81473203|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
27901277|NCT05052697|81473204|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
27901278|NCT05052697|81473205|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
27901279|NCT05052697|81473172|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901280|NCT05052697|81473173|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901281|NCT05052697|81473174|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901282|NCT05052697|81473175|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901283|NCT05052697|81473176|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901284|NCT05052697|81473177|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901285|NCT05052697|81473178|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901286|NCT05052697|81473179|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901287|NCT05052697|81473180|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901288|NCT05052697|81473181|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901289|NCT05052697|81473182|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901290|NCT05052697|81473183|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901291|NCT05052697|81473184|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901292|NCT05052697|81473185|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901293|NCT05052697|81473186|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901294|NCT05052697|81473187|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901295|NCT05052697|81473188|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901296|NCT05052697|81473189|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901297|NCT05052697|81473190|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901298|NCT05052697|81473191|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901299|NCT05052697|81473192|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901300|NCT05052697|81473193|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901301|NCT05052697|81473194|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901302|NCT05052697|81473195|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901303|NCT05052697|81473196|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901304|NCT05052697|81473197|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901305|NCT05052697|81473198|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901306|NCT05052697|81473199|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901307|NCT05052697|81473200|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
27901308|NCT05052697|81473201|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
27901309|NCT05052697|81473202|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
27901310|NCT05052697|81473203|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
27901311|NCT05052697|81473204|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
27901312|NCT05052697|81473205|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
27901313|NCT05052697|81473172|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901314|NCT05052697|81473173|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901315|NCT05052697|81473174|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901316|NCT05052697|81473175|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901317|NCT05052697|81473176|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901318|NCT05052697|81473177|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901319|NCT05052697|81473178|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901320|NCT05052697|81473179|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901321|NCT05052697|81473180|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901322|NCT05052697|81473181|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901323|NCT05052697|81473182|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901324|NCT05052697|81473183|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901325|NCT05052697|81473184|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901326|NCT05052697|81473185|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901327|NCT05052697|81473186|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901328|NCT05052697|81473187|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901329|NCT05052697|81473188|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901330|NCT05052697|81473189|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901331|NCT05052697|81473190|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901332|NCT05052697|81473191|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901333|NCT05052697|81473192|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901334|NCT05052697|81473193|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901335|NCT05052697|81473194|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901336|NCT05052697|81473195|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901337|NCT05052697|81473196|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901338|NCT05052697|81473197|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901339|NCT05052697|81473198|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901340|NCT05052697|81473199|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901341|NCT05052697|81473200|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901342|NCT05052697|81473201|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901343|NCT05052697|81473202|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901344|NCT05052697|81473203|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901345|NCT05052697|81473204|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
27901346|NCT05052697|81473205|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
27901347|NCT05052697|81473172|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901348|NCT05052697|81473173|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901349|NCT05052697|81473174|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901350|NCT05052697|81473175|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901351|NCT05052697|81473176|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901352|NCT05052697|81473177|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901353|NCT05052697|81473178|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27506619|NCT03137381|80047884|FG000|Overall Study|Pregnancy|0|||
27901354|NCT05052697|81473179|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901355|NCT05052697|81473180|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901356|NCT05052697|81473181|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901357|NCT05052697|81473182|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901358|NCT05052697|81473183|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901359|NCT05052697|81473184|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901360|NCT05052697|81473185|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901361|NCT05052697|81473186|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901362|NCT05052697|81473187|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901363|NCT05052697|81473188|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901364|NCT05052697|81473189|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901365|NCT05052697|81473190|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901366|NCT05052697|81473191|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901367|NCT05052697|81473192|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901368|NCT05052697|81473193|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901369|NCT05052697|81473194|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901370|NCT05052697|81473195|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901371|NCT05052697|81473196|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901372|NCT05052697|81473197|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901373|NCT05052697|81473198|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901374|NCT05052697|81473199|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901375|NCT05052697|81473200|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
27901376|NCT05052697|81473201|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
27901377|NCT05052697|81473202|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
27901378|NCT05052697|81473203|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901379|NCT05052697|81473204|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901380|NCT05052697|81473205|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
27901381|NCT01935128|81473207|FG000|Overall Study|Death|1|||
27901382|NCT01935128|81473207|FG000|Overall Study|Adverse Event|6|||
27901383|NCT02864316|81473213|FG000|Overall Study|Progressive Disease|2|||
27901384|NCT02864316|81473214|FG001|Overall Study|Progressive Disease|1|||
27901385|NCT02864316|81473213|FG000|Overall Study|Adverse Event|0|||
27901386|NCT02864316|81473214|FG001|Overall Study|Adverse Event|1|||
27901387|NCT00513357|81473217|FG000|Overall Study|did not receive allocated placebo|2|||
27901388|NCT00513357|81473218|FG001|Overall Study|did not receive allocated placebo|3|||
27901389|NCT00513357|81473217|FG000|Overall Study|Adverse Event|4|||
27901390|NCT00513357|81473218|FG001|Overall Study|Adverse Event|2|||
27901391|NCT00513357|81473217|FG000|Overall Study|Death|2|||
27901392|NCT00513357|81473218|FG001|Overall Study|Death|0|||
27901393|NCT00513357|81473217|FG000|Overall Study|Withdrawal by Subject|5|||
27901394|NCT00513357|81473218|FG001|Overall Study|Withdrawal by Subject|4|||
27901395|NCT00513357|81473217|FG000|Overall Study|Disease Progression|2|||
27901396|NCT00513357|81473218|FG001|Overall Study|Disease Progression|1|||
27901397|NCT00345878|81473220|FG000|Overall Study|Adverse Event|1|||
27901398|NCT00345878|81473221|FG001|Overall Study|Adverse Event|0|||
27901399|NCT00345878|81473220|FG000|Overall Study|Lost to Follow-up|2|||
27901400|NCT00345878|81473221|FG001|Overall Study|Lost to Follow-up|1|||
27901401|NCT00345878|81473220|FG000|Overall Study|Other|1|||
27901402|NCT00345878|81473221|FG001|Overall Study|Other|0|||
27901403|NCT00396383|81473222|FG000|Overall Study|Death|2|||
27901404|NCT00396383|81473222|FG000|Overall Study|Lost to Follow-up|1|||
27901405|NCT02431806|81473225|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
27901406|NCT02431806|81473226|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
27901407|NCT02431806|81473227|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
27901408|NCT02431806|81473228|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
27901409|NCT02431806|81473225|FG000|Double-blind Treatment Period|Adverse Event|4|||
27901410|NCT02431806|81473226|FG001|Double-blind Treatment Period|Adverse Event|7|||
27901411|NCT02431806|81473227|FG002|Double-blind Treatment Period|Adverse Event|11|||
27901412|NCT02431806|81473228|FG003|Double-blind Treatment Period|Adverse Event|7|||
27901413|NCT02431806|81473225|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
27901414|NCT02431806|81473226|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
27901415|NCT02431806|81473227|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
27901416|NCT02431806|81473228|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
27901417|NCT02431806|81473225|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
27901418|NCT02431806|81473226|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
27901419|NCT02431806|81473227|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
27901420|NCT02431806|81473228|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
27901421|NCT02431806|81473225|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
27901422|NCT02431806|81473226|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
27901423|NCT02431806|81473227|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
27614324|NCT01681368|80430226|FG000|Overall Study|Refused further follow up|1|||
27901424|NCT02431806|81473228|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
27901425|NCT02431806|81473225|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
27506620|NCT03137381|80047885|FG001|Overall Study|Pregnancy|0|||
27901426|NCT02431806|81473226|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
27901427|NCT02431806|81473227|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
27901428|NCT02431806|81473228|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
27901429|NCT02431806|81473225|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
27901430|NCT02431806|81473226|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
27901431|NCT02431806|81473227|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
27901432|NCT02431806|81473228|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
27901433|NCT03383692|81473229|FG000|Overall Study|Progressive disease as per RECIST|3|||
27901434|NCT03383692|81473230|FG001|Overall Study|Progressive disease as per RECIST|3|||
27901435|NCT03383692|81473229|FG000|Overall Study|Clinical progression|0|||
27901436|NCT03383692|81473230|FG001|Overall Study|Clinical progression|1|||
27901437|NCT03383692|81473229|FG000|Overall Study|Adverse Event|3|||
27901438|NCT03383692|81473230|FG001|Overall Study|Adverse Event|0|||
27901439|NCT04490018|81473231|FG000|Overall Study|Protocol Violation|0|||
27901440|NCT04490018|81473232|FG001|Overall Study|Protocol Violation|2|||
27901441|NCT04490018|81473233|FG002|Overall Study|Protocol Violation|1|||
27901442|NCT04490018|81473231|FG000|Overall Study|Lost to Follow-up|2|||
27901443|NCT04490018|81473232|FG001|Overall Study|Lost to Follow-up|2|||
27901444|NCT04490018|81473233|FG002|Overall Study|Lost to Follow-up|0|||
27901445|NCT04490018|81473231|FG000|Overall Study|Withdrawal by Subject|2|||
27901446|NCT04490018|81473232|FG001|Overall Study|Withdrawal by Subject|1|||
27901447|NCT04490018|81473233|FG002|Overall Study|Withdrawal by Subject|0|||
27901448|NCT04490018|81473231|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27901449|NCT04490018|81473232|FG001|Overall Study|Withdrawal by parent/guardian|3|||
27901450|NCT04490018|81473233|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27901451|NCT01593254|81473234|FG000|Overall Study|Disease progression|2|||
27901452|NCT01593254|81473235|FG001|Overall Study|Disease progression|7|||
27901453|NCT01593254|81473234|FG000|Overall Study|Study drug toxicity|6|||
27901454|NCT01593254|81473235|FG001|Overall Study|Study drug toxicity|20|||
27901455|NCT01593254|81473234|FG000|Overall Study|Death|3|||
27901456|NCT01593254|81473235|FG001|Overall Study|Death|3|||
27901457|NCT01593254|81473234|FG000|Overall Study|AE unrelated to study drug|0|||
27901458|NCT01593254|81473235|FG001|Overall Study|AE unrelated to study drug|1|||
27901459|NCT01593254|81473234|FG000|Overall Study|participant request to discontinue study treatment|1|||
27901460|NCT01593254|81473235|FG001|Overall Study|participant request to discontinue study treatment|3|||
27901461|NCT01593254|81473234|FG000|Overall Study|participant withdrew consent|0|||
27901462|NCT01593254|81473235|FG001|Overall Study|participant withdrew consent|9|||
27901463|NCT01593254|81473234|FG000|Overall Study|lost to follow up|1|||
27901464|NCT01593254|81473235|FG001|Overall Study|lost to follow up|6|||
27901465|NCT01593254|81473234|FG000|Overall Study|maximum clinical benefit|1|||
27901466|NCT01593254|81473235|FG001|Overall Study|maximum clinical benefit|2|||
27901467|NCT01593254|81473234|FG000|Overall Study|Poor/non compliance|1|||
27901468|NCT01593254|81473235|FG001|Overall Study|Poor/non compliance|1|||
27901469|NCT01593254|81473234|FG000|Overall Study|Pregnancy|0|||
27901470|NCT01593254|81473235|FG001|Overall Study|Pregnancy|3|||
27901471|NCT01593254|81473234|FG000|Overall Study|participant no longer meets study criteria|1|||
27901472|NCT01593254|81473235|FG001|Overall Study|participant no longer meets study criteria|1|||
27901473|NCT01593254|81473234|FG000|Overall Study|Admin reason by sponsor|7|||
27901474|NCT01593254|81473235|FG001|Overall Study|Admin reason by sponsor|3|||
27901475|NCT01593254|81473234|FG000|Overall Study|Imatinib treatment failure|2|||
27901476|NCT01593254|81473235|FG001|Overall Study|Imatinib treatment failure|0|||
27901477|NCT01593254|81473234|FG000|Overall Study|Other Reasons|61|||
27901478|NCT01593254|81473235|FG001|Overall Study|Other Reasons|115|||
27901479|NCT00087126|81473236|FG000|Overall Study|Ineligible - second primary|1|||
27901480|NCT00087126|81473236|FG000|Overall Study|Never treated|1|||
27901481|NCT00096993|81473237|FG000|Overall Study|Death|1|||
27901482|NCT00096993|81473238|FG001|Overall Study|Death|0|||
27901483|NCT00096993|81473237|FG000|Overall Study|Disease progression|56|||
27901484|NCT00096993|81473238|FG001|Overall Study|Disease progression|53|||
27901485|NCT00096993|81473237|FG000|Overall Study|Adverse Event|2|||
27901486|NCT00096993|81473238|FG001|Overall Study|Adverse Event|8|||
27901487|NCT00096993|81473237|FG000|Overall Study|Subject's decision|3|||
27901488|NCT00096993|81473238|FG001|Overall Study|Subject's decision|1|||
27901489|NCT00096993|81473237|FG000|Overall Study|Physician Decision|2|||
27901490|NCT00096993|81473238|FG001|Overall Study|Physician Decision|1|||
27901491|NCT00096993|81473237|FG000|Overall Study|Non-compliance|0|||
27901492|NCT00096993|81473238|FG001|Overall Study|Non-compliance|1|||
27901493|NCT00096993|81473237|FG000|Overall Study|Other unspecified|1|||
27901494|NCT00096993|81473238|FG001|Overall Study|Other unspecified|1|||
27901495|NCT00957424|81476275|FG000|Overall Study|Lost to Follow-up|19|||
27901496|NCT00957424|81476275|FG000|Overall Study|Protocol Violation|3|||
27901497|NCT00957424|81476275|FG000|Overall Study|Withdrawal by Subject|1|||
27901498|NCT01092637|81476276|FG000|Overall Study|Death|47|||
27901499|NCT01092637|81476277|FG001|Overall Study|Death|49|||
27901500|NCT01108237|81476278|FG000|Overall Study|No alignment data|2|||
27901501|NCT01108237|81476279|FG001|Overall Study|No alignment data|15|||
27901502|NCT01108237|81476278|FG000|Overall Study|Did not meet criteria for analysis|7|||
27901503|NCT01108237|81476279|FG001|Overall Study|Did not meet criteria for analysis|0|||
27901504|NCT03810235|81476280|FG000|Overall Study|Withdrawal by Subject|2|||
27901505|NCT03810235|81476281|FG001|Overall Study|Withdrawal by Subject|0|||
27901506|NCT02588092|81476283|FG000|Overall Study|Death|4|||
27901507|NCT02588092|81476284|FG001|Overall Study|Death|3|||
27901508|NCT02588092|81476285|FG002|Overall Study|Death|3|||
27901509|NCT02588092|81476286|FG003|Overall Study|Death|3|||
27901510|NCT02588092|81476287|FG004|Overall Study|Death|2|||
27901511|NCT02588092|81476288|FG005|Overall Study|Death|2|||
27901512|NCT02588092|81476289|FG006|Overall Study|Death|2|||
27901513|NCT02588092|81476290|FG007|Overall Study|Death|1|||
27901514|NCT02588092|81476291|FG008|Overall Study|Death|5|||
27901515|NCT02588092|81476292|FG009|Overall Study|Death|2|||
27901516|NCT02588092|81476283|FG000|Overall Study|Withdrawal by Subject|0|||
27901517|NCT02588092|81476284|FG001|Overall Study|Withdrawal by Subject|0|||
27901518|NCT02588092|81476285|FG002|Overall Study|Withdrawal by Subject|0|||
27901519|NCT02588092|81476286|FG003|Overall Study|Withdrawal by Subject|0|||
27901520|NCT02588092|81476287|FG004|Overall Study|Withdrawal by Subject|0|||
27901521|NCT02588092|81476288|FG005|Overall Study|Withdrawal by Subject|1|||
27901522|NCT02588092|81476289|FG006|Overall Study|Withdrawal by Subject|1|||
27901523|NCT02588092|81476290|FG007|Overall Study|Withdrawal by Subject|2|||
27901524|NCT02588092|81476291|FG008|Overall Study|Withdrawal by Subject|0|||
27901525|NCT02588092|81476292|FG009|Overall Study|Withdrawal by Subject|0|||
27901526|NCT02588092|81476283|FG000|Overall Study|Started Another Treatment|0|||
27901527|NCT02588092|81476284|FG001|Overall Study|Started Another Treatment|0|||
27901528|NCT02588092|81476285|FG002|Overall Study|Started Another Treatment|0|||
27901529|NCT02588092|81476286|FG003|Overall Study|Started Another Treatment|0|||
27851368|NCT02132754|81287007|FG013|Overall Study|Screen Failure|0|||
27851369|NCT02132754|81287008|FG014|Overall Study|Screen Failure|0|||
27851370|NCT02132754|81287009|FG015|Overall Study|Screen Failure|0|||
27851371|NCT02132754|81287010|FG016|Overall Study|Screen Failure|0|||
27851372|NCT02132754|81287011|FG017|Overall Study|Screen Failure|0|||
27851373|NCT02132754|81287012|FG018|Overall Study|Screen Failure|0|||
27851374|NCT02132754|81287013|FG019|Overall Study|Screen Failure|1|||
27851375|NCT02132754|81287014|FG020|Overall Study|Screen Failure|0|||
27851376|NCT02132754|81287015|FG021|Overall Study|Screen Failure|1|||
27851377|NCT02132754|81287016|FG022|Overall Study|Screen Failure|0|||
27851378|NCT02132754|81287017|FG023|Overall Study|Screen Failure|0|||
27851379|NCT02132754|81287018|FG024|Overall Study|Screen Failure|0|||
27851380|NCT02132754|81287019|FG025|Overall Study|Screen Failure|0|||
27851381|NCT02132754|81287020|FG026|Overall Study|Screen Failure|0|||
27851382|NCT02132754|81287021|FG027|Overall Study|Screen Failure|0|||
27851383|NCT02132754|81287022|FG028|Overall Study|Screen Failure|0|||
27851384|NCT02132754|81287023|FG029|Overall Study|Screen Failure|0|||
27851385|NCT02132754|81287024|FG030|Overall Study|Screen Failure|0|||
27851386|NCT02132754|81287025|FG031|Overall Study|Screen Failure|0|||
27851387|NCT02132754|81287026|FG032|Overall Study|Screen Failure|0|||
27851388|NCT02132754|81287027|FG033|Overall Study|Screen Failure|0|||
27851389|NCT02132754|81286994|FG000|Overall Study|Transferred to Extension Study|0|||
27851390|NCT02132754|81286995|FG001|Overall Study|Transferred to Extension Study|0|||
27851391|NCT02132754|81286996|FG002|Overall Study|Transferred to Extension Study|0|||
27851392|NCT02132754|81286997|FG003|Overall Study|Transferred to Extension Study|0|||
27851393|NCT02132754|81286998|FG004|Overall Study|Transferred to Extension Study|0|||
27851394|NCT02132754|81286999|FG005|Overall Study|Transferred to Extension Study|0|||
27851395|NCT02132754|81287000|FG006|Overall Study|Transferred to Extension Study|0|||
27851396|NCT02132754|81287001|FG007|Overall Study|Transferred to Extension Study|0|||
27851397|NCT02132754|81287002|FG008|Overall Study|Transferred to Extension Study|0|||
27851398|NCT02132754|81287003|FG009|Overall Study|Transferred to Extension Study|0|||
27851399|NCT02132754|81287004|FG010|Overall Study|Transferred to Extension Study|0|||
27851400|NCT02132754|81287005|FG011|Overall Study|Transferred to Extension Study|0|||
27851401|NCT02132754|81287006|FG012|Overall Study|Transferred to Extension Study|0|||
27851402|NCT02132754|81287007|FG013|Overall Study|Transferred to Extension Study|0|||
27851403|NCT02132754|81287008|FG014|Overall Study|Transferred to Extension Study|0|||
27851404|NCT02132754|81287009|FG015|Overall Study|Transferred to Extension Study|0|||
27851405|NCT02132754|81287010|FG016|Overall Study|Transferred to Extension Study|0|||
27851406|NCT02132754|81287011|FG017|Overall Study|Transferred to Extension Study|0|||
27851407|NCT02132754|81287012|FG018|Overall Study|Transferred to Extension Study|0|||
27851408|NCT02132754|81287013|FG019|Overall Study|Transferred to Extension Study|0|||
27901530|NCT02588092|81476287|FG004|Overall Study|Started Another Treatment|1|||
27851409|NCT02132754|81287014|FG020|Overall Study|Transferred to Extension Study|0|||
27851410|NCT02132754|81287015|FG021|Overall Study|Transferred to Extension Study|0|||
27851411|NCT02132754|81287016|FG022|Overall Study|Transferred to Extension Study|0|||
27901531|NCT02588092|81476288|FG005|Overall Study|Started Another Treatment|0|||
27901532|NCT02588092|81476289|FG006|Overall Study|Started Another Treatment|0|||
27901533|NCT02588092|81476290|FG007|Overall Study|Started Another Treatment|1|||
27901534|NCT02588092|81476291|FG008|Overall Study|Started Another Treatment|0|||
27901535|NCT02588092|81476292|FG009|Overall Study|Started Another Treatment|0|||
27901536|NCT02588092|81476283|FG000|Overall Study|Sponsor Decision|0|||
27901537|NCT02588092|81476284|FG001|Overall Study|Sponsor Decision|0|||
27901538|NCT02588092|81476285|FG002|Overall Study|Sponsor Decision|0|||
27901539|NCT02588092|81476286|FG003|Overall Study|Sponsor Decision|0|||
27901540|NCT02588092|81476287|FG004|Overall Study|Sponsor Decision|0|||
27901541|NCT02588092|81476288|FG005|Overall Study|Sponsor Decision|0|||
27901542|NCT02588092|81476289|FG006|Overall Study|Sponsor Decision|0|||
27901543|NCT02588092|81476290|FG007|Overall Study|Sponsor Decision|0|||
27901544|NCT02588092|81476291|FG008|Overall Study|Sponsor Decision|1|||
27901545|NCT02588092|81476292|FG009|Overall Study|Sponsor Decision|1|||
27901546|NCT01254721|81476296|FG000|Overall Study|Lost to Follow-up|0|||
27901547|NCT01254721|81476297|FG001|Overall Study|Lost to Follow-up|4|||
27901548|NCT01254721|81476296|FG000|Overall Study|Lack of Efficacy|4|||
27901549|NCT01254721|81476297|FG001|Overall Study|Lack of Efficacy|2|||
27901550|NCT01254721|81476296|FG000|Overall Study|Death|0|||
27901551|NCT01254721|81476297|FG001|Overall Study|Death|1|||
27901552|NCT01254721|81476296|FG000|Overall Study|technical problum|1|||
27901553|NCT01254721|81476297|FG001|Overall Study|technical problum|0|||
27901554|NCT01254721|81476296|FG000|Overall Study|Adverse Event|2|||
27901555|NCT01254721|81476297|FG001|Overall Study|Adverse Event|3|||
27901556|NCT01254721|81476296|FG000|Overall Study|Withdrawal by Subject|8|||
27901557|NCT01254721|81476297|FG001|Overall Study|Withdrawal by Subject|11|||
27901558|NCT01254721|81476296|FG000|Overall Study|Wrongly randomization|0|||
27901559|NCT01254721|81476297|FG001|Overall Study|Wrongly randomization|1|||
27901560|NCT03816007|81476299|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
27901561|NCT03816007|81476300|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
27901562|NCT03816007|81476299|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
27901563|NCT03816007|81476300|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
27901564|NCT03816007|81476299|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
27901565|NCT03816007|81476300|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
27901566|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
27901567|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901568|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901569|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901570|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901571|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901572|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901573|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901574|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
27901575|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
27901576|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
27901577|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
27901578|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
27901579|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
27901580|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
27901581|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
27901582|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
27901583|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
27901584|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
27901585|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
27901586|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
27901587|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
27901588|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
27901589|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
27901590|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
27901591|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
27901592|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
27901593|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
27901594|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
27901595|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
27901596|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
27614325|NCT04157686|80430227|FG000|Overall Study|Adverse Event|1|||
27506621|NCT03137381|80047886|FG002|Overall Study|Pregnancy|1|||
27901597|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
27614326|NCT04157686|80430228|FG001|Overall Study|Adverse Event|0|||
27901598|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
27901599|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
27901600|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
27901601|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
27901602|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901603|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901604|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901605|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
27901606|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901607|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
27901608|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901609|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901610|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
27901611|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
27901612|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
27901613|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
27901614|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
27901615|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
27901616|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
27901617|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
27901618|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
27901619|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
27901620|NCT00528372|81476308|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
27901621|NCT00528372|81476309|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27901622|NCT00528372|81476310|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27901623|NCT00528372|81476311|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
27901624|NCT00528372|81476312|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27901625|NCT00528372|81476313|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27901626|NCT00528372|81476314|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27614327|NCT04157686|80430229|FG002|Overall Study|Adverse Event|1|||
27851412|NCT02132754|81287017|FG023|Overall Study|Transferred to Extension Study|0|||
27851413|NCT02132754|81287018|FG024|Overall Study|Transferred to Extension Study|0|||
27851414|NCT02132754|81287019|FG025|Overall Study|Transferred to Extension Study|0|||
27851415|NCT02132754|81287020|FG026|Overall Study|Transferred to Extension Study|0|||
27851416|NCT02132754|81287021|FG027|Overall Study|Transferred to Extension Study|0|||
27851417|NCT02132754|81287022|FG028|Overall Study|Transferred to Extension Study|0|||
27851418|NCT02132754|81287023|FG029|Overall Study|Transferred to Extension Study|0|||
27851419|NCT02132754|81287024|FG030|Overall Study|Transferred to Extension Study|0|||
27851420|NCT02132754|81287025|FG031|Overall Study|Transferred to Extension Study|0|||
27851421|NCT02132754|81287026|FG032|Overall Study|Transferred to Extension Study|0|||
27851422|NCT02132754|81287027|FG033|Overall Study|Transferred to Extension Study|6|||
27851423|NCT02132754|81286994|FG000|Overall Study|Withdrawal by Subject|0|||
27851424|NCT02132754|81286995|FG001|Overall Study|Withdrawal by Subject|0|||
27851425|NCT02132754|81286996|FG002|Overall Study|Withdrawal by Subject|0|||
27851426|NCT02132754|81286997|FG003|Overall Study|Withdrawal by Subject|0|||
27851427|NCT02132754|81286998|FG004|Overall Study|Withdrawal by Subject|0|||
27851428|NCT02132754|81286999|FG005|Overall Study|Withdrawal by Subject|0|||
27851429|NCT02132754|81287000|FG006|Overall Study|Withdrawal by Subject|0|||
27851430|NCT02132754|81287001|FG007|Overall Study|Withdrawal by Subject|0|||
27851431|NCT02132754|81287002|FG008|Overall Study|Withdrawal by Subject|0|||
27851432|NCT02132754|81287003|FG009|Overall Study|Withdrawal by Subject|1|||
27851433|NCT02132754|81287004|FG010|Overall Study|Withdrawal by Subject|0|||
27851434|NCT02132754|81287005|FG011|Overall Study|Withdrawal by Subject|0|||
27851435|NCT02132754|81287006|FG012|Overall Study|Withdrawal by Subject|1|||
27851436|NCT02132754|81287007|FG013|Overall Study|Withdrawal by Subject|0|||
27851437|NCT02132754|81287008|FG014|Overall Study|Withdrawal by Subject|1|||
27901627|NCT00528372|81476315|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
27901628|NCT00528372|81476316|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
27901629|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
27901630|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
27901631|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
27901632|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
27901633|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
27901634|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
27901635|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
27901636|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
27901637|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
27901638|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
27901639|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
27901640|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
27901641|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
27506622|NCT03137381|80047887|FG003|Overall Study|Pregnancy|0|||
27506623|NCT01189032|80047890|FG000|Overall Study|Adverse Event|1|||
27506624|NCT01189032|80047891|FG001|Overall Study|Adverse Event|3|||
27506625|NCT01189032|80047892|FG002|Overall Study|Adverse Event|4|||
27506626|NCT01189032|80047890|FG000|Overall Study|Lack of Efficacy|2|||
27506627|NCT01189032|80047891|FG001|Overall Study|Lack of Efficacy|3|||
27506628|NCT01189032|80047892|FG002|Overall Study|Lack of Efficacy|0|||
27506629|NCT01189032|80047890|FG000|Overall Study|Withdrawal by Subject|1|||
27506630|NCT01189032|80047891|FG001|Overall Study|Withdrawal by Subject|0|||
27506631|NCT01189032|80047892|FG002|Overall Study|Withdrawal by Subject|1|||
27506632|NCT01189032|80047890|FG000|Overall Study|Protocol Violation|1|||
27506633|NCT01189032|80047891|FG001|Overall Study|Protocol Violation|1|||
27506634|NCT01189032|80047892|FG002|Overall Study|Protocol Violation|1|||
27506635|NCT02923726|80047893|FG000|Overall Study|Death|196|||
27506636|NCT02923726|80047894|FG001|Overall Study|Death|175|||
27506637|NCT02923726|80047893|FG000|Overall Study|Withdrawal by Subject|337|||
27506638|NCT02923726|80047894|FG001|Overall Study|Withdrawal by Subject|307|||
27506639|NCT04139018|80047895|FG000|Overall Study|Screen fail|1|||
27506640|NCT04139018|80047896|FG001|Overall Study|Screen fail|0|||
27506641|NCT04139018|80047895|FG000|Overall Study|Withdrawal by Subject|2|||
27506642|NCT04139018|80047896|FG001|Overall Study|Withdrawal by Subject|0|||
27506643|NCT04139018|80047895|FG000|Overall Study|Lost to Follow-up|0|||
27506644|NCT04139018|80047896|FG001|Overall Study|Lost to Follow-up|1|||
27506645|NCT00815659|80047898|FG000|Overall Study|Adverse Event|9|||
27506646|NCT00815659|80047898|FG000|Overall Study|Withdrawal by Subject|9|||
27506647|NCT00815659|80047898|FG000|Overall Study|Lost to Follow-up|4|||
27506648|NCT00815659|80047898|FG000|Overall Study|Protocol Violation|1|||
27506649|NCT00414596|80047901|FG000|Overall Study|Protocol Violation|2|||
27506650|NCT04960202|80047902|FG000|Overall Study|Other|12|||
27506651|NCT04960202|80047903|FG001|Overall Study|Other|10|||
27506652|NCT04960202|80047902|FG000|Overall Study|Withdrawal by Subject|43|||
27901642|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
27901643|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
27901644|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
27901645|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
27901646|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
27901647|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
27901648|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
27901649|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
27901650|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
27901651|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
27901652|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
27901653|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
27901654|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
27901655|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
27506653|NCT04960202|80047903|FG001|Overall Study|Withdrawal by Subject|45|||
27506654|NCT04960202|80047902|FG000|Overall Study|Lost to Follow-up|20|||
27506655|NCT04960202|80047903|FG001|Overall Study|Lost to Follow-up|17|||
27506656|NCT04960202|80047902|FG000|Overall Study|Death|0|||
27506657|NCT04960202|80047903|FG001|Overall Study|Death|15|||
27506658|NCT02667119|80047904|FG000|Overall Study|Lost to Follow-up|3|||
27506659|NCT02667119|80047905|FG001|Overall Study|Lost to Follow-up|0|||
27901656|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
27901657|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
27506660|NCT00525161|80047906|FG000|Overall Study|Adverse Event|1|||
27506661|NCT02594124|80047927|FG000|Overall Study|Adverse Event|0|||
27506662|NCT02594124|80047928|FG001|Overall Study|Adverse Event|5|||
27506663|NCT02594124|80047929|FG002|Overall Study|Adverse Event|8|||
27728032|NCT01662648|80833101|FG000|Overall Study|LOE and other reason unspecified|1|||
27728033|NCT01662648|80833102|FG001|Overall Study|LOE and other reason unspecified|0|||
27728034|NCT01662648|80833101|FG000|Overall Study|LOE and Participant non-compliant|0|||
27728035|NCT01662648|80833102|FG001|Overall Study|LOE and Participant non-compliant|1|||
27728036|NCT00256295|80833103|FG000|Overall Study|Withdrawal by Subject|3|||
27728037|NCT00256295|80833103|FG000|Overall Study|Death|1|||
27728038|NCT00818259|80833104|FG000|Part I|Withdrawal by Subject|1|||
27728039|NCT00818259|80833105|FG001|Part I|Withdrawal by Subject|0|||
27728040|NCT00818259|80833106|FG002|Part I|Withdrawal by Subject|0|||
27728041|NCT00818259|80833107|FG003|Part I|Withdrawal by Subject|0|||
27728042|NCT00818259|80833108|FG004|Part I|Withdrawal by Subject|0|||
27728043|NCT00818259|80833109|FG005|Part I|Withdrawal by Subject|0|||
27728044|NCT00818259|80833110|FG006|Part I|Withdrawal by Subject|0|||
27728045|NCT00818259|80833111|FG007|Part I|Withdrawal by Subject|0|||
27728046|NCT00818259|80833112|FG008|Part I|Withdrawal by Subject|0|||
27728047|NCT00818259|80833104|FG000|Part II|Physician Decision|0|||
27728048|NCT00818259|80833105|FG001|Part II|Physician Decision|0|||
27728049|NCT00818259|80833106|FG002|Part II|Physician Decision|1|||
27728050|NCT00818259|80833107|FG003|Part II|Physician Decision|0|||
27728051|NCT00818259|80833108|FG004|Part II|Physician Decision|0|||
27728052|NCT00818259|80833109|FG005|Part II|Physician Decision|0|||
27728053|NCT00818259|80833110|FG006|Part II|Physician Decision|0|||
27728054|NCT00818259|80833111|FG007|Part II|Physician Decision|0|||
27728055|NCT00818259|80833112|FG008|Part II|Physician Decision|0|||
27728056|NCT00818259|80833104|FG000|Part II|Lack of Efficacy|0|||
27728057|NCT00818259|80833105|FG001|Part II|Lack of Efficacy|0|||
27728058|NCT00818259|80833106|FG002|Part II|Lack of Efficacy|0|||
27728059|NCT00818259|80833107|FG003|Part II|Lack of Efficacy|1|||
27728060|NCT00818259|80833108|FG004|Part II|Lack of Efficacy|0|||
27728061|NCT00818259|80833109|FG005|Part II|Lack of Efficacy|0|||
27728062|NCT00818259|80833110|FG006|Part II|Lack of Efficacy|0|||
27728063|NCT00818259|80833111|FG007|Part II|Lack of Efficacy|0|||
27728064|NCT00818259|80833112|FG008|Part II|Lack of Efficacy|0|||
27728065|NCT00818259|80833104|FG000|Part II|Not Treated|0|||
27728066|NCT00818259|80833105|FG001|Part II|Not Treated|0|||
27728067|NCT00818259|80833106|FG002|Part II|Not Treated|0|||
27728068|NCT00818259|80833107|FG003|Part II|Not Treated|1|||
27728069|NCT00818259|80833108|FG004|Part II|Not Treated|0|||
27728070|NCT00818259|80833109|FG005|Part II|Not Treated|0|||
27728071|NCT00818259|80833110|FG006|Part II|Not Treated|0|||
27728072|NCT00818259|80833111|FG007|Part II|Not Treated|0|||
27728073|NCT00818259|80833112|FG008|Part II|Not Treated|0|||
27728074|NCT00818259|80833104|FG000|Part IV|Physician Decision|0|||
27728075|NCT00818259|80833105|FG001|Part IV|Physician Decision|0|||
27728076|NCT00818259|80833106|FG002|Part IV|Physician Decision|0|||
27728077|NCT00818259|80833107|FG003|Part IV|Physician Decision|0|||
27728078|NCT00818259|80833108|FG004|Part IV|Physician Decision|0|||
27728079|NCT00818259|80833109|FG005|Part IV|Physician Decision|1|||
27728080|NCT00818259|80833110|FG006|Part IV|Physician Decision|0|||
27728081|NCT00818259|80833111|FG007|Part IV|Physician Decision|0|||
27728082|NCT00818259|80833112|FG008|Part IV|Physician Decision|0|||
27728083|NCT00818259|80833104|FG000|Part V|Adverse Event|0|||
27728084|NCT00818259|80833105|FG001|Part V|Adverse Event|0|||
27728085|NCT00818259|80833106|FG002|Part V|Adverse Event|0|||
27728086|NCT00818259|80833107|FG003|Part V|Adverse Event|0|||
27728087|NCT00818259|80833108|FG004|Part V|Adverse Event|0|||
27728088|NCT00818259|80833109|FG005|Part V|Adverse Event|0|||
27728089|NCT00818259|80833110|FG006|Part V|Adverse Event|0|||
27728090|NCT00818259|80833111|FG007|Part V|Adverse Event|1|||
27728091|NCT00818259|80833112|FG008|Part V|Adverse Event|0|||
27728092|NCT02554929|80833122|FG000|Overall Study|Lost to Follow-up|4|||
27506664|NCT02594124|80047930|FG003|Overall Study|Adverse Event|1|||
27506665|NCT02594124|80047931|FG004|Overall Study|Adverse Event|0|||
27506666|NCT02594124|80047932|FG005|Overall Study|Adverse Event|0|||
27506667|NCT02594124|80047933|FG006|Overall Study|Adverse Event|2|||
27506668|NCT02594124|80047934|FG007|Overall Study|Adverse Event|2|||
27506669|NCT02594124|80047935|FG008|Overall Study|Adverse Event|0|||
27506670|NCT02594124|80047927|FG000|Overall Study|Withdrawal by Subject|2|||
27728093|NCT02554929|80833123|FG001|Overall Study|Lost to Follow-up|4|||
27728094|NCT02554929|80833122|FG000|Overall Study|Withdrawal by Subject|2|||
27728095|NCT02554929|80833123|FG001|Overall Study|Withdrawal by Subject|8|||
27728096|NCT01451645|80833124|FG000|Overall Study|Protocol Violation|1|||
27728097|NCT01451645|80833125|FG001|Overall Study|Protocol Violation|0|||
27728098|NCT01451645|80833124|FG000|Overall Study|Adverse Event|0|||
27728099|NCT01451645|80833125|FG001|Overall Study|Adverse Event|3|||
27728100|NCT01451645|80833124|FG000|Overall Study|Withdrawal by Subject|4|||
27728101|NCT01451645|80833125|FG001|Overall Study|Withdrawal by Subject|2|||
27728102|NCT01451645|80833124|FG000|Overall Study|Lost to Follow-up|4|||
27728103|NCT01451645|80833125|FG001|Overall Study|Lost to Follow-up|3|||
27728104|NCT01818726|80833129|FG000|Overall Study|Administrative reasons|5|||
27728105|NCT01818726|80833130|FG001|Overall Study|Administrative reasons|1|||
27728106|NCT01818726|80833129|FG000|Overall Study|Withdrawal by Subject|0|||
27901658|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
27901659|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
27901660|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
27901661|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
27901662|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
27901663|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
27901664|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
27901665|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
27901666|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
27901667|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
27901668|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
27901669|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
27901670|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
27901671|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
27901672|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
27901673|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
27901674|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901675|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901676|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901677|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901678|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
27901679|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
27901680|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901681|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901682|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
27901683|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27901684|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
27901685|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27901686|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27901687|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27901688|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27901689|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
27901690|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
27901691|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
27901692|NCT00528372|81476308|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
27901693|NCT00528372|81476309|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
27901694|NCT00528372|81476310|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
27901695|NCT00528372|81476311|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
27901696|NCT00528372|81476312|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
27901697|NCT00528372|81476313|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
27901698|NCT00528372|81476314|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
27901699|NCT00528372|81476315|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
27901700|NCT00528372|81476316|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
27901701|NCT00467558|81476317|FG000|Overall Study|Lost to Follow-up|2|||
27901702|NCT00467558|81476318|FG001|Overall Study|Lost to Follow-up|0|||
27901703|NCT02003963|81476319|FG000|Overall Study|Lost to Follow-up|2|||
27901704|NCT02003963|81476320|FG001|Overall Study|Lost to Follow-up|1|||
27901705|NCT03853291|81476321|FG000|Overall Study|Lost to Follow-up|1|||
27901706|NCT03853291|81476322|FG001|Overall Study|Lost to Follow-up|2|||
27901707|NCT03853291|81476323|FG002|Overall Study|Lost to Follow-up|0|||
27901708|NCT03853291|81476324|FG003|Overall Study|Lost to Follow-up|0|||
27901709|NCT03853291|81476325|FG004|Overall Study|Lost to Follow-up|0|||
27901710|NCT03853291|81476326|FG005|Overall Study|Lost to Follow-up|0|||
27901711|NCT03853291|81476321|FG000|Overall Study|Determined to be ineligible|1|||
27901712|NCT03853291|81476322|FG001|Overall Study|Determined to be ineligible|1|||
27901713|NCT03853291|81476323|FG002|Overall Study|Determined to be ineligible|0|||
27901714|NCT03853291|81476324|FG003|Overall Study|Determined to be ineligible|0|||
27901715|NCT03853291|81476325|FG004|Overall Study|Determined to be ineligible|0|||
27901716|NCT03853291|81476326|FG005|Overall Study|Determined to be ineligible|0|||
27506671|NCT02594124|80047928|FG001|Overall Study|Withdrawal by Subject|3|||
27901717|NCT02669667|81476327|FG000|Overall Study|Lost to Follow-up|0|||
27901718|NCT02669667|81476328|FG001|Overall Study|Lost to Follow-up|0|||
27901719|NCT02669667|81476329|FG002|Overall Study|Lost to Follow-up|0|||
27901720|NCT02669667|81476330|FG003|Overall Study|Lost to Follow-up|0|||
27614328|NCT04157686|80430230|FG003|Overall Study|Adverse Event|0|||
27901721|NCT02669667|81476331|FG004|Overall Study|Lost to Follow-up|0|||
27901722|NCT02669667|81476332|FG005|Overall Study|Lost to Follow-up|1|||
27851438|NCT02132754|81287009|FG015|Overall Study|Withdrawal by Subject|2|||
27851439|NCT02132754|81287010|FG016|Overall Study|Withdrawal by Subject|1|||
27851440|NCT02132754|81287011|FG017|Overall Study|Withdrawal by Subject|0|||
27851441|NCT02132754|81287012|FG018|Overall Study|Withdrawal by Subject|0|||
27851442|NCT02132754|81287013|FG019|Overall Study|Withdrawal by Subject|0|||
27851443|NCT02132754|81287014|FG020|Overall Study|Withdrawal by Subject|1|||
27851444|NCT02132754|81287015|FG021|Overall Study|Withdrawal by Subject|0|||
27851445|NCT02132754|81287016|FG022|Overall Study|Withdrawal by Subject|0|||
27851446|NCT02132754|81287017|FG023|Overall Study|Withdrawal by Subject|0|||
27851447|NCT02132754|81287018|FG024|Overall Study|Withdrawal by Subject|1|||
27851448|NCT02132754|81287019|FG025|Overall Study|Withdrawal by Subject|0|||
27851449|NCT02132754|81287020|FG026|Overall Study|Withdrawal by Subject|0|||
27851450|NCT02132754|81287021|FG027|Overall Study|Withdrawal by Subject|1|||
27851451|NCT02132754|81287022|FG028|Overall Study|Withdrawal by Subject|0|||
27851452|NCT02132754|81287023|FG029|Overall Study|Withdrawal by Subject|0|||
27851453|NCT02132754|81287024|FG030|Overall Study|Withdrawal by Subject|0|||
27851454|NCT02132754|81287025|FG031|Overall Study|Withdrawal by Subject|1|||
27851455|NCT02132754|81287026|FG032|Overall Study|Withdrawal by Subject|0|||
27851456|NCT02132754|81287027|FG033|Overall Study|Withdrawal by Subject|2|||
27851457|NCT05020249|81287028|FG000|Overall Study|Protocol Violation|1|||
27851458|NCT05020249|81287029|FG001|Overall Study|Protocol Violation|0|||
27851459|NCT04920916|81287030|FG000|Phase IIa 60 Day Study|Death|2|||
27851460|NCT04920916|81287031|FG001|Phase IIa 60 Day Study|Death|5|||
27851461|NCT04920916|81287030|FG000|1 Year Follow up (Phone Call)|Death|1|||
27851462|NCT04920916|81287031|FG001|1 Year Follow up (Phone Call)|Death|3|||
27851463|NCT04920916|81287030|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
27851464|NCT04920916|81287031|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
27851465|NCT02017860|81287038|FG000|Overall Study|Adverse Event|1|||
27851466|NCT02017860|81287038|FG000|Overall Study|Withdrawal by Subject|1|||
27851467|NCT02562482|81287039|FG000|Overall Study|Enrolled, but did not receive product|4|||
27851468|NCT02562482|81287040|FG001|Overall Study|Enrolled, but did not receive product|0|||
27851469|NCT02562482|81287039|FG000|Overall Study|Lost to Follow-up|9|||
27851470|NCT02562482|81287040|FG001|Overall Study|Lost to Follow-up|6|||
27851471|NCT02562482|81287039|FG000|Overall Study|Moved from area|2|||
27851472|NCT02562482|81287040|FG001|Overall Study|Moved from area|3|||
27851473|NCT02562482|81287039|FG000|Overall Study|Withdrawal by Subject|5|||
27851474|NCT02562482|81287040|FG001|Overall Study|Withdrawal by Subject|3|||
27851475|NCT02562482|81287039|FG000|Overall Study|Physician Decision|1|||
27851476|NCT02562482|81287040|FG001|Overall Study|Physician Decision|3|||
27851477|NCT02562482|81287039|FG000|Overall Study|Illness/Injury unrelated to product|0|||
27851478|NCT02562482|81287040|FG001|Overall Study|Illness/Injury unrelated to product|1|||
27851479|NCT02595008|81287045|FG000|Overall Study|Enrolled In Error|1|||
27851480|NCT02595008|81287046|FG001|Overall Study|Enrolled In Error|0|||
27851481|NCT00546572|81287056|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
27851482|NCT00546572|81287057|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
27851483|NCT00546572|81287056|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
27851484|NCT00546572|81287057|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
27851485|NCT00546572|81287056|FG000|Vax 1 / Year 0|Protocol Violation|3|||
27851486|NCT00546572|81287057|FG001|Vax 1 / Year 0|Protocol Violation|4|||
27851487|NCT00546572|81287056|FG000|Vax 1 / Year 0|Death|2|||
27851488|NCT00546572|81287057|FG001|Vax 1 / Year 0|Death|2|||
27851489|NCT00546572|81287056|FG000|Vax 1 / Year 0|Adverse Event|0|||
27851490|NCT00546572|81287057|FG001|Vax 1 / Year 0|Adverse Event|1|||
27851491|NCT00546572|81287056|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
27851492|NCT00546572|81287057|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
27851493|NCT00546572|81287056|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
27851494|NCT00546572|81287057|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
27851495|NCT00546572|81287056|FG000|Vax 2 / Year 1|Other|1|||
27851496|NCT00546572|81287057|FG001|Vax 2 / Year 1|Other|1|||
27851497|NCT00546572|81287056|FG000|Vax 2 / Year 1|Adverse Event|1|||
27851498|NCT00546572|81287057|FG001|Vax 2 / Year 1|Adverse Event|0|||
27851499|NCT00546572|81287056|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
27851500|NCT00546572|81287057|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
27851501|NCT00103038|81287058|FG000|Overall Study|Withdrawal by Subject|8|||
27851502|NCT00103038|81287058|FG000|Overall Study|Screen failure|3|||
27851503|NCT00103038|81287058|FG000|Overall Study|Death|1|||
27851504|NCT00103038|81287058|FG000|Overall Study|Physician Decision|1|||
27851505|NCT01366092|81287059|FG000|Overall Study|Progressive cGVHD|2|||
27851506|NCT01366092|81287059|FG000|Overall Study|Physician Decision|1|||
27851507|NCT01366092|81287059|FG000|Overall Study|Withdrawal by Subject|1|||
27851508|NCT01875471|81287060|FG000|Overall Study|Adverse Event|0|||
27851509|NCT01875471|81287061|FG001|Overall Study|Adverse Event|1|||
27851510|NCT01875471|81287060|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
27851511|NCT01875471|81287061|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
27851512|NCT00573157|81287062|FG000|Overall Study|Adverse Event|3|||
27901723|NCT02669667|81476333|FG006|Overall Study|Lost to Follow-up|0|||
27901724|NCT03015194|81476336|FG000|Overall Study|Death|10|||
27901725|NCT03015194|81476336|FG000|Overall Study|Withdrawal by Subject|2|||
27901726|NCT03170609|81476342|FG000|Overall Study|Death|0|||
27901727|NCT03170609|81476343|FG001|Overall Study|Death|0|||
27901728|NCT03170609|81476344|FG002|Overall Study|Death|1|||
27901729|NCT03170609|81476345|FG003|Overall Study|Death|0|||
27901730|NCT03170609|81476346|FG004|Overall Study|Death|0|||
27901731|NCT03170609|81476347|FG005|Overall Study|Death|0|||
27901732|NCT03170609|81476348|FG006|Overall Study|Death|0|||
27901733|NCT03170609|81476342|FG000|Overall Study|Withdrawal by Subject|1|||
27901734|NCT03170609|81476343|FG001|Overall Study|Withdrawal by Subject|2|||
27901735|NCT03170609|81476344|FG002|Overall Study|Withdrawal by Subject|0|||
27901736|NCT03170609|81476345|FG003|Overall Study|Withdrawal by Subject|0|||
27901737|NCT03170609|81476346|FG004|Overall Study|Withdrawal by Subject|0|||
27901738|NCT03170609|81476347|FG005|Overall Study|Withdrawal by Subject|0|||
27901739|NCT03170609|81476348|FG006|Overall Study|Withdrawal by Subject|1|||
27901740|NCT03170609|81476342|FG000|Overall Study|Lost to Follow-up|1|||
27901741|NCT03170609|81476343|FG001|Overall Study|Lost to Follow-up|0|||
27901742|NCT03170609|81476344|FG002|Overall Study|Lost to Follow-up|5|||
27901743|NCT03170609|81476345|FG003|Overall Study|Lost to Follow-up|2|||
27901744|NCT03170609|81476346|FG004|Overall Study|Lost to Follow-up|1|||
27901745|NCT03170609|81476347|FG005|Overall Study|Lost to Follow-up|1|||
27901746|NCT03170609|81476348|FG006|Overall Study|Lost to Follow-up|0|||
27901747|NCT03170609|81476342|FG000|Overall Study|Other|1|||
27901748|NCT03170609|81476343|FG001|Overall Study|Other|0|||
27901749|NCT03170609|81476344|FG002|Overall Study|Other|0|||
27901750|NCT03170609|81476345|FG003|Overall Study|Other|0|||
27901751|NCT03170609|81476346|FG004|Overall Study|Other|0|||
27901752|NCT03170609|81476347|FG005|Overall Study|Other|1|||
27728107|NCT01818726|80833130|FG001|Overall Study|Withdrawal by Subject|1|||
27851513|NCT00573157|81287063|FG001|Overall Study|Adverse Event|1|||
27851514|NCT00573157|81287062|FG000|Overall Study|Other|1|||
27851515|NCT00573157|81287063|FG001|Overall Study|Other|1|||
27851516|NCT01940497|81287066|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
27851517|NCT01940497|81287067|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
27851518|NCT01940497|81287066|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
27851519|NCT01940497|81287067|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
27851520|NCT01940497|81287066|FG000|Overall Study|Violation of Entry Criteria|1|||
27851521|NCT01940497|81287067|FG001|Overall Study|Violation of Entry Criteria|1|||
27851522|NCT01940497|81287066|FG000|Overall Study|Refused Treatment|1|||
27851523|NCT01940497|81287067|FG001|Overall Study|Refused Treatment|3|||
27851524|NCT01940497|81287066|FG000|Overall Study|Withdrew Consent|6|||
27851525|NCT01940497|81287067|FG001|Overall Study|Withdrew Consent|2|||
27851526|NCT01940497|81287066|FG000|Overall Study|Administrative/Other|1|||
27851527|NCT01940497|81287067|FG001|Overall Study|Administrative/Other|1|||
27851528|NCT01045993|81287068|FG000|Overall Study|Treated-later found eligibility not met|0|||
27851529|NCT01045993|81287069|FG001|Overall Study|Treated-later found eligibility not met|1|||
27851530|NCT01045993|81287070|FG002|Overall Study|Treated-later found eligibility not met|0|||
27851531|NCT01045993|81287071|FG003|Overall Study|Treated-later found eligibility not met|0|||
27851532|NCT02072824|81287073|FG000|Overall Study|Insufficient clinical response|1|||
27851533|NCT02072824|81287074|FG001|Overall Study|Insufficient clinical response|0|||
27851534|NCT02072824|81287075|FG002|Overall Study|Insufficient clinical response|1|||
27851535|NCT02072824|81287073|FG000|Overall Study|No longer willing to participate|1|||
27851536|NCT02072824|81287074|FG001|Overall Study|No longer willing to participate|0|||
27851537|NCT02072824|81287075|FG002|Overall Study|No longer willing to participate|1|||
27851538|NCT02072824|81287073|FG000|Overall Study|Medication error|0|||
27851539|NCT02072824|81287074|FG001|Overall Study|Medication error|1|||
27851540|NCT02072824|81287075|FG002|Overall Study|Medication error|0|||
27851541|NCT02072824|81287073|FG000|Overall Study|Adverse Event|0|||
27851542|NCT02072824|81287074|FG001|Overall Study|Adverse Event|0|||
27851543|NCT02072824|81287075|FG002|Overall Study|Adverse Event|1|||
27901753|NCT03170609|81476348|FG006|Overall Study|Other|0|||
27901754|NCT00290693|81476349|FG000|Overall Study|Withdrawal by Subject|2|||
27728108|NCT01818726|80833129|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
27851544|NCT04135196|81287079|FG000|Overall Study|Lost to Follow-up|8|||
27851545|NCT04135196|81287080|FG001|Overall Study|Lost to Follow-up|7|||
27851546|NCT04135196|81287081|FG002|Overall Study|Lost to Follow-up|8|||
27901755|NCT00938587|81476350|FG000|Overall Study|Adverse Event|2|||
27901756|NCT00938587|81476351|FG001|Overall Study|Adverse Event|0|||
27851547|NCT04135196|81287082|FG003|Overall Study|Lost to Follow-up|9|||
27851548|NCT04135196|81287083|FG004|Overall Study|Lost to Follow-up|1|||
27851549|NCT04135196|81287079|FG000|Overall Study|Pregnancy|0|||
27851550|NCT04135196|81287080|FG001|Overall Study|Pregnancy|0|||
27851551|NCT04135196|81287081|FG002|Overall Study|Pregnancy|1|||
27851552|NCT04135196|81287082|FG003|Overall Study|Pregnancy|0|||
27901757|NCT00938587|81476352|FG002|Overall Study|Adverse Event|0|||
27901758|NCT00938587|81476353|FG003|Overall Study|Adverse Event|2|||
27901759|NCT00938587|81476350|FG000|Overall Study|Did not meet entrance criteria|0|||
27901760|NCT00938587|81476351|FG001|Overall Study|Did not meet entrance criteria|0|||
27901761|NCT00938587|81476352|FG002|Overall Study|Did not meet entrance criteria|1|||
27901762|NCT00938587|81476353|FG003|Overall Study|Did not meet entrance criteria|0|||
27901763|NCT00938587|81476350|FG000|Overall Study|Withdrawal by Subject|1|||
27901764|NCT00938587|81476351|FG001|Overall Study|Withdrawal by Subject|1|||
27901765|NCT00938587|81476352|FG002|Overall Study|Withdrawal by Subject|0|||
27901766|NCT00938587|81476353|FG003|Overall Study|Withdrawal by Subject|0|||
27901767|NCT03420222|81476355|FG000|Overall Study|Withdrawal by Subject|5|||
27901768|NCT03420222|81476356|FG001|Overall Study|Withdrawal by Subject|0|||
27901769|NCT03420222|81476355|FG000|Overall Study|Physician Decision|0|||
27901770|NCT03420222|81476356|FG001|Overall Study|Physician Decision|1|||
27901771|NCT01903993|81476363|FG000|Overall Study|Death|118|||
27901772|NCT01903993|81476364|FG001|Overall Study|Death|121|||
27901773|NCT01903993|81476363|FG000|Overall Study|Withdrawal by Subject|15|||
27901774|NCT01903993|81476364|FG001|Overall Study|Withdrawal by Subject|4|||
27901775|NCT01903993|81476363|FG000|Overall Study|Lost to Follow-up|2|||
27901776|NCT01903993|81476364|FG001|Overall Study|Lost to Follow-up|3|||
27901777|NCT01903993|81476363|FG000|Overall Study|Study Terminated by Sponsor|8|||
27901778|NCT01903993|81476364|FG001|Overall Study|Study Terminated by Sponsor|14|||
27901779|NCT01903993|81476363|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
27901780|NCT01903993|81476364|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
27901781|NCT00926536|81476368|FG000|Overall Study|Physician Decision|1|||
27901782|NCT00926536|81476369|FG001|Overall Study|Physician Decision|2|||
27901783|NCT00590538|81476372|FG000|Overall Study|Study terminated before completed|2|||
27901784|NCT02570750|81476373|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
27901785|NCT02570750|81476374|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
27901786|NCT02570750|81476373|FG000|Overall Study|Protocol deviation|4|||
27901787|NCT02570750|81476374|FG001|Overall Study|Protocol deviation|2|||
27901788|NCT02570750|81476373|FG000|Overall Study|Withdrawal by Subject|5|||
27901789|NCT02570750|81476374|FG001|Overall Study|Withdrawal by Subject|0|||
27901790|NCT02570750|81476373|FG000|Overall Study|Lost to Follow-up|2|||
27901791|NCT02570750|81476374|FG001|Overall Study|Lost to Follow-up|2|||
27901792|NCT02570750|81476373|FG000|Overall Study|Adverse Event|2|||
27901793|NCT02570750|81476374|FG001|Overall Study|Adverse Event|1|||
27901794|NCT01074255|81476376|FG000|Overall Study|Did not receive EMEND|2|||
27901795|NCT02012959|81476377|FG000|Treatment Phase A|Adverse Event|2|||
27901796|NCT02012959|81476378|FG001|Treatment Phase A|Adverse Event|0|||
27901797|NCT02012959|81476379|FG002|Treatment Phase A|Adverse Event|0|||
27901798|NCT02012959|81476380|FG003|Treatment Phase A|Adverse Event|0|||
27901799|NCT02012959|81476381|FG004|Treatment Phase A|Adverse Event|0|||
27901800|NCT01080391|81476382|FG000|Overall Study|Randomized but not treated|7|||
27901801|NCT01080391|81476383|FG001|Overall Study|Randomized but not treated|4|||
27901802|NCT01366638|81476387|FG000|Overall Study|Withdrawal by Subject|0|||
27901803|NCT01366638|81476388|FG001|Overall Study|Withdrawal by Subject|0|||
27901804|NCT01366638|81476389|FG002|Overall Study|Withdrawal by Subject|6|||
27901805|NCT01366638|81476387|FG000|Overall Study|Other|1|||
27901806|NCT01366638|81476388|FG001|Overall Study|Other|0|||
27901807|NCT01366638|81476389|FG002|Overall Study|Other|0|||
27901808|NCT00723697|81476390|FG000|Overall Study|Physician questionnaires not received|2|||
27901809|NCT00723697|81476390|FG000|Overall Study|Missing Informed Consent Form|10|||
27901810|NCT00723697|81476390|FG000|Overall Study|Other exclusion criteria applied|6|||
27901811|NCT02327013|81476392|FG000|Overall Study|Adverse Event|4|||
27901812|NCT02327013|81476393|FG001|Overall Study|Adverse Event|4|||
27901813|NCT02327013|81476394|FG002|Overall Study|Adverse Event|3|||
27901814|NCT02327013|81476395|FG003|Overall Study|Adverse Event|0|||
27901815|NCT02327013|81476396|FG004|Overall Study|Adverse Event|1|||
27901816|NCT02327013|81476392|FG000|Overall Study|Lack of Efficacy|2|||
27901817|NCT02327013|81476393|FG001|Overall Study|Lack of Efficacy|0|||
27901818|NCT02327013|81476394|FG002|Overall Study|Lack of Efficacy|5|||
27901819|NCT02327013|81476395|FG003|Overall Study|Lack of Efficacy|0|||
27901820|NCT02327013|81476396|FG004|Overall Study|Lack of Efficacy|1|||
27901821|NCT02327013|81476392|FG000|Overall Study|Non-compliance with IMP|1|||
27901822|NCT02327013|81476393|FG001|Overall Study|Non-compliance with IMP|2|||
27901823|NCT02327013|81476394|FG002|Overall Study|Non-compliance with IMP|7|||
27901824|NCT02327013|81476395|FG003|Overall Study|Non-compliance with IMP|0|||
27901825|NCT02327013|81476396|FG004|Overall Study|Non-compliance with IMP|0|||
27901826|NCT02327013|81476392|FG000|Overall Study|Withdrawal of Consent|1|||
27901827|NCT02327013|81476393|FG001|Overall Study|Withdrawal of Consent|0|||
27901828|NCT02327013|81476394|FG002|Overall Study|Withdrawal of Consent|3|||
27901829|NCT02327013|81476395|FG003|Overall Study|Withdrawal of Consent|0|||
27901830|NCT02327013|81476396|FG004|Overall Study|Withdrawal of Consent|0|||
27901831|NCT02327013|81476392|FG000|Overall Study|Lost to Follow-up|2|||
27901832|NCT02327013|81476393|FG001|Overall Study|Lost to Follow-up|4|||
27901833|NCT02327013|81476394|FG002|Overall Study|Lost to Follow-up|5|||
27901834|NCT02327013|81476395|FG003|Overall Study|Lost to Follow-up|0|||
27901835|NCT02327013|81476396|FG004|Overall Study|Lost to Follow-up|0|||
27901836|NCT02327013|81476392|FG000|Overall Study|Administrative or other reason(s)|1|||
27901837|NCT02327013|81476393|FG001|Overall Study|Administrative or other reason(s)|5|||
27901838|NCT02327013|81476394|FG002|Overall Study|Administrative or other reason(s)|11|||
27901839|NCT02327013|81476395|FG003|Overall Study|Administrative or other reason(s)|1|||
27901840|NCT02327013|81476396|FG004|Overall Study|Administrative or other reason(s)|1|||
27901841|NCT02327013|81476392|FG000|Overall Study|Protocol Violation|0|||
27901842|NCT02327013|81476393|FG001|Overall Study|Protocol Violation|0|||
27901843|NCT02327013|81476394|FG002|Overall Study|Protocol Violation|3|||
27901844|NCT02327013|81476395|FG003|Overall Study|Protocol Violation|0|||
27901845|NCT02327013|81476396|FG004|Overall Study|Protocol Violation|1|||
27901846|NCT02327013|81476392|FG000|Overall Study|Withdrawal before treatment|2|||
27901847|NCT02327013|81476393|FG001|Overall Study|Withdrawal before treatment|1|||
27901848|NCT02327013|81476394|FG002|Overall Study|Withdrawal before treatment|5|||
27901849|NCT02327013|81476395|FG003|Overall Study|Withdrawal before treatment|0|||
27901850|NCT02327013|81476396|FG004|Overall Study|Withdrawal before treatment|0|||
27901851|NCT01797094|81476397|FG000|Overall Study|Adverse Event|1|||
27901852|NCT01797094|81476398|FG001|Overall Study|Adverse Event|1|||
27901853|NCT01797094|81476397|FG000|Overall Study|Personal Reasons|4|||
27901854|NCT01797094|81476398|FG001|Overall Study|Personal Reasons|0|||
27901855|NCT01797094|81476397|FG000|Overall Study|Protocol Violation|0|||
27901856|NCT01797094|81476398|FG001|Overall Study|Protocol Violation|1|||
27901857|NCT01797094|81476397|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27901858|NCT01797094|81476398|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27901859|NCT04527978|81476399|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
27901860|NCT04527978|81476400|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
27901861|NCT01810783|81476404|FG000|Overall Study|Adverse Event|32|||
27901862|NCT01810783|81476404|FG000|Overall Study|Withdrawal by Subject|22|||
27901863|NCT01810783|81476404|FG000|Overall Study|Lack of Efficacy|12|||
27901864|NCT01810783|81476404|FG000|Overall Study|Lost to Follow-up|10|||
27901865|NCT01810783|81476404|FG000|Overall Study|Protocol Violation|5|||
27901866|NCT01810783|81476404|FG000|Overall Study|Non-compliance with IMP|4|||
27901867|NCT01810783|81476404|FG000|Overall Study|Adminstrative or other reason(s)|23|||
27901868|NCT01810783|81476404|FG000|Overall Study|Enrolled, not treated|1|||
27901869|NCT02649426|81476405|FG000|Overall Study|Follow-up on going|1|||
27901870|NCT02649426|81476406|FG001|Overall Study|Follow-up on going|26|||
27901871|NCT02649426|81476407|FG002|Overall Study|Follow-up on going|28|||
27901872|NCT02649426|81476408|FG003|Overall Study|Follow-up on going|31|||
27901873|NCT00448812|81476409|FG000|Year 2|Missed visit but remained in study|4|||
27901874|NCT00448812|81476410|FG001|Year 2|Missed visit but remained in study|1|||
27901875|NCT00448812|81476409|FG000|Year 3|Withdrawal by Subject|1|||
27901876|NCT00448812|81476410|FG001|Year 3|Withdrawal by Subject|3|||
27901877|NCT00448812|81476409|FG000|Year 3|Lost to Follow-up|1|||
27901878|NCT00448812|81476410|FG001|Year 3|Lost to Follow-up|0|||
27901879|NCT00448812|81476409|FG000|Year 3|Missed visit but remained in study|2|||
27901880|NCT00448812|81476410|FG001|Year 3|Missed visit but remained in study|0|||
27901881|NCT00448812|81476409|FG000|Year 5|Missed visit but remained in study|1|||
27901882|NCT00448812|81476410|FG001|Year 5|Missed visit but remained in study|0|||
27901883|NCT00869557|81476411|FG000|Randomized Phase|Lost to Follow-up|2|||
27901884|NCT00869557|81476412|FG001|Randomized Phase|Lost to Follow-up|1|||
27901885|NCT00869557|81476411|FG000|Randomized Phase|Investigator's Discretion|1|||
27901886|NCT00869557|81476412|FG001|Randomized Phase|Investigator's Discretion|0|||
27901887|NCT00869557|81476411|FG000|Randomized Phase|Withdrew Consent|0|||
27901888|NCT00869557|81476412|FG001|Randomized Phase|Withdrew Consent|1|||
27901889|NCT00869557|81476411|FG000|Extension Phase|Adverse Event|2|||
27901890|NCT00869557|81476412|FG001|Extension Phase|Adverse Event|2|||
27901891|NCT00869557|81476411|FG000|Extension Phase|Lack of Efficacy|1|||
27901892|NCT00869557|81476412|FG001|Extension Phase|Lack of Efficacy|0|||
27901893|NCT00869557|81476411|FG000|Extension Phase|Lost to Follow-up|3|||
27901894|NCT00869557|81476412|FG001|Extension Phase|Lost to Follow-up|1|||
27901895|NCT00869557|81476411|FG000|Extension Phase|Investigator's Discretion|2|||
27901896|NCT00869557|81476412|FG001|Extension Phase|Investigator's Discretion|0|||
27901897|NCT00869557|81476411|FG000|Extension Phase|Withdrew Consent|2|||
27728109|NCT01818726|80833130|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
27901898|NCT00869557|81476412|FG001|Extension Phase|Withdrew Consent|0|||
27901899|NCT01556932|81476415|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
27901900|NCT01556932|81476416|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
27901901|NCT03564795|81476421|FG000|Overall Study|Withdrawal by Subject|3|||
27901902|NCT03564795|81476421|FG000|Overall Study|Lost to Follow-up|6|||
27506672|NCT02594124|80047929|FG002|Overall Study|Withdrawal by Subject|5|||
27901903|NCT03564795|81476421|FG000|Overall Study|Physician Decision|2|||
27901904|NCT01256385|81476422|FG000|Overall Study|Physician Decision|1|||
27901905|NCT01256385|81476423|FG001|Overall Study|Physician Decision|1|||
27901906|NCT01256385|81476422|FG000|Overall Study|Withdrawal by Subject|2|||
27901907|NCT01256385|81476423|FG001|Overall Study|Withdrawal by Subject|2|||
27901908|NCT00089635|81476426|FG000|Overall Study|Adverse Event|2|||
27901909|NCT00089635|81476426|FG000|Overall Study|Death|17|||
27901910|NCT00089635|81476426|FG000|Overall Study|Disease Progression|12|||
27901911|NCT00089635|81476426|FG000|Overall Study|Lost to Follow-up|3|||
27901912|NCT00089635|81476426|FG000|Overall Study|Withdrawal by Subject|6|||
27901913|NCT00089635|81476426|FG000|Overall Study|Ineligibility determined|1|||
27901914|NCT00089635|81476426|FG000|Overall Study|Other|2|||
27901915|NCT03887117|81476428|FG000|Overall Study|Discontinued prematurely|0|||
27901916|NCT03887117|81476429|FG001|Overall Study|Discontinued prematurely|1|||
27901917|NCT03887117|81476430|FG002|Overall Study|Discontinued prematurely|1|||
27901918|NCT03887117|81476431|FG003|Overall Study|Discontinued prematurely|2|||
27901919|NCT01289574|81476439|FG000|Overall Study|Lack of Efficacy|4|||
27901920|NCT01289574|81476440|FG001|Overall Study|Lack of Efficacy|0|||
27901921|NCT01289574|81476441|FG002|Overall Study|Lack of Efficacy|1|||
27901922|NCT01289574|81476439|FG000|Overall Study|Lost to Follow-up|2|||
27901923|NCT01289574|81476440|FG001|Overall Study|Lost to Follow-up|0|||
27901924|NCT01289574|81476441|FG002|Overall Study|Lost to Follow-up|1|||
27901925|NCT01289574|81476439|FG000|Overall Study|Withdrawal by Subject|1|||
27901926|NCT01289574|81476440|FG001|Overall Study|Withdrawal by Subject|1|||
27901927|NCT01289574|81476441|FG002|Overall Study|Withdrawal by Subject|1|||
27901928|NCT01289574|81476439|FG000|Overall Study|Adverse Event|0|||
27901929|NCT01289574|81476440|FG001|Overall Study|Adverse Event|1|||
27901930|NCT01289574|81476441|FG002|Overall Study|Adverse Event|0|||
27901931|NCT01289574|81476439|FG000|Overall Study|Subject wanted alternate treatment|0|||
27901932|NCT01289574|81476440|FG001|Overall Study|Subject wanted alternate treatment|1|||
27901933|NCT01289574|81476441|FG002|Overall Study|Subject wanted alternate treatment|0|||
27901934|NCT01603394|81476446|FG000|Overall Study|Adverse Event|1|||
27901935|NCT02028169|81476447|FG000|Overall Study|Lost to Follow-up|21|||
27901936|NCT02028169|81476447|FG000|Overall Study|Lack of Efficacy|2|||
27901937|NCT02028169|81476447|FG000|Overall Study|Withdrawal by Subject|2|||
27901938|NCT02028169|81476447|FG000|Overall Study|Adverse Event|1|||
27901939|NCT02028169|81476447|FG000|Overall Study|Cessation of Drug|1|||
27901940|NCT02028169|81476447|FG000|Overall Study|Concomitant Medication Usage|1|||
27901941|NCT00396877|81476450|FG000|Overall Study|Lost to Follow-up|2|||
27901942|NCT00396877|81476451|FG001|Overall Study|Lost to Follow-up|1|||
27901943|NCT00396877|81476450|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
27901944|NCT00396877|81476451|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
27901945|NCT00404924|81476455|FG000|Overall Study|Adverse Event|75|||
27901946|NCT00404924|81476456|FG001|Overall Study|Adverse Event|16|||
27901947|NCT00404924|81476455|FG000|Overall Study|Condition under investigation worsened|475|||
27901948|NCT00404924|81476456|FG001|Overall Study|Condition under investigation worsened|264|||
27901949|NCT00404924|81476455|FG000|Overall Study|Lost to Follow-up|1|||
27901950|NCT00404924|81476456|FG001|Overall Study|Lost to Follow-up|1|||
27901951|NCT00404924|81476455|FG000|Overall Study|Withdrawal by Subject|26|||
27901952|NCT00404924|81476456|FG001|Overall Study|Withdrawal by Subject|13|||
27901953|NCT00404924|81476455|FG000|Overall Study|Other|25|||
27901954|NCT00404924|81476456|FG001|Overall Study|Other|11|||
27901955|NCT00404924|81476455|FG000|Overall Study|Randomised but not received treatment|1|||
27901956|NCT00404924|81476456|FG001|Overall Study|Randomised but not received treatment|1|||
27901957|NCT03681184|81476457|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
27901958|NCT03681184|81476458|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
27901959|NCT00135356|81476459|FG000|Overall Study|Adverse Event|6|||
27901960|NCT00135356|81476460|FG001|Overall Study|Adverse Event|2|||
27901961|NCT00135356|81476459|FG000|Overall Study|Lack of Efficacy|2|||
27901962|NCT00135356|81476460|FG001|Overall Study|Lack of Efficacy|0|||
27901963|NCT00135356|81476459|FG000|Overall Study|Lost to Follow-up|3|||
27901964|NCT00135356|81476460|FG001|Overall Study|Lost to Follow-up|1|||
27901965|NCT00135356|81476459|FG000|Overall Study|Surgery for abdominal fat|1|||
27901966|NCT00135356|81476460|FG001|Overall Study|Surgery for abdominal fat|0|||
27901967|NCT00135356|81476459|FG000|Overall Study|Change in antiviral regimen|0|||
27901968|NCT00135356|81476460|FG001|Overall Study|Change in antiviral regimen|1|||
27901969|NCT00135356|81476459|FG000|Overall Study|Poor/noncompliance|1|||
27901970|NCT00135356|81476460|FG001|Overall Study|Poor/noncompliance|1|||
27901971|NCT00135356|81476459|FG000|Overall Study|No longer meets study criteria|2|||
27506673|NCT02594124|80047930|FG003|Overall Study|Withdrawal by Subject|1|||
27901972|NCT00135356|81476460|FG001|Overall Study|No longer meets study criteria|0|||
27901973|NCT00135356|81476459|FG000|Overall Study|Withdrawal by Subject|2|||
27901974|NCT00135356|81476460|FG001|Overall Study|Withdrawal by Subject|4|||
27901975|NCT00473824|81476461|FG000|Overall Study|Virologic Breakthrough|1|||
27901976|NCT00473824|81476462|FG001|Overall Study|Virologic Breakthrough|0|||
27901977|NCT00473824|81476461|FG000|Overall Study|Adverse Event|1|||
27901978|NCT00473824|81476462|FG001|Overall Study|Adverse Event|0|||
27901979|NCT00473824|81476461|FG000|Overall Study|Death|1|||
27901980|NCT00473824|81476462|FG001|Overall Study|Death|0|||
27901981|NCT00473824|81476461|FG000|Overall Study|Lost to Follow-up|1|||
27901982|NCT00473824|81476462|FG001|Overall Study|Lost to Follow-up|0|||
27901983|NCT00473824|81476461|FG000|Overall Study|Withdrawal by physician|1|||
27901984|NCT00473824|81476462|FG001|Overall Study|Withdrawal by physician|0|||
27901985|NCT04769739|81476463|FG000|Overall Study|Colorectal cancer obstruction|2|||
27614329|NCT04157686|80430231|FG004|Overall Study|Adverse Event|1|||
27614330|NCT04157686|80430232|FG005|Overall Study|Adverse Event|0|||
27614331|NCT04157686|80430233|FG006|Overall Study|Adverse Event|0|||
27614332|NCT04157686|80430234|FG007|Overall Study|Adverse Event|0|||
27614333|NCT04157686|80430227|FG000|Overall Study|Pregnancy|0|||
27614334|NCT04157686|80430228|FG001|Overall Study|Pregnancy|1|||
27614335|NCT04157686|80430229|FG002|Overall Study|Pregnancy|3|||
27614336|NCT04157686|80430230|FG003|Overall Study|Pregnancy|0|||
27614337|NCT04157686|80430231|FG004|Overall Study|Pregnancy|0|||
27614338|NCT04157686|80430232|FG005|Overall Study|Pregnancy|0|||
27614339|NCT04157686|80430233|FG006|Overall Study|Pregnancy|3|||
27614340|NCT04157686|80430234|FG007|Overall Study|Pregnancy|0|||
27614341|NCT04157686|80430227|FG000|Overall Study|Lost to Follow-up|1|||
27614342|NCT04157686|80430228|FG001|Overall Study|Lost to Follow-up|2|||
27614343|NCT04157686|80430229|FG002|Overall Study|Lost to Follow-up|8|||
27614344|NCT04157686|80430230|FG003|Overall Study|Lost to Follow-up|6|||
27614345|NCT04157686|80430231|FG004|Overall Study|Lost to Follow-up|6|||
27614346|NCT04157686|80430232|FG005|Overall Study|Lost to Follow-up|3|||
27614347|NCT04157686|80430233|FG006|Overall Study|Lost to Follow-up|7|||
27614348|NCT04157686|80430234|FG007|Overall Study|Lost to Follow-up|9|||
27614349|NCT04157686|80430227|FG000|Overall Study|Lack of Efficacy|0|||
27614350|NCT04157686|80430228|FG001|Overall Study|Lack of Efficacy|0|||
27614351|NCT04157686|80430229|FG002|Overall Study|Lack of Efficacy|0|||
27614352|NCT04157686|80430230|FG003|Overall Study|Lack of Efficacy|0|||
27614353|NCT04157686|80430231|FG004|Overall Study|Lack of Efficacy|0|||
27614354|NCT04157686|80430232|FG005|Overall Study|Lack of Efficacy|2|||
27614355|NCT04157686|80430233|FG006|Overall Study|Lack of Efficacy|0|||
27614356|NCT04157686|80430234|FG007|Overall Study|Lack of Efficacy|1|||
27614357|NCT04157686|80430227|FG000|Overall Study|Withdrawal by Subject|10|||
27614358|NCT04157686|80430228|FG001|Overall Study|Withdrawal by Subject|10|||
27614359|NCT04157686|80430229|FG002|Overall Study|Withdrawal by Subject|12|||
27614360|NCT04157686|80430230|FG003|Overall Study|Withdrawal by Subject|20|||
27614361|NCT04157686|80430231|FG004|Overall Study|Withdrawal by Subject|12|||
27614362|NCT04157686|80430232|FG005|Overall Study|Withdrawal by Subject|11|||
27614363|NCT04157686|80430233|FG006|Overall Study|Withdrawal by Subject|18|||
27614364|NCT04157686|80430234|FG007|Overall Study|Withdrawal by Subject|24|||
27614365|NCT04157686|80430227|FG000|Overall Study|Physician Decision|0|||
27614366|NCT04157686|80430228|FG001|Overall Study|Physician Decision|0|||
27614367|NCT04157686|80430229|FG002|Overall Study|Physician Decision|1|||
27614368|NCT04157686|80430230|FG003|Overall Study|Physician Decision|0|||
27614369|NCT04157686|80430231|FG004|Overall Study|Physician Decision|1|||
27614370|NCT04157686|80430232|FG005|Overall Study|Physician Decision|0|||
27614371|NCT04157686|80430233|FG006|Overall Study|Physician Decision|3|||
27614372|NCT04157686|80430234|FG007|Overall Study|Physician Decision|0|||
27614373|NCT04157686|80430227|FG000|Overall Study|Death|0|||
27614374|NCT04157686|80430228|FG001|Overall Study|Death|0|||
27614375|NCT04157686|80430229|FG002|Overall Study|Death|0|||
27614376|NCT04157686|80430230|FG003|Overall Study|Death|2|||
27614377|NCT04157686|80430231|FG004|Overall Study|Death|0|||
27614378|NCT04157686|80430232|FG005|Overall Study|Death|0|||
27614379|NCT04157686|80430233|FG006|Overall Study|Death|0|||
27614380|NCT04157686|80430234|FG007|Overall Study|Death|0|||
27614381|NCT04157686|80430227|FG000|Overall Study|Protocol Violation|0|||
27614382|NCT04157686|80430228|FG001|Overall Study|Protocol Violation|0|||
27614383|NCT04157686|80430229|FG002|Overall Study|Protocol Violation|0|||
27614384|NCT04157686|80430230|FG003|Overall Study|Protocol Violation|0|||
27614385|NCT04157686|80430231|FG004|Overall Study|Protocol Violation|1|||
27614386|NCT04157686|80430232|FG005|Overall Study|Protocol Violation|0|||
27614387|NCT04157686|80430233|FG006|Overall Study|Protocol Violation|0|||
27614388|NCT04157686|80430234|FG007|Overall Study|Protocol Violation|0|||
27901986|NCT04769739|81476464|FG001|Overall Study|Colorectal cancer obstruction|0|||
27614389|NCT04157686|80430227|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
27614390|NCT04157686|80430228|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
27614391|NCT04157686|80430229|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
27614392|NCT04157686|80430230|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
27614393|NCT04157686|80430231|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
27614394|NCT04157686|80430232|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
27614395|NCT04157686|80430233|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
27614396|NCT04157686|80430234|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
27614397|NCT02765490|80430235|FG000|Overall Study|Lost to Follow-up|1|||
27614398|NCT02765490|80430236|FG001|Overall Study|Lost to Follow-up|1|||
27614399|NCT02765490|80430235|FG000|Overall Study|Other|0|||
27614400|NCT02765490|80430236|FG001|Overall Study|Other|1|||
27614401|NCT02765490|80430235|FG000|Overall Study|Death|0|||
27901987|NCT04769739|81476465|FG002|Overall Study|Colorectal cancer obstruction|0|||
27614402|NCT02765490|80430236|FG001|Overall Study|Death|1|||
27614403|NCT02243631|80430239|FG000|Overall Study|no synovial fluid on second aspirate|0|||
27614404|NCT02243631|80430240|FG001|Overall Study|no synovial fluid on second aspirate|1|||
27614405|NCT03685708|80430241|FG000|Overall Study|Withdrawal by Subject|0|||
27614406|NCT03685708|80430242|FG001|Overall Study|Withdrawal by Subject|0|||
27728110|NCT02152345|80833131|FG000|Overall Study|Case Cancellations|2|||
27728111|NCT02152345|80833132|FG001|Overall Study|Case Cancellations|4|||
27728112|NCT02152345|80833131|FG000|Overall Study|Withdrawal by Subject|2|||
27728113|NCT02152345|80833132|FG001|Overall Study|Withdrawal by Subject|1|||
27728114|NCT00667576|80833136|FG000|Overall Study|Withdrawal by Subject|1|||
27728115|NCT00667576|80833137|FG001|Overall Study|Withdrawal by Subject|0|||
27728116|NCT00667576|80833138|FG002|Overall Study|Withdrawal by Subject|1|||
27728117|NCT00667576|80833139|FG003|Overall Study|Withdrawal by Subject|1|||
27728118|NCT00667576|80833140|FG004|Overall Study|Withdrawal by Subject|1|||
27728119|NCT00667576|80833136|FG000|Overall Study|Adverse Event|1|||
27728120|NCT00667576|80833137|FG001|Overall Study|Adverse Event|1|||
27728121|NCT00667576|80833138|FG002|Overall Study|Adverse Event|0|||
27728122|NCT00667576|80833139|FG003|Overall Study|Adverse Event|0|||
27728123|NCT00667576|80833140|FG004|Overall Study|Adverse Event|0|||
27728124|NCT00667576|80833136|FG000|Overall Study|Lost to Follow-up|0|||
27728125|NCT00667576|80833137|FG001|Overall Study|Lost to Follow-up|0|||
27728126|NCT00667576|80833138|FG002|Overall Study|Lost to Follow-up|1|||
27728127|NCT00667576|80833139|FG003|Overall Study|Lost to Follow-up|0|||
27728128|NCT00667576|80833140|FG004|Overall Study|Lost to Follow-up|0|||
27728129|NCT00667576|80833136|FG000|Overall Study|Protocol Violation|0|||
27728130|NCT00667576|80833137|FG001|Overall Study|Protocol Violation|0|||
27728131|NCT00667576|80833138|FG002|Overall Study|Protocol Violation|0|||
27728132|NCT00667576|80833139|FG003|Overall Study|Protocol Violation|1|||
27728133|NCT00667576|80833140|FG004|Overall Study|Protocol Violation|0|||
27728134|NCT00667576|80833136|FG000|Overall Study|Physician Decision|0|||
27506674|NCT02594124|80047931|FG004|Overall Study|Withdrawal by Subject|8|||
27506675|NCT02594124|80047932|FG005|Overall Study|Withdrawal by Subject|4|||
27506676|NCT02594124|80047933|FG006|Overall Study|Withdrawal by Subject|13|||
27506677|NCT02594124|80047934|FG007|Overall Study|Withdrawal by Subject|19|||
27728135|NCT00667576|80833137|FG001|Overall Study|Physician Decision|0|||
27728136|NCT00667576|80833138|FG002|Overall Study|Physician Decision|0|||
27728137|NCT00667576|80833139|FG003|Overall Study|Physician Decision|1|||
27506678|NCT02594124|80047935|FG008|Overall Study|Withdrawal by Subject|0|||
27506679|NCT02594124|80047927|FG000|Overall Study|Physician Decision|0|||
27728138|NCT00667576|80833140|FG004|Overall Study|Physician Decision|0|||
27728139|NCT00667576|80833136|FG000|Overall Study|Missed Visit|0|||
27728140|NCT00667576|80833137|FG001|Overall Study|Missed Visit|0|||
27728141|NCT00667576|80833138|FG002|Overall Study|Missed Visit|0|||
27728142|NCT00667576|80833139|FG003|Overall Study|Missed Visit|1|||
27728143|NCT00667576|80833140|FG004|Overall Study|Missed Visit|0|||
27901988|NCT04769739|81476466|FG003|Overall Study|Colorectal cancer obstruction|0|||
27901989|NCT04769739|81476463|FG000|Overall Study|Failed cecal intubation|1|||
27901990|NCT04769739|81476464|FG001|Overall Study|Failed cecal intubation|0|||
27901991|NCT04769739|81476465|FG002|Overall Study|Failed cecal intubation|0|||
27901992|NCT04769739|81476466|FG003|Overall Study|Failed cecal intubation|1|||
27901993|NCT04769739|81476463|FG000|Overall Study|Poor bowel preparation|0|||
27901994|NCT04769739|81476464|FG001|Overall Study|Poor bowel preparation|0|||
27901995|NCT04769739|81476465|FG002|Overall Study|Poor bowel preparation|0|||
27901996|NCT04769739|81476466|FG003|Overall Study|Poor bowel preparation|1|||
27901997|NCT00253370|81476469|FG000|Overall Study|Adverse Event|18|||
27901998|NCT00253370|81476469|FG000|Overall Study|Disease progression|13|||
27901999|NCT00253370|81476469|FG000|Overall Study|Death|2|||
27902000|NCT00253370|81476469|FG000|Overall Study|Withdrawal by Subject|6|||
27902001|NCT00253370|81476469|FG000|Overall Study|Non-protocol therapy|1|||
27902002|NCT00253370|81476469|FG000|Overall Study|Physician Decision|1|||
27902003|NCT00253370|81476469|FG000|Overall Study|Protocol Violation|1|||
27902004|NCT00253370|81476469|FG000|Overall Study|Abdominal pain due to disease|1|||
27902005|NCT04631107|81476470|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
27902006|NCT04631107|81476470|FG000|Second Intervention (1 Night)|Adverse Event|1|||
27902007|NCT04631107|81476470|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
27902008|NCT04631107|81476470|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
27902009|NCT00750919|81476471|FG000|Overall Study|Adverse Event|9|||
27902010|NCT00750919|81476471|FG000|Overall Study|Withdrawal by Subject|1|||
27902011|NCT00750919|81476471|FG000|Overall Study|Lack of Efficacy|8|||
27902012|NCT00750919|81476471|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
27902013|NCT00750919|81476471|FG000|Overall Study|Other|36|||
27902014|NCT04575584|81476477|FG000|Overall Study|Death|6|||
27902015|NCT04575584|81476478|FG001|Overall Study|Death|4|||
27902016|NCT04575584|81476479|FG002|Overall Study|Death|6|||
27902017|NCT04575584|81476480|FG003|Overall Study|Death|2|||
27902018|NCT04575584|81476481|FG004|Overall Study|Death|0|||
27902019|NCT04575584|81476482|FG005|Overall Study|Death|0|||
27851553|NCT04135196|81287083|FG004|Overall Study|Pregnancy|0|||
27851554|NCT04135196|81287079|FG000|Overall Study|Withdrawal by Subject|0|||
27851555|NCT04135196|81287080|FG001|Overall Study|Withdrawal by Subject|0|||
27851556|NCT04135196|81287081|FG002|Overall Study|Withdrawal by Subject|0|||
27851557|NCT04135196|81287082|FG003|Overall Study|Withdrawal by Subject|0|||
27851558|NCT04135196|81287083|FG004|Overall Study|Withdrawal by Subject|1|||
27851559|NCT04209205|81287084|FG000|Overall Study|Adverse Event|2|||
27851560|NCT04209205|81287085|FG001|Overall Study|Adverse Event|3|||
27851561|NCT04209205|81287084|FG000|Overall Study|Lost to Follow-up|3|||
27851562|NCT04209205|81287085|FG001|Overall Study|Lost to Follow-up|1|||
27851563|NCT04209205|81287084|FG000|Overall Study|Physician Decision|1|||
27851564|NCT04209205|81287085|FG001|Overall Study|Physician Decision|1|||
27851565|NCT04209205|81287084|FG000|Overall Study|Subject decision|10|||
27851566|NCT04209205|81287085|FG001|Overall Study|Subject decision|10|||
27851567|NCT04209205|81287084|FG000|Overall Study|Progressive disease|1|||
27851568|NCT04209205|81287085|FG001|Overall Study|Progressive disease|0|||
27851569|NCT04209205|81287084|FG000|Overall Study|Protocol deviation|0|||
27851570|NCT04209205|81287085|FG001|Overall Study|Protocol deviation|1|||
27851571|NCT04209205|81287084|FG000|Overall Study|New therapy for study indication|1|||
27851572|NCT04209205|81287085|FG001|Overall Study|New therapy for study indication|0|||
27851573|NCT04209205|81287084|FG000|Overall Study|Adverse event - placebo not switched|0|||
27851574|NCT04209205|81287085|FG001|Overall Study|Adverse event - placebo not switched|1|||
27851575|NCT04209205|81287084|FG000|Overall Study|Subject decision - placebo not switched|0|||
27851576|NCT04209205|81287085|FG001|Overall Study|Subject decision - placebo not switched|5|||
27851577|NCT04209205|81287084|FG000|Overall Study|Death - placebo not switched|0|||
27851578|NCT04209205|81287085|FG001|Overall Study|Death - placebo not switched|1|||
27851579|NCT00973765|81287089|FG000|Overall Study|Lost to Follow-up|8|||
27851580|NCT00973765|81287090|FG001|Overall Study|Lost to Follow-up|14|||
27851581|NCT01901874|81287095|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
27851582|NCT01901874|81287095|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
27902020|NCT04575584|81476477|FG000|Overall Study|Lost to Follow-up|1|||
27902021|NCT04575584|81476478|FG001|Overall Study|Lost to Follow-up|1|||
27851583|NCT01901874|81287095|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
27851584|NCT01901874|81287095|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
27851585|NCT01901874|81287095|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
27851586|NCT01901874|81287095|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
27902022|NCT04575584|81476479|FG002|Overall Study|Lost to Follow-up|1|||
27902023|NCT04575584|81476480|FG003|Overall Study|Lost to Follow-up|1|||
27902024|NCT04575584|81476481|FG004|Overall Study|Lost to Follow-up|0|||
27902025|NCT04575584|81476482|FG005|Overall Study|Lost to Follow-up|0|||
27902026|NCT04575584|81476477|FG000|Overall Study|Physician Decision|0|||
27902027|NCT04575584|81476478|FG001|Overall Study|Physician Decision|1|||
27902028|NCT04575584|81476479|FG002|Overall Study|Physician Decision|1|||
27902029|NCT04575584|81476480|FG003|Overall Study|Physician Decision|1|||
27902030|NCT04575584|81476481|FG004|Overall Study|Physician Decision|0|||
27902031|NCT04575584|81476482|FG005|Overall Study|Physician Decision|0|||
27902032|NCT04575584|81476477|FG000|Overall Study|Withdrawal by Subject|7|||
27902033|NCT04575584|81476478|FG001|Overall Study|Withdrawal by Subject|9|||
27902034|NCT04575584|81476479|FG002|Overall Study|Withdrawal by Subject|5|||
27902035|NCT04575584|81476480|FG003|Overall Study|Withdrawal by Subject|3|||
27902036|NCT04575584|81476481|FG004|Overall Study|Withdrawal by Subject|0|||
27902037|NCT04575584|81476482|FG005|Overall Study|Withdrawal by Subject|0|||
27902038|NCT04575584|81476477|FG000|Overall Study|Not recorded|0|||
27902039|NCT04575584|81476478|FG001|Overall Study|Not recorded|0|||
27614407|NCT03685708|80430243|FG002|Overall Study|Withdrawal by Subject|1|||
27614408|NCT03685708|80430241|FG000|Overall Study|Screen Fail|0|||
27614409|NCT03685708|80430242|FG001|Overall Study|Screen Fail|1|||
27614410|NCT03685708|80430243|FG002|Overall Study|Screen Fail|1|||
27614411|NCT03685708|80430241|FG000|Overall Study|COVID 19 Pandemic|1|||
27614412|NCT03685708|80430242|FG001|Overall Study|COVID 19 Pandemic|1|||
27614413|NCT03685708|80430243|FG002|Overall Study|COVID 19 Pandemic|6|||
27614414|NCT03685708|80430241|FG000|Overall Study|Disease Progression|0|||
27614415|NCT03685708|80430242|FG001|Overall Study|Disease Progression|0|||
27614416|NCT03685708|80430243|FG002|Overall Study|Disease Progression|1|||
27614417|NCT00962585|80430244|FG000|Overall Study|Adverse Event|0|||
27614418|NCT00962585|80430245|FG001|Overall Study|Adverse Event|2|||
27614419|NCT00962585|80430246|FG002|Overall Study|Adverse Event|1|||
27614420|NCT00962585|80430247|FG003|Overall Study|Adverse Event|0|||
27614421|NCT00962585|80430244|FG000|Overall Study|Lost to Follow-up|3|||
27506680|NCT02594124|80047928|FG001|Overall Study|Physician Decision|2|||
27506681|NCT02594124|80047929|FG002|Overall Study|Physician Decision|0|||
27506682|NCT02594124|80047930|FG003|Overall Study|Physician Decision|0|||
27506683|NCT02594124|80047931|FG004|Overall Study|Physician Decision|0|||
27506684|NCT02594124|80047932|FG005|Overall Study|Physician Decision|0|||
27506685|NCT02594124|80047933|FG006|Overall Study|Physician Decision|0|||
27506686|NCT02594124|80047934|FG007|Overall Study|Physician Decision|1|||
27506687|NCT02594124|80047935|FG008|Overall Study|Physician Decision|0|||
27506688|NCT02594124|80047927|FG000|Overall Study|Commercial drug|0|||
27506689|NCT02594124|80047928|FG001|Overall Study|Commercial drug|1|||
27506690|NCT02594124|80047929|FG002|Overall Study|Commercial drug|6|||
27506691|NCT02594124|80047930|FG003|Overall Study|Commercial drug|3|||
27506692|NCT02594124|80047931|FG004|Overall Study|Commercial drug|0|||
27506693|NCT02594124|80047932|FG005|Overall Study|Commercial drug|0|||
27506694|NCT02594124|80047933|FG006|Overall Study|Commercial drug|7|||
27902040|NCT04575584|81476479|FG002|Overall Study|Not recorded|0|||
27506695|NCT02594124|80047934|FG007|Overall Study|Commercial drug|11|||
27506696|NCT02594124|80047935|FG008|Overall Study|Commercial drug|2|||
27614422|NCT00962585|80430245|FG001|Overall Study|Lost to Follow-up|0|||
27614423|NCT00962585|80430246|FG002|Overall Study|Lost to Follow-up|1|||
27902041|NCT04575584|81476480|FG003|Overall Study|Not recorded|1|||
27902042|NCT04575584|81476481|FG004|Overall Study|Not recorded|0|||
27614424|NCT00962585|80430247|FG003|Overall Study|Lost to Follow-up|0|||
27614425|NCT00962585|80430244|FG000|Overall Study|Protocol Violation|0|||
27902043|NCT04575584|81476482|FG005|Overall Study|Not recorded|0|||
27902044|NCT00840034|81476487|FG000|Acute Treatment Phase|Adverse Event|6|||
27902045|NCT00840034|81476488|FG001|Acute Treatment Phase|Adverse Event|8|||
27902046|NCT00840034|81476487|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
27902047|NCT00840034|81476488|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
27902048|NCT00840034|81476487|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
27902049|NCT00840034|81476488|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
27902050|NCT00840034|81476487|FG000|Acute Treatment Phase|Physician Decision|0|||
27902051|NCT00840034|81476488|FG001|Acute Treatment Phase|Physician Decision|1|||
27902052|NCT00840034|81476487|FG000|Acute Treatment Phase|Protocol Violation|2|||
27902053|NCT00840034|81476488|FG001|Acute Treatment Phase|Protocol Violation|4|||
27902054|NCT00840034|81476487|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
27902055|NCT00840034|81476488|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
27902056|NCT00840034|81476487|FG000|Taper Phase|Adverse Event|1|||
27902057|NCT00840034|81476488|FG001|Taper Phase|Adverse Event|0|||
27902058|NCT00840034|81476487|FG000|Taper Phase|Lost to Follow-up|1|||
27902059|NCT00840034|81476488|FG001|Taper Phase|Lost to Follow-up|1|||
27902060|NCT00840034|81476487|FG000|Taper Phase|Withdrawal by Subject|1|||
27902061|NCT00840034|81476488|FG001|Taper Phase|Withdrawal by Subject|1|||
27902062|NCT03034135|81476491|FG000|Overall Study|Withdrawal by Subject|2|||
27902063|NCT00575510|81476494|FG000|Overall Study|Lost to Follow-up|4|||
27902064|NCT00575510|81476495|FG001|Overall Study|Lost to Follow-up|6|||
27902065|NCT00575510|81476496|FG002|Overall Study|Lost to Follow-up|9|||
27902066|NCT00575510|81476494|FG000|Overall Study|Withdrawal by Subject|1|||
27902067|NCT00575510|81476495|FG001|Overall Study|Withdrawal by Subject|0|||
27902068|NCT00575510|81476496|FG002|Overall Study|Withdrawal by Subject|0|||
27902069|NCT00575510|81476494|FG000|Overall Study|Clinic Called Patient|7|||
27902070|NCT00575510|81476495|FG001|Overall Study|Clinic Called Patient|7|||
27902071|NCT00575510|81476496|FG002|Overall Study|Clinic Called Patient|7|||
27902072|NCT00575510|81476494|FG000|Overall Study|Pregnancy|0|||
27902073|NCT00575510|81476495|FG001|Overall Study|Pregnancy|0|||
27902074|NCT00575510|81476496|FG002|Overall Study|Pregnancy|1|||
27902075|NCT02191046|81476501|FG000|Overall Study|low compliance|5|||
27902076|NCT02191046|81476502|FG001|Overall Study|low compliance|1|||
27902077|NCT02565706|81476503|FG000|Overall Study|Withdrawal by Subject|5|||
27902078|NCT02565706|81476504|FG001|Overall Study|Withdrawal by Subject|7|||
27902079|NCT02565706|81476505|FG002|Overall Study|Withdrawal by Subject|7|||
27902080|NCT02565706|81476506|FG003|Overall Study|Withdrawal by Subject|11|||
27902081|NCT02565706|81476503|FG000|Overall Study|Lost to Follow-up|72|||
27902082|NCT02565706|81476504|FG001|Overall Study|Lost to Follow-up|75|||
27902083|NCT02565706|81476505|FG002|Overall Study|Lost to Follow-up|82|||
27902084|NCT02565706|81476506|FG003|Overall Study|Lost to Follow-up|74|||
27902085|NCT02069093|81476507|FG000|Overall Study|Disease progression|14|||
27902086|NCT02069093|81476507|FG000|Overall Study|New cancer therapy|1|||
27902087|NCT02069093|81476507|FG000|Overall Study|Death|1|||
27902088|NCT02069093|81476507|FG000|Overall Study|Administrative problems|1|||
27902089|NCT02069093|81476507|FG000|Overall Study|Withdrawal by Subject|2|||
27902090|NCT02069093|81476507|FG000|Overall Study|Abnormal laboratory values|1|||
27902091|NCT02069093|81476507|FG000|Overall Study|Adverse Event|10|||
27902092|NCT00195494|81476511|FG000|Year 1|Adverse Event|0|||
27902093|NCT00195494|81476512|FG001|Year 1|Adverse Event|0|||
27902094|NCT00195494|81476513|FG002|Year 1|Adverse Event|0|||
27902095|NCT00195494|81476514|FG003|Year 1|Adverse Event|0|||
27902096|NCT00195494|81476515|FG004|Year 1|Adverse Event|34|||
27902097|NCT00195494|81476516|FG005|Year 1|Adverse Event|27|||
27902098|NCT00195494|81476511|FG000|Year 1|System Toxicity|0|||
27902099|NCT00195494|81476512|FG001|Year 1|System Toxicity|0|||
27902100|NCT00195494|81476513|FG002|Year 1|System Toxicity|0|||
27902101|NCT00195494|81476514|FG003|Year 1|System Toxicity|0|||
27902102|NCT00195494|81476515|FG004|Year 1|System Toxicity|0|||
27902103|NCT00195494|81476516|FG005|Year 1|System Toxicity|1|||
27902104|NCT00195494|81476511|FG000|Year 1|Lack of Efficacy|0|||
27902105|NCT00195494|81476512|FG001|Year 1|Lack of Efficacy|0|||
27902106|NCT00195494|81476513|FG002|Year 1|Lack of Efficacy|0|||
27902107|NCT00195494|81476514|FG003|Year 1|Lack of Efficacy|0|||
27902108|NCT00195494|81476515|FG004|Year 1|Lack of Efficacy|24|||
27902109|NCT00195494|81476516|FG005|Year 1|Lack of Efficacy|9|||
27902110|NCT00195494|81476511|FG000|Year 1|Compliance|0|||
27902111|NCT00195494|81476512|FG001|Year 1|Compliance|0|||
27902112|NCT00195494|81476513|FG002|Year 1|Compliance|0|||
27902113|NCT00195494|81476514|FG003|Year 1|Compliance|0|||
27902114|NCT00195494|81476515|FG004|Year 1|Compliance|5|||
27902115|NCT00195494|81476516|FG005|Year 1|Compliance|1|||
27902116|NCT00195494|81476511|FG000|Year 1|Lost to Follow-up|0|||
27902117|NCT00195494|81476512|FG001|Year 1|Lost to Follow-up|0|||
27902118|NCT00195494|81476513|FG002|Year 1|Lost to Follow-up|0|||
27902119|NCT00195494|81476514|FG003|Year 1|Lost to Follow-up|0|||
27902120|NCT00195494|81476515|FG004|Year 1|Lost to Follow-up|1|||
27902121|NCT00195494|81476516|FG005|Year 1|Lost to Follow-up|0|||
27902122|NCT00195494|81476511|FG000|Year 1|Missed >4 consecutive doses|0|||
27902123|NCT00195494|81476512|FG001|Year 1|Missed >4 consecutive doses|0|||
27902124|NCT00195494|81476513|FG002|Year 1|Missed >4 consecutive doses|0|||
27902125|NCT00195494|81476514|FG003|Year 1|Missed >4 consecutive doses|0|||
27902126|NCT00195494|81476515|FG004|Year 1|Missed >4 consecutive doses|3|||
27902127|NCT00195494|81476516|FG005|Year 1|Missed >4 consecutive doses|2|||
27902128|NCT00195494|81476511|FG000|Year 1|Protocol deviation|0|||
27902129|NCT00195494|81476512|FG001|Year 1|Protocol deviation|0|||
27902130|NCT00195494|81476513|FG002|Year 1|Protocol deviation|0|||
27902131|NCT00195494|81476514|FG003|Year 1|Protocol deviation|0|||
27902132|NCT00195494|81476515|FG004|Year 1|Protocol deviation|2|||
27902133|NCT00195494|81476516|FG005|Year 1|Protocol deviation|3|||
27902134|NCT00195494|81476511|FG000|Year 1|Physician Decision|0|||
27902135|NCT00195494|81476512|FG001|Year 1|Physician Decision|0|||
27902136|NCT00195494|81476513|FG002|Year 1|Physician Decision|0|||
27902137|NCT00195494|81476514|FG003|Year 1|Physician Decision|0|||
27902138|NCT00195494|81476515|FG004|Year 1|Physician Decision|1|||
27902139|NCT00195494|81476516|FG005|Year 1|Physician Decision|0|||
27902140|NCT00195494|81476511|FG000|Year 1|Withdrawal by Subject|0|||
27902141|NCT00195494|81476512|FG001|Year 1|Withdrawal by Subject|0|||
27902142|NCT00195494|81476513|FG002|Year 1|Withdrawal by Subject|0|||
27902143|NCT00195494|81476514|FG003|Year 1|Withdrawal by Subject|0|||
27902144|NCT00195494|81476515|FG004|Year 1|Withdrawal by Subject|8|||
27902145|NCT00195494|81476516|FG005|Year 1|Withdrawal by Subject|9|||
27902146|NCT00195494|81476511|FG000|Year 1|Protocol Violation|0|||
27902147|NCT00195494|81476512|FG001|Year 1|Protocol Violation|0|||
27902148|NCT00195494|81476513|FG002|Year 1|Protocol Violation|0|||
27902149|NCT00195494|81476514|FG003|Year 1|Protocol Violation|0|||
27902150|NCT00195494|81476515|FG004|Year 1|Protocol Violation|1|||
27902151|NCT00195494|81476516|FG005|Year 1|Protocol Violation|1|||
27902152|NCT00195494|81476511|FG000|Year 2|Adverse Event|3|||
27902153|NCT00195494|81476512|FG001|Year 2|Adverse Event|7|||
27902154|NCT00195494|81476513|FG002|Year 2|Adverse Event|5|||
27902155|NCT00195494|81476514|FG003|Year 2|Adverse Event|9|||
27902156|NCT00195494|81476515|FG004|Year 2|Adverse Event|0|||
27902157|NCT00195494|81476516|FG005|Year 2|Adverse Event|0|||
27902158|NCT00195494|81476511|FG000|Year 2|Lack of Efficacy|0|||
27902159|NCT00195494|81476512|FG001|Year 2|Lack of Efficacy|1|||
27902160|NCT00195494|81476513|FG002|Year 2|Lack of Efficacy|7|||
27902161|NCT00195494|81476514|FG003|Year 2|Lack of Efficacy|7|||
27902162|NCT00195494|81476515|FG004|Year 2|Lack of Efficacy|0|||
27902163|NCT00195494|81476516|FG005|Year 2|Lack of Efficacy|0|||
27902164|NCT00195494|81476511|FG000|Year 2|Compliance|1|||
27902165|NCT00195494|81476512|FG001|Year 2|Compliance|0|||
27902166|NCT00195494|81476513|FG002|Year 2|Compliance|0|||
27902167|NCT00195494|81476514|FG003|Year 2|Compliance|2|||
27902168|NCT00195494|81476515|FG004|Year 2|Compliance|0|||
27902169|NCT00195494|81476516|FG005|Year 2|Compliance|0|||
27902170|NCT00195494|81476511|FG000|Year 2|Lost to Follow-up|0|||
27902171|NCT00195494|81476512|FG001|Year 2|Lost to Follow-up|0|||
27902172|NCT00195494|81476513|FG002|Year 2|Lost to Follow-up|1|||
27902173|NCT00195494|81476514|FG003|Year 2|Lost to Follow-up|1|||
27902174|NCT00195494|81476515|FG004|Year 2|Lost to Follow-up|0|||
27902175|NCT00195494|81476516|FG005|Year 2|Lost to Follow-up|0|||
27902176|NCT00195494|81476511|FG000|Year 2|Missed >4 consecutive doses|1|||
27902177|NCT00195494|81476512|FG001|Year 2|Missed >4 consecutive doses|1|||
27902178|NCT00195494|81476513|FG002|Year 2|Missed >4 consecutive doses|1|||
27902179|NCT00195494|81476514|FG003|Year 2|Missed >4 consecutive doses|0|||
27902180|NCT00195494|81476515|FG004|Year 2|Missed >4 consecutive doses|0|||
27902181|NCT00195494|81476516|FG005|Year 2|Missed >4 consecutive doses|0|||
27902182|NCT00195494|81476511|FG000|Year 2|Protocol deviation|0|||
27902183|NCT00195494|81476512|FG001|Year 2|Protocol deviation|1|||
27902184|NCT00195494|81476513|FG002|Year 2|Protocol deviation|0|||
27902185|NCT00195494|81476514|FG003|Year 2|Protocol deviation|0|||
27902186|NCT00195494|81476515|FG004|Year 2|Protocol deviation|0|||
27902187|NCT00195494|81476516|FG005|Year 2|Protocol deviation|0|||
27902188|NCT00195494|81476511|FG000|Year 2|Physician Decision|1|||
27902189|NCT00195494|81476512|FG001|Year 2|Physician Decision|1|||
27902190|NCT00195494|81476513|FG002|Year 2|Physician Decision|0|||
27902191|NCT00195494|81476514|FG003|Year 2|Physician Decision|0|||
27902192|NCT00195494|81476515|FG004|Year 2|Physician Decision|0|||
27902193|NCT00195494|81476516|FG005|Year 2|Physician Decision|0|||
27902194|NCT00195494|81476511|FG000|Year 2|Withdrawal by Subject|1|||
27902195|NCT00195494|81476512|FG001|Year 2|Withdrawal by Subject|5|||
27902196|NCT00195494|81476513|FG002|Year 2|Withdrawal by Subject|4|||
27902197|NCT00195494|81476514|FG003|Year 2|Withdrawal by Subject|3|||
27902198|NCT00195494|81476515|FG004|Year 2|Withdrawal by Subject|0|||
27902199|NCT00195494|81476516|FG005|Year 2|Withdrawal by Subject|0|||
27902200|NCT00195494|81476511|FG000|Year 2|System toxicity|0|||
27902201|NCT00195494|81476512|FG001|Year 2|System toxicity|0|||
27902202|NCT00195494|81476513|FG002|Year 2|System toxicity|0|||
27902203|NCT00195494|81476514|FG003|Year 2|System toxicity|1|||
27902204|NCT00195494|81476515|FG004|Year 2|System toxicity|0|||
27902205|NCT00195494|81476516|FG005|Year 2|System toxicity|0|||
27902206|NCT02651688|81476517|FG000|Overall Study|Non-compliance|0|||
27902207|NCT02651688|81476518|FG001|Overall Study|Non-compliance|0|||
27902208|NCT02651688|81476519|FG002|Overall Study|Non-compliance|1|||
27902209|NCT02651688|81476517|FG000|Overall Study|Principal Investigator (PI) decision|0|||
27902210|NCT02651688|81476518|FG001|Overall Study|Principal Investigator (PI) decision|2|||
27902211|NCT02651688|81476519|FG002|Overall Study|Principal Investigator (PI) decision|0|||
27902212|NCT02651688|81476517|FG000|Overall Study|Lost to Follow-up|1|||
27902213|NCT02651688|81476518|FG001|Overall Study|Lost to Follow-up|3|||
27902214|NCT02651688|81476519|FG002|Overall Study|Lost to Follow-up|0|||
27902215|NCT02651688|81476517|FG000|Overall Study|Withdrawal by Subject|1|||
27902216|NCT02651688|81476518|FG001|Overall Study|Withdrawal by Subject|0|||
27902217|NCT02651688|81476519|FG002|Overall Study|Withdrawal by Subject|2|||
27902218|NCT04318132|81476520|FG000|Overall Study|Protocol Violation|0|||
27902219|NCT04318132|81476521|FG001|Overall Study|Protocol Violation|0|||
27902220|NCT04318132|81476522|FG002|Overall Study|Protocol Violation|3|||
27902221|NCT04318132|81476523|FG003|Overall Study|Protocol Violation|0|||
27902222|NCT00577005|81476524|FG000|Overall Study|Lost to Follow-up|3|||
27902223|NCT00577005|81476525|FG001|Overall Study|Lost to Follow-up|2|||
27902224|NCT00577005|81476524|FG000|Overall Study|Withdrawal by Subject|2|||
27902225|NCT00577005|81476525|FG001|Overall Study|Withdrawal by Subject|1|||
27902226|NCT01738191|81476526|FG000|Overall Study|Withdrawal by Subject|4|||
27902227|NCT01738191|81476527|FG001|Overall Study|Withdrawal by Subject|1|||
27902228|NCT00435188|81476534|FG000|Overall Study|Death|1|||
27902229|NCT00435188|81476535|FG001|Overall Study|Death|6|||
27902230|NCT00435188|81476534|FG000|Overall Study|Withdrawal by Subject|16|||
27902231|NCT00435188|81476535|FG001|Overall Study|Withdrawal by Subject|11|||
27902232|NCT00435188|81476534|FG000|Overall Study|Lost to Follow-up|5|||
27902233|NCT00435188|81476535|FG001|Overall Study|Lost to Follow-up|6|||
27902234|NCT01260584|81476543|FG000|Period 1|Protocol Violation|0|||
27851587|NCT00974974|81287096|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
27851588|NCT00974974|81287097|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
27851589|NCT00974974|81287096|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
27851590|NCT00974974|81287097|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
27851591|NCT00974974|81287096|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
27851592|NCT00974974|81287097|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
27851593|NCT00974974|81287096|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
27851594|NCT00974974|81287097|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
27851595|NCT00974974|81287096|FG000|IR CD-LD Dose Adjustment|Various|0|||
27851596|NCT00974974|81287097|FG001|IR CD-LD Dose Adjustment|Various|9|||
27851597|NCT00974974|81287096|FG000|IPX066 Dose Conversion|Adverse Event|23|||
27851598|NCT00974974|81287097|FG001|IPX066 Dose Conversion|Adverse Event|0|||
27851599|NCT00974974|81287096|FG000|IPX066 Dose Conversion|Death|2|||
27851600|NCT00974974|81287097|FG001|IPX066 Dose Conversion|Death|0|||
27851601|NCT00974974|81287096|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
27851602|NCT00974974|81287097|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
27851603|NCT00974974|81287096|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
27851604|NCT00974974|81287097|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
27851605|NCT00974974|81287096|FG000|IPX066 Dose Conversion|Various|3|||
27851606|NCT00974974|81287097|FG001|IPX066 Dose Conversion|Various|0|||
27851607|NCT00974974|81287096|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
27851608|NCT00974974|81287097|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
27851609|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
27851610|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
27851611|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
27851612|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
27851613|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
27851614|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
27851615|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
27851616|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
27851617|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
27851618|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
27851619|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
27851620|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
27851621|NCT00974974|81287096|FG000|Maintenance - Double Blind Treatment|Various|4|||
27851622|NCT00974974|81287097|FG001|Maintenance - Double Blind Treatment|Various|0|||
27851623|NCT03197558|81287098|FG000|Overall Study|Tubes not placed|1|||
27902235|NCT01260584|81476544|FG001|Period 1|Protocol Violation|0|||
27902236|NCT01260584|81476545|FG002|Period 1|Protocol Violation|1|||
27506697|NCT02594124|80047927|FG000|Overall Study|Reason Not Specified|1|||
27851624|NCT00003138|81287099|FG000|Step 1|Reasons off treatment not documented|60|||
27851625|NCT00003138|81287100|FG001|Step 1|Reasons off treatment not documented|57|||
27851626|NCT00003138|81287099|FG000|Step 1|Never started treatment|1|||
27851627|NCT00003138|81287100|FG001|Step 1|Never started treatment|0|||
27851628|NCT00003138|81287099|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
27902237|NCT01260584|81476546|FG003|Period 1|Protocol Violation|1|||
27902238|NCT01260584|81476543|FG000|Period 1|Adverse Event|0|||
27902239|NCT01260584|81476544|FG001|Period 1|Adverse Event|0|||
27902240|NCT01260584|81476545|FG002|Period 1|Adverse Event|1|||
27902241|NCT01260584|81476546|FG003|Period 1|Adverse Event|0|||
27902242|NCT01260584|81476543|FG000|Period 2|Protocol Violation|0|||
27902243|NCT01260584|81476544|FG001|Period 2|Protocol Violation|2|||
27902244|NCT01260584|81476545|FG002|Period 2|Protocol Violation|3|||
27902245|NCT01260584|81476546|FG003|Period 2|Protocol Violation|1|||
27902246|NCT01260584|81476543|FG000|Period 2|Adverse Event|1|||
27902247|NCT01260584|81476544|FG001|Period 2|Adverse Event|0|||
27902248|NCT01260584|81476545|FG002|Period 2|Adverse Event|2|||
27902249|NCT01260584|81476546|FG003|Period 2|Adverse Event|0|||
27902250|NCT01260584|81476543|FG000|Period 2|Withdrawal by Subject|0|||
27902251|NCT01260584|81476544|FG001|Period 2|Withdrawal by Subject|1|||
27902252|NCT01260584|81476545|FG002|Period 2|Withdrawal by Subject|0|||
27902253|NCT01260584|81476546|FG003|Period 2|Withdrawal by Subject|0|||
27902254|NCT02509078|81476547|FG000|Overall Study|Protocol Violation|1|||
27902255|NCT02509078|81476548|FG001|Overall Study|Protocol Violation|1|||
27902256|NCT01897571|81476549|FG000|Overall Study|Lost to Follow-up|3|||
27902257|NCT01897571|81476550|FG001|Overall Study|Lost to Follow-up|0|||
27902258|NCT01897571|81476551|FG002|Overall Study|Lost to Follow-up|0|||
27902259|NCT01897571|81476552|FG003|Overall Study|Lost to Follow-up|0|||
27902260|NCT01897571|81476553|FG004|Overall Study|Lost to Follow-up|2|||
27902261|NCT01897571|81476554|FG005|Overall Study|Lost to Follow-up|0|||
27902262|NCT01897571|81476555|FG006|Overall Study|Lost to Follow-up|0|||
27902263|NCT01897571|81476556|FG007|Overall Study|Lost to Follow-up|0|||
27902264|NCT01897571|81476557|FG008|Overall Study|Lost to Follow-up|1|||
27902265|NCT01897571|81476558|FG009|Overall Study|Lost to Follow-up|2|||
27902266|NCT01897571|81476559|FG010|Overall Study|Lost to Follow-up|4|||
27902267|NCT01897571|81476549|FG000|Overall Study|Withdrawal by Subject|0|||
27902268|NCT01897571|81476550|FG001|Overall Study|Withdrawal by Subject|0|||
27902269|NCT01897571|81476551|FG002|Overall Study|Withdrawal by Subject|0|||
27902270|NCT01897571|81476552|FG003|Overall Study|Withdrawal by Subject|0|||
27902271|NCT01897571|81476553|FG004|Overall Study|Withdrawal by Subject|0|||
27902272|NCT01897571|81476554|FG005|Overall Study|Withdrawal by Subject|0|||
27902273|NCT01897571|81476555|FG006|Overall Study|Withdrawal by Subject|0|||
27902274|NCT01897571|81476556|FG007|Overall Study|Withdrawal by Subject|1|||
27902275|NCT01897571|81476557|FG008|Overall Study|Withdrawal by Subject|4|||
27902276|NCT01897571|81476558|FG009|Overall Study|Withdrawal by Subject|3|||
27902277|NCT01897571|81476559|FG010|Overall Study|Withdrawal by Subject|1|||
27902278|NCT01897571|81476549|FG000|Overall Study|Other|1|||
27902279|NCT01897571|81476550|FG001|Overall Study|Other|0|||
27902280|NCT01897571|81476551|FG002|Overall Study|Other|0|||
27902281|NCT01897571|81476552|FG003|Overall Study|Other|3|||
27902282|NCT01897571|81476553|FG004|Overall Study|Other|3|||
27902283|NCT01897571|81476554|FG005|Overall Study|Other|4|||
27902284|NCT01897571|81476555|FG006|Overall Study|Other|7|||
27902285|NCT01897571|81476556|FG007|Overall Study|Other|0|||
27902286|NCT01897571|81476557|FG008|Overall Study|Other|0|||
27902287|NCT01897571|81476558|FG009|Overall Study|Other|0|||
27506698|NCT02594124|80047928|FG001|Overall Study|Reason Not Specified|3|||
27728144|NCT01468311|80833144|FG000|Overall Study|mobilization failure|1|||
27902288|NCT01897571|81476559|FG010|Overall Study|Other|0|||
27506699|NCT02594124|80047929|FG002|Overall Study|Reason Not Specified|4|||
27506700|NCT02594124|80047930|FG003|Overall Study|Reason Not Specified|0|||
27902289|NCT01897571|81476549|FG000|Overall Study|Enrolled in rollover study|0|||
27902290|NCT01897571|81476550|FG001|Overall Study|Enrolled in rollover study|0|||
27902291|NCT01897571|81476551|FG002|Overall Study|Enrolled in rollover study|0|||
27902292|NCT01897571|81476552|FG003|Overall Study|Enrolled in rollover study|0|||
27902293|NCT01897571|81476553|FG004|Overall Study|Enrolled in rollover study|0|||
27902294|NCT01897571|81476554|FG005|Overall Study|Enrolled in rollover study|0|||
27902295|NCT01897571|81476555|FG006|Overall Study|Enrolled in rollover study|0|||
27902296|NCT01897571|81476556|FG007|Overall Study|Enrolled in rollover study|9|||
27902297|NCT01897571|81476557|FG008|Overall Study|Enrolled in rollover study|7|||
27902298|NCT01897571|81476558|FG009|Overall Study|Enrolled in rollover study|9|||
27902299|NCT01897571|81476559|FG010|Overall Study|Enrolled in rollover study|1|||
27902300|NCT01897571|81476549|FG000|Overall Study|Death|2|||
27902301|NCT01897571|81476550|FG001|Overall Study|Death|2|||
27902302|NCT01897571|81476551|FG002|Overall Study|Death|3|||
27902303|NCT01897571|81476552|FG003|Overall Study|Death|6|||
27902304|NCT01897571|81476553|FG004|Overall Study|Death|7|||
27902305|NCT01897571|81476554|FG005|Overall Study|Death|9|||
27902306|NCT01897571|81476555|FG006|Overall Study|Death|5|||
27902307|NCT01897571|81476556|FG007|Overall Study|Death|22|||
27902308|NCT01897571|81476557|FG008|Overall Study|Death|23|||
27902309|NCT01897571|81476558|FG009|Overall Study|Death|129|||
27902310|NCT01897571|81476559|FG010|Overall Study|Death|59|||
27902311|NCT01210352|81481398|FG000|Overall Study|Adverse Event|0|||
27902312|NCT01210352|81481399|FG001|Overall Study|Adverse Event|0|||
27902313|NCT01210352|81481400|FG002|Overall Study|Adverse Event|0|||
27902314|NCT01210352|81481401|FG003|Overall Study|Adverse Event|0|||
27902315|NCT01210352|81481402|FG004|Overall Study|Adverse Event|0|||
27902316|NCT01210352|81481403|FG005|Overall Study|Adverse Event|0|||
27902317|NCT01210352|81481404|FG006|Overall Study|Adverse Event|0|||
27902318|NCT01210352|81481405|FG007|Overall Study|Adverse Event|2|||
27902319|NCT01210352|81481406|FG008|Overall Study|Adverse Event|1|||
27902320|NCT01210352|81481398|FG000|Overall Study|Lack of Efficacy|0|||
27902321|NCT01210352|81481399|FG001|Overall Study|Lack of Efficacy|0|||
27902322|NCT01210352|81481400|FG002|Overall Study|Lack of Efficacy|0|||
27902323|NCT01210352|81481401|FG003|Overall Study|Lack of Efficacy|0|||
27902324|NCT01210352|81481402|FG004|Overall Study|Lack of Efficacy|0|||
27902325|NCT01210352|81481403|FG005|Overall Study|Lack of Efficacy|0|||
27902326|NCT01210352|81481404|FG006|Overall Study|Lack of Efficacy|1|||
27902327|NCT01210352|81481405|FG007|Overall Study|Lack of Efficacy|0|||
27902328|NCT01210352|81481406|FG008|Overall Study|Lack of Efficacy|0|||
27614426|NCT00962585|80430245|FG001|Overall Study|Protocol Violation|0|||
27614427|NCT00962585|80430246|FG002|Overall Study|Protocol Violation|1|||
27614428|NCT00962585|80430247|FG003|Overall Study|Protocol Violation|0|||
27614429|NCT00962585|80430244|FG000|Overall Study|Withdrawal by Subject|1|||
27614430|NCT00962585|80430245|FG001|Overall Study|Withdrawal by Subject|0|||
27614431|NCT00962585|80430246|FG002|Overall Study|Withdrawal by Subject|0|||
27614432|NCT00962585|80430247|FG003|Overall Study|Withdrawal by Subject|0|||
27614433|NCT00962585|80430244|FG000|Overall Study|Withdrew Consent|2|||
27614434|NCT00962585|80430245|FG001|Overall Study|Withdrew Consent|0|||
27614435|NCT00962585|80430246|FG002|Overall Study|Withdrew Consent|0|||
27614436|NCT00962585|80430247|FG003|Overall Study|Withdrew Consent|0|||
27614437|NCT01009047|80430256|FG000|Overall Study|Adverse Event|5|||
27614438|NCT01009047|80430257|FG001|Overall Study|Adverse Event|0|||
27614439|NCT01009047|80430256|FG000|Overall Study|Lost to Follow-up|0|||
27614440|NCT01009047|80430257|FG001|Overall Study|Lost to Follow-up|2|||
27614441|NCT01009047|80430256|FG000|Overall Study|Lack of Efficacy|4|||
27614442|NCT01009047|80430257|FG001|Overall Study|Lack of Efficacy|11|||
27614443|NCT01009047|80430256|FG000|Overall Study|Withdrawal by consent|16|||
27614444|NCT01009047|80430257|FG001|Overall Study|Withdrawal by consent|11|||
27614445|NCT01009047|80430256|FG000|Overall Study|Other|3|||
27614446|NCT01009047|80430257|FG001|Overall Study|Other|2|||
27614447|NCT01816763|80430258|FG000|Overall Study|The main reason for an incomplete survey|4|||
27614448|NCT01816763|80430259|FG001|Overall Study|The main reason for an incomplete survey|15|||
27614449|NCT01816763|80430260|FG002|Overall Study|The main reason for an incomplete survey|11|||
27614450|NCT02269943|80430261|FG000|Treatment Period|Death|0|||
27614451|NCT02269943|80430262|FG001|Treatment Period|Death|1|||
27614452|NCT02269943|80430261|FG000|Treatment Period|Adverse Event|1|||
27614453|NCT02269943|80430262|FG001|Treatment Period|Adverse Event|10|||
27614454|NCT02269943|80430261|FG000|Treatment Period|Progressive Disease|5|||
27614455|NCT02269943|80430262|FG001|Treatment Period|Progressive Disease|17|||
27614456|NCT02269943|80430261|FG000|Treatment Period|Symptomatic Deterioration|0|||
27614457|NCT02269943|80430262|FG001|Treatment Period|Symptomatic Deterioration|2|||
27614458|NCT02269943|80430261|FG000|Follow-Up Survival Period|Death|3|||
27902329|NCT01210352|81481398|FG000|Overall Study|Physician Decision|0|||
27902330|NCT01210352|81481399|FG001|Overall Study|Physician Decision|0|||
27902331|NCT01210352|81481400|FG002|Overall Study|Physician Decision|0|||
27902332|NCT01210352|81481401|FG003|Overall Study|Physician Decision|0|||
27902333|NCT01210352|81481402|FG004|Overall Study|Physician Decision|0|||
27902334|NCT01210352|81481403|FG005|Overall Study|Physician Decision|0|||
27902335|NCT01210352|81481404|FG006|Overall Study|Physician Decision|0|||
27902336|NCT01210352|81481405|FG007|Overall Study|Physician Decision|1|||
27902337|NCT01210352|81481406|FG008|Overall Study|Physician Decision|2|||
27614459|NCT02269943|80430262|FG001|Follow-Up Survival Period|Death|16|||
27614460|NCT02269943|80430261|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
27614461|NCT02269943|80430262|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
27614462|NCT02269943|80430261|FG000|Follow-Up Survival Period|Alive|2|||
27614463|NCT02269943|80430262|FG001|Follow-Up Survival Period|Alive|8|||
27614464|NCT01225822|80430267|FG000|Overall Study|Adverse Event|13|||
27614465|NCT01225822|80430268|FG001|Overall Study|Adverse Event|31|||
27902338|NCT01210352|81481398|FG000|Overall Study|Withdrawal by Subject|0|||
27614466|NCT01225822|80430269|FG002|Overall Study|Adverse Event|18|||
27614467|NCT01225822|80430270|FG003|Overall Study|Adverse Event|23|||
27902339|NCT01210352|81481399|FG001|Overall Study|Withdrawal by Subject|0|||
27902340|NCT01210352|81481400|FG002|Overall Study|Withdrawal by Subject|1|||
27902341|NCT01210352|81481401|FG003|Overall Study|Withdrawal by Subject|0|||
27902342|NCT01210352|81481402|FG004|Overall Study|Withdrawal by Subject|0|||
27902343|NCT01210352|81481403|FG005|Overall Study|Withdrawal by Subject|0|||
27902344|NCT01210352|81481404|FG006|Overall Study|Withdrawal by Subject|1|||
27902345|NCT01210352|81481405|FG007|Overall Study|Withdrawal by Subject|0|||
27902346|NCT01210352|81481406|FG008|Overall Study|Withdrawal by Subject|1|||
27902347|NCT01210352|81481398|FG000|Overall Study|Patient Discharged Early|0|||
27902348|NCT01210352|81481399|FG001|Overall Study|Patient Discharged Early|0|||
27902349|NCT01210352|81481400|FG002|Overall Study|Patient Discharged Early|1|||
27902350|NCT01210352|81481401|FG003|Overall Study|Patient Discharged Early|0|||
27902351|NCT01210352|81481402|FG004|Overall Study|Patient Discharged Early|0|||
27902352|NCT01210352|81481403|FG005|Overall Study|Patient Discharged Early|0|||
27902353|NCT01210352|81481404|FG006|Overall Study|Patient Discharged Early|0|||
27902354|NCT01210352|81481405|FG007|Overall Study|Patient Discharged Early|0|||
27902355|NCT01210352|81481406|FG008|Overall Study|Patient Discharged Early|0|||
27902356|NCT01994902|81481407|FG000|Test Period 1|Withdrawal by Subject|3|||
27902357|NCT01994902|81481408|FG001|Test Period 1|Withdrawal by Subject|0|||
27902358|NCT01994902|81481407|FG000|Test Period 1|device deficiency with adverse event|0|||
27902359|NCT01994902|81481408|FG001|Test Period 1|device deficiency with adverse event|1|||
27902360|NCT01994902|81481407|FG000|Test Period 1|Adverse Event|2|||
27902361|NCT01994902|81481408|FG001|Test Period 1|Adverse Event|1|||
27902362|NCT01994902|81481407|FG000|Test Period 1|Lack of Efficacy|0|||
27902363|NCT01994902|81481408|FG001|Test Period 1|Lack of Efficacy|1|||
27902364|NCT01994902|81481407|FG000|Test Period 1|bag too small|1|||
27902365|NCT01994902|81481408|FG001|Test Period 1|bag too small|0|||
27902366|NCT01994902|81481407|FG000|Test Period 2|Withdrawal by Subject|0|||
27902367|NCT01994902|81481408|FG001|Test Period 2|Withdrawal by Subject|2|||
27902368|NCT01994902|81481407|FG000|Test Period 2|Lack of Efficacy|0|||
27902369|NCT01994902|81481408|FG001|Test Period 2|Lack of Efficacy|1|||
27902370|NCT01994902|81481407|FG000|Test Period 2|Other|0|||
27902371|NCT01994902|81481408|FG001|Test Period 2|Other|3|||
27902372|NCT00966355|81481409|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
27902373|NCT00966355|81481410|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
27902374|NCT00966355|81481411|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
27902375|NCT00966355|81481409|FG000|Overall Study|newly diagnosed advanced HCC|11|||
27902376|NCT00966355|81481410|FG001|Overall Study|newly diagnosed advanced HCC|12|||
27902377|NCT00966355|81481411|FG002|Overall Study|newly diagnosed advanced HCC|10|||
27902378|NCT00966355|81481409|FG000|Overall Study|Lost to Follow-up|5|||
27902379|NCT00966355|81481410|FG001|Overall Study|Lost to Follow-up|4|||
27902380|NCT00966355|81481411|FG002|Overall Study|Lost to Follow-up|3|||
27902381|NCT03326518|81481412|FG000|Overall Study|Protocol Violation|1|||
27902382|NCT03326518|81481413|FG001|Overall Study|Protocol Violation|0|||
27902383|NCT03326518|81481414|FG002|Overall Study|Protocol Violation|0|||
27902384|NCT03326518|81481412|FG000|Overall Study|Withdrawal by Subject|1|||
27902385|NCT03326518|81481413|FG001|Overall Study|Withdrawal by Subject|0|||
27902386|NCT03326518|81481414|FG002|Overall Study|Withdrawal by Subject|0|||
27902387|NCT03326518|81481412|FG000|Overall Study|Lost to Follow-up|1|||
27902388|NCT03326518|81481413|FG001|Overall Study|Lost to Follow-up|0|||
27902389|NCT03326518|81481414|FG002|Overall Study|Lost to Follow-up|1|||
27902390|NCT02907619|81481417|FG000|Overall Study|Study terminated by sponsor|18|||
27902391|NCT02907619|81481418|FG001|Overall Study|Study terminated by sponsor|18|||
27902392|NCT02907619|81481419|FG002|Overall Study|Study terminated by sponsor|19|||
27902393|NCT02907619|81481417|FG000|Overall Study|Death|0|||
27902394|NCT02907619|81481418|FG001|Overall Study|Death|0|||
27902395|NCT02907619|81481419|FG002|Overall Study|Death|1|||
27902396|NCT02907619|81481417|FG000|Overall Study|Withdrawal by Subject|1|||
27902397|NCT02907619|81481418|FG001|Overall Study|Withdrawal by Subject|1|||
27902398|NCT02907619|81481419|FG002|Overall Study|Withdrawal by Subject|0|||
27902399|NCT02907619|81481417|FG000|Overall Study|Other|0|||
27902400|NCT02907619|81481418|FG001|Overall Study|Other|1|||
27902401|NCT02907619|81481419|FG002|Overall Study|Other|0|||
27902402|NCT03796676|81481420|FG000|Overall Study|Adverse Event|2|||
27902403|NCT03796676|81481421|FG001|Overall Study|Adverse Event|1|||
27902404|NCT03796676|81481422|FG002|Overall Study|Adverse Event|2|||
27902405|NCT03796676|81481420|FG000|Overall Study|Lost to Follow-up|2|||
27902406|NCT03796676|81481421|FG001|Overall Study|Lost to Follow-up|1|||
27902407|NCT03796676|81481422|FG002|Overall Study|Lost to Follow-up|0|||
27902408|NCT03796676|81481420|FG000|Overall Study|Protocol Violation|0|||
27902409|NCT03796676|81481421|FG001|Overall Study|Protocol Violation|0|||
27902410|NCT03796676|81481422|FG002|Overall Study|Protocol Violation|1|||
27902411|NCT03796676|81481420|FG000|Overall Study|Withdrawal by Subject|1|||
27902412|NCT03796676|81481421|FG001|Overall Study|Withdrawal by Subject|1|||
27902413|NCT03796676|81481422|FG002|Overall Study|Withdrawal by Subject|0|||
27902414|NCT03796676|81481420|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
27902415|NCT03796676|81481421|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
27902416|NCT03796676|81481422|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
27902417|NCT00791492|81481423|FG000|Overall Study|Withdrawal by Subject|1|||
27902418|NCT00791492|81481424|FG001|Overall Study|Withdrawal by Subject|2|||
27902419|NCT00791492|81481423|FG000|Overall Study|Liver transplantation|5|||
27506701|NCT02594124|80047931|FG004|Overall Study|Reason Not Specified|0|||
27506702|NCT02594124|80047932|FG005|Overall Study|Reason Not Specified|1|||
27506703|NCT02594124|80047933|FG006|Overall Study|Reason Not Specified|1|||
27614468|NCT01225822|80430271|FG004|Overall Study|Adverse Event|14|||
27614469|NCT01225822|80430267|FG000|Overall Study|Protocol Violation|6|||
27614470|NCT01225822|80430268|FG001|Overall Study|Protocol Violation|8|||
27614471|NCT01225822|80430269|FG002|Overall Study|Protocol Violation|6|||
27614472|NCT01225822|80430270|FG003|Overall Study|Protocol Violation|7|||
27614473|NCT01225822|80430271|FG004|Overall Study|Protocol Violation|4|||
27614474|NCT01225822|80430267|FG000|Overall Study|Lost to Follow-up|0|||
27614475|NCT01225822|80430268|FG001|Overall Study|Lost to Follow-up|0|||
27506704|NCT02594124|80047934|FG007|Overall Study|Reason Not Specified|6|||
27506705|NCT02594124|80047935|FG008|Overall Study|Reason Not Specified|1|||
27506706|NCT03399552|80047936|FG000|Overall Study|No evidence of disease|1|||
27614476|NCT01225822|80430269|FG002|Overall Study|Lost to Follow-up|0|||
27614477|NCT01225822|80430270|FG003|Overall Study|Lost to Follow-up|1|||
27614478|NCT01225822|80430271|FG004|Overall Study|Lost to Follow-up|0|||
27851629|NCT00003138|81287100|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
27851630|NCT00003138|81287099|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
27851631|NCT00003138|81287100|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
27851632|NCT00003138|81287099|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
27851633|NCT00003138|81287100|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
27851634|NCT00003138|81287099|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
27851635|NCT00003138|81287100|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
27851636|NCT04132336|81287101|FG000|Overall Study|Investigator Decision|0|||
27902420|NCT00791492|81481424|FG001|Overall Study|Liver transplantation|1|||
27902421|NCT01937715|81481429|FG000|Overall Study|Death|0|||
27902422|NCT01937715|81481430|FG001|Overall Study|Death|0|||
27902423|NCT01937715|81481431|FG002|Overall Study|Death|0|||
27902424|NCT01937715|81481432|FG003|Overall Study|Death|1|||
27902425|NCT01937715|81481433|FG004|Overall Study|Death|0|||
27902426|NCT01937715|81481429|FG000|Overall Study|Withdrawal by Subject|0|||
27902427|NCT01937715|81481430|FG001|Overall Study|Withdrawal by Subject|1|||
27902428|NCT01937715|81481431|FG002|Overall Study|Withdrawal by Subject|0|||
27902429|NCT01937715|81481432|FG003|Overall Study|Withdrawal by Subject|0|||
27902430|NCT01937715|81481433|FG004|Overall Study|Withdrawal by Subject|2|||
27902431|NCT01937715|81481429|FG000|Overall Study|Other|0|||
27902432|NCT01937715|81481430|FG001|Overall Study|Other|0|||
27902433|NCT01937715|81481431|FG002|Overall Study|Other|0|||
27902434|NCT01937715|81481432|FG003|Overall Study|Other|3|||
27902435|NCT01937715|81481433|FG004|Overall Study|Other|0|||
27902436|NCT03749109|81481434|FG000|Overall Study|Adverse Event|2|||
27902437|NCT03749109|81481435|FG001|Overall Study|Adverse Event|0|||
27902438|NCT03084315|81481439|FG000|Overall Study|Lost to Follow-up|8|||
27902439|NCT03084315|81481440|FG001|Overall Study|Lost to Follow-up|7|||
27902440|NCT03084315|81481439|FG000|Overall Study|Withdrawal by Subject|2|||
27902441|NCT03084315|81481440|FG001|Overall Study|Withdrawal by Subject|2|||
27902442|NCT00496587|81481441|FG000|Overall Study|Adverse Event|2|||
27902443|NCT00496587|81481441|FG000|Overall Study|Progressive Disease|24|||
27902444|NCT00496587|81481441|FG000|Overall Study|Withdrawal by Subject|2|||
27902445|NCT00496587|81481441|FG000|Overall Study|Death|1|||
27902446|NCT00496587|81481441|FG000|Overall Study|Complications unrelated|2|||
27902447|NCT02700698|81481444|FG000|Overall Study|Withdrawal by Subject|1|||
27902448|NCT02700698|81481445|FG001|Overall Study|Withdrawal by Subject|0|||
27902449|NCT00534105|81481446|FG000|Overall Study|Lost to Follow-up|23|||
27902450|NCT00534105|81481447|FG001|Overall Study|Lost to Follow-up|39|||
27902451|NCT04521114|81481448|FG000|Overall Study|Lost to Follow-up|1|||
27902452|NCT04521114|81481449|FG001|Overall Study|Lost to Follow-up|2|||
27902453|NCT04521114|81481450|FG002|Overall Study|Lost to Follow-up|0|||
27902454|NCT04521114|81481448|FG000|Overall Study|Withdrawal by Subject|1|||
27902455|NCT04521114|81481449|FG001|Overall Study|Withdrawal by Subject|2|||
27902456|NCT04521114|81481450|FG002|Overall Study|Withdrawal by Subject|2|||
27902457|NCT04521114|81481448|FG000|Overall Study|Adverse Event|1|||
27902458|NCT04521114|81481449|FG001|Overall Study|Adverse Event|0|||
27902459|NCT04521114|81481450|FG002|Overall Study|Adverse Event|0|||
27506707|NCT03399552|80047936|FG000|Overall Study|Unevaluable|1|||
27902460|NCT04521114|81481448|FG000|Overall Study|Sponsor Wish|1|||
27902461|NCT04521114|81481449|FG001|Overall Study|Sponsor Wish|0|||
27902462|NCT04521114|81481450|FG002|Overall Study|Sponsor Wish|0|||
27902463|NCT04521114|81481448|FG000|Overall Study|Withdrawal of Consent|2|||
27902464|NCT04521114|81481449|FG001|Overall Study|Withdrawal of Consent|2|||
27902465|NCT04521114|81481450|FG002|Overall Study|Withdrawal of Consent|0|||
27506708|NCT03877510|80047937|FG000|Overall Study|Death|6|||
27614479|NCT01225822|80430267|FG000|Overall Study|Withdrawal by Subject|6|||
27902466|NCT00715520|81481451|FG000|Overall Study|Screen failure|8|||
27902467|NCT00715520|81481452|FG001|Overall Study|Screen failure|1|||
27902468|NCT00715520|81481453|FG002|Overall Study|Screen failure|1|||
27902469|NCT00715520|81481451|FG000|Overall Study|Withdrawal by Subject|2|||
27902470|NCT00715520|81481452|FG001|Overall Study|Withdrawal by Subject|0|||
27902471|NCT00715520|81481453|FG002|Overall Study|Withdrawal by Subject|1|||
27902472|NCT01030718|81481454|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
27902473|NCT01030718|81481455|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
27902474|NCT01030718|81481456|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
27902475|NCT01030718|81481454|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
27902476|NCT01030718|81481455|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
27902477|NCT01030718|81481456|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
27902478|NCT01030718|81481454|FG000|Studies CA180-031 and -036 Combined|Death|0|||
27902479|NCT01030718|81481455|FG001|Studies CA180-031 and -036 Combined|Death|1|||
27902480|NCT01030718|81481456|FG002|Studies CA180-031 and -036 Combined|Death|0|||
27902481|NCT01030718|81481454|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
27902482|NCT01030718|81481455|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
27902483|NCT01030718|81481456|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
27902484|NCT01030718|81481454|FG000|Study CA180-036 Only|insufficient effect|1|||
27902485|NCT01030718|81481455|FG001|Study CA180-036 Only|insufficient effect|1|||
27902486|NCT01030718|81481456|FG002|Study CA180-036 Only|insufficient effect|5|||
27902487|NCT01030718|81481454|FG000|Study CA180-036 Only|Adverse Event|2|||
27902488|NCT01030718|81481455|FG001|Study CA180-036 Only|Adverse Event|3|||
27902489|NCT01030718|81481456|FG002|Study CA180-036 Only|Adverse Event|0|||
27902490|NCT01030718|81481454|FG000|Study CA180-036 Only|Death|0|||
27902491|NCT01030718|81481455|FG001|Study CA180-036 Only|Death|1|||
27902492|NCT01030718|81481456|FG002|Study CA180-036 Only|Death|0|||
27902493|NCT01030718|81481454|FG000|Study CA180-036 Only|Other Reasons|0|||
27902494|NCT01030718|81481455|FG001|Study CA180-036 Only|Other Reasons|2|||
27902495|NCT01030718|81481456|FG002|Study CA180-036 Only|Other Reasons|0|||
27902496|NCT00594386|81481457|FG000|Overall Study|Major protocol violation|2|||
27902497|NCT00594386|81481457|FG000|Overall Study|Lack of Efficacy|12|||
27902498|NCT00594386|81481457|FG000|Overall Study|Adverse Event|68|||
27902499|NCT00594386|81481457|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
27902500|NCT00594386|81481457|FG000|Overall Study|Subject withdrew consent|35|||
27902501|NCT00594386|81481457|FG000|Overall Study|Study ended per sponsor|115|||
27902502|NCT00594386|81481457|FG000|Overall Study|Lost to Follow-up|6|||
27902503|NCT00594386|81481457|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
27902504|NCT00594386|81481457|FG000|Overall Study|Other: Subject moved to Seattle|1|||
27902505|NCT00594386|81481457|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
27902506|NCT00594386|81481457|FG000|Overall Study|Other: Study terminated per investigator|2|||
27902507|NCT00594386|81481457|FG000|Overall Study|Other: Sponsor closure of study|1|||
27902508|NCT00594386|81481457|FG000|Overall Study|Other: Site terminated participation|1|||
27902509|NCT00594386|81481457|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
27902510|NCT00594386|81481457|FG000|Overall Study|Other: Loss of drivers license|1|||
27902511|NCT03268005|81481458|FG000|Overall Study|Death|2|||
27902512|NCT03268005|81481459|FG001|Overall Study|Death|1|||
27902513|NCT03268005|81481458|FG000|Overall Study|Lost to Follow-up|2|||
27902514|NCT03268005|81481459|FG001|Overall Study|Lost to Follow-up|2|||
27902515|NCT03268005|81481458|FG000|Overall Study|Withdrawal by Subject|11|||
27902516|NCT03268005|81481459|FG001|Overall Study|Withdrawal by Subject|11|||
27902517|NCT02107313|81481460|FG000|Overall Study|One participant did not do the FED cohor|0|||
27902518|NCT02107313|81481461|FG001|Overall Study|One participant did not do the FED cohor|1|||
27902519|NCT03301831|81481463|FG000|Overall Study|Lost to Follow-up|5|||
27902520|NCT03301831|81481464|FG001|Overall Study|Lost to Follow-up|3|||
27902521|NCT03301831|81481463|FG000|Overall Study|Protocol Violation|4|||
27902522|NCT03301831|81481464|FG001|Overall Study|Protocol Violation|0|||
27902523|NCT03301831|81481463|FG000|Overall Study|Withdrawal by Subject|11|||
27902524|NCT03301831|81481464|FG001|Overall Study|Withdrawal by Subject|0|||
27902525|NCT03034200|81481467|FG000|Overall Study|Disease progression|8|||
27902526|NCT03034200|81481468|FG001|Overall Study|Disease progression|10|||
27902527|NCT03034200|81481469|FG002|Overall Study|Disease progression|4|||
27902528|NCT03034200|81481467|FG000|Overall Study|Physician Decision|2|||
27902529|NCT03034200|81481468|FG001|Overall Study|Physician Decision|0|||
27902530|NCT03034200|81481469|FG002|Overall Study|Physician Decision|3|||
27902531|NCT03034200|81481467|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
27902532|NCT03034200|81481468|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
27728145|NCT01468311|80833144|FG000|Overall Study|Withdrawal by Subject|1|||
27902533|NCT03034200|81481469|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
27728146|NCT03033745|80833146|FG000|Overall Study|Protocol Violation|0|||
27902534|NCT03034200|81481467|FG000|Overall Study|Adjuvant Therapy|0|||
27902535|NCT03034200|81481468|FG001|Overall Study|Adjuvant Therapy|0|||
27902536|NCT03034200|81481469|FG002|Overall Study|Adjuvant Therapy|1|||
27728147|NCT03033745|80833147|FG001|Overall Study|Protocol Violation|0|||
27728148|NCT03033745|80833148|FG002|Overall Study|Protocol Violation|1|||
27728149|NCT03033745|80833146|FG000|Overall Study|Adverse Event|1|||
27728150|NCT03033745|80833147|FG001|Overall Study|Adverse Event|0|||
27728151|NCT03033745|80833148|FG002|Overall Study|Adverse Event|1|||
27728152|NCT03033745|80833146|FG000|Overall Study|Withdrawal by Subject|0|||
27728153|NCT03033745|80833147|FG001|Overall Study|Withdrawal by Subject|1|||
27728154|NCT03033745|80833148|FG002|Overall Study|Withdrawal by Subject|0|||
27728155|NCT02211261|80833149|FG000|Overall Study|Withdrawal by Subject|0|||
27728156|NCT02211261|80833150|FG001|Overall Study|Withdrawal by Subject|0|||
27728157|NCT02211261|80833151|FG002|Overall Study|Withdrawal by Subject|1|||
27728158|NCT02211261|80833152|FG003|Overall Study|Withdrawal by Subject|0|||
27728159|NCT02211261|80833153|FG004|Overall Study|Withdrawal by Subject|2|||
27728160|NCT02211261|80833154|FG005|Overall Study|Withdrawal by Subject|0|||
27728161|NCT02211261|80833155|FG006|Overall Study|Withdrawal by Subject|0|||
27728162|NCT02211261|80833156|FG007|Overall Study|Withdrawal by Subject|0|||
27728163|NCT02211261|80833157|FG008|Overall Study|Withdrawal by Subject|0|||
27728164|NCT02211261|80833158|FG009|Overall Study|Withdrawal by Subject|0|||
27728165|NCT02211261|80833159|FG010|Overall Study|Withdrawal by Subject|0|||
27728166|NCT02211261|80833149|FG000|Overall Study|Other|0|||
27728167|NCT02211261|80833150|FG001|Overall Study|Other|0|||
27728168|NCT02211261|80833151|FG002|Overall Study|Other|0|||
27728169|NCT02211261|80833152|FG003|Overall Study|Other|0|||
27728170|NCT02211261|80833153|FG004|Overall Study|Other|0|||
27728171|NCT02211261|80833154|FG005|Overall Study|Other|1|||
27728172|NCT02211261|80833155|FG006|Overall Study|Other|0|||
27728173|NCT02211261|80833156|FG007|Overall Study|Other|0|||
27728174|NCT02211261|80833157|FG008|Overall Study|Other|0|||
27728175|NCT02211261|80833158|FG009|Overall Study|Other|2|||
27728176|NCT02211261|80833159|FG010|Overall Study|Other|0|||
27728177|NCT02211261|80833149|FG000|Overall Study|Lost to Follow-up|0|||
27728178|NCT02211261|80833150|FG001|Overall Study|Lost to Follow-up|0|||
27728179|NCT02211261|80833151|FG002|Overall Study|Lost to Follow-up|0|||
27728180|NCT02211261|80833152|FG003|Overall Study|Lost to Follow-up|0|||
27506709|NCT03877510|80047937|FG000|Overall Study|Lost to Follow-up|2|||
27506710|NCT03877510|80047937|FG000|Overall Study|Non-compliance with study drug|2|||
27506711|NCT03877510|80047937|FG000|Overall Study|Lack of Efficacy|14|||
27506712|NCT03877510|80047937|FG000|Overall Study|Adverse Event|20|||
27506713|NCT03877510|80047937|FG000|Overall Study|Withdrawal by Subject|22|||
27506714|NCT03877510|80047937|FG000|Overall Study|Miscellaneous|1|||
27506715|NCT02066181|80047938|FG000|Overall Study|Withdrawal by Subject|1|||
27506716|NCT02066181|80047939|FG001|Overall Study|Withdrawal by Subject|1|||
27506717|NCT03841604|80047949|FG000|Overall Study|Withdrawal by Subject|3|||
27506718|NCT03841604|80047950|FG001|Overall Study|Withdrawal by Subject|1|||
27506719|NCT03841604|80047949|FG000|Overall Study|Adverse Event|4|||
27506720|NCT03841604|80047950|FG001|Overall Study|Adverse Event|2|||
27506721|NCT03841604|80047949|FG000|Overall Study|Physician Decision|1|||
27506722|NCT03841604|80047950|FG001|Overall Study|Physician Decision|0|||
27506723|NCT00724698|80047951|FG000|Overall Study|Adverse Event|9|||
27614480|NCT01225822|80430268|FG001|Overall Study|Withdrawal by Subject|7|||
27506724|NCT00724698|80047951|FG000|Overall Study|Failure of Therapy|4|||
27506725|NCT00724698|80047951|FG000|Overall Study|Poor Compliance|16|||
27506726|NCT00724698|80047951|FG000|Overall Study|Lost to Follow-up|36|||
27614481|NCT01225822|80430269|FG002|Overall Study|Withdrawal by Subject|7|||
27728181|NCT02211261|80833153|FG004|Overall Study|Lost to Follow-up|0|||
27728182|NCT02211261|80833154|FG005|Overall Study|Lost to Follow-up|0|||
27728183|NCT02211261|80833155|FG006|Overall Study|Lost to Follow-up|0|||
27728184|NCT02211261|80833156|FG007|Overall Study|Lost to Follow-up|1|||
27728185|NCT02211261|80833157|FG008|Overall Study|Lost to Follow-up|0|||
27728186|NCT02211261|80833158|FG009|Overall Study|Lost to Follow-up|0|||
27728187|NCT02211261|80833159|FG010|Overall Study|Lost to Follow-up|0|||
27902537|NCT04710368|81481470|FG000|Overall Study|Withdrawal by Subject|9|||
27902538|NCT04710368|81481470|FG000|Overall Study|Lost to Follow-up|4|||
27902539|NCT04710368|81481470|FG000|Overall Study|Death|2|||
27902540|NCT04710368|81481470|FG000|Overall Study|Patient preference|11|||
27902541|NCT04710368|81481470|FG000|Overall Study|Treatment discontinuation|1|||
27902542|NCT00423813|81481489|FG000|Overall Study|Adverse Event|11|||
27902543|NCT00423813|81481490|FG001|Overall Study|Adverse Event|30|||
27902544|NCT00423813|81481491|FG002|Overall Study|Adverse Event|40|||
27902545|NCT00423813|81481489|FG000|Overall Study|Withdrawal by Subject|6|||
27902546|NCT00423813|81481490|FG001|Overall Study|Withdrawal by Subject|8|||
27902547|NCT00423813|81481491|FG002|Overall Study|Withdrawal by Subject|5|||
27902548|NCT00423813|81481489|FG000|Overall Study|Lost to Follow-up|5|||
27902549|NCT00423813|81481490|FG001|Overall Study|Lost to Follow-up|4|||
27902550|NCT00423813|81481491|FG002|Overall Study|Lost to Follow-up|4|||
27902551|NCT00423813|81481489|FG000|Overall Study|Lack of Efficacy|23|||
27902552|NCT00423813|81481490|FG001|Overall Study|Lack of Efficacy|18|||
27902553|NCT00423813|81481491|FG002|Overall Study|Lack of Efficacy|19|||
27902554|NCT00423813|81481489|FG000|Overall Study|Physician Decision|2|||
27902555|NCT00423813|81481490|FG001|Overall Study|Physician Decision|0|||
27902556|NCT00423813|81481491|FG002|Overall Study|Physician Decision|0|||
27902557|NCT00423813|81481489|FG000|Overall Study|Sponsor Decision|0|||
27902558|NCT00423813|81481490|FG001|Overall Study|Sponsor Decision|1|||
27902559|NCT00423813|81481491|FG002|Overall Study|Sponsor Decision|0|||
27902560|NCT00423813|81481489|FG000|Overall Study|Protocol Violation|9|||
27902561|NCT00423813|81481490|FG001|Overall Study|Protocol Violation|4|||
27902562|NCT00423813|81481491|FG002|Overall Study|Protocol Violation|4|||
27902563|NCT00423813|81481489|FG000|Overall Study|Pregnancy|0|||
27902564|NCT00423813|81481490|FG001|Overall Study|Pregnancy|0|||
27902565|NCT00423813|81481491|FG002|Overall Study|Pregnancy|1|||
27902566|NCT00423813|81481489|FG000|Overall Study|Subject started night shift work|1|||
27902567|NCT00423813|81481490|FG001|Overall Study|Subject started night shift work|0|||
27902568|NCT00423813|81481491|FG002|Overall Study|Subject started night shift work|0|||
27902569|NCT00423813|81481489|FG000|Overall Study|Will start exclusionary medications|0|||
27902570|NCT00423813|81481490|FG001|Overall Study|Will start exclusionary medications|1|||
27902571|NCT00423813|81481491|FG002|Overall Study|Will start exclusionary medications|0|||
27902572|NCT00423813|81481489|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
27902573|NCT00423813|81481490|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
27902574|NCT00423813|81481491|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
27902575|NCT01464619|81481492|FG000|Overall Study|Lost to Follow-up|3|||
27902576|NCT01464619|81481493|FG001|Overall Study|Lost to Follow-up|4|||
27902577|NCT02913105|81481494|FG000|Overall Study|Adverse Event|11|||
27902578|NCT02913105|81481495|FG001|Overall Study|Adverse Event|0|||
27902579|NCT02913105|81481496|FG002|Overall Study|Adverse Event|4|||
27902580|NCT02913105|81481494|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27902581|NCT02913105|81481495|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27902582|NCT02913105|81481496|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27902583|NCT02913105|81481494|FG000|Overall Study|Reason Not Specified|3|||
27902584|NCT02913105|81481495|FG001|Overall Study|Reason Not Specified|1|||
27902585|NCT02913105|81481496|FG002|Overall Study|Reason Not Specified|1|||
27902586|NCT02913105|81481494|FG000|Overall Study|Physician Decision|1|||
27902587|NCT02913105|81481495|FG001|Overall Study|Physician Decision|1|||
27902588|NCT02913105|81481496|FG002|Overall Study|Physician Decision|0|||
27902589|NCT02913105|81481494|FG000|Overall Study|Withdrawal by Subject|0|||
27902590|NCT02913105|81481495|FG001|Overall Study|Withdrawal by Subject|3|||
27902591|NCT02913105|81481496|FG002|Overall Study|Withdrawal by Subject|1|||
27902592|NCT02584959|81481497|FG000|Period 1|Withdrawn from study|3|||
27902593|NCT02584959|81481498|FG001|Period 1|Withdrawn from study|4|||
27902594|NCT02584959|81481499|FG002|Period 1|Withdrawn from study|0|||
27902595|NCT02584959|81481497|FG000|Period 2|Withdrawn from study|6|||
27902596|NCT02584959|81481498|FG001|Period 2|Withdrawn from study|1|||
27902597|NCT02584959|81481499|FG002|Period 2|Withdrawn from study|2|||
27902598|NCT02304380|81481500|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27902599|NCT02304380|81481501|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27902600|NCT02304380|81481502|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27902601|NCT02304380|81481503|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
27902602|NCT02304380|81481504|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27902603|NCT02304380|81481505|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
27902604|NCT00303472|81481508|FG000|Treatment Period|Adverse Event|0|||
27902605|NCT00303472|81481509|FG001|Treatment Period|Adverse Event|0|||
27902606|NCT00303472|81481510|FG002|Treatment Period|Adverse Event|0|||
27902607|NCT00303472|81481511|FG003|Treatment Period|Adverse Event|0|||
27902608|NCT00303472|81481512|FG004|Treatment Period|Adverse Event|1|||
27902609|NCT00303472|81481513|FG005|Treatment Period|Adverse Event|0|||
27902610|NCT00303472|81481514|FG006|Treatment Period|Adverse Event|0|||
27902611|NCT00303472|81481508|FG000|Treatment Period|Death|0|||
27902612|NCT00303472|81481509|FG001|Treatment Period|Death|0|||
27902613|NCT00303472|81481510|FG002|Treatment Period|Death|0|||
27902614|NCT00303472|81481511|FG003|Treatment Period|Death|1|||
27902615|NCT00303472|81481512|FG004|Treatment Period|Death|0|||
27902616|NCT00303472|81481513|FG005|Treatment Period|Death|0|||
27902617|NCT00303472|81481514|FG006|Treatment Period|Death|1|||
27902618|NCT00303472|81481508|FG000|Treatment Period|Withdrawal by Subject|0|||
27902619|NCT00303472|81481509|FG001|Treatment Period|Withdrawal by Subject|0|||
27902620|NCT00303472|81481510|FG002|Treatment Period|Withdrawal by Subject|0|||
27902621|NCT00303472|81481511|FG003|Treatment Period|Withdrawal by Subject|1|||
27902622|NCT00303472|81481512|FG004|Treatment Period|Withdrawal by Subject|0|||
27902623|NCT00303472|81481513|FG005|Treatment Period|Withdrawal by Subject|1|||
27902624|NCT00303472|81481514|FG006|Treatment Period|Withdrawal by Subject|0|||
27902625|NCT00303472|81481508|FG000|Treatment Period|Other|0|||
27902626|NCT00303472|81481509|FG001|Treatment Period|Other|0|||
27902627|NCT00303472|81481510|FG002|Treatment Period|Other|0|||
27902628|NCT00303472|81481511|FG003|Treatment Period|Other|0|||
27902629|NCT00303472|81481512|FG004|Treatment Period|Other|1|||
27902630|NCT00303472|81481513|FG005|Treatment Period|Other|0|||
27902631|NCT00303472|81481514|FG006|Treatment Period|Other|1|||
27902632|NCT00303472|81481508|FG000|Treatment Period|Disease Progression (to AML)|0|||
27902633|NCT00303472|81481509|FG001|Treatment Period|Disease Progression (to AML)|0|||
27902634|NCT00303472|81481510|FG002|Treatment Period|Disease Progression (to AML)|0|||
27902635|NCT00303472|81481511|FG003|Treatment Period|Disease Progression (to AML)|0|||
27902636|NCT00303472|81481512|FG004|Treatment Period|Disease Progression (to AML)|1|||
27902637|NCT00303472|81481513|FG005|Treatment Period|Disease Progression (to AML)|0|||
27902638|NCT00303472|81481514|FG006|Treatment Period|Disease Progression (to AML)|0|||
27902639|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Adverse Event|1|||
27902640|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Adverse Event|0|||
27902641|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Adverse Event|1|||
27902642|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Adverse Event|0|||
27902643|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Adverse Event|0|||
27902644|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Adverse Event|0|||
27902645|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Adverse Event|0|||
27902646|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Death|2|||
27902647|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Death|0|||
27902648|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Death|1|||
27902649|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Death|0|||
27506727|NCT00724698|80047951|FG000|Overall Study|No Info|25|||
27728188|NCT00059202|80833162|FG000|Overall Study|Withdrawal by Subject|5|||
27902650|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Death|0|||
27902651|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Death|0|||
27902652|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Death|0|||
27902653|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
27902654|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
27902655|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
27902656|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
27902657|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
27902658|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
27902659|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
27902660|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Physician Decision|0|||
27902661|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Physician Decision|4|||
27902662|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Physician Decision|2|||
27902663|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Physician Decision|3|||
27902664|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Physician Decision|2|||
27902665|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Physician Decision|0|||
27902666|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Physician Decision|0|||
27902667|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
27902668|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
27902669|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
27902670|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
27902671|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
27902672|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
27728189|NCT00059202|80833163|FG001|Overall Study|Withdrawal by Subject|9|||
27902673|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
27902674|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Other|0|||
27902675|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Other|2|||
27902676|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Other|4|||
27506728|NCT03367793|80047954|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
27506729|NCT03367793|80047955|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
27902677|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Other|2|||
27902678|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Other|1|||
27902679|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Other|0|||
27902680|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Other|0|||
27728190|NCT00059202|80833162|FG000|Overall Study|Protocol Violation|1|||
27902681|NCT00303472|81481508|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
27902682|NCT00303472|81481509|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
27902683|NCT00303472|81481510|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
27902684|NCT00303472|81481511|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
27902685|NCT00303472|81481512|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
27902686|NCT00303472|81481513|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
27902687|NCT00303472|81481514|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
27902688|NCT02131636|81481515|FG000|Overall Study|Personal Reasons|4|||
27902689|NCT02131636|81481516|FG001|Overall Study|Personal Reasons|4|||
27902690|NCT02131636|81481515|FG000|Overall Study|Lost to Follow-up|4|||
27902691|NCT02131636|81481516|FG001|Overall Study|Lost to Follow-up|0|||
27902692|NCT02131636|81481515|FG000|Overall Study|Adverse Event|4|||
27902693|NCT02131636|81481516|FG001|Overall Study|Adverse Event|1|||
27902694|NCT03209518|81481519|FG000|Overall Study|Case Report Forms Uncollected|1|||
27902695|NCT03209518|81481519|FG000|Overall Study|Protocol Deviation|1|||
27902696|NCT02007278|81481520|FG000|Overall Study|Failure to comply with an eligibility|0|||
27902697|NCT02007278|81481521|FG001|Overall Study|Failure to comply with an eligibility|1|||
27902698|NCT02007278|81481520|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
27902699|NCT02007278|81481521|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
27902700|NCT02007278|81481520|FG000|Overall Study|Incorrect medication administration|1|||
27902701|NCT02007278|81481521|FG001|Overall Study|Incorrect medication administration|0|||
27902702|NCT02007278|81481520|FG000|Overall Study|Mis-randomization|1|||
27902703|NCT02007278|81481521|FG001|Overall Study|Mis-randomization|1|||
27902704|NCT00422422|81481524|FG000|Overall Study|Lack of Efficacy|1|||
27902705|NCT00422422|81481524|FG000|Overall Study|Protocol Violation|1|||
27902706|NCT00422422|81481524|FG000|Overall Study|Withdrawal by Subject|2|||
27902707|NCT00422422|81481524|FG000|Overall Study|SAE, non-fatal|1|||
27902708|NCT00422422|81481524|FG000|Overall Study|AE, non-serious non-fatal|5|||
27902709|NCT03275389|81481525|FG000|Overall Study|Lost to Follow-up|10|||
27902710|NCT03275389|81481526|FG001|Overall Study|Lost to Follow-up|10|||
27902711|NCT03275389|81481527|FG002|Overall Study|Lost to Follow-up|19|||
27902712|NCT03275389|81481528|FG003|Overall Study|Lost to Follow-up|12|||
27902713|NCT03275389|81481529|FG004|Overall Study|Lost to Follow-up|11|||
27902714|NCT03275389|81481530|FG005|Overall Study|Lost to Follow-up|12|||
27902715|NCT03275389|81481531|FG006|Overall Study|Lost to Follow-up|21|||
27902716|NCT03275389|81481532|FG007|Overall Study|Lost to Follow-up|15|||
27902717|NCT03275389|81481533|FG008|Overall Study|Lost to Follow-up|12|||
27902718|NCT03275389|81481534|FG009|Overall Study|Lost to Follow-up|14|||
27902719|NCT03275389|81481525|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902720|NCT03275389|81481526|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902721|NCT03275389|81481527|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902722|NCT03275389|81481528|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902723|NCT03275389|81481529|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902724|NCT03275389|81481530|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
27902725|NCT03275389|81481531|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902726|NCT03275389|81481532|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902727|NCT03275389|81481533|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
27902728|NCT03275389|81481534|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
27902729|NCT03275389|81481525|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
27902730|NCT03275389|81481526|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27902731|NCT03275389|81481527|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
27902732|NCT03275389|81481528|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
27902733|NCT03275389|81481529|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
27902734|NCT03275389|81481530|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
27902735|NCT03275389|81481531|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
27902736|NCT03275389|81481532|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
27902737|NCT03275389|81481533|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
27902738|NCT03275389|81481534|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
27614482|NCT01225822|80430270|FG003|Overall Study|Withdrawal by Subject|11|||
27614483|NCT01225822|80430271|FG004|Overall Study|Withdrawal by Subject|6|||
27902739|NCT03275389|81481525|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902740|NCT03275389|81481526|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
27902741|NCT03275389|81481527|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902742|NCT03275389|81481528|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
27902743|NCT03275389|81481529|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902744|NCT03275389|81481530|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902745|NCT03275389|81481531|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27728191|NCT00059202|80833163|FG001|Overall Study|Protocol Violation|3|||
27728192|NCT00059202|80833162|FG000|Overall Study|drug toxicity|0|||
27728193|NCT00059202|80833163|FG001|Overall Study|drug toxicity|3|||
27728194|NCT01940484|80833165|FG000|Overall Study|Withdrawal by Subject|3|||
27728195|NCT01940484|80833165|FG000|Overall Study|Underwent transplantation|4|||
27728196|NCT01940484|80833165|FG000|Overall Study|Death|2|||
27728197|NCT01940484|80833165|FG000|Overall Study|Adverse Event|1|||
27728198|NCT00700804|80833166|FG000|Overall Study|Withdrawal by Subject|1|||
27728199|NCT00700804|80833167|FG001|Overall Study|Withdrawal by Subject|2|||
27728200|NCT00700804|80833166|FG000|Overall Study|Protocol Violation|1|||
27728201|NCT00700804|80833167|FG001|Overall Study|Protocol Violation|1|||
27728202|NCT00700804|80833166|FG000|Overall Study|Loose Stools|1|||
27728203|NCT00700804|80833167|FG001|Overall Study|Loose Stools|1|||
27728204|NCT00988247|80833168|FG000|Overall Study|Adverse Event|17|||
27728205|NCT00988247|80833169|FG001|Overall Study|Adverse Event|3|||
27728206|NCT00988247|80833168|FG000|Overall Study|Withdrawal by Subject|44|||
27728207|NCT00988247|80833169|FG001|Overall Study|Withdrawal by Subject|13|||
27728208|NCT00988247|80833168|FG000|Overall Study|Pregnancy|1|||
27728209|NCT00988247|80833169|FG001|Overall Study|Pregnancy|2|||
27728210|NCT00988247|80833168|FG000|Overall Study|Lost to Follow-up|11|||
27728211|NCT00988247|80833169|FG001|Overall Study|Lost to Follow-up|2|||
27728212|NCT00988247|80833168|FG000|Overall Study|Protocol Violation|4|||
27728213|NCT00988247|80833169|FG001|Overall Study|Protocol Violation|5|||
27728214|NCT00988247|80833168|FG000|Overall Study|Sponsor requested withdrawal|3|||
27728215|NCT00988247|80833169|FG001|Overall Study|Sponsor requested withdrawal|1|||
27728216|NCT00988247|80833168|FG000|Overall Study|Other|3|||
27728217|NCT00988247|80833169|FG001|Overall Study|Other|0|||
27728218|NCT01731002|80833170|FG000|Overall Study|Adverse Event|0|||
27728219|NCT01731002|80833171|FG001|Overall Study|Adverse Event|2|||
27728220|NCT01731002|80833172|FG002|Overall Study|Adverse Event|2|||
27728221|NCT01731002|80833170|FG000|Overall Study|Non-Compliant|0|||
27728222|NCT01731002|80833171|FG001|Overall Study|Non-Compliant|1|||
27728223|NCT01731002|80833172|FG002|Overall Study|Non-Compliant|0|||
27728224|NCT01731002|80833170|FG000|Overall Study|Lost to Follow-up|1|||
27728225|NCT01731002|80833171|FG001|Overall Study|Lost to Follow-up|0|||
27728226|NCT01731002|80833172|FG002|Overall Study|Lost to Follow-up|0|||
27728227|NCT01731002|80833170|FG000|Overall Study|Test Agent Discontinuation|0|||
27728228|NCT01731002|80833171|FG001|Overall Study|Test Agent Discontinuation|1|||
27728229|NCT01731002|80833172|FG002|Overall Study|Test Agent Discontinuation|0|||
27728230|NCT01731002|80833170|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
27728231|NCT01731002|80833171|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
27728232|NCT01731002|80833172|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
27728233|NCT01731002|80833170|FG000|Overall Study|Elevated IOP|1|||
27728234|NCT01731002|80833171|FG001|Overall Study|Elevated IOP|0|||
27728235|NCT01731002|80833172|FG002|Overall Study|Elevated IOP|0|||
27728236|NCT01731002|80833170|FG000|Overall Study|Inappropriate use of study medications|0|||
27728237|NCT01731002|80833171|FG001|Overall Study|Inappropriate use of study medications|0|||
27728238|NCT01731002|80833172|FG002|Overall Study|Inappropriate use of study medications|1|||
27728239|NCT00441792|80833181|FG000|Overall Study|Lost to Follow-up|0|||
27506730|NCT03367793|80047956|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
27506731|NCT03367793|80047957|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
27506732|NCT03367793|80047958|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
27506733|NCT03367793|80047959|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
27506734|NCT00728689|80047960|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
27506735|NCT00728689|80047961|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
27728240|NCT00441792|80833182|FG001|Overall Study|Lost to Follow-up|2|||
27728241|NCT02090855|80833185|FG000|Overall Study|no evaluable Standard of Truth results|2|||
27728242|NCT02613208|80833186|FG000|Overall Study|Withdrawal by Subject|1|||
27728243|NCT02613208|80833186|FG000|Overall Study|Change of address|2|||
27728244|NCT02613208|80833186|FG000|Overall Study|Physician Decision|2|||
27728245|NCT02613208|80833186|FG000|Overall Study|Lost to Follow-up|5|||
27506736|NCT03771664|80047962|FG000|Overall Study|Adverse Event|1|||
27506737|NCT03771664|80047963|FG001|Overall Study|Adverse Event|0|||
27728246|NCT02613208|80833186|FG000|Overall Study|Death|37|||
27728247|NCT02908516|80833193|FG000|Overall Study|Study Terminated|3|||
27728248|NCT02908516|80833194|FG001|Overall Study|Study Terminated|3|||
27728249|NCT02949128|80833197|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
27728250|NCT02949128|80833197|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
27728251|NCT02949128|80833197|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
27728252|NCT02949128|80833197|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
27728253|NCT02949128|80833197|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
27728254|NCT02949128|80833197|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
27728255|NCT02949128|80833197|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
27728256|NCT02949128|80833197|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
27728257|NCT02949128|80833197|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
27902746|NCT03275389|81481532|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902747|NCT03275389|81481533|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902748|NCT03275389|81481534|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27902749|NCT03275389|81481525|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902750|NCT03275389|81481526|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902751|NCT03275389|81481527|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
27902752|NCT03275389|81481528|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902753|NCT03275389|81481529|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902754|NCT03275389|81481530|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902755|NCT03275389|81481531|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902756|NCT03275389|81481532|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902757|NCT03275389|81481533|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27902758|NCT03275389|81481534|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
27902759|NCT03275389|81481525|FG000|Overall Study|Other|0|||
27902760|NCT03275389|81481526|FG001|Overall Study|Other|4|||
27902761|NCT03275389|81481527|FG002|Overall Study|Other|3|||
27902762|NCT03275389|81481528|FG003|Overall Study|Other|2|||
27902763|NCT03275389|81481529|FG004|Overall Study|Other|2|||
27902764|NCT03275389|81481530|FG005|Overall Study|Other|2|||
27902765|NCT03275389|81481531|FG006|Overall Study|Other|0|||
27902766|NCT03275389|81481532|FG007|Overall Study|Other|0|||
27902767|NCT03275389|81481533|FG008|Overall Study|Other|1|||
27902768|NCT03275389|81481534|FG009|Overall Study|Other|0|||
27902769|NCT01690299|81481535|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
27902770|NCT01690299|81481536|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
27902771|NCT01690299|81481537|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
27902772|NCT01690299|81481538|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
27902773|NCT01690299|81481539|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
27902774|NCT01690299|81481540|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
27902775|NCT01690299|81481535|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
27902776|NCT01690299|81481536|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27902777|NCT01690299|81481537|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27902778|NCT01690299|81481538|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27902779|NCT01690299|81481539|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27902780|NCT01690299|81481540|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27902781|NCT01690299|81481535|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
27902782|NCT01690299|81481536|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
27902783|NCT01690299|81481537|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27902784|NCT01690299|81481538|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27902785|NCT01690299|81481539|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27902786|NCT01690299|81481540|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27902787|NCT01690299|81481535|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
27902788|NCT01690299|81481536|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
27902789|NCT01690299|81481537|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
27902790|NCT01690299|81481538|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
27902791|NCT01690299|81481539|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
27902792|NCT01690299|81481540|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
27902793|NCT01690299|81481535|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
27902794|NCT01690299|81481536|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
27902795|NCT01690299|81481537|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
27902796|NCT01690299|81481538|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
27902797|NCT01690299|81481539|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
27902798|NCT01690299|81481540|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
27902799|NCT01690299|81481535|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
27902800|NCT01690299|81481536|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
27902801|NCT01690299|81481537|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
27902802|NCT01690299|81481538|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
27902803|NCT01690299|81481539|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
27902804|NCT01690299|81481540|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
27902805|NCT01690299|81481535|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27902806|NCT01690299|81481536|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27902807|NCT01690299|81481537|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27902808|NCT01690299|81481538|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
27902809|NCT01690299|81481539|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
27902810|NCT01690299|81481540|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
27902811|NCT01690299|81481535|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
27902812|NCT01690299|81481536|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
27902813|NCT01690299|81481537|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
27902814|NCT01690299|81481538|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
27902815|NCT01690299|81481539|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
27902816|NCT01690299|81481540|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
27902817|NCT01690299|81481535|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
27902818|NCT01690299|81481536|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
27902819|NCT01690299|81481537|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
27902820|NCT01690299|81481538|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
27902821|NCT01690299|81481539|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
27902822|NCT01690299|81481540|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
27902823|NCT01690299|81481535|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27902824|NCT01690299|81481536|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27902825|NCT01690299|81481537|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27902826|NCT01690299|81481538|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27902827|NCT01690299|81481539|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
27902828|NCT01690299|81481540|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
27902829|NCT02452554|81481541|FG000|Overall Study|Death|2|||
27902830|NCT02452554|81481542|FG001|Overall Study|Death|1|||
27902831|NCT02452554|81481543|FG002|Overall Study|Death|0|||
27902832|NCT02452554|81481544|FG003|Overall Study|Death|0|||
27902833|NCT02452554|81481545|FG004|Overall Study|Death|0|||
27902834|NCT02452554|81481546|FG005|Overall Study|Death|0|||
27902835|NCT02452554|81481541|FG000|Overall Study|Lack of Efficacy|13|||
27902836|NCT02452554|81481542|FG001|Overall Study|Lack of Efficacy|14|||
27902837|NCT02452554|81481543|FG002|Overall Study|Lack of Efficacy|9|||
27902838|NCT02452554|81481544|FG003|Overall Study|Lack of Efficacy|1|||
27902839|NCT02452554|81481545|FG004|Overall Study|Lack of Efficacy|5|||
27902840|NCT02452554|81481546|FG005|Overall Study|Lack of Efficacy|8|||
27902841|NCT02452554|81481541|FG000|Overall Study|Physician Decision|0|||
27902842|NCT02452554|81481542|FG001|Overall Study|Physician Decision|1|||
27902843|NCT02452554|81481543|FG002|Overall Study|Physician Decision|0|||
27902844|NCT02452554|81481544|FG003|Overall Study|Physician Decision|0|||
27902845|NCT02452554|81481545|FG004|Overall Study|Physician Decision|0|||
27902846|NCT02452554|81481546|FG005|Overall Study|Physician Decision|0|||
27902847|NCT02452554|81481541|FG000|Overall Study|Withdrawal by Subject|1|||
27902848|NCT02452554|81481542|FG001|Overall Study|Withdrawal by Subject|0|||
27902849|NCT02452554|81481543|FG002|Overall Study|Withdrawal by Subject|2|||
27902850|NCT02452554|81481544|FG003|Overall Study|Withdrawal by Subject|0|||
27902851|NCT02452554|81481545|FG004|Overall Study|Withdrawal by Subject|0|||
27902852|NCT02452554|81481546|FG005|Overall Study|Withdrawal by Subject|1|||
27902853|NCT02452554|81481541|FG000|Overall Study|Ineligible|0|||
27902854|NCT02452554|81481542|FG001|Overall Study|Ineligible|1|||
27902855|NCT02452554|81481543|FG002|Overall Study|Ineligible|0|||
27902856|NCT02452554|81481544|FG003|Overall Study|Ineligible|0|||
27902857|NCT02452554|81481545|FG004|Overall Study|Ineligible|0|||
27902858|NCT02452554|81481546|FG005|Overall Study|Ineligible|0|||
27902859|NCT02452554|81481541|FG000|Overall Study|Never Received Treatment|1|||
27902860|NCT02452554|81481542|FG001|Overall Study|Never Received Treatment|0|||
27902861|NCT02452554|81481543|FG002|Overall Study|Never Received Treatment|0|||
27902862|NCT02452554|81481544|FG003|Overall Study|Never Received Treatment|0|||
27902863|NCT02452554|81481545|FG004|Overall Study|Never Received Treatment|0|||
27902864|NCT02452554|81481546|FG005|Overall Study|Never Received Treatment|0|||
27902865|NCT01038752|81481554|FG000|Overall Study|Tumor Progression|2|||
27902866|NCT01038752|81481555|FG001|Overall Study|Tumor Progression|2|||
27902867|NCT01038752|81481554|FG000|Overall Study|Lost to Follow-up|3|||
27902868|NCT01038752|81481555|FG001|Overall Study|Lost to Follow-up|3|||
27902869|NCT02109445|81481557|FG000|Overall Study|Symptomatic deterioration|2|||
27902870|NCT02109445|81481557|FG000|Overall Study|Adverse Event|1|||
27902871|NCT02187861|81481558|FG000|Overall Study|Adverse Event|2|||
27902872|NCT02187861|81481559|FG001|Overall Study|Adverse Event|1|||
27902873|NCT02187861|81481560|FG002|Overall Study|Adverse Event|2|||
27902874|NCT02187861|81481561|FG003|Overall Study|Adverse Event|1|||
27902875|NCT02187861|81481558|FG000|Overall Study|Death|0|||
27902876|NCT02187861|81481559|FG001|Overall Study|Death|3|||
27902877|NCT02187861|81481560|FG002|Overall Study|Death|1|||
27902878|NCT02187861|81481561|FG003|Overall Study|Death|2|||
27902879|NCT02187861|81481558|FG000|Overall Study|Physician Decision|0|||
27902880|NCT02187861|81481559|FG001|Overall Study|Physician Decision|1|||
27902881|NCT02187861|81481560|FG002|Overall Study|Physician Decision|0|||
27902882|NCT02187861|81481561|FG003|Overall Study|Physician Decision|3|||
27506738|NCT03771664|80047962|FG000|Overall Study|Lost to Follow-up|1|||
27506739|NCT03771664|80047963|FG001|Overall Study|Lost to Follow-up|0|||
27614484|NCT01225822|80430267|FG000|Overall Study|Other|13|||
27614485|NCT01225822|80430268|FG001|Overall Study|Other|10|||
27614486|NCT01225822|80430269|FG002|Overall Study|Other|7|||
27614487|NCT01225822|80430270|FG003|Overall Study|Other|10|||
27614488|NCT01225822|80430271|FG004|Overall Study|Other|7|||
27851637|NCT04132336|81287102|FG001|Overall Study|Investigator Decision|1|||
27851638|NCT04132336|81287103|FG002|Overall Study|Investigator Decision|0|||
27506740|NCT03771664|80047962|FG000|Overall Study|Withdrawal by Participant|1|||
27506741|NCT03771664|80047963|FG001|Overall Study|Withdrawal by Participant|4|||
27506742|NCT03771664|80047962|FG000|Overall Study|Randomized but not Treated|0|||
27506743|NCT03771664|80047963|FG001|Overall Study|Randomized but not Treated|1|||
27506744|NCT02651675|80047964|FG000|Overall Study|Death|0|||
27506745|NCT02651675|80047965|FG001|Overall Study|Death|0|||
27506746|NCT02651675|80047966|FG002|Overall Study|Death|1|||
27506747|NCT00949702|80047969|FG000|Overall Study|Death|40|||
27506748|NCT00949702|80047969|FG000|Overall Study|Disease progression|7|||
27506749|NCT00949702|80047969|FG000|Overall Study|Withdrawal of consent|1|||
27506750|NCT03525678|80047970|FG000|Overall Study|Withdrawal by Subject|8|||
27506751|NCT03525678|80047971|FG001|Overall Study|Withdrawal by Subject|2|||
27506752|NCT03525678|80047972|FG002|Overall Study|Withdrawal by Subject|2|||
27506753|NCT03525678|80047970|FG000|Overall Study|Physician Decision|2|||
27506754|NCT03525678|80047971|FG001|Overall Study|Physician Decision|4|||
27506755|NCT03525678|80047972|FG002|Overall Study|Physician Decision|0|||
27506756|NCT03525678|80047970|FG000|Overall Study|Lost to Follow-up|2|||
27506757|NCT03525678|80047971|FG001|Overall Study|Lost to Follow-up|1|||
27506758|NCT03525678|80047972|FG002|Overall Study|Lost to Follow-up|2|||
27506759|NCT03525678|80047970|FG000|Overall Study|Death|70|||
27506760|NCT03525678|80047971|FG001|Overall Study|Death|80|||
27506761|NCT03525678|80047972|FG002|Overall Study|Death|16|||
27506762|NCT03525678|80047970|FG000|Overall Study|other reasons|14|||
27506763|NCT03525678|80047971|FG001|Overall Study|other reasons|10|||
27506764|NCT03525678|80047972|FG002|Overall Study|other reasons|5|||
27506765|NCT03525678|80047970|FG000|Overall Study|ongoing at the time of analysis|1|||
27506766|NCT03525678|80047971|FG001|Overall Study|ongoing at the time of analysis|2|||
27506767|NCT03525678|80047972|FG002|Overall Study|ongoing at the time of analysis|0|||
27506768|NCT01457703|80047973|FG000|Overall Study|Screen Failure|5|||
27506769|NCT01457703|80047974|FG001|Overall Study|Screen Failure|7|||
27506770|NCT01457703|80047973|FG000|Overall Study|Withdrawal by Subject|1|||
27506771|NCT01457703|80047974|FG001|Overall Study|Withdrawal by Subject|4|||
27506772|NCT00539591|80047975|FG000|Overall Study|Toxicity|3|||
27506773|NCT00539591|80047976|FG001|Overall Study|Toxicity|0|||
27506774|NCT00539591|80047977|FG002|Overall Study|Toxicity|0|||
27506775|NCT00539591|80047975|FG000|Overall Study|Disease progression|2|||
27506776|NCT00539591|80047976|FG001|Overall Study|Disease progression|2|||
27506777|NCT00539591|80047977|FG002|Overall Study|Disease progression|3|||
27506778|NCT02939287|80047983|FG000|Overall Study|met exclusion criteria|1|||
27506779|NCT02939287|80047984|FG001|Overall Study|met exclusion criteria|1|||
27506780|NCT02939287|80047985|FG002|Overall Study|met exclusion criteria|1|||
27506781|NCT02939287|80047983|FG000|Overall Study|Did not complete survey|2|||
27506782|NCT02939287|80047984|FG001|Overall Study|Did not complete survey|2|||
27506783|NCT02939287|80047985|FG002|Overall Study|Did not complete survey|0|||
27614489|NCT00975221|80430272|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
27506784|NCT02939287|80047983|FG000|Overall Study|Withdrawal by Subject|1|||
27506785|NCT02939287|80047984|FG001|Overall Study|Withdrawal by Subject|1|||
27614490|NCT00975221|80430273|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
27614491|NCT00975221|80430272|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
27506786|NCT02939287|80047985|FG002|Overall Study|Withdrawal by Subject|0|||
27506787|NCT00391586|80047987|FG000|Overall Study|Progressive disease|13|||
27506788|NCT00391586|80047987|FG000|Overall Study|Adverse Event|5|||
27506789|NCT00391586|80047987|FG000|Overall Study|Physician Decision|2|||
27851639|NCT04132336|81287104|FG003|Overall Study|Investigator Decision|0|||
27614492|NCT00975221|80430273|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
27614493|NCT00975221|80430272|FG000|Titration Phase (Weeks 1-12)|Other|0|||
27614494|NCT00975221|80430273|FG001|Titration Phase (Weeks 1-12)|Other|1|||
27614495|NCT00975221|80430272|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
27614496|NCT00975221|80430273|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
27614497|NCT00975221|80430272|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
27614498|NCT00975221|80430273|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
27614499|NCT00975221|80430272|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
27614500|NCT00975221|80430273|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
27614501|NCT03864926|80430276|FG000|Overall Study|Death|0|||
27851640|NCT04132336|81287105|FG004|Overall Study|Investigator Decision|0|||
27851641|NCT04132336|81287106|FG005|Overall Study|Investigator Decision|0|||
27851642|NCT04132336|81287107|FG006|Overall Study|Investigator Decision|0|||
27851643|NCT00652028|81287112|FG000|Overall Study|Adverse Event|1|||
27614502|NCT03864926|80430277|FG001|Overall Study|Death|2|||
27614503|NCT02372058|80430278|FG000|Overall Study|Withdrawal by Subject|3|||
27851644|NCT00652028|81287113|FG001|Overall Study|Adverse Event|0|||
27728258|NCT02949128|80833197|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
27728259|NCT00454207|80833201|FG000|Overall Study|Adverse Event|3|||
27728260|NCT00454207|80833202|FG001|Overall Study|Adverse Event|1|||
27728261|NCT00454207|80833201|FG000|Overall Study|Lack of Efficacy|1|||
27728262|NCT00454207|80833202|FG001|Overall Study|Lack of Efficacy|0|||
27728263|NCT00454207|80833201|FG000|Overall Study|Protocol Violation|0|||
27851645|NCT00652028|81287114|FG002|Overall Study|Adverse Event|0|||
27851646|NCT00652028|81287115|FG003|Overall Study|Adverse Event|0|||
27506790|NCT00391586|80047987|FG000|Overall Study|Death|4|||
27506791|NCT02761330|80047990|FG000|Treatment Week 1|Withdrawal by Subject|0|||
27506792|NCT02761330|80047991|FG001|Treatment Week 1|Withdrawal by Subject|0|||
27506793|NCT02761330|80047992|FG002|Treatment Week 1|Withdrawal by Subject|0|||
27506794|NCT02761330|80047993|FG003|Treatment Week 1|Withdrawal by Subject|1|||
27506795|NCT02761330|80047994|FG004|Treatment Week 1|Withdrawal by Subject|0|||
27506796|NCT02761330|80047995|FG005|Treatment Week 1|Withdrawal by Subject|1|||
27506797|NCT01074502|80047996|FG000|Overall Study|Withdrawal by Subject|1|||
27506798|NCT00914316|80047998|FG000|Phase 1|Physician Decision|4|||
27506799|NCT00914316|80047999|FG001|Phase 1|Physician Decision|0|||
27506800|NCT00914316|80048000|FG002|Phase 1|Physician Decision|1|||
27506801|NCT00914316|80048001|FG003|Phase 1|Physician Decision|2|||
27506802|NCT00914316|80047998|FG000|Phase 1|Withdrawal by Subject|0|||
27506803|NCT00914316|80047999|FG001|Phase 1|Withdrawal by Subject|2|||
27506804|NCT00914316|80048000|FG002|Phase 1|Withdrawal by Subject|4|||
27506805|NCT00914316|80048001|FG003|Phase 1|Withdrawal by Subject|0|||
27506806|NCT00914316|80047998|FG000|Phase 1|Adverse Event|1|||
27506807|NCT00914316|80047999|FG001|Phase 1|Adverse Event|0|||
27506808|NCT00914316|80048000|FG002|Phase 1|Adverse Event|0|||
27506809|NCT00914316|80048001|FG003|Phase 1|Adverse Event|0|||
27506810|NCT00914316|80047998|FG000|Phase 2|Withdrawal by Subject|1|||
27506811|NCT00914316|80047999|FG001|Phase 2|Withdrawal by Subject|0|||
27506812|NCT00914316|80048000|FG002|Phase 2|Withdrawal by Subject|1|||
27506813|NCT00914316|80048001|FG003|Phase 2|Withdrawal by Subject|0|||
27506814|NCT02144610|80048002|FG000|Overall Study|Physician Decision|1|||
27506815|NCT02144610|80048003|FG001|Overall Study|Physician Decision|0|||
27506816|NCT02144610|80048002|FG000|Overall Study|Withdrawal by Subject|1|||
27506817|NCT02144610|80048003|FG001|Overall Study|Withdrawal by Subject|5|||
27506818|NCT02144610|80048002|FG000|Overall Study|Death|2|||
27506819|NCT02144610|80048003|FG001|Overall Study|Death|2|||
27506820|NCT02144610|80048002|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
27506821|NCT02144610|80048003|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
27506822|NCT02144610|80048002|FG000|Overall Study|Other|0|||
27506823|NCT02144610|80048003|FG001|Overall Study|Other|1|||
27506824|NCT01108185|80048004|FG000|Overall Study|Non-compliance|15|||
27506825|NCT01108185|80048004|FG000|Overall Study|Lost to Follow-up|12|||
27506826|NCT03472885|80048008|FG000|24-Week Treatment Period|Adverse Event|1|||
27506827|NCT01774721|80048009|FG000|Overall Study|Death|133|||
27506828|NCT01774721|80048010|FG001|Overall Study|Death|152|||
27506829|NCT01774721|80048009|FG000|Overall Study|Withdrawal by Subject|20|||
27506830|NCT01774721|80048010|FG001|Overall Study|Withdrawal by Subject|14|||
27506831|NCT01774721|80048009|FG000|Overall Study|Lost to Follow-up|6|||
27506832|NCT01774721|80048010|FG001|Overall Study|Lost to Follow-up|7|||
27506833|NCT01774721|80048009|FG000|Overall Study|Did not meet eligibility criteria|0|||
27506834|NCT01774721|80048010|FG001|Overall Study|Did not meet eligibility criteria|3|||
27506835|NCT01774721|80048009|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
27506836|NCT01774721|80048010|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
27506837|NCT01774721|80048009|FG000|Overall Study|Study terminated by sponsor|5|||
27506838|NCT01774721|80048010|FG001|Overall Study|Study terminated by sponsor|0|||
27506839|NCT01774721|80048009|FG000|Overall Study|Disease progression|5|||
27506840|NCT01774721|80048010|FG001|Overall Study|Disease progression|0|||
27506841|NCT01868997|80048011|FG000|Overall Study|Adverse Event|2|||
27506842|NCT01868997|80048012|FG001|Overall Study|Adverse Event|5|||
27614504|NCT01551303|80430289|FG000|Overall Study|failed awareness check on vision test|4|||
27851647|NCT00652028|81287112|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
27506843|NCT01868997|80048011|FG000|Overall Study|Lack of Efficacy|2|||
27506844|NCT01868997|80048012|FG001|Overall Study|Lack of Efficacy|0|||
27506845|NCT01868997|80048011|FG000|Overall Study|Other|3|||
27506846|NCT01868997|80048012|FG001|Overall Study|Other|1|||
27506847|NCT00763035|80048023|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
27506848|NCT00763035|80048024|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
27506849|NCT00763035|80048023|FG000|First Intervention|Adverse Event|0|||
27506850|NCT00763035|80048024|FG001|First Intervention|Adverse Event|1|||
27614505|NCT01551303|80430290|FG001|Overall Study|failed awareness check on vision test|7|||
27506851|NCT00763035|80048023|FG000|Second Intervention|Adverse Event|1|||
27506852|NCT00763035|80048024|FG001|Second Intervention|Adverse Event|0|||
27614506|NCT03518658|80430293|FG000|Overall Study|Other|51|||
27614507|NCT03518658|80430294|FG001|Overall Study|Other|0|||
27728264|NCT00454207|80833202|FG001|Overall Study|Protocol Violation|1|||
27851648|NCT00652028|81287113|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
27902883|NCT02187861|81481558|FG000|Overall Study|Progressive Disease|4|||
27902884|NCT02187861|81481559|FG001|Overall Study|Progressive Disease|42|||
27902885|NCT02187861|81481560|FG002|Overall Study|Progressive Disease|19|||
27902886|NCT02187861|81481561|FG003|Overall Study|Progressive Disease|22|||
27902887|NCT02187861|81481558|FG000|Overall Study|Withdrawal by Subject|0|||
27902888|NCT02187861|81481559|FG001|Overall Study|Withdrawal by Subject|0|||
27902889|NCT02187861|81481560|FG002|Overall Study|Withdrawal by Subject|3|||
27902890|NCT02187861|81481561|FG003|Overall Study|Withdrawal by Subject|3|||
27902891|NCT02187861|81481558|FG000|Overall Study|Other|0|||
27902892|NCT02187861|81481559|FG001|Overall Study|Other|1|||
27902893|NCT02187861|81481560|FG002|Overall Study|Other|7|||
27902894|NCT02187861|81481561|FG003|Overall Study|Other|1|||
27902895|NCT00441363|81481562|FG000|Overall Study|Adverse Event|4|||
27902896|NCT00441363|81481563|FG001|Overall Study|Adverse Event|2|||
27902897|NCT00441363|81481562|FG000|Overall Study|Withdrawal by Subject|3|||
27902898|NCT00441363|81481563|FG001|Overall Study|Withdrawal by Subject|4|||
27902899|NCT00441363|81481562|FG000|Overall Study|Physician Decision|6|||
27902900|NCT00441363|81481563|FG001|Overall Study|Physician Decision|7|||
27902901|NCT00441363|81481562|FG000|Overall Study|Lost to Follow-up|2|||
27902902|NCT00441363|81481563|FG001|Overall Study|Lost to Follow-up|2|||
27902903|NCT00441363|81481562|FG000|Overall Study|Other|2|||
27902904|NCT00441363|81481563|FG001|Overall Study|Other|0|||
27902905|NCT00350779|81481564|FG000|Overall Study|Adverse Event|4|||
27902906|NCT00350779|81481565|FG001|Overall Study|Adverse Event|2|||
27902907|NCT00350779|81481564|FG000|Overall Study|Lack of Efficacy|0|||
27902908|NCT00350779|81481565|FG001|Overall Study|Lack of Efficacy|4|||
27902909|NCT00350779|81481564|FG000|Overall Study|Lost to Follow-up|2|||
27902910|NCT00350779|81481565|FG001|Overall Study|Lost to Follow-up|0|||
27902911|NCT00350779|81481564|FG000|Overall Study|Physician Decision|2|||
27902912|NCT00350779|81481565|FG001|Overall Study|Physician Decision|4|||
27902913|NCT00350779|81481564|FG000|Overall Study|Protocol Violation|3|||
27902914|NCT00350779|81481565|FG001|Overall Study|Protocol Violation|1|||
27902915|NCT00350779|81481564|FG000|Overall Study|Withdrawal by Subject|9|||
27902916|NCT00350779|81481565|FG001|Overall Study|Withdrawal by Subject|8|||
27902917|NCT00350779|81481564|FG000|Overall Study|Patient Moved|2|||
27902918|NCT00350779|81481565|FG001|Overall Study|Patient Moved|1|||
27902919|NCT00350779|81481564|FG000|Overall Study|Non-compliance with study procedures|0|||
27902920|NCT00350779|81481565|FG001|Overall Study|Non-compliance with study procedures|1|||
27902921|NCT04122625|81481569|FG000|Part A (up to 2.92 Years)|Death|2|||
27902922|NCT04122625|81481570|FG001|Part A (up to 2.92 Years)|Death|4|||
27902923|NCT04122625|81481571|FG002|Part A (up to 2.92 Years)|Death|0|||
27902924|NCT04122625|81481572|FG003|Part A (up to 2.92 Years)|Death|0|||
27902925|NCT04122625|81481573|FG004|Part A (up to 2.92 Years)|Death|0|||
27902926|NCT04122625|81481574|FG005|Part A (up to 2.92 Years)|Death|0|||
27902927|NCT04122625|81481569|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
27902928|NCT04122625|81481570|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
27902929|NCT04122625|81481571|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
27902930|NCT04122625|81481572|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
27902931|NCT04122625|81481573|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
27902932|NCT04122625|81481574|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
27902933|NCT04122625|81481569|FG000|Part B (up to 2.33 Years)|Death|0|||
27902934|NCT04122625|81481570|FG001|Part B (up to 2.33 Years)|Death|0|||
27902935|NCT04122625|81481571|FG002|Part B (up to 2.33 Years)|Death|5|||
27902936|NCT04122625|81481572|FG003|Part B (up to 2.33 Years)|Death|7|||
27902937|NCT04122625|81481573|FG004|Part B (up to 2.33 Years)|Death|6|||
27902938|NCT04122625|81481574|FG005|Part B (up to 2.33 Years)|Death|7|||
27902939|NCT00985426|81481575|FG000|Overall Study|Adverse Event|0|||
27902940|NCT00985426|81481576|FG001|Overall Study|Adverse Event|1|||
27902941|NCT00985426|81481575|FG000|Overall Study|Subject Non-Compliance|3|||
27902942|NCT00985426|81481576|FG001|Overall Study|Subject Non-Compliance|3|||
27902943|NCT00985426|81481575|FG000|Overall Study|Withdrawal by Subject|12|||
27902944|NCT00985426|81481576|FG001|Overall Study|Withdrawal by Subject|16|||
27902945|NCT00985426|81481575|FG000|Overall Study|Lost to Follow-up|8|||
27902946|NCT00985426|81481576|FG001|Overall Study|Lost to Follow-up|10|||
27902947|NCT00985426|81481575|FG000|Overall Study|Death|7|||
27902948|NCT00985426|81481576|FG001|Overall Study|Death|3|||
27902949|NCT00985426|81481575|FG000|Overall Study|Protocol Violation|2|||
27902950|NCT00985426|81481576|FG001|Overall Study|Protocol Violation|0|||
27902951|NCT00985426|81481575|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
27902952|NCT00985426|81481576|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
27902953|NCT02588664|81481582|FG000|Overall Study|Death|56|||
27902954|NCT02588664|81481583|FG001|Overall Study|Death|55|||
27902955|NCT02588664|81481582|FG000|Overall Study|Lost to Follow-up|1305|||
27902956|NCT02588664|81481583|FG001|Overall Study|Lost to Follow-up|990|||
27902957|NCT01026818|81481584|FG000|Screening Period|Entry Criteria Not Met|105|||
27902958|NCT01026818|81481585|FG001|Screening Period|Entry Criteria Not Met|0|||
27902959|NCT01026818|81481586|FG002|Screening Period|Entry Criteria Not Met|0|||
27902960|NCT01026818|81481587|FG003|Screening Period|Entry Criteria Not Met|0|||
27902961|NCT01026818|81481584|FG000|Screening Period|Withdrawal by Subject|49|||
27902962|NCT01026818|81481585|FG001|Screening Period|Withdrawal by Subject|0|||
27902963|NCT01026818|81481586|FG002|Screening Period|Withdrawal by Subject|0|||
27902964|NCT01026818|81481587|FG003|Screening Period|Withdrawal by Subject|0|||
27902965|NCT01026818|81481584|FG000|Screening Period|Protocol Deviation|3|||
27902966|NCT01026818|81481585|FG001|Screening Period|Protocol Deviation|0|||
27902967|NCT01026818|81481586|FG002|Screening Period|Protocol Deviation|0|||
27902968|NCT01026818|81481587|FG003|Screening Period|Protocol Deviation|0|||
27902969|NCT01026818|81481584|FG000|Screening Period|Adverse Event|2|||
27902970|NCT01026818|81481585|FG001|Screening Period|Adverse Event|0|||
27902971|NCT01026818|81481586|FG002|Screening Period|Adverse Event|0|||
27902972|NCT01026818|81481587|FG003|Screening Period|Adverse Event|0|||
27902973|NCT01026818|81481584|FG000|Screening Period|Physician Decision|1|||
27902974|NCT01026818|81481585|FG001|Screening Period|Physician Decision|0|||
27902975|NCT01026818|81481586|FG002|Screening Period|Physician Decision|0|||
27902976|NCT01026818|81481587|FG003|Screening Period|Physician Decision|0|||
27902977|NCT01026818|81481584|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
27902978|NCT01026818|81481585|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
27902979|NCT01026818|81481586|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
27902980|NCT01026818|81481587|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
27902981|NCT01026818|81481584|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
27902982|NCT01026818|81481585|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
27902983|NCT01026818|81481586|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
27902984|NCT01026818|81481587|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
27902985|NCT01026818|81481584|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
27902986|NCT01026818|81481585|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
27902987|NCT01026818|81481586|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
27902988|NCT01026818|81481587|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
27902989|NCT01026818|81481584|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
27902990|NCT01026818|81481585|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
27902991|NCT01026818|81481586|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
27902992|NCT01026818|81481587|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
27902993|NCT01026818|81481584|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
27902994|NCT01026818|81481585|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
27902995|NCT01026818|81481586|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
27902996|NCT01026818|81481587|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
27902997|NCT01026818|81481584|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
27902998|NCT01026818|81481585|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
27902999|NCT01026818|81481586|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
27903000|NCT01026818|81481587|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
27903001|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
27903002|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
27903003|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
27903004|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
27903005|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
27903006|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
27903007|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
27903008|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
27903009|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
27903010|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
27903011|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
27903012|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
27903013|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
27903014|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
27903015|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
27903016|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
27903017|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
27903018|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
27728265|NCT00531960|80833208|FG000|Overall Study|Adverse Event|5|||
27728266|NCT00531960|80833209|FG001|Overall Study|Adverse Event|4|||
27728267|NCT00531960|80833208|FG000|Overall Study|Death|3|||
27903019|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
27903020|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
27903021|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
27903022|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
27903023|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
27903024|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
27903025|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
27903026|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
27903027|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
27903028|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
27903029|NCT01026818|81481584|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
27903030|NCT01026818|81481585|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
27903031|NCT01026818|81481586|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
27903032|NCT01026818|81481587|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
27903033|NCT01026818|81481584|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
27614508|NCT03387514|80430295|FG000|Overall Study|Withdrawal by Subject|2|||
27614509|NCT03387514|80430295|FG000|Overall Study|Physician Decision|1|||
27614510|NCT03387514|80430295|FG000|Overall Study|Lost to Follow-up|2|||
27614511|NCT01995357|80430296|FG000|Period 5|Lack of Efficacy|1|||
27614512|NCT01995357|80430297|FG001|Period 5|Lack of Efficacy|0|||
27614513|NCT01995357|80430298|FG002|Period 5|Lack of Efficacy|0|||
27614514|NCT01995357|80430299|FG003|Period 5|Lack of Efficacy|0|||
27614515|NCT01995357|80430300|FG004|Period 5|Lack of Efficacy|0|||
27614516|NCT01995357|80430301|FG005|Period 5|Lack of Efficacy|0|||
27614517|NCT01995357|80430296|FG000|Period 5|Adverse Event|1|||
27614518|NCT01995357|80430297|FG001|Period 5|Adverse Event|0|||
27614519|NCT01995357|80430298|FG002|Period 5|Adverse Event|1|||
27614520|NCT01995357|80430299|FG003|Period 5|Adverse Event|0|||
27614521|NCT01995357|80430300|FG004|Period 5|Adverse Event|0|||
27614522|NCT01995357|80430301|FG005|Period 5|Adverse Event|0|||
27903034|NCT01026818|81481585|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
27903035|NCT01026818|81481586|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
27903036|NCT01026818|81481587|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
27903037|NCT01026818|81481584|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
27903038|NCT01026818|81481585|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
27851649|NCT00652028|81287114|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
27851650|NCT00652028|81287115|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
27851651|NCT00652028|81287112|FG000|Overall Study|Physician Decision|0|||
27851652|NCT00652028|81287113|FG001|Overall Study|Physician Decision|0|||
27851653|NCT00652028|81287114|FG002|Overall Study|Physician Decision|1|||
27851654|NCT00652028|81287115|FG003|Overall Study|Physician Decision|0|||
27851655|NCT03254602|81287116|FG000|Overall Study|Lost to Follow-up|4|||
27851656|NCT02916693|81287117|FG000|Overall Study|Lost to Follow-up|7|||
27851657|NCT03456960|81287118|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27851658|NCT03456960|81287119|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27851659|NCT03456960|81287120|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
27851660|NCT03456960|81287121|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
27851661|NCT03456960|81287122|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27851662|NCT03456960|81287123|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
27851663|NCT03456960|81287118|FG000|Period 2 (1 Day)|Adverse Event|1|||
27851664|NCT03456960|81287119|FG001|Period 2 (1 Day)|Adverse Event|0|||
27851665|NCT03456960|81287120|FG002|Period 2 (1 Day)|Adverse Event|0|||
27851666|NCT03456960|81287121|FG003|Period 2 (1 Day)|Adverse Event|1|||
27851667|NCT03456960|81287122|FG004|Period 2 (1 Day)|Adverse Event|0|||
27851668|NCT03456960|81287123|FG005|Period 2 (1 Day)|Adverse Event|0|||
27851669|NCT01244061|81287124|FG000|Overall Study|Death|1|||
27851670|NCT01244061|81287125|FG001|Overall Study|Death|0|||
27851671|NCT01244061|81287124|FG000|Overall Study|Did not meet entrance criteria|1|||
27851672|NCT01244061|81287125|FG001|Overall Study|Did not meet entrance criteria|0|||
27851673|NCT01244061|81287124|FG000|Overall Study|Lack of Efficacy|1|||
27614523|NCT02019602|80430307|FG000|Screening Period|Ineligibility|4|||
27614524|NCT02019602|80430308|FG001|Screening Period|Ineligibility|0|||
27614525|NCT02019602|80430307|FG000|Screening Period|Adverse Event|1|||
27614526|NCT02019602|80430308|FG001|Screening Period|Adverse Event|0|||
27851674|NCT01244061|81287125|FG001|Overall Study|Lack of Efficacy|3|||
27851675|NCT01244061|81287124|FG000|Overall Study|Lost to Follow-up|34|||
27614527|NCT02213055|80430311|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
27614528|NCT02213055|80430312|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
27614529|NCT02213055|80430311|FG000|Overall Study|Protocol was not Followed during Study|1|||
27614530|NCT02213055|80430312|FG001|Overall Study|Protocol was not Followed during Study|0|||
27851676|NCT01244061|81287125|FG001|Overall Study|Lost to Follow-up|30|||
27851677|NCT01244061|81287124|FG000|Overall Study|Withdrawal by Subject|29|||
27851678|NCT01244061|81287125|FG001|Overall Study|Withdrawal by Subject|46|||
27851679|NCT01244061|81287124|FG000|Overall Study|Other|8|||
27851680|NCT01244061|81287125|FG001|Overall Study|Other|19|||
27728268|NCT00531960|80833209|FG001|Overall Study|Death|2|||
27728269|NCT00531960|80833208|FG000|Overall Study|Lack of Efficacy|42|||
27728270|NCT00531960|80833209|FG001|Overall Study|Lack of Efficacy|41|||
27728271|NCT00531960|80833208|FG000|Overall Study|Violation of Selection Criteria|2|||
27728272|NCT00531960|80833209|FG001|Overall Study|Violation of Selection Criteria|0|||
27728273|NCT00531960|80833208|FG000|Overall Study|Refused Treatment|5|||
27728274|NCT00531960|80833209|FG001|Overall Study|Refused Treatment|6|||
27728275|NCT00531960|80833208|FG000|Overall Study|Other|4|||
27728276|NCT00531960|80833209|FG001|Overall Study|Other|10|||
27728277|NCT00490542|80833215|FG000|Overall Study|Lost to Follow-up|3|||
27728278|NCT00490542|80833216|FG001|Overall Study|Lost to Follow-up|0|||
27728279|NCT00490542|80833215|FG000|Overall Study|Adverse Event|3|||
27728280|NCT00490542|80833216|FG001|Overall Study|Adverse Event|3|||
27728281|NCT00490542|80833215|FG000|Overall Study|Lack of Efficacy|1|||
27728282|NCT00490542|80833216|FG001|Overall Study|Lack of Efficacy|1|||
27728283|NCT00584233|80833217|FG000|Overall Study|Withdrawal by Subject|5|||
27728284|NCT00584233|80833217|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
27728285|NCT00544869|80833218|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
27728286|NCT00544869|80833219|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
27728287|NCT00544869|80833220|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
27728288|NCT00544869|80833218|FG000|Overall Study|Adverse Event|6|||
27728289|NCT00544869|80833219|FG001|Overall Study|Adverse Event|1|||
27728290|NCT00544869|80833220|FG002|Overall Study|Adverse Event|0|||
27728291|NCT00544869|80833218|FG000|Overall Study|Lack of Efficacy|1|||
27728292|NCT00544869|80833219|FG001|Overall Study|Lack of Efficacy|1|||
27728293|NCT00544869|80833220|FG002|Overall Study|Lack of Efficacy|0|||
27728294|NCT00544869|80833218|FG000|Overall Study|Physician Decision|2|||
27728295|NCT00544869|80833219|FG001|Overall Study|Physician Decision|0|||
27728296|NCT00544869|80833220|FG002|Overall Study|Physician Decision|0|||
27728297|NCT00947531|80833228|FG000|Overall Study|Withdrawal by Subject|10|||
27728298|NCT00947531|80833229|FG001|Overall Study|Withdrawal by Subject|7|||
27728299|NCT00947531|80833228|FG000|Overall Study|Administrative Reason|0|||
27728300|NCT00947531|80833229|FG001|Overall Study|Administrative Reason|1|||
27728301|NCT00947531|80833228|FG000|Overall Study|Adverse Event|2|||
27851681|NCT01244061|81287124|FG000|Overall Study|Protocol Violation|1|||
27851682|NCT01244061|81287125|FG001|Overall Study|Protocol Violation|1|||
27851683|NCT01244061|81287124|FG000|Overall Study|Adverse Event|5|||
27851684|NCT01244061|81287125|FG001|Overall Study|Adverse Event|2|||
27851685|NCT01244061|81287124|FG000|Overall Study|Randomized but not treated|2|||
27851686|NCT01244061|81287125|FG001|Overall Study|Randomized but not treated|2|||
27851687|NCT00841906|81287126|FG000|Overall Study|Withdrawal by Subject|2|||
27851688|NCT00841906|81287127|FG001|Overall Study|Withdrawal by Subject|0|||
27851689|NCT02697773|81287131|FG000|Overall Study|Adverse Event|2|||
27851690|NCT02697773|81287132|FG001|Overall Study|Adverse Event|1|||
27851691|NCT02697773|81287133|FG002|Overall Study|Adverse Event|2|||
27851692|NCT02697773|81287131|FG000|Overall Study|Death|0|||
27851693|NCT02697773|81287132|FG001|Overall Study|Death|0|||
27851694|NCT02697773|81287133|FG002|Overall Study|Death|2|||
27851695|NCT02697773|81287131|FG000|Overall Study|Lack of Efficacy|4|||
27851696|NCT02697773|81287132|FG001|Overall Study|Lack of Efficacy|6|||
27851697|NCT02697773|81287133|FG002|Overall Study|Lack of Efficacy|6|||
27903039|NCT01026818|81481586|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
27614531|NCT02213055|80430311|FG000|Overall Study|Documentation Issue at Enrollment|1|||
27614532|NCT02213055|80430312|FG001|Overall Study|Documentation Issue at Enrollment|0|||
27614533|NCT02213055|80430311|FG000|Overall Study|Documentation Issue during Study|10|||
27614534|NCT02213055|80430312|FG001|Overall Study|Documentation Issue during Study|0|||
27614535|NCT02213055|80430311|FG000|Overall Study|Did not have Live Lice|8|||
27614536|NCT02213055|80430312|FG001|Overall Study|Did not have Live Lice|0|||
27614537|NCT02213055|80430311|FG000|Overall Study|Had another Treatment during the Study|3|||
27614538|NCT02213055|80430312|FG001|Overall Study|Had another Treatment during the Study|0|||
27614539|NCT02213055|80430311|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
27614540|NCT02213055|80430312|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
27614541|NCT02213055|80430311|FG000|Overall Study|Did not Return to School|5|||
27614542|NCT02213055|80430312|FG001|Overall Study|Did not Return to School|0|||
27614543|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
27728302|NCT00947531|80833229|FG001|Overall Study|Adverse Event|2|||
27728303|NCT00947531|80833228|FG000|Overall Study|Lack of Efficacy|1|||
27728304|NCT00947531|80833229|FG001|Overall Study|Lack of Efficacy|0|||
27728305|NCT00947531|80833228|FG000|Overall Study|Other|1|||
27728306|NCT00947531|80833229|FG001|Overall Study|Other|1|||
27728307|NCT03038308|80833230|FG000|Overall Study|Surgical resection|1|||
27728308|NCT03038308|80833230|FG000|Overall Study|Withdrawal by Subject|2|||
27728309|NCT03038308|80833230|FG000|Overall Study|Lost to Follow-up|1|||
27851698|NCT02697773|81287131|FG000|Overall Study|Lost to Follow-up|5|||
27851699|NCT02697773|81287132|FG001|Overall Study|Lost to Follow-up|5|||
27851700|NCT02697773|81287133|FG002|Overall Study|Lost to Follow-up|7|||
27851701|NCT02697773|81287131|FG000|Overall Study|Other|15|||
27903040|NCT01026818|81481587|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
27903041|NCT01026818|81481584|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
27903042|NCT01026818|81481585|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
27903043|NCT01026818|81481586|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
27903044|NCT01026818|81481587|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
27903045|NCT01026818|81481584|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
27903046|NCT01026818|81481585|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
27903047|NCT01026818|81481586|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
27903048|NCT01026818|81481587|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
27506853|NCT00763035|80048023|FG000|Second Intervention|Physician Decision|2|||
27506854|NCT00763035|80048024|FG001|Second Intervention|Physician Decision|0|||
27506855|NCT03331315|80048028|FG000|Overall Study|Physician Decision|18|||
27728310|NCT02327260|80833231|FG000|Overall Study|Lost to Follow-up|2|||
27851702|NCT02697773|81287132|FG001|Overall Study|Other|11|||
27851703|NCT02697773|81287133|FG002|Overall Study|Other|10|||
27851704|NCT02697773|81287131|FG000|Overall Study|Protocol Violation|1|||
27851705|NCT02697773|81287132|FG001|Overall Study|Protocol Violation|1|||
27851706|NCT02697773|81287133|FG002|Overall Study|Protocol Violation|0|||
27851707|NCT02697773|81287131|FG000|Overall Study|Withdrawal by Subject|10|||
27851708|NCT02697773|81287132|FG001|Overall Study|Withdrawal by Subject|13|||
27851709|NCT02697773|81287133|FG002|Overall Study|Withdrawal by Subject|13|||
27851710|NCT02697773|81287131|FG000|Overall Study|Randomized but not treated|1|||
27851711|NCT02697773|81287132|FG001|Overall Study|Randomized but not treated|1|||
27851712|NCT02697773|81287133|FG002|Overall Study|Randomized but not treated|0|||
27851713|NCT03828448|81287134|FG000|Overall Study|Sponsor's Discretion|34|||
27851714|NCT02546362|81287135|FG000|4-week Treatment Period|Lost to Follow-up|1|||
27851715|NCT02546362|81287135|FG000|4-week Treatment Period|Change in medication|2|||
27851716|NCT02546362|81287135|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
27851717|NCT02546362|81287135|FG000|12-week Treatment Period|Lost to Follow-up|2|||
27851718|NCT02546362|81287135|FG000|12-week Treatment Period|Change in medication|1|||
27851719|NCT00620659|81287136|FG000|Treatment Period 1|Adverse Event|1|||
27851720|NCT00620659|81287137|FG001|Treatment Period 1|Adverse Event|0|||
27851721|NCT00620659|81287138|FG002|Treatment Period 1|Adverse Event|0|||
27851722|NCT00620659|81287139|FG003|Treatment Period 1|Adverse Event|3|||
27851723|NCT00620659|81287140|FG004|Treatment Period 1|Adverse Event|0|||
27851724|NCT00620659|81287141|FG005|Treatment Period 1|Adverse Event|0|||
27851725|NCT00620659|81287136|FG000|Treatment Period 1|Protocol Violation|1|||
27851726|NCT00620659|81287137|FG001|Treatment Period 1|Protocol Violation|0|||
27851727|NCT00620659|81287138|FG002|Treatment Period 1|Protocol Violation|0|||
27851728|NCT00620659|81287139|FG003|Treatment Period 1|Protocol Violation|0|||
27851729|NCT00620659|81287140|FG004|Treatment Period 1|Protocol Violation|0|||
27851730|NCT00620659|81287141|FG005|Treatment Period 1|Protocol Violation|0|||
27851731|NCT00620659|81287136|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27851732|NCT00620659|81287137|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27851733|NCT00620659|81287138|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27851734|NCT00620659|81287139|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27851735|NCT00620659|81287140|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27851736|NCT00620659|81287141|FG005|Treatment Period 1|Withdrawal by Subject|0|||
27851737|NCT00620659|81287136|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
27851738|NCT00620659|81287137|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
27851739|NCT00620659|81287138|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
27851740|NCT00620659|81287139|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
27851741|NCT00620659|81287140|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
27851742|NCT00620659|81287141|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
27851743|NCT00620659|81287136|FG000|Treatment Period 2|Adverse Event|0|||
27851744|NCT00620659|81287137|FG001|Treatment Period 2|Adverse Event|3|||
27851745|NCT00620659|81287138|FG002|Treatment Period 2|Adverse Event|0|||
27851746|NCT00620659|81287139|FG003|Treatment Period 2|Adverse Event|0|||
27851747|NCT00620659|81287140|FG004|Treatment Period 2|Adverse Event|2|||
27851748|NCT00620659|81287141|FG005|Treatment Period 2|Adverse Event|0|||
27851749|NCT00620659|81287136|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27851750|NCT00620659|81287137|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27851751|NCT00620659|81287138|FG002|Treatment Period 2|Withdrawal by Subject|1|||
27851752|NCT00620659|81287139|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27903049|NCT01026818|81481584|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
27851753|NCT00620659|81287140|FG004|Treatment Period 2|Withdrawal by Subject|3|||
27851754|NCT00620659|81287141|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27851755|NCT00620659|81287136|FG000|Placebo Washout Period 2|Adverse Event|2|||
27851756|NCT00620659|81287137|FG001|Placebo Washout Period 2|Adverse Event|0|||
27851757|NCT00620659|81287138|FG002|Placebo Washout Period 2|Adverse Event|0|||
27851758|NCT00620659|81287139|FG003|Placebo Washout Period 2|Adverse Event|0|||
27851759|NCT00620659|81287140|FG004|Placebo Washout Period 2|Adverse Event|0|||
27851760|NCT00620659|81287141|FG005|Placebo Washout Period 2|Adverse Event|0|||
27851761|NCT00620659|81287136|FG000|Treatment Period 3|Adverse Event|0|||
27851762|NCT00620659|81287137|FG001|Treatment Period 3|Adverse Event|2|||
27903050|NCT01026818|81481585|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
27903051|NCT01026818|81481586|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
27903052|NCT01026818|81481587|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
27903053|NCT01410240|81481590|FG000|Overall Study|Physician Decision|0|||
27903054|NCT01410240|81481591|FG001|Overall Study|Physician Decision|0|||
27903055|NCT01410240|81481592|FG002|Overall Study|Physician Decision|1|||
27903056|NCT01410240|81481590|FG000|Overall Study|Missed week 6 assessments|1|||
27903057|NCT01410240|81481591|FG001|Overall Study|Missed week 6 assessments|1|||
27903058|NCT01410240|81481592|FG002|Overall Study|Missed week 6 assessments|1|||
27903059|NCT01027897|81481593|FG000|Overall Study|Protocol Violation|1|||
27903060|NCT01027897|81481593|FG000|Overall Study|Withdrawal by Subject|1|||
27903061|NCT00204477|81481594|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
27903062|NCT00204477|81481595|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
27903063|NCT00204477|81481594|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
27903064|NCT00204477|81481595|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
27903065|NCT01915771|81481596|FG000|Day 1|Withdrawal by Subject|1|||
27903066|NCT01915771|81481596|FG000|Day 15|Withdrawal by Subject|1|||
27903067|NCT00508157|81481597|FG000|Overall Study|Adverse Event|0|||
27903068|NCT00508157|81481598|FG001|Overall Study|Adverse Event|1|||
27903069|NCT00508157|81481597|FG000|Overall Study|Subject Withdrew Consent|1|||
27903070|NCT00508157|81481598|FG001|Overall Study|Subject Withdrew Consent|0|||
27903071|NCT00508157|81481597|FG000|Overall Study|Lost to Follow-up|1|||
27903072|NCT00508157|81481598|FG001|Overall Study|Lost to Follow-up|0|||
27903073|NCT00508157|81481597|FG000|Overall Study|Subject no longer met study criteria|0|||
27903074|NCT00508157|81481598|FG001|Overall Study|Subject no longer met study criteria|1|||
27903075|NCT00508157|81481597|FG000|Overall Study|Other known cause|0|||
27903076|NCT00508157|81481598|FG001|Overall Study|Other known cause|1|||
27903077|NCT01085084|81481599|FG000|Overall Study|Withdrawal by Subject|1|||
27903078|NCT01085084|81481600|FG001|Overall Study|Withdrawal by Subject|0|||
27903079|NCT01085084|81481601|FG002|Overall Study|Withdrawal by Subject|0|||
27903080|NCT01085084|81481599|FG000|Overall Study|Lost to Follow-up|2|||
27903081|NCT01085084|81481600|FG001|Overall Study|Lost to Follow-up|1|||
27903082|NCT01085084|81481601|FG002|Overall Study|Lost to Follow-up|1|||
27903083|NCT01085084|81481599|FG000|Overall Study|Adverse Event|4|||
27903084|NCT01085084|81481600|FG001|Overall Study|Adverse Event|3|||
27903085|NCT01085084|81481601|FG002|Overall Study|Adverse Event|6|||
27903086|NCT01085084|81481599|FG000|Overall Study|Treatment Failure|0|||
27903087|NCT01085084|81481600|FG001|Overall Study|Treatment Failure|1|||
27903088|NCT01085084|81481601|FG002|Overall Study|Treatment Failure|2|||
27903089|NCT00395642|81481603|FG000|Overall Study|Death|4|||
27903090|NCT00395642|81481603|FG000|Overall Study|Lost to Follow-up|1|||
27903091|NCT00395642|81481603|FG000|Overall Study|Physician Decision|7|||
27903092|NCT00395642|81481603|FG000|Overall Study|Withdrawal by Subject|1|||
27903093|NCT03430856|81481604|FG000|Overall Study|Adverse Event|0|||
27903094|NCT03430856|81481605|FG001|Overall Study|Adverse Event|1|||
27903095|NCT03430856|81481606|FG002|Overall Study|Adverse Event|0|||
27903096|NCT03430856|81481604|FG000|Overall Study|Rescue criteria|1|||
27903097|NCT03430856|81481605|FG001|Overall Study|Rescue criteria|1|||
27903098|NCT03430856|81481606|FG002|Overall Study|Rescue criteria|0|||
27903099|NCT03430856|81481604|FG000|Overall Study|Voluntary withdrawal of consent|1|||
27903100|NCT03430856|81481605|FG001|Overall Study|Voluntary withdrawal of consent|1|||
27903101|NCT03430856|81481606|FG002|Overall Study|Voluntary withdrawal of consent|1|||
27903102|NCT02385110|81481607|FG000|Overall Study|Early Death|1|||
27903103|NCT02385110|81481608|FG001|Overall Study|Early Death|0|||
27903104|NCT01900899|81481613|FG000|Overall Study|Withdrawal by Subject|7|||
27903105|NCT01900899|81481614|FG001|Overall Study|Withdrawal by Subject|1|||
27903106|NCT01900899|81481613|FG000|Overall Study|Migrated from study area|2|||
27903107|NCT01900899|81481614|FG001|Overall Study|Migrated from study area|0|||
27903108|NCT02005627|81481616|FG000|Overall Study|Lost to Follow-up|1|||
27903109|NCT02005627|81481617|FG001|Overall Study|Lost to Follow-up|2|||
27903110|NCT02005627|81481616|FG000|Overall Study|Withdrawal by Subject|1|||
27903111|NCT02005627|81481617|FG001|Overall Study|Withdrawal by Subject|2|||
27903112|NCT00153816|81481618|FG000|Overall Study|Death|6|||
27903113|NCT00153816|81481619|FG001|Overall Study|Death|5|||
27506856|NCT03331315|80048029|FG001|Overall Study|Physician Decision|14|||
27506857|NCT02435992|80048030|FG000|Overall Study|non compliance with protocol|2|||
27903114|NCT00153816|81481620|FG002|Overall Study|Death|4|||
27903115|NCT00153816|81481621|FG003|Overall Study|Death|6|||
27903116|NCT00153816|81481622|FG004|Overall Study|Death|0|||
27903117|NCT00153816|81481623|FG005|Overall Study|Death|2|||
27903118|NCT00153816|81481618|FG000|Overall Study|Lost to Follow-up|7|||
27903119|NCT00153816|81481619|FG001|Overall Study|Lost to Follow-up|8|||
27903120|NCT00153816|81481620|FG002|Overall Study|Lost to Follow-up|5|||
27903121|NCT00153816|81481621|FG003|Overall Study|Lost to Follow-up|8|||
27903122|NCT00153816|81481622|FG004|Overall Study|Lost to Follow-up|7|||
27903123|NCT00153816|81481623|FG005|Overall Study|Lost to Follow-up|9|||
27903124|NCT00153816|81481618|FG000|Overall Study|Withdrawal by Subject|9|||
27903125|NCT00153816|81481619|FG001|Overall Study|Withdrawal by Subject|9|||
27903126|NCT00153816|81481620|FG002|Overall Study|Withdrawal by Subject|9|||
27903127|NCT00153816|81481621|FG003|Overall Study|Withdrawal by Subject|4|||
27903128|NCT00153816|81481622|FG004|Overall Study|Withdrawal by Subject|1|||
27903129|NCT00153816|81481623|FG005|Overall Study|Withdrawal by Subject|5|||
27903130|NCT00153816|81481618|FG000|Overall Study|Follow-up exam not done|8|||
27903131|NCT00153816|81481619|FG001|Overall Study|Follow-up exam not done|7|||
27903132|NCT00153816|81481620|FG002|Overall Study|Follow-up exam not done|11|||
27903133|NCT00153816|81481621|FG003|Overall Study|Follow-up exam not done|10|||
27903134|NCT00153816|81481622|FG004|Overall Study|Follow-up exam not done|8|||
27903135|NCT00153816|81481623|FG005|Overall Study|Follow-up exam not done|9|||
27903136|NCT00153816|81481618|FG000|Overall Study|Follow-up exam done, histology missing|2|||
27903137|NCT00153816|81481619|FG001|Overall Study|Follow-up exam done, histology missing|3|||
27903138|NCT00153816|81481620|FG002|Overall Study|Follow-up exam done, histology missing|3|||
27903139|NCT00153816|81481621|FG003|Overall Study|Follow-up exam done, histology missing|3|||
27903140|NCT00153816|81481622|FG004|Overall Study|Follow-up exam done, histology missing|1|||
27903141|NCT00153816|81481623|FG005|Overall Study|Follow-up exam done, histology missing|2|||
27903142|NCT01324570|81481624|FG000|Overall Study|Adverse Event|4|||
27903143|NCT01324570|81481625|FG001|Overall Study|Adverse Event|7|||
27903144|NCT01324570|81481624|FG000|Overall Study|Withdrawal by Subject|0|||
27903145|NCT01324570|81481625|FG001|Overall Study|Withdrawal by Subject|3|||
27903146|NCT01324570|81481624|FG000|Overall Study|Lack of Efficacy|0|||
27903147|NCT01324570|81481625|FG001|Overall Study|Lack of Efficacy|1|||
27903148|NCT01324570|81481624|FG000|Overall Study|Confirmed or suspected diversion|0|||
27903149|NCT01324570|81481625|FG001|Overall Study|Confirmed or suspected diversion|1|||
27903150|NCT01324570|81481624|FG000|Overall Study|Administrative|0|||
27903151|NCT01324570|81481625|FG001|Overall Study|Administrative|2|||
27903152|NCT03251482|81481626|FG000|Overall Study|Withdrawal by Subject|0|||
27903153|NCT03251482|81481627|FG001|Overall Study|Withdrawal by Subject|1|||
27903154|NCT03251482|81481628|FG002|Overall Study|Withdrawal by Subject|0|||
27903155|NCT03251482|81481629|FG003|Overall Study|Withdrawal by Subject|0|||
27903156|NCT03251482|81481630|FG004|Overall Study|Withdrawal by Subject|0|||
27903157|NCT00957905|81481633|FG000|Part B|Not Treated|0|||
27903158|NCT00957905|81481634|FG001|Part B|Not Treated|1|||
27903159|NCT00957905|81481633|FG000|Part B|Physician Decision|0|||
27903160|NCT00957905|81481634|FG001|Part B|Physician Decision|1|||
27903161|NCT00957905|81481633|FG000|Part B|Death|0|||
27903162|NCT00957905|81481634|FG001|Part B|Death|1|||
27903163|NCT00957905|81481633|FG000|Part B|Protocol Violation|0|||
27903164|NCT00957905|81481634|FG001|Part B|Protocol Violation|1|||
27903165|NCT01588405|81481635|FG000|Overall Study|Adverse Event|1|||
27903166|NCT01588405|81481635|FG000|Overall Study|Clinical Worsening|1|||
27903167|NCT00262002|81481636|FG000|Overall Study|Adverse Event|2|||
27903168|NCT00262002|81481637|FG001|Overall Study|Adverse Event|1|||
27903169|NCT00262002|81481638|FG002|Overall Study|Adverse Event|0|||
27903170|NCT00262002|81481639|FG003|Overall Study|Adverse Event|0|||
27903171|NCT00262002|81481640|FG004|Overall Study|Adverse Event|0|||
27903172|NCT00262002|81481641|FG005|Overall Study|Adverse Event|1|||
27903173|NCT00262002|81481642|FG006|Overall Study|Adverse Event|0|||
27903174|NCT00262002|81481636|FG000|Overall Study|Withdrawal by Subject|4|||
27903175|NCT00262002|81481637|FG001|Overall Study|Withdrawal by Subject|2|||
27903176|NCT00262002|81481638|FG002|Overall Study|Withdrawal by Subject|0|||
27903177|NCT00262002|81481639|FG003|Overall Study|Withdrawal by Subject|1|||
27903178|NCT00262002|81481640|FG004|Overall Study|Withdrawal by Subject|2|||
27903179|NCT00262002|81481641|FG005|Overall Study|Withdrawal by Subject|2|||
27903180|NCT00262002|81481642|FG006|Overall Study|Withdrawal by Subject|2|||
27903181|NCT00262002|81481636|FG000|Overall Study|Lost to Follow-up|2|||
27903182|NCT00262002|81481637|FG001|Overall Study|Lost to Follow-up|0|||
27903183|NCT00262002|81481638|FG002|Overall Study|Lost to Follow-up|0|||
27903184|NCT00262002|81481639|FG003|Overall Study|Lost to Follow-up|2|||
27903185|NCT00262002|81481640|FG004|Overall Study|Lost to Follow-up|0|||
27903186|NCT00262002|81481641|FG005|Overall Study|Lost to Follow-up|1|||
27903187|NCT00262002|81481642|FG006|Overall Study|Lost to Follow-up|0|||
27903188|NCT00262002|81481636|FG000|Overall Study|Inapropriate enrollment|0|||
27903189|NCT00262002|81481637|FG001|Overall Study|Inapropriate enrollment|1|||
27903190|NCT00262002|81481638|FG002|Overall Study|Inapropriate enrollment|0|||
27903191|NCT00262002|81481639|FG003|Overall Study|Inapropriate enrollment|0|||
27903192|NCT00262002|81481640|FG004|Overall Study|Inapropriate enrollment|0|||
27903193|NCT00262002|81481641|FG005|Overall Study|Inapropriate enrollment|0|||
27903194|NCT00262002|81481642|FG006|Overall Study|Inapropriate enrollment|0|||
27903195|NCT00262002|81481636|FG000|Overall Study|Protocol Violation|3|||
27614544|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
27614545|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
27614546|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
27728311|NCT02327260|80833232|FG001|Overall Study|Lost to Follow-up|3|||
27728312|NCT02327260|80833233|FG002|Overall Study|Lost to Follow-up|2|||
27728313|NCT02327260|80833231|FG000|Overall Study|invalid phone number|1|||
27728314|NCT02327260|80833232|FG001|Overall Study|invalid phone number|1|||
27728315|NCT02327260|80833233|FG002|Overall Study|invalid phone number|0|||
27903196|NCT00262002|81481637|FG001|Overall Study|Protocol Violation|2|||
27903197|NCT00262002|81481638|FG002|Overall Study|Protocol Violation|0|||
27903198|NCT00262002|81481639|FG003|Overall Study|Protocol Violation|2|||
27903199|NCT00262002|81481640|FG004|Overall Study|Protocol Violation|5|||
27903200|NCT00262002|81481641|FG005|Overall Study|Protocol Violation|3|||
27903201|NCT00262002|81481642|FG006|Overall Study|Protocol Violation|2|||
27903202|NCT00262002|81481636|FG000|Overall Study|Unable to classify|0|||
27903203|NCT00262002|81481637|FG001|Overall Study|Unable to classify|0|||
27903204|NCT00262002|81481638|FG002|Overall Study|Unable to classify|0|||
27903205|NCT00262002|81481639|FG003|Overall Study|Unable to classify|0|||
27903206|NCT00262002|81481640|FG004|Overall Study|Unable to classify|0|||
27903207|NCT00262002|81481641|FG005|Overall Study|Unable to classify|0|||
27903208|NCT00262002|81481642|FG006|Overall Study|Unable to classify|2|||
27903209|NCT03013985|81481643|FG000|Overall Study|Protocol Violation|2|||
27903210|NCT03013985|81481644|FG001|Overall Study|Protocol Violation|2|||
27903211|NCT03013985|81481643|FG000|Overall Study|Withdrawal by Subject|14|||
27903212|NCT03013985|81481644|FG001|Overall Study|Withdrawal by Subject|17|||
27903213|NCT01653327|81481645|FG000|Overall Study|Withdrawal by Subject|1|||
27903214|NCT02510820|81481649|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27903215|NCT02510820|81481650|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27903216|NCT02510820|81481649|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27903217|NCT02510820|81481650|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27903218|NCT02557516|81481655|FG000|Overall Study|Adverse Event|1|||
27903219|NCT02557516|81481656|FG001|Overall Study|Adverse Event|0|||
27903220|NCT02557516|81481657|FG002|Overall Study|Adverse Event|2|||
27903221|NCT02557516|81481658|FG003|Overall Study|Adverse Event|1|||
27903222|NCT02557516|81481655|FG000|Overall Study|Disease progression|0|||
27903223|NCT02557516|81481656|FG001|Overall Study|Disease progression|2|||
27903224|NCT02557516|81481657|FG002|Overall Study|Disease progression|0|||
27903225|NCT02557516|81481658|FG003|Overall Study|Disease progression|0|||
27903226|NCT02557516|81481655|FG000|Overall Study|Physician Decision|0|||
27903227|NCT02557516|81481656|FG001|Overall Study|Physician Decision|2|||
27903228|NCT02557516|81481657|FG002|Overall Study|Physician Decision|0|||
27903229|NCT02557516|81481658|FG003|Overall Study|Physician Decision|0|||
27903230|NCT02557516|81481655|FG000|Overall Study|Sponsor decision|0|||
27903231|NCT02557516|81481656|FG001|Overall Study|Sponsor decision|1|||
27903232|NCT02557516|81481657|FG002|Overall Study|Sponsor decision|2|||
27903233|NCT02557516|81481658|FG003|Overall Study|Sponsor decision|8|||
27903234|NCT01533688|81481659|FG000|Overall Study|Withdrawal by Subject|5|||
27903235|NCT01533688|81481660|FG001|Overall Study|Withdrawal by Subject|4|||
27903236|NCT01533688|81481661|FG002|Overall Study|Withdrawal by Subject|3|||
27903237|NCT01533688|81481659|FG000|Overall Study|Medically unstable|1|||
27614547|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27903238|NCT01533688|81481660|FG001|Overall Study|Medically unstable|3|||
27903239|NCT01533688|81481661|FG002|Overall Study|Medically unstable|3|||
27903240|NCT01533688|81481659|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
27903241|NCT01533688|81481660|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
27903242|NCT01533688|81481661|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
27903243|NCT00893971|81481662|FG000|Overall Study|Physician Decision|3|||
27903244|NCT03089853|81481663|FG000|Overall Study|Lost to Follow-up|2|||
27903245|NCT03089853|81481664|FG001|Overall Study|Lost to Follow-up|1|||
27903246|NCT02070978|81481665|FG000|Overall Study|Adverse Event|6|||
27903247|NCT02070978|81481666|FG001|Overall Study|Adverse Event|2|||
27903248|NCT02070978|81481667|FG002|Overall Study|Adverse Event|0|||
27614548|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
27614549|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27614550|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27614551|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
27614552|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
27614553|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27614554|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27614555|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
27614556|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
27903249|NCT02070978|81481665|FG000|Overall Study|Lost to Follow-up|1|||
27903250|NCT02070978|81481666|FG001|Overall Study|Lost to Follow-up|3|||
27903251|NCT02070978|81481667|FG002|Overall Study|Lost to Follow-up|4|||
27903252|NCT02070978|81481665|FG000|Overall Study|Withdrawal by Subject|3|||
27903253|NCT02070978|81481666|FG001|Overall Study|Withdrawal by Subject|5|||
27903254|NCT02070978|81481667|FG002|Overall Study|Withdrawal by Subject|3|||
27903255|NCT02070978|81481665|FG000|Overall Study|Protocol Violation|1|||
27903256|NCT02070978|81481666|FG001|Overall Study|Protocol Violation|0|||
27903257|NCT02070978|81481667|FG002|Overall Study|Protocol Violation|3|||
27903258|NCT02070978|81481665|FG000|Overall Study|Lack of Efficacy|0|||
27903259|NCT02070978|81481666|FG001|Overall Study|Lack of Efficacy|1|||
27903260|NCT02070978|81481667|FG002|Overall Study|Lack of Efficacy|0|||
27903261|NCT02070978|81481665|FG000|Overall Study|Death|0|||
27903262|NCT02070978|81481666|FG001|Overall Study|Death|0|||
27903263|NCT02070978|81481667|FG002|Overall Study|Death|2|||
27903264|NCT02070978|81481665|FG000|Overall Study|Un-specified|3|||
27903265|NCT02070978|81481666|FG001|Overall Study|Un-specified|2|||
27903266|NCT02070978|81481667|FG002|Overall Study|Un-specified|2|||
27903267|NCT02070978|81481665|FG000|Overall Study|Terminated by Sponsor|33|||
27614557|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27851763|NCT00620659|81287138|FG002|Treatment Period 3|Adverse Event|0|||
27851764|NCT00620659|81287139|FG003|Treatment Period 3|Adverse Event|0|||
27851765|NCT00620659|81287140|FG004|Treatment Period 3|Adverse Event|0|||
27851766|NCT00620659|81287141|FG005|Treatment Period 3|Adverse Event|0|||
27851767|NCT00620659|81287136|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27851768|NCT00620659|81287137|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27851769|NCT00620659|81287138|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27851770|NCT00620659|81287139|FG003|Treatment Period 3|Withdrawal by Subject|1|||
27851771|NCT00620659|81287140|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27903268|NCT02070978|81481666|FG001|Overall Study|Terminated by Sponsor|40|||
27903269|NCT02070978|81481667|FG002|Overall Study|Terminated by Sponsor|39|||
27903270|NCT01210222|81481668|FG000|Overall Study|Ineligible|2|||
27903271|NCT01210222|81481668|FG000|Overall Study|Never treated|1|||
27903272|NCT02697734|81481675|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
27506858|NCT02435992|80048031|FG001|Overall Study|non compliance with protocol|0|||
27506859|NCT02435992|80048032|FG002|Overall Study|non compliance with protocol|1|||
27506860|NCT02435992|80048033|FG003|Overall Study|non compliance with protocol|0|||
27506861|NCT02435992|80048034|FG004|Overall Study|non compliance with protocol|0|||
27506862|NCT02435992|80048030|FG000|Overall Study|Adverse Event|11|||
27506863|NCT02435992|80048031|FG001|Overall Study|Adverse Event|6|||
27506864|NCT02435992|80048032|FG002|Overall Study|Adverse Event|12|||
27506865|NCT02435992|80048033|FG003|Overall Study|Adverse Event|0|||
27506866|NCT02435992|80048034|FG004|Overall Study|Adverse Event|0|||
27506867|NCT02435992|80048030|FG000|Overall Study|Lack of Efficacy|4|||
27506868|NCT02435992|80048031|FG001|Overall Study|Lack of Efficacy|10|||
27851772|NCT00620659|81287141|FG005|Treatment Period 3|Withdrawal by Subject|0|||
27851773|NCT01386684|81287142|FG000|Overall Study|Lost to Follow-up|51|||
27851774|NCT01386684|81287142|FG000|Overall Study|Other|51|||
27851775|NCT01386684|81287142|FG000|Overall Study|Death|47|||
27851776|NCT01386684|81287142|FG000|Overall Study|Withdrawal of Consent|44|||
27851777|NCT01386684|81287142|FG000|Overall Study|Alternative Therapy Required|37|||
27851778|NCT01386684|81287142|FG000|Overall Study|Disease Progression|28|||
27851779|NCT01386684|81287142|FG000|Overall Study|Adverse Event|20|||
27851780|NCT01386684|81287142|FG000|Overall Study|Noncompliance|8|||
27851781|NCT01386684|81287142|FG000|Overall Study|Protocol Violation|4|||
27851782|NCT01386684|81287142|FG000|Overall Study|Missing|3|||
27851783|NCT01481324|81287143|FG000|Overall Study|Missing Data|0|||
27851784|NCT01481324|81287144|FG001|Overall Study|Missing Data|2|||
27851785|NCT01481324|81287145|FG002|Overall Study|Missing Data|2|||
27851786|NCT03979820|81287148|FG000|Overall Study|Protocol Violation|1|||
27851787|NCT03979820|81287149|FG001|Overall Study|Protocol Violation|0|||
27851788|NCT03979820|81287150|FG002|Overall Study|Protocol Violation|0|||
27851789|NCT03979820|81287151|FG003|Overall Study|Protocol Violation|0|||
27506869|NCT02435992|80048032|FG002|Overall Study|Lack of Efficacy|9|||
27506870|NCT02435992|80048033|FG003|Overall Study|Lack of Efficacy|0|||
27506871|NCT02435992|80048034|FG004|Overall Study|Lack of Efficacy|0|||
27506872|NCT02435992|80048030|FG000|Overall Study|Withdrawal by Subject|10|||
27506873|NCT02435992|80048031|FG001|Overall Study|Withdrawal by Subject|8|||
27506874|NCT02435992|80048032|FG002|Overall Study|Withdrawal by Subject|20|||
27506875|NCT02435992|80048033|FG003|Overall Study|Withdrawal by Subject|0|||
27506876|NCT02435992|80048034|FG004|Overall Study|Withdrawal by Subject|0|||
27506877|NCT02435992|80048030|FG000|Overall Study|Other Reason|1|||
27506878|NCT02435992|80048031|FG001|Overall Study|Other Reason|0|||
27506879|NCT02435992|80048032|FG002|Overall Study|Other Reason|0|||
27506880|NCT02435992|80048033|FG003|Overall Study|Other Reason|0|||
27506881|NCT02435992|80048034|FG004|Overall Study|Other Reason|0|||
27506882|NCT02435992|80048030|FG000|Overall Study|Physician Decision|0|||
27506883|NCT02435992|80048031|FG001|Overall Study|Physician Decision|0|||
27851790|NCT03979820|81287148|FG000|Overall Study|Withdrawal by Subject|0|||
27851791|NCT03979820|81287149|FG001|Overall Study|Withdrawal by Subject|0|||
27851792|NCT03979820|81287150|FG002|Overall Study|Withdrawal by Subject|1|||
27851793|NCT03979820|81287151|FG003|Overall Study|Withdrawal by Subject|0|||
27851794|NCT03979820|81287148|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
27851795|NCT03979820|81287149|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
27851796|NCT03979820|81287150|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
27851797|NCT03979820|81287151|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
27851798|NCT01659736|81287154|FG000|Treatment Period|Adverse Event|1|||
27506884|NCT02435992|80048032|FG002|Overall Study|Physician Decision|1|||
27506885|NCT02435992|80048033|FG003|Overall Study|Physician Decision|0|||
27851799|NCT01659736|81287155|FG001|Treatment Period|Adverse Event|1|||
27506886|NCT02435992|80048034|FG004|Overall Study|Physician Decision|0|||
27506887|NCT02557139|80048036|FG000|Overall Study|Significant liver elevation|1|||
27851800|NCT01659736|81287154|FG000|Treatment Period|Protocol Violation|3|||
27851801|NCT01659736|81287155|FG001|Treatment Period|Protocol Violation|1|||
27506888|NCT02557139|80048037|FG001|Overall Study|Significant liver elevation|0|||
27506889|NCT02557139|80048038|FG002|Overall Study|Significant liver elevation|1|||
27851802|NCT01659736|81287154|FG000|Treatment Period|Withdrawal by Subject|1|||
27851803|NCT01659736|81287155|FG001|Treatment Period|Withdrawal by Subject|0|||
27506890|NCT02557139|80048036|FG000|Overall Study|Withdrawal by Subject|1|||
27506891|NCT02557139|80048037|FG001|Overall Study|Withdrawal by Subject|0|||
27506892|NCT02557139|80048038|FG002|Overall Study|Withdrawal by Subject|0|||
27506893|NCT02557139|80048036|FG000|Overall Study|Illness of prohibited medication|0|||
27506894|NCT02557139|80048037|FG001|Overall Study|Illness of prohibited medication|0|||
27506895|NCT02557139|80048038|FG002|Overall Study|Illness of prohibited medication|1|||
27506896|NCT04004988|80048040|FG000|Period 1|Physician Decision|2|||
27506897|NCT04004988|80048041|FG001|Period 1|Physician Decision|0|||
27506898|NCT04004988|80048040|FG000|Period 1|Withdrawal by Subject|0|||
27506899|NCT04004988|80048041|FG001|Period 1|Withdrawal by Subject|1|||
27506900|NCT04004988|80048040|FG000|Period 1|Adverse Event|1|||
27506901|NCT04004988|80048041|FG001|Period 1|Adverse Event|2|||
27506902|NCT01389596|80048042|FG000|Overall Study|Protocol Violation|3|||
27506903|NCT01389596|80048043|FG001|Overall Study|Protocol Violation|4|||
27506904|NCT01389596|80048044|FG002|Overall Study|Protocol Violation|3|||
27506905|NCT01389596|80048042|FG000|Overall Study|Withdrawal by Subject|1|||
27506906|NCT01389596|80048043|FG001|Overall Study|Withdrawal by Subject|2|||
27506907|NCT01389596|80048044|FG002|Overall Study|Withdrawal by Subject|2|||
27506908|NCT01389596|80048042|FG000|Overall Study|Insufficient Clinical Response|3|||
27506909|NCT01389596|80048043|FG001|Overall Study|Insufficient Clinical Response|4|||
27506910|NCT01389596|80048044|FG002|Overall Study|Insufficient Clinical Response|5|||
27506911|NCT01389596|80048042|FG000|Overall Study|Adverse Event|1|||
27614558|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27903273|NCT02697734|81481676|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
27903274|NCT02697734|81481675|FG000|Core Phase - up to Week 48|Adverse Event|1|||
27903275|NCT02697734|81481676|FG001|Core Phase - up to Week 48|Adverse Event|2|||
27903276|NCT02697734|81481675|FG000|Core Phase - up to Week 48|Physician Decision|1|||
27903277|NCT02697734|81481676|FG001|Core Phase - up to Week 48|Physician Decision|0|||
27903278|NCT02697734|81481675|FG000|Optional Extension Phase|Adverse Event|5|||
27903279|NCT02697734|81481676|FG001|Optional Extension Phase|Adverse Event|1|||
27903280|NCT02697734|81481675|FG000|Optional Extension Phase|Physician Decision|0|||
27903281|NCT02697734|81481676|FG001|Optional Extension Phase|Physician Decision|1|||
27903282|NCT03055494|81481677|FG000|Overall Study|Lost to Follow-up|6|||
27903283|NCT03055494|81481678|FG001|Overall Study|Lost to Follow-up|0|||
27903284|NCT03055494|81481677|FG000|Overall Study|Physician Decision|2|||
27903285|NCT03055494|81481678|FG001|Overall Study|Physician Decision|0|||
27903286|NCT03055494|81481677|FG000|Overall Study|Withdrawal by Subject|1|||
27903287|NCT03055494|81481678|FG001|Overall Study|Withdrawal by Subject|0|||
27903288|NCT03055494|81481677|FG000|Overall Study|Adverse Event|0|||
27903289|NCT03055494|81481678|FG001|Overall Study|Adverse Event|1|||
27903290|NCT03055494|81481677|FG000|Overall Study|Non-compliance with study treatment|1|||
27903291|NCT03055494|81481678|FG001|Overall Study|Non-compliance with study treatment|0|||
27903292|NCT00908596|81481679|FG000|Overall Study|Other reasons|46|||
27903293|NCT00908596|81481680|FG001|Overall Study|Other reasons|6|||
27903294|NCT00908596|81481681|FG002|Overall Study|Other reasons|2|||
27903295|NCT00908596|81481682|FG003|Overall Study|Other reasons|0|||
27903296|NCT00908596|81481679|FG000|Overall Study|Lost to Follow-up|0|||
27903297|NCT00908596|81481680|FG001|Overall Study|Lost to Follow-up|1|||
27903298|NCT00908596|81481681|FG002|Overall Study|Lost to Follow-up|12|||
27903299|NCT00908596|81481682|FG003|Overall Study|Lost to Follow-up|4|||
27903300|NCT00908596|81481679|FG000|Overall Study|Death|0|||
27903301|NCT00908596|81481680|FG001|Overall Study|Death|5|||
27903302|NCT00908596|81481681|FG002|Overall Study|Death|57|||
27903303|NCT00908596|81481682|FG003|Overall Study|Death|32|||
27903304|NCT00908596|81481679|FG000|Overall Study|Protocol Violation|1|||
27903305|NCT00908596|81481680|FG001|Overall Study|Protocol Violation|0|||
27903306|NCT00908596|81481681|FG002|Overall Study|Protocol Violation|0|||
27903307|NCT00908596|81481682|FG003|Overall Study|Protocol Violation|0|||
27903308|NCT00908596|81481679|FG000|Overall Study|Withdrawal by Subject|0|||
27903309|NCT00908596|81481680|FG001|Overall Study|Withdrawal by Subject|1|||
27903310|NCT00908596|81481681|FG002|Overall Study|Withdrawal by Subject|3|||
27506912|NCT01389596|80048043|FG001|Overall Study|Adverse Event|4|||
27506913|NCT01389596|80048044|FG002|Overall Study|Adverse Event|0|||
27506914|NCT01389596|80048042|FG000|Overall Study|Death|0|||
27506915|NCT01389596|80048043|FG001|Overall Study|Death|1|||
27506916|NCT01389596|80048044|FG002|Overall Study|Death|0|||
27506917|NCT01389596|80048042|FG000|Overall Study|Other Unspecified|2|||
27614559|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
27903311|NCT00908596|81481682|FG003|Overall Study|Withdrawal by Subject|1|||
27903312|NCT01348100|81481686|FG000|Overall Study|Subject Withdrew Consent|0|||
27903313|NCT01348100|81481687|FG001|Overall Study|Subject Withdrew Consent|0|||
27903314|NCT01348100|81481688|FG002|Overall Study|Subject Withdrew Consent|2|||
27903315|NCT01348100|81481689|FG003|Overall Study|Subject Withdrew Consent|0|||
27903316|NCT01348100|81481690|FG004|Overall Study|Subject Withdrew Consent|1|||
27903317|NCT01348100|81481691|FG005|Overall Study|Subject Withdrew Consent|0|||
27903318|NCT01348100|81481692|FG006|Overall Study|Subject Withdrew Consent|1|||
27903319|NCT01348100|81481686|FG000|Overall Study|Protocol Deviation|0|||
27728316|NCT02327260|80833231|FG000|Overall Study|non-adherence to protocol|2|||
27728317|NCT02327260|80833232|FG001|Overall Study|non-adherence to protocol|0|||
27728318|NCT02327260|80833233|FG002|Overall Study|non-adherence to protocol|0|||
27728319|NCT02327260|80833231|FG000|Overall Study|cognitive concerns|1|||
27506918|NCT01389596|80048043|FG001|Overall Study|Other Unspecified|1|||
27506919|NCT01389596|80048044|FG002|Overall Study|Other Unspecified|0|||
27728320|NCT02327260|80833232|FG001|Overall Study|cognitive concerns|0|||
27614560|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
27614561|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
27614562|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
27614563|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
27614564|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
27614565|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
27614566|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
27614567|NCT03230864|80430316|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
27614568|NCT03230864|80430317|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
27851804|NCT01659736|81287154|FG000|3-month Follow-up|Lost to Follow-up|0|||
27851805|NCT01659736|81287155|FG001|3-month Follow-up|Lost to Follow-up|1|||
27851806|NCT01338987|81287156|FG000|Overall Study|enrolled on new protocol|0|||
27903320|NCT01348100|81481687|FG001|Overall Study|Protocol Deviation|0|||
27903321|NCT01348100|81481688|FG002|Overall Study|Protocol Deviation|0|||
27506920|NCT03350672|80048045|FG000|Overall Study|Withdrawal by Subject|7|||
27506921|NCT03350672|80048046|FG001|Overall Study|Withdrawal by Subject|0|||
27506922|NCT03350672|80048047|FG002|Overall Study|Withdrawal by Subject|0|||
27506923|NCT01929317|80048048|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
27506924|NCT01929317|80048049|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
27506925|NCT01929317|80048048|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
27506926|NCT01929317|80048049|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
27506927|NCT01929317|80048048|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
27506928|NCT01929317|80048049|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
27506929|NCT01929317|80048048|FG000|Long-term Phase|Adverse Event|5|||
27506930|NCT01929317|80048049|FG001|Long-term Phase|Adverse Event|1|||
27506931|NCT01929317|80048048|FG000|Long-term Phase|Physician Decision|3|||
27506932|NCT01929317|80048049|FG001|Long-term Phase|Physician Decision|0|||
27506933|NCT01929317|80048048|FG000|Long-term Phase|Withdrawal by Subject|4|||
27506934|NCT01929317|80048049|FG001|Long-term Phase|Withdrawal by Subject|0|||
27506935|NCT01929317|80048048|FG000|Long-term Phase|Protocol Violation|1|||
27506936|NCT01929317|80048049|FG001|Long-term Phase|Protocol Violation|0|||
27506937|NCT01929317|80048048|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
27506938|NCT01929317|80048049|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
27506939|NCT01929317|80048048|FG000|Long-term Phase|Study Closed/Terminated|5|||
27506940|NCT01929317|80048049|FG001|Long-term Phase|Study Closed/Terminated|3|||
27506941|NCT01318915|80048057|FG000|Overall Study|Lost to Follow-up|1|||
27506942|NCT01393821|80048058|FG000|Overall Study|Cancel|1|||
27506943|NCT01393821|80048059|FG001|Overall Study|Cancel|1|||
27506944|NCT01393821|80048058|FG000|Overall Study|not evaluable for primary endpoint|4|||
27506945|NCT01393821|80048059|FG001|Overall Study|not evaluable for primary endpoint|2|||
27506946|NCT03220035|80048060|FG000|Overall Study|Adverse Event|1|||
27506947|NCT03220035|80048060|FG000|Overall Study|Protocol Violation|1|||
27506948|NCT03220035|80048060|FG000|Overall Study|Progressive Disease|2|||
27506949|NCT04798196|80048061|FG000|Overall Study|Lost to Follow-up|3|||
27506950|NCT04798196|80048062|FG001|Overall Study|Lost to Follow-up|1|||
27506951|NCT04798196|80048063|FG002|Overall Study|Lost to Follow-up|3|||
27506952|NCT03863080|80048064|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
27506953|NCT03863080|80048065|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
27506954|NCT03863080|80048066|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
27506955|NCT03863080|80048067|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
27506956|NCT03863080|80048064|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
27506957|NCT03863080|80048065|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
27506958|NCT03863080|80048066|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
27506959|NCT03863080|80048067|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
27506960|NCT03863080|80048064|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
27506961|NCT03863080|80048065|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
27506962|NCT03863080|80048066|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
27506963|NCT03863080|80048067|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
27506964|NCT03304626|80048068|FG000|Overall Study|Adverse Event|1|||
27506965|NCT03304626|80048069|FG001|Overall Study|Adverse Event|0|||
27506966|NCT03304626|80048068|FG000|Overall Study|Lack of Efficacy|1|||
27506967|NCT03304626|80048069|FG001|Overall Study|Lack of Efficacy|1|||
27614569|NCT03230864|80430318|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
27614570|NCT03230864|80430319|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
27506968|NCT03219723|80048072|FG000|Overall Study|Case Report Forms Uncollected|6|||
27506969|NCT03219723|80048072|FG000|Overall Study|Protocol Deviation|4|||
27506970|NCT04885998|80048074|FG000|Overall Study|Ongoing in study|3|||
27506971|NCT04885998|80048075|FG001|Overall Study|Ongoing in study|2|||
27506972|NCT04885998|80048076|FG002|Overall Study|Ongoing in study|2|||
27506973|NCT04885998|80048077|FG003|Overall Study|Ongoing in study|6|||
27506974|NCT04885998|80048074|FG000|Overall Study|Withdrawal by Subject|0|||
27506975|NCT04885998|80048075|FG001|Overall Study|Withdrawal by Subject|2|||
27506976|NCT04885998|80048076|FG002|Overall Study|Withdrawal by Subject|1|||
27506977|NCT04885998|80048077|FG003|Overall Study|Withdrawal by Subject|1|||
27506978|NCT04885998|80048074|FG000|Overall Study|Lost to Follow-up|1|||
27506979|NCT04885998|80048075|FG001|Overall Study|Lost to Follow-up|0|||
27506980|NCT04885998|80048076|FG002|Overall Study|Lost to Follow-up|0|||
27728321|NCT02327260|80833233|FG002|Overall Study|cognitive concerns|0|||
27728322|NCT01707030|80833234|FG000|Overall Study|Death|1|||
27506981|NCT04885998|80048077|FG003|Overall Study|Lost to Follow-up|0|||
27506982|NCT04885998|80048074|FG000|Overall Study|Death|2|||
27506983|NCT04885998|80048075|FG001|Overall Study|Death|1|||
27506984|NCT04885998|80048076|FG002|Overall Study|Death|1|||
27506985|NCT04885998|80048077|FG003|Overall Study|Death|0|||
27506986|NCT02851615|80048094|FG000|Overall Study|Cognitive Issue|1|||
27506987|NCT02851615|80048095|FG001|Overall Study|Cognitive Issue|0|||
27506988|NCT02851615|80048094|FG000|Overall Study|Lost to Follow-up|0|||
27506989|NCT02851615|80048095|FG001|Overall Study|Lost to Follow-up|4|||
27506990|NCT00665652|80048096|FG000|Overall Study|Adverse Event|4|||
27506991|NCT00665652|80048096|FG000|Overall Study|Death|1|||
27903322|NCT01348100|81481689|FG003|Overall Study|Protocol Deviation|1|||
27903323|NCT01348100|81481690|FG004|Overall Study|Protocol Deviation|0|||
27903324|NCT01348100|81481691|FG005|Overall Study|Protocol Deviation|0|||
27903325|NCT01348100|81481692|FG006|Overall Study|Protocol Deviation|0|||
27903326|NCT01348100|81481686|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27903327|NCT01348100|81481687|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27903328|NCT01348100|81481688|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27903329|NCT01348100|81481689|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27903330|NCT01348100|81481690|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27903331|NCT01348100|81481691|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
27903332|NCT01348100|81481692|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27903333|NCT01348100|81481686|FG000|Overall Study|Lost to Follow-up|0|||
27903334|NCT01348100|81481687|FG001|Overall Study|Lost to Follow-up|0|||
27506992|NCT00665652|80048096|FG000|Overall Study|No longer met inclusion criteria.|1|||
27506993|NCT02015637|80048097|FG000|Overall Study|Lost to Follow-up|3|||
27506994|NCT02015637|80048098|FG001|Overall Study|Lost to Follow-up|5|||
27903335|NCT01348100|81481688|FG002|Overall Study|Lost to Follow-up|0|||
27903336|NCT01348100|81481689|FG003|Overall Study|Lost to Follow-up|0|||
27506995|NCT02015637|80048097|FG000|Overall Study|Adverse Event|3|||
27614571|NCT03230864|80430316|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
27614572|NCT03230864|80430317|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
27614573|NCT03230864|80430318|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
27851807|NCT01338987|81287157|FG001|Overall Study|enrolled on new protocol|0|||
27851808|NCT01338987|81287158|FG002|Overall Study|enrolled on new protocol|1|||
27851809|NCT01338987|81287159|FG003|Overall Study|enrolled on new protocol|0|||
27851810|NCT01338987|81287160|FG004|Overall Study|enrolled on new protocol|0|||
27851811|NCT01338987|81287156|FG000|Overall Study|Disease progression on study|2|||
27851812|NCT01338987|81287157|FG001|Overall Study|Disease progression on study|1|||
27851813|NCT01338987|81287158|FG002|Overall Study|Disease progression on study|1|||
27851814|NCT01338987|81287159|FG003|Overall Study|Disease progression on study|0|||
27851815|NCT01338987|81287160|FG004|Overall Study|Disease progression on study|0|||
27851816|NCT02238626|81287161|FG000|Overall Study|Adverse Event|3|||
27851817|NCT02238626|81287162|FG001|Overall Study|Adverse Event|5|||
27851818|NCT02238626|81287163|FG002|Overall Study|Adverse Event|0|||
27851819|NCT02238626|81287164|FG003|Overall Study|Adverse Event|3|||
27851820|NCT02238626|81287161|FG000|Overall Study|Lost to Follow-up|2|||
27851821|NCT02238626|81287162|FG001|Overall Study|Lost to Follow-up|4|||
27851822|NCT02238626|81287163|FG002|Overall Study|Lost to Follow-up|2|||
27851823|NCT02238626|81287164|FG003|Overall Study|Lost to Follow-up|2|||
27851824|NCT02238626|81287161|FG000|Overall Study|Withdrawal by Subject|0|||
27903337|NCT01348100|81481690|FG004|Overall Study|Lost to Follow-up|0|||
27903338|NCT01348100|81481691|FG005|Overall Study|Lost to Follow-up|0|||
27903339|NCT01348100|81481692|FG006|Overall Study|Lost to Follow-up|1|||
27903340|NCT01348100|81481686|FG000|Overall Study|Administrative Problems|0|||
27903341|NCT01348100|81481687|FG001|Overall Study|Administrative Problems|0|||
27903342|NCT01348100|81481688|FG002|Overall Study|Administrative Problems|0|||
27903343|NCT01348100|81481689|FG003|Overall Study|Administrative Problems|0|||
27903344|NCT01348100|81481690|FG004|Overall Study|Administrative Problems|0|||
27903345|NCT01348100|81481691|FG005|Overall Study|Administrative Problems|1|||
27903346|NCT01348100|81481692|FG006|Overall Study|Administrative Problems|1|||
27903347|NCT01162122|81481693|FG000|Overall Study|Withdrawal by Subject|52|||
27903348|NCT01162122|81481694|FG001|Overall Study|Withdrawal by Subject|43|||
27903349|NCT01162122|81481693|FG000|Overall Study|Lost to Follow-up|73|||
27903350|NCT01162122|81481694|FG001|Overall Study|Lost to Follow-up|91|||
27903351|NCT01162122|81481693|FG000|Overall Study|Adverse Event|3|||
27903352|NCT01162122|81481694|FG001|Overall Study|Adverse Event|2|||
27903353|NCT01162122|81481693|FG000|Overall Study|Death|51|||
27903354|NCT01162122|81481694|FG001|Overall Study|Death|46|||
27903355|NCT01162122|81481693|FG000|Overall Study|Protocol Violation|2|||
27903356|NCT01162122|81481694|FG001|Overall Study|Protocol Violation|2|||
27903357|NCT01162122|81481693|FG000|Overall Study|Inappropriate enrollment|5|||
27903358|NCT01162122|81481694|FG001|Overall Study|Inappropriate enrollment|4|||
27903359|NCT01162122|81481693|FG000|Overall Study|Administrative reason|1|||
27903360|NCT01162122|81481694|FG001|Overall Study|Administrative reason|1|||
27903361|NCT01162122|81481693|FG000|Overall Study|Unable to classify|3|||
27903362|NCT01162122|81481694|FG001|Overall Study|Unable to classify|7|||
27903363|NCT01162122|81481693|FG000|Overall Study|Missing primary reason|1|||
27903364|NCT01162122|81481694|FG001|Overall Study|Missing primary reason|0|||
27903365|NCT01438814|81481698|FG000|Overall Study|Adverse Event|3|||
27903366|NCT01438814|81481699|FG001|Overall Study|Adverse Event|3|||
27903367|NCT01438814|81481698|FG000|Overall Study|Protocol Violation|1|||
27903368|NCT01438814|81481699|FG001|Overall Study|Protocol Violation|2|||
27903369|NCT01438814|81481698|FG000|Overall Study|Lost to Follow-up|4|||
27506996|NCT02015637|80048098|FG001|Overall Study|Adverse Event|0|||
27851825|NCT02238626|81287162|FG001|Overall Study|Withdrawal by Subject|3|||
27903370|NCT01438814|81481699|FG001|Overall Study|Lost to Follow-up|3|||
27903371|NCT01438814|81481698|FG000|Overall Study|Withdrawal by Subject|4|||
27506997|NCT02015637|80048097|FG000|Overall Study|Did not take study drug|2|||
27506998|NCT02015637|80048098|FG001|Overall Study|Did not take study drug|0|||
27614574|NCT03230864|80430319|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
27614575|NCT03230864|80430316|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27614576|NCT03230864|80430317|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27728323|NCT01707030|80833235|FG001|Overall Study|Death|1|||
27506999|NCT00091949|80048099|FG000|Overall Study|Withdrawal by Subject|117|||
27507000|NCT00091949|80048100|FG001|Overall Study|Withdrawal by Subject|110|||
27507001|NCT00091949|80048099|FG000|Overall Study|Lost to Follow-up|58|||
27507002|NCT00091949|80048100|FG001|Overall Study|Lost to Follow-up|41|||
27507003|NCT02202759|80051392|FG000|Overall Study|Study Terminated by Sponsor|3|||
27507004|NCT02202759|80051393|FG001|Overall Study|Study Terminated by Sponsor|3|||
27507005|NCT02202759|80051394|FG002|Overall Study|Study Terminated by Sponsor|3|||
27507006|NCT02202759|80051392|FG000|Overall Study|Withdrawal by Subject|2|||
27507007|NCT02202759|80051393|FG001|Overall Study|Withdrawal by Subject|1|||
27507008|NCT02202759|80051394|FG002|Overall Study|Withdrawal by Subject|1|||
27507009|NCT02202759|80051392|FG000|Overall Study|Reason not Specified|4|||
27507010|NCT02202759|80051393|FG001|Overall Study|Reason not Specified|11|||
27507011|NCT02202759|80051394|FG002|Overall Study|Reason not Specified|10|||
27507012|NCT03038100|80051395|FG000|Overall Study|Death|289|||
27507013|NCT03038100|80051396|FG001|Overall Study|Death|272|||
27507014|NCT03038100|80051395|FG000|Overall Study|Lost to Follow-up|9|||
27507015|NCT03038100|80051396|FG001|Overall Study|Lost to Follow-up|10|||
27507016|NCT03038100|80051395|FG000|Overall Study|Protocol Deviation|1|||
27507017|NCT03038100|80051396|FG001|Overall Study|Protocol Deviation|4|||
27507018|NCT03038100|80051395|FG000|Overall Study|Withdrawal by Subject|45|||
27507019|NCT03038100|80051396|FG001|Overall Study|Withdrawal by Subject|51|||
27507020|NCT03038100|80051395|FG000|Overall Study|Study Terminated By Sponsor|305|||
27507021|NCT03038100|80051396|FG001|Overall Study|Study Terminated By Sponsor|311|||
27507022|NCT03038100|80051395|FG000|Overall Study|Physician Decision|1|||
27507023|NCT03038100|80051396|FG001|Overall Study|Physician Decision|3|||
27507024|NCT05038982|80051399|FG000|Overall Study|Withdrawal by Subject|0|||
27507025|NCT05038982|80051400|FG001|Overall Study|Withdrawal by Subject|2|||
27507026|NCT00335777|80051402|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
27507027|NCT00335777|80051402|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
27507028|NCT00335777|80051402|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
27507029|NCT00335777|80051402|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
27507030|NCT00335777|80051402|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
27507031|NCT02177032|80051404|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
27507032|NCT02177032|80051405|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
27507033|NCT02177032|80051406|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
27507034|NCT02177032|80051407|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
27507035|NCT02177032|80051404|FG000|Overall Study|Lost to Follow-up|0|||
27507036|NCT02177032|80051405|FG001|Overall Study|Lost to Follow-up|2|||
27507037|NCT02177032|80051406|FG002|Overall Study|Lost to Follow-up|0|||
27507038|NCT02177032|80051407|FG003|Overall Study|Lost to Follow-up|0|||
27507039|NCT02177032|80051404|FG000|Overall Study|OTHER|2|||
27903372|NCT01438814|81481699|FG001|Overall Study|Withdrawal by Subject|2|||
27903373|NCT01438814|81481698|FG000|Overall Study|Other|2|||
27903374|NCT01438814|81481699|FG001|Overall Study|Other|4|||
27903375|NCT03484403|81481700|FG000|Overall Study|Withdrawal by Subject|6|||
27903376|NCT03484403|81481701|FG001|Overall Study|Withdrawal by Subject|4|||
27903377|NCT02886884|81481704|FG000|Follow-up|Withdrawal by Subject|0|||
27903378|NCT02886884|81481705|FG001|Follow-up|Withdrawal by Subject|0|||
27903379|NCT02886884|81481706|FG002|Follow-up|Withdrawal by Subject|0|||
27903380|NCT02886884|81481707|FG003|Follow-up|Withdrawal by Subject|1|||
27903381|NCT01180049|81481711|FG000|Overall Study|Other|9|||
27903382|NCT01180049|81481712|FG001|Overall Study|Other|7|||
27903383|NCT01180049|81481711|FG000|Overall Study|Lost to Follow-up|8|||
27903384|NCT01180049|81481712|FG001|Overall Study|Lost to Follow-up|6|||
27903385|NCT01180049|81481711|FG000|Overall Study|Death|36|||
27903386|NCT01180049|81481712|FG001|Overall Study|Death|35|||
27903387|NCT02688764|81481713|FG000|Overall Study|Adverse Event|3|||
27903388|NCT02688764|81481714|FG001|Overall Study|Adverse Event|3|||
27903389|NCT02688764|81481713|FG000|Overall Study|AE/Kidney transplant|1|||
27903390|NCT02688764|81481714|FG001|Overall Study|AE/Kidney transplant|0|||
27903391|NCT02688764|81481713|FG000|Overall Study|AE/Lack of efficacy|1|||
27903392|NCT02688764|81481714|FG001|Overall Study|AE/Lack of efficacy|0|||
27903393|NCT02688764|81481713|FG000|Overall Study|AE/Non-compl.|1|||
27903394|NCT02688764|81481714|FG001|Overall Study|AE/Non-compl.|0|||
27903395|NCT02688764|81481713|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
27903396|NCT02688764|81481714|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
27903397|NCT02688764|81481713|FG000|Overall Study|AE/Other|0|||
27903398|NCT02688764|81481714|FG001|Overall Study|AE/Other|1|||
27903399|NCT02688764|81481713|FG000|Overall Study|AE/Physician decision|1|||
27903400|NCT02688764|81481714|FG001|Overall Study|AE/Physician decision|0|||
27903401|NCT02688764|81481713|FG000|Overall Study|AE/Withd. parent|3|||
27903402|NCT02688764|81481714|FG001|Overall Study|AE/Withd. parent|0|||
27903403|NCT02688764|81481713|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
27903404|NCT02688764|81481714|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
27903405|NCT02688764|81481713|FG000|Overall Study|AE/Withd. subject|1|||
27903406|NCT02688764|81481714|FG001|Overall Study|AE/Withd. subject|0|||
27903407|NCT02688764|81481713|FG000|Overall Study|Kidney transplant|10|||
27903408|NCT02688764|81481714|FG001|Overall Study|Kidney transplant|4|||
27903409|NCT02688764|81481713|FG000|Overall Study|Lack of Efficacy|3|||
27903410|NCT02688764|81481714|FG001|Overall Study|Lack of Efficacy|2|||
27903411|NCT02688764|81481713|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
27903412|NCT02688764|81481714|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
27903413|NCT02688764|81481713|FG000|Overall Study|Non-compliance with study drug|4|||
27903414|NCT02688764|81481714|FG001|Overall Study|Non-compliance with study drug|0|||
27903415|NCT02688764|81481713|FG000|Overall Study|Non-compl./Physician decision|2|||
27903416|NCT02688764|81481714|FG001|Overall Study|Non-compl./Physician decision|0|||
27903417|NCT02688764|81481713|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
27903418|NCT02688764|81481714|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
27903419|NCT02688764|81481713|FG000|Overall Study|Non-compl./Withd. subject|0|||
27903420|NCT02688764|81481714|FG001|Overall Study|Non-compl./Withd. subject|2|||
27903421|NCT02688764|81481713|FG000|Overall Study|Phosphorus level outside safe range|0|||
27903422|NCT02688764|81481714|FG001|Overall Study|Phosphorus level outside safe range|1|||
27903423|NCT02688764|81481713|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
27903424|NCT02688764|81481714|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
27903425|NCT02688764|81481713|FG000|Overall Study|Study drug taste/Withd. parent|1|||
27903426|NCT02688764|81481714|FG001|Overall Study|Study drug taste/Withd. parent|0|||
27903427|NCT02688764|81481713|FG000|Overall Study|Subject moving out|2|||
27903428|NCT02688764|81481714|FG001|Overall Study|Subject moving out|0|||
27507040|NCT02177032|80051405|FG001|Overall Study|OTHER|0|||
27507041|NCT02177032|80051406|FG002|Overall Study|OTHER|1|||
27507042|NCT02177032|80051407|FG003|Overall Study|OTHER|0|||
27507043|NCT02177032|80051404|FG000|Overall Study|Withdrawal by Subject|1|||
27507044|NCT02177032|80051405|FG001|Overall Study|Withdrawal by Subject|0|||
27507045|NCT02177032|80051406|FG002|Overall Study|Withdrawal by Subject|1|||
27507046|NCT02177032|80051407|FG003|Overall Study|Withdrawal by Subject|0|||
27507047|NCT03133793|80051410|FG000|Overall Study|Withdrawal by Subject|0|||
27507048|NCT03133793|80051411|FG001|Overall Study|Withdrawal by Subject|4|||
27507049|NCT03133793|80051412|FG002|Overall Study|Withdrawal by Subject|2|||
27507050|NCT03133793|80051413|FG003|Overall Study|Withdrawal by Subject|4|||
27728324|NCT01707030|80833234|FG000|Overall Study|Withdrawal by Subject|2|||
27728325|NCT01707030|80833235|FG001|Overall Study|Withdrawal by Subject|3|||
27903429|NCT02688764|81481713|FG000|Overall Study|Subject taken off dialysis|1|||
27903430|NCT02688764|81481714|FG001|Overall Study|Subject taken off dialysis|0|||
27903431|NCT02688764|81481713|FG000|Overall Study|Withdrawal by parent|3|||
27903432|NCT02688764|81481714|FG001|Overall Study|Withdrawal by parent|0|||
27903433|NCT03000530|81481715|FG000|Overall Study|Adverse Event|0|||
27903434|NCT03000530|81481716|FG001|Overall Study|Adverse Event|0|||
27903435|NCT03000530|81481717|FG002|Overall Study|Adverse Event|2|||
27903436|NCT03000530|81481715|FG000|Overall Study|Lost to Follow-up|0|||
27903437|NCT03000530|81481716|FG001|Overall Study|Lost to Follow-up|3|||
27903438|NCT03000530|81481717|FG002|Overall Study|Lost to Follow-up|1|||
27728326|NCT01707030|80833234|FG000|Overall Study|Lost to Follow-up|8|||
27728327|NCT01707030|80833235|FG001|Overall Study|Lost to Follow-up|13|||
27728328|NCT00927563|80833236|FG000|Overall Study|Lost to Follow-up|1|||
27728329|NCT00927563|80833236|FG000|Overall Study|Withdrawal by Subject|1|||
27728330|NCT01929135|80833238|FG000|Overall Study|Lost to Follow-up|1|||
27728331|NCT01929135|80833239|FG001|Overall Study|Lost to Follow-up|1|||
27728332|NCT01289015|80833245|FG000|Overall Study|Protocol Violation|12|||
27728333|NCT01289015|80833246|FG001|Overall Study|Protocol Violation|9|||
27728334|NCT01289015|80833245|FG000|Overall Study|Adverse Event|3|||
27728335|NCT01289015|80833246|FG001|Overall Study|Adverse Event|0|||
27728336|NCT01289015|80833245|FG000|Overall Study|Lost to Follow-up|33|||
27728337|NCT01289015|80833246|FG001|Overall Study|Lost to Follow-up|17|||
27728338|NCT01289015|80833245|FG000|Overall Study|Withdrawal by Subject|17|||
27728339|NCT01289015|80833246|FG001|Overall Study|Withdrawal by Subject|8|||
27728340|NCT01289015|80833245|FG000|Overall Study|Disease progression|1|||
27728341|NCT01289015|80833246|FG001|Overall Study|Disease progression|0|||
27728342|NCT01289015|80833245|FG000|Overall Study|Negative baseline culture and others|33|||
27728343|NCT01289015|80833246|FG001|Overall Study|Negative baseline culture and others|20|||
27728344|NCT00364182|80833249|FG000|First Intervention|Secondary prophylaxis|1|||
27728345|NCT00364182|80833250|FG001|First Intervention|Secondary prophylaxis|0|||
27728346|NCT00364182|80833251|FG002|First Intervention|Secondary prophylaxis|0|||
27728347|NCT00364182|80833249|FG000|First Intervention|Withdrawal by Subject|2|||
27728348|NCT00364182|80833250|FG001|First Intervention|Withdrawal by Subject|0|||
27728349|NCT00364182|80833251|FG002|First Intervention|Withdrawal by Subject|0|||
27728350|NCT00364182|80833249|FG000|Second Intervention|non-compliance|0|||
27728351|NCT00364182|80833250|FG001|Second Intervention|non-compliance|1|||
27728352|NCT00364182|80833251|FG002|Second Intervention|non-compliance|1|||
27728353|NCT00364182|80833249|FG000|Second Intervention|Protocol Violation|0|||
27728354|NCT00364182|80833250|FG001|Second Intervention|Protocol Violation|1|||
27728355|NCT00364182|80833251|FG002|Second Intervention|Protocol Violation|0|||
27728356|NCT00364182|80833249|FG000|Second Intervention|Adverse Event|0|||
27728357|NCT00364182|80833250|FG001|Second Intervention|Adverse Event|0|||
27728358|NCT00364182|80833251|FG002|Second Intervention|Adverse Event|1|||
27728359|NCT00364182|80833249|FG000|Third Intervention|non-compliance|0|||
27728360|NCT00364182|80833250|FG001|Third Intervention|non-compliance|1|||
27728361|NCT00364182|80833251|FG002|Third Intervention|non-compliance|0|||
27728362|NCT00364182|80833249|FG000|Third Intervention|Lost to Follow-up|0|||
27728363|NCT00364182|80833250|FG001|Third Intervention|Lost to Follow-up|0|||
27728364|NCT00364182|80833251|FG002|Third Intervention|Lost to Follow-up|1|||
27728365|NCT02720757|80833252|FG000|Overall Study|Other reason|5|||
27728366|NCT02720757|80833252|FG000|Overall Study|Loss of contact|4|||
27728367|NCT02720757|80833252|FG000|Overall Study|Informed consent withdrawal|1|||
27728368|NCT02720757|80833252|FG000|Overall Study|Patients wish to withdraw|2|||
27728369|NCT02720757|80833252|FG000|Overall Study|Missing|3|||
27851826|NCT02238626|81287163|FG002|Overall Study|Withdrawal by Subject|0|||
27903439|NCT03000530|81481715|FG000|Overall Study|Withdrawal by Subject|0|||
27903440|NCT03000530|81481716|FG001|Overall Study|Withdrawal by Subject|2|||
27903441|NCT03000530|81481717|FG002|Overall Study|Withdrawal by Subject|1|||
27903442|NCT00845676|81481718|FG000|Overall Study|Virologic breakthrough at week 20|1|||
27903443|NCT00845676|81481718|FG000|Overall Study|Adverse Event|1|||
27903444|NCT01451164|81481720|FG000|Overall Study|Adverse Event|19|||
27507051|NCT03133793|80051410|FG000|Overall Study|Lost to Follow-up|1|||
27728370|NCT02720757|80833252|FG000|Overall Study|General exclusion|3|||
27728371|NCT01824979|80833255|FG000|Overall Study|Withdrawal by Subject|5|||
27728372|NCT01824979|80833256|FG001|Overall Study|Withdrawal by Subject|0|||
27728373|NCT01824979|80833255|FG000|Overall Study|Physician Decision|2|||
27728374|NCT01824979|80833256|FG001|Overall Study|Physician Decision|0|||
27728375|NCT01824979|80833255|FG000|Overall Study|Protocol Violation|6|||
27728376|NCT01824979|80833256|FG001|Overall Study|Protocol Violation|13|||
27728377|NCT01214044|80833257|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
27728378|NCT01214044|80833257|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
27728379|NCT01214044|80833257|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
27507052|NCT03133793|80051411|FG001|Overall Study|Lost to Follow-up|0|||
27507053|NCT03133793|80051412|FG002|Overall Study|Lost to Follow-up|2|||
27507054|NCT03133793|80051413|FG003|Overall Study|Lost to Follow-up|0|||
27507055|NCT03133793|80051410|FG000|Overall Study|Death|0|||
27728380|NCT01214044|80833257|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
27507056|NCT03133793|80051411|FG001|Overall Study|Death|0|||
27507057|NCT03133793|80051412|FG002|Overall Study|Death|0|||
27507058|NCT03133793|80051413|FG003|Overall Study|Death|1|||
27507059|NCT01454102|80051414|FG000|Overall Study|Continuing in the treatment period|0|||
27507060|NCT01454102|80051415|FG001|Overall Study|Continuing in the treatment period|0|||
27507061|NCT01454102|80051416|FG002|Overall Study|Continuing in the treatment period|0|||
27507062|NCT01454102|80051417|FG003|Overall Study|Continuing in the treatment period|0|||
27507063|NCT01454102|80051418|FG004|Overall Study|Continuing in the treatment period|3|||
27507064|NCT01454102|80051419|FG005|Overall Study|Continuing in the treatment period|3|||
27507065|NCT01454102|80051420|FG006|Overall Study|Continuing in the treatment period|2|||
27507066|NCT01454102|80051421|FG007|Overall Study|Continuing in the treatment period|0|||
27507067|NCT01454102|80051422|FG008|Overall Study|Continuing in the treatment period|1|||
27507068|NCT01454102|80051423|FG009|Overall Study|Continuing in the treatment period|0|||
27507069|NCT01454102|80051424|FG010|Overall Study|Continuing in the treatment period|0|||
27507070|NCT01454102|80051425|FG011|Overall Study|Continuing in the treatment period|4|||
27507071|NCT01454102|80051426|FG012|Overall Study|Continuing in the treatment period|7|||
27507072|NCT01454102|80051427|FG013|Overall Study|Continuing in the treatment period|4|||
27507073|NCT01454102|80051428|FG014|Overall Study|Continuing in the treatment period|3|||
27507074|NCT01454102|80051429|FG015|Overall Study|Continuing in the treatment period|1|||
27507075|NCT01532986|80051430|FG000|Overall Study|Death|9|||
27507076|NCT01532986|80051431|FG001|Overall Study|Death|9|||
27507077|NCT01532986|80051430|FG000|Overall Study|Withdrawal by Subject|7|||
27507078|NCT01532986|80051431|FG001|Overall Study|Withdrawal by Subject|10|||
27507079|NCT01532986|80051430|FG000|Overall Study|Physician Decision|7|||
27507080|NCT01532986|80051431|FG001|Overall Study|Physician Decision|5|||
27507081|NCT01193244|80051437|FG000|Overall Study|Withdrawal by Subject|79|||
27507082|NCT01193244|80051438|FG001|Overall Study|Withdrawal by Subject|97|||
27507083|NCT01193244|80051437|FG000|Overall Study|Other|303|||
27728381|NCT01214044|80833257|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
27507084|NCT01193244|80051438|FG001|Overall Study|Other|278|||
27507085|NCT01193244|80051437|FG000|Overall Study|Lost to Follow-up|6|||
27507086|NCT01193244|80051438|FG001|Overall Study|Lost to Follow-up|15|||
27507087|NCT01958164|80051439|FG000|Overall Study|Adverse Event|0|||
27728382|NCT01214044|80833257|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
27728383|NCT02908100|80833258|FG000|Overall Study|Adverse Event|7|||
27851827|NCT02238626|81287164|FG003|Overall Study|Withdrawal by Subject|1|||
27851828|NCT02238626|81287161|FG000|Overall Study|Death|0|||
27851829|NCT02238626|81287162|FG001|Overall Study|Death|0|||
27851830|NCT02238626|81287163|FG002|Overall Study|Death|1|||
27728384|NCT02908100|80833259|FG001|Overall Study|Adverse Event|6|||
27728385|NCT02908100|80833260|FG002|Overall Study|Adverse Event|9|||
27614577|NCT03230864|80430318|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
27728386|NCT02908100|80833258|FG000|Overall Study|Death|2|||
27728387|NCT02908100|80833259|FG001|Overall Study|Death|0|||
27728388|NCT02908100|80833260|FG002|Overall Study|Death|0|||
27728389|NCT02908100|80833258|FG000|Overall Study|Lack of Efficacy|2|||
27728390|NCT02908100|80833259|FG001|Overall Study|Lack of Efficacy|3|||
27728391|NCT02908100|80833260|FG002|Overall Study|Lack of Efficacy|3|||
27728392|NCT02908100|80833258|FG000|Overall Study|Lost to Follow-up|0|||
27728393|NCT02908100|80833259|FG001|Overall Study|Lost to Follow-up|1|||
27728394|NCT02908100|80833260|FG002|Overall Study|Lost to Follow-up|2|||
27728395|NCT02908100|80833258|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27728396|NCT02908100|80833259|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27728397|NCT02908100|80833260|FG002|Overall Study|Non-Compliance With Study Drug|2|||
27728398|NCT02908100|80833258|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
27728399|NCT02908100|80833259|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
27728400|NCT02908100|80833260|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
27728401|NCT02908100|80833258|FG000|Overall Study|Physician Decision|0|||
27728402|NCT02908100|80833259|FG001|Overall Study|Physician Decision|1|||
27728403|NCT02908100|80833260|FG002|Overall Study|Physician Decision|0|||
27728404|NCT02908100|80833258|FG000|Overall Study|Pregnancy|1|||
27728405|NCT02908100|80833259|FG001|Overall Study|Pregnancy|2|||
27728406|NCT02908100|80833260|FG002|Overall Study|Pregnancy|0|||
27728407|NCT02908100|80833258|FG000|Overall Study|Withdrawal by Subject|8|||
27728408|NCT02908100|80833259|FG001|Overall Study|Withdrawal by Subject|7|||
27728409|NCT02908100|80833260|FG002|Overall Study|Withdrawal by Subject|5|||
27728410|NCT02908100|80833258|FG000|Overall Study|Randomised in Error|1|||
27728411|NCT02908100|80833259|FG001|Overall Study|Randomised in Error|0|||
27728412|NCT02908100|80833260|FG002|Overall Study|Randomised in Error|0|||
27728413|NCT00122135|80833264|FG000|Overall Study|Withdrawal by Subject|3|||
27728414|NCT00122135|80833265|FG001|Overall Study|Withdrawal by Subject|0|||
27728415|NCT03665038|80833266|FG000|Overall Study|Lost to Follow-up|0|||
27728416|NCT03665038|80833267|FG001|Overall Study|Lost to Follow-up|0|||
27728417|NCT03665038|80833268|FG002|Overall Study|Lost to Follow-up|1|||
27728418|NCT03969875|80833272|FG000|Overall Study|did not receive allocated intervention|3|||
27728419|NCT03969875|80833273|FG001|Overall Study|did not receive allocated intervention|3|||
27728420|NCT03969875|80833274|FG002|Overall Study|did not receive allocated intervention|4|||
27728421|NCT03969875|80833272|FG000|Overall Study|Protocol Violation|4|||
27728422|NCT03969875|80833273|FG001|Overall Study|Protocol Violation|2|||
27728423|NCT03969875|80833274|FG002|Overall Study|Protocol Violation|2|||
27728424|NCT01307033|80833275|FG000|8-week Double-blind Period|Adverse Event|2|||
27728425|NCT01307033|80833276|FG001|8-week Double-blind Period|Adverse Event|0|||
27728426|NCT01307033|80833277|FG002|8-week Double-blind Period|Adverse Event|0|||
27728427|NCT01307033|80833278|FG003|8-week Double-blind Period|Adverse Event|0|||
27728428|NCT01307033|80833275|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
27728429|NCT01307033|80833276|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
27728430|NCT01307033|80833277|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
27728431|NCT01307033|80833278|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
27728432|NCT01307033|80833275|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
27728433|NCT01307033|80833276|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
27728434|NCT01307033|80833277|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
27728435|NCT01307033|80833278|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
27728436|NCT01307033|80833275|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
27728437|NCT01307033|80833276|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
27728438|NCT01307033|80833277|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
27728439|NCT01307033|80833278|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
27728440|NCT01307033|80833275|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
27728441|NCT01307033|80833276|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
27728442|NCT01307033|80833277|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
27728443|NCT01307033|80833278|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
27728444|NCT01307033|80833275|FG000|44-week Open-label Extension|Adverse Event|0|||
27728445|NCT01307033|80833276|FG001|44-week Open-label Extension|Adverse Event|0|||
27728446|NCT01307033|80833277|FG002|44-week Open-label Extension|Adverse Event|2|||
27728447|NCT01307033|80833278|FG003|44-week Open-label Extension|Adverse Event|1|||
27728448|NCT01307033|80833275|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
27728449|NCT01307033|80833276|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
27728450|NCT01307033|80833277|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
27728451|NCT01307033|80833278|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
27728452|NCT01307033|80833275|FG000|44-week Open-label Extension|Physician Decision|0|||
27728453|NCT01307033|80833276|FG001|44-week Open-label Extension|Physician Decision|0|||
27728454|NCT01307033|80833277|FG002|44-week Open-label Extension|Physician Decision|1|||
27728455|NCT01307033|80833278|FG003|44-week Open-label Extension|Physician Decision|0|||
27728456|NCT01307033|80833275|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
27851831|NCT02238626|81287164|FG003|Overall Study|Death|1|||
27728457|NCT01307033|80833276|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
27507088|NCT01958164|80051440|FG001|Overall Study|Adverse Event|2|||
27507089|NCT01958164|80051439|FG000|Overall Study|Lost to Follow-up|2|||
27507090|NCT01958164|80051440|FG001|Overall Study|Lost to Follow-up|3|||
27507091|NCT01198795|80051441|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
27507092|NCT01198795|80051441|FG000|Overall Study|Withdrawal by Subject|17|||
27507093|NCT01198795|80051441|FG000|Overall Study|Lost to Follow-up|15|||
27507094|NCT01198795|80051441|FG000|Overall Study|Adverse Event|9|||
27507095|NCT01198795|80051441|FG000|Overall Study|Lack of Efficacy|5|||
27507096|NCT01198795|80051441|FG000|Overall Study|Protocol Violation|2|||
27507097|NCT01198795|80051441|FG000|Overall Study|Other Reason|4|||
27507098|NCT04154904|80051442|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
27507099|NCT04154904|80051443|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
27507100|NCT04154904|80051444|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
27507101|NCT00478023|80051445|FG000|Overall Study|Adverse Event|11|||
27507102|NCT00478023|80051446|FG001|Overall Study|Adverse Event|7|||
27507103|NCT00478023|80051447|FG002|Overall Study|Adverse Event|8|||
27507104|NCT00478023|80051448|FG003|Overall Study|Adverse Event|14|||
27507105|NCT00478023|80051449|FG004|Overall Study|Adverse Event|6|||
27507106|NCT00478023|80051445|FG000|Overall Study|Death|1|||
27507107|NCT00478023|80051446|FG001|Overall Study|Death|0|||
27507108|NCT00478023|80051447|FG002|Overall Study|Death|0|||
27507109|NCT00478023|80051448|FG003|Overall Study|Death|0|||
27507110|NCT00478023|80051449|FG004|Overall Study|Death|0|||
27507111|NCT00478023|80051445|FG000|Overall Study|Lack of Efficacy|11|||
27507112|NCT00478023|80051446|FG001|Overall Study|Lack of Efficacy|10|||
27507113|NCT00478023|80051447|FG002|Overall Study|Lack of Efficacy|4|||
27507114|NCT00478023|80051448|FG003|Overall Study|Lack of Efficacy|5|||
27507115|NCT00478023|80051449|FG004|Overall Study|Lack of Efficacy|41|||
27507116|NCT00478023|80051445|FG000|Overall Study|Lost to Follow-up|3|||
27507117|NCT00478023|80051446|FG001|Overall Study|Lost to Follow-up|1|||
27903445|NCT01451164|81481721|FG001|Overall Study|Adverse Event|12|||
27507118|NCT00478023|80051447|FG002|Overall Study|Lost to Follow-up|1|||
27507119|NCT00478023|80051448|FG003|Overall Study|Lost to Follow-up|1|||
27507120|NCT00478023|80051449|FG004|Overall Study|Lost to Follow-up|0|||
27507121|NCT00478023|80051445|FG000|Overall Study|Withdrawal by Subject|2|||
27728458|NCT01307033|80833277|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
27507122|NCT00478023|80051446|FG001|Overall Study|Withdrawal by Subject|3|||
27507123|NCT00478023|80051447|FG002|Overall Study|Withdrawal by Subject|2|||
27851832|NCT02238626|81287161|FG000|Overall Study|Other|0|||
27507124|NCT00478023|80051448|FG003|Overall Study|Withdrawal by Subject|4|||
27507125|NCT00478023|80051449|FG004|Overall Study|Withdrawal by Subject|5|||
27507126|NCT00478023|80051445|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
27507127|NCT00478023|80051446|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
27507128|NCT00478023|80051447|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
27507129|NCT00478023|80051448|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
27507130|NCT00478023|80051449|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
27507131|NCT01295814|80051450|FG000|Overall Study|Lack of Efficacy|0|||
27507132|NCT01295814|80051451|FG001|Overall Study|Lack of Efficacy|2|||
27507133|NCT01295814|80051450|FG000|Overall Study|Withdrawal by Subject|2|||
27728459|NCT01307033|80833278|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
27507134|NCT01295814|80051451|FG001|Overall Study|Withdrawal by Subject|0|||
27507135|NCT04032093|80051452|FG000|Overall Study|Lost to Follow-up|7|||
27507136|NCT04032093|80051453|FG001|Overall Study|Lost to Follow-up|7|||
27507137|NCT04032093|80051454|FG002|Overall Study|Lost to Follow-up|6|||
27507138|NCT04032093|80051455|FG003|Overall Study|Lost to Follow-up|10|||
27507139|NCT04032093|80051456|FG004|Overall Study|Lost to Follow-up|13|||
27507140|NCT04032093|80051457|FG005|Overall Study|Lost to Follow-up|7|||
27507141|NCT04032093|80051458|FG006|Overall Study|Lost to Follow-up|7|||
27507142|NCT04032093|80051459|FG007|Overall Study|Lost to Follow-up|5|||
27507143|NCT04032093|80051460|FG008|Overall Study|Lost to Follow-up|9|||
27507144|NCT04032093|80051461|FG009|Overall Study|Lost to Follow-up|12|||
27507145|NCT04032093|80051452|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27728460|NCT01307033|80833275|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
27728461|NCT01307033|80833276|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
27507146|NCT04032093|80051453|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27614578|NCT03230864|80430319|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
27507147|NCT04032093|80051454|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
27728462|NCT01307033|80833277|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
27728463|NCT01307033|80833278|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
27728464|NCT01307033|80833275|FG000|44-week Open-label Extension|Death|0|||
27728465|NCT01307033|80833276|FG001|44-week Open-label Extension|Death|0|||
27728466|NCT01307033|80833277|FG002|44-week Open-label Extension|Death|0|||
27728467|NCT01307033|80833278|FG003|44-week Open-label Extension|Death|1|||
27728468|NCT00771472|80833279|FG000|Overall Study|Physician Decision|2|||
27728469|NCT00771472|80833280|FG001|Overall Study|Physician Decision|3|||
27728470|NCT00771472|80833279|FG000|Overall Study|Progressive Disease|3|||
27728471|NCT00771472|80833280|FG001|Overall Study|Progressive Disease|1|||
27728472|NCT00771472|80833279|FG000|Overall Study|Protocol Violation|1|||
27728473|NCT00771472|80833280|FG001|Overall Study|Protocol Violation|0|||
27728474|NCT02111564|80833281|FG000|Overall Study|Death|109|||
27728475|NCT02111564|80833282|FG001|Overall Study|Death|120|||
27728476|NCT02111564|80833281|FG000|Overall Study|Lost to Follow-up|2|||
27728477|NCT02111564|80833282|FG001|Overall Study|Lost to Follow-up|3|||
27728478|NCT02111564|80833281|FG000|Overall Study|Withdrawal by Subject|20|||
27728479|NCT02111564|80833282|FG001|Overall Study|Withdrawal by Subject|20|||
27851833|NCT02238626|81287162|FG001|Overall Study|Other|2|||
27851834|NCT02238626|81287163|FG002|Overall Study|Other|0|||
27851835|NCT02238626|81287164|FG003|Overall Study|Other|0|||
27851836|NCT03575871|81287172|FG000|Overall Study|Adverse Event|5|||
27507148|NCT04032093|80051455|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
27507149|NCT04032093|80051456|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
27507150|NCT04032093|80051457|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27507151|NCT04032093|80051458|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
27507152|NCT04032093|80051459|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
27507153|NCT04032093|80051460|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
27507154|NCT04032093|80051461|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
27507155|NCT04032093|80051452|FG000|Overall Study|Other|1|||
27507156|NCT04032093|80051453|FG001|Overall Study|Other|0|||
27507157|NCT04032093|80051454|FG002|Overall Study|Other|0|||
27507158|NCT04032093|80051455|FG003|Overall Study|Other|1|||
27507159|NCT04032093|80051456|FG004|Overall Study|Other|1|||
27507160|NCT04032093|80051457|FG005|Overall Study|Other|0|||
27507161|NCT04032093|80051458|FG006|Overall Study|Other|0|||
27507162|NCT04032093|80051459|FG007|Overall Study|Other|0|||
27614579|NCT03230864|80430316|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
27728480|NCT01176916|80833285|FG000|Overall Study|Adverse Event|61|||
27728481|NCT01176916|80833285|FG000|Overall Study|Death|1|||
27728482|NCT01176916|80833285|FG000|Overall Study|Lost to Follow-up|15|||
27728483|NCT01176916|80833285|FG000|Overall Study|Objective progression or relapse|17|||
27728484|NCT01176916|80833285|FG000|Overall Study|Protocol Violation|24|||
27728485|NCT01176916|80833285|FG000|Overall Study|Withdrawal by Subject|37|||
27728486|NCT01176916|80833285|FG000|Overall Study|Other|6|||
27851837|NCT03575871|81287173|FG001|Overall Study|Adverse Event|5|||
27851838|NCT03575871|81287174|FG002|Overall Study|Adverse Event|8|||
27851839|NCT03575871|81287172|FG000|Overall Study|Death|1|||
27851840|NCT03575871|81287173|FG001|Overall Study|Death|0|||
27851841|NCT03575871|81287174|FG002|Overall Study|Death|0|||
27851842|NCT03575871|81287172|FG000|Overall Study|Lack of Efficacy|5|||
27851843|NCT03575871|81287173|FG001|Overall Study|Lack of Efficacy|4|||
27851844|NCT03575871|81287174|FG002|Overall Study|Lack of Efficacy|7|||
27851845|NCT03575871|81287172|FG000|Overall Study|Lost to Follow-up|1|||
27851846|NCT03575871|81287173|FG001|Overall Study|Lost to Follow-up|1|||
27851847|NCT03575871|81287174|FG002|Overall Study|Lost to Follow-up|1|||
27851848|NCT03575871|81287172|FG000|Overall Study|Protocol Deviation|1|||
27851849|NCT03575871|81287173|FG001|Overall Study|Protocol Deviation|1|||
27851850|NCT03575871|81287174|FG002|Overall Study|Protocol Deviation|1|||
27851851|NCT03575871|81287172|FG000|Overall Study|Withdrawal by Subject|6|||
27851852|NCT03575871|81287173|FG001|Overall Study|Withdrawal by Subject|1|||
27851853|NCT03575871|81287174|FG002|Overall Study|Withdrawal by Subject|9|||
27851854|NCT03575871|81287172|FG000|Overall Study|Other than specified|2|||
27851855|NCT03575871|81287173|FG001|Overall Study|Other than specified|2|||
27851856|NCT03575871|81287174|FG002|Overall Study|Other than specified|0|||
27851857|NCT01829113|81287175|FG000|Overall Study|Disease Progression|37|||
27851858|NCT01829113|81287176|FG001|Overall Study|Disease Progression|48|||
27851859|NCT01829113|81287175|FG000|Overall Study|Adverse Event|14|||
27507163|NCT04032093|80051460|FG008|Overall Study|Other|0|||
27507164|NCT04032093|80051461|FG009|Overall Study|Other|1|||
27728487|NCT01176916|80833285|FG000|Overall Study|Withdrawal prior to Treatment|6|||
27903446|NCT01451164|81481722|FG002|Overall Study|Adverse Event|18|||
27507165|NCT04032093|80051452|FG000|Overall Study|Withdrawal by Subject|1|||
27507166|NCT04032093|80051453|FG001|Overall Study|Withdrawal by Subject|3|||
27507167|NCT04032093|80051454|FG002|Overall Study|Withdrawal by Subject|2|||
27507168|NCT04032093|80051455|FG003|Overall Study|Withdrawal by Subject|2|||
27507169|NCT04032093|80051456|FG004|Overall Study|Withdrawal by Subject|3|||
27507170|NCT04032093|80051457|FG005|Overall Study|Withdrawal by Subject|0|||
27507171|NCT04032093|80051458|FG006|Overall Study|Withdrawal by Subject|0|||
27507172|NCT04032093|80051459|FG007|Overall Study|Withdrawal by Subject|0|||
27507173|NCT04032093|80051460|FG008|Overall Study|Withdrawal by Subject|0|||
27507174|NCT04032093|80051461|FG009|Overall Study|Withdrawal by Subject|0|||
27507175|NCT04032093|80051452|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27507176|NCT04032093|80051453|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27507177|NCT04032093|80051454|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27614580|NCT03230864|80430317|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
27614581|NCT03230864|80430318|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
27614582|NCT03230864|80430319|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
27614583|NCT01155388|80430320|FG000|Overall Study|Adverse Event|1|||
27507178|NCT04032093|80051455|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27507179|NCT04032093|80051456|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27507180|NCT04032093|80051457|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27507181|NCT04032093|80051458|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
27507182|NCT04032093|80051459|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
27507183|NCT04032093|80051460|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
27507184|NCT04032093|80051461|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
27507185|NCT04032093|80051452|FG000|Overall Study|Adverse Event|0|||
27507186|NCT04032093|80051453|FG001|Overall Study|Adverse Event|0|||
27507187|NCT04032093|80051454|FG002|Overall Study|Adverse Event|0|||
27507188|NCT04032093|80051455|FG003|Overall Study|Adverse Event|0|||
27507189|NCT04032093|80051456|FG004|Overall Study|Adverse Event|0|||
27507190|NCT04032093|80051457|FG005|Overall Study|Adverse Event|0|||
27507191|NCT04032093|80051458|FG006|Overall Study|Adverse Event|0|||
27507192|NCT04032093|80051459|FG007|Overall Study|Adverse Event|0|||
27507193|NCT04032093|80051460|FG008|Overall Study|Adverse Event|0|||
27507194|NCT04032093|80051461|FG009|Overall Study|Adverse Event|1|||
27507195|NCT04032093|80051452|FG000|Overall Study|Physician Decision|0|||
27507196|NCT04032093|80051453|FG001|Overall Study|Physician Decision|0|||
27507197|NCT04032093|80051454|FG002|Overall Study|Physician Decision|0|||
27507198|NCT04032093|80051455|FG003|Overall Study|Physician Decision|0|||
27614584|NCT01155388|80430321|FG001|Overall Study|Adverse Event|0|||
27614585|NCT03810313|80430324|FG000|Overall Study|Study terminated by sponsor|164|||
27614586|NCT03810313|80430325|FG001|Overall Study|Study terminated by sponsor|159|||
27507199|NCT04032093|80051456|FG004|Overall Study|Physician Decision|0|||
27614587|NCT03810313|80430324|FG000|Overall Study|Subject decision|10|||
27507200|NCT04032093|80051457|FG005|Overall Study|Physician Decision|1|||
27507201|NCT04032093|80051458|FG006|Overall Study|Physician Decision|0|||
27507202|NCT04032093|80051459|FG007|Overall Study|Physician Decision|0|||
27614588|NCT03810313|80430325|FG001|Overall Study|Subject decision|11|||
27507203|NCT04032093|80051460|FG008|Overall Study|Physician Decision|0|||
27507204|NCT04032093|80051461|FG009|Overall Study|Physician Decision|0|||
27507205|NCT02675634|80051462|FG000|Test Period 1|Adverse Event|0|||
27507206|NCT02675634|80051463|FG001|Test Period 1|Adverse Event|1|||
27507207|NCT02675634|80051464|FG002|Test Period 1|Adverse Event|0|||
27507208|NCT02675634|80051465|FG003|Test Period 1|Adverse Event|1|||
27507209|NCT02675634|80051466|FG004|Test Period 1|Adverse Event|0|||
27507210|NCT02675634|80051467|FG005|Test Period 1|Adverse Event|0|||
27507211|NCT02675634|80051462|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
27507212|NCT02675634|80051463|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
27507213|NCT02675634|80051464|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
27507214|NCT02675634|80051465|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
27507215|NCT02675634|80051466|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
27507216|NCT02675634|80051467|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
27903447|NCT01451164|81481723|FG003|Overall Study|Adverse Event|21|||
27507217|NCT02675634|80051462|FG000|Test Period 2|Lack of Efficacy|1|||
27507218|NCT02675634|80051463|FG001|Test Period 2|Lack of Efficacy|0|||
27614589|NCT03810313|80430324|FG000|Overall Study|Lost to Follow-up|3|||
27903448|NCT01451164|81481720|FG000|Overall Study|Withdrawal Criteria|1|||
27903449|NCT01451164|81481721|FG001|Overall Study|Withdrawal Criteria|1|||
27507219|NCT02675634|80051464|FG002|Test Period 2|Lack of Efficacy|0|||
27507220|NCT02675634|80051465|FG003|Test Period 2|Lack of Efficacy|0|||
27507221|NCT02675634|80051466|FG004|Test Period 2|Lack of Efficacy|0|||
27614590|NCT03810313|80430325|FG001|Overall Study|Lost to Follow-up|3|||
27851860|NCT01829113|81287176|FG001|Overall Study|Adverse Event|10|||
27851861|NCT01829113|81287175|FG000|Overall Study|Withdrawal by Subject|17|||
27851862|NCT01829113|81287176|FG001|Overall Study|Withdrawal by Subject|10|||
27851863|NCT01829113|81287175|FG000|Overall Study|Death|4|||
27851864|NCT01829113|81287176|FG001|Overall Study|Death|6|||
27851865|NCT01829113|81287175|FG000|Overall Study|Sponsor Decision|1|||
27851866|NCT01829113|81287176|FG001|Overall Study|Sponsor Decision|1|||
27851867|NCT01829113|81287175|FG000|Overall Study|No Study Treatment Received|3|||
27614591|NCT03810313|80430324|FG000|Overall Study|Adverse Event|2|||
27903450|NCT01451164|81481722|FG002|Overall Study|Withdrawal Criteria|1|||
27614592|NCT03810313|80430325|FG001|Overall Study|Adverse Event|1|||
27614593|NCT03810313|80430324|FG000|Overall Study|Death|2|||
27851868|NCT01829113|81287176|FG001|Overall Study|No Study Treatment Received|2|||
27507222|NCT02675634|80051467|FG005|Test Period 2|Lack of Efficacy|0|||
27507223|NCT02675634|80051462|FG000|Test Period 2|Adverse Event|0|||
27507224|NCT02675634|80051463|FG001|Test Period 2|Adverse Event|0|||
27507225|NCT02675634|80051464|FG002|Test Period 2|Adverse Event|0|||
27903451|NCT01451164|81481723|FG003|Overall Study|Withdrawal Criteria|1|||
27507226|NCT02675634|80051465|FG003|Test Period 2|Adverse Event|0|||
27903452|NCT01451164|81481720|FG000|Overall Study|Physician Decision|2|||
27903453|NCT01451164|81481721|FG001|Overall Study|Physician Decision|0|||
27903454|NCT01451164|81481722|FG002|Overall Study|Physician Decision|1|||
27903455|NCT01451164|81481723|FG003|Overall Study|Physician Decision|0|||
27903456|NCT01451164|81481720|FG000|Overall Study|Withdrawal by Subject|14|||
27903457|NCT01451164|81481721|FG001|Overall Study|Withdrawal by Subject|11|||
27903458|NCT01451164|81481722|FG002|Overall Study|Withdrawal by Subject|16|||
27903459|NCT01451164|81481723|FG003|Overall Study|Withdrawal by Subject|17|||
27903460|NCT01451164|81481720|FG000|Overall Study|Protocol Violation|0|||
27903461|NCT01451164|81481721|FG001|Overall Study|Protocol Violation|1|||
27903462|NCT01451164|81481722|FG002|Overall Study|Protocol Violation|0|||
27903463|NCT01451164|81481723|FG003|Overall Study|Protocol Violation|0|||
27903464|NCT01451164|81481720|FG000|Overall Study|Lack of Efficacy|7|||
27903465|NCT01451164|81481721|FG001|Overall Study|Lack of Efficacy|9|||
27903466|NCT01451164|81481722|FG002|Overall Study|Lack of Efficacy|9|||
27903467|NCT01451164|81481723|FG003|Overall Study|Lack of Efficacy|7|||
27903468|NCT01250171|81481724|FG000|Overall Study|Administrative reasons|1|||
27903469|NCT01250171|81481725|FG001|Overall Study|Administrative reasons|0|||
27903470|NCT01250171|81481726|FG002|Overall Study|Administrative reasons|0|||
27903471|NCT02334384|81481729|FG000|Overall Study|Lost to Follow-up|1|||
27903472|NCT02334384|81481730|FG001|Overall Study|Lost to Follow-up|1|||
27903473|NCT00002525|81481731|FG000|Overall Study|Adverse Event|36|||
27903474|NCT00002525|81481732|FG001|Overall Study|Adverse Event|0|||
27903475|NCT00002525|81481731|FG000|Overall Study|Death|5|||
27903476|NCT00002525|81481732|FG001|Overall Study|Death|0|||
27903477|NCT00002525|81481731|FG000|Overall Study|Withdrawal by Subject|11|||
27903478|NCT00002525|81481732|FG001|Overall Study|Withdrawal by Subject|0|||
27903479|NCT00002525|81481731|FG000|Overall Study|Start non-protocol therapy|1|||
27903480|NCT00002525|81481732|FG001|Overall Study|Start non-protocol therapy|0|||
27903481|NCT00002525|81481731|FG000|Overall Study|Other complicating disease|1|||
27903482|NCT00002525|81481732|FG001|Overall Study|Other complicating disease|0|||
27903483|NCT00002525|81481731|FG000|Overall Study|Duke's A, B1, D disease|92|||
27903484|NCT00002525|81481732|FG001|Overall Study|Duke's A, B1, D disease|0|||
27903485|NCT00002525|81481731|FG000|Overall Study|Error|6|||
27903486|NCT00002525|81481732|FG001|Overall Study|Error|0|||
27903487|NCT00002525|81481731|FG000|Overall Study|Other|26|||
27903488|NCT00002525|81481732|FG001|Overall Study|Other|0|||
27903489|NCT00002525|81481731|FG000|Overall Study|Never start protocol therapy|8|||
27903490|NCT00002525|81481732|FG001|Overall Study|Never start protocol therapy|0|||
27903491|NCT01146561|81481733|FG000|Overall Study|Withdrawal by Subject|1|||
27507227|NCT02675634|80051466|FG004|Test Period 2|Adverse Event|0|||
27507228|NCT02675634|80051467|FG005|Test Period 2|Adverse Event|1|||
27507229|NCT01654302|80051468|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
27507230|NCT01654302|80051469|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
27507231|NCT04085289|80051470|FG000|Overall Study|Withdrawal by Subject|0|||
27507232|NCT04085289|80051471|FG001|Overall Study|Withdrawal by Subject|0|||
27507233|NCT04085289|80051472|FG002|Overall Study|Withdrawal by Subject|1|||
27507234|NCT01147874|80051473|FG000|Overall Study|Adverse Event|5|||
27507235|NCT01147874|80051473|FG000|Overall Study|Investigator's Request|1|||
27507236|NCT01147874|80051473|FG000|Overall Study|Lost to Follow-up|25|||
27507237|NCT01147874|80051473|FG000|Overall Study|Other|5|||
27507238|NCT01147874|80051473|FG000|Overall Study|Protocol Violation|5|||
27507239|NCT01147874|80051473|FG000|Overall Study|Sponsor's Decision|2|||
27507240|NCT01147874|80051473|FG000|Overall Study|Withdrawal by Subject|24|||
27507241|NCT01656408|80051474|FG000|Overall Study|Adverse Event|0|||
27507242|NCT01656408|80051475|FG001|Overall Study|Adverse Event|0|||
27507243|NCT01656408|80051476|FG002|Overall Study|Adverse Event|1|||
27903492|NCT01146561|81481733|FG000|Overall Study|Lost to Follow-up|1|||
27903493|NCT01636947|81481734|FG000|Overall Study|Not Treated|2|||
27903494|NCT01636947|81481735|FG001|Overall Study|Not Treated|2|||
27903495|NCT01636947|81481734|FG000|Overall Study|Lost to Follow-up|4|||
27903496|NCT01636947|81481735|FG001|Overall Study|Lost to Follow-up|0|||
27903497|NCT01636947|81481734|FG000|Overall Study|Protocol Violation|1|||
27903498|NCT01636947|81481735|FG001|Overall Study|Protocol Violation|1|||
27507244|NCT01656408|80051477|FG003|Overall Study|Adverse Event|0|||
27507245|NCT01656408|80051478|FG004|Overall Study|Adverse Event|0|||
27507246|NCT01656408|80051479|FG005|Overall Study|Adverse Event|1|||
27507247|NCT01656408|80051480|FG006|Overall Study|Adverse Event|1|||
27903499|NCT01636947|81481734|FG000|Overall Study|Withdrawal by Subject|3|||
27903500|NCT01636947|81481735|FG001|Overall Study|Withdrawal by Subject|3|||
27903501|NCT01636947|81481734|FG000|Overall Study|Adverse Event|1|||
27903502|NCT01636947|81481735|FG001|Overall Study|Adverse Event|1|||
27903503|NCT01636947|81481734|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27903504|NCT01636947|81481735|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
27903505|NCT01066793|81481736|FG000|Overall Study|Death|4|||
27903506|NCT01066793|81481737|FG001|Overall Study|Death|1|||
27903507|NCT01066793|81481738|FG002|Overall Study|Death|1|||
27507248|NCT01656408|80051481|FG007|Overall Study|Adverse Event|0|||
27507249|NCT01656408|80051482|FG008|Overall Study|Adverse Event|1|||
27507250|NCT01656408|80051483|FG009|Overall Study|Adverse Event|0|||
27507251|NCT01656408|80051474|FG000|Overall Study|Physician Decision|1|||
27507252|NCT01656408|80051475|FG001|Overall Study|Physician Decision|0|||
27507253|NCT01656408|80051476|FG002|Overall Study|Physician Decision|1|||
27507254|NCT01656408|80051477|FG003|Overall Study|Physician Decision|0|||
27507255|NCT01656408|80051478|FG004|Overall Study|Physician Decision|1|||
27507256|NCT01656408|80051479|FG005|Overall Study|Physician Decision|1|||
27507257|NCT01656408|80051480|FG006|Overall Study|Physician Decision|0|||
27507258|NCT01656408|80051481|FG007|Overall Study|Physician Decision|1|||
27507259|NCT01656408|80051482|FG008|Overall Study|Physician Decision|1|||
27507260|NCT01656408|80051483|FG009|Overall Study|Physician Decision|3|||
27728488|NCT05032950|80833289|FG000|Overall Study|Adverse Event|0|||
27728489|NCT05032950|80833290|FG001|Overall Study|Adverse Event|0|||
27903508|NCT01066793|81481739|FG003|Overall Study|Death|0|||
27903509|NCT01066793|81481740|FG004|Overall Study|Death|0|||
27507261|NCT01942837|80051484|FG000|Overall Study|Death|1|||
27728490|NCT05032950|80833291|FG002|Overall Study|Adverse Event|1|||
27728491|NCT05032950|80833292|FG003|Overall Study|Adverse Event|1|||
27728492|NCT05032950|80833293|FG004|Overall Study|Adverse Event|0|||
27728493|NCT05032950|80833294|FG005|Overall Study|Adverse Event|0|||
27728494|NCT02468648|80833297|FG000|Overall Study|Death|1|||
27903510|NCT01066793|81481741|FG005|Overall Study|Death|0|||
27507262|NCT01942837|80051484|FG000|Overall Study|Symptomatic or radiographic progression|49|||
27507263|NCT01942837|80051484|FG000|Overall Study|Adverse Event|6|||
27507264|NCT01942837|80051484|FG000|Overall Study|Physician Decision|3|||
27507265|NCT01942837|80051484|FG000|Overall Study|Withdrawal by Subject|2|||
27903511|NCT01066793|81481736|FG000|Overall Study|Lack of Efficacy|2|||
27728495|NCT01703000|80833298|FG000|Overall Study|Death|1|||
27728496|NCT01661790|80833299|FG000|Overall Study|Lost to Follow-up|0|||
27728497|NCT01661790|80833300|FG001|Overall Study|Lost to Follow-up|2|||
27903512|NCT01066793|81481737|FG001|Overall Study|Lack of Efficacy|1|||
27903513|NCT01066793|81481738|FG002|Overall Study|Lack of Efficacy|0|||
27903514|NCT01066793|81481739|FG003|Overall Study|Lack of Efficacy|0|||
27903515|NCT01066793|81481740|FG004|Overall Study|Lack of Efficacy|0|||
27903516|NCT01066793|81481741|FG005|Overall Study|Lack of Efficacy|0|||
27903517|NCT01066793|81481736|FG000|Overall Study|Lost to Follow-up|180|||
27903518|NCT01066793|81481737|FG001|Overall Study|Lost to Follow-up|39|||
27903519|NCT01066793|81481738|FG002|Overall Study|Lost to Follow-up|82|||
27903520|NCT01066793|81481739|FG003|Overall Study|Lost to Follow-up|16|||
27903521|NCT01066793|81481740|FG004|Overall Study|Lost to Follow-up|0|||
27903522|NCT01066793|81481741|FG005|Overall Study|Lost to Follow-up|1|||
27903523|NCT01066793|81481736|FG000|Overall Study|Physician Decision|3|||
27903524|NCT01066793|81481737|FG001|Overall Study|Physician Decision|0|||
27903525|NCT01066793|81481738|FG002|Overall Study|Physician Decision|0|||
27903526|NCT01066793|81481739|FG003|Overall Study|Physician Decision|0|||
27903527|NCT01066793|81481740|FG004|Overall Study|Physician Decision|0|||
27903528|NCT01066793|81481741|FG005|Overall Study|Physician Decision|0|||
27903529|NCT01066793|81481736|FG000|Overall Study|Protocol Violation|3|||
27903530|NCT01066793|81481737|FG001|Overall Study|Protocol Violation|2|||
27903531|NCT01066793|81481738|FG002|Overall Study|Protocol Violation|2|||
27903532|NCT01066793|81481739|FG003|Overall Study|Protocol Violation|0|||
27903533|NCT01066793|81481740|FG004|Overall Study|Protocol Violation|0|||
27903534|NCT01066793|81481741|FG005|Overall Study|Protocol Violation|0|||
27903535|NCT01066793|81481736|FG000|Overall Study|Withdrawal by Subject|7|||
27903536|NCT01066793|81481737|FG001|Overall Study|Withdrawal by Subject|4|||
27903537|NCT01066793|81481738|FG002|Overall Study|Withdrawal by Subject|1|||
27903538|NCT01066793|81481739|FG003|Overall Study|Withdrawal by Subject|0|||
27903539|NCT01066793|81481740|FG004|Overall Study|Withdrawal by Subject|0|||
27903540|NCT01066793|81481741|FG005|Overall Study|Withdrawal by Subject|0|||
27903541|NCT01066793|81481736|FG000|Overall Study|Early Termination|3|||
27903542|NCT01066793|81481737|FG001|Overall Study|Early Termination|0|||
27903543|NCT01066793|81481738|FG002|Overall Study|Early Termination|0|||
27903544|NCT01066793|81481739|FG003|Overall Study|Early Termination|0|||
27903545|NCT01066793|81481740|FG004|Overall Study|Early Termination|0|||
27903546|NCT01066793|81481741|FG005|Overall Study|Early Termination|0|||
27903547|NCT01066793|81481736|FG000|Overall Study|Lab test not done|7|||
27903548|NCT01066793|81481737|FG001|Overall Study|Lab test not done|0|||
27903549|NCT01066793|81481738|FG002|Overall Study|Lab test not done|0|||
27903550|NCT01066793|81481739|FG003|Overall Study|Lab test not done|1|||
27903551|NCT01066793|81481740|FG004|Overall Study|Lab test not done|0|||
27903552|NCT01066793|81481741|FG005|Overall Study|Lab test not done|0|||
27903553|NCT01066793|81481736|FG000|Overall Study|Miscellaneous|4|||
27903554|NCT01066793|81481737|FG001|Overall Study|Miscellaneous|5|||
27903555|NCT01066793|81481738|FG002|Overall Study|Miscellaneous|6|||
27903556|NCT01066793|81481739|FG003|Overall Study|Miscellaneous|0|||
27903557|NCT01066793|81481740|FG004|Overall Study|Miscellaneous|0|||
27903558|NCT01066793|81481741|FG005|Overall Study|Miscellaneous|0|||
27903559|NCT01066793|81481736|FG000|Overall Study|Non-responders|104|||
27903560|NCT01066793|81481737|FG001|Overall Study|Non-responders|5|||
27903561|NCT01066793|81481738|FG002|Overall Study|Non-responders|11|||
27903562|NCT01066793|81481739|FG003|Overall Study|Non-responders|25|||
27903563|NCT01066793|81481740|FG004|Overall Study|Non-responders|0|||
27903564|NCT01066793|81481741|FG005|Overall Study|Non-responders|0|||
27903565|NCT01066793|81481736|FG000|Overall Study|Other|15|||
27903566|NCT01066793|81481737|FG001|Overall Study|Other|5|||
27903567|NCT01066793|81481738|FG002|Overall Study|Other|6|||
27903568|NCT01066793|81481739|FG003|Overall Study|Other|2|||
27903569|NCT01066793|81481740|FG004|Overall Study|Other|0|||
27903570|NCT01066793|81481741|FG005|Overall Study|Other|0|||
27903571|NCT01066793|81481736|FG000|Overall Study|Relapse|20|||
27903572|NCT01066793|81481737|FG001|Overall Study|Relapse|8|||
27903573|NCT01066793|81481738|FG002|Overall Study|Relapse|2|||
27903574|NCT01066793|81481739|FG003|Overall Study|Relapse|3|||
27903575|NCT01066793|81481740|FG004|Overall Study|Relapse|0|||
27903576|NCT01066793|81481741|FG005|Overall Study|Relapse|0|||
27903577|NCT01066793|81481736|FG000|Overall Study|Result Not Available|1|||
27903578|NCT01066793|81481737|FG001|Overall Study|Result Not Available|0|||
27903579|NCT01066793|81481738|FG002|Overall Study|Result Not Available|0|||
27903580|NCT01066793|81481739|FG003|Overall Study|Result Not Available|0|||
27903581|NCT01066793|81481740|FG004|Overall Study|Result Not Available|0|||
27903582|NCT01066793|81481741|FG005|Overall Study|Result Not Available|0|||
27903583|NCT01066793|81481736|FG000|Overall Study|Treatment Interrupted|1|||
27903584|NCT01066793|81481737|FG001|Overall Study|Treatment Interrupted|1|||
27903585|NCT01066793|81481738|FG002|Overall Study|Treatment Interrupted|0|||
27903586|NCT01066793|81481739|FG003|Overall Study|Treatment Interrupted|0|||
27903587|NCT01066793|81481740|FG004|Overall Study|Treatment Interrupted|0|||
27903588|NCT01066793|81481741|FG005|Overall Study|Treatment Interrupted|0|||
27903589|NCT01066793|81481736|FG000|Overall Study|Treatment Never Started|18|||
27903590|NCT01066793|81481737|FG001|Overall Study|Treatment Never Started|5|||
27903591|NCT01066793|81481738|FG002|Overall Study|Treatment Never Started|4|||
27903592|NCT01066793|81481739|FG003|Overall Study|Treatment Never Started|1|||
27903593|NCT01066793|81481740|FG004|Overall Study|Treatment Never Started|0|||
27903594|NCT01066793|81481741|FG005|Overall Study|Treatment Never Started|0|||
27903595|NCT01066793|81481736|FG000|Overall Study|Treatment Stopped|2|||
27903596|NCT01066793|81481737|FG001|Overall Study|Treatment Stopped|1|||
27903597|NCT01066793|81481738|FG002|Overall Study|Treatment Stopped|0|||
27903598|NCT01066793|81481739|FG003|Overall Study|Treatment Stopped|1|||
27903599|NCT01066793|81481740|FG004|Overall Study|Treatment Stopped|0|||
27903600|NCT01066793|81481741|FG005|Overall Study|Treatment Stopped|0|||
27903601|NCT01658904|81481742|FG000|Overall Study|Principal Investigator discretion|2|||
27903602|NCT01658904|81481743|FG001|Overall Study|Principal Investigator discretion|0|||
27903603|NCT01658904|81481744|FG002|Overall Study|Principal Investigator discretion|0|||
27903604|NCT02749799|81481745|FG000|Overall Study|Adverse Event|2|||
27903605|NCT02749799|81481745|FG000|Overall Study|Lost to Follow-up|4|||
27903606|NCT02749799|81481745|FG000|Overall Study|Protocol Violation|1|||
27903607|NCT02749799|81481745|FG000|Overall Study|Withdrawal by Subject|1|||
27903608|NCT03597139|81485004|FG000|Overall Study|Adverse Event|3|||
27903609|NCT03597139|81485005|FG001|Overall Study|Adverse Event|0|||
27903610|NCT03597139|81485004|FG000|Overall Study|Protocol Non-compliance|1|||
27903611|NCT03597139|81485005|FG001|Overall Study|Protocol Non-compliance|0|||
27903612|NCT00463840|81485006|FG000|Overall Study|Disease progression|7|||
27903613|NCT00463840|81485006|FG000|Overall Study|Withdrawal by Subject|2|||
27903614|NCT00463840|81485006|FG000|Overall Study|Adverse Event|3|||
27903615|NCT02417961|81485008|FG000|Overall Study|Adverse Event|1|||
27903616|NCT02417961|81485008|FG000|Overall Study|Lost to Follow-up|1|||
27903617|NCT02417961|81485008|FG000|Overall Study|Withdrawal by Subject|2|||
27903618|NCT04114656|81485015|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
27903619|NCT04114656|81485016|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
27903620|NCT04114656|81485015|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
27903621|NCT04114656|81485016|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
27903622|NCT04114656|81485015|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
27903623|NCT04114656|81485016|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
27903624|NCT04114656|81485015|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
27903625|NCT04114656|81485016|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
27903626|NCT04114656|81485015|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
27903627|NCT04114656|81485016|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
27903628|NCT04126317|81485017|FG000|Overall Study|Adverse Event|0|||
27903629|NCT04126317|81485018|FG001|Overall Study|Adverse Event|1|||
27903630|NCT04126317|81485017|FG000|Overall Study|Withdrawal by Subject|4|||
27903631|NCT04126317|81485018|FG001|Overall Study|Withdrawal by Subject|1|||
27903632|NCT00048165|81485023|FG000|Completed 6 Months Study|Administration/Other|8|||
27903633|NCT00048165|81485024|FG001|Completed 6 Months Study|Administration/Other|8|||
27903634|NCT00048165|81485023|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
27903635|NCT00048165|81485024|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
27903636|NCT00048165|81485023|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
27903637|NCT00048165|81485024|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
27903638|NCT00048165|81485023|FG000|Completed 6 Months Study|Death|12|||
27903639|NCT00048165|81485024|FG001|Completed 6 Months Study|Death|6|||
27903640|NCT00048165|81485023|FG000|Completed 6 Months Study|Insufficient therapy|1|||
27903641|NCT00048165|81485024|FG001|Completed 6 Months Study|Insufficient therapy|4|||
27903642|NCT00048165|81485023|FG000|Completed 6 Months Study|Other violation|4|||
27903643|NCT00048165|81485024|FG001|Completed 6 Months Study|Other violation|6|||
27903644|NCT00048165|81485023|FG000|Completed 6 Months Study|Refused treatment|5|||
27903645|NCT00048165|81485024|FG001|Completed 6 Months Study|Refused treatment|5|||
27903646|NCT00048165|81485023|FG000|Completed 6 Months Study|Violation criteria|0|||
27903647|NCT00048165|81485024|FG001|Completed 6 Months Study|Violation criteria|2|||
27903648|NCT00048165|81485023|FG000|Completed 6 Months Study|Did not receive study drug|6|||
27903649|NCT00048165|81485024|FG001|Completed 6 Months Study|Did not receive study drug|6|||
27903650|NCT00048165|81485023|FG000|Completed 12 Months Study|Administration/Other|0|||
27507266|NCT01942837|80051484|FG000|Overall Study|Intercurrent Illness|1|||
27507267|NCT01942837|80051484|FG000|Overall Study|On treatment|3|||
27507268|NCT01942837|80051484|FG000|Overall Study|Never initiate the treatment|2|||
27507269|NCT03879772|80051485|FG000|Overall Study|Adverse Event|2|||
27507270|NCT03879772|80051486|FG001|Overall Study|Adverse Event|2|||
27507271|NCT03879772|80051487|FG002|Overall Study|Adverse Event|3|||
27728498|NCT02970929|80833301|FG000|Overall Study|Adverse Event|18|||
27851869|NCT01829113|81287175|FG000|Overall Study|Physician Decision|1|||
27851870|NCT01829113|81287176|FG001|Overall Study|Physician Decision|1|||
27851871|NCT03476343|81287181|FG000|Overall Study|Clinical exam moved to another scanner|7|||
27851872|NCT03476343|81287181|FG000|Overall Study|Clinical order cancelled|4|||
27851873|NCT03476343|81287181|FG000|Overall Study|Neonate did not settle down for the scan|1|||
27851874|NCT01458106|81287182|FG000|Overall Study|Withdrawal by Subject|2|||
27851875|NCT01458106|81287183|FG001|Overall Study|Withdrawal by Subject|0|||
27851876|NCT01458106|81287182|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
27851877|NCT01458106|81287183|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
27851878|NCT01458106|81287182|FG000|Overall Study|Withdrawn Per Protocol|0|||
27851879|NCT01458106|81287183|FG001|Overall Study|Withdrawn Per Protocol|1|||
27851880|NCT00669071|81287200|FG000|Overall Study|Lost to Follow-up|3|||
27851881|NCT00669071|81287200|FG000|Overall Study|Final visit 40 days out of window|1|||
27851882|NCT01197417|81287201|FG000|Overall Study|Physician Decision|3|||
27728499|NCT02970929|80833301|FG000|Overall Study|Lack of Efficacy|8|||
27851883|NCT01197417|81287202|FG001|Overall Study|Physician Decision|2|||
27851884|NCT01197417|81287201|FG000|Overall Study|Withdrawal by Subject|2|||
27851885|NCT01197417|81287202|FG001|Overall Study|Withdrawal by Subject|4|||
27903651|NCT00048165|81485024|FG001|Completed 12 Months Study|Administration/Other|2|||
27903652|NCT00048165|81485023|FG000|Completed 12 Months Study|Death|2|||
27903653|NCT00048165|81485024|FG001|Completed 12 Months Study|Death|1|||
27903654|NCT00048165|81485023|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
27903655|NCT00048165|81485024|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
27903656|NCT00433017|81485025|FG000|Overall Study|Adverse Event|5|||
27903657|NCT00433017|81485026|FG001|Overall Study|Adverse Event|3|||
27903658|NCT00433017|81485025|FG000|Overall Study|Withdrawal by Subject|4|||
27903659|NCT00433017|81485026|FG001|Overall Study|Withdrawal by Subject|5|||
27903660|NCT00433017|81485025|FG000|Overall Study|Lost to Follow-up|3|||
27903661|NCT00433017|81485026|FG001|Overall Study|Lost to Follow-up|4|||
27903662|NCT00433017|81485025|FG000|Overall Study|Administrative problems|80|||
27903663|NCT00433017|81485026|FG001|Overall Study|Administrative problems|86|||
27903664|NCT00433017|81485025|FG000|Overall Study|Protocol Violation|1|||
27903665|NCT00433017|81485026|FG001|Overall Study|Protocol Violation|0|||
27903666|NCT00433017|81485025|FG000|Overall Study|Death|2|||
27903667|NCT00433017|81485026|FG001|Overall Study|Death|2|||
27903668|NCT00433017|81485025|FG000|Overall Study|Subject no longer requires study drug|1|||
27903669|NCT00433017|81485026|FG001|Overall Study|Subject no longer requires study drug|1|||
27903670|NCT03092791|81485027|FG000|Overall Study|Lost to Follow-up|0|||
27903671|NCT03092791|81485028|FG001|Overall Study|Lost to Follow-up|0|||
27903672|NCT03092791|81485029|FG002|Overall Study|Lost to Follow-up|0|||
27903673|NCT03092791|81485030|FG003|Overall Study|Lost to Follow-up|0|||
27903674|NCT03092791|81485031|FG004|Overall Study|Lost to Follow-up|0|||
27903675|NCT03092791|81485032|FG005|Overall Study|Lost to Follow-up|0|||
27903676|NCT03092791|81485033|FG006|Overall Study|Lost to Follow-up|1|||
27903677|NCT03092791|81485034|FG007|Overall Study|Lost to Follow-up|0|||
27903678|NCT03092791|81485027|FG000|Overall Study|Withdrawal of Consent|0|||
27507272|NCT03879772|80051488|FG003|Overall Study|Adverse Event|4|||
27507273|NCT03879772|80051489|FG004|Overall Study|Adverse Event|3|||
27507274|NCT03879772|80051485|FG000|Overall Study|Treatment Failure|1|||
27507275|NCT03879772|80051486|FG001|Overall Study|Treatment Failure|0|||
27507276|NCT03879772|80051487|FG002|Overall Study|Treatment Failure|0|||
27728500|NCT02970929|80833301|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
27903679|NCT03092791|81485028|FG001|Overall Study|Withdrawal of Consent|0|||
27903680|NCT03092791|81485029|FG002|Overall Study|Withdrawal of Consent|0|||
27903681|NCT03092791|81485030|FG003|Overall Study|Withdrawal of Consent|0|||
27903682|NCT03092791|81485031|FG004|Overall Study|Withdrawal of Consent|4|||
27903683|NCT03092791|81485032|FG005|Overall Study|Withdrawal of Consent|12|||
27903684|NCT03092791|81485033|FG006|Overall Study|Withdrawal of Consent|6|||
27903685|NCT03092791|81485034|FG007|Overall Study|Withdrawal of Consent|4|||
27903686|NCT03092791|81485027|FG000|Overall Study|Study Termination|0|||
27903687|NCT03092791|81485028|FG001|Overall Study|Study Termination|0|||
27903688|NCT03092791|81485029|FG002|Overall Study|Study Termination|0|||
27903689|NCT03092791|81485030|FG003|Overall Study|Study Termination|0|||
27903690|NCT03092791|81485031|FG004|Overall Study|Study Termination|55|||
27903691|NCT03092791|81485032|FG005|Overall Study|Study Termination|46|||
27903692|NCT03092791|81485033|FG006|Overall Study|Study Termination|53|||
27903693|NCT03092791|81485034|FG007|Overall Study|Study Termination|55|||
27903694|NCT03092791|81485027|FG000|Overall Study|Death|0|||
27903695|NCT03092791|81485028|FG001|Overall Study|Death|0|||
27903696|NCT03092791|81485029|FG002|Overall Study|Death|0|||
27903697|NCT03092791|81485030|FG003|Overall Study|Death|0|||
27903698|NCT03092791|81485031|FG004|Overall Study|Death|0|||
27903699|NCT03092791|81485032|FG005|Overall Study|Death|1|||
27903700|NCT03092791|81485033|FG006|Overall Study|Death|0|||
27903701|NCT03092791|81485034|FG007|Overall Study|Death|1|||
27903702|NCT03092791|81485027|FG000|Overall Study|Reason Not Specified|0|||
27903703|NCT03092791|81485028|FG001|Overall Study|Reason Not Specified|0|||
27903704|NCT03092791|81485029|FG002|Overall Study|Reason Not Specified|0|||
27903705|NCT03092791|81485030|FG003|Overall Study|Reason Not Specified|0|||
27903706|NCT03092791|81485031|FG004|Overall Study|Reason Not Specified|1|||
27903707|NCT03092791|81485032|FG005|Overall Study|Reason Not Specified|1|||
27903708|NCT03092791|81485033|FG006|Overall Study|Reason Not Specified|0|||
27903709|NCT03092791|81485034|FG007|Overall Study|Reason Not Specified|0|||
27903710|NCT00913770|81485035|FG000|Overall Study|Unable to contact|24|||
27903711|NCT00913770|81485036|FG001|Overall Study|Unable to contact|19|||
27903712|NCT00913770|81485037|FG002|Overall Study|Unable to contact|13|||
27903713|NCT00913770|81485035|FG000|Overall Study|Refused|11|||
27903714|NCT00913770|81485036|FG001|Overall Study|Refused|10|||
27507277|NCT03879772|80051488|FG003|Overall Study|Treatment Failure|2|||
27903715|NCT00913770|81485037|FG002|Overall Study|Refused|8|||
27903716|NCT01119846|81485038|FG000|Overall Study|Adverse Event|1|||
27903717|NCT01119846|81485039|FG001|Overall Study|Adverse Event|0|||
27903718|NCT01119846|81485040|FG002|Overall Study|Adverse Event|6|||
27903719|NCT01119846|81485038|FG000|Overall Study|Physician Decision|1|||
27903720|NCT01119846|81485039|FG001|Overall Study|Physician Decision|0|||
27507278|NCT03879772|80051489|FG004|Overall Study|Treatment Failure|1|||
27903721|NCT01119846|81485040|FG002|Overall Study|Physician Decision|0|||
27903722|NCT01119846|81485038|FG000|Overall Study|Protocol Violation|0|||
27903723|NCT01119846|81485039|FG001|Overall Study|Protocol Violation|0|||
27903724|NCT01119846|81485040|FG002|Overall Study|Protocol Violation|1|||
27903725|NCT01119846|81485038|FG000|Overall Study|Withdrawal by Subject|0|||
27903726|NCT01119846|81485039|FG001|Overall Study|Withdrawal by Subject|0|||
27903727|NCT01119846|81485040|FG002|Overall Study|Withdrawal by Subject|4|||
27903728|NCT01390428|81485045|FG000|Overall Study|Elective Surgery|0|||
27903729|NCT01390428|81485046|FG001|Overall Study|Elective Surgery|0|||
27903730|NCT01390428|81485047|FG002|Overall Study|Elective Surgery|0|||
27507279|NCT03879772|80051485|FG000|Overall Study|Lost to Follow-up|0|||
27507280|NCT03879772|80051486|FG001|Overall Study|Lost to Follow-up|0|||
27507281|NCT03879772|80051487|FG002|Overall Study|Lost to Follow-up|0|||
27507282|NCT03879772|80051488|FG003|Overall Study|Lost to Follow-up|0|||
27507283|NCT03879772|80051489|FG004|Overall Study|Lost to Follow-up|1|||
27507284|NCT03879772|80051485|FG000|Overall Study|Withdrawal by Subject|0|||
27507285|NCT03879772|80051486|FG001|Overall Study|Withdrawal by Subject|1|||
27507286|NCT03879772|80051487|FG002|Overall Study|Withdrawal by Subject|3|||
27507287|NCT03879772|80051488|FG003|Overall Study|Withdrawal by Subject|1|||
27507288|NCT03879772|80051489|FG004|Overall Study|Withdrawal by Subject|1|||
27614594|NCT03810313|80430325|FG001|Overall Study|Death|1|||
27614595|NCT03810313|80430324|FG000|Overall Study|Physician Decision|0|||
27903731|NCT01390428|81485048|FG003|Overall Study|Elective Surgery|0|||
27507289|NCT03879772|80051485|FG000|Overall Study|Protocol Violation|0|||
27614596|NCT03810313|80430325|FG001|Overall Study|Physician Decision|1|||
27903732|NCT01390428|81485049|FG004|Overall Study|Elective Surgery|1|||
27507290|NCT03879772|80051486|FG001|Overall Study|Protocol Violation|0|||
27507291|NCT03879772|80051487|FG002|Overall Study|Protocol Violation|3|||
27507292|NCT03879772|80051488|FG003|Overall Study|Protocol Violation|1|||
27507293|NCT03879772|80051489|FG004|Overall Study|Protocol Violation|2|||
27507294|NCT03879772|80051485|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
27507295|NCT03879772|80051486|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
27507296|NCT03879772|80051487|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
27507297|NCT03879772|80051488|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
27507298|NCT03879772|80051489|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
27507299|NCT02839200|80051490|FG000|Overall Study|Withdrawal by Subject|2|||
27507300|NCT02839200|80051491|FG001|Overall Study|Withdrawal by Subject|0|||
27507301|NCT02839200|80051492|FG002|Overall Study|Withdrawal by Subject|1|||
27507302|NCT02839200|80051493|FG003|Overall Study|Withdrawal by Subject|0|||
27507303|NCT02839200|80051494|FG004|Overall Study|Withdrawal by Subject|0|||
27507304|NCT02839200|80051495|FG005|Overall Study|Withdrawal by Subject|1|||
27507305|NCT02839200|80051490|FG000|Overall Study|Lost to Follow-up|2|||
27507306|NCT02839200|80051491|FG001|Overall Study|Lost to Follow-up|0|||
27507307|NCT02839200|80051492|FG002|Overall Study|Lost to Follow-up|0|||
27507308|NCT02839200|80051493|FG003|Overall Study|Lost to Follow-up|0|||
27507309|NCT02839200|80051494|FG004|Overall Study|Lost to Follow-up|1|||
27507310|NCT02839200|80051495|FG005|Overall Study|Lost to Follow-up|0|||
27903733|NCT01390428|81485050|FG005|Overall Study|Elective Surgery|0|||
27903734|NCT01390428|81485045|FG000|Overall Study|Withdrawal by Subject|0|||
27903735|NCT01390428|81485046|FG001|Overall Study|Withdrawal by Subject|0|||
27903736|NCT01390428|81485047|FG002|Overall Study|Withdrawal by Subject|1|||
27903737|NCT01390428|81485048|FG003|Overall Study|Withdrawal by Subject|0|||
27903738|NCT01390428|81485049|FG004|Overall Study|Withdrawal by Subject|0|||
27903739|NCT01390428|81485050|FG005|Overall Study|Withdrawal by Subject|0|||
27903740|NCT01017601|81485051|FG000|Overall Study|Disease Progression|12|||
27903741|NCT01017601|81485052|FG001|Overall Study|Disease Progression|12|||
27903742|NCT01017601|81485051|FG000|Overall Study|Withdrawal by Subject|0|||
27903743|NCT01017601|81485052|FG001|Overall Study|Withdrawal by Subject|1|||
27903744|NCT00282152|81485055|FG000|Overall Study|Withdrawal by Subject|1|||
27903745|NCT00282152|81485056|FG001|Overall Study|Withdrawal by Subject|0|||
27903746|NCT02014558|81485057|FG000|Overall Study|Never Received Study Drug|0|||
27903747|NCT02014558|81485058|FG001|Overall Study|Never Received Study Drug|0|||
27903748|NCT02014558|81485059|FG002|Overall Study|Never Received Study Drug|0|||
27903749|NCT02014558|81485060|FG003|Overall Study|Never Received Study Drug|0|||
27903750|NCT02014558|81485061|FG004|Overall Study|Never Received Study Drug|1|||
27903751|NCT02014558|81485062|FG005|Overall Study|Never Received Study Drug|0|||
27903752|NCT02014558|81485063|FG006|Overall Study|Never Received Study Drug|1|||
27903753|NCT02014558|81485064|FG007|Overall Study|Never Received Study Drug|0|||
27903754|NCT02014558|81485065|FG008|Overall Study|Never Received Study Drug|2|||
27903755|NCT02014558|81485066|FG009|Overall Study|Never Received Study Drug|0|||
27903756|NCT02014558|81485067|FG010|Overall Study|Never Received Study Drug|2|||
27903757|NCT02014558|81485068|FG011|Overall Study|Never Received Study Drug|2|||
27903758|NCT02014558|81485069|FG012|Overall Study|Never Received Study Drug|0|||
27903759|NCT02014558|81485057|FG000|Overall Study|Adverse Event|0|||
27903760|NCT02014558|81485058|FG001|Overall Study|Adverse Event|0|||
27903761|NCT02014558|81485059|FG002|Overall Study|Adverse Event|0|||
27903762|NCT02014558|81485060|FG003|Overall Study|Adverse Event|0|||
27903763|NCT02014558|81485061|FG004|Overall Study|Adverse Event|1|||
27903764|NCT02014558|81485062|FG005|Overall Study|Adverse Event|0|||
27903765|NCT02014558|81485063|FG006|Overall Study|Adverse Event|0|||
27903766|NCT02014558|81485064|FG007|Overall Study|Adverse Event|0|||
27903767|NCT02014558|81485065|FG008|Overall Study|Adverse Event|2|||
27903768|NCT02014558|81485066|FG009|Overall Study|Adverse Event|2|||
27903769|NCT02014558|81485067|FG010|Overall Study|Adverse Event|5|||
27903770|NCT02014558|81485068|FG011|Overall Study|Adverse Event|21|||
27903771|NCT02014558|81485069|FG012|Overall Study|Adverse Event|3|||
27903772|NCT02014558|81485057|FG000|Overall Study|Death|1|||
27903773|NCT02014558|81485058|FG001|Overall Study|Death|0|||
27903774|NCT02014558|81485059|FG002|Overall Study|Death|0|||
27903775|NCT02014558|81485060|FG003|Overall Study|Death|0|||
27903776|NCT02014558|81485061|FG004|Overall Study|Death|0|||
27903777|NCT02014558|81485062|FG005|Overall Study|Death|0|||
27903778|NCT02014558|81485063|FG006|Overall Study|Death|1|||
27903779|NCT02014558|81485064|FG007|Overall Study|Death|1|||
27903780|NCT02014558|81485065|FG008|Overall Study|Death|2|||
27903781|NCT02014558|81485066|FG009|Overall Study|Death|5|||
27903782|NCT02014558|81485067|FG010|Overall Study|Death|5|||
27903783|NCT02014558|81485068|FG011|Overall Study|Death|19|||
27903784|NCT02014558|81485069|FG012|Overall Study|Death|2|||
27903785|NCT02014558|81485057|FG000|Overall Study|Lack of Efficacy|1|||
27903786|NCT02014558|81485058|FG001|Overall Study|Lack of Efficacy|2|||
27903787|NCT02014558|81485059|FG002|Overall Study|Lack of Efficacy|1|||
27903788|NCT02014558|81485060|FG003|Overall Study|Lack of Efficacy|1|||
27903789|NCT02014558|81485061|FG004|Overall Study|Lack of Efficacy|0|||
27507311|NCT02839200|80051490|FG000|Overall Study|Adverse Event|0|||
27903790|NCT02014558|81485062|FG005|Overall Study|Lack of Efficacy|0|||
27903791|NCT02014558|81485063|FG006|Overall Study|Lack of Efficacy|1|||
27903792|NCT02014558|81485064|FG007|Overall Study|Lack of Efficacy|3|||
27903793|NCT02014558|81485065|FG008|Overall Study|Lack of Efficacy|3|||
27903794|NCT02014558|81485066|FG009|Overall Study|Lack of Efficacy|3|||
27903795|NCT02014558|81485067|FG010|Overall Study|Lack of Efficacy|16|||
27903796|NCT02014558|81485068|FG011|Overall Study|Lack of Efficacy|8|||
27903797|NCT02014558|81485069|FG012|Overall Study|Lack of Efficacy|5|||
27903798|NCT02014558|81485057|FG000|Overall Study|Lost to Follow-up|0|||
27903799|NCT02014558|81485058|FG001|Overall Study|Lost to Follow-up|0|||
27903800|NCT02014558|81485059|FG002|Overall Study|Lost to Follow-up|0|||
27903801|NCT02014558|81485060|FG003|Overall Study|Lost to Follow-up|0|||
27903802|NCT02014558|81485061|FG004|Overall Study|Lost to Follow-up|0|||
27903803|NCT02014558|81485062|FG005|Overall Study|Lost to Follow-up|0|||
27507312|NCT02839200|80051491|FG001|Overall Study|Adverse Event|0|||
27507313|NCT02839200|80051492|FG002|Overall Study|Adverse Event|0|||
27507314|NCT02839200|80051493|FG003|Overall Study|Adverse Event|0|||
27507315|NCT02839200|80051494|FG004|Overall Study|Adverse Event|1|||
27507316|NCT02839200|80051495|FG005|Overall Study|Adverse Event|0|||
27507317|NCT02839200|80051490|FG000|Overall Study|Randomized in error|0|||
27507318|NCT02839200|80051491|FG001|Overall Study|Randomized in error|1|||
27507319|NCT02839200|80051492|FG002|Overall Study|Randomized in error|0|||
27507320|NCT02839200|80051493|FG003|Overall Study|Randomized in error|0|||
27507321|NCT02839200|80051494|FG004|Overall Study|Randomized in error|0|||
27507322|NCT02839200|80051495|FG005|Overall Study|Randomized in error|0|||
27507323|NCT02141295|80051496|FG000|Overall Study|Adverse Event|1|||
27507324|NCT02141295|80051497|FG001|Overall Study|Adverse Event|18|||
27507325|NCT02141295|80051498|FG002|Overall Study|Adverse Event|11|||
27507326|NCT02141295|80051496|FG000|Overall Study|Physician Decision|2|||
27507327|NCT02141295|80051497|FG001|Overall Study|Physician Decision|19|||
27507328|NCT02141295|80051498|FG002|Overall Study|Physician Decision|14|||
27507329|NCT02141295|80051496|FG000|Overall Study|Study terminated by sponsor|0|||
27507330|NCT02141295|80051497|FG001|Overall Study|Study terminated by sponsor|6|||
27507331|NCT02141295|80051498|FG002|Overall Study|Study terminated by sponsor|6|||
27507332|NCT02141295|80051496|FG000|Overall Study|Non-compliance|0|||
27507333|NCT02141295|80051497|FG001|Overall Study|Non-compliance|1|||
27507334|NCT02141295|80051498|FG002|Overall Study|Non-compliance|0|||
27903804|NCT02014558|81485063|FG006|Overall Study|Lost to Follow-up|0|||
27903805|NCT02014558|81485064|FG007|Overall Study|Lost to Follow-up|0|||
27903806|NCT02014558|81485065|FG008|Overall Study|Lost to Follow-up|0|||
27903807|NCT02014558|81485066|FG009|Overall Study|Lost to Follow-up|0|||
27903808|NCT02014558|81485067|FG010|Overall Study|Lost to Follow-up|1|||
27903809|NCT02014558|81485068|FG011|Overall Study|Lost to Follow-up|0|||
27903810|NCT02014558|81485069|FG012|Overall Study|Lost to Follow-up|0|||
27903811|NCT02014558|81485057|FG000|Overall Study|Progressive Disease|1|||
27903812|NCT02014558|81485058|FG001|Overall Study|Progressive Disease|0|||
27903813|NCT02014558|81485059|FG002|Overall Study|Progressive Disease|1|||
27903814|NCT02014558|81485060|FG003|Overall Study|Progressive Disease|1|||
27903815|NCT02014558|81485061|FG004|Overall Study|Progressive Disease|1|||
27903816|NCT02014558|81485062|FG005|Overall Study|Progressive Disease|2|||
27903817|NCT02014558|81485063|FG006|Overall Study|Progressive Disease|1|||
27507335|NCT02141295|80051496|FG000|Overall Study|Progressive disease|3|||
27507336|NCT02141295|80051497|FG001|Overall Study|Progressive disease|32|||
27507337|NCT02141295|80051498|FG002|Overall Study|Progressive disease|50|||
27507338|NCT02141295|80051496|FG000|Overall Study|Reason not specified|0|||
27507339|NCT02141295|80051497|FG001|Overall Study|Reason not specified|9|||
27507340|NCT02141295|80051498|FG002|Overall Study|Reason not specified|10|||
27507341|NCT02141295|80051496|FG000|Overall Study|Withdrawal by Subject|0|||
27903818|NCT02014558|81485064|FG007|Overall Study|Progressive Disease|6|||
27903819|NCT02014558|81485065|FG008|Overall Study|Progressive Disease|5|||
27903820|NCT02014558|81485066|FG009|Overall Study|Progressive Disease|6|||
27507342|NCT02141295|80051497|FG001|Overall Study|Withdrawal by Subject|9|||
27507343|NCT02141295|80051498|FG002|Overall Study|Withdrawal by Subject|4|||
27507344|NCT01812252|80051501|FG000|Overall Study|Persistent Disease|1|||
27507345|NCT01812252|80051502|FG001|Overall Study|Persistent Disease|0|||
27507346|NCT01812252|80051501|FG000|Overall Study|Not transplanted|11|||
27507347|NCT01812252|80051502|FG001|Overall Study|Not transplanted|11|||
27507348|NCT01812252|80051501|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
27507349|NCT01812252|80051502|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
27507350|NCT01812252|80051501|FG000|Overall Study|Withdrawal by Subject|1|||
27507351|NCT01812252|80051502|FG001|Overall Study|Withdrawal by Subject|1|||
27507352|NCT01812252|80051501|FG000|Overall Study|Screen Failure|1|||
27507353|NCT01812252|80051502|FG001|Overall Study|Screen Failure|0|||
27507354|NCT02304367|80051503|FG000|Overall Study|Lack of Response to Bruosumab|1|||
27507355|NCT02304367|80051503|FG000|Overall Study|Sponsor Decision|3|||
27507356|NCT02304367|80051503|FG000|Overall Study|Death|2|||
27507357|NCT02304367|80051503|FG000|Overall Study|Physician Decision|1|||
27507358|NCT02304367|80051503|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
27903821|NCT02014558|81485067|FG010|Overall Study|Progressive Disease|22|||
27903822|NCT02014558|81485068|FG011|Overall Study|Progressive Disease|31|||
27507359|NCT00760617|80051504|FG000|Overall Study|Adverse Event|5|||
27507360|NCT00760617|80051505|FG001|Overall Study|Adverse Event|2|||
27507361|NCT00760617|80051506|FG002|Overall Study|Adverse Event|0|||
27507362|NCT00760617|80051504|FG000|Overall Study|Lost to Follow-up|0|||
27507363|NCT00760617|80051505|FG001|Overall Study|Lost to Follow-up|0|||
27903823|NCT02014558|81485069|FG012|Overall Study|Progressive Disease|6|||
27903824|NCT02014558|81485057|FG000|Overall Study|Withdrawal by Subject|0|||
27903825|NCT02014558|81485058|FG001|Overall Study|Withdrawal by Subject|0|||
27903826|NCT02014558|81485059|FG002|Overall Study|Withdrawal by Subject|0|||
27507364|NCT00760617|80051506|FG002|Overall Study|Lost to Follow-up|5|||
27507365|NCT04411667|80051509|FG000|Overall Study|Physician Decision|1|||
27507366|NCT04411667|80051510|FG001|Overall Study|Physician Decision|0|||
27903827|NCT02014558|81485060|FG003|Overall Study|Withdrawal by Subject|0|||
27903828|NCT02014558|81485061|FG004|Overall Study|Withdrawal by Subject|1|||
27903829|NCT02014558|81485062|FG005|Overall Study|Withdrawal by Subject|0|||
27903830|NCT02014558|81485063|FG006|Overall Study|Withdrawal by Subject|0|||
27903831|NCT02014558|81485064|FG007|Overall Study|Withdrawal by Subject|0|||
27903832|NCT02014558|81485065|FG008|Overall Study|Withdrawal by Subject|0|||
27903833|NCT02014558|81485066|FG009|Overall Study|Withdrawal by Subject|2|||
27903834|NCT02014558|81485067|FG010|Overall Study|Withdrawal by Subject|6|||
27903835|NCT02014558|81485068|FG011|Overall Study|Withdrawal by Subject|10|||
27903836|NCT02014558|81485069|FG012|Overall Study|Withdrawal by Subject|0|||
27903837|NCT02014558|81485057|FG000|Overall Study|Miscellaneous|2|||
27903838|NCT02014558|81485058|FG001|Overall Study|Miscellaneous|1|||
27903839|NCT02014558|81485059|FG002|Overall Study|Miscellaneous|1|||
27903840|NCT02014558|81485060|FG003|Overall Study|Miscellaneous|1|||
27903841|NCT02014558|81485061|FG004|Overall Study|Miscellaneous|0|||
27903842|NCT02014558|81485062|FG005|Overall Study|Miscellaneous|1|||
27903843|NCT02014558|81485063|FG006|Overall Study|Miscellaneous|0|||
27903844|NCT02014558|81485064|FG007|Overall Study|Miscellaneous|1|||
27903845|NCT02014558|81485065|FG008|Overall Study|Miscellaneous|1|||
27903846|NCT02014558|81485066|FG009|Overall Study|Miscellaneous|3|||
27903847|NCT02014558|81485067|FG010|Overall Study|Miscellaneous|12|||
27903848|NCT02014558|81485068|FG011|Overall Study|Miscellaneous|11|||
27903849|NCT02014558|81485069|FG012|Overall Study|Miscellaneous|1|||
27903850|NCT01778751|81485070|FG000|Overall Study|Lost to Follow-up|1|||
27903851|NCT01778751|81485071|FG001|Overall Study|Lost to Follow-up|0|||
27903852|NCT01778751|81485070|FG000|Overall Study|Withdrawal by Subject|0|||
27903853|NCT01778751|81485071|FG001|Overall Study|Withdrawal by Subject|2|||
27903854|NCT01778751|81485070|FG000|Overall Study|Transfered care|1|||
27903855|NCT01778751|81485071|FG001|Overall Study|Transfered care|0|||
27903856|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
27903857|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
27903858|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
27903859|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
27903860|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
27507367|NCT00369265|80051511|FG000|Overall Study|Study terminated|4|||
27903861|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
27903862|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
27903863|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
27903864|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
27903865|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
27903866|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
27507368|NCT00369265|80051512|FG001|Overall Study|Study terminated|7|||
27507369|NCT03337477|80051518|FG000|Overall Study|not categorized into the listed ones|11|||
27507370|NCT03337477|80051519|FG001|Overall Study|not categorized into the listed ones|9|||
27507371|NCT03337477|80051518|FG000|Overall Study|Withdrawal by Subject|0|||
27507372|NCT03337477|80051519|FG001|Overall Study|Withdrawal by Subject|1|||
27507373|NCT03337477|80051518|FG000|Overall Study|Death|0|||
27507374|NCT03337477|80051519|FG001|Overall Study|Death|1|||
27507375|NCT03337477|80051518|FG000|Overall Study|Lost to Follow-up|0|||
27507376|NCT03337477|80051519|FG001|Overall Study|Lost to Follow-up|2|||
27507377|NCT03944577|80051524|FG000|Overall Study|Adverse Event|3|||
27507378|NCT01001325|80051525|FG000|Overall Study|Lost to Follow-up|16|||
27507379|NCT01001325|80051526|FG001|Overall Study|Lost to Follow-up|10|||
27507380|NCT01001325|80051525|FG000|Overall Study|Protocol Violation|2|||
27507381|NCT01001325|80051526|FG001|Overall Study|Protocol Violation|0|||
27507382|NCT00067002|80051528|FG000|Overall Study|Early Death|1|||
27507383|NCT00067002|80051529|FG001|Overall Study|Early Death|2|||
27507384|NCT00067002|80051528|FG000|Overall Study|Delayed|1|||
27507385|NCT00067002|80051529|FG001|Overall Study|Delayed|1|||
27507386|NCT00067002|80051528|FG000|Overall Study|Graft Failure|5|||
27903867|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
27903868|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
27507387|NCT00067002|80051529|FG001|Overall Study|Graft Failure|6|||
27507388|NCT03774576|80051530|FG000|Period 2|Adverse Event|1|||
27507389|NCT01599637|80051531|FG000|Overall Study|administrative problems|0|||
27903869|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
27507390|NCT01599637|80051532|FG001|Overall Study|administrative problems|2|||
27507391|NCT01599637|80051533|FG002|Overall Study|administrative problems|0|||
27507392|NCT01599637|80051531|FG000|Overall Study|Adverse Event|1|||
27507393|NCT01599637|80051532|FG001|Overall Study|Adverse Event|0|||
27903870|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
27903871|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
27903872|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
27903873|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
27903874|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
27903875|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
27851886|NCT01197417|81287201|FG000|Overall Study|Site miscommunication|0|||
27851887|NCT01197417|81287202|FG001|Overall Study|Site miscommunication|1|||
27851888|NCT01197417|81287201|FG000|Overall Study|Subject transferred to intensive care|0|||
27851889|NCT01197417|81287202|FG001|Overall Study|Subject transferred to intensive care|1|||
27851890|NCT01197417|81287201|FG000|Overall Study|Not consented in time to receive drug|0|||
27851891|NCT01197417|81287202|FG001|Overall Study|Not consented in time to receive drug|1|||
27851892|NCT01197417|81287201|FG000|Overall Study|Hypotension|1|||
27507394|NCT01599637|80051533|FG002|Overall Study|Adverse Event|0|||
27851893|NCT01197417|81287202|FG001|Overall Study|Hypotension|2|||
27851894|NCT01197417|81287201|FG000|Overall Study|Found to be ineligible|2|||
27851895|NCT01197417|81287202|FG001|Overall Study|Found to be ineligible|5|||
27851896|NCT01197417|81287201|FG000|Overall Study|No 25-hour magnesium level|0|||
27851897|NCT01197417|81287202|FG001|Overall Study|No 25-hour magnesium level|2|||
27851898|NCT01462318|81287203|FG000|Main Study / TP-DI Study|Other|2|||
27851899|NCT01462318|81287204|FG001|Main Study / TP-DI Study|Other|0|||
27851900|NCT01462318|81287205|FG002|Main Study / TP-DI Study|Other|0|||
27851901|NCT01462318|81287203|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
27851902|NCT01462318|81287204|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
27851903|NCT01462318|81287205|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
27851904|NCT01462318|81287203|FG000|Main Study / TP-DI Study|Adverse Event|4|||
27851905|NCT01462318|81287204|FG001|Main Study / TP-DI Study|Adverse Event|0|||
27851906|NCT01462318|81287205|FG002|Main Study / TP-DI Study|Adverse Event|0|||
27851907|NCT01462318|81287203|FG000|Extension Phase|Lost to Follow-up|0|||
27851908|NCT01462318|81287204|FG001|Extension Phase|Lost to Follow-up|0|||
27851909|NCT01462318|81287205|FG002|Extension Phase|Lost to Follow-up|1|||
27851910|NCT01462318|81287203|FG000|Extension Phase|Other|0|||
27851911|NCT01462318|81287204|FG001|Extension Phase|Other|0|||
27851912|NCT01462318|81287205|FG002|Extension Phase|Other|1|||
27851913|NCT01462318|81287203|FG000|Extension Phase|Disease Progression|0|||
27851914|NCT01462318|81287204|FG001|Extension Phase|Disease Progression|0|||
27851915|NCT01462318|81287205|FG002|Extension Phase|Disease Progression|1|||
27851916|NCT01462318|81287203|FG000|Extension Phase|Withdrawal by Subject|0|||
27851917|NCT01462318|81287204|FG001|Extension Phase|Withdrawal by Subject|0|||
27851918|NCT01462318|81287205|FG002|Extension Phase|Withdrawal by Subject|15|||
27851919|NCT01462318|81287203|FG000|Extension Phase|Investigator Decision|0|||
27851920|NCT01462318|81287204|FG001|Extension Phase|Investigator Decision|0|||
27851921|NCT01462318|81287205|FG002|Extension Phase|Investigator Decision|5|||
27851922|NCT01462318|81287203|FG000|Extension Phase|Adverse Event|0|||
27851923|NCT01462318|81287204|FG001|Extension Phase|Adverse Event|0|||
27851924|NCT01462318|81287205|FG002|Extension Phase|Adverse Event|22|||
27851925|NCT03334721|81287206|FG000|Overall Study|Withdrawal by Subject|1|||
27507395|NCT00918255|80051534|FG000|Overall Study|Adverse Event|1|||
27851926|NCT03334721|81287207|FG001|Overall Study|Withdrawal by Subject|0|||
27851927|NCT03334721|81287206|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
27851928|NCT03334721|81287207|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
27903876|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
27903877|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
27903878|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
27903879|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
27903880|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
27903881|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
27903882|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
27903883|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
27903884|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
27903885|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
27903886|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
27903887|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
27507396|NCT00918255|80051535|FG001|Overall Study|Adverse Event|0|||
27507397|NCT00918255|80051536|FG002|Overall Study|Adverse Event|0|||
27507398|NCT00918255|80051534|FG000|Overall Study|Withdrawal by Subject|1|||
27507399|NCT00918255|80051535|FG001|Overall Study|Withdrawal by Subject|0|||
27507400|NCT00918255|80051536|FG002|Overall Study|Withdrawal by Subject|2|||
27507401|NCT00918255|80051534|FG000|Overall Study|Lack of Efficacy|1|||
27507402|NCT00918255|80051535|FG001|Overall Study|Lack of Efficacy|0|||
27507403|NCT00918255|80051536|FG002|Overall Study|Lack of Efficacy|0|||
27507404|NCT00918255|80051534|FG000|Overall Study|Lost to Follow-up|1|||
27507405|NCT00918255|80051535|FG001|Overall Study|Lost to Follow-up|0|||
27507406|NCT00918255|80051536|FG002|Overall Study|Lost to Follow-up|2|||
27507407|NCT00918255|80051534|FG000|Overall Study|Exceeded allowed number of interventions|0|||
27507408|NCT00918255|80051535|FG001|Overall Study|Exceeded allowed number of interventions|0|||
27507409|NCT00918255|80051536|FG002|Overall Study|Exceeded allowed number of interventions|1|||
27903888|NCT03538691|81485073|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
27903889|NCT03538691|81485074|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
27903890|NCT03538691|81485075|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
27903891|NCT03538691|81485076|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
27903892|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
27903893|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
27903894|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
27903895|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
27903896|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
27903897|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
27903898|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
27507410|NCT00918255|80051534|FG000|Overall Study|Non-compliance|1|||
27507411|NCT00918255|80051535|FG001|Overall Study|Non-compliance|0|||
27507412|NCT00918255|80051536|FG002|Overall Study|Non-compliance|0|||
27507413|NCT00918255|80051534|FG000|Overall Study|Investigator discretion|1|||
27507414|NCT00918255|80051535|FG001|Overall Study|Investigator discretion|0|||
27903899|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
27903900|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
27903901|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
27507415|NCT00918255|80051536|FG002|Overall Study|Investigator discretion|0|||
27507416|NCT00912808|80051538|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
27903902|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
27903903|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
27903904|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
27903905|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
27903906|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
27903907|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
27903908|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
27903909|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
27903910|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
27903911|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
27903912|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
27903913|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
27903914|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
27903915|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
27903916|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
27903917|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
27903918|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
27903919|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
27903920|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
27903921|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
27903922|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
27903923|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
27903924|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
27903925|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
27903926|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
27903927|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
27851929|NCT02780167|81287209|FG000|Overall Study|Adverse Event|9|||
27851930|NCT02780167|81287210|FG001|Overall Study|Adverse Event|8|||
27851931|NCT02780167|81287211|FG002|Overall Study|Adverse Event|8|||
27851932|NCT02780167|81287212|FG003|Overall Study|Adverse Event|12|||
27851933|NCT02780167|81287213|FG004|Overall Study|Adverse Event|8|||
27851934|NCT02780167|81287209|FG000|Overall Study|Lack of Efficacy|6|||
27851935|NCT02780167|81287210|FG001|Overall Study|Lack of Efficacy|5|||
27851936|NCT02780167|81287211|FG002|Overall Study|Lack of Efficacy|6|||
27851937|NCT02780167|81287212|FG003|Overall Study|Lack of Efficacy|1|||
27851938|NCT02780167|81287213|FG004|Overall Study|Lack of Efficacy|0|||
27903928|NCT03538691|81485073|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
27851939|NCT02780167|81287209|FG000|Overall Study|Lost to Follow-up|2|||
27851940|NCT02780167|81287210|FG001|Overall Study|Lost to Follow-up|0|||
27851941|NCT02780167|81287211|FG002|Overall Study|Lost to Follow-up|1|||
27903929|NCT03538691|81485074|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
27903930|NCT03538691|81485075|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
27903931|NCT03538691|81485076|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
27903932|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
27903933|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
27903934|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
27903935|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
27903936|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
27903937|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
27903938|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
27903939|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
27507417|NCT00912808|80051539|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27507418|NCT00912808|80051538|FG000|Washout|Withdrawal by Subject|0|||
27507419|NCT00912808|80051539|FG001|Washout|Withdrawal by Subject|1|||
27507420|NCT00912808|80051538|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27507421|NCT00912808|80051539|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
27507422|NCT00912808|80051538|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
27507423|NCT00912808|80051539|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
27507424|NCT01435382|80051540|FG000|Overall Study|Lost to Follow-up|1|||
27507425|NCT01435382|80051541|FG001|Overall Study|Lost to Follow-up|0|||
27507426|NCT01435382|80051542|FG002|Overall Study|Lost to Follow-up|1|||
27507427|NCT01435382|80051543|FG003|Overall Study|Lost to Follow-up|0|||
27507428|NCT01435382|80051540|FG000|Overall Study|Withdrawal by Subject|0|||
27507429|NCT01435382|80051541|FG001|Overall Study|Withdrawal by Subject|2|||
27507430|NCT01435382|80051542|FG002|Overall Study|Withdrawal by Subject|0|||
27507431|NCT01435382|80051543|FG003|Overall Study|Withdrawal by Subject|1|||
27507432|NCT02531802|80051556|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
27507433|NCT02531802|80051557|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
27507434|NCT02531802|80051558|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
27507435|NCT02531802|80051559|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
27507436|NCT02531802|80051560|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
27507437|NCT02531802|80051561|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
27507438|NCT02531802|80051562|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
27507439|NCT02531802|80051563|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
27507440|NCT02531802|80051564|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
27507441|NCT02531802|80051565|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
27507442|NCT02531802|80051566|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
27507443|NCT02531802|80051567|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
27507444|NCT02531802|80051568|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
27507445|NCT02531802|80051569|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
27507446|NCT02531802|80051570|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
27507447|NCT02531802|80051571|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
27507448|NCT02531802|80051572|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
27507449|NCT02531802|80051573|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
27614597|NCT01388530|80430326|FG000|Overall Study|Lost to Follow-up|5|||
27903940|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
27903941|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
27903942|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
27903943|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
27903944|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
27851942|NCT02780167|81287212|FG003|Overall Study|Lost to Follow-up|0|||
27851943|NCT02780167|81287213|FG004|Overall Study|Lost to Follow-up|0|||
27851944|NCT02780167|81287209|FG000|Overall Study|Does not meet entrance criteria|0|||
27851945|NCT02780167|81287210|FG001|Overall Study|Does not meet entrance criteria|0|||
27851946|NCT02780167|81287211|FG002|Overall Study|Does not meet entrance criteria|1|||
27851947|NCT02780167|81287212|FG003|Overall Study|Does not meet entrance criteria|0|||
27851948|NCT02780167|81287213|FG004|Overall Study|Does not meet entrance criteria|0|||
27851949|NCT02780167|81287209|FG000|Overall Study|No longer meets eligibility criteria|0|||
27851950|NCT02780167|81287210|FG001|Overall Study|No longer meets eligibility criteria|0|||
27851951|NCT02780167|81287211|FG002|Overall Study|No longer meets eligibility criteria|0|||
27903945|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
27507450|NCT02531802|80051574|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
27507451|NCT02531802|80051575|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
27507452|NCT02531802|80051576|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
27507453|NCT02531802|80051556|FG000|Received Vaccination 2|Physician Decision|0|||
27507454|NCT02531802|80051557|FG001|Received Vaccination 2|Physician Decision|0|||
27507455|NCT02531802|80051558|FG002|Received Vaccination 2|Physician Decision|0|||
27507456|NCT02531802|80051559|FG003|Received Vaccination 2|Physician Decision|0|||
27507457|NCT02531802|80051560|FG004|Received Vaccination 2|Physician Decision|0|||
27507458|NCT02531802|80051561|FG005|Received Vaccination 2|Physician Decision|1|||
27507459|NCT02531802|80051562|FG006|Received Vaccination 2|Physician Decision|0|||
27507460|NCT02531802|80051563|FG007|Received Vaccination 2|Physician Decision|0|||
27507461|NCT02531802|80051564|FG008|Received Vaccination 2|Physician Decision|0|||
27507462|NCT02531802|80051565|FG009|Received Vaccination 2|Physician Decision|2|||
27507463|NCT02531802|80051566|FG010|Received Vaccination 2|Physician Decision|0|||
27507464|NCT02531802|80051567|FG011|Received Vaccination 2|Physician Decision|0|||
27507465|NCT02531802|80051568|FG012|Received Vaccination 2|Physician Decision|0|||
27507466|NCT02531802|80051569|FG013|Received Vaccination 2|Physician Decision|1|||
27507467|NCT02531802|80051570|FG014|Received Vaccination 2|Physician Decision|0|||
27507468|NCT02531802|80051571|FG015|Received Vaccination 2|Physician Decision|0|||
27507469|NCT02531802|80051572|FG016|Received Vaccination 2|Physician Decision|0|||
27507470|NCT02531802|80051573|FG017|Received Vaccination 2|Physician Decision|1|||
27507471|NCT02531802|80051574|FG018|Received Vaccination 2|Physician Decision|0|||
27507472|NCT02531802|80051575|FG019|Received Vaccination 2|Physician Decision|0|||
27507473|NCT02531802|80051576|FG020|Received Vaccination 2|Physician Decision|0|||
27507474|NCT02531802|80051556|FG000|Received Vaccination 2|Adverse Event|0|||
27507475|NCT02531802|80051557|FG001|Received Vaccination 2|Adverse Event|0|||
27507476|NCT02531802|80051558|FG002|Received Vaccination 2|Adverse Event|0|||
27507477|NCT02531802|80051559|FG003|Received Vaccination 2|Adverse Event|0|||
27507478|NCT02531802|80051560|FG004|Received Vaccination 2|Adverse Event|0|||
27507479|NCT02531802|80051561|FG005|Received Vaccination 2|Adverse Event|2|||
27507480|NCT02531802|80051562|FG006|Received Vaccination 2|Adverse Event|0|||
27507481|NCT02531802|80051563|FG007|Received Vaccination 2|Adverse Event|0|||
27507482|NCT02531802|80051564|FG008|Received Vaccination 2|Adverse Event|0|||
27507483|NCT02531802|80051565|FG009|Received Vaccination 2|Adverse Event|0|||
27507484|NCT02531802|80051566|FG010|Received Vaccination 2|Adverse Event|0|||
27507485|NCT02531802|80051567|FG011|Received Vaccination 2|Adverse Event|0|||
27507486|NCT02531802|80051568|FG012|Received Vaccination 2|Adverse Event|0|||
27507487|NCT02531802|80051569|FG013|Received Vaccination 2|Adverse Event|0|||
27507488|NCT02531802|80051570|FG014|Received Vaccination 2|Adverse Event|0|||
27507489|NCT02531802|80051571|FG015|Received Vaccination 2|Adverse Event|0|||
27507490|NCT02531802|80051572|FG016|Received Vaccination 2|Adverse Event|0|||
27507491|NCT02531802|80051573|FG017|Received Vaccination 2|Adverse Event|2|||
27507492|NCT02531802|80051574|FG018|Received Vaccination 2|Adverse Event|1|||
27507493|NCT02531802|80051575|FG019|Received Vaccination 2|Adverse Event|0|||
27507494|NCT02531802|80051576|FG020|Received Vaccination 2|Adverse Event|1|||
27507495|NCT02531802|80051556|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
27507496|NCT02531802|80051557|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
27507497|NCT02531802|80051558|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
27507498|NCT02531802|80051559|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
27507499|NCT02531802|80051560|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
27507500|NCT02531802|80051561|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
27507501|NCT02531802|80051562|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
27507502|NCT02531802|80051563|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
27507503|NCT02531802|80051564|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
27507504|NCT02531802|80051565|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
27507505|NCT02531802|80051566|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
27903946|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
27903947|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
27903948|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
27903949|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
27903950|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
27903951|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
27903952|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
27903953|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
27903954|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
27903955|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
27507506|NCT02531802|80051567|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
27507507|NCT02531802|80051568|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
27903956|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
27507508|NCT02531802|80051569|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
27507509|NCT02531802|80051570|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
27507510|NCT02531802|80051571|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
27507511|NCT02531802|80051572|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
27507512|NCT02531802|80051573|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
27507513|NCT02531802|80051574|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
27507514|NCT02531802|80051575|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
27507515|NCT02531802|80051576|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
27507516|NCT01021020|80051577|FG000|Period I|Protocol Violation|1|||
27507517|NCT01021020|80051577|FG000|Period I|Withdrawal by Subject|1|||
27507518|NCT01021020|80051577|FG000|14 Day Washout Period A|Physician Decision|1|||
27507519|NCT01281124|80051578|FG000|Overall Study|Death|1|||
27507520|NCT00686712|80051579|FG000|Overall Study|Protocol Violation|8|||
27507521|NCT00686712|80051580|FG001|Overall Study|Protocol Violation|8|||
27507522|NCT00686712|80051581|FG002|Overall Study|Protocol Violation|10|||
27507523|NCT00686712|80051579|FG000|Overall Study|Lost to Follow-up|1|||
27507524|NCT00686712|80051580|FG001|Overall Study|Lost to Follow-up|2|||
27507525|NCT00686712|80051581|FG002|Overall Study|Lost to Follow-up|3|||
27507526|NCT00686712|80051579|FG000|Overall Study|Adverse Event|1|||
27507527|NCT00686712|80051580|FG001|Overall Study|Adverse Event|1|||
27507528|NCT00686712|80051581|FG002|Overall Study|Adverse Event|0|||
27507529|NCT02131259|80051582|FG000|Overall Study|Progressive disease|751|||
27507530|NCT02131259|80051582|FG000|Overall Study|Adverse Event|341|||
27507531|NCT02131259|80051582|FG000|Overall Study|Lost to Follow-up|7|||
27507532|NCT02131259|80051582|FG000|Overall Study|Relocation|32|||
27507533|NCT02131259|80051582|FG000|Overall Study|Other|63|||
27507534|NCT02131259|80051582|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
27507535|NCT02131259|80051582|FG000|Overall Study|Progressive disease/relocation|1|||
27507536|NCT02131259|80051582|FG000|Overall Study|Progressive disease/other|2|||
27507537|NCT02131259|80051582|FG000|Overall Study|AE/lost to follow-up|1|||
27507538|NCT02131259|80051582|FG000|Overall Study|AE/other|1|||
27507539|NCT02131259|80051582|FG000|Overall Study|Progressive disease/AE/other|1|||
27507540|NCT02131259|80051582|FG000|Overall Study|Missing|3|||
27507541|NCT00106704|80051583|FG000|Overall Study|Adverse Event|10|||
27507542|NCT00106704|80051584|FG001|Overall Study|Adverse Event|7|||
27507543|NCT00106704|80051583|FG000|Overall Study|Death|2|||
27507544|NCT00106704|80051584|FG001|Overall Study|Death|1|||
27507545|NCT00106704|80051583|FG000|Overall Study|Lack of Efficacy|67|||
27507546|NCT00106704|80051584|FG001|Overall Study|Lack of Efficacy|69|||
27507547|NCT00106704|80051583|FG000|Overall Study|Lost to Follow-up|7|||
27507548|NCT00106704|80051584|FG001|Overall Study|Lost to Follow-up|3|||
27507549|NCT00106704|80051583|FG000|Overall Study|Pregnancy|1|||
27507550|NCT00106704|80051584|FG001|Overall Study|Pregnancy|0|||
27507551|NCT00106704|80051583|FG000|Overall Study|Protocol Violation|4|||
27507552|NCT00106704|80051584|FG001|Overall Study|Protocol Violation|7|||
27507553|NCT00106704|80051583|FG000|Overall Study|Withdrawal by Subject|14|||
27507554|NCT00106704|80051584|FG001|Overall Study|Withdrawal by Subject|21|||
27507555|NCT00106704|80051583|FG000|Overall Study|Patient moved|1|||
27507556|NCT00106704|80051584|FG001|Overall Study|Patient moved|0|||
27507557|NCT00106704|80051583|FG000|Overall Study|Site terminated|0|||
27507558|NCT00106704|80051584|FG001|Overall Study|Site terminated|1|||
27507559|NCT00106704|80051583|FG000|Overall Study|Planned major surgery|1|||
27507560|NCT00106704|80051584|FG001|Overall Study|Planned major surgery|0|||
27507561|NCT00106704|80051583|FG000|Overall Study|Patient Received Glycemic Medication|22|||
27507562|NCT00106704|80051584|FG001|Overall Study|Patient Received Glycemic Medication|41|||
27507563|NCT00106704|80051583|FG000|Overall Study|Unable to re-enter US|1|||
27507564|NCT00106704|80051584|FG001|Overall Study|Unable to re-enter US|0|||
27507565|NCT00106704|80051583|FG000|Overall Study|Laboratory test|1|||
27507566|NCT00106704|80051584|FG001|Overall Study|Laboratory test|1|||
27507567|NCT00759941|80051589|FG000|Overall Study|Use of medication|1|||
27507568|NCT00759941|80051590|FG001|Overall Study|Use of medication|0|||
27507569|NCT00759941|80051589|FG000|Overall Study|Adverse Event|1|||
27507570|NCT00759941|80051590|FG001|Overall Study|Adverse Event|0|||
27851952|NCT02780167|81287212|FG003|Overall Study|No longer meets eligibility criteria|1|||
27851953|NCT02780167|81287213|FG004|Overall Study|No longer meets eligibility criteria|1|||
27851954|NCT02780167|81287209|FG000|Overall Study|Protocol Violation|5|||
27851955|NCT02780167|81287210|FG001|Overall Study|Protocol Violation|5|||
27507571|NCT00759941|80051589|FG000|Overall Study|Exited in error by site|1|||
27507572|NCT00759941|80051590|FG001|Overall Study|Exited in error by site|1|||
27507573|NCT02454517|80051599|FG000|Overall Study|Withdrawal by Subject|3|||
27507574|NCT02454517|80051600|FG001|Overall Study|Withdrawal by Subject|0|||
27507575|NCT02454517|80051599|FG000|Overall Study|Lost to Follow-up|4|||
27507576|NCT02454517|80051600|FG001|Overall Study|Lost to Follow-up|7|||
27507577|NCT02454517|80051599|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
27507578|NCT02454517|80051600|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
27507579|NCT00960999|80051601|FG000|Overall Study|Withdrawal by Subject|1|||
27851956|NCT02780167|81287211|FG002|Overall Study|Protocol Violation|1|||
27507580|NCT00960999|80051602|FG001|Overall Study|Withdrawal by Subject|0|||
27507581|NCT00960999|80051601|FG000|Overall Study|Protocol Violation|5|||
27507582|NCT00960999|80051602|FG001|Overall Study|Protocol Violation|2|||
27507583|NCT00960999|80051601|FG000|Overall Study|RT dose constraints not met|2|||
27507584|NCT00960999|80051602|FG001|Overall Study|RT dose constraints not met|0|||
27507585|NCT02224560|80051604|FG000|Overall Study|Protocol Deviation|1|||
27507586|NCT02224560|80051605|FG001|Overall Study|Protocol Deviation|0|||
27507587|NCT02224560|80051606|FG002|Overall Study|Protocol Deviation|0|||
27507588|NCT02224560|80051604|FG000|Overall Study|Withdrawal by Subject|2|||
27507589|NCT02224560|80051605|FG001|Overall Study|Withdrawal by Subject|0|||
27507590|NCT02224560|80051606|FG002|Overall Study|Withdrawal by Subject|1|||
27507591|NCT02224560|80051604|FG000|Overall Study|Met Withdrawal Criteria|1|||
27507592|NCT02224560|80051605|FG001|Overall Study|Met Withdrawal Criteria|0|||
27507593|NCT02224560|80051606|FG002|Overall Study|Met Withdrawal Criteria|0|||
27507594|NCT02224560|80051604|FG000|Overall Study|Adverse Event|4|||
27507595|NCT02224560|80051605|FG001|Overall Study|Adverse Event|1|||
27507596|NCT02224560|80051606|FG002|Overall Study|Adverse Event|1|||
27507597|NCT02224560|80051604|FG000|Overall Study|Withdrawn by Investigator|1|||
27507598|NCT02224560|80051605|FG001|Overall Study|Withdrawn by Investigator|1|||
27507599|NCT02224560|80051606|FG002|Overall Study|Withdrawn by Investigator|0|||
27507600|NCT01780506|80051608|FG000|Double-Blind Phase|Randomized but not Treated|3|||
27507601|NCT01780506|80051609|FG001|Double-Blind Phase|Randomized but not Treated|2|||
27507602|NCT01780506|80051608|FG000|Double-Blind Phase|Adverse Event|4|||
27507603|NCT01780506|80051609|FG001|Double-Blind Phase|Adverse Event|14|||
27507604|NCT01780506|80051608|FG000|Double-Blind Phase|Death|1|||
27507605|NCT01780506|80051609|FG001|Double-Blind Phase|Death|2|||
27507606|NCT01780506|80051608|FG000|Double-Blind Phase|Pregnancy|2|||
27507607|NCT01780506|80051609|FG001|Double-Blind Phase|Pregnancy|1|||
27507608|NCT01780506|80051608|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27507609|NCT01780506|80051609|FG001|Double-Blind Phase|Lack of Efficacy|1|||
27507610|NCT01780506|80051608|FG000|Double-Blind Phase|Investigator's Discretion|5|||
27507611|NCT01780506|80051609|FG001|Double-Blind Phase|Investigator's Discretion|2|||
27507612|NCT01780506|80051608|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
27507613|NCT01780506|80051609|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
27507614|NCT01780506|80051608|FG000|Double-Blind Phase|Protocol Violation|4|||
27507615|NCT01780506|80051609|FG001|Double-Blind Phase|Protocol Violation|3|||
27507616|NCT01780506|80051608|FG000|Double-Blind Phase|Withdrew Consent|23|||
27507617|NCT01780506|80051609|FG001|Double-Blind Phase|Withdrew Consent|24|||
27507618|NCT01780506|80051608|FG000|Double-Blind Phase|Lost to Follow-up|23|||
27507619|NCT01780506|80051609|FG001|Double-Blind Phase|Lost to Follow-up|26|||
27507620|NCT01780506|80051608|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
27507621|NCT01780506|80051609|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
27507622|NCT01747876|80051612|FG000|Overall Study|Adverse Event|1|||
27507623|NCT01747876|80051613|FG001|Overall Study|Adverse Event|0|||
27507624|NCT01747876|80051614|FG002|Overall Study|Adverse Event|2|||
27507625|NCT01747876|80051612|FG000|Overall Study|Withdrawal by Subject|0|||
27507626|NCT01747876|80051613|FG001|Overall Study|Withdrawal by Subject|1|||
27507627|NCT01747876|80051614|FG002|Overall Study|Withdrawal by Subject|1|||
27614598|NCT00089895|80430327|FG000|Overall Study|Consent Withdrawn|11|||
27614599|NCT00089895|80430328|FG001|Overall Study|Consent Withdrawn|14|||
27614600|NCT00089895|80430327|FG000|Overall Study|Technical reason|7|||
27507628|NCT01747876|80051612|FG000|Overall Study|Disease progression|4|||
27507629|NCT01747876|80051613|FG001|Overall Study|Disease progression|13|||
27507630|NCT01747876|80051614|FG002|Overall Study|Disease progression|8|||
27614601|NCT00089895|80430328|FG001|Overall Study|Technical reason|2|||
27507631|NCT01747876|80051612|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
27507632|NCT01747876|80051613|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
27507633|NCT01747876|80051614|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
27507634|NCT04237116|80051625|FG000|Overall Study|Adverse Event|0|||
27507635|NCT04237116|80051626|FG001|Overall Study|Adverse Event|1|||
27507636|NCT04237116|80051625|FG000|Overall Study|Study terminated by Sponsor|4|||
27851957|NCT02780167|81287212|FG003|Overall Study|Protocol Violation|1|||
27851958|NCT02780167|81287213|FG004|Overall Study|Protocol Violation|2|||
27851959|NCT02780167|81287209|FG000|Overall Study|Withdrawal by Subject|6|||
27851960|NCT02780167|81287210|FG001|Overall Study|Withdrawal by Subject|4|||
27507637|NCT04237116|80051626|FG001|Overall Study|Study terminated by Sponsor|1|||
27507638|NCT00912197|80051628|FG000|Overall Study|Withdrawal by Subject|3|||
27507639|NCT00912197|80051629|FG001|Overall Study|Withdrawal by Subject|3|||
27507640|NCT00999804|80051633|FG000|Overall Study|Lack of Efficacy|9|||
27507641|NCT00999804|80051634|FG001|Overall Study|Lack of Efficacy|2|||
27507642|NCT00999804|80051633|FG000|Overall Study|Adverse Event|4|||
27507643|NCT00999804|80051634|FG001|Overall Study|Adverse Event|3|||
27507644|NCT00999804|80051633|FG000|Overall Study|Withdrawal by Subject|4|||
27507645|NCT00999804|80051634|FG001|Overall Study|Withdrawal by Subject|0|||
27507646|NCT00999804|80051633|FG000|Overall Study|Death|1|||
27507647|NCT00999804|80051634|FG001|Overall Study|Death|0|||
27507648|NCT00999804|80051633|FG000|Overall Study|Ineligible|3|||
27507649|NCT00999804|80051634|FG001|Overall Study|Ineligible|0|||
27507650|NCT02628873|80051635|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
27507651|NCT02628873|80051636|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
27507652|NCT02628873|80051635|FG000|Second Test (1 Hour)|Physician Decision|1|||
27507653|NCT02628873|80051636|FG001|Second Test (1 Hour)|Physician Decision|0|||
27507654|NCT01120964|80051637|FG000|Overall Study|Did not receive full treatment|1|||
27507655|NCT01120964|80051638|FG001|Overall Study|Did not receive full treatment|0|||
27507656|NCT02057250|80051639|FG000|AID Assessment Phase|Adverse Event|3|||
27507657|NCT02057250|80051640|FG001|AID Assessment Phase|Adverse Event|2|||
27507658|NCT02057250|80051641|FG002|AID Assessment Phase|Adverse Event|6|||
27507659|NCT02057250|80051642|FG003|AID Assessment Phase|Adverse Event|1|||
27507660|NCT02057250|80051643|FG004|AID Assessment Phase|Adverse Event|0|||
27507661|NCT02057250|80051639|FG000|AID Assessment Phase|Other than specified above|1|||
27507662|NCT02057250|80051640|FG001|AID Assessment Phase|Other than specified above|1|||
27507663|NCT02057250|80051641|FG002|AID Assessment Phase|Other than specified above|1|||
27507664|NCT02057250|80051642|FG003|AID Assessment Phase|Other than specified above|1|||
27507665|NCT02057250|80051643|FG004|AID Assessment Phase|Other than specified above|0|||
27507666|NCT02057250|80051639|FG000|Extension Phase|Adverse Event|0|||
27507667|NCT02057250|80051640|FG001|Extension Phase|Adverse Event|0|||
27507668|NCT02057250|80051641|FG002|Extension Phase|Adverse Event|0|||
27507669|NCT02057250|80051642|FG003|Extension Phase|Adverse Event|0|||
27507670|NCT02057250|80051643|FG004|Extension Phase|Adverse Event|15|||
27507671|NCT02057250|80051639|FG000|Extension Phase|Lack of Efficacy|0|||
27507672|NCT02057250|80051640|FG001|Extension Phase|Lack of Efficacy|0|||
27507673|NCT02057250|80051641|FG002|Extension Phase|Lack of Efficacy|0|||
27507674|NCT02057250|80051642|FG003|Extension Phase|Lack of Efficacy|0|||
27507675|NCT02057250|80051643|FG004|Extension Phase|Lack of Efficacy|10|||
27507676|NCT02057250|80051639|FG000|Extension Phase|Entered in this period but not treated|0|||
27507677|NCT02057250|80051640|FG001|Extension Phase|Entered in this period but not treated|0|||
27507678|NCT02057250|80051641|FG002|Extension Phase|Entered in this period but not treated|0|||
27507679|NCT02057250|80051642|FG003|Extension Phase|Entered in this period but not treated|0|||
27507680|NCT02057250|80051643|FG004|Extension Phase|Entered in this period but not treated|4|||
27507681|NCT02057250|80051639|FG000|Extension Phase|Other than specified above|0|||
27507682|NCT02057250|80051640|FG001|Extension Phase|Other than specified above|0|||
27507683|NCT02057250|80051641|FG002|Extension Phase|Other than specified above|0|||
27507684|NCT02057250|80051642|FG003|Extension Phase|Other than specified above|0|||
27507685|NCT02057250|80051643|FG004|Extension Phase|Other than specified above|7|||
27507686|NCT00446849|80051644|FG000|Acute Phase|Lack of Efficacy|64|||
27507687|NCT00446849|80051644|FG000|Acute Phase|Protocol Violation|10|||
27507688|NCT00446849|80051644|FG000|Acute Phase|Consent withdrawn|4|||
27507689|NCT00446849|80051644|FG000|Acute Phase|Lost to Follow-up|2|||
27507690|NCT00446849|80051644|FG000|Acute Phase|Physician Decision|1|||
27507691|NCT00446849|80051644|FG000|Acute Phase|noncompliance|1|||
27507692|NCT00446849|80051644|FG000|Maintenance Phase|Lack of Efficacy|40|||
27507693|NCT00446849|80051644|FG000|Maintenance Phase|Protocol Violation|7|||
27507694|NCT00446849|80051644|FG000|Maintenance Phase|Adverse Event|6|||
27507695|NCT00446849|80051644|FG000|Maintenance Phase|Consent withdrawn|5|||
27507696|NCT00446849|80051644|FG000|Maintenance Phase|Lost to Follow-up|3|||
27507697|NCT00446849|80051644|FG000|Maintenance Phase|Pregnancy|1|||
27507698|NCT00446849|80051644|FG000|Maintenance Phase|noncompliance|2|||
27507699|NCT00446849|80051644|FG000|Maintenance Phase|prohibited medication use|2|||
27851961|NCT02780167|81287211|FG002|Overall Study|Withdrawal by Subject|4|||
27851962|NCT02780167|81287212|FG003|Overall Study|Withdrawal by Subject|3|||
27507700|NCT00446849|80051644|FG000|Maintenance Phase|antibiotic use|1|||
27851963|NCT02780167|81287213|FG004|Overall Study|Withdrawal by Subject|4|||
27851964|NCT02780167|81287209|FG000|Overall Study|Other|0|||
27851965|NCT02780167|81287210|FG001|Overall Study|Other|0|||
27851966|NCT02780167|81287211|FG002|Overall Study|Other|3|||
27851967|NCT02780167|81287212|FG003|Overall Study|Other|1|||
27507701|NCT00446849|80051644|FG000|Maintenance Phase|study closure|1|||
27507702|NCT00446849|80051644|FG000|Maintenance Phase|hydrocodone use|1|||
27507703|NCT00446849|80051644|FG000|Maintenance Phase|concomitant medication use|1|||
27507704|NCT01709084|80051650|FG000|Overall Study|Lost to Follow-up|4|||
27507705|NCT01709084|80051651|FG001|Overall Study|Lost to Follow-up|7|||
27507706|NCT01709084|80051650|FG000|Overall Study|Withdrawal by Subject|2|||
27507707|NCT01709084|80051651|FG001|Overall Study|Withdrawal by Subject|2|||
27614602|NCT00089895|80430327|FG000|Overall Study|Surgery|0|||
27614603|NCT00089895|80430328|FG001|Overall Study|Surgery|1|||
27614604|NCT00089895|80430327|FG000|Overall Study|Bleeding|0|||
27507708|NCT01709084|80051650|FG000|Overall Study|Adverse Event|5|||
27507709|NCT01709084|80051651|FG001|Overall Study|Adverse Event|0|||
27507710|NCT01709084|80051650|FG000|Overall Study|Other|5|||
27507711|NCT01709084|80051651|FG001|Overall Study|Other|3|||
27507712|NCT01709084|80051650|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
27507713|NCT01709084|80051651|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
27507714|NCT01709084|80051650|FG000|Overall Study|Not Treated|0|||
27507715|NCT01709084|80051651|FG001|Overall Study|Not Treated|2|||
27507716|NCT02392624|80051652|FG000|Overall Study|Withdrawal by Subject|15|||
27507717|NCT02392624|80051653|FG001|Overall Study|Withdrawal by Subject|12|||
27507718|NCT02392624|80051654|FG002|Overall Study|Withdrawal by Subject|9|||
27507719|NCT02392624|80051652|FG000|Overall Study|Adverse Event|4|||
27507720|NCT02392624|80051653|FG001|Overall Study|Adverse Event|1|||
27507721|NCT02392624|80051654|FG002|Overall Study|Adverse Event|2|||
27507722|NCT02392624|80051652|FG000|Overall Study|Pregnancy|1|||
27507723|NCT02392624|80051653|FG001|Overall Study|Pregnancy|0|||
27507724|NCT02392624|80051654|FG002|Overall Study|Pregnancy|0|||
27507725|NCT02392624|80051652|FG000|Overall Study|Protocol Violation|0|||
27507726|NCT02392624|80051653|FG001|Overall Study|Protocol Violation|0|||
27507727|NCT02392624|80051654|FG002|Overall Study|Protocol Violation|1|||
27507728|NCT02392624|80051652|FG000|Overall Study|Sponsor/Investigator Decision|2|||
27507729|NCT02392624|80051653|FG001|Overall Study|Sponsor/Investigator Decision|1|||
27507730|NCT02392624|80051654|FG002|Overall Study|Sponsor/Investigator Decision|0|||
27614605|NCT00089895|80430328|FG001|Overall Study|Bleeding|2|||
27851968|NCT02780167|81287213|FG004|Overall Study|Other|2|||
27851969|NCT02302859|81287216|FG000|Overall Study|Lost Phone|1|||
27851970|NCT02302859|81287217|FG001|Overall Study|Lost Phone|1|||
27851971|NCT02302859|81287216|FG000|Overall Study|Withdrawal by Subject|0|||
27851972|NCT02302859|81287217|FG001|Overall Study|Withdrawal by Subject|1|||
27851973|NCT03314662|81287221|FG000|Overall Study|Withdrawal by Subject|1|||
27851974|NCT03314662|81287222|FG001|Overall Study|Withdrawal by Subject|1|||
27851975|NCT03314662|81287223|FG002|Overall Study|Withdrawal by Subject|1|||
27851976|NCT03314662|81287221|FG000|Overall Study|Lost to Follow-up|5|||
27851977|NCT03314662|81287222|FG001|Overall Study|Lost to Follow-up|4|||
27851978|NCT03314662|81287223|FG002|Overall Study|Lost to Follow-up|4|||
27851979|NCT03314662|81287221|FG000|Overall Study|Death|2|||
27851980|NCT03314662|81287222|FG001|Overall Study|Death|0|||
27851981|NCT03314662|81287223|FG002|Overall Study|Death|0|||
27851982|NCT04032158|81287230|FG000|Overall Study|Study Termination|2|||
27851983|NCT04032158|81287231|FG001|Overall Study|Study Termination|1|||
27507731|NCT02392624|80051652|FG000|Overall Study|Other|49|||
27507732|NCT02392624|80051653|FG001|Overall Study|Other|1|||
27507733|NCT02392624|80051654|FG002|Overall Study|Other|1|||
27507734|NCT02558296|80051655|FG000|Completed the Study Through Week 24|Adverse Event|9|||
27507735|NCT02558296|80051656|FG001|Completed the Study Through Week 24|Adverse Event|3|||
27507736|NCT02558296|80051655|FG000|Completed the Study Through Week 24|Death|7|||
27507737|NCT02558296|80051656|FG001|Completed the Study Through Week 24|Death|7|||
27507738|NCT02558296|80051655|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
27507739|NCT02558296|80051656|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
27507740|NCT02558296|80051655|FG000|Completed the Study Through Week 24|Physician Decision|1|||
27507741|NCT02558296|80051656|FG001|Completed the Study Through Week 24|Physician Decision|0|||
27507742|NCT02558296|80051655|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
27507743|NCT02558296|80051656|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
27851984|NCT02138136|81287232|FG000|Overall Study|Protocol Violation|4|||
27851985|NCT02138136|81287232|FG000|Overall Study|Physician Decision|7|||
27851986|NCT02138136|81287232|FG000|Overall Study|Lack of Efficacy|35|||
27903957|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
27903958|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
27851987|NCT02138136|81287232|FG000|Overall Study|Pregnancy|2|||
27851988|NCT02138136|81287232|FG000|Overall Study|Adverse Event|18|||
27851989|NCT02138136|81287232|FG000|Overall Study|Withdrawal by Subject|36|||
27851990|NCT02138136|81287232|FG000|Overall Study|Lost to Follow-up|32|||
27851991|NCT02138136|81287232|FG000|Overall Study|Withdrawn by Sponsor|5|||
27851992|NCT04156620|81290987|FG000|Overall Study|Adverse event - TP 1|5|||
27851993|NCT04156620|81290988|FG001|Overall Study|Adverse event - TP 1|2|||
27851994|NCT04156620|81290987|FG000|Overall Study|Lost to follow-up TP 1|1|||
27851995|NCT04156620|81290988|FG001|Overall Study|Lost to follow-up TP 1|1|||
27851996|NCT04156620|81290987|FG000|Overall Study|Progressive disease - TP 1|0|||
27851997|NCT04156620|81290988|FG001|Overall Study|Progressive disease - TP 1|1|||
27851998|NCT04156620|81290987|FG000|Overall Study|Subject decision - TP 1|3|||
27851999|NCT04156620|81290988|FG001|Overall Study|Subject decision - TP 1|5|||
27852000|NCT04156620|81290987|FG000|Overall Study|Adverse event - TP 2|5|||
27852001|NCT04156620|81290988|FG001|Overall Study|Adverse event - TP 2|6|||
27852002|NCT04156620|81290987|FG000|Overall Study|Death - TP 2|1|||
27852003|NCT04156620|81290988|FG001|Overall Study|Death - TP 2|0|||
27852004|NCT04156620|81290987|FG000|Overall Study|Lost to follow-up - TP 2|5|||
27852005|NCT04156620|81290988|FG001|Overall Study|Lost to follow-up - TP 2|2|||
27852006|NCT04156620|81290987|FG000|Overall Study|Physician decision - TP 2|4|||
27852007|NCT04156620|81290988|FG001|Overall Study|Physician decision - TP 2|2|||
27852008|NCT04156620|81290987|FG000|Overall Study|Pregnancy - TP 2|1|||
27852009|NCT04156620|81290988|FG001|Overall Study|Pregnancy - TP 2|1|||
27852010|NCT04156620|81290987|FG000|Overall Study|Subject decision - TP 2|11|||
27852011|NCT04156620|81290988|FG001|Overall Study|Subject decision - TP 2|9|||
27852012|NCT04156620|81290987|FG000|Overall Study|New therapy for study indication - TP 2|1|||
27852013|NCT04156620|81290988|FG001|Overall Study|New therapy for study indication - TP 2|0|||
27852014|NCT00608517|81290989|FG000|Overall Study|Death|1|||
27852015|NCT00608517|81290990|FG001|Overall Study|Death|0|||
27852016|NCT00608517|81290991|FG002|Overall Study|Death|0|||
27852017|NCT02581163|81290998|FG000|Overall Study|Failure to return|15|||
27852018|NCT02581163|81290998|FG000|Overall Study|Insufficient virological response|3|||
27852019|NCT02581163|81290998|FG000|Overall Study|Withdrew consent|1|||
27852020|NCT02581163|81290998|FG000|Overall Study|Death|1|||
27852021|NCT02581163|81290998|FG000|Overall Study|Other, not specified|9|||
27852022|NCT00754013|81291001|FG000|Overall Study|Lost to Follow-up|1|||
27852023|NCT00754013|81291002|FG001|Overall Study|Lost to Follow-up|1|||
27852024|NCT00754013|81291001|FG000|Overall Study|didn't return after study termed|3|||
27852025|NCT00754013|81291002|FG001|Overall Study|didn't return after study termed|4|||
27852026|NCT00384176|81291003|FG000|Overall Study|Death|239|||
27852027|NCT00384176|81291004|FG001|Overall Study|Death|247|||
27852028|NCT00384176|81291005|FG002|Overall Study|Death|105|||
27852029|NCT00384176|81291003|FG000|Overall Study|Withdrawal by Subject|52|||
27852030|NCT00384176|81291004|FG001|Overall Study|Withdrawal by Subject|48|||
27852031|NCT00384176|81291005|FG002|Overall Study|Withdrawal by Subject|22|||
27852032|NCT00384176|81291003|FG000|Overall Study|Lost to Follow-up|16|||
27852033|NCT00384176|81291004|FG001|Overall Study|Lost to Follow-up|18|||
27852034|NCT00384176|81291005|FG002|Overall Study|Lost to Follow-up|4|||
27852035|NCT00384176|81291003|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
27852036|NCT00384176|81291004|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
27852037|NCT00384176|81291005|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
27852038|NCT00384176|81291003|FG000|Overall Study|Longer QTC as Visit 1|1|||
27852039|NCT00384176|81291004|FG001|Overall Study|Longer QTC as Visit 1|0|||
27852040|NCT00384176|81291005|FG002|Overall Study|Longer QTC as Visit 1|0|||
27852041|NCT00384176|81291003|FG000|Overall Study|Toxicity of treatment|1|||
27852042|NCT00384176|81291004|FG001|Overall Study|Toxicity of treatment|0|||
27852043|NCT00384176|81291005|FG002|Overall Study|Toxicity of treatment|0|||
27852044|NCT00384176|81291003|FG000|Overall Study|Did not receive study treatment|0|||
27852045|NCT00384176|81291004|FG001|Overall Study|Did not receive study treatment|1|||
27852046|NCT00384176|81291005|FG002|Overall Study|Did not receive study treatment|1|||
27852047|NCT00384176|81291003|FG000|Overall Study|Physician Decision|0|||
27852048|NCT00384176|81291004|FG001|Overall Study|Physician Decision|2|||
27852049|NCT00384176|81291005|FG002|Overall Study|Physician Decision|0|||
27852050|NCT00384176|81291003|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
27852051|NCT00384176|81291004|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
27852052|NCT00384176|81291005|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
27852053|NCT01117337|81291006|FG000|Overall Study|Lost to Follow-up|4|||
27852054|NCT01117337|81291007|FG001|Overall Study|Lost to Follow-up|0|||
27852055|NCT03347422|81291008|FG000|Part A (26 Weeks)|Adverse Event|3|||
27852056|NCT03347422|81291009|FG001|Part A (26 Weeks)|Adverse Event|0|||
27852057|NCT03347422|81291008|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
27852058|NCT03347422|81291009|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
27852059|NCT03347422|81291008|FG000|Part B (149 Weeks)|Adverse Event|0|||
27852060|NCT03347422|81291009|FG001|Part B (149 Weeks)|Adverse Event|1|||
27507744|NCT02558296|80051655|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
27507745|NCT02558296|80051656|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
27507746|NCT02558296|80051655|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
27507747|NCT02558296|80051656|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
27507748|NCT02558296|80051655|FG000|Completed the Study|Adverse Event|14|||
27507749|NCT02558296|80051656|FG001|Completed the Study|Adverse Event|5|||
27507750|NCT02558296|80051655|FG000|Completed the Study|Death|39|||
27903959|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
27903960|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
27903961|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
27903962|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
27903963|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
27903964|NCT03538691|81485073|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
27903965|NCT03538691|81485074|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
27903966|NCT03538691|81485075|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
27903967|NCT03538691|81485076|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
27507751|NCT02558296|80051656|FG001|Completed the Study|Death|25|||
27507752|NCT02558296|80051655|FG000|Completed the Study|Lost to Follow-up|31|||
27507753|NCT02558296|80051656|FG001|Completed the Study|Lost to Follow-up|23|||
27507754|NCT02558296|80051655|FG000|Completed the Study|Physician Decision|6|||
27507755|NCT02558296|80051656|FG001|Completed the Study|Physician Decision|0|||
27507756|NCT02558296|80051655|FG000|Completed the Study|Protocol Violation|2|||
27507757|NCT02558296|80051656|FG001|Completed the Study|Protocol Violation|1|||
27507758|NCT02558296|80051655|FG000|Completed the Study|Withdrawal by Subject|53|||
27507759|NCT02558296|80051656|FG001|Completed the Study|Withdrawal by Subject|31|||
27507760|NCT02558296|80051655|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
27507761|NCT02558296|80051656|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
27507762|NCT02156076|80051657|FG000|Treatment Period|no longer meets study criteria|0|||
27507763|NCT02156076|80051658|FG001|Treatment Period|no longer meets study criteria|0|||
27507764|NCT02156076|80051659|FG002|Treatment Period|no longer meets study criteria|1|||
27507765|NCT02156076|80051660|FG003|Treatment Period|no longer meets study criteria|0|||
27507766|NCT02156076|80051657|FG000|Treatment Period|Poor/non-compliance|0|||
27507767|NCT02156076|80051658|FG001|Treatment Period|Poor/non-compliance|1|||
27507768|NCT02156076|80051659|FG002|Treatment Period|Poor/non-compliance|0|||
27507769|NCT02156076|80051660|FG003|Treatment Period|Poor/non-compliance|0|||
27507770|NCT02156076|80051657|FG000|Treatment Period|Lost to Follow-up|0|||
27507771|NCT02156076|80051658|FG001|Treatment Period|Lost to Follow-up|0|||
27507772|NCT02156076|80051659|FG002|Treatment Period|Lost to Follow-up|0|||
27507773|NCT02156076|80051660|FG003|Treatment Period|Lost to Follow-up|1|||
27507774|NCT02156076|80051657|FG000|Treatment Period|Withdrawal by Subject|0|||
27507775|NCT02156076|80051658|FG001|Treatment Period|Withdrawal by Subject|0|||
27507776|NCT02156076|80051659|FG002|Treatment Period|Withdrawal by Subject|1|||
27507777|NCT02156076|80051660|FG003|Treatment Period|Withdrawal by Subject|0|||
27507778|NCT02156076|80051657|FG000|Treatment Period|Subject request to discontinue treatment|0|||
27507779|NCT02156076|80051658|FG001|Treatment Period|Subject request to discontinue treatment|1|||
27507780|NCT02156076|80051659|FG002|Treatment Period|Subject request to discontinue treatment|0|||
27507781|NCT02156076|80051660|FG003|Treatment Period|Subject request to discontinue treatment|0|||
27507782|NCT02156076|80051657|FG000|Treatment Period|Adverse Event|0|||
27507783|NCT02156076|80051658|FG001|Treatment Period|Adverse Event|0|||
27507784|NCT02156076|80051659|FG002|Treatment Period|Adverse Event|0|||
27507785|NCT02156076|80051660|FG003|Treatment Period|Adverse Event|1|||
27507786|NCT02156076|80051657|FG000|Follow-up Period|Withdrawal by Subject|1|||
27507787|NCT02156076|80051658|FG001|Follow-up Period|Withdrawal by Subject|0|||
27507788|NCT02156076|80051659|FG002|Follow-up Period|Withdrawal by Subject|0|||
27507789|NCT02156076|80051660|FG003|Follow-up Period|Withdrawal by Subject|0|||
27507790|NCT01704599|80051665|FG000|Overall Study|Adverse Event|1|||
27507791|NCT03058146|80051666|FG000|Overall Study|Withdrawal by Subject|4|||
27507792|NCT03058146|80051667|FG001|Overall Study|Withdrawal by Subject|1|||
27507793|NCT03058146|80051666|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
27507794|NCT03058146|80051667|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
27507795|NCT01094119|80051668|FG000|Overall Study|Lack of Efficacy|2|||
27507796|NCT01094119|80051669|FG001|Overall Study|Lack of Efficacy|4|||
27507797|NCT00472030|80051674|FG000|Overall Study|Physician Decision|1|||
27507798|NCT00472030|80051675|FG001|Overall Study|Physician Decision|0|||
27507799|NCT05375760|80051678|FG000|Overall Study|Adverse Event|1|||
27507800|NCT05375760|80051679|FG001|Overall Study|Adverse Event|0|||
27507801|NCT05375760|80051678|FG000|Overall Study|Death|0|||
27507802|NCT05375760|80051679|FG001|Overall Study|Death|1|||
27507803|NCT05375760|80051678|FG000|Overall Study|Lost to Follow-up|6|||
27507804|NCT05375760|80051679|FG001|Overall Study|Lost to Follow-up|6|||
27507805|NCT05375760|80051678|FG000|Overall Study|Withdrawal by Subject|17|||
27507806|NCT05375760|80051679|FG001|Overall Study|Withdrawal by Subject|19|||
27507807|NCT05375760|80051678|FG000|Overall Study|Dosing halted by FDA|96|||
27507808|NCT05375760|80051679|FG001|Overall Study|Dosing halted by FDA|100|||
27507809|NCT05375760|80051678|FG000|Overall Study|Not compliant with study visit|2|||
27507810|NCT05375760|80051679|FG001|Overall Study|Not compliant with study visit|0|||
27507811|NCT05375760|80051678|FG000|Overall Study|Physician Decision|1|||
27507812|NCT05375760|80051679|FG001|Overall Study|Physician Decision|0|||
27507813|NCT05375760|80051678|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
27507814|NCT05375760|80051679|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
27507815|NCT05375760|80051678|FG000|Overall Study|Participant moved|1|||
27507816|NCT05375760|80051679|FG001|Overall Study|Participant moved|0|||
27507817|NCT01216189|80051680|FG000|Overall Study|Lost to Follow-up|21|||
27507818|NCT01216189|80051681|FG001|Overall Study|Lost to Follow-up|3|||
27507819|NCT01216189|80051680|FG000|Overall Study|Death|4|||
27507820|NCT01216189|80051681|FG001|Overall Study|Death|2|||
27507821|NCT01472289|80051682|FG000|Overall Study|Death|2|||
27507822|NCT00885170|80051684|FG000|Overall Study|Adverse Event|12|||
27507823|NCT00885170|80051685|FG001|Overall Study|Adverse Event|4|||
27507824|NCT00885170|80051684|FG000|Overall Study|Excessive bone loss|6|||
27507825|NCT00885170|80051685|FG001|Overall Study|Excessive bone loss|3|||
27507826|NCT00885170|80051684|FG000|Overall Study|Lost to Follow-up|2|||
27507827|NCT00885170|80051685|FG001|Overall Study|Lost to Follow-up|1|||
27507828|NCT00885170|80051684|FG000|Overall Study|Physician Decision|2|||
27507829|NCT00885170|80051685|FG001|Overall Study|Physician Decision|1|||
27507830|NCT00885170|80051684|FG000|Overall Study|Protocol Violation|3|||
27507831|NCT00885170|80051685|FG001|Overall Study|Protocol Violation|1|||
27507832|NCT00885170|80051684|FG000|Overall Study|Withdrawal by Subject|13|||
27507833|NCT00885170|80051685|FG001|Overall Study|Withdrawal by Subject|13|||
27507834|NCT01987453|80051687|FG000|Overall Study|Death|0|||
27507835|NCT01987453|80051688|FG001|Overall Study|Death|0|||
27507836|NCT01987453|80051689|FG002|Overall Study|Death|1|||
27507837|NCT01987453|80051687|FG000|Overall Study|Lack of Efficacy|1|||
27507838|NCT01987453|80051688|FG001|Overall Study|Lack of Efficacy|12|||
27507839|NCT01987453|80051689|FG002|Overall Study|Lack of Efficacy|0|||
27507840|NCT04081103|80051692|FG000|Overall Study|Adverse Event|1|||
27507841|NCT04081103|80051693|FG001|Overall Study|Adverse Event|1|||
27507842|NCT04081103|80051694|FG002|Overall Study|Adverse Event|1|||
27507843|NCT04081103|80051692|FG000|Overall Study|Physician Decision|0|||
27507844|NCT04081103|80051693|FG001|Overall Study|Physician Decision|0|||
27507845|NCT04081103|80051694|FG002|Overall Study|Physician Decision|1|||
27507846|NCT02007096|80051700|FG000|Overall Study|medication not available|2|||
27507847|NCT02007096|80051701|FG001|Overall Study|medication not available|0|||
27507848|NCT02007096|80051700|FG000|Overall Study|did not inject saline|0|||
27507849|NCT02007096|80051701|FG001|Overall Study|did not inject saline|3|||
27507850|NCT02007096|80051700|FG000|Overall Study|did not follow postoperative protocol|8|||
27507851|NCT02007096|80051701|FG001|Overall Study|did not follow postoperative protocol|11|||
27507852|NCT02007096|80051700|FG000|Overall Study|converted to open surgery|1|||
27507853|NCT02007096|80051701|FG001|Overall Study|converted to open surgery|1|||
27507854|NCT02007096|80051700|FG000|Overall Study|no mesh placed|0|||
27507855|NCT02007096|80051701|FG001|Overall Study|no mesh placed|1|||
27507856|NCT00318643|80051702|FG000|Overall Study|Adverse Event|0|||
27903968|NCT02208050|81485077|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
27507857|NCT00318643|80051703|FG001|Overall Study|Adverse Event|0|||
27903969|NCT02208050|81485078|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
27903970|NCT00530790|81485083|FG000|Overall Study|Adverse Event|2|||
27903971|NCT00530790|81485083|FG000|Overall Study|Withdrawal by Subject|2|||
27903972|NCT00530790|81485083|FG000|Overall Study|Physician Decision|1|||
27903973|NCT01870297|81485084|FG000|Overall Study|Adverse Event|0|||
27903974|NCT01870297|81485085|FG001|Overall Study|Adverse Event|0|||
27903975|NCT01870297|81485086|FG002|Overall Study|Adverse Event|0|||
27903976|NCT01870297|81485087|FG003|Overall Study|Adverse Event|0|||
27903977|NCT01870297|81485088|FG004|Overall Study|Adverse Event|2|||
27903978|NCT01870297|81485089|FG005|Overall Study|Adverse Event|0|||
27903979|NCT01870297|81485090|FG006|Overall Study|Adverse Event|0|||
27903980|NCT01870297|81485084|FG000|Overall Study|Lost to Follow-up|0|||
27903981|NCT01870297|81485085|FG001|Overall Study|Lost to Follow-up|1|||
27903982|NCT01870297|81485086|FG002|Overall Study|Lost to Follow-up|1|||
27903983|NCT01870297|81485087|FG003|Overall Study|Lost to Follow-up|0|||
27903984|NCT01870297|81485088|FG004|Overall Study|Lost to Follow-up|0|||
27903985|NCT01870297|81485089|FG005|Overall Study|Lost to Follow-up|0|||
27903986|NCT01870297|81485090|FG006|Overall Study|Lost to Follow-up|0|||
27903987|NCT01870297|81485084|FG000|Overall Study|Withdrawal by Subject|0|||
27903988|NCT01870297|81485085|FG001|Overall Study|Withdrawal by Subject|0|||
27903989|NCT01870297|81485086|FG002|Overall Study|Withdrawal by Subject|0|||
27903990|NCT01870297|81485087|FG003|Overall Study|Withdrawal by Subject|0|||
27903991|NCT01870297|81485088|FG004|Overall Study|Withdrawal by Subject|1|||
27903992|NCT01870297|81485089|FG005|Overall Study|Withdrawal by Subject|1|||
27903993|NCT01870297|81485090|FG006|Overall Study|Withdrawal by Subject|1|||
27903994|NCT01870297|81485084|FG000|Overall Study|Sponsor Decision|0|||
27903995|NCT01870297|81485085|FG001|Overall Study|Sponsor Decision|6|||
27903996|NCT01870297|81485086|FG002|Overall Study|Sponsor Decision|0|||
27903997|NCT01870297|81485087|FG003|Overall Study|Sponsor Decision|0|||
27903998|NCT01870297|81485088|FG004|Overall Study|Sponsor Decision|0|||
27903999|NCT01870297|81485089|FG005|Overall Study|Sponsor Decision|0|||
27904000|NCT01870297|81485090|FG006|Overall Study|Sponsor Decision|1|||
27904001|NCT03035916|81485094|FG000|Overall Study|Puncture failed|0|||
27904002|NCT03035916|81485095|FG001|Overall Study|Puncture failed|2|||
27904003|NCT03035916|81485096|FG002|Overall Study|Puncture failed|0|||
27904004|NCT02824562|81485106|FG000|Overall Study|Lost to Follow-up|3|||
27904005|NCT02824562|81485107|FG001|Overall Study|Lost to Follow-up|4|||
27904006|NCT02824562|81485106|FG000|Overall Study|Death|0|||
27904007|NCT02824562|81485107|FG001|Overall Study|Death|1|||
27904008|NCT03396822|81485111|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
27904009|NCT03396822|81485111|FG000|Overall Study|Physician Decision|1|||
27904010|NCT02432144|81485112|FG000|Overall Study|Participant Non-Compliance|1|||
27904011|NCT01470144|81485113|FG000|Overall Study|Adverse Event|2|||
27904012|NCT01470144|81485113|FG000|Overall Study|Death|1|||
27904013|NCT01470144|81485113|FG000|Overall Study|Lung transplant|6|||
27904014|NCT01470144|81485113|FG000|Overall Study|Patient's and investigator's decision|1|||
27904015|NCT00742027|81485114|FG000|Overall Study|Disease Progression|76|||
27904016|NCT00742027|81485114|FG000|Overall Study|New Cancer Therapy|19|||
27904017|NCT00742027|81485114|FG000|Overall Study|Withdrawal by Subject|18|||
27904018|NCT00742027|81485114|FG000|Overall Study|Death|7|||
27904019|NCT00742027|81485114|FG000|Overall Study|Lost to Follow-up|4|||
27904020|NCT00742027|81485114|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
27904021|NCT00742027|81485114|FG000|Overall Study|Missing|2|||
27904022|NCT00742027|81485114|FG000|Overall Study|Administrative Problems|1|||
27904023|NCT00549601|81485117|FG000|Randomized|Protocol Violation|0|||
27904024|NCT00549601|81485118|FG001|Randomized|Protocol Violation|0|||
27904025|NCT00549601|81485119|FG002|Randomized|Protocol Violation|1|||
27904026|NCT00549601|81485117|FG000|Randomized|Withdrawal by Subject|0|||
27904027|NCT00549601|81485118|FG001|Randomized|Withdrawal by Subject|1|||
27904028|NCT00549601|81485119|FG002|Randomized|Withdrawal by Subject|1|||
27904029|NCT00549601|81485117|FG000|Received Study Drug|Adverse Event|2|||
27904030|NCT00549601|81485118|FG001|Received Study Drug|Adverse Event|5|||
27904031|NCT00549601|81485119|FG002|Received Study Drug|Adverse Event|1|||
27904032|NCT00549601|81485117|FG000|Received Study Drug|Death|0|||
27904033|NCT00549601|81485118|FG001|Received Study Drug|Death|1|||
27904034|NCT00549601|81485119|FG002|Received Study Drug|Death|0|||
27904035|NCT00549601|81485117|FG000|Received Study Drug|Lost to Follow-up|0|||
27904036|NCT00549601|81485118|FG001|Received Study Drug|Lost to Follow-up|1|||
27904037|NCT00549601|81485119|FG002|Received Study Drug|Lost to Follow-up|1|||
27904038|NCT00549601|81485117|FG000|Received Study Drug|Protocol Violation|3|||
27904039|NCT00549601|81485118|FG001|Received Study Drug|Protocol Violation|4|||
27904040|NCT00549601|81485119|FG002|Received Study Drug|Protocol Violation|1|||
27904041|NCT00549601|81485117|FG000|Received Study Drug|Withdrawal by Subject|2|||
27904042|NCT00549601|81485118|FG001|Received Study Drug|Withdrawal by Subject|0|||
27904043|NCT00549601|81485119|FG002|Received Study Drug|Withdrawal by Subject|1|||
27904044|NCT02155322|81485120|FG000|Overall Study|Adverse Event|1|||
27507858|NCT00318643|80051704|FG002|Overall Study|Adverse Event|0|||
27507859|NCT00318643|80051705|FG003|Overall Study|Adverse Event|0|||
27507860|NCT00318643|80051706|FG004|Overall Study|Adverse Event|1|||
27507861|NCT00318643|80051702|FG000|Overall Study|Participant's Decision|0|||
27507862|NCT00318643|80051703|FG001|Overall Study|Participant's Decision|0|||
27507863|NCT00318643|80051704|FG002|Overall Study|Participant's Decision|0|||
27507864|NCT00318643|80051705|FG003|Overall Study|Participant's Decision|0|||
27507865|NCT00318643|80051706|FG004|Overall Study|Participant's Decision|1|||
27507866|NCT00318643|80051702|FG000|Overall Study|Investigator's Decision|0|||
27507867|NCT00318643|80051703|FG001|Overall Study|Investigator's Decision|0|||
27507868|NCT00318643|80051704|FG002|Overall Study|Investigator's Decision|0|||
27507869|NCT00318643|80051705|FG003|Overall Study|Investigator's Decision|0|||
27507870|NCT00318643|80051706|FG004|Overall Study|Investigator's Decision|1|||
27507871|NCT02085161|80051707|FG000|Overall Study|Not Treated|1|||
27507872|NCT02085161|80051708|FG001|Overall Study|Not Treated|0|||
27507873|NCT02085161|80051709|FG002|Overall Study|Not Treated|0|||
27507874|NCT02085161|80051710|FG003|Overall Study|Not Treated|0|||
27507875|NCT02085161|80051707|FG000|Overall Study|Adverse Event|8|||
27507876|NCT02085161|80051708|FG001|Overall Study|Adverse Event|5|||
27507877|NCT02085161|80051709|FG002|Overall Study|Adverse Event|4|||
27507878|NCT02085161|80051710|FG003|Overall Study|Adverse Event|5|||
27507879|NCT02085161|80051707|FG000|Overall Study|Protocol Violation|0|||
27507880|NCT02085161|80051708|FG001|Overall Study|Protocol Violation|1|||
27507881|NCT02085161|80051709|FG002|Overall Study|Protocol Violation|0|||
27507882|NCT02085161|80051710|FG003|Overall Study|Protocol Violation|1|||
27507883|NCT02085161|80051707|FG000|Overall Study|Withdrawal by Subject|2|||
27507884|NCT02085161|80051708|FG001|Overall Study|Withdrawal by Subject|4|||
27507885|NCT02085161|80051709|FG002|Overall Study|Withdrawal by Subject|0|||
27507886|NCT02085161|80051710|FG003|Overall Study|Withdrawal by Subject|3|||
27507887|NCT02085161|80051707|FG000|Overall Study|Other Reason|1|||
27507888|NCT02085161|80051708|FG001|Overall Study|Other Reason|0|||
27507889|NCT02085161|80051709|FG002|Overall Study|Other Reason|1|||
27507890|NCT02085161|80051710|FG003|Overall Study|Other Reason|1|||
27507891|NCT01462370|80051711|FG000|Overall Study|Lack of Qualifying Event|1|||
27507892|NCT01462370|80051712|FG001|Overall Study|Lack of Qualifying Event|1|||
27507893|NCT01462370|80051711|FG000|Overall Study|Physician Decision|0|||
27507894|NCT01462370|80051712|FG001|Overall Study|Physician Decision|1|||
27507895|NCT01462370|80051711|FG000|Overall Study|Withdrawal by Subject|0|||
27507896|NCT01462370|80051712|FG001|Overall Study|Withdrawal by Subject|3|||
27507897|NCT01782378|80051714|FG000|First Series|Lost to Follow-up|7|||
27507898|NCT01782378|80051715|FG001|First Series|Lost to Follow-up|8|||
27507899|NCT01782378|80051714|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
27507900|NCT01782378|80051715|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
27507901|NCT01782378|80051714|FG000|Second Series|Lost to Follow-up|8|||
27507902|NCT01782378|80051715|FG001|Second Series|Lost to Follow-up|7|||
27507903|NCT01782378|80051714|FG000|Second Series|Did not choose to complete S2 Optional|18|||
27507904|NCT01782378|80051715|FG001|Second Series|Did not choose to complete S2 Optional|0|||
27507905|NCT01498068|80051716|FG000|Overall Study|Withdrawal by Subject|1|||
27507906|NCT01498068|80051717|FG001|Overall Study|Withdrawal by Subject|1|||
27507907|NCT04396639|80054485|FG000|Overall Study|Withdrawal by Subject|1|||
27507908|NCT04396639|80054485|FG000|Overall Study|Other|1|||
27507909|NCT01716234|80054495|FG000|Overall Study|Protocol Violation|0|||
27507910|NCT01716234|80054496|FG001|Overall Study|Protocol Violation|0|||
27507911|NCT01716234|80054497|FG002|Overall Study|Protocol Violation|0|||
27507912|NCT01716234|80054498|FG003|Overall Study|Protocol Violation|1|||
27507913|NCT01716234|80054499|FG004|Overall Study|Protocol Violation|1|||
27507914|NCT01716234|80054500|FG005|Overall Study|Protocol Violation|1|||
27507915|NCT01716234|80054501|FG006|Overall Study|Protocol Violation|0|||
27507916|NCT01716234|80054495|FG000|Overall Study|Lack of Efficacy|0|||
27507917|NCT01716234|80054496|FG001|Overall Study|Lack of Efficacy|0|||
27507918|NCT01716234|80054497|FG002|Overall Study|Lack of Efficacy|0|||
27507919|NCT01716234|80054498|FG003|Overall Study|Lack of Efficacy|1|||
27507920|NCT01716234|80054499|FG004|Overall Study|Lack of Efficacy|0|||
27507921|NCT01716234|80054500|FG005|Overall Study|Lack of Efficacy|0|||
27507922|NCT01716234|80054501|FG006|Overall Study|Lack of Efficacy|0|||
27507923|NCT01716234|80054495|FG000|Overall Study|Did not meet protocol eligibility|0|||
27507924|NCT01716234|80054496|FG001|Overall Study|Did not meet protocol eligibility|0|||
27507925|NCT01716234|80054497|FG002|Overall Study|Did not meet protocol eligibility|1|||
27507926|NCT01716234|80054498|FG003|Overall Study|Did not meet protocol eligibility|0|||
27507927|NCT01716234|80054499|FG004|Overall Study|Did not meet protocol eligibility|0|||
27507928|NCT01716234|80054500|FG005|Overall Study|Did not meet protocol eligibility|4|||
27507929|NCT01716234|80054501|FG006|Overall Study|Did not meet protocol eligibility|0|||
27507930|NCT01716234|80054495|FG000|Overall Study|Adverse Event|7|||
27507931|NCT01716234|80054496|FG001|Overall Study|Adverse Event|10|||
27507932|NCT01716234|80054497|FG002|Overall Study|Adverse Event|2|||
27507933|NCT01716234|80054498|FG003|Overall Study|Adverse Event|8|||
27507934|NCT01716234|80054499|FG004|Overall Study|Adverse Event|3|||
27507935|NCT01716234|80054500|FG005|Overall Study|Adverse Event|6|||
27507936|NCT01716234|80054501|FG006|Overall Study|Adverse Event|0|||
27507937|NCT01716234|80054495|FG000|Overall Study|Withdrawal by Subject|3|||
27507938|NCT01716234|80054496|FG001|Overall Study|Withdrawal by Subject|0|||
27507939|NCT01716234|80054497|FG002|Overall Study|Withdrawal by Subject|2|||
27507940|NCT01716234|80054498|FG003|Overall Study|Withdrawal by Subject|2|||
27507941|NCT01716234|80054499|FG004|Overall Study|Withdrawal by Subject|1|||
27507942|NCT01716234|80054500|FG005|Overall Study|Withdrawal by Subject|3|||
27507943|NCT01716234|80054501|FG006|Overall Study|Withdrawal by Subject|0|||
27507944|NCT01520506|80054502|FG000|Overall Study|Missed Visit|4|||
27507945|NCT01520506|80054502|FG000|Overall Study|Lost to Follow-up|1|||
27507946|NCT01520506|80054502|FG000|Overall Study|Withdrawal by Subject|1|||
27507947|NCT02592798|80054511|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
27507948|NCT02592798|80054512|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
27507949|NCT02592798|80054511|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
27507950|NCT02592798|80054512|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
27507951|NCT02592798|80054511|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
27507952|NCT02592798|80054512|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
27507953|NCT02592798|80054511|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
27507954|NCT02592798|80054512|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
27507955|NCT02592798|80054511|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
27507956|NCT02592798|80054512|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
27507957|NCT02592798|80054511|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
27507958|NCT02592798|80054512|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
27507959|NCT02592798|80054511|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
27507960|NCT02592798|80054512|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
27507961|NCT02592798|80054511|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
27507962|NCT02592798|80054512|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
27507963|NCT02592798|80054511|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
27507964|NCT02592798|80054512|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
27507965|NCT02592798|80054511|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
27507966|NCT02592798|80054512|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
27507967|NCT02592798|80054511|FG000|Transition From DB2 to OLE|Other reasons|1|||
27507968|NCT02592798|80054512|FG001|Transition From DB2 to OLE|Other reasons|0|||
27507969|NCT02592798|80054511|FG000|Open Label Period (OLE)|Other reasons|0|||
27507970|NCT02592798|80054512|FG001|Open Label Period (OLE)|Other reasons|2|||
27507971|NCT02592798|80054511|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
27507972|NCT02592798|80054512|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
27507973|NCT02592798|80054511|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
27507974|NCT02592798|80054512|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
27507975|NCT02592798|80054511|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
27507976|NCT02592798|80054512|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
27507977|NCT02592798|80054511|FG000|Open Label Period (OLE)|Adverse Event|0|||
27507978|NCT02592798|80054512|FG001|Open Label Period (OLE)|Adverse Event|1|||
27507979|NCT01668589|80054513|FG000|Overall Study|Lost to Follow-up|29|||
27507980|NCT01668589|80054514|FG001|Overall Study|Lost to Follow-up|37|||
27507981|NCT01668589|80054515|FG002|Overall Study|Lost to Follow-up|15|||
27507982|NCT01668589|80054516|FG003|Overall Study|Lost to Follow-up|5|||
27507983|NCT01668589|80054513|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
27507984|NCT01668589|80054514|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
27507985|NCT01668589|80054515|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
27507986|NCT01668589|80054516|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
27507987|NCT01668589|80054513|FG000|Overall Study|Death|12|||
27507988|NCT01668589|80054514|FG001|Overall Study|Death|3|||
27507989|NCT01668589|80054515|FG002|Overall Study|Death|2|||
27507990|NCT01668589|80054516|FG003|Overall Study|Death|11|||
27507991|NCT01668589|80054513|FG000|Overall Study|Other|44|||
27507992|NCT01668589|80054514|FG001|Overall Study|Other|10|||
27507993|NCT01668589|80054515|FG002|Overall Study|Other|7|||
27507994|NCT01668589|80054516|FG003|Overall Study|Other|15|||
27507995|NCT02461134|80054518|FG000|Overall Study|Adverse Event|1|||
27507996|NCT01519921|80054519|FG000|Overall Study|Adverse Event|10|||
27507997|NCT01519921|80054520|FG001|Overall Study|Adverse Event|9|||
27507998|NCT01519921|80054519|FG000|Overall Study|Lack of Efficacy|4|||
27507999|NCT01519921|80054520|FG001|Overall Study|Lack of Efficacy|3|||
27508000|NCT01519921|80054519|FG000|Overall Study|Withdrawal by Subject|3|||
27508001|NCT01519921|80054520|FG001|Overall Study|Withdrawal by Subject|0|||
27508002|NCT01519921|80054519|FG000|Overall Study|Lost to Follow-up|2|||
27508003|NCT01519921|80054520|FG001|Overall Study|Lost to Follow-up|1|||
27508004|NCT01519921|80054519|FG000|Overall Study|Treatment refusal|2|||
27508005|NCT01519921|80054520|FG001|Overall Study|Treatment refusal|1|||
27508006|NCT01519921|80054519|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
27508007|NCT01519921|80054520|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
27508008|NCT00494676|80054521|FG000|Allocation|Withdrawal by Subject|2|||
27508009|NCT00494676|80054522|FG001|Allocation|Withdrawal by Subject|4|||
27508010|NCT00494676|80054521|FG000|First Intervention|Withdrawal by Subject|1|||
27508011|NCT00494676|80054522|FG001|First Intervention|Withdrawal by Subject|3|||
27904045|NCT02155322|81485120|FG000|Overall Study|Physician Decision|1|||
27904046|NCT02155322|81485120|FG000|Overall Study|Relapse/Recurrence|8|||
27904047|NCT02155322|81485120|FG000|Overall Study|Withdrawal by Subject|4|||
27904048|NCT00621517|81485121|FG000|Overall Study|Lost to Follow-up|3|||
27904049|NCT00621517|81485122|FG001|Overall Study|Lost to Follow-up|3|||
27904050|NCT00621517|81485121|FG000|Overall Study|Withdrawal by Subject|3|||
27904051|NCT00621517|81485122|FG001|Overall Study|Withdrawal by Subject|4|||
27904052|NCT00621517|81485121|FG000|Overall Study|Adverse Event|1|||
27904053|NCT00621517|81485122|FG001|Overall Study|Adverse Event|0|||
27904054|NCT02324699|81485126|FG000|Overall Study|study terminated|1|||
27904055|NCT01754766|81485137|FG000|Overall Study|Personal reasons|1|||
27904056|NCT01754766|81485138|FG001|Overall Study|Personal reasons|1|||
27904057|NCT01754766|81485139|FG002|Overall Study|Personal reasons|0|||
27508012|NCT00494676|80054521|FG000|Second Intervention|Withdrawal by Subject|1|||
27508013|NCT00494676|80054522|FG001|Second Intervention|Withdrawal by Subject|1|||
27508014|NCT01198977|80054523|FG000|Overall Study|Lost to Follow-up|1|||
27508015|NCT01198977|80054524|FG001|Overall Study|Lost to Follow-up|0|||
27508016|NCT01249261|80054525|FG000|Overall Study|Withdrawal by Subject|1|||
27508017|NCT01249261|80054526|FG001|Overall Study|Withdrawal by Subject|0|||
27508018|NCT00831181|80054527|FG000|Overall Study|Adverse Event|12|||
27508019|NCT01523366|80054528|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27508020|NCT01523366|80054529|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27508021|NCT01523366|80054528|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
27508022|NCT01523366|80054529|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
27508023|NCT01772316|80054531|FG000|Overall Study|Serious adverse event|1|||
27508024|NCT01772316|80054531|FG000|Overall Study|Inform consent withdrawn|1|||
27508025|NCT01772316|80054531|FG000|Overall Study|Withdrawn by sponsor decision|5|||
27508026|NCT01083771|80054532|FG000|Overall Study|non-compliant|2|||
27508027|NCT01083771|80054532|FG000|Overall Study|Withdrawal by Subject|3|||
27508028|NCT00199381|80054533|FG000|Overall Study|Withdrawal by Subject|38|||
27508029|NCT00199381|80054533|FG000|Overall Study|Adverse Event|73|||
27508030|NCT00199381|80054533|FG000|Overall Study|Protocol Violation|6|||
27508031|NCT00199381|80054533|FG000|Overall Study|Lack of Efficacy|27|||
27508032|NCT00199381|80054533|FG000|Overall Study|Not including due to early termination|37|||
27508033|NCT00199381|80054533|FG000|Overall Study|Study termination by Sponsor|323|||
27508034|NCT01658436|80054534|FG000|Overall Study|Adverse Event|6|||
27508035|NCT01658436|80054535|FG001|Overall Study|Adverse Event|5|||
27508036|NCT01658436|80054534|FG000|Overall Study|Physician Decision|1|||
27508037|NCT01658436|80054535|FG001|Overall Study|Physician Decision|0|||
27508038|NCT01658436|80054534|FG000|Overall Study|Progressive disease|12|||
27508039|NCT01658436|80054535|FG001|Overall Study|Progressive disease|4|||
27508040|NCT01658436|80054534|FG000|Overall Study|Study terminated by sponsor|0|||
27508041|NCT01658436|80054535|FG001|Overall Study|Study terminated by sponsor|1|||
27508042|NCT01658436|80054534|FG000|Overall Study|Subject/guardian decision|0|||
27508043|NCT01658436|80054535|FG001|Overall Study|Subject/guardian decision|1|||
27508044|NCT01658436|80054534|FG000|Overall Study|Death|1|||
27508045|NCT01658436|80054535|FG001|Overall Study|Death|0|||
27508046|NCT00753506|80054537|FG000|Overall Study|Withdrawal by Subject|4|||
27508047|NCT00753506|80054538|FG001|Overall Study|Withdrawal by Subject|1|||
27508048|NCT00753506|80054537|FG000|Overall Study|Lost to Follow-up|2|||
27508049|NCT00753506|80054538|FG001|Overall Study|Lost to Follow-up|0|||
27508050|NCT00753506|80054537|FG000|Overall Study|Other reason|1|||
27508051|NCT00753506|80054538|FG001|Overall Study|Other reason|1|||
27508052|NCT03023397|80054539|FG000|Run-In|Failed screening allergen challenge|1|||
27508053|NCT03023397|80054540|FG001|Run-In|Failed screening allergen challenge|0|||
27508054|NCT03023397|80054541|FG002|Run-In|Failed screening allergen challenge|0|||
27508055|NCT03023397|80054539|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
27508056|NCT03023397|80054540|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
27508057|NCT03023397|80054541|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
27508058|NCT01077076|80054542|FG000|First Intervention|Withdrawal by Subject|1|||
27508059|NCT01077076|80054543|FG001|First Intervention|Withdrawal by Subject|0|||
27614606|NCT00089895|80430327|FG000|Overall Study|Physician Decision|3|||
27614607|NCT00089895|80430328|FG001|Overall Study|Physician Decision|7|||
27904058|NCT01737879|81485144|FG000|Overall Study|Death|1|||
27508060|NCT01077076|80054544|FG002|First Intervention|Withdrawal by Subject|0|||
27508061|NCT01077076|80054545|FG003|First Intervention|Withdrawal by Subject|0|||
27508062|NCT01077076|80054546|FG004|First Intervention|Withdrawal by Subject|0|||
27508063|NCT01077076|80054547|FG005|First Intervention|Withdrawal by Subject|0|||
27904059|NCT01737879|81485144|FG000|Overall Study|Sponsor decision|40|||
27614608|NCT00089895|80430327|FG000|Overall Study|Exclusion criteria met|6|||
27508064|NCT01077076|80054542|FG000|Third Intervention|Death in the participant's family|0|||
27904060|NCT01483599|81485145|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
27904061|NCT01483599|81485146|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904062|NCT01483599|81485147|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27614609|NCT00089895|80430328|FG001|Overall Study|Exclusion criteria met|6|||
27614610|NCT00089895|80430327|FG000|Overall Study|Not otherwise specified|4|||
27614611|NCT00089895|80430328|FG001|Overall Study|Not otherwise specified|8|||
27614612|NCT00089895|80430327|FG000|Overall Study|Missing|4|||
27614613|NCT00089895|80430328|FG001|Overall Study|Missing|2|||
27508065|NCT01077076|80054543|FG001|Third Intervention|Death in the participant's family|0|||
27508066|NCT01077076|80054544|FG002|Third Intervention|Death in the participant's family|0|||
27508067|NCT01077076|80054545|FG003|Third Intervention|Death in the participant's family|0|||
27508068|NCT01077076|80054546|FG004|Third Intervention|Death in the participant's family|0|||
27508069|NCT01077076|80054547|FG005|Third Intervention|Death in the participant's family|1|||
27508070|NCT00889720|80054550|FG000|Overall Study|Withdrawal by Subject|4|||
27508071|NCT00889720|80054550|FG000|Overall Study|Other|4|||
27508072|NCT01759446|80054551|FG000|Overall Study|Protocol Violation|1|||
27508073|NCT01759446|80054552|FG001|Overall Study|Protocol Violation|0|||
27508074|NCT01759446|80054553|FG002|Overall Study|Protocol Violation|1|||
27508075|NCT01759446|80054554|FG003|Overall Study|Protocol Violation|0|||
27508076|NCT01759446|80054555|FG004|Overall Study|Protocol Violation|0|||
27508077|NCT01759446|80054551|FG000|Overall Study|Withdrawal by Subject|0|||
27508078|NCT01759446|80054552|FG001|Overall Study|Withdrawal by Subject|1|||
27508079|NCT01759446|80054553|FG002|Overall Study|Withdrawal by Subject|0|||
27508080|NCT01759446|80054554|FG003|Overall Study|Withdrawal by Subject|1|||
27508081|NCT01759446|80054555|FG004|Overall Study|Withdrawal by Subject|0|||
27508082|NCT01760733|80054559|FG000|Waiting List|Death|18|||
27508083|NCT01760733|80054559|FG000|Waiting List|Removed from waiting list|41|||
27508084|NCT01760733|80054559|FG000|Waiting List|Not received a transplant yet|13|||
27904063|NCT01483599|81485148|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
27904064|NCT01483599|81485149|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
27904065|NCT01483599|81485150|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
27852061|NCT03347422|81291008|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
27852062|NCT03347422|81291009|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
27904066|NCT01483599|81485151|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
27904067|NCT01483599|81485152|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904068|NCT01483599|81485153|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904069|NCT01483599|81485154|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904070|NCT01483599|81485155|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904071|NCT01483599|81485156|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904072|NCT01483599|81485157|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904073|NCT01483599|81485158|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
27904074|NCT01483599|81485145|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904075|NCT01483599|81485146|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
27904076|NCT01483599|81485147|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27852063|NCT03347422|81291008|FG000|Part B (149 Weeks)|Other|1|||
27852064|NCT03347422|81291009|FG001|Part B (149 Weeks)|Other|0|||
27852065|NCT02963311|81291010|FG000|Overall Study|Withdrawal by Subject|1|||
27852066|NCT02963311|81291010|FG000|Overall Study|Screen Failure|4|||
27852067|NCT00673933|81291014|FG000|Overall Study|Withdrawal by Subject|2|||
27852068|NCT00673933|81291014|FG000|Overall Study|Lost to Follow-up|1|||
27852069|NCT02707861|81291015|FG000|Overall Study|Went onto commercial drug|30|||
27852070|NCT02707861|81291016|FG001|Overall Study|Went onto commercial drug|23|||
27852071|NCT02707861|81291015|FG000|Overall Study|Adverse Event|2|||
27852072|NCT02707861|81291016|FG001|Overall Study|Adverse Event|3|||
27852073|NCT02707861|81291015|FG000|Overall Study|Death|5|||
27852074|NCT02707861|81291016|FG001|Overall Study|Death|2|||
27852075|NCT02707861|81291015|FG000|Overall Study|Lack of Efficacy|0|||
27852076|NCT02707861|81291016|FG001|Overall Study|Lack of Efficacy|2|||
27852077|NCT02707861|81291015|FG000|Overall Study|Physician Decision|1|||
27852078|NCT02707861|81291016|FG001|Overall Study|Physician Decision|4|||
27852079|NCT02707861|81291015|FG000|Overall Study|Withdrawal by Subject|2|||
27852080|NCT02707861|81291016|FG001|Overall Study|Withdrawal by Subject|1|||
27852081|NCT02707861|81291015|FG000|Overall Study|Lost to Follow-up|1|||
27852082|NCT02707861|81291016|FG001|Overall Study|Lost to Follow-up|3|||
27852083|NCT02478320|81291017|FG000|Overall Study|Adverse Event|2|||
27852084|NCT02478320|81291018|FG001|Overall Study|Adverse Event|0|||
27852085|NCT02478320|81291017|FG000|Overall Study|Death|1|||
27852086|NCT02478320|81291018|FG001|Overall Study|Death|0|||
27852087|NCT02478320|81291017|FG000|Overall Study|Lack of Efficacy|4|||
27852088|NCT02478320|81291018|FG001|Overall Study|Lack of Efficacy|0|||
27852089|NCT02478320|81291017|FG000|Overall Study|Withdrawal by Subject|2|||
27852090|NCT02478320|81291018|FG001|Overall Study|Withdrawal by Subject|0|||
27852091|NCT02478320|81291017|FG000|Overall Study|Screen Failure|3|||
27852092|NCT02478320|81291018|FG001|Overall Study|Screen Failure|0|||
27852093|NCT00609466|81291019|FG000|Overall Study|Withdrawal by Subject|0|||
27852094|NCT00609466|81291020|FG001|Overall Study|Withdrawal by Subject|1|||
27852095|NCT00609466|81291021|FG002|Overall Study|Withdrawal by Subject|1|||
27852096|NCT00609466|81291019|FG000|Overall Study|Adverse Event|2|||
27852097|NCT00609466|81291020|FG001|Overall Study|Adverse Event|3|||
27852098|NCT00609466|81291021|FG002|Overall Study|Adverse Event|1|||
27852099|NCT00609466|81291019|FG000|Overall Study|Lack of Efficacy|0|||
27852100|NCT00609466|81291020|FG001|Overall Study|Lack of Efficacy|2|||
27852101|NCT00609466|81291021|FG002|Overall Study|Lack of Efficacy|2|||
27852102|NCT01030341|81291022|FG000|Overall Study|Withdrawal by Subject|1|||
27852103|NCT01030341|81291022|FG000|Overall Study|Lost to Follow-up|2|||
27852104|NCT00922987|81291023|FG000|Overall Study|Insufficient clinical response|1|||
27852105|NCT00922987|81291023|FG000|Overall Study|Protocol Violation|2|||
27852106|NCT00922987|81291023|FG000|Overall Study|Adverse Event|1|||
27852107|NCT02372071|81291024|FG000|Overall Study|Protocol Violation|18|||
27904077|NCT01483599|81485148|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
27904078|NCT01483599|81485149|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27508085|NCT01760733|80054559|FG000|Transplanted|Not reached 10 years post transplant|184|||
27852108|NCT01195272|81291026|FG000|Overall Study|Adverse Event|1|||
27852109|NCT01195272|81291026|FG000|Overall Study|Lack of Efficacy|3|||
27852110|NCT00851643|81291027|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
27852111|NCT00851643|81291028|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27852112|NCT00851643|81291029|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27852113|NCT00851643|81291030|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27852114|NCT00851643|81291031|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27852115|NCT00851643|81291032|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
27852116|NCT00851643|81291027|FG000|Base Study (Up to 12 Months)|Other|0|||
27852117|NCT00851643|81291028|FG001|Base Study (Up to 12 Months)|Other|0|||
27508086|NCT01760733|80054559|FG000|Transplanted|Death|26|||
27508087|NCT01760733|80054559|FG000|Transplanted|Graft loss|7|||
27508088|NCT02699749|80054560|FG000|Overall Study|Other|0|||
27508089|NCT02699749|80054561|FG001|Overall Study|Other|0|||
27508090|NCT02699749|80054562|FG002|Overall Study|Other|2|||
27508091|NCT02699749|80054563|FG003|Overall Study|Other|0|||
27508092|NCT02699749|80054564|FG004|Overall Study|Other|0|||
27508093|NCT02699749|80054565|FG005|Overall Study|Other|1|||
27508094|NCT02699749|80054566|FG006|Overall Study|Other|1|||
27508095|NCT02699749|80054567|FG007|Overall Study|Other|0|||
27508096|NCT02699749|80054568|FG008|Overall Study|Other|0|||
27508097|NCT02699749|80054569|FG009|Overall Study|Other|0|||
27508098|NCT02699749|80054570|FG010|Overall Study|Other|1|||
27508099|NCT02699749|80054571|FG011|Overall Study|Other|0|||
27508100|NCT02699749|80054572|FG012|Overall Study|Other|0|||
27508101|NCT02699749|80054573|FG013|Overall Study|Other|0|||
27508102|NCT02699749|80054560|FG000|Overall Study|Progressive Disease|3|||
27508103|NCT02699749|80054561|FG001|Overall Study|Progressive Disease|3|||
27508104|NCT02699749|80054562|FG002|Overall Study|Progressive Disease|14|||
27508105|NCT02699749|80054563|FG003|Overall Study|Progressive Disease|3|||
27508106|NCT02699749|80054564|FG004|Overall Study|Progressive Disease|3|||
27508107|NCT02699749|80054565|FG005|Overall Study|Progressive Disease|7|||
27508108|NCT02699749|80054566|FG006|Overall Study|Progressive Disease|5|||
27508109|NCT02699749|80054567|FG007|Overall Study|Progressive Disease|5|||
27508110|NCT02699749|80054568|FG008|Overall Study|Progressive Disease|6|||
27508111|NCT02699749|80054569|FG009|Overall Study|Progressive Disease|6|||
27508112|NCT02699749|80054570|FG010|Overall Study|Progressive Disease|5|||
27508113|NCT02699749|80054571|FG011|Overall Study|Progressive Disease|4|||
27508114|NCT02699749|80054572|FG012|Overall Study|Progressive Disease|3|||
27508115|NCT02699749|80054573|FG013|Overall Study|Progressive Disease|5|||
27508116|NCT02699749|80054560|FG000|Overall Study|Death|0|||
27508117|NCT02699749|80054561|FG001|Overall Study|Death|0|||
27508118|NCT02699749|80054562|FG002|Overall Study|Death|0|||
27508119|NCT02699749|80054563|FG003|Overall Study|Death|0|||
27508120|NCT02699749|80054564|FG004|Overall Study|Death|0|||
27508121|NCT02699749|80054565|FG005|Overall Study|Death|0|||
27508122|NCT02699749|80054566|FG006|Overall Study|Death|0|||
27508123|NCT02699749|80054567|FG007|Overall Study|Death|0|||
27508124|NCT02699749|80054568|FG008|Overall Study|Death|0|||
27508125|NCT02699749|80054569|FG009|Overall Study|Death|0|||
27508126|NCT02699749|80054570|FG010|Overall Study|Death|0|||
27508127|NCT02699749|80054571|FG011|Overall Study|Death|0|||
27508128|NCT02699749|80054572|FG012|Overall Study|Death|0|||
27508129|NCT02699749|80054573|FG013|Overall Study|Death|1|||
27508130|NCT02699749|80054560|FG000|Overall Study|Lost to Follow-up|0|||
27508131|NCT02699749|80054561|FG001|Overall Study|Lost to Follow-up|0|||
27508132|NCT02699749|80054562|FG002|Overall Study|Lost to Follow-up|0|||
27508133|NCT02699749|80054563|FG003|Overall Study|Lost to Follow-up|0|||
27508134|NCT02699749|80054564|FG004|Overall Study|Lost to Follow-up|0|||
27508135|NCT02699749|80054565|FG005|Overall Study|Lost to Follow-up|1|||
27508136|NCT02699749|80054566|FG006|Overall Study|Lost to Follow-up|0|||
27508137|NCT02699749|80054567|FG007|Overall Study|Lost to Follow-up|1|||
27508138|NCT02699749|80054568|FG008|Overall Study|Lost to Follow-up|0|||
27508139|NCT02699749|80054569|FG009|Overall Study|Lost to Follow-up|0|||
27508140|NCT02699749|80054570|FG010|Overall Study|Lost to Follow-up|0|||
27508141|NCT02699749|80054571|FG011|Overall Study|Lost to Follow-up|0|||
27508142|NCT02699749|80054572|FG012|Overall Study|Lost to Follow-up|0|||
27508143|NCT02699749|80054573|FG013|Overall Study|Lost to Follow-up|0|||
27508144|NCT01383356|80054574|FG000|Period 1|Adverse Event|5|||
27508145|NCT01383356|80054575|FG001|Period 1|Adverse Event|3|||
27508146|NCT01383356|80054574|FG000|Period 1|Non-compliance|3|||
27508147|NCT01383356|80054575|FG001|Period 1|Non-compliance|0|||
27508148|NCT01383356|80054574|FG000|Period 1|Out of Range Mid-study-Test|0|||
27508149|NCT01383356|80054575|FG001|Period 1|Out of Range Mid-study-Test|1|||
27508150|NCT01383356|80054574|FG000|Period 1|Personal|0|||
27508151|NCT01383356|80054575|FG001|Period 1|Personal|2|||
27508152|NCT02396199|80054579|FG000|Overall Study|Lost to Follow-up|1|||
27508153|NCT02396199|80054579|FG000|Overall Study|Death|4|||
27508154|NCT02035267|80054580|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
27508155|NCT02035267|80054581|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
27614614|NCT00209274|80430332|FG000|Overall Study|Missed visit|3|||
27614615|NCT00209274|80430333|FG001|Overall Study|Missed visit|2|||
27614616|NCT00209274|80430332|FG000|Overall Study|Death|32|||
27614617|NCT00209274|80430333|FG001|Overall Study|Death|15|||
27852118|NCT00851643|81291029|FG002|Base Study (Up to 12 Months)|Other|0|||
27508156|NCT02035267|80054582|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
27508157|NCT02035267|80054583|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
27508158|NCT02035267|80054580|FG000|Overall Study|Adverse Event|0|||
27904079|NCT01483599|81485150|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904080|NCT01483599|81485151|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
27904081|NCT01483599|81485152|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904082|NCT01483599|81485153|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904083|NCT01483599|81485154|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904084|NCT01483599|81485155|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27508159|NCT02035267|80054581|FG001|Overall Study|Adverse Event|0|||
27508160|NCT02035267|80054582|FG002|Overall Study|Adverse Event|1|||
27508161|NCT02035267|80054583|FG003|Overall Study|Adverse Event|0|||
27508162|NCT02035267|80054580|FG000|Overall Study|Lost to Follow-up|0|||
27508163|NCT02035267|80054581|FG001|Overall Study|Lost to Follow-up|0|||
27508164|NCT02035267|80054582|FG002|Overall Study|Lost to Follow-up|0|||
27508165|NCT02035267|80054583|FG003|Overall Study|Lost to Follow-up|1|||
27508166|NCT02035267|80054580|FG000|Overall Study|Other unspecified|0|||
27508167|NCT02035267|80054581|FG001|Overall Study|Other unspecified|1|||
27508168|NCT02035267|80054582|FG002|Overall Study|Other unspecified|0|||
27508169|NCT02035267|80054583|FG003|Overall Study|Other unspecified|0|||
27508170|NCT02754440|80054584|FG000|Overall Study|Protocol Violation|3|||
27508171|NCT02754440|80054585|FG001|Overall Study|Protocol Violation|2|||
27508172|NCT02754440|80054586|FG002|Overall Study|Protocol Violation|2|||
27508173|NCT02754440|80054587|FG003|Overall Study|Protocol Violation|6|||
27508174|NCT02754440|80054584|FG000|Overall Study|Adverse Event|3|||
27508175|NCT02754440|80054585|FG001|Overall Study|Adverse Event|1|||
27508176|NCT02754440|80054586|FG002|Overall Study|Adverse Event|0|||
27508177|NCT02754440|80054587|FG003|Overall Study|Adverse Event|9|||
27508178|NCT02754440|80054584|FG000|Overall Study|Withdrawal by Subject|0|||
27508179|NCT02754440|80054585|FG001|Overall Study|Withdrawal by Subject|0|||
27508180|NCT02754440|80054586|FG002|Overall Study|Withdrawal by Subject|0|||
27508181|NCT02754440|80054587|FG003|Overall Study|Withdrawal by Subject|1|||
27508182|NCT02754440|80054584|FG000|Overall Study|Equipment failure|0|||
27904085|NCT01483599|81485156|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904086|NCT01483599|81485157|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27508183|NCT02754440|80054585|FG001|Overall Study|Equipment failure|5|||
27508184|NCT02754440|80054586|FG002|Overall Study|Equipment failure|5|||
27508185|NCT02754440|80054587|FG003|Overall Study|Equipment failure|7|||
27508186|NCT02754440|80054584|FG000|Overall Study|Subject issues not resulting in AE|0|||
27508187|NCT02754440|80054585|FG001|Overall Study|Subject issues not resulting in AE|0|||
27508188|NCT02754440|80054586|FG002|Overall Study|Subject issues not resulting in AE|0|||
27508189|NCT02754440|80054587|FG003|Overall Study|Subject issues not resulting in AE|12|||
27508190|NCT03694353|80054588|FG000|Overall Study|Withdrawal by Subject|1|||
27508191|NCT03694353|80054588|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
27508192|NCT03818321|80054593|FG000|Overall Study|Withdrawal by Subject|1|||
27904087|NCT01483599|81485158|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
27904088|NCT01483599|81485145|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
27904089|NCT01483599|81485146|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904090|NCT01483599|81485147|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904091|NCT01483599|81485148|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904092|NCT01483599|81485149|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27508193|NCT03818321|80054594|FG001|Overall Study|Withdrawal by Subject|2|||
27508194|NCT00408317|80054595|FG000|First Intervention Period|Adverse Event|0|||
27508195|NCT00408317|80054596|FG001|First Intervention Period|Adverse Event|1|||
27508196|NCT00408317|80054595|FG000|Second Intervention Period|Adverse Event|2|||
27508197|NCT00408317|80054596|FG001|Second Intervention Period|Adverse Event|0|||
27508198|NCT00408317|80054595|FG000|Second Intervention Period|Protocol Violation|0|||
27508199|NCT00408317|80054596|FG001|Second Intervention Period|Protocol Violation|1|||
27508200|NCT00408317|80054595|FG000|Second Intervention Period|Withdrawal of consent|0|||
27508201|NCT00408317|80054596|FG001|Second Intervention Period|Withdrawal of consent|1|||
27508202|NCT03388164|80054599|FG000|Overall Study|Withdrawal by Subject|3|||
27508203|NCT03388164|80054600|FG001|Overall Study|Withdrawal by Subject|1|||
27508204|NCT00716417|80054602|FG000|Overall Study|Adverse Event|0|||
27904093|NCT01483599|81485150|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904094|NCT01483599|81485151|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904095|NCT01483599|81485152|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904096|NCT01483599|81485153|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904097|NCT01483599|81485154|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27508205|NCT00716417|80054603|FG001|Overall Study|Adverse Event|0|||
27508206|NCT00716417|80054604|FG002|Overall Study|Adverse Event|2|||
27508207|NCT00716417|80054605|FG003|Overall Study|Adverse Event|1|||
27508208|NCT00716417|80054606|FG004|Overall Study|Adverse Event|0|||
27508209|NCT00716417|80054607|FG005|Overall Study|Adverse Event|0|||
27508210|NCT00716417|80054608|FG006|Overall Study|Adverse Event|3|||
27508211|NCT00716417|80054609|FG007|Overall Study|Adverse Event|1|||
27508212|NCT00716417|80054610|FG008|Overall Study|Adverse Event|0|||
27904098|NCT01483599|81485155|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904099|NCT01483599|81485156|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904100|NCT01483599|81485157|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904101|NCT01483599|81485158|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
27904102|NCT01483599|81485145|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
27904103|NCT01483599|81485146|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
27904104|NCT01483599|81485147|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
27904105|NCT01483599|81485148|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
27852119|NCT00851643|81291030|FG003|Base Study (Up to 12 Months)|Other|0|||
27508213|NCT00716417|80054611|FG009|Overall Study|Adverse Event|3|||
27852120|NCT00851643|81291031|FG004|Base Study (Up to 12 Months)|Other|0|||
27852121|NCT00851643|81291032|FG005|Base Study (Up to 12 Months)|Other|1|||
27852122|NCT00851643|81291027|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
27852123|NCT00851643|81291028|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
27852124|NCT00851643|81291029|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
27852125|NCT00851643|81291030|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
27852126|NCT00851643|81291031|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
27852127|NCT00851643|81291032|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
27852128|NCT00851643|81291027|FG000|Extension Study (Up to 36 Months)|Moved|0|||
27852129|NCT00851643|81291028|FG001|Extension Study (Up to 36 Months)|Moved|2|||
27852130|NCT00851643|81291029|FG002|Extension Study (Up to 36 Months)|Moved|1|||
27852131|NCT00851643|81291030|FG003|Extension Study (Up to 36 Months)|Moved|1|||
27852132|NCT00851643|81291031|FG004|Extension Study (Up to 36 Months)|Moved|0|||
27852133|NCT00851643|81291032|FG005|Extension Study (Up to 36 Months)|Moved|1|||
27852134|NCT03567382|81291041|FG000|Overall Study|Lost to Follow-up|1|||
27852135|NCT03567382|81291042|FG001|Overall Study|Lost to Follow-up|21|||
27852136|NCT03567382|81291043|FG002|Overall Study|Lost to Follow-up|1|||
27852137|NCT03567382|81291044|FG003|Overall Study|Lost to Follow-up|21|||
27852138|NCT03567382|81291041|FG000|Overall Study|Withdrawal by Subject|2|||
27852139|NCT03567382|81291042|FG001|Overall Study|Withdrawal by Subject|14|||
27852140|NCT03567382|81291043|FG002|Overall Study|Withdrawal by Subject|1|||
27852141|NCT03567382|81291044|FG003|Overall Study|Withdrawal by Subject|12|||
27852142|NCT03733210|81291047|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
27852143|NCT03733210|81291048|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
27852144|NCT02932228|81291049|FG000|Overall Study|Death|8|||
27852145|NCT02932228|81291050|FG001|Overall Study|Death|23|||
27852146|NCT02932228|81291049|FG000|Overall Study|not eligible upon chart review|2|||
27852147|NCT02932228|81291050|FG001|Overall Study|not eligible upon chart review|5|||
27852148|NCT01929031|81291052|FG000|Overall Study|Adverse Event|3|||
27852149|NCT01929031|81291053|FG001|Overall Study|Adverse Event|1|||
27852150|NCT01929031|81291054|FG002|Overall Study|Adverse Event|1|||
27852151|NCT01929031|81291055|FG003|Overall Study|Adverse Event|0|||
27852152|NCT01929031|81291056|FG004|Overall Study|Adverse Event|0|||
27852153|NCT01929031|81291057|FG005|Overall Study|Adverse Event|0|||
27852154|NCT01929031|81291052|FG000|Overall Study|Protocol Violation|1|||
27852155|NCT01929031|81291053|FG001|Overall Study|Protocol Violation|0|||
27852156|NCT01929031|81291054|FG002|Overall Study|Protocol Violation|0|||
27852157|NCT01929031|81291055|FG003|Overall Study|Protocol Violation|0|||
27852158|NCT01929031|81291056|FG004|Overall Study|Protocol Violation|0|||
27852159|NCT01929031|81291057|FG005|Overall Study|Protocol Violation|1|||
27852160|NCT01929031|81291052|FG000|Overall Study|Reason other than specified above|0|||
27852161|NCT01929031|81291053|FG001|Overall Study|Reason other than specified above|1|||
27852162|NCT01929031|81291054|FG002|Overall Study|Reason other than specified above|0|||
27852163|NCT01929031|81291055|FG003|Overall Study|Reason other than specified above|0|||
27508214|NCT00716417|80054602|FG000|Overall Study|Withdrawal by Subject|0|||
27508215|NCT00716417|80054603|FG001|Overall Study|Withdrawal by Subject|1|||
27508216|NCT00716417|80054604|FG002|Overall Study|Withdrawal by Subject|0|||
27508217|NCT00716417|80054605|FG003|Overall Study|Withdrawal by Subject|2|||
27508218|NCT00716417|80054606|FG004|Overall Study|Withdrawal by Subject|0|||
27508219|NCT00716417|80054607|FG005|Overall Study|Withdrawal by Subject|0|||
27904106|NCT01483599|81485149|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
27904107|NCT01483599|81485150|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
27904108|NCT01483599|81485151|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
27904109|NCT01483599|81485152|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
27904110|NCT01483599|81485153|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
27904111|NCT01483599|81485154|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
27904112|NCT01483599|81485155|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
27904113|NCT01483599|81485156|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
27904114|NCT01483599|81485157|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
27904115|NCT01483599|81485158|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
27904116|NCT01483599|81485145|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
27904117|NCT01483599|81485146|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
27904118|NCT01483599|81485147|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
27904119|NCT01483599|81485148|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
27904120|NCT01483599|81485149|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
27904121|NCT01483599|81485150|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
27904122|NCT01483599|81485151|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
27904123|NCT01483599|81485152|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
27904124|NCT01483599|81485153|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
27904125|NCT01483599|81485154|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
27904126|NCT01483599|81485155|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
27904127|NCT01483599|81485156|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
27904128|NCT01483599|81485157|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
27904129|NCT01483599|81485158|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
27904130|NCT01483599|81485145|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904131|NCT01483599|81485146|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904132|NCT01483599|81485147|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904133|NCT01483599|81485148|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904134|NCT01483599|81485149|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904135|NCT01483599|81485150|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904136|NCT01483599|81485151|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904137|NCT01483599|81485152|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27904138|NCT01483599|81485153|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27508220|NCT00716417|80054608|FG006|Overall Study|Withdrawal by Subject|1|||
27508221|NCT00716417|80054609|FG007|Overall Study|Withdrawal by Subject|0|||
27508222|NCT00716417|80054610|FG008|Overall Study|Withdrawal by Subject|0|||
27508223|NCT00716417|80054611|FG009|Overall Study|Withdrawal by Subject|0|||
27508224|NCT00716417|80054602|FG000|Overall Study|Progressive disease|3|||
27508225|NCT00716417|80054603|FG001|Overall Study|Progressive disease|5|||
27508226|NCT00716417|80054604|FG002|Overall Study|Progressive disease|3|||
27508227|NCT00716417|80054605|FG003|Overall Study|Progressive disease|8|||
27508228|NCT00716417|80054606|FG004|Overall Study|Progressive disease|0|||
27508229|NCT00716417|80054607|FG005|Overall Study|Progressive disease|3|||
27508230|NCT00716417|80054608|FG006|Overall Study|Progressive disease|3|||
27508231|NCT00716417|80054609|FG007|Overall Study|Progressive disease|1|||
27508232|NCT00716417|80054610|FG008|Overall Study|Progressive disease|5|||
27508233|NCT00716417|80054611|FG009|Overall Study|Progressive disease|0|||
27508234|NCT00716417|80054602|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
27508235|NCT00716417|80054603|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
27508236|NCT00716417|80054604|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
27508237|NCT00716417|80054605|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
27508238|NCT00716417|80054606|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
27508239|NCT00716417|80054607|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
27508240|NCT00716417|80054608|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
27614618|NCT00209274|80430332|FG000|Overall Study|Withdrawal by Subject|30|||
27614619|NCT00209274|80430333|FG001|Overall Study|Withdrawal by Subject|15|||
27614620|NCT00209274|80430332|FG000|Overall Study|Randomized not treated (RNT)|6|||
27614621|NCT00209274|80430333|FG001|Overall Study|Randomized not treated (RNT)|15|||
27614622|NCT00988351|80430335|FG000|Overall Study|Withdrawal by Subject|8|||
27904139|NCT01483599|81485154|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27508241|NCT00716417|80054609|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
27508242|NCT00716417|80054610|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
27508243|NCT00716417|80054611|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
27508244|NCT00716417|80054602|FG000|Overall Study|On patient request due to toxicities|0|||
27614623|NCT00988351|80430336|FG001|Overall Study|Withdrawal by Subject|0|||
27508245|NCT00716417|80054603|FG001|Overall Study|On patient request due to toxicities|0|||
27508246|NCT00716417|80054604|FG002|Overall Study|On patient request due to toxicities|0|||
27904140|NCT01483599|81485155|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904141|NCT01483599|81485156|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
27904142|NCT01483599|81485157|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27904143|NCT01483599|81485158|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
27508247|NCT00716417|80054605|FG003|Overall Study|On patient request due to toxicities|0|||
27508248|NCT00716417|80054606|FG004|Overall Study|On patient request due to toxicities|0|||
27904144|NCT01483599|81485145|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904145|NCT01483599|81485146|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904146|NCT01483599|81485147|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904147|NCT01483599|81485148|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904148|NCT01483599|81485149|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904149|NCT01483599|81485150|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904150|NCT01483599|81485151|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904151|NCT01483599|81485152|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904152|NCT01483599|81485153|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
27904153|NCT01483599|81485154|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27508249|NCT00716417|80054607|FG005|Overall Study|On patient request due to toxicities|0|||
27508250|NCT00716417|80054608|FG006|Overall Study|On patient request due to toxicities|0|||
27508251|NCT00716417|80054609|FG007|Overall Study|On patient request due to toxicities|1|||
27508252|NCT00716417|80054610|FG008|Overall Study|On patient request due to toxicities|0|||
27508253|NCT00716417|80054611|FG009|Overall Study|On patient request due to toxicities|0|||
27508254|NCT02453321|80054616|FG000|Overall Study|Weakness|1|||
27508255|NCT02453321|80054617|FG001|Overall Study|Weakness|1|||
27508256|NCT02453321|80054618|FG002|Overall Study|Weakness|2|||
27508257|NCT02453321|80054616|FG000|Overall Study|Deep Venous Thrombosis|0|||
27508258|NCT02453321|80054617|FG001|Overall Study|Deep Venous Thrombosis|1|||
27508259|NCT02453321|80054618|FG002|Overall Study|Deep Venous Thrombosis|0|||
27508260|NCT00521404|80054619|FG000|Overall Study|Adverse Event|13|||
27508261|NCT00521404|80054619|FG000|Overall Study|Disease Progression|33|||
27508262|NCT00521404|80054619|FG000|Overall Study|Investigator decision|5|||
27508263|NCT00521404|80054619|FG000|Overall Study|Withdrawal of consent|3|||
27508264|NCT00521404|80054619|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
27508265|NCT00521404|80054619|FG000|Overall Study|Other|7|||
27508266|NCT01263197|80054620|FG000|First Intervention (Period 1)|Adverse Event|0|||
27508267|NCT01263197|80054621|FG001|First Intervention (Period 1)|Adverse Event|0|||
27508268|NCT01263197|80054622|FG002|First Intervention (Period 1)|Adverse Event|0|||
27508269|NCT01263197|80054623|FG003|First Intervention (Period 1)|Adverse Event|0|||
27508270|NCT01263197|80054624|FG004|First Intervention (Period 1)|Adverse Event|0|||
27508271|NCT01263197|80054625|FG005|First Intervention (Period 1)|Adverse Event|1|||
27508272|NCT01263197|80054620|FG000|Washout Period 1|Protocol Violation|0|||
27508273|NCT01263197|80054621|FG001|Washout Period 1|Protocol Violation|0|||
27508274|NCT01263197|80054622|FG002|Washout Period 1|Protocol Violation|0|||
27508275|NCT01263197|80054623|FG003|Washout Period 1|Protocol Violation|0|||
27508276|NCT01263197|80054624|FG004|Washout Period 1|Protocol Violation|1|||
27508277|NCT01263197|80054625|FG005|Washout Period 1|Protocol Violation|0|||
27508278|NCT01263197|80054620|FG000|Washout Period 2|Physician Decision|0|||
27614624|NCT00988351|80430335|FG000|Overall Study|Lost to Follow-up|6|||
27614625|NCT00988351|80430336|FG001|Overall Study|Lost to Follow-up|9|||
27614626|NCT00988351|80430335|FG000|Overall Study|not using CPAP|5|||
27614627|NCT00988351|80430336|FG001|Overall Study|not using CPAP|3|||
27852164|NCT01929031|81291056|FG004|Overall Study|Reason other than specified above|1|||
27508279|NCT01263197|80054621|FG001|Washout Period 2|Physician Decision|0|||
27508280|NCT01263197|80054622|FG002|Washout Period 2|Physician Decision|0|||
27508281|NCT01263197|80054623|FG003|Washout Period 2|Physician Decision|0|||
27614628|NCT01235975|80430337|FG000|Overall Study|Serious Adverse Event|0|||
27614629|NCT01235975|80430338|FG001|Overall Study|Serious Adverse Event|1|||
27852165|NCT01929031|81291057|FG005|Overall Study|Reason other than specified above|0|||
27852166|NCT01649271|81291060|FG000|Overall Study|Progressive disease|4|||
27852167|NCT01649271|81291061|FG001|Overall Study|Progressive disease|5|||
27852168|NCT01649271|81291060|FG000|Overall Study|Other Adverse Event|0|||
27852169|NCT01649271|81291061|FG001|Overall Study|Other Adverse Event|2|||
27508282|NCT01263197|80054624|FG004|Washout Period 2|Physician Decision|0|||
27508283|NCT01263197|80054625|FG005|Washout Period 2|Physician Decision|1|||
27508284|NCT01263197|80054620|FG000|Washout Period 2|Protocol Violation|0|||
27508285|NCT01263197|80054621|FG001|Washout Period 2|Protocol Violation|0|||
27508286|NCT01263197|80054622|FG002|Washout Period 2|Protocol Violation|0|||
27508287|NCT01263197|80054623|FG003|Washout Period 2|Protocol Violation|1|||
27508288|NCT01263197|80054624|FG004|Washout Period 2|Protocol Violation|0|||
27508289|NCT01263197|80054625|FG005|Washout Period 2|Protocol Violation|0|||
27508290|NCT01263197|80054620|FG000|Third Intervention (Period 3)|Adverse Event|0|||
27508291|NCT01263197|80054621|FG001|Third Intervention (Period 3)|Adverse Event|1|||
27508292|NCT01263197|80054622|FG002|Third Intervention (Period 3)|Adverse Event|0|||
27508293|NCT01263197|80054623|FG003|Third Intervention (Period 3)|Adverse Event|0|||
27508294|NCT01263197|80054624|FG004|Third Intervention (Period 3)|Adverse Event|0|||
27508295|NCT01263197|80054625|FG005|Third Intervention (Period 3)|Adverse Event|0|||
27508296|NCT01192191|80054626|FG000|Overall Study|Adverse Event|7|||
27508297|NCT01192191|80054627|FG001|Overall Study|Adverse Event|12|||
27508298|NCT01192191|80054626|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
27508299|NCT01192191|80054627|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
27508300|NCT01192191|80054626|FG000|Overall Study|Lost to Follow-up|0|||
27508301|NCT01192191|80054627|FG001|Overall Study|Lost to Follow-up|1|||
27508302|NCT01192191|80054626|FG000|Overall Study|Withdrawal by Subject|1|||
27508303|NCT01192191|80054627|FG001|Overall Study|Withdrawal by Subject|6|||
27508304|NCT02038933|80054630|FG000|Overall Study|Disease progression|104|||
27508305|NCT02038933|80054630|FG000|Overall Study|Study drug toxicity|6|||
27508306|NCT02038933|80054630|FG000|Overall Study|Adverse event unrelated to study drug|6|||
27508307|NCT02038933|80054630|FG000|Overall Study|Participant request to discontinue treatment|2|||
27508308|NCT02038933|80054630|FG000|Overall Study|Lost to Follow-up|1|||
27508309|NCT02038933|80054630|FG000|Overall Study|Other reasons|2|||
27508310|NCT00891904|80054631|FG000|Overall Study|Death|1|||
27508311|NCT00891904|80054631|FG000|Overall Study|Adverse Event|1|||
27508312|NCT02367833|80054632|FG000|Overall Study|Withdrawal by Subject|1|||
27508313|NCT02367833|80054633|FG001|Overall Study|Withdrawal by Subject|1|||
27508314|NCT02367833|80054634|FG002|Overall Study|Withdrawal by Subject|0|||
27508315|NCT00560352|80054635|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27508316|NCT00560352|80054636|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27508317|NCT00560352|80054637|FG002|Overall Study|Adverse event unrelated to study drug|1|||
27508318|NCT00560352|80054635|FG000|Overall Study|Study drug toxicity|3|||
27508319|NCT00560352|80054636|FG001|Overall Study|Study drug toxicity|0|||
27508320|NCT00560352|80054637|FG002|Overall Study|Study drug toxicity|1|||
27508321|NCT00560352|80054635|FG000|Overall Study|Disease progression|0|||
27508322|NCT00560352|80054636|FG001|Overall Study|Disease progression|1|||
27508323|NCT00560352|80054637|FG002|Overall Study|Disease progression|1|||
27508324|NCT00560352|80054635|FG000|Overall Study|Withdrawal by Subject|1|||
27508325|NCT00560352|80054636|FG001|Overall Study|Withdrawal by Subject|1|||
27508326|NCT00560352|80054637|FG002|Overall Study|Withdrawal by Subject|1|||
27508327|NCT00560352|80054635|FG000|Overall Study|Maximum clinical benefit|1|||
27508328|NCT00560352|80054636|FG001|Overall Study|Maximum clinical benefit|0|||
27508329|NCT00560352|80054637|FG002|Overall Study|Maximum clinical benefit|0|||
27614630|NCT01235975|80430337|FG000|Overall Study|Withdrawal by Subject|8|||
27508330|NCT03860259|80054638|FG000|Overall Study|Lost to Follow-up|5|||
27508331|NCT03860259|80054639|FG001|Overall Study|Lost to Follow-up|5|||
27508332|NCT03860259|80054638|FG000|Overall Study|Protocol Violation|1|||
27508333|NCT03860259|80054639|FG001|Overall Study|Protocol Violation|0|||
27508334|NCT02055118|80054642|FG000|Overall Study|Withdrawal by Subject|0|||
27508335|NCT02055118|80054643|FG001|Overall Study|Withdrawal by Subject|2|||
27508336|NCT02055118|80054644|FG002|Overall Study|Withdrawal by Subject|0|||
27508337|NCT00888134|80054645|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
27508338|NCT00888134|80054645|FG000|Follow-up|being followed for long-term survival|1|||
27508339|NCT04226742|80054646|FG000|Overall Study|Lost to Follow-up|16|||
27508340|NCT04226742|80054647|FG001|Overall Study|Lost to Follow-up|13|||
27508341|NCT04226742|80054646|FG000|Overall Study|Withdrawal by Subject|5|||
27508342|NCT04226742|80054647|FG001|Overall Study|Withdrawal by Subject|3|||
27508343|NCT00439517|80054650|FG000|Overall Study|Subject on treatment|1|||
27508344|NCT00439517|80054651|FG001|Overall Study|Subject on treatment|0|||
27508345|NCT00439517|80054650|FG000|Overall Study|Subject in survival follow-up|1|||
27508346|NCT00439517|80054651|FG001|Overall Study|Subject in survival follow-up|0|||
27508347|NCT02161016|80054652|FG000|Overall Study|withdrawn by IRB|1|||
27508348|NCT04308291|80054657|FG000|Run-In Phase|Withdrawal by Subject|4|||
27508349|NCT04308291|80054657|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
27508350|NCT04308291|80054657|FG000|Study Phase 6-M|Physician Decision|2|||
27508351|NCT04308291|80054657|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
27508352|NCT04308291|80054657|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
27508353|NCT04308291|80054657|FG000|Study Phase 12-M|Physician Decision|2|||
27508354|NCT04308291|80054657|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
27508355|NCT03040336|80054658|FG000|Overall Study|Death|1|||
27508356|NCT03040336|80054659|FG001|Overall Study|Death|0|||
27508357|NCT03040336|80054658|FG000|Overall Study|Withdrawal by Subject|2|||
27508358|NCT03040336|80054659|FG001|Overall Study|Withdrawal by Subject|3|||
27508359|NCT03557034|80054662|FG000|Overall Study|Withdrawal by Subject|1|||
27508360|NCT03557034|80054663|FG001|Overall Study|Withdrawal by Subject|0|||
27904154|NCT01483599|81485155|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904155|NCT01483599|81485156|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
27904156|NCT01483599|81485157|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
27904157|NCT01483599|81485158|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
27904158|NCT01483599|81485145|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27508361|NCT02766023|80054667|FG000|Overall Study|Lost to Follow-up|23|||
27508362|NCT02766023|80054668|FG001|Overall Study|Lost to Follow-up|11|||
27508363|NCT02766023|80054667|FG000|Overall Study|Pregnancy|1|||
27508364|NCT02766023|80054668|FG001|Overall Study|Pregnancy|0|||
27508365|NCT02766023|80054667|FG000|Overall Study|Adverse Event|1|||
27508366|NCT02766023|80054668|FG001|Overall Study|Adverse Event|0|||
27508367|NCT02766023|80054667|FG000|Overall Study|Withdrawal by Subject|4|||
27508368|NCT02766023|80054668|FG001|Overall Study|Withdrawal by Subject|5|||
27508369|NCT02766023|80054667|FG000|Overall Study|Physician Decision|1|||
27508370|NCT02766023|80054668|FG001|Overall Study|Physician Decision|0|||
27508371|NCT02766023|80054667|FG000|Overall Study|Not Eligible at Enrollment|0|||
27614631|NCT01235975|80430338|FG001|Overall Study|Withdrawal by Subject|2|||
27614632|NCT01235975|80430337|FG000|Overall Study|Migrated/moved from study area|2|||
27904159|NCT01483599|81485146|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27508372|NCT02766023|80054668|FG001|Overall Study|Not Eligible at Enrollment|1|||
27508373|NCT02578706|80054669|FG000|Overall Study|Withdrawal by Subject|1|||
27508374|NCT02578706|80054670|FG001|Overall Study|Withdrawal by Subject|0|||
27508375|NCT02578706|80054671|FG002|Overall Study|Withdrawal by Subject|0|||
27508376|NCT02578706|80054669|FG000|Overall Study|Lost to Follow-up|0|||
27508377|NCT02578706|80054670|FG001|Overall Study|Lost to Follow-up|4|||
27508378|NCT02578706|80054671|FG002|Overall Study|Lost to Follow-up|0|||
27508379|NCT02578706|80054669|FG000|Overall Study|Physician Decision|0|||
27508380|NCT02578706|80054670|FG001|Overall Study|Physician Decision|1|||
27508381|NCT02578706|80054671|FG002|Overall Study|Physician Decision|0|||
27508382|NCT03312634|80054676|FG000|Overall Study|Adverse Event|11|||
27508383|NCT03312634|80054677|FG001|Overall Study|Adverse Event|0|||
27508384|NCT03312634|80054676|FG000|Overall Study|Sponsor request|2|||
27508385|NCT03312634|80054677|FG001|Overall Study|Sponsor request|0|||
27508386|NCT03312634|80054676|FG000|Overall Study|Withdrawal by Subject|31|||
27508387|NCT03312634|80054677|FG001|Overall Study|Withdrawal by Subject|9|||
27508388|NCT03312634|80054676|FG000|Overall Study|Enrolled in an interventional study|0|||
27508389|NCT03312634|80054677|FG001|Overall Study|Enrolled in an interventional study|52|||
27508390|NCT03312634|80054676|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
27508391|NCT03312634|80054677|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
27508392|NCT03312634|80054676|FG000|Overall Study|Death|0|||
27508393|NCT03312634|80054677|FG001|Overall Study|Death|1|||
27508394|NCT03312634|80054676|FG000|Overall Study|Non-compliance|0|||
27508395|NCT03312634|80054677|FG001|Overall Study|Non-compliance|2|||
27508396|NCT03312634|80054676|FG000|Overall Study|Lost to Follow-up|0|||
27508397|NCT03312634|80054677|FG001|Overall Study|Lost to Follow-up|1|||
27508398|NCT03312634|80054676|FG000|Overall Study|Enrolled into non-interventional study|0|||
27508399|NCT03312634|80054677|FG001|Overall Study|Enrolled into non-interventional study|5|||
27614633|NCT01235975|80430338|FG001|Overall Study|Migrated/moved from study area|1|||
27614634|NCT01235975|80430337|FG000|Overall Study|Lost to Follow-up|7|||
27614635|NCT01235975|80430338|FG001|Overall Study|Lost to Follow-up|3|||
27852170|NCT01649271|81291060|FG000|Overall Study|Withdrawal by Subject|1|||
27852171|NCT01649271|81291061|FG001|Overall Study|Withdrawal by Subject|0|||
27852172|NCT01649271|81291060|FG000|Overall Study|Other than stated above|1|||
27852173|NCT01649271|81291061|FG001|Overall Study|Other than stated above|0|||
27852174|NCT02823652|81291063|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
27852175|NCT02823652|81291064|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
27852176|NCT02823652|81291065|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
27852177|NCT02823652|81291063|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
27614636|NCT01129336|80430339|FG000|Overall Study|Protocol Violation|1|||
27852178|NCT02823652|81291064|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
27852179|NCT02823652|81291065|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
27614637|NCT01129336|80430340|FG001|Overall Study|Protocol Violation|0|||
27614638|NCT01129336|80430339|FG000|Overall Study|Disease Progression|1|||
27614639|NCT01129336|80430340|FG001|Overall Study|Disease Progression|4|||
27614640|NCT01129336|80430339|FG000|Overall Study|Lost to Follow-up|1|||
27614641|NCT01129336|80430340|FG001|Overall Study|Lost to Follow-up|0|||
27614642|NCT01129336|80430339|FG000|Overall Study|Withdrawal by Subject|7|||
27904160|NCT01483599|81485147|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27508400|NCT03312634|80054676|FG000|Overall Study|Worsening clinical condition|0|||
27508401|NCT03312634|80054677|FG001|Overall Study|Worsening clinical condition|1|||
27508402|NCT03312634|80054676|FG000|Overall Study|Participant did not want to travel|0|||
27508403|NCT03312634|80054677|FG001|Overall Study|Participant did not want to travel|1|||
27508404|NCT03312634|80054676|FG000|Overall Study|Physician Decision|1|||
27508405|NCT03312634|80054677|FG001|Overall Study|Physician Decision|0|||
27508406|NCT03312634|80054676|FG000|Overall Study|Other|13|||
27508407|NCT03312634|80054677|FG001|Overall Study|Other|0|||
27508408|NCT01642589|80054679|FG000|Overall Study|Withdrawal by Subject|1|||
27508409|NCT01642589|80054680|FG001|Overall Study|Withdrawal by Subject|1|||
27508410|NCT03131219|80054681|FG000|Initial Evaluation Period|Adverse Event|2|||
27508411|NCT03131219|80054682|FG001|Initial Evaluation Period|Adverse Event|0|||
27508412|NCT03131219|80054681|FG000|Initial Evaluation Period|Protocol Violation|1|||
27508413|NCT03131219|80054682|FG001|Initial Evaluation Period|Protocol Violation|0|||
27508414|NCT03131219|80054681|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
27508415|NCT03131219|80054682|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
27508416|NCT03131219|80054681|FG000|Initial Evaluation Period|Physician Decision|1|||
27508417|NCT03131219|80054682|FG001|Initial Evaluation Period|Physician Decision|0|||
27508418|NCT03131219|80054681|FG000|Extension Period|Physician Decision|1|||
27508419|NCT03131219|80054682|FG001|Extension Period|Physician Decision|0|||
27508420|NCT02565108|80054689|FG000|Overall Study|Adverse Event|1|||
27508421|NCT02565108|80054690|FG001|Overall Study|Adverse Event|0|||
27508422|NCT02565108|80054689|FG000|Overall Study|Withdrew Consent|1|||
27508423|NCT02565108|80054690|FG001|Overall Study|Withdrew Consent|0|||
27508424|NCT01526733|80054691|FG000|Phase 1|Protocol Violation|1|||
27508425|NCT01526733|80054692|FG001|Phase 1|Protocol Violation|0|||
27508426|NCT01526733|80054691|FG000|Phase 1|Withdrawal by Subject|1|||
27508427|NCT01526733|80054692|FG001|Phase 1|Withdrawal by Subject|1|||
27508428|NCT01092546|80054696|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
27508429|NCT05660577|80054697|FG000|Overall Study|Discontinued|9|||
27508430|NCT05024032|80054698|FG000|Overall Study|Withdrawal by Subject|0|||
27508431|NCT05024032|80054699|FG001|Overall Study|Withdrawal by Subject|3|||
27508432|NCT05024032|80054700|FG002|Overall Study|Withdrawal by Subject|4|||
27508433|NCT05024032|80054698|FG000|Overall Study|Adverse Event|0|||
27508434|NCT05024032|80054699|FG001|Overall Study|Adverse Event|1|||
27508435|NCT05024032|80054700|FG002|Overall Study|Adverse Event|0|||
27508436|NCT05024032|80054698|FG000|Overall Study|Protocol Deviation|1|||
27508437|NCT05024032|80054699|FG001|Overall Study|Protocol Deviation|0|||
27508438|NCT05024032|80054700|FG002|Overall Study|Protocol Deviation|0|||
27508439|NCT01054885|80054701|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
27508440|NCT01054885|80054702|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27508441|NCT01054885|80054703|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27508442|NCT01054885|80054704|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27508443|NCT01054885|80054705|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27508444|NCT01054885|80054706|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27508445|NCT01054885|80054707|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
27508446|NCT01054885|80054701|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
27508447|NCT01054885|80054702|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
27508448|NCT01054885|80054703|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
27508449|NCT01054885|80054704|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
27508450|NCT01054885|80054705|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
27508451|NCT01054885|80054706|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
27508452|NCT01054885|80054707|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
27508453|NCT01054885|80054701|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
27508454|NCT01054885|80054702|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27508455|NCT01054885|80054703|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27508456|NCT01054885|80054704|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27614643|NCT01129336|80430340|FG001|Overall Study|Withdrawal by Subject|4|||
27508457|NCT01054885|80054705|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27508458|NCT01054885|80054706|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27508459|NCT01054885|80054707|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
27508460|NCT01054885|80054701|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
27508461|NCT01054885|80054702|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27508462|NCT01054885|80054703|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27614644|NCT01129336|80430339|FG000|Overall Study|Adverse Event|0|||
27508463|NCT01054885|80054704|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27508464|NCT01054885|80054705|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27508465|NCT01054885|80054706|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27508466|NCT01054885|80054707|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
27508467|NCT01054885|80054701|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
27508468|NCT01054885|80054702|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
27508469|NCT01054885|80054703|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
27614645|NCT01129336|80430340|FG001|Overall Study|Adverse Event|1|||
27508470|NCT01054885|80054704|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
27508471|NCT01054885|80054705|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
27508472|NCT01054885|80054706|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
27508473|NCT01054885|80054707|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
27508474|NCT01054885|80054701|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
27508475|NCT01054885|80054702|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27508476|NCT01054885|80054703|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27508477|NCT01054885|80054704|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27508478|NCT01054885|80054705|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27508479|NCT01054885|80054706|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27508480|NCT01054885|80054707|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
27508481|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
27508482|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
27508483|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
27508484|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
27508485|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
27508486|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
27508487|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
27508488|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27508489|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27508490|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
27508491|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
27508492|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27508493|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
27508494|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
27508495|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
27508496|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
27508497|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
27508498|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
27508499|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
27508500|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
27508501|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
27508502|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
27508503|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
27508504|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
27508505|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
27508506|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
27508507|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
27508508|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
27508509|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
27508510|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
27904161|NCT01483599|81485148|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904162|NCT01483599|81485149|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904163|NCT01483599|81485150|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904164|NCT01483599|81485151|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904165|NCT01483599|81485152|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904166|NCT01483599|81485153|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
27904167|NCT01483599|81485154|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904168|NCT01483599|81485155|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
27904169|NCT01483599|81485156|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904170|NCT01483599|81485157|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
27904171|NCT01483599|81485158|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
27904172|NCT01483599|81485145|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904173|NCT01483599|81485146|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904174|NCT01483599|81485147|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904175|NCT01483599|81485148|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904176|NCT01483599|81485149|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904177|NCT01483599|81485150|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27614646|NCT01129336|80430339|FG000|Overall Study|Missing Study Completion Status|2|||
27614647|NCT01129336|80430340|FG001|Overall Study|Missing Study Completion Status|3|||
27614648|NCT01129336|80430339|FG000|Overall Study|Death|0|||
27728501|NCT02970929|80833301|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
27904178|NCT01483599|81485151|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904179|NCT01483599|81485152|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904180|NCT01483599|81485153|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
27904181|NCT01483599|81485154|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904182|NCT01483599|81485155|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27904183|NCT01483599|81485156|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
27508511|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
27508512|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
27508513|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
27508514|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
27508515|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
27508516|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27508517|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27508518|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
27508519|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27508520|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27904184|NCT01483599|81485157|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
27904185|NCT01483599|81485158|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
27904186|NCT01483599|81485145|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
27904187|NCT01483599|81485146|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
27904188|NCT01483599|81485147|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
27508521|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
27508522|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
27904189|NCT01483599|81485148|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
27904190|NCT01483599|81485149|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
27904191|NCT01483599|81485150|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
27904192|NCT01483599|81485151|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
27904193|NCT01483599|81485152|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
27904194|NCT01483599|81485153|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
27904195|NCT01483599|81485154|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
27904196|NCT01483599|81485155|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
27904197|NCT01483599|81485156|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
27904198|NCT01483599|81485157|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
27904199|NCT01483599|81485158|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
27904200|NCT02469168|81485159|FG000|Overall Study|Trial closed|1|||
27904201|NCT02469168|81485160|FG001|Overall Study|Trial closed|0|||
27904202|NCT03230838|81485162|FG000|Overall Study|Withdrawal by Subject|3|||
27904203|NCT03230838|81485163|FG001|Overall Study|Withdrawal by Subject|0|||
27904204|NCT03230838|81485162|FG000|Overall Study|Temperature excursion|1|||
27904205|NCT03230838|81485163|FG001|Overall Study|Temperature excursion|0|||
27904206|NCT01554163|81485164|FG000|Overall Study|Adverse Event|3|||
27904207|NCT01554163|81485165|FG001|Overall Study|Adverse Event|0|||
27904208|NCT01554163|81485164|FG000|Overall Study|Lack of Efficacy|1|||
27508523|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27508524|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
27508525|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27508526|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27508527|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27508528|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
27508529|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
27508530|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
27508531|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
27508532|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
27508533|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
27508534|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
27508535|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
27508536|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
27508537|NCT01054885|80054701|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27508538|NCT01054885|80054702|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
27508539|NCT01054885|80054703|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27508540|NCT01054885|80054704|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
27508541|NCT01054885|80054705|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
27508542|NCT01054885|80054706|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
27614649|NCT01129336|80430340|FG001|Overall Study|Death|4|||
27904209|NCT01554163|81485165|FG001|Overall Study|Lack of Efficacy|0|||
27904210|NCT01554163|81485164|FG000|Overall Study|Lost to Follow-up|1|||
27904211|NCT01554163|81485165|FG001|Overall Study|Lost to Follow-up|0|||
27904212|NCT01554163|81485164|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27508543|NCT01054885|80054707|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
27508544|NCT00473564|80054710|FG000|Overall Study|robot surgery aborted in OR|23|||
27508545|NCT00432172|80054717|FG000|Overall Study|Physician Decision|0|||
27508546|NCT00432172|80054718|FG001|Overall Study|Physician Decision|0|||
27508547|NCT00432172|80054719|FG002|Overall Study|Physician Decision|2|||
27508548|NCT00432172|80054720|FG003|Overall Study|Physician Decision|0|||
27508549|NCT00432172|80054717|FG000|Overall Study|Adverse Event|4|||
27508550|NCT00432172|80054718|FG001|Overall Study|Adverse Event|2|||
27904213|NCT01554163|81485165|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27904214|NCT01554163|81485164|FG000|Overall Study|Protocol Violation|0|||
27904215|NCT01554163|81485165|FG001|Overall Study|Protocol Violation|4|||
27904216|NCT01554163|81485164|FG000|Overall Study|Withdrawal by Subject|1|||
27904217|NCT01554163|81485165|FG001|Overall Study|Withdrawal by Subject|5|||
27904218|NCT01554163|81485164|FG000|Overall Study|Not Treated|1|||
27904219|NCT01554163|81485165|FG001|Overall Study|Not Treated|0|||
27904220|NCT01243177|81485168|FG000|Overall Study|Lack of Efficacy|47|||
27904221|NCT01243177|81485169|FG001|Overall Study|Lack of Efficacy|31|||
27904222|NCT01243177|81485168|FG000|Overall Study|Protocol Violation|11|||
27904223|NCT01243177|81485169|FG001|Overall Study|Protocol Violation|10|||
27904224|NCT01243177|81485168|FG000|Overall Study|Lost to Follow-up|15|||
27904225|NCT01243177|81485169|FG001|Overall Study|Lost to Follow-up|18|||
27904226|NCT01243177|81485168|FG000|Overall Study|Withdrawal by Subject|46|||
27904227|NCT01243177|81485169|FG001|Overall Study|Withdrawal by Subject|38|||
27904228|NCT01243177|81485168|FG000|Overall Study|AE, serious fatal|0|||
27904229|NCT01243177|81485169|FG001|Overall Study|AE, serious fatal|1|||
27904230|NCT01243177|81485168|FG000|Overall Study|SAE, non-fatal|7|||
27904231|NCT01243177|81485169|FG001|Overall Study|SAE, non-fatal|9|||
27904232|NCT01243177|81485168|FG000|Overall Study|AE, non-serious non-fatal|40|||
27904233|NCT01243177|81485169|FG001|Overall Study|AE, non-serious non-fatal|58|||
27904234|NCT01243177|81485168|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
27904235|NCT01243177|81485169|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
27904236|NCT01243177|81485168|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27904237|NCT01243177|81485169|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
27904238|NCT01243177|81485168|FG000|Overall Study|Other Reason|11|||
27904239|NCT01243177|81485169|FG001|Overall Study|Other Reason|12|||
27904240|NCT01375374|81485174|FG000|Overall Study|Adverse Event|1|||
27904241|NCT00055497|81485175|FG000|Overall Study|Adverse Event|1|||
27904242|NCT00055497|81485176|FG001|Overall Study|Adverse Event|1|||
27904243|NCT00055497|81485177|FG002|Overall Study|Adverse Event|1|||
27904244|NCT00055497|81485178|FG003|Overall Study|Adverse Event|28|||
27904245|NCT00055497|81485175|FG000|Overall Study|Withdrawal by Subject|3|||
27904246|NCT00055497|81485176|FG001|Overall Study|Withdrawal by Subject|1|||
27904247|NCT00055497|81485177|FG002|Overall Study|Withdrawal by Subject|1|||
27904248|NCT00055497|81485178|FG003|Overall Study|Withdrawal by Subject|15|||
27904249|NCT00055497|81485175|FG000|Overall Study|Lost to Follow-up|0|||
27904250|NCT00055497|81485176|FG001|Overall Study|Lost to Follow-up|1|||
27904251|NCT00055497|81485177|FG002|Overall Study|Lost to Follow-up|0|||
27904252|NCT00055497|81485178|FG003|Overall Study|Lost to Follow-up|5|||
27904253|NCT00055497|81485175|FG000|Overall Study|Protocol Violation|0|||
27904254|NCT00055497|81485176|FG001|Overall Study|Protocol Violation|0|||
27904255|NCT00055497|81485177|FG002|Overall Study|Protocol Violation|0|||
27904256|NCT00055497|81485178|FG003|Overall Study|Protocol Violation|3|||
27904257|NCT00055497|81485175|FG000|Overall Study|Lack of Efficacy|1|||
27904258|NCT00055497|81485176|FG001|Overall Study|Lack of Efficacy|0|||
27904259|NCT00055497|81485177|FG002|Overall Study|Lack of Efficacy|0|||
27904260|NCT00055497|81485178|FG003|Overall Study|Lack of Efficacy|27|||
27904261|NCT00055497|81485175|FG000|Overall Study|Administrative Reasons|0|||
27904262|NCT00055497|81485176|FG001|Overall Study|Administrative Reasons|0|||
27904263|NCT00055497|81485177|FG002|Overall Study|Administrative Reasons|0|||
27904264|NCT00055497|81485178|FG003|Overall Study|Administrative Reasons|1|||
27904265|NCT00055497|81485175|FG000|Overall Study|Other|0|||
27904266|NCT00055497|81485176|FG001|Overall Study|Other|0|||
27904267|NCT00055497|81485177|FG002|Overall Study|Other|0|||
27904268|NCT00055497|81485178|FG003|Overall Study|Other|11|||
27904269|NCT02380859|81485180|FG000|Overall Study|Withdrawal by Subject|2|||
27904270|NCT02380859|81485181|FG001|Overall Study|Withdrawal by Subject|0|||
27904271|NCT00073008|81485184|FG000|Overall Study|Missing|6|||
27904272|NCT00073008|81485185|FG001|Overall Study|Missing|6|||
27904273|NCT00073008|81485184|FG000|Overall Study|Withdrawal by Subject|2|||
27904274|NCT00073008|81485185|FG001|Overall Study|Withdrawal by Subject|2|||
27904275|NCT00073008|81485184|FG000|Overall Study|Lost to Follow-up|1|||
27904276|NCT00073008|81485185|FG001|Overall Study|Lost to Follow-up|3|||
27904277|NCT00073008|81485184|FG000|Overall Study|Death|46|||
27904278|NCT00073008|81485185|FG001|Overall Study|Death|47|||
27904279|NCT00073008|81485184|FG000|Overall Study|"Other selected on Case Report Form"|7|||
27904280|NCT00073008|81485185|FG001|Overall Study|"Other selected on Case Report Form"|5|||
27904281|NCT00419159|81485189|FG000|Overall Study|Adverse Event|7|||
27904282|NCT00419159|81485190|FG001|Overall Study|Adverse Event|15|||
27508551|NCT00432172|80054719|FG002|Overall Study|Adverse Event|4|||
27508552|NCT00432172|80054720|FG003|Overall Study|Adverse Event|3|||
27508553|NCT00432172|80054717|FG000|Overall Study|Disease progression|0|||
27508554|NCT00432172|80054718|FG001|Overall Study|Disease progression|2|||
27508555|NCT00432172|80054719|FG002|Overall Study|Disease progression|5|||
27508556|NCT00432172|80054720|FG003|Overall Study|Disease progression|1|||
27614650|NCT03428815|80430341|FG000|Overall Study|Lost to Follow-up|2|||
27614651|NCT03428815|80430342|FG001|Overall Study|Lost to Follow-up|2|||
27614652|NCT03428815|80430341|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
27852180|NCT02823652|81291063|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
27852181|NCT02823652|81291064|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
27852182|NCT02823652|81291065|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
27852183|NCT02823652|81291063|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
27852184|NCT02823652|81291064|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
27852185|NCT02823652|81291065|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
27852186|NCT03970837|81291068|FG000|Overall Study|Adverse Event|23|||
27852187|NCT03970837|81291069|FG001|Overall Study|Adverse Event|20|||
27852188|NCT03970837|81291070|FG002|Overall Study|Adverse Event|16|||
27852189|NCT03970837|81291071|FG003|Overall Study|Adverse Event|6|||
27852190|NCT03970837|81291072|FG004|Overall Study|Adverse Event|4|||
27852191|NCT03970837|81291073|FG005|Overall Study|Adverse Event|5|||
27852192|NCT03970837|81291074|FG006|Overall Study|Adverse Event|1|||
27852193|NCT03970837|81291075|FG007|Overall Study|Adverse Event|5|||
27852194|NCT03970837|81291076|FG008|Overall Study|Adverse Event|0|||
27852195|NCT03970837|81291077|FG009|Overall Study|Adverse Event|0|||
27852196|NCT03970837|81291078|FG010|Overall Study|Adverse Event|1|||
27852197|NCT03970837|81291079|FG011|Overall Study|Adverse Event|1|||
27852198|NCT03970837|81291068|FG000|Overall Study|Lack of Efficacy|14|||
27852199|NCT03970837|81291069|FG001|Overall Study|Lack of Efficacy|12|||
27852200|NCT03970837|81291070|FG002|Overall Study|Lack of Efficacy|1|||
27852201|NCT03970837|81291071|FG003|Overall Study|Lack of Efficacy|2|||
27852202|NCT03970837|81291072|FG004|Overall Study|Lack of Efficacy|3|||
27852203|NCT03970837|81291073|FG005|Overall Study|Lack of Efficacy|4|||
27852204|NCT03970837|81291074|FG006|Overall Study|Lack of Efficacy|6|||
27852205|NCT03970837|81291075|FG007|Overall Study|Lack of Efficacy|1|||
27614653|NCT03428815|80430342|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
27852206|NCT03970837|81291076|FG008|Overall Study|Lack of Efficacy|1|||
27508557|NCT00432172|80054717|FG000|Overall Study|Withdrawal by Subject|0|||
27852207|NCT03970837|81291077|FG009|Overall Study|Lack of Efficacy|0|||
27852208|NCT03970837|81291078|FG010|Overall Study|Lack of Efficacy|0|||
27852209|NCT03970837|81291079|FG011|Overall Study|Lack of Efficacy|0|||
27852210|NCT03970837|81291068|FG000|Overall Study|Lost to Follow-up|6|||
27852211|NCT03970837|81291069|FG001|Overall Study|Lost to Follow-up|5|||
27508558|NCT00432172|80054718|FG001|Overall Study|Withdrawal by Subject|1|||
27852212|NCT03970837|81291070|FG002|Overall Study|Lost to Follow-up|5|||
27852213|NCT03970837|81291071|FG003|Overall Study|Lost to Follow-up|1|||
27508559|NCT00432172|80054719|FG002|Overall Study|Withdrawal by Subject|0|||
27508560|NCT00432172|80054720|FG003|Overall Study|Withdrawal by Subject|2|||
27508561|NCT00432172|80054717|FG000|Overall Study|No treatment received|2|||
27508562|NCT00432172|80054718|FG001|Overall Study|No treatment received|2|||
27508563|NCT00432172|80054719|FG002|Overall Study|No treatment received|0|||
27508564|NCT00432172|80054720|FG003|Overall Study|No treatment received|1|||
27508565|NCT00275509|80054721|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
27508566|NCT00275509|80054722|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
27508567|NCT01208207|80054723|FG000|Part I|Adverse Event|19|||
27508568|NCT01208207|80054724|FG001|Part I|Adverse Event|2|||
27508569|NCT01208207|80054725|FG002|Part I|Adverse Event|6|||
27508570|NCT01208207|80054726|FG003|Part I|Adverse Event|0|||
27508571|NCT01208207|80054727|FG004|Part I|Adverse Event|0|||
27508572|NCT01208207|80054728|FG005|Part I|Adverse Event|0|||
27508573|NCT01208207|80054729|FG006|Part I|Adverse Event|0|||
27508574|NCT01208207|80054723|FG000|Part I|Lack of Efficacy|21|||
27508575|NCT01208207|80054724|FG001|Part I|Lack of Efficacy|3|||
27508576|NCT01208207|80054725|FG002|Part I|Lack of Efficacy|2|||
27508577|NCT01208207|80054726|FG003|Part I|Lack of Efficacy|0|||
27508578|NCT01208207|80054727|FG004|Part I|Lack of Efficacy|0|||
27508579|NCT01208207|80054728|FG005|Part I|Lack of Efficacy|0|||
27508580|NCT01208207|80054729|FG006|Part I|Lack of Efficacy|0|||
27508581|NCT01208207|80054723|FG000|Part I|Lost to Follow-up|6|||
27508582|NCT01208207|80054724|FG001|Part I|Lost to Follow-up|1|||
27508583|NCT01208207|80054725|FG002|Part I|Lost to Follow-up|0|||
27508584|NCT01208207|80054726|FG003|Part I|Lost to Follow-up|0|||
27508585|NCT01208207|80054727|FG004|Part I|Lost to Follow-up|0|||
27508586|NCT01208207|80054728|FG005|Part I|Lost to Follow-up|0|||
27508587|NCT01208207|80054729|FG006|Part I|Lost to Follow-up|0|||
27508588|NCT01208207|80054723|FG000|Part I|Non-Compliance With Study Drug|1|||
27508589|NCT01208207|80054724|FG001|Part I|Non-Compliance With Study Drug|0|||
27508590|NCT01208207|80054725|FG002|Part I|Non-Compliance With Study Drug|1|||
27508591|NCT01208207|80054726|FG003|Part I|Non-Compliance With Study Drug|0|||
27508592|NCT01208207|80054727|FG004|Part I|Non-Compliance With Study Drug|0|||
27508593|NCT01208207|80054728|FG005|Part I|Non-Compliance With Study Drug|0|||
27508594|NCT01208207|80054729|FG006|Part I|Non-Compliance With Study Drug|0|||
27508595|NCT01208207|80054723|FG000|Part I|Physician Decision|0|||
27508596|NCT01208207|80054724|FG001|Part I|Physician Decision|1|||
27508597|NCT01208207|80054725|FG002|Part I|Physician Decision|0|||
27508598|NCT01208207|80054726|FG003|Part I|Physician Decision|0|||
27904283|NCT00419159|81485189|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27904284|NCT00419159|81485190|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27904285|NCT00419159|81485189|FG000|Overall Study|Subject's no longer requires study drug|0|||
27904286|NCT00419159|81485190|FG001|Overall Study|Subject's no longer requires study drug|1|||
27904287|NCT00419159|81485189|FG000|Overall Study|Protocol Violation|1|||
27904288|NCT00419159|81485190|FG001|Overall Study|Protocol Violation|0|||
27904289|NCT00419159|81485189|FG000|Overall Study|Withdrawal by Subject|10|||
27904290|NCT00419159|81485190|FG001|Overall Study|Withdrawal by Subject|3|||
27904291|NCT00419159|81485189|FG000|Overall Study|Lost to Follow-up|0|||
27904292|NCT00419159|81485190|FG001|Overall Study|Lost to Follow-up|1|||
27508599|NCT01208207|80054727|FG004|Part I|Physician Decision|0|||
27508600|NCT01208207|80054728|FG005|Part I|Physician Decision|0|||
27508601|NCT01208207|80054729|FG006|Part I|Physician Decision|0|||
27904293|NCT00419159|81485189|FG000|Overall Study|Death|2|||
27508602|NCT01208207|80054723|FG000|Part I|Progressive Disease|1|||
27508603|NCT01208207|80054724|FG001|Part I|Progressive Disease|0|||
27508604|NCT01208207|80054725|FG002|Part I|Progressive Disease|0|||
27508605|NCT01208207|80054726|FG003|Part I|Progressive Disease|0|||
27508606|NCT01208207|80054727|FG004|Part I|Progressive Disease|0|||
27508607|NCT01208207|80054728|FG005|Part I|Progressive Disease|0|||
27508608|NCT01208207|80054729|FG006|Part I|Progressive Disease|0|||
27508609|NCT01208207|80054723|FG000|Part I|Protocol Violation|8|||
27508610|NCT01208207|80054724|FG001|Part I|Protocol Violation|0|||
27508611|NCT01208207|80054725|FG002|Part I|Protocol Violation|2|||
27508612|NCT01208207|80054726|FG003|Part I|Protocol Violation|0|||
27508613|NCT01208207|80054727|FG004|Part I|Protocol Violation|0|||
27508614|NCT01208207|80054728|FG005|Part I|Protocol Violation|0|||
27508615|NCT01208207|80054729|FG006|Part I|Protocol Violation|0|||
27508616|NCT01208207|80054723|FG000|Part I|Withdrawal by Subject|14|||
27508617|NCT01208207|80054724|FG001|Part I|Withdrawal by Subject|4|||
27508618|NCT01208207|80054725|FG002|Part I|Withdrawal by Subject|4|||
27508619|NCT01208207|80054726|FG003|Part I|Withdrawal by Subject|0|||
27508620|NCT01208207|80054727|FG004|Part I|Withdrawal by Subject|0|||
27508621|NCT01208207|80054728|FG005|Part I|Withdrawal by Subject|0|||
27508622|NCT01208207|80054729|FG006|Part I|Withdrawal by Subject|0|||
27508623|NCT01208207|80054723|FG000|Part II|Withdrawal by Subject|0|||
27508624|NCT01208207|80054724|FG001|Part II|Withdrawal by Subject|0|||
27508625|NCT01208207|80054725|FG002|Part II|Withdrawal by Subject|0|||
27508626|NCT01208207|80054726|FG003|Part II|Withdrawal by Subject|10|||
27508627|NCT01208207|80054727|FG004|Part II|Withdrawal by Subject|9|||
27508628|NCT01208207|80054728|FG005|Part II|Withdrawal by Subject|3|||
27508629|NCT01208207|80054729|FG006|Part II|Withdrawal by Subject|5|||
27508630|NCT01208207|80054723|FG000|Part II|Adverse Event|0|||
27508631|NCT01208207|80054724|FG001|Part II|Adverse Event|0|||
27508632|NCT01208207|80054725|FG002|Part II|Adverse Event|0|||
27508633|NCT01208207|80054726|FG003|Part II|Adverse Event|5|||
27508634|NCT01208207|80054727|FG004|Part II|Adverse Event|9|||
27508635|NCT01208207|80054728|FG005|Part II|Adverse Event|4|||
27508636|NCT01208207|80054729|FG006|Part II|Adverse Event|2|||
27614654|NCT03428815|80430341|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
27614655|NCT03428815|80430342|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
27614656|NCT01310868|80430345|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
27614657|NCT02291289|80430346|FG000|Induction Treatment|Withdrawal by Subject|0|||
27614658|NCT02291289|80430347|FG001|Induction Treatment|Withdrawal by Subject|0|||
27614659|NCT02291289|80430348|FG002|Induction Treatment|Withdrawal by Subject|0|||
27614660|NCT02291289|80430349|FG003|Induction Treatment|Withdrawal by Subject|24|||
27614661|NCT02291289|80430350|FG004|Induction Treatment|Withdrawal by Subject|0|||
27614662|NCT02291289|80430351|FG005|Induction Treatment|Withdrawal by Subject|0|||
27614663|NCT02291289|80430352|FG006|Induction Treatment|Withdrawal by Subject|0|||
27614664|NCT02291289|80430353|FG007|Induction Treatment|Withdrawal by Subject|0|||
27614665|NCT02291289|80430354|FG008|Induction Treatment|Withdrawal by Subject|0|||
27614666|NCT02291289|80430355|FG009|Induction Treatment|Withdrawal by Subject|18|||
27614667|NCT02291289|80430356|FG010|Induction Treatment|Withdrawal by Subject|0|||
27614668|NCT02291289|80430357|FG011|Induction Treatment|Withdrawal by Subject|0|||
27614669|NCT02291289|80430358|FG012|Induction Treatment|Withdrawal by Subject|0|||
27614670|NCT02291289|80430346|FG000|Induction Treatment|Adverse Event|0|||
27614671|NCT02291289|80430347|FG001|Induction Treatment|Adverse Event|0|||
27614672|NCT02291289|80430348|FG002|Induction Treatment|Adverse Event|0|||
27614673|NCT02291289|80430349|FG003|Induction Treatment|Adverse Event|3|||
27614674|NCT02291289|80430350|FG004|Induction Treatment|Adverse Event|0|||
27614675|NCT02291289|80430351|FG005|Induction Treatment|Adverse Event|0|||
27614676|NCT02291289|80430352|FG006|Induction Treatment|Adverse Event|0|||
27614677|NCT02291289|80430353|FG007|Induction Treatment|Adverse Event|0|||
27614678|NCT02291289|80430354|FG008|Induction Treatment|Adverse Event|0|||
27614679|NCT02291289|80430355|FG009|Induction Treatment|Adverse Event|1|||
27614680|NCT02291289|80430356|FG010|Induction Treatment|Adverse Event|0|||
27614681|NCT02291289|80430357|FG011|Induction Treatment|Adverse Event|0|||
27614682|NCT02291289|80430358|FG012|Induction Treatment|Adverse Event|0|||
27614683|NCT02291289|80430346|FG000|Induction Treatment|Death|25|||
27614684|NCT02291289|80430347|FG001|Induction Treatment|Death|0|||
27614685|NCT02291289|80430348|FG002|Induction Treatment|Death|0|||
27614686|NCT02291289|80430349|FG003|Induction Treatment|Death|111|||
27614687|NCT02291289|80430350|FG004|Induction Treatment|Death|0|||
27614688|NCT02291289|80430351|FG005|Induction Treatment|Death|0|||
27614689|NCT02291289|80430352|FG006|Induction Treatment|Death|1|||
27614690|NCT02291289|80430353|FG007|Induction Treatment|Death|0|||
27614691|NCT02291289|80430354|FG008|Induction Treatment|Death|0|||
27614692|NCT02291289|80430355|FG009|Induction Treatment|Death|82|||
27614693|NCT02291289|80430356|FG010|Induction Treatment|Death|0|||
27614694|NCT02291289|80430357|FG011|Induction Treatment|Death|0|||
27614695|NCT02291289|80430358|FG012|Induction Treatment|Death|0|||
27614696|NCT02291289|80430346|FG000|Induction Treatment|Lost to Follow-up|1|||
27614697|NCT02291289|80430347|FG001|Induction Treatment|Lost to Follow-up|0|||
27508637|NCT01208207|80054723|FG000|Part II|Lack of Efficacy|0|||
27508638|NCT01208207|80054724|FG001|Part II|Lack of Efficacy|0|||
27508639|NCT01208207|80054725|FG002|Part II|Lack of Efficacy|0|||
27508640|NCT01208207|80054726|FG003|Part II|Lack of Efficacy|6|||
27508641|NCT01208207|80054727|FG004|Part II|Lack of Efficacy|4|||
27614698|NCT02291289|80430348|FG002|Induction Treatment|Lost to Follow-up|0|||
27614699|NCT02291289|80430349|FG003|Induction Treatment|Lost to Follow-up|12|||
27614700|NCT02291289|80430350|FG004|Induction Treatment|Lost to Follow-up|0|||
27508642|NCT01208207|80054728|FG005|Part II|Lack of Efficacy|3|||
27508643|NCT01208207|80054729|FG006|Part II|Lack of Efficacy|3|||
27508644|NCT01208207|80054723|FG000|Part II|Lost to Follow-up|0|||
27508645|NCT01208207|80054724|FG001|Part II|Lost to Follow-up|0|||
27508646|NCT01208207|80054725|FG002|Part II|Lost to Follow-up|0|||
27508647|NCT01208207|80054726|FG003|Part II|Lost to Follow-up|4|||
27508648|NCT01208207|80054727|FG004|Part II|Lost to Follow-up|0|||
27508649|NCT01208207|80054728|FG005|Part II|Lost to Follow-up|2|||
27508650|NCT01208207|80054729|FG006|Part II|Lost to Follow-up|1|||
27508651|NCT01208207|80054723|FG000|Part II|Non-Compliance With Study Drug|0|||
27508652|NCT01208207|80054724|FG001|Part II|Non-Compliance With Study Drug|0|||
27508653|NCT01208207|80054725|FG002|Part II|Non-Compliance With Study Drug|0|||
27508654|NCT01208207|80054726|FG003|Part II|Non-Compliance With Study Drug|4|||
27508655|NCT01208207|80054727|FG004|Part II|Non-Compliance With Study Drug|1|||
27508656|NCT01208207|80054728|FG005|Part II|Non-Compliance With Study Drug|1|||
27508657|NCT01208207|80054729|FG006|Part II|Non-Compliance With Study Drug|0|||
27508658|NCT01208207|80054723|FG000|Part II|Physician Decision|0|||
27508659|NCT01208207|80054724|FG001|Part II|Physician Decision|0|||
27508660|NCT01208207|80054725|FG002|Part II|Physician Decision|0|||
27508661|NCT01208207|80054726|FG003|Part II|Physician Decision|1|||
27508662|NCT01208207|80054727|FG004|Part II|Physician Decision|0|||
27508663|NCT01208207|80054728|FG005|Part II|Physician Decision|2|||
27508664|NCT01208207|80054729|FG006|Part II|Physician Decision|0|||
27508665|NCT01208207|80054723|FG000|Part II|Protocol Violation|0|||
27508666|NCT01208207|80054724|FG001|Part II|Protocol Violation|0|||
27508667|NCT01208207|80054725|FG002|Part II|Protocol Violation|0|||
27508668|NCT01208207|80054726|FG003|Part II|Protocol Violation|1|||
27508669|NCT01208207|80054727|FG004|Part II|Protocol Violation|0|||
27508670|NCT01208207|80054728|FG005|Part II|Protocol Violation|0|||
27508671|NCT01208207|80054729|FG006|Part II|Protocol Violation|0|||
27508672|NCT01208207|80054723|FG000|Part II|Technical Problems|0|||
27508673|NCT01208207|80054724|FG001|Part II|Technical Problems|0|||
27508674|NCT01208207|80054725|FG002|Part II|Technical Problems|0|||
27508675|NCT01208207|80054726|FG003|Part II|Technical Problems|1|||
27508676|NCT01208207|80054727|FG004|Part II|Technical Problems|0|||
27508677|NCT01208207|80054728|FG005|Part II|Technical Problems|1|||
27508678|NCT01208207|80054729|FG006|Part II|Technical Problems|0|||
27508679|NCT01112917|80054730|FG000|Overall Study|Death|2|||
27508680|NCT01112917|80054731|FG001|Overall Study|Death|11|||
27508681|NCT01112917|80054730|FG000|Overall Study|Lost to Follow-up|1|||
27508682|NCT01112917|80054731|FG001|Overall Study|Lost to Follow-up|1|||
27508683|NCT01112917|80054730|FG000|Overall Study|Withdrawal by Subject|1|||
27508684|NCT01112917|80054731|FG001|Overall Study|Withdrawal by Subject|3|||
27508685|NCT01112917|80054730|FG000|Overall Study|Unable to Convert Filter|3|||
27508686|NCT01112917|80054731|FG001|Overall Study|Unable to Convert Filter|0|||
27508687|NCT00871975|80054732|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
27508688|NCT00871975|80054732|FG000|Overall Study|Catheters could not be inserted|1|||
27508689|NCT00871975|80054732|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
27508690|NCT00871975|80054732|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
27508691|NCT01459497|80054733|FG000|Overall Study|Inability to meet trial constraints.|1|||
27508692|NCT01459497|80054734|FG001|Overall Study|Inability to meet trial constraints.|0|||
27508693|NCT01459497|80054733|FG000|Overall Study|Physician Decision|1|||
27508694|NCT01459497|80054734|FG001|Overall Study|Physician Decision|1|||
27508695|NCT01459497|80054733|FG000|Overall Study|Hospitalization.|0|||
27508696|NCT01459497|80054734|FG001|Overall Study|Hospitalization.|3|||
27508697|NCT01459497|80054733|FG000|Overall Study|Disease progression.|0|||
27508698|NCT01459497|80054734|FG001|Overall Study|Disease progression.|1|||
27508699|NCT01578486|80054736|FG000|Overall Study|Physician Decision|3|||
27508700|NCT01578486|80054736|FG000|Overall Study|Withdrawal by Subject|2|||
27508701|NCT03131570|80054737|FG000|Overall Study|Adverse Event|1|||
27508702|NCT03131570|80054738|FG001|Overall Study|Adverse Event|0|||
27508703|NCT02170077|80054739|FG000|Overall Study|Withdrawal by Subject|3|||
27508704|NCT02170077|80054740|FG001|Overall Study|Withdrawal by Subject|4|||
27508705|NCT02170077|80054741|FG002|Overall Study|Withdrawal by Subject|2|||
27508706|NCT02170077|80054739|FG000|Overall Study|Adverse Event|4|||
27508707|NCT02170077|80054740|FG001|Overall Study|Adverse Event|4|||
27508708|NCT02170077|80054741|FG002|Overall Study|Adverse Event|4|||
27508709|NCT02170077|80054739|FG000|Overall Study|Lost to Follow-up|0|||
27508710|NCT02170077|80054740|FG001|Overall Study|Lost to Follow-up|1|||
27508711|NCT02170077|80054741|FG002|Overall Study|Lost to Follow-up|0|||
27614701|NCT02291289|80430351|FG005|Induction Treatment|Lost to Follow-up|0|||
27508712|NCT02170077|80054739|FG000|Overall Study|Exclusion criteria|2|||
27508713|NCT02170077|80054740|FG001|Overall Study|Exclusion criteria|2|||
27508714|NCT02170077|80054741|FG002|Overall Study|Exclusion criteria|5|||
27508715|NCT02170077|80054739|FG000|Overall Study|Exacerbation of seizures|0|||
27508716|NCT02170077|80054740|FG001|Overall Study|Exacerbation of seizures|2|||
27508717|NCT02170077|80054741|FG002|Overall Study|Exacerbation of seizures|1|||
27508718|NCT02000440|80054744|FG000|Overall Study|Adverse Event|3|||
27852214|NCT03970837|81291072|FG004|Overall Study|Lost to Follow-up|0|||
27508719|NCT02000440|80054744|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
27508720|NCT00658359|80054761|FG000|Overall Study|Death|3|||
27508721|NCT00658359|80054762|FG001|Overall Study|Death|1|||
27508722|NCT00658359|80054763|FG002|Overall Study|Death|2|||
27508723|NCT00658359|80054761|FG000|Overall Study|Adverse Event|13|||
27508724|NCT00658359|80054762|FG001|Overall Study|Adverse Event|6|||
27508725|NCT00658359|80054763|FG002|Overall Study|Adverse Event|9|||
27508726|NCT00658359|80054761|FG000|Overall Study|Protocol Violation|1|||
27508727|NCT00658359|80054762|FG001|Overall Study|Protocol Violation|0|||
27508728|NCT00658359|80054763|FG002|Overall Study|Protocol Violation|0|||
27508729|NCT00658359|80054761|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
27508730|NCT00658359|80054762|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
27852215|NCT03970837|81291073|FG005|Overall Study|Lost to Follow-up|2|||
27852216|NCT03970837|81291074|FG006|Overall Study|Lost to Follow-up|0|||
27852217|NCT03970837|81291075|FG007|Overall Study|Lost to Follow-up|0|||
27508731|NCT00658359|80054763|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
27508732|NCT00658359|80054761|FG000|Overall Study|Withdrawal by Subject|7|||
27508733|NCT00658359|80054762|FG001|Overall Study|Withdrawal by Subject|4|||
27508734|NCT00658359|80054763|FG002|Overall Study|Withdrawal by Subject|2|||
27508735|NCT00658359|80054761|FG000|Overall Study|Lost to Follow-up|2|||
27508736|NCT00658359|80054762|FG001|Overall Study|Lost to Follow-up|2|||
27508737|NCT00658359|80054763|FG002|Overall Study|Lost to Follow-up|4|||
27508738|NCT00658359|80054761|FG000|Overall Study|Lack of Efficacy|0|||
27508739|NCT00658359|80054762|FG001|Overall Study|Lack of Efficacy|1|||
27508740|NCT00658359|80054763|FG002|Overall Study|Lack of Efficacy|0|||
27508741|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
27508742|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
27508743|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Adverse Event|31|||
27508744|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Adverse Event|21|||
27508745|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
27508746|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
27852218|NCT03970837|81291076|FG008|Overall Study|Lost to Follow-up|0|||
27852219|NCT03970837|81291077|FG009|Overall Study|Lost to Follow-up|0|||
27852220|NCT03970837|81291078|FG010|Overall Study|Lost to Follow-up|0|||
27852221|NCT03970837|81291079|FG011|Overall Study|Lost to Follow-up|0|||
27508747|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
27852222|NCT03970837|81291068|FG000|Overall Study|Protocol Violation|1|||
27852223|NCT03970837|81291069|FG001|Overall Study|Protocol Violation|0|||
27508748|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
27508749|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
27508750|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
27508751|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
27508752|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
27508753|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Administrative problems|3|||
27508754|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Administrative problems|3|||
27508755|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Death|5|||
27508756|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Death|8|||
27508757|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Disease progression|139|||
27508758|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Disease progression|119|||
27508759|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
27508760|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
27508761|NCT00785785|80054765|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
27508762|NCT00785785|80054766|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
27508763|NCT00785785|80054765|FG000|Optional Extension Phase|Adverse Event|4|||
27508764|NCT00785785|80054766|FG001|Optional Extension Phase|Adverse Event|5|||
27508765|NCT00785785|80054765|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
27508766|NCT00785785|80054766|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
27508767|NCT00785785|80054765|FG000|Optional Extension Phase|Lost to Follow-up|1|||
27508768|NCT00785785|80054766|FG001|Optional Extension Phase|Lost to Follow-up|0|||
27508769|NCT00785785|80054765|FG000|Optional Extension Phase|Administrative problems|2|||
27508770|NCT00785785|80054766|FG001|Optional Extension Phase|Administrative problems|0|||
27508771|NCT00785785|80054765|FG000|Optional Extension Phase|Death|1|||
27508772|NCT00785785|80054766|FG001|Optional Extension Phase|Death|5|||
27508773|NCT00785785|80054765|FG000|Optional Extension Phase|Disease progression|22|||
27508774|NCT00785785|80054766|FG001|Optional Extension Phase|Disease progression|70|||
27508775|NCT00785785|80054765|FG000|Optional Extension Phase|Protocol deviation|0|||
27508776|NCT00785785|80054766|FG001|Optional Extension Phase|Protocol deviation|2|||
27508777|NCT00785785|80054765|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
27508778|NCT00785785|80054766|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
27508779|NCT01143246|80054767|FG000|Overall Study|Adverse Event|24|||
27508780|NCT01143246|80054768|FG001|Overall Study|Adverse Event|28|||
27508781|NCT01143246|80054767|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
27508782|NCT01143246|80054768|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
27614702|NCT02291289|80430352|FG006|Induction Treatment|Lost to Follow-up|0|||
27614703|NCT02291289|80430353|FG007|Induction Treatment|Lost to Follow-up|0|||
27614704|NCT02291289|80430354|FG008|Induction Treatment|Lost to Follow-up|0|||
27614705|NCT02291289|80430355|FG009|Induction Treatment|Lost to Follow-up|9|||
27614706|NCT02291289|80430356|FG010|Induction Treatment|Lost to Follow-up|0|||
27614707|NCT02291289|80430357|FG011|Induction Treatment|Lost to Follow-up|0|||
27904294|NCT00419159|81485190|FG001|Overall Study|Death|2|||
27904295|NCT00419159|81485189|FG000|Overall Study|Disease progression|79|||
27904296|NCT00419159|81485190|FG001|Overall Study|Disease progression|76|||
27904297|NCT01709864|81485196|FG000|Overall Study|Physician Decision|0|||
27904298|NCT01709864|81485197|FG001|Overall Study|Physician Decision|1|||
27614708|NCT02291289|80430358|FG012|Induction Treatment|Lost to Follow-up|0|||
27614709|NCT02291289|80430346|FG000|Induction Treatment|Non-Compliance|0|||
27614710|NCT02291289|80430347|FG001|Induction Treatment|Non-Compliance|0|||
27614711|NCT02291289|80430348|FG002|Induction Treatment|Non-Compliance|0|||
27614712|NCT02291289|80430349|FG003|Induction Treatment|Non-Compliance|1|||
27614713|NCT02291289|80430350|FG004|Induction Treatment|Non-Compliance|0|||
27614714|NCT02291289|80430351|FG005|Induction Treatment|Non-Compliance|0|||
27614715|NCT02291289|80430352|FG006|Induction Treatment|Non-Compliance|0|||
27614716|NCT02291289|80430353|FG007|Induction Treatment|Non-Compliance|0|||
27904299|NCT01709864|81485196|FG000|Overall Study|subject/guardian decision|5|||
27904300|NCT01709864|81485197|FG001|Overall Study|subject/guardian decision|6|||
27614717|NCT02291289|80430354|FG008|Induction Treatment|Non-Compliance|0|||
27614718|NCT02291289|80430355|FG009|Induction Treatment|Non-Compliance|1|||
27614719|NCT02291289|80430356|FG010|Induction Treatment|Non-Compliance|0|||
27614720|NCT02291289|80430357|FG011|Induction Treatment|Non-Compliance|0|||
27614721|NCT02291289|80430358|FG012|Induction Treatment|Non-Compliance|0|||
27614722|NCT02291289|80430346|FG000|Induction Treatment|Reason Not Specified|0|||
27614723|NCT02291289|80430347|FG001|Induction Treatment|Reason Not Specified|0|||
27614724|NCT02291289|80430348|FG002|Induction Treatment|Reason Not Specified|0|||
27614725|NCT02291289|80430349|FG003|Induction Treatment|Reason Not Specified|4|||
27614726|NCT02291289|80430350|FG004|Induction Treatment|Reason Not Specified|0|||
27614727|NCT02291289|80430351|FG005|Induction Treatment|Reason Not Specified|0|||
27904301|NCT01709864|81485196|FG000|Overall Study|Lost to Follow-up|1|||
27508783|NCT01143246|80054767|FG000|Overall Study|Lost to Follow-up|0|||
27508784|NCT01143246|80054768|FG001|Overall Study|Lost to Follow-up|1|||
27508785|NCT01143246|80054767|FG000|Overall Study|Death|16|||
27508786|NCT01143246|80054768|FG001|Overall Study|Death|15|||
27614728|NCT02291289|80430352|FG006|Induction Treatment|Reason Not Specified|0|||
27904302|NCT01709864|81485197|FG001|Overall Study|Lost to Follow-up|0|||
27508787|NCT01143246|80054767|FG000|Overall Study|Reason not Specified|3|||
27508788|NCT01143246|80054768|FG001|Overall Study|Reason not Specified|5|||
27852224|NCT03970837|81291070|FG002|Overall Study|Protocol Violation|0|||
27904303|NCT01709864|81485196|FG000|Overall Study|non-compliance with study treatment|1|||
27508789|NCT03155841|80054769|FG000|Overall Study|Protocol Violation|3|||
27852225|NCT03970837|81291071|FG003|Overall Study|Protocol Violation|0|||
27852226|NCT03970837|81291072|FG004|Overall Study|Protocol Violation|0|||
27852227|NCT03970837|81291073|FG005|Overall Study|Protocol Violation|0|||
27852228|NCT03970837|81291074|FG006|Overall Study|Protocol Violation|0|||
27852229|NCT03970837|81291075|FG007|Overall Study|Protocol Violation|0|||
27852230|NCT03970837|81291076|FG008|Overall Study|Protocol Violation|0|||
27852231|NCT03970837|81291077|FG009|Overall Study|Protocol Violation|0|||
27852232|NCT03970837|81291078|FG010|Overall Study|Protocol Violation|0|||
27852233|NCT03970837|81291079|FG011|Overall Study|Protocol Violation|0|||
27852234|NCT03970837|81291068|FG000|Overall Study|Physician Decision|5|||
27852235|NCT03970837|81291069|FG001|Overall Study|Physician Decision|8|||
27852236|NCT03970837|81291070|FG002|Overall Study|Physician Decision|4|||
27852237|NCT03970837|81291071|FG003|Overall Study|Physician Decision|1|||
27852238|NCT03970837|81291072|FG004|Overall Study|Physician Decision|5|||
27852239|NCT03970837|81291073|FG005|Overall Study|Physician Decision|2|||
27852240|NCT03970837|81291074|FG006|Overall Study|Physician Decision|4|||
27852241|NCT03970837|81291075|FG007|Overall Study|Physician Decision|5|||
27852242|NCT03970837|81291076|FG008|Overall Study|Physician Decision|0|||
27852243|NCT03970837|81291077|FG009|Overall Study|Physician Decision|1|||
27852244|NCT03970837|81291078|FG010|Overall Study|Physician Decision|0|||
27904304|NCT01709864|81485197|FG001|Overall Study|non-compliance with study treatment|1|||
27852245|NCT03970837|81291079|FG011|Overall Study|Physician Decision|0|||
27852246|NCT03970837|81291068|FG000|Overall Study|Withdrawal by Subject|32|||
27852247|NCT03970837|81291069|FG001|Overall Study|Withdrawal by Subject|35|||
27904305|NCT01709864|81485196|FG000|Overall Study|Adverse Event|0|||
27904306|NCT01709864|81485197|FG001|Overall Study|Adverse Event|2|||
27904307|NCT01709864|81485196|FG000|Overall Study|Death|0|||
27904308|NCT01709864|81485197|FG001|Overall Study|Death|1|||
27904309|NCT00791700|81485204|FG000|Overall Study|Insufficient clinical response|1|||
27904310|NCT00791700|81485205|FG001|Overall Study|Insufficient clinical response|4|||
27904311|NCT00791700|81485206|FG002|Overall Study|Insufficient clinical response|1|||
27904312|NCT00791700|81485207|FG003|Overall Study|Insufficient clinical response|8|||
27904313|NCT00791700|81485204|FG000|Overall Study|No longer willing to participate|1|||
27904314|NCT00791700|81485205|FG001|Overall Study|No longer willing to participate|1|||
27904315|NCT00791700|81485206|FG002|Overall Study|No longer willing to participate|0|||
27904316|NCT00791700|81485207|FG003|Overall Study|No longer willing to participate|8|||
27904317|NCT00791700|81485204|FG000|Overall Study|Non-compliance with study treatment|0|||
27904318|NCT00791700|81485205|FG001|Overall Study|Non-compliance with study treatment|2|||
27904319|NCT00791700|81485206|FG002|Overall Study|Non-compliance with study treatment|0|||
27904320|NCT00791700|81485207|FG003|Overall Study|Non-compliance with study treatment|4|||
27904321|NCT00791700|81485204|FG000|Overall Study|Withdrawn due to pregnancy|0|||
27904322|NCT00791700|81485205|FG001|Overall Study|Withdrawn due to pregnancy|0|||
27904323|NCT00791700|81485206|FG002|Overall Study|Withdrawn due to pregnancy|0|||
27904324|NCT00791700|81485207|FG003|Overall Study|Withdrawn due to pregnancy|1|||
27904325|NCT00791700|81485204|FG000|Overall Study|Other|0|||
27904326|NCT00791700|81485205|FG001|Overall Study|Other|1|||
27904327|NCT00791700|81485206|FG002|Overall Study|Other|0|||
27904328|NCT00791700|81485207|FG003|Overall Study|Other|1|||
27904329|NCT00791700|81485204|FG000|Overall Study|Death|0|||
27904330|NCT00791700|81485205|FG001|Overall Study|Death|0|||
27904331|NCT00791700|81485206|FG002|Overall Study|Death|0|||
27904332|NCT00791700|81485207|FG003|Overall Study|Death|1|||
27904333|NCT00791700|81485204|FG000|Overall Study|Lost to Follow-up|4|||
27904334|NCT00791700|81485205|FG001|Overall Study|Lost to Follow-up|3|||
27904335|NCT00791700|81485206|FG002|Overall Study|Lost to Follow-up|4|||
27904336|NCT00791700|81485207|FG003|Overall Study|Lost to Follow-up|6|||
27904337|NCT00791700|81485204|FG000|Overall Study|Adverse Event|0|||
27904338|NCT00791700|81485205|FG001|Overall Study|Adverse Event|0|||
27904339|NCT00791700|81485206|FG002|Overall Study|Adverse Event|1|||
27904340|NCT00791700|81485207|FG003|Overall Study|Adverse Event|1|||
27904341|NCT03959488|81485208|FG000|Season 1|Other|6|||
27904342|NCT03959488|81485209|FG001|Season 1|Other|7|||
27904343|NCT03959488|81485210|FG002|Season 1|Other|0|||
27904344|NCT03959488|81485211|FG003|Season 1|Other|0|||
27904345|NCT03959488|81485212|FG004|Season 1|Other|0|||
27904346|NCT03959488|81485208|FG000|Season 1|Withdrawal by parent/guardian|43|||
27904347|NCT03959488|81485209|FG001|Season 1|Withdrawal by parent/guardian|28|||
27904348|NCT03959488|81485210|FG002|Season 1|Withdrawal by parent/guardian|0|||
27904349|NCT03959488|81485211|FG003|Season 1|Withdrawal by parent/guardian|0|||
27904350|NCT03959488|81485212|FG004|Season 1|Withdrawal by parent/guardian|0|||
27904351|NCT03959488|81485208|FG000|Season 1|Due to COVID-19 pandemic|2|||
27904352|NCT03959488|81485209|FG001|Season 1|Due to COVID-19 pandemic|3|||
27904353|NCT03959488|81485210|FG002|Season 1|Due to COVID-19 pandemic|0|||
27904354|NCT03959488|81485211|FG003|Season 1|Due to COVID-19 pandemic|0|||
27904355|NCT03959488|81485212|FG004|Season 1|Due to COVID-19 pandemic|0|||
27508790|NCT03155841|80054770|FG001|Overall Study|Protocol Violation|4|||
27508791|NCT00148317|80054774|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
27508792|NCT00148317|80054774|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
27508793|NCT00148317|80054774|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
27508794|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
27508795|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
27508796|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
27508797|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Death|9|||
27614729|NCT02291289|80430353|FG007|Induction Treatment|Reason Not Specified|0|||
27728502|NCT02970929|80833301|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
27904356|NCT03959488|81485208|FG000|Season 1|Lost to Follow-up|17|||
27904357|NCT03959488|81485209|FG001|Season 1|Lost to Follow-up|7|||
27904358|NCT03959488|81485210|FG002|Season 1|Lost to Follow-up|0|||
27904359|NCT03959488|81485211|FG003|Season 1|Lost to Follow-up|0|||
27904360|NCT03959488|81485212|FG004|Season 1|Lost to Follow-up|0|||
27904361|NCT03959488|81485208|FG000|Season 1|Death|5|||
27904362|NCT03959488|81485209|FG001|Season 1|Death|1|||
27904363|NCT03959488|81485210|FG002|Season 1|Death|0|||
27904364|NCT03959488|81485211|FG003|Season 1|Death|0|||
27904365|NCT03959488|81485212|FG004|Season 1|Death|0|||
27904366|NCT03959488|81485208|FG000|Season 2|Other|0|||
27904367|NCT03959488|81485209|FG001|Season 2|Other|0|||
27904368|NCT03959488|81485210|FG002|Season 2|Other|2|||
27904369|NCT03959488|81485211|FG003|Season 2|Other|0|||
27904370|NCT03959488|81485212|FG004|Season 2|Other|0|||
27904371|NCT03959488|81485208|FG000|Season 2|Withdrawal by parent/guardian|0|||
27904372|NCT03959488|81485209|FG001|Season 2|Withdrawal by parent/guardian|0|||
27904373|NCT03959488|81485210|FG002|Season 2|Withdrawal by parent/guardian|3|||
27904374|NCT03959488|81485211|FG003|Season 2|Withdrawal by parent/guardian|1|||
27904375|NCT03959488|81485212|FG004|Season 2|Withdrawal by parent/guardian|1|||
27904376|NCT03959488|81485208|FG000|Season 2|Lost to Follow-up|0|||
27904377|NCT03959488|81485209|FG001|Season 2|Lost to Follow-up|0|||
27904378|NCT03959488|81485210|FG002|Season 2|Lost to Follow-up|1|||
27904379|NCT03959488|81485211|FG003|Season 2|Lost to Follow-up|0|||
27508798|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Death|0|||
27508799|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Death|0|||
27508800|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
27508801|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
27508802|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
27508803|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
27508804|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
27508805|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
27508806|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Other|135|||
27508807|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Other|0|||
27508808|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Other|0|||
27508809|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
27508810|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
27508811|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
27508812|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
27508813|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
27508814|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
27508815|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
27508816|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
27508817|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
27614730|NCT02291289|80430354|FG008|Induction Treatment|Reason Not Specified|0|||
27904380|NCT03959488|81485212|FG004|Season 2|Lost to Follow-up|1|||
27904381|NCT03594955|81485214|FG000|Overall Study|Adverse Event|1|||
27904382|NCT03594955|81485214|FG000|Overall Study|Progressive disease|5|||
27904383|NCT03594955|81485214|FG000|Overall Study|Sponsor's decision|1|||
27904384|NCT00080483|81485215|FG000|Overall Study|Lost to Follow-up|1|||
27904385|NCT00080483|81485216|FG001|Overall Study|Lost to Follow-up|1|||
27904386|NCT00080483|81485215|FG000|Overall Study|Physician Decision|1|||
27904387|NCT00080483|81485216|FG001|Overall Study|Physician Decision|1|||
27904388|NCT05268016|81485217|FG000|Overall Study|Unacceptable toxicity or AE|2|||
27852248|NCT03970837|81291070|FG002|Overall Study|Withdrawal by Subject|12|||
27852249|NCT03970837|81291071|FG003|Overall Study|Withdrawal by Subject|8|||
27852250|NCT03970837|81291072|FG004|Overall Study|Withdrawal by Subject|6|||
27852251|NCT03970837|81291073|FG005|Overall Study|Withdrawal by Subject|8|||
27852252|NCT03970837|81291074|FG006|Overall Study|Withdrawal by Subject|2|||
27852253|NCT03970837|81291075|FG007|Overall Study|Withdrawal by Subject|3|||
27852254|NCT03970837|81291076|FG008|Overall Study|Withdrawal by Subject|0|||
27904389|NCT05268016|81485218|FG001|Overall Study|Unacceptable toxicity or AE|2|||
27904390|NCT05268016|81485219|FG002|Overall Study|Unacceptable toxicity or AE|4|||
27904391|NCT05268016|81485220|FG003|Overall Study|Unacceptable toxicity or AE|3|||
27904392|NCT05268016|81485221|FG004|Overall Study|Unacceptable toxicity or AE|1|||
27904393|NCT05268016|81485217|FG000|Overall Study|Withdrawal by Subject|1|||
27904394|NCT05268016|81485218|FG001|Overall Study|Withdrawal by Subject|3|||
27904395|NCT05268016|81485219|FG002|Overall Study|Withdrawal by Subject|2|||
27904396|NCT05268016|81485220|FG003|Overall Study|Withdrawal by Subject|2|||
27904397|NCT05268016|81485221|FG004|Overall Study|Withdrawal by Subject|1|||
27904398|NCT05268016|81485217|FG000|Overall Study|Lost to Follow-up|4|||
27904399|NCT05268016|81485218|FG001|Overall Study|Lost to Follow-up|7|||
27904400|NCT05268016|81485219|FG002|Overall Study|Lost to Follow-up|1|||
27904401|NCT05268016|81485220|FG003|Overall Study|Lost to Follow-up|3|||
27852255|NCT03970837|81291077|FG009|Overall Study|Withdrawal by Subject|0|||
27852256|NCT03970837|81291078|FG010|Overall Study|Withdrawal by Subject|0|||
27852257|NCT03970837|81291079|FG011|Overall Study|Withdrawal by Subject|1|||
27852258|NCT03970837|81291068|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
27852259|NCT03970837|81291069|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
27852260|NCT03970837|81291070|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
27852261|NCT03970837|81291071|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
27852262|NCT03970837|81291072|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
27852263|NCT03970837|81291073|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27852264|NCT03970837|81291074|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27852265|NCT03970837|81291075|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27852266|NCT03970837|81291076|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
27852267|NCT03970837|81291077|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
27852268|NCT03970837|81291078|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
27852269|NCT03970837|81291079|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
27852270|NCT03970837|81291068|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27852271|NCT03970837|81291069|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27852272|NCT03970837|81291070|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27852273|NCT03970837|81291071|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27852274|NCT03970837|81291072|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27852275|NCT03970837|81291073|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
27852276|NCT03970837|81291074|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
27852277|NCT03970837|81291075|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
27852278|NCT03970837|81291076|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
27852279|NCT03970837|81291077|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
27852280|NCT03970837|81291078|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
27852281|NCT03970837|81291079|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
27852282|NCT01206816|81291080|FG000|Overall Study|Protocol Violation|0|||
27904402|NCT05268016|81485221|FG004|Overall Study|Lost to Follow-up|5|||
27904403|NCT05268016|81485217|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
27852283|NCT01206816|81291081|FG001|Overall Study|Protocol Violation|0|||
27852284|NCT01206816|81291082|FG002|Overall Study|Protocol Violation|1|||
27958622|NCT01791517|81680058|FG000|Phase II|Lens Handling Difficulties|0|||
27852285|NCT01206816|81291083|FG003|Overall Study|Protocol Violation|0|||
27852286|NCT01206816|81291084|FG004|Overall Study|Protocol Violation|0|||
27958623|NCT01791517|81680059|FG001|Phase II|Lens Handling Difficulties|0|||
27958624|NCT01791517|81680060|FG002|Phase II|Lens Handling Difficulties|0|||
27958625|NCT01791517|81680061|FG003|Phase II|Lens Handling Difficulties|0|||
27958626|NCT01791517|81680062|FG004|Phase II|Lens Handling Difficulties|0|||
27958627|NCT01791517|81680063|FG005|Phase II|Lens Handling Difficulties|0|||
27614731|NCT02291289|80430355|FG009|Induction Treatment|Reason Not Specified|7|||
27852287|NCT01206816|81291085|FG005|Overall Study|Protocol Violation|0|||
27904404|NCT05268016|81485218|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
27852288|NCT01206816|81291086|FG006|Overall Study|Protocol Violation|0|||
27852289|NCT01206816|81291080|FG000|Overall Study|Withdrawal by Subject|0|||
27852290|NCT01206816|81291081|FG001|Overall Study|Withdrawal by Subject|0|||
27852291|NCT01206816|81291082|FG002|Overall Study|Withdrawal by Subject|1|||
27852292|NCT01206816|81291083|FG003|Overall Study|Withdrawal by Subject|0|||
27852293|NCT01206816|81291084|FG004|Overall Study|Withdrawal by Subject|0|||
27852294|NCT01206816|81291085|FG005|Overall Study|Withdrawal by Subject|0|||
27852295|NCT01206816|81291086|FG006|Overall Study|Withdrawal by Subject|0|||
27852296|NCT01206816|81291080|FG000|Overall Study|Progressive disease|3|||
27852297|NCT01206816|81291081|FG001|Overall Study|Progressive disease|3|||
27852298|NCT01206816|81291082|FG002|Overall Study|Progressive disease|13|||
27852299|NCT01206816|81291083|FG003|Overall Study|Progressive disease|3|||
27852300|NCT01206816|81291084|FG004|Overall Study|Progressive disease|3|||
27852301|NCT01206816|81291085|FG005|Overall Study|Progressive disease|16|||
27852302|NCT01206816|81291086|FG006|Overall Study|Progressive disease|3|||
27852303|NCT01206816|81291080|FG000|Overall Study|Other AE|0|||
27852304|NCT01206816|81291081|FG001|Overall Study|Other AE|0|||
27852305|NCT01206816|81291082|FG002|Overall Study|Other AE|4|||
27852306|NCT01206816|81291083|FG003|Overall Study|Other AE|0|||
27852307|NCT01206816|81291084|FG004|Overall Study|Other AE|0|||
27852308|NCT01206816|81291085|FG005|Overall Study|Other AE|3|||
27904405|NCT05268016|81485219|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
27904406|NCT05268016|81485220|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
27904407|NCT05268016|81485221|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
27904408|NCT05268016|81485217|FG000|Overall Study|Lack of Efficacy|0|||
27904409|NCT05268016|81485218|FG001|Overall Study|Lack of Efficacy|0|||
27904410|NCT05268016|81485219|FG002|Overall Study|Lack of Efficacy|0|||
27904411|NCT05268016|81485220|FG003|Overall Study|Lack of Efficacy|0|||
27904412|NCT05268016|81485221|FG004|Overall Study|Lack of Efficacy|4|||
27904413|NCT05268016|81485217|FG000|Overall Study|Physician Decision|0|||
27904414|NCT05268016|81485218|FG001|Overall Study|Physician Decision|0|||
27904415|NCT05268016|81485219|FG002|Overall Study|Physician Decision|0|||
27904416|NCT05268016|81485220|FG003|Overall Study|Physician Decision|1|||
27904417|NCT05268016|81485221|FG004|Overall Study|Physician Decision|0|||
27904418|NCT05268016|81485217|FG000|Overall Study|Other|1|||
27904419|NCT05268016|81485218|FG001|Overall Study|Other|0|||
27904420|NCT05268016|81485219|FG002|Overall Study|Other|1|||
27904421|NCT05268016|81485220|FG003|Overall Study|Other|2|||
27904422|NCT05268016|81485221|FG004|Overall Study|Other|0|||
27904423|NCT02756819|81485222|FG000|Overall Study|Lost for observation|23|||
27904424|NCT02756819|81485222|FG000|Overall Study|Patient's unwillingness|16|||
27904425|NCT02756819|81485222|FG000|Overall Study|Insufficient efficacy|2|||
27904426|NCT02756819|81485222|FG000|Overall Study|Adverse Event|2|||
27904427|NCT02756819|81485222|FG000|Overall Study|Reason not Specified|9|||
27904428|NCT01990768|81485223|FG000|Intervention Started|Found to be ineligible|14|||
27904429|NCT01990768|81485224|FG001|Intervention Started|Found to be ineligible|13|||
27904430|NCT01990768|81485225|FG002|Intervention Started|Found to be ineligible|11|||
27904431|NCT01990768|81485223|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
27904432|NCT01990768|81485224|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
27904433|NCT01990768|81485225|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
27904434|NCT01990768|81485223|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
27904435|NCT01990768|81485224|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
27904436|NCT01990768|81485225|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
27904437|NCT01990768|81485223|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
27904438|NCT01990768|81485224|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
27904439|NCT01990768|81485225|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
27904440|NCT01990768|81485223|FG000|Intervention Started|Patient care priority|1|||
27904441|NCT01990768|81485224|FG001|Intervention Started|Patient care priority|2|||
27904442|NCT01990768|81485225|FG002|Intervention Started|Patient care priority|3|||
27614732|NCT02291289|80430356|FG010|Induction Treatment|Reason Not Specified|0|||
27904443|NCT01990768|81485223|FG000|Intervention Started|IV lost|2|||
27904444|NCT01990768|81485224|FG001|Intervention Started|IV lost|2|||
27904445|NCT01990768|81485225|FG002|Intervention Started|IV lost|2|||
27614733|NCT02291289|80430357|FG011|Induction Treatment|Reason Not Specified|0|||
27904446|NCT01990768|81485223|FG000|Intervention Started|Required CPR|1|||
27904447|NCT01990768|81485224|FG001|Intervention Started|Required CPR|1|||
27852309|NCT01206816|81291086|FG006|Overall Study|Other AE|2|||
27852310|NCT01206816|81291080|FG000|Overall Study|other than stated above|0|||
27852311|NCT01206816|81291081|FG001|Overall Study|other than stated above|0|||
27852312|NCT01206816|81291082|FG002|Overall Study|other than stated above|1|||
27852313|NCT01206816|81291083|FG003|Overall Study|other than stated above|0|||
27852314|NCT01206816|81291084|FG004|Overall Study|other than stated above|0|||
27852315|NCT01206816|81291085|FG005|Overall Study|other than stated above|0|||
27508818|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Other|3|||
27508819|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Other|0|||
27508820|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Other|0|||
27508821|NCT02118584|80054777|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
27508822|NCT02118584|80054778|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
27508823|NCT02118584|80054779|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
27508824|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
27508825|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
27508826|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
27508827|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
27508828|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
27508829|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
27508830|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
27508831|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
27508832|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
27508833|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
27508834|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
27508835|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
27508836|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
27508837|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
27508838|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
27508839|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
27508840|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
27508841|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
27508842|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
27508843|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
27508844|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
27508845|NCT02118584|80054777|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
27508846|NCT02118584|80054778|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
27508847|NCT02118584|80054779|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
27508848|NCT02919995|80054788|FG000|Overall Study|Adverse Event|0|||
27508849|NCT02919995|80054789|FG001|Overall Study|Adverse Event|0|||
27508850|NCT02919995|80054790|FG002|Overall Study|Adverse Event|0|||
27508851|NCT02919995|80054791|FG003|Overall Study|Adverse Event|0|||
27508852|NCT02919995|80054792|FG004|Overall Study|Adverse Event|0|||
27508853|NCT02919995|80054793|FG005|Overall Study|Adverse Event|1|||
27508854|NCT00705016|80054794|FG000|Overall Study|Adverse Event|6|||
27508855|NCT00705016|80054795|FG001|Overall Study|Adverse Event|11|||
27508856|NCT00705016|80054796|FG002|Overall Study|Adverse Event|10|||
27508857|NCT00705016|80054794|FG000|Overall Study|Death|5|||
27508858|NCT00705016|80054795|FG001|Overall Study|Death|7|||
27508859|NCT00705016|80054796|FG002|Overall Study|Death|5|||
27508860|NCT00705016|80054794|FG000|Overall Study|Protocol Violation|0|||
27508861|NCT00705016|80054795|FG001|Overall Study|Protocol Violation|1|||
27508862|NCT00705016|80054796|FG002|Overall Study|Protocol Violation|1|||
27508863|NCT00705016|80054794|FG000|Overall Study|Withdrawal by Subject|4|||
27508864|NCT00705016|80054795|FG001|Overall Study|Withdrawal by Subject|3|||
27508865|NCT00705016|80054796|FG002|Overall Study|Withdrawal by Subject|2|||
27508866|NCT00705016|80054794|FG000|Overall Study|Progressive Disease|33|||
27508867|NCT00705016|80054795|FG001|Overall Study|Progressive Disease|29|||
27508868|NCT00705016|80054796|FG002|Overall Study|Progressive Disease|33|||
27508869|NCT00705016|80054794|FG000|Overall Study|Symptomatic Deterioration|3|||
27508870|NCT00705016|80054795|FG001|Overall Study|Symptomatic Deterioration|1|||
27508871|NCT00705016|80054796|FG002|Overall Study|Symptomatic Deterioration|1|||
27508872|NCT00705016|80054794|FG000|Overall Study|Other|9|||
27508873|NCT00705016|80054795|FG001|Overall Study|Other|6|||
27508874|NCT00705016|80054796|FG002|Overall Study|Other|6|||
27508875|NCT02668653|80054798|FG000|Overall Study|Refractory disease|41|||
27508876|NCT02668653|80054799|FG001|Overall Study|Refractory disease|70|||
27508877|NCT02668653|80054798|FG000|Overall Study|Relapse|44|||
27508878|NCT02668653|80054799|FG001|Overall Study|Relapse|65|||
27508879|NCT02668653|80054798|FG000|Overall Study|Adverse Event|58|||
27508880|NCT02668653|80054799|FG001|Overall Study|Adverse Event|23|||
27508881|NCT02668653|80054798|FG000|Overall Study|Subject decision to stop study drug|25|||
27508882|NCT02668653|80054799|FG001|Overall Study|Subject decision to stop study drug|23|||
27508883|NCT02668653|80054798|FG000|Overall Study|Other reasons not specified|16|||
27508884|NCT02668653|80054799|FG001|Overall Study|Other reasons not specified|11|||
27508885|NCT02668653|80054798|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
27508886|NCT02668653|80054799|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
27508887|NCT02668653|80054798|FG000|Overall Study|Investigator decision|10|||
27508888|NCT02668653|80054799|FG001|Overall Study|Investigator decision|7|||
27508889|NCT02668653|80054798|FG000|Overall Study|Failure to meet continuation criteria|5|||
27508890|NCT02668653|80054799|FG001|Overall Study|Failure to meet continuation criteria|12|||
27508891|NCT02668653|80054798|FG000|Overall Study|Lost to Follow-up|1|||
27508892|NCT02668653|80054799|FG001|Overall Study|Lost to Follow-up|0|||
27508893|NCT02668653|80054798|FG000|Overall Study|Pregnancy|0|||
27508894|NCT02668653|80054799|FG001|Overall Study|Pregnancy|1|||
27508895|NCT02668653|80054798|FG000|Overall Study|Death|0|||
27508896|NCT02668653|80054799|FG001|Overall Study|Death|1|||
27508897|NCT01244893|80054804|FG000|Baseline|Protocol Violation|0|||
27508898|NCT01244893|80054805|FG001|Baseline|Protocol Violation|1|||
27508899|NCT01244893|80054804|FG000|1-Week Follow Up|Lost to Follow-up|1|||
27508900|NCT01244893|80054805|FG001|1-Week Follow Up|Lost to Follow-up|0|||
27508901|NCT05021978|80054810|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
27508902|NCT05021978|80054811|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
27508903|NCT05021978|80054812|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
27508904|NCT05021978|80054813|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
27508905|NCT05021978|80054810|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
27508906|NCT05021978|80054811|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
27508907|NCT05021978|80054812|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
27508908|NCT05021978|80054813|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
27508909|NCT01354314|80057612|FG000|Overall Study|Lost to Follow-up|1|||
27508910|NCT01354314|80057613|FG001|Overall Study|Lost to Follow-up|0|||
27508911|NCT01354314|80057614|FG002|Overall Study|Lost to Follow-up|1|||
27508912|NCT01354314|80057615|FG003|Overall Study|Lost to Follow-up|1|||
27508913|NCT01354314|80057612|FG000|Overall Study|Withdrawal by Subject|0|||
27508914|NCT01354314|80057613|FG001|Overall Study|Withdrawal by Subject|0|||
27508915|NCT01354314|80057614|FG002|Overall Study|Withdrawal by Subject|1|||
27508916|NCT01354314|80057615|FG003|Overall Study|Withdrawal by Subject|0|||
27508917|NCT01354314|80057612|FG000|Overall Study|Adverse Event|0|||
27508918|NCT01354314|80057613|FG001|Overall Study|Adverse Event|0|||
27508919|NCT01354314|80057614|FG002|Overall Study|Adverse Event|0|||
27508920|NCT01354314|80057615|FG003|Overall Study|Adverse Event|1|||
27508921|NCT01354314|80057612|FG000|Overall Study|Protocol Violation|1|||
27508922|NCT01354314|80057613|FG001|Overall Study|Protocol Violation|1|||
27508923|NCT01354314|80057614|FG002|Overall Study|Protocol Violation|0|||
27508924|NCT01354314|80057615|FG003|Overall Study|Protocol Violation|0|||
27508925|NCT01354314|80057612|FG000|Overall Study|Less than 90% Adherence|4|||
27508926|NCT01354314|80057613|FG001|Overall Study|Less than 90% Adherence|2|||
27508927|NCT01354314|80057614|FG002|Overall Study|Less than 90% Adherence|6|||
27508928|NCT01354314|80057615|FG003|Overall Study|Less than 90% Adherence|4|||
27508929|NCT03125395|80057616|FG000|Overall Study|Adverse Event|2|||
27508930|NCT03125395|80057616|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
27508931|NCT03125395|80057616|FG000|Overall Study|Physician Decision|2|||
27508932|NCT03125395|80057616|FG000|Overall Study|Commercial drug is available|5|||
27508933|NCT01780974|80057619|FG000|Overall Study|Death|1|||
27508934|NCT01780974|80057620|FG001|Overall Study|Death|0|||
27508935|NCT01780974|80057619|FG000|Overall Study|Adverse Event|1|||
27508936|NCT01780974|80057620|FG001|Overall Study|Adverse Event|3|||
27508937|NCT01867671|80057622|FG000|Overall Study|Adverse Event|5|||
27508938|NCT01867671|80057623|FG001|Overall Study|Adverse Event|3|||
27508939|NCT01867671|80057622|FG000|Overall Study|Anaphylaxis|0|||
27508940|NCT01867671|80057623|FG001|Overall Study|Anaphylaxis|1|||
27508941|NCT01867671|80057622|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
27508942|NCT01867671|80057623|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
27508943|NCT01867671|80057622|FG000|Overall Study|Lost to Follow-up|0|||
27508944|NCT01867671|80057623|FG001|Overall Study|Lost to Follow-up|1|||
27508945|NCT01867671|80057622|FG000|Overall Study|Non-compliance with Study Drug|1|||
27508946|NCT01867671|80057623|FG001|Overall Study|Non-compliance with Study Drug|2|||
27614734|NCT02291289|80430358|FG012|Induction Treatment|Reason Not Specified|0|||
27614735|NCT02291289|80430346|FG000|Induction Treatment|Physician Decision|0|||
27614736|NCT02291289|80430347|FG001|Induction Treatment|Physician Decision|0|||
27614737|NCT02291289|80430348|FG002|Induction Treatment|Physician Decision|0|||
27614738|NCT02291289|80430349|FG003|Induction Treatment|Physician Decision|3|||
27614739|NCT02291289|80430350|FG004|Induction Treatment|Physician Decision|0|||
27614740|NCT02291289|80430351|FG005|Induction Treatment|Physician Decision|0|||
27614741|NCT02291289|80430352|FG006|Induction Treatment|Physician Decision|0|||
27508947|NCT01867671|80057622|FG000|Overall Study|Withdrawal by Subject|21|||
27508948|NCT01867671|80057623|FG001|Overall Study|Withdrawal by Subject|21|||
27614742|NCT02291289|80430353|FG007|Induction Treatment|Physician Decision|0|||
27508949|NCT00942604|80057624|FG000|Overall Study|Protocol Violation|1|||
27508950|NCT00942604|80057625|FG001|Overall Study|Protocol Violation|1|||
27508951|NCT00942604|80057624|FG000|Overall Study|Adverse Event|0|||
27614743|NCT02291289|80430354|FG008|Induction Treatment|Physician Decision|0|||
27508952|NCT00942604|80057625|FG001|Overall Study|Adverse Event|1|||
27508953|NCT00942604|80057624|FG000|Overall Study|Withdrawal by Subject|0|||
27508954|NCT00942604|80057625|FG001|Overall Study|Withdrawal by Subject|1|||
27508955|NCT00942604|80057624|FG000|Overall Study|Patient relocation|1|||
27508956|NCT00942604|80057625|FG001|Overall Study|Patient relocation|1|||
27614744|NCT02291289|80430355|FG009|Induction Treatment|Physician Decision|1|||
27508957|NCT00628108|80057626|FG000|Overall Study|Adverse Event|0|||
27508958|NCT00628108|80057627|FG001|Overall Study|Adverse Event|3|||
27508959|NCT00628108|80057626|FG000|Overall Study|Withdrawal by Subject|1|||
27508960|NCT00628108|80057627|FG001|Overall Study|Withdrawal by Subject|0|||
27508961|NCT00118417|80057628|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
27508962|NCT00118417|80057629|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
27508963|NCT00118417|80057628|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
27508964|NCT00118417|80057629|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
27852316|NCT01206816|81291086|FG006|Overall Study|other than stated above|1|||
27904448|NCT01990768|81485225|FG002|Intervention Started|Required CPR|0|||
27508965|NCT00118417|80057628|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
27508966|NCT00118417|80057629|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
27852317|NCT02312063|81291087|FG000|Overall Study|Withdrawal by Subject|0|||
27852318|NCT02312063|81291088|FG001|Overall Study|Withdrawal by Subject|1|||
27852319|NCT01460901|81291089|FG000|Overall Study|Withdrawal by Subject|2|||
27852320|NCT01902628|81291090|FG000|Overall Study|Withdrawal of participant's consent|7|||
27852321|NCT01902628|81291090|FG000|Overall Study|Adverse Event|41|||
27852322|NCT01902628|81291090|FG000|Overall Study|Lost to Follow-up|35|||
27852323|NCT02435836|81291091|FG000|Overall Study|Lost to Follow-up|21|||
27904449|NCT01990768|81485223|FG000|Intervention Started|Seizure or hx of seizure|0|||
27904450|NCT01990768|81485224|FG001|Intervention Started|Seizure or hx of seizure|0|||
27904451|NCT01990768|81485225|FG002|Intervention Started|Seizure or hx of seizure|2|||
27904452|NCT01990768|81485223|FG000|Intervention Started|Discovered to be pregnant|0|||
27904453|NCT01990768|81485224|FG001|Intervention Started|Discovered to be pregnant|1|||
27904454|NCT01990768|81485225|FG002|Intervention Started|Discovered to be pregnant|0|||
27904455|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
27904456|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
27904457|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
27904458|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
27904459|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
27904460|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
27904461|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
27904462|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
27614745|NCT02291289|80430356|FG010|Induction Treatment|Physician Decision|0|||
27614746|NCT02291289|80430357|FG011|Induction Treatment|Physician Decision|0|||
27614747|NCT02291289|80430358|FG012|Induction Treatment|Physician Decision|0|||
27728503|NCT02970929|80833301|FG000|Overall Study|LOST TO FOLLOWUP|6|||
27728504|NCT02970929|80833301|FG000|Overall Study|MOVED OUT OF STATE|1|||
27728505|NCT02970929|80833301|FG000|Overall Study|Withdrawal by Subject|16|||
27852324|NCT02435836|81291091|FG000|Overall Study|Lack of Efficacy|1|||
27852325|NCT02435836|81291091|FG000|Overall Study|Withdrawal by Subject|236|||
27852326|NCT02435836|81291091|FG000|Overall Study|Insufficient Clinical Response|26|||
27852327|NCT02435836|81291091|FG000|Overall Study|Adverse Event|44|||
27852328|NCT02435836|81291091|FG000|Overall Study|Sponsor discontinued trial|167|||
27852329|NCT02435836|81291091|FG000|Overall Study|Noncompliance|27|||
27852330|NCT02435836|81291091|FG000|Overall Study|Protocol Violation|6|||
27852331|NCT02435836|81291091|FG000|Overall Study|Met Withdrawal Criteria|7|||
27852332|NCT02435836|81291091|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
27852333|NCT04053465|81291092|FG000|Overall Study|Withdrawal by Subject|4|||
27852334|NCT04053465|81291093|FG001|Overall Study|Withdrawal by Subject|4|||
27852335|NCT02192164|81291094|FG000|Overall Study|Other|8|||
27852336|NCT02192164|81291094|FG000|Overall Study|Withdrawal by Subject|1|||
27852337|NCT02192164|81291094|FG000|Overall Study|Physician Decision|4|||
27852338|NCT02192164|81291094|FG000|Overall Study|Did not meet the exclusion criteria|1|||
27852339|NCT03096847|81291100|FG000|Overall Study|Other|2|||
27852340|NCT03096847|81291101|FG001|Overall Study|Other|1|||
27852341|NCT03096847|81291102|FG002|Overall Study|Other|2|||
27852342|NCT03096847|81291100|FG000|Overall Study|Lost to Follow-up|1|||
27852343|NCT03096847|81291101|FG001|Overall Study|Lost to Follow-up|0|||
27852344|NCT03096847|81291102|FG002|Overall Study|Lost to Follow-up|1|||
27852345|NCT03096847|81291100|FG000|Overall Study|Death|6|||
27852346|NCT03096847|81291101|FG001|Overall Study|Death|0|||
27852347|NCT03096847|81291102|FG002|Overall Study|Death|2|||
27852348|NCT03096847|81291100|FG000|Overall Study|Protocol Violation|3|||
27852349|NCT03096847|81291101|FG001|Overall Study|Protocol Violation|0|||
27852350|NCT03096847|81291102|FG002|Overall Study|Protocol Violation|6|||
27852351|NCT03096847|81291100|FG000|Overall Study|Physician Decision|12|||
27852352|NCT03096847|81291101|FG001|Overall Study|Physician Decision|2|||
27852353|NCT03096847|81291102|FG002|Overall Study|Physician Decision|8|||
27852354|NCT03096847|81291100|FG000|Overall Study|Withdrawal by Subject|24|||
27852355|NCT03096847|81291101|FG001|Overall Study|Withdrawal by Subject|1|||
27852356|NCT03096847|81291102|FG002|Overall Study|Withdrawal by Subject|12|||
27852357|NCT03096847|81291100|FG000|Overall Study|Adverse Event|72|||
27852358|NCT03096847|81291101|FG001|Overall Study|Adverse Event|6|||
27852359|NCT03096847|81291102|FG002|Overall Study|Adverse Event|28|||
27852360|NCT03096847|81291100|FG000|Overall Study|Progressive disease|97|||
27852361|NCT03096847|81291101|FG001|Overall Study|Progressive disease|10|||
27852362|NCT03096847|81291102|FG002|Overall Study|Progressive disease|78|||
27852363|NCT03096847|81291100|FG000|Overall Study|Non-compliance with study medication|1|||
27852364|NCT03096847|81291101|FG001|Overall Study|Non-compliance with study medication|0|||
27852365|NCT03096847|81291102|FG002|Overall Study|Non-compliance with study medication|0|||
27852366|NCT03096847|81291100|FG000|Overall Study|New therapy for study indication|1|||
27852367|NCT03096847|81291101|FG001|Overall Study|New therapy for study indication|0|||
27852368|NCT03096847|81291102|FG002|Overall Study|New therapy for study indication|1|||
27852369|NCT01700049|81291112|FG000|Overall Study|Withdrawal by Subject|1|||
27852370|NCT01359644|81291113|FG000|Treatment Period|Lack of Efficacy|0|||
27852371|NCT01359644|81291114|FG001|Treatment Period|Lack of Efficacy|1|||
27852372|NCT01359644|81291115|FG002|Treatment Period|Lack of Efficacy|0|||
27852373|NCT01359644|81291116|FG003|Treatment Period|Lack of Efficacy|0|||
27852374|NCT01359644|81291117|FG004|Treatment Period|Lack of Efficacy|0|||
27852375|NCT01359644|81291118|FG005|Treatment Period|Lack of Efficacy|0|||
27508967|NCT00118417|80057628|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
27508968|NCT00118417|80057629|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
27508969|NCT00118417|80057628|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
27508970|NCT00118417|80057629|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
27508971|NCT01064947|80057632|FG000|Overall Study|negative culture|41|||
27508972|NCT02395081|80057639|FG000|Overall Study|Withdrawal by Subject|1|||
27508973|NCT02395081|80057640|FG001|Overall Study|Withdrawal by Subject|1|||
27508974|NCT02395081|80057641|FG002|Overall Study|Withdrawal by Subject|0|||
27508975|NCT02395081|80057639|FG000|Overall Study|Moved where blood couldn't be collected|4|||
27508976|NCT02395081|80057640|FG001|Overall Study|Moved where blood couldn't be collected|1|||
27508977|NCT02395081|80057641|FG002|Overall Study|Moved where blood couldn't be collected|3|||
27508978|NCT02395081|80057639|FG000|Overall Study|Fetal Loss|2|||
27508979|NCT02395081|80057640|FG001|Overall Study|Fetal Loss|3|||
27508980|NCT02395081|80057641|FG002|Overall Study|Fetal Loss|1|||
27508981|NCT00354432|80057647|FG000|Overall Study|Adverse Event|3|||
27508982|NCT00354432|80057648|FG001|Overall Study|Adverse Event|1|||
27508983|NCT00354432|80057649|FG002|Overall Study|Adverse Event|5|||
27508984|NCT00354432|80057650|FG003|Overall Study|Adverse Event|5|||
27508985|NCT00354432|80057647|FG000|Overall Study|Off/Toxicity|3|||
27508986|NCT00354432|80057648|FG001|Overall Study|Off/Toxicity|7|||
27508987|NCT00354432|80057649|FG002|Overall Study|Off/Toxicity|5|||
27508988|NCT00354432|80057650|FG003|Overall Study|Off/Toxicity|5|||
27508989|NCT03809104|80057651|FG000|Overall Study|Withdrawal by Subject|3|||
27508990|NCT00396253|80057657|FG000|Overall Study|Protocol Violation|1|||
27508991|NCT00396253|80057657|FG000|Overall Study|Withdrawal by Subject|7|||
27508992|NCT00396253|80057657|FG000|Overall Study|Death|3|||
27508993|NCT00396253|80057657|FG000|Overall Study|Physician Decision|1|||
27852376|NCT01359644|81291119|FG006|Treatment Period|Lack of Efficacy|0|||
27852377|NCT01359644|81291120|FG007|Treatment Period|Lack of Efficacy|0|||
27852378|NCT01359644|81291121|FG008|Treatment Period|Lack of Efficacy|0|||
27852379|NCT01359644|81291122|FG009|Treatment Period|Lack of Efficacy|0|||
27852380|NCT01359644|81291113|FG000|Treatment Period|Adverse Event|0|||
27852381|NCT01359644|81291114|FG001|Treatment Period|Adverse Event|0|||
27508994|NCT00396253|80057657|FG000|Overall Study|Change in eligibility status|1|||
27508995|NCT03614156|80057660|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
27614748|NCT02291289|80430346|FG000|Induction Treatment|Protocol Violation|0|||
27852382|NCT01359644|81291115|FG002|Treatment Period|Adverse Event|1|||
27614749|NCT02291289|80430347|FG001|Induction Treatment|Protocol Violation|0|||
27508996|NCT03614156|80057661|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
27508997|NCT03614156|80057662|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
27508998|NCT03614156|80057663|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
27508999|NCT03614156|80057660|FG000|Open-Label Treatment Period|Adverse Event|7|||
27509000|NCT03614156|80057661|FG001|Open-Label Treatment Period|Adverse Event|0|||
27509001|NCT03614156|80057662|FG002|Open-Label Treatment Period|Adverse Event|0|||
27509002|NCT03614156|80057663|FG003|Open-Label Treatment Period|Adverse Event|0|||
27509003|NCT03614156|80057660|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
27509004|NCT03614156|80057661|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
27509005|NCT03614156|80057662|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
27509006|NCT03614156|80057663|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
27509007|NCT03614156|80057660|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
27509008|NCT03614156|80057661|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
27509009|NCT03614156|80057662|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
27509010|NCT03614156|80057663|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
27509011|NCT03614156|80057660|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
27509012|NCT03614156|80057661|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
27509013|NCT03614156|80057662|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
27509014|NCT03614156|80057663|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
27509015|NCT03614156|80057660|FG000|Open-Label Treatment Period|Protocol Violation|2|||
27509016|NCT03614156|80057661|FG001|Open-Label Treatment Period|Protocol Violation|0|||
27509017|NCT03614156|80057662|FG002|Open-Label Treatment Period|Protocol Violation|0|||
27509018|NCT03614156|80057663|FG003|Open-Label Treatment Period|Protocol Violation|0|||
27509019|NCT03614156|80057660|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
27509020|NCT03614156|80057661|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
27509021|NCT03614156|80057662|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
27509022|NCT03614156|80057663|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
27509023|NCT03614156|80057660|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
27509024|NCT03614156|80057661|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
27509025|NCT03614156|80057662|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
27509026|NCT03614156|80057663|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
27509027|NCT03614156|80057660|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
27509028|NCT03614156|80057661|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
27509029|NCT03614156|80057662|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
27509030|NCT03614156|80057663|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
27509031|NCT03614156|80057660|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27509032|NCT03614156|80057661|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
27509033|NCT03614156|80057662|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27509034|NCT03614156|80057663|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
27509035|NCT03614156|80057660|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27509036|NCT03614156|80057661|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27509037|NCT03614156|80057662|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
27509038|NCT03614156|80057663|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
27509039|NCT03614156|80057660|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
27509040|NCT03614156|80057661|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
27509041|NCT03614156|80057662|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
27509042|NCT03614156|80057663|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
27509043|NCT03614156|80057660|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
27509044|NCT03614156|80057661|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
27509045|NCT03614156|80057662|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
27509046|NCT03614156|80057663|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
27509047|NCT03614156|80057660|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
27509048|NCT03614156|80057661|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
27509049|NCT03614156|80057662|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
27509050|NCT03614156|80057663|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
27509051|NCT03614156|80057660|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
27509052|NCT03614156|80057661|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
27904463|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
27904464|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
27509053|NCT03614156|80057662|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
27509054|NCT03614156|80057663|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
27509055|NCT03614156|80057660|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
27509056|NCT03614156|80057661|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
27509057|NCT03614156|80057662|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
27509058|NCT03614156|80057663|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
27509059|NCT03614156|80057660|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
27509060|NCT03614156|80057661|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
27509061|NCT03614156|80057662|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
27509062|NCT03614156|80057663|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
27509063|NCT00706238|80057664|FG000|Overall Study|Disease progression|4|||
27509064|NCT00706238|80057664|FG000|Overall Study|Other|1|||
27509065|NCT01803607|80057665|FG000|Overall Study|Adverse Event|5|||
27509066|NCT01803607|80057666|FG001|Overall Study|Adverse Event|3|||
27509067|NCT01803607|80057665|FG000|Overall Study|Lack of Efficacy|0|||
27509068|NCT01803607|80057666|FG001|Overall Study|Lack of Efficacy|1|||
27509069|NCT01803607|80057665|FG000|Overall Study|Protocol Violation|3|||
27509070|NCT01803607|80057666|FG001|Overall Study|Protocol Violation|2|||
27509071|NCT01803607|80057665|FG000|Overall Study|Study terminated by sponsor|54|||
27509072|NCT01803607|80057666|FG001|Overall Study|Study terminated by sponsor|56|||
27509073|NCT01803607|80057665|FG000|Overall Study|Withdrawal by Subject|6|||
27509074|NCT01803607|80057666|FG001|Overall Study|Withdrawal by Subject|5|||
27509075|NCT01421719|80057667|FG000|Overall Study|Withdrawal by Subject|4|||
27509076|NCT03077412|80057672|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
27509077|NCT03077412|80057673|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
27509078|NCT03077412|80057674|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
27509079|NCT03077412|80057672|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
27509080|NCT03077412|80057673|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
27509081|NCT03077412|80057674|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
27509082|NCT03077412|80057672|FG000|Overall Study|Adverse Event|1|||
27509083|NCT03077412|80057673|FG001|Overall Study|Adverse Event|2|||
27509084|NCT03077412|80057674|FG002|Overall Study|Adverse Event|2|||
27509085|NCT03077412|80057672|FG000|Overall Study|Investigator's Discretion|0|||
27509086|NCT03077412|80057673|FG001|Overall Study|Investigator's Discretion|1|||
27509087|NCT03077412|80057674|FG002|Overall Study|Investigator's Discretion|1|||
27509088|NCT03077412|80057672|FG000|Overall Study|Withdrew Consent|0|||
27509089|NCT03077412|80057673|FG001|Overall Study|Withdrew Consent|2|||
27509090|NCT03077412|80057674|FG002|Overall Study|Withdrew Consent|0|||
27509091|NCT02577718|80057678|FG000|Overall Study|Death|6|||
27509092|NCT02577718|80057678|FG000|Overall Study|Withdrawal by Subject|2|||
27509093|NCT04161157|80057680|FG000|Overall Study|Lost to Follow-up|4|||
27509094|NCT04161157|80057680|FG000|Overall Study|Death|3|||
27509095|NCT04161157|80057680|FG000|Overall Study|Ineligible|2|||
27509096|NCT04161157|80057680|FG000|Overall Study|Withdrawal by Subject|4|||
27509097|NCT03041181|80057681|FG000|Overall Study|Disease Progression|1|||
27509098|NCT03041181|80057682|FG001|Overall Study|Disease Progression|2|||
27509099|NCT00068692|80057683|FG000|Step 1: Registration|Disese progression/relapse|5|||
27509100|NCT00068692|80057684|FG001|Step 1: Registration|Disese progression/relapse|0|||
27509101|NCT00068692|80057685|FG002|Step 1: Registration|Disese progression/relapse|0|||
27509102|NCT00068692|80057686|FG003|Step 1: Registration|Disese progression/relapse|0|||
27509103|NCT00068692|80057687|FG004|Step 1: Registration|Disese progression/relapse|0|||
27509104|NCT00068692|80057688|FG005|Step 1: Registration|Disese progression/relapse|0|||
27509105|NCT00068692|80057689|FG006|Step 1: Registration|Disese progression/relapse|0|||
27509106|NCT00068692|80057690|FG007|Step 1: Registration|Disese progression/relapse|0|||
27509107|NCT00068692|80057683|FG000|Step 1: Registration|Adverse Event|7|||
27509108|NCT00068692|80057684|FG001|Step 1: Registration|Adverse Event|0|||
27509109|NCT00068692|80057685|FG002|Step 1: Registration|Adverse Event|0|||
27509110|NCT00068692|80057686|FG003|Step 1: Registration|Adverse Event|0|||
27509111|NCT00068692|80057687|FG004|Step 1: Registration|Adverse Event|0|||
27509112|NCT00068692|80057688|FG005|Step 1: Registration|Adverse Event|0|||
27509113|NCT00068692|80057689|FG006|Step 1: Registration|Adverse Event|0|||
27509114|NCT00068692|80057690|FG007|Step 1: Registration|Adverse Event|0|||
27509115|NCT00068692|80057683|FG000|Step 1: Registration|Death|1|||
27509116|NCT00068692|80057684|FG001|Step 1: Registration|Death|0|||
27509117|NCT00068692|80057685|FG002|Step 1: Registration|Death|0|||
27509118|NCT00068692|80057686|FG003|Step 1: Registration|Death|0|||
27509119|NCT00068692|80057687|FG004|Step 1: Registration|Death|0|||
27509120|NCT00068692|80057688|FG005|Step 1: Registration|Death|0|||
27509121|NCT00068692|80057689|FG006|Step 1: Registration|Death|0|||
27509122|NCT00068692|80057690|FG007|Step 1: Registration|Death|0|||
27509123|NCT00068692|80057683|FG000|Step 1: Registration|Withdrawal by Subject|11|||
27509124|NCT00068692|80057684|FG001|Step 1: Registration|Withdrawal by Subject|0|||
27509125|NCT00068692|80057685|FG002|Step 1: Registration|Withdrawal by Subject|0|||
27509126|NCT00068692|80057686|FG003|Step 1: Registration|Withdrawal by Subject|0|||
27509127|NCT00068692|80057687|FG004|Step 1: Registration|Withdrawal by Subject|0|||
27509128|NCT00068692|80057688|FG005|Step 1: Registration|Withdrawal by Subject|0|||
27509129|NCT00068692|80057689|FG006|Step 1: Registration|Withdrawal by Subject|0|||
27509130|NCT00068692|80057690|FG007|Step 1: Registration|Withdrawal by Subject|0|||
27509131|NCT00068692|80057683|FG000|Step 1: Registration|Alternative therapy|2|||
27509132|NCT00068692|80057684|FG001|Step 1: Registration|Alternative therapy|0|||
27509133|NCT00068692|80057685|FG002|Step 1: Registration|Alternative therapy|0|||
27509134|NCT00068692|80057686|FG003|Step 1: Registration|Alternative therapy|0|||
27509135|NCT00068692|80057687|FG004|Step 1: Registration|Alternative therapy|0|||
27509136|NCT00068692|80057688|FG005|Step 1: Registration|Alternative therapy|0|||
27509137|NCT00068692|80057689|FG006|Step 1: Registration|Alternative therapy|0|||
27509138|NCT00068692|80057690|FG007|Step 1: Registration|Alternative therapy|0|||
27509139|NCT00068692|80057683|FG000|Step 1: Registration|Complicating disease|2|||
27509140|NCT00068692|80057684|FG001|Step 1: Registration|Complicating disease|0|||
27509141|NCT00068692|80057685|FG002|Step 1: Registration|Complicating disease|0|||
27509142|NCT00068692|80057686|FG003|Step 1: Registration|Complicating disease|0|||
27509143|NCT00068692|80057687|FG004|Step 1: Registration|Complicating disease|0|||
27509144|NCT00068692|80057688|FG005|Step 1: Registration|Complicating disease|0|||
27509145|NCT00068692|80057689|FG006|Step 1: Registration|Complicating disease|0|||
27509146|NCT00068692|80057690|FG007|Step 1: Registration|Complicating disease|0|||
27509147|NCT00068692|80057683|FG000|Step 1: Registration|Protocol Violation|1|||
27509148|NCT00068692|80057684|FG001|Step 1: Registration|Protocol Violation|0|||
27509149|NCT00068692|80057685|FG002|Step 1: Registration|Protocol Violation|0|||
27509150|NCT00068692|80057686|FG003|Step 1: Registration|Protocol Violation|0|||
27509151|NCT00068692|80057687|FG004|Step 1: Registration|Protocol Violation|0|||
27509152|NCT00068692|80057688|FG005|Step 1: Registration|Protocol Violation|0|||
27509153|NCT00068692|80057689|FG006|Step 1: Registration|Protocol Violation|0|||
27509154|NCT00068692|80057690|FG007|Step 1: Registration|Protocol Violation|0|||
27509155|NCT00068692|80057683|FG000|Step 1: Registration|Not eligible|6|||
27509156|NCT00068692|80057684|FG001|Step 1: Registration|Not eligible|0|||
27509157|NCT00068692|80057685|FG002|Step 1: Registration|Not eligible|0|||
27509158|NCT00068692|80057686|FG003|Step 1: Registration|Not eligible|0|||
27509159|NCT00068692|80057687|FG004|Step 1: Registration|Not eligible|0|||
27509160|NCT00068692|80057688|FG005|Step 1: Registration|Not eligible|0|||
27509161|NCT00068692|80057689|FG006|Step 1: Registration|Not eligible|0|||
27509162|NCT00068692|80057690|FG007|Step 1: Registration|Not eligible|0|||
27509163|NCT00068692|80057683|FG000|Step 1: Registration|Other|2|||
27509164|NCT00068692|80057684|FG001|Step 1: Registration|Other|0|||
27509165|NCT00068692|80057685|FG002|Step 1: Registration|Other|0|||
27509166|NCT00068692|80057686|FG003|Step 1: Registration|Other|0|||
27509167|NCT00068692|80057687|FG004|Step 1: Registration|Other|0|||
27509168|NCT00068692|80057688|FG005|Step 1: Registration|Other|0|||
27509169|NCT00068692|80057689|FG006|Step 1: Registration|Other|0|||
27509170|NCT00068692|80057690|FG007|Step 1: Registration|Other|0|||
27614750|NCT02291289|80430348|FG002|Induction Treatment|Protocol Violation|0|||
27852383|NCT01359644|81291116|FG003|Treatment Period|Adverse Event|0|||
27852384|NCT01359644|81291117|FG004|Treatment Period|Adverse Event|0|||
27852385|NCT01359644|81291118|FG005|Treatment Period|Adverse Event|1|||
27852386|NCT01359644|81291119|FG006|Treatment Period|Adverse Event|0|||
27852387|NCT01359644|81291120|FG007|Treatment Period|Adverse Event|0|||
27852388|NCT01359644|81291121|FG008|Treatment Period|Adverse Event|0|||
27852389|NCT01359644|81291122|FG009|Treatment Period|Adverse Event|0|||
27904465|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
27904466|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
27509171|NCT00068692|80057683|FG000|Step 1: Registration|Not start protocol therapy|3|||
27509172|NCT00068692|80057684|FG001|Step 1: Registration|Not start protocol therapy|0|||
27614751|NCT02291289|80430349|FG003|Induction Treatment|Protocol Violation|3|||
27509173|NCT00068692|80057685|FG002|Step 1: Registration|Not start protocol therapy|0|||
27509174|NCT00068692|80057686|FG003|Step 1: Registration|Not start protocol therapy|0|||
27509175|NCT00068692|80057687|FG004|Step 1: Registration|Not start protocol therapy|0|||
27509176|NCT00068692|80057688|FG005|Step 1: Registration|Not start protocol therapy|0|||
27852390|NCT01359644|81291113|FG000|Treatment Period|Lost to Follow-up|0|||
27852391|NCT01359644|81291114|FG001|Treatment Period|Lost to Follow-up|0|||
27904467|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Death|3|||
27904468|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Death|1|||
27509177|NCT00068692|80057689|FG006|Step 1: Registration|Not start protocol therapy|0|||
27509178|NCT00068692|80057690|FG007|Step 1: Registration|Not start protocol therapy|0|||
27509179|NCT00068692|80057683|FG000|Step 1: Registration|Registered but not randomized|0|||
27509180|NCT00068692|80057684|FG001|Step 1: Registration|Registered but not randomized|1|||
27509181|NCT00068692|80057685|FG002|Step 1: Registration|Registered but not randomized|0|||
27509182|NCT00068692|80057686|FG003|Step 1: Registration|Registered but not randomized|0|||
27509183|NCT00068692|80057687|FG004|Step 1: Registration|Registered but not randomized|0|||
27904469|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Death|1|||
27904470|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Discharged|2|||
27904471|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Discharged|1|||
27904472|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Discharged|0|||
27904473|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
27904474|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
27509184|NCT00068692|80057688|FG005|Step 1: Registration|Registered but not randomized|0|||
27509185|NCT00068692|80057689|FG006|Step 1: Registration|Registered but not randomized|0|||
27509186|NCT00068692|80057690|FG007|Step 1: Registration|Registered but not randomized|0|||
27509187|NCT00068692|80057683|FG000|Step 2: Randomization|Disesae progression/replase|0|||
27509188|NCT00068692|80057684|FG001|Step 2: Randomization|Disesae progression/replase|0|||
27509189|NCT00068692|80057685|FG002|Step 2: Randomization|Disesae progression/replase|1|||
27509190|NCT00068692|80057686|FG003|Step 2: Randomization|Disesae progression/replase|1|||
27509191|NCT00068692|80057687|FG004|Step 2: Randomization|Disesae progression/replase|0|||
27509192|NCT00068692|80057688|FG005|Step 2: Randomization|Disesae progression/replase|0|||
27509193|NCT00068692|80057689|FG006|Step 2: Randomization|Disesae progression/replase|0|||
27509194|NCT00068692|80057690|FG007|Step 2: Randomization|Disesae progression/replase|0|||
27509195|NCT00068692|80057683|FG000|Step 2: Randomization|Adverse Event|0|||
27509196|NCT00068692|80057684|FG001|Step 2: Randomization|Adverse Event|0|||
27509197|NCT00068692|80057685|FG002|Step 2: Randomization|Adverse Event|4|||
27509198|NCT00068692|80057686|FG003|Step 2: Randomization|Adverse Event|2|||
27509199|NCT00068692|80057687|FG004|Step 2: Randomization|Adverse Event|2|||
27509200|NCT00068692|80057688|FG005|Step 2: Randomization|Adverse Event|3|||
27509201|NCT00068692|80057689|FG006|Step 2: Randomization|Adverse Event|4|||
27509202|NCT00068692|80057690|FG007|Step 2: Randomization|Adverse Event|4|||
27509203|NCT00068692|80057683|FG000|Step 2: Randomization|Death|0|||
27509204|NCT00068692|80057684|FG001|Step 2: Randomization|Death|0|||
27509205|NCT00068692|80057685|FG002|Step 2: Randomization|Death|0|||
27509206|NCT00068692|80057686|FG003|Step 2: Randomization|Death|0|||
27509207|NCT00068692|80057687|FG004|Step 2: Randomization|Death|1|||
27509208|NCT00068692|80057688|FG005|Step 2: Randomization|Death|0|||
27509209|NCT00068692|80057689|FG006|Step 2: Randomization|Death|0|||
27509210|NCT00068692|80057690|FG007|Step 2: Randomization|Death|1|||
27509211|NCT00068692|80057683|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
27509212|NCT00068692|80057684|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
27509213|NCT00068692|80057685|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
27509214|NCT00068692|80057686|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
27509215|NCT00068692|80057687|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
27509216|NCT00068692|80057688|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
27509217|NCT00068692|80057689|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
27509218|NCT00068692|80057690|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
27509219|NCT00068692|80057683|FG000|Step 2: Randomization|alternative therapy|0|||
27509220|NCT00068692|80057684|FG001|Step 2: Randomization|alternative therapy|0|||
27509221|NCT00068692|80057685|FG002|Step 2: Randomization|alternative therapy|0|||
27509222|NCT00068692|80057686|FG003|Step 2: Randomization|alternative therapy|1|||
27509223|NCT00068692|80057687|FG004|Step 2: Randomization|alternative therapy|1|||
27509224|NCT00068692|80057688|FG005|Step 2: Randomization|alternative therapy|0|||
27509225|NCT00068692|80057689|FG006|Step 2: Randomization|alternative therapy|0|||
27509226|NCT00068692|80057690|FG007|Step 2: Randomization|alternative therapy|0|||
27509227|NCT00068692|80057683|FG000|Step 2: Randomization|Physician Decision|0|||
27509228|NCT00068692|80057684|FG001|Step 2: Randomization|Physician Decision|0|||
27509229|NCT00068692|80057685|FG002|Step 2: Randomization|Physician Decision|0|||
27509230|NCT00068692|80057686|FG003|Step 2: Randomization|Physician Decision|1|||
27509231|NCT00068692|80057687|FG004|Step 2: Randomization|Physician Decision|1|||
27904475|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
27904476|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
27509232|NCT00068692|80057688|FG005|Step 2: Randomization|Physician Decision|0|||
27509233|NCT00068692|80057689|FG006|Step 2: Randomization|Physician Decision|0|||
27509234|NCT00068692|80057690|FG007|Step 2: Randomization|Physician Decision|0|||
27509235|NCT00068692|80057683|FG000|Step 2: Randomization|Other|0|||
27509236|NCT00068692|80057684|FG001|Step 2: Randomization|Other|0|||
27509237|NCT00068692|80057685|FG002|Step 2: Randomization|Other|0|||
27509238|NCT00068692|80057686|FG003|Step 2: Randomization|Other|1|||
27509239|NCT00068692|80057687|FG004|Step 2: Randomization|Other|0|||
27904477|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
27904478|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
27904479|NCT01990768|81485223|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
27904480|NCT01990768|81485224|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
27904481|NCT01990768|81485225|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
27904482|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
27904483|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
27904484|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
27904485|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
27904486|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
27904487|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
27904488|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
27904489|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
27904490|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
27904491|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
27904492|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
27904493|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
27904494|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
27904495|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
27904496|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
27904497|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
27904498|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
27904499|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
27904500|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
27904501|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
27904502|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
27904503|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
27904504|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
27904505|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
27904506|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
27904507|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
27904508|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
27904509|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
27904510|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
27904511|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
27904512|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
27904513|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
27904514|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
27904515|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
27904516|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
27904517|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
27904518|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
27904519|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
27904520|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
27904521|NCT01990768|81485223|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
27904522|NCT01990768|81485224|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
27904523|NCT01990768|81485225|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
27904524|NCT01990768|81485223|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
27904525|NCT01990768|81485224|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
27904526|NCT01990768|81485225|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
27904527|NCT01990768|81485223|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
27904528|NCT01990768|81485224|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
27904529|NCT01990768|81485225|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
27904530|NCT01990768|81485223|FG000|6-Month Follow-up|No contact information|5|||
27904531|NCT01990768|81485224|FG001|6-Month Follow-up|No contact information|6|||
27904532|NCT01990768|81485225|FG002|6-Month Follow-up|No contact information|5|||
27904533|NCT01990768|81485223|FG000|6-Month Follow-up|Homeless|4|||
27904534|NCT01990768|81485224|FG001|6-Month Follow-up|Homeless|3|||
27904535|NCT01990768|81485225|FG002|6-Month Follow-up|Homeless|6|||
27904536|NCT01990768|81485223|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
27904537|NCT01990768|81485224|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
27904538|NCT01990768|81485225|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
27904539|NCT01990768|81485223|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
27904540|NCT01990768|81485224|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
27904541|NCT01990768|81485225|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
27904542|NCT01990768|81485223|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
27904543|NCT01990768|81485224|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
27904544|NCT01990768|81485225|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
27904545|NCT02065518|81485232|FG000|Overall Study|Lost to Follow-up|3|||
27904546|NCT02065518|81485233|FG001|Overall Study|Lost to Follow-up|4|||
27904547|NCT02065518|81485234|FG002|Overall Study|Lost to Follow-up|0|||
27904548|NCT02065518|81485235|FG003|Overall Study|Lost to Follow-up|3|||
27904549|NCT02065518|81485232|FG000|Overall Study|Withdrawal by Subject|3|||
27904550|NCT02065518|81485233|FG001|Overall Study|Withdrawal by Subject|4|||
27904551|NCT02065518|81485234|FG002|Overall Study|Withdrawal by Subject|9|||
27904552|NCT02065518|81485235|FG003|Overall Study|Withdrawal by Subject|2|||
27904553|NCT01216332|81485236|FG000|Overall Study|Withdrawal by Subject|4|||
27904554|NCT01216332|81485237|FG001|Overall Study|Withdrawal by Subject|0|||
27904555|NCT02985021|81485240|FG000|Overall Study|Inability to comply with study procedures|1|||
27904556|NCT02849171|81485241|FG000|Overall Study|Withdrawal by Subject|1|||
27904557|NCT02849171|81485241|FG000|Overall Study|Not treated|1|||
27904558|NCT01125813|81485252|FG000|Overall Study|Death|1|||
27904559|NCT01125813|81485252|FG000|Overall Study|Withdrawal by Subject|1|||
27904560|NCT01125813|81485252|FG000|Overall Study|Screen Failures|4|||
27904561|NCT01306214|81485253|FG000|Overall Study|Death|0|||
27904562|NCT01306214|81485254|FG001|Overall Study|Death|0|||
27904563|NCT01306214|81485255|FG002|Overall Study|Death|1|||
27904564|NCT01306214|81485253|FG000|Overall Study|Lost to Follow-up|3|||
27904565|NCT01306214|81485254|FG001|Overall Study|Lost to Follow-up|5|||
27904566|NCT01306214|81485255|FG002|Overall Study|Lost to Follow-up|4|||
27904567|NCT01306214|81485253|FG000|Overall Study|Withdrawal by Subject|24|||
27904568|NCT01306214|81485254|FG001|Overall Study|Withdrawal by Subject|22|||
27904569|NCT01306214|81485255|FG002|Overall Study|Withdrawal by Subject|16|||
27904570|NCT01306214|81485253|FG000|Overall Study|Not treated|1|||
27509240|NCT00068692|80057688|FG005|Step 2: Randomization|Other|1|||
27509241|NCT00068692|80057689|FG006|Step 2: Randomization|Other|0|||
27904571|NCT01306214|81485254|FG001|Overall Study|Not treated|1|||
27904572|NCT01306214|81485255|FG002|Overall Study|Not treated|1|||
27904573|NCT03066778|81485256|FG000|Overall Study|Death|195|||
27904574|NCT03066778|81485257|FG001|Overall Study|Death|205|||
27904575|NCT03066778|81485256|FG000|Overall Study|Withdrawal by Subject|5|||
27904576|NCT03066778|81485257|FG001|Overall Study|Withdrawal by Subject|7|||
27904577|NCT02797678|81485258|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
27904578|NCT02797678|81485259|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
27904579|NCT02797678|81485260|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
27904580|NCT02797678|81485261|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
27904581|NCT02797678|81485258|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
27904582|NCT02797678|81485259|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
27904583|NCT02797678|81485260|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
27904584|NCT02797678|81485261|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
27904585|NCT02797678|81485258|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
27904586|NCT02797678|81485259|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
27904587|NCT02797678|81485260|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
27904588|NCT02797678|81485261|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
27904589|NCT03472521|81485264|FG000|Overall Study|Lost to Follow-up|3|||
27904590|NCT03472521|81485265|FG001|Overall Study|Lost to Follow-up|2|||
27904591|NCT03472521|81485264|FG000|Overall Study|Discontinued intervention|3|||
27904592|NCT03472521|81485265|FG001|Overall Study|Discontinued intervention|1|||
27904593|NCT00551525|81485266|FG000|Overall Study|Protocol Violation|5|||
27904594|NCT01133288|81485267|FG000|Eligibility Assessment|met exclusion criteria|5|||
27904595|NCT01133288|81485267|FG000|Intervention Allocation|study terminated|2|||
27904596|NCT02087943|81485268|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
27904597|NCT02087943|81485269|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
27904598|NCT02087943|81485270|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
27904599|NCT02087943|81485271|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
27904600|NCT02087943|81485272|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
27904601|NCT02087943|81485268|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
27904602|NCT02087943|81485269|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
27904603|NCT02087943|81485270|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
27904604|NCT02087943|81485271|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
27904605|NCT02087943|81485272|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
27904606|NCT02087943|81485268|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
27904607|NCT02087943|81485269|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
27904608|NCT02087943|81485270|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
27904609|NCT02087943|81485271|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
27904610|NCT02087943|81485272|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
27904611|NCT02087943|81485268|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
27904612|NCT02087943|81485269|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
27904613|NCT02087943|81485270|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
27904614|NCT02087943|81485271|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
27904615|NCT02087943|81485272|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
27904616|NCT02087943|81485268|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27904617|NCT02087943|81485269|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
27904618|NCT02087943|81485270|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27904619|NCT02087943|81485271|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27904620|NCT02087943|81485272|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
27904621|NCT02087943|81485268|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
27904622|NCT02087943|81485269|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
27904623|NCT02087943|81485270|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
27509242|NCT00068692|80057690|FG007|Step 2: Randomization|Other|0|||
27509243|NCT00068692|80057683|FG000|Step 2: Randomization|never start protocol therapy|0|||
27509244|NCT00068692|80057684|FG001|Step 2: Randomization|never start protocol therapy|0|||
27509245|NCT00068692|80057685|FG002|Step 2: Randomization|never start protocol therapy|1|||
27509246|NCT00068692|80057686|FG003|Step 2: Randomization|never start protocol therapy|0|||
27509247|NCT00068692|80057687|FG004|Step 2: Randomization|never start protocol therapy|1|||
27509248|NCT00068692|80057688|FG005|Step 2: Randomization|never start protocol therapy|0|||
27728506|NCT00680836|80833306|FG000|Overall Study|Withdrawal by Subject|3|||
27728507|NCT00680836|80833307|FG001|Overall Study|Withdrawal by Subject|0|||
27728508|NCT00680836|80833306|FG000|Overall Study|Lost to Follow-up|3|||
27728509|NCT00680836|80833307|FG001|Overall Study|Lost to Follow-up|1|||
27728510|NCT00680836|80833306|FG000|Overall Study|Physician Decision|2|||
27728511|NCT00680836|80833307|FG001|Overall Study|Physician Decision|1|||
27728512|NCT02772757|80833313|FG000|Overall Study|Withdrawal by Subject|1|||
27728513|NCT02772757|80833314|FG001|Overall Study|Withdrawal by Subject|0|||
27728514|NCT02772757|80833315|FG002|Overall Study|Withdrawal by Subject|1|||
27728515|NCT02772757|80833313|FG000|Overall Study|Protocol Violation|0|||
27728516|NCT02772757|80833314|FG001|Overall Study|Protocol Violation|0|||
27904624|NCT02087943|81485271|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
27904625|NCT02087943|81485272|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
27509249|NCT00068692|80057689|FG006|Step 2: Randomization|never start protocol therapy|0|||
27509250|NCT00068692|80057690|FG007|Step 2: Randomization|never start protocol therapy|0|||
27728517|NCT02772757|80833315|FG002|Overall Study|Protocol Violation|1|||
27852392|NCT01359644|81291115|FG002|Treatment Period|Lost to Follow-up|0|||
27852393|NCT01359644|81291116|FG003|Treatment Period|Lost to Follow-up|0|||
27852394|NCT01359644|81291117|FG004|Treatment Period|Lost to Follow-up|0|||
27852395|NCT01359644|81291118|FG005|Treatment Period|Lost to Follow-up|1|||
27509251|NCT00477386|80057691|FG000|Overall Study|Adverse Event|4|||
27509252|NCT00477386|80057692|FG001|Overall Study|Adverse Event|8|||
27852396|NCT01359644|81291119|FG006|Treatment Period|Lost to Follow-up|0|||
27852397|NCT01359644|81291120|FG007|Treatment Period|Lost to Follow-up|0|||
27852398|NCT01359644|81291121|FG008|Treatment Period|Lost to Follow-up|0|||
27852399|NCT01359644|81291122|FG009|Treatment Period|Lost to Follow-up|0|||
27852400|NCT01359644|81291113|FG000|Follow-up Period|Withdrawal by Subject|0|||
27852401|NCT01359644|81291114|FG001|Follow-up Period|Withdrawal by Subject|0|||
27852402|NCT01359644|81291115|FG002|Follow-up Period|Withdrawal by Subject|0|||
27852403|NCT01359644|81291116|FG003|Follow-up Period|Withdrawal by Subject|0|||
27852404|NCT01359644|81291117|FG004|Follow-up Period|Withdrawal by Subject|0|||
27852405|NCT01359644|81291118|FG005|Follow-up Period|Withdrawal by Subject|1|||
27852406|NCT01359644|81291119|FG006|Follow-up Period|Withdrawal by Subject|0|||
27852407|NCT01359644|81291120|FG007|Follow-up Period|Withdrawal by Subject|0|||
27852408|NCT01359644|81291121|FG008|Follow-up Period|Withdrawal by Subject|0|||
27852409|NCT01359644|81291122|FG009|Follow-up Period|Withdrawal by Subject|0|||
27852410|NCT01359644|81291113|FG000|Follow-up Period|Lost to Follow-up|0|||
27852411|NCT01359644|81291114|FG001|Follow-up Period|Lost to Follow-up|0|||
27904626|NCT02087943|81485268|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
27904627|NCT02087943|81485269|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
27904628|NCT02087943|81485270|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
27904629|NCT02087943|81485271|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
27904630|NCT02087943|81485272|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
27904631|NCT02087943|81485268|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27852412|NCT01359644|81291115|FG002|Follow-up Period|Lost to Follow-up|0|||
27852413|NCT01359644|81291116|FG003|Follow-up Period|Lost to Follow-up|0|||
27852414|NCT01359644|81291117|FG004|Follow-up Period|Lost to Follow-up|0|||
27852415|NCT01359644|81291118|FG005|Follow-up Period|Lost to Follow-up|0|||
27852416|NCT01359644|81291119|FG006|Follow-up Period|Lost to Follow-up|1|||
27509253|NCT00477386|80057691|FG000|Overall Study|Disease progression, relapse|3|||
27509254|NCT00477386|80057692|FG001|Overall Study|Disease progression, relapse|4|||
27509255|NCT00477386|80057691|FG000|Overall Study|Disease progression, refractory|1|||
27509256|NCT00477386|80057692|FG001|Overall Study|Disease progression, refractory|3|||
27509257|NCT00477386|80057691|FG000|Overall Study|Other|1|||
27509258|NCT00477386|80057692|FG001|Overall Study|Other|2|||
27904632|NCT02087943|81485269|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27904633|NCT02087943|81485270|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
27904634|NCT02087943|81485271|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27904635|NCT02087943|81485272|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
27904636|NCT02087943|81485268|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27904637|NCT02087943|81485269|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27904638|NCT02087943|81485270|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27509259|NCT00477386|80057691|FG000|Overall Study|Physician Decision|1|||
27509260|NCT00477386|80057692|FG001|Overall Study|Physician Decision|0|||
27509261|NCT00477386|80057691|FG000|Overall Study|Withdrawal by Subject|1|||
27509262|NCT00477386|80057692|FG001|Overall Study|Withdrawal by Subject|0|||
27509263|NCT02266888|80057693|FG000|Overall Study|Death|2|||
27509264|NCT02266888|80057694|FG001|Overall Study|Death|2|||
27509265|NCT02266888|80057695|FG002|Overall Study|Death|4|||
27509266|NCT02266888|80057696|FG003|Overall Study|Death|2|||
27509267|NCT02266888|80057693|FG000|Overall Study|Physician Decision|0|||
27509268|NCT02266888|80057694|FG001|Overall Study|Physician Decision|1|||
27509269|NCT02266888|80057695|FG002|Overall Study|Physician Decision|2|||
27509270|NCT02266888|80057696|FG003|Overall Study|Physician Decision|2|||
27509271|NCT02266888|80057693|FG000|Overall Study|Study Terminated|5|||
27509272|NCT02266888|80057694|FG001|Overall Study|Study Terminated|1|||
27509273|NCT02266888|80057695|FG002|Overall Study|Study Terminated|0|||
27509274|NCT02266888|80057696|FG003|Overall Study|Study Terminated|0|||
27509275|NCT02266888|80057693|FG000|Overall Study|No Longer Eligible|0|||
27509276|NCT02266888|80057694|FG001|Overall Study|No Longer Eligible|0|||
27509277|NCT02266888|80057695|FG002|Overall Study|No Longer Eligible|0|||
27509278|NCT02266888|80057696|FG003|Overall Study|No Longer Eligible|2|||
27509279|NCT02266888|80057693|FG000|Overall Study|Randomization Closed|0|||
27509280|NCT02266888|80057694|FG001|Overall Study|Randomization Closed|0|||
27509281|NCT02266888|80057695|FG002|Overall Study|Randomization Closed|4|||
27509282|NCT02266888|80057696|FG003|Overall Study|Randomization Closed|0|||
27509283|NCT02266888|80057693|FG000|Overall Study|Personnel unavailable at transplant|0|||
27509284|NCT02266888|80057694|FG001|Overall Study|Personnel unavailable at transplant|0|||
27509285|NCT02266888|80057695|FG002|Overall Study|Personnel unavailable at transplant|0|||
27509286|NCT02266888|80057696|FG003|Overall Study|Personnel unavailable at transplant|1|||
27509287|NCT02266888|80057693|FG000|Overall Study|Transfer of care|0|||
27509288|NCT02266888|80057694|FG001|Overall Study|Transfer of care|0|||
27509289|NCT02266888|80057695|FG002|Overall Study|Transfer of care|1|||
27509290|NCT02266888|80057696|FG003|Overall Study|Transfer of care|0|||
27509291|NCT02858362|80057699|FG000|Overall Study|Protocol Violation|0|||
27509292|NCT02858362|80057700|FG001|Overall Study|Protocol Violation|1|||
27509293|NCT02858362|80057701|FG002|Overall Study|Protocol Violation|0|||
27509294|NCT02858362|80057699|FG000|Overall Study|Withdrawal by Subject|1|||
27509295|NCT02858362|80057700|FG001|Overall Study|Withdrawal by Subject|0|||
27728518|NCT02772757|80833313|FG000|Overall Study|Physician Decision|0|||
27852417|NCT01359644|81291120|FG007|Follow-up Period|Lost to Follow-up|2|||
27852418|NCT01359644|81291121|FG008|Follow-up Period|Lost to Follow-up|0|||
27852419|NCT01359644|81291122|FG009|Follow-up Period|Lost to Follow-up|0|||
27852420|NCT01111019|81291131|FG000|Overall Study|Withdrew Prematurely|2|||
27852421|NCT01111019|81291131|FG000|Overall Study|Other|1|||
27852422|NCT00855803|81291132|FG000|Overall Study|Death|2|||
27852423|NCT00855803|81291132|FG000|Overall Study|Lost to Follow-up|2|||
27852424|NCT00855803|81291132|FG000|Overall Study|Technical inability to undergo procedure|2|||
27904639|NCT02087943|81485271|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
27904640|NCT02087943|81485272|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
27509296|NCT02858362|80057701|FG002|Overall Study|Withdrawal by Subject|0|||
27509297|NCT02858362|80057699|FG000|Overall Study|Early Study Termination|0|||
27509298|NCT02858362|80057700|FG001|Overall Study|Early Study Termination|0|||
27509299|NCT02858362|80057701|FG002|Overall Study|Early Study Termination|3|||
27509300|NCT02858362|80057699|FG000|Overall Study|Lost to Follow-up|1|||
27509301|NCT02858362|80057700|FG001|Overall Study|Lost to Follow-up|0|||
27509302|NCT02858362|80057701|FG002|Overall Study|Lost to Follow-up|0|||
27728519|NCT02772757|80833314|FG001|Overall Study|Physician Decision|3|||
27509303|NCT02745119|80057702|FG000|Overall Study|Adverse Event|1|||
27509304|NCT02745119|80057703|FG001|Overall Study|Adverse Event|0|||
27509305|NCT02745119|80057704|FG002|Overall Study|Adverse Event|1|||
27509306|NCT02745119|80057705|FG003|Overall Study|Adverse Event|3|||
27509307|NCT02745119|80057702|FG000|Overall Study|Death|3|||
27509308|NCT02745119|80057703|FG001|Overall Study|Death|3|||
27509309|NCT02745119|80057704|FG002|Overall Study|Death|0|||
27509310|NCT02745119|80057705|FG003|Overall Study|Death|4|||
27509311|NCT02745119|80057702|FG000|Overall Study|Lost to Follow-up|0|||
27509312|NCT02745119|80057703|FG001|Overall Study|Lost to Follow-up|0|||
27509313|NCT02745119|80057704|FG002|Overall Study|Lost to Follow-up|0|||
27509314|NCT02745119|80057705|FG003|Overall Study|Lost to Follow-up|1|||
27509315|NCT02745119|80057702|FG000|Overall Study|Protocol Deviation|0|||
27509316|NCT02745119|80057703|FG001|Overall Study|Protocol Deviation|0|||
27509317|NCT02745119|80057704|FG002|Overall Study|Protocol Deviation|0|||
27509318|NCT02745119|80057705|FG003|Overall Study|Protocol Deviation|1|||
27509319|NCT02745119|80057702|FG000|Overall Study|Withdrawal by Subject|7|||
27509320|NCT02745119|80057703|FG001|Overall Study|Withdrawal by Subject|15|||
27509321|NCT02745119|80057704|FG002|Overall Study|Withdrawal by Subject|8|||
27509322|NCT02745119|80057705|FG003|Overall Study|Withdrawal by Subject|14|||
27509323|NCT02745119|80057702|FG000|Overall Study|Study Terminated by Sponsor|134|||
27509324|NCT02745119|80057703|FG001|Overall Study|Study Terminated by Sponsor|252|||
27509325|NCT02745119|80057704|FG002|Overall Study|Study Terminated by Sponsor|135|||
27509326|NCT02745119|80057705|FG003|Overall Study|Study Terminated by Sponsor|251|||
27728520|NCT02772757|80833315|FG002|Overall Study|Physician Decision|3|||
27852425|NCT00855803|81291132|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
27852426|NCT00855803|81291132|FG000|Overall Study|Withdrawal by Subject|3|||
27852427|NCT00855803|81291132|FG000|Overall Study|Physician Decision|3|||
27852428|NCT00750308|81291135|FG000|First Treatment|Adverse Event|0|||
27852429|NCT00750308|81291136|FG001|First Treatment|Adverse Event|1|||
27852430|NCT00750308|81291137|FG002|First Treatment|Adverse Event|0|||
27852431|NCT00750308|81291138|FG003|First Treatment|Adverse Event|0|||
27852432|NCT00750308|81291139|FG004|First Treatment|Adverse Event|0|||
27852433|NCT00750308|81291140|FG005|First Treatment|Adverse Event|0|||
27852434|NCT00750308|81291141|FG006|First Treatment|Adverse Event|0|||
27852435|NCT00750308|81291142|FG007|First Treatment|Adverse Event|0|||
27852436|NCT00750308|81291143|FG008|First Treatment|Adverse Event|0|||
27852437|NCT00750308|81291144|FG009|First Treatment|Adverse Event|0|||
27852438|NCT00750308|81291145|FG010|First Treatment|Adverse Event|1|||
27852439|NCT00750308|81291146|FG011|First Treatment|Adverse Event|1|||
27852440|NCT00750308|81291135|FG000|First Treatment|Withdrawal by Subject|0|||
27852441|NCT00750308|81291136|FG001|First Treatment|Withdrawal by Subject|0|||
27852442|NCT00750308|81291137|FG002|First Treatment|Withdrawal by Subject|0|||
27852443|NCT00750308|81291138|FG003|First Treatment|Withdrawal by Subject|1|||
27852444|NCT00750308|81291139|FG004|First Treatment|Withdrawal by Subject|0|||
27852445|NCT00750308|81291140|FG005|First Treatment|Withdrawal by Subject|0|||
27852446|NCT00750308|81291141|FG006|First Treatment|Withdrawal by Subject|0|||
27852447|NCT00750308|81291142|FG007|First Treatment|Withdrawal by Subject|1|||
27852448|NCT00750308|81291143|FG008|First Treatment|Withdrawal by Subject|0|||
27852449|NCT00750308|81291144|FG009|First Treatment|Withdrawal by Subject|0|||
27852450|NCT00750308|81291145|FG010|First Treatment|Withdrawal by Subject|0|||
27852451|NCT00750308|81291146|FG011|First Treatment|Withdrawal by Subject|0|||
27852452|NCT00750308|81291135|FG000|Second Treatment|Adverse Event|0|||
27852453|NCT00750308|81291136|FG001|Second Treatment|Adverse Event|0|||
27852454|NCT00750308|81291137|FG002|Second Treatment|Adverse Event|0|||
27852455|NCT00750308|81291138|FG003|Second Treatment|Adverse Event|0|||
27852456|NCT00750308|81291139|FG004|Second Treatment|Adverse Event|0|||
27852457|NCT00750308|81291140|FG005|Second Treatment|Adverse Event|1|||
27852458|NCT00750308|81291141|FG006|Second Treatment|Adverse Event|0|||
27852459|NCT00750308|81291142|FG007|Second Treatment|Adverse Event|0|||
27852460|NCT00750308|81291143|FG008|Second Treatment|Adverse Event|1|||
27728521|NCT02939131|80833316|FG000|Overall Study|Unable to get to clinic|6|||
27728522|NCT02939131|80833317|FG001|Overall Study|Unable to get to clinic|4|||
27852461|NCT00750308|81291144|FG009|Second Treatment|Adverse Event|0|||
27852462|NCT00750308|81291145|FG010|Second Treatment|Adverse Event|0|||
27852463|NCT00750308|81291146|FG011|Second Treatment|Adverse Event|0|||
27852464|NCT00750308|81291135|FG000|Second Treatment|Withdrawal by Subject|0|||
27852465|NCT00750308|81291136|FG001|Second Treatment|Withdrawal by Subject|0|||
27852466|NCT00750308|81291137|FG002|Second Treatment|Withdrawal by Subject|0|||
27852467|NCT00750308|81291138|FG003|Second Treatment|Withdrawal by Subject|0|||
27852468|NCT00750308|81291139|FG004|Second Treatment|Withdrawal by Subject|1|||
27852469|NCT00750308|81291140|FG005|Second Treatment|Withdrawal by Subject|0|||
27509327|NCT02745119|80057702|FG000|Overall Study|Physician Decision|0|||
27509328|NCT02745119|80057703|FG001|Overall Study|Physician Decision|2|||
27509329|NCT02745119|80057704|FG002|Overall Study|Physician Decision|2|||
27509330|NCT02745119|80057705|FG003|Overall Study|Physician Decision|2|||
27509331|NCT02745119|80057702|FG000|Overall Study|Reason Not Specified|0|||
27728523|NCT02939131|80833316|FG000|Overall Study|Lost to Follow-up|2|||
27852470|NCT00750308|81291141|FG006|Second Treatment|Withdrawal by Subject|0|||
27904641|NCT02087943|81485268|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
27904642|NCT02087943|81485269|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
27904643|NCT02087943|81485270|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
27904644|NCT02087943|81485271|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
27904645|NCT02087943|81485272|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
27904646|NCT01313221|81485273|FG000|Overall Study|Protocol Violation|0|||
27904647|NCT01313221|81485274|FG001|Overall Study|Protocol Violation|1|||
27904648|NCT01313221|81485275|FG002|Overall Study|Protocol Violation|1|||
27904649|NCT01313221|81485273|FG000|Overall Study|Non-compliance|3|||
27904650|NCT01313221|81485274|FG001|Overall Study|Non-compliance|0|||
27904651|NCT01313221|81485275|FG002|Overall Study|Non-compliance|2|||
27904652|NCT01313221|81485273|FG000|Overall Study|Withdrawal by Subject|2|||
27904653|NCT01313221|81485274|FG001|Overall Study|Withdrawal by Subject|3|||
27509332|NCT02745119|80057703|FG001|Overall Study|Reason Not Specified|2|||
27509333|NCT02745119|80057704|FG002|Overall Study|Reason Not Specified|0|||
27509334|NCT02745119|80057705|FG003|Overall Study|Reason Not Specified|1|||
27509335|NCT02377817|80057706|FG000|Overall Study|Transportation/childcare barriers.|2|||
27509336|NCT02377817|80057707|FG001|Overall Study|Transportation/childcare barriers.|0|||
27509337|NCT02377817|80057706|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
27509338|NCT02377817|80057707|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
27509339|NCT02215252|80057719|FG000|Overall Study|Adverse Event|1|||
27509340|NCT02215252|80057720|FG001|Overall Study|Adverse Event|5|||
27509341|NCT02215252|80057721|FG002|Overall Study|Adverse Event|2|||
27509342|NCT02215252|80057719|FG000|Overall Study|Lost to Follow-up|0|||
27509343|NCT02215252|80057720|FG001|Overall Study|Lost to Follow-up|0|||
27509344|NCT02215252|80057721|FG002|Overall Study|Lost to Follow-up|1|||
27509345|NCT02215252|80057719|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
27509346|NCT02215252|80057720|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
27509347|NCT02215252|80057721|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
27509348|NCT02215252|80057719|FG000|Overall Study|Protocol Violation|0|||
27509349|NCT02215252|80057720|FG001|Overall Study|Protocol Violation|1|||
27904654|NCT01313221|81485275|FG002|Overall Study|Withdrawal by Subject|5|||
27904655|NCT01313221|81485273|FG000|Overall Study|Requirement for alternative therapy|0|||
27509350|NCT02215252|80057721|FG002|Overall Study|Protocol Violation|0|||
27509351|NCT02215252|80057719|FG000|Overall Study|Withdrawal by Subject|1|||
27509352|NCT02215252|80057720|FG001|Overall Study|Withdrawal by Subject|0|||
27509353|NCT02215252|80057721|FG002|Overall Study|Withdrawal by Subject|0|||
27509354|NCT02215252|80057719|FG000|Overall Study|Other|0|||
27509355|NCT02215252|80057720|FG001|Overall Study|Other|1|||
27509356|NCT02215252|80057721|FG002|Overall Study|Other|1|||
27509357|NCT01821118|80057764|FG000|Overall Study|Death|0|||
27509358|NCT01821118|80057765|FG001|Overall Study|Death|1|||
27509359|NCT00753649|80057766|FG000|Overall Study|Migrated/moved from study area|1|||
27509360|NCT00753649|80057767|FG001|Overall Study|Migrated/moved from study area|0|||
27509361|NCT00753649|80057766|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
27509362|NCT00753649|80057767|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
27509363|NCT00753649|80057766|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
27509364|NCT00753649|80057767|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
27509365|NCT00753649|80057766|FG000|Overall Study|Protocol Violation|2|||
27509366|NCT00753649|80057767|FG001|Overall Study|Protocol Violation|0|||
27904656|NCT01313221|81485274|FG001|Overall Study|Requirement for alternative therapy|1|||
27904657|NCT01313221|81485275|FG002|Overall Study|Requirement for alternative therapy|1|||
27904658|NCT01313221|81485273|FG000|Overall Study|Lost to Follow-up|6|||
27904659|NCT01313221|81485274|FG001|Overall Study|Lost to Follow-up|3|||
27904660|NCT01313221|81485275|FG002|Overall Study|Lost to Follow-up|1|||
27904661|NCT01313221|81485273|FG000|Overall Study|Other|1|||
27509367|NCT01702311|80057768|FG000|Overall Study|Withdrawal by Subject|3|||
27509368|NCT01702311|80057769|FG001|Overall Study|Withdrawal by Subject|2|||
27509369|NCT01702311|80057768|FG000|Overall Study|Discharge less than 24 hours|10|||
27509370|NCT01702311|80057769|FG001|Overall Study|Discharge less than 24 hours|7|||
27509371|NCT01702311|80057768|FG000|Overall Study|Physician Decision|3|||
27509372|NCT01702311|80057769|FG001|Overall Study|Physician Decision|4|||
27614752|NCT02291289|80430350|FG004|Induction Treatment|Protocol Violation|0|||
27904662|NCT01313221|81485274|FG001|Overall Study|Other|0|||
27904663|NCT01313221|81485275|FG002|Overall Study|Other|0|||
27904664|NCT01313221|81485273|FG000|Overall Study|Adverse Event|0|||
27614753|NCT02291289|80430351|FG005|Induction Treatment|Protocol Violation|0|||
27728524|NCT02939131|80833317|FG001|Overall Study|Lost to Follow-up|4|||
27904665|NCT01313221|81485274|FG001|Overall Study|Adverse Event|0|||
27509373|NCT00807001|80057770|FG000|Overall Study|Non-compliance|0|||
27509374|NCT00807001|80057771|FG001|Overall Study|Non-compliance|1|||
27509375|NCT00807001|80057772|FG002|Overall Study|Non-compliance|0|||
27509376|NCT00807001|80057773|FG003|Overall Study|Non-compliance|0|||
27509377|NCT00807001|80057774|FG004|Overall Study|Non-compliance|0|||
27904666|NCT01313221|81485275|FG002|Overall Study|Adverse Event|7|||
27904667|NCT01313221|81485273|FG000|Overall Study|Disease progression|0|||
27509378|NCT03895840|80057775|FG000|Overall Study|Withdrawal by Subject|21|||
27509379|NCT03349034|80057776|FG000|Overall Study|catheters dislodged during transport|2|||
27509380|NCT03349034|80057777|FG001|Overall Study|catheters dislodged during transport|0|||
27509381|NCT03349034|80057776|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
27509382|NCT03349034|80057777|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
27509383|NCT03349034|80057776|FG000|Overall Study|soft tissue flap used|1|||
27509384|NCT03349034|80057777|FG001|Overall Study|soft tissue flap used|0|||
27509385|NCT03349034|80057776|FG000|Overall Study|Other|0|||
27509386|NCT03349034|80057777|FG001|Overall Study|Other|1|||
27509387|NCT01523756|80057778|FG000|Baseline Period|Adverse Event|0|||
27509388|NCT01523756|80057779|FG001|Baseline Period|Adverse Event|1|||
27509389|NCT01523756|80057778|FG000|Test Period 1|Adverse Event|1|||
27509390|NCT01523756|80057779|FG001|Test Period 1|Adverse Event|0|||
27509391|NCT01523756|80057778|FG000|Test Period 2|Withdrawal by Subject|0|||
27509392|NCT01523756|80057779|FG001|Test Period 2|Withdrawal by Subject|1|||
27509393|NCT03822117|80057782|FG000|Overall Study|Death|18|||
27509394|NCT03822117|80057783|FG001|Overall Study|Death|17|||
27509395|NCT03822117|80057784|FG002|Overall Study|Death|12|||
27509396|NCT03822117|80057785|FG003|Overall Study|Death|4|||
27509397|NCT03822117|80057782|FG000|Overall Study|Lost to Follow-up|1|||
27509398|NCT03822117|80057783|FG001|Overall Study|Lost to Follow-up|2|||
27509399|NCT03822117|80057784|FG002|Overall Study|Lost to Follow-up|3|||
27509400|NCT03822117|80057785|FG003|Overall Study|Lost to Follow-up|0|||
27509401|NCT03822117|80057782|FG000|Overall Study|Study Terminated by Sponsor|25|||
27509402|NCT03822117|80057783|FG001|Overall Study|Study Terminated by Sponsor|11|||
27509403|NCT03822117|80057784|FG002|Overall Study|Study Terminated by Sponsor|6|||
27509404|NCT03822117|80057785|FG003|Overall Study|Study Terminated by Sponsor|0|||
27509405|NCT03822117|80057782|FG000|Overall Study|Withdrawal by Subject|4|||
27509406|NCT03822117|80057783|FG001|Overall Study|Withdrawal by Subject|0|||
27509407|NCT03822117|80057784|FG002|Overall Study|Withdrawal by Subject|3|||
27509408|NCT03822117|80057785|FG003|Overall Study|Withdrawal by Subject|0|||
27509409|NCT03822117|80057782|FG000|Overall Study|Disease Progression|1|||
27509410|NCT03822117|80057783|FG001|Overall Study|Disease Progression|2|||
27509411|NCT03822117|80057784|FG002|Overall Study|Disease Progression|1|||
27509412|NCT03822117|80057785|FG003|Overall Study|Disease Progression|0|||
27509413|NCT03822117|80057782|FG000|Overall Study|Never Returned to Hospital|0|||
27509414|NCT03822117|80057783|FG001|Overall Study|Never Returned to Hospital|0|||
27509415|NCT03822117|80057784|FG002|Overall Study|Never Returned to Hospital|1|||
27509416|NCT03822117|80057785|FG003|Overall Study|Never Returned to Hospital|0|||
27904668|NCT01313221|81485274|FG001|Overall Study|Disease progression|0|||
27904669|NCT01313221|81485275|FG002|Overall Study|Disease progression|2|||
27904670|NCT01313221|81485273|FG000|Overall Study|Physician Decision|0|||
27904671|NCT01313221|81485274|FG001|Overall Study|Physician Decision|0|||
27904672|NCT01313221|81485275|FG002|Overall Study|Physician Decision|2|||
27904673|NCT01313221|81485273|FG000|Overall Study|Pregnancy|0|||
27904674|NCT01313221|81485274|FG001|Overall Study|Pregnancy|0|||
27509417|NCT00750438|80057789|FG000|Overall Study|Protocol Violation|4|||
27509418|NCT00750438|80057790|FG001|Overall Study|Protocol Violation|1|||
27509419|NCT00750438|80057789|FG000|Overall Study|Physician Decision|2|||
27509420|NCT00750438|80057790|FG001|Overall Study|Physician Decision|2|||
27509421|NCT00750438|80057789|FG000|Overall Study|Withdrawal by Subject|1|||
27904675|NCT01313221|81485275|FG002|Overall Study|Pregnancy|2|||
27904676|NCT03488563|81485283|FG000|Overall Study|Lost to Follow-up|7|||
27904677|NCT03488563|81485284|FG001|Overall Study|Lost to Follow-up|6|||
27904678|NCT03488563|81485285|FG002|Overall Study|Lost to Follow-up|7|||
27904679|NCT03488563|81485283|FG000|Overall Study|Withdrawal by Subject|8|||
27904680|NCT03488563|81485284|FG001|Overall Study|Withdrawal by Subject|7|||
27904681|NCT03488563|81485285|FG002|Overall Study|Withdrawal by Subject|7|||
27904682|NCT03488563|81485283|FG000|Overall Study|Physician Decision|0|||
27509422|NCT00750438|80057790|FG001|Overall Study|Withdrawal by Subject|1|||
27509423|NCT01598506|80057792|FG000|Overall Study|Withdrawal by Subject|2|||
27509424|NCT01177397|80057793|FG000|Overall Study|Protocol Violation|0|||
27509425|NCT01177397|80057794|FG001|Overall Study|Protocol Violation|0|||
27509426|NCT01177397|80057795|FG002|Overall Study|Protocol Violation|0|||
27509427|NCT01177397|80057796|FG003|Overall Study|Protocol Violation|0|||
27509428|NCT01177397|80057797|FG004|Overall Study|Protocol Violation|0|||
27509429|NCT01177397|80057798|FG005|Overall Study|Protocol Violation|1|||
27509430|NCT01177397|80057799|FG006|Overall Study|Protocol Violation|0|||
27509431|NCT01177397|80057800|FG007|Overall Study|Protocol Violation|0|||
27509432|NCT01177397|80057801|FG008|Overall Study|Protocol Violation|0|||
27509433|NCT01177397|80057802|FG009|Overall Study|Protocol Violation|0|||
27509434|NCT01177397|80057803|FG010|Overall Study|Protocol Violation|0|||
27509435|NCT01177397|80057804|FG011|Overall Study|Protocol Violation|0|||
27509436|NCT01177397|80057793|FG000|Overall Study|Lost to Follow-up|0|||
27509437|NCT01177397|80057794|FG001|Overall Study|Lost to Follow-up|0|||
27509438|NCT01177397|80057795|FG002|Overall Study|Lost to Follow-up|0|||
27509439|NCT01177397|80057796|FG003|Overall Study|Lost to Follow-up|0|||
27509440|NCT01177397|80057797|FG004|Overall Study|Lost to Follow-up|1|||
27614754|NCT02291289|80430352|FG006|Induction Treatment|Protocol Violation|0|||
27852471|NCT00750308|81291142|FG007|Second Treatment|Withdrawal by Subject|0|||
27852472|NCT00750308|81291143|FG008|Second Treatment|Withdrawal by Subject|0|||
27852473|NCT00750308|81291144|FG009|Second Treatment|Withdrawal by Subject|0|||
27852474|NCT00750308|81291145|FG010|Second Treatment|Withdrawal by Subject|0|||
27852475|NCT00750308|81291146|FG011|Second Treatment|Withdrawal by Subject|0|||
27852476|NCT00750308|81291135|FG000|Third Treatment|Withdrawal by Subject|0|||
27852477|NCT00750308|81291136|FG001|Third Treatment|Withdrawal by Subject|1|||
27852478|NCT00750308|81291137|FG002|Third Treatment|Withdrawal by Subject|0|||
27852479|NCT00750308|81291138|FG003|Third Treatment|Withdrawal by Subject|0|||
27852480|NCT00750308|81291139|FG004|Third Treatment|Withdrawal by Subject|0|||
27852481|NCT00750308|81291140|FG005|Third Treatment|Withdrawal by Subject|0|||
27852482|NCT00750308|81291141|FG006|Third Treatment|Withdrawal by Subject|0|||
27852483|NCT00750308|81291142|FG007|Third Treatment|Withdrawal by Subject|0|||
27852484|NCT00750308|81291143|FG008|Third Treatment|Withdrawal by Subject|0|||
27852485|NCT00750308|81291144|FG009|Third Treatment|Withdrawal by Subject|0|||
27852486|NCT00750308|81291145|FG010|Third Treatment|Withdrawal by Subject|0|||
27852487|NCT00750308|81291146|FG011|Third Treatment|Withdrawal by Subject|0|||
27852488|NCT02639052|81291148|FG000|Overall Study|Lost to Follow-up|1|||
27852489|NCT01769339|81291149|FG000|Overall Study|Lost to Follow-up|42|||
27852490|NCT01769339|81291149|FG000|Overall Study|Adverse Event|1|||
27852491|NCT00102687|81291155|FG000|Initial Period|Withdrawal by Subject|6|||
27852492|NCT00102687|81291156|FG001|Initial Period|Withdrawal by Subject|3|||
27852493|NCT00102687|81291157|FG002|Initial Period|Withdrawal by Subject|5|||
27852494|NCT00102687|81291158|FG003|Initial Period|Withdrawal by Subject|0|||
27852495|NCT00102687|81291159|FG004|Initial Period|Withdrawal by Subject|0|||
27852496|NCT00102687|81291155|FG000|Initial Period|Adverse Event|4|||
27852497|NCT00102687|81291156|FG001|Initial Period|Adverse Event|7|||
27852498|NCT00102687|81291157|FG002|Initial Period|Adverse Event|9|||
27852499|NCT00102687|81291158|FG003|Initial Period|Adverse Event|0|||
27852500|NCT00102687|81291159|FG004|Initial Period|Adverse Event|0|||
27852501|NCT00102687|81291155|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
27852502|NCT00102687|81291156|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
27852503|NCT00102687|81291157|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
27852504|NCT00102687|81291158|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
27852505|NCT00102687|81291159|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
27852506|NCT00102687|81291155|FG000|Initial Period|Protocol Violation|0|||
27852507|NCT00102687|81291156|FG001|Initial Period|Protocol Violation|0|||
27852508|NCT00102687|81291157|FG002|Initial Period|Protocol Violation|2|||
27904683|NCT03488563|81485284|FG001|Overall Study|Physician Decision|0|||
27509441|NCT01177397|80057798|FG005|Overall Study|Lost to Follow-up|0|||
27614755|NCT02291289|80430353|FG007|Induction Treatment|Protocol Violation|0|||
27614756|NCT02291289|80430354|FG008|Induction Treatment|Protocol Violation|0|||
27614757|NCT02291289|80430355|FG009|Induction Treatment|Protocol Violation|2|||
27852509|NCT00102687|81291158|FG003|Initial Period|Protocol Violation|0|||
27509442|NCT01177397|80057799|FG006|Overall Study|Lost to Follow-up|0|||
27728525|NCT02939131|80833316|FG000|Overall Study|severe debilitation|1|||
27852510|NCT00102687|81291159|FG004|Initial Period|Protocol Violation|0|||
27852511|NCT00102687|81291155|FG000|Initial Period|Physician Decision|2|||
27852512|NCT00102687|81291156|FG001|Initial Period|Physician Decision|9|||
27852513|NCT00102687|81291157|FG002|Initial Period|Physician Decision|6|||
27904684|NCT03488563|81485285|FG002|Overall Study|Physician Decision|1|||
27904685|NCT03488563|81485283|FG000|Overall Study|Protocol Violation|3|||
27904686|NCT03488563|81485284|FG001|Overall Study|Protocol Violation|2|||
27904687|NCT03488563|81485285|FG002|Overall Study|Protocol Violation|6|||
27904688|NCT03488563|81485283|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
27904689|NCT03488563|81485284|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
27904690|NCT03488563|81485285|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
27904691|NCT03488563|81485283|FG000|Overall Study|Use of prohibited medication|2|||
27509443|NCT01177397|80057800|FG007|Overall Study|Lost to Follow-up|2|||
27509444|NCT01177397|80057801|FG008|Overall Study|Lost to Follow-up|0|||
27509445|NCT01177397|80057802|FG009|Overall Study|Lost to Follow-up|0|||
27509446|NCT01177397|80057803|FG010|Overall Study|Lost to Follow-up|0|||
27509447|NCT01177397|80057804|FG011|Overall Study|Lost to Follow-up|0|||
27904692|NCT03488563|81485284|FG001|Overall Study|Use of prohibited medication|0|||
27904693|NCT03488563|81485285|FG002|Overall Study|Use of prohibited medication|0|||
27904694|NCT03488563|81485283|FG000|Overall Study|Adverse Event|1|||
27904695|NCT03488563|81485284|FG001|Overall Study|Adverse Event|0|||
27904696|NCT03488563|81485285|FG002|Overall Study|Adverse Event|1|||
27904697|NCT03488563|81485283|FG000|Overall Study|Subject returned for ET visit|0|||
27904698|NCT03488563|81485284|FG001|Overall Study|Subject returned for ET visit|1|||
27904699|NCT03488563|81485285|FG002|Overall Study|Subject returned for ET visit|0|||
27904700|NCT03488563|81485283|FG000|Overall Study|Sponsor's decision|0|||
27904701|NCT03488563|81485284|FG001|Overall Study|Sponsor's decision|0|||
27904702|NCT03488563|81485285|FG002|Overall Study|Sponsor's decision|1|||
27904703|NCT00731731|81485286|FG000|Overall Study|Protocol Violation|0|||
27904704|NCT00731731|81485287|FG001|Overall Study|Protocol Violation|0|||
27904705|NCT00731731|81485288|FG002|Overall Study|Protocol Violation|1|||
27904706|NCT00731731|81485286|FG000|Overall Study|Cancel prior to treatment|0|||
27904707|NCT00731731|81485287|FG001|Overall Study|Cancel prior to treatment|0|||
27904708|NCT00731731|81485288|FG002|Overall Study|Cancel prior to treatment|2|||
27904709|NCT03373461|81485291|FG000|Part 2|Adverse Event|0|||
27904710|NCT03373461|81485292|FG001|Part 2|Adverse Event|1|||
27904711|NCT03373461|81485293|FG002|Part 2|Adverse Event|0|||
27904712|NCT03373461|81485294|FG003|Part 2|Adverse Event|0|||
27904713|NCT03373461|81485295|FG004|Part 2|Adverse Event|1|||
27904714|NCT01777139|81485296|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
27904715|NCT01777139|81485297|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
27904716|NCT01777139|81485296|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
27904717|NCT01777139|81485297|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
27904718|NCT01777139|81485296|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
27904719|NCT01777139|81485297|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
27904720|NCT01777139|81485296|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
27904721|NCT01777139|81485297|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
27904722|NCT01777139|81485296|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
27904723|NCT01777139|81485297|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
27904724|NCT01777139|81485296|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
27904725|NCT01777139|81485297|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
27904726|NCT01777139|81485296|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
27904727|NCT01777139|81485297|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
27904728|NCT01777139|81485296|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
27904729|NCT01777139|81485297|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
27904730|NCT02933528|81488419|FG000|Overall Study|Lost to Follow-up|2|||
27904731|NCT03173456|81488428|FG000|Baseline|Medication dispensing system malfunction'|0|||
27904732|NCT03173456|81488429|FG001|Baseline|Medication dispensing system malfunction'|1|||
27904733|NCT03173456|81488430|FG002|Baseline|Medication dispensing system malfunction'|0|||
27904734|NCT03173456|81488431|FG003|Baseline|Medication dispensing system malfunction'|0|||
27904735|NCT03173456|81488432|FG004|Baseline|Medication dispensing system malfunction'|2|||
27904736|NCT03173456|81488428|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
27904737|NCT03173456|81488429|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
27904738|NCT03173456|81488430|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
27509448|NCT01177397|80057793|FG000|Overall Study|Death|0|||
27509449|NCT01177397|80057794|FG001|Overall Study|Death|0|||
27904739|NCT03173456|81488431|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
27904740|NCT03173456|81488432|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
27904741|NCT02178358|81488433|FG000|Overall Study|Withdrawal by Subject|0|||
27904742|NCT02178358|81488434|FG001|Overall Study|Withdrawal by Subject|2|||
27904743|NCT02178358|81488435|FG002|Overall Study|Withdrawal by Subject|2|||
27904744|NCT02178358|81488433|FG000|Overall Study|Lost to Follow-up|1|||
27904745|NCT02178358|81488434|FG001|Overall Study|Lost to Follow-up|0|||
27509450|NCT01177397|80057795|FG002|Overall Study|Death|1|||
27509451|NCT01177397|80057796|FG003|Overall Study|Death|1|||
27509452|NCT01177397|80057797|FG004|Overall Study|Death|0|||
27509453|NCT01177397|80057798|FG005|Overall Study|Death|0|||
27904746|NCT02178358|81488435|FG002|Overall Study|Lost to Follow-up|0|||
27904747|NCT04336475|81488436|FG000|Overall Study|pain|1|||
27904748|NCT04336475|81488437|FG001|Overall Study|pain|0|||
27904749|NCT04336475|81488436|FG000|Overall Study|upper respiratory infection|1|||
27904750|NCT04336475|81488437|FG001|Overall Study|upper respiratory infection|0|||
27904751|NCT04336475|81488436|FG000|Overall Study|Lost to Follow-up|0|||
27904752|NCT04336475|81488437|FG001|Overall Study|Lost to Follow-up|2|||
27904753|NCT02442206|81488438|FG000|Period 1|Adverse Event|1|||
27904754|NCT02442206|81488439|FG001|Period 1|Adverse Event|1|||
27904755|NCT02442206|81488438|FG000|Period 1|withdrew consent|0|||
27904756|NCT02442206|81488439|FG001|Period 1|withdrew consent|1|||
27904757|NCT02442206|81488438|FG000|Period 1|COPD exacerbation|0|||
27904758|NCT02442206|81488439|FG001|Period 1|COPD exacerbation|1|||
27904759|NCT02442206|81488438|FG000|Period 2|Adverse Event|1|||
27904760|NCT02442206|81488439|FG001|Period 2|Adverse Event|0|||
27904761|NCT01299896|81488447|FG000|Overall Study|Withdrawal by Subject|1|||
27904762|NCT01299896|81488448|FG001|Overall Study|Withdrawal by Subject|7|||
27904763|NCT01299896|81488447|FG000|Overall Study|Lost to Follow-up|0|||
27904764|NCT01299896|81488448|FG001|Overall Study|Lost to Follow-up|11|||
27904765|NCT01424241|81488449|FG000|Overall Study|Withdrawal by Subject|1|||
27509454|NCT01177397|80057799|FG006|Overall Study|Death|0|||
27509455|NCT01177397|80057800|FG007|Overall Study|Death|5|||
27509456|NCT01177397|80057801|FG008|Overall Study|Death|2|||
27509457|NCT01177397|80057802|FG009|Overall Study|Death|1|||
27509458|NCT01177397|80057803|FG010|Overall Study|Death|0|||
27728526|NCT02939131|80833317|FG001|Overall Study|severe debilitation|0|||
27728527|NCT02939131|80833316|FG000|Overall Study|Other|0|||
27728528|NCT02939131|80833317|FG001|Overall Study|Other|1|||
27728529|NCT02939131|80833316|FG000|Overall Study|not willing to adhere to protocol|2|||
27728530|NCT02939131|80833317|FG001|Overall Study|not willing to adhere to protocol|0|||
27509459|NCT01177397|80057804|FG011|Overall Study|Death|0|||
27509460|NCT01177397|80057793|FG000|Overall Study|Withdrawal by Subject|0|||
27509461|NCT01177397|80057794|FG001|Overall Study|Withdrawal by Subject|0|||
27509462|NCT01177397|80057795|FG002|Overall Study|Withdrawal by Subject|1|||
27509463|NCT01177397|80057796|FG003|Overall Study|Withdrawal by Subject|1|||
27509464|NCT01177397|80057797|FG004|Overall Study|Withdrawal by Subject|1|||
27509465|NCT01177397|80057798|FG005|Overall Study|Withdrawal by Subject|2|||
27852514|NCT00102687|81291158|FG003|Initial Period|Physician Decision|0|||
27852515|NCT00102687|81291159|FG004|Initial Period|Physician Decision|0|||
27852516|NCT00102687|81291155|FG000|Initial Period|Sponsor's decision|0|||
27852517|NCT00102687|81291156|FG001|Initial Period|Sponsor's decision|1|||
27852518|NCT00102687|81291157|FG002|Initial Period|Sponsor's decision|1|||
27852519|NCT00102687|81291158|FG003|Initial Period|Sponsor's decision|0|||
27509466|NCT01177397|80057799|FG006|Overall Study|Withdrawal by Subject|0|||
27509467|NCT01177397|80057800|FG007|Overall Study|Withdrawal by Subject|5|||
27509468|NCT01177397|80057801|FG008|Overall Study|Withdrawal by Subject|9|||
27509469|NCT01177397|80057802|FG009|Overall Study|Withdrawal by Subject|1|||
27509470|NCT01177397|80057803|FG010|Overall Study|Withdrawal by Subject|1|||
27509471|NCT01177397|80057804|FG011|Overall Study|Withdrawal by Subject|0|||
27509472|NCT01177397|80057793|FG000|Overall Study|Adverse Event|0|||
27509473|NCT01177397|80057794|FG001|Overall Study|Adverse Event|0|||
27509474|NCT01177397|80057795|FG002|Overall Study|Adverse Event|1|||
27509475|NCT01177397|80057796|FG003|Overall Study|Adverse Event|2|||
27509476|NCT01177397|80057797|FG004|Overall Study|Adverse Event|0|||
27509477|NCT01177397|80057798|FG005|Overall Study|Adverse Event|12|||
27509478|NCT01177397|80057799|FG006|Overall Study|Adverse Event|1|||
27509479|NCT01177397|80057800|FG007|Overall Study|Adverse Event|14|||
27509480|NCT01177397|80057801|FG008|Overall Study|Adverse Event|8|||
27509481|NCT01177397|80057802|FG009|Overall Study|Adverse Event|6|||
27509482|NCT01177397|80057803|FG010|Overall Study|Adverse Event|3|||
27614758|NCT02291289|80430356|FG010|Induction Treatment|Protocol Violation|0|||
27852520|NCT00102687|81291159|FG004|Initial Period|Sponsor's decision|0|||
27852521|NCT00102687|81291155|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
27904766|NCT01424241|81488449|FG000|Overall Study|Time constraints|2|||
27904767|NCT00703326|81488451|FG000|Overall Study|Lost to Follow-up|47|||
27904768|NCT00703326|81488452|FG001|Overall Study|Lost to Follow-up|18|||
27614759|NCT02291289|80430357|FG011|Induction Treatment|Protocol Violation|0|||
27614760|NCT02291289|80430358|FG012|Induction Treatment|Protocol Violation|0|||
27852522|NCT00102687|81291156|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
27904769|NCT00703326|81488451|FG000|Overall Study|Withdrawal by Subject|54|||
27904770|NCT00703326|81488452|FG001|Overall Study|Withdrawal by Subject|20|||
27509483|NCT01177397|80057804|FG011|Overall Study|Adverse Event|7|||
27509484|NCT01177397|80057793|FG000|Overall Study|Disease progression|1|||
27509485|NCT01177397|80057794|FG001|Overall Study|Disease progression|2|||
27509486|NCT01177397|80057795|FG002|Overall Study|Disease progression|5|||
27509487|NCT01177397|80057796|FG003|Overall Study|Disease progression|5|||
27728531|NCT02116621|80833318|FG000|Baseline|Withdrawal by Subject|0|||
27904771|NCT00703326|81488451|FG000|Overall Study|Adverse Event|1|||
27728532|NCT02116621|80833319|FG001|Baseline|Withdrawal by Subject|4|||
27904772|NCT00703326|81488452|FG001|Overall Study|Adverse Event|0|||
27509488|NCT01177397|80057797|FG004|Overall Study|Disease progression|4|||
27509489|NCT01177397|80057798|FG005|Overall Study|Disease progression|10|||
27509490|NCT01177397|80057799|FG006|Overall Study|Disease progression|10|||
27509491|NCT01177397|80057800|FG007|Overall Study|Disease progression|21|||
27509492|NCT01177397|80057801|FG008|Overall Study|Disease progression|18|||
27509493|NCT01177397|80057802|FG009|Overall Study|Disease progression|12|||
27509494|NCT01177397|80057803|FG010|Overall Study|Disease progression|10|||
27509495|NCT01177397|80057804|FG011|Overall Study|Disease progression|8|||
27509496|NCT01177397|80057793|FG000|Overall Study|Other reasons|0|||
27509497|NCT01177397|80057794|FG001|Overall Study|Other reasons|0|||
27509498|NCT01177397|80057795|FG002|Overall Study|Other reasons|1|||
27509499|NCT01177397|80057796|FG003|Overall Study|Other reasons|0|||
27509500|NCT01177397|80057797|FG004|Overall Study|Other reasons|1|||
27509501|NCT01177397|80057798|FG005|Overall Study|Other reasons|1|||
27509502|NCT01177397|80057799|FG006|Overall Study|Other reasons|2|||
27509503|NCT01177397|80057800|FG007|Overall Study|Other reasons|6|||
27509504|NCT01177397|80057801|FG008|Overall Study|Other reasons|10|||
27509505|NCT01177397|80057802|FG009|Overall Study|Other reasons|8|||
27509506|NCT01177397|80057803|FG010|Overall Study|Other reasons|0|||
27509507|NCT01177397|80057804|FG011|Overall Study|Other reasons|2|||
27509508|NCT02492763|80057806|FG000|Overall Study|Withdrawal by Subject|0|||
27509509|NCT02492763|80057807|FG001|Overall Study|Withdrawal by Subject|2|||
27509510|NCT02492763|80057808|FG002|Overall Study|Withdrawal by Subject|1|||
27509511|NCT02492763|80057809|FG003|Overall Study|Withdrawal by Subject|0|||
27509512|NCT02492763|80057806|FG000|Overall Study|Adverse Event|3|||
27509513|NCT02492763|80057807|FG001|Overall Study|Adverse Event|1|||
27509514|NCT02492763|80057808|FG002|Overall Study|Adverse Event|1|||
27509515|NCT02492763|80057809|FG003|Overall Study|Adverse Event|2|||
27509516|NCT02492763|80057806|FG000|Overall Study|Death|0|||
27509517|NCT02492763|80057807|FG001|Overall Study|Death|0|||
27509518|NCT02492763|80057808|FG002|Overall Study|Death|1|||
27509519|NCT02492763|80057809|FG003|Overall Study|Death|0|||
27509520|NCT02492763|80057806|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
27509521|NCT02492763|80057807|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
27509522|NCT02492763|80057808|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
27509523|NCT02492763|80057809|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
27509524|NCT02492763|80057806|FG000|Overall Study|Lost to Follow-up|0|||
27509525|NCT02492763|80057807|FG001|Overall Study|Lost to Follow-up|0|||
27509526|NCT02492763|80057808|FG002|Overall Study|Lost to Follow-up|1|||
27509527|NCT02492763|80057809|FG003|Overall Study|Lost to Follow-up|0|||
27509528|NCT02492763|80057806|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27509529|NCT02492763|80057807|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27509530|NCT02492763|80057808|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27509531|NCT02492763|80057809|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27509532|NCT02492763|80057806|FG000|Overall Study|Screen Failure|0|||
27509533|NCT02492763|80057807|FG001|Overall Study|Screen Failure|0|||
27509534|NCT02492763|80057808|FG002|Overall Study|Screen Failure|0|||
27509535|NCT02492763|80057809|FG003|Overall Study|Screen Failure|1|||
27509536|NCT02492763|80057806|FG000|Overall Study|Study Terminated by Sponsor|13|||
27509537|NCT02492763|80057807|FG001|Overall Study|Study Terminated by Sponsor|10|||
27509538|NCT02492763|80057808|FG002|Overall Study|Study Terminated by Sponsor|6|||
27509539|NCT02492763|80057809|FG003|Overall Study|Study Terminated by Sponsor|10|||
27509540|NCT01287741|80057810|FG000|Overall Study|Withdrawal by Subject|35|||
27509541|NCT01287741|80057811|FG001|Overall Study|Withdrawal by Subject|38|||
27509542|NCT01287741|80057810|FG000|Overall Study|Protocol Violation|2|||
27852523|NCT00102687|81291157|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
27852524|NCT00102687|81291158|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
27852525|NCT00102687|81291159|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
27852526|NCT00102687|81291155|FG000|Initial Period|Death|1|||
27852527|NCT00102687|81291156|FG001|Initial Period|Death|1|||
27852528|NCT00102687|81291157|FG002|Initial Period|Death|1|||
27852529|NCT00102687|81291158|FG003|Initial Period|Death|0|||
27852530|NCT00102687|81291159|FG004|Initial Period|Death|0|||
27852531|NCT00102687|81291155|FG000|Maintenance Period|Withdrawal by Subject|4|||
27852532|NCT00102687|81291156|FG001|Maintenance Period|Withdrawal by Subject|0|||
27852533|NCT00102687|81291157|FG002|Maintenance Period|Withdrawal by Subject|2|||
27509543|NCT01287741|80057811|FG001|Overall Study|Protocol Violation|0|||
27509544|NCT01287741|80057810|FG000|Overall Study|Physician Decision|15|||
27509545|NCT01287741|80057811|FG001|Overall Study|Physician Decision|23|||
27509546|NCT01287741|80057810|FG000|Overall Study|Non-compliance|8|||
27509547|NCT01287741|80057811|FG001|Overall Study|Non-compliance|6|||
27509548|NCT01287741|80057810|FG000|Overall Study|Lost to Follow-up|10|||
27509549|NCT01287741|80057811|FG001|Overall Study|Lost to Follow-up|8|||
27509550|NCT01287741|80057810|FG000|Overall Study|Death|32|||
27614761|NCT02291289|80430346|FG000|Induction Treatment|Missing|4|||
27614762|NCT02291289|80430347|FG001|Induction Treatment|Missing|0|||
27509551|NCT01287741|80057811|FG001|Overall Study|Death|44|||
27614763|NCT02291289|80430348|FG002|Induction Treatment|Missing|0|||
27614764|NCT02291289|80430349|FG003|Induction Treatment|Missing|14|||
27614765|NCT02291289|80430350|FG004|Induction Treatment|Missing|0|||
27614766|NCT02291289|80430351|FG005|Induction Treatment|Missing|0|||
27614767|NCT02291289|80430352|FG006|Induction Treatment|Missing|0|||
27614768|NCT02291289|80430353|FG007|Induction Treatment|Missing|0|||
27614769|NCT02291289|80430354|FG008|Induction Treatment|Missing|0|||
27614770|NCT02291289|80430355|FG009|Induction Treatment|Missing|54|||
27614771|NCT02291289|80430356|FG010|Induction Treatment|Missing|0|||
27614772|NCT02291289|80430357|FG011|Induction Treatment|Missing|0|||
27614773|NCT02291289|80430358|FG012|Induction Treatment|Missing|0|||
27852534|NCT00102687|81291158|FG003|Maintenance Period|Withdrawal by Subject|3|||
27852535|NCT00102687|81291159|FG004|Maintenance Period|Withdrawal by Subject|1|||
27614774|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27614775|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27614776|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27728533|NCT02116621|80833318|FG000|Three Month Follow-up|Death|1|||
27852536|NCT00102687|81291155|FG000|Maintenance Period|Adverse Event|1|||
27509552|NCT01287741|80057810|FG000|Overall Study|Adverse Event|4|||
27509553|NCT01287741|80057811|FG001|Overall Study|Adverse Event|6|||
27614777|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27614778|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
27614779|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
27614780|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27852537|NCT00102687|81291156|FG001|Maintenance Period|Adverse Event|0|||
27852538|NCT00102687|81291157|FG002|Maintenance Period|Adverse Event|0|||
27509554|NCT01287741|80057810|FG000|Overall Study|Study terminated by Sponsor|307|||
27509555|NCT01287741|80057811|FG001|Overall Study|Study terminated by Sponsor|315|||
27509556|NCT01287741|80057810|FG000|Overall Study|Progressive disease|190|||
27614781|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27614782|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27852539|NCT00102687|81291158|FG003|Maintenance Period|Adverse Event|1|||
27509557|NCT01287741|80057811|FG001|Overall Study|Progressive disease|166|||
27509558|NCT01287741|80057810|FG000|Overall Study|Reason not specified|23|||
27509559|NCT01287741|80057811|FG001|Overall Study|Reason not specified|9|||
27509560|NCT04198714|80057812|FG000|Overall Study|Physician Decision|0|||
27509561|NCT04198714|80057813|FG001|Overall Study|Physician Decision|1|||
27509562|NCT03682770|80057821|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
27509563|NCT03682770|80057822|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
27509564|NCT03682770|80057823|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
27509565|NCT03682770|80057824|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
27509566|NCT03682770|80057825|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
27509567|NCT03682770|80057826|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
27509568|NCT03682770|80057827|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
27509569|NCT03682770|80057821|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
27509570|NCT03682770|80057822|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
27509571|NCT03682770|80057823|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
27509572|NCT03682770|80057824|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
27852540|NCT00102687|81291159|FG004|Maintenance Period|Adverse Event|3|||
27852541|NCT00102687|81291155|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
27852542|NCT00102687|81291156|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
27852543|NCT00102687|81291157|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
27852544|NCT00102687|81291158|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
27852545|NCT00102687|81291159|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
27852546|NCT00102687|81291155|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
27852547|NCT00102687|81291156|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
27852548|NCT00102687|81291157|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
27852549|NCT00102687|81291158|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
27852550|NCT00102687|81291159|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
27852551|NCT00102687|81291155|FG000|Maintenance Period|Death|0|||
27852552|NCT00102687|81291156|FG001|Maintenance Period|Death|0|||
27852553|NCT00102687|81291157|FG002|Maintenance Period|Death|0|||
27852554|NCT00102687|81291158|FG003|Maintenance Period|Death|1|||
27852555|NCT00102687|81291159|FG004|Maintenance Period|Death|1|||
27852556|NCT00102687|81291155|FG000|Maintenance Period|Physician Decision|1|||
27852557|NCT00102687|81291156|FG001|Maintenance Period|Physician Decision|2|||
27852558|NCT00102687|81291157|FG002|Maintenance Period|Physician Decision|3|||
27852559|NCT00102687|81291158|FG003|Maintenance Period|Physician Decision|0|||
27852560|NCT00102687|81291159|FG004|Maintenance Period|Physician Decision|4|||
27852561|NCT01524913|81291160|FG000|Overall Study|Lost to Follow-up|4|||
27852562|NCT01524913|81291161|FG001|Overall Study|Lost to Follow-up|0|||
27852563|NCT01524913|81291162|FG002|Overall Study|Lost to Follow-up|0|||
27852564|NCT02856880|81291164|FG000|Overall Study|Withdrawal of consent|1|||
27852565|NCT03118570|81291165|FG000|Overall Study|Adverse Event|2|||
27852566|NCT03118570|81291166|FG001|Overall Study|Adverse Event|0|||
27852567|NCT03118570|81291167|FG002|Overall Study|Adverse Event|0|||
27852568|NCT03118570|81291168|FG003|Overall Study|Adverse Event|0|||
27852569|NCT03118570|81291169|FG004|Overall Study|Adverse Event|3|||
27852570|NCT03118570|81291165|FG000|Overall Study|Withdrawal by Subject|0|||
27852571|NCT03118570|81291166|FG001|Overall Study|Withdrawal by Subject|1|||
27852572|NCT03118570|81291167|FG002|Overall Study|Withdrawal by Subject|4|||
27852573|NCT03118570|81291168|FG003|Overall Study|Withdrawal by Subject|0|||
27852574|NCT03118570|81291169|FG004|Overall Study|Withdrawal by Subject|1|||
27852575|NCT03118570|81291165|FG000|Overall Study|Lost to Follow-up|2|||
27852576|NCT03118570|81291166|FG001|Overall Study|Lost to Follow-up|3|||
27852577|NCT03118570|81291167|FG002|Overall Study|Lost to Follow-up|1|||
27852578|NCT03118570|81291168|FG003|Overall Study|Lost to Follow-up|0|||
27852579|NCT03118570|81291169|FG004|Overall Study|Lost to Follow-up|1|||
27852580|NCT03118570|81291165|FG000|Overall Study|Other, Not Specified|1|||
27509573|NCT03682770|80057825|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
27509574|NCT03682770|80057826|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
27852581|NCT03118570|81291166|FG001|Overall Study|Other, Not Specified|3|||
27852582|NCT03118570|81291167|FG002|Overall Study|Other, Not Specified|0|||
27509575|NCT03682770|80057827|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
27509576|NCT03682770|80057821|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
27728534|NCT02116621|80833319|FG001|Three Month Follow-up|Death|1|||
27852583|NCT03118570|81291168|FG003|Overall Study|Other, Not Specified|0|||
27852584|NCT03118570|81291169|FG004|Overall Study|Other, Not Specified|0|||
27852585|NCT00793780|81291170|FG000|Overall Study|Withdrawal by Subject|2|||
27728535|NCT02116621|80833318|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
27728536|NCT02116621|80833319|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
27728537|NCT02116621|80833318|FG000|Three Month Follow-up|Lost to Follow-up|0|||
27728538|NCT02116621|80833319|FG001|Three Month Follow-up|Lost to Follow-up|1|||
27728539|NCT02116621|80833318|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
27728540|NCT02116621|80833319|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
27728541|NCT02116621|80833318|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
27728542|NCT02116621|80833319|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
27728543|NCT02116621|80833318|FG000|Six Month Follow-up|Lost to Follow-up|2|||
27728544|NCT02116621|80833319|FG001|Six Month Follow-up|Lost to Follow-up|1|||
27728545|NCT02116621|80833318|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
27728546|NCT02116621|80833319|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
27728547|NCT02116621|80833318|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
27728548|NCT02116621|80833319|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
27728549|NCT02116621|80833318|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
27728550|NCT02116621|80833319|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
27728551|NCT02116621|80833318|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
27728552|NCT02116621|80833319|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
27728553|NCT02116621|80833318|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
27728554|NCT02116621|80833319|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
27728555|NCT02522767|80833320|FG000|Double-blind|Withdrawal by Subject|8|||
27728556|NCT02522767|80833321|FG001|Double-blind|Withdrawal by Subject|11|||
27728557|NCT02522767|80833320|FG000|Double-blind|Lost to Follow-up|1|||
27728558|NCT02522767|80833321|FG001|Double-blind|Lost to Follow-up|0|||
27728559|NCT02522767|80833320|FG000|Double-blind|Adverse Event|1|||
27728560|NCT02522767|80833321|FG001|Double-blind|Adverse Event|10|||
27728561|NCT02522767|80833320|FG000|Double-blind|Protocol Violation|0|||
27728562|NCT02522767|80833321|FG001|Double-blind|Protocol Violation|1|||
27728563|NCT02522767|80833320|FG000|Double-blind|Lack of Efficacy|0|||
27728564|NCT02522767|80833321|FG001|Double-blind|Lack of Efficacy|2|||
27728565|NCT02522767|80833320|FG000|Double-blind|Protocol Deviation|1|||
27728566|NCT02522767|80833321|FG001|Double-blind|Protocol Deviation|0|||
27728567|NCT02522767|80833320|FG000|Open-label|Withdrawal by Subject|2|||
27728568|NCT02522767|80833321|FG001|Open-label|Withdrawal by Subject|3|||
27728569|NCT02522767|80833320|FG000|Open-label|Lost to Follow-up|0|||
27728570|NCT02522767|80833321|FG001|Open-label|Lost to Follow-up|1|||
27728571|NCT02522767|80833320|FG000|Open-label|Adverse Event|2|||
27728572|NCT02522767|80833321|FG001|Open-label|Adverse Event|1|||
27728573|NCT02522767|80833320|FG000|Open-label|Lack of Efficacy|1|||
27728574|NCT02522767|80833321|FG001|Open-label|Lack of Efficacy|1|||
27728575|NCT02522767|80833320|FG000|Open-label|Protocol Violation|0|||
27728576|NCT02522767|80833321|FG001|Open-label|Protocol Violation|1|||
27728577|NCT02382133|80833322|FG000|Overall Study|Death|22|||
27728578|NCT02382133|80833322|FG000|Overall Study|transfer out of ICU|4|||
27728579|NCT02382133|80833322|FG000|Overall Study|Physician Decision|2|||
27728580|NCT02382133|80833322|FG000|Overall Study|arterial catheter loss|4|||
27728581|NCT02382133|80833322|FG000|Overall Study|pressure injury both sites|1|||
27728582|NCT03480802|80833323|FG000|Overall Study|Lost to Follow-up|5|||
27728583|NCT03480802|80833324|FG001|Overall Study|Lost to Follow-up|1|||
27728584|NCT03480802|80833323|FG000|Overall Study|Withdrawal by Subject|2|||
27728585|NCT03480802|80833324|FG001|Overall Study|Withdrawal by Subject|1|||
27728586|NCT03480802|80833323|FG000|Overall Study|Relocated|0|||
27728587|NCT03480802|80833324|FG001|Overall Study|Relocated|1|||
27728588|NCT00189462|80833325|FG000|Overall Study|Lack of Efficacy|5|||
27728589|NCT00189462|80833326|FG001|Overall Study|Lack of Efficacy|1|||
27728590|NCT00189462|80833325|FG000|Overall Study|Lost to Follow-up|18|||
27728591|NCT00189462|80833326|FG001|Overall Study|Lost to Follow-up|20|||
27728592|NCT00483327|80833327|FG000|Overall Study|Adverse Event|1|||
27728593|NCT00483327|80833327|FG000|Overall Study|Withdrawal by Subject|3|||
27728594|NCT00483327|80833327|FG000|Overall Study|Lost to Follow-up|4|||
27728595|NCT00483327|80833327|FG000|Overall Study|Patient Non Compliance|2|||
27728596|NCT00934102|80833328|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
27728597|NCT00934102|80833329|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
27728598|NCT00934102|80833330|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
27728599|NCT04336163|80833335|FG000|Overall Study|Lost to Follow-up|55|||
27852586|NCT00793780|81291171|FG001|Overall Study|Withdrawal by Subject|1|||
27852587|NCT01568320|81291174|FG000|Overall Study|Death|20|||
27728600|NCT04336163|80833336|FG001|Overall Study|Lost to Follow-up|0|||
27728601|NCT00804687|80833337|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
27728602|NCT00804687|80833338|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
27728603|NCT00804687|80833339|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
27728604|NCT00804687|80833340|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
27728605|NCT00804687|80833341|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
27728606|NCT00804687|80833342|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
27509577|NCT03682770|80057822|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
27509578|NCT03682770|80057823|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
27509579|NCT03682770|80057824|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
27509580|NCT03682770|80057825|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
27509581|NCT03682770|80057826|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
27509582|NCT03682770|80057827|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
27509583|NCT03682770|80057821|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
27509584|NCT03682770|80057822|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
27509585|NCT03682770|80057823|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
27509586|NCT03682770|80057824|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
27509587|NCT03682770|80057825|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
27509588|NCT03682770|80057826|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
27509589|NCT03682770|80057827|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
27509590|NCT03682770|80057821|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
27509591|NCT03682770|80057822|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
27509592|NCT03682770|80057823|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
27509593|NCT03682770|80057824|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
27509594|NCT03682770|80057825|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
27509595|NCT03682770|80057826|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
27509596|NCT03682770|80057827|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
27509597|NCT03682770|80057821|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
27509598|NCT03682770|80057822|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
27509599|NCT03682770|80057823|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
27509600|NCT03682770|80057824|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
27509601|NCT03682770|80057825|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
27509602|NCT03682770|80057826|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
27509603|NCT03682770|80057827|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
27509604|NCT03682770|80057821|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
27509605|NCT03682770|80057822|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
27509606|NCT03682770|80057823|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
27509607|NCT03682770|80057824|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
27509608|NCT03682770|80057825|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
27509609|NCT03682770|80057826|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
27509610|NCT03682770|80057827|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
27509611|NCT03682770|80057821|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
27509612|NCT03682770|80057822|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
27509613|NCT03682770|80057823|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
27509614|NCT03682770|80057824|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
27509615|NCT03682770|80057825|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
27509616|NCT03682770|80057826|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
27509617|NCT03682770|80057827|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
27509618|NCT03682770|80057821|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
27509619|NCT03682770|80057822|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
27509620|NCT03682770|80057823|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
27509621|NCT03682770|80057824|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
27509622|NCT03682770|80057825|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
27509623|NCT03682770|80057826|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
27509624|NCT03682770|80057827|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
27509625|NCT03682770|80057821|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
27509626|NCT03682770|80057822|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
27509627|NCT03682770|80057823|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
27509628|NCT03682770|80057824|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
27509629|NCT03682770|80057825|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
27509630|NCT03682770|80057826|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
27509631|NCT03682770|80057827|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
27509632|NCT03682770|80057821|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
27509633|NCT03682770|80057822|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
27509634|NCT03682770|80057823|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
27509635|NCT03682770|80057824|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
27509636|NCT03682770|80057825|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
27509637|NCT03682770|80057826|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
27509638|NCT03682770|80057827|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
27852588|NCT01568320|81291174|FG000|Overall Study|Lost to Follow-up|9|||
27852589|NCT01568320|81291174|FG000|Overall Study|Withdrawal by Subject|10|||
27852590|NCT01568320|81291174|FG000|Overall Study|Conversion to open repair|1|||
27509639|NCT03682770|80057821|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
27509640|NCT03682770|80057822|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
27509641|NCT03682770|80057823|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
27509642|NCT03682770|80057824|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
27509643|NCT03682770|80057825|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
27509644|NCT03682770|80057826|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
27509645|NCT03682770|80057827|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
27509646|NCT04639258|80057828|FG000|Overall Study|Screen failure|5|||
27509647|NCT04639258|80057828|FG000|Overall Study|Physician Decision|2|||
27509648|NCT04639258|80057828|FG000|Overall Study|Early study termination|3|||
27509649|NCT04639258|80057828|FG000|Overall Study|Withdrawal by Subject|1|||
27509650|NCT01442103|80057831|FG000|Overall Study|Lost to Follow-up|2|||
27509651|NCT01600716|80057832|FG000|Overall Study|Other Reasons|3|||
27509652|NCT01600716|80057833|FG001|Overall Study|Other Reasons|1|||
27509653|NCT01600716|80057832|FG000|Overall Study|Personal Reasons|0|||
27509654|NCT01600716|80057833|FG001|Overall Study|Personal Reasons|2|||
27509655|NCT01600716|80057832|FG000|Overall Study|Lost to Follow-up|0|||
27509656|NCT01600716|80057833|FG001|Overall Study|Lost to Follow-up|2|||
27509657|NCT01600716|80057832|FG000|Overall Study|Pregnancy|1|||
27509658|NCT01600716|80057833|FG001|Overall Study|Pregnancy|0|||
27509659|NCT01600716|80057832|FG000|Overall Study|Lack of Efficacy|2|||
27509660|NCT01600716|80057833|FG001|Overall Study|Lack of Efficacy|1|||
27509661|NCT01600716|80057832|FG000|Overall Study|Adverse Event|1|||
27509662|NCT01600716|80057833|FG001|Overall Study|Adverse Event|1|||
27509663|NCT00071058|80057837|FG000|Overall Study|brain tumor-removed from study|1|||
27509664|NCT03584789|80057838|FG000|Overall Study|refused EHR permission|19|||
27509665|NCT03584789|80057839|FG001|Overall Study|refused EHR permission|28|||
27509666|NCT03584789|80057840|FG002|Overall Study|refused EHR permission|23|||
27509667|NCT03584789|80057838|FG000|Overall Study|patients tied to a provider who retired|0|||
27509668|NCT03584789|80057839|FG001|Overall Study|patients tied to a provider who retired|0|||
27509669|NCT03584789|80057840|FG002|Overall Study|patients tied to a provider who retired|3|||
27509670|NCT02504151|80057841|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
27509671|NCT02504151|80057842|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
27509672|NCT02504151|80057841|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
27509673|NCT02504151|80057842|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
27509674|NCT02504151|80057841|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27509675|NCT02504151|80057842|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
27509676|NCT02504151|80057841|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
27509677|NCT02504151|80057842|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
27509678|NCT00482053|80057843|FG000|Inter-treatment Period|Disease progression|1|||
27509679|NCT02873377|80057847|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
27509680|NCT02873377|80057848|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
27509681|NCT02873377|80057847|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
27509682|NCT02873377|80057848|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
27509683|NCT02608684|80057849|FG000|Overall Study|Physician Decision|2|||
27509684|NCT02608684|80057849|FG000|Overall Study|Withdrawal by Subject|1|||
27509685|NCT01662102|80057850|FG000|Overall Study|Sponsor's decision|1|||
27509686|NCT01662102|80057851|FG001|Overall Study|Sponsor's decision|0|||
27509687|NCT02362282|80057857|FG000|Overall Study|Withdrawal by Subject|1|||
27509688|NCT02362282|80057858|FG001|Overall Study|Withdrawal by Subject|0|||
27509689|NCT02500797|80057859|FG000|Overall Study|Cancel (rapid disease progression)|0|||
27509690|NCT02500797|80057860|FG001|Overall Study|Cancel (rapid disease progression)|0|||
27509691|NCT02500797|80057861|FG002|Overall Study|Cancel (rapid disease progression)|0|||
27509692|NCT02500797|80057862|FG003|Overall Study|Cancel (rapid disease progression)|0|||
27509693|NCT02500797|80057863|FG004|Overall Study|Cancel (rapid disease progression)|1|||
27509694|NCT02500797|80057864|FG005|Overall Study|Cancel (rapid disease progression)|1|||
27509695|NCT02500797|80057865|FG006|Overall Study|Cancel (rapid disease progression)|0|||
27509696|NCT02500797|80057866|FG007|Overall Study|Cancel (rapid disease progression)|0|||
27509697|NCT02500797|80057859|FG000|Overall Study|Withdrawal by Subject|1|||
27509698|NCT02500797|80057860|FG001|Overall Study|Withdrawal by Subject|0|||
27509699|NCT02500797|80057861|FG002|Overall Study|Withdrawal by Subject|0|||
27509700|NCT02500797|80057862|FG003|Overall Study|Withdrawal by Subject|0|||
27509701|NCT02500797|80057863|FG004|Overall Study|Withdrawal by Subject|0|||
27509702|NCT02500797|80057864|FG005|Overall Study|Withdrawal by Subject|0|||
27509703|NCT02500797|80057865|FG006|Overall Study|Withdrawal by Subject|0|||
27509704|NCT02500797|80057866|FG007|Overall Study|Withdrawal by Subject|0|||
27509705|NCT01265537|80057867|FG000|Overall Study|Adverse Event|2|||
27509706|NCT01265537|80057868|FG001|Overall Study|Adverse Event|1|||
27509707|NCT01265537|80057867|FG000|Overall Study|Physician Decision|0|||
27509708|NCT01265537|80057868|FG001|Overall Study|Physician Decision|1|||
27852591|NCT01568320|81291174|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
27852592|NCT01995266|81291179|FG000|Overall Study|Death|1|||
27509709|NCT02581410|80057873|FG000|Vaccination Phase|Adverse Event|2|||
27509710|NCT02581410|80057874|FG001|Vaccination Phase|Adverse Event|1|||
27509711|NCT02581410|80057873|FG000|Vaccination Phase|Withdrawal by Subject|0|||
27509712|NCT02581410|80057874|FG001|Vaccination Phase|Withdrawal by Subject|1|||
27509713|NCT02581410|80057873|FG000|Vaccination Phase|Migrated/moved from study area|0|||
27509714|NCT02581410|80057874|FG001|Vaccination Phase|Migrated/moved from study area|1|||
27509715|NCT02581410|80057873|FG000|End of Study Phase|Adverse Event|4|||
27509716|NCT02581410|80057874|FG001|End of Study Phase|Adverse Event|3|||
27509717|NCT02581410|80057873|FG000|End of Study Phase|Withdrawal by Subject|1|||
27509718|NCT02581410|80057874|FG001|End of Study Phase|Withdrawal by Subject|2|||
27509719|NCT02581410|80057873|FG000|End of Study Phase|Migrated/moved from study area|0|||
27509720|NCT02581410|80057874|FG001|End of Study Phase|Migrated/moved from study area|3|||
27509721|NCT02581410|80057873|FG000|End of Study Phase|Lost to Follow-up|0|||
27509722|NCT02581410|80057874|FG001|End of Study Phase|Lost to Follow-up|2|||
27509723|NCT02581410|80057873|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
27509724|NCT02581410|80057874|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
27509725|NCT02892448|80057878|FG000|Overall Study|Screening failure|2|||
27509726|NCT02892448|80057879|FG001|Overall Study|Screening failure|2|||
27509727|NCT02892448|80057880|FG002|Overall Study|Screening failure|1|||
27509728|NCT01388335|80057881|FG000|Period 1|Progressive Disease|1|||
27509729|NCT01388335|80057881|FG000|Period 2|Progressive Disease|2|||
27509730|NCT01388335|80057881|FG000|Period 2|Sponsor Decision|1|||
27509731|NCT01388335|80057881|FG000|Safety Extension|Progressive Disease|7|||
27509732|NCT04287517|80057886|FG000|Overall Study|Withdrawal by Subject|1|||
27509733|NCT04287517|80057887|FG001|Overall Study|Withdrawal by Subject|1|||
27509734|NCT02633020|80057896|FG000|Overall Study|Adverse Event|1|||
27509735|NCT02633020|80057897|FG001|Overall Study|Adverse Event|0|||
27509736|NCT00790842|80057898|FG000|Dose Level 1|Adverse Event|1|||
27509737|NCT00790842|80057899|FG001|Dose Level 1|Adverse Event|0|||
27509738|NCT00790842|80057900|FG002|Dose Level 1|Adverse Event|0|||
27509739|NCT00790842|80057901|FG003|Dose Level 1|Adverse Event|2|||
27509740|NCT00790842|80057902|FG004|Dose Level 1|Adverse Event|0|||
27509741|NCT00790842|80057903|FG005|Dose Level 1|Adverse Event|0|||
27509742|NCT00790842|80057904|FG006|Dose Level 1|Adverse Event|0|||
27509743|NCT00790842|80057905|FG007|Dose Level 1|Adverse Event|1|||
27509744|NCT00790842|80057906|FG008|Dose Level 1|Adverse Event|0|||
27509745|NCT00790842|80057907|FG009|Dose Level 1|Adverse Event|0|||
27509746|NCT00790842|80057908|FG010|Dose Level 1|Adverse Event|0|||
27509747|NCT00790842|80057898|FG000|Dose Level 1|Physician Decision|1|||
27509748|NCT00790842|80057899|FG001|Dose Level 1|Physician Decision|0|||
27509749|NCT00790842|80057900|FG002|Dose Level 1|Physician Decision|0|||
27509750|NCT00790842|80057901|FG003|Dose Level 1|Physician Decision|0|||
27509751|NCT00790842|80057902|FG004|Dose Level 1|Physician Decision|0|||
27509752|NCT00790842|80057903|FG005|Dose Level 1|Physician Decision|0|||
27509753|NCT00790842|80057904|FG006|Dose Level 1|Physician Decision|0|||
27509754|NCT00790842|80057905|FG007|Dose Level 1|Physician Decision|1|||
27509755|NCT00790842|80057906|FG008|Dose Level 1|Physician Decision|0|||
27509756|NCT00790842|80057907|FG009|Dose Level 1|Physician Decision|0|||
27509757|NCT00790842|80057908|FG010|Dose Level 1|Physician Decision|0|||
27509758|NCT00790842|80057898|FG000|Dose Level 1|Withdrawal by Subject|1|||
27509759|NCT00790842|80057899|FG001|Dose Level 1|Withdrawal by Subject|0|||
27509760|NCT00790842|80057900|FG002|Dose Level 1|Withdrawal by Subject|0|||
27509761|NCT00790842|80057901|FG003|Dose Level 1|Withdrawal by Subject|0|||
27509762|NCT00790842|80057902|FG004|Dose Level 1|Withdrawal by Subject|0|||
27509763|NCT00790842|80057903|FG005|Dose Level 1|Withdrawal by Subject|0|||
27509764|NCT00790842|80057904|FG006|Dose Level 1|Withdrawal by Subject|0|||
27509765|NCT00790842|80057905|FG007|Dose Level 1|Withdrawal by Subject|0|||
27509766|NCT00790842|80057906|FG008|Dose Level 1|Withdrawal by Subject|0|||
27509767|NCT00790842|80057907|FG009|Dose Level 1|Withdrawal by Subject|0|||
27509768|NCT00790842|80057908|FG010|Dose Level 1|Withdrawal by Subject|0|||
27509769|NCT00790842|80057898|FG000|Dose Level 2|Death|0|||
27509770|NCT00790842|80057899|FG001|Dose Level 2|Death|1|||
27509771|NCT00790842|80057900|FG002|Dose Level 2|Death|0|||
27852593|NCT01995266|81291179|FG000|Overall Study|Lack of Efficacy|6|||
27852594|NCT01995266|81291179|FG000|Overall Study|Adverse Event|2|||
27509772|NCT00790842|80057901|FG003|Dose Level 2|Death|0|||
27509773|NCT00790842|80057902|FG004|Dose Level 2|Death|1|||
27509774|NCT00790842|80057903|FG005|Dose Level 2|Death|0|||
27509775|NCT00790842|80057904|FG006|Dose Level 2|Death|0|||
27509776|NCT00790842|80057905|FG007|Dose Level 2|Death|0|||
27509777|NCT00790842|80057906|FG008|Dose Level 2|Death|0|||
27509778|NCT00790842|80057907|FG009|Dose Level 2|Death|0|||
27509779|NCT00790842|80057908|FG010|Dose Level 2|Death|0|||
27509780|NCT00790842|80057898|FG000|Dose Level 2|Physician Decision|0|||
27509781|NCT00790842|80057899|FG001|Dose Level 2|Physician Decision|1|||
27509782|NCT00790842|80057900|FG002|Dose Level 2|Physician Decision|0|||
27509783|NCT00790842|80057901|FG003|Dose Level 2|Physician Decision|0|||
27509784|NCT00790842|80057902|FG004|Dose Level 2|Physician Decision|0|||
27509785|NCT00790842|80057903|FG005|Dose Level 2|Physician Decision|0|||
27509786|NCT00790842|80057904|FG006|Dose Level 2|Physician Decision|0|||
27509787|NCT00790842|80057905|FG007|Dose Level 2|Physician Decision|0|||
27509788|NCT00790842|80057906|FG008|Dose Level 2|Physician Decision|0|||
27509789|NCT00790842|80057907|FG009|Dose Level 2|Physician Decision|0|||
27509790|NCT00790842|80057908|FG010|Dose Level 2|Physician Decision|0|||
27509791|NCT00790842|80057898|FG000|Dose Level 2|Withdrawal by Subject|0|||
27509792|NCT00790842|80057899|FG001|Dose Level 2|Withdrawal by Subject|1|||
27509793|NCT00790842|80057900|FG002|Dose Level 2|Withdrawal by Subject|0|||
27509794|NCT00790842|80057901|FG003|Dose Level 2|Withdrawal by Subject|0|||
27509795|NCT00790842|80057902|FG004|Dose Level 2|Withdrawal by Subject|0|||
27509796|NCT00790842|80057903|FG005|Dose Level 2|Withdrawal by Subject|0|||
27509797|NCT00790842|80057904|FG006|Dose Level 2|Withdrawal by Subject|0|||
27509798|NCT00790842|80057905|FG007|Dose Level 2|Withdrawal by Subject|0|||
27509799|NCT00790842|80057906|FG008|Dose Level 2|Withdrawal by Subject|0|||
27509800|NCT00790842|80057907|FG009|Dose Level 2|Withdrawal by Subject|0|||
27509801|NCT00790842|80057908|FG010|Dose Level 2|Withdrawal by Subject|0|||
27509802|NCT00790842|80057898|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509803|NCT00790842|80057899|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509804|NCT00790842|80057900|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509805|NCT00790842|80057901|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509806|NCT00790842|80057902|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509807|NCT00790842|80057903|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509808|NCT00790842|80057904|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509809|NCT00790842|80057905|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509810|NCT00790842|80057906|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
27509811|NCT00790842|80057907|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509812|NCT00790842|80057908|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
27509813|NCT00790842|80057898|FG000|Dose Level 3|Adverse Event|0|||
27509814|NCT00790842|80057899|FG001|Dose Level 3|Adverse Event|0|||
27509815|NCT00790842|80057900|FG002|Dose Level 3|Adverse Event|1|||
27509816|NCT00790842|80057901|FG003|Dose Level 3|Adverse Event|0|||
27509817|NCT00790842|80057902|FG004|Dose Level 3|Adverse Event|0|||
27509818|NCT00790842|80057903|FG005|Dose Level 3|Adverse Event|0|||
27509819|NCT00790842|80057904|FG006|Dose Level 3|Adverse Event|0|||
27509820|NCT00790842|80057905|FG007|Dose Level 3|Adverse Event|0|||
27509821|NCT00790842|80057906|FG008|Dose Level 3|Adverse Event|0|||
27509822|NCT00790842|80057907|FG009|Dose Level 3|Adverse Event|0|||
27509823|NCT00790842|80057908|FG010|Dose Level 3|Adverse Event|0|||
27509824|NCT00790842|80057898|FG000|Dose Level 3|Withdrawal by Subject|0|||
27509825|NCT00790842|80057899|FG001|Dose Level 3|Withdrawal by Subject|0|||
27509826|NCT00790842|80057900|FG002|Dose Level 3|Withdrawal by Subject|3|||
27509827|NCT00790842|80057901|FG003|Dose Level 3|Withdrawal by Subject|0|||
27509828|NCT00790842|80057902|FG004|Dose Level 3|Withdrawal by Subject|0|||
27509829|NCT00790842|80057903|FG005|Dose Level 3|Withdrawal by Subject|0|||
27509830|NCT00790842|80057904|FG006|Dose Level 3|Withdrawal by Subject|0|||
27509831|NCT00790842|80057905|FG007|Dose Level 3|Withdrawal by Subject|0|||
27509832|NCT00790842|80057906|FG008|Dose Level 3|Withdrawal by Subject|0|||
27509833|NCT00790842|80057907|FG009|Dose Level 3|Withdrawal by Subject|2|||
27509834|NCT00790842|80057908|FG010|Dose Level 3|Withdrawal by Subject|0|||
27509835|NCT00790842|80057898|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509836|NCT00790842|80057899|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509837|NCT00790842|80057900|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509838|NCT00790842|80057901|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509839|NCT00790842|80057902|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509840|NCT00790842|80057903|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
27509841|NCT00790842|80057904|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509842|NCT00790842|80057905|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509843|NCT00790842|80057906|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509844|NCT00790842|80057907|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509845|NCT00790842|80057908|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
27509846|NCT00790842|80057898|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509847|NCT00790842|80057899|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509848|NCT00790842|80057900|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
27509849|NCT00790842|80057901|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509850|NCT00790842|80057902|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509851|NCT00790842|80057903|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509852|NCT00790842|80057904|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509853|NCT00790842|80057905|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509854|NCT00790842|80057906|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509855|NCT00790842|80057907|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509856|NCT00790842|80057908|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
27509857|NCT00790842|80057898|FG000|Dose Level 4|Adverse Event|0|||
27509858|NCT00790842|80057899|FG001|Dose Level 4|Adverse Event|0|||
27509859|NCT00790842|80057900|FG002|Dose Level 4|Adverse Event|0|||
27509860|NCT00790842|80057901|FG003|Dose Level 4|Adverse Event|0|||
27509861|NCT00790842|80057902|FG004|Dose Level 4|Adverse Event|0|||
27509862|NCT00790842|80057903|FG005|Dose Level 4|Adverse Event|0|||
27509863|NCT00790842|80057904|FG006|Dose Level 4|Adverse Event|1|||
27509864|NCT00790842|80057905|FG007|Dose Level 4|Adverse Event|0|||
27509865|NCT00790842|80057906|FG008|Dose Level 4|Adverse Event|0|||
27509866|NCT00790842|80057907|FG009|Dose Level 4|Adverse Event|0|||
27852595|NCT00038649|81291182|FG000|Overall Study|Adverse Event|9|||
27852596|NCT02377063|81291183|FG000|Overall Study|Non-compliance|5|||
27852597|NCT04465630|81291188|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
27852598|NCT04465630|81291188|FG000|Overall Study|Screen failure|8|||
27852599|NCT04465630|81291188|FG000|Overall Study|Baseline failure|16|||
27509867|NCT00790842|80057908|FG010|Dose Level 4|Adverse Event|0|||
27509868|NCT00790842|80057898|FG000|Dose Level 4|Physician Decision|0|||
27614783|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27614784|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
27614785|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
27614786|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27614787|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Death|0|||
27614788|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Death|29|||
27614789|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Death|16|||
27614790|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Death|0|||
27614791|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Death|188|||
27614792|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Death|107|||
27614793|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Death|0|||
27614794|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Death|1|||
27614795|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Death|1|||
27614796|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Death|0|||
27614797|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Death|46|||
27614798|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Death|19|||
27614799|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Death|0|||
27614800|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Adverse Event|0|||
27614801|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Adverse Event|0|||
27614802|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Adverse Event|0|||
27614803|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Adverse Event|0|||
27614804|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Adverse Event|1|||
27614805|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Adverse Event|1|||
27614806|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Adverse Event|0|||
27614807|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Adverse Event|0|||
27614808|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Adverse Event|0|||
27614809|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Adverse Event|0|||
27614810|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Adverse Event|0|||
27614811|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Adverse Event|0|||
27614812|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Adverse Event|0|||
27614813|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614814|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
27614815|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614816|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614817|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
27614818|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
27614819|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614820|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
27614821|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614822|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614823|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
27614824|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
27614825|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
27614826|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
27614827|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
27614828|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
27614829|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
27614830|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
27614831|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
27614832|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
27614833|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
27614834|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
27614835|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
27614836|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
27614837|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
27728607|NCT00804687|80833337|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
27728608|NCT00804687|80833338|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
27728609|NCT00804687|80833339|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
27728610|NCT00804687|80833340|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
27728611|NCT00804687|80833341|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
27728612|NCT00804687|80833342|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
27728613|NCT00804687|80833337|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
27728614|NCT00804687|80833338|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
27728615|NCT00804687|80833339|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
27614838|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
27852600|NCT02093221|81291192|FG000|Overall Study|Adverse Event|1|||
27852601|NCT02093221|81291193|FG001|Overall Study|Adverse Event|0|||
27852602|NCT02093221|81291194|FG002|Overall Study|Adverse Event|0|||
27852603|NCT02093221|81291195|FG003|Overall Study|Adverse Event|0|||
27852604|NCT02093221|81291196|FG004|Overall Study|Adverse Event|0|||
27852605|NCT02093221|81291192|FG000|Overall Study|Withdrawal by Subject|1|||
27852606|NCT02093221|81291193|FG001|Overall Study|Withdrawal by Subject|1|||
27852607|NCT02093221|81291194|FG002|Overall Study|Withdrawal by Subject|4|||
27852608|NCT02093221|81291195|FG003|Overall Study|Withdrawal by Subject|1|||
27852609|NCT02093221|81291196|FG004|Overall Study|Withdrawal by Subject|1|||
27852610|NCT02093221|81291192|FG000|Overall Study|Lost to Follow-up|2|||
27852611|NCT02093221|81291193|FG001|Overall Study|Lost to Follow-up|0|||
27852612|NCT02093221|81291194|FG002|Overall Study|Lost to Follow-up|1|||
27852613|NCT02093221|81291195|FG003|Overall Study|Lost to Follow-up|1|||
27852614|NCT02093221|81291196|FG004|Overall Study|Lost to Follow-up|0|||
27852615|NCT02093221|81291192|FG000|Overall Study|Death|0|||
27852616|NCT02093221|81291193|FG001|Overall Study|Death|1|||
27852617|NCT02093221|81291194|FG002|Overall Study|Death|0|||
27852618|NCT02093221|81291195|FG003|Overall Study|Death|0|||
27852619|NCT02093221|81291196|FG004|Overall Study|Death|0|||
27852620|NCT02093221|81291192|FG000|Overall Study|Protocol Violation|0|||
27852621|NCT02093221|81291193|FG001|Overall Study|Protocol Violation|1|||
27852622|NCT02093221|81291194|FG002|Overall Study|Protocol Violation|0|||
27852623|NCT02093221|81291195|FG003|Overall Study|Protocol Violation|0|||
27852624|NCT02093221|81291196|FG004|Overall Study|Protocol Violation|0|||
27852625|NCT02093221|81291192|FG000|Overall Study|Study termination|6|||
27852626|NCT02093221|81291193|FG001|Overall Study|Study termination|5|||
27852627|NCT02093221|81291194|FG002|Overall Study|Study termination|4|||
27852628|NCT02093221|81291195|FG003|Overall Study|Study termination|6|||
27852629|NCT02093221|81291196|FG004|Overall Study|Study termination|7|||
27852630|NCT02566993|81291197|FG000|Overall Study|Randomized but not treated|5|||
27852631|NCT02566993|81291198|FG001|Overall Study|Randomized but not treated|16|||
27852632|NCT02566993|81291197|FG000|Overall Study|Progressive disease|213|||
27852633|NCT02566993|81291198|FG001|Overall Study|Progressive disease|152|||
27852634|NCT02566993|81291197|FG000|Overall Study|Withdrawal by Subject|12|||
27614839|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Physician Decision|0|||
27852635|NCT02566993|81291198|FG001|Overall Study|Withdrawal by Subject|28|||
27852636|NCT02566993|81291197|FG000|Overall Study|Death|17|||
27852637|NCT02566993|81291198|FG001|Overall Study|Death|23|||
27852638|NCT02566993|81291197|FG000|Overall Study|Physician Decision|10|||
27728616|NCT00804687|80833340|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
27852639|NCT02566993|81291198|FG001|Overall Study|Physician Decision|17|||
27852640|NCT02566993|81291197|FG000|Overall Study|Study drug-related adverse event|20|||
27852641|NCT02566993|81291198|FG001|Overall Study|Study drug-related adverse event|41|||
27904773|NCT01884545|81488453|FG000|Overall Study|Lost to Follow-up|6|||
27904774|NCT01884545|81488454|FG001|Overall Study|Lost to Follow-up|4|||
27904775|NCT01884545|81488455|FG002|Overall Study|Lost to Follow-up|9|||
27904776|NCT01884545|81488456|FG003|Overall Study|Lost to Follow-up|4|||
27904777|NCT01884545|81488453|FG000|Overall Study|Patient withdrawn|7|||
27904778|NCT01884545|81488454|FG001|Overall Study|Patient withdrawn|12|||
27904779|NCT01884545|81488455|FG002|Overall Study|Patient withdrawn|5|||
27614840|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Physician Decision|2|||
27614841|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Physician Decision|0|||
27614842|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Physician Decision|0|||
27852642|NCT02566993|81291197|FG000|Overall Study|Non study drug-related adverse event|9|||
27852643|NCT02566993|81291198|FG001|Overall Study|Non study drug-related adverse event|9|||
27852644|NCT02566993|81291197|FG000|Overall Study|Symptomatic deterioration|9|||
27852645|NCT02566993|81291198|FG001|Overall Study|Symptomatic deterioration|16|||
27852646|NCT02566993|81291197|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
27904780|NCT01884545|81488456|FG003|Overall Study|Patient withdrawn|5|||
27904781|NCT01884545|81488453|FG000|Overall Study|Non-adherence|0|||
27904782|NCT01884545|81488454|FG001|Overall Study|Non-adherence|2|||
27852647|NCT02566993|81291198|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
27852648|NCT02566993|81291197|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
27852649|NCT02566993|81291198|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
27852650|NCT02566993|81291197|FG000|Overall Study|Screening failure|2|||
27852651|NCT02566993|81291198|FG001|Overall Study|Screening failure|0|||
27852652|NCT02566993|81291197|FG000|Overall Study|Lost to Follow-up|0|||
27852653|NCT02566993|81291198|FG001|Overall Study|Lost to Follow-up|1|||
27852654|NCT02566993|81291197|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
27852655|NCT02566993|81291198|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
27852656|NCT00912093|81291199|FG000|The Controlled Phase|Death|0|||
27852657|NCT00912093|81291200|FG001|The Controlled Phase|Death|1|||
27852658|NCT00912093|81291201|FG002|The Controlled Phase|Death|0|||
27852659|NCT00912093|81291202|FG003|The Controlled Phase|Death|0|||
27852660|NCT00912093|81291203|FG004|The Controlled Phase|Death|0|||
27904783|NCT01884545|81488455|FG002|Overall Study|Non-adherence|0|||
27614843|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Physician Decision|3|||
27614844|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Physician Decision|0|||
27614845|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Physician Decision|0|||
27614846|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Physician Decision|0|||
27614847|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Physician Decision|0|||
27614848|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Physician Decision|0|||
27614849|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Physician Decision|1|||
27904784|NCT01884545|81488456|FG003|Overall Study|Non-adherence|0|||
27904785|NCT02626000|81488460|FG000|Overall Study|Decision by Sponsor|1|||
27904786|NCT02626000|81488460|FG000|Overall Study|Death|29|||
27904787|NCT04348500|81488465|FG000|Overall Study|Death|2|||
27509869|NCT00790842|80057899|FG001|Dose Level 4|Physician Decision|0|||
27509870|NCT00790842|80057900|FG002|Dose Level 4|Physician Decision|0|||
27509871|NCT00790842|80057901|FG003|Dose Level 4|Physician Decision|0|||
27509872|NCT00790842|80057902|FG004|Dose Level 4|Physician Decision|0|||
27509873|NCT00790842|80057903|FG005|Dose Level 4|Physician Decision|0|||
27509874|NCT00790842|80057904|FG006|Dose Level 4|Physician Decision|1|||
27509875|NCT00790842|80057905|FG007|Dose Level 4|Physician Decision|0|||
27509876|NCT00790842|80057906|FG008|Dose Level 4|Physician Decision|0|||
27509877|NCT00790842|80057907|FG009|Dose Level 4|Physician Decision|0|||
27509878|NCT00790842|80057908|FG010|Dose Level 4|Physician Decision|1|||
27509879|NCT00790842|80057898|FG000|Dose Level 4|Withdrawal by Subject|0|||
27904788|NCT04348500|81488466|FG001|Overall Study|Death|2|||
27904789|NCT04348500|81488465|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
27904790|NCT04348500|81488466|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
27904791|NCT02560623|81488467|FG000|Overall Study|Unable to swallow sponge|0|||
27904792|NCT02560623|81488468|FG001|Overall Study|Unable to swallow sponge|1|||
27904793|NCT02560623|81488469|FG002|Overall Study|Unable to swallow sponge|0|||
27904794|NCT02560623|81488470|FG003|Overall Study|Unable to swallow sponge|0|||
27904795|NCT02560623|81488467|FG000|Overall Study|Intervention prior to sponge administration|0|||
27904796|NCT02560623|81488468|FG001|Overall Study|Intervention prior to sponge administration|1|||
27904797|NCT02560623|81488469|FG002|Overall Study|Intervention prior to sponge administration|0|||
27904798|NCT02560623|81488470|FG003|Overall Study|Intervention prior to sponge administration|0|||
27904799|NCT03297021|81488471|FG000|Overall Study|Incomplete/illegible data sheet|4|||
27904800|NCT03297021|81488472|FG001|Overall Study|Incomplete/illegible data sheet|2|||
27904801|NCT03297021|81488473|FG002|Overall Study|Incomplete/illegible data sheet|3|||
27904802|NCT03297021|81488471|FG000|Overall Study|Missing Post-Op Data|1|||
27904803|NCT03297021|81488472|FG001|Overall Study|Missing Post-Op Data|2|||
27904804|NCT03297021|81488473|FG002|Overall Study|Missing Post-Op Data|1|||
27904805|NCT00642954|81488474|FG000|Overall Study|Progressive Disease|3|||
27904806|NCT00642954|81488475|FG001|Overall Study|Progressive Disease|3|||
27904807|NCT00642954|81488476|FG002|Overall Study|Progressive Disease|3|||
27904808|NCT00642954|81488477|FG003|Overall Study|Progressive Disease|3|||
27904809|NCT00642954|81488478|FG004|Overall Study|Progressive Disease|9|||
27904810|NCT00642954|81488474|FG000|Overall Study|Withdrawal by Subject|0|||
27904811|NCT00642954|81488475|FG001|Overall Study|Withdrawal by Subject|0|||
27904812|NCT00642954|81488476|FG002|Overall Study|Withdrawal by Subject|0|||
27904813|NCT00642954|81488477|FG003|Overall Study|Withdrawal by Subject|0|||
27904814|NCT00642954|81488478|FG004|Overall Study|Withdrawal by Subject|1|||
27904815|NCT00642954|81488474|FG000|Overall Study|Adverse Event|1|||
27904816|NCT00642954|81488475|FG001|Overall Study|Adverse Event|1|||
27904817|NCT00642954|81488476|FG002|Overall Study|Adverse Event|0|||
27904818|NCT00642954|81488477|FG003|Overall Study|Adverse Event|0|||
27904819|NCT00642954|81488478|FG004|Overall Study|Adverse Event|6|||
27904820|NCT00585325|81488479|FG000|Overall Study|Withdrawal by Subject|1|||
27904821|NCT00585325|81488480|FG001|Overall Study|Withdrawal by Subject|1|||
27904822|NCT01270321|81488481|FG000|Overall Study|Death|3|||
27904823|NCT01270321|81488482|FG001|Overall Study|Death|1|||
27904824|NCT01270321|81488483|FG002|Overall Study|Death|4|||
27904825|NCT01270321|81488481|FG000|Overall Study|Adverse Event|7|||
27904826|NCT01270321|81488482|FG001|Overall Study|Adverse Event|9|||
27904827|NCT01270321|81488483|FG002|Overall Study|Adverse Event|5|||
27904828|NCT02697591|81488486|FG000|Overall Study|Lost to Follow-up|0|||
27904829|NCT02697591|81488487|FG001|Overall Study|Lost to Follow-up|0|||
27904830|NCT02697591|81488488|FG002|Overall Study|Lost to Follow-up|0|||
27904831|NCT02697591|81488489|FG003|Overall Study|Lost to Follow-up|0|||
27509880|NCT00790842|80057899|FG001|Dose Level 4|Withdrawal by Subject|0|||
27509881|NCT00790842|80057900|FG002|Dose Level 4|Withdrawal by Subject|0|||
27509882|NCT00790842|80057901|FG003|Dose Level 4|Withdrawal by Subject|0|||
27509883|NCT00790842|80057902|FG004|Dose Level 4|Withdrawal by Subject|0|||
27509884|NCT00790842|80057903|FG005|Dose Level 4|Withdrawal by Subject|0|||
27509885|NCT00790842|80057904|FG006|Dose Level 4|Withdrawal by Subject|0|||
27614850|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Physician Decision|3|||
27614851|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Physician Decision|0|||
27904832|NCT02697591|81488490|FG004|Overall Study|Lost to Follow-up|0|||
27904833|NCT02697591|81488491|FG005|Overall Study|Lost to Follow-up|1|||
27614852|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Not Treated|0|||
27614853|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Not Treated|0|||
27904834|NCT02697591|81488492|FG006|Overall Study|Lost to Follow-up|1|||
27904835|NCT02697591|81488493|FG007|Overall Study|Lost to Follow-up|0|||
27904836|NCT02697591|81488494|FG008|Overall Study|Lost to Follow-up|0|||
27904837|NCT02697591|81488495|FG009|Overall Study|Lost to Follow-up|1|||
27904838|NCT02697591|81488486|FG000|Overall Study|Withdrawal by Subject|1|||
27904839|NCT02697591|81488487|FG001|Overall Study|Withdrawal by Subject|1|||
27904840|NCT02697591|81488488|FG002|Overall Study|Withdrawal by Subject|2|||
27509886|NCT00790842|80057905|FG007|Dose Level 4|Withdrawal by Subject|0|||
27509887|NCT00790842|80057906|FG008|Dose Level 4|Withdrawal by Subject|0|||
27509888|NCT00790842|80057907|FG009|Dose Level 4|Withdrawal by Subject|0|||
27509889|NCT00790842|80057908|FG010|Dose Level 4|Withdrawal by Subject|1|||
27509890|NCT00790842|80057898|FG000|Expansion Cohort|Adverse Event|0|||
27509891|NCT00790842|80057899|FG001|Expansion Cohort|Adverse Event|0|||
27509892|NCT00790842|80057900|FG002|Expansion Cohort|Adverse Event|0|||
27509893|NCT00790842|80057901|FG003|Expansion Cohort|Adverse Event|0|||
27509894|NCT00790842|80057902|FG004|Expansion Cohort|Adverse Event|0|||
27509895|NCT00790842|80057903|FG005|Expansion Cohort|Adverse Event|0|||
27509896|NCT00790842|80057904|FG006|Expansion Cohort|Adverse Event|1|||
27509897|NCT00790842|80057905|FG007|Expansion Cohort|Adverse Event|0|||
27509898|NCT00790842|80057906|FG008|Expansion Cohort|Adverse Event|0|||
27509899|NCT00790842|80057907|FG009|Expansion Cohort|Adverse Event|0|||
27509900|NCT00790842|80057908|FG010|Expansion Cohort|Adverse Event|0|||
27509901|NCT00790842|80057898|FG000|Expansion Cohort|Death|0|||
27509902|NCT00790842|80057899|FG001|Expansion Cohort|Death|0|||
27509903|NCT00790842|80057900|FG002|Expansion Cohort|Death|2|||
27509904|NCT00790842|80057901|FG003|Expansion Cohort|Death|0|||
27509905|NCT00790842|80057902|FG004|Expansion Cohort|Death|0|||
27509906|NCT00790842|80057903|FG005|Expansion Cohort|Death|0|||
27509907|NCT00790842|80057904|FG006|Expansion Cohort|Death|0|||
27509908|NCT00790842|80057905|FG007|Expansion Cohort|Death|0|||
27509909|NCT00790842|80057906|FG008|Expansion Cohort|Death|0|||
27509910|NCT00790842|80057907|FG009|Expansion Cohort|Death|0|||
27509911|NCT00790842|80057908|FG010|Expansion Cohort|Death|0|||
27509912|NCT00790842|80057898|FG000|Expansion Cohort|Physician Decision|0|||
27509913|NCT00790842|80057899|FG001|Expansion Cohort|Physician Decision|0|||
27509914|NCT00790842|80057900|FG002|Expansion Cohort|Physician Decision|1|||
27509915|NCT00790842|80057901|FG003|Expansion Cohort|Physician Decision|0|||
27509916|NCT00790842|80057902|FG004|Expansion Cohort|Physician Decision|0|||
27509917|NCT00790842|80057903|FG005|Expansion Cohort|Physician Decision|0|||
27509918|NCT00790842|80057904|FG006|Expansion Cohort|Physician Decision|0|||
27509919|NCT00790842|80057905|FG007|Expansion Cohort|Physician Decision|0|||
27509920|NCT00790842|80057906|FG008|Expansion Cohort|Physician Decision|0|||
27509921|NCT00790842|80057907|FG009|Expansion Cohort|Physician Decision|0|||
27509922|NCT00790842|80057908|FG010|Expansion Cohort|Physician Decision|0|||
27509923|NCT00790842|80057898|FG000|Expansion Cohort|Withdrawal by Subject|0|||
27509924|NCT00790842|80057899|FG001|Expansion Cohort|Withdrawal by Subject|0|||
27509925|NCT00790842|80057900|FG002|Expansion Cohort|Withdrawal by Subject|3|||
27509926|NCT00790842|80057901|FG003|Expansion Cohort|Withdrawal by Subject|0|||
27509927|NCT00790842|80057902|FG004|Expansion Cohort|Withdrawal by Subject|0|||
27509928|NCT00790842|80057903|FG005|Expansion Cohort|Withdrawal by Subject|0|||
27509929|NCT00790842|80057904|FG006|Expansion Cohort|Withdrawal by Subject|0|||
27509930|NCT00790842|80057905|FG007|Expansion Cohort|Withdrawal by Subject|0|||
27728617|NCT00804687|80833341|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
27852661|NCT00912093|81291199|FG000|The Controlled Phase|Medical Condition|0|||
27509931|NCT00790842|80057906|FG008|Expansion Cohort|Withdrawal by Subject|0|||
27509932|NCT00790842|80057907|FG009|Expansion Cohort|Withdrawal by Subject|0|||
27509933|NCT00790842|80057908|FG010|Expansion Cohort|Withdrawal by Subject|0|||
27509934|NCT00790842|80057898|FG000|Expansion Cohort|Study Closure|0|||
27509935|NCT00790842|80057899|FG001|Expansion Cohort|Study Closure|0|||
27509936|NCT00790842|80057900|FG002|Expansion Cohort|Study Closure|1|||
27509937|NCT00790842|80057901|FG003|Expansion Cohort|Study Closure|0|||
27509938|NCT00790842|80057902|FG004|Expansion Cohort|Study Closure|0|||
27852662|NCT00912093|81291200|FG001|The Controlled Phase|Medical Condition|1|||
27852663|NCT00912093|81291201|FG002|The Controlled Phase|Medical Condition|0|||
27852664|NCT00912093|81291202|FG003|The Controlled Phase|Medical Condition|0|||
27852665|NCT00912093|81291203|FG004|The Controlled Phase|Medical Condition|0|||
27852666|NCT00912093|81291199|FG000|The Controlled Phase|Lost to Follow-up|0|||
27852667|NCT00912093|81291200|FG001|The Controlled Phase|Lost to Follow-up|0|||
27852668|NCT00912093|81291201|FG002|The Controlled Phase|Lost to Follow-up|0|||
27852669|NCT00912093|81291202|FG003|The Controlled Phase|Lost to Follow-up|0|||
27904841|NCT02697591|81488489|FG003|Overall Study|Withdrawal by Subject|1|||
27904842|NCT02697591|81488490|FG004|Overall Study|Withdrawal by Subject|7|||
27904843|NCT02697591|81488491|FG005|Overall Study|Withdrawal by Subject|6|||
27904844|NCT02697591|81488492|FG006|Overall Study|Withdrawal by Subject|9|||
27904845|NCT02697591|81488493|FG007|Overall Study|Withdrawal by Subject|1|||
27904846|NCT02697591|81488494|FG008|Overall Study|Withdrawal by Subject|6|||
27509939|NCT00790842|80057903|FG005|Expansion Cohort|Study Closure|0|||
27509940|NCT00790842|80057904|FG006|Expansion Cohort|Study Closure|0|||
27509941|NCT00790842|80057905|FG007|Expansion Cohort|Study Closure|0|||
27509942|NCT00790842|80057906|FG008|Expansion Cohort|Study Closure|0|||
27509943|NCT00790842|80057907|FG009|Expansion Cohort|Study Closure|0|||
27509944|NCT00790842|80057908|FG010|Expansion Cohort|Study Closure|0|||
27509945|NCT00714870|80057909|FG000|Overall Study|Lost to Follow-up|22|||
27509946|NCT00714870|80057910|FG001|Overall Study|Lost to Follow-up|5|||
27509947|NCT00714870|80057909|FG000|Overall Study|patient unable to come b/c back pain|1|||
27509948|NCT00714870|80057910|FG001|Overall Study|patient unable to come b/c back pain|0|||
27509949|NCT00714870|80057909|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
27509950|NCT00714870|80057910|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
27904847|NCT02697591|81488495|FG009|Overall Study|Withdrawal by Subject|10|||
27904848|NCT02697591|81488486|FG000|Overall Study|Physician Decision|1|||
27904849|NCT02697591|81488487|FG001|Overall Study|Physician Decision|0|||
27904850|NCT02697591|81488488|FG002|Overall Study|Physician Decision|0|||
27904851|NCT02697591|81488489|FG003|Overall Study|Physician Decision|0|||
27904852|NCT02697591|81488490|FG004|Overall Study|Physician Decision|1|||
27904853|NCT02697591|81488491|FG005|Overall Study|Physician Decision|2|||
27904854|NCT02697591|81488492|FG006|Overall Study|Physician Decision|0|||
27904855|NCT02697591|81488493|FG007|Overall Study|Physician Decision|0|||
27904856|NCT02697591|81488494|FG008|Overall Study|Physician Decision|1|||
27904857|NCT02697591|81488495|FG009|Overall Study|Physician Decision|1|||
27904858|NCT02697591|81488486|FG000|Overall Study|Death|2|||
27509951|NCT01708902|80057911|FG000|Overall Study|Adverse Event|3|||
27509952|NCT01708902|80057912|FG001|Overall Study|Adverse Event|4|||
27509953|NCT01708902|80057913|FG002|Overall Study|Adverse Event|9|||
27509954|NCT01708902|80057914|FG003|Overall Study|Adverse Event|2|||
27509955|NCT01708902|80057915|FG004|Overall Study|Adverse Event|7|||
27509956|NCT01708902|80057916|FG005|Overall Study|Adverse Event|3|||
27509957|NCT01708902|80057917|FG006|Overall Study|Adverse Event|5|||
27509958|NCT01708902|80057911|FG000|Overall Study|Lack of Efficacy|3|||
27509959|NCT01708902|80057912|FG001|Overall Study|Lack of Efficacy|1|||
27509960|NCT01708902|80057913|FG002|Overall Study|Lack of Efficacy|0|||
27509961|NCT01708902|80057914|FG003|Overall Study|Lack of Efficacy|0|||
27509962|NCT01708902|80057915|FG004|Overall Study|Lack of Efficacy|0|||
27509963|NCT01708902|80057916|FG005|Overall Study|Lack of Efficacy|1|||
27509964|NCT01708902|80057917|FG006|Overall Study|Lack of Efficacy|0|||
27509965|NCT01708902|80057911|FG000|Overall Study|Non compliance with protocol|0|||
27509966|NCT01708902|80057912|FG001|Overall Study|Non compliance with protocol|2|||
27509967|NCT01708902|80057913|FG002|Overall Study|Non compliance with protocol|1|||
27509968|NCT01708902|80057914|FG003|Overall Study|Non compliance with protocol|3|||
27509969|NCT01708902|80057915|FG004|Overall Study|Non compliance with protocol|0|||
27509970|NCT01708902|80057916|FG005|Overall Study|Non compliance with protocol|0|||
27509971|NCT01708902|80057917|FG006|Overall Study|Non compliance with protocol|0|||
27509972|NCT01708902|80057911|FG000|Overall Study|Lost to Follow-up|2|||
27509973|NCT01708902|80057912|FG001|Overall Study|Lost to Follow-up|1|||
27509974|NCT01708902|80057913|FG002|Overall Study|Lost to Follow-up|2|||
27509975|NCT01708902|80057914|FG003|Overall Study|Lost to Follow-up|2|||
27509976|NCT01708902|80057915|FG004|Overall Study|Lost to Follow-up|0|||
27509977|NCT01708902|80057916|FG005|Overall Study|Lost to Follow-up|0|||
27509978|NCT01708902|80057917|FG006|Overall Study|Lost to Follow-up|1|||
27509979|NCT01708902|80057911|FG000|Overall Study|Refused to continue trial medication|8|||
27509980|NCT01708902|80057912|FG001|Overall Study|Refused to continue trial medication|0|||
27509981|NCT01708902|80057913|FG002|Overall Study|Refused to continue trial medication|4|||
27509982|NCT01708902|80057914|FG003|Overall Study|Refused to continue trial medication|2|||
27509983|NCT01708902|80057915|FG004|Overall Study|Refused to continue trial medication|8|||
27509984|NCT01708902|80057916|FG005|Overall Study|Refused to continue trial medication|1|||
27509985|NCT01708902|80057917|FG006|Overall Study|Refused to continue trial medication|1|||
27509986|NCT01708902|80057911|FG000|Overall Study|Other Reason|1|||
27509987|NCT01708902|80057912|FG001|Overall Study|Other Reason|0|||
27509988|NCT01708902|80057913|FG002|Overall Study|Other Reason|1|||
27509989|NCT01708902|80057914|FG003|Overall Study|Other Reason|1|||
27509990|NCT01708902|80057915|FG004|Overall Study|Other Reason|1|||
27509991|NCT01708902|80057916|FG005|Overall Study|Other Reason|2|||
27509992|NCT01708902|80057917|FG006|Overall Study|Other Reason|0|||
27509993|NCT00198822|80057920|FG000|Overall Study|Lost to Follow-up|14|||
27509994|NCT00198822|80057921|FG001|Overall Study|Lost to Follow-up|20|||
27509995|NCT00198822|80057922|FG002|Overall Study|Lost to Follow-up|21|||
27509996|NCT00346697|80057923|FG000|Overall Study|Lost to Follow-up|0|||
27509997|NCT00346697|80057924|FG001|Overall Study|Lost to Follow-up|1|||
27509998|NCT02284243|80057927|FG000|Overall Study|Lack of Efficacy|3|||
27509999|NCT02284243|80057928|FG001|Overall Study|Lack of Efficacy|3|||
27852670|NCT00912093|81291203|FG004|The Controlled Phase|Lost to Follow-up|1|||
27852671|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Adverse Event|9|||
27510000|NCT02284243|80057927|FG000|Overall Study|Adverse Event|1|||
27510001|NCT02284243|80057928|FG001|Overall Study|Adverse Event|0|||
27510002|NCT00892099|80057929|FG000|Overall Study|Death|1|||
27510003|NCT00892099|80057930|FG001|Overall Study|Death|0|||
27510004|NCT00892099|80057931|FG002|Overall Study|Death|1|||
27510005|NCT00892099|80057929|FG000|Overall Study|Adverse Event|1|||
27510006|NCT00892099|80057930|FG001|Overall Study|Adverse Event|0|||
27510007|NCT00892099|80057931|FG002|Overall Study|Adverse Event|0|||
27510008|NCT00892099|80057929|FG000|Overall Study|replocated|1|||
27510009|NCT00892099|80057930|FG001|Overall Study|replocated|0|||
27510010|NCT00892099|80057931|FG002|Overall Study|replocated|2|||
27852672|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Adverse Event|4|||
27852673|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Adverse Event|5|||
27852674|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Adverse Event|9|||
27852675|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Adverse Event|8|||
27510011|NCT00892099|80057929|FG000|Overall Study|Prolonged hospitalization|1|||
27510012|NCT00892099|80057930|FG001|Overall Study|Prolonged hospitalization|0|||
27510013|NCT00892099|80057931|FG002|Overall Study|Prolonged hospitalization|1|||
27510014|NCT00892099|80057929|FG000|Overall Study|no further details|1|||
27510015|NCT00892099|80057930|FG001|Overall Study|no further details|0|||
27510016|NCT00892099|80057931|FG002|Overall Study|no further details|1|||
27510017|NCT00892099|80057929|FG000|Overall Study|kidney function recovered|0|||
27510018|NCT00892099|80057930|FG001|Overall Study|kidney function recovered|1|||
27510019|NCT00892099|80057931|FG002|Overall Study|kidney function recovered|0|||
27510020|NCT00892099|80057929|FG000|Overall Study|investigator decision|0|||
27904859|NCT02697591|81488487|FG001|Overall Study|Death|3|||
27904860|NCT02697591|81488488|FG002|Overall Study|Death|1|||
27904861|NCT02697591|81488489|FG003|Overall Study|Death|1|||
27904862|NCT02697591|81488490|FG004|Overall Study|Death|4|||
27904863|NCT02697591|81488491|FG005|Overall Study|Death|5|||
27904864|NCT02697591|81488492|FG006|Overall Study|Death|3|||
27904865|NCT02697591|81488493|FG007|Overall Study|Death|1|||
27904866|NCT02697591|81488494|FG008|Overall Study|Death|1|||
27904867|NCT02697591|81488495|FG009|Overall Study|Death|5|||
27510021|NCT00892099|80057930|FG001|Overall Study|investigator decision|0|||
27510022|NCT00892099|80057931|FG002|Overall Study|investigator decision|1|||
27510023|NCT00892099|80057929|FG000|Overall Study|Lost to Follow-up|0|||
27510024|NCT00892099|80057930|FG001|Overall Study|Lost to Follow-up|0|||
27510025|NCT00892099|80057931|FG002|Overall Study|Lost to Follow-up|1|||
27510026|NCT01470326|80057932|FG000|Overall Study|Protocol Violation|32|||
27510027|NCT01470326|80057932|FG000|Overall Study|No Drug Administration Information|2|||
27510028|NCT01470326|80057932|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
27510029|NCT00885534|80057937|FG000|Overall Study|Patient deemed ineligible|1|||
27510030|NCT00929695|80057939|FG000|Overall Study|Death|2|||
27510031|NCT00929695|80057940|FG001|Overall Study|Death|1|||
27510032|NCT00929695|80057939|FG000|Overall Study|Withdrawal by Subject|0|||
27510033|NCT00929695|80057940|FG001|Overall Study|Withdrawal by Subject|2|||
27510034|NCT00929695|80057939|FG000|Overall Study|discharge home|4|||
27904868|NCT02697591|81488486|FG000|Overall Study|Reason not Specified|0|||
27904869|NCT02697591|81488487|FG001|Overall Study|Reason not Specified|0|||
27904870|NCT02697591|81488488|FG002|Overall Study|Reason not Specified|0|||
27904871|NCT02697591|81488489|FG003|Overall Study|Reason not Specified|1|||
27904872|NCT02697591|81488490|FG004|Overall Study|Reason not Specified|1|||
27904873|NCT02697591|81488491|FG005|Overall Study|Reason not Specified|2|||
27904874|NCT02697591|81488492|FG006|Overall Study|Reason not Specified|3|||
27904875|NCT02697591|81488493|FG007|Overall Study|Reason not Specified|1|||
27904876|NCT02697591|81488494|FG008|Overall Study|Reason not Specified|1|||
27510035|NCT00929695|80057940|FG001|Overall Study|discharge home|3|||
27510036|NCT00929695|80057939|FG000|Overall Study|incorrect stratification|2|||
27510037|NCT00929695|80057940|FG001|Overall Study|incorrect stratification|0|||
27510038|NCT03530124|80057941|FG000|Overall Study|Withdrawal by Subject|0|||
27510039|NCT03530124|80057942|FG001|Overall Study|Withdrawal by Subject|1|||
27510040|NCT03530124|80057941|FG000|Overall Study|Protocol Violation|1|||
27510041|NCT03530124|80057942|FG001|Overall Study|Protocol Violation|0|||
27510042|NCT03530124|80057941|FG000|Overall Study|Discharged prior to study completion|1|||
27510043|NCT03530124|80057942|FG001|Overall Study|Discharged prior to study completion|0|||
27510044|NCT01298648|80057943|FG000|Overall Study|Withdrawal by Subject|2|||
27510045|NCT01298648|80057943|FG000|Overall Study|Lost to Follow-up|21|||
27510046|NCT03486834|80057944|FG000|Overall Study|Withdrawal by Subject|46|||
27510047|NCT03486834|80057945|FG001|Overall Study|Withdrawal by Subject|46|||
27510048|NCT03486834|80057946|FG002|Overall Study|Withdrawal by Subject|52|||
27510049|NCT03486834|80057944|FG000|Overall Study|Adverse Event|8|||
27510050|NCT03486834|80057945|FG001|Overall Study|Adverse Event|7|||
27510051|NCT03486834|80057946|FG002|Overall Study|Adverse Event|0|||
27510052|NCT03486834|80057944|FG000|Overall Study|Lost to Follow-up|41|||
27510053|NCT03486834|80057945|FG001|Overall Study|Lost to Follow-up|24|||
27510054|NCT03486834|80057946|FG002|Overall Study|Lost to Follow-up|39|||
27904877|NCT02697591|81488495|FG009|Overall Study|Reason not Specified|3|||
27904878|NCT03539484|81488502|FG000|Overall Study|Death|1|||
27510055|NCT03486834|80057944|FG000|Overall Study|Non-compliance with Study Drug|2|||
27904879|NCT03539484|81488503|FG001|Overall Study|Death|0|||
27904880|NCT03539484|81488504|FG002|Overall Study|Death|0|||
27510056|NCT03486834|80057945|FG001|Overall Study|Non-compliance with Study Drug|2|||
27510057|NCT03486834|80057946|FG002|Overall Study|Non-compliance with Study Drug|0|||
27510058|NCT03486834|80057944|FG000|Overall Study|Physician Decision|5|||
27510059|NCT03486834|80057945|FG001|Overall Study|Physician Decision|2|||
27510060|NCT03486834|80057946|FG002|Overall Study|Physician Decision|3|||
27510061|NCT03486834|80057944|FG000|Overall Study|Pregnancy|10|||
27510062|NCT03486834|80057945|FG001|Overall Study|Pregnancy|12|||
27510063|NCT03486834|80057946|FG002|Overall Study|Pregnancy|12|||
27510064|NCT03486834|80057944|FG000|Overall Study|Protocol Deviation|2|||
27904881|NCT03539484|81488505|FG003|Overall Study|Death|2|||
27904882|NCT03539484|81488506|FG004|Overall Study|Death|8|||
27904883|NCT03539484|81488507|FG005|Overall Study|Death|3|||
27904884|NCT03539484|81488508|FG006|Overall Study|Death|0|||
27904885|NCT03539484|81488502|FG000|Overall Study|Lost to Follow-up|0|||
27904886|NCT03539484|81488503|FG001|Overall Study|Lost to Follow-up|1|||
27904887|NCT03539484|81488504|FG002|Overall Study|Lost to Follow-up|0|||
27904888|NCT03539484|81488505|FG003|Overall Study|Lost to Follow-up|0|||
27904889|NCT03539484|81488506|FG004|Overall Study|Lost to Follow-up|1|||
27904890|NCT03539484|81488507|FG005|Overall Study|Lost to Follow-up|0|||
27904891|NCT03539484|81488508|FG006|Overall Study|Lost to Follow-up|0|||
27904892|NCT03539484|81488502|FG000|Overall Study|Withdrawal by Subject|0|||
27904893|NCT03539484|81488503|FG001|Overall Study|Withdrawal by Subject|0|||
27904894|NCT03539484|81488504|FG002|Overall Study|Withdrawal by Subject|0|||
27904895|NCT03539484|81488505|FG003|Overall Study|Withdrawal by Subject|0|||
27904896|NCT03539484|81488506|FG004|Overall Study|Withdrawal by Subject|2|||
27904897|NCT03539484|81488507|FG005|Overall Study|Withdrawal by Subject|0|||
27904898|NCT03539484|81488508|FG006|Overall Study|Withdrawal by Subject|1|||
27614854|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Not Treated|2|||
27614855|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Not Treated|0|||
27614856|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Not Treated|0|||
27614857|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Not Treated|0|||
27614858|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Not Treated|0|||
27614859|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Not Treated|0|||
27614860|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Not Treated|0|||
27614861|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Not Treated|0|||
27614862|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Not Treated|0|||
27614863|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Not Treated|0|||
27614864|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Not Treated|0|||
27614865|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614866|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
27614867|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614868|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27904899|NCT03539484|81488502|FG000|Overall Study|Study Terminated by Sponsor|0|||
27614869|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27904900|NCT03539484|81488503|FG001|Overall Study|Study Terminated by Sponsor|0|||
27904901|NCT03539484|81488504|FG002|Overall Study|Study Terminated by Sponsor|1|||
27510065|NCT03486834|80057945|FG001|Overall Study|Protocol Deviation|3|||
27510066|NCT03486834|80057946|FG002|Overall Study|Protocol Deviation|3|||
27510067|NCT03486834|80057944|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
27510068|NCT03486834|80057945|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
27510069|NCT03486834|80057946|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
27614870|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27904902|NCT03539484|81488505|FG003|Overall Study|Study Terminated by Sponsor|1|||
27904903|NCT03539484|81488506|FG004|Overall Study|Study Terminated by Sponsor|2|||
27904904|NCT03539484|81488507|FG005|Overall Study|Study Terminated by Sponsor|2|||
27904905|NCT03539484|81488508|FG006|Overall Study|Study Terminated by Sponsor|1|||
27904906|NCT02182830|81488529|FG000|Overall Study|Not Treated|1|||
27904907|NCT02182830|81488530|FG001|Overall Study|Not Treated|1|||
27904908|NCT02182830|81488529|FG000|Overall Study|Trial stopped, reason missing|3|||
27904909|NCT02182830|81488530|FG001|Overall Study|Trial stopped, reason missing|3|||
27904910|NCT02182830|81488529|FG000|Overall Study|Consent withdrawn|8|||
27904911|NCT02182830|81488530|FG001|Overall Study|Consent withdrawn|8|||
27904912|NCT02182830|81488529|FG000|Overall Study|Lost to Follow-up|3|||
27904913|NCT02182830|81488530|FG001|Overall Study|Lost to Follow-up|3|||
27904914|NCT00076999|81488531|FG000|Overall Study|Adverse Event|2|||
27904915|NCT00076999|81488532|FG001|Overall Study|Adverse Event|8|||
27904916|NCT00076999|81488533|FG002|Overall Study|Adverse Event|6|||
27904917|NCT00076999|81488534|FG003|Overall Study|Adverse Event|0|||
27904918|NCT00076999|81488535|FG004|Overall Study|Adverse Event|2|||
27904919|NCT00076999|81488531|FG000|Overall Study|Protocol Violation|0|||
27904920|NCT00076999|81488532|FG001|Overall Study|Protocol Violation|3|||
27904921|NCT00076999|81488533|FG002|Overall Study|Protocol Violation|4|||
27904922|NCT00076999|81488534|FG003|Overall Study|Protocol Violation|0|||
27904923|NCT00076999|81488535|FG004|Overall Study|Protocol Violation|9|||
27904924|NCT00076999|81488531|FG000|Overall Study|Lost to Follow-up|2|||
27904925|NCT00076999|81488532|FG001|Overall Study|Lost to Follow-up|1|||
27904926|NCT00076999|81488533|FG002|Overall Study|Lost to Follow-up|0|||
27904927|NCT00076999|81488534|FG003|Overall Study|Lost to Follow-up|0|||
27904928|NCT00076999|81488535|FG004|Overall Study|Lost to Follow-up|0|||
27904929|NCT00076999|81488531|FG000|Overall Study|Withdrawal by Subject|0|||
27904930|NCT00076999|81488532|FG001|Overall Study|Withdrawal by Subject|4|||
27904931|NCT00076999|81488533|FG002|Overall Study|Withdrawal by Subject|3|||
27904932|NCT00076999|81488534|FG003|Overall Study|Withdrawal by Subject|0|||
27904933|NCT00076999|81488535|FG004|Overall Study|Withdrawal by Subject|1|||
27904934|NCT00076999|81488531|FG000|Overall Study|Other reason (not specified)|8|||
27904935|NCT00076999|81488532|FG001|Overall Study|Other reason (not specified)|8|||
27904936|NCT00076999|81488533|FG002|Overall Study|Other reason (not specified)|4|||
27904937|NCT00076999|81488534|FG003|Overall Study|Other reason (not specified)|1|||
27904938|NCT00076999|81488535|FG004|Overall Study|Other reason (not specified)|13|||
27904939|NCT04702997|81488536|FG000|Overall Study|Withdrawal by Subject|1|||
27904940|NCT04702997|81488537|FG001|Overall Study|Withdrawal by Subject|1|||
27904941|NCT04165135|81488538|FG000|Overall Study|Protocol Violation|10|||
27904942|NCT04165135|81488538|FG000|Overall Study|Participants withdrawal of consent|5|||
27904943|NCT02290925|81488539|FG000|First Period of Three Months|Lost to Follow-up|2|||
27904944|NCT02290925|81488540|FG001|First Period of Three Months|Lost to Follow-up|1|||
27904945|NCT02290925|81488539|FG000|First Period of Three Months|Death|1|||
27904946|NCT02290925|81488540|FG001|First Period of Three Months|Death|0|||
27904947|NCT02290925|81488539|FG000|First Period of Three Months|Insulin Started|1|||
27904948|NCT02290925|81488540|FG001|First Period of Three Months|Insulin Started|1|||
27904949|NCT02290925|81488539|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
27904950|NCT02290925|81488540|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
27904951|NCT02290925|81488539|FG000|Second Period of 3 Months|insulin started|0|||
27904952|NCT02290925|81488540|FG001|Second Period of 3 Months|insulin started|1|||
27904953|NCT01118663|81488541|FG000|Overall Study|Adverse Event|2|||
27904954|NCT01118663|81488542|FG001|Overall Study|Adverse Event|1|||
27904955|NCT01118663|81488541|FG000|Overall Study|Withdrawal by Subject|0|||
27904956|NCT01118663|81488542|FG001|Overall Study|Withdrawal by Subject|1|||
27904957|NCT01796301|81488549|FG000|Overall Study|Withdrawal by Subject|15|||
27904958|NCT01796301|81488550|FG001|Overall Study|Withdrawal by Subject|15|||
27904959|NCT01796301|81488549|FG000|Overall Study|Lost to Follow-up|3|||
27904960|NCT01796301|81488550|FG001|Overall Study|Lost to Follow-up|3|||
27904961|NCT01796301|81488549|FG000|Overall Study|Death|0|||
27904962|NCT01796301|81488550|FG001|Overall Study|Death|1|||
27904963|NCT01796301|81488549|FG000|Overall Study|Decision by Sponsor|0|||
27904964|NCT01796301|81488550|FG001|Overall Study|Decision by Sponsor|1|||
27904965|NCT02776670|81488551|FG000|Overall Study|Adverse Event|0|||
27904966|NCT02776670|81488552|FG001|Overall Study|Adverse Event|2|||
27904967|NCT02776670|81488551|FG000|Overall Study|Protocol Violation|0|||
27904968|NCT02776670|81488552|FG001|Overall Study|Protocol Violation|2|||
27904969|NCT02776670|81488551|FG000|Overall Study|Withdrawal by Subject|0|||
27510070|NCT03486834|80057944|FG000|Overall Study|Randomized but not treated|4|||
27510071|NCT03486834|80057945|FG001|Overall Study|Randomized but not treated|4|||
27904970|NCT02776670|81488552|FG001|Overall Study|Withdrawal by Subject|1|||
27904971|NCT02776670|81488551|FG000|Overall Study|Other - Reason not given|0|||
27904972|NCT02776670|81488552|FG001|Overall Study|Other - Reason not given|1|||
27904973|NCT00734656|81488553|FG000|Lab Session 1|Withdrawal by Subject|2|||
27904974|NCT00734656|81488554|FG001|Lab Session 1|Withdrawal by Subject|0|||
27904975|NCT00734656|81488555|FG002|Lab Session 1|Withdrawal by Subject|0|||
27904976|NCT00734656|81488556|FG003|Lab Session 1|Withdrawal by Subject|0|||
27904977|NCT00734656|81488553|FG000|Washout 1|Withdrawal by Subject|1|||
27904978|NCT00734656|81488554|FG001|Washout 1|Withdrawal by Subject|5|||
27904979|NCT00734656|81488555|FG002|Washout 1|Withdrawal by Subject|2|||
27904980|NCT00734656|81488556|FG003|Washout 1|Withdrawal by Subject|3|||
27904981|NCT00734656|81488553|FG000|Lab Session 2|Withdrawal by Subject|1|||
27904982|NCT00734656|81488554|FG001|Lab Session 2|Withdrawal by Subject|0|||
27904983|NCT00734656|81488555|FG002|Lab Session 2|Withdrawal by Subject|0|||
27904984|NCT00734656|81488556|FG003|Lab Session 2|Withdrawal by Subject|1|||
27904985|NCT00734656|81488553|FG000|Washout 2|Withdrawal by Subject|1|||
27904986|NCT00734656|81488554|FG001|Washout 2|Withdrawal by Subject|1|||
27904987|NCT00734656|81488555|FG002|Washout 2|Withdrawal by Subject|1|||
27904988|NCT00734656|81488556|FG003|Washout 2|Withdrawal by Subject|0|||
27904989|NCT00734656|81488553|FG000|Washout 3|Withdrawal by Subject|1|||
27904990|NCT00734656|81488554|FG001|Washout 3|Withdrawal by Subject|0|||
27904991|NCT00734656|81488555|FG002|Washout 3|Withdrawal by Subject|0|||
27904992|NCT00734656|81488556|FG003|Washout 3|Withdrawal by Subject|1|||
27904993|NCT00734656|81488553|FG000|Lab Session 4|Withdrawal by Subject|0|||
27904994|NCT00734656|81488554|FG001|Lab Session 4|Withdrawal by Subject|0|||
27904995|NCT00734656|81488555|FG002|Lab Session 4|Withdrawal by Subject|0|||
27904996|NCT00734656|81488556|FG003|Lab Session 4|Withdrawal by Subject|1|||
27904997|NCT01887288|81488560|FG000|Overall Study|The study was terminated and the PI has|16|||
27904998|NCT04424914|81488567|FG000|Overall Study|Other|0|||
27904999|NCT04424914|81488568|FG001|Overall Study|Other|0|||
27905000|NCT04424914|81488569|FG002|Overall Study|Other|28|||
27905001|NCT04424914|81488567|FG000|Overall Study|Withdrawal by Subject|3|||
27905002|NCT04424914|81488568|FG001|Overall Study|Withdrawal by Subject|0|||
27905003|NCT04424914|81488569|FG002|Overall Study|Withdrawal by Subject|0|||
27905004|NCT04424914|81488567|FG000|Overall Study|Study terminated by sponsor|23|||
27905005|NCT04424914|81488568|FG001|Overall Study|Study terminated by sponsor|7|||
27905006|NCT04424914|81488569|FG002|Overall Study|Study terminated by sponsor|0|||
27905007|NCT04424914|81488567|FG000|Overall Study|Lost to Follow-up|0|||
27905008|NCT04424914|81488568|FG001|Overall Study|Lost to Follow-up|0|||
27905009|NCT04424914|81488569|FG002|Overall Study|Lost to Follow-up|1|||
27905010|NCT04424914|81488567|FG000|Overall Study|Death|3|||
27905011|NCT04424914|81488568|FG001|Overall Study|Death|1|||
27905012|NCT04424914|81488569|FG002|Overall Study|Death|0|||
27905013|NCT02347072|81488584|FG000|Overall Study|Adverse Event|2|||
27905014|NCT02347072|81488584|FG000|Overall Study|Withdrawal by Subject|6|||
27905015|NCT02347072|81488584|FG000|Overall Study|Physician Decision|1|||
27905016|NCT02347072|81488584|FG000|Overall Study|Lost to Follow-up|2|||
27905017|NCT02347072|81488584|FG000|Overall Study|Protocol Violation|1|||
27905018|NCT02347072|81488584|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
27510072|NCT03486834|80057946|FG002|Overall Study|Randomized but not treated|1|||
27510073|NCT01652534|80061684|FG000|Overall Study|Lack of Efficacy|1|||
27510074|NCT01652534|80061685|FG001|Overall Study|Lack of Efficacy|0|||
27510075|NCT02721966|80061686|FG000|Overall Study|Protocol Violation|1|||
27510076|NCT02721966|80061687|FG001|Overall Study|Protocol Violation|0|||
27510077|NCT02721966|80061688|FG002|Overall Study|Protocol Violation|0|||
27510078|NCT02721966|80061689|FG003|Overall Study|Protocol Violation|0|||
27510079|NCT02721966|80061690|FG004|Overall Study|Protocol Violation|0|||
27510080|NCT02721966|80061686|FG000|Overall Study|Withdrawal by Subject|9|||
27510081|NCT02721966|80061687|FG001|Overall Study|Withdrawal by Subject|2|||
27510082|NCT02721966|80061688|FG002|Overall Study|Withdrawal by Subject|3|||
27510083|NCT02721966|80061689|FG003|Overall Study|Withdrawal by Subject|7|||
27510084|NCT02721966|80061690|FG004|Overall Study|Withdrawal by Subject|0|||
27510085|NCT02721966|80061686|FG000|Overall Study|Adverse Event|4|||
27510086|NCT02721966|80061687|FG001|Overall Study|Adverse Event|4|||
27510087|NCT02721966|80061688|FG002|Overall Study|Adverse Event|3|||
27905019|NCT03585712|81488587|FG000|Treatment Period 1|Protocol Violation|1|||
27905020|NCT03585712|81488588|FG001|Treatment Period 1|Protocol Violation|0|||
27905021|NCT03585712|81488589|FG002|Treatment Period 1|Protocol Violation|0|||
27905022|NCT03585712|81488587|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
27905023|NCT03585712|81488588|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
27905024|NCT03585712|81488589|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
27905025|NCT03585712|81488587|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
27510088|NCT02721966|80061689|FG003|Overall Study|Adverse Event|0|||
27510089|NCT02721966|80061690|FG004|Overall Study|Adverse Event|0|||
27510090|NCT02721966|80061686|FG000|Overall Study|Death|1|||
27510091|NCT02721966|80061687|FG001|Overall Study|Death|0|||
27905026|NCT03585712|81488588|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
27905027|NCT03585712|81488589|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
27510092|NCT02721966|80061688|FG002|Overall Study|Death|0|||
27510093|NCT02721966|80061689|FG003|Overall Study|Death|0|||
27510094|NCT02721966|80061690|FG004|Overall Study|Death|0|||
27510095|NCT02721966|80061686|FG000|Overall Study|Lack of Efficacy|7|||
27510096|NCT02721966|80061687|FG001|Overall Study|Lack of Efficacy|4|||
27510097|NCT02721966|80061688|FG002|Overall Study|Lack of Efficacy|0|||
27510098|NCT02721966|80061689|FG003|Overall Study|Lack of Efficacy|0|||
27510099|NCT02721966|80061690|FG004|Overall Study|Lack of Efficacy|0|||
27510100|NCT02721966|80061686|FG000|Overall Study|Lost to Follow-up|0|||
27510101|NCT02721966|80061687|FG001|Overall Study|Lost to Follow-up|0|||
27510102|NCT02721966|80061688|FG002|Overall Study|Lost to Follow-up|3|||
27510103|NCT02721966|80061689|FG003|Overall Study|Lost to Follow-up|0|||
27510104|NCT02721966|80061690|FG004|Overall Study|Lost to Follow-up|0|||
27510105|NCT02721966|80061686|FG000|Overall Study|Physician Decision|1|||
27510106|NCT02721966|80061687|FG001|Overall Study|Physician Decision|1|||
27510107|NCT02721966|80061688|FG002|Overall Study|Physician Decision|0|||
27510108|NCT02721966|80061689|FG003|Overall Study|Physician Decision|0|||
27510109|NCT02721966|80061690|FG004|Overall Study|Physician Decision|0|||
27510110|NCT02721966|80061686|FG000|Overall Study|Pregnancy|1|||
27510111|NCT02721966|80061687|FG001|Overall Study|Pregnancy|0|||
27510112|NCT02721966|80061688|FG002|Overall Study|Pregnancy|0|||
27510113|NCT02721966|80061689|FG003|Overall Study|Pregnancy|0|||
27510114|NCT02721966|80061690|FG004|Overall Study|Pregnancy|0|||
27510115|NCT02721966|80061686|FG000|Overall Study|Did not continue to period 2|5|||
27510116|NCT02721966|80061687|FG001|Overall Study|Did not continue to period 2|12|||
27510117|NCT02721966|80061688|FG002|Overall Study|Did not continue to period 2|0|||
27510118|NCT02721966|80061689|FG003|Overall Study|Did not continue to period 2|0|||
27510119|NCT02721966|80061690|FG004|Overall Study|Did not continue to period 2|5|||
27510120|NCT02904954|80061691|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
27510121|NCT02904954|80061692|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
27510122|NCT02904954|80061691|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
27510123|NCT02904954|80061692|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
27510124|NCT02904954|80061691|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
27510125|NCT02904954|80061692|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
27510126|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Recurrence|2|||
27510127|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Recurrence|0|||
27510128|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Adverse Event|2|||
27510129|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Adverse Event|6|||
27510130|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Participant wishes|12|||
27510131|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Participant wishes|7|||
27510132|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Physician Decision|2|||
27510133|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Physician Decision|1|||
27510134|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
27510135|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
27510136|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Death|0|||
27510137|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Death|1|||
27510138|NCT02904954|80061691|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
27510139|NCT02904954|80061692|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
27510140|NCT00755183|80061695|FG000|Overall Study|Adverse Event|5|||
27510141|NCT00755183|80061696|FG001|Overall Study|Adverse Event|2|||
27510142|NCT00755183|80061695|FG000|Overall Study|Protocol Violation|0|||
27510143|NCT00755183|80061696|FG001|Overall Study|Protocol Violation|1|||
27510144|NCT00755183|80061695|FG000|Overall Study|Withdrawal by Subject|0|||
27510145|NCT00755183|80061696|FG001|Overall Study|Withdrawal by Subject|2|||
27510146|NCT00755183|80061695|FG000|Overall Study|Administrative|2|||
27510147|NCT00755183|80061696|FG001|Overall Study|Administrative|1|||
27510148|NCT01077050|80061697|FG000|Overall Study|Subjects signed ICF could not be located|1|||
27510149|NCT01077050|80061697|FG000|Overall Study|Screen failure|8|||
27510150|NCT00131248|80061698|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
27510151|NCT00131248|80061699|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
27510152|NCT04292899|80061700|FG000|Overall Study|Death|21|||
27510153|NCT04292899|80061701|FG001|Overall Study|Death|28|||
27510154|NCT04292899|80061702|FG002|Overall Study|Death|188|||
27510155|NCT04292899|80061703|FG003|Overall Study|Death|371|||
27510156|NCT04292899|80061700|FG000|Overall Study|Lost to Follow-up|8|||
27510157|NCT04292899|80061701|FG001|Overall Study|Lost to Follow-up|4|||
27510158|NCT04292899|80061702|FG002|Overall Study|Lost to Follow-up|22|||
27510159|NCT04292899|80061703|FG003|Overall Study|Lost to Follow-up|235|||
27510160|NCT04292899|80061700|FG000|Overall Study|Withdrew consent|1|||
27510161|NCT04292899|80061701|FG001|Overall Study|Withdrew consent|0|||
27510162|NCT04292899|80061702|FG002|Overall Study|Withdrew consent|11|||
27510163|NCT04292899|80061703|FG003|Overall Study|Withdrew consent|32|||
27510164|NCT04292899|80061700|FG000|Overall Study|Adverse Event|2|||
27510165|NCT04292899|80061701|FG001|Overall Study|Adverse Event|1|||
27510166|NCT04292899|80061702|FG002|Overall Study|Adverse Event|2|||
27510167|NCT04292899|80061703|FG003|Overall Study|Adverse Event|2|||
27510168|NCT04292899|80061700|FG000|Overall Study|Investigator's Discretion|0|||
27510169|NCT04292899|80061701|FG001|Overall Study|Investigator's Discretion|0|||
27905028|NCT03585712|81488587|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
27905029|NCT03585712|81488588|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
27905030|NCT03585712|81488589|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
27905031|NCT01004432|81488592|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
27905032|NCT01004432|81488593|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27905033|NCT01004432|81488594|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27905034|NCT01004432|81488595|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27905035|NCT01004432|81488596|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
27905036|NCT01004432|81488592|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
27905037|NCT01004432|81488593|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27905038|NCT01004432|81488594|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27905039|NCT01004432|81488595|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27905040|NCT01004432|81488596|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
27905041|NCT01004432|81488592|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
27905042|NCT01004432|81488593|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27905043|NCT01004432|81488594|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27905044|NCT01004432|81488595|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27905045|NCT01004432|81488596|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
27905046|NCT01004432|81488592|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
27905047|NCT01004432|81488593|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27905048|NCT01004432|81488594|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27905049|NCT01004432|81488595|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27905050|NCT01004432|81488596|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
27905051|NCT01004432|81488592|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
27905052|NCT01004432|81488593|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27905053|NCT01004432|81488594|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27905054|NCT01004432|81488595|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27905055|NCT01004432|81488596|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
27905056|NCT01004432|81488592|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
27905057|NCT01004432|81488593|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
27905058|NCT01004432|81488594|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
27905059|NCT01004432|81488595|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
27905060|NCT01004432|81488596|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
27905061|NCT01004432|81488592|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
27905062|NCT01004432|81488593|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
27905063|NCT01004432|81488594|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
27905064|NCT01004432|81488595|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
27905065|NCT01004432|81488596|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
27905066|NCT01004432|81488592|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
27905067|NCT01004432|81488593|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
27905068|NCT01004432|81488594|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
27905069|NCT01004432|81488595|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
27905070|NCT01004432|81488596|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
27905071|NCT01004432|81488592|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27905072|NCT01004432|81488593|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27905073|NCT01004432|81488594|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27905074|NCT01004432|81488595|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
27905075|NCT01004432|81488596|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
27905076|NCT01004432|81488592|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
27905077|NCT01004432|81488593|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
27905078|NCT01004432|81488594|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
27905079|NCT01004432|81488595|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
27905080|NCT01004432|81488596|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
27905081|NCT01004432|81488592|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
27905082|NCT01004432|81488593|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
27905083|NCT01004432|81488594|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
27905084|NCT01004432|81488595|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
27905085|NCT01004432|81488596|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
27905086|NCT01004432|81488592|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27905087|NCT01004432|81488593|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27510170|NCT04292899|80061702|FG002|Overall Study|Investigator's Discretion|0|||
27510171|NCT04292899|80061703|FG003|Overall Study|Investigator's Discretion|3|||
27510172|NCT04292899|80061700|FG000|Overall Study|Non-compliance With Study Drug|0|||
27510173|NCT04292899|80061701|FG001|Overall Study|Non-compliance With Study Drug|0|||
27510174|NCT04292899|80061702|FG002|Overall Study|Non-compliance With Study Drug|0|||
27510175|NCT04292899|80061703|FG003|Overall Study|Non-compliance With Study Drug|1|||
27510176|NCT04292899|80061700|FG000|Overall Study|Protocol Violation|0|||
27510177|NCT04292899|80061701|FG001|Overall Study|Protocol Violation|0|||
27510178|NCT04292899|80061702|FG002|Overall Study|Protocol Violation|0|||
27510179|NCT04292899|80061703|FG003|Overall Study|Protocol Violation|1|||
27510180|NCT00930046|80061711|FG000|Overall Study|Wound catheter malfunctioned|1|||
27510181|NCT00930046|80061712|FG001|Overall Study|Wound catheter malfunctioned|2|||
27510182|NCT00943618|80061713|FG000|Overall Study|Lost to Follow-up|38|||
27510183|NCT00943618|80061714|FG001|Overall Study|Lost to Follow-up|48|||
27510184|NCT00943618|80061715|FG002|Overall Study|Lost to Follow-up|20|||
27510185|NCT00943618|80061713|FG000|Overall Study|Discontinued Medication|17|||
27510186|NCT00943618|80061714|FG001|Overall Study|Discontinued Medication|29|||
27510187|NCT00943618|80061715|FG002|Overall Study|Discontinued Medication|11|||
27510188|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
27510189|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
27510190|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
27510191|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
27510192|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Other|2|||
27510193|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
27510194|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
27510195|NCT02509026|80061717|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
27510196|NCT02509026|80061717|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
27510197|NCT02509026|80061717|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
27510198|NCT02509026|80061717|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
27510199|NCT02509026|80061717|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
27510200|NCT02509026|80061717|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
27510201|NCT02357368|80061718|FG000|Overall Study|Lost to Follow-up|0|||
27510202|NCT02357368|80061719|FG001|Overall Study|Lost to Follow-up|0|||
27510203|NCT02357368|80061720|FG002|Overall Study|Lost to Follow-up|0|||
27510204|NCT02357368|80061721|FG003|Overall Study|Lost to Follow-up|1|||
27510205|NCT02357368|80061718|FG000|Overall Study|Pregnancy|3|||
27510206|NCT02357368|80061719|FG001|Overall Study|Pregnancy|2|||
27510207|NCT02357368|80061720|FG002|Overall Study|Pregnancy|0|||
27510208|NCT02357368|80061721|FG003|Overall Study|Pregnancy|0|||
27510209|NCT02357368|80061718|FG000|Overall Study|Withdrawal by Subject|3|||
27510210|NCT02357368|80061719|FG001|Overall Study|Withdrawal by Subject|1|||
27510211|NCT02357368|80061720|FG002|Overall Study|Withdrawal by Subject|1|||
27510212|NCT02357368|80061721|FG003|Overall Study|Withdrawal by Subject|2|||
27510213|NCT00981058|80061722|FG000|Overall Study|Adverse Event|1|||
27510214|NCT00981058|80061723|FG001|Overall Study|Adverse Event|1|||
27510215|NCT00981058|80061722|FG000|Overall Study|Progressive Disease|61|||
27510216|NCT00981058|80061723|FG001|Overall Study|Progressive Disease|49|||
27510217|NCT00981058|80061722|FG000|Overall Study|Lost to Follow-up|16|||
27510218|NCT00981058|80061723|FG001|Overall Study|Lost to Follow-up|15|||
27510219|NCT00981058|80061722|FG000|Overall Study|New Anticancer Therapy|6|||
27510220|NCT00981058|80061723|FG001|Overall Study|New Anticancer Therapy|6|||
27510221|NCT00981058|80061722|FG000|Overall Study|Noncompliance|1|||
27510222|NCT00981058|80061723|FG001|Overall Study|Noncompliance|0|||
27510223|NCT00981058|80061722|FG000|Overall Study|Radiologist Error|0|||
27510224|NCT00981058|80061723|FG001|Overall Study|Radiologist Error|1|||
27510225|NCT00981058|80061722|FG000|Overall Study|Randomization Error|1|||
27510226|NCT00981058|80061723|FG001|Overall Study|Randomization Error|2|||
27510227|NCT00981058|80061722|FG000|Overall Study|Withdrawal by Subject|25|||
27510228|NCT00981058|80061723|FG001|Overall Study|Withdrawal by Subject|23|||
27510229|NCT00981058|80061722|FG000|Overall Study|On study treatment at conclusion|9|||
27510230|NCT00981058|80061723|FG001|Overall Study|On study treatment at conclusion|0|||
27510231|NCT02318706|80061724|FG000|Double-blind Phase|Adverse Event|7|||
27510232|NCT02318706|80061725|FG001|Double-blind Phase|Adverse Event|4|||
27510233|NCT02318706|80061726|FG002|Double-blind Phase|Adverse Event|3|||
27510234|NCT02318706|80061727|FG003|Double-blind Phase|Adverse Event|10|||
27510235|NCT02318706|80061728|FG004|Double-blind Phase|Adverse Event|0|||
27510236|NCT02318706|80061724|FG000|Double-blind Phase|Lost to Follow-up|1|||
27510237|NCT02318706|80061725|FG001|Double-blind Phase|Lost to Follow-up|0|||
27510238|NCT02318706|80061726|FG002|Double-blind Phase|Lost to Follow-up|0|||
27510239|NCT02318706|80061727|FG003|Double-blind Phase|Lost to Follow-up|0|||
27510240|NCT02318706|80061728|FG004|Double-blind Phase|Lost to Follow-up|0|||
27510241|NCT02318706|80061724|FG000|Double-blind Phase|Protocol Violation|4|||
27510242|NCT02318706|80061725|FG001|Double-blind Phase|Protocol Violation|2|||
27510243|NCT02318706|80061726|FG002|Double-blind Phase|Protocol Violation|4|||
27510244|NCT02318706|80061727|FG003|Double-blind Phase|Protocol Violation|3|||
27614871|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614872|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614873|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27510245|NCT02318706|80061728|FG004|Double-blind Phase|Protocol Violation|0|||
27510246|NCT02318706|80061724|FG000|Double-blind Phase|Withdrawal by Subject|9|||
27510247|NCT02318706|80061725|FG001|Double-blind Phase|Withdrawal by Subject|5|||
27905088|NCT01004432|81488594|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27510248|NCT02318706|80061726|FG002|Double-blind Phase|Withdrawal by Subject|7|||
27510249|NCT02318706|80061727|FG003|Double-blind Phase|Withdrawal by Subject|10|||
27510250|NCT02318706|80061728|FG004|Double-blind Phase|Withdrawal by Subject|0|||
27510251|NCT02318706|80061724|FG000|Double-blind Phase|Other|4|||
27510252|NCT02318706|80061725|FG001|Double-blind Phase|Other|1|||
27510253|NCT02318706|80061726|FG002|Double-blind Phase|Other|2|||
27510254|NCT02318706|80061727|FG003|Double-blind Phase|Other|1|||
27510255|NCT02318706|80061728|FG004|Double-blind Phase|Other|0|||
27510256|NCT02318706|80061724|FG000|Double-blind Phase|Death|0|||
27510257|NCT02318706|80061725|FG001|Double-blind Phase|Death|0|||
27510258|NCT02318706|80061726|FG002|Double-blind Phase|Death|2|||
27510259|NCT02318706|80061727|FG003|Double-blind Phase|Death|0|||
27510260|NCT02318706|80061728|FG004|Double-blind Phase|Death|0|||
27510261|NCT02318706|80061724|FG000|Open-label Extension Phase|Adverse Event|0|||
27510262|NCT02318706|80061725|FG001|Open-label Extension Phase|Adverse Event|0|||
27510263|NCT02318706|80061726|FG002|Open-label Extension Phase|Adverse Event|0|||
27510264|NCT02318706|80061727|FG003|Open-label Extension Phase|Adverse Event|0|||
27510265|NCT02318706|80061728|FG004|Open-label Extension Phase|Adverse Event|21|||
27510266|NCT02318706|80061724|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
27510267|NCT02318706|80061725|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
27510268|NCT02318706|80061726|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
27510269|NCT02318706|80061727|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
27510270|NCT02318706|80061728|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
27510271|NCT02318706|80061724|FG000|Open-label Extension Phase|Death|0|||
27510272|NCT02318706|80061725|FG001|Open-label Extension Phase|Death|0|||
27510273|NCT02318706|80061726|FG002|Open-label Extension Phase|Death|0|||
27510274|NCT02318706|80061727|FG003|Open-label Extension Phase|Death|0|||
27510275|NCT02318706|80061728|FG004|Open-label Extension Phase|Death|1|||
27510276|NCT02318706|80061724|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
27510277|NCT02318706|80061725|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
27510278|NCT02318706|80061726|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
27510279|NCT02318706|80061727|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
27510280|NCT02318706|80061728|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
27510281|NCT02637037|80061729|FG000|Overall Study|Positive drug screen at admission|1|||
27510282|NCT02637037|80061730|FG001|Overall Study|Positive drug screen at admission|0|||
27510283|NCT02637037|80061729|FG000|Overall Study|Withdrawal by Subject|2|||
27510284|NCT02637037|80061730|FG001|Overall Study|Withdrawal by Subject|1|||
27510285|NCT02637037|80061729|FG000|Overall Study|Adverse Event|1|||
27510286|NCT02637037|80061730|FG001|Overall Study|Adverse Event|0|||
27510287|NCT00670306|80061731|FG000|Overall Study|Adverse Event|8|||
27510288|NCT00670306|80061731|FG000|Overall Study|Lack of Efficacy|10|||
27905089|NCT01004432|81488595|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
27905090|NCT01004432|81488596|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
27905091|NCT01004432|81488592|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27905092|NCT01004432|81488593|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27905093|NCT01004432|81488594|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27905094|NCT01004432|81488595|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
27905095|NCT01004432|81488596|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
27905096|NCT01004432|81488592|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27905097|NCT01004432|81488593|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27905098|NCT01004432|81488594|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27905099|NCT01004432|81488595|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
27905100|NCT01004432|81488596|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
27905101|NCT01004432|81488592|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27905102|NCT01004432|81488593|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27905103|NCT01004432|81488594|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27905104|NCT01004432|81488595|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
27905105|NCT01004432|81488596|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
27905106|NCT01709409|81488597|FG000|Overall Study|Protocol Violation|1|||
27905107|NCT01709409|81488598|FG001|Overall Study|Protocol Violation|0|||
27905108|NCT02412878|81488599|FG000|Overall Study|Withdrawal by Subject|19|||
27905109|NCT02412878|81488600|FG001|Overall Study|Withdrawal by Subject|10|||
27510289|NCT00670306|80061731|FG000|Overall Study|Withdrawal by Subject|9|||
27510290|NCT00670306|80061731|FG000|Overall Study|Physician Decision|1|||
27510291|NCT00670306|80061731|FG000|Overall Study|Lost to Follow-up|8|||
27510292|NCT00670306|80061731|FG000|Overall Study|incl/excl criterias did not meet|19|||
27510293|NCT02819804|80061732|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
27510294|NCT03524118|80061733|FG000|Overall Study|Lost to Follow-up|0|||
27510295|NCT03524118|80061734|FG001|Overall Study|Lost to Follow-up|0|||
27510296|NCT03524118|80061735|FG002|Overall Study|Lost to Follow-up|0|||
27510297|NCT03524118|80061736|FG003|Overall Study|Lost to Follow-up|0|||
27852676|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Adverse Event|0|||
27852677|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Adverse Event|0|||
27852678|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
27852679|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
27852680|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
27852681|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
27852682|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
27852683|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
27852684|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
27852685|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Death|1|||
27852686|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Death|1|||
27852687|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Death|1|||
27852688|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Death|1|||
27852689|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Death|0|||
27852690|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Death|0|||
27852691|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Death|0|||
27852692|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
27852693|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
27852694|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
27852695|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
27852696|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
27852697|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
27852698|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
27852699|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
27852700|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
27852701|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
27852702|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
27852703|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
27852704|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
27852705|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
27852706|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
27852707|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
27852708|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
27852709|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
27852710|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
27852711|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
27852712|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
27852713|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Other|2|||
27852714|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Other|9|||
27852715|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Other|9|||
27852716|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Other|3|||
27852717|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Other|2|||
27852718|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Other|0|||
27510298|NCT03524118|80061737|FG004|Overall Study|Lost to Follow-up|1|||
27510299|NCT03524118|80061738|FG005|Overall Study|Lost to Follow-up|0|||
27852719|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Other|0|||
27852720|NCT00361335|81291207|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
27852721|NCT00361335|81291208|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
27852722|NCT00361335|81291209|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
27852723|NCT00361335|81291210|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
27852724|NCT00361335|81291211|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
27852725|NCT00361335|81291212|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
27852726|NCT00361335|81291213|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
27905110|NCT02412878|81488599|FG000|Overall Study|Lost to Follow-up|2|||
27905111|NCT02412878|81488600|FG001|Overall Study|Lost to Follow-up|3|||
27905112|NCT01578499|81488601|FG000|Overall Study|Reason not Specified|0|||
27905113|NCT01578499|81488602|FG001|Overall Study|Reason not Specified|1|||
27905114|NCT01578499|81488601|FG000|Overall Study|Lost to Follow-up|2|||
27905115|NCT01578499|81488602|FG001|Overall Study|Lost to Follow-up|1|||
27905116|NCT01578499|81488601|FG000|Overall Study|Withdrawal by Subject|10|||
27905117|NCT01578499|81488602|FG001|Overall Study|Withdrawal by Subject|16|||
27614874|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614875|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614876|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614877|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
27614878|NCT02291289|80430346|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
27614879|NCT02291289|80430347|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
27614880|NCT02291289|80430348|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
27614881|NCT02291289|80430349|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
27614882|NCT02291289|80430350|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
27852727|NCT00361335|81291207|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
27852728|NCT00361335|81291208|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
27852729|NCT00361335|81291209|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
27852730|NCT00361335|81291210|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
27852731|NCT00361335|81291211|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
27852732|NCT00361335|81291212|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
27852733|NCT00361335|81291213|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
27852734|NCT00361335|81291207|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
27852735|NCT00361335|81291208|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
27852736|NCT00361335|81291209|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
27852737|NCT00361335|81291210|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
27852738|NCT00361335|81291211|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
27852739|NCT00361335|81291212|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
27852740|NCT00361335|81291213|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
27852741|NCT00361335|81291207|FG000|SC Period: Week E0 to Week E24|Death|0|||
27852742|NCT00361335|81291208|FG001|SC Period: Week E0 to Week E24|Death|0|||
27852743|NCT00361335|81291209|FG002|SC Period: Week E0 to Week E24|Death|0|||
27852744|NCT00361335|81291210|FG003|SC Period: Week E0 to Week E24|Death|0|||
27852745|NCT00361335|81291211|FG004|SC Period: Week E0 to Week E24|Death|0|||
27852746|NCT00361335|81291212|FG005|SC Period: Week E0 to Week E24|Death|0|||
27852747|NCT00361335|81291213|FG006|SC Period: Week E0 to Week E24|Death|1|||
27852748|NCT00361335|81291207|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
27852749|NCT00361335|81291208|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
27852750|NCT00361335|81291209|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
27852751|NCT00361335|81291210|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
27852752|NCT00361335|81291211|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
27852753|NCT00361335|81291212|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
27852754|NCT00361335|81291213|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
27852755|NCT00361335|81291207|FG000|SC Period: Week E0 to Week E24|Other|1|||
27852756|NCT00361335|81291208|FG001|SC Period: Week E0 to Week E24|Other|0|||
27852757|NCT00361335|81291209|FG002|SC Period: Week E0 to Week E24|Other|0|||
27852758|NCT00361335|81291210|FG003|SC Period: Week E0 to Week E24|Other|1|||
27852759|NCT00361335|81291211|FG004|SC Period: Week E0 to Week E24|Other|0|||
27852760|NCT00361335|81291212|FG005|SC Period: Week E0 to Week E24|Other|1|||
27852761|NCT00361335|81291213|FG006|SC Period: Week E0 to Week E24|Other|2|||
27852762|NCT00361335|81291207|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
27852763|NCT00361335|81291208|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
27852764|NCT00361335|81291209|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
27852765|NCT00361335|81291210|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
27852766|NCT00361335|81291211|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
27852767|NCT00361335|81291212|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
27852768|NCT00361335|81291213|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
27614883|NCT02291289|80430351|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
27852769|NCT01744093|81291215|FG000|Overall Study|Withdrawal by Subject|6|||
27852770|NCT01744093|81291216|FG001|Overall Study|Withdrawal by Subject|1|||
27852771|NCT03095118|81291217|FG000|Overall Study|Adverse Event|1|||
27852772|NCT03095118|81291217|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
27852773|NCT03285308|81291219|FG000|Overall Study|Adverse Event|3|||
27852774|NCT03285308|81291220|FG001|Overall Study|Adverse Event|7|||
27852775|NCT03285308|81291219|FG000|Overall Study|Withdrawal by Subject|8|||
27852776|NCT03285308|81291220|FG001|Overall Study|Withdrawal by Subject|9|||
27905118|NCT01578499|81488601|FG000|Overall Study|Death|20|||
27905119|NCT01578499|81488602|FG001|Overall Study|Death|25|||
27852777|NCT03285308|81291219|FG000|Overall Study|Lost to Follow-up|3|||
27852778|NCT03285308|81291220|FG001|Overall Study|Lost to Follow-up|1|||
27852779|NCT03285308|81291219|FG000|Overall Study|Protocol Deviation|6|||
27905120|NCT01578499|81488601|FG000|Overall Study|Died and End of Study Page not Completed|2|||
27905121|NCT01578499|81488602|FG001|Overall Study|Died and End of Study Page not Completed|0|||
27905122|NCT01308463|81488603|FG000|Overall Study|Study Discontinued|23|||
27905123|NCT01308463|81488603|FG000|Overall Study|Death|4|||
27905124|NCT01308463|81488603|FG000|Overall Study|Revision|2|||
27905125|NCT01905592|81488604|FG000|Overall Study|Disease Progression|51|||
27905126|NCT01905592|81488605|FG001|Overall Study|Disease Progression|110|||
27905127|NCT01905592|81488604|FG000|Overall Study|Toxicity|1|||
27905128|NCT01905592|81488605|FG001|Overall Study|Toxicity|16|||
27905129|NCT01905592|81488604|FG000|Overall Study|Physician Decision|0|||
27905130|NCT01905592|81488605|FG001|Overall Study|Physician Decision|2|||
27905131|NCT01905592|81488604|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
27905132|NCT01905592|81488605|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
27614884|NCT02291289|80430352|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
27614885|NCT02291289|80430353|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
27852780|NCT03285308|81291220|FG001|Overall Study|Protocol Deviation|5|||
27852781|NCT03285308|81291219|FG000|Overall Study|Reason not Specified|0|||
27852782|NCT03285308|81291220|FG001|Overall Study|Reason not Specified|1|||
27852783|NCT00629265|81291223|FG000|Overall Study|Lost to Follow-up|4|||
27852784|NCT00629265|81291224|FG001|Overall Study|Lost to Follow-up|5|||
27852785|NCT00629265|81291223|FG000|Overall Study|Withdrawal by Subject|11|||
27852786|NCT00629265|81291224|FG001|Overall Study|Withdrawal by Subject|8|||
27852787|NCT00629265|81291223|FG000|Overall Study|Death|1|||
27852788|NCT00629265|81291224|FG001|Overall Study|Death|0|||
27852789|NCT00629265|81291223|FG000|Overall Study|Adverse Event|2|||
27852790|NCT00629265|81291224|FG001|Overall Study|Adverse Event|0|||
27852791|NCT00629265|81291223|FG000|Overall Study|HNC Recurrence|4|||
27852792|NCT00629265|81291224|FG001|Overall Study|HNC Recurrence|0|||
27852793|NCT00629265|81291223|FG000|Overall Study|Other CA Requiring Treatment|1|||
27852794|NCT00629265|81291224|FG001|Overall Study|Other CA Requiring Treatment|3|||
27510300|NCT03524118|80061733|FG000|Overall Study|Other|0|||
27852795|NCT00629265|81291223|FG000|Overall Study|Needed Esophageal Dilation|4|||
27852796|NCT00629265|81291224|FG001|Overall Study|Needed Esophageal Dilation|1|||
27905133|NCT01905592|81488604|FG000|Overall Study|Protocol Violation|0|||
27905134|NCT01905592|81488605|FG001|Overall Study|Protocol Violation|1|||
27905135|NCT01905592|81488604|FG000|Overall Study|Sponsor's decision|1|||
27510301|NCT03524118|80061734|FG001|Overall Study|Other|1|||
27510302|NCT03524118|80061735|FG002|Overall Study|Other|0|||
27852797|NCT00629265|81291223|FG000|Overall Study|Unrelated Medical Complications|3|||
27852798|NCT00629265|81291224|FG001|Overall Study|Unrelated Medical Complications|1|||
27852799|NCT00629265|81291223|FG000|Overall Study|Unknown Reason|2|||
27905136|NCT01905592|81488605|FG001|Overall Study|Sponsor's decision|1|||
27905137|NCT01905592|81488604|FG000|Overall Study|Not treated|7|||
27905138|NCT01905592|81488605|FG001|Overall Study|Not treated|3|||
27905139|NCT01905592|81488604|FG000|Overall Study|Withdrawal by Subject|10|||
27905140|NCT01905592|81488605|FG001|Overall Study|Withdrawal by Subject|2|||
27905141|NCT01204918|81488606|FG000|Overall Study|Withdrawal by Subject|4|||
27905142|NCT01204918|81488607|FG001|Overall Study|Withdrawal by Subject|10|||
27905143|NCT01204918|81488608|FG002|Overall Study|Withdrawal by Subject|5|||
27905144|NCT04202965|81488609|FG000|Overall Study|Adverse Event|3|||
27905145|NCT04202965|81488609|FG000|Overall Study|Did not meet inclusion criteria|1|||
27905146|NCT03076515|81488610|FG000|Overall Study|DMC decision based on interim analysis|25|||
27905147|NCT03076515|81488611|FG001|Overall Study|DMC decision based on interim analysis|29|||
27905148|NCT04571385|81488614|FG000|Overall Study|Participant non-compliance|1|||
27905149|NCT04571385|81488615|FG001|Overall Study|Participant non-compliance|0|||
27905150|NCT04571385|81488616|FG002|Overall Study|Participant non-compliance|0|||
27510303|NCT03524118|80061736|FG003|Overall Study|Other|0|||
27510304|NCT03524118|80061737|FG004|Overall Study|Other|1|||
27510305|NCT03524118|80061738|FG005|Overall Study|Other|1|||
27510306|NCT03524118|80061733|FG000|Overall Study|Physician Decision|0|||
27510307|NCT03524118|80061734|FG001|Overall Study|Physician Decision|0|||
27510308|NCT03524118|80061735|FG002|Overall Study|Physician Decision|0|||
27510309|NCT03524118|80061736|FG003|Overall Study|Physician Decision|0|||
27510310|NCT03524118|80061737|FG004|Overall Study|Physician Decision|1|||
27510311|NCT03524118|80061738|FG005|Overall Study|Physician Decision|0|||
27510312|NCT03524118|80061733|FG000|Overall Study|Protocol Violation|0|||
27510313|NCT03524118|80061734|FG001|Overall Study|Protocol Violation|0|||
27510314|NCT03524118|80061735|FG002|Overall Study|Protocol Violation|1|||
27510315|NCT03524118|80061736|FG003|Overall Study|Protocol Violation|0|||
27510316|NCT03524118|80061737|FG004|Overall Study|Protocol Violation|1|||
27510317|NCT03524118|80061738|FG005|Overall Study|Protocol Violation|0|||
27510318|NCT03524118|80061733|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27510319|NCT03524118|80061734|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27510320|NCT03524118|80061735|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27510321|NCT03524118|80061736|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
27510322|NCT03524118|80061737|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
27510323|NCT03524118|80061738|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27510324|NCT01931566|80061741|FG000|Overall Study|Randomized But Not Treated|6|||
27510325|NCT01931566|80061742|FG001|Overall Study|Randomized But Not Treated|9|||
27510326|NCT01931566|80061743|FG002|Overall Study|Randomized But Not Treated|14|||
27510327|NCT01931566|80061741|FG000|Overall Study|Adverse Event|37|||
27510328|NCT01931566|80061742|FG001|Overall Study|Adverse Event|167|||
27510329|NCT01931566|80061743|FG002|Overall Study|Adverse Event|132|||
27510330|NCT01931566|80061741|FG000|Overall Study|Major Protocol Deviation|5|||
27510331|NCT01931566|80061742|FG001|Overall Study|Major Protocol Deviation|14|||
27510332|NCT01931566|80061743|FG002|Overall Study|Major Protocol Deviation|21|||
27510333|NCT01931566|80061741|FG000|Overall Study|Lost to Follow-up|3|||
27510334|NCT01931566|80061742|FG001|Overall Study|Lost to Follow-up|26|||
27510335|NCT01931566|80061743|FG002|Overall Study|Lost to Follow-up|23|||
27510336|NCT01931566|80061741|FG000|Overall Study|Voluntary Withdrawal|78|||
27510337|NCT01931566|80061742|FG001|Overall Study|Voluntary Withdrawal|245|||
27510338|NCT01931566|80061743|FG002|Overall Study|Voluntary Withdrawal|225|||
27510339|NCT01931566|80061741|FG000|Overall Study|Study Termination|289|||
27510340|NCT01931566|80061742|FG001|Overall Study|Study Termination|968|||
27510341|NCT01931566|80061743|FG002|Overall Study|Study Termination|1037|||
27510342|NCT01931566|80061741|FG000|Overall Study|Reason Not Specified|11|||
27510343|NCT01931566|80061742|FG001|Overall Study|Reason Not Specified|47|||
27510344|NCT01931566|80061743|FG002|Overall Study|Reason Not Specified|53|||
27510345|NCT01931566|80061741|FG000|Overall Study|Missing|0|||
27510346|NCT01931566|80061742|FG001|Overall Study|Missing|0|||
27510347|NCT01931566|80061743|FG002|Overall Study|Missing|1|||
27510348|NCT00035932|80061744|FG000|Overall Study|Adverse Event|10|||
27510349|NCT00035932|80061745|FG001|Overall Study|Adverse Event|9|||
27510350|NCT00035932|80061746|FG002|Overall Study|Adverse Event|9|||
27905151|NCT04571385|81488614|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
27905152|NCT04571385|81488615|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
27905153|NCT04571385|81488616|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
27905154|NCT04571385|81488614|FG000|Overall Study|Screen failure|0|||
27905155|NCT04571385|81488615|FG001|Overall Study|Screen failure|0|||
27905156|NCT04571385|81488616|FG002|Overall Study|Screen failure|1|||
27905157|NCT00560703|81488617|FG000|Overall Study|Adverse Event|0|||
27510351|NCT00035932|80061744|FG000|Overall Study|Death|0|||
27510352|NCT00035932|80061745|FG001|Overall Study|Death|0|||
27510353|NCT00035932|80061746|FG002|Overall Study|Death|1|||
27510354|NCT00035932|80061744|FG000|Overall Study|Disease Progression / Relapse|1|||
27510355|NCT00035932|80061745|FG001|Overall Study|Disease Progression / Relapse|1|||
27614886|NCT02291289|80430354|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
27510356|NCT00035932|80061746|FG002|Overall Study|Disease Progression / Relapse|0|||
27510357|NCT00035932|80061744|FG000|Overall Study|Lost to Follow-up|4|||
27510358|NCT00035932|80061745|FG001|Overall Study|Lost to Follow-up|4|||
27510359|NCT00035932|80061746|FG002|Overall Study|Lost to Follow-up|3|||
27510360|NCT00035932|80061744|FG000|Overall Study|Noncompliance|6|||
27510361|NCT00035932|80061745|FG001|Overall Study|Noncompliance|7|||
27510362|NCT00035932|80061746|FG002|Overall Study|Noncompliance|6|||
27510363|NCT00035932|80061744|FG000|Overall Study|Protocol Violation While on Study|0|||
27510364|NCT00035932|80061745|FG001|Overall Study|Protocol Violation While on Study|1|||
27510365|NCT00035932|80061746|FG002|Overall Study|Protocol Violation While on Study|2|||
27510366|NCT00035932|80061744|FG000|Overall Study|Withdrawal by Subject|1|||
27510367|NCT00035932|80061745|FG001|Overall Study|Withdrawal by Subject|5|||
27510368|NCT00035932|80061746|FG002|Overall Study|Withdrawal by Subject|0|||
27510369|NCT00035932|80061744|FG000|Overall Study|Study Termination by Sponsor|1|||
27510370|NCT00035932|80061745|FG001|Overall Study|Study Termination by Sponsor|0|||
27510371|NCT00035932|80061746|FG002|Overall Study|Study Termination by Sponsor|0|||
27510372|NCT00035932|80061744|FG000|Overall Study|Lack of Efficacy|33|||
27510373|NCT00035932|80061745|FG001|Overall Study|Lack of Efficacy|33|||
27510374|NCT00035932|80061746|FG002|Overall Study|Lack of Efficacy|28|||
27510375|NCT01584440|80061747|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
27510376|NCT01584440|80061748|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27510377|NCT01584440|80061749|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27510378|NCT01584440|80061750|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27510379|NCT01584440|80061751|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
27510380|NCT01584440|80061747|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
27510381|NCT01584440|80061748|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
27510382|NCT01584440|80061749|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
27510383|NCT01584440|80061750|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
27510384|NCT01584440|80061751|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
27510385|NCT01584440|80061747|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
27510386|NCT01584440|80061748|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27510387|NCT01584440|80061749|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27510388|NCT01584440|80061750|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27510389|NCT01584440|80061751|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
27510390|NCT01584440|80061747|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
27510391|NCT01584440|80061748|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
27510392|NCT01584440|80061749|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
27510393|NCT01584440|80061750|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
27510394|NCT01584440|80061751|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
27510395|NCT01584440|80061747|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
27510396|NCT01584440|80061748|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27510397|NCT01584440|80061749|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27510398|NCT01584440|80061750|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27510399|NCT01584440|80061751|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
27510400|NCT01584440|80061747|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27510401|NCT01584440|80061748|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
27510402|NCT01584440|80061749|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27510403|NCT01584440|80061750|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27510404|NCT01584440|80061751|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
27510405|NCT01584440|80061747|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
27510406|NCT01584440|80061748|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
27510407|NCT01584440|80061749|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
27510408|NCT01584440|80061750|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
27510409|NCT01584440|80061751|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
27510410|NCT01584440|80061747|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
27510411|NCT01584440|80061748|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
27510412|NCT01584440|80061749|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
27510413|NCT01584440|80061750|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
27510414|NCT01584440|80061751|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
27510415|NCT01584440|80061747|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27510416|NCT01584440|80061748|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27510417|NCT01584440|80061749|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
27510418|NCT01584440|80061750|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27510419|NCT01584440|80061751|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
27510420|NCT02999672|80061752|FG000|Overall Study|Death|0|||
27510421|NCT02999672|80061753|FG001|Overall Study|Death|1|||
27510422|NCT02999672|80061752|FG000|Overall Study|Study Terminated by Sponsor|0|||
27510423|NCT02999672|80061753|FG001|Overall Study|Study Terminated by Sponsor|1|||
27510424|NCT02999672|80061752|FG000|Overall Study|Progressive Disease|9|||
27510425|NCT02999672|80061753|FG001|Overall Study|Progressive Disease|5|||
27510426|NCT02999672|80061752|FG000|Overall Study|Adverse Event|4|||
27510427|NCT02999672|80061753|FG001|Overall Study|Adverse Event|0|||
27510428|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
27510429|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
27510430|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
27510431|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
27510432|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27510433|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
27510434|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
27510435|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
27614887|NCT02291289|80430355|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
27614888|NCT02291289|80430356|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
27614889|NCT02291289|80430357|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
27614890|NCT02291289|80430358|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
27510436|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
27510437|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
27510438|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
27510439|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
27510440|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
27510441|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
27510442|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
27614891|NCT02291289|80430346|FG000|Early Disease Progression|Death|0|||
27614892|NCT02291289|80430347|FG001|Early Disease Progression|Death|0|||
27510443|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
27510444|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
27510445|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
27510446|NCT03739203|80061754|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
27510447|NCT03739203|80061755|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
27510448|NCT03739203|80061756|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
27510449|NCT03739203|80061754|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
27510450|NCT03739203|80061755|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
27510451|NCT03739203|80061756|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
27510452|NCT03739203|80061754|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
27510453|NCT03739203|80061755|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
27614893|NCT02291289|80430348|FG002|Early Disease Progression|Death|0|||
27905158|NCT00560703|81488618|FG001|Overall Study|Adverse Event|2|||
27905159|NCT00560703|81488617|FG000|Overall Study|Protocol Violation|0|||
27905160|NCT00560703|81488618|FG001|Overall Study|Protocol Violation|2|||
27905161|NCT00560703|81488617|FG000|Overall Study|Withdrawal by Subject|0|||
27905162|NCT00560703|81488618|FG001|Overall Study|Withdrawal by Subject|1|||
27905163|NCT00560703|81488617|FG000|Overall Study|non-compliance|0|||
27905164|NCT00560703|81488618|FG001|Overall Study|non-compliance|1|||
27905165|NCT01066871|81488619|FG000|Overall Study|Lost to Follow-up|0|||
27905166|NCT01066871|81488620|FG001|Overall Study|Lost to Follow-up|2|||
27905167|NCT01066871|81488621|FG002|Overall Study|Lost to Follow-up|2|||
27905168|NCT01066871|81488622|FG003|Overall Study|Lost to Follow-up|0|||
27905169|NCT01066871|81488619|FG000|Overall Study|Protocol Violation|1|||
27905170|NCT01066871|81488620|FG001|Overall Study|Protocol Violation|0|||
27905171|NCT01066871|81488621|FG002|Overall Study|Protocol Violation|3|||
27905172|NCT01066871|81488622|FG003|Overall Study|Protocol Violation|2|||
27905173|NCT01066871|81488619|FG000|Overall Study|Lack of Efficacy|0|||
27905174|NCT01066871|81488620|FG001|Overall Study|Lack of Efficacy|0|||
27905175|NCT01066871|81488621|FG002|Overall Study|Lack of Efficacy|0|||
27905176|NCT01066871|81488622|FG003|Overall Study|Lack of Efficacy|1|||
27905177|NCT01066871|81488619|FG000|Overall Study|Withdrawal by Subject|3|||
27905178|NCT01066871|81488620|FG001|Overall Study|Withdrawal by Subject|1|||
27905179|NCT01066871|81488621|FG002|Overall Study|Withdrawal by Subject|0|||
27905180|NCT01066871|81488622|FG003|Overall Study|Withdrawal by Subject|0|||
27905181|NCT01066871|81488619|FG000|Overall Study|Other|0|||
27905182|NCT01066871|81488620|FG001|Overall Study|Other|2|||
27905183|NCT01066871|81488621|FG002|Overall Study|Other|1|||
27905184|NCT01066871|81488622|FG003|Overall Study|Other|2|||
27905185|NCT02282163|81488623|FG000|Overall Study|Protocol Violation|1|||
27905186|NCT04186221|81488624|FG000|Overall Study|Death|1|||
27905187|NCT01597492|81488625|FG000|Overall Study|Withdrawal by Subject|1|||
27905188|NCT01597492|81488626|FG001|Overall Study|Withdrawal by Subject|2|||
27905189|NCT01597492|81488625|FG000|Overall Study|Adverse Event|3|||
27905190|NCT01597492|81488626|FG001|Overall Study|Adverse Event|0|||
27905191|NCT01597492|81488625|FG000|Overall Study|Lost to Follow-up|0|||
27905192|NCT01597492|81488626|FG001|Overall Study|Lost to Follow-up|2|||
27905193|NCT01597492|81488625|FG000|Overall Study|Other Reason|2|||
27510454|NCT03739203|80061756|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
27510455|NCT03739203|80061754|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
27510456|NCT03739203|80061755|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
27510457|NCT03739203|80061756|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
27510458|NCT03739203|80061754|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
27510459|NCT03739203|80061755|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
27510460|NCT03739203|80061756|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
27510461|NCT00737672|80061757|FG000|Overall Study|Graft Abandonment|48|||
27614894|NCT02291289|80430349|FG003|Early Disease Progression|Death|0|||
27905194|NCT01597492|81488626|FG001|Overall Study|Other Reason|0|||
27905195|NCT01616758|81488627|FG000|Overall Study|Adverse Event|1|||
27905196|NCT01616758|81488627|FG000|Overall Study|Withdrawal by Subject|2|||
27905197|NCT01616758|81488627|FG000|Overall Study|Disease progression|18|||
27905198|NCT01616758|81488627|FG000|Overall Study|Study termination by Sponsor|1|||
27905199|NCT03519919|81488640|FG000|Overall Study|Withdrawal by Subject|1|||
27905200|NCT03519919|81488640|FG000|Overall Study|Lack of Efficacy|1|||
27905201|NCT03519919|81488640|FG000|Overall Study|Screen Failure|1|||
27905202|NCT02782377|81488641|FG000|Overall Study|Physician Decision|5|||
27905203|NCT00802672|81488642|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
27905204|NCT00802672|81488643|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
27905205|NCT00802672|81488644|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
27905206|NCT00802672|81488642|FG000|Overall Study|Adverse Event|1|||
27905207|NCT00802672|81488643|FG001|Overall Study|Adverse Event|1|||
27905208|NCT00802672|81488644|FG002|Overall Study|Adverse Event|1|||
27905209|NCT00802672|81488642|FG000|Overall Study|Protocol Violation|2|||
27905210|NCT00802672|81488643|FG001|Overall Study|Protocol Violation|1|||
27905211|NCT00802672|81488644|FG002|Overall Study|Protocol Violation|1|||
27905212|NCT00802672|81488642|FG000|Overall Study|Lost to Follow-up|5|||
27905213|NCT00802672|81488643|FG001|Overall Study|Lost to Follow-up|5|||
27905214|NCT00802672|81488644|FG002|Overall Study|Lost to Follow-up|3|||
27905215|NCT00802672|81488642|FG000|Overall Study|Withdrawal by Subject|1|||
27905216|NCT00802672|81488643|FG001|Overall Study|Withdrawal by Subject|1|||
27905217|NCT00802672|81488644|FG002|Overall Study|Withdrawal by Subject|2|||
27905218|NCT00802672|81488642|FG000|Overall Study|other|3|||
27614895|NCT02291289|80430350|FG004|Early Disease Progression|Death|0|||
27905219|NCT00802672|81488643|FG001|Overall Study|other|1|||
27905220|NCT00802672|81488644|FG002|Overall Study|other|2|||
27510462|NCT00737672|80061758|FG001|Overall Study|Graft Abandonment|56|||
27510463|NCT00737672|80061757|FG000|Overall Study|Death|23|||
27510464|NCT00737672|80061758|FG001|Overall Study|Death|22|||
27510465|NCT00737672|80061757|FG000|Overall Study|Withdrawal by Subject|1|||
27510466|NCT00737672|80061758|FG001|Overall Study|Withdrawal by Subject|2|||
27510467|NCT00737672|80061757|FG000|Overall Study|Lost to Follow-up|1|||
27510468|NCT00737672|80061758|FG001|Overall Study|Lost to Follow-up|0|||
27510469|NCT00737672|80061757|FG000|Overall Study|Miscellaneous|7|||
27510470|NCT00737672|80061758|FG001|Overall Study|Miscellaneous|1|||
27510471|NCT00737672|80061757|FG000|Overall Study|Physician Decision|0|||
27510472|NCT00737672|80061758|FG001|Overall Study|Physician Decision|2|||
27510473|NCT01012440|80061762|FG000|Overall Study|Withdrawal by Subject|2|||
27510474|NCT00297258|80061763|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
27510475|NCT00297258|80061763|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
27510476|NCT00297258|80061763|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
27510477|NCT00297258|80061763|FG000|Overall Study|Intercurrent Illness|3|||
27510478|NCT00297258|80061763|FG000|Overall Study|Intercurrent Death|2|||
27510479|NCT00297258|80061763|FG000|Overall Study|Deteriorization of General Condition|1|||
27510480|NCT00297258|80061763|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
27510481|NCT00297258|80061763|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
27510482|NCT00297258|80061763|FG000|Overall Study|Switch to Commercial Treatment|1|||
27510483|NCT00297258|80061763|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
27510484|NCT01286480|80061764|FG000|Overall Study|Withdrawal by Subject|5|||
27510485|NCT01286480|80061765|FG001|Overall Study|Withdrawal by Subject|3|||
27510486|NCT01635153|80061767|FG000|Overall Study|Lost to Follow-up|40|||
27510487|NCT01635153|80061768|FG001|Overall Study|Lost to Follow-up|43|||
27510488|NCT01976741|80061772|FG000|Overall Study|Withdrawal by Subject|1|||
27510489|NCT01976741|80061773|FG001|Overall Study|Withdrawal by Subject|0|||
27510490|NCT01976741|80061774|FG002|Overall Study|Withdrawal by Subject|1|||
27510491|NCT01976741|80061775|FG003|Overall Study|Withdrawal by Subject|1|||
27510492|NCT01976741|80061776|FG004|Overall Study|Withdrawal by Subject|0|||
27510493|NCT01976741|80061777|FG005|Overall Study|Withdrawal by Subject|0|||
27510494|NCT01976741|80061778|FG006|Overall Study|Withdrawal by Subject|1|||
27510495|NCT01976741|80061779|FG007|Overall Study|Withdrawal by Subject|4|||
27510496|NCT01976741|80061780|FG008|Overall Study|Withdrawal by Subject|0|||
27510497|NCT01976741|80061781|FG009|Overall Study|Withdrawal by Subject|0|||
27510498|NCT01976741|80061772|FG000|Overall Study|Adverse Event|0|||
27510499|NCT01976741|80061773|FG001|Overall Study|Adverse Event|0|||
27510500|NCT01976741|80061774|FG002|Overall Study|Adverse Event|2|||
27510501|NCT01976741|80061775|FG003|Overall Study|Adverse Event|0|||
27510502|NCT01976741|80061776|FG004|Overall Study|Adverse Event|0|||
27510503|NCT01976741|80061777|FG005|Overall Study|Adverse Event|0|||
27510504|NCT01976741|80061778|FG006|Overall Study|Adverse Event|3|||
27510505|NCT01976741|80061779|FG007|Overall Study|Adverse Event|8|||
27510506|NCT01976741|80061780|FG008|Overall Study|Adverse Event|1|||
27510507|NCT01976741|80061781|FG009|Overall Study|Adverse Event|4|||
27510508|NCT00334113|80061782|FG000|Overall Study|Lost to Follow-up|2|||
27510509|NCT00334113|80061783|FG001|Overall Study|Lost to Follow-up|2|||
27510510|NCT00334113|80061782|FG000|Overall Study|Withdrawal by Subject|0|||
27510511|NCT00334113|80061783|FG001|Overall Study|Withdrawal by Subject|1|||
27510512|NCT00953056|80061784|FG000|Overall Study|Withdrew Consent|0|||
27510513|NCT00953056|80061785|FG001|Overall Study|Withdrew Consent|0|||
27510514|NCT00953056|80061786|FG002|Overall Study|Withdrew Consent|0|||
27510515|NCT00953056|80061787|FG003|Overall Study|Withdrew Consent|0|||
27510516|NCT00953056|80061788|FG004|Overall Study|Withdrew Consent|2|||
27510517|NCT00953056|80061789|FG005|Overall Study|Withdrew Consent|3|||
27510518|NCT00953056|80061784|FG000|Overall Study|Serious Adverse Event|0|||
27510519|NCT00953056|80061785|FG001|Overall Study|Serious Adverse Event|0|||
27510520|NCT00953056|80061786|FG002|Overall Study|Serious Adverse Event|0|||
27510521|NCT00953056|80061787|FG003|Overall Study|Serious Adverse Event|0|||
27510522|NCT00953056|80061788|FG004|Overall Study|Serious Adverse Event|0|||
27510523|NCT00953056|80061789|FG005|Overall Study|Serious Adverse Event|1|||
27510524|NCT01339052|80061790|FG000|Overall Study|Disease progression|13|||
27510525|NCT01339052|80061791|FG001|Overall Study|Disease progression|46|||
27510526|NCT01339052|80061790|FG000|Overall Study|Adverse Event|1|||
27510527|NCT01339052|80061791|FG001|Overall Study|Adverse Event|1|||
27510528|NCT01339052|80061790|FG000|Overall Study|Withdrawal by Subject|0|||
27510529|NCT01339052|80061791|FG001|Overall Study|Withdrawal by Subject|3|||
27510530|NCT01339052|80061790|FG000|Overall Study|Physician Decision|1|||
27510531|NCT01339052|80061791|FG001|Overall Study|Physician Decision|0|||
27510532|NCT00616759|80061792|FG000|Overall Study|Physician Decision|2|||
27510533|NCT00616759|80061793|FG001|Overall Study|Physician Decision|0|||
27510534|NCT00616759|80061792|FG000|Overall Study|Withdrawal by Subject|1|||
27510535|NCT00616759|80061793|FG001|Overall Study|Withdrawal by Subject|2|||
27510536|NCT00888940|80061794|FG000|Overall Study|Adverse Event|12|||
27510537|NCT00888940|80061795|FG001|Overall Study|Adverse Event|3|||
27510538|NCT00888940|80061794|FG000|Overall Study|Lost to Follow-up|5|||
27510539|NCT00888940|80061795|FG001|Overall Study|Lost to Follow-up|5|||
27510540|NCT00888940|80061794|FG000|Overall Study|Randomized Not Treated|11|||
27905221|NCT02769312|81488645|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
27510541|NCT00888940|80061795|FG001|Overall Study|Randomized Not Treated|13|||
27510542|NCT01166282|80061796|FG000|Open-label Period|Adverse Event|0|||
27510543|NCT01166282|80061797|FG001|Open-label Period|Adverse Event|0|||
27510544|NCT01166282|80061798|FG002|Open-label Period|Adverse Event|6|||
27510545|NCT01166282|80061796|FG000|Open-label Period|Withdrawal by Subject|0|||
27510546|NCT01166282|80061797|FG001|Open-label Period|Withdrawal by Subject|0|||
27510547|NCT01166282|80061798|FG002|Open-label Period|Withdrawal by Subject|4|||
27614896|NCT02291289|80430351|FG005|Early Disease Progression|Death|0|||
27614897|NCT02291289|80430352|FG006|Early Disease Progression|Death|0|||
27905222|NCT02769312|81488646|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
27905223|NCT02769312|81488645|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
27905224|NCT02769312|81488646|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
27905225|NCT02769312|81488645|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
27905226|NCT02769312|81488646|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
27905227|NCT02769312|81488645|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
27905228|NCT02769312|81488646|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
27905229|NCT02769312|81488645|FG000|Follow-up|Lost to Follow-up|1|||
27905230|NCT02769312|81488646|FG001|Follow-up|Lost to Follow-up|1|||
27905231|NCT00385827|81488649|FG000|Part 1|Adverse Event|1|||
27905232|NCT00385827|81488650|FG001|Part 1|Adverse Event|0|||
27905233|NCT00385827|81488651|FG002|Part 1|Adverse Event|0|||
27905234|NCT00385827|81488649|FG000|Part 1|Death|2|||
27905235|NCT00385827|81488650|FG001|Part 1|Death|0|||
27905236|NCT00385827|81488651|FG002|Part 1|Death|0|||
27905237|NCT00385827|81488649|FG000|Part 1|Lack of Efficacy|5|||
27905238|NCT00385827|81488650|FG001|Part 1|Lack of Efficacy|0|||
27905239|NCT00385827|81488651|FG002|Part 1|Lack of Efficacy|0|||
27905240|NCT00385827|81488649|FG000|Part 1|Other|1|||
27905241|NCT00385827|81488650|FG001|Part 1|Other|0|||
27905242|NCT00385827|81488651|FG002|Part 1|Other|0|||
27905243|NCT00385827|81488649|FG000|Part 2|Adverse Event|0|||
27905244|NCT00385827|81488650|FG001|Part 2|Adverse Event|6|||
27905245|NCT00385827|81488651|FG002|Part 2|Adverse Event|10|||
27905246|NCT00385827|81488649|FG000|Part 2|Death|0|||
27905247|NCT00385827|81488650|FG001|Part 2|Death|0|||
27905248|NCT00385827|81488651|FG002|Part 2|Death|2|||
27905249|NCT00385827|81488649|FG000|Part 2|Lack of Efficacy|0|||
27905250|NCT00385827|81488650|FG001|Part 2|Lack of Efficacy|14|||
27905251|NCT00385827|81488651|FG002|Part 2|Lack of Efficacy|13|||
27905252|NCT00385827|81488649|FG000|Part 2|Randomized but not treated|0|||
27905253|NCT00385827|81488650|FG001|Part 2|Randomized but not treated|2|||
27905254|NCT00385827|81488651|FG002|Part 2|Randomized but not treated|2|||
27905255|NCT00385827|81488649|FG000|Part 2|Other|0|||
27905256|NCT00385827|81488650|FG001|Part 2|Other|11|||
27905257|NCT00385827|81488651|FG002|Part 2|Other|21|||
27905258|NCT02669043|81488652|FG000|Overall Study|Didn't meet I/E criteria|4|||
27905259|NCT03337048|81488653|FG000|Overall Study|Withdrawal by Subject|2|||
27905260|NCT03337048|81488654|FG001|Overall Study|Withdrawal by Subject|0|||
27510548|NCT01166282|80061796|FG000|Open-label Period|Lack of Efficacy|0|||
27510549|NCT01166282|80061797|FG001|Open-label Period|Lack of Efficacy|0|||
27510550|NCT01166282|80061798|FG002|Open-label Period|Lack of Efficacy|2|||
27510551|NCT01166282|80061796|FG000|Open-label Period|Remission|0|||
27614898|NCT02291289|80430353|FG007|Early Disease Progression|Death|0|||
27510552|NCT01166282|80061797|FG001|Open-label Period|Remission|0|||
27905261|NCT03337048|81488655|FG002|Overall Study|Withdrawal by Subject|0|||
27905262|NCT01928199|81488656|FG000|Overall Study|Lost to Follow-up|2|||
27905263|NCT01928199|81488657|FG001|Overall Study|Lost to Follow-up|1|||
27510553|NCT01166282|80061798|FG002|Open-label Period|Remission|4|||
27510554|NCT01166282|80061796|FG000|Open-label Period|Irregular Compliance|0|||
27905264|NCT01928199|81488656|FG000|Overall Study|Withdrawal by Subject|3|||
27905265|NCT01928199|81488657|FG001|Overall Study|Withdrawal by Subject|5|||
27905266|NCT04399538|81488662|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
27905267|NCT04399538|81488663|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
27905268|NCT04399538|81488664|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
27510555|NCT01166282|80061797|FG001|Open-label Period|Irregular Compliance|0|||
27510556|NCT01166282|80061798|FG002|Open-label Period|Irregular Compliance|1|||
27510557|NCT00248040|80061799|FG000|Overall Study|transplantectomy|2|||
27510558|NCT00248040|80061800|FG001|Overall Study|transplantectomy|1|||
27510559|NCT00248040|80061801|FG002|Overall Study|transplantectomy|3|||
27510560|NCT00248040|80061799|FG000|Overall Study|transplant cancelled post treat start|1|||
27510561|NCT00248040|80061800|FG001|Overall Study|transplant cancelled post treat start|0|||
27510562|NCT00248040|80061801|FG002|Overall Study|transplant cancelled post treat start|0|||
27510563|NCT00248040|80061799|FG000|Overall Study|Death|0|||
27510564|NCT00248040|80061800|FG001|Overall Study|Death|0|||
27510565|NCT00248040|80061801|FG002|Overall Study|Death|1|||
27510566|NCT00060840|80061802|FG000|Overall Study|Change in surgical plan|2|||
27510567|NCT00060840|80061803|FG001|Overall Study|Change in surgical plan|6|||
27510568|NCT00060840|80061802|FG000|Overall Study|Death|0|||
27510569|NCT00060840|80061803|FG001|Overall Study|Death|1|||
27510570|NCT00060840|80061802|FG000|Overall Study|Withdrawal by Subject|0|||
27510571|NCT00060840|80061803|FG001|Overall Study|Withdrawal by Subject|1|||
27510572|NCT00060840|80061802|FG000|Overall Study|Subinvestigator unavailable|0|||
27510573|NCT00060840|80061803|FG001|Overall Study|Subinvestigator unavailable|1|||
27510574|NCT00060840|80061802|FG000|Overall Study|Physician Decision|1|||
27510575|NCT00060840|80061803|FG001|Overall Study|Physician Decision|0|||
27510576|NCT00060840|80061802|FG000|Overall Study|Other|1|||
27510577|NCT00060840|80061803|FG001|Overall Study|Other|0|||
27510578|NCT03819114|80061804|FG000|Overall Study|Protocol Violation|0|||
27510579|NCT03819114|80061805|FG001|Overall Study|Protocol Violation|1|||
27510580|NCT03819114|80061806|FG002|Overall Study|Protocol Violation|1|||
27510581|NCT03819114|80061807|FG003|Overall Study|Protocol Violation|0|||
27510582|NCT03819114|80061804|FG000|Overall Study|Lost to Follow-up|0|||
27510583|NCT03819114|80061805|FG001|Overall Study|Lost to Follow-up|0|||
27510584|NCT03819114|80061806|FG002|Overall Study|Lost to Follow-up|1|||
27510585|NCT03819114|80061807|FG003|Overall Study|Lost to Follow-up|0|||
27510586|NCT03848832|80061808|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
27510587|NCT03848832|80061809|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
27510588|NCT03848832|80061810|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
27510589|NCT03848832|80061808|FG000|Overall Study|Withdrawal by Subject|0|||
27510590|NCT03848832|80061809|FG001|Overall Study|Withdrawal by Subject|0|||
27510591|NCT03848832|80061810|FG002|Overall Study|Withdrawal by Subject|1|||
27510592|NCT03848832|80061808|FG000|Overall Study|Withdrawal (Covid-19)|0|||
27510593|NCT03848832|80061809|FG001|Overall Study|Withdrawal (Covid-19)|2|||
27510594|NCT03848832|80061810|FG002|Overall Study|Withdrawal (Covid-19)|0|||
27510595|NCT03848832|80061808|FG000|Overall Study|Physician Decision|2|||
27510596|NCT03848832|80061809|FG001|Overall Study|Physician Decision|1|||
27852800|NCT00629265|81291224|FG001|Overall Study|Unknown Reason|2|||
27852801|NCT03955471|81291225|FG000|Overall Study|Death|22|||
27852802|NCT03955471|81291225|FG000|Overall Study|Lost to Follow-up|1|||
27852803|NCT03955471|81291225|FG000|Overall Study|Withdrawal by Subject|6|||
27852804|NCT03955471|81291225|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
27852805|NCT00321737|81291228|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
27852806|NCT00321737|81291229|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
27852807|NCT00321737|81291230|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
27852808|NCT00321737|81291228|FG000|Overall Study|Adverse Event|11|||
27510597|NCT03848832|80061810|FG002|Overall Study|Physician Decision|3|||
27510598|NCT03848832|80061808|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
27510599|NCT03848832|80061809|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
27510600|NCT03848832|80061810|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
27510601|NCT03848832|80061808|FG000|Overall Study|Adverse Event|1|||
27510602|NCT03848832|80061809|FG001|Overall Study|Adverse Event|0|||
27852809|NCT00321737|81291229|FG001|Overall Study|Adverse Event|3|||
27510603|NCT03848832|80061810|FG002|Overall Study|Adverse Event|0|||
27510604|NCT01134055|80061811|FG000|Overall Study|Adverse Event|5|||
27510605|NCT01134055|80061812|FG001|Overall Study|Adverse Event|2|||
27510606|NCT01134055|80061813|FG002|Overall Study|Adverse Event|2|||
27510607|NCT01134055|80061814|FG003|Overall Study|Adverse Event|2|||
27510608|NCT01134055|80061815|FG004|Overall Study|Adverse Event|5|||
27510609|NCT01134055|80061816|FG005|Overall Study|Adverse Event|7|||
27510610|NCT01134055|80061817|FG006|Overall Study|Adverse Event|2|||
27510611|NCT01134055|80061811|FG000|Overall Study|Lost to Follow-up|0|||
27510612|NCT01134055|80061812|FG001|Overall Study|Lost to Follow-up|1|||
27510613|NCT01134055|80061813|FG002|Overall Study|Lost to Follow-up|0|||
27510614|NCT01134055|80061814|FG003|Overall Study|Lost to Follow-up|1|||
27510615|NCT01134055|80061815|FG004|Overall Study|Lost to Follow-up|0|||
27510616|NCT01134055|80061816|FG005|Overall Study|Lost to Follow-up|0|||
27510617|NCT01134055|80061817|FG006|Overall Study|Lost to Follow-up|0|||
27510618|NCT01134055|80061811|FG000|Overall Study|Withdrawal by Subject|3|||
27510619|NCT01134055|80061812|FG001|Overall Study|Withdrawal by Subject|3|||
27510620|NCT01134055|80061813|FG002|Overall Study|Withdrawal by Subject|1|||
27510621|NCT01134055|80061814|FG003|Overall Study|Withdrawal by Subject|2|||
27510622|NCT01134055|80061815|FG004|Overall Study|Withdrawal by Subject|0|||
27510623|NCT01134055|80061816|FG005|Overall Study|Withdrawal by Subject|0|||
27510624|NCT01134055|80061817|FG006|Overall Study|Withdrawal by Subject|8|||
27510625|NCT01134055|80061811|FG000|Overall Study|Protocol Violation|0|||
27510626|NCT01134055|80061812|FG001|Overall Study|Protocol Violation|0|||
27510627|NCT01134055|80061813|FG002|Overall Study|Protocol Violation|0|||
27510628|NCT01134055|80061814|FG003|Overall Study|Protocol Violation|1|||
27510629|NCT01134055|80061815|FG004|Overall Study|Protocol Violation|1|||
27510630|NCT01134055|80061816|FG005|Overall Study|Protocol Violation|0|||
27510631|NCT01134055|80061817|FG006|Overall Study|Protocol Violation|0|||
27510632|NCT01134055|80061811|FG000|Overall Study|Physician Decision|0|||
27510633|NCT01134055|80061812|FG001|Overall Study|Physician Decision|0|||
27510634|NCT01134055|80061813|FG002|Overall Study|Physician Decision|0|||
27510635|NCT01134055|80061814|FG003|Overall Study|Physician Decision|0|||
27510636|NCT01134055|80061815|FG004|Overall Study|Physician Decision|0|||
27510637|NCT01134055|80061816|FG005|Overall Study|Physician Decision|0|||
27510638|NCT01134055|80061817|FG006|Overall Study|Physician Decision|1|||
27510639|NCT00622440|80061818|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
27510640|NCT00622440|80061819|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
27510641|NCT00622440|80061818|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
27510642|NCT00622440|80061819|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
27510643|NCT00622440|80061818|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
27510644|NCT00622440|80061819|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
27510645|NCT00622440|80061818|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
27510646|NCT00622440|80061819|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
27510647|NCT00566696|80061821|FG000|Overall Study|Met Exclusion Criteria|2|||
27510648|NCT00566696|80061821|FG000|Overall Study|Muromonab not available|1|||
27510649|NCT00566696|80061821|FG000|Overall Study|Health Status Change|1|||
27510650|NCT00566696|80061821|FG000|Overall Study|Physician Decision|1|||
27510651|NCT00566696|80061821|FG000|Overall Study|Non-Patient Donors|37|||
27510652|NCT03181932|80061825|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
27510653|NCT03181932|80061826|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
27510654|NCT03181932|80061825|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
27510655|NCT03181932|80061826|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
27510656|NCT03181932|80061825|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
27510657|NCT03181932|80061826|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
27510658|NCT03181932|80061825|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
27510659|NCT03181932|80061826|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
27510660|NCT03181932|80061825|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
27510661|NCT03181932|80061826|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
27510662|NCT03181932|80061825|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
27510663|NCT03181932|80061826|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
27510664|NCT03181932|80061825|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
27510665|NCT03181932|80061826|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
27510666|NCT03181932|80061825|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
27510667|NCT03181932|80061826|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
27510668|NCT03181932|80061825|FG000|Period 2 (Open-label Period)|Reason missing|2|||
27510669|NCT03181932|80061826|FG001|Period 2 (Open-label Period)|Reason missing|0|||
27510670|NCT00927953|80061829|FG000|Overall Study|Death|2|||
27510671|NCT00927953|80061830|FG001|Overall Study|Death|1|||
27510672|NCT00286468|80061831|FG000|Overall Study|Hyperglycemic Rescue|28|||
27510673|NCT00286468|80061832|FG001|Overall Study|Hyperglycemic Rescue|30|||
27510674|NCT00286468|80061833|FG002|Overall Study|Hyperglycemic Rescue|31|||
27510675|NCT00286468|80061831|FG000|Overall Study|Adverse Event|2|||
27510676|NCT00286468|80061832|FG001|Overall Study|Adverse Event|6|||
27510677|NCT00286468|80061833|FG002|Overall Study|Adverse Event|4|||
27510678|NCT00286468|80061831|FG000|Overall Study|Protocol Violation|0|||
27510679|NCT00286468|80061832|FG001|Overall Study|Protocol Violation|3|||
27510680|NCT00286468|80061833|FG002|Overall Study|Protocol Violation|1|||
27510681|NCT00286468|80061831|FG000|Overall Study|Lost to Follow-up|1|||
27905269|NCT04399538|81488665|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
27905270|NCT04399538|81488666|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
27905271|NCT04399538|81488662|FG000|Double-Blind Treatment|Adverse Event|0|||
27905272|NCT04399538|81488663|FG001|Double-Blind Treatment|Adverse Event|0|||
27905273|NCT04399538|81488664|FG002|Double-Blind Treatment|Adverse Event|0|||
27905274|NCT04399538|81488665|FG003|Double-Blind Treatment|Adverse Event|0|||
27905275|NCT04399538|81488666|FG004|Double-Blind Treatment|Adverse Event|1|||
27905276|NCT04399538|81488662|FG000|Follow-Up|Adverse Event|0|||
27905277|NCT04399538|81488663|FG001|Follow-Up|Adverse Event|0|||
27905278|NCT04399538|81488664|FG002|Follow-Up|Adverse Event|0|||
27905279|NCT04399538|81488665|FG003|Follow-Up|Adverse Event|0|||
27905280|NCT04399538|81488666|FG004|Follow-Up|Adverse Event|1|||
27905281|NCT04399538|81488662|FG000|Follow-Up|Withdrawal by Subject|0|||
27905282|NCT04399538|81488663|FG001|Follow-Up|Withdrawal by Subject|0|||
27905283|NCT04399538|81488664|FG002|Follow-Up|Withdrawal by Subject|0|||
27905284|NCT04399538|81488665|FG003|Follow-Up|Withdrawal by Subject|2|||
27905285|NCT04399538|81488666|FG004|Follow-Up|Withdrawal by Subject|0|||
27905286|NCT01317004|81488667|FG000|Overall Study|Withdrawal by Subject|1|||
27905287|NCT01317004|81488668|FG001|Overall Study|Withdrawal by Subject|4|||
27905288|NCT01317004|81488667|FG000|Overall Study|Protocol Violation|0|||
27905289|NCT01317004|81488668|FG001|Overall Study|Protocol Violation|2|||
27510682|NCT00286468|80061832|FG001|Overall Study|Lost to Follow-up|1|||
27905290|NCT01317004|81488667|FG000|Overall Study|Adverse Event|3|||
27905291|NCT01317004|81488668|FG001|Overall Study|Adverse Event|3|||
27905292|NCT01711619|81488669|FG000|Overall Study|Early study termination|10|||
27510683|NCT00286468|80061833|FG002|Overall Study|Lost to Follow-up|2|||
27510684|NCT00286468|80061831|FG000|Overall Study|Withdrawal by Subject|3|||
27905293|NCT01711619|81488670|FG001|Overall Study|Early study termination|14|||
27905294|NCT01711619|81488669|FG000|Overall Study|Withdrawal by Subject|3|||
27905295|NCT01711619|81488670|FG001|Overall Study|Withdrawal by Subject|7|||
27905296|NCT01711619|81488669|FG000|Overall Study|Protocol Violation|2|||
27905297|NCT01711619|81488670|FG001|Overall Study|Protocol Violation|3|||
27905298|NCT01711619|81488669|FG000|Overall Study|Adverse Event|2|||
27905299|NCT01711619|81488670|FG001|Overall Study|Adverse Event|0|||
27905300|NCT01711619|81488669|FG000|Overall Study|Lost to Follow-up|1|||
27905301|NCT01711619|81488670|FG001|Overall Study|Lost to Follow-up|0|||
27905302|NCT03046056|81488673|FG000|Overall Study|Non-responder at Week 10|6|||
27905303|NCT03046056|81488674|FG001|Overall Study|Non-responder at Week 10|6|||
27905304|NCT03046056|81488675|FG002|Overall Study|Non-responder at Week 10|4|||
27905305|NCT03046056|81488673|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
27905306|NCT03046056|81488674|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
27905307|NCT03046056|81488675|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
27905308|NCT03046056|81488673|FG000|Overall Study|Adverse Event|1|||
27905309|NCT03046056|81488674|FG001|Overall Study|Adverse Event|5|||
27905310|NCT03046056|81488675|FG002|Overall Study|Adverse Event|0|||
27905311|NCT03046056|81488673|FG000|Overall Study|Non-compliance With Study Drug|0|||
27905312|NCT03046056|81488674|FG001|Overall Study|Non-compliance With Study Drug|0|||
27905313|NCT03046056|81488675|FG002|Overall Study|Non-compliance With Study Drug|2|||
27905314|NCT03046056|81488673|FG000|Overall Study|Protocol Violation|1|||
27905315|NCT03046056|81488674|FG001|Overall Study|Protocol Violation|1|||
27905316|NCT03046056|81488675|FG002|Overall Study|Protocol Violation|0|||
27905317|NCT03046056|81488673|FG000|Overall Study|Investigator's Discretion|0|||
27905318|NCT03046056|81488674|FG001|Overall Study|Investigator's Discretion|1|||
27905319|NCT03046056|81488675|FG002|Overall Study|Investigator's Discretion|0|||
27905320|NCT03046056|81488673|FG000|Overall Study|Withdrew Consent|1|||
27905321|NCT03046056|81488674|FG001|Overall Study|Withdrew Consent|0|||
27905322|NCT03046056|81488675|FG002|Overall Study|Withdrew Consent|0|||
27905323|NCT02437188|81488676|FG000|Overall Study|Randomized but did not receive surgery|4|||
27905324|NCT02437188|81488677|FG001|Overall Study|Randomized but did not receive surgery|8|||
27905325|NCT02437188|81488676|FG000|Overall Study|Adverse Event|0|||
27905326|NCT02437188|81488677|FG001|Overall Study|Adverse Event|1|||
27905327|NCT04750278|81488678|FG000|Overall Study|Death|9|||
27905328|NCT04750278|81488679|FG001|Overall Study|Death|10|||
27905329|NCT04750278|81488680|FG002|Overall Study|Death|10|||
27905330|NCT04750278|81488678|FG000|Overall Study|Withdrawal by Subject|4|||
27905331|NCT04750278|81488679|FG001|Overall Study|Withdrawal by Subject|1|||
27905332|NCT04750278|81488680|FG002|Overall Study|Withdrawal by Subject|2|||
27905333|NCT04750278|81488678|FG000|Overall Study|Lost to Follow-up|1|||
27728618|NCT00804687|80833342|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
27852810|NCT00321737|81291230|FG002|Overall Study|Adverse Event|6|||
27852811|NCT00321737|81291228|FG000|Overall Study|Lost to Follow-up|5|||
27852812|NCT00321737|81291229|FG001|Overall Study|Lost to Follow-up|5|||
27852813|NCT00321737|81291230|FG002|Overall Study|Lost to Follow-up|6|||
27852814|NCT00321737|81291228|FG000|Overall Study|Withdrawal by Subject|19|||
27852815|NCT00321737|81291229|FG001|Overall Study|Withdrawal by Subject|12|||
27852816|NCT00321737|81291230|FG002|Overall Study|Withdrawal by Subject|17|||
27852817|NCT00321737|81291228|FG000|Overall Study|Protocol Violation|0|||
27852818|NCT00321737|81291229|FG001|Overall Study|Protocol Violation|0|||
27852819|NCT00321737|81291230|FG002|Overall Study|Protocol Violation|1|||
27852820|NCT00321737|81291228|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
27852821|NCT00321737|81291229|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
27852822|NCT00321737|81291230|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
27852823|NCT00321737|81291228|FG000|Overall Study|Possible Barrett's Esophagus|2|||
27852824|NCT00321737|81291229|FG001|Overall Study|Possible Barrett's Esophagus|1|||
27852825|NCT00321737|81291230|FG002|Overall Study|Possible Barrett's Esophagus|1|||
27852826|NCT00321737|81291228|FG000|Overall Study|Therapeutic Failure|6|||
27852827|NCT00321737|81291229|FG001|Overall Study|Therapeutic Failure|0|||
27852828|NCT00321737|81291230|FG002|Overall Study|Therapeutic Failure|2|||
27852829|NCT00321737|81291228|FG000|Overall Study|Pregnancy|0|||
27852830|NCT00321737|81291229|FG001|Overall Study|Pregnancy|2|||
27852831|NCT00321737|81291230|FG002|Overall Study|Pregnancy|0|||
27852832|NCT00321737|81291228|FG000|Overall Study|Noncompliance|2|||
27852833|NCT00321737|81291229|FG001|Overall Study|Noncompliance|0|||
27852834|NCT00321737|81291230|FG002|Overall Study|Noncompliance|0|||
27852835|NCT00321737|81291228|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
27852836|NCT00321737|81291229|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
27852837|NCT00321737|81291230|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
27852838|NCT01249365|81291231|FG000|Overall Study|Lost to Follow-up|1|||
27852839|NCT02139124|81291232|FG000|Overall Study|Adverse Event|2|||
27905334|NCT04750278|81488679|FG001|Overall Study|Lost to Follow-up|1|||
27852840|NCT02139124|81291233|FG001|Overall Study|Adverse Event|0|||
27852841|NCT02139124|81291234|FG002|Overall Study|Adverse Event|1|||
27905335|NCT04750278|81488680|FG002|Overall Study|Lost to Follow-up|1|||
27905336|NCT04750278|81488678|FG000|Overall Study|Pregnancy|1|||
27905337|NCT04750278|81488679|FG001|Overall Study|Pregnancy|0|||
27905338|NCT04750278|81488680|FG002|Overall Study|Pregnancy|0|||
27510685|NCT00286468|80061832|FG001|Overall Study|Withdrawal by Subject|8|||
27510686|NCT00286468|80061833|FG002|Overall Study|Withdrawal by Subject|11|||
27510687|NCT00286468|80061831|FG000|Overall Study|Physician Decision|3|||
27510688|NCT00286468|80061832|FG001|Overall Study|Physician Decision|2|||
27510689|NCT00286468|80061833|FG002|Overall Study|Physician Decision|1|||
27510690|NCT00711191|80061834|FG000|Overall Study|Adverse Event|1|||
27510691|NCT00711191|80061835|FG001|Overall Study|Adverse Event|1|||
27510692|NCT00711191|80061836|FG002|Overall Study|Adverse Event|2|||
27510693|NCT00711191|80061834|FG000|Overall Study|Objective progression or relapse|2|||
27510694|NCT00711191|80061835|FG001|Overall Study|Objective progression or relapse|3|||
27510695|NCT00711191|80061836|FG002|Overall Study|Objective progression or relapse|7|||
27510696|NCT00711191|80061834|FG000|Overall Study|Withdrawal by Subject|0|||
27510697|NCT00711191|80061835|FG001|Overall Study|Withdrawal by Subject|1|||
27510698|NCT00711191|80061836|FG002|Overall Study|Withdrawal by Subject|3|||
27510699|NCT02633306|80061837|FG000|Overall Study|Withdrawal by Subject|3|||
27510700|NCT00043979|80061839|FG000|Period 1|recipient with progressive disease|7|||
27510701|NCT00043979|80061840|FG001|Period 1|recipient with progressive disease|4|||
27510702|NCT00043979|80061841|FG002|Period 1|recipient with progressive disease|3|||
27510703|NCT01663103|80061842|FG000|Overall Study|Withdrawal by Subject|1|||
27510704|NCT01663103|80061843|FG001|Overall Study|Withdrawal by Subject|2|||
27510705|NCT01663103|80061842|FG000|Overall Study|Adverse Event|1|||
27510706|NCT01663103|80061843|FG001|Overall Study|Adverse Event|0|||
27510707|NCT01663103|80061842|FG000|Overall Study|dog bite|1|||
27510708|NCT01663103|80061843|FG001|Overall Study|dog bite|0|||
27510709|NCT00719472|80061846|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
27510710|NCT00719472|80061846|FG000|Enrolled in Study|Subject decision to withdraw|8|||
27510711|NCT00719472|80061846|FG000|Enrolled in Study|Various Reasons|17|||
27510712|NCT00719472|80061846|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
27510713|NCT00719472|80061846|FG000|Received Cycle 1 Treatment|Death|5|||
27510714|NCT00719472|80061846|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
27510715|NCT00719472|80061846|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
27510716|NCT00719472|80061846|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
27510717|NCT00719472|80061846|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
27510718|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
27510719|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Death|6|||
27510720|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Disease progression|3|||
27510721|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
27510722|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
27510723|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
27510724|NCT00719472|80061846|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
27852842|NCT02139124|81291235|FG003|Overall Study|Adverse Event|2|||
27852843|NCT02139124|81291236|FG004|Overall Study|Adverse Event|5|||
27852844|NCT02139124|81291232|FG000|Overall Study|Withdrawal by Subject|2|||
27852845|NCT02139124|81291233|FG001|Overall Study|Withdrawal by Subject|2|||
27852846|NCT02139124|81291234|FG002|Overall Study|Withdrawal by Subject|2|||
27852847|NCT02139124|81291235|FG003|Overall Study|Withdrawal by Subject|2|||
27852848|NCT02139124|81291236|FG004|Overall Study|Withdrawal by Subject|3|||
27852849|NCT02139124|81291232|FG000|Overall Study|Protocol Violation|0|||
27510725|NCT00936715|80061847|FG000|Overall Study|Investigators Discretion|1|||
27510726|NCT00936715|80061847|FG000|Overall Study|Protocol Violation|1|||
27905339|NCT04750278|81488678|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
27510727|NCT00936715|80061847|FG000|Overall Study|Safety or Tolerability Reasons|4|||
27510728|NCT04540913|80061848|FG000|Overall Study|Withdrawal by Subject|14|||
27510729|NCT04540913|80061849|FG001|Overall Study|Withdrawal by Subject|3|||
27614899|NCT02291289|80430354|FG008|Early Disease Progression|Death|0|||
27510730|NCT00811018|80061850|FG000|Overall Study|Additional Chronic Treatment|31|||
27510731|NCT00811018|80061850|FG000|Overall Study|Adverse Event|79|||
27510732|NCT00811018|80061850|FG000|Overall Study|Death|147|||
27510733|NCT00811018|80061850|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
27510734|NCT00811018|80061850|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
27510735|NCT00811018|80061850|FG000|Overall Study|Investigator Decision|57|||
27510736|NCT00811018|80061850|FG000|Overall Study|Lost to Follow-up|19|||
27510737|NCT00811018|80061850|FG000|Overall Study|Pregnancy|6|||
27510738|NCT00811018|80061850|FG000|Overall Study|Sponsor Decision|450|||
27510739|NCT00811018|80061850|FG000|Overall Study|Withdrawal by Subject|70|||
27510740|NCT00811018|80061850|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
27510741|NCT00811018|80061850|FG000|Overall Study|Other|26|||
27510742|NCT02395471|80061851|FG000|Overall Study|Lost to Follow-up|2|||
27510743|NCT02395471|80061852|FG001|Overall Study|Lost to Follow-up|0|||
27510744|NCT02395471|80061851|FG000|Overall Study|Withdrawal by Subject|2|||
27510745|NCT02395471|80061852|FG001|Overall Study|Withdrawal by Subject|1|||
27510746|NCT02395471|80061851|FG000|Overall Study|Physician Decision|1|||
27510747|NCT02395471|80061852|FG001|Overall Study|Physician Decision|0|||
27510748|NCT02395471|80061851|FG000|Overall Study|Protocol Violation|0|||
27510749|NCT02395471|80061852|FG001|Overall Study|Protocol Violation|1|||
27510750|NCT02395471|80061851|FG000|Overall Study|Failure to swollow sponge twice|1|||
27510751|NCT02395471|80061852|FG001|Overall Study|Failure to swollow sponge twice|0|||
27510752|NCT02395471|80061851|FG000|Overall Study|Patient did not return for procedure|0|||
27510753|NCT02395471|80061852|FG001|Overall Study|Patient did not return for procedure|1|||
27510754|NCT02395471|80061851|FG000|Overall Study|Subject not eligible|1|||
27510755|NCT02395471|80061852|FG001|Overall Study|Subject not eligible|0|||
27510756|NCT02736578|80061853|FG000|Overall Study|Adverse Event|1|||
27510757|NCT02736578|80061854|FG001|Overall Study|Adverse Event|0|||
27510758|NCT03710161|80061855|FG000|Overall Study|Study halted due to COVID pandemic|3|||
27510759|NCT03710161|80061856|FG001|Overall Study|Study halted due to COVID pandemic|2|||
27510760|NCT02136069|80061857|FG000|Overall Study|UC flare-up|1|||
27510761|NCT02136069|80061858|FG001|Overall Study|UC flare-up|0|||
27510762|NCT02136069|80061857|FG000|Overall Study|Adverse Event|6|||
27510763|NCT02136069|80061858|FG001|Overall Study|Adverse Event|8|||
27510764|NCT02136069|80061857|FG000|Overall Study|Death|0|||
27510765|NCT02136069|80061858|FG001|Overall Study|Death|1|||
27510766|NCT02136069|80061857|FG000|Overall Study|Lack of Efficacy|10|||
27510767|NCT02136069|80061858|FG001|Overall Study|Lack of Efficacy|4|||
27510768|NCT02136069|80061857|FG000|Overall Study|Lost to Follow-up|1|||
27510769|NCT02136069|80061858|FG001|Overall Study|Lost to Follow-up|0|||
27510770|NCT02136069|80061857|FG000|Overall Study|Non-Compliance|1|||
27510771|NCT02136069|80061858|FG001|Overall Study|Non-Compliance|0|||
27510772|NCT02136069|80061857|FG000|Overall Study|Physician Decision|5|||
27510773|NCT02136069|80061858|FG001|Overall Study|Physician Decision|4|||
27510774|NCT02136069|80061857|FG000|Overall Study|Withdrawal by Subject|10|||
27510775|NCT02136069|80061858|FG001|Overall Study|Withdrawal by Subject|11|||
27510776|NCT02625909|80061859|FG000|Overall Study|Death|2|||
27510777|NCT02625909|80061860|FG001|Overall Study|Death|0|||
27510778|NCT02625909|80061859|FG000|Overall Study|Lost to Follow-up|3|||
27510779|NCT02625909|80061860|FG001|Overall Study|Lost to Follow-up|5|||
27510780|NCT02625909|80061859|FG000|Overall Study|Lack of Efficacy|9|||
27510781|NCT02625909|80061860|FG001|Overall Study|Lack of Efficacy|2|||
27614900|NCT02291289|80430355|FG009|Early Disease Progression|Death|0|||
27614901|NCT02291289|80430356|FG010|Early Disease Progression|Death|0|||
27614902|NCT02291289|80430357|FG011|Early Disease Progression|Death|0|||
27852850|NCT02139124|81291233|FG001|Overall Study|Protocol Violation|0|||
27852851|NCT02139124|81291234|FG002|Overall Study|Protocol Violation|0|||
27852852|NCT02139124|81291235|FG003|Overall Study|Protocol Violation|1|||
27852853|NCT02139124|81291236|FG004|Overall Study|Protocol Violation|1|||
27905340|NCT04750278|81488679|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
27510782|NCT02625909|80061859|FG000|Overall Study|Reinfection|3|||
27510783|NCT02625909|80061860|FG001|Overall Study|Reinfection|2|||
27510784|NCT00470275|80061861|FG000|Overall Study|Death|1|||
27510785|NCT00470275|80061861|FG000|Overall Study|Lack of Efficacy|7|||
27510786|NCT00470275|80061861|FG000|Overall Study|Withdrawal by Subject|2|||
27510787|NCT00865566|80061862|FG000|Overall Study|Death|1|||
27852854|NCT02139124|81291232|FG000|Overall Study|non-compliant|1|||
27510788|NCT00865566|80061863|FG001|Overall Study|Death|11|||
27510789|NCT00865566|80061862|FG000|Overall Study|Lost to Follow-up|314|||
27510790|NCT00865566|80061863|FG001|Overall Study|Lost to Follow-up|315|||
27510791|NCT00865566|80061862|FG000|Overall Study|Withdrawal by Subject|45|||
27510792|NCT00865566|80061863|FG001|Overall Study|Withdrawal by Subject|65|||
27510793|NCT00865566|80061862|FG000|Overall Study|Physician Decision|0|||
27510794|NCT00865566|80061863|FG001|Overall Study|Physician Decision|1|||
27510795|NCT00865566|80061862|FG000|Overall Study|Participant relocated|78|||
27510796|NCT00865566|80061863|FG001|Overall Study|Participant relocated|107|||
27510797|NCT00865566|80061862|FG000|Overall Study|Participant unable to adhere|27|||
27510798|NCT00865566|80061863|FG001|Overall Study|Participant unable to adhere|42|||
27614903|NCT02291289|80430358|FG012|Early Disease Progression|Death|10|||
27510799|NCT00865566|80061862|FG000|Overall Study|Other; N=245 due to early study closure|154|||
27510800|NCT00865566|80061863|FG001|Overall Study|Other; N=245 due to early study closure|139|||
27510801|NCT00865566|80061862|FG000|Overall Study|HIV infection|5|||
27510802|NCT00865566|80061863|FG001|Overall Study|HIV infection|7|||
27510803|NCT01391546|80061864|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
27510804|NCT01391546|80061865|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
27510805|NCT00599339|80061866|FG000|Overall Study|Adverse Event|79|||
27510806|NCT00599339|80061866|FG000|Overall Study|Withdrawal by Subject|137|||
27510807|NCT00599339|80061866|FG000|Overall Study|Other Reason|179|||
27510808|NCT00599339|80061866|FG000|Overall Study|Lost to Follow-up|221|||
27510809|NCT00599339|80061866|FG000|Overall Study|No valid data consent|36|||
27510810|NCT00599339|80061866|FG000|Overall Study|Study Termination Status Unknown|12|||
27510811|NCT00357006|80061867|FG000|Overall Study|Lost to Follow-up|1|||
27510812|NCT00357006|80061868|FG001|Overall Study|Lost to Follow-up|2|||
27510813|NCT00357006|80061869|FG002|Overall Study|Lost to Follow-up|1|||
27905341|NCT04750278|81488680|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
27905342|NCT04750278|81488678|FG000|Overall Study|Non-compliance|0|||
27905343|NCT04750278|81488679|FG001|Overall Study|Non-compliance|0|||
27905344|NCT04750278|81488680|FG002|Overall Study|Non-compliance|1|||
27905345|NCT04750278|81488678|FG000|Overall Study|Transfer to Outside Facility|0|||
27905346|NCT04750278|81488679|FG001|Overall Study|Transfer to Outside Facility|2|||
27905347|NCT04750278|81488680|FG002|Overall Study|Transfer to Outside Facility|1|||
27905348|NCT04750278|81488678|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
27905349|NCT04750278|81488679|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
27905350|NCT04750278|81488680|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
27905351|NCT04750278|81488678|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
27905352|NCT04750278|81488679|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
27905353|NCT04750278|81488680|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
27905354|NCT03951753|81488684|FG000|Overall Study|Adverse Event|1|||
27905355|NCT03951753|81488685|FG001|Overall Study|Adverse Event|0|||
27905356|NCT03951753|81488686|FG002|Overall Study|Adverse Event|3|||
27905357|NCT03951753|81488684|FG000|Overall Study|Withdrawal by Subject|3|||
27905358|NCT03951753|81488685|FG001|Overall Study|Withdrawal by Subject|1|||
27905359|NCT03951753|81488686|FG002|Overall Study|Withdrawal by Subject|0|||
27905360|NCT03951753|81488684|FG000|Overall Study|Lost to Follow-up|0|||
27905361|NCT03951753|81488685|FG001|Overall Study|Lost to Follow-up|0|||
27905362|NCT03951753|81488686|FG002|Overall Study|Lost to Follow-up|1|||
27905363|NCT03774394|81488689|FG000|Overall Study|Withdrawal by Subject|2|||
27905364|NCT03774394|81488690|FG001|Overall Study|Withdrawal by Subject|0|||
27905365|NCT02756364|81488691|FG000|Overall Study|Site Terminated by Sponsor|24|||
27905366|NCT02756364|81488692|FG001|Overall Study|Site Terminated by Sponsor|30|||
27905367|NCT02756364|81488693|FG002|Overall Study|Site Terminated by Sponsor|21|||
27905368|NCT02756364|81488691|FG000|Overall Study|Death|20|||
27905369|NCT02756364|81488692|FG001|Overall Study|Death|15|||
27905370|NCT02756364|81488693|FG002|Overall Study|Death|18|||
27905371|NCT02756364|81488691|FG000|Overall Study|Withdrawal by Patient|2|||
27905372|NCT02756364|81488692|FG001|Overall Study|Withdrawal by Patient|1|||
27905373|NCT02756364|81488693|FG002|Overall Study|Withdrawal by Patient|8|||
27905374|NCT02756364|81488691|FG000|Overall Study|Lost to Follow-up|0|||
27905375|NCT02756364|81488692|FG001|Overall Study|Lost to Follow-up|1|||
27905376|NCT02756364|81488693|FG002|Overall Study|Lost to Follow-up|1|||
27905377|NCT03699540|81488694|FG000|Overall Study|Lost to Follow-up|1|||
27905378|NCT01172808|81488695|FG000|Overall Study|Adverse Event|8|||
27905379|NCT01172808|81488696|FG001|Overall Study|Adverse Event|4|||
27905380|NCT01172808|81488697|FG002|Overall Study|Adverse Event|8|||
27905381|NCT01172808|81488698|FG003|Overall Study|Adverse Event|3|||
27905382|NCT01172808|81488695|FG000|Overall Study|Lack of Efficacy|1|||
27905383|NCT01172808|81488696|FG001|Overall Study|Lack of Efficacy|0|||
27905384|NCT01172808|81488697|FG002|Overall Study|Lack of Efficacy|0|||
27905385|NCT01172808|81488698|FG003|Overall Study|Lack of Efficacy|0|||
27905386|NCT01172808|81488695|FG000|Overall Study|Protocol Violation|2|||
27905387|NCT01172808|81488696|FG001|Overall Study|Protocol Violation|2|||
27905388|NCT01172808|81488697|FG002|Overall Study|Protocol Violation|2|||
27905389|NCT01172808|81488698|FG003|Overall Study|Protocol Violation|0|||
27905390|NCT01172808|81488695|FG000|Overall Study|Lost to Follow-up|0|||
27905391|NCT01172808|81488696|FG001|Overall Study|Lost to Follow-up|1|||
27905392|NCT01172808|81488697|FG002|Overall Study|Lost to Follow-up|1|||
27905393|NCT01172808|81488698|FG003|Overall Study|Lost to Follow-up|3|||
27905394|NCT01172808|81488695|FG000|Overall Study|Withdrawal by Subject|4|||
27510814|NCT00357006|80061867|FG000|Overall Study|Withdrawal by Subject|1|||
27510815|NCT00357006|80061868|FG001|Overall Study|Withdrawal by Subject|3|||
27510816|NCT00357006|80061869|FG002|Overall Study|Withdrawal by Subject|2|||
27510817|NCT03038880|80061870|FG000|Overall Study|Death|1|||
27510818|NCT03038880|80061871|FG001|Overall Study|Death|2|||
27510819|NCT03038880|80061872|FG002|Overall Study|Death|0|||
27510820|NCT03038880|80061870|FG000|Overall Study|Physician Decision|2|||
27510821|NCT03038880|80061871|FG001|Overall Study|Physician Decision|1|||
27510822|NCT03038880|80061872|FG002|Overall Study|Physician Decision|0|||
27510823|NCT02991040|80061873|FG000|Overall Study|Withdrawal by Subject|2|||
27510824|NCT02991040|80061873|FG000|Overall Study|Lost to Follow-up|2|||
27510825|NCT03847896|80061874|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
27510826|NCT03847896|80061875|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
27510827|NCT03847896|80061876|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
27510828|NCT03847896|80061877|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
27510829|NCT03847896|80061878|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
27510830|NCT03847896|80061874|FG000|Overall Study|Withdrawal by Subject|2|||
27510831|NCT03847896|80061875|FG001|Overall Study|Withdrawal by Subject|10|||
27510832|NCT03847896|80061876|FG002|Overall Study|Withdrawal by Subject|5|||
27510833|NCT03847896|80061877|FG003|Overall Study|Withdrawal by Subject|9|||
27510834|NCT03847896|80061878|FG004|Overall Study|Withdrawal by Subject|8|||
27510835|NCT03847896|80061874|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27510836|NCT03847896|80061875|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27510837|NCT03847896|80061876|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27510838|NCT03847896|80061877|FG003|Overall Study|Withdrawal by parent/guardian|0|||
27510839|NCT03847896|80061878|FG004|Overall Study|Withdrawal by parent/guardian|0|||
27510840|NCT03847896|80061874|FG000|Overall Study|Adverse Event|2|||
27510841|NCT03847896|80061875|FG001|Overall Study|Adverse Event|1|||
27510842|NCT03847896|80061876|FG002|Overall Study|Adverse Event|3|||
27510843|NCT03847896|80061877|FG003|Overall Study|Adverse Event|2|||
27510844|NCT03847896|80061878|FG004|Overall Study|Adverse Event|4|||
27510845|NCT03847896|80061874|FG000|Overall Study|A severe exacerbation event|0|||
27510846|NCT03847896|80061875|FG001|Overall Study|A severe exacerbation event|0|||
27510847|NCT03847896|80061876|FG002|Overall Study|A severe exacerbation event|0|||
27510848|NCT03847896|80061877|FG003|Overall Study|A severe exacerbation event|0|||
27510849|NCT03847896|80061878|FG004|Overall Study|A severe exacerbation event|3|||
27510850|NCT03847896|80061874|FG000|Overall Study|Protocol Violation|0|||
27614904|NCT02291289|80430346|FG000|Early Disease Progression|Lost to Follow-up|0|||
27614905|NCT02291289|80430347|FG001|Early Disease Progression|Lost to Follow-up|0|||
27614906|NCT02291289|80430348|FG002|Early Disease Progression|Lost to Follow-up|0|||
27614907|NCT02291289|80430349|FG003|Early Disease Progression|Lost to Follow-up|0|||
27614908|NCT02291289|80430350|FG004|Early Disease Progression|Lost to Follow-up|0|||
27614909|NCT02291289|80430351|FG005|Early Disease Progression|Lost to Follow-up|0|||
27614910|NCT02291289|80430352|FG006|Early Disease Progression|Lost to Follow-up|0|||
27614911|NCT02291289|80430353|FG007|Early Disease Progression|Lost to Follow-up|0|||
27614912|NCT02291289|80430354|FG008|Early Disease Progression|Lost to Follow-up|0|||
27614913|NCT02291289|80430355|FG009|Early Disease Progression|Lost to Follow-up|0|||
27614914|NCT02291289|80430356|FG010|Early Disease Progression|Lost to Follow-up|0|||
27614915|NCT02291289|80430357|FG011|Early Disease Progression|Lost to Follow-up|0|||
27614916|NCT02291289|80430358|FG012|Early Disease Progression|Lost to Follow-up|1|||
27614917|NCT01468922|80430362|FG000|Overall Study|Screening failure|0|||
27614918|NCT01468922|80430363|FG001|Overall Study|Screening failure|0|||
27614919|NCT01468922|80430364|FG002|Overall Study|Screening failure|0|||
27614920|NCT01468922|80430365|FG003|Overall Study|Screening failure|0|||
27614921|NCT01468922|80430366|FG004|Overall Study|Screening failure|0|||
27614922|NCT01468922|80430367|FG005|Overall Study|Screening failure|0|||
27614923|NCT01468922|80430368|FG006|Overall Study|Screening failure|0|||
27614924|NCT01468922|80430369|FG007|Overall Study|Screening failure|0|||
27614925|NCT01468922|80430370|FG008|Overall Study|Screening failure|1|||
27614926|NCT01468922|80430362|FG000|Overall Study|Per patient choice|1|||
27614927|NCT01468922|80430363|FG001|Overall Study|Per patient choice|0|||
27614928|NCT01468922|80430364|FG002|Overall Study|Per patient choice|0|||
27614929|NCT01468922|80430365|FG003|Overall Study|Per patient choice|0|||
27614930|NCT01468922|80430366|FG004|Overall Study|Per patient choice|0|||
27614931|NCT01468922|80430367|FG005|Overall Study|Per patient choice|0|||
27614932|NCT01468922|80430368|FG006|Overall Study|Per patient choice|0|||
27614933|NCT01468922|80430369|FG007|Overall Study|Per patient choice|0|||
27614934|NCT01468922|80430370|FG008|Overall Study|Per patient choice|0|||
27614935|NCT01468922|80430362|FG000|Overall Study|Switched to alternative treatment|1|||
27614936|NCT01468922|80430363|FG001|Overall Study|Switched to alternative treatment|0|||
27614937|NCT01468922|80430364|FG002|Overall Study|Switched to alternative treatment|0|||
27905395|NCT01172808|81488696|FG001|Overall Study|Withdrawal by Subject|1|||
27510851|NCT03847896|80061875|FG001|Overall Study|Protocol Violation|2|||
27510852|NCT03847896|80061876|FG002|Overall Study|Protocol Violation|1|||
27510853|NCT03847896|80061877|FG003|Overall Study|Protocol Violation|0|||
27510854|NCT03847896|80061878|FG004|Overall Study|Protocol Violation|2|||
27510855|NCT03847896|80061874|FG000|Overall Study|Lost to Follow-up|0|||
27510856|NCT03847896|80061875|FG001|Overall Study|Lost to Follow-up|0|||
27510857|NCT03847896|80061876|FG002|Overall Study|Lost to Follow-up|0|||
27510858|NCT03847896|80061877|FG003|Overall Study|Lost to Follow-up|1|||
27510859|NCT03847896|80061878|FG004|Overall Study|Lost to Follow-up|0|||
27510860|NCT03847896|80061874|FG000|Overall Study|Condition under investigation worsened|0|||
27510861|NCT03847896|80061875|FG001|Overall Study|Condition under investigation worsened|0|||
27510862|NCT03847896|80061876|FG002|Overall Study|Condition under investigation worsened|0|||
27510863|NCT03847896|80061877|FG003|Overall Study|Condition under investigation worsened|1|||
27510864|NCT03847896|80061878|FG004|Overall Study|Condition under investigation worsened|1|||
27510865|NCT03847896|80061874|FG000|Overall Study|Lack of Efficacy|0|||
27510866|NCT03847896|80061875|FG001|Overall Study|Lack of Efficacy|0|||
27510867|NCT03847896|80061876|FG002|Overall Study|Lack of Efficacy|0|||
27510868|NCT03847896|80061877|FG003|Overall Study|Lack of Efficacy|2|||
27510869|NCT03847896|80061878|FG004|Overall Study|Lack of Efficacy|2|||
27510870|NCT03847896|80061874|FG000|Overall Study|Other reasons|3|||
27510871|NCT03847896|80061875|FG001|Overall Study|Other reasons|3|||
27510872|NCT03847896|80061876|FG002|Overall Study|Other reasons|1|||
27510873|NCT03847896|80061877|FG003|Overall Study|Other reasons|2|||
27510874|NCT03847896|80061878|FG004|Overall Study|Other reasons|1|||
27510875|NCT01671319|80061880|FG000|Overall Study|Withdrawal by Subject|1|||
27510876|NCT01185080|80061881|FG000|Overall Study|Adverse Event|1|||
27510877|NCT01185080|80061882|FG001|Overall Study|Adverse Event|1|||
27510878|NCT01185080|80061883|FG002|Overall Study|Adverse Event|0|||
27510879|NCT01185080|80061881|FG000|Overall Study|Personal reasons|0|||
27510880|NCT01185080|80061882|FG001|Overall Study|Personal reasons|0|||
27510881|NCT01185080|80061883|FG002|Overall Study|Personal reasons|1|||
27510882|NCT00802945|80061894|FG000|Overall Study|Death|27|||
27510883|NCT00802945|80061895|FG001|Overall Study|Death|23|||
27510884|NCT00802945|80061894|FG000|Overall Study|Terminated by sponsor|8|||
27510885|NCT00802945|80061895|FG001|Overall Study|Terminated by sponsor|12|||
27510886|NCT00996333|80061896|FG000|Overall Study|Screen failure|1|||
27510887|NCT00996333|80061896|FG000|Overall Study|Withdrawal by Subject|1|||
27510888|NCT00996333|80061896|FG000|Overall Study|Death|4|||
27510889|NCT00996333|80061896|FG000|Overall Study|Adverse Event|1|||
27510890|NCT00996333|80061896|FG000|Overall Study|Physician Decision|1|||
27510891|NCT00996333|80061896|FG000|Overall Study|Other|5|||
27510892|NCT03534180|80061902|FG000|Overall Study|Withdrawal by Subject|1|||
27510893|NCT02447003|80061903|FG000|Overall Study|Other|0|||
27510894|NCT02447003|80061904|FG001|Overall Study|Other|4|||
27510895|NCT02447003|80061903|FG000|Overall Study|Site discontinued|0|||
27510896|NCT02447003|80061904|FG001|Overall Study|Site discontinued|2|||
27510897|NCT02447003|80061903|FG000|Overall Study|Physician Decision|0|||
27510898|NCT02447003|80061904|FG001|Overall Study|Physician Decision|1|||
27510899|NCT02447003|80061903|FG000|Overall Study|Withdrawal by Subject|4|||
27510900|NCT02447003|80061904|FG001|Overall Study|Withdrawal by Subject|3|||
27510901|NCT02447003|80061903|FG000|Overall Study|Sponsor Decision|6|||
27510902|NCT02447003|80061904|FG001|Overall Study|Sponsor Decision|11|||
27510903|NCT02447003|80061903|FG000|Overall Study|Progressive Disease|1|||
27510904|NCT02447003|80061904|FG001|Overall Study|Progressive Disease|0|||
27510905|NCT02447003|80061903|FG000|Overall Study|Lost to Follow-up|5|||
27510906|NCT02447003|80061904|FG001|Overall Study|Lost to Follow-up|0|||
27510907|NCT02447003|80061903|FG000|Overall Study|Death|154|||
27510908|NCT02447003|80061904|FG001|Overall Study|Death|63|||
27510909|NCT02541604|80061905|FG000|Overall Study|Death|6|||
27905396|NCT01172808|81488697|FG002|Overall Study|Withdrawal by Subject|3|||
27905397|NCT01172808|81488698|FG003|Overall Study|Withdrawal by Subject|2|||
27905398|NCT01172808|81488695|FG000|Overall Study|Other|6|||
27905399|NCT01172808|81488696|FG001|Overall Study|Other|5|||
27905400|NCT01172808|81488697|FG002|Overall Study|Other|9|||
27510910|NCT02541604|80061906|FG001|Overall Study|Death|5|||
27510911|NCT02541604|80061907|FG002|Overall Study|Death|7|||
27510912|NCT02541604|80061908|FG003|Overall Study|Death|2|||
27510913|NCT02541604|80061909|FG004|Overall Study|Death|9|||
27510914|NCT02541604|80061910|FG005|Overall Study|Death|8|||
27510915|NCT02541604|80061911|FG006|Overall Study|Death|9|||
27510916|NCT02541604|80061912|FG007|Overall Study|Death|9|||
27510917|NCT02541604|80061913|FG008|Overall Study|Death|3|||
27510918|NCT02541604|80061914|FG009|Overall Study|Death|4|||
27510919|NCT02541604|80061915|FG010|Overall Study|Death|2|||
27510920|NCT02541604|80061916|FG011|Overall Study|Death|3|||
27510921|NCT02541604|80061905|FG000|Overall Study|Lost to Follow-up|2|||
27852855|NCT02139124|81291233|FG001|Overall Study|non-compliant|0|||
27510922|NCT02541604|80061906|FG001|Overall Study|Lost to Follow-up|0|||
27510923|NCT02541604|80061907|FG002|Overall Study|Lost to Follow-up|1|||
27510924|NCT02541604|80061908|FG003|Overall Study|Lost to Follow-up|0|||
27510925|NCT02541604|80061909|FG004|Overall Study|Lost to Follow-up|0|||
27510926|NCT02541604|80061910|FG005|Overall Study|Lost to Follow-up|1|||
27510927|NCT02541604|80061911|FG006|Overall Study|Lost to Follow-up|1|||
27852856|NCT02139124|81291234|FG002|Overall Study|non-compliant|0|||
27852857|NCT02139124|81291235|FG003|Overall Study|non-compliant|2|||
27852858|NCT02139124|81291236|FG004|Overall Study|non-compliant|0|||
27852859|NCT02139124|81291232|FG000|Overall Study|incarceration|0|||
27852860|NCT02139124|81291233|FG001|Overall Study|incarceration|0|||
27905401|NCT01172808|81488698|FG003|Overall Study|Other|7|||
27905402|NCT01398358|81488699|FG000|Overall Study|Lost to Follow-up|11|||
27905403|NCT01398358|81488700|FG001|Overall Study|Lost to Follow-up|21|||
27905404|NCT01398358|81488701|FG002|Overall Study|Lost to Follow-up|18|||
27905405|NCT01398358|81488699|FG000|Overall Study|Withdrawal by Subject|3|||
27905406|NCT01398358|81488700|FG001|Overall Study|Withdrawal by Subject|2|||
27905407|NCT01398358|81488701|FG002|Overall Study|Withdrawal by Subject|2|||
27905408|NCT01398358|81488699|FG000|Overall Study|no longer eligible|1|||
27905409|NCT01398358|81488700|FG001|Overall Study|no longer eligible|0|||
27905410|NCT01398358|81488701|FG002|Overall Study|no longer eligible|1|||
27905411|NCT01763203|81488702|FG000|Overall Study|Death|4|||
27905412|NCT01763203|81488703|FG001|Overall Study|Death|7|||
27905413|NCT01763203|81488702|FG000|Overall Study|Lost to Follow-up|12|||
27905414|NCT01763203|81488703|FG001|Overall Study|Lost to Follow-up|12|||
27905415|NCT01763203|81488702|FG000|Overall Study|Withdrawal by Subject|8|||
27905416|NCT01763203|81488703|FG001|Overall Study|Withdrawal by Subject|12|||
27905417|NCT01763203|81488702|FG000|Overall Study|Moved out of study region|7|||
27905418|NCT01763203|81488703|FG001|Overall Study|Moved out of study region|10|||
27905419|NCT01763203|81488702|FG000|Overall Study|Physician Decision|2|||
27905420|NCT01763203|81488703|FG001|Overall Study|Physician Decision|1|||
27905421|NCT01908582|81488710|FG000|Period 2|Physician Decision|1|||
27905422|NCT01908582|81488710|FG000|Period 2|Withdrawal by Subject|1|||
27905423|NCT01607346|81488715|FG000|Overall Study|Adverse Event|3|||
27905424|NCT02190721|81488716|FG000|Overall Study|Patient was out of the city|0|||
27905425|NCT02190721|81488717|FG001|Overall Study|Patient was out of the city|1|||
27905426|NCT02190721|81488718|FG002|Overall Study|Patient was out of the city|0|||
27905427|NCT03124537|81488721|FG000|Overall Study|Lost to Follow-up|3|||
27905428|NCT03124537|81488722|FG001|Overall Study|Lost to Follow-up|5|||
27905429|NCT03124537|81488721|FG000|Overall Study|App Crash, Incomplete Data|7|||
27510928|NCT02541604|80061912|FG007|Overall Study|Lost to Follow-up|0|||
27510929|NCT02541604|80061913|FG008|Overall Study|Lost to Follow-up|0|||
27510930|NCT02541604|80061914|FG009|Overall Study|Lost to Follow-up|0|||
27510931|NCT02541604|80061915|FG010|Overall Study|Lost to Follow-up|0|||
27510932|NCT02541604|80061916|FG011|Overall Study|Lost to Follow-up|0|||
27510933|NCT02541604|80061905|FG000|Overall Study|Withdrawal by Subject|2|||
27510934|NCT02541604|80061906|FG001|Overall Study|Withdrawal by Subject|0|||
27510935|NCT02541604|80061907|FG002|Overall Study|Withdrawal by Subject|1|||
27510936|NCT02541604|80061908|FG003|Overall Study|Withdrawal by Subject|0|||
27510937|NCT02541604|80061909|FG004|Overall Study|Withdrawal by Subject|1|||
27510938|NCT02541604|80061910|FG005|Overall Study|Withdrawal by Subject|1|||
27510939|NCT02541604|80061911|FG006|Overall Study|Withdrawal by Subject|0|||
27510940|NCT02541604|80061912|FG007|Overall Study|Withdrawal by Subject|0|||
27510941|NCT02541604|80061913|FG008|Overall Study|Withdrawal by Subject|1|||
27510942|NCT02541604|80061914|FG009|Overall Study|Withdrawal by Subject|0|||
27510943|NCT02541604|80061915|FG010|Overall Study|Withdrawal by Subject|0|||
27510944|NCT02541604|80061916|FG011|Overall Study|Withdrawal by Subject|0|||
27510945|NCT02541604|80061905|FG000|Overall Study|Study Terminated by Sponsor|1|||
27510946|NCT02541604|80061906|FG001|Overall Study|Study Terminated by Sponsor|4|||
27510947|NCT02541604|80061907|FG002|Overall Study|Study Terminated by Sponsor|2|||
27510948|NCT02541604|80061908|FG003|Overall Study|Study Terminated by Sponsor|1|||
27852861|NCT02139124|81291234|FG002|Overall Study|incarceration|1|||
27905430|NCT03124537|81488722|FG001|Overall Study|App Crash, Incomplete Data|8|||
27905431|NCT01048099|81488723|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
27905432|NCT01048099|81488723|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
27905433|NCT01393106|81488725|FG000|Overall Study|Adverse Event|3|||
27905434|NCT01393106|81488725|FG000|Overall Study|Withdrawal by Subject|1|||
27905435|NCT01393106|81488725|FG000|Overall Study|Lack of Efficacy|1|||
27905436|NCT00298363|81488731|FG000|Overall Study|Lost to Follow-up|0|||
27905437|NCT00298363|81488732|FG001|Overall Study|Lost to Follow-up|0|||
27905438|NCT00298363|81488733|FG002|Overall Study|Lost to Follow-up|1|||
27905439|NCT00298363|81488731|FG000|Overall Study|Physician Decision|4|||
27905440|NCT00298363|81488732|FG001|Overall Study|Physician Decision|1|||
27905441|NCT00298363|81488733|FG002|Overall Study|Physician Decision|0|||
27905442|NCT00298363|81488731|FG000|Overall Study|Protocol Violation|1|||
27510949|NCT02541604|80061909|FG004|Overall Study|Study Terminated by Sponsor|0|||
27510950|NCT02541604|80061910|FG005|Overall Study|Study Terminated by Sponsor|0|||
27510951|NCT02541604|80061911|FG006|Overall Study|Study Terminated by Sponsor|0|||
27510952|NCT02541604|80061912|FG007|Overall Study|Study Terminated by Sponsor|0|||
27905443|NCT00298363|81488732|FG001|Overall Study|Protocol Violation|1|||
27905444|NCT00298363|81488733|FG002|Overall Study|Protocol Violation|0|||
27905445|NCT00298363|81488731|FG000|Overall Study|Withdrawal by Subject|5|||
27905446|NCT00298363|81488732|FG001|Overall Study|Withdrawal by Subject|1|||
27905447|NCT00298363|81488733|FG002|Overall Study|Withdrawal by Subject|3|||
27905448|NCT00298363|81488731|FG000|Overall Study|Adverse Event|5|||
27905449|NCT00298363|81488732|FG001|Overall Study|Adverse Event|2|||
27905450|NCT00298363|81488733|FG002|Overall Study|Adverse Event|2|||
27510953|NCT02541604|80061913|FG008|Overall Study|Study Terminated by Sponsor|0|||
27905451|NCT00298363|81488731|FG000|Overall Study|Lack of Efficacy|2|||
27905452|NCT00298363|81488732|FG001|Overall Study|Lack of Efficacy|3|||
27905453|NCT00298363|81488733|FG002|Overall Study|Lack of Efficacy|0|||
27905454|NCT00316914|81488734|FG000|Overall Study|Withdrawal by Subject|5|||
27905455|NCT00316914|81488735|FG001|Overall Study|Withdrawal by Subject|3|||
27905456|NCT00316914|81488734|FG000|Overall Study|Adverse Event|8|||
27905457|NCT00316914|81488735|FG001|Overall Study|Adverse Event|7|||
27905458|NCT00316914|81488734|FG000|Overall Study|Other Problems|6|||
27905459|NCT00316914|81488735|FG001|Overall Study|Other Problems|11|||
27905460|NCT00316914|81488734|FG000|Overall Study|Missing end of treatment documentation|14|||
27905461|NCT00316914|81488735|FG001|Overall Study|Missing end of treatment documentation|15|||
27905462|NCT02020512|81488738|FG000|Overall Study|Adverse Event|1|||
27905463|NCT02020512|81488738|FG000|Overall Study|Lost to Follow-up|3|||
27905464|NCT02020512|81488738|FG000|Overall Study|Protocol Violation|4|||
27905465|NCT01281956|81488741|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
27905466|NCT01281956|81488742|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
27905467|NCT03423147|81488745|FG000|Overall Study|Lost to Follow-up|5|||
27905468|NCT03423147|81488746|FG001|Overall Study|Lost to Follow-up|8|||
27905469|NCT03423147|81488745|FG000|Overall Study|Withdrawal by Subject|1|||
27905470|NCT03423147|81488746|FG001|Overall Study|Withdrawal by Subject|0|||
27905471|NCT03423147|81488745|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
27905472|NCT03423147|81488746|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
27905473|NCT03423147|81488745|FG000|Overall Study|Age < 18|1|||
27905474|NCT03423147|81488746|FG001|Overall Study|Age < 18|0|||
27905475|NCT03423147|81488745|FG000|Overall Study|No Trial of Labor|0|||
27905476|NCT03423147|81488746|FG001|Overall Study|No Trial of Labor|1|||
27905477|NCT00741598|81493118|FG000|Overall Study|Lost to Follow-up|3|||
27905478|NCT00741598|81493119|FG001|Overall Study|Lost to Follow-up|4|||
27905479|NCT00741598|81493118|FG000|Overall Study|Lack of Efficacy|1|||
27905480|NCT00741598|81493119|FG001|Overall Study|Lack of Efficacy|2|||
27905481|NCT00741598|81493118|FG000|Overall Study|Physician Decision|1|||
27905482|NCT00741598|81493119|FG001|Overall Study|Physician Decision|1|||
27905483|NCT00741598|81493118|FG000|Overall Study|Pregnancy|1|||
27905484|NCT00741598|81493119|FG001|Overall Study|Pregnancy|0|||
27905485|NCT00741598|81493118|FG000|Overall Study|Withdrawal by Subject|3|||
27905486|NCT00741598|81493119|FG001|Overall Study|Withdrawal by Subject|2|||
27905487|NCT01386944|81493120|FG000|Overall Study|Adverse Event|26|||
27905488|NCT01386944|81493120|FG000|Overall Study|Lack of Efficacy|14|||
27510954|NCT02541604|80061914|FG009|Overall Study|Study Terminated by Sponsor|0|||
27510955|NCT02541604|80061915|FG010|Overall Study|Study Terminated by Sponsor|0|||
27510956|NCT02541604|80061916|FG011|Overall Study|Study Terminated by Sponsor|0|||
27510957|NCT02541604|80061905|FG000|Overall Study|Medical condition may jeopardize safety|0|||
27510958|NCT02541604|80061906|FG001|Overall Study|Medical condition may jeopardize safety|0|||
27510959|NCT02541604|80061907|FG002|Overall Study|Medical condition may jeopardize safety|0|||
27614938|NCT01468922|80430365|FG003|Overall Study|Switched to alternative treatment|0|||
27614939|NCT01468922|80430366|FG004|Overall Study|Switched to alternative treatment|1|||
27614940|NCT01468922|80430367|FG005|Overall Study|Switched to alternative treatment|0|||
27614941|NCT01468922|80430368|FG006|Overall Study|Switched to alternative treatment|0|||
27614942|NCT01468922|80430369|FG007|Overall Study|Switched to alternative treatment|0|||
27614943|NCT01468922|80430370|FG008|Overall Study|Switched to alternative treatment|0|||
27614944|NCT01468922|80430362|FG000|Overall Study|Enrolled on new protocol|0|||
27614945|NCT01468922|80430363|FG001|Overall Study|Enrolled on new protocol|0|||
27614946|NCT01468922|80430364|FG002|Overall Study|Enrolled on new protocol|0|||
27614947|NCT01468922|80430365|FG003|Overall Study|Enrolled on new protocol|0|||
27614948|NCT01468922|80430366|FG004|Overall Study|Enrolled on new protocol|1|||
27614949|NCT01468922|80430367|FG005|Overall Study|Enrolled on new protocol|0|||
27614950|NCT01468922|80430368|FG006|Overall Study|Enrolled on new protocol|0|||
27614951|NCT01468922|80430369|FG007|Overall Study|Enrolled on new protocol|0|||
27614952|NCT01468922|80430370|FG008|Overall Study|Enrolled on new protocol|0|||
27614953|NCT01468922|80430362|FG000|Overall Study|Adverse Event|0|||
27614954|NCT01468922|80430363|FG001|Overall Study|Adverse Event|0|||
27614955|NCT01468922|80430364|FG002|Overall Study|Adverse Event|0|||
27614956|NCT01468922|80430365|FG003|Overall Study|Adverse Event|0|||
27905489|NCT01386944|81493120|FG000|Overall Study|Lost to Follow-up|8|||
27905490|NCT01386944|81493120|FG000|Overall Study|Unspecified reason|8|||
27905491|NCT02131233|81493122|FG000|Overall Study|Not Treated|2|||
27905492|NCT02131233|81493123|FG001|Overall Study|Not Treated|3|||
27905493|NCT02131233|81493122|FG000|Overall Study|Adverse Event|7|||
27614957|NCT01468922|80430366|FG004|Overall Study|Adverse Event|0|||
27614958|NCT01468922|80430367|FG005|Overall Study|Adverse Event|0|||
27614959|NCT01468922|80430368|FG006|Overall Study|Adverse Event|0|||
27614960|NCT01468922|80430369|FG007|Overall Study|Adverse Event|1|||
27905494|NCT02131233|81493123|FG001|Overall Study|Adverse Event|6|||
27905495|NCT02131233|81493122|FG000|Overall Study|Death|0|||
27905496|NCT02131233|81493123|FG001|Overall Study|Death|1|||
27614961|NCT01468922|80430370|FG008|Overall Study|Adverse Event|0|||
27905497|NCT02131233|81493122|FG000|Overall Study|Lack of Efficacy|6|||
27905498|NCT02131233|81493123|FG001|Overall Study|Lack of Efficacy|3|||
27905499|NCT02131233|81493122|FG000|Overall Study|Lost to Follow-up|14|||
27614962|NCT01468922|80430362|FG000|Overall Study|Infection of blood|0|||
27614963|NCT01468922|80430363|FG001|Overall Study|Infection of blood|0|||
27614964|NCT01468922|80430364|FG002|Overall Study|Infection of blood|0|||
27614965|NCT01468922|80430365|FG003|Overall Study|Infection of blood|0|||
27614966|NCT01468922|80430366|FG004|Overall Study|Infection of blood|0|||
27614967|NCT01468922|80430367|FG005|Overall Study|Infection of blood|0|||
27614968|NCT01468922|80430368|FG006|Overall Study|Infection of blood|0|||
27614969|NCT01468922|80430369|FG007|Overall Study|Infection of blood|1|||
27905500|NCT02131233|81493123|FG001|Overall Study|Lost to Follow-up|13|||
27905501|NCT02131233|81493122|FG000|Overall Study|Non-Compliance With Study Drug|8|||
27905502|NCT02131233|81493123|FG001|Overall Study|Non-Compliance With Study Drug|5|||
27905503|NCT02131233|81493122|FG000|Overall Study|Physician Decision|7|||
27905504|NCT02131233|81493123|FG001|Overall Study|Physician Decision|0|||
27905505|NCT02131233|81493122|FG000|Overall Study|Pregnancy|4|||
27905506|NCT02131233|81493123|FG001|Overall Study|Pregnancy|0|||
27905507|NCT02131233|81493122|FG000|Overall Study|Withdrawal by Subject|18|||
27905508|NCT02131233|81493123|FG001|Overall Study|Withdrawal by Subject|11|||
27905509|NCT00534638|81493124|FG000|Overall Study|Withdrawal by Subject|3|||
27905510|NCT00534638|81493125|FG001|Overall Study|Withdrawal by Subject|4|||
27905511|NCT00534638|81493124|FG000|Overall Study|Migrated/moved from study area|13|||
27905512|NCT00534638|81493125|FG001|Overall Study|Migrated/moved from study area|11|||
27905513|NCT00534638|81493124|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
27905514|NCT00534638|81493125|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
27905515|NCT00534638|81493124|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
27905516|NCT00534638|81493125|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
27905517|NCT00534638|81493124|FG000|Overall Study|Other|1685|||
27905518|NCT00534638|81493125|FG001|Overall Study|Other|902|||
27905519|NCT01605825|81493126|FG000|Overall Study|Adverse Event|4|||
27905520|NCT01605825|81493127|FG001|Overall Study|Adverse Event|2|||
27905521|NCT01605825|81493126|FG000|Overall Study|Withdrawal by Subject|0|||
27905522|NCT01605825|81493127|FG001|Overall Study|Withdrawal by Subject|1|||
27905523|NCT01605825|81493126|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
27905524|NCT01605825|81493127|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
27905525|NCT01605825|81493126|FG000|Overall Study|Non-Compliance with Protocol|3|||
27905526|NCT01605825|81493127|FG001|Overall Study|Non-Compliance with Protocol|0|||
27905527|NCT04003623|81493129|FG000|Overall Study|Withdrawal by Subject|1|||
27905528|NCT04003623|81493130|FG001|Overall Study|Withdrawal by Subject|0|||
27905529|NCT03272347|81493131|FG000|Overall Study|Death|0|||
27905530|NCT03272347|81493132|FG001|Overall Study|Death|0|||
27905531|NCT03272347|81493133|FG002|Overall Study|Death|0|||
27905532|NCT03272347|81493134|FG003|Overall Study|Death|1|||
27905533|NCT03272347|81493131|FG000|Overall Study|Lost to Follow-up|1|||
27905534|NCT03272347|81493132|FG001|Overall Study|Lost to Follow-up|3|||
27905535|NCT03272347|81493133|FG002|Overall Study|Lost to Follow-up|5|||
27905536|NCT03272347|81493134|FG003|Overall Study|Lost to Follow-up|1|||
27905537|NCT03272347|81493131|FG000|Overall Study|Physician Decision|4|||
27905538|NCT03272347|81493132|FG001|Overall Study|Physician Decision|2|||
27905539|NCT03272347|81493133|FG002|Overall Study|Physician Decision|5|||
27905540|NCT03272347|81493134|FG003|Overall Study|Physician Decision|4|||
27905541|NCT03272347|81493131|FG000|Overall Study|Screen Failure|1|||
27614970|NCT01468922|80430370|FG008|Overall Study|Infection of blood|0|||
27614971|NCT01468922|80430362|FG000|Overall Study|Patient choice - surgery|0|||
27614972|NCT01468922|80430363|FG001|Overall Study|Patient choice - surgery|0|||
27614973|NCT01468922|80430364|FG002|Overall Study|Patient choice - surgery|0|||
27614974|NCT01468922|80430365|FG003|Overall Study|Patient choice - surgery|0|||
27614975|NCT01468922|80430366|FG004|Overall Study|Patient choice - surgery|0|||
27614976|NCT01468922|80430367|FG005|Overall Study|Patient choice - surgery|0|||
27614977|NCT01468922|80430368|FG006|Overall Study|Patient choice - surgery|0|||
27905542|NCT03272347|81493132|FG001|Overall Study|Screen Failure|0|||
27905543|NCT03272347|81493133|FG002|Overall Study|Screen Failure|0|||
27905544|NCT03272347|81493134|FG003|Overall Study|Screen Failure|0|||
27614978|NCT01468922|80430369|FG007|Overall Study|Patient choice - surgery|1|||
27614979|NCT01468922|80430370|FG008|Overall Study|Patient choice - surgery|0|||
27614980|NCT01468922|80430362|FG000|Overall Study|Refused further treatment|0|||
27614981|NCT01468922|80430363|FG001|Overall Study|Refused further treatment|0|||
27614982|NCT01468922|80430364|FG002|Overall Study|Refused further treatment|0|||
27614983|NCT01468922|80430365|FG003|Overall Study|Refused further treatment|0|||
27614984|NCT01468922|80430366|FG004|Overall Study|Refused further treatment|0|||
27905545|NCT03272347|81493131|FG000|Overall Study|Withdrawal by Subject|5|||
27905546|NCT03272347|81493132|FG001|Overall Study|Withdrawal by Subject|1|||
27905547|NCT03272347|81493133|FG002|Overall Study|Withdrawal by Subject|2|||
27905548|NCT03272347|81493134|FG003|Overall Study|Withdrawal by Subject|1|||
27905549|NCT01882803|81493135|FG000|Overall Study|Disease Progression|1|||
27614985|NCT01468922|80430367|FG005|Overall Study|Refused further treatment|0|||
27905550|NCT01882803|81493135|FG000|Overall Study|Withdrawal by Subject|9|||
27905551|NCT01882803|81493135|FG000|Overall Study|Death|68|||
27905552|NCT01882803|81493135|FG000|Overall Study|Physician Decision|3|||
27614986|NCT01468922|80430368|FG006|Overall Study|Refused further treatment|0|||
27614987|NCT01468922|80430369|FG007|Overall Study|Refused further treatment|1|||
27614988|NCT01468922|80430370|FG008|Overall Study|Refused further treatment|0|||
27614989|NCT01865617|80430376|FG000|Overall Study|Death|27|||
27614990|NCT01865617|80430377|FG001|Overall Study|Death|3|||
27614991|NCT01865617|80430378|FG002|Overall Study|Death|1|||
27614992|NCT01865617|80430379|FG003|Overall Study|Death|1|||
27614993|NCT01865617|80430380|FG004|Overall Study|Death|5|||
27614994|NCT01865617|80430381|FG005|Overall Study|Death|1|||
27614995|NCT01865617|80430382|FG006|Overall Study|Death|11|||
27614996|NCT01865617|80430383|FG007|Overall Study|Death|1|||
27614997|NCT01865617|80430384|FG008|Overall Study|Death|11|||
27614998|NCT01865617|80430385|FG009|Overall Study|Death|3|||
27614999|NCT01865617|80430386|FG010|Overall Study|Death|32|||
27615000|NCT01865617|80430387|FG011|Overall Study|Death|6|||
27905553|NCT01882803|81493135|FG000|Overall Study|Lost to Follow-up|3|||
27905554|NCT01882803|81493135|FG000|Overall Study|Follow-up Completed|39|||
27510960|NCT02541604|80061908|FG003|Overall Study|Medical condition may jeopardize safety|0|||
27510961|NCT02541604|80061909|FG004|Overall Study|Medical condition may jeopardize safety|0|||
27510962|NCT02541604|80061910|FG005|Overall Study|Medical condition may jeopardize safety|0|||
27510963|NCT02541604|80061911|FG006|Overall Study|Medical condition may jeopardize safety|0|||
27510964|NCT02541604|80061912|FG007|Overall Study|Medical condition may jeopardize safety|1|||
27510965|NCT02541604|80061913|FG008|Overall Study|Medical condition may jeopardize safety|0|||
27510966|NCT02541604|80061914|FG009|Overall Study|Medical condition may jeopardize safety|0|||
27510967|NCT02541604|80061915|FG010|Overall Study|Medical condition may jeopardize safety|0|||
27510968|NCT02541604|80061916|FG011|Overall Study|Medical condition may jeopardize safety|0|||
27510969|NCT03216226|80061917|FG000|Overall Study|Adverse Event|3|||
27510970|NCT03216226|80061918|FG001|Overall Study|Adverse Event|0|||
27510971|NCT03216226|80061917|FG000|Overall Study|Protocol Violation|1|||
27510972|NCT03216226|80061918|FG001|Overall Study|Protocol Violation|3|||
27510973|NCT03216226|80061917|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
27510974|NCT03216226|80061918|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
27510975|NCT03216226|80061917|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
27510976|NCT03216226|80061918|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
27510977|NCT03216226|80061917|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
27615001|NCT01865617|80430388|FG012|Overall Study|Death|13|||
27615002|NCT01865617|80430376|FG000|Overall Study|Lost to Follow-up|2|||
27615003|NCT01865617|80430377|FG001|Overall Study|Lost to Follow-up|0|||
27615004|NCT01865617|80430378|FG002|Overall Study|Lost to Follow-up|0|||
27615005|NCT01865617|80430379|FG003|Overall Study|Lost to Follow-up|0|||
27852862|NCT02139124|81291235|FG003|Overall Study|incarceration|0|||
27852863|NCT02139124|81291236|FG004|Overall Study|incarceration|0|||
27852864|NCT02139124|81291232|FG000|Overall Study|subject moved|1|||
27852865|NCT02139124|81291233|FG001|Overall Study|subject moved|0|||
27852866|NCT02139124|81291234|FG002|Overall Study|subject moved|0|||
27905555|NCT01882803|81493135|FG000|Overall Study|Study Terminated by the Sponsor|6|||
27905556|NCT00321906|81493136|FG000|Overall Study|Adverse Event|36|||
27905557|NCT00321906|81493137|FG001|Overall Study|Adverse Event|44|||
27905558|NCT00321906|81493136|FG000|Overall Study|Death|9|||
27905559|NCT00321906|81493137|FG001|Overall Study|Death|6|||
27905560|NCT00321906|81493136|FG000|Overall Study|Lost to Follow-up|1|||
27905561|NCT00321906|81493137|FG001|Overall Study|Lost to Follow-up|2|||
27905562|NCT00321906|81493136|FG000|Overall Study|Withdrawal by Subject|0|||
27905563|NCT00321906|81493137|FG001|Overall Study|Withdrawal by Subject|4|||
27905564|NCT02937636|81493138|FG000|Overall Study|Other (Not specified)|3|||
27905565|NCT02937636|81493139|FG001|Overall Study|Other (Not specified)|2|||
27905566|NCT01911793|81493140|FG000|Overall Study|Physician Decision|1|||
27905567|NCT01911793|81493141|FG001|Overall Study|Physician Decision|5|||
27905568|NCT01863732|81493145|FG000|Overall Study|Adverse Event|2|||
27905569|NCT01863732|81493146|FG001|Overall Study|Adverse Event|0|||
27905570|NCT01863732|81493147|FG002|Overall Study|Adverse Event|3|||
27905571|NCT01863732|81493148|FG003|Overall Study|Adverse Event|3|||
27905572|NCT01863732|81493145|FG000|Overall Study|Lack of Efficacy|1|||
27905573|NCT01863732|81493146|FG001|Overall Study|Lack of Efficacy|0|||
27905574|NCT01863732|81493147|FG002|Overall Study|Lack of Efficacy|2|||
27905575|NCT01863732|81493148|FG003|Overall Study|Lack of Efficacy|1|||
27905576|NCT01863732|81493145|FG000|Overall Study|Lost to Follow-up|2|||
27905577|NCT01863732|81493146|FG001|Overall Study|Lost to Follow-up|2|||
27905578|NCT01863732|81493147|FG002|Overall Study|Lost to Follow-up|1|||
27905579|NCT01863732|81493148|FG003|Overall Study|Lost to Follow-up|1|||
27905580|NCT01863732|81493145|FG000|Overall Study|Physician Decision|1|||
27905581|NCT01863732|81493146|FG001|Overall Study|Physician Decision|0|||
27905582|NCT01863732|81493147|FG002|Overall Study|Physician Decision|1|||
27905583|NCT01863732|81493148|FG003|Overall Study|Physician Decision|0|||
27905584|NCT01863732|81493145|FG000|Overall Study|Pregnancy|0|||
27905585|NCT01863732|81493146|FG001|Overall Study|Pregnancy|0|||
27905586|NCT01863732|81493147|FG002|Overall Study|Pregnancy|0|||
27905587|NCT01863732|81493148|FG003|Overall Study|Pregnancy|1|||
27905588|NCT01863732|81493145|FG000|Overall Study|Technical problems|0|||
27905589|NCT01863732|81493146|FG001|Overall Study|Technical problems|1|||
27905590|NCT01863732|81493147|FG002|Overall Study|Technical problems|1|||
27905591|NCT01863732|81493148|FG003|Overall Study|Technical problems|0|||
27905592|NCT01863732|81493145|FG000|Overall Study|Subject/guardian decision|6|||
27905593|NCT01863732|81493146|FG001|Overall Study|Subject/guardian decision|9|||
27905594|NCT01863732|81493147|FG002|Overall Study|Subject/guardian decision|3|||
27905595|NCT01863732|81493148|FG003|Overall Study|Subject/guardian decision|1|||
27905596|NCT01863732|81493145|FG000|Overall Study|Death|1|||
27905597|NCT01863732|81493146|FG001|Overall Study|Death|0|||
27905598|NCT01863732|81493147|FG002|Overall Study|Death|0|||
27905599|NCT01863732|81493148|FG003|Overall Study|Death|1|||
27905600|NCT04152083|81493151|FG000|Overall Study|Lost to Follow-up|2|||
27905601|NCT04152083|81493152|FG001|Overall Study|Lost to Follow-up|1|||
27905602|NCT04152083|81493151|FG000|Overall Study|Adverse Event|1|||
27905603|NCT04152083|81493152|FG001|Overall Study|Adverse Event|0|||
27905604|NCT04152083|81493151|FG000|Overall Study|Randomized but not treated|3|||
27905605|NCT04152083|81493152|FG001|Overall Study|Randomized but not treated|2|||
27905606|NCT01502956|81493153|FG000|Overall Study|Death|0|||
27905607|NCT01502956|81493154|FG001|Overall Study|Death|2|||
27905608|NCT01502956|81493153|FG000|Overall Study|Lost to Follow-up|14|||
27905609|NCT01502956|81493154|FG001|Overall Study|Lost to Follow-up|11|||
27905610|NCT01502956|81493153|FG000|Overall Study|Physician Decision|2|||
27905611|NCT01502956|81493154|FG001|Overall Study|Physician Decision|3|||
27905612|NCT01502956|81493153|FG000|Overall Study|Withdrawal by Subject|8|||
27905613|NCT01502956|81493154|FG001|Overall Study|Withdrawal by Subject|10|||
27905614|NCT01031004|81493155|FG000|Overall Study|Protocol Violation|0|||
27905615|NCT01031004|81493156|FG001|Overall Study|Protocol Violation|1|||
27905616|NCT01031004|81493155|FG000|Overall Study|Lost to Follow-up|1|||
27905617|NCT01031004|81493156|FG001|Overall Study|Lost to Follow-up|0|||
27905618|NCT01134393|81493158|FG000|Overall Study|Adverse Event|18|||
27905619|NCT01134393|81493158|FG000|Overall Study|Lack of Efficacy|2|||
27905620|NCT01134393|81493158|FG000|Overall Study|Protocol Violation|12|||
27905621|NCT01134393|81493158|FG000|Overall Study|Lost to Follow-up|3|||
27905622|NCT01134393|81493158|FG000|Overall Study|Withdrawal by Subject|11|||
27905623|NCT01134393|81493158|FG000|Overall Study|Other|6|||
27905624|NCT00948922|81493165|FG000|Overall Study|Did not start study treatment|2|||
27905625|NCT00948922|81493166|FG001|Overall Study|Did not start study treatment|5|||
27905626|NCT00948922|81493167|FG002|Overall Study|Did not start study treatment|0|||
27905627|NCT00948922|81493165|FG000|Overall Study|Withdrawal by Subject|0|||
27905628|NCT00948922|81493166|FG001|Overall Study|Withdrawal by Subject|2|||
27905629|NCT00948922|81493167|FG002|Overall Study|Withdrawal by Subject|1|||
27905630|NCT00948922|81493165|FG000|Overall Study|Death|3|||
27905631|NCT00948922|81493166|FG001|Overall Study|Death|0|||
27905632|NCT00948922|81493167|FG002|Overall Study|Death|0|||
27905633|NCT00948922|81493165|FG000|Overall Study|Disease progression|0|||
27905634|NCT00948922|81493166|FG001|Overall Study|Disease progression|1|||
27905635|NCT00948922|81493167|FG002|Overall Study|Disease progression|0|||
27905636|NCT00948922|81493165|FG000|Overall Study|Insurance issues|1|||
27615006|NCT01865617|80430380|FG004|Overall Study|Lost to Follow-up|0|||
27905637|NCT00948922|81493166|FG001|Overall Study|Insurance issues|0|||
27905638|NCT00948922|81493167|FG002|Overall Study|Insurance issues|0|||
27510978|NCT03216226|80061918|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
27510979|NCT00803569|80061919|FG000|Overall Study|Progressive Disease|3|||
27510980|NCT00803569|80061919|FG000|Overall Study|Noncompliance|1|||
27510981|NCT01327482|80061920|FG000|Overall Study|Adverse Event|1|||
27510982|NCT02536963|80061921|FG000|Overall Study|Withdrawal by Subject|18|||
27510983|NCT00998296|80061925|FG000|Overall Study|Progressive disease|0|||
27510984|NCT00998296|80061926|FG001|Overall Study|Progressive disease|1|||
27510985|NCT00998296|80061927|FG002|Overall Study|Progressive disease|0|||
27510986|NCT00998296|80061928|FG003|Overall Study|Progressive disease|0|||
27510987|NCT00998296|80061929|FG004|Overall Study|Progressive disease|0|||
27510988|NCT00998296|80061930|FG005|Overall Study|Progressive disease|0|||
27510989|NCT00998296|80061931|FG006|Overall Study|Progressive disease|1|||
27510990|NCT00998296|80061932|FG007|Overall Study|Progressive disease|0|||
27510991|NCT00998296|80061933|FG008|Overall Study|Progressive disease|0|||
27510992|NCT00998296|80061934|FG009|Overall Study|Progressive disease|14|||
27510993|NCT00998296|80061935|FG010|Overall Study|Progressive disease|5|||
27510994|NCT00998296|80061925|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
27510995|NCT00998296|80061926|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
27905639|NCT00948922|81493165|FG000|Overall Study|Transplant eligibility issues|2|||
27905640|NCT00948922|81493166|FG001|Overall Study|Transplant eligibility issues|3|||
27905641|NCT00948922|81493167|FG002|Overall Study|Transplant eligibility issues|0|||
27905642|NCT00948922|81493165|FG000|Overall Study|Not evaluable at time of analysis|0|||
27905643|NCT00948922|81493166|FG001|Overall Study|Not evaluable at time of analysis|3|||
27905644|NCT00948922|81493167|FG002|Overall Study|Not evaluable at time of analysis|0|||
27510996|NCT00998296|80061927|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
27510997|NCT00998296|80061928|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
27510998|NCT00998296|80061929|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
27510999|NCT00998296|80061930|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
27511000|NCT00998296|80061931|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
27511001|NCT00998296|80061932|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
27511002|NCT00998296|80061933|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
27511003|NCT00998296|80061934|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
27511004|NCT00998296|80061935|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
27511005|NCT00998296|80061925|FG000|Overall Study|Other adverse event|0|||
27511006|NCT00998296|80061926|FG001|Overall Study|Other adverse event|0|||
27511007|NCT00998296|80061927|FG002|Overall Study|Other adverse event|0|||
27511008|NCT00998296|80061928|FG003|Overall Study|Other adverse event|0|||
27511009|NCT00998296|80061929|FG004|Overall Study|Other adverse event|1|||
27511010|NCT00998296|80061930|FG005|Overall Study|Other adverse event|0|||
27511011|NCT00998296|80061931|FG006|Overall Study|Other adverse event|0|||
27511012|NCT00998296|80061932|FG007|Overall Study|Other adverse event|0|||
27852867|NCT02139124|81291235|FG003|Overall Study|subject moved|0|||
27852868|NCT02139124|81291236|FG004|Overall Study|subject moved|0|||
27852869|NCT02139124|81291232|FG000|Overall Study|Lost to Follow-up|3|||
27852870|NCT02139124|81291233|FG001|Overall Study|Lost to Follow-up|2|||
27852871|NCT02139124|81291234|FG002|Overall Study|Lost to Follow-up|0|||
27852872|NCT02139124|81291235|FG003|Overall Study|Lost to Follow-up|5|||
27905645|NCT03465709|81493170|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
27905646|NCT03465709|81493170|FG000|Overall Study|Withdrawal by Subject|3|||
27905647|NCT03824366|81493171|FG000|Overall Study|Death|1|||
27905648|NCT03824366|81493171|FG000|Overall Study|Previously unidentified metal artifact|1|||
27511013|NCT00998296|80061933|FG008|Overall Study|Other adverse event|0|||
27511014|NCT00998296|80061934|FG009|Overall Study|Other adverse event|1|||
27511015|NCT00998296|80061935|FG010|Overall Study|Other adverse event|2|||
27511016|NCT00998296|80061925|FG000|Overall Study|Refused to continue taking trial med.|0|||
27511017|NCT00998296|80061926|FG001|Overall Study|Refused to continue taking trial med.|0|||
27852873|NCT02139124|81291236|FG004|Overall Study|Lost to Follow-up|4|||
27852874|NCT00289874|81291239|FG000|Overall Study|Adverse Event|1|||
27852875|NCT00289874|81291240|FG001|Overall Study|Adverse Event|5|||
27852876|NCT00289874|81291239|FG000|Overall Study|Lost to Follow-up|1|||
27905649|NCT03824366|81493171|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
27905650|NCT03824366|81493171|FG000|Overall Study|Withdrawal by Subject|1|||
27905651|NCT05114564|81493176|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
27905652|NCT05114564|81493177|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
27905653|NCT05114564|81493176|FG000|First Intervention|Adverse Event|0|||
27905654|NCT05114564|81493177|FG001|First Intervention|Adverse Event|1|||
27905655|NCT00255164|81493178|FG000|Overall Study|Adverse Event|10|||
27905656|NCT00255164|81493179|FG001|Overall Study|Adverse Event|6|||
27905657|NCT00255164|81493180|FG002|Overall Study|Adverse Event|9|||
27905658|NCT00255164|81493178|FG000|Overall Study|Lost to Follow-up|4|||
27905659|NCT00255164|81493179|FG001|Overall Study|Lost to Follow-up|3|||
27905660|NCT00255164|81493180|FG002|Overall Study|Lost to Follow-up|4|||
27905661|NCT00255164|81493178|FG000|Overall Study|Withdrawal by Subject|18|||
27905662|NCT00255164|81493179|FG001|Overall Study|Withdrawal by Subject|17|||
27905663|NCT00255164|81493180|FG002|Overall Study|Withdrawal by Subject|8|||
27905664|NCT00255164|81493178|FG000|Overall Study|Noncompliance|0|||
27905665|NCT00255164|81493179|FG001|Overall Study|Noncompliance|1|||
27905666|NCT00255164|81493180|FG002|Overall Study|Noncompliance|2|||
27905667|NCT00255164|81493178|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
27905668|NCT00255164|81493179|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
27905669|NCT00255164|81493180|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
27728619|NCT00804687|80833337|FG000|Period 5: Treatment Period|Positive drug test|1|||
27905670|NCT00255164|81493178|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
27905671|NCT00255164|81493179|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
27905672|NCT00255164|81493180|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
27905673|NCT00255164|81493178|FG000|Overall Study|Possible Barrett's Esophagus|1|||
27905674|NCT00255164|81493179|FG001|Overall Study|Possible Barrett's Esophagus|3|||
27905675|NCT00255164|81493180|FG002|Overall Study|Possible Barrett's Esophagus|8|||
27905676|NCT00255164|81493178|FG000|Overall Study|Esophageal Stricture|0|||
27905677|NCT00255164|81493179|FG001|Overall Study|Esophageal Stricture|0|||
27905678|NCT00255164|81493180|FG002|Overall Study|Esophageal Stricture|1|||
27905679|NCT00255164|81493178|FG000|Overall Study|Therapeutic Failure|11|||
27905680|NCT00255164|81493179|FG001|Overall Study|Therapeutic Failure|2|||
27905681|NCT00255164|81493180|FG002|Overall Study|Therapeutic Failure|3|||
27905682|NCT03743025|81493181|FG000|Overall Study|Surgery was cancelled|2|||
27905683|NCT03743025|81493182|FG001|Overall Study|Surgery was cancelled|1|||
27905684|NCT01006590|81493187|FG000|Overall Study|Adverse Event|2|||
27905685|NCT01006590|81493188|FG001|Overall Study|Adverse Event|3|||
27905686|NCT01006590|81493187|FG000|Overall Study|Death|1|||
27905687|NCT01006590|81493188|FG001|Overall Study|Death|1|||
27905688|NCT01006590|81493187|FG000|Overall Study|Lost to Follow-up|1|||
27905689|NCT01006590|81493188|FG001|Overall Study|Lost to Follow-up|1|||
27905690|NCT01006590|81493187|FG000|Overall Study|Protocol Violation|1|||
27905691|NCT01006590|81493188|FG001|Overall Study|Protocol Violation|0|||
27905692|NCT01006590|81493187|FG000|Overall Study|Withdrawal by Subject|4|||
27905693|NCT01006590|81493188|FG001|Overall Study|Withdrawal by Subject|2|||
27905694|NCT01006590|81493187|FG000|Overall Study|Study specific discontinuation criteria|16|||
27905695|NCT01006590|81493188|FG001|Overall Study|Study specific discontinuation criteria|23|||
27905696|NCT01006590|81493187|FG000|Overall Study|Other|3|||
27905697|NCT01006590|81493188|FG001|Overall Study|Other|2|||
27905698|NCT02328937|81493194|FG000|Period 1|Lost to Follow-up|0|||
27905699|NCT02328937|81493195|FG001|Period 1|Lost to Follow-up|0|||
27905700|NCT02328937|81493196|FG002|Period 1|Lost to Follow-up|0|||
27905701|NCT02328937|81493197|FG003|Period 1|Lost to Follow-up|1|||
27905702|NCT02328937|81493198|FG004|Period 1|Lost to Follow-up|0|||
27905703|NCT02328937|81493199|FG005|Period 1|Lost to Follow-up|0|||
27905704|NCT02328937|81493194|FG000|Period 2|Adverse Event|0|||
27905705|NCT02328937|81493195|FG001|Period 2|Adverse Event|0|||
27905706|NCT02328937|81493196|FG002|Period 2|Adverse Event|1|||
27615007|NCT01865617|80430381|FG005|Overall Study|Lost to Follow-up|0|||
27905707|NCT02328937|81493197|FG003|Period 2|Adverse Event|0|||
27905708|NCT02328937|81493198|FG004|Period 2|Adverse Event|0|||
27905709|NCT02328937|81493199|FG005|Period 2|Adverse Event|0|||
27511018|NCT00998296|80061927|FG002|Overall Study|Refused to continue taking trial med.|0|||
27511019|NCT00998296|80061928|FG003|Overall Study|Refused to continue taking trial med.|0|||
27511020|NCT00998296|80061929|FG004|Overall Study|Refused to continue taking trial med.|0|||
27511021|NCT00998296|80061930|FG005|Overall Study|Refused to continue taking trial med.|0|||
27511022|NCT00998296|80061931|FG006|Overall Study|Refused to continue taking trial med.|0|||
27511023|NCT00998296|80061932|FG007|Overall Study|Refused to continue taking trial med.|0|||
27511024|NCT00998296|80061933|FG008|Overall Study|Refused to continue taking trial med.|0|||
27511025|NCT00998296|80061934|FG009|Overall Study|Refused to continue taking trial med.|2|||
27511026|NCT00998296|80061935|FG010|Overall Study|Refused to continue taking trial med.|0|||
27511027|NCT00998296|80061925|FG000|Overall Study|Reason other than those specified above|0|||
27511028|NCT00998296|80061926|FG001|Overall Study|Reason other than those specified above|0|||
27511029|NCT00998296|80061927|FG002|Overall Study|Reason other than those specified above|0|||
27511030|NCT00998296|80061928|FG003|Overall Study|Reason other than those specified above|0|||
27511031|NCT00998296|80061929|FG004|Overall Study|Reason other than those specified above|0|||
27511032|NCT00998296|80061930|FG005|Overall Study|Reason other than those specified above|0|||
27511033|NCT00998296|80061931|FG006|Overall Study|Reason other than those specified above|0|||
27511034|NCT00998296|80061932|FG007|Overall Study|Reason other than those specified above|0|||
27511035|NCT00998296|80061933|FG008|Overall Study|Reason other than those specified above|0|||
27511036|NCT00998296|80061934|FG009|Overall Study|Reason other than those specified above|1|||
27511037|NCT00998296|80061935|FG010|Overall Study|Reason other than those specified above|0|||
27511038|NCT01104311|80061936|FG000|Overall Study|Withdrawal by Subject|6|||
27511039|NCT01104311|80061937|FG001|Overall Study|Withdrawal by Subject|6|||
27511040|NCT01104311|80061936|FG000|Overall Study|Protocol Violation|0|||
27511041|NCT01104311|80061937|FG001|Overall Study|Protocol Violation|1|||
27511042|NCT01104311|80061936|FG000|Overall Study|Physician Decision|2|||
27511043|NCT01104311|80061937|FG001|Overall Study|Physician Decision|2|||
27511044|NCT01104311|80061936|FG000|Overall Study|low compliance|1|||
27511045|NCT01104311|80061937|FG001|Overall Study|low compliance|1|||
27511046|NCT01104311|80061936|FG000|Overall Study|Adverse Event|1|||
27511047|NCT01104311|80061937|FG001|Overall Study|Adverse Event|2|||
27511048|NCT01746901|80061938|FG000|Naloxone Challenge Phase|Adverse Event|2|||
27511049|NCT01746901|80061939|FG001|Naloxone Challenge Phase|Adverse Event|0|||
27511050|NCT01746901|80061940|FG002|Naloxone Challenge Phase|Adverse Event|0|||
27511051|NCT01746901|80061941|FG003|Naloxone Challenge Phase|Adverse Event|0|||
27511052|NCT01746901|80061942|FG004|Naloxone Challenge Phase|Adverse Event|0|||
27511053|NCT01746901|80061943|FG005|Naloxone Challenge Phase|Adverse Event|0|||
27511054|NCT01746901|80061944|FG006|Naloxone Challenge Phase|Adverse Event|0|||
27511055|NCT01746901|80061945|FG007|Naloxone Challenge Phase|Adverse Event|0|||
27511056|NCT01746901|80061946|FG008|Naloxone Challenge Phase|Adverse Event|0|||
27511057|NCT01746901|80061938|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
27511058|NCT01746901|80061939|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27511059|NCT01746901|80061940|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27615008|NCT01865617|80430382|FG006|Overall Study|Lost to Follow-up|0|||
27615009|NCT01865617|80430383|FG007|Overall Study|Lost to Follow-up|0|||
27615010|NCT01865617|80430384|FG008|Overall Study|Lost to Follow-up|0|||
27852877|NCT00289874|81291240|FG001|Overall Study|Lost to Follow-up|1|||
27852878|NCT00289874|81291239|FG000|Overall Study|Protocol Violation|3|||
27852879|NCT00289874|81291240|FG001|Overall Study|Protocol Violation|2|||
27852880|NCT00289874|81291239|FG000|Overall Study|Did not meet eligibility|1|||
27852881|NCT00289874|81291240|FG001|Overall Study|Did not meet eligibility|0|||
27852882|NCT00307034|81291242|FG000|Overall Study|Adverse Event|1|||
27852883|NCT00307034|81291243|FG001|Overall Study|Adverse Event|2|||
27852884|NCT00307034|81291242|FG000|Overall Study|Withdrawal by Subject|1|||
27852885|NCT00307034|81291243|FG001|Overall Study|Withdrawal by Subject|2|||
27852886|NCT00307034|81291242|FG000|Overall Study|Lost to Follow-up|0|||
27852887|NCT00307034|81291243|FG001|Overall Study|Lost to Follow-up|3|||
27852888|NCT03649412|81291246|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
27852889|NCT03649412|81291247|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
27852890|NCT03649412|81291246|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
27852891|NCT03649412|81291247|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
27852892|NCT03649412|81291246|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
27852893|NCT03649412|81291247|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
27852894|NCT03649412|81291246|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
27852895|NCT03649412|81291247|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
27511060|NCT01746901|80061941|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27511061|NCT01746901|80061942|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27511062|NCT01746901|80061943|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27615011|NCT01865617|80430385|FG009|Overall Study|Lost to Follow-up|0|||
27852896|NCT03649412|81291246|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
27852897|NCT03649412|81291247|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
27852898|NCT03649412|81291246|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
27852899|NCT03649412|81291247|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
27852900|NCT04556552|81291248|FG000|Overall Study|Lost to Follow-up|1|||
27511063|NCT01746901|80061944|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27511064|NCT01746901|80061945|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27511065|NCT01746901|80061946|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
27511066|NCT01746901|80061938|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511067|NCT01746901|80061939|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
27511068|NCT01746901|80061940|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511069|NCT01746901|80061941|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511070|NCT01746901|80061942|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511071|NCT01746901|80061943|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511072|NCT01746901|80061944|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511073|NCT01746901|80061945|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511074|NCT01746901|80061946|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
27511075|NCT01746901|80061938|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511076|NCT01746901|80061939|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
27511077|NCT01746901|80061940|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
27511078|NCT01746901|80061941|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511079|NCT01746901|80061942|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511080|NCT01746901|80061943|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511081|NCT01746901|80061944|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511082|NCT01746901|80061945|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511083|NCT01746901|80061946|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
27511084|NCT01746901|80061938|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511085|NCT01746901|80061939|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
27511086|NCT01746901|80061940|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
27511087|NCT01746901|80061941|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511088|NCT01746901|80061942|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511089|NCT01746901|80061943|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511090|NCT01746901|80061944|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511091|NCT01746901|80061945|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511092|NCT01746901|80061946|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
27511093|NCT01746901|80061938|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511094|NCT01746901|80061939|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
27511095|NCT01746901|80061940|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
27511096|NCT01746901|80061941|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511097|NCT01746901|80061942|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511098|NCT01746901|80061943|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511099|NCT01746901|80061944|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511100|NCT01746901|80061945|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511101|NCT01746901|80061946|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
27511102|NCT01746901|80061938|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
27511103|NCT01746901|80061939|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
27511104|NCT01746901|80061940|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
27511105|NCT01746901|80061941|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
27511106|NCT01746901|80061942|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
27511107|NCT01746901|80061943|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
27511108|NCT01746901|80061944|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
27511109|NCT01746901|80061945|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
27511110|NCT01746901|80061946|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
27511111|NCT01746901|80061938|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511112|NCT01746901|80061939|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511113|NCT01746901|80061940|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511114|NCT01746901|80061941|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511115|NCT01746901|80061942|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511116|NCT01746901|80061943|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511117|NCT01746901|80061944|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511118|NCT01746901|80061945|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
27511119|NCT01746901|80061946|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
27511120|NCT01746901|80061938|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511121|NCT01746901|80061939|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511122|NCT01746901|80061940|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511123|NCT01746901|80061941|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511124|NCT01746901|80061942|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511125|NCT01746901|80061943|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
27852901|NCT04556552|81291249|FG001|Overall Study|Lost to Follow-up|0|||
27511126|NCT01746901|80061944|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
27511127|NCT01746901|80061945|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511128|NCT01746901|80061946|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
27511129|NCT01746901|80061938|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511130|NCT01746901|80061939|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511131|NCT01746901|80061940|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511132|NCT01746901|80061941|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
27511133|NCT01746901|80061942|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511134|NCT01746901|80061943|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511135|NCT01746901|80061944|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511136|NCT01746901|80061945|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511137|NCT01746901|80061946|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
27511138|NCT01746901|80061938|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511139|NCT01746901|80061939|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511140|NCT01746901|80061940|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511141|NCT01746901|80061941|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511142|NCT01746901|80061942|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511143|NCT01746901|80061943|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
27511144|NCT01746901|80061944|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511145|NCT01746901|80061945|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
27511146|NCT01746901|80061946|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
27511147|NCT01746901|80061938|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511148|NCT01746901|80061939|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511149|NCT01746901|80061940|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511150|NCT01746901|80061941|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511151|NCT01746901|80061942|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511152|NCT01746901|80061943|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511153|NCT01746901|80061944|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
27511154|NCT01746901|80061945|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
27511155|NCT01746901|80061946|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
27511156|NCT01076361|80061956|FG000|Overall Study|22 leads were excluded from analysis|21|||
27511157|NCT01413204|80061963|FG000|Overall Study|Adverse Event|1|||
27511158|NCT01413204|80061964|FG001|Overall Study|Adverse Event|2|||
27511159|NCT01413204|80061965|FG002|Overall Study|Adverse Event|2|||
27511160|NCT01413204|80061963|FG000|Overall Study|Physician Decision|3|||
27511161|NCT01413204|80061964|FG001|Overall Study|Physician Decision|0|||
27511162|NCT01413204|80061965|FG002|Overall Study|Physician Decision|2|||
27511163|NCT01413204|80061963|FG000|Overall Study|Withdrawal by Subject|1|||
27511164|NCT01413204|80061964|FG001|Overall Study|Withdrawal by Subject|4|||
27511165|NCT01413204|80061965|FG002|Overall Study|Withdrawal by Subject|4|||
27511166|NCT01413204|80061963|FG000|Overall Study|Clearly not eligible for the study|0|||
27511167|NCT01413204|80061964|FG001|Overall Study|Clearly not eligible for the study|0|||
27511168|NCT01413204|80061965|FG002|Overall Study|Clearly not eligible for the study|1|||
27511169|NCT01413204|80061963|FG000|Overall Study|Fasting plasma glucose level increased|1|||
27511170|NCT01413204|80061964|FG001|Overall Study|Fasting plasma glucose level increased|0|||
27511171|NCT01413204|80061965|FG002|Overall Study|Fasting plasma glucose level increased|10|||
27511172|NCT04646044|80061966|FG000|Overall Study|Lost to Follow-up|0|||
27511173|NCT04646044|80061967|FG001|Overall Study|Lost to Follow-up|0|||
27511174|NCT04646044|80061968|FG002|Overall Study|Lost to Follow-up|1|||
27511175|NCT04646044|80061969|FG003|Overall Study|Lost to Follow-up|0|||
27511176|NCT04646044|80061966|FG000|Overall Study|Withdrawal by Subject|0|||
27511177|NCT04646044|80061967|FG001|Overall Study|Withdrawal by Subject|1|||
27511178|NCT04646044|80061968|FG002|Overall Study|Withdrawal by Subject|0|||
27511179|NCT04646044|80061969|FG003|Overall Study|Withdrawal by Subject|0|||
27511180|NCT04041414|80061978|FG000|Overall Study|Lost to Follow-up|1|||
27511181|NCT04041414|80061979|FG001|Overall Study|Lost to Follow-up|2|||
27511182|NCT01701674|80061989|FG000|Overall Study|Unable to safely complete treatment|1|||
27511183|NCT03714672|80061990|FG000|Overall Study|Adverse Event|0|||
27511184|NCT03714672|80061991|FG001|Overall Study|Adverse Event|0|||
27511185|NCT03714672|80061992|FG002|Overall Study|Adverse Event|3|||
27511186|NCT03714672|80061993|FG003|Overall Study|Adverse Event|0|||
27511187|NCT03714672|80061990|FG000|Overall Study|Physician Decision|0|||
27511188|NCT03714672|80061991|FG001|Overall Study|Physician Decision|1|||
27511189|NCT03714672|80061992|FG002|Overall Study|Physician Decision|0|||
27511190|NCT03714672|80061993|FG003|Overall Study|Physician Decision|0|||
27511191|NCT03714672|80061990|FG000|Overall Study|Other Reason|1|||
27511192|NCT03714672|80061991|FG001|Overall Study|Other Reason|2|||
27511193|NCT03714672|80061992|FG002|Overall Study|Other Reason|1|||
27511194|NCT03714672|80061993|FG003|Overall Study|Other Reason|1|||
27511195|NCT03714672|80061990|FG000|Overall Study|Lost to Follow-up|1|||
27511196|NCT03714672|80061991|FG001|Overall Study|Lost to Follow-up|1|||
27511197|NCT03714672|80061992|FG002|Overall Study|Lost to Follow-up|0|||
27511198|NCT03714672|80061993|FG003|Overall Study|Lost to Follow-up|0|||
27615012|NCT01865617|80430386|FG010|Overall Study|Lost to Follow-up|0|||
27615013|NCT01865617|80430387|FG011|Overall Study|Lost to Follow-up|0|||
27615014|NCT01865617|80430388|FG012|Overall Study|Lost to Follow-up|0|||
27615015|NCT01865617|80430376|FG000|Overall Study|Withdrawal by Subject|1|||
27905710|NCT02716779|81493200|FG000|Monotherapy|Adverse Event|0|||
27905711|NCT02716779|81493201|FG001|Monotherapy|Adverse Event|1|||
27511199|NCT00993967|80061994|FG000|Overall Study|Adverse Event|8|||
27511200|NCT00993967|80061994|FG000|Overall Study|Death|1|||
27511201|NCT00993967|80061994|FG000|Overall Study|Lost to Follow-up|14|||
27511202|NCT00993967|80061994|FG000|Overall Study|Withdrawal by Subject|36|||
27511203|NCT00993967|80061994|FG000|Overall Study|Protocol Violation|2|||
27511204|NCT04200352|80066114|FG000|Overall Study|Death|1|||
27511205|NCT04200352|80066114|FG000|Overall Study|Adverse Event|6|||
27511206|NCT04200352|80066114|FG000|Overall Study|Withdrawal by parent/guardian|6|||
27511207|NCT04200352|80066114|FG000|Overall Study|Lack of Efficacy|1|||
27511208|NCT04200352|80066114|FG000|Overall Study|Other than specified|6|||
27511209|NCT01376804|80066115|FG000|Treatment Period|Withdrawal by Subject|1|||
27511210|NCT01376804|80066115|FG000|Treatment Period|Adverse Event|6|||
27511211|NCT01376804|80066115|FG000|Treatment Period|Patient did not receive study drug|1|||
27511212|NCT02281383|80066116|FG000|Overall Study|Progressive Disease|1|||
27511213|NCT02281383|80066116|FG000|Overall Study|Withdrawal by Subject|6|||
27511214|NCT02281383|80066116|FG000|Overall Study|Protocol Violation|2|||
27511215|NCT02281383|80066116|FG000|Overall Study|Death|1|||
27511216|NCT02281383|80066116|FG000|Overall Study|Adverse Event|2|||
27511217|NCT03048578|80066121|FG000|Overall Study|Withdrawal by Subject|5|||
27511218|NCT03048578|80066122|FG001|Overall Study|Withdrawal by Subject|6|||
27511219|NCT03048578|80066121|FG000|Overall Study|Lost to Follow-up|22|||
27511220|NCT03048578|80066122|FG001|Overall Study|Lost to Follow-up|10|||
27511221|NCT03048578|80066121|FG000|Overall Study|Adverse Event|1|||
27511222|NCT03048578|80066122|FG001|Overall Study|Adverse Event|2|||
27511223|NCT03048578|80066121|FG000|Overall Study|Terminated|3|||
27511224|NCT03048578|80066122|FG001|Overall Study|Terminated|2|||
27511225|NCT00686686|80066123|FG000|Overall Study|Non-compliance|1|||
27511226|NCT00686686|80066123|FG000|Overall Study|Adverse Event|2|||
27511227|NCT00686686|80066123|FG000|Overall Study|Lost to Follow-up|3|||
27511228|NCT02598583|80066124|FG000|Extension Period|Withdrawal by Subject|1|||
27511229|NCT02598583|80066125|FG001|Extension Period|Withdrawal by Subject|0|||
27511230|NCT00423917|80066126|FG000|Overall Study|Cancel|2|||
27511231|NCT00423917|80066126|FG000|Overall Study|Ineligible|1|||
27511232|NCT01039519|80066127|FG000|Treatment|Progressive disease|20|||
27511233|NCT01039519|80066127|FG000|Treatment|Treatment failure|2|||
27511234|NCT01039519|80066127|FG000|Treatment|Adverse Event|3|||
27511235|NCT01039519|80066127|FG000|Treatment|Physician Decision|2|||
27511236|NCT01039519|80066127|FG000|Survival Follow-up|Death|23|||
27511237|NCT01039519|80066127|FG000|Survival Follow-up|Sponsor decision|4|||
27511238|NCT00345358|80066132|FG000|Primary Vaccination Phase|Other|0|||
27511239|NCT00345358|80066133|FG001|Primary Vaccination Phase|Other|1|||
27511240|NCT00345358|80066134|FG002|Primary Vaccination Phase|Other|1|||
27511241|NCT00345358|80066135|FG003|Primary Vaccination Phase|Other|0|||
27511242|NCT00345358|80066132|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
27511243|NCT00345358|80066133|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
27511244|NCT00345358|80066134|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
27511245|NCT00345358|80066135|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
27511246|NCT00345358|80066132|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
27511247|NCT00345358|80066133|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
27511248|NCT00345358|80066134|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
27511249|NCT00345358|80066135|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
27511250|NCT00345358|80066132|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
27511251|NCT00345358|80066133|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
27511252|NCT00345358|80066134|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
27511253|NCT00345358|80066135|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
27511254|NCT00345358|80066132|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
27511255|NCT00345358|80066133|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
27511256|NCT00345358|80066134|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
27511257|NCT00345358|80066135|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
27511258|NCT00345358|80066132|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
27511259|NCT00345358|80066133|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
27511260|NCT00345358|80066134|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
27852902|NCT04556552|81291248|FG000|Overall Study|Claustrophobia|0|||
27511261|NCT00345358|80066135|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
27511262|NCT00602472|80066138|FG000|Overall Study|Adverse Event|5|||
27511263|NCT00602472|80066139|FG001|Overall Study|Adverse Event|23|||
27511264|NCT00602472|80066138|FG000|Overall Study|Protocol Violation|4|||
27511265|NCT00602472|80066139|FG001|Overall Study|Protocol Violation|19|||
27615016|NCT01865617|80430377|FG001|Overall Study|Withdrawal by Subject|0|||
27615017|NCT01865617|80430378|FG002|Overall Study|Withdrawal by Subject|0|||
27511266|NCT00602472|80066138|FG000|Overall Study|Withdrawal by Subject|8|||
27511267|NCT00602472|80066139|FG001|Overall Study|Withdrawal by Subject|14|||
27511268|NCT00602472|80066138|FG000|Overall Study|Other incl. lack of efficacy|4|||
27511269|NCT00602472|80066139|FG001|Overall Study|Other incl. lack of efficacy|2|||
27511270|NCT01342211|80066143|FG000|Overall Study|Lost to Follow-up|0|||
27511271|NCT01342211|80066144|FG001|Overall Study|Lost to Follow-up|0|||
27511272|NCT01342211|80066145|FG002|Overall Study|Lost to Follow-up|0|||
27511273|NCT01342211|80066146|FG003|Overall Study|Lost to Follow-up|1|||
27511274|NCT01342211|80066147|FG004|Overall Study|Lost to Follow-up|0|||
27511275|NCT01342211|80066143|FG000|Overall Study|Adverse Event|0|||
27511276|NCT01342211|80066144|FG001|Overall Study|Adverse Event|0|||
27511277|NCT01342211|80066145|FG002|Overall Study|Adverse Event|0|||
27511278|NCT01342211|80066146|FG003|Overall Study|Adverse Event|0|||
27511279|NCT01342211|80066147|FG004|Overall Study|Adverse Event|1|||
27511280|NCT01342211|80066143|FG000|Overall Study|Withdrawal by Subject|0|||
27511281|NCT01342211|80066144|FG001|Overall Study|Withdrawal by Subject|0|||
27511282|NCT01342211|80066145|FG002|Overall Study|Withdrawal by Subject|0|||
27511283|NCT01342211|80066146|FG003|Overall Study|Withdrawal by Subject|1|||
27511284|NCT01342211|80066147|FG004|Overall Study|Withdrawal by Subject|0|||
27511285|NCT01342211|80066143|FG000|Overall Study|Randomized, but not Treated|0|||
27511286|NCT01342211|80066144|FG001|Overall Study|Randomized, but not Treated|2|||
27511287|NCT01342211|80066145|FG002|Overall Study|Randomized, but not Treated|0|||
27511288|NCT01342211|80066146|FG003|Overall Study|Randomized, but not Treated|0|||
27511289|NCT01342211|80066147|FG004|Overall Study|Randomized, but not Treated|1|||
27511290|NCT00499083|80066148|FG000|Overall Study|Not evaluable|3|||
27511291|NCT01524796|80066150|FG000|Overall Study|Adverse Event|13|||
27511292|NCT01524796|80066150|FG000|Overall Study|Lack of Efficacy|3|||
27511293|NCT01524796|80066150|FG000|Overall Study|Lost to Follow-up|1|||
27511294|NCT01524796|80066150|FG000|Overall Study|The price|1|||
27511295|NCT01524796|80066150|FG000|Overall Study|Withdrawal by Subject|4|||
27511296|NCT01524796|80066150|FG000|Overall Study|Move|1|||
27511297|NCT01524796|80066150|FG000|Overall Study|Deterioration of pains|1|||
27511298|NCT01524796|80066150|FG000|Overall Study|Gall stone surgery|1|||
27511299|NCT01524796|80066150|FG000|Overall Study|Nervous about confidentiality|1|||
27511300|NCT01524796|80066150|FG000|Overall Study|Switch to carbamazapine|1|||
27511301|NCT01524796|80066150|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
27511302|NCT01075685|80066152|FG000|Overall Study|Protocol Violation|9|||
27511303|NCT01075685|80066153|FG001|Overall Study|Protocol Violation|1|||
27511304|NCT01075685|80066152|FG000|Overall Study|Withdrawal by Subject|20|||
27511305|NCT01075685|80066153|FG001|Overall Study|Withdrawal by Subject|5|||
27511306|NCT01075685|80066152|FG000|Overall Study|Lost to Follow-up|563|||
27511307|NCT01075685|80066153|FG001|Overall Study|Lost to Follow-up|220|||
27511308|NCT02792829|80066157|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511309|NCT02792829|80066158|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
27511310|NCT02792829|80066159|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511311|NCT02792829|80066160|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511312|NCT02792829|80066161|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511313|NCT02792829|80066162|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511314|NCT02792829|80066163|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511315|NCT02792829|80066164|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
27511316|NCT02792829|80066157|FG000|Treatment Period 2|Adverse Event|0|||
27511317|NCT02792829|80066158|FG001|Treatment Period 2|Adverse Event|0|||
27511318|NCT02792829|80066159|FG002|Treatment Period 2|Adverse Event|0|||
27511319|NCT02792829|80066160|FG003|Treatment Period 2|Adverse Event|0|||
27511320|NCT02792829|80066161|FG004|Treatment Period 2|Adverse Event|1|||
27511321|NCT02792829|80066162|FG005|Treatment Period 2|Adverse Event|0|||
27511322|NCT02792829|80066163|FG006|Treatment Period 2|Adverse Event|1|||
27511323|NCT02792829|80066164|FG007|Treatment Period 2|Adverse Event|1|||
27511324|NCT02792829|80066157|FG000|Treatment Period 2|Use of proscribed medications|0|||
27511325|NCT02792829|80066158|FG001|Treatment Period 2|Use of proscribed medications|0|||
27511326|NCT02792829|80066159|FG002|Treatment Period 2|Use of proscribed medications|0|||
27511327|NCT02792829|80066160|FG003|Treatment Period 2|Use of proscribed medications|0|||
27511328|NCT02792829|80066161|FG004|Treatment Period 2|Use of proscribed medications|0|||
27511329|NCT02792829|80066162|FG005|Treatment Period 2|Use of proscribed medications|0|||
27511330|NCT02792829|80066163|FG006|Treatment Period 2|Use of proscribed medications|0|||
27511331|NCT02792829|80066164|FG007|Treatment Period 2|Use of proscribed medications|1|||
27511332|NCT00594815|80066168|FG000|Overall Study|Never Treated|3|||
27511333|NCT00594815|80066168|FG000|Overall Study|Withdrawal by Subject|2|||
27511334|NCT00594815|80066168|FG000|Overall Study|Toxicity|4|||
27511335|NCT02350478|80066169|FG000|Overall Study|Lost to Follow-up|5|||
27511336|NCT02350478|80066170|FG001|Overall Study|Lost to Follow-up|1|||
27511337|NCT01411891|80066171|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
27511338|NCT01411891|80066172|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
27511339|NCT02873702|80066173|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
27511340|NCT02873702|80066174|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
27511341|NCT02873702|80066175|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
27511342|NCT02873702|80066176|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
27511343|NCT02873702|80066173|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
27511344|NCT02873702|80066174|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
27511345|NCT02873702|80066175|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
27511346|NCT02873702|80066176|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
27511347|NCT02873702|80066173|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
27511348|NCT02873702|80066174|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
27511349|NCT02873702|80066175|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
27511350|NCT02873702|80066176|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
27511351|NCT02873702|80066173|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
27511352|NCT02873702|80066174|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
27511353|NCT02873702|80066175|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
27511354|NCT02873702|80066176|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
27511355|NCT02873702|80066173|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
27511356|NCT02873702|80066174|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
27511357|NCT02873702|80066175|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
27511358|NCT02873702|80066176|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
27511359|NCT02561832|80066179|FG000|Overall Study|Withdrawal by Subject|1|||
27511360|NCT02561832|80066180|FG001|Overall Study|Withdrawal by Subject|1|||
27511361|NCT02561832|80066179|FG000|Overall Study|Adverse Event|3|||
27615018|NCT01865617|80430379|FG003|Overall Study|Withdrawal by Subject|0|||
27615019|NCT01865617|80430380|FG004|Overall Study|Withdrawal by Subject|0|||
27615020|NCT01865617|80430381|FG005|Overall Study|Withdrawal by Subject|0|||
27615021|NCT01865617|80430382|FG006|Overall Study|Withdrawal by Subject|0|||
27615022|NCT01865617|80430383|FG007|Overall Study|Withdrawal by Subject|0|||
27615023|NCT01865617|80430384|FG008|Overall Study|Withdrawal by Subject|0|||
27615024|NCT01865617|80430385|FG009|Overall Study|Withdrawal by Subject|0|||
27615025|NCT01865617|80430386|FG010|Overall Study|Withdrawal by Subject|0|||
27615026|NCT01865617|80430387|FG011|Overall Study|Withdrawal by Subject|0|||
27615027|NCT01865617|80430388|FG012|Overall Study|Withdrawal by Subject|0|||
27615028|NCT01865617|80430376|FG000|Overall Study|Patient proceeded to new therapy|0|||
27615029|NCT01865617|80430377|FG001|Overall Study|Patient proceeded to new therapy|0|||
27615030|NCT01865617|80430378|FG002|Overall Study|Patient proceeded to new therapy|0|||
27615031|NCT01865617|80430379|FG003|Overall Study|Patient proceeded to new therapy|0|||
27615032|NCT01865617|80430380|FG004|Overall Study|Patient proceeded to new therapy|2|||
27615033|NCT01865617|80430381|FG005|Overall Study|Patient proceeded to new therapy|0|||
27615034|NCT01865617|80430382|FG006|Overall Study|Patient proceeded to new therapy|0|||
27615035|NCT01865617|80430383|FG007|Overall Study|Patient proceeded to new therapy|0|||
27615036|NCT01865617|80430384|FG008|Overall Study|Patient proceeded to new therapy|0|||
27615037|NCT01865617|80430385|FG009|Overall Study|Patient proceeded to new therapy|0|||
27615038|NCT01865617|80430386|FG010|Overall Study|Patient proceeded to new therapy|0|||
27511362|NCT02561832|80066180|FG001|Overall Study|Adverse Event|0|||
27511363|NCT02561832|80066179|FG000|Overall Study|Disease progression|3|||
27511364|NCT02561832|80066180|FG001|Overall Study|Disease progression|3|||
27511365|NCT00372593|80066183|FG000|Overall Study|Adverse Event|43|||
27511366|NCT00372593|80066184|FG001|Overall Study|Adverse Event|45|||
27511367|NCT00372593|80066185|FG002|Overall Study|Adverse Event|0|||
27511368|NCT00372593|80066183|FG000|Overall Study|Death|16|||
27511369|NCT00372593|80066184|FG001|Overall Study|Death|20|||
27511370|NCT00372593|80066185|FG002|Overall Study|Death|1|||
27511371|NCT00372593|80066183|FG000|Overall Study|Lack of Efficacy|82|||
27511372|NCT00372593|80066184|FG001|Overall Study|Lack of Efficacy|71|||
27511373|NCT00372593|80066185|FG002|Overall Study|Lack of Efficacy|2|||
27511374|NCT00372593|80066183|FG000|Overall Study|Lost to Follow-up|1|||
27511375|NCT00372593|80066184|FG001|Overall Study|Lost to Follow-up|0|||
27511376|NCT00372593|80066185|FG002|Overall Study|Lost to Follow-up|0|||
27511377|NCT00372593|80066183|FG000|Overall Study|Physician Decision|42|||
27511378|NCT00372593|80066184|FG001|Overall Study|Physician Decision|41|||
27511379|NCT00372593|80066185|FG002|Overall Study|Physician Decision|0|||
27511380|NCT00372593|80066183|FG000|Overall Study|Ineligible|20|||
27511381|NCT00372593|80066184|FG001|Overall Study|Ineligible|21|||
27511382|NCT00372593|80066185|FG002|Overall Study|Ineligible|1|||
27511383|NCT02461758|80066188|FG000|Overall Study|Lost to Follow-up|0|||
27511384|NCT02461758|80066189|FG001|Overall Study|Lost to Follow-up|1|||
27511385|NCT02461758|80066190|FG002|Overall Study|Lost to Follow-up|1|||
27511386|NCT02461758|80066191|FG003|Overall Study|Lost to Follow-up|0|||
27511387|NCT04953728|80066194|FG000|Overall Study|Withdrawal by Subject|3|||
27511388|NCT04953728|80066194|FG000|Overall Study|Physician Decision|1|||
27511389|NCT02872935|80066198|FG000|Overall Study|Other|0|||
27511390|NCT02872935|80066199|FG001|Overall Study|Other|1|||
27511391|NCT00804908|80066200|FG000|Overall Study|Other|115|||
27511392|NCT00804908|80066201|FG001|Overall Study|Other|116|||
27511393|NCT00804908|80066202|FG002|Overall Study|Other|114|||
27511394|NCT01273519|80066205|FG000|Overall Study|Adverse Event|3|||
27511395|NCT01273519|80066206|FG001|Overall Study|Adverse Event|0|||
27511396|NCT01273519|80066207|FG002|Overall Study|Adverse Event|0|||
27511397|NCT01273519|80066205|FG000|Overall Study|Lost to Follow-up|2|||
27511398|NCT01273519|80066206|FG001|Overall Study|Lost to Follow-up|1|||
27511399|NCT01273519|80066207|FG002|Overall Study|Lost to Follow-up|3|||
27511400|NCT01273519|80066205|FG000|Overall Study|Lack of Efficacy|8|||
27511401|NCT01273519|80066206|FG001|Overall Study|Lack of Efficacy|3|||
27511402|NCT01273519|80066207|FG002|Overall Study|Lack of Efficacy|4|||
27511403|NCT01273519|80066205|FG000|Overall Study|Other|6|||
27511404|NCT01273519|80066206|FG001|Overall Study|Other|1|||
27511405|NCT01273519|80066207|FG002|Overall Study|Other|1|||
27511406|NCT05083585|80066208|FG000|Overall Study|Death|1|||
27511407|NCT05083585|80066209|FG001|Overall Study|Death|1|||
27511408|NCT05083585|80066208|FG000|Overall Study|Lost to Follow-up|1|||
27511409|NCT05083585|80066209|FG001|Overall Study|Lost to Follow-up|1|||
27511410|NCT05083585|80066208|FG000|Overall Study|Withdrawal by Subject|2|||
27511411|NCT05083585|80066209|FG001|Overall Study|Withdrawal by Subject|0|||
27511412|NCT05083585|80066208|FG000|Overall Study|Randomized but not vaccinated|2|||
27511413|NCT05083585|80066209|FG001|Overall Study|Randomized but not vaccinated|0|||
27905712|NCT02716779|81493202|FG002|Monotherapy|Adverse Event|1|||
27905713|NCT02716779|81493200|FG000|Combination Therapy|Adverse Event|0|||
27905714|NCT02716779|81493201|FG001|Combination Therapy|Adverse Event|2|||
27905715|NCT02716779|81493202|FG002|Combination Therapy|Adverse Event|1|||
27905716|NCT03332095|81493203|FG000|Overall Study|Lost to Follow-up|1|||
27905717|NCT03332095|81493204|FG001|Overall Study|Lost to Follow-up|0|||
27905718|NCT03332095|81493203|FG000|Overall Study|Pregnancy|0|||
27905719|NCT03332095|81493204|FG001|Overall Study|Pregnancy|1|||
27905720|NCT00162097|81493205|FG000|Overall Study|Participant no longer met study criteria|0|||
27905721|NCT00162097|81493206|FG001|Overall Study|Participant no longer met study criteria|0|||
27905722|NCT00162097|81493207|FG002|Overall Study|Participant no longer met study criteria|0|||
27905723|NCT00162097|81493208|FG003|Overall Study|Participant no longer met study criteria|1|||
27905724|NCT01760447|81493210|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
27905725|NCT01760447|81493211|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
27905726|NCT01760447|81493212|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
27511414|NCT01063283|80066217|FG000|Cycle 1|Adverse Event|2|||
27511415|NCT01063283|80066218|FG001|Cycle 1|Adverse Event|0|||
27852903|NCT04556552|81291249|FG001|Overall Study|Claustrophobia|1|||
27852904|NCT04556552|81291248|FG000|Overall Study|Inability to continue|0|||
27852905|NCT04556552|81291249|FG001|Overall Study|Inability to continue|1|||
27852906|NCT03258853|81291252|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
27852907|NCT03258853|81291253|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
27905727|NCT01760447|81493213|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
27511416|NCT01063283|80066219|FG002|Cycle 1|Adverse Event|0|||
27511417|NCT01063283|80066217|FG000|Cycle 1|Technical failure in data collection|1|||
27511418|NCT01063283|80066218|FG001|Cycle 1|Technical failure in data collection|0|||
27511419|NCT01063283|80066219|FG002|Cycle 1|Technical failure in data collection|0|||
27511420|NCT01519869|80066222|FG000|Overall Study|Lost to Follow-up|1|||
27511421|NCT00829504|80066223|FG000|First Intervention|Adverse Event|1|||
27511422|NCT00829504|80066224|FG001|First Intervention|Adverse Event|0|||
27511423|NCT00829504|80066223|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27905728|NCT01760447|81493210|FG000|Weeks 0-20|Withdrawal by Subject|2|||
27905729|NCT01760447|81493211|FG001|Weeks 0-20|Withdrawal by Subject|0|||
27905730|NCT01760447|81493212|FG002|Weeks 0-20|Withdrawal by Subject|1|||
27905731|NCT01760447|81493213|FG003|Weeks 0-20|Withdrawal by Subject|0|||
27905732|NCT01760447|81493210|FG000|Weeks 0-20|Lost to Follow-up|1|||
27905733|NCT01760447|81493211|FG001|Weeks 0-20|Lost to Follow-up|0|||
27905734|NCT01760447|81493212|FG002|Weeks 0-20|Lost to Follow-up|1|||
27905735|NCT01760447|81493213|FG003|Weeks 0-20|Lost to Follow-up|1|||
27905736|NCT01760447|81493210|FG000|Weeks 0-20|Randomized but not treated|0|||
27905737|NCT01760447|81493211|FG001|Weeks 0-20|Randomized but not treated|0|||
27905738|NCT01760447|81493212|FG002|Weeks 0-20|Randomized but not treated|2|||
27905739|NCT01760447|81493213|FG003|Weeks 0-20|Randomized but not treated|0|||
27905740|NCT01760447|81493210|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
27905741|NCT01760447|81493211|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
27905742|NCT01760447|81493212|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
27905743|NCT01760447|81493213|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
27905744|NCT01760447|81493210|FG000|Weeks 20-54|Withdrawal by Subject|2|||
27905745|NCT01760447|81493211|FG001|Weeks 20-54|Withdrawal by Subject|1|||
27905746|NCT01760447|81493212|FG002|Weeks 20-54|Withdrawal by Subject|1|||
27905747|NCT01760447|81493213|FG003|Weeks 20-54|Withdrawal by Subject|2|||
27905748|NCT01760447|81493210|FG000|Weeks 20-54|Lost to Follow-up|0|||
27905749|NCT01760447|81493211|FG001|Weeks 20-54|Lost to Follow-up|0|||
27905750|NCT01760447|81493212|FG002|Weeks 20-54|Lost to Follow-up|1|||
27905751|NCT01760447|81493213|FG003|Weeks 20-54|Lost to Follow-up|2|||
27905752|NCT03469999|81493217|FG000|Overall Study|Lost to Follow-up|2|||
27905753|NCT02869893|81493218|FG000|Overall Study|participant aversion to IV|5|||
27905754|NCT02869893|81493218|FG000|Overall Study|participant fear of MRI scanner|2|||
27905755|NCT02227368|81493219|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
27905756|NCT02227368|81493220|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
27905757|NCT02227368|81493219|FG000|Overall Study|Lost to Follow-up|1|||
27905758|NCT02227368|81493220|FG001|Overall Study|Lost to Follow-up|0|||
27905759|NCT02227368|81493219|FG000|Overall Study|Adverse Event|1|||
27905760|NCT02227368|81493220|FG001|Overall Study|Adverse Event|0|||
27905761|NCT03313310|81493229|FG000|Phase 2|Lost to Follow-up|4|||
27905762|NCT03313310|81493230|FG001|Phase 2|Lost to Follow-up|0|||
27905763|NCT03313310|81493229|FG000|Phase 3|Lost to Follow-up|0|||
27905764|NCT03313310|81493230|FG001|Phase 3|Lost to Follow-up|1|||
27905765|NCT01698268|81493233|FG000|Overall Study|Physician Decision|2|||
27905766|NCT01698268|81493234|FG001|Overall Study|Physician Decision|1|||
27905767|NCT02075008|81493235|FG000|Overall Study|Technical problems|1|||
27905768|NCT02075008|81493235|FG000|Overall Study|Pregnancy|1|||
27905769|NCT02075008|81493235|FG000|Overall Study|Physician Decision|1|||
27905770|NCT02075008|81493235|FG000|Overall Study|Lost to Follow-up|1|||
27905771|NCT02075008|81493235|FG000|Overall Study|Lack of Efficacy|1|||
27905772|NCT02075008|81493235|FG000|Overall Study|Death|1|||
27905773|NCT02075008|81493235|FG000|Overall Study|Adverse Event|5|||
27905774|NCT02075008|81493235|FG000|Overall Study|Withdrawal by Subject|6|||
27905775|NCT02075008|81493235|FG000|Overall Study|Study terminated by Sponsor|159|||
27905776|NCT01084538|81493236|FG000|Overall Study|Drug not available|30|||
27905777|NCT01084538|81493236|FG000|Overall Study|Adverse Event|9|||
27905778|NCT01084538|81493236|FG000|Overall Study|Kidney transplant|6|||
27905779|NCT01084538|81493236|FG000|Overall Study|Serious Adverse Event|3|||
27905780|NCT01084538|81493236|FG000|Overall Study|Lack of effectiveness|2|||
27905781|NCT01084538|81493236|FG000|Overall Study|Patient noncompliance|2|||
27905782|NCT01084538|81493236|FG000|Overall Study|Hyperphosphatemia|2|||
27905783|NCT01084538|81493236|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
27905784|NCT01084538|81493236|FG000|Overall Study|Change of residence|2|||
27905785|NCT01084538|81493236|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
27905786|NCT01084538|81493236|FG000|Overall Study|Reason unknown|8|||
27905787|NCT03334188|81493237|FG000|Overall Study|Withdrawal by Subject|0|||
27905788|NCT03334188|81493238|FG001|Overall Study|Withdrawal by Subject|1|||
27905789|NCT03334188|81493237|FG000|Overall Study|Death|1|||
27905790|NCT03334188|81493238|FG001|Overall Study|Death|0|||
27905791|NCT03334188|81493237|FG000|Overall Study|Never had qualifying clinic visit|7|||
27905792|NCT03334188|81493238|FG001|Overall Study|Never had qualifying clinic visit|7|||
27905793|NCT04105842|81493241|FG000|Overall Study|Withdrawal by Subject|2|||
27905794|NCT02263729|81493242|FG000|Overall Study|Lost to Follow-up|1|||
27905795|NCT02263729|81493243|FG001|Overall Study|Lost to Follow-up|1|||
27905796|NCT01677182|81493244|FG000|Overall Study|Adverse Event|2|||
27905797|NCT01677182|81493245|FG001|Overall Study|Adverse Event|1|||
27905798|NCT01677182|81493246|FG002|Overall Study|Adverse Event|8|||
27905799|NCT01677182|81493244|FG000|Overall Study|Protocol Violation|5|||
27905800|NCT01677182|81493245|FG001|Overall Study|Protocol Violation|1|||
27905801|NCT01677182|81493246|FG002|Overall Study|Protocol Violation|4|||
27905802|NCT01677182|81493244|FG000|Overall Study|Lost to Follow-up|4|||
27905803|NCT01677182|81493245|FG001|Overall Study|Lost to Follow-up|0|||
27905804|NCT01677182|81493246|FG002|Overall Study|Lost to Follow-up|3|||
27511424|NCT00829504|80066224|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27511425|NCT00829504|80066223|FG000|Second Intervention|Physician Decision|1|||
27511426|NCT00829504|80066224|FG001|Second Intervention|Physician Decision|0|||
27511427|NCT02379637|80066225|FG000|Overall Study|Protocol Violation|0|||
27511428|NCT02379637|80066226|FG001|Overall Study|Protocol Violation|1|||
27511429|NCT02379637|80066225|FG000|Overall Study|Adverse Event|1|||
27511430|NCT02379637|80066226|FG001|Overall Study|Adverse Event|0|||
27511431|NCT02379637|80066225|FG000|Overall Study|Withdrawal by Subject|1|||
27511432|NCT02379637|80066226|FG001|Overall Study|Withdrawal by Subject|0|||
27511433|NCT05097963|80066228|FG000|Overall Study|Protocol Violation|13|||
27511434|NCT05097963|80066228|FG000|Overall Study|Withdrawal by Subject|21|||
27511435|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
27511436|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
27511437|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
27511438|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
27511439|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
27511440|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
27511441|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
27511442|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
27511443|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
27511444|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
27511445|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27511446|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
27511447|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27511448|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27511449|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27511450|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27511451|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27511452|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
27615039|NCT01865617|80430387|FG011|Overall Study|Patient proceeded to new therapy|0|||
27615040|NCT01865617|80430388|FG012|Overall Study|Patient proceeded to new therapy|0|||
27615041|NCT01865617|80430376|FG000|Overall Study|Other|0|||
27615042|NCT01865617|80430377|FG001|Overall Study|Other|0|||
27905805|NCT01677182|81493244|FG000|Overall Study|Withdrawal by Subject|7|||
27905806|NCT01677182|81493245|FG001|Overall Study|Withdrawal by Subject|12|||
27905807|NCT01677182|81493246|FG002|Overall Study|Withdrawal by Subject|10|||
27905808|NCT01677182|81493244|FG000|Overall Study|Study termination|12|||
27905809|NCT01677182|81493245|FG001|Overall Study|Study termination|9|||
27905810|NCT01677182|81493246|FG002|Overall Study|Study termination|11|||
27905811|NCT01677182|81493244|FG000|Overall Study|Lack of Efficacy|3|||
27905812|NCT01677182|81493245|FG001|Overall Study|Lack of Efficacy|0|||
27905813|NCT01677182|81493246|FG002|Overall Study|Lack of Efficacy|1|||
27905814|NCT01677182|81493244|FG000|Overall Study|Other reasons|1|||
27905815|NCT01677182|81493245|FG001|Overall Study|Other reasons|5|||
27905816|NCT01677182|81493246|FG002|Overall Study|Other reasons|2|||
27905817|NCT00572455|81493247|FG000|Stage I (14 Days)|Adverse Event|0|||
27905818|NCT00572455|81493248|FG001|Stage I (14 Days)|Adverse Event|0|||
27905819|NCT00572455|81493249|FG002|Stage I (14 Days)|Adverse Event|0|||
27905820|NCT00572455|81493250|FG003|Stage I (14 Days)|Adverse Event|0|||
27905821|NCT00572455|81493251|FG004|Stage I (14 Days)|Adverse Event|0|||
27905822|NCT00572455|81493252|FG005|Stage I (14 Days)|Adverse Event|3|||
27905823|NCT00572455|81493253|FG006|Stage I (14 Days)|Adverse Event|0|||
27905824|NCT00572455|81493254|FG007|Stage I (14 Days)|Adverse Event|0|||
27905825|NCT00572455|81493255|FG008|Stage I (14 Days)|Adverse Event|0|||
27905826|NCT00572455|81493256|FG009|Stage I (14 Days)|Adverse Event|0|||
27905827|NCT00572455|81493257|FG010|Stage I (14 Days)|Adverse Event|0|||
27905828|NCT00572455|81493258|FG011|Stage I (14 Days)|Adverse Event|0|||
27905829|NCT00572455|81493259|FG012|Stage I (14 Days)|Adverse Event|0|||
27905830|NCT00572455|81493260|FG013|Stage I (14 Days)|Adverse Event|0|||
27905831|NCT00572455|81493247|FG000|Stage I (14 Days)|Other|0|||
27905832|NCT00572455|81493248|FG001|Stage I (14 Days)|Other|0|||
27905833|NCT00572455|81493249|FG002|Stage I (14 Days)|Other|0|||
27905834|NCT00572455|81493250|FG003|Stage I (14 Days)|Other|0|||
27905835|NCT00572455|81493251|FG004|Stage I (14 Days)|Other|1|||
27905836|NCT00572455|81493252|FG005|Stage I (14 Days)|Other|0|||
27905837|NCT00572455|81493253|FG006|Stage I (14 Days)|Other|0|||
27905838|NCT00572455|81493254|FG007|Stage I (14 Days)|Other|0|||
27905839|NCT00572455|81493255|FG008|Stage I (14 Days)|Other|0|||
27905840|NCT00572455|81493256|FG009|Stage I (14 Days)|Other|0|||
27615043|NCT01865617|80430378|FG002|Overall Study|Other|0|||
27905841|NCT00572455|81493257|FG010|Stage I (14 Days)|Other|0|||
27905842|NCT00572455|81493258|FG011|Stage I (14 Days)|Other|0|||
27905843|NCT00572455|81493259|FG012|Stage I (14 Days)|Other|0|||
27905844|NCT00572455|81493260|FG013|Stage I (14 Days)|Other|0|||
27615044|NCT01865617|80430379|FG003|Overall Study|Other|0|||
27905845|NCT00572455|81493247|FG000|Stage II (28 Days)|Adverse Event|0|||
27905846|NCT00572455|81493248|FG001|Stage II (28 Days)|Adverse Event|0|||
27905847|NCT00572455|81493249|FG002|Stage II (28 Days)|Adverse Event|0|||
27905848|NCT00572455|81493250|FG003|Stage II (28 Days)|Adverse Event|0|||
27905849|NCT00572455|81493251|FG004|Stage II (28 Days)|Adverse Event|0|||
27905850|NCT00572455|81493252|FG005|Stage II (28 Days)|Adverse Event|0|||
27905851|NCT00572455|81493253|FG006|Stage II (28 Days)|Adverse Event|0|||
27905852|NCT00572455|81493254|FG007|Stage II (28 Days)|Adverse Event|0|||
27905853|NCT00572455|81493255|FG008|Stage II (28 Days)|Adverse Event|1|||
27905854|NCT00572455|81493256|FG009|Stage II (28 Days)|Adverse Event|3|||
27905855|NCT00572455|81493257|FG010|Stage II (28 Days)|Adverse Event|3|||
27511453|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
27511454|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
27511455|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
27511456|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
27511457|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
27511458|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
27511459|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
27511460|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
27511461|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
27511462|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|Other|0|||
27511463|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|Other|0|||
27511464|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|Other|1|||
27511465|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|Other|1|||
27511466|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|Other|0|||
27511467|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|Other|0|||
27511468|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|Other|0|||
27511469|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|Other|1|||
27511470|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|Other|0|||
27511471|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|Death|0|||
27511472|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|Death|0|||
27511473|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|Death|0|||
27511474|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|Death|0|||
27511475|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|Death|0|||
27511476|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|Death|1|||
27511477|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|Death|0|||
27511478|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|Death|0|||
27511479|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|Death|0|||
27511480|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27511481|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27511482|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27511483|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27852908|NCT02989168|81291256|FG000|Overall Study|Withdrawal by Subject|2|||
27852909|NCT02989168|81291257|FG001|Overall Study|Withdrawal by Subject|0|||
27852910|NCT02989168|81291256|FG000|Overall Study|Physician Decision|0|||
27852911|NCT02989168|81291257|FG001|Overall Study|Physician Decision|1|||
27852912|NCT02989168|81291256|FG000|Overall Study|Adverse Event|1|||
27852913|NCT02989168|81291257|FG001|Overall Study|Adverse Event|2|||
27852914|NCT02989168|81291256|FG000|Overall Study|Sponsor stopped study.|1|||
27852915|NCT02989168|81291257|FG001|Overall Study|Sponsor stopped study.|0|||
27852916|NCT00062010|81291258|FG000|Overall Study|Ineligible|3|||
27852917|NCT02056392|81291259|FG000|Overall Study|Lost to Follow-up|0|||
27852918|NCT02056392|81291260|FG001|Overall Study|Lost to Follow-up|1|||
27852919|NCT02056392|81291261|FG002|Overall Study|Lost to Follow-up|2|||
27852920|NCT02056392|81291262|FG003|Overall Study|Lost to Follow-up|0|||
27852921|NCT02056392|81291263|FG004|Overall Study|Lost to Follow-up|0|||
27852922|NCT02056392|81291264|FG005|Overall Study|Lost to Follow-up|0|||
27852923|NCT02056392|81291259|FG000|Overall Study|Protocol Violation|1|||
27852924|NCT02056392|81291260|FG001|Overall Study|Protocol Violation|0|||
27852925|NCT02056392|81291261|FG002|Overall Study|Protocol Violation|1|||
27852926|NCT02056392|81291262|FG003|Overall Study|Protocol Violation|0|||
27852927|NCT02056392|81291263|FG004|Overall Study|Protocol Violation|0|||
27852928|NCT02056392|81291264|FG005|Overall Study|Protocol Violation|0|||
27852929|NCT02056392|81291259|FG000|Overall Study|Withdrawal by Subject|1|||
27905856|NCT00572455|81493258|FG011|Stage II (28 Days)|Adverse Event|4|||
27905857|NCT00572455|81493259|FG012|Stage II (28 Days)|Adverse Event|5|||
27852930|NCT02056392|81291260|FG001|Overall Study|Withdrawal by Subject|0|||
27905858|NCT00572455|81493260|FG013|Stage II (28 Days)|Adverse Event|1|||
27511484|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27511485|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
27852931|NCT02056392|81291261|FG002|Overall Study|Withdrawal by Subject|0|||
27852932|NCT02056392|81291262|FG003|Overall Study|Withdrawal by Subject|0|||
27905859|NCT00572455|81493247|FG000|Stage II (28 Days)|Death|0|||
27852933|NCT02056392|81291263|FG004|Overall Study|Withdrawal by Subject|1|||
27852934|NCT02056392|81291264|FG005|Overall Study|Withdrawal by Subject|0|||
27905860|NCT00572455|81493248|FG001|Stage II (28 Days)|Death|0|||
27905861|NCT00572455|81493249|FG002|Stage II (28 Days)|Death|0|||
27905862|NCT00572455|81493250|FG003|Stage II (28 Days)|Death|0|||
27511486|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
27511487|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27511488|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
27511489|NCT00557856|80066229|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
27511490|NCT00557856|80066230|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511491|NCT00557856|80066231|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511492|NCT00557856|80066232|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511493|NCT00557856|80066233|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511494|NCT00557856|80066234|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511495|NCT00557856|80066235|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511496|NCT00557856|80066236|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511497|NCT00557856|80066237|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
27511498|NCT00557856|80066229|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511499|NCT00557856|80066230|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511500|NCT00557856|80066231|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511501|NCT00557856|80066232|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511502|NCT00557856|80066233|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511503|NCT00557856|80066234|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511504|NCT00557856|80066235|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511505|NCT00557856|80066236|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
27511506|NCT00557856|80066237|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
27511507|NCT00557856|80066229|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511508|NCT00557856|80066230|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511509|NCT00557856|80066231|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511510|NCT00557856|80066232|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511511|NCT00557856|80066233|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511512|NCT00557856|80066234|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511513|NCT00557856|80066235|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511514|NCT00557856|80066236|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
27511515|NCT00557856|80066237|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
27511516|NCT00557856|80066229|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
27511517|NCT00557856|80066230|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
27511518|NCT00557856|80066231|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
27511519|NCT00557856|80066232|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
27511520|NCT00557856|80066233|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
27511521|NCT00557856|80066234|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
27511522|NCT00557856|80066235|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
27511523|NCT00557856|80066236|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
27511524|NCT00557856|80066237|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
27511525|NCT00557856|80066229|FG000|Part 2: Exploratory Phase|Other|0|||
27511526|NCT00557856|80066230|FG001|Part 2: Exploratory Phase|Other|0|||
27511527|NCT00557856|80066231|FG002|Part 2: Exploratory Phase|Other|0|||
27511528|NCT00557856|80066232|FG003|Part 2: Exploratory Phase|Other|0|||
27511529|NCT00557856|80066233|FG004|Part 2: Exploratory Phase|Other|0|||
27511530|NCT00557856|80066234|FG005|Part 2: Exploratory Phase|Other|0|||
27511531|NCT00557856|80066235|FG006|Part 2: Exploratory Phase|Other|0|||
27511532|NCT00557856|80066236|FG007|Part 2: Exploratory Phase|Other|0|||
27511533|NCT00557856|80066237|FG008|Part 2: Exploratory Phase|Other|1|||
27511534|NCT00557856|80066229|FG000|Part 2: Exploratory Phase|Death|0|||
27511535|NCT00557856|80066230|FG001|Part 2: Exploratory Phase|Death|0|||
27511536|NCT00557856|80066231|FG002|Part 2: Exploratory Phase|Death|0|||
27511537|NCT00557856|80066232|FG003|Part 2: Exploratory Phase|Death|0|||
27511538|NCT00557856|80066233|FG004|Part 2: Exploratory Phase|Death|0|||
27511539|NCT00557856|80066234|FG005|Part 2: Exploratory Phase|Death|0|||
27511540|NCT00557856|80066235|FG006|Part 2: Exploratory Phase|Death|0|||
27511541|NCT00557856|80066236|FG007|Part 2: Exploratory Phase|Death|0|||
27511542|NCT00557856|80066237|FG008|Part 2: Exploratory Phase|Death|2|||
27511543|NCT00557856|80066229|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
27511544|NCT00557856|80066230|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
27511545|NCT00557856|80066231|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
27511546|NCT00557856|80066232|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
27852935|NCT02749292|81291267|FG000|Overall Study|Physician Decision|1|||
27852936|NCT02749292|81291268|FG001|Overall Study|Physician Decision|0|||
27511547|NCT00557856|80066233|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
27511548|NCT00557856|80066234|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
27511549|NCT00557856|80066235|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
27511550|NCT00557856|80066236|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
27852937|NCT02749292|81291267|FG000|Overall Study|Withdrawal by Subject|5|||
27511551|NCT00557856|80066237|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
27511552|NCT00400946|80066242|FG000|Overall Study|Ineligible|0|||
27511553|NCT00400946|80066243|FG001|Overall Study|Ineligible|0|||
27511554|NCT00400946|80066244|FG002|Overall Study|Ineligible|0|||
27511555|NCT00400946|80066245|FG003|Overall Study|Ineligible|5|||
27511556|NCT00400946|80066246|FG004|Overall Study|Ineligible|1|||
27615045|NCT01865617|80430380|FG004|Overall Study|Other|0|||
27615046|NCT01865617|80430381|FG005|Overall Study|Other|0|||
27615047|NCT01865617|80430382|FG006|Overall Study|Other|1|||
27615048|NCT01865617|80430383|FG007|Overall Study|Other|0|||
27615049|NCT01865617|80430384|FG008|Overall Study|Other|0|||
27615050|NCT01865617|80430385|FG009|Overall Study|Other|0|||
27615051|NCT01865617|80430386|FG010|Overall Study|Other|0|||
27615052|NCT01865617|80430387|FG011|Overall Study|Other|0|||
27615053|NCT01865617|80430388|FG012|Overall Study|Other|0|||
27615054|NCT00245011|80430392|FG000|Overall Study|Lack of Efficacy|1|||
27615055|NCT04039503|80430395|FG000|Overall Study|Adverse Event|3|||
27615056|NCT04039503|80430396|FG001|Overall Study|Adverse Event|0|||
27615057|NCT04039503|80430397|FG002|Overall Study|Adverse Event|2|||
27615058|NCT04039503|80430398|FG003|Overall Study|Adverse Event|0|||
27615059|NCT04039503|80430395|FG000|Overall Study|Lost to Follow-up|0|||
27615060|NCT04039503|80430396|FG001|Overall Study|Lost to Follow-up|0|||
27615061|NCT04039503|80430397|FG002|Overall Study|Lost to Follow-up|1|||
27615062|NCT04039503|80430398|FG003|Overall Study|Lost to Follow-up|0|||
27615063|NCT04039503|80430395|FG000|Overall Study|Protocol Violation|0|||
27615064|NCT04039503|80430396|FG001|Overall Study|Protocol Violation|1|||
27615065|NCT04039503|80430397|FG002|Overall Study|Protocol Violation|2|||
27615066|NCT04039503|80430398|FG003|Overall Study|Protocol Violation|1|||
27615067|NCT04039503|80430395|FG000|Overall Study|Withdrawal by Subject|4|||
27615068|NCT04039503|80430396|FG001|Overall Study|Withdrawal by Subject|3|||
27615069|NCT04039503|80430397|FG002|Overall Study|Withdrawal by Subject|5|||
27615070|NCT04039503|80430398|FG003|Overall Study|Withdrawal by Subject|2|||
27615071|NCT04908683|80430399|FG000|Overall Study|Failure to meet continuation criteria|34|||
27615072|NCT04908683|80430400|FG001|Overall Study|Failure to meet continuation criteria|22|||
27615073|NCT04908683|80430399|FG000|Overall Study|Initiated prohibited medication|3|||
27615074|NCT04908683|80430400|FG001|Overall Study|Initiated prohibited medication|0|||
27615075|NCT04908683|80430399|FG000|Overall Study|Randomized by mistake|1|||
27615076|NCT04908683|80430400|FG001|Overall Study|Randomized by mistake|0|||
27615077|NCT04908683|80430399|FG000|Overall Study|Lost to Follow-up|679|||
27615078|NCT04908683|80430400|FG001|Overall Study|Lost to Follow-up|341|||
27615079|NCT04908683|80430399|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
27511557|NCT00400946|80066242|FG000|Overall Study|Induction Failure|0|||
27511558|NCT00400946|80066243|FG001|Overall Study|Induction Failure|0|||
27511559|NCT00400946|80066244|FG002|Overall Study|Induction Failure|0|||
27511560|NCT00400946|80066245|FG003|Overall Study|Induction Failure|11|||
27511561|NCT00400946|80066246|FG004|Overall Study|Induction Failure|8|||
27511562|NCT00400946|80066242|FG000|Overall Study|Induction Death|0|||
27511563|NCT00400946|80066243|FG001|Overall Study|Induction Death|0|||
27511564|NCT00400946|80066244|FG002|Overall Study|Induction Death|0|||
27511565|NCT00400946|80066245|FG003|Overall Study|Induction Death|13|||
27511566|NCT00400946|80066246|FG004|Overall Study|Induction Death|3|||
27511567|NCT00400946|80066242|FG000|Overall Study|Lost to Follow-up|1|||
27511568|NCT00400946|80066243|FG001|Overall Study|Lost to Follow-up|1|||
27511569|NCT00400946|80066244|FG002|Overall Study|Lost to Follow-up|0|||
27511570|NCT00400946|80066245|FG003|Overall Study|Lost to Follow-up|0|||
27511571|NCT00400946|80066246|FG004|Overall Study|Lost to Follow-up|1|||
27511572|NCT00400946|80066242|FG000|Overall Study|Remission Death|1|||
27511573|NCT00400946|80066243|FG001|Overall Study|Remission Death|1|||
27511574|NCT00400946|80066244|FG002|Overall Study|Remission Death|0|||
27511575|NCT00400946|80066245|FG003|Overall Study|Remission Death|0|||
27511576|NCT00400946|80066246|FG004|Overall Study|Remission Death|1|||
27511577|NCT00400946|80066242|FG000|Overall Study|Relapse|9|||
27511578|NCT00400946|80066243|FG001|Overall Study|Relapse|2|||
27511579|NCT00400946|80066244|FG002|Overall Study|Relapse|1|||
27511580|NCT00400946|80066245|FG003|Overall Study|Relapse|1|||
27511581|NCT00400946|80066246|FG004|Overall Study|Relapse|5|||
27511582|NCT00400946|80066242|FG000|Overall Study|Transplant in CR1|0|||
27615080|NCT04908683|80430400|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
27615081|NCT04908683|80430399|FG000|Overall Study|Physician Decision|44|||
27615082|NCT04908683|80430400|FG001|Overall Study|Physician Decision|35|||
27905863|NCT00572455|81493251|FG004|Stage II (28 Days)|Death|0|||
27905864|NCT00572455|81493252|FG005|Stage II (28 Days)|Death|0|||
27511583|NCT00400946|80066243|FG001|Overall Study|Transplant in CR1|0|||
27511584|NCT00400946|80066244|FG002|Overall Study|Transplant in CR1|0|||
27511585|NCT00400946|80066245|FG003|Overall Study|Transplant in CR1|10|||
27511586|NCT00400946|80066246|FG004|Overall Study|Transplant in CR1|1|||
27511587|NCT00400946|80066242|FG000|Overall Study|Withdrawal by Subject|2|||
27511588|NCT00400946|80066243|FG001|Overall Study|Withdrawal by Subject|5|||
27511589|NCT00400946|80066244|FG002|Overall Study|Withdrawal by Subject|1|||
27615083|NCT04908683|80430399|FG000|Overall Study|Technical problems|12|||
27615084|NCT04908683|80430400|FG001|Overall Study|Technical problems|9|||
27615085|NCT04908683|80430399|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
27511590|NCT00400946|80066245|FG003|Overall Study|Withdrawal by Subject|5|||
27511591|NCT00400946|80066246|FG004|Overall Study|Withdrawal by Subject|8|||
27511592|NCT00400946|80066242|FG000|Overall Study|Clinical|1|||
27511593|NCT00400946|80066243|FG001|Overall Study|Clinical|2|||
27511594|NCT00400946|80066244|FG002|Overall Study|Clinical|0|||
27511595|NCT00400946|80066245|FG003|Overall Study|Clinical|2|||
27511596|NCT00400946|80066246|FG004|Overall Study|Clinical|9|||
27511597|NCT00400946|80066242|FG000|Overall Study|Other|0|||
27511598|NCT00400946|80066243|FG001|Overall Study|Other|0|||
27511599|NCT00400946|80066244|FG002|Overall Study|Other|0|||
27511600|NCT00400946|80066245|FG003|Overall Study|Other|0|||
27511601|NCT00400946|80066246|FG004|Overall Study|Other|1|||
27511602|NCT01254422|80066247|FG000|Overall Study|Protocol Violation|1|||
27511603|NCT01254422|80066248|FG001|Overall Study|Protocol Violation|0|||
27511604|NCT01254422|80066247|FG000|Overall Study|Adverse Event|1|||
27511605|NCT01254422|80066248|FG001|Overall Study|Adverse Event|0|||
27511606|NCT01254422|80066247|FG000|Overall Study|Serious adverse event|0|||
27511607|NCT01254422|80066248|FG001|Overall Study|Serious adverse event|1|||
27511608|NCT01254422|80066247|FG000|Overall Study|Lost to Follow-up|1|||
27511609|NCT01254422|80066248|FG001|Overall Study|Lost to Follow-up|0|||
27511610|NCT00196313|80066252|FG000|Overall Study|Protocol Violation|2|||
27905865|NCT00572455|81493253|FG006|Stage II (28 Days)|Death|0|||
27905866|NCT00572455|81493254|FG007|Stage II (28 Days)|Death|0|||
27905867|NCT00572455|81493255|FG008|Stage II (28 Days)|Death|1|||
27905868|NCT00572455|81493256|FG009|Stage II (28 Days)|Death|0|||
27905869|NCT00572455|81493257|FG010|Stage II (28 Days)|Death|0|||
27905870|NCT00572455|81493258|FG011|Stage II (28 Days)|Death|0|||
27905871|NCT00572455|81493259|FG012|Stage II (28 Days)|Death|0|||
27905872|NCT00572455|81493260|FG013|Stage II (28 Days)|Death|0|||
27905873|NCT00572455|81493247|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
27905874|NCT00572455|81493248|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
27905875|NCT00572455|81493249|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
27905876|NCT00572455|81493250|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
27905877|NCT00572455|81493251|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
27905878|NCT00572455|81493252|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
27905879|NCT00572455|81493253|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
27905880|NCT00572455|81493254|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
27905881|NCT00572455|81493255|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
27905882|NCT00572455|81493256|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
27905883|NCT00572455|81493257|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
27905884|NCT00572455|81493258|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
27905885|NCT00572455|81493259|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
27905886|NCT00572455|81493260|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
27905887|NCT00572455|81493247|FG000|Stage II (28 Days)|Other|0|||
27905888|NCT00572455|81493248|FG001|Stage II (28 Days)|Other|0|||
27905889|NCT00572455|81493249|FG002|Stage II (28 Days)|Other|0|||
27905890|NCT00572455|81493250|FG003|Stage II (28 Days)|Other|0|||
27905891|NCT00572455|81493251|FG004|Stage II (28 Days)|Other|0|||
27905892|NCT00572455|81493252|FG005|Stage II (28 Days)|Other|0|||
27905893|NCT00572455|81493253|FG006|Stage II (28 Days)|Other|0|||
27905894|NCT00572455|81493254|FG007|Stage II (28 Days)|Other|0|||
27905895|NCT00572455|81493255|FG008|Stage II (28 Days)|Other|1|||
27905896|NCT00572455|81493256|FG009|Stage II (28 Days)|Other|0|||
27905897|NCT00572455|81493257|FG010|Stage II (28 Days)|Other|0|||
27511611|NCT00196313|80066253|FG001|Overall Study|Protocol Violation|3|||
27511612|NCT00196313|80066252|FG000|Overall Study|Withdrawal by Subject|3|||
27511613|NCT00196313|80066253|FG001|Overall Study|Withdrawal by Subject|1|||
27511614|NCT00196313|80066252|FG000|Overall Study|Adverse Event|3|||
27511615|NCT00196313|80066253|FG001|Overall Study|Adverse Event|1|||
27728620|NCT00804687|80833338|FG001|Period 5: Treatment Period|Positive drug test|0|||
27905898|NCT00572455|81493258|FG011|Stage II (28 Days)|Other|0|||
27905899|NCT00572455|81493259|FG012|Stage II (28 Days)|Other|0|||
27905900|NCT00572455|81493260|FG013|Stage II (28 Days)|Other|0|||
27905901|NCT00572455|81493247|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
27905902|NCT00572455|81493248|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
27905903|NCT00572455|81493249|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
27905904|NCT00572455|81493250|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
27905905|NCT00572455|81493251|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
27905906|NCT00572455|81493252|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
27905907|NCT00572455|81493253|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
27905908|NCT00572455|81493254|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
27511616|NCT00196313|80066252|FG000|Overall Study|Subject Pregnant|1|||
27511617|NCT00196313|80066253|FG001|Overall Study|Subject Pregnant|1|||
27511618|NCT00196313|80066252|FG000|Overall Study|Lost to Follow-up|2|||
27511619|NCT00196313|80066253|FG001|Overall Study|Lost to Follow-up|2|||
27511620|NCT00080899|80066258|FG000|Overall Study|Adverse Event|1|||
27511621|NCT00214201|80066267|FG000|Overall Study|Withdrawal by Subject|2|||
27511622|NCT00214201|80066268|FG001|Overall Study|Withdrawal by Subject|0|||
27511623|NCT00214201|80066267|FG000|Overall Study|Death|0|||
27511624|NCT00214201|80066268|FG001|Overall Study|Death|2|||
27511625|NCT03436082|80066271|FG000|Overall Study|Did not undergo procedure|1|||
27511626|NCT03436082|80066272|FG001|Overall Study|Did not undergo procedure|0|||
27511627|NCT01605799|80066278|FG000|Overall Study|Withdrawal by Subject|2|||
27511628|NCT01605799|80066279|FG001|Overall Study|Withdrawal by Subject|1|||
27511629|NCT01626872|80066280|FG000|Overall Study|Physician Decision|13|||
27511630|NCT01626872|80066281|FG001|Overall Study|Physician Decision|9|||
27511631|NCT01626872|80066282|FG002|Overall Study|Physician Decision|6|||
27511632|NCT01626872|80066280|FG000|Overall Study|Withdrawal by Subject|19|||
27511633|NCT01626872|80066281|FG001|Overall Study|Withdrawal by Subject|27|||
27511634|NCT01626872|80066282|FG002|Overall Study|Withdrawal by Subject|8|||
27511635|NCT01626872|80066280|FG000|Overall Study|Adverse Event (including Death)|20|||
27511636|NCT01626872|80066281|FG001|Overall Study|Adverse Event (including Death)|28|||
27511637|NCT01626872|80066282|FG002|Overall Study|Adverse Event (including Death)|8|||
27511638|NCT01626872|80066280|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
27511639|NCT01626872|80066281|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
27511640|NCT01626872|80066282|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
27511641|NCT02803580|80066283|FG000|Overall Study|Death|13|||
27511642|NCT02803580|80066283|FG000|Overall Study|Lost to Follow-up|19|||
27511643|NCT02803580|80066283|FG000|Overall Study|Withdrawal by Subject|3|||
27511644|NCT02803580|80066283|FG000|Overall Study|Inclusion in clinical trial|1|||
27511645|NCT01544335|80066284|FG000|Overall Study|Lost to Follow-up|27|||
27511646|NCT01544335|80066284|FG000|Overall Study|Death|4|||
27511647|NCT01544335|80066284|FG000|Overall Study|Disease progression|3|||
27511648|NCT01544335|80066284|FG000|Overall Study|Baseline Measurements not Available|19|||
27511649|NCT04555616|80066285|FG000|Overall Study|Death|1|||
27511650|NCT04555616|80066286|FG001|Overall Study|Death|0|||
27511651|NCT04555616|80066287|FG002|Overall Study|Death|1|||
27511652|NCT04555616|80066285|FG000|Overall Study|Withdrawal by Subject|2|||
27511653|NCT04555616|80066286|FG001|Overall Study|Withdrawal by Subject|1|||
27511654|NCT04555616|80066287|FG002|Overall Study|Withdrawal by Subject|0|||
27511655|NCT00670748|80066288|FG000|Overall Study|Death during treatment|1|||
27511656|NCT00670748|80066289|FG001|Overall Study|Death during treatment|1|||
27511657|NCT00670748|80066290|FG002|Overall Study|Death during treatment|1|||
27511658|NCT00670748|80066291|FG003|Overall Study|Death during treatment|0|||
27511659|NCT00670748|80066288|FG000|Overall Study|Not off study|2|||
27511660|NCT00670748|80066289|FG001|Overall Study|Not off study|1|||
27511661|NCT00670748|80066290|FG002|Overall Study|Not off study|1|||
27511662|NCT00670748|80066291|FG003|Overall Study|Not off study|1|||
27511663|NCT02624986|80066292|FG000|Overall Study|Death|0|||
27511664|NCT02624986|80066293|FG001|Overall Study|Death|1|||
27511665|NCT02624986|80066294|FG002|Overall Study|Death|2|||
27511666|NCT02624986|80066295|FG003|Overall Study|Death|2|||
27511667|NCT02624986|80066296|FG004|Overall Study|Death|2|||
27511668|NCT02624986|80066297|FG005|Overall Study|Death|0|||
27511669|NCT02624986|80066298|FG006|Overall Study|Death|0|||
27511670|NCT02624986|80066299|FG007|Overall Study|Death|1|||
27511671|NCT02624986|80066292|FG000|Overall Study|Study Terminated by Sponsor|1|||
27511672|NCT02624986|80066293|FG001|Overall Study|Study Terminated by Sponsor|1|||
27511673|NCT02624986|80066294|FG002|Overall Study|Study Terminated by Sponsor|0|||
27511674|NCT02624986|80066295|FG003|Overall Study|Study Terminated by Sponsor|1|||
27511675|NCT02624986|80066296|FG004|Overall Study|Study Terminated by Sponsor|2|||
27511676|NCT02624986|80066297|FG005|Overall Study|Study Terminated by Sponsor|2|||
27511677|NCT02624986|80066298|FG006|Overall Study|Study Terminated by Sponsor|4|||
27511678|NCT02624986|80066299|FG007|Overall Study|Study Terminated by Sponsor|3|||
27511679|NCT02624986|80066292|FG000|Overall Study|Progressive Disease|0|||
27511680|NCT02624986|80066293|FG001|Overall Study|Progressive Disease|1|||
27511681|NCT02624986|80066294|FG002|Overall Study|Progressive Disease|0|||
27511682|NCT02624986|80066295|FG003|Overall Study|Progressive Disease|0|||
27511683|NCT02624986|80066296|FG004|Overall Study|Progressive Disease|0|||
27511684|NCT02624986|80066297|FG005|Overall Study|Progressive Disease|0|||
27511685|NCT02624986|80066298|FG006|Overall Study|Progressive Disease|0|||
27511686|NCT02624986|80066299|FG007|Overall Study|Progressive Disease|0|||
27852938|NCT02749292|81291268|FG001|Overall Study|Withdrawal by Subject|7|||
27511687|NCT02624986|80066292|FG000|Overall Study|Protocol Violation|1|||
27511688|NCT02624986|80066293|FG001|Overall Study|Protocol Violation|0|||
27511689|NCT02624986|80066294|FG002|Overall Study|Protocol Violation|0|||
27511690|NCT02624986|80066295|FG003|Overall Study|Protocol Violation|0|||
27511691|NCT02624986|80066296|FG004|Overall Study|Protocol Violation|0|||
27511692|NCT02624986|80066297|FG005|Overall Study|Protocol Violation|0|||
27511693|NCT02624986|80066298|FG006|Overall Study|Protocol Violation|0|||
27511694|NCT02624986|80066299|FG007|Overall Study|Protocol Violation|0|||
27511695|NCT02624986|80066292|FG000|Overall Study|Withdrawal by Subject|0|||
27511696|NCT02624986|80066293|FG001|Overall Study|Withdrawal by Subject|0|||
27511697|NCT02624986|80066294|FG002|Overall Study|Withdrawal by Subject|0|||
27511698|NCT02624986|80066295|FG003|Overall Study|Withdrawal by Subject|0|||
27511699|NCT02624986|80066296|FG004|Overall Study|Withdrawal by Subject|0|||
27511700|NCT02624986|80066297|FG005|Overall Study|Withdrawal by Subject|0|||
27511701|NCT02624986|80066298|FG006|Overall Study|Withdrawal by Subject|0|||
27511702|NCT02624986|80066299|FG007|Overall Study|Withdrawal by Subject|1|||
27511703|NCT01106248|80066300|FG000|Overall Study|Adverse Event|1|||
27511704|NCT01106248|80066300|FG000|Overall Study|Administrative|2|||
27511705|NCT03763877|80066303|FG000|Overall Study|Withdrawal by Subject|3|||
27511706|NCT03763877|80066304|FG001|Overall Study|Withdrawal by Subject|1|||
27511707|NCT03763877|80066305|FG002|Overall Study|Withdrawal by Subject|3|||
27511708|NCT03763877|80066306|FG003|Overall Study|Withdrawal by Subject|4|||
27511709|NCT03763877|80066303|FG000|Overall Study|Adverse Event|1|||
27511710|NCT03763877|80066304|FG001|Overall Study|Adverse Event|1|||
27511711|NCT03763877|80066305|FG002|Overall Study|Adverse Event|3|||
27511712|NCT03763877|80066306|FG003|Overall Study|Adverse Event|1|||
27511713|NCT03763877|80066303|FG000|Overall Study|Protocol Violation|1|||
27511714|NCT03763877|80066304|FG001|Overall Study|Protocol Violation|1|||
27511715|NCT03763877|80066305|FG002|Overall Study|Protocol Violation|0|||
27511716|NCT03763877|80066306|FG003|Overall Study|Protocol Violation|0|||
27511717|NCT03763877|80066303|FG000|Overall Study|Lost to Follow-up|0|||
27511718|NCT03763877|80066304|FG001|Overall Study|Lost to Follow-up|1|||
27511719|NCT03763877|80066305|FG002|Overall Study|Lost to Follow-up|1|||
27511720|NCT03763877|80066306|FG003|Overall Study|Lost to Follow-up|0|||
27511721|NCT02346721|80066312|FG000|Overall Study|Withdrew Consent|3|||
27511722|NCT02346721|80066312|FG000|Overall Study|Lack of Efficacy|1|||
27852939|NCT02749292|81291267|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
27905909|NCT00572455|81493255|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
27905910|NCT00572455|81493256|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
27905911|NCT00572455|81493257|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
27905912|NCT00572455|81493258|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
27905913|NCT00572455|81493259|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
27905914|NCT00572455|81493260|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
27905915|NCT02187029|81493264|FG000|Overall Study|Adverse Event|0|||
27905916|NCT02187029|81493265|FG001|Overall Study|Adverse Event|1|||
27905917|NCT02187029|81493266|FG002|Overall Study|Adverse Event|1|||
27905918|NCT02187029|81493267|FG003|Overall Study|Adverse Event|0|||
27905919|NCT02187029|81493264|FG000|Overall Study|Study Terminated by Sponsor|0|||
27905920|NCT02187029|81493265|FG001|Overall Study|Study Terminated by Sponsor|0|||
27905921|NCT02187029|81493266|FG002|Overall Study|Study Terminated by Sponsor|10|||
27905922|NCT02187029|81493267|FG003|Overall Study|Study Terminated by Sponsor|3|||
27905923|NCT02187029|81493264|FG000|Overall Study|Withdrawal by Subject|1|||
27905924|NCT02187029|81493265|FG001|Overall Study|Withdrawal by Subject|0|||
27905925|NCT02187029|81493266|FG002|Overall Study|Withdrawal by Subject|0|||
27905926|NCT02187029|81493267|FG003|Overall Study|Withdrawal by Subject|0|||
27905927|NCT03883477|81493268|FG000|Overall Study|Death|1|||
27905928|NCT03883477|81493269|FG001|Overall Study|Death|0|||
27905929|NCT03883477|81493268|FG000|Overall Study|Protocol Violation|0|||
27905930|NCT03883477|81493269|FG001|Overall Study|Protocol Violation|1|||
27905931|NCT03754972|81493271|FG000|Overall Study|Protocol Violation|25|||
27905932|NCT03859648|81493272|FG000|Overall Study|Lost to Follow-up|1|||
27905933|NCT03859648|81493272|FG000|Overall Study|Adverse Event|1|||
27905934|NCT00548249|81493273|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
27905935|NCT00548249|81493274|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
27905936|NCT00548249|81493275|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
27905937|NCT00548249|81493276|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
27905938|NCT00548249|81493277|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
27852940|NCT02749292|81291268|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
27852941|NCT02749292|81291267|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
27852942|NCT02749292|81291268|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
27852943|NCT02749292|81291267|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
27852944|NCT02749292|81291268|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
27852945|NCT02749292|81291267|FG000|Overall Study|Adverse Event|4|||
27852946|NCT02749292|81291268|FG001|Overall Study|Adverse Event|1|||
27852947|NCT02749292|81291267|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
27905939|NCT00548249|81493273|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
27905940|NCT00548249|81493274|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
27905941|NCT00548249|81493275|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
27905942|NCT00548249|81493276|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
27511723|NCT01039376|80066313|FG000|Overall Study|Lost to Follow-up|5|||
27511724|NCT01039376|80066314|FG001|Overall Study|Lost to Follow-up|12|||
27511725|NCT01039376|80066313|FG000|Overall Study|Physician Decision|15|||
27511726|NCT01039376|80066314|FG001|Overall Study|Physician Decision|10|||
27905943|NCT00548249|81493277|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
27905944|NCT00548249|81493273|FG000|Overall Study|Protocol Violation|1|||
27905945|NCT00548249|81493274|FG001|Overall Study|Protocol Violation|1|||
27511727|NCT01039376|80066313|FG000|Overall Study|Withdrawal by Subject|20|||
27511728|NCT01039376|80066314|FG001|Overall Study|Withdrawal by Subject|32|||
27511729|NCT01039376|80066313|FG000|Overall Study|Study terminated by Sponsor|90|||
27511730|NCT01039376|80066314|FG001|Overall Study|Study terminated by Sponsor|72|||
27905946|NCT00548249|81493275|FG002|Overall Study|Protocol Violation|4|||
27905947|NCT00548249|81493276|FG003|Overall Study|Protocol Violation|0|||
27905948|NCT00548249|81493277|FG004|Overall Study|Protocol Violation|3|||
27905949|NCT00548249|81493273|FG000|Overall Study|Miscellaneous|2|||
27905950|NCT00548249|81493274|FG001|Overall Study|Miscellaneous|3|||
27905951|NCT00548249|81493275|FG002|Overall Study|Miscellaneous|2|||
27905952|NCT00548249|81493276|FG003|Overall Study|Miscellaneous|0|||
27905953|NCT00548249|81493277|FG004|Overall Study|Miscellaneous|2|||
27905954|NCT00548249|81493273|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
27905955|NCT00548249|81493274|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
27905956|NCT00548249|81493275|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
27905957|NCT00548249|81493276|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
27905958|NCT00548249|81493277|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
27905959|NCT00548249|81493273|FG000|Overall Study|Adverse Event|2|||
27905960|NCT00548249|81493274|FG001|Overall Study|Adverse Event|2|||
27905961|NCT00548249|81493275|FG002|Overall Study|Adverse Event|0|||
27905962|NCT00548249|81493276|FG003|Overall Study|Adverse Event|1|||
27905963|NCT00548249|81493277|FG004|Overall Study|Adverse Event|1|||
27905964|NCT00548249|81493273|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
27905965|NCT00548249|81493274|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
27905966|NCT00548249|81493275|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
27905967|NCT00548249|81493276|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
27905968|NCT00548249|81493277|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
27905969|NCT00548249|81493273|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
27852948|NCT02749292|81291268|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
27852949|NCT02749292|81291267|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
27852950|NCT02749292|81291268|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
27852951|NCT02749292|81291267|FG000|Overall Study|Requiring glucocorticoids|0|||
27852952|NCT02749292|81291268|FG001|Overall Study|Requiring glucocorticoids|3|||
27852953|NCT02749292|81291267|FG000|Overall Study|Cancer|1|||
27852954|NCT02749292|81291268|FG001|Overall Study|Cancer|0|||
27852955|NCT04430855|81291277|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
27852956|NCT04430855|81291278|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
27852957|NCT04430855|81291277|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
27852958|NCT04430855|81291278|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
27852959|NCT04430855|81291277|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
27852960|NCT04430855|81291278|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
27511731|NCT01209689|80066316|FG000|Overall Study|Insufficient Therapeutic Response|7|||
27852961|NCT04430855|81291277|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
27852962|NCT04430855|81291278|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
27905970|NCT00548249|81493274|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
27905971|NCT00548249|81493275|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
27905972|NCT00548249|81493276|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
27905973|NCT00548249|81493277|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
27905974|NCT00548249|81493273|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
27905975|NCT00548249|81493274|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
27905976|NCT00548249|81493275|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
27905977|NCT00548249|81493276|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
27905978|NCT00548249|81493277|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
27905979|NCT00548249|81493273|FG000|Overall Study|Prolonged hospitalization|0|||
27905980|NCT00548249|81493274|FG001|Overall Study|Prolonged hospitalization|0|||
27905981|NCT00548249|81493275|FG002|Overall Study|Prolonged hospitalization|2|||
27905982|NCT00548249|81493276|FG003|Overall Study|Prolonged hospitalization|1|||
27905983|NCT00548249|81493277|FG004|Overall Study|Prolonged hospitalization|0|||
27905984|NCT00548249|81493273|FG000|Overall Study|Withdrawal by Subject|2|||
27905985|NCT00548249|81493274|FG001|Overall Study|Withdrawal by Subject|0|||
27905986|NCT00548249|81493275|FG002|Overall Study|Withdrawal by Subject|0|||
27905987|NCT00548249|81493276|FG003|Overall Study|Withdrawal by Subject|0|||
27905988|NCT00548249|81493277|FG004|Overall Study|Withdrawal by Subject|0|||
27905989|NCT00548249|81493273|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
27905990|NCT00548249|81493274|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
27905991|NCT00548249|81493275|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
27905992|NCT00548249|81493276|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
27905993|NCT00548249|81493277|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
27905994|NCT00548249|81493273|FG000|Overall Study|Sponsor's request|0|||
27905995|NCT00548249|81493274|FG001|Overall Study|Sponsor's request|0|||
27905996|NCT00548249|81493275|FG002|Overall Study|Sponsor's request|0|||
27905997|NCT00548249|81493276|FG003|Overall Study|Sponsor's request|1|||
27905998|NCT00548249|81493277|FG004|Overall Study|Sponsor's request|0|||
27905999|NCT01121536|81493278|FG000|Overall Study|Adverse Event|63|||
27906000|NCT01121536|81493278|FG000|Overall Study|Lack of Efficacy|35|||
27906001|NCT01121536|81493278|FG000|Overall Study|Withdrawal by Subject|65|||
27906002|NCT01121536|81493278|FG000|Overall Study|Protocol Violation|20|||
27906003|NCT01121536|81493278|FG000|Overall Study|Noncompliance with study medication|12|||
27906004|NCT01121536|81493278|FG000|Overall Study|Noncompliance with study procedures|9|||
27906005|NCT01121536|81493278|FG000|Overall Study|Lost to Follow-up|39|||
27906006|NCT01121536|81493278|FG000|Overall Study|Other|118|||
27906007|NCT01641471|81493281|FG000|Overall Study|Withdrawal by Subject|19|||
27906008|NCT01641471|81493282|FG001|Overall Study|Withdrawal by Subject|19|||
27906009|NCT01641471|81493281|FG000|Overall Study|Lost to Follow-up|2|||
27906010|NCT01641471|81493282|FG001|Overall Study|Lost to Follow-up|4|||
27906011|NCT01641471|81493281|FG000|Overall Study|Protocol Violation|2|||
27906012|NCT01641471|81493282|FG001|Overall Study|Protocol Violation|4|||
27906013|NCT03762681|81493283|FG000|Part 1|Withdrawal by Subject|0|||
27906014|NCT03762681|81493284|FG001|Part 1|Withdrawal by Subject|0|||
27906015|NCT03762681|81493285|FG002|Part 1|Withdrawal by Subject|0|||
27906016|NCT03762681|81493286|FG003|Part 1|Withdrawal by Subject|1|||
27615086|NCT04908683|80430400|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
27906017|NCT03762681|81493287|FG004|Part 1|Withdrawal by Subject|0|||
27511732|NCT01209689|80066317|FG001|Overall Study|Insufficient Therapeutic Response|2|||
27511733|NCT01209689|80066316|FG000|Overall Study|Refused Treatment|8|||
27511734|NCT01209689|80066317|FG001|Overall Study|Refused Treatment|3|||
27511735|NCT01209689|80066316|FG000|Overall Study|Adverse Event|4|||
27511736|NCT01209689|80066317|FG001|Overall Study|Adverse Event|0|||
27511737|NCT01209689|80066316|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
27511738|NCT01209689|80066317|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
27511739|NCT01209689|80066316|FG000|Overall Study|Failure to Return|3|||
27511740|NCT01209689|80066317|FG001|Overall Study|Failure to Return|0|||
27511741|NCT01209689|80066316|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
27511742|NCT01209689|80066317|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
27615087|NCT04908683|80430399|FG000|Overall Study|Protocol Violation|2|||
27615088|NCT04908683|80430400|FG001|Overall Study|Protocol Violation|0|||
27615089|NCT04908683|80430399|FG000|Overall Study|Withdrawal by Subject|1188|||
27615090|NCT04908683|80430400|FG001|Overall Study|Withdrawal by Subject|570|||
27615091|NCT04908683|80430399|FG000|Overall Study|Site Closure by Sponsor|6|||
27615092|NCT04908683|80430400|FG001|Overall Study|Site Closure by Sponsor|3|||
27615093|NCT04908683|80430399|FG000|Overall Study|Adverse Event|21|||
27615094|NCT04908683|80430400|FG001|Overall Study|Adverse Event|11|||
27615095|NCT04908683|80430399|FG000|Overall Study|Death|101|||
27615096|NCT04908683|80430400|FG001|Overall Study|Death|61|||
27615097|NCT04908683|80430399|FG000|Overall Study|Sponsor's decision|14398|||
27615098|NCT04908683|80430400|FG001|Overall Study|Sponsor's decision|7205|||
27906018|NCT03762681|81493288|FG005|Part 1|Withdrawal by Subject|0|||
27906019|NCT03762681|81493289|FG006|Part 1|Withdrawal by Subject|0|||
27906020|NCT03762681|81493290|FG007|Part 1|Withdrawal by Subject|0|||
27906021|NCT03762681|81493283|FG000|Part 2a|Pandemic Travel Restrictions|0|||
27906022|NCT03762681|81493284|FG001|Part 2a|Pandemic Travel Restrictions|0|||
27906023|NCT03762681|81493285|FG002|Part 2a|Pandemic Travel Restrictions|0|||
27906024|NCT03762681|81493286|FG003|Part 2a|Pandemic Travel Restrictions|0|||
27906025|NCT03762681|81493287|FG004|Part 2a|Pandemic Travel Restrictions|0|||
27906026|NCT03762681|81493288|FG005|Part 2a|Pandemic Travel Restrictions|0|||
27906027|NCT03762681|81493289|FG006|Part 2a|Pandemic Travel Restrictions|0|||
27906028|NCT03762681|81493290|FG007|Part 2a|Pandemic Travel Restrictions|1|||
27906029|NCT01342445|81493292|FG000|Overall Study|Experienced side effects|0|||
27906030|NCT01342445|81493293|FG001|Overall Study|Experienced side effects|2|||
27906031|NCT01502033|81493294|FG000|Overall Study|1 participant had scalp discomfort|1|||
27906032|NCT01502033|81493294|FG000|Overall Study|1 participant had worsening depression|1|||
27906033|NCT01502033|81493294|FG000|Overall Study|1 participant went back to school|1|||
27906034|NCT00632125|81493295|FG000|Overall Study|Death|82|||
27906035|NCT00632125|81493295|FG000|Overall Study|Withdrawal by Subject|44|||
27906036|NCT00632125|81493295|FG000|Overall Study|Adverse Event|36|||
27906037|NCT00632125|81493295|FG000|Overall Study|Renal transplantation|17|||
27906038|NCT00632125|81493295|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
27906039|NCT00632125|81493295|FG000|Overall Study|Non-compliance|8|||
27511743|NCT02141204|80066318|FG000|Overall Study|Lost to Follow-up|2|||
27511744|NCT02141204|80066319|FG001|Overall Study|Lost to Follow-up|1|||
27615099|NCT04908683|80430399|FG000|Overall Study|Other|92|||
27615100|NCT04908683|80430400|FG001|Overall Study|Other|50|||
27906040|NCT00632125|81493295|FG000|Overall Study|Development of uncontrolled hypertension|5|||
27615101|NCT04908683|80430399|FG000|Overall Study|Randomized not vaccinated|108|||
27615102|NCT04908683|80430400|FG001|Overall Study|Randomized not vaccinated|52|||
27615103|NCT03929913|80430404|FG000|Overall Study|Death|4|||
27728621|NCT00804687|80833339|FG002|Period 5: Treatment Period|Positive drug test|0|||
27728622|NCT00804687|80833340|FG003|Period 5: Treatment Period|Positive drug test|0|||
27728623|NCT00804687|80833341|FG004|Period 5: Treatment Period|Positive drug test|0|||
27728624|NCT00804687|80833342|FG005|Period 5: Treatment Period|Positive drug test|0|||
27728625|NCT00331006|80833344|FG000|Screening Phase|Withdrawal by Subject|1|||
27728626|NCT00331006|80833344|FG000|Screening Phase|enrollment halted|1|||
27728627|NCT00331006|80833344|FG000|Screening Phase|Lost to Follow-up|1|||
27852963|NCT04430855|81291277|FG000|Period 1 (Weeks 1-12)|Other|0|||
27728628|NCT00331006|80833344|FG000|Screening Phase|Ineligible for treatment phase|4|||
27852964|NCT04430855|81291278|FG001|Period 1 (Weeks 1-12)|Other|1|||
27852965|NCT04430855|81291277|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
27852966|NCT04430855|81291278|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
27852967|NCT04430855|81291277|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
27852968|NCT04430855|81291278|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
27852969|NCT04430855|81291277|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
27852970|NCT04430855|81291278|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
27852971|NCT00759902|81291281|FG000|Overall Study|Adverse Event|0|||
27852972|NCT00759902|81291282|FG001|Overall Study|Adverse Event|1|||
27852973|NCT01970865|81291284|FG000|Overall Study|Death|3|||
27852974|NCT01970865|81291285|FG001|Overall Study|Death|2|||
27852975|NCT01970865|81291286|FG002|Overall Study|Death|3|||
27852976|NCT01970865|81291287|FG003|Overall Study|Death|6|||
27511745|NCT02141204|80066318|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
27511746|NCT02141204|80066319|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
27511747|NCT02141204|80066318|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
27511748|NCT02141204|80066319|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
27511749|NCT02141204|80066318|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
27511750|NCT02141204|80066319|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
27511751|NCT03339219|80066320|FG000|Overall Study|Death|12|||
27511752|NCT03339219|80066320|FG000|Overall Study|Site Terminated by Sponsor|22|||
27511753|NCT03339219|80066320|FG000|Overall Study|Withdrawal by Subject|1|||
27511754|NCT01587924|80066321|FG000|Overall Study|Adverse Event|0|||
27511755|NCT01587924|80066322|FG001|Overall Study|Adverse Event|2|||
27511756|NCT01587924|80066323|FG002|Overall Study|Adverse Event|0|||
27511757|NCT01587924|80066324|FG003|Overall Study|Adverse Event|0|||
27511758|NCT01587924|80066321|FG000|Overall Study|Protocol Violation|2|||
27511759|NCT01587924|80066322|FG001|Overall Study|Protocol Violation|1|||
27511760|NCT01587924|80066323|FG002|Overall Study|Protocol Violation|2|||
27511761|NCT01587924|80066324|FG003|Overall Study|Protocol Violation|1|||
27511762|NCT01587924|80066321|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
27511763|NCT01587924|80066322|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
27511764|NCT01587924|80066323|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
27511765|NCT01587924|80066324|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
27511766|NCT01587924|80066321|FG000|Overall Study|Withdrawal by Subject|0|||
27511767|NCT01587924|80066322|FG001|Overall Study|Withdrawal by Subject|1|||
27511768|NCT01587924|80066323|FG002|Overall Study|Withdrawal by Subject|1|||
27511769|NCT01587924|80066324|FG003|Overall Study|Withdrawal by Subject|0|||
27511770|NCT01657019|80066331|FG000|Overall Study|Withdrawal by Subject|65|||
27511771|NCT01657019|80066331|FG000|Overall Study|Adverse Event|55|||
27511772|NCT01657019|80066331|FG000|Overall Study|Lost to Follow-up|48|||
27511773|NCT01657019|80066331|FG000|Overall Study|Protocol Violation|6|||
27511774|NCT01657019|80066331|FG000|Overall Study|Lack of Efficacy|3|||
27511775|NCT01657019|80066331|FG000|Overall Study|Other|58|||
27511776|NCT00853567|80066338|FG000|Overall Study|Study prematurely terminated|71|||
27511777|NCT02640508|80066340|FG000|Overall Study|Death|19|||
27511778|NCT02640508|80066340|FG000|Overall Study|Withdrawal by Subject|8|||
27511779|NCT02640508|80066340|FG000|Overall Study|Physician Decision|1|||
27615104|NCT03929913|80430404|FG000|Overall Study|Lost to Follow-up|1|||
27511780|NCT02640508|80066340|FG000|Overall Study|Lost to Follow-up|1|||
27511781|NCT02533453|80066343|FG000|Overall Study|Adverse Event|6|||
27615105|NCT03929913|80430404|FG000|Overall Study|Failed Procedure|2|||
27511782|NCT02533453|80066343|FG000|Overall Study|Protocol Violation|1|||
27511783|NCT02533453|80066343|FG000|Overall Study|Withdrawal by Subject|2|||
27511784|NCT00357552|80066344|FG000|Screening|Did not meet eligibility criteria|84|||
27511785|NCT00357552|80066344|FG000|Weeks 0 to 24|Death|1|||
27511786|NCT00357552|80066344|FG000|Weeks 24 to 104|Death|3|||
27511787|NCT00357552|80066344|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
27511788|NCT03179319|80066348|FG000|Overall Study|Lost to Follow-up|6|||
27511789|NCT03179319|80066349|FG001|Overall Study|Lost to Follow-up|0|||
27511790|NCT02351856|80066363|FG000|Overall Study|Adverse Event|2|||
27511791|NCT02351856|80066363|FG000|Overall Study|Physician Decision|5|||
27511792|NCT02351856|80066363|FG000|Overall Study|Study terminated by sponsor|1|||
27511793|NCT01936870|80066364|FG000|Overall Study|No Visit After Treatment|176|||
27511794|NCT01936870|80066364|FG000|Overall Study|Protocol Violation|12|||
27511795|NCT01936870|80066364|FG000|Overall Study|No Drug Administration|1|||
27511796|NCT02157883|80066367|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
27511797|NCT02157883|80066367|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
27511798|NCT02157883|80066367|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
27511799|NCT02157883|80066367|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
27511800|NCT02157883|80066367|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
27511801|NCT04294680|80066370|FG000|Overall Study|Withdrawal by Subject|2|||
27511802|NCT04294680|80066371|FG001|Overall Study|Withdrawal by Subject|1|||
27511803|NCT04294680|80066370|FG000|Overall Study|Follow-up visits completed outside of window|1|||
27511804|NCT04294680|80066371|FG001|Overall Study|Follow-up visits completed outside of window|0|||
27511805|NCT00934362|80066374|FG000|Overall Study|Adverse Event|1|||
27511806|NCT00934362|80066375|FG001|Overall Study|Adverse Event|0|||
27511807|NCT00048074|80066376|FG000|Overall Study|Adverse Event|46|||
27511808|NCT00048074|80066377|FG001|Overall Study|Adverse Event|41|||
27511809|NCT00048074|80066378|FG002|Overall Study|Adverse Event|53|||
27511810|NCT00048074|80066376|FG000|Overall Study|Death|3|||
27511811|NCT00048074|80066377|FG001|Overall Study|Death|3|||
27511812|NCT00048074|80066378|FG002|Overall Study|Death|2|||
27511813|NCT00048074|80066376|FG000|Overall Study|Lost to Follow-up|2|||
27511814|NCT00048074|80066377|FG001|Overall Study|Lost to Follow-up|6|||
27511815|NCT00048074|80066378|FG002|Overall Study|Lost to Follow-up|6|||
27511816|NCT00048074|80066376|FG000|Overall Study|Withdrawal by Subject|28|||
27511817|NCT00048074|80066377|FG001|Overall Study|Withdrawal by Subject|30|||
27511818|NCT00048074|80066378|FG002|Overall Study|Withdrawal by Subject|35|||
27511819|NCT00048074|80066376|FG000|Overall Study|Protocol Violation|1|||
27511820|NCT00048074|80066377|FG001|Overall Study|Protocol Violation|3|||
27511821|NCT00048074|80066378|FG002|Overall Study|Protocol Violation|0|||
27511822|NCT00048074|80066376|FG000|Overall Study|Study participation was terminated|0|||
27511823|NCT00048074|80066377|FG001|Overall Study|Study participation was terminated|1|||
27511824|NCT00048074|80066378|FG002|Overall Study|Study participation was terminated|0|||
27511825|NCT00048074|80066376|FG000|Overall Study|Husband ill|0|||
27511826|NCT00048074|80066377|FG001|Overall Study|Husband ill|1|||
27511827|NCT00048074|80066378|FG002|Overall Study|Husband ill|0|||
27511828|NCT00048074|80066376|FG000|Overall Study|Poor compliance|0|||
27511829|NCT00048074|80066377|FG001|Overall Study|Poor compliance|1|||
27511830|NCT00048074|80066378|FG002|Overall Study|Poor compliance|0|||
27511831|NCT00048074|80066376|FG000|Overall Study|Out of station|0|||
27511832|NCT00048074|80066377|FG001|Overall Study|Out of station|1|||
27511833|NCT00048074|80066378|FG002|Overall Study|Out of station|1|||
27511834|NCT00048074|80066376|FG000|Overall Study|Social reasons|1|||
27511835|NCT00048074|80066377|FG001|Overall Study|Social reasons|0|||
27511836|NCT00048074|80066378|FG002|Overall Study|Social reasons|0|||
27511837|NCT03894813|80066381|FG000|Overall Study|Adverse Event|1|||
27511838|NCT03894813|80066382|FG001|Overall Study|Adverse Event|1|||
27511839|NCT03894813|80066381|FG000|Overall Study|Lack of Efficacy|3|||
27511840|NCT03894813|80066382|FG001|Overall Study|Lack of Efficacy|3|||
27511841|NCT03894813|80066381|FG000|Overall Study|Lost to Follow-up|1|||
27511842|NCT03894813|80066382|FG001|Overall Study|Lost to Follow-up|0|||
27511843|NCT03894813|80066381|FG000|Overall Study|Pregnancy|2|||
27511844|NCT03894813|80066382|FG001|Overall Study|Pregnancy|1|||
27511845|NCT03894813|80066381|FG000|Overall Study|Protocol Violation|3|||
27511846|NCT03894813|80066382|FG001|Overall Study|Protocol Violation|7|||
27852977|NCT01970865|81291288|FG004|Overall Study|Death|9|||
27852978|NCT01970865|81291289|FG005|Overall Study|Death|3|||
27852979|NCT01970865|81291290|FG006|Overall Study|Death|2|||
27906041|NCT00632125|81493295|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
27906042|NCT00272844|81493296|FG000|Overall Study|Withdrawal by Subject|5|||
27906043|NCT00660595|81493299|FG000|Overall Study|Lost to Follow-up|0|||
27511847|NCT03894813|80066381|FG000|Overall Study|Withdrawal by Subject|1|||
27511848|NCT03894813|80066382|FG001|Overall Study|Withdrawal by Subject|3|||
27511849|NCT03894813|80066381|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
27511850|NCT03894813|80066382|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
27511851|NCT02453711|80066385|FG000|Overall Study|Withdrawal by Subject|5|||
27511852|NCT02453711|80066386|FG001|Overall Study|Withdrawal by Subject|4|||
27511853|NCT02453711|80066387|FG002|Overall Study|Withdrawal by Subject|6|||
27511854|NCT02453711|80066388|FG003|Overall Study|Withdrawal by Subject|4|||
27511855|NCT02453711|80066389|FG004|Overall Study|Withdrawal by Subject|1|||
27511856|NCT02453711|80066390|FG005|Overall Study|Withdrawal by Subject|1|||
27511857|NCT02453711|80066391|FG006|Overall Study|Withdrawal by Subject|0|||
27511858|NCT02453711|80066392|FG007|Overall Study|Withdrawal by Subject|1|||
27511859|NCT02453711|80066393|FG008|Overall Study|Withdrawal by Subject|7|||
27511860|NCT02453711|80066385|FG000|Overall Study|Lost to Follow-up|5|||
27511861|NCT02453711|80066386|FG001|Overall Study|Lost to Follow-up|3|||
27511862|NCT02453711|80066387|FG002|Overall Study|Lost to Follow-up|2|||
27511863|NCT02453711|80066388|FG003|Overall Study|Lost to Follow-up|3|||
27511864|NCT02453711|80066389|FG004|Overall Study|Lost to Follow-up|1|||
27511865|NCT02453711|80066390|FG005|Overall Study|Lost to Follow-up|5|||
27511866|NCT02453711|80066391|FG006|Overall Study|Lost to Follow-up|2|||
27511867|NCT02453711|80066392|FG007|Overall Study|Lost to Follow-up|6|||
27511868|NCT02453711|80066393|FG008|Overall Study|Lost to Follow-up|6|||
27511869|NCT02453711|80066385|FG000|Overall Study|Death|0|||
27511870|NCT02453711|80066386|FG001|Overall Study|Death|0|||
27511871|NCT02453711|80066387|FG002|Overall Study|Death|0|||
27511872|NCT02453711|80066388|FG003|Overall Study|Death|0|||
27511873|NCT02453711|80066389|FG004|Overall Study|Death|0|||
27511874|NCT02453711|80066390|FG005|Overall Study|Death|0|||
27511875|NCT02453711|80066391|FG006|Overall Study|Death|1|||
27511876|NCT02453711|80066392|FG007|Overall Study|Death|0|||
27511877|NCT02453711|80066393|FG008|Overall Study|Death|0|||
27511878|NCT02453711|80066385|FG000|Overall Study|Unclassified|1|||
27511879|NCT02453711|80066386|FG001|Overall Study|Unclassified|0|||
27511880|NCT02453711|80066387|FG002|Overall Study|Unclassified|1|||
27511881|NCT02453711|80066388|FG003|Overall Study|Unclassified|0|||
27511882|NCT02453711|80066389|FG004|Overall Study|Unclassified|0|||
27511883|NCT02453711|80066390|FG005|Overall Study|Unclassified|0|||
27511884|NCT02453711|80066391|FG006|Overall Study|Unclassified|0|||
27511885|NCT02453711|80066392|FG007|Overall Study|Unclassified|0|||
27511886|NCT02453711|80066393|FG008|Overall Study|Unclassified|0|||
27511887|NCT02668393|80066394|FG000|Overall Study|Progressive disease|6|||
27511888|NCT02668393|80066395|FG001|Overall Study|Progressive disease|3|||
27511889|NCT02668393|80066394|FG000|Overall Study|Adverse Event|0|||
27511890|NCT02668393|80066395|FG001|Overall Study|Adverse Event|2|||
27511891|NCT02668393|80066394|FG000|Overall Study|Withdrawal from the trial|0|||
27511892|NCT02668393|80066395|FG001|Overall Study|Withdrawal from the trial|1|||
27511893|NCT02668393|80066394|FG000|Overall Study|Lack of benefit and side effects|1|||
27511894|NCT02668393|80066395|FG001|Overall Study|Lack of benefit and side effects|0|||
27511895|NCT02560558|80066398|FG000|Overall Study|Adverse Event|1|||
27511896|NCT02560558|80066399|FG001|Overall Study|Adverse Event|0|||
27511897|NCT02560558|80066398|FG000|Overall Study|Death|0|||
27511898|NCT02560558|80066399|FG001|Overall Study|Death|2|||
27511899|NCT02560558|80066398|FG000|Overall Study|Lost to Follow-up|0|||
27511900|NCT02560558|80066399|FG001|Overall Study|Lost to Follow-up|4|||
27511901|NCT02560558|80066398|FG000|Overall Study|Protocol Violation|3|||
27511902|NCT02560558|80066399|FG001|Overall Study|Protocol Violation|0|||
27511903|NCT02560558|80066398|FG000|Overall Study|Withdrawal by Subject|3|||
27511904|NCT02560558|80066399|FG001|Overall Study|Withdrawal by Subject|0|||
27511905|NCT00220636|80066400|FG000|Overall Study|Withdrawal by Subject|4|||
27511906|NCT01310075|80066401|FG000|Overall Study|Lost to Follow-up|1|||
27511907|NCT01310075|80066402|FG001|Overall Study|Lost to Follow-up|0|||
27511908|NCT01310075|80066401|FG000|Overall Study|Physician Decision|10|||
27511909|NCT01310075|80066402|FG001|Overall Study|Physician Decision|7|||
27511910|NCT01310075|80066401|FG000|Overall Study|Protocol Violation|2|||
27511911|NCT01310075|80066402|FG001|Overall Study|Protocol Violation|2|||
27511912|NCT01310075|80066401|FG000|Overall Study|Withdrawal by Subject|1|||
27511913|NCT01310075|80066402|FG001|Overall Study|Withdrawal by Subject|1|||
27511914|NCT00256997|80066403|FG000|Overall Study|Protocol Violation|1|||
27511915|NCT00256997|80066404|FG001|Overall Study|Protocol Violation|4|||
27511916|NCT00256997|80066403|FG000|Overall Study|Lack of Efficacy|1|||
27511917|NCT00256997|80066404|FG001|Overall Study|Lack of Efficacy|4|||
27615106|NCT00581113|80430406|FG000|Overall Study|Withdrawal by Subject|0|||
27511918|NCT00256997|80066403|FG000|Overall Study|Death|2|||
27511919|NCT00256997|80066404|FG001|Overall Study|Death|0|||
27511920|NCT00256997|80066403|FG000|Overall Study|Adverse Event|4|||
27511921|NCT00256997|80066404|FG001|Overall Study|Adverse Event|0|||
27511922|NCT00256997|80066403|FG000|Overall Study|Lost to Follow-up|3|||
27511923|NCT00256997|80066404|FG001|Overall Study|Lost to Follow-up|5|||
27511924|NCT00256997|80066403|FG000|Overall Study|Withdrawal by Subject|13|||
27511925|NCT00256997|80066404|FG001|Overall Study|Withdrawal by Subject|3|||
27511926|NCT00256997|80066403|FG000|Overall Study|Started but not treated|2|||
27511927|NCT00256997|80066404|FG001|Overall Study|Started but not treated|0|||
27511928|NCT00256997|80066403|FG000|Overall Study|Other|5|||
27511929|NCT00256997|80066404|FG001|Overall Study|Other|8|||
27511930|NCT00256997|80066403|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
27615107|NCT00581113|80430407|FG001|Overall Study|Withdrawal by Subject|1|||
27511931|NCT00256997|80066404|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
27511932|NCT00256997|80066403|FG000|Overall Study|Participant Non-compliant|3|||
27511933|NCT00256997|80066404|FG001|Overall Study|Participant Non-compliant|6|||
27511934|NCT00256997|80066403|FG000|Overall Study|Investigator Withdrew Participant|2|||
27511935|NCT00256997|80066404|FG001|Overall Study|Investigator Withdrew Participant|1|||
27511936|NCT04154189|80066405|FG000|Overall Study|Withdrawal by Subject|4|||
27511937|NCT04154189|80066406|FG001|Overall Study|Withdrawal by Subject|6|||
27511938|NCT04154189|80066405|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
27511939|NCT04154189|80066406|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
27511940|NCT04154189|80066405|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
27511941|NCT04154189|80066406|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
27511942|NCT04154189|80066405|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
27511943|NCT04154189|80066406|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
27511944|NCT04154189|80066405|FG000|Overall Study|Death|25|||
27615108|NCT00709592|80430408|FG000|Overall Study|Unable to proceed to transplant|0|||
27615109|NCT00709592|80430409|FG001|Overall Study|Unable to proceed to transplant|1|||
27615110|NCT01818141|80430410|FG000|Overall Study|Withdrawal by Subject|2|||
27615111|NCT01818141|80430411|FG001|Overall Study|Withdrawal by Subject|0|||
27615112|NCT01818141|80430410|FG000|Overall Study|No baseline C.diff colonies|1|||
27615113|NCT01818141|80430411|FG001|Overall Study|No baseline C.diff colonies|1|||
27615114|NCT01818141|80430410|FG000|Overall Study|Lost to Follow-up|0|||
27615115|NCT01818141|80430411|FG001|Overall Study|Lost to Follow-up|2|||
27615116|NCT02743793|80430416|FG000|Overall Study|Death|1|||
27615117|NCT02743793|80430417|FG001|Overall Study|Death|1|||
27615118|NCT02743793|80430416|FG000|Overall Study|Withdrawal by Subject|0|||
27615119|NCT02743793|80430417|FG001|Overall Study|Withdrawal by Subject|1|||
27615120|NCT02743793|80430416|FG000|Overall Study|Screen Failure|4|||
27615121|NCT02743793|80430417|FG001|Overall Study|Screen Failure|0|||
27615122|NCT02743793|80430416|FG000|Overall Study|No Primary Care Physician|0|||
27615123|NCT02743793|80430417|FG001|Overall Study|No Primary Care Physician|1|||
27615124|NCT02743793|80430416|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
27615125|NCT02743793|80430417|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
27615126|NCT02743793|80430416|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
27615127|NCT02743793|80430417|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
27615128|NCT04537897|80430421|FG000|Overall Study|Other than listed|0|||
27615129|NCT04537897|80430422|FG001|Overall Study|Other than listed|0|||
27615130|NCT04537897|80430423|FG002|Overall Study|Other than listed|0|||
27615131|NCT04537897|80430424|FG003|Overall Study|Other than listed|0|||
27615132|NCT04537897|80430425|FG004|Overall Study|Other than listed|0|||
27615133|NCT04537897|80430426|FG005|Overall Study|Other than listed|0|||
27615134|NCT04537897|80430427|FG006|Overall Study|Other than listed|1|||
27615135|NCT04537897|80430428|FG007|Overall Study|Other than listed|0|||
27615136|NCT04537897|80430429|FG008|Overall Study|Other than listed|0|||
27615137|NCT04537897|80430421|FG000|Overall Study|Adverse Event|0|||
27615138|NCT04537897|80430422|FG001|Overall Study|Adverse Event|0|||
27615139|NCT04537897|80430423|FG002|Overall Study|Adverse Event|0|||
27615140|NCT04537897|80430424|FG003|Overall Study|Adverse Event|1|||
27615141|NCT04537897|80430425|FG004|Overall Study|Adverse Event|0|||
27615142|NCT04537897|80430426|FG005|Overall Study|Adverse Event|0|||
27615143|NCT04537897|80430427|FG006|Overall Study|Adverse Event|0|||
27615144|NCT04537897|80430428|FG007|Overall Study|Adverse Event|0|||
27615145|NCT04537897|80430429|FG008|Overall Study|Adverse Event|0|||
27615146|NCT04537897|80430421|FG000|Overall Study|Withdrawal by Subject|0|||
27615147|NCT04537897|80430422|FG001|Overall Study|Withdrawal by Subject|1|||
27615148|NCT04537897|80430423|FG002|Overall Study|Withdrawal by Subject|0|||
27615149|NCT04537897|80430424|FG003|Overall Study|Withdrawal by Subject|0|||
27615150|NCT04537897|80430425|FG004|Overall Study|Withdrawal by Subject|0|||
27615151|NCT04537897|80430426|FG005|Overall Study|Withdrawal by Subject|0|||
27615152|NCT04537897|80430427|FG006|Overall Study|Withdrawal by Subject|0|||
27615153|NCT04537897|80430428|FG007|Overall Study|Withdrawal by Subject|0|||
27615154|NCT04537897|80430429|FG008|Overall Study|Withdrawal by Subject|0|||
27615155|NCT04867785|80430430|FG000|Overall Study|Adverse Event|1|||
27615156|NCT04867785|80430431|FG001|Overall Study|Adverse Event|0|||
27511945|NCT04154189|80066406|FG001|Overall Study|Death|25|||
27511946|NCT03962504|80066407|FG000|Overall Study|Other|11|||
27511947|NCT03962504|80066408|FG001|Overall Study|Other|32|||
27615157|NCT04867785|80430432|FG002|Overall Study|Adverse Event|1|||
27615158|NCT04867785|80430433|FG003|Overall Study|Adverse Event|0|||
27615159|NCT04867785|80430434|FG004|Overall Study|Adverse Event|0|||
27615160|NCT04867785|80430435|FG005|Overall Study|Adverse Event|0|||
27615161|NCT04867785|80430436|FG006|Overall Study|Adverse Event|0|||
27511948|NCT04816669|80066409|FG000|Part 1|Adverse Event|1|||
27511949|NCT04816669|80066410|FG001|Part 1|Adverse Event|1|||
27511950|NCT04816669|80066411|FG002|Part 1|Adverse Event|0|||
27511951|NCT04816669|80066412|FG003|Part 1|Adverse Event|0|||
27511952|NCT04816669|80066409|FG000|Part 1|Lost to Follow-up|2|||
27511953|NCT04816669|80066410|FG001|Part 1|Lost to Follow-up|2|||
27511954|NCT04816669|80066411|FG002|Part 1|Lost to Follow-up|0|||
27511955|NCT04816669|80066412|FG003|Part 1|Lost to Follow-up|0|||
27511956|NCT04816669|80066409|FG000|Part 1|Protocol Violation|0|||
27511957|NCT04816669|80066410|FG001|Part 1|Protocol Violation|1|||
27511958|NCT04816669|80066411|FG002|Part 1|Protocol Violation|0|||
27511959|NCT04816669|80066412|FG003|Part 1|Protocol Violation|0|||
27511960|NCT04816669|80066409|FG000|Part 1|Withdrawal by Subject|1|||
27511961|NCT04816669|80066410|FG001|Part 1|Withdrawal by Subject|2|||
27511962|NCT04816669|80066411|FG002|Part 1|Withdrawal by Subject|0|||
27511963|NCT04816669|80066412|FG003|Part 1|Withdrawal by Subject|0|||
27511964|NCT04816669|80066409|FG000|Part 2|Other|0|||
27511965|NCT04816669|80066410|FG001|Part 2|Other|0|||
27511966|NCT04816669|80066411|FG002|Part 2|Other|1|||
27511967|NCT04816669|80066412|FG003|Part 2|Other|0|||
27511968|NCT04816669|80066409|FG000|Part 2|Withdrawal by Subject|0|||
27511969|NCT04816669|80066410|FG001|Part 2|Withdrawal by Subject|0|||
27511970|NCT04816669|80066411|FG002|Part 2|Withdrawal by Subject|0|||
27511971|NCT04816669|80066412|FG003|Part 2|Withdrawal by Subject|1|||
27511972|NCT04816669|80066409|FG000|Part 2|Lost to Follow-up|0|||
27511973|NCT04816669|80066410|FG001|Part 2|Lost to Follow-up|0|||
27615162|NCT04867785|80430437|FG007|Overall Study|Adverse Event|2|||
27615163|NCT04867785|80430430|FG000|Overall Study|Lost to Follow-up|4|||
27615164|NCT04867785|80430431|FG001|Overall Study|Lost to Follow-up|4|||
27615165|NCT04867785|80430432|FG002|Overall Study|Lost to Follow-up|3|||
27615166|NCT04867785|80430433|FG003|Overall Study|Lost to Follow-up|2|||
27615167|NCT04867785|80430434|FG004|Overall Study|Lost to Follow-up|0|||
27615168|NCT04867785|80430435|FG005|Overall Study|Lost to Follow-up|1|||
27615169|NCT04867785|80430436|FG006|Overall Study|Lost to Follow-up|0|||
27615170|NCT04867785|80430437|FG007|Overall Study|Lost to Follow-up|1|||
27615171|NCT04867785|80430430|FG000|Overall Study|Withdrawal by Subject|6|||
27615172|NCT04867785|80430431|FG001|Overall Study|Withdrawal by Subject|2|||
27615173|NCT04867785|80430432|FG002|Overall Study|Withdrawal by Subject|2|||
27615174|NCT04867785|80430433|FG003|Overall Study|Withdrawal by Subject|1|||
27615175|NCT04867785|80430434|FG004|Overall Study|Withdrawal by Subject|2|||
27615176|NCT04867785|80430435|FG005|Overall Study|Withdrawal by Subject|0|||
27615177|NCT04867785|80430436|FG006|Overall Study|Withdrawal by Subject|2|||
27615178|NCT04867785|80430437|FG007|Overall Study|Withdrawal by Subject|5|||
27615179|NCT04867785|80430430|FG000|Overall Study|Physician Decision|0|||
27615180|NCT04867785|80430431|FG001|Overall Study|Physician Decision|0|||
27615181|NCT04867785|80430432|FG002|Overall Study|Physician Decision|0|||
27615182|NCT04867785|80430433|FG003|Overall Study|Physician Decision|0|||
27615183|NCT04867785|80430434|FG004|Overall Study|Physician Decision|0|||
27615184|NCT04867785|80430435|FG005|Overall Study|Physician Decision|0|||
27615185|NCT04867785|80430436|FG006|Overall Study|Physician Decision|0|||
27615186|NCT04867785|80430437|FG007|Overall Study|Physician Decision|1|||
27615187|NCT04867785|80430430|FG000|Overall Study|Inadvertent Enrollment|0|||
27615188|NCT04867785|80430431|FG001|Overall Study|Inadvertent Enrollment|0|||
27615189|NCT04867785|80430432|FG002|Overall Study|Inadvertent Enrollment|0|||
27615190|NCT04867785|80430433|FG003|Overall Study|Inadvertent Enrollment|1|||
27615191|NCT04867785|80430434|FG004|Overall Study|Inadvertent Enrollment|1|||
27615192|NCT04867785|80430435|FG005|Overall Study|Inadvertent Enrollment|0|||
27615193|NCT04867785|80430436|FG006|Overall Study|Inadvertent Enrollment|0|||
27615194|NCT04867785|80430437|FG007|Overall Study|Inadvertent Enrollment|1|||
27615195|NCT04867785|80430430|FG000|Overall Study|Eligibility Criteria Not Met|0|||
27615196|NCT04867785|80430431|FG001|Overall Study|Eligibility Criteria Not Met|0|||
27615197|NCT04867785|80430432|FG002|Overall Study|Eligibility Criteria Not Met|0|||
27615198|NCT04867785|80430433|FG003|Overall Study|Eligibility Criteria Not Met|0|||
27615199|NCT04867785|80430434|FG004|Overall Study|Eligibility Criteria Not Met|0|||
27615200|NCT04867785|80430435|FG005|Overall Study|Eligibility Criteria Not Met|0|||
27615201|NCT04867785|80430436|FG006|Overall Study|Eligibility Criteria Not Met|0|||
27615202|NCT04867785|80430437|FG007|Overall Study|Eligibility Criteria Not Met|1|||
27511974|NCT04816669|80066411|FG002|Part 2|Lost to Follow-up|1|||
27511975|NCT04816669|80066412|FG003|Part 2|Lost to Follow-up|0|||
27511976|NCT03083873|80066418|FG000|Overall Study|Death|6|||
27511977|NCT03083873|80066419|FG001|Overall Study|Death|15|||
27511978|NCT03083873|80066420|FG002|Overall Study|Death|13|||
27511979|NCT03083873|80066421|FG003|Overall Study|Death|9|||
27511980|NCT03083873|80066422|FG004|Overall Study|Death|0|||
27615203|NCT01950273|80430438|FG000|Overall Study|Protocol Violation|1|||
27615204|NCT01950273|80430439|FG001|Overall Study|Protocol Violation|0|||
27615205|NCT01950273|80430438|FG000|Overall Study|Withdrawal by Subject|2|||
27615206|NCT01950273|80430439|FG001|Overall Study|Withdrawal by Subject|0|||
27615207|NCT01950273|80430438|FG000|Overall Study|Other not defined above|1|||
27615208|NCT01950273|80430439|FG001|Overall Study|Other not defined above|0|||
27852980|NCT01970865|81291291|FG007|Overall Study|Death|3|||
27511981|NCT03083873|80066418|FG000|Overall Study|Sponsor Terminated Study|0|||
27511982|NCT03083873|80066419|FG001|Overall Study|Sponsor Terminated Study|1|||
27511983|NCT03083873|80066420|FG002|Overall Study|Sponsor Terminated Study|2|||
27511984|NCT03083873|80066421|FG003|Overall Study|Sponsor Terminated Study|3|||
27615209|NCT04276090|80434072|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
27615210|NCT04276090|80434073|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
27615211|NCT04466618|80434096|FG000|Overall Study|Withdrawal by Subject|0|||
27852981|NCT01970865|81291292|FG008|Overall Study|Death|2|||
27852982|NCT01970865|81291293|FG009|Overall Study|Death|2|||
27852983|NCT01970865|81291294|FG010|Overall Study|Death|8|||
27852984|NCT01970865|81291295|FG011|Overall Study|Death|13|||
27852985|NCT01970865|81291296|FG012|Overall Study|Death|25|||
27852986|NCT01970865|81291297|FG013|Overall Study|Death|46|||
27852987|NCT01970865|81291298|FG014|Overall Study|Death|37|||
27852988|NCT01970865|81291299|FG015|Overall Study|Death|22|||
27852989|NCT01970865|81291300|FG016|Overall Study|Death|1|||
27852990|NCT01970865|81291301|FG017|Overall Study|Death|17|||
27852991|NCT01970865|81291284|FG000|Overall Study|Lost to Follow-up|0|||
27852992|NCT01970865|81291285|FG001|Overall Study|Lost to Follow-up|0|||
27852993|NCT01970865|81291286|FG002|Overall Study|Lost to Follow-up|0|||
27852994|NCT01970865|81291287|FG003|Overall Study|Lost to Follow-up|1|||
27852995|NCT01970865|81291288|FG004|Overall Study|Lost to Follow-up|1|||
27852996|NCT01970865|81291289|FG005|Overall Study|Lost to Follow-up|0|||
27852997|NCT01970865|81291290|FG006|Overall Study|Lost to Follow-up|0|||
27852998|NCT01970865|81291291|FG007|Overall Study|Lost to Follow-up|0|||
27852999|NCT01970865|81291292|FG008|Overall Study|Lost to Follow-up|0|||
27853000|NCT01970865|81291293|FG009|Overall Study|Lost to Follow-up|0|||
27853001|NCT01970865|81291294|FG010|Overall Study|Lost to Follow-up|1|||
27853002|NCT01970865|81291295|FG011|Overall Study|Lost to Follow-up|0|||
27853003|NCT01970865|81291296|FG012|Overall Study|Lost to Follow-up|2|||
27853004|NCT01970865|81291297|FG013|Overall Study|Lost to Follow-up|0|||
27853005|NCT01970865|81291298|FG014|Overall Study|Lost to Follow-up|1|||
27853006|NCT01970865|81291299|FG015|Overall Study|Lost to Follow-up|4|||
27853007|NCT01970865|81291300|FG016|Overall Study|Lost to Follow-up|0|||
27853008|NCT01970865|81291301|FG017|Overall Study|Lost to Follow-up|1|||
27853009|NCT01970865|81291284|FG000|Overall Study|Other|0|||
27853010|NCT01970865|81291285|FG001|Overall Study|Other|1|||
27853011|NCT01970865|81291286|FG002|Overall Study|Other|0|||
27853012|NCT01970865|81291287|FG003|Overall Study|Other|1|||
27853013|NCT01970865|81291288|FG004|Overall Study|Other|1|||
27853014|NCT01970865|81291289|FG005|Overall Study|Other|0|||
27853015|NCT01970865|81291290|FG006|Overall Study|Other|1|||
27853016|NCT01970865|81291291|FG007|Overall Study|Other|0|||
27853017|NCT01970865|81291292|FG008|Overall Study|Other|0|||
27853018|NCT01970865|81291293|FG009|Overall Study|Other|0|||
27853019|NCT01970865|81291294|FG010|Overall Study|Other|2|||
27853020|NCT01970865|81291295|FG011|Overall Study|Other|3|||
27853021|NCT01970865|81291296|FG012|Overall Study|Other|8|||
27853022|NCT01970865|81291297|FG013|Overall Study|Other|3|||
27853023|NCT01970865|81291298|FG014|Overall Study|Other|2|||
27853024|NCT01970865|81291299|FG015|Overall Study|Other|3|||
27853025|NCT01970865|81291300|FG016|Overall Study|Other|0|||
27853026|NCT01970865|81291301|FG017|Overall Study|Other|2|||
27853027|NCT01970865|81291284|FG000|Overall Study|Participant refused further follow-up|0|||
27853028|NCT01970865|81291285|FG001|Overall Study|Participant refused further follow-up|0|||
27853029|NCT01970865|81291286|FG002|Overall Study|Participant refused further follow-up|0|||
27853030|NCT01970865|81291287|FG003|Overall Study|Participant refused further follow-up|2|||
27906044|NCT00660595|81493300|FG001|Overall Study|Lost to Follow-up|1|||
27906045|NCT00660595|81493299|FG000|Overall Study|Did not consent to participate in study|12|||
27615212|NCT04466618|80434097|FG001|Overall Study|Withdrawal by Subject|1|||
27615213|NCT01734850|80434099|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
27906046|NCT00660595|81493300|FG001|Overall Study|Did not consent to participate in study|8|||
27511985|NCT03083873|80066422|FG004|Overall Study|Sponsor Terminated Study|0|||
27511986|NCT03083873|80066418|FG000|Overall Study|Lost to Follow-up|0|||
27511987|NCT03083873|80066419|FG001|Overall Study|Lost to Follow-up|1|||
27511988|NCT03083873|80066420|FG002|Overall Study|Lost to Follow-up|1|||
27511989|NCT03083873|80066421|FG003|Overall Study|Lost to Follow-up|0|||
27511990|NCT03083873|80066422|FG004|Overall Study|Lost to Follow-up|0|||
27511991|NCT03083873|80066418|FG000|Overall Study|Withdrawal by Subject|2|||
27511992|NCT03083873|80066419|FG001|Overall Study|Withdrawal by Subject|0|||
27511993|NCT03083873|80066420|FG002|Overall Study|Withdrawal by Subject|0|||
27511994|NCT03083873|80066421|FG003|Overall Study|Withdrawal by Subject|0|||
27615214|NCT01734850|80434100|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
27615215|NCT01734850|80434101|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
27615216|NCT01734850|80434099|FG000|Overall Study|Not infused due to manufacturing failure|0|||
27615217|NCT01734850|80434100|FG001|Overall Study|Not infused due to manufacturing failure|0|||
27615218|NCT01734850|80434101|FG002|Overall Study|Not infused due to manufacturing failure|1|||
27615219|NCT04006366|80434104|FG000|Overall Study|Withdrawal by Subject|1|||
27615220|NCT00358215|80434107|FG000|Overall Study|Ineligibility determined|4|||
27615221|NCT00358215|80434108|FG001|Overall Study|Ineligibility determined|3|||
27615222|NCT00358215|80434107|FG000|Overall Study|Adverse Event|83|||
27615223|NCT00358215|80434108|FG001|Overall Study|Adverse Event|65|||
27615224|NCT00358215|80434107|FG000|Overall Study|Withdrawal by Subject|111|||
27615225|NCT00358215|80434108|FG001|Overall Study|Withdrawal by Subject|102|||
27615226|NCT00358215|80434107|FG000|Overall Study|Participant request|65|||
27615227|NCT00358215|80434108|FG001|Overall Study|Participant request|64|||
27615228|NCT00358215|80434107|FG000|Overall Study|Physician Decision|47|||
27615229|NCT00358215|80434108|FG001|Overall Study|Physician Decision|39|||
27615230|NCT00358215|80434107|FG000|Overall Study|Lost to Follow-up|16|||
27615231|NCT00358215|80434108|FG001|Overall Study|Lost to Follow-up|22|||
27615232|NCT00358215|80434107|FG000|Overall Study|Death|265|||
27615233|NCT00358215|80434108|FG001|Overall Study|Death|281|||
27615234|NCT00358215|80434107|FG000|Overall Study|Protocol Violation|64|||
27615235|NCT00358215|80434108|FG001|Overall Study|Protocol Violation|59|||
27615236|NCT00358215|80434107|FG000|Overall Study|Pregnancy|1|||
27615237|NCT00358215|80434108|FG001|Overall Study|Pregnancy|0|||
27615238|NCT00358215|80434107|FG000|Overall Study|Other|21|||
27615239|NCT00358215|80434108|FG001|Overall Study|Other|14|||
27615240|NCT00358215|80434107|FG000|Overall Study|Did not receive investigational product|2|||
27615241|NCT00358215|80434108|FG001|Overall Study|Did not receive investigational product|3|||
27615242|NCT00570661|80434109|FG000|Overall Study|Disease worsening|5|||
27615243|NCT00570661|80434109|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
27615244|NCT00570661|80434109|FG000|Overall Study|Adverse Event|1|||
27615245|NCT01555021|80434110|FG000|Overall Study|Lost to Follow-up|1|||
27615246|NCT01555021|80434111|FG001|Overall Study|Lost to Follow-up|2|||
27853031|NCT01970865|81291288|FG004|Overall Study|Participant refused further follow-up|3|||
27853032|NCT01970865|81291289|FG005|Overall Study|Participant refused further follow-up|0|||
27853033|NCT01970865|81291290|FG006|Overall Study|Participant refused further follow-up|0|||
27853034|NCT01970865|81291291|FG007|Overall Study|Participant refused further follow-up|0|||
27853035|NCT01970865|81291292|FG008|Overall Study|Participant refused further follow-up|0|||
27853036|NCT01970865|81291293|FG009|Overall Study|Participant refused further follow-up|0|||
27853037|NCT01970865|81291294|FG010|Overall Study|Participant refused further follow-up|1|||
27853038|NCT01970865|81291295|FG011|Overall Study|Participant refused further follow-up|4|||
27853039|NCT01970865|81291296|FG012|Overall Study|Participant refused further follow-up|7|||
27853040|NCT01970865|81291297|FG013|Overall Study|Participant refused further follow-up|8|||
27853041|NCT01970865|81291298|FG014|Overall Study|Participant refused further follow-up|3|||
27511995|NCT03083873|80066422|FG004|Overall Study|Withdrawal by Subject|0|||
27511996|NCT03083873|80066418|FG000|Overall Study|Did Not Receive TIL|2|||
27615247|NCT01091428|80434112|FG000|Phase 1|Progressive Disease|24|||
27615248|NCT01091428|80434113|FG001|Phase 1|Progressive Disease|8|||
27615249|NCT01091428|80434114|FG002|Phase 1|Progressive Disease|0|||
27615250|NCT01091428|80434115|FG003|Phase 1|Progressive Disease|0|||
27615251|NCT01091428|80434112|FG000|Phase 1|Symptomatic Deterioration|3|||
27615252|NCT01091428|80434113|FG001|Phase 1|Symptomatic Deterioration|2|||
27615253|NCT01091428|80434114|FG002|Phase 1|Symptomatic Deterioration|0|||
27615254|NCT01091428|80434115|FG003|Phase 1|Symptomatic Deterioration|0|||
27853042|NCT01970865|81291299|FG015|Overall Study|Participant refused further follow-up|11|||
27615255|NCT01091428|80434112|FG000|Phase 1|Adverse Event|2|||
27615256|NCT01091428|80434113|FG001|Phase 1|Adverse Event|0|||
27615257|NCT01091428|80434114|FG002|Phase 1|Adverse Event|0|||
27615258|NCT01091428|80434115|FG003|Phase 1|Adverse Event|0|||
27853043|NCT01970865|81291300|FG016|Overall Study|Participant refused further follow-up|0|||
27511997|NCT03083873|80066419|FG001|Overall Study|Did Not Receive TIL|5|||
27511998|NCT03083873|80066420|FG002|Overall Study|Did Not Receive TIL|3|||
27511999|NCT03083873|80066421|FG003|Overall Study|Did Not Receive TIL|1|||
27512000|NCT03083873|80066422|FG004|Overall Study|Did Not Receive TIL|0|||
27512001|NCT02840461|80066423|FG000|Overall Study|Adverse Event|1|||
27512002|NCT02840461|80066424|FG001|Overall Study|Adverse Event|5|||
27512003|NCT02840461|80066425|FG002|Overall Study|Adverse Event|3|||
27512004|NCT02840461|80066423|FG000|Overall Study|Lost to Follow-up|10|||
27512005|NCT02840461|80066424|FG001|Overall Study|Lost to Follow-up|7|||
27512006|NCT02840461|80066425|FG002|Overall Study|Lost to Follow-up|6|||
27512007|NCT02840461|80066423|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
27512008|NCT02840461|80066424|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
27512009|NCT02840461|80066425|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
27512010|NCT02840461|80066423|FG000|Overall Study|Protocol Violation|2|||
27512011|NCT02840461|80066424|FG001|Overall Study|Protocol Violation|3|||
27512012|NCT02840461|80066425|FG002|Overall Study|Protocol Violation|1|||
27512013|NCT02840461|80066423|FG000|Overall Study|Withdrawal by Subject|10|||
27512014|NCT02840461|80066424|FG001|Overall Study|Withdrawal by Subject|6|||
27512015|NCT02840461|80066425|FG002|Overall Study|Withdrawal by Subject|2|||
27512016|NCT02840461|80066423|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
27615259|NCT01091428|80434112|FG000|Phase 1|Withdrawal by Subject|7|||
27615260|NCT01091428|80434113|FG001|Phase 1|Withdrawal by Subject|0|||
27728629|NCT00331006|80833344|FG000|Treatment Phase|Withdrawal by Subject|1|||
27728630|NCT00331006|80833344|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
27728631|NCT00331006|80833344|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
27728632|NCT01442181|80833345|FG000|Overall Study|patient refused surgery|1|||
27906047|NCT00660595|81493299|FG000|Overall Study|Participant left hospital|1|||
27906048|NCT00660595|81493300|FG001|Overall Study|Participant left hospital|0|||
27906049|NCT00660595|81493299|FG000|Overall Study|Non Specified reasons|5|||
27906050|NCT00660595|81493300|FG001|Overall Study|Non Specified reasons|0|||
27906051|NCT05459558|81493301|FG000|Overall Study|Adverse Event|1|||
27906052|NCT05459558|81493302|FG001|Overall Study|Adverse Event|0|||
27906053|NCT05459558|81493303|FG002|Overall Study|Adverse Event|0|||
27906054|NCT05459558|81493301|FG000|Overall Study|Scheduling issue|0|||
27906055|NCT05459558|81493302|FG001|Overall Study|Scheduling issue|1|||
27906056|NCT05459558|81493303|FG002|Overall Study|Scheduling issue|3|||
27906057|NCT05459558|81493301|FG000|Overall Study|Withdrawal by Subject|0|||
27906058|NCT05459558|81493302|FG001|Overall Study|Withdrawal by Subject|0|||
27906059|NCT05459558|81493303|FG002|Overall Study|Withdrawal by Subject|2|||
27906060|NCT02732015|81493304|FG000|Overall Study|Lost to Follow-up|0|||
27906061|NCT02732015|81493305|FG001|Overall Study|Lost to Follow-up|1|||
27906062|NCT00631163|81493309|FG000|Number of Participants in Year 1|Adverse Event|12|||
27906063|NCT00631163|81493309|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
27906064|NCT00631163|81493309|FG000|Number of Participants in Year 1|Death|6|||
27906065|NCT00631163|81493309|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
27906066|NCT00631163|81493309|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
27615261|NCT01091428|80434114|FG002|Phase 1|Withdrawal by Subject|0|||
27615262|NCT01091428|80434115|FG003|Phase 1|Withdrawal by Subject|0|||
27615263|NCT01091428|80434112|FG000|Phase 1|Reason not specified|0|||
27615264|NCT01091428|80434113|FG001|Phase 1|Reason not specified|1|||
27615265|NCT01091428|80434114|FG002|Phase 1|Reason not specified|0|||
27615266|NCT01091428|80434115|FG003|Phase 1|Reason not specified|0|||
27615267|NCT01091428|80434112|FG000|Phase 1|Single-Patient IND|2|||
27615268|NCT01091428|80434113|FG001|Phase 1|Single-Patient IND|0|||
27615269|NCT01091428|80434114|FG002|Phase 1|Single-Patient IND|0|||
27615270|NCT01091428|80434115|FG003|Phase 1|Single-Patient IND|0|||
27615271|NCT01091428|80434112|FG000|Phase 2|Progressive Disease|0|||
27728633|NCT01442181|80833346|FG001|Overall Study|patient refused surgery|0|||
27728634|NCT01442181|80833345|FG000|Overall Study|no insurance for surgery|1|||
27728635|NCT01442181|80833346|FG001|Overall Study|no insurance for surgery|0|||
27728636|NCT01442181|80833345|FG000|Overall Study|low ejection factor|0|||
27728637|NCT01442181|80833346|FG001|Overall Study|low ejection factor|1|||
27728638|NCT01442181|80833345|FG000|Overall Study|Lost to Follow-up|1|||
27906067|NCT00631163|81493309|FG000|Number of Participants in Year 1|Administrative problems|6|||
27615272|NCT01091428|80434113|FG001|Phase 2|Progressive Disease|0|||
27906068|NCT00631163|81493309|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
27906069|NCT00631163|81493309|FG000|Number of Participants in Year 2|Adverse Event|1|||
27512017|NCT02840461|80066424|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
27512018|NCT02840461|80066425|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
27512019|NCT04421027|80066426|FG000|Treatment Period|Adverse Event|5|||
27512020|NCT04421027|80066427|FG001|Treatment Period|Adverse Event|3|||
27615273|NCT01091428|80434114|FG002|Phase 2|Progressive Disease|44|||
27728639|NCT01442181|80833346|FG001|Overall Study|Lost to Follow-up|1|||
27728640|NCT01442181|80833345|FG000|Overall Study|patient in an additional study|1|||
27906070|NCT00631163|81493309|FG000|Number of Participants in Year 2|Protocol Violation|1|||
27615274|NCT01091428|80434115|FG003|Phase 2|Progressive Disease|46|||
27615275|NCT01091428|80434112|FG000|Phase 2|Symptomatic Deterioration|0|||
27512021|NCT04421027|80066428|FG002|Treatment Period|Adverse Event|0|||
27512022|NCT04421027|80066429|FG003|Treatment Period|Adverse Event|0|||
27512023|NCT04421027|80066426|FG000|Treatment Period|Death|98|||
27512024|NCT04421027|80066427|FG001|Treatment Period|Death|61|||
27512025|NCT04421027|80066428|FG002|Treatment Period|Death|0|||
27512026|NCT04421027|80066429|FG003|Treatment Period|Death|0|||
27512027|NCT04421027|80066426|FG000|Treatment Period|Lost to Follow-up|22|||
27512028|NCT04421027|80066427|FG001|Treatment Period|Lost to Follow-up|20|||
27512029|NCT04421027|80066428|FG002|Treatment Period|Lost to Follow-up|0|||
27512030|NCT04421027|80066429|FG003|Treatment Period|Lost to Follow-up|0|||
27512031|NCT04421027|80066426|FG000|Treatment Period|Other-Unknown|15|||
27512032|NCT04421027|80066427|FG001|Treatment Period|Other-Unknown|9|||
27512033|NCT04421027|80066428|FG002|Treatment Period|Other-Unknown|0|||
27512034|NCT04421027|80066429|FG003|Treatment Period|Other-Unknown|0|||
27512035|NCT04421027|80066426|FG000|Treatment Period|Physician Decision|1|||
27512036|NCT04421027|80066427|FG001|Treatment Period|Physician Decision|1|||
27512037|NCT04421027|80066428|FG002|Treatment Period|Physician Decision|0|||
27512038|NCT04421027|80066429|FG003|Treatment Period|Physician Decision|0|||
27512039|NCT04421027|80066426|FG000|Treatment Period|Withdrawal by Subject|7|||
27512040|NCT04421027|80066427|FG001|Treatment Period|Withdrawal by Subject|12|||
27512041|NCT04421027|80066428|FG002|Treatment Period|Withdrawal by Subject|0|||
27512042|NCT04421027|80066429|FG003|Treatment Period|Withdrawal by Subject|0|||
27512043|NCT04421027|80066426|FG000|Treatment Period|Randomized Not Dosed|9|||
27512044|NCT04421027|80066427|FG001|Treatment Period|Randomized Not Dosed|14|||
27512045|NCT04421027|80066428|FG002|Treatment Period|Randomized Not Dosed|0|||
27512046|NCT04421027|80066429|FG003|Treatment Period|Randomized Not Dosed|0|||
27512047|NCT04421027|80066426|FG000|Follow-Up Period|Adverse Event|0|||
27512048|NCT04421027|80066427|FG001|Follow-Up Period|Adverse Event|0|||
27512049|NCT04421027|80066428|FG002|Follow-Up Period|Adverse Event|0|||
27512050|NCT04421027|80066429|FG003|Follow-Up Period|Adverse Event|3|||
27512051|NCT04421027|80066426|FG000|Follow-Up Period|Death|0|||
27512052|NCT04421027|80066427|FG001|Follow-Up Period|Death|0|||
27512053|NCT04421027|80066428|FG002|Follow-Up Period|Death|16|||
27512054|NCT04421027|80066429|FG003|Follow-Up Period|Death|17|||
27615276|NCT01091428|80434113|FG001|Phase 2|Symptomatic Deterioration|0|||
27615277|NCT01091428|80434114|FG002|Phase 2|Symptomatic Deterioration|1|||
27615278|NCT01091428|80434115|FG003|Phase 2|Symptomatic Deterioration|6|||
27615279|NCT01091428|80434112|FG000|Phase 2|Adverse Event|0|||
27615280|NCT01091428|80434113|FG001|Phase 2|Adverse Event|0|||
27615281|NCT01091428|80434114|FG002|Phase 2|Adverse Event|12|||
27615282|NCT01091428|80434115|FG003|Phase 2|Adverse Event|5|||
27615283|NCT01091428|80434112|FG000|Phase 2|Withdrawal by Subject|0|||
27615284|NCT01091428|80434113|FG001|Phase 2|Withdrawal by Subject|0|||
27615285|NCT01091428|80434114|FG002|Phase 2|Withdrawal by Subject|9|||
27512055|NCT04421027|80066426|FG000|Follow-Up Period|Lost to Follow-up|0|||
27512056|NCT04421027|80066427|FG001|Follow-Up Period|Lost to Follow-up|0|||
27615286|NCT01091428|80434115|FG003|Phase 2|Withdrawal by Subject|8|||
27615287|NCT01091428|80434112|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
27512057|NCT04421027|80066428|FG002|Follow-Up Period|Lost to Follow-up|7|||
27512058|NCT04421027|80066429|FG003|Follow-Up Period|Lost to Follow-up|7|||
27512059|NCT04421027|80066426|FG000|Follow-Up Period|Protocol Deviation|0|||
27512060|NCT04421027|80066427|FG001|Follow-Up Period|Protocol Deviation|0|||
27512061|NCT04421027|80066428|FG002|Follow-Up Period|Protocol Deviation|1|||
27615288|NCT01091428|80434113|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
27615289|NCT01091428|80434114|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
27615290|NCT01091428|80434115|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
27615291|NCT01091428|80434112|FG000|Phase 2|Reason not specified|0|||
27853044|NCT01970865|81291301|FG017|Overall Study|Participant refused further follow-up|6|||
27906071|NCT00631163|81493309|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
27906072|NCT00264290|81493311|FG000|Intervention (8 Weeks)|Adverse Event|1|||
27906073|NCT00264290|81493312|FG001|Intervention (8 Weeks)|Adverse Event|0|||
27906074|NCT00376532|81493316|FG000|Overall Study|Lack sufficient blood sample|6|||
27906075|NCT00376532|81493317|FG001|Overall Study|Lack sufficient blood sample|6|||
27906076|NCT02383355|81493318|FG000|Overall Study|Adverse Event|2|||
27512062|NCT04421027|80066429|FG003|Follow-Up Period|Protocol Deviation|0|||
27512063|NCT04421027|80066426|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
27512064|NCT04421027|80066427|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
27512065|NCT04421027|80066428|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
27512066|NCT04421027|80066429|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
27512067|NCT04421027|80066426|FG000|Follow-Up Period|Left message, participant did not call back|0|||
27512068|NCT04421027|80066427|FG001|Follow-Up Period|Left message, participant did not call back|0|||
27512069|NCT04421027|80066428|FG002|Follow-Up Period|Left message, participant did not call back|0|||
27512070|NCT04421027|80066429|FG003|Follow-Up Period|Left message, participant did not call back|1|||
27512071|NCT04421027|80066426|FG000|Follow-Up Period|Participant died|0|||
27512072|NCT04421027|80066427|FG001|Follow-Up Period|Participant died|0|||
27512073|NCT04421027|80066428|FG002|Follow-Up Period|Participant died|0|||
27512074|NCT04421027|80066429|FG003|Follow-Up Period|Participant died|1|||
27512075|NCT04421027|80066426|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
27512076|NCT04421027|80066427|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
27512077|NCT04421027|80066428|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
27512078|NCT04421027|80066429|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
27512079|NCT00834093|80066430|FG000|Overall Study|Progressive Disease|3|||
27512080|NCT00834093|80066430|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
27512081|NCT02817464|80066431|FG000|Overall Study|Lost to Follow-up|1|||
27512082|NCT02817464|80066432|FG001|Overall Study|Lost to Follow-up|0|||
27512083|NCT02817464|80066431|FG000|Overall Study|Discontinued early due to personal decision|1|||
27512084|NCT02817464|80066432|FG001|Overall Study|Discontinued early due to personal decision|1|||
27512085|NCT03212144|80066433|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
27512086|NCT03212144|80066434|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
27512087|NCT03212144|80066433|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
27512088|NCT03212144|80066434|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
27512089|NCT01903811|80066436|FG000|Overall Study|No measurable disease|1|||
27512090|NCT01903811|80066437|FG001|Overall Study|No measurable disease|1|||
27512091|NCT01903811|80066436|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
27512092|NCT01903811|80066437|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
27512093|NCT01903811|80066436|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
27512094|NCT01903811|80066437|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
27512095|NCT01903811|80066436|FG000|Overall Study|Withdrawal by Subject|0|||
27512096|NCT01903811|80066437|FG001|Overall Study|Withdrawal by Subject|1|||
27512097|NCT01941186|80066438|FG000|Follow-up|Lost to Follow-up|1|||
27512098|NCT01941186|80066439|FG001|Follow-up|Lost to Follow-up|0|||
27512099|NCT01165216|80066440|FG000|Overall Study|Adverse Event|6|||
27512100|NCT01165216|80066441|FG001|Overall Study|Adverse Event|3|||
27512101|NCT01165216|80066440|FG000|Overall Study|Withdrawal by Subject|1|||
27512102|NCT01165216|80066441|FG001|Overall Study|Withdrawal by Subject|1|||
27853045|NCT04049617|81291302|FG000|Overall Study|Adverse Event|0|||
27853046|NCT04049617|81291303|FG001|Overall Study|Adverse Event|0|||
27853047|NCT04049617|81291304|FG002|Overall Study|Adverse Event|0|||
27853048|NCT04049617|81291305|FG003|Overall Study|Adverse Event|1|||
27853049|NCT04049617|81291306|FG004|Overall Study|Adverse Event|0|||
27853050|NCT04049617|81291307|FG005|Overall Study|Adverse Event|0|||
27853051|NCT04049617|81291302|FG000|Overall Study|Death|0|||
27853052|NCT04049617|81291303|FG001|Overall Study|Death|0|||
27853053|NCT04049617|81291304|FG002|Overall Study|Death|0|||
27853054|NCT04049617|81291305|FG003|Overall Study|Death|0|||
27853055|NCT04049617|81291306|FG004|Overall Study|Death|0|||
27853056|NCT04049617|81291307|FG005|Overall Study|Death|1|||
27853057|NCT04049617|81291302|FG000|Overall Study|Lost to Follow-up|0|||
27512103|NCT01165216|80066440|FG000|Overall Study|Disease progression|1|||
27512104|NCT01165216|80066441|FG001|Overall Study|Disease progression|3|||
27512105|NCT00541385|80066442|FG000|Overall Study|Adverse Event|6|||
27512106|NCT00541385|80066443|FG001|Overall Study|Adverse Event|3|||
27512107|NCT00541385|80066442|FG000|Overall Study|Withdrawal by Subject|2|||
27512108|NCT00541385|80066443|FG001|Overall Study|Withdrawal by Subject|2|||
27512109|NCT00541385|80066442|FG000|Overall Study|Lost to Follow-up|6|||
27512110|NCT00541385|80066443|FG001|Overall Study|Lost to Follow-up|1|||
27512111|NCT00541385|80066442|FG000|Overall Study|Parasite reappearance/malaria|67|||
27512112|NCT00541385|80066443|FG001|Overall Study|Parasite reappearance/malaria|32|||
27512113|NCT04328077|80066444|FG000|Overall Study|Lost to Follow-up|0|||
27512114|NCT04328077|80066445|FG001|Overall Study|Lost to Follow-up|1|||
27512115|NCT04328077|80066446|FG002|Overall Study|Lost to Follow-up|0|||
27512116|NCT04328077|80066447|FG003|Overall Study|Lost to Follow-up|0|||
27512117|NCT04328077|80066444|FG000|Overall Study|Withdrawal by Subject|0|||
27512118|NCT04328077|80066445|FG001|Overall Study|Withdrawal by Subject|1|||
27512119|NCT04328077|80066446|FG002|Overall Study|Withdrawal by Subject|1|||
27512120|NCT04328077|80066447|FG003|Overall Study|Withdrawal by Subject|3|||
27512121|NCT01528969|80066449|FG000|Overall Study|absent from the school at baseline|2|||
27512122|NCT01528969|80066450|FG001|Overall Study|absent from the school at baseline|0|||
27512123|NCT01255436|80066451|FG000|Overall Study|Lost to Follow-up|178|||
27615292|NCT01091428|80434113|FG001|Phase 2|Reason not specified|0|||
27615293|NCT01091428|80434114|FG002|Phase 2|Reason not specified|4|||
27906077|NCT02383355|81493319|FG001|Overall Study|Adverse Event|0|||
27906078|NCT02226120|81493320|FG000|Overall Study|Adverse Event|60|||
27906079|NCT02226120|81493320|FG000|Overall Study|Death|172|||
27906080|NCT02226120|81493320|FG000|Overall Study|Study terminated by sponsor|1|||
27906081|NCT02226120|81493320|FG000|Overall Study|Technical problems|4|||
27906082|NCT02226120|81493320|FG000|Overall Study|Lost to Follow-up|13|||
27906083|NCT02226120|81493320|FG000|Overall Study|Physician Decision|21|||
27906084|NCT02226120|81493320|FG000|Overall Study|Withdrawal by parent/guardian|36|||
27906085|NCT02226120|81493320|FG000|Overall Study|Non-compliance with study drug|10|||
27906086|NCT02226120|81493320|FG000|Overall Study|Protocol deviation|1|||
27906087|NCT02226120|81493320|FG000|Overall Study|missing treatment disposition pages|2|||
27906088|NCT00694356|81493321|FG000|Overall Study|Adverse Event|1|||
27906089|NCT00694356|81493322|FG001|Overall Study|Adverse Event|0|||
27906090|NCT00694356|81493323|FG002|Overall Study|Adverse Event|0|||
27906091|NCT00694356|81493321|FG000|Overall Study|Progressive Disease|2|||
27906092|NCT00694356|81493322|FG001|Overall Study|Progressive Disease|6|||
27906093|NCT00694356|81493323|FG002|Overall Study|Progressive Disease|6|||
27906094|NCT00255840|81493324|FG000|Overall Study|Lost to Follow-up|10|||
27906095|NCT00255840|81493325|FG001|Overall Study|Lost to Follow-up|14|||
27906096|NCT00255840|81493324|FG000|Overall Study|Discontinued intervention|53|||
27906097|NCT00255840|81493325|FG001|Overall Study|Discontinued intervention|56|||
27906098|NCT02906579|81493327|FG000|Overall Study|Adverse Event|1|||
27906099|NCT02906579|81493327|FG000|Overall Study|Physician Decision|1|||
27906100|NCT01370616|81493328|FG000|Overall Study|Adverse Event|11|||
27906101|NCT01370616|81493329|FG001|Overall Study|Adverse Event|16|||
27906102|NCT01370616|81493328|FG000|Overall Study|Death|1|||
27906103|NCT01370616|81493329|FG001|Overall Study|Death|0|||
27906104|NCT01370616|81493328|FG000|Overall Study|Lack of Efficacy|6|||
27906105|NCT01370616|81493329|FG001|Overall Study|Lack of Efficacy|2|||
27906106|NCT01370616|81493328|FG000|Overall Study|Lost to Follow-up|0|||
27906107|NCT01370616|81493329|FG001|Overall Study|Lost to Follow-up|3|||
27906108|NCT01370616|81493328|FG000|Overall Study|Physician Decision|6|||
27615294|NCT01091428|80434115|FG003|Phase 2|Reason not specified|3|||
27615295|NCT01091428|80434112|FG000|Phase 2|Physician Decision|0|||
27615296|NCT01091428|80434113|FG001|Phase 2|Physician Decision|0|||
27728641|NCT01442181|80833346|FG001|Overall Study|patient in an additional study|0|||
27906109|NCT01370616|81493329|FG001|Overall Study|Physician Decision|6|||
27906110|NCT01370616|81493328|FG000|Overall Study|Progressive Disease|0|||
27906111|NCT01370616|81493329|FG001|Overall Study|Progressive Disease|1|||
27906112|NCT01370616|81493328|FG000|Overall Study|Recovery|1|||
27906113|NCT01370616|81493329|FG001|Overall Study|Recovery|0|||
27906114|NCT01370616|81493328|FG000|Overall Study|Technical Problems|3|||
27906115|NCT01370616|81493329|FG001|Overall Study|Technical Problems|5|||
27906116|NCT01370616|81493328|FG000|Overall Study|Withdrawal by Subject|34|||
27512124|NCT01255436|80066452|FG001|Overall Study|Lost to Follow-up|191|||
27512125|NCT01255436|80066451|FG000|Overall Study|Death, stroke, or MI|4|||
27512126|NCT01255436|80066452|FG001|Overall Study|Death, stroke, or MI|3|||
27512127|NCT00975780|80066454|FG000|Follow Up|Death|88|||
27512128|NCT00975780|80066455|FG001|Follow Up|Death|122|||
27512129|NCT00975780|80066454|FG000|Follow Up|Facility Withdrawal|7|||
27615297|NCT01091428|80434114|FG002|Phase 2|Physician Decision|2|||
27615298|NCT01091428|80434115|FG003|Phase 2|Physician Decision|0|||
27906117|NCT01370616|81493329|FG001|Overall Study|Withdrawal by Subject|34|||
27906118|NCT01548768|81493333|FG000|Overall Study|Withdrawal by Subject|0|||
27906119|NCT01548768|81493334|FG001|Overall Study|Withdrawal by Subject|2|||
27906120|NCT01548768|81493335|FG002|Overall Study|Withdrawal by Subject|1|||
27512130|NCT00975780|80066455|FG001|Follow Up|Facility Withdrawal|23|||
27512131|NCT00975780|80066454|FG000|Follow Up|Discharged from Facility|7|||
27512132|NCT00975780|80066455|FG001|Follow Up|Discharged from Facility|12|||
27512133|NCT02948634|80066458|FG000|Overall Study|Lack of efficacy and study suspended|10|||
27512134|NCT02948634|80066459|FG001|Overall Study|Lack of efficacy and study suspended|2|||
27512135|NCT01417377|80066464|FG000|Overall Study|Lost to Follow-up|12|||
27512136|NCT01417377|80066464|FG000|Overall Study|Enrolled, but not treated|1|||
27512137|NCT02888119|80066467|FG000|Overall Study|Lost to Follow-up|5|||
27512138|NCT02888119|80066468|FG001|Overall Study|Lost to Follow-up|4|||
27512139|NCT02888119|80066469|FG002|Overall Study|Lost to Follow-up|0|||
27512140|NCT00526071|80066470|FG000|Overall Study|Adverse Event|1|||
27512141|NCT00526071|80066470|FG000|Overall Study|Withdrawal by Subject|1|||
27512142|NCT00526071|80066470|FG000|Overall Study|Lack of Response to Study Drug|4|||
27512143|NCT00295880|80070357|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
27512144|NCT00295880|80070357|FG000|Overall Study|Unit randomization did not occur|1|||
27512145|NCT01750229|80070358|FG000|Randomized Crossover Phase|Adverse Event|1|||
27512146|NCT01750229|80070358|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
27512147|NCT01750229|80070358|FG000|Long-term Follow-up Phase|Adverse Event|2|||
27512148|NCT01750229|80070358|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
27512149|NCT01379508|80070359|FG000|Treatment to Week 104|Adverse Event|2|||
27512150|NCT01379508|80070360|FG001|Treatment to Week 104|Adverse Event|0|||
27512151|NCT01379508|80070361|FG002|Treatment to Week 104|Adverse Event|5|||
27512152|NCT01379508|80070362|FG003|Treatment to Week 104|Adverse Event|0|||
27512153|NCT01379508|80070359|FG000|Treatment to Week 104|Abnormal lab value|1|||
27512154|NCT01379508|80070360|FG001|Treatment to Week 104|Abnormal lab value|0|||
27512155|NCT01379508|80070361|FG002|Treatment to Week 104|Abnormal lab value|0|||
27512156|NCT01379508|80070362|FG003|Treatment to Week 104|Abnormal lab value|0|||
27512157|NCT01379508|80070359|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
27512158|NCT01379508|80070360|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
27512159|NCT01379508|80070361|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
27512160|NCT01379508|80070362|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
27512161|NCT01379508|80070359|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
27512162|NCT01379508|80070360|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
27512163|NCT01379508|80070361|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
27512164|NCT01379508|80070362|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
27512165|NCT01379508|80070359|FG000|Treatment to Week 104|Lost to Follow-up|5|||
27512166|NCT01379508|80070360|FG001|Treatment to Week 104|Lost to Follow-up|0|||
27512167|NCT01379508|80070361|FG002|Treatment to Week 104|Lost to Follow-up|3|||
27512168|NCT01379508|80070362|FG003|Treatment to Week 104|Lost to Follow-up|0|||
27512169|NCT01379508|80070359|FG000|Treatment to Week 104|Administrative problems|3|||
27512170|NCT01379508|80070360|FG001|Treatment to Week 104|Administrative problems|1|||
27512171|NCT01379508|80070361|FG002|Treatment to Week 104|Administrative problems|0|||
27512172|NCT01379508|80070362|FG003|Treatment to Week 104|Administrative problems|0|||
27512173|NCT01379508|80070359|FG000|Treatment to Week 104|Protocol Violation|1|||
27512174|NCT01379508|80070360|FG001|Treatment to Week 104|Protocol Violation|1|||
27615299|NCT01990300|80434116|FG000|Overall Study|Case Report Forms Uncollected|89|||
27615300|NCT01990300|80434116|FG000|Overall Study|Protocol Deviation|53|||
27906121|NCT01548768|81493336|FG003|Overall Study|Withdrawal by Subject|0|||
27906122|NCT01548768|81493333|FG000|Overall Study|Physician Decision|1|||
27906123|NCT01548768|81493334|FG001|Overall Study|Physician Decision|0|||
27906124|NCT01548768|81493335|FG002|Overall Study|Physician Decision|0|||
27906125|NCT01548768|81493336|FG003|Overall Study|Physician Decision|0|||
27906126|NCT01548768|81493333|FG000|Overall Study|Adverse Event|0|||
27906127|NCT01548768|81493334|FG001|Overall Study|Adverse Event|0|||
27906128|NCT01548768|81493335|FG002|Overall Study|Adverse Event|0|||
27906129|NCT01548768|81493336|FG003|Overall Study|Adverse Event|1|||
27906130|NCT01548768|81493333|FG000|Overall Study|Non-Compliance|0|||
27906131|NCT01548768|81493334|FG001|Overall Study|Non-Compliance|0|||
27906132|NCT01548768|81493335|FG002|Overall Study|Non-Compliance|0|||
27906133|NCT01548768|81493336|FG003|Overall Study|Non-Compliance|3|||
27906134|NCT00460746|81493337|FG000|Overall Study|Adverse Event|1|||
27906135|NCT00460746|81493337|FG000|Overall Study|Lost to Follow-up|1|||
27512175|NCT01379508|80070361|FG002|Treatment to Week 104|Protocol Violation|1|||
27512176|NCT01379508|80070362|FG003|Treatment to Week 104|Protocol Violation|0|||
27512177|NCT01379508|80070359|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
27512178|NCT01379508|80070360|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
27512179|NCT01379508|80070361|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
27512180|NCT01379508|80070362|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
27512181|NCT01379508|80070359|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
27906136|NCT04227405|81493338|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
27512182|NCT01379508|80070360|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
27512183|NCT01379508|80070361|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
27615301|NCT02769065|80434118|FG000|Overall Study|Voluntary Withdrawal|1|||
27906137|NCT04227405|81493339|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
27906138|NCT04227405|81493338|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
27906139|NCT04227405|81493339|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
27906140|NCT04227405|81493338|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
27906141|NCT04227405|81493339|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
27906142|NCT01408901|81493344|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
27906143|NCT01408901|81493345|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
27906144|NCT01408901|81493346|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
27906145|NCT01408901|81493347|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
27906146|NCT01408901|81493344|FG000|6-Week Follow-Up|Death|1|||
27906147|NCT01408901|81493345|FG001|6-Week Follow-Up|Death|0|||
27906148|NCT01408901|81493346|FG002|6-Week Follow-Up|Death|0|||
27906149|NCT01408901|81493347|FG003|6-Week Follow-Up|Death|0|||
27906150|NCT01408901|81493344|FG000|6-Week Follow-Up|Cancelled visit|0|||
27906151|NCT01408901|81493345|FG001|6-Week Follow-Up|Cancelled visit|1|||
27906152|NCT01408901|81493346|FG002|6-Week Follow-Up|Cancelled visit|0|||
27906153|NCT01408901|81493347|FG003|6-Week Follow-Up|Cancelled visit|2|||
27906154|NCT01408901|81493344|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
27906155|NCT01408901|81493345|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
27906156|NCT01408901|81493346|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
27906157|NCT01408901|81493347|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
27906158|NCT01408901|81493344|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
27906159|NCT01408901|81493345|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
27906160|NCT01408901|81493346|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
27906161|NCT01408901|81493347|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
27906162|NCT01408901|81493344|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
27906163|NCT01408901|81493345|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
27906164|NCT01408901|81493346|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
27906165|NCT01408901|81493347|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
27906166|NCT01408901|81493344|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
27906167|NCT01408901|81493345|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
27906168|NCT01408901|81493346|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
27906169|NCT01408901|81493347|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
27906170|NCT01408901|81493344|FG000|26-Week Follow-Up|Death|0|||
27906171|NCT01408901|81493345|FG001|26-Week Follow-Up|Death|1|||
27906172|NCT01408901|81493346|FG002|26-Week Follow-Up|Death|0|||
27906173|NCT01408901|81493347|FG003|26-Week Follow-Up|Death|0|||
27906174|NCT02168777|81493352|FG000|Overall Study|Withdrawal by Subject|1|||
27906175|NCT02168777|81493353|FG001|Overall Study|Withdrawal by Subject|0|||
27906176|NCT02168777|81493354|FG002|Overall Study|Withdrawal by Subject|2|||
27906177|NCT02168777|81493352|FG000|Overall Study|Adverse Event|1|||
27906178|NCT02168777|81493353|FG001|Overall Study|Adverse Event|0|||
27906179|NCT02168777|81493354|FG002|Overall Study|Adverse Event|1|||
27906180|NCT02168777|81493352|FG000|Overall Study|Disease recurrence|0|||
27906181|NCT02168777|81493353|FG001|Overall Study|Disease recurrence|0|||
27906182|NCT02168777|81493354|FG002|Overall Study|Disease recurrence|1|||
27906183|NCT02168777|81493352|FG000|Overall Study|Radiological disease progression|0|||
27906184|NCT02168777|81493353|FG001|Overall Study|Radiological disease progression|5|||
27906185|NCT02168777|81493354|FG002|Overall Study|Radiological disease progression|5|||
27512184|NCT01379508|80070362|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
27512185|NCT01379508|80070359|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
27512186|NCT01379508|80070360|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
27512187|NCT01379508|80070361|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
27512188|NCT01379508|80070362|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
27512189|NCT01379508|80070359|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
27512190|NCT01379508|80070360|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
27512191|NCT01379508|80070361|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
27512192|NCT01379508|80070362|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
27512193|NCT03196349|80070363|FG000|Overall Study|Did not receive study drug|0|||
27512194|NCT03196349|80070364|FG001|Overall Study|Did not receive study drug|1|||
27512195|NCT03196349|80070365|FG002|Overall Study|Did not receive study drug|2|||
27512196|NCT03196349|80070363|FG000|Overall Study|No data entered|2|||
27512197|NCT03196349|80070364|FG001|Overall Study|No data entered|4|||
27512198|NCT03196349|80070365|FG002|Overall Study|No data entered|0|||
27512199|NCT03196349|80070363|FG000|Overall Study|Study Terminated early|15|||
27512200|NCT03196349|80070364|FG001|Overall Study|Study Terminated early|9|||
27512201|NCT03196349|80070365|FG002|Overall Study|Study Terminated early|11|||
27512202|NCT01317277|80070366|FG000|Overall Study|Lost to Follow-up|3|||
27906186|NCT02168777|81493352|FG000|Overall Study|Clinical disease progression|0|||
27906187|NCT02168777|81493353|FG001|Overall Study|Clinical disease progression|1|||
27906188|NCT02168777|81493354|FG002|Overall Study|Clinical disease progression|2|||
27906189|NCT02168777|81493352|FG000|Overall Study|Other reason|0|||
27906190|NCT02168777|81493353|FG001|Overall Study|Other reason|1|||
27512203|NCT01317277|80070367|FG001|Overall Study|Lost to Follow-up|1|||
27512204|NCT01317277|80070366|FG000|Overall Study|Lost MEMS|1|||
27512205|NCT01317277|80070367|FG001|Overall Study|Lost MEMS|1|||
27512206|NCT01317277|80070366|FG000|Overall Study|Unable to comply with intervention|1|||
27512207|NCT01317277|80070367|FG001|Overall Study|Unable to comply with intervention|0|||
27512208|NCT01317277|80070366|FG000|Overall Study|Withdrawal by Subject|1|||
27512209|NCT01317277|80070367|FG001|Overall Study|Withdrawal by Subject|0|||
27512210|NCT01317277|80070366|FG000|Overall Study|Adverse Event|1|||
27512211|NCT01317277|80070367|FG001|Overall Study|Adverse Event|0|||
27512212|NCT00774566|80070368|FG000|Overall Study|Protocol Violation|18|||
27512213|NCT00774566|80070369|FG001|Overall Study|Protocol Violation|15|||
27512214|NCT01047553|80070373|FG000|Overall Study|Adverse Event|10|||
27512215|NCT01047553|80070374|FG001|Overall Study|Adverse Event|5|||
27512216|NCT01047553|80070373|FG000|Overall Study|Withdrawal by Subject|4|||
27512217|NCT01047553|80070374|FG001|Overall Study|Withdrawal by Subject|2|||
27512218|NCT01047553|80070373|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
27728642|NCT01442181|80833345|FG000|Overall Study|atrial fibrillation not noted|0|||
27906191|NCT02168777|81493354|FG002|Overall Study|Other reason|0|||
27906192|NCT03442088|81493359|FG000|Overall Study|Adverse Event|1|||
27906193|NCT03442088|81493359|FG000|Overall Study|Lack of Efficacy|2|||
27512219|NCT01047553|80070374|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
27512220|NCT01047553|80070373|FG000|Overall Study|Lost to Follow-up|1|||
27512221|NCT01047553|80070374|FG001|Overall Study|Lost to Follow-up|0|||
27512222|NCT01047553|80070373|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
27512223|NCT01047553|80070374|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
27512224|NCT01047553|80070373|FG000|Overall Study|PI's decision|0|||
27512225|NCT01047553|80070374|FG001|Overall Study|PI's decision|1|||
27512226|NCT01509053|80070377|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
27512227|NCT01509053|80070377|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
27512228|NCT01509053|80070377|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
27512229|NCT01509053|80070377|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
27512230|NCT01509053|80070377|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
27512231|NCT01509053|80070377|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
27512232|NCT01763996|80070381|FG000|Treatment Period 2|Adverse Event|0|||
27512233|NCT01763996|80070382|FG001|Treatment Period 2|Adverse Event|1|||
27512234|NCT02978781|80070383|FG000|Part A|Adverse Event|1|||
27512235|NCT02978781|80070384|FG001|Part A|Adverse Event|1|||
27512236|NCT02978781|80070385|FG002|Part A|Adverse Event|0|||
27512237|NCT02978781|80070386|FG003|Part A|Adverse Event|0|||
27512238|NCT02978781|80070387|FG004|Part A|Adverse Event|0|||
27512239|NCT02978781|80070383|FG000|Part A|Withdrawal by Subject|0|||
27512240|NCT02978781|80070384|FG001|Part A|Withdrawal by Subject|1|||
27512241|NCT02978781|80070385|FG002|Part A|Withdrawal by Subject|0|||
27512242|NCT02978781|80070386|FG003|Part A|Withdrawal by Subject|0|||
27512243|NCT02978781|80070387|FG004|Part A|Withdrawal by Subject|0|||
27512244|NCT02978781|80070383|FG000|Part B|Withdrawal by Subject|0|||
27512245|NCT02978781|80070384|FG001|Part B|Withdrawal by Subject|0|||
27512246|NCT02978781|80070385|FG002|Part B|Withdrawal by Subject|0|||
27512247|NCT02978781|80070386|FG003|Part B|Withdrawal by Subject|1|||
27512248|NCT02978781|80070387|FG004|Part B|Withdrawal by Subject|0|||
27512249|NCT02978781|80070383|FG000|Part C|Adverse Event|0|||
27512250|NCT02978781|80070384|FG001|Part C|Adverse Event|0|||
27512251|NCT02978781|80070385|FG002|Part C|Adverse Event|0|||
27512252|NCT02978781|80070386|FG003|Part C|Adverse Event|0|||
27512253|NCT02978781|80070387|FG004|Part C|Adverse Event|2|||
27512254|NCT02978781|80070383|FG000|Part C|Withdrawal by Subject|0|||
27512255|NCT02978781|80070384|FG001|Part C|Withdrawal by Subject|0|||
27512256|NCT02978781|80070385|FG002|Part C|Withdrawal by Subject|0|||
27512257|NCT02978781|80070386|FG003|Part C|Withdrawal by Subject|0|||
27512258|NCT02978781|80070387|FG004|Part C|Withdrawal by Subject|1|||
27512259|NCT02978781|80070383|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
27512260|NCT02978781|80070384|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
27512261|NCT02978781|80070385|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
27512262|NCT02978781|80070386|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
27512263|NCT02978781|80070387|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
27512264|NCT00865280|80070388|FG000|Overall Study|Withdrawal by Subject|4|||
27512265|NCT00865280|80070389|FG001|Overall Study|Withdrawal by Subject|1|||
27512266|NCT00865280|80070388|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
27512267|NCT00865280|80070389|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
27512268|NCT00865280|80070388|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
27512269|NCT00865280|80070389|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
27512270|NCT00865280|80070388|FG000|Overall Study|Exclusion Condition|1|||
27512271|NCT00865280|80070389|FG001|Overall Study|Exclusion Condition|0|||
27512272|NCT00865280|80070388|FG000|Overall Study|Adverse Event|0|||
27512273|NCT00865280|80070389|FG001|Overall Study|Adverse Event|1|||
27512274|NCT00098813|80070390|FG000|Overall Study|Death|8|||
27512275|NCT00098813|80070390|FG000|Overall Study|Protocol Violation|1|||
27512276|NCT00098813|80070390|FG000|Overall Study|Withdrawal by Subject|7|||
27512277|NCT00098813|80070390|FG000|Overall Study|Progression of Disease|1|||
27512278|NCT00098813|80070390|FG000|Overall Study|Other complicating disease|1|||
27512279|NCT00098813|80070390|FG000|Overall Study|Reversal of RAI resistance|1|||
27512280|NCT00828204|80070391|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
27512281|NCT00828204|80070392|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
27512282|NCT00828204|80070391|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
27512283|NCT00828204|80070392|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
27512284|NCT00828204|80070391|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
27512285|NCT00828204|80070392|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
27512286|NCT00828204|80070391|FG000|Main Study: After Study Restart|Adverse Event|0|||
27512287|NCT00828204|80070392|FG001|Main Study: After Study Restart|Adverse Event|2|||
27512288|NCT00828204|80070391|FG000|Main Study: After Study Restart|Noncompliance|0|||
27512289|NCT00828204|80070392|FG001|Main Study: After Study Restart|Noncompliance|1|||
27512290|NCT00828204|80070391|FG000|Extension Study|Lost to Follow-up|0|||
27512291|NCT00828204|80070392|FG001|Extension Study|Lost to Follow-up|1|||
27512292|NCT00828204|80070391|FG000|Extension Study|Physician Decision|0|||
27512293|NCT00828204|80070392|FG001|Extension Study|Physician Decision|2|||
27512294|NCT01621802|80070393|FG000|Overall Study|Protocol Violation|0|||
27512295|NCT01621802|80070394|FG001|Overall Study|Protocol Violation|0|||
27512296|NCT01621802|80070395|FG002|Overall Study|Protocol Violation|0|||
27512297|NCT01621802|80070396|FG003|Overall Study|Protocol Violation|0|||
27512298|NCT01621802|80070397|FG004|Overall Study|Protocol Violation|0|||
27512299|NCT01621802|80070398|FG005|Overall Study|Protocol Violation|1|||
27512300|NCT01621802|80070393|FG000|Overall Study|Withdrawal by Subject|8|||
27512301|NCT01621802|80070394|FG001|Overall Study|Withdrawal by Subject|4|||
27512302|NCT01621802|80070395|FG002|Overall Study|Withdrawal by Subject|4|||
27615302|NCT02769065|80434119|FG001|Overall Study|Voluntary Withdrawal|0|||
27615303|NCT02769065|80434120|FG002|Overall Study|Voluntary Withdrawal|0|||
27512303|NCT01621802|80070396|FG003|Overall Study|Withdrawal by Subject|2|||
27512304|NCT01621802|80070397|FG004|Overall Study|Withdrawal by Subject|2|||
27512305|NCT01621802|80070398|FG005|Overall Study|Withdrawal by Subject|0|||
27512306|NCT01621802|80070393|FG000|Overall Study|Migrated/moved from study area|0|||
27512307|NCT01621802|80070394|FG001|Overall Study|Migrated/moved from study area|0|||
27512308|NCT01621802|80070395|FG002|Overall Study|Migrated/moved from study area|2|||
27512309|NCT01621802|80070396|FG003|Overall Study|Migrated/moved from study area|0|||
27512310|NCT01621802|80070397|FG004|Overall Study|Migrated/moved from study area|1|||
27512311|NCT01621802|80070398|FG005|Overall Study|Migrated/moved from study area|0|||
27512312|NCT01621802|80070393|FG000|Overall Study|Others|3|||
27512313|NCT01621802|80070394|FG001|Overall Study|Others|3|||
27512314|NCT01621802|80070395|FG002|Overall Study|Others|3|||
27512315|NCT01621802|80070396|FG003|Overall Study|Others|2|||
27512316|NCT01621802|80070397|FG004|Overall Study|Others|1|||
27512317|NCT01621802|80070398|FG005|Overall Study|Others|0|||
27512318|NCT01621802|80070393|FG000|Overall Study|Lost to Follow-up|36|||
27512319|NCT01621802|80070394|FG001|Overall Study|Lost to Follow-up|16|||
27512320|NCT01621802|80070395|FG002|Overall Study|Lost to Follow-up|24|||
27512321|NCT01621802|80070396|FG003|Overall Study|Lost to Follow-up|7|||
27512322|NCT01621802|80070397|FG004|Overall Study|Lost to Follow-up|31|||
27512323|NCT01621802|80070398|FG005|Overall Study|Lost to Follow-up|11|||
27512324|NCT01253577|80070399|FG000|Overall Study|Lost to Follow-up|3|||
27512325|NCT01467960|80070402|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
27512326|NCT01467960|80070403|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
27512327|NCT01467960|80070404|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
27512328|NCT01467960|80070405|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
27512329|NCT01467960|80070406|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
27512330|NCT01467960|80070407|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
27512331|NCT02425943|80070408|FG000|Overall Study|Adverse Event|3|||
27512332|NCT02425943|80070409|FG001|Overall Study|Adverse Event|1|||
27512333|NCT02425943|80070408|FG000|Overall Study|Lost to Follow-up|59|||
27512334|NCT02425943|80070409|FG001|Overall Study|Lost to Follow-up|37|||
27512335|NCT02425943|80070408|FG000|Overall Study|Protocol Violation|4|||
27512336|NCT02425943|80070409|FG001|Overall Study|Protocol Violation|1|||
27512337|NCT02425943|80070408|FG000|Overall Study|Withdrawal by Subject|64|||
27512338|NCT02425943|80070409|FG001|Overall Study|Withdrawal by Subject|31|||
27512339|NCT02425943|80070408|FG000|Overall Study|Other|6|||
27512340|NCT02425943|80070409|FG001|Overall Study|Other|0|||
27512341|NCT02722304|80070410|FG000|Overall Study|Study Terminated by Sponsor|1|||
27512342|NCT02722304|80070411|FG001|Overall Study|Study Terminated by Sponsor|0|||
27512343|NCT02722304|80070412|FG002|Overall Study|Study Terminated by Sponsor|2|||
27512344|NCT02722304|80070413|FG003|Overall Study|Study Terminated by Sponsor|1|||
27512345|NCT02722304|80070414|FG004|Overall Study|Study Terminated by Sponsor|1|||
27512346|NCT02722304|80070410|FG000|Overall Study|Other|0|||
27512347|NCT02722304|80070411|FG001|Overall Study|Other|0|||
27512348|NCT02722304|80070412|FG002|Overall Study|Other|0|||
27512349|NCT02722304|80070413|FG003|Overall Study|Other|1|||
27512350|NCT02722304|80070414|FG004|Overall Study|Other|1|||
27512351|NCT00363480|80070417|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
27512352|NCT00363480|80070417|FG000|Overall Study|Adverse Event|4|||
27512353|NCT00363480|80070417|FG000|Overall Study|Lost to Follow-up|5|||
27512354|NCT00363480|80070417|FG000|Overall Study|Withdrawal by Subject|5|||
27512355|NCT00363480|80070417|FG000|Overall Study|Non-compliance of subject|1|||
27512356|NCT00363480|80070417|FG000|Overall Study|Participant discontinued on its own|1|||
27512357|NCT02280408|80070418|FG000|Overall Study|Lost to Follow-up|0|||
27512358|NCT02280408|80070419|FG001|Overall Study|Lost to Follow-up|2|||
27512359|NCT02280408|80070420|FG002|Overall Study|Lost to Follow-up|0|||
27512360|NCT02280408|80070421|FG003|Overall Study|Lost to Follow-up|0|||
27512361|NCT01781299|80070424|FG000|Overall Study|Withdrawal by Subject|0|||
27512362|NCT01781299|80070425|FG001|Overall Study|Withdrawal by Subject|1|||
27512363|NCT02282605|80070426|FG000|Overall Study|negative SA result on Day -1|3|||
27512364|NCT02282605|80070427|FG001|Overall Study|negative SA result on Day -1|0|||
27512365|NCT02282605|80070428|FG002|Overall Study|negative SA result on Day -1|0|||
27512366|NCT02399163|80070429|FG000|Overall Study|Adverse Event|2|||
27512367|NCT02399163|80070429|FG000|Overall Study|Protocol Deviation|2|||
27512368|NCT02399163|80070429|FG000|Overall Study|Withdrawal by Participant|5|||
27512369|NCT04413617|80070431|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27512370|NCT04413617|80070432|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27512371|NCT04413617|80070433|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27512372|NCT04413617|80070434|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
27512373|NCT04413617|80070435|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
27512374|NCT04413617|80070431|FG000|Overall Study|Protocol Violation|0|||
27512375|NCT04413617|80070432|FG001|Overall Study|Protocol Violation|1|||
27906194|NCT03442088|81493359|FG000|Overall Study|Lost to Follow-up|2|||
27512376|NCT04413617|80070433|FG002|Overall Study|Protocol Violation|0|||
27512377|NCT04413617|80070434|FG003|Overall Study|Protocol Violation|0|||
27512378|NCT04413617|80070435|FG004|Overall Study|Protocol Violation|1|||
27512379|NCT04413617|80070431|FG000|Overall Study|Lack of Efficacy|2|||
27512380|NCT04413617|80070432|FG001|Overall Study|Lack of Efficacy|0|||
27512381|NCT04413617|80070433|FG002|Overall Study|Lack of Efficacy|2|||
27512382|NCT04413617|80070434|FG003|Overall Study|Lack of Efficacy|1|||
27512383|NCT04413617|80070435|FG004|Overall Study|Lack of Efficacy|0|||
27512384|NCT04413617|80070431|FG000|Overall Study|Withdrawal by Subject|3|||
27512385|NCT04413617|80070432|FG001|Overall Study|Withdrawal by Subject|4|||
27512386|NCT04413617|80070433|FG002|Overall Study|Withdrawal by Subject|2|||
27512387|NCT04413617|80070434|FG003|Overall Study|Withdrawal by Subject|5|||
27512388|NCT04413617|80070435|FG004|Overall Study|Withdrawal by Subject|3|||
27512389|NCT04413617|80070431|FG000|Overall Study|Death|1|||
27512390|NCT04413617|80070432|FG001|Overall Study|Death|0|||
27512391|NCT04413617|80070433|FG002|Overall Study|Death|0|||
27512392|NCT04413617|80070434|FG003|Overall Study|Death|0|||
27512393|NCT04413617|80070435|FG004|Overall Study|Death|0|||
27512394|NCT04413617|80070431|FG000|Overall Study|Adverse Event|1|||
27512395|NCT04413617|80070432|FG001|Overall Study|Adverse Event|0|||
27512396|NCT04413617|80070433|FG002|Overall Study|Adverse Event|0|||
27512397|NCT04413617|80070434|FG003|Overall Study|Adverse Event|1|||
27512398|NCT04413617|80070435|FG004|Overall Study|Adverse Event|1|||
27512399|NCT04413617|80070431|FG000|Overall Study|COVID-19|0|||
27512400|NCT04413617|80070432|FG001|Overall Study|COVID-19|1|||
27512401|NCT04413617|80070433|FG002|Overall Study|COVID-19|0|||
27512402|NCT04413617|80070434|FG003|Overall Study|COVID-19|0|||
27512403|NCT04413617|80070435|FG004|Overall Study|COVID-19|0|||
27512404|NCT01583296|80070436|FG000|Overall Study|Withdrawal by Subject|11|||
27512405|NCT01583296|80070437|FG001|Overall Study|Withdrawal by Subject|10|||
27512406|NCT00387790|80070438|FG000|Overall Study|Adverse Event|5|||
27512407|NCT00387790|80070438|FG000|Overall Study|Lack of Efficacy|2|||
27512408|NCT00387790|80070438|FG000|Overall Study|Physician Decision|2|||
27512409|NCT00387790|80070438|FG000|Overall Study|Withdrawal by Subject|3|||
27512410|NCT00387790|80070438|FG000|Overall Study|Ineligible for study|2|||
27512411|NCT00775190|80070443|FG000|Overall Study|Lost to Follow-up|2|||
27512412|NCT00775190|80070444|FG001|Overall Study|Lost to Follow-up|3|||
27512413|NCT00775190|80070443|FG000|Overall Study|Withdrawal by Subject|1|||
27512414|NCT00775190|80070444|FG001|Overall Study|Withdrawal by Subject|2|||
27512415|NCT00775190|80070443|FG000|Overall Study|Protocol Violation|1|||
27512416|NCT00775190|80070444|FG001|Overall Study|Protocol Violation|0|||
27512417|NCT03070964|80070445|FG000|Overall Study|Progressive disease|8|||
27512418|NCT03070964|80070445|FG000|Overall Study|Treatment-unrelated adverse event|2|||
27512419|NCT03070964|80070445|FG000|Overall Study|Never treated|1|||
27512420|NCT03070964|80070445|FG000|Overall Study|Physician Decision|1|||
27512421|NCT03070964|80070445|FG000|Overall Study|Withdrawal by Subject|1|||
27512422|NCT03070964|80070445|FG000|Overall Study|Adverse Event|1|||
27512423|NCT02223858|80070450|FG000|Overall Study|Death|1|||
27512424|NCT02223858|80070451|FG001|Overall Study|Death|1|||
27512425|NCT02223858|80070450|FG000|Overall Study|Lost to Follow-up|6|||
27512426|NCT02223858|80070451|FG001|Overall Study|Lost to Follow-up|11|||
27512427|NCT02223858|80070450|FG000|Overall Study|Withdrawal by Subject|8|||
27512428|NCT02223858|80070451|FG001|Overall Study|Withdrawal by Subject|5|||
27512429|NCT02223858|80070450|FG000|Overall Study|Refused|9|||
27512430|NCT02223858|80070451|FG001|Overall Study|Refused|9|||
27512431|NCT03983317|80070452|FG000|Overall Study|Physician Decision|5|||
27512432|NCT03158285|80070468|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
27512433|NCT03158285|80070469|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
27512434|NCT03158285|80070470|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
27512435|NCT03158285|80070468|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
27906195|NCT01972464|81493363|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
27906196|NCT01972464|81493364|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
27906197|NCT01972464|81493363|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
27906198|NCT01972464|81493364|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
27906199|NCT01972464|81493363|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
27906200|NCT01972464|81493364|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
27906201|NCT01972464|81493363|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
27906202|NCT01972464|81493364|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
27906203|NCT00069823|81493365|FG000|Overall Study|Did not have follow-up diary cards|6|||
27906204|NCT00069823|81493366|FG001|Overall Study|Did not have follow-up diary cards|3|||
27906205|NCT01687283|81493367|FG000|Overall Study|Adverse Event|11|||
27512436|NCT03158285|80070469|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
27512437|NCT03158285|80070470|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
27512438|NCT03158285|80070468|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
27512439|NCT03158285|80070469|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
27512440|NCT03158285|80070470|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
27906206|NCT01687283|81493368|FG001|Overall Study|Adverse Event|4|||
27906207|NCT01687283|81493367|FG000|Overall Study|Lack of Efficacy|3|||
27906208|NCT01687283|81493368|FG001|Overall Study|Lack of Efficacy|1|||
27906209|NCT01687283|81493367|FG000|Overall Study|Protocol Violation|1|||
27906210|NCT01687283|81493368|FG001|Overall Study|Protocol Violation|3|||
27512441|NCT03158285|80070468|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27512442|NCT03158285|80070469|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
27512443|NCT03158285|80070470|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
27512444|NCT03158285|80070468|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
27512445|NCT03158285|80070469|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
27512446|NCT03158285|80070470|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
27512447|NCT03158285|80070468|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
27512448|NCT03158285|80070469|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
27512449|NCT03158285|80070470|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
27512450|NCT03158285|80070468|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
27512451|NCT03158285|80070469|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
27512452|NCT03158285|80070470|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
27512453|NCT03158285|80070468|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
27512454|NCT03158285|80070469|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
27853058|NCT04049617|81291303|FG001|Overall Study|Lost to Follow-up|0|||
27853059|NCT04049617|81291304|FG002|Overall Study|Lost to Follow-up|0|||
27853060|NCT04049617|81291305|FG003|Overall Study|Lost to Follow-up|1|||
27853061|NCT04049617|81291306|FG004|Overall Study|Lost to Follow-up|0|||
27853062|NCT04049617|81291307|FG005|Overall Study|Lost to Follow-up|0|||
27853063|NCT04049617|81291302|FG000|Overall Study|Withdrew consent|0|||
27853064|NCT04049617|81291303|FG001|Overall Study|Withdrew consent|0|||
27512455|NCT03158285|80070470|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
27512456|NCT03158285|80070468|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
27512457|NCT03158285|80070469|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
27512458|NCT03158285|80070470|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
27512459|NCT03158285|80070468|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
27512460|NCT03158285|80070469|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
27512461|NCT03158285|80070470|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
27512462|NCT03158285|80070468|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
27512463|NCT03158285|80070469|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
27512464|NCT03158285|80070470|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
27512465|NCT03158285|80070468|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
27512466|NCT03158285|80070469|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
27512467|NCT03158285|80070470|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
27512468|NCT03158285|80070468|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
27512469|NCT03158285|80070469|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
27512470|NCT03158285|80070470|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
27615304|NCT02769065|80434121|FG003|Overall Study|Voluntary Withdrawal|0|||
27615305|NCT02769065|80434122|FG004|Overall Study|Voluntary Withdrawal|0|||
27853065|NCT04049617|81291304|FG002|Overall Study|Withdrew consent|1|||
27512471|NCT03158285|80070468|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
27512472|NCT03158285|80070469|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
27512473|NCT03158285|80070470|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
27512474|NCT03158285|80070468|FG000|Active Treatment Period: Week 52-100|Death|1|||
27512475|NCT03158285|80070469|FG001|Active Treatment Period: Week 52-100|Death|0|||
27512476|NCT03158285|80070470|FG002|Active Treatment Period: Week 52-100|Death|0|||
27512477|NCT03158285|80070468|FG000|Active Treatment Period: Week 52-100|Other|4|||
27512478|NCT03158285|80070469|FG001|Active Treatment Period: Week 52-100|Other|1|||
27512479|NCT03158285|80070470|FG002|Active Treatment Period: Week 52-100|Other|0|||
27512480|NCT02175030|80070471|FG000|Overall Study|Failed screen after consent|7|||
27512481|NCT02175030|80070472|FG001|Overall Study|Failed screen after consent|6|||
27512482|NCT02175030|80070471|FG000|Overall Study|Failed IUD Insertion|20|||
27512483|NCT02175030|80070472|FG001|Overall Study|Failed IUD Insertion|21|||
27512484|NCT02175030|80070471|FG000|Overall Study|Physician Decision|1|||
27512485|NCT02175030|80070472|FG001|Overall Study|Physician Decision|1|||
27512486|NCT02175030|80070471|FG000|Overall Study|Lost to Follow-up|6|||
27512487|NCT02175030|80070472|FG001|Overall Study|Lost to Follow-up|6|||
27512488|NCT02175030|80070471|FG000|Overall Study|Withdrawal by Subject|1|||
27512489|NCT02175030|80070472|FG001|Overall Study|Withdrawal by Subject|4|||
27512490|NCT03695367|80070475|FG000|Overall Study|Missed the Day 28 visit.|1|||
27512491|NCT03695367|80070476|FG001|Overall Study|Missed the Day 28 visit.|0|||
27512492|NCT03695367|80070475|FG000|Overall Study|Lost to Follow-up|0|||
27512493|NCT03695367|80070476|FG001|Overall Study|Lost to Follow-up|1|||
27512494|NCT03695367|80070475|FG000|Overall Study|Withdrawal by Subject|0|||
27512495|NCT03695367|80070476|FG001|Overall Study|Withdrawal by Subject|1|||
27512496|NCT03695367|80070475|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
27512497|NCT03695367|80070476|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
27512498|NCT02167139|80070479|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
27512499|NCT02167139|80070480|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
27512500|NCT02167139|80070481|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
27512501|NCT02167139|80070482|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
27512502|NCT02167139|80070479|FG000|Randomised, Double-blind|Adverse Event|2|||
27512503|NCT02167139|80070480|FG001|Randomised, Double-blind|Adverse Event|9|||
27512504|NCT02167139|80070481|FG002|Randomised, Double-blind|Adverse Event|0|||
27512505|NCT02167139|80070482|FG003|Randomised, Double-blind|Adverse Event|0|||
27512506|NCT02167139|80070479|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
27512507|NCT02167139|80070480|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
27512508|NCT02167139|80070481|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
27512509|NCT02167139|80070482|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
27512510|NCT02167139|80070479|FG000|Randomised, Double-blind|Other|3|||
27512511|NCT02167139|80070480|FG001|Randomised, Double-blind|Other|0|||
27512512|NCT02167139|80070481|FG002|Randomised, Double-blind|Other|0|||
27512513|NCT02167139|80070482|FG003|Randomised, Double-blind|Other|0|||
27512514|NCT02167139|80070479|FG000|Transition-extension|Adverse Event|2|||
27512515|NCT02167139|80070480|FG001|Transition-extension|Adverse Event|0|||
27512516|NCT02167139|80070481|FG002|Transition-extension|Adverse Event|2|||
27512517|NCT02167139|80070482|FG003|Transition-extension|Adverse Event|3|||
27512518|NCT02167139|80070479|FG000|Transition-extension|Withdrawal by Subject|2|||
27512519|NCT02167139|80070480|FG001|Transition-extension|Withdrawal by Subject|0|||
27512520|NCT02167139|80070481|FG002|Transition-extension|Withdrawal by Subject|4|||
27512521|NCT02167139|80070482|FG003|Transition-extension|Withdrawal by Subject|1|||
27512522|NCT02167139|80070479|FG000|Transition-extension|Lack of Efficacy|0|||
27512523|NCT02167139|80070480|FG001|Transition-extension|Lack of Efficacy|0|||
27512524|NCT02167139|80070481|FG002|Transition-extension|Lack of Efficacy|1|||
27512525|NCT02167139|80070482|FG003|Transition-extension|Lack of Efficacy|1|||
27512526|NCT02167139|80070479|FG000|Transition-extension|Other|1|||
27512527|NCT02167139|80070480|FG001|Transition-extension|Other|0|||
27512528|NCT02167139|80070481|FG002|Transition-extension|Other|1|||
27512529|NCT02167139|80070482|FG003|Transition-extension|Other|0|||
27512530|NCT02167139|80070479|FG000|Transition-extension|Lost to Follow-up|1|||
27512531|NCT02167139|80070480|FG001|Transition-extension|Lost to Follow-up|0|||
27512532|NCT02167139|80070481|FG002|Transition-extension|Lost to Follow-up|0|||
27853066|NCT04049617|81291305|FG003|Overall Study|Withdrew consent|0|||
27853067|NCT04049617|81291306|FG004|Overall Study|Withdrew consent|0|||
27512533|NCT02167139|80070482|FG003|Transition-extension|Lost to Follow-up|0|||
27853068|NCT04049617|81291307|FG005|Overall Study|Withdrew consent|0|||
27512534|NCT03554486|80070484|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
27512535|NCT03554486|80070485|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
27512536|NCT03554486|80070486|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
27512537|NCT03554486|80070484|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
27512538|NCT03554486|80070485|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
27512539|NCT03554486|80070486|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
27853069|NCT03439852|81291312|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
27512540|NCT03554486|80070484|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
27512541|NCT03554486|80070485|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
27512542|NCT03554486|80070486|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
27512543|NCT01160822|80070492|FG000|Overall Study|Adverse Event|0|||
27512544|NCT01160822|80070493|FG001|Overall Study|Adverse Event|0|||
27512545|NCT01160822|80070494|FG002|Overall Study|Adverse Event|0|||
27512546|NCT01160822|80070495|FG003|Overall Study|Adverse Event|0|||
27512547|NCT01160822|80070496|FG004|Overall Study|Adverse Event|1|||
27512548|NCT01160822|80070497|FG005|Overall Study|Adverse Event|2|||
27512549|NCT01160822|80070498|FG006|Overall Study|Adverse Event|5|||
27512550|NCT01160822|80070492|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27512551|NCT01160822|80070493|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27512552|NCT01160822|80070494|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27512553|NCT01160822|80070495|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27512554|NCT01160822|80070496|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
27512555|NCT01160822|80070497|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
27512556|NCT01160822|80070498|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
27512557|NCT01160822|80070492|FG000|Overall Study|Withdrawal by Subject|0|||
27512558|NCT01160822|80070493|FG001|Overall Study|Withdrawal by Subject|0|||
27512559|NCT01160822|80070494|FG002|Overall Study|Withdrawal by Subject|0|||
27512560|NCT01160822|80070495|FG003|Overall Study|Withdrawal by Subject|0|||
27512561|NCT01160822|80070496|FG004|Overall Study|Withdrawal by Subject|0|||
27512562|NCT01160822|80070497|FG005|Overall Study|Withdrawal by Subject|0|||
27512563|NCT01160822|80070498|FG006|Overall Study|Withdrawal by Subject|1|||
27512564|NCT01160822|80070492|FG000|Overall Study|Lost to Follow-up|0|||
27512565|NCT01160822|80070493|FG001|Overall Study|Lost to Follow-up|0|||
27512566|NCT01160822|80070494|FG002|Overall Study|Lost to Follow-up|0|||
27512567|NCT01160822|80070495|FG003|Overall Study|Lost to Follow-up|0|||
27512568|NCT01160822|80070496|FG004|Overall Study|Lost to Follow-up|1|||
27512569|NCT01160822|80070497|FG005|Overall Study|Lost to Follow-up|0|||
27512570|NCT01160822|80070498|FG006|Overall Study|Lost to Follow-up|0|||
27512571|NCT01160822|80070492|FG000|Overall Study|Administrative problems|0|||
27512572|NCT01160822|80070493|FG001|Overall Study|Administrative problems|0|||
27512573|NCT01160822|80070494|FG002|Overall Study|Administrative problems|0|||
27512574|NCT01160822|80070495|FG003|Overall Study|Administrative problems|0|||
27512575|NCT01160822|80070496|FG004|Overall Study|Administrative problems|1|||
27512576|NCT01160822|80070497|FG005|Overall Study|Administrative problems|0|||
27512577|NCT01160822|80070498|FG006|Overall Study|Administrative problems|0|||
27512578|NCT01160822|80070492|FG000|Overall Study|Protocol deviation|0|||
27512579|NCT01160822|80070493|FG001|Overall Study|Protocol deviation|0|||
27512580|NCT01160822|80070494|FG002|Overall Study|Protocol deviation|0|||
27512581|NCT01160822|80070495|FG003|Overall Study|Protocol deviation|0|||
27512582|NCT01160822|80070496|FG004|Overall Study|Protocol deviation|2|||
27512583|NCT01160822|80070497|FG005|Overall Study|Protocol deviation|0|||
27512584|NCT01160822|80070498|FG006|Overall Study|Protocol deviation|0|||
27512585|NCT00380367|80070500|FG000|Overall Study|Lost to Follow-up|1|||
27512586|NCT00380367|80070500|FG000|Overall Study|Withdrawal by Subject|1|||
27512587|NCT00433004|80070501|FG000|Overall Study|Lost to Follow-up|5|||
27512588|NCT00433004|80070502|FG001|Overall Study|Lost to Follow-up|7|||
27512589|NCT01088048|80070506|FG000|Overall Study|Adverse Event|7|||
27512590|NCT01088048|80070507|FG001|Overall Study|Adverse Event|9|||
27512591|NCT01088048|80070508|FG002|Overall Study|Adverse Event|7|||
27512592|NCT01088048|80070509|FG003|Overall Study|Adverse Event|5|||
27512593|NCT01088048|80070510|FG004|Overall Study|Adverse Event|6|||
27512594|NCT01088048|80070511|FG005|Overall Study|Adverse Event|3|||
27615306|NCT02769065|80434123|FG005|Overall Study|Voluntary Withdrawal|0|||
27615307|NCT02769065|80434124|FG006|Overall Study|Voluntary Withdrawal|0|||
27615308|NCT02769065|80434125|FG007|Overall Study|Voluntary Withdrawal|0|||
27615309|NCT02769065|80434126|FG008|Overall Study|Voluntary Withdrawal|0|||
27615310|NCT02769065|80434127|FG009|Overall Study|Voluntary Withdrawal|0|||
27615311|NCT02769065|80434128|FG010|Overall Study|Voluntary Withdrawal|0|||
27615312|NCT02769065|80434129|FG011|Overall Study|Voluntary Withdrawal|0|||
27512595|NCT01088048|80070512|FG006|Overall Study|Adverse Event|3|||
27512596|NCT01088048|80070513|FG007|Overall Study|Adverse Event|0|||
27512597|NCT01088048|80070514|FG008|Overall Study|Adverse Event|2|||
27512598|NCT01088048|80070515|FG009|Overall Study|Adverse Event|2|||
27512599|NCT01088048|80070506|FG000|Overall Study|Withdrew Consent|1|||
27512600|NCT01088048|80070507|FG001|Overall Study|Withdrew Consent|1|||
27512601|NCT01088048|80070508|FG002|Overall Study|Withdrew Consent|1|||
27512602|NCT01088048|80070509|FG003|Overall Study|Withdrew Consent|1|||
27615313|NCT02769065|80434130|FG012|Overall Study|Voluntary Withdrawal|0|||
27512603|NCT01088048|80070510|FG004|Overall Study|Withdrew Consent|2|||
27512604|NCT01088048|80070511|FG005|Overall Study|Withdrew Consent|1|||
27512605|NCT01088048|80070512|FG006|Overall Study|Withdrew Consent|0|||
27512606|NCT01088048|80070513|FG007|Overall Study|Withdrew Consent|2|||
27512607|NCT01088048|80070514|FG008|Overall Study|Withdrew Consent|2|||
27512608|NCT01088048|80070515|FG009|Overall Study|Withdrew Consent|1|||
27512609|NCT01088048|80070506|FG000|Overall Study|Concomitant Medication Prohibited|1|||
27512610|NCT01088048|80070507|FG001|Overall Study|Concomitant Medication Prohibited|0|||
27512611|NCT01088048|80070508|FG002|Overall Study|Concomitant Medication Prohibited|0|||
27512612|NCT01088048|80070509|FG003|Overall Study|Concomitant Medication Prohibited|0|||
27512613|NCT01088048|80070510|FG004|Overall Study|Concomitant Medication Prohibited|0|||
27512614|NCT01088048|80070511|FG005|Overall Study|Concomitant Medication Prohibited|0|||
27512615|NCT01088048|80070512|FG006|Overall Study|Concomitant Medication Prohibited|0|||
27512616|NCT01088048|80070513|FG007|Overall Study|Concomitant Medication Prohibited|0|||
27512617|NCT01088048|80070514|FG008|Overall Study|Concomitant Medication Prohibited|0|||
27512618|NCT01088048|80070515|FG009|Overall Study|Concomitant Medication Prohibited|0|||
27512619|NCT01088048|80070506|FG000|Overall Study|Investigator Request|2|||
27512620|NCT01088048|80070507|FG001|Overall Study|Investigator Request|2|||
27512621|NCT01088048|80070508|FG002|Overall Study|Investigator Request|0|||
27512622|NCT01088048|80070509|FG003|Overall Study|Investigator Request|0|||
27512623|NCT01088048|80070510|FG004|Overall Study|Investigator Request|3|||
27512624|NCT01088048|80070511|FG005|Overall Study|Investigator Request|1|||
27512625|NCT01088048|80070512|FG006|Overall Study|Investigator Request|1|||
27512626|NCT01088048|80070513|FG007|Overall Study|Investigator Request|0|||
27512627|NCT01088048|80070514|FG008|Overall Study|Investigator Request|0|||
27512628|NCT01088048|80070515|FG009|Overall Study|Investigator Request|0|||
27512629|NCT01088048|80070506|FG000|Overall Study|Patient Non-compliance|0|||
27512630|NCT01088048|80070507|FG001|Overall Study|Patient Non-compliance|1|||
27512631|NCT01088048|80070508|FG002|Overall Study|Patient Non-compliance|0|||
27512632|NCT01088048|80070509|FG003|Overall Study|Patient Non-compliance|0|||
27512633|NCT01088048|80070510|FG004|Overall Study|Patient Non-compliance|0|||
27512634|NCT01088048|80070511|FG005|Overall Study|Patient Non-compliance|0|||
27512635|NCT01088048|80070512|FG006|Overall Study|Patient Non-compliance|0|||
27512636|NCT01088048|80070513|FG007|Overall Study|Patient Non-compliance|0|||
27512637|NCT01088048|80070514|FG008|Overall Study|Patient Non-compliance|0|||
27512638|NCT01088048|80070515|FG009|Overall Study|Patient Non-compliance|0|||
27512639|NCT01088048|80070506|FG000|Overall Study|Disease Progression|7|||
27512640|NCT01088048|80070507|FG001|Overall Study|Disease Progression|4|||
27512641|NCT01088048|80070508|FG002|Overall Study|Disease Progression|3|||
27512642|NCT01088048|80070509|FG003|Overall Study|Disease Progression|5|||
27512643|NCT01088048|80070510|FG004|Overall Study|Disease Progression|3|||
27512644|NCT01088048|80070511|FG005|Overall Study|Disease Progression|3|||
27512645|NCT01088048|80070512|FG006|Overall Study|Disease Progression|2|||
27512646|NCT01088048|80070513|FG007|Overall Study|Disease Progression|1|||
27512647|NCT01088048|80070514|FG008|Overall Study|Disease Progression|0|||
27512648|NCT01088048|80070515|FG009|Overall Study|Disease Progression|0|||
27512649|NCT01088048|80070506|FG000|Overall Study|Death|1|||
27512650|NCT01088048|80070507|FG001|Overall Study|Death|5|||
27512651|NCT01088048|80070508|FG002|Overall Study|Death|3|||
27512652|NCT01088048|80070509|FG003|Overall Study|Death|3|||
27512653|NCT01088048|80070510|FG004|Overall Study|Death|1|||
27512654|NCT01088048|80070511|FG005|Overall Study|Death|3|||
27512655|NCT01088048|80070512|FG006|Overall Study|Death|0|||
27512656|NCT01088048|80070513|FG007|Overall Study|Death|0|||
27512657|NCT01088048|80070514|FG008|Overall Study|Death|3|||
27512658|NCT01088048|80070515|FG009|Overall Study|Death|1|||
27512659|NCT01088048|80070506|FG000|Overall Study|Other|3|||
27512660|NCT01088048|80070507|FG001|Overall Study|Other|5|||
27512661|NCT01088048|80070508|FG002|Overall Study|Other|0|||
27512662|NCT01088048|80070509|FG003|Overall Study|Other|0|||
27512663|NCT01088048|80070510|FG004|Overall Study|Other|2|||
27512664|NCT01088048|80070511|FG005|Overall Study|Other|0|||
27512665|NCT01088048|80070512|FG006|Overall Study|Other|0|||
27512666|NCT01088048|80070513|FG007|Overall Study|Other|2|||
27512667|NCT01088048|80070514|FG008|Overall Study|Other|0|||
27512668|NCT01088048|80070515|FG009|Overall Study|Other|0|||
27512669|NCT01677377|80070516|FG000|Overall Study|Protocol Violation|1|||
27512670|NCT01677377|80070517|FG001|Overall Study|Protocol Violation|0|||
27615314|NCT02769065|80434131|FG013|Overall Study|Voluntary Withdrawal|0|||
27615315|NCT02769065|80434132|FG014|Overall Study|Voluntary Withdrawal|0|||
27906211|NCT01687283|81493367|FG000|Overall Study|protocol defined stopping criteria|8|||
27512671|NCT01677377|80070518|FG002|Overall Study|Protocol Violation|0|||
27512672|NCT01677377|80070516|FG000|Overall Study|Lost to Follow-up|0|||
27512673|NCT01677377|80070517|FG001|Overall Study|Lost to Follow-up|1|||
27512674|NCT01677377|80070518|FG002|Overall Study|Lost to Follow-up|1|||
27615316|NCT02769065|80434133|FG015|Overall Study|Voluntary Withdrawal|0|||
27512675|NCT01677377|80070516|FG000|Overall Study|Withdrawal by Subject|0|||
27512676|NCT01677377|80070517|FG001|Overall Study|Withdrawal by Subject|0|||
27512677|NCT01677377|80070518|FG002|Overall Study|Withdrawal by Subject|3|||
27512678|NCT01677377|80070516|FG000|Overall Study|Lack of Efficacy|0|||
27512679|NCT01677377|80070517|FG001|Overall Study|Lack of Efficacy|0|||
27512680|NCT01677377|80070518|FG002|Overall Study|Lack of Efficacy|1|||
27512681|NCT01677377|80070516|FG000|Overall Study|Pregnancy|0|||
27512682|NCT01677377|80070517|FG001|Overall Study|Pregnancy|0|||
27615317|NCT02769065|80434134|FG016|Overall Study|Voluntary Withdrawal|0|||
27512683|NCT01677377|80070518|FG002|Overall Study|Pregnancy|1|||
27512684|NCT00643162|80070521|FG000|Overall Study|Withdrawal by Subject|1|||
27512685|NCT00643162|80070522|FG001|Overall Study|Withdrawal by Subject|1|||
27512686|NCT01716052|80070527|FG000|Overall Study|Withdrawal of funding|1|||
27512687|NCT01716052|80070528|FG001|Overall Study|Withdrawal of funding|1|||
27512688|NCT01229267|80070529|FG000|Overall Study|Adverse Event|4|||
27512689|NCT01229267|80070530|FG001|Overall Study|Adverse Event|6|||
27512690|NCT01229267|80070531|FG002|Overall Study|Adverse Event|3|||
27512691|NCT01229267|80070532|FG003|Overall Study|Adverse Event|2|||
27512692|NCT01229267|80070533|FG004|Overall Study|Adverse Event|10|||
27512693|NCT01229267|80070529|FG000|Overall Study|Death|40|||
27512694|NCT01229267|80070530|FG001|Overall Study|Death|37|||
27512695|NCT01229267|80070531|FG002|Overall Study|Death|35|||
27512696|NCT01229267|80070532|FG003|Overall Study|Death|13|||
27512697|NCT01229267|80070533|FG004|Overall Study|Death|103|||
27512698|NCT01229267|80070529|FG000|Overall Study|Withdrawal by Subject|23|||
27512699|NCT01229267|80070530|FG001|Overall Study|Withdrawal by Subject|22|||
27512700|NCT01229267|80070531|FG002|Overall Study|Withdrawal by Subject|32|||
27512701|NCT01229267|80070532|FG003|Overall Study|Withdrawal by Subject|14|||
27512702|NCT01229267|80070533|FG004|Overall Study|Withdrawal by Subject|59|||
27512703|NCT01229267|80070529|FG000|Overall Study|Protocol Violation|0|||
27512704|NCT01229267|80070530|FG001|Overall Study|Protocol Violation|1|||
27512705|NCT01229267|80070531|FG002|Overall Study|Protocol Violation|0|||
27512706|NCT01229267|80070532|FG003|Overall Study|Protocol Violation|0|||
27512707|NCT01229267|80070533|FG004|Overall Study|Protocol Violation|0|||
27512708|NCT01229267|80070529|FG000|Overall Study|Progressive disease|0|||
27512709|NCT01229267|80070530|FG001|Overall Study|Progressive disease|0|||
27512710|NCT01229267|80070531|FG002|Overall Study|Progressive disease|0|||
27512711|NCT01229267|80070532|FG003|Overall Study|Progressive disease|0|||
27512712|NCT01229267|80070533|FG004|Overall Study|Progressive disease|1|||
27512713|NCT01229267|80070529|FG000|Overall Study|Physician Decision|8|||
27512714|NCT01229267|80070530|FG001|Overall Study|Physician Decision|11|||
27512715|NCT01229267|80070531|FG002|Overall Study|Physician Decision|8|||
27512716|NCT01229267|80070532|FG003|Overall Study|Physician Decision|3|||
27512717|NCT01229267|80070533|FG004|Overall Study|Physician Decision|25|||
27512718|NCT01229267|80070529|FG000|Overall Study|Lost to Follow-up|6|||
27512719|NCT01229267|80070530|FG001|Overall Study|Lost to Follow-up|5|||
27512720|NCT01229267|80070531|FG002|Overall Study|Lost to Follow-up|8|||
27512721|NCT01229267|80070532|FG003|Overall Study|Lost to Follow-up|3|||
27512722|NCT01229267|80070533|FG004|Overall Study|Lost to Follow-up|22|||
27512723|NCT02379091|80070534|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27512724|NCT02379091|80070535|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27512725|NCT02379091|80070536|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27512726|NCT02379091|80070537|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27512727|NCT02379091|80070534|FG000|Overall Study|Principal Investigator Discretion|0|||
27512728|NCT02379091|80070535|FG001|Overall Study|Principal Investigator Discretion|1|||
27512729|NCT02379091|80070536|FG002|Overall Study|Principal Investigator Discretion|0|||
27512730|NCT02379091|80070537|FG003|Overall Study|Principal Investigator Discretion|0|||
27512731|NCT02379091|80070534|FG000|Overall Study|Lost to Follow-up|0|||
27512732|NCT02379091|80070535|FG001|Overall Study|Lost to Follow-up|0|||
27512733|NCT02379091|80070536|FG002|Overall Study|Lost to Follow-up|0|||
27512734|NCT02379091|80070537|FG003|Overall Study|Lost to Follow-up|1|||
27512735|NCT02379091|80070534|FG000|Overall Study|Voluntary Withdrawal|2|||
27512736|NCT02379091|80070535|FG001|Overall Study|Voluntary Withdrawal|5|||
27512737|NCT02379091|80070536|FG002|Overall Study|Voluntary Withdrawal|2|||
27512738|NCT02379091|80070537|FG003|Overall Study|Voluntary Withdrawal|4|||
27512739|NCT02379091|80070534|FG000|Overall Study|Study Termination|7|||
27512740|NCT02379091|80070535|FG001|Overall Study|Study Termination|2|||
27512741|NCT02379091|80070536|FG002|Overall Study|Study Termination|5|||
27512742|NCT02379091|80070537|FG003|Overall Study|Study Termination|8|||
27512743|NCT02379091|80070534|FG000|Overall Study|Lack of Efficacy|3|||
27512744|NCT02379091|80070535|FG001|Overall Study|Lack of Efficacy|0|||
27512745|NCT02379091|80070536|FG002|Overall Study|Lack of Efficacy|0|||
27512746|NCT02379091|80070537|FG003|Overall Study|Lack of Efficacy|0|||
27512747|NCT00611026|80070538|FG000|Randomized to Double-blind Treatment|Not treated|2|||
27512748|NCT00611026|80070539|FG001|Randomized to Double-blind Treatment|Not treated|1|||
27512749|NCT00611026|80070540|FG002|Randomized to Double-blind Treatment|Not treated|3|||
27512750|NCT00611026|80070538|FG000|Double-blind Treatment Period|Death|1|||
27512751|NCT00611026|80070539|FG001|Double-blind Treatment Period|Death|0|||
27512752|NCT00611026|80070540|FG002|Double-blind Treatment Period|Death|0|||
27512753|NCT00611026|80070538|FG000|Double-blind Treatment Period|Adverse Event|9|||
27512754|NCT00611026|80070539|FG001|Double-blind Treatment Period|Adverse Event|28|||
27512755|NCT00611026|80070540|FG002|Double-blind Treatment Period|Adverse Event|46|||
27512756|NCT00611026|80070538|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
27512757|NCT00611026|80070539|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
27512758|NCT00611026|80070540|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
27512759|NCT00611026|80070538|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
27512760|NCT00611026|80070539|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
27512761|NCT00611026|80070540|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
27615318|NCT02769065|80434135|FG017|Overall Study|Voluntary Withdrawal|0|||
27615319|NCT02769065|80434136|FG018|Overall Study|Voluntary Withdrawal|0|||
27615320|NCT02769065|80434137|FG019|Overall Study|Voluntary Withdrawal|0|||
27615321|NCT02769065|80434138|FG020|Overall Study|Voluntary Withdrawal|0|||
27615322|NCT02769065|80434139|FG021|Overall Study|Voluntary Withdrawal|0|||
27728643|NCT01442181|80833346|FG001|Overall Study|atrial fibrillation not noted|1|||
27906212|NCT01687283|81493368|FG001|Overall Study|protocol defined stopping criteria|10|||
27906213|NCT01687283|81493367|FG000|Overall Study|Lost to Follow-up|1|||
27512762|NCT00611026|80070538|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
27512763|NCT00611026|80070539|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
27512764|NCT00611026|80070540|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
27512765|NCT00611026|80070538|FG000|Double-blind Treatment Period|Other|13|||
27512766|NCT00611026|80070539|FG001|Double-blind Treatment Period|Other|20|||
27512767|NCT00611026|80070540|FG002|Double-blind Treatment Period|Other|18|||
27512768|NCT00948441|80070541|FG000|Overall Study|no longer meet inclusion criteria|1|||
27512769|NCT00948441|80070542|FG001|Overall Study|no longer meet inclusion criteria|4|||
27512770|NCT01399372|80070545|FG000|Overall Study|Protocol Violation|3|||
27512771|NCT01399372|80070546|FG001|Overall Study|Protocol Violation|1|||
27512772|NCT01469377|80070547|FG000|Overall Study|Protocol Deviation|7|||
27512773|NCT01469377|80070548|FG001|Overall Study|Protocol Deviation|10|||
27512774|NCT01469377|80070549|FG002|Overall Study|Protocol Deviation|10|||
27512775|NCT01469377|80070547|FG000|Overall Study|Lost to Follow-up|3|||
27512776|NCT01469377|80070548|FG001|Overall Study|Lost to Follow-up|2|||
27512777|NCT01469377|80070549|FG002|Overall Study|Lost to Follow-up|5|||
27512778|NCT01469377|80070547|FG000|Overall Study|Withdrawal of Consent|12|||
27512779|NCT01469377|80070548|FG001|Overall Study|Withdrawal of Consent|14|||
27512780|NCT01469377|80070549|FG002|Overall Study|Withdrawal of Consent|15|||
27512781|NCT01469377|80070547|FG000|Overall Study|Adverse Event|8|||
27512782|NCT01469377|80070548|FG001|Overall Study|Adverse Event|18|||
27512783|NCT01469377|80070549|FG002|Overall Study|Adverse Event|36|||
27512784|NCT01469377|80070547|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27512785|NCT01469377|80070548|FG001|Overall Study|Insufficient Therapeutic Response|4|||
27512786|NCT01469377|80070549|FG002|Overall Study|Insufficient Therapeutic Response|0|||
27512787|NCT01469377|80070547|FG000|Overall Study|Other Miscellaneous Reasons|2|||
27512788|NCT01469377|80070548|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27512789|NCT01469377|80070549|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27512790|NCT02106390|80070550|FG000|Overall Study|Withdrawal by Subject|15|||
27512791|NCT02106390|80070551|FG001|Overall Study|Withdrawal by Subject|16|||
27512792|NCT02106390|80070552|FG002|Overall Study|Withdrawal by Subject|15|||
27512793|NCT02106390|80070550|FG000|Overall Study|Lost to Follow-up|25|||
27512794|NCT02106390|80070551|FG001|Overall Study|Lost to Follow-up|20|||
27512795|NCT02106390|80070552|FG002|Overall Study|Lost to Follow-up|13|||
27512796|NCT02106390|80070550|FG000|Overall Study|Other: Administrative Reason|8|||
27512797|NCT02106390|80070551|FG001|Overall Study|Other: Administrative Reason|5|||
27512798|NCT02106390|80070552|FG002|Overall Study|Other: Administrative Reason|12|||
27512799|NCT02106390|80070550|FG000|Overall Study|Other: Unspecified|1|||
27512800|NCT02106390|80070551|FG001|Overall Study|Other: Unspecified|4|||
27512801|NCT02106390|80070552|FG002|Overall Study|Other: Unspecified|2|||
27512802|NCT02106390|80070550|FG000|Overall Study|Adverse Event|0|||
27512803|NCT02106390|80070551|FG001|Overall Study|Adverse Event|2|||
27512804|NCT02106390|80070552|FG002|Overall Study|Adverse Event|1|||
27512805|NCT02106390|80070550|FG000|Overall Study|Protocol Violation|0|||
27512806|NCT02106390|80070551|FG001|Overall Study|Protocol Violation|1|||
27512807|NCT02106390|80070552|FG002|Overall Study|Protocol Violation|0|||
27512808|NCT03967444|80070557|FG000|Overall Study|Lost to Follow-up|1|||
27512809|NCT03967444|80070558|FG001|Overall Study|Lost to Follow-up|2|||
27512810|NCT03052426|80070559|FG000|Overall Study|Withdrawal by Subject|0|||
27512811|NCT03052426|80070560|FG001|Overall Study|Withdrawal by Subject|1|||
27512812|NCT03052426|80070561|FG002|Overall Study|Withdrawal by Subject|0|||
27512813|NCT03052426|80070559|FG000|Overall Study|Lost to Follow-up|2|||
27512814|NCT03052426|80070560|FG001|Overall Study|Lost to Follow-up|0|||
27512815|NCT03052426|80070561|FG002|Overall Study|Lost to Follow-up|1|||
27512816|NCT03252925|80070562|FG000|Overall Study|Withdrawal by Subject|1|||
27512817|NCT03252925|80070563|FG001|Overall Study|Withdrawal by Subject|0|||
27512818|NCT03252925|80070562|FG000|Overall Study|Protocol Violation|6|||
27512819|NCT03252925|80070563|FG001|Overall Study|Protocol Violation|0|||
27512820|NCT03252925|80070562|FG000|Overall Study|Adverse Event|1|||
27512821|NCT03252925|80070563|FG001|Overall Study|Adverse Event|0|||
27512822|NCT03252925|80070562|FG000|Overall Study|Lost to Follow-up|6|||
27512823|NCT03252925|80070563|FG001|Overall Study|Lost to Follow-up|6|||
27512824|NCT00950859|80070564|FG000|Overall Study|Adverse Event|3|||
27906214|NCT01687283|81493368|FG001|Overall Study|Lost to Follow-up|1|||
27512825|NCT00950859|80070565|FG001|Overall Study|Adverse Event|3|||
27615323|NCT02769065|80434140|FG022|Overall Study|Voluntary Withdrawal|0|||
27906215|NCT01687283|81493367|FG000|Overall Study|Investigator discretion|2|||
27906216|NCT01687283|81493368|FG001|Overall Study|Investigator discretion|0|||
27906217|NCT01687283|81493367|FG000|Overall Study|Withdrawal by Subject|9|||
27906218|NCT01687283|81493368|FG001|Overall Study|Withdrawal by Subject|8|||
27906219|NCT00564278|81493369|FG000|Overall Study|Lost to Follow-up|35|||
27906220|NCT00564278|81493370|FG001|Overall Study|Lost to Follow-up|33|||
27906221|NCT00564278|81493369|FG000|Overall Study|Physician Decision|1|||
27906222|NCT00564278|81493370|FG001|Overall Study|Physician Decision|2|||
27906223|NCT00564278|81493369|FG000|Overall Study|Withdrawal by Subject|11|||
27906224|NCT00564278|81493370|FG001|Overall Study|Withdrawal by Subject|7|||
27906225|NCT03162328|81493377|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
27906226|NCT03162328|81493378|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
27906227|NCT03162328|81493379|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
27906228|NCT03162328|81493377|FG000|Screening Period|Withdrawal by Subject|1|||
27906229|NCT03162328|81493378|FG001|Screening Period|Withdrawal by Subject|0|||
27906230|NCT03162328|81493379|FG002|Screening Period|Withdrawal by Subject|0|||
27906231|NCT03162328|81493377|FG000|Study Period|Withdrawal by Subject|0|||
27906232|NCT03162328|81493378|FG001|Study Period|Withdrawal by Subject|0|||
27906233|NCT03162328|81493379|FG002|Study Period|Withdrawal by Subject|1|||
27906234|NCT01301079|81493380|FG000|Overall Study|Lost to Follow-up|2|||
27906235|NCT01301079|81493381|FG001|Overall Study|Lost to Follow-up|2|||
27906236|NCT03544281|81493382|FG000|Overall Study|Death|3|||
27906237|NCT03544281|81493383|FG001|Overall Study|Death|2|||
27906238|NCT03544281|81493384|FG002|Overall Study|Death|6|||
27906239|NCT03544281|81493385|FG003|Overall Study|Death|8|||
27906240|NCT03544281|81493386|FG004|Overall Study|Death|4|||
27906241|NCT03544281|81493387|FG005|Overall Study|Death|2|||
27906242|NCT03544281|81493388|FG006|Overall Study|Death|4|||
27906243|NCT03544281|81493389|FG007|Overall Study|Death|5|||
27906244|NCT03544281|81493390|FG008|Overall Study|Death|5|||
27906245|NCT03544281|81493391|FG009|Overall Study|Death|8|||
27906246|NCT03544281|81493392|FG010|Overall Study|Death|6|||
27906247|NCT03544281|81493393|FG011|Overall Study|Death|4|||
27906248|NCT03544281|81493382|FG000|Overall Study|Lost to Follow-up|0|||
27906249|NCT03544281|81493383|FG001|Overall Study|Lost to Follow-up|0|||
27906250|NCT03544281|81493384|FG002|Overall Study|Lost to Follow-up|0|||
27906251|NCT03544281|81493385|FG003|Overall Study|Lost to Follow-up|0|||
27906252|NCT03544281|81493386|FG004|Overall Study|Lost to Follow-up|0|||
27906253|NCT03544281|81493387|FG005|Overall Study|Lost to Follow-up|0|||
27906254|NCT03544281|81493388|FG006|Overall Study|Lost to Follow-up|0|||
27906255|NCT03544281|81493389|FG007|Overall Study|Lost to Follow-up|0|||
27906256|NCT03544281|81493390|FG008|Overall Study|Lost to Follow-up|0|||
27906257|NCT03544281|81493391|FG009|Overall Study|Lost to Follow-up|0|||
27906258|NCT03544281|81493392|FG010|Overall Study|Lost to Follow-up|1|||
27906259|NCT03544281|81493393|FG011|Overall Study|Lost to Follow-up|0|||
27906260|NCT03544281|81493382|FG000|Overall Study|Physician Decision|0|||
27906261|NCT03544281|81493383|FG001|Overall Study|Physician Decision|0|||
27906262|NCT03544281|81493384|FG002|Overall Study|Physician Decision|0|||
27906263|NCT03544281|81493385|FG003|Overall Study|Physician Decision|0|||
27906264|NCT03544281|81493386|FG004|Overall Study|Physician Decision|0|||
27906265|NCT03544281|81493387|FG005|Overall Study|Physician Decision|0|||
27906266|NCT03544281|81493388|FG006|Overall Study|Physician Decision|0|||
27906267|NCT03544281|81493389|FG007|Overall Study|Physician Decision|1|||
27906268|NCT03544281|81493390|FG008|Overall Study|Physician Decision|0|||
27906269|NCT03544281|81493391|FG009|Overall Study|Physician Decision|0|||
27906270|NCT03544281|81493392|FG010|Overall Study|Physician Decision|0|||
27906271|NCT03544281|81493393|FG011|Overall Study|Physician Decision|0|||
27512826|NCT00950859|80070564|FG000|Overall Study|Insufficient Viral Load Response|12|||
27615324|NCT02769065|80434141|FG023|Overall Study|Voluntary Withdrawal|0|||
27906272|NCT03544281|81493382|FG000|Overall Study|Withdrawal by Subject|2|||
27906273|NCT03544281|81493383|FG001|Overall Study|Withdrawal by Subject|0|||
27906274|NCT03544281|81493384|FG002|Overall Study|Withdrawal by Subject|1|||
27906275|NCT03544281|81493385|FG003|Overall Study|Withdrawal by Subject|2|||
27906276|NCT03544281|81493386|FG004|Overall Study|Withdrawal by Subject|0|||
27906277|NCT03544281|81493387|FG005|Overall Study|Withdrawal by Subject|0|||
27906278|NCT03544281|81493388|FG006|Overall Study|Withdrawal by Subject|0|||
27906279|NCT03544281|81493389|FG007|Overall Study|Withdrawal by Subject|0|||
27906280|NCT03544281|81493390|FG008|Overall Study|Withdrawal by Subject|2|||
27906281|NCT03544281|81493391|FG009|Overall Study|Withdrawal by Subject|3|||
27906282|NCT03544281|81493392|FG010|Overall Study|Withdrawal by Subject|0|||
27906283|NCT03544281|81493393|FG011|Overall Study|Withdrawal by Subject|4|||
27906284|NCT03544281|81493382|FG000|Overall Study|Ongoing at the time of analysis|7|||
27615325|NCT02769065|80434142|FG024|Overall Study|Voluntary Withdrawal|0|||
27615326|NCT02769065|80434143|FG025|Overall Study|Voluntary Withdrawal|0|||
27853070|NCT03439852|81291313|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
27853071|NCT03439852|81291312|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
27853072|NCT03439852|81291313|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
27853073|NCT03439852|81291312|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
27853074|NCT03439852|81291313|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
27853075|NCT01946191|81291320|FG000|Allocation|Did not complete orientation|1|||
27853076|NCT01946191|81291321|FG001|Allocation|Did not complete orientation|1|||
27853077|NCT01946191|81291320|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
27853078|NCT01946191|81291321|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
27853079|NCT01946191|81291320|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
27853080|NCT01946191|81291321|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
27853081|NCT01946191|81291320|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
27853082|NCT01946191|81291321|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
27853083|NCT00622466|81291325|FG000|Overall Study|Death|1|||
27853084|NCT00622466|81291325|FG000|Overall Study|Adverse Event|1|||
27853085|NCT00622466|81291325|FG000|Overall Study|Withdrawal by Subject|2|||
27853086|NCT02685202|81291328|FG000|Overall Study|Lost to Follow-up|9|||
27853087|NCT02229539|81291329|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
27853088|NCT02229539|81291330|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
27853089|NCT02229539|81291331|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
27853090|NCT02229539|81291329|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
27853091|NCT02229539|81291330|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
27853092|NCT02229539|81291331|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
27615327|NCT02769065|80434144|FG026|Overall Study|Voluntary Withdrawal|0|||
27615328|NCT02769065|80434145|FG027|Overall Study|Voluntary Withdrawal|0|||
27615329|NCT02769065|80434146|FG028|Overall Study|Voluntary Withdrawal|0|||
27615330|NCT02769065|80434147|FG029|Overall Study|Voluntary Withdrawal|0|||
27615331|NCT02769065|80434118|FG000|Overall Study|Reason Not Specified|0|||
27615332|NCT02769065|80434119|FG001|Overall Study|Reason Not Specified|0|||
27853093|NCT02229539|81291329|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
27853094|NCT02229539|81291330|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
27853095|NCT02229539|81291331|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
27853096|NCT02229539|81291329|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
27853097|NCT02229539|81291330|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
27853098|NCT02229539|81291331|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
27853099|NCT02229539|81291329|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
27853100|NCT02229539|81291330|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
27853101|NCT02229539|81291331|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
27853102|NCT02229539|81291329|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
27853103|NCT02229539|81291330|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
27853104|NCT02229539|81291331|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
27853105|NCT02229539|81291329|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
27853106|NCT02229539|81291330|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
27853107|NCT02229539|81291331|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
27853108|NCT02229539|81291329|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
27853109|NCT02229539|81291330|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
27853110|NCT02229539|81291331|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
27853111|NCT02229539|81291329|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
27853112|NCT02229539|81291330|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
27853113|NCT02229539|81291331|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
27853114|NCT01181271|81291332|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
27853115|NCT01181271|81291332|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
27853116|NCT01181271|81291332|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
27853117|NCT01181271|81291332|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
27853118|NCT02751359|81291333|FG000|Overall Study|Lost to Follow-up|1|||
27853119|NCT02667288|81291334|FG000|Overall Study|Protocol Violation|5|||
27853120|NCT02667288|81291334|FG000|Overall Study|Lost to Follow-up|3|||
27853121|NCT02667288|81291334|FG000|Overall Study|Withdrawal by Subject|5|||
27853122|NCT02533375|81294948|FG000|Overall Study|Lack of Efficacy|3|||
27853123|NCT02533375|81294948|FG000|Overall Study|Adverse Event|2|||
27853124|NCT02771795|81294951|FG000|Overall Study|Withdrawal by Subject|47|||
27853125|NCT02771795|81294952|FG001|Overall Study|Withdrawal by Subject|37|||
27853126|NCT02771795|81294951|FG000|Overall Study|Termination by premature discontinuation of study|168|||
27853127|NCT02771795|81294952|FG001|Overall Study|Termination by premature discontinuation of study|185|||
27853128|NCT00614926|81294953|FG000|Overall Study|Burden of travel|1|||
27615333|NCT02769065|80434120|FG002|Overall Study|Reason Not Specified|0|||
27512827|NCT00950859|80070565|FG001|Overall Study|Insufficient Viral Load Response|3|||
27512828|NCT00950859|80070564|FG000|Overall Study|Protocol Violation|1|||
27512829|NCT00950859|80070565|FG001|Overall Study|Protocol Violation|1|||
27512830|NCT00950859|80070564|FG000|Overall Study|Lost to Follow-up|0|||
27512831|NCT00950859|80070565|FG001|Overall Study|Lost to Follow-up|3|||
27512832|NCT00123422|80070566|FG000|Overall Study|Physician Decision|2|||
27512833|NCT00123422|80070567|FG001|Overall Study|Physician Decision|2|||
27615334|NCT02769065|80434121|FG003|Overall Study|Reason Not Specified|0|||
27615335|NCT02769065|80434122|FG004|Overall Study|Reason Not Specified|0|||
27615336|NCT02769065|80434123|FG005|Overall Study|Reason Not Specified|0|||
27853129|NCT00614926|81294954|FG001|Overall Study|Burden of travel|0|||
27853130|NCT00614926|81294953|FG000|Overall Study|Adverse Event|3|||
27853131|NCT00614926|81294954|FG001|Overall Study|Adverse Event|0|||
27853132|NCT03918109|81294955|FG000|Overall Study|Withdrawal by Subject|0|||
27853133|NCT03918109|81294956|FG001|Overall Study|Withdrawal by Subject|0|||
27853134|NCT03918109|81294957|FG002|Overall Study|Withdrawal by Subject|2|||
27853135|NCT03918109|81294958|FG003|Overall Study|Withdrawal by Subject|1|||
27853136|NCT03918109|81294955|FG000|Overall Study|Lost to Follow-up|0|||
27853137|NCT03918109|81294956|FG001|Overall Study|Lost to Follow-up|0|||
27853138|NCT03918109|81294957|FG002|Overall Study|Lost to Follow-up|0|||
27853139|NCT03918109|81294958|FG003|Overall Study|Lost to Follow-up|1|||
27853140|NCT00871741|81294959|FG000|Overall Study|Premature study termination|9|||
27512834|NCT00123422|80070568|FG002|Overall Study|Physician Decision|6|||
27512835|NCT00123422|80070566|FG000|Overall Study|Withdrawal by Subject|1|||
27853141|NCT00871741|81294960|FG001|Overall Study|Premature study termination|7|||
27853142|NCT02991430|81294966|FG000|Treatment Period 1|Adverse Event|1|||
27512836|NCT00123422|80070567|FG001|Overall Study|Withdrawal by Subject|2|||
27615337|NCT02769065|80434124|FG006|Overall Study|Reason Not Specified|1|||
27853143|NCT02991430|81294967|FG001|Treatment Period 1|Adverse Event|0|||
27853144|NCT02991430|81294968|FG002|Treatment Period 1|Adverse Event|2|||
27512837|NCT00123422|80070568|FG002|Overall Study|Withdrawal by Subject|2|||
27512838|NCT00123422|80070566|FG000|Overall Study|Lost to Follow-up|1|||
27512839|NCT00123422|80070567|FG001|Overall Study|Lost to Follow-up|2|||
27512840|NCT00123422|80070568|FG002|Overall Study|Lost to Follow-up|2|||
27512841|NCT03527732|80070569|FG000|Overall Study|Lost to Follow-up|21|||
27512842|NCT03527732|80070570|FG001|Overall Study|Lost to Follow-up|23|||
27512843|NCT03527732|80070571|FG002|Overall Study|Lost to Follow-up|80|||
27512844|NCT03527732|80070572|FG003|Overall Study|Lost to Follow-up|62|||
27512845|NCT03527732|80070573|FG004|Overall Study|Lost to Follow-up|12|||
27512846|NCT03527732|80070574|FG005|Overall Study|Lost to Follow-up|20|||
27512847|NCT04455815|80070583|FG000|Randomisation Phase|Adverse Event|1|||
27512848|NCT04455815|80070584|FG001|Randomisation Phase|Adverse Event|0|||
27512849|NCT04455815|80070583|FG000|Treatment Phase|Adverse Event|0|||
27512850|NCT04455815|80070584|FG001|Treatment Phase|Adverse Event|1|||
27512851|NCT04455815|80070583|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
27512852|NCT04455815|80070584|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
27512853|NCT04455815|80070583|FG000|Treatment Phase|Withdrawal by Subject|1|||
27512854|NCT04455815|80070584|FG001|Treatment Phase|Withdrawal by Subject|1|||
27512855|NCT04463069|80070585|FG000|Overall Study|Withdrawal by Subject|2|||
27512856|NCT04463069|80070586|FG001|Overall Study|Withdrawal by Subject|10|||
27512857|NCT04463069|80070585|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
27512858|NCT04463069|80070586|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
27512859|NCT03636893|80070587|FG000|Overall Study|Death|0|||
27512860|NCT03636893|80070588|FG001|Overall Study|Death|1|||
27512861|NCT03636893|80070587|FG000|Overall Study|Protocol Violation|0|||
27512862|NCT03636893|80070588|FG001|Overall Study|Protocol Violation|3|||
27615338|NCT02769065|80434125|FG007|Overall Study|Reason Not Specified|0|||
27615339|NCT02769065|80434126|FG008|Overall Study|Reason Not Specified|0|||
27615340|NCT02769065|80434127|FG009|Overall Study|Reason Not Specified|0|||
27615341|NCT02769065|80434128|FG010|Overall Study|Reason Not Specified|0|||
27615342|NCT02769065|80434129|FG011|Overall Study|Reason Not Specified|0|||
27615343|NCT02769065|80434130|FG012|Overall Study|Reason Not Specified|0|||
27615344|NCT02769065|80434131|FG013|Overall Study|Reason Not Specified|0|||
27615345|NCT02769065|80434132|FG014|Overall Study|Reason Not Specified|0|||
27615346|NCT02769065|80434133|FG015|Overall Study|Reason Not Specified|0|||
27615347|NCT02769065|80434134|FG016|Overall Study|Reason Not Specified|0|||
27615348|NCT02769065|80434135|FG017|Overall Study|Reason Not Specified|0|||
27615349|NCT02769065|80434136|FG018|Overall Study|Reason Not Specified|0|||
27615350|NCT02769065|80434137|FG019|Overall Study|Reason Not Specified|0|||
27615351|NCT02769065|80434138|FG020|Overall Study|Reason Not Specified|0|||
27615352|NCT02769065|80434139|FG021|Overall Study|Reason Not Specified|0|||
27615353|NCT02769065|80434140|FG022|Overall Study|Reason Not Specified|0|||
27615354|NCT02769065|80434141|FG023|Overall Study|Reason Not Specified|0|||
27615355|NCT02769065|80434142|FG024|Overall Study|Reason Not Specified|0|||
27615356|NCT02769065|80434143|FG025|Overall Study|Reason Not Specified|0|||
27615357|NCT02769065|80434144|FG026|Overall Study|Reason Not Specified|0|||
27615358|NCT02769065|80434145|FG027|Overall Study|Reason Not Specified|0|||
27615359|NCT02769065|80434146|FG028|Overall Study|Reason Not Specified|0|||
27615360|NCT02769065|80434147|FG029|Overall Study|Reason Not Specified|0|||
27512863|NCT03636893|80070587|FG000|Overall Study|Withdrawal by Subject|1|||
27615361|NCT02769065|80434118|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615362|NCT02769065|80434119|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615363|NCT02769065|80434120|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615364|NCT02769065|80434121|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615365|NCT02769065|80434122|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615366|NCT02769065|80434123|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615367|NCT02769065|80434124|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615368|NCT02769065|80434125|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615369|NCT02769065|80434126|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615370|NCT02769065|80434127|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615371|NCT02769065|80434128|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
27615372|NCT02769065|80434129|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615373|NCT02769065|80434130|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615374|NCT02769065|80434131|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615375|NCT02769065|80434132|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615376|NCT02769065|80434133|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615377|NCT02769065|80434134|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
27512864|NCT03636893|80070588|FG001|Overall Study|Withdrawal by Subject|2|||
27615378|NCT02769065|80434135|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615379|NCT02769065|80434136|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615380|NCT02769065|80434137|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
27906285|NCT03544281|81493383|FG001|Overall Study|Ongoing at the time of analysis|2|||
27906286|NCT03544281|81493384|FG002|Overall Study|Ongoing at the time of analysis|6|||
27906287|NCT03544281|81493385|FG003|Overall Study|Ongoing at the time of analysis|6|||
27906288|NCT03544281|81493386|FG004|Overall Study|Ongoing at the time of analysis|8|||
27906289|NCT03544281|81493387|FG005|Overall Study|Ongoing at the time of analysis|10|||
27906290|NCT03544281|81493388|FG006|Overall Study|Ongoing at the time of analysis|8|||
27906291|NCT03544281|81493389|FG007|Overall Study|Ongoing at the time of analysis|6|||
27512865|NCT03636893|80070587|FG000|Overall Study|Refusal to surgery|4|||
27512866|NCT03636893|80070588|FG001|Overall Study|Refusal to surgery|3|||
27512867|NCT03636893|80070587|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
27512868|NCT03636893|80070588|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
27512869|NCT03636893|80070587|FG000|Overall Study|Adverse Event|1|||
27512870|NCT03636893|80070588|FG001|Overall Study|Adverse Event|1|||
27906292|NCT03544281|81493390|FG008|Overall Study|Ongoing at the time of analysis|6|||
27512871|NCT02427464|80070591|FG000|Overall Study|Adverse Event|6|||
27512872|NCT02427464|80070592|FG001|Overall Study|Adverse Event|1|||
27512873|NCT02427464|80070591|FG000|Overall Study|Lost to Follow-up|16|||
27512874|NCT02427464|80070592|FG001|Overall Study|Lost to Follow-up|5|||
27512875|NCT02427464|80070591|FG000|Overall Study|Physician Decision|2|||
27512876|NCT02427464|80070592|FG001|Overall Study|Physician Decision|0|||
27512877|NCT02427464|80070591|FG000|Overall Study|Withdrawal by Subject|10|||
27512878|NCT02427464|80070592|FG001|Overall Study|Withdrawal by Subject|8|||
27512879|NCT02427464|80070591|FG000|Overall Study|Noncompliance|16|||
27512880|NCT02427464|80070592|FG001|Overall Study|Noncompliance|10|||
27512881|NCT00473382|80070593|FG000|Core Study|Adverse Event|3|||
27512882|NCT00473382|80070594|FG001|Core Study|Adverse Event|1|||
27512883|NCT00473382|80070595|FG002|Core Study|Adverse Event|1|||
27512884|NCT00473382|80070593|FG000|Core Study|Death|3|||
27512885|NCT00473382|80070594|FG001|Core Study|Death|5|||
27512886|NCT00473382|80070595|FG002|Core Study|Death|10|||
27512887|NCT00473382|80070593|FG000|Core Study|Lost to Follow-up|3|||
27512888|NCT00473382|80070594|FG001|Core Study|Lost to Follow-up|3|||
27512889|NCT00473382|80070595|FG002|Core Study|Lost to Follow-up|3|||
27512890|NCT00473382|80070593|FG000|Core Study|Physician Decision|1|||
27512891|NCT00473382|80070594|FG001|Core Study|Physician Decision|2|||
27512892|NCT00473382|80070595|FG002|Core Study|Physician Decision|2|||
27512893|NCT00473382|80070593|FG000|Core Study|Subject non-compliance|5|||
27512894|NCT00473382|80070594|FG001|Core Study|Subject non-compliance|2|||
27512895|NCT00473382|80070595|FG002|Core Study|Subject non-compliance|1|||
27512896|NCT00473382|80070593|FG000|Core Study|Subject needed other treatment|1|||
27512897|NCT00473382|80070594|FG001|Core Study|Subject needed other treatment|3|||
27906293|NCT03544281|81493391|FG009|Overall Study|Ongoing at the time of analysis|6|||
27512898|NCT00473382|80070595|FG002|Core Study|Subject needed other treatment|2|||
27512899|NCT00473382|80070593|FG000|Core Study|Subject's decision|12|||
27512900|NCT00473382|80070594|FG001|Core Study|Subject's decision|11|||
27512901|NCT00473382|80070595|FG002|Core Study|Subject's decision|10|||
27512902|NCT00473382|80070593|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
27512903|NCT00473382|80070594|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
27512904|NCT00473382|80070595|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
27512905|NCT00473382|80070593|FG000|Open-label Extension Through Month 48|Death|1|||
27512906|NCT00473382|80070594|FG001|Open-label Extension Through Month 48|Death|3|||
27512907|NCT00473382|80070595|FG002|Open-label Extension Through Month 48|Death|3|||
27512908|NCT00473382|80070593|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
27512909|NCT00473382|80070594|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
27512910|NCT00473382|80070595|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
27512911|NCT00473382|80070593|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
27512912|NCT00473382|80070594|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
27512913|NCT00473382|80070595|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
27615381|NCT02769065|80434138|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615382|NCT02769065|80434139|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615383|NCT02769065|80434140|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615384|NCT02769065|80434141|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615385|NCT02769065|80434142|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615386|NCT02769065|80434143|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615387|NCT02769065|80434144|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615388|NCT02769065|80434145|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615389|NCT02769065|80434146|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615390|NCT02769065|80434147|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
27615391|NCT00653263|80434148|FG000|Overall Study|Withdrawal by Subject|1|||
27615392|NCT00653263|80434148|FG000|Overall Study|Physician Decision|1|||
27615393|NCT03040687|80434149|FG000|Overall Study|Withdrawal by Subject|1|||
27615394|NCT03040687|80434150|FG001|Overall Study|Withdrawal by Subject|0|||
27615395|NCT03040687|80434151|FG002|Overall Study|Withdrawal by Subject|0|||
27615396|NCT04642469|80434152|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
27615397|NCT04642469|80434153|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
27615398|NCT04642469|80434152|FG000|Overall Study|Death|1|||
27615399|NCT04642469|80434153|FG001|Overall Study|Death|2|||
27615400|NCT04642469|80434152|FG000|Overall Study|Study/site closed following amendment 1|11|||
27615401|NCT04642469|80434153|FG001|Overall Study|Study/site closed following amendment 1|11|||
27615402|NCT04642469|80434152|FG000|Overall Study|Other|1|||
27615403|NCT04642469|80434153|FG001|Overall Study|Other|1|||
27615404|NCT04642469|80434152|FG000|Overall Study|Withdrawal by Subject|1|||
27615405|NCT04642469|80434153|FG001|Overall Study|Withdrawal by Subject|0|||
27615406|NCT04426006|80434169|FG000|Inclusion|Protocol Violation|1|||
27615407|NCT04426006|80434169|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
27615408|NCT04426006|80434169|FG000|Inclusion|Blood sample at inclusion not done|1|||
27615409|NCT04426006|80434169|FG000|3 Months|Lost to Follow-up|17|||
27615410|NCT04426006|80434169|FG000|12 Months|Lost to Follow-up|38|||
27728644|NCT00618748|80833347|FG000|Overall Study|Adverse Event|4|||
27728645|NCT00618748|80833348|FG001|Overall Study|Adverse Event|3|||
27728646|NCT00618748|80833349|FG002|Overall Study|Adverse Event|8|||
27728647|NCT00618748|80833347|FG000|Overall Study|Physician Decision|3|||
27728648|NCT00618748|80833348|FG001|Overall Study|Physician Decision|1|||
27728649|NCT00618748|80833349|FG002|Overall Study|Physician Decision|1|||
27728650|NCT00618748|80833347|FG000|Overall Study|Withdrawal by Subject|4|||
27728651|NCT00618748|80833348|FG001|Overall Study|Withdrawal by Subject|1|||
27728652|NCT00618748|80833349|FG002|Overall Study|Withdrawal by Subject|5|||
27728653|NCT00773279|80833350|FG000|Period 1|Adverse Event|2|||
27728654|NCT00773279|80833351|FG001|Period 1|Adverse Event|1|||
27728655|NCT00773279|80833350|FG000|Period 1|Lack of Efficacy|0|||
27728656|NCT00773279|80833351|FG001|Period 1|Lack of Efficacy|2|||
27728657|NCT00773279|80833350|FG000|Period 1|Unclassified|5|||
27728658|NCT00773279|80833351|FG001|Period 1|Unclassified|1|||
27728659|NCT00773279|80833350|FG000|Period 2|Adverse Event|0|||
27728660|NCT00773279|80833351|FG001|Period 2|Adverse Event|1|||
27728661|NCT00773279|80833350|FG000|Period 2|Lack of Efficacy|1|||
27728662|NCT00773279|80833351|FG001|Period 2|Lack of Efficacy|0|||
27728663|NCT00773279|80833350|FG000|Period 2|Protocol Violation|0|||
27728664|NCT00773279|80833351|FG001|Period 2|Protocol Violation|3|||
27853145|NCT02991430|81294966|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27853146|NCT02991430|81294967|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27728665|NCT00773279|80833350|FG000|Period 2|Unclassified|2|||
27728666|NCT00773279|80833351|FG001|Period 2|Unclassified|2|||
27728667|NCT04134494|80833352|FG000|Overall Study|Lost to Follow-up|2|||
27728668|NCT01262625|80833353|FG000|Overall Study|Administrative Error|1|||
27728669|NCT01262625|80833354|FG001|Overall Study|Administrative Error|1|||
27728670|NCT01262625|80833353|FG000|Overall Study|Site Closed|1|||
27728671|NCT01262625|80833354|FG001|Overall Study|Site Closed|0|||
27512914|NCT00473382|80070593|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
27512915|NCT00473382|80070594|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
27512916|NCT00473382|80070595|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
27512917|NCT00473382|80070593|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
27512918|NCT00473382|80070594|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
27512919|NCT00473382|80070595|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
27512920|NCT00473382|80070593|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
27615411|NCT01951092|80434171|FG000|Overall Study|Lost to Follow-up|10|||
27615412|NCT01951092|80434171|FG000|Overall Study|Incarceration|1|||
27615413|NCT01951092|80434171|FG000|Overall Study|Transfer of Care|1|||
27615414|NCT03249376|80434172|FG000|Overall Study|Adverse Event|11|||
27512921|NCT00473382|80070594|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
27512922|NCT00473382|80070595|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
27512923|NCT00473382|80070593|FG000|Open-label Extension Through Month 60|Death|1|||
27512924|NCT00473382|80070594|FG001|Open-label Extension Through Month 60|Death|7|||
27512925|NCT00473382|80070595|FG002|Open-label Extension Through Month 60|Death|4|||
27615415|NCT03249376|80434173|FG001|Overall Study|Adverse Event|5|||
27615416|NCT03249376|80434172|FG000|Overall Study|Lack of Efficacy|2|||
27615417|NCT03249376|80434173|FG001|Overall Study|Lack of Efficacy|4|||
27615418|NCT03249376|80434172|FG000|Overall Study|Protocol Violation|3|||
27615419|NCT03249376|80434173|FG001|Overall Study|Protocol Violation|2|||
27615420|NCT03249376|80434172|FG000|Overall Study|Physician Decision|0|||
27615421|NCT03249376|80434173|FG001|Overall Study|Physician Decision|2|||
27615422|NCT03249376|80434172|FG000|Overall Study|Withdrawal by Subject|3|||
27615423|NCT03249376|80434173|FG001|Overall Study|Withdrawal by Subject|9|||
27615424|NCT03249376|80434172|FG000|Overall Study|LTFU|2|||
27615425|NCT03249376|80434173|FG001|Overall Study|LTFU|1|||
27615426|NCT01282476|80434174|FG000|Overall Study|Death|11|||
27615427|NCT01781611|80434177|FG000|Overall Study|Adverse Event|4|||
27615428|NCT01781611|80434178|FG001|Overall Study|Adverse Event|0|||
27615429|NCT03390036|80434179|FG000|Overall Study|Lost to Follow-up|1|||
27512926|NCT00473382|80070593|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
27512927|NCT00473382|80070594|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
27512928|NCT00473382|80070595|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
27512929|NCT00473382|80070593|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
27512930|NCT00473382|80070594|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
27512931|NCT00473382|80070595|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
27512932|NCT00473382|80070593|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
27512933|NCT00473382|80070594|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
27512934|NCT00473382|80070595|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
27512935|NCT00473382|80070593|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
27512936|NCT00473382|80070594|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
27512937|NCT00473382|80070595|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
27512938|NCT01474239|80070596|FG000|Overall Study|Disease Progression|37|||
27512939|NCT01474239|80070597|FG001|Overall Study|Disease Progression|25|||
27512940|NCT01474239|80070596|FG000|Overall Study|Adverse Event|12|||
27512941|NCT01474239|80070597|FG001|Overall Study|Adverse Event|3|||
27512942|NCT01474239|80070596|FG000|Overall Study|Withdrawal by Subject|1|||
27512943|NCT01474239|80070597|FG001|Overall Study|Withdrawal by Subject|2|||
27512944|NCT01474239|80070596|FG000|Overall Study|Death|1|||
27512945|NCT01474239|80070597|FG001|Overall Study|Death|1|||
27512946|NCT01474239|80070596|FG000|Overall Study|Clinical Disease Progression|7|||
27512947|NCT01474239|80070597|FG001|Overall Study|Clinical Disease Progression|1|||
27512948|NCT01474239|80070596|FG000|Overall Study|Withdrawal for Economic Reason|1|||
27512949|NCT01474239|80070597|FG001|Overall Study|Withdrawal for Economic Reason|0|||
27512950|NCT01908803|80070598|FG000|Overall Study|Adverse Event|1|||
27512951|NCT01908803|80070599|FG001|Overall Study|Adverse Event|0|||
27512952|NCT01908803|80070598|FG000|Overall Study|Physician Decision|0|||
27512953|NCT01908803|80070599|FG001|Overall Study|Physician Decision|1|||
27615430|NCT03390036|80434180|FG001|Overall Study|Lost to Follow-up|0|||
27615431|NCT03390036|80434181|FG002|Overall Study|Lost to Follow-up|0|||
27615432|NCT03390036|80434179|FG000|Overall Study|Lack of Efficacy|1|||
27615433|NCT03390036|80434180|FG001|Overall Study|Lack of Efficacy|0|||
27615434|NCT03390036|80434181|FG002|Overall Study|Lack of Efficacy|0|||
27615435|NCT01927731|80434184|FG000|Overall Study|Graft Failure|1|||
27615436|NCT01927731|80434185|FG001|Overall Study|Graft Failure|2|||
27615437|NCT01927731|80434184|FG000|Overall Study|Physician Decision|2|||
27615438|NCT01927731|80434185|FG001|Overall Study|Physician Decision|3|||
27615439|NCT01927731|80434184|FG000|Overall Study|Withdrawal by Subject|0|||
27615440|NCT01927731|80434185|FG001|Overall Study|Withdrawal by Subject|2|||
27615441|NCT01927731|80434184|FG000|Overall Study|Death|0|||
27615442|NCT01927731|80434185|FG001|Overall Study|Death|3|||
27615443|NCT02982720|80434187|FG000|Overall Study|Adverse Event|3|||
27512954|NCT01908803|80070598|FG000|Overall Study|Withdrawal by Subject|1|||
27512955|NCT01908803|80070599|FG001|Overall Study|Withdrawal by Subject|0|||
27512956|NCT01908803|80070598|FG000|Overall Study|Randomization Error|1|||
27512957|NCT01908803|80070599|FG001|Overall Study|Randomization Error|0|||
27512958|NCT01908803|80070598|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
27615444|NCT02982720|80434187|FG000|Overall Study|Death|1|||
27615445|NCT01394250|80434188|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
27615446|NCT01394250|80434189|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
27615447|NCT01394250|80434188|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
27615448|NCT01394250|80434189|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
27615449|NCT01313923|80434190|FG000|Overall Study|Physician Decision|3|||
27615450|NCT04430335|80434194|FG000|Overall Study|Withdrawal by Subject|1|||
27512959|NCT01908803|80070599|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
27512960|NCT02259088|80070600|FG000|Overall Study|Adverse Event|6|||
27512961|NCT02259088|80070601|FG001|Overall Study|Adverse Event|4|||
27512962|NCT02259088|80070600|FG000|Overall Study|Lost to Follow-up|2|||
27512963|NCT02259088|80070601|FG001|Overall Study|Lost to Follow-up|0|||
27512964|NCT02259088|80070600|FG000|Overall Study|Death|2|||
27512965|NCT02259088|80070601|FG001|Overall Study|Death|0|||
27512966|NCT02259088|80070600|FG000|Overall Study|Physician Decision|5|||
27512967|NCT02259088|80070601|FG001|Overall Study|Physician Decision|2|||
27512968|NCT02259088|80070600|FG000|Overall Study|Protocol deviation|5|||
27512969|NCT02259088|80070601|FG001|Overall Study|Protocol deviation|0|||
27512970|NCT02259088|80070600|FG000|Overall Study|Subject/guardian decision|8|||
27512971|NCT02259088|80070601|FG001|Overall Study|Subject/guardian decision|8|||
27512972|NCT00515619|80070604|FG000|Overall Study|Adverse Event|34|||
27512973|NCT00515619|80070604|FG000|Overall Study|Lack of Efficacy|92|||
27512974|NCT00515619|80070604|FG000|Overall Study|Withdrawal by Subject|66|||
27512975|NCT00515619|80070604|FG000|Overall Study|Protocol Violation|3|||
27512976|NCT00515619|80070604|FG000|Overall Study|Lost to Follow-up|4|||
27512977|NCT00515619|80070604|FG000|Overall Study|Unsatisfactory compliance|6|||
27512978|NCT00515619|80070604|FG000|Overall Study|Other: Site discontinuing trials|2|||
27512979|NCT00515619|80070604|FG000|Overall Study|Other: Subject cannot attend visits|2|||
27512980|NCT00515619|80070604|FG000|Overall Study|Other: Subject required surgery|1|||
27512981|NCT00515619|80070604|FG000|Overall Study|Other: Subject moved to another country|1|||
27512982|NCT00515619|80070604|FG000|Overall Study|Other: Investigator decision|1|||
27512983|NCT00515619|80070604|FG000|Overall Study|Other: Subject became pregnant|1|||
27512984|NCT00515619|80070604|FG000|Overall Study|Other: Request from sponsor|1|||
27512985|NCT00515619|80070604|FG000|Overall Study|Other: Drug available on license|1|||
27512986|NCT00515619|80070604|FG000|Overall Study|Other: Subject interested in other AED|1|||
27512987|NCT02597478|80070605|FG000|Overall Study|Withdrawal by Subject|2|||
27512988|NCT02597478|80070606|FG001|Overall Study|Withdrawal by Subject|0|||
27512989|NCT02597478|80070605|FG000|Overall Study|Change of opioid dose|1|||
27512990|NCT02597478|80070606|FG001|Overall Study|Change of opioid dose|0|||
27512991|NCT02597478|80070605|FG000|Overall Study|Insufficient exertional dyspnea|0|||
27512992|NCT02597478|80070606|FG001|Overall Study|Insufficient exertional dyspnea|1|||
27512993|NCT01623050|80070607|FG000|Overall Study|Lost to Follow-up|9|||
27512994|NCT01967576|80070608|FG000|Overall Study|Withdrawal by Subject|3|||
27512995|NCT01967576|80070608|FG000|Overall Study|Progressed/Removed from treatment|1|||
27512996|NCT01967576|80070608|FG000|Overall Study|Study closing at site|1|||
27512997|NCT01967576|80070608|FG000|Overall Study|Adverse Event|1|||
27512998|NCT01967576|80070608|FG000|Overall Study|Refused further treatment|1|||
27512999|NCT00074490|80070609|FG000|Overall Study|Progressive malignancy|0|||
27906294|NCT03544281|81493392|FG010|Overall Study|Ongoing at the time of analysis|5|||
27513000|NCT00074490|80070610|FG001|Overall Study|Progressive malignancy|7|||
27513001|NCT00074490|80070611|FG002|Overall Study|Progressive malignancy|0|||
27513002|NCT00074490|80070612|FG003|Overall Study|Progressive malignancy|0|||
27513003|NCT00074490|80070613|FG004|Overall Study|Progressive malignancy|3|||
27615451|NCT01088529|80434199|FG000|Overall Study|Did not receive study treatment|0|||
27615452|NCT01088529|80434200|FG001|Overall Study|Did not receive study treatment|1|||
27615453|NCT01729728|80434201|FG000|Overall Study|Adverse Event|0|||
27615454|NCT01729728|80434202|FG001|Overall Study|Adverse Event|6|||
27906295|NCT03544281|81493393|FG011|Overall Study|Ongoing at the time of analysis|8|||
27906296|NCT03544281|81493382|FG000|Overall Study|Investigator Site Closed|0|||
27906297|NCT03544281|81493383|FG001|Overall Study|Investigator Site Closed|0|||
27906298|NCT03544281|81493384|FG002|Overall Study|Investigator Site Closed|0|||
27906299|NCT03544281|81493385|FG003|Overall Study|Investigator Site Closed|0|||
27906300|NCT03544281|81493386|FG004|Overall Study|Investigator Site Closed|0|||
27906301|NCT03544281|81493387|FG005|Overall Study|Investigator Site Closed|0|||
27906302|NCT03544281|81493388|FG006|Overall Study|Investigator Site Closed|0|||
27906303|NCT03544281|81493389|FG007|Overall Study|Investigator Site Closed|0|||
27906304|NCT03544281|81493390|FG008|Overall Study|Investigator Site Closed|0|||
27906305|NCT03544281|81493391|FG009|Overall Study|Investigator Site Closed|1|||
27906306|NCT03544281|81493392|FG010|Overall Study|Investigator Site Closed|0|||
27906307|NCT03544281|81493393|FG011|Overall Study|Investigator Site Closed|0|||
27906308|NCT03544281|81493382|FG000|Overall Study|Did not receive study treatment|0|||
27906309|NCT03544281|81493383|FG001|Overall Study|Did not receive study treatment|0|||
27906310|NCT03544281|81493384|FG002|Overall Study|Did not receive study treatment|0|||
27906311|NCT03544281|81493385|FG003|Overall Study|Did not receive study treatment|0|||
27906312|NCT03544281|81493386|FG004|Overall Study|Did not receive study treatment|0|||
27906313|NCT03544281|81493387|FG005|Overall Study|Did not receive study treatment|0|||
27906314|NCT03544281|81493388|FG006|Overall Study|Did not receive study treatment|1|||
27906315|NCT03544281|81493389|FG007|Overall Study|Did not receive study treatment|0|||
27906316|NCT03544281|81493390|FG008|Overall Study|Did not receive study treatment|0|||
27906317|NCT03544281|81493391|FG009|Overall Study|Did not receive study treatment|0|||
27906318|NCT03544281|81493392|FG010|Overall Study|Did not receive study treatment|0|||
27906319|NCT03544281|81493393|FG011|Overall Study|Did not receive study treatment|0|||
27906320|NCT01887678|81493394|FG000|Overall Study|Adverse Event|4|||
27906321|NCT01887678|81493395|FG001|Overall Study|Adverse Event|6|||
27906322|NCT01887678|81493394|FG000|Overall Study|Exceeded rescue medication dosage|4|||
27906323|NCT01887678|81493395|FG001|Overall Study|Exceeded rescue medication dosage|5|||
27906324|NCT01887678|81493394|FG000|Overall Study|Withdrawal of consent|3|||
27906325|NCT01887678|81493395|FG001|Overall Study|Withdrawal of consent|4|||
27906326|NCT01887678|81493394|FG000|Overall Study|Lost to Follow-up|4|||
27906327|NCT01887678|81493395|FG001|Overall Study|Lost to Follow-up|2|||
27906328|NCT01887678|81493394|FG000|Overall Study|Deterioration of clinical condition|0|||
27906329|NCT01887678|81493395|FG001|Overall Study|Deterioration of clinical condition|4|||
27615455|NCT01729728|80434203|FG002|Overall Study|Adverse Event|0|||
27906330|NCT01887678|81493394|FG000|Overall Study|Lack of Efficacy|1|||
27906331|NCT01887678|81493395|FG001|Overall Study|Lack of Efficacy|2|||
27906332|NCT01887678|81493394|FG000|Overall Study|Non-compliance|0|||
27615456|NCT01729728|80434201|FG000|Overall Study|Protocol Violation|1|||
27615457|NCT01729728|80434202|FG001|Overall Study|Protocol Violation|0|||
27906333|NCT01887678|81493395|FG001|Overall Study|Non-compliance|3|||
27906334|NCT01887678|81493394|FG000|Overall Study|Specified|1|||
27906335|NCT01887678|81493395|FG001|Overall Study|Specified|2|||
27906336|NCT00703118|81493396|FG000|Overall Study|Adverse Event|1|||
27906337|NCT00703118|81493397|FG001|Overall Study|Adverse Event|2|||
27906338|NCT00703118|81493398|FG002|Overall Study|Adverse Event|2|||
27906339|NCT00703118|81493396|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
27906340|NCT00703118|81493397|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
27906341|NCT00703118|81493398|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
27906342|NCT00703118|81493396|FG000|Overall Study|Lost to Follow-up|6|||
27906343|NCT00703118|81493397|FG001|Overall Study|Lost to Follow-up|4|||
27906344|NCT00703118|81493398|FG002|Overall Study|Lost to Follow-up|4|||
27906345|NCT00703118|81493396|FG000|Overall Study|Withdrawal by Subject|8|||
27906346|NCT00703118|81493397|FG001|Overall Study|Withdrawal by Subject|7|||
27906347|NCT00703118|81493398|FG002|Overall Study|Withdrawal by Subject|13|||
27906348|NCT00703118|81493396|FG000|Overall Study|Other|0|||
27906349|NCT00703118|81493397|FG001|Overall Study|Other|0|||
27906350|NCT00703118|81493398|FG002|Overall Study|Other|1|||
27906351|NCT02309723|81493402|FG000|Overall Study|Withdrawal by Subject|24|||
27906352|NCT02309723|81493403|FG001|Overall Study|Withdrawal by Subject|23|||
27615458|NCT01729728|80434203|FG002|Overall Study|Protocol Violation|1|||
27906353|NCT02309723|81493404|FG002|Overall Study|Withdrawal by Subject|24|||
27906354|NCT00849290|81493405|FG000|Overall Study|Adverse Event|3|||
27615459|NCT02341456|80434204|FG000|Overall Study|Disease progression|2|||
27615460|NCT02341456|80434205|FG001|Overall Study|Disease progression|3|||
27906355|NCT00849290|81493405|FG000|Overall Study|Death|14|||
27906356|NCT00849290|81493405|FG000|Overall Study|Withdrawal by Subject|11|||
27906357|NCT00849290|81493405|FG000|Overall Study|Lost to Follow-up|2|||
27615461|NCT02341456|80434206|FG002|Overall Study|Disease progression|1|||
27615462|NCT02341456|80434204|FG000|Overall Study|Death|1|||
27906358|NCT00849290|81493405|FG000|Overall Study|Protocol Violation|5|||
27513004|NCT00074490|80070614|FG005|Overall Study|Progressive malignancy|0|||
27513005|NCT01330108|80070615|FG000|Overall Study|Withdrawal by Subject|4|||
27513006|NCT02283762|80070616|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
27513007|NCT02283762|80070617|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
27513008|NCT02283762|80070616|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
27513009|NCT02283762|80070617|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
27513010|NCT02283762|80070616|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
27513011|NCT02283762|80070617|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
27513012|NCT02283762|80070616|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
27513013|NCT02283762|80070617|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
27513014|NCT02283762|80070616|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
27513015|NCT02283762|80070617|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
27513016|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
27513017|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
27513018|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
27513019|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
27513020|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
27513021|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
27513022|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
27513023|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
27513024|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
27513025|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
27513026|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
27513027|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
27513028|NCT02283762|80070616|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
27513029|NCT02283762|80070617|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
27513030|NCT00419952|80070619|FG000|Overall Study|Adverse Event|8|||
27513031|NCT00419952|80070620|FG001|Overall Study|Adverse Event|10|||
27513032|NCT00419952|80070619|FG000|Overall Study|Withdrawal by Subject|44|||
27513033|NCT00419952|80070620|FG001|Overall Study|Withdrawal by Subject|43|||
27513034|NCT00419952|80070619|FG000|Overall Study|Lost to Follow-up|43|||
27513035|NCT00419952|80070620|FG001|Overall Study|Lost to Follow-up|34|||
27513036|NCT00419952|80070619|FG000|Overall Study|Protocol Violation|32|||
27513037|NCT00419952|80070620|FG001|Overall Study|Protocol Violation|24|||
27906359|NCT00849290|81493405|FG000|Overall Study|Disease Progression|20|||
27906360|NCT03246061|81493406|FG000|Overall Study|Still in follow-up|15|||
27906361|NCT03246061|81493407|FG001|Overall Study|Still in follow-up|21|||
27906362|NCT01491841|81493408|FG000|Overall Study|Screen Failure|10|||
27906363|NCT01491841|81493408|FG000|Overall Study|Withdrawal by Subject|1|||
27906364|NCT00199849|81493411|FG000|Overall Study|Unrelated illness or complication|0|||
27906365|NCT00199849|81493412|FG001|Overall Study|Unrelated illness or complication|1|||
27906366|NCT00199849|81493413|FG002|Overall Study|Unrelated illness or complication|0|||
27906367|NCT00199849|81493411|FG000|Overall Study|Progressive disease requiring intervention|0|||
27906368|NCT00199849|81493412|FG001|Overall Study|Progressive disease requiring intervention|0|||
27906369|NCT00199849|81493413|FG002|Overall Study|Progressive disease requiring intervention|1|||
27906370|NCT00199849|81493411|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
27906371|NCT00199849|81493412|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
27906372|NCT00199849|81493413|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
27906373|NCT02137226|81493414|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
27906374|NCT02137226|81493415|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
27906375|NCT02137226|81493416|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
27906376|NCT02137226|81493417|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
27906377|NCT02137226|81493418|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
27906378|NCT02137226|81493414|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
27906379|NCT02137226|81493415|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
27906380|NCT02137226|81493416|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
27615463|NCT02341456|80434205|FG001|Overall Study|Death|1|||
27615464|NCT02341456|80434206|FG002|Overall Study|Death|1|||
27615465|NCT02341456|80434204|FG000|Overall Study|Withdrawal by Subject|0|||
27906381|NCT02137226|81493417|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
27906382|NCT02137226|81493418|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
27906383|NCT02137226|81493414|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
27906384|NCT02137226|81493415|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
27906385|NCT02137226|81493416|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
27513038|NCT00419952|80070619|FG000|Overall Study|Pregnancy|4|||
27513039|NCT00419952|80070620|FG001|Overall Study|Pregnancy|2|||
27906386|NCT02137226|81493417|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
27513040|NCT00419952|80070619|FG000|Overall Study|Physician Decision|1|||
27513041|NCT00419952|80070620|FG001|Overall Study|Physician Decision|3|||
27615466|NCT02341456|80434205|FG001|Overall Study|Withdrawal by Subject|1|||
27615467|NCT02341456|80434206|FG002|Overall Study|Withdrawal by Subject|1|||
27513042|NCT00419952|80070619|FG000|Overall Study|Incorrectly enrolled|10|||
27513043|NCT00419952|80070620|FG001|Overall Study|Incorrectly enrolled|3|||
27513044|NCT00419952|80070619|FG000|Overall Study|Intake of prohibited medication|2|||
27513045|NCT00419952|80070620|FG001|Overall Study|Intake of prohibited medication|2|||
27513046|NCT00419952|80070619|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
27513047|NCT00419952|80070620|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
27513048|NCT00419952|80070619|FG000|Overall Study|Diary or medication non-compliance|2|||
27513049|NCT00419952|80070620|FG001|Overall Study|Diary or medication non-compliance|4|||
27513050|NCT00419952|80070619|FG000|Overall Study|Abnormal ECG|1|||
27513051|NCT00419952|80070620|FG001|Overall Study|Abnormal ECG|0|||
27513052|NCT00990704|80070621|FG000|Overall Study|Adverse Event|1|||
27513053|NCT00990704|80070622|FG001|Overall Study|Adverse Event|1|||
27513054|NCT00990704|80070621|FG000|Overall Study|Physician Decision|0|||
27513055|NCT00990704|80070622|FG001|Overall Study|Physician Decision|1|||
27513056|NCT00721968|80070623|FG000|Overall Study|Lost to Follow-up|2|||
27513057|NCT00721968|80070624|FG001|Overall Study|Lost to Follow-up|0|||
27513058|NCT00479687|80070625|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
27513059|NCT00479687|80070626|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
27513060|NCT00479687|80070627|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
27513061|NCT00479687|80070625|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
27513062|NCT00479687|80070626|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
27513063|NCT00479687|80070627|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
27513064|NCT00479687|80070625|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
27513065|NCT00479687|80070626|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
27906387|NCT02137226|81493418|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
27906388|NCT02137226|81493414|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
27906389|NCT02137226|81493415|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
27906390|NCT02137226|81493416|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
27906391|NCT02137226|81493417|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
27906392|NCT02137226|81493418|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
27906393|NCT02137226|81493414|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
27906394|NCT02137226|81493415|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27906395|NCT02137226|81493416|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27906396|NCT02137226|81493417|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27906397|NCT02137226|81493418|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
27906398|NCT02137226|81493414|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
27906399|NCT02137226|81493415|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
27906400|NCT02137226|81493416|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
27906401|NCT02137226|81493417|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
27906402|NCT02137226|81493418|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
27906403|NCT02137226|81493414|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
27906404|NCT02137226|81493415|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
27906405|NCT02137226|81493416|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
27906406|NCT02137226|81493417|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
27906407|NCT02137226|81493418|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
27906408|NCT02137226|81493414|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
27906409|NCT02137226|81493415|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
27906410|NCT02137226|81493416|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
27906411|NCT02137226|81493417|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
27906412|NCT02137226|81493418|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
27906413|NCT02137226|81493414|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
27906414|NCT02137226|81493415|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
27906415|NCT02137226|81493416|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
27906416|NCT02137226|81493417|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
27906417|NCT02137226|81493418|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
27906418|NCT02137226|81493414|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27906419|NCT02137226|81493415|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27906420|NCT02137226|81493416|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
27906421|NCT02137226|81493417|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27906422|NCT02137226|81493418|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
27906423|NCT02137226|81493414|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27906424|NCT02137226|81493415|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27906425|NCT02137226|81493416|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
27906426|NCT02137226|81493417|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27906427|NCT02137226|81493418|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
27906428|NCT02137226|81493414|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
27906429|NCT02137226|81493415|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
27906430|NCT02137226|81493416|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
27513066|NCT00479687|80070627|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
27513067|NCT00479687|80070625|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
27513068|NCT00479687|80070626|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
27513069|NCT00479687|80070627|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
27513070|NCT00479687|80070625|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
27513071|NCT00479687|80070626|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
27513072|NCT00479687|80070627|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
27513073|NCT00479687|80070625|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
27513074|NCT00479687|80070626|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
27513075|NCT00479687|80070627|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
27513076|NCT00479687|80070625|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
27513077|NCT00479687|80070626|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
27513078|NCT00479687|80070627|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
27513079|NCT00479687|80070625|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
27513080|NCT00479687|80070626|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
27513081|NCT00479687|80070627|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
27513082|NCT00479687|80070625|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
27513083|NCT00479687|80070626|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
27513084|NCT00479687|80070627|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
27513085|NCT00122980|80070628|FG000|Overall Study|Death|0|||
27513086|NCT00122980|80070629|FG001|Overall Study|Death|1|||
27513087|NCT00122980|80070628|FG000|Overall Study|Physician Decision|2|||
27513088|NCT00122980|80070629|FG001|Overall Study|Physician Decision|0|||
27513089|NCT00122980|80070628|FG000|Overall Study|Protocol Violation|5|||
27513090|NCT00122980|80070629|FG001|Overall Study|Protocol Violation|1|||
27513091|NCT00122980|80070628|FG000|Overall Study|Withdrawal by Subject|2|||
27513092|NCT00122980|80070629|FG001|Overall Study|Withdrawal by Subject|3|||
27513093|NCT00122980|80070628|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
27513094|NCT00122980|80070629|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
27513095|NCT00122980|80070628|FG000|Overall Study|Study termination|27|||
27513096|NCT00122980|80070629|FG001|Overall Study|Study termination|35|||
27513097|NCT00006289|80070630|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
27615468|NCT02341456|80434204|FG000|Overall Study|Moved to local access programme.|0|||
27906431|NCT02137226|81493417|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
27906432|NCT02137226|81493418|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
27906433|NCT03041467|81493419|FG000|Overall Study|Death|46|||
27906434|NCT03041467|81493420|FG001|Overall Study|Death|39|||
27906435|NCT03041467|81493419|FG000|Overall Study|Withdrawal by Subject|36|||
27906436|NCT03041467|81493420|FG001|Overall Study|Withdrawal by Subject|37|||
27906437|NCT03041467|81493419|FG000|Overall Study|Lost to Follow-up|6|||
27906438|NCT03041467|81493420|FG001|Overall Study|Lost to Follow-up|8|||
27906439|NCT03041467|81493419|FG000|Overall Study|Declined consent for study extension|21|||
27906440|NCT03041467|81493420|FG001|Overall Study|Declined consent for study extension|33|||
27906441|NCT03041467|81493419|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
27906442|NCT03041467|81493420|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
27906443|NCT02173379|81493421|FG000|Overall Study|Lost to Follow-up|89|||
27906444|NCT02173379|81493422|FG001|Overall Study|Lost to Follow-up|81|||
27906445|NCT02173379|81493421|FG000|Overall Study|Withdrawal by Subject|24|||
27513098|NCT00006289|80070631|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
27513099|NCT00006289|80070630|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
27513100|NCT00006289|80070631|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
27513101|NCT00882557|80070632|FG000|Overall Study|Withdrawal by Subject|1|||
27513102|NCT00882557|80070633|FG001|Overall Study|Withdrawal by Subject|0|||
27513103|NCT00882557|80070632|FG000|Overall Study|Trouble with Vein Access|1|||
27906446|NCT02173379|81493422|FG001|Overall Study|Withdrawal by Subject|29|||
27906447|NCT02173379|81493421|FG000|Overall Study|Physician Decision|8|||
27906448|NCT02173379|81493422|FG001|Overall Study|Physician Decision|8|||
27906449|NCT02173379|81493421|FG000|Overall Study|Death|75|||
27906450|NCT02173379|81493422|FG001|Overall Study|Death|72|||
27906451|NCT02173379|81493421|FG000|Overall Study|Other Reason|1|||
27906452|NCT02173379|81493422|FG001|Overall Study|Other Reason|0|||
27906453|NCT02113007|81493424|FG000|Overall Study|Progressive disease|2|||
27906454|NCT01911780|81493426|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
27906455|NCT01911780|81493427|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
27906456|NCT01911780|81493426|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
27906457|NCT01911780|81493427|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
27906458|NCT01911780|81493426|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
27906459|NCT01911780|81493427|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
27906460|NCT01911780|81493426|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
27906461|NCT01911780|81493427|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
27906462|NCT01911780|81493426|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
27906463|NCT01911780|81493427|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
27906464|NCT01911780|81493426|FG000|Extension Period (52 Weeks)|Personal reason|1|||
27906465|NCT01911780|81493427|FG001|Extension Period (52 Weeks)|Personal reason|1|||
27906466|NCT00978341|81493437|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
27906467|NCT00978341|81493438|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
27906468|NCT01716520|81493445|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27906469|NCT01716520|81493446|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27906470|NCT01716520|81493447|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
27906471|NCT01716520|81493448|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
27906472|NCT01716520|81493449|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
27906473|NCT01716520|81493450|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
27906474|NCT01716520|81493445|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
27906475|NCT01716520|81493446|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906476|NCT01716520|81493447|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
27513104|NCT00882557|80070633|FG001|Overall Study|Trouble with Vein Access|0|||
27513105|NCT00882557|80070632|FG000|Overall Study|Randomized Not Treated|0|||
27513106|NCT00882557|80070633|FG001|Overall Study|Randomized Not Treated|1|||
27513107|NCT01262989|80070636|FG000|Period 1|Lost to Follow-up|1|||
27513108|NCT01262989|80070637|FG001|Period 1|Lost to Follow-up|1|||
27513109|NCT01262989|80070636|FG000|Period 1|Intercurrent disease|0|||
27513110|NCT01262989|80070637|FG001|Period 1|Intercurrent disease|1|||
27513111|NCT01262989|80070636|FG000|Period 1|Positive answer for exclusion criteria|0|||
27513112|NCT01262989|80070637|FG001|Period 1|Positive answer for exclusion criteria|1|||
27513113|NCT01262989|80070636|FG000|Period 2|Intercurrent disease|0|||
27513114|NCT01262989|80070637|FG001|Period 2|Intercurrent disease|1|||
27513115|NCT02537015|80070638|FG000|Overall Study|Adverse Event|3|||
27513116|NCT02537015|80070638|FG000|Overall Study|Withdrawal by Subject|2|||
27513117|NCT02537015|80070638|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27513118|NCT01033448|80070643|FG000|Overall Study|Withdrawal by Subject|4|||
27513119|NCT01033448|80070643|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
27513120|NCT01033448|80070643|FG000|Overall Study|Lost to Follow-up|3|||
27513121|NCT01033448|80070643|FG000|Overall Study|Withdrew due to other reasons|3|||
27513122|NCT01033448|80070643|FG000|Overall Study|Unknown disposition|1|||
27513123|NCT00092443|80070644|FG000|Overall Study|Adverse Event|9|||
27513124|NCT00092443|80070645|FG001|Overall Study|Adverse Event|13|||
27513125|NCT00092443|80070644|FG000|Overall Study|Lost to Follow-up|7|||
27513126|NCT00092443|80070645|FG001|Overall Study|Lost to Follow-up|3|||
27513127|NCT00092443|80070644|FG000|Overall Study|Protocol Violation|11|||
27513128|NCT00092443|80070645|FG001|Overall Study|Protocol Violation|9|||
27513129|NCT00092443|80070644|FG000|Overall Study|Withdrawal by Subject|9|||
27513130|NCT00092443|80070645|FG001|Overall Study|Withdrawal by Subject|11|||
27513131|NCT00092443|80070644|FG000|Overall Study|Moved|5|||
27513132|NCT00092443|80070645|FG001|Overall Study|Moved|5|||
27513133|NCT00092443|80070644|FG000|Overall Study|Other|17|||
27513134|NCT00092443|80070645|FG001|Overall Study|Other|13|||
27906477|NCT01716520|81493448|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
27513135|NCT01869764|80070648|FG000|Overall Study|Withdrawal by Subject|0|||
27513136|NCT01869764|80070649|FG001|Overall Study|Withdrawal by Subject|2|||
27513137|NCT03345784|80070650|FG000|Overall Study|Withdrawal by Subject|2|||
27513138|NCT03345784|80070651|FG001|Overall Study|Withdrawal by Subject|1|||
27906478|NCT01716520|81493449|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906479|NCT01716520|81493450|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
27906480|NCT01716520|81493445|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27906481|NCT01716520|81493446|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27906482|NCT01716520|81493447|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27906483|NCT01716520|81493448|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27906484|NCT01716520|81493449|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27906485|NCT01716520|81493450|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27906486|NCT01716520|81493445|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27906487|NCT01716520|81493446|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
27906488|NCT01716520|81493447|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27906489|NCT01716520|81493448|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27906490|NCT01716520|81493449|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27906491|NCT01716520|81493450|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
27906492|NCT01716520|81493445|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27906493|NCT01716520|81493446|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27906494|NCT01716520|81493447|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27513139|NCT03224819|80070652|FG000|Overall Study|Withdrawal by Subject|0|||
27513140|NCT03224819|80070653|FG001|Overall Study|Withdrawal by Subject|0|||
27906495|NCT01716520|81493448|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27906496|NCT01716520|81493449|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
27513141|NCT03224819|80070654|FG002|Overall Study|Withdrawal by Subject|0|||
27513142|NCT03224819|80070655|FG003|Overall Study|Withdrawal by Subject|0|||
27513143|NCT03224819|80070656|FG004|Overall Study|Withdrawal by Subject|0|||
27513144|NCT03224819|80070657|FG005|Overall Study|Withdrawal by Subject|0|||
27513145|NCT03224819|80070658|FG006|Overall Study|Withdrawal by Subject|0|||
27513146|NCT03224819|80070659|FG007|Overall Study|Withdrawal by Subject|0|||
27513147|NCT03224819|80070660|FG008|Overall Study|Withdrawal by Subject|0|||
27513148|NCT03224819|80070661|FG009|Overall Study|Withdrawal by Subject|0|||
27513149|NCT03224819|80070662|FG010|Overall Study|Withdrawal by Subject|0|||
27513150|NCT03224819|80070663|FG011|Overall Study|Withdrawal by Subject|0|||
27513151|NCT03224819|80070664|FG012|Overall Study|Withdrawal by Subject|1|||
27513152|NCT03224819|80070665|FG013|Overall Study|Withdrawal by Subject|0|||
27513153|NCT03224819|80070652|FG000|Overall Study|Sponsor Decision|0|||
27513154|NCT03224819|80070653|FG001|Overall Study|Sponsor Decision|0|||
27513155|NCT03224819|80070654|FG002|Overall Study|Sponsor Decision|0|||
27513156|NCT03224819|80070655|FG003|Overall Study|Sponsor Decision|1|||
27513157|NCT03224819|80070656|FG004|Overall Study|Sponsor Decision|1|||
27513158|NCT03224819|80070657|FG005|Overall Study|Sponsor Decision|2|||
27513159|NCT03224819|80070658|FG006|Overall Study|Sponsor Decision|1|||
27513160|NCT03224819|80070659|FG007|Overall Study|Sponsor Decision|1|||
27513161|NCT03224819|80070660|FG008|Overall Study|Sponsor Decision|1|||
27513162|NCT03224819|80070661|FG009|Overall Study|Sponsor Decision|2|||
27513163|NCT03224819|80070662|FG010|Overall Study|Sponsor Decision|1|||
27513164|NCT03224819|80070663|FG011|Overall Study|Sponsor Decision|1|||
27513165|NCT03224819|80070664|FG012|Overall Study|Sponsor Decision|1|||
27513166|NCT03224819|80070665|FG013|Overall Study|Sponsor Decision|0|||
27513167|NCT03224819|80070652|FG000|Overall Study|Lost to Follow-up|0|||
27513168|NCT03224819|80070653|FG001|Overall Study|Lost to Follow-up|0|||
27513169|NCT03224819|80070654|FG002|Overall Study|Lost to Follow-up|0|||
27513170|NCT03224819|80070655|FG003|Overall Study|Lost to Follow-up|0|||
27513171|NCT03224819|80070656|FG004|Overall Study|Lost to Follow-up|0|||
27513172|NCT03224819|80070657|FG005|Overall Study|Lost to Follow-up|0|||
27513173|NCT03224819|80070658|FG006|Overall Study|Lost to Follow-up|0|||
27513174|NCT03224819|80070659|FG007|Overall Study|Lost to Follow-up|0|||
27513175|NCT03224819|80070660|FG008|Overall Study|Lost to Follow-up|1|||
27513176|NCT03224819|80070661|FG009|Overall Study|Lost to Follow-up|0|||
27513177|NCT03224819|80070662|FG010|Overall Study|Lost to Follow-up|0|||
27513178|NCT03224819|80070663|FG011|Overall Study|Lost to Follow-up|0|||
27513179|NCT03224819|80070664|FG012|Overall Study|Lost to Follow-up|0|||
27513180|NCT03224819|80070665|FG013|Overall Study|Lost to Follow-up|0|||
27513181|NCT03224819|80070652|FG000|Overall Study|Death|0|||
27513182|NCT03224819|80070653|FG001|Overall Study|Death|1|||
27513183|NCT03224819|80070654|FG002|Overall Study|Death|0|||
27513184|NCT03224819|80070655|FG003|Overall Study|Death|0|||
27513185|NCT03224819|80070656|FG004|Overall Study|Death|0|||
27513186|NCT03224819|80070657|FG005|Overall Study|Death|0|||
27513187|NCT03224819|80070658|FG006|Overall Study|Death|0|||
27513188|NCT03224819|80070659|FG007|Overall Study|Death|1|||
27513189|NCT03224819|80070660|FG008|Overall Study|Death|0|||
27513190|NCT03224819|80070661|FG009|Overall Study|Death|0|||
27513191|NCT03224819|80070662|FG010|Overall Study|Death|0|||
27906497|NCT01716520|81493450|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
27906498|NCT01716520|81493445|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27906499|NCT01716520|81493446|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27906500|NCT01716520|81493447|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
27906501|NCT01716520|81493448|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27906502|NCT01716520|81493449|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
27906503|NCT01716520|81493450|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
27906504|NCT01716520|81493445|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
27906505|NCT01716520|81493446|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
27906506|NCT01716520|81493447|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
27906507|NCT01716520|81493448|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
27906508|NCT01716520|81493449|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
27906509|NCT01716520|81493450|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
27513192|NCT03224819|80070663|FG011|Overall Study|Death|1|||
27513193|NCT03224819|80070664|FG012|Overall Study|Death|0|||
27513194|NCT03224819|80070665|FG013|Overall Study|Death|0|||
27513195|NCT02447302|80070666|FG000|Overall Study|Physician Decision|1|||
27513196|NCT02447302|80070667|FG001|Overall Study|Physician Decision|0|||
27513197|NCT02447302|80070668|FG002|Overall Study|Physician Decision|0|||
27513198|NCT02447302|80070666|FG000|Overall Study|Adverse Event|4|||
27513199|NCT02447302|80070667|FG001|Overall Study|Adverse Event|3|||
27513200|NCT02447302|80070668|FG002|Overall Study|Adverse Event|0|||
27513201|NCT02447302|80070666|FG000|Overall Study|Withdrawal by Subject|0|||
27513202|NCT02447302|80070667|FG001|Overall Study|Withdrawal by Subject|1|||
27513203|NCT02447302|80070668|FG002|Overall Study|Withdrawal by Subject|5|||
27513204|NCT02447302|80070666|FG000|Overall Study|Sponsor Decision|0|||
27513205|NCT02447302|80070667|FG001|Overall Study|Sponsor Decision|0|||
27513206|NCT02447302|80070668|FG002|Overall Study|Sponsor Decision|1|||
27513207|NCT01301027|80070672|FG000|Overall Study|Physician Decision|2|||
27513208|NCT01301027|80070673|FG001|Overall Study|Physician Decision|0|||
27513209|NCT01301027|80070672|FG000|Overall Study|Withdrawal by Subject|2|||
27513210|NCT01301027|80070673|FG001|Overall Study|Withdrawal by Subject|3|||
27853147|NCT02991430|81294968|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27853148|NCT02991430|81294966|FG000|Treatment Period 2|Study Termination|6|||
27853149|NCT02991430|81294967|FG001|Treatment Period 2|Study Termination|3|||
27853150|NCT02991430|81294968|FG002|Treatment Period 2|Study Termination|3|||
27853151|NCT02991430|81294966|FG000|Treatment Period 2|Lost to Follow-up|0|||
27853152|NCT02991430|81294967|FG001|Treatment Period 2|Lost to Follow-up|0|||
27853153|NCT02991430|81294968|FG002|Treatment Period 2|Lost to Follow-up|1|||
27853154|NCT02991430|81294966|FG000|Post-treatment Observation Period|Study Termination|3|||
27513211|NCT01301027|80070672|FG000|Overall Study|Adverse Event|0|||
27906510|NCT01716520|81493445|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27906511|NCT01716520|81493446|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27906512|NCT01716520|81493447|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27513212|NCT01301027|80070673|FG001|Overall Study|Adverse Event|2|||
27513213|NCT01301027|80070672|FG000|Overall Study|Fracture|1|||
27513214|NCT01301027|80070673|FG001|Overall Study|Fracture|3|||
27513215|NCT01301027|80070672|FG000|Overall Study|Transplant|0|||
27513216|NCT01301027|80070673|FG001|Overall Study|Transplant|2|||
27513217|NCT01301027|80070672|FG000|Overall Study|Volume Overload|3|||
27513218|NCT01301027|80070673|FG001|Overall Study|Volume Overload|0|||
27513219|NCT00241839|80073881|FG000|Overall Study|Withdrawal by Subject|18|||
27513220|NCT00241839|80073882|FG001|Overall Study|Withdrawal by Subject|17|||
27513221|NCT00241839|80073881|FG000|Overall Study|Adverse Event|1|||
27513222|NCT00241839|80073882|FG001|Overall Study|Adverse Event|1|||
27513223|NCT00329797|80073885|FG000|Overall Study|Protocol Violation|1|||
27513224|NCT00329797|80073886|FG001|Overall Study|Protocol Violation|0|||
27513225|NCT00329797|80073885|FG000|Overall Study|Withdrawal by Subject|6|||
27513226|NCT00329797|80073886|FG001|Overall Study|Withdrawal by Subject|6|||
27513227|NCT01006291|80073887|FG000|Overall Study|Adverse Event|2|||
27513228|NCT01006291|80073888|FG001|Overall Study|Adverse Event|1|||
27513229|NCT01006291|80073889|FG002|Overall Study|Adverse Event|2|||
27513230|NCT01006291|80073887|FG000|Overall Study|Lack of Efficacy|2|||
27513231|NCT01006291|80073888|FG001|Overall Study|Lack of Efficacy|2|||
27513232|NCT01006291|80073889|FG002|Overall Study|Lack of Efficacy|1|||
27513233|NCT01006291|80073887|FG000|Overall Study|Protocol Violation|3|||
27513234|NCT01006291|80073888|FG001|Overall Study|Protocol Violation|3|||
27513235|NCT01006291|80073889|FG002|Overall Study|Protocol Violation|3|||
27513236|NCT01006291|80073887|FG000|Overall Study|Withdrawal criteria|5|||
27513237|NCT01006291|80073888|FG001|Overall Study|Withdrawal criteria|4|||
27513238|NCT01006291|80073889|FG002|Overall Study|Withdrawal criteria|4|||
27513239|NCT01006291|80073887|FG000|Overall Study|Other|14|||
27513240|NCT01006291|80073888|FG001|Overall Study|Other|14|||
27513241|NCT01006291|80073889|FG002|Overall Study|Other|17|||
27513242|NCT00787267|80073891|FG000|Overall Study|Screen failure/Ineligible|10|||
27513243|NCT00787267|80073891|FG000|Overall Study|No Reason Provided|1|||
27513244|NCT00787267|80073891|FG000|Overall Study|Withdrawal by Subject|1|||
27513245|NCT00960570|80073893|FG000|21 Day Washout Period|Adverse Event|1|||
27513246|NCT00960570|80073893|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
27513247|NCT00960570|80073893|FG000|1 Day Period Between Dosing|Adverse Event|2|||
27513248|NCT00960570|80073893|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
27615469|NCT02341456|80434205|FG001|Overall Study|Moved to local access programme.|1|||
27906513|NCT01716520|81493448|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27513249|NCT02657408|80073909|FG000|Overall Study|Adverse Event|3|||
27513250|NCT02657408|80073910|FG001|Overall Study|Adverse Event|7|||
27513251|NCT00441064|80073912|FG000|Overall Study|Adverse Event|1|||
27513252|NCT00441064|80073913|FG001|Overall Study|Adverse Event|0|||
27513253|NCT00441064|80073912|FG000|Overall Study|Abnormal laboratory values|0|||
27513254|NCT00441064|80073913|FG001|Overall Study|Abnormal laboratory values|2|||
27513255|NCT00441064|80073912|FG000|Overall Study|Abnormal test procedure results|0|||
27513256|NCT00441064|80073913|FG001|Overall Study|Abnormal test procedure results|1|||
27513257|NCT00441064|80073912|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27513258|NCT00441064|80073913|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27513259|NCT00441064|80073912|FG000|Overall Study|Protocol Deviation|3|||
27513260|NCT00441064|80073913|FG001|Overall Study|Protocol Deviation|2|||
27513261|NCT00441064|80073912|FG000|Overall Study|Patient withdrew consent|5|||
27513262|NCT00441064|80073913|FG001|Overall Study|Patient withdrew consent|2|||
27513263|NCT05300763|80073914|FG000|Overall Study|Adverse Event|0|||
27513264|NCT05300763|80073915|FG001|Overall Study|Adverse Event|1|||
27513265|NCT05300763|80073914|FG000|Overall Study|Major Protocol Deviation|1|||
27513266|NCT05300763|80073915|FG001|Overall Study|Major Protocol Deviation|0|||
27513267|NCT05300763|80073914|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
27513268|NCT05300763|80073915|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
27513269|NCT00775593|80073916|FG000|Overall Study|Unmet eligibility criteria|6|||
27513270|NCT00775593|80073916|FG000|Overall Study|Death|1|||
27513271|NCT00711477|80073919|FG000|Overall Study|Adverse Event|3|||
27513272|NCT00711477|80073920|FG001|Overall Study|Adverse Event|1|||
27513273|NCT00711477|80073919|FG000|Overall Study|Lost to Follow-up|0|||
27513274|NCT00711477|80073920|FG001|Overall Study|Lost to Follow-up|1|||
27513275|NCT00711477|80073919|FG000|Overall Study|Noncompliance|0|||
27513276|NCT00711477|80073920|FG001|Overall Study|Noncompliance|1|||
27513277|NCT00806819|80073921|FG000|Overall Study|progressive disease (modified RECIST )|217|||
27513278|NCT00806819|80073922|FG001|Overall Study|progressive disease (modified RECIST )|216|||
27513279|NCT00806819|80073921|FG000|Overall Study|Worsening or AE of underlying disease|18|||
27513280|NCT00806819|80073922|FG001|Overall Study|Worsening or AE of underlying disease|25|||
27513281|NCT00806819|80073921|FG000|Overall Study|Other AE|38|||
27513282|NCT00806819|80073922|FG001|Overall Study|Other AE|40|||
27513283|NCT00806819|80073921|FG000|Overall Study|Protocol Violation|9|||
27513284|NCT00806819|80073922|FG001|Overall Study|Protocol Violation|4|||
27513285|NCT00806819|80073921|FG000|Overall Study|Lost to Follow-up|1|||
27513286|NCT00806819|80073922|FG001|Overall Study|Lost to Follow-up|0|||
27513287|NCT00806819|80073921|FG000|Overall Study|Withdrawal by Subject|32|||
27513288|NCT00806819|80073922|FG001|Overall Study|Withdrawal by Subject|29|||
27513289|NCT00806819|80073921|FG000|Overall Study|Not treated|6|||
27513290|NCT00806819|80073922|FG001|Overall Study|Not treated|3|||
27513291|NCT00806819|80073921|FG000|Overall Study|Reasons other than stated above|25|||
27513292|NCT00806819|80073922|FG001|Overall Study|Reasons other than stated above|41|||
27513293|NCT02105961|80073923|FG000|Overall Study|Adverse Event|18|||
27513294|NCT02105961|80073924|FG001|Overall Study|Adverse Event|7|||
27513295|NCT02105961|80073925|FG002|Overall Study|Adverse Event|13|||
27513296|NCT02105961|80073923|FG000|Overall Study|Lack of Efficacy|3|||
27513297|NCT02105961|80073924|FG001|Overall Study|Lack of Efficacy|0|||
27513298|NCT02105961|80073925|FG002|Overall Study|Lack of Efficacy|3|||
27513299|NCT02105961|80073923|FG000|Overall Study|Lost to Follow-up|2|||
27513300|NCT02105961|80073924|FG001|Overall Study|Lost to Follow-up|0|||
27513301|NCT02105961|80073925|FG002|Overall Study|Lost to Follow-up|1|||
27513302|NCT02105961|80073923|FG000|Overall Study|Physician Decision|3|||
27513303|NCT02105961|80073924|FG001|Overall Study|Physician Decision|3|||
27513304|NCT02105961|80073925|FG002|Overall Study|Physician Decision|2|||
27513305|NCT02105961|80073923|FG000|Overall Study|Withdrawal by Subject|15|||
27853155|NCT02991430|81294967|FG001|Post-treatment Observation Period|Study Termination|6|||
27513306|NCT02105961|80073924|FG001|Overall Study|Withdrawal by Subject|7|||
27513307|NCT02105961|80073925|FG002|Overall Study|Withdrawal by Subject|11|||
27513308|NCT03599089|80073930|FG000|Overall Study|Lost to Follow-up|1|||
27513309|NCT03599089|80073931|FG001|Overall Study|Lost to Follow-up|0|||
27513310|NCT03599089|80073932|FG002|Overall Study|Lost to Follow-up|0|||
27513311|NCT03599089|80073933|FG003|Overall Study|Lost to Follow-up|0|||
27513312|NCT03599089|80073930|FG000|Overall Study|Withdrawal by Subject|2|||
27513313|NCT03599089|80073931|FG001|Overall Study|Withdrawal by Subject|1|||
27513314|NCT03599089|80073932|FG002|Overall Study|Withdrawal by Subject|0|||
27513315|NCT03599089|80073933|FG003|Overall Study|Withdrawal by Subject|0|||
27513316|NCT03599089|80073930|FG000|Overall Study|Lack of Efficacy|0|||
27513317|NCT03599089|80073931|FG001|Overall Study|Lack of Efficacy|0|||
27513318|NCT03599089|80073932|FG002|Overall Study|Lack of Efficacy|1|||
27513319|NCT03599089|80073933|FG003|Overall Study|Lack of Efficacy|2|||
27513320|NCT01296672|80073934|FG000|Overall Study|Lost to Follow-up|73|||
27513321|NCT01296672|80073935|FG001|Overall Study|Lost to Follow-up|18|||
27513322|NCT02249832|80073937|FG000|Overall Study|Withdrawal by Subject|3|||
27513323|NCT02249832|80073937|FG000|Overall Study|Lost to Follow-up|10|||
27513324|NCT02656693|80073939|FG000|Overall Study|Pregnancy|1|||
27513325|NCT02656693|80073940|FG001|Overall Study|Pregnancy|1|||
27513326|NCT02656693|80073941|FG002|Overall Study|Pregnancy|1|||
27513327|NCT02656693|80073939|FG000|Overall Study|Bariatric surgery|0|||
27513328|NCT02656693|80073940|FG001|Overall Study|Bariatric surgery|1|||
27513329|NCT02656693|80073941|FG002|Overall Study|Bariatric surgery|2|||
27513330|NCT05343624|80073942|FG000|Overall Study|Chart review not completed|1|||
27513331|NCT02527421|80073943|FG000|Overall Study|Withdrawal by Subject|1|||
27513332|NCT02527421|80073944|FG001|Overall Study|Withdrawal by Subject|0|||
27513333|NCT01776307|80073945|FG000|Overall Study|Not dosed|0|||
27513334|NCT01776307|80073946|FG001|Overall Study|Not dosed|0|||
27513335|NCT01776307|80073947|FG002|Overall Study|Not dosed|1|||
27513336|NCT03500224|80073951|FG000|Overall Study|Withdrawal by Subject|2|||
27513337|NCT01554241|80073953|FG000|Overall Study|Death|3|||
27513338|NCT01554241|80073954|FG001|Overall Study|Death|1|||
27513339|NCT01554241|80073955|FG002|Overall Study|Death|1|||
27513340|NCT01554241|80073956|FG003|Overall Study|Death|0|||
27513341|NCT01554241|80073953|FG000|Overall Study|protocol specified renal stone|0|||
27513342|NCT01554241|80073954|FG001|Overall Study|protocol specified renal stone|0|||
27513343|NCT01554241|80073955|FG002|Overall Study|protocol specified renal stone|0|||
27513344|NCT01554241|80073956|FG003|Overall Study|protocol specified renal stone|1|||
27513345|NCT01554241|80073953|FG000|Overall Study|protocol specified change in eGFR|0|||
27513346|NCT01554241|80073954|FG001|Overall Study|protocol specified change in eGFR|0|||
27513347|NCT01554241|80073955|FG002|Overall Study|protocol specified change in eGFR|1|||
27513348|NCT01554241|80073956|FG003|Overall Study|protocol specified change in eGFR|0|||
27513349|NCT01554241|80073953|FG000|Overall Study|Withdrawal by Subject|0|||
27513350|NCT01554241|80073954|FG001|Overall Study|Withdrawal by Subject|0|||
27513351|NCT01554241|80073955|FG002|Overall Study|Withdrawal by Subject|2|||
27513352|NCT01554241|80073956|FG003|Overall Study|Withdrawal by Subject|0|||
27513353|NCT03565497|80073960|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
27513354|NCT03565497|80073961|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
27513355|NCT03565497|80073962|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
27513356|NCT03565497|80073960|FG000|Overall Study|Lost to Follow-up|1|||
27513357|NCT03565497|80073961|FG001|Overall Study|Lost to Follow-up|1|||
27513358|NCT03565497|80073962|FG002|Overall Study|Lost to Follow-up|2|||
27513359|NCT03565497|80073960|FG000|Overall Study|Withdrawal by Subject|1|||
27513360|NCT03565497|80073961|FG001|Overall Study|Withdrawal by Subject|1|||
27513361|NCT03565497|80073962|FG002|Overall Study|Withdrawal by Subject|1|||
27513362|NCT01419197|80073963|FG000|Overall Study|Death|247|||
27513363|NCT01419197|80073964|FG001|Overall Study|Death|122|||
27513364|NCT01419197|80073963|FG000|Overall Study|Physician Decision|4|||
27513365|NCT01419197|80073964|FG001|Overall Study|Physician Decision|4|||
27513366|NCT01419197|80073963|FG000|Overall Study|Non-compliance|3|||
27513367|NCT01419197|80073964|FG001|Overall Study|Non-compliance|1|||
27513368|NCT01419197|80073963|FG000|Overall Study|Withdrawal by Subject|33|||
27513369|NCT01419197|80073964|FG001|Overall Study|Withdrawal by Subject|32|||
27513370|NCT01419197|80073963|FG000|Overall Study|Study Completed by Sponsor|103|||
27513371|NCT01419197|80073964|FG001|Overall Study|Study Completed by Sponsor|34|||
27513372|NCT01419197|80073963|FG000|Overall Study|Reason Not Specified|0|||
27513373|NCT01419197|80073964|FG001|Overall Study|Reason Not Specified|1|||
27513374|NCT01419197|80073963|FG000|Overall Study|Lost to Follow-up|14|||
27513375|NCT01419197|80073964|FG001|Overall Study|Lost to Follow-up|4|||
27513376|NCT04040933|80073965|FG000|Overall Study|Protocol Violation|1|||
27513377|NCT04040933|80073965|FG000|Overall Study|Withdrawal by Subject|2|||
27513378|NCT00509145|80073966|FG000|Overall Study|Death|0|||
27513379|NCT00509145|80073967|FG001|Overall Study|Death|2|||
27513380|NCT00509145|80073966|FG000|Overall Study|Adverse Event|42|||
27513381|NCT00509145|80073967|FG001|Overall Study|Adverse Event|28|||
27513382|NCT00509145|80073966|FG000|Overall Study|Withdrawal by Subject|32|||
27513383|NCT00509145|80073967|FG001|Overall Study|Withdrawal by Subject|38|||
27513384|NCT00509145|80073966|FG000|Overall Study|Physician Decision|11|||
27513385|NCT00509145|80073967|FG001|Overall Study|Physician Decision|14|||
27513386|NCT00509145|80073966|FG000|Overall Study|Protocol Violation|1|||
27513387|NCT00509145|80073967|FG001|Overall Study|Protocol Violation|6|||
27513388|NCT00509145|80073966|FG000|Overall Study|Pregnancy|3|||
27513389|NCT00509145|80073967|FG001|Overall Study|Pregnancy|8|||
27513390|NCT00509145|80073966|FG000|Overall Study|Lost to Follow-up|6|||
27513391|NCT00509145|80073967|FG001|Overall Study|Lost to Follow-up|5|||
27513392|NCT00509145|80073966|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
27513393|NCT00509145|80073967|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
27513394|NCT00509145|80073966|FG000|Overall Study|Other|6|||
27513395|NCT00509145|80073967|FG001|Overall Study|Other|6|||
27513396|NCT00706342|80073968|FG000|Overall Study|Adverse Event|3|||
27513397|NCT00706342|80073968|FG000|Overall Study|Not responding to treatment|2|||
27513398|NCT00706342|80073968|FG000|Overall Study|Withdrawn due to failure to respond|1|||
27513399|NCT00706342|80073968|FG000|Overall Study|Death|1|||
27513400|NCT00706342|80073968|FG000|Overall Study|Withdrew from the study on his own.|1|||
27513401|NCT00706342|80073968|FG000|Overall Study|Investigator discretion|2|||
27513402|NCT00706342|80073968|FG000|Overall Study|Non-responder Week 12|1|||
27513403|NCT00706342|80073968|FG000|Overall Study|Ongoing|6|||
27513404|NCT00706342|80073968|FG000|Overall Study|WIthdrawal of consent|1|||
27513405|NCT02834793|80073978|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
27513406|NCT02834793|80073979|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
27513407|NCT02834793|80073980|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
27513408|NCT02834793|80073981|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
27513409|NCT02834793|80073978|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
27513410|NCT02834793|80073979|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
27513411|NCT02834793|80073980|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
27513412|NCT02834793|80073981|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
27513413|NCT02834793|80073978|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
27513414|NCT02834793|80073979|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
27513415|NCT02834793|80073980|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
27513416|NCT02834793|80073981|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
27513417|NCT02834793|80073978|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
27513418|NCT02834793|80073979|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
27513419|NCT02834793|80073980|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
27513420|NCT02834793|80073981|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
27513421|NCT02834793|80073978|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
27513422|NCT02834793|80073979|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
27513423|NCT02834793|80073980|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
27513424|NCT02834793|80073981|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
27513425|NCT02834793|80073978|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
27513426|NCT02834793|80073979|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
27513427|NCT02834793|80073980|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
27513428|NCT02834793|80073981|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
27513429|NCT02834793|80073978|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
27513430|NCT02834793|80073979|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
27513431|NCT02834793|80073980|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
27513432|NCT02834793|80073981|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
27513433|NCT02834793|80073978|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
27513434|NCT02834793|80073979|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
27513435|NCT02834793|80073980|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
27513436|NCT02834793|80073981|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
27513437|NCT02834793|80073978|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
27513438|NCT02834793|80073979|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
27513439|NCT02834793|80073980|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
27513440|NCT02834793|80073981|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
27513441|NCT02834793|80073978|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
27513442|NCT02834793|80073979|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
27513443|NCT02834793|80073980|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
27513444|NCT02834793|80073981|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
27513445|NCT02834793|80073978|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
27513446|NCT02834793|80073979|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
27513447|NCT02834793|80073980|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
27513448|NCT02834793|80073981|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
27513449|NCT02834793|80073978|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
27513450|NCT02834793|80073979|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
27513451|NCT02834793|80073980|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
27513452|NCT02834793|80073981|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
27513453|NCT02834793|80073978|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
27513454|NCT02834793|80073979|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
27513455|NCT02834793|80073980|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
27513456|NCT02834793|80073981|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
27513457|NCT02834793|80073978|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
27513458|NCT02834793|80073979|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
27513459|NCT02834793|80073980|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
27513460|NCT02834793|80073981|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
27513461|NCT02834793|80073978|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
27513462|NCT02834793|80073979|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
27513463|NCT02834793|80073980|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
27513464|NCT02834793|80073981|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
27513465|NCT01938716|80073982|FG000|Overall Study|Physician Decision|2|||
27513466|NCT01938716|80073982|FG000|Overall Study|Withdrawal by Subject|2|||
27615470|NCT02341456|80434206|FG002|Overall Study|Moved to local access programme.|1|||
27728672|NCT00727402|80833355|FG000|Overall Study|Physician Decision|116|||
27513467|NCT02970942|80073983|FG000|Overall Study|Death|0|||
27513468|NCT02970942|80073984|FG001|Overall Study|Death|1|||
27513469|NCT02970942|80073985|FG002|Overall Study|Death|0|||
27513470|NCT02970942|80073986|FG003|Overall Study|Death|0|||
27513471|NCT02970942|80073983|FG000|Overall Study|Lost to Follow-up|1|||
27513472|NCT02970942|80073984|FG001|Overall Study|Lost to Follow-up|0|||
27513473|NCT02970942|80073985|FG002|Overall Study|Lost to Follow-up|2|||
27513474|NCT02970942|80073986|FG003|Overall Study|Lost to Follow-up|1|||
27513475|NCT02970942|80073983|FG000|Overall Study|Withdrawal by Subject|3|||
27513476|NCT02970942|80073984|FG001|Overall Study|Withdrawal by Subject|5|||
27513477|NCT02970942|80073985|FG002|Overall Study|Withdrawal by Subject|3|||
27513478|NCT02970942|80073986|FG003|Overall Study|Withdrawal by Subject|2|||
27513479|NCT02207088|80073989|FG000|Overall Study|Adverse Event|2|||
27513480|NCT00606593|80073992|FG000|Overall Study|Adverse Event|0|||
27513481|NCT00606593|80073993|FG001|Overall Study|Adverse Event|0|||
27513482|NCT00606593|80073994|FG002|Overall Study|Adverse Event|0|||
27513483|NCT00606593|80073995|FG003|Overall Study|Adverse Event|1|||
27513484|NCT00606593|80073996|FG004|Overall Study|Adverse Event|1|||
27513485|NCT00606593|80073997|FG005|Overall Study|Adverse Event|0|||
27513486|NCT00606593|80073998|FG006|Overall Study|Adverse Event|1|||
27513487|NCT00606593|80073999|FG007|Overall Study|Adverse Event|2|||
27513488|NCT00606593|80074000|FG008|Overall Study|Adverse Event|1|||
27513489|NCT00606593|80074001|FG009|Overall Study|Adverse Event|0|||
27513490|NCT00606593|80073992|FG000|Overall Study|Withdrawal of consent|1|||
27513491|NCT00606593|80073993|FG001|Overall Study|Withdrawal of consent|0|||
27513492|NCT00606593|80073994|FG002|Overall Study|Withdrawal of consent|1|||
27513493|NCT00606593|80073995|FG003|Overall Study|Withdrawal of consent|0|||
27513494|NCT00606593|80073996|FG004|Overall Study|Withdrawal of consent|0|||
27906514|NCT01716520|81493449|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
27906515|NCT01716520|81493450|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
27906516|NCT01716520|81493445|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906517|NCT01716520|81493446|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906518|NCT01716520|81493447|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906519|NCT01716520|81493448|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
27906520|NCT01716520|81493449|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906521|NCT01716520|81493450|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
27906522|NCT01716520|81493445|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
27906523|NCT01716520|81493446|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
27906524|NCT01716520|81493447|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
27906525|NCT01716520|81493448|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
27906526|NCT01716520|81493449|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
27513495|NCT00606593|80073997|FG005|Overall Study|Withdrawal of consent|0|||
27513496|NCT00606593|80073998|FG006|Overall Study|Withdrawal of consent|0|||
27513497|NCT00606593|80073999|FG007|Overall Study|Withdrawal of consent|0|||
27513498|NCT00606593|80074000|FG008|Overall Study|Withdrawal of consent|0|||
27513499|NCT00606593|80074001|FG009|Overall Study|Withdrawal of consent|0|||
27513500|NCT00606593|80073992|FG000|Overall Study|Administrative/Other|0|||
27615471|NCT02341456|80434204|FG000|Overall Study|Physician Decision|1|||
27513501|NCT00606593|80073993|FG001|Overall Study|Administrative/Other|0|||
27513502|NCT00606593|80073994|FG002|Overall Study|Administrative/Other|1|||
27513503|NCT00606593|80073995|FG003|Overall Study|Administrative/Other|0|||
27513504|NCT00606593|80073996|FG004|Overall Study|Administrative/Other|0|||
27513505|NCT00606593|80073997|FG005|Overall Study|Administrative/Other|0|||
27513506|NCT00606593|80073998|FG006|Overall Study|Administrative/Other|0|||
27513507|NCT00606593|80073999|FG007|Overall Study|Administrative/Other|0|||
27513508|NCT00606593|80074000|FG008|Overall Study|Administrative/Other|0|||
27513509|NCT00606593|80074001|FG009|Overall Study|Administrative/Other|0|||
27513510|NCT00993148|80074002|FG000|Overall Study|Lost to Follow-up|2|||
27513511|NCT00993148|80074002|FG000|Overall Study|never initiated treatment|1|||
27513512|NCT02252939|80074004|FG000|Overall Study|Lost to Follow-up|3|||
27513513|NCT03313037|80074005|FG000|Overall Study|Protocol Violation|4|||
27513514|NCT03313037|80074006|FG001|Overall Study|Protocol Violation|1|||
27513515|NCT03313037|80074005|FG000|Overall Study|Other|1|||
27513516|NCT03313037|80074006|FG001|Overall Study|Other|1|||
27513517|NCT03313037|80074005|FG000|Overall Study|Withdrawal by Subject|4|||
27513518|NCT03313037|80074006|FG001|Overall Study|Withdrawal by Subject|3|||
27513519|NCT03313037|80074005|FG000|Overall Study|No longer meets eligibility criteria|1|||
27513520|NCT03313037|80074006|FG001|Overall Study|No longer meets eligibility criteria|7|||
27513521|NCT03313037|80074005|FG000|Overall Study|Lost to Follow-up|9|||
27513522|NCT03313037|80074006|FG001|Overall Study|Lost to Follow-up|8|||
27513523|NCT03313037|80074005|FG000|Overall Study|Randomized but not treated|1|||
27513524|NCT03313037|80074006|FG001|Overall Study|Randomized but not treated|0|||
27513525|NCT04343235|80074008|FG000|Overall Study|Lost to Follow-up|3|||
27513526|NCT04343235|80074009|FG001|Overall Study|Lost to Follow-up|2|||
27513527|NCT01432730|80074010|FG000|Period 1|Adverse Event|2|||
27513528|NCT01432730|80074011|FG001|Period 1|Adverse Event|0|||
27513529|NCT01432730|80074010|FG000|Period 2|Adverse Event|0|||
27513530|NCT01432730|80074011|FG001|Period 2|Adverse Event|4|||
27513531|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
27513532|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
27513533|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
27513534|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
27513535|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
27513536|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
27513537|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
27513538|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
27513539|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
27513540|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
27513541|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
27513542|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
27513543|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
27513544|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
27513545|NCT04173494|80074014|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
27513546|NCT04173494|80074015|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
27513547|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
27513548|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
27513549|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
27513550|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
27513551|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
27513552|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
27513553|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
27513554|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
27513555|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
27513556|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
27513557|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
27513558|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
27513559|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
27513560|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
27513561|NCT04173494|80074014|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
27853156|NCT02991430|81294968|FG002|Post-treatment Observation Period|Study Termination|5|||
27853157|NCT00706381|81294969|FG000|Overall Study|Lost to Follow-up|0|||
27853158|NCT00706381|81294970|FG001|Overall Study|Lost to Follow-up|1|||
27853159|NCT00706381|81294971|FG002|Overall Study|Lost to Follow-up|1|||
27513562|NCT04173494|80074015|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
27513563|NCT00441116|80074021|FG000|Overall Study|Adverse Event|1|||
27513564|NCT00441116|80074022|FG001|Overall Study|Adverse Event|1|||
27513565|NCT00441116|80074021|FG000|Overall Study|Withdrawal by Subject|1|||
27513566|NCT00441116|80074022|FG001|Overall Study|Withdrawal by Subject|0|||
27853160|NCT00706381|81294972|FG003|Overall Study|Lost to Follow-up|0|||
27853161|NCT01215513|81294973|FG000|Overall Study|Not completed CS42|9|||
27906527|NCT01716520|81493450|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
27906528|NCT01716520|81493445|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
27906529|NCT01716520|81493446|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27906530|NCT01716520|81493447|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27906531|NCT01716520|81493448|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27906532|NCT01716520|81493449|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27906533|NCT01716520|81493450|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
27906534|NCT01716520|81493445|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27906535|NCT01716520|81493446|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27906536|NCT01716520|81493447|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27906537|NCT01716520|81493448|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27906538|NCT01716520|81493449|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
27906539|NCT01716520|81493450|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
27906540|NCT01716520|81493445|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27906541|NCT01716520|81493446|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
27906542|NCT01716520|81493447|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27906543|NCT01716520|81493448|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27906544|NCT01716520|81493449|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27513567|NCT00441116|80074021|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
27513568|NCT00441116|80074022|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
27513569|NCT00312195|80074023|FG000|Overall Study|Adverse Event|4|||
27513570|NCT00312195|80074024|FG001|Overall Study|Adverse Event|6|||
27513571|NCT00312195|80074023|FG000|Overall Study|Lost to Follow-up|1|||
27513572|NCT00312195|80074024|FG001|Overall Study|Lost to Follow-up|0|||
27513573|NCT00312195|80074023|FG000|Overall Study|Protocol Violation|1|||
27513574|NCT00312195|80074024|FG001|Overall Study|Protocol Violation|0|||
27513575|NCT02446899|80074025|FG000|Overall Study|Adverse Event|4|||
27513576|NCT02446899|80074026|FG001|Overall Study|Adverse Event|7|||
27513577|NCT02446899|80074025|FG000|Overall Study|Condition Under Investigation Worsened|1|||
27513578|NCT02446899|80074026|FG001|Overall Study|Condition Under Investigation Worsened|4|||
27513579|NCT02446899|80074025|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
27513580|NCT02446899|80074026|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
27513581|NCT02446899|80074025|FG000|Overall Study|Lack of Efficacy|2|||
27513582|NCT02446899|80074026|FG001|Overall Study|Lack of Efficacy|8|||
27513583|NCT02446899|80074025|FG000|Overall Study|Lost to Follow-up|1|||
27513584|NCT02446899|80074026|FG001|Overall Study|Lost to Follow-up|3|||
27513585|NCT02446899|80074025|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
27513586|NCT02446899|80074026|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
27513587|NCT02446899|80074025|FG000|Overall Study|Withdrawal by Subject|11|||
27513588|NCT02446899|80074026|FG001|Overall Study|Withdrawal by Subject|19|||
27513589|NCT02446899|80074025|FG000|Overall Study|Miscellaneous|5|||
27513590|NCT02446899|80074026|FG001|Overall Study|Miscellaneous|4|||
27513591|NCT02446899|80074025|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
27513592|NCT02446899|80074026|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
27513593|NCT00796419|80074033|FG000|Overall Study|Death|0|||
27513594|NCT00796419|80074034|FG001|Overall Study|Death|1|||
27513595|NCT00899431|80074035|FG000|Overall Study|Physician Decision|1|||
27513596|NCT00899431|80074036|FG001|Overall Study|Physician Decision|0|||
27513597|NCT00899431|80074037|FG002|Overall Study|Physician Decision|0|||
27513598|NCT00125164|80074038|FG000|Overall Study|Adverse Event|0|||
27513599|NCT00125164|80074039|FG001|Overall Study|Adverse Event|0|||
27513600|NCT00125164|80074040|FG002|Overall Study|Adverse Event|2|||
27513601|NCT00125164|80074041|FG003|Overall Study|Adverse Event|4|||
27513602|NCT00125164|80074038|FG000|Overall Study|Lost to Follow-up|0|||
27513603|NCT00125164|80074039|FG001|Overall Study|Lost to Follow-up|0|||
27513604|NCT00125164|80074040|FG002|Overall Study|Lost to Follow-up|1|||
27513605|NCT00125164|80074041|FG003|Overall Study|Lost to Follow-up|1|||
27513606|NCT00125164|80074038|FG000|Overall Study|Withdrawal by Subject|2|||
27513607|NCT00125164|80074039|FG001|Overall Study|Withdrawal by Subject|0|||
27513608|NCT00125164|80074040|FG002|Overall Study|Withdrawal by Subject|1|||
27513609|NCT00125164|80074041|FG003|Overall Study|Withdrawal by Subject|1|||
27513610|NCT01146795|80074042|FG000|Overall Study|Withdrawal by Subject|4|||
27513611|NCT01146795|80074042|FG000|Overall Study|Adverse Event|6|||
27513612|NCT01146795|80074042|FG000|Overall Study|Still in treatment at study closure|10|||
27513613|NCT02722499|80074043|FG000|Overall Study|Lost to Follow-up|2|||
27513614|NCT02722499|80074044|FG001|Overall Study|Lost to Follow-up|0|||
27513615|NCT02722499|80074045|FG002|Overall Study|Lost to Follow-up|1|||
27513616|NCT02709538|80074048|FG000|Overall Study|Adverse Event|13|||
27513617|NCT02709538|80074049|FG001|Overall Study|Adverse Event|2|||
27513618|NCT02709538|80074050|FG002|Overall Study|Adverse Event|3|||
27513619|NCT02709538|80074048|FG000|Overall Study|Lack of Efficacy|1|||
27513620|NCT02709538|80074049|FG001|Overall Study|Lack of Efficacy|0|||
27513621|NCT02709538|80074050|FG002|Overall Study|Lack of Efficacy|0|||
27513622|NCT02709538|80074048|FG000|Overall Study|Lost to Follow-up|24|||
27513623|NCT02709538|80074049|FG001|Overall Study|Lost to Follow-up|8|||
27513624|NCT02709538|80074050|FG002|Overall Study|Lost to Follow-up|4|||
27513625|NCT02709538|80074048|FG000|Overall Study|Physician Decision|1|||
27513626|NCT02709538|80074049|FG001|Overall Study|Physician Decision|0|||
27513627|NCT02709538|80074050|FG002|Overall Study|Physician Decision|0|||
27513628|NCT02709538|80074048|FG000|Overall Study|Withdrawal by Subject|40|||
27513629|NCT02709538|80074049|FG001|Overall Study|Withdrawal by Subject|7|||
27513630|NCT02709538|80074050|FG002|Overall Study|Withdrawal by Subject|4|||
27513631|NCT02709538|80074048|FG000|Overall Study|Non-compliance with study procedures|5|||
27513632|NCT02709538|80074049|FG001|Overall Study|Non-compliance with study procedures|0|||
27513633|NCT02709538|80074050|FG002|Overall Study|Non-compliance with study procedures|0|||
27513634|NCT02709538|80074048|FG000|Overall Study|Non-compliance with study drug|2|||
27513635|NCT02709538|80074049|FG001|Overall Study|Non-compliance with study drug|0|||
27513636|NCT02709538|80074050|FG002|Overall Study|Non-compliance with study drug|0|||
27513637|NCT02709538|80074048|FG000|Overall Study|Protocol deviation|10|||
27513638|NCT02709538|80074049|FG001|Overall Study|Protocol deviation|4|||
27513639|NCT02709538|80074050|FG002|Overall Study|Protocol deviation|4|||
27513640|NCT02709538|80074048|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
27513641|NCT02709538|80074049|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
27513642|NCT02709538|80074050|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
27513643|NCT02709538|80074048|FG000|Overall Study|Other|16|||
27513644|NCT02709538|80074049|FG001|Overall Study|Other|7|||
27513645|NCT02709538|80074050|FG002|Overall Study|Other|5|||
27513646|NCT00101452|80074051|FG000|Overall Study|Adverse Event|2|||
27513647|NCT00101452|80074052|FG001|Overall Study|Adverse Event|0|||
27513648|NCT00101452|80074053|FG002|Overall Study|Adverse Event|1|||
27513649|NCT00101452|80074051|FG000|Overall Study|Lost to Follow-up|13|||
27513650|NCT00101452|80074052|FG001|Overall Study|Lost to Follow-up|8|||
27513651|NCT00101452|80074053|FG002|Overall Study|Lost to Follow-up|14|||
27513652|NCT00101452|80074051|FG000|Overall Study|Withdrawal by Subject|10|||
27513653|NCT00101452|80074052|FG001|Overall Study|Withdrawal by Subject|14|||
27513654|NCT00101452|80074053|FG002|Overall Study|Withdrawal by Subject|9|||
27513655|NCT00101452|80074051|FG000|Overall Study|Baseline Fail|2|||
27513656|NCT00101452|80074052|FG001|Overall Study|Baseline Fail|1|||
27513657|NCT00101452|80074053|FG002|Overall Study|Baseline Fail|2|||
27513658|NCT00101452|80074051|FG000|Overall Study|Physician Decision|0|||
27513659|NCT00101452|80074052|FG001|Overall Study|Physician Decision|3|||
27513660|NCT00101452|80074053|FG002|Overall Study|Physician Decision|2|||
27513661|NCT00101452|80074051|FG000|Overall Study|Protocol Violation|2|||
27513662|NCT00101452|80074052|FG001|Overall Study|Protocol Violation|1|||
27513663|NCT00101452|80074053|FG002|Overall Study|Protocol Violation|3|||
27513664|NCT00101452|80074051|FG000|Overall Study|Other|15|||
27513665|NCT00101452|80074052|FG001|Overall Study|Other|16|||
27513666|NCT00101452|80074053|FG002|Overall Study|Other|12|||
27513667|NCT01864603|80074054|FG000|Stage 2|DSMB design modification|86056|||
27513668|NCT01864603|80074055|FG001|Stage 2|DSMB design modification|92558|||
27513669|NCT04080167|80074066|FG000|Overall Study|Lost to Follow-up-Patients|7|||
27513670|NCT04080167|80074067|FG001|Overall Study|Lost to Follow-up-Patients|14|||
27513671|NCT04080167|80074068|FG002|Overall Study|Lost to Follow-up-Patients|0|||
27513672|NCT04080167|80074066|FG000|Overall Study|Lost to Follow-up-Providers|2|||
27513673|NCT04080167|80074067|FG001|Overall Study|Lost to Follow-up-Providers|2|||
27513674|NCT04080167|80074068|FG002|Overall Study|Lost to Follow-up-Providers|0|||
27513675|NCT04080167|80074066|FG000|Overall Study|Withdrawal by Subject|1|||
27513676|NCT04080167|80074067|FG001|Overall Study|Withdrawal by Subject|2|||
27513677|NCT04080167|80074068|FG002|Overall Study|Withdrawal by Subject|0|||
27513678|NCT04080167|80074066|FG000|Overall Study|Withdrawal by Provider|0|||
27513679|NCT04080167|80074067|FG001|Overall Study|Withdrawal by Provider|0|||
27513680|NCT04080167|80074068|FG002|Overall Study|Withdrawal by Provider|4|||
27513681|NCT04080167|80074066|FG000|Overall Study|Death-Patient|2|||
27513682|NCT04080167|80074067|FG001|Overall Study|Death-Patient|1|||
27513683|NCT04080167|80074068|FG002|Overall Study|Death-Patient|0|||
27513684|NCT04080167|80074066|FG000|Overall Study|Hydroxyurea New Starts|0|||
27513685|NCT04080167|80074067|FG001|Overall Study|Hydroxyurea New Starts|0|||
27513686|NCT04080167|80074068|FG002|Overall Study|Hydroxyurea New Starts|1|||
27513687|NCT04080167|80074066|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
27513688|NCT04080167|80074067|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
27513689|NCT04080167|80074068|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
27513690|NCT02779556|80074069|FG000|Baseline|Partial baseline interview completed|1|||
27513691|NCT02779556|80074070|FG001|Baseline|Partial baseline interview completed|0|||
27513692|NCT02779556|80074069|FG000|3 Months|Lost to Follow-up|40|||
27513693|NCT02779556|80074070|FG001|3 Months|Lost to Follow-up|29|||
27513694|NCT02779556|80074069|FG000|3 Months|Missed 3 month clinic visit|27|||
27513695|NCT02779556|80074070|FG001|3 Months|Missed 3 month clinic visit|19|||
27513696|NCT02779556|80074069|FG000|6 Month|Lost to Follow-up|33|||
27513697|NCT02779556|80074070|FG001|6 Month|Lost to Follow-up|39|||
27513698|NCT02779556|80074069|FG000|6 Month HbA1c|No value collected during window|69|||
27728673|NCT01446809|80833356|FG000|Overall Study|Adverse Event|0|||
27513699|NCT02779556|80074070|FG001|6 Month HbA1c|No value collected during window|50|||
27513700|NCT02779556|80074069|FG000|12 Month HbA1c|No value collected during window|138|||
27513701|NCT02779556|80074070|FG001|12 Month HbA1c|No value collected during window|102|||
27513702|NCT01590888|80074071|FG000|Overall Study|Adverse Event|3|||
27513703|NCT01590888|80074072|FG001|Overall Study|Adverse Event|0|||
27513704|NCT01590888|80074073|FG002|Overall Study|Adverse Event|1|||
27513705|NCT01590888|80074071|FG000|Overall Study|Lost to Follow-up|1|||
27513706|NCT01590888|80074072|FG001|Overall Study|Lost to Follow-up|0|||
27513707|NCT01590888|80074073|FG002|Overall Study|Lost to Follow-up|0|||
27513708|NCT01711216|80074076|FG000|Overall Study|Adverse Event|4|||
27513709|NCT01711216|80074076|FG000|Overall Study|Pregnancy|56|||
27513710|NCT01711216|80074076|FG000|Overall Study|Withdrawal by Subject|6|||
27513711|NCT01711216|80074076|FG000|Overall Study|Lost to Follow-up|46|||
27513712|NCT01711216|80074076|FG000|Overall Study|variety of other minor reasons|83|||
27513713|NCT01711216|80074076|FG000|Overall Study|no reason specified|22|||
27513714|NCT01696188|80074079|FG000|Overall Study|Protocol Violation|1|||
27513715|NCT01696188|80074080|FG001|Overall Study|Protocol Violation|1|||
27513716|NCT01733680|80074085|FG000|Overall Study|Withdrawal by Subject|0|||
27513717|NCT01733680|80074086|FG001|Overall Study|Withdrawal by Subject|1|||
27513718|NCT01474018|80074087|FG000|Overall Study|Lost to Follow-up|0|||
27513719|NCT01474018|80074088|FG001|Overall Study|Lost to Follow-up|1|||
27513720|NCT01474018|80074087|FG000|Overall Study|Withdrawal by Subject|0|||
27513721|NCT01474018|80074088|FG001|Overall Study|Withdrawal by Subject|2|||
27513722|NCT03116152|80074092|FG000|Overall Study|Disease Progression|49|||
27513723|NCT03116152|80074093|FG001|Overall Study|Disease Progression|47|||
27513724|NCT03116152|80074092|FG000|Overall Study|Death|5|||
27513725|NCT03116152|80074093|FG001|Overall Study|Death|2|||
27513726|NCT03116152|80074092|FG000|Overall Study|Adverse Event|21|||
27513727|NCT03116152|80074093|FG001|Overall Study|Adverse Event|7|||
27513728|NCT03116152|80074092|FG000|Overall Study|Protocol Violation|2|||
27513729|NCT03116152|80074093|FG001|Overall Study|Protocol Violation|2|||
27513730|NCT03116152|80074092|FG000|Overall Study|Withdrawal by Subject|0|||
27513731|NCT03116152|80074093|FG001|Overall Study|Withdrawal by Subject|1|||
27513732|NCT03116152|80074092|FG000|Overall Study|Physician Decision|3|||
27513733|NCT03116152|80074093|FG001|Overall Study|Physician Decision|2|||
27513734|NCT03116152|80074092|FG000|Overall Study|other|11|||
27513735|NCT03116152|80074093|FG001|Overall Study|other|34|||
27513736|NCT00392769|80074096|FG000|Overall Study|Clinical Deterioration|9|||
27513737|NCT00392769|80074096|FG000|Overall Study|Adverse Event|1|||
27513738|NCT01011309|80074097|FG000|Overall Study|Adverse Event|2|||
27513739|NCT01011309|80074098|FG001|Overall Study|Adverse Event|1|||
27513740|NCT01011309|80074099|FG002|Overall Study|Adverse Event|2|||
27513741|NCT01011309|80074097|FG000|Overall Study|Lack of Efficacy|0|||
27513742|NCT01011309|80074098|FG001|Overall Study|Lack of Efficacy|1|||
27513743|NCT01011309|80074099|FG002|Overall Study|Lack of Efficacy|0|||
27513744|NCT01011309|80074097|FG000|Overall Study|Protocol Violation|0|||
27513745|NCT01011309|80074098|FG001|Overall Study|Protocol Violation|1|||
27513746|NCT01011309|80074099|FG002|Overall Study|Protocol Violation|3|||
27513747|NCT02660983|80074107|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
27513748|NCT02660983|80074108|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
27513749|NCT02660983|80074107|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
27513750|NCT02660983|80074108|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
27513751|NCT02660983|80074107|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
27513752|NCT02660983|80074108|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
27513753|NCT02660983|80074107|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
27615472|NCT02341456|80434205|FG001|Overall Study|Physician Decision|0|||
27615473|NCT02341456|80434206|FG002|Overall Study|Physician Decision|0|||
27615474|NCT03382600|80434208|FG000|Overall Study|Adverse Event|3|||
27615475|NCT03382600|80434209|FG001|Overall Study|Adverse Event|3|||
27615476|NCT03382600|80434208|FG000|Overall Study|Clinical Disease Progression|2|||
27615477|NCT03382600|80434209|FG001|Overall Study|Clinical Disease Progression|4|||
27615478|NCT03382600|80434208|FG000|Overall Study|Radiological Progression|40|||
27615479|NCT03382600|80434209|FG001|Overall Study|Radiological Progression|31|||
27615480|NCT03382600|80434208|FG000|Overall Study|Withdrawal by Subject|0|||
27615481|NCT03382600|80434209|FG001|Overall Study|Withdrawal by Subject|1|||
27615482|NCT03382600|80434208|FG000|Overall Study|Other|9|||
27615483|NCT03382600|80434209|FG001|Overall Study|Other|7|||
27615484|NCT01993823|80434210|FG000|Overall Study|Requested by the patient|6|||
27615485|NCT01993823|80434211|FG001|Overall Study|Requested by the patient|11|||
27615486|NCT01993823|80434210|FG000|Overall Study|Protocol Violation|0|||
27615487|NCT01993823|80434211|FG001|Overall Study|Protocol Violation|1|||
27615488|NCT01993823|80434210|FG000|Overall Study|Lost to Follow-up|1|||
27513754|NCT02660983|80074108|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
27513755|NCT02660983|80074107|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
27513756|NCT02660983|80074108|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
27513757|NCT02660983|80074107|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
27513758|NCT02660983|80074108|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
27513759|NCT02660983|80074107|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
27513760|NCT02660983|80074108|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
27513761|NCT04254913|80074109|FG000|Overall Study|Adverse Event|1|||
27513762|NCT00845897|80074112|FG000|Overall Study|Lost to Follow-up|1|||
27513763|NCT00845897|80074113|FG001|Overall Study|Lost to Follow-up|1|||
27513764|NCT00845897|80074114|FG002|Overall Study|Lost to Follow-up|0|||
27615489|NCT01993823|80434211|FG001|Overall Study|Lost to Follow-up|4|||
27513765|NCT00845897|80074112|FG000|Overall Study|Withdrawal by Subject|0|||
27513766|NCT00845897|80074113|FG001|Overall Study|Withdrawal by Subject|3|||
27513767|NCT00845897|80074114|FG002|Overall Study|Withdrawal by Subject|2|||
27513768|NCT00845897|80074112|FG000|Overall Study|Ulcer did not heal|1|||
27513769|NCT00845897|80074113|FG001|Overall Study|Ulcer did not heal|0|||
27513770|NCT00845897|80074114|FG002|Overall Study|Ulcer did not heal|1|||
27513771|NCT00845897|80074112|FG000|Overall Study|Too ill to participate|0|||
27513772|NCT00845897|80074113|FG001|Overall Study|Too ill to participate|1|||
27513773|NCT00845897|80074114|FG002|Overall Study|Too ill to participate|0|||
27513774|NCT04195893|80074115|FG000|Second Intervention|Withdrawal by Subject|1|||
27513775|NCT04195893|80074116|FG001|Second Intervention|Withdrawal by Subject|0|||
27513776|NCT03037580|80074117|FG000|Overall Study|Withdrawal by Subject|3|||
27513777|NCT03037580|80074118|FG001|Overall Study|Withdrawal by Subject|0|||
27513778|NCT03037580|80074117|FG000|Overall Study|Adverse Event|1|||
27513779|NCT03037580|80074118|FG001|Overall Study|Adverse Event|0|||
27513780|NCT03037580|80074117|FG000|Overall Study|Study Terminated by Sponsor|12|||
27513781|NCT03037580|80074118|FG001|Overall Study|Study Terminated by Sponsor|15|||
27513782|NCT03037580|80074117|FG000|Overall Study|Death|0|||
27513783|NCT03037580|80074118|FG001|Overall Study|Death|1|||
27513784|NCT01215097|80074119|FG000|Overall Study|Adverse Event|1|||
27513785|NCT01215097|80074120|FG001|Overall Study|Adverse Event|3|||
27513786|NCT01215097|80074119|FG000|Overall Study|Protocol Violation|0|||
27513787|NCT01215097|80074120|FG001|Overall Study|Protocol Violation|2|||
27513788|NCT01215097|80074119|FG000|Overall Study|Lost to Follow-up|2|||
27513789|NCT01215097|80074120|FG001|Overall Study|Lost to Follow-up|0|||
27513790|NCT01215097|80074119|FG000|Overall Study|Withdrawal by Subject|6|||
27513791|NCT01215097|80074120|FG001|Overall Study|Withdrawal by Subject|3|||
27513792|NCT01215097|80074119|FG000|Overall Study|Lack of Efficacy|0|||
27513793|NCT01215097|80074120|FG001|Overall Study|Lack of Efficacy|3|||
27513794|NCT01215097|80074119|FG000|Overall Study|patient's refusal to come|2|||
27513795|NCT01215097|80074120|FG001|Overall Study|patient's refusal to come|2|||
27513796|NCT01215097|80074119|FG000|Overall Study|patient's private reason|1|||
27513797|NCT01215097|80074120|FG001|Overall Study|patient's private reason|1|||
27513798|NCT00357903|80074123|FG000|Overall Study|Adverse Event|87|||
27513799|NCT00357903|80074124|FG001|Overall Study|Adverse Event|4|||
27513800|NCT00357903|80074123|FG000|Overall Study|Death|33|||
27513801|NCT00357903|80074124|FG001|Overall Study|Death|0|||
27513802|NCT00357903|80074123|FG000|Overall Study|Lost to Follow-up|23|||
27513803|NCT00357903|80074124|FG001|Overall Study|Lost to Follow-up|4|||
27513804|NCT00357903|80074123|FG000|Overall Study|Physician Decision|39|||
27513805|NCT00357903|80074124|FG001|Overall Study|Physician Decision|5|||
27513806|NCT00357903|80074123|FG000|Overall Study|Withdrawal by Subject|57|||
27513807|NCT00357903|80074124|FG001|Overall Study|Withdrawal by Subject|7|||
27513808|NCT00357903|80074123|FG000|Overall Study|Completed month 12 only|0|||
27513809|NCT00357903|80074124|FG001|Overall Study|Completed month 12 only|1|||
27513810|NCT00357903|80074123|FG000|Overall Study|Protocol issues|14|||
27513811|NCT00357903|80074124|FG001|Overall Study|Protocol issues|3|||
27513812|NCT00357903|80074123|FG000|Overall Study|Response status|61|||
27513813|NCT00357903|80074124|FG001|Overall Study|Response status|9|||
27513814|NCT00357903|80074123|FG000|Overall Study|Other|49|||
27513815|NCT00357903|80074124|FG001|Overall Study|Other|10|||
27513816|NCT04270370|80074125|FG000|Overall Study|Lost to Follow-up|1|||
27513817|NCT04270370|80074126|FG001|Overall Study|Lost to Follow-up|0|||
27513818|NCT04270370|80074127|FG002|Overall Study|Lost to Follow-up|0|||
27513819|NCT04270370|80074128|FG003|Overall Study|Lost to Follow-up|0|||
27513820|NCT04270370|80074129|FG004|Overall Study|Lost to Follow-up|0|||
27513821|NCT04270370|80074130|FG005|Overall Study|Lost to Follow-up|0|||
27513822|NCT04270370|80074131|FG006|Overall Study|Lost to Follow-up|0|||
27513823|NCT04270370|80074132|FG007|Overall Study|Lost to Follow-up|0|||
27513824|NCT04270370|80074133|FG008|Overall Study|Lost to Follow-up|1|||
27513825|NCT04270370|80074134|FG009|Overall Study|Lost to Follow-up|0|||
27513826|NCT04270370|80074135|FG010|Overall Study|Lost to Follow-up|0|||
27513827|NCT04270370|80074136|FG011|Overall Study|Lost to Follow-up|0|||
27513828|NCT02876601|80074137|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
27513829|NCT02876601|80074138|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
27513830|NCT02876601|80074139|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
27513831|NCT02876601|80074140|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
27513832|NCT02067676|80074141|FG000|Overall Study|Withdrawal by Subject|1|||
27513833|NCT02067676|80074142|FG001|Overall Study|Withdrawal by Subject|0|||
27513834|NCT02067676|80074143|FG002|Overall Study|Withdrawal by Subject|0|||
27513835|NCT02067676|80074144|FG003|Overall Study|Withdrawal by Subject|0|||
27513836|NCT02067676|80074145|FG004|Overall Study|Withdrawal by Subject|0|||
27513837|NCT02067676|80074146|FG005|Overall Study|Withdrawal by Subject|0|||
27513838|NCT01235741|80074148|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
27513839|NCT01235741|80074149|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
27513840|NCT01235741|80074150|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
27513841|NCT01235741|80074148|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
27513842|NCT01235741|80074149|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
27513843|NCT01235741|80074150|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
27615490|NCT01799720|80434212|FG000|Overall Study|Withdrawal by Subject|3|||
27513844|NCT01235741|80074148|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
27513845|NCT01235741|80074149|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
27513846|NCT01235741|80074150|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
27513847|NCT01235741|80074148|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
27513848|NCT01235741|80074149|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
27513849|NCT01235741|80074150|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
27513850|NCT01235741|80074148|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
27513851|NCT01235741|80074149|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
27513852|NCT01235741|80074150|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
27513853|NCT01235741|80074148|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
27513854|NCT01235741|80074149|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
27513855|NCT01235741|80074150|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
27513856|NCT01235741|80074148|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
27513857|NCT01235741|80074149|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
27513858|NCT01235741|80074150|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
27513859|NCT01235741|80074148|FG000|Randomized to Treatment|Adverse Event|0|||
27513860|NCT01235741|80074149|FG001|Randomized to Treatment|Adverse Event|1|||
27513861|NCT01235741|80074150|FG002|Randomized to Treatment|Adverse Event|1|||
27513862|NCT01235741|80074148|FG000|Randomized to Treatment|Sponsor terminated study|0|||
27513863|NCT01235741|80074149|FG001|Randomized to Treatment|Sponsor terminated study|35|||
27513864|NCT01235741|80074150|FG002|Randomized to Treatment|Sponsor terminated study|34|||
27513865|NCT01235741|80074148|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
27513866|NCT01235741|80074149|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
27513867|NCT01235741|80074150|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
27513868|NCT01235741|80074148|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
27513869|NCT01235741|80074149|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
27513870|NCT01235741|80074150|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
27513871|NCT01235741|80074148|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
27513872|NCT01235741|80074149|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
27513873|NCT01235741|80074150|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
27513874|NCT02302339|80074157|FG000|Overall Study|Lost to Follow-up|1|||
27513875|NCT02302339|80074158|FG001|Overall Study|Lost to Follow-up|0|||
27513876|NCT02302339|80074159|FG002|Overall Study|Lost to Follow-up|0|||
27513877|NCT02302339|80074160|FG003|Overall Study|Lost to Follow-up|0|||
27513878|NCT02302339|80074157|FG000|Overall Study|Withdrawal by Subject|0|||
27513879|NCT02302339|80074158|FG001|Overall Study|Withdrawal by Subject|2|||
27513880|NCT02302339|80074159|FG002|Overall Study|Withdrawal by Subject|1|||
27513881|NCT02302339|80074160|FG003|Overall Study|Withdrawal by Subject|0|||
27513882|NCT03181529|80074161|FG000|Overall Study|Withdrawal by Subject|1|||
27513883|NCT03181529|80074162|FG001|Overall Study|Withdrawal by Subject|1|||
27513884|NCT03181529|80074161|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
27513885|NCT03181529|80074162|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
27513886|NCT02269267|80074163|FG000|Overall Study|Death|5|||
27513887|NCT01276054|80074164|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
27513888|NCT01276054|80074165|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
27513889|NCT00843284|80074166|FG000|Overall Study|Adverse Event|39|||
27513890|NCT00843284|80074166|FG000|Overall Study|Lack of Efficacy|5|||
27513891|NCT00843284|80074166|FG000|Overall Study|Lost to Follow-up|11|||
27513892|NCT00843284|80074166|FG000|Overall Study|Other|10|||
27513893|NCT00843284|80074166|FG000|Overall Study|Withdrawal by Subject|4|||
27513894|NCT00843284|80074166|FG000|Overall Study|Death|3|||
27513895|NCT00641667|80074168|FG000|Overall Study|Withdrawal by Subject|1|||
27513896|NCT00641667|80074168|FG000|Overall Study|Adverse Event|1|||
27513897|NCT00641667|80074168|FG000|Overall Study|Physician Decision|1|||
27513898|NCT00641667|80074168|FG000|Overall Study|Worsening of underlying disease|3|||
27513899|NCT01646125|80074175|FG000|Overall Study|Untreated|2|||
27513900|NCT01646125|80074176|FG001|Overall Study|Untreated|5|||
27513901|NCT01646125|80074175|FG000|Overall Study|Adverse Event|2|||
27513902|NCT01646125|80074176|FG001|Overall Study|Adverse Event|1|||
27615491|NCT01799720|80434213|FG001|Overall Study|Withdrawal by Subject|0|||
27906545|NCT01716520|81493450|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
27906546|NCT01716520|81493445|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27906547|NCT01716520|81493446|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27906548|NCT01716520|81493447|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27906549|NCT01716520|81493448|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27906550|NCT01716520|81493449|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
27906551|NCT01716520|81493450|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
27906552|NCT01716520|81493445|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27906553|NCT01716520|81493446|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27906554|NCT01716520|81493447|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
27906555|NCT01716520|81493448|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27906556|NCT01716520|81493449|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27906557|NCT01716520|81493450|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
27906558|NCT01775787|81496632|FG000|First 7-10 Days|Adverse Event|0|||
27906559|NCT01775787|81496633|FG001|First 7-10 Days|Adverse Event|1|||
27906560|NCT01775787|81496632|FG000|First 7-10 Days|family emergency|0|||
27906561|NCT01775787|81496633|FG001|First 7-10 Days|family emergency|1|||
27906562|NCT01775787|81496632|FG000|First 7-10 Days|time commitment|0|||
27906563|NCT01775787|81496633|FG001|First 7-10 Days|time commitment|2|||
27513903|NCT01646125|80074175|FG000|Overall Study|Death|1|||
27513904|NCT01646125|80074176|FG001|Overall Study|Death|1|||
27513905|NCT01646125|80074175|FG000|Overall Study|Physician Decision|1|||
27513906|NCT01646125|80074176|FG001|Overall Study|Physician Decision|3|||
27513907|NCT01646125|80074175|FG000|Overall Study|Progressive disease|22|||
27513908|NCT01646125|80074176|FG001|Overall Study|Progressive disease|16|||
27513909|NCT01646125|80074175|FG000|Overall Study|Study terminated by sponsor|2|||
27513910|NCT01646125|80074176|FG001|Overall Study|Study terminated by sponsor|1|||
27513911|NCT01646125|80074175|FG000|Overall Study|Subject/Guardian decision|1|||
27513912|NCT01646125|80074176|FG001|Overall Study|Subject/Guardian decision|1|||
27513913|NCT02998268|80074177|FG000|Overall Study|Adverse Event|0|||
27513914|NCT02998268|80074178|FG001|Overall Study|Adverse Event|2|||
27513915|NCT02998268|80074177|FG000|Overall Study|Withdrawal by Subject|0|||
27513916|NCT02998268|80074178|FG001|Overall Study|Withdrawal by Subject|1|||
27513917|NCT02930018|80074187|FG000|Overall Study|Lost to Follow-up|1|||
27513918|NCT02930018|80074188|FG001|Overall Study|Lost to Follow-up|1|||
27513919|NCT02930018|80074187|FG000|Overall Study|Withdrawal by Subject|5|||
27513920|NCT02930018|80074188|FG001|Overall Study|Withdrawal by Subject|2|||
27513921|NCT03436290|80074190|FG000|Overall Study|Post-randomization Exclusion|1|||
27513922|NCT03436290|80074191|FG001|Overall Study|Post-randomization Exclusion|0|||
27513923|NCT03436290|80074190|FG000|Overall Study|Death|6|||
27513924|NCT03436290|80074191|FG001|Overall Study|Death|0|||
27513925|NCT03436290|80074190|FG000|Overall Study|Withdrawal by Subject|4|||
27513926|NCT03436290|80074191|FG001|Overall Study|Withdrawal by Subject|0|||
27513927|NCT03436290|80074190|FG000|Overall Study|Protocol Violation|30|||
27513928|NCT03436290|80074191|FG001|Overall Study|Protocol Violation|0|||
27513929|NCT02228980|80074193|FG000|Overall Study|Adverse Event|14|||
27513930|NCT02228980|80074194|FG001|Overall Study|Adverse Event|0|||
27513931|NCT02228980|80074195|FG002|Overall Study|Adverse Event|0|||
27513932|NCT02228980|80074196|FG003|Overall Study|Adverse Event|0|||
27513933|NCT02228980|80074193|FG000|Overall Study|Protocol Violation|7|||
27513934|NCT02228980|80074194|FG001|Overall Study|Protocol Violation|0|||
27513935|NCT02228980|80074195|FG002|Overall Study|Protocol Violation|0|||
27513936|NCT02228980|80074196|FG003|Overall Study|Protocol Violation|0|||
27513937|NCT02228980|80074193|FG000|Overall Study|Withdrawal by Subject|3|||
27513938|NCT02228980|80074194|FG001|Overall Study|Withdrawal by Subject|3|||
27513939|NCT02228980|80074195|FG002|Overall Study|Withdrawal by Subject|2|||
27513940|NCT02228980|80074196|FG003|Overall Study|Withdrawal by Subject|3|||
27513941|NCT03110770|80074197|FG000|Overall Study|Death|1|||
27513942|NCT03110770|80074198|FG001|Overall Study|Death|0|||
27513943|NCT03110770|80074199|FG002|Overall Study|Death|0|||
27513944|NCT03110770|80074200|FG003|Overall Study|Death|1|||
27513945|NCT03110770|80074201|FG004|Overall Study|Death|0|||
27513946|NCT03110770|80074197|FG000|Overall Study|Enrolled but did not receive product|0|||
27513947|NCT03110770|80074198|FG001|Overall Study|Enrolled but did not receive product|0|||
27513948|NCT03110770|80074199|FG002|Overall Study|Enrolled but did not receive product|0|||
27513949|NCT03110770|80074200|FG003|Overall Study|Enrolled but did not receive product|8|||
27513950|NCT03110770|80074201|FG004|Overall Study|Enrolled but did not receive product|7|||
27513951|NCT03110770|80074197|FG000|Overall Study|Lost to Follow-up|0|||
27513952|NCT03110770|80074198|FG001|Overall Study|Lost to Follow-up|0|||
27906564|NCT01775787|81496632|FG000|First 7-10 Days|concerns with using IV|1|||
27513953|NCT03110770|80074199|FG002|Overall Study|Lost to Follow-up|0|||
27513954|NCT03110770|80074200|FG003|Overall Study|Lost to Follow-up|53|||
27513955|NCT03110770|80074201|FG004|Overall Study|Lost to Follow-up|45|||
27513956|NCT03110770|80074197|FG000|Overall Study|Investigator Decision|0|||
27513957|NCT03110770|80074198|FG001|Overall Study|Investigator Decision|0|||
27513958|NCT03110770|80074199|FG002|Overall Study|Investigator Decision|0|||
27906565|NCT01775787|81496633|FG001|First 7-10 Days|concerns with using IV|2|||
27906566|NCT01775787|81496632|FG000|Second 7-10 Days|time commitment|0|||
27906567|NCT01775787|81496633|FG001|Second 7-10 Days|time commitment|1|||
27906568|NCT01775787|81496632|FG000|Second 7-10 Days|concerns with using IV|0|||
27906569|NCT01775787|81496633|FG001|Second 7-10 Days|concerns with using IV|1|||
27906570|NCT02496039|81496641|FG000|Overall Study|Adverse Event|3|||
27906571|NCT02496039|81496641|FG000|Overall Study|Protocol Violation|1|||
27906572|NCT00645671|81496647|FG000|Overall Study|Protocol Violation|1|||
27906573|NCT00645671|81496648|FG001|Overall Study|Protocol Violation|0|||
27906574|NCT00645671|81496647|FG000|Overall Study|Withdrawal by Subject|0|||
27906575|NCT00645671|81496648|FG001|Overall Study|Withdrawal by Subject|4|||
27906576|NCT00645671|81496647|FG000|Overall Study|Adverse Event|0|||
27906577|NCT00645671|81496648|FG001|Overall Study|Adverse Event|1|||
27906578|NCT00645671|81496647|FG000|Overall Study|Physician Decision|0|||
27906579|NCT00645671|81496648|FG001|Overall Study|Physician Decision|1|||
27906580|NCT00869128|81496649|FG000|Overall Study|lack of Compliance|6|||
27906581|NCT00869128|81496650|FG001|Overall Study|lack of Compliance|6|||
27906582|NCT00045734|81496651|FG000|Overall Study|Protocol Violation|1|||
27906583|NCT01190189|81496652|FG000|Overall Study|Lost to Follow-up|4|||
27906584|NCT01190189|81496652|FG000|Overall Study|Withdrawal by Subject|1|||
27906585|NCT01190189|81496652|FG000|Overall Study|Migrated/moved from study area|1|||
27906586|NCT04676724|81496653|FG000|Overall Study|Adverse Event|2|||
27906587|NCT04676724|81496654|FG001|Overall Study|Adverse Event|0|||
27906588|NCT04676724|81496653|FG000|Overall Study|Lost to Follow-up|1|||
27906589|NCT04676724|81496654|FG001|Overall Study|Lost to Follow-up|0|||
27906590|NCT04676724|81496653|FG000|Overall Study|Physician Decision|0|||
27906591|NCT04676724|81496654|FG001|Overall Study|Physician Decision|1|||
27906592|NCT04676724|81496653|FG000|Overall Study|Withdrawal by Subject|3|||
27906593|NCT04676724|81496654|FG001|Overall Study|Withdrawal by Subject|2|||
27906594|NCT00940888|81496658|FG000|Overall Study|Unsuccessful Implant|4|||
27906595|NCT00940888|81496658|FG000|Overall Study|Death|461|||
27906596|NCT00940888|81496658|FG000|Overall Study|Withdrawn - Non-Death|364|||
27906597|NCT00940888|81496658|FG000|Overall Study|Lost to Follow-up|6|||
27906598|NCT02401035|81496659|FG000|Overall Study|Withdrawal by Subject|1|||
27906599|NCT02401035|81496660|FG001|Overall Study|Withdrawal by Subject|0|||
27906600|NCT04501952|81496663|FG000|Overall Study|Adverse Event|0|||
27906601|NCT04501952|81496664|FG001|Overall Study|Adverse Event|3|||
27906602|NCT04501952|81496663|FG000|Overall Study|Investigator's Discretion|0|||
27906603|NCT04501952|81496664|FG001|Overall Study|Investigator's Discretion|1|||
27906604|NCT04501952|81496663|FG000|Overall Study|Protocol Violation|1|||
27906605|NCT04501952|81496664|FG001|Overall Study|Protocol Violation|1|||
27906606|NCT04501952|81496663|FG000|Overall Study|Withdrew Consent|5|||
27906607|NCT04501952|81496664|FG001|Overall Study|Withdrew Consent|4|||
27906608|NCT04501952|81496663|FG000|Overall Study|Lost to Follow-up|7|||
27906609|NCT04501952|81496664|FG001|Overall Study|Lost to Follow-up|2|||
27906610|NCT04501952|81496663|FG000|Overall Study|Randomized and Never Treated|13|||
27906611|NCT04501952|81496664|FG001|Overall Study|Randomized and Never Treated|9|||
27906612|NCT00624832|81496665|FG000|Overall Study|Adverse Event|0|||
27906613|NCT00624832|81496666|FG001|Overall Study|Adverse Event|1|||
27906614|NCT00624832|81496667|FG002|Overall Study|Adverse Event|0|||
27906615|NCT00624832|81496668|FG003|Overall Study|Adverse Event|1|||
27906616|NCT00624832|81496665|FG000|Overall Study|Abnormal Laboratory Value|2|||
27906617|NCT00624832|81496666|FG001|Overall Study|Abnormal Laboratory Value|0|||
27906618|NCT00624832|81496667|FG002|Overall Study|Abnormal Laboratory Value|0|||
27906619|NCT00624832|81496668|FG003|Overall Study|Abnormal Laboratory Value|0|||
27906620|NCT00985686|81496671|FG000|Overall Study|Lost to Follow-up|1|||
27906621|NCT00985686|81496672|FG001|Overall Study|Lost to Follow-up|1|||
27906622|NCT00985686|81496673|FG002|Overall Study|Lost to Follow-up|0|||
27906623|NCT00985686|81496674|FG003|Overall Study|Lost to Follow-up|2|||
27906624|NCT03131687|81496681|FG000|Overall Study|Adverse Event|0|||
27906625|NCT03131687|81496682|FG001|Overall Study|Adverse Event|1|||
27906626|NCT03131687|81496683|FG002|Overall Study|Adverse Event|0|||
27906627|NCT03131687|81496684|FG003|Overall Study|Adverse Event|1|||
27906628|NCT03131687|81496685|FG004|Overall Study|Adverse Event|2|||
27906629|NCT03131687|81496686|FG005|Overall Study|Adverse Event|2|||
27906630|NCT03131687|81496681|FG000|Overall Study|Death|1|||
27906631|NCT03131687|81496682|FG001|Overall Study|Death|0|||
27906632|NCT03131687|81496683|FG002|Overall Study|Death|0|||
27906633|NCT03131687|81496684|FG003|Overall Study|Death|0|||
27513959|NCT03110770|80074200|FG003|Overall Study|Investigator Decision|5|||
27906634|NCT03131687|81496685|FG004|Overall Study|Death|0|||
27906635|NCT03131687|81496686|FG005|Overall Study|Death|0|||
27906636|NCT03131687|81496681|FG000|Overall Study|Withdrawal by Subject|3|||
27906637|NCT03131687|81496682|FG001|Overall Study|Withdrawal by Subject|3|||
27906638|NCT03131687|81496683|FG002|Overall Study|Withdrawal by Subject|3|||
27906639|NCT03131687|81496684|FG003|Overall Study|Withdrawal by Subject|1|||
27906640|NCT03131687|81496685|FG004|Overall Study|Withdrawal by Subject|2|||
27906641|NCT03131687|81496686|FG005|Overall Study|Withdrawal by Subject|1|||
27906642|NCT03131687|81496681|FG000|Overall Study|Lost to Follow-up|1|||
27906643|NCT03131687|81496682|FG001|Overall Study|Lost to Follow-up|4|||
27906644|NCT03131687|81496683|FG002|Overall Study|Lost to Follow-up|0|||
27906645|NCT03131687|81496684|FG003|Overall Study|Lost to Follow-up|1|||
27906646|NCT03131687|81496685|FG004|Overall Study|Lost to Follow-up|4|||
27906647|NCT03131687|81496686|FG005|Overall Study|Lost to Follow-up|2|||
27906648|NCT03131687|81496681|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
27906649|NCT03131687|81496682|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
27906650|NCT03131687|81496683|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
27906651|NCT03131687|81496684|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
27906652|NCT03131687|81496685|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
27906653|NCT03131687|81496686|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
27906654|NCT03131687|81496681|FG000|Overall Study|Principle Investigator Decision|0|||
27906655|NCT03131687|81496682|FG001|Overall Study|Principle Investigator Decision|1|||
27906656|NCT03131687|81496683|FG002|Overall Study|Principle Investigator Decision|0|||
27906657|NCT03131687|81496684|FG003|Overall Study|Principle Investigator Decision|0|||
27906658|NCT03131687|81496685|FG004|Overall Study|Principle Investigator Decision|0|||
27906659|NCT03131687|81496686|FG005|Overall Study|Principle Investigator Decision|0|||
27906660|NCT03131687|81496681|FG000|Overall Study|Inadvertent Enrollment|0|||
27906661|NCT03131687|81496682|FG001|Overall Study|Inadvertent Enrollment|0|||
27906662|NCT03131687|81496683|FG002|Overall Study|Inadvertent Enrollment|0|||
27906663|NCT03131687|81496684|FG003|Overall Study|Inadvertent Enrollment|1|||
27906664|NCT03131687|81496685|FG004|Overall Study|Inadvertent Enrollment|0|||
27906665|NCT03131687|81496686|FG005|Overall Study|Inadvertent Enrollment|0|||
27906666|NCT00531947|81496701|FG000|Overall Study|Adverse Event|5|||
27906667|NCT00531947|81496702|FG001|Overall Study|Adverse Event|10|||
27513960|NCT03110770|80074201|FG004|Overall Study|Investigator Decision|3|||
27513961|NCT03110770|80074197|FG000|Overall Study|Withdrawal by Subject|0|||
27906668|NCT00531947|81496701|FG000|Overall Study|Lost to Follow-up|12|||
27906669|NCT00531947|81496702|FG001|Overall Study|Lost to Follow-up|9|||
27906670|NCT00531947|81496701|FG000|Overall Study|Withdrawal by Subject|14|||
27906671|NCT00531947|81496702|FG001|Overall Study|Withdrawal by Subject|19|||
27513962|NCT03110770|80074198|FG001|Overall Study|Withdrawal by Subject|0|||
27513963|NCT03110770|80074199|FG002|Overall Study|Withdrawal by Subject|0|||
27513964|NCT03110770|80074200|FG003|Overall Study|Withdrawal by Subject|24|||
27513965|NCT03110770|80074201|FG004|Overall Study|Withdrawal by Subject|24|||
27513966|NCT03110770|80074197|FG000|Overall Study|Moved from area|5|||
27513967|NCT03110770|80074198|FG001|Overall Study|Moved from area|0|||
27513968|NCT03110770|80074199|FG002|Overall Study|Moved from area|2|||
27513969|NCT03110770|80074200|FG003|Overall Study|Moved from area|42|||
27513970|NCT03110770|80074201|FG004|Overall Study|Moved from area|43|||
27513971|NCT03110770|80074197|FG000|Overall Study|Illness/Injury unrelated to product|0|||
27513972|NCT03110770|80074198|FG001|Overall Study|Illness/Injury unrelated to product|0|||
27513973|NCT03110770|80074199|FG002|Overall Study|Illness/Injury unrelated to product|0|||
27513974|NCT03110770|80074200|FG003|Overall Study|Illness/Injury unrelated to product|0|||
27513975|NCT03110770|80074201|FG004|Overall Study|Illness/Injury unrelated to product|1|||
27513976|NCT00554216|80074202|FG000|Overall Study|Lost to Follow-up|92|||
27513977|NCT00554216|80074203|FG001|Overall Study|Lost to Follow-up|31|||
27513978|NCT00554216|80074204|FG002|Overall Study|Lost to Follow-up|63|||
27513979|NCT00554216|80074202|FG000|Overall Study|Adverse Event|16|||
27513980|NCT00554216|80074203|FG001|Overall Study|Adverse Event|16|||
27513981|NCT00554216|80074204|FG002|Overall Study|Adverse Event|36|||
27513982|NCT00554216|80074202|FG000|Overall Study|Withdrawal by Subject|92|||
27513983|NCT00554216|80074203|FG001|Overall Study|Withdrawal by Subject|31|||
27513984|NCT00554216|80074204|FG002|Overall Study|Withdrawal by Subject|43|||
27513985|NCT00554216|80074202|FG000|Overall Study|Non compliance|10|||
27513986|NCT00554216|80074203|FG001|Overall Study|Non compliance|4|||
27513987|NCT00554216|80074204|FG002|Overall Study|Non compliance|5|||
27513988|NCT00554216|80074202|FG000|Overall Study|Pregnancy|2|||
27513989|NCT00554216|80074203|FG001|Overall Study|Pregnancy|1|||
27513990|NCT00554216|80074204|FG002|Overall Study|Pregnancy|14|||
27513991|NCT00554216|80074202|FG000|Overall Study|Restricted med|3|||
27615492|NCT01799720|80434214|FG002|Overall Study|Withdrawal by Subject|0|||
27615493|NCT01799720|80434212|FG000|Overall Study|Protocol Violation|0|||
27615494|NCT01799720|80434213|FG001|Overall Study|Protocol Violation|1|||
27728674|NCT01446809|80833357|FG001|Overall Study|Adverse Event|0|||
27906672|NCT00531947|81496701|FG000|Overall Study|Protocol Violation|2|||
27906673|NCT00531947|81496702|FG001|Overall Study|Protocol Violation|1|||
27906674|NCT00531947|81496701|FG000|Overall Study|Non-Compliance|4|||
27906675|NCT00531947|81496702|FG001|Overall Study|Non-Compliance|7|||
27906676|NCT00531947|81496701|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
27906677|NCT00531947|81496702|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
27906678|NCT00705341|81496703|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
27513992|NCT00554216|80074203|FG001|Overall Study|Restricted med|1|||
27513993|NCT00554216|80074204|FG002|Overall Study|Restricted med|1|||
27615495|NCT01799720|80434214|FG002|Overall Study|Protocol Violation|0|||
27513994|NCT00554216|80074202|FG000|Overall Study|Other|12|||
27513995|NCT00554216|80074203|FG001|Overall Study|Other|7|||
27513996|NCT00554216|80074204|FG002|Overall Study|Other|10|||
27513997|NCT00554216|80074202|FG000|Overall Study|Lack of Efficacy|15|||
27513998|NCT00554216|80074203|FG001|Overall Study|Lack of Efficacy|3|||
27513999|NCT00554216|80074204|FG002|Overall Study|Lack of Efficacy|0|||
27514000|NCT04629066|80077496|FG000|Overall Study|Lost to Follow-up|3|||
27514001|NCT04629066|80077497|FG001|Overall Study|Lost to Follow-up|2|||
27514002|NCT01092117|80077498|FG000|Index Procedure to 1 Month|Death|1|||
27514003|NCT01092117|80077498|FG000|1 Month|Death|1|||
27514004|NCT01092117|80077498|FG000|1 Month|Withdrawal by Subject|1|||
27853162|NCT01215513|81294973|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
27853163|NCT01215513|81294973|FG000|Overall Study|Adverse event (CS42A)|2|||
27853164|NCT01215513|81294973|FG000|Overall Study|Physician decision (CS42A)|6|||
27853165|NCT01215513|81294973|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
27853166|NCT01215513|81294973|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
27853167|NCT00197496|81294974|FG000|Baseline to Discharge|not interested|1|||
27906679|NCT00705341|81496704|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
27853168|NCT00197496|81294975|FG001|Baseline to Discharge|not interested|0|||
27853169|NCT00197496|81294974|FG000|Baseline to Discharge|MRSA|1|||
27906680|NCT00705341|81496705|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
27906681|NCT00705341|81496706|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
27906682|NCT00705341|81496703|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
27853170|NCT00197496|81294975|FG001|Baseline to Discharge|MRSA|0|||
27906683|NCT00705341|81496704|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
27906684|NCT00705341|81496705|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
27906685|NCT00705341|81496706|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
27906686|NCT01133704|81496713|FG000|Overall Study|Death|44|||
27906687|NCT01133704|81496714|FG001|Overall Study|Death|26|||
27906688|NCT01133704|81496713|FG000|Overall Study|Patient refused to continue|4|||
27906689|NCT01133704|81496714|FG001|Overall Study|Patient refused to continue|0|||
27906690|NCT01133704|81496713|FG000|Overall Study|Study Closure|1|||
27906691|NCT01133704|81496714|FG001|Overall Study|Study Closure|0|||
27906692|NCT01471444|81496715|FG000|Overall Study|Physician Decision|3|||
27906693|NCT01471444|81496716|FG001|Overall Study|Physician Decision|2|||
27906694|NCT01471444|81496715|FG000|Overall Study|Withdrawal by Subject|0|||
27906695|NCT01471444|81496716|FG001|Overall Study|Withdrawal by Subject|1|||
27906696|NCT02757625|81496728|FG000|Overall Study|Investigator's discretion|0|||
27906697|NCT02757625|81496729|FG001|Overall Study|Investigator's discretion|0|||
27906698|NCT02757625|81496730|FG002|Overall Study|Investigator's discretion|1|||
27514005|NCT01092117|80077498|FG000|1 Month|Lost to Follow-up|1|||
27514006|NCT01092117|80077498|FG000|6 Months|Death|2|||
27514007|NCT01092117|80077498|FG000|6 Months|Withdrawal by Subject|3|||
27514008|NCT01092117|80077498|FG000|12 Month|Death|11|||
27514009|NCT01092117|80077498|FG000|12 Month|Withdrawal by Subject|2|||
27906699|NCT02757625|81496731|FG003|Overall Study|Investigator's discretion|0|||
27906700|NCT02757625|81496728|FG000|Overall Study|Adverse Event|0|||
27906701|NCT02757625|81496729|FG001|Overall Study|Adverse Event|0|||
27906702|NCT02757625|81496730|FG002|Overall Study|Adverse Event|1|||
27906703|NCT02757625|81496731|FG003|Overall Study|Adverse Event|0|||
27906704|NCT01563913|81496732|FG000|Overall Study|Physician Decision|1|||
27906705|NCT01563913|81496733|FG001|Overall Study|Physician Decision|0|||
27906706|NCT01563913|81496732|FG000|Overall Study|Spouse Passed Away|1|||
27906707|NCT01563913|81496733|FG001|Overall Study|Spouse Passed Away|0|||
27906708|NCT01048944|81496734|FG000|Overall Study|Protocol Violation|8|||
27906709|NCT01048944|81496735|FG001|Overall Study|Protocol Violation|10|||
27906710|NCT01048944|81496736|FG002|Overall Study|Protocol Violation|10|||
27906711|NCT01048944|81496737|FG003|Overall Study|Protocol Violation|2|||
27906712|NCT00790556|81496740|FG000|Treatment Period 1|Physician Decision|1|||
27906713|NCT00790556|81496741|FG001|Treatment Period 1|Physician Decision|0|||
27906714|NCT00790556|81496740|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27906715|NCT00790556|81496741|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27906716|NCT02634801|81496742|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
27906717|NCT02634801|81496743|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
27906718|NCT02634801|81496744|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
27906719|NCT02634801|81496742|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
27906720|NCT02634801|81496743|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
27906721|NCT02634801|81496744|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
27906722|NCT02634801|81496742|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
27906723|NCT02634801|81496743|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
27906724|NCT02634801|81496744|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
27906725|NCT02634801|81496742|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
27906726|NCT02634801|81496743|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
27906727|NCT02634801|81496744|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
27906728|NCT02634801|81496742|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
27906729|NCT02634801|81496743|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
27906730|NCT02634801|81496744|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
27906731|NCT02634801|81496742|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
27906732|NCT02634801|81496743|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
27906733|NCT02634801|81496744|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
27906734|NCT02634801|81496742|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
27906735|NCT02634801|81496743|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
27906736|NCT02634801|81496744|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
27906737|NCT02634801|81496742|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
27906738|NCT02634801|81496743|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
27906739|NCT02634801|81496744|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
27906740|NCT02634801|81496742|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
27906741|NCT02634801|81496743|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
27906742|NCT02634801|81496744|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
27906743|NCT02634801|81496742|FG000|Follow-up Period|Lost to Follow-up|3|||
27906744|NCT02634801|81496743|FG001|Follow-up Period|Lost to Follow-up|1|||
27906745|NCT02634801|81496744|FG002|Follow-up Period|Lost to Follow-up|2|||
27906746|NCT02634801|81496742|FG000|Follow-up Period|Physician Decision|0|||
27906747|NCT02634801|81496743|FG001|Follow-up Period|Physician Decision|0|||
27906748|NCT02634801|81496744|FG002|Follow-up Period|Physician Decision|1|||
27906749|NCT02634801|81496742|FG000|Follow-up Period|Withdrawal by Subject|1|||
27906750|NCT02634801|81496743|FG001|Follow-up Period|Withdrawal by Subject|2|||
27906751|NCT02634801|81496744|FG002|Follow-up Period|Withdrawal by Subject|5|||
27906752|NCT02634801|81496742|FG000|Follow-up Period|Adverse Event|1|||
27906753|NCT02634801|81496743|FG001|Follow-up Period|Adverse Event|5|||
27906754|NCT02634801|81496744|FG002|Follow-up Period|Adverse Event|0|||
27906755|NCT01148459|81496750|FG000|Overall Study|Serious Adverse Event|5|||
27906756|NCT01148459|81496751|FG001|Overall Study|Serious Adverse Event|4|||
27906757|NCT01148459|81496750|FG000|Overall Study|Withdrawal by Subject|1|||
27514010|NCT01092117|80077498|FG000|12 Month|Lost to Follow-up|1|||
27514011|NCT01092117|80077498|FG000|Year 2|Death|5|||
27514012|NCT01092117|80077498|FG000|Year 2|Withdrawal by Subject|4|||
27906758|NCT01148459|81496751|FG001|Overall Study|Withdrawal by Subject|0|||
27906759|NCT01148459|81496750|FG000|Overall Study|Migrated/moved from study area|3|||
27906760|NCT01148459|81496751|FG001|Overall Study|Migrated/moved from study area|6|||
27514013|NCT01092117|80077498|FG000|Year 2|Lost to Follow-up|1|||
27514014|NCT01092117|80077498|FG000|Year 3|Death|7|||
27514015|NCT01092117|80077498|FG000|Year 3|Withdrawal by Subject|9|||
27906761|NCT01148459|81496750|FG000|Overall Study|Lost to Follow-up|2|||
27906762|NCT01148459|81496751|FG001|Overall Study|Lost to Follow-up|0|||
27906763|NCT01148459|81496750|FG000|Overall Study|Refusal|1|||
27906764|NCT01148459|81496751|FG001|Overall Study|Refusal|0|||
27906765|NCT01148459|81496750|FG000|Overall Study|Failure to comply with study procedures|0|||
27906766|NCT01148459|81496751|FG001|Overall Study|Failure to comply with study procedures|1|||
27514016|NCT01092117|80077498|FG000|Year 3|Lost to Follow-up|3|||
27514017|NCT01092117|80077498|FG000|Year 4|Death|8|||
27514018|NCT01092117|80077498|FG000|Year 4|Withdrawal by Subject|4|||
27514019|NCT01092117|80077498|FG000|Year 4|Lost to Follow-up|4|||
27514020|NCT00499590|80077502|FG000|Overall Study|Study Terminated|112|||
27514021|NCT00499590|80077503|FG001|Overall Study|Study Terminated|112|||
27514022|NCT00499590|80077504|FG002|Overall Study|Study Terminated|112|||
27514023|NCT00499590|80077502|FG000|Overall Study|Not treated|1|||
27514024|NCT00499590|80077503|FG001|Overall Study|Not treated|0|||
27514025|NCT00499590|80077504|FG002|Overall Study|Not treated|1|||
27514026|NCT01742286|80077512|FG000|Escalation Phase|Administrative problems|1|||
27514027|NCT01742286|80077513|FG001|Escalation Phase|Administrative problems|1|||
27514028|NCT01742286|80077514|FG002|Escalation Phase|Administrative problems|0|||
27514029|NCT01742286|80077515|FG003|Escalation Phase|Administrative problems|0|||
27514030|NCT01742286|80077516|FG004|Escalation Phase|Administrative problems|0|||
27514031|NCT01742286|80077517|FG005|Escalation Phase|Administrative problems|0|||
27514032|NCT01742286|80077518|FG006|Escalation Phase|Administrative problems|2|||
27514033|NCT01742286|80077512|FG000|Escalation Phase|Adverse Event|0|||
27514034|NCT01742286|80077513|FG001|Escalation Phase|Adverse Event|1|||
27514035|NCT01742286|80077514|FG002|Escalation Phase|Adverse Event|2|||
27514036|NCT01742286|80077515|FG003|Escalation Phase|Adverse Event|0|||
27853171|NCT00197496|81294974|FG000|Baseline to Discharge|Physician Decision|0|||
27853172|NCT00197496|81294975|FG001|Baseline to Discharge|Physician Decision|1|||
27853173|NCT00197496|81294974|FG000|Baseline to Discharge|Protocol Violation|0|||
27853174|NCT00197496|81294975|FG001|Baseline to Discharge|Protocol Violation|1|||
27853175|NCT00197496|81294974|FG000|Follow-up|Lost to Follow-up|2|||
27853176|NCT00197496|81294975|FG001|Follow-up|Lost to Follow-up|1|||
27853177|NCT01570283|81294976|FG000|Cohort 1: Dose Level 1|Death|0|||
27853178|NCT01570283|81294977|FG001|Cohort 1: Dose Level 1|Death|1|||
27853179|NCT01570283|81294978|FG002|Cohort 1: Dose Level 1|Death|0|||
27853180|NCT01570283|81294979|FG003|Cohort 1: Dose Level 1|Death|0|||
27853181|NCT01570283|81294980|FG004|Cohort 1: Dose Level 1|Death|0|||
27853182|NCT01570283|81294981|FG005|Cohort 1: Dose Level 1|Death|0|||
27853183|NCT01570283|81294976|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27853184|NCT01570283|81294977|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
27853185|NCT01570283|81294978|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27853186|NCT01570283|81294979|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27853187|NCT01570283|81294980|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27853188|NCT01570283|81294981|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
27853189|NCT01570283|81294976|FG000|Cohort 2: Dose Level 2|Death|0|||
27853190|NCT01570283|81294977|FG001|Cohort 2: Dose Level 2|Death|0|||
27853191|NCT01570283|81294978|FG002|Cohort 2: Dose Level 2|Death|1|||
27853192|NCT01570283|81294979|FG003|Cohort 2: Dose Level 2|Death|0|||
27853193|NCT01570283|81294980|FG004|Cohort 2: Dose Level 2|Death|0|||
27853194|NCT01570283|81294981|FG005|Cohort 2: Dose Level 2|Death|0|||
27514037|NCT01742286|80077516|FG004|Escalation Phase|Adverse Event|0|||
27514038|NCT01742286|80077517|FG005|Escalation Phase|Adverse Event|1|||
27514039|NCT01742286|80077518|FG006|Escalation Phase|Adverse Event|0|||
27514040|NCT01742286|80077512|FG000|Escalation Phase|Disease progression|3|||
27514041|NCT01742286|80077513|FG001|Escalation Phase|Disease progression|7|||
27514042|NCT01742286|80077514|FG002|Escalation Phase|Disease progression|4|||
27514043|NCT01742286|80077515|FG003|Escalation Phase|Disease progression|1|||
27514044|NCT01742286|80077516|FG004|Escalation Phase|Disease progression|4|||
27514045|NCT01742286|80077517|FG005|Escalation Phase|Disease progression|3|||
27514046|NCT01742286|80077518|FG006|Escalation Phase|Disease progression|2|||
27514047|NCT01742286|80077512|FG000|Escalation Phase|Death|0|||
27853195|NCT01570283|81294976|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27853196|NCT01570283|81294977|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27853197|NCT01570283|81294978|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27853198|NCT01570283|81294979|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
27514048|NCT01742286|80077513|FG001|Escalation Phase|Death|0|||
27514049|NCT01742286|80077514|FG002|Escalation Phase|Death|0|||
27514050|NCT01742286|80077515|FG003|Escalation Phase|Death|0|||
27514051|NCT01742286|80077516|FG004|Escalation Phase|Death|0|||
27514052|NCT01742286|80077517|FG005|Escalation Phase|Death|1|||
27514053|NCT01742286|80077518|FG006|Escalation Phase|Death|0|||
27514054|NCT01742286|80077512|FG000|Escalation Phase|Physician Decision|0|||
27514055|NCT01742286|80077513|FG001|Escalation Phase|Physician Decision|3|||
27514056|NCT01742286|80077514|FG002|Escalation Phase|Physician Decision|0|||
27514057|NCT01742286|80077515|FG003|Escalation Phase|Physician Decision|1|||
27514058|NCT01742286|80077516|FG004|Escalation Phase|Physician Decision|0|||
27514059|NCT01742286|80077517|FG005|Escalation Phase|Physician Decision|0|||
27728675|NCT01446809|80833358|FG002|Overall Study|Adverse Event|1|||
27853199|NCT01570283|81294980|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27514060|NCT01742286|80077518|FG006|Escalation Phase|Physician Decision|2|||
27514061|NCT01742286|80077512|FG000|Escalation Phase|Subject/guardian decision|1|||
27514062|NCT01742286|80077513|FG001|Escalation Phase|Subject/guardian decision|0|||
27514063|NCT01742286|80077514|FG002|Escalation Phase|Subject/guardian decision|0|||
27514064|NCT01742286|80077515|FG003|Escalation Phase|Subject/guardian decision|0|||
27514065|NCT01742286|80077516|FG004|Escalation Phase|Subject/guardian decision|0|||
27514066|NCT01742286|80077517|FG005|Escalation Phase|Subject/guardian decision|0|||
27514067|NCT01742286|80077518|FG006|Escalation Phase|Subject/guardian decision|0|||
27514068|NCT01742286|80077512|FG000|Expansion Phase|Administrative problems|0|||
27514069|NCT01742286|80077513|FG001|Expansion Phase|Administrative problems|0|||
27514070|NCT01742286|80077514|FG002|Expansion Phase|Administrative problems|0|||
27514071|NCT01742286|80077515|FG003|Expansion Phase|Administrative problems|0|||
27514072|NCT01742286|80077516|FG004|Expansion Phase|Administrative problems|0|||
27514073|NCT01742286|80077517|FG005|Expansion Phase|Administrative problems|0|||
27514074|NCT01742286|80077518|FG006|Expansion Phase|Administrative problems|5|||
27514075|NCT01742286|80077512|FG000|Expansion Phase|Physician Decision|0|||
27514076|NCT01742286|80077513|FG001|Expansion Phase|Physician Decision|0|||
27514077|NCT01742286|80077514|FG002|Expansion Phase|Physician Decision|4|||
27514078|NCT01742286|80077515|FG003|Expansion Phase|Physician Decision|0|||
27514079|NCT01742286|80077516|FG004|Expansion Phase|Physician Decision|0|||
27514080|NCT01742286|80077517|FG005|Expansion Phase|Physician Decision|0|||
27514081|NCT01742286|80077518|FG006|Expansion Phase|Physician Decision|9|||
27514082|NCT01742286|80077512|FG000|Expansion Phase|Adverse Event|0|||
27514083|NCT01742286|80077513|FG001|Expansion Phase|Adverse Event|0|||
27514084|NCT01742286|80077514|FG002|Expansion Phase|Adverse Event|0|||
27514085|NCT01742286|80077515|FG003|Expansion Phase|Adverse Event|0|||
27514086|NCT01742286|80077516|FG004|Expansion Phase|Adverse Event|0|||
27514087|NCT01742286|80077517|FG005|Expansion Phase|Adverse Event|0|||
27514088|NCT01742286|80077518|FG006|Expansion Phase|Adverse Event|6|||
27514089|NCT01742286|80077512|FG000|Expansion Phase|Disease progression|0|||
27514090|NCT01742286|80077513|FG001|Expansion Phase|Disease progression|0|||
27514091|NCT01742286|80077514|FG002|Expansion Phase|Disease progression|3|||
27514092|NCT01742286|80077515|FG003|Expansion Phase|Disease progression|0|||
27514093|NCT01742286|80077516|FG004|Expansion Phase|Disease progression|0|||
27514094|NCT01742286|80077517|FG005|Expansion Phase|Disease progression|0|||
27514095|NCT01742286|80077518|FG006|Expansion Phase|Disease progression|15|||
27514096|NCT01742286|80077512|FG000|Expansion Phase|Withdrawal by Subject|0|||
27514097|NCT01742286|80077513|FG001|Expansion Phase|Withdrawal by Subject|0|||
27514098|NCT01742286|80077514|FG002|Expansion Phase|Withdrawal by Subject|0|||
27514099|NCT01742286|80077515|FG003|Expansion Phase|Withdrawal by Subject|0|||
27514100|NCT01742286|80077516|FG004|Expansion Phase|Withdrawal by Subject|0|||
27514101|NCT01742286|80077517|FG005|Expansion Phase|Withdrawal by Subject|0|||
27514102|NCT01742286|80077518|FG006|Expansion Phase|Withdrawal by Subject|1|||
27514103|NCT00607373|80077519|FG000|Treatment Period|Adverse Event|0|||
27514104|NCT00607373|80077520|FG001|Treatment Period|Adverse Event|4|||
27514105|NCT00607373|80077519|FG000|Treatment Period|Physician Decision|0|||
27514106|NCT00607373|80077520|FG001|Treatment Period|Physician Decision|1|||
27514107|NCT00607373|80077519|FG000|Treatment Period|Withdrawal by Subject|0|||
27514108|NCT00607373|80077520|FG001|Treatment Period|Withdrawal by Subject|1|||
27514109|NCT00607373|80077519|FG000|Follow-up Period|Other|0|||
27514110|NCT00607373|80077520|FG001|Follow-up Period|Other|1|||
27514111|NCT00607373|80077519|FG000|Follow-up Period|Protocol Violation|0|||
27514112|NCT00607373|80077520|FG001|Follow-up Period|Protocol Violation|1|||
27514113|NCT00607373|80077519|FG000|Follow-up Period|Withdrawal by Subject|1|||
27514114|NCT00607373|80077520|FG001|Follow-up Period|Withdrawal by Subject|3|||
27514115|NCT02920242|80077521|FG000|Overall Study|Withdrawal by Subject|1|||
27615496|NCT01799720|80434212|FG000|Overall Study|Pregnancy|0|||
27615497|NCT01799720|80434213|FG001|Overall Study|Pregnancy|0|||
27615498|NCT01799720|80434214|FG002|Overall Study|Pregnancy|1|||
27615499|NCT01868074|80434215|FG000|Overall Study|Lost to Follow-up|3|||
27615500|NCT01868074|80434216|FG001|Overall Study|Lost to Follow-up|2|||
27615501|NCT01868074|80434215|FG000|Overall Study|Withdrawal by Subject|4|||
27728676|NCT01446809|80833356|FG000|Overall Study|Failure to complete study procedures|0|||
27514116|NCT02920242|80077522|FG001|Overall Study|Withdrawal by Subject|0|||
27514117|NCT02920242|80077523|FG002|Overall Study|Withdrawal by Subject|1|||
27514118|NCT02920242|80077521|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
27514119|NCT02920242|80077522|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
27514120|NCT02920242|80077523|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
27514121|NCT01148979|80077525|FG000|Overall Study|Lost to Follow-up|0|||
27514122|NCT01148979|80077526|FG001|Overall Study|Lost to Follow-up|1|||
27514123|NCT02504216|80077527|FG000|Overall Study|Lost to Follow-up|3|||
27514124|NCT02504216|80077528|FG001|Overall Study|Lost to Follow-up|3|||
27514125|NCT02504216|80077527|FG000|Overall Study|Withdrawal by Subject|8|||
27514126|NCT02504216|80077528|FG001|Overall Study|Withdrawal by Subject|12|||
27514127|NCT03275350|80077529|FG000|Overall Study|Lost to Follow-up|4|||
27514128|NCT03275350|80077530|FG001|Overall Study|Lost to Follow-up|6|||
27615502|NCT01868074|80434216|FG001|Overall Study|Withdrawal by Subject|2|||
27514129|NCT03275350|80077529|FG000|Overall Study|Death|2|||
27514130|NCT03275350|80077530|FG001|Overall Study|Death|1|||
27514131|NCT03275350|80077529|FG000|Overall Study|Physician Decision|1|||
27514132|NCT03275350|80077530|FG001|Overall Study|Physician Decision|0|||
27514133|NCT03275350|80077529|FG000|Overall Study|Incarcerated|1|||
27514134|NCT03275350|80077530|FG001|Overall Study|Incarcerated|1|||
27514135|NCT05366738|80077531|FG000|Overall Study|Adverse Event|0|||
27514136|NCT05366738|80077532|FG001|Overall Study|Adverse Event|1|||
27514137|NCT05366738|80077533|FG002|Overall Study|Adverse Event|0|||
27514138|NCT00393861|80077536|FG000|Overall Study|Adverse Event|2|||
27514139|NCT00393861|80077536|FG000|Overall Study|Disease Progression|24|||
27514140|NCT00929643|80077537|FG000|Overall Study|Protocol Violation|2|||
27514141|NCT01358721|80077538|FG000|Overall Study|Withdrawal by Subject|0|||
27514142|NCT01358721|80077539|FG001|Overall Study|Withdrawal by Subject|0|||
27514143|NCT01358721|80077540|FG002|Overall Study|Withdrawal by Subject|0|||
27514144|NCT01358721|80077541|FG003|Overall Study|Withdrawal by Subject|1|||
27514145|NCT01358721|80077538|FG000|Overall Study|Death|0|||
27514146|NCT01358721|80077539|FG001|Overall Study|Death|2|||
27514147|NCT01358721|80077540|FG002|Overall Study|Death|0|||
27514148|NCT01358721|80077541|FG003|Overall Study|Death|0|||
27514149|NCT01358721|80077538|FG000|Overall Study|Study Drug Toxicity|1|||
27514150|NCT01358721|80077539|FG001|Overall Study|Study Drug Toxicity|3|||
27514151|NCT01358721|80077540|FG002|Overall Study|Study Drug Toxicity|4|||
27514152|NCT01358721|80077541|FG003|Overall Study|Study Drug Toxicity|5|||
27514153|NCT01358721|80077538|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
27514154|NCT01358721|80077539|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
27514155|NCT01358721|80077540|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
27514156|NCT01358721|80077541|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
27514157|NCT01358721|80077538|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
27514158|NCT01358721|80077539|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
27514159|NCT01358721|80077540|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
27514160|NCT01358721|80077541|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
27514161|NCT01358721|80077538|FG000|Overall Study|Adverse Event related to study drug|1|||
27514162|NCT01358721|80077539|FG001|Overall Study|Adverse Event related to study drug|0|||
27514163|NCT01358721|80077540|FG002|Overall Study|Adverse Event related to study drug|0|||
27514164|NCT01358721|80077541|FG003|Overall Study|Adverse Event related to study drug|1|||
27514165|NCT01358721|80077538|FG000|Overall Study|Disease Progression|19|||
27514166|NCT01358721|80077539|FG001|Overall Study|Disease Progression|15|||
27514167|NCT01358721|80077540|FG002|Overall Study|Disease Progression|17|||
27514168|NCT01358721|80077541|FG003|Overall Study|Disease Progression|15|||
27514169|NCT01358721|80077538|FG000|Overall Study|Out of State/Unmet Criteria|0|||
27514170|NCT01358721|80077539|FG001|Overall Study|Out of State/Unmet Criteria|0|||
27514171|NCT01358721|80077540|FG002|Overall Study|Out of State/Unmet Criteria|1|||
27514172|NCT01358721|80077541|FG003|Overall Study|Out of State/Unmet Criteria|0|||
27514173|NCT00808080|80077543|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
27514174|NCT01874340|80077544|FG000|Overall Study|Study terminated by Sponsor|6|||
27514175|NCT01874340|80077545|FG001|Overall Study|Study terminated by Sponsor|8|||
27514176|NCT01874340|80077546|FG002|Overall Study|Study terminated by Sponsor|8|||
27514177|NCT01874340|80077547|FG003|Overall Study|Study terminated by Sponsor|4|||
27514178|NCT01874340|80077544|FG000|Overall Study|Withdrawal by Subject|0|||
27514179|NCT01874340|80077545|FG001|Overall Study|Withdrawal by Subject|0|||
27514180|NCT01874340|80077546|FG002|Overall Study|Withdrawal by Subject|0|||
27514181|NCT01874340|80077547|FG003|Overall Study|Withdrawal by Subject|1|||
27514182|NCT02745080|80077554|FG000|Overall Study|Adverse Event|13|||
27514183|NCT02745080|80077555|FG001|Overall Study|Adverse Event|21|||
27514184|NCT02745080|80077554|FG000|Overall Study|Lack of Efficacy|11|||
27514185|NCT02745080|80077555|FG001|Overall Study|Lack of Efficacy|23|||
27514186|NCT02745080|80077554|FG000|Overall Study|Lost to Follow-up|3|||
27514187|NCT02745080|80077555|FG001|Overall Study|Lost to Follow-up|3|||
27514188|NCT02745080|80077554|FG000|Overall Study|Physician Decision|3|||
27514189|NCT02745080|80077555|FG001|Overall Study|Physician Decision|0|||
27514190|NCT02745080|80077554|FG000|Overall Study|Protocol Violation|3|||
27514191|NCT02745080|80077555|FG001|Overall Study|Protocol Violation|1|||
27514192|NCT02745080|80077554|FG000|Overall Study|Withdrawal by Subject|22|||
27514193|NCT02745080|80077555|FG001|Overall Study|Withdrawal by Subject|41|||
27615503|NCT02589392|80434219|FG000|Overall Study|Adverse Event|1|||
27906767|NCT00977613|81496752|FG000|Overall Study|Lost to Follow-up|16|||
27514194|NCT02405442|80077556|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
27514195|NCT02405442|80077557|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
27514196|NCT02405442|80077558|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
27514197|NCT02405442|80077559|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
27514198|NCT02405442|80077556|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
27514199|NCT02405442|80077557|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
27906768|NCT03077607|81496753|FG000|Period 1 (15 Days)|Adverse Event|1|||
27514200|NCT02405442|80077558|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
27514201|NCT02405442|80077559|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
27514202|NCT02405442|80077556|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
27514203|NCT02405442|80077557|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
27514204|NCT02405442|80077558|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
27514205|NCT02405442|80077559|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
27514206|NCT02405442|80077556|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
27514207|NCT02405442|80077557|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
27514208|NCT02405442|80077558|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
27514209|NCT02405442|80077559|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
27514210|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
27514211|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
27514212|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
27514213|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
27514214|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
27514215|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
27514216|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
27514217|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
27514218|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
27514219|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
27514220|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
27514221|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
27514222|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
27514223|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
27514224|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
27514225|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
27514226|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
27514227|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
27514228|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
27514229|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
27514230|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
27514231|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
27514232|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
27514233|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
27514234|NCT02405442|80077556|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
27514235|NCT02405442|80077557|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
27514236|NCT02405442|80077558|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
27514237|NCT02405442|80077559|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
27514238|NCT02405442|80077556|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
27514239|NCT02405442|80077557|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
27514240|NCT02405442|80077558|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
27514241|NCT02405442|80077559|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
27514242|NCT02405442|80077556|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
27514243|NCT02405442|80077557|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
27514244|NCT02405442|80077558|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
27514245|NCT02405442|80077559|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
27514246|NCT02405442|80077556|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
27514247|NCT02405442|80077557|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
27514248|NCT02405442|80077558|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
27514249|NCT02405442|80077559|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
27514250|NCT00734539|80077562|FG000|Main Study|Death|33|||
27514251|NCT00734539|80077563|FG001|Main Study|Death|32|||
27514252|NCT00734539|80077562|FG000|Main Study|Physician Decision|2|||
27514253|NCT00734539|80077563|FG001|Main Study|Physician Decision|0|||
27514254|NCT00734539|80077562|FG000|Main Study|Withdrawal by Subject|1|||
27514255|NCT00734539|80077563|FG001|Main Study|Withdrawal by Subject|3|||
27514256|NCT00734539|80077562|FG000|Main Study|Enrolled in error; ineligible|1|||
27514257|NCT00734539|80077563|FG001|Main Study|Enrolled in error; ineligible|0|||
27514258|NCT02605122|80077564|FG000|Overall Study|Withdrawal by Subject|4|||
27514259|NCT02605122|80077565|FG001|Overall Study|Withdrawal by Subject|1|||
27514260|NCT02605122|80077564|FG000|Overall Study|Lost to Follow-up|1|||
27514261|NCT02605122|80077565|FG001|Overall Study|Lost to Follow-up|1|||
27514262|NCT02969655|80077567|FG000|Overall Study|Withdrawal by Subject|3|||
27514263|NCT02969655|80077568|FG001|Overall Study|Withdrawal by Subject|2|||
27514264|NCT02969655|80077567|FG000|Overall Study|Physician Decision|4|||
27514265|NCT02969655|80077568|FG001|Overall Study|Physician Decision|3|||
27514266|NCT02969655|80077567|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
27514267|NCT02969655|80077568|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
27514268|NCT02969655|80077567|FG000|Overall Study|Adverse Event|10|||
27514269|NCT02969655|80077568|FG001|Overall Study|Adverse Event|8|||
27514270|NCT02762370|80077569|FG000|Overall Study|Protocol Violation|1|||
27615504|NCT02589392|80434220|FG001|Overall Study|Adverse Event|1|||
27615505|NCT02589392|80434219|FG000|Overall Study|Withdrawal by Subject|1|||
27615506|NCT02589392|80434220|FG001|Overall Study|Withdrawal by Subject|2|||
27615507|NCT02589392|80434219|FG000|Overall Study|Protocol Violation|1|||
27615508|NCT02589392|80434220|FG001|Overall Study|Protocol Violation|1|||
27615509|NCT02589392|80434219|FG000|Overall Study|Lost to Follow-up|2|||
27615510|NCT02589392|80434220|FG001|Overall Study|Lost to Follow-up|2|||
27615511|NCT02589392|80434219|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
27615512|NCT02589392|80434220|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
27615513|NCT00972543|80434221|FG000|Overall Study|Adverse Event|1|||
27615514|NCT00972543|80434222|FG001|Overall Study|Adverse Event|0|||
27615515|NCT00972543|80434221|FG000|Overall Study|Early study termination by sponsor|4|||
27615516|NCT00972543|80434222|FG001|Overall Study|Early study termination by sponsor|1|||
27615517|NCT00584805|80434223|FG000|Overall Study|No longer at risk of exposure|39|||
27728677|NCT01446809|80833357|FG001|Overall Study|Failure to complete study procedures|0|||
27728678|NCT01446809|80833358|FG002|Overall Study|Failure to complete study procedures|1|||
27728679|NCT02337387|80833361|FG000|Overall Study|Adverse Event|0|||
27728680|NCT02337387|80833362|FG001|Overall Study|Adverse Event|1|||
27728681|NCT02337387|80833363|FG002|Overall Study|Adverse Event|0|||
27728682|NCT02337387|80833364|FG003|Overall Study|Adverse Event|0|||
27728683|NCT02337387|80833361|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
27728684|NCT02337387|80833362|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
27728685|NCT02337387|80833363|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
27728686|NCT02337387|80833364|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
27728687|NCT01461044|80838085|FG000|Overall Study|Death|58|||
27728688|NCT01461044|80838086|FG001|Overall Study|Death|35|||
27728689|NCT01461044|80838085|FG000|Overall Study|Lost to Follow-up|12|||
27728690|NCT01461044|80838086|FG001|Overall Study|Lost to Follow-up|5|||
27728691|NCT00382967|80838088|FG000|Overall Study|Protocol Violation|1|||
27728692|NCT00382967|80838089|FG001|Overall Study|Protocol Violation|1|||
27728693|NCT01126580|80838090|FG000|Overall Study|Adverse Event|14|||
27728694|NCT01126580|80838091|FG001|Overall Study|Adverse Event|8|||
27728695|NCT01126580|80838092|FG002|Overall Study|Adverse Event|12|||
27728696|NCT01126580|80838090|FG000|Overall Study|Withdrawal by Subject|11|||
27728697|NCT01126580|80838091|FG001|Overall Study|Withdrawal by Subject|19|||
27728698|NCT01126580|80838092|FG002|Overall Study|Withdrawal by Subject|14|||
27728699|NCT01126580|80838090|FG000|Overall Study|Sponsor Decision|5|||
27728700|NCT01126580|80838091|FG001|Overall Study|Sponsor Decision|4|||
27728701|NCT01126580|80838092|FG002|Overall Study|Sponsor Decision|7|||
27728702|NCT01126580|80838090|FG000|Overall Study|Physician Decision|1|||
27514271|NCT02762370|80077570|FG001|Overall Study|Protocol Violation|0|||
27514272|NCT03710083|80077571|FG000|Overall Study|Withdrawal by Subject|2|||
27514273|NCT03710083|80077571|FG000|Overall Study|Unsuccessful Procedure|1|||
27514274|NCT02840799|80077572|FG000|Phase 1|Physician Decision|1|||
27514275|NCT02840799|80077573|FG001|Phase 1|Physician Decision|3|||
27514276|NCT02840799|80077572|FG000|Phase 1|Withdrawal by Subject|4|||
27514277|NCT02840799|80077573|FG001|Phase 1|Withdrawal by Subject|0|||
27514278|NCT02840799|80077572|FG000|Phase 2 (Crossover)|Adverse Event|0|||
27514279|NCT02840799|80077573|FG001|Phase 2 (Crossover)|Adverse Event|1|||
27514280|NCT02840799|80077572|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
27514281|NCT02840799|80077573|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
27514282|NCT02139592|80077584|FG000|Overall Study|Case Report Forms Uncollected|8|||
27514283|NCT03566485|80077585|FG000|Overall Study|Disease progression|5|||
27514284|NCT03566485|80077586|FG001|Overall Study|Disease progression|4|||
27514285|NCT03566485|80077585|FG000|Overall Study|Clinical progression|0|||
27514286|NCT03566485|80077586|FG001|Overall Study|Clinical progression|1|||
27514287|NCT03566485|80077585|FG000|Overall Study|Toxicity|0|||
27514288|NCT03566485|80077586|FG001|Overall Study|Toxicity|2|||
27514289|NCT04543279|80077589|FG000|Overall Study|Withdrawal by Subject|1|||
27514290|NCT04543279|80077590|FG001|Overall Study|Withdrawal by Subject|0|||
27514291|NCT04543279|80077589|FG000|Overall Study|Adverse Event|1|||
27514292|NCT04543279|80077590|FG001|Overall Study|Adverse Event|0|||
27514293|NCT04543279|80077589|FG000|Overall Study|Physician Decision|1|||
27514294|NCT04543279|80077590|FG001|Overall Study|Physician Decision|0|||
27514295|NCT01918306|80077592|FG000|Overall Study|progresive disease|4|||
27615518|NCT00584805|80434223|FG000|Overall Study|Relocation|36|||
27728703|NCT01126580|80838091|FG001|Overall Study|Physician Decision|1|||
27728704|NCT01126580|80838092|FG002|Overall Study|Physician Decision|2|||
27728705|NCT01126580|80838090|FG000|Overall Study|Entry Criteria Not Met|1|||
27514296|NCT01918306|80077593|FG001|Overall Study|progresive disease|0|||
27728706|NCT01126580|80838091|FG001|Overall Study|Entry Criteria Not Met|1|||
27728707|NCT01126580|80838092|FG002|Overall Study|Entry Criteria Not Met|2|||
27728708|NCT01126580|80838090|FG000|Overall Study|Lack of Efficacy|2|||
27728709|NCT01126580|80838091|FG001|Overall Study|Lack of Efficacy|3|||
27514297|NCT01918306|80077594|FG002|Overall Study|progresive disease|1|||
27615519|NCT00584805|80434223|FG000|Overall Study|Withdrawal by Subject|18|||
27615520|NCT00584805|80434223|FG000|Overall Study|Non-compliance|1|||
27615521|NCT00584805|80434223|FG000|Overall Study|Lost to follow up|3|||
27615522|NCT00584805|80434223|FG000|Overall Study|Screen failures|2|||
27615523|NCT02226172|80434224|FG000|Overall Study|Participant refused further follow-up|4|||
27615524|NCT02226172|80434224|FG000|Overall Study|Other|5|||
27615525|NCT02226172|80434224|FG000|Overall Study|Death|1|||
27615526|NCT02226172|80434224|FG000|Overall Study|Study terminated by sponsor|1|||
27615527|NCT02226172|80434224|FG000|Overall Study|Adverse Event|6|||
27615528|NCT03653416|80434225|FG000|Overall Study|Protocol Violation|6|||
27615529|NCT03653416|80434226|FG001|Overall Study|Protocol Violation|1|||
27615530|NCT00884286|80434232|FG000|Overall Study|Progressive disease|21|||
27615531|NCT00884286|80434233|FG001|Overall Study|Progressive disease|28|||
27615532|NCT00884286|80434232|FG000|Overall Study|Toxicity|4|||
27615533|NCT00884286|80434233|FG001|Overall Study|Toxicity|1|||
27615534|NCT00884286|80434232|FG000|Overall Study|Death|2|||
27615535|NCT00884286|80434233|FG001|Overall Study|Death|2|||
27615536|NCT00884286|80434232|FG000|Overall Study|Physician Decision|1|||
27615537|NCT00884286|80434233|FG001|Overall Study|Physician Decision|0|||
27615538|NCT00884286|80434232|FG000|Overall Study|Septic shock|1|||
27615539|NCT00884286|80434233|FG001|Overall Study|Septic shock|0|||
27615540|NCT00884286|80434232|FG000|Overall Study|Thrombus in right auricle|1|||
27615541|NCT00884286|80434233|FG001|Overall Study|Thrombus in right auricle|0|||
27615542|NCT00884286|80434232|FG000|Overall Study|Not treated|2|||
27615543|NCT00884286|80434233|FG001|Overall Study|Not treated|1|||
27615544|NCT00884286|80434232|FG000|Overall Study|Comprised lung carcinoma|0|||
27615545|NCT00884286|80434233|FG001|Overall Study|Comprised lung carcinoma|1|||
27615546|NCT03875911|80434234|FG000|Overall Study|Lost to Follow-up|3|||
27615547|NCT03875911|80434235|FG001|Overall Study|Lost to Follow-up|6|||
27615548|NCT03875911|80434236|FG002|Overall Study|Lost to Follow-up|2|||
27615549|NCT03875911|80434234|FG000|Overall Study|Surgery cancelled|1|||
27615550|NCT03875911|80434235|FG001|Overall Study|Surgery cancelled|0|||
27615551|NCT03875911|80434236|FG002|Overall Study|Surgery cancelled|1|||
27615552|NCT03875911|80434234|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
27615553|NCT03875911|80434235|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
27615554|NCT03875911|80434236|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
27615555|NCT04140890|80434244|FG000|Overall Study|Withdrawal by Subject|0|||
27615556|NCT04140890|80434245|FG001|Overall Study|Withdrawal by Subject|1|||
27615557|NCT00386308|80434246|FG000|Overall Study|Adverse Event|3|||
27615558|NCT00386308|80434247|FG001|Overall Study|Adverse Event|3|||
27615559|NCT00386308|80434246|FG000|Overall Study|Protocol Violation|2|||
27615560|NCT00386308|80434247|FG001|Overall Study|Protocol Violation|5|||
27615561|NCT00386308|80434246|FG000|Overall Study|Lack of Efficacy|0|||
27615562|NCT00386308|80434247|FG001|Overall Study|Lack of Efficacy|2|||
27615563|NCT00386308|80434246|FG000|Overall Study|Lost to Follow-up|10|||
27615564|NCT00386308|80434247|FG001|Overall Study|Lost to Follow-up|6|||
27615565|NCT00386308|80434246|FG000|Overall Study|Withdrawal by Subject|6|||
27514298|NCT01918306|80077595|FG003|Overall Study|progresive disease|1|||
27514299|NCT01918306|80077592|FG000|Overall Study|Withdrawal by Subject|0|||
27514300|NCT01918306|80077593|FG001|Overall Study|Withdrawal by Subject|0|||
27514301|NCT01918306|80077594|FG002|Overall Study|Withdrawal by Subject|0|||
27514302|NCT01918306|80077595|FG003|Overall Study|Withdrawal by Subject|2|||
27514303|NCT01918306|80077592|FG000|Overall Study|neutropenia|1|||
27514304|NCT01918306|80077593|FG001|Overall Study|neutropenia|0|||
27514305|NCT01918306|80077594|FG002|Overall Study|neutropenia|0|||
27514306|NCT01918306|80077595|FG003|Overall Study|neutropenia|0|||
27514307|NCT01918306|80077592|FG000|Overall Study|Lack of Efficacy|1|||
27514308|NCT01918306|80077593|FG001|Overall Study|Lack of Efficacy|0|||
27514309|NCT01918306|80077594|FG002|Overall Study|Lack of Efficacy|0|||
27514310|NCT01918306|80077595|FG003|Overall Study|Lack of Efficacy|0|||
27514311|NCT01918306|80077592|FG000|Overall Study|progress disease, crossover|0|||
27514312|NCT01918306|80077593|FG001|Overall Study|progress disease, crossover|0|||
27615566|NCT00386308|80434247|FG001|Overall Study|Withdrawal by Subject|2|||
27615567|NCT00386308|80434246|FG000|Overall Study|Other Event|8|||
27514313|NCT01918306|80077594|FG002|Overall Study|progress disease, crossover|1|||
27514314|NCT01918306|80077595|FG003|Overall Study|progress disease, crossover|0|||
27514315|NCT00831493|80077596|FG000|Overall Study|Intractable nausea and vomiting|1|||
27514316|NCT00750152|80077597|FG000|Overall Study|Adverse Event|2|||
27514317|NCT00750152|80077598|FG001|Overall Study|Adverse Event|1|||
27514318|NCT00750152|80077597|FG000|Overall Study|Lost to Follow-up|8|||
27514319|NCT00750152|80077598|FG001|Overall Study|Lost to Follow-up|13|||
27615568|NCT00386308|80434247|FG001|Overall Study|Other Event|1|||
27615569|NCT03525574|80434253|FG000|Overall Study|Adverse Event|15|||
27615570|NCT03525574|80434254|FG001|Overall Study|Adverse Event|0|||
27615571|NCT03525574|80434253|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
27615572|NCT03525574|80434254|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
27615573|NCT03525574|80434253|FG000|Overall Study|Lost to Follow-up|4|||
27615574|NCT03525574|80434254|FG001|Overall Study|Lost to Follow-up|0|||
27615575|NCT03525574|80434253|FG000|Overall Study|Commercial drug is Available for participant|48|||
27615576|NCT03525574|80434254|FG001|Overall Study|Commercial drug is Available for participant|0|||
27514320|NCT00750152|80077597|FG000|Overall Study|Withdrawal by Subject|3|||
27514321|NCT00750152|80077598|FG001|Overall Study|Withdrawal by Subject|3|||
27514322|NCT00750152|80077597|FG000|Overall Study|Physician Decision|1|||
27514323|NCT00750152|80077598|FG001|Overall Study|Physician Decision|1|||
27514324|NCT00750152|80077597|FG000|Overall Study|Non-compliance|0|||
27514325|NCT00750152|80077598|FG001|Overall Study|Non-compliance|1|||
27514326|NCT00750152|80077597|FG000|Overall Study|Termination by sponsor|1|||
27514327|NCT00750152|80077598|FG001|Overall Study|Termination by sponsor|0|||
27514328|NCT00750152|80077597|FG000|Overall Study|Other|7|||
27514329|NCT00750152|80077598|FG001|Overall Study|Other|8|||
27514330|NCT00862082|80077599|FG000|Overall Study|Sponsor decision to terminate the study|5|||
27514331|NCT00862082|80077600|FG001|Overall Study|Sponsor decision to terminate the study|0|||
27514332|NCT00862082|80077599|FG000|Overall Study|Withdrawal by Subject|0|||
27514333|NCT00862082|80077600|FG001|Overall Study|Withdrawal by Subject|1|||
27514334|NCT01396057|80077601|FG000|Overall Study|Adverse Event|2|||
27514335|NCT01396057|80077602|FG001|Overall Study|Adverse Event|6|||
27514336|NCT01396057|80077601|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27514337|NCT01396057|80077602|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
27514338|NCT01396057|80077601|FG000|Overall Study|Protocol deviation|4|||
27514339|NCT01396057|80077602|FG001|Overall Study|Protocol deviation|4|||
27514340|NCT01396057|80077601|FG000|Overall Study|Consent withdrawn|3|||
27514341|NCT01396057|80077602|FG001|Overall Study|Consent withdrawn|2|||
27514342|NCT02644109|80077604|FG000|Overall Study|Adverse Event|0|||
27514343|NCT02644109|80077605|FG001|Overall Study|Adverse Event|4|||
27514344|NCT01134705|80077606|FG000|Overall Study|Adverse Event|1|||
27514345|NCT01134705|80077607|FG001|Overall Study|Adverse Event|7|||
27514346|NCT01134705|80077606|FG000|Overall Study|Withdrawal by Subject|6|||
27514347|NCT01134705|80077607|FG001|Overall Study|Withdrawal by Subject|6|||
27514348|NCT01134705|80077606|FG000|Overall Study|Pregnancy|1|||
27514349|NCT01134705|80077607|FG001|Overall Study|Pregnancy|0|||
27514350|NCT01134705|80077606|FG000|Overall Study|Lost to Follow-up|5|||
27514351|NCT01134705|80077607|FG001|Overall Study|Lost to Follow-up|2|||
27514352|NCT01134705|80077606|FG000|Overall Study|Protocol Violation|1|||
27514353|NCT01134705|80077607|FG001|Overall Study|Protocol Violation|1|||
27514354|NCT01134705|80077606|FG000|Overall Study|Other|1|||
27514355|NCT01134705|80077607|FG001|Overall Study|Other|6|||
27514356|NCT03583385|80077608|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27514357|NCT03583385|80077609|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27514358|NCT03583385|80077608|FG000|Treatment Period 2|Adverse Event|1|||
27514359|NCT03583385|80077609|FG001|Treatment Period 2|Adverse Event|0|||
27514360|NCT00634101|80077612|FG000|Overall Study|Study Terminated|3|||
27514361|NCT00634101|80077613|FG001|Overall Study|Study Terminated|3|||
27514362|NCT00634101|80077612|FG000|Overall Study|Lost to Follow-up|2|||
27514363|NCT00634101|80077613|FG001|Overall Study|Lost to Follow-up|0|||
27514364|NCT00114517|80077614|FG000|Overall Study|Adverse Event|6|||
27514365|NCT00114517|80077615|FG001|Overall Study|Adverse Event|1|||
27514366|NCT00114517|80077616|FG002|Overall Study|Adverse Event|6|||
27514367|NCT00114517|80077617|FG003|Overall Study|Adverse Event|3|||
27514368|NCT00114517|80077614|FG000|Overall Study|Lost to Follow-up|2|||
27514369|NCT00114517|80077615|FG001|Overall Study|Lost to Follow-up|2|||
27514370|NCT00114517|80077616|FG002|Overall Study|Lost to Follow-up|2|||
27514371|NCT00114517|80077617|FG003|Overall Study|Lost to Follow-up|1|||
27514372|NCT00114517|80077614|FG000|Overall Study|Too busy|3|||
27514373|NCT00114517|80077615|FG001|Overall Study|Too busy|1|||
27514374|NCT00114517|80077616|FG002|Overall Study|Too busy|1|||
27514375|NCT00114517|80077617|FG003|Overall Study|Too busy|2|||
27514376|NCT00114517|80077614|FG000|Overall Study|Moved from area|0|||
27514377|NCT00114517|80077615|FG001|Overall Study|Moved from area|3|||
27514378|NCT00114517|80077616|FG002|Overall Study|Moved from area|2|||
27615577|NCT03525574|80434253|FG000|Overall Study|Death|1|||
27728710|NCT01126580|80838092|FG002|Overall Study|Lack of Efficacy|4|||
27514379|NCT00114517|80077617|FG003|Overall Study|Moved from area|1|||
27514380|NCT00114517|80077614|FG000|Overall Study|Did not want estradiol|1|||
27514381|NCT00114517|80077615|FG001|Overall Study|Did not want estradiol|1|||
27728711|NCT01126580|80838090|FG000|Overall Study|Protocol Violation|0|||
27514382|NCT00114517|80077616|FG002|Overall Study|Did not want estradiol|0|||
27514383|NCT00114517|80077617|FG003|Overall Study|Did not want estradiol|0|||
27514384|NCT00114517|80077614|FG000|Overall Study|Armed-services duty|0|||
27514385|NCT00114517|80077615|FG001|Overall Study|Armed-services duty|1|||
27514386|NCT00114517|80077616|FG002|Overall Study|Armed-services duty|0|||
27514387|NCT00114517|80077617|FG003|Overall Study|Armed-services duty|1|||
27514388|NCT00114517|80077614|FG000|Overall Study|Competing family issue|0|||
27514389|NCT00114517|80077615|FG001|Overall Study|Competing family issue|1|||
27514390|NCT00114517|80077616|FG002|Overall Study|Competing family issue|0|||
27514391|NCT00114517|80077617|FG003|Overall Study|Competing family issue|1|||
27514392|NCT00114517|80077614|FG000|Overall Study|Physician Decision|0|||
27514393|NCT00114517|80077615|FG001|Overall Study|Physician Decision|1|||
27514394|NCT00114517|80077616|FG002|Overall Study|Physician Decision|0|||
27514395|NCT00114517|80077617|FG003|Overall Study|Physician Decision|0|||
27514396|NCT00114517|80077614|FG000|Overall Study|Lost interest|0|||
27514397|NCT00114517|80077615|FG001|Overall Study|Lost interest|0|||
27514398|NCT00114517|80077616|FG002|Overall Study|Lost interest|1|||
27514399|NCT00114517|80077617|FG003|Overall Study|Lost interest|0|||
27514400|NCT00114517|80077614|FG000|Overall Study|Weight increase|0|||
27514401|NCT00114517|80077615|FG001|Overall Study|Weight increase|0|||
27514402|NCT00114517|80077616|FG002|Overall Study|Weight increase|1|||
27514403|NCT00114517|80077617|FG003|Overall Study|Weight increase|0|||
27514404|NCT00114517|80077614|FG000|Overall Study|Concern about blood clots|0|||
27514405|NCT00114517|80077615|FG001|Overall Study|Concern about blood clots|0|||
27615578|NCT03525574|80434254|FG001|Overall Study|Death|0|||
27906769|NCT03077607|81496754|FG001|Period 1 (15 Days)|Adverse Event|0|||
27906770|NCT03077607|81496753|FG000|Period 1 (15 Days)|Death|1|||
27906771|NCT03077607|81496754|FG001|Period 1 (15 Days)|Death|0|||
27906772|NCT03077607|81496753|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
27906773|NCT03077607|81496754|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
27906774|NCT03077607|81496753|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
27906775|NCT03077607|81496754|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
27514406|NCT00114517|80077616|FG002|Overall Study|Concern about blood clots|1|||
27514407|NCT00114517|80077617|FG003|Overall Study|Concern about blood clots|0|||
27514408|NCT00114517|80077614|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
27514409|NCT00114517|80077615|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
27514410|NCT00114517|80077616|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
27514411|NCT00114517|80077617|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
27514412|NCT03198507|80077618|FG000|Overall Study|Withdrawal by Subject|1|||
27514413|NCT03198507|80077619|FG001|Overall Study|Withdrawal by Subject|0|||
27514414|NCT00939393|80077620|FG000|Overall Study|Withdrawal by Subject|1|||
27514415|NCT00939393|80077621|FG001|Overall Study|Withdrawal by Subject|0|||
27514416|NCT00939393|80077620|FG000|Overall Study|Lost to Follow-up|3|||
27514417|NCT00939393|80077621|FG001|Overall Study|Lost to Follow-up|0|||
27514418|NCT01396070|80077622|FG000|Overall Study|Withdrawal by Subject|2|||
27514419|NCT01396070|80077622|FG000|Overall Study|Death|2|||
27514420|NCT01396070|80077622|FG000|Overall Study|Adverse Event|8|||
27514421|NCT01396070|80077622|FG000|Overall Study|Physician Decision|3|||
27514422|NCT01396070|80077622|FG000|Overall Study|Lack of Efficacy|4|||
27514423|NCT04075734|80077624|FG000|Overall Study|Lost to Follow-up|1|||
27514424|NCT04075734|80077625|FG001|Overall Study|Lost to Follow-up|1|||
27514425|NCT04075734|80077626|FG002|Overall Study|Lost to Follow-up|0|||
27514426|NCT04075734|80077624|FG000|Overall Study|Withdrawal by Subject|3|||
27514427|NCT04075734|80077625|FG001|Overall Study|Withdrawal by Subject|0|||
27514428|NCT04075734|80077626|FG002|Overall Study|Withdrawal by Subject|0|||
27514429|NCT00126490|80077627|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
27514430|NCT00481091|80077628|FG000|Overall Study|Withdrawal by Subject|0|||
27514431|NCT00481091|80077629|FG001|Overall Study|Withdrawal by Subject|1|||
27514432|NCT00481091|80077630|FG002|Overall Study|Withdrawal by Subject|1|||
27514433|NCT00481091|80077631|FG003|Overall Study|Withdrawal by Subject|0|||
27514434|NCT00481091|80077632|FG004|Overall Study|Withdrawal by Subject|0|||
27514435|NCT00481091|80077633|FG005|Overall Study|Withdrawal by Subject|0|||
27514436|NCT00481091|80077634|FG006|Overall Study|Withdrawal by Subject|0|||
27514437|NCT00481091|80077635|FG007|Overall Study|Withdrawal by Subject|0|||
27514438|NCT00481091|80077636|FG008|Overall Study|Withdrawal by Subject|1|||
27514439|NCT00481091|80077637|FG009|Overall Study|Withdrawal by Subject|6|||
27514440|NCT00481091|80077628|FG000|Overall Study|Other, Not Specified|0|||
27514441|NCT00481091|80077629|FG001|Overall Study|Other, Not Specified|1|||
27514442|NCT00481091|80077630|FG002|Overall Study|Other, Not Specified|1|||
27514443|NCT00481091|80077631|FG003|Overall Study|Other, Not Specified|0|||
27514444|NCT00481091|80077632|FG004|Overall Study|Other, Not Specified|0|||
27514445|NCT00481091|80077633|FG005|Overall Study|Other, Not Specified|1|||
27514446|NCT00481091|80077634|FG006|Overall Study|Other, Not Specified|0|||
27514447|NCT00481091|80077635|FG007|Overall Study|Other, Not Specified|0|||
27514448|NCT00481091|80077636|FG008|Overall Study|Other, Not Specified|0|||
27514449|NCT00481091|80077637|FG009|Overall Study|Other, Not Specified|4|||
27514450|NCT00481091|80077628|FG000|Overall Study|Adverse Event|1|||
27514451|NCT00481091|80077629|FG001|Overall Study|Adverse Event|2|||
27514452|NCT00481091|80077630|FG002|Overall Study|Adverse Event|0|||
27514453|NCT00481091|80077631|FG003|Overall Study|Adverse Event|1|||
27514454|NCT00481091|80077632|FG004|Overall Study|Adverse Event|1|||
27514455|NCT00481091|80077633|FG005|Overall Study|Adverse Event|1|||
27514456|NCT00481091|80077634|FG006|Overall Study|Adverse Event|2|||
27514457|NCT00481091|80077635|FG007|Overall Study|Adverse Event|1|||
27514458|NCT00481091|80077636|FG008|Overall Study|Adverse Event|1|||
27514459|NCT00481091|80077637|FG009|Overall Study|Adverse Event|6|||
27514460|NCT00481091|80077628|FG000|Overall Study|Progressive disease clinical|0|||
27514461|NCT00481091|80077629|FG001|Overall Study|Progressive disease clinical|0|||
27514462|NCT00481091|80077630|FG002|Overall Study|Progressive disease clinical|0|||
27514463|NCT00481091|80077631|FG003|Overall Study|Progressive disease clinical|0|||
27615579|NCT03525574|80434253|FG000|Overall Study|Other non-compliance|2|||
27906776|NCT00627926|81496755|FG000|Overall Study|Adverse Event|26|||
27615580|NCT03525574|80434254|FG001|Overall Study|Other non-compliance|0|||
27615581|NCT03525574|80434253|FG000|Overall Study|Physician Decision|6|||
27615582|NCT03525574|80434254|FG001|Overall Study|Physician Decision|0|||
27615583|NCT03525574|80434253|FG000|Overall Study|Other|58|||
27906777|NCT00627926|81496756|FG001|Overall Study|Adverse Event|37|||
27906778|NCT00627926|81496757|FG002|Overall Study|Adverse Event|36|||
27514464|NCT00481091|80077632|FG004|Overall Study|Progressive disease clinical|0|||
27514465|NCT00481091|80077633|FG005|Overall Study|Progressive disease clinical|0|||
27514466|NCT00481091|80077634|FG006|Overall Study|Progressive disease clinical|0|||
27514467|NCT00481091|80077635|FG007|Overall Study|Progressive disease clinical|0|||
27514468|NCT00481091|80077636|FG008|Overall Study|Progressive disease clinical|1|||
27514469|NCT00481091|80077637|FG009|Overall Study|Progressive disease clinical|7|||
27514470|NCT00481091|80077628|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
27906779|NCT00627926|81496755|FG000|Overall Study|Death|1|||
27906780|NCT00627926|81496756|FG001|Overall Study|Death|0|||
27906781|NCT00627926|81496757|FG002|Overall Study|Death|0|||
27906782|NCT00627926|81496755|FG000|Overall Study|Lost to Follow-up|4|||
27906783|NCT00627926|81496756|FG001|Overall Study|Lost to Follow-up|3|||
27906784|NCT00627926|81496757|FG002|Overall Study|Lost to Follow-up|4|||
27906785|NCT00627926|81496755|FG000|Overall Study|Withdrawal by Subject|2|||
27906786|NCT00627926|81496756|FG001|Overall Study|Withdrawal by Subject|1|||
27906787|NCT00627926|81496757|FG002|Overall Study|Withdrawal by Subject|0|||
27906788|NCT00627926|81496755|FG000|Overall Study|Lack of Efficacy|118|||
27906789|NCT00627926|81496756|FG001|Overall Study|Lack of Efficacy|40|||
27906790|NCT00627926|81496757|FG002|Overall Study|Lack of Efficacy|38|||
27906791|NCT00627926|81496755|FG000|Overall Study|Noncompliance/unspecified|8|||
27906792|NCT00627926|81496756|FG001|Overall Study|Noncompliance/unspecified|23|||
27906793|NCT00627926|81496757|FG002|Overall Study|Noncompliance/unspecified|17|||
27906794|NCT02081001|81496758|FG000|Overall Study|Adverse Event|0|||
27906795|NCT02081001|81496759|FG001|Overall Study|Adverse Event|0|||
27906796|NCT02081001|81496760|FG002|Overall Study|Adverse Event|0|||
27906797|NCT02081001|81496761|FG003|Overall Study|Adverse Event|0|||
27906798|NCT02081001|81496762|FG004|Overall Study|Adverse Event|1|||
27906799|NCT02081001|81496763|FG005|Overall Study|Adverse Event|0|||
27906800|NCT02081001|81496764|FG006|Overall Study|Adverse Event|0|||
27906801|NCT02081001|81496765|FG007|Overall Study|Adverse Event|0|||
27906802|NCT02081001|81496766|FG008|Overall Study|Adverse Event|0|||
27906803|NCT02081001|81496767|FG009|Overall Study|Adverse Event|0|||
27906804|NCT02081001|81496768|FG010|Overall Study|Adverse Event|0|||
27906805|NCT02081001|81496769|FG011|Overall Study|Adverse Event|0|||
27906806|NCT01808222|81496771|FG000|Overall Study|mpMR scan was not performed|1|||
27906807|NCT02686814|81496772|FG000|Overall Study|Physician Decision|14|||
27906808|NCT02686814|81496772|FG000|Overall Study|Withdrawal by Subject|4|||
27906809|NCT02686814|81496772|FG000|Overall Study|Death|1|||
27906810|NCT03307837|81496773|FG000|Overall Study|Withdrawal by Subject|0|||
27906811|NCT03307837|81496774|FG001|Overall Study|Withdrawal by Subject|0|||
27514471|NCT00481091|80077629|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
27615584|NCT03525574|80434254|FG001|Overall Study|Other|0|||
27906812|NCT03307837|81496775|FG002|Overall Study|Withdrawal by Subject|1|||
27906813|NCT03307837|81496776|FG003|Overall Study|Withdrawal by Subject|0|||
27906814|NCT03307837|81496777|FG004|Overall Study|Withdrawal by Subject|0|||
27906815|NCT03307837|81496778|FG005|Overall Study|Withdrawal by Subject|1|||
27906816|NCT03307837|81496773|FG000|Overall Study|Lost to Follow-up|1|||
27906817|NCT03307837|81496774|FG001|Overall Study|Lost to Follow-up|1|||
27514472|NCT00481091|80077630|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514473|NCT00481091|80077631|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514474|NCT00481091|80077632|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514475|NCT00481091|80077633|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
27514476|NCT00481091|80077634|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514477|NCT00481091|80077635|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514478|NCT00481091|80077636|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514479|NCT00481091|80077637|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
27514480|NCT00481091|80077628|FG000|Overall Study|Progressive disease other|1|||
27514481|NCT00481091|80077629|FG001|Overall Study|Progressive disease other|1|||
27514482|NCT00481091|80077630|FG002|Overall Study|Progressive disease other|0|||
27514483|NCT00481091|80077631|FG003|Overall Study|Progressive disease other|1|||
27514484|NCT00481091|80077632|FG004|Overall Study|Progressive disease other|1|||
27514485|NCT00481091|80077633|FG005|Overall Study|Progressive disease other|1|||
27514486|NCT00481091|80077634|FG006|Overall Study|Progressive disease other|0|||
27514487|NCT00481091|80077635|FG007|Overall Study|Progressive disease other|2|||
27514488|NCT00481091|80077636|FG008|Overall Study|Progressive disease other|0|||
27514489|NCT00481091|80077637|FG009|Overall Study|Progressive disease other|0|||
27514490|NCT00481091|80077628|FG000|Overall Study|No reason given|0|||
27514491|NCT00481091|80077629|FG001|Overall Study|No reason given|0|||
27514492|NCT00481091|80077630|FG002|Overall Study|No reason given|1|||
27514493|NCT00481091|80077631|FG003|Overall Study|No reason given|1|||
27514494|NCT00481091|80077632|FG004|Overall Study|No reason given|1|||
27514495|NCT00481091|80077633|FG005|Overall Study|No reason given|0|||
27514496|NCT00481091|80077634|FG006|Overall Study|No reason given|1|||
27514497|NCT00481091|80077635|FG007|Overall Study|No reason given|1|||
27514498|NCT00481091|80077636|FG008|Overall Study|No reason given|1|||
27514499|NCT00481091|80077637|FG009|Overall Study|No reason given|4|||
27514500|NCT02023697|80077640|FG000|Treatment Period|Radiological progression|13|||
27514501|NCT02023697|80077641|FG001|Treatment Period|Radiological progression|17|||
27514502|NCT02023697|80077642|FG002|Treatment Period|Radiological progression|26|||
27514503|NCT02023697|80077640|FG000|Treatment Period|Never Treated|5|||
27514504|NCT02023697|80077641|FG001|Treatment Period|Never Treated|6|||
27514505|NCT02023697|80077642|FG002|Treatment Period|Never Treated|10|||
27514506|NCT02023697|80077640|FG000|Treatment Period|Adverse Event|13|||
27514507|NCT02023697|80077641|FG001|Treatment Period|Adverse Event|25|||
27514508|NCT02023697|80077642|FG002|Treatment Period|Adverse Event|23|||
27514509|NCT02023697|80077640|FG000|Treatment Period|Logistical difficulties|1|||
27514510|NCT02023697|80077641|FG001|Treatment Period|Logistical difficulties|1|||
27514511|NCT02023697|80077642|FG002|Treatment Period|Logistical difficulties|1|||
27514512|NCT02023697|80077640|FG000|Treatment Period|Clinical progression|10|||
27514513|NCT02023697|80077641|FG001|Treatment Period|Clinical progression|8|||
27514514|NCT02023697|80077642|FG002|Treatment Period|Clinical progression|28|||
27514515|NCT02023697|80077640|FG000|Treatment Period|Withdrawal by Subject|4|||
27514516|NCT02023697|80077641|FG001|Treatment Period|Withdrawal by Subject|5|||
27514517|NCT02023697|80077642|FG002|Treatment Period|Withdrawal by Subject|13|||
27514518|NCT02023697|80077640|FG000|Treatment Period|Safety outcome reached|0|||
27514519|NCT02023697|80077641|FG001|Treatment Period|Safety outcome reached|1|||
27514520|NCT02023697|80077642|FG002|Treatment Period|Safety outcome reached|0|||
27514521|NCT02023697|80077640|FG000|Treatment Period|Physician Decision|0|||
27514522|NCT02023697|80077641|FG001|Treatment Period|Physician Decision|0|||
27514523|NCT02023697|80077642|FG002|Treatment Period|Physician Decision|1|||
27514524|NCT02023697|80077640|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
27514525|NCT02023697|80077641|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
27514526|NCT02023697|80077642|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
27514527|NCT02023697|80077640|FG000|Active Follow-up Period|Lost to Follow-up|1|||
27514528|NCT02023697|80077641|FG001|Active Follow-up Period|Lost to Follow-up|1|||
27514529|NCT02023697|80077642|FG002|Active Follow-up Period|Lost to Follow-up|1|||
27514530|NCT02023697|80077640|FG000|Active Follow-up Period|Deterioration of general condition|1|||
27514531|NCT02023697|80077641|FG001|Active Follow-up Period|Deterioration of general condition|1|||
27514532|NCT02023697|80077642|FG002|Active Follow-up Period|Deterioration of general condition|1|||
27514533|NCT02023697|80077640|FG000|Active Follow-up Period|Other unspecified|2|||
27514534|NCT02023697|80077641|FG001|Active Follow-up Period|Other unspecified|0|||
27514535|NCT02023697|80077642|FG002|Active Follow-up Period|Other unspecified|1|||
27514536|NCT02023697|80077640|FG000|Active Follow-up Period|Clinical progression|0|||
27514537|NCT02023697|80077641|FG001|Active Follow-up Period|Clinical progression|2|||
27514538|NCT02023697|80077642|FG002|Active Follow-up Period|Clinical progression|1|||
27514539|NCT02023697|80077640|FG000|Active Follow-up Period|Radiological progression|0|||
27514540|NCT02023697|80077641|FG001|Active Follow-up Period|Radiological progression|0|||
27514541|NCT02023697|80077642|FG002|Active Follow-up Period|Radiological progression|1|||
27514542|NCT02023697|80077640|FG000|Active Follow-up Period|Death|83|||
27514543|NCT02023697|80077641|FG001|Active Follow-up Period|Death|82|||
27514544|NCT02023697|80077642|FG002|Active Follow-up Period|Death|87|||
27514545|NCT02023697|80077640|FG000|Long-term Follow-up Period|Death|9|||
27514546|NCT02023697|80077641|FG001|Long-term Follow-up Period|Death|6|||
27514547|NCT02023697|80077642|FG002|Long-term Follow-up Period|Death|4|||
27514548|NCT02023697|80077640|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
27514549|NCT02023697|80077641|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
27514550|NCT02023697|80077642|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
27514551|NCT02023697|80077640|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
27514552|NCT02023697|80077641|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
27514553|NCT02023697|80077642|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
27514554|NCT02023697|80077640|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
27514555|NCT02023697|80077641|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
27514556|NCT02023697|80077642|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
27514557|NCT02023697|80077640|FG000|Long-term Follow-up Period|Technical problems|0|||
27514558|NCT02023697|80077641|FG001|Long-term Follow-up Period|Technical problems|0|||
27514559|NCT02023697|80077642|FG002|Long-term Follow-up Period|Technical problems|1|||
27514560|NCT02023697|80077640|FG000|Long-term Follow-up Period|Other unspecified|6|||
27514561|NCT02023697|80077641|FG001|Long-term Follow-up Period|Other unspecified|3|||
27514562|NCT02023697|80077642|FG002|Long-term Follow-up Period|Other unspecified|5|||
27514563|NCT03237286|80077643|FG000|Overall Study|Withdrawal by Subject|1|||
27514564|NCT03237286|80077644|FG001|Overall Study|Withdrawal by Subject|0|||
27514565|NCT03237286|80077645|FG002|Overall Study|Withdrawal by Subject|2|||
27514566|NCT03237286|80077643|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
27514567|NCT03237286|80077644|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
27514568|NCT03237286|80077645|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
27514569|NCT00555061|80077650|FG000|Overall Study|Adverse Event|3|||
27514570|NCT00555061|80077650|FG000|Overall Study|Protocol Violation|1|||
27514571|NCT00555061|80077650|FG000|Overall Study|Lost to Follow-up|2|||
27514572|NCT00555061|80077650|FG000|Overall Study|Withdrawal by Subject|2|||
27514573|NCT00555061|80077650|FG000|Overall Study|Participant enrolled, but never treated|1|||
27514574|NCT05334212|80077654|FG000|Overall Study|Study terminated prematurely|7|||
27514575|NCT00001213|80077655|FG000|Overall Study|Death|18|||
27514576|NCT00068419|80077656|FG000|Overall Study|Adverse Event|3|||
27514577|NCT00068419|80077656|FG000|Overall Study|Lack of Efficacy|24|||
27514578|NCT00068419|80077656|FG000|Overall Study|Lost to Follow-up|1|||
27514579|NCT00068419|80077656|FG000|Overall Study|Physician Decision|7|||
27514580|NCT00068419|80077656|FG000|Overall Study|Withdrawal by Subject|14|||
27514581|NCT00068419|80077656|FG000|Overall Study|Ineligible|11|||
27514582|NCT01765218|80077657|FG000|Overall Study|Protocol Violation|1|||
27514583|NCT01765218|80077658|FG001|Overall Study|Protocol Violation|2|||
27514584|NCT02954172|80077661|FG000|Overall Study|Protocol Violation|3|||
27514585|NCT02954172|80077662|FG001|Overall Study|Protocol Violation|0|||
27514586|NCT02954172|80077661|FG000|Overall Study|allergic reaction|2|||
27514587|NCT02954172|80077662|FG001|Overall Study|allergic reaction|1|||
27514588|NCT02954172|80077661|FG000|Overall Study|non-measurable lesions at baseline|1|||
27514589|NCT02954172|80077662|FG001|Overall Study|non-measurable lesions at baseline|2|||
27514590|NCT03783078|80077663|FG000|Overall Study|Participants Ongoing|29|||
27514591|NCT03783078|80077663|FG000|Overall Study|Death|26|||
27514592|NCT00476229|80077664|FG000|Overall Study|Progressive shortness of breath|1|||
27514593|NCT01069900|80077665|FG000|Overall Study|Technical problems|0|||
27514594|NCT01069900|80077666|FG001|Overall Study|Technical problems|1|||
27514595|NCT01069900|80077665|FG000|Overall Study|Lost to Follow-up|7|||
27514596|NCT01069900|80077666|FG001|Overall Study|Lost to Follow-up|1|||
27615585|NCT03525574|80434253|FG000|Overall Study|Enrolled but never dosed|1|||
27853200|NCT01570283|81294981|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
27853201|NCT01570283|81294976|FG000|Cohort 3: Dose Level 3|Death|0|||
27853202|NCT01570283|81294977|FG001|Cohort 3: Dose Level 3|Death|0|||
27853203|NCT01570283|81294978|FG002|Cohort 3: Dose Level 3|Death|0|||
27853204|NCT01570283|81294979|FG003|Cohort 3: Dose Level 3|Death|0|||
27853205|NCT01570283|81294980|FG004|Cohort 3: Dose Level 3|Death|0|||
27853206|NCT01570283|81294981|FG005|Cohort 3: Dose Level 3|Death|1|||
27853207|NCT01570283|81294976|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27853208|NCT01570283|81294977|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27853209|NCT01570283|81294978|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27853210|NCT01570283|81294979|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27853211|NCT01570283|81294980|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
27853212|NCT01570283|81294981|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
27853213|NCT02858492|81294986|FG000|Overall Study|Withdrawal by Subject|0|||
27514597|NCT01069900|80077665|FG000|Overall Study|Withdrawal by Subject|6|||
27514598|NCT01069900|80077666|FG001|Overall Study|Withdrawal by Subject|1|||
27514599|NCT01069900|80077665|FG000|Overall Study|Protocol Violation|4|||
27514600|NCT01069900|80077666|FG001|Overall Study|Protocol Violation|1|||
27853214|NCT02858492|81294987|FG001|Overall Study|Withdrawal by Subject|1|||
27853215|NCT02858492|81294988|FG002|Overall Study|Withdrawal by Subject|0|||
27853216|NCT02858492|81294989|FG003|Overall Study|Withdrawal by Subject|1|||
27615586|NCT03525574|80434254|FG001|Overall Study|Enrolled but never dosed|0|||
27615587|NCT03525574|80434253|FG000|Overall Study|Not enrolled in 105 study|0|||
27615588|NCT03525574|80434254|FG001|Overall Study|Not enrolled in 105 study|3|||
27615589|NCT04249336|80434261|FG000|Overall Study|Lost to Follow-up|3|||
27615590|NCT04249336|80434262|FG001|Overall Study|Lost to Follow-up|3|||
27615591|NCT04249336|80434263|FG002|Overall Study|Lost to Follow-up|3|||
27615592|NCT04249336|80434264|FG003|Overall Study|Lost to Follow-up|3|||
27615593|NCT02222896|80434271|FG000|Abdomen|Did not qualify|34|||
27615594|NCT02222896|80434272|FG001|Abdomen|Did not qualify|10|||
27615595|NCT02222896|80434273|FG002|Abdomen|Did not qualify|32|||
27615596|NCT02222896|80434271|FG000|Groin|Did not qualify|43|||
27615597|NCT02222896|80434272|FG001|Groin|Did not qualify|9|||
27615598|NCT02222896|80434273|FG002|Groin|Did not qualify|40|||
27615599|NCT03632434|80434274|FG000|Overall Study|Withdrawal by Subject|2|||
27615600|NCT00791921|80434280|FG000|Overall Study|Protocol planed|24|||
27615601|NCT00791921|80434281|FG001|Overall Study|Protocol planed|88|||
27615602|NCT00791921|80434280|FG000|Overall Study|Withdrawal by Subject|1|||
27615603|NCT00791921|80434281|FG001|Overall Study|Withdrawal by Subject|2|||
27615604|NCT00791921|80434280|FG000|Overall Study|Adverse Event|8|||
27615605|NCT00791921|80434281|FG001|Overall Study|Adverse Event|2|||
27615606|NCT00791921|80434280|FG000|Overall Study|Lack of Efficacy|0|||
27615607|NCT00791921|80434281|FG001|Overall Study|Lack of Efficacy|2|||
27615608|NCT00791921|80434280|FG000|Overall Study|Lack of study drug administration|1|||
27615609|NCT00791921|80434281|FG001|Overall Study|Lack of study drug administration|1|||
27615610|NCT00791921|80434280|FG000|Overall Study|Reason other than those above|0|||
27615611|NCT00791921|80434281|FG001|Overall Study|Reason other than those above|1|||
27615612|NCT01464255|80434282|FG000|Overall Study|unresolve corneal staining|0|||
27615613|NCT01464255|80434283|FG001|Overall Study|unresolve corneal staining|1|||
27615614|NCT00445601|80434290|FG000|Overall Study|Withdrawal by Subject|11|||
27615615|NCT00445601|80434291|FG001|Overall Study|Withdrawal by Subject|11|||
27514601|NCT01069900|80077665|FG000|Overall Study|Insufficient Therapeutic effect|1|||
27514602|NCT01069900|80077666|FG001|Overall Study|Insufficient Therapeutic effect|0|||
27514603|NCT04530136|80077669|FG000|Overall Study|Lost to Follow-up|2|||
27514604|NCT04530136|80077670|FG001|Overall Study|Lost to Follow-up|3|||
27514605|NCT04530136|80077669|FG000|Overall Study|Withdrawal by Subject|1|||
27514606|NCT04530136|80077670|FG001|Overall Study|Withdrawal by Subject|0|||
27514607|NCT04530136|80077669|FG000|Overall Study|Death|0|||
27514608|NCT04530136|80077670|FG001|Overall Study|Death|1|||
27514609|NCT00436345|80077671|FG000|Overall Study|ICU resident beyond follow-up period|3|||
27514610|NCT00436345|80077672|FG001|Overall Study|ICU resident beyond follow-up period|0|||
27514611|NCT03241368|80077673|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
27514612|NCT03241368|80077673|FG000|Overall Study|Lost to Follow-up|1|||
27514613|NCT03241368|80077673|FG000|Overall Study|Physician Decision|6|||
27514614|NCT03241368|80077673|FG000|Overall Study|Withdrawal by Subject|6|||
27514615|NCT03241368|80077673|FG000|Overall Study|Protocol Violation|1|||
27514616|NCT03091348|80077674|FG000|Overall Study|Lost to Follow-up|2|||
27514617|NCT03091348|80077675|FG001|Overall Study|Lost to Follow-up|1|||
27514618|NCT03926611|80077678|FG000|Overall Study|Adverse Event|0|||
27514619|NCT03926611|80077679|FG001|Overall Study|Adverse Event|0|||
27514620|NCT03926611|80077680|FG002|Overall Study|Adverse Event|0|||
27615616|NCT00445601|80434290|FG000|Overall Study|TURBT Complication|12|||
27615617|NCT00445601|80434291|FG001|Overall Study|TURBT Complication|8|||
27615618|NCT00445601|80434290|FG000|Overall Study|Incorrect Disease Status|6|||
27615619|NCT00445601|80434291|FG001|Overall Study|Incorrect Disease Status|6|||
27514621|NCT03926611|80077681|FG003|Overall Study|Adverse Event|3|||
27514622|NCT03926611|80077682|FG004|Overall Study|Adverse Event|1|||
27514623|NCT03926611|80077683|FG005|Overall Study|Adverse Event|3|||
27514624|NCT03926611|80077684|FG006|Overall Study|Adverse Event|0|||
27514625|NCT03926611|80077678|FG000|Overall Study|Lack of Efficacy|1|||
27514626|NCT03926611|80077679|FG001|Overall Study|Lack of Efficacy|2|||
27514627|NCT03926611|80077680|FG002|Overall Study|Lack of Efficacy|0|||
27514628|NCT03926611|80077681|FG003|Overall Study|Lack of Efficacy|0|||
27514629|NCT03926611|80077682|FG004|Overall Study|Lack of Efficacy|1|||
27514630|NCT03926611|80077683|FG005|Overall Study|Lack of Efficacy|0|||
27514631|NCT03926611|80077684|FG006|Overall Study|Lack of Efficacy|1|||
27514632|NCT03926611|80077678|FG000|Overall Study|Physician Decision|0|||
27514633|NCT03926611|80077679|FG001|Overall Study|Physician Decision|0|||
27514634|NCT03926611|80077680|FG002|Overall Study|Physician Decision|0|||
27514635|NCT03926611|80077681|FG003|Overall Study|Physician Decision|0|||
27514636|NCT03926611|80077682|FG004|Overall Study|Physician Decision|0|||
27514637|NCT03926611|80077683|FG005|Overall Study|Physician Decision|1|||
27514638|NCT03926611|80077684|FG006|Overall Study|Physician Decision|0|||
27615620|NCT00445601|80434290|FG000|Overall Study|Drug Delivery Issue|2|||
27615621|NCT00445601|80434291|FG001|Overall Study|Drug Delivery Issue|2|||
27615622|NCT00445601|80434290|FG000|Overall Study|Adverse Event|2|||
27514639|NCT03926611|80077678|FG000|Overall Study|Protocol Violation|1|||
27514640|NCT03926611|80077679|FG001|Overall Study|Protocol Violation|0|||
27615623|NCT00445601|80434291|FG001|Overall Study|Adverse Event|0|||
27615624|NCT00445601|80434290|FG000|Overall Study|Death prior to TURBT|0|||
27615625|NCT00445601|80434291|FG001|Overall Study|Death prior to TURBT|1|||
27615626|NCT00003509|80434292|FG000|Overall Study|Not evaluable|5|||
27615627|NCT01163149|80434295|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
27615628|NCT01163149|80434296|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27615629|NCT01163149|80434297|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
27514641|NCT03926611|80077680|FG002|Overall Study|Protocol Violation|0|||
27514642|NCT03926611|80077681|FG003|Overall Study|Protocol Violation|1|||
27514643|NCT03926611|80077682|FG004|Overall Study|Protocol Violation|1|||
27514644|NCT03926611|80077683|FG005|Overall Study|Protocol Violation|1|||
27514645|NCT03926611|80077684|FG006|Overall Study|Protocol Violation|1|||
27514646|NCT03926611|80077678|FG000|Overall Study|Technical problems|0|||
27615630|NCT01163149|80434295|FG000|Extension Treatment Period|Adverse Event|0|||
27615631|NCT01163149|80434296|FG001|Extension Treatment Period|Adverse Event|1|||
27615632|NCT01163149|80434297|FG002|Extension Treatment Period|Adverse Event|0|||
27615633|NCT01163149|80434295|FG000|Extension Treatment Period|Noncompliance|0|||
27615634|NCT01163149|80434296|FG001|Extension Treatment Period|Noncompliance|0|||
27615635|NCT01163149|80434297|FG002|Extension Treatment Period|Noncompliance|1|||
27615636|NCT02397460|80434298|FG000|Treatment Period 2|Adverse Event|0|||
27615637|NCT02397460|80434299|FG001|Treatment Period 2|Adverse Event|0|||
27615638|NCT02397460|80434300|FG002|Treatment Period 2|Adverse Event|0|||
27615639|NCT02397460|80434301|FG003|Treatment Period 2|Adverse Event|0|||
27615640|NCT02397460|80434302|FG004|Treatment Period 2|Adverse Event|0|||
27615641|NCT02397460|80434303|FG005|Treatment Period 2|Adverse Event|0|||
27615642|NCT02397460|80434304|FG006|Treatment Period 2|Adverse Event|0|||
27615643|NCT02397460|80434305|FG007|Treatment Period 2|Adverse Event|1|||
27615644|NCT02397460|80434298|FG000|Treatment Period 4|Adverse Event|0|||
27615645|NCT02397460|80434299|FG001|Treatment Period 4|Adverse Event|1|||
27615646|NCT02397460|80434300|FG002|Treatment Period 4|Adverse Event|0|||
27615647|NCT02397460|80434301|FG003|Treatment Period 4|Adverse Event|0|||
27615648|NCT02397460|80434302|FG004|Treatment Period 4|Adverse Event|0|||
27615649|NCT02397460|80434303|FG005|Treatment Period 4|Adverse Event|0|||
27615650|NCT02397460|80434304|FG006|Treatment Period 4|Adverse Event|0|||
27615651|NCT02397460|80434305|FG007|Treatment Period 4|Adverse Event|0|||
27615652|NCT02397460|80434298|FG000|Treatment Period 4|Physician Decision|0|||
27615653|NCT02397460|80434299|FG001|Treatment Period 4|Physician Decision|0|||
27615654|NCT02397460|80434300|FG002|Treatment Period 4|Physician Decision|0|||
27615655|NCT02397460|80434301|FG003|Treatment Period 4|Physician Decision|0|||
27615656|NCT02397460|80434302|FG004|Treatment Period 4|Physician Decision|1|||
27514647|NCT03926611|80077679|FG001|Overall Study|Technical problems|0|||
27514648|NCT03926611|80077680|FG002|Overall Study|Technical problems|0|||
27514649|NCT03926611|80077681|FG003|Overall Study|Technical problems|0|||
27514650|NCT03926611|80077682|FG004|Overall Study|Technical problems|0|||
27514651|NCT03926611|80077683|FG005|Overall Study|Technical problems|1|||
27514652|NCT03926611|80077684|FG006|Overall Study|Technical problems|0|||
27514653|NCT03926611|80077678|FG000|Overall Study|Withdrawal by Subject|1|||
27514654|NCT03926611|80077679|FG001|Overall Study|Withdrawal by Subject|1|||
27514655|NCT03926611|80077680|FG002|Overall Study|Withdrawal by Subject|1|||
27514656|NCT03926611|80077681|FG003|Overall Study|Withdrawal by Subject|0|||
27514657|NCT03926611|80077682|FG004|Overall Study|Withdrawal by Subject|0|||
27514658|NCT03926611|80077683|FG005|Overall Study|Withdrawal by Subject|1|||
27514659|NCT03926611|80077684|FG006|Overall Study|Withdrawal by Subject|3|||
27514660|NCT03926611|80077678|FG000|Overall Study|Covid-19 pandemic|0|||
27514661|NCT03926611|80077679|FG001|Overall Study|Covid-19 pandemic|0|||
27514662|NCT03926611|80077680|FG002|Overall Study|Covid-19 pandemic|1|||
27514663|NCT03926611|80077681|FG003|Overall Study|Covid-19 pandemic|0|||
27514664|NCT03926611|80077682|FG004|Overall Study|Covid-19 pandemic|1|||
27514665|NCT03926611|80077683|FG005|Overall Study|Covid-19 pandemic|2|||
27514666|NCT03926611|80077684|FG006|Overall Study|Covid-19 pandemic|0|||
27514667|NCT02474069|80077685|FG000|Selection Phase (SP)|Adverse Event|8|||
27514668|NCT02474069|80077686|FG001|Selection Phase (SP)|Adverse Event|0|||
27514669|NCT02474069|80077687|FG002|Selection Phase (SP)|Adverse Event|0|||
27514670|NCT02474069|80077685|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
27514671|NCT02474069|80077686|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
27514672|NCT02474069|80077687|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
27514673|NCT02474069|80077685|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
27514674|NCT02474069|80077686|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
27514675|NCT02474069|80077687|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
27514676|NCT02474069|80077685|FG000|Selection Phase (SP)|Physician Decision|1|||
27514677|NCT02474069|80077686|FG001|Selection Phase (SP)|Physician Decision|0|||
27514678|NCT02474069|80077687|FG002|Selection Phase (SP)|Physician Decision|0|||
27514679|NCT02474069|80077685|FG000|Selection Phase (SP)|Protocol Violation|1|||
27514680|NCT02474069|80077686|FG001|Selection Phase (SP)|Protocol Violation|0|||
27514681|NCT02474069|80077687|FG002|Selection Phase (SP)|Protocol Violation|0|||
27514682|NCT02474069|80077685|FG000|Selection Phase (SP)|No longer requires treatment|1|||
27514683|NCT02474069|80077686|FG001|Selection Phase (SP)|No longer requires treatment|0|||
27615657|NCT02397460|80434303|FG005|Treatment Period 4|Physician Decision|0|||
27615658|NCT02397460|80434304|FG006|Treatment Period 4|Physician Decision|0|||
27728712|NCT01126580|80838091|FG001|Overall Study|Protocol Violation|1|||
27615659|NCT02397460|80434305|FG007|Treatment Period 4|Physician Decision|0|||
27514684|NCT02474069|80077687|FG002|Selection Phase (SP)|No longer requires treatment|0|||
27514685|NCT02474069|80077685|FG000|Selection Phase (SP)|Technical Problem|1|||
27514686|NCT02474069|80077686|FG001|Selection Phase (SP)|Technical Problem|0|||
27514687|NCT02474069|80077687|FG002|Selection Phase (SP)|Technical Problem|0|||
27514688|NCT02474069|80077685|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
27514689|NCT02474069|80077686|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
27514690|NCT02474069|80077687|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
27514691|NCT02474069|80077685|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
27514692|NCT02474069|80077686|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
27514693|NCT02474069|80077687|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
27514694|NCT02474069|80077685|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
27514695|NCT02474069|80077686|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
27514696|NCT02474069|80077687|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
27514697|NCT02474069|80077685|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
27514698|NCT02474069|80077686|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
27514699|NCT02474069|80077687|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
27514700|NCT02474069|80077685|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
27514701|NCT02474069|80077686|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
27514702|NCT02474069|80077687|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
27514703|NCT02474069|80077685|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
27514704|NCT02474069|80077686|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
27514705|NCT02474069|80077687|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
27514706|NCT02704143|80077691|FG000|Overall Study|disease progression|10|||
27514707|NCT01120717|80077692|FG000|Overall Study|Withdrawal by Subject|11|||
27514708|NCT01120717|80077693|FG001|Overall Study|Withdrawal by Subject|6|||
27514709|NCT01120717|80077692|FG000|Overall Study|Adverse Event|10|||
27514710|NCT01120717|80077693|FG001|Overall Study|Adverse Event|6|||
27514711|NCT01120717|80077692|FG000|Overall Study|Protocol Deviation|2|||
27514712|NCT01120717|80077693|FG001|Overall Study|Protocol Deviation|5|||
27514713|NCT01120717|80077692|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27514714|NCT01120717|80077693|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27514715|NCT01120717|80077692|FG000|Overall Study|Lost to Follow-up|2|||
27514716|NCT01120717|80077693|FG001|Overall Study|Lost to Follow-up|3|||
27514717|NCT01120717|80077692|FG000|Overall Study|Death|3|||
27514718|NCT01120717|80077693|FG001|Overall Study|Death|1|||
27514719|NCT01120717|80077692|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
27514720|NCT01120717|80077693|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
27514721|NCT00202878|80077707|FG000|Overall Study|Death|964|||
27514722|NCT00202878|80077708|FG001|Overall Study|Death|968|||
27514723|NCT00202878|80077707|FG000|Overall Study|Only Vital Status Known|357|||
27514724|NCT00202878|80077708|FG001|Overall Study|Only Vital Status Known|356|||
27514725|NCT00202878|80077707|FG000|Overall Study|Lost to Follow-up|44|||
27514726|NCT00202878|80077708|FG001|Overall Study|Lost to Follow-up|49|||
27615660|NCT00604786|80434306|FG000|Overall Study|Lost to Follow-up|2|||
27615661|NCT00604786|80434307|FG001|Overall Study|Lost to Follow-up|0|||
27615662|NCT02404493|80434313|FG000|Overall Study|Adverse Event|1|||
27615663|NCT02404493|80434314|FG001|Overall Study|Adverse Event|1|||
27615664|NCT00976703|80434317|FG000|Overall Study|Physician Decision|1|||
27615665|NCT00976703|80434318|FG001|Overall Study|Physician Decision|1|||
27615666|NCT00976703|80434317|FG000|Overall Study|ineligible for study|2|||
27906818|NCT03307837|81496775|FG002|Overall Study|Lost to Follow-up|0|||
27906819|NCT03307837|81496776|FG003|Overall Study|Lost to Follow-up|0|||
27906820|NCT03307837|81496777|FG004|Overall Study|Lost to Follow-up|0|||
27906821|NCT03307837|81496778|FG005|Overall Study|Lost to Follow-up|1|||
27906822|NCT01763827|81496780|FG000|Overall Study|Withdrawal by Subject|1|||
27906823|NCT01763827|81496781|FG001|Overall Study|Withdrawal by Subject|0|||
27906824|NCT01763827|81496782|FG002|Overall Study|Withdrawal by Subject|0|||
27906825|NCT01763827|81496783|FG003|Overall Study|Withdrawal by Subject|0|||
27906826|NCT01763827|81496784|FG004|Overall Study|Withdrawal by Subject|2|||
27906827|NCT01763827|81496785|FG005|Overall Study|Withdrawal by Subject|0|||
27514727|NCT00202878|80077707|FG000|Overall Study|Site Closure|39|||
27514728|NCT00202878|80077708|FG001|Overall Study|Site Closure|36|||
27514729|NCT00202878|80077707|FG000|Overall Study|Withdrawal by Subject|795|||
27514730|NCT00202878|80077708|FG001|Overall Study|Withdrawal by Subject|808|||
27615667|NCT00976703|80434318|FG001|Overall Study|ineligible for study|2|||
27906828|NCT01763827|81496780|FG000|Overall Study|Decision by sponsor|2|||
27906829|NCT01763827|81496781|FG001|Overall Study|Decision by sponsor|0|||
27514731|NCT01497366|80077709|FG000|Overall Study|Virologic failure|2|||
27514732|NCT01497366|80077710|FG001|Overall Study|Virologic failure|50|||
27514733|NCT01497366|80077709|FG000|Overall Study|Lost to Follow-up|11|||
27514734|NCT01497366|80077710|FG001|Overall Study|Lost to Follow-up|10|||
27514735|NCT01497366|80077709|FG000|Overall Study|Withdrawal by Subject|6|||
27906830|NCT01763827|81496782|FG002|Overall Study|Decision by sponsor|3|||
27906831|NCT01763827|81496783|FG003|Overall Study|Decision by sponsor|0|||
27906832|NCT01763827|81496784|FG004|Overall Study|Decision by sponsor|2|||
27906833|NCT01763827|81496785|FG005|Overall Study|Decision by sponsor|1|||
27906834|NCT01763827|81496780|FG000|Overall Study|Lost to Follow-up|0|||
27906835|NCT01763827|81496781|FG001|Overall Study|Lost to Follow-up|1|||
27615668|NCT00972179|80434322|FG000|Overall Study|Noncompliance|1|||
27615669|NCT00972179|80434323|FG001|Overall Study|Noncompliance|0|||
27615670|NCT00972179|80434324|FG002|Overall Study|Noncompliance|0|||
27615671|NCT00972179|80434325|FG003|Overall Study|Noncompliance|0|||
27615672|NCT00972179|80434326|FG004|Overall Study|Noncompliance|1|||
27615673|NCT00972179|80434327|FG005|Overall Study|Noncompliance|0|||
27615674|NCT00972179|80434328|FG006|Overall Study|Noncompliance|1|||
27615675|NCT00972179|80434322|FG000|Overall Study|Withdrawal by Subject|0|||
27615676|NCT00972179|80434323|FG001|Overall Study|Withdrawal by Subject|3|||
27615677|NCT00972179|80434324|FG002|Overall Study|Withdrawal by Subject|0|||
27615678|NCT00972179|80434325|FG003|Overall Study|Withdrawal by Subject|1|||
27615679|NCT00972179|80434326|FG004|Overall Study|Withdrawal by Subject|0|||
27615680|NCT00972179|80434327|FG005|Overall Study|Withdrawal by Subject|0|||
27615681|NCT00972179|80434328|FG006|Overall Study|Withdrawal by Subject|2|||
27615682|NCT00972179|80434322|FG000|Overall Study|Administrative Decision|0|||
27615683|NCT00972179|80434323|FG001|Overall Study|Administrative Decision|0|||
27615684|NCT00972179|80434324|FG002|Overall Study|Administrative Decision|0|||
27615685|NCT00972179|80434325|FG003|Overall Study|Administrative Decision|0|||
27615686|NCT00972179|80434326|FG004|Overall Study|Administrative Decision|1|||
27615687|NCT00972179|80434327|FG005|Overall Study|Administrative Decision|0|||
27615688|NCT00972179|80434328|FG006|Overall Study|Administrative Decision|0|||
27615689|NCT00972179|80434322|FG000|Overall Study|Lost to Follow-up|0|||
27615690|NCT00972179|80434323|FG001|Overall Study|Lost to Follow-up|0|||
27615691|NCT00972179|80434324|FG002|Overall Study|Lost to Follow-up|1|||
27615692|NCT00972179|80434325|FG003|Overall Study|Lost to Follow-up|0|||
27615693|NCT00972179|80434326|FG004|Overall Study|Lost to Follow-up|0|||
27615694|NCT00972179|80434327|FG005|Overall Study|Lost to Follow-up|3|||
27615695|NCT00972179|80434328|FG006|Overall Study|Lost to Follow-up|1|||
27615696|NCT03257995|80434329|FG000|Overall Study|Adverse Event|0|||
27615697|NCT03257995|80434330|FG001|Overall Study|Adverse Event|1|||
27615698|NCT03257995|80434331|FG002|Overall Study|Adverse Event|0|||
27615699|NCT03257995|80434332|FG003|Overall Study|Adverse Event|0|||
27615700|NCT03257995|80434333|FG004|Overall Study|Adverse Event|0|||
27615701|NCT03257995|80434334|FG005|Overall Study|Adverse Event|0|||
27615702|NCT03257995|80434329|FG000|Overall Study|Protocol deviation|0|||
27615703|NCT03257995|80434330|FG001|Overall Study|Protocol deviation|0|||
27615704|NCT03257995|80434331|FG002|Overall Study|Protocol deviation|0|||
27615705|NCT03257995|80434332|FG003|Overall Study|Protocol deviation|0|||
27615706|NCT03257995|80434333|FG004|Overall Study|Protocol deviation|0|||
27615707|NCT03257995|80434334|FG005|Overall Study|Protocol deviation|2|||
27615708|NCT00312858|80434335|FG000|Overall Study|Adverse Event|0|||
27615709|NCT00312858|80434336|FG001|Overall Study|Adverse Event|1|||
27615710|NCT00312858|80434335|FG000|Overall Study|Lost to Follow-up|25|||
27853217|NCT02858492|81294986|FG000|Overall Study|Adverse Event|0|||
27853218|NCT02858492|81294987|FG001|Overall Study|Adverse Event|0|||
27853219|NCT02858492|81294988|FG002|Overall Study|Adverse Event|0|||
27853220|NCT02858492|81294989|FG003|Overall Study|Adverse Event|3|||
27853221|NCT02858492|81294986|FG000|Overall Study|Lack of Efficacy|0|||
27853222|NCT02858492|81294987|FG001|Overall Study|Lack of Efficacy|0|||
27906836|NCT01763827|81496782|FG002|Overall Study|Lost to Follow-up|1|||
27906837|NCT01763827|81496783|FG003|Overall Study|Lost to Follow-up|1|||
27906838|NCT01763827|81496784|FG004|Overall Study|Lost to Follow-up|2|||
27906839|NCT01763827|81496785|FG005|Overall Study|Lost to Follow-up|1|||
27906840|NCT02779075|81496786|FG000|Overall Study|Withdrawal by Subject|1|||
27906841|NCT02779075|81496787|FG001|Overall Study|Withdrawal by Subject|3|||
27906842|NCT02779075|81496786|FG000|Overall Study|IV lost during 2nd study|1|||
27906843|NCT02779075|81496787|FG001|Overall Study|IV lost during 2nd study|0|||
27906844|NCT01429441|81496789|FG000|Overall Study|Adverse Event|5|||
27906845|NCT01429441|81496790|FG001|Overall Study|Adverse Event|1|||
27906846|NCT01429441|81496789|FG000|Overall Study|Death|0|||
27615711|NCT00312858|80434336|FG001|Overall Study|Lost to Follow-up|42|||
27615712|NCT00312858|80434335|FG000|Overall Study|Protocol Violation|3|||
27615713|NCT00312858|80434336|FG001|Overall Study|Protocol Violation|8|||
27615714|NCT00312858|80434335|FG000|Overall Study|Withdraw by Participant|20|||
27615715|NCT00312858|80434336|FG001|Overall Study|Withdraw by Participant|20|||
27615716|NCT00312858|80434335|FG000|Overall Study|Participant Moved|11|||
27615717|NCT00312858|80434336|FG001|Overall Study|Participant Moved|10|||
27615718|NCT00312858|80434335|FG000|Overall Study|Other|9|||
27853223|NCT02858492|81294988|FG002|Overall Study|Lack of Efficacy|0|||
27615719|NCT00312858|80434336|FG001|Overall Study|Other|12|||
27615720|NCT03285113|80434338|FG000|Overall Study|Unable to implant leads|2|||
27615721|NCT02838628|80434339|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
27906847|NCT01429441|81496790|FG001|Overall Study|Death|2|||
27906848|NCT01429441|81496789|FG000|Overall Study|Lost to Follow-up|5|||
27906849|NCT01429441|81496790|FG001|Overall Study|Lost to Follow-up|2|||
27906850|NCT01429441|81496789|FG000|Overall Study|Physician Decision|1|||
27906851|NCT01429441|81496790|FG001|Overall Study|Physician Decision|0|||
27906852|NCT01429441|81496789|FG000|Overall Study|Withdrawal by Subject|27|||
27906853|NCT01429441|81496790|FG001|Overall Study|Withdrawal by Subject|18|||
27906854|NCT04854057|81496791|FG000|Overall Study|Adverse Event|0|||
27906855|NCT04854057|81496792|FG001|Overall Study|Adverse Event|1|||
27906856|NCT03333486|81496793|FG000|Overall Study|Withdrawal by Subject|1|||
27906857|NCT03333486|81496793|FG000|Overall Study|Lost to Follow-up|1|||
27906858|NCT00593606|81496795|FG000|Overall Study|Adverse Event|13|||
27906859|NCT00593606|81496795|FG000|Overall Study|Withdrawal by Subject|1|||
27906860|NCT00593606|81496795|FG000|Overall Study|Protocol Violation|3|||
27906861|NCT00593606|81496795|FG000|Overall Study|Lost to Follow-up|2|||
27906862|NCT00593606|81496795|FG000|Overall Study|Run-In Failure|5|||
27906863|NCT00593606|81496795|FG000|Overall Study|Screen Failure|3|||
27906864|NCT00187278|81496797|FG000|Overall Study|Protocol Violation|10|||
27906865|NCT00187278|81496798|FG001|Overall Study|Protocol Violation|13|||
27906866|NCT01693185|81496799|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
27906867|NCT01693185|81496800|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
27906868|NCT01937884|81496801|FG000|Overall Study|Withdrawal by Subject|1|||
27906869|NCT01937884|81496802|FG001|Overall Study|Withdrawal by Subject|0|||
27906870|NCT04391842|81496806|FG000|Overall Study|Withdrawal by Subject|2|||
27906871|NCT04035499|81496809|FG000|Overall Study|Death|2|||
27906872|NCT04035499|81496809|FG000|Overall Study|Withdrawal by Subject|1|||
27906873|NCT00313586|81496810|FG000|Overall Study|Disease progression|14|||
27906874|NCT00313586|81496811|FG001|Overall Study|Disease progression|19|||
27906875|NCT00313586|81496812|FG002|Overall Study|Disease progression|10|||
27906876|NCT00313586|81496813|FG003|Overall Study|Disease progression|3|||
27906877|NCT00313586|81496810|FG000|Overall Study|Adverse Event|12|||
27906878|NCT00313586|81496811|FG001|Overall Study|Adverse Event|18|||
27906879|NCT00313586|81496812|FG002|Overall Study|Adverse Event|3|||
27906880|NCT00313586|81496813|FG003|Overall Study|Adverse Event|10|||
27906881|NCT00313586|81496810|FG000|Overall Study|Death|11|||
27906882|NCT00313586|81496811|FG001|Overall Study|Death|8|||
27906883|NCT00313586|81496812|FG002|Overall Study|Death|1|||
27906884|NCT00313586|81496813|FG003|Overall Study|Death|7|||
27906885|NCT00313586|81496810|FG000|Overall Study|Withdrawal by Subject|13|||
27906886|NCT00313586|81496811|FG001|Overall Study|Withdrawal by Subject|6|||
27906887|NCT00313586|81496812|FG002|Overall Study|Withdrawal by Subject|6|||
27906888|NCT00313586|81496813|FG003|Overall Study|Withdrawal by Subject|2|||
27906889|NCT00313586|81496810|FG000|Overall Study|Alternative therapy|3|||
27906890|NCT00313586|81496811|FG001|Overall Study|Alternative therapy|6|||
27906891|NCT00313586|81496812|FG002|Overall Study|Alternative therapy|2|||
27906892|NCT00313586|81496813|FG003|Overall Study|Alternative therapy|0|||
27906893|NCT00313586|81496810|FG000|Overall Study|Other complicating disease|2|||
27906894|NCT00313586|81496811|FG001|Overall Study|Other complicating disease|2|||
27906895|NCT00313586|81496812|FG002|Overall Study|Other complicating disease|0|||
27514736|NCT01497366|80077710|FG001|Overall Study|Withdrawal by Subject|6|||
27514737|NCT01497366|80077709|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
27514738|NCT01497366|80077710|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
27514739|NCT01497366|80077709|FG000|Overall Study|Other|5|||
27514740|NCT01497366|80077710|FG001|Overall Study|Other|0|||
27853224|NCT02858492|81294989|FG003|Overall Study|Lack of Efficacy|1|||
27853225|NCT02858492|81294986|FG000|Overall Study|Protocol defined stopping criteria|0|||
27853226|NCT02858492|81294987|FG001|Overall Study|Protocol defined stopping criteria|0|||
27853227|NCT02858492|81294988|FG002|Overall Study|Protocol defined stopping criteria|0|||
27853228|NCT02858492|81294989|FG003|Overall Study|Protocol defined stopping criteria|1|||
27853229|NCT00444457|81294995|FG000|Infant Series|Other|0|||
27853230|NCT00444457|81294996|FG001|Infant Series|Other|1|||
27853231|NCT00444457|81294997|FG002|Infant Series|Other|0|||
27906896|NCT00313586|81496813|FG003|Overall Study|Other complicating disease|0|||
27906897|NCT00313586|81496810|FG000|Overall Study|Did not achieve HI-major/better response|10|||
27906898|NCT00313586|81496811|FG001|Overall Study|Did not achieve HI-major/better response|7|||
27853232|NCT00444457|81294998|FG003|Infant Series|Other|0|||
27853233|NCT00444457|81294995|FG000|Infant Series|Parent or legal guardian request|18|||
27853234|NCT00444457|81294996|FG001|Infant Series|Parent or legal guardian request|29|||
27906899|NCT00313586|81496812|FG002|Overall Study|Did not achieve HI-major/better response|2|||
27906900|NCT00313586|81496813|FG003|Overall Study|Did not achieve HI-major/better response|1|||
27906901|NCT00313586|81496810|FG000|Overall Study|Physician Decision|2|||
27906902|NCT00313586|81496811|FG001|Overall Study|Physician Decision|1|||
27906903|NCT00313586|81496812|FG002|Overall Study|Physician Decision|0|||
27906904|NCT00313586|81496813|FG003|Overall Study|Physician Decision|0|||
27906905|NCT00313586|81496810|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
27906906|NCT00313586|81496811|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
27906907|NCT00313586|81496812|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
27514741|NCT01497366|80077709|FG000|Overall Study|Death|1|||
27906908|NCT00313586|81496813|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
27906909|NCT00313586|81496810|FG000|Overall Study|Lost insurance|0|||
27615722|NCT02838628|80434340|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
27615723|NCT02838628|80434339|FG000|Recurrence Follow-up Period|Adverse Event|1|||
27615724|NCT02838628|80434340|FG001|Recurrence Follow-up Period|Adverse Event|0|||
27615725|NCT02838628|80434339|FG000|Recurrence Follow-up Period|Non-compliance|0|||
27615726|NCT02838628|80434340|FG001|Recurrence Follow-up Period|Non-compliance|1|||
27615727|NCT02838628|80434339|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
27615728|NCT02838628|80434340|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
27615729|NCT02838628|80434339|FG000|Recurrence Follow-up Period|Other un-specified|1|||
27514742|NCT01497366|80077710|FG001|Overall Study|Death|1|||
27514743|NCT01497366|80077709|FG000|Overall Study|Randomized but not treated|7|||
27514744|NCT01497366|80077710|FG001|Overall Study|Randomized but not treated|21|||
27514745|NCT01950013|80077711|FG000|Overall Study|Withdrawal by Subject|0|||
27514746|NCT01950013|80077712|FG001|Overall Study|Withdrawal by Subject|2|||
27514747|NCT01950013|80077713|FG002|Overall Study|Withdrawal by Subject|0|||
27514748|NCT01026324|80077714|FG000|Follow up/Survival|Withdrawal by Subject|1|||
27514749|NCT01026324|80077715|FG001|Follow up/Survival|Withdrawal by Subject|0|||
27514750|NCT01026324|80077716|FG002|Follow up/Survival|Withdrawal by Subject|0|||
27514751|NCT02424578|80077717|FG000|Overall Study|Withdrawal by Subject|0|||
27514752|NCT02424578|80077718|FG001|Overall Study|Withdrawal by Subject|1|||
27514753|NCT01262820|80077719|FG000|Overall Study|Adverse Event|5|||
27615730|NCT02838628|80434340|FG001|Recurrence Follow-up Period|Other un-specified|1|||
27615731|NCT01804816|80434341|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
27615732|NCT01804816|80434341|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
27615733|NCT00967018|80434346|FG000|Overall Study|Adverse Event|2|||
27615734|NCT00967018|80434346|FG000|Overall Study|Physician Decision|7|||
27615735|NCT00967018|80434346|FG000|Overall Study|Lost to Follow-up|2|||
27615736|NCT00967018|80434346|FG000|Overall Study|Withdrawal by Subject|1|||
27615737|NCT00967018|80434346|FG000|Overall Study|Miscellaneous Reasons|9|||
27615738|NCT02954575|80434348|FG000|Overall Study|Withdrawal by Subject|2|||
27615739|NCT02954575|80434348|FG000|Overall Study|Adverse Event|1|||
27615740|NCT00802841|80434350|FG000|Overall Study|Administrative problems|1|||
27615741|NCT00802841|80434351|FG001|Overall Study|Administrative problems|0|||
27615742|NCT00802841|80434350|FG000|Overall Study|Lost to Follow-up|2|||
27615743|NCT00802841|80434351|FG001|Overall Study|Lost to Follow-up|1|||
27615744|NCT00802841|80434350|FG000|Overall Study|Death|1|||
27615745|NCT00802841|80434351|FG001|Overall Study|Death|2|||
27615746|NCT00802841|80434350|FG000|Overall Study|Adverse Event|8|||
27615747|NCT00802841|80434351|FG001|Overall Study|Adverse Event|2|||
27615748|NCT00802841|80434350|FG000|Overall Study|Disease progression|7|||
27615749|NCT00802841|80434351|FG001|Overall Study|Disease progression|3|||
27615750|NCT00802841|80434350|FG000|Overall Study|Withdrawal by Subject|9|||
27615751|NCT00802841|80434351|FG001|Overall Study|Withdrawal by Subject|5|||
27615752|NCT00802841|80434350|FG000|Overall Study|Protocol deviation|2|||
27615753|NCT00802841|80434351|FG001|Overall Study|Protocol deviation|6|||
27615754|NCT00802841|80434350|FG000|Overall Study|Treatment duration completed|66|||
27615755|NCT00802841|80434351|FG001|Overall Study|Treatment duration completed|76|||
27615756|NCT02836613|80434352|FG000|Overall Study|Accidental drowning|1|||
27615757|NCT02836613|80434353|FG001|Overall Study|Accidental drowning|0|||
27615758|NCT02836613|80434352|FG000|Overall Study|Lost to Follow-up|0|||
27615759|NCT02836613|80434353|FG001|Overall Study|Lost to Follow-up|1|||
27615760|NCT02836613|80434352|FG000|Overall Study|Withdrawal by Subject|0|||
27615761|NCT02836613|80434353|FG001|Overall Study|Withdrawal by Subject|2|||
27615762|NCT00180713|80434359|FG000|Overall Study|Withdrawal by Subject|2|||
27615763|NCT00180713|80434360|FG001|Overall Study|Withdrawal by Subject|0|||
27615764|NCT00180713|80434359|FG000|Overall Study|Adverse Event|3|||
27615765|NCT00180713|80434360|FG001|Overall Study|Adverse Event|3|||
27615766|NCT00211237|80434363|FG000|Baseline|Withdrew|1|||
27615767|NCT00211237|80434364|FG001|Baseline|Withdrew|3|||
27615768|NCT00211237|80434365|FG002|Baseline|Withdrew|0|||
27853235|NCT00444457|81294997|FG002|Infant Series|Parent or legal guardian request|34|||
27853236|NCT00444457|81294998|FG003|Infant Series|Parent or legal guardian request|14|||
27853237|NCT00444457|81294995|FG000|Infant Series|Lost to Follow-up|10|||
27853238|NCT00444457|81294996|FG001|Infant Series|Lost to Follow-up|11|||
27853239|NCT00444457|81294997|FG002|Infant Series|Lost to Follow-up|7|||
27853240|NCT00444457|81294998|FG003|Infant Series|Lost to Follow-up|6|||
27853241|NCT00444457|81294995|FG000|Infant Series|Protocol Violation|16|||
27853242|NCT00444457|81294996|FG001|Infant Series|Protocol Violation|8|||
27615769|NCT00211237|80434363|FG000|Baseline|Refused random assignment|1|||
27853243|NCT00444457|81294997|FG002|Infant Series|Protocol Violation|6|||
27853244|NCT00444457|81294998|FG003|Infant Series|Protocol Violation|3|||
27853245|NCT00444457|81294995|FG000|Infant Series|Failed to return|5|||
27853246|NCT00444457|81294996|FG001|Infant Series|Failed to return|4|||
27615770|NCT00211237|80434364|FG001|Baseline|Refused random assignment|0|||
27615771|NCT00211237|80434365|FG002|Baseline|Refused random assignment|0|||
27615772|NCT00211237|80434363|FG000|1 Month|Death|2|||
27514754|NCT01262820|80077719|FG000|Overall Study|Lack of Efficacy|9|||
27514755|NCT01262820|80077719|FG000|Overall Study|Drug held for 21+ days|1|||
27514756|NCT03023813|80077724|FG000|Overall Study|Lost to Follow-up|1|||
27514757|NCT03023813|80077725|FG001|Overall Study|Lost to Follow-up|2|||
27514758|NCT03023813|80077726|FG002|Overall Study|Lost to Follow-up|0|||
27853247|NCT00444457|81294997|FG002|Infant Series|Failed to return|4|||
27853248|NCT00444457|81294998|FG003|Infant Series|Failed to return|2|||
27853249|NCT00444457|81294995|FG000|Infant Series|Investigator request|4|||
27853250|NCT00444457|81294996|FG001|Infant Series|Investigator request|3|||
27514759|NCT03773796|80077727|FG000|Overall Study|Adverse Event|1|||
27514760|NCT03773796|80077727|FG000|Overall Study|Withdrawal by Subject|1|||
27514761|NCT03773796|80077727|FG000|Overall Study|Lack of Efficacy|1|||
27514762|NCT01071798|80077734|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
27514763|NCT01071798|80077734|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
27514764|NCT01071798|80077734|FG000|Participants Who Received One Cycle|Patient requirement|20|||
27514765|NCT01071798|80077734|FG000|Participants Who Received One Cycle|Death|5|||
27514766|NCT01071798|80077734|FG000|Participants Who Received One Cycle|Change of therapy|6|||
27514767|NCT01071798|80077734|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
27514768|NCT01071798|80077734|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
27514769|NCT01071798|80077734|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
27514770|NCT01071798|80077734|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
27514771|NCT01071798|80077734|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
27514772|NCT00233064|80077737|FG000|Overall Study|Lost to Follow-up|7|||
27514773|NCT00233064|80077738|FG001|Overall Study|Lost to Follow-up|7|||
27514774|NCT00233064|80077737|FG000|Overall Study|Withdrawal by Subject|5|||
27514775|NCT00233064|80077738|FG001|Overall Study|Withdrawal by Subject|3|||
27514776|NCT00233064|80077737|FG000|Overall Study|Death|0|||
27514777|NCT00233064|80077738|FG001|Overall Study|Death|1|||
27514778|NCT00233064|80077737|FG000|Overall Study|Relocation|0|||
27514779|NCT00233064|80077738|FG001|Overall Study|Relocation|1|||
27514780|NCT00233064|80077737|FG000|Overall Study|Protocol Violation|1|||
27514781|NCT00233064|80077738|FG001|Overall Study|Protocol Violation|0|||
27514782|NCT00233064|80077737|FG000|Overall Study|Moved to Dom. Republic|1|||
27514783|NCT00233064|80077738|FG001|Overall Study|Moved to Dom. Republic|0|||
27514784|NCT00539864|80077743|FG000|Overall Study|Lost to Follow-up|0|||
27514785|NCT00539864|80077744|FG001|Overall Study|Lost to Follow-up|1|||
27514786|NCT00539864|80077743|FG000|Overall Study|Withdrawal by Subject|1|||
27514787|NCT00539864|80077744|FG001|Overall Study|Withdrawal by Subject|1|||
27514788|NCT00330967|80077745|FG000|Overall Study|Withdrawal by Subject|0|||
27514789|NCT00330967|80077746|FG001|Overall Study|Withdrawal by Subject|5|||
27514790|NCT00330967|80077745|FG000|Overall Study|Physician Decision|0|||
27514791|NCT00330967|80077746|FG001|Overall Study|Physician Decision|9|||
27514792|NCT00485134|80077748|FG000|Overall Study|Lost to Follow-up|1|||
27514793|NCT00485134|80077749|FG001|Overall Study|Lost to Follow-up|0|||
27514794|NCT00485134|80077750|FG002|Overall Study|Lost to Follow-up|0|||
27514795|NCT00485134|80077751|FG003|Overall Study|Lost to Follow-up|0|||
27514796|NCT00485134|80077752|FG004|Overall Study|Lost to Follow-up|0|||
27514797|NCT00485134|80077753|FG005|Overall Study|Lost to Follow-up|0|||
27514798|NCT00485134|80077754|FG006|Overall Study|Lost to Follow-up|0|||
27514799|NCT00485134|80077755|FG007|Overall Study|Lost to Follow-up|0|||
27514800|NCT00485134|80077748|FG000|Overall Study|Withdrawal by Subject|0|||
27615773|NCT00211237|80434364|FG001|1 Month|Death|1|||
27853251|NCT00444457|81294997|FG002|Infant Series|Investigator request|3|||
27853252|NCT00444457|81294998|FG003|Infant Series|Investigator request|2|||
27853253|NCT00444457|81294995|FG000|Infant Series|Other|0|||
27853254|NCT00444457|81294996|FG001|Infant Series|Other|2|||
27853255|NCT00444457|81294997|FG002|Infant Series|Other|4|||
27853256|NCT00444457|81294998|FG003|Infant Series|Other|0|||
27853257|NCT00444457|81294995|FG000|Infant Series|Adverse Event|1|||
27853258|NCT00444457|81294996|FG001|Infant Series|Adverse Event|2|||
27853259|NCT00444457|81294997|FG002|Infant Series|Adverse Event|2|||
27853260|NCT00444457|81294998|FG003|Infant Series|Adverse Event|0|||
27853261|NCT00444457|81294995|FG000|Infant Series|Death|0|||
27853262|NCT00444457|81294996|FG001|Infant Series|Death|1|||
27853263|NCT00444457|81294997|FG002|Infant Series|Death|1|||
27853264|NCT00444457|81294998|FG003|Infant Series|Death|1|||
27853265|NCT00444457|81294995|FG000|After Infant Series|Other|0|||
27853266|NCT00444457|81294996|FG001|After Infant Series|Other|1|||
27615774|NCT00211237|80434365|FG002|1 Month|Death|0|||
27728713|NCT01126580|80838092|FG002|Overall Study|Protocol Violation|2|||
27514801|NCT00485134|80077749|FG001|Overall Study|Withdrawal by Subject|1|||
27514802|NCT00485134|80077750|FG002|Overall Study|Withdrawal by Subject|0|||
27514803|NCT00485134|80077751|FG003|Overall Study|Withdrawal by Subject|0|||
27514804|NCT00485134|80077752|FG004|Overall Study|Withdrawal by Subject|0|||
27514805|NCT00485134|80077753|FG005|Overall Study|Withdrawal by Subject|0|||
27514806|NCT00485134|80077754|FG006|Overall Study|Withdrawal by Subject|0|||
27853267|NCT00444457|81294997|FG002|After Infant Series|Other|1|||
27853268|NCT00444457|81294998|FG003|After Infant Series|Other|1|||
27514807|NCT00485134|80077755|FG007|Overall Study|Withdrawal by Subject|0|||
27615775|NCT00211237|80434363|FG000|1 Month|Lost to Follow-up|0|||
27853269|NCT00444457|81294995|FG000|After Infant Series|Parent or legal guardian request|4|||
27906910|NCT00313586|81496811|FG001|Overall Study|Lost insurance|1|||
27615776|NCT00211237|80434364|FG001|1 Month|Lost to Follow-up|2|||
27615777|NCT00211237|80434365|FG002|1 Month|Lost to Follow-up|0|||
27615778|NCT00211237|80434363|FG000|1 Month|Withdrew|0|||
27615779|NCT00211237|80434364|FG001|1 Month|Withdrew|4|||
27615780|NCT00211237|80434365|FG002|1 Month|Withdrew|0|||
27615781|NCT00211237|80434363|FG000|1 Month|Additional surgery needed|1|||
27615782|NCT00211237|80434364|FG001|1 Month|Additional surgery needed|0|||
27615783|NCT00211237|80434365|FG002|1 Month|Additional surgery needed|0|||
27615784|NCT00211237|80434363|FG000|1 Month|Non-medical problem|0|||
27615785|NCT00211237|80434364|FG001|1 Month|Non-medical problem|2|||
27615786|NCT00211237|80434365|FG002|1 Month|Non-medical problem|0|||
27615787|NCT00211237|80434363|FG000|3 Months|Death|7|||
27615788|NCT00211237|80434364|FG001|3 Months|Death|3|||
27615789|NCT00211237|80434365|FG002|3 Months|Death|0|||
27615790|NCT00211237|80434363|FG000|3 Months|Could not comply with protocol|1|||
27615791|NCT00211237|80434364|FG001|3 Months|Could not comply with protocol|0|||
27514808|NCT00485134|80077748|FG000|Overall Study|Change in health status|0|||
27615792|NCT00211237|80434365|FG002|3 Months|Could not comply with protocol|0|||
27615793|NCT00211237|80434363|FG000|3 Months|Withdrew|0|||
27615794|NCT00211237|80434364|FG001|3 Months|Withdrew|1|||
27615795|NCT00211237|80434365|FG002|3 Months|Withdrew|0|||
27615796|NCT00211237|80434363|FG000|3 Months|Non-medical problem|0|||
27615797|NCT00211237|80434364|FG001|3 Months|Non-medical problem|0|||
27615798|NCT00211237|80434365|FG002|3 Months|Non-medical problem|1|||
27615799|NCT00211237|80434363|FG000|6 Months|Death|6|||
27615800|NCT00211237|80434364|FG001|6 Months|Death|0|||
27615801|NCT00211237|80434365|FG002|6 Months|Death|3|||
27615802|NCT00211237|80434363|FG000|6 Months|Lost to Follow-up|2|||
27615803|NCT00211237|80434364|FG001|6 Months|Lost to Follow-up|0|||
27615804|NCT00211237|80434365|FG002|6 Months|Lost to Follow-up|0|||
27615805|NCT00211237|80434363|FG000|6 Months|Could not comply with protocol|0|||
27615806|NCT00211237|80434364|FG001|6 Months|Could not comply with protocol|2|||
27615807|NCT00211237|80434365|FG002|6 Months|Could not comply with protocol|0|||
27615808|NCT00211237|80434363|FG000|12 Months|Death|8|||
27615809|NCT00211237|80434364|FG001|12 Months|Death|2|||
27514809|NCT00485134|80077749|FG001|Overall Study|Change in health status|1|||
27514810|NCT00485134|80077750|FG002|Overall Study|Change in health status|2|||
27514811|NCT00485134|80077751|FG003|Overall Study|Change in health status|1|||
27514812|NCT00485134|80077752|FG004|Overall Study|Change in health status|0|||
27514813|NCT00485134|80077753|FG005|Overall Study|Change in health status|1|||
27514814|NCT00485134|80077754|FG006|Overall Study|Change in health status|0|||
27514815|NCT00485134|80077755|FG007|Overall Study|Change in health status|0|||
27514816|NCT00485134|80077748|FG000|Overall Study|Withdrew for adverse event|0|||
27514817|NCT00485134|80077749|FG001|Overall Study|Withdrew for adverse event|0|||
27514818|NCT00485134|80077750|FG002|Overall Study|Withdrew for adverse event|1|||
27514819|NCT00485134|80077751|FG003|Overall Study|Withdrew for adverse event|0|||
27514820|NCT00485134|80077752|FG004|Overall Study|Withdrew for adverse event|0|||
27514821|NCT00485134|80077753|FG005|Overall Study|Withdrew for adverse event|0|||
27615810|NCT00211237|80434365|FG002|12 Months|Death|3|||
27615811|NCT00211237|80434363|FG000|12 Months|Lost to Follow-up|1|||
27615812|NCT00211237|80434364|FG001|12 Months|Lost to Follow-up|0|||
27615813|NCT00211237|80434365|FG002|12 Months|Lost to Follow-up|1|||
27615814|NCT00211237|80434363|FG000|12 Months|Withdrew|0|||
27615815|NCT00211237|80434364|FG001|12 Months|Withdrew|0|||
27615816|NCT00211237|80434365|FG002|12 Months|Withdrew|1|||
27615817|NCT00211237|80434363|FG000|12 Months|unrelated medical problem|0|||
27615818|NCT00211237|80434364|FG001|12 Months|unrelated medical problem|0|||
27615819|NCT00211237|80434365|FG002|12 Months|unrelated medical problem|1|||
27615820|NCT02248961|80434367|FG000|Overall Study|Adverse Event|1|||
27615821|NCT02248961|80434368|FG001|Overall Study|Adverse Event|0|||
27615822|NCT02248961|80434367|FG000|Overall Study|Withdrawal by Subject|1|||
27615823|NCT02248961|80434368|FG001|Overall Study|Withdrawal by Subject|2|||
27615824|NCT02248961|80434367|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
27615825|NCT02248961|80434368|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
27615826|NCT04213989|80434382|FG000|Overall Study|Withdrawal by Subject|3|||
27615827|NCT04213989|80434383|FG001|Overall Study|Withdrawal by Subject|2|||
27615828|NCT04213989|80434382|FG000|Overall Study|Physician Decision|1|||
27615829|NCT04213989|80434383|FG001|Overall Study|Physician Decision|0|||
27514822|NCT00485134|80077754|FG006|Overall Study|Withdrew for adverse event|0|||
27615830|NCT04213989|80434382|FG000|Overall Study|Lost to Follow-up|0|||
27615831|NCT04213989|80434383|FG001|Overall Study|Lost to Follow-up|4|||
27615832|NCT04781647|80434384|FG000|Overall Study|Study terminated by Sponsor|11|||
27615833|NCT04781647|80434385|FG001|Overall Study|Study terminated by Sponsor|9|||
27615834|NCT04781647|80434386|FG002|Overall Study|Study terminated by Sponsor|9|||
27615835|NCT04781647|80434384|FG000|Overall Study|Withdrawal by Subject|1|||
27615836|NCT04781647|80434385|FG001|Overall Study|Withdrawal by Subject|2|||
27615837|NCT04781647|80434386|FG002|Overall Study|Withdrawal by Subject|0|||
27615838|NCT04781647|80434384|FG000|Overall Study|Adverse Event|0|||
27615839|NCT04781647|80434385|FG001|Overall Study|Adverse Event|1|||
27615840|NCT04781647|80434386|FG002|Overall Study|Adverse Event|1|||
27615841|NCT04781647|80434384|FG000|Overall Study|Protocol Violation|1|||
27615842|NCT04781647|80434385|FG001|Overall Study|Protocol Violation|0|||
27615843|NCT04781647|80434386|FG002|Overall Study|Protocol Violation|0|||
27615844|NCT04781647|80434384|FG000|Overall Study|Pregnancy|0|||
27615845|NCT04781647|80434385|FG001|Overall Study|Pregnancy|0|||
27615846|NCT04781647|80434386|FG002|Overall Study|Pregnancy|1|||
27615847|NCT04781647|80434384|FG000|Overall Study|Virology rebounded|1|||
27615848|NCT04781647|80434385|FG001|Overall Study|Virology rebounded|0|||
27615849|NCT04781647|80434386|FG002|Overall Study|Virology rebounded|0|||
27615850|NCT00007475|80434389|FG000|Overall Study|Withdrawal by Subject|1|||
27615851|NCT00007475|80434390|FG001|Overall Study|Withdrawal by Subject|0|||
27615852|NCT00007475|80434391|FG002|Overall Study|Withdrawal by Subject|0|||
27615853|NCT00007475|80434392|FG003|Overall Study|Withdrawal by Subject|0|||
27615854|NCT00007475|80434389|FG000|Overall Study|Adverse Event|3|||
27615855|NCT00007475|80434390|FG001|Overall Study|Adverse Event|0|||
27615856|NCT00007475|80434391|FG002|Overall Study|Adverse Event|0|||
27615857|NCT00007475|80434392|FG003|Overall Study|Adverse Event|0|||
27615858|NCT00451217|80437495|FG000|Overall Study|Lost to Follow-up|0|||
27615859|NCT00451217|80437496|FG001|Overall Study|Lost to Follow-up|1|||
27615860|NCT00451217|80437497|FG002|Overall Study|Lost to Follow-up|1|||
27615861|NCT00451217|80437498|FG003|Overall Study|Lost to Follow-up|1|||
27728714|NCT01126580|80838090|FG000|Overall Study|Lost to Follow-up|15|||
27728715|NCT01126580|80838091|FG001|Overall Study|Lost to Follow-up|13|||
27728716|NCT01126580|80838092|FG002|Overall Study|Lost to Follow-up|9|||
27728717|NCT01126580|80838090|FG000|Overall Study|Treatment Non-compliance|0|||
27514823|NCT00485134|80077755|FG007|Overall Study|Withdrew for adverse event|0|||
27514824|NCT00485134|80077748|FG000|Overall Study|Positive drug test|0|||
27514825|NCT00485134|80077749|FG001|Overall Study|Positive drug test|0|||
27514826|NCT00485134|80077750|FG002|Overall Study|Positive drug test|0|||
27514827|NCT00485134|80077751|FG003|Overall Study|Positive drug test|0|||
27514828|NCT00485134|80077752|FG004|Overall Study|Positive drug test|2|||
27514829|NCT00485134|80077753|FG005|Overall Study|Positive drug test|1|||
27514830|NCT00485134|80077754|FG006|Overall Study|Positive drug test|0|||
27514831|NCT00485134|80077755|FG007|Overall Study|Positive drug test|0|||
27514832|NCT00485134|80077748|FG000|Overall Study|Non-compliance|0|||
27514833|NCT00485134|80077749|FG001|Overall Study|Non-compliance|0|||
27514834|NCT00485134|80077750|FG002|Overall Study|Non-compliance|0|||
27514835|NCT00485134|80077751|FG003|Overall Study|Non-compliance|0|||
27514836|NCT00485134|80077752|FG004|Overall Study|Non-compliance|1|||
27514837|NCT00485134|80077753|FG005|Overall Study|Non-compliance|2|||
27514838|NCT00485134|80077754|FG006|Overall Study|Non-compliance|2|||
27514839|NCT00485134|80077755|FG007|Overall Study|Non-compliance|0|||
27514840|NCT00485134|80077748|FG000|Overall Study|Unable to comply with study schedule|0|||
27514841|NCT00485134|80077749|FG001|Overall Study|Unable to comply with study schedule|0|||
27514842|NCT00485134|80077750|FG002|Overall Study|Unable to comply with study schedule|0|||
27514843|NCT00485134|80077751|FG003|Overall Study|Unable to comply with study schedule|0|||
27514844|NCT00485134|80077752|FG004|Overall Study|Unable to comply with study schedule|0|||
27514845|NCT00485134|80077753|FG005|Overall Study|Unable to comply with study schedule|0|||
27514846|NCT00485134|80077754|FG006|Overall Study|Unable to comply with study schedule|0|||
27514847|NCT00485134|80077755|FG007|Overall Study|Unable to comply with study schedule|1|||
27514848|NCT00485134|80077748|FG000|Overall Study|Pregnancy|0|||
27514849|NCT00485134|80077749|FG001|Overall Study|Pregnancy|0|||
27514850|NCT00485134|80077750|FG002|Overall Study|Pregnancy|0|||
27514851|NCT00485134|80077751|FG003|Overall Study|Pregnancy|0|||
27514852|NCT00485134|80077752|FG004|Overall Study|Pregnancy|0|||
27514853|NCT00485134|80077753|FG005|Overall Study|Pregnancy|0|||
27514854|NCT00485134|80077754|FG006|Overall Study|Pregnancy|1|||
27514855|NCT00485134|80077755|FG007|Overall Study|Pregnancy|0|||
27514856|NCT02238080|80077759|FG000|Overall Study|Death|13|||
27514857|NCT02238080|80077759|FG000|Overall Study|Treatment interrupted|6|||
27514858|NCT02238080|80077759|FG000|Overall Study|Withdrawal by Subject|2|||
27514859|NCT02238080|80077759|FG000|Overall Study|Other|4|||
27514860|NCT01798849|80077760|FG000|Overall Study|Physician Decision|0|||
27514861|NCT01798849|80077761|FG001|Overall Study|Physician Decision|0|||
27514862|NCT01798849|80077762|FG002|Overall Study|Physician Decision|1|||
27514863|NCT00467753|80077766|FG000|Overall Study|Lost to Follow-up|1|||
27615862|NCT00451217|80437495|FG000|Overall Study|Withdrawal by Subject|1|||
27615863|NCT00451217|80437496|FG001|Overall Study|Withdrawal by Subject|0|||
27615864|NCT00451217|80437497|FG002|Overall Study|Withdrawal by Subject|0|||
27514864|NCT00467753|80077767|FG001|Overall Study|Lost to Follow-up|2|||
27514865|NCT00467753|80077766|FG000|Overall Study|Adverse Event|2|||
27906911|NCT00313586|81496812|FG002|Overall Study|Lost insurance|0|||
27906912|NCT00313586|81496813|FG003|Overall Study|Lost insurance|0|||
27514866|NCT00467753|80077767|FG001|Overall Study|Adverse Event|0|||
27514867|NCT00947882|80077771|FG000|Overall Study|Adverse Event|0|||
27615865|NCT00451217|80437498|FG003|Overall Study|Withdrawal by Subject|0|||
27615866|NCT00451217|80437495|FG000|Overall Study|Not Treated|1|||
27615867|NCT00451217|80437496|FG001|Overall Study|Not Treated|1|||
27514868|NCT00947882|80077772|FG001|Overall Study|Adverse Event|1|||
27514869|NCT00947882|80077773|FG002|Overall Study|Adverse Event|4|||
27615868|NCT00451217|80437497|FG002|Overall Study|Not Treated|3|||
27514870|NCT00947882|80077774|FG003|Overall Study|Adverse Event|4|||
27514871|NCT00947882|80077771|FG000|Overall Study|Withdrawal by Subject|2|||
27514872|NCT00947882|80077772|FG001|Overall Study|Withdrawal by Subject|0|||
27514873|NCT00947882|80077773|FG002|Overall Study|Withdrawal by Subject|8|||
27514874|NCT00947882|80077774|FG003|Overall Study|Withdrawal by Subject|2|||
27514875|NCT00947882|80077771|FG000|Overall Study|Protocol Violation|0|||
27514876|NCT00947882|80077772|FG001|Overall Study|Protocol Violation|0|||
27514877|NCT00947882|80077773|FG002|Overall Study|Protocol Violation|1|||
27514878|NCT00947882|80077774|FG003|Overall Study|Protocol Violation|0|||
27514879|NCT00947882|80077771|FG000|Overall Study|Lost to Follow-up|0|||
27514880|NCT00947882|80077772|FG001|Overall Study|Lost to Follow-up|2|||
27514881|NCT00947882|80077773|FG002|Overall Study|Lost to Follow-up|1|||
27514882|NCT00947882|80077774|FG003|Overall Study|Lost to Follow-up|0|||
27514883|NCT00947882|80077771|FG000|Overall Study|Other/Unknown|10|||
27514884|NCT00947882|80077772|FG001|Overall Study|Other/Unknown|13|||
27514885|NCT00947882|80077773|FG002|Overall Study|Other/Unknown|3|||
27514886|NCT00947882|80077774|FG003|Overall Study|Other/Unknown|6|||
27514887|NCT00947882|80077771|FG000|Overall Study|Trial Terminated by Sponsor|62|||
27514888|NCT00947882|80077772|FG001|Overall Study|Trial Terminated by Sponsor|61|||
27514889|NCT00947882|80077773|FG002|Overall Study|Trial Terminated by Sponsor|62|||
27514890|NCT00947882|80077774|FG003|Overall Study|Trial Terminated by Sponsor|70|||
27514891|NCT02442804|80077775|FG000|Overall Study|Withdrawal by Subject|0|||
27514892|NCT02442804|80077776|FG001|Overall Study|Withdrawal by Subject|1|||
27514893|NCT02442804|80077775|FG000|Overall Study|Adverse Event|1|||
27514894|NCT02442804|80077776|FG001|Overall Study|Adverse Event|0|||
27514895|NCT00661427|80077777|FG000|Overall Study|Adverse Event|5|||
27514896|NCT00661427|80077778|FG001|Overall Study|Adverse Event|5|||
27514897|NCT00661427|80077777|FG000|Overall Study|Patient not treated|0|||
27514898|NCT00661427|80077778|FG001|Overall Study|Patient not treated|2|||
27514899|NCT01712399|80077779|FG000|Overall Study|Lost to Follow-up|1|||
27514900|NCT01712399|80077779|FG000|Overall Study|Withdrawal by Subject|39|||
27514901|NCT01712399|80077779|FG000|Overall Study|Death|1|||
27514902|NCT01712399|80077779|FG000|Overall Study|Adverse Event|11|||
27514903|NCT01712399|80077779|FG000|Overall Study|Study closure|345|||
27514904|NCT01616693|80077780|FG000|Evaluated for Safety|Physician Decision|1|||
27514905|NCT01616693|80077781|FG001|Evaluated for Safety|Physician Decision|0|||
27514906|NCT01616693|80077782|FG002|Evaluated for Safety|Physician Decision|1|||
27514907|NCT01616693|80077783|FG003|Evaluated for Safety|Physician Decision|0|||
27514908|NCT01616693|80077780|FG000|Received Both Vaccines|Adverse Event|2|||
27514909|NCT01616693|80077781|FG001|Received Both Vaccines|Adverse Event|0|||
27514910|NCT01616693|80077782|FG002|Received Both Vaccines|Adverse Event|0|||
27514911|NCT01616693|80077783|FG003|Received Both Vaccines|Adverse Event|0|||
27514912|NCT01616693|80077780|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
27514913|NCT01616693|80077781|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
27514914|NCT01616693|80077782|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
27514915|NCT01616693|80077783|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
27514916|NCT01616693|80077780|FG000|Received Both Vaccines|Lost to Follow-up|4|||
27514917|NCT01616693|80077781|FG001|Received Both Vaccines|Lost to Follow-up|3|||
27514918|NCT01616693|80077782|FG002|Received Both Vaccines|Lost to Follow-up|4|||
27514919|NCT01616693|80077783|FG003|Received Both Vaccines|Lost to Follow-up|4|||
27514920|NCT01616693|80077780|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
27514921|NCT01616693|80077781|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
27514922|NCT01616693|80077782|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
27514923|NCT01616693|80077783|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
27514924|NCT00635219|80077784|FG000|Overall Study|Adverse Event|12|||
27514925|NCT00635219|80077785|FG001|Overall Study|Adverse Event|10|||
27514926|NCT00635219|80077786|FG002|Overall Study|Adverse Event|18|||
27514927|NCT00635219|80077787|FG003|Overall Study|Adverse Event|15|||
27514928|NCT00635219|80077788|FG004|Overall Study|Adverse Event|19|||
27514929|NCT00635219|80077784|FG000|Overall Study|Lack of Efficacy|5|||
27514930|NCT00635219|80077785|FG001|Overall Study|Lack of Efficacy|6|||
27514931|NCT00635219|80077786|FG002|Overall Study|Lack of Efficacy|3|||
27514932|NCT00635219|80077787|FG003|Overall Study|Lack of Efficacy|4|||
27514933|NCT00635219|80077788|FG004|Overall Study|Lack of Efficacy|6|||
27514934|NCT00635219|80077784|FG000|Overall Study|Non-compliance With Study Product|0|||
27514935|NCT00635219|80077785|FG001|Overall Study|Non-compliance With Study Product|0|||
27514936|NCT00635219|80077786|FG002|Overall Study|Non-compliance With Study Product|0|||
27514937|NCT00635219|80077787|FG003|Overall Study|Non-compliance With Study Product|2|||
27514938|NCT00635219|80077788|FG004|Overall Study|Non-compliance With Study Product|1|||
27514939|NCT00635219|80077784|FG000|Overall Study|Protocol Violation|0|||
27514940|NCT00635219|80077785|FG001|Overall Study|Protocol Violation|2|||
27514941|NCT00635219|80077786|FG002|Overall Study|Protocol Violation|3|||
27514942|NCT00635219|80077787|FG003|Overall Study|Protocol Violation|2|||
27514943|NCT00635219|80077788|FG004|Overall Study|Protocol Violation|4|||
27514944|NCT00635219|80077784|FG000|Overall Study|Withdrawal of Consent|8|||
27514945|NCT00635219|80077785|FG001|Overall Study|Withdrawal of Consent|6|||
27514946|NCT00635219|80077786|FG002|Overall Study|Withdrawal of Consent|8|||
27514947|NCT00635219|80077787|FG003|Overall Study|Withdrawal of Consent|11|||
27514948|NCT00635219|80077788|FG004|Overall Study|Withdrawal of Consent|8|||
27514949|NCT00635219|80077784|FG000|Overall Study|Lost to Follow-up|0|||
27514950|NCT00635219|80077785|FG001|Overall Study|Lost to Follow-up|0|||
27514951|NCT00635219|80077786|FG002|Overall Study|Lost to Follow-up|2|||
27514952|NCT00635219|80077787|FG003|Overall Study|Lost to Follow-up|0|||
27514953|NCT00635219|80077788|FG004|Overall Study|Lost to Follow-up|3|||
27514954|NCT00635219|80077784|FG000|Overall Study|Administrative or Other Reasons|0|||
27514955|NCT00635219|80077785|FG001|Overall Study|Administrative or Other Reasons|1|||
27514956|NCT00635219|80077786|FG002|Overall Study|Administrative or Other Reasons|1|||
27514957|NCT00635219|80077787|FG003|Overall Study|Administrative or Other Reasons|0|||
27514958|NCT00635219|80077788|FG004|Overall Study|Administrative or Other Reasons|1|||
27514959|NCT00223080|80077793|FG000|Overall Study|Withdrawal by Subject|253|||
27514960|NCT00223080|80077794|FG001|Overall Study|Withdrawal by Subject|232|||
27514961|NCT00223080|80077793|FG000|Overall Study|Required contraindicated med|0|||
27514962|NCT00223080|80077794|FG001|Overall Study|Required contraindicated med|1|||
27514963|NCT00223080|80077793|FG000|Overall Study|Non-compliant|7|||
27514964|NCT00223080|80077794|FG001|Overall Study|Non-compliant|7|||
27514965|NCT00223080|80077793|FG000|Overall Study|Moved from study area|37|||
27514966|NCT00223080|80077794|FG001|Overall Study|Moved from study area|47|||
27514967|NCT00223080|80077793|FG000|Overall Study|Lost to Follow-up|259|||
27514968|NCT00223080|80077794|FG001|Overall Study|Lost to Follow-up|284|||
27514969|NCT00223080|80077793|FG000|Overall Study|Death|85|||
27514970|NCT00223080|80077794|FG001|Overall Study|Death|74|||
27514971|NCT00223080|80077793|FG000|Overall Study|Other|14|||
27514972|NCT00223080|80077794|FG001|Overall Study|Other|11|||
27514973|NCT00223080|80077793|FG000|Overall Study|Reason not provided|141|||
27514974|NCT00223080|80077794|FG001|Overall Study|Reason not provided|140|||
27514975|NCT00223080|80077793|FG000|Overall Study|Adverse Event|0|||
27514976|NCT00223080|80077794|FG001|Overall Study|Adverse Event|1|||
27514977|NCT02703337|80077795|FG000|Period One (Part A)|Withdrawal by Subject|0|||
27514978|NCT02703337|80077796|FG001|Period One (Part A)|Withdrawal by Subject|0|||
27514979|NCT02703337|80077797|FG002|Period One (Part A)|Withdrawal by Subject|0|||
27514980|NCT02703337|80077798|FG003|Period One (Part A)|Withdrawal by Subject|0|||
27514981|NCT02703337|80077799|FG004|Period One (Part A)|Withdrawal by Subject|1|||
27514982|NCT02703337|80077800|FG005|Period One (Part A)|Withdrawal by Subject|0|||
27514983|NCT02703337|80077801|FG006|Period One (Part A)|Withdrawal by Subject|0|||
27514984|NCT02703337|80077802|FG007|Period One (Part A)|Withdrawal by Subject|0|||
27514985|NCT02100696|80077803|FG000|Induction Phase|Adverse Event|0|||
27514986|NCT02100696|80077804|FG001|Induction Phase|Adverse Event|0|||
27514987|NCT02100696|80077805|FG002|Induction Phase|Adverse Event|1|||
27514988|NCT02100696|80077806|FG003|Induction Phase|Adverse Event|0|||
27514989|NCT02100696|80077807|FG004|Induction Phase|Adverse Event|0|||
27514990|NCT02100696|80077808|FG005|Induction Phase|Adverse Event|0|||
27514991|NCT02100696|80077803|FG000|Induction Phase|Lost to Follow-up|1|||
27514992|NCT02100696|80077804|FG001|Induction Phase|Lost to Follow-up|0|||
27514993|NCT02100696|80077805|FG002|Induction Phase|Lost to Follow-up|1|||
27514994|NCT02100696|80077806|FG003|Induction Phase|Lost to Follow-up|0|||
27514995|NCT02100696|80077807|FG004|Induction Phase|Lost to Follow-up|0|||
27514996|NCT02100696|80077808|FG005|Induction Phase|Lost to Follow-up|0|||
27514997|NCT02100696|80077803|FG000|Induction Phase|Protocol Violation|0|||
27514998|NCT02100696|80077804|FG001|Induction Phase|Protocol Violation|1|||
27514999|NCT02100696|80077805|FG002|Induction Phase|Protocol Violation|1|||
27515000|NCT02100696|80077806|FG003|Induction Phase|Protocol Violation|0|||
27515001|NCT02100696|80077807|FG004|Induction Phase|Protocol Violation|0|||
27515002|NCT02100696|80077808|FG005|Induction Phase|Protocol Violation|0|||
27515003|NCT02100696|80077803|FG000|Induction Phase|Withdrawal by Subject|8|||
27515004|NCT02100696|80077804|FG001|Induction Phase|Withdrawal by Subject|2|||
27515005|NCT02100696|80077805|FG002|Induction Phase|Withdrawal by Subject|13|||
27515006|NCT02100696|80077806|FG003|Induction Phase|Withdrawal by Subject|0|||
27515007|NCT02100696|80077807|FG004|Induction Phase|Withdrawal by Subject|0|||
27615869|NCT00451217|80437498|FG003|Overall Study|Not Treated|4|||
27615870|NCT01500226|80437503|FG000|Overall Study|Adverse Event|31|||
27615871|NCT01500226|80437504|FG001|Overall Study|Adverse Event|38|||
27615872|NCT01500226|80437503|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
27515008|NCT02100696|80077808|FG005|Induction Phase|Withdrawal by Subject|0|||
27515009|NCT02100696|80077803|FG000|Induction Phase|Physician Decision|1|||
27515010|NCT02100696|80077804|FG001|Induction Phase|Physician Decision|0|||
27515011|NCT02100696|80077805|FG002|Induction Phase|Physician Decision|2|||
27515012|NCT02100696|80077806|FG003|Induction Phase|Physician Decision|0|||
27515013|NCT02100696|80077807|FG004|Induction Phase|Physician Decision|0|||
27515014|NCT02100696|80077808|FG005|Induction Phase|Physician Decision|0|||
27515015|NCT02100696|80077803|FG000|Induction Phase|Multiple Reasons|5|||
27515016|NCT02100696|80077804|FG001|Induction Phase|Multiple Reasons|2|||
27515017|NCT02100696|80077805|FG002|Induction Phase|Multiple Reasons|8|||
27515018|NCT02100696|80077806|FG003|Induction Phase|Multiple Reasons|0|||
27515019|NCT02100696|80077807|FG004|Induction Phase|Multiple Reasons|0|||
27515020|NCT02100696|80077808|FG005|Induction Phase|Multiple Reasons|0|||
27515021|NCT02100696|80077803|FG000|Maintenance Phase|Adverse Event|0|||
27515022|NCT02100696|80077804|FG001|Maintenance Phase|Adverse Event|0|||
27515023|NCT02100696|80077805|FG002|Maintenance Phase|Adverse Event|0|||
27515024|NCT02100696|80077806|FG003|Maintenance Phase|Adverse Event|0|||
27515025|NCT02100696|80077807|FG004|Maintenance Phase|Adverse Event|0|||
27515026|NCT02100696|80077808|FG005|Maintenance Phase|Adverse Event|2|||
27515027|NCT02100696|80077803|FG000|Maintenance Phase|Lost to Follow-up|0|||
27515028|NCT02100696|80077804|FG001|Maintenance Phase|Lost to Follow-up|0|||
27515029|NCT02100696|80077805|FG002|Maintenance Phase|Lost to Follow-up|0|||
27515030|NCT02100696|80077806|FG003|Maintenance Phase|Lost to Follow-up|0|||
27515031|NCT02100696|80077807|FG004|Maintenance Phase|Lost to Follow-up|1|||
27515032|NCT02100696|80077808|FG005|Maintenance Phase|Lost to Follow-up|0|||
27515033|NCT02100696|80077803|FG000|Maintenance Phase|Protocol Violation|0|||
27515034|NCT02100696|80077804|FG001|Maintenance Phase|Protocol Violation|0|||
27515035|NCT02100696|80077805|FG002|Maintenance Phase|Protocol Violation|0|||
27515036|NCT02100696|80077806|FG003|Maintenance Phase|Protocol Violation|0|||
27515037|NCT02100696|80077807|FG004|Maintenance Phase|Protocol Violation|1|||
27515038|NCT02100696|80077808|FG005|Maintenance Phase|Protocol Violation|0|||
27515039|NCT02100696|80077803|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27615873|NCT01500226|80437504|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
27615874|NCT01500226|80437503|FG000|Overall Study|Withdrawal by Subject|93|||
27615875|NCT01500226|80437504|FG001|Overall Study|Withdrawal by Subject|96|||
27615876|NCT01500226|80437503|FG000|Overall Study|Death|12|||
27615877|NCT01500226|80437504|FG001|Overall Study|Death|4|||
27615878|NCT01500226|80437503|FG000|Overall Study|Disease Progression|16|||
27615879|NCT01500226|80437504|FG001|Overall Study|Disease Progression|14|||
27615880|NCT01500226|80437503|FG000|Overall Study|Protocol Violation|53|||
27615881|NCT01500226|80437504|FG001|Overall Study|Protocol Violation|39|||
27615882|NCT01500226|80437503|FG000|Overall Study|Physician Decision|17|||
27615883|NCT01500226|80437504|FG001|Overall Study|Physician Decision|15|||
27615884|NCT01500226|80437503|FG000|Overall Study|Lack of Efficacy|14|||
27615885|NCT01500226|80437504|FG001|Overall Study|Lack of Efficacy|30|||
27615886|NCT01500226|80437503|FG000|Overall Study|Lost to Follow-up|9|||
27615887|NCT01500226|80437504|FG001|Overall Study|Lost to Follow-up|5|||
27615888|NCT01500226|80437503|FG000|Overall Study|Other Reasons|19|||
27615889|NCT01500226|80437504|FG001|Overall Study|Other Reasons|16|||
27615890|NCT02218489|80437505|FG000|Overall Study|Withdrawal by Subject|4|||
27615891|NCT02218489|80437506|FG001|Overall Study|Withdrawal by Subject|3|||
27615892|NCT02218489|80437505|FG000|Overall Study|Lost to Follow-up|1|||
27615893|NCT02218489|80437506|FG001|Overall Study|Lost to Follow-up|0|||
27615894|NCT00550173|80437507|FG000|Overall Study|Death|45|||
27615895|NCT00550173|80437508|FG001|Overall Study|Death|38|||
27615896|NCT00550173|80437509|FG002|Overall Study|Death|50|||
27615897|NCT00550173|80437507|FG000|Overall Study|Physician Decision|1|||
27615898|NCT00550173|80437508|FG001|Overall Study|Physician Decision|2|||
27615899|NCT00550173|80437509|FG002|Overall Study|Physician Decision|2|||
27615900|NCT00550173|80437507|FG000|Overall Study|Withdrawal by Subject|9|||
27615901|NCT00550173|80437508|FG001|Overall Study|Withdrawal by Subject|12|||
27615902|NCT00550173|80437509|FG002|Overall Study|Withdrawal by Subject|17|||
27615903|NCT00550173|80437507|FG000|Overall Study|Sponsor Decision|13|||
27615904|NCT00550173|80437508|FG001|Overall Study|Sponsor Decision|7|||
27615905|NCT00550173|80437509|FG002|Overall Study|Sponsor Decision|1|||
27615906|NCT00550173|80437507|FG000|Overall Study|Lost to Follow-up|4|||
27615907|NCT00550173|80437508|FG001|Overall Study|Lost to Follow-up|4|||
27615908|NCT00550173|80437509|FG002|Overall Study|Lost to Follow-up|3|||
27615909|NCT02411591|80437515|FG000|Overall Study|Adverse Event|0|||
27615910|NCT02411591|80437516|FG001|Overall Study|Adverse Event|4|||
27615911|NCT02411591|80437517|FG002|Overall Study|Adverse Event|2|||
27615912|NCT02411591|80437515|FG000|Overall Study|Withdrawal by Subject|0|||
27615913|NCT02411591|80437516|FG001|Overall Study|Withdrawal by Subject|3|||
27515040|NCT02100696|80077804|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27515041|NCT02100696|80077805|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27515042|NCT02100696|80077806|FG003|Maintenance Phase|Withdrawal by Subject|1|||
27515043|NCT02100696|80077807|FG004|Maintenance Phase|Withdrawal by Subject|4|||
27615914|NCT02411591|80437517|FG002|Overall Study|Withdrawal by Subject|0|||
27615915|NCT02411591|80437515|FG000|Overall Study|Physician Decision|0|||
27615916|NCT02411591|80437516|FG001|Overall Study|Physician Decision|3|||
27615917|NCT02411591|80437517|FG002|Overall Study|Physician Decision|1|||
27615918|NCT05221749|80437520|FG000|Overall Study|Lost to Follow-up|2|||
27615919|NCT05221749|80437521|FG001|Overall Study|Lost to Follow-up|3|||
27615920|NCT04147260|80437526|FG000|Overall Study|Adverse Event|1|||
27615921|NCT04147260|80437527|FG001|Overall Study|Adverse Event|0|||
27615922|NCT04147260|80437528|FG002|Overall Study|Adverse Event|1|||
27515044|NCT02100696|80077808|FG005|Maintenance Phase|Withdrawal by Subject|2|||
27615923|NCT04147260|80437529|FG003|Overall Study|Adverse Event|2|||
27615924|NCT04147260|80437530|FG004|Overall Study|Adverse Event|0|||
27615925|NCT04147260|80437526|FG000|Overall Study|Withdrawal by Subject|0|||
27615926|NCT04147260|80437527|FG001|Overall Study|Withdrawal by Subject|0|||
27615927|NCT04147260|80437528|FG002|Overall Study|Withdrawal by Subject|1|||
27515045|NCT02100696|80077803|FG000|Maintenance Phase|Physician Decision|0|||
27515046|NCT02100696|80077804|FG001|Maintenance Phase|Physician Decision|0|||
27515047|NCT02100696|80077805|FG002|Maintenance Phase|Physician Decision|0|||
27515048|NCT02100696|80077806|FG003|Maintenance Phase|Physician Decision|0|||
27515049|NCT02100696|80077807|FG004|Maintenance Phase|Physician Decision|1|||
27515050|NCT02100696|80077808|FG005|Maintenance Phase|Physician Decision|0|||
27515051|NCT02100696|80077803|FG000|Maintenance Phase|Multiple Reasons|0|||
27515052|NCT02100696|80077804|FG001|Maintenance Phase|Multiple Reasons|0|||
27515053|NCT02100696|80077805|FG002|Maintenance Phase|Multiple Reasons|0|||
27515054|NCT02100696|80077806|FG003|Maintenance Phase|Multiple Reasons|0|||
27515055|NCT02100696|80077807|FG004|Maintenance Phase|Multiple Reasons|2|||
27515056|NCT02100696|80077808|FG005|Maintenance Phase|Multiple Reasons|1|||
27515057|NCT01500720|80077809|FG000|Overall Study|Randomized But Not Treated|1|||
27515058|NCT01500720|80077810|FG001|Overall Study|Randomized But Not Treated|1|||
27515059|NCT01500720|80077809|FG000|Overall Study|Other|4|||
27515060|NCT01500720|80077810|FG001|Overall Study|Other|8|||
27515061|NCT01818752|80077811|FG000|Overall Study|Adverse Event|64|||
27515062|NCT01818752|80077812|FG001|Overall Study|Adverse Event|74|||
27515063|NCT01818752|80077811|FG000|Overall Study|Death|14|||
27515064|NCT01818752|80077812|FG001|Overall Study|Death|18|||
27515065|NCT01818752|80077811|FG000|Overall Study|Non-compliance|16|||
27515066|NCT01818752|80077812|FG001|Overall Study|Non-compliance|20|||
27515067|NCT01818752|80077811|FG000|Overall Study|Withdrawal by Subject|15|||
27515068|NCT01818752|80077812|FG001|Overall Study|Withdrawal by Subject|14|||
27515069|NCT01818752|80077811|FG000|Overall Study|Physician Decision|9|||
27515070|NCT01818752|80077812|FG001|Overall Study|Physician Decision|8|||
27515071|NCT01818752|80077811|FG000|Overall Study|Disease Progression|54|||
27515072|NCT01818752|80077812|FG001|Overall Study|Disease Progression|48|||
27515073|NCT01818752|80077811|FG000|Overall Study|Other|7|||
27515074|NCT01818752|80077812|FG001|Overall Study|Other|8|||
27515075|NCT01818752|80077811|FG000|Overall Study|Continuing Treatment|1|||
27515076|NCT01818752|80077812|FG001|Overall Study|Continuing Treatment|4|||
27515077|NCT01818752|80077811|FG000|Overall Study|Randomized but not Dosed|7|||
27515078|NCT01818752|80077812|FG001|Overall Study|Randomized but not Dosed|4|||
27515079|NCT00867815|80077813|FG000|Overall Study|Lost to Follow-up|1|||
27515080|NCT00104520|80077818|FG000|Overall Study|Unrelated adverse event|34|||
27515081|NCT00104520|80077819|FG001|Overall Study|Unrelated adverse event|47|||
27515082|NCT00104520|80077818|FG000|Overall Study|Study drug intolerance|0|||
27515083|NCT00104520|80077819|FG001|Overall Study|Study drug intolerance|1|||
27515084|NCT00104520|80077818|FG000|Overall Study|Related adverse event|13|||
27515085|NCT00104520|80077819|FG001|Overall Study|Related adverse event|15|||
27515086|NCT00104520|80077818|FG000|Overall Study|Lost to Follow-up|1|||
27515087|NCT00104520|80077819|FG001|Overall Study|Lost to Follow-up|0|||
27515088|NCT00104520|80077818|FG000|Overall Study|Noncompliance|0|||
27515089|NCT00104520|80077819|FG001|Overall Study|Noncompliance|2|||
27515090|NCT00104520|80077818|FG000|Overall Study|Personal/administrative|1|||
27515091|NCT00104520|80077819|FG001|Overall Study|Personal/administrative|1|||
27515092|NCT00104520|80077818|FG000|Overall Study|Other|1|||
27515093|NCT00104520|80077819|FG001|Overall Study|Other|5|||
27515094|NCT00373113|80080807|FG000|Overall Study|Death|1|||
27515095|NCT00373113|80080808|FG001|Overall Study|Death|7|||
27515096|NCT00373113|80080807|FG000|Overall Study|Adverse Event|38|||
27515097|NCT00373113|80080808|FG001|Overall Study|Adverse Event|24|||
27515098|NCT00373113|80080807|FG000|Overall Study|Study terminated by sponsor|9|||
27515099|NCT00373113|80080808|FG001|Overall Study|Study terminated by sponsor|1|||
27515100|NCT00373113|80080807|FG000|Overall Study|Global deterioration of health status|10|||
27515101|NCT00373113|80080808|FG001|Overall Study|Global deterioration of health status|7|||
27515102|NCT00373113|80080807|FG000|Overall Study|Lost to Follow-up|1|||
27515103|NCT00373113|80080808|FG001|Overall Study|Lost to Follow-up|3|||
27515104|NCT00373113|80080807|FG000|Overall Study|Objective progression or relapse|150|||
27515105|NCT00373113|80080808|FG001|Overall Study|Objective progression or relapse|169|||
27515106|NCT00373113|80080807|FG000|Overall Study|Other|14|||
27515107|NCT00373113|80080808|FG001|Overall Study|Other|17|||
27515108|NCT00373113|80080807|FG000|Overall Study|Protocol Violation|5|||
27515109|NCT00373113|80080808|FG001|Overall Study|Protocol Violation|1|||
27515110|NCT00373113|80080807|FG000|Overall Study|Withdrawal by Subject|10|||
27515111|NCT00373113|80080808|FG001|Overall Study|Withdrawal by Subject|15|||
27906913|NCT00313586|81496810|FG000|Overall Study|Moved|0|||
27515112|NCT02152956|80080812|FG000|Overall Study|Adverse Event|0|||
27515113|NCT02152956|80080813|FG001|Overall Study|Adverse Event|0|||
27515114|NCT02152956|80080814|FG002|Overall Study|Adverse Event|0|||
27515115|NCT02152956|80080815|FG003|Overall Study|Adverse Event|0|||
27515116|NCT02152956|80080816|FG004|Overall Study|Adverse Event|0|||
27515117|NCT02152956|80080817|FG005|Overall Study|Adverse Event|0|||
27515118|NCT02152956|80080818|FG006|Overall Study|Adverse Event|0|||
27515119|NCT02152956|80080819|FG007|Overall Study|Adverse Event|0|||
27515120|NCT02152956|80080820|FG008|Overall Study|Adverse Event|0|||
27515121|NCT02152956|80080821|FG009|Overall Study|Adverse Event|0|||
27515122|NCT02152956|80080822|FG010|Overall Study|Adverse Event|0|||
27615928|NCT04147260|80437529|FG003|Overall Study|Withdrawal by Subject|1|||
27615929|NCT04147260|80437530|FG004|Overall Study|Withdrawal by Subject|0|||
27615930|NCT01221181|80437536|FG000|Overall Study|Lost to Follow-up|1|||
27615931|NCT00437125|80437537|FG000|Overall Study|Adverse Event|12|||
27615932|NCT00437125|80437537|FG000|Overall Study|Death|1|||
27615933|NCT00437125|80437537|FG000|Overall Study|Clinical Relapse|1|||
27615934|NCT00437125|80437537|FG000|Overall Study|Lack of Efficacy|1|||
27615935|NCT00437125|80437537|FG000|Overall Study|Lost to Follow-up|1|||
27615936|NCT00437125|80437537|FG000|Overall Study|Withdrawal by Subject|13|||
27615937|NCT00437125|80437537|FG000|Overall Study|Withdrawal by Caregiver|2|||
27615938|NCT00437125|80437537|FG000|Overall Study|Physician Decision|1|||
27615939|NCT01824472|80437538|FG000|Overall Study|Lost to Follow-up|0|||
27615940|NCT01824472|80437539|FG001|Overall Study|Lost to Follow-up|0|||
27615941|NCT01824472|80437540|FG002|Overall Study|Lost to Follow-up|1|||
27906914|NCT00313586|81496811|FG001|Overall Study|Moved|1|||
27906915|NCT00313586|81496812|FG002|Overall Study|Moved|0|||
27906916|NCT00313586|81496813|FG003|Overall Study|Moved|0|||
27906917|NCT00313586|81496810|FG000|Overall Study|Death before starting treatment|1|||
27906918|NCT00313586|81496811|FG001|Overall Study|Death before starting treatment|0|||
27906919|NCT00313586|81496812|FG002|Overall Study|Death before starting treatment|0|||
27906920|NCT00313586|81496813|FG003|Overall Study|Death before starting treatment|0|||
27906921|NCT03178851|81496818|FG000|Overall Study|Death|48|||
27906922|NCT03178851|81496819|FG001|Overall Study|Death|2|||
27515123|NCT02152956|80080823|FG011|Overall Study|Adverse Event|4|||
27515124|NCT02152956|80080824|FG012|Overall Study|Adverse Event|0|||
27515125|NCT02152956|80080812|FG000|Overall Study|Death|0|||
27515126|NCT02152956|80080813|FG001|Overall Study|Death|3|||
27515127|NCT02152956|80080814|FG002|Overall Study|Death|3|||
27515128|NCT02152956|80080815|FG003|Overall Study|Death|4|||
27515129|NCT02152956|80080816|FG004|Overall Study|Death|1|||
27515130|NCT02152956|80080817|FG005|Overall Study|Death|2|||
27515131|NCT02152956|80080818|FG006|Overall Study|Death|6|||
27515132|NCT02152956|80080819|FG007|Overall Study|Death|6|||
27515133|NCT02152956|80080820|FG008|Overall Study|Death|4|||
27515134|NCT02152956|80080821|FG009|Overall Study|Death|5|||
27515135|NCT02152956|80080822|FG010|Overall Study|Death|3|||
27515136|NCT02152956|80080823|FG011|Overall Study|Death|143|||
27515137|NCT02152956|80080824|FG012|Overall Study|Death|12|||
27515138|NCT02152956|80080812|FG000|Overall Study|Lost to Follow-up|0|||
27515139|NCT02152956|80080813|FG001|Overall Study|Lost to Follow-up|1|||
27515140|NCT02152956|80080814|FG002|Overall Study|Lost to Follow-up|0|||
27515141|NCT02152956|80080815|FG003|Overall Study|Lost to Follow-up|0|||
27515142|NCT02152956|80080816|FG004|Overall Study|Lost to Follow-up|0|||
27515143|NCT02152956|80080817|FG005|Overall Study|Lost to Follow-up|0|||
27515144|NCT02152956|80080818|FG006|Overall Study|Lost to Follow-up|0|||
27515145|NCT02152956|80080819|FG007|Overall Study|Lost to Follow-up|0|||
27515146|NCT02152956|80080820|FG008|Overall Study|Lost to Follow-up|0|||
27515147|NCT02152956|80080821|FG009|Overall Study|Lost to Follow-up|0|||
27515148|NCT02152956|80080822|FG010|Overall Study|Lost to Follow-up|0|||
27515149|NCT02152956|80080823|FG011|Overall Study|Lost to Follow-up|3|||
27515150|NCT02152956|80080824|FG012|Overall Study|Lost to Follow-up|0|||
27515151|NCT02152956|80080812|FG000|Overall Study|Withdrawal by Subject|1|||
27515152|NCT02152956|80080813|FG001|Overall Study|Withdrawal by Subject|0|||
27515153|NCT02152956|80080814|FG002|Overall Study|Withdrawal by Subject|1|||
27515154|NCT02152956|80080815|FG003|Overall Study|Withdrawal by Subject|0|||
27515155|NCT02152956|80080816|FG004|Overall Study|Withdrawal by Subject|2|||
27515156|NCT02152956|80080817|FG005|Overall Study|Withdrawal by Subject|2|||
27515157|NCT02152956|80080818|FG006|Overall Study|Withdrawal by Subject|0|||
27515158|NCT02152956|80080819|FG007|Overall Study|Withdrawal by Subject|0|||
27515159|NCT02152956|80080820|FG008|Overall Study|Withdrawal by Subject|1|||
27515160|NCT02152956|80080821|FG009|Overall Study|Withdrawal by Subject|0|||
27515161|NCT02152956|80080822|FG010|Overall Study|Withdrawal by Subject|0|||
27615942|NCT01824472|80437538|FG000|Overall Study|Withdrawal by Subject|1|||
27615943|NCT01824472|80437539|FG001|Overall Study|Withdrawal by Subject|5|||
27615944|NCT01824472|80437540|FG002|Overall Study|Withdrawal by Subject|3|||
27615945|NCT01824472|80437538|FG000|Overall Study|Ineligible post randomization&screening|0|||
27615946|NCT01824472|80437539|FG001|Overall Study|Ineligible post randomization&screening|2|||
27615947|NCT01824472|80437540|FG002|Overall Study|Ineligible post randomization&screening|0|||
27906923|NCT03178851|81496820|FG002|Overall Study|Death|25|||
27515162|NCT02152956|80080823|FG011|Overall Study|Withdrawal by Subject|4|||
27515163|NCT02152956|80080824|FG012|Overall Study|Withdrawal by Subject|0|||
27515164|NCT02152956|80080812|FG000|Overall Study|Physician Decision|0|||
27515165|NCT02152956|80080813|FG001|Overall Study|Physician Decision|0|||
27515166|NCT02152956|80080814|FG002|Overall Study|Physician Decision|0|||
27515167|NCT02152956|80080815|FG003|Overall Study|Physician Decision|0|||
27906924|NCT03178851|81496818|FG000|Overall Study|Withdrawal by Subject|8|||
27615948|NCT03722264|80437541|FG000|Overall Study|Physician Decision|3|||
27615949|NCT00393094|80437542|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
27615950|NCT00393094|80437542|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
27615951|NCT00849680|80437556|FG000|Overall Study|Adverse Event|0|||
27615952|NCT00849680|80437557|FG001|Overall Study|Adverse Event|0|||
27615953|NCT00849680|80437558|FG002|Overall Study|Adverse Event|0|||
27615954|NCT00849680|80437559|FG003|Overall Study|Adverse Event|0|||
27615955|NCT00849680|80437560|FG004|Overall Study|Adverse Event|0|||
27615956|NCT00849680|80437561|FG005|Overall Study|Adverse Event|0|||
27615957|NCT00849680|80437562|FG006|Overall Study|Adverse Event|2|||
27615958|NCT00849680|80437563|FG007|Overall Study|Adverse Event|0|||
27615959|NCT00849680|80437556|FG000|Overall Study|Lost to Follow-up|7|||
27615960|NCT00849680|80437557|FG001|Overall Study|Lost to Follow-up|3|||
27615961|NCT00849680|80437558|FG002|Overall Study|Lost to Follow-up|12|||
27615962|NCT00849680|80437559|FG003|Overall Study|Lost to Follow-up|11|||
27615963|NCT00849680|80437560|FG004|Overall Study|Lost to Follow-up|8|||
27615964|NCT00849680|80437561|FG005|Overall Study|Lost to Follow-up|11|||
27615965|NCT00849680|80437562|FG006|Overall Study|Lost to Follow-up|12|||
27615966|NCT00849680|80437563|FG007|Overall Study|Lost to Follow-up|5|||
27615967|NCT00849680|80437556|FG000|Overall Study|Subject moved|1|||
27615968|NCT00849680|80437557|FG001|Overall Study|Subject moved|0|||
27615969|NCT00849680|80437558|FG002|Overall Study|Subject moved|3|||
27615970|NCT00849680|80437559|FG003|Overall Study|Subject moved|1|||
27615971|NCT00849680|80437560|FG004|Overall Study|Subject moved|0|||
27906925|NCT03178851|81496819|FG001|Overall Study|Withdrawal by Subject|0|||
27906926|NCT03178851|81496820|FG002|Overall Study|Withdrawal by Subject|0|||
27906927|NCT03178851|81496818|FG000|Overall Study|Lost to Follow-up|5|||
27906928|NCT03178851|81496819|FG001|Overall Study|Lost to Follow-up|2|||
27515168|NCT02152956|80080816|FG004|Overall Study|Physician Decision|0|||
27515169|NCT02152956|80080817|FG005|Overall Study|Physician Decision|0|||
27515170|NCT02152956|80080818|FG006|Overall Study|Physician Decision|0|||
27515171|NCT02152956|80080819|FG007|Overall Study|Physician Decision|0|||
27515172|NCT02152956|80080820|FG008|Overall Study|Physician Decision|0|||
27515173|NCT02152956|80080821|FG009|Overall Study|Physician Decision|0|||
27515174|NCT02152956|80080822|FG010|Overall Study|Physician Decision|0|||
27906929|NCT03178851|81496820|FG002|Overall Study|Lost to Follow-up|0|||
27906930|NCT03178851|81496818|FG000|Overall Study|Adverse Event|0|||
27515175|NCT02152956|80080823|FG011|Overall Study|Physician Decision|1|||
27515176|NCT02152956|80080824|FG012|Overall Study|Physician Decision|0|||
27515177|NCT02152956|80080812|FG000|Overall Study|Study terminated by sponsor|0|||
27515178|NCT02152956|80080813|FG001|Overall Study|Study terminated by sponsor|0|||
27515179|NCT02152956|80080814|FG002|Overall Study|Study terminated by sponsor|0|||
27515180|NCT02152956|80080815|FG003|Overall Study|Study terminated by sponsor|0|||
27515181|NCT02152956|80080816|FG004|Overall Study|Study terminated by sponsor|0|||
27515182|NCT02152956|80080817|FG005|Overall Study|Study terminated by sponsor|0|||
27515183|NCT02152956|80080818|FG006|Overall Study|Study terminated by sponsor|0|||
27515184|NCT02152956|80080819|FG007|Overall Study|Study terminated by sponsor|0|||
27515185|NCT02152956|80080820|FG008|Overall Study|Study terminated by sponsor|0|||
27515186|NCT02152956|80080821|FG009|Overall Study|Study terminated by sponsor|0|||
27515187|NCT02152956|80080822|FG010|Overall Study|Study terminated by sponsor|0|||
27515188|NCT02152956|80080823|FG011|Overall Study|Study terminated by sponsor|29|||
27515189|NCT02152956|80080824|FG012|Overall Study|Study terminated by sponsor|0|||
27515190|NCT02152956|80080812|FG000|Overall Study|progressive disease|0|||
27515191|NCT02152956|80080813|FG001|Overall Study|progressive disease|0|||
27515192|NCT02152956|80080814|FG002|Overall Study|progressive disease|0|||
27906931|NCT03178851|81496819|FG001|Overall Study|Adverse Event|0|||
27906932|NCT03178851|81496820|FG002|Overall Study|Adverse Event|1|||
27906933|NCT03178851|81496818|FG000|Overall Study|Study Termination by Sponsor|31|||
27906934|NCT03178851|81496819|FG001|Overall Study|Study Termination by Sponsor|7|||
27906935|NCT03178851|81496820|FG002|Overall Study|Study Termination by Sponsor|26|||
27906936|NCT01447719|81496823|FG000|Overall Study|Image acquisition failure|2|||
27906937|NCT01447719|81496823|FG000|Overall Study|Invalid image or not imaged|3|||
27906938|NCT01447719|81496823|FG000|Overall Study|Subject still living at end of study|79|||
27515193|NCT02152956|80080815|FG003|Overall Study|progressive disease|0|||
27515194|NCT02152956|80080816|FG004|Overall Study|progressive disease|0|||
27515195|NCT02152956|80080817|FG005|Overall Study|progressive disease|0|||
27515196|NCT02152956|80080818|FG006|Overall Study|progressive disease|0|||
27515197|NCT02152956|80080819|FG007|Overall Study|progressive disease|0|||
27615972|NCT00849680|80437561|FG005|Overall Study|Subject moved|2|||
27615973|NCT00849680|80437562|FG006|Overall Study|Subject moved|2|||
27615974|NCT00849680|80437563|FG007|Overall Study|Subject moved|2|||
27906939|NCT01447719|81496823|FG000|Overall Study|Withdrawal by Subject|2|||
27906940|NCT01447719|81496823|FG000|Overall Study|Family withdrew autopsy consent|7|||
27906941|NCT03315455|81496824|FG000|Overall Study|Ongoing in the Study|13|||
27515198|NCT02152956|80080820|FG008|Overall Study|progressive disease|1|||
27515199|NCT02152956|80080821|FG009|Overall Study|progressive disease|0|||
27615975|NCT00849680|80437556|FG000|Overall Study|Withdrawal by Subject|2|||
27615976|NCT00849680|80437557|FG001|Overall Study|Withdrawal by Subject|0|||
27515200|NCT02152956|80080822|FG010|Overall Study|progressive disease|0|||
27515201|NCT02152956|80080823|FG011|Overall Study|progressive disease|1|||
27515202|NCT02152956|80080824|FG012|Overall Study|progressive disease|0|||
27515203|NCT01499277|80080825|FG000|Overall Study|Adverse Event|3|||
27515204|NCT01499277|80080826|FG001|Overall Study|Adverse Event|6|||
27515205|NCT01499277|80080825|FG000|Overall Study|Death|3|||
27515206|NCT01499277|80080826|FG001|Overall Study|Death|2|||
27515207|NCT01499277|80080825|FG000|Overall Study|Lost to Follow-up|15|||
27515208|NCT01499277|80080826|FG001|Overall Study|Lost to Follow-up|8|||
27515209|NCT01499277|80080825|FG000|Overall Study|Protocol Violation|2|||
27615977|NCT00849680|80437558|FG002|Overall Study|Withdrawal by Subject|0|||
27615978|NCT00849680|80437559|FG003|Overall Study|Withdrawal by Subject|2|||
27615979|NCT00849680|80437560|FG004|Overall Study|Withdrawal by Subject|2|||
27615980|NCT00849680|80437561|FG005|Overall Study|Withdrawal by Subject|2|||
27853270|NCT00444457|81294996|FG001|After Infant Series|Parent or legal guardian request|11|||
27853271|NCT00444457|81294997|FG002|After Infant Series|Parent or legal guardian request|6|||
27853272|NCT00444457|81294998|FG003|After Infant Series|Parent or legal guardian request|3|||
27853273|NCT00444457|81294995|FG000|After Infant Series|Failed to return|7|||
27853274|NCT00444457|81294996|FG001|After Infant Series|Failed to return|6|||
27853275|NCT00444457|81294997|FG002|After Infant Series|Failed to return|5|||
27853276|NCT00444457|81294998|FG003|After Infant Series|Failed to return|1|||
27853277|NCT00444457|81294995|FG000|After Infant Series|Lost to Follow-up|5|||
27853278|NCT00444457|81294996|FG001|After Infant Series|Lost to Follow-up|5|||
27853279|NCT00444457|81294997|FG002|After Infant Series|Lost to Follow-up|5|||
27853280|NCT00444457|81294998|FG003|After Infant Series|Lost to Follow-up|2|||
27853281|NCT00444457|81294995|FG000|After Infant Series|Protocol Violation|2|||
27906942|NCT03315455|81496825|FG001|Overall Study|Ongoing in the Study|24|||
27906943|NCT03315455|81496826|FG002|Overall Study|Ongoing in the Study|17|||
27906944|NCT03315455|81496827|FG003|Overall Study|Ongoing in the Study|15|||
27906945|NCT03315455|81496824|FG000|Overall Study|Withdrawal by Subject|0|||
27515210|NCT01499277|80080826|FG001|Overall Study|Protocol Violation|3|||
27515211|NCT01499277|80080825|FG000|Overall Study|Withdrawal by Subject|16|||
27515212|NCT01499277|80080826|FG001|Overall Study|Withdrawal by Subject|6|||
27515213|NCT01499277|80080825|FG000|Overall Study|Lack of therapeutic response and other|8|||
27515214|NCT01499277|80080826|FG001|Overall Study|Lack of therapeutic response and other|7|||
27515215|NCT00823615|80080830|FG000|Period 2|Lost to Follow-up|2|||
27515216|NCT00823615|80080831|FG001|Period 2|Lost to Follow-up|0|||
27515217|NCT00823615|80080830|FG000|Period 2|Time/Job Conflict|1|||
27515218|NCT00823615|80080831|FG001|Period 2|Time/Job Conflict|2|||
27515219|NCT00782834|80080833|FG000|Treatment Phase|fibrous tumor not GIST|1|||
27515220|NCT01305577|80080836|FG000|Overall Study|Adverse Event|2|||
27515221|NCT01305577|80080837|FG001|Overall Study|Adverse Event|2|||
27515222|NCT01305577|80080838|FG002|Overall Study|Adverse Event|1|||
27515223|NCT01305577|80080836|FG000|Overall Study|Withdrawal by Subject|7|||
27515224|NCT01305577|80080837|FG001|Overall Study|Withdrawal by Subject|5|||
27515225|NCT01305577|80080838|FG002|Overall Study|Withdrawal by Subject|6|||
27515226|NCT01305577|80080836|FG000|Overall Study|Lost to Follow-up|4|||
27515227|NCT01305577|80080837|FG001|Overall Study|Lost to Follow-up|3|||
27515228|NCT01305577|80080838|FG002|Overall Study|Lost to Follow-up|2|||
27515229|NCT01305577|80080836|FG000|Overall Study|Protocol Deviation|0|||
27515230|NCT01305577|80080837|FG001|Overall Study|Protocol Deviation|1|||
27515231|NCT01305577|80080838|FG002|Overall Study|Protocol Deviation|1|||
27515232|NCT01727024|80080839|FG000|Period 1|Lost to Follow-up|1|||
27515233|NCT01727024|80080840|FG001|Period 1|Lost to Follow-up|1|||
27515234|NCT01727024|80080839|FG000|Period 1|Withdrawal by Subject|2|||
27515235|NCT01727024|80080840|FG001|Period 1|Withdrawal by Subject|3|||
27515236|NCT03052400|80080841|FG000|Overall Study|Lost to Follow-up|1|||
27615981|NCT00849680|80437562|FG006|Overall Study|Withdrawal by Subject|1|||
27615982|NCT00849680|80437563|FG007|Overall Study|Withdrawal by Subject|1|||
27728718|NCT01126580|80838091|FG001|Overall Study|Treatment Non-compliance|2|||
27906946|NCT03315455|81496825|FG001|Overall Study|Withdrawal by Subject|1|||
27906947|NCT03315455|81496826|FG002|Overall Study|Withdrawal by Subject|0|||
27906948|NCT03315455|81496827|FG003|Overall Study|Withdrawal by Subject|0|||
27906949|NCT01215435|81496834|FG000|Overall Study|Adverse Event|1|||
27906950|NCT01215435|81496835|FG001|Overall Study|Adverse Event|0|||
27906951|NCT01215435|81496834|FG000|Overall Study|Protocol Violation|2|||
27906952|NCT01215435|81496835|FG001|Overall Study|Protocol Violation|0|||
27515237|NCT03052400|80080842|FG001|Overall Study|Lost to Follow-up|0|||
27615983|NCT00849680|80437556|FG000|Overall Study|Subject unable to comply with protocol|1|||
27906953|NCT01215435|81496834|FG000|Overall Study|Withdrawal Criteria|8|||
27515238|NCT03052400|80080841|FG000|Overall Study|Withdrawal by Subject|0|||
27515239|NCT03052400|80080842|FG001|Overall Study|Withdrawal by Subject|1|||
27615984|NCT00849680|80437557|FG001|Overall Study|Subject unable to comply with protocol|0|||
27906954|NCT01215435|81496835|FG001|Overall Study|Withdrawal Criteria|11|||
27515240|NCT01738646|80080845|FG000|Overall Study|Still Receiving Treatment|2|||
27515241|NCT01587898|80080846|FG000|Overall Study|Adverse Event|1|||
27728719|NCT01126580|80838092|FG002|Overall Study|Treatment Non-compliance|3|||
27615985|NCT00849680|80437558|FG002|Overall Study|Subject unable to comply with protocol|0|||
27615986|NCT00849680|80437559|FG003|Overall Study|Subject unable to comply with protocol|0|||
27615987|NCT00849680|80437560|FG004|Overall Study|Subject unable to comply with protocol|0|||
27615988|NCT00849680|80437561|FG005|Overall Study|Subject unable to comply with protocol|0|||
27615989|NCT00849680|80437562|FG006|Overall Study|Subject unable to comply with protocol|0|||
27615990|NCT00849680|80437563|FG007|Overall Study|Subject unable to comply with protocol|0|||
27615991|NCT03537261|80437565|FG000|Overall Study|Lost to Follow-up|4|||
27615992|NCT03537261|80437566|FG001|Overall Study|Lost to Follow-up|5|||
27615993|NCT03537261|80437565|FG000|Overall Study|Withdrawal by Subject|4|||
27615994|NCT03537261|80437566|FG001|Overall Study|Withdrawal by Subject|6|||
27615995|NCT03537261|80437565|FG000|Overall Study|Did not return study questionnaires|0|||
27615996|NCT03537261|80437566|FG001|Overall Study|Did not return study questionnaires|1|||
27615997|NCT01076088|80437570|FG000|Overall Study|Adverse Event|1|||
27615998|NCT01076088|80437571|FG001|Overall Study|Adverse Event|6|||
27615999|NCT01076088|80437572|FG002|Overall Study|Adverse Event|3|||
27616000|NCT01076088|80437573|FG003|Overall Study|Adverse Event|2|||
27616001|NCT01076088|80437574|FG004|Overall Study|Adverse Event|3|||
27616002|NCT01076088|80437575|FG005|Overall Study|Adverse Event|3|||
27616003|NCT01076088|80437570|FG000|Overall Study|Lost to Follow-up|1|||
27616004|NCT01076088|80437571|FG001|Overall Study|Lost to Follow-up|1|||
27616005|NCT01076088|80437572|FG002|Overall Study|Lost to Follow-up|0|||
27616006|NCT01076088|80437573|FG003|Overall Study|Lost to Follow-up|1|||
27616007|NCT01076088|80437574|FG004|Overall Study|Lost to Follow-up|1|||
27616008|NCT01076088|80437575|FG005|Overall Study|Lost to Follow-up|2|||
27616009|NCT01076088|80437570|FG000|Overall Study|Non-compliance with study drug|0|||
27616010|NCT01076088|80437571|FG001|Overall Study|Non-compliance with study drug|0|||
27616011|NCT01076088|80437572|FG002|Overall Study|Non-compliance with study drug|0|||
27616012|NCT01076088|80437573|FG003|Overall Study|Non-compliance with study drug|1|||
27616013|NCT01076088|80437574|FG004|Overall Study|Non-compliance with study drug|0|||
27616014|NCT01076088|80437575|FG005|Overall Study|Non-compliance with study drug|0|||
27616015|NCT01076088|80437570|FG000|Overall Study|Physician Decision|1|||
27616016|NCT01076088|80437571|FG001|Overall Study|Physician Decision|3|||
27616017|NCT01076088|80437572|FG002|Overall Study|Physician Decision|0|||
27616018|NCT01076088|80437573|FG003|Overall Study|Physician Decision|1|||
27616019|NCT01076088|80437574|FG004|Overall Study|Physician Decision|1|||
27616020|NCT01076088|80437575|FG005|Overall Study|Physician Decision|0|||
27616021|NCT01076088|80437570|FG000|Overall Study|Withdrawal by Subject|8|||
27616022|NCT01076088|80437571|FG001|Overall Study|Withdrawal by Subject|8|||
27616023|NCT01076088|80437572|FG002|Overall Study|Withdrawal by Subject|14|||
27616024|NCT01076088|80437573|FG003|Overall Study|Withdrawal by Subject|10|||
27616025|NCT01076088|80437574|FG004|Overall Study|Withdrawal by Subject|11|||
27616026|NCT01076088|80437575|FG005|Overall Study|Withdrawal by Subject|17|||
27616027|NCT01076088|80437570|FG000|Overall Study|Other protocol specified criteria|0|||
27616028|NCT01076088|80437571|FG001|Overall Study|Other protocol specified criteria|0|||
27616029|NCT01076088|80437572|FG002|Overall Study|Other protocol specified criteria|0|||
27616030|NCT01076088|80437573|FG003|Overall Study|Other protocol specified criteria|0|||
27616031|NCT01076088|80437574|FG004|Overall Study|Other protocol specified criteria|0|||
27616032|NCT01076088|80437575|FG005|Overall Study|Other protocol specified criteria|1|||
27616033|NCT02846558|80437578|FG000|Overall Study|Adverse Event|1|||
27616034|NCT02846558|80437579|FG001|Overall Study|Adverse Event|0|||
27616035|NCT02846558|80437580|FG002|Overall Study|Adverse Event|0|||
27616036|NCT02846558|80437581|FG003|Overall Study|Adverse Event|0|||
27616037|NCT02846558|80437578|FG000|Overall Study|Withdrawal by Subject|5|||
27616038|NCT02846558|80437579|FG001|Overall Study|Withdrawal by Subject|4|||
27616039|NCT02846558|80437580|FG002|Overall Study|Withdrawal by Subject|2|||
27616040|NCT02846558|80437581|FG003|Overall Study|Withdrawal by Subject|2|||
27616041|NCT02846558|80437578|FG000|Overall Study|Lost to Follow-up|2|||
27616042|NCT02846558|80437579|FG001|Overall Study|Lost to Follow-up|0|||
27616043|NCT02846558|80437580|FG002|Overall Study|Lost to Follow-up|0|||
27616044|NCT02846558|80437581|FG003|Overall Study|Lost to Follow-up|0|||
27616045|NCT02531295|80437584|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
27616046|NCT02531295|80437585|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
27616047|NCT02531295|80437586|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
27616048|NCT02531295|80437587|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
27616049|NCT02531295|80437588|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
27616050|NCT02531295|80437589|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
27616051|NCT02632786|80437590|FG000|Overall Study|Adverse Event|2|||
27616052|NCT02632786|80437591|FG001|Overall Study|Adverse Event|1|||
27616053|NCT02632786|80437590|FG000|Overall Study|Death|3|||
27616054|NCT02632786|80437591|FG001|Overall Study|Death|2|||
27853282|NCT00444457|81294996|FG001|After Infant Series|Protocol Violation|4|||
27616055|NCT02632786|80437590|FG000|Overall Study|Physician Decision|5|||
27616056|NCT02632786|80437591|FG001|Overall Study|Physician Decision|4|||
27906955|NCT01215435|81496834|FG000|Overall Study|Lost to Follow-up|3|||
27616057|NCT02632786|80437590|FG000|Overall Study|Withdrawal by Subject|1|||
27616058|NCT02632786|80437591|FG001|Overall Study|Withdrawal by Subject|0|||
27616059|NCT02169219|80437592|FG000|Overall Study|Lack of Efficacy|6|||
27616060|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
27616061|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
27616062|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
27616063|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
27616064|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
27616065|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
27616066|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
27616067|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
27616068|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
27616069|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
27616070|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
27616071|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
27616072|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
27616073|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
27616074|NCT01815736|80437593|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
27616075|NCT01815736|80437594|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
27616076|NCT01815736|80437593|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
27616077|NCT01815736|80437594|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
27616078|NCT01815736|80437593|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
27616079|NCT01815736|80437594|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
27616080|NCT01815736|80437593|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
27616081|NCT01815736|80437594|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
27616082|NCT01815736|80437593|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
27616083|NCT01815736|80437594|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
27616084|NCT01815736|80437593|FG000|Extension Treatment Phase- After Week 96|Death|1|||
27616085|NCT01815736|80437594|FG001|Extension Treatment Phase- After Week 96|Death|0|||
27616086|NCT00598481|80437595|FG000|Treatment|Physician Decision|1|||
27616087|NCT04747275|80437596|FG000|Overall Study|Study terminated|0|||
27616088|NCT04747275|80437597|FG001|Overall Study|Study terminated|1|||
27616089|NCT04242875|80437605|FG000|Overall Study|Adverse Event|2|||
27616090|NCT00478608|80437608|FG000|Overall Study|Adverse Event|1|||
27616091|NCT00478608|80437608|FG000|Overall Study|Serious Adverse Event|14|||
27616092|NCT00478608|80437608|FG000|Overall Study|Withdrawal by Subject|2|||
27616093|NCT00478608|80437608|FG000|Overall Study|Protocol Violation|3|||
27616094|NCT00729690|80437609|FG000|Overall Study|IT Catheter Malfunction|0|||
27616095|NCT00729690|80437610|FG001|Overall Study|IT Catheter Malfunction|2|||
27616096|NCT00729690|80437611|FG002|Overall Study|IT Catheter Malfunction|2|||
27616097|NCT00219141|80437612|FG000|Overall Study|Adverse Event|4|||
27616098|NCT00219141|80437613|FG001|Overall Study|Adverse Event|10|||
27616099|NCT00219141|80437614|FG002|Overall Study|Adverse Event|5|||
27616100|NCT00219141|80437612|FG000|Overall Study|Lack of Efficacy|3|||
27616101|NCT00219141|80437613|FG001|Overall Study|Lack of Efficacy|2|||
27616102|NCT00219141|80437614|FG002|Overall Study|Lack of Efficacy|0|||
27616103|NCT00219141|80437612|FG000|Overall Study|Administrative problems|0|||
27616104|NCT00219141|80437613|FG001|Overall Study|Administrative problems|1|||
27616105|NCT00219141|80437614|FG002|Overall Study|Administrative problems|0|||
27616106|NCT00219141|80437612|FG000|Overall Study|Lost to Follow-up|2|||
27616107|NCT00219141|80437613|FG001|Overall Study|Lost to Follow-up|4|||
27616108|NCT00219141|80437614|FG002|Overall Study|Lost to Follow-up|1|||
27616109|NCT00219141|80437612|FG000|Overall Study|Protocol Violation|3|||
27616110|NCT00219141|80437613|FG001|Overall Study|Protocol Violation|1|||
27616111|NCT00219141|80437614|FG002|Overall Study|Protocol Violation|1|||
27616112|NCT00219141|80437612|FG000|Overall Study|Withdrawal by Subject|1|||
27616113|NCT00219141|80437613|FG001|Overall Study|Withdrawal by Subject|3|||
27616114|NCT00219141|80437614|FG002|Overall Study|Withdrawal by Subject|5|||
27616115|NCT00219141|80437612|FG000|Overall Study|Condition no longer requires study drug|1|||
27616116|NCT00219141|80437613|FG001|Overall Study|Condition no longer requires study drug|0|||
27616117|NCT00219141|80437614|FG002|Overall Study|Condition no longer requires study drug|0|||
27616118|NCT01058863|80437619|FG000|Overall Study|Lost to Follow-up|1|||
27616119|NCT01058863|80437619|FG000|Overall Study|Withdrawal by Subject|1|||
27616120|NCT01058863|80437619|FG000|Overall Study|Sponsor requested withdrawal|1|||
27616121|NCT01058863|80437619|FG000|Overall Study|Randomized in error|1|||
27853283|NCT00444457|81294997|FG002|After Infant Series|Protocol Violation|2|||
27853284|NCT00444457|81294998|FG003|After Infant Series|Protocol Violation|2|||
27853285|NCT00444457|81294995|FG000|After Infant Series|Adverse Event|2|||
27853286|NCT00444457|81294996|FG001|After Infant Series|Adverse Event|2|||
27906956|NCT01215435|81496835|FG001|Overall Study|Lost to Follow-up|0|||
27906957|NCT01215435|81496834|FG000|Overall Study|Unclassified|5|||
27906958|NCT01215435|81496835|FG001|Overall Study|Unclassified|5|||
27906959|NCT02348008|81496838|FG000|Overall Study|Adverse Event|2|||
27906960|NCT02348008|81496839|FG001|Overall Study|Adverse Event|3|||
27906961|NCT02348008|81496840|FG002|Overall Study|Adverse Event|3|||
27906962|NCT02348008|81496838|FG000|Overall Study|Disease Progression|1|||
27906963|NCT02348008|81496839|FG001|Overall Study|Disease Progression|5|||
27906964|NCT02348008|81496840|FG002|Overall Study|Disease Progression|16|||
27906965|NCT02348008|81496838|FG000|Overall Study|Withdrawal by Subject|0|||
27906966|NCT02348008|81496839|FG001|Overall Study|Withdrawal by Subject|1|||
27906967|NCT02348008|81496840|FG002|Overall Study|Withdrawal by Subject|0|||
27906968|NCT02348008|81496838|FG000|Overall Study|Symptomatic Deterioration|0|||
27906969|NCT02348008|81496839|FG001|Overall Study|Symptomatic Deterioration|1|||
27906970|NCT02348008|81496840|FG002|Overall Study|Symptomatic Deterioration|0|||
27906971|NCT00582426|81496841|FG000|Overall Study|Lost to Follow-up|0|||
27906972|NCT00582426|81496842|FG001|Overall Study|Lost to Follow-up|2|||
27906973|NCT00582426|81496841|FG000|Overall Study|Adverse Event|4|||
27906974|NCT00582426|81496842|FG001|Overall Study|Adverse Event|2|||
27906975|NCT00582426|81496841|FG000|Overall Study|Protocol Violation|6|||
27906976|NCT00582426|81496842|FG001|Overall Study|Protocol Violation|2|||
27515242|NCT01587898|80080847|FG001|Overall Study|Adverse Event|1|||
27515243|NCT01587898|80080848|FG002|Overall Study|Adverse Event|0|||
27515244|NCT01587898|80080849|FG003|Overall Study|Adverse Event|0|||
27515245|NCT01587898|80080846|FG000|Overall Study|Protocol Violation|0|||
27515246|NCT01587898|80080847|FG001|Overall Study|Protocol Violation|2|||
27515247|NCT01587898|80080848|FG002|Overall Study|Protocol Violation|1|||
27515248|NCT01587898|80080849|FG003|Overall Study|Protocol Violation|1|||
27515249|NCT01587898|80080846|FG000|Overall Study|Lost to Follow-up|0|||
27515250|NCT01587898|80080847|FG001|Overall Study|Lost to Follow-up|0|||
27515251|NCT01587898|80080848|FG002|Overall Study|Lost to Follow-up|0|||
27515252|NCT01587898|80080849|FG003|Overall Study|Lost to Follow-up|1|||
27515253|NCT01587898|80080846|FG000|Overall Study|Withdrawal by Subject|2|||
27515254|NCT01587898|80080847|FG001|Overall Study|Withdrawal by Subject|1|||
27515255|NCT01587898|80080848|FG002|Overall Study|Withdrawal by Subject|0|||
27515256|NCT01587898|80080849|FG003|Overall Study|Withdrawal by Subject|0|||
27515257|NCT01587898|80080846|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
27515258|NCT01587898|80080847|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
27515259|NCT01587898|80080848|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
27515260|NCT01587898|80080849|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
27515261|NCT01821560|80080850|FG000|Overall Study|Lost to Follow-up|5|||
27515262|NCT01821560|80080851|FG001|Overall Study|Lost to Follow-up|5|||
27515263|NCT01821560|80080850|FG000|Overall Study|Withdrawal by Subject|1|||
27515264|NCT01821560|80080851|FG001|Overall Study|Withdrawal by Subject|1|||
27515265|NCT01821560|80080850|FG000|Overall Study|Protocol Violation|0|||
27515266|NCT01821560|80080851|FG001|Overall Study|Protocol Violation|1|||
27906977|NCT00582426|81496841|FG000|Overall Study|Death|4|||
27515267|NCT02147561|80080852|FG000|Overall Study|Lost to Follow-up|3|||
27515268|NCT02147561|80080852|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
27515269|NCT01112306|80080854|FG000|Overall Study|Death|175|||
27515270|NCT01112306|80080854|FG000|Overall Study|Lost to Follow-up|9|||
27515271|NCT01112306|80080854|FG000|Overall Study|Withdrawal by Subject|31|||
27515272|NCT01112306|80080854|FG000|Overall Study|Other|70|||
27515273|NCT00899392|80080855|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
27515274|NCT00899392|80080856|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
27515275|NCT02636361|80080857|FG000|Period 4|Physician Decision|0|||
27515276|NCT02636361|80080858|FG001|Period 4|Physician Decision|0|||
27515277|NCT02636361|80080859|FG002|Period 4|Physician Decision|0|||
27515278|NCT02636361|80080860|FG003|Period 4|Physician Decision|1|||
27515279|NCT02636361|80080861|FG004|Period 4|Physician Decision|0|||
27515280|NCT02175199|80080864|FG000|Overall Study|Withdrawal by Subject|1|||
27515281|NCT02175199|80080865|FG001|Overall Study|Withdrawal by Subject|5|||
27515282|NCT02175199|80080864|FG000|Overall Study|Randomized in Error|1|||
27515283|NCT02175199|80080865|FG001|Overall Study|Randomized in Error|0|||
27515284|NCT02175199|80080864|FG000|Overall Study|Sponsor Decision|1|||
27515285|NCT02175199|80080865|FG001|Overall Study|Sponsor Decision|0|||
27515286|NCT01561313|80080872|FG000|Overall Study|Withdrawal by Subject|1|||
27906978|NCT00582426|81496842|FG001|Overall Study|Death|3|||
27906979|NCT00582426|81496841|FG000|Overall Study|Withdrawal by Subject|3|||
27906980|NCT00582426|81496842|FG001|Overall Study|Withdrawal by Subject|2|||
27515287|NCT01561313|80080873|FG001|Overall Study|Withdrawal by Subject|0|||
27515288|NCT01561313|80080872|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
27515289|NCT01561313|80080873|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
27515290|NCT00534599|80080874|FG000|Overall Study|Adverse Event|25|||
27515291|NCT00534599|80080875|FG001|Overall Study|Adverse Event|4|||
27515292|NCT00534599|80080874|FG000|Overall Study|Incorrect enrollment|2|||
27515293|NCT00534599|80080875|FG001|Overall Study|Incorrect enrollment|1|||
27906981|NCT00582426|81496841|FG000|Overall Study|Disease Progression|2|||
27906982|NCT00582426|81496842|FG001|Overall Study|Disease Progression|2|||
27515294|NCT00534599|80080874|FG000|Overall Study|Mis-randomization|2|||
27616122|NCT03486899|80437620|FG000|Overall Study|Lost to Follow-up|4|||
27616123|NCT03486899|80437621|FG001|Overall Study|Lost to Follow-up|1|||
27616124|NCT03486899|80437622|FG002|Overall Study|Lost to Follow-up|4|||
27616125|NCT03486899|80437623|FG003|Overall Study|Lost to Follow-up|3|||
27616126|NCT03486899|80437620|FG000|Overall Study|Death|1|||
27616127|NCT03486899|80437621|FG001|Overall Study|Death|0|||
27616128|NCT03486899|80437622|FG002|Overall Study|Death|0|||
27616129|NCT03486899|80437623|FG003|Overall Study|Death|1|||
27616130|NCT03486899|80437620|FG000|Overall Study|Adverse Event|0|||
27616131|NCT03486899|80437621|FG001|Overall Study|Adverse Event|2|||
27616132|NCT03486899|80437622|FG002|Overall Study|Adverse Event|0|||
27515295|NCT00534599|80080875|FG001|Overall Study|Mis-randomization|2|||
27515296|NCT00534599|80080874|FG000|Overall Study|Developed study-specific d/c criteria|5|||
27515297|NCT00534599|80080875|FG001|Overall Study|Developed study-specific d/c criteria|0|||
27515298|NCT00534599|80080874|FG000|Overall Study|Lack of Efficacy|0|||
27515299|NCT00534599|80080875|FG001|Overall Study|Lack of Efficacy|1|||
27515300|NCT00534599|80080874|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
27515301|NCT00534599|80080875|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
27515302|NCT00534599|80080874|FG000|Overall Study|Protocol Violation|1|||
27515303|NCT00534599|80080875|FG001|Overall Study|Protocol Violation|3|||
27515304|NCT00534599|80080874|FG000|Overall Study|Lost to Follow-up|11|||
27515305|NCT00534599|80080875|FG001|Overall Study|Lost to Follow-up|14|||
27515306|NCT00534599|80080874|FG000|Overall Study|Withdrawal by Subject|4|||
27515307|NCT00534599|80080875|FG001|Overall Study|Withdrawal by Subject|6|||
27515308|NCT00534599|80080874|FG000|Overall Study|Other|7|||
27515309|NCT00534599|80080875|FG001|Overall Study|Other|0|||
27515310|NCT02934503|80080876|FG000|Overall Study|progression of disease|3|||
27515311|NCT02934503|80080876|FG000|Overall Study|Withdrawal by Subject|1|||
27515312|NCT04556383|80080883|FG000|PCP|Lack of Efficacy|28|||
27616133|NCT03486899|80437623|FG003|Overall Study|Adverse Event|2|||
27616134|NCT03486899|80437620|FG000|Overall Study|Withdrawal by Subject|3|||
27616135|NCT03486899|80437621|FG001|Overall Study|Withdrawal by Subject|7|||
27616136|NCT03486899|80437622|FG002|Overall Study|Withdrawal by Subject|4|||
27616137|NCT03486899|80437623|FG003|Overall Study|Withdrawal by Subject|3|||
27616138|NCT03486899|80437620|FG000|Overall Study|Other Reasons|0|||
27616139|NCT03486899|80437621|FG001|Overall Study|Other Reasons|1|||
27616140|NCT03486899|80437622|FG002|Overall Study|Other Reasons|0|||
27616141|NCT03486899|80437623|FG003|Overall Study|Other Reasons|1|||
27616142|NCT01225835|80437626|FG000|Overall Study|Completed protocol|2|||
27616143|NCT01225835|80437627|FG001|Overall Study|Completed protocol|1|||
27616144|NCT01225835|80437626|FG000|Overall Study|Did not meet hCG criterion|2|||
27616145|NCT01225835|80437627|FG001|Overall Study|Did not meet hCG criterion|0|||
27616146|NCT01225835|80437626|FG000|Overall Study|Adverse Event|2|||
27616147|NCT01225835|80437627|FG001|Overall Study|Adverse Event|1|||
27616148|NCT01225835|80437626|FG000|Overall Study|Other|1|||
27616149|NCT01225835|80437627|FG001|Overall Study|Other|1|||
27616150|NCT03044353|80437628|FG000|Overall Study|Adverse Event|0|||
27616151|NCT03044353|80437629|FG001|Overall Study|Adverse Event|1|||
27616152|NCT03044353|80437630|FG002|Overall Study|Adverse Event|0|||
27616153|NCT01196104|80437632|FG000|Overall Study|Lost to Follow-up|1|||
27616154|NCT01196104|80437633|FG001|Overall Study|Lost to Follow-up|0|||
27616155|NCT01196104|80437632|FG000|Overall Study|Physician Decision|0|||
27616156|NCT01196104|80437633|FG001|Overall Study|Physician Decision|1|||
27616157|NCT01196104|80437632|FG000|Overall Study|Withdrawal by Subject|3|||
27616158|NCT01196104|80437633|FG001|Overall Study|Withdrawal by Subject|3|||
27616159|NCT01196104|80437632|FG000|Overall Study|Various|0|||
27906983|NCT00582426|81496841|FG000|Overall Study|Use of illicit drugs|1|||
27906984|NCT00582426|81496842|FG001|Overall Study|Use of illicit drugs|0|||
27906985|NCT00329745|81496847|FG000|Overall Study|Protocol Violation|1|||
27616160|NCT01196104|80437633|FG001|Overall Study|Various|1|||
27616161|NCT02698436|80437634|FG000|Overall Study|Adverse Event|1|||
27616162|NCT02698436|80437635|FG001|Overall Study|Adverse Event|0|||
27616163|NCT02698436|80437634|FG000|Overall Study|Withdrawal by Subject|3|||
27616164|NCT02698436|80437635|FG001|Overall Study|Withdrawal by Subject|3|||
27616165|NCT02698436|80437634|FG000|Overall Study|Lost to Follow-up|2|||
27616166|NCT02698436|80437635|FG001|Overall Study|Lost to Follow-up|4|||
27616167|NCT02698436|80437634|FG000|Overall Study|Non-compliance with study regimen|1|||
27906986|NCT00329745|81496848|FG001|Overall Study|Protocol Violation|0|||
27515313|NCT04556383|80080884|FG001|PCP|Lack of Efficacy|23|||
27616168|NCT02698436|80437635|FG001|Overall Study|Non-compliance with study regimen|0|||
27616169|NCT00776100|80437645|FG000|Overall Study|Disease Progression|1|||
27616170|NCT00776100|80437646|FG001|Overall Study|Disease Progression|0|||
27616171|NCT00919893|80437647|FG000|Overall Study|Protocol Violation|19|||
27616172|NCT00919893|80437648|FG001|Overall Study|Protocol Violation|9|||
27616173|NCT00750893|80437649|FG000|Overall Study|Adverse Event|5|||
27616174|NCT00750893|80437649|FG000|Overall Study|Withdrawal by Subject|10|||
27616175|NCT00750893|80437649|FG000|Overall Study|Lost to Follow-up|510|||
27515314|NCT04556383|80080885|FG002|PCP|Lack of Efficacy|23|||
27616176|NCT00750893|80437649|FG000|Overall Study|Other|17|||
27616177|NCT01900054|80437650|FG000|Overall Study|Physician Decision|1|||
27616178|NCT01900054|80437650|FG000|Overall Study|Withdrawal by Subject|1|||
27616179|NCT01734382|80437651|FG000|Part 1|Adverse Event|2|||
27616180|NCT01734382|80437652|FG001|Part 1|Adverse Event|0|||
27616181|NCT01734382|80437653|FG002|Part 1|Adverse Event|0|||
27616182|NCT01734382|80437651|FG000|Part 2|Adverse Event|0|||
27616183|NCT01734382|80437652|FG001|Part 2|Adverse Event|0|||
27616184|NCT01734382|80437653|FG002|Part 2|Adverse Event|1|||
27616185|NCT01734382|80437651|FG000|Part 2|Lack of Efficacy|0|||
27616186|NCT01734382|80437652|FG001|Part 2|Lack of Efficacy|1|||
27616187|NCT01734382|80437653|FG002|Part 2|Lack of Efficacy|1|||
27616188|NCT01734382|80437651|FG000|Part 2|Other|0|||
27616189|NCT01734382|80437652|FG001|Part 2|Other|0|||
27616190|NCT01734382|80437653|FG002|Part 2|Other|1|||
27616191|NCT01734382|80437651|FG000|Part 2|Physician Decision|0|||
27616192|NCT01734382|80437652|FG001|Part 2|Physician Decision|0|||
27616193|NCT01734382|80437653|FG002|Part 2|Physician Decision|3|||
27616194|NCT01734382|80437651|FG000|Part 2|Protocol Violation|0|||
27616195|NCT01734382|80437652|FG001|Part 2|Protocol Violation|1|||
27616196|NCT01734382|80437653|FG002|Part 2|Protocol Violation|0|||
27616197|NCT01734382|80437651|FG000|Part 2|Withdrawal by Subject|0|||
27616198|NCT01734382|80437652|FG001|Part 2|Withdrawal by Subject|0|||
27616199|NCT01734382|80437653|FG002|Part 2|Withdrawal by Subject|1|||
27616200|NCT00627042|80437654|FG000|Overall Study|Withdrawal by Subject|2|||
27616201|NCT00109928|80437657|FG000|Overall Study|Adverse Event|2|||
27616202|NCT00109928|80437657|FG000|Overall Study|Progression|6|||
27616203|NCT00109928|80437657|FG000|Overall Study|Death|2|||
27616204|NCT00109928|80437657|FG000|Overall Study|not protocol specified|2|||
27616205|NCT00109928|80437657|FG000|Overall Study|not eligible|1|||
27616206|NCT00442286|80437661|FG000|Overall Study|Death|2|||
27616207|NCT00442286|80437662|FG001|Overall Study|Death|2|||
27616208|NCT00442286|80437661|FG000|Overall Study|Lost to Follow-up|1|||
27616209|NCT00442286|80437662|FG001|Overall Study|Lost to Follow-up|0|||
27616210|NCT00442286|80437661|FG000|Overall Study|Withdrawal by Subject|2|||
27616211|NCT00442286|80437662|FG001|Overall Study|Withdrawal by Subject|0|||
27616212|NCT00442286|80437661|FG000|Overall Study|System explanted|1|||
27616213|NCT00442286|80437662|FG001|Overall Study|System explanted|0|||
27616214|NCT00442286|80437661|FG000|Overall Study|Patient Injury|1|||
27616215|NCT00442286|80437662|FG001|Overall Study|Patient Injury|0|||
27616216|NCT03135548|80437664|FG000|Overall Study|Lost to Follow-up|3|||
27616217|NCT03135548|80437665|FG001|Overall Study|Lost to Follow-up|0|||
27616218|NCT03135548|80437666|FG002|Overall Study|Lost to Follow-up|0|||
27616219|NCT03135548|80437664|FG000|Overall Study|Withdrawal by Subject|2|||
27616220|NCT03135548|80437665|FG001|Overall Study|Withdrawal by Subject|2|||
27616221|NCT03135548|80437666|FG002|Overall Study|Withdrawal by Subject|1|||
27616222|NCT03135548|80437664|FG000|Overall Study|Other than listed|0|||
27616223|NCT03135548|80437665|FG001|Overall Study|Other than listed|2|||
27616224|NCT03135548|80437666|FG002|Overall Study|Other than listed|2|||
27616225|NCT03541642|80437670|FG000|Overall Study|Withdrawal by Subject|1|||
27616226|NCT03541642|80437671|FG001|Overall Study|Withdrawal by Subject|2|||
27853287|NCT00444457|81294997|FG002|After Infant Series|Adverse Event|0|||
27853288|NCT00444457|81294998|FG003|After Infant Series|Adverse Event|0|||
27853289|NCT00444457|81294995|FG000|After Infant Series|Investigator request|0|||
27853290|NCT00444457|81294996|FG001|After Infant Series|Investigator request|0|||
27853291|NCT00444457|81294997|FG002|After Infant Series|Investigator request|0|||
27853292|NCT00444457|81294998|FG003|After Infant Series|Investigator request|1|||
27853293|NCT00444457|81294995|FG000|After Infant Series|Other|0|||
27853294|NCT00444457|81294996|FG001|After Infant Series|Other|1|||
27853295|NCT00444457|81294997|FG002|After Infant Series|Other|0|||
27853296|NCT00444457|81294998|FG003|After Infant Series|Other|0|||
27853297|NCT00444457|81294995|FG000|Toddler Dose|Lost to Follow-up|4|||
27853298|NCT00444457|81294996|FG001|Toddler Dose|Lost to Follow-up|1|||
27853299|NCT00444457|81294997|FG002|Toddler Dose|Lost to Follow-up|1|||
27853300|NCT00444457|81294998|FG003|Toddler Dose|Lost to Follow-up|3|||
27853301|NCT00444457|81294995|FG000|Toddler Dose|Failed to return|2|||
27853302|NCT00444457|81294996|FG001|Toddler Dose|Failed to return|2|||
27853303|NCT00444457|81294997|FG002|Toddler Dose|Failed to return|1|||
27616227|NCT03541642|80437670|FG000|Overall Study|Lost to Follow-up|16|||
27616228|NCT03541642|80437671|FG001|Overall Study|Lost to Follow-up|12|||
27616229|NCT03541642|80437670|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
27616230|NCT03541642|80437671|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
27853304|NCT00444457|81294998|FG003|Toddler Dose|Failed to return|3|||
27853305|NCT00444457|81294995|FG000|Toddler Dose|Parent or legal guardian request|0|||
27853306|NCT00444457|81294996|FG001|Toddler Dose|Parent or legal guardian request|3|||
27853307|NCT00444457|81294997|FG002|Toddler Dose|Parent or legal guardian request|2|||
27616231|NCT03050398|80437672|FG000|Overall Study|Study terminated by sponsor|8|||
27616232|NCT02733042|80437674|FG000|Overall Study|Adverse Event|1|||
27616233|NCT02733042|80437675|FG001|Overall Study|Adverse Event|0|||
27616234|NCT02733042|80437676|FG002|Overall Study|Adverse Event|1|||
27616235|NCT02733042|80437677|FG003|Overall Study|Adverse Event|1|||
27616236|NCT02733042|80437678|FG004|Overall Study|Adverse Event|0|||
27616237|NCT02733042|80437679|FG005|Overall Study|Adverse Event|0|||
27853308|NCT00444457|81294998|FG003|Toddler Dose|Parent or legal guardian request|1|||
27853309|NCT00444457|81294995|FG000|Toddler Dose|Protocol Violation|1|||
27515315|NCT04556383|80080886|FG003|PCP|Lack of Efficacy|0|||
27515316|NCT04556383|80080883|FG000|PCP|Study terminated by sponsor|15|||
27515317|NCT04556383|80080884|FG001|PCP|Study terminated by sponsor|13|||
27515318|NCT04556383|80080885|FG002|PCP|Study terminated by sponsor|16|||
27515319|NCT04556383|80080886|FG003|PCP|Study terminated by sponsor|0|||
27515320|NCT04556383|80080883|FG000|PCP|Withdrawal by Subject|8|||
27515321|NCT04556383|80080884|FG001|PCP|Withdrawal by Subject|6|||
27515322|NCT04556383|80080885|FG002|PCP|Withdrawal by Subject|6|||
27515323|NCT04556383|80080886|FG003|PCP|Withdrawal by Subject|0|||
27515324|NCT04556383|80080883|FG000|PCP|Adverse Event|1|||
27515325|NCT04556383|80080884|FG001|PCP|Adverse Event|7|||
27515326|NCT04556383|80080885|FG002|PCP|Adverse Event|7|||
27515327|NCT04556383|80080886|FG003|PCP|Adverse Event|0|||
27515328|NCT04556383|80080883|FG000|PCP|Other, Not Specified|1|||
27515329|NCT04556383|80080884|FG001|PCP|Other, Not Specified|2|||
27515330|NCT04556383|80080885|FG002|PCP|Other, Not Specified|1|||
27515331|NCT04556383|80080886|FG003|PCP|Other, Not Specified|0|||
27616238|NCT02733042|80437680|FG006|Overall Study|Adverse Event|0|||
27728720|NCT00355264|80838093|FG000|Extension (Variable Duration)|Adverse Event|1|||
27728721|NCT00355264|80838093|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
27728722|NCT00151892|80838096|FG000|Overall Study|Lack of Efficacy|50|||
27853310|NCT00444457|81294996|FG001|Toddler Dose|Protocol Violation|0|||
27515332|NCT04556383|80080883|FG000|PCP|Protocol Violation|1|||
27515333|NCT04556383|80080884|FG001|PCP|Protocol Violation|0|||
27515334|NCT04556383|80080885|FG002|PCP|Protocol Violation|1|||
27515335|NCT04556383|80080886|FG003|PCP|Protocol Violation|0|||
27515336|NCT04556383|80080883|FG000|PCP|Lost to Follow-up|1|||
27515337|NCT04556383|80080884|FG001|PCP|Lost to Follow-up|0|||
27515338|NCT04556383|80080885|FG002|PCP|Lost to Follow-up|0|||
27515339|NCT04556383|80080886|FG003|PCP|Lost to Follow-up|0|||
27515340|NCT04556383|80080883|FG000|PCP|Physician Decision|0|||
27515341|NCT04556383|80080884|FG001|PCP|Physician Decision|1|||
27515342|NCT04556383|80080885|FG002|PCP|Physician Decision|0|||
27515343|NCT04556383|80080886|FG003|PCP|Physician Decision|0|||
27515344|NCT04556383|80080883|FG000|PCP|Site terminated by sponsor|0|||
27515345|NCT04556383|80080884|FG001|PCP|Site terminated by sponsor|1|||
27515346|NCT04556383|80080885|FG002|PCP|Site terminated by sponsor|0|||
27515347|NCT04556383|80080886|FG003|PCP|Site terminated by sponsor|0|||
27515348|NCT04556383|80080883|FG000|OLE|Study terminated by sponsor|0|||
27515349|NCT04556383|80080884|FG001|OLE|Study terminated by sponsor|0|||
27515350|NCT04556383|80080885|FG002|OLE|Study terminated by sponsor|0|||
27515351|NCT04556383|80080886|FG003|OLE|Study terminated by sponsor|68|||
27515352|NCT04556383|80080883|FG000|OLE|Withdrawal by Subject|0|||
27515353|NCT04556383|80080884|FG001|OLE|Withdrawal by Subject|0|||
27853311|NCT00444457|81294997|FG002|Toddler Dose|Protocol Violation|0|||
27853312|NCT00444457|81294998|FG003|Toddler Dose|Protocol Violation|1|||
27853313|NCT00499174|81294999|FG000|Overall Study|Physician Decision|78|||
27853314|NCT00499174|81295000|FG001|Overall Study|Physician Decision|9|||
27853315|NCT01833533|81295002|FG000|Overall Study|Adverse Event|0|||
27728723|NCT00151892|80838097|FG001|Overall Study|Lack of Efficacy|57|||
27853316|NCT01833533|81295003|FG001|Overall Study|Adverse Event|1|||
27853317|NCT01833533|81295002|FG000|Overall Study|Lost to Follow-up|4|||
27853318|NCT01833533|81295003|FG001|Overall Study|Lost to Follow-up|9|||
27853319|NCT01833533|81295002|FG000|Overall Study|To Enter an Extension Study|0|||
27853320|NCT01833533|81295003|FG001|Overall Study|To Enter an Extension Study|4|||
27853321|NCT01833533|81295002|FG000|Overall Study|Other|2|||
27853322|NCT01833533|81295003|FG001|Overall Study|Other|7|||
27853323|NCT00741936|81295004|FG000|Overall Study|Lost to Follow-up|1|||
27853324|NCT00741936|81295005|FG001|Overall Study|Lost to Follow-up|1|||
27853325|NCT00741936|81295004|FG000|Overall Study|Adverse Event|3|||
27853326|NCT00741936|81295005|FG001|Overall Study|Adverse Event|4|||
27853327|NCT00741936|81295004|FG000|Overall Study|Pregnancy|0|||
27853328|NCT00741936|81295005|FG001|Overall Study|Pregnancy|1|||
27515354|NCT04556383|80080885|FG002|OLE|Withdrawal by Subject|0|||
27515355|NCT04556383|80080886|FG003|OLE|Withdrawal by Subject|10|||
27515356|NCT04556383|80080883|FG000|OLE|Lack of Efficacy|0|||
27515357|NCT04556383|80080884|FG001|OLE|Lack of Efficacy|0|||
27515358|NCT04556383|80080885|FG002|OLE|Lack of Efficacy|0|||
27515359|NCT04556383|80080886|FG003|OLE|Lack of Efficacy|7|||
27515360|NCT04556383|80080883|FG000|OLE|Adverse Event|0|||
27515361|NCT04556383|80080884|FG001|OLE|Adverse Event|0|||
27515362|NCT04556383|80080885|FG002|OLE|Adverse Event|0|||
27515363|NCT04556383|80080886|FG003|OLE|Adverse Event|2|||
27515364|NCT04556383|80080883|FG000|OLE|Other, Not Specified|0|||
27515365|NCT04556383|80080884|FG001|OLE|Other, Not Specified|0|||
27515366|NCT04556383|80080885|FG002|OLE|Other, Not Specified|0|||
27515367|NCT04556383|80080886|FG003|OLE|Other, Not Specified|2|||
27515368|NCT04556383|80080883|FG000|OLE|Death|0|||
27616239|NCT02733042|80437681|FG007|Overall Study|Adverse Event|0|||
27853329|NCT00741936|81295004|FG000|Overall Study|Protocol Violation|2|||
27853330|NCT00741936|81295005|FG001|Overall Study|Protocol Violation|0|||
27853331|NCT00741936|81295004|FG000|Overall Study|Lack of Efficacy|0|||
27853332|NCT00741936|81295005|FG001|Overall Study|Lack of Efficacy|2|||
27616240|NCT02733042|80437682|FG008|Overall Study|Adverse Event|0|||
27616241|NCT02733042|80437683|FG009|Overall Study|Adverse Event|0|||
27616242|NCT02733042|80437684|FG010|Overall Study|Adverse Event|2|||
27616243|NCT02733042|80437685|FG011|Overall Study|Adverse Event|2|||
27616244|NCT02733042|80437686|FG012|Overall Study|Adverse Event|0|||
27616245|NCT02733042|80437687|FG013|Overall Study|Adverse Event|2|||
27616246|NCT02733042|80437688|FG014|Overall Study|Adverse Event|0|||
27616247|NCT02733042|80437689|FG015|Overall Study|Adverse Event|0|||
27616248|NCT02733042|80437690|FG016|Overall Study|Adverse Event|0|||
27616249|NCT02733042|80437691|FG017|Overall Study|Adverse Event|1|||
27616250|NCT02733042|80437692|FG018|Overall Study|Adverse Event|0|||
27616251|NCT02733042|80437674|FG000|Overall Study|Progressive Disease|2|||
27616252|NCT02733042|80437675|FG001|Overall Study|Progressive Disease|1|||
27616253|NCT02733042|80437676|FG002|Overall Study|Progressive Disease|3|||
27616254|NCT02733042|80437677|FG003|Overall Study|Progressive Disease|1|||
27616255|NCT02733042|80437678|FG004|Overall Study|Progressive Disease|2|||
27616256|NCT02733042|80437679|FG005|Overall Study|Progressive Disease|3|||
27616257|NCT02733042|80437680|FG006|Overall Study|Progressive Disease|0|||
27616258|NCT02733042|80437681|FG007|Overall Study|Progressive Disease|3|||
27616259|NCT02733042|80437682|FG008|Overall Study|Progressive Disease|3|||
27616260|NCT02733042|80437683|FG009|Overall Study|Progressive Disease|2|||
27616261|NCT02733042|80437684|FG010|Overall Study|Progressive Disease|2|||
27616262|NCT02733042|80437685|FG011|Overall Study|Progressive Disease|2|||
27616263|NCT02733042|80437686|FG012|Overall Study|Progressive Disease|8|||
27616264|NCT02733042|80437687|FG013|Overall Study|Progressive Disease|1|||
27616265|NCT02733042|80437688|FG014|Overall Study|Progressive Disease|4|||
27616266|NCT02733042|80437689|FG015|Overall Study|Progressive Disease|7|||
27616267|NCT02733042|80437690|FG016|Overall Study|Progressive Disease|2|||
27616268|NCT02733042|80437691|FG017|Overall Study|Progressive Disease|3|||
27616269|NCT02733042|80437692|FG018|Overall Study|Progressive Disease|4|||
27853333|NCT00741936|81295004|FG000|Overall Study|Low compliance|3|||
27515369|NCT04556383|80080884|FG001|OLE|Death|0|||
27515370|NCT04556383|80080885|FG002|OLE|Death|0|||
27515371|NCT04556383|80080886|FG003|OLE|Death|1|||
27515372|NCT04556383|80080883|FG000|OLE|Lost to Follow-up|0|||
27515373|NCT04556383|80080884|FG001|OLE|Lost to Follow-up|0|||
27515374|NCT04556383|80080885|FG002|OLE|Lost to Follow-up|0|||
27515375|NCT04556383|80080886|FG003|OLE|Lost to Follow-up|1|||
27515376|NCT00744042|80080887|FG000|Overall Study|Withdrawal by Subject|1|||
27515377|NCT00916929|80080889|FG000|Overall Study|Lost to Follow-up|1|||
27515378|NCT00916929|80080890|FG001|Overall Study|Lost to Follow-up|3|||
27515379|NCT00916929|80080889|FG000|Overall Study|Death|5|||
27515380|NCT00916929|80080890|FG001|Overall Study|Death|10|||
27515381|NCT00916929|80080889|FG000|Overall Study|Withdrawal by Subject|1|||
27515382|NCT00916929|80080890|FG001|Overall Study|Withdrawal by Subject|5|||
27515383|NCT00916929|80080889|FG000|Overall Study|Left ventricular epicardial lead|1|||
27515384|NCT00916929|80080890|FG001|Overall Study|Left ventricular epicardial lead|2|||
27515385|NCT00916929|80080889|FG000|Overall Study|Transferred to hospice care|1|||
27515386|NCT00916929|80080890|FG001|Overall Study|Transferred to hospice care|1|||
27515387|NCT00916929|80080889|FG000|Overall Study|System explant|1|||
27515388|NCT00916929|80080890|FG001|Overall Study|System explant|0|||
27515389|NCT00916929|80080889|FG000|Overall Study|Moved to another state|0|||
27515390|NCT00916929|80080890|FG001|Overall Study|Moved to another state|1|||
27515391|NCT00916929|80080889|FG000|Overall Study|Device unable to process impedance data|0|||
27515392|NCT00916929|80080890|FG001|Overall Study|Device unable to process impedance data|7|||
27515393|NCT02314637|80080891|FG000|Overall Study|Adverse Event|4|||
27515394|NCT02314637|80080892|FG001|Overall Study|Adverse Event|8|||
27515395|NCT02314637|80080891|FG000|Overall Study|Lack of Efficacy|1|||
27515396|NCT02314637|80080892|FG001|Overall Study|Lack of Efficacy|0|||
27515397|NCT02314637|80080891|FG000|Overall Study|Physician Decision|5|||
27616270|NCT02733042|80437674|FG000|Overall Study|Withdrawal by Subject|0|||
27616271|NCT02733042|80437675|FG001|Overall Study|Withdrawal by Subject|1|||
27616272|NCT02733042|80437676|FG002|Overall Study|Withdrawal by Subject|2|||
27906987|NCT00329745|81496847|FG000|Overall Study|Withdrawal by Subject|0|||
27515398|NCT02314637|80080892|FG001|Overall Study|Physician Decision|2|||
27515399|NCT02314637|80080891|FG000|Overall Study|Withdrawal by Subject|5|||
27515400|NCT02314637|80080892|FG001|Overall Study|Withdrawal by Subject|4|||
27515401|NCT02314637|80080891|FG000|Overall Study|Other Reason|1|||
27515402|NCT02314637|80080892|FG001|Overall Study|Other Reason|0|||
27515403|NCT02791763|80080893|FG000|Overall Study|Protocol Violation|0|||
27515404|NCT02791763|80080894|FG001|Overall Study|Protocol Violation|0|||
27616273|NCT02733042|80437677|FG003|Overall Study|Withdrawal by Subject|1|||
27616274|NCT02733042|80437678|FG004|Overall Study|Withdrawal by Subject|1|||
27616275|NCT02733042|80437679|FG005|Overall Study|Withdrawal by Subject|0|||
27616276|NCT02733042|80437680|FG006|Overall Study|Withdrawal by Subject|0|||
27616277|NCT02733042|80437681|FG007|Overall Study|Withdrawal by Subject|0|||
27515405|NCT02791763|80080895|FG002|Overall Study|Protocol Violation|1|||
27616278|NCT02733042|80437682|FG008|Overall Study|Withdrawal by Subject|1|||
27616279|NCT02733042|80437683|FG009|Overall Study|Withdrawal by Subject|1|||
27616280|NCT02733042|80437684|FG010|Overall Study|Withdrawal by Subject|0|||
27616281|NCT02733042|80437685|FG011|Overall Study|Withdrawal by Subject|2|||
27616282|NCT02733042|80437686|FG012|Overall Study|Withdrawal by Subject|1|||
27616283|NCT02733042|80437687|FG013|Overall Study|Withdrawal by Subject|1|||
27616284|NCT02733042|80437688|FG014|Overall Study|Withdrawal by Subject|0|||
27853334|NCT00741936|81295005|FG001|Overall Study|Low compliance|0|||
27853335|NCT01408628|81295008|FG000|Consented|Withdrawal by Subject|12|||
27853336|NCT01408628|81295008|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
27853337|NCT01408628|81295008|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
27853338|NCT01408628|81295008|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
27853339|NCT01753336|81295009|FG000|Overall Study|Patient decision|12|||
27853340|NCT01753336|81295009|FG000|Overall Study|Lost to Follow-up|3|||
27853341|NCT01753336|81295009|FG000|Overall Study|Physician Decision|2|||
27853342|NCT01753336|81295009|FG000|Overall Study|Sponsor's decision|2|||
27853343|NCT01753336|81295009|FG000|Overall Study|Withdrawal by Subject|1|||
27853344|NCT01951885|81295010|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
27853345|NCT01951885|81295011|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
27853346|NCT01951885|81295010|FG000|Overall Study|Adverse Event|1|||
27853347|NCT01951885|81295011|FG001|Overall Study|Adverse Event|0|||
27906988|NCT00329745|81496848|FG001|Overall Study|Withdrawal by Subject|1|||
27906989|NCT00329745|81496847|FG000|Overall Study|Lost to Follow-up|86|||
27906990|NCT00329745|81496848|FG001|Overall Study|Lost to Follow-up|101|||
27906991|NCT00048997|81496851|FG000|Overall Study|Protocol Violation|7|||
27906992|NCT00048997|81496852|FG001|Overall Study|Protocol Violation|2|||
27906993|NCT00048997|81496851|FG000|Overall Study|Withdrawal by Subject|6|||
27906994|NCT00048997|81496852|FG001|Overall Study|Withdrawal by Subject|1|||
27906995|NCT01765569|81496858|FG000|Period B|Withdrawal by Subject|1|||
27906996|NCT01765569|81496858|FG000|Period C|Death|1|||
27906997|NCT01490840|81496859|FG000|Phase 1|Lost to Follow-up|1|||
27906998|NCT01490840|81496860|FG001|Phase 1|Lost to Follow-up|0|||
27906999|NCT01490840|81496859|FG000|Phase 1|Adverse Event|2|||
27907000|NCT01490840|81496860|FG001|Phase 1|Adverse Event|1|||
27907001|NCT01490840|81496859|FG000|Phase 1|Withdrawal by Subject|6|||
27907002|NCT01490840|81496860|FG001|Phase 1|Withdrawal by Subject|5|||
27515406|NCT02791763|80080893|FG000|Overall Study|Withdrawal by Subject|5|||
27515407|NCT02791763|80080894|FG001|Overall Study|Withdrawal by Subject|1|||
27515408|NCT02791763|80080895|FG002|Overall Study|Withdrawal by Subject|0|||
27515409|NCT02791763|80080893|FG000|Overall Study|Physician Decision|0|||
27515410|NCT02791763|80080894|FG001|Overall Study|Physician Decision|1|||
27515411|NCT02791763|80080895|FG002|Overall Study|Physician Decision|0|||
27515412|NCT02791763|80080893|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
27515413|NCT02791763|80080894|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
27515414|NCT02791763|80080895|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
27515415|NCT02791763|80080893|FG000|Overall Study|Cancer event|1|||
27515416|NCT02791763|80080894|FG001|Overall Study|Cancer event|3|||
27515417|NCT02791763|80080895|FG002|Overall Study|Cancer event|0|||
27515418|NCT02791763|80080893|FG000|Overall Study|Participant had renal transplant|3|||
27515419|NCT02791763|80080894|FG001|Overall Study|Participant had renal transplant|0|||
27515420|NCT02791763|80080895|FG002|Overall Study|Participant had renal transplant|0|||
27515421|NCT02791763|80080893|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
27515422|NCT02791763|80080894|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
27515423|NCT02791763|80080895|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
27515424|NCT02791763|80080893|FG000|Overall Study|Adverse Event|12|||
27515425|NCT02791763|80080894|FG001|Overall Study|Adverse Event|13|||
27515426|NCT02791763|80080895|FG002|Overall Study|Adverse Event|7|||
27515427|NCT02929407|80080903|FG000|Overall Study|Adverse Event|1|||
27515428|NCT00740857|80080904|FG000|Overall Study|Withdrawal by Subject|1|||
27515429|NCT00740857|80080905|FG001|Overall Study|Withdrawal by Subject|0|||
27515430|NCT00740857|80080906|FG002|Overall Study|Withdrawal by Subject|0|||
27515431|NCT00567398|80080912|FG000|Overall Study|Adverse Event|6|||
27515432|NCT00567398|80080913|FG001|Overall Study|Adverse Event|14|||
27515433|NCT00567398|80080912|FG000|Overall Study|Physician Decision|0|||
27515434|NCT00567398|80080913|FG001|Overall Study|Physician Decision|4|||
27515435|NCT00567398|80080912|FG000|Overall Study|Withdrawal by Subject|0|||
27515436|NCT00567398|80080913|FG001|Overall Study|Withdrawal by Subject|2|||
27515437|NCT00567398|80080912|FG000|Overall Study|Renal Transplantation|0|||
27907003|NCT01490840|81496859|FG000|Phase 1|Visit 6a omitted|1|||
27907004|NCT01490840|81496860|FG001|Phase 1|Visit 6a omitted|0|||
27515438|NCT00567398|80080913|FG001|Overall Study|Renal Transplantation|3|||
27515439|NCT00567398|80080912|FG000|Overall Study|Other|1|||
27515440|NCT00567398|80080913|FG001|Overall Study|Other|0|||
27515441|NCT02331277|80080914|FG000|Overall Study|Withdrawal by Subject|1|||
27515442|NCT02331277|80080915|FG001|Overall Study|Withdrawal by Subject|0|||
27515443|NCT00771953|80080916|FG000|Overall Study|Adverse Event|5|||
27616285|NCT02733042|80437689|FG015|Overall Study|Withdrawal by Subject|0|||
27515444|NCT00771953|80080917|FG001|Overall Study|Adverse Event|3|||
27515445|NCT00771953|80080916|FG000|Overall Study|Death|2|||
27853348|NCT01951885|81295010|FG000|Overall Study|Withdrawal by Subject|0|||
27907005|NCT01490840|81496859|FG000|Phase 2|Withdrawal by Subject|4|||
27616286|NCT02733042|80437690|FG016|Overall Study|Withdrawal by Subject|0|||
27616287|NCT02733042|80437691|FG017|Overall Study|Withdrawal by Subject|0|||
27616288|NCT02733042|80437692|FG018|Overall Study|Withdrawal by Subject|0|||
27616289|NCT02733042|80437674|FG000|Overall Study|Other Reasons|0|||
27616290|NCT02733042|80437675|FG001|Overall Study|Other Reasons|0|||
27616291|NCT02733042|80437676|FG002|Overall Study|Other Reasons|1|||
27616292|NCT02733042|80437677|FG003|Overall Study|Other Reasons|0|||
27616293|NCT02733042|80437678|FG004|Overall Study|Other Reasons|0|||
27616294|NCT02733042|80437679|FG005|Overall Study|Other Reasons|0|||
27616295|NCT02733042|80437680|FG006|Overall Study|Other Reasons|0|||
27616296|NCT02733042|80437681|FG007|Overall Study|Other Reasons|0|||
27616297|NCT02733042|80437682|FG008|Overall Study|Other Reasons|0|||
27616298|NCT02733042|80437683|FG009|Overall Study|Other Reasons|1|||
27616299|NCT02733042|80437684|FG010|Overall Study|Other Reasons|1|||
27616300|NCT02733042|80437685|FG011|Overall Study|Other Reasons|0|||
27616301|NCT02733042|80437686|FG012|Overall Study|Other Reasons|0|||
27616302|NCT02733042|80437687|FG013|Overall Study|Other Reasons|0|||
27616303|NCT02733042|80437688|FG014|Overall Study|Other Reasons|0|||
27616304|NCT02733042|80437689|FG015|Overall Study|Other Reasons|1|||
27616305|NCT02733042|80437690|FG016|Overall Study|Other Reasons|0|||
27616306|NCT02733042|80437691|FG017|Overall Study|Other Reasons|1|||
27616307|NCT02733042|80437692|FG018|Overall Study|Other Reasons|0|||
27616308|NCT02733042|80437674|FG000|Overall Study|Death|0|||
27616309|NCT02733042|80437675|FG001|Overall Study|Death|0|||
27616310|NCT02733042|80437676|FG002|Overall Study|Death|0|||
27616311|NCT02733042|80437677|FG003|Overall Study|Death|0|||
27616312|NCT02733042|80437678|FG004|Overall Study|Death|0|||
27616313|NCT02733042|80437679|FG005|Overall Study|Death|0|||
27616314|NCT02733042|80437680|FG006|Overall Study|Death|1|||
27616315|NCT02733042|80437681|FG007|Overall Study|Death|0|||
27616316|NCT02733042|80437682|FG008|Overall Study|Death|1|||
27616317|NCT02733042|80437683|FG009|Overall Study|Death|0|||
27907006|NCT01490840|81496860|FG001|Phase 2|Withdrawal by Subject|3|||
27515446|NCT00771953|80080917|FG001|Overall Study|Death|2|||
27515447|NCT00771953|80080916|FG000|Overall Study|Progression before active Tx|1|||
27515448|NCT00771953|80080917|FG001|Overall Study|Progression before active Tx|2|||
27515449|NCT00771953|80080916|FG000|Overall Study|Sponsor decision|1|||
27515450|NCT00771953|80080917|FG001|Overall Study|Sponsor decision|0|||
27515451|NCT00771953|80080916|FG000|Overall Study|Other complicating disease|1|||
27515452|NCT00771953|80080917|FG001|Overall Study|Other complicating disease|0|||
27515453|NCT00771953|80080916|FG000|Overall Study|Withdrawal by Subject|0|||
27515454|NCT00771953|80080917|FG001|Overall Study|Withdrawal by Subject|3|||
27515455|NCT00539188|80080918|FG000|Overall Study|Withdrawal by Subject|1|||
27515456|NCT00539188|80080919|FG001|Overall Study|Withdrawal by Subject|0|||
27515457|NCT00539188|80080918|FG000|Overall Study|Lost to Follow-up|2|||
27515458|NCT00539188|80080919|FG001|Overall Study|Lost to Follow-up|1|||
27515459|NCT02744040|80080923|FG000|Overall Study|Withdrawal by Subject|3|||
27515460|NCT02744040|80080924|FG001|Overall Study|Withdrawal by Subject|2|||
27515461|NCT02744040|80080925|FG002|Overall Study|Withdrawal by Subject|2|||
27515462|NCT02744040|80080923|FG000|Overall Study|Physician Decision|0|||
27515463|NCT02744040|80080924|FG001|Overall Study|Physician Decision|8|||
27515464|NCT02744040|80080925|FG002|Overall Study|Physician Decision|13|||
27515465|NCT02744040|80080923|FG000|Overall Study|Lost to Follow-up|3|||
27515466|NCT02744040|80080924|FG001|Overall Study|Lost to Follow-up|1|||
27515467|NCT02744040|80080925|FG002|Overall Study|Lost to Follow-up|7|||
27515468|NCT02260180|80080930|FG000|Overall Study|Adverse Event|2|||
27515469|NCT02260180|80080931|FG001|Overall Study|Adverse Event|0|||
27515470|NCT02260180|80080932|FG002|Overall Study|Adverse Event|1|||
27616318|NCT02733042|80437684|FG010|Overall Study|Death|1|||
27616319|NCT02733042|80437685|FG011|Overall Study|Death|0|||
27616320|NCT02733042|80437686|FG012|Overall Study|Death|0|||
27616321|NCT02733042|80437687|FG013|Overall Study|Death|0|||
27616322|NCT02733042|80437688|FG014|Overall Study|Death|1|||
27907007|NCT01490840|81496859|FG000|Phase 2|Permanent interruption of fingolimod|0|||
27515471|NCT02404025|80080935|FG000|Overall Study|Adverse Event|1|||
27515472|NCT02404025|80080935|FG000|Overall Study|Lack of Efficacy|3|||
27515473|NCT01387542|80080936|FG000|Overall Study|Adverse Event|3|||
27515474|NCT01387542|80080936|FG000|Overall Study|Withdrawal by Subject|1|||
27616323|NCT02733042|80437689|FG015|Overall Study|Death|2|||
27616324|NCT02733042|80437690|FG016|Overall Study|Death|0|||
27616325|NCT02733042|80437691|FG017|Overall Study|Death|0|||
27616326|NCT02733042|80437692|FG018|Overall Study|Death|0|||
27616327|NCT00422799|80437693|FG000|Overall Study|Withdrawal by Subject|6|||
27616328|NCT00422799|80437693|FG000|Overall Study|Adverse Event|7|||
27616329|NCT01186328|80437694|FG000|Overall Study|Death|1|||
27907008|NCT01490840|81496860|FG001|Phase 2|Permanent interruption of fingolimod|1|||
27515475|NCT01387542|80080936|FG000|Overall Study|Changed diagnosis|1|||
27616330|NCT01186328|80437695|FG001|Overall Study|Death|0|||
27616331|NCT01186328|80437696|FG002|Overall Study|Death|0|||
27616332|NCT00305864|80437697|FG000|Overall Study|Ineligible / No protocol treatment|0|||
27616333|NCT00305864|80437698|FG001|Overall Study|Ineligible / No protocol treatment|1|||
27515476|NCT01387542|80080936|FG000|Overall Study|Insufficient response|1|||
27515477|NCT01387542|80080936|FG000|Overall Study|Non-compliant|1|||
27515478|NCT01387542|80080936|FG000|Overall Study|Lost to Follow-up|1|||
27616334|NCT00305864|80437699|FG002|Overall Study|Ineligible / No protocol treatment|1|||
27728724|NCT00151892|80838096|FG000|Overall Study|Patient request|10|||
27728725|NCT00151892|80838097|FG001|Overall Study|Patient request|7|||
27515479|NCT01587014|80080939|FG000|Overall Study|Death|2|||
27515480|NCT01309282|80080950|FG000|Overall Study|Lost to Follow-up|1|||
27515481|NCT01209325|80080955|FG000|Overall Study|Lost to Follow-up|24|||
27515482|NCT01209325|80080955|FG000|Overall Study|Adverse Event|1|||
27515483|NCT01209325|80080955|FG000|Overall Study|Relocated|3|||
27515484|NCT01209325|80080955|FG000|Overall Study|Refusal after starting therapy|8|||
27515485|NCT01209325|80080955|FG000|Overall Study|Protocol Violation|4|||
27515486|NCT01209325|80080955|FG000|Overall Study|Refusal prior to therapy|1|||
27616335|NCT00305864|80437700|FG003|Overall Study|Ineligible / No protocol treatment|13|||
27616336|NCT04537949|80437701|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
27853349|NCT01951885|81295011|FG001|Overall Study|Withdrawal by Subject|1|||
27853350|NCT01951885|81295010|FG000|Overall Study|ineligible due to a change in donor|0|||
27853351|NCT01951885|81295011|FG001|Overall Study|ineligible due to a change in donor|1|||
27853352|NCT01951885|81295010|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
27853353|NCT01951885|81295011|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
27853354|NCT03052322|81295016|FG000|Overall Study|Other un-specified|1|||
27853355|NCT03052322|81295017|FG001|Overall Study|Other un-specified|2|||
27853356|NCT03052322|81295016|FG000|Overall Study|Withdrawal by Subject|10|||
27853357|NCT03052322|81295017|FG001|Overall Study|Withdrawal by Subject|9|||
27515487|NCT01209325|80080955|FG000|Overall Study|Incarceration|2|||
27515488|NCT02563067|80080956|FG000|Overall Study|Subject/guardian decision|14|||
27515489|NCT02563067|80080957|FG001|Overall Study|Subject/guardian decision|20|||
27515490|NCT02563067|80080958|FG002|Overall Study|Subject/guardian decision|16|||
27515491|NCT02563067|80080956|FG000|Overall Study|Physician Decision|0|||
27515492|NCT02563067|80080957|FG001|Overall Study|Physician Decision|1|||
27515493|NCT02563067|80080958|FG002|Overall Study|Physician Decision|3|||
27515494|NCT02563067|80080956|FG000|Overall Study|Lost to Follow-up|1|||
27515495|NCT02563067|80080957|FG001|Overall Study|Lost to Follow-up|2|||
27515496|NCT02563067|80080958|FG002|Overall Study|Lost to Follow-up|0|||
27515497|NCT02563067|80080956|FG000|Overall Study|Technical problems|0|||
27515498|NCT02563067|80080957|FG001|Overall Study|Technical problems|1|||
27515499|NCT02563067|80080958|FG002|Overall Study|Technical problems|0|||
27515500|NCT02563067|80080956|FG000|Overall Study|Lack of Efficacy|1|||
27515501|NCT02563067|80080957|FG001|Overall Study|Lack of Efficacy|0|||
27515502|NCT02563067|80080958|FG002|Overall Study|Lack of Efficacy|0|||
27515503|NCT02563067|80080956|FG000|Overall Study|Death|0|||
27515504|NCT02563067|80080957|FG001|Overall Study|Death|1|||
27515505|NCT02563067|80080958|FG002|Overall Study|Death|1|||
27515506|NCT02563067|80080956|FG000|Overall Study|Adverse Event|2|||
27515507|NCT02563067|80080957|FG001|Overall Study|Adverse Event|1|||
27515508|NCT02563067|80080958|FG002|Overall Study|Adverse Event|0|||
27515509|NCT02563067|80080956|FG000|Overall Study|Death post Treatment/safety period|1|||
27515510|NCT02563067|80080957|FG001|Overall Study|Death post Treatment/safety period|0|||
27515511|NCT02563067|80080958|FG002|Overall Study|Death post Treatment/safety period|0|||
27515512|NCT01598129|80080959|FG000|Overall Study|Disease progression|6|||
27515513|NCT01598129|80080959|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
27515514|NCT01598129|80080959|FG000|Overall Study|Withdrawal by Subject|1|||
27515515|NCT00243269|80080960|FG000|Overall Study|Protocol Violation|2|||
27515516|NCT00243269|80080961|FG001|Overall Study|Protocol Violation|1|||
27515517|NCT00243269|80080962|FG002|Overall Study|Protocol Violation|0|||
27515518|NCT00243269|80080963|FG003|Overall Study|Protocol Violation|1|||
27515519|NCT00243269|80080960|FG000|Overall Study|Lost to Follow-up|1|||
27515520|NCT00243269|80080961|FG001|Overall Study|Lost to Follow-up|0|||
27515521|NCT00243269|80080962|FG002|Overall Study|Lost to Follow-up|1|||
27515522|NCT00243269|80080963|FG003|Overall Study|Lost to Follow-up|3|||
27515523|NCT04681352|80080964|FG000|Overall Study|Lost to Follow-up|2|||
27515524|NCT04681352|80080964|FG000|Overall Study|Withdrawal by Subject|22|||
27515525|NCT01942733|80080965|FG000|Overall Study|Lost to Follow-up|1|||
27616337|NCT04537949|80437702|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
27616338|NCT04537949|80437703|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
27853358|NCT03052322|81295016|FG000|Overall Study|Death|0|||
27515526|NCT01942733|80080965|FG000|Overall Study|Non-compliance with IMP|1|||
27515527|NCT01942733|80080965|FG000|Overall Study|Administrative|1|||
27515528|NCT03214666|80080966|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
27515529|NCT03214666|80080967|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
27515530|NCT03214666|80080968|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
27515531|NCT03214666|80080969|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
27515532|NCT03214666|80080970|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
27515533|NCT03214666|80080971|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
27515534|NCT01802073|80080975|FG000|Overall Study|Lost to Follow-up|0|||
27515535|NCT01802073|80080976|FG001|Overall Study|Lost to Follow-up|1|||
27515536|NCT01802073|80080975|FG000|Overall Study|Non-compliant|4|||
27515537|NCT01802073|80080976|FG001|Overall Study|Non-compliant|2|||
27515538|NCT01802073|80080975|FG000|Overall Study|Withdrawal by Subject|1|||
27616339|NCT04537949|80437704|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
27515539|NCT01802073|80080976|FG001|Overall Study|Withdrawal by Subject|1|||
27515540|NCT01802073|80080975|FG000|Overall Study|Physician Decision|0|||
27515541|NCT01802073|80080976|FG001|Overall Study|Physician Decision|7|||
27515542|NCT00615901|80080977|FG000|Overall Study|Withdrawal by Subject|2|||
27515543|NCT00615901|80080977|FG000|Overall Study|Adverse Event|7|||
27515544|NCT01705509|80080980|FG000|Inclusion CPET|Screen Failure|5|||
27515545|NCT01705509|80080980|FG000|Inclusion CPET|Withdrawal by Subject|2|||
27515546|NCT01705509|80080980|FG000|CPET w/ Ranexa|Screen Failure|2|||
27515547|NCT00856518|80080981|FG000|Overall Study|Lost to Follow-up|4|||
27616340|NCT04537949|80437705|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
27616341|NCT04537949|80437706|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
27616342|NCT04537949|80437707|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
27616343|NCT04537949|80437708|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
27616344|NCT04537949|80437701|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
27616345|NCT04537949|80437702|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
27616346|NCT04537949|80437703|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
27616347|NCT04537949|80437704|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
27616348|NCT04537949|80437705|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
27616349|NCT04537949|80437706|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
27616350|NCT04537949|80437707|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
27616351|NCT04537949|80437708|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
27616352|NCT04537949|80437701|FG000|Follow-up Phase|Lost to Follow-up|0|||
27616353|NCT04537949|80437702|FG001|Follow-up Phase|Lost to Follow-up|3|||
27616354|NCT04537949|80437703|FG002|Follow-up Phase|Lost to Follow-up|0|||
27616355|NCT04537949|80437704|FG003|Follow-up Phase|Lost to Follow-up|0|||
27616356|NCT04537949|80437705|FG004|Follow-up Phase|Lost to Follow-up|0|||
27616357|NCT04537949|80437706|FG005|Follow-up Phase|Lost to Follow-up|0|||
27616358|NCT04537949|80437707|FG006|Follow-up Phase|Lost to Follow-up|0|||
27616359|NCT04537949|80437708|FG007|Follow-up Phase|Lost to Follow-up|0|||
27616360|NCT04537949|80437701|FG000|Follow-up Phase|personal reasons|0|||
27616361|NCT04537949|80437702|FG001|Follow-up Phase|personal reasons|0|||
27616362|NCT04537949|80437703|FG002|Follow-up Phase|personal reasons|0|||
27616363|NCT04537949|80437704|FG003|Follow-up Phase|personal reasons|1|||
27616364|NCT04537949|80437705|FG004|Follow-up Phase|personal reasons|1|||
27616365|NCT04537949|80437706|FG005|Follow-up Phase|personal reasons|0|||
27616366|NCT04537949|80437707|FG006|Follow-up Phase|personal reasons|0|||
27616367|NCT04537949|80437708|FG007|Follow-up Phase|personal reasons|0|||
27616368|NCT04537949|80437701|FG000|Follow-up Phase|Withdrawal by Subject|0|||
27616369|NCT04537949|80437702|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27616370|NCT04537949|80437703|FG002|Follow-up Phase|Withdrawal by Subject|0|||
27616371|NCT04537949|80437704|FG003|Follow-up Phase|Withdrawal by Subject|0|||
27616372|NCT04537949|80437705|FG004|Follow-up Phase|Withdrawal by Subject|1|||
27616373|NCT04537949|80437706|FG005|Follow-up Phase|Withdrawal by Subject|0|||
27616374|NCT04537949|80437707|FG006|Follow-up Phase|Withdrawal by Subject|0|||
27616375|NCT04537949|80437708|FG007|Follow-up Phase|Withdrawal by Subject|0|||
27616376|NCT00284089|80437711|FG000|Multiple Dose Phase|Adverse Event|1|||
27616377|NCT00284089|80437712|FG001|Multiple Dose Phase|Adverse Event|0|||
27616378|NCT00284089|80437713|FG002|Multiple Dose Phase|Adverse Event|1|||
27616379|NCT00284089|80437714|FG003|Multiple Dose Phase|Adverse Event|1|||
27616380|NCT00284089|80437711|FG000|Multiple Dose Phase|Protocol Violation|0|||
27616381|NCT00284089|80437712|FG001|Multiple Dose Phase|Protocol Violation|0|||
27616382|NCT00284089|80437713|FG002|Multiple Dose Phase|Protocol Violation|1|||
27616383|NCT00284089|80437714|FG003|Multiple Dose Phase|Protocol Violation|0|||
27616384|NCT00284089|80437711|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
27616385|NCT00284089|80437712|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
27616386|NCT00284089|80437713|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
27515548|NCT00856518|80080982|FG001|Overall Study|Lost to Follow-up|2|||
27515549|NCT00145119|80080983|FG000|Overall Study|Death|45|||
27515550|NCT02036853|80080986|FG000|Overall Study|Adverse Event|0|||
27515551|NCT02036853|80080987|FG001|Overall Study|Adverse Event|2|||
27515552|NCT02036853|80080986|FG000|Overall Study|Lack of Efficacy|0|||
27515553|NCT02036853|80080987|FG001|Overall Study|Lack of Efficacy|2|||
27515554|NCT02036853|80080986|FG000|Overall Study|Physician Decision|0|||
27515555|NCT02036853|80080987|FG001|Overall Study|Physician Decision|1|||
27515556|NCT02036853|80080986|FG000|Overall Study|Withdrawal by Subject|0|||
27515557|NCT02036853|80080987|FG001|Overall Study|Withdrawal by Subject|1|||
27515558|NCT01409811|80080994|FG000|Overall Study|Insurance denial|1|||
27515559|NCT03120351|80080995|FG000|Overall Study|Physician Decision|1|||
27616387|NCT00284089|80437714|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
27616388|NCT00284089|80437711|FG000|Multiple Dose Phase|Death|0|||
27616389|NCT00284089|80437712|FG001|Multiple Dose Phase|Death|0|||
27616390|NCT00284089|80437713|FG002|Multiple Dose Phase|Death|1|||
27616391|NCT00284089|80437714|FG003|Multiple Dose Phase|Death|1|||
27616392|NCT00284089|80437711|FG000|Extension Phase|Adverse Event|0|||
27616393|NCT00284089|80437712|FG001|Extension Phase|Adverse Event|0|||
27616394|NCT00284089|80437713|FG002|Extension Phase|Adverse Event|2|||
27616395|NCT00284089|80437714|FG003|Extension Phase|Adverse Event|2|||
27616396|NCT00284089|80437711|FG000|Extension Phase|condition no longer requires study drug|2|||
27616397|NCT00284089|80437712|FG001|Extension Phase|condition no longer requires study drug|0|||
27515560|NCT03120351|80080996|FG001|Overall Study|Physician Decision|1|||
27616398|NCT00284089|80437713|FG002|Extension Phase|condition no longer requires study drug|2|||
27616399|NCT00284089|80437714|FG003|Extension Phase|condition no longer requires study drug|7|||
27616400|NCT00284089|80437711|FG000|Extension Phase|Protocol Violation|0|||
27616401|NCT00284089|80437712|FG001|Extension Phase|Protocol Violation|0|||
27616402|NCT00284089|80437713|FG002|Extension Phase|Protocol Violation|1|||
27616403|NCT00284089|80437714|FG003|Extension Phase|Protocol Violation|0|||
27616404|NCT00284089|80437711|FG000|Extension Phase|Withdrawal by Subject|0|||
27616405|NCT00284089|80437712|FG001|Extension Phase|Withdrawal by Subject|0|||
27616406|NCT00284089|80437713|FG002|Extension Phase|Withdrawal by Subject|1|||
27616407|NCT00284089|80437714|FG003|Extension Phase|Withdrawal by Subject|3|||
27616408|NCT01991197|80437715|FG000|Overall Study|Lost to Follow-up|1|||
27616409|NCT01991197|80437716|FG001|Overall Study|Lost to Follow-up|1|||
27616410|NCT01991197|80437715|FG000|Overall Study|Physician Decision|0|||
27616411|NCT01991197|80437716|FG001|Overall Study|Physician Decision|2|||
27616412|NCT01991197|80437715|FG000|Overall Study|Withdrawal by Subject|2|||
27616413|NCT01991197|80437716|FG001|Overall Study|Withdrawal by Subject|0|||
27616414|NCT02930122|80437717|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
27616415|NCT02930122|80437718|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
27616416|NCT02942004|80437720|FG000|Overall Study|Withdrawal by Subject|0|||
27616417|NCT02942004|80437721|FG001|Overall Study|Withdrawal by Subject|2|||
27616418|NCT02942004|80437722|FG002|Overall Study|Withdrawal by Subject|3|||
27616419|NCT02942004|80437720|FG000|Overall Study|Lost to Follow-up|1|||
27616420|NCT02942004|80437721|FG001|Overall Study|Lost to Follow-up|1|||
27907009|NCT01490840|81496859|FG000|Phase 2|Lost to Follow-up|1|||
27515561|NCT01338298|80080997|FG000|Overall Study|Withdrawal by Subject|1|||
27515562|NCT01338298|80080998|FG001|Overall Study|Withdrawal by Subject|1|||
27515563|NCT01338298|80080997|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
27515564|NCT01338298|80080998|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
27515565|NCT01338298|80080997|FG000|Overall Study|Administrative error|0|||
27515566|NCT01338298|80080998|FG001|Overall Study|Administrative error|1|||
27515567|NCT01338298|80080997|FG000|Overall Study|Positive symptom worsening|1|||
27515568|NCT01338298|80080998|FG001|Overall Study|Positive symptom worsening|0|||
27515569|NCT01338298|80080997|FG000|Overall Study|Depressive symptoms and nausea|1|||
27515570|NCT01338298|80080998|FG001|Overall Study|Depressive symptoms and nausea|0|||
27515571|NCT01338298|80080997|FG000|Overall Study|Non-adherence|1|||
27515572|NCT01338298|80080998|FG001|Overall Study|Non-adherence|0|||
27515573|NCT02032238|80080999|FG000|Overall Study|Lost to Follow-up|2|||
27515574|NCT02032238|80081000|FG001|Overall Study|Lost to Follow-up|0|||
27515575|NCT00834080|80081001|FG000|Overall Study|Adverse Event|7|||
27515576|NCT00834080|80081001|FG000|Overall Study|Lost to Follow-up|7|||
27515577|NCT00834080|80081001|FG000|Overall Study|Withdrawal by Subject|5|||
27515578|NCT00834080|80081001|FG000|Overall Study|Other - Pregnancy|1|||
27515579|NCT00834080|80081001|FG000|Overall Study|Other - False positive tests of the UDS|1|||
27515580|NCT00834080|80081001|FG000|Overall Study|Physician Decision|1|||
27515581|NCT00834080|80081001|FG000|Overall Study|Subject Relocated|1|||
27515582|NCT02164461|80081002|FG000|Overall Study|Adverse Event|0|||
27515583|NCT02164461|80081003|FG001|Overall Study|Adverse Event|0|||
27515584|NCT02164461|80081004|FG002|Overall Study|Adverse Event|1|||
27515585|NCT02164461|80081002|FG000|Overall Study|Disease Progression|1|||
27515586|NCT02164461|80081003|FG001|Overall Study|Disease Progression|3|||
27515587|NCT02164461|80081004|FG002|Overall Study|Disease Progression|4|||
27515588|NCT02164461|80081002|FG000|Overall Study|Withdrawal by Subject|0|||
27515589|NCT02164461|80081003|FG001|Overall Study|Withdrawal by Subject|3|||
27515590|NCT02164461|80081004|FG002|Overall Study|Withdrawal by Subject|0|||
27515591|NCT01640314|80081009|FG000|Overall Study|Protocol Violation|0|||
27515592|NCT01640314|80081010|FG001|Overall Study|Protocol Violation|1|||
27515593|NCT00636363|80081011|FG000|Overall Study|Conjunctivitis|0|||
27515594|NCT00636363|80081012|FG001|Overall Study|Conjunctivitis|0|||
27515595|NCT00636363|80081013|FG002|Overall Study|Conjunctivitis|1|||
27515596|NCT00636363|80081011|FG000|Overall Study|Adverse Event|0|||
27515597|NCT00636363|80081012|FG001|Overall Study|Adverse Event|0|||
27515598|NCT00636363|80081013|FG002|Overall Study|Adverse Event|1|||
27515599|NCT00636363|80081011|FG000|Overall Study|Positive slit lamp finding|0|||
27515600|NCT00636363|80081012|FG001|Overall Study|Positive slit lamp finding|2|||
27515601|NCT00636363|80081013|FG002|Overall Study|Positive slit lamp finding|1|||
27515602|NCT00636363|80081011|FG000|Overall Study|Study related symptoms/complaints|8|||
27515603|NCT00636363|80081012|FG001|Overall Study|Study related symptoms/complaints|7|||
27515604|NCT00636363|80081013|FG002|Overall Study|Study related symptoms/complaints|4|||
27515605|NCT00636363|80081011|FG000|Overall Study|Met ineligibility criteria|0|||
27515606|NCT00636363|80081012|FG001|Overall Study|Met ineligibility criteria|0|||
27515607|NCT00636363|80081013|FG002|Overall Study|Met ineligibility criteria|3|||
27515608|NCT00636363|80081011|FG000|Overall Study|Missed > 1 visit|0|||
27515609|NCT00636363|80081012|FG001|Overall Study|Missed > 1 visit|1|||
27515610|NCT00636363|80081013|FG002|Overall Study|Missed > 1 visit|3|||
27515611|NCT00636363|80081011|FG000|Overall Study|Lack of motivation|1|||
27616421|NCT02942004|80437722|FG002|Overall Study|Lost to Follow-up|2|||
27616422|NCT02942004|80437720|FG000|Overall Study|Randomized but not dosed|3|||
27616423|NCT02942004|80437721|FG001|Overall Study|Randomized but not dosed|9|||
27616424|NCT02942004|80437722|FG002|Overall Study|Randomized but not dosed|4|||
27515612|NCT00636363|80081012|FG001|Overall Study|Lack of motivation|0|||
27515613|NCT00636363|80081013|FG002|Overall Study|Lack of motivation|1|||
27515614|NCT00636363|80081011|FG000|Overall Study|Protocol Violation|0|||
27616425|NCT01544491|80437723|FG000|Overall Study|Withdrawal by Subject|3|||
27616426|NCT01544491|80437724|FG001|Overall Study|Withdrawal by Subject|2|||
27616427|NCT01544491|80437723|FG000|Overall Study|Lost to Follow-up|0|||
27616428|NCT01544491|80437724|FG001|Overall Study|Lost to Follow-up|1|||
27616429|NCT01544491|80437723|FG000|Overall Study|administrative problems|2|||
27616430|NCT01544491|80437724|FG001|Overall Study|administrative problems|0|||
27616431|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
27616432|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
27616433|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
27616434|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
27616435|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
27616436|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
27616437|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
27616438|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
27616439|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
27616440|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
27616441|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
27616442|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
27616443|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
27616444|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
27616445|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
27515615|NCT00636363|80081012|FG001|Overall Study|Protocol Violation|3|||
27515616|NCT00636363|80081013|FG002|Overall Study|Protocol Violation|0|||
27515617|NCT00636363|80081011|FG000|Overall Study|Lost to Follow-up|3|||
27515618|NCT00636363|80081012|FG001|Overall Study|Lost to Follow-up|4|||
27515619|NCT00636363|80081013|FG002|Overall Study|Lost to Follow-up|2|||
27515620|NCT00636363|80081011|FG000|Overall Study|Withdrawal by Subject|1|||
27515621|NCT00636363|80081012|FG001|Overall Study|Withdrawal by Subject|3|||
27515622|NCT00636363|80081013|FG002|Overall Study|Withdrawal by Subject|2|||
27515623|NCT01124006|80081014|FG000|Overall Study|Withdrawal by Subject|2|||
27515624|NCT01124006|80081015|FG001|Overall Study|Withdrawal by Subject|2|||
27515625|NCT01124006|80081016|FG002|Overall Study|Withdrawal by Subject|0|||
27515626|NCT01124006|80081014|FG000|Overall Study|Lost to Follow-up|1|||
27515627|NCT01124006|80081015|FG001|Overall Study|Lost to Follow-up|0|||
27515628|NCT01124006|80081016|FG002|Overall Study|Lost to Follow-up|1|||
27515629|NCT01124006|80081014|FG000|Overall Study|Other|0|||
27515630|NCT01124006|80081015|FG001|Overall Study|Other|0|||
27515631|NCT01124006|80081016|FG002|Overall Study|Other|1|||
27515632|NCT00635999|80081017|FG000|Overall Study|Withdrawal by Subject|4|||
27515633|NCT00635999|80081018|FG001|Overall Study|Withdrawal by Subject|2|||
27515634|NCT00635999|80081019|FG002|Overall Study|Withdrawal by Subject|1|||
27515635|NCT01324401|80081020|FG000|Overall Study|Withdrawn before any treatment|0|||
27515636|NCT01324401|80081021|FG001|Overall Study|Withdrawn before any treatment|3|||
27515637|NCT01324401|80081020|FG000|Overall Study|Adverse Event|1|||
27515638|NCT01324401|80081021|FG001|Overall Study|Adverse Event|3|||
27515639|NCT03544333|80081025|FG000|Overall Study|Withdrawal by Subject|1|||
27515640|NCT03544333|80081026|FG001|Overall Study|Withdrawal by Subject|0|||
27515641|NCT01738477|80081027|FG000|Overall Study|Lost to Follow-up|1|||
27515642|NCT01738477|80081028|FG001|Overall Study|Lost to Follow-up|4|||
27515643|NCT00942994|80081031|FG000|Overall Study|Adverse Event|7|||
27515644|NCT00942994|80081032|FG001|Overall Study|Adverse Event|4|||
27515645|NCT00942994|80081031|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27515646|NCT00942994|80081032|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27515647|NCT00942994|80081031|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27515648|NCT00942994|80081032|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27515649|NCT00942994|80081031|FG000|Overall Study|Patient withdrew consent|5|||
27515650|NCT00942994|80081032|FG001|Overall Study|Patient withdrew consent|8|||
27515651|NCT00942994|80081031|FG000|Overall Study|Lost to Follow-up|1|||
27515652|NCT00942994|80081032|FG001|Overall Study|Lost to Follow-up|4|||
27515653|NCT00942994|80081031|FG000|Overall Study|Protocol deviation|1|||
27515654|NCT00942994|80081032|FG001|Overall Study|Protocol deviation|2|||
27515655|NCT00742235|80081034|FG000|Overall Study|Lost to Follow-up|0|||
27616446|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
27515656|NCT00742235|80081035|FG001|Overall Study|Lost to Follow-up|31|||
27616447|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
27616448|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
27515657|NCT02118961|80081039|FG000|Overall Study|Withdrawal by Subject|1|||
27515658|NCT02118961|80081040|FG001|Overall Study|Withdrawal by Subject|0|||
27515659|NCT00578292|80081046|FG000|Overall Study|Death|1|||
27515660|NCT00578292|80081046|FG000|Overall Study|Graft failure|2|||
27515661|NCT02433080|80081047|FG000|Overall Study|Lost to Follow-up|1|||
27515662|NCT02433080|80081048|FG001|Overall Study|Lost to Follow-up|2|||
27515663|NCT02433080|80081047|FG000|Overall Study|Withdrawal by Subject|0|||
27515664|NCT02433080|80081048|FG001|Overall Study|Withdrawal by Subject|2|||
27616449|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
27616450|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
27616451|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
27616452|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
27616453|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
27616454|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
27616455|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
27616456|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
27616457|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
27616458|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
27616459|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
27616460|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
27616461|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
27616462|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
27616463|NCT03890120|80437725|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
27515665|NCT00943072|80081050|FG000|Overall Study|Adverse Event|0|||
27515666|NCT00943072|80081051|FG001|Overall Study|Adverse Event|3|||
27515667|NCT00943072|80081050|FG000|Overall Study|Death|0|||
27515668|NCT00943072|80081051|FG001|Overall Study|Death|2|||
27515669|NCT00943072|80081050|FG000|Overall Study|Withdrawal by Subject|3|||
27515670|NCT00943072|80081051|FG001|Overall Study|Withdrawal by Subject|1|||
27515671|NCT00943072|80081050|FG000|Overall Study|Protocol Violation|0|||
27515672|NCT00943072|80081051|FG001|Overall Study|Protocol Violation|1|||
27515673|NCT00943072|80081050|FG000|Overall Study|Lost to Follow-up|1|||
27515674|NCT00943072|80081051|FG001|Overall Study|Lost to Follow-up|2|||
27515675|NCT00943072|80081050|FG000|Overall Study|Lack of Efficacy|0|||
27515676|NCT00943072|80081051|FG001|Overall Study|Lack of Efficacy|4|||
27515677|NCT00943072|80081050|FG000|Overall Study|Other|1|||
27515678|NCT00943072|80081051|FG001|Overall Study|Other|1|||
27515679|NCT01994889|80081057|FG000|Overall Study|Adverse Event|5|||
27515680|NCT01994889|80081058|FG001|Overall Study|Adverse Event|12|||
27515681|NCT01994889|80081059|FG002|Overall Study|Adverse Event|11|||
27515682|NCT01994889|80081057|FG000|Overall Study|Cardiac Device Implantation|0|||
27515683|NCT01994889|80081058|FG001|Overall Study|Cardiac Device Implantation|2|||
27515684|NCT01994889|80081059|FG002|Overall Study|Cardiac Device Implantation|0|||
27515685|NCT01994889|80081057|FG000|Overall Study|Organ Transplantation|1|||
27515686|NCT01994889|80081058|FG001|Overall Study|Organ Transplantation|5|||
27515687|NCT01994889|80081059|FG002|Overall Study|Organ Transplantation|5|||
27515688|NCT01994889|80081057|FG000|Overall Study|No longer willing to participate|8|||
27515689|NCT01994889|80081058|FG001|Overall Study|No longer willing to participate|17|||
27515690|NCT01994889|80081059|FG002|Overall Study|No longer willing to participate|37|||
27515691|NCT01994889|80081057|FG000|Overall Study|Lost to Follow-up|0|||
27515692|NCT01994889|80081058|FG001|Overall Study|Lost to Follow-up|1|||
27515693|NCT01994889|80081059|FG002|Overall Study|Lost to Follow-up|0|||
27515694|NCT01994889|80081057|FG000|Overall Study|Protocol Violation|0|||
27515695|NCT01994889|80081058|FG001|Overall Study|Protocol Violation|1|||
27515696|NCT01994889|80081059|FG002|Overall Study|Protocol Violation|1|||
27616464|NCT03890120|80437726|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
27616465|NCT03890120|80437727|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
27616466|NCT03890120|80437728|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
27616467|NCT03890120|80437725|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
27616468|NCT03890120|80437726|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
27616469|NCT03890120|80437727|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
27616470|NCT03890120|80437728|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
27616471|NCT03890120|80437725|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
27616472|NCT03890120|80437726|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
27616473|NCT03890120|80437727|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
27616474|NCT03890120|80437728|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
27907010|NCT01490840|81496860|FG001|Phase 2|Lost to Follow-up|1|||
27907011|NCT01490840|81496859|FG000|Phase 2|Adverse Event|1|||
27907012|NCT01490840|81496860|FG001|Phase 2|Adverse Event|1|||
27515697|NCT01994889|80081057|FG000|Overall Study|Death|14|||
27515698|NCT01994889|80081058|FG001|Overall Study|Death|25|||
27515699|NCT01994889|80081059|FG002|Overall Study|Death|38|||
27515700|NCT03085797|80081060|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
27515701|NCT03085797|80081061|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
27515702|NCT03085797|80081060|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
27515703|NCT03085797|80081061|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
27515704|NCT03085797|80081060|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
27515705|NCT03085797|80081061|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
27515706|NCT00947193|80081062|FG000|Overall Study|Lost to Follow-up|1|||
27515707|NCT00947193|80081063|FG001|Overall Study|Lost to Follow-up|0|||
27515708|NCT00947193|80081062|FG000|Overall Study|Withdrawal by Subject|1|||
27515709|NCT00947193|80081063|FG001|Overall Study|Withdrawal by Subject|0|||
27515710|NCT00947193|80081062|FG000|Overall Study|Factor VIII >1%|1|||
27515711|NCT00947193|80081063|FG001|Overall Study|Factor VIII >1%|0|||
27515712|NCT03698591|80081065|FG000|Overall Study|Withdrawal by Subject|2|||
27515713|NCT03698591|80081066|FG001|Overall Study|Withdrawal by Subject|2|||
27515714|NCT03698591|80081065|FG000|Overall Study|Failed drug screen|1|||
27515715|NCT03698591|80081066|FG001|Overall Study|Failed drug screen|1|||
27515716|NCT03698591|80081065|FG000|Overall Study|Failed health screen|0|||
27515717|NCT03698591|80081066|FG001|Overall Study|Failed health screen|1|||
27515718|NCT03698591|80081065|FG000|Overall Study|Ineligible for financial compensation|1|||
27515719|NCT03698591|80081066|FG001|Overall Study|Ineligible for financial compensation|0|||
27515720|NCT03698591|80081065|FG000|Overall Study|Equipment Error|1|||
27515721|NCT03698591|80081066|FG001|Overall Study|Equipment Error|0|||
27515722|NCT03698591|80081065|FG000|Overall Study|Could not establish TMS dosage|0|||
27515723|NCT03698591|80081066|FG001|Overall Study|Could not establish TMS dosage|1|||
27515724|NCT02695420|80081067|FG000|Overall Study|Death|0|||
27515725|NCT02695420|80081068|FG001|Overall Study|Death|1|||
27515726|NCT02695420|80081069|FG002|Overall Study|Death|0|||
27515727|NCT02695420|80081070|FG003|Overall Study|Death|0|||
27515728|NCT02034409|80081071|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
27515729|NCT02034409|80081072|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
27515730|NCT02034409|80081071|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
27515731|NCT02034409|80081072|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
27515732|NCT02034409|80081071|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
27515733|NCT02034409|80081072|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
27515734|NCT02034409|80081071|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
27515735|NCT02034409|80081072|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
27515736|NCT02034409|80081071|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
27515737|NCT02034409|80081072|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
27515738|NCT02034409|80081071|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
27515739|NCT02034409|80081072|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
27515740|NCT01010867|80081073|FG000|Overall Study|< 50% adherence to probiotic|1|||
27515741|NCT00084136|80081074|FG000|PI Comparison|Death|10|||
27515742|NCT00084136|80081075|FG001|PI Comparison|Death|9|||
27515743|NCT00084136|80081076|FG002|PI Comparison|Death|0|||
27515744|NCT00084136|80081074|FG000|PI Comparison|Lost to Follow-up|11|||
27515745|NCT00084136|80081075|FG001|PI Comparison|Lost to Follow-up|8|||
27515746|NCT00084136|80081076|FG002|PI Comparison|Lost to Follow-up|0|||
27515747|NCT00084136|80081074|FG000|PI Comparison|Withdrawal by Subject|33|||
27515748|NCT00084136|80081075|FG001|PI Comparison|Withdrawal by Subject|30|||
27515749|NCT00084136|80081076|FG002|PI Comparison|Withdrawal by Subject|0|||
27515750|NCT00084136|80081074|FG000|PI Comparison|Clinic site closed|1|||
27515751|NCT00084136|80081075|FG001|PI Comparison|Clinic site closed|0|||
27515752|NCT00084136|80081076|FG002|PI Comparison|Clinic site closed|0|||
27515753|NCT00084136|80081074|FG000|NRTI Comparison|Death|20|||
27515754|NCT00084136|80081075|FG001|NRTI Comparison|Death|0|||
27515755|NCT00084136|80081076|FG002|NRTI Comparison|Death|18|||
27515756|NCT00084136|80081074|FG000|NRTI Comparison|Lost to Follow-up|14|||
27515757|NCT00084136|80081075|FG001|NRTI Comparison|Lost to Follow-up|0|||
27515758|NCT00084136|80081076|FG002|NRTI Comparison|Lost to Follow-up|12|||
27515759|NCT00084136|80081074|FG000|NRTI Comparison|Withdrawal by Subject|54|||
27515760|NCT00084136|80081075|FG001|NRTI Comparison|Withdrawal by Subject|0|||
27515761|NCT00084136|80081076|FG002|NRTI Comparison|Withdrawal by Subject|38|||
27515762|NCT00084136|80081074|FG000|NRTI Comparison|Clinic site closed|12|||
27515763|NCT00084136|80081075|FG001|NRTI Comparison|Clinic site closed|0|||
27515764|NCT00084136|80081076|FG002|NRTI Comparison|Clinic site closed|14|||
27515765|NCT00084136|80081074|FG000|NRTI Comparison|Not reason above|1|||
27515766|NCT00084136|80081075|FG001|NRTI Comparison|Not reason above|0|||
27515767|NCT00084136|80081076|FG002|NRTI Comparison|Not reason above|0|||
27515768|NCT00280748|80081077|FG000|Overall Study|Decline in performance|3|||
27515769|NCT00280748|80081077|FG000|Overall Study|Extra-cranial disease progression|1|||
27515770|NCT02078960|80081085|FG000|Treatment Period|Other|0|||
27515771|NCT02078960|80081086|FG001|Treatment Period|Other|0|||
27515772|NCT02078960|80081087|FG002|Treatment Period|Other|1|||
27515773|NCT02078960|80081085|FG000|Treatment Period|Lack of Efficacy|0|||
27515774|NCT02078960|80081086|FG001|Treatment Period|Lack of Efficacy|1|||
27515775|NCT02078960|80081087|FG002|Treatment Period|Lack of Efficacy|0|||
27515776|NCT02078960|80081085|FG000|Treatment Period|Disease progression - accelerated phase|0|||
27515777|NCT02078960|80081086|FG001|Treatment Period|Disease progression - accelerated phase|1|||
27616475|NCT03890120|80437725|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
27515778|NCT02078960|80081087|FG002|Treatment Period|Disease progression - accelerated phase|0|||
27515779|NCT02078960|80081085|FG000|Treatment Period|Disease progression - blast phase|1|||
27515780|NCT02078960|80081086|FG001|Treatment Period|Disease progression - blast phase|0|||
27515781|NCT02078960|80081087|FG002|Treatment Period|Disease progression - blast phase|0|||
27616476|NCT03890120|80437726|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
27616477|NCT03890120|80437727|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
27907013|NCT02112877|81496861|FG000|Overall Study|Withdrawal by Subject|1|||
27907014|NCT02112877|81496862|FG001|Overall Study|Withdrawal by Subject|7|||
27907015|NCT02112877|81496861|FG000|Overall Study|Visit Missed|1|||
27907016|NCT02112877|81496862|FG001|Overall Study|Visit Missed|6|||
27907017|NCT00593918|81496863|FG000|Overall Study|Withdrawal by Subject|5|||
27907018|NCT00593918|81496864|FG001|Overall Study|Withdrawal by Subject|24|||
27907019|NCT01300247|81496865|FG000|Overall Study|Death|1|||
27907020|NCT01300247|81496866|FG001|Overall Study|Death|1|||
27907021|NCT01300247|81496865|FG000|Overall Study|Lost to Follow-up|2|||
27907022|NCT01300247|81496866|FG001|Overall Study|Lost to Follow-up|0|||
27907023|NCT01300247|81496865|FG000|Overall Study|Withdrawal by Subject|1|||
27907024|NCT01300247|81496866|FG001|Overall Study|Withdrawal by Subject|0|||
27907025|NCT01300247|81496865|FG000|Overall Study|Non-Compliance|0|||
27907026|NCT01300247|81496866|FG001|Overall Study|Non-Compliance|1|||
27907027|NCT00992017|81496870|FG000|Overall Study|Lost to Follow-up|2|||
27907028|NCT00992017|81496870|FG000|Overall Study|Withdrawal by Subject|2|||
27907029|NCT00992017|81496870|FG000|Overall Study|Unable to get to clinic|5|||
27907030|NCT00992017|81496870|FG000|Overall Study|Not adhere to study requirements|1|||
27907031|NCT00703677|81496871|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
27907032|NCT02903420|81496873|FG000|Overall Study|Death|3|||
27907033|NCT00564395|81496875|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
27907034|NCT00564395|81496876|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
27907035|NCT00564395|81496875|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
27907036|NCT00564395|81496876|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
27907037|NCT03411902|81496877|FG000|Overall Study|Lost to Follow-up|3|||
27907038|NCT03411902|81496878|FG001|Overall Study|Lost to Follow-up|0|||
27907039|NCT01949142|81496879|FG000|Overall Study|Withdrawal of consent|1|||
27907040|NCT01949142|81496880|FG001|Overall Study|Withdrawal of consent|0|||
27907041|NCT01949142|81496879|FG000|Overall Study|Lost to Follow-up|1|||
27907042|NCT01949142|81496880|FG001|Overall Study|Lost to Follow-up|1|||
27907043|NCT01949142|81496879|FG000|Overall Study|Parent changed their mind|1|||
27907044|NCT01949142|81496880|FG001|Overall Study|Parent changed their mind|0|||
27907045|NCT01409915|81496881|FG000|Overall Study|Adverse Event|0|||
27907046|NCT01409915|81496882|FG001|Overall Study|Adverse Event|2|||
27907047|NCT01409915|81496881|FG000|Overall Study|Withdrawal by Subject|0|||
27907048|NCT01409915|81496882|FG001|Overall Study|Withdrawal by Subject|1|||
27907049|NCT01409915|81496881|FG000|Overall Study|Protocol Violation|1|||
27907050|NCT01409915|81496882|FG001|Overall Study|Protocol Violation|0|||
27907051|NCT01121263|81496883|FG000|Overall Study|Death|3|||
27907052|NCT01121263|81496884|FG001|Overall Study|Death|2|||
27907053|NCT01121263|81496883|FG000|Overall Study|Lost to Follow-up|22|||
27907054|NCT01121263|81496884|FG001|Overall Study|Lost to Follow-up|12|||
27907055|NCT01121263|81496883|FG000|Overall Study|Withdrawal by Subject|0|||
27907056|NCT01121263|81496884|FG001|Overall Study|Withdrawal by Subject|1|||
27907057|NCT01066663|81496885|FG000|Overall Study|Adverse Event|0|||
27907058|NCT01066663|81496886|FG001|Overall Study|Adverse Event|0|||
27907059|NCT01066663|81496887|FG002|Overall Study|Adverse Event|1|||
27907060|NCT01358578|81496889|FG000|Induction Period|Adverse Event|2|||
27907061|NCT01358578|81496890|FG001|Induction Period|Adverse Event|4|||
27907062|NCT01358578|81496891|FG002|Induction Period|Adverse Event|2|||
27515782|NCT02078960|80081085|FG000|Treatment Period|Withdrawal by Subject|0|||
27515783|NCT02078960|80081086|FG001|Treatment Period|Withdrawal by Subject|1|||
27515784|NCT02078960|80081087|FG002|Treatment Period|Withdrawal by Subject|1|||
27515785|NCT02078960|80081085|FG000|Treatment Period|Adverse Event|1|||
27515786|NCT02078960|80081086|FG001|Treatment Period|Adverse Event|0|||
27515787|NCT02078960|80081087|FG002|Treatment Period|Adverse Event|0|||
27515788|NCT02078960|80081085|FG000|Treatment Period|Death|0|||
27515789|NCT02078960|80081086|FG001|Treatment Period|Death|0|||
27515790|NCT02078960|80081087|FG002|Treatment Period|Death|1|||
27515791|NCT02078960|80081085|FG000|Follow-up Period|Death|2|||
27515792|NCT02078960|80081086|FG001|Follow-up Period|Death|0|||
27515793|NCT02078960|80081087|FG002|Follow-up Period|Death|0|||
27907063|NCT01358578|81496892|FG003|Induction Period|Adverse Event|6|||
27907064|NCT01358578|81496893|FG004|Induction Period|Adverse Event|0|||
27907065|NCT01358578|81496894|FG005|Induction Period|Adverse Event|0|||
27907066|NCT01358578|81496889|FG000|Induction Period|Lack of Efficacy|0|||
27515794|NCT02078960|80081085|FG000|Follow-up Period|Lost to Follow-up|0|||
27907067|NCT01358578|81496890|FG001|Induction Period|Lack of Efficacy|0|||
27907068|NCT01358578|81496891|FG002|Induction Period|Lack of Efficacy|9|||
27907069|NCT01358578|81496892|FG003|Induction Period|Lack of Efficacy|1|||
27907070|NCT01358578|81496893|FG004|Induction Period|Lack of Efficacy|0|||
27907071|NCT01358578|81496894|FG005|Induction Period|Lack of Efficacy|0|||
27907072|NCT01358578|81496889|FG000|Induction Period|Lost to Follow-up|0|||
27515795|NCT02078960|80081086|FG001|Follow-up Period|Lost to Follow-up|1|||
27515796|NCT02078960|80081087|FG002|Follow-up Period|Lost to Follow-up|0|||
27515797|NCT03304249|80081088|FG000|Overall Study|Lost to Follow-up|8|||
27515798|NCT03304249|80081089|FG001|Overall Study|Lost to Follow-up|10|||
27515799|NCT03304249|80081088|FG000|Overall Study|Withdrawal by Subject|12|||
27616478|NCT03890120|80437728|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
27616479|NCT03890120|80437725|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
27616480|NCT03890120|80437726|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
27616481|NCT03890120|80437727|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
27907073|NCT01358578|81496890|FG001|Induction Period|Lost to Follow-up|0|||
27907074|NCT01358578|81496891|FG002|Induction Period|Lost to Follow-up|1|||
27907075|NCT01358578|81496892|FG003|Induction Period|Lost to Follow-up|4|||
27907076|NCT01358578|81496893|FG004|Induction Period|Lost to Follow-up|0|||
27907077|NCT01358578|81496894|FG005|Induction Period|Lost to Follow-up|0|||
27515800|NCT03304249|80081089|FG001|Overall Study|Withdrawal by Subject|2|||
27515801|NCT03304249|80081088|FG000|Overall Study|Moved Out of District|4|||
27515802|NCT03304249|80081089|FG001|Overall Study|Moved Out of District|2|||
27515803|NCT01510769|80081090|FG000|Overall Study|Adverse Event|7|||
27515804|NCT01510769|80081091|FG001|Overall Study|Adverse Event|6|||
27515805|NCT01510769|80081092|FG002|Overall Study|Adverse Event|4|||
27515806|NCT01510769|80081090|FG000|Overall Study|Gout Flare|0|||
27515807|NCT01510769|80081091|FG001|Overall Study|Gout Flare|3|||
27515808|NCT01510769|80081092|FG002|Overall Study|Gout Flare|1|||
27515809|NCT01510769|80081090|FG000|Overall Study|Protocol Violation|11|||
27515810|NCT01510769|80081091|FG001|Overall Study|Protocol Violation|10|||
27515811|NCT01510769|80081092|FG002|Overall Study|Protocol Violation|9|||
27515812|NCT01510769|80081090|FG000|Overall Study|Lost to Follow-up|5|||
27515813|NCT01510769|80081091|FG001|Overall Study|Lost to Follow-up|1|||
27515814|NCT01510769|80081092|FG002|Overall Study|Lost to Follow-up|5|||
27515815|NCT01510769|80081090|FG000|Overall Study|Withdrawal by Subject|3|||
27515816|NCT01510769|80081091|FG001|Overall Study|Withdrawal by Subject|4|||
27515817|NCT01510769|80081092|FG002|Overall Study|Withdrawal by Subject|3|||
27515818|NCT01510769|80081090|FG000|Overall Study|Death|1|||
27515819|NCT01510769|80081091|FG001|Overall Study|Death|1|||
27515820|NCT01510769|80081092|FG002|Overall Study|Death|0|||
27515821|NCT02267317|80081095|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
27515822|NCT02267317|80081096|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27515823|NCT02267317|80081097|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27515824|NCT02267317|80081098|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27515825|NCT02267317|80081099|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27515826|NCT02267317|80081100|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
27515827|NCT02267317|80081095|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
27515828|NCT02267317|80081096|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27515829|NCT02267317|80081097|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27515830|NCT02267317|80081098|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27515831|NCT02267317|80081099|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27515832|NCT02267317|80081100|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
27515833|NCT00486291|80081101|FG000|Overall Study|Adverse Event|3|||
27515834|NCT00486291|80081102|FG001|Overall Study|Adverse Event|4|||
27515835|NCT00486291|80081101|FG000|Overall Study|Lost to Follow-up|3|||
27515836|NCT00486291|80081102|FG001|Overall Study|Lost to Follow-up|7|||
27515837|NCT00486291|80081101|FG000|Overall Study|protocol non-compliance|10|||
27515838|NCT00486291|80081102|FG001|Overall Study|protocol non-compliance|15|||
27515839|NCT00486291|80081101|FG000|Overall Study|requirement for restricted medication|0|||
27515840|NCT00486291|80081102|FG001|Overall Study|requirement for restricted medication|3|||
27515841|NCT02974543|80081103|FG000|Overall Study|Withdrawal by Subject|1|||
27515842|NCT02974543|80081104|FG001|Overall Study|Withdrawal by Subject|0|||
27515843|NCT01297491|80081105|FG000|Overall Study|Adverse Event|11|||
27515844|NCT01297491|80081106|FG001|Overall Study|Adverse Event|6|||
27515845|NCT01297491|80081105|FG000|Overall Study|Physician Decision|3|||
27515846|NCT01297491|80081106|FG001|Overall Study|Physician Decision|2|||
27515847|NCT01297491|80081105|FG000|Overall Study|Progressive disease|11|||
27515848|NCT01297491|80081106|FG001|Overall Study|Progressive disease|20|||
27616482|NCT03890120|80437728|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
27616483|NCT02091869|80437731|FG000|Overall Study|Withdrawal by Subject|0|||
27616484|NCT02091869|80437732|FG001|Overall Study|Withdrawal by Subject|3|||
27616485|NCT02593539|80437735|FG000|Overall Study|Adverse Event|1|||
27616486|NCT00289770|80437736|FG000|Year 15|Withdrawal by Subject|1|||
27616487|NCT02564055|80437754|FG000|Overall Study|Adverse Event|1|||
27515849|NCT01297491|80081105|FG000|Overall Study|Patient/Guardian decision|3|||
27515850|NCT01297491|80081106|FG001|Overall Study|Patient/Guardian decision|4|||
27515851|NCT01297491|80081105|FG000|Overall Study|Death|2|||
27515852|NCT01297491|80081106|FG001|Overall Study|Death|1|||
27515853|NCT00402740|80081107|FG000|Overall Study|Withdrawal by Subject|18|||
27515854|NCT00402740|80081107|FG000|Overall Study|Death|50|||
27515855|NCT00402740|80081107|FG000|Overall Study|Lost to Follow-up|6|||
27515856|NCT00402740|80081107|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
27515857|NCT00402740|80081107|FG000|Overall Study|Subject disposition unknown.|1|||
27616488|NCT02564055|80437755|FG001|Overall Study|Adverse Event|0|||
27616489|NCT02564055|80437756|FG002|Overall Study|Adverse Event|4|||
27515858|NCT00452361|80081114|FG000|Overall Study|Adverse Event|8|||
27515859|NCT00452361|80081115|FG001|Overall Study|Adverse Event|0|||
27907078|NCT01358578|81496889|FG000|Induction Period|Physician Decision|2|||
27907079|NCT01358578|81496890|FG001|Induction Period|Physician Decision|1|||
27907080|NCT01358578|81496891|FG002|Induction Period|Physician Decision|2|||
27616490|NCT02564055|80437757|FG003|Overall Study|Adverse Event|1|||
27907081|NCT01358578|81496892|FG003|Induction Period|Physician Decision|0|||
27907082|NCT01358578|81496893|FG004|Induction Period|Physician Decision|0|||
27907083|NCT01358578|81496894|FG005|Induction Period|Physician Decision|0|||
27907084|NCT01358578|81496889|FG000|Induction Period|Protocol Deviation|3|||
27907085|NCT01358578|81496890|FG001|Induction Period|Protocol Deviation|5|||
27907086|NCT01358578|81496891|FG002|Induction Period|Protocol Deviation|0|||
27907087|NCT01358578|81496892|FG003|Induction Period|Protocol Deviation|3|||
27907088|NCT01358578|81496893|FG004|Induction Period|Protocol Deviation|0|||
27907089|NCT01358578|81496894|FG005|Induction Period|Protocol Deviation|0|||
27907090|NCT01358578|81496889|FG000|Induction Period|technical problems|0|||
27907091|NCT01358578|81496890|FG001|Induction Period|technical problems|0|||
27907092|NCT01358578|81496891|FG002|Induction Period|technical problems|1|||
27907093|NCT01358578|81496892|FG003|Induction Period|technical problems|1|||
27907094|NCT01358578|81496893|FG004|Induction Period|technical problems|0|||
27907095|NCT01358578|81496894|FG005|Induction Period|technical problems|0|||
27907096|NCT01358578|81496889|FG000|Induction Period|Withdrawal by Subject|5|||
27907097|NCT01358578|81496890|FG001|Induction Period|Withdrawal by Subject|5|||
27907098|NCT01358578|81496891|FG002|Induction Period|Withdrawal by Subject|10|||
27907099|NCT01358578|81496892|FG003|Induction Period|Withdrawal by Subject|6|||
27907100|NCT01358578|81496893|FG004|Induction Period|Withdrawal by Subject|0|||
27907101|NCT01358578|81496894|FG005|Induction Period|Withdrawal by Subject|0|||
27907102|NCT01358578|81496889|FG000|Maintenance Period|Adverse Event|2|||
27907103|NCT01358578|81496890|FG001|Maintenance Period|Adverse Event|7|||
27907104|NCT01358578|81496891|FG002|Maintenance Period|Adverse Event|0|||
27616491|NCT02564055|80437758|FG004|Overall Study|Adverse Event|4|||
27616492|NCT02564055|80437759|FG005|Overall Study|Adverse Event|1|||
27907105|NCT01358578|81496892|FG003|Maintenance Period|Adverse Event|6|||
27907106|NCT01358578|81496893|FG004|Maintenance Period|Adverse Event|4|||
27907107|NCT01358578|81496894|FG005|Maintenance Period|Adverse Event|3|||
27907108|NCT01358578|81496889|FG000|Maintenance Period|Lack of Efficacy|10|||
27907109|NCT01358578|81496890|FG001|Maintenance Period|Lack of Efficacy|2|||
27907110|NCT01358578|81496891|FG002|Maintenance Period|Lack of Efficacy|0|||
27907111|NCT01358578|81496892|FG003|Maintenance Period|Lack of Efficacy|11|||
27907112|NCT01358578|81496893|FG004|Maintenance Period|Lack of Efficacy|3|||
27907113|NCT01358578|81496894|FG005|Maintenance Period|Lack of Efficacy|0|||
27907114|NCT01358578|81496889|FG000|Maintenance Period|Lost to Follow-up|4|||
27515860|NCT00452361|80081114|FG000|Overall Study|Withdrawal by Subject|0|||
27515861|NCT00452361|80081115|FG001|Overall Study|Withdrawal by Subject|1|||
27515862|NCT00452361|80081114|FG000|Overall Study|Premature termination|13|||
27515863|NCT00452361|80081115|FG001|Overall Study|Premature termination|9|||
27515864|NCT01456897|80084678|FG000|Overall Study|Adverse Event|19|||
27515865|NCT01456897|80084679|FG001|Overall Study|Adverse Event|22|||
27515866|NCT01456897|80084678|FG000|Overall Study|Protocol Violation|3|||
27515867|NCT01456897|80084679|FG001|Overall Study|Protocol Violation|4|||
27515868|NCT01456897|80084678|FG000|Overall Study|Physician Decision|5|||
27907115|NCT01358578|81496890|FG001|Maintenance Period|Lost to Follow-up|0|||
27907116|NCT01358578|81496891|FG002|Maintenance Period|Lost to Follow-up|0|||
27907117|NCT01358578|81496892|FG003|Maintenance Period|Lost to Follow-up|5|||
27907118|NCT01358578|81496893|FG004|Maintenance Period|Lost to Follow-up|1|||
27515869|NCT01456897|80084679|FG001|Overall Study|Physician Decision|3|||
27515870|NCT01456897|80084678|FG000|Overall Study|Withdrawal by Subject|44|||
27515871|NCT01456897|80084679|FG001|Overall Study|Withdrawal by Subject|17|||
27515872|NCT01456897|80084678|FG000|Overall Study|Lack of Efficacy|4|||
27515873|NCT01456897|80084679|FG001|Overall Study|Lack of Efficacy|11|||
27616493|NCT02564055|80437754|FG000|Overall Study|Protocol Violation|1|||
27616494|NCT02564055|80437755|FG001|Overall Study|Protocol Violation|0|||
27907119|NCT01358578|81496894|FG005|Maintenance Period|Lost to Follow-up|1|||
27907120|NCT01358578|81496889|FG000|Maintenance Period|Non-compliance with study treatment|3|||
27907121|NCT01358578|81496890|FG001|Maintenance Period|Non-compliance with study treatment|1|||
27515874|NCT00934440|80084689|FG000|Overall Study|Lost to Follow-up|1|||
27515875|NCT02054104|80084692|FG000|Overall Study|Did not want to continue due to college classes|1|||
27515876|NCT02054104|80084693|FG001|Overall Study|Did not want to continue due to college classes|0|||
27616495|NCT02564055|80437756|FG002|Overall Study|Protocol Violation|0|||
27907122|NCT01358578|81496891|FG002|Maintenance Period|Non-compliance with study treatment|0|||
27907123|NCT01358578|81496892|FG003|Maintenance Period|Non-compliance with study treatment|2|||
27907124|NCT01358578|81496893|FG004|Maintenance Period|Non-compliance with study treatment|1|||
27515877|NCT02054104|80084692|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
27907125|NCT01358578|81496894|FG005|Maintenance Period|Non-compliance with study treatment|2|||
27907126|NCT01358578|81496889|FG000|Maintenance Period|Physician Decision|0|||
27907127|NCT01358578|81496890|FG001|Maintenance Period|Physician Decision|1|||
27907128|NCT01358578|81496891|FG002|Maintenance Period|Physician Decision|0|||
27515878|NCT02054104|80084693|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
27515879|NCT02054104|80084692|FG000|Overall Study|No evidence of immunologic response|2|||
27515880|NCT02054104|80084693|FG001|Overall Study|No evidence of immunologic response|2|||
27515881|NCT02054104|80084692|FG000|Overall Study|Disease Progression On Study|4|||
27515882|NCT02054104|80084693|FG001|Overall Study|Disease Progression On Study|5|||
27515883|NCT02054104|80084692|FG000|Overall Study|Diagnosis of lymphoma|0|||
27616496|NCT02564055|80437757|FG003|Overall Study|Protocol Violation|0|||
27616497|NCT02564055|80437758|FG004|Overall Study|Protocol Violation|0|||
27616498|NCT02564055|80437759|FG005|Overall Study|Protocol Violation|0|||
27616499|NCT02564055|80437754|FG000|Overall Study|Reached stopping criteria|0|||
27616500|NCT02564055|80437755|FG001|Overall Study|Reached stopping criteria|0|||
27616501|NCT02564055|80437756|FG002|Overall Study|Reached stopping criteria|0|||
27616502|NCT02564055|80437757|FG003|Overall Study|Reached stopping criteria|0|||
27616503|NCT02564055|80437758|FG004|Overall Study|Reached stopping criteria|0|||
27616504|NCT02564055|80437759|FG005|Overall Study|Reached stopping criteria|1|||
27616505|NCT02564055|80437754|FG000|Overall Study|Lost to Follow-up|0|||
27616506|NCT02564055|80437755|FG001|Overall Study|Lost to Follow-up|1|||
27616507|NCT02564055|80437756|FG002|Overall Study|Lost to Follow-up|4|||
27616508|NCT02564055|80437757|FG003|Overall Study|Lost to Follow-up|2|||
27616509|NCT02564055|80437758|FG004|Overall Study|Lost to Follow-up|1|||
27616510|NCT02564055|80437759|FG005|Overall Study|Lost to Follow-up|0|||
27853359|NCT03052322|81295017|FG001|Overall Study|Death|2|||
27853360|NCT03052322|81295016|FG000|Overall Study|Lack of Efficacy|1|||
27853361|NCT03052322|81295017|FG001|Overall Study|Lack of Efficacy|2|||
27853362|NCT03052322|81295016|FG000|Overall Study|Protocol Violation|1|||
27853363|NCT03052322|81295017|FG001|Overall Study|Protocol Violation|0|||
27853364|NCT03052322|81295016|FG000|Overall Study|Lost to Follow-up|2|||
27853365|NCT03052322|81295017|FG001|Overall Study|Lost to Follow-up|4|||
27853366|NCT03052322|81295016|FG000|Overall Study|Adverse Event|6|||
27853367|NCT03052322|81295017|FG001|Overall Study|Adverse Event|13|||
27853368|NCT01335997|81295019|FG000|Period I and II|Adverse Event|63|||
27853369|NCT01335997|81295020|FG001|Period I and II|Adverse Event|43|||
27853370|NCT01335997|81295019|FG000|Period I and II|Noncompliance with Study Drug|1|||
27853371|NCT01335997|81295020|FG001|Period I and II|Noncompliance with Study Drug|1|||
27853372|NCT01335997|81295019|FG000|Period I and II|Lost to Follow-up|3|||
27853373|NCT01335997|81295020|FG001|Period I and II|Lost to Follow-up|5|||
27853374|NCT01335997|81295019|FG000|Period I and II|Withdrawal by Subject|9|||
27853375|NCT01335997|81295020|FG001|Period I and II|Withdrawal by Subject|4|||
27853376|NCT01335997|81295019|FG000|Period I and II|Study Terminated by Sponsor|406|||
27853377|NCT01335997|81295020|FG001|Period I and II|Study Terminated by Sponsor|415|||
27853378|NCT01335997|81295019|FG000|Period I and II|Protocol Violation|9|||
27853379|NCT01335997|81295020|FG001|Period I and II|Protocol Violation|10|||
27853380|NCT01335997|81295019|FG000|Period I and II|Physician Decision|2|||
27853381|NCT01335997|81295020|FG001|Period I and II|Physician Decision|1|||
27853382|NCT01335997|81295019|FG000|Period III|Adverse Event|0|||
27853383|NCT01335997|81295020|FG001|Period III|Adverse Event|2|||
27853384|NCT01335997|81295019|FG000|Period III|Study Terminated by Sponsor|77|||
27853385|NCT01335997|81295020|FG001|Period III|Study Terminated by Sponsor|76|||
27853386|NCT01335997|81295019|FG000|Period III|Protocol Violation|0|||
27853387|NCT01335997|81295020|FG001|Period III|Protocol Violation|1|||
27853388|NCT01335997|81295019|FG000|Period III|Lost to Follow-up|1|||
27853389|NCT01335997|81295020|FG001|Period III|Lost to Follow-up|0|||
27853390|NCT01661179|81295023|FG000|Overall Study|Death|1|||
27853391|NCT01661179|81295023|FG000|Overall Study|Withdrawal by Subject|1|||
27853392|NCT01661179|81295023|FG000|Overall Study|Other Eligibility criteria|4|||
27853393|NCT00557076|81295024|FG000|Overall Study|Unblinding|0|||
27853394|NCT00557076|81295025|FG001|Overall Study|Unblinding|1|||
27853395|NCT01055132|81295026|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
27853396|NCT01055132|81295027|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
27853397|NCT01055132|81295026|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
27853398|NCT01055132|81295027|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
27853399|NCT00712985|81295028|FG000|Overall Study|1 withdrew prior to start of drug|1|||
27907129|NCT01358578|81496892|FG003|Maintenance Period|Physician Decision|1|||
27515884|NCT02054104|80084693|FG001|Overall Study|Diagnosis of lymphoma|1|||
27515885|NCT02054104|80084692|FG000|Overall Study|Inconclusive response|0|||
27616511|NCT02564055|80437754|FG000|Overall Study|Physician Decision|0|||
27616512|NCT02564055|80437755|FG001|Overall Study|Physician Decision|0|||
27853400|NCT00712985|81295028|FG000|Overall Study|1 patient moved out of state|1|||
27853401|NCT00712985|81295028|FG000|Overall Study|Lack of Efficacy|3|||
27515886|NCT02054104|80084693|FG001|Overall Study|Inconclusive response|1|||
27515887|NCT04248491|80084698|FG000|Overall Study|Lost to Follow-up|1|||
27515888|NCT04248491|80084699|FG001|Overall Study|Lost to Follow-up|0|||
27907130|NCT01358578|81496893|FG004|Maintenance Period|Physician Decision|0|||
27907131|NCT01358578|81496894|FG005|Maintenance Period|Physician Decision|0|||
27907132|NCT01358578|81496889|FG000|Maintenance Period|Pregnancy|1|||
27907133|NCT01358578|81496890|FG001|Maintenance Period|Pregnancy|0|||
27907134|NCT01358578|81496891|FG002|Maintenance Period|Pregnancy|0|||
27907135|NCT01358578|81496892|FG003|Maintenance Period|Pregnancy|0|||
27907136|NCT01358578|81496893|FG004|Maintenance Period|Pregnancy|0|||
27907137|NCT01358578|81496894|FG005|Maintenance Period|Pregnancy|0|||
27907138|NCT01358578|81496889|FG000|Maintenance Period|Protocol deviation|7|||
27907139|NCT01358578|81496890|FG001|Maintenance Period|Protocol deviation|4|||
27907140|NCT01358578|81496891|FG002|Maintenance Period|Protocol deviation|0|||
27907141|NCT01358578|81496892|FG003|Maintenance Period|Protocol deviation|2|||
27907142|NCT01358578|81496893|FG004|Maintenance Period|Protocol deviation|2|||
27907143|NCT01358578|81496894|FG005|Maintenance Period|Protocol deviation|2|||
27907144|NCT01358578|81496889|FG000|Maintenance Period|Withdrawal by Subject|12|||
27907145|NCT01358578|81496890|FG001|Maintenance Period|Withdrawal by Subject|7|||
27907146|NCT01358578|81496891|FG002|Maintenance Period|Withdrawal by Subject|2|||
27907147|NCT01358578|81496892|FG003|Maintenance Period|Withdrawal by Subject|15|||
27616513|NCT02564055|80437756|FG002|Overall Study|Physician Decision|1|||
27616514|NCT02564055|80437757|FG003|Overall Study|Physician Decision|0|||
27616515|NCT02564055|80437758|FG004|Overall Study|Physician Decision|0|||
27616516|NCT02564055|80437759|FG005|Overall Study|Physician Decision|0|||
27616517|NCT02564055|80437754|FG000|Overall Study|Withdrawal by Subject|4|||
27616518|NCT02564055|80437755|FG001|Overall Study|Withdrawal by Subject|4|||
27907148|NCT01358578|81496893|FG004|Maintenance Period|Withdrawal by Subject|6|||
27616519|NCT02564055|80437756|FG002|Overall Study|Withdrawal by Subject|3|||
27616520|NCT02564055|80437757|FG003|Overall Study|Withdrawal by Subject|3|||
27616521|NCT02564055|80437758|FG004|Overall Study|Withdrawal by Subject|10|||
27616522|NCT02564055|80437759|FG005|Overall Study|Withdrawal by Subject|10|||
27616523|NCT00663117|80437762|FG000|Overall Study|Lack of Efficacy|1|||
27616524|NCT00663117|80437763|FG001|Overall Study|Lack of Efficacy|0|||
27616525|NCT04716881|80437766|FG000|Overall Study|Adverse Event|1|||
27616526|NCT04716881|80437766|FG000|Overall Study|Lost to Follow-up|1|||
27616527|NCT04424290|80437770|FG000|Overall Study|Not treated|0|||
27616528|NCT04424290|80437771|FG001|Overall Study|Not treated|0|||
27616529|NCT04424290|80437772|FG002|Overall Study|Not treated|1|||
27616530|NCT04424290|80437773|FG003|Overall Study|Not treated|0|||
27616531|NCT04424290|80437774|FG004|Overall Study|Not treated|1|||
27616532|NCT04424290|80437770|FG000|Overall Study|Adverse Event|0|||
27616533|NCT04424290|80437771|FG001|Overall Study|Adverse Event|0|||
27616534|NCT04424290|80437772|FG002|Overall Study|Adverse Event|0|||
27616535|NCT04424290|80437773|FG003|Overall Study|Adverse Event|2|||
27616536|NCT04424290|80437774|FG004|Overall Study|Adverse Event|0|||
27616537|NCT04424290|80437770|FG000|Overall Study|Withdrawal by Subject|0|||
27616538|NCT04424290|80437771|FG001|Overall Study|Withdrawal by Subject|0|||
27616539|NCT04424290|80437772|FG002|Overall Study|Withdrawal by Subject|0|||
27616540|NCT04424290|80437773|FG003|Overall Study|Withdrawal by Subject|0|||
27616541|NCT04424290|80437774|FG004|Overall Study|Withdrawal by Subject|1|||
27616542|NCT04424290|80437770|FG000|Overall Study|Other than listed|0|||
27616543|NCT04424290|80437771|FG001|Overall Study|Other than listed|0|||
27616544|NCT04424290|80437772|FG002|Overall Study|Other than listed|0|||
27616545|NCT04424290|80437773|FG003|Overall Study|Other than listed|1|||
27616546|NCT04424290|80437774|FG004|Overall Study|Other than listed|0|||
27616547|NCT01836458|80437775|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27616548|NCT01836458|80437776|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27616549|NCT01836458|80437777|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
27616550|NCT01836458|80437778|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
27616551|NCT01454830|80437781|FG000|Overall Study|Withdrawal by Subject|4|||
27616552|NCT01454830|80437782|FG001|Overall Study|Withdrawal by Subject|4|||
27616553|NCT01454830|80437781|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
27616554|NCT01454830|80437782|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
27616555|NCT01454830|80437781|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
27616556|NCT01454830|80437782|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
27616557|NCT01454830|80437781|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
27616558|NCT01454830|80437782|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
27616559|NCT01454830|80437781|FG000|Overall Study|Withdrawal - no polysomnography|3|||
27907149|NCT01358578|81496894|FG005|Maintenance Period|Withdrawal by Subject|3|||
27907150|NCT01358578|81496889|FG000|Follow-up Period|Adverse Event|1|||
27616560|NCT01454830|80437782|FG001|Overall Study|Withdrawal - no polysomnography|2|||
27616561|NCT00333788|80437783|FG000|Overall Study|Adverse Event|44|||
27616562|NCT00333788|80437783|FG000|Overall Study|Lack of Efficacy|80|||
27616563|NCT00333788|80437783|FG000|Overall Study|Lost to Follow-up|2|||
27616564|NCT00333788|80437783|FG000|Overall Study|Withdrawal by Subject|24|||
27728726|NCT00151892|80838096|FG000|Overall Study|Lost to Follow-up|5|||
27907151|NCT01358578|81496890|FG001|Follow-up Period|Adverse Event|1|||
27907152|NCT01358578|81496891|FG002|Follow-up Period|Adverse Event|0|||
27907153|NCT01358578|81496892|FG003|Follow-up Period|Adverse Event|0|||
27616565|NCT00333788|80437783|FG000|Overall Study|Other: Non-compliance|2|||
27616566|NCT00333788|80437783|FG000|Overall Study|Other: Moved|2|||
27616567|NCT00333788|80437783|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
27616568|NCT00333788|80437783|FG000|Overall Study|Other: Investigator decision|1|||
27616569|NCT00333788|80437783|FG000|Overall Study|Other: Quality of life concern|1|||
27616570|NCT00333788|80437783|FG000|Overall Study|Other: Sponsor decision|1|||
27616571|NCT00333788|80437783|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
27616572|NCT00333788|80437783|FG000|Overall Study|Other: Medical monitor decision|1|||
27616573|NCT00333788|80437783|FG000|Overall Study|Other: Physician decision|1|||
27616574|NCT00333788|80437783|FG000|Overall Study|Other: Signed consent for another study|1|||
27616575|NCT00767104|80437787|FG000|Overall Study|Lost to Follow-up|1|||
27616576|NCT00767104|80437788|FG001|Overall Study|Lost to Follow-up|2|||
27616577|NCT03958630|80437789|FG000|Overall Study|Withdrawal by Subject|0|||
27616578|NCT03958630|80437790|FG001|Overall Study|Withdrawal by Subject|0|||
27616579|NCT03958630|80437791|FG002|Overall Study|Withdrawal by Subject|1|||
27616580|NCT03958630|80437789|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
27616581|NCT03958630|80437790|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
27616582|NCT03958630|80437791|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
27616583|NCT04640571|80437792|FG000|Overall Study|Withdrawal by Subject|0|||
27616584|NCT04640571|80437793|FG001|Overall Study|Withdrawal by Subject|0|||
27616585|NCT04640571|80437794|FG002|Overall Study|Withdrawal by Subject|0|||
27616586|NCT04640571|80437795|FG003|Overall Study|Withdrawal by Subject|0|||
27616587|NCT04640571|80437796|FG004|Overall Study|Withdrawal by Subject|0|||
27616588|NCT04640571|80437797|FG005|Overall Study|Withdrawal by Subject|2|||
27616589|NCT01083160|80437798|FG000|Overall Study|Adverse Event|1|||
27616590|NCT01190176|80437799|FG000|Overall Study|Withdrawal by Subject|1|||
27616591|NCT01190176|80437799|FG000|Overall Study|Lost to Follow-up|1|||
27616592|NCT01625338|80437800|FG000|Overall Study|Enrolled but not Treated|0|||
27616593|NCT01625338|80437801|FG001|Overall Study|Enrolled but not Treated|0|||
27616594|NCT01625338|80437802|FG002|Overall Study|Enrolled but not Treated|1|||
27616595|NCT01625338|80437800|FG000|Overall Study|Efficacy Failure|27|||
27616596|NCT01625338|80437801|FG001|Overall Study|Efficacy Failure|39|||
27616597|NCT01625338|80437802|FG002|Overall Study|Efficacy Failure|31|||
27616598|NCT01625338|80437800|FG000|Overall Study|Lost to Follow-up|3|||
27616599|NCT01625338|80437801|FG001|Overall Study|Lost to Follow-up|3|||
27616600|NCT01625338|80437802|FG002|Overall Study|Lost to Follow-up|2|||
27616601|NCT01625338|80437800|FG000|Overall Study|Investigator Decision|0|||
27616602|NCT01625338|80437801|FG001|Overall Study|Investigator Decision|2|||
27616603|NCT01625338|80437802|FG002|Overall Study|Investigator Decision|1|||
27616604|NCT01625338|80437800|FG000|Overall Study|Subject Withdrew Consent|1|||
27616605|NCT01625338|80437801|FG001|Overall Study|Subject Withdrew Consent|0|||
27616606|NCT01625338|80437802|FG002|Overall Study|Subject Withdrew Consent|2|||
27616607|NCT01625338|80437800|FG000|Overall Study|Adverse Event|1|||
27616608|NCT01625338|80437801|FG001|Overall Study|Adverse Event|0|||
27616609|NCT01625338|80437802|FG002|Overall Study|Adverse Event|1|||
27616610|NCT01625338|80437800|FG000|Overall Study|Study Discontinued by Sponsor|0|||
27616611|NCT01625338|80437801|FG001|Overall Study|Study Discontinued by Sponsor|0|||
27616612|NCT01625338|80437802|FG002|Overall Study|Study Discontinued by Sponsor|1|||
27616613|NCT02169830|80437805|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
27616614|NCT02169830|80437806|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
27616615|NCT02169830|80437807|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
27616616|NCT02169830|80437805|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
27616617|NCT02169830|80437806|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
27616618|NCT02169830|80437807|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
27616619|NCT02169830|80437805|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
27616620|NCT02169830|80437806|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
27616621|NCT02169830|80437807|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27616622|NCT02169830|80437805|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
27616623|NCT02169830|80437806|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
27616624|NCT02169830|80437807|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
27616625|NCT02169830|80437805|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
27616626|NCT02169830|80437806|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
27616627|NCT02169830|80437807|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
27616628|NCT04230980|80437810|FG000|Overall Study|Lost to Follow-up|1|||
27616629|NCT04230980|80437811|FG001|Overall Study|Lost to Follow-up|2|||
27616630|NCT04230980|80437810|FG000|Overall Study|Adverse Event|0|||
27616631|NCT04230980|80437811|FG001|Overall Study|Adverse Event|1|||
27728727|NCT00151892|80838097|FG001|Overall Study|Lost to Follow-up|10|||
27728728|NCT00151892|80838096|FG000|Overall Study|Adverse Event|6|||
27728729|NCT00151892|80838097|FG001|Overall Study|Adverse Event|3|||
27515889|NCT00859456|80084700|FG000|Overall Study|Adverse Event|3|||
27616632|NCT02771210|80437812|FG000|Period 1|Adverse Event|5|||
27616633|NCT02771210|80437813|FG001|Period 1|Adverse Event|3|||
27616634|NCT02771210|80437812|FG000|Period 1|Lack of Efficacy|3|||
27616635|NCT02771210|80437813|FG001|Period 1|Lack of Efficacy|6|||
27616636|NCT02771210|80437812|FG000|Period 1|Lost to Follow-up|2|||
27616637|NCT02771210|80437813|FG001|Period 1|Lost to Follow-up|0|||
27616638|NCT02771210|80437812|FG000|Period 1|Physician Decision|0|||
27616639|NCT02771210|80437813|FG001|Period 1|Physician Decision|1|||
27616640|NCT02771210|80437812|FG000|Period 1|Withdrawal by Subject|0|||
27616641|NCT02771210|80437813|FG001|Period 1|Withdrawal by Subject|3|||
27616642|NCT02771210|80437812|FG000|Period 1|Withdrawal of informed consent|1|||
27616643|NCT02771210|80437813|FG001|Period 1|Withdrawal of informed consent|5|||
27616644|NCT02771210|80437812|FG000|Period 2|Adverse Event|1|||
27616645|NCT02771210|80437813|FG001|Period 2|Adverse Event|0|||
27616646|NCT02771210|80437812|FG000|Period 2|Lack of Efficacy|0|||
27616647|NCT02771210|80437813|FG001|Period 2|Lack of Efficacy|1|||
27616648|NCT02771210|80437812|FG000|Period 2|Withdrawal by Subject|1|||
27616649|NCT02771210|80437813|FG001|Period 2|Withdrawal by Subject|0|||
27616650|NCT02771210|80437812|FG000|Period 2|Withdrawal of informed consent|0|||
27616651|NCT02771210|80437813|FG001|Period 2|Withdrawal of informed consent|2|||
27616652|NCT01449721|80437814|FG000|Overall Study|Physician Decision|0|||
27616653|NCT01449721|80437815|FG001|Overall Study|Physician Decision|1|||
27616654|NCT01449721|80437814|FG000|Overall Study|Physician Decision|0|||
27616655|NCT01449721|80437815|FG001|Overall Study|Physician Decision|1|||
27616656|NCT01349660|80437820|FG000|Overall Study|Still Receiving Study Treatment|0|||
27616657|NCT01349660|80437821|FG001|Overall Study|Still Receiving Study Treatment|0|||
27616658|NCT01349660|80437822|FG002|Overall Study|Still Receiving Study Treatment|1|||
27616659|NCT01349660|80437820|FG000|Overall Study|Disease Progression|2|||
27616660|NCT01349660|80437821|FG001|Overall Study|Disease Progression|4|||
27616661|NCT01349660|80437822|FG002|Overall Study|Disease Progression|50|||
27616662|NCT01349660|80437820|FG000|Overall Study|Adverse Event|1|||
27616663|NCT01349660|80437821|FG001|Overall Study|Adverse Event|1|||
27616664|NCT01349660|80437822|FG002|Overall Study|Adverse Event|12|||
27616665|NCT01349660|80437820|FG000|Overall Study|Withdrawal by Subject|2|||
27616666|NCT01349660|80437821|FG001|Overall Study|Withdrawal by Subject|0|||
27616667|NCT01349660|80437822|FG002|Overall Study|Withdrawal by Subject|9|||
27616668|NCT01349660|80437820|FG000|Overall Study|Death|1|||
27616669|NCT01349660|80437821|FG001|Overall Study|Death|1|||
27616670|NCT01349660|80437822|FG002|Overall Study|Death|0|||
27616671|NCT01349660|80437820|FG000|Overall Study|Non-Permitted Interventions|0|||
27616672|NCT01349660|80437821|FG001|Overall Study|Non-Permitted Interventions|0|||
27616673|NCT01349660|80437822|FG002|Overall Study|Non-Permitted Interventions|2|||
27616674|NCT01349660|80437820|FG000|Overall Study|Study Compliance|0|||
27616675|NCT01349660|80437821|FG001|Overall Study|Study Compliance|0|||
27616676|NCT01349660|80437822|FG002|Overall Study|Study Compliance|1|||
27616677|NCT01349660|80437820|FG000|Overall Study|Declining Performance Status|0|||
27616678|NCT01349660|80437821|FG001|Overall Study|Declining Performance Status|0|||
27616679|NCT01349660|80437822|FG002|Overall Study|Declining Performance Status|1|||
27616680|NCT00918749|80437823|FG000|Overall Study|Adverse Event|1|||
27616681|NCT00918749|80437824|FG001|Overall Study|Adverse Event|0|||
27616682|NCT00918749|80437825|FG002|Overall Study|Adverse Event|1|||
27616683|NCT00918749|80437823|FG000|Overall Study|Lost to Follow-up|0|||
27616684|NCT00918749|80437824|FG001|Overall Study|Lost to Follow-up|0|||
27616685|NCT00918749|80437825|FG002|Overall Study|Lost to Follow-up|1|||
27616686|NCT00918749|80437823|FG000|Overall Study|Withdrawal by Subject|5|||
27616687|NCT00918749|80437824|FG001|Overall Study|Withdrawal by Subject|3|||
27616688|NCT00918749|80437825|FG002|Overall Study|Withdrawal by Subject|5|||
27616689|NCT00918749|80437823|FG000|Overall Study|No Study Medication Taken|1|||
27616690|NCT00918749|80437824|FG001|Overall Study|No Study Medication Taken|0|||
27616691|NCT00918749|80437825|FG002|Overall Study|No Study Medication Taken|0|||
27616692|NCT03095599|80437827|FG000|Overall Study|Withdrawal by Subject|1|||
27616693|NCT03095599|80437828|FG001|Overall Study|Withdrawal by Subject|0|||
27616694|NCT03095599|80437827|FG000|Overall Study|Lost to Follow-up|1|||
27616695|NCT03095599|80437828|FG001|Overall Study|Lost to Follow-up|0|||
27616696|NCT03095599|80437827|FG000|Overall Study|Withdrawal prior to vaccination|1|||
27616697|NCT03095599|80437828|FG001|Overall Study|Withdrawal prior to vaccination|0|||
27616698|NCT00802737|80440484|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
27616699|NCT00802737|80440485|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
27616700|NCT00802737|80440486|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
27616701|NCT00802737|80440484|FG000|Overall Study|Death|6|||
27616702|NCT00802737|80440485|FG001|Overall Study|Death|5|||
27616703|NCT00802737|80440486|FG002|Overall Study|Death|1|||
27616704|NCT00802737|80440484|FG000|Overall Study|Adverse Event|1|||
27616705|NCT00802737|80440485|FG001|Overall Study|Adverse Event|0|||
27616706|NCT00802737|80440486|FG002|Overall Study|Adverse Event|0|||
27616707|NCT00802737|80440484|FG000|Overall Study|Received Prohibited Therapy|1|||
27616708|NCT00802737|80440485|FG001|Overall Study|Received Prohibited Therapy|0|||
27616709|NCT00802737|80440486|FG002|Overall Study|Received Prohibited Therapy|0|||
27616710|NCT00802737|80440484|FG000|Overall Study|Ongoing CLL-Treatment|0|||
27616711|NCT00802737|80440485|FG001|Overall Study|Ongoing CLL-Treatment|1|||
27616712|NCT00802737|80440486|FG002|Overall Study|Ongoing CLL-Treatment|0|||
27616713|NCT00802737|80440484|FG000|Overall Study|Participant too Unwell|0|||
27616714|NCT00802737|80440485|FG001|Overall Study|Participant too Unwell|2|||
27616715|NCT00802737|80440486|FG002|Overall Study|Participant too Unwell|0|||
27616716|NCT04467840|80440491|FG000|Overall Study|Death|35|||
27616717|NCT04467840|80440492|FG001|Overall Study|Death|39|||
27616718|NCT04467840|80440491|FG000|Overall Study|Withdrawal by Subject|8|||
27616719|NCT04467840|80440492|FG001|Overall Study|Withdrawal by Subject|4|||
27616720|NCT04467840|80440491|FG000|Overall Study|Adverse Event|2|||
27616721|NCT04467840|80440492|FG001|Overall Study|Adverse Event|0|||
27616722|NCT04467840|80440491|FG000|Overall Study|Lost to Follow-up|1|||
27616723|NCT04467840|80440492|FG001|Overall Study|Lost to Follow-up|3|||
27616724|NCT04467840|80440491|FG000|Overall Study|Physician Decision|1|||
27616725|NCT04467840|80440492|FG001|Overall Study|Physician Decision|0|||
27616726|NCT04467840|80440491|FG000|Overall Study|Other|1|||
27616727|NCT04467840|80440492|FG001|Overall Study|Other|5|||
27616728|NCT04467840|80440491|FG000|Overall Study|Missing study completion status|3|||
27616729|NCT04467840|80440492|FG001|Overall Study|Missing study completion status|1|||
27616730|NCT01959880|80440495|FG000|Overall Study|Withdrawal by Subject|11|||
27616731|NCT01959880|80440496|FG001|Overall Study|Withdrawal by Subject|13|||
27616732|NCT01959880|80440497|FG002|Overall Study|Withdrawal by Subject|8|||
27616733|NCT01959880|80440498|FG003|Overall Study|Withdrawal by Subject|7|||
27616734|NCT01959880|80440495|FG000|Overall Study|Death|1|||
27616735|NCT01959880|80440496|FG001|Overall Study|Death|10|||
27616736|NCT01959880|80440497|FG002|Overall Study|Death|1|||
27616737|NCT01959880|80440498|FG003|Overall Study|Death|2|||
27616738|NCT01959880|80440495|FG000|Overall Study|Lost to Follow-up|95|||
27616739|NCT01959880|80440496|FG001|Overall Study|Lost to Follow-up|18|||
27616740|NCT01959880|80440497|FG002|Overall Study|Lost to Follow-up|15|||
27616741|NCT01959880|80440498|FG003|Overall Study|Lost to Follow-up|8|||
27616742|NCT01959880|80440495|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
27616743|NCT01959880|80440496|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
27616744|NCT01959880|80440497|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
27616745|NCT01959880|80440498|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
27616746|NCT01959880|80440495|FG000|Overall Study|Study completed early-FDA approved|1003|||
27616747|NCT01959880|80440496|FG001|Overall Study|Study completed early-FDA approved|311|||
27616748|NCT01959880|80440497|FG002|Overall Study|Study completed early-FDA approved|179|||
27616749|NCT01959880|80440498|FG003|Overall Study|Study completed early-FDA approved|152|||
27616750|NCT00896454|80440499|FG000|Overall Study|Death|10|||
27616751|NCT00896454|80440499|FG000|Overall Study|Adverse Event|8|||
27616752|NCT00896454|80440499|FG000|Overall Study|Disease Progression|5|||
27616753|NCT00896454|80440499|FG000|Overall Study|Other|4|||
27616754|NCT00896454|80440499|FG000|Overall Study|Requirement for alternative therapy|3|||
27616755|NCT00896454|80440499|FG000|Overall Study|Ongoing in study|2|||
27616756|NCT00896454|80440499|FG000|Overall Study|Withdrawal by Subject|1|||
27616757|NCT01513967|80440500|FG000|Overall Study|Pregnancy|0|||
27616758|NCT01513967|80440501|FG001|Overall Study|Pregnancy|0|||
27616759|NCT01513967|80440502|FG002|Overall Study|Pregnancy|0|||
27616760|NCT01513967|80440503|FG003|Overall Study|Pregnancy|0|||
27616761|NCT01513967|80440504|FG004|Overall Study|Pregnancy|0|||
27616762|NCT01513967|80440505|FG005|Overall Study|Pregnancy|0|||
27616763|NCT01513967|80440506|FG006|Overall Study|Pregnancy|1|||
27616764|NCT01513967|80440507|FG007|Overall Study|Pregnancy|0|||
27616765|NCT01513967|80440500|FG000|Overall Study|missed a study visit|0|||
27616766|NCT01513967|80440501|FG001|Overall Study|missed a study visit|0|||
27616767|NCT01513967|80440502|FG002|Overall Study|missed a study visit|0|||
27616768|NCT01513967|80440503|FG003|Overall Study|missed a study visit|0|||
27616769|NCT01513967|80440504|FG004|Overall Study|missed a study visit|0|||
27616770|NCT01513967|80440505|FG005|Overall Study|missed a study visit|0|||
27616771|NCT01513967|80440506|FG006|Overall Study|missed a study visit|1|||
27616772|NCT01513967|80440507|FG007|Overall Study|missed a study visit|0|||
27616773|NCT01513967|80440500|FG000|Overall Study|excluded due to positive drug screen|0|||
27616774|NCT01513967|80440501|FG001|Overall Study|excluded due to positive drug screen|0|||
27616775|NCT01513967|80440502|FG002|Overall Study|excluded due to positive drug screen|0|||
27616776|NCT01513967|80440503|FG003|Overall Study|excluded due to positive drug screen|0|||
27616777|NCT01513967|80440504|FG004|Overall Study|excluded due to positive drug screen|0|||
27616778|NCT01513967|80440505|FG005|Overall Study|excluded due to positive drug screen|0|||
27616779|NCT01513967|80440506|FG006|Overall Study|excluded due to positive drug screen|0|||
27616780|NCT01513967|80440507|FG007|Overall Study|excluded due to positive drug screen|2|||
27616781|NCT01513967|80440500|FG000|Overall Study|Physician Decision|0|||
27616782|NCT01513967|80440501|FG001|Overall Study|Physician Decision|0|||
27616783|NCT01513967|80440502|FG002|Overall Study|Physician Decision|0|||
27616784|NCT01513967|80440503|FG003|Overall Study|Physician Decision|0|||
27616785|NCT01513967|80440504|FG004|Overall Study|Physician Decision|0|||
27616786|NCT01513967|80440505|FG005|Overall Study|Physician Decision|1|||
27616787|NCT01513967|80440506|FG006|Overall Study|Physician Decision|0|||
27616788|NCT01513967|80440507|FG007|Overall Study|Physician Decision|0|||
27616789|NCT01880554|80440515|FG000|Overall Study|Protocol Violation|14|||
27728730|NCT00151892|80838096|FG000|Overall Study|Protocol Violation|3|||
27728731|NCT00151892|80838097|FG001|Overall Study|Protocol Violation|3|||
27728732|NCT00151892|80838096|FG000|Overall Study|Non-compliance|0|||
27728733|NCT00151892|80838097|FG001|Overall Study|Non-compliance|1|||
27728734|NCT00151892|80838096|FG000|Overall Study|Pregnancy|0|||
27728735|NCT00151892|80838097|FG001|Overall Study|Pregnancy|1|||
27728736|NCT00151892|80838096|FG000|Overall Study|Did not return for a visit|1|||
27728737|NCT00151892|80838097|FG001|Overall Study|Did not return for a visit|0|||
27728738|NCT00151892|80838096|FG000|Overall Study|Used prohibited corticosteroids|1|||
27728739|NCT00151892|80838097|FG001|Overall Study|Used prohibited corticosteroids|0|||
27728740|NCT00151892|80838096|FG000|Overall Study|Lack of study medication at center|0|||
27728741|NCT00151892|80838097|FG001|Overall Study|Lack of study medication at center|1|||
27728742|NCT00546364|80838099|FG000|Overall Study|Disease progression|5|||
27728743|NCT00546364|80838100|FG001|Overall Study|Disease progression|11|||
27728744|NCT00546364|80838101|FG002|Overall Study|Disease progression|8|||
27728745|NCT00546364|80838099|FG000|Overall Study|Completed and off treatment|1|||
27728746|NCT00546364|80838100|FG001|Overall Study|Completed and off treatment|0|||
27728747|NCT00546364|80838101|FG002|Overall Study|Completed and off treatment|2|||
27728748|NCT00546364|80838099|FG000|Overall Study|Administrative reason by sponsor|1|||
27728749|NCT00546364|80838100|FG001|Overall Study|Administrative reason by sponsor|0|||
27728750|NCT00546364|80838101|FG002|Overall Study|Administrative reason by sponsor|0|||
27728751|NCT00546364|80838099|FG000|Overall Study|Poor compliance/noncompliance|0|||
27728752|NCT00546364|80838100|FG001|Overall Study|Poor compliance/noncompliance|0|||
27728753|NCT00546364|80838101|FG002|Overall Study|Poor compliance/noncompliance|1|||
27728754|NCT00546364|80838099|FG000|Overall Study|No longer meets study criteria|1|||
27728755|NCT00546364|80838100|FG001|Overall Study|No longer meets study criteria|1|||
27728756|NCT00546364|80838101|FG002|Overall Study|No longer meets study criteria|0|||
27728757|NCT00546364|80838099|FG000|Overall Study|Withdrawal by Subject|5|||
27728758|NCT00546364|80838100|FG001|Overall Study|Withdrawal by Subject|6|||
27728759|NCT00546364|80838101|FG002|Overall Study|Withdrawal by Subject|3|||
27728760|NCT00546364|80838099|FG000|Overall Study|Prior taxotere|1|||
27728761|NCT00546364|80838100|FG001|Overall Study|Prior taxotere|0|||
27616790|NCT01880554|80440515|FG000|Overall Study|Simon's design requirements|2|||
27616791|NCT01024751|80440524|FG000|Enrolled Participants|Ineligible at baseline|3|||
27616792|NCT01024751|80440525|FG001|Enrolled Participants|Ineligible at baseline|4|||
27616793|NCT01024751|80440524|FG000|Eligible Participants|Withdrawal by Subject|0|||
27616794|NCT01024751|80440525|FG001|Eligible Participants|Withdrawal by Subject|1|||
27616795|NCT01024751|80440524|FG000|Eligible Participants|Lost to Follow-up|0|||
27616796|NCT01024751|80440525|FG001|Eligible Participants|Lost to Follow-up|1|||
27616797|NCT01024751|80440524|FG000|Eligible Participants|Ineligible|0|||
27616798|NCT01024751|80440525|FG001|Eligible Participants|Ineligible|1|||
27616799|NCT02696226|80440526|FG000|Overall Study|Study terminated - lack of enrollment|1|||
27616800|NCT02696226|80440527|FG001|Overall Study|Study terminated - lack of enrollment|0|||
27616801|NCT02696226|80440528|FG002|Overall Study|Study terminated - lack of enrollment|2|||
27616802|NCT02696226|80440529|FG003|Overall Study|Study terminated - lack of enrollment|0|||
27616803|NCT01811563|80440530|FG000|Overall Study|Lost to Follow-up|5|||
27616804|NCT01811563|80440531|FG001|Overall Study|Lost to Follow-up|2|||
27616805|NCT01811563|80440530|FG000|Overall Study|Incorrect Randomization procedure|0|||
27616806|NCT01811563|80440531|FG001|Overall Study|Incorrect Randomization procedure|1|||
27616807|NCT00507026|80440537|FG000|Overall Study|Lack of Efficacy|6|||
27616808|NCT00507026|80440538|FG001|Overall Study|Lack of Efficacy|4|||
27616809|NCT00507026|80440539|FG002|Overall Study|Lack of Efficacy|21|||
27616810|NCT00507026|80440537|FG000|Overall Study|Withdrawal by Subject|2|||
27616811|NCT00507026|80440538|FG001|Overall Study|Withdrawal by Subject|0|||
27616812|NCT00507026|80440539|FG002|Overall Study|Withdrawal by Subject|0|||
27616813|NCT00507026|80440537|FG000|Overall Study|Investigator Decision|1|||
27616814|NCT00507026|80440538|FG001|Overall Study|Investigator Decision|0|||
27728762|NCT00546364|80838101|FG002|Overall Study|Prior taxotere|0|||
27728763|NCT00546364|80838099|FG000|Overall Study|Mixed response|1|||
27728764|NCT00546364|80838100|FG001|Overall Study|Mixed response|0|||
27728765|NCT00546364|80838101|FG002|Overall Study|Mixed response|0|||
27728766|NCT00546364|80838099|FG000|Overall Study|Palliative treatment|1|||
27728767|NCT00546364|80838100|FG001|Overall Study|Palliative treatment|0|||
27728768|NCT00546364|80838101|FG002|Overall Study|Palliative treatment|1|||
27616815|NCT00507026|80440539|FG002|Overall Study|Investigator Decision|0|||
27728769|NCT00546364|80838099|FG000|Overall Study|Target lesions resected|1|||
27728770|NCT00546364|80838100|FG001|Overall Study|Target lesions resected|0|||
27728771|NCT00546364|80838101|FG002|Overall Study|Target lesions resected|0|||
27728772|NCT00546364|80838099|FG000|Overall Study|Physician Decision|0|||
27728773|NCT00546364|80838100|FG001|Overall Study|Physician Decision|0|||
27616816|NCT00507026|80440537|FG000|Overall Study|Adverse Event|2|||
27728774|NCT00546364|80838101|FG002|Overall Study|Physician Decision|1|||
27728775|NCT00546364|80838099|FG000|Overall Study|Sponsor decision|0|||
27728776|NCT00546364|80838100|FG001|Overall Study|Sponsor decision|0|||
27616817|NCT00507026|80440538|FG001|Overall Study|Adverse Event|0|||
27616818|NCT00507026|80440539|FG002|Overall Study|Adverse Event|0|||
27616819|NCT00507026|80440537|FG000|Overall Study|Protocol Violation|1|||
27616820|NCT00507026|80440538|FG001|Overall Study|Protocol Violation|0|||
27616821|NCT00507026|80440539|FG002|Overall Study|Protocol Violation|0|||
27616822|NCT00507026|80440537|FG000|Overall Study|Other|1|||
27616823|NCT00507026|80440538|FG001|Overall Study|Other|0|||
27616824|NCT00507026|80440539|FG002|Overall Study|Other|0|||
27616825|NCT01163747|80440540|FG000|Overall Study|Adverse Event|0|||
27616826|NCT01163747|80440541|FG001|Overall Study|Adverse Event|5|||
27616827|NCT01163747|80440540|FG000|Overall Study|Insufficient Therapeutic Response|0|||
27616828|NCT01163747|80440541|FG001|Overall Study|Insufficient Therapeutic Response|1|||
27616829|NCT01163747|80440540|FG000|Overall Study|Protocol Violation|0|||
27616830|NCT01163747|80440541|FG001|Overall Study|Protocol Violation|1|||
27616831|NCT01163747|80440540|FG000|Overall Study|Refused Treatment|6|||
27616832|NCT01163747|80440541|FG001|Overall Study|Refused Treatment|4|||
27616833|NCT00681187|80440547|FG000|Overall Study|Withdrawal by Subject|1|||
27616834|NCT00681187|80440548|FG001|Overall Study|Withdrawal by Subject|0|||
27616835|NCT00681187|80440547|FG000|Overall Study|Death|0|||
27616836|NCT00681187|80440548|FG001|Overall Study|Death|1|||
27616837|NCT00681187|80440547|FG000|Overall Study|Adverse Event|0|||
27616838|NCT00681187|80440548|FG001|Overall Study|Adverse Event|1|||
27616839|NCT01349829|80440549|FG000|Overall Study|Lost to Follow-up|4|||
27616840|NCT01349829|80440550|FG001|Overall Study|Lost to Follow-up|8|||
27616841|NCT01349829|80440549|FG000|Overall Study|Consent withdrawal|3|||
27728777|NCT00546364|80838101|FG002|Overall Study|Sponsor decision|1|||
27728778|NCT01552057|80838105|FG000|Overall Study|Adverse Event|14|||
27728779|NCT01552057|80838106|FG001|Overall Study|Adverse Event|15|||
27728780|NCT01552057|80838105|FG000|Overall Study|Lack of Efficacy|8|||
27728781|NCT01552057|80838106|FG001|Overall Study|Lack of Efficacy|23|||
27728782|NCT01552057|80838105|FG000|Overall Study|Withdrawal by Subject|5|||
27616842|NCT01349829|80440550|FG001|Overall Study|Consent withdrawal|8|||
27616843|NCT01349829|80440549|FG000|Overall Study|Migrated/moved|2|||
27616844|NCT01349829|80440550|FG001|Overall Study|Migrated/moved|7|||
27616845|NCT01458249|80440559|FG000|Overall Study|Not treated|1|||
27616846|NCT01458249|80440559|FG000|Overall Study|Adverse Event|4|||
27616847|NCT01458249|80440559|FG000|Overall Study|Other|2|||
27616848|NCT01458249|80440559|FG000|Overall Study|Ongoing|1|||
27616849|NCT00654238|80440560|FG000|Overall Study|Screen Failures|4|||
27616850|NCT01327547|80440562|FG000|Overall Study|Adverse Event|4|||
27616851|NCT01327547|80440563|FG001|Overall Study|Adverse Event|1|||
27616852|NCT01327547|80440562|FG000|Overall Study|Death|1|||
27728783|NCT01552057|80838106|FG001|Overall Study|Withdrawal by Subject|8|||
27728784|NCT01552057|80838105|FG000|Overall Study|Entry Criteria Not Met|2|||
27728785|NCT01552057|80838106|FG001|Overall Study|Entry Criteria Not Met|2|||
27728786|NCT01552057|80838105|FG000|Overall Study|Physician Decision|1|||
27728787|NCT01552057|80838106|FG001|Overall Study|Physician Decision|0|||
27728788|NCT01756274|80838107|FG000|Overall Study|Protocol Violation|2|||
27728789|NCT01756274|80838107|FG000|Overall Study|Laboratory error|1|||
27728790|NCT03029832|80838108|FG000|Overall Study|Safety Follow-Up Completed|2|||
27728791|NCT03029832|80838109|FG001|Overall Study|Safety Follow-Up Completed|0|||
27728792|NCT03029832|80838108|FG000|Overall Study|Death due to Disease Progression|1|||
27616853|NCT01327547|80440563|FG001|Overall Study|Death|2|||
27616854|NCT01327547|80440562|FG000|Overall Study|Lost to Follow-up|6|||
27616855|NCT01327547|80440563|FG001|Overall Study|Lost to Follow-up|6|||
27616856|NCT01327547|80440562|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
27728793|NCT03029832|80838109|FG001|Overall Study|Death due to Disease Progression|0|||
27728794|NCT03029832|80838108|FG000|Overall Study|Study Terminated By Sponsor|1|||
27728795|NCT03029832|80838109|FG001|Overall Study|Study Terminated By Sponsor|1|||
27728796|NCT01444300|80838110|FG000|Overall Study|Adverse Event|4|||
27728797|NCT01444300|80838111|FG001|Overall Study|Adverse Event|0|||
27728798|NCT02731742|80838115|FG000|Overall Study|Death|1|||
27728799|NCT02731742|80838116|FG001|Overall Study|Death|2|||
27907154|NCT01358578|81496893|FG004|Follow-up Period|Adverse Event|0|||
27907155|NCT01358578|81496894|FG005|Follow-up Period|Adverse Event|0|||
27907156|NCT01358578|81496889|FG000|Follow-up Period|Lack of Efficacy|3|||
27616857|NCT01327547|80440563|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
27616858|NCT01327547|80440562|FG000|Overall Study|Withdrawal by Subject|3|||
27616859|NCT01327547|80440563|FG001|Overall Study|Withdrawal by Subject|7|||
27616860|NCT01327547|80440562|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
27616861|NCT01327547|80440563|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
27616862|NCT01327547|80440562|FG000|Overall Study|Protocol Violation|1|||
27616863|NCT01327547|80440563|FG001|Overall Study|Protocol Violation|0|||
27616864|NCT01327547|80440562|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
27616865|NCT01327547|80440563|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
27616866|NCT01327547|80440562|FG000|Overall Study|Required prohibited medication|2|||
27616867|NCT01327547|80440563|FG001|Overall Study|Required prohibited medication|0|||
27728800|NCT02731742|80838117|FG002|Overall Study|Death|5|||
27728801|NCT02731742|80838118|FG003|Overall Study|Death|0|||
27728802|NCT02731742|80838115|FG000|Overall Study|Physician Decision|0|||
27728803|NCT02731742|80838116|FG001|Overall Study|Physician Decision|0|||
27728804|NCT02731742|80838117|FG002|Overall Study|Physician Decision|0|||
27728805|NCT02731742|80838118|FG003|Overall Study|Physician Decision|1|||
27728806|NCT02731742|80838115|FG000|Overall Study|Study Terminated by Sponsor|2|||
27728807|NCT02731742|80838116|FG001|Overall Study|Study Terminated by Sponsor|1|||
27728808|NCT02731742|80838117|FG002|Overall Study|Study Terminated by Sponsor|1|||
27728809|NCT02731742|80838118|FG003|Overall Study|Study Terminated by Sponsor|1|||
27728810|NCT01763164|80838121|FG000|Treatment Phase|Participant/Guardian decision|26|||
27728811|NCT01763164|80838122|FG001|Treatment Phase|Participant/Guardian decision|14|||
27728812|NCT01763164|80838121|FG000|Treatment Phase|Protocol Violation|1|||
27728813|NCT01763164|80838122|FG001|Treatment Phase|Protocol Violation|1|||
27728814|NCT01763164|80838121|FG000|Treatment Phase|Progressive Disease|142|||
27728815|NCT01763164|80838122|FG001|Treatment Phase|Progressive Disease|76|||
27728816|NCT01763164|80838121|FG000|Treatment Phase|Physician Decision|24|||
27728817|NCT01763164|80838122|FG001|Treatment Phase|Physician Decision|13|||
27728818|NCT01763164|80838121|FG000|Treatment Phase|Death|10|||
27728819|NCT01763164|80838122|FG001|Treatment Phase|Death|1|||
27728820|NCT01763164|80838121|FG000|Treatment Phase|Adverse Event|66|||
27728821|NCT01763164|80838122|FG001|Treatment Phase|Adverse Event|8|||
27728822|NCT01763164|80838121|FG000|Treatment Phase|Randomized but not Treated|0|||
27728823|NCT01763164|80838122|FG001|Treatment Phase|Randomized but not Treated|19|||
27728824|NCT01763164|80838121|FG000|Treatment Phase|Other|0|||
27728825|NCT01763164|80838122|FG001|Treatment Phase|Other|1|||
27728826|NCT01763164|80838121|FG000|Follow up Phase|New therapy for study indication|12|||
27728827|NCT01763164|80838122|FG001|Follow up Phase|New therapy for study indication|3|||
27728828|NCT01763164|80838121|FG000|Follow up Phase|Death|21|||
27728829|NCT01763164|80838122|FG001|Follow up Phase|Death|4|||
27728830|NCT01763164|80838121|FG000|Follow up Phase|Subject/guardian decision|9|||
27728831|NCT01763164|80838122|FG001|Follow up Phase|Subject/guardian decision|2|||
27728832|NCT01763164|80838121|FG000|Follow up Phase|Progressive disease|127|||
27728833|NCT01763164|80838122|FG001|Follow up Phase|Progressive disease|62|||
27728834|NCT01763164|80838121|FG000|Follow up Phase|Physician Decision|10|||
27728835|NCT01763164|80838122|FG001|Follow up Phase|Physician Decision|3|||
27728836|NCT01763164|80838121|FG000|Follow up Phase|Lost to Follow-up|1|||
27728837|NCT01763164|80838122|FG001|Follow up Phase|Lost to Follow-up|0|||
27728838|NCT01763164|80838121|FG000|Follow up Phase|Adverse Event|17|||
27728839|NCT01763164|80838122|FG001|Follow up Phase|Adverse Event|1|||
27728840|NCT04436276|80838123|FG000|Overall Study|Adverse Event|0|||
27728841|NCT04436276|80838124|FG001|Overall Study|Adverse Event|0|||
27728842|NCT04436276|80838125|FG002|Overall Study|Adverse Event|0|||
27728843|NCT04436276|80838126|FG003|Overall Study|Adverse Event|0|||
27728844|NCT04436276|80838127|FG004|Overall Study|Adverse Event|0|||
27728845|NCT04436276|80838128|FG005|Overall Study|Adverse Event|0|||
27853402|NCT01553279|81295032|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
27853403|NCT01553279|81295033|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
27853404|NCT01553279|81295032|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
27853405|NCT01553279|81295033|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
27853406|NCT01553279|81295032|FG000|Interim Period|Withdrawal by Subject|2|||
27853407|NCT01553279|81295033|FG001|Interim Period|Withdrawal by Subject|2|||
27853408|NCT01553279|81295032|FG000|Interim Period|Lost to Follow-up|1|||
27853409|NCT01553279|81295033|FG001|Interim Period|Lost to Follow-up|0|||
27853410|NCT01553279|81295032|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
27853411|NCT01553279|81295033|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
27853412|NCT01553279|81295032|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
27853413|NCT01553279|81295033|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
27853414|NCT03365011|81295034|FG000|Overall Study|Withdrawal by Subject|1|||
27853415|NCT03365011|81295035|FG001|Overall Study|Withdrawal by Subject|2|||
27853416|NCT01449279|81295036|FG000|Overall Study|Lack of Efficacy|5|||
27853417|NCT01449279|81295036|FG000|Overall Study|Toxicity|2|||
27853418|NCT00931268|81295038|FG000|Overall Study|Lost to Follow-up|6|||
27853419|NCT00891839|81295039|FG000|Overall Study|Adverse Event|2|||
27853420|NCT00891839|81295039|FG000|Overall Study|Withdrawal by Subject|2|||
27853421|NCT00891839|81295039|FG000|Overall Study|Disease progression|3|||
27853422|NCT00423319|81295040|FG000|Overall Study|Death|2|||
27853423|NCT00423319|81295041|FG001|Overall Study|Death|0|||
27853424|NCT00423319|81295040|FG000|Overall Study|Adverse Event|93|||
27853425|NCT00423319|81295041|FG001|Overall Study|Adverse Event|112|||
27728846|NCT04436276|80838129|FG006|Overall Study|Adverse Event|0|||
27728847|NCT04436276|80838130|FG007|Overall Study|Adverse Event|0|||
27728848|NCT04436276|80838131|FG008|Overall Study|Adverse Event|0|||
27728849|NCT04436276|80838132|FG009|Overall Study|Adverse Event|0|||
27728850|NCT04436276|80838133|FG010|Overall Study|Adverse Event|0|||
27728851|NCT04436276|80838134|FG011|Overall Study|Adverse Event|0|||
27728852|NCT04436276|80838135|FG012|Overall Study|Adverse Event|0|||
27728853|NCT04436276|80838136|FG013|Overall Study|Adverse Event|0|||
27728854|NCT04436276|80838137|FG014|Overall Study|Adverse Event|0|||
27853426|NCT00423319|81295040|FG000|Overall Study|Withdrawal by Subject|86|||
27853427|NCT00423319|81295041|FG001|Overall Study|Withdrawal by Subject|99|||
27728855|NCT04436276|80838138|FG015|Overall Study|Adverse Event|0|||
27728856|NCT04436276|80838139|FG016|Overall Study|Adverse Event|1|||
27728857|NCT04436276|80838140|FG017|Overall Study|Adverse Event|0|||
27728858|NCT04436276|80838141|FG018|Overall Study|Adverse Event|0|||
27728859|NCT04436276|80838142|FG019|Overall Study|Adverse Event|0|||
27728860|NCT04436276|80838143|FG020|Overall Study|Adverse Event|0|||
27728861|NCT04436276|80838144|FG021|Overall Study|Adverse Event|0|||
27728862|NCT04436276|80838145|FG022|Overall Study|Adverse Event|0|||
27728863|NCT04436276|80838123|FG000|Overall Study|Death|0|||
27515890|NCT00859456|80084700|FG000|Overall Study|Progressive disease|2|||
27728864|NCT04436276|80838124|FG001|Overall Study|Death|0|||
27515891|NCT00859456|80084700|FG000|Overall Study|Non-compliance|3|||
27515892|NCT01191762|80084701|FG000|Overall Study|Adverse Event|1|||
27515893|NCT01191762|80084702|FG001|Overall Study|Adverse Event|0|||
27515894|NCT00854113|80084703|FG000|Overall Study|Adverse Event|0|||
27515895|NCT00854113|80084704|FG001|Overall Study|Adverse Event|0|||
27515896|NCT00854113|80084705|FG002|Overall Study|Adverse Event|0|||
27515897|NCT00854113|80084706|FG003|Overall Study|Adverse Event|0|||
27515898|NCT00854113|80084707|FG004|Overall Study|Adverse Event|0|||
27515899|NCT00854113|80084708|FG005|Overall Study|Adverse Event|0|||
27515900|NCT00854113|80084709|FG006|Overall Study|Adverse Event|0|||
27515901|NCT00854113|80084710|FG007|Overall Study|Adverse Event|2|||
27515902|NCT00854113|80084711|FG008|Overall Study|Adverse Event|0|||
27515903|NCT00854113|80084712|FG009|Overall Study|Adverse Event|0|||
27515904|NCT00854113|80084713|FG010|Overall Study|Adverse Event|0|||
27515905|NCT00854113|80084703|FG000|Overall Study|Withdrawal by Subject|0|||
27515906|NCT00854113|80084704|FG001|Overall Study|Withdrawal by Subject|0|||
27515907|NCT00854113|80084705|FG002|Overall Study|Withdrawal by Subject|0|||
27515908|NCT00854113|80084706|FG003|Overall Study|Withdrawal by Subject|0|||
27515909|NCT00854113|80084707|FG004|Overall Study|Withdrawal by Subject|0|||
27515910|NCT00854113|80084708|FG005|Overall Study|Withdrawal by Subject|0|||
27515911|NCT00854113|80084709|FG006|Overall Study|Withdrawal by Subject|0|||
27515912|NCT00854113|80084710|FG007|Overall Study|Withdrawal by Subject|1|||
27515913|NCT00854113|80084711|FG008|Overall Study|Withdrawal by Subject|1|||
27515914|NCT00854113|80084712|FG009|Overall Study|Withdrawal by Subject|0|||
27515915|NCT00854113|80084713|FG010|Overall Study|Withdrawal by Subject|0|||
27515916|NCT01519167|80084720|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
27515917|NCT01519167|80084721|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
27515918|NCT01519167|80084720|FG000|Overall Study|Adverse Event|0|||
27515919|NCT01519167|80084721|FG001|Overall Study|Adverse Event|1|||
27515920|NCT01519167|80084720|FG000|Overall Study|Lack of Efficacy|0|||
27515921|NCT01519167|80084721|FG001|Overall Study|Lack of Efficacy|1|||
27515922|NCT01519167|80084720|FG000|Overall Study|Medical condition changes&deep sedation|0|||
27515923|NCT01519167|80084721|FG001|Overall Study|Medical condition changes&deep sedation|2|||
27515924|NCT01519167|80084720|FG000|Overall Study|Physician Decision|0|||
27515925|NCT01519167|80084721|FG001|Overall Study|Physician Decision|1|||
27515926|NCT00640224|80084722|FG000|Overall Study|Lost to Follow-up|5|||
27515927|NCT00640224|80084723|FG001|Overall Study|Lost to Follow-up|2|||
27515928|NCT00640224|80084724|FG002|Overall Study|Lost to Follow-up|0|||
27515929|NCT00640224|80084725|FG003|Overall Study|Lost to Follow-up|0|||
27515930|NCT00640224|80084722|FG000|Overall Study|Withdrawal by Subject|1|||
27515931|NCT00640224|80084723|FG001|Overall Study|Withdrawal by Subject|0|||
27515932|NCT00640224|80084724|FG002|Overall Study|Withdrawal by Subject|0|||
27515933|NCT00640224|80084725|FG003|Overall Study|Withdrawal by Subject|0|||
27515934|NCT00640224|80084722|FG000|Overall Study|Headaches|0|||
27515935|NCT00640224|80084723|FG001|Overall Study|Headaches|1|||
27515936|NCT00640224|80084724|FG002|Overall Study|Headaches|0|||
27515937|NCT00640224|80084725|FG003|Overall Study|Headaches|0|||
27515938|NCT00715910|80084728|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
27515939|NCT00715910|80084729|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
27853428|NCT00423319|81295040|FG000|Overall Study|Lost to Follow-up|4|||
27853429|NCT00423319|81295041|FG001|Overall Study|Lost to Follow-up|3|||
27853430|NCT00423319|81295040|FG000|Overall Study|Poor compliance or noncompliance|1|||
27853431|NCT00423319|81295041|FG001|Overall Study|Poor compliance or noncompliance|1|||
27853432|NCT00423319|81295040|FG000|Overall Study|No longer meets study criteria|15|||
27853433|NCT00423319|81295041|FG001|Overall Study|No longer meets study criteria|15|||
27853434|NCT00423319|81295040|FG000|Overall Study|Other|23|||
27853435|NCT00423319|81295041|FG001|Overall Study|Other|22|||
27853436|NCT00448136|81295044|FG000|Overall Study|Death|3|||
27728865|NCT04436276|80838125|FG002|Overall Study|Death|0|||
27853437|NCT00448136|81295045|FG001|Overall Study|Death|8|||
27907157|NCT01358578|81496890|FG001|Follow-up Period|Lack of Efficacy|0|||
27515940|NCT00715910|80084730|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
27515941|NCT00715910|80084731|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
27515942|NCT00715910|80084732|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
27515943|NCT00715910|80084733|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
27515944|NCT00715910|80084728|FG000|Booster and ESFU Phase|Other|0|||
27515945|NCT00715910|80084729|FG001|Booster and ESFU Phase|Other|0|||
27728866|NCT04436276|80838126|FG003|Overall Study|Death|0|||
27907158|NCT01358578|81496891|FG002|Follow-up Period|Lack of Efficacy|4|||
27907159|NCT01358578|81496892|FG003|Follow-up Period|Lack of Efficacy|1|||
27907160|NCT01358578|81496893|FG004|Follow-up Period|Lack of Efficacy|0|||
27907161|NCT01358578|81496894|FG005|Follow-up Period|Lack of Efficacy|0|||
27515946|NCT00715910|80084730|FG002|Booster and ESFU Phase|Other|0|||
27515947|NCT00715910|80084731|FG003|Booster and ESFU Phase|Other|5|||
27515948|NCT00715910|80084732|FG004|Booster and ESFU Phase|Other|1|||
27515949|NCT00715910|80084733|FG005|Booster and ESFU Phase|Other|0|||
27515950|NCT04380519|80084734|FG000|Overall Study|Withdrawal by Subject|4|||
27515951|NCT04380519|80084735|FG001|Overall Study|Withdrawal by Subject|0|||
27515952|NCT04380519|80084736|FG002|Overall Study|Withdrawal by Subject|1|||
27515953|NCT04380519|80084734|FG000|Overall Study|Death|14|||
27515954|NCT04380519|80084735|FG001|Overall Study|Death|9|||
27515955|NCT04380519|80084736|FG002|Overall Study|Death|6|||
27515956|NCT04380519|80084734|FG000|Overall Study|Adverse Event|0|||
27515957|NCT04380519|80084735|FG001|Overall Study|Adverse Event|1|||
27515958|NCT04380519|80084736|FG002|Overall Study|Adverse Event|0|||
27515959|NCT04380519|80084734|FG000|Overall Study|relatives' decision|0|||
27515960|NCT04380519|80084735|FG001|Overall Study|relatives' decision|1|||
27515961|NCT04380519|80084736|FG002|Overall Study|relatives' decision|0|||
27515962|NCT01516034|80084737|FG000|Overall Study|Physician Decision|1|||
27515963|NCT01516034|80084737|FG000|Overall Study|Lack of Efficacy|7|||
27515964|NCT01689532|80084738|FG000|Overall Study|Adverse Event|9|||
27515965|NCT01689532|80084739|FG001|Overall Study|Adverse Event|5|||
27515966|NCT01689532|80084738|FG000|Overall Study|Lack of Efficacy|2|||
27515967|NCT01689532|80084739|FG001|Overall Study|Lack of Efficacy|2|||
27515968|NCT01689532|80084738|FG000|Overall Study|Withdrawal by Subject|1|||
27515969|NCT01689532|80084739|FG001|Overall Study|Withdrawal by Subject|2|||
27515970|NCT01689532|80084738|FG000|Overall Study|Physician Decision|2|||
27515971|NCT01689532|80084739|FG001|Overall Study|Physician Decision|0|||
27728867|NCT04436276|80838127|FG004|Overall Study|Death|0|||
27728868|NCT04436276|80838128|FG005|Overall Study|Death|0|||
27728869|NCT04436276|80838129|FG006|Overall Study|Death|0|||
27728870|NCT04436276|80838130|FG007|Overall Study|Death|0|||
27728871|NCT04436276|80838131|FG008|Overall Study|Death|0|||
27728872|NCT04436276|80838132|FG009|Overall Study|Death|0|||
27728873|NCT04436276|80838133|FG010|Overall Study|Death|0|||
27728874|NCT04436276|80838134|FG011|Overall Study|Death|0|||
27728875|NCT04436276|80838135|FG012|Overall Study|Death|1|||
27728876|NCT04436276|80838136|FG013|Overall Study|Death|0|||
27728877|NCT04436276|80838137|FG014|Overall Study|Death|1|||
27728878|NCT04436276|80838138|FG015|Overall Study|Death|0|||
27728879|NCT04436276|80838139|FG016|Overall Study|Death|0|||
27728880|NCT04436276|80838140|FG017|Overall Study|Death|0|||
27728881|NCT04436276|80838141|FG018|Overall Study|Death|0|||
27728882|NCT04436276|80838142|FG019|Overall Study|Death|2|||
27728883|NCT04436276|80838143|FG020|Overall Study|Death|0|||
27728884|NCT04436276|80838144|FG021|Overall Study|Death|1|||
27728885|NCT04436276|80838145|FG022|Overall Study|Death|0|||
27728886|NCT04436276|80838123|FG000|Overall Study|Lost to Follow-up|0|||
27728887|NCT04436276|80838124|FG001|Overall Study|Lost to Follow-up|2|||
27728888|NCT04436276|80838125|FG002|Overall Study|Lost to Follow-up|2|||
27728889|NCT04436276|80838126|FG003|Overall Study|Lost to Follow-up|1|||
27728890|NCT04436276|80838127|FG004|Overall Study|Lost to Follow-up|4|||
27515972|NCT00502203|80084748|FG000|Overall Study|Inevaluable|1|||
27515973|NCT02687191|80084749|FG000|Overall Study|Death|0|||
27515974|NCT02687191|80084750|FG001|Overall Study|Death|1|||
27515975|NCT02687191|80084751|FG002|Overall Study|Death|1|||
27515976|NCT02687191|80084752|FG003|Overall Study|Death|0|||
27515977|NCT02687191|80084753|FG004|Overall Study|Death|1|||
27515978|NCT02687191|80084754|FG005|Overall Study|Death|1|||
27515979|NCT02687191|80084749|FG000|Overall Study|Withdrawal by Subject|0|||
27515980|NCT02687191|80084750|FG001|Overall Study|Withdrawal by Subject|0|||
27728891|NCT04436276|80838128|FG005|Overall Study|Lost to Follow-up|1|||
27728892|NCT04436276|80838129|FG006|Overall Study|Lost to Follow-up|0|||
27907162|NCT01358578|81496889|FG000|Follow-up Period|Lost to Follow-up|0|||
27728893|NCT04436276|80838130|FG007|Overall Study|Lost to Follow-up|0|||
27728894|NCT04436276|80838131|FG008|Overall Study|Lost to Follow-up|1|||
27728895|NCT04436276|80838132|FG009|Overall Study|Lost to Follow-up|0|||
27907163|NCT01358578|81496890|FG001|Follow-up Period|Lost to Follow-up|1|||
27907164|NCT01358578|81496891|FG002|Follow-up Period|Lost to Follow-up|0|||
27515981|NCT02687191|80084751|FG002|Overall Study|Withdrawal by Subject|0|||
27515982|NCT02687191|80084752|FG003|Overall Study|Withdrawal by Subject|1|||
27515983|NCT02687191|80084753|FG004|Overall Study|Withdrawal by Subject|0|||
27515984|NCT02687191|80084754|FG005|Overall Study|Withdrawal by Subject|0|||
27515985|NCT04784442|80084755|FG000|Overall Study|Adverse Event|1|||
27515986|NCT04784442|80084756|FG001|Overall Study|Adverse Event|0|||
27515987|NCT04784442|80084757|FG002|Overall Study|Adverse Event|2|||
27515988|NCT04784442|80084758|FG003|Overall Study|Adverse Event|1|||
27515989|NCT04784442|80084755|FG000|Overall Study|Protocol Violation|1|||
27728896|NCT04436276|80838133|FG010|Overall Study|Lost to Follow-up|5|||
27728897|NCT04436276|80838134|FG011|Overall Study|Lost to Follow-up|5|||
27907165|NCT01358578|81496892|FG003|Follow-up Period|Lost to Follow-up|4|||
27907166|NCT01358578|81496893|FG004|Follow-up Period|Lost to Follow-up|0|||
27907167|NCT01358578|81496894|FG005|Follow-up Period|Lost to Follow-up|0|||
27907168|NCT01358578|81496889|FG000|Follow-up Period|non- compliance with study treatment|1|||
27616868|NCT01327547|80440562|FG000|Overall Study|Non-compliance with study procedures|1|||
27616869|NCT01327547|80440563|FG001|Overall Study|Non-compliance with study procedures|0|||
27616870|NCT01327547|80440562|FG000|Overall Study|By investigator in subject's interest|0|||
27616871|NCT01327547|80440563|FG001|Overall Study|By investigator in subject's interest|1|||
27616872|NCT02080520|80440564|FG000|Overall Study|Self-reported symptoms|5|||
27616873|NCT02080520|80440565|FG001|Overall Study|Self-reported symptoms|6|||
27616874|NCT02080520|80440564|FG000|Overall Study|Unable to contact|2|||
27616875|NCT02080520|80440565|FG001|Overall Study|Unable to contact|1|||
27616876|NCT02080520|80440564|FG000|Overall Study|Initiated aspirin|2|||
27907169|NCT01358578|81496890|FG001|Follow-up Period|non- compliance with study treatment|0|||
27616877|NCT02080520|80440565|FG001|Overall Study|Initiated aspirin|0|||
27616878|NCT02080520|80440564|FG000|Overall Study|Atrial fibrillation|1|||
27616879|NCT02080520|80440565|FG001|Overall Study|Atrial fibrillation|1|||
27616880|NCT02080520|80440564|FG000|Overall Study|Cancer|1|||
27616881|NCT02080520|80440565|FG001|Overall Study|Cancer|2|||
27616882|NCT02080520|80440564|FG000|Overall Study|Not interested in study|1|||
27616883|NCT02080520|80440565|FG001|Overall Study|Not interested in study|3|||
27616884|NCT02080520|80440564|FG000|Overall Study|Too busy|1|||
27616885|NCT02080520|80440565|FG001|Overall Study|Too busy|1|||
27616886|NCT02080520|80440564|FG000|Overall Study|Work-related injury|1|||
27728898|NCT04436276|80838135|FG012|Overall Study|Lost to Follow-up|4|||
27907170|NCT01358578|81496891|FG002|Follow-up Period|non- compliance with study treatment|0|||
27907171|NCT01358578|81496892|FG003|Follow-up Period|non- compliance with study treatment|0|||
27907172|NCT01358578|81496893|FG004|Follow-up Period|non- compliance with study treatment|0|||
27728899|NCT04436276|80838136|FG013|Overall Study|Lost to Follow-up|1|||
27728900|NCT04436276|80838137|FG014|Overall Study|Lost to Follow-up|7|||
27728901|NCT04436276|80838138|FG015|Overall Study|Lost to Follow-up|7|||
27728902|NCT04436276|80838139|FG016|Overall Study|Lost to Follow-up|1|||
27728903|NCT04436276|80838140|FG017|Overall Study|Lost to Follow-up|0|||
27728904|NCT04436276|80838141|FG018|Overall Study|Lost to Follow-up|1|||
27728905|NCT04436276|80838142|FG019|Overall Study|Lost to Follow-up|1|||
27728906|NCT04436276|80838143|FG020|Overall Study|Lost to Follow-up|2|||
27728907|NCT04436276|80838144|FG021|Overall Study|Lost to Follow-up|1|||
27728908|NCT04436276|80838145|FG022|Overall Study|Lost to Follow-up|1|||
27728909|NCT04436276|80838123|FG000|Overall Study|Physician Decision|1|||
27728910|NCT04436276|80838124|FG001|Overall Study|Physician Decision|0|||
27728911|NCT04436276|80838125|FG002|Overall Study|Physician Decision|2|||
27728912|NCT04436276|80838126|FG003|Overall Study|Physician Decision|1|||
27907173|NCT01358578|81496894|FG005|Follow-up Period|non- compliance with study treatment|0|||
27907174|NCT01358578|81496889|FG000|Follow-up Period|Pregnancy|1|||
27907175|NCT01358578|81496890|FG001|Follow-up Period|Pregnancy|0|||
27907176|NCT01358578|81496891|FG002|Follow-up Period|Pregnancy|0|||
27907177|NCT01358578|81496892|FG003|Follow-up Period|Pregnancy|0|||
27907178|NCT01358578|81496893|FG004|Follow-up Period|Pregnancy|0|||
27907179|NCT01358578|81496894|FG005|Follow-up Period|Pregnancy|0|||
27907180|NCT01358578|81496889|FG000|Follow-up Period|Withdrawal by Subject|3|||
27907181|NCT01358578|81496890|FG001|Follow-up Period|Withdrawal by Subject|3|||
27907182|NCT01358578|81496891|FG002|Follow-up Period|Withdrawal by Subject|1|||
27907183|NCT01358578|81496892|FG003|Follow-up Period|Withdrawal by Subject|12|||
27907184|NCT01358578|81496893|FG004|Follow-up Period|Withdrawal by Subject|0|||
27907185|NCT01358578|81496894|FG005|Follow-up Period|Withdrawal by Subject|0|||
27907186|NCT01358578|81496889|FG000|Follow-up Period|Physician Decision|1|||
27728913|NCT04436276|80838127|FG004|Overall Study|Physician Decision|0|||
27728914|NCT04436276|80838128|FG005|Overall Study|Physician Decision|0|||
27728915|NCT04436276|80838129|FG006|Overall Study|Physician Decision|0|||
27728916|NCT04436276|80838130|FG007|Overall Study|Physician Decision|0|||
27728917|NCT04436276|80838131|FG008|Overall Study|Physician Decision|0|||
27728918|NCT04436276|80838132|FG009|Overall Study|Physician Decision|0|||
27728919|NCT04436276|80838133|FG010|Overall Study|Physician Decision|0|||
27728920|NCT04436276|80838134|FG011|Overall Study|Physician Decision|1|||
27728921|NCT04436276|80838135|FG012|Overall Study|Physician Decision|2|||
27907187|NCT01358578|81496890|FG001|Follow-up Period|Physician Decision|1|||
27907188|NCT01358578|81496891|FG002|Follow-up Period|Physician Decision|0|||
27907189|NCT01358578|81496892|FG003|Follow-up Period|Physician Decision|2|||
27728922|NCT04436276|80838136|FG013|Overall Study|Physician Decision|0|||
27728923|NCT04436276|80838137|FG014|Overall Study|Physician Decision|0|||
27728924|NCT04436276|80838138|FG015|Overall Study|Physician Decision|0|||
27616887|NCT02080520|80440565|FG001|Overall Study|Work-related injury|0|||
27728925|NCT04436276|80838139|FG016|Overall Study|Physician Decision|0|||
27616888|NCT02080520|80440564|FG000|Overall Study|Personal reasons|0|||
27616889|NCT02080520|80440565|FG001|Overall Study|Personal reasons|3|||
27616890|NCT04668989|80440566|FG000|First Intervention|Covid-19 related self-isolation|0|||
27728926|NCT04436276|80838140|FG017|Overall Study|Physician Decision|0|||
27616891|NCT04668989|80440567|FG001|First Intervention|Covid-19 related self-isolation|1|||
27616892|NCT04668989|80440566|FG000|Second Intervention|Adverse Event|0|||
27616893|NCT04668989|80440567|FG001|Second Intervention|Adverse Event|1|||
27616894|NCT04102540|80440568|FG000|Overall Study|Withdrawn by PI|2|||
27616895|NCT04102540|80440568|FG000|Overall Study|Lost to Follow-up|6|||
27616896|NCT01425632|80440569|FG000|Overall Study|Adverse Event|0|||
27616897|NCT01425632|80440570|FG001|Overall Study|Adverse Event|1|||
27616898|NCT01425632|80440571|FG002|Overall Study|Adverse Event|1|||
27616899|NCT01425632|80440569|FG000|Overall Study|Physician Decision|1|||
27616900|NCT01425632|80440570|FG001|Overall Study|Physician Decision|0|||
27616901|NCT01425632|80440571|FG002|Overall Study|Physician Decision|0|||
27616902|NCT01425632|80440569|FG000|Overall Study|Protocol Violation|0|||
27616903|NCT01425632|80440570|FG001|Overall Study|Protocol Violation|0|||
27616904|NCT01425632|80440571|FG002|Overall Study|Protocol Violation|2|||
27616905|NCT01425632|80440569|FG000|Overall Study|Withdrawal by Subject|0|||
27616906|NCT01425632|80440570|FG001|Overall Study|Withdrawal by Subject|0|||
27616907|NCT01425632|80440571|FG002|Overall Study|Withdrawal by Subject|1|||
27907190|NCT01358578|81496893|FG004|Follow-up Period|Physician Decision|0|||
27907191|NCT01358578|81496894|FG005|Follow-up Period|Physician Decision|0|||
27907192|NCT02020889|81496895|FG000|Overall Study|Adverse Event|0|||
27907193|NCT02020889|81496896|FG001|Overall Study|Adverse Event|1|||
27907194|NCT02020889|81496895|FG000|Overall Study|Lack of Efficacy|1|||
27907195|NCT02020889|81496896|FG001|Overall Study|Lack of Efficacy|0|||
27907196|NCT02020889|81496895|FG000|Overall Study|Lost to Follow-up|1|||
27907197|NCT02020889|81496896|FG001|Overall Study|Lost to Follow-up|0|||
27907198|NCT02020889|81496895|FG000|Overall Study|Physician Decision|2|||
27907199|NCT02020889|81496896|FG001|Overall Study|Physician Decision|0|||
27616908|NCT00372060|80440572|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
27616909|NCT00372060|80440573|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
27616910|NCT00372060|80440572|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
27616911|NCT00372060|80440573|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
27616912|NCT00372060|80440572|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
27616913|NCT00372060|80440573|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
27616914|NCT00372060|80440572|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
27616915|NCT00372060|80440573|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
27616916|NCT00372060|80440572|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
27616917|NCT00372060|80440573|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
27616918|NCT00372060|80440572|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
27616919|NCT00372060|80440573|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
27616920|NCT00432679|80440574|FG000|Overall Study|Adverse Event|2|||
27616921|NCT00432679|80440575|FG001|Overall Study|Adverse Event|1|||
27616922|NCT00432679|80440574|FG000|Overall Study|Withdrawal by Subject|3|||
27616923|NCT00432679|80440575|FG001|Overall Study|Withdrawal by Subject|2|||
27616924|NCT00372528|80440576|FG000|Overall Study|Lack of Efficacy|1|||
27616925|NCT00372528|80440576|FG000|Overall Study|Adverse Event|1|||
27616926|NCT00372528|80440576|FG000|Overall Study|Study Terminated by Sponsor|18|||
27616927|NCT00372528|80440576|FG000|Overall Study|Other|1|||
27616928|NCT01244763|80440577|FG000|Overall Study|Adverse Event|1|||
27616929|NCT01244763|80440578|FG001|Overall Study|Adverse Event|0|||
27907200|NCT02020889|81496895|FG000|Overall Study|Withdrawal by Subject|3|||
27515990|NCT04784442|80084756|FG001|Overall Study|Protocol Violation|0|||
27515991|NCT04784442|80084757|FG002|Overall Study|Protocol Violation|0|||
27515992|NCT04784442|80084758|FG003|Overall Study|Protocol Violation|0|||
27515993|NCT04784442|80084755|FG000|Overall Study|Non-compliance with study drug|1|||
27515994|NCT04784442|80084756|FG001|Overall Study|Non-compliance with study drug|0|||
27515995|NCT04784442|80084757|FG002|Overall Study|Non-compliance with study drug|0|||
27515996|NCT04784442|80084758|FG003|Overall Study|Non-compliance with study drug|0|||
27515997|NCT00530504|80084764|FG000|Overall Study|Death|54|||
27515998|NCT00530504|80084764|FG000|Overall Study|Lost to Follow-up|26|||
27515999|NCT00530504|80084764|FG000|Overall Study|Withdrawal by Subject|39|||
27516000|NCT00530504|80084764|FG000|Overall Study|Exited study due to other reasons|33|||
27516001|NCT02123472|80084765|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
27516002|NCT02123472|80084766|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
27516003|NCT01808092|80084767|FG000|Overall Study|Death|39|||
27516004|NCT01808092|80084768|FG001|Overall Study|Death|29|||
27516005|NCT01808092|80084767|FG000|Overall Study|Lost to Follow-up|3|||
27516006|NCT01808092|80084768|FG001|Overall Study|Lost to Follow-up|7|||
27616930|NCT01244763|80440579|FG002|Overall Study|Adverse Event|0|||
27616931|NCT01244763|80440580|FG003|Overall Study|Adverse Event|0|||
27516007|NCT01808092|80084767|FG000|Overall Study|Withdrawal by Subject|9|||
27616932|NCT01244763|80440581|FG004|Overall Study|Adverse Event|0|||
27516008|NCT01808092|80084768|FG001|Overall Study|Withdrawal by Subject|4|||
27616933|NCT01244763|80440582|FG005|Overall Study|Adverse Event|1|||
27616934|NCT01244763|80440577|FG000|Overall Study|Death|1|||
27907201|NCT02020889|81496896|FG001|Overall Study|Withdrawal by Subject|2|||
27907202|NCT04153565|81496897|FG000|Overall Study|Death|13|||
27907203|NCT01931397|81496898|FG000|Overall Study|Physician Decision|2|||
27907204|NCT01931397|81496898|FG000|Overall Study|Withdrawal by Subject|8|||
27907205|NCT01931397|81496898|FG000|Overall Study|moved out of state|1|||
27907206|NCT01663857|81496899|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
27907207|NCT01663857|81496900|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
27907208|NCT01663857|81496901|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
27907209|NCT01663857|81496902|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
27907210|NCT01663857|81496899|FG000|Overall Study|Lost to Follow-up|0|||
27907211|NCT01663857|81496900|FG001|Overall Study|Lost to Follow-up|0|||
27907212|NCT01663857|81496901|FG002|Overall Study|Lost to Follow-up|3|||
27907213|NCT01663857|81496902|FG003|Overall Study|Lost to Follow-up|1|||
27907214|NCT02315664|81496903|FG000|Overall Study|Lost to Follow-up|1|||
27907215|NCT02315664|81496904|FG001|Overall Study|Lost to Follow-up|1|||
27907216|NCT02315664|81496903|FG000|Overall Study|Withdrawal by Subject|0|||
27907217|NCT02315664|81496904|FG001|Overall Study|Withdrawal by Subject|3|||
27907218|NCT01877668|81496908|FG000|Overall Study|Death|0|||
27907219|NCT01877668|81496909|FG001|Overall Study|Death|0|||
27907220|NCT01877668|81496910|FG002|Overall Study|Death|0|||
27907221|NCT01877668|81496911|FG003|Overall Study|Death|1|||
27907222|NCT01877668|81496912|FG004|Overall Study|Death|0|||
27728927|NCT04436276|80838141|FG018|Overall Study|Physician Decision|0|||
27907223|NCT01877668|81496908|FG000|Overall Study|No longer met study criteria|1|||
27907224|NCT01877668|81496909|FG001|Overall Study|No longer met study criteria|0|||
27907225|NCT01877668|81496910|FG002|Overall Study|No longer met study criteria|1|||
27907226|NCT01877668|81496911|FG003|Overall Study|No longer met study criteria|0|||
27907227|NCT01877668|81496912|FG004|Overall Study|No longer met study criteria|0|||
27907228|NCT01877668|81496908|FG000|Overall Study|Insufficient clinical response|0|||
27907229|NCT01877668|81496909|FG001|Overall Study|Insufficient clinical response|1|||
27907230|NCT01877668|81496910|FG002|Overall Study|Insufficient clinical response|2|||
27907231|NCT01877668|81496911|FG003|Overall Study|Insufficient clinical response|2|||
27907232|NCT01877668|81496912|FG004|Overall Study|Insufficient clinical response|0|||
27907233|NCT01877668|81496908|FG000|Overall Study|Lost to Follow-up|0|||
27907234|NCT01877668|81496909|FG001|Overall Study|Lost to Follow-up|2|||
27907235|NCT01877668|81496910|FG002|Overall Study|Lost to Follow-up|1|||
27907236|NCT01877668|81496911|FG003|Overall Study|Lost to Follow-up|0|||
27907237|NCT01877668|81496912|FG004|Overall Study|Lost to Follow-up|0|||
27907238|NCT01877668|81496908|FG000|Overall Study|Withdrawal by Subject|2|||
27907239|NCT01877668|81496909|FG001|Overall Study|Withdrawal by Subject|0|||
27907240|NCT01877668|81496910|FG002|Overall Study|Withdrawal by Subject|3|||
27907241|NCT01877668|81496911|FG003|Overall Study|Withdrawal by Subject|2|||
27907242|NCT01877668|81496912|FG004|Overall Study|Withdrawal by Subject|2|||
27907243|NCT01877668|81496908|FG000|Overall Study|Other|1|||
27907244|NCT01877668|81496909|FG001|Overall Study|Other|1|||
27907245|NCT01877668|81496910|FG002|Overall Study|Other|1|||
27728928|NCT04436276|80838142|FG019|Overall Study|Physician Decision|0|||
27728929|NCT04436276|80838143|FG020|Overall Study|Physician Decision|1|||
27728930|NCT04436276|80838144|FG021|Overall Study|Physician Decision|2|||
27728931|NCT04436276|80838145|FG022|Overall Study|Physician Decision|0|||
27728932|NCT04436276|80838123|FG000|Overall Study|Protocol Violation|0|||
27728933|NCT04436276|80838124|FG001|Overall Study|Protocol Violation|0|||
27728934|NCT04436276|80838125|FG002|Overall Study|Protocol Violation|0|||
27728935|NCT04436276|80838126|FG003|Overall Study|Protocol Violation|0|||
27728936|NCT04436276|80838127|FG004|Overall Study|Protocol Violation|0|||
27728937|NCT04436276|80838128|FG005|Overall Study|Protocol Violation|0|||
27728938|NCT04436276|80838129|FG006|Overall Study|Protocol Violation|0|||
27728939|NCT04436276|80838130|FG007|Overall Study|Protocol Violation|0|||
27728940|NCT04436276|80838131|FG008|Overall Study|Protocol Violation|0|||
27728941|NCT04436276|80838132|FG009|Overall Study|Protocol Violation|0|||
27728942|NCT04436276|80838133|FG010|Overall Study|Protocol Violation|0|||
27907246|NCT01877668|81496911|FG003|Overall Study|Other|1|||
27907247|NCT01877668|81496912|FG004|Overall Study|Other|3|||
27728943|NCT04436276|80838134|FG011|Overall Study|Protocol Violation|0|||
27907248|NCT01877668|81496908|FG000|Overall Study|Protocol Violation|1|||
27907249|NCT01877668|81496909|FG001|Overall Study|Protocol Violation|1|||
27907250|NCT01877668|81496910|FG002|Overall Study|Protocol Violation|0|||
27728944|NCT04436276|80838135|FG012|Overall Study|Protocol Violation|0|||
27728945|NCT04436276|80838136|FG013|Overall Study|Protocol Violation|1|||
27728946|NCT04436276|80838137|FG014|Overall Study|Protocol Violation|0|||
27728947|NCT04436276|80838138|FG015|Overall Study|Protocol Violation|1|||
27853438|NCT00448136|81295044|FG000|Overall Study|Investigator's decision (progression)|1|||
27853439|NCT00448136|81295045|FG001|Overall Study|Investigator's decision (progression)|0|||
27728948|NCT04436276|80838139|FG016|Overall Study|Protocol Violation|0|||
27728949|NCT04436276|80838140|FG017|Overall Study|Protocol Violation|0|||
27907251|NCT01877668|81496911|FG003|Overall Study|Protocol Violation|0|||
27907252|NCT01877668|81496912|FG004|Overall Study|Protocol Violation|3|||
27907253|NCT01877668|81496908|FG000|Overall Study|Adverse event related to study drug|2|||
27907254|NCT01877668|81496909|FG001|Overall Study|Adverse event related to study drug|2|||
27907255|NCT01877668|81496910|FG002|Overall Study|Adverse event related to study drug|2|||
27616935|NCT01244763|80440578|FG001|Overall Study|Death|0|||
27616936|NCT01244763|80440579|FG002|Overall Study|Death|1|||
27616937|NCT01244763|80440580|FG003|Overall Study|Death|0|||
27616938|NCT01244763|80440581|FG004|Overall Study|Death|2|||
27616939|NCT01244763|80440582|FG005|Overall Study|Death|0|||
27616940|NCT01244763|80440577|FG000|Overall Study|Physician Decision|0|||
27616941|NCT01244763|80440578|FG001|Overall Study|Physician Decision|0|||
27728950|NCT04436276|80838141|FG018|Overall Study|Protocol Violation|0|||
27728951|NCT04436276|80838142|FG019|Overall Study|Protocol Violation|0|||
27728952|NCT04436276|80838143|FG020|Overall Study|Protocol Violation|0|||
27516009|NCT01808092|80084767|FG000|Overall Study|Other Eligibility criteria|3|||
27516010|NCT01808092|80084768|FG001|Overall Study|Other Eligibility criteria|5|||
27516011|NCT01354899|80084770|FG000|Overall Study|discharge from the hospital|2|||
27516012|NCT01354899|80084770|FG000|Overall Study|Protocol Violation|1|||
27728953|NCT04436276|80838144|FG021|Overall Study|Protocol Violation|0|||
27728954|NCT04436276|80838145|FG022|Overall Study|Protocol Violation|0|||
27728955|NCT04436276|80838123|FG000|Overall Study|Withdrawal by Subject|25|||
27728956|NCT04436276|80838124|FG001|Overall Study|Withdrawal by Subject|22|||
27728957|NCT04436276|80838125|FG002|Overall Study|Withdrawal by Subject|24|||
27728958|NCT04436276|80838126|FG003|Overall Study|Withdrawal by Subject|23|||
27728959|NCT04436276|80838127|FG004|Overall Study|Withdrawal by Subject|14|||
27728960|NCT04436276|80838128|FG005|Overall Study|Withdrawal by Subject|0|||
27728961|NCT04436276|80838129|FG006|Overall Study|Withdrawal by Subject|0|||
27728962|NCT04436276|80838130|FG007|Overall Study|Withdrawal by Subject|1|||
27728963|NCT04436276|80838131|FG008|Overall Study|Withdrawal by Subject|0|||
27728964|NCT04436276|80838132|FG009|Overall Study|Withdrawal by Subject|1|||
27907256|NCT01877668|81496911|FG003|Overall Study|Adverse event related to study drug|2|||
27907257|NCT01877668|81496912|FG004|Overall Study|Adverse event related to study drug|1|||
27907258|NCT01877668|81496908|FG000|Overall Study|Adverse event unrelated to study drug|4|||
27907259|NCT01877668|81496909|FG001|Overall Study|Adverse event unrelated to study drug|1|||
27907260|NCT01877668|81496910|FG002|Overall Study|Adverse event unrelated to study drug|2|||
27907261|NCT01877668|81496911|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27516013|NCT03865381|80084773|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
27516014|NCT03865381|80084773|FG000|Overall Study|Withdrawal by Subject|2|||
27516015|NCT00335764|80084774|FG000|Overall Study|wrong histology|1|||
27516016|NCT00335764|80084775|FG001|Overall Study|wrong histology|0|||
27516017|NCT00335764|80084776|FG002|Overall Study|wrong histology|0|||
27516018|NCT00335764|80084777|FG003|Overall Study|wrong histology|0|||
27516019|NCT00335764|80084778|FG004|Overall Study|wrong histology|1|||
27516020|NCT00918736|80084779|FG000|Overall Study|Withdrawal by Subject|4|||
27516021|NCT00647270|80084780|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
27516022|NCT00647270|80084781|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
27516023|NCT00647270|80084782|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
27516024|NCT00647270|80084780|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
27516025|NCT00647270|80084781|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
27516026|NCT00647270|80084782|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
27516027|NCT00647270|80084780|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
27516028|NCT00647270|80084781|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
27516029|NCT00647270|80084782|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
27516030|NCT00647270|80084780|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
27516031|NCT00647270|80084781|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
27516032|NCT00647270|80084782|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
27516033|NCT00647270|80084780|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
27516034|NCT00647270|80084781|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
27516035|NCT00647270|80084782|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
27516036|NCT00647270|80084780|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
27516037|NCT00647270|80084781|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
27516038|NCT00647270|80084782|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
27516039|NCT00647270|80084780|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
27516040|NCT00647270|80084781|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
27516041|NCT00647270|80084782|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
27516042|NCT00475982|80084789|FG000|Overall Study|surgery rescheduled|7|||
27516043|NCT00475982|80084790|FG001|Overall Study|surgery rescheduled|3|||
27516044|NCT00324961|80084791|FG000|Overall Study|Adverse Event|5|||
27516045|NCT00324961|80084791|FG000|Overall Study|Consent Withdrawn|11|||
27516046|NCT00324961|80084791|FG000|Overall Study|Lost to Follow-up|22|||
27616942|NCT01244763|80440579|FG002|Overall Study|Physician Decision|1|||
27728965|NCT04436276|80838133|FG010|Overall Study|Withdrawal by Subject|17|||
27728966|NCT04436276|80838134|FG011|Overall Study|Withdrawal by Subject|7|||
27728967|NCT04436276|80838135|FG012|Overall Study|Withdrawal by Subject|10|||
27853440|NCT01558297|81295046|FG000|Overall Study|Withdrawal by Subject|2|||
27853441|NCT01558297|81295047|FG001|Overall Study|Withdrawal by Subject|2|||
27853442|NCT01558297|81295048|FG002|Overall Study|Withdrawal by Subject|1|||
27616943|NCT01244763|80440580|FG003|Overall Study|Physician Decision|0|||
27616944|NCT01244763|80440581|FG004|Overall Study|Physician Decision|0|||
27616945|NCT01244763|80440582|FG005|Overall Study|Physician Decision|0|||
27616946|NCT01244763|80440577|FG000|Overall Study|Withdrawal by Subject|1|||
27616947|NCT01244763|80440578|FG001|Overall Study|Withdrawal by Subject|2|||
27616948|NCT01244763|80440579|FG002|Overall Study|Withdrawal by Subject|0|||
27616949|NCT01244763|80440580|FG003|Overall Study|Withdrawal by Subject|1|||
27616950|NCT01244763|80440581|FG004|Overall Study|Withdrawal by Subject|1|||
27616951|NCT01244763|80440582|FG005|Overall Study|Withdrawal by Subject|2|||
27616952|NCT01244763|80440577|FG000|Overall Study|Lost to Follow-up|0|||
27616953|NCT01244763|80440578|FG001|Overall Study|Lost to Follow-up|1|||
27616954|NCT01244763|80440579|FG002|Overall Study|Lost to Follow-up|0|||
27616955|NCT01244763|80440580|FG003|Overall Study|Lost to Follow-up|0|||
27616956|NCT01244763|80440581|FG004|Overall Study|Lost to Follow-up|0|||
27907262|NCT01877668|81496912|FG004|Overall Study|Adverse event unrelated to study drug|1|||
27907263|NCT01087203|81496913|FG000|Overall Study|Lost to Follow-up|2|||
27907264|NCT01087203|81496914|FG001|Overall Study|Lost to Follow-up|0|||
27907265|NCT01087203|81496913|FG000|Overall Study|Withdrawal by Subject|2|||
27907266|NCT01087203|81496914|FG001|Overall Study|Withdrawal by Subject|6|||
27907267|NCT01087203|81496913|FG000|Overall Study|Lack of Efficacy|1|||
27907268|NCT01087203|81496914|FG001|Overall Study|Lack of Efficacy|2|||
27907269|NCT01087203|81496913|FG000|Overall Study|Study terminated by sponsor|27|||
27907270|NCT01087203|81496914|FG001|Overall Study|Study terminated by sponsor|27|||
27907271|NCT01189461|81496915|FG000|Overall Study|Lack of Efficacy|13|||
27907272|NCT01189461|81496915|FG000|Overall Study|Lost to Follow-up|1|||
27907273|NCT01189461|81496915|FG000|Overall Study|Withdrawal by Subject|6|||
27907274|NCT01189461|81496915|FG000|Overall Study|Protocol Violation|1|||
27907275|NCT01189461|81496915|FG000|Overall Study|Adverse Event|2|||
27907276|NCT01189461|81496915|FG000|Overall Study|Did not meet entrance criteria|3|||
27907277|NCT01189461|81496915|FG000|Overall Study|Other|8|||
27907278|NCT03628716|81496916|FG000|Overall Study|Adverse Event|1|||
27907279|NCT03628716|81496917|FG001|Overall Study|Adverse Event|1|||
27907280|NCT03628716|81496916|FG000|Overall Study|Death|1|||
27907281|NCT03628716|81496917|FG001|Overall Study|Death|0|||
27907282|NCT03628716|81496916|FG000|Overall Study|Lack of Efficacy|15|||
27907283|NCT03628716|81496917|FG001|Overall Study|Lack of Efficacy|20|||
27907284|NCT03628716|81496916|FG000|Overall Study|Withdrawal by Subject|1|||
27907285|NCT03628716|81496917|FG001|Overall Study|Withdrawal by Subject|2|||
27907286|NCT03628716|81496916|FG000|Overall Study|Study Terminated by Sponsor|1|||
27907287|NCT03628716|81496917|FG001|Overall Study|Study Terminated by Sponsor|0|||
27907288|NCT03504189|81496918|FG000|Overall Study|Withdrawal by Subject|1|||
27907289|NCT03504189|81496918|FG000|Overall Study|Screening Failure|1|||
27907290|NCT03504189|81496918|FG000|Overall Study|Device Failure|2|||
27907291|NCT04625413|81496920|FG000|Overall Study|Hospice|2|||
27907292|NCT04625413|81496920|FG000|Overall Study|Distress|1|||
27907293|NCT04625413|81496920|FG000|Overall Study|Not feeling well|1|||
27907294|NCT03042910|81500327|FG000|Overall Study|Adverse Event|1|||
27907295|NCT03042910|81500327|FG000|Overall Study|Disease Progression|2|||
27907296|NCT03042910|81500327|FG000|Overall Study|Withdrawal by Subject|3|||
27907297|NCT03042910|81500327|FG000|Overall Study|Enrolled but not treated|1|||
27907298|NCT01212159|81500328|FG000|Overall Study|Withdrawal by Subject|12|||
27907299|NCT01212159|81500329|FG001|Overall Study|Withdrawal by Subject|12|||
27516047|NCT00324961|80084791|FG000|Overall Study|Protocol Violation|3|||
27516048|NCT00324961|80084791|FG000|Overall Study|Other|2|||
27516049|NCT01837823|80084796|FG000|Overall Study|Lost to Follow-up|6|||
27516050|NCT00459186|80084797|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
27516051|NCT00459186|80084797|FG000|PET Imaging and Assessment|Adverse Event|3|||
27516052|NCT01396447|80084798|FG000|Overall Study|Did Not Receive Treatment|3|||
27516053|NCT01396447|80084799|FG001|Overall Study|Did Not Receive Treatment|2|||
27516054|NCT01396447|80084800|FG002|Overall Study|Did Not Receive Treatment|1|||
27516055|NCT01396447|80084801|FG003|Overall Study|Did Not Receive Treatment|0|||
27516056|NCT01396447|80084798|FG000|Overall Study|Adverse Event|15|||
27516057|NCT01396447|80084799|FG001|Overall Study|Adverse Event|12|||
27516058|NCT01396447|80084800|FG002|Overall Study|Adverse Event|12|||
27516059|NCT01396447|80084801|FG003|Overall Study|Adverse Event|17|||
27516060|NCT01396447|80084798|FG000|Overall Study|Insufficient Therapeutic Response|5|||
27516061|NCT01396447|80084799|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27907300|NCT04074330|81500330|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
27907301|NCT04074330|81500331|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
27907302|NCT04074330|81500332|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
27907303|NCT04074330|81500333|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
27907304|NCT04074330|81500334|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
27516062|NCT01396447|80084800|FG002|Overall Study|Insufficient Therapeutic Response|2|||
27516063|NCT01396447|80084801|FG003|Overall Study|Insufficient Therapeutic Response|4|||
27516064|NCT01396447|80084798|FG000|Overall Study|Protocol Violation|5|||
27516065|NCT01396447|80084799|FG001|Overall Study|Protocol Violation|2|||
27907305|NCT04074330|81500335|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
27616957|NCT01244763|80440582|FG005|Overall Study|Lost to Follow-up|0|||
27907306|NCT04074330|81500336|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
27907307|NCT04074330|81500337|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
27907308|NCT04074330|81500338|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
27907309|NCT04074330|81500339|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
27907310|NCT04074330|81500330|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
27907311|NCT04074330|81500331|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
27616958|NCT01244763|80440577|FG000|Overall Study|Enrolled into the Extension Study|0|||
27616959|NCT01244763|80440578|FG001|Overall Study|Enrolled into the Extension Study|0|||
27616960|NCT01244763|80440579|FG002|Overall Study|Enrolled into the Extension Study|0|||
27907312|NCT04074330|81500332|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
27907313|NCT04074330|81500333|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
27907314|NCT04074330|81500334|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
27907315|NCT04074330|81500335|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
27907316|NCT04074330|81500336|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
27907317|NCT04074330|81500337|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
27907318|NCT04074330|81500338|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
27907319|NCT04074330|81500339|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
27907320|NCT04074330|81500330|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907321|NCT04074330|81500331|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907322|NCT04074330|81500332|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
27907323|NCT04074330|81500333|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907324|NCT04074330|81500334|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27516066|NCT01396447|80084800|FG002|Overall Study|Protocol Violation|3|||
27516067|NCT01396447|80084801|FG003|Overall Study|Protocol Violation|7|||
27516068|NCT01396447|80084798|FG000|Overall Study|Withdrawal of Consent|11|||
27516069|NCT01396447|80084799|FG001|Overall Study|Withdrawal of Consent|9|||
27516070|NCT01396447|80084800|FG002|Overall Study|Withdrawal of Consent|4|||
27516071|NCT01396447|80084801|FG003|Overall Study|Withdrawal of Consent|15|||
27516072|NCT01396447|80084798|FG000|Overall Study|Lost to Follow-up|4|||
27516073|NCT01396447|80084799|FG001|Overall Study|Lost to Follow-up|8|||
27516074|NCT01396447|80084800|FG002|Overall Study|Lost to Follow-up|7|||
27516075|NCT01396447|80084801|FG003|Overall Study|Lost to Follow-up|9|||
27516076|NCT01396447|80084798|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27516077|NCT01396447|80084799|FG001|Overall Study|Other Miscellaneous Reasons|2|||
27516078|NCT01396447|80084800|FG002|Overall Study|Other Miscellaneous Reasons|1|||
27516079|NCT01396447|80084801|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27516080|NCT01105767|80084802|FG000|Overall Study|Lost to Follow-up|1160|||
27516081|NCT01105767|80084803|FG001|Overall Study|Lost to Follow-up|1614|||
27516082|NCT01105767|80084804|FG002|Overall Study|Lost to Follow-up|1184|||
27516083|NCT00862641|80084805|FG000|Overall Study|Randomized, but drug not received|1|||
27516084|NCT00862641|80084806|FG001|Overall Study|Randomized, but drug not received|4|||
27516085|NCT00862641|80084807|FG002|Overall Study|Randomized, but drug not received|1|||
27516086|NCT00862641|80084808|FG003|Overall Study|Randomized, but drug not received|4|||
27516087|NCT01501955|80084809|FG000|Overall Study|Withdrawal by Subject|1|||
27516088|NCT01501955|80084810|FG001|Overall Study|Withdrawal by Subject|0|||
27516089|NCT01501955|80084809|FG000|Overall Study|Adverse Event|1|||
27516090|NCT01501955|80084810|FG001|Overall Study|Adverse Event|3|||
27516091|NCT03073733|80084821|FG000|Overall Study|Lost to Follow-up|1|||
27516092|NCT03073733|80084822|FG001|Overall Study|Lost to Follow-up|0|||
27516093|NCT03073733|80084823|FG002|Overall Study|Lost to Follow-up|0|||
27516094|NCT03073733|80084821|FG000|Overall Study|Physician Decision|0|||
27516095|NCT03073733|80084822|FG001|Overall Study|Physician Decision|1|||
27516096|NCT03073733|80084823|FG002|Overall Study|Physician Decision|0|||
27516097|NCT03073733|80084821|FG000|Overall Study|Withdrawal by Subject|0|||
27516098|NCT03073733|80084822|FG001|Overall Study|Withdrawal by Subject|0|||
27516099|NCT03073733|80084823|FG002|Overall Study|Withdrawal by Subject|1|||
27516100|NCT01243242|80084824|FG000|Overall Study|Adverse Event|1|||
27516101|NCT01243242|80084825|FG001|Overall Study|Adverse Event|1|||
27516102|NCT01243242|80084824|FG000|Overall Study|Withdrawal by Subject|1|||
27516103|NCT01243242|80084825|FG001|Overall Study|Withdrawal by Subject|1|||
27516104|NCT01243242|80084824|FG000|Overall Study|Physician Decision|0|||
27516105|NCT01243242|80084825|FG001|Overall Study|Physician Decision|1|||
27516106|NCT01243242|80084824|FG000|Overall Study|sponsor decision|0|||
27516107|NCT01243242|80084825|FG001|Overall Study|sponsor decision|1|||
27516108|NCT01243242|80084824|FG000|Overall Study|non compliance|1|||
27516109|NCT01243242|80084825|FG001|Overall Study|non compliance|0|||
27516110|NCT00275340|80084827|FG000|Overall Study|Lost to Follow-up|2|||
27516111|NCT00275340|80084828|FG001|Overall Study|Lost to Follow-up|4|||
27516112|NCT02873429|80084829|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
27516113|NCT02873429|80084830|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
27516114|NCT02873429|80084829|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
27616961|NCT01244763|80440580|FG003|Overall Study|Enrolled into the Extension Study|0|||
27516115|NCT02873429|80084830|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
27616962|NCT01244763|80440581|FG004|Overall Study|Enrolled into the Extension Study|0|||
27616963|NCT01244763|80440582|FG005|Overall Study|Enrolled into the Extension Study|1|||
27616964|NCT00180674|80440583|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
27616965|NCT00180674|80440583|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
27616966|NCT03873246|80440585|FG000|Overall Study|Adverse Event|1|||
27616967|NCT03873246|80440586|FG001|Overall Study|Adverse Event|3|||
27616968|NCT03873246|80440587|FG002|Overall Study|Adverse Event|3|||
27616969|NCT03873246|80440585|FG000|Overall Study|Lost to Follow-up|4|||
27616970|NCT03873246|80440586|FG001|Overall Study|Lost to Follow-up|4|||
27616971|NCT03873246|80440587|FG002|Overall Study|Lost to Follow-up|5|||
27616972|NCT03873246|80440585|FG000|Overall Study|Protocol Violation|0|||
27616973|NCT03873246|80440586|FG001|Overall Study|Protocol Violation|1|||
27616974|NCT03873246|80440587|FG002|Overall Study|Protocol Violation|0|||
27616975|NCT03873246|80440585|FG000|Overall Study|Withdrawal by Subject|0|||
27616976|NCT03873246|80440586|FG001|Overall Study|Withdrawal by Subject|4|||
27616977|NCT03873246|80440587|FG002|Overall Study|Withdrawal by Subject|1|||
27616978|NCT00107380|80440589|FG000|Overall Study|Adverse Event|7|||
27616979|NCT00107380|80440589|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
27616980|NCT00107380|80440589|FG000|Overall Study|Progression/relapse|4|||
27616981|NCT00107380|80440589|FG000|Overall Study|Death|3|||
27616982|NCT00107380|80440589|FG000|Overall Study|Other - not protocol specified|7|||
27616983|NCT00107380|80440589|FG000|Overall Study|Ineligible|2|||
27616984|NCT01567163|80440590|FG000|Overall Study|Progressive Disease|2|||
27616985|NCT01567163|80440590|FG000|Overall Study|Lost to Follow-up|2|||
27616986|NCT01702428|80440596|FG000|Overall Study|Adverse Event|2|||
27616987|NCT01702428|80440597|FG001|Overall Study|Adverse Event|0|||
27616988|NCT01702428|80440598|FG002|Overall Study|Adverse Event|0|||
27616989|NCT01702428|80440599|FG003|Overall Study|Adverse Event|0|||
27616990|NCT01702428|80440596|FG000|Overall Study|Lost to Follow-up|33|||
27616991|NCT01702428|80440597|FG001|Overall Study|Lost to Follow-up|41|||
27616992|NCT01702428|80440598|FG002|Overall Study|Lost to Follow-up|37|||
27616993|NCT01702428|80440599|FG003|Overall Study|Lost to Follow-up|44|||
27616994|NCT01702428|80440596|FG000|Overall Study|Parents cannot assist to site|1|||
27516116|NCT02873429|80084829|FG000|16 Weeks|Lost to Follow-up|3|||
27516117|NCT02873429|80084830|FG001|16 Weeks|Lost to Follow-up|0|||
27516118|NCT04027608|80084832|FG000|Overall Study|Withdrawal by Subject|13|||
27516119|NCT04027608|80084833|FG001|Overall Study|Withdrawal by Subject|2|||
27516120|NCT04027608|80084832|FG000|Overall Study|Protocol Violation|2|||
27516121|NCT04027608|80084833|FG001|Overall Study|Protocol Violation|1|||
27516122|NCT04027608|80084832|FG000|Overall Study|Physician Decision|1|||
27516123|NCT04027608|80084833|FG001|Overall Study|Physician Decision|0|||
27516124|NCT04027608|80084832|FG000|Overall Study|Lost to Follow-up|20|||
27516125|NCT04027608|80084833|FG001|Overall Study|Lost to Follow-up|4|||
27516126|NCT00531427|80084834|FG000|Overall Study|Withdrawal by Subject|7|||
27516127|NCT00531427|80084835|FG001|Overall Study|Withdrawal by Subject|13|||
27516128|NCT00531427|80084834|FG000|Overall Study|Adverse Event|44|||
27516129|NCT00531427|80084835|FG001|Overall Study|Adverse Event|30|||
27616995|NCT01702428|80440597|FG001|Overall Study|Parents cannot assist to site|0|||
27616996|NCT01702428|80440598|FG002|Overall Study|Parents cannot assist to site|1|||
27616997|NCT01702428|80440599|FG003|Overall Study|Parents cannot assist to site|0|||
27616998|NCT01702428|80440596|FG000|Overall Study|Lost Coverage|0|||
27616999|NCT01702428|80440597|FG001|Overall Study|Lost Coverage|0|||
27617000|NCT01702428|80440598|FG002|Overall Study|Lost Coverage|0|||
27617001|NCT01702428|80440599|FG003|Overall Study|Lost Coverage|1|||
27617002|NCT01702428|80440596|FG000|Overall Study|Lost Health Plan|3|||
27617003|NCT01702428|80440597|FG001|Overall Study|Lost Health Plan|5|||
27617004|NCT01702428|80440598|FG002|Overall Study|Lost Health Plan|0|||
27617005|NCT01702428|80440599|FG003|Overall Study|Lost Health Plan|2|||
27617006|NCT01702428|80440596|FG000|Overall Study|Mother transferred care|0|||
27617007|NCT01702428|80440597|FG001|Overall Study|Mother transferred care|1|||
27617008|NCT01702428|80440598|FG002|Overall Study|Mother transferred care|0|||
27617009|NCT01702428|80440599|FG003|Overall Study|Mother transferred care|0|||
27617010|NCT01702428|80440596|FG000|Overall Study|Parents too busy|1|||
27617011|NCT01702428|80440597|FG001|Overall Study|Parents too busy|0|||
27617012|NCT01702428|80440598|FG002|Overall Study|Parents too busy|0|||
27516130|NCT00531427|80084834|FG000|Overall Study|Lost to Follow-up|4|||
27516131|NCT00531427|80084835|FG001|Overall Study|Lost to Follow-up|3|||
27516132|NCT00531427|80084834|FG000|Overall Study|Lack of Efficacy|14|||
27617013|NCT01702428|80440599|FG003|Overall Study|Parents too busy|0|||
27617014|NCT01702428|80440596|FG000|Overall Study|Protocol Violation|3|||
27617015|NCT01702428|80440597|FG001|Overall Study|Protocol Violation|0|||
27617016|NCT01702428|80440598|FG002|Overall Study|Protocol Violation|1|||
27617017|NCT01702428|80440599|FG003|Overall Study|Protocol Violation|0|||
27617018|NCT01702428|80440596|FG000|Overall Study|Withdrawal by Subject|21|||
27617019|NCT01702428|80440597|FG001|Overall Study|Withdrawal by Subject|23|||
27617020|NCT01702428|80440598|FG002|Overall Study|Withdrawal by Subject|14|||
27516133|NCT00531427|80084835|FG001|Overall Study|Lack of Efficacy|39|||
27516134|NCT00531427|80084834|FG000|Overall Study|Administrative|4|||
27728968|NCT04436276|80838136|FG013|Overall Study|Withdrawal by Subject|6|||
27728969|NCT04436276|80838137|FG014|Overall Study|Withdrawal by Subject|20|||
27617021|NCT01702428|80440599|FG003|Overall Study|Withdrawal by Subject|10|||
27617022|NCT01012973|80440601|FG000|Overall Study|Adverse Event|5|||
27617023|NCT01012973|80440602|FG001|Overall Study|Adverse Event|5|||
27617024|NCT01012973|80440601|FG000|Overall Study|Lack of Efficacy|0|||
27617025|NCT01012973|80440602|FG001|Overall Study|Lack of Efficacy|5|||
27728970|NCT04436276|80838138|FG015|Overall Study|Withdrawal by Subject|6|||
27728971|NCT04436276|80838139|FG016|Overall Study|Withdrawal by Subject|11|||
27728972|NCT04436276|80838140|FG017|Overall Study|Withdrawal by Subject|4|||
27617026|NCT01012973|80440601|FG000|Overall Study|Lost to Follow-up|1|||
27728973|NCT04436276|80838141|FG018|Overall Study|Withdrawal by Subject|14|||
27728974|NCT04436276|80838142|FG019|Overall Study|Withdrawal by Subject|24|||
27728975|NCT04436276|80838143|FG020|Overall Study|Withdrawal by Subject|24|||
27728976|NCT04436276|80838144|FG021|Overall Study|Withdrawal by Subject|16|||
27728977|NCT04436276|80838145|FG022|Overall Study|Withdrawal by Subject|14|||
27728978|NCT04436276|80838123|FG000|Overall Study|Other|3|||
27728979|NCT04436276|80838124|FG001|Overall Study|Other|2|||
27728980|NCT04436276|80838125|FG002|Overall Study|Other|5|||
27728981|NCT04436276|80838126|FG003|Overall Study|Other|9|||
27728982|NCT04436276|80838127|FG004|Overall Study|Other|23|||
27728983|NCT04436276|80838128|FG005|Overall Study|Other|1|||
27728984|NCT04436276|80838129|FG006|Overall Study|Other|0|||
27728985|NCT04436276|80838130|FG007|Overall Study|Other|0|||
27728986|NCT04436276|80838131|FG008|Overall Study|Other|0|||
27728987|NCT04436276|80838132|FG009|Overall Study|Other|0|||
27728988|NCT04436276|80838133|FG010|Overall Study|Other|3|||
27728989|NCT04436276|80838134|FG011|Overall Study|Other|1|||
27728990|NCT04436276|80838135|FG012|Overall Study|Other|1|||
27728991|NCT04436276|80838136|FG013|Overall Study|Other|2|||
27728992|NCT04436276|80838137|FG014|Overall Study|Other|3|||
27728993|NCT04436276|80838138|FG015|Overall Study|Other|0|||
27728994|NCT04436276|80838139|FG016|Overall Study|Other|0|||
27728995|NCT04436276|80838140|FG017|Overall Study|Other|6|||
27728996|NCT04436276|80838141|FG018|Overall Study|Other|1|||
27728997|NCT04436276|80838142|FG019|Overall Study|Other|0|||
27728998|NCT04436276|80838143|FG020|Overall Study|Other|2|||
27728999|NCT04436276|80838144|FG021|Overall Study|Other|2|||
27729000|NCT04436276|80838145|FG022|Overall Study|Other|60|||
27729001|NCT01817790|80838146|FG000|Overall Study|Adverse Event|0|||
27729002|NCT01817790|80838147|FG001|Overall Study|Adverse Event|2|||
27729003|NCT01817790|80838146|FG000|Overall Study|Lost to Follow-up|0|||
27729004|NCT01817790|80838147|FG001|Overall Study|Lost to Follow-up|1|||
27729005|NCT01817790|80838146|FG000|Overall Study|Protocol Violation|2|||
27729006|NCT01817790|80838147|FG001|Overall Study|Protocol Violation|1|||
27729007|NCT01817790|80838146|FG000|Overall Study|Withdrawal by Subject|1|||
27729008|NCT01817790|80838147|FG001|Overall Study|Withdrawal by Subject|3|||
27729009|NCT01817790|80838146|FG000|Overall Study|Other: Could not attend appointment|1|||
27729010|NCT01817790|80838147|FG001|Overall Study|Other: Could not attend appointment|1|||
27729011|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729012|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
27729013|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729014|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729015|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729016|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
27729017|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
27729018|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
27729019|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
27729020|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
27729021|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
27617027|NCT01012973|80440602|FG001|Overall Study|Lost to Follow-up|0|||
27617028|NCT01012973|80440601|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
27617029|NCT01012973|80440602|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
27729022|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
27729023|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729024|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
27729025|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
27729026|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
27729027|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
27729028|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
27617030|NCT01012973|80440601|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
27729029|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
27729030|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
27729031|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729032|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729033|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729034|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
27729035|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729036|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
27729037|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
27729038|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
27729039|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
27729040|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
27729041|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
27729042|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
27729043|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
27729044|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
27729045|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
27729046|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
27729047|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
27729048|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
27729049|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
27907325|NCT04074330|81500335|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907326|NCT04074330|81500336|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27617031|NCT01012973|80440602|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
27617032|NCT01012973|80440601|FG000|Overall Study|Protocol Violation|5|||
27617033|NCT01012973|80440602|FG001|Overall Study|Protocol Violation|2|||
27617034|NCT01012973|80440601|FG000|Overall Study|Withdrawal by Subject|4|||
27617035|NCT01012973|80440602|FG001|Overall Study|Withdrawal by Subject|6|||
27729050|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
27729051|NCT00289913|80838152|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
27729052|NCT00289913|80838153|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729053|NCT00289913|80838154|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
27729054|NCT00289913|80838155|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729055|NCT00289913|80838156|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729056|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729057|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729058|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
27729059|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729060|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729061|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
27729062|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
27729063|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
27729064|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
27729065|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
27729066|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
27729067|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
27729068|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
27729069|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
27729070|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
27729071|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
27729072|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
27729073|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
27729074|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729075|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729076|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
27729077|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729078|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
27729079|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729080|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27907327|NCT04074330|81500337|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907328|NCT04074330|81500338|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907329|NCT04074330|81500339|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
27907330|NCT04074330|81500330|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27907331|NCT04074330|81500331|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27617036|NCT03293485|80440604|FG000|Overall Study|Death|1|||
27617037|NCT03293485|80440604|FG000|Overall Study|Screen Failure|2|||
27617038|NCT03293485|80440604|FG000|Overall Study|Withdrawal by Subject|2|||
27617039|NCT01723826|80440605|FG000|Overall Study|Adverse Event|4|||
27617040|NCT01723826|80440606|FG001|Overall Study|Adverse Event|1|||
27617041|NCT01723826|80440607|FG002|Overall Study|Adverse Event|4|||
27617042|NCT01723826|80440608|FG003|Overall Study|Adverse Event|5|||
27617043|NCT01723826|80440605|FG000|Overall Study|Death according to AE eCRF|2|||
27617044|NCT01723826|80440606|FG001|Overall Study|Death according to AE eCRF|3|||
27617045|NCT01723826|80440607|FG002|Overall Study|Death according to AE eCRF|3|||
27617046|NCT01723826|80440608|FG003|Overall Study|Death according to AE eCRF|7|||
27617047|NCT01723826|80440605|FG000|Overall Study|Lost to Follow-up|1|||
27617048|NCT01723826|80440606|FG001|Overall Study|Lost to Follow-up|3|||
27617049|NCT01723826|80440607|FG002|Overall Study|Lost to Follow-up|1|||
27617050|NCT01723826|80440608|FG003|Overall Study|Lost to Follow-up|1|||
27617051|NCT01723826|80440605|FG000|Overall Study|Non-compliance|0|||
27617052|NCT01723826|80440606|FG001|Overall Study|Non-compliance|1|||
27617053|NCT01723826|80440607|FG002|Overall Study|Non-compliance|3|||
27617054|NCT01723826|80440608|FG003|Overall Study|Non-compliance|3|||
27617055|NCT01723826|80440605|FG000|Overall Study|Non-compliance With Study Drug|0|||
27617056|NCT01723826|80440606|FG001|Overall Study|Non-compliance With Study Drug|1|||
27617057|NCT01723826|80440607|FG002|Overall Study|Non-compliance With Study Drug|0|||
27617058|NCT01723826|80440608|FG003|Overall Study|Non-compliance With Study Drug|0|||
27617059|NCT01723826|80440605|FG000|Overall Study|Other Reason|8|||
27617060|NCT01723826|80440606|FG001|Overall Study|Other Reason|6|||
27617061|NCT01723826|80440607|FG002|Overall Study|Other Reason|12|||
27617062|NCT01723826|80440608|FG003|Overall Study|Other Reason|14|||
27617063|NCT01723826|80440605|FG000|Overall Study|Physician Decision|1|||
27617064|NCT01723826|80440606|FG001|Overall Study|Physician Decision|3|||
27617065|NCT01723826|80440607|FG002|Overall Study|Physician Decision|4|||
27617066|NCT01723826|80440608|FG003|Overall Study|Physician Decision|11|||
27617067|NCT01723826|80440605|FG000|Overall Study|Protocol Violation|1|||
27617068|NCT01723826|80440606|FG001|Overall Study|Protocol Violation|1|||
27617069|NCT01723826|80440607|FG002|Overall Study|Protocol Violation|3|||
27617070|NCT01723826|80440608|FG003|Overall Study|Protocol Violation|1|||
27617071|NCT01723826|80440605|FG000|Overall Study|Withdrawal by Subject|10|||
27617072|NCT01723826|80440606|FG001|Overall Study|Withdrawal by Subject|17|||
27617073|NCT01723826|80440607|FG002|Overall Study|Withdrawal by Subject|27|||
27617074|NCT01723826|80440608|FG003|Overall Study|Withdrawal by Subject|48|||
27617075|NCT03237013|80440609|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
27617076|NCT03237013|80440610|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
27617077|NCT03237013|80440611|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
27617078|NCT01712789|80440612|FG000|Overall Study|Lack of Efficacy|2|||
27617079|NCT01712789|80440612|FG000|Overall Study|Lost to Follow-up|1|||
27617080|NCT01712789|80440612|FG000|Overall Study|Progressive Disease|504|||
27617081|NCT01712789|80440612|FG000|Overall Study|Death|57|||
27617082|NCT01712789|80440612|FG000|Overall Study|Adverse Event|52|||
27617083|NCT01712789|80440612|FG000|Overall Study|Miscellaneous|31|||
27617084|NCT01712789|80440612|FG000|Overall Study|Withdrawal by Subject|21|||
27617085|NCT01712789|80440612|FG000|Overall Study|Transition to Commercial Treatment|8|||
27617086|NCT01712789|80440612|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
27617087|NCT02040090|80440615|FG000|Overall Study|Adverse Event|2|||
27617088|NCT02040090|80440616|FG001|Overall Study|Adverse Event|0|||
27617089|NCT02040090|80440615|FG000|Overall Study|Physician Decision|1|||
27617090|NCT02040090|80440616|FG001|Overall Study|Physician Decision|0|||
27617091|NCT02040090|80440615|FG000|Overall Study|Withdrawal by Subject|0|||
27617092|NCT02040090|80440616|FG001|Overall Study|Withdrawal by Subject|1|||
27617093|NCT02040090|80440615|FG000|Overall Study|Lost to Follow-up|0|||
27617094|NCT02040090|80440616|FG001|Overall Study|Lost to Follow-up|1|||
27617095|NCT01007552|80440622|FG000|Overall Study|Withdrawal by Subject|1|||
27617096|NCT03023332|80440625|FG000|Overall Study|Withdrawal by Subject|10|||
27617097|NCT03023332|80440626|FG001|Overall Study|Withdrawal by Subject|5|||
27729081|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
27617098|NCT03023332|80440627|FG002|Overall Study|Withdrawal by Subject|4|||
27617099|NCT03023332|80440628|FG003|Overall Study|Withdrawal by Subject|7|||
27617100|NCT03023332|80440625|FG000|Overall Study|Lost to Follow-up|13|||
27617101|NCT03023332|80440626|FG001|Overall Study|Lost to Follow-up|16|||
27617102|NCT03023332|80440627|FG002|Overall Study|Lost to Follow-up|8|||
27617103|NCT03023332|80440628|FG003|Overall Study|Lost to Follow-up|13|||
27617104|NCT03023332|80440625|FG000|Overall Study|Death|1|||
27617105|NCT03023332|80440626|FG001|Overall Study|Death|0|||
27617106|NCT03023332|80440627|FG002|Overall Study|Death|0|||
27617107|NCT03023332|80440628|FG003|Overall Study|Death|0|||
27617108|NCT01010217|80440629|FG000|Overall Study|Lost to Follow-up|4|||
27617109|NCT01010217|80440630|FG001|Overall Study|Lost to Follow-up|5|||
27617110|NCT01010217|80440631|FG002|Overall Study|Lost to Follow-up|1|||
27617111|NCT01010217|80440632|FG003|Overall Study|Lost to Follow-up|0|||
27617112|NCT01010217|80440633|FG004|Overall Study|Lost to Follow-up|0|||
27617113|NCT01010217|80440629|FG000|Overall Study|Withdrawal by Subject|1|||
27617114|NCT01010217|80440630|FG001|Overall Study|Withdrawal by Subject|0|||
27617115|NCT01010217|80440631|FG002|Overall Study|Withdrawal by Subject|0|||
27617116|NCT01010217|80440632|FG003|Overall Study|Withdrawal by Subject|0|||
27617117|NCT01010217|80440633|FG004|Overall Study|Withdrawal by Subject|0|||
27617118|NCT01010217|80440629|FG000|Overall Study|Physician Decision|0|||
27617119|NCT01010217|80440630|FG001|Overall Study|Physician Decision|0|||
27617120|NCT01010217|80440631|FG002|Overall Study|Physician Decision|0|||
27617121|NCT01010217|80440632|FG003|Overall Study|Physician Decision|6|||
27617122|NCT01010217|80440633|FG004|Overall Study|Physician Decision|3|||
27617123|NCT00474175|80440643|FG000|Overall Study|Lack of Efficacy|0|||
27617124|NCT00474175|80440644|FG001|Overall Study|Lack of Efficacy|0|||
27617125|NCT00474175|80440645|FG002|Overall Study|Lack of Efficacy|1|||
27617126|NCT00474175|80440643|FG000|Overall Study|Withdrawal by Subject|0|||
27617127|NCT00474175|80440644|FG001|Overall Study|Withdrawal by Subject|1|||
27617128|NCT00474175|80440645|FG002|Overall Study|Withdrawal by Subject|1|||
27617129|NCT00474175|80440643|FG000|Overall Study|Ineligible|1|||
27617130|NCT00474175|80440644|FG001|Overall Study|Ineligible|3|||
27617131|NCT00474175|80440645|FG002|Overall Study|Ineligible|1|||
27617132|NCT00474175|80440643|FG000|Overall Study|Protocol Violation|0|||
27617133|NCT00474175|80440644|FG001|Overall Study|Protocol Violation|2|||
27617134|NCT00474175|80440645|FG002|Overall Study|Protocol Violation|1|||
27617135|NCT00474175|80440643|FG000|Overall Study|Administrative|0|||
27617136|NCT00474175|80440644|FG001|Overall Study|Administrative|1|||
27617137|NCT00474175|80440645|FG002|Overall Study|Administrative|0|||
27617138|NCT00419003|80440646|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
27907332|NCT04074330|81500332|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27907333|NCT04074330|81500333|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27907334|NCT04074330|81500334|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27907335|NCT04074330|81500335|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
27907336|NCT04074330|81500336|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27907337|NCT04074330|81500337|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
27907338|NCT04074330|81500338|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27729082|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
27729083|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
27729084|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
27907339|NCT04074330|81500339|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
27907340|NCT04074330|81500330|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
27907341|NCT04074330|81500331|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
27907342|NCT04074330|81500332|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
27907343|NCT04074330|81500333|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
27617139|NCT00419003|80440647|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
27617140|NCT00419003|80440646|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
27617141|NCT00419003|80440647|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
27617142|NCT00311155|80440650|FG000|Overall Study|Adverse Event|21|||
27617143|NCT00311155|80440650|FG000|Overall Study|Withdrawal by Subject|17|||
27617144|NCT00311155|80440650|FG000|Overall Study|Did not meet entry criteria|55|||
27617145|NCT00378105|80440659|FG000|Overall Study|Adverse Event|3|||
27907344|NCT04074330|81500334|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
27907345|NCT04074330|81500335|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
27907346|NCT04074330|81500336|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
27907347|NCT04074330|81500337|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
27907348|NCT04074330|81500338|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
27907349|NCT04074330|81500339|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
27907350|NCT04074330|81500330|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
27907351|NCT04074330|81500331|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
27907352|NCT04074330|81500332|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
27907353|NCT04074330|81500333|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
27907354|NCT04074330|81500334|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
27907355|NCT04074330|81500335|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
27907356|NCT04074330|81500336|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
27907357|NCT04074330|81500337|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
27617146|NCT00378105|80440660|FG001|Overall Study|Adverse Event|1|||
27617147|NCT00378105|80440659|FG000|Overall Study|Withdrawal by Subject|3|||
27617148|NCT00378105|80440660|FG001|Overall Study|Withdrawal by Subject|3|||
27617149|NCT00378105|80440659|FG000|Overall Study|Death|1|||
27617150|NCT00378105|80440660|FG001|Overall Study|Death|0|||
27617151|NCT00378105|80440659|FG000|Overall Study|Going to transplant|7|||
27617152|NCT00378105|80440660|FG001|Overall Study|Going to transplant|8|||
27617153|NCT00378105|80440659|FG000|Overall Study|Progressive disease|3|||
27617154|NCT00378105|80440660|FG001|Overall Study|Progressive disease|3|||
27907358|NCT04074330|81500338|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
27516135|NCT00531427|80084835|FG001|Overall Study|Administrative|9|||
27516136|NCT01864005|80084836|FG000|Overall Study|Protocol Violation|0|||
27516137|NCT01864005|80084837|FG001|Overall Study|Protocol Violation|1|||
27516138|NCT01864005|80084836|FG000|Overall Study|Withdrawal by Subject|0|||
27516139|NCT01864005|80084837|FG001|Overall Study|Withdrawal by Subject|1|||
27907359|NCT04074330|81500339|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
27907360|NCT04074330|81500330|FG000|Dose Expansion (up to 42 Months)|Death|0|||
27907361|NCT04074330|81500331|FG001|Dose Expansion (up to 42 Months)|Death|0|||
27907362|NCT04074330|81500332|FG002|Dose Expansion (up to 42 Months)|Death|0|||
27907363|NCT04074330|81500333|FG003|Dose Expansion (up to 42 Months)|Death|0|||
27907364|NCT04074330|81500334|FG004|Dose Expansion (up to 42 Months)|Death|0|||
27907365|NCT04074330|81500335|FG005|Dose Expansion (up to 42 Months)|Death|0|||
27907366|NCT04074330|81500336|FG006|Dose Expansion (up to 42 Months)|Death|0|||
27907367|NCT04074330|81500337|FG007|Dose Expansion (up to 42 Months)|Death|0|||
27907368|NCT04074330|81500338|FG008|Dose Expansion (up to 42 Months)|Death|1|||
27907369|NCT04074330|81500339|FG009|Dose Expansion (up to 42 Months)|Death|0|||
27907370|NCT04074330|81500330|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907371|NCT04074330|81500331|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907372|NCT04074330|81500332|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907373|NCT04074330|81500333|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907374|NCT04074330|81500334|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907375|NCT04074330|81500335|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907376|NCT04074330|81500336|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907377|NCT04074330|81500337|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
27907378|NCT04074330|81500338|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
27907379|NCT04074330|81500339|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
27907380|NCT00103662|81500347|FG000|Overall Study|Entered Rescue Procedure|0|||
27907381|NCT00103662|81500348|FG001|Overall Study|Entered Rescue Procedure|7|||
27907382|NCT00103662|81500347|FG000|Overall Study|Death|7|||
27907383|NCT00103662|81500348|FG001|Overall Study|Death|7|||
27907384|NCT00103662|81500347|FG000|Overall Study|Elective Withdrawal|5|||
27907385|NCT00103662|81500348|FG001|Overall Study|Elective Withdrawal|5|||
27907386|NCT00103662|81500347|FG000|Overall Study|Lost to Follow-up|0|||
27907387|NCT00103662|81500348|FG001|Overall Study|Lost to Follow-up|1|||
27907388|NCT00103662|81500347|FG000|Overall Study|Other|6|||
27907389|NCT00103662|81500348|FG001|Overall Study|Other|9|||
27907390|NCT00103662|81500347|FG000|Overall Study|Failed mobilization|0|||
27907391|NCT00103662|81500348|FG001|Overall Study|Failed mobilization|4|||
27907392|NCT00103662|81500347|FG000|Overall Study|Intercurrent illness|1|||
27907393|NCT00103662|81500348|FG001|Overall Study|Intercurrent illness|0|||
27907394|NCT03130959|81500349|FG000|Overall Study|Disease progression|19|||
27907395|NCT03130959|81500350|FG001|Overall Study|Disease progression|7|||
27907396|NCT03130959|81500351|FG002|Overall Study|Disease progression|12|||
27907397|NCT03130959|81500352|FG003|Overall Study|Disease progression|7|||
27907398|NCT03130959|81500353|FG004|Overall Study|Disease progression|12|||
27907399|NCT03130959|81500354|FG005|Overall Study|Disease progression|3|||
27907400|NCT03130959|81500355|FG006|Overall Study|Disease progression|6|||
27907401|NCT03130959|81500356|FG007|Overall Study|Disease progression|3|||
27907402|NCT03130959|81500357|FG008|Overall Study|Disease progression|15|||
27516140|NCT01864005|80084836|FG000|Overall Study|Incorrect enrolment|1|||
27516141|NCT01864005|80084837|FG001|Overall Study|Incorrect enrolment|0|||
27516142|NCT01864005|80084836|FG000|Overall Study|Disease need|1|||
27516143|NCT01864005|80084837|FG001|Overall Study|Disease need|1|||
27516144|NCT01864005|80084836|FG000|Overall Study|Need GP IIb/IIIa|1|||
27516145|NCT01864005|80084837|FG001|Overall Study|Need GP IIb/IIIa|3|||
27516146|NCT00145158|80084840|FG000|Overall Study|premature withdrawal|2|||
27516147|NCT00145158|80084841|FG001|Overall Study|premature withdrawal|3|||
27516148|NCT04335136|80084848|FG000|Overall Study|Death|8|||
27516149|NCT04335136|80084849|FG001|Overall Study|Death|4|||
27516150|NCT04335136|80084848|FG000|Overall Study|Lost to Follow-up|2|||
27516151|NCT04335136|80084849|FG001|Overall Study|Lost to Follow-up|0|||
27907403|NCT03130959|81500358|FG009|Overall Study|Disease progression|8|||
27907404|NCT03130959|81500349|FG000|Overall Study|Study drug toxicity|2|||
27907405|NCT03130959|81500350|FG001|Overall Study|Study drug toxicity|2|||
27907406|NCT03130959|81500351|FG002|Overall Study|Study drug toxicity|1|||
27907407|NCT03130959|81500352|FG003|Overall Study|Study drug toxicity|2|||
27907408|NCT03130959|81500353|FG004|Overall Study|Study drug toxicity|1|||
27907409|NCT03130959|81500354|FG005|Overall Study|Study drug toxicity|1|||
27516152|NCT04335136|80084848|FG000|Overall Study|Protocol Violation|1|||
27516153|NCT04335136|80084849|FG001|Overall Study|Protocol Violation|0|||
27516154|NCT04335136|80084848|FG000|Overall Study|Withdrawal by Subject|1|||
27516155|NCT04335136|80084849|FG001|Overall Study|Withdrawal by Subject|1|||
27516156|NCT04335136|80084848|FG000|Overall Study|Health-threatening condition|0|||
27907410|NCT03130959|81500355|FG006|Overall Study|Study drug toxicity|3|||
27907411|NCT03130959|81500356|FG007|Overall Study|Study drug toxicity|0|||
27516157|NCT04335136|80084849|FG001|Overall Study|Health-threatening condition|1|||
27516158|NCT04335136|80084848|FG000|Overall Study|Adverse Event|0|||
27516159|NCT04335136|80084849|FG001|Overall Study|Adverse Event|1|||
27516160|NCT04335136|80084848|FG000|Overall Study|Erroneously randomized|2|||
27516161|NCT04335136|80084849|FG001|Overall Study|Erroneously randomized|0|||
27853443|NCT00910091|81295049|FG000|Pre-assignment|Withdrawal by Subject|0|||
27853444|NCT00910091|81295050|FG001|Pre-assignment|Withdrawal by Subject|2|||
27853445|NCT00910091|81295049|FG000|Treatment and Survival|Withdrawal by Subject|3|||
27853446|NCT00910091|81295050|FG001|Treatment and Survival|Withdrawal by Subject|4|||
27516162|NCT00548184|80084853|FG000|Overall Study|Adverse Event|3|||
27516163|NCT00548184|80084853|FG000|Overall Study|took other drug|1|||
27516164|NCT00548184|80084853|FG000|Overall Study|Found Her2 negative|1|||
27516165|NCT04050202|80084854|FG000|Overall Study|Lost to Follow-up|2|||
27617155|NCT00378105|80440659|FG000|Overall Study|remain on study|3|||
27617156|NCT00378105|80440660|FG001|Overall Study|remain on study|11|||
27617157|NCT00378105|80440659|FG000|Overall Study|Physician Decision|0|||
27617158|NCT00378105|80440660|FG001|Overall Study|Physician Decision|2|||
27617159|NCT00378105|80440659|FG000|Overall Study|Going non-protocol therapy|0|||
27617160|NCT00378105|80440660|FG001|Overall Study|Going non-protocol therapy|1|||
27617161|NCT00378105|80440659|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
27617162|NCT00378105|80440660|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
27617163|NCT03055832|80440661|FG000|Week 2|Withdrawal by Subject|1|||
27617164|NCT03055832|80440662|FG001|Week 2|Withdrawal by Subject|0|||
27617165|NCT00179010|80440663|FG000|Overall Study|Muscle probe defective|1|||
27617166|NCT00179010|80440664|FG001|Overall Study|Muscle probe defective|1|||
27617167|NCT00179010|80440663|FG000|Overall Study|Failure to place arterial line|0|||
27617168|NCT00179010|80440664|FG001|Overall Study|Failure to place arterial line|1|||
27617169|NCT01676220|80440665|FG000|Overall Study|Randomized But Not Treated|4|||
27617170|NCT01676220|80440666|FG001|Overall Study|Randomized But Not Treated|1|||
27617171|NCT01676220|80440665|FG000|Overall Study|Adverse Event|10|||
27617172|NCT01676220|80440666|FG001|Overall Study|Adverse Event|8|||
27617173|NCT01676220|80440665|FG000|Overall Study|Lack of Efficacy|2|||
27617174|NCT01676220|80440666|FG001|Overall Study|Lack of Efficacy|5|||
27617175|NCT01676220|80440665|FG000|Overall Study|Protocol Violation|11|||
27617176|NCT01676220|80440666|FG001|Overall Study|Protocol Violation|12|||
27617177|NCT01676220|80440665|FG000|Overall Study|Received Rescue Therapy|14|||
27617178|NCT01676220|80440666|FG001|Overall Study|Received Rescue Therapy|22|||
27617179|NCT01676220|80440665|FG000|Overall Study|Personal Reason|34|||
27853447|NCT00910091|81295049|FG000|Treatment and Survival|Adverse Event|1|||
27516166|NCT02116205|80084857|FG000|Overall Study|Withdrawal by Subject|2|||
27516167|NCT02116205|80084858|FG001|Overall Study|Withdrawal by Subject|4|||
27516168|NCT02116205|80084859|FG002|Overall Study|Withdrawal by Subject|1|||
27516169|NCT02116205|80084860|FG003|Overall Study|Withdrawal by Subject|3|||
27516170|NCT02116205|80084857|FG000|Overall Study|Lost to Follow-up|0|||
27516171|NCT02116205|80084858|FG001|Overall Study|Lost to Follow-up|2|||
27516172|NCT02116205|80084859|FG002|Overall Study|Lost to Follow-up|1|||
27516173|NCT02116205|80084860|FG003|Overall Study|Lost to Follow-up|2|||
27516174|NCT02116205|80084857|FG000|Overall Study|Physician Decision|0|||
27516175|NCT02116205|80084858|FG001|Overall Study|Physician Decision|1|||
27516176|NCT02116205|80084859|FG002|Overall Study|Physician Decision|1|||
27516177|NCT02116205|80084860|FG003|Overall Study|Physician Decision|1|||
27516178|NCT02116205|80084857|FG000|Overall Study|Exclusion criteria|0|||
27516179|NCT02116205|80084858|FG001|Overall Study|Exclusion criteria|0|||
27516180|NCT02116205|80084859|FG002|Overall Study|Exclusion criteria|1|||
27516181|NCT02116205|80084860|FG003|Overall Study|Exclusion criteria|0|||
27516182|NCT01536067|80084861|FG000|Overall Study|Disease Progression|1|||
27516183|NCT00975689|80084863|FG000|Overall Study|Adverse Event|0|||
27516184|NCT00975689|80084864|FG001|Overall Study|Adverse Event|3|||
27516185|NCT00975689|80084863|FG000|Overall Study|Withdrawal by Subject|1|||
27516186|NCT00975689|80084864|FG001|Overall Study|Withdrawal by Subject|0|||
27516187|NCT00975689|80084863|FG000|Overall Study|Physician Decision|1|||
27516188|NCT00975689|80084864|FG001|Overall Study|Physician Decision|0|||
27853448|NCT00910091|81295050|FG001|Treatment and Survival|Adverse Event|0|||
27853449|NCT02177136|81295051|FG000|DB Phase|Withdrawal by Subject|2|||
27617180|NCT01676220|80440666|FG001|Overall Study|Personal Reason|45|||
27617181|NCT01676220|80440665|FG000|Overall Study|Lost to Follow-up|11|||
27617182|NCT01676220|80440666|FG001|Overall Study|Lost to Follow-up|18|||
27617183|NCT01676220|80440665|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
27617184|NCT01676220|80440666|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
27617185|NCT01676220|80440665|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
27516189|NCT01290796|80084875|FG000|Overall Study|Lost to Follow-up|21|||
27516190|NCT01290796|80084875|FG000|Overall Study|Withdrawal by Subject|4|||
27516191|NCT01290796|80084875|FG000|Overall Study|Physician Decision|2|||
27516192|NCT01290796|80084875|FG000|Overall Study|Secondary Surgical Intervention|2|||
27516193|NCT01290796|80084875|FG000|Overall Study|Withdrawal by Sponsor|1|||
27516194|NCT01601652|80084876|FG000|Overall Study|Death|1|||
27516195|NCT00790088|80084877|FG000|Overall Study|Protocol Violation|11|||
27516196|NCT00790088|80084877|FG000|Overall Study|Withdrawal by Subject|17|||
27516197|NCT00790088|80084877|FG000|Overall Study|Lost to Follow-up|7|||
27516198|NCT00790088|80084877|FG000|Overall Study|Physician Decision|4|||
27516199|NCT00835211|80084878|FG000|First Intervention|Withdrawal by Subject|0|||
27516200|NCT00835211|80084879|FG001|First Intervention|Withdrawal by Subject|1|||
27516201|NCT00835211|80084878|FG000|Washout: 7 Days|Adverse Event|2|||
27516202|NCT00835211|80084879|FG001|Washout: 7 Days|Adverse Event|1|||
27516203|NCT00835211|80084878|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27516204|NCT00835211|80084879|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27516205|NCT00228553|80084880|FG000|Overall Study|Adverse Event|112|||
27516206|NCT00228553|80084880|FG000|Overall Study|Lack of Efficacy|34|||
27516207|NCT00228553|80084880|FG000|Overall Study|Lost to Follow-up|67|||
27516208|NCT00228553|80084880|FG000|Overall Study|Physician Decision|48|||
27516209|NCT00228553|80084880|FG000|Overall Study|Protocol Violation|6|||
27516210|NCT00228553|80084880|FG000|Overall Study|Withdrawal by Subject|115|||
27516211|NCT00228553|80084880|FG000|Overall Study|Pregnancy|2|||
27516212|NCT00228553|80084880|FG000|Overall Study|Miscellaneous|46|||
27516213|NCT00488683|80084881|FG000|Overall Study|Withdrawal by Subject|1|||
27617186|NCT01676220|80440666|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
27617187|NCT01676220|80440665|FG000|Overall Study|Perceived Lack of Efficacy|3|||
27617188|NCT01676220|80440666|FG001|Overall Study|Perceived Lack of Efficacy|1|||
27617189|NCT01676220|80440665|FG000|Overall Study|Non Serious Hypoglycemia|2|||
27617190|NCT01676220|80440666|FG001|Overall Study|Non Serious Hypoglycemia|0|||
27617191|NCT01676220|80440665|FG000|Overall Study|No More Need of Insulin|1|||
27617192|NCT01676220|80440666|FG001|Overall Study|No More Need of Insulin|0|||
27729085|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
27729086|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
27729087|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
27729088|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
27729089|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
27729090|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
27729091|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
27729092|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
27729093|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
27729094|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
27729095|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
27729096|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
27729097|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
27729098|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
27729099|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
27729100|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
27729101|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
27729102|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
27729103|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
27729104|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
27729105|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
27853450|NCT02177136|81295052|FG001|DB Phase|Withdrawal by Subject|0|||
27853451|NCT02177136|81295053|FG002|DB Phase|Withdrawal by Subject|0|||
27853452|NCT02177136|81295054|FG003|DB Phase|Withdrawal by Subject|0|||
27853453|NCT02177136|81295051|FG000|DB Phase|Discontinued Due to Pruritus|1|||
27853454|NCT02177136|81295052|FG001|DB Phase|Discontinued Due to Pruritus|3|||
27853455|NCT02177136|81295053|FG002|DB Phase|Discontinued Due to Pruritus|0|||
27853456|NCT02177136|81295054|FG003|DB Phase|Discontinued Due to Pruritus|0|||
27853457|NCT02177136|81295051|FG000|DB Phase|Adverse Event|3|||
27853458|NCT02177136|81295052|FG001|DB Phase|Adverse Event|2|||
27907412|NCT03130959|81500357|FG008|Overall Study|Study drug toxicity|3|||
27907413|NCT03130959|81500358|FG009|Overall Study|Study drug toxicity|3|||
27516214|NCT00488683|80084882|FG001|Overall Study|Withdrawal by Subject|2|||
27516215|NCT00488683|80084883|FG002|Overall Study|Withdrawal by Subject|2|||
27516216|NCT00488683|80084881|FG000|Overall Study|Lost to Follow-up|5|||
27516217|NCT00488683|80084882|FG001|Overall Study|Lost to Follow-up|3|||
27516218|NCT00488683|80084883|FG002|Overall Study|Lost to Follow-up|0|||
27516219|NCT00488683|80084881|FG000|Overall Study|Protocol Violation|5|||
27516220|NCT00488683|80084882|FG001|Overall Study|Protocol Violation|1|||
27617193|NCT03590743|80440674|FG000|Overall Study|Withdrawal by Subject|0|||
27617194|NCT03590743|80440675|FG001|Overall Study|Withdrawal by Subject|1|||
27853459|NCT02177136|81295053|FG002|DB Phase|Adverse Event|3|||
27516221|NCT00488683|80084883|FG002|Overall Study|Protocol Violation|0|||
27516222|NCT00488683|80084881|FG000|Overall Study|Unable to Classify|1|||
27516223|NCT00488683|80084882|FG001|Overall Study|Unable to Classify|0|||
27617195|NCT03389893|80440676|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
27516224|NCT00488683|80084883|FG002|Overall Study|Unable to Classify|0|||
27853460|NCT02177136|81295054|FG003|DB Phase|Adverse Event|0|||
27729106|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
27729107|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
27729108|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
27729109|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
27729110|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
27729111|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
27729112|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
27729113|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
27729114|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
27516225|NCT01068600|80084884|FG000|Overall Study|Withdrawal by Subject|5|||
27516226|NCT01068600|80084885|FG001|Overall Study|Withdrawal by Subject|6|||
27516227|NCT01068600|80084884|FG000|Overall Study|Adverse Event|3|||
27516228|NCT01068600|80084885|FG001|Overall Study|Adverse Event|3|||
27516229|NCT01068600|80084884|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27516230|NCT01068600|80084885|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27516231|NCT01068600|80084884|FG000|Overall Study|Lost to Follow-up|1|||
27516232|NCT01068600|80084885|FG001|Overall Study|Lost to Follow-up|2|||
27516233|NCT01068600|80084884|FG000|Overall Study|Protocol deviation|1|||
27516234|NCT01068600|80084885|FG001|Overall Study|Protocol deviation|1|||
27516235|NCT01068600|80084884|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27516236|NCT01068600|80084885|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27516237|NCT01068600|80084884|FG000|Overall Study|Administrative problems|0|||
27516238|NCT01068600|80084885|FG001|Overall Study|Administrative problems|1|||
27516239|NCT01015638|80084886|FG000|Overall Study|Withdrawal by Subject|1|||
27516240|NCT01015638|80084887|FG001|Overall Study|Withdrawal by Subject|0|||
27516241|NCT01657461|80084888|FG000|Overall Study|Death|9|||
27516242|NCT01657461|80084889|FG001|Overall Study|Death|12|||
27516243|NCT01657461|80084888|FG000|Overall Study|Lost to Follow-up|0|||
27516244|NCT01657461|80084889|FG001|Overall Study|Lost to Follow-up|3|||
27516245|NCT01657461|80084888|FG000|Overall Study|Physician Decision|0|||
27617196|NCT03389893|80440677|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
27617197|NCT03389893|80440678|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
27617198|NCT03389893|80440679|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
27617199|NCT03389893|80440676|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
27617200|NCT03389893|80440677|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
27617201|NCT03389893|80440678|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
27617202|NCT03389893|80440679|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
27617203|NCT03389893|80440676|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
27617204|NCT03389893|80440677|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
27617205|NCT03389893|80440678|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
27617206|NCT03389893|80440679|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
27617207|NCT03389893|80440676|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
27617208|NCT03389893|80440677|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
27617209|NCT03389893|80440678|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
27617210|NCT03389893|80440679|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
27617211|NCT00197028|80440680|FG000|Overall Study|Adverse Event|2|||
27617212|NCT00197028|80440681|FG001|Overall Study|Adverse Event|2|||
27617213|NCT00197028|80440680|FG000|Overall Study|Protocol Violation|2|||
27617214|NCT00197028|80440681|FG001|Overall Study|Protocol Violation|1|||
27617215|NCT00197028|80440680|FG000|Overall Study|Withdrawal by Subject|8|||
27617216|NCT00197028|80440681|FG001|Overall Study|Withdrawal by Subject|12|||
27617217|NCT00197028|80440680|FG000|Overall Study|Lost to Follow-up|1|||
27617218|NCT00197028|80440681|FG001|Overall Study|Lost to Follow-up|0|||
27617219|NCT00197028|80440680|FG000|Overall Study|Other|3|||
27617220|NCT00197028|80440681|FG001|Overall Study|Other|6|||
27617221|NCT03658811|80440686|FG000|Overall Study|Lost to Follow-up|3|||
27617222|NCT00293462|80440687|FG000|Overall Study|Withdrawal by Subject|4|||
27617223|NCT00293462|80440688|FG001|Overall Study|Withdrawal by Subject|3|||
27617224|NCT00293462|80440689|FG002|Overall Study|Withdrawal by Subject|8|||
27617225|NCT00293462|80440687|FG000|Overall Study|Death|1|||
27617226|NCT00293462|80440688|FG001|Overall Study|Death|0|||
27617227|NCT00293462|80440689|FG002|Overall Study|Death|0|||
27617228|NCT00293462|80440687|FG000|Overall Study|Lost to Follow-up|0|||
27617229|NCT00293462|80440688|FG001|Overall Study|Lost to Follow-up|1|||
27617230|NCT00293462|80440689|FG002|Overall Study|Lost to Follow-up|0|||
27617231|NCT00293462|80440687|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
27617232|NCT00293462|80440688|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
27617233|NCT00293462|80440689|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
27729115|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
27516246|NCT01657461|80084889|FG001|Overall Study|Physician Decision|2|||
27516247|NCT01657461|80084888|FG000|Overall Study|Withdrawal by Subject|1|||
27516248|NCT01657461|80084889|FG001|Overall Study|Withdrawal by Subject|3|||
27729116|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
27729117|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
27516249|NCT00884741|80084890|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
27516250|NCT00884741|80084891|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
27516251|NCT00884741|80084892|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
27516252|NCT00884741|80084893|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
27516253|NCT00884741|80084890|FG000|Step 1 Registration: Tissue Screening|Death|3|||
27516254|NCT00884741|80084891|FG001|Step 1 Registration: Tissue Screening|Death|0|||
27516255|NCT00884741|80084892|FG002|Step 1 Registration: Tissue Screening|Death|0|||
27516256|NCT00884741|80084893|FG003|Step 1 Registration: Tissue Screening|Death|0|||
27516257|NCT00884741|80084890|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
27516258|NCT00884741|80084891|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
27516259|NCT00884741|80084892|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
27516260|NCT00884741|80084893|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
27516261|NCT00884741|80084890|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
27516262|NCT00884741|80084891|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
27516263|NCT00884741|80084892|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
27516264|NCT00884741|80084893|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
27516265|NCT00884741|80084890|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
27516266|NCT00884741|80084891|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
27516267|NCT00884741|80084892|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
27516268|NCT00884741|80084893|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
27516269|NCT00884741|80084890|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
27853461|NCT02177136|81295051|FG000|DB Phase|Protocol Violation|0|||
27853462|NCT02177136|81295052|FG001|DB Phase|Protocol Violation|0|||
27853463|NCT02177136|81295053|FG002|DB Phase|Protocol Violation|1|||
27853464|NCT02177136|81295054|FG003|DB Phase|Protocol Violation|0|||
27853465|NCT02177136|81295051|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
27853466|NCT02177136|81295052|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
27853467|NCT02177136|81295053|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
27516270|NCT00884741|80084891|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
27516271|NCT00884741|80084892|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
27516272|NCT00884741|80084893|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
27516273|NCT00884741|80084890|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
27516274|NCT00884741|80084891|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
27516275|NCT00884741|80084892|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
27516276|NCT00884741|80084893|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
27516277|NCT00884741|80084890|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
27516278|NCT00884741|80084891|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
27516279|NCT00884741|80084892|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
27516280|NCT00884741|80084893|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
27516281|NCT00884741|80084890|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
27516282|NCT00884741|80084891|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
27516283|NCT00884741|80084892|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
27516284|NCT00884741|80084893|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
27516285|NCT00884741|80084890|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
27516286|NCT00884741|80084891|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
27516287|NCT00884741|80084892|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
27516288|NCT00884741|80084893|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
27516289|NCT00884741|80084890|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
27516290|NCT00884741|80084891|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
27516291|NCT00884741|80084892|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
27516292|NCT00884741|80084893|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
27516293|NCT00884741|80084890|FG000|Randomization|Protocol Violation|0|||
27516294|NCT00884741|80084891|FG001|Randomization|Protocol Violation|0|||
27516295|NCT00884741|80084892|FG002|Randomization|Protocol Violation|8|||
27516296|NCT00884741|80084893|FG003|Randomization|Protocol Violation|8|||
27516297|NCT03180840|80084894|FG000|Overall Study|Withdrawal by Subject|1|||
27516298|NCT00314795|80084902|FG000|Overall Study|Adverse Event|8|||
27516299|NCT00314795|80084902|FG000|Overall Study|Death|4|||
27516300|NCT00314795|80084902|FG000|Overall Study|Reason not Specified|3|||
27516301|NCT00314795|80084902|FG000|Overall Study|Renal Transplant|3|||
27516302|NCT00314795|80084902|FG000|Overall Study|Participants Withdrew Consent|2|||
27516303|NCT02872285|80084903|FG000|Overall Study|Withdrawal by Subject|2|||
27516304|NCT02872285|80084904|FG001|Overall Study|Withdrawal by Subject|0|||
27516305|NCT02872285|80084903|FG000|Overall Study|Lost to Follow-up|2|||
27516306|NCT02872285|80084904|FG001|Overall Study|Lost to Follow-up|2|||
27516307|NCT02872285|80084903|FG000|Overall Study|Discontinued due to back surgery|1|||
27516308|NCT02872285|80084904|FG001|Overall Study|Discontinued due to back surgery|0|||
27853468|NCT02177136|81295054|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
27853469|NCT02177136|81295051|FG000|LTSE Phase|Withdrawal by Subject|0|||
27853470|NCT02177136|81295052|FG001|LTSE Phase|Withdrawal by Subject|0|||
27617234|NCT00293462|80440687|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
27617235|NCT00293462|80440688|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
27617236|NCT00293462|80440689|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
27617237|NCT00293462|80440687|FG000|Overall Study|Refuse Radiation Treatment|1|||
27617238|NCT00293462|80440688|FG001|Overall Study|Refuse Radiation Treatment|0|||
27617239|NCT00293462|80440689|FG002|Overall Study|Refuse Radiation Treatment|0|||
27617240|NCT00293462|80440687|FG000|Overall Study|No Show|0|||
27729118|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
27729119|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
27729120|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
27729121|NCT00289913|80838152|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
27729122|NCT00289913|80838153|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
27729123|NCT00289913|80838154|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
27729124|NCT00289913|80838155|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
27729125|NCT00289913|80838156|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
27729126|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729127|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
27729128|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729129|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729130|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
27729131|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
27729132|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
27729133|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
27729134|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
27729135|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
27729136|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729137|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729138|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729139|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
27729140|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
27729141|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729142|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729143|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729144|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
27729145|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
27729146|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
27729147|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
27729148|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
27729149|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
27729150|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
27729151|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
27729152|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
27729153|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
27853471|NCT02177136|81295053|FG002|LTSE Phase|Withdrawal by Subject|0|||
27853472|NCT02177136|81295054|FG003|LTSE Phase|Withdrawal by Subject|6|||
27853473|NCT02177136|81295051|FG000|LTSE Phase|Adverse Event|0|||
27853474|NCT02177136|81295052|FG001|LTSE Phase|Adverse Event|0|||
27853475|NCT02177136|81295053|FG002|LTSE Phase|Adverse Event|0|||
27853476|NCT02177136|81295054|FG003|LTSE Phase|Adverse Event|10|||
27853477|NCT02177136|81295051|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
27853478|NCT02177136|81295052|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
27853479|NCT02177136|81295053|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
27853480|NCT02177136|81295054|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
27853481|NCT02177136|81295051|FG000|LTSE Phase|Physician Decision|0|||
27853482|NCT02177136|81295052|FG001|LTSE Phase|Physician Decision|0|||
27853483|NCT02177136|81295053|FG002|LTSE Phase|Physician Decision|0|||
27853484|NCT02177136|81295054|FG003|LTSE Phase|Physician Decision|2|||
27853485|NCT02177136|81295051|FG000|LTSE Phase|Lost to Follow-up|0|||
27853486|NCT02177136|81295052|FG001|LTSE Phase|Lost to Follow-up|0|||
27853487|NCT02177136|81295053|FG002|LTSE Phase|Lost to Follow-up|0|||
27516309|NCT03704636|80084905|FG000|Overall Study|Inadequate Venous Flow|3|||
27516310|NCT03179605|80084906|FG000|Overall Study|Withdrawal by Subject|1|||
27617241|NCT00293462|80440688|FG001|Overall Study|No Show|0|||
27853488|NCT02177136|81295054|FG003|LTSE Phase|Lost to Follow-up|1|||
27617242|NCT00293462|80440689|FG002|Overall Study|No Show|1|||
27617243|NCT00293462|80440687|FG000|Overall Study|Went back to his home country|0|||
27853489|NCT02177136|81295051|FG000|LTSE Phase|Participant Moved|0|||
27853490|NCT02177136|81295052|FG001|LTSE Phase|Participant Moved|0|||
27853491|NCT02177136|81295053|FG002|LTSE Phase|Participant Moved|0|||
27853492|NCT02177136|81295054|FG003|LTSE Phase|Participant Moved|1|||
27853493|NCT02939950|81295055|FG000|Overall Study|Lost to Follow-up|13|||
27853494|NCT02939950|81295056|FG001|Overall Study|Lost to Follow-up|16|||
27853495|NCT02939950|81295055|FG000|Overall Study|Positive slit lamp findings|0|||
27853496|NCT02939950|81295056|FG001|Overall Study|Positive slit lamp findings|1|||
27853497|NCT02939950|81295055|FG000|Overall Study|Chalazion upper lid|0|||
27853498|NCT02939950|81295056|FG001|Overall Study|Chalazion upper lid|1|||
27853499|NCT02939950|81295055|FG000|Overall Study|Lack of motivation|0|||
27853500|NCT02939950|81295056|FG001|Overall Study|Lack of motivation|2|||
27853501|NCT02939950|81295055|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
27853502|NCT02939950|81295056|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
27853503|NCT02939950|81295055|FG000|Overall Study|Military orders|1|||
27853504|NCT02939950|81295056|FG001|Overall Study|Military orders|0|||
27853505|NCT02939950|81295055|FG000|Overall Study|Participant Relocated|5|||
27853506|NCT02939950|81295056|FG001|Overall Study|Participant Relocated|3|||
27853507|NCT02939950|81295055|FG000|Overall Study|Study related symptoms|8|||
27853508|NCT02939950|81295056|FG001|Overall Study|Study related symptoms|8|||
27853509|NCT02939950|81295055|FG000|Overall Study|Unacceptable lens movement|2|||
27853510|NCT02939950|81295056|FG001|Overall Study|Unacceptable lens movement|0|||
27853511|NCT02939950|81295055|FG000|Overall Study|Protocol Violation|6|||
27853512|NCT02939950|81295056|FG001|Overall Study|Protocol Violation|3|||
27853513|NCT02939950|81295055|FG000|Overall Study|Physician Decision|2|||
27853514|NCT02939950|81295056|FG001|Overall Study|Physician Decision|0|||
27853515|NCT02939950|81295055|FG000|Overall Study|Pregnancy|6|||
27853516|NCT02939950|81295056|FG001|Overall Study|Pregnancy|7|||
27853517|NCT02939950|81295055|FG000|Overall Study|Withdrawal by Subject|12|||
27853518|NCT02939950|81295056|FG001|Overall Study|Withdrawal by Subject|28|||
27853519|NCT02939950|81295055|FG000|Overall Study|Adverse Event|7|||
27853520|NCT02939950|81295056|FG001|Overall Study|Adverse Event|3|||
27853521|NCT02939950|81295055|FG000|Overall Study|Randomized, not dispensed|1|||
27853522|NCT02939950|81295056|FG001|Overall Study|Randomized, not dispensed|0|||
27617244|NCT00293462|80440688|FG001|Overall Study|Went back to his home country|0|||
27617245|NCT00293462|80440689|FG002|Overall Study|Went back to his home country|1|||
27617246|NCT00293462|80440687|FG000|Overall Study|Blood clot after chemotherapy|0|||
27617247|NCT00293462|80440688|FG001|Overall Study|Blood clot after chemotherapy|0|||
27617248|NCT00293462|80440689|FG002|Overall Study|Blood clot after chemotherapy|1|||
27617249|NCT00293462|80440687|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
27853523|NCT02939950|81295055|FG000|Overall Study|Ineligible at Baseline|2|||
27853524|NCT02939950|81295056|FG001|Overall Study|Ineligible at Baseline|8|||
27853525|NCT01117766|81295057|FG000|First Intervention|Adverse Event|0|||
27853526|NCT01117766|81295058|FG001|First Intervention|Adverse Event|1|||
27853527|NCT01117766|81295057|FG000|First Intervention|Protocol Violation|1|||
27853528|NCT01117766|81295058|FG001|First Intervention|Protocol Violation|0|||
27853529|NCT01117766|81295057|FG000|Washout Period|Protocol Violation|0|||
27853530|NCT01117766|81295058|FG001|Washout Period|Protocol Violation|2|||
27853531|NCT01117766|81295057|FG000|Second Intervention|Lost to Follow-up|1|||
27853532|NCT01117766|81295058|FG001|Second Intervention|Lost to Follow-up|0|||
27853533|NCT01117766|81295057|FG000|Second Intervention|Other|1|||
27853534|NCT01117766|81295058|FG001|Second Intervention|Other|2|||
27853535|NCT01117766|81295057|FG000|Second Intervention|Adverse Event|0|||
27853536|NCT01117766|81295058|FG001|Second Intervention|Adverse Event|2|||
27853537|NCT01117766|81295057|FG000|Second Intervention|Withdrawal by Subject|0|||
27853538|NCT01117766|81295058|FG001|Second Intervention|Withdrawal by Subject|1|||
27853539|NCT03578237|81295059|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
27853540|NCT03578237|81295060|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
27853541|NCT02980874|81295066|FG000|Overall Study|Adverse Event|2|||
27853542|NCT02980874|81295067|FG001|Overall Study|Adverse Event|7|||
27853543|NCT02980874|81295066|FG000|Overall Study|Withdrawal by Subject|7|||
27853544|NCT02980874|81295067|FG001|Overall Study|Withdrawal by Subject|2|||
27853545|NCT02980874|81295066|FG000|Overall Study|Lost to Follow-up|5|||
27853546|NCT02980874|81295067|FG001|Overall Study|Lost to Follow-up|5|||
27853547|NCT02980874|81295066|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
27617250|NCT00293462|80440688|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
27853548|NCT02980874|81295067|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
27853549|NCT02980874|81295066|FG000|Overall Study|Unknown study completion status|1|||
27853550|NCT02980874|81295067|FG001|Overall Study|Unknown study completion status|0|||
27853551|NCT02304458|81295068|FG000|Overall Study|Adverse Event|0|||
27853552|NCT02304458|81295069|FG001|Overall Study|Adverse Event|0|||
27853553|NCT02304458|81295070|FG002|Overall Study|Adverse Event|7|||
27853554|NCT02304458|81295071|FG003|Overall Study|Adverse Event|0|||
27853555|NCT02304458|81295072|FG004|Overall Study|Adverse Event|0|||
27853556|NCT02304458|81295073|FG005|Overall Study|Adverse Event|0|||
27853557|NCT02304458|81295074|FG006|Overall Study|Adverse Event|3|||
27853558|NCT02304458|81295075|FG007|Overall Study|Adverse Event|4|||
27853559|NCT02304458|81295068|FG000|Overall Study|Death|0|||
27617251|NCT00293462|80440689|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
27617252|NCT00293462|80440687|FG000|Overall Study|Possible Tracheostomy leakage|0|||
27617253|NCT00293462|80440688|FG001|Overall Study|Possible Tracheostomy leakage|1|||
27617254|NCT00293462|80440689|FG002|Overall Study|Possible Tracheostomy leakage|0|||
27617255|NCT00293462|80440687|FG000|Overall Study|Low radiation dose in oral cavity|0|||
27617256|NCT00293462|80440688|FG001|Overall Study|Low radiation dose in oral cavity|1|||
27617257|NCT00293462|80440689|FG002|Overall Study|Low radiation dose in oral cavity|0|||
27617258|NCT00293462|80440687|FG000|Overall Study|Physician Decision|0|||
27617259|NCT00293462|80440688|FG001|Overall Study|Physician Decision|1|||
27617260|NCT00293462|80440689|FG002|Overall Study|Physician Decision|0|||
27617261|NCT01818700|80440692|FG000|Overall Study|Adverse Event|67|||
27617262|NCT01818700|80440692|FG000|Overall Study|Lack of Efficacy|2|||
27617263|NCT01818700|80440692|FG000|Overall Study|Lost to Follow-up|5|||
27617264|NCT01818700|80440692|FG000|Overall Study|Withdrawal by Subject|27|||
27617265|NCT01818700|80440692|FG000|Overall Study|Protocol Violation|2|||
27617266|NCT01818700|80440692|FG000|Overall Study|Other|1|||
27617267|NCT00322374|80440693|FG000|Starting Dose|Physician Decision|2|||
27617268|NCT00322374|80440694|FG001|Starting Dose|Physician Decision|0|||
27617269|NCT00322374|80440695|FG002|Starting Dose|Physician Decision|0|||
27617270|NCT00322374|80440696|FG003|Starting Dose|Physician Decision|0|||
27617271|NCT00322374|80440693|FG000|Starting Dose|Study Drug Toxicity|4|||
27617272|NCT00322374|80440694|FG001|Starting Dose|Study Drug Toxicity|0|||
27617273|NCT00322374|80440695|FG002|Starting Dose|Study Drug Toxicity|0|||
27617274|NCT00322374|80440696|FG003|Starting Dose|Study Drug Toxicity|0|||
27617275|NCT00322374|80440693|FG000|First Escalation|Documented Disease Progression|0|||
27617276|NCT00322374|80440694|FG001|First Escalation|Documented Disease Progression|6|||
27617277|NCT00322374|80440695|FG002|First Escalation|Documented Disease Progression|0|||
27617278|NCT00322374|80440696|FG003|First Escalation|Documented Disease Progression|0|||
27617279|NCT00322374|80440693|FG000|First Escalation|Physician Decision|0|||
27617280|NCT00322374|80440694|FG001|First Escalation|Physician Decision|12|||
27617281|NCT00322374|80440695|FG002|First Escalation|Physician Decision|0|||
27617282|NCT00322374|80440696|FG003|First Escalation|Physician Decision|0|||
27617283|NCT00322374|80440693|FG000|First Escalation|Study Drug Toxicity|0|||
27617284|NCT00322374|80440694|FG001|First Escalation|Study Drug Toxicity|11|||
27617285|NCT00322374|80440695|FG002|First Escalation|Study Drug Toxicity|0|||
27617286|NCT00322374|80440696|FG003|First Escalation|Study Drug Toxicity|0|||
27617287|NCT00322374|80440693|FG000|First Escalation|Participant Request|0|||
27617288|NCT00322374|80440694|FG001|First Escalation|Participant Request|1|||
27617289|NCT00322374|80440695|FG002|First Escalation|Participant Request|0|||
27617290|NCT00322374|80440696|FG003|First Escalation|Participant Request|0|||
27617291|NCT00322374|80440693|FG000|Second Escalation|Physician Decision|0|||
27617292|NCT00322374|80440694|FG001|Second Escalation|Physician Decision|0|||
27617293|NCT00322374|80440695|FG002|Second Escalation|Physician Decision|5|||
27617294|NCT00322374|80440696|FG003|Second Escalation|Physician Decision|0|||
27617295|NCT00322374|80440693|FG000|Second Escalation|Study Drug Toxicity|0|||
27617296|NCT00322374|80440694|FG001|Second Escalation|Study Drug Toxicity|0|||
27617297|NCT00322374|80440695|FG002|Second Escalation|Study Drug Toxicity|1|||
27617298|NCT00322374|80440696|FG003|Second Escalation|Study Drug Toxicity|0|||
27617299|NCT01683994|80440697|FG000|Overall Study|Withdrawal by Subject|1|||
27617300|NCT01683994|80440698|FG001|Overall Study|Withdrawal by Subject|0|||
27617301|NCT01683994|80440699|FG002|Overall Study|Withdrawal by Subject|0|||
27617302|NCT01683994|80440700|FG003|Overall Study|Withdrawal by Subject|1|||
27617303|NCT01683994|80440701|FG004|Overall Study|Withdrawal by Subject|0|||
27617304|NCT01683994|80440697|FG000|Overall Study|Intercurrent illness|0|||
27617305|NCT01683994|80440698|FG001|Overall Study|Intercurrent illness|0|||
27617306|NCT01683994|80440699|FG002|Overall Study|Intercurrent illness|0|||
27617307|NCT01683994|80440700|FG003|Overall Study|Intercurrent illness|2|||
27617308|NCT01683994|80440701|FG004|Overall Study|Intercurrent illness|1|||
27617309|NCT02268396|80440703|FG000|Overall Study|Adverse Event|3|||
27617310|NCT02268396|80440703|FG000|Overall Study|Administrative|2|||
27617311|NCT02268396|80440703|FG000|Overall Study|Withdrawal by Subject|1|||
27617312|NCT02268396|80440703|FG000|Overall Study|Lost to Follow-up|2|||
27617313|NCT02268396|80440703|FG000|Overall Study|Protocol-Specified Criteria|2|||
27617314|NCT02268396|80440703|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
27617315|NCT03000673|80440706|FG000|Overall Study|Withdrawal by Subject|1|||
27617316|NCT03000673|80440707|FG001|Overall Study|Withdrawal by Subject|0|||
27617317|NCT03000673|80440708|FG002|Overall Study|Withdrawal by Subject|0|||
27617318|NCT03000673|80440709|FG003|Overall Study|Withdrawal by Subject|0|||
27617319|NCT04004208|80440714|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27617320|NCT04004208|80440715|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27617321|NCT04004208|80440714|FG000|Overall Study|Death|3|||
27617322|NCT04004208|80440715|FG001|Overall Study|Death|0|||
27617323|NCT04004208|80440714|FG000|Overall Study|COVID-19 pandemic|1|||
27617324|NCT04004208|80440715|FG001|Overall Study|COVID-19 pandemic|0|||
27617325|NCT04004208|80440714|FG000|Overall Study|Physician Decision|1|||
27617326|NCT04004208|80440715|FG001|Overall Study|Physician Decision|0|||
27617327|NCT04004208|80440714|FG000|Overall Study|Adverse Event|1|||
27617328|NCT04004208|80440715|FG001|Overall Study|Adverse Event|1|||
27617329|NCT01619787|80440717|FG000|Overall Study|Lost to Follow-up|5|||
27617330|NCT01167179|80440721|FG000|Overall Study|disease recurrence|4|||
27617331|NCT01167179|80440722|FG001|Overall Study|disease recurrence|4|||
27617332|NCT01167179|80440721|FG000|Overall Study|Death|4|||
27617333|NCT01167179|80440722|FG001|Overall Study|Death|10|||
27617334|NCT01167179|80440721|FG000|Overall Study|Withdrawal by Subject|1|||
27617335|NCT01167179|80440722|FG001|Overall Study|Withdrawal by Subject|2|||
27617336|NCT01167179|80440721|FG000|Overall Study|diverse|6|||
27617337|NCT01167179|80440722|FG001|Overall Study|diverse|5|||
27617338|NCT03615482|80440723|FG000|Overall Study|Death|1|||
27617339|NCT03615482|80440724|FG001|Overall Study|Death|0|||
27617340|NCT03615482|80440723|FG000|Overall Study|Lost to Follow-up|7|||
27617341|NCT03615482|80440724|FG001|Overall Study|Lost to Follow-up|7|||
27617342|NCT03615482|80440723|FG000|Overall Study|Physician Decision|2|||
27617343|NCT03615482|80440724|FG001|Overall Study|Physician Decision|3|||
27617344|NCT03615482|80440723|FG000|Overall Study|Withdrawal by Subject|7|||
27617345|NCT03615482|80440724|FG001|Overall Study|Withdrawal by Subject|7|||
27617346|NCT00605319|80440725|FG000|Overall Study|Adverse Event|6|||
27617347|NCT00737061|80440726|FG000|Waiting Period|Lost to Follow-up|6|||
27617348|NCT00737061|80440726|FG000|Waiting Period|Withdrawal by Subject|1|||
27617349|NCT00737061|80440726|FG000|Waiting Period|Bilateral placement failure|34|||
27617350|NCT00737061|80440726|FG000|Waiting Period|Deemed patent following HSG|26|||
27617351|NCT00737061|80440726|FG000|Waiting Period|Alternative contraception failure|3|||
27617352|NCT00737061|80440726|FG000|Waiting Period|Elected surgical tubal ligation|5|||
27617353|NCT00737061|80440726|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
27617354|NCT00737061|80440726|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
27617355|NCT00737061|80440726|FG000|1 Year Wearing Period|Discontinued reilance|3|||
27617356|NCT00737061|80440726|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
27617357|NCT00097370|80440727|FG000|Stage 1|Adverse Event|3|||
27617358|NCT00097370|80440727|FG000|Stage 1|Withdrawal by Subject|1|||
27617359|NCT00097370|80440727|FG000|Stage 1|Lack of Efficacy|2|||
27617360|NCT00097370|80440727|FG000|Stage 2|Adverse Event|5|||
27617361|NCT00097370|80440727|FG000|Stage 2|Withdrawal by Subject|1|||
27617362|NCT00097370|80440727|FG000|Stage 2|Lack of Efficacy|3|||
27617363|NCT00097370|80440727|FG000|Stage 2|Pregnancy|1|||
27617364|NCT00097370|80440727|FG000|Stage 2|Sponsor Terminated Study|2|||
27617365|NCT00097370|80440727|FG000|Stage 2|Lost to Follow-up|1|||
27617366|NCT00097370|80440727|FG000|Stage 3|Adverse Event|2|||
27617367|NCT00097370|80440727|FG000|Stage 3|Withdrawal by Subject|3|||
27617368|NCT00097370|80440727|FG000|Stage 3|Lack of Efficacy|1|||
27617369|NCT00097370|80440727|FG000|Stage 3|Sponsor Terminated Study|52|||
27617370|NCT00097370|80440727|FG000|Stage 3|Lost to Follow-up|1|||
27617371|NCT00830947|80440728|FG000|Overall Study|Lost to Follow-up|4|||
27617372|NCT00830947|80440729|FG001|Overall Study|Lost to Follow-up|4|||
27617373|NCT02148718|80440732|FG000|Overall Study|Protocol Violation|26|||
27617374|NCT02148718|80440732|FG000|Overall Study|Discontinued Study Prematurely|5|||
27617375|NCT00429793|80440736|FG000|Overall Study|Improper pre-protocol treatment|3|||
27617376|NCT00429793|80440736|FG000|Overall Study|Required test not done|1|||
27617377|NCT00429793|80440736|FG000|Overall Study|Never treated|1|||
27617378|NCT00429793|80440736|FG000|Overall Study|Non-measurable|1|||
27617379|NCT00502996|80440737|FG000|Overall Study|Lost to Follow-up|9|||
27617380|NCT00502996|80440737|FG000|Overall Study|Protocol Violation|2|||
27617381|NCT00502996|80440737|FG000|Overall Study|Treatment failure|25|||
27617382|NCT00502996|80440737|FG000|Overall Study|Withdrawal Informed Consent|6|||
27617383|NCT00502996|80440737|FG000|Overall Study|Adverse Event|2|||
27617384|NCT01857323|80440738|FG000|Overall Study|Adverse Event|1|||
27617385|NCT01857323|80440738|FG000|Overall Study|Withdrawal by Subject|3|||
27617386|NCT01857323|80440738|FG000|Overall Study|Non-compliance|1|||
27617387|NCT01857323|80440738|FG000|Overall Study|Protocol Violation|6|||
27617388|NCT01857323|80440738|FG000|Overall Study|Lost to Follow-up|1|||
27617389|NCT01857323|80440738|FG000|Overall Study|Other|4|||
27617390|NCT01857323|80440738|FG000|Overall Study|Did not complete 180 doses|48|||
27617391|NCT03930186|80440739|FG000|Weeks 0 to 16|Adverse Event|6|||
27617392|NCT03930186|80440739|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
27617393|NCT03930186|80440739|FG000|Weeks 16 to 32|Adverse Event|1|||
27617394|NCT03930186|80440739|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
27617395|NCT03029780|80440740|FG000|Overall Study|Disease Progression|20|||
27617396|NCT03029780|80440741|FG001|Overall Study|Disease Progression|22|||
27617397|NCT03029780|80440740|FG000|Overall Study|Study Drug Toxicity|15|||
27617398|NCT03029780|80440741|FG001|Overall Study|Study Drug Toxicity|11|||
27617399|NCT03029780|80440740|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27617400|NCT03029780|80440741|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27617401|NCT03029780|80440740|FG000|Overall Study|Participant request to discontinue study treatment|4|||
27617402|NCT03029780|80440741|FG001|Overall Study|Participant request to discontinue study treatment|1|||
27617403|NCT03029780|80440740|FG000|Overall Study|Maximum clinical benefit|1|||
27617404|NCT03029780|80440741|FG001|Overall Study|Maximum clinical benefit|0|||
27853560|NCT02304458|81295069|FG001|Overall Study|Death|0|||
27617405|NCT03029780|80440740|FG000|Overall Study|Participant no longer meets study criteria|0|||
27617406|NCT03029780|80440741|FG001|Overall Study|Participant no longer meets study criteria|1|||
27617407|NCT03029780|80440740|FG000|Overall Study|Other reasons|6|||
27617408|NCT03029780|80440741|FG001|Overall Study|Other reasons|6|||
27617409|NCT03029780|80440740|FG000|Overall Study|Not reported|1|||
27617410|NCT03029780|80440741|FG001|Overall Study|Not reported|1|||
27617411|NCT03029780|80440740|FG000|Overall Study|Death|2|||
27617412|NCT03029780|80440741|FG001|Overall Study|Death|6|||
27617413|NCT00725010|80440742|FG000|Overall Study|Toxicity|9|||
27617414|NCT00725010|80440742|FG000|Overall Study|Tumor Progression|7|||
27617415|NCT00725010|80440742|FG000|Overall Study|Withdrawal by Subject|2|||
27617416|NCT00725010|80440742|FG000|Overall Study|Death|1|||
27617417|NCT00725010|80440742|FG000|Overall Study|Lost to Follow-up|1|||
27617418|NCT00725010|80440742|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
27617419|NCT00725010|80440742|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
27617420|NCT00725010|80440742|FG000|Overall Study|No further documentation|1|||
27617421|NCT00725010|80440742|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
27617422|NCT01628510|80440746|FG000|Overall Study|Withdrawal by Subject|0|||
27617423|NCT01628510|80440747|FG001|Overall Study|Withdrawal by Subject|4|||
27617424|NCT01628510|80440746|FG000|Overall Study|Death|3|||
27617425|NCT01628510|80440747|FG001|Overall Study|Death|1|||
27617426|NCT01804673|80440755|FG000|Overall Study|Adverse Event|4|||
27617427|NCT01804673|80440755|FG000|Overall Study|Withdrawal by Subject|1|||
27617428|NCT01804673|80440755|FG000|Overall Study|Lack of Efficacy|9|||
27617429|NCT01804673|80440755|FG000|Overall Study|Change to Oral Therapy|37|||
27617430|NCT01804673|80440755|FG000|Overall Study|No Further Therapy Required|84|||
27617431|NCT01804673|80440755|FG000|Overall Study|Use of Prohibited Medication|1|||
27617432|NCT01804673|80440755|FG000|Overall Study|Other|4|||
27617433|NCT02959138|80440759|FG000|Overall Study|Enrolled but Never Treated|0|||
27617434|NCT02959138|80440760|FG001|Overall Study|Enrolled but Never Treated|1|||
27617435|NCT02959138|80440761|FG002|Overall Study|Enrolled but Never Treated|0|||
27617436|NCT04179461|80444503|FG000|Overall Study|Lost to Follow-up|4|||
27617437|NCT03330119|80444511|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
27617438|NCT03330119|80444512|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
27617439|NCT01661881|80444516|FG000|Overall Study|Disease Progression|1|||
27617440|NCT04159896|80444525|FG000|Overall Study|Lack of Efficacy|7|||
27617441|NCT04159896|80444525|FG000|Overall Study|Withdrawal by Subject|1|||
27617442|NCT04159896|80444525|FG000|Overall Study|Adverse Event|1|||
27617443|NCT04159896|80444525|FG000|Overall Study|A transient ischaemic attack|1|||
27617444|NCT04545619|80444531|FG000|Overall Study|due to equipment challenges|1|||
27617445|NCT01316692|80444532|FG000|Overall Study|Adverse Event|5|||
27617446|NCT01316692|80444532|FG000|Overall Study|Disease Progression|7|||
27617447|NCT01440049|80444536|FG000|Overall Study|Adverse Event|5|||
27617448|NCT01155726|80444537|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
27617449|NCT01155726|80444538|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
27617450|NCT01155726|80444539|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
27617451|NCT01155726|80444540|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
27617452|NCT00647348|80444541|FG000|Overall Study|Lost to Follow-up|3|||
27617453|NCT00647348|80444542|FG001|Overall Study|Lost to Follow-up|6|||
27516311|NCT02194985|80084907|FG000|Overall Study|Adverse Event|1|||
27516312|NCT02194985|80084907|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
27516313|NCT02194985|80084907|FG000|Overall Study|Physician Decision|4|||
27516314|NCT02194985|80084907|FG000|Overall Study|Lost to Follow-up|1|||
27516315|NCT02194985|80084907|FG000|Overall Study|Withdrawal by Subject|2|||
27516316|NCT00838513|80084920|FG000|Screening Period|Screen Failure|3|||
27516317|NCT00838513|80084920|FG000|Extension Treatment Period|Death|1|||
27516318|NCT00838513|80084920|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
27516319|NCT01012219|80084921|FG000|Period 1|Withdrawal by Subject|1|||
27516320|NCT01012219|80084921|FG000|Period 2|Withdrawal by Subject|1|||
27516321|NCT01546623|80084928|FG000|Overall Study|Adverse Event|2|||
27516322|NCT01546623|80084929|FG001|Overall Study|Adverse Event|3|||
27516323|NCT01546623|80084928|FG000|Overall Study|Major Protocol Deviation|1|||
27516324|NCT01546623|80084929|FG001|Overall Study|Major Protocol Deviation|1|||
27617454|NCT02176928|80444543|FG000|Overall Study|Lost to Follow-up|2|||
27617455|NCT02176928|80444544|FG001|Overall Study|Lost to Follow-up|4|||
27617456|NCT02320721|80444545|FG000|Overall Study|Adverse Event|6|||
27617457|NCT02320721|80444546|FG001|Overall Study|Adverse Event|6|||
27617458|NCT02320721|80444545|FG000|Overall Study|Lack of Efficacy|2|||
27617459|NCT02320721|80444546|FG001|Overall Study|Lack of Efficacy|0|||
27617460|NCT02320721|80444545|FG000|Overall Study|Poor compliance to protocol|3|||
27617461|NCT02320721|80444546|FG001|Overall Study|Poor compliance to protocol|7|||
27617462|NCT02320721|80444545|FG000|Overall Study|Randomized but not treated|0|||
27617463|NCT02320721|80444546|FG001|Overall Study|Randomized but not treated|1|||
27617464|NCT02320721|80444545|FG000|Overall Study|Hypoglycemia|1|||
27617465|NCT02320721|80444546|FG001|Overall Study|Hypoglycemia|0|||
27617466|NCT02320721|80444545|FG000|Overall Study|Other than specified above|15|||
27617467|NCT02320721|80444546|FG001|Overall Study|Other than specified above|20|||
27853561|NCT02304458|81295070|FG002|Overall Study|Death|2|||
27853562|NCT02304458|81295071|FG003|Overall Study|Death|0|||
27853563|NCT02304458|81295072|FG004|Overall Study|Death|0|||
27853564|NCT02304458|81295073|FG005|Overall Study|Death|0|||
27853565|NCT02304458|81295074|FG006|Overall Study|Death|1|||
27853566|NCT02304458|81295075|FG007|Overall Study|Death|0|||
27853567|NCT02304458|81295068|FG000|Overall Study|Lack of Efficacy|4|||
27853568|NCT02304458|81295069|FG001|Overall Study|Lack of Efficacy|6|||
27853569|NCT02304458|81295070|FG002|Overall Study|Lack of Efficacy|38|||
27853570|NCT02304458|81295071|FG003|Overall Study|Lack of Efficacy|5|||
27853571|NCT02304458|81295072|FG004|Overall Study|Lack of Efficacy|6|||
27907414|NCT03130959|81500349|FG000|Overall Study|Other reasons|0|||
27907415|NCT03130959|81500350|FG001|Overall Study|Other reasons|0|||
27907416|NCT03130959|81500351|FG002|Overall Study|Other reasons|0|||
27907417|NCT03130959|81500352|FG003|Overall Study|Other reasons|0|||
27853572|NCT02304458|81295073|FG005|Overall Study|Lack of Efficacy|6|||
27853573|NCT02304458|81295074|FG006|Overall Study|Lack of Efficacy|21|||
27907418|NCT03130959|81500353|FG004|Overall Study|Other reasons|0|||
27907419|NCT03130959|81500354|FG005|Overall Study|Other reasons|1|||
27853574|NCT02304458|81295075|FG007|Overall Study|Lack of Efficacy|4|||
27907420|NCT03130959|81500355|FG006|Overall Study|Other reasons|1|||
27907421|NCT03130959|81500356|FG007|Overall Study|Other reasons|0|||
27617468|NCT02189863|80444547|FG000|First 2 Weeks|Motion Sickness|4|||
27729154|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
27729155|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
27729156|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
27729157|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
27729158|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
27729159|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
27729160|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
27729161|NCT00289913|80838152|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729162|NCT00289913|80838153|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
27729163|NCT00289913|80838154|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729164|NCT00289913|80838155|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729165|NCT00289913|80838156|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
27729166|NCT03823391|80838157|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
27729167|NCT03823391|80838158|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
27729168|NCT03823391|80838157|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
27617469|NCT02189863|80444548|FG001|First 2 Weeks|Motion Sickness|2|||
27617470|NCT02471404|80444551|FG000|Overall Study|Adverse Event|7|||
27729169|NCT03823391|80838158|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
27729170|NCT00891202|80838160|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
27729171|NCT00891202|80838161|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
27729172|NCT00891202|80838162|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
27729173|NCT00891202|80838163|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
27729174|NCT00891202|80838160|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
27729175|NCT00891202|80838161|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
27907422|NCT03130959|81500357|FG008|Overall Study|Other reasons|0|||
27617471|NCT02471404|80444552|FG001|Overall Study|Adverse Event|1|||
27617472|NCT02471404|80444553|FG002|Overall Study|Adverse Event|2|||
27617473|NCT02471404|80444551|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
27617474|NCT02471404|80444552|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
27617475|NCT02471404|80444553|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
27617476|NCT02471404|80444551|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
27617477|NCT02471404|80444552|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
27617478|NCT02471404|80444553|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
27617479|NCT02471404|80444551|FG000|Overall Study|Lost to Follow-up|1|||
27617480|NCT02471404|80444552|FG001|Overall Study|Lost to Follow-up|1|||
27617481|NCT02471404|80444553|FG002|Overall Study|Lost to Follow-up|3|||
27617482|NCT02471404|80444551|FG000|Overall Study|Protocol Violation|1|||
27729176|NCT00891202|80838162|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
27729177|NCT00891202|80838163|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
27729178|NCT00891202|80838160|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
27907423|NCT03130959|81500358|FG009|Overall Study|Other reasons|0|||
27907424|NCT03130959|81500349|FG000|Overall Study|Subject request to discontinue therapy|0|||
27907425|NCT03130959|81500350|FG001|Overall Study|Subject request to discontinue therapy|0|||
27617483|NCT02471404|80444552|FG001|Overall Study|Protocol Violation|0|||
27617484|NCT02471404|80444553|FG002|Overall Study|Protocol Violation|0|||
27853575|NCT02304458|81295068|FG000|Overall Study|Physician Decision|2|||
27853576|NCT02304458|81295069|FG001|Overall Study|Physician Decision|0|||
27853577|NCT02304458|81295070|FG002|Overall Study|Physician Decision|16|||
27853578|NCT02304458|81295071|FG003|Overall Study|Physician Decision|1|||
27853579|NCT02304458|81295072|FG004|Overall Study|Physician Decision|0|||
27907426|NCT03130959|81500351|FG002|Overall Study|Subject request to discontinue therapy|1|||
27617485|NCT02471404|80444551|FG000|Overall Study|Withdrawal by Subject|8|||
27617486|NCT02471404|80444552|FG001|Overall Study|Withdrawal by Subject|4|||
27617487|NCT02471404|80444553|FG002|Overall Study|Withdrawal by Subject|5|||
27617488|NCT02471404|80444551|FG000|Overall Study|Other reasons not specified|10|||
27617489|NCT02471404|80444552|FG001|Overall Study|Other reasons not specified|7|||
27617490|NCT02471404|80444553|FG002|Overall Study|Other reasons not specified|12|||
27617491|NCT04963062|80444554|FG000|Overall Study|withdrew by the study team|4|||
27617492|NCT04963062|80444555|FG001|Overall Study|withdrew by the study team|2|||
27617493|NCT01349907|80444556|FG000|Overall Study|Adverse Event|37|||
27617494|NCT01349907|80444557|FG001|Overall Study|Adverse Event|11|||
27617495|NCT01349907|80444556|FG000|Overall Study|Treatment failure|13|||
27617496|NCT01349907|80444557|FG001|Overall Study|Treatment failure|4|||
27617497|NCT01349907|80444556|FG000|Overall Study|Lost to Follow-up|25|||
27617498|NCT01349907|80444557|FG001|Overall Study|Lost to Follow-up|6|||
27617499|NCT01349907|80444556|FG000|Overall Study|Withdrawal by Subject|30|||
27617500|NCT01349907|80444557|FG001|Overall Study|Withdrawal by Subject|8|||
27617501|NCT01349907|80444556|FG000|Overall Study|Protocol Violation|33|||
27617502|NCT01349907|80444557|FG001|Overall Study|Protocol Violation|13|||
27617503|NCT01349907|80444556|FG000|Overall Study|Administrative|1|||
27617504|NCT01349907|80444557|FG001|Overall Study|Administrative|1|||
27617505|NCT02325713|80444558|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617506|NCT02325713|80444559|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617507|NCT02325713|80444560|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617508|NCT02325713|80444561|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617509|NCT02325713|80444562|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617510|NCT02325713|80444563|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617511|NCT02325713|80444564|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617512|NCT02325713|80444565|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617513|NCT02325713|80444566|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617514|NCT02325713|80444567|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617515|NCT02325713|80444568|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
27617516|NCT02325713|80444569|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617517|NCT02325713|80444570|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617518|NCT02325713|80444571|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617519|NCT02325713|80444572|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617520|NCT02325713|80444573|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
27617521|NCT02325713|80444558|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
27617522|NCT02325713|80444559|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27853580|NCT02304458|81295073|FG005|Overall Study|Physician Decision|0|||
27853581|NCT02304458|81295074|FG006|Overall Study|Physician Decision|3|||
27516325|NCT01546623|80084928|FG000|Overall Study|High Prostate specific antigen|2|||
27516326|NCT01546623|80084929|FG001|Overall Study|High Prostate specific antigen|1|||
27516327|NCT01546623|80084928|FG000|Overall Study|Did Not Receive Study Drug|1|||
27516328|NCT01546623|80084929|FG001|Overall Study|Did Not Receive Study Drug|1|||
27516329|NCT01086358|80084930|FG000|First Intervention|Lost to Follow-up|9|||
27516330|NCT01086358|80084931|FG001|First Intervention|Lost to Follow-up|4|||
27516331|NCT01086358|80084930|FG000|First Intervention|Withdrawal by Subject|0|||
27516332|NCT01086358|80084931|FG001|First Intervention|Withdrawal by Subject|1|||
27516333|NCT01086358|80084930|FG000|Second Intervention|Lost to Follow-up|4|||
27516334|NCT01086358|80084931|FG001|Second Intervention|Lost to Follow-up|4|||
27516335|NCT02741518|80084932|FG000|Overall Study|Withdrawal by Subject|1|||
27516336|NCT02741518|80084933|FG001|Overall Study|Withdrawal by Subject|1|||
27516337|NCT02813577|80084934|FG000|Overall Study|Study terminated|4|||
27516338|NCT04345367|80084936|FG000|Overall Study|Other|3|||
27516339|NCT04345367|80084937|FG001|Overall Study|Other|4|||
27516340|NCT04345367|80084936|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
27516341|NCT04345367|80084937|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
27516342|NCT04345367|80084936|FG000|Overall Study|Withdrawal by Subject|11|||
27516343|NCT04345367|80084937|FG001|Overall Study|Withdrawal by Subject|11|||
27516344|NCT04345367|80084936|FG000|Overall Study|Protocol Violation|4|||
27516345|NCT04345367|80084937|FG001|Overall Study|Protocol Violation|3|||
27516346|NCT04345367|80084936|FG000|Overall Study|Lost to Follow-up|2|||
27516347|NCT04345367|80084937|FG001|Overall Study|Lost to Follow-up|4|||
27516348|NCT04345367|80084936|FG000|Overall Study|Lack of Efficacy|2|||
27617523|NCT02325713|80444560|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617524|NCT02325713|80444561|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27853582|NCT02304458|81295075|FG007|Overall Study|Physician Decision|0|||
27617525|NCT02325713|80444562|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617526|NCT02325713|80444563|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617527|NCT02325713|80444564|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617528|NCT02325713|80444565|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27853583|NCT02304458|81295068|FG000|Overall Study|Protocol Violation|0|||
27853584|NCT02304458|81295069|FG001|Overall Study|Protocol Violation|0|||
27617529|NCT02325713|80444566|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617530|NCT02325713|80444567|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617531|NCT02325713|80444568|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617532|NCT02325713|80444569|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617533|NCT02325713|80444570|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617534|NCT02325713|80444571|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617535|NCT02325713|80444572|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27729179|NCT00891202|80838161|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
27729180|NCT00891202|80838162|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
27729181|NCT00891202|80838163|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
27729182|NCT00891202|80838160|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
27729183|NCT00891202|80838161|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
27729184|NCT00891202|80838162|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
27729185|NCT00891202|80838163|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
27516349|NCT04345367|80084937|FG001|Overall Study|Lack of Efficacy|0|||
27516350|NCT04345367|80084936|FG000|Overall Study|Death|2|||
27617536|NCT02325713|80444573|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
27617537|NCT02325713|80444558|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617538|NCT02325713|80444559|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617539|NCT02325713|80444560|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617540|NCT02325713|80444561|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617541|NCT02325713|80444562|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617542|NCT02325713|80444563|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617543|NCT02325713|80444564|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617544|NCT02325713|80444565|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617545|NCT02325713|80444566|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617546|NCT02325713|80444567|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
27617547|NCT02325713|80444568|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617548|NCT02325713|80444569|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617549|NCT02325713|80444570|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617550|NCT02325713|80444571|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617551|NCT02325713|80444572|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617552|NCT02325713|80444573|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
27617553|NCT02420327|80444576|FG000|Overall Study|Adverse Event|7|||
27617554|NCT02420327|80444576|FG000|Overall Study|Pregnancy|1|||
27617555|NCT02420327|80444576|FG000|Overall Study|Withdrawal by Subject|6|||
27617556|NCT02420327|80444576|FG000|Overall Study|Lost to Follow-up|1|||
27617557|NCT02420327|80444576|FG000|Overall Study|Protocol Violation|1|||
27617558|NCT00802659|80444577|FG000|Overall Study|Physician Decision|0|||
27617559|NCT00802659|80444578|FG001|Overall Study|Physician Decision|1|||
27617560|NCT00802659|80444579|FG002|Overall Study|Physician Decision|0|||
27617561|NCT00802659|80444580|FG003|Overall Study|Physician Decision|0|||
27617562|NCT01653847|80444581|FG000|Overall Study|Withdrawal by Subject|1|||
27617563|NCT01653847|80444582|FG001|Overall Study|Withdrawal by Subject|0|||
27516351|NCT04345367|80084937|FG001|Overall Study|Death|0|||
27516352|NCT04345367|80084936|FG000|Overall Study|Adverse Event|10|||
27617564|NCT02886728|80444583|FG000|Overall Study|Withdrew Consent|31|||
27617565|NCT02886728|80444584|FG001|Overall Study|Withdrew Consent|13|||
27617566|NCT02886728|80444585|FG002|Overall Study|Withdrew Consent|11|||
27617567|NCT02886728|80444586|FG003|Overall Study|Withdrew Consent|47|||
27617568|NCT02886728|80444583|FG000|Overall Study|Lost to Follow-up|12|||
27617569|NCT02886728|80444584|FG001|Overall Study|Lost to Follow-up|6|||
27617570|NCT02886728|80444585|FG002|Overall Study|Lost to Follow-up|13|||
27516353|NCT04345367|80084937|FG001|Overall Study|Adverse Event|9|||
27516354|NCT00970684|80084938|FG000|Overall Study|Lack of Efficacy|5|||
27617571|NCT02886728|80444586|FG003|Overall Study|Lost to Follow-up|12|||
27617572|NCT02886728|80444583|FG000|Overall Study|Adverse Event|13|||
27617573|NCT02886728|80444584|FG001|Overall Study|Adverse Event|5|||
27729186|NCT02582658|80838164|FG000|Overall Study|Failure to Return|10|||
27729187|NCT02582658|80838164|FG000|Overall Study|Insufficient Virological Response|2|||
27516355|NCT00970684|80084938|FG000|Overall Study|Adverse Event|4|||
27516356|NCT00970684|80084938|FG000|Overall Study|Withdrawal by Subject|1|||
27516357|NCT00724867|80084944|FG000|Overall Study|Adverse Event|25|||
27516358|NCT00724867|80084944|FG000|Overall Study|Lack of Efficacy|14|||
27729188|NCT02582658|80838164|FG000|Overall Study|Withdrawn Consent|1|||
27516359|NCT00724867|80084944|FG000|Overall Study|Lost to Follow-up|12|||
27516360|NCT00724867|80084944|FG000|Overall Study|Non-compliance with study drug|6|||
27516361|NCT00724867|80084944|FG000|Overall Study|Physician Decision|17|||
27617574|NCT02886728|80444585|FG002|Overall Study|Adverse Event|5|||
27617575|NCT02886728|80444586|FG003|Overall Study|Adverse Event|11|||
27617576|NCT02886728|80444583|FG000|Overall Study|Investigator's Discretion|11|||
27617577|NCT02886728|80444584|FG001|Overall Study|Investigator's Discretion|7|||
27516362|NCT00724867|80084944|FG000|Overall Study|Protocol Violation|1|||
27729189|NCT02582658|80838164|FG000|Overall Study|Death|1|||
27729190|NCT02582658|80838164|FG000|Overall Study|Not further specified|11|||
27729191|NCT00403260|80838166|FG000|Overall Study|Adverse Event|5|||
27729192|NCT00403260|80838167|FG001|Overall Study|Adverse Event|4|||
27729193|NCT00403260|80838166|FG000|Overall Study|Withdrawal by Subject|5|||
27729194|NCT00403260|80838167|FG001|Overall Study|Withdrawal by Subject|6|||
27729195|NCT00403260|80838166|FG000|Overall Study|Lost to Follow-up|49|||
27729196|NCT00403260|80838167|FG001|Overall Study|Lost to Follow-up|25|||
27729197|NCT00403260|80838166|FG000|Overall Study|Re-appearance of P. falciparum|34|||
27729198|NCT00403260|80838167|FG001|Overall Study|Re-appearance of P. falciparum|25|||
27729199|NCT00403260|80838166|FG000|Overall Study|P. vivax infection|26|||
27729200|NCT00403260|80838167|FG001|Overall Study|P. vivax infection|4|||
27729201|NCT00403260|80838166|FG000|Overall Study|Mixed infection with P. vivax|2|||
27729202|NCT00403260|80838167|FG001|Overall Study|Mixed infection with P. vivax|0|||
27729203|NCT00403260|80838166|FG000|Overall Study|Mixed infection with P. falciparum|1|||
27729204|NCT00403260|80838167|FG001|Overall Study|Mixed infection with P. falciparum|0|||
27729205|NCT00403260|80838166|FG000|Overall Study|P. vivax infection at screening|1|||
27729206|NCT00403260|80838167|FG001|Overall Study|P. vivax infection at screening|0|||
27729207|NCT00403260|80838166|FG000|Overall Study|P. ovale infection|1|||
27729208|NCT00403260|80838167|FG001|Overall Study|P. ovale infection|0|||
27729209|NCT00403260|80838166|FG000|Overall Study|Gametocyte re-appearance|1|||
27729210|NCT00403260|80838167|FG001|Overall Study|Gametocyte re-appearance|1|||
27729211|NCT00403260|80838166|FG000|Overall Study|Withdrawn from study accidentally|0|||
27729212|NCT00403260|80838167|FG001|Overall Study|Withdrawn from study accidentally|1|||
27729213|NCT00755079|80838168|FG000|Overall Study|Lost to Follow-up|1|||
27907427|NCT03130959|81500352|FG003|Overall Study|Subject request to discontinue therapy|1|||
27729214|NCT00755079|80838169|FG001|Overall Study|Lost to Follow-up|3|||
27729215|NCT00755079|80838168|FG000|Overall Study|Adverse Event|0|||
27729216|NCT00755079|80838169|FG001|Overall Study|Adverse Event|1|||
27729217|NCT00755079|80838168|FG000|Overall Study|Withdrawal by Subject|0|||
27729218|NCT00755079|80838169|FG001|Overall Study|Withdrawal by Subject|2|||
27729219|NCT00054132|80838170|FG000|Overall Study|Not Treated|1|||
27729220|NCT01752023|80838171|FG000|Overall Study|Physician Decision|2|||
27729221|NCT01752023|80838172|FG001|Overall Study|Physician Decision|1|||
27729222|NCT00179959|80838173|FG000|Overall Study|Lost to Follow-up|3|||
27729223|NCT00179959|80838174|FG001|Overall Study|Lost to Follow-up|1|||
27729224|NCT00179959|80838173|FG000|Overall Study|Withdrawal by Subject|3|||
27729225|NCT00179959|80838174|FG001|Overall Study|Withdrawal by Subject|2|||
27729226|NCT01709331|80838179|FG000|Overall Study|Adverse Event|1|||
27853585|NCT02304458|81295070|FG002|Overall Study|Protocol Violation|1|||
27853586|NCT02304458|81295071|FG003|Overall Study|Protocol Violation|0|||
27907428|NCT03130959|81500353|FG004|Overall Study|Subject request to discontinue therapy|0|||
27907429|NCT03130959|81500354|FG005|Overall Study|Subject request to discontinue therapy|0|||
27907430|NCT03130959|81500355|FG006|Overall Study|Subject request to discontinue therapy|1|||
27907431|NCT03130959|81500356|FG007|Overall Study|Subject request to discontinue therapy|1|||
27907432|NCT03130959|81500357|FG008|Overall Study|Subject request to discontinue therapy|0|||
27907433|NCT03130959|81500358|FG009|Overall Study|Subject request to discontinue therapy|0|||
27907434|NCT03130959|81500349|FG000|Overall Study|Not reported|0|||
27907435|NCT03130959|81500350|FG001|Overall Study|Not reported|0|||
27729227|NCT00977470|80838183|FG000|Overall Study|Lack of Efficacy|32|||
27729228|NCT00977470|80838184|FG001|Overall Study|Lack of Efficacy|30|||
27729229|NCT00977470|80838183|FG000|Overall Study|Physician Decision|2|||
27729230|NCT00977470|80838184|FG001|Overall Study|Physician Decision|0|||
27729231|NCT00977470|80838183|FG000|Overall Study|Adverse Event|1|||
27729232|NCT00977470|80838184|FG001|Overall Study|Adverse Event|2|||
27729233|NCT00977470|80838183|FG000|Overall Study|Protocol Violation|1|||
27729234|NCT00977470|80838184|FG001|Overall Study|Protocol Violation|0|||
27729235|NCT00977470|80838183|FG000|Overall Study|Withdrawal by Subject|0|||
27853587|NCT02304458|81295072|FG004|Overall Study|Protocol Violation|0|||
27853588|NCT02304458|81295073|FG005|Overall Study|Protocol Violation|0|||
27853589|NCT02304458|81295074|FG006|Overall Study|Protocol Violation|0|||
27853590|NCT02304458|81295075|FG007|Overall Study|Protocol Violation|0|||
27853591|NCT02304458|81295068|FG000|Overall Study|Withdrawal by Subject|1|||
27853592|NCT02304458|81295069|FG001|Overall Study|Withdrawal by Subject|0|||
27853593|NCT02304458|81295070|FG002|Overall Study|Withdrawal by Subject|7|||
27853594|NCT02304458|81295071|FG003|Overall Study|Withdrawal by Subject|0|||
27853595|NCT02304458|81295072|FG004|Overall Study|Withdrawal by Subject|0|||
27853596|NCT02304458|81295073|FG005|Overall Study|Withdrawal by Subject|0|||
27853597|NCT02304458|81295074|FG006|Overall Study|Withdrawal by Subject|1|||
27853598|NCT02304458|81295075|FG007|Overall Study|Withdrawal by Subject|0|||
27853599|NCT00076804|81295078|FG000|Overall Study|Death|9|||
27729236|NCT00977470|80838184|FG001|Overall Study|Withdrawal by Subject|2|||
27853600|NCT00076804|81295079|FG001|Overall Study|Death|20|||
27729237|NCT00977470|80838183|FG000|Overall Study|Death|0|||
27853601|NCT00076804|81295078|FG000|Overall Study|Lost to Follow-up|9|||
27853602|NCT00076804|81295079|FG001|Overall Study|Lost to Follow-up|9|||
27853603|NCT00076804|81295078|FG000|Overall Study|Withdrawal by Subject|10|||
27907436|NCT03130959|81500351|FG002|Overall Study|Not reported|0|||
27907437|NCT03130959|81500352|FG003|Overall Study|Not reported|1|||
27907438|NCT03130959|81500353|FG004|Overall Study|Not reported|0|||
27907439|NCT03130959|81500354|FG005|Overall Study|Not reported|1|||
27907440|NCT03130959|81500355|FG006|Overall Study|Not reported|0|||
27907441|NCT03130959|81500356|FG007|Overall Study|Not reported|0|||
27907442|NCT03130959|81500357|FG008|Overall Study|Not reported|0|||
27907443|NCT03130959|81500358|FG009|Overall Study|Not reported|1|||
27907444|NCT03130959|81500349|FG000|Overall Study|Adverse Event unrelated to drug|0|||
27907445|NCT03130959|81500350|FG001|Overall Study|Adverse Event unrelated to drug|0|||
27907446|NCT03130959|81500351|FG002|Overall Study|Adverse Event unrelated to drug|1|||
27907447|NCT03130959|81500352|FG003|Overall Study|Adverse Event unrelated to drug|1|||
27907448|NCT03130959|81500353|FG004|Overall Study|Adverse Event unrelated to drug|1|||
27907449|NCT03130959|81500354|FG005|Overall Study|Adverse Event unrelated to drug|0|||
27907450|NCT03130959|81500355|FG006|Overall Study|Adverse Event unrelated to drug|1|||
27907451|NCT03130959|81500356|FG007|Overall Study|Adverse Event unrelated to drug|0|||
27907452|NCT03130959|81500357|FG008|Overall Study|Adverse Event unrelated to drug|1|||
27907453|NCT03130959|81500358|FG009|Overall Study|Adverse Event unrelated to drug|1|||
27907454|NCT03130959|81500349|FG000|Overall Study|Participant withdrew consent|0|||
27907455|NCT03130959|81500350|FG001|Overall Study|Participant withdrew consent|1|||
27907456|NCT03130959|81500351|FG002|Overall Study|Participant withdrew consent|0|||
27907457|NCT03130959|81500352|FG003|Overall Study|Participant withdrew consent|2|||
27907458|NCT03130959|81500353|FG004|Overall Study|Participant withdrew consent|1|||
27907459|NCT03130959|81500354|FG005|Overall Study|Participant withdrew consent|0|||
27907460|NCT03130959|81500355|FG006|Overall Study|Participant withdrew consent|0|||
27907461|NCT03130959|81500356|FG007|Overall Study|Participant withdrew consent|0|||
27907462|NCT03130959|81500357|FG008|Overall Study|Participant withdrew consent|0|||
27907463|NCT03130959|81500358|FG009|Overall Study|Participant withdrew consent|2|||
27907464|NCT03130959|81500349|FG000|Overall Study|Administrative reason by sponsor|1|||
27853604|NCT00076804|81295079|FG001|Overall Study|Withdrawal by Subject|8|||
27853605|NCT00076804|81295078|FG000|Overall Study|Early study Closure|32|||
27853606|NCT00076804|81295079|FG001|Overall Study|Early study Closure|32|||
27853607|NCT04355663|81295080|FG000|Overall Study|Physician Decision|2|||
27853608|NCT04355663|81295081|FG001|Overall Study|Physician Decision|7|||
27853609|NCT04355663|81295082|FG002|Overall Study|Physician Decision|0|||
27853610|NCT04355663|81295080|FG000|Overall Study|Adverse Event|0|||
27853611|NCT04355663|81295081|FG001|Overall Study|Adverse Event|0|||
27853612|NCT04355663|81295082|FG002|Overall Study|Adverse Event|1|||
27853613|NCT04355663|81295080|FG000|Overall Study|Withdrawal by Subject|0|||
27853614|NCT04355663|81295081|FG001|Overall Study|Withdrawal by Subject|8|||
27853615|NCT04355663|81295082|FG002|Overall Study|Withdrawal by Subject|3|||
27853616|NCT03340064|81295083|FG000|First Period|Adverse Event, non-fatal|2|||
27853617|NCT03340064|81295084|FG001|First Period|Adverse Event, non-fatal|0|||
27853618|NCT03340064|81295083|FG000|First Period|Lack of Efficacy|3|||
27907465|NCT03130959|81500350|FG001|Overall Study|Administrative reason by sponsor|0|||
27907466|NCT03130959|81500351|FG002|Overall Study|Administrative reason by sponsor|1|||
27907467|NCT03130959|81500352|FG003|Overall Study|Administrative reason by sponsor|0|||
27907468|NCT03130959|81500353|FG004|Overall Study|Administrative reason by sponsor|0|||
27907469|NCT03130959|81500354|FG005|Overall Study|Administrative reason by sponsor|0|||
27907470|NCT03130959|81500355|FG006|Overall Study|Administrative reason by sponsor|0|||
27907471|NCT03130959|81500356|FG007|Overall Study|Administrative reason by sponsor|0|||
27907472|NCT03130959|81500357|FG008|Overall Study|Administrative reason by sponsor|0|||
27907473|NCT03130959|81500358|FG009|Overall Study|Administrative reason by sponsor|0|||
27907474|NCT03130959|81500349|FG000|Overall Study|Lost to Follow-up|1|||
27907475|NCT03130959|81500350|FG001|Overall Study|Lost to Follow-up|0|||
27907476|NCT03130959|81500351|FG002|Overall Study|Lost to Follow-up|0|||
27907477|NCT03130959|81500352|FG003|Overall Study|Lost to Follow-up|0|||
27907478|NCT03130959|81500353|FG004|Overall Study|Lost to Follow-up|0|||
27907479|NCT03130959|81500354|FG005|Overall Study|Lost to Follow-up|0|||
27907480|NCT03130959|81500355|FG006|Overall Study|Lost to Follow-up|0|||
27907481|NCT03130959|81500356|FG007|Overall Study|Lost to Follow-up|0|||
27907482|NCT03130959|81500357|FG008|Overall Study|Lost to Follow-up|0|||
27907483|NCT03130959|81500358|FG009|Overall Study|Lost to Follow-up|0|||
27907484|NCT00885378|81500359|FG000|Overall Study|Lack of Efficacy|2|||
27907485|NCT00885378|81500360|FG001|Overall Study|Lack of Efficacy|2|||
27907486|NCT00885378|81500359|FG000|Overall Study|Withdrawal by Subject|1|||
27907487|NCT00885378|81500360|FG001|Overall Study|Withdrawal by Subject|2|||
27907488|NCT00885378|81500359|FG000|Overall Study|Lost to Follow-up|1|||
27853619|NCT03340064|81295084|FG001|First Period|Lack of Efficacy|0|||
27907489|NCT00885378|81500360|FG001|Overall Study|Lost to Follow-up|2|||
27907490|NCT00885378|81500359|FG000|Overall Study|Poor/Noncompliance|2|||
27907491|NCT00885378|81500360|FG001|Overall Study|Poor/Noncompliance|2|||
27853620|NCT03340064|81295083|FG000|Second Period|Adverse Event, non-fatal|1|||
27853621|NCT03340064|81295084|FG001|Second Period|Adverse Event, non-fatal|1|||
27853622|NCT03340064|81295083|FG000|Second Period|Lack of Efficacy|11|||
27729238|NCT00977470|80838184|FG001|Overall Study|Death|2|||
27729239|NCT00977470|80838183|FG000|Overall Study|clinical decline|0|||
27729240|NCT00977470|80838184|FG001|Overall Study|clinical decline|1|||
27729241|NCT00977470|80838183|FG000|Overall Study|prolonged recovery post-surgery|0|||
27729242|NCT00977470|80838184|FG001|Overall Study|prolonged recovery post-surgery|1|||
27729243|NCT00977470|80838183|FG000|Overall Study|Still on-study|2|||
27729244|NCT00977470|80838184|FG001|Overall Study|Still on-study|0|||
27729245|NCT01254669|80838187|FG000|Overall Study|Withdrawal by Subject|0|||
27729246|NCT01254669|80838188|FG001|Overall Study|Withdrawal by Subject|1|||
27729247|NCT01254669|80838187|FG000|Overall Study|time constraint|2|||
27729248|NCT01254669|80838188|FG001|Overall Study|time constraint|2|||
27729249|NCT01254669|80838187|FG000|Overall Study|called to clinic during intervention|1|||
27729250|NCT01254669|80838188|FG001|Overall Study|called to clinic during intervention|1|||
27729251|NCT01869348|80838189|FG000|Overall Study|Withdrawal by Subject|1|||
27729252|NCT01869348|80838190|FG001|Overall Study|Withdrawal by Subject|1|||
27729253|NCT03283085|80838191|FG000|Overall Study|Adverse Event|18|||
27729254|NCT03283085|80838192|FG001|Overall Study|Adverse Event|3|||
27729255|NCT03283085|80838193|FG002|Overall Study|Adverse Event|13|||
27729256|NCT03283085|80838194|FG003|Overall Study|Adverse Event|0|||
27729257|NCT03283085|80838195|FG004|Overall Study|Adverse Event|0|||
27729258|NCT03283085|80838196|FG005|Overall Study|Adverse Event|5|||
27729259|NCT03283085|80838191|FG000|Overall Study|Death|0|||
27729260|NCT03283085|80838192|FG001|Overall Study|Death|0|||
27729261|NCT03283085|80838193|FG002|Overall Study|Death|3|||
27729262|NCT03283085|80838194|FG003|Overall Study|Death|1|||
27729263|NCT03283085|80838195|FG004|Overall Study|Death|0|||
27729264|NCT03283085|80838196|FG005|Overall Study|Death|0|||
27729265|NCT03283085|80838191|FG000|Overall Study|Withdrawal by Subject|42|||
27729266|NCT03283085|80838192|FG001|Overall Study|Withdrawal by Subject|21|||
27729267|NCT03283085|80838193|FG002|Overall Study|Withdrawal by Subject|66|||
27729268|NCT03283085|80838194|FG003|Overall Study|Withdrawal by Subject|3|||
27729269|NCT03283085|80838195|FG004|Overall Study|Withdrawal by Subject|3|||
27729270|NCT03283085|80838196|FG005|Overall Study|Withdrawal by Subject|5|||
27729271|NCT03283085|80838191|FG000|Overall Study|Physician Decision|14|||
27729272|NCT03283085|80838192|FG001|Overall Study|Physician Decision|8|||
27729273|NCT03283085|80838193|FG002|Overall Study|Physician Decision|19|||
27729274|NCT03283085|80838194|FG003|Overall Study|Physician Decision|0|||
27729275|NCT03283085|80838195|FG004|Overall Study|Physician Decision|0|||
27729276|NCT03283085|80838196|FG005|Overall Study|Physician Decision|2|||
27729277|NCT03283085|80838191|FG000|Overall Study|Site Terminated by Sponsor|1|||
27729278|NCT03283085|80838192|FG001|Overall Study|Site Terminated by Sponsor|0|||
27729279|NCT03283085|80838193|FG002|Overall Study|Site Terminated by Sponsor|3|||
27729280|NCT03283085|80838194|FG003|Overall Study|Site Terminated by Sponsor|0|||
27729281|NCT03283085|80838195|FG004|Overall Study|Site Terminated by Sponsor|0|||
27729282|NCT03283085|80838196|FG005|Overall Study|Site Terminated by Sponsor|0|||
27729283|NCT03283085|80838191|FG000|Overall Study|Lost to Follow-up|2|||
27729284|NCT03283085|80838192|FG001|Overall Study|Lost to Follow-up|0|||
27729285|NCT03283085|80838193|FG002|Overall Study|Lost to Follow-up|2|||
27729286|NCT03283085|80838194|FG003|Overall Study|Lost to Follow-up|0|||
27729287|NCT03283085|80838195|FG004|Overall Study|Lost to Follow-up|0|||
27729288|NCT03283085|80838196|FG005|Overall Study|Lost to Follow-up|1|||
27729289|NCT03283085|80838191|FG000|Overall Study|Pregnancy|0|||
27729290|NCT03283085|80838192|FG001|Overall Study|Pregnancy|0|||
27729291|NCT03283085|80838193|FG002|Overall Study|Pregnancy|1|||
27729292|NCT03283085|80838194|FG003|Overall Study|Pregnancy|0|||
27729293|NCT03283085|80838195|FG004|Overall Study|Pregnancy|0|||
27729294|NCT03283085|80838196|FG005|Overall Study|Pregnancy|0|||
27729295|NCT03283085|80838191|FG000|Overall Study|Lack of Efficacy|12|||
27729296|NCT03283085|80838192|FG001|Overall Study|Lack of Efficacy|6|||
27729297|NCT03283085|80838193|FG002|Overall Study|Lack of Efficacy|24|||
27617578|NCT02886728|80444585|FG002|Overall Study|Investigator's Discretion|5|||
27617579|NCT02886728|80444586|FG003|Overall Study|Investigator's Discretion|11|||
27729298|NCT03283085|80838194|FG003|Overall Study|Lack of Efficacy|1|||
27729299|NCT03283085|80838195|FG004|Overall Study|Lack of Efficacy|1|||
27729300|NCT03283085|80838196|FG005|Overall Study|Lack of Efficacy|0|||
27729301|NCT03283085|80838191|FG000|Overall Study|Reason not Specified|0|||
27729302|NCT03283085|80838192|FG001|Overall Study|Reason not Specified|4|||
27729303|NCT03283085|80838193|FG002|Overall Study|Reason not Specified|8|||
27729304|NCT03283085|80838194|FG003|Overall Study|Reason not Specified|0|||
27729305|NCT03283085|80838195|FG004|Overall Study|Reason not Specified|0|||
27729306|NCT03283085|80838196|FG005|Overall Study|Reason not Specified|1|||
27729307|NCT02118792|80838211|FG000|Overall Study|Withdrawal by Subject|6|||
27729308|NCT02118792|80838212|FG001|Overall Study|Withdrawal by Subject|3|||
27729309|NCT02118792|80838211|FG000|Overall Study|Lost to Follow-up|4|||
27729310|NCT02118792|80838212|FG001|Overall Study|Lost to Follow-up|4|||
27729311|NCT02118792|80838211|FG000|Overall Study|Adverse Event|5|||
27729312|NCT02118792|80838212|FG001|Overall Study|Adverse Event|4|||
27729313|NCT02118792|80838211|FG000|Overall Study|Withdrawal by parent/guardian|14|||
27729314|NCT02118792|80838212|FG001|Overall Study|Withdrawal by parent/guardian|20|||
27907492|NCT00885378|81500359|FG000|Overall Study|Protocol Violation|2|||
27907493|NCT00885378|81500360|FG001|Overall Study|Protocol Violation|0|||
27907494|NCT02098395|81500361|FG000|Overall Study|Protocol Violation|2|||
27907495|NCT02098395|81500362|FG001|Overall Study|Protocol Violation|2|||
27907496|NCT02098395|81500363|FG002|Overall Study|Protocol Violation|0|||
27907497|NCT02098395|81500364|FG003|Overall Study|Protocol Violation|7|||
27907498|NCT02098395|81500361|FG000|Overall Study|Withdrawal by Subject|10|||
27907499|NCT02098395|81500362|FG001|Overall Study|Withdrawal by Subject|10|||
27907500|NCT02098395|81500363|FG002|Overall Study|Withdrawal by Subject|5|||
27907501|NCT02098395|81500364|FG003|Overall Study|Withdrawal by Subject|13|||
27907502|NCT02098395|81500361|FG000|Overall Study|Adverse Event|12|||
27907503|NCT02098395|81500362|FG001|Overall Study|Adverse Event|19|||
27907504|NCT02098395|81500363|FG002|Overall Study|Adverse Event|34|||
27907505|NCT02098395|81500364|FG003|Overall Study|Adverse Event|2|||
27516363|NCT00724867|80084944|FG000|Overall Study|Withdrawal by Subject|31|||
27516364|NCT00724867|80084944|FG000|Overall Study|Sponsor decision to end study|14|||
27516365|NCT00724867|80084944|FG000|Overall Study|Subject incarcerated|1|||
27516366|NCT00724867|80084944|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
27729315|NCT02118792|80838211|FG000|Overall Study|Other|1|||
27729316|NCT02118792|80838212|FG001|Overall Study|Other|6|||
27729317|NCT02118792|80838211|FG000|Overall Study|Randomised but not treated|1|||
27729318|NCT02118792|80838212|FG001|Overall Study|Randomised but not treated|0|||
27729319|NCT01524991|80838214|FG000|Overall Study|Adverse Event|12|||
27729320|NCT01524991|80838214|FG000|Overall Study|Death|1|||
27729321|NCT01524991|80838214|FG000|Overall Study|Disease ProgressionDu|17|||
27729322|NCT01524991|80838214|FG000|Overall Study|Other complicating disease|1|||
27729323|NCT01524991|80838214|FG000|Overall Study|Withdrawal by Subject|2|||
27729324|NCT01524991|80838214|FG000|Overall Study|Symptomatic Deterioration|1|||
27729325|NCT03049449|80838224|FG000|Overall Study|Did not receive treatment.|0|||
27729326|NCT03049449|80838225|FG001|Overall Study|Did not receive treatment.|0|||
27729327|NCT03049449|80838226|FG002|Overall Study|Did not receive treatment.|0|||
27729328|NCT03049449|80838227|FG003|Overall Study|Did not receive treatment.|0|||
27729329|NCT03049449|80838228|FG004|Overall Study|Did not receive treatment.|0|||
27729330|NCT03049449|80838229|FG005|Overall Study|Did not receive treatment.|0|||
27729331|NCT03049449|80838230|FG006|Overall Study|Did not receive treatment.|0|||
27729332|NCT03049449|80838231|FG007|Overall Study|Did not receive treatment.|0|||
27729333|NCT03049449|80838232|FG008|Overall Study|Did not receive treatment.|1|||
27729334|NCT03049449|80838233|FG009|Overall Study|Did not receive treatment.|0|||
27729335|NCT03049449|80838224|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
27729336|NCT03049449|80838225|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
27907506|NCT02098395|81500361|FG000|Overall Study|Lost to Follow-up|2|||
27907507|NCT02098395|81500362|FG001|Overall Study|Lost to Follow-up|1|||
27516367|NCT00724867|80084944|FG000|Overall Study|Subject moved out of state|1|||
27516368|NCT00724867|80084944|FG000|Overall Study|Elected to exit due to site closure|2|||
27516369|NCT00282308|80084945|FG000|Treatment Period|Lost to Follow-up|1|||
27516370|NCT00282308|80084946|FG001|Treatment Period|Lost to Follow-up|0|||
27516371|NCT00282308|80084947|FG002|Treatment Period|Lost to Follow-up|0|||
27516372|NCT00282308|80084945|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
27516373|NCT00282308|80084946|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
27516374|NCT00282308|80084947|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
27516375|NCT00282308|80084945|FG000|Treatment Period|Adverse Event|0|||
27516376|NCT00282308|80084946|FG001|Treatment Period|Adverse Event|2|||
27516377|NCT00282308|80084947|FG002|Treatment Period|Adverse Event|0|||
27516378|NCT00282308|80084945|FG000|Treatment Period|Not Treated with Study Drug|1|||
27516379|NCT00282308|80084946|FG001|Treatment Period|Not Treated with Study Drug|0|||
27516380|NCT00282308|80084947|FG002|Treatment Period|Not Treated with Study Drug|0|||
27516381|NCT00282308|80084945|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
27516382|NCT00282308|80084946|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
27516383|NCT00282308|80084947|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
27617580|NCT02886728|80444583|FG000|Overall Study|Death|3|||
27617581|NCT02886728|80444584|FG001|Overall Study|Death|1|||
27617582|NCT02886728|80444585|FG002|Overall Study|Death|0|||
27907508|NCT02098395|81500363|FG002|Overall Study|Lost to Follow-up|0|||
27907509|NCT02098395|81500364|FG003|Overall Study|Lost to Follow-up|3|||
27907510|NCT02098395|81500361|FG000|Overall Study|Unclassified|0|||
27907511|NCT02098395|81500362|FG001|Overall Study|Unclassified|0|||
27516384|NCT00282308|80084945|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
27907512|NCT02098395|81500363|FG002|Overall Study|Unclassified|3|||
27907513|NCT02098395|81500364|FG003|Overall Study|Unclassified|2|||
27617583|NCT02886728|80444586|FG003|Overall Study|Death|0|||
27617584|NCT02886728|80444583|FG000|Overall Study|Protocol Violation|0|||
27907514|NCT01859949|81500365|FG000|Overall Study|Family Matters|0|||
27907515|NCT01859949|81500366|FG001|Overall Study|Family Matters|1|||
27617585|NCT02886728|80444584|FG001|Overall Study|Protocol Violation|0|||
27729337|NCT03049449|80838226|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
27907516|NCT01859949|81500365|FG000|Overall Study|Physician Decision|2|||
27729338|NCT03049449|80838227|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
27729339|NCT03049449|80838228|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
27729340|NCT03049449|80838229|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
27729341|NCT03049449|80838230|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
27729342|NCT03049449|80838231|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
27729343|NCT03049449|80838232|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
27729344|NCT03049449|80838233|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
27729345|NCT03049449|80838224|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729346|NCT03049449|80838225|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729347|NCT03049449|80838226|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729348|NCT03049449|80838227|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729349|NCT03049449|80838228|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729350|NCT03049449|80838229|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729351|NCT03049449|80838230|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729352|NCT03049449|80838231|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
27729353|NCT03049449|80838232|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
27729354|NCT03049449|80838233|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
27729355|NCT01552681|80838239|FG000|Overall Study|Withdrawal by Subject|4|||
27729356|NCT01552681|80838240|FG001|Overall Study|Withdrawal by Subject|0|||
27729357|NCT01552681|80838239|FG000|Overall Study|Physician Decision|1|||
27729358|NCT01552681|80838240|FG001|Overall Study|Physician Decision|0|||
27729359|NCT01552681|80838239|FG000|Overall Study|Subject moved away|0|||
27729360|NCT01552681|80838240|FG001|Overall Study|Subject moved away|1|||
27729361|NCT01551693|80838248|FG000|Overall Study|Disease Progression|1|||
27729362|NCT01551693|80838249|FG001|Overall Study|Disease Progression|0|||
27729363|NCT01551693|80838248|FG000|Overall Study|Adverse Event|0|||
27729364|NCT01551693|80838249|FG001|Overall Study|Adverse Event|1|||
27729365|NCT01551693|80838248|FG000|Overall Study|Withdrawal by Subject|0|||
27729366|NCT01551693|80838249|FG001|Overall Study|Withdrawal by Subject|1|||
27729367|NCT02965378|80838250|FG000|Overall Study|Progression|16|||
27729368|NCT02965378|80838251|FG001|Overall Study|Progression|4|||
27729369|NCT02965378|80838250|FG000|Overall Study|Adverse Event|5|||
27729370|NCT02965378|80838251|FG001|Overall Study|Adverse Event|2|||
27729371|NCT02965378|80838250|FG000|Overall Study|Death|2|||
27729372|NCT02965378|80838251|FG001|Overall Study|Death|0|||
27729373|NCT02965378|80838250|FG000|Overall Study|Refusal|2|||
27729374|NCT02965378|80838251|FG001|Overall Study|Refusal|1|||
27853623|NCT03340064|81295084|FG001|Second Period|Lack of Efficacy|0|||
27853624|NCT03340064|81295083|FG000|Second Period|Physician Decision|3|||
27853625|NCT03340064|81295084|FG001|Second Period|Physician Decision|0|||
27853626|NCT03340064|81295083|FG000|Second Period|Withdrawal by Subject|2|||
27853627|NCT03340064|81295084|FG001|Second Period|Withdrawal by Subject|1|||
27853628|NCT03340064|81295083|FG000|Second Period|Approved Drug Available For Indication|1|||
27853629|NCT03340064|81295084|FG001|Second Period|Approved Drug Available For Indication|0|||
27853630|NCT03340064|81295083|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
27853631|NCT03340064|81295084|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
27853632|NCT02722148|81295085|FG000|Overall Study|Lost to Follow-up|2|||
27853633|NCT02722148|81295085|FG000|Overall Study|Non compliant with treatment regimen|3|||
27853634|NCT00704730|81295088|FG000|Overall Study|Adverse Event|35|||
27853635|NCT00704730|81295089|FG001|Overall Study|Adverse Event|9|||
27853636|NCT00704730|81295088|FG000|Overall Study|Death|11|||
27516385|NCT00282308|80084946|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
27516386|NCT00282308|80084947|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
27516387|NCT00282308|80084945|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
27516388|NCT00282308|80084946|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
27516389|NCT00282308|80084947|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
27516390|NCT00282308|80084945|FG000|Safety Follow-up Period|Adverse Event|0|||
27516391|NCT00282308|80084946|FG001|Safety Follow-up Period|Adverse Event|0|||
27516392|NCT00282308|80084947|FG002|Safety Follow-up Period|Adverse Event|1|||
27516393|NCT00282308|80084945|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
27516394|NCT00282308|80084946|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
27516395|NCT00282308|80084947|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
27516396|NCT00282308|80084945|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
27516397|NCT00282308|80084946|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
27516398|NCT00282308|80084947|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
27516399|NCT00282308|80084945|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
27516400|NCT00282308|80084946|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
27516401|NCT00282308|80084947|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
27516402|NCT01761240|80084948|FG000|Overall Study|Progressive disease:radiology assessment|3|||
27516403|NCT01761240|80084949|FG001|Overall Study|Progressive disease:radiology assessment|3|||
27516404|NCT01761240|80084950|FG002|Overall Study|Progressive disease:radiology assessment|0|||
27516405|NCT01761240|80084951|FG003|Overall Study|Progressive disease:radiology assessment|0|||
27516406|NCT01761240|80084952|FG004|Overall Study|Progressive disease:radiology assessment|0|||
27516407|NCT01761240|80084948|FG000|Overall Study|Progressive disease:clinical assessment|0|||
27617586|NCT02886728|80444585|FG002|Overall Study|Protocol Violation|0|||
27729375|NCT02965378|80838250|FG000|Overall Study|Not protocol specified|0|||
27729376|NCT02965378|80838251|FG001|Overall Study|Not protocol specified|2|||
27729377|NCT01552902|80838257|FG000|Overall Study|Adverse Event|1|||
27729378|NCT01552902|80838258|FG001|Overall Study|Adverse Event|15|||
27907517|NCT01859949|81500366|FG001|Overall Study|Physician Decision|4|||
27907518|NCT01859949|81500365|FG000|Overall Study|Withdrawal by Subject|11|||
27907519|NCT01859949|81500366|FG001|Overall Study|Withdrawal by Subject|10|||
27907520|NCT01859949|81500365|FG000|Overall Study|Protocol Violation|1|||
27907521|NCT01859949|81500366|FG001|Overall Study|Protocol Violation|1|||
27907522|NCT01859949|81500365|FG000|Overall Study|Adverse Event|0|||
27907523|NCT01859949|81500366|FG001|Overall Study|Adverse Event|1|||
27907524|NCT04547140|81500378|FG000|Overall Study|Adverse Event|0|||
27907525|NCT04547140|81500379|FG001|Overall Study|Adverse Event|1|||
27907526|NCT04547140|81500378|FG000|Overall Study|Withdrawal by Subject|0|||
27907527|NCT04547140|81500379|FG001|Overall Study|Withdrawal by Subject|1|||
27907528|NCT04547140|81500378|FG000|Overall Study|Lost to Follow-up|3|||
27907529|NCT04547140|81500379|FG001|Overall Study|Lost to Follow-up|1|||
27907530|NCT04547140|81500378|FG000|Overall Study|Death|2|||
27907531|NCT04547140|81500379|FG001|Overall Study|Death|1|||
27907532|NCT04547140|81500378|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
27907533|NCT04547140|81500379|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
27907534|NCT04547140|81500378|FG000|Overall Study|Pregnancy|1|||
27907535|NCT04547140|81500379|FG001|Overall Study|Pregnancy|0|||
27907536|NCT04547140|81500378|FG000|Overall Study|Reason Not Specified|4|||
27907537|NCT04547140|81500379|FG001|Overall Study|Reason Not Specified|1|||
27907538|NCT01904032|81500380|FG000|Overall Study|Adverse Event|3|||
27907539|NCT01904032|81500381|FG001|Overall Study|Adverse Event|1|||
27907540|NCT01904032|81500380|FG000|Overall Study|Lost to Follow-up|4|||
27907541|NCT01904032|81500381|FG001|Overall Study|Lost to Follow-up|2|||
27907542|NCT00314808|81500382|FG000|Overall Study|Disease Progression without AE|4|||
27907543|NCT00314808|81500382|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
27907544|NCT02499263|81500383|FG000|Overall Study|Lost to Follow-up|9|||
27907545|NCT02499263|81500383|FG000|Overall Study|Participant's withdrawal of consent|4|||
27907546|NCT02499263|81500383|FG000|Overall Study|Lack of Efficacy|22|||
27907547|NCT02499263|81500383|FG000|Overall Study|investigator's judgment|12|||
27729379|NCT01552902|80838259|FG002|Overall Study|Adverse Event|14|||
27729380|NCT01552902|80838257|FG000|Overall Study|Protocol Violation|3|||
27907548|NCT02499263|81500383|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
27907549|NCT02499263|81500383|FG000|Overall Study|Participant's decision|3|||
27907550|NCT02499263|81500383|FG000|Overall Study|Pregnancy|1|||
27907551|NCT02144077|81500384|FG000|Overall Study|Withdrawal by Subject|3|||
27907552|NCT02144077|81500385|FG001|Overall Study|Withdrawal by Subject|3|||
27907553|NCT02144077|81500384|FG000|Overall Study|Adverse Event|2|||
27729381|NCT01552902|80838258|FG001|Overall Study|Protocol Violation|3|||
27729382|NCT01552902|80838259|FG002|Overall Study|Protocol Violation|3|||
27729383|NCT01552902|80838257|FG000|Overall Study|Lack of Efficacy|4|||
27729384|NCT01552902|80838258|FG001|Overall Study|Lack of Efficacy|3|||
27729385|NCT01552902|80838259|FG002|Overall Study|Lack of Efficacy|1|||
27729386|NCT01552902|80838257|FG000|Overall Study|Withdrawal by Subject|1|||
27729387|NCT01552902|80838258|FG001|Overall Study|Withdrawal by Subject|9|||
27907554|NCT02144077|81500385|FG001|Overall Study|Adverse Event|3|||
27907555|NCT02144077|81500384|FG000|Overall Study|Lost to Follow-up|2|||
27907556|NCT02144077|81500385|FG001|Overall Study|Lost to Follow-up|2|||
27907557|NCT02144077|81500384|FG000|Overall Study|Protocol Violation|1|||
27907558|NCT02144077|81500385|FG001|Overall Study|Protocol Violation|2|||
27729388|NCT01552902|80838259|FG002|Overall Study|Withdrawal by Subject|6|||
27729389|NCT01552902|80838257|FG000|Overall Study|Lost to Follow-up|1|||
27907559|NCT02144077|81500384|FG000|Overall Study|Death|0|||
27907560|NCT02144077|81500385|FG001|Overall Study|Death|1|||
27907561|NCT02144077|81500384|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
27907562|NCT02144077|81500385|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
27907563|NCT03060291|81500386|FG000|3-month Follow-up|Declined to respond|8|||
27907564|NCT03060291|81500387|FG001|3-month Follow-up|Declined to respond|10|||
27907565|NCT03060291|81500388|FG002|3-month Follow-up|Declined to respond|2|||
27729390|NCT01552902|80838258|FG001|Overall Study|Lost to Follow-up|3|||
27907566|NCT03060291|81500386|FG000|6-month Follow-up|Declined to respond|7|||
27907567|NCT03060291|81500387|FG001|6-month Follow-up|Declined to respond|13|||
27516408|NCT01761240|80084949|FG001|Overall Study|Progressive disease:clinical assessment|0|||
27516409|NCT01761240|80084950|FG002|Overall Study|Progressive disease:clinical assessment|3|||
27516410|NCT01761240|80084951|FG003|Overall Study|Progressive disease:clinical assessment|1|||
27516411|NCT01761240|80084952|FG004|Overall Study|Progressive disease:clinical assessment|0|||
27516412|NCT01761240|80084948|FG000|Overall Study|Withdrawal by Subject|0|||
27516413|NCT01761240|80084949|FG001|Overall Study|Withdrawal by Subject|0|||
27516414|NCT01761240|80084950|FG002|Overall Study|Withdrawal by Subject|0|||
27516415|NCT01761240|80084951|FG003|Overall Study|Withdrawal by Subject|3|||
27516416|NCT01761240|80084952|FG004|Overall Study|Withdrawal by Subject|1|||
27516417|NCT01761240|80084948|FG000|Overall Study|Adverse Event|0|||
27516418|NCT01761240|80084949|FG001|Overall Study|Adverse Event|0|||
27516419|NCT01761240|80084950|FG002|Overall Study|Adverse Event|0|||
27516420|NCT01761240|80084951|FG003|Overall Study|Adverse Event|1|||
27516421|NCT01761240|80084952|FG004|Overall Study|Adverse Event|6|||
27516422|NCT01761240|80084948|FG000|Overall Study|Death|0|||
27516423|NCT01761240|80084949|FG001|Overall Study|Death|1|||
27516424|NCT01761240|80084950|FG002|Overall Study|Death|1|||
27516425|NCT01761240|80084951|FG003|Overall Study|Death|2|||
27516426|NCT01761240|80084952|FG004|Overall Study|Death|1|||
27516427|NCT01761240|80084948|FG000|Overall Study|Non-compliance|0|||
27516428|NCT01761240|80084949|FG001|Overall Study|Non-compliance|0|||
27516429|NCT01761240|80084950|FG002|Overall Study|Non-compliance|1|||
27907568|NCT03060291|81500388|FG002|6-month Follow-up|Declined to respond|4|||
27907569|NCT03060291|81500386|FG000|12-month Follow-up|Declined to respond|7|||
27907570|NCT03060291|81500387|FG001|12-month Follow-up|Declined to respond|16|||
27907571|NCT03060291|81500388|FG002|12-month Follow-up|Declined to respond|6|||
27907572|NCT03117361|81500389|FG000|Overall Study|Progressive disease|5|||
27907573|NCT03117361|81500389|FG000|Overall Study|Death|1|||
27907574|NCT03117361|81500389|FG000|Overall Study|Physician Decision|2|||
27907575|NCT03117361|81500389|FG000|Overall Study|On study treatment at the end of study|1|||
27907576|NCT03117361|81500389|FG000|Overall Study|Treatment-related adverse event|1|||
27907577|NCT00524771|81500390|FG000|Overall Study|Protocol Violation|220|||
27907578|NCT00524771|81500391|FG001|Overall Study|Protocol Violation|585|||
27907579|NCT03026283|81500395|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
27907580|NCT03026283|81500396|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
27907581|NCT03026283|81500397|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
27907582|NCT03026283|81500398|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
27907583|NCT03026283|81500399|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
27516430|NCT01761240|80084951|FG003|Overall Study|Non-compliance|0|||
27516431|NCT01761240|80084952|FG004|Overall Study|Non-compliance|0|||
27907584|NCT03026283|81500400|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
27907585|NCT03026283|81500401|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
27907586|NCT03026283|81500402|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
27907587|NCT03026283|81500395|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
27907588|NCT03026283|81500396|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
27907589|NCT03026283|81500397|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
27907590|NCT03026283|81500398|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
27907591|NCT03026283|81500399|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
27907592|NCT03026283|81500400|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
27907593|NCT03026283|81500401|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
27907594|NCT03026283|81500402|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
27907595|NCT03026283|81500395|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907596|NCT03026283|81500396|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
27907597|NCT03026283|81500397|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907598|NCT03026283|81500398|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907599|NCT03026283|81500399|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907600|NCT03026283|81500400|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907601|NCT03026283|81500401|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907602|NCT03026283|81500402|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
27907603|NCT03026283|81500395|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27516432|NCT00422513|80084953|FG000|Overall Study|Lack of Efficacy|4|||
27516433|NCT00422513|80084954|FG001|Overall Study|Lack of Efficacy|5|||
27729391|NCT01552902|80838259|FG002|Overall Study|Lost to Follow-up|6|||
27907604|NCT03026283|81500396|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27907605|NCT03026283|81500397|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
27907606|NCT03026283|81500398|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27907607|NCT03026283|81500399|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27516434|NCT00422513|80084953|FG000|Overall Study|Protocol Violation|23|||
27516435|NCT00422513|80084954|FG001|Overall Study|Protocol Violation|7|||
27516436|NCT00422513|80084953|FG000|Overall Study|Refused Treatment|4|||
27516437|NCT00422513|80084954|FG001|Overall Study|Refused Treatment|2|||
27516438|NCT00422513|80084953|FG000|Overall Study|Withdrawal by Subject|2|||
27729392|NCT01552902|80838257|FG000|Overall Study|Other|3|||
27516439|NCT00422513|80084954|FG001|Overall Study|Withdrawal by Subject|1|||
27516440|NCT00422513|80084953|FG000|Overall Study|early termination of the study|67|||
27516441|NCT00422513|80084954|FG001|Overall Study|early termination of the study|80|||
27516442|NCT00422513|80084953|FG000|Overall Study|Adverse Event|4|||
27516443|NCT00422513|80084954|FG001|Overall Study|Adverse Event|4|||
27516444|NCT00422513|80084953|FG000|Overall Study|Death|3|||
27516445|NCT00422513|80084954|FG001|Overall Study|Death|7|||
27516446|NCT01090323|80084955|FG000|Overall Study|Adverse Event|12|||
27516447|NCT01090323|80084956|FG001|Overall Study|Adverse Event|2|||
27516448|NCT01090323|80084955|FG000|Overall Study|Abnormal Lab Values|3|||
27516449|NCT01090323|80084956|FG001|Overall Study|Abnormal Lab Values|1|||
27516450|NCT01090323|80084955|FG000|Overall Study|Abnormal Test Procedure Results|2|||
27516451|NCT01090323|80084956|FG001|Overall Study|Abnormal Test Procedure Results|0|||
27516452|NCT01090323|80084955|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27516453|NCT01090323|80084956|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27516454|NCT01090323|80084955|FG000|Overall Study|Condition no longer requires drug|5|||
27516455|NCT01090323|80084956|FG001|Overall Study|Condition no longer requires drug|4|||
27516456|NCT01090323|80084955|FG000|Overall Study|Protocol Violation|2|||
27516457|NCT01090323|80084956|FG001|Overall Study|Protocol Violation|1|||
27516458|NCT01090323|80084955|FG000|Overall Study|Withdrew consent|33|||
27516459|NCT01090323|80084956|FG001|Overall Study|Withdrew consent|11|||
27516460|NCT01090323|80084955|FG000|Overall Study|Lost to Follow-up|11|||
27516461|NCT01090323|80084956|FG001|Overall Study|Lost to Follow-up|6|||
27516462|NCT01090323|80084955|FG000|Overall Study|Administrative problems|6|||
27516463|NCT01090323|80084956|FG001|Overall Study|Administrative problems|4|||
27516464|NCT01090323|80084955|FG000|Overall Study|Death|1|||
27516465|NCT01090323|80084956|FG001|Overall Study|Death|2|||
27516466|NCT01090323|80084955|FG000|Overall Study|Stopped end of core|7|||
27516467|NCT01090323|80084956|FG001|Overall Study|Stopped end of core|0|||
27516468|NCT01090323|80084955|FG000|Overall Study|Stopped end of extension 1#|3|||
27516469|NCT01090323|80084956|FG001|Overall Study|Stopped end of extension 1#|1|||
27516470|NCT00475306|80084959|FG000|Overall Study|Protocol Violation|1|||
27516471|NCT00475306|80084960|FG001|Overall Study|Protocol Violation|1|||
27516472|NCT00475306|80084961|FG002|Overall Study|Protocol Violation|0|||
27516473|NCT00475306|80084962|FG003|Overall Study|Protocol Violation|1|||
27516474|NCT01282463|80084963|FG000|Overall Study|Lost to Follow-up|1|||
27516475|NCT01282463|80084964|FG001|Overall Study|Lost to Follow-up|0|||
27516476|NCT01282463|80084965|FG002|Overall Study|Lost to Follow-up|0|||
27516477|NCT01282463|80084963|FG000|Overall Study|Withdrawal by Subject|6|||
27516478|NCT01282463|80084964|FG001|Overall Study|Withdrawal by Subject|2|||
27516479|NCT01282463|80084965|FG002|Overall Study|Withdrawal by Subject|3|||
27516480|NCT01282463|80084963|FG000|Overall Study|"Never Treated Death"|0|||
27516481|NCT01282463|80084964|FG001|Overall Study|"Never Treated Death"|1|||
27516482|NCT01282463|80084965|FG002|Overall Study|"Never Treated Death"|0|||
27516483|NCT01282463|80084963|FG000|Overall Study|"Never Treated PD"|0|||
27516484|NCT01282463|80084964|FG001|Overall Study|"Never Treated PD"|1|||
27516485|NCT01282463|80084965|FG002|Overall Study|"Never Treated PD"|0|||
27516486|NCT01282463|80084963|FG000|Overall Study|Protocol Violation|0|||
27516487|NCT01282463|80084964|FG001|Overall Study|Protocol Violation|0|||
27516488|NCT01282463|80084965|FG002|Overall Study|Protocol Violation|1|||
27516489|NCT01282463|80084963|FG000|Overall Study|Physician Decision|1|||
27516490|NCT01282463|80084964|FG001|Overall Study|Physician Decision|0|||
27516491|NCT01282463|80084965|FG002|Overall Study|Physician Decision|0|||
27516492|NCT00336856|80084966|FG000|Overall Study|Withdrawal by Subject|3|||
27516493|NCT00336856|80084966|FG000|Overall Study|Found ineligible at time of analysis|1|||
27516494|NCT02039843|80084967|FG000|Randomization and Observation Period|Adverse Event|2|||
27516495|NCT02039843|80084968|FG001|Randomization and Observation Period|Adverse Event|0|||
27516496|NCT02039843|80084967|FG000|Randomization and Observation Period|Death|1|||
27516497|NCT02039843|80084968|FG001|Randomization and Observation Period|Death|0|||
27516498|NCT02039843|80084967|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
27516499|NCT02039843|80084968|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
27516500|NCT02039843|80084967|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
27516501|NCT02039843|80084968|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
27516502|NCT02039843|80084967|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
27516503|NCT02039843|80084968|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
27729393|NCT01552902|80838258|FG001|Overall Study|Other|4|||
27516504|NCT02039843|80084967|FG000|Pairing With a Study Dog|Death|1|||
27516505|NCT02039843|80084968|FG001|Pairing With a Study Dog|Death|0|||
27516506|NCT02039843|80084967|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
27516507|NCT02039843|80084968|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
27516508|NCT02039843|80084967|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
27516509|NCT02039843|80084968|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
27516510|NCT02039843|80084967|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
27516511|NCT02039843|80084968|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
27617587|NCT02886728|80444586|FG003|Overall Study|Protocol Violation|4|||
27516512|NCT02500056|80084975|FG000|Overall Study|Lost to Follow-up|3|||
27516513|NCT02500056|80084976|FG001|Overall Study|Lost to Follow-up|7|||
27516514|NCT02500056|80084975|FG000|Overall Study|Recurrence|1|||
27516515|NCT02500056|80084976|FG001|Overall Study|Recurrence|0|||
27617588|NCT02886728|80444583|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27617589|NCT02886728|80444584|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27617590|NCT02886728|80444585|FG002|Overall Study|Non-Compliance with Study Drug|1|||
27617591|NCT02886728|80444586|FG003|Overall Study|Non-Compliance with Study Drug|0|||
27617592|NCT02886728|80444583|FG000|Overall Study|Pregnancy|0|||
27617593|NCT02886728|80444584|FG001|Overall Study|Pregnancy|0|||
27617594|NCT02886728|80444585|FG002|Overall Study|Pregnancy|1|||
27617595|NCT02886728|80444586|FG003|Overall Study|Pregnancy|0|||
27617596|NCT02886728|80444583|FG000|Overall Study|Randomized but Not Dosed|1|||
27617597|NCT02886728|80444584|FG001|Overall Study|Randomized but Not Dosed|0|||
27617598|NCT02886728|80444585|FG002|Overall Study|Randomized but Not Dosed|0|||
27617599|NCT02886728|80444586|FG003|Overall Study|Randomized but Not Dosed|2|||
27617600|NCT00873093|80444587|FG000|Overall Study|Adverse Event|0|||
27617601|NCT00873093|80444588|FG001|Overall Study|Adverse Event|2|||
27907608|NCT03026283|81500400|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27516516|NCT02500056|80084975|FG000|Overall Study|Death|3|||
27516517|NCT02500056|80084976|FG001|Overall Study|Death|1|||
27516518|NCT00243841|80084977|FG000|Overall Study|Physician Decision|0|||
27516519|NCT00243841|80084978|FG001|Overall Study|Physician Decision|0|||
27516520|NCT00243841|80084979|FG002|Overall Study|Physician Decision|1|||
27516521|NCT00243841|80084980|FG003|Overall Study|Physician Decision|0|||
27516522|NCT00243841|80084981|FG004|Overall Study|Physician Decision|0|||
27516523|NCT00243841|80084982|FG005|Overall Study|Physician Decision|2|||
27516524|NCT04889118|80084983|FG000|Overall Study|Death|33|||
27516525|NCT04889118|80084984|FG001|Overall Study|Death|37|||
27516526|NCT04889118|80084983|FG000|Overall Study|Ongoing in Study|31|||
27516527|NCT04889118|80084984|FG001|Overall Study|Ongoing in Study|30|||
27516528|NCT00743106|80084985|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
27516529|NCT00743106|80084986|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
27516530|NCT01964755|80084991|FG000|Overall Study|Death|2|||
27516531|NCT03753789|80084992|FG000|Overall Study|Withdrawal by Subject|2|||
27516532|NCT00029146|80084993|FG000|Overall Study|Lost to Follow-up|2|||
27516533|NCT00029146|80084994|FG001|Overall Study|Lost to Follow-up|1|||
27516534|NCT04881942|80084997|FG000|Overall Study|Adverse Event|0|||
27516535|NCT04881942|80084998|FG001|Overall Study|Adverse Event|0|||
27516536|NCT04881942|80084999|FG002|Overall Study|Adverse Event|0|||
27516537|NCT04881942|80085000|FG003|Overall Study|Adverse Event|0|||
27516538|NCT04881942|80085001|FG004|Overall Study|Adverse Event|1|||
27516539|NCT04881942|80084997|FG000|Overall Study|Alternates|0|||
27516540|NCT04881942|80084998|FG001|Overall Study|Alternates|0|||
27516541|NCT04881942|80084999|FG002|Overall Study|Alternates|0|||
27516542|NCT04881942|80085000|FG003|Overall Study|Alternates|0|||
27516543|NCT04881942|80085001|FG004|Overall Study|Alternates|2|||
27516544|NCT00573144|80085005|FG000|Overall Study|Withdrawal by Subject|2|||
27516545|NCT00573144|80085006|FG001|Overall Study|Withdrawal by Subject|3|||
27516546|NCT00552188|80085007|FG000|Overall Study|Adverse Event|0|||
27516547|NCT00552188|80085008|FG001|Overall Study|Adverse Event|2|||
27516548|NCT00552188|80085007|FG000|Overall Study|Lost to Follow-up|2|||
27516549|NCT00552188|80085008|FG001|Overall Study|Lost to Follow-up|1|||
27516550|NCT00552188|80085007|FG000|Overall Study|Withdrawal of consent|0|||
27516551|NCT00552188|80085008|FG001|Overall Study|Withdrawal of consent|1|||
27516552|NCT00552188|80085007|FG000|Overall Study|Subject returned to home country|0|||
27516553|NCT00552188|80085008|FG001|Overall Study|Subject returned to home country|1|||
27516554|NCT00375609|80085009|FG000|Overall Study|Did not receive treatment|1|||
27516555|NCT00375609|80085010|FG001|Overall Study|Did not receive treatment|0|||
27516556|NCT00375609|80085011|FG002|Overall Study|Did not receive treatment|0|||
27516557|NCT00375609|80085009|FG000|Overall Study|Adverse Event|0|||
27516558|NCT00375609|80085010|FG001|Overall Study|Adverse Event|3|||
27516559|NCT00375609|80085011|FG002|Overall Study|Adverse Event|0|||
27516560|NCT00375609|80085009|FG000|Overall Study|Lost to Follow-up|1|||
27516561|NCT00375609|80085010|FG001|Overall Study|Lost to Follow-up|0|||
27516562|NCT00375609|80085011|FG002|Overall Study|Lost to Follow-up|0|||
27516563|NCT00375609|80085009|FG000|Overall Study|Physician Decision|0|||
27516564|NCT00375609|80085010|FG001|Overall Study|Physician Decision|0|||
27516565|NCT00375609|80085011|FG002|Overall Study|Physician Decision|1|||
27516566|NCT00375609|80085009|FG000|Overall Study|Withdrawal by Subject|1|||
27516567|NCT00375609|80085010|FG001|Overall Study|Withdrawal by Subject|4|||
27516568|NCT00375609|80085011|FG002|Overall Study|Withdrawal by Subject|0|||
27516569|NCT00375609|80085009|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
27516570|NCT00375609|80085010|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
27617602|NCT00873093|80444589|FG002|Overall Study|Adverse Event|0|||
27516571|NCT00375609|80085011|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
27617603|NCT00873093|80444590|FG003|Overall Study|Adverse Event|0|||
27617604|NCT00873093|80444591|FG004|Overall Study|Adverse Event|0|||
27617605|NCT00873093|80444587|FG000|Overall Study|Death|0|||
27617606|NCT00873093|80444588|FG001|Overall Study|Death|3|||
27617607|NCT00873093|80444589|FG002|Overall Study|Death|2|||
27617608|NCT00873093|80444590|FG003|Overall Study|Death|0|||
27617609|NCT00873093|80444591|FG004|Overall Study|Death|0|||
27617610|NCT00873093|80444587|FG000|Overall Study|Physician Decision|0|||
27617611|NCT00873093|80444588|FG001|Overall Study|Physician Decision|17|||
27617612|NCT00873093|80444589|FG002|Overall Study|Physician Decision|10|||
27617613|NCT00873093|80444590|FG003|Overall Study|Physician Decision|10|||
27617614|NCT00873093|80444591|FG004|Overall Study|Physician Decision|2|||
27617615|NCT00873093|80444587|FG000|Overall Study|Withdrawal by Subject|1|||
27617616|NCT00873093|80444588|FG001|Overall Study|Withdrawal by Subject|4|||
27617617|NCT00873093|80444589|FG002|Overall Study|Withdrawal by Subject|4|||
27617618|NCT00873093|80444590|FG003|Overall Study|Withdrawal by Subject|0|||
27617619|NCT00873093|80444591|FG004|Overall Study|Withdrawal by Subject|0|||
27617620|NCT00873093|80444587|FG000|Overall Study|Ineligible|0|||
27617621|NCT00873093|80444588|FG001|Overall Study|Ineligible|1|||
27617622|NCT00873093|80444589|FG002|Overall Study|Ineligible|0|||
27617623|NCT00873093|80444590|FG003|Overall Study|Ineligible|1|||
27617624|NCT00873093|80444591|FG004|Overall Study|Ineligible|0|||
27617625|NCT02206152|80444593|FG000|Pre-Randomization|Withdrawal by Subject|2|||
27617626|NCT01708187|80444594|FG000|Overall Study|Lost to Follow-up|0|||
27617627|NCT01708187|80444595|FG001|Overall Study|Lost to Follow-up|1|||
27617628|NCT00467142|80444598|FG000|Overall Study|Withdrawal by Subject|1|||
27617629|NCT00467142|80444598|FG000|Overall Study|Adverse Event|1|||
27617630|NCT00467142|80444598|FG000|Overall Study|Protocol Violation|1|||
27617631|NCT02234310|80444599|FG000|Overall Study|Physician Decision|1|||
27617632|NCT02234310|80444599|FG000|Overall Study|Adverse Event|1|||
27617633|NCT02234310|80444599|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
27617634|NCT02234310|80444599|FG000|Overall Study|Withdrawal by Subject|2|||
27617635|NCT00163215|80444602|FG000|Overall Study|Lack of Efficacy|3|||
27617636|NCT00163215|80444602|FG000|Overall Study|Withdrawal by Subject|5|||
27617637|NCT00163215|80444602|FG000|Overall Study|Other|7|||
27617638|NCT04496167|80444604|FG000|Overall Study|Adverse Event|6|||
27617639|NCT04496167|80444605|FG001|Overall Study|Adverse Event|2|||
27617640|NCT04496167|80444604|FG000|Overall Study|Withdrawal by Subject|7|||
27617641|NCT04496167|80444605|FG001|Overall Study|Withdrawal by Subject|6|||
27617642|NCT04496167|80444604|FG000|Overall Study|Lost to Follow-up|3|||
27617643|NCT04496167|80444605|FG001|Overall Study|Lost to Follow-up|5|||
27617644|NCT04496167|80444604|FG000|Overall Study|Not Treated|1|||
27617645|NCT04496167|80444605|FG001|Overall Study|Not Treated|2|||
27617646|NCT04496167|80444604|FG000|Overall Study|Other Than Specified|1|||
27617647|NCT04496167|80444605|FG001|Overall Study|Other Than Specified|1|||
27617648|NCT00798174|80444606|FG000|Overall Study|inability to implant azygos coil|3|||
27617649|NCT00798174|80444607|FG001|Overall Study|inability to implant azygos coil|3|||
27617650|NCT00798174|80444606|FG000|Overall Study|Inability to sedate for DFT testing|1|||
27617651|NCT00798174|80444607|FG001|Overall Study|Inability to sedate for DFT testing|0|||
27617652|NCT00742885|80444612|FG000|Overall Study|Lost to Follow-up|1|||
27617653|NCT00742885|80444613|FG001|Overall Study|Lost to Follow-up|0|||
27617654|NCT00742274|80444614|FG000|Overall Study|Death|1|||
27617655|NCT00742274|80444615|FG001|Overall Study|Death|0|||
27617656|NCT00742274|80444614|FG000|Overall Study|Withdrawal by Subject|1|||
27617657|NCT00742274|80444615|FG001|Overall Study|Withdrawal by Subject|2|||
27617658|NCT00742274|80444614|FG000|Overall Study|Removed for medical reasons|1|||
27617659|NCT00742274|80444615|FG001|Overall Study|Removed for medical reasons|1|||
27617660|NCT00531011|80444616|FG000|Overall Study|Withdrawal by Subject|2|||
27617661|NCT00531011|80444617|FG001|Overall Study|Withdrawal by Subject|4|||
27617662|NCT00531011|80444616|FG000|Overall Study|Death|1|||
27617663|NCT00531011|80444617|FG001|Overall Study|Death|0|||
27617664|NCT00531011|80444616|FG000|Overall Study|Lost to Follow-up|1|||
27617665|NCT00531011|80444617|FG001|Overall Study|Lost to Follow-up|0|||
27617666|NCT00531011|80444616|FG000|Overall Study|Physician Decision|0|||
27617667|NCT00531011|80444617|FG001|Overall Study|Physician Decision|3|||
27617668|NCT02909101|80444620|FG000|Overall Study|Lost to Follow-up|1|||
27617669|NCT02909101|80444621|FG001|Overall Study|Lost to Follow-up|1|||
27617670|NCT01158378|80444628|FG000|Overall Study|Death|4|||
27617671|NCT01158378|80444629|FG001|Overall Study|Death|5|||
27617672|NCT01158378|80444628|FG000|Overall Study|Lost to Follow-up|2|||
27907609|NCT03026283|81500401|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27617673|NCT01158378|80444629|FG001|Overall Study|Lost to Follow-up|4|||
27617674|NCT01158378|80444628|FG000|Overall Study|Withdrawal by Subject|4|||
27617675|NCT01158378|80444629|FG001|Overall Study|Withdrawal by Subject|0|||
27617676|NCT01994720|80444633|FG000|Overall Study|Withdrawal by Subject|46|||
27617677|NCT01994720|80444634|FG001|Overall Study|Withdrawal by Subject|56|||
27617678|NCT00439179|80444635|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
27617679|NCT00439179|80444636|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
27617680|NCT00439179|80444637|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
27617681|NCT00439179|80444638|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
27617682|NCT02084082|80444639|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
27617683|NCT02084082|80444640|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
27729394|NCT01552902|80838259|FG002|Overall Study|Other|3|||
27729395|NCT01587989|80838262|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
27729396|NCT01587989|80838263|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
27907610|NCT03026283|81500402|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
27516572|NCT00139477|80088217|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
27516573|NCT00139477|80088218|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
27516574|NCT00139477|80088217|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
27516575|NCT00139477|80088218|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
27516576|NCT00139477|80088217|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
27516577|NCT00139477|80088218|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
27516578|NCT00139477|80088217|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
27516579|NCT00139477|80088218|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
27516580|NCT00139477|80088217|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
27516581|NCT00139477|80088218|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
27516582|NCT00139477|80088217|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
27516583|NCT00139477|80088218|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
27516584|NCT00139477|80088217|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
27516585|NCT00139477|80088218|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
27516586|NCT01767142|80088219|FG000|Overall Study|Lost to Follow-up|3|||
27516587|NCT02365480|80088224|FG000|Overall Study|Withdrawal by Subject|2|||
27516588|NCT02365480|80088225|FG001|Overall Study|Withdrawal by Subject|0|||
27516589|NCT01454778|80088230|FG000|Overall Study|Lost to Follow-up|2|||
27516590|NCT01454778|80088230|FG000|Overall Study|Death|1|||
27516591|NCT01057589|80088231|FG000|Overall Study|Disease Progression|35|||
27516592|NCT01057589|80088231|FG000|Overall Study|Adverse Event|10|||
27516593|NCT01057589|80088231|FG000|Overall Study|Physician Decision|8|||
27516594|NCT01057589|80088231|FG000|Overall Study|Withdrawal by Subject|3|||
27516595|NCT01057589|80088231|FG000|Overall Study|Sponsor Decision|1|||
27516596|NCT01057589|80088231|FG000|Overall Study|Death|8|||
27729397|NCT01587989|80838264|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
27729398|NCT01587989|80838262|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
27729399|NCT01587989|80838263|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
27729400|NCT01587989|80838264|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
27729401|NCT01587989|80838262|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
27729402|NCT01587989|80838263|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
27729403|NCT01587989|80838264|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
27729404|NCT01587989|80838262|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
27729405|NCT01587989|80838263|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
27729406|NCT01587989|80838264|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
27729407|NCT01587989|80838262|FG000|Randomized Study Treatment|Screening failure|0|||
27853637|NCT00704730|81295089|FG001|Overall Study|Death|5|||
27853638|NCT00704730|81295088|FG000|Overall Study|Physician Decision|2|||
27853639|NCT00704730|81295089|FG001|Overall Study|Physician Decision|0|||
27853640|NCT00704730|81295088|FG000|Overall Study|Did not receive drug|5|||
27907611|NCT03026283|81500395|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
27907612|NCT03026283|81500396|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
27907613|NCT03026283|81500397|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
27907614|NCT03026283|81500398|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
27907615|NCT03026283|81500399|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
27907616|NCT03026283|81500400|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
27907617|NCT03026283|81500401|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
27907618|NCT03026283|81500402|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
27907619|NCT03026283|81500395|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
27516597|NCT01057589|80088231|FG000|Overall Study|Lost to Follow-up|1|||
27516598|NCT01915303|80088232|FG000|Core Phase|Adverse Event|7|||
27853641|NCT00704730|81295089|FG001|Overall Study|Did not receive drug|2|||
27853642|NCT00704730|81295088|FG000|Overall Study|Disease progression per PI|58|||
27853643|NCT00704730|81295089|FG001|Overall Study|Disease progression per PI|67|||
27853644|NCT00704730|81295088|FG000|Overall Study|data unavailable|1|||
27853645|NCT00704730|81295089|FG001|Overall Study|data unavailable|0|||
27853646|NCT00704730|81295088|FG000|Overall Study|Withdrawal by Subject|9|||
27853647|NCT00704730|81295089|FG001|Overall Study|Withdrawal by Subject|13|||
27853648|NCT03796039|81295090|FG000|Overall Study|Death|2|||
27907620|NCT03026283|81500396|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
27907621|NCT03026283|81500397|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
27516599|NCT01915303|80088232|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
27516600|NCT01915303|80088232|FG000|Core Phase|Death|2|||
27516601|NCT01915303|80088232|FG000|Core Phase|Protocol Violation|2|||
27853649|NCT03796039|81295091|FG001|Overall Study|Death|1|||
27853650|NCT03796039|81295090|FG000|Overall Study|Withdrawal by Subject|7|||
27617684|NCT02084082|80444641|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
27617685|NCT02084082|80444642|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
27617686|NCT02084082|80444639|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27617687|NCT02084082|80444640|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27617688|NCT02084082|80444641|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
27617689|NCT02084082|80444642|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
27617690|NCT02419755|80444643|FG000|Overall Study|Death|1|||
27617691|NCT02419755|80444644|FG001|Overall Study|Death|3|||
27617692|NCT02419755|80444643|FG000|Overall Study|Relapse|0|||
27617693|NCT02419755|80444644|FG001|Overall Study|Relapse|1|||
27617694|NCT02419755|80444643|FG000|Overall Study|Ineligible|1|||
27617695|NCT02419755|80444644|FG001|Overall Study|Ineligible|0|||
27617696|NCT02419755|80444643|FG000|Overall Study|Withdrawal by Subject|1|||
27617697|NCT02419755|80444644|FG001|Overall Study|Withdrawal by Subject|0|||
27617698|NCT03405662|80444649|FG000|Overall Study|COVID-19 restriction|1|||
27617699|NCT03405662|80444650|FG001|Overall Study|COVID-19 restriction|0|||
27729408|NCT01587989|80838263|FG001|Randomized Study Treatment|Screening failure|1|||
27729409|NCT01587989|80838264|FG002|Randomized Study Treatment|Screening failure|0|||
27853651|NCT03796039|81295091|FG001|Overall Study|Withdrawal by Subject|4|||
27853652|NCT00914459|81295097|FG000|Overall Study|Protocol Violation|0|||
27853653|NCT00914459|81295098|FG001|Overall Study|Protocol Violation|1|||
27853654|NCT00914459|81295097|FG000|Overall Study|Parent/Legal guardian request|1|||
27853655|NCT00914459|81295098|FG001|Overall Study|Parent/Legal guardian request|0|||
27516602|NCT01915303|80088232|FG000|Core Phase|Abnormal lab value|1|||
27516603|NCT01915303|80088232|FG000|Core Phase|Withdrawal by Subject|1|||
27516604|NCT01915303|80088232|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
27516605|NCT01915303|80088232|FG000|Extension Phase|Withdrawal by Subject|4|||
27516606|NCT01915303|80088232|FG000|Extension Phase|Adverse Event|3|||
27516607|NCT01915303|80088232|FG000|Extension Phase|Death|1|||
27516608|NCT01915303|80088232|FG000|Extension Phase|Protocol Violation|1|||
27516609|NCT00348881|80088234|FG000|Overall Study|Lost to Follow-up|12|||
27516610|NCT00348881|80088235|FG001|Overall Study|Lost to Follow-up|6|||
27516611|NCT00348881|80088234|FG000|Overall Study|Withdrawal by Subject|3|||
27516612|NCT00348881|80088235|FG001|Overall Study|Withdrawal by Subject|4|||
27516613|NCT00348881|80088234|FG000|Overall Study|Adverse Event|2|||
27516614|NCT00348881|80088235|FG001|Overall Study|Adverse Event|0|||
27516615|NCT00348881|80088234|FG000|Overall Study|Serious Adverse Event|0|||
27516616|NCT00348881|80088235|FG001|Overall Study|Serious Adverse Event|2|||
27516617|NCT01032889|80088236|FG000|Overall Study|Adverse Event|2|||
27516618|NCT01032889|80088237|FG001|Overall Study|Adverse Event|2|||
27516619|NCT01032889|80088238|FG002|Overall Study|Adverse Event|0|||
27516620|NCT01032889|80088236|FG000|Overall Study|Withdrawal of Consent|1|||
27516621|NCT01032889|80088237|FG001|Overall Study|Withdrawal of Consent|2|||
27516622|NCT01032889|80088238|FG002|Overall Study|Withdrawal of Consent|1|||
27516623|NCT01032889|80088236|FG000|Overall Study|Patient Request|0|||
27516624|NCT01032889|80088237|FG001|Overall Study|Patient Request|1|||
27516625|NCT01032889|80088238|FG002|Overall Study|Patient Request|0|||
27516626|NCT01032889|80088236|FG000|Overall Study|Lost to Follow-up|1|||
27516627|NCT01032889|80088237|FG001|Overall Study|Lost to Follow-up|1|||
27516628|NCT01032889|80088238|FG002|Overall Study|Lost to Follow-up|0|||
27516629|NCT01032889|80088236|FG000|Overall Study|Lack of Submental Fat|2|||
27516630|NCT01032889|80088237|FG001|Overall Study|Lack of Submental Fat|8|||
27516631|NCT01032889|80088238|FG002|Overall Study|Lack of Submental Fat|1|||
27516632|NCT01032889|80088236|FG000|Overall Study|Miscellaneous Reasons|2|||
27516633|NCT01032889|80088237|FG001|Overall Study|Miscellaneous Reasons|1|||
27516634|NCT01032889|80088238|FG002|Overall Study|Miscellaneous Reasons|1|||
27516635|NCT01388985|80088239|FG000|Overall Study|Death|0|||
27617700|NCT03405662|80444649|FG000|Overall Study|unblinding|0|||
27853656|NCT01102374|81295099|FG000|Overall Study|Death|9|||
27853657|NCT01102374|81295100|FG001|Overall Study|Death|13|||
27853658|NCT01102374|81295099|FG000|Overall Study|Lost to Follow-up|7|||
27853659|NCT01102374|81295100|FG001|Overall Study|Lost to Follow-up|6|||
27853660|NCT03512262|81295109|FG000|Overall Study|Adverse Event|8|||
27853661|NCT03512262|81295110|FG001|Overall Study|Adverse Event|3|||
27853662|NCT03512262|81295109|FG000|Overall Study|Death (non-treatment emergent)|1|||
27516636|NCT01388985|80088240|FG001|Overall Study|Death|1|||
27617701|NCT03405662|80444650|FG001|Overall Study|unblinding|1|||
27516637|NCT01388985|80088239|FG000|Overall Study|Lost to Follow-up|30|||
27853663|NCT03512262|81295110|FG001|Overall Study|Death (non-treatment emergent)|0|||
27853664|NCT03512262|81295109|FG000|Overall Study|Withdrawal by Subject|17|||
27516638|NCT01388985|80088240|FG001|Overall Study|Lost to Follow-up|30|||
27516639|NCT01388985|80088239|FG000|Overall Study|Withdrawal by Subject|13|||
27516640|NCT01388985|80088240|FG001|Overall Study|Withdrawal by Subject|4|||
27516641|NCT01388985|80088239|FG000|Overall Study|Subject unavailable|1|||
27617702|NCT03405662|80444649|FG000|Overall Study|placement in memory care facility|0|||
27617703|NCT03405662|80444650|FG001|Overall Study|placement in memory care facility|2|||
27617704|NCT00577720|80444655|FG000|Overall Study|Adverse Event|2|||
27617705|NCT00577720|80444656|FG001|Overall Study|Adverse Event|1|||
27617706|NCT00577720|80444657|FG002|Overall Study|Adverse Event|0|||
27617707|NCT00577720|80444658|FG003|Overall Study|Adverse Event|4|||
27617708|NCT00577720|80444655|FG000|Overall Study|Lost to Follow-up|0|||
27617709|NCT00577720|80444656|FG001|Overall Study|Lost to Follow-up|0|||
27907622|NCT03026283|81500398|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
27907623|NCT03026283|81500399|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
27907624|NCT03026283|81500400|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
27907625|NCT03026283|81500401|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
27907626|NCT03026283|81500402|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
27907627|NCT03026283|81500395|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
27907628|NCT03026283|81500396|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
27907629|NCT03026283|81500397|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
27907630|NCT03026283|81500398|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
27907631|NCT03026283|81500399|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
27907632|NCT03026283|81500400|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
27907633|NCT03026283|81500401|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
27907634|NCT03026283|81500402|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
27907635|NCT03026283|81500395|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27907636|NCT03026283|81500396|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27617710|NCT00577720|80444657|FG002|Overall Study|Lost to Follow-up|1|||
27617711|NCT00577720|80444658|FG003|Overall Study|Lost to Follow-up|0|||
27617712|NCT00577720|80444655|FG000|Overall Study|Protocol Violation|0|||
27617713|NCT00577720|80444656|FG001|Overall Study|Protocol Violation|0|||
27907637|NCT03026283|81500397|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27907638|NCT03026283|81500398|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
27516642|NCT01388985|80088240|FG001|Overall Study|Subject unavailable|1|||
27617714|NCT00577720|80444657|FG002|Overall Study|Protocol Violation|0|||
27617715|NCT00577720|80444658|FG003|Overall Study|Protocol Violation|1|||
27617716|NCT00577720|80444655|FG000|Overall Study|Withdrawal by Subject|2|||
27516643|NCT01388985|80088239|FG000|Overall Study|Other (no reason)|0|||
27516644|NCT01388985|80088240|FG001|Overall Study|Other (no reason)|1|||
27516645|NCT01388985|80088239|FG000|Overall Study|Error of nurse|5|||
27516646|NCT01388985|80088240|FG001|Overall Study|Error of nurse|1|||
27516647|NCT05194579|80088241|FG000|Overall Study|Lost to Follow-up|2|||
27729410|NCT01587989|80838262|FG000|Randomized Study Treatment|Physician Decision|0|||
27729411|NCT01587989|80838263|FG001|Randomized Study Treatment|Physician Decision|0|||
27729412|NCT01587989|80838264|FG002|Randomized Study Treatment|Physician Decision|1|||
27729413|NCT01324830|80838267|FG000|Overall Study|Progressive Disease|3|||
27729414|NCT01324830|80838268|FG001|Overall Study|Progressive Disease|2|||
27729415|NCT01324830|80838269|FG002|Overall Study|Progressive Disease|3|||
27729416|NCT01324830|80838270|FG003|Overall Study|Progressive Disease|3|||
27729417|NCT01324830|80838271|FG004|Overall Study|Progressive Disease|6|||
27729418|NCT01324830|80838272|FG005|Overall Study|Progressive Disease|6|||
27516648|NCT05194579|80088242|FG001|Overall Study|Lost to Follow-up|3|||
27617717|NCT00577720|80444656|FG001|Overall Study|Withdrawal by Subject|0|||
27617718|NCT00577720|80444657|FG002|Overall Study|Withdrawal by Subject|0|||
27617719|NCT00577720|80444658|FG003|Overall Study|Withdrawal by Subject|2|||
27617720|NCT03056040|80444662|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
27617721|NCT03056040|80444663|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
27617722|NCT03056040|80444662|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
27729419|NCT01324830|80838273|FG006|Overall Study|Progressive Disease|3|||
27729420|NCT01324830|80838274|FG007|Overall Study|Progressive Disease|3|||
27907639|NCT03026283|81500399|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27516649|NCT05194579|80088241|FG000|Overall Study|Withdrawal by Subject|3|||
27516650|NCT05194579|80088242|FG001|Overall Study|Withdrawal by Subject|4|||
27516651|NCT05194579|80088241|FG000|Overall Study|Refused further study procedures|0|||
27516652|NCT05194579|80088242|FG001|Overall Study|Refused further study procedures|1|||
27516653|NCT05194579|80088241|FG000|Overall Study|Protocol deviation|1|||
27516654|NCT05194579|80088242|FG001|Overall Study|Protocol deviation|0|||
27516655|NCT00463567|80088243|FG000|Overall Study|Adverse Event|29|||
27516656|NCT00463567|80088244|FG001|Overall Study|Adverse Event|26|||
27516657|NCT00463567|80088245|FG002|Overall Study|Adverse Event|17|||
27516658|NCT00463567|80088246|FG003|Overall Study|Adverse Event|46|||
27516659|NCT00463567|80088247|FG004|Overall Study|Adverse Event|10|||
27516660|NCT00463567|80088248|FG005|Overall Study|Adverse Event|10|||
27516661|NCT00463567|80088249|FG006|Overall Study|Adverse Event|4|||
27516662|NCT00463567|80088243|FG000|Overall Study|Withdrawal by Subject|29|||
27516663|NCT00463567|80088244|FG001|Overall Study|Withdrawal by Subject|22|||
27516664|NCT00463567|80088245|FG002|Overall Study|Withdrawal by Subject|20|||
27516665|NCT00463567|80088246|FG003|Overall Study|Withdrawal by Subject|37|||
27516666|NCT00463567|80088247|FG004|Overall Study|Withdrawal by Subject|6|||
27617723|NCT03056040|80444663|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
27617724|NCT03056040|80444662|FG000|Primary Evaluation Period|Pregnancy|0|||
27617725|NCT03056040|80444663|FG001|Primary Evaluation Period|Pregnancy|1|||
27516667|NCT00463567|80088248|FG005|Overall Study|Withdrawal by Subject|5|||
27516668|NCT00463567|80088249|FG006|Overall Study|Withdrawal by Subject|1|||
27516669|NCT00463567|80088243|FG000|Overall Study|Protocol Deviation|13|||
27516670|NCT00463567|80088244|FG001|Overall Study|Protocol Deviation|9|||
27516671|NCT00463567|80088245|FG002|Overall Study|Protocol Deviation|14|||
27516672|NCT00463567|80088246|FG003|Overall Study|Protocol Deviation|11|||
27516673|NCT00463567|80088247|FG004|Overall Study|Protocol Deviation|1|||
27516674|NCT00463567|80088248|FG005|Overall Study|Protocol Deviation|1|||
27516675|NCT00463567|80088249|FG006|Overall Study|Protocol Deviation|2|||
27516676|NCT00463567|80088243|FG000|Overall Study|Lost to Follow-up|12|||
27516677|NCT00463567|80088244|FG001|Overall Study|Lost to Follow-up|6|||
27516678|NCT00463567|80088245|FG002|Overall Study|Lost to Follow-up|13|||
27516679|NCT00463567|80088246|FG003|Overall Study|Lost to Follow-up|8|||
27516680|NCT00463567|80088247|FG004|Overall Study|Lost to Follow-up|1|||
27516681|NCT00463567|80088248|FG005|Overall Study|Lost to Follow-up|1|||
27516682|NCT00463567|80088249|FG006|Overall Study|Lost to Follow-up|1|||
27516683|NCT00463567|80088243|FG000|Overall Study|Administrative problems|5|||
27516684|NCT00463567|80088244|FG001|Overall Study|Administrative problems|3|||
27516685|NCT00463567|80088245|FG002|Overall Study|Administrative problems|6|||
27516686|NCT00463567|80088246|FG003|Overall Study|Administrative problems|9|||
27516687|NCT00463567|80088247|FG004|Overall Study|Administrative problems|3|||
27516688|NCT00463567|80088248|FG005|Overall Study|Administrative problems|2|||
27516689|NCT00463567|80088249|FG006|Overall Study|Administrative problems|2|||
27516690|NCT00463567|80088243|FG000|Overall Study|Lack of Efficacy|4|||
27516691|NCT00463567|80088244|FG001|Overall Study|Lack of Efficacy|9|||
27516692|NCT00463567|80088245|FG002|Overall Study|Lack of Efficacy|9|||
27516693|NCT00463567|80088246|FG003|Overall Study|Lack of Efficacy|17|||
27516694|NCT00463567|80088247|FG004|Overall Study|Lack of Efficacy|1|||
27516695|NCT00463567|80088248|FG005|Overall Study|Lack of Efficacy|0|||
27516696|NCT00463567|80088249|FG006|Overall Study|Lack of Efficacy|1|||
27516697|NCT00463567|80088243|FG000|Overall Study|Abnormal lab value(s)|1|||
27516698|NCT00463567|80088244|FG001|Overall Study|Abnormal lab value(s)|1|||
27729421|NCT01324830|80838275|FG008|Overall Study|Progressive Disease|3|||
27907640|NCT03026283|81500400|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27907641|NCT03026283|81500401|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27907642|NCT03026283|81500402|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
27907643|NCT03026283|81500395|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
27907644|NCT03026283|81500396|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
27907645|NCT03026283|81500397|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
27907646|NCT03026283|81500398|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
27907647|NCT03026283|81500399|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
27907648|NCT03026283|81500400|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
27907649|NCT03026283|81500401|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
27907650|NCT03026283|81500402|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
27907651|NCT01516736|81500403|FG000|Overall Study|Withdrawal by Subject|10|||
27907652|NCT01516736|81500404|FG001|Overall Study|Withdrawal by Subject|4|||
27907653|NCT01516736|81500403|FG000|Overall Study|Adverse Event|4|||
27907654|NCT01516736|81500404|FG001|Overall Study|Adverse Event|5|||
27907655|NCT01516736|81500403|FG000|Overall Study|Death|3|||
27907656|NCT01516736|81500404|FG001|Overall Study|Death|1|||
27907657|NCT01516736|81500403|FG000|Overall Study|Physician Decision|2|||
27907658|NCT01516736|81500404|FG001|Overall Study|Physician Decision|1|||
27907659|NCT01516736|81500403|FG000|Overall Study|Lack of Efficacy|1|||
27907660|NCT01516736|81500404|FG001|Overall Study|Lack of Efficacy|0|||
27907661|NCT01516736|81500403|FG000|Overall Study|Protocol Violation|0|||
27907662|NCT01516736|81500404|FG001|Overall Study|Protocol Violation|1|||
27907663|NCT01516736|81500403|FG000|Overall Study|Other (not specified)|0|||
27907664|NCT01516736|81500404|FG001|Overall Study|Other (not specified)|1|||
27516699|NCT00463567|80088245|FG002|Overall Study|Abnormal lab value(s)|2|||
27516700|NCT00463567|80088246|FG003|Overall Study|Abnormal lab value(s)|1|||
27516701|NCT00463567|80088247|FG004|Overall Study|Abnormal lab value(s)|1|||
27516702|NCT00463567|80088248|FG005|Overall Study|Abnormal lab value(s)|0|||
27516703|NCT00463567|80088249|FG006|Overall Study|Abnormal lab value(s)|0|||
27516704|NCT00463567|80088243|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27516705|NCT00463567|80088244|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27516706|NCT00463567|80088245|FG002|Overall Study|Abnormal test procedure result(s)|6|||
27516707|NCT00463567|80088246|FG003|Overall Study|Abnormal test procedure result(s)|2|||
27516708|NCT00463567|80088247|FG004|Overall Study|Abnormal test procedure result(s)|0|||
27516709|NCT00463567|80088248|FG005|Overall Study|Abnormal test procedure result(s)|2|||
27516710|NCT00463567|80088249|FG006|Overall Study|Abnormal test procedure result(s)|0|||
27516711|NCT00463567|80088243|FG000|Overall Study|Death|1|||
27516712|NCT00463567|80088244|FG001|Overall Study|Death|0|||
27516713|NCT00463567|80088245|FG002|Overall Study|Death|2|||
27729422|NCT01324830|80838276|FG009|Overall Study|Progressive Disease|6|||
27729423|NCT01324830|80838277|FG010|Overall Study|Progressive Disease|2|||
27907665|NCT01134263|81500405|FG000|Overall Study|Serious adverse event|2|||
27907666|NCT01134263|81500406|FG001|Overall Study|Serious adverse event|1|||
27516714|NCT00463567|80088246|FG003|Overall Study|Death|0|||
27516715|NCT00463567|80088247|FG004|Overall Study|Death|0|||
27516716|NCT00463567|80088248|FG005|Overall Study|Death|0|||
27516717|NCT00463567|80088249|FG006|Overall Study|Death|0|||
27516718|NCT01410357|80088250|FG000|Overall Study|Death|2|||
27516719|NCT01410357|80088251|FG001|Overall Study|Death|1|||
27516720|NCT01410357|80088250|FG000|Overall Study|Withdrawal by Subject|1|||
27516721|NCT01410357|80088251|FG001|Overall Study|Withdrawal by Subject|2|||
27516722|NCT01410357|80088250|FG000|Overall Study|Lost to Follow-up|23|||
27516723|NCT01410357|80088251|FG001|Overall Study|Lost to Follow-up|21|||
27516724|NCT00702715|80088252|FG000|Overall Study|Lost to Follow-up|1|||
27516725|NCT00702715|80088253|FG001|Overall Study|Lost to Follow-up|0|||
27516726|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
27516727|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
27516728|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
27729424|NCT01324830|80838278|FG011|Overall Study|Progressive Disease|1|||
27729425|NCT01324830|80838279|FG012|Overall Study|Progressive Disease|1|||
27907667|NCT01134263|81500407|FG002|Overall Study|Serious adverse event|1|||
27516729|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
27516730|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
27516731|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
27516732|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
27516733|NCT00946985|80088255|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
27516734|NCT00946985|80088255|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
27516735|NCT04535453|80088258|FG000|Overall Study|Death|0|||
27516736|NCT04535453|80088259|FG001|Overall Study|Death|1|||
27516737|NCT04535453|80088260|FG002|Overall Study|Death|0|||
27516738|NCT04535453|80088261|FG003|Overall Study|Death|0|||
27516739|NCT04535453|80088262|FG004|Overall Study|Death|0|||
27516740|NCT04535453|80088263|FG005|Overall Study|Death|0|||
27516741|NCT04535453|80088264|FG006|Overall Study|Death|0|||
27516742|NCT04535453|80088265|FG007|Overall Study|Death|0|||
27516743|NCT04535453|80088266|FG008|Overall Study|Death|0|||
27516744|NCT04535453|80088267|FG009|Overall Study|Death|0|||
27516745|NCT04535453|80088268|FG010|Overall Study|Death|0|||
27516746|NCT04535453|80088269|FG011|Overall Study|Death|0|||
27516747|NCT04535453|80088258|FG000|Overall Study|Lost to Follow-up|1|||
27516748|NCT04535453|80088259|FG001|Overall Study|Lost to Follow-up|1|||
27516749|NCT04535453|80088260|FG002|Overall Study|Lost to Follow-up|1|||
27516750|NCT04535453|80088261|FG003|Overall Study|Lost to Follow-up|0|||
27516751|NCT04535453|80088262|FG004|Overall Study|Lost to Follow-up|3|||
27516752|NCT04535453|80088263|FG005|Overall Study|Lost to Follow-up|1|||
27516753|NCT04535453|80088264|FG006|Overall Study|Lost to Follow-up|0|||
27516754|NCT04535453|80088265|FG007|Overall Study|Lost to Follow-up|0|||
27516755|NCT04535453|80088266|FG008|Overall Study|Lost to Follow-up|1|||
27516756|NCT04535453|80088267|FG009|Overall Study|Lost to Follow-up|1|||
27516757|NCT04535453|80088268|FG010|Overall Study|Lost to Follow-up|0|||
27516758|NCT04535453|80088269|FG011|Overall Study|Lost to Follow-up|0|||
27516759|NCT04535453|80088258|FG000|Overall Study|Physician Decision|0|||
27516760|NCT04535453|80088259|FG001|Overall Study|Physician Decision|0|||
27516761|NCT04535453|80088260|FG002|Overall Study|Physician Decision|0|||
27516762|NCT04535453|80088261|FG003|Overall Study|Physician Decision|1|||
27516763|NCT04535453|80088262|FG004|Overall Study|Physician Decision|0|||
27516764|NCT04535453|80088263|FG005|Overall Study|Physician Decision|0|||
27516765|NCT04535453|80088264|FG006|Overall Study|Physician Decision|0|||
27907668|NCT01134263|81500408|FG003|Overall Study|Serious adverse event|1|||
27907669|NCT01134263|81500409|FG004|Overall Study|Serious adverse event|1|||
27907670|NCT01134263|81500405|FG000|Overall Study|Other adverse event|1|||
27907671|NCT01134263|81500406|FG001|Overall Study|Other adverse event|2|||
27907672|NCT01134263|81500407|FG002|Overall Study|Other adverse event|5|||
27907673|NCT01134263|81500408|FG003|Overall Study|Other adverse event|3|||
27907674|NCT01134263|81500409|FG004|Overall Study|Other adverse event|0|||
27907675|NCT01134263|81500405|FG000|Overall Study|Protocol Violation|8|||
27907676|NCT01134263|81500406|FG001|Overall Study|Protocol Violation|7|||
27907677|NCT01134263|81500407|FG002|Overall Study|Protocol Violation|2|||
27907678|NCT01134263|81500408|FG003|Overall Study|Protocol Violation|4|||
27907679|NCT01134263|81500409|FG004|Overall Study|Protocol Violation|2|||
27907680|NCT01134263|81500405|FG000|Overall Study|Lost to Follow-up|4|||
27907681|NCT01134263|81500406|FG001|Overall Study|Lost to Follow-up|3|||
27516766|NCT04535453|80088265|FG007|Overall Study|Physician Decision|0|||
27516767|NCT04535453|80088266|FG008|Overall Study|Physician Decision|0|||
27516768|NCT04535453|80088267|FG009|Overall Study|Physician Decision|0|||
27516769|NCT04535453|80088268|FG010|Overall Study|Physician Decision|0|||
27729426|NCT01324830|80838280|FG013|Overall Study|Progressive Disease|1|||
27853665|NCT03512262|81295110|FG001|Overall Study|Withdrawal by Subject|9|||
27853666|NCT03512262|81295109|FG000|Overall Study|Lost to Follow-up|7|||
27853667|NCT03512262|81295110|FG001|Overall Study|Lost to Follow-up|1|||
27853668|NCT03512262|81295109|FG000|Overall Study|Other than Specified|2|||
27853669|NCT03512262|81295110|FG001|Overall Study|Other than Specified|2|||
27853670|NCT03493542|81295111|FG000|Overall Study|Ongoing|2|||
27853671|NCT03493542|81295112|FG001|Overall Study|Ongoing|3|||
27853672|NCT03493542|81295111|FG000|Overall Study|Withdrawal by parent or guardian|3|||
27853673|NCT03493542|81295112|FG001|Overall Study|Withdrawal by parent or guardian|0|||
27853674|NCT03493542|81295111|FG000|Overall Study|Withdrawal by Subject|2|||
27516770|NCT04535453|80088269|FG011|Overall Study|Physician Decision|0|||
27516771|NCT04535453|80088258|FG000|Overall Study|Withdrawal by Subject|3|||
27853675|NCT03493542|81295112|FG001|Overall Study|Withdrawal by Subject|6|||
27516772|NCT04535453|80088259|FG001|Overall Study|Withdrawal by Subject|6|||
27907682|NCT01134263|81500407|FG002|Overall Study|Lost to Follow-up|5|||
27907683|NCT01134263|81500408|FG003|Overall Study|Lost to Follow-up|3|||
27907684|NCT01134263|81500409|FG004|Overall Study|Lost to Follow-up|1|||
27907685|NCT01134263|81500405|FG000|Overall Study|Withdrawal by Subject|8|||
27516773|NCT04535453|80088260|FG002|Overall Study|Withdrawal by Subject|3|||
27516774|NCT04535453|80088261|FG003|Overall Study|Withdrawal by Subject|3|||
27516775|NCT04535453|80088262|FG004|Overall Study|Withdrawal by Subject|2|||
27516776|NCT04535453|80088263|FG005|Overall Study|Withdrawal by Subject|1|||
27907686|NCT01134263|81500406|FG001|Overall Study|Withdrawal by Subject|6|||
27516777|NCT04535453|80088264|FG006|Overall Study|Withdrawal by Subject|1|||
27729427|NCT01324830|80838281|FG014|Overall Study|Progressive Disease|1|||
27729428|NCT01324830|80838282|FG015|Overall Study|Progressive Disease|3|||
27729429|NCT01324830|80838283|FG016|Overall Study|Progressive Disease|2|||
27729430|NCT01324830|80838284|FG017|Overall Study|Progressive Disease|3|||
27907687|NCT01134263|81500407|FG002|Overall Study|Withdrawal by Subject|16|||
27907688|NCT01134263|81500408|FG003|Overall Study|Withdrawal by Subject|7|||
27907689|NCT01134263|81500409|FG004|Overall Study|Withdrawal by Subject|5|||
27907690|NCT01134263|81500405|FG000|Overall Study|Enrolled, but not treated|1|||
27907691|NCT01134263|81500406|FG001|Overall Study|Enrolled, but not treated|1|||
27907692|NCT01134263|81500407|FG002|Overall Study|Enrolled, but not treated|0|||
27907693|NCT01134263|81500408|FG003|Overall Study|Enrolled, but not treated|1|||
27907694|NCT01134263|81500409|FG004|Overall Study|Enrolled, but not treated|0|||
27907695|NCT03665077|81500410|FG000|Overall Study|Lost to Follow-up|2|||
27907696|NCT03665077|81500410|FG000|Overall Study|Physician Decision|2|||
27907697|NCT03061188|81500411|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
27907698|NCT03061188|81500412|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
27907699|NCT03061188|81500413|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
27907700|NCT03061188|81500414|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
27907701|NCT03061188|81500411|FG000|On Follow-up for 3 Years|Death|0|||
27907702|NCT03061188|81500412|FG001|On Follow-up for 3 Years|Death|3|||
27907703|NCT03061188|81500413|FG002|On Follow-up for 3 Years|Death|5|||
27907704|NCT03061188|81500414|FG003|On Follow-up for 3 Years|Death|4|||
27907705|NCT03061188|81500411|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
27907706|NCT03061188|81500412|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
27907707|NCT03061188|81500413|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
27907708|NCT03061188|81500414|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
27907709|NCT00339833|81500417|FG000|Overall Study|Withdrawal by Subject|1|||
27907710|NCT00339833|81500418|FG001|Overall Study|Withdrawal by Subject|2|||
27907711|NCT00339833|81500417|FG000|Overall Study|toothache|0|||
27907712|NCT00339833|81500418|FG001|Overall Study|toothache|1|||
27907713|NCT00339833|81500417|FG000|Overall Study|indigestion|0|||
27907714|NCT00339833|81500418|FG001|Overall Study|indigestion|1|||
27907715|NCT00339833|81500417|FG000|Overall Study|Chest pain|0|||
27907716|NCT00339833|81500418|FG001|Overall Study|Chest pain|1|||
27907717|NCT00339833|81500417|FG000|Overall Study|minor infection|0|||
27907718|NCT00339833|81500418|FG001|Overall Study|minor infection|1|||
27907719|NCT00339833|81500417|FG000|Overall Study|Poor venous access|2|||
27907720|NCT00339833|81500418|FG001|Overall Study|Poor venous access|2|||
27907721|NCT00339833|81500417|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
27907722|NCT00339833|81500418|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
27907723|NCT00339833|81500417|FG000|Overall Study|Error in data records|1|||
27907724|NCT00339833|81500418|FG001|Overall Study|Error in data records|0|||
27907725|NCT03782571|81500419|FG000|Period 1|Withdrawal by Subject|1|||
27907726|NCT03782571|81500420|FG001|Period 1|Withdrawal by Subject|0|||
27907727|NCT03782571|81500421|FG002|Period 1|Withdrawal by Subject|0|||
27907728|NCT03782571|81500422|FG003|Period 1|Withdrawal by Subject|0|||
27907729|NCT03782571|81500419|FG000|Period 3|Subject Unable to Attend V5|1|||
27907730|NCT03782571|81500420|FG001|Period 3|Subject Unable to Attend V5|0|||
27907731|NCT03782571|81500421|FG002|Period 3|Subject Unable to Attend V5|0|||
27907732|NCT03782571|81500422|FG003|Period 3|Subject Unable to Attend V5|0|||
27907733|NCT03782571|81500419|FG000|Period 3|Adverse Event|1|||
27907734|NCT03782571|81500420|FG001|Period 3|Adverse Event|0|||
27907735|NCT03782571|81500421|FG002|Period 3|Adverse Event|0|||
27907736|NCT03782571|81500422|FG003|Period 3|Adverse Event|0|||
27907737|NCT03148067|81500425|FG000|Overall Study|Lost to Follow-up|3|||
27907738|NCT03148067|81500425|FG000|Overall Study|Death|1|||
27907739|NCT01639703|81500426|FG000|Overall Study|Withdrawal by Subject|5|||
27907740|NCT01639703|81500426|FG000|Overall Study|Other reason|7|||
27907741|NCT04304508|81500427|FG000|Overall Study|Subject Decision|29|||
27907742|NCT04304508|81500428|FG001|Overall Study|Subject Decision|39|||
27907743|NCT04304508|81500429|FG002|Overall Study|Subject Decision|37|||
27516778|NCT04535453|80088265|FG007|Overall Study|Withdrawal by Subject|1|||
27516779|NCT04535453|80088266|FG008|Overall Study|Withdrawal by Subject|1|||
27729431|NCT01324830|80838285|FG018|Overall Study|Progressive Disease|4|||
27729432|NCT01324830|80838267|FG000|Overall Study|Dose limiting toxicity|0|||
27729433|NCT01324830|80838268|FG001|Overall Study|Dose limiting toxicity|0|||
27729434|NCT01324830|80838269|FG002|Overall Study|Dose limiting toxicity|0|||
27907744|NCT04304508|81500430|FG003|Overall Study|Subject Decision|48|||
27907745|NCT04304508|81500427|FG000|Overall Study|Death|6|||
27907746|NCT04304508|81500428|FG001|Overall Study|Death|1|||
27907747|NCT04304508|81500429|FG002|Overall Study|Death|8|||
27907748|NCT04304508|81500430|FG003|Overall Study|Death|5|||
27907749|NCT04304508|81500427|FG000|Overall Study|Non-compliance With Study Drug|3|||
27907750|NCT04304508|81500428|FG001|Overall Study|Non-compliance With Study Drug|1|||
27907751|NCT04304508|81500429|FG002|Overall Study|Non-compliance With Study Drug|2|||
27907752|NCT04304508|81500430|FG003|Overall Study|Non-compliance With Study Drug|0|||
27907753|NCT04304508|81500427|FG000|Overall Study|Switching To Other Therapy|1|||
27907754|NCT04304508|81500428|FG001|Overall Study|Switching To Other Therapy|1|||
27907755|NCT04304508|81500429|FG002|Overall Study|Switching To Other Therapy|1|||
27907756|NCT04304508|81500430|FG003|Overall Study|Switching To Other Therapy|2|||
27907757|NCT04304508|81500427|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
27907758|NCT04304508|81500428|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
27907759|NCT04304508|81500429|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
27907760|NCT04304508|81500430|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
27907761|NCT04304508|81500427|FG000|Overall Study|Withdrawal by Subject|7|||
27907762|NCT04304508|81500428|FG001|Overall Study|Withdrawal by Subject|5|||
27907763|NCT04304508|81500429|FG002|Overall Study|Withdrawal by Subject|11|||
27907764|NCT04304508|81500430|FG003|Overall Study|Withdrawal by Subject|6|||
27907765|NCT04304508|81500427|FG000|Overall Study|Logistical Difficulties|2|||
27907766|NCT04304508|81500428|FG001|Overall Study|Logistical Difficulties|2|||
27729435|NCT01324830|80838270|FG003|Overall Study|Dose limiting toxicity|0|||
27729436|NCT01324830|80838271|FG004|Overall Study|Dose limiting toxicity|1|||
27729437|NCT01324830|80838272|FG005|Overall Study|Dose limiting toxicity|0|||
27729438|NCT01324830|80838273|FG006|Overall Study|Dose limiting toxicity|0|||
27729439|NCT01324830|80838274|FG007|Overall Study|Dose limiting toxicity|0|||
27729440|NCT01324830|80838275|FG008|Overall Study|Dose limiting toxicity|0|||
27729441|NCT01324830|80838276|FG009|Overall Study|Dose limiting toxicity|0|||
27729442|NCT01324830|80838277|FG010|Overall Study|Dose limiting toxicity|0|||
27729443|NCT01324830|80838278|FG011|Overall Study|Dose limiting toxicity|0|||
27729444|NCT01324830|80838279|FG012|Overall Study|Dose limiting toxicity|0|||
27729445|NCT01324830|80838280|FG013|Overall Study|Dose limiting toxicity|0|||
27729446|NCT01324830|80838281|FG014|Overall Study|Dose limiting toxicity|0|||
27729447|NCT01324830|80838282|FG015|Overall Study|Dose limiting toxicity|0|||
27729448|NCT01324830|80838283|FG016|Overall Study|Dose limiting toxicity|1|||
27853676|NCT00468728|81295113|FG000|Treatment|criteria for mITT population|4|||
27853677|NCT00468728|81295114|FG001|Treatment|criteria for mITT population|11|||
27853678|NCT00468728|81295113|FG000|Follow-up|mITT failure|34|||
27853679|NCT00468728|81295114|FG001|Follow-up|mITT failure|31|||
27853680|NCT03582826|81295115|FG000|Overall Study|Lost to Follow-up|39|||
27853681|NCT03582826|81295116|FG001|Overall Study|Lost to Follow-up|0|||
27853682|NCT03582826|81295115|FG000|Overall Study|Withdrawal by Subject|2|||
27853683|NCT03582826|81295116|FG001|Overall Study|Withdrawal by Subject|0|||
27853684|NCT01173471|81295119|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27853685|NCT01173471|81295120|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27853686|NCT01173471|81295121|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
27853687|NCT01173471|81295122|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27853688|NCT01173471|81295119|FG000|Overall Study|Condition under investigation worsened|2|||
27853689|NCT01173471|81295120|FG001|Overall Study|Condition under investigation worsened|0|||
27853690|NCT01173471|81295121|FG002|Overall Study|Condition under investigation worsened|0|||
27853691|NCT01173471|81295122|FG003|Overall Study|Condition under investigation worsened|0|||
27853692|NCT01173471|81295119|FG000|Overall Study|Lost to Follow-up|0|||
27853693|NCT01173471|81295120|FG001|Overall Study|Lost to Follow-up|0|||
27853694|NCT01173471|81295121|FG002|Overall Study|Lost to Follow-up|1|||
27853695|NCT01173471|81295122|FG003|Overall Study|Lost to Follow-up|0|||
27853696|NCT01173471|81295119|FG000|Overall Study|Reason given as Other|0|||
27853697|NCT01173471|81295120|FG001|Overall Study|Reason given as Other|0|||
27853698|NCT01173471|81295121|FG002|Overall Study|Reason given as Other|1|||
27853699|NCT01173471|81295122|FG003|Overall Study|Reason given as Other|0|||
27853700|NCT03923530|81295123|FG000|Overall Study|Withdrawal by Subject|1|||
27853701|NCT03923530|81295123|FG000|Overall Study|screen failure|3|||
27853702|NCT03185013|81295124|FG000|Overall Study|Withdrawal by Subject|5|||
27853703|NCT03185013|81295125|FG001|Overall Study|Withdrawal by Subject|3|||
27853704|NCT03185013|81295124|FG000|Overall Study|Adverse Event|1|||
27853705|NCT03185013|81295125|FG001|Overall Study|Adverse Event|0|||
27853706|NCT03185013|81295124|FG000|Overall Study|Progressive Disease|1|||
27853707|NCT03185013|81295125|FG001|Overall Study|Progressive Disease|0|||
27853708|NCT03185013|81295124|FG000|Overall Study|Lost to Follow-up|8|||
27853709|NCT03185013|81295125|FG001|Overall Study|Lost to Follow-up|2|||
27853710|NCT03185013|81295124|FG000|Overall Study|Physician Decision|1|||
27853711|NCT03185013|81295125|FG001|Overall Study|Physician Decision|0|||
27907767|NCT04304508|81500429|FG002|Overall Study|Logistical Difficulties|3|||
27907768|NCT04304508|81500430|FG003|Overall Study|Logistical Difficulties|2|||
27907769|NCT04304508|81500427|FG000|Overall Study|Missing Information|1|||
27729449|NCT01324830|80838284|FG017|Overall Study|Dose limiting toxicity|1|||
27729450|NCT01324830|80838285|FG018|Overall Study|Dose limiting toxicity|1|||
27729451|NCT01324830|80838267|FG000|Overall Study|Reason not mentioned above|0|||
27853712|NCT03185013|81295124|FG000|Overall Study|Protocol Deviation|2|||
27853713|NCT03185013|81295125|FG001|Overall Study|Protocol Deviation|0|||
27853714|NCT03185013|81295124|FG000|Overall Study|Reason not Specified|3|||
27853715|NCT03185013|81295125|FG001|Overall Study|Reason not Specified|2|||
27907770|NCT04304508|81500428|FG001|Overall Study|Missing Information|2|||
27907771|NCT04304508|81500429|FG002|Overall Study|Missing Information|1|||
27907772|NCT04304508|81500430|FG003|Overall Study|Missing Information|3|||
27907773|NCT04304508|81500427|FG000|Overall Study|Other|7|||
27729452|NCT01324830|80838268|FG001|Overall Study|Reason not mentioned above|0|||
27729453|NCT01324830|80838269|FG002|Overall Study|Reason not mentioned above|0|||
27729454|NCT01324830|80838270|FG003|Overall Study|Reason not mentioned above|0|||
27729455|NCT01324830|80838271|FG004|Overall Study|Reason not mentioned above|0|||
27729456|NCT01324830|80838272|FG005|Overall Study|Reason not mentioned above|0|||
27853716|NCT03185013|81295124|FG000|Overall Study|Death|1|||
27853717|NCT03185013|81295125|FG001|Overall Study|Death|0|||
27729457|NCT01324830|80838273|FG006|Overall Study|Reason not mentioned above|0|||
27729458|NCT01324830|80838274|FG007|Overall Study|Reason not mentioned above|0|||
27729459|NCT01324830|80838275|FG008|Overall Study|Reason not mentioned above|0|||
27729460|NCT01324830|80838276|FG009|Overall Study|Reason not mentioned above|0|||
27729461|NCT01324830|80838277|FG010|Overall Study|Reason not mentioned above|0|||
27729462|NCT01324830|80838278|FG011|Overall Study|Reason not mentioned above|0|||
27729463|NCT01324830|80838279|FG012|Overall Study|Reason not mentioned above|0|||
27729464|NCT01324830|80838280|FG013|Overall Study|Reason not mentioned above|0|||
27729465|NCT01324830|80838281|FG014|Overall Study|Reason not mentioned above|0|||
27729466|NCT01324830|80838282|FG015|Overall Study|Reason not mentioned above|0|||
27729467|NCT01324830|80838283|FG016|Overall Study|Reason not mentioned above|0|||
27729468|NCT01324830|80838284|FG017|Overall Study|Reason not mentioned above|1|||
27729469|NCT01324830|80838285|FG018|Overall Study|Reason not mentioned above|0|||
27729470|NCT01324830|80838267|FG000|Overall Study|Adverse Event, serious fatal|0|||
27729471|NCT01324830|80838268|FG001|Overall Study|Adverse Event, serious fatal|1|||
27729472|NCT01324830|80838269|FG002|Overall Study|Adverse Event, serious fatal|0|||
27729473|NCT01324830|80838270|FG003|Overall Study|Adverse Event, serious fatal|0|||
27729474|NCT01324830|80838271|FG004|Overall Study|Adverse Event, serious fatal|0|||
27729475|NCT01324830|80838272|FG005|Overall Study|Adverse Event, serious fatal|0|||
27729476|NCT01324830|80838273|FG006|Overall Study|Adverse Event, serious fatal|0|||
27729477|NCT01324830|80838274|FG007|Overall Study|Adverse Event, serious fatal|0|||
27729478|NCT01324830|80838275|FG008|Overall Study|Adverse Event, serious fatal|0|||
27729479|NCT01324830|80838276|FG009|Overall Study|Adverse Event, serious fatal|0|||
27729480|NCT01324830|80838277|FG010|Overall Study|Adverse Event, serious fatal|0|||
27729481|NCT01324830|80838278|FG011|Overall Study|Adverse Event, serious fatal|0|||
27729482|NCT01324830|80838279|FG012|Overall Study|Adverse Event, serious fatal|0|||
27729483|NCT01324830|80838280|FG013|Overall Study|Adverse Event, serious fatal|0|||
27729484|NCT01324830|80838281|FG014|Overall Study|Adverse Event, serious fatal|0|||
27729485|NCT01324830|80838282|FG015|Overall Study|Adverse Event, serious fatal|0|||
27729486|NCT01324830|80838283|FG016|Overall Study|Adverse Event, serious fatal|0|||
27729487|NCT01324830|80838284|FG017|Overall Study|Adverse Event, serious fatal|0|||
27729488|NCT01324830|80838285|FG018|Overall Study|Adverse Event, serious fatal|0|||
27729489|NCT01324830|80838267|FG000|Overall Study|Adverse Event, non-fatal|0|||
27729490|NCT01324830|80838268|FG001|Overall Study|Adverse Event, non-fatal|0|||
27729491|NCT01324830|80838269|FG002|Overall Study|Adverse Event, non-fatal|0|||
27729492|NCT01324830|80838270|FG003|Overall Study|Adverse Event, non-fatal|0|||
27729493|NCT01324830|80838271|FG004|Overall Study|Adverse Event, non-fatal|0|||
27729494|NCT01324830|80838272|FG005|Overall Study|Adverse Event, non-fatal|0|||
27729495|NCT01324830|80838273|FG006|Overall Study|Adverse Event, non-fatal|0|||
27729496|NCT01324830|80838274|FG007|Overall Study|Adverse Event, non-fatal|0|||
27729497|NCT01324830|80838275|FG008|Overall Study|Adverse Event, non-fatal|2|||
27729498|NCT01324830|80838276|FG009|Overall Study|Adverse Event, non-fatal|0|||
27729499|NCT01324830|80838277|FG010|Overall Study|Adverse Event, non-fatal|1|||
27729500|NCT01324830|80838278|FG011|Overall Study|Adverse Event, non-fatal|0|||
27729501|NCT01324830|80838279|FG012|Overall Study|Adverse Event, non-fatal|0|||
27729502|NCT01324830|80838280|FG013|Overall Study|Adverse Event, non-fatal|0|||
27729503|NCT01324830|80838281|FG014|Overall Study|Adverse Event, non-fatal|0|||
27729504|NCT01324830|80838282|FG015|Overall Study|Adverse Event, non-fatal|0|||
27729505|NCT01324830|80838283|FG016|Overall Study|Adverse Event, non-fatal|0|||
27853718|NCT04619992|81295127|FG000|Overall Study|Withdrawal by Subject|1|||
27853719|NCT04619992|81295128|FG001|Overall Study|Withdrawal by Subject|0|||
27853720|NCT00430495|81295129|FG000|Overall Study|Adverse Event|2|||
27617726|NCT03056040|80444662|FG000|Extension Period|Physician Decision|3|||
27617727|NCT03056040|80444663|FG001|Extension Period|Physician Decision|3|||
27617728|NCT03056040|80444662|FG000|Extension Period|Lost to Follow-up|0|||
27617729|NCT03056040|80444663|FG001|Extension Period|Lost to Follow-up|1|||
27729506|NCT01324830|80838284|FG017|Overall Study|Adverse Event, non-fatal|1|||
27729507|NCT01324830|80838285|FG018|Overall Study|Adverse Event, non-fatal|0|||
27729508|NCT01324830|80838267|FG000|Overall Study|Withdrawal by Subject|0|||
27729509|NCT01324830|80838268|FG001|Overall Study|Withdrawal by Subject|0|||
27729510|NCT01324830|80838269|FG002|Overall Study|Withdrawal by Subject|0|||
27729511|NCT01324830|80838270|FG003|Overall Study|Withdrawal by Subject|0|||
27729512|NCT01324830|80838271|FG004|Overall Study|Withdrawal by Subject|0|||
27729513|NCT01324830|80838272|FG005|Overall Study|Withdrawal by Subject|1|||
27729514|NCT01324830|80838273|FG006|Overall Study|Withdrawal by Subject|0|||
27729515|NCT01324830|80838274|FG007|Overall Study|Withdrawal by Subject|0|||
27617730|NCT03056040|80444662|FG000|Extension Period|Death|0|||
27516780|NCT04535453|80088267|FG009|Overall Study|Withdrawal by Subject|1|||
27516781|NCT04535453|80088268|FG010|Overall Study|Withdrawal by Subject|0|||
27617731|NCT03056040|80444663|FG001|Extension Period|Death|3|||
27617732|NCT03056040|80444662|FG000|Extension Period|Withdrawal by Subject|1|||
27617733|NCT03056040|80444663|FG001|Extension Period|Withdrawal by Subject|0|||
27617734|NCT03255941|80444664|FG000|Overall Study|Not eligible or refused injection|37|||
27729516|NCT01324830|80838275|FG008|Overall Study|Withdrawal by Subject|0|||
27729517|NCT01324830|80838276|FG009|Overall Study|Withdrawal by Subject|0|||
27729518|NCT01324830|80838277|FG010|Overall Study|Withdrawal by Subject|1|||
27729519|NCT01324830|80838278|FG011|Overall Study|Withdrawal by Subject|0|||
27729520|NCT01324830|80838279|FG012|Overall Study|Withdrawal by Subject|0|||
27729521|NCT01324830|80838280|FG013|Overall Study|Withdrawal by Subject|0|||
27729522|NCT01324830|80838281|FG014|Overall Study|Withdrawal by Subject|0|||
27853721|NCT00430495|81295130|FG001|Overall Study|Adverse Event|3|||
27853722|NCT00430495|81295131|FG002|Overall Study|Adverse Event|2|||
27853723|NCT00430495|81295132|FG003|Overall Study|Adverse Event|0|||
27853724|NCT00430495|81295129|FG000|Overall Study|Death|0|||
27853725|NCT00430495|81295130|FG001|Overall Study|Death|0|||
27853726|NCT00430495|81295131|FG002|Overall Study|Death|1|||
27853727|NCT00430495|81295132|FG003|Overall Study|Death|0|||
27853728|NCT00430495|81295129|FG000|Overall Study|Lost to Follow-up|0|||
27907774|NCT04304508|81500428|FG001|Overall Study|Other|6|||
27907775|NCT04304508|81500429|FG002|Overall Study|Other|5|||
27907776|NCT04304508|81500430|FG003|Overall Study|Other|4|||
27907777|NCT04304508|81500427|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
27907778|NCT04304508|81500428|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
27907779|NCT04304508|81500429|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
27907780|NCT04304508|81500430|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
27907781|NCT04304508|81500427|FG000|Overall Study|Physician Decision|3|||
27907782|NCT04304508|81500428|FG001|Overall Study|Physician Decision|4|||
27907783|NCT04304508|81500429|FG002|Overall Study|Physician Decision|9|||
27907784|NCT04304508|81500430|FG003|Overall Study|Physician Decision|7|||
27516782|NCT04535453|80088269|FG011|Overall Study|Withdrawal by Subject|1|||
27907785|NCT04304508|81500427|FG000|Overall Study|Study drug never administered|10|||
27907786|NCT04304508|81500428|FG001|Overall Study|Study drug never administered|4|||
27907787|NCT04304508|81500429|FG002|Overall Study|Study drug never administered|4|||
27907788|NCT04304508|81500430|FG003|Overall Study|Study drug never administered|4|||
27907789|NCT04304508|81500427|FG000|Overall Study|Adverse Event|49|||
27907790|NCT04304508|81500428|FG001|Overall Study|Adverse Event|50|||
27907791|NCT04304508|81500429|FG002|Overall Study|Adverse Event|51|||
27907792|NCT04304508|81500430|FG003|Overall Study|Adverse Event|56|||
27907793|NCT04304508|81500427|FG000|Overall Study|Lost to Follow-up|1|||
27907794|NCT04304508|81500428|FG001|Overall Study|Lost to Follow-up|5|||
27907795|NCT04304508|81500429|FG002|Overall Study|Lost to Follow-up|2|||
27907796|NCT04304508|81500430|FG003|Overall Study|Lost to Follow-up|3|||
27907797|NCT02579382|81500432|FG000|Main Study Phase|Lost to Follow-up|0|||
27907798|NCT02579382|81500433|FG001|Main Study Phase|Lost to Follow-up|0|||
27907799|NCT02579382|81500434|FG002|Main Study Phase|Lost to Follow-up|2|||
27907800|NCT02579382|81500435|FG003|Main Study Phase|Lost to Follow-up|0|||
27907801|NCT02579382|81500432|FG000|Main Study Phase|Withdrew Consent|0|||
27907802|NCT02579382|81500433|FG001|Main Study Phase|Withdrew Consent|0|||
27729523|NCT01324830|80838282|FG015|Overall Study|Withdrawal by Subject|0|||
27729524|NCT01324830|80838283|FG016|Overall Study|Withdrawal by Subject|0|||
27853729|NCT00430495|81295130|FG001|Overall Study|Lost to Follow-up|1|||
27853730|NCT00430495|81295131|FG002|Overall Study|Lost to Follow-up|4|||
27853731|NCT00430495|81295132|FG003|Overall Study|Lost to Follow-up|0|||
27853732|NCT00430495|81295129|FG000|Overall Study|Protocol Violation|1|||
27853733|NCT00430495|81295130|FG001|Overall Study|Protocol Violation|0|||
27853734|NCT00430495|81295131|FG002|Overall Study|Protocol Violation|1|||
27853735|NCT00430495|81295132|FG003|Overall Study|Protocol Violation|0|||
27853736|NCT00430495|81295129|FG000|Overall Study|Disease Progression|1|||
27853737|NCT00430495|81295130|FG001|Overall Study|Disease Progression|1|||
27907803|NCT02579382|81500434|FG002|Main Study Phase|Withdrew Consent|0|||
27516783|NCT04535453|80088258|FG000|Overall Study|Other|0|||
27853738|NCT00430495|81295131|FG002|Overall Study|Disease Progression|0|||
27853739|NCT00430495|81295132|FG003|Overall Study|Disease Progression|0|||
27853740|NCT00430495|81295129|FG000|Overall Study|Other|8|||
27907804|NCT02579382|81500435|FG003|Main Study Phase|Withdrew Consent|2|||
27907805|NCT02579382|81500432|FG000|Main Study Phase|Lack of Efficacy|0|||
27907806|NCT02579382|81500433|FG001|Main Study Phase|Lack of Efficacy|0|||
27907807|NCT02579382|81500434|FG002|Main Study Phase|Lack of Efficacy|0|||
27907808|NCT02579382|81500435|FG003|Main Study Phase|Lack of Efficacy|1|||
27907809|NCT02579382|81500432|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
27907810|NCT02579382|81500433|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
27907811|NCT02579382|81500434|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
27907812|NCT02579382|81500435|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
27907813|NCT02579382|81500432|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
27907814|NCT02579382|81500433|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
27907815|NCT02579382|81500434|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
27907816|NCT02579382|81500435|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
27907817|NCT02579382|81500432|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
27907818|NCT02579382|81500433|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
27907819|NCT02579382|81500434|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
27907820|NCT02579382|81500435|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
27907821|NCT02579382|81500432|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
27907822|NCT02579382|81500433|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
27907823|NCT02579382|81500434|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
27907824|NCT02579382|81500435|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
27907825|NCT02579382|81500432|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
27907826|NCT02579382|81500433|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
27516784|NCT04535453|80088259|FG001|Overall Study|Other|0|||
27516785|NCT04535453|80088260|FG002|Overall Study|Other|1|||
27617735|NCT03255941|80444665|FG001|Overall Study|Not eligible or refused injection|44|||
27907827|NCT02579382|81500434|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
27907828|NCT02579382|81500435|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
27907829|NCT02579382|81500432|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
27907830|NCT02579382|81500433|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
27907831|NCT02579382|81500434|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
27907832|NCT02579382|81500435|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
27907833|NCT05446142|81500436|FG000|Period 2|Adverse Event|1|||
27907834|NCT05446142|81500437|FG001|Period 2|Adverse Event|0|||
27907835|NCT05446142|81500438|FG002|Period 2|Adverse Event|0|||
27907836|NCT05446142|81500439|FG003|Period 2|Adverse Event|0|||
27907837|NCT05446142|81500440|FG004|Period 2|Adverse Event|0|||
27907838|NCT05446142|81500441|FG005|Period 2|Adverse Event|0|||
27907839|NCT00565604|81500442|FG000|Overall Study|Failure to treat|2|||
27907840|NCT00565604|81500442|FG000|Overall Study|Lost to Follow-up|2|||
27907841|NCT02585713|81500443|FG000|Overall Study|Withdrew prior to treatment|2|||
27907842|NCT02585713|81500444|FG001|Overall Study|Withdrew prior to treatment|7|||
27907843|NCT02585713|81500443|FG000|Overall Study|Other|3|||
27907844|NCT02585713|81500444|FG001|Overall Study|Other|1|||
27907845|NCT02784288|81500449|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
27907846|NCT02232061|81500457|FG000|Overall Study|Administrative problems|1|||
27907847|NCT02232061|81500457|FG000|Overall Study|Withdrawal by Subject|1|||
27907848|NCT00625183|81500458|FG000|Overall Study|Disease Progression|1|||
27907849|NCT00805129|81500459|FG000|Overall Study|Not treated|1|||
27907850|NCT02849704|81500460|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
27907851|NCT02849704|81500461|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
27907852|NCT02849704|81500460|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
27907853|NCT02849704|81500461|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
27907854|NCT02849704|81500460|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
27907855|NCT02849704|81500461|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
27907856|NCT01808261|81500464|FG000|Overall Study|Physician Decision|0|||
27907857|NCT01808261|81500465|FG001|Overall Study|Physician Decision|2|||
27907858|NCT01808261|81500464|FG000|Overall Study|Study Closed/Terminated|25|||
27907859|NCT01808261|81500465|FG001|Overall Study|Study Closed/Terminated|23|||
27907860|NCT01808261|81500464|FG000|Overall Study|Adverse event, non-fatal|2|||
27907861|NCT01808261|81500465|FG001|Overall Study|Adverse event, non-fatal|0|||
27907862|NCT01808261|81500464|FG000|Overall Study|Consent withdrawn by subject|6|||
27907863|NCT01808261|81500465|FG001|Overall Study|Consent withdrawn by subject|7|||
27907864|NCT01808261|81500464|FG000|Overall Study|Lost to Follow-up|3|||
27907865|NCT01808261|81500465|FG001|Overall Study|Lost to Follow-up|1|||
27907866|NCT03630705|81500466|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
27516786|NCT04535453|80088261|FG003|Overall Study|Other|0|||
27516787|NCT04535453|80088262|FG004|Overall Study|Other|1|||
27516788|NCT04535453|80088263|FG005|Overall Study|Other|0|||
27516789|NCT04535453|80088264|FG006|Overall Study|Other|1|||
27516790|NCT04535453|80088265|FG007|Overall Study|Other|1|||
27617736|NCT03255941|80444666|FG002|Overall Study|Not eligible or refused injection|5|||
27907867|NCT03630705|81500467|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
27907868|NCT03630705|81500468|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
27907869|NCT03630705|81500469|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27516791|NCT04535453|80088266|FG008|Overall Study|Other|1|||
27516792|NCT04535453|80088267|FG009|Overall Study|Other|0|||
27907870|NCT03630705|81500466|FG000|Overall Study|Lost to Follow-up|1|||
27907871|NCT03630705|81500467|FG001|Overall Study|Lost to Follow-up|2|||
27907872|NCT03630705|81500468|FG002|Overall Study|Lost to Follow-up|0|||
27907873|NCT03630705|81500469|FG003|Overall Study|Lost to Follow-up|0|||
27907874|NCT03536663|81500470|FG000|Endexo|Protocol Violation|1|||
27907875|NCT01509664|81500471|FG000|Overall Study|Lost to Follow-up|15|||
27907876|NCT01509664|81500472|FG001|Overall Study|Lost to Follow-up|21|||
27907877|NCT01421147|81500475|FG000|Treatment Period|Adverse Event|2|||
27907878|NCT01421147|81500476|FG001|Treatment Period|Adverse Event|3|||
27907879|NCT01421147|81500475|FG000|Treatment Period|Lost to Follow-up|2|||
27907880|NCT01421147|81500476|FG001|Treatment Period|Lost to Follow-up|1|||
27907881|NCT01421147|81500475|FG000|Treatment Period|Physician Decision|2|||
27907882|NCT01421147|81500476|FG001|Treatment Period|Physician Decision|2|||
27907883|NCT01421147|81500475|FG000|Treatment Period|Withdrawal by Subject|10|||
27907884|NCT01421147|81500476|FG001|Treatment Period|Withdrawal by Subject|5|||
27907885|NCT01421147|81500475|FG000|Extension Period|Adverse Event|0|||
27907886|NCT01421147|81500476|FG001|Extension Period|Adverse Event|2|||
27907887|NCT01421147|81500475|FG000|Extension Period|Death|0|||
27907888|NCT01421147|81500476|FG001|Extension Period|Death|1|||
27907889|NCT01421147|81500475|FG000|Extension Period|Lost to Follow-up|2|||
27907890|NCT01421147|81500476|FG001|Extension Period|Lost to Follow-up|5|||
27907891|NCT01421147|81500475|FG000|Extension Period|Physician Decision|1|||
27907892|NCT01421147|81500476|FG001|Extension Period|Physician Decision|0|||
27907893|NCT01421147|81500475|FG000|Extension Period|Withdrawal by Subject|5|||
27907894|NCT01421147|81500476|FG001|Extension Period|Withdrawal by Subject|3|||
27907895|NCT04446429|81500477|FG000|Overall Study|Lost to Follow-up|6|||
27907896|NCT04446429|81500478|FG001|Overall Study|Lost to Follow-up|0|||
27907897|NCT02840474|81500481|FG000|Overall Study|Lost to Follow-up|1|||
27907898|NCT02840474|81500482|FG001|Overall Study|Lost to Follow-up|0|||
27907899|NCT01670045|81500483|FG000|Overall Study|Withdrawal by Subject|3|||
27907900|NCT01670045|81500483|FG000|Overall Study|Adverse Event|1|||
27907901|NCT01670045|81500483|FG000|Overall Study|Death|1|||
27907902|NCT01670045|81500483|FG000|Overall Study|Lost to Follow-up|11|||
27907903|NCT03134911|81500484|FG000|Overall Study|Screen failure|31|||
27907904|NCT03134911|81500484|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
27907905|NCT02501161|81500485|FG000|Overall Study|Adverse Event|2|||
27907906|NCT02501161|81500486|FG001|Overall Study|Adverse Event|6|||
27907907|NCT02501161|81500485|FG000|Overall Study|Lost to Follow-up|7|||
27907908|NCT02501161|81500486|FG001|Overall Study|Lost to Follow-up|4|||
27907909|NCT02501161|81500485|FG000|Overall Study|Withdrawal by Subject|10|||
27907910|NCT02501161|81500486|FG001|Overall Study|Withdrawal by Subject|15|||
27907911|NCT02501161|81500485|FG000|Overall Study|Other|3|||
27907912|NCT02501161|81500486|FG001|Overall Study|Other|0|||
27907913|NCT00493311|81500491|FG000|Overall Study|Need for rescue medication|2|||
27907914|NCT00493311|81500492|FG001|Overall Study|Need for rescue medication|2|||
27907915|NCT03334422|81500493|FG000|Overall Study|Adverse Event|1|||
27907916|NCT03334422|81500494|FG001|Overall Study|Adverse Event|3|||
27907917|NCT03334422|81500495|FG002|Overall Study|Adverse Event|2|||
27516793|NCT04535453|80088268|FG010|Overall Study|Other|0|||
27516794|NCT04535453|80088269|FG011|Overall Study|Other|0|||
27516795|NCT01754727|80088270|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
27516796|NCT01525225|80088271|FG000|Enrollment|No longer met study criteria|1|||
27516797|NCT01525225|80088271|FG000|Enrollment|Other|1|||
27516798|NCT01182844|80088272|FG000|Overall Study|Withdrawal by Subject|0|||
27516799|NCT01182844|80088273|FG001|Overall Study|Withdrawal by Subject|2|||
27516800|NCT00946153|80088274|FG000|Phase 2|Adverse Event|0|||
27516801|NCT00946153|80088275|FG001|Phase 2|Adverse Event|0|||
27516802|NCT00946153|80088276|FG002|Phase 2|Adverse Event|0|||
27516803|NCT00946153|80088277|FG003|Phase 2|Adverse Event|0|||
27516804|NCT00946153|80088278|FG004|Phase 2|Adverse Event|6|||
27516805|NCT00946153|80088274|FG000|Phase 2|Need more reduction of dose|0|||
27516806|NCT00946153|80088275|FG001|Phase 2|Need more reduction of dose|0|||
27516807|NCT00946153|80088276|FG002|Phase 2|Need more reduction of dose|0|||
27516808|NCT00946153|80088277|FG003|Phase 2|Need more reduction of dose|0|||
27516809|NCT00946153|80088278|FG004|Phase 2|Need more reduction of dose|2|||
27516810|NCT00946153|80088274|FG000|Phase 2|Physician Decision|0|||
27907918|NCT03334422|81500496|FG003|Overall Study|Adverse Event|2|||
27516811|NCT00946153|80088275|FG001|Phase 2|Physician Decision|0|||
27516812|NCT00946153|80088276|FG002|Phase 2|Physician Decision|0|||
27617737|NCT03255941|80444667|FG003|Overall Study|Not eligible or refused injection|6|||
27729525|NCT01324830|80838284|FG017|Overall Study|Withdrawal by Subject|0|||
27907919|NCT03334422|81500493|FG000|Overall Study|Lack of Efficacy|10|||
27516813|NCT00946153|80088277|FG003|Phase 2|Physician Decision|0|||
27516814|NCT00946153|80088278|FG004|Phase 2|Physician Decision|1|||
27907920|NCT03334422|81500494|FG001|Overall Study|Lack of Efficacy|2|||
27907921|NCT03334422|81500495|FG002|Overall Study|Lack of Efficacy|7|||
27907922|NCT03334422|81500496|FG003|Overall Study|Lack of Efficacy|3|||
27907923|NCT03334422|81500493|FG000|Overall Study|Withdrawal by Subject|8|||
27907924|NCT03334422|81500494|FG001|Overall Study|Withdrawal by Subject|3|||
27907925|NCT03334422|81500495|FG002|Overall Study|Withdrawal by Subject|1|||
27907926|NCT03334422|81500496|FG003|Overall Study|Withdrawal by Subject|0|||
27907927|NCT03334422|81500493|FG000|Overall Study|Lost to Follow-up|0|||
27907928|NCT03334422|81500494|FG001|Overall Study|Lost to Follow-up|0|||
27907929|NCT03334422|81500495|FG002|Overall Study|Lost to Follow-up|0|||
27907930|NCT03334422|81500496|FG003|Overall Study|Lost to Follow-up|1|||
27907931|NCT03334422|81500493|FG000|Overall Study|Inability to obtain laboratory samples|0|||
27907932|NCT03334422|81500494|FG001|Overall Study|Inability to obtain laboratory samples|1|||
27907933|NCT03334422|81500495|FG002|Overall Study|Inability to obtain laboratory samples|0|||
27907934|NCT03334422|81500496|FG003|Overall Study|Inability to obtain laboratory samples|0|||
27907935|NCT03334422|81500493|FG000|Overall Study|Pregnancy|0|||
27907936|NCT03334422|81500494|FG001|Overall Study|Pregnancy|1|||
27907937|NCT03334422|81500495|FG002|Overall Study|Pregnancy|0|||
27617738|NCT03255941|80444664|FG000|Overall Study|Did not complete exit interview|1|||
27617739|NCT03255941|80444665|FG001|Overall Study|Did not complete exit interview|2|||
27617740|NCT03255941|80444666|FG002|Overall Study|Did not complete exit interview|0|||
27617741|NCT03255941|80444667|FG003|Overall Study|Did not complete exit interview|0|||
27853741|NCT00430495|81295130|FG001|Overall Study|Other|2|||
27853742|NCT00430495|81295131|FG002|Overall Study|Other|5|||
27853743|NCT00430495|81295132|FG003|Overall Study|Other|4|||
27853744|NCT00430495|81295129|FG000|Overall Study|Randomized but not Treated|2|||
27853745|NCT00430495|81295130|FG001|Overall Study|Randomized but not Treated|0|||
27853746|NCT00430495|81295131|FG002|Overall Study|Randomized but not Treated|0|||
27853747|NCT00430495|81295132|FG003|Overall Study|Randomized but not Treated|0|||
27853748|NCT01691820|81295133|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
27853749|NCT01691820|81295134|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
27853750|NCT01691820|81295133|FG000|Overall Study|Migrated/moved from study area|7|||
27853751|NCT01691820|81295134|FG001|Overall Study|Migrated/moved from study area|4|||
27853752|NCT01691820|81295133|FG000|Overall Study|Lost to Follow-up|6|||
27853753|NCT01691820|81295134|FG001|Overall Study|Lost to Follow-up|17|||
27617742|NCT01923389|80444668|FG000|Overall Study|Protocol Violation|1|||
27617743|NCT01923389|80444669|FG001|Overall Study|Protocol Violation|0|||
27617744|NCT01439711|80444671|FG000|Overall Study|Ineligible|13|||
27617745|NCT01439711|80444671|FG000|Overall Study|Cancel|3|||
27617746|NCT01439711|80444671|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
27617747|NCT01439711|80444671|FG000|Overall Study|Adverse Event|5|||
27617748|NCT01439711|80444671|FG000|Overall Study|Withdrawal by Subject|3|||
27617749|NCT01439711|80444671|FG000|Overall Study|Progression During Active Tx|3|||
27617750|NCT01439711|80444671|FG000|Overall Study|Noncompliance|3|||
27617751|NCT01439711|80444671|FG000|Overall Study|No MRI|9|||
27617752|NCT01579578|80444672|FG000|Overall Study|Death|4|||
27617753|NCT01579578|80444673|FG001|Overall Study|Death|1|||
27617754|NCT01579578|80444672|FG000|Overall Study|Lost to Follow-up|1|||
27617755|NCT01579578|80444673|FG001|Overall Study|Lost to Follow-up|1|||
27617756|NCT01579578|80444672|FG000|Overall Study|Withdrawal by Subject|2|||
27617757|NCT01579578|80444673|FG001|Overall Study|Withdrawal by Subject|1|||
27617758|NCT01579578|80444672|FG000|Overall Study|Eligibility criteria|3|||
27617759|NCT01579578|80444673|FG001|Overall Study|Eligibility criteria|9|||
27617760|NCT01579578|80444672|FG000|Overall Study|Ongoing|3|||
27617761|NCT01579578|80444673|FG001|Overall Study|Ongoing|0|||
27617762|NCT03824938|80444677|FG000|Overall Study|Withdrawal by Subject|2|||
27853754|NCT01691820|81295133|FG000|Overall Study|Other (unspecified)|4|||
27907938|NCT03334422|81500496|FG003|Overall Study|Pregnancy|0|||
27516815|NCT00946153|80088274|FG000|Phase 2|14 days washout for recovery due to AE|0|||
27516816|NCT00946153|80088275|FG001|Phase 2|14 days washout for recovery due to AE|0|||
27516817|NCT00946153|80088276|FG002|Phase 2|14 days washout for recovery due to AE|0|||
27516818|NCT00946153|80088277|FG003|Phase 2|14 days washout for recovery due to AE|0|||
27516819|NCT00946153|80088278|FG004|Phase 2|14 days washout for recovery due to AE|4|||
27516820|NCT02509117|80088279|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516821|NCT02509117|80088280|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
27516822|NCT02509117|80088281|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516823|NCT02509117|80088282|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516824|NCT02509117|80088283|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516825|NCT02509117|80088284|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516826|NCT02509117|80088285|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516827|NCT02509117|80088286|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516828|NCT02509117|80088287|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27617763|NCT03824938|80444678|FG001|Overall Study|Withdrawal by Subject|1|||
27853755|NCT01691820|81295134|FG001|Overall Study|Other (unspecified)|1|||
27853756|NCT04874636|81295135|FG000|Overall Study|Adverse Event|17|||
27907939|NCT01093586|81500497|FG000|Overall Study|Failed to engraft|3|||
27617764|NCT03824938|80444679|FG002|Overall Study|Withdrawal by Subject|0|||
27853757|NCT04874636|81295136|FG001|Overall Study|Adverse Event|7|||
27907940|NCT01042392|81500499|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
27617765|NCT03824938|80444680|FG003|Overall Study|Withdrawal by Subject|2|||
27617766|NCT03824938|80444681|FG004|Overall Study|Withdrawal by Subject|0|||
27617767|NCT03824938|80444682|FG005|Overall Study|Withdrawal by Subject|1|||
27617768|NCT03824938|80444677|FG000|Overall Study|Lost to Follow-up|0|||
27617769|NCT03824938|80444678|FG001|Overall Study|Lost to Follow-up|1|||
27617770|NCT03824938|80444679|FG002|Overall Study|Lost to Follow-up|0|||
27617771|NCT03824938|80444680|FG003|Overall Study|Lost to Follow-up|0|||
27617772|NCT03824938|80444681|FG004|Overall Study|Lost to Follow-up|1|||
27617773|NCT03824938|80444682|FG005|Overall Study|Lost to Follow-up|0|||
27617774|NCT01461993|80444685|FG000|Overall Study|Withdrawal by Subject|60|||
27617775|NCT01461993|80444686|FG001|Overall Study|Withdrawal by Subject|53|||
27617776|NCT01461993|80444687|FG002|Overall Study|Withdrawal by Subject|16|||
27617777|NCT01461993|80444685|FG000|Overall Study|Lost to Follow-up|44|||
27617778|NCT01461993|80444686|FG001|Overall Study|Lost to Follow-up|48|||
27617779|NCT01461993|80444687|FG002|Overall Study|Lost to Follow-up|22|||
27617780|NCT01461993|80444685|FG000|Overall Study|Protocol Violation|10|||
27617781|NCT01461993|80444686|FG001|Overall Study|Protocol Violation|9|||
27617782|NCT01461993|80444687|FG002|Overall Study|Protocol Violation|7|||
27617783|NCT01461993|80444685|FG000|Overall Study|Adverse Event|9|||
27617784|NCT01461993|80444686|FG001|Overall Study|Adverse Event|11|||
27853758|NCT04874636|81295135|FG000|Overall Study|Lost to Follow-up|1|||
27853759|NCT04874636|81295136|FG001|Overall Study|Lost to Follow-up|0|||
27853760|NCT04874636|81295135|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27853761|NCT04874636|81295136|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27853762|NCT04874636|81295135|FG000|Overall Study|Physician Decision|1|||
27853763|NCT04874636|81295136|FG001|Overall Study|Physician Decision|0|||
27853764|NCT04874636|81295135|FG000|Overall Study|Withdrawal by Subject|6|||
27853765|NCT04874636|81295136|FG001|Overall Study|Withdrawal by Subject|5|||
27617785|NCT01461993|80444687|FG002|Overall Study|Adverse Event|3|||
27617786|NCT01461993|80444685|FG000|Overall Study|No longer met eligibility criteria|13|||
27617787|NCT01461993|80444686|FG001|Overall Study|No longer met eligibility criteria|18|||
27617788|NCT01461993|80444687|FG002|Overall Study|No longer met eligibility criteria|10|||
27617789|NCT01461993|80444685|FG000|Overall Study|Did not meet entrance criteria|2|||
27617790|NCT01461993|80444686|FG001|Overall Study|Did not meet entrance criteria|3|||
27617791|NCT01461993|80444687|FG002|Overall Study|Did not meet entrance criteria|0|||
27617792|NCT01461993|80444685|FG000|Overall Study|Other|13|||
27617793|NCT01461993|80444686|FG001|Overall Study|Other|15|||
27617794|NCT01461993|80444687|FG002|Overall Study|Other|6|||
27617795|NCT01657682|80444690|FG000|Overall Study|Lost to Follow-up|1|||
27617796|NCT01657682|80444691|FG001|Overall Study|Lost to Follow-up|0|||
27617797|NCT01657682|80444692|FG002|Overall Study|Lost to Follow-up|0|||
27617798|NCT01657682|80444690|FG000|Overall Study|Withdrawal by Subject|0|||
27617799|NCT01657682|80444691|FG001|Overall Study|Withdrawal by Subject|1|||
27617800|NCT01657682|80444692|FG002|Overall Study|Withdrawal by Subject|1|||
27617801|NCT01657682|80444690|FG000|Overall Study|Adverse Event|0|||
27617802|NCT01657682|80444691|FG001|Overall Study|Adverse Event|1|||
27853766|NCT00986180|81295139|FG000|Overall Study|Adverse Event|21|||
27853767|NCT00986180|81295140|FG001|Overall Study|Adverse Event|23|||
27853768|NCT00986180|81295139|FG000|Overall Study|Lack of Efficacy|4|||
27853769|NCT00986180|81295140|FG001|Overall Study|Lack of Efficacy|3|||
27516829|NCT02509117|80088288|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
27516830|NCT02509117|80088279|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516831|NCT02509117|80088280|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516832|NCT02509117|80088281|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516833|NCT02509117|80088282|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516834|NCT02509117|80088283|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516835|NCT02509117|80088284|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516836|NCT02509117|80088285|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516837|NCT02509117|80088286|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516838|NCT02509117|80088287|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
27516839|NCT02509117|80088288|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
27516840|NCT02509117|80088279|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516841|NCT02509117|80088280|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27617803|NCT01657682|80444692|FG002|Overall Study|Adverse Event|0|||
27617804|NCT00885495|80444693|FG000|Overall Study|Adverse Event|1|||
27853770|NCT00986180|81295139|FG000|Overall Study|Lost to Follow-up|5|||
27853771|NCT00986180|81295140|FG001|Overall Study|Lost to Follow-up|7|||
27907941|NCT01042392|81500500|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
27617805|NCT00885495|80444694|FG001|Overall Study|Adverse Event|2|||
27617806|NCT00885495|80444693|FG000|Overall Study|Protocol Violation|0|||
27617807|NCT00885495|80444694|FG001|Overall Study|Protocol Violation|1|||
27617808|NCT00885495|80444693|FG000|Overall Study|Withdrawal by Subject|1|||
27617809|NCT00885495|80444694|FG001|Overall Study|Withdrawal by Subject|0|||
27617810|NCT01489020|80444695|FG000|Overall Study|Withdrawal by Subject|1|||
27729526|NCT01324830|80838285|FG018|Overall Study|Withdrawal by Subject|1|||
27729527|NCT00331760|80838286|FG000|Overall Study|Ineligible / no protocol treatment|15|||
27729528|NCT00331760|80838287|FG001|Overall Study|Ineligible / no protocol treatment|8|||
27729529|NCT00434967|80838288|FG000|Overall Study|Adverse Event|2|||
27729530|NCT00434967|80838289|FG001|Overall Study|Adverse Event|4|||
27729531|NCT00434967|80838290|FG002|Overall Study|Adverse Event|3|||
27729532|NCT00434967|80838291|FG003|Overall Study|Adverse Event|3|||
27729533|NCT00434967|80838288|FG000|Overall Study|Lost to Follow-up|0|||
27729534|NCT00434967|80838289|FG001|Overall Study|Lost to Follow-up|0|||
27729535|NCT00434967|80838290|FG002|Overall Study|Lost to Follow-up|1|||
27729536|NCT00434967|80838291|FG003|Overall Study|Lost to Follow-up|0|||
27729537|NCT00434967|80838288|FG000|Overall Study|Withdrawal by Subject|2|||
27729538|NCT00434967|80838289|FG001|Overall Study|Withdrawal by Subject|2|||
27729539|NCT00434967|80838290|FG002|Overall Study|Withdrawal by Subject|4|||
27729540|NCT00434967|80838291|FG003|Overall Study|Withdrawal by Subject|6|||
27729541|NCT00434967|80838288|FG000|Overall Study|Randomized in error|0|||
27729542|NCT00434967|80838289|FG001|Overall Study|Randomized in error|0|||
27729543|NCT00434967|80838290|FG002|Overall Study|Randomized in error|0|||
27729544|NCT00434967|80838291|FG003|Overall Study|Randomized in error|1|||
27729545|NCT00434967|80838288|FG000|Overall Study|Protocol Violation|0|||
27729546|NCT00434967|80838289|FG001|Overall Study|Protocol Violation|1|||
27729547|NCT00434967|80838290|FG002|Overall Study|Protocol Violation|0|||
27907942|NCT01042392|81500501|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
27516842|NCT02509117|80088281|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516843|NCT02509117|80088282|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516844|NCT02509117|80088283|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516845|NCT02509117|80088284|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516846|NCT02509117|80088285|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516847|NCT02509117|80088286|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516848|NCT02509117|80088287|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
27516849|NCT02509117|80088288|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
27516850|NCT00653939|80088289|FG000|Overall Study|Adverse Event|1|||
27516851|NCT00653939|80088290|FG001|Overall Study|Adverse Event|3|||
27516852|NCT00653939|80088289|FG000|Overall Study|Withdrawal by Subject|3|||
27516853|NCT00653939|80088290|FG001|Overall Study|Withdrawal by Subject|3|||
27516854|NCT00653939|80088289|FG000|Overall Study|Physician Decision|4|||
27516855|NCT00653939|80088290|FG001|Overall Study|Physician Decision|0|||
27516856|NCT00653939|80088289|FG000|Overall Study|Disease Progression|2|||
27516857|NCT00653939|80088290|FG001|Overall Study|Disease Progression|3|||
27516858|NCT00653939|80088289|FG000|Overall Study|Other|2|||
27516859|NCT00653939|80088290|FG001|Overall Study|Other|6|||
27516860|NCT00119678|80088291|FG000|Double-blind Treatment Period|Death|1|||
27516861|NCT00119678|80088292|FG001|Double-blind Treatment Period|Death|0|||
27516862|NCT00119678|80088291|FG000|Double-blind Treatment Period|Adverse Event|7|||
27516863|NCT00119678|80088292|FG001|Double-blind Treatment Period|Adverse Event|1|||
27516864|NCT00119678|80088291|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
27516865|NCT00119678|80088292|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
27516866|NCT00119678|80088291|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
27516867|NCT00119678|80088292|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
27516868|NCT00119678|80088291|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
27516869|NCT00119678|80088292|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
27516870|NCT00119678|80088291|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
27516871|NCT00119678|80088292|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
27516872|NCT00119678|80088291|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
27516873|NCT00119678|80088292|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
27516874|NCT00119678|80088291|FG000|Double-blind Treatment Period|Pregnancy|0|||
27516875|NCT00119678|80088292|FG001|Double-blind Treatment Period|Pregnancy|2|||
27516876|NCT00119678|80088291|FG000|Double-blind Treatment Period|Not treated|1|||
27516877|NCT00119678|80088292|FG001|Double-blind Treatment Period|Not treated|2|||
27516878|NCT00119678|80088291|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
27516879|NCT00119678|80088292|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
27729548|NCT00434967|80838291|FG003|Overall Study|Protocol Violation|1|||
27853772|NCT00986180|81295139|FG000|Overall Study|Physician Decision|1|||
27853773|NCT00986180|81295140|FG001|Overall Study|Physician Decision|3|||
27516880|NCT00119678|80088291|FG000|Open-label Treatment Period|Death|1|||
27516881|NCT00119678|80088292|FG001|Open-label Treatment Period|Death|0|||
27516882|NCT00119678|80088291|FG000|Open-label Treatment Period|Adverse Event|3|||
27516883|NCT00119678|80088292|FG001|Open-label Treatment Period|Adverse Event|0|||
27729549|NCT00434967|80838288|FG000|Overall Study|Physician Decision|1|||
27516884|NCT00119678|80088291|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
27729550|NCT00434967|80838289|FG001|Overall Study|Physician Decision|1|||
27516885|NCT00119678|80088292|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
27516886|NCT00119678|80088291|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
27729551|NCT00434967|80838290|FG002|Overall Study|Physician Decision|1|||
27729552|NCT00434967|80838291|FG003|Overall Study|Physician Decision|0|||
27516887|NCT00119678|80088292|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
27516888|NCT00119678|80088291|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
27516889|NCT00119678|80088292|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
27729553|NCT00434967|80838288|FG000|Overall Study|Patient Disposition Challenges|2|||
27729554|NCT00434967|80838289|FG001|Overall Study|Patient Disposition Challenges|0|||
27729555|NCT00434967|80838290|FG002|Overall Study|Patient Disposition Challenges|0|||
27729556|NCT00434967|80838291|FG003|Overall Study|Patient Disposition Challenges|3|||
27729557|NCT01523873|80838292|FG000|Overall Study|Protocol Violation|422|||
27729558|NCT00619957|80838293|FG000|Month 24 Double-Blind|Adverse Event|9|||
27729559|NCT00619957|80838294|FG001|Month 24 Double-Blind|Adverse Event|7|||
27729560|NCT00619957|80838293|FG000|Month 24 Double-Blind|Protocol Violation|1|||
27729561|NCT00619957|80838294|FG001|Month 24 Double-Blind|Protocol Violation|0|||
27729562|NCT00619957|80838293|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
27729563|NCT00619957|80838294|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
27729564|NCT00619957|80838293|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
27729565|NCT00619957|80838294|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
27729566|NCT00619957|80838293|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
27729567|NCT00619957|80838294|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
27729568|NCT00619957|80838293|FG000|Month 48 Open-Label|Adverse Event|4|||
27729569|NCT00619957|80838294|FG001|Month 48 Open-Label|Adverse Event|4|||
27729570|NCT00619957|80838293|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
27729571|NCT00619957|80838294|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
27729572|NCT00619957|80838293|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
27729573|NCT00619957|80838294|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
27729574|NCT01879410|80838296|FG000|Overall Study|Adverse Event|9|||
27729575|NCT01879410|80838297|FG001|Overall Study|Adverse Event|14|||
27729576|NCT01879410|80838296|FG000|Overall Study|Lack of Efficacy|4|||
27729577|NCT01879410|80838297|FG001|Overall Study|Lack of Efficacy|6|||
27729578|NCT01879410|80838296|FG000|Overall Study|Protocol Violation|1|||
27729579|NCT01879410|80838297|FG001|Overall Study|Protocol Violation|7|||
27729580|NCT01879410|80838296|FG000|Overall Study|Lost to Follow-up|2|||
27729581|NCT01879410|80838297|FG001|Overall Study|Lost to Follow-up|1|||
27729582|NCT01879410|80838296|FG000|Overall Study|Withdrawal by Subject|7|||
27729583|NCT01879410|80838297|FG001|Overall Study|Withdrawal by Subject|8|||
27729584|NCT01879410|80838296|FG000|Overall Study|Randomised in Error|1|||
27729585|NCT01879410|80838297|FG001|Overall Study|Randomised in Error|2|||
27729586|NCT00420511|80838299|FG000|Overall Study|Adverse Event|1|||
27729587|NCT00420511|80838300|FG001|Overall Study|Adverse Event|1|||
27729588|NCT00420511|80838299|FG000|Overall Study|Lost to Follow-up|1|||
27729589|NCT00420511|80838300|FG001|Overall Study|Lost to Follow-up|0|||
27729590|NCT02159807|80838301|FG000|Overall Study|Adverse Event|0|||
27729591|NCT02159807|80838302|FG001|Overall Study|Adverse Event|0|||
27853774|NCT00986180|81295139|FG000|Overall Study|Protocol Violation|2|||
27853775|NCT00986180|81295140|FG001|Overall Study|Protocol Violation|0|||
27853776|NCT00986180|81295139|FG000|Overall Study|Withdrawal by Subject|1|||
27853777|NCT00986180|81295140|FG001|Overall Study|Withdrawal by Subject|9|||
27853778|NCT00986180|81295139|FG000|Overall Study|Miscellanies|10|||
27853779|NCT00986180|81295140|FG001|Overall Study|Miscellanies|11|||
27853780|NCT00477295|81295141|FG000|Overall Study|Adverse Event|31|||
27853781|NCT00477295|81295142|FG001|Overall Study|Adverse Event|35|||
27853782|NCT00477295|81295141|FG000|Overall Study|Withdrawal by Subject|35|||
27853783|NCT00477295|81295142|FG001|Overall Study|Withdrawal by Subject|24|||
27853784|NCT00477295|81295141|FG000|Overall Study|Lack of Efficacy|23|||
27853785|NCT00477295|81295142|FG001|Overall Study|Lack of Efficacy|23|||
27853786|NCT00477295|81295141|FG000|Overall Study|Protocol Violation|3|||
27853787|NCT00477295|81295142|FG001|Overall Study|Protocol Violation|8|||
27907943|NCT01042392|81500502|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
27516890|NCT00119678|80088291|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
27516891|NCT00119678|80088292|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
27516892|NCT00119678|80088291|FG000|Open-label Treatment Period|Pregnancy|1|||
27516893|NCT00119678|80088292|FG001|Open-label Treatment Period|Pregnancy|0|||
27729592|NCT02159807|80838303|FG002|Overall Study|Adverse Event|1|||
27729593|NCT02159807|80838301|FG000|Overall Study|No CSF|1|||
27729594|NCT02159807|80838302|FG001|Overall Study|No CSF|1|||
27729595|NCT02159807|80838303|FG002|Overall Study|No CSF|1|||
27729596|NCT02159807|80838301|FG000|Overall Study|elevated blood pressure|0|||
27729597|NCT02159807|80838302|FG001|Overall Study|elevated blood pressure|0|||
27853788|NCT00477295|81295141|FG000|Overall Study|Physician Decision|4|||
27853789|NCT00477295|81295142|FG001|Overall Study|Physician Decision|5|||
27853790|NCT00477295|81295141|FG000|Overall Study|Lost to Follow-up|21|||
27853791|NCT00477295|81295142|FG001|Overall Study|Lost to Follow-up|11|||
27853792|NCT00477295|81295141|FG000|Overall Study|Other|4|||
27853793|NCT00477295|81295142|FG001|Overall Study|Other|3|||
27853794|NCT04397445|81295152|FG000|Overall Study|Withdrawal by Subject|1|||
27729598|NCT02159807|80838303|FG002|Overall Study|elevated blood pressure|1|||
27729599|NCT01505894|80838304|FG000|Overall Study|Adverse Event|1|||
27729600|NCT01505894|80838305|FG001|Overall Study|Adverse Event|0|||
27729601|NCT01505894|80838306|FG002|Overall Study|Adverse Event|0|||
27729602|NCT01505894|80838307|FG003|Overall Study|Adverse Event|0|||
27729603|NCT01505894|80838308|FG004|Overall Study|Adverse Event|0|||
27729604|NCT01505894|80838309|FG005|Overall Study|Adverse Event|0|||
27729605|NCT01505894|80838310|FG006|Overall Study|Adverse Event|0|||
27729606|NCT01505894|80838311|FG007|Overall Study|Adverse Event|0|||
27729607|NCT01505894|80838312|FG008|Overall Study|Adverse Event|0|||
27729608|NCT01505894|80838304|FG000|Overall Study|Other than specified|0|||
27729609|NCT01505894|80838305|FG001|Overall Study|Other than specified|0|||
27729610|NCT01505894|80838306|FG002|Overall Study|Other than specified|0|||
27729611|NCT01505894|80838307|FG003|Overall Study|Other than specified|0|||
27729612|NCT01505894|80838308|FG004|Overall Study|Other than specified|1|||
27729613|NCT01505894|80838309|FG005|Overall Study|Other than specified|0|||
27729614|NCT01505894|80838310|FG006|Overall Study|Other than specified|0|||
27729615|NCT01505894|80838311|FG007|Overall Study|Other than specified|0|||
27729616|NCT01505894|80838312|FG008|Overall Study|Other than specified|0|||
27729617|NCT01961544|80838313|FG000|Overall Study|Protocol Violation|1|||
27729618|NCT01961544|80838313|FG000|Overall Study|Withdrawal by Subject|7|||
27729619|NCT01961544|80838313|FG000|Overall Study|Adverse Event|1|||
27729620|NCT01961544|80838313|FG000|Overall Study|Physician Decision|2|||
27729621|NCT01961544|80838313|FG000|Overall Study|Poor Tolerance|1|||
27729622|NCT01961544|80838313|FG000|Overall Study|Aggravation of Steral Pain|1|||
27729623|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
27729624|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
27729625|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
27729626|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
27729627|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
27729628|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
27729629|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
27729630|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
27729631|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27729632|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
27729633|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27729634|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
27729635|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
27729636|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27729637|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
27853795|NCT04397445|81295153|FG001|Overall Study|Withdrawal by Subject|0|||
27516894|NCT00119678|80088291|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
27516895|NCT00119678|80088292|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
27516896|NCT01137604|80088295|FG000|Overall Study|Adverse Event|3|||
27516897|NCT01137604|80088296|FG001|Overall Study|Adverse Event|6|||
27516898|NCT01137604|80088297|FG002|Overall Study|Adverse Event|9|||
27516899|NCT01137604|80088298|FG003|Overall Study|Adverse Event|9|||
27516900|NCT01137604|80088295|FG000|Overall Study|Participant Choice|0|||
27516901|NCT01137604|80088296|FG001|Overall Study|Participant Choice|2|||
27516902|NCT01137604|80088297|FG002|Overall Study|Participant Choice|2|||
27516903|NCT01137604|80088298|FG003|Overall Study|Participant Choice|0|||
27516904|NCT01137604|80088295|FG000|Overall Study|Withdrawal of consent|0|||
27516905|NCT01137604|80088296|FG001|Overall Study|Withdrawal of consent|0|||
27516906|NCT01137604|80088297|FG002|Overall Study|Withdrawal of consent|0|||
27516907|NCT01137604|80088298|FG003|Overall Study|Withdrawal of consent|2|||
27516908|NCT01137604|80088295|FG000|Overall Study|Clinical progression/deterioration|1|||
27617811|NCT01489020|80444696|FG001|Overall Study|Withdrawal by Subject|0|||
27516909|NCT01137604|80088296|FG001|Overall Study|Clinical progression/deterioration|2|||
27516910|NCT01137604|80088297|FG002|Overall Study|Clinical progression/deterioration|2|||
27516911|NCT01137604|80088298|FG003|Overall Study|Clinical progression/deterioration|0|||
27516912|NCT00146848|80088301|FG000|Pre-randomization|Death|19|||
27729638|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
27729639|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
27729640|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
27853796|NCT04397445|81295154|FG002|Overall Study|Withdrawal by Subject|0|||
27516913|NCT00146848|80088302|FG001|Pre-randomization|Death|0|||
27617812|NCT01489020|80444697|FG002|Overall Study|Withdrawal by Subject|0|||
27853797|NCT04397445|81295155|FG003|Overall Study|Withdrawal by Subject|0|||
27516914|NCT00146848|80088303|FG002|Pre-randomization|Death|0|||
27729641|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
27729642|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
27729643|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
27729644|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
27729645|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
27729646|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
27729647|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
27729648|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
27729649|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
27729650|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
27729651|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
27729652|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
27729653|NCT05195528|80838314|FG000|Placebo-controlled Treatment Period|Other|0|||
27729654|NCT05195528|80838315|FG001|Placebo-controlled Treatment Period|Other|0|||
27729655|NCT05195528|80838316|FG002|Placebo-controlled Treatment Period|Other|1|||
27729656|NCT05195528|80838317|FG003|Placebo-controlled Treatment Period|Other|0|||
27729657|NCT05195528|80838318|FG004|Placebo-controlled Treatment Period|Other|0|||
27729658|NCT05195528|80838314|FG000|Extension Period|PTE or AE or SAE|0|||
27729659|NCT05195528|80838315|FG001|Extension Period|PTE or AE or SAE|4|||
27729660|NCT05195528|80838316|FG002|Extension Period|PTE or AE or SAE|5|||
27729661|NCT05195528|80838317|FG003|Extension Period|PTE or AE or SAE|4|||
27729662|NCT05195528|80838318|FG004|Extension Period|PTE or AE or SAE|4|||
27729663|NCT05195528|80838314|FG000|Extension Period|Protocol Violation|0|||
27729664|NCT05195528|80838315|FG001|Extension Period|Protocol Violation|2|||
27729665|NCT05195528|80838316|FG002|Extension Period|Protocol Violation|1|||
27729666|NCT05195528|80838317|FG003|Extension Period|Protocol Violation|0|||
27729667|NCT05195528|80838318|FG004|Extension Period|Protocol Violation|1|||
27729668|NCT05195528|80838314|FG000|Extension Period|Lost to Follow-up|0|||
27729669|NCT05195528|80838315|FG001|Extension Period|Lost to Follow-up|6|||
27729670|NCT05195528|80838316|FG002|Extension Period|Lost to Follow-up|13|||
27729671|NCT05195528|80838317|FG003|Extension Period|Lost to Follow-up|3|||
27729672|NCT05195528|80838318|FG004|Extension Period|Lost to Follow-up|7|||
27729673|NCT05195528|80838314|FG000|Extension Period|Withdrawal by Subject|0|||
27729674|NCT05195528|80838315|FG001|Extension Period|Withdrawal by Subject|12|||
27729675|NCT05195528|80838316|FG002|Extension Period|Withdrawal by Subject|9|||
27729676|NCT05195528|80838317|FG003|Extension Period|Withdrawal by Subject|6|||
27729677|NCT05195528|80838318|FG004|Extension Period|Withdrawal by Subject|5|||
27729678|NCT05195528|80838314|FG000|Extension Period|Lack of Efficacy|0|||
27729679|NCT05195528|80838315|FG001|Extension Period|Lack of Efficacy|3|||
27729680|NCT05195528|80838316|FG002|Extension Period|Lack of Efficacy|0|||
27729681|NCT05195528|80838317|FG003|Extension Period|Lack of Efficacy|0|||
27729682|NCT05195528|80838318|FG004|Extension Period|Lack of Efficacy|2|||
27729683|NCT05195528|80838314|FG000|Extension Period|Not Treated|0|||
27729684|NCT05195528|80838315|FG001|Extension Period|Not Treated|0|||
27729685|NCT05195528|80838316|FG002|Extension Period|Not Treated|2|||
27729686|NCT05195528|80838317|FG003|Extension Period|Not Treated|3|||
27729687|NCT05195528|80838318|FG004|Extension Period|Not Treated|0|||
27729688|NCT05195528|80838314|FG000|Extension Period|Other|0|||
27729689|NCT05195528|80838315|FG001|Extension Period|Other|1|||
27729690|NCT05195528|80838316|FG002|Extension Period|Other|1|||
27729691|NCT05195528|80838317|FG003|Extension Period|Other|0|||
27729692|NCT05195528|80838318|FG004|Extension Period|Other|0|||
27729693|NCT00404092|80838319|FG000|Overall Study|Death|1|||
27729694|NCT00404092|80838320|FG001|Overall Study|Death|0|||
27729695|NCT00404092|80838321|FG002|Overall Study|Death|0|||
27729696|NCT00404092|80838322|FG003|Overall Study|Death|0|||
27729697|NCT00404092|80838319|FG000|Overall Study|Adverse Event|0|||
27907944|NCT01042392|81500499|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
27907945|NCT01042392|81500500|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
27907946|NCT01042392|81500501|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
27729698|NCT00404092|80838320|FG001|Overall Study|Adverse Event|0|||
27729699|NCT00404092|80838321|FG002|Overall Study|Adverse Event|1|||
27729700|NCT00404092|80838322|FG003|Overall Study|Adverse Event|0|||
27729701|NCT01708057|80838328|FG000|Overall Study|Withdrawal due to study termination.|1|||
27729702|NCT01708057|80838329|FG001|Overall Study|Withdrawal due to study termination.|1|||
27729703|NCT01708057|80838330|FG002|Overall Study|Withdrawal due to study termination.|1|||
27729704|NCT03569202|80838331|FG000|Part 3|Physician Decision|1|||
27729705|NCT03569202|80838332|FG001|Part 3|Physician Decision|0|||
27729706|NCT03569202|80838331|FG000|Part 3|Other|1|||
27729707|NCT03569202|80838332|FG001|Part 3|Other|1|||
27729708|NCT01107444|80838333|FG000|Overall Study|Withdrawal by Subject|8|||
27729709|NCT01107444|80838334|FG001|Overall Study|Withdrawal by Subject|12|||
27729710|NCT01107444|80838333|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
27729711|NCT01107444|80838334|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
27729712|NCT00793793|80838335|FG000|Overall Study|Adverse Event|0|||
27729713|NCT00793793|80838336|FG001|Overall Study|Adverse Event|0|||
27907947|NCT01042392|81500502|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
27907948|NCT01042392|81500499|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
27907949|NCT01042392|81500500|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
27907950|NCT01042392|81500501|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
27907951|NCT01042392|81500502|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
27907952|NCT01042392|81500499|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
27907953|NCT01042392|81500500|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
27907954|NCT01042392|81500501|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
27907955|NCT01042392|81500502|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
27907956|NCT01042392|81500499|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
27907957|NCT01042392|81500500|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
27907958|NCT01042392|81500501|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
27907959|NCT01042392|81500502|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
27907960|NCT01042392|81500499|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
27907961|NCT01042392|81500500|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
27907962|NCT01042392|81500501|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
27907963|NCT01042392|81500502|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
27907964|NCT01042392|81500499|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
27907965|NCT01042392|81500500|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
27907966|NCT01042392|81500501|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
27907967|NCT01042392|81500502|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
27907968|NCT01042392|81500499|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
27907969|NCT01042392|81500500|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
27907970|NCT01042392|81500501|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
27907971|NCT01042392|81500502|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
27907972|NCT01042392|81500499|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
27907973|NCT01042392|81500500|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
27907974|NCT01042392|81500501|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
27907975|NCT01042392|81500502|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
27907976|NCT02821416|81500503|FG000|Overall Study|Adverse Event|0|||
27907977|NCT02821416|81500504|FG001|Overall Study|Adverse Event|1|||
27907978|NCT02821416|81500503|FG000|Overall Study|Withdrawal by Subject|2|||
27907979|NCT02821416|81500504|FG001|Overall Study|Withdrawal by Subject|0|||
27907980|NCT02821416|81500503|FG000|Overall Study|Lost to Follow-up|1|||
27907981|NCT02821416|81500504|FG001|Overall Study|Lost to Follow-up|0|||
27907982|NCT00759655|81500507|FG000|Overall Study|Termination of the study by sponsor|1|||
27907983|NCT04727528|81500508|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
27907984|NCT04727528|81500509|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
27617813|NCT01489020|80444698|FG003|Overall Study|Withdrawal by Subject|0|||
27617814|NCT01489020|80444699|FG004|Overall Study|Withdrawal by Subject|0|||
27617815|NCT01489020|80444700|FG005|Overall Study|Withdrawal by Subject|0|||
27617816|NCT01489020|80444695|FG000|Overall Study|Adverse Event|0|||
27617817|NCT01489020|80444696|FG001|Overall Study|Adverse Event|0|||
27617818|NCT01489020|80444697|FG002|Overall Study|Adverse Event|3|||
27617819|NCT01489020|80444698|FG003|Overall Study|Adverse Event|0|||
27617820|NCT01489020|80444699|FG004|Overall Study|Adverse Event|3|||
27729714|NCT00793793|80838337|FG002|Overall Study|Adverse Event|1|||
27729715|NCT00793793|80838338|FG003|Overall Study|Adverse Event|1|||
27729716|NCT00793793|80838339|FG004|Overall Study|Adverse Event|0|||
27729717|NCT00793793|80838340|FG005|Overall Study|Adverse Event|1|||
27729718|NCT00793793|80838341|FG006|Overall Study|Adverse Event|2|||
27729719|NCT00793793|80838342|FG007|Overall Study|Adverse Event|0|||
27729720|NCT00793793|80838343|FG008|Overall Study|Adverse Event|0|||
27729721|NCT00793793|80838344|FG009|Overall Study|Adverse Event|0|||
27729722|NCT00793793|80838345|FG010|Overall Study|Adverse Event|0|||
27729723|NCT00793793|80838346|FG011|Overall Study|Adverse Event|2|||
27729724|NCT00793793|80838335|FG000|Overall Study|Protocol Violation|0|||
27729725|NCT00793793|80838336|FG001|Overall Study|Protocol Violation|0|||
27729726|NCT00793793|80838337|FG002|Overall Study|Protocol Violation|0|||
27729727|NCT00793793|80838338|FG003|Overall Study|Protocol Violation|1|||
27729728|NCT00793793|80838339|FG004|Overall Study|Protocol Violation|0|||
27729729|NCT00793793|80838340|FG005|Overall Study|Protocol Violation|0|||
27729730|NCT00793793|80838341|FG006|Overall Study|Protocol Violation|0|||
27729731|NCT00793793|80838342|FG007|Overall Study|Protocol Violation|0|||
27617821|NCT01489020|80444700|FG005|Overall Study|Adverse Event|0|||
27617822|NCT01489020|80444695|FG000|Overall Study|Concomitant disease|0|||
27729732|NCT00793793|80838343|FG008|Overall Study|Protocol Violation|0|||
27729733|NCT00793793|80838344|FG009|Overall Study|Protocol Violation|0|||
27729734|NCT00793793|80838345|FG010|Overall Study|Protocol Violation|0|||
27729735|NCT00793793|80838346|FG011|Overall Study|Protocol Violation|0|||
27729736|NCT00793793|80838335|FG000|Overall Study|Lost to Follow-up|0|||
27729737|NCT00793793|80838336|FG001|Overall Study|Lost to Follow-up|0|||
27729738|NCT00793793|80838337|FG002|Overall Study|Lost to Follow-up|1|||
27729739|NCT00793793|80838338|FG003|Overall Study|Lost to Follow-up|0|||
27729740|NCT00793793|80838339|FG004|Overall Study|Lost to Follow-up|0|||
27729741|NCT00793793|80838340|FG005|Overall Study|Lost to Follow-up|0|||
27729742|NCT00793793|80838341|FG006|Overall Study|Lost to Follow-up|0|||
27729743|NCT00793793|80838342|FG007|Overall Study|Lost to Follow-up|0|||
27729744|NCT00793793|80838343|FG008|Overall Study|Lost to Follow-up|1|||
27729745|NCT00793793|80838344|FG009|Overall Study|Lost to Follow-up|3|||
27729746|NCT00793793|80838345|FG010|Overall Study|Lost to Follow-up|1|||
27729747|NCT00793793|80838346|FG011|Overall Study|Lost to Follow-up|0|||
27729748|NCT00793793|80838335|FG000|Overall Study|Withdrawal by Subject|0|||
27729749|NCT00793793|80838336|FG001|Overall Study|Withdrawal by Subject|0|||
27729750|NCT00793793|80838337|FG002|Overall Study|Withdrawal by Subject|0|||
27729751|NCT00793793|80838338|FG003|Overall Study|Withdrawal by Subject|0|||
27729752|NCT00793793|80838339|FG004|Overall Study|Withdrawal by Subject|1|||
27729753|NCT00793793|80838340|FG005|Overall Study|Withdrawal by Subject|0|||
27729754|NCT00793793|80838341|FG006|Overall Study|Withdrawal by Subject|0|||
27729755|NCT00793793|80838342|FG007|Overall Study|Withdrawal by Subject|0|||
27729756|NCT00793793|80838343|FG008|Overall Study|Withdrawal by Subject|1|||
27729757|NCT00793793|80838344|FG009|Overall Study|Withdrawal by Subject|0|||
27729758|NCT00793793|80838345|FG010|Overall Study|Withdrawal by Subject|0|||
27729759|NCT00793793|80838346|FG011|Overall Study|Withdrawal by Subject|0|||
27729760|NCT00793793|80838335|FG000|Overall Study|reason not specified|0|||
27729761|NCT00793793|80838336|FG001|Overall Study|reason not specified|1|||
27729762|NCT00793793|80838337|FG002|Overall Study|reason not specified|0|||
27729763|NCT00793793|80838338|FG003|Overall Study|reason not specified|1|||
27729764|NCT00793793|80838339|FG004|Overall Study|reason not specified|1|||
27729765|NCT00793793|80838340|FG005|Overall Study|reason not specified|1|||
27729766|NCT00793793|80838341|FG006|Overall Study|reason not specified|2|||
27729767|NCT00793793|80838342|FG007|Overall Study|reason not specified|0|||
27729768|NCT00793793|80838343|FG008|Overall Study|reason not specified|7|||
27729769|NCT00793793|80838344|FG009|Overall Study|reason not specified|6|||
27729770|NCT00793793|80838345|FG010|Overall Study|reason not specified|2|||
27853798|NCT02570113|81295156|FG000|Overall Study|Withdrawal by Subject|3|||
27853799|NCT01765582|81295157|FG000|Overall Study|Other|3|||
27853800|NCT01765582|81295158|FG001|Overall Study|Other|6|||
27853801|NCT01765582|81295159|FG002|Overall Study|Other|9|||
27853802|NCT01765582|81295157|FG000|Overall Study|Lost to Follow-up|2|||
27853803|NCT01765582|81295158|FG001|Overall Study|Lost to Follow-up|2|||
27853804|NCT01765582|81295159|FG002|Overall Study|Lost to Follow-up|1|||
27853805|NCT01765582|81295157|FG000|Overall Study|Death|31|||
27853806|NCT01765582|81295158|FG001|Overall Study|Death|36|||
27853807|NCT01765582|81295159|FG002|Overall Study|Death|33|||
27853808|NCT01765582|81295157|FG000|Overall Study|Sponsor Decision|46|||
27853809|NCT01765582|81295158|FG001|Overall Study|Sponsor Decision|42|||
27853810|NCT01765582|81295159|FG002|Overall Study|Sponsor Decision|42|||
27853811|NCT01765582|81295157|FG000|Overall Study|Withdrawal of Consent|11|||
27853812|NCT01765582|81295158|FG001|Overall Study|Withdrawal of Consent|6|||
27853813|NCT01765582|81295159|FG002|Overall Study|Withdrawal of Consent|10|||
27853814|NCT03734666|81295162|FG000|Overall Study|Other|7|||
27853815|NCT03734666|81295163|FG001|Overall Study|Other|4|||
27853816|NCT03734666|81295162|FG000|Overall Study|Lost to Follow-up|12|||
27853817|NCT03734666|81295163|FG001|Overall Study|Lost to Follow-up|12|||
27853818|NCT00390221|81295168|FG000|Overall Study|Lost to Follow-up|0|||
27853819|NCT00390221|81295169|FG001|Overall Study|Lost to Follow-up|3|||
27853820|NCT00390221|81295170|FG002|Overall Study|Lost to Follow-up|0|||
27853821|NCT00390221|81295168|FG000|Overall Study|Adverse Event|1|||
27853822|NCT00390221|81295169|FG001|Overall Study|Adverse Event|4|||
27853823|NCT00390221|81295170|FG002|Overall Study|Adverse Event|3|||
27853824|NCT00390221|81295168|FG000|Overall Study|Investigator Decision|0|||
27853825|NCT00390221|81295169|FG001|Overall Study|Investigator Decision|0|||
27853826|NCT00390221|81295170|FG002|Overall Study|Investigator Decision|1|||
27853827|NCT00390221|81295168|FG000|Overall Study|Withdrawal by Subject|13|||
27617823|NCT01489020|80444696|FG001|Overall Study|Concomitant disease|0|||
27617824|NCT01489020|80444697|FG002|Overall Study|Concomitant disease|0|||
27853828|NCT00390221|81295169|FG001|Overall Study|Withdrawal by Subject|9|||
27853829|NCT00390221|81295170|FG002|Overall Study|Withdrawal by Subject|7|||
27853830|NCT00390221|81295168|FG000|Overall Study|Subject Non-compliance|1|||
27853831|NCT00390221|81295169|FG001|Overall Study|Subject Non-compliance|0|||
27853832|NCT00390221|81295170|FG002|Overall Study|Subject Non-compliance|2|||
27729771|NCT00793793|80838346|FG011|Overall Study|reason not specified|4|||
27729772|NCT02604264|80838350|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
27729773|NCT02604264|80838351|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
27729774|NCT02689492|80838352|FG000|Overall Study|Lost to Follow-up|61|||
27729775|NCT02689492|80838352|FG000|Overall Study|Withdrawal by Subject|11|||
27853833|NCT00390221|81295168|FG000|Overall Study|Other|3|||
27729776|NCT02689492|80838352|FG000|Overall Study|Death|9|||
27729777|NCT02689492|80838352|FG000|Overall Study|Physician Decision|2|||
27729778|NCT02689492|80838352|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
27729779|NCT02689492|80838352|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
27729780|NCT02689492|80838352|FG000|Overall Study|Other than listed|1|||
27729781|NCT04897867|80838353|FG000|Overall Study|Withdrawal of Consent|1|||
27729782|NCT04897867|80838353|FG000|Overall Study|Pregnancy|1|||
27729783|NCT04897867|80838353|FG000|Overall Study|Lost to Follow-up|7|||
27729784|NCT04897867|80838353|FG000|Overall Study|Reason not Specified|2|||
27729785|NCT02663895|80838356|FG000|Overall Study|Adverse Event|3|||
27729786|NCT02663895|80838356|FG000|Overall Study|Physician Decision|2|||
27729787|NCT02663895|80838356|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
27729788|NCT02663895|80838356|FG000|Overall Study|Withdrawal by Subject|1|||
27729789|NCT03182738|80838357|FG000|Overall Study|Lost to Follow-up|9|||
27729790|NCT03182738|80838358|FG001|Overall Study|Lost to Follow-up|3|||
27729791|NCT03182738|80838357|FG000|Overall Study|Pregnancy|0|||
27729792|NCT03182738|80838358|FG001|Overall Study|Pregnancy|1|||
27729793|NCT03182738|80838357|FG000|Overall Study|Withdrawal by Subject|0|||
27729794|NCT03182738|80838358|FG001|Overall Study|Withdrawal by Subject|1|||
27729795|NCT00929240|80838359|FG000|Initial Treatment Phase|Adverse Event|31|||
27729796|NCT00929240|80838360|FG001|Initial Treatment Phase|Adverse Event|0|||
27729797|NCT00929240|80838361|FG002|Initial Treatment Phase|Adverse Event|0|||
27729798|NCT00929240|80838359|FG000|Initial Treatment Phase|Disease progression|41|||
27729799|NCT00929240|80838360|FG001|Initial Treatment Phase|Disease progression|0|||
27729800|NCT00929240|80838361|FG002|Initial Treatment Phase|Disease progression|0|||
27729801|NCT00929240|80838359|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
27729802|NCT00929240|80838360|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
27729803|NCT00929240|80838361|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
27516915|NCT00146848|80088301|FG000|Pre-randomization|Lost to Follow-up|70|||
27516916|NCT00146848|80088302|FG001|Pre-randomization|Lost to Follow-up|0|||
27516917|NCT00146848|80088303|FG002|Pre-randomization|Lost to Follow-up|0|||
27516918|NCT00146848|80088301|FG000|Pre-randomization|Physician Decision|8|||
27516919|NCT00146848|80088302|FG001|Pre-randomization|Physician Decision|0|||
27516920|NCT00146848|80088303|FG002|Pre-randomization|Physician Decision|0|||
27516921|NCT00146848|80088301|FG000|Pre-randomization|Protocol Violation|172|||
27516922|NCT00146848|80088302|FG001|Pre-randomization|Protocol Violation|0|||
27516923|NCT00146848|80088303|FG002|Pre-randomization|Protocol Violation|0|||
27516924|NCT00146848|80088301|FG000|Pre-randomization|Withdrawal by Subject|40|||
27516925|NCT00146848|80088302|FG001|Pre-randomization|Withdrawal by Subject|0|||
27516926|NCT00146848|80088303|FG002|Pre-randomization|Withdrawal by Subject|0|||
27516927|NCT00146848|80088301|FG000|Post-randomization|Lost to Follow-up|12|||
27516928|NCT00146848|80088302|FG001|Post-randomization|Lost to Follow-up|15|||
27516929|NCT00146848|80088303|FG002|Post-randomization|Lost to Follow-up|12|||
27617825|NCT01489020|80444698|FG003|Overall Study|Concomitant disease|0|||
27617826|NCT01489020|80444699|FG004|Overall Study|Concomitant disease|3|||
27729804|NCT00929240|80838359|FG000|Initial Treatment Phase|Protocol Violation|5|||
27729805|NCT00929240|80838360|FG001|Initial Treatment Phase|Protocol Violation|0|||
27729806|NCT00929240|80838361|FG002|Initial Treatment Phase|Protocol Violation|0|||
27729807|NCT00929240|80838359|FG000|Initial Treatment Phase|Death|2|||
27729808|NCT00929240|80838360|FG001|Initial Treatment Phase|Death|0|||
27729809|NCT00929240|80838361|FG002|Initial Treatment Phase|Death|0|||
27729810|NCT00929240|80838359|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
27729811|NCT00929240|80838360|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
27729812|NCT00929240|80838361|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
27729813|NCT00929240|80838359|FG000|Initial Treatment Phase|Physician Decision|4|||
27729814|NCT00929240|80838360|FG001|Initial Treatment Phase|Physician Decision|0|||
27729815|NCT00929240|80838361|FG002|Initial Treatment Phase|Physician Decision|0|||
27729816|NCT00929240|80838359|FG000|Maintenance Phase|Disease progression|0|||
27729817|NCT00929240|80838360|FG001|Maintenance Phase|Disease progression|73|||
27729818|NCT00929240|80838361|FG002|Maintenance Phase|Disease progression|60|||
27729819|NCT00929240|80838359|FG000|Maintenance Phase|Adverse Event|0|||
27729820|NCT00929240|80838360|FG001|Maintenance Phase|Adverse Event|9|||
27729821|NCT00929240|80838361|FG002|Maintenance Phase|Adverse Event|12|||
27729822|NCT00929240|80838359|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27907985|NCT04727528|81500508|FG000|Open-label Period|Randomized who did not receive treatment|1|||
27907986|NCT04727528|81500509|FG001|Open-label Period|Randomized who did not receive treatment|0|||
27907987|NCT04727528|81500508|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27516930|NCT00146848|80088301|FG000|Post-randomization|Withdrawn|26|||
27907988|NCT04727528|81500509|FG001|Double-blind Treatment Phase|Adverse Event|1|||
27907989|NCT04727528|81500508|FG000|Double-blind Treatment Phase|Death|0|||
27516931|NCT00146848|80088302|FG001|Post-randomization|Withdrawn|32|||
27617827|NCT01489020|80444700|FG005|Overall Study|Concomitant disease|0|||
27617828|NCT01066156|80444701|FG000|Overall Study|ineligible|2|||
27617829|NCT01066156|80444701|FG000|Overall Study|Lost to Follow-up|7|||
27729823|NCT00929240|80838360|FG001|Maintenance Phase|Withdrawal by Subject|2|||
27729824|NCT00929240|80838361|FG002|Maintenance Phase|Withdrawal by Subject|6|||
27729825|NCT00929240|80838359|FG000|Maintenance Phase|Protocol Violation|0|||
27729826|NCT00929240|80838360|FG001|Maintenance Phase|Protocol Violation|1|||
27729827|NCT00929240|80838361|FG002|Maintenance Phase|Protocol Violation|0|||
27729828|NCT00929240|80838359|FG000|Maintenance Phase|Health authority/Study termination|0|||
27729829|NCT00929240|80838360|FG001|Maintenance Phase|Health authority/Study termination|1|||
27729830|NCT00929240|80838361|FG002|Maintenance Phase|Health authority/Study termination|2|||
27729831|NCT00929240|80838359|FG000|Maintenance Phase|Physician Decision|0|||
27729832|NCT00929240|80838360|FG001|Maintenance Phase|Physician Decision|2|||
27516932|NCT00146848|80088303|FG002|Post-randomization|Withdrawn|27|||
27516933|NCT00271505|80088304|FG000|Overall Study|Screen Failure|3|||
27516934|NCT00271505|80088304|FG000|Overall Study|Adverse Event|1|||
27516935|NCT00271505|80088304|FG000|Overall Study|Death|1|||
27516936|NCT03672097|80088305|FG000|Period 1|Withdrawal by Subject|2|||
27516937|NCT03672097|80088305|FG000|Period 1|Adverse Event|1|||
27516938|NCT03672097|80088305|FG000|Period 1|Did not receive treatment|1|||
27516939|NCT03672097|80088305|FG000|Period 2|Withdrawal by Subject|3|||
27516940|NCT03672097|80088305|FG000|Period 2|Other|1|||
27516941|NCT04074161|80088306|FG000|Overall Study|Withdrawal by Subject|2|||
27617830|NCT01066156|80444701|FG000|Overall Study|Withdrawal by Subject|1|||
27617831|NCT04793464|80444702|FG000|Overall Study|Lost to Follow-up|458|||
27617832|NCT04793464|80444703|FG001|Overall Study|Lost to Follow-up|168|||
27729833|NCT00929240|80838361|FG002|Maintenance Phase|Physician Decision|1|||
27729834|NCT00929240|80838359|FG000|Maintenance Phase|Change of treatment|0|||
27729835|NCT00929240|80838360|FG001|Maintenance Phase|Change of treatment|4|||
27729836|NCT00929240|80838361|FG002|Maintenance Phase|Change of treatment|0|||
27729837|NCT00929240|80838359|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
27729838|NCT00929240|80838360|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
27729839|NCT00929240|80838361|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
27729840|NCT00929240|80838359|FG000|Maintenance Phase|Participant not treated|0|||
27729841|NCT00929240|80838360|FG001|Maintenance Phase|Participant not treated|2|||
27729842|NCT00929240|80838361|FG002|Maintenance Phase|Participant not treated|0|||
27729843|NCT03882424|80838362|FG000|Overall Study|Lost to Follow-up|3|||
27729844|NCT03882424|80838363|FG001|Overall Study|Lost to Follow-up|0|||
27729845|NCT03882424|80838364|FG002|Overall Study|Lost to Follow-up|0|||
27729846|NCT03882424|80838362|FG000|Overall Study|schedule conflict|1|||
27729847|NCT03882424|80838363|FG001|Overall Study|schedule conflict|0|||
27729848|NCT03882424|80838364|FG002|Overall Study|schedule conflict|0|||
27729849|NCT02393209|80838365|FG000|Overall Study|Study Terminated by Sponsor|1|||
27729850|NCT02393209|80838366|FG001|Overall Study|Study Terminated by Sponsor|1|||
27729851|NCT02393209|80838367|FG002|Overall Study|Study Terminated by Sponsor|0|||
27729852|NCT02393209|80838368|FG003|Overall Study|Study Terminated by Sponsor|0|||
27729853|NCT02393209|80838365|FG000|Overall Study|Withdrawal by Patient|1|||
27729854|NCT02393209|80838366|FG001|Overall Study|Withdrawal by Patient|0|||
27729855|NCT02393209|80838367|FG002|Overall Study|Withdrawal by Patient|0|||
27729856|NCT02393209|80838368|FG003|Overall Study|Withdrawal by Patient|0|||
27729857|NCT02393209|80838365|FG000|Overall Study|Death|2|||
27729858|NCT02393209|80838366|FG001|Overall Study|Death|2|||
27729859|NCT02393209|80838367|FG002|Overall Study|Death|0|||
27729860|NCT02393209|80838368|FG003|Overall Study|Death|0|||
27729861|NCT02393209|80838365|FG000|Overall Study|Death due to Disease Progression|2|||
27729862|NCT02393209|80838366|FG001|Overall Study|Death due to Disease Progression|2|||
27729863|NCT02393209|80838367|FG002|Overall Study|Death due to Disease Progression|0|||
27729864|NCT02393209|80838368|FG003|Overall Study|Death due to Disease Progression|0|||
27729865|NCT02393209|80838365|FG000|Overall Study|Death from Legionella Infection|0|||
27729866|NCT02393209|80838366|FG001|Overall Study|Death from Legionella Infection|1|||
27729867|NCT02393209|80838367|FG002|Overall Study|Death from Legionella Infection|0|||
27729868|NCT02393209|80838368|FG003|Overall Study|Death from Legionella Infection|0|||
27729869|NCT02393209|80838365|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
27729870|NCT02393209|80838366|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
27729871|NCT02393209|80838367|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
27729872|NCT02393209|80838368|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
27729873|NCT02393209|80838365|FG000|Overall Study|Lost to Follow-up|0|||
27729874|NCT02393209|80838366|FG001|Overall Study|Lost to Follow-up|1|||
27729875|NCT02393209|80838367|FG002|Overall Study|Lost to Follow-up|0|||
27729876|NCT02393209|80838368|FG003|Overall Study|Lost to Follow-up|0|||
27729877|NCT01384292|80838371|FG000|Part B|Severe non-compliance to protocol|1|||
27907990|NCT04727528|81500509|FG001|Double-blind Treatment Phase|Death|1|||
27907991|NCT04727528|81500508|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
27729878|NCT01384292|80838372|FG001|Part B|Severe non-compliance to protocol|0|||
27729879|NCT01384292|80838373|FG002|Part B|Severe non-compliance to protocol|0|||
27729880|NCT01624194|80838377|FG000|Overall Study|Lost to Follow-up|1|||
27516942|NCT04074161|80088307|FG001|Overall Study|Withdrawal by Subject|4|||
27516943|NCT04074161|80088308|FG002|Overall Study|Withdrawal by Subject|1|||
27516944|NCT04074161|80088306|FG000|Overall Study|Lost to Follow-up|4|||
27617833|NCT04793464|80444704|FG002|Overall Study|Lost to Follow-up|5|||
27729881|NCT01624194|80838378|FG001|Overall Study|Lost to Follow-up|0|||
27729882|NCT01624194|80838377|FG000|Overall Study|Withdrawal by Subject|1|||
27729883|NCT01624194|80838378|FG001|Overall Study|Withdrawal by Subject|0|||
27729884|NCT01805180|80838379|FG000|Lead-in Donor Phase|screen failure|1|||
27729885|NCT01805180|80838380|FG001|Lead-in Donor Phase|screen failure|0|||
27729886|NCT01805180|80838381|FG002|Lead-in Donor Phase|screen failure|0|||
27729887|NCT01299727|80838382|FG000|Overall Study|Withdrawal by Subject|1|||
27729888|NCT01299727|80838383|FG001|Overall Study|Withdrawal by Subject|0|||
27729889|NCT01299727|80838384|FG002|Overall Study|Withdrawal by Subject|0|||
27729890|NCT01299727|80838382|FG000|Overall Study|Adverse Event|0|||
27729891|NCT01299727|80838383|FG001|Overall Study|Adverse Event|0|||
27729892|NCT01299727|80838384|FG002|Overall Study|Adverse Event|1|||
27729893|NCT01299727|80838382|FG000|Overall Study|Completed the Treatment Period|3|||
27729894|NCT01299727|80838383|FG001|Overall Study|Completed the Treatment Period|4|||
27729895|NCT01299727|80838384|FG002|Overall Study|Completed the Treatment Period|3|||
27729896|NCT00191854|80838385|FG000|Overall Study|Death|26|||
27729897|NCT00191854|80838386|FG001|Overall Study|Death|23|||
27729898|NCT00191854|80838387|FG002|Overall Study|Death|29|||
27729899|NCT00191854|80838385|FG000|Overall Study|Lost to Follow-up|7|||
27729900|NCT00191854|80838386|FG001|Overall Study|Lost to Follow-up|5|||
27729901|NCT00191854|80838387|FG002|Overall Study|Lost to Follow-up|5|||
27729902|NCT00191854|80838385|FG000|Overall Study|Withdrawal by Subject|4|||
27729903|NCT00191854|80838386|FG001|Overall Study|Withdrawal by Subject|2|||
27729904|NCT00191854|80838387|FG002|Overall Study|Withdrawal by Subject|3|||
27729905|NCT00191854|80838385|FG000|Overall Study|Sponsor Decision|0|||
27729906|NCT00191854|80838386|FG001|Overall Study|Sponsor Decision|0|||
27729907|NCT00191854|80838387|FG002|Overall Study|Sponsor Decision|1|||
27729908|NCT00191854|80838385|FG000|Overall Study|Screen Failure|0|||
27729909|NCT00191854|80838386|FG001|Overall Study|Screen Failure|0|||
27729910|NCT00191854|80838387|FG002|Overall Study|Screen Failure|1|||
27516945|NCT04074161|80088307|FG001|Overall Study|Lost to Follow-up|5|||
27516946|NCT04074161|80088308|FG002|Overall Study|Lost to Follow-up|3|||
27516947|NCT02238067|80088309|FG000|Overall Study|Not completed survey at Month 6|45|||
27516948|NCT01675167|80088310|FG000|Open-label Titration Phase|Adverse Event|81|||
27516949|NCT01675167|80088311|FG001|Open-label Titration Phase|Adverse Event|0|||
27516950|NCT01675167|80088312|FG002|Open-label Titration Phase|Adverse Event|0|||
27516951|NCT01675167|80088310|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
27516952|NCT01675167|80088311|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
27516953|NCT01675167|80088312|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
27729911|NCT01354132|80838388|FG000|Randomization|Physician Decision|1|||
27516954|NCT01675167|80088310|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
27516955|NCT01675167|80088311|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
27516956|NCT01675167|80088312|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
27516957|NCT01675167|80088310|FG000|Open-label Titration Phase|Protocol Violation|43|||
27516958|NCT01675167|80088311|FG001|Open-label Titration Phase|Protocol Violation|0|||
27516959|NCT01675167|80088312|FG002|Open-label Titration Phase|Protocol Violation|0|||
27516960|NCT01675167|80088310|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
27516961|NCT01675167|80088311|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
27516962|NCT01675167|80088312|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
27516963|NCT01675167|80088310|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
27516964|NCT01675167|80088311|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
27516965|NCT01675167|80088312|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
27516966|NCT01675167|80088310|FG000|Open-label Titration Phase|Other|55|||
27516967|NCT01675167|80088311|FG001|Open-label Titration Phase|Other|0|||
27516968|NCT01675167|80088312|FG002|Open-label Titration Phase|Other|0|||
27516969|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
27516970|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
27516971|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
27516972|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27729912|NCT01354132|80838389|FG001|Randomization|Physician Decision|0|||
27853834|NCT00390221|81295169|FG001|Overall Study|Other|4|||
27516973|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
27516974|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
27516975|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27729913|NCT01354132|80838388|FG000|Randomization|Withdrawal by Subject|0|||
27729914|NCT01354132|80838389|FG001|Randomization|Withdrawal by Subject|1|||
27729915|NCT01354132|80838388|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
27516976|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Adverse Event|5|||
27516977|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Adverse Event|13|||
27516978|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
27729916|NCT01354132|80838389|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
27729917|NCT01354132|80838388|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
27729918|NCT01354132|80838389|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
27729919|NCT01354132|80838388|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
27516979|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
27516980|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
27516981|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27516982|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
27516983|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
27516984|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
27516985|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
27516986|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
27516987|NCT01675167|80088310|FG000|Double-blind Treatment Phase|Other|0|||
27516988|NCT01675167|80088311|FG001|Double-blind Treatment Phase|Other|7|||
27516989|NCT01675167|80088312|FG002|Double-blind Treatment Phase|Other|5|||
27516990|NCT02036970|80088317|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27516991|NCT02036970|80088318|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27516992|NCT02036970|80088319|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
27516993|NCT02036970|80088320|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
27516994|NCT02036970|80088321|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27516995|NCT02036970|80088322|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
27516996|NCT02036970|80088323|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
27516997|NCT02036970|80088324|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
27516998|NCT02036970|80088325|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
27516999|NCT02036970|80088326|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
27517000|NCT02036970|80088317|FG000|Part 1: Day 1 Through Week 16|Death|0|||
27517001|NCT02036970|80088318|FG001|Part 1: Day 1 Through Week 16|Death|0|||
27517002|NCT02036970|80088319|FG002|Part 1: Day 1 Through Week 16|Death|0|||
27517003|NCT02036970|80088320|FG003|Part 1: Day 1 Through Week 16|Death|0|||
27517004|NCT02036970|80088321|FG004|Part 1: Day 1 Through Week 16|Death|0|||
27517005|NCT02036970|80088322|FG005|Part 1: Day 1 Through Week 16|Death|0|||
27517006|NCT02036970|80088323|FG006|Part 1: Day 1 Through Week 16|Death|0|||
27517007|NCT02036970|80088324|FG007|Part 1: Day 1 Through Week 16|Death|0|||
27517008|NCT02036970|80088325|FG008|Part 1: Day 1 Through Week 16|Death|1|||
27517009|NCT02036970|80088326|FG009|Part 1: Day 1 Through Week 16|Death|0|||
27517010|NCT02036970|80088317|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
27517011|NCT02036970|80088318|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517012|NCT02036970|80088319|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
27517013|NCT02036970|80088320|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517014|NCT02036970|80088321|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517015|NCT02036970|80088322|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517016|NCT02036970|80088323|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517017|NCT02036970|80088324|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517018|NCT02036970|80088325|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
27517019|NCT02036970|80088326|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
27517020|NCT02036970|80088317|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517021|NCT02036970|80088318|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517022|NCT02036970|80088319|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517023|NCT02036970|80088320|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517024|NCT02036970|80088321|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
27517025|NCT02036970|80088322|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517026|NCT02036970|80088323|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517027|NCT02036970|80088324|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
27517028|NCT02036970|80088325|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
27517029|NCT02036970|80088326|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
27517030|NCT02036970|80088317|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517031|NCT02036970|80088318|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517032|NCT02036970|80088319|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517033|NCT02036970|80088320|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
27517034|NCT02036970|80088321|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517035|NCT02036970|80088322|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517036|NCT02036970|80088323|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517037|NCT02036970|80088324|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517038|NCT02036970|80088325|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517039|NCT02036970|80088326|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
27517040|NCT02036970|80088317|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
27517041|NCT02036970|80088318|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
27517042|NCT02036970|80088319|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
27517043|NCT02036970|80088320|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
27517044|NCT02036970|80088321|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
27517045|NCT02036970|80088322|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
27517046|NCT02036970|80088323|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
27517047|NCT02036970|80088324|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
27517048|NCT02036970|80088325|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
27729920|NCT01354132|80838389|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
27729921|NCT01948830|80838390|FG000|Overall Study|Physician Decision|1|||
27729922|NCT01948830|80838391|FG001|Overall Study|Physician Decision|3|||
27729923|NCT01948830|80838390|FG000|Overall Study|Protocol deviation|1|||
27729924|NCT01948830|80838391|FG001|Overall Study|Protocol deviation|2|||
27729925|NCT01948830|80838390|FG000|Overall Study|Lost to Follow-up|5|||
27729926|NCT01948830|80838391|FG001|Overall Study|Lost to Follow-up|4|||
27729927|NCT01948830|80838390|FG000|Overall Study|Withdrawal by Subject|14|||
27729928|NCT01948830|80838391|FG001|Overall Study|Withdrawal by Subject|17|||
27729929|NCT01948830|80838390|FG000|Overall Study|Adverse Event|9|||
27729930|NCT01948830|80838391|FG001|Overall Study|Adverse Event|2|||
27729931|NCT01948830|80838390|FG000|Overall Study|Death|3|||
27729932|NCT01948830|80838391|FG001|Overall Study|Death|4|||
27729933|NCT02502864|80838392|FG000|Overall Study|Withdrawal by Subject|1|||
27729934|NCT00974220|80838394|FG000|Treatment Period 1|Adverse Event|2|||
27729935|NCT00974220|80838395|FG001|Treatment Period 1|Adverse Event|1|||
27729936|NCT00974220|80838394|FG000|Treatment Period 1|noncompliant subjects|0|||
27729937|NCT00974220|80838395|FG001|Treatment Period 1|noncompliant subjects|1|||
27729938|NCT01976806|80838396|FG000|Overall Study|Lost to Follow-up|1|||
27729939|NCT01976806|80838397|FG001|Overall Study|Lost to Follow-up|4|||
27729940|NCT01976806|80838396|FG000|Overall Study|Adverse Event|1|||
27729941|NCT01976806|80838397|FG001|Overall Study|Adverse Event|1|||
27729942|NCT01976806|80838396|FG000|Overall Study|Withdrawal by Subject|1|||
27729943|NCT01976806|80838397|FG001|Overall Study|Withdrawal by Subject|1|||
27729944|NCT02203149|80838398|FG000|Part 1|Adverse Event|0|||
27729945|NCT02203149|80838399|FG001|Part 1|Adverse Event|1|||
27729946|NCT02203149|80838400|FG002|Part 1|Adverse Event|0|||
27729947|NCT02203149|80838401|FG003|Part 1|Adverse Event|0|||
27729948|NCT02203149|80838402|FG004|Part 1|Adverse Event|0|||
27729949|NCT02203149|80838398|FG000|Part 2|Death|0|||
27729950|NCT02203149|80838399|FG001|Part 2|Death|0|||
27729951|NCT02203149|80838400|FG002|Part 2|Death|1|||
27729952|NCT02203149|80838401|FG003|Part 2|Death|1|||
27517049|NCT02036970|80088326|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
27729953|NCT02203149|80838402|FG004|Part 2|Death|0|||
27729954|NCT02203149|80838398|FG000|Part 2|Withdrawal by Subject|0|||
27729955|NCT02203149|80838399|FG001|Part 2|Withdrawal by Subject|0|||
27729956|NCT02203149|80838400|FG002|Part 2|Withdrawal by Subject|0|||
27729957|NCT02203149|80838401|FG003|Part 2|Withdrawal by Subject|1|||
27729958|NCT02203149|80838402|FG004|Part 2|Withdrawal by Subject|0|||
27729959|NCT02203149|80838398|FG000|Part 2|Adverse Event|0|||
27729960|NCT02203149|80838399|FG001|Part 2|Adverse Event|0|||
27729961|NCT02203149|80838400|FG002|Part 2|Adverse Event|0|||
27729962|NCT02203149|80838401|FG003|Part 2|Adverse Event|1|||
27729963|NCT02203149|80838402|FG004|Part 2|Adverse Event|1|||
27729964|NCT01279057|80838403|FG000|Overall Study|Adverse Event|1|||
27729965|NCT01279057|80838404|FG001|Overall Study|Adverse Event|0|||
27729966|NCT01279057|80838405|FG002|Overall Study|Adverse Event|1|||
27729967|NCT01279057|80838403|FG000|Overall Study|Insufficient therapeutic response|0|||
27729968|NCT01279057|80838404|FG001|Overall Study|Insufficient therapeutic response|0|||
27729969|NCT01279057|80838405|FG002|Overall Study|Insufficient therapeutic response|1|||
27729970|NCT01279057|80838403|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27729971|NCT01279057|80838404|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
27729972|NCT01279057|80838405|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
27729973|NCT01279057|80838403|FG000|Overall Study|Withdrew consent|2|||
27729974|NCT01279057|80838404|FG001|Overall Study|Withdrew consent|0|||
27729975|NCT01279057|80838405|FG002|Overall Study|Withdrew consent|1|||
27729976|NCT01279057|80838403|FG000|Overall Study|Pregnancy|0|||
27729977|NCT01279057|80838404|FG001|Overall Study|Pregnancy|1|||
27729978|NCT01279057|80838405|FG002|Overall Study|Pregnancy|0|||
27729979|NCT01279057|80838403|FG000|Overall Study|Other|3|||
27729980|NCT01279057|80838404|FG001|Overall Study|Other|3|||
27729981|NCT01279057|80838405|FG002|Overall Study|Other|0|||
27729982|NCT00888355|80838406|FG000|Overall Study|Adverse Event|10|||
27729983|NCT00888355|80838407|FG001|Overall Study|Adverse Event|0|||
27729984|NCT00888355|80838408|FG002|Overall Study|Adverse Event|3|||
27729985|NCT00888355|80838409|FG003|Overall Study|Adverse Event|3|||
27729986|NCT00888355|80838406|FG000|Overall Study|Lack of Efficacy|9|||
27729987|NCT00888355|80838407|FG001|Overall Study|Lack of Efficacy|2|||
27729988|NCT00888355|80838408|FG002|Overall Study|Lack of Efficacy|5|||
27729989|NCT00888355|80838409|FG003|Overall Study|Lack of Efficacy|2|||
27729990|NCT00888355|80838406|FG000|Overall Study|Lost to Follow-up|0|||
27729991|NCT00888355|80838407|FG001|Overall Study|Lost to Follow-up|2|||
27729992|NCT00888355|80838408|FG002|Overall Study|Lost to Follow-up|2|||
27729993|NCT00888355|80838409|FG003|Overall Study|Lost to Follow-up|0|||
27729994|NCT00888355|80838406|FG000|Overall Study|Protocol Violation|3|||
27729995|NCT00888355|80838407|FG001|Overall Study|Protocol Violation|2|||
27729996|NCT00888355|80838408|FG002|Overall Study|Protocol Violation|1|||
27729997|NCT00888355|80838409|FG003|Overall Study|Protocol Violation|2|||
27729998|NCT00888355|80838406|FG000|Overall Study|Withdrawal by Subject|0|||
27517050|NCT02036970|80088317|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517051|NCT02036970|80088318|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517052|NCT02036970|80088319|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517053|NCT02036970|80088320|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517054|NCT02036970|80088321|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517055|NCT02036970|80088322|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517056|NCT02036970|80088323|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517057|NCT02036970|80088324|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
27517058|NCT02036970|80088325|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517059|NCT02036970|80088326|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
27517060|NCT02036970|80088317|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517061|NCT02036970|80088318|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
27517062|NCT02036970|80088319|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
27517063|NCT02036970|80088320|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517064|NCT02036970|80088321|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517065|NCT02036970|80088322|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517066|NCT02036970|80088323|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517067|NCT02036970|80088324|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517068|NCT02036970|80088325|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
27517069|NCT02036970|80088326|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
27517070|NCT02036970|80088317|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
27517071|NCT02036970|80088318|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
27517072|NCT02036970|80088319|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
27517073|NCT02036970|80088320|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
27517074|NCT02036970|80088321|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
27517075|NCT02036970|80088322|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
27517076|NCT02036970|80088323|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
27517077|NCT02036970|80088324|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
27517078|NCT02036970|80088325|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
27517079|NCT02036970|80088326|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
27517080|NCT00904033|80088327|FG000|Overall Study|Withdrawal by Subject|1|||
27517081|NCT00904033|80088328|FG001|Overall Study|Withdrawal by Subject|1|||
27517082|NCT00904033|80088329|FG002|Overall Study|Withdrawal by Subject|0|||
27517083|NCT00904033|80088330|FG003|Overall Study|Withdrawal by Subject|0|||
27517084|NCT00904033|80088327|FG000|Overall Study|Physician Decision|0|||
27517085|NCT00904033|80088328|FG001|Overall Study|Physician Decision|0|||
27517086|NCT00904033|80088329|FG002|Overall Study|Physician Decision|1|||
27517087|NCT00904033|80088330|FG003|Overall Study|Physician Decision|0|||
27517088|NCT00904033|80088327|FG000|Overall Study|Unable to obtain final blood draw|0|||
27517089|NCT00904033|80088328|FG001|Overall Study|Unable to obtain final blood draw|0|||
27517090|NCT00904033|80088329|FG002|Overall Study|Unable to obtain final blood draw|0|||
27517091|NCT00904033|80088330|FG003|Overall Study|Unable to obtain final blood draw|2|||
27517092|NCT00759564|80088331|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
27517093|NCT00759564|80088332|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
27517094|NCT00759564|80088333|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
27517095|NCT00759564|80088334|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
27517096|NCT00759564|80088335|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
27517097|NCT01731938|80088346|FG000|Preliminary Part I|Withdrawal by Subject|2|||
27517098|NCT01731938|80088347|FG001|Preliminary Part I|Withdrawal by Subject|2|||
27517099|NCT01731938|80088346|FG000|Preliminary Part I|Physician Decision|1|||
27517100|NCT01731938|80088347|FG001|Preliminary Part I|Physician Decision|0|||
27517101|NCT01731938|80088346|FG000|Preliminary Part I|Lost to Follow-up|0|||
27517102|NCT01731938|80088347|FG001|Preliminary Part I|Lost to Follow-up|3|||
27517103|NCT01731938|80088346|FG000|Preliminary Part I|Missed Week 6 visit|0|||
27517104|NCT01731938|80088347|FG001|Preliminary Part I|Missed Week 6 visit|3|||
27517105|NCT01731938|80088346|FG000|Primary Part II|Withdrawal by Subject|5|||
27517106|NCT01731938|80088347|FG001|Primary Part II|Withdrawal by Subject|4|||
27517107|NCT01731938|80088346|FG000|Primary Part II|Lost to Follow-up|4|||
27517108|NCT01731938|80088347|FG001|Primary Part II|Lost to Follow-up|5|||
27517109|NCT01731938|80088346|FG000|Primary Part II|Death|2|||
27907992|NCT04727528|81500509|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
27907993|NCT04727528|81500508|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
27907994|NCT04727528|81500509|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
27517110|NCT01731938|80088347|FG001|Primary Part II|Death|1|||
27517111|NCT01731938|80088346|FG000|Primary Part II|Missed Week 6 visit|2|||
27729999|NCT00888355|80838407|FG001|Overall Study|Withdrawal by Subject|3|||
27907995|NCT04727528|81500508|FG000|Double-blind Treatment Phase|Physician Decision|0|||
27517112|NCT01731938|80088347|FG001|Primary Part II|Missed Week 6 visit|3|||
27517113|NCT00003590|80088348|FG000|Overall Study|Ineligible Patient|1|||
27517114|NCT00003590|80088348|FG000|Overall Study|Adverse Event|7|||
27517115|NCT00003590|80088348|FG000|Overall Study|Withdrawal by Subject|1|||
27517116|NCT00003590|80088348|FG000|Overall Study|Lack of Efficacy|11|||
27517117|NCT00003590|80088348|FG000|Overall Study|Death|1|||
27517118|NCT00003590|80088348|FG000|Overall Study|Physician Decision|1|||
27517119|NCT03425253|80088349|FG000|Overall Study|Adverse Event|2|||
27517120|NCT03425253|80088349|FG000|Overall Study|Lost to Follow-up|3|||
27517121|NCT03425253|80088349|FG000|Overall Study|Withdrew Consent|6|||
27517122|NCT03425253|80088349|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
27517123|NCT00763698|80088350|FG000|Overall Study|Unsuccessful Implant|5|||
27517124|NCT00763698|80088350|FG000|Overall Study|Death|4|||
27517125|NCT00763698|80088350|FG000|Overall Study|Withdrawal by Subject|1|||
27517126|NCT04359901|80088351|FG000|Overall Study|Withdrawal by Subject|0|||
27517127|NCT04359901|80088352|FG001|Overall Study|Withdrawal by Subject|1|||
27517128|NCT04359901|80088351|FG000|Overall Study|Death|6|||
27517129|NCT04359901|80088352|FG001|Overall Study|Death|2|||
27517130|NCT00684060|80088353|FG000|Overall Study|Lost to Follow-up|1|||
27517131|NCT00684060|80088354|FG001|Overall Study|Lost to Follow-up|0|||
27517132|NCT00684060|80088353|FG000|Overall Study|New stenosis identified|1|||
27730000|NCT00888355|80838408|FG002|Overall Study|Withdrawal by Subject|1|||
27730001|NCT00888355|80838409|FG003|Overall Study|Withdrawal by Subject|3|||
27730002|NCT01070329|80838410|FG000|Overall Study|Adverse Event|13|||
27730003|NCT01070329|80838411|FG001|Overall Study|Adverse Event|10|||
27730004|NCT01070329|80838410|FG000|Overall Study|Lost to Follow-up|22|||
27730005|NCT01070329|80838411|FG001|Overall Study|Lost to Follow-up|12|||
27730006|NCT01070329|80838410|FG000|Overall Study|Withdrawal by Subject|9|||
27730007|NCT01070329|80838411|FG001|Overall Study|Withdrawal by Subject|11|||
27730008|NCT01070329|80838410|FG000|Overall Study|Protocol Violation|3|||
27730009|NCT01070329|80838411|FG001|Overall Study|Protocol Violation|8|||
27730010|NCT01070329|80838410|FG000|Overall Study|Lack of Efficacy|2|||
27730011|NCT01070329|80838411|FG001|Overall Study|Lack of Efficacy|6|||
27730012|NCT01070329|80838410|FG000|Overall Study|Physician Decision|2|||
27730013|NCT01070329|80838411|FG001|Overall Study|Physician Decision|1|||
27730014|NCT01070329|80838410|FG000|Overall Study|Entry Criteria Not Met|1|||
27730015|NCT01070329|80838411|FG001|Overall Study|Entry Criteria Not Met|0|||
27730016|NCT01070329|80838410|FG000|Overall Study|Sponsor Decision|0|||
27730017|NCT01070329|80838411|FG001|Overall Study|Sponsor Decision|1|||
27730018|NCT00855439|80838412|FG000|Overall Study|Withdrawal by Subject|2|||
27730019|NCT00855439|80838413|FG001|Overall Study|Withdrawal by Subject|0|||
27730020|NCT00855439|80838412|FG000|Overall Study|Pregnancy|1|||
27730021|NCT00855439|80838413|FG001|Overall Study|Pregnancy|0|||
27730022|NCT01485614|80838416|FG000|Randomization|Not Treated|1|||
27730023|NCT01485614|80838417|FG001|Randomization|Not Treated|0|||
27730024|NCT01485614|80838418|FG002|Randomization|Not Treated|0|||
27730025|NCT01485614|80838419|FG003|Randomization|Not Treated|0|||
27730026|NCT01485614|80838416|FG000|Weeks 0-20|Lost to Follow-up|2|||
27730027|NCT01485614|80838417|FG001|Weeks 0-20|Lost to Follow-up|0|||
27730028|NCT01485614|80838418|FG002|Weeks 0-20|Lost to Follow-up|0|||
27730029|NCT01485614|80838419|FG003|Weeks 0-20|Lost to Follow-up|0|||
27730030|NCT01485614|80838416|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
27730031|NCT01485614|80838417|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
27907996|NCT04727528|81500509|FG001|Double-blind Treatment Phase|Physician Decision|1|||
27907997|NCT04727528|81500508|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
27907998|NCT04727528|81500509|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27907999|NCT01744483|81500510|FG000|Overall Study|Death|9|||
27908000|NCT01744483|81500511|FG001|Overall Study|Death|4|||
27908001|NCT01744483|81500512|FG002|Overall Study|Death|11|||
27730032|NCT01485614|80838418|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
27730033|NCT01485614|80838419|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
27730034|NCT01485614|80838416|FG000|Weeks 0-20|Withdrawal by Subject|3|||
27730035|NCT01485614|80838417|FG001|Weeks 0-20|Withdrawal by Subject|2|||
27730036|NCT01485614|80838418|FG002|Weeks 0-20|Withdrawal by Subject|1|||
27730037|NCT01485614|80838419|FG003|Weeks 0-20|Withdrawal by Subject|0|||
27730038|NCT01485614|80838416|FG000|Weeks 20-54|Lost to Follow-up|4|||
27730039|NCT01485614|80838417|FG001|Weeks 20-54|Lost to Follow-up|3|||
27730040|NCT01485614|80838418|FG002|Weeks 20-54|Lost to Follow-up|1|||
27730041|NCT01485614|80838419|FG003|Weeks 20-54|Lost to Follow-up|0|||
27730042|NCT01485614|80838416|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
27730043|NCT01485614|80838417|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
27730044|NCT01485614|80838418|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
27730045|NCT01485614|80838419|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
27517133|NCT00684060|80088354|FG001|Overall Study|New stenosis identified|0|||
27908002|NCT01744483|81500510|FG000|Overall Study|Lost to Follow-up|8|||
27517134|NCT00684060|80088353|FG000|Overall Study|Unable to collect MRI|1|||
27730046|NCT01485614|80838416|FG000|Weeks 20-54|Withdrawal by Subject|5|||
27730047|NCT01485614|80838417|FG001|Weeks 20-54|Withdrawal by Subject|3|||
27730048|NCT01485614|80838418|FG002|Weeks 20-54|Withdrawal by Subject|0|||
27517135|NCT00684060|80088354|FG001|Overall Study|Unable to collect MRI|2|||
27517136|NCT00684060|80088353|FG000|Overall Study|Death|0|||
27730049|NCT01485614|80838419|FG003|Weeks 20-54|Withdrawal by Subject|0|||
27730050|NCT00709202|80838424|FG000|Overall Study|Withdrawal by Subject|6|||
27730051|NCT00709202|80838425|FG001|Overall Study|Withdrawal by Subject|6|||
27517137|NCT00684060|80088354|FG001|Overall Study|Death|1|||
27517138|NCT01590758|80088355|FG000|Overall Study|Withdrawal by Subject|0|||
27517139|NCT01590758|80088356|FG001|Overall Study|Withdrawal by Subject|3|||
27517140|NCT01590758|80088355|FG000|Overall Study|Physician Decision|1|||
27517141|NCT01590758|80088356|FG001|Overall Study|Physician Decision|2|||
27517142|NCT01590758|80088355|FG000|Overall Study|Lost to Follow-up|4|||
27517143|NCT01590758|80088356|FG001|Overall Study|Lost to Follow-up|2|||
27517144|NCT02105662|80088357|FG000|Overall Study|Lost to Follow-up|5|||
27517145|NCT02105662|80088357|FG000|Overall Study|Withdrawal by Subject|1|||
27517146|NCT04491604|80088358|FG000|Overall Study|Withdrawal by Subject|3|||
27517147|NCT03083990|80088363|FG000|Overall Study|Adverse Event|1|||
27517148|NCT03083990|80088364|FG001|Overall Study|Adverse Event|0|||
27517149|NCT00337675|80088365|FG000|Overall Study|Adverse Event|10|||
27517150|NCT00337675|80088366|FG001|Overall Study|Adverse Event|9|||
27517151|NCT00337675|80088367|FG002|Overall Study|Adverse Event|19|||
27517152|NCT00337675|80088365|FG000|Overall Study|Lack of Efficacy|10|||
27517153|NCT00337675|80088366|FG001|Overall Study|Lack of Efficacy|7|||
27517154|NCT00337675|80088367|FG002|Overall Study|Lack of Efficacy|9|||
27517155|NCT00337675|80088365|FG000|Overall Study|Lost to Follow-up|22|||
27517156|NCT00337675|80088366|FG001|Overall Study|Lost to Follow-up|19|||
27517157|NCT00337675|80088367|FG002|Overall Study|Lost to Follow-up|17|||
27517158|NCT00337675|80088365|FG000|Overall Study|Physician Decision|9|||
27517159|NCT00337675|80088366|FG001|Overall Study|Physician Decision|17|||
27517160|NCT00337675|80088367|FG002|Overall Study|Physician Decision|14|||
27517161|NCT00337675|80088365|FG000|Overall Study|Protocol Violation|21|||
27517162|NCT00337675|80088366|FG001|Overall Study|Protocol Violation|24|||
27517163|NCT00337675|80088367|FG002|Overall Study|Protocol Violation|19|||
27517164|NCT00337675|80088365|FG000|Overall Study|Withdrawal by Subject|25|||
27517165|NCT00337675|80088366|FG001|Overall Study|Withdrawal by Subject|25|||
27517166|NCT00337675|80088367|FG002|Overall Study|Withdrawal by Subject|19|||
27517167|NCT00337675|80088365|FG000|Overall Study|Progressive Disease|0|||
27517168|NCT00337675|80088366|FG001|Overall Study|Progressive Disease|2|||
27517169|NCT00337675|80088367|FG002|Overall Study|Progressive Disease|0|||
27517170|NCT00337675|80088365|FG000|Overall Study|Trial Terminated|0|||
27517171|NCT00337675|80088366|FG001|Overall Study|Trial Terminated|0|||
27517172|NCT00337675|80088367|FG002|Overall Study|Trial Terminated|2|||
27517173|NCT03976648|80088368|FG000|Overall Study|Adverse Event|0|||
27517174|NCT03976648|80088369|FG001|Overall Study|Adverse Event|2|||
27517175|NCT03976648|80088368|FG000|Overall Study|Study terminated by sponsor|21|||
27517176|NCT03976648|80088369|FG001|Overall Study|Study terminated by sponsor|8|||
27517177|NCT02925338|80088370|FG000|Overall Study|Death|0|||
27517178|NCT02925338|80088371|FG001|Overall Study|Death|2|||
27517179|NCT02925338|80088372|FG002|Overall Study|Death|1|||
27517180|NCT02925338|80088373|FG003|Overall Study|Death|0|||
27517181|NCT02925338|80088374|FG004|Overall Study|Death|0|||
27517182|NCT02925338|80088370|FG000|Overall Study|Lost to Follow-up|30|||
27517183|NCT02925338|80088371|FG001|Overall Study|Lost to Follow-up|10|||
27517184|NCT02925338|80088372|FG002|Overall Study|Lost to Follow-up|1|||
27517185|NCT02925338|80088373|FG003|Overall Study|Lost to Follow-up|16|||
27517186|NCT02925338|80088374|FG004|Overall Study|Lost to Follow-up|3|||
27517187|NCT02925338|80088370|FG000|Overall Study|Withdrawal by Subject|3|||
27517188|NCT02925338|80088371|FG001|Overall Study|Withdrawal by Subject|0|||
27517189|NCT02925338|80088372|FG002|Overall Study|Withdrawal by Subject|3|||
27517190|NCT02925338|80088373|FG003|Overall Study|Withdrawal by Subject|2|||
27517191|NCT02925338|80088374|FG004|Overall Study|Withdrawal by Subject|2|||
27517192|NCT02925338|80088370|FG000|Overall Study|Missing|38|||
27517193|NCT02925338|80088371|FG001|Overall Study|Missing|27|||
27517194|NCT02925338|80088372|FG002|Overall Study|Missing|0|||
27517195|NCT02925338|80088373|FG003|Overall Study|Missing|3|||
27517196|NCT02925338|80088374|FG004|Overall Study|Missing|2|||
27517197|NCT02925338|80088370|FG000|Overall Study|Participant's Decision|11|||
27517198|NCT02925338|80088371|FG001|Overall Study|Participant's Decision|7|||
27517199|NCT02925338|80088372|FG002|Overall Study|Participant's Decision|3|||
27517200|NCT02925338|80088373|FG003|Overall Study|Participant's Decision|8|||
27517201|NCT02925338|80088374|FG004|Overall Study|Participant's Decision|1|||
27517202|NCT02925338|80088370|FG000|Overall Study|Treatment Discontinuation|144|||
27517203|NCT02925338|80088371|FG001|Overall Study|Treatment Discontinuation|65|||
27517204|NCT02925338|80088372|FG002|Overall Study|Treatment Discontinuation|56|||
27908003|NCT01744483|81500511|FG001|Overall Study|Lost to Follow-up|9|||
27517205|NCT02925338|80088373|FG003|Overall Study|Treatment Discontinuation|131|||
27517206|NCT02925338|80088374|FG004|Overall Study|Treatment Discontinuation|22|||
27517207|NCT00505076|80088375|FG000|Overall Study|Adverse Event|1|||
27517208|NCT00505076|80088376|FG001|Overall Study|Adverse Event|0|||
27517209|NCT00505076|80088377|FG002|Overall Study|Adverse Event|1|||
27517210|NCT00505076|80088375|FG000|Overall Study|Protocol Violation|2|||
27517211|NCT00505076|80088376|FG001|Overall Study|Protocol Violation|1|||
27517212|NCT00505076|80088377|FG002|Overall Study|Protocol Violation|2|||
27517213|NCT00505076|80088375|FG000|Overall Study|Withdrawal by Subject|0|||
27517214|NCT00505076|80088376|FG001|Overall Study|Withdrawal by Subject|1|||
27517215|NCT00505076|80088377|FG002|Overall Study|Withdrawal by Subject|2|||
27517216|NCT01159431|80088379|FG000|Overall Study|Adverse Event|1|||
27517217|NCT01159431|80088380|FG001|Overall Study|Adverse Event|2|||
27617834|NCT04793464|80444702|FG000|Overall Study|Withdrawal by Subject|43|||
27617835|NCT04793464|80444703|FG001|Overall Study|Withdrawal by Subject|15|||
27617836|NCT04793464|80444704|FG002|Overall Study|Withdrawal by Subject|0|||
27617837|NCT03638635|80444705|FG000|Initial Hospitalization|Study terminated prematurely|0|||
27617838|NCT03638635|80444706|FG001|Initial Hospitalization|Study terminated prematurely|1|||
27617839|NCT03638635|80444705|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
27617840|NCT03638635|80444706|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
27617841|NCT03638635|80444705|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
27617842|NCT03638635|80444706|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
27617843|NCT01628874|80444707|FG000|Overall Study|Physician Decision|1|||
27617844|NCT01628874|80444708|FG001|Overall Study|Physician Decision|1|||
27617845|NCT01628874|80444707|FG000|Overall Study|Age >4 months|4|||
27617846|NCT01628874|80444708|FG001|Overall Study|Age >4 months|2|||
27617847|NCT03100838|80444727|FG000|Overall Study|Adverse Event|1|||
27617848|NCT03100838|80444728|FG001|Overall Study|Adverse Event|0|||
27617849|NCT03100838|80444729|FG002|Overall Study|Adverse Event|0|||
27617850|NCT03100838|80444730|FG003|Overall Study|Adverse Event|0|||
27617851|NCT03100838|80444727|FG000|Overall Study|Physician Decision|1|||
27617852|NCT03100838|80444728|FG001|Overall Study|Physician Decision|1|||
27617853|NCT03100838|80444729|FG002|Overall Study|Physician Decision|1|||
27617854|NCT03100838|80444730|FG003|Overall Study|Physician Decision|1|||
27617855|NCT03100838|80444727|FG000|Overall Study|Pregnancy|0|||
27617856|NCT03100838|80444728|FG001|Overall Study|Pregnancy|1|||
27617857|NCT03100838|80444729|FG002|Overall Study|Pregnancy|0|||
27617858|NCT03100838|80444730|FG003|Overall Study|Pregnancy|0|||
27617859|NCT03100838|80444727|FG000|Overall Study|Lost to Follow-up|0|||
27617860|NCT03100838|80444728|FG001|Overall Study|Lost to Follow-up|0|||
27617861|NCT03100838|80444729|FG002|Overall Study|Lost to Follow-up|1|||
27617862|NCT03100838|80444730|FG003|Overall Study|Lost to Follow-up|0|||
27617863|NCT01383993|80444731|FG000|Overall Study|Adverse Event|1|||
27617864|NCT01383993|80444732|FG001|Overall Study|Adverse Event|1|||
27617865|NCT01383993|80444733|FG002|Overall Study|Adverse Event|0|||
27617866|NCT01383993|80444731|FG000|Overall Study|Withdrawal by Subject|0|||
27617867|NCT01383993|80444732|FG001|Overall Study|Withdrawal by Subject|0|||
27617868|NCT01383993|80444733|FG002|Overall Study|Withdrawal by Subject|1|||
27617869|NCT01383993|80444731|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
27617870|NCT01383993|80444732|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
27617871|NCT01383993|80444733|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
27617872|NCT02555371|80444734|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
27617873|NCT02555371|80444735|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27617874|NCT02555371|80444736|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27617875|NCT02555371|80444737|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27617876|NCT02555371|80444738|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
27617877|NCT02555371|80444734|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
27617878|NCT02555371|80444735|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27617879|NCT02555371|80444736|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27617880|NCT02555371|80444737|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27617881|NCT02555371|80444738|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
27617882|NCT02555371|80444734|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
27617883|NCT02555371|80444735|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27617884|NCT02555371|80444736|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27617885|NCT02555371|80444737|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27617886|NCT02555371|80444738|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
27617887|NCT02555371|80444734|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
27617888|NCT02555371|80444735|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27517218|NCT01159431|80088379|FG000|Overall Study|non-compliance|1|||
27517219|NCT01159431|80088380|FG001|Overall Study|non-compliance|1|||
27517220|NCT01159431|80088379|FG000|Overall Study|Lack of Efficacy|0|||
27517221|NCT01159431|80088380|FG001|Overall Study|Lack of Efficacy|3|||
27517222|NCT02604160|80088381|FG000|Overall Study|Protocol Violation|0|||
27517223|NCT02604160|80088382|FG001|Overall Study|Protocol Violation|1|||
27517224|NCT02604160|80088381|FG000|Overall Study|Physician Decision|0|||
27617889|NCT02555371|80444736|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27617890|NCT02555371|80444737|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27617891|NCT02555371|80444738|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
27617892|NCT02555371|80444734|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
27517225|NCT02604160|80088382|FG001|Overall Study|Physician Decision|1|||
27617893|NCT02555371|80444735|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27617894|NCT02555371|80444736|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27617895|NCT02555371|80444737|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27617896|NCT02555371|80444738|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
27617897|NCT02555371|80444734|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
27617898|NCT02555371|80444735|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
27617899|NCT02555371|80444736|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
27617900|NCT02555371|80444737|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
27617901|NCT02555371|80444738|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
27617902|NCT02555371|80444734|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
27617903|NCT02555371|80444735|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
27617904|NCT02555371|80444736|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
27617905|NCT02555371|80444737|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
27617906|NCT02555371|80444738|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
27617907|NCT02555371|80444734|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27617908|NCT02555371|80444735|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
27617909|NCT02555371|80444736|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27617910|NCT02555371|80444737|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27617911|NCT02555371|80444738|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
27617912|NCT02555371|80444734|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
27617913|NCT02555371|80444735|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
27617914|NCT02555371|80444736|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
27617915|NCT02555371|80444737|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
27617916|NCT02555371|80444738|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
27617917|NCT02555371|80444734|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27617918|NCT02555371|80444735|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27617919|NCT02555371|80444736|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27617920|NCT02555371|80444737|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
27617921|NCT02555371|80444738|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
27617922|NCT02555371|80444734|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27617923|NCT02555371|80444735|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27617924|NCT02555371|80444736|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27617925|NCT02555371|80444737|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
27617926|NCT02555371|80444738|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
27617927|NCT02555371|80444734|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27617928|NCT02555371|80444735|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27617929|NCT02555371|80444736|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27617930|NCT02555371|80444737|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
27853835|NCT00390221|81295170|FG002|Overall Study|Other|2|||
27853836|NCT02400671|81295171|FG000|Overall Study|Death|5|||
27853837|NCT02400671|81295172|FG001|Overall Study|Death|3|||
27853838|NCT02400671|81295173|FG002|Overall Study|Death|4|||
27908004|NCT01744483|81500512|FG002|Overall Study|Lost to Follow-up|11|||
27908005|NCT01744483|81500510|FG000|Overall Study|Protocol Violation|1|||
27908006|NCT01744483|81500511|FG001|Overall Study|Protocol Violation|2|||
27908007|NCT01744483|81500512|FG002|Overall Study|Protocol Violation|1|||
27517226|NCT01097005|80088383|FG000|Overall Study|Case Report Form not collected|18|||
27517227|NCT01097005|80088383|FG000|Overall Study|Subjects cannot visit the hospital|1|||
27517228|NCT01097005|80088383|FG000|Overall Study|Poor medication compliance|1|||
27517229|NCT01097005|80088383|FG000|Overall Study|No examination data available|244|||
27517230|NCT01097005|80088383|FG000|Overall Study|Deviation from exclusion criteria|37|||
27517231|NCT01097005|80088383|FG000|Overall Study|Adverse Event|14|||
27517232|NCT01097005|80088383|FG000|Overall Study|Discontinuance by complication|50|||
27517233|NCT01652469|80088384|FG000|Overall Study|Withdrawal by Subject|1|||
27517234|NCT01652469|80088385|FG001|Overall Study|Withdrawal by Subject|4|||
27517235|NCT01652469|80088384|FG000|Overall Study|Lost to Follow-up|0|||
27517236|NCT01652469|80088385|FG001|Overall Study|Lost to Follow-up|2|||
27517237|NCT00171834|80088386|FG000|Overall Study|Adverse Event|2|||
27517238|NCT00171834|80088387|FG001|Overall Study|Adverse Event|1|||
27517239|NCT00171834|80088388|FG002|Overall Study|Adverse Event|3|||
27517240|NCT00171834|80088389|FG003|Overall Study|Adverse Event|2|||
27617931|NCT02555371|80444738|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
27617932|NCT02555371|80444734|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27617933|NCT02555371|80444735|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27853839|NCT02400671|81295171|FG000|Overall Study|Lost to Follow-up|20|||
27853840|NCT02400671|81295172|FG001|Overall Study|Lost to Follow-up|27|||
27853841|NCT02400671|81295173|FG002|Overall Study|Lost to Follow-up|24|||
27853842|NCT02400671|81295171|FG000|Overall Study|Withdrawal by Subject|2|||
27908008|NCT01744483|81500510|FG000|Overall Study|Withdrawal by Subject|4|||
27908009|NCT01744483|81500511|FG001|Overall Study|Withdrawal by Subject|6|||
27517241|NCT00171834|80088390|FG004|Overall Study|Adverse Event|2|||
27517242|NCT00171834|80088391|FG005|Overall Study|Adverse Event|15|||
27517243|NCT00171834|80088392|FG006|Overall Study|Adverse Event|1|||
27517244|NCT00171834|80088386|FG000|Overall Study|Withdrawal by Subject|0|||
27617934|NCT02555371|80444736|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27617935|NCT02555371|80444737|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
27617936|NCT02555371|80444738|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
27908010|NCT01744483|81500512|FG002|Overall Study|Withdrawal by Subject|2|||
27908011|NCT01744483|81500510|FG000|Overall Study|No ICU Admit|5|||
27908012|NCT01744483|81500511|FG001|Overall Study|No ICU Admit|1|||
27908013|NCT01744483|81500512|FG002|Overall Study|No ICU Admit|2|||
27908014|NCT01744483|81500510|FG000|Overall Study|Routed to OSH|2|||
27908015|NCT01744483|81500511|FG001|Overall Study|Routed to OSH|0|||
27517245|NCT00171834|80088387|FG001|Overall Study|Withdrawal by Subject|2|||
27517246|NCT00171834|80088388|FG002|Overall Study|Withdrawal by Subject|0|||
27517247|NCT00171834|80088389|FG003|Overall Study|Withdrawal by Subject|1|||
27517248|NCT00171834|80088390|FG004|Overall Study|Withdrawal by Subject|1|||
27517249|NCT00171834|80088391|FG005|Overall Study|Withdrawal by Subject|1|||
27517250|NCT00171834|80088392|FG006|Overall Study|Withdrawal by Subject|0|||
27517251|NCT00171834|80088386|FG000|Overall Study|Death from study indication|0|||
27517252|NCT00171834|80088387|FG001|Overall Study|Death from study indication|1|||
27517253|NCT00171834|80088388|FG002|Overall Study|Death from study indication|0|||
27517254|NCT00171834|80088389|FG003|Overall Study|Death from study indication|0|||
27517255|NCT00171834|80088390|FG004|Overall Study|Death from study indication|1|||
27517256|NCT00171834|80088391|FG005|Overall Study|Death from study indication|0|||
27517257|NCT00171834|80088392|FG006|Overall Study|Death from study indication|0|||
27517258|NCT00171834|80088386|FG000|Overall Study|Disease Progression|4|||
27517259|NCT00171834|80088387|FG001|Overall Study|Disease Progression|8|||
27517260|NCT00171834|80088388|FG002|Overall Study|Disease Progression|8|||
27517261|NCT00171834|80088389|FG003|Overall Study|Disease Progression|9|||
27517262|NCT00171834|80088390|FG004|Overall Study|Disease Progression|2|||
27517263|NCT00171834|80088391|FG005|Overall Study|Disease Progression|18|||
27517264|NCT00171834|80088392|FG006|Overall Study|Disease Progression|3|||
27517265|NCT00171834|80088386|FG000|Overall Study|Treatment Duration Completed|0|||
27517266|NCT00171834|80088387|FG001|Overall Study|Treatment Duration Completed|0|||
27517267|NCT00171834|80088388|FG002|Overall Study|Treatment Duration Completed|1|||
27517268|NCT00171834|80088389|FG003|Overall Study|Treatment Duration Completed|0|||
27517269|NCT00171834|80088390|FG004|Overall Study|Treatment Duration Completed|2|||
27517270|NCT00171834|80088391|FG005|Overall Study|Treatment Duration Completed|1|||
27517271|NCT00171834|80088392|FG006|Overall Study|Treatment Duration Completed|0|||
27517272|NCT00591318|80088393|FG000|Overall Study|Lack of Efficacy|2|||
27517273|NCT00591318|80088394|FG001|Overall Study|Lack of Efficacy|0|||
27517274|NCT00591318|80088393|FG000|Overall Study|Adverse Event|2|||
27517275|NCT00591318|80088394|FG001|Overall Study|Adverse Event|0|||
27517276|NCT03337490|80088395|FG000|Overall Study|Withdrawal by Subject|1|||
27517277|NCT03337490|80088396|FG001|Overall Study|Withdrawal by Subject|0|||
27517278|NCT03337490|80088397|FG002|Overall Study|Withdrawal by Subject|0|||
27517279|NCT03337490|80088395|FG000|Overall Study|Lack of Efficacy|10|||
27517280|NCT03337490|80088396|FG001|Overall Study|Lack of Efficacy|12|||
27517281|NCT03337490|80088397|FG002|Overall Study|Lack of Efficacy|35|||
27517282|NCT03337490|80088395|FG000|Overall Study|Physician Decision|0|||
27517283|NCT03337490|80088396|FG001|Overall Study|Physician Decision|1|||
27517284|NCT03337490|80088397|FG002|Overall Study|Physician Decision|0|||
27517285|NCT03337490|80088395|FG000|Overall Study|Lost to Follow-up|0|||
27517286|NCT03337490|80088396|FG001|Overall Study|Lost to Follow-up|1|||
27517287|NCT03337490|80088397|FG002|Overall Study|Lost to Follow-up|0|||
27517288|NCT00530816|80088398|FG000|Overall Study|Progressive Disease|16|||
27517289|NCT00530816|80088399|FG001|Overall Study|Progressive Disease|24|||
27517290|NCT00530816|80088400|FG002|Overall Study|Progressive Disease|24|||
27517291|NCT00530816|80088398|FG000|Overall Study|Adverse Event|6|||
27517292|NCT00530816|80088399|FG001|Overall Study|Adverse Event|13|||
27517293|NCT00530816|80088400|FG002|Overall Study|Adverse Event|7|||
27908016|NCT01744483|81500512|FG002|Overall Study|Routed to OSH|1|||
27517294|NCT00530816|80088398|FG000|Overall Study|Other|3|||
27517295|NCT00530816|80088399|FG001|Overall Study|Other|3|||
27517296|NCT00530816|80088400|FG002|Overall Study|Other|4|||
27517297|NCT00530816|80088398|FG000|Overall Study|Withdrawal by Subject|1|||
27517298|NCT00530816|80088399|FG001|Overall Study|Withdrawal by Subject|2|||
27517299|NCT00530816|80088400|FG002|Overall Study|Withdrawal by Subject|6|||
27517300|NCT02565784|80088401|FG000|First Treatment|Adverse Event|1|||
27517301|NCT02565784|80088401|FG000|First Treatment|Withdrawal by Subject|1|||
27517302|NCT02565784|80088401|FG000|Second Treatment|Withdrawal by Subject|2|||
27617937|NCT02555371|80444734|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27617938|NCT02555371|80444735|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27617939|NCT02555371|80444736|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27617940|NCT02555371|80444737|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
27617941|NCT02555371|80444738|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
27617942|NCT03935217|80444739|FG000|Overall Study|Adverse Event|1|||
27617943|NCT03935217|80444740|FG001|Overall Study|Adverse Event|0|||
27617944|NCT03935217|80444739|FG000|Overall Study|Lost to Follow-up|0|||
27617945|NCT03935217|80444740|FG001|Overall Study|Lost to Follow-up|1|||
27617946|NCT03935217|80444739|FG000|Overall Study|Withdrawal by Subject|0|||
27617947|NCT03935217|80444740|FG001|Overall Study|Withdrawal by Subject|2|||
27617948|NCT02487446|80444741|FG000|Period 1|Physician Decision|0|||
27617949|NCT02487446|80444742|FG001|Period 1|Physician Decision|1|||
27617950|NCT02487446|80444741|FG000|Period 1|Lack of Efficacy|1|||
27617951|NCT02487446|80444742|FG001|Period 1|Lack of Efficacy|0|||
27617952|NCT02487446|80444741|FG000|Period 1|Protocol deviation|3|||
27617953|NCT02487446|80444742|FG001|Period 1|Protocol deviation|2|||
27617954|NCT02487446|80444741|FG000|Period 1|Lost to Follow-up|2|||
27617955|NCT02487446|80444742|FG001|Period 1|Lost to Follow-up|0|||
27617956|NCT02487446|80444741|FG000|Period 1|Withdrawal by Subject|2|||
27617957|NCT02487446|80444742|FG001|Period 1|Withdrawal by Subject|0|||
27617958|NCT02487446|80444741|FG000|Period 1|Adverse Event|5|||
27617959|NCT02487446|80444742|FG001|Period 1|Adverse Event|5|||
27617960|NCT02487446|80444741|FG000|Washout|Lost to Follow-up|0|||
27617961|NCT02487446|80444742|FG001|Washout|Lost to Follow-up|2|||
27617962|NCT02487446|80444741|FG000|Washout|Withdrawal by Subject|1|||
27617963|NCT02487446|80444742|FG001|Washout|Withdrawal by Subject|4|||
27908017|NCT01090050|81500513|FG000|Overall Study|Lost to Follow-up|0|||
27908018|NCT01090050|81500514|FG001|Overall Study|Lost to Follow-up|1|||
27908019|NCT01090050|81500513|FG000|Overall Study|Lack of Efficacy|1|||
27908020|NCT01090050|81500514|FG001|Overall Study|Lack of Efficacy|5|||
27617964|NCT02487446|80444741|FG000|Washout|Adverse Event|2|||
27617965|NCT02487446|80444742|FG001|Washout|Adverse Event|2|||
27617966|NCT02487446|80444741|FG000|Period 2|Protocol deviation|0|||
27617967|NCT02487446|80444742|FG001|Period 2|Protocol deviation|1|||
27617968|NCT02487446|80444741|FG000|Period 2|Lost to Follow-up|1|||
27617969|NCT02487446|80444742|FG001|Period 2|Lost to Follow-up|1|||
27617970|NCT02487446|80444741|FG000|Period 2|Withdrawal by Subject|1|||
27617971|NCT02487446|80444742|FG001|Period 2|Withdrawal by Subject|1|||
27908021|NCT01090050|81500513|FG000|Overall Study|Physician Decision|0|||
27908022|NCT01090050|81500514|FG001|Overall Study|Physician Decision|1|||
27908023|NCT02683239|81500517|FG000|Overall Study|Protocol Violation|35|||
27908024|NCT02683239|81500518|FG001|Overall Study|Protocol Violation|23|||
27617972|NCT02487446|80444741|FG000|Period 2|Adverse Event|6|||
27617973|NCT02487446|80444742|FG001|Period 2|Adverse Event|2|||
27617974|NCT00146640|80444743|FG000|Overall Study|Adverse Event|12|||
27617975|NCT00146640|80444744|FG001|Overall Study|Adverse Event|10|||
27617976|NCT00146640|80444743|FG000|Overall Study|Medical Reasons|3|||
27617977|NCT00146640|80444744|FG001|Overall Study|Medical Reasons|0|||
27617978|NCT00146640|80444743|FG000|Overall Study|Non-Medical Reasons|8|||
27617979|NCT00146640|80444744|FG001|Overall Study|Non-Medical Reasons|4|||
27617980|NCT02139982|80444745|FG000|Overall Study|Lack of Efficacy|0|||
27617981|NCT02139982|80444746|FG001|Overall Study|Lack of Efficacy|1|||
27617982|NCT02139982|80444747|FG002|Overall Study|Lack of Efficacy|0|||
27617983|NCT02139982|80444748|FG003|Overall Study|Lack of Efficacy|1|||
27617984|NCT02139982|80444749|FG004|Overall Study|Lack of Efficacy|0|||
27617985|NCT02139982|80444750|FG005|Overall Study|Lack of Efficacy|0|||
27617986|NCT02139982|80444751|FG006|Overall Study|Lack of Efficacy|0|||
27617987|NCT02139982|80444752|FG007|Overall Study|Lack of Efficacy|0|||
27617988|NCT02139982|80444753|FG008|Overall Study|Lack of Efficacy|0|||
27617989|NCT02139982|80444754|FG009|Overall Study|Lack of Efficacy|0|||
27908025|NCT02683239|81500519|FG002|Overall Study|Protocol Violation|26|||
27617990|NCT02107443|80444755|FG000|Overall Study|Death|42|||
27617991|NCT02107443|80444756|FG001|Overall Study|Death|30|||
27617992|NCT02107443|80444755|FG000|Overall Study|Study Protocol Violation|3|||
27617993|NCT02107443|80444756|FG001|Overall Study|Study Protocol Violation|1|||
27617994|NCT02107443|80444755|FG000|Overall Study|Registered but Not Eligible|0|||
27617995|NCT02107443|80444756|FG001|Overall Study|Registered but Not Eligible|1|||
27617996|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
27617997|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
27617998|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
27617999|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
27618000|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Changed Mind|2|||
27908026|NCT02683239|81500520|FG003|Overall Study|Protocol Violation|4|||
27618001|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Changed Mind|0|||
27618002|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
27618003|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
27618004|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
27908027|NCT02683239|81500521|FG004|Overall Study|Protocol Violation|35|||
27618005|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
27618006|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
27618007|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
27618008|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
27618009|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
27618010|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Other Medical|9|||
27618011|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Other Medical|5|||
27618012|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Disease Progression|4|||
27517303|NCT02560025|80088405|FG000|Overall Study|Ineligible after consent/ registration|3|||
27517304|NCT02948088|80088406|FG000|Overall Study|Lost to Follow-up|8|||
27517305|NCT02948088|80088406|FG000|Overall Study|Death|1|||
27517306|NCT02948088|80088406|FG000|Overall Study|Withdrawal by Subject|4|||
27517307|NCT02948088|80088406|FG000|Overall Study|Other|2|||
27517308|NCT01214395|80088407|FG000|Overall Study|All patients had infection|5|||
27517309|NCT03079102|80088412|FG000|Overall Study|Physician Decision|0|||
27618013|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Disease Progression|2|||
27618014|NCT02107443|80444755|FG000|Overall Study|Withdrawal: Personal Issues|0|||
27618015|NCT02107443|80444756|FG001|Overall Study|Withdrawal: Personal Issues|3|||
27618016|NCT02431533|80444757|FG000|Overall Study|Withdrawal by Subject|1|||
27618017|NCT02431533|80444758|FG001|Overall Study|Withdrawal by Subject|3|||
27618018|NCT02431533|80444757|FG000|Overall Study|Developed Exclusionary criteria|1|||
27618019|NCT02431533|80444758|FG001|Overall Study|Developed Exclusionary criteria|0|||
27618020|NCT02781506|80444759|FG000|Overall Study|Adverse Event|5|||
27618021|NCT01152554|80444762|FG000|Overall Study|Withdrawal by Subject|73|||
27618022|NCT01152554|80444763|FG001|Overall Study|Withdrawal by Subject|28|||
27618023|NCT01152554|80444762|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
27618024|NCT01152554|80444763|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
27618025|NCT01152554|80444762|FG000|Overall Study|Adverse Event|67|||
27618026|NCT01152554|80444763|FG001|Overall Study|Adverse Event|14|||
27618027|NCT01152554|80444762|FG000|Overall Study|Severe non-compliance to protocol|36|||
27618028|NCT01152554|80444763|FG001|Overall Study|Severe non-compliance to protocol|14|||
27618029|NCT01152554|80444762|FG000|Overall Study|Condition under investigation worsened|5|||
27618030|NCT01152554|80444763|FG001|Overall Study|Condition under investigation worsened|2|||
27618031|NCT01152554|80444762|FG000|Overall Study|Lack of Efficacy|20|||
27618032|NCT01152554|80444763|FG001|Overall Study|Lack of Efficacy|3|||
27618033|NCT01152554|80444762|FG000|Overall Study|Study-specific withdrawal criteria|17|||
27618034|NCT01152554|80444763|FG001|Overall Study|Study-specific withdrawal criteria|8|||
27618035|NCT01152554|80444762|FG000|Overall Study|Lost to Follow-up|87|||
27618036|NCT01152554|80444763|FG001|Overall Study|Lost to Follow-up|32|||
27618037|NCT01152554|80444762|FG000|Overall Study|Other|28|||
27618038|NCT01152554|80444763|FG001|Overall Study|Other|8|||
27618039|NCT01152554|80444762|FG000|Overall Study|Death|1|||
27618040|NCT01152554|80444763|FG001|Overall Study|Death|1|||
27618041|NCT01473420|80444766|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
27618042|NCT01473420|80444767|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
27618043|NCT01473420|80444766|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
27618044|NCT01473420|80444767|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
27618045|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
27618046|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
27618047|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
27618048|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
27618049|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
27618050|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
27618051|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
27618052|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
27618053|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
27730052|NCT02620020|80838426|FG000|Overall Study|Adverse Event|8|||
27730053|NCT02620020|80838427|FG001|Overall Study|Adverse Event|4|||
27730054|NCT02620020|80838428|FG002|Overall Study|Adverse Event|3|||
27730055|NCT02620020|80838429|FG003|Overall Study|Adverse Event|5|||
27730056|NCT02620020|80838426|FG000|Overall Study|Lost to Follow-up|4|||
27517310|NCT03079102|80088413|FG001|Overall Study|Physician Decision|1|||
27730057|NCT02620020|80838427|FG001|Overall Study|Lost to Follow-up|8|||
27730058|NCT02620020|80838428|FG002|Overall Study|Lost to Follow-up|1|||
27730059|NCT02620020|80838429|FG003|Overall Study|Lost to Follow-up|4|||
27730060|NCT02620020|80838426|FG000|Overall Study|Physician Decision|7|||
27730061|NCT02620020|80838427|FG001|Overall Study|Physician Decision|4|||
27517311|NCT03567343|80088415|FG000|Overall Study|Lost to Follow-up|2|||
27517312|NCT03567343|80088416|FG001|Overall Study|Lost to Follow-up|1|||
27517313|NCT03567343|80088415|FG000|Overall Study|No longer eligible|2|||
27517314|NCT03567343|80088416|FG001|Overall Study|No longer eligible|1|||
27517315|NCT03567343|80088415|FG000|Overall Study|Adverse Event|1|||
27517316|NCT03567343|80088416|FG001|Overall Study|Adverse Event|0|||
27517317|NCT03567343|80088415|FG000|Overall Study|Protocol Violation|1|||
27517318|NCT03567343|80088416|FG001|Overall Study|Protocol Violation|1|||
27517319|NCT01868542|80088422|FG000|Overall Study|Protocol Violation|0|||
27517320|NCT01868542|80088423|FG001|Overall Study|Protocol Violation|1|||
27517321|NCT01868542|80088422|FG000|Overall Study|Unclassified|0|||
27517322|NCT01868542|80088423|FG001|Overall Study|Unclassified|1|||
27517323|NCT01433289|80088424|FG000|Overall Study|Pregnancy|0|||
27517324|NCT01433289|80088425|FG001|Overall Study|Pregnancy|1|||
27517325|NCT01433289|80088426|FG002|Overall Study|Pregnancy|0|||
27517326|NCT01433289|80088427|FG003|Overall Study|Pregnancy|0|||
27517327|NCT02756806|80088430|FG000|Overall Study|Study terminated early|5|||
27618054|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
27618055|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
27618056|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
27618057|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
27618058|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
27618059|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
27730062|NCT02620020|80838428|FG002|Overall Study|Physician Decision|3|||
27730063|NCT02620020|80838429|FG003|Overall Study|Physician Decision|4|||
27730064|NCT02620020|80838426|FG000|Overall Study|Protocol Violation|5|||
27730065|NCT02620020|80838427|FG001|Overall Study|Protocol Violation|2|||
27730066|NCT02620020|80838428|FG002|Overall Study|Protocol Violation|1|||
27730067|NCT02620020|80838429|FG003|Overall Study|Protocol Violation|1|||
27730068|NCT02620020|80838426|FG000|Overall Study|Withdrawal by Subject|20|||
27730069|NCT02620020|80838427|FG001|Overall Study|Withdrawal by Subject|16|||
27730070|NCT02620020|80838428|FG002|Overall Study|Withdrawal by Subject|17|||
27730071|NCT02620020|80838429|FG003|Overall Study|Withdrawal by Subject|12|||
27730072|NCT02620020|80838426|FG000|Overall Study|Death|0|||
27730073|NCT02620020|80838427|FG001|Overall Study|Death|1|||
27730074|NCT02620020|80838428|FG002|Overall Study|Death|0|||
27517328|NCT02230670|80088431|FG000|Overall Study|Adverse Event|1|||
27618060|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
27618061|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
27618062|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
27618063|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
27908028|NCT02683239|81500522|FG005|Overall Study|Protocol Violation|4|||
27908029|NCT02683239|81500523|FG006|Overall Study|Protocol Violation|5|||
27908030|NCT02683239|81500517|FG000|Overall Study|Adverse Event|64|||
27908031|NCT02683239|81500518|FG001|Overall Study|Adverse Event|39|||
27908032|NCT02683239|81500519|FG002|Overall Study|Adverse Event|42|||
27908033|NCT02683239|81500520|FG003|Overall Study|Adverse Event|16|||
27908034|NCT02683239|81500521|FG004|Overall Study|Adverse Event|189|||
27908035|NCT02683239|81500522|FG005|Overall Study|Adverse Event|9|||
27908036|NCT02683239|81500523|FG006|Overall Study|Adverse Event|9|||
27908037|NCT02683239|81500517|FG000|Overall Study|Physician Decision|38|||
27908038|NCT02683239|81500518|FG001|Overall Study|Physician Decision|19|||
27908039|NCT02683239|81500519|FG002|Overall Study|Physician Decision|14|||
27517329|NCT02230670|80088432|FG001|Overall Study|Adverse Event|2|||
27517330|NCT02230670|80088431|FG000|Overall Study|Withdrawal by Subject|2|||
27517331|NCT02230670|80088432|FG001|Overall Study|Withdrawal by Subject|2|||
27517332|NCT02230670|80088431|FG000|Overall Study|Physician Decision|0|||
27517333|NCT02230670|80088432|FG001|Overall Study|Physician Decision|1|||
27517334|NCT02230670|80088431|FG000|Overall Study|Protocol Violation|0|||
27517335|NCT02230670|80088432|FG001|Overall Study|Protocol Violation|1|||
27517336|NCT02230670|80088431|FG000|Overall Study|Progression to Child-Pugh C|1|||
27517337|NCT02230670|80088432|FG001|Overall Study|Progression to Child-Pugh C|2|||
27517338|NCT03887702|80088433|FG000|Overall Study|Study terminated|0|||
27517339|NCT03887702|80088434|FG001|Overall Study|Study terminated|0|||
27517340|NCT03887702|80088435|FG002|Overall Study|Study terminated|2|||
27517341|NCT03887702|80088436|FG003|Overall Study|Study terminated|2|||
27517342|NCT02059291|80088437|FG000|Epoch 2|Lack of Efficacy|0|||
27517343|NCT02059291|80088438|FG001|Epoch 2|Lack of Efficacy|0|||
27517344|NCT02059291|80088439|FG002|Epoch 2|Lack of Efficacy|0|||
27517345|NCT02059291|80088440|FG003|Epoch 2|Lack of Efficacy|1|||
27517346|NCT02059291|80088441|FG004|Epoch 2|Lack of Efficacy|0|||
27517347|NCT02059291|80088442|FG005|Epoch 2|Lack of Efficacy|1|||
27517348|NCT02059291|80088443|FG006|Epoch 2|Lack of Efficacy|0|||
27517349|NCT02059291|80088444|FG007|Epoch 2|Lack of Efficacy|0|||
27517350|NCT02059291|80088445|FG008|Epoch 2|Lack of Efficacy|0|||
27517351|NCT02059291|80088446|FG009|Epoch 2|Lack of Efficacy|0|||
27618064|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
27618065|NCT01473420|80444766|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
27618066|NCT01473420|80444767|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
27618067|NCT02391038|80444768|FG000|Overall Study|Progressive disease|3|||
27618068|NCT02391038|80444769|FG001|Overall Study|Progressive disease|3|||
27618069|NCT02391038|80444770|FG002|Overall Study|Progressive disease|6|||
27618070|NCT01052662|80444771|FG000|Overall Study|Lost to Follow-up|15|||
27618071|NCT01052662|80444772|FG001|Overall Study|Lost to Follow-up|13|||
27618072|NCT01052662|80444773|FG002|Overall Study|Lost to Follow-up|18|||
27618073|NCT01052662|80444771|FG000|Overall Study|Withdrawal by Subject|3|||
27618074|NCT01052662|80444772|FG001|Overall Study|Withdrawal by Subject|2|||
27618075|NCT01052662|80444773|FG002|Overall Study|Withdrawal by Subject|1|||
27618076|NCT01052662|80444771|FG000|Overall Study|Pharmacy issue|1|||
27618077|NCT01052662|80444772|FG001|Overall Study|Pharmacy issue|3|||
27730075|NCT02620020|80838429|FG003|Overall Study|Death|0|||
27908040|NCT02683239|81500520|FG003|Overall Study|Physician Decision|73|||
27908041|NCT02683239|81500521|FG004|Overall Study|Physician Decision|143|||
27517352|NCT02059291|80088447|FG010|Epoch 2|Lack of Efficacy|0|||
27517353|NCT02059291|80088448|FG011|Epoch 2|Lack of Efficacy|0|||
27517354|NCT02059291|80088449|FG012|Epoch 2|Lack of Efficacy|0|||
27517355|NCT02059291|80088450|FG013|Epoch 2|Lack of Efficacy|0|||
27517356|NCT02059291|80088451|FG014|Epoch 2|Lack of Efficacy|0|||
27517357|NCT02059291|80088452|FG015|Epoch 2|Lack of Efficacy|0|||
27730076|NCT00388947|80838430|FG000|Overall Study|Protocol Violation|47|||
27730077|NCT01246206|80838434|FG000|Overall Study|Patient did not receive study regiments.|1|||
27730078|NCT00424398|80838438|FG000|Overall Study|Withdrawal by Subject|2|||
27730079|NCT00424398|80838439|FG001|Overall Study|Withdrawal by Subject|1|||
27730080|NCT00424398|80838440|FG002|Overall Study|Withdrawal by Subject|0|||
27908042|NCT02683239|81500522|FG005|Overall Study|Physician Decision|14|||
27908043|NCT02683239|81500523|FG006|Overall Study|Physician Decision|15|||
27517358|NCT02059291|80088453|FG016|Epoch 2|Lack of Efficacy|0|||
27730081|NCT00424398|80838438|FG000|Overall Study|Subject met exclusion criteria|1|||
27730082|NCT00424398|80838439|FG001|Overall Study|Subject met exclusion criteria|0|||
27730083|NCT00424398|80838440|FG002|Overall Study|Subject met exclusion criteria|0|||
27730084|NCT01290887|80838441|FG000|Overall Study|Adverse Event|6|||
27730085|NCT01290887|80838442|FG001|Overall Study|Adverse Event|11|||
27730086|NCT01290887|80838441|FG000|Overall Study|Lack of Efficacy|4|||
27730087|NCT01290887|80838442|FG001|Overall Study|Lack of Efficacy|5|||
27730088|NCT01290887|80838441|FG000|Overall Study|Withdrawal by Subject|26|||
27730089|NCT01290887|80838442|FG001|Overall Study|Withdrawal by Subject|32|||
27730090|NCT01290887|80838441|FG000|Overall Study|Protocol Violation|2|||
27730091|NCT01290887|80838442|FG001|Overall Study|Protocol Violation|1|||
27730092|NCT01290887|80838441|FG000|Overall Study|Lost to Follow-up|4|||
27730093|NCT01290887|80838442|FG001|Overall Study|Lost to Follow-up|4|||
27730094|NCT01290887|80838441|FG000|Overall Study|Non-compliance to study procedures|0|||
27730095|NCT01290887|80838442|FG001|Overall Study|Non-compliance to study procedures|1|||
27730096|NCT01290887|80838441|FG000|Overall Study|Non-compliance to study medications|1|||
27730097|NCT01290887|80838442|FG001|Overall Study|Non-compliance to study medications|0|||
27730098|NCT01290887|80838441|FG000|Overall Study|Sponsor closure of study|420|||
27730099|NCT01290887|80838442|FG001|Overall Study|Sponsor closure of study|476|||
27730100|NCT01290887|80838441|FG000|Overall Study|Other|3|||
27730101|NCT01290887|80838442|FG001|Overall Study|Other|6|||
27730102|NCT03093402|80838445|FG000|Overall Study|Lost to Follow-up|1|||
27730103|NCT03093402|80838446|FG001|Overall Study|Lost to Follow-up|0|||
27730104|NCT03093402|80838447|FG002|Overall Study|Lost to Follow-up|0|||
27730105|NCT03093402|80838448|FG003|Overall Study|Lost to Follow-up|0|||
27730106|NCT03093402|80838445|FG000|Overall Study|Withdrawal by Subject|3|||
27730107|NCT03093402|80838446|FG001|Overall Study|Withdrawal by Subject|3|||
27730108|NCT03093402|80838447|FG002|Overall Study|Withdrawal by Subject|0|||
27730109|NCT03093402|80838448|FG003|Overall Study|Withdrawal by Subject|1|||
27730110|NCT03093402|80838445|FG000|Overall Study|Withdrew prior to dosing|2|||
27730111|NCT03093402|80838446|FG001|Overall Study|Withdrew prior to dosing|1|||
27730112|NCT03093402|80838447|FG002|Overall Study|Withdrew prior to dosing|2|||
27730113|NCT03093402|80838448|FG003|Overall Study|Withdrew prior to dosing|3|||
27730114|NCT03093402|80838445|FG000|Overall Study|Ineligible for study|1|||
27730115|NCT03093402|80838446|FG001|Overall Study|Ineligible for study|0|||
27730116|NCT03093402|80838447|FG002|Overall Study|Ineligible for study|0|||
27730117|NCT03093402|80838448|FG003|Overall Study|Ineligible for study|0|||
27730118|NCT03093402|80838445|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
27730119|NCT03093402|80838446|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
27730120|NCT03093402|80838447|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
27730121|NCT03093402|80838448|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
27730122|NCT00675025|80838451|FG000|Overall Study|Study Terminated by Sponsor|38|||
27730123|NCT00675025|80838452|FG001|Overall Study|Study Terminated by Sponsor|42|||
27730124|NCT00675025|80838451|FG000|Overall Study|Adverse Event|6|||
27730125|NCT00675025|80838452|FG001|Overall Study|Adverse Event|11|||
27730126|NCT00675025|80838451|FG000|Overall Study|Lost to Follow-up|6|||
27730127|NCT00675025|80838452|FG001|Overall Study|Lost to Follow-up|4|||
27730128|NCT00675025|80838451|FG000|Overall Study|Withdrawal by Subject|4|||
27730129|NCT00675025|80838452|FG001|Overall Study|Withdrawal by Subject|6|||
27730130|NCT03529409|80838455|FG000|Randomized|Lost to Follow-up|0|||
27730131|NCT03529409|80838456|FG001|Randomized|Lost to Follow-up|0|||
27730132|NCT03529409|80838457|FG002|Randomized|Lost to Follow-up|4|||
27730133|NCT03529409|80838455|FG000|Randomized|Excluded|0|||
27730134|NCT03529409|80838456|FG001|Randomized|Excluded|0|||
27730135|NCT03529409|80838457|FG002|Randomized|Excluded|1|||
27730136|NCT03529409|80838455|FG000|Post-treatment Assessment|Death|1|||
27730137|NCT03529409|80838456|FG001|Post-treatment Assessment|Death|0|||
27730138|NCT03529409|80838457|FG002|Post-treatment Assessment|Death|0|||
27730139|NCT03529409|80838455|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
27730140|NCT03529409|80838456|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
27730141|NCT03529409|80838457|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
27730142|NCT03529409|80838455|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
27730143|NCT03529409|80838456|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
27730144|NCT03529409|80838457|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
27730145|NCT03529409|80838455|FG000|Follow-up Assessment|Death|1|||
27908044|NCT02683239|81500517|FG000|Overall Study|Withdrawal by Subject|187|||
27908045|NCT02683239|81500518|FG001|Overall Study|Withdrawal by Subject|99|||
27908046|NCT02683239|81500519|FG002|Overall Study|Withdrawal by Subject|91|||
27908047|NCT02683239|81500520|FG003|Overall Study|Withdrawal by Subject|18|||
27730146|NCT03529409|80838456|FG001|Follow-up Assessment|Death|0|||
27730147|NCT03529409|80838457|FG002|Follow-up Assessment|Death|0|||
27730148|NCT03529409|80838455|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
27730149|NCT03529409|80838456|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
27730150|NCT03529409|80838457|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
27908048|NCT02683239|81500521|FG004|Overall Study|Withdrawal by Subject|248|||
27908049|NCT02683239|81500522|FG005|Overall Study|Withdrawal by Subject|22|||
27908050|NCT02683239|81500523|FG006|Overall Study|Withdrawal by Subject|28|||
27908051|NCT02683239|81500517|FG000|Overall Study|Lost to Follow-up|77|||
27908052|NCT02683239|81500518|FG001|Overall Study|Lost to Follow-up|24|||
27908053|NCT02683239|81500519|FG002|Overall Study|Lost to Follow-up|25|||
27908054|NCT02683239|81500520|FG003|Overall Study|Lost to Follow-up|7|||
27908055|NCT02683239|81500521|FG004|Overall Study|Lost to Follow-up|88|||
27908056|NCT02683239|81500522|FG005|Overall Study|Lost to Follow-up|8|||
27908057|NCT02683239|81500523|FG006|Overall Study|Lost to Follow-up|11|||
27517359|NCT02059291|80088454|FG017|Epoch 2|Lack of Efficacy|0|||
27517360|NCT02059291|80088455|FG018|Epoch 2|Lack of Efficacy|0|||
27517361|NCT02059291|80088456|FG019|Epoch 2|Lack of Efficacy|0|||
27517362|NCT02059291|80088457|FG020|Epoch 2|Lack of Efficacy|0|||
27517363|NCT02059291|80088458|FG021|Epoch 2|Lack of Efficacy|0|||
27517364|NCT02059291|80088459|FG022|Epoch 2|Lack of Efficacy|0|||
27517365|NCT02059291|80088460|FG023|Epoch 2|Lack of Efficacy|0|||
27517366|NCT02059291|80088461|FG024|Epoch 2|Lack of Efficacy|0|||
27517367|NCT02059291|80088437|FG000|Epoch 2|Adverse Event|0|||
27517368|NCT02059291|80088438|FG001|Epoch 2|Adverse Event|0|||
27517369|NCT02059291|80088439|FG002|Epoch 2|Adverse Event|1|||
27517370|NCT02059291|80088440|FG003|Epoch 2|Adverse Event|1|||
27517371|NCT02059291|80088441|FG004|Epoch 2|Adverse Event|0|||
27517372|NCT02059291|80088442|FG005|Epoch 2|Adverse Event|0|||
27517373|NCT02059291|80088443|FG006|Epoch 2|Adverse Event|0|||
27517374|NCT02059291|80088444|FG007|Epoch 2|Adverse Event|1|||
27517375|NCT02059291|80088445|FG008|Epoch 2|Adverse Event|1|||
27517376|NCT02059291|80088446|FG009|Epoch 2|Adverse Event|0|||
27517377|NCT02059291|80088447|FG010|Epoch 2|Adverse Event|0|||
27517378|NCT02059291|80088448|FG011|Epoch 2|Adverse Event|0|||
27517379|NCT02059291|80088449|FG012|Epoch 2|Adverse Event|0|||
27517380|NCT02059291|80088450|FG013|Epoch 2|Adverse Event|0|||
27517381|NCT02059291|80088451|FG014|Epoch 2|Adverse Event|0|||
27517382|NCT02059291|80088452|FG015|Epoch 2|Adverse Event|0|||
27517383|NCT02059291|80088453|FG016|Epoch 2|Adverse Event|0|||
27517384|NCT02059291|80088454|FG017|Epoch 2|Adverse Event|0|||
27517385|NCT02059291|80088455|FG018|Epoch 2|Adverse Event|0|||
27517386|NCT02059291|80088456|FG019|Epoch 2|Adverse Event|0|||
27517387|NCT02059291|80088457|FG020|Epoch 2|Adverse Event|0|||
27517388|NCT02059291|80088458|FG021|Epoch 2|Adverse Event|0|||
27517389|NCT02059291|80088459|FG022|Epoch 2|Adverse Event|0|||
27517390|NCT02059291|80088460|FG023|Epoch 2|Adverse Event|0|||
27517391|NCT02059291|80088461|FG024|Epoch 2|Adverse Event|0|||
27517392|NCT02059291|80088437|FG000|Epoch 2|Withdrawal by Subject|0|||
27517393|NCT02059291|80088438|FG001|Epoch 2|Withdrawal by Subject|1|||
27517394|NCT02059291|80088439|FG002|Epoch 2|Withdrawal by Subject|0|||
27517395|NCT02059291|80088440|FG003|Epoch 2|Withdrawal by Subject|0|||
27517396|NCT02059291|80088441|FG004|Epoch 2|Withdrawal by Subject|0|||
27517397|NCT02059291|80088442|FG005|Epoch 2|Withdrawal by Subject|1|||
27517398|NCT02059291|80088443|FG006|Epoch 2|Withdrawal by Subject|0|||
27517399|NCT02059291|80088444|FG007|Epoch 2|Withdrawal by Subject|0|||
27517400|NCT02059291|80088445|FG008|Epoch 2|Withdrawal by Subject|1|||
27517401|NCT02059291|80088446|FG009|Epoch 2|Withdrawal by Subject|0|||
27517402|NCT02059291|80088447|FG010|Epoch 2|Withdrawal by Subject|0|||
27517403|NCT02059291|80088448|FG011|Epoch 2|Withdrawal by Subject|0|||
27517404|NCT02059291|80088449|FG012|Epoch 2|Withdrawal by Subject|0|||
27517405|NCT02059291|80088450|FG013|Epoch 2|Withdrawal by Subject|0|||
27517406|NCT02059291|80088451|FG014|Epoch 2|Withdrawal by Subject|0|||
27517407|NCT02059291|80088452|FG015|Epoch 2|Withdrawal by Subject|0|||
27517408|NCT02059291|80088453|FG016|Epoch 2|Withdrawal by Subject|0|||
27517409|NCT02059291|80088454|FG017|Epoch 2|Withdrawal by Subject|0|||
27517410|NCT02059291|80088455|FG018|Epoch 2|Withdrawal by Subject|0|||
27517411|NCT02059291|80088456|FG019|Epoch 2|Withdrawal by Subject|0|||
27517412|NCT02059291|80088457|FG020|Epoch 2|Withdrawal by Subject|0|||
27517413|NCT02059291|80088458|FG021|Epoch 2|Withdrawal by Subject|0|||
27908058|NCT02683239|81500517|FG000|Overall Study|Death|9|||
27908059|NCT02683239|81500518|FG001|Overall Study|Death|5|||
27517414|NCT02059291|80088459|FG022|Epoch 2|Withdrawal by Subject|0|||
27517415|NCT02059291|80088460|FG023|Epoch 2|Withdrawal by Subject|0|||
27517416|NCT02059291|80088461|FG024|Epoch 2|Withdrawal by Subject|0|||
27517417|NCT02059291|80088437|FG000|Epoch 3|Physician Decision|0|||
27517418|NCT02059291|80088438|FG001|Epoch 3|Physician Decision|0|||
27908060|NCT02683239|81500519|FG002|Overall Study|Death|8|||
27908061|NCT02683239|81500520|FG003|Overall Study|Death|0|||
27517419|NCT02059291|80088439|FG002|Epoch 3|Physician Decision|0|||
27517420|NCT02059291|80088440|FG003|Epoch 3|Physician Decision|0|||
27517421|NCT02059291|80088441|FG004|Epoch 3|Physician Decision|0|||
27517422|NCT02059291|80088442|FG005|Epoch 3|Physician Decision|0|||
27517423|NCT02059291|80088443|FG006|Epoch 3|Physician Decision|0|||
27517424|NCT02059291|80088444|FG007|Epoch 3|Physician Decision|0|||
27517425|NCT02059291|80088445|FG008|Epoch 3|Physician Decision|0|||
27517426|NCT02059291|80088446|FG009|Epoch 3|Physician Decision|0|||
27517427|NCT02059291|80088447|FG010|Epoch 3|Physician Decision|0|||
27908062|NCT02683239|81500521|FG004|Overall Study|Death|12|||
27517428|NCT02059291|80088448|FG011|Epoch 3|Physician Decision|0|||
27517429|NCT02059291|80088449|FG012|Epoch 3|Physician Decision|0|||
27517430|NCT02059291|80088450|FG013|Epoch 3|Physician Decision|1|||
27517431|NCT02059291|80088451|FG014|Epoch 3|Physician Decision|0|||
27517432|NCT02059291|80088452|FG015|Epoch 3|Physician Decision|1|||
27517433|NCT02059291|80088453|FG016|Epoch 3|Physician Decision|0|||
27517434|NCT02059291|80088454|FG017|Epoch 3|Physician Decision|0|||
27517435|NCT02059291|80088455|FG018|Epoch 3|Physician Decision|0|||
27517436|NCT02059291|80088456|FG019|Epoch 3|Physician Decision|0|||
27517437|NCT02059291|80088457|FG020|Epoch 3|Physician Decision|0|||
27517438|NCT02059291|80088458|FG021|Epoch 3|Physician Decision|0|||
27517439|NCT02059291|80088459|FG022|Epoch 3|Physician Decision|0|||
27517440|NCT02059291|80088460|FG023|Epoch 3|Physician Decision|0|||
27517441|NCT02059291|80088461|FG024|Epoch 3|Physician Decision|0|||
27517442|NCT02059291|80088437|FG000|Epoch 3|Adverse Event|0|||
27517443|NCT02059291|80088438|FG001|Epoch 3|Adverse Event|0|||
27517444|NCT02059291|80088439|FG002|Epoch 3|Adverse Event|0|||
27517445|NCT02059291|80088440|FG003|Epoch 3|Adverse Event|0|||
27618078|NCT01052662|80444773|FG002|Overall Study|Pharmacy issue|3|||
27517446|NCT02059291|80088441|FG004|Epoch 3|Adverse Event|0|||
27517447|NCT02059291|80088442|FG005|Epoch 3|Adverse Event|0|||
27517448|NCT02059291|80088443|FG006|Epoch 3|Adverse Event|0|||
27517449|NCT02059291|80088444|FG007|Epoch 3|Adverse Event|0|||
27517450|NCT02059291|80088445|FG008|Epoch 3|Adverse Event|0|||
27517451|NCT02059291|80088446|FG009|Epoch 3|Adverse Event|0|||
27517452|NCT02059291|80088447|FG010|Epoch 3|Adverse Event|0|||
27517453|NCT02059291|80088448|FG011|Epoch 3|Adverse Event|0|||
27517454|NCT02059291|80088449|FG012|Epoch 3|Adverse Event|0|||
27517455|NCT02059291|80088450|FG013|Epoch 3|Adverse Event|0|||
27517456|NCT02059291|80088451|FG014|Epoch 3|Adverse Event|0|||
27517457|NCT02059291|80088452|FG015|Epoch 3|Adverse Event|1|||
27517458|NCT02059291|80088453|FG016|Epoch 3|Adverse Event|0|||
27517459|NCT02059291|80088454|FG017|Epoch 3|Adverse Event|0|||
27517460|NCT02059291|80088455|FG018|Epoch 3|Adverse Event|0|||
27517461|NCT02059291|80088456|FG019|Epoch 3|Adverse Event|0|||
27517462|NCT02059291|80088457|FG020|Epoch 3|Adverse Event|0|||
27517463|NCT02059291|80088458|FG021|Epoch 3|Adverse Event|0|||
27517464|NCT02059291|80088459|FG022|Epoch 3|Adverse Event|0|||
27517465|NCT02059291|80088460|FG023|Epoch 3|Adverse Event|0|||
27908063|NCT02683239|81500522|FG005|Overall Study|Death|1|||
27908064|NCT02683239|81500523|FG006|Overall Study|Death|0|||
27517466|NCT02059291|80088461|FG024|Epoch 3|Adverse Event|0|||
27517467|NCT02059291|80088437|FG000|Epoch 3|Lack of Efficacy|0|||
27517468|NCT02059291|80088438|FG001|Epoch 3|Lack of Efficacy|0|||
27517469|NCT02059291|80088439|FG002|Epoch 3|Lack of Efficacy|0|||
27517470|NCT02059291|80088440|FG003|Epoch 3|Lack of Efficacy|0|||
27517471|NCT02059291|80088441|FG004|Epoch 3|Lack of Efficacy|0|||
27517472|NCT02059291|80088442|FG005|Epoch 3|Lack of Efficacy|0|||
27517473|NCT02059291|80088443|FG006|Epoch 3|Lack of Efficacy|0|||
27517474|NCT02059291|80088444|FG007|Epoch 3|Lack of Efficacy|0|||
27517475|NCT02059291|80088445|FG008|Epoch 3|Lack of Efficacy|0|||
27517476|NCT02059291|80088446|FG009|Epoch 3|Lack of Efficacy|0|||
27517477|NCT02059291|80088447|FG010|Epoch 3|Lack of Efficacy|0|||
27517478|NCT02059291|80088448|FG011|Epoch 3|Lack of Efficacy|0|||
27517479|NCT02059291|80088449|FG012|Epoch 3|Lack of Efficacy|0|||
27517480|NCT02059291|80088450|FG013|Epoch 3|Lack of Efficacy|0|||
27517481|NCT02059291|80088451|FG014|Epoch 3|Lack of Efficacy|0|||
27517482|NCT02059291|80088452|FG015|Epoch 3|Lack of Efficacy|3|||
27517483|NCT02059291|80088453|FG016|Epoch 3|Lack of Efficacy|0|||
27517484|NCT02059291|80088454|FG017|Epoch 3|Lack of Efficacy|0|||
27517485|NCT02059291|80088455|FG018|Epoch 3|Lack of Efficacy|0|||
27517486|NCT02059291|80088456|FG019|Epoch 3|Lack of Efficacy|0|||
27517487|NCT02059291|80088457|FG020|Epoch 3|Lack of Efficacy|0|||
27517488|NCT02059291|80088458|FG021|Epoch 3|Lack of Efficacy|0|||
27517489|NCT02059291|80088459|FG022|Epoch 3|Lack of Efficacy|0|||
27517490|NCT02059291|80088460|FG023|Epoch 3|Lack of Efficacy|0|||
27517491|NCT02059291|80088461|FG024|Epoch 3|Lack of Efficacy|0|||
27517492|NCT02059291|80088437|FG000|Epoch 3|Withdrawal by Subject|0|||
27517493|NCT02059291|80088438|FG001|Epoch 3|Withdrawal by Subject|0|||
27517494|NCT02059291|80088439|FG002|Epoch 3|Withdrawal by Subject|0|||
27517495|NCT02059291|80088440|FG003|Epoch 3|Withdrawal by Subject|0|||
27517496|NCT02059291|80088441|FG004|Epoch 3|Withdrawal by Subject|0|||
27517497|NCT02059291|80088442|FG005|Epoch 3|Withdrawal by Subject|0|||
27517498|NCT02059291|80088443|FG006|Epoch 3|Withdrawal by Subject|0|||
27517499|NCT02059291|80088444|FG007|Epoch 3|Withdrawal by Subject|0|||
27517500|NCT02059291|80088445|FG008|Epoch 3|Withdrawal by Subject|0|||
27517501|NCT02059291|80088446|FG009|Epoch 3|Withdrawal by Subject|0|||
27517502|NCT02059291|80088447|FG010|Epoch 3|Withdrawal by Subject|0|||
27517503|NCT02059291|80088448|FG011|Epoch 3|Withdrawal by Subject|0|||
27730151|NCT03160560|80838458|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
27730152|NCT03160560|80838459|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27517504|NCT02059291|80088449|FG012|Epoch 3|Withdrawal by Subject|0|||
27517505|NCT02059291|80088450|FG013|Epoch 3|Withdrawal by Subject|0|||
27517506|NCT02059291|80088451|FG014|Epoch 3|Withdrawal by Subject|0|||
27517507|NCT02059291|80088452|FG015|Epoch 3|Withdrawal by Subject|1|||
27517508|NCT02059291|80088453|FG016|Epoch 3|Withdrawal by Subject|0|||
27517509|NCT02059291|80088454|FG017|Epoch 3|Withdrawal by Subject|0|||
27517510|NCT02059291|80088455|FG018|Epoch 3|Withdrawal by Subject|0|||
27517511|NCT02059291|80088456|FG019|Epoch 3|Withdrawal by Subject|0|||
27517512|NCT02059291|80088457|FG020|Epoch 3|Withdrawal by Subject|0|||
27517513|NCT02059291|80088458|FG021|Epoch 3|Withdrawal by Subject|0|||
27517514|NCT02059291|80088459|FG022|Epoch 3|Withdrawal by Subject|0|||
27517515|NCT02059291|80088460|FG023|Epoch 3|Withdrawal by Subject|0|||
27517516|NCT02059291|80088461|FG024|Epoch 3|Withdrawal by Subject|0|||
27517517|NCT02059291|80088437|FG000|Epoch 4|Adverse Event|0|||
27517518|NCT02059291|80088438|FG001|Epoch 4|Adverse Event|0|||
27517519|NCT02059291|80088439|FG002|Epoch 4|Adverse Event|0|||
27517520|NCT02059291|80088440|FG003|Epoch 4|Adverse Event|0|||
27517521|NCT02059291|80088441|FG004|Epoch 4|Adverse Event|0|||
27517522|NCT02059291|80088442|FG005|Epoch 4|Adverse Event|0|||
27517523|NCT02059291|80088443|FG006|Epoch 4|Adverse Event|0|||
27517524|NCT02059291|80088444|FG007|Epoch 4|Adverse Event|0|||
27517525|NCT02059291|80088445|FG008|Epoch 4|Adverse Event|0|||
27517526|NCT02059291|80088446|FG009|Epoch 4|Adverse Event|0|||
27517527|NCT02059291|80088447|FG010|Epoch 4|Adverse Event|0|||
27517528|NCT02059291|80088448|FG011|Epoch 4|Adverse Event|0|||
27517529|NCT02059291|80088449|FG012|Epoch 4|Adverse Event|0|||
27517530|NCT02059291|80088450|FG013|Epoch 4|Adverse Event|0|||
27517531|NCT02059291|80088451|FG014|Epoch 4|Adverse Event|0|||
27517532|NCT02059291|80088452|FG015|Epoch 4|Adverse Event|0|||
27517533|NCT02059291|80088453|FG016|Epoch 4|Adverse Event|1|||
27517534|NCT02059291|80088454|FG017|Epoch 4|Adverse Event|0|||
27517535|NCT02059291|80088455|FG018|Epoch 4|Adverse Event|0|||
27517536|NCT02059291|80088456|FG019|Epoch 4|Adverse Event|0|||
27517537|NCT02059291|80088457|FG020|Epoch 4|Adverse Event|0|||
27517538|NCT02059291|80088458|FG021|Epoch 4|Adverse Event|0|||
27517539|NCT02059291|80088459|FG022|Epoch 4|Adverse Event|1|||
27517540|NCT02059291|80088460|FG023|Epoch 4|Adverse Event|0|||
27517541|NCT02059291|80088461|FG024|Epoch 4|Adverse Event|0|||
27517542|NCT02059291|80088437|FG000|Epoch 4|Pregnancy|0|||
27517543|NCT02059291|80088438|FG001|Epoch 4|Pregnancy|0|||
27517544|NCT02059291|80088439|FG002|Epoch 4|Pregnancy|0|||
27517545|NCT02059291|80088440|FG003|Epoch 4|Pregnancy|0|||
27517546|NCT02059291|80088441|FG004|Epoch 4|Pregnancy|0|||
27517547|NCT02059291|80088442|FG005|Epoch 4|Pregnancy|0|||
27517548|NCT02059291|80088443|FG006|Epoch 4|Pregnancy|0|||
27517549|NCT02059291|80088444|FG007|Epoch 4|Pregnancy|0|||
27517550|NCT02059291|80088445|FG008|Epoch 4|Pregnancy|0|||
27517551|NCT02059291|80088446|FG009|Epoch 4|Pregnancy|0|||
27517552|NCT02059291|80088447|FG010|Epoch 4|Pregnancy|0|||
27517553|NCT02059291|80088448|FG011|Epoch 4|Pregnancy|0|||
27517554|NCT02059291|80088449|FG012|Epoch 4|Pregnancy|0|||
27517555|NCT02059291|80088450|FG013|Epoch 4|Pregnancy|0|||
27517556|NCT02059291|80088451|FG014|Epoch 4|Pregnancy|0|||
27517557|NCT02059291|80088452|FG015|Epoch 4|Pregnancy|0|||
27517558|NCT02059291|80088453|FG016|Epoch 4|Pregnancy|1|||
27517559|NCT02059291|80088454|FG017|Epoch 4|Pregnancy|0|||
27517560|NCT02059291|80088455|FG018|Epoch 4|Pregnancy|0|||
27517561|NCT02059291|80088456|FG019|Epoch 4|Pregnancy|0|||
27517562|NCT02059291|80088457|FG020|Epoch 4|Pregnancy|0|||
27517563|NCT02059291|80088458|FG021|Epoch 4|Pregnancy|0|||
27517564|NCT02059291|80088459|FG022|Epoch 4|Pregnancy|0|||
27517565|NCT02059291|80088460|FG023|Epoch 4|Pregnancy|0|||
27517566|NCT02059291|80088461|FG024|Epoch 4|Pregnancy|0|||
27517567|NCT02059291|80088437|FG000|Epoch 4|Withdrawal by Subject|0|||
27517568|NCT02059291|80088438|FG001|Epoch 4|Withdrawal by Subject|0|||
27517569|NCT02059291|80088439|FG002|Epoch 4|Withdrawal by Subject|0|||
27517570|NCT02059291|80088440|FG003|Epoch 4|Withdrawal by Subject|0|||
27517571|NCT02059291|80088441|FG004|Epoch 4|Withdrawal by Subject|0|||
27517572|NCT02059291|80088442|FG005|Epoch 4|Withdrawal by Subject|0|||
27517573|NCT02059291|80088443|FG006|Epoch 4|Withdrawal by Subject|0|||
27517574|NCT02059291|80088444|FG007|Epoch 4|Withdrawal by Subject|0|||
27517575|NCT02059291|80088445|FG008|Epoch 4|Withdrawal by Subject|0|||
27517576|NCT02059291|80088446|FG009|Epoch 4|Withdrawal by Subject|0|||
27517577|NCT02059291|80088447|FG010|Epoch 4|Withdrawal by Subject|0|||
27517578|NCT02059291|80088448|FG011|Epoch 4|Withdrawal by Subject|0|||
27517579|NCT02059291|80088449|FG012|Epoch 4|Withdrawal by Subject|0|||
27517580|NCT02059291|80088450|FG013|Epoch 4|Withdrawal by Subject|0|||
27517581|NCT02059291|80088451|FG014|Epoch 4|Withdrawal by Subject|0|||
27517582|NCT02059291|80088452|FG015|Epoch 4|Withdrawal by Subject|0|||
27517583|NCT02059291|80088453|FG016|Epoch 4|Withdrawal by Subject|0|||
27730153|NCT03160560|80838460|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
27730154|NCT03160560|80838461|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
27730155|NCT03160560|80838458|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
27730156|NCT03160560|80838459|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27730157|NCT03160560|80838460|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27730158|NCT03160560|80838461|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
27517584|NCT02059291|80088454|FG017|Epoch 4|Withdrawal by Subject|0|||
27730159|NCT00474240|80838464|FG000|Overall Study|Withdrawal by Subject|1|||
27517585|NCT02059291|80088455|FG018|Epoch 4|Withdrawal by Subject|0|||
27517586|NCT02059291|80088456|FG019|Epoch 4|Withdrawal by Subject|0|||
27517587|NCT02059291|80088457|FG020|Epoch 4|Withdrawal by Subject|1|||
27853843|NCT02400671|81295172|FG001|Overall Study|Withdrawal by Subject|2|||
27517588|NCT02059291|80088458|FG021|Epoch 4|Withdrawal by Subject|0|||
27517589|NCT02059291|80088459|FG022|Epoch 4|Withdrawal by Subject|0|||
27517590|NCT02059291|80088460|FG023|Epoch 4|Withdrawal by Subject|0|||
27517591|NCT02059291|80088461|FG024|Epoch 4|Withdrawal by Subject|0|||
27517592|NCT02059291|80088437|FG000|Epoch 4|Lack of Efficacy|0|||
27517593|NCT02059291|80088438|FG001|Epoch 4|Lack of Efficacy|0|||
27517594|NCT02059291|80088439|FG002|Epoch 4|Lack of Efficacy|0|||
27517595|NCT02059291|80088440|FG003|Epoch 4|Lack of Efficacy|0|||
27517596|NCT02059291|80088441|FG004|Epoch 4|Lack of Efficacy|0|||
27517597|NCT02059291|80088442|FG005|Epoch 4|Lack of Efficacy|0|||
27517598|NCT02059291|80088443|FG006|Epoch 4|Lack of Efficacy|0|||
27517599|NCT02059291|80088444|FG007|Epoch 4|Lack of Efficacy|0|||
27517600|NCT02059291|80088445|FG008|Epoch 4|Lack of Efficacy|0|||
27517601|NCT02059291|80088446|FG009|Epoch 4|Lack of Efficacy|0|||
27517602|NCT02059291|80088447|FG010|Epoch 4|Lack of Efficacy|0|||
27517603|NCT02059291|80088448|FG011|Epoch 4|Lack of Efficacy|0|||
27517604|NCT02059291|80088449|FG012|Epoch 4|Lack of Efficacy|0|||
27730160|NCT00474240|80838465|FG001|Overall Study|Withdrawal by Subject|1|||
27730161|NCT00474240|80838466|FG002|Overall Study|Withdrawal by Subject|0|||
27618079|NCT01052662|80444771|FG000|Overall Study|Adverse Event|1|||
27618080|NCT01052662|80444772|FG001|Overall Study|Adverse Event|1|||
27618081|NCT01052662|80444773|FG002|Overall Study|Adverse Event|0|||
27618082|NCT01052662|80444771|FG000|Overall Study|Legal Problem|2|||
27618083|NCT01052662|80444772|FG001|Overall Study|Legal Problem|0|||
27618084|NCT01052662|80444773|FG002|Overall Study|Legal Problem|0|||
27618085|NCT01052662|80444771|FG000|Overall Study|Administrative|0|||
27618086|NCT01052662|80444772|FG001|Overall Study|Administrative|3|||
27618087|NCT01052662|80444773|FG002|Overall Study|Administrative|0|||
27618088|NCT01528709|80444774|FG000|Overall Study|Death|2|||
27618089|NCT01528709|80444775|FG001|Overall Study|Death|0|||
27618090|NCT01528709|80444774|FG000|Overall Study|Withdrawal by Subject|10|||
27618091|NCT01528709|80444775|FG001|Overall Study|Withdrawal by Subject|15|||
27618092|NCT01528709|80444774|FG000|Overall Study|allergy|1|||
27618093|NCT01528709|80444775|FG001|Overall Study|allergy|0|||
27618094|NCT00701311|80444776|FG000|Overall Study|Lack of Efficacy|3|||
27618095|NCT00701311|80444776|FG000|Overall Study|Adverse Event|3|||
27618096|NCT00701311|80444776|FG000|Overall Study|Withdrawal by Subject|2|||
27618097|NCT00136916|80444778|FG000|Overall Study|Never received study treatment|3|||
27618098|NCT00136916|80444779|FG001|Overall Study|Never received study treatment|5|||
27618099|NCT00136916|80444778|FG000|Overall Study|Death|1|||
27618100|NCT00136916|80444779|FG001|Overall Study|Death|3|||
27618101|NCT00136916|80444778|FG000|Overall Study|Adverse Event|27|||
27618102|NCT00136916|80444779|FG001|Overall Study|Adverse Event|8|||
27618103|NCT00136916|80444778|FG000|Overall Study|Laboratory abnormality|0|||
27618104|NCT00136916|80444779|FG001|Overall Study|Laboratory abnormality|1|||
27618105|NCT00136916|80444778|FG000|Overall Study|Lack of Efficacy|13|||
27618106|NCT00136916|80444779|FG001|Overall Study|Lack of Efficacy|3|||
27618107|NCT00136916|80444778|FG000|Overall Study|Lost to Follow-up|12|||
27618108|NCT00136916|80444779|FG001|Overall Study|Lost to Follow-up|14|||
27618109|NCT00136916|80444778|FG000|Overall Study|Withdrawal by Subject|44|||
27618110|NCT00136916|80444779|FG001|Overall Study|Withdrawal by Subject|46|||
27618111|NCT00136916|80444778|FG000|Overall Study|Other|22|||
27618112|NCT00136916|80444779|FG001|Overall Study|Other|24|||
27618113|NCT00136916|80444778|FG000|Overall Study|Discontinued in follow up period|3|||
27618114|NCT00136916|80444779|FG001|Overall Study|Discontinued in follow up period|0|||
27618115|NCT00388362|80444783|FG000|Enrolled|Ineligible|1|||
27618116|NCT00388362|80444783|FG000|Enrolled|Adverse Event|9|||
27618117|NCT00388362|80444783|FG000|Enrolled|Death|1|||
27618118|NCT00388362|80444783|FG000|Enrolled|Loss insurance|1|||
27618119|NCT00388362|80444783|FG000|Enrolled|Withdrawal by Subject|1|||
27618120|NCT00388362|80444783|FG000|Remained on Study Median of 514 Days|Death|2|||
27618121|NCT02764775|80444788|FG000|Overall Study|Death|1|||
27618122|NCT02764775|80444788|FG000|Overall Study|Lost to Follow-up|2|||
27618123|NCT02764775|80444788|FG000|Overall Study|Withdrawal by Subject|3|||
27618124|NCT00235495|80444791|FG000|Overall Study|Death|52|||
27618125|NCT00235495|80444792|FG001|Overall Study|Death|42|||
27618126|NCT00235495|80444791|FG000|Overall Study|Withdrawal by Subject|5|||
27618127|NCT00235495|80444792|FG001|Overall Study|Withdrawal by Subject|3|||
27618128|NCT00235495|80444791|FG000|Overall Study|Lost to Follow-up|11|||
27618129|NCT00235495|80444792|FG001|Overall Study|Lost to Follow-up|13|||
27517605|NCT02059291|80088450|FG013|Epoch 4|Lack of Efficacy|0|||
27517606|NCT02059291|80088451|FG014|Epoch 4|Lack of Efficacy|0|||
27517607|NCT02059291|80088452|FG015|Epoch 4|Lack of Efficacy|0|||
27517608|NCT02059291|80088453|FG016|Epoch 4|Lack of Efficacy|0|||
27517609|NCT02059291|80088454|FG017|Epoch 4|Lack of Efficacy|0|||
27517610|NCT02059291|80088455|FG018|Epoch 4|Lack of Efficacy|0|||
27517611|NCT02059291|80088456|FG019|Epoch 4|Lack of Efficacy|0|||
27517612|NCT02059291|80088457|FG020|Epoch 4|Lack of Efficacy|0|||
27618130|NCT00235495|80444791|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
27618131|NCT00235495|80444792|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
27618132|NCT04227340|80444805|FG000|Overall Study|Withdrawal by Subject|3|||
27618133|NCT00131911|80444807|FG000|Overall Study|Withdrawal by Subject|1|||
27618134|NCT00131911|80444808|FG001|Overall Study|Withdrawal by Subject|0|||
27618135|NCT00610675|80444809|FG000|Overall Study|Untreated|4|||
27618136|NCT00610675|80444809|FG000|Overall Study|Adverse Event|67|||
27618137|NCT00610675|80444809|FG000|Overall Study|Insufficient Effect|31|||
27730162|NCT00474240|80838467|FG003|Overall Study|Withdrawal by Subject|2|||
27517613|NCT02059291|80088458|FG021|Epoch 4|Lack of Efficacy|0|||
27517614|NCT02059291|80088459|FG022|Epoch 4|Lack of Efficacy|0|||
27618138|NCT00610675|80444809|FG000|Overall Study|Withdrawal by Subject|28|||
27618139|NCT00610675|80444809|FG000|Overall Study|Reasons unrelated to trial|27|||
27618140|NCT00610675|80444809|FG000|Overall Study|Lack of Compliance|7|||
27618141|NCT00610675|80444809|FG000|Overall Study|Lost to Follow-up|31|||
27618142|NCT00610675|80444809|FG000|Overall Study|Other reason (not specified)|25|||
27618143|NCT00479674|80444810|FG000|Overall Study|Adverse Event|18|||
27853844|NCT02400671|81295173|FG002|Overall Study|Withdrawal by Subject|0|||
27517615|NCT02059291|80088460|FG023|Epoch 4|Lack of Efficacy|1|||
27517616|NCT02059291|80088461|FG024|Epoch 4|Lack of Efficacy|0|||
27517617|NCT01155011|80088467|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
27517618|NCT01155011|80088468|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
27517619|NCT01155011|80088467|FG000|Baseline to 6 Months|investigator decision, moved|4|||
27517620|NCT01155011|80088468|FG001|Baseline to 6 Months|investigator decision, moved|5|||
27517621|NCT01155011|80088467|FG000|Baseline to 6 Months|Death|0|||
27517622|NCT01155011|80088468|FG001|Baseline to 6 Months|Death|1|||
27517623|NCT01155011|80088467|FG000|6 to 12 Months|Withdrawal by Subject|8|||
27517624|NCT01155011|80088468|FG001|6 to 12 Months|Withdrawal by Subject|5|||
27517625|NCT01155011|80088467|FG000|6 to 12 Months|Death|1|||
27517626|NCT01155011|80088468|FG001|6 to 12 Months|Death|5|||
27517627|NCT00006409|80088469|FG000|Baseline|Protocol Violation|48|||
27517628|NCT00006409|80088470|FG001|Baseline|Protocol Violation|70|||
27517629|NCT00006409|80088471|FG002|Baseline|Protocol Violation|0|||
27517630|NCT00006409|80088472|FG003|Baseline|Protocol Violation|0|||
27517631|NCT00006409|80088473|FG004|Baseline|Protocol Violation|0|||
27517632|NCT00006409|80088474|FG005|Baseline|Protocol Violation|0|||
27517633|NCT00006409|80088469|FG000|Post-2 Year Intervention|Protocol Violation|0|||
27517634|NCT00006409|80088470|FG001|Post-2 Year Intervention|Protocol Violation|0|||
27517635|NCT00006409|80088471|FG002|Post-2 Year Intervention|Protocol Violation|251|||
27517636|NCT00006409|80088472|FG003|Post-2 Year Intervention|Protocol Violation|168|||
27517637|NCT00006409|80088473|FG004|Post-2 Year Intervention|Protocol Violation|0|||
27517638|NCT00006409|80088474|FG005|Post-2 Year Intervention|Protocol Violation|0|||
27517639|NCT00006409|80088469|FG000|Post-3 Year Intervention|Protocol Violation|0|||
27517640|NCT00006409|80088470|FG001|Post-3 Year Intervention|Protocol Violation|0|||
27517641|NCT00006409|80088471|FG002|Post-3 Year Intervention|Protocol Violation|0|||
27517642|NCT00006409|80088472|FG003|Post-3 Year Intervention|Protocol Violation|0|||
27517643|NCT00006409|80088473|FG004|Post-3 Year Intervention|Protocol Violation|62|||
27517644|NCT00006409|80088474|FG005|Post-3 Year Intervention|Protocol Violation|62|||
27517645|NCT01008423|80088475|FG000|Overall Study|Adverse Event|13|||
27517646|NCT01008423|80088476|FG001|Overall Study|Adverse Event|6|||
27517647|NCT01008423|80088475|FG000|Overall Study|Withdrawal by Subject|4|||
27517648|NCT01008423|80088476|FG001|Overall Study|Withdrawal by Subject|7|||
27517649|NCT01008423|80088475|FG000|Overall Study|Lost to Follow-up|0|||
27517650|NCT01008423|80088476|FG001|Overall Study|Lost to Follow-up|2|||
27517651|NCT01008423|80088475|FG000|Overall Study|Low Cortisol|0|||
27517652|NCT01008423|80088476|FG001|Overall Study|Low Cortisol|1|||
27517653|NCT01008423|80088475|FG000|Overall Study|Lack of Efficacy|0|||
27517654|NCT01008423|80088476|FG001|Overall Study|Lack of Efficacy|5|||
27517655|NCT01008423|80088475|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
27517656|NCT01008423|80088476|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
27517657|NCT01008423|80088475|FG000|Overall Study|Personal Conflict|1|||
27517658|NCT01008423|80088476|FG001|Overall Study|Personal Conflict|0|||
27517659|NCT01008423|80088475|FG000|Overall Study|Other|0|||
27517660|NCT01008423|80088476|FG001|Overall Study|Other|1|||
27517661|NCT03113136|80088477|FG000|Overall Study|Lost to Follow-up|22|||
27517662|NCT03113136|80088478|FG001|Overall Study|Lost to Follow-up|47|||
27517663|NCT03113136|80088479|FG002|Overall Study|Lost to Follow-up|54|||
27517664|NCT03113136|80088477|FG000|Overall Study|Withdrawal by Subject|4|||
27517665|NCT03113136|80088478|FG001|Overall Study|Withdrawal by Subject|13|||
27517666|NCT03113136|80088479|FG002|Overall Study|Withdrawal by Subject|14|||
27517667|NCT03113136|80088477|FG000|Overall Study|Ineligible|0|||
27517668|NCT03113136|80088478|FG001|Overall Study|Ineligible|2|||
27517669|NCT03113136|80088479|FG002|Overall Study|Ineligible|1|||
27517670|NCT03113136|80088477|FG000|Overall Study|Study Team Decision|1|||
27517671|NCT03113136|80088478|FG001|Overall Study|Study Team Decision|4|||
27517672|NCT03113136|80088479|FG002|Overall Study|Study Team Decision|0|||
27517673|NCT02273596|80088480|FG000|24-Week Treatment Period|Adverse Event|3|||
27517674|NCT02273596|80088480|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
27517675|NCT02273596|80088480|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
27517676|NCT02273596|80088480|FG000|24-Week Treatment Period|Physician Decision|1|||
27517677|NCT02273596|80088480|FG000|24-Week Treatment Period|Protocol Deviation|1|||
27517678|NCT02273596|80088480|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
27517679|NCT02273596|80088480|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
27517680|NCT02273596|80088480|FG000|Extension Period|Lost to Follow-up|1|||
27517681|NCT02273596|80088480|FG000|Extension Period|Protocol Deviation|1|||
27517682|NCT01788215|80088481|FG000|Overall Study|Withdrawal by Subject|0|||
27517683|NCT01788215|80088482|FG001|Overall Study|Withdrawal by Subject|1|||
27517684|NCT01788215|80088481|FG000|Overall Study|Lost to Follow-up|2|||
27517685|NCT01788215|80088482|FG001|Overall Study|Lost to Follow-up|0|||
27517686|NCT02445794|80088483|FG000|Overall Study|Adverse Event|0|||
27517687|NCT02445794|80088484|FG001|Overall Study|Adverse Event|0|||
27517688|NCT02445794|80088485|FG002|Overall Study|Adverse Event|2|||
27517689|NCT02445794|80088486|FG003|Overall Study|Adverse Event|0|||
27517690|NCT00246740|80088487|FG000|Initial Enrollment|Death|1|||
27517691|NCT00246740|80088488|FG001|Initial Enrollment|Death|0|||
27618144|NCT00479674|80444810|FG000|Overall Study|Withdrawal by Subject|6|||
27618145|NCT00479674|80444810|FG000|Overall Study|Physician Decision|14|||
27618146|NCT00479674|80444810|FG000|Overall Study|none provided|3|||
27517692|NCT00246740|80088487|FG000|Initial Enrollment|Additional surgery scheduled|0|||
27517693|NCT00246740|80088488|FG001|Initial Enrollment|Additional surgery scheduled|2|||
27618147|NCT00900627|80444820|FG000|Overall Study|Condition under investigation worsened|4|||
27618148|NCT00900627|80444821|FG001|Overall Study|Condition under investigation worsened|0|||
27618149|NCT00900627|80444822|FG002|Overall Study|Condition under investigation worsened|5|||
27618150|NCT00900627|80444823|FG003|Overall Study|Condition under investigation worsened|3|||
27730163|NCT00474240|80838468|FG004|Overall Study|Withdrawal by Subject|3|||
27730164|NCT00474240|80838469|FG005|Overall Study|Withdrawal by Subject|1|||
27730165|NCT00474240|80838464|FG000|Overall Study|Adverse Event|0|||
27730166|NCT00474240|80838465|FG001|Overall Study|Adverse Event|0|||
27730167|NCT00474240|80838466|FG002|Overall Study|Adverse Event|9|||
27730168|NCT00474240|80838467|FG003|Overall Study|Adverse Event|14|||
27730169|NCT00474240|80838468|FG004|Overall Study|Adverse Event|5|||
27730170|NCT00474240|80838469|FG005|Overall Study|Adverse Event|16|||
27730171|NCT00474240|80838464|FG000|Overall Study|Removed due to lab value|0|||
27730172|NCT00474240|80838465|FG001|Overall Study|Removed due to lab value|0|||
27730173|NCT00474240|80838466|FG002|Overall Study|Removed due to lab value|0|||
27730174|NCT00474240|80838467|FG003|Overall Study|Removed due to lab value|0|||
27730175|NCT00474240|80838468|FG004|Overall Study|Removed due to lab value|0|||
27730176|NCT00474240|80838469|FG005|Overall Study|Removed due to lab value|1|||
27730177|NCT01227967|80838476|FG000|Overall Study|Protocol Violation|3|||
27908065|NCT02683239|81500517|FG000|Overall Study|Lack of Efficacy|50|||
27908066|NCT02683239|81500518|FG001|Overall Study|Lack of Efficacy|23|||
27908067|NCT02683239|81500519|FG002|Overall Study|Lack of Efficacy|12|||
27908068|NCT02683239|81500520|FG003|Overall Study|Lack of Efficacy|2|||
27908069|NCT02683239|81500521|FG004|Overall Study|Lack of Efficacy|29|||
27517694|NCT00246740|80088487|FG000|Initial Enrollment|Surgery schedule change|4|||
27730178|NCT01227967|80838477|FG001|Overall Study|Protocol Violation|1|||
27853845|NCT00468650|81295174|FG000|Overall Study|Lost to Follow-up|4|||
27853846|NCT00468650|81295174|FG000|Overall Study|Withdrawal by Subject|2|||
27730179|NCT01227967|80838476|FG000|Overall Study|Death|0|||
27730180|NCT01227967|80838477|FG001|Overall Study|Death|1|||
27730181|NCT01227967|80838476|FG000|Overall Study|Lost to Follow-up|8|||
27730182|NCT01227967|80838477|FG001|Overall Study|Lost to Follow-up|3|||
27730183|NCT01227967|80838476|FG000|Overall Study|Withdrawal by Subject|4|||
27730184|NCT01227967|80838477|FG001|Overall Study|Withdrawal by Subject|3|||
27730185|NCT01227967|80838476|FG000|Overall Study|Physician Decision|0|||
27730186|NCT01227967|80838477|FG001|Overall Study|Physician Decision|1|||
27730187|NCT01227967|80838476|FG000|Overall Study|Never Started Treatment|0|||
27730188|NCT01227967|80838477|FG001|Overall Study|Never Started Treatment|4|||
27730189|NCT01227967|80838476|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
27730190|NCT01227967|80838477|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
27730191|NCT00961961|80838478|FG000|Phase I|Withdrawal by Subject|7|||
27730192|NCT00961961|80838479|FG001|Phase I|Withdrawal by Subject|0|||
27853847|NCT00468650|81295174|FG000|Overall Study|Protocol Violation|1|||
27853848|NCT01892657|81295175|FG000|Overall Study|Withdrawal by Subject|6|||
27853849|NCT01892657|81295175|FG000|Overall Study|Protocol Violation|12|||
27853850|NCT05256134|81295178|FG000|Overall Study|Study Terminated by Sponsor|11|||
27908070|NCT02683239|81500522|FG005|Overall Study|Lack of Efficacy|2|||
27908071|NCT02683239|81500523|FG006|Overall Study|Lack of Efficacy|3|||
27908072|NCT02683239|81500517|FG000|Overall Study|Missing data|0|||
27517695|NCT00246740|80088488|FG001|Initial Enrollment|Surgery schedule change|4|||
27517696|NCT00246740|80088487|FG000|Initial Enrollment|Other|1|||
27517697|NCT00246740|80088488|FG001|Initial Enrollment|Other|2|||
27517698|NCT00881868|80088489|FG000|Overall Study|Adverse Event|0|||
27517699|NCT00881868|80088490|FG001|Overall Study|Adverse Event|1|||
27517700|NCT00881868|80088489|FG000|Overall Study|Lost to Follow-up|2|||
27517701|NCT00881868|80088490|FG001|Overall Study|Lost to Follow-up|1|||
27517702|NCT00881868|80088489|FG000|Overall Study|Physician Decision|4|||
27517703|NCT00881868|80088490|FG001|Overall Study|Physician Decision|0|||
27517704|NCT00881868|80088489|FG000|Overall Study|Protocol Violation|2|||
27517705|NCT00881868|80088490|FG001|Overall Study|Protocol Violation|0|||
27517706|NCT03189524|80088491|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
27730193|NCT00961961|80838480|FG002|Phase I|Withdrawal by Subject|0|||
27730194|NCT00961961|80838481|FG003|Phase I|Withdrawal by Subject|0|||
27730195|NCT00961961|80838478|FG000|Phase I|Lost to Follow-up|10|||
27730196|NCT00961961|80838479|FG001|Phase I|Lost to Follow-up|0|||
27853851|NCT05256134|81295179|FG001|Overall Study|Study Terminated by Sponsor|10|||
27730197|NCT00961961|80838480|FG002|Phase I|Lost to Follow-up|0|||
27730198|NCT00961961|80838481|FG003|Phase I|Lost to Follow-up|0|||
27730199|NCT00961961|80838478|FG000|Phase I|Lack of Efficacy|94|||
27730200|NCT00961961|80838479|FG001|Phase I|Lack of Efficacy|0|||
27730201|NCT00961961|80838480|FG002|Phase I|Lack of Efficacy|0|||
27908073|NCT02683239|81500518|FG001|Overall Study|Missing data|1|||
27908074|NCT02683239|81500519|FG002|Overall Study|Missing data|1|||
27517707|NCT03189524|80088492|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
27517708|NCT03189524|80088493|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
27517709|NCT03189524|80088491|FG000|Overall Study|Death|2|||
27517710|NCT03189524|80088492|FG001|Overall Study|Death|2|||
27517711|NCT03189524|80088493|FG002|Overall Study|Death|1|||
27517712|NCT03189524|80088491|FG000|Overall Study|Lost to Follow-up|1|||
27517713|NCT03189524|80088492|FG001|Overall Study|Lost to Follow-up|0|||
27517714|NCT03189524|80088493|FG002|Overall Study|Lost to Follow-up|8|||
27517715|NCT03189524|80088491|FG000|Overall Study|Withdrawal by Subject|1|||
27517716|NCT03189524|80088492|FG001|Overall Study|Withdrawal by Subject|1|||
27517717|NCT03189524|80088493|FG002|Overall Study|Withdrawal by Subject|3|||
27853852|NCT05256134|81295178|FG000|Overall Study|Withdrawal by Subject|1|||
27618151|NCT00900627|80444824|FG004|Overall Study|Condition under investigation worsened|0|||
27618152|NCT00900627|80444825|FG005|Overall Study|Condition under investigation worsened|0|||
27618153|NCT00900627|80444820|FG000|Overall Study|Withdrawal by Subject|1|||
27618154|NCT00900627|80444821|FG001|Overall Study|Withdrawal by Subject|0|||
27618155|NCT00900627|80444822|FG002|Overall Study|Withdrawal by Subject|1|||
27618156|NCT00900627|80444823|FG003|Overall Study|Withdrawal by Subject|0|||
27618157|NCT00900627|80444824|FG004|Overall Study|Withdrawal by Subject|1|||
27618158|NCT00900627|80444825|FG005|Overall Study|Withdrawal by Subject|2|||
27618159|NCT00900627|80444820|FG000|Overall Study|Adverse Event|1|||
27618160|NCT00900627|80444821|FG001|Overall Study|Adverse Event|2|||
27618161|NCT00900627|80444822|FG002|Overall Study|Adverse Event|0|||
27618162|NCT00900627|80444823|FG003|Overall Study|Adverse Event|3|||
27618163|NCT00900627|80444824|FG004|Overall Study|Adverse Event|0|||
27618164|NCT00900627|80444825|FG005|Overall Study|Adverse Event|0|||
27618165|NCT00900627|80444820|FG000|Overall Study|Death|0|||
27517718|NCT03189524|80088491|FG000|Overall Study|Progressive Disease|0|||
27517719|NCT03189524|80088492|FG001|Overall Study|Progressive Disease|2|||
27517720|NCT03189524|80088493|FG002|Overall Study|Progressive Disease|0|||
27517721|NCT03890666|80088496|FG000|Overall Study|Withdrawal by Subject|0|||
27517722|NCT03890666|80088497|FG001|Overall Study|Withdrawal by Subject|1|||
27517723|NCT03890666|80088496|FG000|Overall Study|Protocol deviation|1|||
27517724|NCT03890666|80088497|FG001|Overall Study|Protocol deviation|4|||
27517725|NCT03890666|80088496|FG000|Overall Study|Lost to Follow-up|2|||
27517726|NCT03890666|80088497|FG001|Overall Study|Lost to Follow-up|5|||
27517727|NCT03890666|80088496|FG000|Overall Study|Other than specified|1|||
27517728|NCT03890666|80088497|FG001|Overall Study|Other than specified|8|||
27517729|NCT00781885|80088498|FG000|Overall Study|Physician Decision|1|||
27517730|NCT01136785|80088499|FG000|Overall Study|Protocol Violation|2|||
27517731|NCT01136785|80088500|FG001|Overall Study|Protocol Violation|1|||
27618166|NCT00900627|80444821|FG001|Overall Study|Death|0|||
27618167|NCT00900627|80444822|FG002|Overall Study|Death|0|||
27618168|NCT00900627|80444823|FG003|Overall Study|Death|0|||
27517732|NCT02654717|80088501|FG000|Overall Study|Adverse Event|2|||
27517733|NCT02654717|80088502|FG001|Overall Study|Adverse Event|2|||
27517734|NCT02654717|80088501|FG000|Overall Study|Protocol Violation|1|||
27517735|NCT02654717|80088502|FG001|Overall Study|Protocol Violation|2|||
27517736|NCT02654717|80088501|FG000|Overall Study|Withdrawal by Subject|0|||
27517737|NCT02654717|80088502|FG001|Overall Study|Withdrawal by Subject|1|||
27517738|NCT02654717|80088501|FG000|Overall Study|Non-permitted medication|3|||
27517739|NCT02654717|80088502|FG001|Overall Study|Non-permitted medication|0|||
27517740|NCT01523275|80088503|FG000|Overall Study|Lost to Follow-up|1|||
27517741|NCT01523275|80088504|FG001|Overall Study|Lost to Follow-up|2|||
27517742|NCT01523275|80088503|FG000|Overall Study|Withdrawal by Subject|1|||
27517743|NCT01523275|80088504|FG001|Overall Study|Withdrawal by Subject|0|||
27517744|NCT03288142|80088505|FG000|Overall Study|Lost to Follow-up|22|||
27517745|NCT03288142|80088506|FG001|Overall Study|Lost to Follow-up|15|||
27517746|NCT04849559|80088509|FG000|Overall Study|Withdrawal by Subject|2|||
27618169|NCT00900627|80444824|FG004|Overall Study|Death|28|||
27618170|NCT00900627|80444825|FG005|Overall Study|Death|24|||
27618171|NCT02117544|80444826|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
27618172|NCT02117544|80444827|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
27517747|NCT04849559|80088510|FG001|Overall Study|Withdrawal by Subject|1|||
27517748|NCT00796991|80088511|FG000|Overall Study|Adverse Event|0|||
27618173|NCT01646320|80444828|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
27618174|NCT01646320|80444829|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
27618175|NCT01646320|80444828|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
27730202|NCT00961961|80838481|FG003|Phase I|Lack of Efficacy|0|||
27730203|NCT00961961|80838478|FG000|Phase I|Adverse Event|7|||
27517749|NCT00796991|80088512|FG001|Overall Study|Adverse Event|0|||
27517750|NCT00796991|80088513|FG002|Overall Study|Adverse Event|1|||
27517751|NCT00796991|80088511|FG000|Overall Study|Death|2|||
27517752|NCT00796991|80088512|FG001|Overall Study|Death|0|||
27517753|NCT00796991|80088513|FG002|Overall Study|Death|0|||
27517754|NCT00796991|80088511|FG000|Overall Study|Disease Progression|10|||
27517755|NCT00796991|80088512|FG001|Overall Study|Disease Progression|9|||
27730204|NCT00961961|80838479|FG001|Phase I|Adverse Event|0|||
27730205|NCT00961961|80838480|FG002|Phase I|Adverse Event|0|||
27730206|NCT00961961|80838481|FG003|Phase I|Adverse Event|0|||
27730207|NCT00961961|80838478|FG000|Phase I|Physician Decision|8|||
27730208|NCT00961961|80838479|FG001|Phase I|Physician Decision|0|||
27730209|NCT00961961|80838480|FG002|Phase I|Physician Decision|0|||
27730210|NCT00961961|80838481|FG003|Phase I|Physician Decision|0|||
27730211|NCT00961961|80838478|FG000|Phase II|Lost to Follow-up|0|||
27730212|NCT00961961|80838479|FG001|Phase II|Lost to Follow-up|0|||
27730213|NCT00961961|80838480|FG002|Phase II|Lost to Follow-up|10|||
27730214|NCT00961961|80838481|FG003|Phase II|Lost to Follow-up|7|||
27730215|NCT00961961|80838478|FG000|Phase II|Adverse Event|0|||
27730216|NCT00961961|80838479|FG001|Phase II|Adverse Event|0|||
27730217|NCT00961961|80838480|FG002|Phase II|Adverse Event|0|||
27730218|NCT00961961|80838481|FG003|Phase II|Adverse Event|1|||
27730219|NCT00961961|80838478|FG000|Phase II|Physician Decision|0|||
27730220|NCT00961961|80838479|FG001|Phase II|Physician Decision|0|||
27730221|NCT00961961|80838480|FG002|Phase II|Physician Decision|1|||
27730222|NCT00961961|80838481|FG003|Phase II|Physician Decision|0|||
27730223|NCT00961961|80838478|FG000|Phase II|Withdrawal by Subject|0|||
27730224|NCT00961961|80838479|FG001|Phase II|Withdrawal by Subject|0|||
27730225|NCT00961961|80838480|FG002|Phase II|Withdrawal by Subject|1|||
27730226|NCT00961961|80838481|FG003|Phase II|Withdrawal by Subject|0|||
27730227|NCT00669617|80838482|FG000|Period 1|Withdrawal by Subject|0|||
27730228|NCT00669617|80838483|FG001|Period 1|Withdrawal by Subject|0|||
27730229|NCT00669617|80838484|FG002|Period 1|Withdrawal by Subject|1|||
27730230|NCT00669617|80838485|FG003|Period 1|Withdrawal by Subject|0|||
27730231|NCT00669617|80838486|FG004|Period 1|Withdrawal by Subject|0|||
27730232|NCT00669617|80838482|FG000|Period 1|Protocol Deviation|0|||
27730233|NCT00669617|80838483|FG001|Period 1|Protocol Deviation|0|||
27730234|NCT00669617|80838484|FG002|Period 1|Protocol Deviation|0|||
27730235|NCT00669617|80838485|FG003|Period 1|Protocol Deviation|0|||
27730236|NCT00669617|80838486|FG004|Period 1|Protocol Deviation|1|||
27730237|NCT00669617|80838482|FG000|Period 3|Lost to Follow-up|1|||
27730238|NCT00669617|80838483|FG001|Period 3|Lost to Follow-up|0|||
27730239|NCT00669617|80838484|FG002|Period 3|Lost to Follow-up|0|||
27730240|NCT00669617|80838485|FG003|Period 3|Lost to Follow-up|0|||
27730241|NCT00669617|80838486|FG004|Period 3|Lost to Follow-up|0|||
27730242|NCT01431287|80838490|FG000|Overall Study|not treated|0|||
27730243|NCT01431287|80838491|FG001|Overall Study|not treated|0|||
27730244|NCT01431287|80838492|FG002|Overall Study|not treated|1|||
27730245|NCT01431287|80838493|FG003|Overall Study|not treated|0|||
27730246|NCT01431287|80838494|FG004|Overall Study|not treated|0|||
27730247|NCT01431287|80838490|FG000|Overall Study|Adverse Event|59|||
27730248|NCT01431287|80838491|FG001|Overall Study|Adverse Event|57|||
27730249|NCT01431287|80838492|FG002|Overall Study|Adverse Event|53|||
27730250|NCT01431287|80838493|FG003|Overall Study|Adverse Event|33|||
27730251|NCT01431287|80838494|FG004|Overall Study|Adverse Event|41|||
27730252|NCT01431287|80838490|FG000|Overall Study|Non compliant with protocol|6|||
27730253|NCT01431287|80838491|FG001|Overall Study|Non compliant with protocol|6|||
27730254|NCT01431287|80838492|FG002|Overall Study|Non compliant with protocol|5|||
27730255|NCT01431287|80838493|FG003|Overall Study|Non compliant with protocol|6|||
27730256|NCT01431287|80838494|FG004|Overall Study|Non compliant with protocol|5|||
27730257|NCT01431287|80838490|FG000|Overall Study|Lost to Follow-up|0|||
27730258|NCT01431287|80838491|FG001|Overall Study|Lost to Follow-up|3|||
27730259|NCT01431287|80838492|FG002|Overall Study|Lost to Follow-up|2|||
27730260|NCT01431287|80838493|FG003|Overall Study|Lost to Follow-up|3|||
27730261|NCT01431287|80838494|FG004|Overall Study|Lost to Follow-up|1|||
27730262|NCT01431287|80838490|FG000|Overall Study|Consent withdrawn not due to AE|29|||
27730263|NCT01431287|80838491|FG001|Overall Study|Consent withdrawn not due to AE|30|||
27730264|NCT01431287|80838492|FG002|Overall Study|Consent withdrawn not due to AE|34|||
27730265|NCT01431287|80838493|FG003|Overall Study|Consent withdrawn not due to AE|19|||
27853853|NCT05256134|81295179|FG001|Overall Study|Withdrawal by Subject|3|||
27853854|NCT02516410|81295180|FG000|Overall Study|Adverse Event|0|||
27853855|NCT02516410|81295181|FG001|Overall Study|Adverse Event|1|||
27853856|NCT02516410|81295180|FG000|Overall Study|Withdrawal by Subject|0|||
27730266|NCT01431287|80838494|FG004|Overall Study|Consent withdrawn not due to AE|29|||
27730267|NCT01431287|80838490|FG000|Overall Study|not stated above|4|||
27730268|NCT01431287|80838491|FG001|Overall Study|not stated above|2|||
27730269|NCT01431287|80838492|FG002|Overall Study|not stated above|2|||
27730270|NCT01431287|80838493|FG003|Overall Study|not stated above|2|||
27730271|NCT01431287|80838494|FG004|Overall Study|not stated above|1|||
27730272|NCT01147497|80838496|FG000|Overall Study|failed insertion|2|||
27730273|NCT01147497|80838497|FG001|Overall Study|failed insertion|0|||
27730274|NCT03636906|80838498|FG000|Overall Study|Adverse Event|0|||
27730275|NCT03636906|80838499|FG001|Overall Study|Adverse Event|0|||
27730276|NCT03636906|80838500|FG002|Overall Study|Adverse Event|1|||
27730277|NCT03636906|80838498|FG000|Overall Study|Lost to Follow-up|1|||
27730278|NCT03636906|80838499|FG001|Overall Study|Lost to Follow-up|0|||
27730279|NCT03636906|80838500|FG002|Overall Study|Lost to Follow-up|0|||
27754904|NCT02065622|80929634|FG004|Maintenance Study|Withdrawal by Subject|7|||
27730280|NCT03636906|80838498|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
27730281|NCT03636906|80838499|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
27730282|NCT03636906|80838500|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
27730283|NCT03636906|80838498|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
27730284|NCT03636906|80838499|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
27730285|NCT03636906|80838500|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
27730286|NCT03636906|80838498|FG000|Overall Study|Other|0|||
27730287|NCT03636906|80838499|FG001|Overall Study|Other|0|||
27730288|NCT03636906|80838500|FG002|Overall Study|Other|1|||
27730289|NCT00461175|80842657|FG000|Overall Study|Protocol Violation|522|||
27730290|NCT00461175|80842658|FG001|Overall Study|Protocol Violation|365|||
27730291|NCT00950170|80842661|FG000|Overall Study|Parent/Legal Guardian Request|1|||
27730292|NCT00950170|80842661|FG000|Overall Study|Adverse Event|2|||
27730293|NCT00950170|80842661|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
27730294|NCT00127127|80842663|FG000|Overall Study|Adverse Event|0|||
27730295|NCT00127127|80842664|FG001|Overall Study|Adverse Event|2|||
27730296|NCT00127127|80842665|FG002|Overall Study|Adverse Event|0|||
27730297|NCT00127127|80842666|FG003|Overall Study|Adverse Event|1|||
27730298|NCT00127127|80842663|FG000|Overall Study|Lack of Efficacy|1|||
27730299|NCT00127127|80842664|FG001|Overall Study|Lack of Efficacy|3|||
27730300|NCT00127127|80842665|FG002|Overall Study|Lack of Efficacy|0|||
27730301|NCT00127127|80842666|FG003|Overall Study|Lack of Efficacy|2|||
27730302|NCT01642212|80842667|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
27730303|NCT01642212|80842668|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27730304|NCT01642212|80842669|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27730305|NCT01642212|80842670|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27730306|NCT01642212|80842671|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
27730307|NCT01642212|80842667|FG000|Double-blind Treatment|Other|0|||
27730308|NCT01642212|80842668|FG001|Double-blind Treatment|Other|2|||
27730309|NCT01642212|80842669|FG002|Double-blind Treatment|Other|1|||
27730310|NCT01642212|80842670|FG003|Double-blind Treatment|Other|0|||
27730311|NCT01642212|80842671|FG004|Double-blind Treatment|Other|0|||
27730312|NCT01642212|80842667|FG000|Double-blind Treatment|Non-compliance|0|||
27730313|NCT01642212|80842668|FG001|Double-blind Treatment|Non-compliance|1|||
27730314|NCT01642212|80842669|FG002|Double-blind Treatment|Non-compliance|0|||
27730315|NCT01642212|80842670|FG003|Double-blind Treatment|Non-compliance|0|||
27730316|NCT01642212|80842671|FG004|Double-blind Treatment|Non-compliance|0|||
27730317|NCT01642212|80842667|FG000|Double-blind Treatment|Adverse Event|0|||
27730318|NCT01642212|80842668|FG001|Double-blind Treatment|Adverse Event|0|||
27730319|NCT01642212|80842669|FG002|Double-blind Treatment|Adverse Event|1|||
27730320|NCT01642212|80842670|FG003|Double-blind Treatment|Adverse Event|0|||
27730321|NCT01642212|80842671|FG004|Double-blind Treatment|Adverse Event|0|||
27730322|NCT01642212|80842667|FG000|Open-label Extension|Adverse Event|0|||
27730323|NCT01642212|80842668|FG001|Open-label Extension|Adverse Event|0|||
27730324|NCT01642212|80842669|FG002|Open-label Extension|Adverse Event|0|||
27730325|NCT01642212|80842670|FG003|Open-label Extension|Adverse Event|3|||
27730326|NCT01642212|80842671|FG004|Open-label Extension|Adverse Event|0|||
27730327|NCT01642212|80842667|FG000|Open-label Extension|Sponsor Decision|0|||
27730328|NCT01642212|80842668|FG001|Open-label Extension|Sponsor Decision|0|||
27730329|NCT01642212|80842669|FG002|Open-label Extension|Sponsor Decision|0|||
27730330|NCT01642212|80842670|FG003|Open-label Extension|Sponsor Decision|7|||
27730331|NCT01642212|80842671|FG004|Open-label Extension|Sponsor Decision|4|||
27730332|NCT01642212|80842667|FG000|Open-label Extension|Consent Withdrawn|0|||
27730333|NCT01642212|80842668|FG001|Open-label Extension|Consent Withdrawn|0|||
27730334|NCT01642212|80842669|FG002|Open-label Extension|Consent Withdrawn|0|||
27730335|NCT01642212|80842670|FG003|Open-label Extension|Consent Withdrawn|0|||
27730336|NCT01642212|80842671|FG004|Open-label Extension|Consent Withdrawn|2|||
27853857|NCT02516410|81295181|FG001|Overall Study|Withdrawal by Subject|1|||
27853858|NCT02551666|81295185|FG000|Overall Study|Withdrawal by Subject|1|||
27853859|NCT02551666|81295186|FG001|Overall Study|Withdrawal by Subject|3|||
27517756|NCT00796991|80088513|FG002|Overall Study|Disease Progression|7|||
27730337|NCT01642212|80842667|FG000|Open-label Extension|Lost to Follow-up|0|||
27730338|NCT01642212|80842668|FG001|Open-label Extension|Lost to Follow-up|0|||
27730339|NCT01642212|80842669|FG002|Open-label Extension|Lost to Follow-up|0|||
27730340|NCT01642212|80842670|FG003|Open-label Extension|Lost to Follow-up|0|||
27730341|NCT01642212|80842671|FG004|Open-label Extension|Lost to Follow-up|1|||
27730342|NCT01642212|80842667|FG000|Open-label Extension|Other|0|||
27730343|NCT01642212|80842668|FG001|Open-label Extension|Other|0|||
27730344|NCT01642212|80842669|FG002|Open-label Extension|Other|0|||
27730345|NCT01642212|80842670|FG003|Open-label Extension|Other|0|||
27730346|NCT01642212|80842671|FG004|Open-label Extension|Other|1|||
27730347|NCT00670007|80842672|FG000|Overall Study|Drug abuse|1|||
27730348|NCT00670007|80842672|FG000|Overall Study|Lung transplant|1|||
27730349|NCT00670007|80842672|FG000|Overall Study|Travel/Vacation|1|||
27517757|NCT00796991|80088511|FG000|Overall Study|Study Drug Toxicity|3|||
27908075|NCT02683239|81500520|FG003|Overall Study|Missing data|0|||
27517758|NCT00796991|80088512|FG001|Overall Study|Study Drug Toxicity|3|||
27517759|NCT00796991|80088513|FG002|Overall Study|Study Drug Toxicity|5|||
27517760|NCT00796991|80088511|FG000|Overall Study|Withdrawal by Subject|0|||
27517761|NCT00796991|80088512|FG001|Overall Study|Withdrawal by Subject|0|||
27517762|NCT00796991|80088513|FG002|Overall Study|Withdrawal by Subject|1|||
27517763|NCT02547363|80088514|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
27517764|NCT02547363|80088515|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
27517765|NCT02547363|80088514|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
27517766|NCT02547363|80088515|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
27517767|NCT02547363|80088514|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
27517768|NCT02547363|80088515|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
27517769|NCT02547363|80088514|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
27517770|NCT02547363|80088515|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
27517771|NCT02547363|80088514|FG000|12-month Follow-up|Withdrawal by Subject|4|||
27517772|NCT02547363|80088515|FG001|12-month Follow-up|Withdrawal by Subject|3|||
27517773|NCT02547363|80088514|FG000|12-month Follow-up|Lost to Follow-up|4|||
27517774|NCT02547363|80088515|FG001|12-month Follow-up|Lost to Follow-up|1|||
27517775|NCT02547363|80088514|FG000|12-month Follow-up|Lack of Efficacy|1|||
27517776|NCT02547363|80088515|FG001|12-month Follow-up|Lack of Efficacy|1|||
27517777|NCT02547363|80088514|FG000|12-month Follow-up|Other|1|||
27517778|NCT02547363|80088515|FG001|12-month Follow-up|Other|0|||
27517779|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
27618176|NCT01646320|80444829|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
27618177|NCT01646320|80444828|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
27618178|NCT01646320|80444829|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
27618179|NCT01646320|80444828|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
27618180|NCT01646320|80444829|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
27618181|NCT01646320|80444828|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
27618182|NCT01646320|80444829|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
27618183|NCT01646320|80444828|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
27618184|NCT01646320|80444829|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
27618185|NCT01646320|80444828|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
27618186|NCT01646320|80444829|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
27618187|NCT01646320|80444828|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
27618188|NCT01646320|80444829|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
27618189|NCT01646320|80444828|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
27618190|NCT01646320|80444829|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
27618191|NCT01646320|80444828|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
27618192|NCT01646320|80444829|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
27618193|NCT01646320|80444828|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
27618194|NCT01646320|80444829|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
27618195|NCT03499600|80449030|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
27618196|NCT03499600|80449031|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
27618197|NCT03929302|80449032|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
27618198|NCT03929302|80449033|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
27618199|NCT03929302|80449034|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
27618200|NCT03929302|80449032|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
27618201|NCT03929302|80449033|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
27618202|NCT03929302|80449034|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
27618203|NCT03929302|80449032|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
27618204|NCT03929302|80449033|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
27618205|NCT03929302|80449034|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
27618206|NCT02025205|80449035|FG000|Overall Study|Withdrawal by Subject|1|||
27618207|NCT02025205|80449036|FG001|Overall Study|Withdrawal by Subject|1|||
27618208|NCT02025205|80449035|FG000|Overall Study|Protocol Violation|2|||
27618209|NCT02025205|80449036|FG001|Overall Study|Protocol Violation|1|||
27618210|NCT02025205|80449035|FG000|Overall Study|Death|0|||
27618211|NCT02025205|80449036|FG001|Overall Study|Death|1|||
27618212|NCT01871285|80449037|FG000|First Intervention (1 Day)|Adverse Event|1|||
27618213|NCT01871285|80449038|FG001|First Intervention (1 Day)|Adverse Event|0|||
27618214|NCT01871285|80449039|FG002|First Intervention (1 Day)|Adverse Event|0|||
27908076|NCT02683239|81500521|FG004|Overall Study|Missing data|1|||
27908077|NCT02683239|81500522|FG005|Overall Study|Missing data|0|||
27908078|NCT02683239|81500523|FG006|Overall Study|Missing data|0|||
27517780|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
27517781|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
27517782|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
27517783|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
27517784|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
27517785|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
27517786|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
27517787|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
27517788|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
27517789|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
27517790|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
27517791|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
27517792|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
27517793|NCT00612105|80088516|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
27517794|NCT00612105|80088517|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
27517795|NCT00612105|80088516|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
27517796|NCT00612105|80088517|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
27517797|NCT00612105|80088516|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
27517798|NCT00612105|80088517|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
27517799|NCT00612105|80088516|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
27517800|NCT00612105|80088517|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
27517801|NCT00612105|80088516|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
27517802|NCT00612105|80088517|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
27517803|NCT02160899|80088518|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
27517804|NCT02160899|80088519|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
27517805|NCT02160899|80088520|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
27517806|NCT02160899|80088521|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
27517807|NCT02160899|80088522|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
27517808|NCT02160899|80088523|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
27517809|NCT00796978|80088526|FG000|Overall Study|Cardiac adverse event|5|||
27517810|NCT00796978|80088526|FG000|Overall Study|Adverse Event|4|||
27517811|NCT00796978|80088526|FG000|Overall Study|Withdrawal by Subject|3|||
27517812|NCT02466659|80088529|FG000|Overall Study|Lost to Follow-up|5|||
27517813|NCT02466659|80088530|FG001|Overall Study|Lost to Follow-up|2|||
27517814|NCT01596062|80088533|FG000|Overall Study|Adverse Event|1|||
27517815|NCT01596062|80088534|FG001|Overall Study|Adverse Event|0|||
27517816|NCT01596062|80088535|FG002|Overall Study|Adverse Event|2|||
27517817|NCT01596062|80088533|FG000|Overall Study|Lack of Efficacy|0|||
27517818|NCT01596062|80088534|FG001|Overall Study|Lack of Efficacy|0|||
27517819|NCT01596062|80088535|FG002|Overall Study|Lack of Efficacy|1|||
27517820|NCT03645434|80088536|FG000|Period 1|Adverse Event|0|||
27517821|NCT03645434|80088537|FG001|Period 1|Adverse Event|0|||
27517822|NCT03645434|80088538|FG002|Period 1|Adverse Event|0|||
27517823|NCT03645434|80088539|FG003|Period 1|Adverse Event|1|||
27517824|NCT03645434|80088540|FG004|Period 1|Adverse Event|0|||
27517825|NCT03645434|80088541|FG005|Period 1|Adverse Event|0|||
27517826|NCT03645434|80088536|FG000|Period 1|COPD exacerbation|0|||
27517827|NCT03645434|80088537|FG001|Period 1|COPD exacerbation|0|||
27517828|NCT03645434|80088538|FG002|Period 1|COPD exacerbation|0|||
27517829|NCT03645434|80088539|FG003|Period 1|COPD exacerbation|0|||
27517830|NCT03645434|80088540|FG004|Period 1|COPD exacerbation|1|||
27517831|NCT03645434|80088541|FG005|Period 1|COPD exacerbation|0|||
27517832|NCT00344487|80088542|FG000|Overall Study|immunologic failure|1|||
27517833|NCT02102204|80091646|FG000|Overall Study|Withdrawal by Subject|137|||
27517834|NCT02102204|80091646|FG000|Overall Study|Death|92|||
27517835|NCT02102204|80091646|FG000|Overall Study|Lost to Follow-up|65|||
27517836|NCT02102204|80091646|FG000|Overall Study|Sponsor Decision|5|||
27517837|NCT02102204|80091646|FG000|Overall Study|Ongoing|5|||
27517838|NCT01325337|80091647|FG000|Overall Study|Adverse Event|0|||
27517839|NCT01325337|80091648|FG001|Overall Study|Adverse Event|2|||
27517840|NCT01325337|80091649|FG002|Overall Study|Adverse Event|2|||
27517841|NCT01325337|80091650|FG003|Overall Study|Adverse Event|1|||
27517842|NCT01325337|80091651|FG004|Overall Study|Adverse Event|2|||
27517843|NCT01325337|80091647|FG000|Overall Study|Lost to Follow-up|2|||
27517844|NCT01325337|80091648|FG001|Overall Study|Lost to Follow-up|2|||
27517845|NCT01325337|80091649|FG002|Overall Study|Lost to Follow-up|2|||
27517846|NCT01325337|80091650|FG003|Overall Study|Lost to Follow-up|1|||
27517847|NCT01325337|80091651|FG004|Overall Study|Lost to Follow-up|2|||
27517848|NCT01325337|80091647|FG000|Overall Study|Personal Reasons|2|||
27517849|NCT01325337|80091648|FG001|Overall Study|Personal Reasons|5|||
27517850|NCT01325337|80091649|FG002|Overall Study|Personal Reasons|4|||
27517851|NCT01325337|80091650|FG003|Overall Study|Personal Reasons|8|||
27517852|NCT01325337|80091651|FG004|Overall Study|Personal Reasons|3|||
27517853|NCT01325337|80091647|FG000|Overall Study|Withdrawal by Subject|1|||
27517854|NCT01325337|80091648|FG001|Overall Study|Withdrawal by Subject|0|||
27517855|NCT01325337|80091649|FG002|Overall Study|Withdrawal by Subject|1|||
27517856|NCT01325337|80091650|FG003|Overall Study|Withdrawal by Subject|0|||
27517857|NCT01325337|80091651|FG004|Overall Study|Withdrawal by Subject|1|||
27517858|NCT00796523|80091652|FG000|Overall Study|Lost to Follow-up|9|||
27618215|NCT01871285|80449040|FG003|First Intervention (1 Day)|Adverse Event|0|||
27618216|NCT01871285|80449037|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
27618217|NCT01871285|80449038|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
27618218|NCT01871285|80449039|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
27618219|NCT01871285|80449040|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
27618220|NCT01040780|80449041|FG000|Overall Study|Protocol Violation|1|||
27618221|NCT01040780|80449042|FG001|Overall Study|Protocol Violation|3|||
27618222|NCT03268590|80449043|FG000|Overall Study|Previously unknown exclusion criteria|1|||
27618223|NCT04796935|80449044|FG000|Overall Study|Withdrawal by Subject|0|||
27618224|NCT04796935|80449045|FG001|Overall Study|Withdrawal by Subject|1|||
27618225|NCT04796935|80449044|FG000|Overall Study|Physician Decision|0|||
27618226|NCT04796935|80449045|FG001|Overall Study|Physician Decision|1|||
27618227|NCT04796935|80449044|FG000|Overall Study|Device not available|1|||
27618228|NCT04796935|80449045|FG001|Overall Study|Device not available|0|||
27618229|NCT04796935|80449044|FG000|Overall Study|Trained provider not available|1|||
27618230|NCT04796935|80449045|FG001|Overall Study|Trained provider not available|0|||
27618231|NCT04834362|80449047|FG000|Overall Study|Death|1|||
27618232|NCT04834362|80449048|FG001|Overall Study|Death|2|||
27618233|NCT01625910|80449049|FG000|Overall Study|Lost to Follow-up|3|||
27618234|NCT01625910|80449050|FG001|Overall Study|Lost to Follow-up|4|||
27618235|NCT03824236|80449051|FG000|Overall Study|Lost to Follow-up|0|||
27618236|NCT03824236|80449052|FG001|Overall Study|Lost to Follow-up|0|||
27618237|NCT03824236|80449053|FG002|Overall Study|Lost to Follow-up|1|||
27618238|NCT00463151|80449056|FG000|Overall Study|Adverse Event|0|||
27618239|NCT00463151|80449057|FG001|Overall Study|Adverse Event|0|||
27618240|NCT00463151|80449058|FG002|Overall Study|Adverse Event|1|||
27618241|NCT00463151|80449059|FG003|Overall Study|Adverse Event|0|||
27618242|NCT00463151|80449056|FG000|Overall Study|Lack of Efficacy|2|||
27618243|NCT00463151|80449057|FG001|Overall Study|Lack of Efficacy|5|||
27618244|NCT00463151|80449058|FG002|Overall Study|Lack of Efficacy|2|||
27618245|NCT00463151|80449059|FG003|Overall Study|Lack of Efficacy|5|||
27618246|NCT00463151|80449056|FG000|Overall Study|Protocol Violation|0|||
27618247|NCT00463151|80449057|FG001|Overall Study|Protocol Violation|0|||
27618248|NCT00463151|80449058|FG002|Overall Study|Protocol Violation|0|||
27618249|NCT00463151|80449059|FG003|Overall Study|Protocol Violation|1|||
27618250|NCT00463151|80449056|FG000|Overall Study|Withdrawal by Subject|0|||
27618251|NCT00463151|80449057|FG001|Overall Study|Withdrawal by Subject|0|||
27618252|NCT00463151|80449058|FG002|Overall Study|Withdrawal by Subject|0|||
27618253|NCT00463151|80449059|FG003|Overall Study|Withdrawal by Subject|1|||
27618254|NCT00683449|80449060|FG000|Overall Study|Lost to Follow-up|0|||
27618255|NCT00683449|80449061|FG001|Overall Study|Lost to Follow-up|1|||
27618256|NCT00683449|80449062|FG002|Overall Study|Lost to Follow-up|0|||
27853860|NCT01672970|81295187|FG000|Overall Study|Lack of Efficacy|12|||
27853861|NCT01672970|81295187|FG000|Overall Study|Adverse Event|18|||
27853862|NCT01672970|81295187|FG000|Overall Study|Withdrawal by Subject|2|||
27853863|NCT01672970|81295187|FG000|Overall Study|Lost to Follow-up|5|||
27853864|NCT01672970|81295187|FG000|Overall Study|Other|9|||
27853865|NCT01672970|81295187|FG000|Overall Study|Enrolled but not treated|1|||
27853866|NCT01959035|81295188|FG000|Overall Study|Adverse Event|5|||
27853867|NCT01959035|81295188|FG000|Overall Study|Withdrawal by Subject|4|||
27853868|NCT01959035|81295188|FG000|Overall Study|Lost to Follow-up|1|||
27853869|NCT01959035|81295188|FG000|Overall Study|Other (no primary reason given)|1|||
27853870|NCT02145026|81295191|FG000|Overall Study|Adverse Event|2|||
27853871|NCT02145026|81295191|FG000|Overall Study|Death|4|||
27908079|NCT00154375|81500527|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
27908080|NCT00154375|81500528|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
27908081|NCT00154375|81500527|FG000|Overall Study|Adverse Event|18|||
27908082|NCT00154375|81500528|FG001|Overall Study|Adverse Event|20|||
27908083|NCT00154375|81500527|FG000|Overall Study|Withdrawal by Subject|14|||
27908084|NCT00154375|81500528|FG001|Overall Study|Withdrawal by Subject|10|||
27908085|NCT00154375|81500527|FG000|Overall Study|Death|5|||
27908086|NCT00154375|81500528|FG001|Overall Study|Death|13|||
27618257|NCT00683449|80449063|FG003|Overall Study|Lost to Follow-up|0|||
27618258|NCT00683449|80449064|FG004|Overall Study|Lost to Follow-up|0|||
27618259|NCT03628924|80449072|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
27618260|NCT03628924|80449073|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27618261|NCT03628924|80449074|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27618262|NCT03628924|80449075|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27618263|NCT03628924|80449076|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27618264|NCT03628924|80449077|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27618265|NCT03628924|80449078|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
27853872|NCT02145026|81295191|FG000|Overall Study|Withdrawal by Subject|2|||
27618266|NCT03628924|80449072|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27853873|NCT02145026|81295191|FG000|Overall Study|Physician Decision|4|||
27908087|NCT00154375|81500527|FG000|Overall Study|Study drug no longer required|5|||
27908088|NCT00154375|81500528|FG001|Overall Study|Study drug no longer required|3|||
27908089|NCT00154375|81500527|FG000|Overall Study|Lost to Follow-up|2|||
27908090|NCT00154375|81500528|FG001|Overall Study|Lost to Follow-up|1|||
27908091|NCT00154375|81500527|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27908092|NCT00154375|81500528|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27908093|NCT00154375|81500527|FG000|Overall Study|Protocol Violation|0|||
27908094|NCT00154375|81500528|FG001|Overall Study|Protocol Violation|1|||
27908095|NCT00154375|81500527|FG000|Overall Study|Suspected progression of disease|44|||
27908096|NCT00154375|81500528|FG001|Overall Study|Suspected progression of disease|30|||
27908097|NCT02308228|81500531|FG000|Overall Study|Adverse Event|3|||
27908098|NCT02308228|81500532|FG001|Overall Study|Adverse Event|4|||
27908099|NCT02308228|81500531|FG000|Overall Study|Withdrawal by Subject|5|||
27908100|NCT02308228|81500532|FG001|Overall Study|Withdrawal by Subject|3|||
27908101|NCT02819440|81500534|FG000|Overall Study|Adverse Event|3|||
27908102|NCT02819440|81500535|FG001|Overall Study|Adverse Event|1|||
27908103|NCT02819440|81500534|FG000|Overall Study|Lost to Follow-up|1|||
27908104|NCT02819440|81500535|FG001|Overall Study|Lost to Follow-up|3|||
27908105|NCT02819440|81500534|FG000|Overall Study|Withdrawal by Subject|9|||
27908106|NCT02819440|81500535|FG001|Overall Study|Withdrawal by Subject|8|||
27908107|NCT02499120|81500538|FG000|Overall Study|Death|52|||
27908108|NCT02499120|81500539|FG001|Overall Study|Death|43|||
27908109|NCT02499120|81500538|FG000|Overall Study|Lost to Follow-up|1|||
27908110|NCT02499120|81500539|FG001|Overall Study|Lost to Follow-up|2|||
27908111|NCT02499120|81500538|FG000|Overall Study|Participant refused further follow-up|1|||
27908112|NCT02499120|81500539|FG001|Overall Study|Participant refused further follow-up|0|||
27618267|NCT03628924|80449073|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27618268|NCT03628924|80449074|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
27618269|NCT03628924|80449075|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27618270|NCT03628924|80449076|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27618271|NCT03628924|80449077|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27618272|NCT03628924|80449078|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
27908113|NCT02499120|81500538|FG000|Overall Study|Withdrawal by Subject|2|||
27908114|NCT02499120|81500539|FG001|Overall Study|Withdrawal by Subject|5|||
27908115|NCT02499120|81500538|FG000|Overall Study|Other|9|||
27908116|NCT02499120|81500539|FG001|Overall Study|Other|10|||
27908117|NCT02497404|81500540|FG000|Overall Study|Adverse Event|1|||
27908118|NCT03746405|81500547|FG000|Overall Study|Withdrawal by Subject|3|||
27908119|NCT03746405|81500548|FG001|Overall Study|Withdrawal by Subject|0|||
27908120|NCT03746405|81500547|FG000|Overall Study|technical difficulties|0|||
27908121|NCT03746405|81500548|FG001|Overall Study|technical difficulties|2|||
27908122|NCT00070564|81500549|FG000|Overall Study|Progression|2|||
27908123|NCT00070564|81500550|FG001|Overall Study|Progression|4|||
27908124|NCT00070564|81500551|FG002|Overall Study|Progression|7|||
27908125|NCT00070564|81500552|FG003|Overall Study|Progression|7|||
27908126|NCT00070564|81500553|FG004|Overall Study|Progression|1|||
27908127|NCT00070564|81500554|FG005|Overall Study|Progression|0|||
27908128|NCT00070564|81500549|FG000|Overall Study|Delinquent|1|||
27908129|NCT00070564|81500550|FG001|Overall Study|Delinquent|4|||
27908130|NCT00070564|81500551|FG002|Overall Study|Delinquent|2|||
27908131|NCT00070564|81500552|FG003|Overall Study|Delinquent|0|||
27908132|NCT00070564|81500553|FG004|Overall Study|Delinquent|0|||
27908133|NCT00070564|81500554|FG005|Overall Study|Delinquent|0|||
27618273|NCT03628924|80449072|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
27618274|NCT03628924|80449073|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
27618275|NCT03628924|80449074|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
27618276|NCT03628924|80449075|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
27618277|NCT03628924|80449076|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
27618278|NCT03628924|80449077|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
27618279|NCT03628924|80449078|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
27618280|NCT03628924|80449072|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27618281|NCT03628924|80449073|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
27730350|NCT00670007|80842672|FG000|Overall Study|Adverse event, serious fatal|1|||
27730351|NCT00670007|80842672|FG000|Overall Study|Adverse Event|1|||
27908134|NCT00070564|81500549|FG000|Overall Study|Adverse Event|150|||
27908135|NCT00070564|81500550|FG001|Overall Study|Adverse Event|142|||
27908136|NCT00070564|81500551|FG002|Overall Study|Adverse Event|120|||
27908137|NCT00070564|81500552|FG003|Overall Study|Adverse Event|108|||
27908138|NCT00070564|81500553|FG004|Overall Study|Adverse Event|63|||
27908139|NCT00070564|81500554|FG005|Overall Study|Adverse Event|36|||
27908140|NCT00070564|81500549|FG000|Overall Study|Death|4|||
27908141|NCT00070564|81500550|FG001|Overall Study|Death|1|||
27908142|NCT00070564|81500551|FG002|Overall Study|Death|5|||
27908143|NCT00070564|81500552|FG003|Overall Study|Death|3|||
27908144|NCT00070564|81500553|FG004|Overall Study|Death|0|||
27908145|NCT00070564|81500554|FG005|Overall Study|Death|1|||
27908146|NCT00070564|81500549|FG000|Overall Study|Other, not protocol specified|17|||
27908147|NCT00070564|81500550|FG001|Overall Study|Other, not protocol specified|15|||
27908148|NCT00070564|81500551|FG002|Overall Study|Other, not protocol specified|14|||
27908149|NCT00070564|81500552|FG003|Overall Study|Other, not protocol specified|19|||
27908150|NCT00070564|81500553|FG004|Overall Study|Other, not protocol specified|6|||
27908151|NCT00070564|81500554|FG005|Overall Study|Other, not protocol specified|7|||
27908152|NCT00070564|81500549|FG000|Overall Study|Withdrawal by Subject|26|||
27908153|NCT00070564|81500550|FG001|Overall Study|Withdrawal by Subject|37|||
27908154|NCT00070564|81500551|FG002|Overall Study|Withdrawal by Subject|23|||
27908155|NCT00070564|81500552|FG003|Overall Study|Withdrawal by Subject|30|||
27908156|NCT00070564|81500553|FG004|Overall Study|Withdrawal by Subject|8|||
27908157|NCT00070564|81500554|FG005|Overall Study|Withdrawal by Subject|8|||
27908158|NCT00070564|81500549|FG000|Overall Study|Not reported|0|||
27908159|NCT00070564|81500550|FG001|Overall Study|Not reported|0|||
27908160|NCT00070564|81500551|FG002|Overall Study|Not reported|0|||
27908161|NCT00070564|81500552|FG003|Overall Study|Not reported|0|||
27908162|NCT00070564|81500553|FG004|Overall Study|Not reported|1|||
27908163|NCT00070564|81500554|FG005|Overall Study|Not reported|0|||
27908164|NCT03374488|81500555|FG000|Overall Study|Death|13|||
27908165|NCT03374488|81500556|FG001|Overall Study|Death|13|||
27618282|NCT03628924|80449074|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27618283|NCT03628924|80449075|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27618284|NCT03628924|80449076|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27618285|NCT03628924|80449077|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27618286|NCT03628924|80449078|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
27618287|NCT03628924|80449072|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
27618288|NCT03628924|80449073|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
27618289|NCT03628924|80449074|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
27618290|NCT03628924|80449075|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
27618291|NCT03628924|80449076|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
27618292|NCT03628924|80449077|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
27618293|NCT03628924|80449078|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
27618294|NCT03628924|80449072|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
27853874|NCT01680497|81295192|FG000|Overall Study|Lost to Follow-up|2|||
27853875|NCT01797835|81295193|FG000|Overall Study|Lost to Follow-up|31|||
27853876|NCT01797835|81295194|FG001|Overall Study|Lost to Follow-up|27|||
27853877|NCT01550744|81295195|FG000|Open-Label|Lost to Follow-up|7|||
27853878|NCT01550744|81295196|FG001|Open-Label|Lost to Follow-up|0|||
27853879|NCT01550744|81295197|FG002|Open-Label|Lost to Follow-up|0|||
27853880|NCT01550744|81295195|FG000|Open-Label|Withdrawal by Subject|13|||
27908166|NCT03374488|81500555|FG000|Overall Study|Withdrawal by Subject|3|||
27908167|NCT03374488|81500556|FG001|Overall Study|Withdrawal by Subject|1|||
27908168|NCT03374488|81500555|FG000|Overall Study|Physician Decision|3|||
27908169|NCT03374488|81500556|FG001|Overall Study|Physician Decision|0|||
27908170|NCT00391872|81500557|FG000|Overall Study|Protocol Violation|7|||
27908171|NCT00391872|81500558|FG001|Overall Study|Protocol Violation|2|||
27908172|NCT00391872|81500557|FG000|Overall Study|Withdrawal by Subject|296|||
27908173|NCT00391872|81500558|FG001|Overall Study|Withdrawal by Subject|249|||
27908174|NCT00391872|81500557|FG000|Overall Study|Reason unknown|2|||
27908175|NCT00391872|81500558|FG001|Overall Study|Reason unknown|4|||
27908176|NCT00391872|81500557|FG000|Overall Study|Lost to Follow-up|2|||
27908177|NCT00391872|81500558|FG001|Overall Study|Lost to Follow-up|0|||
27908178|NCT00460239|81500559|FG000|Overall Study|Physician Decision|0|||
27908179|NCT00460239|81500560|FG001|Overall Study|Physician Decision|1|||
27517859|NCT00796523|80091653|FG001|Overall Study|Lost to Follow-up|7|||
27517860|NCT01932437|80091654|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27517861|NCT01932437|80091655|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27517862|NCT01932437|80091656|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27517863|NCT01932437|80091657|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27517864|NCT01932437|80091658|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
27853881|NCT01550744|81295196|FG001|Open-Label|Withdrawal by Subject|0|||
27853882|NCT01550744|81295197|FG002|Open-Label|Withdrawal by Subject|0|||
27517865|NCT01932437|80091659|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
27517866|NCT01667419|80091665|FG000|Overall Study|Reason Not Specified|1|||
27730352|NCT00670007|80842672|FG000|Overall Study|Withdrawal by Subject|4|||
27853883|NCT01550744|81295195|FG000|Open-Label|Adverse Event|11|||
27853884|NCT01550744|81295196|FG001|Open-Label|Adverse Event|0|||
27853885|NCT01550744|81295197|FG002|Open-Label|Adverse Event|0|||
27908180|NCT00460239|81500561|FG002|Overall Study|Physician Decision|0|||
27908181|NCT00460239|81500562|FG003|Overall Study|Physician Decision|0|||
27908182|NCT00460239|81500563|FG004|Overall Study|Physician Decision|0|||
27908183|NCT00460239|81500564|FG005|Overall Study|Physician Decision|2|||
27908184|NCT00460239|81500565|FG006|Overall Study|Physician Decision|0|||
27908185|NCT00460239|81500566|FG007|Overall Study|Physician Decision|0|||
27908186|NCT00460239|81500567|FG008|Overall Study|Physician Decision|0|||
27517867|NCT01667419|80091666|FG001|Overall Study|Reason Not Specified|0|||
27517868|NCT01667419|80091667|FG002|Overall Study|Reason Not Specified|0|||
27517869|NCT01667419|80091668|FG003|Overall Study|Reason Not Specified|0|||
27517870|NCT01667419|80091665|FG000|Overall Study|Withdrawal by Subject|16|||
27517871|NCT01667419|80091666|FG001|Overall Study|Withdrawal by Subject|8|||
27517872|NCT01667419|80091667|FG002|Overall Study|Withdrawal by Subject|9|||
27517873|NCT01667419|80091668|FG003|Overall Study|Withdrawal by Subject|8|||
27517874|NCT01667419|80091665|FG000|Overall Study|Non-compliance|0|||
27517875|NCT01667419|80091666|FG001|Overall Study|Non-compliance|0|||
27618295|NCT03628924|80449073|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
27618296|NCT03628924|80449074|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
27618297|NCT03628924|80449075|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
27618298|NCT03628924|80449076|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
27618299|NCT03628924|80449077|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
27618300|NCT03628924|80449078|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
27618301|NCT03628924|80449072|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
27618302|NCT03628924|80449073|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
27618303|NCT03628924|80449074|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
27618304|NCT03628924|80449075|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
27618305|NCT03628924|80449076|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
27618306|NCT03628924|80449077|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
27618307|NCT03628924|80449078|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
27618308|NCT03628924|80449072|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
27618309|NCT03628924|80449073|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
27618310|NCT03628924|80449074|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
27517876|NCT01667419|80091667|FG002|Overall Study|Non-compliance|0|||
27517877|NCT01667419|80091668|FG003|Overall Study|Non-compliance|1|||
27517878|NCT01667419|80091665|FG000|Overall Study|Protocol Violation|1|||
27517879|NCT01667419|80091666|FG001|Overall Study|Protocol Violation|0|||
27517880|NCT01667419|80091667|FG002|Overall Study|Protocol Violation|0|||
27517881|NCT01667419|80091668|FG003|Overall Study|Protocol Violation|0|||
27517882|NCT01667419|80091665|FG000|Overall Study|Lost to Follow-up|7|||
27517883|NCT01667419|80091666|FG001|Overall Study|Lost to Follow-up|6|||
27517884|NCT01667419|80091667|FG002|Overall Study|Lost to Follow-up|2|||
27517885|NCT01667419|80091668|FG003|Overall Study|Lost to Follow-up|4|||
27517886|NCT01667419|80091665|FG000|Overall Study|Death|18|||
27517887|NCT01667419|80091666|FG001|Overall Study|Death|33|||
27517888|NCT01667419|80091667|FG002|Overall Study|Death|25|||
27517889|NCT01667419|80091668|FG003|Overall Study|Death|26|||
27517890|NCT00233454|80091669|FG000|Overall Study|Death|6|||
27517891|NCT01368562|80091672|FG000|Overall Study|Adverse Event|1|||
27517892|NCT01368562|80091672|FG000|Overall Study|Disease progression|1|||
27517893|NCT01368562|80091672|FG000|Overall Study|Lost to Follow-up|1|||
27517894|NCT01368562|80091672|FG000|Overall Study|Death|6|||
27517895|NCT01368562|80091672|FG000|Overall Study|Unresponsive to treatment|5|||
27517896|NCT01368562|80091672|FG000|Overall Study|Other|3|||
27517897|NCT01368562|80091672|FG000|Overall Study|Other than specified|2|||
27517898|NCT04093024|80091673|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
27517899|NCT04093024|80091674|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
27517900|NCT04093024|80091673|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
27517901|NCT04093024|80091674|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
27517902|NCT04093024|80091673|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
27517903|NCT04093024|80091674|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
27517904|NCT04093024|80091673|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
27517905|NCT04093024|80091674|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
27517906|NCT01958489|80091677|FG000|Period 2|Adverse Event|0|||
27517907|NCT01958489|80091678|FG001|Period 2|Adverse Event|1|||
27517908|NCT03595228|80091679|FG000|Overall Study|Death|2|||
27618311|NCT03628924|80449075|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
27618312|NCT03628924|80449076|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
27618313|NCT03628924|80449077|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
27618314|NCT03628924|80449078|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
27618315|NCT03628924|80449072|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
27908187|NCT00460239|81500559|FG000|Overall Study|Withdrawal by Subject|0|||
27517909|NCT03595228|80091679|FG000|Overall Study|Lack of Efficacy|13|||
27517910|NCT03595228|80091679|FG000|Overall Study|Withdrawal by Subject|3|||
27517911|NCT03595228|80091679|FG000|Overall Study|Withdrawal by Sponsor|1|||
27517912|NCT01181986|80091681|FG000|Phase 1|Lost to Follow-up|0|||
27517913|NCT01181986|80091682|FG001|Phase 1|Lost to Follow-up|1|||
27517914|NCT01181986|80091683|FG002|Phase 1|Lost to Follow-up|1|||
27517915|NCT01181986|80091681|FG000|Phase 1|Adverse Event|0|||
27517916|NCT01181986|80091682|FG001|Phase 1|Adverse Event|0|||
27517917|NCT01181986|80091683|FG002|Phase 1|Adverse Event|1|||
27517918|NCT01181986|80091681|FG000|Phase 1|Protocol Violation|1|||
27618316|NCT03628924|80449073|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
27618317|NCT03628924|80449074|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
27517919|NCT01181986|80091682|FG001|Phase 1|Protocol Violation|0|||
27517920|NCT01181986|80091683|FG002|Phase 1|Protocol Violation|0|||
27517921|NCT01181986|80091681|FG000|Phase 2|Adverse Event|0|||
27517922|NCT01181986|80091682|FG001|Phase 2|Adverse Event|3|||
27517923|NCT01181986|80091683|FG002|Phase 2|Adverse Event|0|||
27517924|NCT01181986|80091681|FG000|Phase 2|Medical condition|0|||
27517925|NCT01181986|80091682|FG001|Phase 2|Medical condition|1|||
27517926|NCT01181986|80091683|FG002|Phase 2|Medical condition|0|||
27517927|NCT03615040|80091684|FG000|Overall Study|Withdrawal by Subject|2|||
27517928|NCT03615040|80091685|FG001|Overall Study|Withdrawal by Subject|1|||
27517929|NCT03615040|80091684|FG000|Overall Study|Physician Decision|2|||
27517930|NCT03615040|80091685|FG001|Overall Study|Physician Decision|2|||
27517931|NCT03615040|80091684|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
27517932|NCT03615040|80091685|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
27517933|NCT03615040|80091684|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
27730353|NCT03157531|80842673|FG000|Overall Study|Death|2|||
27730354|NCT03157531|80842673|FG000|Overall Study|Lost to Follow-up|4|||
27730355|NCT01335971|80842674|FG000|Overall Study|Withdrawal by Subject|1|||
27908188|NCT00460239|81500560|FG001|Overall Study|Withdrawal by Subject|0|||
27517934|NCT03615040|80091685|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
27517935|NCT03615040|80091684|FG000|Overall Study|Death|0|||
27517936|NCT03615040|80091685|FG001|Overall Study|Death|2|||
27517937|NCT03135119|80091691|FG000|Overall Study|Lost to Follow-up|2|||
27517938|NCT03135119|80091692|FG001|Overall Study|Lost to Follow-up|0|||
27517939|NCT03135119|80091691|FG000|Overall Study|Physician Decision|1|||
27517940|NCT03135119|80091692|FG001|Overall Study|Physician Decision|1|||
27517941|NCT03135119|80091691|FG000|Overall Study|COVID-19 Shutdown|2|||
27618318|NCT03628924|80449075|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
27618319|NCT03628924|80449076|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
27618320|NCT03628924|80449077|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
27618321|NCT03628924|80449078|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
27618322|NCT03628924|80449072|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
27618323|NCT03628924|80449073|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
27517942|NCT03135119|80091692|FG001|Overall Study|COVID-19 Shutdown|2|||
27517943|NCT01284491|80091693|FG000|Overall Study|Study termination|13|||
27517944|NCT00003472|80091694|FG000|Overall Study|Not evaluable|3|||
27517945|NCT02365233|80091695|FG000|Overall Study|IRB withheld the data|1|||
27618324|NCT03628924|80449074|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
27618325|NCT03628924|80449075|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
27618326|NCT03628924|80449076|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
27618327|NCT03628924|80449077|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
27618328|NCT03628924|80449078|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
27618329|NCT02276547|80449084|FG000|Overall Study|Death|2|||
27618330|NCT02276547|80449084|FG000|Overall Study|Explant|2|||
27517946|NCT02365233|80091696|FG001|Overall Study|IRB withheld the data|2|||
27517947|NCT02365233|80091697|FG002|Overall Study|IRB withheld the data|2|||
27517948|NCT01639729|80091698|FG000|Overall Study|Withdrawal by Subject|1|||
27517949|NCT01639729|80091699|FG001|Overall Study|Withdrawal by Subject|0|||
27517950|NCT01639729|80091700|FG002|Overall Study|Withdrawal by Subject|1|||
27517951|NCT01639729|80091701|FG003|Overall Study|Withdrawal by Subject|1|||
27517952|NCT01639729|80091702|FG004|Overall Study|Withdrawal by Subject|0|||
27517953|NCT01639729|80091703|FG005|Overall Study|Withdrawal by Subject|0|||
27517954|NCT02891070|80091704|FG000|Overall Study|Adverse Event|1|||
27517955|NCT02891070|80091705|FG001|Overall Study|Adverse Event|0|||
27517956|NCT02891070|80091704|FG000|Overall Study|Physician Decision|0|||
27517957|NCT02891070|80091705|FG001|Overall Study|Physician Decision|1|||
27517958|NCT02891070|80091704|FG000|Overall Study|Lost to Follow-up|4|||
27517959|NCT02891070|80091705|FG001|Overall Study|Lost to Follow-up|4|||
27618331|NCT02240680|80449086|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
27618332|NCT02240680|80449087|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
27908189|NCT00460239|81500561|FG002|Overall Study|Withdrawal by Subject|0|||
27517960|NCT02891070|80091704|FG000|Overall Study|Other|1|||
27517961|NCT02891070|80091705|FG001|Overall Study|Other|0|||
27517962|NCT02891070|80091704|FG000|Overall Study|Protocol Violation|0|||
27517963|NCT02891070|80091705|FG001|Overall Study|Protocol Violation|1|||
27517964|NCT02891070|80091704|FG000|Overall Study|Withdrawal by Subject|1|||
27517965|NCT02891070|80091705|FG001|Overall Study|Withdrawal by Subject|2|||
27517966|NCT02891070|80091704|FG000|Overall Study|Death|3|||
27517967|NCT02891070|80091705|FG001|Overall Study|Death|0|||
27517968|NCT01363349|80091706|FG000|Overall Study|Adverse Event|6|||
27517969|NCT01363349|80091707|FG001|Overall Study|Adverse Event|7|||
27730356|NCT01335971|80842675|FG001|Overall Study|Withdrawal by Subject|0|||
27517970|NCT01363349|80091706|FG000|Overall Study|Lack of Efficacy|3|||
27517971|NCT01363349|80091707|FG001|Overall Study|Lack of Efficacy|10|||
27618333|NCT02240680|80449088|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
27618334|NCT02240680|80449089|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
27618335|NCT02240680|80449086|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
27618336|NCT02240680|80449087|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
27618337|NCT02240680|80449088|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
27618338|NCT02240680|80449089|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
27618339|NCT02240680|80449086|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
27618340|NCT02240680|80449087|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
27618341|NCT02240680|80449088|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
27618342|NCT02240680|80449089|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
27730357|NCT01335971|80842676|FG002|Overall Study|Withdrawal by Subject|0|||
27730358|NCT01335971|80842674|FG000|Overall Study|Did not complete bronchoscopy|1|||
27730359|NCT01335971|80842675|FG001|Overall Study|Did not complete bronchoscopy|1|||
27517972|NCT01363349|80091706|FG000|Overall Study|Non compliance/Protocol deviations|2|||
27517973|NCT01363349|80091707|FG001|Overall Study|Non compliance/Protocol deviations|2|||
27517974|NCT01363349|80091706|FG000|Overall Study|Withdrawal by Subject|14|||
27517975|NCT01363349|80091707|FG001|Overall Study|Withdrawal by Subject|6|||
27517976|NCT01363349|80091706|FG000|Overall Study|Lost to Follow-up|5|||
27517977|NCT01363349|80091707|FG001|Overall Study|Lost to Follow-up|6|||
27517978|NCT01363349|80091706|FG000|Overall Study|Not reported|36|||
27517979|NCT01363349|80091707|FG001|Overall Study|Not reported|37|||
27517980|NCT01363349|80091706|FG000|Overall Study|missing|1|||
27517981|NCT01363349|80091707|FG001|Overall Study|missing|2|||
27517982|NCT01485172|80091710|FG000|Overall Study|Adverse Event|2|||
27517983|NCT01485172|80091711|FG001|Overall Study|Adverse Event|1|||
27517984|NCT01485172|80091712|FG002|Overall Study|Adverse Event|2|||
27517985|NCT01485172|80091713|FG003|Overall Study|Adverse Event|2|||
27517986|NCT01485172|80091714|FG004|Overall Study|Adverse Event|1|||
27517987|NCT01485172|80091715|FG005|Overall Study|Adverse Event|2|||
27517988|NCT01485172|80091710|FG000|Overall Study|Lack of Efficacy|2|||
27517989|NCT01485172|80091711|FG001|Overall Study|Lack of Efficacy|0|||
27517990|NCT01485172|80091712|FG002|Overall Study|Lack of Efficacy|0|||
27517991|NCT01485172|80091713|FG003|Overall Study|Lack of Efficacy|0|||
27517992|NCT01485172|80091714|FG004|Overall Study|Lack of Efficacy|0|||
27517993|NCT01485172|80091715|FG005|Overall Study|Lack of Efficacy|0|||
27517994|NCT01485172|80091710|FG000|Overall Study|Protocol Violation|0|||
27517995|NCT01485172|80091711|FG001|Overall Study|Protocol Violation|0|||
27517996|NCT01485172|80091712|FG002|Overall Study|Protocol Violation|4|||
27517997|NCT01485172|80091713|FG003|Overall Study|Protocol Violation|5|||
27517998|NCT01485172|80091714|FG004|Overall Study|Protocol Violation|1|||
27618343|NCT02240680|80449086|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
27618344|NCT02240680|80449087|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
27618345|NCT02240680|80449088|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
27618346|NCT02240680|80449089|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
27618347|NCT02240680|80449086|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
27618348|NCT02240680|80449087|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
27618349|NCT02240680|80449088|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
27618350|NCT02240680|80449089|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
27618351|NCT02240680|80449086|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
27618352|NCT02240680|80449087|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
27517999|NCT01485172|80091715|FG005|Overall Study|Protocol Violation|0|||
27518000|NCT01485172|80091710|FG000|Overall Study|Protocol defined stopping criteria|1|||
27518001|NCT01485172|80091711|FG001|Overall Study|Protocol defined stopping criteria|0|||
27618353|NCT02240680|80449088|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
27618354|NCT02240680|80449089|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
27618355|NCT02240680|80449086|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
27730360|NCT01335971|80842676|FG002|Overall Study|Did not complete bronchoscopy|1|||
27518002|NCT01485172|80091712|FG002|Overall Study|Protocol defined stopping criteria|0|||
27518003|NCT01485172|80091713|FG003|Overall Study|Protocol defined stopping criteria|0|||
27518004|NCT01485172|80091714|FG004|Overall Study|Protocol defined stopping criteria|1|||
27518005|NCT01485172|80091715|FG005|Overall Study|Protocol defined stopping criteria|0|||
27518006|NCT01485172|80091710|FG000|Overall Study|Lost to Follow-up|0|||
27518007|NCT01485172|80091711|FG001|Overall Study|Lost to Follow-up|0|||
27518008|NCT01485172|80091712|FG002|Overall Study|Lost to Follow-up|1|||
27518009|NCT01485172|80091713|FG003|Overall Study|Lost to Follow-up|0|||
27518010|NCT01485172|80091714|FG004|Overall Study|Lost to Follow-up|0|||
27518011|NCT01485172|80091715|FG005|Overall Study|Lost to Follow-up|1|||
27518012|NCT01485172|80091710|FG000|Overall Study|Physician Decision|0|||
27518013|NCT01485172|80091711|FG001|Overall Study|Physician Decision|0|||
27518014|NCT01485172|80091712|FG002|Overall Study|Physician Decision|0|||
27518015|NCT01485172|80091713|FG003|Overall Study|Physician Decision|0|||
27518016|NCT01485172|80091714|FG004|Overall Study|Physician Decision|1|||
27730361|NCT02251912|80842679|FG000|Overall Study|Withdrawal by Subject|2|||
27730362|NCT02251912|80842680|FG001|Overall Study|Withdrawal by Subject|3|||
27730363|NCT02251912|80842679|FG000|Overall Study|Adverse Event|0|||
27730364|NCT02251912|80842680|FG001|Overall Study|Adverse Event|2|||
27730365|NCT00611247|80842681|FG000|Overall Study|Death|1|||
27730366|NCT00611247|80842682|FG001|Overall Study|Death|5|||
27730367|NCT00611247|80842681|FG000|Overall Study|Lack of Efficacy|1|||
27730368|NCT00611247|80842682|FG001|Overall Study|Lack of Efficacy|16|||
27730369|NCT00981526|80842683|FG000|Overall Study|Withdrawal by Subject|0|||
27730370|NCT00981526|80842684|FG001|Overall Study|Withdrawal by Subject|2|||
27730371|NCT00981526|80842683|FG000|Overall Study|Physician Decision|4|||
27730372|NCT00981526|80842684|FG001|Overall Study|Physician Decision|4|||
27730373|NCT02932267|80842690|FG000|Overall Study|Withdrawal by Subject|3|||
27730374|NCT02932267|80842690|FG000|Overall Study|Lost to Follow-up|4|||
27730375|NCT02932267|80842690|FG000|Overall Study|Pregnancy|1|||
27730376|NCT03619213|80842691|FG000|Overall Study|Lost to Follow-up|2|||
27730377|NCT03619213|80842692|FG001|Overall Study|Lost to Follow-up|1|||
27730378|NCT03619213|80842691|FG000|Overall Study|Withdrawal by Subject|8|||
27730379|NCT03619213|80842692|FG001|Overall Study|Withdrawal by Subject|10|||
27730380|NCT00542191|80842693|FG000|Overall Study|Death|3|||
27730381|NCT03486392|80842694|FG000|Overall Study|Lost to Follow-up|0|||
27730382|NCT03486392|80842695|FG001|Overall Study|Lost to Follow-up|0|||
27730383|NCT03486392|80842696|FG002|Overall Study|Lost to Follow-up|8|||
27730384|NCT03486392|80842697|FG003|Overall Study|Lost to Follow-up|5|||
27730385|NCT03486392|80842698|FG004|Overall Study|Lost to Follow-up|2|||
27518017|NCT01485172|80091715|FG005|Overall Study|Physician Decision|0|||
27518018|NCT01485172|80091710|FG000|Overall Study|Withdrawal by Subject|2|||
27518019|NCT01485172|80091711|FG001|Overall Study|Withdrawal by Subject|0|||
27518020|NCT01485172|80091712|FG002|Overall Study|Withdrawal by Subject|0|||
27518021|NCT01485172|80091713|FG003|Overall Study|Withdrawal by Subject|1|||
27518022|NCT01485172|80091714|FG004|Overall Study|Withdrawal by Subject|1|||
27518023|NCT01485172|80091715|FG005|Overall Study|Withdrawal by Subject|1|||
27518024|NCT00701662|80091716|FG000|Overall Study|Lack of Efficacy|1|||
27618356|NCT02240680|80449087|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
27618357|NCT02240680|80449088|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
27518025|NCT01087736|80091717|FG000|Overall Study|Lost to Follow-up|1|||
27618358|NCT02240680|80449089|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
27730386|NCT03486392|80842694|FG000|Overall Study|Withdrawal by Subject|3|||
27730387|NCT03486392|80842695|FG001|Overall Study|Withdrawal by Subject|0|||
27730388|NCT03486392|80842696|FG002|Overall Study|Withdrawal by Subject|6|||
27730389|NCT03486392|80842697|FG003|Overall Study|Withdrawal by Subject|4|||
27730390|NCT03486392|80842698|FG004|Overall Study|Withdrawal by Subject|1|||
27730391|NCT03486392|80842694|FG000|Overall Study|Death|0|||
27730392|NCT03486392|80842695|FG001|Overall Study|Death|0|||
27518026|NCT01087736|80091718|FG001|Overall Study|Lost to Follow-up|0|||
27518027|NCT01087736|80091717|FG000|Overall Study|Death|0|||
27518028|NCT01087736|80091718|FG001|Overall Study|Death|1|||
27518029|NCT01087736|80091717|FG000|Overall Study|Withdrawal by Subject|0|||
27518030|NCT01087736|80091718|FG001|Overall Study|Withdrawal by Subject|1|||
27518031|NCT00476008|80091720|FG000|Overall Study|Adverse Event|4|||
27518032|NCT00476008|80091721|FG001|Overall Study|Adverse Event|4|||
27518033|NCT00476008|80091720|FG000|Overall Study|Placebo concerns|2|||
27518034|NCT00476008|80091721|FG001|Overall Study|Placebo concerns|2|||
27518035|NCT00476008|80091720|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
27518036|NCT00476008|80091721|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
27518037|NCT00476008|80091720|FG000|Overall Study|Withdrawal by Subject|0|||
27518038|NCT00476008|80091721|FG001|Overall Study|Withdrawal by Subject|1|||
27518039|NCT00476008|80091720|FG000|Overall Study|Death|1|||
27518040|NCT00476008|80091721|FG001|Overall Study|Death|0|||
27518041|NCT01402102|80091723|FG000|Overall Study|Protocol Violation|1|||
27518042|NCT01402102|80091724|FG001|Overall Study|Protocol Violation|0|||
27518043|NCT01402102|80091723|FG000|Overall Study|Insufficiency of compliance|1|||
27518044|NCT01402102|80091724|FG001|Overall Study|Insufficiency of compliance|1|||
27518045|NCT01402102|80091723|FG000|Overall Study|Withdrawal by Subject|0|||
27518046|NCT01402102|80091724|FG001|Overall Study|Withdrawal by Subject|2|||
27518047|NCT02529553|80091725|FG000|Overall Study|Progressive Disease|1|||
27518048|NCT02529553|80091726|FG001|Overall Study|Progressive Disease|0|||
27518049|NCT02529553|80091727|FG002|Overall Study|Progressive Disease|1|||
27518050|NCT02529553|80091728|FG003|Overall Study|Progressive Disease|3|||
27518051|NCT02529553|80091729|FG004|Overall Study|Progressive Disease|2|||
27518052|NCT02529553|80091730|FG005|Overall Study|Progressive Disease|3|||
27518053|NCT02529553|80091731|FG006|Overall Study|Progressive Disease|3|||
27518054|NCT02529553|80091732|FG007|Overall Study|Progressive Disease|5|||
27518055|NCT02529553|80091733|FG008|Overall Study|Progressive Disease|3|||
27518056|NCT02529553|80091725|FG000|Overall Study|Physician Decision|0|||
27518057|NCT02529553|80091726|FG001|Overall Study|Physician Decision|1|||
27518058|NCT02529553|80091727|FG002|Overall Study|Physician Decision|0|||
27518059|NCT02529553|80091728|FG003|Overall Study|Physician Decision|0|||
27518060|NCT02529553|80091729|FG004|Overall Study|Physician Decision|1|||
27518061|NCT02529553|80091730|FG005|Overall Study|Physician Decision|0|||
27518062|NCT02529553|80091731|FG006|Overall Study|Physician Decision|0|||
27518063|NCT02529553|80091732|FG007|Overall Study|Physician Decision|0|||
27518064|NCT02529553|80091733|FG008|Overall Study|Physician Decision|0|||
27518065|NCT02529553|80091725|FG000|Overall Study|Withdrawal by Subject|0|||
27518066|NCT02529553|80091726|FG001|Overall Study|Withdrawal by Subject|0|||
27518067|NCT02529553|80091727|FG002|Overall Study|Withdrawal by Subject|0|||
27518068|NCT02529553|80091728|FG003|Overall Study|Withdrawal by Subject|0|||
27518069|NCT02529553|80091729|FG004|Overall Study|Withdrawal by Subject|0|||
27518070|NCT02529553|80091730|FG005|Overall Study|Withdrawal by Subject|1|||
27518071|NCT02529553|80091731|FG006|Overall Study|Withdrawal by Subject|0|||
27518072|NCT02529553|80091732|FG007|Overall Study|Withdrawal by Subject|1|||
27518073|NCT02529553|80091733|FG008|Overall Study|Withdrawal by Subject|0|||
27518074|NCT03137069|80091734|FG000|Overall Study|Withdrawal by Subject|1|||
27518075|NCT03137069|80091735|FG001|Overall Study|Withdrawal by Subject|2|||
27518076|NCT03137069|80091736|FG002|Overall Study|Withdrawal by Subject|2|||
27518077|NCT03137069|80091737|FG003|Overall Study|Withdrawal by Subject|2|||
27518078|NCT03137069|80091738|FG004|Overall Study|Withdrawal by Subject|0|||
27518079|NCT03137069|80091739|FG005|Overall Study|Withdrawal by Subject|0|||
27518080|NCT03137069|80091734|FG000|Overall Study|Adverse Event|0|||
27518081|NCT03137069|80091735|FG001|Overall Study|Adverse Event|3|||
27518082|NCT03137069|80091736|FG002|Overall Study|Adverse Event|1|||
27518083|NCT03137069|80091737|FG003|Overall Study|Adverse Event|1|||
27518084|NCT03137069|80091738|FG004|Overall Study|Adverse Event|0|||
27518085|NCT03137069|80091739|FG005|Overall Study|Adverse Event|1|||
27518086|NCT03137069|80091734|FG000|Overall Study|Protocol Violation|0|||
27518087|NCT03137069|80091735|FG001|Overall Study|Protocol Violation|1|||
27518088|NCT03137069|80091736|FG002|Overall Study|Protocol Violation|0|||
27518089|NCT03137069|80091737|FG003|Overall Study|Protocol Violation|1|||
27518090|NCT03137069|80091738|FG004|Overall Study|Protocol Violation|1|||
27518091|NCT03137069|80091739|FG005|Overall Study|Protocol Violation|1|||
27518092|NCT03137069|80091734|FG000|Overall Study|Physician Decision|0|||
27518093|NCT03137069|80091735|FG001|Overall Study|Physician Decision|0|||
27518094|NCT03137069|80091736|FG002|Overall Study|Physician Decision|0|||
27518095|NCT03137069|80091737|FG003|Overall Study|Physician Decision|1|||
27518096|NCT03137069|80091738|FG004|Overall Study|Physician Decision|0|||
27518097|NCT03137069|80091739|FG005|Overall Study|Physician Decision|0|||
27518098|NCT03137069|80091734|FG000|Overall Study|Study Terminated by Sponsor|0|||
27518099|NCT03137069|80091735|FG001|Overall Study|Study Terminated by Sponsor|0|||
27518100|NCT03137069|80091736|FG002|Overall Study|Study Terminated by Sponsor|0|||
27518101|NCT03137069|80091737|FG003|Overall Study|Study Terminated by Sponsor|0|||
27518102|NCT03137069|80091738|FG004|Overall Study|Study Terminated by Sponsor|1|||
27518103|NCT03137069|80091739|FG005|Overall Study|Study Terminated by Sponsor|0|||
27518104|NCT03137069|80091734|FG000|Overall Study|Data Entry Error|0|||
27518105|NCT03137069|80091735|FG001|Overall Study|Data Entry Error|0|||
27518106|NCT03137069|80091736|FG002|Overall Study|Data Entry Error|0|||
27518107|NCT03137069|80091737|FG003|Overall Study|Data Entry Error|1|||
27518108|NCT03137069|80091738|FG004|Overall Study|Data Entry Error|0|||
27518109|NCT03137069|80091739|FG005|Overall Study|Data Entry Error|0|||
27518110|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
27518111|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
27518112|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Adverse Event|7|||
27518113|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Adverse Event|6|||
27518114|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
27518115|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
27518116|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Physician Decision|4|||
27518117|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Physician Decision|4|||
27518118|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
27518119|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
27518120|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
27518121|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
27518122|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
27518123|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
27518124|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Non-compliance|1|||
27518125|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Non-compliance|0|||
27518126|NCT00470834|80091742|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
27518127|NCT00470834|80091743|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
27518128|NCT00470834|80091742|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
27518129|NCT00470834|80091743|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
27518130|NCT00470834|80091742|FG000|Extension Period (24 Months)|Adverse Event|3|||
27518131|NCT00470834|80091743|FG001|Extension Period (24 Months)|Adverse Event|4|||
27518132|NCT00470834|80091742|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
27518133|NCT00470834|80091743|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
27518134|NCT00470834|80091742|FG000|Extension Period (24 Months)|Physician Decision|4|||
27518135|NCT00470834|80091743|FG001|Extension Period (24 Months)|Physician Decision|3|||
27518136|NCT00470834|80091742|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
27518137|NCT00470834|80091743|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
27518138|NCT00470834|80091742|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
27518139|NCT00470834|80091743|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
27518140|NCT00470834|80091742|FG000|Extension Period (24 Months)|Non-compliance|0|||
27518141|NCT00470834|80091743|FG001|Extension Period (24 Months)|Non-compliance|1|||
27518142|NCT00470834|80091742|FG000|Extension Period (24 Months)|Disease Progression|0|||
27518143|NCT00470834|80091743|FG001|Extension Period (24 Months)|Disease Progression|1|||
27518144|NCT00200356|80091747|FG000|Overall Study|Lack of Efficacy|3|||
27518145|NCT00200356|80091748|FG001|Overall Study|Lack of Efficacy|3|||
27518146|NCT00200356|80091747|FG000|Overall Study|Protocol Violation|4|||
27518147|NCT00200356|80091748|FG001|Overall Study|Protocol Violation|4|||
27518148|NCT00200356|80091747|FG000|Overall Study|Nontreatment|1|||
27518149|NCT00200356|80091748|FG001|Overall Study|Nontreatment|0|||
27518150|NCT01947855|80091751|FG000|Overall Study|Withdrawal by Subject|1|||
27518151|NCT01947855|80091752|FG001|Overall Study|Withdrawal by Subject|0|||
27518152|NCT01947855|80091753|FG002|Overall Study|Withdrawal by Subject|0|||
27518153|NCT04657666|80091756|FG000|Period 1|Withdrawal of participant consent|2|||
27518154|NCT04657666|80091757|FG001|Period 1|Withdrawal of participant consent|1|||
27518155|NCT04657666|80091756|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
27518156|NCT04657666|80091757|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
27518157|NCT04657666|80091756|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
27518158|NCT04657666|80091757|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
27518159|NCT04657666|80091756|FG000|Period 2|Other|2|||
27518160|NCT04657666|80091757|FG001|Period 2|Other|0|||
27518161|NCT04657666|80091756|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
27518162|NCT04657666|80091757|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
27518163|NCT01324141|80091758|FG000|Overall Study|Declined to participate before treatment started|1|||
27518164|NCT01324141|80091758|FG000|Overall Study|Disease progression on study|1|||
27518165|NCT03263702|80091759|FG000|Overall Study|Lost to Follow-up|2|||
27518166|NCT03263702|80091760|FG001|Overall Study|Lost to Follow-up|2|||
27518167|NCT03263702|80091759|FG000|Overall Study|Withdrawal by Subject|1|||
27518168|NCT03263702|80091760|FG001|Overall Study|Withdrawal by Subject|2|||
27518169|NCT02270944|80091764|FG000|Overall Study|Lost to Follow-up|9|||
27518170|NCT02270944|80091765|FG001|Overall Study|Lost to Follow-up|4|||
27518171|NCT02270944|80091764|FG000|Overall Study|Withdrawal by Subject|2|||
27518172|NCT02270944|80091765|FG001|Overall Study|Withdrawal by Subject|1|||
27518173|NCT01237899|80091769|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
27518174|NCT01237899|80091770|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
27518175|NCT01237899|80091771|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
27518176|NCT01237899|80091772|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
27518177|NCT01237899|80091773|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
27518178|NCT01237899|80091774|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
27518179|NCT01237899|80091775|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
27518180|NCT01237899|80091776|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
27518181|NCT01237899|80091777|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
27518182|NCT01237899|80091778|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
27518183|NCT01237899|80091779|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
27518184|NCT00363545|80091780|FG000|Overall Study|Serious Adverse Event|0|||
27518185|NCT00363545|80091781|FG001|Overall Study|Serious Adverse Event|1|||
27518186|NCT00363545|80091780|FG000|Overall Study|Withdrawal by Subject|12|||
27518187|NCT00363545|80091781|FG001|Overall Study|Withdrawal by Subject|15|||
27518188|NCT00363545|80091780|FG000|Overall Study|Migrated/moved from study area|3|||
27518189|NCT00363545|80091781|FG001|Overall Study|Migrated/moved from study area|6|||
27518190|NCT00363545|80091780|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
27518191|NCT00363545|80091781|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
27518192|NCT00363545|80091780|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
27518193|NCT00363545|80091781|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
27518194|NCT00363545|80091780|FG000|Overall Study|Others|1|||
27518195|NCT00363545|80091781|FG001|Overall Study|Others|0|||
27518196|NCT02874144|80091782|FG000|Overall Study|Lost to Follow-up|3|||
27518197|NCT02874144|80091783|FG001|Overall Study|Lost to Follow-up|5|||
27518198|NCT02343549|80091784|FG000|Overall Study|Death|11|||
27518199|NCT02343549|80091784|FG000|Overall Study|Withdrawal by Subject|2|||
27518200|NCT01250145|80091787|FG000|Overall Study|Adverse Event|2|||
27518201|NCT01250145|80091788|FG001|Overall Study|Adverse Event|1|||
27518202|NCT01250145|80091787|FG000|Overall Study|Withdrawal by Subject|0|||
27618359|NCT02240680|80449086|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
27618360|NCT02240680|80449087|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
27618361|NCT02240680|80449088|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
27618362|NCT02240680|80449089|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
27618363|NCT02061761|80449090|FG000|Overall Study|Disease progression|2|||
27618364|NCT02061761|80449091|FG001|Overall Study|Disease progression|8|||
27618365|NCT02061761|80449092|FG002|Overall Study|Disease progression|4|||
27618366|NCT02061761|80449093|FG003|Overall Study|Disease progression|5|||
27618367|NCT02061761|80449094|FG004|Overall Study|Disease progression|9|||
27618368|NCT02061761|80449095|FG005|Overall Study|Disease progression|3|||
27730393|NCT03486392|80842696|FG002|Overall Study|Death|0|||
27518203|NCT01250145|80091788|FG001|Overall Study|Withdrawal by Subject|4|||
27518204|NCT02082340|80091789|FG000|Overall Study|Lost to Follow-up|1|||
27518205|NCT02082340|80091790|FG001|Overall Study|Lost to Follow-up|1|||
27518206|NCT03539549|80091796|FG000|Overall Study|Adverse Event|12|||
27518207|NCT03539549|80091796|FG000|Overall Study|Lost to Follow-up|1|||
27518208|NCT03539549|80091796|FG000|Overall Study|Death|2|||
27518209|NCT03539549|80091796|FG000|Overall Study|Progressive Disease|1|||
27518210|NCT03539549|80091796|FG000|Overall Study|Reason not Specified|1|||
27518211|NCT01168219|80091797|FG000|Overall Study|off study before starting treatment|2|||
27518212|NCT01168219|80091797|FG000|Overall Study|withdrew before transplant|1|||
27518213|NCT01168219|80091797|FG000|Overall Study|ineligible due to CML|2|||
27518214|NCT02160041|80091799|FG000|Overall Study|Adverse Event|11|||
27518215|NCT02160041|80091799|FG000|Overall Study|Death|2|||
27518216|NCT02160041|80091799|FG000|Overall Study|disease progression|57|||
27518217|NCT02160041|80091799|FG000|Overall Study|Protocol Violation|1|||
27518218|NCT02160041|80091799|FG000|Overall Study|non-compliance with study|1|||
27518219|NCT02160041|80091799|FG000|Overall Study|Physician Decision|3|||
27518220|NCT02160041|80091799|FG000|Overall Study|Withdrawal by Subject|8|||
27518221|NCT02160041|80091799|FG000|Overall Study|study terminated by by sponsor|1|||
27518222|NCT01536392|80091802|FG000|Overall Study|Adverse Event|2|||
27518223|NCT01536392|80091803|FG001|Overall Study|Adverse Event|2|||
27518224|NCT01536392|80091802|FG000|Overall Study|Physician Decision|2|||
27518225|NCT01536392|80091803|FG001|Overall Study|Physician Decision|3|||
27518226|NCT01536392|80091802|FG000|Overall Study|Withdrawal by Subject|3|||
27518227|NCT01536392|80091803|FG001|Overall Study|Withdrawal by Subject|6|||
27518228|NCT01536392|80091802|FG000|Overall Study|Non Compliance|3|||
27618369|NCT02061761|80449096|FG006|Overall Study|Disease progression|1|||
27730394|NCT03486392|80842697|FG003|Overall Study|Death|0|||
27730395|NCT03486392|80842698|FG004|Overall Study|Death|1|||
27730396|NCT01756456|80842699|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
27518229|NCT01536392|80091803|FG001|Overall Study|Non Compliance|4|||
27518230|NCT01536392|80091802|FG000|Overall Study|Completed therapy early|3|||
27518231|NCT01536392|80091803|FG001|Overall Study|Completed therapy early|0|||
27518232|NCT02720042|80091810|FG000|Overall Study|Death|3|||
27518233|NCT02720042|80091810|FG000|Overall Study|Lost to Follow-up|4|||
27518234|NCT02720042|80091810|FG000|Overall Study|Withdrawal by Subject|1|||
27518235|NCT02720042|80091810|FG000|Overall Study|Physician Decision|3|||
27518236|NCT02720042|80091810|FG000|Overall Study|Phasix Mesh explanted|1|||
27518237|NCT02720042|80091810|FG000|Overall Study|unable due to non-study-related illness|3|||
27618370|NCT02061761|80449097|FG007|Overall Study|Disease progression|2|||
27618371|NCT02061761|80449098|FG008|Overall Study|Disease progression|28|||
27618372|NCT02061761|80449090|FG000|Overall Study|Study Drug toxicity|0|||
27618373|NCT02061761|80449091|FG001|Overall Study|Study Drug toxicity|0|||
27618374|NCT02061761|80449092|FG002|Overall Study|Study Drug toxicity|0|||
27908190|NCT00460239|81500562|FG003|Overall Study|Withdrawal by Subject|0|||
27908191|NCT00460239|81500563|FG004|Overall Study|Withdrawal by Subject|0|||
27908192|NCT00460239|81500564|FG005|Overall Study|Withdrawal by Subject|1|||
27908193|NCT00460239|81500565|FG006|Overall Study|Withdrawal by Subject|0|||
27908194|NCT00460239|81500566|FG007|Overall Study|Withdrawal by Subject|0|||
27908195|NCT00460239|81500567|FG008|Overall Study|Withdrawal by Subject|0|||
27908196|NCT02080364|81500568|FG000|Baseline Period|Protocol Violation|2|||
27908197|NCT02080364|81500569|FG001|Baseline Period|Protocol Violation|1|||
27908198|NCT02080364|81500570|FG002|Baseline Period|Protocol Violation|0|||
27908199|NCT02080364|81500571|FG003|Baseline Period|Protocol Violation|0|||
27908200|NCT02080364|81500568|FG000|Baseline Period|Other|0|||
27908201|NCT02080364|81500569|FG001|Baseline Period|Other|1|||
27908202|NCT02080364|81500570|FG002|Baseline Period|Other|1|||
27908203|NCT02080364|81500571|FG003|Baseline Period|Other|0|||
27908204|NCT02080364|81500568|FG000|Treatment Period|Adverse Event|10|||
27908205|NCT02080364|81500569|FG001|Treatment Period|Adverse Event|15|||
27908206|NCT02080364|81500570|FG002|Treatment Period|Adverse Event|11|||
27908207|NCT02080364|81500571|FG003|Treatment Period|Adverse Event|14|||
27908208|NCT02080364|81500568|FG000|Treatment Period|Lost to Follow-up|2|||
27908209|NCT02080364|81500569|FG001|Treatment Period|Lost to Follow-up|3|||
27908210|NCT02080364|81500570|FG002|Treatment Period|Lost to Follow-up|5|||
27908211|NCT02080364|81500571|FG003|Treatment Period|Lost to Follow-up|0|||
27908212|NCT02080364|81500568|FG000|Treatment Period|Protocol Violation|5|||
27908213|NCT02080364|81500569|FG001|Treatment Period|Protocol Violation|3|||
27908214|NCT02080364|81500570|FG002|Treatment Period|Protocol Violation|5|||
27908215|NCT02080364|81500571|FG003|Treatment Period|Protocol Violation|1|||
27908216|NCT02080364|81500568|FG000|Treatment Period|Withdrawal by Subject|16|||
27908217|NCT02080364|81500569|FG001|Treatment Period|Withdrawal by Subject|16|||
27908218|NCT02080364|81500570|FG002|Treatment Period|Withdrawal by Subject|15|||
27908219|NCT02080364|81500571|FG003|Treatment Period|Withdrawal by Subject|10|||
27908220|NCT02080364|81500568|FG000|Treatment Period|Study Terminated by Sponsor|0|||
27908221|NCT02080364|81500569|FG001|Treatment Period|Study Terminated by Sponsor|0|||
27908222|NCT02080364|81500570|FG002|Treatment Period|Study Terminated by Sponsor|180|||
27518238|NCT03085914|80091814|FG000|Overall Study|Death|6|||
27518239|NCT03085914|80091815|FG001|Overall Study|Death|6|||
27518240|NCT03085914|80091816|FG002|Overall Study|Death|4|||
27518241|NCT03085914|80091817|FG003|Overall Study|Death|1|||
27518242|NCT03085914|80091818|FG004|Overall Study|Death|5|||
27518243|NCT03085914|80091819|FG005|Overall Study|Death|2|||
27518244|NCT03085914|80091820|FG006|Overall Study|Death|2|||
27518245|NCT03085914|80091814|FG000|Overall Study|Withdrawal by Subject|1|||
27518246|NCT03085914|80091815|FG001|Overall Study|Withdrawal by Subject|1|||
27518247|NCT03085914|80091816|FG002|Overall Study|Withdrawal by Subject|2|||
27518248|NCT03085914|80091817|FG003|Overall Study|Withdrawal by Subject|2|||
27518249|NCT03085914|80091818|FG004|Overall Study|Withdrawal by Subject|2|||
27518250|NCT03085914|80091819|FG005|Overall Study|Withdrawal by Subject|0|||
27518251|NCT03085914|80091820|FG006|Overall Study|Withdrawal by Subject|1|||
27518252|NCT03085914|80091814|FG000|Overall Study|Lost to Follow-up|0|||
27518253|NCT03085914|80091815|FG001|Overall Study|Lost to Follow-up|0|||
27518254|NCT03085914|80091816|FG002|Overall Study|Lost to Follow-up|1|||
27518255|NCT03085914|80091817|FG003|Overall Study|Lost to Follow-up|0|||
27518256|NCT03085914|80091818|FG004|Overall Study|Lost to Follow-up|0|||
27518257|NCT03085914|80091819|FG005|Overall Study|Lost to Follow-up|1|||
27518258|NCT03085914|80091820|FG006|Overall Study|Lost to Follow-up|1|||
27518259|NCT03085914|80091814|FG000|Overall Study|Reason was not specified,|2|||
27518260|NCT03085914|80091815|FG001|Overall Study|Reason was not specified,|2|||
27518261|NCT03085914|80091816|FG002|Overall Study|Reason was not specified,|2|||
27518262|NCT03085914|80091817|FG003|Overall Study|Reason was not specified,|3|||
27518263|NCT03085914|80091818|FG004|Overall Study|Reason was not specified,|3|||
27618375|NCT02061761|80449093|FG003|Overall Study|Study Drug toxicity|0|||
27618376|NCT02061761|80449094|FG004|Overall Study|Study Drug toxicity|0|||
27518264|NCT03085914|80091819|FG005|Overall Study|Reason was not specified,|3|||
27518265|NCT03085914|80091820|FG006|Overall Study|Reason was not specified,|6|||
27518266|NCT03085914|80091814|FG000|Overall Study|Progressive Disease|0|||
27518267|NCT03085914|80091815|FG001|Overall Study|Progressive Disease|0|||
27518268|NCT03085914|80091816|FG002|Overall Study|Progressive Disease|2|||
27518269|NCT03085914|80091817|FG003|Overall Study|Progressive Disease|2|||
27908223|NCT02080364|81500571|FG003|Treatment Period|Study Terminated by Sponsor|183|||
27908224|NCT02080364|81500568|FG000|Treatment Period|Other|14|||
27908225|NCT02080364|81500569|FG001|Treatment Period|Other|12|||
27908226|NCT02080364|81500570|FG002|Treatment Period|Other|21|||
27908227|NCT02080364|81500571|FG003|Treatment Period|Other|16|||
27518270|NCT03085914|80091818|FG004|Overall Study|Progressive Disease|1|||
27518271|NCT03085914|80091819|FG005|Overall Study|Progressive Disease|1|||
27518272|NCT03085914|80091820|FG006|Overall Study|Progressive Disease|1|||
27518273|NCT03085914|80091814|FG000|Overall Study|Study Terminated by the Sponsor|0|||
27518274|NCT03085914|80091815|FG001|Overall Study|Study Terminated by the Sponsor|0|||
27518275|NCT03085914|80091816|FG002|Overall Study|Study Terminated by the Sponsor|0|||
27518276|NCT03085914|80091817|FG003|Overall Study|Study Terminated by the Sponsor|1|||
27518277|NCT03085914|80091818|FG004|Overall Study|Study Terminated by the Sponsor|2|||
27518278|NCT03085914|80091819|FG005|Overall Study|Study Terminated by the Sponsor|1|||
27518279|NCT03085914|80091820|FG006|Overall Study|Study Terminated by the Sponsor|0|||
27518280|NCT02576145|80091821|FG000|Overall Study|Adverse Event|1|||
27518281|NCT02576145|80091822|FG001|Overall Study|Adverse Event|0|||
27518282|NCT02576145|80091821|FG000|Overall Study|Withdrawal by Subject|1|||
27518283|NCT02576145|80091822|FG001|Overall Study|Withdrawal by Subject|0|||
27518284|NCT02576145|80091821|FG000|Overall Study|Acute rejection|1|||
27518285|NCT02576145|80091822|FG001|Overall Study|Acute rejection|0|||
27518286|NCT02576145|80091821|FG000|Overall Study|Tetanus Titers Decreased|0|||
27518287|NCT02576145|80091822|FG001|Overall Study|Tetanus Titers Decreased|1|||
27518288|NCT04145219|80091823|FG000|Overall Study|Adverse Event|18|||
27518289|NCT04145219|80091824|FG001|Overall Study|Adverse Event|6|||
27518290|NCT04145219|80091823|FG000|Overall Study|Lost to Follow-up|2|||
27518291|NCT04145219|80091824|FG001|Overall Study|Lost to Follow-up|3|||
27518292|NCT04145219|80091823|FG000|Overall Study|Physician Decision|0|||
27518293|NCT04145219|80091824|FG001|Overall Study|Physician Decision|2|||
27518294|NCT04145219|80091823|FG000|Overall Study|Withdrawal by Subject|12|||
27518295|NCT04145219|80091824|FG001|Overall Study|Withdrawal by Subject|8|||
27518296|NCT04145219|80091823|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
27518297|NCT04145219|80091824|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
27518298|NCT01788358|80091828|FG000|Overall Study|Other|11|||
27518299|NCT01788358|80091828|FG000|Overall Study|Logistical difficulties|1|||
27518300|NCT01788358|80091828|FG000|Overall Study|Lost to Follow-up|5|||
27518301|NCT01788358|80091828|FG000|Overall Study|Protocol Violation|3|||
27518302|NCT01788358|80091828|FG000|Overall Study|Withdrawal by Subject|26|||
27618377|NCT02061761|80449095|FG005|Overall Study|Study Drug toxicity|1|||
27618378|NCT02061761|80449096|FG006|Overall Study|Study Drug toxicity|0|||
27618379|NCT02061761|80449097|FG007|Overall Study|Study Drug toxicity|2|||
27618380|NCT02061761|80449098|FG008|Overall Study|Study Drug toxicity|6|||
27618381|NCT02061761|80449090|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
27618382|NCT02061761|80449091|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
27618383|NCT02061761|80449092|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
27618384|NCT02061761|80449093|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
27618385|NCT02061761|80449094|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
27618386|NCT02061761|80449095|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
27618387|NCT02061761|80449096|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
27618388|NCT02061761|80449097|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
27618389|NCT02061761|80449098|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
27618390|NCT02061761|80449090|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27618391|NCT02061761|80449091|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27618392|NCT02061761|80449092|FG002|Overall Study|Participant request to discontinue study treatment|2|||
27618393|NCT02061761|80449093|FG003|Overall Study|Participant request to discontinue study treatment|2|||
27618394|NCT02061761|80449094|FG004|Overall Study|Participant request to discontinue study treatment|0|||
27618395|NCT02061761|80449095|FG005|Overall Study|Participant request to discontinue study treatment|1|||
27618396|NCT02061761|80449096|FG006|Overall Study|Participant request to discontinue study treatment|0|||
27618397|NCT02061761|80449097|FG007|Overall Study|Participant request to discontinue study treatment|0|||
27618398|NCT02061761|80449098|FG008|Overall Study|Participant request to discontinue study treatment|2|||
27618399|NCT02061761|80449090|FG000|Overall Study|Withdrawal by Subject|0|||
27618400|NCT02061761|80449091|FG001|Overall Study|Withdrawal by Subject|0|||
27618401|NCT02061761|80449092|FG002|Overall Study|Withdrawal by Subject|0|||
27618402|NCT02061761|80449093|FG003|Overall Study|Withdrawal by Subject|0|||
27618403|NCT02061761|80449094|FG004|Overall Study|Withdrawal by Subject|0|||
27618404|NCT02061761|80449095|FG005|Overall Study|Withdrawal by Subject|0|||
27618405|NCT02061761|80449096|FG006|Overall Study|Withdrawal by Subject|0|||
27618406|NCT02061761|80449097|FG007|Overall Study|Withdrawal by Subject|0|||
27618407|NCT02061761|80449098|FG008|Overall Study|Withdrawal by Subject|2|||
27618408|NCT02061761|80449090|FG000|Overall Study|Maximum clinical benefit|0|||
27618409|NCT02061761|80449091|FG001|Overall Study|Maximum clinical benefit|0|||
27618410|NCT02061761|80449092|FG002|Overall Study|Maximum clinical benefit|0|||
27618411|NCT02061761|80449093|FG003|Overall Study|Maximum clinical benefit|1|||
27618412|NCT02061761|80449094|FG004|Overall Study|Maximum clinical benefit|0|||
27618413|NCT02061761|80449095|FG005|Overall Study|Maximum clinical benefit|0|||
27618414|NCT02061761|80449096|FG006|Overall Study|Maximum clinical benefit|0|||
27853886|NCT01550744|81295195|FG000|Open-Label|Lack of Efficacy|4|||
27518303|NCT01788358|80091828|FG000|Overall Study|Lack of Efficacy|1|||
27518304|NCT01788358|80091828|FG000|Overall Study|Adverse Event|51|||
27618415|NCT02061761|80449097|FG007|Overall Study|Maximum clinical benefit|0|||
27618416|NCT02061761|80449098|FG008|Overall Study|Maximum clinical benefit|6|||
27618417|NCT02061761|80449090|FG000|Overall Study|Participant no longer meets study criteria|0|||
27618418|NCT02061761|80449091|FG001|Overall Study|Participant no longer meets study criteria|0|||
27618419|NCT02061761|80449092|FG002|Overall Study|Participant no longer meets study criteria|0|||
27618420|NCT02061761|80449093|FG003|Overall Study|Participant no longer meets study criteria|0|||
27618421|NCT02061761|80449094|FG004|Overall Study|Participant no longer meets study criteria|0|||
27618422|NCT02061761|80449095|FG005|Overall Study|Participant no longer meets study criteria|0|||
27618423|NCT02061761|80449096|FG006|Overall Study|Participant no longer meets study criteria|0|||
27618424|NCT02061761|80449097|FG007|Overall Study|Participant no longer meets study criteria|0|||
27618425|NCT02061761|80449098|FG008|Overall Study|Participant no longer meets study criteria|1|||
27618426|NCT02061761|80449090|FG000|Overall Study|Other reasons|0|||
27618427|NCT02061761|80449091|FG001|Overall Study|Other reasons|0|||
27618428|NCT02061761|80449092|FG002|Overall Study|Other reasons|0|||
27618429|NCT02061761|80449093|FG003|Overall Study|Other reasons|0|||
27618430|NCT02061761|80449094|FG004|Overall Study|Other reasons|2|||
27618431|NCT02061761|80449095|FG005|Overall Study|Other reasons|0|||
27618432|NCT02061761|80449096|FG006|Overall Study|Other reasons|0|||
27618433|NCT02061761|80449097|FG007|Overall Study|Other reasons|0|||
27618434|NCT02061761|80449098|FG008|Overall Study|Other reasons|6|||
27618435|NCT01113463|80449099|FG000|Overall Study|Physician Decision|5|||
27618436|NCT03300817|80449100|FG000|Overall Study|Withdrawal by Subject|1|||
27618437|NCT03300817|80449100|FG000|Overall Study|Adverse Event|1|||
27518305|NCT04525885|80091829|FG000|Overall Study|Screen Failure|1|||
27518306|NCT04525885|80091830|FG001|Overall Study|Screen Failure|0|||
27518307|NCT04525885|80091831|FG002|Overall Study|Screen Failure|0|||
27518308|NCT04525885|80091829|FG000|Overall Study|Withdrawal by Subject|14|||
27518309|NCT04525885|80091830|FG001|Overall Study|Withdrawal by Subject|6|||
27518310|NCT04525885|80091831|FG002|Overall Study|Withdrawal by Subject|20|||
27518311|NCT04525885|80091829|FG000|Overall Study|Physician Decision|1|||
27518312|NCT04525885|80091830|FG001|Overall Study|Physician Decision|0|||
27518313|NCT04525885|80091831|FG002|Overall Study|Physician Decision|1|||
27518314|NCT03801031|80091835|FG000|Overall Study|Lost to Follow-up|1|||
27518315|NCT03801031|80091836|FG001|Overall Study|Lost to Follow-up|0|||
27518316|NCT03801031|80091835|FG000|Overall Study|Unable to comply|1|||
27518317|NCT03801031|80091836|FG001|Overall Study|Unable to comply|0|||
27518318|NCT03801031|80091835|FG000|Overall Study|Withdrawal by Subject|0|||
27518319|NCT03801031|80091836|FG001|Overall Study|Withdrawal by Subject|1|||
27518320|NCT02437110|80091837|FG000|Screening|Lost to Follow-up|3|||
27518321|NCT02437110|80091837|FG000|Screening|Physician Decision|1|||
27518322|NCT02437110|80091837|FG000|ART|Adverse Event|3|||
27518323|NCT02437110|80091837|FG000|ART|Protocol Violation|3|||
27518324|NCT02437110|80091837|FG000|ART|Withdrawal by Subject|4|||
27518325|NCT02437110|80091837|FG000|ART|Lost to follow-up prior to start of intervention|1|||
27518326|NCT02437110|80091837|FG000|ART|Physician decision prior to start of intervention|2|||
27518327|NCT02437110|80091837|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
27518328|NCT02437110|80091837|FG000|Post-ART|Lost to Follow-up|3|||
27518329|NCT02437110|80091837|FG000|Post-ART|Protocol Violation|4|||
27518330|NCT02437110|80091837|FG000|Post-ART|Withdrawal by Subject|3|||
27518331|NCT01451437|80091838|FG000|Overall Study|Adverse Event|0|||
27518332|NCT01451437|80091839|FG001|Overall Study|Adverse Event|0|||
27518333|NCT01451437|80091840|FG002|Overall Study|Adverse Event|0|||
27518334|NCT01451437|80091841|FG003|Overall Study|Adverse Event|0|||
27518335|NCT01451437|80091842|FG004|Overall Study|Adverse Event|0|||
27518336|NCT01451437|80091843|FG005|Overall Study|Adverse Event|1|||
27518337|NCT01451437|80091844|FG006|Overall Study|Adverse Event|1|||
27518338|NCT01451437|80091845|FG007|Overall Study|Adverse Event|2|||
27518339|NCT01451437|80091846|FG008|Overall Study|Adverse Event|1|||
27518340|NCT01451437|80091838|FG000|Overall Study|Physician Decision|1|||
27518341|NCT01451437|80091839|FG001|Overall Study|Physician Decision|1|||
27518342|NCT01451437|80091840|FG002|Overall Study|Physician Decision|2|||
27518343|NCT01451437|80091841|FG003|Overall Study|Physician Decision|0|||
27518344|NCT01451437|80091842|FG004|Overall Study|Physician Decision|0|||
27618438|NCT03300817|80449100|FG000|Overall Study|Subject Found to be Ineligible|2|||
27618439|NCT00619476|80449103|FG000|Overall Study|Adverse Event|12|||
27618440|NCT00619476|80449104|FG001|Overall Study|Adverse Event|6|||
27908228|NCT01223937|81500590|FG000|Overall Study|Withdrawal by Subject|3|||
27518345|NCT01451437|80091843|FG005|Overall Study|Physician Decision|0|||
27518346|NCT01451437|80091844|FG006|Overall Study|Physician Decision|0|||
27518347|NCT01451437|80091845|FG007|Overall Study|Physician Decision|0|||
27908229|NCT01223937|81500591|FG001|Overall Study|Withdrawal by Subject|2|||
27518348|NCT01451437|80091846|FG008|Overall Study|Physician Decision|0|||
27518349|NCT01451437|80091838|FG000|Overall Study|Disease Progression|0|||
27518350|NCT01451437|80091839|FG001|Overall Study|Disease Progression|0|||
27518351|NCT01451437|80091840|FG002|Overall Study|Disease Progression|1|||
27518352|NCT01451437|80091841|FG003|Overall Study|Disease Progression|1|||
27518353|NCT01451437|80091842|FG004|Overall Study|Disease Progression|3|||
27518354|NCT01451437|80091843|FG005|Overall Study|Disease Progression|2|||
27618441|NCT00619476|80449105|FG002|Overall Study|Adverse Event|12|||
27618442|NCT00619476|80449106|FG003|Overall Study|Adverse Event|16|||
27618443|NCT00619476|80449103|FG000|Overall Study|Lack of Efficacy|6|||
27618444|NCT00619476|80449104|FG001|Overall Study|Lack of Efficacy|1|||
27618445|NCT00619476|80449105|FG002|Overall Study|Lack of Efficacy|1|||
27618446|NCT00619476|80449106|FG003|Overall Study|Lack of Efficacy|4|||
27618447|NCT00619476|80449103|FG000|Overall Study|Protocol Violation|5|||
27618448|NCT00619476|80449104|FG001|Overall Study|Protocol Violation|4|||
27618449|NCT00619476|80449105|FG002|Overall Study|Protocol Violation|4|||
27618450|NCT00619476|80449106|FG003|Overall Study|Protocol Violation|9|||
27618451|NCT00619476|80449103|FG000|Overall Study|Lost to Follow-up|1|||
27618452|NCT00619476|80449104|FG001|Overall Study|Lost to Follow-up|2|||
27618453|NCT00619476|80449105|FG002|Overall Study|Lost to Follow-up|0|||
27618454|NCT00619476|80449106|FG003|Overall Study|Lost to Follow-up|1|||
27618455|NCT00619476|80449103|FG000|Overall Study|Investigator Discretion|2|||
27618456|NCT00619476|80449104|FG001|Overall Study|Investigator Discretion|2|||
27618457|NCT00619476|80449105|FG002|Overall Study|Investigator Discretion|2|||
27618458|NCT00619476|80449106|FG003|Overall Study|Investigator Discretion|0|||
27618459|NCT00619476|80449103|FG000|Overall Study|Withdrawal by Subject|5|||
27618460|NCT00619476|80449104|FG001|Overall Study|Withdrawal by Subject|7|||
27618461|NCT00619476|80449105|FG002|Overall Study|Withdrawal by Subject|5|||
27618462|NCT00619476|80449106|FG003|Overall Study|Withdrawal by Subject|4|||
27618463|NCT00801242|80449107|FG000|Overall Study|Adverse Event|10|||
27618464|NCT00801242|80449107|FG000|Overall Study|Withdrawal by Subject|13|||
27618465|NCT00801242|80449107|FG000|Overall Study|Protocol Violation|5|||
27618466|NCT00801242|80449107|FG000|Overall Study|Physician Decision|3|||
27618467|NCT00801242|80449107|FG000|Overall Study|Lost to Follow-up|1|||
27618468|NCT00801242|80449107|FG000|Overall Study|Miscellaneous reasons|20|||
27618469|NCT02800928|80449112|FG000|Overall Study|Withdrawal by Subject|1|||
27618470|NCT02800928|80449113|FG001|Overall Study|Withdrawal by Subject|1|||
27618471|NCT02800928|80449112|FG000|Overall Study|Protocol Violation|1|||
27618472|NCT02800928|80449113|FG001|Overall Study|Protocol Violation|1|||
27618473|NCT02013687|80449116|FG000|Overall Study|Lost to Follow-up|0|||
27618474|NCT02013687|80449117|FG001|Overall Study|Lost to Follow-up|0|||
27618475|NCT02013687|80449118|FG002|Overall Study|Lost to Follow-up|1|||
27618476|NCT02013687|80449119|FG003|Overall Study|Lost to Follow-up|0|||
27618477|NCT02013687|80449116|FG000|Overall Study|Protocol Violation|0|||
27618478|NCT02013687|80449117|FG001|Overall Study|Protocol Violation|0|||
27618479|NCT02013687|80449118|FG002|Overall Study|Protocol Violation|0|||
27618480|NCT02013687|80449119|FG003|Overall Study|Protocol Violation|1|||
27618481|NCT02013687|80449116|FG000|Overall Study|Withdrawal by Subject|0|||
27618482|NCT02013687|80449117|FG001|Overall Study|Withdrawal by Subject|0|||
27618483|NCT02013687|80449118|FG002|Overall Study|Withdrawal by Subject|0|||
27618484|NCT02013687|80449119|FG003|Overall Study|Withdrawal by Subject|1|||
27618485|NCT02013687|80449116|FG000|Overall Study|Missed visits due to patient travel|0|||
27618486|NCT02013687|80449117|FG001|Overall Study|Missed visits due to patient travel|0|||
27618487|NCT02013687|80449118|FG002|Overall Study|Missed visits due to patient travel|1|||
27618488|NCT02013687|80449119|FG003|Overall Study|Missed visits due to patient travel|0|||
27618489|NCT02761629|80449120|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
27618490|NCT02761629|80449121|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
27618491|NCT02761629|80449120|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27618492|NCT02761629|80449121|FG001|Overall Study|Insufficient Therapeutic Response|7|||
27618493|NCT02761629|80449120|FG000|Overall Study|Failure to Return|2|||
27618494|NCT02761629|80449121|FG001|Overall Study|Failure to Return|4|||
27618495|NCT02761629|80449120|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
27618496|NCT02761629|80449121|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
27618497|NCT02761629|80449120|FG000|Overall Study|Protocol Violation|2|||
27618498|NCT02761629|80449121|FG001|Overall Study|Protocol Violation|2|||
27618499|NCT02761629|80449120|FG000|Overall Study|Withdrawal by Subject|0|||
27618500|NCT02761629|80449121|FG001|Overall Study|Withdrawal by Subject|3|||
27618501|NCT02761629|80449120|FG000|Overall Study|Other|0|||
27618502|NCT02761629|80449121|FG001|Overall Study|Other|2|||
27618503|NCT02761629|80449120|FG000|Overall Study|Lost to Follow-up|4|||
27618504|NCT02761629|80449121|FG001|Overall Study|Lost to Follow-up|1|||
27618505|NCT02761629|80449120|FG000|Overall Study|Randomized But Not Treated|8|||
27618506|NCT02761629|80449121|FG001|Overall Study|Randomized But Not Treated|4|||
27618507|NCT01256476|80449125|FG000|Overall Study|Adverse Event|2|||
27618508|NCT01256476|80449126|FG001|Overall Study|Adverse Event|1|||
27618509|NCT01256476|80449125|FG000|Overall Study|Withdrawal by Subject|2|||
27853887|NCT01550744|81295196|FG001|Open-Label|Lack of Efficacy|0|||
27618510|NCT01256476|80449126|FG001|Overall Study|Withdrawal by Subject|1|||
27618511|NCT01256476|80449125|FG000|Overall Study|Lost to Follow-up|1|||
27618512|NCT01256476|80449126|FG001|Overall Study|Lost to Follow-up|2|||
27618513|NCT01256476|80449125|FG000|Overall Study|Persistent ALT or AST elevation|1|||
27618514|NCT01256476|80449126|FG001|Overall Study|Persistent ALT or AST elevation|0|||
27618515|NCT01256476|80449125|FG000|Overall Study|Physician Decision|0|||
27618516|NCT01256476|80449126|FG001|Overall Study|Physician Decision|1|||
27853888|NCT01550744|81295197|FG002|Open-Label|Lack of Efficacy|0|||
27908230|NCT01223937|81500590|FG000|Overall Study|Lost to Follow-up|1|||
27908231|NCT01223937|81500591|FG001|Overall Study|Lost to Follow-up|4|||
27908232|NCT01223937|81500590|FG000|Overall Study|Adverse Event|1|||
27908233|NCT01223937|81500591|FG001|Overall Study|Adverse Event|4|||
27908234|NCT01223937|81500590|FG000|Overall Study|Protocol Violation|8|||
27908235|NCT01223937|81500591|FG001|Overall Study|Protocol Violation|7|||
27908236|NCT01223937|81500590|FG000|Overall Study|Other|4|||
27908237|NCT01223937|81500591|FG001|Overall Study|Other|1|||
27908238|NCT00856999|81500592|FG000|Overall Study|Withdrawal by Subject|5|||
27908239|NCT02942277|81500595|FG000|Year 1|Withdrawal by Subject|0|||
27908240|NCT02942277|81500596|FG001|Year 1|Withdrawal by Subject|0|||
27908241|NCT02942277|81500597|FG002|Year 1|Withdrawal by Subject|0|||
27908242|NCT02942277|81500598|FG003|Year 1|Withdrawal by Subject|0|||
27908243|NCT02942277|81500599|FG004|Year 1|Withdrawal by Subject|1|||
27908244|NCT02942277|81500600|FG005|Year 1|Withdrawal by Subject|3|||
27908245|NCT02942277|81500601|FG006|Year 1|Withdrawal by Subject|0|||
27908246|NCT02942277|81500602|FG007|Year 1|Withdrawal by Subject|1|||
27908247|NCT02942277|81500603|FG008|Year 1|Withdrawal by Subject|0|||
27908248|NCT02942277|81500604|FG009|Year 1|Withdrawal by Subject|0|||
27908249|NCT02942277|81500605|FG010|Year 1|Withdrawal by Subject|3|||
27908250|NCT02942277|81500595|FG000|Year 1|Travel|0|||
27908251|NCT02942277|81500596|FG001|Year 1|Travel|1|||
27908252|NCT02942277|81500597|FG002|Year 1|Travel|0|||
27518355|NCT01451437|80091844|FG006|Overall Study|Disease Progression|3|||
27518356|NCT01451437|80091845|FG007|Overall Study|Disease Progression|1|||
27518357|NCT01451437|80091846|FG008|Overall Study|Disease Progression|3|||
27518358|NCT01451437|80091838|FG000|Overall Study|Protocol Violation|0|||
27518359|NCT01451437|80091839|FG001|Overall Study|Protocol Violation|0|||
27518360|NCT01451437|80091840|FG002|Overall Study|Protocol Violation|0|||
27518361|NCT01451437|80091841|FG003|Overall Study|Protocol Violation|0|||
27518362|NCT01451437|80091842|FG004|Overall Study|Protocol Violation|0|||
27518363|NCT01451437|80091843|FG005|Overall Study|Protocol Violation|0|||
27518364|NCT01451437|80091844|FG006|Overall Study|Protocol Violation|1|||
27518365|NCT01451437|80091845|FG007|Overall Study|Protocol Violation|0|||
27518366|NCT01451437|80091846|FG008|Overall Study|Protocol Violation|0|||
27518367|NCT01451437|80091838|FG000|Overall Study|Withdrawal by Subject|0|||
27518368|NCT01451437|80091839|FG001|Overall Study|Withdrawal by Subject|0|||
27518369|NCT01451437|80091840|FG002|Overall Study|Withdrawal by Subject|0|||
27518370|NCT01451437|80091841|FG003|Overall Study|Withdrawal by Subject|0|||
27518371|NCT01451437|80091842|FG004|Overall Study|Withdrawal by Subject|1|||
27518372|NCT01451437|80091843|FG005|Overall Study|Withdrawal by Subject|0|||
27518373|NCT01451437|80091844|FG006|Overall Study|Withdrawal by Subject|1|||
27518374|NCT01451437|80091845|FG007|Overall Study|Withdrawal by Subject|0|||
27518375|NCT01451437|80091846|FG008|Overall Study|Withdrawal by Subject|0|||
27518376|NCT02870933|80091847|FG000|Overall Study|Death|2|||
27518377|NCT02870933|80091848|FG001|Overall Study|Death|1|||
27518378|NCT02870933|80091847|FG000|Overall Study|Withdrawal by Subject|0|||
27518379|NCT02870933|80091848|FG001|Overall Study|Withdrawal by Subject|1|||
27518380|NCT04661579|80091849|FG000|Overall Study|Lost to Follow-up|19|||
27518381|NCT04661579|80091850|FG001|Overall Study|Lost to Follow-up|10|||
27518382|NCT04661579|80091851|FG002|Overall Study|Lost to Follow-up|2|||
27518383|NCT04661579|80091852|FG003|Overall Study|Lost to Follow-up|7|||
27518384|NCT04661579|80091853|FG004|Overall Study|Lost to Follow-up|11|||
27518385|NCT04661579|80091849|FG000|Overall Study|Physician Decision|2|||
27518386|NCT04661579|80091850|FG001|Overall Study|Physician Decision|0|||
27518387|NCT04661579|80091851|FG002|Overall Study|Physician Decision|0|||
27518388|NCT04661579|80091852|FG003|Overall Study|Physician Decision|1|||
27518389|NCT04661579|80091853|FG004|Overall Study|Physician Decision|0|||
27518390|NCT04661579|80091849|FG000|Overall Study|Withdrawal by Subject|1|||
27518391|NCT04661579|80091850|FG001|Overall Study|Withdrawal by Subject|4|||
27518392|NCT04661579|80091851|FG002|Overall Study|Withdrawal by Subject|0|||
27518393|NCT04661579|80091852|FG003|Overall Study|Withdrawal by Subject|2|||
27518394|NCT04661579|80091853|FG004|Overall Study|Withdrawal by Subject|0|||
27518395|NCT04661579|80091849|FG000|Overall Study|Death|1|||
27518396|NCT04661579|80091850|FG001|Overall Study|Death|0|||
27908253|NCT02942277|81500598|FG003|Year 1|Travel|0|||
27908254|NCT02942277|81500599|FG004|Year 1|Travel|4|||
27908255|NCT02942277|81500600|FG005|Year 1|Travel|5|||
27908256|NCT02942277|81500601|FG006|Year 1|Travel|0|||
27518397|NCT04661579|80091851|FG002|Overall Study|Death|0|||
27518398|NCT04661579|80091852|FG003|Overall Study|Death|0|||
27518399|NCT04661579|80091853|FG004|Overall Study|Death|0|||
27518400|NCT04661579|80091849|FG000|Overall Study|Other|1|||
27518401|NCT04661579|80091850|FG001|Overall Study|Other|2|||
27518402|NCT04661579|80091851|FG002|Overall Study|Other|1|||
27518403|NCT04661579|80091852|FG003|Overall Study|Other|1|||
27518404|NCT04661579|80091853|FG004|Overall Study|Other|1|||
27518405|NCT04661579|80091849|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
27518406|NCT04661579|80091850|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
27908257|NCT02942277|81500602|FG007|Year 1|Travel|0|||
27908258|NCT02942277|81500603|FG008|Year 1|Travel|0|||
27908259|NCT02942277|81500604|FG009|Year 1|Travel|0|||
27518407|NCT04661579|80091851|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
27518408|NCT04661579|80091852|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
27518409|NCT04661579|80091853|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
27518410|NCT03232333|80091854|FG000|Overall Study|Infection or Osteomyelitis|9|||
27518411|NCT03232333|80091854|FG000|Overall Study|Lost to Follow-up|4|||
27518412|NCT03232333|80091854|FG000|Overall Study|Withdrawal by Subject|2|||
27518413|NCT00160667|80091855|FG000|Overall Study|Adverse Event|3|||
27518414|NCT00160667|80091856|FG001|Overall Study|Adverse Event|1|||
27518415|NCT00160667|80091857|FG002|Overall Study|Adverse Event|4|||
27518416|NCT00160667|80091855|FG000|Overall Study|Withdrawal by Subject|2|||
27518417|NCT00160667|80091856|FG001|Overall Study|Withdrawal by Subject|0|||
27518418|NCT00160667|80091857|FG002|Overall Study|Withdrawal by Subject|1|||
27518419|NCT00160667|80091855|FG000|Overall Study|Lack of Efficacy|0|||
27518420|NCT00160667|80091856|FG001|Overall Study|Lack of Efficacy|1|||
27518421|NCT00160667|80091857|FG002|Overall Study|Lack of Efficacy|0|||
27518422|NCT00160667|80091855|FG000|Overall Study|Protocol Violation|0|||
27518423|NCT00160667|80091856|FG001|Overall Study|Protocol Violation|1|||
27518424|NCT00160667|80091857|FG002|Overall Study|Protocol Violation|0|||
27518425|NCT00160667|80091855|FG000|Overall Study|Patient decision|0|||
27518426|NCT00160667|80091856|FG001|Overall Study|Patient decision|0|||
27518427|NCT00160667|80091857|FG002|Overall Study|Patient decision|1|||
27518428|NCT01675544|80091860|FG000|Overall Study|Withdrawal by Subject|2|||
27518429|NCT03844945|80091861|FG000|Overall Study|Adverse Event|1|||
27518430|NCT03844945|80091862|FG001|Overall Study|Adverse Event|1|||
27518431|NCT03844945|80091863|FG002|Overall Study|Adverse Event|4|||
27518432|NCT03844945|80091864|FG003|Overall Study|Adverse Event|0|||
27518433|NCT03844945|80091861|FG000|Overall Study|Withdrawal by Subject|0|||
27518434|NCT03844945|80091862|FG001|Overall Study|Withdrawal by Subject|0|||
27518435|NCT03844945|80091863|FG002|Overall Study|Withdrawal by Subject|1|||
27518436|NCT03844945|80091864|FG003|Overall Study|Withdrawal by Subject|0|||
27518437|NCT03844945|80091861|FG000|Overall Study|Lack of Efficacy|0|||
27518438|NCT03844945|80091862|FG001|Overall Study|Lack of Efficacy|0|||
27518439|NCT03844945|80091863|FG002|Overall Study|Lack of Efficacy|0|||
27518440|NCT03844945|80091864|FG003|Overall Study|Lack of Efficacy|1|||
27518441|NCT00992589|80091865|FG000|Open-Label Phase|Adverse Event|4|||
27518442|NCT00992589|80091866|FG001|Open-Label Phase|Adverse Event|0|||
27518443|NCT00992589|80091867|FG002|Open-Label Phase|Adverse Event|0|||
27518444|NCT00992589|80091868|FG003|Open-Label Phase|Adverse Event|0|||
27518445|NCT00992589|80091865|FG000|Open-Label Phase|Withdrawal by Subject|20|||
27518446|NCT00992589|80091866|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27518447|NCT00992589|80091867|FG002|Open-Label Phase|Withdrawal by Subject|0|||
27518448|NCT00992589|80091868|FG003|Open-Label Phase|Withdrawal by Subject|0|||
27518449|NCT00992589|80091865|FG000|Open-Label Phase|Lost to Follow-up|1|||
27518450|NCT00992589|80091866|FG001|Open-Label Phase|Lost to Follow-up|0|||
27518451|NCT00992589|80091867|FG002|Open-Label Phase|Lost to Follow-up|0|||
27518452|NCT00992589|80091868|FG003|Open-Label Phase|Lost to Follow-up|0|||
27518453|NCT00992589|80091865|FG000|Open-Label Phase|Protocol Violation|3|||
27518454|NCT00992589|80091866|FG001|Open-Label Phase|Protocol Violation|0|||
27518455|NCT00992589|80091867|FG002|Open-Label Phase|Protocol Violation|0|||
27518456|NCT00992589|80091868|FG003|Open-Label Phase|Protocol Violation|0|||
27518457|NCT00992589|80091865|FG000|Open-Label Phase|Physician Decision|4|||
27518458|NCT00992589|80091866|FG001|Open-Label Phase|Physician Decision|0|||
27518459|NCT00992589|80091867|FG002|Open-Label Phase|Physician Decision|0|||
27518460|NCT00992589|80091868|FG003|Open-Label Phase|Physician Decision|0|||
27518461|NCT00992589|80091865|FG000|Open-Label Phase|Other|45|||
27518462|NCT00992589|80091866|FG001|Open-Label Phase|Other|0|||
27518463|NCT00992589|80091867|FG002|Open-Label Phase|Other|0|||
27518464|NCT00992589|80091868|FG003|Open-Label Phase|Other|0|||
27518465|NCT00992589|80091865|FG000|Double-Blind Phase|Adverse Event|0|||
27518466|NCT00992589|80091866|FG001|Double-Blind Phase|Adverse Event|6|||
27518467|NCT00992589|80091867|FG002|Double-Blind Phase|Adverse Event|2|||
27518468|NCT00992589|80091868|FG003|Double-Blind Phase|Adverse Event|3|||
27518469|NCT00992589|80091865|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27518470|NCT00992589|80091866|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
27518471|NCT00992589|80091867|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
27908260|NCT02942277|81500605|FG010|Year 1|Travel|8|||
27518472|NCT00992589|80091868|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
27518473|NCT00992589|80091865|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27518474|NCT00992589|80091866|FG001|Double-Blind Phase|Lost to Follow-up|0|||
27518475|NCT00992589|80091867|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27518476|NCT00992589|80091868|FG003|Double-Blind Phase|Lost to Follow-up|2|||
27518477|NCT00992589|80091865|FG000|Double-Blind Phase|Other|0|||
27518478|NCT00992589|80091866|FG001|Double-Blind Phase|Other|1|||
27518479|NCT00992589|80091867|FG002|Double-Blind Phase|Other|6|||
27518480|NCT00992589|80091868|FG003|Double-Blind Phase|Other|3|||
27518481|NCT00832624|80091869|FG000|Overall Study|Study Terminated|10|||
27518482|NCT01981551|80091870|FG000|Overall Study|Refused further treatment|8|||
27518483|NCT01981551|80091870|FG000|Overall Study|Adverse Event|1|||
27518484|NCT01018810|80091871|FG000|Overall Study|Withdrawal by Subject|0|||
27518485|NCT01018810|80091872|FG001|Overall Study|Withdrawal by Subject|1|||
27518486|NCT01018810|80091873|FG002|Overall Study|Withdrawal by Subject|0|||
27518487|NCT01018810|80091874|FG003|Overall Study|Withdrawal by Subject|0|||
27518488|NCT01018810|80091875|FG004|Overall Study|Withdrawal by Subject|0|||
27518489|NCT01018810|80091871|FG000|Overall Study|Sponsor Decision|2|||
27518490|NCT01018810|80091872|FG001|Overall Study|Sponsor Decision|0|||
27518491|NCT01018810|80091873|FG002|Overall Study|Sponsor Decision|1|||
27518492|NCT01018810|80091874|FG003|Overall Study|Sponsor Decision|1|||
27518493|NCT01018810|80091875|FG004|Overall Study|Sponsor Decision|1|||
27518494|NCT04450381|80091876|FG000|Overall Study|Protocol Violation|4|||
27518495|NCT04450381|80091876|FG000|Overall Study|Wrong device setting|2|||
27518496|NCT03207763|80091877|FG000|Overall Study|Lost to Follow-up|1|||
27518497|NCT03207763|80091878|FG001|Overall Study|Lost to Follow-up|0|||
27518498|NCT00439738|80091882|FG000|Overall Study|Withdrawal by Subject|16|||
27518499|NCT00439738|80091883|FG001|Overall Study|Withdrawal by Subject|13|||
27618517|NCT01256476|80449125|FG000|Overall Study|Subject non-compliance|0|||
27618518|NCT01256476|80449126|FG001|Overall Study|Subject non-compliance|1|||
27618519|NCT01256476|80449125|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
27618520|NCT01256476|80449126|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
27618521|NCT03018106|80449127|FG000|Overall Study|Lost to Follow-up|0|||
27618522|NCT03018106|80449128|FG001|Overall Study|Lost to Follow-up|1|||
27618523|NCT03619174|80449151|FG000|Overall Study|Lost to Follow-up|3|||
27618524|NCT03619174|80449152|FG001|Overall Study|Lost to Follow-up|0|||
27618525|NCT03619174|80449151|FG000|Overall Study|Withdrawal by Subject|4|||
27618526|NCT03619174|80449152|FG001|Overall Study|Withdrawal by Subject|3|||
27618527|NCT03619174|80449151|FG000|Overall Study|Pregnancy|1|||
27618528|NCT03619174|80449152|FG001|Overall Study|Pregnancy|1|||
27730397|NCT01756456|80842700|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
27730398|NCT01756456|80842701|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
27518500|NCT00439738|80091882|FG000|Overall Study|Adverse Event|6|||
27518501|NCT00439738|80091883|FG001|Overall Study|Adverse Event|4|||
27518502|NCT00439738|80091882|FG000|Overall Study|Lost to Follow-up|5|||
27518503|NCT00439738|80091883|FG001|Overall Study|Lost to Follow-up|6|||
27518504|NCT00439738|80091882|FG000|Overall Study|Protocol Violation|6|||
27518505|NCT00439738|80091883|FG001|Overall Study|Protocol Violation|3|||
27518506|NCT00439738|80091882|FG000|Overall Study|Lack of Efficacy|2|||
27518507|NCT00439738|80091883|FG001|Overall Study|Lack of Efficacy|2|||
27518508|NCT00439738|80091882|FG000|Overall Study|Abnormal Lab Values|1|||
27518509|NCT00439738|80091883|FG001|Overall Study|Abnormal Lab Values|0|||
27518510|NCT03830892|80091884|FG000|Overall Study|Physician Decision|2|||
27518511|NCT03830892|80091885|FG001|Overall Study|Physician Decision|3|||
27730399|NCT01756456|80842702|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
27908261|NCT02942277|81500595|FG000|Year 1|Joined Army|0|||
27908262|NCT02942277|81500596|FG001|Year 1|Joined Army|1|||
27908263|NCT02942277|81500597|FG002|Year 1|Joined Army|0|||
27908264|NCT02942277|81500598|FG003|Year 1|Joined Army|0|||
27908265|NCT02942277|81500599|FG004|Year 1|Joined Army|0|||
27908266|NCT02942277|81500600|FG005|Year 1|Joined Army|0|||
27908267|NCT02942277|81500601|FG006|Year 1|Joined Army|0|||
27908268|NCT02942277|81500602|FG007|Year 1|Joined Army|0|||
27908269|NCT02942277|81500603|FG008|Year 1|Joined Army|0|||
27908270|NCT02942277|81500604|FG009|Year 1|Joined Army|0|||
27908271|NCT02942277|81500605|FG010|Year 1|Joined Army|0|||
27518512|NCT03830892|80091884|FG000|Overall Study|Study terminated due to COVID|4|||
27518513|NCT03830892|80091885|FG001|Overall Study|Study terminated due to COVID|0|||
27518514|NCT03830892|80091884|FG000|Overall Study|Protocol Violation|0|||
27518515|NCT03830892|80091885|FG001|Overall Study|Protocol Violation|1|||
27518516|NCT03830892|80091884|FG000|Overall Study|Withdrawal by Subject|0|||
27518517|NCT03830892|80091885|FG001|Overall Study|Withdrawal by Subject|2|||
27730400|NCT01756456|80842703|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
27908272|NCT02942277|81500595|FG000|Year 1|Subject met withdrawal criteria|0|||
27618529|NCT03619174|80449151|FG000|Overall Study|Discomfort during treatment|1|||
27618530|NCT03619174|80449152|FG001|Overall Study|Discomfort during treatment|0|||
27618531|NCT01403987|80449153|FG000|Overall Study|Residents forgot their secret PIN|18|||
27853889|NCT01550744|81295195|FG000|Open-Label|Protocol Violation|4|||
27908273|NCT02942277|81500596|FG001|Year 1|Subject met withdrawal criteria|0|||
27518518|NCT00490529|80091886|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
27518519|NCT00490529|80091886|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
27518520|NCT00490529|80091886|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
27518521|NCT00490529|80091886|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
27518522|NCT00490529|80091886|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
27618532|NCT01403987|80449154|FG001|Overall Study|Residents forgot their secret PIN|17|||
27618533|NCT01403987|80449155|FG002|Overall Study|Residents forgot their secret PIN|18|||
27618534|NCT02703532|80449156|FG000|Overall Study|Withdrawal by Subject|0|||
27618535|NCT02703532|80449157|FG001|Overall Study|Withdrawal by Subject|1|||
27618536|NCT02703532|80449158|FG002|Overall Study|Withdrawal by Subject|0|||
27618537|NCT02703532|80449159|FG003|Overall Study|Withdrawal by Subject|1|||
27618538|NCT02703532|80449156|FG000|Overall Study|Lost to Follow-up|2|||
27618539|NCT02703532|80449157|FG001|Overall Study|Lost to Follow-up|0|||
27618540|NCT02703532|80449158|FG002|Overall Study|Lost to Follow-up|2|||
27618541|NCT02703532|80449159|FG003|Overall Study|Lost to Follow-up|0|||
27618542|NCT02839681|80449160|FG000|Overall Study|Death|2|||
27618543|NCT01077024|80449165|FG000|Overall Study|Lost to Follow-up|20|||
27618544|NCT01077024|80449166|FG001|Overall Study|Lost to Follow-up|14|||
27618545|NCT01077024|80449165|FG000|Overall Study|Withdrawal by Subject|0|||
27618546|NCT01077024|80449166|FG001|Overall Study|Withdrawal by Subject|2|||
27618547|NCT01077024|80449165|FG000|Overall Study|Incarcerated|7|||
27618548|NCT01077024|80449166|FG001|Overall Study|Incarcerated|8|||
27618549|NCT01077024|80449165|FG000|Overall Study|Other|4|||
27618550|NCT01077024|80449166|FG001|Overall Study|Other|4|||
27618551|NCT00003377|80449167|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
27618552|NCT00003377|80449168|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
27618553|NCT00003377|80449169|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
27618554|NCT00003377|80449170|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
27618555|NCT00003377|80449171|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
27618556|NCT00003377|80449167|FG000|Period II|Ureteral stent complications|0|||
27618557|NCT00003377|80449168|FG001|Period II|Ureteral stent complications|0|||
27618558|NCT00003377|80449169|FG002|Period II|Ureteral stent complications|0|||
27618559|NCT00003377|80449170|FG003|Period II|Ureteral stent complications|0|||
27618560|NCT00003377|80449171|FG004|Period II|Ureteral stent complications|1|||
27618561|NCT00280293|80449172|FG000|Overall Study|Protocol Violation|3|||
27618562|NCT00280293|80449173|FG001|Overall Study|Protocol Violation|0|||
27618563|NCT00280293|80449172|FG000|Overall Study|Physician Decision|5|||
27618564|NCT00280293|80449173|FG001|Overall Study|Physician Decision|4|||
27618565|NCT00280293|80449172|FG000|Overall Study|Lost to Follow-up|14|||
27618566|NCT00280293|80449173|FG001|Overall Study|Lost to Follow-up|12|||
27618567|NCT00280293|80449172|FG000|Overall Study|Withdrawal by Subject|3|||
27618568|NCT00280293|80449173|FG001|Overall Study|Withdrawal by Subject|5|||
27618569|NCT00280293|80449172|FG000|Overall Study|Incarceration/Legal Reasons|1|||
27618570|NCT00280293|80449173|FG001|Overall Study|Incarceration/Legal Reasons|1|||
27618571|NCT00280293|80449172|FG000|Overall Study|Adverse Event|0|||
27618572|NCT00280293|80449173|FG001|Overall Study|Adverse Event|1|||
27618573|NCT00329719|80449174|FG000|Overall Study|Lost to Follow-up|0|||
27618574|NCT00329719|80449175|FG001|Overall Study|Lost to Follow-up|0|||
27618575|NCT00329719|80449176|FG002|Overall Study|Lost to Follow-up|0|||
27618576|NCT00329719|80449177|FG003|Overall Study|Lost to Follow-up|1|||
27618577|NCT00231894|80449179|FG000|Overall Study|Withdrawal by Subject|1|||
27618578|NCT00231894|80449180|FG001|Overall Study|Withdrawal by Subject|1|||
27618579|NCT03785340|80449181|FG000|Overall Study|Lost to Follow-up|2|||
27618580|NCT03785340|80449182|FG001|Overall Study|Lost to Follow-up|0|||
27618581|NCT03785340|80449181|FG000|Overall Study|Adverse Event|1|||
27618582|NCT03785340|80449182|FG001|Overall Study|Adverse Event|0|||
27618583|NCT02408549|80449183|FG000|Overall Study|Adverse Event|15|||
27618584|NCT02408549|80449183|FG000|Overall Study|Death|4|||
27618585|NCT02408549|80449183|FG000|Overall Study|Lack of Efficacy|17|||
27618586|NCT02408549|80449183|FG000|Overall Study|Protocol Violation|4|||
27618587|NCT02408549|80449183|FG000|Overall Study|Lost to Follow-up|6|||
27618588|NCT02408549|80449183|FG000|Overall Study|Consent withdrawn|30|||
27853890|NCT01550744|81295196|FG001|Open-Label|Protocol Violation|0|||
27853891|NCT01550744|81295197|FG002|Open-Label|Protocol Violation|0|||
27853892|NCT01550744|81295195|FG000|Open-Label|Not all 3 study drug injections received|2|||
27618589|NCT02408549|80449183|FG000|Overall Study|Neurology research program closing at site|1|||
27618590|NCT02408549|80449183|FG000|Overall Study|Site closure|1|||
27618591|NCT02408549|80449183|FG000|Overall Study|Pregnancy|1|||
27618592|NCT02408549|80449183|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
27618593|NCT02408549|80449183|FG000|Overall Study|Subject moved to another place, far from site|1|||
27853893|NCT01550744|81295196|FG001|Open-Label|Not all 3 study drug injections received|0|||
27618594|NCT02408549|80449183|FG000|Overall Study|Study terminated at site|1|||
27618595|NCT05114590|80449187|FG000|Overall Study|Adverse Event|1|||
27618596|NCT05114590|80449187|FG000|Overall Study|Investigator decision|1|||
27618597|NCT05114590|80449187|FG000|Overall Study|Lost to Follow-up|5|||
27618598|NCT05114590|80449187|FG000|Overall Study|Withdrawal by Subject|5|||
27618599|NCT05114590|80449187|FG000|Overall Study|Other|2|||
27618600|NCT01782326|80449188|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
27618601|NCT01782326|80449189|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
27618602|NCT01782326|80449188|FG000|Planned Treatment Epoch|Death|29|||
27618603|NCT01782326|80449189|FG001|Planned Treatment Epoch|Death|30|||
27618604|NCT01782326|80449188|FG000|Planned Treatment Epoch|Physician Decision|18|||
27618605|NCT01782326|80449189|FG001|Planned Treatment Epoch|Physician Decision|16|||
27618606|NCT01782326|80449188|FG000|Planned Treatment Epoch|Protocol deviation|2|||
27618607|NCT01782326|80449189|FG001|Planned Treatment Epoch|Protocol deviation|3|||
27853894|NCT01550744|81295197|FG002|Open-Label|Not all 3 study drug injections received|0|||
27618608|NCT01782326|80449188|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
27618609|NCT01782326|80449189|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
27618610|NCT01782326|80449188|FG000|Planned Treatment Epoch|Technical problems|0|||
27618611|NCT01782326|80449189|FG001|Planned Treatment Epoch|Technical problems|4|||
27618612|NCT01782326|80449188|FG000|Double-blind Treatment|Adverse Event|129|||
27618613|NCT01782326|80449189|FG001|Double-blind Treatment|Adverse Event|145|||
27618614|NCT01782326|80449188|FG000|Double-blind Treatment|Subject/guardian decision|111|||
27618615|NCT01782326|80449189|FG001|Double-blind Treatment|Subject/guardian decision|125|||
27618616|NCT01782326|80449188|FG000|Double-blind Treatment|Lack of Efficacy|17|||
27618617|NCT01782326|80449189|FG001|Double-blind Treatment|Lack of Efficacy|22|||
27618618|NCT01782326|80449188|FG000|Double-blind Treatment|Physician Decision|13|||
27618619|NCT01782326|80449189|FG001|Double-blind Treatment|Physician Decision|16|||
27618620|NCT01782326|80449188|FG000|Double-blind Treatment|Protocol deviation|8|||
27618621|NCT01782326|80449189|FG001|Double-blind Treatment|Protocol deviation|7|||
27618622|NCT01782326|80449188|FG000|Double-blind Treatment|Technical problems|0|||
27618623|NCT01782326|80449189|FG001|Double-blind Treatment|Technical problems|5|||
27518523|NCT00490529|80091886|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
27518524|NCT02350764|80091892|FG000|Overall Study|Adverse Event|4|||
27518525|NCT02350764|80091892|FG000|Overall Study|Death|3|||
27518526|NCT02350764|80091892|FG000|Overall Study|Physician Decision|2|||
27618624|NCT03712098|80449190|FG000|Overall Study|Lost to Follow-up|3|||
27618625|NCT03712098|80449191|FG001|Overall Study|Lost to Follow-up|7|||
27618626|NCT03712098|80449190|FG000|Overall Study|Withdrawal by Subject|9|||
27618627|NCT03712098|80449191|FG001|Overall Study|Withdrawal by Subject|4|||
27618628|NCT03712098|80449190|FG000|Overall Study|Protocol Violation|2|||
27618629|NCT03712098|80449191|FG001|Overall Study|Protocol Violation|1|||
27618630|NCT04012814|80449192|FG000|Overall Study|Lost to Follow-up|4|||
27518527|NCT02350764|80091892|FG000|Overall Study|Withdrawal by Subject|2|||
27518528|NCT01715857|80091893|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
27518529|NCT02878798|80091894|FG000|Overall Study|Withdrawal by Subject|5|||
27518530|NCT02878798|80091895|FG001|Overall Study|Withdrawal by Subject|4|||
27518531|NCT02878798|80091894|FG000|Overall Study|Lost to Follow-up|2|||
27518532|NCT02878798|80091895|FG001|Overall Study|Lost to Follow-up|2|||
27518533|NCT02878798|80091894|FG000|Overall Study|Protocol Violation|0|||
27518534|NCT02878798|80091895|FG001|Overall Study|Protocol Violation|1|||
27518535|NCT01227018|80091896|FG000|Overall Study|Disease progression|9|||
27518536|NCT01227018|80091896|FG000|Overall Study|Toxicity|2|||
27518537|NCT01227018|80091896|FG000|Overall Study|Withdrew after beginning treatment|4|||
27518538|NCT02855541|80091897|FG000|Overall Study|Change in health status|2|||
27518539|NCT02855541|80091897|FG000|Overall Study|Withdrawal by Subject|2|||
27518540|NCT00777153|80091898|FG000|Overall Study|Lost to Follow-up|1|||
27518541|NCT00777153|80091899|FG001|Overall Study|Lost to Follow-up|1|||
27518542|NCT00777153|80091900|FG002|Overall Study|Lost to Follow-up|0|||
27518543|NCT00777153|80091898|FG000|Overall Study|Death|85|||
27518544|NCT00777153|80091899|FG001|Overall Study|Death|73|||
27518545|NCT00777153|80091900|FG002|Overall Study|Death|33|||
27518546|NCT00777153|80091898|FG000|Overall Study|Withdrawal by Subject|3|||
27518547|NCT00777153|80091899|FG001|Overall Study|Withdrawal by Subject|4|||
27518548|NCT00777153|80091900|FG002|Overall Study|Withdrawal by Subject|3|||
27518549|NCT00777153|80091898|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
27518550|NCT00777153|80091899|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
27518551|NCT00777153|80091900|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
27518552|NCT00874939|80091901|FG000|Overall Study|Study terminated|4|||
27518553|NCT00545272|80091902|FG000|Overall Study|Protocol deviation|0|||
27518554|NCT00545272|80091903|FG001|Overall Study|Protocol deviation|1|||
27518555|NCT00545272|80091904|FG002|Overall Study|Protocol deviation|0|||
27518556|NCT00545272|80091905|FG003|Overall Study|Protocol deviation|1|||
27518557|NCT00545272|80091906|FG004|Overall Study|Protocol deviation|0|||
27518558|NCT00545272|80091907|FG005|Overall Study|Protocol deviation|1|||
27618631|NCT04012814|80449192|FG000|Overall Study|Withdrawal by Subject|2|||
27618632|NCT04012814|80449192|FG000|Overall Study|Protocol Violation|1|||
27618633|NCT04012814|80449192|FG000|Overall Study|Adverse Event|1|||
27618634|NCT03909165|80449199|FG000|Overall Study|Physician Decision|0|||
27618635|NCT03909165|80449200|FG001|Overall Study|Physician Decision|1|||
27618636|NCT03909165|80449201|FG002|Overall Study|Physician Decision|0|||
27618637|NCT03909165|80449202|FG003|Overall Study|Physician Decision|0|||
27618638|NCT03909165|80449203|FG004|Overall Study|Physician Decision|0|||
27618639|NCT03909165|80449199|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27618640|NCT03909165|80449200|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27518559|NCT00545272|80091902|FG000|Overall Study|Adverse Event|0|||
27518560|NCT00545272|80091903|FG001|Overall Study|Adverse Event|0|||
27518561|NCT00545272|80091904|FG002|Overall Study|Adverse Event|1|||
27518562|NCT00545272|80091905|FG003|Overall Study|Adverse Event|0|||
27618641|NCT03909165|80449201|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27518563|NCT00545272|80091906|FG004|Overall Study|Adverse Event|0|||
27518564|NCT00545272|80091907|FG005|Overall Study|Adverse Event|1|||
27518565|NCT00545272|80091902|FG000|Overall Study|Abnormal laboratory value(s)|0|||
27518566|NCT00545272|80091903|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27518567|NCT00545272|80091904|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27518568|NCT00545272|80091905|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27518569|NCT00545272|80091906|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27618642|NCT03909165|80449202|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27618643|NCT03909165|80449203|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
27618644|NCT03909165|80449199|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
27618645|NCT03909165|80449200|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
27618646|NCT03909165|80449201|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
27618647|NCT03909165|80449202|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
27618648|NCT03909165|80449203|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
27618649|NCT03909165|80449199|FG000|Overall Study|Previous Drug Exposure|0|||
27618650|NCT03909165|80449200|FG001|Overall Study|Previous Drug Exposure|0|||
27618651|NCT03909165|80449201|FG002|Overall Study|Previous Drug Exposure|1|||
27618652|NCT03909165|80449202|FG003|Overall Study|Previous Drug Exposure|0|||
27618653|NCT03909165|80449203|FG004|Overall Study|Previous Drug Exposure|0|||
27618654|NCT03909165|80449199|FG000|Overall Study|Early Discharge|1|||
27618655|NCT03909165|80449200|FG001|Overall Study|Early Discharge|0|||
27618656|NCT03909165|80449201|FG002|Overall Study|Early Discharge|0|||
27618657|NCT03909165|80449202|FG003|Overall Study|Early Discharge|0|||
27618658|NCT03909165|80449203|FG004|Overall Study|Early Discharge|0|||
27618659|NCT01318811|80449208|FG000|Overall Study|Physician Decision|1|||
27618660|NCT01318811|80449209|FG001|Overall Study|Physician Decision|1|||
27618661|NCT01318811|80449208|FG000|Overall Study|CRRT stopped for head CT|0|||
27618662|NCT01318811|80449209|FG001|Overall Study|CRRT stopped for head CT|1|||
27618663|NCT01318811|80449208|FG000|Overall Study|Death|0|||
27618664|NCT01318811|80449209|FG001|Overall Study|Death|1|||
27618665|NCT01318811|80449208|FG000|Overall Study|CRRT stopped for head MRI|0|||
27618666|NCT01318811|80449209|FG001|Overall Study|CRRT stopped for head MRI|1|||
27518570|NCT00545272|80091907|FG005|Overall Study|Abnormal laboratory value(s)|1|||
27518571|NCT00545272|80091902|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27518572|NCT00545272|80091903|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27618667|NCT00901485|80449210|FG000|Overall Study|Lack of Efficacy|0|||
27618668|NCT00901485|80449211|FG001|Overall Study|Lack of Efficacy|2|||
27618669|NCT00901485|80449210|FG000|Overall Study|Withdrawal by Subject|1|||
27618670|NCT00901485|80449211|FG001|Overall Study|Withdrawal by Subject|2|||
27618671|NCT01767129|80449214|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
27618672|NCT01767129|80449215|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
27618673|NCT02554513|80449218|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
27618674|NCT02554513|80449219|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
27618675|NCT00813488|80449220|FG000|Titration Period 1|Adverse Event|6|||
27618676|NCT00813488|80449221|FG001|Titration Period 1|Adverse Event|1|||
27618677|NCT00813488|80449220|FG000|Titration Period 1|Lack of Efficacy|9|||
27908274|NCT02942277|81500597|FG002|Year 1|Subject met withdrawal criteria|0|||
27908275|NCT02942277|81500598|FG003|Year 1|Subject met withdrawal criteria|1|||
27618678|NCT00813488|80449221|FG001|Titration Period 1|Lack of Efficacy|7|||
27618679|NCT00813488|80449220|FG000|Titration Period 1|Withdrawal by Subject|2|||
27618680|NCT00813488|80449221|FG001|Titration Period 1|Withdrawal by Subject|2|||
27618681|NCT00813488|80449220|FG000|Titration Period 1|Protocol Violation|4|||
27618682|NCT00813488|80449221|FG001|Titration Period 1|Protocol Violation|3|||
27618683|NCT00813488|80449220|FG000|Titration Period 1|Non-compliance to study medication|4|||
27618684|NCT00813488|80449221|FG001|Titration Period 1|Non-compliance to study medication|1|||
27618685|NCT00813488|80449220|FG000|Titration Period 1|Non-compliance to study procedures|2|||
27618686|NCT00813488|80449221|FG001|Titration Period 1|Non-compliance to study procedures|2|||
27618687|NCT00813488|80449220|FG000|Titration Period 1|Technical Difficulties|0|||
27618688|NCT00813488|80449221|FG001|Titration Period 1|Technical Difficulties|1|||
27618689|NCT00813488|80449220|FG000|Titration Period 2|Adverse Event|2|||
27618690|NCT00813488|80449221|FG001|Titration Period 2|Adverse Event|3|||
27618691|NCT00813488|80449220|FG000|Titration Period 2|Lack of Efficacy|8|||
27618692|NCT00813488|80449221|FG001|Titration Period 2|Lack of Efficacy|4|||
27618693|NCT00813488|80449220|FG000|Titration Period 2|Protocol Violation|3|||
27618694|NCT00813488|80449221|FG001|Titration Period 2|Protocol Violation|2|||
27618695|NCT00813488|80449220|FG000|Titration Period 2|Lost to Follow-up|1|||
27618696|NCT00813488|80449221|FG001|Titration Period 2|Lost to Follow-up|0|||
27908276|NCT02942277|81500599|FG004|Year 1|Subject met withdrawal criteria|0|||
27908277|NCT02942277|81500600|FG005|Year 1|Subject met withdrawal criteria|0|||
27518573|NCT00545272|80091904|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27618697|NCT00813488|80449220|FG000|Titration Period 2|Non-compliance with study procedures|2|||
27618698|NCT00813488|80449221|FG001|Titration Period 2|Non-compliance with study procedures|1|||
27618699|NCT00813488|80449220|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
27618700|NCT00813488|80449221|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
27618701|NCT00813488|80449220|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
27908278|NCT02942277|81500601|FG006|Year 1|Subject met withdrawal criteria|0|||
27908279|NCT02942277|81500602|FG007|Year 1|Subject met withdrawal criteria|0|||
27908280|NCT02942277|81500603|FG008|Year 1|Subject met withdrawal criteria|0|||
27908281|NCT02942277|81500604|FG009|Year 1|Subject met withdrawal criteria|0|||
27908282|NCT02942277|81500605|FG010|Year 1|Subject met withdrawal criteria|0|||
27908283|NCT02942277|81500595|FG000|Year 1|Lost to Follow-up|0|||
27908284|NCT02942277|81500596|FG001|Year 1|Lost to Follow-up|0|||
27908285|NCT02942277|81500597|FG002|Year 1|Lost to Follow-up|0|||
27908286|NCT02942277|81500598|FG003|Year 1|Lost to Follow-up|0|||
27908287|NCT02942277|81500599|FG004|Year 1|Lost to Follow-up|1|||
27908288|NCT02942277|81500600|FG005|Year 1|Lost to Follow-up|0|||
27908289|NCT02942277|81500601|FG006|Year 1|Lost to Follow-up|0|||
27908290|NCT02942277|81500602|FG007|Year 1|Lost to Follow-up|0|||
27908291|NCT02942277|81500603|FG008|Year 1|Lost to Follow-up|0|||
27908292|NCT02942277|81500604|FG009|Year 1|Lost to Follow-up|0|||
27908293|NCT02942277|81500605|FG010|Year 1|Lost to Follow-up|2|||
27908294|NCT02942277|81500595|FG000|Year 1|Protocol Violation|0|||
27908295|NCT02942277|81500596|FG001|Year 1|Protocol Violation|0|||
27908296|NCT02942277|81500597|FG002|Year 1|Protocol Violation|0|||
27908297|NCT02942277|81500598|FG003|Year 1|Protocol Violation|0|||
27908298|NCT02942277|81500599|FG004|Year 1|Protocol Violation|1|||
27518574|NCT00545272|80091905|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27518575|NCT00545272|80091906|FG004|Overall Study|Abnormal test procedure result(s)|1|||
27518576|NCT00545272|80091907|FG005|Overall Study|Abnormal test procedure result(s)|0|||
27518577|NCT00545272|80091902|FG000|Overall Study|Lost to Follow-up|0|||
27518578|NCT00545272|80091903|FG001|Overall Study|Lost to Follow-up|0|||
27618702|NCT00813488|80449221|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
27618703|NCT00813488|80449220|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
27618704|NCT00813488|80449221|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
27618705|NCT00813488|80449220|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
27618706|NCT00813488|80449221|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
27618707|NCT00813488|80449220|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
27618708|NCT00813488|80449221|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
27908299|NCT02942277|81500600|FG005|Year 1|Protocol Violation|1|||
27908300|NCT02942277|81500601|FG006|Year 1|Protocol Violation|0|||
27518579|NCT00545272|80091904|FG002|Overall Study|Lost to Follow-up|0|||
27518580|NCT00545272|80091905|FG003|Overall Study|Lost to Follow-up|0|||
27518581|NCT00545272|80091906|FG004|Overall Study|Lost to Follow-up|1|||
27518582|NCT00545272|80091907|FG005|Overall Study|Lost to Follow-up|0|||
27518583|NCT00612807|80091910|FG000|Overall Study|Withdrawal by Subject|2|||
27518584|NCT00612807|80091911|FG001|Overall Study|Withdrawal by Subject|0|||
27518585|NCT00776919|80091912|FG000|Overall Study|Withdrawal by Subject|16|||
27518586|NCT00776919|80091913|FG001|Overall Study|Withdrawal by Subject|14|||
27518587|NCT00776919|80091914|FG002|Overall Study|Withdrawal by Subject|15|||
27518588|NCT00776919|80091915|FG003|Overall Study|Withdrawal by Subject|26|||
27518589|NCT00776919|80091912|FG000|Overall Study|Lost to Follow-up|8|||
27518590|NCT00776919|80091913|FG001|Overall Study|Lost to Follow-up|12|||
27908301|NCT02942277|81500602|FG007|Year 1|Protocol Violation|0|||
27908302|NCT02942277|81500603|FG008|Year 1|Protocol Violation|0|||
27908303|NCT02942277|81500604|FG009|Year 1|Protocol Violation|0|||
27908304|NCT02942277|81500605|FG010|Year 1|Protocol Violation|2|||
27908305|NCT02942277|81500595|FG000|Year 1|Pregnancy|0|||
27908306|NCT02942277|81500596|FG001|Year 1|Pregnancy|0|||
27908307|NCT02942277|81500597|FG002|Year 1|Pregnancy|0|||
27908308|NCT02942277|81500598|FG003|Year 1|Pregnancy|0|||
27908309|NCT02942277|81500599|FG004|Year 1|Pregnancy|0|||
27908310|NCT02942277|81500600|FG005|Year 1|Pregnancy|1|||
27908311|NCT02942277|81500601|FG006|Year 1|Pregnancy|0|||
27518591|NCT00776919|80091914|FG002|Overall Study|Lost to Follow-up|11|||
27518592|NCT00776919|80091915|FG003|Overall Study|Lost to Follow-up|8|||
27908312|NCT02942277|81500602|FG007|Year 1|Pregnancy|0|||
27908313|NCT02942277|81500603|FG008|Year 1|Pregnancy|0|||
27618709|NCT00813488|80449220|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
27618710|NCT00813488|80449221|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
27618711|NCT00813488|80449220|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
27618712|NCT00813488|80449221|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
27618713|NCT00813488|80449220|FG000|Double-blind Treatment Period 2|Other|1|||
27618714|NCT00813488|80449221|FG001|Double-blind Treatment Period 2|Other|0|||
27618715|NCT00813488|80449220|FG000|Open-label Extension|Adverse Event|1|||
27618716|NCT00813488|80449221|FG001|Open-label Extension|Adverse Event|2|||
27618717|NCT00813488|80449220|FG000|Open-label Extension|Lack of Efficacy|3|||
27618718|NCT00813488|80449221|FG001|Open-label Extension|Lack of Efficacy|0|||
27618719|NCT00813488|80449220|FG000|Open-label Extension|Withdrawal by Subject|0|||
27618720|NCT00813488|80449221|FG001|Open-label Extension|Withdrawal by Subject|2|||
27618721|NCT00813488|80449220|FG000|Open-label Extension|Protocol Violation|1|||
27618722|NCT00813488|80449221|FG001|Open-label Extension|Protocol Violation|2|||
27618723|NCT00813488|80449220|FG000|Open-label Extension|Non-compliance study medication|4|||
27618724|NCT00813488|80449221|FG001|Open-label Extension|Non-compliance study medication|0|||
27618725|NCT00813488|80449220|FG000|Open-label Extension|Non-compliance study procedures|2|||
27618726|NCT00813488|80449221|FG001|Open-label Extension|Non-compliance study procedures|1|||
27618727|NCT00813488|80449220|FG000|Open-label Extension|Other|1|||
27618728|NCT00813488|80449221|FG001|Open-label Extension|Other|0|||
27618729|NCT00504348|80449222|FG000|Overall Study|Adverse Event|3|||
27618730|NCT00504348|80449222|FG000|Overall Study|Lack of Efficacy|4|||
27618731|NCT00504348|80449222|FG000|Overall Study|Physician Decision|1|||
27618732|NCT00680056|80449249|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
27518593|NCT00776919|80091912|FG000|Overall Study|Adverse Event|1|||
27518594|NCT00776919|80091913|FG001|Overall Study|Adverse Event|0|||
27518595|NCT00776919|80091914|FG002|Overall Study|Adverse Event|2|||
27518596|NCT00776919|80091915|FG003|Overall Study|Adverse Event|2|||
27518597|NCT00776919|80091912|FG000|Overall Study|Protocol Violation|1|||
27518598|NCT00776919|80091913|FG001|Overall Study|Protocol Violation|2|||
27518599|NCT00776919|80091914|FG002|Overall Study|Protocol Violation|0|||
27518600|NCT00776919|80091915|FG003|Overall Study|Protocol Violation|1|||
27518601|NCT00776919|80091912|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
27518602|NCT00776919|80091913|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
27518603|NCT00776919|80091914|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
27518604|NCT00776919|80091915|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
27518605|NCT03805659|80091916|FG000|Overall Study|Withdrawal by Subject|0|||
27518606|NCT03805659|80091917|FG001|Overall Study|Withdrawal by Subject|1|||
27518607|NCT01761162|80091919|FG000|Overall Study|Withdrawal by Subject|3|||
27518608|NCT03087617|80091920|FG000|Overall Study|Lost to Follow-up|32|||
27518609|NCT03087617|80091921|FG001|Overall Study|Lost to Follow-up|30|||
27518610|NCT03087617|80091922|FG002|Overall Study|Lost to Follow-up|30|||
27518611|NCT03087617|80091923|FG003|Overall Study|Lost to Follow-up|39|||
27518612|NCT04364984|80091925|FG000|Overall Study|Death|2|||
27518613|NCT04364984|80091926|FG001|Overall Study|Death|2|||
27518614|NCT04364984|80091927|FG002|Overall Study|Death|0|||
27518615|NCT01311024|80091930|FG000|Overall Study|Protocol Violation|35|||
27518616|NCT01311024|80091931|FG001|Overall Study|Protocol Violation|22|||
27518617|NCT01541397|80091932|FG000|Overall Study|Study ended prior to data collection|4|||
27518618|NCT01541397|80091933|FG001|Overall Study|Study ended prior to data collection|2|||
27518619|NCT00773838|80091936|FG000|Overall Study|Adverse Event|29|||
27518620|NCT00773838|80091936|FG000|Overall Study|Lost to Follow-up|1|||
27518621|NCT00773838|80091936|FG000|Overall Study|Physician Decision|8|||
27518622|NCT00773838|80091936|FG000|Overall Study|Progressive Disease|82|||
27518623|NCT00773838|80091936|FG000|Overall Study|Protocol Violation|2|||
27518624|NCT00773838|80091936|FG000|Overall Study|Withdrawal by Subject|21|||
27518625|NCT01978938|80091937|FG000|Overall Study|Lost to Follow-up|12|||
27518626|NCT01978938|80091938|FG001|Overall Study|Lost to Follow-up|6|||
27518627|NCT01978938|80091937|FG000|Overall Study|Withdrawal by Subject|8|||
27618733|NCT00680056|80449250|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
27618734|NCT00680056|80449249|FG000|Second Intervention|Protocol Violation|3|||
27618735|NCT00680056|80449250|FG001|Second Intervention|Protocol Violation|1|||
27618736|NCT03699124|80449256|FG000|Overall Study|Adverse Event|6|||
27518628|NCT01978938|80091938|FG001|Overall Study|Withdrawal by Subject|4|||
27518629|NCT01978938|80091937|FG000|Overall Study|Adverse Event, non-fatal|2|||
27518630|NCT01978938|80091938|FG001|Overall Study|Adverse Event, non-fatal|1|||
27518631|NCT01978938|80091937|FG000|Overall Study|Participant noncompliance|1|||
27518632|NCT01978938|80091938|FG001|Overall Study|Participant noncompliance|1|||
27518633|NCT01978938|80091937|FG000|Overall Study|Did not meet inclusion criteria|0|||
27518634|NCT01978938|80091938|FG001|Overall Study|Did not meet inclusion criteria|1|||
27908314|NCT02942277|81500604|FG009|Year 1|Pregnancy|0|||
27518635|NCT01978938|80091937|FG000|Overall Study|Previously scheduled procedure|0|||
27730401|NCT01756456|80842704|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
27730402|NCT01756456|80842699|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27730403|NCT01756456|80842700|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27730404|NCT01756456|80842701|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27730405|NCT01756456|80842702|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
27908315|NCT02942277|81500605|FG010|Year 1|Pregnancy|0|||
27908316|NCT02942277|81500595|FG000|Year 2|Lost to Follow-up|0|||
27908317|NCT02942277|81500596|FG001|Year 2|Lost to Follow-up|0|||
27908318|NCT02942277|81500597|FG002|Year 2|Lost to Follow-up|0|||
27908319|NCT02942277|81500598|FG003|Year 2|Lost to Follow-up|0|||
27908320|NCT02942277|81500599|FG004|Year 2|Lost to Follow-up|2|||
27908321|NCT02942277|81500600|FG005|Year 2|Lost to Follow-up|1|||
27908322|NCT02942277|81500601|FG006|Year 2|Lost to Follow-up|0|||
27908323|NCT02942277|81500602|FG007|Year 2|Lost to Follow-up|0|||
27730406|NCT01756456|80842703|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
27730407|NCT01756456|80842704|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
27730408|NCT01756456|80842699|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27730409|NCT01756456|80842700|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
27730410|NCT01756456|80842701|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27730411|NCT01756456|80842702|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27730412|NCT01756456|80842703|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27730413|NCT01756456|80842704|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
27730414|NCT01756456|80842699|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
27730415|NCT01756456|80842700|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
27908324|NCT02942277|81500603|FG008|Year 2|Lost to Follow-up|0|||
27908325|NCT02942277|81500604|FG009|Year 2|Lost to Follow-up|0|||
27908326|NCT02942277|81500605|FG010|Year 2|Lost to Follow-up|0|||
27618737|NCT03699124|80449257|FG001|Overall Study|Adverse Event|5|||
27618738|NCT03699124|80449258|FG002|Overall Study|Adverse Event|2|||
27618739|NCT03699124|80449256|FG000|Overall Study|Death|0|||
27618740|NCT03699124|80449257|FG001|Overall Study|Death|2|||
27618741|NCT03699124|80449258|FG002|Overall Study|Death|0|||
27618742|NCT03699124|80449256|FG000|Overall Study|Lost to Follow-up|20|||
27618743|NCT03699124|80449257|FG001|Overall Study|Lost to Follow-up|16|||
27618744|NCT03699124|80449258|FG002|Overall Study|Lost to Follow-up|15|||
27618745|NCT03699124|80449256|FG000|Overall Study|Protocol Violation|1|||
27618746|NCT03699124|80449257|FG001|Overall Study|Protocol Violation|0|||
27908327|NCT02942277|81500595|FG000|Year 2|Did not rescreen|0|||
27908328|NCT02942277|81500596|FG001|Year 2|Did not rescreen|0|||
27908329|NCT02942277|81500597|FG002|Year 2|Did not rescreen|1|||
27908330|NCT02942277|81500598|FG003|Year 2|Did not rescreen|1|||
27908331|NCT02942277|81500599|FG004|Year 2|Did not rescreen|9|||
27518636|NCT01978938|80091938|FG001|Overall Study|Previously scheduled procedure|1|||
27518637|NCT01024309|80091939|FG000|Overall Study|Physician Decision|4|||
27518638|NCT01024309|80091940|FG001|Overall Study|Physician Decision|0|||
27518639|NCT01024309|80091939|FG000|Overall Study|Withdrawal by Subject|4|||
27518640|NCT01024309|80091940|FG001|Overall Study|Withdrawal by Subject|4|||
27518641|NCT01124864|80091943|FG000|Overall Study|Follow up phase competed as per protocol|18|||
27518642|NCT01124864|80091944|FG001|Overall Study|Follow up phase competed as per protocol|22|||
27518643|NCT01124864|80091945|FG002|Overall Study|Follow up phase competed as per protocol|24|||
27518644|NCT01124864|80091946|FG003|Overall Study|Follow up phase competed as per protocol|18|||
27518645|NCT01124864|80091947|FG004|Overall Study|Follow up phase competed as per protocol|26|||
27518646|NCT01124864|80091948|FG005|Overall Study|Follow up phase competed as per protocol|2|||
27518647|NCT01124864|80091943|FG000|Overall Study|Death|6|||
27518648|NCT01124864|80091944|FG001|Overall Study|Death|9|||
27518649|NCT01124864|80091945|FG002|Overall Study|Death|6|||
27618747|NCT03699124|80449258|FG002|Overall Study|Protocol Violation|0|||
27618748|NCT03699124|80449256|FG000|Overall Study|Withdrawal by Subject|13|||
27618749|NCT03699124|80449257|FG001|Overall Study|Withdrawal by Subject|14|||
27618750|NCT03699124|80449258|FG002|Overall Study|Withdrawal by Subject|13|||
27618751|NCT03699124|80449256|FG000|Overall Study|Other reasons|5|||
27730416|NCT01756456|80842701|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
27730417|NCT01756456|80842702|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
27730418|NCT01756456|80842703|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
27730419|NCT01756456|80842704|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
27730420|NCT01756456|80842699|FG000|Treatment Period: Phase I/II|Other causes|0|||
27908332|NCT02942277|81500600|FG005|Year 2|Did not rescreen|6|||
27908333|NCT02942277|81500601|FG006|Year 2|Did not rescreen|0|||
27908334|NCT02942277|81500602|FG007|Year 2|Did not rescreen|1|||
27518650|NCT01124864|80091946|FG003|Overall Study|Death|2|||
27908335|NCT02942277|81500603|FG008|Year 2|Did not rescreen|0|||
27908336|NCT02942277|81500604|FG009|Year 2|Did not rescreen|0|||
27518651|NCT01124864|80091947|FG004|Overall Study|Death|1|||
27908337|NCT02942277|81500605|FG010|Year 2|Did not rescreen|21|||
27518652|NCT01124864|80091948|FG005|Overall Study|Death|0|||
27618752|NCT03699124|80449257|FG001|Overall Study|Other reasons|3|||
27908338|NCT02942277|81500595|FG000|Year 2|Met withdrawal criteria|0|||
27908339|NCT02942277|81500596|FG001|Year 2|Met withdrawal criteria|0|||
27908340|NCT02942277|81500597|FG002|Year 2|Met withdrawal criteria|0|||
27908341|NCT02942277|81500598|FG003|Year 2|Met withdrawal criteria|0|||
27908342|NCT02942277|81500599|FG004|Year 2|Met withdrawal criteria|1|||
27908343|NCT02942277|81500600|FG005|Year 2|Met withdrawal criteria|2|||
27908344|NCT02942277|81500601|FG006|Year 2|Met withdrawal criteria|0|||
27908345|NCT02942277|81500602|FG007|Year 2|Met withdrawal criteria|0|||
27908346|NCT02942277|81500603|FG008|Year 2|Met withdrawal criteria|0|||
27908347|NCT02942277|81500604|FG009|Year 2|Met withdrawal criteria|0|||
27908348|NCT02942277|81500605|FG010|Year 2|Met withdrawal criteria|1|||
27908349|NCT02942277|81500595|FG000|Year 2|Travel|0|||
27518653|NCT01124864|80091943|FG000|Overall Study|Withdrawal by Subject|2|||
27518654|NCT01124864|80091944|FG001|Overall Study|Withdrawal by Subject|3|||
27518655|NCT01124864|80091945|FG002|Overall Study|Withdrawal by Subject|4|||
27518656|NCT01124864|80091946|FG003|Overall Study|Withdrawal by Subject|0|||
27518657|NCT01124864|80091947|FG004|Overall Study|Withdrawal by Subject|2|||
27518658|NCT01124864|80091948|FG005|Overall Study|Withdrawal by Subject|1|||
27518659|NCT01124864|80091943|FG000|Overall Study|Lost to Follow-up|1|||
27518660|NCT01124864|80091944|FG001|Overall Study|Lost to Follow-up|1|||
27518661|NCT01124864|80091945|FG002|Overall Study|Lost to Follow-up|0|||
27518662|NCT01124864|80091946|FG003|Overall Study|Lost to Follow-up|1|||
27518663|NCT01124864|80091947|FG004|Overall Study|Lost to Follow-up|0|||
27518664|NCT01124864|80091948|FG005|Overall Study|Lost to Follow-up|0|||
27518665|NCT01124864|80091943|FG000|Overall Study|Protocol Violation|1|||
27518666|NCT01124864|80091944|FG001|Overall Study|Protocol Violation|0|||
27518667|NCT01124864|80091945|FG002|Overall Study|Protocol Violation|0|||
27518668|NCT01124864|80091946|FG003|Overall Study|Protocol Violation|0|||
27518669|NCT01124864|80091947|FG004|Overall Study|Protocol Violation|1|||
27518670|NCT01124864|80091948|FG005|Overall Study|Protocol Violation|0|||
27518671|NCT00689117|80091949|FG000|Overall Study|Adverse Event|6|||
27518672|NCT00689117|80091950|FG001|Overall Study|Adverse Event|0|||
27518673|NCT00689117|80091951|FG002|Overall Study|Adverse Event|5|||
27518674|NCT00689117|80091952|FG003|Overall Study|Adverse Event|0|||
27518675|NCT00689117|80091949|FG000|Overall Study|Lost to Follow-up|26|||
27518676|NCT00689117|80091950|FG001|Overall Study|Lost to Follow-up|19|||
27518677|NCT00689117|80091951|FG002|Overall Study|Lost to Follow-up|17|||
27518678|NCT00689117|80091952|FG003|Overall Study|Lost to Follow-up|11|||
27518679|NCT00689117|80091949|FG000|Overall Study|Lack of Efficacy|1|||
27518680|NCT00689117|80091950|FG001|Overall Study|Lack of Efficacy|2|||
27518681|NCT00689117|80091951|FG002|Overall Study|Lack of Efficacy|2|||
27518682|NCT00689117|80091952|FG003|Overall Study|Lack of Efficacy|2|||
27518683|NCT00689117|80091949|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
27518684|NCT00689117|80091950|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
27518685|NCT00689117|80091951|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
27518686|NCT00689117|80091952|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
27518687|NCT00689117|80091949|FG000|Overall Study|Withdrawal by Subject|19|||
27518688|NCT00689117|80091950|FG001|Overall Study|Withdrawal by Subject|18|||
27518689|NCT00689117|80091951|FG002|Overall Study|Withdrawal by Subject|26|||
27518690|NCT00689117|80091952|FG003|Overall Study|Withdrawal by Subject|13|||
27518691|NCT00689117|80091949|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
27518692|NCT00689117|80091950|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
27518693|NCT00689117|80091951|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
27518694|NCT00689117|80091952|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
27518695|NCT00689117|80091949|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
27908350|NCT02942277|81500596|FG001|Year 2|Travel|1|||
27518696|NCT00689117|80091950|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
27518697|NCT00689117|80091951|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27518698|NCT00689117|80091952|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
27908351|NCT02942277|81500597|FG002|Year 2|Travel|0|||
27908352|NCT02942277|81500598|FG003|Year 2|Travel|0|||
27908353|NCT02942277|81500599|FG004|Year 2|Travel|0|||
27908354|NCT02942277|81500600|FG005|Year 2|Travel|1|||
27908355|NCT02942277|81500601|FG006|Year 2|Travel|0|||
27908356|NCT02942277|81500602|FG007|Year 2|Travel|0|||
27908357|NCT02942277|81500603|FG008|Year 2|Travel|0|||
27908358|NCT02942277|81500604|FG009|Year 2|Travel|1|||
27908359|NCT02942277|81500605|FG010|Year 2|Travel|3|||
27908360|NCT02942277|81500595|FG000|Year 2|Non-compliant|0|||
27908361|NCT02942277|81500596|FG001|Year 2|Non-compliant|0|||
27908362|NCT02942277|81500597|FG002|Year 2|Non-compliant|0|||
27908363|NCT02942277|81500598|FG003|Year 2|Non-compliant|0|||
27908364|NCT02942277|81500599|FG004|Year 2|Non-compliant|1|||
27518699|NCT00689117|80091949|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
27518700|NCT00689117|80091950|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
27518701|NCT00689117|80091951|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
27518702|NCT00689117|80091952|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
27518703|NCT00689117|80091949|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
27518704|NCT00689117|80091950|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
27518705|NCT00689117|80091951|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
27518706|NCT00689117|80091952|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
27518707|NCT00689117|80091949|FG000|Overall Study|Use of Prohibitive Medication|2|||
27518708|NCT00689117|80091950|FG001|Overall Study|Use of Prohibitive Medication|1|||
27518709|NCT00689117|80091951|FG002|Overall Study|Use of Prohibitive Medication|3|||
27518710|NCT00689117|80091952|FG003|Overall Study|Use of Prohibitive Medication|0|||
27518711|NCT00689117|80091949|FG000|Overall Study|Pregnancy|0|||
27518712|NCT00689117|80091950|FG001|Overall Study|Pregnancy|2|||
27518713|NCT00689117|80091951|FG002|Overall Study|Pregnancy|0|||
27518714|NCT00689117|80091952|FG003|Overall Study|Pregnancy|2|||
27518715|NCT00689117|80091949|FG000|Overall Study|Incarceration|2|||
27518716|NCT00689117|80091950|FG001|Overall Study|Incarceration|0|||
27518717|NCT00689117|80091951|FG002|Overall Study|Incarceration|0|||
27518718|NCT00689117|80091952|FG003|Overall Study|Incarceration|0|||
27518719|NCT00689117|80091949|FG000|Overall Study|Fear of Birth Defects|0|||
27518720|NCT00689117|80091950|FG001|Overall Study|Fear of Birth Defects|0|||
27518721|NCT00689117|80091951|FG002|Overall Study|Fear of Birth Defects|1|||
27518722|NCT00689117|80091952|FG003|Overall Study|Fear of Birth Defects|0|||
27518723|NCT00689117|80091949|FG000|Overall Study|Transportation|1|||
27518724|NCT00689117|80091950|FG001|Overall Study|Transportation|0|||
27518725|NCT00689117|80091951|FG002|Overall Study|Transportation|0|||
27518726|NCT00689117|80091952|FG003|Overall Study|Transportation|0|||
27518727|NCT00689117|80091949|FG000|Overall Study|Patient Withdrew from Study|0|||
27518728|NCT00689117|80091950|FG001|Overall Study|Patient Withdrew from Study|0|||
27518729|NCT00689117|80091951|FG002|Overall Study|Patient Withdrew from Study|0|||
27518730|NCT00689117|80091952|FG003|Overall Study|Patient Withdrew from Study|1|||
27518731|NCT00689117|80091949|FG000|Overall Study|Personal Reason|0|||
27518732|NCT00689117|80091950|FG001|Overall Study|Personal Reason|1|||
27518733|NCT00689117|80091951|FG002|Overall Study|Personal Reason|0|||
27518734|NCT00689117|80091952|FG003|Overall Study|Personal Reason|0|||
27518735|NCT00689117|80091949|FG000|Overall Study|Dispensing Error|0|||
27518736|NCT00689117|80091950|FG001|Overall Study|Dispensing Error|1|||
27518737|NCT00689117|80091951|FG002|Overall Study|Dispensing Error|0|||
27518738|NCT00689117|80091952|FG003|Overall Study|Dispensing Error|0|||
27518739|NCT00486811|80091956|FG000|Overall Study|Adverse Event|28|||
27518740|NCT00486811|80091957|FG001|Overall Study|Adverse Event|60|||
27518741|NCT00486811|80091958|FG002|Overall Study|Adverse Event|135|||
27518742|NCT00486811|80091956|FG000|Overall Study|Lack of Efficacy|34|||
27518743|NCT00486811|80091957|FG001|Overall Study|Lack of Efficacy|14|||
27518744|NCT00486811|80091958|FG002|Overall Study|Lack of Efficacy|7|||
27518745|NCT00486811|80091956|FG000|Overall Study|Lost to Follow-up|4|||
27518746|NCT00486811|80091957|FG001|Overall Study|Lost to Follow-up|6|||
27518747|NCT00486811|80091958|FG002|Overall Study|Lost to Follow-up|4|||
27518748|NCT00486811|80091956|FG000|Overall Study|Withdrawal by Subject|33|||
27518749|NCT00486811|80091957|FG001|Overall Study|Withdrawal by Subject|44|||
27618753|NCT03699124|80449258|FG002|Overall Study|Other reasons|10|||
27908365|NCT02942277|81500600|FG005|Year 2|Non-compliant|1|||
27908366|NCT02942277|81500601|FG006|Year 2|Non-compliant|0|||
27908367|NCT02942277|81500602|FG007|Year 2|Non-compliant|0|||
27908368|NCT02942277|81500603|FG008|Year 2|Non-compliant|0|||
27518750|NCT00486811|80091958|FG002|Overall Study|Withdrawal by Subject|58|||
27518751|NCT00486811|80091956|FG000|Overall Study|Study drug non-compliant|5|||
27518752|NCT00486811|80091957|FG001|Overall Study|Study drug non-compliant|6|||
27518753|NCT00486811|80091958|FG002|Overall Study|Study drug non-compliant|3|||
27518754|NCT00486811|80091956|FG000|Overall Study|All other|18|||
27518755|NCT00486811|80091957|FG001|Overall Study|All other|11|||
27518756|NCT00486811|80091958|FG002|Overall Study|All other|7|||
27518757|NCT00095940|80091961|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
27518758|NCT00095940|80091962|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
27518759|NCT00095940|80091963|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
27518760|NCT00095940|80091964|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
27908369|NCT02942277|81500604|FG009|Year 2|Non-compliant|0|||
27908370|NCT02942277|81500605|FG010|Year 2|Non-compliant|0|||
27908371|NCT02942277|81500595|FG000|Year 2|Withdrawal by Subject|0|||
27618754|NCT00777803|80449261|FG000|Overall Study|Lost to Follow-up|12|||
27618755|NCT00777803|80449262|FG001|Overall Study|Lost to Follow-up|5|||
27618756|NCT00777803|80449261|FG000|Overall Study|Adverse Event|1|||
27618757|NCT00777803|80449262|FG001|Overall Study|Adverse Event|0|||
27618758|NCT00777803|80449261|FG000|Overall Study|Non-compliance|2|||
27618759|NCT00777803|80449262|FG001|Overall Study|Non-compliance|2|||
27618760|NCT03398356|80449269|FG000|Before Treatment|Lost to Follow-up|1|||
27618761|NCT03398356|80449270|FG001|Before Treatment|Lost to Follow-up|2|||
27618762|NCT03398356|80449271|FG002|Before Treatment|Lost to Follow-up|0|||
27618763|NCT03398356|80449269|FG000|Before Treatment|drug intolerance|2|||
27618764|NCT03398356|80449270|FG001|Before Treatment|drug intolerance|1|||
27618765|NCT03398356|80449271|FG002|Before Treatment|drug intolerance|0|||
27618766|NCT03398356|80449269|FG000|Before Treatment|Withdrawal by Subject|0|||
27618767|NCT03398356|80449270|FG001|Before Treatment|Withdrawal by Subject|5|||
27618768|NCT03398356|80449271|FG002|Before Treatment|Withdrawal by Subject|0|||
27618769|NCT03398356|80449269|FG000|Before Treatment|Physician Decision|0|||
27618770|NCT03398356|80449270|FG001|Before Treatment|Physician Decision|0|||
27618771|NCT03398356|80449271|FG002|Before Treatment|Physician Decision|11|||
27618772|NCT03398356|80449269|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
27618773|NCT03398356|80449270|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
27618774|NCT03398356|80449271|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
27618775|NCT03285711|80449272|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
27618776|NCT03285711|80449273|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
27618777|NCT03285711|80449274|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
27618778|NCT03285711|80449275|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
27618779|NCT03285711|80449272|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
27618780|NCT03285711|80449273|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
27618781|NCT03285711|80449274|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
27618782|NCT03285711|80449275|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
27618783|NCT03285711|80449272|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
27618784|NCT03285711|80449273|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
27618785|NCT03285711|80449274|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
27618786|NCT03285711|80449275|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
27618787|NCT03285711|80449272|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
27618788|NCT03285711|80449273|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
27618789|NCT03285711|80449274|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
27618790|NCT03285711|80449275|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
27618791|NCT00062868|80449276|FG000|Dose Level 1|Death|2|||
27618792|NCT00062868|80449277|FG001|Dose Level 1|Death|0|||
27618793|NCT00062868|80449278|FG002|Dose Level 1|Death|0|||
27618794|NCT00062868|80449279|FG003|Dose Level 1|Death|2|||
27618795|NCT00062868|80449280|FG004|Dose Level 1|Death|0|||
27618796|NCT00062868|80449281|FG005|Dose Level 1|Death|0|||
27618797|NCT00062868|80449282|FG006|Dose Level 1|Death|3|||
27618798|NCT00062868|80449283|FG007|Dose Level 1|Death|0|||
27618799|NCT00062868|80449284|FG008|Dose Level 1|Death|0|||
27730421|NCT01756456|80842700|FG001|Treatment Period: Phase I/II|Other causes|0|||
27730422|NCT01756456|80842701|FG002|Treatment Period: Phase I/II|Other causes|0|||
27730423|NCT01756456|80842702|FG003|Treatment Period: Phase I/II|Other causes|1|||
27730424|NCT01756456|80842703|FG004|Treatment Period: Phase I/II|Other causes|2|||
27730425|NCT01756456|80842704|FG005|Treatment Period: Phase I/II|Other causes|2|||
27730426|NCT01756456|80842699|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
27730427|NCT01756456|80842700|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
27853895|NCT01550744|81295195|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
27853896|NCT01550744|81295196|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
27853897|NCT01550744|81295197|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
27853898|NCT01550744|81295195|FG000|Open-Label|Other|1|||
27908372|NCT02942277|81500596|FG001|Year 2|Withdrawal by Subject|0|||
27908373|NCT02942277|81500597|FG002|Year 2|Withdrawal by Subject|0|||
27908374|NCT02942277|81500598|FG003|Year 2|Withdrawal by Subject|0|||
27908375|NCT02942277|81500599|FG004|Year 2|Withdrawal by Subject|0|||
27853899|NCT01550744|81295196|FG001|Open-Label|Other|0|||
27853900|NCT01550744|81295197|FG002|Open-Label|Other|0|||
27853901|NCT01550744|81295195|FG000|Double-Blind|Lost to Follow-up|0|||
27518761|NCT00095940|80091965|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
27618800|NCT00062868|80449285|FG009|Dose Level 1|Death|0|||
27618801|NCT00062868|80449286|FG010|Dose Level 1|Death|0|||
27730428|NCT01756456|80842701|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
27853902|NCT01550744|81295196|FG001|Double-Blind|Lost to Follow-up|6|||
27730429|NCT01756456|80842702|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
27908376|NCT02942277|81500600|FG005|Year 2|Withdrawal by Subject|0|||
27618802|NCT00062868|80449287|FG011|Dose Level 1|Death|0|||
27618803|NCT00062868|80449288|FG012|Dose Level 1|Death|0|||
27618804|NCT00062868|80449289|FG013|Dose Level 1|Death|0|||
27618805|NCT00062868|80449290|FG014|Dose Level 1|Death|0|||
27853903|NCT01550744|81295197|FG002|Double-Blind|Lost to Follow-up|12|||
27618806|NCT00062868|80449291|FG015|Dose Level 1|Death|0|||
27618807|NCT00062868|80449292|FG016|Dose Level 1|Death|0|||
27618808|NCT00062868|80449293|FG017|Dose Level 1|Death|0|||
27618809|NCT00062868|80449294|FG018|Dose Level 1|Death|7|||
27618810|NCT00062868|80449295|FG019|Dose Level 1|Death|0|||
27618811|NCT00062868|80449296|FG020|Dose Level 1|Death|1|||
27618812|NCT00062868|80449276|FG000|Dose Level 1|Lost to Follow-up|0|||
27618813|NCT00062868|80449277|FG001|Dose Level 1|Lost to Follow-up|0|||
27618814|NCT00062868|80449278|FG002|Dose Level 1|Lost to Follow-up|0|||
27618815|NCT00062868|80449279|FG003|Dose Level 1|Lost to Follow-up|0|||
27618816|NCT00062868|80449280|FG004|Dose Level 1|Lost to Follow-up|0|||
27618817|NCT00062868|80449281|FG005|Dose Level 1|Lost to Follow-up|0|||
27618818|NCT00062868|80449282|FG006|Dose Level 1|Lost to Follow-up|0|||
27618819|NCT00062868|80449283|FG007|Dose Level 1|Lost to Follow-up|0|||
27618820|NCT00062868|80449284|FG008|Dose Level 1|Lost to Follow-up|0|||
27618821|NCT00062868|80449285|FG009|Dose Level 1|Lost to Follow-up|0|||
27618822|NCT00062868|80449286|FG010|Dose Level 1|Lost to Follow-up|0|||
27618823|NCT00062868|80449287|FG011|Dose Level 1|Lost to Follow-up|0|||
27618824|NCT00062868|80449288|FG012|Dose Level 1|Lost to Follow-up|1|||
27618825|NCT00062868|80449289|FG013|Dose Level 1|Lost to Follow-up|0|||
27618826|NCT00062868|80449290|FG014|Dose Level 1|Lost to Follow-up|0|||
27618827|NCT00062868|80449291|FG015|Dose Level 1|Lost to Follow-up|0|||
27618828|NCT00062868|80449292|FG016|Dose Level 1|Lost to Follow-up|0|||
27618829|NCT00062868|80449293|FG017|Dose Level 1|Lost to Follow-up|0|||
27618830|NCT00062868|80449294|FG018|Dose Level 1|Lost to Follow-up|2|||
27618831|NCT00062868|80449295|FG019|Dose Level 1|Lost to Follow-up|0|||
27618832|NCT00062868|80449296|FG020|Dose Level 1|Lost to Follow-up|1|||
27618833|NCT00062868|80449276|FG000|Dose Level 2|Death|0|||
27618834|NCT00062868|80449277|FG001|Dose Level 2|Death|3|||
27618835|NCT00062868|80449278|FG002|Dose Level 2|Death|0|||
27618836|NCT00062868|80449279|FG003|Dose Level 2|Death|0|||
27618837|NCT00062868|80449280|FG004|Dose Level 2|Death|2|||
27618838|NCT00062868|80449281|FG005|Dose Level 2|Death|0|||
27618839|NCT00062868|80449282|FG006|Dose Level 2|Death|0|||
27618840|NCT00062868|80449283|FG007|Dose Level 2|Death|0|||
27618841|NCT00062868|80449284|FG008|Dose Level 2|Death|0|||
27618842|NCT00062868|80449285|FG009|Dose Level 2|Death|0|||
27618843|NCT00062868|80449286|FG010|Dose Level 2|Death|1|||
27618844|NCT00062868|80449287|FG011|Dose Level 2|Death|0|||
27618845|NCT00062868|80449288|FG012|Dose Level 2|Death|0|||
27618846|NCT00062868|80449289|FG013|Dose Level 2|Death|0|||
27618847|NCT00062868|80449290|FG014|Dose Level 2|Death|0|||
27618848|NCT00062868|80449291|FG015|Dose Level 2|Death|0|||
27618849|NCT00062868|80449292|FG016|Dose Level 2|Death|2|||
27618850|NCT00062868|80449293|FG017|Dose Level 2|Death|0|||
27618851|NCT00062868|80449294|FG018|Dose Level 2|Death|0|||
27618852|NCT00062868|80449295|FG019|Dose Level 2|Death|0|||
27618853|NCT00062868|80449296|FG020|Dose Level 2|Death|0|||
27618854|NCT00062868|80449276|FG000|Dose Level 2|Lost to Follow-up|0|||
27618855|NCT00062868|80449277|FG001|Dose Level 2|Lost to Follow-up|0|||
27618856|NCT00062868|80449278|FG002|Dose Level 2|Lost to Follow-up|0|||
27618857|NCT00062868|80449279|FG003|Dose Level 2|Lost to Follow-up|0|||
27618858|NCT00062868|80449280|FG004|Dose Level 2|Lost to Follow-up|0|||
27618859|NCT00062868|80449281|FG005|Dose Level 2|Lost to Follow-up|0|||
27618860|NCT00062868|80449282|FG006|Dose Level 2|Lost to Follow-up|0|||
27618861|NCT00062868|80449283|FG007|Dose Level 2|Lost to Follow-up|0|||
27618862|NCT00062868|80449284|FG008|Dose Level 2|Lost to Follow-up|0|||
27618863|NCT00062868|80449285|FG009|Dose Level 2|Lost to Follow-up|0|||
27618864|NCT00062868|80449286|FG010|Dose Level 2|Lost to Follow-up|0|||
27618865|NCT00062868|80449287|FG011|Dose Level 2|Lost to Follow-up|0|||
27618866|NCT00062868|80449288|FG012|Dose Level 2|Lost to Follow-up|0|||
27618867|NCT00062868|80449289|FG013|Dose Level 2|Lost to Follow-up|1|||
27618868|NCT00062868|80449290|FG014|Dose Level 2|Lost to Follow-up|0|||
27618869|NCT00062868|80449291|FG015|Dose Level 2|Lost to Follow-up|0|||
27618870|NCT00062868|80449292|FG016|Dose Level 2|Lost to Follow-up|1|||
27853904|NCT01550744|81295195|FG000|Double-Blind|Withdrawal by Subject|0|||
27853905|NCT01550744|81295196|FG001|Double-Blind|Withdrawal by Subject|2|||
27853906|NCT01550744|81295197|FG002|Double-Blind|Withdrawal by Subject|15|||
27618871|NCT00062868|80449293|FG017|Dose Level 2|Lost to Follow-up|0|||
27618872|NCT00062868|80449294|FG018|Dose Level 2|Lost to Follow-up|0|||
27618873|NCT00062868|80449295|FG019|Dose Level 2|Lost to Follow-up|0|||
27618874|NCT00062868|80449296|FG020|Dose Level 2|Lost to Follow-up|0|||
27618875|NCT00062868|80449276|FG000|Dose Level 3|Death|0|||
27618876|NCT00062868|80449277|FG001|Dose Level 3|Death|0|||
27618877|NCT00062868|80449278|FG002|Dose Level 3|Death|0|||
27618878|NCT00062868|80449279|FG003|Dose Level 3|Death|0|||
27618879|NCT00062868|80449280|FG004|Dose Level 3|Death|0|||
27618880|NCT00062868|80449281|FG005|Dose Level 3|Death|0|||
27618881|NCT00062868|80449282|FG006|Dose Level 3|Death|0|||
27618882|NCT00062868|80449283|FG007|Dose Level 3|Death|0|||
27618883|NCT00062868|80449284|FG008|Dose Level 3|Death|0|||
27618884|NCT00062868|80449285|FG009|Dose Level 3|Death|0|||
27618885|NCT00062868|80449286|FG010|Dose Level 3|Death|0|||
27618886|NCT00062868|80449287|FG011|Dose Level 3|Death|1|||
27618887|NCT00062868|80449288|FG012|Dose Level 3|Death|0|||
27618888|NCT00062868|80449289|FG013|Dose Level 3|Death|0|||
27618889|NCT00062868|80449290|FG014|Dose Level 3|Death|0|||
27618890|NCT00062868|80449291|FG015|Dose Level 3|Death|0|||
27618891|NCT00062868|80449292|FG016|Dose Level 3|Death|0|||
27618892|NCT00062868|80449293|FG017|Dose Level 3|Death|1|||
27618893|NCT00062868|80449294|FG018|Dose Level 3|Death|0|||
27618894|NCT00062868|80449295|FG019|Dose Level 3|Death|0|||
27618895|NCT00062868|80449296|FG020|Dose Level 3|Death|0|||
27618896|NCT00062868|80449276|FG000|Dose Level 3|Lost to Follow-up|0|||
27618897|NCT00062868|80449277|FG001|Dose Level 3|Lost to Follow-up|0|||
27618898|NCT00062868|80449278|FG002|Dose Level 3|Lost to Follow-up|0|||
27618899|NCT00062868|80449279|FG003|Dose Level 3|Lost to Follow-up|0|||
27618900|NCT00062868|80449280|FG004|Dose Level 3|Lost to Follow-up|0|||
27618901|NCT00062868|80449281|FG005|Dose Level 3|Lost to Follow-up|0|||
27618902|NCT00062868|80449282|FG006|Dose Level 3|Lost to Follow-up|0|||
27618903|NCT00062868|80449283|FG007|Dose Level 3|Lost to Follow-up|0|||
27618904|NCT00062868|80449284|FG008|Dose Level 3|Lost to Follow-up|0|||
27618905|NCT00062868|80449285|FG009|Dose Level 3|Lost to Follow-up|0|||
27618906|NCT00062868|80449286|FG010|Dose Level 3|Lost to Follow-up|0|||
27618907|NCT00062868|80449287|FG011|Dose Level 3|Lost to Follow-up|0|||
27618908|NCT00062868|80449288|FG012|Dose Level 3|Lost to Follow-up|0|||
27618909|NCT00062868|80449289|FG013|Dose Level 3|Lost to Follow-up|0|||
27618910|NCT00062868|80449290|FG014|Dose Level 3|Lost to Follow-up|1|||
27618911|NCT00062868|80449291|FG015|Dose Level 3|Lost to Follow-up|0|||
27618912|NCT00062868|80449292|FG016|Dose Level 3|Lost to Follow-up|0|||
27618913|NCT00062868|80449293|FG017|Dose Level 3|Lost to Follow-up|0|||
27618914|NCT00062868|80449294|FG018|Dose Level 3|Lost to Follow-up|0|||
27618915|NCT00062868|80449295|FG019|Dose Level 3|Lost to Follow-up|0|||
27618916|NCT00062868|80449296|FG020|Dose Level 3|Lost to Follow-up|0|||
27618917|NCT00062868|80449276|FG000|Dose Level 3|Withdrew|0|||
27618918|NCT00062868|80449277|FG001|Dose Level 3|Withdrew|0|||
27618919|NCT00062868|80449278|FG002|Dose Level 3|Withdrew|2|||
27618920|NCT00062868|80449279|FG003|Dose Level 3|Withdrew|0|||
27618921|NCT00062868|80449280|FG004|Dose Level 3|Withdrew|0|||
27618922|NCT00062868|80449281|FG005|Dose Level 3|Withdrew|0|||
27618923|NCT00062868|80449282|FG006|Dose Level 3|Withdrew|0|||
27618924|NCT00062868|80449283|FG007|Dose Level 3|Withdrew|0|||
27618925|NCT00062868|80449284|FG008|Dose Level 3|Withdrew|0|||
27618926|NCT00062868|80449285|FG009|Dose Level 3|Withdrew|0|||
27618927|NCT00062868|80449286|FG010|Dose Level 3|Withdrew|0|||
27618928|NCT00062868|80449287|FG011|Dose Level 3|Withdrew|0|||
27618929|NCT00062868|80449288|FG012|Dose Level 3|Withdrew|0|||
27618930|NCT00062868|80449289|FG013|Dose Level 3|Withdrew|0|||
27618931|NCT00062868|80449290|FG014|Dose Level 3|Withdrew|0|||
27618932|NCT00062868|80449291|FG015|Dose Level 3|Withdrew|0|||
27618933|NCT00062868|80449292|FG016|Dose Level 3|Withdrew|0|||
27618934|NCT00062868|80449293|FG017|Dose Level 3|Withdrew|0|||
27618935|NCT00062868|80449294|FG018|Dose Level 3|Withdrew|0|||
27618936|NCT00062868|80449295|FG019|Dose Level 3|Withdrew|0|||
27618937|NCT00062868|80449296|FG020|Dose Level 3|Withdrew|0|||
27618938|NCT02297503|80449299|FG000|Overall Study|Withdrawal by Subject|1|||
27618939|NCT02297503|80449300|FG001|Overall Study|Withdrawal by Subject|1|||
27618940|NCT02297503|80449299|FG000|Overall Study|Protocol Violation|1|||
27618941|NCT02297503|80449300|FG001|Overall Study|Protocol Violation|0|||
27618942|NCT02297503|80449299|FG000|Overall Study|Pregnancy|0|||
27618943|NCT02297503|80449300|FG001|Overall Study|Pregnancy|1|||
27618944|NCT02297503|80449299|FG000|Overall Study|Lost to Follow-up|0|||
27618945|NCT02297503|80449300|FG001|Overall Study|Lost to Follow-up|1|||
27618946|NCT02297503|80449299|FG000|Overall Study|Medical reason|0|||
27618947|NCT02297503|80449300|FG001|Overall Study|Medical reason|1|||
27618948|NCT02448719|80449308|FG000|Overall Study|Withdrawal by Subject|0|||
27618949|NCT02448719|80449309|FG001|Overall Study|Withdrawal by Subject|0|||
27618950|NCT02448719|80449310|FG002|Overall Study|Withdrawal by Subject|0|||
27618951|NCT02448719|80449311|FG003|Overall Study|Withdrawal by Subject|0|||
27618952|NCT02448719|80449312|FG004|Overall Study|Withdrawal by Subject|1|||
27618953|NCT02448719|80449313|FG005|Overall Study|Withdrawal by Subject|0|||
27618954|NCT02448719|80449314|FG006|Overall Study|Withdrawal by Subject|0|||
27730430|NCT01756456|80842703|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
27853907|NCT01550744|81295195|FG000|Double-Blind|Adverse Event|0|||
27853908|NCT01550744|81295196|FG001|Double-Blind|Adverse Event|4|||
27618955|NCT02448719|80449315|FG007|Overall Study|Withdrawal by Subject|0|||
27618956|NCT02448719|80449316|FG008|Overall Study|Withdrawal by Subject|0|||
27618957|NCT02448719|80449317|FG009|Overall Study|Withdrawal by Subject|0|||
27618958|NCT02448719|80449318|FG010|Overall Study|Withdrawal by Subject|0|||
27618959|NCT03697460|80449319|FG000|Overall Study|Withdrawal by Subject|3|||
27618960|NCT02337361|80449320|FG000|3-month Follow-up|Lost to Follow-up|19|||
27618961|NCT02337361|80449321|FG001|3-month Follow-up|Lost to Follow-up|14|||
27618962|NCT02337361|80449320|FG000|6-month Follow-up|Lost to Follow-up|2|||
27618963|NCT02337361|80449321|FG001|6-month Follow-up|Lost to Follow-up|4|||
27618964|NCT05124899|80449324|FG000|Overall Study|Lost to Follow-up|3|||
27618965|NCT00278564|80449326|FG000|Overall Study|Lack of Efficacy|4|||
27618966|NCT01237678|80449327|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
27618967|NCT01237678|80449328|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
27618968|NCT01237678|80449329|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
27618969|NCT01237678|80449327|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
27618970|NCT01237678|80449328|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
27618971|NCT01237678|80449329|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
27618972|NCT01237678|80449327|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
27618973|NCT01237678|80449328|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
27618974|NCT01237678|80449329|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
27618975|NCT01237678|80449327|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
27618976|NCT01237678|80449328|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
27618977|NCT01237678|80449329|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
27618978|NCT01237678|80449327|FG000|Phase II|Adverse Event|0|||
27618979|NCT01237678|80449328|FG001|Phase II|Adverse Event|39|||
27618980|NCT01237678|80449329|FG002|Phase II|Adverse Event|9|||
27618981|NCT01237678|80449327|FG000|Phase II|Death|0|||
27618982|NCT01237678|80449328|FG001|Phase II|Death|0|||
27618983|NCT01237678|80449329|FG002|Phase II|Death|2|||
27618984|NCT01237678|80449327|FG000|Phase II|Lack of Efficacy|0|||
27618985|NCT01237678|80449328|FG001|Phase II|Lack of Efficacy|25|||
27618986|NCT01237678|80449329|FG002|Phase II|Lack of Efficacy|3|||
27618987|NCT01237678|80449327|FG000|Phase II|Withdrawal by Subject|0|||
27618988|NCT01237678|80449328|FG001|Phase II|Withdrawal by Subject|1|||
27618989|NCT01237678|80449329|FG002|Phase II|Withdrawal by Subject|5|||
27618990|NCT01237678|80449327|FG000|Phase II|Completed Cycles 4-6|0|||
27618991|NCT01237678|80449328|FG001|Phase II|Completed Cycles 4-6|11|||
27618992|NCT01237678|80449329|FG002|Phase II|Completed Cycles 4-6|21|||
27618993|NCT01237678|80449327|FG000|Phase II|Sponsor Decision/Study Closed|0|||
27618994|NCT01237678|80449328|FG001|Phase II|Sponsor Decision/Study Closed|18|||
27618995|NCT01237678|80449329|FG002|Phase II|Sponsor Decision/Study Closed|7|||
27618996|NCT01237678|80449327|FG000|Phase II|Randomized but were not treated|0|||
27618997|NCT01237678|80449328|FG001|Phase II|Randomized but were not treated|4|||
27618998|NCT01237678|80449329|FG002|Phase II|Randomized but were not treated|3|||
27618999|NCT03220737|80449336|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
27619000|NCT03220737|80449337|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
27619001|NCT03220737|80449338|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
27619002|NCT03220737|80449339|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
27619003|NCT03220737|80449340|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
27619004|NCT03220737|80449341|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
27619005|NCT03220737|80449342|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
27619006|NCT03220737|80449336|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
27619007|NCT03220737|80449337|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
27619008|NCT03220737|80449338|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
27619009|NCT03220737|80449339|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
27619010|NCT03220737|80449340|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
27619011|NCT03220737|80449341|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
27619012|NCT03220737|80449342|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
27619013|NCT03220737|80449336|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
27619014|NCT03220737|80449337|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
27619015|NCT03220737|80449338|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
27619016|NCT03220737|80449339|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
27619017|NCT03220737|80449340|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
27853909|NCT01550744|81295197|FG002|Double-Blind|Adverse Event|15|||
27908377|NCT02942277|81500601|FG006|Year 2|Withdrawal by Subject|1|||
27908378|NCT02942277|81500602|FG007|Year 2|Withdrawal by Subject|0|||
27908379|NCT02942277|81500603|FG008|Year 2|Withdrawal by Subject|0|||
27908380|NCT02942277|81500604|FG009|Year 2|Withdrawal by Subject|0|||
27908381|NCT02942277|81500605|FG010|Year 2|Withdrawal by Subject|0|||
27908382|NCT02087670|81500606|FG000|Overall Study|Withdrawal by Subject|3|||
27619018|NCT03220737|80449341|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
27619019|NCT03220737|80449342|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
27853910|NCT01550744|81295195|FG000|Double-Blind|Death|0|||
27853911|NCT01550744|81295196|FG001|Double-Blind|Death|1|||
27853912|NCT01550744|81295197|FG002|Double-Blind|Death|0|||
27853913|NCT01550744|81295195|FG000|Double-Blind|Lack of Efficacy|0|||
27853914|NCT01550744|81295196|FG001|Double-Blind|Lack of Efficacy|2|||
27619020|NCT03220737|80449336|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27619021|NCT03220737|80449337|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27619022|NCT03220737|80449338|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
27619023|NCT03220737|80449339|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27619024|NCT03220737|80449340|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27853915|NCT01550744|81295197|FG002|Double-Blind|Lack of Efficacy|8|||
27908383|NCT02087670|81500607|FG001|Overall Study|Withdrawal by Subject|2|||
27908384|NCT04999085|81500608|FG000|Overall Study|Death|1|||
27908385|NCT02500719|81500609|FG000|Overall Study|Lost to Follow-up|2|||
27908386|NCT02500719|81500610|FG001|Overall Study|Lost to Follow-up|3|||
27908387|NCT02500719|81500609|FG000|Overall Study|Trauma history|1|||
27908388|NCT02500719|81500610|FG001|Overall Study|Trauma history|0|||
27908389|NCT02500719|81500609|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
27908390|NCT02500719|81500610|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
27908391|NCT02500719|81500609|FG000|Overall Study|Did not meet criteria for PTSD|0|||
27908392|NCT02500719|81500610|FG001|Overall Study|Did not meet criteria for PTSD|1|||
27908393|NCT02500719|81500609|FG000|Overall Study|Claustrophobia|0|||
27908394|NCT02500719|81500610|FG001|Overall Study|Claustrophobia|1|||
27518762|NCT00095940|80091966|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
27518763|NCT00095940|80091967|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
27518764|NCT00095940|80091968|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
27518765|NCT00095940|80091969|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
27518766|NCT00095940|80091961|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
27518767|NCT00095940|80091962|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
27518768|NCT00095940|80091963|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
27518769|NCT00095940|80091964|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
27518770|NCT00095940|80091965|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
27518771|NCT00095940|80091966|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
27518772|NCT00095940|80091967|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
27518773|NCT00095940|80091968|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
27518774|NCT00095940|80091969|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
27518775|NCT00095940|80091961|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518776|NCT00095940|80091962|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518777|NCT00095940|80091963|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518778|NCT00095940|80091964|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518779|NCT00095940|80091965|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518780|NCT00095940|80091966|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518781|NCT00095940|80091967|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518782|NCT00095940|80091968|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
27518783|NCT00095940|80091969|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
27518784|NCT00783198|80094972|FG000|Overall Study|Adverse Event|15|||
27518785|NCT00783198|80094973|FG001|Overall Study|Adverse Event|19|||
27518786|NCT00783198|80094974|FG002|Overall Study|Adverse Event|3|||
27518787|NCT00783198|80094972|FG000|Overall Study|Lost to Follow-up|11|||
27518788|NCT00783198|80094973|FG001|Overall Study|Lost to Follow-up|1|||
27518789|NCT00783198|80094974|FG002|Overall Study|Lost to Follow-up|7|||
27518790|NCT00783198|80094972|FG000|Overall Study|Withdrawal by Subject|22|||
27518791|NCT00783198|80094973|FG001|Overall Study|Withdrawal by Subject|14|||
27518792|NCT00783198|80094974|FG002|Overall Study|Withdrawal by Subject|20|||
27518793|NCT00783198|80094972|FG000|Overall Study|Noncompliance with protocol|7|||
27518794|NCT00783198|80094973|FG001|Overall Study|Noncompliance with protocol|7|||
27518795|NCT00783198|80094974|FG002|Overall Study|Noncompliance with protocol|10|||
27518796|NCT00783198|80094972|FG000|Overall Study|Did not meet protocol eligibility|0|||
27518797|NCT00783198|80094973|FG001|Overall Study|Did not meet protocol eligibility|1|||
27518798|NCT00783198|80094974|FG002|Overall Study|Did not meet protocol eligibility|0|||
27518799|NCT00783198|80094972|FG000|Overall Study|Administrative|2|||
27518800|NCT00783198|80094973|FG001|Overall Study|Administrative|1|||
27518801|NCT00783198|80094974|FG002|Overall Study|Administrative|2|||
27518802|NCT02674204|80094976|FG000|Overall Study|Adverse Event|1|||
27518803|NCT02674204|80094977|FG001|Overall Study|Adverse Event|0|||
27518804|NCT01206322|80094978|FG000|Overall Study|Adverse Event|0|||
27518805|NCT01206322|80094979|FG001|Overall Study|Adverse Event|0|||
27518806|NCT01206322|80094980|FG002|Overall Study|Adverse Event|0|||
27518807|NCT01206322|80094981|FG003|Overall Study|Adverse Event|1|||
27518808|NCT01754402|80094985|FG000|Overall Study|Death|0|||
27518809|NCT01754402|80094986|FG001|Overall Study|Death|0|||
27518810|NCT01754402|80094987|FG002|Overall Study|Death|1|||
27518811|NCT01754402|80094985|FG000|Overall Study|Adverse Event|2|||
27518812|NCT01754402|80094986|FG001|Overall Study|Adverse Event|2|||
27518813|NCT01754402|80094987|FG002|Overall Study|Adverse Event|1|||
27518814|NCT01754402|80094985|FG000|Overall Study|Withdrawal by Subject|0|||
27518815|NCT01754402|80094986|FG001|Overall Study|Withdrawal by Subject|0|||
27908395|NCT02500719|81500609|FG000|Overall Study|History of head trauma|0|||
27908396|NCT02500719|81500610|FG001|Overall Study|History of head trauma|1|||
27518816|NCT01754402|80094987|FG002|Overall Study|Withdrawal by Subject|1|||
27518817|NCT01754402|80094985|FG000|Overall Study|Lack of Efficacy|0|||
27518818|NCT01754402|80094986|FG001|Overall Study|Lack of Efficacy|0|||
27518819|NCT01754402|80094987|FG002|Overall Study|Lack of Efficacy|1|||
27518820|NCT00668733|80094988|FG000|Overall Study|Lost to Follow-up|2|||
27518821|NCT00668733|80094989|FG001|Overall Study|Lost to Follow-up|3|||
27518822|NCT00668733|80094988|FG000|Overall Study|Withdrawal by Subject|0|||
27853916|NCT01550744|81295195|FG000|Double-Blind|Protocol Violation|0|||
27730431|NCT01756456|80842704|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
27730432|NCT01756456|80842699|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27730433|NCT01756456|80842700|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
27730434|NCT01756456|80842701|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27730435|NCT01756456|80842702|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27730436|NCT01756456|80842703|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27730437|NCT01756456|80842704|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
27730438|NCT01756456|80842699|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27730439|NCT01756456|80842700|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27730440|NCT01756456|80842701|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27730441|NCT01756456|80842702|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27853917|NCT01550744|81295196|FG001|Double-Blind|Protocol Violation|0|||
27853918|NCT01550744|81295197|FG002|Double-Blind|Protocol Violation|4|||
27853919|NCT01550744|81295195|FG000|Double-Blind|Pregnancy|0|||
27853920|NCT01550744|81295196|FG001|Double-Blind|Pregnancy|0|||
27853921|NCT01550744|81295197|FG002|Double-Blind|Pregnancy|3|||
27853922|NCT01550744|81295195|FG000|Double-Blind|Other|0|||
27853923|NCT01550744|81295196|FG001|Double-Blind|Other|2|||
27853924|NCT01550744|81295197|FG002|Double-Blind|Other|10|||
27853925|NCT00127036|81295204|FG000|Overall Study|Insufficient Data for Analysis|6|||
27853926|NCT00127036|81295205|FG001|Overall Study|Insufficient Data for Analysis|11|||
27853927|NCT00127036|81295204|FG000|Overall Study|Screen Failure|2|||
27853928|NCT00127036|81295205|FG001|Overall Study|Screen Failure|0|||
27853929|NCT01470612|81295206|FG000|Overall Study|Adverse Event|20|||
27853930|NCT01470612|81295207|FG001|Overall Study|Adverse Event|80|||
27853931|NCT01470612|81295206|FG000|Overall Study|Death|0|||
27853932|NCT01470612|81295207|FG001|Overall Study|Death|1|||
27853933|NCT01470612|81295206|FG000|Overall Study|Lack of Efficacy|20|||
27853934|NCT01470612|81295207|FG001|Overall Study|Lack of Efficacy|326|||
27853935|NCT01470612|81295206|FG000|Overall Study|Lost to Follow-up|2|||
27853936|NCT01470612|81295207|FG001|Overall Study|Lost to Follow-up|5|||
27853937|NCT01470612|81295206|FG000|Overall Study|Did not meet entrance criteria|0|||
27853938|NCT01470612|81295207|FG001|Overall Study|Did not meet entrance criteria|1|||
27853939|NCT01470612|81295206|FG000|Overall Study|Pregnancy|2|||
27853940|NCT01470612|81295207|FG001|Overall Study|Pregnancy|10|||
27853941|NCT01470612|81295206|FG000|Overall Study|Protocol Violation|2|||
27853942|NCT01470612|81295207|FG001|Overall Study|Protocol Violation|7|||
27853943|NCT01470612|81295206|FG000|Overall Study|Withdrawal by Subject|24|||
27853944|NCT01470612|81295207|FG001|Overall Study|Withdrawal by Subject|79|||
27853945|NCT01470612|81295206|FG000|Overall Study|Other|14|||
27853946|NCT01470612|81295207|FG001|Overall Study|Other|156|||
27853947|NCT01347866|81295208|FG000|Overall Study|Death|0|||
27853948|NCT01347866|81295209|FG001|Overall Study|Death|0|||
27853949|NCT01347866|81295210|FG002|Overall Study|Death|0|||
27853950|NCT01347866|81295211|FG003|Overall Study|Death|1|||
27853951|NCT01347866|81295212|FG004|Overall Study|Death|2|||
27853952|NCT01347866|81295213|FG005|Overall Study|Death|2|||
27853953|NCT01347866|81295214|FG006|Overall Study|Death|1|||
27853954|NCT01347866|81295215|FG007|Overall Study|Death|0|||
27853955|NCT01347866|81295216|FG008|Overall Study|Death|4|||
27853956|NCT01347866|81295217|FG009|Overall Study|Death|1|||
27853957|NCT01347866|81295218|FG010|Overall Study|Death|3|||
27853958|NCT01347866|81295219|FG011|Overall Study|Death|1|||
27853959|NCT01347866|81295220|FG012|Overall Study|Death|2|||
27853960|NCT01347866|81295221|FG013|Overall Study|Death|0|||
27853961|NCT01347866|81295222|FG014|Overall Study|Death|0|||
27853962|NCT01347866|81295223|FG015|Overall Study|Death|1|||
27853963|NCT01347866|81295224|FG016|Overall Study|Death|0|||
27853964|NCT01347866|81295208|FG000|Overall Study|Lost to Follow-up|0|||
27853965|NCT01347866|81295209|FG001|Overall Study|Lost to Follow-up|0|||
27853966|NCT01347866|81295210|FG002|Overall Study|Lost to Follow-up|0|||
27853967|NCT01347866|81295211|FG003|Overall Study|Lost to Follow-up|0|||
27908397|NCT01831427|81500611|FG000|Overall Study|Adverse Event|0|||
27853968|NCT01347866|81295212|FG004|Overall Study|Lost to Follow-up|0|||
27853969|NCT01347866|81295213|FG005|Overall Study|Lost to Follow-up|0|||
27853970|NCT01347866|81295214|FG006|Overall Study|Lost to Follow-up|0|||
27853971|NCT01347866|81295215|FG007|Overall Study|Lost to Follow-up|1|||
27853972|NCT01347866|81295216|FG008|Overall Study|Lost to Follow-up|1|||
27853973|NCT01347866|81295217|FG009|Overall Study|Lost to Follow-up|0|||
27853974|NCT01347866|81295218|FG010|Overall Study|Lost to Follow-up|0|||
27908398|NCT01831427|81500612|FG001|Overall Study|Adverse Event|1|||
27908399|NCT01831427|81500613|FG002|Overall Study|Adverse Event|0|||
27853975|NCT01347866|81295219|FG011|Overall Study|Lost to Follow-up|0|||
27853976|NCT01347866|81295220|FG012|Overall Study|Lost to Follow-up|0|||
27853977|NCT01347866|81295221|FG013|Overall Study|Lost to Follow-up|0|||
27853978|NCT01347866|81295222|FG014|Overall Study|Lost to Follow-up|0|||
27853979|NCT01347866|81295223|FG015|Overall Study|Lost to Follow-up|0|||
27853980|NCT01347866|81295224|FG016|Overall Study|Lost to Follow-up|0|||
27853981|NCT01347866|81295208|FG000|Overall Study|Other|3|||
27908400|NCT01831427|81500614|FG003|Overall Study|Adverse Event|0|||
27908401|NCT01831427|81500615|FG004|Overall Study|Adverse Event|0|||
27908402|NCT01831427|81500616|FG005|Overall Study|Adverse Event|1|||
27908403|NCT01831427|81500617|FG006|Overall Study|Adverse Event|0|||
27908404|NCT01831427|81500618|FG007|Overall Study|Adverse Event|1|||
27908405|NCT01831427|81500619|FG008|Overall Study|Adverse Event|0|||
27908406|NCT01831427|81500620|FG009|Overall Study|Adverse Event|0|||
27908407|NCT01831427|81500621|FG010|Overall Study|Adverse Event|2|||
27908408|NCT01831427|81500611|FG000|Overall Study|Investigator's Discretion|0|||
27908409|NCT01831427|81500612|FG001|Overall Study|Investigator's Discretion|0|||
27908410|NCT01831427|81500613|FG002|Overall Study|Investigator's Discretion|0|||
27908411|NCT01831427|81500614|FG003|Overall Study|Investigator's Discretion|1|||
27908412|NCT01831427|81500615|FG004|Overall Study|Investigator's Discretion|0|||
27908413|NCT01831427|81500616|FG005|Overall Study|Investigator's Discretion|0|||
27908414|NCT01831427|81500617|FG006|Overall Study|Investigator's Discretion|0|||
27908415|NCT01831427|81500618|FG007|Overall Study|Investigator's Discretion|0|||
27908416|NCT01831427|81500619|FG008|Overall Study|Investigator's Discretion|0|||
27908417|NCT01831427|81500620|FG009|Overall Study|Investigator's Discretion|0|||
27908418|NCT01831427|81500621|FG010|Overall Study|Investigator's Discretion|0|||
27908419|NCT01831427|81500611|FG000|Overall Study|Withdrew Consent|0|||
27619025|NCT03220737|80449341|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27619026|NCT03220737|80449342|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
27619027|NCT03220737|80449336|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27619028|NCT03220737|80449337|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27619029|NCT03220737|80449338|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27619030|NCT03220737|80449339|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27619031|NCT03220737|80449340|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
27619032|NCT03220737|80449341|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27908420|NCT01831427|81500612|FG001|Overall Study|Withdrew Consent|0|||
27518823|NCT00668733|80094989|FG001|Overall Study|Withdrawal by Subject|4|||
27518824|NCT01014910|80094990|FG000|Overall Study|Withdrawal by Subject|0|||
27518825|NCT01014910|80094991|FG001|Overall Study|Withdrawal by Subject|2|||
27518826|NCT02881567|80094992|FG000|Overall Study|Adverse Event|1|||
27518827|NCT02881567|80094992|FG000|Overall Study|Lost to Follow-up|3|||
27518828|NCT02881567|80094992|FG000|Overall Study|Consent withdrawn|1|||
27518829|NCT02881567|80094992|FG000|Overall Study|Investigator decision|1|||
27518830|NCT02881567|80094992|FG000|Overall Study|Study terminated by sponsor|9|||
27518831|NCT02881567|80094992|FG000|Overall Study|Reason not Specified|3|||
27518832|NCT01386970|80094993|FG000|Overall Study|Withdrawal by Subject|0|||
27518833|NCT01386970|80094994|FG001|Overall Study|Withdrawal by Subject|1|||
27518834|NCT01386970|80094993|FG000|Overall Study|Adverse Event|4|||
27518835|NCT01386970|80094994|FG001|Overall Study|Adverse Event|1|||
27518836|NCT01349049|80095000|FG000|Overall Study|Disease progression|3|||
27518837|NCT01349049|80095001|FG001|Overall Study|Disease progression|5|||
27518838|NCT01349049|80095002|FG002|Overall Study|Disease progression|3|||
27518839|NCT01349049|80095003|FG003|Overall Study|Disease progression|2|||
27518840|NCT01349049|80095004|FG004|Overall Study|Disease progression|2|||
27518841|NCT01349049|80095005|FG005|Overall Study|Disease progression|2|||
27518842|NCT01349049|80095006|FG006|Overall Study|Disease progression|3|||
27518843|NCT01349049|80095007|FG007|Overall Study|Disease progression|2|||
27518844|NCT01349049|80095008|FG008|Overall Study|Disease progression|33|||
27518845|NCT01349049|80095000|FG000|Overall Study|Adverse Event|0|||
27518846|NCT01349049|80095001|FG001|Overall Study|Adverse Event|1|||
27518847|NCT01349049|80095002|FG002|Overall Study|Adverse Event|0|||
27518848|NCT01349049|80095003|FG003|Overall Study|Adverse Event|0|||
27518849|NCT01349049|80095004|FG004|Overall Study|Adverse Event|0|||
27518850|NCT01349049|80095005|FG005|Overall Study|Adverse Event|3|||
27518851|NCT01349049|80095006|FG006|Overall Study|Adverse Event|1|||
27518852|NCT01349049|80095007|FG007|Overall Study|Adverse Event|0|||
27518853|NCT01349049|80095008|FG008|Overall Study|Adverse Event|4|||
27518854|NCT01349049|80095000|FG000|Overall Study|Physician Decision|0|||
27518855|NCT01349049|80095001|FG001|Overall Study|Physician Decision|1|||
27518856|NCT01349049|80095002|FG002|Overall Study|Physician Decision|0|||
27518857|NCT01349049|80095003|FG003|Overall Study|Physician Decision|0|||
27619033|NCT03220737|80449342|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
27853982|NCT01347866|81295209|FG001|Overall Study|Other|1|||
27908421|NCT01831427|81500613|FG002|Overall Study|Withdrew Consent|0|||
27908422|NCT01831427|81500614|FG003|Overall Study|Withdrew Consent|0|||
27908423|NCT01831427|81500615|FG004|Overall Study|Withdrew Consent|0|||
27518858|NCT01349049|80095004|FG004|Overall Study|Physician Decision|0|||
27518859|NCT01349049|80095005|FG005|Overall Study|Physician Decision|0|||
27518860|NCT01349049|80095006|FG006|Overall Study|Physician Decision|0|||
27518861|NCT01349049|80095007|FG007|Overall Study|Physician Decision|0|||
27518862|NCT01349049|80095008|FG008|Overall Study|Physician Decision|2|||
27518863|NCT01349049|80095000|FG000|Overall Study|Protocol Violation|0|||
27518864|NCT01349049|80095001|FG001|Overall Study|Protocol Violation|0|||
27518865|NCT01349049|80095002|FG002|Overall Study|Protocol Violation|0|||
27518866|NCT01349049|80095003|FG003|Overall Study|Protocol Violation|0|||
27908424|NCT01831427|81500616|FG005|Overall Study|Withdrew Consent|0|||
27619034|NCT03220737|80449336|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
27619035|NCT03220737|80449337|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27619036|NCT03220737|80449338|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27619037|NCT03220737|80449339|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27619038|NCT03220737|80449340|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27619039|NCT03220737|80449341|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27619040|NCT03220737|80449342|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
27619041|NCT03220737|80449336|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
27619042|NCT03220737|80449337|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27619043|NCT03220737|80449338|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27619044|NCT03220737|80449339|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27619045|NCT03220737|80449340|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27619046|NCT03220737|80449341|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27619047|NCT03220737|80449342|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
27619048|NCT03220737|80449336|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
27619049|NCT03220737|80449337|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27619050|NCT03220737|80449338|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27619051|NCT03220737|80449339|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27619052|NCT03220737|80449340|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27619053|NCT03220737|80449341|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27619054|NCT03220737|80449342|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
27619055|NCT03369951|80449343|FG000|Overall Study|Withdrawal by Subject|3|||
27619056|NCT03369951|80449343|FG000|Overall Study|Death|1|||
27619057|NCT03369951|80449343|FG000|Overall Study|Lost to Follow-up|1|||
27619058|NCT03369951|80449343|FG000|Overall Study|Protocol Violation|1|||
27619059|NCT01511536|80449346|FG000|Phase 1|Other|0|||
27619060|NCT01511536|80449347|FG001|Phase 1|Other|1|||
27518867|NCT01349049|80095004|FG004|Overall Study|Protocol Violation|0|||
27518868|NCT01349049|80095005|FG005|Overall Study|Protocol Violation|0|||
27518869|NCT01349049|80095006|FG006|Overall Study|Protocol Violation|0|||
27518870|NCT01349049|80095007|FG007|Overall Study|Protocol Violation|0|||
27518871|NCT01349049|80095008|FG008|Overall Study|Protocol Violation|1|||
27518872|NCT01349049|80095000|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
27518873|NCT01349049|80095001|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
27518874|NCT01349049|80095002|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
27518875|NCT01349049|80095003|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
27518876|NCT01349049|80095004|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
27518877|NCT01349049|80095005|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
27518878|NCT01349049|80095006|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
27518879|NCT01349049|80095007|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
27518880|NCT01349049|80095008|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
27518881|NCT01349049|80095000|FG000|Overall Study|Other|0|||
27518882|NCT01349049|80095001|FG001|Overall Study|Other|0|||
27518883|NCT01349049|80095002|FG002|Overall Study|Other|0|||
27518884|NCT01349049|80095003|FG003|Overall Study|Other|0|||
27518885|NCT01349049|80095004|FG004|Overall Study|Other|0|||
27518886|NCT01349049|80095005|FG005|Overall Study|Other|1|||
27518887|NCT01349049|80095006|FG006|Overall Study|Other|0|||
27518888|NCT01349049|80095007|FG007|Overall Study|Other|0|||
27518889|NCT01349049|80095008|FG008|Overall Study|Other|4|||
27518890|NCT01349049|80095000|FG000|Overall Study|Death|0|||
27518891|NCT01349049|80095001|FG001|Overall Study|Death|0|||
27518892|NCT01349049|80095002|FG002|Overall Study|Death|0|||
27518893|NCT01349049|80095003|FG003|Overall Study|Death|0|||
27518894|NCT01349049|80095004|FG004|Overall Study|Death|0|||
27518895|NCT01349049|80095005|FG005|Overall Study|Death|0|||
27518896|NCT01349049|80095006|FG006|Overall Study|Death|0|||
27518897|NCT01349049|80095007|FG007|Overall Study|Death|1|||
27518898|NCT01349049|80095008|FG008|Overall Study|Death|5|||
27518899|NCT01349049|80095000|FG000|Overall Study|Non-compliance|0|||
27518900|NCT01349049|80095001|FG001|Overall Study|Non-compliance|0|||
27518901|NCT01349049|80095002|FG002|Overall Study|Non-compliance|0|||
27518902|NCT01349049|80095003|FG003|Overall Study|Non-compliance|1|||
27619061|NCT01511536|80449348|FG002|Phase 1|Other|0|||
27619062|NCT01511536|80449346|FG000|Phase 2|Other|0|||
27518903|NCT01349049|80095004|FG004|Overall Study|Non-compliance|0|||
27518904|NCT01349049|80095005|FG005|Overall Study|Non-compliance|0|||
27518905|NCT01349049|80095006|FG006|Overall Study|Non-compliance|0|||
27518906|NCT01349049|80095007|FG007|Overall Study|Non-compliance|0|||
27518907|NCT01349049|80095008|FG008|Overall Study|Non-compliance|0|||
27518908|NCT01349049|80095000|FG000|Overall Study|Withdrawal by Subject|0|||
27518909|NCT01349049|80095001|FG001|Overall Study|Withdrawal by Subject|0|||
27518910|NCT01349049|80095002|FG002|Overall Study|Withdrawal by Subject|0|||
27518911|NCT01349049|80095003|FG003|Overall Study|Withdrawal by Subject|0|||
27518912|NCT01349049|80095004|FG004|Overall Study|Withdrawal by Subject|0|||
27518913|NCT01349049|80095005|FG005|Overall Study|Withdrawal by Subject|0|||
27518914|NCT01349049|80095006|FG006|Overall Study|Withdrawal by Subject|0|||
27518915|NCT01349049|80095007|FG007|Overall Study|Withdrawal by Subject|0|||
27518916|NCT01349049|80095008|FG008|Overall Study|Withdrawal by Subject|6|||
27518917|NCT01149148|80095011|FG000|Overall Study|Lost to Follow-up|1|||
27518918|NCT01149148|80095012|FG001|Overall Study|Lost to Follow-up|2|||
27518919|NCT01149148|80095011|FG000|Overall Study|Death|1|||
27518920|NCT01149148|80095012|FG001|Overall Study|Death|0|||
27518921|NCT02864862|80095018|FG000|Overall Study|Lost to Follow-up|1|||
27518922|NCT02864862|80095019|FG001|Overall Study|Lost to Follow-up|0|||
27518923|NCT02864862|80095020|FG002|Overall Study|Lost to Follow-up|1|||
27518924|NCT02864862|80095018|FG000|Overall Study|Protocol Violation|0|||
27518925|NCT02864862|80095019|FG001|Overall Study|Protocol Violation|0|||
27518926|NCT02864862|80095020|FG002|Overall Study|Protocol Violation|1|||
27518927|NCT01433250|80095026|FG000|Overall Study|Protocol Violation|0|||
27518928|NCT01433250|80095027|FG001|Overall Study|Protocol Violation|1|||
27518929|NCT01433250|80095026|FG000|Overall Study|Withdrawal by Subject|3|||
27518930|NCT01433250|80095027|FG001|Overall Study|Withdrawal by Subject|2|||
27518931|NCT02660138|80095028|FG000|Overall Study|Adverse Event|0|||
27518932|NCT02660138|80095029|FG001|Overall Study|Adverse Event|3|||
27518933|NCT02660138|80095030|FG002|Overall Study|Adverse Event|2|||
27518934|NCT02660138|80095028|FG000|Overall Study|Lack of Efficacy|1|||
27518935|NCT02660138|80095029|FG001|Overall Study|Lack of Efficacy|2|||
27518936|NCT02660138|80095030|FG002|Overall Study|Lack of Efficacy|1|||
27518937|NCT02660138|80095028|FG000|Overall Study|Withdrawal by Subject|7|||
27518938|NCT02660138|80095029|FG001|Overall Study|Withdrawal by Subject|6|||
27518939|NCT02660138|80095030|FG002|Overall Study|Withdrawal by Subject|6|||
27518940|NCT02660138|80095028|FG000|Overall Study|Lost to Follow-up|4|||
27518941|NCT02660138|80095029|FG001|Overall Study|Lost to Follow-up|4|||
27518942|NCT02660138|80095030|FG002|Overall Study|Lost to Follow-up|1|||
27518943|NCT02660138|80095028|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
27518944|NCT02660138|80095029|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
27518945|NCT02660138|80095030|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
27518946|NCT02660138|80095028|FG000|Overall Study|Other|1|||
27518947|NCT02660138|80095029|FG001|Overall Study|Other|1|||
27518948|NCT02660138|80095030|FG002|Overall Study|Other|0|||
27518949|NCT02660138|80095028|FG000|Overall Study|Not treated|0|||
27518950|NCT02660138|80095029|FG001|Overall Study|Not treated|1|||
27518951|NCT02660138|80095030|FG002|Overall Study|Not treated|0|||
27518952|NCT01317550|80095031|FG000|Overall Study|Withdrawal by Subject|1|||
27518953|NCT01317550|80095032|FG001|Overall Study|Withdrawal by Subject|0|||
27518954|NCT01317550|80095033|FG002|Overall Study|Withdrawal by Subject|0|||
27518955|NCT01317550|80095034|FG003|Overall Study|Withdrawal by Subject|0|||
27518956|NCT01317550|80095031|FG000|Overall Study|Lack of compliance study med|1|||
27518957|NCT01317550|80095032|FG001|Overall Study|Lack of compliance study med|0|||
27518958|NCT01317550|80095033|FG002|Overall Study|Lack of compliance study med|0|||
27619063|NCT01511536|80449347|FG001|Phase 2|Other|0|||
27730442|NCT01756456|80842703|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
27730443|NCT01756456|80842704|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
27730444|NCT01756456|80842699|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
27730445|NCT01756456|80842700|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
27853983|NCT01347866|81295210|FG002|Overall Study|Other|1|||
27853984|NCT01347866|81295211|FG003|Overall Study|Other|4|||
27853985|NCT01347866|81295212|FG004|Overall Study|Other|5|||
27853986|NCT01347866|81295213|FG005|Overall Study|Other|0|||
27853987|NCT01347866|81295214|FG006|Overall Study|Other|5|||
27853988|NCT01347866|81295215|FG007|Overall Study|Other|3|||
27853989|NCT01347866|81295216|FG008|Overall Study|Other|22|||
27853990|NCT01347866|81295217|FG009|Overall Study|Other|5|||
27853991|NCT01347866|81295218|FG010|Overall Study|Other|0|||
27853992|NCT01347866|81295219|FG011|Overall Study|Other|3|||
27853993|NCT01347866|81295220|FG012|Overall Study|Other|4|||
27853994|NCT01347866|81295221|FG013|Overall Study|Other|4|||
27908425|NCT01831427|81500617|FG006|Overall Study|Withdrew Consent|2|||
27908426|NCT01831427|81500618|FG007|Overall Study|Withdrew Consent|0|||
27518959|NCT01317550|80095034|FG003|Overall Study|Lack of compliance study med|0|||
27518960|NCT03353740|80095035|FG000|Overall Study|Images for these participants not viable|52|||
27518961|NCT00926029|80095038|FG000|Overall Study|Lost to Follow-up|2|||
27518962|NCT00926029|80095039|FG001|Overall Study|Lost to Follow-up|1|||
27518963|NCT00926029|80095040|FG002|Overall Study|Lost to Follow-up|1|||
27518964|NCT01256294|80095041|FG000|Overall Study|Adverse Event|1|||
27518965|NCT01256294|80095042|FG001|Overall Study|Adverse Event|0|||
27518966|NCT01256294|80095041|FG000|Overall Study|Withdrawal by Subject|1|||
27518967|NCT01256294|80095042|FG001|Overall Study|Withdrawal by Subject|1|||
27518968|NCT01256294|80095041|FG000|Overall Study|Protocol deviation|2|||
27518969|NCT01256294|80095042|FG001|Overall Study|Protocol deviation|1|||
27518970|NCT01395524|80095047|FG000|Overall Study|Non-compliance with study schedule|1|||
27518971|NCT01395524|80095048|FG001|Overall Study|Non-compliance with study schedule|0|||
27853995|NCT01347866|81295222|FG014|Overall Study|Other|2|||
27853996|NCT01347866|81295223|FG015|Overall Study|Other|3|||
27908427|NCT01831427|81500619|FG008|Overall Study|Withdrew Consent|0|||
27908428|NCT01831427|81500620|FG009|Overall Study|Withdrew Consent|1|||
27908429|NCT01831427|81500621|FG010|Overall Study|Withdrew Consent|1|||
27908430|NCT01844817|81500625|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
27908431|NCT01844817|81500626|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
27908432|NCT01844817|81500625|FG000|Treatment|Progressive Disease|27|||
27908433|NCT01844817|81500626|FG001|Treatment|Progressive Disease|36|||
27908434|NCT01844817|81500625|FG000|Treatment|Adverse Event|17|||
27730446|NCT01756456|80842701|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
27730447|NCT01756456|80842702|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
27730448|NCT01756456|80842703|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
27730449|NCT01756456|80842704|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
27730450|NCT01756456|80842699|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
27730451|NCT01756456|80842700|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
27730452|NCT01756456|80842701|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
27730453|NCT01756456|80842702|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
27518972|NCT01395524|80095049|FG002|Overall Study|Non-compliance with study schedule|1|||
27518973|NCT01395524|80095047|FG000|Overall Study|Lost to Follow-up|3|||
27518974|NCT01395524|80095048|FG001|Overall Study|Lost to Follow-up|1|||
27518975|NCT01395524|80095049|FG002|Overall Study|Lost to Follow-up|1|||
27518976|NCT01395524|80095047|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
27518977|NCT01395524|80095048|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
27518978|NCT01395524|80095049|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
27518979|NCT01395524|80095047|FG000|Overall Study|Severe noncompliance with protocol|1|||
27518980|NCT01395524|80095048|FG001|Overall Study|Severe noncompliance with protocol|0|||
27518981|NCT01395524|80095049|FG002|Overall Study|Severe noncompliance with protocol|0|||
27518982|NCT01395524|80095047|FG000|Overall Study|Adverse Event|4|||
27518983|NCT01395524|80095048|FG001|Overall Study|Adverse Event|4|||
27518984|NCT01395524|80095049|FG002|Overall Study|Adverse Event|3|||
27518985|NCT01395524|80095047|FG000|Overall Study|Death|1|||
27518986|NCT01395524|80095048|FG001|Overall Study|Death|0|||
27518987|NCT01395524|80095049|FG002|Overall Study|Death|0|||
27518988|NCT01395524|80095047|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
27730454|NCT01756456|80842703|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
27730455|NCT01756456|80842704|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
27730456|NCT01756456|80842699|FG000|Follow Up Period Phase I/II|Other causes|0|||
27730457|NCT01756456|80842700|FG001|Follow Up Period Phase I/II|Other causes|0|||
27730458|NCT01756456|80842701|FG002|Follow Up Period Phase I/II|Other causes|0|||
27730459|NCT01756456|80842702|FG003|Follow Up Period Phase I/II|Other causes|1|||
27730460|NCT01756456|80842703|FG004|Follow Up Period Phase I/II|Other causes|3|||
27730461|NCT01756456|80842704|FG005|Follow Up Period Phase I/II|Other causes|5|||
27730462|NCT02197377|80842705|FG000|Overall Study|Insertion Failure|0|||
27730463|NCT02197377|80842706|FG001|Overall Study|Insertion Failure|3|||
27730464|NCT01727258|80842707|FG000|Overall Study|Adverse Event|0|||
27730465|NCT01727258|80842708|FG001|Overall Study|Adverse Event|2|||
27730466|NCT01727258|80842709|FG002|Overall Study|Adverse Event|0|||
27730467|NCT01727258|80842707|FG000|Overall Study|Noncompliance with Study Drug|0|||
27730468|NCT01727258|80842708|FG001|Overall Study|Noncompliance with Study Drug|0|||
27730469|NCT01727258|80842709|FG002|Overall Study|Noncompliance with Study Drug|1|||
27730470|NCT01727258|80842707|FG000|Overall Study|Withdrawal by Subject|1|||
27730471|NCT01727258|80842708|FG001|Overall Study|Withdrawal by Subject|1|||
27853997|NCT01347866|81295224|FG016|Overall Study|Other|0|||
27853998|NCT01347866|81295208|FG000|Overall Study|Subject refused further follow-up|2|||
27853999|NCT01347866|81295209|FG001|Overall Study|Subject refused further follow-up|0|||
27854000|NCT01347866|81295210|FG002|Overall Study|Subject refused further follow-up|0|||
27908435|NCT01844817|81500626|FG001|Treatment|Adverse Event|9|||
27908436|NCT01844817|81500625|FG000|Treatment|Withdrawal by Subject|10|||
27908437|NCT01844817|81500626|FG001|Treatment|Withdrawal by Subject|6|||
27908438|NCT01844817|81500625|FG000|Treatment|Death|10|||
27908439|NCT01844817|81500626|FG001|Treatment|Death|8|||
27908440|NCT01844817|81500625|FG000|Treatment|Lost to Follow-up|0|||
27908441|NCT01844817|81500626|FG001|Treatment|Lost to Follow-up|1|||
27854001|NCT01347866|81295211|FG003|Overall Study|Subject refused further follow-up|2|||
27854002|NCT01347866|81295212|FG004|Overall Study|Subject refused further follow-up|0|||
27908442|NCT01844817|81500625|FG000|Treatment|Other|0|||
27908443|NCT01844817|81500626|FG001|Treatment|Other|3|||
27908444|NCT01980628|81500627|FG000|Overall Study|Adverse Event|12|||
27908445|NCT01980628|81500627|FG000|Overall Study|Physician Decision|5|||
27518989|NCT01395524|80095048|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27518990|NCT01395524|80095049|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27518991|NCT01395524|80095047|FG000|Overall Study|Withdrawal by Subject|4|||
27730472|NCT01727258|80842709|FG002|Overall Study|Withdrawal by Subject|0|||
27730473|NCT01727258|80842707|FG000|Overall Study|Lost to Follow-up|1|||
27730474|NCT01727258|80842708|FG001|Overall Study|Lost to Follow-up|0|||
27730475|NCT01727258|80842709|FG002|Overall Study|Lost to Follow-up|0|||
27730476|NCT02586805|80842710|FG000|Overall Study|Withdrawal by Subject|3|||
27908446|NCT01980628|81500627|FG000|Overall Study|Withdrawal by Subject|4|||
27908447|NCT01980628|81500627|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
27518992|NCT01395524|80095048|FG001|Overall Study|Withdrawal by Subject|8|||
27730477|NCT02586805|80842711|FG001|Overall Study|Withdrawal by Subject|1|||
27730478|NCT02586805|80842712|FG002|Overall Study|Withdrawal by Subject|1|||
27730479|NCT02586805|80842713|FG003|Overall Study|Withdrawal by Subject|2|||
27730480|NCT02586805|80842710|FG000|Overall Study|Adverse Event|2|||
27730481|NCT02586805|80842711|FG001|Overall Study|Adverse Event|0|||
27730482|NCT02586805|80842712|FG002|Overall Study|Adverse Event|1|||
27730483|NCT02586805|80842713|FG003|Overall Study|Adverse Event|0|||
27730484|NCT02586805|80842710|FG000|Overall Study|Lost to Follow-up|0|||
27730485|NCT02586805|80842711|FG001|Overall Study|Lost to Follow-up|0|||
27730486|NCT02586805|80842712|FG002|Overall Study|Lost to Follow-up|1|||
27730487|NCT02586805|80842713|FG003|Overall Study|Lost to Follow-up|0|||
27730488|NCT02586805|80842710|FG000|Overall Study|Physician Decision|1|||
27730489|NCT02586805|80842711|FG001|Overall Study|Physician Decision|0|||
27730490|NCT02586805|80842712|FG002|Overall Study|Physician Decision|0|||
27730491|NCT02586805|80842713|FG003|Overall Study|Physician Decision|0|||
27730492|NCT01268293|80842714|FG000|Overall Study|Disease progression|7|||
27854003|NCT01347866|81295213|FG005|Overall Study|Subject refused further follow-up|1|||
27854004|NCT01347866|81295214|FG006|Overall Study|Subject refused further follow-up|0|||
27854005|NCT01347866|81295215|FG007|Overall Study|Subject refused further follow-up|0|||
27854006|NCT01347866|81295216|FG008|Overall Study|Subject refused further follow-up|4|||
27854007|NCT01347866|81295217|FG009|Overall Study|Subject refused further follow-up|1|||
27908448|NCT02815267|81500628|FG000|Double-Blind Phase|Adverse Event|0|||
27908449|NCT02815267|81500629|FG001|Double-Blind Phase|Adverse Event|3|||
27908450|NCT02815267|81500628|FG000|Double-Blind Phase|Lost to Follow-up|17|||
27518993|NCT01395524|80095049|FG002|Overall Study|Withdrawal by Subject|8|||
27730493|NCT01268293|80842714|FG000|Overall Study|Adverse Event|1|||
27730494|NCT01268293|80842714|FG000|Overall Study|Subject choice|1|||
27730495|NCT04003610|80842715|FG000|Overall Study|Lost to Follow-up|0|||
27854008|NCT01347866|81295218|FG010|Overall Study|Subject refused further follow-up|0|||
27854009|NCT01347866|81295219|FG011|Overall Study|Subject refused further follow-up|0|||
27854010|NCT01347866|81295220|FG012|Overall Study|Subject refused further follow-up|1|||
27854011|NCT01347866|81295221|FG013|Overall Study|Subject refused further follow-up|3|||
27854012|NCT01347866|81295222|FG014|Overall Study|Subject refused further follow-up|1|||
27854013|NCT01347866|81295223|FG015|Overall Study|Subject refused further follow-up|0|||
27854014|NCT01347866|81295224|FG016|Overall Study|Subject refused further follow-up|2|||
27854015|NCT02006628|81295230|FG000|Overall Study|Adverse Event|1|||
27854016|NCT02006628|81295231|FG001|Overall Study|Adverse Event|1|||
27854017|NCT02006628|81295230|FG000|Overall Study|Withdrawal by Subject|2|||
27854018|NCT02006628|81295231|FG001|Overall Study|Withdrawal by Subject|1|||
27854019|NCT00856830|81295234|FG000|Irinotecan & Bendamustine|Death|0|||
27854020|NCT00856830|81295235|FG001|Irinotecan & Bendamustine|Death|0|||
27854021|NCT00856830|81295236|FG002|Irinotecan & Bendamustine|Death|0|||
27854022|NCT00856830|81295237|FG003|Irinotecan & Bendamustine|Death|2|||
27854023|NCT00856830|81295234|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
27854024|NCT00856830|81295235|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
27854025|NCT00856830|81295236|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
27854026|NCT00856830|81295237|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
27854027|NCT00673387|81295238|FG000|Overall Study|Withdrawal by Subject|15|||
27854028|NCT00673387|81295239|FG001|Overall Study|Withdrawal by Subject|16|||
27854029|NCT00673387|81295240|FG002|Overall Study|Withdrawal by Subject|20|||
27854030|NCT00673387|81295241|FG003|Overall Study|Withdrawal by Subject|16|||
27854031|NCT00673387|81295242|FG004|Overall Study|Withdrawal by Subject|18|||
27854032|NCT00673387|81295243|FG005|Overall Study|Withdrawal by Subject|21|||
27854033|NCT00673387|81295244|FG006|Overall Study|Withdrawal by Subject|15|||
27854034|NCT00673387|81295245|FG007|Overall Study|Withdrawal by Subject|21|||
27854035|NCT00673387|81295238|FG000|Overall Study|Adverse Event|3|||
27854036|NCT00673387|81295239|FG001|Overall Study|Adverse Event|1|||
27854037|NCT00673387|81295240|FG002|Overall Study|Adverse Event|5|||
27854038|NCT00673387|81295241|FG003|Overall Study|Adverse Event|2|||
27854039|NCT00673387|81295242|FG004|Overall Study|Adverse Event|6|||
27854040|NCT00673387|81295243|FG005|Overall Study|Adverse Event|2|||
27854041|NCT00673387|81295244|FG006|Overall Study|Adverse Event|5|||
27854042|NCT00673387|81295245|FG007|Overall Study|Adverse Event|5|||
27854043|NCT00673387|81295238|FG000|Overall Study|Physician Decision|0|||
27854044|NCT00673387|81295239|FG001|Overall Study|Physician Decision|0|||
27854045|NCT00673387|81295240|FG002|Overall Study|Physician Decision|0|||
27854046|NCT00673387|81295241|FG003|Overall Study|Physician Decision|0|||
27854047|NCT00673387|81295242|FG004|Overall Study|Physician Decision|0|||
27854048|NCT00673387|81295243|FG005|Overall Study|Physician Decision|5|||
27854049|NCT00673387|81295244|FG006|Overall Study|Physician Decision|1|||
27854050|NCT00673387|81295245|FG007|Overall Study|Physician Decision|1|||
27854051|NCT00673387|81295238|FG000|Overall Study|Protocol Violation|3|||
27518994|NCT01395524|80095047|FG000|Overall Study|Did not receive treatment|1|||
27730496|NCT04003610|80842716|FG001|Overall Study|Lost to Follow-up|1|||
27730497|NCT04003610|80842717|FG002|Overall Study|Lost to Follow-up|0|||
27730498|NCT04003610|80842715|FG000|Overall Study|Death|0|||
27730499|NCT04003610|80842716|FG001|Overall Study|Death|0|||
27730500|NCT04003610|80842717|FG002|Overall Study|Death|3|||
27730501|NCT04003610|80842715|FG000|Overall Study|Study Terminated by Sponsor|0|||
27730502|NCT04003610|80842716|FG001|Overall Study|Study Terminated by Sponsor|0|||
27518995|NCT01395524|80095048|FG001|Overall Study|Did not receive treatment|1|||
27730503|NCT04003610|80842717|FG002|Overall Study|Study Terminated by Sponsor|3|||
27730504|NCT01838044|80842718|FG000|Overall Study|Adverse Event|4|||
27730505|NCT01838044|80842719|FG001|Overall Study|Adverse Event|6|||
27730506|NCT01838044|80842718|FG000|Overall Study|Protocol Violation|3|||
27730507|NCT01838044|80842719|FG001|Overall Study|Protocol Violation|3|||
27730508|NCT01838044|80842718|FG000|Overall Study|Withdrawal by Subject|0|||
27730509|NCT01838044|80842719|FG001|Overall Study|Withdrawal by Subject|2|||
27730510|NCT01838044|80842718|FG000|Overall Study|Insufficient clinical response|1|||
27730511|NCT01838044|80842719|FG001|Overall Study|Insufficient clinical response|2|||
27730512|NCT01838044|80842718|FG000|Overall Study|Medication error without associated AE|0|||
27730513|NCT01838044|80842719|FG001|Overall Study|Medication error without associated AE|1|||
27730514|NCT01838044|80842718|FG000|Overall Study|Lost to Follow-up|0|||
27730515|NCT01838044|80842719|FG001|Overall Study|Lost to Follow-up|2|||
27730516|NCT01413958|80842720|FG000|Overall Study|Lost to Follow-up|0|||
27730517|NCT01413958|80842721|FG001|Overall Study|Lost to Follow-up|1|||
27730518|NCT00688909|80842722|FG000|Overall Study|Adverse Event|28|||
27730519|NCT00688909|80842722|FG000|Overall Study|Patient withdrew consent|2|||
27730520|NCT00688909|80842722|FG000|Overall Study|Administrative problems|1|||
27730521|NCT00688909|80842722|FG000|Overall Study|Protocol Violation|2|||
27730522|NCT00548548|80842733|FG000|Overall Study|Death|345|||
27730523|NCT00548548|80842734|FG001|Overall Study|Death|348|||
27730524|NCT00548548|80842733|FG000|Overall Study|Lost to Follow-up|17|||
27730525|NCT00548548|80842734|FG001|Overall Study|Lost to Follow-up|18|||
27730526|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
27730527|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
27730528|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
27730529|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
27730530|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
27730531|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
27730532|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
27730533|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
27730534|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
27730535|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
27730536|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
27730537|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
27730538|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
27730539|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
27730540|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
27730541|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
27730542|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
27730543|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
27730544|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
27730545|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
27730546|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
27730547|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
27854052|NCT00673387|81295239|FG001|Overall Study|Protocol Violation|0|||
27854053|NCT00673387|81295240|FG002|Overall Study|Protocol Violation|1|||
27854054|NCT00673387|81295241|FG003|Overall Study|Protocol Violation|2|||
27854055|NCT00673387|81295242|FG004|Overall Study|Protocol Violation|0|||
27854056|NCT00673387|81295243|FG005|Overall Study|Protocol Violation|1|||
27854057|NCT00673387|81295244|FG006|Overall Study|Protocol Violation|1|||
27854058|NCT00673387|81295245|FG007|Overall Study|Protocol Violation|3|||
27854059|NCT00673387|81295238|FG000|Overall Study|Lost to Follow-up|8|||
27854060|NCT00673387|81295239|FG001|Overall Study|Lost to Follow-up|6|||
27854061|NCT00673387|81295240|FG002|Overall Study|Lost to Follow-up|5|||
27854062|NCT00673387|81295241|FG003|Overall Study|Lost to Follow-up|6|||
27854063|NCT00673387|81295242|FG004|Overall Study|Lost to Follow-up|6|||
27854064|NCT00673387|81295243|FG005|Overall Study|Lost to Follow-up|5|||
27854065|NCT00673387|81295244|FG006|Overall Study|Lost to Follow-up|8|||
27854066|NCT00673387|81295245|FG007|Overall Study|Lost to Follow-up|5|||
27854067|NCT01321008|81295246|FG000|Overall Study|Early Study Termination|1|||
27730548|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
27730549|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
27730550|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
27730551|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
27730552|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
27730553|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
27854068|NCT00975286|81295248|FG000|Overall Study|Adverse Event|9|||
27730554|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
27730555|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
27730556|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
27730557|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
27730558|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
27730559|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
27730560|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
27730561|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
27730562|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
27730563|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
27730564|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
27730565|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
27730566|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
27730567|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
27730568|NCT00100048|80842735|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
27730569|NCT00100048|80842736|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
27730570|NCT00100048|80842737|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
27730571|NCT00100048|80842738|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
27730572|NCT00100048|80842739|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
27730573|NCT00100048|80842740|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
27730574|NCT02347631|80842748|FG000|First Intervention (2 Months)|Adverse Event|1|||
27730575|NCT02347631|80842749|FG001|First Intervention (2 Months)|Adverse Event|1|||
27730576|NCT02347631|80842748|FG000|First Intervention (2 Months)|Pregnancy|1|||
27730577|NCT02347631|80842749|FG001|First Intervention (2 Months)|Pregnancy|0|||
27730578|NCT02347631|80842748|FG000|First Intervention (2 Months)|Moved out of area|0|||
27730579|NCT02347631|80842749|FG001|First Intervention (2 Months)|Moved out of area|2|||
27730580|NCT02347631|80842748|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
27730581|NCT02347631|80842749|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
27730582|NCT02347631|80842748|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
27730583|NCT02347631|80842749|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
27730584|NCT02347631|80842748|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
27730585|NCT02347631|80842749|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
27730586|NCT02347631|80842748|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
27730587|NCT02347631|80842749|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
27730588|NCT02347631|80842748|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
27730589|NCT02347631|80842749|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
27730590|NCT00395967|80842750|FG000|Treatment Period|Failed Mobilization|1|||
27730591|NCT00395967|80842750|FG000|Follow-up Period|Death|1|||
27730592|NCT00395967|80842750|FG000|Follow-up Period|Lost to Follow-up|1|||
27730593|NCT02853760|80842751|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
27730594|NCT02853760|80842752|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
27730595|NCT02853760|80842753|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
27730596|NCT02853760|80842754|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
27730597|NCT02853760|80842755|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
27730598|NCT02853760|80842756|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
27730599|NCT03437447|80842758|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27730600|NCT03437447|80842759|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27730601|NCT03437447|80842760|FG002|Treatment Period 1|Withdrawal by Subject|1|||
27730602|NCT01023789|80842761|FG000|3 - Year Visit|Death|29|||
27854069|NCT00975286|81295249|FG001|Overall Study|Adverse Event|19|||
27854070|NCT00975286|81295248|FG000|Overall Study|Protocol Violation|1|||
27854071|NCT00975286|81295249|FG001|Overall Study|Protocol Violation|2|||
27730603|NCT01023789|80842761|FG000|3 - Year Visit|Withdrawal of consent|1|||
27730604|NCT01023789|80842761|FG000|3 - Year Visit|Lost to Follow-up|13|||
27730605|NCT02507349|80842766|FG000|Overall Study|Death|12|||
27730606|NCT02507349|80842767|FG001|Overall Study|Death|16|||
27730607|NCT02507349|80842766|FG000|Overall Study|Withdrawal by Subject|1|||
27730608|NCT02507349|80842767|FG001|Overall Study|Withdrawal by Subject|1|||
27730609|NCT02507349|80842766|FG000|Overall Study|Lost to Follow-up|174|||
27730610|NCT02507349|80842767|FG001|Overall Study|Lost to Follow-up|144|||
27730611|NCT02959814|80842768|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
27730612|NCT02959814|80842768|FG000|Overall Study|Excluded based on anatomical criteria|2|||
27730613|NCT02959814|80842768|FG000|Overall Study|Protocol Violation|7|||
27730614|NCT02959814|80842768|FG000|Overall Study|FFR not measured|2|||
27730615|NCT02959814|80842768|FG000|Overall Study|In-procedure QFR not computed|6|||
27730616|NCT02959814|80842768|FG000|Overall Study|Excluded by FFR core-lab|24|||
27730617|NCT03219164|80842770|FG000|Overall Study|Study Terminated by Sponsor|16|||
27730618|NCT03219164|80842771|FG001|Overall Study|Study Terminated by Sponsor|12|||
27908451|NCT02815267|81500629|FG001|Double-Blind Phase|Lost to Follow-up|9|||
27908452|NCT02815267|81500628|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
27908453|NCT02815267|81500629|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
27908454|NCT02815267|81500628|FG000|Double-Blind Phase|Protocol Violation|3|||
27908455|NCT02815267|81500629|FG001|Double-Blind Phase|Protocol Violation|2|||
27908456|NCT02815267|81500628|FG000|Double-Blind Phase|Site withdrawal|1|||
27908457|NCT02815267|81500629|FG001|Double-Blind Phase|Site withdrawal|6|||
27518996|NCT01395524|80095049|FG002|Overall Study|Did not receive treatment|3|||
27518997|NCT01395524|80095047|FG000|Overall Study|Subject had spinal surgery|0|||
27518998|NCT01395524|80095048|FG001|Overall Study|Subject had spinal surgery|0|||
27518999|NCT01395524|80095049|FG002|Overall Study|Subject had spinal surgery|1|||
27519000|NCT00600119|80095050|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
27519001|NCT00600119|80095051|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
27519002|NCT00600119|80095052|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
27519003|NCT00600119|80095053|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
27519004|NCT00600119|80095054|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
27519005|NCT00600119|80095055|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
27519006|NCT00600119|80095050|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27519007|NCT00600119|80095051|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
27519008|NCT00600119|80095052|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
27519009|NCT00600119|80095053|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27519010|NCT00600119|80095054|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27519011|NCT00600119|80095055|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27519012|NCT00600119|80095050|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
27519013|NCT00600119|80095051|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
27519014|NCT00600119|80095052|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
27519015|NCT00600119|80095053|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
27519016|NCT00600119|80095054|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
27519017|NCT00600119|80095055|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
27519018|NCT00600119|80095050|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
27519019|NCT00600119|80095051|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27519020|NCT00600119|80095052|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27519021|NCT00600119|80095053|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27519022|NCT00600119|80095054|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27519023|NCT00600119|80095055|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
27519024|NCT00600119|80095050|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
27519025|NCT00600119|80095051|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
27519026|NCT00600119|80095052|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
27519027|NCT00600119|80095053|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
27519028|NCT00600119|80095054|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
27519029|NCT00600119|80095055|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
27519030|NCT00600119|80095050|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
27519031|NCT00600119|80095051|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
27519032|NCT00600119|80095052|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27519033|NCT00600119|80095053|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27519034|NCT00600119|80095054|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27519035|NCT00600119|80095055|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
27519036|NCT00600119|80095050|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
27519037|NCT00600119|80095051|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
27519038|NCT00600119|80095052|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27519039|NCT00600119|80095053|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
27519040|NCT00600119|80095054|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
27519041|NCT00600119|80095055|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
27519042|NCT00600119|80095050|FG000|Double-blind Treatment Period|Other|0|||
27519043|NCT00600119|80095051|FG001|Double-blind Treatment Period|Other|0|||
27519044|NCT00600119|80095052|FG002|Double-blind Treatment Period|Other|0|||
27519045|NCT00600119|80095053|FG003|Double-blind Treatment Period|Other|0|||
27519046|NCT00600119|80095054|FG004|Double-blind Treatment Period|Other|2|||
27519047|NCT00600119|80095055|FG005|Double-blind Treatment Period|Other|1|||
27519048|NCT00600119|80095050|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27519049|NCT00600119|80095051|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
27908458|NCT02815267|81500628|FG000|Double-Blind Phase|Received a disallowed medication|1|||
27519050|NCT00600119|80095052|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27519051|NCT00600119|80095053|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27519052|NCT00600119|80095054|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
27519053|NCT00600119|80095055|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
27519054|NCT00600119|80095050|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27519055|NCT00600119|80095051|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
27519056|NCT00600119|80095052|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27519057|NCT00600119|80095053|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27519058|NCT00600119|80095054|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27519059|NCT00600119|80095055|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
27519060|NCT00600119|80095050|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
27519061|NCT00600119|80095051|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
27519062|NCT00600119|80095052|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
27519063|NCT00600119|80095053|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
27519064|NCT00600119|80095054|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
27519065|NCT00600119|80095055|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
27519066|NCT00600119|80095050|FG000|Double-blind Treatment Period|Physician Decision|2|||
27519067|NCT00600119|80095051|FG001|Double-blind Treatment Period|Physician Decision|0|||
27519068|NCT00600119|80095052|FG002|Double-blind Treatment Period|Physician Decision|0|||
27519069|NCT00600119|80095053|FG003|Double-blind Treatment Period|Physician Decision|0|||
27519070|NCT00600119|80095054|FG004|Double-blind Treatment Period|Physician Decision|0|||
27519071|NCT00600119|80095055|FG005|Double-blind Treatment Period|Physician Decision|0|||
27519072|NCT00600119|80095050|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27519073|NCT00600119|80095051|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
27519074|NCT00600119|80095052|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
27519075|NCT00600119|80095053|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27519076|NCT00600119|80095054|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
27519077|NCT00600119|80095055|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
27519078|NCT00600119|80095050|FG000|Double-blind Treatment Period|Adverse Event|1|||
27519079|NCT00600119|80095051|FG001|Double-blind Treatment Period|Adverse Event|1|||
27519080|NCT00600119|80095052|FG002|Double-blind Treatment Period|Adverse Event|0|||
27519081|NCT00600119|80095053|FG003|Double-blind Treatment Period|Adverse Event|1|||
27519082|NCT00600119|80095054|FG004|Double-blind Treatment Period|Adverse Event|2|||
27519083|NCT00600119|80095055|FG005|Double-blind Treatment Period|Adverse Event|10|||
27519084|NCT00600119|80095050|FG000|Follow-up Period|Adverse Event|0|||
27519085|NCT00600119|80095051|FG001|Follow-up Period|Adverse Event|0|||
27519086|NCT00600119|80095052|FG002|Follow-up Period|Adverse Event|0|||
27519087|NCT00600119|80095053|FG003|Follow-up Period|Adverse Event|0|||
27519088|NCT00600119|80095054|FG004|Follow-up Period|Adverse Event|0|||
27519089|NCT00600119|80095055|FG005|Follow-up Period|Adverse Event|1|||
27519090|NCT00600119|80095050|FG000|Follow-up Period|Other|1|||
27519091|NCT00600119|80095051|FG001|Follow-up Period|Other|0|||
27519092|NCT00600119|80095052|FG002|Follow-up Period|Other|0|||
27519093|NCT00600119|80095053|FG003|Follow-up Period|Other|0|||
27519094|NCT00600119|80095054|FG004|Follow-up Period|Other|0|||
27519095|NCT00600119|80095055|FG005|Follow-up Period|Other|0|||
27519096|NCT04255394|80095059|FG000|Overall Study|Death|35|||
27519097|NCT04255394|80095060|FG001|Overall Study|Death|25|||
27519098|NCT04255394|80095059|FG000|Overall Study|Device removed|2|||
27519099|NCT04255394|80095060|FG001|Overall Study|Device removed|10|||
27519100|NCT04255394|80095059|FG000|Overall Study|Withdrawal by Subject|9|||
27519101|NCT04255394|80095060|FG001|Overall Study|Withdrawal by Subject|8|||
27519102|NCT04255394|80095059|FG000|Overall Study|Screen Failure/Not treated|12|||
27519103|NCT04255394|80095060|FG001|Overall Study|Screen Failure/Not treated|8|||
27519104|NCT04255394|80095059|FG000|Overall Study|Lost to Follow-up|123|||
27519105|NCT04255394|80095060|FG001|Overall Study|Lost to Follow-up|265|||
27519106|NCT04255394|80095059|FG000|Overall Study|Adverse Event|1|||
27519107|NCT04255394|80095060|FG001|Overall Study|Adverse Event|3|||
27519108|NCT03658876|80095061|FG000|Overall Study|Protocol Violation|3|||
27519109|NCT03658876|80095062|FG001|Overall Study|Protocol Violation|2|||
27519110|NCT03658876|80095061|FG000|Overall Study|Withdrawal by Subject|2|||
27519111|NCT03658876|80095062|FG001|Overall Study|Withdrawal by Subject|0|||
27519112|NCT03658876|80095061|FG000|Overall Study|Death|0|||
27519113|NCT03658876|80095062|FG001|Overall Study|Death|1|||
27519114|NCT03658876|80095061|FG000|Overall Study|Intercurrent illness|6|||
27519115|NCT03658876|80095062|FG001|Overall Study|Intercurrent illness|4|||
27519116|NCT03658876|80095061|FG000|Overall Study|Transplantation/other operation|1|||
27519117|NCT03658876|80095062|FG001|Overall Study|Transplantation/other operation|5|||
27519118|NCT01381562|80095063|FG000|Overall Study|Adverse Event|0|||
27519119|NCT01381562|80095064|FG001|Overall Study|Adverse Event|1|||
27519120|NCT01381562|80095065|FG002|Overall Study|Adverse Event|0|||
27519121|NCT03462511|80095066|FG000|Overall Study|Withdrawal by Subject|2|||
27519122|NCT03462511|80095067|FG001|Overall Study|Withdrawal by Subject|3|||
27519123|NCT02338882|80095068|FG000|Overall Study|Death|1|||
27519124|NCT02338882|80095069|FG001|Overall Study|Death|0|||
27519125|NCT02338882|80095068|FG000|Overall Study|Lost to Follow-up|6|||
27519126|NCT02338882|80095069|FG001|Overall Study|Lost to Follow-up|3|||
27519127|NCT03595618|80095070|FG000|Overall Study|Adverse Event|16|||
27519128|NCT03595618|80095071|FG001|Overall Study|Adverse Event|17|||
27519129|NCT03595618|80095072|FG002|Overall Study|Adverse Event|20|||
27519130|NCT03595618|80095073|FG003|Overall Study|Adverse Event|8|||
27519131|NCT03595618|80095070|FG000|Overall Study|Withdrawal by Subject|12|||
27519132|NCT03595618|80095071|FG001|Overall Study|Withdrawal by Subject|14|||
27519133|NCT03595618|80095072|FG002|Overall Study|Withdrawal by Subject|14|||
27519134|NCT03595618|80095073|FG003|Overall Study|Withdrawal by Subject|10|||
27854072|NCT00975286|81295248|FG000|Overall Study|Withdrawal by Subject|0|||
27854073|NCT00975286|81295249|FG001|Overall Study|Withdrawal by Subject|2|||
27854074|NCT00975286|81295248|FG000|Overall Study|Familial and Personal Reasons|2|||
27854075|NCT00975286|81295249|FG001|Overall Study|Familial and Personal Reasons|2|||
27854076|NCT00975286|81295248|FG000|Overall Study|Poor Compliance to Protocol|0|||
27854077|NCT00975286|81295249|FG001|Overall Study|Poor Compliance to Protocol|2|||
27854078|NCT00975286|81295248|FG000|Overall Study|Sponsor Decision|0|||
27854079|NCT00975286|81295249|FG001|Overall Study|Sponsor Decision|2|||
27854080|NCT00816361|81295250|FG000|Overall Study|Withdrawal by Subject|0|||
27854081|NCT00816361|81295251|FG001|Overall Study|Withdrawal by Subject|0|||
27854082|NCT00816361|81295252|FG002|Overall Study|Withdrawal by Subject|0|||
27854083|NCT00816361|81295253|FG003|Overall Study|Withdrawal by Subject|0|||
27854084|NCT00816361|81295254|FG004|Overall Study|Withdrawal by Subject|1|||
27854085|NCT00816361|81295255|FG005|Overall Study|Withdrawal by Subject|2|||
27908459|NCT02815267|81500629|FG001|Double-Blind Phase|Received a disallowed medication|1|||
27908460|NCT02815267|81500628|FG000|Open-Label Phase|Adverse Event|1|||
27854086|NCT00816361|81295256|FG006|Overall Study|Withdrawal by Subject|0|||
27854087|NCT00816361|81295257|FG007|Overall Study|Withdrawal by Subject|2|||
27854088|NCT00816361|81295258|FG008|Overall Study|Withdrawal by Subject|1|||
27854089|NCT00816361|81295250|FG000|Overall Study|Death|4|||
27854090|NCT00816361|81295251|FG001|Overall Study|Death|3|||
27854091|NCT00816361|81295252|FG002|Overall Study|Death|3|||
27854092|NCT00816361|81295253|FG003|Overall Study|Death|3|||
27854093|NCT00816361|81295254|FG004|Overall Study|Death|1|||
27854094|NCT00816361|81295255|FG005|Overall Study|Death|1|||
27854095|NCT00816361|81295256|FG006|Overall Study|Death|3|||
27854096|NCT00816361|81295257|FG007|Overall Study|Death|7|||
27854097|NCT00816361|81295258|FG008|Overall Study|Death|8|||
27854098|NCT00816361|81295250|FG000|Overall Study|Other|0|||
27854099|NCT00816361|81295251|FG001|Overall Study|Other|0|||
27854100|NCT00816361|81295252|FG002|Overall Study|Other|0|||
27854101|NCT00816361|81295253|FG003|Overall Study|Other|0|||
27854102|NCT00816361|81295254|FG004|Overall Study|Other|0|||
27854103|NCT00816361|81295255|FG005|Overall Study|Other|0|||
27854104|NCT00816361|81295256|FG006|Overall Study|Other|0|||
27854105|NCT00816361|81295257|FG007|Overall Study|Other|0|||
27854106|NCT00816361|81295258|FG008|Overall Study|Other|1|||
27854107|NCT01300052|81295261|FG000|Overall Study|Adverse Event|3|||
27854108|NCT01300052|81295262|FG001|Overall Study|Adverse Event|0|||
27854109|NCT01300052|81295261|FG000|Overall Study|Withdrawal by Subject|2|||
27908461|NCT02815267|81500629|FG001|Open-Label Phase|Adverse Event|1|||
27908462|NCT02815267|81500628|FG000|Open-Label Phase|Lost to Follow-up|23|||
27908463|NCT02815267|81500629|FG001|Open-Label Phase|Lost to Follow-up|9|||
27908464|NCT02815267|81500628|FG000|Open-Label Phase|Withdrawal by Subject|24|||
27908465|NCT02815267|81500629|FG001|Open-Label Phase|Withdrawal by Subject|13|||
27908466|NCT02815267|81500628|FG000|Open-Label Phase|Protocol Violation|0|||
27908467|NCT02815267|81500629|FG001|Open-Label Phase|Protocol Violation|1|||
27908468|NCT02815267|81500628|FG000|Open-Label Phase|Administrative|21|||
27908469|NCT02815267|81500629|FG001|Open-Label Phase|Administrative|12|||
27908470|NCT02815267|81500628|FG000|Open-Label Phase|Other|2|||
27908471|NCT02815267|81500629|FG001|Open-Label Phase|Other|5|||
27908472|NCT02306850|81500633|FG000|Overall Study|Lack of Efficacy|2|||
27908473|NCT00158262|81500638|FG000|Overall Study|Lost to Follow-up|1|||
27908474|NCT00158262|81500639|FG001|Overall Study|Lost to Follow-up|1|||
27908475|NCT00824655|81500640|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
27908476|NCT00824655|81500641|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
27908477|NCT00824655|81500640|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
27908478|NCT00824655|81500641|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
27908479|NCT04472494|81500642|FG000|Pre-treatment|Other reasons|2|||
27908480|NCT04472494|81500643|FG001|Pre-treatment|Other reasons|0|||
27908481|NCT04472494|81500642|FG000|Treatment|Death|5|||
27908482|NCT04472494|81500643|FG001|Treatment|Death|2|||
27908483|NCT04472494|81500642|FG000|Treatment|Hospital discharge|1|||
27908484|NCT04472494|81500643|FG001|Treatment|Hospital discharge|1|||
27854110|NCT01300052|81295262|FG001|Overall Study|Withdrawal by Subject|2|||
27854111|NCT01300052|81295261|FG000|Overall Study|Protocol Violation|1|||
27908485|NCT01962948|81500644|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
27908486|NCT01962948|81500645|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
27958628|NCT01791517|81680064|FG006|Phase II|Lens Handling Difficulties|0|||
27854112|NCT01300052|81295262|FG001|Overall Study|Protocol Violation|1|||
27519135|NCT03595618|80095070|FG000|Overall Study|Lost to Follow-up|6|||
27908487|NCT01962948|81500646|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
27908488|NCT01962948|81500647|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
27908489|NCT01467271|81500648|FG000|Overall Study|Death|84|||
27908490|NCT01467271|81500648|FG000|Overall Study|Lost to Follow-up|83|||
27908491|NCT01467271|81500648|FG000|Overall Study|Retraction of patient's consent|21|||
27908492|NCT01467271|81500648|FG000|Overall Study|Other reason|14|||
27908493|NCT02164318|81500649|FG000|Overall Study|Withdrawal by Subject|0|||
27908494|NCT02164318|81500650|FG001|Overall Study|Withdrawal by Subject|1|||
27908495|NCT02164318|81500651|FG002|Overall Study|Withdrawal by Subject|0|||
27908496|NCT02164318|81500652|FG003|Overall Study|Withdrawal by Subject|1|||
27908497|NCT05568797|81500653|FG000|Overall Study|Adverse Event|0|||
27908498|NCT05568797|81500654|FG001|Overall Study|Adverse Event|8|||
27908499|NCT05568797|81500653|FG000|Overall Study|Lost to Follow-up|2|||
27908500|NCT05568797|81500654|FG001|Overall Study|Lost to Follow-up|3|||
27908501|NCT05568797|81500653|FG000|Overall Study|Withdrawal by Subject|1|||
27908502|NCT05568797|81500654|FG001|Overall Study|Withdrawal by Subject|10|||
27908503|NCT05568797|81500653|FG000|Overall Study|Other|2|||
27908504|NCT05568797|81500654|FG001|Overall Study|Other|2|||
27908505|NCT00809094|81500655|FG000|Overall Study|Lost to Follow-up|0|||
27908506|NCT00809094|81500656|FG001|Overall Study|Lost to Follow-up|1|||
27908507|NCT03076996|81500659|FG000|Overall Study|Withdrawal by Subject|2|||
27908508|NCT03076996|81500659|FG000|Overall Study|Lost to Follow-up|3|||
27908509|NCT03076996|81500659|FG000|Overall Study|Literacy precluded participation|1|||
27908510|NCT01462110|81500667|FG000|Overall Study|Adverse Event|1|||
27908511|NCT01462110|81500668|FG001|Overall Study|Adverse Event|0|||
27908512|NCT01990573|81500669|FG000|Overall Study|Physician Decision|0|||
27908513|NCT01990573|81500670|FG001|Overall Study|Physician Decision|0|||
27908514|NCT01990573|81500671|FG002|Overall Study|Physician Decision|1|||
27908515|NCT01054222|81500672|FG000|Overall Study|Lack of Efficacy|1|||
27908516|NCT01054222|81500672|FG000|Overall Study|Lost to Follow-up|4|||
27908517|NCT01054222|81500672|FG000|Overall Study|Withdrawal by Subject|6|||
27908518|NCT03373760|81500676|FG000|Overall Study|Adverse Event|8|||
27908519|NCT03373760|81500676|FG000|Overall Study|Disease Progression|46|||
27908520|NCT03373760|81500676|FG000|Overall Study|Death|4|||
27908521|NCT02600923|81503279|FG000|Overall Study|Death|10|||
27908522|NCT02600923|81503279|FG000|Overall Study|Adverse Event|3|||
27908523|NCT02600923|81503279|FG000|Overall Study|Global deterioration of health status|2|||
27908524|NCT02600923|81503279|FG000|Overall Study|Insufficient clinical response|6|||
27908525|NCT02600923|81503279|FG000|Overall Study|Lost to Follow-up|1|||
27908526|NCT02600923|81503279|FG000|Overall Study|Withdrawal by Subject|5|||
27908527|NCT02600923|81503279|FG000|Overall Study|Objective progression or relapse|50|||
27908528|NCT02600923|81503279|FG000|Overall Study|Study terminated by Sponsor|53|||
27908529|NCT02600923|81503279|FG000|Overall Study|Not treated|1|||
27908530|NCT04888494|81503280|FG000|Overall Study|Lost to Follow-up|2|||
27908531|NCT04888494|81503281|FG001|Overall Study|Lost to Follow-up|3|||
27908532|NCT04888494|81503280|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
27908533|NCT04888494|81503281|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
27908534|NCT00186485|81503283|FG000|Overall Study|Lost to Follow-up|3|||
27908535|NCT02793947|81503284|FG000|Overall Study|Death|1|||
27908536|NCT02793947|81503285|FG001|Overall Study|Death|0|||
27908537|NCT02793947|81503284|FG000|Overall Study|Physician Decision|1|||
27908538|NCT02793947|81503285|FG001|Overall Study|Physician Decision|5|||
27908539|NCT01909973|81503287|FG000|Overall Study|Lost to Follow-up|1|||
27908540|NCT01909973|81503288|FG001|Overall Study|Lost to Follow-up|0|||
27908541|NCT00003896|81503289|FG000|Overall Study|Adverse Event|16|||
27908542|NCT00003896|81503289|FG000|Overall Study|Withdrawal by Subject|1|||
27908543|NCT00003896|81503289|FG000|Overall Study|Lack of Efficacy|1|||
27908544|NCT00003896|81503289|FG000|Overall Study|Death|3|||
27908545|NCT00003896|81503289|FG000|Overall Study|not protocol specified|3|||
27908546|NCT00003896|81503289|FG000|Overall Study|ineligible|5|||
27908547|NCT05464420|81503296|FG000|Overall Study|Death|0|||
27908548|NCT05464420|81503297|FG001|Overall Study|Death|0|||
27519136|NCT03595618|80095071|FG001|Overall Study|Lost to Follow-up|4|||
27619064|NCT01511536|80449348|FG002|Phase 2|Other|9|||
27908549|NCT05464420|81503298|FG002|Overall Study|Death|0|||
27908550|NCT05464420|81503299|FG003|Overall Study|Death|1|||
27908551|NCT05464420|81503296|FG000|Overall Study|Lost to Follow-up|16|||
27908552|NCT05464420|81503297|FG001|Overall Study|Lost to Follow-up|11|||
27908553|NCT05464420|81503298|FG002|Overall Study|Lost to Follow-up|11|||
27908554|NCT05464420|81503299|FG003|Overall Study|Lost to Follow-up|11|||
27908555|NCT05464420|81503296|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
27619065|NCT04707391|80449349|FG000|Overall Study|Adverse Event|5|||
27908556|NCT05464420|81503297|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
27908557|NCT05464420|81503298|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
27908558|NCT05464420|81503299|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
27619066|NCT04707391|80449350|FG001|Overall Study|Adverse Event|8|||
27908559|NCT05464420|81503296|FG000|Overall Study|Withdrawal by Subject|4|||
27730619|NCT03219164|80842770|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
27619067|NCT04707391|80449349|FG000|Overall Study|Lost to Follow-up|44|||
27619068|NCT04707391|80449350|FG001|Overall Study|Lost to Follow-up|31|||
27619069|NCT04707391|80449349|FG000|Overall Study|Protocol Violation|1|||
27619070|NCT04707391|80449350|FG001|Overall Study|Protocol Violation|5|||
27619071|NCT04707391|80449349|FG000|Overall Study|Withdrawal by Subject|27|||
27619072|NCT04707391|80449350|FG001|Overall Study|Withdrawal by Subject|25|||
27619073|NCT04707391|80449349|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
27619074|NCT04707391|80449350|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
27619075|NCT04707391|80449349|FG000|Overall Study|Other|0|||
27619076|NCT04707391|80449350|FG001|Overall Study|Other|2|||
27619077|NCT00848211|80449358|FG000|Overall Study|Protocol Violation|0|||
27619078|NCT00848211|80449359|FG001|Overall Study|Protocol Violation|1|||
27619079|NCT00848211|80449360|FG002|Overall Study|Protocol Violation|1|||
27619080|NCT00848211|80449361|FG003|Overall Study|Protocol Violation|0|||
27619081|NCT00848211|80449358|FG000|Overall Study|Adverse Event|0|||
27619082|NCT00848211|80449359|FG001|Overall Study|Adverse Event|0|||
27619083|NCT00848211|80449360|FG002|Overall Study|Adverse Event|0|||
27619084|NCT00848211|80449361|FG003|Overall Study|Adverse Event|0|||
27619085|NCT03738241|80449364|FG000|Overall Study|Withdrawal by Subject|0|||
27619086|NCT03738241|80449365|FG001|Overall Study|Withdrawal by Subject|0|||
27619087|NCT03738241|80449366|FG002|Overall Study|Withdrawal by Subject|0|||
27619088|NCT03738241|80449367|FG003|Overall Study|Withdrawal by Subject|0|||
27619089|NCT03738241|80449368|FG004|Overall Study|Withdrawal by Subject|0|||
27619090|NCT03738241|80449369|FG005|Overall Study|Withdrawal by Subject|0|||
27619091|NCT03738241|80449370|FG006|Overall Study|Withdrawal by Subject|0|||
27619092|NCT03738241|80449371|FG007|Overall Study|Withdrawal by Subject|0|||
27619093|NCT03738241|80449372|FG008|Overall Study|Withdrawal by Subject|0|||
27619094|NCT03738241|80449373|FG009|Overall Study|Withdrawal by Subject|1|||
27619095|NCT03738241|80449364|FG000|Overall Study|Physician Decision|0|||
27619096|NCT03738241|80449365|FG001|Overall Study|Physician Decision|0|||
27619097|NCT03738241|80449366|FG002|Overall Study|Physician Decision|0|||
27619098|NCT03738241|80449367|FG003|Overall Study|Physician Decision|0|||
27619099|NCT03738241|80449368|FG004|Overall Study|Physician Decision|0|||
27619100|NCT03738241|80449369|FG005|Overall Study|Physician Decision|0|||
27619101|NCT03738241|80449370|FG006|Overall Study|Physician Decision|0|||
27619102|NCT03738241|80449371|FG007|Overall Study|Physician Decision|0|||
27619103|NCT03738241|80449372|FG008|Overall Study|Physician Decision|1|||
27619104|NCT03738241|80449373|FG009|Overall Study|Physician Decision|0|||
27619105|NCT03738241|80449364|FG000|Overall Study|Adverse Event|1|||
27619106|NCT03738241|80449365|FG001|Overall Study|Adverse Event|0|||
27619107|NCT03738241|80449366|FG002|Overall Study|Adverse Event|0|||
27619108|NCT03738241|80449367|FG003|Overall Study|Adverse Event|0|||
27619109|NCT03738241|80449368|FG004|Overall Study|Adverse Event|0|||
27619110|NCT03738241|80449369|FG005|Overall Study|Adverse Event|0|||
27619111|NCT03738241|80449370|FG006|Overall Study|Adverse Event|0|||
27619112|NCT03738241|80449371|FG007|Overall Study|Adverse Event|0|||
27619113|NCT03738241|80449372|FG008|Overall Study|Adverse Event|0|||
27619114|NCT03738241|80449373|FG009|Overall Study|Adverse Event|0|||
27619115|NCT03660943|80449374|FG000|Overall Study|Adverse Event|5|||
27619116|NCT03660943|80449375|FG001|Overall Study|Adverse Event|3|||
27619117|NCT03660943|80449374|FG000|Overall Study|Death|0|||
27619118|NCT03660943|80449375|FG001|Overall Study|Death|2|||
27619119|NCT03660943|80449374|FG000|Overall Study|Lost to Follow-up|7|||
27619120|NCT03660943|80449375|FG001|Overall Study|Lost to Follow-up|3|||
27619121|NCT03660943|80449374|FG000|Overall Study|Protocol Violation|3|||
27619122|NCT03660943|80449375|FG001|Overall Study|Protocol Violation|5|||
27619123|NCT03660943|80449374|FG000|Overall Study|Withdrawal by Subject|8|||
27619124|NCT03660943|80449375|FG001|Overall Study|Withdrawal by Subject|15|||
27619125|NCT03660943|80449374|FG000|Overall Study|Lack of Efficacy|9|||
27619126|NCT03660943|80449375|FG001|Overall Study|Lack of Efficacy|12|||
27619127|NCT03660943|80449374|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
27730620|NCT03219164|80842771|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
27730621|NCT03219164|80842770|FG000|Overall Study|Lost to Follow-up|1|||
27854113|NCT02746471|81298692|FG000|Overall Study|Death|43|||
27854114|NCT02746471|81298692|FG000|Overall Study|Exited before 36 months|1119|||
27854115|NCT00761865|81298693|FG000|Overall Study|Lost to Follow-up|8|||
27854116|NCT00761865|81298694|FG001|Overall Study|Lost to Follow-up|7|||
27854117|NCT03914950|81298695|FG000|Overall Study|Physician Decision|54|||
27854118|NCT02269163|81298696|FG000|Overall Study|Lost to Follow-up|1|||
27854119|NCT02269163|81298697|FG001|Overall Study|Lost to Follow-up|0|||
27854120|NCT02269163|81298696|FG000|Overall Study|Major protocol violation|0|||
27854121|NCT02269163|81298697|FG001|Overall Study|Major protocol violation|1|||
27619128|NCT03660943|80449375|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
27730622|NCT03219164|80842771|FG001|Overall Study|Lost to Follow-up|1|||
27619129|NCT01458275|80449376|FG000|Overall Study|Adverse Event|3|||
27619130|NCT01458275|80449377|FG001|Overall Study|Adverse Event|4|||
27619131|NCT01458275|80449378|FG002|Overall Study|Adverse Event|1|||
27519137|NCT03595618|80095072|FG002|Overall Study|Lost to Follow-up|5|||
27519138|NCT03595618|80095073|FG003|Overall Study|Lost to Follow-up|6|||
27519139|NCT03595618|80095070|FG000|Overall Study|Protocol Violation|2|||
27519140|NCT03595618|80095071|FG001|Overall Study|Protocol Violation|0|||
27519141|NCT03595618|80095072|FG002|Overall Study|Protocol Violation|6|||
27519142|NCT03595618|80095073|FG003|Overall Study|Protocol Violation|2|||
27519143|NCT03595618|80095070|FG000|Overall Study|Physician Decision|0|||
27519144|NCT03595618|80095071|FG001|Overall Study|Physician Decision|0|||
27519145|NCT03595618|80095072|FG002|Overall Study|Physician Decision|1|||
27519146|NCT03595618|80095073|FG003|Overall Study|Physician Decision|2|||
27519147|NCT03595618|80095070|FG000|Overall Study|Miscellaneous|7|||
27519148|NCT03595618|80095071|FG001|Overall Study|Miscellaneous|5|||
27519149|NCT03595618|80095072|FG002|Overall Study|Miscellaneous|10|||
27519150|NCT03595618|80095073|FG003|Overall Study|Miscellaneous|6|||
27519151|NCT00798759|80095082|FG000|Overall Study|Adverse Event|3|||
27519152|NCT00798759|80095083|FG001|Overall Study|Adverse Event|3|||
27519153|NCT00798759|80095082|FG000|Overall Study|Lost to Follow-up|1|||
27519154|NCT00798759|80095083|FG001|Overall Study|Lost to Follow-up|1|||
27519155|NCT00798759|80095082|FG000|Overall Study|Protocol Violation|4|||
27519156|NCT00798759|80095083|FG001|Overall Study|Protocol Violation|8|||
27519157|NCT00798759|80095082|FG000|Overall Study|Other|0|||
27519158|NCT00798759|80095083|FG001|Overall Study|Other|1|||
27519159|NCT00638183|80095088|FG000|Overall Study|Adverse Event|23|||
27519160|NCT00638183|80095088|FG000|Overall Study|Lack of Efficacy|14|||
27519161|NCT00638183|80095088|FG000|Overall Study|Physician Decision|9|||
27519162|NCT00638183|80095088|FG000|Overall Study|Lost to Follow-up|46|||
27519163|NCT00638183|80095088|FG000|Overall Study|Other reason not defined above|27|||
27519164|NCT02894502|80095092|FG000|Baseline|Withdrawal by Subject|24|||
27519165|NCT02894502|80095093|FG001|Baseline|Withdrawal by Subject|31|||
27519166|NCT02894502|80095094|FG002|Baseline|Withdrawal by Subject|36|||
27519167|NCT02894502|80095092|FG000|Baseline|Death|3|||
27519168|NCT02894502|80095093|FG001|Baseline|Death|1|||
27519169|NCT02894502|80095094|FG002|Baseline|Death|9|||
27519170|NCT02894502|80095092|FG000|First Follow up|Withdrawal by Subject|32|||
27519171|NCT02894502|80095093|FG001|First Follow up|Withdrawal by Subject|29|||
27519172|NCT02894502|80095094|FG002|First Follow up|Withdrawal by Subject|37|||
27519173|NCT02894502|80095092|FG000|First Follow up|Death|2|||
27519174|NCT02894502|80095093|FG001|First Follow up|Death|2|||
27519175|NCT02894502|80095094|FG002|First Follow up|Death|3|||
27519176|NCT02894502|80095092|FG000|Second Follow up|Withdrawal by Subject|13|||
27519177|NCT02894502|80095093|FG001|Second Follow up|Withdrawal by Subject|15|||
27519178|NCT02894502|80095094|FG002|Second Follow up|Withdrawal by Subject|13|||
27519179|NCT02894502|80095092|FG000|Second Follow up|Death|2|||
27519180|NCT02894502|80095093|FG001|Second Follow up|Death|3|||
27519181|NCT02894502|80095094|FG002|Second Follow up|Death|1|||
27519182|NCT02894502|80095092|FG000|Third Follow up|Withdrawal by Subject|5|||
27519183|NCT02894502|80095093|FG001|Third Follow up|Withdrawal by Subject|6|||
27519184|NCT02894502|80095094|FG002|Third Follow up|Withdrawal by Subject|3|||
27519185|NCT02894502|80095092|FG000|Third Follow up|Death|1|||
27519186|NCT02894502|80095093|FG001|Third Follow up|Death|1|||
27519187|NCT02894502|80095094|FG002|Third Follow up|Death|0|||
27519188|NCT00792571|80095097|FG000|Overall Study|Death|1|||
27519189|NCT00792571|80095097|FG000|Overall Study|Adverse Event|4|||
27519190|NCT00792571|80095097|FG000|Overall Study|Withdrawal by Subject|1|||
27519191|NCT00792571|80095097|FG000|Overall Study|Other|4|||
27519192|NCT03836001|80095098|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
27519193|NCT03836001|80095099|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
27519194|NCT03836001|80095100|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
27519195|NCT03836001|80095098|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
27519196|NCT03836001|80095099|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
27519197|NCT03836001|80095100|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
27519198|NCT03836001|80095098|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
27519199|NCT03836001|80095099|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
27519200|NCT03836001|80095100|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
27519201|NCT03836001|80095098|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
27519202|NCT03836001|80095099|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
27519203|NCT03836001|80095100|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
27519204|NCT01589653|80095101|FG000|Overall Study|Protocol Violation|3|||
27519205|NCT01589653|80095102|FG001|Overall Study|Protocol Violation|1|||
27519206|NCT01589653|80095101|FG000|Overall Study|Withdrawal criteria|4|||
27619132|NCT01458275|80449376|FG000|Overall Study|Lost to Follow-up|3|||
27619133|NCT01458275|80449377|FG001|Overall Study|Lost to Follow-up|2|||
27519207|NCT01589653|80095102|FG001|Overall Study|Withdrawal criteria|7|||
27519208|NCT01589653|80095101|FG000|Overall Study|Unclassified|0|||
27519209|NCT01589653|80095102|FG001|Overall Study|Unclassified|3|||
27519210|NCT03179202|80095103|FG000|Overall Study|Screen Failure|67|||
27519211|NCT03179202|80095103|FG000|Overall Study|Subject Lost to Follow Up|12|||
27519212|NCT03179202|80095103|FG000|Overall Study|Withdrawal by Subject|7|||
27519213|NCT03179202|80095103|FG000|Overall Study|Adverse Event|3|||
27519214|NCT03179202|80095103|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
27519215|NCT03179202|80095103|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
27519216|NCT04493892|80095106|FG000|Overall Study|Withdrawal by Subject|15|||
27519217|NCT03598114|80095107|FG000|Overall Study|Staff turnover/left the program|3|||
27519218|NCT03598114|80095108|FG001|Overall Study|Staff turnover/left the program|39|||
27519219|NCT03255083|80095113|FG000|Overall Study|Clinical progression|1|||
27519220|NCT03255083|80095114|FG001|Overall Study|Clinical progression|0|||
27519221|NCT03255083|80095115|FG002|Overall Study|Clinical progression|0|||
27519222|NCT03255083|80095116|FG003|Overall Study|Clinical progression|0|||
27519223|NCT03255083|80095113|FG000|Overall Study|Adverse Event|0|||
27519224|NCT03255083|80095114|FG001|Overall Study|Adverse Event|1|||
27519225|NCT03255083|80095115|FG002|Overall Study|Adverse Event|0|||
27519226|NCT03255083|80095116|FG003|Overall Study|Adverse Event|0|||
27519227|NCT03255083|80095113|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
27519228|NCT03255083|80095114|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
27519229|NCT03255083|80095115|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
27519230|NCT03255083|80095116|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
27519231|NCT03255083|80095113|FG000|Overall Study|Withdrawal by Subject|1|||
27519232|NCT03255083|80095114|FG001|Overall Study|Withdrawal by Subject|1|||
27519233|NCT03255083|80095115|FG002|Overall Study|Withdrawal by Subject|1|||
27519234|NCT03255083|80095116|FG003|Overall Study|Withdrawal by Subject|0|||
27519235|NCT00966875|80095117|FG000|Part A|Adverse Event|2|||
27519236|NCT00966875|80095118|FG001|Part A|Adverse Event|1|||
27519237|NCT00966875|80095119|FG002|Part A|Adverse Event|0|||
27519238|NCT00966875|80095120|FG003|Part A|Adverse Event|1|||
27519239|NCT00966875|80095121|FG004|Part A|Adverse Event|0|||
27519240|NCT00966875|80095122|FG005|Part A|Adverse Event|1|||
27519241|NCT00966875|80095123|FG006|Part A|Adverse Event|0|||
27519242|NCT00966875|80095124|FG007|Part A|Adverse Event|3|||
27519243|NCT00966875|80095125|FG008|Part A|Adverse Event|3|||
27519244|NCT00966875|80095117|FG000|Part A|Entry Criteria|0|||
27519245|NCT00966875|80095118|FG001|Part A|Entry Criteria|0|||
27519246|NCT00966875|80095119|FG002|Part A|Entry Criteria|0|||
27519247|NCT00966875|80095120|FG003|Part A|Entry Criteria|0|||
27519248|NCT00966875|80095121|FG004|Part A|Entry Criteria|0|||
27519249|NCT00966875|80095122|FG005|Part A|Entry Criteria|2|||
27519250|NCT00966875|80095123|FG006|Part A|Entry Criteria|0|||
27519251|NCT00966875|80095124|FG007|Part A|Entry Criteria|0|||
27519252|NCT00966875|80095125|FG008|Part A|Entry Criteria|0|||
27519253|NCT00966875|80095117|FG000|Part A|Lack of Efficacy|0|||
27519254|NCT00966875|80095118|FG001|Part A|Lack of Efficacy|1|||
27519255|NCT00966875|80095119|FG002|Part A|Lack of Efficacy|0|||
27519256|NCT00966875|80095120|FG003|Part A|Lack of Efficacy|0|||
27519257|NCT00966875|80095121|FG004|Part A|Lack of Efficacy|0|||
27519258|NCT00966875|80095122|FG005|Part A|Lack of Efficacy|0|||
27519259|NCT00966875|80095123|FG006|Part A|Lack of Efficacy|4|||
27519260|NCT00966875|80095124|FG007|Part A|Lack of Efficacy|0|||
27519261|NCT00966875|80095125|FG008|Part A|Lack of Efficacy|0|||
27519262|NCT00966875|80095117|FG000|Part A|Lost to Follow-up|2|||
27519263|NCT00966875|80095118|FG001|Part A|Lost to Follow-up|0|||
27519264|NCT00966875|80095119|FG002|Part A|Lost to Follow-up|0|||
27519265|NCT00966875|80095120|FG003|Part A|Lost to Follow-up|0|||
27519266|NCT00966875|80095121|FG004|Part A|Lost to Follow-up|0|||
27519267|NCT00966875|80095122|FG005|Part A|Lost to Follow-up|1|||
27519268|NCT00966875|80095123|FG006|Part A|Lost to Follow-up|0|||
27519269|NCT00966875|80095124|FG007|Part A|Lost to Follow-up|0|||
27519270|NCT00966875|80095125|FG008|Part A|Lost to Follow-up|0|||
27519271|NCT00966875|80095117|FG000|Part A|Parent/Caregiver Decision|0|||
27854122|NCT02269163|81298696|FG000|Overall Study|Other|2|||
27519272|NCT00966875|80095118|FG001|Part A|Parent/Caregiver Decision|0|||
27519273|NCT00966875|80095119|FG002|Part A|Parent/Caregiver Decision|0|||
27519274|NCT00966875|80095120|FG003|Part A|Parent/Caregiver Decision|1|||
27519275|NCT00966875|80095121|FG004|Part A|Parent/Caregiver Decision|0|||
27519276|NCT00966875|80095122|FG005|Part A|Parent/Caregiver Decision|0|||
27519277|NCT00966875|80095123|FG006|Part A|Parent/Caregiver Decision|0|||
27519278|NCT00966875|80095124|FG007|Part A|Parent/Caregiver Decision|0|||
27519279|NCT00966875|80095125|FG008|Part A|Parent/Caregiver Decision|0|||
27519280|NCT00966875|80095117|FG000|Part A|Physician Decision|0|||
27519281|NCT00966875|80095118|FG001|Part A|Physician Decision|0|||
27519282|NCT00966875|80095119|FG002|Part A|Physician Decision|0|||
27519283|NCT00966875|80095120|FG003|Part A|Physician Decision|0|||
27519284|NCT00966875|80095121|FG004|Part A|Physician Decision|1|||
27519285|NCT00966875|80095122|FG005|Part A|Physician Decision|0|||
27519286|NCT00966875|80095123|FG006|Part A|Physician Decision|1|||
27519287|NCT00966875|80095124|FG007|Part A|Physician Decision|0|||
27519288|NCT00966875|80095125|FG008|Part A|Physician Decision|2|||
27519289|NCT00966875|80095117|FG000|Part A|Sponsor Decision|0|||
27519290|NCT00966875|80095118|FG001|Part A|Sponsor Decision|0|||
27519291|NCT00966875|80095119|FG002|Part A|Sponsor Decision|1|||
27519292|NCT00966875|80095120|FG003|Part A|Sponsor Decision|0|||
27519293|NCT00966875|80095121|FG004|Part A|Sponsor Decision|1|||
27519294|NCT00966875|80095122|FG005|Part A|Sponsor Decision|0|||
27519295|NCT00966875|80095123|FG006|Part A|Sponsor Decision|0|||
27730623|NCT03219164|80842770|FG000|Overall Study|Adverse Event|1|||
27730624|NCT03219164|80842771|FG001|Overall Study|Adverse Event|0|||
27730625|NCT03219164|80842770|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27730626|NCT03219164|80842771|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27730627|NCT03219164|80842770|FG000|Overall Study|Protocol Violation|0|||
27730628|NCT03219164|80842771|FG001|Overall Study|Protocol Violation|1|||
27730629|NCT03219164|80842770|FG000|Overall Study|Withdrew Assent|1|||
27730630|NCT03219164|80842771|FG001|Overall Study|Withdrew Assent|0|||
27730631|NCT00430755|80842772|FG000|Overall Study|Withdrawal by Subject|53|||
27730632|NCT01562028|80842773|FG000|Overall Study|Withdrawal by Subject|1|||
27730633|NCT01562028|80842774|FG001|Overall Study|Withdrawal by Subject|1|||
27730634|NCT01562028|80842773|FG000|Overall Study|Lost to Follow-up|2|||
27730635|NCT01562028|80842774|FG001|Overall Study|Lost to Follow-up|1|||
27730636|NCT02495948|80842775|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
27730637|NCT02495948|80842776|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
27730638|NCT02495948|80842775|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
27730639|NCT02495948|80842776|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
27730640|NCT04223609|80842777|FG000|Overall Study|Adverse Event|0|||
27730641|NCT04223609|80842778|FG001|Overall Study|Adverse Event|1|||
27730642|NCT04223609|80842777|FG000|Overall Study|Missed last visit|0|||
27730643|NCT04223609|80842778|FG001|Overall Study|Missed last visit|1|||
27730644|NCT01946178|80842787|FG000|Overall Study|Pregnancy|1|||
27730645|NCT01946178|80842787|FG000|Overall Study|Lost to Follow-up|1|||
27730646|NCT03588741|80842788|FG000|Overall Study|Withdrawal by Subject|1|||
27730647|NCT00828464|80842791|FG000|Overall Study|Withdrawal by Subject|1|||
27730648|NCT00868790|80842792|FG000|Period 1|Adverse Event|1|||
27730649|NCT00868790|80842793|FG001|Period 1|Adverse Event|0|||
27730650|NCT00868790|80842794|FG002|Period 1|Adverse Event|0|||
27730651|NCT00868790|80842795|FG003|Period 1|Adverse Event|0|||
27730652|NCT00868790|80842796|FG004|Period 1|Adverse Event|0|||
27730653|NCT00868790|80842797|FG005|Period 1|Adverse Event|0|||
27908560|NCT05464420|81503297|FG001|Overall Study|Withdrawal by Subject|8|||
27730654|NCT00868790|80842798|FG006|Period 1|Adverse Event|0|||
27730655|NCT00868790|80842799|FG007|Period 1|Adverse Event|3|||
27730656|NCT00868790|80842800|FG008|Period 1|Adverse Event|1|||
27730657|NCT00868790|80842801|FG009|Period 1|Adverse Event|0|||
27730658|NCT00868790|80842802|FG010|Period 1|Adverse Event|0|||
27730659|NCT00868790|80842803|FG011|Period 1|Adverse Event|0|||
27730660|NCT00868790|80842804|FG012|Period 1|Adverse Event|0|||
27730661|NCT00868790|80842805|FG013|Period 1|Adverse Event|1|||
27730662|NCT00868790|80842792|FG000|Period 1|Protocol Violation|1|||
27730663|NCT00868790|80842793|FG001|Period 1|Protocol Violation|0|||
27730664|NCT00868790|80842794|FG002|Period 1|Protocol Violation|0|||
27908561|NCT05464420|81503298|FG002|Overall Study|Withdrawal by Subject|3|||
27908562|NCT05464420|81503299|FG003|Overall Study|Withdrawal by Subject|1|||
27908563|NCT05464420|81503296|FG000|Overall Study|Protocol Violation|0|||
27908564|NCT05464420|81503297|FG001|Overall Study|Protocol Violation|0|||
27908565|NCT05464420|81503298|FG002|Overall Study|Protocol Violation|1|||
27908566|NCT05464420|81503299|FG003|Overall Study|Protocol Violation|1|||
27908567|NCT05464420|81503296|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
27908568|NCT05464420|81503297|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
27908569|NCT05464420|81503298|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
27519296|NCT00966875|80095124|FG007|Part A|Sponsor Decision|2|||
27519297|NCT00966875|80095125|FG008|Part A|Sponsor Decision|1|||
27519298|NCT00966875|80095117|FG000|Part A|Withdrawal by Subject|2|||
27519299|NCT00966875|80095118|FG001|Part A|Withdrawal by Subject|2|||
27519300|NCT00966875|80095119|FG002|Part A|Withdrawal by Subject|1|||
27519301|NCT00966875|80095120|FG003|Part A|Withdrawal by Subject|1|||
27519302|NCT00966875|80095121|FG004|Part A|Withdrawal by Subject|3|||
27519303|NCT00966875|80095122|FG005|Part A|Withdrawal by Subject|0|||
27519304|NCT00966875|80095123|FG006|Part A|Withdrawal by Subject|5|||
27519305|NCT00966875|80095124|FG007|Part A|Withdrawal by Subject|1|||
27519306|NCT00966875|80095125|FG008|Part A|Withdrawal by Subject|1|||
27730665|NCT00868790|80842795|FG003|Period 1|Protocol Violation|0|||
27519307|NCT00966875|80095117|FG000|Part A|Protocol Violation|0|||
27730666|NCT00868790|80842796|FG004|Period 1|Protocol Violation|0|||
27730667|NCT00868790|80842797|FG005|Period 1|Protocol Violation|0|||
27908570|NCT05464420|81503299|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
27908571|NCT02998151|81503300|FG000|Overall Study|Withdrawal by Subject|3|||
27519308|NCT00966875|80095118|FG001|Part A|Protocol Violation|0|||
27519309|NCT00966875|80095119|FG002|Part A|Protocol Violation|0|||
27730668|NCT00868790|80842798|FG006|Period 1|Protocol Violation|0|||
27730669|NCT00868790|80842799|FG007|Period 1|Protocol Violation|0|||
27730670|NCT00868790|80842800|FG008|Period 1|Protocol Violation|0|||
27730671|NCT00868790|80842801|FG009|Period 1|Protocol Violation|0|||
27730672|NCT00868790|80842802|FG010|Period 1|Protocol Violation|0|||
27730673|NCT00868790|80842803|FG011|Period 1|Protocol Violation|0|||
27730674|NCT00868790|80842804|FG012|Period 1|Protocol Violation|0|||
27730675|NCT00868790|80842805|FG013|Period 1|Protocol Violation|0|||
27730676|NCT00868790|80842792|FG000|Period 1|Withdrawal by Subject|0|||
27730677|NCT00868790|80842793|FG001|Period 1|Withdrawal by Subject|1|||
27908572|NCT02998151|81503300|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
27908573|NCT02998151|81503300|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
27908574|NCT02998996|81503305|FG000|Overall Study|Lost to Follow-up|0|||
27908575|NCT02998996|81503306|FG001|Overall Study|Lost to Follow-up|0|||
27908576|NCT02998996|81503307|FG002|Overall Study|Lost to Follow-up|1|||
27908577|NCT02998996|81503308|FG003|Overall Study|Lost to Follow-up|0|||
27908578|NCT02998996|81503309|FG004|Overall Study|Lost to Follow-up|0|||
27908579|NCT02998996|81503310|FG005|Overall Study|Lost to Follow-up|0|||
27619134|NCT01458275|80449378|FG002|Overall Study|Lost to Follow-up|5|||
27619135|NCT01458275|80449376|FG000|Overall Study|Protocol Violation|5|||
27619136|NCT01458275|80449377|FG001|Overall Study|Protocol Violation|5|||
27619137|NCT01458275|80449378|FG002|Overall Study|Protocol Violation|2|||
27619138|NCT01458275|80449376|FG000|Overall Study|Withdrawal by Subject|3|||
27619139|NCT01458275|80449377|FG001|Overall Study|Withdrawal by Subject|2|||
27619140|NCT01458275|80449378|FG002|Overall Study|Withdrawal by Subject|1|||
27730678|NCT00868790|80842794|FG002|Period 1|Withdrawal by Subject|0|||
27730679|NCT00868790|80842795|FG003|Period 1|Withdrawal by Subject|0|||
27730680|NCT00868790|80842796|FG004|Period 1|Withdrawal by Subject|0|||
27730681|NCT00868790|80842797|FG005|Period 1|Withdrawal by Subject|0|||
27730682|NCT00868790|80842798|FG006|Period 1|Withdrawal by Subject|0|||
27730683|NCT00868790|80842799|FG007|Period 1|Withdrawal by Subject|0|||
27730684|NCT00868790|80842800|FG008|Period 1|Withdrawal by Subject|0|||
27730685|NCT00868790|80842801|FG009|Period 1|Withdrawal by Subject|0|||
27730686|NCT00868790|80842802|FG010|Period 1|Withdrawal by Subject|0|||
27730687|NCT00868790|80842803|FG011|Period 1|Withdrawal by Subject|0|||
27730688|NCT00868790|80842804|FG012|Period 1|Withdrawal by Subject|0|||
27730689|NCT00868790|80842805|FG013|Period 1|Withdrawal by Subject|1|||
27730690|NCT00868790|80842792|FG000|Period 1|Abnormal Triglycerides|0|||
27730691|NCT00868790|80842793|FG001|Period 1|Abnormal Triglycerides|0|||
27730692|NCT00868790|80842794|FG002|Period 1|Abnormal Triglycerides|0|||
27730693|NCT00868790|80842795|FG003|Period 1|Abnormal Triglycerides|0|||
27730694|NCT00868790|80842796|FG004|Period 1|Abnormal Triglycerides|1|||
27730695|NCT00868790|80842797|FG005|Period 1|Abnormal Triglycerides|0|||
27730696|NCT00868790|80842798|FG006|Period 1|Abnormal Triglycerides|0|||
27730697|NCT00868790|80842799|FG007|Period 1|Abnormal Triglycerides|0|||
27730698|NCT00868790|80842800|FG008|Period 1|Abnormal Triglycerides|0|||
27730699|NCT00868790|80842801|FG009|Period 1|Abnormal Triglycerides|0|||
27730700|NCT00868790|80842802|FG010|Period 1|Abnormal Triglycerides|0|||
27730701|NCT00868790|80842803|FG011|Period 1|Abnormal Triglycerides|0|||
27730702|NCT00868790|80842804|FG012|Period 1|Abnormal Triglycerides|0|||
27730703|NCT00868790|80842805|FG013|Period 1|Abnormal Triglycerides|0|||
27730704|NCT00868790|80842792|FG000|Period 1|Lost to Follow-up|0|||
27730705|NCT00868790|80842793|FG001|Period 1|Lost to Follow-up|0|||
27730706|NCT00868790|80842794|FG002|Period 1|Lost to Follow-up|0|||
27730707|NCT00868790|80842795|FG003|Period 1|Lost to Follow-up|0|||
27730708|NCT00868790|80842796|FG004|Period 1|Lost to Follow-up|0|||
27730709|NCT00868790|80842797|FG005|Period 1|Lost to Follow-up|1|||
27730710|NCT00868790|80842798|FG006|Period 1|Lost to Follow-up|0|||
27730711|NCT00868790|80842799|FG007|Period 1|Lost to Follow-up|0|||
27730712|NCT00868790|80842800|FG008|Period 1|Lost to Follow-up|0|||
27730713|NCT00868790|80842801|FG009|Period 1|Lost to Follow-up|0|||
27730714|NCT00868790|80842802|FG010|Period 1|Lost to Follow-up|0|||
27730715|NCT00868790|80842803|FG011|Period 1|Lost to Follow-up|0|||
27730716|NCT00868790|80842804|FG012|Period 1|Lost to Follow-up|0|||
27730717|NCT00868790|80842805|FG013|Period 1|Lost to Follow-up|0|||
27730718|NCT00868790|80842792|FG000|Period 2|Adverse Event|0|||
27908580|NCT02998996|81503305|FG000|Overall Study|Pregnancy|0|||
27619141|NCT01809210|80449379|FG000|Overall Study|Withdrawal by Subject|0|||
27619142|NCT01809210|80449380|FG001|Overall Study|Withdrawal by Subject|0|||
27730719|NCT00868790|80842793|FG001|Period 2|Adverse Event|0|||
27730720|NCT00868790|80842794|FG002|Period 2|Adverse Event|0|||
27730721|NCT00868790|80842795|FG003|Period 2|Adverse Event|0|||
27730722|NCT00868790|80842796|FG004|Period 2|Adverse Event|0|||
27730723|NCT00868790|80842797|FG005|Period 2|Adverse Event|0|||
27730724|NCT00868790|80842798|FG006|Period 2|Adverse Event|0|||
27730725|NCT00868790|80842799|FG007|Period 2|Adverse Event|0|||
27730726|NCT00868790|80842800|FG008|Period 2|Adverse Event|1|||
27908581|NCT02998996|81503306|FG001|Overall Study|Pregnancy|1|||
27908582|NCT02998996|81503307|FG002|Overall Study|Pregnancy|0|||
27908583|NCT02998996|81503308|FG003|Overall Study|Pregnancy|0|||
27619143|NCT01809210|80449381|FG002|Overall Study|Withdrawal by Subject|1|||
27730727|NCT00868790|80842801|FG009|Period 2|Adverse Event|0|||
27730728|NCT00868790|80842802|FG010|Period 2|Adverse Event|0|||
27730729|NCT00868790|80842803|FG011|Period 2|Adverse Event|0|||
27730730|NCT00868790|80842804|FG012|Period 2|Adverse Event|0|||
27730731|NCT00868790|80842805|FG013|Period 2|Adverse Event|0|||
27730732|NCT00868790|80842792|FG000|Period 2|Lost to Follow-up|0|||
27730733|NCT00868790|80842793|FG001|Period 2|Lost to Follow-up|1|||
27730734|NCT00868790|80842794|FG002|Period 2|Lost to Follow-up|0|||
27730735|NCT00868790|80842795|FG003|Period 2|Lost to Follow-up|0|||
27730736|NCT00868790|80842796|FG004|Period 2|Lost to Follow-up|0|||
27730737|NCT00868790|80842797|FG005|Period 2|Lost to Follow-up|1|||
27730738|NCT00868790|80842798|FG006|Period 2|Lost to Follow-up|0|||
27730739|NCT00868790|80842799|FG007|Period 2|Lost to Follow-up|0|||
27730740|NCT00868790|80842800|FG008|Period 2|Lost to Follow-up|0|||
27730741|NCT00868790|80842801|FG009|Period 2|Lost to Follow-up|0|||
27730742|NCT00868790|80842802|FG010|Period 2|Lost to Follow-up|0|||
27730743|NCT00868790|80842803|FG011|Period 2|Lost to Follow-up|0|||
27730744|NCT00868790|80842804|FG012|Period 2|Lost to Follow-up|0|||
27730745|NCT00868790|80842805|FG013|Period 2|Lost to Follow-up|0|||
27730746|NCT00868790|80842792|FG000|Period 2|Withdrawal by Subject|0|||
27730747|NCT00868790|80842793|FG001|Period 2|Withdrawal by Subject|0|||
27730748|NCT00868790|80842794|FG002|Period 2|Withdrawal by Subject|0|||
27730749|NCT00868790|80842795|FG003|Period 2|Withdrawal by Subject|0|||
27730750|NCT00868790|80842796|FG004|Period 2|Withdrawal by Subject|0|||
27730751|NCT00868790|80842797|FG005|Period 2|Withdrawal by Subject|0|||
27619144|NCT01809210|80449382|FG003|Overall Study|Withdrawal by Subject|1|||
27619145|NCT01809210|80449383|FG004|Overall Study|Withdrawal by Subject|1|||
27619146|NCT01809210|80449384|FG005|Overall Study|Withdrawal by Subject|0|||
27619147|NCT01809210|80449385|FG006|Overall Study|Withdrawal by Subject|4|||
27619148|NCT01809210|80449379|FG000|Overall Study|Death|1|||
27730752|NCT00868790|80842798|FG006|Period 2|Withdrawal by Subject|0|||
27730753|NCT00868790|80842799|FG007|Period 2|Withdrawal by Subject|0|||
27730754|NCT00868790|80842800|FG008|Period 2|Withdrawal by Subject|1|||
27730755|NCT00868790|80842801|FG009|Period 2|Withdrawal by Subject|0|||
27908584|NCT02998996|81503309|FG004|Overall Study|Pregnancy|0|||
27519310|NCT00966875|80095120|FG003|Part A|Protocol Violation|0|||
27519311|NCT00966875|80095121|FG004|Part A|Protocol Violation|0|||
27730756|NCT00868790|80842802|FG010|Period 2|Withdrawal by Subject|0|||
27730757|NCT00868790|80842803|FG011|Period 2|Withdrawal by Subject|0|||
27730758|NCT00868790|80842804|FG012|Period 2|Withdrawal by Subject|0|||
27730759|NCT00868790|80842805|FG013|Period 2|Withdrawal by Subject|1|||
27730760|NCT00868790|80842792|FG000|Period 3|Adverse Event|0|||
27730761|NCT00868790|80842793|FG001|Period 3|Adverse Event|0|||
27730762|NCT00868790|80842794|FG002|Period 3|Adverse Event|0|||
27730763|NCT00868790|80842795|FG003|Period 3|Adverse Event|0|||
27730764|NCT00868790|80842796|FG004|Period 3|Adverse Event|0|||
27730765|NCT00868790|80842797|FG005|Period 3|Adverse Event|0|||
27730766|NCT00868790|80842798|FG006|Period 3|Adverse Event|0|||
27730767|NCT00868790|80842799|FG007|Period 3|Adverse Event|0|||
27730768|NCT00868790|80842800|FG008|Period 3|Adverse Event|0|||
27730769|NCT00868790|80842801|FG009|Period 3|Adverse Event|1|||
27730770|NCT00868790|80842802|FG010|Period 3|Adverse Event|0|||
27730771|NCT00868790|80842803|FG011|Period 3|Adverse Event|0|||
27730772|NCT00868790|80842804|FG012|Period 3|Adverse Event|0|||
27730773|NCT00868790|80842805|FG013|Period 3|Adverse Event|0|||
27730774|NCT00868790|80842792|FG000|Period 3|Protocol Violation|0|||
27730775|NCT00868790|80842793|FG001|Period 3|Protocol Violation|0|||
27730776|NCT00868790|80842794|FG002|Period 3|Protocol Violation|0|||
27730777|NCT00868790|80842795|FG003|Period 3|Protocol Violation|0|||
27730778|NCT00868790|80842796|FG004|Period 3|Protocol Violation|0|||
27730779|NCT00868790|80842797|FG005|Period 3|Protocol Violation|0|||
27730780|NCT00868790|80842798|FG006|Period 3|Protocol Violation|0|||
27730781|NCT00868790|80842799|FG007|Period 3|Protocol Violation|0|||
27730782|NCT00868790|80842800|FG008|Period 3|Protocol Violation|0|||
27730783|NCT00868790|80842801|FG009|Period 3|Protocol Violation|0|||
27730784|NCT00868790|80842802|FG010|Period 3|Protocol Violation|1|||
27730785|NCT00868790|80842803|FG011|Period 3|Protocol Violation|0|||
27854123|NCT02269163|81298697|FG001|Overall Study|Other|2|||
27908585|NCT02998996|81503310|FG005|Overall Study|Pregnancy|0|||
27908586|NCT02998996|81503305|FG000|Overall Study|Family reasons|0|||
27519312|NCT00966875|80095122|FG005|Part A|Protocol Violation|0|||
27519313|NCT00966875|80095123|FG006|Part A|Protocol Violation|2|||
27730786|NCT00868790|80842804|FG012|Period 3|Protocol Violation|0|||
27730787|NCT00868790|80842805|FG013|Period 3|Protocol Violation|0|||
27730788|NCT00868790|80842792|FG000|Period 3|Study Terminated by Sponsor|0|||
27730789|NCT00868790|80842793|FG001|Period 3|Study Terminated by Sponsor|0|||
27730790|NCT00868790|80842794|FG002|Period 3|Study Terminated by Sponsor|0|||
27730791|NCT00868790|80842795|FG003|Period 3|Study Terminated by Sponsor|1|||
27519314|NCT00966875|80095124|FG007|Part A|Protocol Violation|1|||
27519315|NCT00966875|80095125|FG008|Part A|Protocol Violation|1|||
27730792|NCT00868790|80842796|FG004|Period 3|Study Terminated by Sponsor|0|||
27730793|NCT00868790|80842797|FG005|Period 3|Study Terminated by Sponsor|0|||
27730794|NCT00868790|80842798|FG006|Period 3|Study Terminated by Sponsor|0|||
27730795|NCT00868790|80842799|FG007|Period 3|Study Terminated by Sponsor|0|||
27730796|NCT00868790|80842800|FG008|Period 3|Study Terminated by Sponsor|0|||
27730797|NCT00868790|80842801|FG009|Period 3|Study Terminated by Sponsor|0|||
27730798|NCT00868790|80842802|FG010|Period 3|Study Terminated by Sponsor|0|||
27730799|NCT00868790|80842803|FG011|Period 3|Study Terminated by Sponsor|0|||
27730800|NCT00868790|80842804|FG012|Period 3|Study Terminated by Sponsor|0|||
27730801|NCT00868790|80842805|FG013|Period 3|Study Terminated by Sponsor|0|||
27908587|NCT02998996|81503306|FG001|Overall Study|Family reasons|0|||
27730802|NCT00868790|80842792|FG000|Period 4|Adverse Event|0|||
27730803|NCT00868790|80842793|FG001|Period 4|Adverse Event|0|||
27730804|NCT00868790|80842794|FG002|Period 4|Adverse Event|0|||
27730805|NCT00868790|80842795|FG003|Period 4|Adverse Event|0|||
27730806|NCT00868790|80842796|FG004|Period 4|Adverse Event|0|||
27730807|NCT00868790|80842797|FG005|Period 4|Adverse Event|0|||
27730808|NCT00868790|80842798|FG006|Period 4|Adverse Event|0|||
27730809|NCT00868790|80842799|FG007|Period 4|Adverse Event|1|||
27730810|NCT00868790|80842800|FG008|Period 4|Adverse Event|0|||
27730811|NCT00868790|80842801|FG009|Period 4|Adverse Event|0|||
27730812|NCT00868790|80842802|FG010|Period 4|Adverse Event|1|||
27730813|NCT00868790|80842803|FG011|Period 4|Adverse Event|0|||
27730814|NCT00868790|80842804|FG012|Period 4|Adverse Event|1|||
27730815|NCT00868790|80842805|FG013|Period 4|Adverse Event|0|||
27730816|NCT00868790|80842792|FG000|Period 4|Lost to Follow-up|0|||
27730817|NCT00868790|80842793|FG001|Period 4|Lost to Follow-up|0|||
27730818|NCT00868790|80842794|FG002|Period 4|Lost to Follow-up|0|||
27730819|NCT00868790|80842795|FG003|Period 4|Lost to Follow-up|0|||
27730820|NCT00868790|80842796|FG004|Period 4|Lost to Follow-up|0|||
27730821|NCT00868790|80842797|FG005|Period 4|Lost to Follow-up|0|||
27730822|NCT00868790|80842798|FG006|Period 4|Lost to Follow-up|0|||
27730823|NCT00868790|80842799|FG007|Period 4|Lost to Follow-up|1|||
27730824|NCT00868790|80842800|FG008|Period 4|Lost to Follow-up|0|||
27730825|NCT00868790|80842801|FG009|Period 4|Lost to Follow-up|0|||
27730826|NCT00868790|80842802|FG010|Period 4|Lost to Follow-up|0|||
27730827|NCT00868790|80842803|FG011|Period 4|Lost to Follow-up|0|||
27730828|NCT00868790|80842804|FG012|Period 4|Lost to Follow-up|0|||
27730829|NCT00868790|80842805|FG013|Period 4|Lost to Follow-up|0|||
27730830|NCT00868790|80842792|FG000|Period 4|Study Terminated by Sponsor|2|||
27730831|NCT00868790|80842793|FG001|Period 4|Study Terminated by Sponsor|0|||
27730832|NCT00868790|80842794|FG002|Period 4|Study Terminated by Sponsor|0|||
27730833|NCT00868790|80842795|FG003|Period 4|Study Terminated by Sponsor|0|||
27730834|NCT00868790|80842796|FG004|Period 4|Study Terminated by Sponsor|0|||
27730835|NCT00868790|80842797|FG005|Period 4|Study Terminated by Sponsor|0|||
27519316|NCT00966875|80095117|FG000|Part B|Adverse Event|0|||
27519317|NCT00966875|80095118|FG001|Part B|Adverse Event|1|||
27519318|NCT00966875|80095119|FG002|Part B|Adverse Event|1|||
27519319|NCT00966875|80095120|FG003|Part B|Adverse Event|0|||
27519320|NCT00966875|80095121|FG004|Part B|Adverse Event|1|||
27519321|NCT00966875|80095122|FG005|Part B|Adverse Event|0|||
27519322|NCT00966875|80095123|FG006|Part B|Adverse Event|5|||
27519323|NCT00966875|80095124|FG007|Part B|Adverse Event|2|||
27519324|NCT00966875|80095125|FG008|Part B|Adverse Event|2|||
27519325|NCT00966875|80095117|FG000|Part B|Death|0|||
27519326|NCT00966875|80095118|FG001|Part B|Death|0|||
27519327|NCT00966875|80095119|FG002|Part B|Death|1|||
27519328|NCT00966875|80095120|FG003|Part B|Death|0|||
27519329|NCT00966875|80095121|FG004|Part B|Death|0|||
27519330|NCT00966875|80095122|FG005|Part B|Death|0|||
27519331|NCT00966875|80095123|FG006|Part B|Death|0|||
27519332|NCT00966875|80095124|FG007|Part B|Death|1|||
27519333|NCT00966875|80095125|FG008|Part B|Death|0|||
27519334|NCT00966875|80095117|FG000|Part B|Lack of Efficacy|2|||
27519335|NCT00966875|80095118|FG001|Part B|Lack of Efficacy|1|||
27519336|NCT00966875|80095119|FG002|Part B|Lack of Efficacy|1|||
27519337|NCT00966875|80095120|FG003|Part B|Lack of Efficacy|1|||
27519338|NCT00966875|80095121|FG004|Part B|Lack of Efficacy|2|||
27519339|NCT00966875|80095122|FG005|Part B|Lack of Efficacy|3|||
27519340|NCT00966875|80095123|FG006|Part B|Lack of Efficacy|12|||
27619149|NCT01809210|80449380|FG001|Overall Study|Death|1|||
27730836|NCT00868790|80842798|FG006|Period 4|Study Terminated by Sponsor|0|||
27730837|NCT00868790|80842799|FG007|Period 4|Study Terminated by Sponsor|1|||
27730838|NCT00868790|80842800|FG008|Period 4|Study Terminated by Sponsor|2|||
27730839|NCT00868790|80842801|FG009|Period 4|Study Terminated by Sponsor|0|||
27730840|NCT00868790|80842802|FG010|Period 4|Study Terminated by Sponsor|2|||
27730841|NCT00868790|80842803|FG011|Period 4|Study Terminated by Sponsor|1|||
27730842|NCT00868790|80842804|FG012|Period 4|Study Terminated by Sponsor|0|||
27519341|NCT00966875|80095124|FG007|Part B|Lack of Efficacy|9|||
27730843|NCT00868790|80842805|FG013|Period 4|Study Terminated by Sponsor|1|||
27730844|NCT00868790|80842792|FG000|Period 4|Abnormal ALT/AST|0|||
27730845|NCT00868790|80842793|FG001|Period 4|Abnormal ALT/AST|0|||
27730846|NCT00868790|80842794|FG002|Period 4|Abnormal ALT/AST|1|||
27730847|NCT00868790|80842795|FG003|Period 4|Abnormal ALT/AST|0|||
27730848|NCT00868790|80842796|FG004|Period 4|Abnormal ALT/AST|0|||
27730849|NCT00868790|80842797|FG005|Period 4|Abnormal ALT/AST|0|||
27730850|NCT00868790|80842798|FG006|Period 4|Abnormal ALT/AST|0|||
27519342|NCT00966875|80095125|FG008|Part B|Lack of Efficacy|6|||
27519343|NCT00966875|80095117|FG000|Part B|Lost to Follow-up|0|||
27519344|NCT00966875|80095118|FG001|Part B|Lost to Follow-up|0|||
27519345|NCT00966875|80095119|FG002|Part B|Lost to Follow-up|0|||
27519346|NCT00966875|80095120|FG003|Part B|Lost to Follow-up|1|||
27619150|NCT01809210|80449381|FG002|Overall Study|Death|2|||
27730851|NCT00868790|80842799|FG007|Period 4|Abnormal ALT/AST|0|||
27730852|NCT00868790|80842800|FG008|Period 4|Abnormal ALT/AST|0|||
27730853|NCT00868790|80842801|FG009|Period 4|Abnormal ALT/AST|0|||
27519347|NCT00966875|80095121|FG004|Part B|Lost to Follow-up|0|||
27519348|NCT00966875|80095122|FG005|Part B|Lost to Follow-up|0|||
27619151|NCT01809210|80449382|FG003|Overall Study|Death|0|||
27619152|NCT01809210|80449383|FG004|Overall Study|Death|1|||
27619153|NCT01809210|80449384|FG005|Overall Study|Death|3|||
27908588|NCT02998996|81503307|FG002|Overall Study|Family reasons|0|||
27908589|NCT02998996|81503308|FG003|Overall Study|Family reasons|0|||
27908590|NCT02998996|81503309|FG004|Overall Study|Family reasons|1|||
27908591|NCT02998996|81503310|FG005|Overall Study|Family reasons|0|||
27908592|NCT01344759|81503311|FG000|Overall Study|Patients failed to reach sedation level|0|||
27908593|NCT01344759|81503312|FG001|Overall Study|Patients failed to reach sedation level|2|||
27908594|NCT02447328|81503315|FG000|Overall Study|Withdrawal by Subject|1|||
27908595|NCT02559570|81503316|FG000|Overall Study|Adverse Event|0|||
27908596|NCT02559570|81503317|FG001|Overall Study|Adverse Event|2|||
27908597|NCT02559570|81503318|FG002|Overall Study|Adverse Event|0|||
27908598|NCT02559570|81503319|FG003|Overall Study|Adverse Event|1|||
27908599|NCT02559570|81503320|FG004|Overall Study|Adverse Event|0|||
27908600|NCT02559570|81503316|FG000|Overall Study|Withdrawal of Consent|0|||
27908601|NCT02559570|81503317|FG001|Overall Study|Withdrawal of Consent|0|||
27908602|NCT02559570|81503318|FG002|Overall Study|Withdrawal of Consent|1|||
27908603|NCT02559570|81503319|FG003|Overall Study|Withdrawal of Consent|2|||
27908604|NCT02559570|81503320|FG004|Overall Study|Withdrawal of Consent|1|||
27908605|NCT02559570|81503316|FG000|Overall Study|Lost to Follow-up|1|||
27908606|NCT02559570|81503317|FG001|Overall Study|Lost to Follow-up|0|||
27908607|NCT02559570|81503318|FG002|Overall Study|Lost to Follow-up|0|||
27908608|NCT02559570|81503319|FG003|Overall Study|Lost to Follow-up|0|||
27908609|NCT02559570|81503320|FG004|Overall Study|Lost to Follow-up|0|||
27908610|NCT02559570|81503316|FG000|Overall Study|Protocol Violation|1|||
27908611|NCT02559570|81503317|FG001|Overall Study|Protocol Violation|0|||
27908612|NCT02559570|81503318|FG002|Overall Study|Protocol Violation|0|||
27908613|NCT02559570|81503319|FG003|Overall Study|Protocol Violation|0|||
27908614|NCT02559570|81503320|FG004|Overall Study|Protocol Violation|1|||
27908615|NCT02559570|81503316|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27908616|NCT02559570|81503317|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27908617|NCT02559570|81503318|FG002|Overall Study|Other Miscellaneous Reasons|1|||
27908618|NCT02559570|81503319|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27908619|NCT02559570|81503320|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27908620|NCT00004088|81503324|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
27908621|NCT00004088|81503324|FG000|Overall Study|Withdrawal by Subject|1|||
27908622|NCT00004088|81503324|FG000|Overall Study|Protocol Violation|3|||
27908623|NCT00004088|81503324|FG000|Overall Study|Physician Decision|1|||
27908624|NCT01951573|81503325|FG000|Washout Period|Adverse Event|0|||
27908625|NCT01951573|81503326|FG001|Washout Period|Adverse Event|1|||
27908626|NCT02072941|81503333|FG000|Overall Study|Withdrawal by Subject|29|||
27908627|NCT02072941|81503334|FG001|Overall Study|Withdrawal by Subject|21|||
27908628|NCT02072941|81503333|FG000|Overall Study|Lost to Follow-up|4|||
27908629|NCT02072941|81503334|FG001|Overall Study|Lost to Follow-up|4|||
27908630|NCT02072941|81503333|FG000|Overall Study|Death|3|||
27908631|NCT02072941|81503334|FG001|Overall Study|Death|2|||
27908632|NCT02072941|81503333|FG000|Overall Study|Removed by Study Staff|2|||
27908633|NCT02072941|81503334|FG001|Overall Study|Removed by Study Staff|2|||
27908634|NCT04441788|81503337|FG000|Overall Study|Voluntary Withdrawl|0|||
27908635|NCT04441788|81503338|FG001|Overall Study|Voluntary Withdrawl|1|||
27519349|NCT00966875|80095123|FG006|Part B|Lost to Follow-up|0|||
27519350|NCT00966875|80095124|FG007|Part B|Lost to Follow-up|0|||
27519351|NCT00966875|80095125|FG008|Part B|Lost to Follow-up|1|||
27519352|NCT00966875|80095117|FG000|Part B|Physician Decision|0|||
27519353|NCT00966875|80095118|FG001|Part B|Physician Decision|0|||
27519354|NCT00966875|80095119|FG002|Part B|Physician Decision|1|||
27519355|NCT00966875|80095120|FG003|Part B|Physician Decision|0|||
27519356|NCT00966875|80095121|FG004|Part B|Physician Decision|2|||
27519357|NCT00966875|80095122|FG005|Part B|Physician Decision|1|||
27619154|NCT01809210|80449385|FG006|Overall Study|Death|1|||
27908636|NCT04441788|81503339|FG002|Overall Study|Voluntary Withdrawl|0|||
27908637|NCT04441788|81503337|FG000|Overall Study|Ineligibility|1|||
27908638|NCT04441788|81503338|FG001|Overall Study|Ineligibility|0|||
27908639|NCT04441788|81503339|FG002|Overall Study|Ineligibility|0|||
27908640|NCT04441788|81503337|FG000|Overall Study|Adverse Event|0|||
27908641|NCT04441788|81503338|FG001|Overall Study|Adverse Event|0|||
27908642|NCT04441788|81503339|FG002|Overall Study|Adverse Event|4|||
27908643|NCT04441788|81503337|FG000|Overall Study|Study Terminated by Sponsor|16|||
27908644|NCT04441788|81503338|FG001|Overall Study|Study Terminated by Sponsor|16|||
27908645|NCT04441788|81503339|FG002|Overall Study|Study Terminated by Sponsor|12|||
27519358|NCT00966875|80095123|FG006|Part B|Physician Decision|0|||
27519359|NCT00966875|80095124|FG007|Part B|Physician Decision|0|||
27519360|NCT00966875|80095125|FG008|Part B|Physician Decision|2|||
27519361|NCT00966875|80095117|FG000|Part B|Sponsor Decision|1|||
27619155|NCT02449044|80449386|FG000|Overall Study|Lost to Follow-up|2|||
27619156|NCT02449044|80449386|FG000|Overall Study|Withdrawal by Subject|13|||
27908646|NCT00520039|81503350|FG000|Overall Study|Exclusion criteria met at first visit|7|||
27619157|NCT02449044|80449386|FG000|Overall Study|Adverse Event|30|||
27619158|NCT02449044|80449386|FG000|Overall Study|Met Withdrawal Criteria|7|||
27619159|NCT02449044|80449386|FG000|Overall Study|Physician Decision|9|||
27619160|NCT02449044|80449386|FG000|Overall Study|Sponsor Discontinued Trial|3|||
27619161|NCT02400307|80449387|FG000|Overall Study|Enrolled and Never Dosed|1|||
27619162|NCT02400307|80449388|FG001|Overall Study|Enrolled and Never Dosed|0|||
27619163|NCT02059161|80449389|FG000|Overall Study|Pregnancy|0|||
27619164|NCT02059161|80449390|FG001|Overall Study|Pregnancy|2|||
27619165|NCT02059161|80449389|FG000|Overall Study|Adverse Event|2|||
27619166|NCT02059161|80449390|FG001|Overall Study|Adverse Event|6|||
27619167|NCT02059161|80449389|FG000|Overall Study|Lost to Follow-up|20|||
27619168|NCT02059161|80449390|FG001|Overall Study|Lost to Follow-up|12|||
27908647|NCT00520039|81503351|FG001|Overall Study|Exclusion criteria met at first visit|5|||
27908648|NCT04676152|81503354|FG000|Overall Study|screen fail|9|||
27908649|NCT00571103|81503355|FG000|Overall Study|Withdrawal by Subject|1|||
27908650|NCT00571103|81503355|FG000|Overall Study|Lost to Follow-up|1|||
27908651|NCT03360019|81503361|FG000|Overall Study|Withdrawal by Subject|2|||
27908652|NCT03360019|81503362|FG001|Overall Study|Withdrawal by Subject|0|||
27908653|NCT03360019|81503363|FG002|Overall Study|Withdrawal by Subject|0|||
27908654|NCT03360019|81503361|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
27908655|NCT03360019|81503362|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
27908656|NCT03360019|81503363|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
27908657|NCT02095197|81503364|FG000|Overall Study|Lost to Follow-up|0|||
27908658|NCT02095197|81503365|FG001|Overall Study|Lost to Follow-up|3|||
27908659|NCT03091738|81503368|FG000|Overall Study|Adverse Event|1|||
27908660|NCT03091738|81503368|FG000|Overall Study|Lost to Follow-up|1|||
27908661|NCT00171158|81503369|FG000|Core Study|Death|27|||
27908662|NCT00171158|81503369|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
27908663|NCT00171158|81503369|FG000|Core Study|Protocol Violation|4|||
27619169|NCT02059161|80449389|FG000|Overall Study|Physician Decision|4|||
27619170|NCT02059161|80449390|FG001|Overall Study|Physician Decision|4|||
27619171|NCT02059161|80449389|FG000|Overall Study|Protocol Violation|1|||
27619172|NCT02059161|80449390|FG001|Overall Study|Protocol Violation|1|||
27619173|NCT02059161|80449389|FG000|Overall Study|Withdrawal by Subject|16|||
27619174|NCT02059161|80449390|FG001|Overall Study|Withdrawal by Subject|13|||
27619175|NCT02059161|80449389|FG000|Overall Study|Randomized in error, no study drug|0|||
27619176|NCT02059161|80449390|FG001|Overall Study|Randomized in error, no study drug|1|||
27619177|NCT02059161|80449389|FG000|Overall Study|Non-compliance with study drug|6|||
27619178|NCT02059161|80449390|FG001|Overall Study|Non-compliance with study drug|2|||
27619179|NCT03101592|80449391|FG000|Overall Study|participant files could not be located|111|||
27619180|NCT03101592|80449392|FG001|Overall Study|participant files could not be located|170|||
27619181|NCT03101592|80449393|FG002|Overall Study|participant files could not be located|118|||
27619182|NCT02748512|80449397|FG000|Overall Study|Lost to Follow-up|1|||
27619183|NCT02748512|80449398|FG001|Overall Study|Lost to Follow-up|1|||
27619184|NCT00614744|80449399|FG000|Overall Study|Lost to Follow-up|5|||
27619185|NCT00614744|80449400|FG001|Overall Study|Lost to Follow-up|4|||
27619186|NCT00614744|80449399|FG000|Overall Study|Incomplete for Behavior Issues|0|||
27619187|NCT00614744|80449400|FG001|Overall Study|Incomplete for Behavior Issues|2|||
27619188|NCT01651403|80449401|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
27619189|NCT01651403|80449402|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
27619190|NCT01651403|80449401|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
27619191|NCT01651403|80449402|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
27619192|NCT01651403|80449401|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
27619193|NCT01651403|80449402|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
27619194|NCT01651403|80449401|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
27619195|NCT01651403|80449402|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
27619196|NCT01651403|80449401|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
27619197|NCT01651403|80449402|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
27619198|NCT01651403|80449401|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
27619199|NCT01651403|80449402|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
27908664|NCT00171158|81503369|FG000|Core Study|Administrative problems|1|||
27908665|NCT00171158|81503369|FG000|Core Study|Adverse event, non-fatal|21|||
27908666|NCT00171158|81503369|FG000|Core Study|Consent withdrawn by subject|6|||
27619200|NCT00738530|80449408|FG000|Overall Study|Death|220|||
27619201|NCT00738530|80449409|FG001|Overall Study|Death|224|||
27619202|NCT00738530|80449408|FG000|Overall Study|Lost to Follow-up|8|||
27619203|NCT00738530|80449409|FG001|Overall Study|Lost to Follow-up|6|||
27619204|NCT00738530|80449408|FG000|Overall Study|Withdrawal by Subject|6|||
27619205|NCT00738530|80449409|FG001|Overall Study|Withdrawal by Subject|8|||
27908667|NCT00171158|81503369|FG000|Core Study|No longer required drug (BMT)|14|||
27908668|NCT00171158|81503369|FG000|Core Study|Abnormal Laboratory Values|2|||
27908669|NCT00171158|81503369|FG000|Core Study|Lost to Follow-up|1|||
27908670|NCT00171158|81503369|FG000|E2 Extension|Other|7|||
27908671|NCT03959527|81503373|FG000|Overall Study|Withdrawal by Subject|8|||
27908672|NCT03959527|81503374|FG001|Overall Study|Withdrawal by Subject|3|||
27908673|NCT03959527|81503373|FG000|Overall Study|Lost to Follow-up|31|||
27908674|NCT03959527|81503374|FG001|Overall Study|Lost to Follow-up|15|||
27908675|NCT03959527|81503373|FG000|Overall Study|Did not meet eligibility criteria|1|||
27908676|NCT03959527|81503374|FG001|Overall Study|Did not meet eligibility criteria|1|||
27908677|NCT03959527|81503373|FG000|Overall Study|Protocol Violation|10|||
27908678|NCT03959527|81503374|FG001|Overall Study|Protocol Violation|5|||
27908679|NCT02716584|81503375|FG000|Overall Study|Lost to Follow-up|8|||
27908680|NCT02716584|81503376|FG001|Overall Study|Lost to Follow-up|5|||
27908681|NCT02029274|81503377|FG000|Overall Study|Adverse Event|1|||
27908682|NCT02029274|81503378|FG001|Overall Study|Adverse Event|0|||
27908683|NCT02029274|81503379|FG002|Overall Study|Adverse Event|2|||
27908684|NCT02029274|81503380|FG003|Overall Study|Adverse Event|2|||
27908685|NCT00420628|81503383|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
27908686|NCT00420628|81503384|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
27908687|NCT00420628|81503383|FG000|Overall Study|Lost to Follow-up|3|||
27908688|NCT00420628|81503384|FG001|Overall Study|Lost to Follow-up|2|||
27908689|NCT00420628|81503383|FG000|Overall Study|Adverse Event|1|||
27908690|NCT00420628|81503384|FG001|Overall Study|Adverse Event|0|||
27908691|NCT00878800|81503385|FG000|Overall Study|Adverse Event|0|||
27908692|NCT00878800|81503386|FG001|Overall Study|Adverse Event|0|||
27908693|NCT00878800|81503387|FG002|Overall Study|Adverse Event|2|||
27908694|NCT00878800|81503388|FG003|Overall Study|Adverse Event|0|||
27908695|NCT00878800|81503389|FG004|Overall Study|Adverse Event|1|||
27908696|NCT00878800|81503385|FG000|Overall Study|Progressive disease|1|||
27908697|NCT00878800|81503386|FG001|Overall Study|Progressive disease|5|||
27908698|NCT00878800|81503387|FG002|Overall Study|Progressive disease|6|||
27908699|NCT00878800|81503388|FG003|Overall Study|Progressive disease|5|||
27908700|NCT00878800|81503389|FG004|Overall Study|Progressive disease|13|||
27908701|NCT00878800|81503385|FG000|Overall Study|Withdrew consent|1|||
27908702|NCT00878800|81503386|FG001|Overall Study|Withdrew consent|1|||
27908703|NCT00878800|81503387|FG002|Overall Study|Withdrew consent|0|||
27908704|NCT00878800|81503388|FG003|Overall Study|Withdrew consent|1|||
27908705|NCT00878800|81503389|FG004|Overall Study|Withdrew consent|1|||
27908706|NCT00878800|81503385|FG000|Overall Study|Death|0|||
27908707|NCT00878800|81503386|FG001|Overall Study|Death|0|||
27908708|NCT00878800|81503387|FG002|Overall Study|Death|1|||
27908709|NCT00878800|81503388|FG003|Overall Study|Death|0|||
27908710|NCT00878800|81503389|FG004|Overall Study|Death|0|||
27908711|NCT00878800|81503385|FG000|Overall Study|Other|1|||
27908712|NCT00878800|81503386|FG001|Overall Study|Other|1|||
27908713|NCT00878800|81503387|FG002|Overall Study|Other|0|||
27908714|NCT00878800|81503388|FG003|Overall Study|Other|0|||
27908715|NCT00878800|81503389|FG004|Overall Study|Other|1|||
27908716|NCT01210482|81503392|FG000|Overall Study|Protocol Violation|1|||
27908717|NCT01210482|81503392|FG000|Overall Study|Case Report Forms were not collected|18|||
27519362|NCT00966875|80095118|FG001|Part B|Sponsor Decision|0|||
27519363|NCT00966875|80095119|FG002|Part B|Sponsor Decision|0|||
27519364|NCT00966875|80095120|FG003|Part B|Sponsor Decision|0|||
27519365|NCT00966875|80095121|FG004|Part B|Sponsor Decision|0|||
27519366|NCT00966875|80095122|FG005|Part B|Sponsor Decision|1|||
27519367|NCT00966875|80095123|FG006|Part B|Sponsor Decision|0|||
27519368|NCT00966875|80095124|FG007|Part B|Sponsor Decision|2|||
27519369|NCT00966875|80095125|FG008|Part B|Sponsor Decision|1|||
27519370|NCT00966875|80095117|FG000|Part B|Withdrawal by Subject|2|||
27519371|NCT00966875|80095118|FG001|Part B|Withdrawal by Subject|1|||
27519372|NCT00966875|80095119|FG002|Part B|Withdrawal by Subject|2|||
27619206|NCT02507219|80449410|FG000|Overall Study|Physician Decision|1|||
27619207|NCT02507219|80449411|FG001|Overall Study|Physician Decision|0|||
27908718|NCT01210482|81503392|FG000|Overall Study|Duplicated|2|||
27908719|NCT01210482|81503392|FG000|Overall Study|No Drug Administration|28|||
27908720|NCT04039204|81503393|FG000|Overall Study|Withdrawal by Subject|0|||
27908721|NCT04039204|81503394|FG001|Overall Study|Withdrawal by Subject|2|||
27908722|NCT00765817|81503399|FG000|Overall Study|Adverse Event|13|||
27908723|NCT00765817|81503400|FG001|Overall Study|Adverse Event|1|||
27908724|NCT00765817|81503399|FG000|Overall Study|Death|0|||
27908725|NCT00765817|81503400|FG001|Overall Study|Death|1|||
27908726|NCT00765817|81503399|FG000|Overall Study|Entry criteria not met|2|||
27908727|NCT00765817|81503400|FG001|Overall Study|Entry criteria not met|2|||
27908728|NCT00765817|81503399|FG000|Overall Study|Loss of glucose control|0|||
27908729|NCT00765817|81503400|FG001|Overall Study|Loss of glucose control|2|||
27908730|NCT00765817|81503399|FG000|Overall Study|Lost to Follow-up|1|||
27908731|NCT00765817|81503400|FG001|Overall Study|Lost to Follow-up|3|||
27908732|NCT00765817|81503399|FG000|Overall Study|Physician Decision|2|||
27908733|NCT00765817|81503400|FG001|Overall Study|Physician Decision|1|||
27519373|NCT00966875|80095120|FG003|Part B|Withdrawal by Subject|1|||
27519374|NCT00966875|80095121|FG004|Part B|Withdrawal by Subject|2|||
27519375|NCT00966875|80095122|FG005|Part B|Withdrawal by Subject|1|||
27519376|NCT00966875|80095123|FG006|Part B|Withdrawal by Subject|4|||
27519377|NCT00966875|80095124|FG007|Part B|Withdrawal by Subject|5|||
27908734|NCT00765817|81503399|FG000|Overall Study|Protocol Violation|1|||
27908735|NCT00765817|81503400|FG001|Overall Study|Protocol Violation|1|||
27908736|NCT00765817|81503399|FG000|Overall Study|Subject decision|7|||
27908737|NCT00765817|81503400|FG001|Overall Study|Subject decision|11|||
27908738|NCT00662311|81503401|FG000|Overall Study|Respiratory Infection|1|||
27908739|NCT00662311|81503402|FG001|Overall Study|Respiratory Infection|0|||
27908740|NCT00662311|81503403|FG002|Overall Study|Respiratory Infection|0|||
27908741|NCT02781818|81503404|FG000|Overall Study|Lost to Follow-up|4|||
27908742|NCT02781818|81503405|FG001|Overall Study|Lost to Follow-up|2|||
27908743|NCT02781818|81503406|FG002|Overall Study|Lost to Follow-up|1|||
27908744|NCT01404949|81503417|FG000|Overall Study|Not Treated|1|||
27908745|NCT01272908|81503418|FG000|Initial Treatment Period|Adverse Event|1|||
27908746|NCT01272908|81503418|FG000|Initial Treatment Period|Lack of Efficacy|5|||
27908747|NCT01272908|81503418|FG000|Initial Treatment Period|Protocol Violation|1|||
27908748|NCT01272908|81503418|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
27908749|NCT01272908|81503418|FG000|Re-Treatment Period|Adverse Event|2|||
27908750|NCT01272908|81503418|FG000|Re-Treatment Period|Lack of Efficacy|3|||
27908751|NCT01272908|81503418|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
27908752|NCT00217581|81503427|FG000|Overall Study|Withdrawal by Subject|1|||
27519378|NCT00966875|80095125|FG008|Part B|Withdrawal by Subject|5|||
27730854|NCT00868790|80842802|FG010|Period 4|Abnormal ALT/AST|0|||
27519379|NCT00966875|80095117|FG000|Part B|Entry Criteria|0|||
27519380|NCT00966875|80095118|FG001|Part B|Entry Criteria|0|||
27519381|NCT00966875|80095119|FG002|Part B|Entry Criteria|0|||
27519382|NCT00966875|80095120|FG003|Part B|Entry Criteria|0|||
27619208|NCT02507219|80449412|FG002|Overall Study|Physician Decision|0|||
27619209|NCT02507219|80449413|FG003|Overall Study|Physician Decision|0|||
27619210|NCT02507219|80449414|FG004|Overall Study|Physician Decision|0|||
27619211|NCT02507219|80449415|FG005|Overall Study|Physician Decision|0|||
27619212|NCT02507219|80449410|FG000|Overall Study|Withdrawal by Subject|0|||
27619213|NCT02507219|80449411|FG001|Overall Study|Withdrawal by Subject|0|||
27619214|NCT02507219|80449412|FG002|Overall Study|Withdrawal by Subject|0|||
27619215|NCT02507219|80449413|FG003|Overall Study|Withdrawal by Subject|0|||
27619216|NCT02507219|80449414|FG004|Overall Study|Withdrawal by Subject|1|||
27619217|NCT02507219|80449415|FG005|Overall Study|Withdrawal by Subject|0|||
27619218|NCT01627340|80449417|FG000|Overall Study|Adverse Event|1|||
27619219|NCT01627340|80449418|FG001|Overall Study|Adverse Event|0|||
27619220|NCT01627340|80449417|FG000|Overall Study|Lost to Follow-up|8|||
27730855|NCT00868790|80842803|FG011|Period 4|Abnormal ALT/AST|0|||
27908753|NCT03084302|81503428|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
27908754|NCT03084302|81503428|FG000|Overall Study|No valid objective monitor data|6|||
27519383|NCT00966875|80095121|FG004|Part B|Entry Criteria|0|||
27519384|NCT00966875|80095122|FG005|Part B|Entry Criteria|0|||
27519385|NCT00966875|80095123|FG006|Part B|Entry Criteria|1|||
27519386|NCT00966875|80095124|FG007|Part B|Entry Criteria|0|||
27519387|NCT00966875|80095125|FG008|Part B|Entry Criteria|1|||
27519388|NCT02366091|80095126|FG000|Overall Study|Withdrawal by Subject|3|||
27519389|NCT02366091|80095127|FG001|Overall Study|Withdrawal by Subject|7|||
27519390|NCT02366091|80095128|FG002|Overall Study|Withdrawal by Subject|3|||
27519391|NCT02366091|80095129|FG003|Overall Study|Withdrawal by Subject|1|||
27519392|NCT00294762|80095130|FG000|Overall Study|Did not receive study treatment|3|||
27519393|NCT00294762|80095131|FG001|Overall Study|Did not receive study treatment|3|||
27519394|NCT04268823|80095132|FG000|Overall Study|Adverse Event|1|||
27519395|NCT04268823|80095133|FG001|Overall Study|Adverse Event|0|||
27519396|NCT04268823|80095132|FG000|Overall Study|Participant Decision|1|||
27519397|NCT04268823|80095133|FG001|Overall Study|Participant Decision|0|||
27519398|NCT01343693|80095137|FG000|Overall Study|Lost to Follow-up|9|||
27519399|NCT00109590|80095140|FG000|Overall Study|Lost to Follow-up|1|||
27519400|NCT00109590|80095141|FG001|Overall Study|Lost to Follow-up|0|||
27519401|NCT00109590|80095142|FG002|Overall Study|Lost to Follow-up|1|||
27519402|NCT00109590|80095140|FG000|Overall Study|Never Started Treatment|1|||
27519403|NCT00109590|80095141|FG001|Overall Study|Never Started Treatment|2|||
27619221|NCT01627340|80449418|FG001|Overall Study|Lost to Follow-up|4|||
27908755|NCT00905567|81503429|FG000|Washout|Withdrawal by Subject|0|||
27908756|NCT00905567|81503430|FG001|Washout|Withdrawal by Subject|1|||
27908757|NCT01939223|81503431|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
27519404|NCT00109590|80095142|FG002|Overall Study|Never Started Treatment|3|||
27619222|NCT01627340|80449417|FG000|Overall Study|Pregnancy|1|||
27519405|NCT01233232|80095143|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
27619223|NCT01627340|80449418|FG001|Overall Study|Pregnancy|0|||
27519406|NCT01233232|80095144|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
27519407|NCT01233232|80095145|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
27519408|NCT00905645|80095146|FG000|Overall Study|Death (not device related)|10|||
27519409|NCT00905645|80095147|FG001|Overall Study|Death (not device related)|4|||
27619224|NCT01627340|80449417|FG000|Overall Study|Withdrawal by Subject|2|||
27619225|NCT01627340|80449418|FG001|Overall Study|Withdrawal by Subject|0|||
27619226|NCT02501811|80449419|FG000|Overall Study|Death|1|||
27730856|NCT00868790|80842804|FG012|Period 4|Abnormal ALT/AST|0|||
27730857|NCT00868790|80842805|FG013|Period 4|Abnormal ALT/AST|0|||
27619227|NCT02501811|80449420|FG001|Overall Study|Death|3|||
27619228|NCT02501811|80449421|FG002|Overall Study|Death|2|||
27619229|NCT02501811|80449422|FG003|Overall Study|Death|3|||
27619230|NCT02501811|80449419|FG000|Overall Study|Withdrawal by Subject|3|||
27619231|NCT02501811|80449420|FG001|Overall Study|Withdrawal by Subject|3|||
27619232|NCT02501811|80449421|FG002|Overall Study|Withdrawal by Subject|2|||
27619233|NCT02501811|80449422|FG003|Overall Study|Withdrawal by Subject|3|||
27619234|NCT02501811|80449419|FG000|Overall Study|Lost to Follow-up|0|||
27619235|NCT02501811|80449420|FG001|Overall Study|Lost to Follow-up|0|||
27619236|NCT02501811|80449421|FG002|Overall Study|Lost to Follow-up|2|||
27619237|NCT02501811|80449422|FG003|Overall Study|Lost to Follow-up|1|||
27619238|NCT01668147|80449423|FG000|Overall Study|Withdrawal by Subject|6|||
27619239|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
27619240|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
27619241|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
27619242|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
27619243|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
27619244|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
27619245|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
27619246|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
27619247|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
27619248|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
27619249|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
27619250|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
27619251|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
27619252|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
27619253|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
27619254|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
27619255|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
27619256|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
27619257|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
27619258|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
27619259|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
27619260|NCT02718417|80449426|FG000|Chemotherapy Phase (CP)|Other|2|||
27619261|NCT02718417|80449427|FG001|Chemotherapy Phase (CP)|Other|0|||
27619262|NCT02718417|80449428|FG002|Chemotherapy Phase (CP)|Other|1|||
27619263|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Adverse Event|21|||
27619264|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Adverse Event|26|||
27619265|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Adverse Event|0|||
27619266|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
27619267|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
27619268|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
27619269|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
27619270|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
27619271|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
27619272|NCT02718417|80449426|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
27619273|NCT02718417|80449427|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
27619274|NCT02718417|80449428|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
27619275|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Physician's decision|6|||
27619276|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Physician's decision|7|||
27619277|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Physician's decision|0|||
27619278|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Progressive disease|100|||
27619279|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Progressive disease|88|||
27619280|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Progressive disease|0|||
27619281|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Other|2|||
27619282|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Other|1|||
27730858|NCT00868790|80842792|FG000|Post-study|Withdrawal by Subject|0|||
27730859|NCT00868790|80842793|FG001|Post-study|Withdrawal by Subject|0|||
27730860|NCT00868790|80842794|FG002|Post-study|Withdrawal by Subject|0|||
27730861|NCT00868790|80842795|FG003|Post-study|Withdrawal by Subject|0|||
27730862|NCT00868790|80842796|FG004|Post-study|Withdrawal by Subject|1|||
27730863|NCT00868790|80842797|FG005|Post-study|Withdrawal by Subject|0|||
27619283|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Other|0|||
27619284|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
27619285|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
27619286|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
27619287|NCT02718417|80449426|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
27908758|NCT01939223|81503432|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
27908759|NCT01939223|81503431|FG000|Overall Study|Disease recurrence (radiological)|1|||
27619288|NCT02718417|80449427|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
27730864|NCT00868790|80842798|FG006|Post-study|Withdrawal by Subject|0|||
27730865|NCT00868790|80842799|FG007|Post-study|Withdrawal by Subject|0|||
27730866|NCT00868790|80842800|FG008|Post-study|Withdrawal by Subject|0|||
27730867|NCT00868790|80842801|FG009|Post-study|Withdrawal by Subject|0|||
27730868|NCT00868790|80842802|FG010|Post-study|Withdrawal by Subject|0|||
27730869|NCT00868790|80842803|FG011|Post-study|Withdrawal by Subject|0|||
27730870|NCT00868790|80842804|FG012|Post-study|Withdrawal by Subject|0|||
27730871|NCT00868790|80842805|FG013|Post-study|Withdrawal by Subject|0|||
27730872|NCT00868790|80842792|FG000|Post-study|Excluded Medication|0|||
27730873|NCT00868790|80842793|FG001|Post-study|Excluded Medication|0|||
27730874|NCT00868790|80842794|FG002|Post-study|Excluded Medication|0|||
27730875|NCT00868790|80842795|FG003|Post-study|Excluded Medication|0|||
27730876|NCT00868790|80842796|FG004|Post-study|Excluded Medication|0|||
27730877|NCT00868790|80842797|FG005|Post-study|Excluded Medication|0|||
27730878|NCT00868790|80842798|FG006|Post-study|Excluded Medication|0|||
27730879|NCT00868790|80842799|FG007|Post-study|Excluded Medication|2|||
27730880|NCT00868790|80842800|FG008|Post-study|Excluded Medication|0|||
27730881|NCT00868790|80842801|FG009|Post-study|Excluded Medication|1|||
27730882|NCT00868790|80842802|FG010|Post-study|Excluded Medication|0|||
27730883|NCT00868790|80842803|FG011|Post-study|Excluded Medication|0|||
27730884|NCT00868790|80842804|FG012|Post-study|Excluded Medication|0|||
27730885|NCT00868790|80842805|FG013|Post-study|Excluded Medication|0|||
27730886|NCT01267955|80842808|FG000|Stage 1 (6 Months)|Death|3|||
27730887|NCT01267955|80842808|FG000|Stage 2 (6 Months)|Death|5|||
27730888|NCT01267955|80842808|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
27730889|NCT01596257|80842809|FG000|Overall Study|Inadequate Collection|23|||
27730890|NCT01596257|80842810|FG001|Overall Study|Inadequate Collection|19|||
27730891|NCT01427309|80842811|FG000|Overall Study|Lost to Follow-up|130|||
27730892|NCT01427309|80842812|FG001|Overall Study|Lost to Follow-up|145|||
27730893|NCT01427309|80842813|FG002|Overall Study|Lost to Follow-up|122|||
27730894|NCT01427309|80842814|FG003|Overall Study|Lost to Follow-up|135|||
27730895|NCT01427309|80842811|FG000|Overall Study|Protocol Violation|42|||
27730896|NCT01427309|80842812|FG001|Overall Study|Protocol Violation|69|||
27730897|NCT01427309|80842813|FG002|Overall Study|Protocol Violation|125|||
27730898|NCT01427309|80842814|FG003|Overall Study|Protocol Violation|124|||
27730899|NCT01427309|80842811|FG000|Overall Study|Adverse Event|0|||
27730900|NCT01427309|80842812|FG001|Overall Study|Adverse Event|0|||
27730901|NCT01427309|80842813|FG002|Overall Study|Adverse Event|3|||
27730902|NCT01427309|80842814|FG003|Overall Study|Adverse Event|1|||
27730903|NCT01427309|80842811|FG000|Overall Study|Serious adverse event|52|||
27730904|NCT01427309|80842812|FG001|Overall Study|Serious adverse event|45|||
27730905|NCT01427309|80842813|FG002|Overall Study|Serious adverse event|50|||
27730906|NCT01427309|80842814|FG003|Overall Study|Serious adverse event|61|||
27730907|NCT01427309|80842811|FG000|Overall Study|Withdrawal by Subject|148|||
27730908|NCT01427309|80842812|FG001|Overall Study|Withdrawal by Subject|148|||
27730909|NCT01427309|80842813|FG002|Overall Study|Withdrawal by Subject|61|||
27730910|NCT01427309|80842814|FG003|Overall Study|Withdrawal by Subject|55|||
27730911|NCT02076165|80842815|FG000|Overall Study|Lost to Follow-up|7|||
27730912|NCT02076165|80842816|FG001|Overall Study|Lost to Follow-up|5|||
27730913|NCT02076165|80842815|FG000|Overall Study|Refused follow-up assessment|1|||
27730914|NCT02076165|80842816|FG001|Overall Study|Refused follow-up assessment|1|||
27730915|NCT02497001|80842817|FG000|Overall Study|Lost to Follow-up|10|||
27730916|NCT02497001|80842818|FG001|Overall Study|Lost to Follow-up|2|||
27730917|NCT02497001|80842819|FG002|Overall Study|Lost to Follow-up|0|||
27730918|NCT02497001|80842820|FG003|Overall Study|Lost to Follow-up|2|||
27730919|NCT02497001|80842817|FG000|Overall Study|Adverse Event|28|||
27730920|NCT02497001|80842818|FG001|Overall Study|Adverse Event|30|||
27730921|NCT02497001|80842819|FG002|Overall Study|Adverse Event|11|||
27730922|NCT02497001|80842820|FG003|Overall Study|Adverse Event|11|||
27908760|NCT01939223|81503432|FG001|Overall Study|Disease recurrence (radiological)|3|||
27730923|NCT02497001|80842817|FG000|Overall Study|Withdrawal by Subject|14|||
27730924|NCT02497001|80842818|FG001|Overall Study|Withdrawal by Subject|37|||
27730925|NCT02497001|80842819|FG002|Overall Study|Withdrawal by Subject|19|||
27730926|NCT02497001|80842820|FG003|Overall Study|Withdrawal by Subject|15|||
27730927|NCT02497001|80842817|FG000|Overall Study|Physician Decision|5|||
27730928|NCT02497001|80842818|FG001|Overall Study|Physician Decision|11|||
27730929|NCT02497001|80842819|FG002|Overall Study|Physician Decision|5|||
27730930|NCT02497001|80842820|FG003|Overall Study|Physician Decision|1|||
27730931|NCT02497001|80842817|FG000|Overall Study|subjects that were not treated|1|||
27730932|NCT02497001|80842818|FG001|Overall Study|subjects that were not treated|2|||
27730933|NCT02497001|80842819|FG002|Overall Study|subjects that were not treated|2|||
27730934|NCT02497001|80842820|FG003|Overall Study|subjects that were not treated|1|||
27730935|NCT02497001|80842817|FG000|Overall Study|Major Protocol Deviation|3|||
27730936|NCT02497001|80842818|FG001|Overall Study|Major Protocol Deviation|4|||
27730937|NCT02497001|80842819|FG002|Overall Study|Major Protocol Deviation|4|||
27730938|NCT02497001|80842820|FG003|Overall Study|Major Protocol Deviation|4|||
27730939|NCT02497001|80842817|FG000|Overall Study|Lack of Efficacy|10|||
27730940|NCT02497001|80842818|FG001|Overall Study|Lack of Efficacy|16|||
27730941|NCT02497001|80842819|FG002|Overall Study|Lack of Efficacy|6|||
27730942|NCT02497001|80842820|FG003|Overall Study|Lack of Efficacy|6|||
27730943|NCT02497001|80842817|FG000|Overall Study|Protocol Violation|3|||
27730944|NCT02497001|80842818|FG001|Overall Study|Protocol Violation|1|||
27730945|NCT02497001|80842819|FG002|Overall Study|Protocol Violation|3|||
27730946|NCT02497001|80842820|FG003|Overall Study|Protocol Violation|1|||
27730947|NCT01658514|80842821|FG000|Overall Study|Protocol Violation|1|||
27730948|NCT01658514|80842822|FG001|Overall Study|Protocol Violation|0|||
27730949|NCT01658514|80842823|FG002|Overall Study|Protocol Violation|2|||
27730950|NCT03168867|80842824|FG000|Overall Study|Withdrawal by Subject|1|||
27730951|NCT03168867|80842825|FG001|Overall Study|Withdrawal by Subject|5|||
27730952|NCT05340504|80842826|FG000|Overall Study|Withdrawal by Subject|1|||
27730953|NCT05340504|80842827|FG001|Overall Study|Withdrawal by Subject|0|||
27730954|NCT02690701|80842828|FG000|Treatment Period 1|Adverse Event|2|||
27730955|NCT02690701|80842829|FG001|Treatment Period 1|Adverse Event|2|||
27730956|NCT02690701|80842828|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27730957|NCT02690701|80842829|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27730958|NCT02690701|80842828|FG000|Treatment Period 2|Adverse Event|2|||
27519410|NCT00905645|80095148|FG002|Overall Study|Death (not device related)|15|||
27519411|NCT00905645|80095149|FG003|Overall Study|Death (not device related)|8|||
27519412|NCT00905645|80095146|FG000|Overall Study|Explantation of study device(s)|78|||
27519413|NCT00905645|80095147|FG001|Overall Study|Explantation of study device(s)|47|||
27519414|NCT00905645|80095148|FG002|Overall Study|Explantation of study device(s)|28|||
27519415|NCT00905645|80095149|FG003|Overall Study|Explantation of study device(s)|21|||
27519416|NCT00905645|80095146|FG000|Overall Study|Subject Request|41|||
27519417|NCT00905645|80095147|FG001|Overall Study|Subject Request|17|||
27519418|NCT00905645|80095148|FG002|Overall Study|Subject Request|13|||
27519419|NCT00905645|80095149|FG003|Overall Study|Subject Request|11|||
27519420|NCT00905645|80095146|FG000|Overall Study|Lost to Follow-up|299|||
27519421|NCT00905645|80095147|FG001|Overall Study|Lost to Follow-up|103|||
27519422|NCT00905645|80095148|FG002|Overall Study|Lost to Follow-up|51|||
27519423|NCT00905645|80095149|FG003|Overall Study|Lost to Follow-up|12|||
27519424|NCT03319745|80095155|FG000|Overall Study|Death|1|||
27519425|NCT03319745|80095155|FG000|Overall Study|Toxicity Precluding Surgery|1|||
27519426|NCT01642615|80095156|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
27519427|NCT01642615|80095157|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27519428|NCT01642615|80095158|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27519429|NCT01642615|80095156|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
27519430|NCT01642615|80095157|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
27519431|NCT01642615|80095158|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
27519432|NCT01642615|80095156|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
27519433|NCT01642615|80095157|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
27519434|NCT01642615|80095158|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
27519435|NCT01642615|80095156|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
27519436|NCT01642615|80095157|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
27519437|NCT01642615|80095158|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
27519438|NCT01642615|80095156|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
27519439|NCT01642615|80095157|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
27519440|NCT01642615|80095158|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
27519441|NCT01642615|80095156|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
27730959|NCT02690701|80842829|FG001|Treatment Period 2|Adverse Event|0|||
27730960|NCT02690701|80842828|FG000|Treatment Period 2|Lack of Efficacy|1|||
27730961|NCT02690701|80842829|FG001|Treatment Period 2|Lack of Efficacy|0|||
27730962|NCT02690701|80842828|FG000|Treatment Period 2|Lost to Follow-up|0|||
27730963|NCT02690701|80842829|FG001|Treatment Period 2|Lost to Follow-up|2|||
27730964|NCT02690701|80842828|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27730965|NCT02690701|80842829|FG001|Treatment Period 2|Withdrawal by Subject|2|||
27730966|NCT02690701|80842828|FG000|Treatment Period 2|Protocol Violation|0|||
27730967|NCT02690701|80842829|FG001|Treatment Period 2|Protocol Violation|1|||
27730968|NCT01889602|80842830|FG000|First Intervention|Adverse Event|1|||
27730969|NCT01889602|80842831|FG001|First Intervention|Adverse Event|1|||
27730970|NCT01889602|80842832|FG002|First Intervention|Adverse Event|1|||
27730971|NCT01889602|80842830|FG000|First Intervention|Protocol Violation|0|||
27730972|NCT01889602|80842831|FG001|First Intervention|Protocol Violation|1|||
27730973|NCT01889602|80842832|FG002|First Intervention|Protocol Violation|1|||
27730974|NCT01889602|80842830|FG000|First Intervention|Study ending|0|||
27730975|NCT01889602|80842831|FG001|First Intervention|Study ending|1|||
27730976|NCT01889602|80842832|FG002|First Intervention|Study ending|0|||
27519442|NCT01642615|80095157|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
27519443|NCT01642615|80095158|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
27519444|NCT01642615|80095156|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
27730977|NCT01889602|80842830|FG000|Second Intervention|Adverse Event|0|||
27730978|NCT01889602|80842831|FG001|Second Intervention|Adverse Event|0|||
27730979|NCT01889602|80842832|FG002|Second Intervention|Adverse Event|1|||
27730980|NCT01889602|80842830|FG000|Second Intervention|Study ending|1|||
27730981|NCT01889602|80842831|FG001|Second Intervention|Study ending|0|||
27730982|NCT01889602|80842832|FG002|Second Intervention|Study ending|0|||
27730983|NCT01889602|80842830|FG000|Second Intervention|Withdrawal by Subject|0|||
27730984|NCT01889602|80842831|FG001|Second Intervention|Withdrawal by Subject|0|||
27730985|NCT01889602|80842832|FG002|Second Intervention|Withdrawal by Subject|1|||
27730986|NCT01889602|80842830|FG000|Third Intervention|Protocol Violation|1|||
27730987|NCT01889602|80842831|FG001|Third Intervention|Protocol Violation|0|||
27730988|NCT01889602|80842832|FG002|Third Intervention|Protocol Violation|0|||
27730989|NCT01889602|80842830|FG000|Third Intervention|Withdrawal by Subject|2|||
27730990|NCT01889602|80842831|FG001|Third Intervention|Withdrawal by Subject|2|||
27730991|NCT01889602|80842832|FG002|Third Intervention|Withdrawal by Subject|0|||
27730992|NCT00348140|80842834|FG000|Overall Study|Adverse Event|46|||
27730993|NCT00348140|80842835|FG001|Overall Study|Adverse Event|49|||
27730994|NCT00348140|80842836|FG002|Overall Study|Adverse Event|78|||
27730995|NCT00348140|80842834|FG000|Overall Study|Lost to Follow-up|4|||
27730996|NCT00348140|80842835|FG001|Overall Study|Lost to Follow-up|4|||
27730997|NCT00348140|80842836|FG002|Overall Study|Lost to Follow-up|4|||
27730998|NCT00348140|80842834|FG000|Overall Study|Protocol Violation|12|||
27730999|NCT00348140|80842835|FG001|Overall Study|Protocol Violation|13|||
27731000|NCT00348140|80842836|FG002|Overall Study|Protocol Violation|14|||
27731001|NCT00348140|80842834|FG000|Overall Study|Withdrawal by Subject|32|||
27731002|NCT00348140|80842835|FG001|Overall Study|Withdrawal by Subject|40|||
27731003|NCT00348140|80842836|FG002|Overall Study|Withdrawal by Subject|40|||
27731004|NCT00348140|80842834|FG000|Overall Study|Non-compliance|8|||
27731005|NCT00348140|80842835|FG001|Overall Study|Non-compliance|13|||
27731006|NCT00348140|80842836|FG002|Overall Study|Non-compliance|5|||
27731007|NCT00348140|80842834|FG000|Overall Study|Participant at risk due to study drug|2|||
27731008|NCT00348140|80842835|FG001|Overall Study|Participant at risk due to study drug|0|||
27731009|NCT00348140|80842836|FG002|Overall Study|Participant at risk due to study drug|0|||
27731010|NCT00348140|80842834|FG000|Overall Study|Conditional medication increased dose|1|||
27731011|NCT00348140|80842835|FG001|Overall Study|Conditional medication increased dose|0|||
27731012|NCT00348140|80842836|FG002|Overall Study|Conditional medication increased dose|0|||
27731013|NCT00348140|80842834|FG000|Overall Study|Caregiver related|4|||
27731014|NCT00348140|80842835|FG001|Overall Study|Caregiver related|7|||
27731015|NCT00348140|80842836|FG002|Overall Study|Caregiver related|3|||
27731016|NCT00348140|80842834|FG000|Overall Study|Participant hospitalised|3|||
27731017|NCT00348140|80842835|FG001|Overall Study|Participant hospitalised|0|||
27731018|NCT00348140|80842836|FG002|Overall Study|Participant hospitalised|0|||
27731019|NCT00348140|80842834|FG000|Overall Study|Efficacy related|1|||
27731020|NCT00348140|80842835|FG001|Overall Study|Efficacy related|1|||
27731021|NCT00348140|80842836|FG002|Overall Study|Efficacy related|0|||
27731022|NCT00348140|80842834|FG000|Overall Study|Administration related|3|||
27731023|NCT00348140|80842835|FG001|Overall Study|Administration related|1|||
27731024|NCT00348140|80842836|FG002|Overall Study|Administration related|1|||
27731025|NCT00348140|80842834|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
27731026|NCT00348140|80842835|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
27731027|NCT00348140|80842836|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
27731028|NCT00348140|80842834|FG000|Overall Study|Participant unwell|1|||
27731029|NCT00348140|80842835|FG001|Overall Study|Participant unwell|0|||
27731030|NCT00348140|80842836|FG002|Overall Study|Participant unwell|0|||
27731031|NCT00348140|80842834|FG000|Overall Study|Screen failure|1|||
27731032|NCT00348140|80842835|FG001|Overall Study|Screen failure|0|||
27731033|NCT00348140|80842836|FG002|Overall Study|Screen failure|0|||
27731034|NCT00348140|80842834|FG000|Overall Study|Investigator decided to discontinue|4|||
27731035|NCT00348140|80842835|FG001|Overall Study|Investigator decided to discontinue|1|||
27731036|NCT00348140|80842836|FG002|Overall Study|Investigator decided to discontinue|4|||
27731037|NCT00348140|80842834|FG000|Overall Study|Decided to discontinue on their own|1|||
27731038|NCT00348140|80842835|FG001|Overall Study|Decided to discontinue on their own|4|||
27731039|NCT00348140|80842836|FG002|Overall Study|Decided to discontinue on their own|1|||
27731040|NCT00348140|80842834|FG000|Overall Study|Use of prohibited drug|1|||
27731041|NCT00348140|80842835|FG001|Overall Study|Use of prohibited drug|0|||
27731042|NCT00348140|80842836|FG002|Overall Study|Use of prohibited drug|2|||
27731043|NCT00348140|80842834|FG000|Overall Study|Disease progression|1|||
27854124|NCT02269163|81298696|FG000|Overall Study|Withdrawal by Subject|0|||
27854125|NCT02269163|81298697|FG001|Overall Study|Withdrawal by Subject|3|||
27854126|NCT02269163|81298696|FG000|Overall Study|Physician Decision|0|||
27731044|NCT00348140|80842835|FG001|Overall Study|Disease progression|2|||
27731045|NCT00348140|80842836|FG002|Overall Study|Disease progression|5|||
27731046|NCT00348140|80842834|FG000|Overall Study|Increased risk of cardiac infarction|0|||
27731047|NCT00348140|80842835|FG001|Overall Study|Increased risk of cardiac infarction|1|||
27731048|NCT00348140|80842836|FG002|Overall Study|Increased risk of cardiac infarction|0|||
27731049|NCT00348140|80842834|FG000|Overall Study|Serious adverse event|0|||
27731050|NCT00348140|80842835|FG001|Overall Study|Serious adverse event|1|||
27854127|NCT02269163|81298697|FG001|Overall Study|Physician Decision|1|||
27731051|NCT00348140|80842836|FG002|Overall Study|Serious adverse event|0|||
27731052|NCT00348140|80842834|FG000|Overall Study|Abnormal ECG|0|||
27731053|NCT00348140|80842835|FG001|Overall Study|Abnormal ECG|1|||
27731054|NCT00348140|80842836|FG002|Overall Study|Abnormal ECG|3|||
27854128|NCT01007942|81298700|FG000|Overall Study|Adverse Event|29|||
27731055|NCT00348140|80842834|FG000|Overall Study|Participant died|0|||
27731056|NCT00348140|80842835|FG001|Overall Study|Participant died|1|||
27731057|NCT00348140|80842836|FG002|Overall Study|Participant died|0|||
27731058|NCT00348140|80842834|FG000|Overall Study|Exclusion criteria met|0|||
27731059|NCT00348140|80842835|FG001|Overall Study|Exclusion criteria met|0|||
27731060|NCT00348140|80842836|FG002|Overall Study|Exclusion criteria met|1|||
27731061|NCT00348140|80842834|FG000|Overall Study|Memory declined|0|||
27731062|NCT00348140|80842835|FG001|Overall Study|Memory declined|0|||
27731063|NCT00348140|80842836|FG002|Overall Study|Memory declined|1|||
27731064|NCT01053429|80842840|FG000|Overall Study|Adverse Event|64|||
27731065|NCT01053429|80842840|FG000|Overall Study|Other|309|||
27731066|NCT00862251|80842841|FG000|Overall Study|Adverse Event|8|||
27731067|NCT00862251|80842842|FG001|Overall Study|Adverse Event|3|||
27731068|NCT00862251|80842843|FG002|Overall Study|Adverse Event|1|||
27731069|NCT00862251|80842841|FG000|Overall Study|Lost to Follow-up|0|||
27731070|NCT00862251|80842842|FG001|Overall Study|Lost to Follow-up|0|||
27731071|NCT00862251|80842843|FG002|Overall Study|Lost to Follow-up|1|||
27731072|NCT00862251|80842841|FG000|Overall Study|Protocol Violation|2|||
27731073|NCT00862251|80842842|FG001|Overall Study|Protocol Violation|0|||
27731074|NCT00862251|80842843|FG002|Overall Study|Protocol Violation|1|||
27731075|NCT00862251|80842841|FG000|Overall Study|Withdrawal by Subject|9|||
27731076|NCT00862251|80842842|FG001|Overall Study|Withdrawal by Subject|2|||
27731077|NCT00862251|80842843|FG002|Overall Study|Withdrawal by Subject|6|||
27731078|NCT00600171|80842844|FG000|Overall Study|Adverse Event|0|||
27731079|NCT00600171|80842845|FG001|Overall Study|Adverse Event|1|||
27731080|NCT00600171|80842846|FG002|Overall Study|Adverse Event|0|||
27731081|NCT00600171|80842847|FG003|Overall Study|Adverse Event|0|||
27731082|NCT00600171|80842848|FG004|Overall Study|Adverse Event|1|||
27731083|NCT00600171|80842849|FG005|Overall Study|Adverse Event|0|||
27731084|NCT00600171|80842844|FG000|Overall Study|Lack of Efficacy|9|||
27731085|NCT00600171|80842845|FG001|Overall Study|Lack of Efficacy|12|||
27731086|NCT00600171|80842846|FG002|Overall Study|Lack of Efficacy|3|||
27731087|NCT00600171|80842847|FG003|Overall Study|Lack of Efficacy|5|||
27731088|NCT00600171|80842848|FG004|Overall Study|Lack of Efficacy|4|||
27731089|NCT00600171|80842849|FG005|Overall Study|Lack of Efficacy|0|||
27731090|NCT00600171|80842844|FG000|Overall Study|Protocol Violation|1|||
27731091|NCT00600171|80842845|FG001|Overall Study|Protocol Violation|2|||
27731092|NCT00600171|80842846|FG002|Overall Study|Protocol Violation|0|||
27731093|NCT00600171|80842847|FG003|Overall Study|Protocol Violation|1|||
27731094|NCT00600171|80842848|FG004|Overall Study|Protocol Violation|0|||
27731095|NCT00600171|80842849|FG005|Overall Study|Protocol Violation|0|||
27731096|NCT00600171|80842844|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
27731097|NCT00600171|80842845|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27731098|NCT00600171|80842846|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
27731099|NCT00600171|80842847|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
27731100|NCT00600171|80842848|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27731101|NCT00600171|80842849|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
27731102|NCT00600171|80842844|FG000|Overall Study|Withdrawal by Subject|3|||
27731103|NCT00600171|80842845|FG001|Overall Study|Withdrawal by Subject|0|||
27731104|NCT00600171|80842846|FG002|Overall Study|Withdrawal by Subject|0|||
27731105|NCT00600171|80842847|FG003|Overall Study|Withdrawal by Subject|1|||
27731106|NCT00600171|80842848|FG004|Overall Study|Withdrawal by Subject|1|||
27731107|NCT00600171|80842849|FG005|Overall Study|Withdrawal by Subject|1|||
27731108|NCT00600171|80842844|FG000|Overall Study|Physician Decision|0|||
27731109|NCT00600171|80842845|FG001|Overall Study|Physician Decision|1|||
27731110|NCT00600171|80842846|FG002|Overall Study|Physician Decision|0|||
27731111|NCT00600171|80842847|FG003|Overall Study|Physician Decision|1|||
27731112|NCT00600171|80842848|FG004|Overall Study|Physician Decision|0|||
27731113|NCT00600171|80842849|FG005|Overall Study|Physician Decision|2|||
27731114|NCT00600171|80842844|FG000|Overall Study|Lost to Follow-up|0|||
27731115|NCT00600171|80842845|FG001|Overall Study|Lost to Follow-up|0|||
27854129|NCT01007942|81298701|FG001|Overall Study|Adverse Event|14|||
27854130|NCT01007942|81298700|FG000|Overall Study|Abnormal test procedure|0|||
27731116|NCT00600171|80842846|FG002|Overall Study|Lost to Follow-up|0|||
27731117|NCT00600171|80842847|FG003|Overall Study|Lost to Follow-up|1|||
27731118|NCT00600171|80842848|FG004|Overall Study|Lost to Follow-up|0|||
27731119|NCT00600171|80842849|FG005|Overall Study|Lost to Follow-up|0|||
27731120|NCT01614964|80842850|FG000|Overall Study|Withdrawal by Subject|2|||
27731121|NCT01614964|80842851|FG001|Overall Study|Withdrawal by Subject|0|||
27731122|NCT01614964|80842850|FG000|Overall Study|Lost to Follow-up|3|||
27731123|NCT01614964|80842851|FG001|Overall Study|Lost to Follow-up|0|||
27731124|NCT00473876|80842852|FG000|Overall Study|Lost to Follow-up|3|||
27731125|NCT00473876|80842853|FG001|Overall Study|Lost to Follow-up|1|||
27731126|NCT00206726|80842858|FG000|Overall Study|Delayed recovery of blood counts|1|||
27731127|NCT00206726|80842858|FG000|Overall Study|Progressive disease or relapsed disease|18|||
27731128|NCT00206726|80842858|FG000|Overall Study|Placed on new protocol|1|||
27731129|NCT00206726|80842858|FG000|Overall Study|Bone marrow transplant|1|||
27731130|NCT00206726|80842858|FG000|Overall Study|Adverse Event|17|||
27731131|NCT00206726|80842858|FG000|Overall Study|Death|4|||
27731132|NCT00206726|80842858|FG000|Overall Study|Protocol Violation|1|||
27731133|NCT00206726|80842858|FG000|Overall Study|Withdrawal by Subject|8|||
27731134|NCT03772327|80842861|FG000|Overall Study|Lost to Follow-up|3|||
27731135|NCT03772327|80842862|FG001|Overall Study|Lost to Follow-up|4|||
27731136|NCT03772327|80842861|FG000|Overall Study|Withdrawal by Subject|2|||
27731137|NCT03772327|80842862|FG001|Overall Study|Withdrawal by Subject|3|||
27731138|NCT01193686|80842863|FG000|Overall Study|Withdrawal by Subject|4|||
27731139|NCT01193686|80842864|FG001|Overall Study|Withdrawal by Subject|1|||
27731140|NCT01193686|80842863|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
27731141|NCT01193686|80842864|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
27731142|NCT01412229|80842865|FG000|Overall Study|Physician Decision|1|||
27731143|NCT04426695|80842868|FG000|Overall Study|Death|2|||
27731144|NCT04426695|80842869|FG001|Overall Study|Death|0|||
27731145|NCT04426695|80842870|FG002|Overall Study|Death|1|||
27731146|NCT04426695|80842871|FG003|Overall Study|Death|27|||
27731147|NCT04426695|80842872|FG004|Overall Study|Death|25|||
27731148|NCT04426695|80842873|FG005|Overall Study|Death|21|||
27731149|NCT04426695|80842874|FG006|Overall Study|Death|42|||
27731150|NCT04426695|80842875|FG007|Overall Study|Death|23|||
27731151|NCT04426695|80842876|FG008|Overall Study|Death|37|||
27731152|NCT04426695|80842877|FG009|Overall Study|Death|14|||
27731153|NCT04426695|80842878|FG010|Overall Study|Death|8|||
27731154|NCT04426695|80842879|FG011|Overall Study|Death|7|||
27731155|NCT04426695|80842880|FG012|Overall Study|Death|13|||
27731156|NCT04426695|80842881|FG013|Overall Study|Death|25|||
27731157|NCT04426695|80842882|FG014|Overall Study|Death|19|||
27731158|NCT04426695|80842883|FG015|Overall Study|Death|7|||
27731159|NCT04426695|80842884|FG016|Overall Study|Death|8|||
27731160|NCT04426695|80842885|FG017|Overall Study|Death|4|||
27731161|NCT04426695|80842868|FG000|Overall Study|Lost to Follow-up|2|||
27731162|NCT04426695|80842869|FG001|Overall Study|Lost to Follow-up|4|||
27731163|NCT04426695|80842870|FG002|Overall Study|Lost to Follow-up|1|||
27731164|NCT04426695|80842871|FG003|Overall Study|Lost to Follow-up|19|||
27731165|NCT04426695|80842872|FG004|Overall Study|Lost to Follow-up|10|||
27731166|NCT04426695|80842873|FG005|Overall Study|Lost to Follow-up|14|||
27731167|NCT04426695|80842874|FG006|Overall Study|Lost to Follow-up|5|||
27731168|NCT04426695|80842875|FG007|Overall Study|Lost to Follow-up|14|||
27731169|NCT04426695|80842876|FG008|Overall Study|Lost to Follow-up|10|||
27731170|NCT04426695|80842877|FG009|Overall Study|Lost to Follow-up|11|||
27731171|NCT04426695|80842878|FG010|Overall Study|Lost to Follow-up|12|||
27731172|NCT04426695|80842879|FG011|Overall Study|Lost to Follow-up|6|||
27731173|NCT04426695|80842880|FG012|Overall Study|Lost to Follow-up|2|||
27731174|NCT04426695|80842881|FG013|Overall Study|Lost to Follow-up|2|||
27731175|NCT04426695|80842882|FG014|Overall Study|Lost to Follow-up|2|||
27731176|NCT04426695|80842883|FG015|Overall Study|Lost to Follow-up|0|||
27731177|NCT04426695|80842884|FG016|Overall Study|Lost to Follow-up|0|||
27731178|NCT04426695|80842885|FG017|Overall Study|Lost to Follow-up|0|||
27731179|NCT04426695|80842868|FG000|Overall Study|Participant Decision|1|||
27731180|NCT04426695|80842869|FG001|Overall Study|Participant Decision|2|||
27519445|NCT01642615|80095157|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
27519446|NCT01642615|80095158|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
27519447|NCT01642615|80095156|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27519448|NCT01642615|80095157|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
27519449|NCT01642615|80095158|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
27519450|NCT01642615|80095156|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
27519451|NCT01642615|80095157|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
27519452|NCT01642615|80095158|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
27519453|NCT03180619|80095159|FG000|Overall Study|Withdrew Consent|5|||
27519454|NCT03180619|80095160|FG001|Overall Study|Withdrew Consent|0|||
27619289|NCT02718417|80449428|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
27731181|NCT04426695|80842870|FG002|Overall Study|Participant Decision|2|||
27731182|NCT04426695|80842871|FG003|Overall Study|Participant Decision|12|||
27731183|NCT04426695|80842872|FG004|Overall Study|Participant Decision|18|||
27731184|NCT04426695|80842873|FG005|Overall Study|Participant Decision|22|||
27731185|NCT04426695|80842874|FG006|Overall Study|Participant Decision|13|||
27731186|NCT04426695|80842875|FG007|Overall Study|Participant Decision|13|||
27731187|NCT04426695|80842876|FG008|Overall Study|Participant Decision|10|||
27731188|NCT04426695|80842877|FG009|Overall Study|Participant Decision|15|||
27731189|NCT04426695|80842878|FG010|Overall Study|Participant Decision|16|||
27731190|NCT04426695|80842879|FG011|Overall Study|Participant Decision|17|||
27731191|NCT04426695|80842880|FG012|Overall Study|Participant Decision|2|||
27731192|NCT04426695|80842881|FG013|Overall Study|Participant Decision|1|||
27731193|NCT04426695|80842882|FG014|Overall Study|Participant Decision|2|||
27731194|NCT04426695|80842883|FG015|Overall Study|Participant Decision|0|||
27731195|NCT04426695|80842884|FG016|Overall Study|Participant Decision|0|||
27731196|NCT04426695|80842885|FG017|Overall Study|Participant Decision|0|||
27731197|NCT04426695|80842868|FG000|Overall Study|Adverse Event|0|||
27731198|NCT04426695|80842869|FG001|Overall Study|Adverse Event|0|||
27731199|NCT04426695|80842870|FG002|Overall Study|Adverse Event|0|||
27731200|NCT04426695|80842871|FG003|Overall Study|Adverse Event|0|||
27731201|NCT04426695|80842872|FG004|Overall Study|Adverse Event|0|||
27731202|NCT04426695|80842873|FG005|Overall Study|Adverse Event|0|||
27731203|NCT04426695|80842874|FG006|Overall Study|Adverse Event|0|||
27731204|NCT04426695|80842875|FG007|Overall Study|Adverse Event|1|||
27731205|NCT04426695|80842876|FG008|Overall Study|Adverse Event|0|||
27731206|NCT04426695|80842877|FG009|Overall Study|Adverse Event|0|||
27731207|NCT04426695|80842878|FG010|Overall Study|Adverse Event|1|||
27731208|NCT04426695|80842879|FG011|Overall Study|Adverse Event|1|||
27731209|NCT04426695|80842880|FG012|Overall Study|Adverse Event|0|||
27731210|NCT04426695|80842881|FG013|Overall Study|Adverse Event|0|||
27731211|NCT04426695|80842882|FG014|Overall Study|Adverse Event|0|||
27731212|NCT04426695|80842883|FG015|Overall Study|Adverse Event|0|||
27731213|NCT04426695|80842884|FG016|Overall Study|Adverse Event|0|||
27731214|NCT04426695|80842885|FG017|Overall Study|Adverse Event|0|||
27731215|NCT04426695|80842868|FG000|Overall Study|Sponsor Request|0|||
27731216|NCT04426695|80842869|FG001|Overall Study|Sponsor Request|0|||
27731217|NCT04426695|80842870|FG002|Overall Study|Sponsor Request|0|||
27731218|NCT04426695|80842871|FG003|Overall Study|Sponsor Request|0|||
27731219|NCT04426695|80842872|FG004|Overall Study|Sponsor Request|0|||
27731220|NCT04426695|80842873|FG005|Overall Study|Sponsor Request|0|||
27731221|NCT04426695|80842874|FG006|Overall Study|Sponsor Request|1|||
27519455|NCT03180619|80095161|FG002|Overall Study|Withdrew Consent|2|||
27519456|NCT03180619|80095159|FG000|Overall Study|Death|2|||
27519457|NCT03180619|80095160|FG001|Overall Study|Death|1|||
27519458|NCT03180619|80095161|FG002|Overall Study|Death|2|||
27908761|NCT01939223|81503431|FG000|Overall Study|Study stopped by Sponsor|5|||
27908762|NCT01939223|81503432|FG001|Overall Study|Study stopped by Sponsor|7|||
27519459|NCT03180619|80095159|FG000|Overall Study|Adverse Event|2|||
27519460|NCT03180619|80095160|FG001|Overall Study|Adverse Event|0|||
27519461|NCT03180619|80095161|FG002|Overall Study|Adverse Event|1|||
27519462|NCT03180619|80095159|FG000|Overall Study|Investigator's discretion|2|||
27519463|NCT03180619|80095160|FG001|Overall Study|Investigator's discretion|0|||
27519464|NCT03180619|80095161|FG002|Overall Study|Investigator's discretion|1|||
27519465|NCT02520089|80095162|FG000|Overall Study|Lost to Follow-up|3|||
27519466|NCT02520089|80095163|FG001|Overall Study|Lost to Follow-up|4|||
27731222|NCT04426695|80842875|FG007|Overall Study|Sponsor Request|0|||
27731223|NCT04426695|80842876|FG008|Overall Study|Sponsor Request|0|||
27731224|NCT04426695|80842877|FG009|Overall Study|Sponsor Request|0|||
27731225|NCT04426695|80842878|FG010|Overall Study|Sponsor Request|0|||
27731226|NCT04426695|80842879|FG011|Overall Study|Sponsor Request|0|||
27731227|NCT04426695|80842880|FG012|Overall Study|Sponsor Request|0|||
27731228|NCT04426695|80842881|FG013|Overall Study|Sponsor Request|0|||
27731229|NCT04426695|80842882|FG014|Overall Study|Sponsor Request|0|||
27731230|NCT04426695|80842883|FG015|Overall Study|Sponsor Request|0|||
27854131|NCT01007942|81298701|FG001|Overall Study|Abnormal test procedure|1|||
27854132|NCT01007942|81298700|FG000|Overall Study|Disease progression|217|||
27854133|NCT01007942|81298701|FG001|Overall Study|Disease progression|242|||
27854134|NCT01007942|81298700|FG000|Overall Study|New cancer therapy|5|||
27854135|NCT01007942|81298701|FG001|Overall Study|New cancer therapy|1|||
27854136|NCT01007942|81298700|FG000|Overall Study|Protocol Violation|1|||
27519467|NCT01261780|80095164|FG000|Overall Study|Withdrawal by Subject|1|||
27519468|NCT01261780|80095165|FG001|Overall Study|Withdrawal by Subject|0|||
27519469|NCT01261780|80095164|FG000|Overall Study|Event not related to subject|1|||
27519470|NCT01261780|80095165|FG001|Overall Study|Event not related to subject|2|||
27731231|NCT04426695|80842884|FG016|Overall Study|Sponsor Request|0|||
27731232|NCT04426695|80842885|FG017|Overall Study|Sponsor Request|0|||
27854137|NCT01007942|81298701|FG001|Overall Study|Protocol Violation|1|||
27854138|NCT01007942|81298700|FG000|Overall Study|Withdrawal by Subject|19|||
27854139|NCT01007942|81298701|FG001|Overall Study|Withdrawal by Subject|14|||
27854140|NCT01007942|81298700|FG000|Overall Study|Lost to Follow-up|1|||
27854141|NCT01007942|81298701|FG001|Overall Study|Lost to Follow-up|0|||
27908763|NCT01939223|81503431|FG000|Overall Study|Withdrawal by Subject|6|||
27731233|NCT04426695|80842868|FG000|Overall Study|Physician Decision|0|||
27731234|NCT04426695|80842869|FG001|Overall Study|Physician Decision|0|||
27908764|NCT01939223|81503432|FG001|Overall Study|Withdrawal by Subject|0|||
27519471|NCT01578850|80095166|FG000|Period 1|Insufficient Clinical Response|1|||
27731235|NCT04426695|80842870|FG002|Overall Study|Physician Decision|0|||
27731236|NCT04426695|80842871|FG003|Overall Study|Physician Decision|0|||
27731237|NCT04426695|80842872|FG004|Overall Study|Physician Decision|0|||
27731238|NCT04426695|80842873|FG005|Overall Study|Physician Decision|0|||
27619290|NCT02718417|80449426|FG000|Observation Phase (OP)|Adverse Event|0|||
27519472|NCT01578850|80095167|FG001|Period 1|Insufficient Clinical Response|0|||
27519473|NCT01578850|80095168|FG002|Period 1|Insufficient Clinical Response|0|||
27519474|NCT01578850|80095166|FG000|Period 1|Adverse Event|11|||
27731239|NCT04426695|80842874|FG006|Overall Study|Physician Decision|0|||
27908765|NCT00536510|81503451|FG000|Overall Study|Adverse Event|27|||
27731240|NCT04426695|80842875|FG007|Overall Study|Physician Decision|0|||
27731241|NCT04426695|80842876|FG008|Overall Study|Physician Decision|0|||
27731242|NCT04426695|80842877|FG009|Overall Study|Physician Decision|1|||
27731243|NCT04426695|80842878|FG010|Overall Study|Physician Decision|0|||
27731244|NCT04426695|80842879|FG011|Overall Study|Physician Decision|0|||
27731245|NCT04426695|80842880|FG012|Overall Study|Physician Decision|1|||
27731246|NCT04426695|80842881|FG013|Overall Study|Physician Decision|0|||
27731247|NCT04426695|80842882|FG014|Overall Study|Physician Decision|0|||
27731248|NCT04426695|80842883|FG015|Overall Study|Physician Decision|0|||
27908766|NCT00536510|81503452|FG001|Overall Study|Adverse Event|4|||
27908767|NCT00536510|81503451|FG000|Overall Study|Lost to Follow-up|11|||
27908768|NCT00536510|81503452|FG001|Overall Study|Lost to Follow-up|8|||
27908769|NCT00536510|81503451|FG000|Overall Study|Protocol Violation|4|||
27908770|NCT00536510|81503452|FG001|Overall Study|Protocol Violation|5|||
27908771|NCT00536510|81503451|FG000|Overall Study|Withdrawal by Subject|16|||
27908772|NCT00536510|81503452|FG001|Overall Study|Withdrawal by Subject|9|||
27908773|NCT00536510|81503451|FG000|Overall Study|Flushing with Product|20|||
27519475|NCT01578850|80095167|FG001|Period 1|Adverse Event|0|||
27519476|NCT01578850|80095168|FG002|Period 1|Adverse Event|0|||
27519477|NCT01578850|80095166|FG000|Period 1|Death|1|||
27619291|NCT02718417|80449427|FG001|Observation Phase (OP)|Adverse Event|0|||
27619292|NCT02718417|80449428|FG002|Observation Phase (OP)|Adverse Event|1|||
27619293|NCT02718417|80449426|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
27619294|NCT02718417|80449427|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
27619295|NCT02718417|80449428|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
27619296|NCT02718417|80449426|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
27619297|NCT02718417|80449427|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
27619298|NCT02718417|80449428|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
27619299|NCT02718417|80449426|FG000|Observation Phase (OP)|Physician Decision|0|||
27619300|NCT02718417|80449427|FG001|Observation Phase (OP)|Physician Decision|0|||
27619301|NCT02718417|80449428|FG002|Observation Phase (OP)|Physician Decision|9|||
27619302|NCT02718417|80449426|FG000|Observation Phase (OP)|Progressive disease|0|||
27619303|NCT02718417|80449427|FG001|Observation Phase (OP)|Progressive disease|0|||
27619304|NCT02718417|80449428|FG002|Observation Phase (OP)|Progressive disease|92|||
27731249|NCT04426695|80842884|FG016|Overall Study|Physician Decision|0|||
27519478|NCT01578850|80095167|FG001|Period 1|Death|0|||
27519479|NCT01578850|80095168|FG002|Period 1|Death|0|||
27519480|NCT01578850|80095166|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
27519481|NCT01578850|80095167|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
27519482|NCT01578850|80095168|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
27519483|NCT01578850|80095166|FG000|Period 1|Withdrawal by Subject|9|||
27519484|NCT01578850|80095167|FG001|Period 1|Withdrawal by Subject|0|||
27519485|NCT01578850|80095168|FG002|Period 1|Withdrawal by Subject|0|||
27519486|NCT01578850|80095166|FG000|Period 1|Study Terminated by Sponsor|3|||
27519487|NCT01578850|80095167|FG001|Period 1|Study Terminated by Sponsor|0|||
27519488|NCT01578850|80095168|FG002|Period 1|Study Terminated by Sponsor|0|||
27519489|NCT01578850|80095166|FG000|Period 2|Insufficient Clinical Response|0|||
27519490|NCT01578850|80095167|FG001|Period 2|Insufficient Clinical Response|1|||
27519491|NCT01578850|80095168|FG002|Period 2|Insufficient Clinical Response|0|||
27519492|NCT01578850|80095166|FG000|Period 2|Adverse Event|0|||
27519493|NCT01578850|80095167|FG001|Period 2|Adverse Event|3|||
27519494|NCT01578850|80095168|FG002|Period 2|Adverse Event|6|||
27519495|NCT01578850|80095166|FG000|Period 2|Lost to Follow-up|0|||
27519496|NCT01578850|80095167|FG001|Period 2|Lost to Follow-up|1|||
27519497|NCT01578850|80095168|FG002|Period 2|Lost to Follow-up|2|||
27519498|NCT01578850|80095166|FG000|Period 2|Withdrawal by Subject|0|||
27519499|NCT01578850|80095167|FG001|Period 2|Withdrawal by Subject|2|||
27519500|NCT01578850|80095168|FG002|Period 2|Withdrawal by Subject|2|||
27519501|NCT01578850|80095166|FG000|Period 2|Study Terminated by Sponsor|0|||
27519502|NCT01578850|80095167|FG001|Period 2|Study Terminated by Sponsor|5|||
27519503|NCT01578850|80095168|FG002|Period 2|Study Terminated by Sponsor|4|||
27519504|NCT01578850|80095166|FG000|Period 2|Unspecified Reasons|0|||
27731250|NCT04426695|80842885|FG017|Overall Study|Physician Decision|0|||
27519505|NCT01578850|80095167|FG001|Period 2|Unspecified Reasons|1|||
27519506|NCT01578850|80095168|FG002|Period 2|Unspecified Reasons|0|||
27519507|NCT00910299|80095172|FG000|Overall Study|Withdrawal by Subject|16|||
27519508|NCT00910299|80095173|FG001|Overall Study|Withdrawal by Subject|13|||
27731251|NCT04426695|80842868|FG000|Overall Study|Randomized but Never Treated|3|||
27731252|NCT04426695|80842869|FG001|Overall Study|Randomized but Never Treated|1|||
27731253|NCT04426695|80842870|FG002|Overall Study|Randomized but Never Treated|0|||
27731254|NCT04426695|80842871|FG003|Overall Study|Randomized but Never Treated|4|||
27731255|NCT04426695|80842872|FG004|Overall Study|Randomized but Never Treated|5|||
27908774|NCT00536510|81503452|FG001|Overall Study|Flushing with Product|0|||
27519509|NCT00910299|80095172|FG000|Overall Study|Sponsor Decision|58|||
27519510|NCT00910299|80095173|FG001|Overall Study|Sponsor Decision|60|||
27519511|NCT00910299|80095172|FG000|Overall Study|Didn't receive any study drug|2|||
27519512|NCT00910299|80095173|FG001|Overall Study|Didn't receive any study drug|1|||
27519513|NCT01028300|80095174|FG000|Overall Study|Study Terminated|4|||
27619305|NCT02718417|80449426|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
27619306|NCT02718417|80449427|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
27619307|NCT02718417|80449428|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
27619308|NCT02718417|80449426|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
27619309|NCT02718417|80449427|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
27619310|NCT02718417|80449428|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
27619311|NCT02718417|80449426|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
27619312|NCT02718417|80449427|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
27619313|NCT02718417|80449428|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
27619314|NCT02718417|80449426|FG000|Observation Phase (OP)|Other|0|||
27619315|NCT02718417|80449427|FG001|Observation Phase (OP)|Other|0|||
27619316|NCT02718417|80449428|FG002|Observation Phase (OP)|Other|7|||
27619317|NCT02718417|80449426|FG000|Follow-up Phase|Adverse Event|3|||
27619318|NCT02718417|80449427|FG001|Follow-up Phase|Adverse Event|1|||
27619319|NCT02718417|80449428|FG002|Follow-up Phase|Adverse Event|1|||
27619320|NCT02718417|80449426|FG000|Follow-up Phase|Other|4|||
27619321|NCT02718417|80449427|FG001|Follow-up Phase|Other|6|||
27619322|NCT02718417|80449428|FG002|Follow-up Phase|Other|4|||
27619323|NCT02718417|80449426|FG000|Follow-up Phase|Withdrawal by Subject|19|||
27619324|NCT02718417|80449427|FG001|Follow-up Phase|Withdrawal by Subject|17|||
27619325|NCT02718417|80449428|FG002|Follow-up Phase|Withdrawal by Subject|5|||
27619326|NCT02718417|80449426|FG000|Follow-up Phase|Study terminated by sponsor|100|||
27619327|NCT02718417|80449427|FG001|Follow-up Phase|Study terminated by sponsor|138|||
27619328|NCT02718417|80449428|FG002|Follow-up Phase|Study terminated by sponsor|6|||
27619329|NCT02718417|80449426|FG000|Follow-up Phase|Lost to Follow-up|2|||
27619330|NCT02718417|80449427|FG001|Follow-up Phase|Lost to Follow-up|3|||
27619331|NCT02718417|80449428|FG002|Follow-up Phase|Lost to Follow-up|0|||
27908775|NCT00536510|81503451|FG000|Overall Study|Laboratory Adverse Event|2|||
27908776|NCT00536510|81503452|FG001|Overall Study|Laboratory Adverse Event|1|||
27908777|NCT00536510|81503451|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
27908778|NCT00536510|81503452|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
27908779|NCT05285787|81503455|FG000|Overall Study|Withdrawal by Subject|1|||
27908780|NCT00707980|81503456|FG000|Overall Study|Adverse Event|49|||
27908781|NCT00707980|81503456|FG000|Overall Study|Lack of Efficacy|35|||
27908782|NCT00707980|81503456|FG000|Overall Study|Non-Compliance with Study Drug|28|||
27908783|NCT00707980|81503456|FG000|Overall Study|Protocol Deviations|19|||
27908784|NCT00707980|81503456|FG000|Overall Study|Withdrawal of Consent|81|||
27908785|NCT00707980|81503456|FG000|Overall Study|Lost to Follow-up|59|||
27908786|NCT00707980|81503456|FG000|Overall Study|Other|39|||
27908787|NCT02609984|81503463|FG000|Overall Study|Death|29|||
27908788|NCT02609984|81503464|FG001|Overall Study|Death|26|||
27908789|NCT02609984|81503463|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
27908790|NCT02609984|81503464|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
27908791|NCT02609984|81503463|FG000|Overall Study|Lost to Follow-up|1|||
27908792|NCT02609984|81503464|FG001|Overall Study|Lost to Follow-up|2|||
27908793|NCT02609984|81503463|FG000|Overall Study|Withdrawal by Subject|0|||
27908794|NCT02609984|81503464|FG001|Overall Study|Withdrawal by Subject|1|||
27908795|NCT02609984|81503463|FG000|Overall Study|Disease Progression|2|||
27908796|NCT02609984|81503464|FG001|Overall Study|Disease Progression|0|||
27908797|NCT00905424|81503465|FG000|Overall Study|Lost to Follow-up|3|||
27619332|NCT02718417|80449426|FG000|Follow-up Phase|Death leading to discontinuation|7|||
27619333|NCT02718417|80449427|FG001|Follow-up Phase|Death leading to discontinuation|7|||
27619334|NCT02718417|80449428|FG002|Follow-up Phase|Death leading to discontinuation|3|||
27619335|NCT02718417|80449426|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
27619336|NCT02718417|80449427|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
27619337|NCT02718417|80449428|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
27619338|NCT02718417|80449426|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
27619339|NCT02718417|80449427|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
27908798|NCT00905424|81503466|FG001|Overall Study|Lost to Follow-up|3|||
27519514|NCT00095147|80095175|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
27519515|NCT00095147|80095176|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
27519516|NCT00095147|80095177|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
27519517|NCT00095147|80095178|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
27519518|NCT00095147|80095179|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
27519519|NCT00095147|80095175|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
27519520|NCT00095147|80095176|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
27519521|NCT00095147|80095177|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
27519522|NCT00095147|80095178|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
27519523|NCT00095147|80095179|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
27519524|NCT00095147|80095175|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
27619340|NCT02718417|80449428|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
27908799|NCT00905424|81503465|FG000|Overall Study|Withdrawal by Subject|1|||
27908800|NCT00905424|81503466|FG001|Overall Study|Withdrawal by Subject|2|||
27908801|NCT00905424|81503465|FG000|Overall Study|Adverse Event|4|||
27519525|NCT00095147|80095176|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
27519526|NCT00095147|80095177|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
27519527|NCT00095147|80095178|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
27519528|NCT00095147|80095179|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
27519529|NCT00095147|80095175|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
27519530|NCT00095147|80095176|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
27519531|NCT00095147|80095177|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
27519532|NCT00095147|80095178|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
27519533|NCT00095147|80095179|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
27519534|NCT00095147|80095175|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
27519535|NCT00095147|80095176|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
27519536|NCT00095147|80095177|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
27519537|NCT00095147|80095178|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
27519538|NCT00095147|80095179|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
27519539|NCT00095147|80095175|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
27519540|NCT00095147|80095176|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
27519541|NCT00095147|80095177|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
27519542|NCT00095147|80095178|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
27519543|NCT00095147|80095179|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
27519544|NCT00095147|80095175|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
27519545|NCT00095147|80095176|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
27519546|NCT00095147|80095177|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
27519547|NCT00095147|80095178|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
27519548|NCT00095147|80095179|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
27519549|NCT00095147|80095175|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
27519550|NCT00095147|80095176|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
27519551|NCT00095147|80095177|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
27519552|NCT00095147|80095178|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
27519553|NCT00095147|80095179|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
27519554|NCT00095147|80095175|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
27519555|NCT00095147|80095176|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
27519556|NCT00095147|80095177|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
27519557|NCT00095147|80095178|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
27519558|NCT00095147|80095179|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
27619341|NCT02718417|80449426|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
27619342|NCT02718417|80449427|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
27619343|NCT02718417|80449428|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
27619344|NCT02718417|80449426|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
27619345|NCT02718417|80449427|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
27619346|NCT02718417|80449428|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
27619347|NCT02718417|80449426|FG000|Long-term Follow-up Phase|Other|0|||
27619348|NCT02718417|80449427|FG001|Long-term Follow-up Phase|Other|2|||
27619349|NCT02718417|80449428|FG002|Long-term Follow-up Phase|Other|0|||
27619350|NCT00231179|80449429|FG000|Overall Study|Lost to Follow-up|21|||
27619351|NCT00231179|80449430|FG001|Overall Study|Lost to Follow-up|21|||
27619352|NCT00231179|80449429|FG000|Overall Study|Withdrawal by Subject|3|||
27619353|NCT00231179|80449430|FG001|Overall Study|Withdrawal by Subject|3|||
27619354|NCT00593554|80449433|FG000|Overall Study|Death|1|||
27619355|NCT00593554|80449434|FG001|Overall Study|Death|2|||
27619356|NCT00593554|80449433|FG000|Overall Study|Physician Decision|0|||
27619357|NCT00593554|80449434|FG001|Overall Study|Physician Decision|1|||
27619358|NCT00593554|80449433|FG000|Overall Study|Withdrawal by Subject|1|||
27619359|NCT00593554|80449434|FG001|Overall Study|Withdrawal by Subject|0|||
27619360|NCT00593554|80449433|FG000|Overall Study|Disease Progression|1|||
27619361|NCT00593554|80449434|FG001|Overall Study|Disease Progression|2|||
27619362|NCT02478359|80449435|FG000|Overall Study|Disenrolled from health plan|106|||
27619363|NCT02478359|80449436|FG001|Overall Study|Disenrolled from health plan|65|||
27619364|NCT01290094|80449437|FG000|Overall Study|Withdrawal by Subject|1|||
27619365|NCT01290094|80449437|FG000|Overall Study|Lost to Follow-up|5|||
27731256|NCT04426695|80842873|FG005|Overall Study|Randomized but Never Treated|5|||
27731257|NCT04426695|80842874|FG006|Overall Study|Randomized but Never Treated|4|||
27731258|NCT04426695|80842875|FG007|Overall Study|Randomized but Never Treated|6|||
27731259|NCT04426695|80842876|FG008|Overall Study|Randomized but Never Treated|6|||
27519559|NCT00095147|80095175|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
27519560|NCT00095147|80095176|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
27519561|NCT00095147|80095177|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
27619366|NCT01177813|80449438|FG000|Overall Study|Adverse Event|8|||
27619367|NCT01177813|80449439|FG001|Overall Study|Adverse Event|2|||
27619368|NCT01177813|80449440|FG002|Overall Study|Adverse Event|4|||
27619369|NCT01177813|80449441|FG003|Overall Study|Adverse Event|6|||
27619370|NCT01177813|80449442|FG004|Overall Study|Adverse Event|3|||
27619371|NCT01177813|80449438|FG000|Overall Study|Lack of Efficacy|1|||
27619372|NCT01177813|80449439|FG001|Overall Study|Lack of Efficacy|0|||
27619373|NCT01177813|80449440|FG002|Overall Study|Lack of Efficacy|0|||
27619374|NCT01177813|80449441|FG003|Overall Study|Lack of Efficacy|0|||
27619375|NCT01177813|80449442|FG004|Overall Study|Lack of Efficacy|0|||
27619376|NCT01177813|80449438|FG000|Overall Study|Protocol Violation|3|||
27619377|NCT01177813|80449439|FG001|Overall Study|Protocol Violation|2|||
27619378|NCT01177813|80449440|FG002|Overall Study|Protocol Violation|2|||
27619379|NCT01177813|80449441|FG003|Overall Study|Protocol Violation|0|||
27619380|NCT01177813|80449442|FG004|Overall Study|Protocol Violation|1|||
27619381|NCT01177813|80449438|FG000|Overall Study|Lost to Follow-up|12|||
27619382|NCT01177813|80449439|FG001|Overall Study|Lost to Follow-up|5|||
27619383|NCT01177813|80449440|FG002|Overall Study|Lost to Follow-up|6|||
27619384|NCT01177813|80449441|FG003|Overall Study|Lost to Follow-up|3|||
27619385|NCT01177813|80449442|FG004|Overall Study|Lost to Follow-up|0|||
27619386|NCT01177813|80449438|FG000|Overall Study|Withdrawal by Subject|12|||
27619387|NCT01177813|80449439|FG001|Overall Study|Withdrawal by Subject|7|||
27619388|NCT01177813|80449440|FG002|Overall Study|Withdrawal by Subject|6|||
27619389|NCT01177813|80449441|FG003|Overall Study|Withdrawal by Subject|5|||
27619390|NCT01177813|80449442|FG004|Overall Study|Withdrawal by Subject|3|||
27619391|NCT01177813|80449438|FG000|Overall Study|Other reason not defined above|5|||
27619392|NCT01177813|80449439|FG001|Overall Study|Other reason not defined above|2|||
27619393|NCT01177813|80449440|FG002|Overall Study|Other reason not defined above|2|||
27619394|NCT01177813|80449441|FG003|Overall Study|Other reason not defined above|3|||
27619395|NCT01177813|80449442|FG004|Overall Study|Other reason not defined above|2|||
27619396|NCT00590980|80452920|FG000|Overall Study|Did not meet all inclusion criteria|10|||
27619397|NCT00604721|80452921|FG000|Overall Study|Physician Decision|1|||
27619398|NCT00604721|80452921|FG000|Overall Study|Withdrawal by Subject|1|||
27619399|NCT01222247|80452923|FG000|Overall Study|Lost to Follow-up|2|||
27619400|NCT01222247|80452924|FG001|Overall Study|Lost to Follow-up|2|||
27619401|NCT04285229|80452925|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27619402|NCT04285229|80452926|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27619403|NCT04285229|80452927|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27619404|NCT04285229|80452928|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27619405|NCT04285229|80452929|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27619406|NCT04285229|80452930|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27619407|NCT04285229|80452925|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
27619408|NCT04285229|80452926|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
27619409|NCT04285229|80452927|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
27619410|NCT04285229|80452928|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
27619411|NCT04285229|80452929|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
27619412|NCT04285229|80452930|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
27619413|NCT04285229|80452925|FG000|Extended Treatment Period|Adverse Event|0|||
27619414|NCT04285229|80452926|FG001|Extended Treatment Period|Adverse Event|0|||
27619415|NCT04285229|80452927|FG002|Extended Treatment Period|Adverse Event|0|||
27619416|NCT04285229|80452928|FG003|Extended Treatment Period|Adverse Event|1|||
27619417|NCT04285229|80452929|FG004|Extended Treatment Period|Adverse Event|0|||
27619418|NCT04285229|80452930|FG005|Extended Treatment Period|Adverse Event|0|||
27619419|NCT04285229|80452925|FG000|Extended Treatment Period|Physician Decision|0|||
27619420|NCT04285229|80452926|FG001|Extended Treatment Period|Physician Decision|0|||
27619421|NCT04285229|80452927|FG002|Extended Treatment Period|Physician Decision|1|||
27619422|NCT04285229|80452928|FG003|Extended Treatment Period|Physician Decision|0|||
27619423|NCT04285229|80452929|FG004|Extended Treatment Period|Physician Decision|0|||
27619424|NCT04285229|80452930|FG005|Extended Treatment Period|Physician Decision|0|||
27619425|NCT04285229|80452925|FG000|Follow-up Period|Adverse Event|0|||
27619426|NCT04285229|80452926|FG001|Follow-up Period|Adverse Event|0|||
27619427|NCT04285229|80452927|FG002|Follow-up Period|Adverse Event|0|||
27619428|NCT04285229|80452928|FG003|Follow-up Period|Adverse Event|0|||
27619429|NCT04285229|80452929|FG004|Follow-up Period|Adverse Event|1|||
27619430|NCT04285229|80452930|FG005|Follow-up Period|Adverse Event|4|||
27619431|NCT04285229|80452925|FG000|Follow-up Period|Withdrawal by Subject|0|||
27619432|NCT04285229|80452926|FG001|Follow-up Period|Withdrawal by Subject|0|||
27619433|NCT04285229|80452927|FG002|Follow-up Period|Withdrawal by Subject|0|||
27619434|NCT04285229|80452928|FG003|Follow-up Period|Withdrawal by Subject|0|||
27619435|NCT04285229|80452929|FG004|Follow-up Period|Withdrawal by Subject|0|||
27619436|NCT04285229|80452930|FG005|Follow-up Period|Withdrawal by Subject|5|||
27619437|NCT04285229|80452925|FG000|Follow-up Period|Covid-19|0|||
27619438|NCT04285229|80452926|FG001|Follow-up Period|Covid-19|0|||
27619439|NCT04285229|80452927|FG002|Follow-up Period|Covid-19|0|||
27619440|NCT04285229|80452928|FG003|Follow-up Period|Covid-19|0|||
27619441|NCT04285229|80452929|FG004|Follow-up Period|Covid-19|0|||
27619442|NCT04285229|80452930|FG005|Follow-up Period|Covid-19|2|||
27619443|NCT04285229|80452925|FG000|Follow-up Period|Physician Decision|0|||
27619444|NCT04285229|80452926|FG001|Follow-up Period|Physician Decision|0|||
27619445|NCT04285229|80452927|FG002|Follow-up Period|Physician Decision|0|||
27619446|NCT04285229|80452928|FG003|Follow-up Period|Physician Decision|0|||
27619447|NCT04285229|80452929|FG004|Follow-up Period|Physician Decision|0|||
27619448|NCT04285229|80452930|FG005|Follow-up Period|Physician Decision|1|||
27619449|NCT04003974|80452931|FG000|Overall Study|Missing|1|||
27619450|NCT04003974|80452932|FG001|Overall Study|Missing|0|||
27619451|NCT04003974|80452931|FG000|Overall Study|Withdrawal by Subject|0|||
27619452|NCT04003974|80452932|FG001|Overall Study|Withdrawal by Subject|2|||
27619453|NCT03073005|80452950|FG000|Overall Study|Death|6|||
27619454|NCT03073005|80452951|FG001|Overall Study|Death|0|||
27619455|NCT03073005|80452952|FG002|Overall Study|Death|7|||
27619456|NCT03073005|80452953|FG003|Overall Study|Death|0|||
27619457|NCT03073005|80452950|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
27619458|NCT03073005|80452951|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
27619459|NCT03073005|80452952|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
27619460|NCT03073005|80452953|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
27619461|NCT03073005|80452950|FG000|Overall Study|Lost to Follow-up|2|||
27619462|NCT03073005|80452951|FG001|Overall Study|Lost to Follow-up|2|||
27619463|NCT03073005|80452952|FG002|Overall Study|Lost to Follow-up|1|||
27519562|NCT00095147|80095178|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
27519563|NCT00095147|80095179|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
27519564|NCT00095147|80095175|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
27519565|NCT00095147|80095176|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
27519566|NCT00095147|80095177|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
27519567|NCT00095147|80095178|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
27519568|NCT00095147|80095179|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
27519569|NCT00095147|80095175|FG000|Long-term Extension Period|Death|0|||
27519570|NCT00095147|80095176|FG001|Long-term Extension Period|Death|0|||
27519571|NCT00095147|80095177|FG002|Long-term Extension Period|Death|0|||
27519572|NCT00095147|80095178|FG003|Long-term Extension Period|Death|0|||
27519573|NCT00095147|80095179|FG004|Long-term Extension Period|Death|3|||
27519574|NCT00095147|80095175|FG000|Long-term Extension Period|Adverse Event|0|||
27519575|NCT00095147|80095176|FG001|Long-term Extension Period|Adverse Event|0|||
27519576|NCT00095147|80095177|FG002|Long-term Extension Period|Adverse Event|0|||
27519577|NCT00095147|80095178|FG003|Long-term Extension Period|Adverse Event|0|||
27519578|NCT00095147|80095179|FG004|Long-term Extension Period|Adverse Event|11|||
27519579|NCT00095147|80095175|FG000|Long-term Extension Period|Lack of Efficacy|0|||
27519580|NCT00095147|80095176|FG001|Long-term Extension Period|Lack of Efficacy|0|||
27519581|NCT00095147|80095177|FG002|Long-term Extension Period|Lack of Efficacy|0|||
27519582|NCT00095147|80095178|FG003|Long-term Extension Period|Lack of Efficacy|0|||
27519583|NCT00095147|80095179|FG004|Long-term Extension Period|Lack of Efficacy|9|||
27519584|NCT00095147|80095175|FG000|Long-term Extension Period|Lost to Follow-up|0|||
27519585|NCT00095147|80095176|FG001|Long-term Extension Period|Lost to Follow-up|0|||
27519586|NCT00095147|80095177|FG002|Long-term Extension Period|Lost to Follow-up|0|||
27519587|NCT00095147|80095178|FG003|Long-term Extension Period|Lost to Follow-up|0|||
27519588|NCT00095147|80095179|FG004|Long-term Extension Period|Lost to Follow-up|6|||
27519589|NCT00095147|80095175|FG000|Long-term Extension Period|Withdrawal of consent|0|||
27519590|NCT00095147|80095176|FG001|Long-term Extension Period|Withdrawal of consent|0|||
27519591|NCT00095147|80095177|FG002|Long-term Extension Period|Withdrawal of consent|0|||
27519592|NCT00095147|80095178|FG003|Long-term Extension Period|Withdrawal of consent|0|||
27519593|NCT00095147|80095179|FG004|Long-term Extension Period|Withdrawal of consent|12|||
27519594|NCT00095147|80095175|FG000|Long-term Extension Period|Pregnancy|0|||
27519595|NCT00095147|80095176|FG001|Long-term Extension Period|Pregnancy|0|||
27519596|NCT00095147|80095177|FG002|Long-term Extension Period|Pregnancy|0|||
27519597|NCT00095147|80095178|FG003|Long-term Extension Period|Pregnancy|0|||
27519598|NCT00095147|80095179|FG004|Long-term Extension Period|Pregnancy|1|||
27519599|NCT00095147|80095175|FG000|Long-term Extension Period|No longer meets study criteria|0|||
27519600|NCT00095147|80095176|FG001|Long-term Extension Period|No longer meets study criteria|0|||
27519601|NCT00095147|80095177|FG002|Long-term Extension Period|No longer meets study criteria|0|||
27519602|NCT00095147|80095178|FG003|Long-term Extension Period|No longer meets study criteria|0|||
27519603|NCT00095147|80095179|FG004|Long-term Extension Period|No longer meets study criteria|1|||
27519604|NCT00095147|80095175|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
27519605|NCT00095147|80095176|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
27519606|NCT00095147|80095177|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
27519607|NCT00095147|80095178|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
27519608|NCT00095147|80095179|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
27519609|NCT00095147|80095175|FG000|Long-term Extension Period|Leaving country|0|||
27619464|NCT03073005|80452953|FG003|Overall Study|Lost to Follow-up|2|||
27519610|NCT00095147|80095176|FG001|Long-term Extension Period|Leaving country|0|||
27519611|NCT00095147|80095177|FG002|Long-term Extension Period|Leaving country|0|||
27519612|NCT00095147|80095178|FG003|Long-term Extension Period|Leaving country|0|||
27619465|NCT03073005|80452950|FG000|Overall Study|Withdrawal by Subject|0|||
27619466|NCT03073005|80452951|FG001|Overall Study|Withdrawal by Subject|4|||
27619467|NCT03073005|80452952|FG002|Overall Study|Withdrawal by Subject|4|||
27619468|NCT03073005|80452953|FG003|Overall Study|Withdrawal by Subject|4|||
27619469|NCT03772314|80452954|FG000|Overall Study|Adverse Event|7|||
27619470|NCT03772314|80452955|FG001|Overall Study|Adverse Event|2|||
27619471|NCT00619151|80452957|FG000|Overall Study|Study terminated prior to followup|1|||
27619472|NCT00619151|80452958|FG001|Overall Study|Study terminated prior to followup|0|||
27619473|NCT00691028|80452959|FG000|Open-label Period|Adverse Event|0|||
27619474|NCT00691028|80452960|FG001|Open-label Period|Adverse Event|0|||
27619475|NCT00691028|80452961|FG002|Open-label Period|Adverse Event|0|||
27619476|NCT00691028|80452962|FG003|Open-label Period|Adverse Event|16|||
27619477|NCT00691028|80452959|FG000|Open-label Period|Withdrawal by Subject|0|||
27619478|NCT00691028|80452960|FG001|Open-label Period|Withdrawal by Subject|0|||
27619479|NCT00691028|80452961|FG002|Open-label Period|Withdrawal by Subject|0|||
27619480|NCT00691028|80452962|FG003|Open-label Period|Withdrawal by Subject|3|||
27619481|NCT00691028|80452959|FG000|Open-label Period|not come to a hospital|0|||
27619482|NCT00691028|80452960|FG001|Open-label Period|not come to a hospital|0|||
27619483|NCT00691028|80452961|FG002|Open-label Period|not come to a hospital|0|||
27619484|NCT00691028|80452962|FG003|Open-label Period|not come to a hospital|1|||
27619485|NCT00691028|80452959|FG000|Double-blind Period|Adverse Event|8|||
27619486|NCT00691028|80452960|FG001|Double-blind Period|Adverse Event|9|||
27619487|NCT00691028|80452961|FG002|Double-blind Period|Adverse Event|6|||
27619488|NCT00691028|80452962|FG003|Double-blind Period|Adverse Event|0|||
27619489|NCT00691028|80452959|FG000|Double-blind Period|Lack of Efficacy|4|||
27619490|NCT00691028|80452960|FG001|Double-blind Period|Lack of Efficacy|3|||
27619491|NCT00691028|80452961|FG002|Double-blind Period|Lack of Efficacy|2|||
27619492|NCT00691028|80452962|FG003|Double-blind Period|Lack of Efficacy|0|||
27619493|NCT00691028|80452959|FG000|Double-blind Period|Withdrawal by Subject|1|||
27619494|NCT00691028|80452960|FG001|Double-blind Period|Withdrawal by Subject|0|||
27619495|NCT00691028|80452961|FG002|Double-blind Period|Withdrawal by Subject|1|||
27619496|NCT00691028|80452962|FG003|Double-blind Period|Withdrawal by Subject|0|||
27619497|NCT00691028|80452959|FG000|Double-blind Period|not come to a hospital.|0|||
27619498|NCT00691028|80452960|FG001|Double-blind Period|not come to a hospital.|1|||
27619499|NCT00691028|80452961|FG002|Double-blind Period|not come to a hospital.|0|||
27619500|NCT00691028|80452962|FG003|Double-blind Period|not come to a hospital.|0|||
27619501|NCT02081391|80452967|FG000|12-hour Treatment|Withdrawal by Subject|3|||
27619502|NCT02081391|80452968|FG001|12-hour Treatment|Withdrawal by Subject|2|||
27619503|NCT02081391|80452969|FG002|12-hour Treatment|Withdrawal by Subject|0|||
27619504|NCT02081391|80452970|FG003|12-hour Treatment|Withdrawal by Subject|0|||
27619505|NCT02081391|80452967|FG000|12-hour Treatment|Physician Decision|4|||
27619506|NCT02081391|80452968|FG001|12-hour Treatment|Physician Decision|1|||
27619507|NCT02081391|80452969|FG002|12-hour Treatment|Physician Decision|0|||
27619508|NCT02081391|80452970|FG003|12-hour Treatment|Physician Decision|0|||
27619509|NCT02081391|80452967|FG000|12-hour Treatment|Lack of Efficacy|3|||
27619510|NCT02081391|80452968|FG001|12-hour Treatment|Lack of Efficacy|0|||
27619511|NCT02081391|80452969|FG002|12-hour Treatment|Lack of Efficacy|0|||
27619512|NCT02081391|80452970|FG003|12-hour Treatment|Lack of Efficacy|0|||
27619513|NCT02081391|80452967|FG000|12-hour Treatment|Adverse Event|4|||
27619514|NCT02081391|80452968|FG001|12-hour Treatment|Adverse Event|2|||
27619515|NCT02081391|80452969|FG002|12-hour Treatment|Adverse Event|0|||
27619516|NCT02081391|80452970|FG003|12-hour Treatment|Adverse Event|0|||
27619517|NCT02081391|80452967|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
27619518|NCT02081391|80452968|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
27619519|NCT02081391|80452969|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
27619520|NCT02081391|80452970|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
27619521|NCT02081391|80452967|FG000|12-hour Treatment|Further reasons|2|||
27619522|NCT02081391|80452968|FG001|12-hour Treatment|Further reasons|1|||
27619523|NCT02081391|80452969|FG002|12-hour Treatment|Further reasons|0|||
27619524|NCT02081391|80452970|FG003|12-hour Treatment|Further reasons|0|||
27619525|NCT02081391|80452967|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
27619526|NCT02081391|80452968|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
27619527|NCT02081391|80452969|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
27619528|NCT02081391|80452970|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
27619529|NCT02081391|80452967|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
27619530|NCT02081391|80452968|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
27619531|NCT02081391|80452969|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
27619532|NCT02081391|80452970|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
27854142|NCT01007942|81298700|FG000|Overall Study|Administrative problems|2|||
27619533|NCT02081391|80452967|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
27619534|NCT02081391|80452968|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
27619535|NCT02081391|80452969|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
27619536|NCT02081391|80452970|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
27619537|NCT02081391|80452967|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
27619538|NCT02081391|80452968|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
27619539|NCT02081391|80452969|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
27619540|NCT02081391|80452970|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
27619541|NCT02081391|80452967|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
27619542|NCT02081391|80452968|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
27619543|NCT02081391|80452969|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
27619544|NCT02081391|80452970|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
27619545|NCT02081391|80452967|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
27619546|NCT02081391|80452968|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
27519613|NCT00095147|80095179|FG004|Long-term Extension Period|Leaving country|1|||
27519614|NCT00311584|80095180|FG000|Overall Study|Death|1|||
27519615|NCT00311584|80095181|FG001|Overall Study|Death|0|||
27519616|NCT00311584|80095180|FG000|Overall Study|Lack of Efficacy|12|||
27519617|NCT00311584|80095181|FG001|Overall Study|Lack of Efficacy|15|||
27519618|NCT00311584|80095180|FG000|Overall Study|Physician Decision|4|||
27519619|NCT00311584|80095181|FG001|Overall Study|Physician Decision|5|||
27519620|NCT00311584|80095180|FG000|Overall Study|Withdrawal by Subject|1|||
27519621|NCT00311584|80095181|FG001|Overall Study|Withdrawal by Subject|1|||
27519622|NCT00311584|80095180|FG000|Overall Study|ineligible|2|||
27519623|NCT00311584|80095181|FG001|Overall Study|ineligible|2|||
27519624|NCT00313781|80095182|FG000|Before Crossover|Death|22|||
27519625|NCT00313781|80095183|FG001|Before Crossover|Death|8|||
27519626|NCT00313781|80095184|FG002|Before Crossover|Death|0|||
27519627|NCT00313781|80095182|FG000|Before Crossover|Lost to Follow-up|0|||
27519628|NCT00313781|80095183|FG001|Before Crossover|Lost to Follow-up|3|||
27519629|NCT00313781|80095184|FG002|Before Crossover|Lost to Follow-up|0|||
27519630|NCT00313781|80095182|FG000|Before Crossover|Withdrawal by Subject|3|||
27519631|NCT00313781|80095183|FG001|Before Crossover|Withdrawal by Subject|1|||
27519632|NCT00313781|80095184|FG002|Before Crossover|Withdrawal by Subject|0|||
27519633|NCT00313781|80095182|FG000|Before Crossover|Other|45|||
27519634|NCT00313781|80095183|FG001|Before Crossover|Other|30|||
27519635|NCT00313781|80095184|FG002|Before Crossover|Other|0|||
27519636|NCT00313781|80095182|FG000|Before Crossover|Crossover|0|||
27519637|NCT00313781|80095183|FG001|Before Crossover|Crossover|37|||
27519638|NCT00313781|80095184|FG002|Before Crossover|Crossover|0|||
27519639|NCT00313781|80095182|FG000|Before Crossover|Randomized, not treated|5|||
27519640|NCT00313781|80095183|FG001|Before Crossover|Randomized, not treated|0|||
27519641|NCT00313781|80095184|FG002|Before Crossover|Randomized, not treated|0|||
27519642|NCT00313781|80095182|FG000|After Crossover|Death|0|||
27519643|NCT00313781|80095183|FG001|After Crossover|Death|0|||
27519644|NCT00313781|80095184|FG002|After Crossover|Death|6|||
27519645|NCT00313781|80095182|FG000|After Crossover|Withdrawal by Subject|0|||
27519646|NCT00313781|80095183|FG001|After Crossover|Withdrawal by Subject|0|||
27519647|NCT00313781|80095184|FG002|After Crossover|Withdrawal by Subject|3|||
27519648|NCT00313781|80095182|FG000|After Crossover|Other|0|||
27519649|NCT00313781|80095183|FG001|After Crossover|Other|0|||
27519650|NCT00313781|80095184|FG002|After Crossover|Other|18|||
27519651|NCT01883453|80095185|FG000|Overall Study|No episode of common cold|25|||
27519652|NCT01883453|80095186|FG001|Overall Study|No episode of common cold|23|||
27519653|NCT04605991|80095194|FG000|Overall Study|Adverse Event|5|||
27519654|NCT04605991|80095194|FG000|Overall Study|Lack of Efficacy|1|||
27519655|NCT04605991|80095194|FG000|Overall Study|Lost to Follow-up|8|||
27519656|NCT04605991|80095194|FG000|Overall Study|Physician Decision|4|||
27519657|NCT04605991|80095194|FG000|Overall Study|Withdrawal by Subject|14|||
27519658|NCT04605991|80095194|FG000|Overall Study|Non-compliance with study|1|||
27519659|NCT01425463|80095195|FG000|Overall Study|Adverse Event|5|||
27519660|NCT01425463|80095196|FG001|Overall Study|Adverse Event|7|||
27519661|NCT01425463|80095195|FG000|Overall Study|Lack of Efficacy|1|||
27519662|NCT01425463|80095196|FG001|Overall Study|Lack of Efficacy|1|||
27519663|NCT01425463|80095195|FG000|Overall Study|Protocol Violation|2|||
27519664|NCT01425463|80095196|FG001|Overall Study|Protocol Violation|2|||
27619547|NCT02081391|80452969|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
27619548|NCT02081391|80452970|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
27619549|NCT02412761|80452971|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27619550|NCT02412761|80452972|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27731260|NCT04426695|80842877|FG009|Overall Study|Randomized but Never Treated|3|||
27519665|NCT01425463|80095195|FG000|Overall Study|Lost to Follow-up|5|||
27519666|NCT01425463|80095196|FG001|Overall Study|Lost to Follow-up|2|||
27519667|NCT01425463|80095195|FG000|Overall Study|Withdrawal by Subject|7|||
27519668|NCT01425463|80095196|FG001|Overall Study|Withdrawal by Subject|5|||
27519669|NCT01425463|80095195|FG000|Overall Study|Unknown Reason|4|||
27519670|NCT01425463|80095196|FG001|Overall Study|Unknown Reason|7|||
27519671|NCT00065429|80095197|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
27519672|NCT00065429|80095198|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
27519673|NCT00065429|80095199|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
27519674|NCT00065429|80095200|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
27519675|NCT00065429|80095201|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
27908802|NCT00905424|81503466|FG001|Overall Study|Adverse Event|2|||
27908803|NCT00905424|81503465|FG000|Overall Study|Non-compliance with study medication|2|||
27908804|NCT00905424|81503466|FG001|Overall Study|Non-compliance with study medication|0|||
27908805|NCT00905424|81503465|FG000|Overall Study|Sponsor decision|1|||
27908806|NCT00905424|81503466|FG001|Overall Study|Sponsor decision|0|||
27908807|NCT00905424|81503465|FG000|Overall Study|Positive urine drug screen|0|||
27908808|NCT00905424|81503466|FG001|Overall Study|Positive urine drug screen|1|||
27908809|NCT00905424|81503465|FG000|Overall Study|Non-adherence to visit schedule|0|||
27908810|NCT00905424|81503466|FG001|Overall Study|Non-adherence to visit schedule|1|||
27908811|NCT01098162|81503474|FG000|Overall Study|Adverse Event|37|||
27908812|NCT01098162|81503474|FG000|Overall Study|Lack of Efficacy|4|||
27908813|NCT01098162|81503474|FG000|Overall Study|Wish of Patient|7|||
27908814|NCT01098162|81503474|FG000|Overall Study|Lost to Follow-up|9|||
27908815|NCT01098162|81503474|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
27908816|NCT01098162|81503474|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
27908817|NCT01098162|81503474|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
27908818|NCT01098162|81503474|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
27908819|NCT01098162|81503474|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
27908820|NCT01098162|81503474|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
27908821|NCT01098162|81503474|FG000|Overall Study|Other Reason|1|||
27908822|NCT01098162|81503474|FG000|Overall Study|Reason Unknown|26|||
27908823|NCT01853748|81503475|FG000|Allocation|Withdrawal by Subject|1|||
27908824|NCT01853748|81503476|FG001|Allocation|Withdrawal by Subject|13|||
27908825|NCT01853748|81503475|FG000|Allocation|not sufficient to receive intervention|0|||
27908826|NCT01853748|81503476|FG001|Allocation|not sufficient to receive intervention|1|||
27908827|NCT01853748|81503475|FG000|Follow-Up|Withdrawal by Subject|7|||
27908828|NCT01853748|81503476|FG001|Follow-Up|Withdrawal by Subject|6|||
27908829|NCT01853748|81503475|FG000|Follow-Up|Adverse Event|67|||
27908830|NCT01853748|81503476|FG001|Follow-Up|Adverse Event|7|||
27908831|NCT01853748|81503475|FG000|Follow-Up|not available for data collection|16|||
27908832|NCT01853748|81503476|FG001|Follow-Up|not available for data collection|4|||
27908833|NCT02281955|81503483|FG000|Overall Study|Death|1|||
27908834|NCT02207400|81503491|FG000|Overall Study|Adverse Event|1|||
27908835|NCT02207400|81503492|FG001|Overall Study|Adverse Event|1|||
27908836|NCT02207400|81503491|FG000|Overall Study|Lost to Follow-up|6|||
27908837|NCT02207400|81503492|FG001|Overall Study|Lost to Follow-up|7|||
27908838|NCT02207400|81503491|FG000|Overall Study|Protocol Violation|1|||
27908839|NCT02207400|81503492|FG001|Overall Study|Protocol Violation|1|||
27908840|NCT02207400|81503491|FG000|Overall Study|Withdrawal by Subject|8|||
27908841|NCT02207400|81503492|FG001|Overall Study|Withdrawal by Subject|4|||
27908842|NCT02207400|81503491|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
27908843|NCT02207400|81503492|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
27908844|NCT01843803|81503496|FG000|Overall Study|not a Veteran, did not see provider|1|||
27908845|NCT01843803|81503497|FG001|Overall Study|not a Veteran, did not see provider|3|||
27519676|NCT00065429|80095202|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
27519677|NCT00065429|80095203|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
27519678|NCT00065429|80095197|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
27519679|NCT00065429|80095198|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
27519680|NCT00065429|80095199|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
27519681|NCT00065429|80095200|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
27519682|NCT00065429|80095201|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
27519683|NCT00065429|80095202|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
27519684|NCT00065429|80095203|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
27519685|NCT00065429|80095197|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
27519686|NCT00065429|80095198|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
27519687|NCT00065429|80095199|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
27519688|NCT00065429|80095200|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
27519689|NCT00065429|80095201|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
27519690|NCT00065429|80095202|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
27519691|NCT00065429|80095203|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
27519692|NCT00065429|80095197|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
27731261|NCT04426695|80842878|FG010|Overall Study|Randomized but Never Treated|3|||
27731262|NCT04426695|80842879|FG011|Overall Study|Randomized but Never Treated|6|||
27731263|NCT04426695|80842880|FG012|Overall Study|Randomized but Never Treated|1|||
27908846|NCT02149264|81503498|FG000|Overall Study|Withdrawal by Subject|9|||
27908847|NCT02149264|81503498|FG000|Overall Study|Adverse Event|7|||
27519693|NCT00065429|80095198|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
27731264|NCT04426695|80842881|FG013|Overall Study|Randomized but Never Treated|2|||
27731265|NCT04426695|80842882|FG014|Overall Study|Randomized but Never Treated|0|||
27908848|NCT02149264|81503498|FG000|Overall Study|Physician Decision|3|||
27519694|NCT00065429|80095199|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
27908849|NCT02149264|81503498|FG000|Overall Study|Protocol Violation|1|||
27908850|NCT00196105|81503499|FG000|Overall Study|Lost to Follow-up|4|||
27908851|NCT00196105|81503500|FG001|Overall Study|Lost to Follow-up|5|||
27908852|NCT00196105|81503501|FG002|Overall Study|Lost to Follow-up|7|||
27908853|NCT04265261|81503512|FG000|Overall Study|Adverse Event|2|||
27908854|NCT04265261|81503513|FG001|Overall Study|Adverse Event|0|||
27908855|NCT04265261|81503514|FG002|Overall Study|Adverse Event|0|||
27908856|NCT04265261|81503512|FG000|Overall Study|Death|1|||
27908857|NCT04265261|81503513|FG001|Overall Study|Death|0|||
27908858|NCT04265261|81503514|FG002|Overall Study|Death|0|||
27908859|NCT04265261|81503512|FG000|Overall Study|Lost to Follow-up|4|||
27908860|NCT04265261|81503513|FG001|Overall Study|Lost to Follow-up|1|||
27908861|NCT04265261|81503514|FG002|Overall Study|Lost to Follow-up|3|||
27908862|NCT04265261|81503512|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27908863|NCT04265261|81503513|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27908864|NCT04265261|81503514|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27908865|NCT04265261|81503512|FG000|Overall Study|Physician Decision|0|||
27908866|NCT04265261|81503513|FG001|Overall Study|Physician Decision|0|||
27908867|NCT04265261|81503514|FG002|Overall Study|Physician Decision|1|||
27908868|NCT04265261|81503512|FG000|Overall Study|Protocol Deviation|0|||
27908869|NCT04265261|81503513|FG001|Overall Study|Protocol Deviation|2|||
27908870|NCT04265261|81503514|FG002|Overall Study|Protocol Deviation|0|||
27908871|NCT04265261|81503512|FG000|Overall Study|Withdrawal by Subject|2|||
27908872|NCT04265261|81503513|FG001|Overall Study|Withdrawal by Subject|1|||
27908873|NCT04265261|81503514|FG002|Overall Study|Withdrawal by Subject|4|||
27908874|NCT01720524|81503515|FG000|Part A|Insufficient Clinical Response|2|||
27908875|NCT01720524|81503516|FG001|Part A|Insufficient Clinical Response|4|||
27908876|NCT01720524|81503515|FG000|Part A|Adverse Event|2|||
27908877|NCT01720524|81503516|FG001|Part A|Adverse Event|2|||
27908878|NCT01720524|81503515|FG000|Part A|Death|2|||
27619551|NCT02412761|80452973|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27619552|NCT02412761|80452974|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27619553|NCT02412761|80452975|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27619554|NCT02412761|80452976|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27854143|NCT01007942|81298701|FG001|Overall Study|Administrative problems|0|||
27908879|NCT01720524|81503516|FG001|Part A|Death|1|||
27908880|NCT01720524|81503515|FG000|Part A|Lost to Follow-up|0|||
27908881|NCT01720524|81503516|FG001|Part A|Lost to Follow-up|1|||
27908882|NCT01720524|81503515|FG000|Part A|Missed 28 day follow-up visit|1|||
27908883|NCT01720524|81503516|FG001|Part A|Missed 28 day follow-up visit|1|||
27908884|NCT01720524|81503515|FG000|Part A|Withdrawal by Subject|0|||
27519695|NCT00065429|80095200|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
27519696|NCT00065429|80095201|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
27519697|NCT00065429|80095202|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
27519698|NCT00065429|80095203|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
27519699|NCT00065429|80095197|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
27519700|NCT00065429|80095198|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
27519701|NCT00065429|80095199|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
27519702|NCT00065429|80095200|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
27519703|NCT00065429|80095201|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
27519704|NCT00065429|80095202|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
27519705|NCT00065429|80095203|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
27519706|NCT00065429|80095197|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
27519707|NCT00065429|80095198|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
27519708|NCT00065429|80095199|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
27519709|NCT00065429|80095200|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
27519710|NCT00065429|80095201|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
27519711|NCT00065429|80095202|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
27519712|NCT00065429|80095203|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
27519713|NCT00065429|80095197|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
27519714|NCT00065429|80095198|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
27519715|NCT00065429|80095199|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
27619555|NCT01755689|80452977|FG000|Overall Study|Withdrawal by Subject|1|||
27619556|NCT01755689|80452978|FG001|Overall Study|Withdrawal by Subject|3|||
27619557|NCT01755689|80452979|FG002|Overall Study|Withdrawal by Subject|2|||
27854144|NCT01007942|81298700|FG000|Overall Study|Death|3|||
27854145|NCT01007942|81298701|FG001|Overall Study|Death|2|||
27854146|NCT01007942|81298700|FG000|Overall Study|Patients untreated|4|||
27854147|NCT01007942|81298701|FG001|Overall Study|Patients untreated|3|||
27854148|NCT03247517|81298702|FG000|Overall Study|Adverse Event|0|||
27854149|NCT03247517|81298703|FG001|Overall Study|Adverse Event|4|||
27854150|NCT03247517|81298704|FG002|Overall Study|Adverse Event|2|||
27908885|NCT01720524|81503516|FG001|Part A|Withdrawal by Subject|1|||
27908886|NCT01720524|81503515|FG000|Part A|Other|0|||
27908887|NCT01720524|81503516|FG001|Part A|Other|1|||
27908888|NCT01720524|81503515|FG000|Part A|Lost to Follow-up|0|||
27908889|NCT01720524|81503516|FG001|Part A|Lost to Follow-up|1|||
27908890|NCT01720524|81503515|FG000|Part B|No longer willing to participate in study|1|||
27908891|NCT01720524|81503516|FG001|Part B|No longer willing to participate in study|4|||
27908892|NCT01720524|81503515|FG000|Part B|Other|2|||
27619558|NCT01755689|80452980|FG003|Overall Study|Withdrawal by Subject|1|||
27619559|NCT01755689|80452981|FG004|Overall Study|Withdrawal by Subject|1|||
27619560|NCT01755689|80452977|FG000|Overall Study|Migrated/moved from study area|0|||
27619561|NCT01755689|80452978|FG001|Overall Study|Migrated/moved from study area|1|||
27619562|NCT01755689|80452979|FG002|Overall Study|Migrated/moved from study area|1|||
27854151|NCT03247517|81298702|FG000|Overall Study|Lost to Follow-up|2|||
27854152|NCT03247517|81298703|FG001|Overall Study|Lost to Follow-up|6|||
27854153|NCT03247517|81298704|FG002|Overall Study|Lost to Follow-up|4|||
27854154|NCT03247517|81298702|FG000|Overall Study|Consent withdrawn by caregiver|1|||
27854155|NCT03247517|81298703|FG001|Overall Study|Consent withdrawn by caregiver|4|||
27854156|NCT03247517|81298704|FG002|Overall Study|Consent withdrawn by caregiver|7|||
27854157|NCT03247517|81298702|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
27854158|NCT03247517|81298703|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
27854159|NCT03247517|81298704|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
27854160|NCT03247517|81298702|FG000|Overall Study|Protocol Violation|0|||
27854161|NCT03247517|81298703|FG001|Overall Study|Protocol Violation|2|||
27854162|NCT03247517|81298704|FG002|Overall Study|Protocol Violation|0|||
27854163|NCT03247517|81298702|FG000|Overall Study|Multiple reasons|3|||
27854164|NCT03247517|81298703|FG001|Overall Study|Multiple reasons|1|||
27854165|NCT03247517|81298704|FG002|Overall Study|Multiple reasons|0|||
27854166|NCT00857584|81298709|FG000|Overall Study|Lack of Efficacy|1|||
27854167|NCT00857584|81298710|FG001|Overall Study|Lack of Efficacy|2|||
27854168|NCT00857584|81298709|FG000|Overall Study|Adverse Event|2|||
27854169|NCT00857584|81298710|FG001|Overall Study|Adverse Event|2|||
27854170|NCT00857584|81298709|FG000|Overall Study|Physician Decision|1|||
27854171|NCT00857584|81298710|FG001|Overall Study|Physician Decision|1|||
27854172|NCT02091141|81298713|FG000|Overall Study|Death|280|||
27854173|NCT02091141|81298714|FG001|Overall Study|Death|118|||
27854174|NCT02091141|81298715|FG002|Overall Study|Death|46|||
27854175|NCT02091141|81298716|FG003|Overall Study|Death|13|||
27854176|NCT02091141|81298717|FG004|Overall Study|Death|31|||
27854177|NCT02091141|81298718|FG005|Overall Study|Death|16|||
27854178|NCT02091141|81298719|FG006|Overall Study|Death|12|||
27908893|NCT01720524|81503516|FG001|Part B|Other|0|||
27908894|NCT01720524|81503515|FG000|Part B|Lost to Follow-up|2|||
27908895|NCT01720524|81503516|FG001|Part B|Lost to Follow-up|3|||
27519716|NCT00065429|80095200|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
27519717|NCT00065429|80095201|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
27519718|NCT00065429|80095202|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
27519719|NCT00065429|80095203|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
27519720|NCT01175083|80095204|FG000|Primary Epoch|Withdrawal by Subject|0|||
27519721|NCT01175083|80095205|FG001|Primary Epoch|Withdrawal by Subject|0|||
27519722|NCT01175083|80095206|FG002|Primary Epoch|Withdrawal by Subject|0|||
27519723|NCT01175083|80095207|FG003|Primary Epoch|Withdrawal by Subject|0|||
27519724|NCT01175083|80095208|FG004|Primary Epoch|Withdrawal by Subject|0|||
27519725|NCT01175083|80095209|FG005|Primary Epoch|Withdrawal by Subject|2|||
27519726|NCT01175083|80095204|FG000|Primary Epoch|Lost to Follow-up|0|||
27519727|NCT01175083|80095205|FG001|Primary Epoch|Lost to Follow-up|0|||
27519728|NCT01175083|80095206|FG002|Primary Epoch|Lost to Follow-up|0|||
27519729|NCT01175083|80095207|FG003|Primary Epoch|Lost to Follow-up|0|||
27519730|NCT01175083|80095208|FG004|Primary Epoch|Lost to Follow-up|0|||
27519731|NCT01175083|80095209|FG005|Primary Epoch|Lost to Follow-up|1|||
27519732|NCT01175083|80095204|FG000|Booster Epoch|Death|0|||
27519733|NCT01175083|80095205|FG001|Booster Epoch|Death|0|||
27519734|NCT01175083|80095206|FG002|Booster Epoch|Death|1|||
27519735|NCT01175083|80095207|FG003|Booster Epoch|Death|0|||
27519736|NCT01175083|80095208|FG004|Booster Epoch|Death|0|||
27519737|NCT01175083|80095209|FG005|Booster Epoch|Death|0|||
27519738|NCT01175083|80095204|FG000|Booster Epoch|Withdrawal by Subject|0|||
27519739|NCT01175083|80095205|FG001|Booster Epoch|Withdrawal by Subject|0|||
27519740|NCT01175083|80095206|FG002|Booster Epoch|Withdrawal by Subject|0|||
27619563|NCT01755689|80452980|FG003|Overall Study|Migrated/moved from study area|1|||
27619564|NCT01755689|80452981|FG004|Overall Study|Migrated/moved from study area|1|||
27619565|NCT01755689|80452977|FG000|Overall Study|Lost to Follow-up|1|||
27854179|NCT02091141|81298713|FG000|Overall Study|Withdrawal by Subject|21|||
27854180|NCT02091141|81298714|FG001|Overall Study|Withdrawal by Subject|13|||
27854181|NCT02091141|81298715|FG002|Overall Study|Withdrawal by Subject|3|||
27908896|NCT01720524|81503515|FG000|Part B|Death|0|||
27908897|NCT01720524|81503516|FG001|Part B|Death|2|||
27519741|NCT01175083|80095207|FG003|Booster Epoch|Withdrawal by Subject|1|||
27619566|NCT01755689|80452978|FG001|Overall Study|Lost to Follow-up|0|||
27854182|NCT02091141|81298716|FG003|Overall Study|Withdrawal by Subject|2|||
27854183|NCT02091141|81298717|FG004|Overall Study|Withdrawal by Subject|2|||
27908898|NCT02466971|81503517|FG000|Overall Study|eligible and never treated|14|||
27908899|NCT02466971|81503518|FG001|Overall Study|eligible and never treated|20|||
27519742|NCT01175083|80095208|FG004|Booster Epoch|Withdrawal by Subject|0|||
27519743|NCT01175083|80095209|FG005|Booster Epoch|Withdrawal by Subject|0|||
27519744|NCT00955305|80095215|FG000|Overall Study|Disease progression|39|||
27519745|NCT00955305|80095216|FG001|Overall Study|Disease progression|41|||
27908900|NCT02466971|81503517|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
27908901|NCT02466971|81503518|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
27908902|NCT02466971|81503517|FG000|Overall Study|ineligible and treated|1|||
27908903|NCT02466971|81503518|FG001|Overall Study|ineligible and treated|0|||
27908904|NCT02466971|81503517|FG000|Overall Study|ineligible and never treated|0|||
27908905|NCT02466971|81503518|FG001|Overall Study|ineligible and never treated|1|||
27908906|NCT01021332|81503520|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
27908907|NCT01021332|81503520|FG000|Overall Study|Adverse Event|43|||
27908908|NCT01021332|81503520|FG000|Overall Study|Lack of Efficacy|19|||
27908909|NCT01021332|81503520|FG000|Overall Study|Withdrawal of Consent|23|||
27519746|NCT00955305|80095215|FG000|Overall Study|Adverse Event|22|||
27519747|NCT00955305|80095216|FG001|Overall Study|Adverse Event|22|||
27519748|NCT00955305|80095215|FG000|Overall Study|Death|2|||
27519749|NCT00955305|80095216|FG001|Overall Study|Death|1|||
27619567|NCT01755689|80452979|FG002|Overall Study|Lost to Follow-up|1|||
27619568|NCT01755689|80452980|FG003|Overall Study|Lost to Follow-up|0|||
27619569|NCT01755689|80452981|FG004|Overall Study|Lost to Follow-up|2|||
27619570|NCT01755689|80452977|FG000|Overall Study|Pregnancy|1|||
27731266|NCT04426695|80842883|FG015|Overall Study|Randomized but Never Treated|0|||
27731267|NCT04426695|80842884|FG016|Overall Study|Randomized but Never Treated|0|||
27619571|NCT01755689|80452978|FG001|Overall Study|Pregnancy|1|||
27619572|NCT01755689|80452979|FG002|Overall Study|Pregnancy|2|||
27619573|NCT01755689|80452980|FG003|Overall Study|Pregnancy|4|||
27619574|NCT01755689|80452981|FG004|Overall Study|Pregnancy|2|||
27619575|NCT02015195|80452982|FG000|Overall Study|Adverse Event|0|||
27619576|NCT02015195|80452983|FG001|Overall Study|Adverse Event|0|||
27619577|NCT02015195|80452984|FG002|Overall Study|Adverse Event|0|||
27619578|NCT02015195|80452985|FG003|Overall Study|Adverse Event|1|||
27619579|NCT02015195|80452986|FG004|Overall Study|Adverse Event|0|||
27619580|NCT02015195|80452987|FG005|Overall Study|Adverse Event|0|||
27619581|NCT02015195|80452988|FG006|Overall Study|Adverse Event|0|||
27619582|NCT02451930|80452989|FG000|Overall Study|Death|0|||
27619583|NCT02451930|80452990|FG001|Overall Study|Death|15|||
27619584|NCT02451930|80452989|FG000|Overall Study|Lost to Follow-up|0|||
27619585|NCT02451930|80452990|FG001|Overall Study|Lost to Follow-up|3|||
27619586|NCT02451930|80452989|FG000|Overall Study|Sponsor Decision|2|||
27731268|NCT04426695|80842885|FG017|Overall Study|Randomized but Never Treated|0|||
27731269|NCT01628926|80842888|FG000|Overall Study|Adverse Event|13|||
27619587|NCT02451930|80452990|FG001|Overall Study|Sponsor Decision|10|||
27731270|NCT01628926|80842889|FG001|Overall Study|Adverse Event|11|||
27731271|NCT01628926|80842890|FG002|Overall Study|Adverse Event|9|||
27731272|NCT01628926|80842888|FG000|Overall Study|Lack of Efficacy|2|||
27731273|NCT01628926|80842889|FG001|Overall Study|Lack of Efficacy|1|||
27731274|NCT01628926|80842890|FG002|Overall Study|Lack of Efficacy|5|||
27854184|NCT02091141|81298718|FG005|Overall Study|Withdrawal by Subject|3|||
27854185|NCT02091141|81298719|FG006|Overall Study|Withdrawal by Subject|0|||
27854186|NCT02091141|81298713|FG000|Overall Study|Lost to Follow-up|21|||
27854187|NCT02091141|81298714|FG001|Overall Study|Lost to Follow-up|5|||
27854188|NCT02091141|81298715|FG002|Overall Study|Lost to Follow-up|1|||
27854189|NCT02091141|81298716|FG003|Overall Study|Lost to Follow-up|0|||
27854190|NCT02091141|81298717|FG004|Overall Study|Lost to Follow-up|1|||
27854191|NCT02091141|81298718|FG005|Overall Study|Lost to Follow-up|2|||
27854192|NCT02091141|81298719|FG006|Overall Study|Lost to Follow-up|0|||
27854193|NCT02091141|81298713|FG000|Overall Study|Reason Not Specified|6|||
27854194|NCT02091141|81298714|FG001|Overall Study|Reason Not Specified|5|||
27854195|NCT02091141|81298715|FG002|Overall Study|Reason Not Specified|2|||
27854196|NCT02091141|81298716|FG003|Overall Study|Reason Not Specified|0|||
27908910|NCT01021332|81503520|FG000|Overall Study|Lost to Follow-up|4|||
27731275|NCT01628926|80842888|FG000|Overall Study|Withdrawal by Subject|6|||
27731276|NCT01628926|80842889|FG001|Overall Study|Withdrawal by Subject|4|||
27731277|NCT01628926|80842890|FG002|Overall Study|Withdrawal by Subject|2|||
27731278|NCT01628926|80842888|FG000|Overall Study|Protocol Violation|0|||
27731279|NCT01628926|80842889|FG001|Overall Study|Protocol Violation|1|||
27854197|NCT02091141|81298717|FG004|Overall Study|Reason Not Specified|0|||
27854198|NCT02091141|81298718|FG005|Overall Study|Reason Not Specified|0|||
27854199|NCT02091141|81298719|FG006|Overall Study|Reason Not Specified|1|||
27854200|NCT02091141|81298713|FG000|Overall Study|Study Ended by Sponsor|1|||
27908911|NCT01021332|81503520|FG000|Overall Study|Protocol Violation|9|||
27519750|NCT00955305|80095215|FG000|Overall Study|Withdrawal by Subject|5|||
27519751|NCT00955305|80095216|FG001|Overall Study|Withdrawal by Subject|4|||
27519752|NCT00955305|80095215|FG000|Overall Study|Alternative therapy|4|||
27519753|NCT00955305|80095216|FG001|Overall Study|Alternative therapy|0|||
27519754|NCT00955305|80095215|FG000|Overall Study|Other complicating disease|2|||
27519755|NCT00955305|80095216|FG001|Overall Study|Other complicating disease|4|||
27519756|NCT00955305|80095215|FG000|Overall Study|Physician Decision|1|||
27619588|NCT02451930|80452989|FG000|Overall Study|Withdrawal by Subject|0|||
27619589|NCT02451930|80452990|FG001|Overall Study|Withdrawal by Subject|1|||
27619590|NCT02451930|80452989|FG000|Overall Study|Other|0|||
27619591|NCT02451930|80452990|FG001|Overall Study|Other|1|||
27619592|NCT01813422|80452991|FG000|Overall Study|Withdrawal by Subject|14|||
27619593|NCT01813422|80452992|FG001|Overall Study|Withdrawal by Subject|8|||
27619594|NCT01813422|80452991|FG000|Overall Study|Death|2|||
27619595|NCT01813422|80452992|FG001|Overall Study|Death|3|||
27731280|NCT01628926|80842890|FG002|Overall Study|Protocol Violation|0|||
27731281|NCT01628926|80842888|FG000|Overall Study|Discontinuation criteria|3|||
27731282|NCT01628926|80842889|FG001|Overall Study|Discontinuation criteria|4|||
27908912|NCT01021332|81503520|FG000|Overall Study|Miscellaneous|3|||
27908913|NCT00807612|81503525|FG000|Overall Study|Death|8|||
27519757|NCT00955305|80095216|FG001|Overall Study|Physician Decision|0|||
27908914|NCT00807612|81503525|FG000|Overall Study|Study early termination|5|||
27908915|NCT00807612|81503525|FG000|Overall Study|Withdrawal by Subject|1|||
27908916|NCT03810456|81503526|FG000|Treatment|Urgent Family Matters|3|||
27908917|NCT03810456|81503527|FG001|Treatment|Urgent Family Matters|0|||
27908918|NCT03810456|81503528|FG002|Treatment|Urgent Family Matters|0|||
27908919|NCT03810456|81503526|FG000|Treatment|Scheduling Conflicts|0|||
27908920|NCT03810456|81503527|FG001|Treatment|Scheduling Conflicts|11|||
27908921|NCT03810456|81503528|FG002|Treatment|Scheduling Conflicts|0|||
27908922|NCT03810456|81503526|FG000|Treatment|No Longer Interested|0|||
27908923|NCT03810456|81503527|FG001|Treatment|No Longer Interested|12|||
27908924|NCT03810456|81503528|FG002|Treatment|No Longer Interested|0|||
27908925|NCT03810456|81503526|FG000|Treatment|Transportation Issues|0|||
27908926|NCT03810456|81503527|FG001|Treatment|Transportation Issues|1|||
27908927|NCT03810456|81503528|FG002|Treatment|Transportation Issues|0|||
27908928|NCT03810456|81503526|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
27908929|NCT03810456|81503527|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
27908930|NCT03810456|81503528|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
27908931|NCT03810456|81503526|FG000|1 Month Follow-Up|Relocated to Different State|1|||
27908932|NCT03810456|81503527|FG001|1 Month Follow-Up|Relocated to Different State|0|||
27908933|NCT03810456|81503528|FG002|1 Month Follow-Up|Relocated to Different State|1|||
27908934|NCT03810456|81503526|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
27908935|NCT03810456|81503527|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
27519758|NCT00955305|80095215|FG000|Overall Study|Continued presence of residual disease|0|||
27519759|NCT00955305|80095216|FG001|Overall Study|Continued presence of residual disease|1|||
27519760|NCT00955305|80095215|FG000|Overall Study|Functional decline|2|||
27519761|NCT00955305|80095216|FG001|Overall Study|Functional decline|0|||
27619596|NCT01813422|80452991|FG000|Overall Study|Sponsor Decision|2|||
27619597|NCT01813422|80452992|FG001|Overall Study|Sponsor Decision|1|||
27619598|NCT01813422|80452991|FG000|Overall Study|Lost to Follow-up|2|||
27619599|NCT01813422|80452992|FG001|Overall Study|Lost to Follow-up|4|||
27619600|NCT03677375|80452993|FG000|Overall Study|Incomplete procedure|8|||
27854201|NCT02091141|81298714|FG001|Overall Study|Study Ended by Sponsor|9|||
27854202|NCT02091141|81298715|FG002|Overall Study|Study Ended by Sponsor|0|||
27854203|NCT02091141|81298716|FG003|Overall Study|Study Ended by Sponsor|0|||
27854204|NCT02091141|81298717|FG004|Overall Study|Study Ended by Sponsor|0|||
27854205|NCT02091141|81298718|FG005|Overall Study|Study Ended by Sponsor|0|||
27854206|NCT02091141|81298719|FG006|Overall Study|Study Ended by Sponsor|0|||
27854207|NCT02091141|81298713|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
27854208|NCT02091141|81298714|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
27854209|NCT02091141|81298715|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
27854210|NCT02091141|81298716|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
27854211|NCT02091141|81298717|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
27854212|NCT02091141|81298718|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
27854213|NCT02091141|81298719|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
27854214|NCT01429051|81298720|FG000|Titration Phase|Death|1|||
27854215|NCT01429051|81298720|FG000|Titration Phase|Withdrawal by Subject|7|||
27854216|NCT01429051|81298720|FG000|Titration Phase|Physician Decision|1|||
27854217|NCT01429051|81298720|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
27854218|NCT01429051|81298720|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
27854219|NCT01429051|81298720|FG000|Efficacy Phase|Adverse Event|1|||
27854220|NCT01429051|81298720|FG000|Efficacy Phase|Death|1|||
27854221|NCT01429051|81298720|FG000|Tolerability Phase|Death|5|||
27854222|NCT01429051|81298720|FG000|Tolerability Phase|Adverse Event|2|||
27854223|NCT01429051|81298720|FG000|Tolerability Phase|Withdrawal by Subject|5|||
27854224|NCT01429051|81298720|FG000|Tolerability Phase|Physician Decision|1|||
27854225|NCT01429051|81298720|FG000|Tolerability Phase|Other|2|||
27854226|NCT01229735|81298721|FG000|Overall Study|Lack of Efficacy|8|||
27854227|NCT01229735|81298722|FG001|Overall Study|Lack of Efficacy|8|||
27854228|NCT01229735|81298721|FG000|Overall Study|Protocol Violation|13|||
27854229|NCT01229735|81298722|FG001|Overall Study|Protocol Violation|8|||
27854230|NCT01229735|81298721|FG000|Overall Study|Lost to Follow-up|0|||
27854231|NCT01229735|81298722|FG001|Overall Study|Lost to Follow-up|2|||
27854232|NCT01229735|81298721|FG000|Overall Study|Withdrawal by Subject|18|||
27854233|NCT01229735|81298722|FG001|Overall Study|Withdrawal by Subject|17|||
27854234|NCT01229735|81298721|FG000|Overall Study|Other Reason|13|||
27908936|NCT03810456|81503528|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
27619601|NCT03677375|80452993|FG000|Overall Study|Adverse Event|3|||
27619602|NCT03677375|80452993|FG000|Overall Study|Physician Decision|1|||
27619603|NCT01603121|80453013|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
27619604|NCT01603121|80453014|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
27619605|NCT00997243|80453015|FG000|Overall Study|Early termination of study by sponsor|7|||
27619606|NCT01154036|80453016|FG000|Phase I|Physician Decision|0|||
27619607|NCT01154036|80453017|FG001|Phase I|Physician Decision|1|||
27619608|NCT01154036|80453018|FG002|Phase I|Physician Decision|0|||
27731283|NCT01628926|80842890|FG002|Overall Study|Discontinuation criteria|0|||
27731284|NCT01628926|80842888|FG000|Overall Study|Physician Decision|2|||
27731285|NCT01628926|80842889|FG001|Overall Study|Physician Decision|2|||
27731286|NCT01628926|80842890|FG002|Overall Study|Physician Decision|1|||
27519762|NCT00955305|80095215|FG000|Overall Study|Maximum response achieved|0|||
27519763|NCT00955305|80095216|FG001|Overall Study|Maximum response achieved|1|||
27519764|NCT00955305|80095215|FG000|Overall Study|Lost to Follow-up|0|||
27519765|NCT00955305|80095216|FG001|Overall Study|Lost to Follow-up|1|||
27519766|NCT00955305|80095215|FG000|Overall Study|No off-treatment reason submitted|1|||
27519767|NCT00955305|80095216|FG001|Overall Study|No off-treatment reason submitted|0|||
27519768|NCT00955305|80095215|FG000|Overall Study|Never started protocol treatment|5|||
27519769|NCT00955305|80095216|FG001|Overall Study|Never started protocol treatment|5|||
27519770|NCT00955305|80095215|FG000|Overall Study|Ineligible|5|||
27519771|NCT00955305|80095216|FG001|Overall Study|Ineligible|7|||
27519772|NCT00732940|80095217|FG000|Overall Study|Withdrawal by Subject|1|||
27519773|NCT00732940|80095218|FG001|Overall Study|Withdrawal by Subject|2|||
27519774|NCT00732940|80095217|FG000|Overall Study|Adverse Event|0|||
27519775|NCT00732940|80095218|FG001|Overall Study|Adverse Event|1|||
27519776|NCT00732940|80095217|FG000|Overall Study|Lost to Follow-up|1|||
27519777|NCT00732940|80095218|FG001|Overall Study|Lost to Follow-up|0|||
27519778|NCT03032380|80095219|FG000|Overall Study|Adverse Event|0|||
27519779|NCT03032380|80095220|FG001|Overall Study|Adverse Event|1|||
27519780|NCT03032380|80095219|FG000|Overall Study|Lack of Efficacy|1|||
27519781|NCT03032380|80095220|FG001|Overall Study|Lack of Efficacy|0|||
27519782|NCT03032380|80095219|FG000|Overall Study|Withdrawal by Subject|2|||
27519783|NCT03032380|80095220|FG001|Overall Study|Withdrawal by Subject|3|||
27519784|NCT03032380|80095219|FG000|Overall Study|Recovery|0|||
27519785|NCT03032380|80095220|FG001|Overall Study|Recovery|1|||
27519786|NCT03032380|80095219|FG000|Overall Study|Death|39|||
27519787|NCT03032380|80095220|FG001|Overall Study|Death|34|||
27519788|NCT03032380|80095219|FG000|Overall Study|Other - Miscellaneous|0|||
27519789|NCT03032380|80095220|FG001|Overall Study|Other - Miscellaneous|1|||
27519790|NCT02255435|80095221|FG000|Overall Study|Patient's Limited Time Availability|0|||
27731287|NCT04187092|80842891|FG000|Overall Study|Lost to Follow-up|1|||
27731288|NCT04187092|80842892|FG001|Overall Study|Lost to Follow-up|1|||
27731289|NCT04187092|80842891|FG000|Overall Study|Withdrawal by Subject|1|||
27731290|NCT04187092|80842892|FG001|Overall Study|Withdrawal by Subject|1|||
27731291|NCT04187092|80842891|FG000|Overall Study|Adverse Event|0|||
27731292|NCT04187092|80842892|FG001|Overall Study|Adverse Event|1|||
27731293|NCT03068715|80842895|FG000|Overall Study|No longer met inclusion criteria|1|||
27731294|NCT03068715|80842896|FG001|Overall Study|No longer met inclusion criteria|0|||
27731295|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
27731296|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
27731297|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
27731298|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
27731299|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
27731300|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
27731301|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
27731302|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
27731303|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
27731304|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
27731305|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
27731306|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
27731307|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
27731308|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
27731309|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
27731310|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
27519791|NCT02255435|80095222|FG001|Overall Study|Patient's Limited Time Availability|0|||
27519792|NCT02255435|80095223|FG002|Overall Study|Patient's Limited Time Availability|0|||
27519793|NCT02255435|80095224|FG003|Overall Study|Patient's Limited Time Availability|0|||
27519794|NCT02255435|80095225|FG004|Overall Study|Patient's Limited Time Availability|0|||
27619609|NCT01154036|80453019|FG003|Phase I|Physician Decision|0|||
27619610|NCT01154036|80453020|FG004|Phase I|Physician Decision|0|||
27619611|NCT01154036|80453021|FG005|Phase I|Physician Decision|0|||
27619612|NCT01154036|80453022|FG006|Phase I|Physician Decision|0|||
27519795|NCT02255435|80095226|FG005|Overall Study|Patient's Limited Time Availability|0|||
27519796|NCT02255435|80095227|FG006|Overall Study|Patient's Limited Time Availability|0|||
27519797|NCT02255435|80095228|FG007|Overall Study|Patient's Limited Time Availability|1|||
27519798|NCT02255435|80095229|FG008|Overall Study|Patient's Limited Time Availability|0|||
27519799|NCT02255435|80095230|FG009|Overall Study|Patient's Limited Time Availability|0|||
27519800|NCT02255435|80095221|FG000|Overall Study|Withdrawal by Subject|0|||
27519801|NCT02255435|80095222|FG001|Overall Study|Withdrawal by Subject|0|||
27519802|NCT02255435|80095223|FG002|Overall Study|Withdrawal by Subject|0|||
27519803|NCT02255435|80095224|FG003|Overall Study|Withdrawal by Subject|0|||
27519804|NCT02255435|80095225|FG004|Overall Study|Withdrawal by Subject|0|||
27519805|NCT02255435|80095226|FG005|Overall Study|Withdrawal by Subject|0|||
27519806|NCT02255435|80095227|FG006|Overall Study|Withdrawal by Subject|0|||
27519807|NCT02255435|80095228|FG007|Overall Study|Withdrawal by Subject|0|||
27519808|NCT02255435|80095229|FG008|Overall Study|Withdrawal by Subject|1|||
27519809|NCT02255435|80095230|FG009|Overall Study|Withdrawal by Subject|4|||
27519810|NCT02255435|80095221|FG000|Overall Study|Administrative reasons|0|||
27519811|NCT02255435|80095222|FG001|Overall Study|Administrative reasons|0|||
27519812|NCT02255435|80095223|FG002|Overall Study|Administrative reasons|0|||
27519813|NCT02255435|80095224|FG003|Overall Study|Administrative reasons|0|||
27519814|NCT02255435|80095225|FG004|Overall Study|Administrative reasons|0|||
27519815|NCT02255435|80095226|FG005|Overall Study|Administrative reasons|0|||
27731311|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
27731312|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
27731313|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
27731314|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27908937|NCT03810456|81503526|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
27731315|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27908938|NCT03810456|81503527|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
27908939|NCT03810456|81503528|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
27908940|NCT03810456|81503526|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
27908941|NCT03810456|81503527|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
27908942|NCT03810456|81503528|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
27908943|NCT03810456|81503526|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
27908944|NCT03810456|81503527|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
27908945|NCT03810456|81503528|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
27908946|NCT03810456|81503526|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
27908947|NCT03810456|81503527|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
27908948|NCT03810456|81503528|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
27908949|NCT03339713|81503529|FG000|Overall Study|Lost to Follow-up|2|||
27908950|NCT03339713|81503530|FG001|Overall Study|Lost to Follow-up|1|||
27908951|NCT03339713|81503529|FG000|Overall Study|Protocol Violation|1|||
27731316|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27731317|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27731318|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
27731319|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
27731320|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
27731321|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
27731322|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
27731323|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
27731324|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
27731325|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
27731326|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
27731327|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
27731328|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
27731329|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
27731330|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
27731331|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
27731332|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
27731333|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
27731334|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
27731335|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
27731336|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
27731337|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
27731338|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
27908952|NCT03339713|81503530|FG001|Overall Study|Protocol Violation|0|||
27908953|NCT03339713|81503529|FG000|Overall Study|Withdrawal by Subject|1|||
27908954|NCT03339713|81503530|FG001|Overall Study|Withdrawal by Subject|1|||
27908955|NCT01153009|81503531|FG000|Overall Study|Adverse Event|4|||
27908956|NCT01153009|81503532|FG001|Overall Study|Adverse Event|14|||
27908957|NCT01153009|81503533|FG002|Overall Study|Adverse Event|14|||
27519816|NCT02255435|80095227|FG006|Overall Study|Administrative reasons|0|||
27908958|NCT01153009|81503534|FG003|Overall Study|Adverse Event|10|||
27619613|NCT01154036|80453023|FG007|Phase I|Physician Decision|0|||
27619614|NCT01154036|80453016|FG000|Phase I|Lost to Follow-up|0|||
27619615|NCT01154036|80453017|FG001|Phase I|Lost to Follow-up|3|||
27619616|NCT01154036|80453018|FG002|Phase I|Lost to Follow-up|6|||
27619617|NCT01154036|80453019|FG003|Phase I|Lost to Follow-up|0|||
27619618|NCT01154036|80453020|FG004|Phase I|Lost to Follow-up|0|||
27619619|NCT01154036|80453021|FG005|Phase I|Lost to Follow-up|0|||
27619620|NCT01154036|80453022|FG006|Phase I|Lost to Follow-up|0|||
27619621|NCT01154036|80453023|FG007|Phase I|Lost to Follow-up|0|||
27619622|NCT01154036|80453016|FG000|Phase I|Protocol Violation|0|||
27619623|NCT01154036|80453017|FG001|Phase I|Protocol Violation|3|||
27619624|NCT01154036|80453018|FG002|Phase I|Protocol Violation|9|||
27619625|NCT01154036|80453019|FG003|Phase I|Protocol Violation|0|||
27619626|NCT01154036|80453020|FG004|Phase I|Protocol Violation|0|||
27854235|NCT01229735|81298722|FG001|Overall Study|Other Reason|10|||
27854236|NCT01229735|81298721|FG000|Overall Study|SAE, non-fatal|0|||
27854237|NCT01229735|81298722|FG001|Overall Study|SAE, non-fatal|4|||
27854238|NCT01229735|81298721|FG000|Overall Study|AE, non-serious non-fatal|13|||
27854239|NCT01229735|81298722|FG001|Overall Study|AE, non-serious non-fatal|17|||
27854240|NCT01229735|81298721|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
27854241|NCT01229735|81298722|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
27908959|NCT01153009|81503531|FG000|Overall Study|Lack of Efficacy|9|||
27908960|NCT01153009|81503532|FG001|Overall Study|Lack of Efficacy|0|||
27908961|NCT01153009|81503533|FG002|Overall Study|Lack of Efficacy|2|||
27908962|NCT01153009|81503534|FG003|Overall Study|Lack of Efficacy|1|||
27908963|NCT01153009|81503531|FG000|Overall Study|Noncompliance with Study Medication|1|||
27908964|NCT01153009|81503532|FG001|Overall Study|Noncompliance with Study Medication|3|||
27908965|NCT01153009|81503533|FG002|Overall Study|Noncompliance with Study Medication|4|||
27908966|NCT01153009|81503534|FG003|Overall Study|Noncompliance with Study Medication|1|||
27908967|NCT01153009|81503531|FG000|Overall Study|Protocol Deviations|4|||
27908968|NCT01153009|81503532|FG001|Overall Study|Protocol Deviations|3|||
27908969|NCT01153009|81503533|FG002|Overall Study|Protocol Deviations|3|||
27908970|NCT01153009|81503534|FG003|Overall Study|Protocol Deviations|2|||
27908971|NCT01153009|81503531|FG000|Overall Study|Withdrawal of Consent|5|||
27908972|NCT01153009|81503532|FG001|Overall Study|Withdrawal of Consent|5|||
27908973|NCT01153009|81503533|FG002|Overall Study|Withdrawal of Consent|4|||
27908974|NCT01153009|81503534|FG003|Overall Study|Withdrawal of Consent|6|||
27908975|NCT01153009|81503531|FG000|Overall Study|Lost to Follow-up|8|||
27908976|NCT01153009|81503532|FG001|Overall Study|Lost to Follow-up|8|||
27908977|NCT01153009|81503533|FG002|Overall Study|Lost to Follow-up|11|||
27908978|NCT01153009|81503534|FG003|Overall Study|Lost to Follow-up|15|||
27908979|NCT01153009|81503531|FG000|Overall Study|Other|1|||
27908980|NCT01153009|81503532|FG001|Overall Study|Other|1|||
27908981|NCT01153009|81503533|FG002|Overall Study|Other|3|||
27908982|NCT01153009|81503534|FG003|Overall Study|Other|2|||
27908983|NCT01497067|81503535|FG000|Overall Study|Lost to Follow-up|56|||
27908984|NCT01497067|81503535|FG000|Overall Study|Adverse Event|3|||
27908985|NCT01497067|81503535|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
27908986|NCT01497067|81503535|FG000|Overall Study|Other|13|||
27908987|NCT02734862|81503536|FG000|Part A|Death|3|||
27908988|NCT02734862|81503537|FG001|Part A|Death|4|||
27908989|NCT02734862|81503538|FG002|Part A|Death|6|||
27908990|NCT02734862|81503536|FG000|Part A|Lost to Follow-up|2|||
27908991|NCT02734862|81503537|FG001|Part A|Lost to Follow-up|1|||
27908992|NCT02734862|81503538|FG002|Part A|Lost to Follow-up|1|||
27908993|NCT02734862|81503536|FG000|Part A|Withdrawal by Subject|1|||
27908994|NCT02734862|81503537|FG001|Part A|Withdrawal by Subject|1|||
27908995|NCT02734862|81503538|FG002|Part A|Withdrawal by Subject|2|||
27908996|NCT02734862|81503536|FG000|Part A|Physician Decision|2|||
27908997|NCT02734862|81503537|FG001|Part A|Physician Decision|0|||
27908998|NCT02734862|81503538|FG002|Part A|Physician Decision|1|||
27908999|NCT02734862|81503536|FG000|Part A|Adverse Event|2|||
27619627|NCT01154036|80453021|FG005|Phase I|Protocol Violation|0|||
27854242|NCT00325195|81298729|FG000|Randomized|Not dosed|5|||
27854243|NCT00325195|81298730|FG001|Randomized|Not dosed|5|||
27909000|NCT02734862|81503537|FG001|Part A|Adverse Event|0|||
27909001|NCT02734862|81503538|FG002|Part A|Adverse Event|1|||
27909002|NCT02734862|81503536|FG000|Part A|Noncompliance|1|||
27909003|NCT02734862|81503537|FG001|Part A|Noncompliance|1|||
27909004|NCT02734862|81503538|FG002|Part A|Noncompliance|0|||
27909005|NCT02734862|81503536|FG000|Part A|Other|1|||
27909006|NCT02734862|81503537|FG001|Part A|Other|1|||
27909007|NCT02734862|81503538|FG002|Part A|Other|3|||
27909008|NCT02734862|81503536|FG000|Part B|Death|8|||
27909009|NCT02734862|81503537|FG001|Part B|Death|3|||
27619628|NCT01154036|80453022|FG006|Phase I|Protocol Violation|0|||
27909010|NCT02734862|81503538|FG002|Part B|Death|5|||
27619629|NCT01154036|80453023|FG007|Phase I|Protocol Violation|0|||
27619630|NCT01154036|80453016|FG000|Phase I|Withdrawal by Subject|2|||
27619631|NCT01154036|80453017|FG001|Phase I|Withdrawal by Subject|10|||
27909011|NCT02734862|81503536|FG000|Part B|Lost to Follow-up|2|||
27909012|NCT02734862|81503537|FG001|Part B|Lost to Follow-up|2|||
27909013|NCT02734862|81503538|FG002|Part B|Lost to Follow-up|0|||
27619632|NCT01154036|80453018|FG002|Phase I|Withdrawal by Subject|29|||
27619633|NCT01154036|80453019|FG003|Phase I|Withdrawal by Subject|0|||
27619634|NCT01154036|80453020|FG004|Phase I|Withdrawal by Subject|0|||
27619635|NCT01154036|80453021|FG005|Phase I|Withdrawal by Subject|0|||
27619636|NCT01154036|80453022|FG006|Phase I|Withdrawal by Subject|0|||
27619637|NCT01154036|80453023|FG007|Phase I|Withdrawal by Subject|0|||
27619638|NCT01154036|80453016|FG000|Phase I|Adverse Event|1|||
27619639|NCT01154036|80453017|FG001|Phase I|Adverse Event|11|||
27619640|NCT01154036|80453018|FG002|Phase I|Adverse Event|12|||
27619641|NCT01154036|80453019|FG003|Phase I|Adverse Event|0|||
27619642|NCT01154036|80453020|FG004|Phase I|Adverse Event|0|||
27619643|NCT01154036|80453021|FG005|Phase I|Adverse Event|0|||
27619644|NCT01154036|80453022|FG006|Phase I|Adverse Event|0|||
27619645|NCT01154036|80453023|FG007|Phase I|Adverse Event|0|||
27619646|NCT01154036|80453016|FG000|Phase II|Adverse Event|0|||
27619647|NCT01154036|80453017|FG001|Phase II|Adverse Event|0|||
27619648|NCT01154036|80453018|FG002|Phase II|Adverse Event|0|||
27619649|NCT01154036|80453019|FG003|Phase II|Adverse Event|0|||
27619650|NCT01154036|80453020|FG004|Phase II|Adverse Event|1|||
27619651|NCT01154036|80453021|FG005|Phase II|Adverse Event|1|||
27619652|NCT01154036|80453022|FG006|Phase II|Adverse Event|1|||
27619653|NCT01154036|80453023|FG007|Phase II|Adverse Event|1|||
27619654|NCT01154036|80453016|FG000|Phase II|Physician Decision|0|||
27619655|NCT01154036|80453017|FG001|Phase II|Physician Decision|0|||
27619656|NCT01154036|80453018|FG002|Phase II|Physician Decision|0|||
27619657|NCT01154036|80453019|FG003|Phase II|Physician Decision|0|||
27619658|NCT01154036|80453020|FG004|Phase II|Physician Decision|0|||
27619659|NCT01154036|80453021|FG005|Phase II|Physician Decision|0|||
27619660|NCT01154036|80453022|FG006|Phase II|Physician Decision|1|||
27619661|NCT01154036|80453023|FG007|Phase II|Physician Decision|0|||
27619662|NCT01154036|80453016|FG000|Phase II|Lost to Follow-up|0|||
27619663|NCT01154036|80453017|FG001|Phase II|Lost to Follow-up|0|||
27619664|NCT01154036|80453018|FG002|Phase II|Lost to Follow-up|0|||
27619665|NCT01154036|80453019|FG003|Phase II|Lost to Follow-up|1|||
27619666|NCT01154036|80453020|FG004|Phase II|Lost to Follow-up|2|||
27619667|NCT01154036|80453021|FG005|Phase II|Lost to Follow-up|0|||
27619668|NCT01154036|80453022|FG006|Phase II|Lost to Follow-up|2|||
27619669|NCT01154036|80453023|FG007|Phase II|Lost to Follow-up|1|||
27619670|NCT01154036|80453016|FG000|Phase II|Protocol Violation|0|||
27619671|NCT01154036|80453017|FG001|Phase II|Protocol Violation|0|||
27619672|NCT01154036|80453018|FG002|Phase II|Protocol Violation|0|||
27619673|NCT01154036|80453019|FG003|Phase II|Protocol Violation|0|||
27619674|NCT01154036|80453020|FG004|Phase II|Protocol Violation|1|||
27619675|NCT01154036|80453021|FG005|Phase II|Protocol Violation|2|||
27619676|NCT01154036|80453022|FG006|Phase II|Protocol Violation|0|||
27619677|NCT01154036|80453023|FG007|Phase II|Protocol Violation|0|||
27619678|NCT01154036|80453016|FG000|Phase II|Withdrawal by Subject|0|||
27619679|NCT01154036|80453017|FG001|Phase II|Withdrawal by Subject|0|||
27619680|NCT01154036|80453018|FG002|Phase II|Withdrawal by Subject|0|||
27619681|NCT01154036|80453019|FG003|Phase II|Withdrawal by Subject|0|||
27619682|NCT01154036|80453020|FG004|Phase II|Withdrawal by Subject|4|||
27619683|NCT01154036|80453021|FG005|Phase II|Withdrawal by Subject|2|||
27619684|NCT01154036|80453022|FG006|Phase II|Withdrawal by Subject|5|||
27619685|NCT01154036|80453023|FG007|Phase II|Withdrawal by Subject|4|||
27619686|NCT00946647|80453026|FG000|Phase 1 Part|Adverse Event|2|||
27619687|NCT00946647|80453027|FG001|Phase 1 Part|Adverse Event|5|||
27619688|NCT00946647|80453028|FG002|Phase 1 Part|Adverse Event|3|||
27619689|NCT00946647|80453029|FG003|Phase 1 Part|Adverse Event|0|||
27619690|NCT00946647|80453030|FG004|Phase 1 Part|Adverse Event|0|||
27619691|NCT00946647|80453026|FG000|Phase 1 Part|Disease progression|3|||
27619692|NCT00946647|80453027|FG001|Phase 1 Part|Disease progression|6|||
27619693|NCT00946647|80453028|FG002|Phase 1 Part|Disease progression|1|||
27619694|NCT00946647|80453029|FG003|Phase 1 Part|Disease progression|0|||
27619695|NCT00946647|80453030|FG004|Phase 1 Part|Disease progression|0|||
27731339|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
27619696|NCT00946647|80453026|FG000|Phase 1 Part|Withdrawal by Subject|1|||
27619697|NCT00946647|80453027|FG001|Phase 1 Part|Withdrawal by Subject|4|||
27619698|NCT00946647|80453028|FG002|Phase 1 Part|Withdrawal by Subject|3|||
27619699|NCT00946647|80453029|FG003|Phase 1 Part|Withdrawal by Subject|0|||
27619700|NCT00946647|80453030|FG004|Phase 1 Part|Withdrawal by Subject|0|||
27731340|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
27619701|NCT00946647|80453026|FG000|Phase 1 Part|Abnormal values|0|||
27619702|NCT00946647|80453027|FG001|Phase 1 Part|Abnormal values|2|||
27619703|NCT00946647|80453028|FG002|Phase 1 Part|Abnormal values|0|||
27619704|NCT00946647|80453029|FG003|Phase 1 Part|Abnormal values|0|||
27619705|NCT00946647|80453030|FG004|Phase 1 Part|Abnormal values|0|||
27731341|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
27619706|NCT00946647|80453026|FG000|Phase 1 Part|Reason missing|0|||
27619707|NCT00946647|80453027|FG001|Phase 1 Part|Reason missing|1|||
27619708|NCT00946647|80453028|FG002|Phase 1 Part|Reason missing|0|||
27619709|NCT00946647|80453029|FG003|Phase 1 Part|Reason missing|0|||
27619710|NCT00946647|80453030|FG004|Phase 1 Part|Reason missing|0|||
27619711|NCT00946647|80453026|FG000|Phase ll Part|Untreated|0|||
27619712|NCT00946647|80453027|FG001|Phase ll Part|Untreated|0|||
27619713|NCT00946647|80453028|FG002|Phase ll Part|Untreated|0|||
27619714|NCT00946647|80453029|FG003|Phase ll Part|Untreated|0|||
27619715|NCT00946647|80453030|FG004|Phase ll Part|Untreated|2|||
27619716|NCT00946647|80453026|FG000|Phase ll Part|Adverse Event|0|||
27619717|NCT00946647|80453027|FG001|Phase ll Part|Adverse Event|0|||
27619718|NCT00946647|80453028|FG002|Phase ll Part|Adverse Event|0|||
27619719|NCT00946647|80453029|FG003|Phase ll Part|Adverse Event|10|||
27619720|NCT00946647|80453030|FG004|Phase ll Part|Adverse Event|6|||
27619721|NCT00946647|80453026|FG000|Phase ll Part|Withdrawal by Subject|0|||
27619722|NCT00946647|80453027|FG001|Phase ll Part|Withdrawal by Subject|0|||
27619723|NCT00946647|80453028|FG002|Phase ll Part|Withdrawal by Subject|0|||
27619724|NCT00946647|80453029|FG003|Phase ll Part|Withdrawal by Subject|8|||
27619725|NCT00946647|80453030|FG004|Phase ll Part|Withdrawal by Subject|6|||
27619726|NCT00946647|80453026|FG000|Phase ll Part|Administrative problems|0|||
27619727|NCT00946647|80453027|FG001|Phase ll Part|Administrative problems|0|||
27619728|NCT00946647|80453028|FG002|Phase ll Part|Administrative problems|0|||
27619729|NCT00946647|80453029|FG003|Phase ll Part|Administrative problems|3|||
27619730|NCT00946647|80453030|FG004|Phase ll Part|Administrative problems|8|||
27619731|NCT00946647|80453026|FG000|Phase ll Part|Death|0|||
27619732|NCT00946647|80453027|FG001|Phase ll Part|Death|0|||
27619733|NCT00946647|80453028|FG002|Phase ll Part|Death|0|||
27619734|NCT00946647|80453029|FG003|Phase ll Part|Death|7|||
27619735|NCT00946647|80453030|FG004|Phase ll Part|Death|4|||
27619736|NCT00946647|80453026|FG000|Phase ll Part|Disease progression|0|||
27619737|NCT00946647|80453027|FG001|Phase ll Part|Disease progression|0|||
27619738|NCT00946647|80453028|FG002|Phase ll Part|Disease progression|0|||
27619739|NCT00946647|80453029|FG003|Phase ll Part|Disease progression|6|||
27619740|NCT00946647|80453030|FG004|Phase ll Part|Disease progression|14|||
27619741|NCT00946647|80453026|FG000|Phase ll Part|Protocol Violation|0|||
27619742|NCT00946647|80453027|FG001|Phase ll Part|Protocol Violation|0|||
27619743|NCT00946647|80453028|FG002|Phase ll Part|Protocol Violation|0|||
27619744|NCT00946647|80453029|FG003|Phase ll Part|Protocol Violation|4|||
27619745|NCT00946647|80453030|FG004|Phase ll Part|Protocol Violation|2|||
27619746|NCT00946647|80453026|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
27619747|NCT00946647|80453027|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
27619748|NCT00946647|80453028|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
27619749|NCT00946647|80453029|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
27619750|NCT00946647|80453030|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
27619751|NCT02998528|80453033|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
27619752|NCT02998528|80453034|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
27619753|NCT02998528|80453035|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
27619754|NCT02998528|80453033|FG000|Randomization Period|Participant withdrew consent|0|||
27619755|NCT02998528|80453034|FG001|Randomization Period|Participant withdrew consent|3|||
27619756|NCT02998528|80453035|FG002|Randomization Period|Participant withdrew consent|0|||
27619757|NCT02998528|80453033|FG000|Randomization Period|Participant no longer meets study criteria|1|||
27619758|NCT02998528|80453034|FG001|Randomization Period|Participant no longer meets study criteria|3|||
27619759|NCT02998528|80453035|FG002|Randomization Period|Participant no longer meets study criteria|2|||
27619760|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
27619761|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
27619762|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
27619763|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
27619764|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
27619765|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
27619766|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
27619767|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
27619768|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
27619769|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
27619770|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
27619771|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
27619772|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
27619773|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
27619774|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
27619775|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Death|1|||
27619776|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Death|0|||
27619777|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Death|0|||
27619778|NCT02998528|80453033|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
27619779|NCT02998528|80453034|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
27619780|NCT02998528|80453035|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
27619781|NCT02998528|80453033|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
27854244|NCT00325195|81298731|FG002|Randomized|Not dosed|3|||
27854245|NCT00325195|81298729|FG000|Received Intervention: ITT Population|Adverse Event|15|||
27854246|NCT00325195|81298730|FG001|Received Intervention: ITT Population|Adverse Event|17|||
27854247|NCT00325195|81298731|FG002|Received Intervention: ITT Population|Adverse Event|1|||
27619782|NCT02998528|80453034|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
27854248|NCT00325195|81298729|FG000|Received Intervention: ITT Population|Death|3|||
27854249|NCT00325195|81298730|FG001|Received Intervention: ITT Population|Death|1|||
27854250|NCT00325195|81298731|FG002|Received Intervention: ITT Population|Death|0|||
27854251|NCT00325195|81298729|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
27909014|NCT02734862|81503536|FG000|Part B|Withdrawal by Subject|3|||
27909015|NCT02734862|81503537|FG001|Part B|Withdrawal by Subject|1|||
27909016|NCT02734862|81503538|FG002|Part B|Withdrawal by Subject|0|||
27909017|NCT02734862|81503536|FG000|Part B|Other|0|||
27909018|NCT02734862|81503537|FG001|Part B|Other|1|||
27909019|NCT02734862|81503538|FG002|Part B|Other|0|||
27909020|NCT02532283|81503539|FG000|Overall Study|Adverse Event|0|||
27519817|NCT02255435|80095228|FG007|Overall Study|Administrative reasons|0|||
27519818|NCT02255435|80095229|FG008|Overall Study|Administrative reasons|0|||
27519819|NCT02255435|80095230|FG009|Overall Study|Administrative reasons|2|||
27519820|NCT03041129|80095231|FG000|Overall Study|Withdrawal by Subject|2|||
27519821|NCT03041129|80095232|FG001|Overall Study|Withdrawal by Subject|0|||
27519822|NCT03041129|80095233|FG002|Overall Study|Withdrawal by Subject|0|||
27519823|NCT03041129|80095234|FG003|Overall Study|Withdrawal by Subject|0|||
27519824|NCT02471612|80095235|FG000|Overall Study|Lost to Follow-up|2|||
27519825|NCT00361634|80095236|FG000|Overall Study|Lost to Follow-up|1|||
27619783|NCT02998528|80453035|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
27619784|NCT02998528|80453033|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
27619785|NCT02998528|80453034|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
27619786|NCT02998528|80453035|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
27619787|NCT02998528|80453033|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
27619788|NCT02998528|80453034|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
27619789|NCT02998528|80453035|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
27619790|NCT02998528|80453033|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
27619791|NCT02998528|80453034|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
27619792|NCT02998528|80453035|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
27619793|NCT02998528|80453033|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
27619794|NCT02998528|80453034|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
27619795|NCT02998528|80453035|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
27619796|NCT00114959|80453036|FG000|Overall Study|Lack of Efficacy|6|||
27619797|NCT00114959|80453036|FG000|Overall Study|Physician Decision|1|||
27619798|NCT00114959|80453036|FG000|Overall Study|Death|1|||
27619799|NCT01347645|80453040|FG000|Overall Study|Death|1|||
27619800|NCT01347645|80453041|FG001|Overall Study|Death|5|||
27619801|NCT01347645|80453042|FG002|Overall Study|Death|2|||
27619802|NCT01347645|80453043|FG003|Overall Study|Death|7|||
27619803|NCT01347645|80453044|FG004|Overall Study|Death|7|||
27619804|NCT01347645|80453040|FG000|Overall Study|Lost to Follow-up|1|||
27619805|NCT01347645|80453041|FG001|Overall Study|Lost to Follow-up|1|||
27619806|NCT01347645|80453042|FG002|Overall Study|Lost to Follow-up|0|||
27619807|NCT01347645|80453043|FG003|Overall Study|Lost to Follow-up|1|||
27619808|NCT01347645|80453044|FG004|Overall Study|Lost to Follow-up|1|||
27619809|NCT01347645|80453040|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
27619810|NCT01347645|80453041|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
27619811|NCT01347645|80453042|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
27619812|NCT01347645|80453043|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
27854252|NCT00325195|81298730|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
27909021|NCT02532283|81503540|FG001|Overall Study|Adverse Event|1|||
27909022|NCT02532283|81503539|FG000|Overall Study|Death|1|||
27909023|NCT02532283|81503540|FG001|Overall Study|Death|0|||
27519826|NCT00361634|80095236|FG000|Overall Study|Withdrawal by Subject|1|||
27519827|NCT01478048|80095237|FG000|Overall Study|Disease Progression|52|||
27619813|NCT01347645|80453044|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
27619814|NCT01347645|80453040|FG000|Overall Study|Other|1|||
27619815|NCT01347645|80453041|FG001|Overall Study|Other|0|||
27619816|NCT01347645|80453042|FG002|Overall Study|Other|0|||
27619817|NCT01347645|80453043|FG003|Overall Study|Other|0|||
27619818|NCT01347645|80453044|FG004|Overall Study|Other|1|||
27854253|NCT00325195|81298731|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
27909024|NCT02532283|81503539|FG000|Overall Study|Lost to Follow-up|0|||
27909025|NCT02532283|81503540|FG001|Overall Study|Lost to Follow-up|1|||
27909026|NCT02532283|81503539|FG000|Overall Study|Withdrawal by Subject|8|||
27909027|NCT02532283|81503540|FG001|Overall Study|Withdrawal by Subject|3|||
27854254|NCT00325195|81298729|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
27854255|NCT00325195|81298730|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
27619819|NCT01347645|80453040|FG000|Overall Study|Withdrawal by Subject|0|||
27619820|NCT01347645|80453041|FG001|Overall Study|Withdrawal by Subject|0|||
27619821|NCT01347645|80453042|FG002|Overall Study|Withdrawal by Subject|0|||
27619822|NCT01347645|80453043|FG003|Overall Study|Withdrawal by Subject|3|||
27619823|NCT01347645|80453044|FG004|Overall Study|Withdrawal by Subject|3|||
27909028|NCT01827592|81503541|FG000|Overall Study|Adverse Event|11|||
27909029|NCT01827592|81503542|FG001|Overall Study|Adverse Event|9|||
27619824|NCT01347645|80453040|FG000|Overall Study|Physician Decision|0|||
27619825|NCT01347645|80453041|FG001|Overall Study|Physician Decision|0|||
27619826|NCT01347645|80453042|FG002|Overall Study|Physician Decision|0|||
27619827|NCT01347645|80453043|FG003|Overall Study|Physician Decision|0|||
27619828|NCT01347645|80453044|FG004|Overall Study|Physician Decision|1|||
27619829|NCT01347645|80453040|FG000|Overall Study|Adverse Event|0|||
27619830|NCT01347645|80453041|FG001|Overall Study|Adverse Event|0|||
27619831|NCT01347645|80453042|FG002|Overall Study|Adverse Event|0|||
27619832|NCT01347645|80453043|FG003|Overall Study|Adverse Event|1|||
27619833|NCT01347645|80453044|FG004|Overall Study|Adverse Event|1|||
27619834|NCT03053492|80453047|FG000|Overall Study|Adverse Event|1|||
27619835|NCT03053492|80453048|FG001|Overall Study|Adverse Event|1|||
27619836|NCT03053492|80453047|FG000|Overall Study|Withdrawal by Subject|7|||
27619837|NCT03053492|80453048|FG001|Overall Study|Withdrawal by Subject|5|||
27619838|NCT03005288|80453049|FG000|Overall Study|Withdrawal by Subject|7|||
27619839|NCT03005288|80453050|FG001|Overall Study|Withdrawal by Subject|5|||
27619840|NCT03005288|80453049|FG000|Overall Study|Lost to Follow-up|0|||
27619841|NCT03005288|80453050|FG001|Overall Study|Lost to Follow-up|1|||
27619842|NCT03005288|80453049|FG000|Overall Study|Adverse Event|5|||
27619843|NCT03005288|80453050|FG001|Overall Study|Adverse Event|0|||
27854256|NCT00325195|81298731|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
27854257|NCT00325195|81298729|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
27854258|NCT00325195|81298730|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
27854259|NCT00325195|81298731|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
27854260|NCT02674061|81298732|FG000|Overall Study|Death|229|||
27909030|NCT01827592|81503543|FG002|Overall Study|Adverse Event|2|||
27909031|NCT01827592|81503541|FG000|Overall Study|Physician Decision|0|||
27909032|NCT01827592|81503542|FG001|Overall Study|Physician Decision|2|||
27619844|NCT03005288|80453049|FG000|Overall Study|Protocol deviation|0|||
27619845|NCT03005288|80453050|FG001|Overall Study|Protocol deviation|1|||
27619846|NCT03005288|80453049|FG000|Overall Study|Physician Decision|0|||
27619847|NCT03005288|80453050|FG001|Overall Study|Physician Decision|1|||
27619848|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27619849|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
27909033|NCT01827592|81503543|FG002|Overall Study|Physician Decision|1|||
27519828|NCT01478048|80095238|FG001|Overall Study|Disease Progression|35|||
27619850|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
27619851|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
27619852|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
27619853|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
27619854|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27619855|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27619856|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27619857|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
27854261|NCT02674061|81298733|FG001|Overall Study|Death|77|||
27854262|NCT02674061|81298732|FG000|Overall Study|Lost to Follow-up|3|||
27909034|NCT01827592|81503541|FG000|Overall Study|Protocol Violation|2|||
27519829|NCT01478048|80095237|FG000|Overall Study|study drug toxicity|11|||
27519830|NCT01478048|80095238|FG001|Overall Study|study drug toxicity|14|||
27519831|NCT01478048|80095237|FG000|Overall Study|Adverse Event|2|||
27519832|NCT01478048|80095238|FG001|Overall Study|Adverse Event|11|||
27519833|NCT01478048|80095237|FG000|Overall Study|subject request to discontinue treatment|3|||
27519834|NCT01478048|80095238|FG001|Overall Study|subject request to discontinue treatment|5|||
27519835|NCT01478048|80095237|FG000|Overall Study|Withdrawal by Subject|2|||
27519836|NCT01478048|80095238|FG001|Overall Study|Withdrawal by Subject|5|||
27619858|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27619859|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27619860|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27619861|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
27619862|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
27619863|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27619864|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27854263|NCT02674061|81298733|FG001|Overall Study|Lost to Follow-up|3|||
27854264|NCT02674061|81298732|FG000|Overall Study|Withdrawal by Subject|9|||
27619865|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27619866|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27619867|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
27731342|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
27731343|NCT01707992|80842897|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
27731344|NCT01707992|80842898|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
27731345|NCT01707992|80842899|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
27731346|NCT01707992|80842900|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
27731347|NCT01707992|80842901|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
27731348|NCT01707992|80842902|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
27731349|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
27731350|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
27731351|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
27731352|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
27731353|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
27731354|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
27731355|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
27731356|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
27731357|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
27731358|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
27731359|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
27731360|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
27731361|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
27731362|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
27731363|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
27731364|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
27731365|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
27731366|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
27731367|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
27731368|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
27731369|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
27519837|NCT01478048|80095237|FG000|Overall Study|non-specified|6|||
27519838|NCT01478048|80095238|FG001|Overall Study|non-specified|4|||
27519839|NCT01478048|80095237|FG000|Overall Study|poor/non-compliance|0|||
27519840|NCT01478048|80095238|FG001|Overall Study|poor/non-compliance|1|||
27519841|NCT01478048|80095237|FG000|Overall Study|no longer meets study criteria|1|||
27519842|NCT01478048|80095238|FG001|Overall Study|no longer meets study criteria|0|||
27731370|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
27731371|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
27731372|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
27731373|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
27731374|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
27731375|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
27731376|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
27731377|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
27731378|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
27731379|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Death|0|||
27731380|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Death|0|||
27731381|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Death|0|||
27731382|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Death|2|||
27731383|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Death|0|||
27731384|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Death|0|||
27731385|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
27731386|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
27731387|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
27731388|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
27854265|NCT02674061|81298733|FG001|Overall Study|Withdrawal by Subject|1|||
27854266|NCT02674061|81298732|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
27854267|NCT02674061|81298733|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
27854268|NCT02384941|81298734|FG000|Overall Study|Adverse Event|11|||
27854269|NCT02384941|81298735|FG001|Overall Study|Adverse Event|13|||
27854270|NCT02384941|81298736|FG002|Overall Study|Adverse Event|17|||
27854271|NCT02384941|81298734|FG000|Overall Study|Lost to Follow-up|3|||
27519843|NCT02410343|80095239|FG000|Core Period (24 Weeks)|Adverse Event|1|||
27854272|NCT02384941|81298735|FG001|Overall Study|Lost to Follow-up|2|||
27519844|NCT02410343|80095240|FG001|Core Period (24 Weeks)|Adverse Event|0|||
27519845|NCT02410343|80095239|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
27854273|NCT02384941|81298736|FG002|Overall Study|Lost to Follow-up|1|||
27854274|NCT02384941|81298734|FG000|Overall Study|Non-Compliance With Study Drug|2|||
27731389|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
27731390|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
27731391|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
27731392|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
27731393|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
27731394|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
27731395|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
27731396|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
27731397|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
27731398|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
27731399|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
27731400|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
27731401|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
27731402|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
27731403|NCT01707992|80842897|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27731404|NCT01707992|80842898|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27731405|NCT01707992|80842899|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27731406|NCT01707992|80842900|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27731407|NCT01707992|80842901|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
27731408|NCT01707992|80842902|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
27731409|NCT02928952|80842907|FG000|Overall Study|Lost to Follow-up|5|||
27519846|NCT02410343|80095240|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
27731410|NCT02928952|80842908|FG001|Overall Study|Lost to Follow-up|5|||
27731411|NCT02928952|80842907|FG000|Overall Study|Withdrawal by Subject|5|||
27731412|NCT02928952|80842908|FG001|Overall Study|Withdrawal by Subject|1|||
27731413|NCT02928952|80842907|FG000|Overall Study|Physician Decision|0|||
27731414|NCT02928952|80842908|FG001|Overall Study|Physician Decision|1|||
27731415|NCT03244059|80842909|FG000|Specific Aim 1|Physician Decision|1|||
27731416|NCT03244059|80842910|FG001|Specific Aim 1|Physician Decision|0|||
27731417|NCT03244059|80842909|FG000|Specific Aim 2|Physician Decision|1|||
27731418|NCT03244059|80842910|FG001|Specific Aim 2|Physician Decision|0|||
27731419|NCT01700829|80842911|FG000|Overall Study|Withdrawal by Subject|1|||
27731420|NCT01700829|80842912|FG001|Overall Study|Withdrawal by Subject|1|||
27731421|NCT03838484|80842913|FG000|Overall Study|Lost to Follow-up|0|||
27854275|NCT02384941|81298735|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27854276|NCT02384941|81298736|FG002|Overall Study|Non-Compliance With Study Drug|1|||
27854277|NCT02384941|81298734|FG000|Overall Study|Physician Decision|1|||
27854278|NCT02384941|81298735|FG001|Overall Study|Physician Decision|1|||
27854279|NCT02384941|81298736|FG002|Overall Study|Physician Decision|0|||
27854280|NCT02384941|81298734|FG000|Overall Study|Protocol Violation|3|||
27854281|NCT02384941|81298735|FG001|Overall Study|Protocol Violation|0|||
27854282|NCT02384941|81298736|FG002|Overall Study|Protocol Violation|0|||
27854283|NCT02384941|81298734|FG000|Overall Study|Withdrawal by Subject|26|||
27854284|NCT02384941|81298735|FG001|Overall Study|Withdrawal by Subject|19|||
27854285|NCT02384941|81298736|FG002|Overall Study|Withdrawal by Subject|20|||
27854286|NCT02384941|81298734|FG000|Overall Study|Pregnancy|0|||
27854287|NCT02384941|81298735|FG001|Overall Study|Pregnancy|0|||
27854288|NCT02384941|81298736|FG002|Overall Study|Pregnancy|1|||
27854289|NCT02384941|81298734|FG000|Overall Study|Other than specified above|4|||
27854290|NCT02384941|81298735|FG001|Overall Study|Other than specified above|0|||
27854291|NCT02384941|81298736|FG002|Overall Study|Other than specified above|1|||
27854292|NCT05065983|81298737|FG000|Overall Study|Lost to Follow-up|2|||
27854293|NCT04319159|81298741|FG000|Overall Study|Screening failure|13|||
27854294|NCT04319159|81298741|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
27854295|NCT04319159|81298741|FG000|Overall Study|Withdrawal by Subject|1|||
27854296|NCT00541970|81298742|FG000|Month 7|Protocol Violation|9|||
27854297|NCT00541970|81298743|FG001|Month 7|Protocol Violation|13|||
27854298|NCT00541970|81298744|FG002|Month 7|Protocol Violation|11|||
27854299|NCT00541970|81298745|FG003|Month 7|Protocol Violation|5|||
27854300|NCT00541970|81298742|FG000|Month 12|Adverse Event|0|||
27519847|NCT02410343|80095239|FG000|Extension Period (12 Months)|Adverse Event|1|||
27731422|NCT03838484|80842914|FG001|Overall Study|Lost to Follow-up|1|||
27731423|NCT03838484|80842915|FG002|Overall Study|Lost to Follow-up|0|||
27731424|NCT03838484|80842916|FG003|Overall Study|Lost to Follow-up|0|||
27731425|NCT00607048|80842928|FG000|Overall Study|Adverse Event|0|||
27731426|NCT00607048|80842929|FG001|Overall Study|Adverse Event|1|||
27854301|NCT00541970|81298743|FG001|Month 12|Adverse Event|1|||
27854302|NCT00541970|81298744|FG002|Month 12|Adverse Event|1|||
27854303|NCT00541970|81298745|FG003|Month 12|Adverse Event|1|||
27854304|NCT00541970|81298742|FG000|Month 12|Protocol Violation|12|||
27854305|NCT00541970|81298743|FG001|Month 12|Protocol Violation|21|||
27854306|NCT00541970|81298744|FG002|Month 12|Protocol Violation|20|||
27854307|NCT00541970|81298745|FG003|Month 12|Protocol Violation|15|||
27854308|NCT00541970|81298742|FG000|Month 18|Adverse Event|0|||
27731427|NCT00607048|80842930|FG002|Overall Study|Adverse Event|0|||
27731428|NCT00607048|80842931|FG003|Overall Study|Adverse Event|0|||
27731429|NCT00607048|80842932|FG004|Overall Study|Adverse Event|4|||
27731430|NCT00607048|80842933|FG005|Overall Study|Adverse Event|0|||
27731431|NCT00607048|80842928|FG000|Overall Study|Global deterioration of health|1|||
27731432|NCT00607048|80842929|FG001|Overall Study|Global deterioration of health|0|||
27731433|NCT00607048|80842930|FG002|Overall Study|Global deterioration of health|0|||
27731434|NCT00607048|80842931|FG003|Overall Study|Global deterioration of health|0|||
27731435|NCT00607048|80842932|FG004|Overall Study|Global deterioration of health|0|||
27731436|NCT00607048|80842933|FG005|Overall Study|Global deterioration of health|0|||
27731437|NCT00607048|80842928|FG000|Overall Study|Objective disease progression - relapse|1|||
27731438|NCT00607048|80842929|FG001|Overall Study|Objective disease progression - relapse|2|||
27731439|NCT00607048|80842930|FG002|Overall Study|Objective disease progression - relapse|4|||
27731440|NCT00607048|80842931|FG003|Overall Study|Objective disease progression - relapse|2|||
27909035|NCT01827592|81503542|FG001|Overall Study|Protocol Violation|1|||
27909036|NCT01827592|81503543|FG002|Overall Study|Protocol Violation|0|||
27909037|NCT01827592|81503541|FG000|Overall Study|Lost to Follow-up|1|||
27909038|NCT01827592|81503542|FG001|Overall Study|Lost to Follow-up|2|||
27519848|NCT02410343|80095240|FG001|Extension Period (12 Months)|Adverse Event|0|||
27519849|NCT02410343|80095239|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
27519850|NCT02410343|80095240|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
27731441|NCT00607048|80842932|FG004|Overall Study|Objective disease progression - relapse|2|||
27731442|NCT00607048|80842933|FG005|Overall Study|Objective disease progression - relapse|2|||
27731443|NCT00607048|80842928|FG000|Overall Study|Withdrawal by Subject|0|||
27731444|NCT00607048|80842929|FG001|Overall Study|Withdrawal by Subject|0|||
27731445|NCT00607048|80842930|FG002|Overall Study|Withdrawal by Subject|0|||
27731446|NCT00607048|80842931|FG003|Overall Study|Withdrawal by Subject|1|||
27731447|NCT00607048|80842932|FG004|Overall Study|Withdrawal by Subject|0|||
27731448|NCT00607048|80842933|FG005|Overall Study|Withdrawal by Subject|2|||
27731449|NCT00607048|80842928|FG000|Overall Study|Other|1|||
27731450|NCT00607048|80842929|FG001|Overall Study|Other|1|||
27731451|NCT00607048|80842930|FG002|Overall Study|Other|0|||
27731452|NCT00607048|80842931|FG003|Overall Study|Other|0|||
27731453|NCT00607048|80842932|FG004|Overall Study|Other|0|||
27731454|NCT00607048|80842933|FG005|Overall Study|Other|1|||
27731455|NCT00450580|80842936|FG000|Overall Study|Adverse Event|5|||
27731456|NCT00450580|80842937|FG001|Overall Study|Adverse Event|7|||
27731457|NCT00450580|80842936|FG000|Overall Study|Lost to Follow-up|4|||
27731458|NCT00450580|80842937|FG001|Overall Study|Lost to Follow-up|5|||
27731459|NCT00450580|80842936|FG000|Overall Study|Withdrawal by Subject|2|||
27731460|NCT00450580|80842937|FG001|Overall Study|Withdrawal by Subject|2|||
27731461|NCT00450580|80842936|FG000|Overall Study|Protocol Violation|1|||
27731462|NCT00450580|80842937|FG001|Overall Study|Protocol Violation|1|||
27731463|NCT00450580|80842936|FG000|Overall Study|Protocol-defined virologic failure|1|||
27731464|NCT00450580|80842937|FG001|Overall Study|Protocol-defined virologic failure|0|||
27731465|NCT00450580|80842936|FG000|Overall Study|Could not comply with scheduled visits|1|||
27731466|NCT00450580|80842937|FG001|Overall Study|Could not comply with scheduled visits|0|||
27731467|NCT00450580|80842936|FG000|Overall Study|Patient went to Brazil|1|||
27731468|NCT00450580|80842937|FG001|Overall Study|Patient went to Brazil|0|||
27731469|NCT00450580|80842936|FG000|Overall Study|Patient could not swallow Norvir|1|||
27731470|NCT00450580|80842937|FG001|Overall Study|Patient could not swallow Norvir|0|||
27731471|NCT00450580|80842936|FG000|Overall Study|Withdrawal due to pregnancy|0|||
27731472|NCT00450580|80842937|FG001|Overall Study|Withdrawal due to pregnancy|1|||
27519851|NCT02717832|80095245|FG000|Overall Study|Inability to place IV|3|||
27519852|NCT00096356|80095246|FG000|Overall Study|Adverse Event|11|||
27519853|NCT00096356|80095247|FG001|Overall Study|Adverse Event|9|||
27519854|NCT00096356|80095246|FG000|Overall Study|Physician Decision|5|||
27519855|NCT00096356|80095247|FG001|Overall Study|Physician Decision|3|||
27519856|NCT00096356|80095246|FG000|Overall Study|Withdrawal by Subject|17|||
27519857|NCT00096356|80095247|FG001|Overall Study|Withdrawal by Subject|23|||
27519858|NCT00096356|80095246|FG000|Overall Study|Lack of Efficacy|1|||
27519859|NCT00096356|80095247|FG001|Overall Study|Lack of Efficacy|0|||
27519860|NCT00096356|80095246|FG000|Overall Study|multiple reasons|10|||
27519861|NCT00096356|80095247|FG001|Overall Study|multiple reasons|18|||
27519862|NCT01250496|80095248|FG000|Overall Study|Study terminated|124|||
27519863|NCT01250496|80095249|FG001|Overall Study|Study terminated|124|||
27731473|NCT03403400|80842940|FG000|Overall Study|Lost to Follow-up|1|||
27731474|NCT03403400|80842941|FG001|Overall Study|Lost to Follow-up|0|||
27909039|NCT01827592|81503543|FG002|Overall Study|Lost to Follow-up|2|||
27731475|NCT03403400|80842942|FG002|Overall Study|Lost to Follow-up|1|||
27731476|NCT03403400|80842940|FG000|Overall Study|Hospitalization|1|||
27731477|NCT03403400|80842941|FG001|Overall Study|Hospitalization|0|||
27731478|NCT03403400|80842942|FG002|Overall Study|Hospitalization|0|||
27519864|NCT03060551|80095250|FG000|Overall Study|Withdrawal by Subject|1|||
27731479|NCT03403400|80842940|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
27909040|NCT01827592|81503541|FG000|Overall Study|Withdrawal by Subject|12|||
27519865|NCT03060551|80095250|FG000|Overall Study|Adverse Event|1|||
27519866|NCT01463007|80095251|FG000|Overall Study|Physician Decision|1|||
27731480|NCT03403400|80842941|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
27731481|NCT03403400|80842942|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
27731482|NCT02397473|80842943|FG000|Treatment Phase|Adverse Event|1|||
27731483|NCT02397473|80842944|FG001|Treatment Phase|Adverse Event|2|||
27731484|NCT02397473|80842943|FG000|Treatment Phase|Lack of Efficacy|8|||
27731485|NCT02397473|80842944|FG001|Treatment Phase|Lack of Efficacy|1|||
27731486|NCT02397473|80842943|FG000|Treatment Phase|Lost to Follow-up|1|||
27731487|NCT02397473|80842944|FG001|Treatment Phase|Lost to Follow-up|0|||
27731488|NCT02397473|80842943|FG000|Treatment Phase|Withdrawal by Subject|2|||
27731489|NCT02397473|80842944|FG001|Treatment Phase|Withdrawal by Subject|1|||
27731490|NCT02397473|80842943|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
27731491|NCT02397473|80842944|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
27731492|NCT02397473|80842943|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
27731493|NCT02397473|80842944|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
27731494|NCT02397473|80842943|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
27731495|NCT02397473|80842944|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
27909041|NCT01827592|81503542|FG001|Overall Study|Withdrawal by Subject|11|||
27909042|NCT01827592|81503543|FG002|Overall Study|Withdrawal by Subject|11|||
27909043|NCT01827592|81503541|FG000|Overall Study|Patient's substantial non-compliance|1|||
27909044|NCT01827592|81503542|FG001|Overall Study|Patient's substantial non-compliance|1|||
27909045|NCT01827592|81503543|FG002|Overall Study|Patient's substantial non-compliance|6|||
27909046|NCT01827592|81503541|FG000|Overall Study|Trial terminated by Sponsor|47|||
27909047|NCT01827592|81503542|FG001|Overall Study|Trial terminated by Sponsor|53|||
27909048|NCT01827592|81503543|FG002|Overall Study|Trial terminated by Sponsor|51|||
27909049|NCT01827592|81503541|FG000|Overall Study|Others|0|||
27909050|NCT01827592|81503542|FG001|Overall Study|Others|1|||
27909051|NCT01827592|81503543|FG002|Overall Study|Others|3|||
27909052|NCT05359952|81503546|FG000|Overall Study|Lost to Follow-up|1|||
27909053|NCT05359952|81503547|FG001|Overall Study|Lost to Follow-up|0|||
27909054|NCT04754542|81503548|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
27909055|NCT04754542|81503549|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
27909056|NCT00547248|81503550|FG000|Overall Study|Protocol Violation|0|||
27909057|NCT00547248|81503551|FG001|Overall Study|Protocol Violation|0|||
27909058|NCT00547248|81503552|FG002|Overall Study|Protocol Violation|1|||
27909059|NCT00547248|81503553|FG003|Overall Study|Protocol Violation|1|||
27909060|NCT00547248|81503550|FG000|Overall Study|Migrated/moved from study area|0|||
27909061|NCT00547248|81503551|FG001|Overall Study|Migrated/moved from study area|0|||
27909062|NCT00547248|81503552|FG002|Overall Study|Migrated/moved from study area|2|||
27909063|NCT00547248|81503553|FG003|Overall Study|Migrated/moved from study area|0|||
27909064|NCT00547248|81503550|FG000|Overall Study|Withdrawal by Subject|0|||
27909065|NCT00547248|81503551|FG001|Overall Study|Withdrawal by Subject|0|||
27909066|NCT00547248|81503552|FG002|Overall Study|Withdrawal by Subject|7|||
27909067|NCT00547248|81503553|FG003|Overall Study|Withdrawal by Subject|1|||
27519867|NCT01139008|80098174|FG000|Overall Study|Withdrawal by Subject|5|||
27519868|NCT01139008|80098174|FG000|Overall Study|Non-compliant, lost product|1|||
27519869|NCT02156271|80098175|FG000|Overall Study|Physician Decision|4|||
27519870|NCT02156271|80098176|FG001|Overall Study|Physician Decision|3|||
27519871|NCT01499368|80098177|FG000|Overall Study|Did not meet I/E criteria|8|||
27519872|NCT01499368|80098178|FG001|Overall Study|Did not meet I/E criteria|4|||
27519873|NCT01499368|80098179|FG002|Overall Study|Did not meet I/E criteria|4|||
27519874|NCT01499368|80098177|FG000|Overall Study|Prohibited Concomitant medication|1|||
27519875|NCT01499368|80098178|FG001|Overall Study|Prohibited Concomitant medication|1|||
27519876|NCT01499368|80098179|FG002|Overall Study|Prohibited Concomitant medication|0|||
27519877|NCT01499368|80098177|FG000|Overall Study|Withdrawal by Subject|11|||
27519878|NCT01499368|80098178|FG001|Overall Study|Withdrawal by Subject|10|||
27519879|NCT01499368|80098179|FG002|Overall Study|Withdrawal by Subject|8|||
27519880|NCT01499368|80098177|FG000|Overall Study|Lost to Follow-up|3|||
27519881|NCT01499368|80098178|FG001|Overall Study|Lost to Follow-up|2|||
27519882|NCT01499368|80098179|FG002|Overall Study|Lost to Follow-up|5|||
27619868|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27619869|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
27619870|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
27731496|NCT02397473|80842943|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
27731497|NCT02397473|80842944|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
27731498|NCT02397473|80842943|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
27519883|NCT01499368|80098177|FG000|Overall Study|Adverse Event|4|||
27519884|NCT01499368|80098178|FG001|Overall Study|Adverse Event|0|||
27519885|NCT01499368|80098179|FG002|Overall Study|Adverse Event|2|||
27519886|NCT01499368|80098177|FG000|Overall Study|Physician Decision|0|||
27519887|NCT01499368|80098178|FG001|Overall Study|Physician Decision|1|||
27519888|NCT01499368|80098179|FG002|Overall Study|Physician Decision|0|||
27519889|NCT01499368|80098177|FG000|Overall Study|Deviation from visit window|0|||
27519890|NCT01499368|80098178|FG001|Overall Study|Deviation from visit window|0|||
27519891|NCT01499368|80098179|FG002|Overall Study|Deviation from visit window|1|||
27519892|NCT01499368|80098177|FG000|Overall Study|Error of Prescriptions|0|||
27519893|NCT01499368|80098178|FG001|Overall Study|Error of Prescriptions|0|||
27519894|NCT01499368|80098179|FG002|Overall Study|Error of Prescriptions|1|||
27519895|NCT01457352|80098180|FG000|Period 1|Adverse Event|2|||
27519896|NCT01457352|80098181|FG001|Period 1|Adverse Event|0|||
27519897|NCT01457352|80098180|FG000|Period 1|Withdrawal by Subject|2|||
27519898|NCT01457352|80098181|FG001|Period 1|Withdrawal by Subject|0|||
27519899|NCT01457352|80098180|FG000|Period 1|Physician Decision|2|||
27519900|NCT01457352|80098181|FG001|Period 1|Physician Decision|0|||
27519901|NCT01457352|80098180|FG000|Period 1|MS related disease progression|1|||
27519902|NCT01457352|80098181|FG001|Period 1|MS related disease progression|0|||
27519903|NCT01457352|80098180|FG000|Period 1|Withdrawn|1|||
27519904|NCT01457352|80098181|FG001|Period 1|Withdrawn|0|||
27519905|NCT01457352|80098180|FG000|Period 1|withdrew per sponsor|1|||
27519906|NCT01457352|80098181|FG001|Period 1|withdrew per sponsor|0|||
27519907|NCT01457352|80098180|FG000|Period 1|Protocol Violation|4|||
27519908|NCT01457352|80098181|FG001|Period 1|Protocol Violation|0|||
27519909|NCT01457352|80098180|FG000|Period 1|Did not meet eligibility criteria|3|||
27519910|NCT01457352|80098181|FG001|Period 1|Did not meet eligibility criteria|0|||
27731499|NCT02397473|80842944|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
27909068|NCT00549549|81503558|FG000|Overall Study|Adverse Event|5|||
27909069|NCT00549549|81503559|FG001|Overall Study|Adverse Event|3|||
27909070|NCT00549549|81503560|FG002|Overall Study|Adverse Event|1|||
27909071|NCT00549549|81503561|FG003|Overall Study|Adverse Event|9|||
27909072|NCT00549549|81503558|FG000|Overall Study|Lack of Efficacy|9|||
27909073|NCT00549549|81503559|FG001|Overall Study|Lack of Efficacy|6|||
27909074|NCT00549549|81503560|FG002|Overall Study|Lack of Efficacy|4|||
27909075|NCT00549549|81503561|FG003|Overall Study|Lack of Efficacy|2|||
27909076|NCT00549549|81503558|FG000|Overall Study|Lost to Follow-up|1|||
27909077|NCT00549549|81503559|FG001|Overall Study|Lost to Follow-up|0|||
27519911|NCT01457352|80098180|FG000|Period 2|Withdrawal by Subject|23|||
27519912|NCT01457352|80098181|FG001|Period 2|Withdrawal by Subject|0|||
27519913|NCT01457352|80098180|FG000|Period 2|Adverse Event|22|||
27519914|NCT01457352|80098181|FG001|Period 2|Adverse Event|0|||
27519915|NCT01457352|80098180|FG000|Period 2|no analysis|10|||
27519916|NCT01457352|80098181|FG001|Period 2|no analysis|0|||
27519917|NCT01457352|80098180|FG000|Period 2|Lack of Efficacy|8|||
27519918|NCT01457352|80098181|FG001|Period 2|Lack of Efficacy|0|||
27519919|NCT01457352|80098180|FG000|Period 2|Protocol Violation|4|||
27519920|NCT01457352|80098181|FG001|Period 2|Protocol Violation|0|||
27519921|NCT01457352|80098180|FG000|Period 2|Sponsor's withdrawal|7|||
27519922|NCT01457352|80098181|FG001|Period 2|Sponsor's withdrawal|0|||
27519923|NCT01457352|80098180|FG000|Period 2|Lost to Follow-up|1|||
27519924|NCT01457352|80098181|FG001|Period 2|Lost to Follow-up|0|||
27519925|NCT01457352|80098180|FG000|Period 2|dose change|1|||
27519926|NCT01457352|80098181|FG001|Period 2|dose change|0|||
27519927|NCT01457352|80098180|FG000|Period 2|Physician Decision|1|||
27519928|NCT01457352|80098181|FG001|Period 2|Physician Decision|0|||
27519929|NCT01457352|80098180|FG000|Period 2|Did not meet eligibility criteria|3|||
27519930|NCT01457352|80098181|FG001|Period 2|Did not meet eligibility criteria|0|||
27519931|NCT01457352|80098180|FG000|Period 3|Adverse Event|1|||
27519932|NCT01457352|80098181|FG001|Period 3|Adverse Event|1|||
27519933|NCT01457352|80098180|FG000|Period 3|Withdrawal by Subject|0|||
27519934|NCT01457352|80098181|FG001|Period 3|Withdrawal by Subject|2|||
27519935|NCT01457352|80098180|FG000|Period 3|incorrect treatment|0|||
27519936|NCT01457352|80098181|FG001|Period 3|incorrect treatment|1|||
27519937|NCT01457352|80098180|FG000|Period 3|Sponsor's withdrawal|0|||
27519938|NCT01457352|80098181|FG001|Period 3|Sponsor's withdrawal|1|||
27519939|NCT02395172|80098183|FG000|Overall Study|Participants randomized but not treated|3|||
27519940|NCT02395172|80098184|FG001|Overall Study|Participants randomized but not treated|31|||
27519941|NCT02184572|80098185|FG000|Overall Study|Lost to Follow-up|29|||
27519942|NCT02184572|80098186|FG001|Overall Study|Lost to Follow-up|21|||
27519943|NCT02184572|80098185|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
27519944|NCT02184572|80098186|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
27519945|NCT02184572|80098185|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
27519946|NCT02184572|80098186|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
27519947|NCT02184572|80098185|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
27519948|NCT02184572|80098186|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
27519949|NCT02184572|80098185|FG000|Overall Study|Traveling Outside The Country|1|||
27519950|NCT02184572|80098186|FG001|Overall Study|Traveling Outside The Country|0|||
27519951|NCT02184572|80098185|FG000|Overall Study|Withdrawal by Subject|14|||
27519952|NCT02184572|80098186|FG001|Overall Study|Withdrawal by Subject|9|||
27519953|NCT00510653|80098202|FG000|Overall Study|Withdrawal by Subject|8|||
27519954|NCT00510653|80098202|FG000|Overall Study|Monetary|3|||
27519955|NCT01794338|80098203|FG000|Overall Study|Death|2|||
27909078|NCT00549549|81503560|FG002|Overall Study|Lost to Follow-up|1|||
27909079|NCT00549549|81503561|FG003|Overall Study|Lost to Follow-up|2|||
27619871|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
27619872|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
27619873|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
27731500|NCT02305563|80842946|FG000|Treatment Period|Disease progression|0|||
27731501|NCT02305563|80842947|FG001|Treatment Period|Disease progression|0|||
27731502|NCT02305563|80842948|FG002|Treatment Period|Disease progression|15|||
27731503|NCT02305563|80842949|FG003|Treatment Period|Disease progression|6|||
27731504|NCT02305563|80842950|FG004|Treatment Period|Disease progression|6|||
27731505|NCT02305563|80842946|FG000|Treatment Period|Study drug toxicity|0|||
27731506|NCT02305563|80842947|FG001|Treatment Period|Study drug toxicity|0|||
27731507|NCT02305563|80842948|FG002|Treatment Period|Study drug toxicity|0|||
27731508|NCT02305563|80842949|FG003|Treatment Period|Study drug toxicity|1|||
27731509|NCT02305563|80842950|FG004|Treatment Period|Study drug toxicity|2|||
27731510|NCT02305563|80842946|FG000|Treatment Period|Death|0|||
27731511|NCT02305563|80842947|FG001|Treatment Period|Death|0|||
27731512|NCT02305563|80842948|FG002|Treatment Period|Death|1|||
27731513|NCT02305563|80842949|FG003|Treatment Period|Death|2|||
27731514|NCT02305563|80842950|FG004|Treatment Period|Death|1|||
27731515|NCT02305563|80842946|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
27731516|NCT02305563|80842947|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
27731517|NCT02305563|80842948|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
27731518|NCT02305563|80842949|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
27731519|NCT02305563|80842950|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
27731520|NCT02305563|80842946|FG000|Treatment Period|Participant request to stop therapy|0|||
27731521|NCT02305563|80842947|FG001|Treatment Period|Participant request to stop therapy|2|||
27731522|NCT02305563|80842948|FG002|Treatment Period|Participant request to stop therapy|0|||
27731523|NCT02305563|80842949|FG003|Treatment Period|Participant request to stop therapy|1|||
27731524|NCT02305563|80842950|FG004|Treatment Period|Participant request to stop therapy|0|||
27731525|NCT02305563|80842946|FG000|Treatment Period|Participant withdrew consent|0|||
27731526|NCT02305563|80842947|FG001|Treatment Period|Participant withdrew consent|0|||
27731527|NCT02305563|80842948|FG002|Treatment Period|Participant withdrew consent|1|||
27731528|NCT02305563|80842949|FG003|Treatment Period|Participant withdrew consent|1|||
27731529|NCT02305563|80842950|FG004|Treatment Period|Participant withdrew consent|1|||
27731530|NCT02305563|80842946|FG000|Treatment Period|Maximum clinical benefit|0|||
27731531|NCT02305563|80842947|FG001|Treatment Period|Maximum clinical benefit|0|||
27731532|NCT02305563|80842948|FG002|Treatment Period|Maximum clinical benefit|0|||
27731533|NCT02305563|80842949|FG003|Treatment Period|Maximum clinical benefit|0|||
27731534|NCT02305563|80842950|FG004|Treatment Period|Maximum clinical benefit|1|||
27731535|NCT02305563|80842946|FG000|Treatment Period|Poor/non-compliance|0|||
27731536|NCT02305563|80842947|FG001|Treatment Period|Poor/non-compliance|0|||
27731537|NCT02305563|80842948|FG002|Treatment Period|Poor/non-compliance|0|||
27731538|NCT02305563|80842949|FG003|Treatment Period|Poor/non-compliance|0|||
27731539|NCT02305563|80842950|FG004|Treatment Period|Poor/non-compliance|1|||
27731540|NCT02305563|80842946|FG000|Treatment Period|Administrative reason by Sponsor|0|||
27731541|NCT02305563|80842947|FG001|Treatment Period|Administrative reason by Sponsor|0|||
27854309|NCT00541970|81298743|FG001|Month 18|Adverse Event|1|||
27854310|NCT00541970|81298744|FG002|Month 18|Adverse Event|1|||
27854311|NCT00541970|81298745|FG003|Month 18|Adverse Event|1|||
27854312|NCT00541970|81298742|FG000|Month 18|Protocol Violation|14|||
27854313|NCT00541970|81298743|FG001|Month 18|Protocol Violation|23|||
27519956|NCT01794338|80098204|FG001|Overall Study|Death|0|||
27519957|NCT01794338|80098203|FG000|Overall Study|Lost to Follow-up|6|||
27519958|NCT01794338|80098204|FG001|Overall Study|Lost to Follow-up|9|||
27519959|NCT01989468|80098205|FG000|Overall Study|Adverse Event|10|||
27519960|NCT01989468|80098206|FG001|Overall Study|Adverse Event|15|||
27519961|NCT01989468|80098207|FG002|Overall Study|Adverse Event|4|||
27519962|NCT01989468|80098208|FG003|Overall Study|Adverse Event|5|||
27519963|NCT01989468|80098209|FG004|Overall Study|Adverse Event|4|||
27519964|NCT01989468|80098205|FG000|Overall Study|Lack of Efficacy|11|||
27519965|NCT01989468|80098206|FG001|Overall Study|Lack of Efficacy|11|||
27519966|NCT01989468|80098207|FG002|Overall Study|Lack of Efficacy|7|||
27519967|NCT01989468|80098208|FG003|Overall Study|Lack of Efficacy|4|||
27519968|NCT01989468|80098209|FG004|Overall Study|Lack of Efficacy|2|||
27519969|NCT01989468|80098205|FG000|Overall Study|Lost to Follow-up|5|||
27519970|NCT01989468|80098206|FG001|Overall Study|Lost to Follow-up|2|||
27519971|NCT01989468|80098207|FG002|Overall Study|Lost to Follow-up|0|||
27519972|NCT01989468|80098208|FG003|Overall Study|Lost to Follow-up|1|||
27519973|NCT01989468|80098209|FG004|Overall Study|Lost to Follow-up|1|||
27519974|NCT01989468|80098205|FG000|Overall Study|Physician Decision|4|||
27519975|NCT01989468|80098206|FG001|Overall Study|Physician Decision|1|||
27519976|NCT01989468|80098207|FG002|Overall Study|Physician Decision|0|||
27519977|NCT01989468|80098208|FG003|Overall Study|Physician Decision|1|||
27619874|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27519978|NCT01989468|80098209|FG004|Overall Study|Physician Decision|0|||
27519979|NCT01989468|80098205|FG000|Overall Study|Pregnancy|0|||
27519980|NCT01989468|80098206|FG001|Overall Study|Pregnancy|1|||
27731542|NCT02305563|80842948|FG002|Treatment Period|Administrative reason by Sponsor|0|||
27731543|NCT02305563|80842949|FG003|Treatment Period|Administrative reason by Sponsor|0|||
27731544|NCT02305563|80842950|FG004|Treatment Period|Administrative reason by Sponsor|1|||
27519981|NCT01989468|80098207|FG002|Overall Study|Pregnancy|0|||
27519982|NCT01989468|80098208|FG003|Overall Study|Pregnancy|0|||
27519983|NCT01989468|80098209|FG004|Overall Study|Pregnancy|0|||
27519984|NCT01989468|80098205|FG000|Overall Study|Technical Problems|3|||
27519985|NCT01989468|80098206|FG001|Overall Study|Technical Problems|1|||
27519986|NCT01989468|80098207|FG002|Overall Study|Technical Problems|3|||
27519987|NCT01989468|80098208|FG003|Overall Study|Technical Problems|1|||
27519988|NCT01989468|80098209|FG004|Overall Study|Technical Problems|0|||
27731545|NCT02305563|80842946|FG000|Treatment Period|other reason|2|||
27731546|NCT02305563|80842947|FG001|Treatment Period|other reason|0|||
27731547|NCT02305563|80842948|FG002|Treatment Period|other reason|2|||
27731548|NCT02305563|80842949|FG003|Treatment Period|other reason|2|||
27731549|NCT02305563|80842950|FG004|Treatment Period|other reason|1|||
27731550|NCT02305563|80842946|FG000|Treatment Period|Randomized but not treated|0|||
27731551|NCT02305563|80842947|FG001|Treatment Period|Randomized but not treated|0|||
27731552|NCT02305563|80842948|FG002|Treatment Period|Randomized but not treated|0|||
27731553|NCT02305563|80842949|FG003|Treatment Period|Randomized but not treated|0|||
27731554|NCT02305563|80842950|FG004|Treatment Period|Randomized but not treated|2|||
27731555|NCT02305563|80842946|FG000|Treatment Period|added ULO, then disease progression|0|||
27731556|NCT02305563|80842947|FG001|Treatment Period|added ULO, then disease progression|0|||
27731557|NCT02305563|80842948|FG002|Treatment Period|added ULO, then disease progression|0|||
27731558|NCT02305563|80842949|FG003|Treatment Period|added ULO, then disease progression|0|||
27731559|NCT02305563|80842950|FG004|Treatment Period|added ULO, then disease progression|4|||
27731560|NCT02305563|80842946|FG000|Treatment Period|added ULO; then other reason|0|||
27731561|NCT02305563|80842947|FG001|Treatment Period|added ULO; then other reason|0|||
27731562|NCT02305563|80842948|FG002|Treatment Period|added ULO; then other reason|0|||
27731563|NCT02305563|80842949|FG003|Treatment Period|added ULO; then other reason|0|||
27731564|NCT02305563|80842950|FG004|Treatment Period|added ULO; then other reason|1|||
27731565|NCT02305563|80842946|FG000|Treatment Period|added ULO, then request to stop|0|||
27731566|NCT02305563|80842947|FG001|Treatment Period|added ULO, then request to stop|0|||
27731567|NCT02305563|80842948|FG002|Treatment Period|added ULO, then request to stop|0|||
27731568|NCT02305563|80842949|FG003|Treatment Period|added ULO, then request to stop|0|||
27731569|NCT02305563|80842950|FG004|Treatment Period|added ULO, then request to stop|1|||
27731570|NCT02305563|80842946|FG000|Follow-up Period|Death|0|||
27731571|NCT02305563|80842947|FG001|Follow-up Period|Death|0|||
27731572|NCT02305563|80842948|FG002|Follow-up Period|Death|5|||
27731573|NCT02305563|80842949|FG003|Follow-up Period|Death|4|||
27731574|NCT02305563|80842950|FG004|Follow-up Period|Death|7|||
27731575|NCT02305563|80842946|FG000|Follow-up Period|Participant withdrew consent|0|||
27731576|NCT02305563|80842947|FG001|Follow-up Period|Participant withdrew consent|0|||
27731577|NCT02305563|80842948|FG002|Follow-up Period|Participant withdrew consent|2|||
27731578|NCT02305563|80842949|FG003|Follow-up Period|Participant withdrew consent|1|||
27731579|NCT02305563|80842950|FG004|Follow-up Period|Participant withdrew consent|0|||
27731580|NCT02305563|80842946|FG000|Follow-up Period|other reason|0|||
27731581|NCT02305563|80842947|FG001|Follow-up Period|other reason|0|||
27731582|NCT02305563|80842948|FG002|Follow-up Period|other reason|0|||
27519989|NCT01989468|80098205|FG000|Overall Study|Subject Guardian Decision|11|||
27519990|NCT01989468|80098206|FG001|Overall Study|Subject Guardian Decision|6|||
27519991|NCT01989468|80098207|FG002|Overall Study|Subject Guardian Decision|4|||
27519992|NCT01989468|80098208|FG003|Overall Study|Subject Guardian Decision|4|||
27519993|NCT01989468|80098209|FG004|Overall Study|Subject Guardian Decision|1|||
27519994|NCT01989468|80098205|FG000|Overall Study|Death|3|||
27519995|NCT01989468|80098206|FG001|Overall Study|Death|0|||
27519996|NCT01989468|80098207|FG002|Overall Study|Death|1|||
27519997|NCT01989468|80098208|FG003|Overall Study|Death|0|||
27519998|NCT01989468|80098209|FG004|Overall Study|Death|0|||
27519999|NCT02600819|80098210|FG000|GEN Phase|Adverse Event|2|||
27520000|NCT02600819|80098211|FG001|GEN Phase|Adverse Event|0|||
27520001|NCT02600819|80098210|FG000|GEN Phase|Death|2|||
27520002|NCT02600819|80098211|FG001|GEN Phase|Death|0|||
27731583|NCT02305563|80842949|FG003|Follow-up Period|other reason|0|||
27731584|NCT02305563|80842950|FG004|Follow-up Period|other reason|1|||
27731585|NCT02305563|80842946|FG000|Follow-up Period|Followup no longer required per protocol|3|||
27731586|NCT02305563|80842947|FG001|Follow-up Period|Followup no longer required per protocol|3|||
27731587|NCT02305563|80842948|FG002|Follow-up Period|Followup no longer required per protocol|4|||
27731588|NCT02305563|80842949|FG003|Follow-up Period|Followup no longer required per protocol|1|||
27854314|NCT00541970|81298744|FG002|Month 18|Protocol Violation|24|||
27520003|NCT02600819|80098210|FG000|GEN Phase|Investigator's Discretion|4|||
27520004|NCT02600819|80098211|FG001|GEN Phase|Investigator's Discretion|0|||
27520005|NCT02600819|80098210|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
27520006|NCT02600819|80098211|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
27520007|NCT02600819|80098210|FG000|GEN Phase|Withdrew Consent|5|||
27520008|NCT02600819|80098211|FG001|GEN Phase|Withdrew Consent|0|||
27520009|NCT02600819|80098210|FG000|GEN Phase|Lost to Follow-up|2|||
27619875|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27520010|NCT02600819|80098211|FG001|GEN Phase|Lost to Follow-up|0|||
27520011|NCT01643772|80098212|FG000|Overall Study|Protocol Violation|0|||
27520012|NCT01643772|80098213|FG001|Overall Study|Protocol Violation|0|||
27520013|NCT01643772|80098214|FG002|Overall Study|Protocol Violation|0|||
27520014|NCT01643772|80098215|FG003|Overall Study|Protocol Violation|1|||
27520015|NCT01643772|80098212|FG000|Overall Study|Adverse Event|0|||
27520016|NCT01643772|80098213|FG001|Overall Study|Adverse Event|0|||
27520017|NCT01643772|80098214|FG002|Overall Study|Adverse Event|0|||
27520018|NCT01643772|80098215|FG003|Overall Study|Adverse Event|1|||
27520019|NCT01049009|80098216|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27520020|NCT01049009|80098217|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27520021|NCT01049009|80098216|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27520022|NCT01049009|80098217|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27520023|NCT01049009|80098216|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
27520024|NCT01049009|80098217|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
27520025|NCT01049009|80098216|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
27520026|NCT01049009|80098217|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
27520027|NCT02338232|80098218|FG000|Overall Study|Screen Failure|3|||
27520028|NCT02338232|80098218|FG000|Overall Study|Withdrawal by Subject|6|||
27520029|NCT02338232|80098218|FG000|Overall Study|Adverse Event|2|||
27520030|NCT03860818|80098219|FG000|Overall Study|Death|144|||
27520031|NCT03860818|80098220|FG001|Overall Study|Death|195|||
27520032|NCT03860818|80098219|FG000|Overall Study|Graft Loss|32|||
27520033|NCT03860818|80098220|FG001|Overall Study|Graft Loss|45|||
27520034|NCT03316911|80098221|FG000|Overall Study|Lost to Follow-up|33|||
27520035|NCT03316911|80098222|FG001|Overall Study|Lost to Follow-up|29|||
27520036|NCT01022398|80098223|FG000|Overall Study|Study terminated|2|||
27520037|NCT01022398|80098224|FG001|Overall Study|Study terminated|2|||
27520038|NCT04129151|80098228|FG000|Overall Study|Adverse Event|1|||
27520039|NCT04129151|80098228|FG000|Overall Study|Disease Progression|7|||
27520040|NCT04129151|80098228|FG000|Overall Study|Study closure|1|||
27520041|NCT00717236|80098229|FG000|Double-Blind Period|Adverse Event|33|||
27520042|NCT00717236|80098230|FG001|Double-Blind Period|Adverse Event|6|||
27520043|NCT00717236|80098229|FG000|Double-Blind Period|Lack of Efficacy|6|||
27520044|NCT00717236|80098230|FG001|Double-Blind Period|Lack of Efficacy|6|||
27520045|NCT00717236|80098229|FG000|Double-Blind Period|Lost to Follow-up|3|||
27520046|NCT00717236|80098230|FG001|Double-Blind Period|Lost to Follow-up|5|||
27520047|NCT00717236|80098229|FG000|Double-Blind Period|Withdrawal by Subject|10|||
27520048|NCT00717236|80098230|FG001|Double-Blind Period|Withdrawal by Subject|2|||
27520049|NCT00717236|80098229|FG000|Double-Blind Period|Loss of efficacy|3|||
27520050|NCT00717236|80098230|FG001|Double-Blind Period|Loss of efficacy|0|||
27520051|NCT00717236|80098229|FG000|Double-Blind Period|Other: Death|1|||
27520052|NCT00717236|80098230|FG001|Double-Blind Period|Other: Death|0|||
27520053|NCT00717236|80098229|FG000|Double-Blind Period|Other: Pregnancy|1|||
27520054|NCT00717236|80098230|FG001|Double-Blind Period|Other: Pregnancy|0|||
27520055|NCT00717236|80098229|FG000|Double-Blind Period|Other: Protocol Violation|2|||
27520056|NCT00717236|80098230|FG001|Double-Blind Period|Other: Protocol Violation|0|||
27520057|NCT00717236|80098229|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
27520058|NCT00717236|80098230|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
27619876|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27619877|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
27619878|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
27619879|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619880|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619881|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
27619882|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
27619883|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619884|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619885|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619886|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619887|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
27619888|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27520059|NCT00717236|80098229|FG000|Double-Blind Period|Other: Site withdrew|2|||
27520060|NCT00717236|80098230|FG001|Double-Blind Period|Other: Site withdrew|0|||
27520061|NCT00717236|80098229|FG000|Double-Blind Period|Other: Screening failure|1|||
27520062|NCT00717236|80098230|FG001|Double-Blind Period|Other: Screening failure|0|||
27520063|NCT00717236|80098229|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
27520064|NCT00717236|80098230|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
27520065|NCT00717236|80098229|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
27520066|NCT00717236|80098230|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
27520067|NCT00717236|80098229|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
27520068|NCT00717236|80098230|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
27619889|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27619890|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
27731589|NCT02305563|80842950|FG004|Follow-up Period|Followup no longer required per protocol|4|||
27520069|NCT00717236|80098229|FG000|Double-Blind Period|Other: History of cancer|1|||
27520070|NCT00717236|80098230|FG001|Double-Blind Period|Other: History of cancer|0|||
27520071|NCT00717236|80098229|FG000|Double-Blind Period|Other: Sponsor request|1|||
27520072|NCT00717236|80098230|FG001|Double-Blind Period|Other: Sponsor request|0|||
27520073|NCT00717236|80098229|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
27520074|NCT00717236|80098230|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
27520075|NCT00717236|80098229|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
27520076|NCT00717236|80098230|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
27520077|NCT00717236|80098229|FG000|Double-Blind Period|Other: Subject moved|1|||
27520078|NCT00717236|80098230|FG001|Double-Blind Period|Other: Subject moved|1|||
27520079|NCT00717236|80098229|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
27520080|NCT00717236|80098230|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
27520081|NCT00717236|80098229|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
27520082|NCT00717236|80098230|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
27520083|NCT00717236|80098229|FG000|Double-Blind Period|Other: Transportation problems|0|||
27520084|NCT00717236|80098230|FG001|Double-Blind Period|Other: Transportation problems|1|||
27520085|NCT00717236|80098229|FG000|Double-Blind Period|Other: Investigator Decision|0|||
27520086|NCT00717236|80098230|FG001|Double-Blind Period|Other: Investigator Decision|1|||
27520087|NCT00717236|80098229|FG000|Open-Label Period|Adverse Event|29|||
27520088|NCT00717236|80098230|FG001|Open-Label Period|Adverse Event|4|||
27520089|NCT00717236|80098229|FG000|Open-Label Period|Lack of Efficacy|30|||
27520090|NCT00717236|80098230|FG001|Open-Label Period|Lack of Efficacy|8|||
27520091|NCT00717236|80098229|FG000|Open-Label Period|Lost to Follow-up|28|||
27520092|NCT00717236|80098230|FG001|Open-Label Period|Lost to Follow-up|4|||
27520093|NCT00717236|80098229|FG000|Open-Label Period|Withdrawal by Subject|20|||
27520094|NCT00717236|80098230|FG001|Open-Label Period|Withdrawal by Subject|2|||
27520095|NCT00717236|80098229|FG000|Open-Label Period|Loss of Efficacy|6|||
27520096|NCT00717236|80098230|FG001|Open-Label Period|Loss of Efficacy|1|||
27520097|NCT00717236|80098229|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
27520098|NCT00717236|80098230|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
27520099|NCT00717236|80098229|FG000|Open-Label Period|Other: Lack of Compliance|1|||
27520100|NCT00717236|80098230|FG001|Open-Label Period|Other: Lack of Compliance|1|||
27520101|NCT00717236|80098229|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
27520102|NCT00717236|80098230|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
27520103|NCT00717236|80098229|FG000|Open-Label Period|Other: Moved|1|||
27520104|NCT00717236|80098230|FG001|Open-Label Period|Other: Moved|0|||
27520105|NCT00717236|80098229|FG000|Open-Label Period|Other: Investigator Decision|1|||
27520106|NCT00717236|80098230|FG001|Open-Label Period|Other: Investigator Decision|0|||
27520107|NCT00717236|80098229|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
27520108|NCT00717236|80098230|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
27520109|NCT00717236|80098229|FG000|Open-Label Period|Other: Sponsor Request|3|||
27520110|NCT00717236|80098230|FG001|Open-Label Period|Other: Sponsor Request|0|||
27520111|NCT00717236|80098229|FG000|Open-Label Period|Other: Cataract Surgery|1|||
27520112|NCT00717236|80098230|FG001|Open-Label Period|Other: Cataract Surgery|0|||
27520113|NCT00717236|80098229|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
27520114|NCT00717236|80098230|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
27520115|NCT00717236|80098229|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
27520116|NCT00717236|80098230|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
27619891|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
27731590|NCT04348851|80842951|FG000|Post-Test 1|Withdrawal by Subject|0|||
27731591|NCT04348851|80842952|FG001|Post-Test 1|Withdrawal by Subject|1|||
27731592|NCT04348851|80842953|FG002|Post-Test 1|Withdrawal by Subject|0|||
27731593|NCT04348851|80842954|FG003|Post-Test 1|Withdrawal by Subject|0|||
27731594|NCT04348851|80842951|FG000|Post-Test 1|Lost to Follow-up|0|||
27731595|NCT04348851|80842952|FG001|Post-Test 1|Lost to Follow-up|1|||
27731596|NCT04348851|80842953|FG002|Post-Test 1|Lost to Follow-up|0|||
27731597|NCT04348851|80842954|FG003|Post-Test 1|Lost to Follow-up|0|||
27731598|NCT04348851|80842951|FG000|Post-Test 2|Stroke survivor death|0|||
27731599|NCT04348851|80842952|FG001|Post-Test 2|Stroke survivor death|1|||
27731600|NCT04348851|80842953|FG002|Post-Test 2|Stroke survivor death|0|||
27520117|NCT00717236|80098229|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
27619892|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27731601|NCT04348851|80842954|FG003|Post-Test 2|Stroke survivor death|1|||
27731602|NCT00642642|80842955|FG000|Treatment & Follow Up|Adverse Event|2|||
27731603|NCT00642642|80842955|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
27520118|NCT00717236|80098230|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
27520119|NCT00883688|80098231|FG000|Overall Study|Ineligible|2|||
27854315|NCT00541970|81298745|FG003|Month 18|Protocol Violation|16|||
27619893|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27520120|NCT01700387|80098232|FG000|Overall Study|Withdrawal by Subject|1|||
27520121|NCT01700387|80098233|FG001|Overall Study|Withdrawal by Subject|2|||
27520122|NCT01700387|80098232|FG000|Overall Study|Adverse Event|1|||
27520123|NCT01700387|80098233|FG001|Overall Study|Adverse Event|1|||
27520124|NCT01700387|80098232|FG000|Overall Study|Lost to Follow-up|2|||
27520125|NCT01700387|80098233|FG001|Overall Study|Lost to Follow-up|1|||
27520126|NCT02208063|80098234|FG000|Overall Study|Death|3|||
27520127|NCT02208063|80098235|FG001|Overall Study|Death|5|||
27520128|NCT02208063|80098234|FG000|Overall Study|Not Specified in report|3|||
27520129|NCT02208063|80098235|FG001|Overall Study|Not Specified in report|4|||
27520130|NCT02208063|80098234|FG000|Overall Study|Withdrawal by Subject|5|||
27520131|NCT02208063|80098235|FG001|Overall Study|Withdrawal by Subject|2|||
27520132|NCT02208063|80098234|FG000|Overall Study|Lost to Follow-up|1|||
27520133|NCT02208063|80098235|FG001|Overall Study|Lost to Follow-up|0|||
27520134|NCT01431638|80098236|FG000|Overall Study|Adverse Event|1|||
27520135|NCT01431638|80098237|FG001|Overall Study|Adverse Event|3|||
27520136|NCT01431638|80098238|FG002|Overall Study|Adverse Event|1|||
27520137|NCT01431638|80098236|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27520138|NCT01431638|80098237|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27520139|NCT01431638|80098238|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
27520140|NCT01431638|80098236|FG000|Overall Study|Participants condition no longer requires study drug|0|||
27520141|NCT01431638|80098237|FG001|Overall Study|Participants condition no longer requires study drug|1|||
27520142|NCT01431638|80098238|FG002|Overall Study|Participants condition no longer requires study drug|0|||
27520143|NCT01431638|80098236|FG000|Overall Study|Participant withdrew consent|14|||
27520144|NCT01431638|80098237|FG001|Overall Study|Participant withdrew consent|5|||
27520145|NCT01431638|80098238|FG002|Overall Study|Participant withdrew consent|8|||
27520146|NCT01431638|80098236|FG000|Overall Study|Lost to Follow-up|7|||
27520147|NCT01431638|80098237|FG001|Overall Study|Lost to Follow-up|9|||
27520148|NCT01431638|80098238|FG002|Overall Study|Lost to Follow-up|7|||
27520149|NCT01431638|80098236|FG000|Overall Study|Administrative problems|1|||
27520150|NCT01431638|80098237|FG001|Overall Study|Administrative problems|4|||
27520151|NCT01431638|80098238|FG002|Overall Study|Administrative problems|6|||
27520152|NCT01431638|80098236|FG000|Overall Study|Death|1|||
27520153|NCT01431638|80098237|FG001|Overall Study|Death|0|||
27520154|NCT01431638|80098238|FG002|Overall Study|Death|0|||
27520155|NCT01431638|80098236|FG000|Overall Study|Protocol deviation|1|||
27520156|NCT01431638|80098237|FG001|Overall Study|Protocol deviation|1|||
27520157|NCT01431638|80098238|FG002|Overall Study|Protocol deviation|4|||
27520158|NCT01431638|80098236|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
27520159|NCT01431638|80098237|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
27520160|NCT01431638|80098238|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
27520161|NCT00934648|80098239|FG000|Overall Study|Failure to return|8|||
27520162|NCT00934648|80098239|FG000|Overall Study|Withdrawal by Subject|1|||
27520163|NCT00444678|80098240|FG000|Overall Study|Toxicity|11|||
27520164|NCT00444678|80098240|FG000|Overall Study|Disease Progression|12|||
27520165|NCT00444678|80098240|FG000|Overall Study|Death|3|||
27520166|NCT00444678|80098240|FG000|Overall Study|Physician Decision|3|||
27520167|NCT00444678|80098240|FG000|Overall Study|Withdrawal by Subject|2|||
27520168|NCT00734747|80098244|FG000|SRS Procedure|No staples placed|3|||
27520169|NCT00734747|80098244|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
27520170|NCT01236547|80098245|FG000|Overall Study|Protocol Violation|0|||
27520171|NCT01236547|80098246|FG001|Overall Study|Protocol Violation|1|||
27619894|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27619895|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27619896|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27619897|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
27619898|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619899|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619900|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619901|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619902|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
27619903|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619904|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619905|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27619906|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27520172|NCT01236547|80098247|FG002|Overall Study|Protocol Violation|1|||
27520173|NCT01236547|80098248|FG003|Overall Study|Protocol Violation|6|||
27520174|NCT01236547|80098249|FG004|Overall Study|Protocol Violation|12|||
27520175|NCT01185353|80098251|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27520176|NCT01185353|80098252|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27520177|NCT01185353|80098253|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27520178|NCT01185353|80098254|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
27520179|NCT01185353|80098255|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
27520180|NCT01185353|80098256|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27520181|NCT01185353|80098257|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27520182|NCT01185353|80098258|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27520183|NCT01185353|80098259|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27520184|NCT01185353|80098260|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
27520185|NCT01185353|80098251|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520186|NCT01185353|80098252|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520187|NCT01185353|80098253|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520188|NCT01185353|80098254|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520189|NCT01185353|80098255|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
27520190|NCT01185353|80098256|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520191|NCT01185353|80098257|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520192|NCT01185353|80098258|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520193|NCT01185353|80098259|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520194|NCT01185353|80098260|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
27520195|NCT01185353|80098251|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
27520196|NCT01185353|80098252|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520197|NCT01185353|80098253|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520198|NCT01185353|80098254|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520199|NCT01185353|80098255|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
27520200|NCT01185353|80098256|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520201|NCT01185353|80098257|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520202|NCT01185353|80098258|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520203|NCT01185353|80098259|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520204|NCT01185353|80098260|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
27520205|NCT01185353|80098251|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520206|NCT01185353|80098252|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520207|NCT01185353|80098253|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
27520208|NCT01185353|80098254|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520209|NCT01185353|80098255|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
27520210|NCT01185353|80098256|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520211|NCT01185353|80098257|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520212|NCT01185353|80098258|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520213|NCT01185353|80098259|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520214|NCT01185353|80098260|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
27520215|NCT01185353|80098251|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520216|NCT01185353|80098252|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520217|NCT01185353|80098253|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520218|NCT01185353|80098254|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520219|NCT01185353|80098255|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
27520220|NCT01185353|80098256|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520221|NCT01185353|80098257|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520222|NCT01185353|80098258|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520223|NCT01185353|80098259|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520224|NCT01185353|80098260|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
27520225|NCT01185353|80098251|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
27520226|NCT01185353|80098252|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520227|NCT01185353|80098253|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520228|NCT01185353|80098254|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520229|NCT01185353|80098255|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
27520230|NCT01185353|80098256|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520231|NCT01185353|80098257|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520232|NCT01185353|80098258|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520233|NCT01185353|80098259|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520234|NCT01185353|80098260|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
27520235|NCT01185353|80098251|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520236|NCT01185353|80098252|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520237|NCT01185353|80098253|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
27520238|NCT01185353|80098254|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520239|NCT01185353|80098255|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520240|NCT01185353|80098256|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
27520241|NCT01185353|80098257|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27619907|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
27520242|NCT01185353|80098258|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520243|NCT01185353|80098259|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520244|NCT01185353|80098260|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
27520245|NCT01185353|80098251|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27619908|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619909|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619910|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619911|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
27619912|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
27619913|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
27619914|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619915|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619916|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619917|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
27619918|NCT02018861|80453053|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619919|NCT02018861|80453054|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619920|NCT02018861|80453055|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619921|NCT02018861|80453056|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
27619922|NCT02018861|80453057|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
27619923|NCT02018861|80453058|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619924|NCT02018861|80453059|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619925|NCT02018861|80453060|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619926|NCT02018861|80453061|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619927|NCT02018861|80453062|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
27619928|NCT02018861|80453053|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27619929|NCT02018861|80453054|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27619930|NCT02018861|80453055|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27520246|NCT01185353|80098252|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
27520247|NCT01185353|80098253|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520248|NCT01185353|80098254|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
27520249|NCT01185353|80098255|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520250|NCT01185353|80098256|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520251|NCT01185353|80098257|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520252|NCT01185353|80098258|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520253|NCT01185353|80098259|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520254|NCT01185353|80098260|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
27520255|NCT01185353|80098251|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520256|NCT01185353|80098252|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520257|NCT01185353|80098253|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520258|NCT01185353|80098254|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
27520259|NCT01185353|80098255|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520260|NCT01185353|80098256|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520261|NCT01185353|80098257|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
27520262|NCT01185353|80098258|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520263|NCT01185353|80098259|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520264|NCT01185353|80098260|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
27520265|NCT01185353|80098251|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27520266|NCT01185353|80098252|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27520267|NCT01185353|80098253|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
27520268|NCT01185353|80098254|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
27520269|NCT01185353|80098255|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27520270|NCT01185353|80098256|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
27520271|NCT01185353|80098257|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
27520272|NCT01185353|80098258|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27520273|NCT01185353|80098259|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27520274|NCT01185353|80098260|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
27520275|NCT01185353|80098251|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520276|NCT01185353|80098252|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520277|NCT01185353|80098253|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520278|NCT01185353|80098254|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520279|NCT01185353|80098255|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520280|NCT01185353|80098256|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520281|NCT01185353|80098257|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
27520282|NCT01185353|80098258|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520283|NCT01185353|80098259|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27619931|NCT02018861|80453056|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27619932|NCT02018861|80453057|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27619933|NCT02018861|80453058|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27520284|NCT01185353|80098260|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
27520285|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27520286|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27619934|NCT02018861|80453059|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
27619935|NCT02018861|80453060|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
27619936|NCT02018861|80453061|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27619937|NCT02018861|80453062|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
27619938|NCT02018861|80453053|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619939|NCT02018861|80453054|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619940|NCT02018861|80453055|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619941|NCT02018861|80453056|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619942|NCT02018861|80453057|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619943|NCT02018861|80453058|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619944|NCT02018861|80453059|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
27619945|NCT02018861|80453060|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
27619946|NCT02018861|80453061|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619947|NCT02018861|80453062|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
27619948|NCT02018861|80453053|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619949|NCT02018861|80453054|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619950|NCT02018861|80453055|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619951|NCT02018861|80453056|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619952|NCT02018861|80453057|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27909080|NCT00549549|81503558|FG000|Overall Study|Withdrawal by Subject|0|||
27909081|NCT00549549|81503559|FG001|Overall Study|Withdrawal by Subject|4|||
27909082|NCT00549549|81503560|FG002|Overall Study|Withdrawal by Subject|1|||
27909083|NCT00549549|81503561|FG003|Overall Study|Withdrawal by Subject|0|||
27909084|NCT00549549|81503558|FG000|Overall Study|Other|9|||
27909085|NCT00549549|81503559|FG001|Overall Study|Other|9|||
27909086|NCT00549549|81503560|FG002|Overall Study|Other|9|||
27909087|NCT00549549|81503561|FG003|Overall Study|Other|11|||
27909088|NCT00549549|81503558|FG000|Overall Study|Randomized but not treated|0|||
27909089|NCT00549549|81503559|FG001|Overall Study|Randomized but not treated|0|||
27909090|NCT00549549|81503560|FG002|Overall Study|Randomized but not treated|1|||
27909091|NCT00549549|81503561|FG003|Overall Study|Randomized but not treated|1|||
27520287|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27520288|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27520289|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27520290|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27520291|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
27520292|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
27520293|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
27520294|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
27520295|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520296|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520297|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520298|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520299|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520300|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520301|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
27520302|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
27520303|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
27520304|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
27520305|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520306|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520307|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520308|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520309|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520310|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520311|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
27520312|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
27520313|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
27520314|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
27520315|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520316|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520317|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27854316|NCT00541970|81298742|FG000|Month 24|Adverse Event|0|||
27909092|NCT02465437|81503563|FG000|Overall Study|Physician Decision|0|||
27909093|NCT02465437|81503564|FG001|Overall Study|Physician Decision|0|||
27520318|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520319|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520320|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520321|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520322|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520323|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
27520324|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
27520325|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Death|0|||
27520326|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Death|0|||
27520327|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Death|0|||
27520328|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Death|0|||
27520329|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Death|0|||
27520330|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Death|0|||
27520331|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Death|0|||
27520332|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Death|0|||
27909094|NCT02465437|81503565|FG002|Overall Study|Physician Decision|1|||
27909095|NCT02465437|81503566|FG003|Overall Study|Physician Decision|0|||
27909096|NCT02465437|81503563|FG000|Overall Study|Withdrawal by Subject|1|||
27909097|NCT02465437|81503564|FG001|Overall Study|Withdrawal by Subject|0|||
27909098|NCT02465437|81503565|FG002|Overall Study|Withdrawal by Subject|0|||
27909099|NCT02465437|81503566|FG003|Overall Study|Withdrawal by Subject|1|||
27909100|NCT02465437|81503563|FG000|Overall Study|Adverse Event|0|||
27909101|NCT02465437|81503564|FG001|Overall Study|Adverse Event|1|||
27909102|NCT02465437|81503565|FG002|Overall Study|Adverse Event|0|||
27520333|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Death|0|||
27520334|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Death|1|||
27520335|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520336|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520337|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520338|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520339|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520340|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520341|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520342|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520343|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
27520344|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
27520345|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520346|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520347|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520348|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520349|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520350|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520351|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520352|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520353|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
27520354|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
27520355|NCT01185353|80098251|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520356|NCT01185353|80098252|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520357|NCT01185353|80098253|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520358|NCT01185353|80098254|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520359|NCT01185353|80098255|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520360|NCT01185353|80098256|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520361|NCT01185353|80098257|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520362|NCT01185353|80098258|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520363|NCT01185353|80098259|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
27520364|NCT01185353|80098260|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
27520365|NCT01185353|80098251|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520366|NCT01185353|80098252|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520367|NCT01185353|80098253|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520368|NCT01185353|80098254|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520369|NCT01185353|80098255|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520370|NCT01185353|80098256|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520371|NCT01185353|80098257|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27854317|NCT00541970|81298743|FG001|Month 24|Adverse Event|1|||
27854318|NCT00541970|81298744|FG002|Month 24|Adverse Event|1|||
27854319|NCT00541970|81298745|FG003|Month 24|Adverse Event|1|||
27854320|NCT00541970|81298742|FG000|Month 24|Protocol Violation|29|||
27854321|NCT00541970|81298743|FG001|Month 24|Protocol Violation|31|||
27854322|NCT00541970|81298744|FG002|Month 24|Protocol Violation|31|||
27854323|NCT00541970|81298745|FG003|Month 24|Protocol Violation|21|||
27854324|NCT00541970|81298742|FG000|Month 36|Protocol Violation|61|||
27854325|NCT00541970|81298743|FG001|Month 36|Protocol Violation|66|||
27854326|NCT00541970|81298744|FG002|Month 36|Protocol Violation|66|||
27854327|NCT00541970|81298745|FG003|Month 36|Protocol Violation|60|||
27854328|NCT00541970|81298742|FG000|Month 48|Withdrawal by Subject|2|||
27854329|NCT00541970|81298743|FG001|Month 48|Withdrawal by Subject|4|||
27854330|NCT00541970|81298744|FG002|Month 48|Withdrawal by Subject|4|||
27619953|NCT02018861|80453058|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619954|NCT02018861|80453059|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619955|NCT02018861|80453060|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619956|NCT02018861|80453061|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
27619957|NCT02018861|80453062|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
27619958|NCT02018861|80453053|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619959|NCT02018861|80453054|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619960|NCT02018861|80453055|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619961|NCT02018861|80453056|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619962|NCT02018861|80453057|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619963|NCT02018861|80453058|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619964|NCT02018861|80453059|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619965|NCT02018861|80453060|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619966|NCT02018861|80453061|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
27619967|NCT02018861|80453062|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
27619968|NCT02018861|80453053|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619969|NCT02018861|80453054|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619970|NCT02018861|80453055|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619971|NCT02018861|80453056|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619972|NCT02018861|80453057|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619973|NCT02018861|80453058|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619974|NCT02018861|80453059|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619975|NCT02018861|80453060|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619976|NCT02018861|80453061|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
27619977|NCT02018861|80453062|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
27619978|NCT01744496|80453063|FG000|Titration Period|Adverse Event|2|||
27619979|NCT01744496|80453064|FG001|Titration Period|Adverse Event|1|||
27619980|NCT01744496|80453063|FG000|Titration Period|Personal reasons|0|||
27619981|NCT01744496|80453064|FG001|Titration Period|Personal reasons|1|||
27619982|NCT01744496|80453063|FG000|Maintenance Period|Adverse Event|1|||
27619983|NCT01744496|80453064|FG001|Maintenance Period|Adverse Event|3|||
27619984|NCT01744496|80453063|FG000|Maintenance Period|Protocol Violation|1|||
27619985|NCT01744496|80453064|FG001|Maintenance Period|Protocol Violation|0|||
27619986|NCT01744496|80453063|FG000|Maintenance Period|Withdrawal by Subject|1|||
27619987|NCT01744496|80453064|FG001|Maintenance Period|Withdrawal by Subject|1|||
27619988|NCT01744496|80453063|FG000|Maintenance Period|Subject left town|1|||
27619989|NCT01744496|80453064|FG001|Maintenance Period|Subject left town|0|||
27619990|NCT04990440|80453073|FG000|Overall Study|Sponsor's Decision|0|||
27619991|NCT04990440|80453074|FG001|Overall Study|Sponsor's Decision|0|||
27619992|NCT04990440|80453075|FG002|Overall Study|Sponsor's Decision|1|||
27909103|NCT02465437|81503566|FG003|Overall Study|Adverse Event|0|||
27909104|NCT00184002|81503569|FG000|Overall Study|Adverse Event|9|||
27909105|NCT00184002|81503569|FG000|Overall Study|Death|3|||
27909106|NCT00184002|81503569|FG000|Overall Study|Physician Decision|1|||
27909107|NCT00184002|81503569|FG000|Overall Study|Withdrawal by Subject|4|||
27909108|NCT01310127|81506825|FG000|Overall Study|Protocol Violation|1|||
27520372|NCT01185353|80098258|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
27520373|NCT01185353|80098259|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
27520374|NCT01185353|80098260|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
27520375|NCT01185353|80098251|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520376|NCT01185353|80098252|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520377|NCT01185353|80098253|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520378|NCT01185353|80098254|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520379|NCT01185353|80098255|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520380|NCT01185353|80098256|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520381|NCT01185353|80098257|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
27520382|NCT01185353|80098258|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
27520383|NCT01185353|80098259|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
27520384|NCT01185353|80098260|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
27520385|NCT01185353|80098251|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27619993|NCT02427646|80453076|FG000|Overall Study|Lack of Efficacy|2|||
27619994|NCT02427646|80453077|FG001|Overall Study|Lack of Efficacy|3|||
27619995|NCT02427646|80453076|FG000|Overall Study|Physician Decision|1|||
27619996|NCT02427646|80453077|FG001|Overall Study|Physician Decision|4|||
27619997|NCT02427646|80453076|FG000|Overall Study|Protocol Violation|3|||
27619998|NCT02427646|80453077|FG001|Overall Study|Protocol Violation|3|||
27619999|NCT02427646|80453076|FG000|Overall Study|Bothersome hand weakness|2|||
27909109|NCT01310127|81506826|FG001|Overall Study|Protocol Violation|1|||
27620000|NCT02427646|80453077|FG001|Overall Study|Bothersome hand weakness|4|||
27620001|NCT01477749|80453078|FG000|Overall Study|Physician Decision|4|||
27909110|NCT01310127|81506825|FG000|Overall Study|advanced psc cataract outlier|1|||
27520386|NCT01185353|80098252|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27909111|NCT01310127|81506826|FG001|Overall Study|advanced psc cataract outlier|0|||
27909112|NCT02028507|81506827|FG000|Overall Study|Progressive Disease|122|||
27909113|NCT02028507|81506828|FG001|Overall Study|Progressive Disease|90|||
27909114|NCT02028507|81506829|FG002|Overall Study|Progressive Disease|102|||
27909115|NCT02028507|81506830|FG003|Overall Study|Progressive Disease|89|||
27909116|NCT02028507|81506827|FG000|Overall Study|Adverse Event|8|||
27909117|NCT02028507|81506828|FG001|Overall Study|Adverse Event|25|||
27909118|NCT02028507|81506829|FG002|Overall Study|Adverse Event|3|||
27909119|NCT02028507|81506830|FG003|Overall Study|Adverse Event|16|||
27909120|NCT02028507|81506827|FG000|Overall Study|Withdrawal by Subject|6|||
27909121|NCT02028507|81506828|FG001|Overall Study|Withdrawal by Subject|8|||
27909122|NCT02028507|81506829|FG002|Overall Study|Withdrawal by Subject|5|||
27909123|NCT02028507|81506830|FG003|Overall Study|Withdrawal by Subject|9|||
27909124|NCT02028507|81506827|FG000|Overall Study|Protocol Violation|2|||
27909125|NCT02028507|81506828|FG001|Overall Study|Protocol Violation|4|||
27909126|NCT02028507|81506829|FG002|Overall Study|Protocol Violation|1|||
27909127|NCT02028507|81506830|FG003|Overall Study|Protocol Violation|3|||
27909128|NCT02028507|81506827|FG000|Overall Study|Physician Decision|0|||
27909129|NCT02028507|81506828|FG001|Overall Study|Physician Decision|4|||
27909130|NCT02028507|81506829|FG002|Overall Study|Physician Decision|0|||
27909131|NCT02028507|81506830|FG003|Overall Study|Physician Decision|0|||
27909132|NCT02028507|81506827|FG000|Overall Study|Death|1|||
27909133|NCT02028507|81506828|FG001|Overall Study|Death|0|||
27520387|NCT01185353|80098253|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27520388|NCT01185353|80098254|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27520389|NCT01185353|80098255|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27520390|NCT01185353|80098256|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27520391|NCT01185353|80098257|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27520392|NCT01185353|80098258|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
27520393|NCT01185353|80098259|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
27520394|NCT01185353|80098260|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
27520395|NCT00779259|80098261|FG000|Quinine Alone|Adverse Event|2|||
27520396|NCT01395784|80098263|FG000|Overall Study|Lost to Follow-up|7|||
27520397|NCT01395784|80098263|FG000|Overall Study|Withdrawal by Subject|3|||
27520398|NCT01395784|80098263|FG000|Overall Study|Physician Decision|5|||
27520399|NCT04610281|80098266|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
27520400|NCT04610281|80098267|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
27520401|NCT03126344|80098271|FG000|Overall Study|Lost to Follow-up|0|||
27520402|NCT03126344|80098272|FG001|Overall Study|Lost to Follow-up|0|||
27520403|NCT03126344|80098273|FG002|Overall Study|Lost to Follow-up|5|||
27520404|NCT00724711|80098276|FG000|Overall Study|Adverse Event|7|||
27520405|NCT00724711|80098277|FG001|Overall Study|Adverse Event|3|||
27520406|NCT00724711|80098276|FG000|Overall Study|Pregnancy|0|||
27520407|NCT00724711|80098277|FG001|Overall Study|Pregnancy|1|||
27520408|NCT00724711|80098276|FG000|Overall Study|Lack of Efficacy|0|||
27520409|NCT00724711|80098277|FG001|Overall Study|Lack of Efficacy|1|||
27520410|NCT00724711|80098276|FG000|Overall Study|Physician Decision|0|||
27520411|NCT00724711|80098277|FG001|Overall Study|Physician Decision|3|||
27520412|NCT00724711|80098276|FG000|Overall Study|Withdrawal by Subject|5|||
27520413|NCT00724711|80098277|FG001|Overall Study|Withdrawal by Subject|4|||
27520414|NCT00724711|80098276|FG000|Overall Study|Lost to Follow-up|4|||
27520415|NCT00724711|80098277|FG001|Overall Study|Lost to Follow-up|5|||
27520416|NCT00724711|80098276|FG000|Overall Study|Protocol Violation|1|||
27520417|NCT00724711|80098277|FG001|Overall Study|Protocol Violation|0|||
27520418|NCT00483756|80098278|FG000|Overall Study|Death|2|||
27520419|NCT00483756|80098279|FG001|Overall Study|Death|0|||
27520420|NCT00483756|80098280|FG002|Overall Study|Death|1|||
27520421|NCT00483756|80098278|FG000|Overall Study|Adverse Event|19|||
27520422|NCT00483756|80098279|FG001|Overall Study|Adverse Event|38|||
27520423|NCT00483756|80098280|FG002|Overall Study|Adverse Event|40|||
27520424|NCT00483756|80098278|FG000|Overall Study|Lack of Efficacy|1|||
27520425|NCT00483756|80098279|FG001|Overall Study|Lack of Efficacy|0|||
27520426|NCT00483756|80098280|FG002|Overall Study|Lack of Efficacy|0|||
27520427|NCT00483756|80098278|FG000|Overall Study|Lost to Follow-up|3|||
27520428|NCT00483756|80098279|FG001|Overall Study|Lost to Follow-up|1|||
27909134|NCT02028507|81506829|FG002|Overall Study|Death|1|||
27909135|NCT02028507|81506830|FG003|Overall Study|Death|3|||
27909136|NCT02028507|81506827|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
27520429|NCT00483756|80098280|FG002|Overall Study|Lost to Follow-up|0|||
27520430|NCT00483756|80098278|FG000|Overall Study|Withdrawal by Subject|5|||
27520431|NCT00483756|80098279|FG001|Overall Study|Withdrawal by Subject|3|||
27909137|NCT02028507|81506828|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
27909138|NCT02028507|81506829|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
27909139|NCT02028507|81506830|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
27909140|NCT02028507|81506827|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
27909141|NCT02028507|81506828|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
27909142|NCT02028507|81506829|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
27520432|NCT00483756|80098280|FG002|Overall Study|Withdrawal by Subject|4|||
27520433|NCT00483756|80098278|FG000|Overall Study|Other|2|||
27520434|NCT00483756|80098279|FG001|Overall Study|Other|4|||
27520435|NCT00483756|80098280|FG002|Overall Study|Other|3|||
27520436|NCT00483756|80098278|FG000|Overall Study|Randomized, Not Treated|1|||
27520437|NCT00483756|80098279|FG001|Overall Study|Randomized, Not Treated|4|||
27520438|NCT00483756|80098280|FG002|Overall Study|Randomized, Not Treated|4|||
27520439|NCT01242813|80098281|FG000|Overall Study|Lost to Follow-up|2|||
27520440|NCT02743611|80098282|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
27520441|NCT02743611|80098283|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
27520442|NCT02743611|80098284|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
27520443|NCT02743611|80098285|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
27520444|NCT01699867|80098286|FG000|Overall Study|Screening Failure|3|||
27520445|NCT02736890|80098287|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
27520446|NCT02736890|80098288|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
27520447|NCT02736890|80098287|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
27520448|NCT02736890|80098288|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
27620002|NCT03633903|80453081|FG000|Overall Study|Withdrawal by Subject|1|||
27620003|NCT03633903|80453082|FG001|Overall Study|Withdrawal by Subject|2|||
27620004|NCT03633903|80453081|FG000|Overall Study|Lost to Follow-up|5|||
27620005|NCT03633903|80453082|FG001|Overall Study|Lost to Follow-up|5|||
27620006|NCT01656759|80453084|FG000|Overall Study|Protocol Violation|2|||
27620007|NCT01656759|80453085|FG001|Overall Study|Protocol Violation|3|||
27620008|NCT00513019|80453086|FG000|Overall Study|Adverse Event|1|||
27620009|NCT00513019|80453087|FG001|Overall Study|Adverse Event|0|||
27620010|NCT00513019|80453086|FG000|Overall Study|Withdrawal by Subject|4|||
27620011|NCT00513019|80453087|FG001|Overall Study|Withdrawal by Subject|5|||
27620012|NCT03212365|80453090|FG000|Overall Study|Discharged prior to Xa level|12|||
27620013|NCT03212365|80453091|FG001|Overall Study|Discharged prior to Xa level|8|||
27620014|NCT03212365|80453090|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
27620015|NCT03212365|80453091|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
27620016|NCT03212365|80453090|FG000|Overall Study|Refused study medication|3|||
27620017|NCT03212365|80453091|FG001|Overall Study|Refused study medication|0|||
27620018|NCT03212365|80453090|FG000|Overall Study|Initiated heparin infusion on floor|1|||
27620019|NCT03212365|80453091|FG001|Overall Study|Initiated heparin infusion on floor|1|||
27620020|NCT03212365|80453090|FG000|Overall Study|Unexpected return to OR|1|||
27620021|NCT03212365|80453091|FG001|Overall Study|Unexpected return to OR|1|||
27620022|NCT03212365|80453090|FG000|Overall Study|Medication distribution error|1|||
27620023|NCT03212365|80453091|FG001|Overall Study|Medication distribution error|0|||
27620024|NCT03212365|80453090|FG000|Overall Study|Required epidural placement|1|||
27620025|NCT03212365|80453091|FG001|Overall Study|Required epidural placement|0|||
27620026|NCT03212365|80453090|FG000|Overall Study|Withdrawal by Subject|0|||
27620027|NCT03212365|80453091|FG001|Overall Study|Withdrawal by Subject|1|||
27620028|NCT03212365|80453090|FG000|Overall Study|developed acute renal failure|0|||
27620029|NCT03212365|80453091|FG001|Overall Study|developed acute renal failure|1|||
27620030|NCT02322775|80453092|FG000|Overall Study|Adverse Event|1|||
27620031|NCT02322775|80453093|FG001|Overall Study|Adverse Event|0|||
27620032|NCT02322775|80453092|FG000|Overall Study|Lost to Follow-up|0|||
27620033|NCT02322775|80453093|FG001|Overall Study|Lost to Follow-up|1|||
27620034|NCT02322775|80453092|FG000|Overall Study|Protocol Violation|1|||
27620035|NCT02322775|80453093|FG001|Overall Study|Protocol Violation|0|||
27909143|NCT02028507|81506830|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
27520449|NCT00608569|80098289|FG000|Overall Study|Death|4|||
27520450|NCT00608569|80098290|FG001|Overall Study|Death|3|||
27520451|NCT00608569|80098289|FG000|Overall Study|Lost to Follow-up|4|||
27520452|NCT00608569|80098290|FG001|Overall Study|Lost to Follow-up|5|||
27520453|NCT00608569|80098289|FG000|Overall Study|Withdrawal by Subject|1|||
27909144|NCT02028507|81506827|FG000|Overall Study|Randomized But Not Treated|3|||
27909145|NCT02028507|81506828|FG001|Overall Study|Randomized But Not Treated|6|||
27620036|NCT02322775|80453092|FG000|Overall Study|Withdrawal by Subject|3|||
27620037|NCT02322775|80453093|FG001|Overall Study|Withdrawal by Subject|4|||
27520454|NCT00608569|80098290|FG001|Overall Study|Withdrawal by Subject|0|||
27620038|NCT02322775|80453092|FG000|Overall Study|Not willing to perform all FU visits|0|||
27620039|NCT02322775|80453093|FG001|Overall Study|Not willing to perform all FU visits|1|||
27520455|NCT00608569|80098289|FG000|Overall Study|Adverse Event|1|||
27520456|NCT00608569|80098290|FG001|Overall Study|Adverse Event|0|||
27520457|NCT00608569|80098289|FG000|Overall Study|Unable to adhere with study requirements|0|||
27520458|NCT00608569|80098290|FG001|Overall Study|Unable to adhere with study requirements|1|||
27520459|NCT02116530|80098291|FG000|Overall Study|Withdrawal by Subject|1|||
27620040|NCT01106976|80453094|FG000|Overall Study|Lost to Follow-up|8|||
27620041|NCT01375959|80453095|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
27620042|NCT01375959|80453096|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
27620043|NCT01375959|80453095|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
27854331|NCT00541970|81298745|FG003|Month 48|Withdrawal by Subject|2|||
27909146|NCT02028507|81506829|FG002|Overall Study|Randomized But Not Treated|0|||
27520460|NCT02116530|80098292|FG001|Overall Study|Withdrawal by Subject|2|||
27520461|NCT02116530|80098291|FG000|Overall Study|Adverse Event|4|||
27520462|NCT02116530|80098292|FG001|Overall Study|Adverse Event|0|||
27520463|NCT02116530|80098291|FG000|Overall Study|Physician Decision|1|||
27520464|NCT02116530|80098292|FG001|Overall Study|Physician Decision|0|||
27520465|NCT02116530|80098291|FG000|Overall Study|Lost to Follow-up|1|||
27520466|NCT02116530|80098292|FG001|Overall Study|Lost to Follow-up|0|||
27520467|NCT02116530|80098291|FG000|Overall Study|Other Medical Problems|2|||
27520468|NCT02116530|80098292|FG001|Overall Study|Other Medical Problems|2|||
27520469|NCT03720652|80098296|FG000|Overall Study|Withdrawal by Subject|2|||
27520470|NCT03720652|80098297|FG001|Overall Study|Withdrawal by Subject|7|||
27520471|NCT03720652|80098296|FG000|Overall Study|Lost to Follow-up|0|||
27520472|NCT03720652|80098297|FG001|Overall Study|Lost to Follow-up|4|||
27520473|NCT03642132|80098298|FG000|Chemotherapy Period|Adverse Event|1|||
27520474|NCT03642132|80098299|FG001|Chemotherapy Period|Adverse Event|1|||
27520475|NCT03642132|80098300|FG002|Chemotherapy Period|Adverse Event|0|||
27520476|NCT03642132|80098298|FG000|Chemotherapy Period|Physician's decision|4|||
27520477|NCT03642132|80098299|FG001|Chemotherapy Period|Physician's decision|1|||
27520478|NCT03642132|80098300|FG002|Chemotherapy Period|Physician's decision|0|||
27520479|NCT03642132|80098298|FG000|Chemotherapy Period|Progressive disease|0|||
27520480|NCT03642132|80098299|FG001|Chemotherapy Period|Progressive disease|0|||
27520481|NCT03642132|80098300|FG002|Chemotherapy Period|Progressive disease|1|||
27520482|NCT03642132|80098298|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
27520483|NCT03642132|80098299|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
27520484|NCT03642132|80098300|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
27520485|NCT03642132|80098298|FG000|Chemotherapy Period|Other|1|||
27520486|NCT03642132|80098299|FG001|Chemotherapy Period|Other|0|||
27520487|NCT03642132|80098300|FG002|Chemotherapy Period|Other|2|||
27520488|NCT03642132|80098298|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
27520489|NCT03642132|80098299|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
27520490|NCT03642132|80098300|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
27520491|NCT03642132|80098298|FG000|Maintenance Period|Adverse Event|1|||
27520492|NCT03642132|80098299|FG001|Maintenance Period|Adverse Event|2|||
27520493|NCT03642132|80098300|FG002|Maintenance Period|Adverse Event|0|||
27520494|NCT03642132|80098298|FG000|Maintenance Period|Non-compliance with study drug|0|||
27520495|NCT03642132|80098299|FG001|Maintenance Period|Non-compliance with study drug|0|||
27520496|NCT03642132|80098300|FG002|Maintenance Period|Non-compliance with study drug|1|||
27520497|NCT03642132|80098298|FG000|Maintenance Period|Physician's decision|2|||
27520498|NCT03642132|80098299|FG001|Maintenance Period|Physician's decision|2|||
27520499|NCT03642132|80098300|FG002|Maintenance Period|Physician's decision|2|||
27520500|NCT03642132|80098298|FG000|Maintenance Period|Progressive disease|9|||
27520501|NCT03642132|80098299|FG001|Maintenance Period|Progressive disease|3|||
27520502|NCT03642132|80098300|FG002|Maintenance Period|Progressive disease|6|||
27520503|NCT03642132|80098298|FG000|Maintenance Period|Other|0|||
27520504|NCT03642132|80098299|FG001|Maintenance Period|Other|0|||
27520505|NCT03642132|80098300|FG002|Maintenance Period|Other|3|||
27520506|NCT03642132|80098298|FG000|Maintenance Period|Withdrawal by Subject|1|||
27520507|NCT03642132|80098299|FG001|Maintenance Period|Withdrawal by Subject|1|||
27520508|NCT03642132|80098300|FG002|Maintenance Period|Withdrawal by Subject|2|||
27520509|NCT03642132|80098298|FG000|Follow-up Period|Other|0|||
27520510|NCT03642132|80098299|FG001|Follow-up Period|Other|0|||
27520511|NCT03642132|80098300|FG002|Follow-up Period|Other|1|||
27520512|NCT03642132|80098298|FG000|Follow-up Period|Withdrawal by Subject|1|||
27520513|NCT03642132|80098299|FG001|Follow-up Period|Withdrawal by Subject|2|||
27520514|NCT03642132|80098300|FG002|Follow-up Period|Withdrawal by Subject|0|||
27520515|NCT03642132|80098298|FG000|Follow-up Period|Study terminated by sponsor|1|||
27520516|NCT03642132|80098299|FG001|Follow-up Period|Study terminated by sponsor|0|||
27520517|NCT03642132|80098300|FG002|Follow-up Period|Study terminated by sponsor|1|||
27520518|NCT03642132|80098298|FG000|Follow-up Period|Lack of Efficacy|1|||
27520519|NCT03642132|80098299|FG001|Follow-up Period|Lack of Efficacy|0|||
27520520|NCT03642132|80098300|FG002|Follow-up Period|Lack of Efficacy|0|||
27520521|NCT03642132|80098298|FG000|Follow-up Period|Death|1|||
27854332|NCT00541970|81298742|FG000|Month 48|Other|3|||
27520522|NCT03642132|80098299|FG001|Follow-up Period|Death|0|||
27520523|NCT03642132|80098300|FG002|Follow-up Period|Death|2|||
27520524|NCT03642132|80098298|FG000|Follow-up Period|Adverse Event|1|||
27520525|NCT03642132|80098299|FG001|Follow-up Period|Adverse Event|0|||
27520526|NCT03642132|80098300|FG002|Follow-up Period|Adverse Event|0|||
27520527|NCT01853618|80098301|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
27520528|NCT01853618|80098302|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
27520529|NCT01853618|80098303|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
27520530|NCT01853618|80098304|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
27520531|NCT01853618|80098305|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
27520532|NCT01853618|80098301|FG000|Overall Study|Progressive disease|1|||
27520533|NCT01853618|80098302|FG001|Overall Study|Progressive disease|1|||
27520534|NCT01853618|80098303|FG002|Overall Study|Progressive disease|1|||
27520535|NCT01853618|80098304|FG003|Overall Study|Progressive disease|1|||
27854333|NCT00541970|81298743|FG001|Month 48|Other|1|||
27520536|NCT01853618|80098305|FG004|Overall Study|Progressive disease|2|||
27520537|NCT01853618|80098301|FG000|Overall Study|Physician Decision|0|||
27520538|NCT01853618|80098302|FG001|Overall Study|Physician Decision|1|||
27520539|NCT01853618|80098303|FG002|Overall Study|Physician Decision|1|||
27520540|NCT01853618|80098304|FG003|Overall Study|Physician Decision|0|||
27520541|NCT01853618|80098305|FG004|Overall Study|Physician Decision|0|||
27520542|NCT01853618|80098301|FG000|Overall Study|Refused further treatment|0|||
27520543|NCT01853618|80098302|FG001|Overall Study|Refused further treatment|0|||
27520544|NCT01853618|80098303|FG002|Overall Study|Refused further treatment|0|||
27520545|NCT01853618|80098304|FG003|Overall Study|Refused further treatment|0|||
27520546|NCT01853618|80098305|FG004|Overall Study|Refused further treatment|1|||
27520547|NCT00388583|80098308|FG000|Overall Study|Protocol Violation|1|||
27520548|NCT00388583|80098309|FG001|Overall Study|Protocol Violation|0|||
27520549|NCT00388583|80098308|FG000|Overall Study|Withdrawal by Subject|3|||
27520550|NCT00388583|80098309|FG001|Overall Study|Withdrawal by Subject|3|||
27520551|NCT00388583|80098308|FG000|Overall Study|Serious Adverse Event|2|||
27520552|NCT00388583|80098309|FG001|Overall Study|Serious Adverse Event|0|||
27520553|NCT00388583|80098308|FG000|Overall Study|Did not receive vaccine|0|||
27909147|NCT02028507|81506830|FG003|Overall Study|Randomized But Not Treated|4|||
27520554|NCT00388583|80098309|FG001|Overall Study|Did not receive vaccine|1|||
27520555|NCT01105065|80098314|FG000|Overall Study|Adverse Event|5|||
27520556|NCT01105065|80098314|FG000|Overall Study|Technical Problems|1|||
27520557|NCT01865552|80098317|FG000|Period 1|Adverse Event|1|||
27520558|NCT01865552|80098318|FG001|Period 1|Adverse Event|0|||
27520559|NCT01865552|80098319|FG002|Period 1|Adverse Event|0|||
27520560|NCT01865552|80098320|FG003|Period 1|Adverse Event|1|||
27520561|NCT01865552|80098321|FG004|Period 1|Adverse Event|1|||
27520562|NCT01865552|80098322|FG005|Period 1|Adverse Event|1|||
27520563|NCT01865552|80098317|FG000|Period 1|Pathological lab|0|||
27520564|NCT01865552|80098318|FG001|Period 1|Pathological lab|0|||
27520565|NCT01865552|80098319|FG002|Period 1|Pathological lab|0|||
27520566|NCT01865552|80098320|FG003|Period 1|Pathological lab|0|||
27520567|NCT01865552|80098321|FG004|Period 1|Pathological lab|1|||
27520568|NCT01865552|80098322|FG005|Period 1|Pathological lab|0|||
27520569|NCT01865552|80098317|FG000|Period 1|Other|0|||
27520570|NCT01865552|80098318|FG001|Period 1|Other|0|||
27520571|NCT01865552|80098319|FG002|Period 1|Other|0|||
27520572|NCT01865552|80098320|FG003|Period 1|Other|0|||
27520573|NCT01865552|80098321|FG004|Period 1|Other|1|||
27520574|NCT01865552|80098322|FG005|Period 1|Other|0|||
27520575|NCT02522624|80098323|FG000|Overall Study|Technical failure|1|||
27520576|NCT02522624|80098324|FG001|Overall Study|Technical failure|0|||
27520577|NCT00499616|80098326|FG000|Overall Study|Death|1|||
27520578|NCT00499616|80098327|FG001|Overall Study|Death|5|||
27520579|NCT00499616|80098328|FG002|Overall Study|Death|3|||
27520580|NCT00499616|80098329|FG003|Overall Study|Death|1|||
27520581|NCT00499616|80098326|FG000|Overall Study|Lack of Efficacy|5|||
27520582|NCT00499616|80098327|FG001|Overall Study|Lack of Efficacy|0|||
27520583|NCT00499616|80098328|FG002|Overall Study|Lack of Efficacy|19|||
27520584|NCT00499616|80098329|FG003|Overall Study|Lack of Efficacy|0|||
27520585|NCT00499616|80098326|FG000|Overall Study|Lost to Follow-up|0|||
27520586|NCT00499616|80098327|FG001|Overall Study|Lost to Follow-up|0|||
27520587|NCT00499616|80098328|FG002|Overall Study|Lost to Follow-up|1|||
27520588|NCT00499616|80098329|FG003|Overall Study|Lost to Follow-up|0|||
27620044|NCT01375959|80453096|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
27620045|NCT01375959|80453095|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27620046|NCT01375959|80453096|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
27620047|NCT00124982|80453097|FG000|Short-term Period|Death|1|||
27909148|NCT02028507|81506827|FG000|Overall Study|Enzyme defect|0|||
27520589|NCT00499616|80098326|FG000|Overall Study|Physician Decision|6|||
27520590|NCT00499616|80098327|FG001|Overall Study|Physician Decision|16|||
27620048|NCT00124982|80453098|FG001|Short-term Period|Death|1|||
27620049|NCT00124982|80453099|FG002|Short-term Period|Death|0|||
27909149|NCT02028507|81506828|FG001|Overall Study|Enzyme defect|0|||
27909150|NCT02028507|81506829|FG002|Overall Study|Enzyme defect|0|||
27909151|NCT02028507|81506830|FG003|Overall Study|Enzyme defect|1|||
27620050|NCT00124982|80453097|FG000|Short-term Period|Adverse Event|17|||
27909152|NCT02028507|81506827|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
27520591|NCT00499616|80098328|FG002|Overall Study|Physician Decision|9|||
27520592|NCT00499616|80098329|FG003|Overall Study|Physician Decision|0|||
27620051|NCT00124982|80453098|FG001|Short-term Period|Adverse Event|22|||
27620052|NCT00124982|80453099|FG002|Short-term Period|Adverse Event|0|||
27520593|NCT00499616|80098326|FG000|Overall Study|Withdrawal by Subject|1|||
27520594|NCT00499616|80098327|FG001|Overall Study|Withdrawal by Subject|0|||
27520595|NCT00499616|80098328|FG002|Overall Study|Withdrawal by Subject|1|||
27520596|NCT00499616|80098329|FG003|Overall Study|Withdrawal by Subject|0|||
27520597|NCT00499616|80098326|FG000|Overall Study|Ineligible|1|||
27520598|NCT00499616|80098327|FG001|Overall Study|Ineligible|2|||
27520599|NCT00499616|80098328|FG002|Overall Study|Ineligible|0|||
27520600|NCT00499616|80098329|FG003|Overall Study|Ineligible|15|||
27520601|NCT00499616|80098326|FG000|Overall Study|Not evaluable|0|||
27520602|NCT00499616|80098327|FG001|Overall Study|Not evaluable|0|||
27520603|NCT00499616|80098328|FG002|Overall Study|Not evaluable|0|||
27520604|NCT00499616|80098329|FG003|Overall Study|Not evaluable|41|||
27520605|NCT00499616|80098326|FG000|Overall Study|Patient/Parent Refusal|1|||
27520606|NCT00499616|80098327|FG001|Overall Study|Patient/Parent Refusal|5|||
27520607|NCT00499616|80098328|FG002|Overall Study|Patient/Parent Refusal|3|||
27520608|NCT00499616|80098329|FG003|Overall Study|Patient/Parent Refusal|0|||
27520609|NCT02043899|80098331|FG000|Overall Study|Adverse Event|3|||
27520610|NCT02043899|80098331|FG000|Overall Study|Physician Decision|1|||
27520611|NCT02043899|80098331|FG000|Overall Study|Withdrawal by Subject|2|||
27520612|NCT02043899|80098331|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
27520613|NCT02043899|80098331|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
27520614|NCT02043899|80098331|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
27520615|NCT02043899|80098331|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
27520616|NCT02043899|80098331|FG000|Overall Study|Treatment delayed|1|||
27520617|NCT04644315|80098336|FG000|Overall Study|Subject withdrawal of consent|1|||
27520618|NCT01771809|80098337|FG000|Overall Study|Adverse Event|4|||
27520619|NCT01771809|80098338|FG001|Overall Study|Adverse Event|12|||
27520620|NCT01771809|80098337|FG000|Overall Study|Protocol Violation|0|||
27520621|NCT01771809|80098338|FG001|Overall Study|Protocol Violation|1|||
27520622|NCT01771809|80098337|FG000|Overall Study|Withdrawal by Subject|34|||
27520623|NCT01771809|80098338|FG001|Overall Study|Withdrawal by Subject|42|||
27520624|NCT01771809|80098337|FG000|Overall Study|Lost to Follow-up|1|||
27520625|NCT01771809|80098338|FG001|Overall Study|Lost to Follow-up|3|||
27520626|NCT01771809|80098337|FG000|Overall Study|Other (Insufficient clinical response)|22|||
27520627|NCT01771809|80098338|FG001|Overall Study|Other (Insufficient clinical response)|20|||
27520628|NCT01771809|80098337|FG000|Overall Study|Death|1|||
27520629|NCT01771809|80098338|FG001|Overall Study|Death|0|||
27520630|NCT01771809|80098337|FG000|Overall Study|Other (other)|9|||
27520631|NCT01771809|80098338|FG001|Overall Study|Other (other)|5|||
27520632|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
27520633|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
27520634|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
27520635|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
27520636|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
27520637|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
27520638|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
27520639|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
27520640|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
27520641|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
27520642|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
27520643|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
27520644|NCT01087788|80098347|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
27520645|NCT01087788|80098348|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
27520646|NCT01087788|80098349|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
27520647|NCT01087788|80098347|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
27520648|NCT01087788|80098348|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
27520649|NCT01087788|80098349|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
27520650|NCT01087788|80098347|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
27520651|NCT01087788|80098348|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
27520652|NCT01087788|80098349|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
27520653|NCT01087788|80098347|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
27520654|NCT01087788|80098348|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
27520655|NCT01087788|80098349|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
27520656|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
27520657|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
27520658|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
27520659|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
27520660|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
27520661|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
27520662|NCT01087788|80098347|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
27520663|NCT01087788|80098348|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
27520664|NCT01087788|80098349|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
27854334|NCT00541970|81298744|FG002|Month 48|Other|1|||
27854335|NCT00541970|81298745|FG003|Month 48|Other|0|||
27520665|NCT01087788|80098347|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
27520666|NCT01087788|80098348|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
27620053|NCT00124982|80453097|FG000|Short-term Period|Lack of Efficacy|32|||
27620054|NCT00124982|80453098|FG001|Short-term Period|Lack of Efficacy|73|||
27854336|NCT00541970|81298742|FG000|Month 48|Lost to Follow-up|66|||
27520667|NCT01087788|80098349|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
27520668|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
27520669|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
27520670|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
27520671|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
27520672|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
27520673|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
27520674|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
27520675|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
27520676|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
27520677|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
27520678|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
27520679|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
27520680|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
27520681|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
27520682|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
27520683|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
27520684|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
27520685|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
27520686|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
27520687|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
27520688|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
27520689|NCT01087788|80098347|FG000|24-weeks Dose-blind Period|Patient moved|0|||
27520690|NCT01087788|80098348|FG001|24-weeks Dose-blind Period|Patient moved|0|||
27520691|NCT01087788|80098349|FG002|24-weeks Dose-blind Period|Patient moved|1|||
27520692|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
27520693|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
27520694|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
27520695|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
27520696|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
27520697|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
27520698|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
27520699|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
27520700|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
27520701|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
27520702|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
27520703|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
27520704|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
27520705|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
27520706|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
27520707|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
27520708|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
27520709|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
27520710|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
27520711|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
27520712|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
27520713|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
27520714|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
27520715|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
27520716|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
27520717|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
27520718|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
27520719|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
27520720|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
27520721|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
27520722|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
27520723|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
27520724|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
27520725|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
27520726|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
27520727|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
27520728|NCT01087788|80098347|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
27520729|NCT01087788|80098348|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
27520730|NCT01087788|80098349|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
27520731|NCT03560518|80098352|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
27520732|NCT03560518|80098353|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
27909153|NCT02028507|81506828|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
27909154|NCT02028507|81506829|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
27520733|NCT03560518|80098354|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
27520734|NCT03560518|80098352|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
27520735|NCT03560518|80098353|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
27520736|NCT03560518|80098354|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
27520737|NCT03560518|80098352|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27520738|NCT03560518|80098353|FG001|Double Blind Treatment Period|Protocol Violation|2|||
27520739|NCT03560518|80098354|FG002|Double Blind Treatment Period|Protocol Violation|0|||
27520740|NCT03560518|80098352|FG000|Double Blind Treatment Period|Pregnancy|0|||
27520741|NCT03560518|80098353|FG001|Double Blind Treatment Period|Pregnancy|2|||
27520742|NCT03560518|80098354|FG002|Double Blind Treatment Period|Pregnancy|0|||
27520743|NCT03560518|80098352|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
27520744|NCT03560518|80098353|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
27520745|NCT03560518|80098354|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
27520746|NCT03560518|80098352|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
27520747|NCT03560518|80098353|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
27520748|NCT03560518|80098354|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
27520749|NCT03560518|80098352|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
27520750|NCT03560518|80098353|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
27520751|NCT03560518|80098354|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
27520752|NCT03560518|80098352|FG000|Double Blind Treatment Period|Adverse Event|0|||
27520753|NCT03560518|80098353|FG001|Double Blind Treatment Period|Adverse Event|3|||
27520754|NCT03560518|80098354|FG002|Double Blind Treatment Period|Adverse Event|1|||
27520755|NCT03320824|80098357|FG000|Overall Study|Withdrawal by Subject|8|||
27520756|NCT03320824|80098358|FG001|Overall Study|Withdrawal by Subject|1|||
27520757|NCT03320824|80098357|FG000|Overall Study|Lost to Follow-up|10|||
27520758|NCT03320824|80098358|FG001|Overall Study|Lost to Follow-up|1|||
27520759|NCT03320824|80098357|FG000|Overall Study|moved out of state|0|||
27520760|NCT03320824|80098358|FG001|Overall Study|moved out of state|1|||
27520761|NCT03320824|80098357|FG000|Overall Study|could not complete final visit|0|||
27520762|NCT03320824|80098358|FG001|Overall Study|could not complete final visit|1|||
27520763|NCT02051933|80098359|FG000|Overall Study|Physician Decision|0|||
27520764|NCT02051933|80098360|FG001|Overall Study|Physician Decision|1|||
27520765|NCT00899353|80098361|FG000|Overall Study|Adverse Event|2|||
27520766|NCT00899353|80098361|FG000|Overall Study|Lost to Follow-up|1|||
27520767|NCT00899353|80098361|FG000|Overall Study|Withdrawal by Subject|2|||
27520768|NCT00606905|80098362|FG000|Overall Study|No Pregnancy|9|||
27520769|NCT00606905|80098363|FG001|Overall Study|No Pregnancy|6|||
27520770|NCT00606905|80098362|FG000|Overall Study|Non-Index Pregnancy|1|||
27520771|NCT00606905|80098363|FG001|Overall Study|Non-Index Pregnancy|4|||
27520772|NCT00606905|80098362|FG000|Overall Study|Withdrew|5|||
27520773|NCT00606905|80098363|FG001|Overall Study|Withdrew|5|||
27520774|NCT00167778|80098364|FG000|Overall Study|Withdrawal by Subject|1|||
27520775|NCT02730793|80098366|FG000|Overall Study|Physician Decision|0|||
27520776|NCT02730793|80098367|FG001|Overall Study|Physician Decision|1|||
27520777|NCT02730793|80098366|FG000|Overall Study|Withdrawal by Subject|0|||
27520778|NCT02730793|80098367|FG001|Overall Study|Withdrawal by Subject|1|||
27520779|NCT01270802|80098376|FG000|Overall Study|Withdrawal by Subject|1|||
27520780|NCT01270802|80098377|FG001|Overall Study|Withdrawal by Subject|0|||
27520781|NCT01270802|80098376|FG000|Overall Study|Adverse Event|1|||
27520782|NCT01270802|80098377|FG001|Overall Study|Adverse Event|0|||
27520783|NCT01270802|80098376|FG000|Overall Study|Lost to Follow-up|0|||
27520784|NCT01270802|80098377|FG001|Overall Study|Lost to Follow-up|1|||
27520785|NCT00145977|80098378|FG000|Overall Study|Lack of Efficacy|0|||
27520786|NCT00145977|80098379|FG001|Overall Study|Lack of Efficacy|4|||
27520787|NCT00145977|80098378|FG000|Overall Study|Lost to Follow-up|1|||
27520788|NCT00145977|80098379|FG001|Overall Study|Lost to Follow-up|0|||
27520789|NCT00145977|80098378|FG000|Overall Study|Withdrawal by Subject|1|||
27520790|NCT00145977|80098379|FG001|Overall Study|Withdrawal by Subject|0|||
27520791|NCT00978757|80098380|FG000|Overall Study|Physician Decision|1|||
27520792|NCT00978757|80098381|FG001|Overall Study|Physician Decision|3|||
27520793|NCT00097981|80098382|FG000|Overall Study|Adverse Event|31|||
27520794|NCT00097981|80098383|FG001|Overall Study|Adverse Event|44|||
27520795|NCT00097981|80098382|FG000|Overall Study|Withdrawal by Subject|10|||
27520796|NCT00097981|80098383|FG001|Overall Study|Withdrawal by Subject|8|||
27520797|NCT00097981|80098382|FG000|Overall Study|Protocol Violation|1|||
27520798|NCT00097981|80098383|FG001|Overall Study|Protocol Violation|1|||
27520799|NCT00097981|80098382|FG000|Overall Study|Death|2|||
27520800|NCT00097981|80098383|FG001|Overall Study|Death|4|||
27520801|NCT00097981|80098382|FG000|Overall Study|Physician Decision|7|||
27520802|NCT00097981|80098383|FG001|Overall Study|Physician Decision|1|||
27520803|NCT00097981|80098382|FG000|Overall Study|Disease Progression|8|||
27520804|NCT00097981|80098383|FG001|Overall Study|Disease Progression|2|||
27520805|NCT00097981|80098382|FG000|Overall Study|Transplant planned|28|||
27520806|NCT00097981|80098383|FG001|Overall Study|Transplant planned|27|||
27520807|NCT00097981|80098382|FG000|Overall Study|Other|19|||
27520808|NCT00097981|80098383|FG001|Overall Study|Other|13|||
27520809|NCT01713933|80098396|FG000|Overall Study|Lost to Follow-up|2|||
27520810|NCT01713933|80098396|FG000|Overall Study|Withdrawal by Subject|3|||
27520811|NCT01713933|80098396|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
27520812|NCT01252667|80098399|FG000|Overall Study|Transplant aborted post-conditioning|0|||
27520813|NCT01252667|80098400|FG001|Overall Study|Transplant aborted post-conditioning|0|||
27520814|NCT01252667|80098401|FG002|Overall Study|Transplant aborted post-conditioning|0|||
27520815|NCT01252667|80098402|FG003|Overall Study|Transplant aborted post-conditioning|0|||
27520816|NCT01252667|80098403|FG004|Overall Study|Transplant aborted post-conditioning|0|||
27520817|NCT01252667|80098404|FG005|Overall Study|Transplant aborted post-conditioning|1|||
27520818|NCT01332799|80098405|FG000|Overall Study|Insufficient funding|10|||
27520819|NCT01332799|80098406|FG001|Overall Study|Insufficient funding|10|||
27520820|NCT03531632|80098407|FG000|Overall Study|Adverse Event|0|||
27520821|NCT03531632|80098408|FG001|Overall Study|Adverse Event|0|||
27520822|NCT03531632|80098409|FG002|Overall Study|Adverse Event|1|||
27520823|NCT03531632|80098407|FG000|Overall Study|Death|4|||
27520824|NCT03531632|80098408|FG001|Overall Study|Death|0|||
27520825|NCT03531632|80098409|FG002|Overall Study|Death|14|||
27520826|NCT03531632|80098407|FG000|Overall Study|Study Terminated|1|||
27520827|NCT03531632|80098408|FG001|Overall Study|Study Terminated|3|||
27520828|NCT03531632|80098409|FG002|Overall Study|Study Terminated|11|||
27520829|NCT01221285|80098413|FG000|Overall Study|Withdrawal by Subject|1|||
27520830|NCT01239732|80098414|FG000|Overall Study|Termination of study per protocol|667|||
27520831|NCT01239732|80098414|FG000|Overall Study|Death|226|||
27520832|NCT01239732|80098414|FG000|Overall Study|Withdrawal by Subject|87|||
27520833|NCT01239732|80098414|FG000|Overall Study|Adverse Event|6|||
27520834|NCT01239732|80098414|FG000|Overall Study|Protocol Violation|3|||
27520835|NCT01239732|80098414|FG000|Overall Study|Participant non compliance|5|||
27520836|NCT01239732|80098414|FG000|Overall Study|Study termination by sponsor|2|||
27520837|NCT01239732|80098414|FG000|Overall Study|Investigator's decision|4|||
27620055|NCT00124982|80453099|FG002|Short-term Period|Lack of Efficacy|0|||
27620056|NCT00124982|80453097|FG000|Short-term Period|Lost to Follow-up|8|||
27620057|NCT00124982|80453098|FG001|Short-term Period|Lost to Follow-up|5|||
27620058|NCT00124982|80453099|FG002|Short-term Period|Lost to Follow-up|0|||
27620059|NCT00124982|80453097|FG000|Short-term Period|Withdrawal of Consent|7|||
27620060|NCT00124982|80453098|FG001|Short-term Period|Withdrawal of Consent|9|||
27620061|NCT00124982|80453099|FG002|Short-term Period|Withdrawal of Consent|0|||
27520838|NCT01239732|80098414|FG000|Overall Study|Treatment failure|2|||
27520839|NCT01239732|80098414|FG000|Overall Study|Other|19|||
27520840|NCT00505778|80098415|FG000|Overall Study|Adverse Event|2|||
27520841|NCT00505778|80098416|FG001|Overall Study|Adverse Event|7|||
27520842|NCT00505778|80098415|FG000|Overall Study|Physician Decision|8|||
27520843|NCT00505778|80098416|FG001|Overall Study|Physician Decision|14|||
27520844|NCT00505778|80098415|FG000|Overall Study|Lost to Follow-up|17|||
27520845|NCT00505778|80098416|FG001|Overall Study|Lost to Follow-up|23|||
27520846|NCT00505778|80098415|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
27520847|NCT00505778|80098416|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
27520848|NCT00505778|80098415|FG000|Overall Study|Protocol Violation|7|||
27520849|NCT00505778|80098416|FG001|Overall Study|Protocol Violation|9|||
27520850|NCT00505778|80098415|FG000|Overall Study|Withdrawal by Subject|29|||
27520851|NCT00505778|80098416|FG001|Overall Study|Withdrawal by Subject|14|||
27520852|NCT00505778|80098415|FG000|Overall Study|Relapse|65|||
27520853|NCT00505778|80098416|FG001|Overall Study|Relapse|65|||
27520854|NCT00505778|80098415|FG000|Overall Study|Took No Study Drug|2|||
27520855|NCT00505778|80098416|FG001|Overall Study|Took No Study Drug|2|||
27520856|NCT02364336|80098419|FG000|Overall Study|Adverse Event|0|||
27520857|NCT02364336|80098420|FG001|Overall Study|Adverse Event|1|||
27520858|NCT01755026|80098421|FG000|Overall Study|Adverse Event|1|||
27520859|NCT01755026|80098422|FG001|Overall Study|Adverse Event|0|||
27520860|NCT01755026|80098421|FG000|Overall Study|Withdrawal by Subject|1|||
27620062|NCT00124982|80453097|FG000|Short-term Period|Poor/Non-compliance|3|||
27620063|NCT00124982|80453098|FG001|Short-term Period|Poor/Non-compliance|1|||
27620064|NCT00124982|80453099|FG002|Short-term Period|Poor/Non-compliance|0|||
27620065|NCT00124982|80453097|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
27620066|NCT00124982|80453098|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
27620067|NCT00124982|80453099|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
27620068|NCT00124982|80453097|FG000|Short-term Period|Participant Decision|1|||
27620069|NCT00124982|80453098|FG001|Short-term Period|Participant Decision|0|||
27620070|NCT00124982|80453099|FG002|Short-term Period|Participant Decision|0|||
27620071|NCT00124982|80453097|FG000|Short-term Period|Participant Chose Own Doctor|0|||
27620072|NCT00124982|80453098|FG001|Short-term Period|Participant Chose Own Doctor|1|||
27620073|NCT00124982|80453099|FG002|Short-term Period|Participant Chose Own Doctor|0|||
27520861|NCT01755026|80098422|FG001|Overall Study|Withdrawal by Subject|1|||
27520862|NCT00913458|80098423|FG000|Phase 1|Non-Responder|54|||
27520863|NCT00913458|80098424|FG001|Phase 1|Non-Responder|0|||
27520864|NCT00913458|80098425|FG002|Phase 1|Non-Responder|0|||
27520865|NCT00913458|80098426|FG003|Phase 1|Non-Responder|0|||
27620074|NCT00124982|80453097|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
27620075|NCT00124982|80453098|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
27620076|NCT00124982|80453099|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
27620077|NCT00124982|80453097|FG000|Short-term Period|Participant Had Lymphopenia|1|||
27620078|NCT00124982|80453098|FG001|Short-term Period|Participant Had Lymphopenia|0|||
27620079|NCT00124982|80453099|FG002|Short-term Period|Participant Had Lymphopenia|0|||
27620080|NCT00124982|80453097|FG000|Long-term Period|Death|0|||
27620081|NCT00124982|80453098|FG001|Long-term Period|Death|0|||
27620082|NCT00124982|80453099|FG002|Long-term Period|Death|1|||
27620083|NCT00124982|80453097|FG000|Long-term Period|Adverse Event|0|||
27620084|NCT00124982|80453098|FG001|Long-term Period|Adverse Event|0|||
27520866|NCT00913458|80098427|FG004|Phase 1|Non-Responder|0|||
27520867|NCT00913458|80098428|FG005|Phase 1|Non-Responder|0|||
27520868|NCT00913458|80098429|FG006|Phase 1|Non-Responder|0|||
27520869|NCT00913458|80098423|FG000|Phase 1|Subject Request|17|||
27520870|NCT00913458|80098424|FG001|Phase 1|Subject Request|0|||
27520871|NCT00913458|80098425|FG002|Phase 1|Subject Request|0|||
27520872|NCT00913458|80098426|FG003|Phase 1|Subject Request|0|||
27520873|NCT00913458|80098427|FG004|Phase 1|Subject Request|0|||
27520874|NCT00913458|80098428|FG005|Phase 1|Subject Request|0|||
27520875|NCT00913458|80098429|FG006|Phase 1|Subject Request|0|||
27520876|NCT00913458|80098423|FG000|Phase 1|Adverse Event|20|||
27520877|NCT00913458|80098424|FG001|Phase 1|Adverse Event|0|||
27520878|NCT00913458|80098425|FG002|Phase 1|Adverse Event|0|||
27520879|NCT00913458|80098426|FG003|Phase 1|Adverse Event|0|||
27520880|NCT00913458|80098427|FG004|Phase 1|Adverse Event|0|||
27520881|NCT00913458|80098428|FG005|Phase 1|Adverse Event|0|||
27520882|NCT00913458|80098429|FG006|Phase 1|Adverse Event|0|||
27520883|NCT00913458|80098423|FG000|Phase 1|Lost to Follow-up|2|||
27520884|NCT00913458|80098424|FG001|Phase 1|Lost to Follow-up|0|||
27520885|NCT00913458|80098425|FG002|Phase 1|Lost to Follow-up|0|||
27520886|NCT00913458|80098426|FG003|Phase 1|Lost to Follow-up|0|||
27520887|NCT00913458|80098427|FG004|Phase 1|Lost to Follow-up|0|||
27520888|NCT00913458|80098428|FG005|Phase 1|Lost to Follow-up|0|||
27520889|NCT00913458|80098429|FG006|Phase 1|Lost to Follow-up|0|||
27520890|NCT00913458|80098423|FG000|Phase 1|Protocol Violation|10|||
27520891|NCT00913458|80098424|FG001|Phase 1|Protocol Violation|0|||
27520892|NCT00913458|80098425|FG002|Phase 1|Protocol Violation|0|||
27520893|NCT00913458|80098426|FG003|Phase 1|Protocol Violation|0|||
27520894|NCT00913458|80098427|FG004|Phase 1|Protocol Violation|0|||
27520895|NCT00913458|80098428|FG005|Phase 1|Protocol Violation|0|||
27520896|NCT00913458|80098429|FG006|Phase 1|Protocol Violation|0|||
27520897|NCT00913458|80098423|FG000|Phase 1|Sponsor|2|||
27520898|NCT00913458|80098424|FG001|Phase 1|Sponsor|0|||
27520899|NCT00913458|80098425|FG002|Phase 1|Sponsor|0|||
27520900|NCT00913458|80098426|FG003|Phase 1|Sponsor|0|||
27520901|NCT00913458|80098427|FG004|Phase 1|Sponsor|0|||
27520902|NCT00913458|80098428|FG005|Phase 1|Sponsor|0|||
27520903|NCT00913458|80098429|FG006|Phase 1|Sponsor|0|||
27520904|NCT00913458|80098423|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
27520905|NCT00913458|80098424|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
27520906|NCT00913458|80098425|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
27520907|NCT00913458|80098426|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
27520908|NCT00913458|80098427|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
27520909|NCT00913458|80098428|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
27520910|NCT00913458|80098429|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
27520911|NCT00913458|80098423|FG000|Phase 2|Non-Responder|0|||
27520912|NCT00913458|80098424|FG001|Phase 2|Non-Responder|5|||
27520913|NCT00913458|80098425|FG002|Phase 2|Non-Responder|7|||
27520914|NCT00913458|80098426|FG003|Phase 2|Non-Responder|12|||
27520915|NCT00913458|80098427|FG004|Phase 2|Non-Responder|0|||
27520916|NCT00913458|80098428|FG005|Phase 2|Non-Responder|0|||
27520917|NCT00913458|80098429|FG006|Phase 2|Non-Responder|0|||
27520918|NCT00913458|80098423|FG000|Phase 2|Subject Request|0|||
27520919|NCT00913458|80098424|FG001|Phase 2|Subject Request|0|||
27520920|NCT00913458|80098425|FG002|Phase 2|Subject Request|1|||
27520921|NCT00913458|80098426|FG003|Phase 2|Subject Request|2|||
27620085|NCT00124982|80453099|FG002|Long-term Period|Adverse Event|17|||
27854337|NCT00541970|81298743|FG001|Month 48|Lost to Follow-up|68|||
27520922|NCT00913458|80098427|FG004|Phase 2|Subject Request|0|||
27520923|NCT00913458|80098428|FG005|Phase 2|Subject Request|0|||
27620086|NCT00124982|80453097|FG000|Long-term Period|Lack of Efficacy|0|||
27620087|NCT00124982|80453098|FG001|Long-term Period|Lack of Efficacy|0|||
27620088|NCT00124982|80453099|FG002|Long-term Period|Lack of Efficacy|46|||
27520924|NCT00913458|80098429|FG006|Phase 2|Subject Request|0|||
27520925|NCT00913458|80098423|FG000|Phase 2|Adverse Event|0|||
27520926|NCT00913458|80098424|FG001|Phase 2|Adverse Event|3|||
27520927|NCT00913458|80098425|FG002|Phase 2|Adverse Event|0|||
27520928|NCT00913458|80098426|FG003|Phase 2|Adverse Event|1|||
27520929|NCT00913458|80098427|FG004|Phase 2|Adverse Event|0|||
27520930|NCT00913458|80098428|FG005|Phase 2|Adverse Event|0|||
27520931|NCT00913458|80098429|FG006|Phase 2|Adverse Event|0|||
27520932|NCT00913458|80098423|FG000|Phase 2|Lost to Follow-up|0|||
27520933|NCT00913458|80098424|FG001|Phase 2|Lost to Follow-up|0|||
27520934|NCT00913458|80098425|FG002|Phase 2|Lost to Follow-up|0|||
27520935|NCT00913458|80098426|FG003|Phase 2|Lost to Follow-up|1|||
27520936|NCT00913458|80098427|FG004|Phase 2|Lost to Follow-up|0|||
27520937|NCT00913458|80098428|FG005|Phase 2|Lost to Follow-up|0|||
27520938|NCT00913458|80098429|FG006|Phase 2|Lost to Follow-up|0|||
27520939|NCT00913458|80098423|FG000|Phase 2|Protocol Violation|0|||
27520940|NCT00913458|80098424|FG001|Phase 2|Protocol Violation|2|||
27520941|NCT00913458|80098425|FG002|Phase 2|Protocol Violation|0|||
27520942|NCT00913458|80098426|FG003|Phase 2|Protocol Violation|0|||
27520943|NCT00913458|80098427|FG004|Phase 2|Protocol Violation|0|||
27520944|NCT00913458|80098428|FG005|Phase 2|Protocol Violation|0|||
27520945|NCT00913458|80098429|FG006|Phase 2|Protocol Violation|0|||
27520946|NCT00913458|80098423|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
27520947|NCT00913458|80098424|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
27520948|NCT00913458|80098425|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
27520949|NCT00913458|80098426|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
27520950|NCT00913458|80098427|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
27520951|NCT00913458|80098428|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
27520952|NCT00913458|80098429|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
27520953|NCT00913458|80098423|FG000|Phase 3|Adverse Event|0|||
27520954|NCT00913458|80098424|FG001|Phase 3|Adverse Event|0|||
27520955|NCT00913458|80098425|FG002|Phase 3|Adverse Event|0|||
27520956|NCT00913458|80098426|FG003|Phase 3|Adverse Event|0|||
27520957|NCT00913458|80098427|FG004|Phase 3|Adverse Event|5|||
27520958|NCT00913458|80098428|FG005|Phase 3|Adverse Event|4|||
27520959|NCT00913458|80098429|FG006|Phase 3|Adverse Event|1|||
27520960|NCT00913458|80098423|FG000|Phase 3|Lost to Follow-up|0|||
27520961|NCT00913458|80098424|FG001|Phase 3|Lost to Follow-up|0|||
27520962|NCT00913458|80098425|FG002|Phase 3|Lost to Follow-up|0|||
27520963|NCT00913458|80098426|FG003|Phase 3|Lost to Follow-up|0|||
27520964|NCT00913458|80098427|FG004|Phase 3|Lost to Follow-up|2|||
27520965|NCT00913458|80098428|FG005|Phase 3|Lost to Follow-up|0|||
27520966|NCT00913458|80098429|FG006|Phase 3|Lost to Follow-up|0|||
27520967|NCT00913458|80098423|FG000|Phase 3|Non-Responder|0|||
27520968|NCT00913458|80098424|FG001|Phase 3|Non-Responder|0|||
27520969|NCT00913458|80098425|FG002|Phase 3|Non-Responder|0|||
27520970|NCT00913458|80098426|FG003|Phase 3|Non-Responder|0|||
27520971|NCT00913458|80098427|FG004|Phase 3|Non-Responder|0|||
27520972|NCT00913458|80098428|FG005|Phase 3|Non-Responder|1|||
27520973|NCT00913458|80098429|FG006|Phase 3|Non-Responder|3|||
27520974|NCT00913458|80098423|FG000|Phase 3|Withdrawal by Subject|0|||
27520975|NCT00913458|80098424|FG001|Phase 3|Withdrawal by Subject|0|||
27520976|NCT00913458|80098425|FG002|Phase 3|Withdrawal by Subject|0|||
27520977|NCT00913458|80098426|FG003|Phase 3|Withdrawal by Subject|0|||
27520978|NCT00913458|80098427|FG004|Phase 3|Withdrawal by Subject|1|||
27520979|NCT00913458|80098428|FG005|Phase 3|Withdrawal by Subject|2|||
27520980|NCT00913458|80098429|FG006|Phase 3|Withdrawal by Subject|0|||
27520981|NCT00913458|80098423|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
27520982|NCT00913458|80098424|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
27520983|NCT00913458|80098425|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
27520984|NCT00913458|80098426|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
27520985|NCT00913458|80098427|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
27520986|NCT00913458|80098428|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
27520987|NCT00913458|80098429|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
27520988|NCT03148691|80098431|FG000|Overall Study|Protocol Violation|1|||
27520989|NCT03148691|80098432|FG001|Overall Study|Protocol Violation|2|||
27520990|NCT03148691|80098433|FG002|Overall Study|Protocol Violation|7|||
27520991|NCT03148691|80098431|FG000|Overall Study|Lost to Follow-up|0|||
27520992|NCT03148691|80098432|FG001|Overall Study|Lost to Follow-up|0|||
27520993|NCT03148691|80098433|FG002|Overall Study|Lost to Follow-up|1|||
27520994|NCT03148691|80098431|FG000|Overall Study|Other|1|||
27520995|NCT03148691|80098432|FG001|Overall Study|Other|0|||
27520996|NCT03148691|80098433|FG002|Overall Study|Other|0|||
27520997|NCT03148691|80098431|FG000|Overall Study|Withdrawal by Subject|1|||
27854338|NCT00541970|81298744|FG002|Month 48|Lost to Follow-up|68|||
27520998|NCT03148691|80098432|FG001|Overall Study|Withdrawal by Subject|0|||
27520999|NCT03148691|80098433|FG002|Overall Study|Withdrawal by Subject|0|||
27521000|NCT01870076|80098450|FG000|Overall Study|Withdrawal by Subject|1|||
27521001|NCT01870076|80098451|FG001|Overall Study|Withdrawal by Subject|0|||
27521002|NCT01870076|80098452|FG002|Overall Study|Withdrawal by Subject|1|||
27521003|NCT01870076|80098453|FG003|Overall Study|Withdrawal by Subject|0|||
27521004|NCT03412565|80098456|FG000|Overall Study|Lost to Follow-up|0|||
27620089|NCT00124982|80453097|FG000|Long-term Period|Lost to Follow-up|0|||
27521005|NCT03412565|80098457|FG001|Overall Study|Lost to Follow-up|0|||
27521006|NCT03412565|80098458|FG002|Overall Study|Lost to Follow-up|1|||
27521007|NCT03412565|80098459|FG003|Overall Study|Lost to Follow-up|0|||
27521008|NCT03412565|80098456|FG000|Overall Study|Physician Decision|0|||
27620090|NCT00124982|80453098|FG001|Long-term Period|Lost to Follow-up|0|||
27521009|NCT03412565|80098457|FG001|Overall Study|Physician Decision|0|||
27521010|NCT03412565|80098458|FG002|Overall Study|Physician Decision|0|||
27620091|NCT00124982|80453099|FG002|Long-term Period|Lost to Follow-up|4|||
27620092|NCT00124982|80453097|FG000|Long-term Period|Withdrawal by Subject|0|||
27620093|NCT00124982|80453098|FG001|Long-term Period|Withdrawal by Subject|0|||
27620094|NCT00124982|80453099|FG002|Long-term Period|Withdrawal by Subject|16|||
27620095|NCT00124982|80453097|FG000|Long-term Period|Pregnancy|0|||
27620096|NCT00124982|80453098|FG001|Long-term Period|Pregnancy|0|||
27620097|NCT00124982|80453099|FG002|Long-term Period|Pregnancy|1|||
27620098|NCT00124982|80453097|FG000|Long-term Period|Poor/Non-compliance|0|||
27620099|NCT00124982|80453098|FG001|Long-term Period|Poor/Non-compliance|0|||
27620100|NCT00124982|80453099|FG002|Long-term Period|Poor/Non-compliance|2|||
27620101|NCT00124982|80453097|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
27620102|NCT00124982|80453098|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
27620103|NCT00124982|80453099|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
27620104|NCT00124982|80453097|FG000|Long-term Period|Neurologist Recommendation|0|||
27620105|NCT00124982|80453098|FG001|Long-term Period|Neurologist Recommendation|0|||
27620106|NCT00124982|80453099|FG002|Long-term Period|Neurologist Recommendation|1|||
27620107|NCT00057811|80453102|FG000|Overall Study|Lack of Efficacy|1|||
27620108|NCT00057811|80453103|FG001|Overall Study|Lack of Efficacy|4|||
27620109|NCT00057811|80453102|FG000|Overall Study|Physician Decision|1|||
27620110|NCT00057811|80453103|FG001|Overall Study|Physician Decision|0|||
27620111|NCT00057811|80453102|FG000|Overall Study|Withdrawal by Subject|3|||
27620112|NCT00057811|80453103|FG001|Overall Study|Withdrawal by Subject|4|||
27620113|NCT00057811|80453102|FG000|Overall Study|Ineligible|4|||
27620114|NCT00057811|80453103|FG001|Overall Study|Ineligible|2|||
27620115|NCT00057811|80453102|FG000|Overall Study|Inevaluable|1|||
27620116|NCT00057811|80453103|FG001|Overall Study|Inevaluable|2|||
27620117|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Adverse Event|5|||
27620118|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Adverse Event|13|||
27620119|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Adverse Event|0|||
27620120|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
27620121|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
27620122|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
27620123|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
27620124|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
27620125|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
27620126|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
27620127|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
27620128|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
27620129|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
27620130|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
27620131|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
27620132|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
27620133|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
27620134|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
27620135|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Physician Decision|2|||
27620136|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Physician Decision|3|||
27620137|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Physician Decision|0|||
27620138|NCT01449929|80453105|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
27620139|NCT01449929|80453106|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
27620140|NCT01449929|80453107|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
27620141|NCT01449929|80453105|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
27620142|NCT01449929|80453106|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
27620143|NCT01449929|80453107|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
27620144|NCT01449929|80453105|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
27620145|NCT01449929|80453106|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
27620146|NCT01449929|80453107|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
27620147|NCT01449929|80453105|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
27620148|NCT01449929|80453106|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
27620149|NCT01449929|80453107|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
27620150|NCT00810641|80453112|FG000|Overall Study|Withdrawal by Subject|0|||
27620151|NCT00810641|80453113|FG001|Overall Study|Withdrawal by Subject|1|||
27620152|NCT00810641|80453114|FG002|Overall Study|Withdrawal by Subject|2|||
27620153|NCT02462083|80453115|FG000|Overall Study|Sponsor request|39|||
27620154|NCT02462083|80453115|FG000|Overall Study|Withdrawal by Subject|87|||
27620155|NCT02462083|80453115|FG000|Overall Study|Lost to Follow-up|41|||
27620156|NCT02462083|80453115|FG000|Overall Study|Lack of Efficacy|151|||
27620157|NCT02462083|80453115|FG000|Overall Study|Pregnancy|1|||
27620158|NCT02462083|80453115|FG000|Overall Study|Protocol Violation|6|||
27620159|NCT02462083|80453115|FG000|Overall Study|Adverse Event|33|||
27620160|NCT02462083|80453115|FG000|Overall Study|Worsening condition|16|||
27620161|NCT02462083|80453115|FG000|Overall Study|Other than specified|45|||
27620162|NCT00372567|80453116|FG000|Phase 3 Study|Adverse Event|5|||
27521011|NCT03412565|80098459|FG003|Overall Study|Physician Decision|1|||
27521012|NCT03412565|80098456|FG000|Overall Study|Withdrawal by Subject|0|||
27521013|NCT03412565|80098457|FG001|Overall Study|Withdrawal by Subject|4|||
27909155|NCT02028507|81506830|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
27909156|NCT02028507|81506827|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
27909157|NCT02028507|81506828|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
27909158|NCT02028507|81506829|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
27909159|NCT02028507|81506830|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
27909160|NCT04530838|81506833|FG000|Overall Study|Other|2|||
27909161|NCT04530838|81506834|FG001|Overall Study|Other|1|||
27909162|NCT04530838|81506835|FG002|Overall Study|Other|0|||
27909163|NCT04530838|81506833|FG000|Overall Study|Physician Decision|0|||
27909164|NCT04530838|81506834|FG001|Overall Study|Physician Decision|0|||
27909165|NCT04530838|81506835|FG002|Overall Study|Physician Decision|1|||
27909166|NCT04530838|81506833|FG000|Overall Study|Death|0|||
27909167|NCT04530838|81506834|FG001|Overall Study|Death|0|||
27909168|NCT04530838|81506835|FG002|Overall Study|Death|1|||
27909169|NCT04530838|81506833|FG000|Overall Study|Adverse Event|0|||
27909170|NCT04530838|81506834|FG001|Overall Study|Adverse Event|1|||
27909171|NCT04530838|81506835|FG002|Overall Study|Adverse Event|0|||
27909172|NCT04530838|81506833|FG000|Overall Study|No longer meets eligibility criteria|1|||
27909173|NCT04530838|81506834|FG001|Overall Study|No longer meets eligibility criteria|0|||
27909174|NCT04530838|81506835|FG002|Overall Study|No longer meets eligibility criteria|2|||
27909175|NCT04530838|81506833|FG000|Overall Study|Withdrawal by parent/guardian|5|||
27909176|NCT04530838|81506834|FG001|Overall Study|Withdrawal by parent/guardian|2|||
27909177|NCT04530838|81506835|FG002|Overall Study|Withdrawal by parent/guardian|2|||
27909178|NCT05291689|81506836|FG000|Overall Study|Adverse Event|3|||
27909179|NCT05291689|81506836|FG000|Overall Study|Lack of Efficacy|10|||
27909180|NCT05291689|81506836|FG000|Overall Study|Withdrawal by Subject|4|||
27909181|NCT01738919|81506837|FG000|Overall Study|Lost to Follow-up|1|||
27909182|NCT01738919|81506838|FG001|Overall Study|Lost to Follow-up|0|||
27909183|NCT01738919|81506837|FG000|Overall Study|Immigrated|0|||
27909184|NCT01738919|81506838|FG001|Overall Study|Immigrated|1|||
27909185|NCT01738919|81506837|FG000|Overall Study|Withdrawal by Subject|0|||
27909186|NCT01738919|81506838|FG001|Overall Study|Withdrawal by Subject|1|||
27909187|NCT01738919|81506837|FG000|Overall Study|Not treated in accordance to guidelines|0|||
27620163|NCT00372567|80453117|FG001|Phase 3 Study|Adverse Event|1|||
27620164|NCT00372567|80453118|FG002|Phase 3 Study|Adverse Event|1|||
27620165|NCT00372567|80453116|FG000|Phase 3 Study|Death|1|||
27620166|NCT00372567|80453117|FG001|Phase 3 Study|Death|1|||
27909188|NCT01738919|81506838|FG001|Overall Study|Not treated in accordance to guidelines|1|||
27909189|NCT00320788|81506840|FG000|Overall Study|Adverse Event|0|||
27909190|NCT00320788|81506841|FG001|Overall Study|Adverse Event|0|||
27909191|NCT00320788|81506842|FG002|Overall Study|Adverse Event|0|||
27909192|NCT00320788|81506843|FG003|Overall Study|Adverse Event|1|||
27909193|NCT00320788|81506844|FG004|Overall Study|Adverse Event|0|||
27909194|NCT00320788|81506840|FG000|Overall Study|Death|0|||
27909195|NCT00320788|81506841|FG001|Overall Study|Death|0|||
27909196|NCT00320788|81506842|FG002|Overall Study|Death|1|||
27909197|NCT00320788|81506843|FG003|Overall Study|Death|0|||
27909198|NCT00320788|81506844|FG004|Overall Study|Death|1|||
27909199|NCT00320788|81506840|FG000|Overall Study|Lost to Follow-up|0|||
27909200|NCT00320788|81506841|FG001|Overall Study|Lost to Follow-up|2|||
27909201|NCT00320788|81506842|FG002|Overall Study|Lost to Follow-up|1|||
27909202|NCT00320788|81506843|FG003|Overall Study|Lost to Follow-up|0|||
27909203|NCT00320788|81506844|FG004|Overall Study|Lost to Follow-up|0|||
27909204|NCT00320788|81506840|FG000|Overall Study|Decision by the Sponsor|1|||
27909205|NCT00320788|81506841|FG001|Overall Study|Decision by the Sponsor|1|||
27909206|NCT00320788|81506842|FG002|Overall Study|Decision by the Sponsor|0|||
27909207|NCT00320788|81506843|FG003|Overall Study|Decision by the Sponsor|0|||
27909208|NCT00320788|81506844|FG004|Overall Study|Decision by the Sponsor|1|||
27909209|NCT00320788|81506840|FG000|Overall Study|Other|1|||
27909210|NCT00320788|81506841|FG001|Overall Study|Other|2|||
27909211|NCT00320788|81506842|FG002|Overall Study|Other|1|||
27521014|NCT03412565|80098458|FG002|Overall Study|Withdrawal by Subject|5|||
27521015|NCT03412565|80098459|FG003|Overall Study|Withdrawal by Subject|5|||
27521016|NCT03412565|80098456|FG000|Overall Study|Death|1|||
27521017|NCT03412565|80098457|FG001|Overall Study|Death|3|||
27909212|NCT00320788|81506843|FG003|Overall Study|Other|1|||
27909213|NCT00320788|81506844|FG004|Overall Study|Other|1|||
27909214|NCT00320788|81506840|FG000|Overall Study|Physician Decision|1|||
27909215|NCT00320788|81506841|FG001|Overall Study|Physician Decision|1|||
27909216|NCT00320788|81506842|FG002|Overall Study|Physician Decision|0|||
27909217|NCT00320788|81506843|FG003|Overall Study|Physician Decision|0|||
27909218|NCT00320788|81506844|FG004|Overall Study|Physician Decision|0|||
27909219|NCT00320788|81506840|FG000|Overall Study|Protocol Violation|0|||
27521018|NCT03412565|80098458|FG002|Overall Study|Death|4|||
27909220|NCT00320788|81506841|FG001|Overall Study|Protocol Violation|0|||
27909221|NCT00320788|81506842|FG002|Overall Study|Protocol Violation|0|||
27521019|NCT03412565|80098459|FG003|Overall Study|Death|5|||
27521020|NCT03412565|80098456|FG000|Overall Study|Data collection ended|0|||
27521021|NCT03412565|80098457|FG001|Overall Study|Data collection ended|41|||
27521022|NCT03412565|80098458|FG002|Overall Study|Data collection ended|41|||
27521023|NCT03412565|80098459|FG003|Overall Study|Data collection ended|40|||
27521024|NCT01128621|80098460|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
27521025|NCT01128621|80098461|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
27521026|NCT02123251|80098462|FG000|Overall Study|Death|1|||
27521027|NCT02123251|80098463|FG001|Overall Study|Death|1|||
27521028|NCT02123251|80098462|FG000|Overall Study|Withdrawal by Subject|0|||
27521029|NCT02123251|80098463|FG001|Overall Study|Withdrawal by Subject|3|||
27521030|NCT02123251|80098462|FG000|Overall Study|Lost Medicaid eligibility|29|||
27521031|NCT02123251|80098463|FG001|Overall Study|Lost Medicaid eligibility|22|||
27521032|NCT02123251|80098462|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
27521033|NCT02123251|80098463|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
27521034|NCT01239992|80098464|FG000|Overall Study|Withdrawal by Subject|2|||
27521035|NCT02929498|80101303|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
27521036|NCT02929498|80101304|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
27521037|NCT02929498|80101305|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
27521038|NCT02929498|80101303|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
27521039|NCT02929498|80101304|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
27521040|NCT02929498|80101305|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
27521041|NCT02788279|80101308|FG000|Overall Study|Death|62|||
27521042|NCT02788279|80101309|FG001|Overall Study|Death|136|||
27521043|NCT02788279|80101310|FG002|Overall Study|Death|72|||
27521044|NCT02788279|80101308|FG000|Overall Study|Withdrawal by Subject|10|||
27521045|NCT02788279|80101309|FG001|Overall Study|Withdrawal by Subject|15|||
27521046|NCT02788279|80101310|FG002|Overall Study|Withdrawal by Subject|5|||
27521047|NCT02788279|80101308|FG000|Overall Study|Lost to Follow-up|0|||
27521048|NCT02788279|80101309|FG001|Overall Study|Lost to Follow-up|3|||
27521049|NCT02788279|80101310|FG002|Overall Study|Lost to Follow-up|2|||
27521050|NCT02788279|80101308|FG000|Overall Study|Sponsor decision|18|||
27521051|NCT02788279|80101309|FG001|Overall Study|Sponsor decision|29|||
27521052|NCT02788279|80101310|FG002|Overall Study|Sponsor decision|11|||
27521053|NCT02577887|80101311|FG000|Overall Study|Death|93|||
27521054|NCT02577887|80101311|FG000|Overall Study|Protocol Violation|125|||
27521055|NCT02577887|80101311|FG000|Overall Study|Withdrawal by Subject|80|||
27521056|NCT00588861|80101312|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
27521057|NCT00588861|80101313|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
27521058|NCT00588861|80101312|FG000|6 Months|Patients did not return for follow-up|98|||
27521059|NCT00588861|80101313|FG001|6 Months|Patients did not return for follow-up|73|||
27521060|NCT00588861|80101312|FG000|1 Year|Patients did not return for follow-up|89|||
27521061|NCT00588861|80101313|FG001|1 Year|Patients did not return for follow-up|82|||
27521062|NCT00588861|80101312|FG000|2 Years|Patients did not return for follow-up|92|||
27521063|NCT00588861|80101313|FG001|2 Years|Patients did not return for follow-up|87|||
27521064|NCT00588861|80101312|FG000|4 Years|Patients did not return for follow-up|91|||
27521065|NCT00588861|80101313|FG001|4 Years|Patients did not return for follow-up|103|||
27521066|NCT00588861|80101312|FG000|6 Years|Patients did not return for follow-up|104|||
27521067|NCT00588861|80101313|FG001|6 Years|Patients did not return for follow-up|109|||
27521068|NCT00588861|80101312|FG000|8 Years|Patients did not return for follow-up|105|||
27521069|NCT00588861|80101313|FG001|8 Years|Patients did not return for follow-up|114|||
27521070|NCT00588861|80101312|FG000|10 Years|Incomplete due to study termination|107|||
27521071|NCT00588861|80101313|FG001|10 Years|Incomplete due to study termination|114|||
27521072|NCT02880956|80101321|FG000|Overall Study|Adverse Event|3|||
27521073|NCT02880956|80101322|FG001|Overall Study|Adverse Event|6|||
27521074|NCT02880956|80101323|FG002|Overall Study|Adverse Event|5|||
27521075|NCT02880956|80101324|FG003|Overall Study|Adverse Event|4|||
27521076|NCT02880956|80101321|FG000|Overall Study|Withdrawal by Subject|9|||
27521077|NCT02880956|80101322|FG001|Overall Study|Withdrawal by Subject|4|||
27521078|NCT02880956|80101323|FG002|Overall Study|Withdrawal by Subject|6|||
27521079|NCT02880956|80101324|FG003|Overall Study|Withdrawal by Subject|11|||
27521080|NCT02880956|80101321|FG000|Overall Study|Lost to Follow-up|0|||
27521081|NCT02880956|80101322|FG001|Overall Study|Lost to Follow-up|1|||
27521082|NCT02880956|80101323|FG002|Overall Study|Lost to Follow-up|0|||
27521083|NCT02880956|80101324|FG003|Overall Study|Lost to Follow-up|0|||
27521084|NCT02880956|80101321|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
27521085|NCT02880956|80101322|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
27521086|NCT02880956|80101323|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
27521087|NCT02880956|80101324|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
27521088|NCT02880956|80101321|FG000|Overall Study|Other, Not Specified|4|||
27521089|NCT02880956|80101322|FG001|Overall Study|Other, Not Specified|2|||
27521090|NCT02880956|80101323|FG002|Overall Study|Other, Not Specified|0|||
27521091|NCT02880956|80101324|FG003|Overall Study|Other, Not Specified|3|||
27521092|NCT00853970|80101325|FG000|Overall Study|Withdrawal by Subject|2|||
27521093|NCT00853970|80101326|FG001|Overall Study|Withdrawal by Subject|1|||
27854339|NCT00541970|81298745|FG003|Month 48|Lost to Follow-up|73|||
27854340|NCT00541970|81298742|FG000|Month 60|Protocol Violation|78|||
27854341|NCT00541970|81298743|FG001|Month 60|Protocol Violation|77|||
27854342|NCT00541970|81298744|FG002|Month 60|Protocol Violation|82|||
27854343|NCT00541970|81298745|FG003|Month 60|Protocol Violation|72|||
27854344|NCT02558231|81298748|FG000|Overall Study|Death|4|||
27854345|NCT02558231|81298749|FG001|Overall Study|Death|12|||
27854346|NCT02558231|81298748|FG000|Overall Study|Lost to Follow-up|7|||
27854347|NCT02558231|81298749|FG001|Overall Study|Lost to Follow-up|4|||
27854348|NCT02558231|81298748|FG000|Overall Study|Withdrawal by Subject|7|||
27854349|NCT02558231|81298749|FG001|Overall Study|Withdrawal by Subject|4|||
27854350|NCT02558231|81298748|FG000|Overall Study|Physician Decision|7|||
27854351|NCT02558231|81298749|FG001|Overall Study|Physician Decision|5|||
27854352|NCT02558231|81298748|FG000|Overall Study|Sponsor Decision|0|||
27854353|NCT02558231|81298749|FG001|Overall Study|Sponsor Decision|1|||
27854354|NCT02618408|81298755|FG000|Overall Study|Withdrawal by Subject|1|||
27854355|NCT02618408|81298756|FG001|Overall Study|Withdrawal by Subject|0|||
27854356|NCT02618408|81298757|FG002|Overall Study|Withdrawal by Subject|4|||
27854357|NCT02618408|81298755|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
27854358|NCT02618408|81298756|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
27854359|NCT02618408|81298757|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
27854360|NCT02618408|81298755|FG000|Overall Study|Lost to Follow-up|4|||
27854361|NCT02618408|81298756|FG001|Overall Study|Lost to Follow-up|2|||
27854362|NCT02618408|81298757|FG002|Overall Study|Lost to Follow-up|6|||
27854363|NCT02618408|81298755|FG000|Overall Study|Adverse Event|4|||
27521094|NCT00853970|80101325|FG000|Overall Study|Cancelled surgery|4|||
27521095|NCT00853970|80101326|FG001|Overall Study|Cancelled surgery|2|||
27521096|NCT02122783|80101332|FG000|Overall Study|Adverse Event|0|||
27521097|NCT02122783|80101333|FG001|Overall Study|Adverse Event|1|||
27521098|NCT02081859|80101346|FG000|Overall Study|No fertilization|2|||
27521099|NCT02081859|80101347|FG001|Overall Study|No fertilization|2|||
27521100|NCT02081859|80101346|FG000|Overall Study|No sperm|1|||
27521101|NCT02081859|80101347|FG001|Overall Study|No sperm|0|||
27521102|NCT02081859|80101346|FG000|Overall Study|Unanticipated freeze all cycle|2|||
27521103|NCT02081859|80101347|FG001|Overall Study|Unanticipated freeze all cycle|6|||
27521104|NCT02081859|80101346|FG000|Overall Study|< 4 embryos|27|||
27521105|NCT02081859|80101347|FG001|Overall Study|< 4 embryos|23|||
27521106|NCT02081859|80101346|FG000|Overall Study|Other reasons|2|||
27521107|NCT02081859|80101347|FG001|Overall Study|Other reasons|0|||
27521108|NCT00870584|80101348|FG000|Overall Study|Adverse Event|3|||
27521109|NCT00870584|80101349|FG001|Overall Study|Adverse Event|3|||
27521110|NCT00870584|80101348|FG000|Overall Study|Withdrawal by Subject|6|||
27521111|NCT00870584|80101349|FG001|Overall Study|Withdrawal by Subject|7|||
27521112|NCT00870584|80101348|FG000|Overall Study|Lost to Follow-up|5|||
27521113|NCT00870584|80101349|FG001|Overall Study|Lost to Follow-up|1|||
27521114|NCT00870584|80101348|FG000|Overall Study|Protocol Deviation|2|||
27521115|NCT00870584|80101349|FG001|Overall Study|Protocol Deviation|2|||
27521116|NCT00727441|80101350|FG000|Overall Study|Disease Progression|11|||
27521117|NCT00727441|80101351|FG001|Overall Study|Disease Progression|14|||
27521118|NCT00727441|80101352|FG002|Overall Study|Disease Progression|17|||
27521119|NCT00727441|80101350|FG000|Overall Study|Eligibility|7|||
27521120|NCT00727441|80101351|FG001|Overall Study|Eligibility|5|||
27521121|NCT00727441|80101352|FG002|Overall Study|Eligibility|7|||
27521122|NCT00727441|80101350|FG000|Overall Study|Death|0|||
27521123|NCT00727441|80101351|FG001|Overall Study|Death|1|||
27521124|NCT00727441|80101352|FG002|Overall Study|Death|1|||
27521125|NCT00727441|80101350|FG000|Overall Study|Physician Decision|0|||
27521126|NCT00727441|80101351|FG001|Overall Study|Physician Decision|1|||
27521127|NCT00727441|80101352|FG002|Overall Study|Physician Decision|0|||
27521128|NCT00727441|80101350|FG000|Overall Study|Withdrawal by Subject|0|||
27521129|NCT00727441|80101351|FG001|Overall Study|Withdrawal by Subject|1|||
27521130|NCT00727441|80101352|FG002|Overall Study|Withdrawal by Subject|0|||
27521131|NCT03579602|80101353|FG000|Overall Study|Subject unable to receive study drug|0|||
27521132|NCT03579602|80101354|FG001|Overall Study|Subject unable to receive study drug|2|||
27521133|NCT03579602|80101353|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
27521134|NCT03579602|80101354|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
27521135|NCT02536404|80101372|FG000|Overall Study|Adverse Event|5|||
27521136|NCT02536404|80101373|FG001|Overall Study|Adverse Event|0|||
27521137|NCT02536404|80101372|FG000|Overall Study|Withdrawal by Subject|4|||
27521138|NCT02536404|80101373|FG001|Overall Study|Withdrawal by Subject|1|||
27521139|NCT02536404|80101372|FG000|Overall Study|Physician Decision|10|||
27521140|NCT02536404|80101373|FG001|Overall Study|Physician Decision|0|||
27854364|NCT02618408|81298756|FG001|Overall Study|Adverse Event|0|||
27854365|NCT02618408|81298757|FG002|Overall Study|Adverse Event|10|||
27854366|NCT02618408|81298755|FG000|Overall Study|Physician Decision|1|||
27854367|NCT02618408|81298756|FG001|Overall Study|Physician Decision|1|||
27854368|NCT02618408|81298757|FG002|Overall Study|Physician Decision|2|||
27854369|NCT02618408|81298755|FG000|Overall Study|Protocol Violation|1|||
27620167|NCT00372567|80453118|FG002|Phase 3 Study|Death|0|||
27620168|NCT00372567|80453116|FG000|Phase 3 Study|Protocol Violation|0|||
27620169|NCT00372567|80453117|FG001|Phase 3 Study|Protocol Violation|0|||
27620170|NCT00372567|80453118|FG002|Phase 3 Study|Protocol Violation|1|||
27620171|NCT00372567|80453116|FG000|Phase 3 Study|Objective progression or relapse|10|||
27620172|NCT00372567|80453117|FG001|Phase 3 Study|Objective progression or relapse|13|||
27620173|NCT00372567|80453118|FG002|Phase 3 Study|Objective progression or relapse|4|||
27909222|NCT00320788|81506843|FG003|Overall Study|Protocol Violation|0|||
27909223|NCT00320788|81506844|FG004|Overall Study|Protocol Violation|1|||
27909224|NCT00320788|81506840|FG000|Overall Study|Withdrawal by Subject|3|||
27909225|NCT00320788|81506841|FG001|Overall Study|Withdrawal by Subject|0|||
27909226|NCT00320788|81506842|FG002|Overall Study|Withdrawal by Subject|0|||
27909227|NCT00320788|81506843|FG003|Overall Study|Withdrawal by Subject|3|||
27854370|NCT02618408|81298756|FG001|Overall Study|Protocol Violation|1|||
27909228|NCT00320788|81506844|FG004|Overall Study|Withdrawal by Subject|1|||
27909229|NCT01381926|81506845|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
27909230|NCT01381926|81506846|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
27521141|NCT02536404|80101372|FG000|Overall Study|Sponsor decision|1|||
27521142|NCT02536404|80101373|FG001|Overall Study|Sponsor decision|0|||
27521143|NCT02142387|80101374|FG000|Overall Study|<19 years old|49|||
27521144|NCT02142387|80101375|FG001|Overall Study|<19 years old|326|||
27521145|NCT02142387|80101374|FG000|Overall Study|non-cardiac etiology|504|||
27521146|NCT02142387|80101375|FG001|Overall Study|non-cardiac etiology|3431|||
27521147|NCT02142387|80101374|FG000|Overall Study|CPR not performed|74|||
27521148|NCT02142387|80101375|FG001|Overall Study|CPR not performed|473|||
27521149|NCT02142387|80101374|FG000|Overall Study|witnessed by paramedic|139|||
27521150|NCT02142387|80101375|FG001|Overall Study|witnessed by paramedic|917|||
27521151|NCT02142387|80101374|FG000|Overall Study|incomplete data|1|||
27521152|NCT02142387|80101375|FG001|Overall Study|incomplete data|9|||
27521153|NCT02142387|80101374|FG000|Overall Study|occurred not at home|298|||
27521154|NCT02142387|80101375|FG001|Overall Study|occurred not at home|2474|||
27521155|NCT02551991|80101376|FG000|Overall Study|Death|5|||
27521156|NCT02551991|80101377|FG001|Overall Study|Death|7|||
27521157|NCT02551991|80101378|FG002|Overall Study|Death|8|||
27521158|NCT02551991|80101379|FG003|Overall Study|Death|7|||
27521159|NCT02551991|80101380|FG004|Overall Study|Death|17|||
27521160|NCT02551991|80101376|FG000|Overall Study|Withdrawal by Subject|1|||
27521161|NCT02551991|80101377|FG001|Overall Study|Withdrawal by Subject|0|||
27521162|NCT02551991|80101378|FG002|Overall Study|Withdrawal by Subject|0|||
27521163|NCT02551991|80101379|FG003|Overall Study|Withdrawal by Subject|0|||
27521164|NCT02551991|80101380|FG004|Overall Study|Withdrawal by Subject|2|||
27521165|NCT02551991|80101376|FG000|Overall Study|Lost to Follow-up|0|||
27521166|NCT02551991|80101377|FG001|Overall Study|Lost to Follow-up|0|||
27521167|NCT02551991|80101378|FG002|Overall Study|Lost to Follow-up|1|||
27521168|NCT02551991|80101379|FG003|Overall Study|Lost to Follow-up|0|||
27521169|NCT02551991|80101380|FG004|Overall Study|Lost to Follow-up|0|||
27521170|NCT02551991|80101376|FG000|Overall Study|Sponsor Decision|1|||
27521171|NCT02551991|80101377|FG001|Overall Study|Sponsor Decision|0|||
27521172|NCT02551991|80101378|FG002|Overall Study|Sponsor Decision|1|||
27521173|NCT02551991|80101379|FG003|Overall Study|Sponsor Decision|0|||
27521174|NCT02551991|80101380|FG004|Overall Study|Sponsor Decision|5|||
27521175|NCT02551991|80101376|FG000|Overall Study|Other|0|||
27854371|NCT02618408|81298757|FG002|Overall Study|Protocol Violation|2|||
27854372|NCT02618408|81298755|FG000|Overall Study|Other, Multiple Categories|0|||
27854373|NCT02618408|81298756|FG001|Overall Study|Other, Multiple Categories|0|||
27854374|NCT02618408|81298757|FG002|Overall Study|Other, Multiple Categories|4|||
27854375|NCT00424775|81298758|FG000|Overall Study|Adverse Event|2|||
27854376|NCT00424775|81298759|FG001|Overall Study|Adverse Event|0|||
27854377|NCT00424775|81298758|FG000|Overall Study|Lack of Efficacy|1|||
27854378|NCT00424775|81298759|FG001|Overall Study|Lack of Efficacy|0|||
27854379|NCT02981303|81298764|FG000|Overall Study|Progressive Disease|17|||
27854380|NCT02981303|81298765|FG001|Overall Study|Progressive Disease|37|||
27854381|NCT02981303|81298764|FG000|Overall Study|Adverse Event|1|||
27854382|NCT02981303|81298765|FG001|Overall Study|Adverse Event|4|||
27909231|NCT01381926|81506845|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
27909232|NCT01381926|81506846|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
27521176|NCT02551991|80101377|FG001|Overall Study|Other|0|||
27521177|NCT02551991|80101378|FG002|Overall Study|Other|0|||
27521178|NCT02551991|80101379|FG003|Overall Study|Other|0|||
27521179|NCT02551991|80101380|FG004|Overall Study|Other|1|||
27521180|NCT01853839|80101387|FG000|Overall Study|Violated inclusion criteria|2|||
27521181|NCT01853839|80101387|FG000|Overall Study|Not meet ITT population definition|58|||
27854383|NCT02981303|81298764|FG000|Overall Study|Withdrawal by Subject|0|||
27521182|NCT01853839|80101387|FG000|Overall Study|End of treatment visit too early|33|||
27620174|NCT00372567|80453116|FG000|Phase 3 Study|Global deterioration of health status|0|||
27620175|NCT00372567|80453117|FG001|Phase 3 Study|Global deterioration of health status|1|||
27854384|NCT02981303|81298765|FG001|Overall Study|Withdrawal by Subject|1|||
27909233|NCT03335813|81506849|FG000|Overall Study|Withdrawal by Subject|1|||
27909234|NCT00426764|81506853|FG000|Overall Study|Protocol Violation|1|||
27909235|NCT00426764|81506853|FG000|Overall Study|Withdrawal by Subject|4|||
27909236|NCT00426764|81506853|FG000|Overall Study|Physician Decision|6|||
27909237|NCT00426764|81506853|FG000|Overall Study|Compassionate Use|1|||
27909238|NCT00426764|81506853|FG000|Overall Study|Progressive Disease|83|||
27909239|NCT00426764|81506853|FG000|Overall Study|Adverse Event|24|||
27909240|NCT00426764|81506853|FG000|Overall Study|Other|1|||
27909241|NCT00426764|81506853|FG000|Overall Study|Death|1|||
27620176|NCT00372567|80453118|FG002|Phase 3 Study|Global deterioration of health status|0|||
27620177|NCT00372567|80453116|FG000|Phase 3 Study|Other|2|||
27620178|NCT00372567|80453117|FG001|Phase 3 Study|Other|2|||
27620179|NCT00372567|80453118|FG002|Phase 3 Study|Other|1|||
27620180|NCT00372567|80453116|FG000|Phase 3 Study|study terminated by sponsor|13|||
27620181|NCT00372567|80453117|FG001|Phase 3 Study|study terminated by sponsor|8|||
27620182|NCT00372567|80453118|FG002|Phase 3 Study|study terminated by sponsor|5|||
27620183|NCT02950545|80453119|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
27731604|NCT00642642|80842955|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
27731605|NCT01535235|80842960|FG000|Overall Study|Adverse Event|1|||
27731606|NCT01535235|80842961|FG001|Overall Study|Adverse Event|0|||
27731607|NCT02344576|80842962|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
27909242|NCT00426764|81506853|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
27909243|NCT01601496|81506854|FG000|Overall Study|Physician Decision|1|||
27731608|NCT02344576|80842963|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
27731609|NCT02344576|80842964|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
27731610|NCT02344576|80842965|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
27731611|NCT02344576|80842962|FG000|1-Month Follow-Up|Death|13|||
27731612|NCT02344576|80842963|FG001|1-Month Follow-Up|Death|8|||
27731613|NCT02344576|80842964|FG002|1-Month Follow-Up|Death|0|||
27731614|NCT02344576|80842965|FG003|1-Month Follow-Up|Death|0|||
27731615|NCT02344576|80842962|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
27731616|NCT02344576|80842963|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
27731617|NCT02344576|80842964|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
27731618|NCT02344576|80842965|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
27854385|NCT01968694|81298766|FG000|Washout (1 Month)|Lost to Follow-up|0|||
27854386|NCT01968694|81298767|FG001|Washout (1 Month)|Lost to Follow-up|1|||
27854387|NCT02582866|81298770|FG000|Overall Study|Death|1|||
27854388|NCT02582866|81298770|FG000|Overall Study|Lack of Efficacy|2|||
27854389|NCT02582866|81298770|FG000|Overall Study|Lost to Follow-up|2|||
27854390|NCT02582866|81298770|FG000|Overall Study|Withdrawal by Subject|7|||
27854391|NCT02582866|81298770|FG000|Overall Study|Investigator decision|5|||
27854392|NCT02582866|81298770|FG000|Overall Study|Participant wants to get pregnant|1|||
27854393|NCT02582866|81298770|FG000|Overall Study|Pregnancy|2|||
27854394|NCT02582866|81298770|FG000|Overall Study|Sponsor decision|1|||
27854395|NCT02582866|81298770|FG000|Overall Study|Withdrawal due to personal reasons|1|||
27854396|NCT00415194|81298771|FG000|Overall Study|Adverse Event|37|||
27909244|NCT01601496|81506854|FG000|Overall Study|Withdrawal by Subject|1|||
27909245|NCT01601496|81506854|FG000|Overall Study|Lost to Follow-up|6|||
27909246|NCT01601496|81506854|FG000|Overall Study|Death|4|||
27909247|NCT01601496|81506854|FG000|Overall Study|Other: patient refusal to continue|3|||
27521183|NCT01853839|80101387|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
27521184|NCT00796445|80101388|FG000|Overall Study|Protocol Violation|5|||
27521185|NCT00796445|80101389|FG001|Overall Study|Protocol Violation|3|||
27521186|NCT00796445|80101388|FG000|Overall Study|Adverse event, serious fatal|10|||
27521187|NCT00796445|80101389|FG001|Overall Study|Adverse event, serious fatal|5|||
27521188|NCT00796445|80101388|FG000|Overall Study|Adverse event, non-fatal|4|||
27521189|NCT00796445|80101389|FG001|Overall Study|Adverse event, non-fatal|0|||
27521190|NCT00796445|80101388|FG000|Overall Study|Disease progression/recurrence|537|||
27521191|NCT00796445|80101389|FG001|Overall Study|Disease progression/recurrence|268|||
27521192|NCT00796445|80101388|FG000|Overall Study|Other|10|||
27521193|NCT00796445|80101389|FG001|Overall Study|Other|7|||
27521194|NCT00796445|80101388|FG000|Overall Study|Withdrawal by Subject|18|||
27521195|NCT00796445|80101389|FG001|Overall Study|Withdrawal by Subject|9|||
27521196|NCT00796445|80101388|FG000|Overall Study|Invalid Informed Consent Form|1|||
27521197|NCT00796445|80101389|FG001|Overall Study|Invalid Informed Consent Form|0|||
27521198|NCT03472547|80101390|FG000|Overall Study|Withdrawal by Subject|30|||
27521199|NCT00308581|80101391|FG000|Induction Phase|Adverse Event|0|||
27521200|NCT00308581|80101392|FG001|Induction Phase|Adverse Event|0|||
27521201|NCT00308581|80101393|FG002|Induction Phase|Adverse Event|37|||
27521202|NCT00308581|80101391|FG000|Induction Phase|Lack of Efficacy|0|||
27521203|NCT00308581|80101392|FG001|Induction Phase|Lack of Efficacy|0|||
27521204|NCT00308581|80101393|FG002|Induction Phase|Lack of Efficacy|121|||
27521205|NCT00308581|80101391|FG000|Induction Phase|Withdrawal by Subject|0|||
27731619|NCT02344576|80842962|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
27854397|NCT00415194|81298772|FG001|Overall Study|Adverse Event|32|||
27854398|NCT00415194|81298771|FG000|Overall Study|Entry Criteria Not Met|4|||
27909248|NCT01540981|81506857|FG000|Overall Study|Withdrawal by Subject|1|||
27909249|NCT01540981|81506858|FG001|Overall Study|Withdrawal by Subject|0|||
27909250|NCT00656175|81506861|FG000|Overall Study|Adverse Event|1|||
27854399|NCT00415194|81298772|FG001|Overall Study|Entry Criteria Not Met|8|||
27854400|NCT00415194|81298771|FG000|Overall Study|Lost to Follow-up|1|||
27731620|NCT02344576|80842963|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
27731621|NCT02344576|80842964|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
27521206|NCT00308581|80101392|FG001|Induction Phase|Withdrawal by Subject|0|||
27521207|NCT00308581|80101393|FG002|Induction Phase|Withdrawal by Subject|5|||
27521208|NCT00308581|80101391|FG000|Induction Phase|Unknown reason|0|||
27521209|NCT00308581|80101392|FG001|Induction Phase|Unknown reason|0|||
27521210|NCT00308581|80101393|FG002|Induction Phase|Unknown reason|3|||
27521211|NCT00308581|80101391|FG000|Randomized Maintenance Phase|Adverse Event|10|||
27521212|NCT00308581|80101392|FG001|Randomized Maintenance Phase|Adverse Event|17|||
27521213|NCT00308581|80101393|FG002|Randomized Maintenance Phase|Adverse Event|0|||
27521214|NCT00308581|80101391|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
27521215|NCT00308581|80101392|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
27731622|NCT02344576|80842965|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
27731623|NCT02344576|80842962|FG000|6-Month Follow-Up|Death|14|||
27731624|NCT02344576|80842963|FG001|6-Month Follow-Up|Death|14|||
27731625|NCT02344576|80842964|FG002|6-Month Follow-Up|Death|0|||
27731626|NCT02344576|80842965|FG003|6-Month Follow-Up|Death|0|||
27731627|NCT02344576|80842962|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
27731628|NCT02344576|80842963|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
27731629|NCT02344576|80842964|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
27731630|NCT02344576|80842965|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
27731631|NCT02344576|80842962|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
27731632|NCT02344576|80842963|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
27731633|NCT02344576|80842964|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
27731634|NCT02344576|80842965|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
27731635|NCT00254566|80842966|FG000|Overall Study|Death|1|||
27731636|NCT00254566|80842967|FG001|Overall Study|Death|0|||
27731637|NCT00254566|80842966|FG000|Overall Study|Adverse Event|5|||
27854401|NCT00415194|81298772|FG001|Overall Study|Lost to Follow-up|0|||
27854402|NCT00415194|81298771|FG000|Overall Study|Physician Decision|10|||
27854403|NCT00415194|81298772|FG001|Overall Study|Physician Decision|16|||
27854404|NCT00415194|81298771|FG000|Overall Study|Progressive Disease|180|||
27854405|NCT00415194|81298772|FG001|Overall Study|Progressive Disease|217|||
27854406|NCT00415194|81298771|FG000|Overall Study|Protocol Violation|4|||
27854407|NCT00415194|81298772|FG001|Overall Study|Protocol Violation|2|||
27854408|NCT00415194|81298771|FG000|Overall Study|Withdrawal by Subject|28|||
27854409|NCT00415194|81298772|FG001|Overall Study|Withdrawal by Subject|21|||
27854410|NCT00415194|81298771|FG000|Overall Study|Death Due to Study Disease|26|||
27854411|NCT00415194|81298772|FG001|Overall Study|Death Due to Study Disease|29|||
27854412|NCT00415194|81298771|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
27854413|NCT00415194|81298772|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
27854414|NCT00415194|81298771|FG000|Overall Study|Death Due to Procedural Related AE|0|||
27854415|NCT00415194|81298772|FG001|Overall Study|Death Due to Procedural Related AE|1|||
27854416|NCT00415194|81298771|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
27854417|NCT00415194|81298772|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
27854418|NCT00354341|81298773|FG000|Overall Study|Adverse Event|1|||
27854419|NCT00354341|81298774|FG001|Overall Study|Adverse Event|0|||
27854420|NCT00354341|81298773|FG000|Overall Study|Death|0|||
27854421|NCT00354341|81298774|FG001|Overall Study|Death|2|||
27854422|NCT00354341|81298773|FG000|Overall Study|Refused treatment|1|||
27854423|NCT00354341|81298774|FG001|Overall Study|Refused treatment|2|||
27854424|NCT00354341|81298773|FG000|Overall Study|Failure to return|0|||
27854425|NCT00354341|81298774|FG001|Overall Study|Failure to return|1|||
27854426|NCT00354341|81298773|FG000|Overall Study|Other|1|||
27854427|NCT00354341|81298774|FG001|Overall Study|Other|2|||
27854428|NCT02444793|81298775|FG000|Overall Study|Lost to Follow-up|2|||
27854429|NCT02444793|81298776|FG001|Overall Study|Lost to Follow-up|2|||
27854430|NCT02444793|81298777|FG002|Overall Study|Lost to Follow-up|0|||
27854431|NCT02444793|81298778|FG003|Overall Study|Lost to Follow-up|0|||
27854432|NCT02444793|81298775|FG000|Overall Study|Death|0|||
27854433|NCT02444793|81298776|FG001|Overall Study|Death|3|||
27854434|NCT02444793|81298777|FG002|Overall Study|Death|0|||
27854435|NCT02444793|81298778|FG003|Overall Study|Death|0|||
27854436|NCT02444793|81298775|FG000|Overall Study|Other|0|||
27854437|NCT02444793|81298776|FG001|Overall Study|Other|0|||
27521216|NCT00308581|80101393|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
27521217|NCT00308581|80101391|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
27731638|NCT00254566|80842967|FG001|Overall Study|Adverse Event|4|||
27731639|NCT00254566|80842966|FG000|Overall Study|Lack of Efficacy|12|||
27731640|NCT00254566|80842967|FG001|Overall Study|Lack of Efficacy|9|||
27731641|NCT00254566|80842966|FG000|Overall Study|Other|1|||
27731642|NCT00254566|80842967|FG001|Overall Study|Other|5|||
27731643|NCT00254566|80842966|FG000|Overall Study|Withdrawal by Subject|5|||
27854438|NCT02444793|81298777|FG002|Overall Study|Other|2|||
27854439|NCT02444793|81298778|FG003|Overall Study|Other|0|||
27854440|NCT02444793|81298775|FG000|Overall Study|Objective progression or relapse|9|||
27854441|NCT02444793|81298776|FG001|Overall Study|Objective progression or relapse|1|||
27731644|NCT00254566|80842967|FG001|Overall Study|Withdrawal by Subject|6|||
27731645|NCT00254566|80842966|FG000|Overall Study|Lost to Follow-up|7|||
27731646|NCT00254566|80842967|FG001|Overall Study|Lost to Follow-up|2|||
27731647|NCT01075178|80842973|FG000|Subject Matching|eligible but not matched|130|||
27731648|NCT01075178|80842974|FG001|Subject Matching|eligible but not matched|403|||
27731649|NCT01075178|80842973|FG000|Subject Chart Review|died before chart review period|0|||
27731650|NCT01075178|80842974|FG001|Subject Chart Review|died before chart review period|2|||
27731651|NCT01075178|80842973|FG000|Subject Chart Review|no data collected due to site closure|3|||
27731652|NCT01075178|80842974|FG001|Subject Chart Review|no data collected due to site closure|4|||
27731653|NCT01075178|80842973|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
27731654|NCT01075178|80842974|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
27731655|NCT01769105|80842976|FG000|First Intervention|Protocol Violation|2|||
27731656|NCT01769105|80842977|FG001|First Intervention|Protocol Violation|2|||
27731657|NCT01769105|80842976|FG000|Cross-over|Lost to Follow-up|5|||
27731658|NCT01769105|80842977|FG001|Cross-over|Lost to Follow-up|0|||
27731659|NCT01672957|80842980|FG000|Overall Study|Protocol Violation|48|||
27731660|NCT01672957|80842980|FG000|Overall Study|Death|2|||
27731661|NCT01672957|80842980|FG000|Overall Study|ICF Signed After Transplantation|5|||
27731662|NCT02949830|80842981|FG000|Overall Study|Adverse Event|1|||
27731663|NCT02949830|80842981|FG000|Overall Study|Withdrawal by Subject|1|||
27731664|NCT02886702|80842982|FG000|Overall Study|Other|4|||
27731665|NCT02886702|80842983|FG001|Overall Study|Other|3|||
27731666|NCT02886702|80842984|FG002|Overall Study|Other|9|||
27731667|NCT02886702|80842982|FG000|Overall Study|Withdrawal by Subject|24|||
27731668|NCT02886702|80842983|FG001|Overall Study|Withdrawal by Subject|18|||
27731669|NCT02886702|80842984|FG002|Overall Study|Withdrawal by Subject|22|||
27731670|NCT02886702|80842982|FG000|Overall Study|Significant Worsening of Condition|0|||
27731671|NCT02886702|80842983|FG001|Overall Study|Significant Worsening of Condition|1|||
27731672|NCT02886702|80842984|FG002|Overall Study|Significant Worsening of Condition|0|||
27731673|NCT02886702|80842982|FG000|Overall Study|Protocol Violation|2|||
27731674|NCT02886702|80842983|FG001|Overall Study|Protocol Violation|2|||
27731675|NCT02886702|80842984|FG002|Overall Study|Protocol Violation|1|||
27731676|NCT02886702|80842982|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27731677|NCT02886702|80842983|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27731678|NCT02886702|80842984|FG002|Overall Study|Non-Compliance With Study Drug|4|||
27731679|NCT02886702|80842982|FG000|Overall Study|Lost to Follow-up|11|||
27731680|NCT02886702|80842983|FG001|Overall Study|Lost to Follow-up|13|||
27731681|NCT02886702|80842984|FG002|Overall Study|Lost to Follow-up|8|||
27731682|NCT02886702|80842982|FG000|Overall Study|Lack of Efficacy|3|||
27731683|NCT02886702|80842983|FG001|Overall Study|Lack of Efficacy|4|||
27731684|NCT02886702|80842984|FG002|Overall Study|Lack of Efficacy|5|||
27731685|NCT02886702|80842982|FG000|Overall Study|Adverse Event|4|||
27854442|NCT02444793|81298777|FG002|Overall Study|Objective progression or relapse|2|||
27521218|NCT00308581|80101392|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
27521219|NCT00308581|80101393|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
27521220|NCT00308581|80101391|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
27521221|NCT00308581|80101392|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
27521222|NCT00308581|80101393|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
27521223|NCT00308581|80101391|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
27521224|NCT00308581|80101392|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
27521225|NCT00308581|80101393|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
27521226|NCT00308581|80101391|FG000|Randomized Maintenance Phase|Unknown reason|3|||
27521227|NCT00308581|80101392|FG001|Randomized Maintenance Phase|Unknown reason|0|||
27521228|NCT00308581|80101393|FG002|Randomized Maintenance Phase|Unknown reason|0|||
27521229|NCT01075191|80101394|FG000|Overall Study|Death|1|||
27521230|NCT01075191|80101394|FG000|Overall Study|Intensification|3|||
27521231|NCT01075191|80101394|FG000|Overall Study|Co-morbidities|1|||
27521232|NCT01075191|80101394|FG000|Overall Study|Adverse Event|4|||
27521233|NCT01075191|80101394|FG000|Overall Study|Noncompliance|3|||
27521234|NCT01075191|80101394|FG000|Overall Study|Therapy Break|3|||
27521235|NCT01075191|80101394|FG000|Overall Study|Patient's Wish|2|||
27521236|NCT01075191|80101394|FG000|Overall Study|Unknown Reasons|1|||
27731686|NCT02886702|80842983|FG001|Overall Study|Adverse Event|9|||
27731687|NCT02886702|80842984|FG002|Overall Study|Adverse Event|3|||
27854443|NCT02444793|81298778|FG003|Overall Study|Objective progression or relapse|3|||
27854444|NCT01855074|81298779|FG000|Overall Study|Adverse Event|1|||
27521237|NCT04604132|80101395|FG000|Overall Study|Adverse Event|2|||
27521238|NCT04604132|80101396|FG001|Overall Study|Adverse Event|0|||
27521239|NCT04604132|80101397|FG002|Overall Study|Adverse Event|0|||
27521240|NCT04604132|80101398|FG003|Overall Study|Adverse Event|1|||
27731688|NCT02886702|80842982|FG000|Overall Study|Administrative Reasons|0|||
27731689|NCT02886702|80842983|FG001|Overall Study|Administrative Reasons|0|||
27731690|NCT02886702|80842984|FG002|Overall Study|Administrative Reasons|1|||
27731691|NCT01392183|80842986|FG000|First Drug Administration|Adverse Event|3|||
27731692|NCT01392183|80842987|FG001|First Drug Administration|Adverse Event|2|||
27521241|NCT04604132|80101399|FG004|Overall Study|Adverse Event|2|||
27521242|NCT04604132|80101395|FG000|Overall Study|Study terminated by sponsor|0|||
27521243|NCT04604132|80101396|FG001|Overall Study|Study terminated by sponsor|0|||
27521244|NCT04604132|80101397|FG002|Overall Study|Study terminated by sponsor|0|||
27521245|NCT04604132|80101398|FG003|Overall Study|Study terminated by sponsor|0|||
27521246|NCT04604132|80101399|FG004|Overall Study|Study terminated by sponsor|1|||
27521247|NCT04604132|80101395|FG000|Overall Study|Progressive disease: Clinical progression|0|||
27521248|NCT04604132|80101396|FG001|Overall Study|Progressive disease: Clinical progression|0|||
27521249|NCT04604132|80101397|FG002|Overall Study|Progressive disease: Clinical progression|1|||
27521250|NCT04604132|80101398|FG003|Overall Study|Progressive disease: Clinical progression|0|||
27521251|NCT04604132|80101399|FG004|Overall Study|Progressive disease: Clinical progression|0|||
27521252|NCT04604132|80101395|FG000|Overall Study|Progressive disease: Radiological progression|8|||
27521253|NCT04604132|80101396|FG001|Overall Study|Progressive disease: Radiological progression|7|||
27521254|NCT04604132|80101397|FG002|Overall Study|Progressive disease: Radiological progression|10|||
27521255|NCT04604132|80101398|FG003|Overall Study|Progressive disease: Radiological progression|4|||
27521256|NCT04604132|80101399|FG004|Overall Study|Progressive disease: Radiological progression|3|||
27521257|NCT04604132|80101395|FG000|Overall Study|Death|3|||
27521258|NCT04604132|80101396|FG001|Overall Study|Death|1|||
27521259|NCT04604132|80101397|FG002|Overall Study|Death|2|||
27521260|NCT04604132|80101398|FG003|Overall Study|Death|1|||
27521261|NCT04604132|80101399|FG004|Overall Study|Death|0|||
27521262|NCT03700684|80101402|FG000|Overall Study|COVID-19|0|||
27521263|NCT03700684|80101403|FG001|Overall Study|COVID-19|0|||
27521264|NCT03700684|80101404|FG002|Overall Study|COVID-19|2|||
27521265|NCT02015221|80101405|FG000|Overall Study|Withdrawal by Subject|8|||
27521266|NCT02015221|80101406|FG001|Overall Study|Withdrawal by Subject|6|||
27521267|NCT02015221|80101405|FG000|Overall Study|Lost to Follow-up|1|||
27521268|NCT02015221|80101406|FG001|Overall Study|Lost to Follow-up|0|||
27521269|NCT00523367|80101407|FG000|Overall Study|19 screen failures|19|||
27521270|NCT00523367|80101407|FG000|Overall Study|4 Withdrawn by PI|4|||
27521271|NCT02785770|80101408|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
27521272|NCT02785770|80101409|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
27521273|NCT02785770|80101410|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
27521274|NCT02785770|80101411|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
27521275|NCT02785770|80101408|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
27521276|NCT02785770|80101409|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
27521277|NCT02785770|80101410|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
27521278|NCT02785770|80101411|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
27521279|NCT02785770|80101408|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
27521280|NCT02785770|80101409|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
27521281|NCT02785770|80101410|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
27521282|NCT02785770|80101411|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
27521283|NCT02431260|80101415|FG000|Overall Study|Subject Decision|0|||
27521284|NCT02431260|80101416|FG001|Overall Study|Subject Decision|1|||
27521285|NCT02431260|80101417|FG002|Overall Study|Subject Decision|1|||
27521286|NCT02431260|80101418|FG003|Overall Study|Subject Decision|0|||
27521287|NCT02431260|80101419|FG004|Overall Study|Subject Decision|0|||
27521288|NCT02431260|80101420|FG005|Overall Study|Subject Decision|0|||
27521289|NCT02431260|80101421|FG006|Overall Study|Subject Decision|0|||
27521290|NCT02431260|80101422|FG007|Overall Study|Subject Decision|0|||
27521291|NCT02431260|80101423|FG008|Overall Study|Subject Decision|1|||
27521292|NCT02431260|80101424|FG009|Overall Study|Subject Decision|1|||
27521293|NCT02431260|80101425|FG010|Overall Study|Subject Decision|0|||
27521294|NCT02431260|80101426|FG011|Overall Study|Subject Decision|1|||
27521295|NCT02431260|80101427|FG012|Overall Study|Subject Decision|0|||
27521296|NCT02431260|80101428|FG013|Overall Study|Subject Decision|0|||
27521297|NCT02431260|80101415|FG000|Overall Study|Death|4|||
27521298|NCT02431260|80101416|FG001|Overall Study|Death|4|||
27521299|NCT02431260|80101417|FG002|Overall Study|Death|3|||
27521300|NCT02431260|80101418|FG003|Overall Study|Death|4|||
27521301|NCT02431260|80101419|FG004|Overall Study|Death|2|||
27521302|NCT02431260|80101420|FG005|Overall Study|Death|2|||
27521303|NCT02431260|80101421|FG006|Overall Study|Death|3|||
27521304|NCT02431260|80101422|FG007|Overall Study|Death|1|||
27521305|NCT02431260|80101423|FG008|Overall Study|Death|6|||
27521306|NCT02431260|80101424|FG009|Overall Study|Death|6|||
27521307|NCT02431260|80101425|FG010|Overall Study|Death|3|||
27521308|NCT02431260|80101426|FG011|Overall Study|Death|2|||
27521309|NCT02431260|80101427|FG012|Overall Study|Death|5|||
27521310|NCT02431260|80101428|FG013|Overall Study|Death|1|||
27521311|NCT02431260|80101415|FG000|Overall Study|Lost to Follow-up|0|||
27521312|NCT02431260|80101416|FG001|Overall Study|Lost to Follow-up|0|||
27521313|NCT02431260|80101417|FG002|Overall Study|Lost to Follow-up|0|||
27521314|NCT02431260|80101418|FG003|Overall Study|Lost to Follow-up|0|||
27521315|NCT02431260|80101419|FG004|Overall Study|Lost to Follow-up|0|||
27521316|NCT02431260|80101420|FG005|Overall Study|Lost to Follow-up|1|||
27521317|NCT02431260|80101421|FG006|Overall Study|Lost to Follow-up|0|||
27620184|NCT02950545|80453120|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
27620185|NCT02950545|80453121|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
27620186|NCT02950545|80453122|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
27620187|NCT02950545|80453123|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
27620188|NCT02950545|80453124|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
27620189|NCT02950545|80453119|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
27620190|NCT02950545|80453120|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
27620191|NCT02950545|80453121|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
27620192|NCT02950545|80453122|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
27620193|NCT02950545|80453123|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
27620194|NCT02950545|80453124|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
27620195|NCT02950545|80453119|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
27620196|NCT02950545|80453120|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
27620197|NCT02950545|80453121|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
27854445|NCT01855074|81298779|FG000|Overall Study|Lost to Follow-up|4|||
27854446|NCT01855074|81298779|FG000|Overall Study|Withdrawal by Subject|8|||
27854447|NCT01855074|81298779|FG000|Overall Study|Started but not treated|1|||
27854448|NCT02500641|81298780|FG000|Overall Study|Adverse Event|0|||
27854449|NCT02500641|81298781|FG001|Overall Study|Adverse Event|2|||
27854450|NCT02500641|81298780|FG000|Overall Study|Withdrawal by Subject|4|||
27854451|NCT02500641|81298781|FG001|Overall Study|Withdrawal by Subject|5|||
27854452|NCT02500641|81298780|FG000|Overall Study|Unable to follow study procedures|3|||
27521318|NCT02431260|80101422|FG007|Overall Study|Lost to Follow-up|0|||
27521319|NCT02431260|80101423|FG008|Overall Study|Lost to Follow-up|0|||
27521320|NCT02431260|80101424|FG009|Overall Study|Lost to Follow-up|0|||
27521321|NCT02431260|80101425|FG010|Overall Study|Lost to Follow-up|0|||
27521322|NCT02431260|80101426|FG011|Overall Study|Lost to Follow-up|0|||
27521323|NCT02431260|80101427|FG012|Overall Study|Lost to Follow-up|0|||
27521324|NCT02431260|80101428|FG013|Overall Study|Lost to Follow-up|0|||
27521325|NCT02431260|80101415|FG000|Overall Study|Study Terminated by the Sponsor|0|||
27521326|NCT02431260|80101416|FG001|Overall Study|Study Terminated by the Sponsor|0|||
27521327|NCT02431260|80101417|FG002|Overall Study|Study Terminated by the Sponsor|2|||
27521328|NCT02431260|80101418|FG003|Overall Study|Study Terminated by the Sponsor|1|||
27521329|NCT02431260|80101419|FG004|Overall Study|Study Terminated by the Sponsor|1|||
27521330|NCT02431260|80101420|FG005|Overall Study|Study Terminated by the Sponsor|0|||
27521331|NCT02431260|80101421|FG006|Overall Study|Study Terminated by the Sponsor|1|||
27521332|NCT02431260|80101422|FG007|Overall Study|Study Terminated by the Sponsor|2|||
27521333|NCT02431260|80101423|FG008|Overall Study|Study Terminated by the Sponsor|1|||
27521334|NCT02431260|80101424|FG009|Overall Study|Study Terminated by the Sponsor|1|||
27620198|NCT02950545|80453122|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
27620199|NCT02950545|80453123|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
27620200|NCT02950545|80453124|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
27620201|NCT02950545|80453119|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
27620202|NCT02950545|80453120|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
27521335|NCT02431260|80101425|FG010|Overall Study|Study Terminated by the Sponsor|1|||
27620203|NCT02950545|80453121|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
27620204|NCT02950545|80453122|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
27620205|NCT02950545|80453123|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
27620206|NCT02950545|80453124|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
27854453|NCT02500641|81298781|FG001|Overall Study|Unable to follow study procedures|2|||
27854454|NCT02500641|81298780|FG000|Overall Study|Protocol Violation|1|||
27909251|NCT00656175|81506862|FG001|Overall Study|Adverse Event|0|||
27521336|NCT02431260|80101426|FG011|Overall Study|Study Terminated by the Sponsor|0|||
27521337|NCT02431260|80101427|FG012|Overall Study|Study Terminated by the Sponsor|4|||
27521338|NCT02431260|80101428|FG013|Overall Study|Study Terminated by the Sponsor|0|||
27521339|NCT02431260|80101415|FG000|Overall Study|Physician Decision|0|||
27521340|NCT02431260|80101416|FG001|Overall Study|Physician Decision|0|||
27521341|NCT02431260|80101417|FG002|Overall Study|Physician Decision|0|||
27521342|NCT02431260|80101418|FG003|Overall Study|Physician Decision|0|||
27521343|NCT02431260|80101419|FG004|Overall Study|Physician Decision|0|||
27521344|NCT02431260|80101420|FG005|Overall Study|Physician Decision|1|||
27521345|NCT02431260|80101421|FG006|Overall Study|Physician Decision|0|||
27521346|NCT02431260|80101422|FG007|Overall Study|Physician Decision|0|||
27521347|NCT02431260|80101423|FG008|Overall Study|Physician Decision|0|||
27521348|NCT02431260|80101424|FG009|Overall Study|Physician Decision|0|||
27521349|NCT02431260|80101425|FG010|Overall Study|Physician Decision|0|||
27521350|NCT02431260|80101426|FG011|Overall Study|Physician Decision|0|||
27521351|NCT02431260|80101427|FG012|Overall Study|Physician Decision|0|||
27521352|NCT02431260|80101428|FG013|Overall Study|Physician Decision|0|||
27620207|NCT02950545|80453119|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
27620208|NCT02950545|80453120|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
27521353|NCT02431260|80101415|FG000|Overall Study|Other Unspecified|0|||
27854455|NCT02500641|81298781|FG001|Overall Study|Protocol Violation|2|||
27521354|NCT02431260|80101416|FG001|Overall Study|Other Unspecified|0|||
27521355|NCT02431260|80101417|FG002|Overall Study|Other Unspecified|0|||
27521356|NCT02431260|80101418|FG003|Overall Study|Other Unspecified|0|||
27521357|NCT02431260|80101419|FG004|Overall Study|Other Unspecified|0|||
27521358|NCT02431260|80101420|FG005|Overall Study|Other Unspecified|0|||
27521359|NCT02431260|80101421|FG006|Overall Study|Other Unspecified|0|||
27521360|NCT02431260|80101422|FG007|Overall Study|Other Unspecified|0|||
27521361|NCT02431260|80101423|FG008|Overall Study|Other Unspecified|0|||
27521362|NCT02431260|80101424|FG009|Overall Study|Other Unspecified|0|||
27521363|NCT02431260|80101425|FG010|Overall Study|Other Unspecified|0|||
27521364|NCT02431260|80101426|FG011|Overall Study|Other Unspecified|1|||
27521365|NCT02431260|80101427|FG012|Overall Study|Other Unspecified|1|||
27521366|NCT02431260|80101428|FG013|Overall Study|Other Unspecified|0|||
27521367|NCT01256190|80101429|FG000|Overall Study|Lost to Follow-up|2|||
27521368|NCT01256190|80101430|FG001|Overall Study|Lost to Follow-up|0|||
27521369|NCT03499964|80101440|FG000|Overall Study|Lack of Efficacy|6|||
27521370|NCT03499964|80101441|FG001|Overall Study|Lack of Efficacy|26|||
27521371|NCT03499964|80101440|FG000|Overall Study|Adverse Event|1|||
27521372|NCT03499964|80101441|FG001|Overall Study|Adverse Event|0|||
27521373|NCT03499964|80101440|FG000|Overall Study|Death|1|||
27521374|NCT03499964|80101441|FG001|Overall Study|Death|0|||
27521375|NCT03499964|80101440|FG000|Overall Study|Withdrawal by Subject|2|||
27521376|NCT03499964|80101441|FG001|Overall Study|Withdrawal by Subject|1|||
27521377|NCT03499964|80101440|FG000|Overall Study|Lost to Follow-up|1|||
27521378|NCT03499964|80101441|FG001|Overall Study|Lost to Follow-up|0|||
27521379|NCT01253811|80101447|FG000|Overall Study|Withdrawal criteria|1|||
27521380|NCT01561898|80101448|FG000|Overall Study|Withdrawal by Subject|0|||
27521381|NCT01561898|80101449|FG001|Overall Study|Withdrawal by Subject|8|||
27521382|NCT01561898|80101450|FG002|Overall Study|Withdrawal by Subject|12|||
27521383|NCT01561898|80101451|FG003|Overall Study|Withdrawal by Subject|5|||
27521384|NCT01561898|80101448|FG000|Overall Study|Lack of Efficacy|0|||
27521385|NCT01561898|80101449|FG001|Overall Study|Lack of Efficacy|8|||
27521386|NCT01561898|80101450|FG002|Overall Study|Lack of Efficacy|10|||
27521387|NCT01561898|80101451|FG003|Overall Study|Lack of Efficacy|5|||
27521388|NCT01561898|80101448|FG000|Overall Study|Worsening of complications|0|||
27521389|NCT01561898|80101449|FG001|Overall Study|Worsening of complications|1|||
27521390|NCT01561898|80101450|FG002|Overall Study|Worsening of complications|0|||
27521391|NCT01561898|80101451|FG003|Overall Study|Worsening of complications|0|||
27521392|NCT01561898|80101448|FG000|Overall Study|Lost to Follow-up|0|||
27521393|NCT01561898|80101449|FG001|Overall Study|Lost to Follow-up|0|||
27521394|NCT01561898|80101450|FG002|Overall Study|Lost to Follow-up|1|||
27521395|NCT01561898|80101451|FG003|Overall Study|Lost to Follow-up|0|||
27521396|NCT01561898|80101448|FG000|Overall Study|Adverse Event|1|||
27521397|NCT01561898|80101449|FG001|Overall Study|Adverse Event|19|||
27521398|NCT01561898|80101450|FG002|Overall Study|Adverse Event|14|||
27521399|NCT01561898|80101451|FG003|Overall Study|Adverse Event|9|||
27521400|NCT01561898|80101448|FG000|Overall Study|Physician Decision|1|||
27521401|NCT01561898|80101449|FG001|Overall Study|Physician Decision|5|||
27521402|NCT01561898|80101450|FG002|Overall Study|Physician Decision|7|||
27521403|NCT01561898|80101451|FG003|Overall Study|Physician Decision|1|||
27521404|NCT00393510|80101452|FG000|Overall Study|Physician Decision|3|||
27521405|NCT00393510|80101453|FG001|Overall Study|Physician Decision|9|||
27521406|NCT05315908|80101456|FG000|Overall Study|Lost to Follow-up|4477|||
27521407|NCT05315908|80101457|FG001|Overall Study|Lost to Follow-up|4606|||
27521408|NCT01037088|80101458|FG000|Overall Study|Withdrawal by Subject|3|||
27521409|NCT00422084|80101459|FG000|Overall Study|Adverse Event|21|||
27854456|NCT02500641|81298780|FG000|Overall Study|Lost to Follow-up|1|||
27854457|NCT02500641|81298781|FG001|Overall Study|Lost to Follow-up|0|||
27854458|NCT02500641|81298780|FG000|Overall Study|Sponsor decision|1|||
27854459|NCT02500641|81298781|FG001|Overall Study|Sponsor decision|0|||
27731693|NCT01392183|80842986|FG000|First Drug Administration|Death|1|||
27854460|NCT02500641|81298780|FG000|Overall Study|Non compliance to study drug|0|||
27854461|NCT02500641|81298781|FG001|Overall Study|Non compliance to study drug|1|||
27854462|NCT00548093|81298782|FG000|Overall Study|Death|33|||
27854463|NCT00548093|81298783|FG001|Overall Study|Death|13|||
27854464|NCT00548093|81298782|FG000|Overall Study|Lost to Follow-up|3|||
27854465|NCT00548093|81298783|FG001|Overall Study|Lost to Follow-up|1|||
27854466|NCT00548093|81298782|FG000|Overall Study|Objective progression or relapse|1|||
27854467|NCT00548093|81298783|FG001|Overall Study|Objective progression or relapse|1|||
27854468|NCT00548093|81298782|FG000|Overall Study|Other|11|||
27854469|NCT00548093|81298783|FG001|Overall Study|Other|1|||
27854470|NCT00548093|81298782|FG000|Overall Study|Withdrawal by Subject|1|||
27854471|NCT00548093|81298783|FG001|Overall Study|Withdrawal by Subject|0|||
27854472|NCT00548093|81298782|FG000|Overall Study|Completed post-treatment follow-up|1|||
27854473|NCT00548093|81298783|FG001|Overall Study|Completed post-treatment follow-up|0|||
27854474|NCT01859130|81298784|FG000|Overall Study|Death|4|||
27854475|NCT01859130|81298784|FG000|Overall Study|Lost to Follow-up|16|||
27521410|NCT00422084|80101460|FG001|Overall Study|Adverse Event|7|||
27521411|NCT00422084|80101459|FG000|Overall Study|Withdrawal by Subject|12|||
27521412|NCT00422084|80101460|FG001|Overall Study|Withdrawal by Subject|9|||
27854476|NCT01859130|81298784|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
27854477|NCT01859130|81298784|FG000|Overall Study|Physician Decision|6|||
27854478|NCT01859130|81298784|FG000|Overall Study|Withdrawal by Subject|17|||
27854479|NCT01859130|81298784|FG000|Overall Study|Adverse Event|11|||
27854480|NCT00826449|81298786|FG000|Overall Study|Disease Progression|4|||
27854481|NCT00826449|81298786|FG000|Overall Study|Withdrawal by Subject|1|||
27854482|NCT03123861|81298787|FG000|Overall Study|Protocol Violation|1|||
27854483|NCT03123861|81298788|FG001|Overall Study|Protocol Violation|1|||
27854484|NCT03123861|81298787|FG000|Overall Study|Withdrawal by Subject|2|||
27854485|NCT03123861|81298788|FG001|Overall Study|Withdrawal by Subject|2|||
27854486|NCT01150890|81298789|FG000|Overall Study|Other|0|||
27854487|NCT01150890|81298790|FG001|Overall Study|Other|1|||
27854488|NCT01150890|81298791|FG002|Overall Study|Other|0|||
27854489|NCT01150890|81298792|FG003|Overall Study|Other|2|||
27620209|NCT02950545|80453121|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
27620210|NCT02950545|80453122|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
27620211|NCT02950545|80453123|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
27620212|NCT02950545|80453124|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
27620213|NCT02886936|80453125|FG000|Overall Study|Lost to Follow-up|4|||
27620214|NCT02886936|80453126|FG001|Overall Study|Lost to Follow-up|3|||
27620215|NCT02886936|80453127|FG002|Overall Study|Lost to Follow-up|0|||
27620216|NCT01880515|80453128|FG000|Overall Study|Lost to Follow-up|3|||
27620217|NCT01880515|80453129|FG001|Overall Study|Lost to Follow-up|2|||
27620218|NCT01880515|80453128|FG000|Overall Study|Disease Progression|5|||
27731694|NCT01392183|80842987|FG001|First Drug Administration|Death|0|||
27731695|NCT01392183|80842986|FG000|First Drug Administration|Withdrawal by Subject|10|||
27731696|NCT01392183|80842987|FG001|First Drug Administration|Withdrawal by Subject|17|||
27731697|NCT01285349|80842988|FG000|Overall Study|Lost to Follow-up|27|||
27854490|NCT01150890|81298789|FG000|Overall Study|Pregnancy|0|||
27854491|NCT01150890|81298790|FG001|Overall Study|Pregnancy|0|||
27854492|NCT01150890|81298791|FG002|Overall Study|Pregnancy|0|||
27854493|NCT01150890|81298792|FG003|Overall Study|Pregnancy|1|||
27854494|NCT01150890|81298789|FG000|Overall Study|Administrative Decision|4|||
27854495|NCT01150890|81298790|FG001|Overall Study|Administrative Decision|4|||
27854496|NCT01150890|81298791|FG002|Overall Study|Administrative Decision|5|||
27854497|NCT01150890|81298792|FG003|Overall Study|Administrative Decision|6|||
27854498|NCT01150890|81298789|FG000|Overall Study|Ineligibility determined|0|||
27854499|NCT01150890|81298790|FG001|Overall Study|Ineligibility determined|1|||
27854500|NCT01150890|81298791|FG002|Overall Study|Ineligibility determined|0|||
27854501|NCT01150890|81298792|FG003|Overall Study|Ineligibility determined|0|||
27854502|NCT01150890|81298789|FG000|Overall Study|Adverse Event|0|||
27854503|NCT01150890|81298790|FG001|Overall Study|Adverse Event|0|||
27854504|NCT01150890|81298791|FG002|Overall Study|Adverse Event|2|||
27854505|NCT01150890|81298792|FG003|Overall Study|Adverse Event|0|||
27854506|NCT01150890|81298789|FG000|Overall Study|Withdrawal by Subject|0|||
27854507|NCT01150890|81298790|FG001|Overall Study|Withdrawal by Subject|0|||
27854508|NCT01150890|81298791|FG002|Overall Study|Withdrawal by Subject|2|||
27854509|NCT01150890|81298792|FG003|Overall Study|Withdrawal by Subject|1|||
27854510|NCT01150890|81298789|FG000|Overall Study|Disease progression|0|||
27854511|NCT01150890|81298790|FG001|Overall Study|Disease progression|7|||
27854512|NCT01150890|81298791|FG002|Overall Study|Disease progression|3|||
27854513|NCT01150890|81298792|FG003|Overall Study|Disease progression|7|||
27854514|NCT00418821|81298796|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
27909252|NCT00656175|81506861|FG000|Overall Study|Transportation issues|0|||
27620219|NCT01880515|80453129|FG001|Overall Study|Disease Progression|7|||
27620220|NCT00983619|80453133|FG000|Overall Study|Lost to Follow-up|0|||
27620221|NCT00983619|80453134|FG001|Overall Study|Lost to Follow-up|1|||
27620222|NCT00983619|80453135|FG002|Overall Study|Lost to Follow-up|0|||
27620223|NCT00983619|80453136|FG003|Overall Study|Lost to Follow-up|0|||
27731698|NCT01285349|80842989|FG001|Overall Study|Lost to Follow-up|20|||
27731699|NCT01285349|80842990|FG002|Overall Study|Lost to Follow-up|27|||
27731700|NCT01961115|80842991|FG000|Overall Study|Disease Progression|1|||
27731701|NCT01961115|80842992|FG001|Overall Study|Disease Progression|0|||
27731702|NCT01961115|80842993|FG002|Overall Study|Disease Progression|3|||
27731703|NCT01961115|80842991|FG000|Overall Study|Adverse Event|1|||
27731704|NCT01961115|80842992|FG001|Overall Study|Adverse Event|0|||
27731705|NCT01961115|80842993|FG002|Overall Study|Adverse Event|1|||
27731706|NCT02304926|80842994|FG000|Overall Study|Lost to Follow-up|2|||
27731707|NCT02304926|80842995|FG001|Overall Study|Lost to Follow-up|1|||
27731708|NCT01993888|80842996|FG000|Overall Study|Death|1|||
27731709|NCT01993888|80842997|FG001|Overall Study|Death|1|||
27731710|NCT01993888|80842996|FG000|Overall Study|Lost to Follow-up|1|||
27731711|NCT01993888|80842997|FG001|Overall Study|Lost to Follow-up|1|||
27731712|NCT01993888|80842996|FG000|Overall Study|Withdrawal by Subject|0|||
27731713|NCT01993888|80842997|FG001|Overall Study|Withdrawal by Subject|1|||
27731714|NCT00808444|80842998|FG000|Overall Study|Withdrawal by Subject|1|||
27731715|NCT00808444|80842999|FG001|Overall Study|Withdrawal by Subject|0|||
27731716|NCT00808444|80842998|FG000|Overall Study|Lost to Follow-up|0|||
27731717|NCT00808444|80842999|FG001|Overall Study|Lost to Follow-up|1|||
27620224|NCT00983619|80453137|FG004|Overall Study|Lost to Follow-up|0|||
27620225|NCT00983619|80453138|FG005|Overall Study|Lost to Follow-up|2|||
27620226|NCT00983619|80453139|FG006|Overall Study|Lost to Follow-up|0|||
27620227|NCT00983619|80453140|FG007|Overall Study|Lost to Follow-up|0|||
27620228|NCT00983619|80453141|FG008|Overall Study|Lost to Follow-up|0|||
27620229|NCT00983619|80453142|FG009|Overall Study|Lost to Follow-up|0|||
27620230|NCT00983619|80453143|FG010|Overall Study|Lost to Follow-up|0|||
27620231|NCT00983619|80453144|FG011|Overall Study|Lost to Follow-up|2|||
27620232|NCT00983619|80453133|FG000|Overall Study|Withdrawal by Subject|2|||
27620233|NCT00983619|80453134|FG001|Overall Study|Withdrawal by Subject|1|||
27620234|NCT00983619|80453135|FG002|Overall Study|Withdrawal by Subject|1|||
27620235|NCT00983619|80453136|FG003|Overall Study|Withdrawal by Subject|3|||
27620236|NCT00983619|80453137|FG004|Overall Study|Withdrawal by Subject|1|||
27620237|NCT00983619|80453138|FG005|Overall Study|Withdrawal by Subject|23|||
27620238|NCT00983619|80453139|FG006|Overall Study|Withdrawal by Subject|0|||
27620239|NCT00983619|80453140|FG007|Overall Study|Withdrawal by Subject|0|||
27620240|NCT00983619|80453141|FG008|Overall Study|Withdrawal by Subject|0|||
27620241|NCT00983619|80453142|FG009|Overall Study|Withdrawal by Subject|0|||
27620242|NCT00983619|80453143|FG010|Overall Study|Withdrawal by Subject|1|||
27620243|NCT00983619|80453144|FG011|Overall Study|Withdrawal by Subject|1|||
27620244|NCT00983619|80453133|FG000|Overall Study|Death|0|||
27620245|NCT00983619|80453134|FG001|Overall Study|Death|2|||
27620246|NCT00983619|80453135|FG002|Overall Study|Death|2|||
27620247|NCT00983619|80453136|FG003|Overall Study|Death|1|||
27620248|NCT00983619|80453137|FG004|Overall Study|Death|2|||
27854515|NCT02575911|81298798|FG000|Overall Study|Lost to Follow-up|1|||
27521413|NCT00422084|80101459|FG000|Overall Study|Lost to Follow-up|14|||
27521414|NCT00422084|80101460|FG001|Overall Study|Lost to Follow-up|9|||
27521415|NCT00422084|80101459|FG000|Overall Study|Protocol Violation|4|||
27521416|NCT00422084|80101460|FG001|Overall Study|Protocol Violation|1|||
27521417|NCT00422084|80101459|FG000|Overall Study|Lack of Efficacy|40|||
27521418|NCT00422084|80101460|FG001|Overall Study|Lack of Efficacy|42|||
27521419|NCT00422084|80101459|FG000|Overall Study|P. vivax infection|3|||
27909253|NCT00656175|81506862|FG001|Overall Study|Transportation issues|1|||
27909254|NCT01051557|81506863|FG000|Overall Study|Physician Decision|1|||
27909255|NCT01051557|81506864|FG001|Overall Study|Physician Decision|0|||
27909256|NCT01051557|81506865|FG002|Overall Study|Physician Decision|0|||
27909257|NCT01051557|81506866|FG003|Overall Study|Physician Decision|0|||
27909258|NCT01051557|81506867|FG004|Overall Study|Physician Decision|0|||
27521420|NCT00422084|80101460|FG001|Overall Study|P. vivax infection|6|||
27521421|NCT00422084|80101459|FG000|Overall Study|Cyesis|1|||
27521422|NCT00422084|80101460|FG001|Overall Study|Cyesis|0|||
27521423|NCT00422084|80101459|FG000|Overall Study|Withdrawn from study accidentally|1|||
27521424|NCT00422084|80101460|FG001|Overall Study|Withdrawn from study accidentally|0|||
27521425|NCT00422084|80101459|FG000|Overall Study|Non-compliance|1|||
27521426|NCT00422084|80101460|FG001|Overall Study|Non-compliance|0|||
27521427|NCT00422084|80101459|FG000|Overall Study|Re-location|0|||
27620249|NCT00983619|80453138|FG005|Overall Study|Death|30|||
27620250|NCT00983619|80453139|FG006|Overall Study|Death|1|||
27620251|NCT00983619|80453140|FG007|Overall Study|Death|0|||
27620252|NCT00983619|80453141|FG008|Overall Study|Death|1|||
27620253|NCT00983619|80453142|FG009|Overall Study|Death|2|||
27620254|NCT00983619|80453143|FG010|Overall Study|Death|9|||
27620255|NCT00983619|80453144|FG011|Overall Study|Death|8|||
27620256|NCT00983619|80453133|FG000|Overall Study|Other|1|||
27620257|NCT00983619|80453134|FG001|Overall Study|Other|0|||
27620258|NCT00983619|80453135|FG002|Overall Study|Other|0|||
27620259|NCT00983619|80453136|FG003|Overall Study|Other|1|||
27620260|NCT00983619|80453137|FG004|Overall Study|Other|0|||
27620261|NCT00983619|80453138|FG005|Overall Study|Other|12|||
27620262|NCT00983619|80453139|FG006|Overall Study|Other|2|||
27620263|NCT00983619|80453140|FG007|Overall Study|Other|2|||
27620264|NCT00983619|80453141|FG008|Overall Study|Other|0|||
27521428|NCT00422084|80101460|FG001|Overall Study|Re-location|1|||
27521429|NCT00422084|80101459|FG000|Overall Study|Not defined|1|||
27521430|NCT00422084|80101460|FG001|Overall Study|Not defined|1|||
27620265|NCT00983619|80453142|FG009|Overall Study|Other|1|||
27909259|NCT01051557|81506868|FG005|Overall Study|Physician Decision|0|||
27620266|NCT00983619|80453143|FG010|Overall Study|Other|1|||
27620267|NCT00983619|80453144|FG011|Overall Study|Other|0|||
27620268|NCT00322868|80453145|FG000|Overall Study|disease progression|1|||
27620269|NCT01853254|80453146|FG000|Overall Study|Abnormal Laboratory Test|1|||
27620270|NCT01853254|80453146|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
27620271|NCT01853254|80453146|FG000|Overall Study|Death|1|||
27909260|NCT01051557|81506869|FG006|Overall Study|Physician Decision|0|||
27521431|NCT01806662|80101466|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
27521432|NCT01806662|80101467|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
27620272|NCT01853254|80453146|FG000|Overall Study|Failure to Return|43|||
27620273|NCT01853254|80453146|FG000|Overall Study|Insufficient Therapeutic Response|22|||
27620274|NCT01853254|80453146|FG000|Overall Study|Refusal of Treatment|1|||
27620275|NCT01853254|80453146|FG000|Overall Study|Other Protocol Violation|1|||
27620276|NCT01853254|80453146|FG000|Overall Study|Withdrawal of Consent|16|||
27620277|NCT01853254|80453146|FG000|Overall Study|Administrative/Other|16|||
27620278|NCT01115998|80453147|FG000|Overall Study|Lost to Follow-up|6|||
27620279|NCT01115998|80453148|FG001|Overall Study|Lost to Follow-up|6|||
27620280|NCT03606460|80453149|FG000|Overall Study|Lost to Follow-up|1|||
27620281|NCT03606460|80453150|FG001|Overall Study|Lost to Follow-up|8|||
27620282|NCT00765362|80453151|FG000|Overall Study|Death|9|||
27620283|NCT00765362|80453151|FG000|Overall Study|Adverse Event|2|||
27620284|NCT00765362|80453151|FG000|Overall Study|Protocol Violation|18|||
27620285|NCT00765362|80453151|FG000|Overall Study|Withdrawal by Subject|13|||
27620286|NCT00765362|80453151|FG000|Overall Study|Lost to Follow-up|95|||
27620287|NCT01333943|80453152|FG000|Overall Study|Known neuropathy|1|||
27620288|NCT01333943|80453153|FG001|Overall Study|Known neuropathy|0|||
27521433|NCT01806662|80101466|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
27521434|NCT01806662|80101467|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
27521435|NCT01806662|80101466|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
27909261|NCT01051557|81506863|FG000|Overall Study|disease progression|3|||
27909262|NCT01051557|81506864|FG001|Overall Study|disease progression|3|||
27620289|NCT01925170|80453154|FG000|Overall Study|Unverified cancer status|53|||
27620290|NCT01770860|80453157|FG000|Overall Study|Withdrawal by Subject|4|||
27620291|NCT01770860|80453157|FG000|Overall Study|Lost to Follow-up|1|||
27620292|NCT01770860|80453157|FG000|Overall Study|Administrative decision made by the PI|1|||
27620293|NCT00654940|80453158|FG000|Period 1|Adverse Event|0|||
27620294|NCT00654940|80453159|FG001|Period 1|Adverse Event|1|||
27620295|NCT00654940|80453158|FG000|Period 1|Intolerable Pain Level|1|||
27620296|NCT00654940|80453159|FG001|Period 1|Intolerable Pain Level|0|||
27620297|NCT03523871|80453160|FG000|Overall Study|Death|1|||
27620298|NCT04822298|80453161|FG000|Overall Study|Death|3|||
27620299|NCT02956967|80453162|FG000|Overall Study|Adverse Event|3|||
27620300|NCT02956967|80453162|FG000|Overall Study|Reason non-related to neutropenia|10|||
27620301|NCT02956967|80453162|FG000|Overall Study|Lost to Follow-up|5|||
27620302|NCT02956967|80453162|FG000|Overall Study|Missing|1|||
27620303|NCT02956967|80453162|FG000|Overall Study|Termination of Nivestim administration|29|||
27620304|NCT01561079|80453163|FG000|Overall Study|Physician Decision|17|||
27620305|NCT01561079|80453163|FG000|Overall Study|Withdrawal by Subject|59|||
27620306|NCT01561079|80453163|FG000|Overall Study|Protocol Violation|2|||
27620307|NCT00924664|80453164|FG000|Overall Study|Adverse Event|23|||
27620308|NCT00924664|80453165|FG001|Overall Study|Adverse Event|39|||
27620309|NCT00924664|80453164|FG000|Overall Study|Lack of Efficacy|10|||
27620310|NCT00924664|80453165|FG001|Overall Study|Lack of Efficacy|15|||
27620311|NCT00924664|80453164|FG000|Overall Study|Lost to Follow-up|10|||
27620312|NCT00924664|80453165|FG001|Overall Study|Lost to Follow-up|12|||
27620313|NCT00924664|80453164|FG000|Overall Study|Withdrawal by Subject|47|||
27620314|NCT00924664|80453165|FG001|Overall Study|Withdrawal by Subject|71|||
27620315|NCT00924664|80453164|FG000|Overall Study|Protocol Violation|2|||
27620316|NCT00924664|80453165|FG001|Overall Study|Protocol Violation|5|||
27620317|NCT00924664|80453164|FG000|Overall Study|Pregnancy|1|||
27620318|NCT00924664|80453165|FG001|Overall Study|Pregnancy|1|||
27620319|NCT00924664|80453164|FG000|Overall Study|Death|0|||
27620320|NCT00924664|80453165|FG001|Overall Study|Death|2|||
27620321|NCT00924664|80453164|FG000|Overall Study|Study terminated by sponsor|199|||
27620322|NCT00924664|80453165|FG001|Overall Study|Study terminated by sponsor|330|||
27620323|NCT00924664|80453164|FG000|Overall Study|Other|29|||
27620324|NCT00924664|80453165|FG001|Overall Study|Other|52|||
27620325|NCT00924664|80453164|FG000|Overall Study|Randomized but not Treated|1|||
27620326|NCT00924664|80453165|FG001|Overall Study|Randomized but not Treated|0|||
27620327|NCT02711995|80453166|FG000|Washout (90 Days)|Conflicting medication|1|||
27620328|NCT00209027|80453167|FG000|Overall Study|study terminated|10|||
27620329|NCT00209027|80453168|FG001|Overall Study|study terminated|0|||
27521436|NCT01806662|80101467|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
27521437|NCT01806662|80101466|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
27521438|NCT01806662|80101467|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
27521439|NCT00864916|80101468|FG000|Overall Study|Lost to Follow-up|4|||
27521440|NCT00864916|80101469|FG001|Overall Study|Lost to Follow-up|4|||
27521441|NCT00864916|80101468|FG000|Overall Study|Protocol Violation|1|||
27854516|NCT00584844|81298802|FG000|Overall Study|Withdrawal by Subject|59|||
27854517|NCT00584844|81298802|FG000|Overall Study|Screen Failure|20|||
27854518|NCT01971970|81298803|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
27854519|NCT01971970|81298804|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
27909263|NCT01051557|81506865|FG002|Overall Study|disease progression|5|||
27521442|NCT00864916|80101469|FG001|Overall Study|Protocol Violation|0|||
27521443|NCT00864916|80101468|FG000|Overall Study|Withdrawal by Subject|1|||
27620330|NCT00664521|80453169|FG000|Overall Study|Adverse Event|4|||
27620331|NCT00664521|80453170|FG001|Overall Study|Adverse Event|1|||
27620332|NCT00664521|80453169|FG000|Overall Study|Lost to Follow-up|1|||
27620333|NCT00664521|80453170|FG001|Overall Study|Lost to Follow-up|0|||
27620334|NCT00664521|80453169|FG000|Overall Study|Other|1|||
27620335|NCT00664521|80453170|FG001|Overall Study|Other|0|||
27620336|NCT01712685|80453176|FG000|Overall Study|pt declined to participate before trmt|1|||
27620337|NCT01852162|80453180|FG000|Overall Study|Adverse Event|1|||
27620338|NCT01852162|80453181|FG001|Overall Study|Adverse Event|0|||
27620339|NCT01852162|80453180|FG000|Overall Study|Withdrawal by Subject|3|||
27620340|NCT01852162|80453181|FG001|Overall Study|Withdrawal by Subject|1|||
27620341|NCT02015663|80453186|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
27620342|NCT02015663|80453187|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
27620343|NCT02015663|80453186|FG000|Overall Study|Withdrawal by Subject|1|||
27620344|NCT02015663|80453187|FG001|Overall Study|Withdrawal by Subject|0|||
27620345|NCT02015663|80453186|FG000|Overall Study|Protocol Violation|0|||
27620346|NCT02015663|80453187|FG001|Overall Study|Protocol Violation|1|||
27620347|NCT02015663|80453186|FG000|Overall Study|Adverse Event|3|||
27620348|NCT02015663|80453187|FG001|Overall Study|Adverse Event|0|||
27620349|NCT02015663|80453186|FG000|Overall Study|Administrative problems|10|||
27620350|NCT02015663|80453187|FG001|Overall Study|Administrative problems|11|||
27521444|NCT00864916|80101469|FG001|Overall Study|Withdrawal by Subject|0|||
27521445|NCT02282293|80101475|FG000|Overall Study|Lost to Follow-up|2|||
27521446|NCT02282293|80101476|FG001|Overall Study|Lost to Follow-up|2|||
27521447|NCT02282293|80101475|FG000|Overall Study|Unable to comply with study procedures|1|||
27620351|NCT00965484|80453188|FG000|Overall Study|Protocol Violation|1|||
27620352|NCT00965484|80453188|FG000|Overall Study|Withdrawal by Subject|1|||
27620353|NCT00630539|80453189|FG000|Overall Study|Adverse Event|1|||
27620354|NCT00630539|80453190|FG001|Overall Study|Adverse Event|3|||
27620355|NCT00630539|80453191|FG002|Overall Study|Adverse Event|1|||
27620356|NCT00630539|80453192|FG003|Overall Study|Adverse Event|2|||
27521448|NCT02282293|80101476|FG001|Overall Study|Unable to comply with study procedures|0|||
27521449|NCT02282293|80101475|FG000|Overall Study|Moved out of study area|0|||
27521450|NCT02282293|80101476|FG001|Overall Study|Moved out of study area|1|||
27521451|NCT00220779|80101478|FG000|Overall Study|Adverse Event|1|||
27521452|NCT00220779|80101479|FG001|Overall Study|Adverse Event|0|||
27521453|NCT00220779|80101480|FG002|Overall Study|Adverse Event|0|||
27521454|NCT00220779|80101478|FG000|Overall Study|Withdrawal by Subject|1|||
27521455|NCT00220779|80101479|FG001|Overall Study|Withdrawal by Subject|4|||
27521456|NCT00220779|80101480|FG002|Overall Study|Withdrawal by Subject|1|||
27521457|NCT00220779|80101478|FG000|Overall Study|Non-compliance|1|||
27521458|NCT00220779|80101479|FG001|Overall Study|Non-compliance|0|||
27521459|NCT00220779|80101480|FG002|Overall Study|Non-compliance|0|||
27521460|NCT00220779|80101478|FG000|Overall Study|Too time consuming|1|||
27521461|NCT00220779|80101479|FG001|Overall Study|Too time consuming|0|||
27521462|NCT00220779|80101480|FG002|Overall Study|Too time consuming|0|||
27521463|NCT00220779|80101478|FG000|Overall Study|Pregnancy|0|||
27521464|NCT00220779|80101479|FG001|Overall Study|Pregnancy|0|||
27521465|NCT00220779|80101480|FG002|Overall Study|Pregnancy|2|||
27521466|NCT00220779|80101478|FG000|Overall Study|Lack of Efficacy|3|||
27521467|NCT00220779|80101479|FG001|Overall Study|Lack of Efficacy|0|||
27521468|NCT00220779|80101480|FG002|Overall Study|Lack of Efficacy|1|||
27521469|NCT04931888|80101481|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
27521470|NCT04931888|80101482|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
27521471|NCT04931888|80101483|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
27521472|NCT04931888|80101484|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
27521473|NCT02586506|80101485|FG000|Overall Study|Protocol Violation|6|||
27521474|NCT02586506|80101485|FG000|Overall Study|Lost to Follow-up|1|||
27521475|NCT02586506|80101485|FG000|Overall Study|Other Reason|2|||
27521476|NCT00917644|80101486|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
27521477|NCT00917644|80101487|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
27521478|NCT00917644|80101486|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
27521479|NCT00917644|80101487|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
27521480|NCT00917644|80101486|FG000|Period 2: Second Intervention|family emergency|1|||
27521481|NCT00917644|80101487|FG001|Period 2: Second Intervention|family emergency|0|||
27521482|NCT00835731|80101490|FG000|Overall Study|Withdrawal by Subject|1|||
27521483|NCT00835731|80101491|FG001|Overall Study|Withdrawal by Subject|0|||
27521484|NCT00835731|80101490|FG000|Overall Study|Physician Decision|1|||
27521485|NCT00835731|80101491|FG001|Overall Study|Physician Decision|1|||
27521486|NCT02184455|80101496|FG000|Overall Study|Lost to Follow-up|1|||
27521487|NCT02694757|80101501|FG000|Overall Study|Lack of Efficacy|3|||
27521488|NCT00811642|80101503|FG000|Overall Study|Adverse Event|3|||
27620357|NCT00630539|80453189|FG000|Overall Study|Withdrawal by Subject|0|||
27620358|NCT00630539|80453190|FG001|Overall Study|Withdrawal by Subject|1|||
27521489|NCT00811642|80101503|FG000|Overall Study|Protocol Violation|1|||
27521490|NCT00811642|80101503|FG000|Overall Study|Death|2|||
27521491|NCT00811642|80101503|FG000|Overall Study|Withdrawal by Subject|7|||
27521492|NCT00811642|80101503|FG000|Overall Study|Cumulative use of antifungal agent|2|||
27521493|NCT00282347|80101504|FG000|Treatment Period|Death|2|||
27521494|NCT00282347|80101505|FG001|Treatment Period|Death|0|||
27521495|NCT00282347|80101504|FG000|Treatment Period|Lost to Follow-up|2|||
27620359|NCT00630539|80453191|FG002|Overall Study|Withdrawal by Subject|0|||
27620360|NCT00630539|80453192|FG003|Overall Study|Withdrawal by Subject|1|||
27620361|NCT03290079|80453193|FG000|Overall Study|Death|2|||
27620362|NCT00262743|80453194|FG000|Overall Study|Adverse Event|0|||
27620363|NCT00262743|80453195|FG001|Overall Study|Adverse Event|9|||
27620364|NCT00262743|80453194|FG000|Overall Study|Disease progression|0|||
27620365|NCT00262743|80453195|FG001|Overall Study|Disease progression|3|||
27620366|NCT00506285|80453199|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
27620367|NCT00506285|80453200|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
27620368|NCT00506285|80453199|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
27620369|NCT00506285|80453200|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
27620370|NCT00506285|80453199|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
27620371|NCT00506285|80453200|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
27620372|NCT00506285|80453199|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
27620373|NCT00506285|80453200|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
27620374|NCT00506285|80453199|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
27620375|NCT00506285|80453200|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
27620376|NCT02819479|80453201|FG000|Overall Study|Adverse Event|2|||
27620377|NCT00772928|80453202|FG000|Overall Study|Lost to Follow-up|9|||
27620378|NCT00772928|80453203|FG001|Overall Study|Lost to Follow-up|6|||
27620379|NCT00772928|80453202|FG000|Overall Study|Protocol Violation|10|||
27620380|NCT00772928|80453203|FG001|Overall Study|Protocol Violation|12|||
27620381|NCT00772928|80453202|FG000|Overall Study|Withdrawal by Subject|25|||
27620382|NCT00772928|80453203|FG001|Overall Study|Withdrawal by Subject|22|||
27620383|NCT00772928|80453202|FG000|Overall Study|Did not receive vaccine|0|||
27620384|NCT00772928|80453203|FG001|Overall Study|Did not receive vaccine|1|||
27620385|NCT01866917|80453205|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
27620386|NCT01866917|80453206|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
27854520|NCT01971970|81298803|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
27521496|NCT00282347|80101505|FG001|Treatment Period|Lost to Follow-up|5|||
27521497|NCT00282347|80101504|FG000|Treatment Period|Withdrawal by Subject|1|||
27521498|NCT00282347|80101505|FG001|Treatment Period|Withdrawal by Subject|3|||
27521499|NCT00282347|80101504|FG000|Treatment Period|Physician Decision|0|||
27521500|NCT00282347|80101505|FG001|Treatment Period|Physician Decision|1|||
27521501|NCT00282347|80101504|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
27521502|NCT00282347|80101505|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
27521503|NCT00282347|80101504|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
27521504|NCT00282347|80101505|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
27521505|NCT00282347|80101504|FG000|Safety Follow-up Period|Physician Decision|1|||
27521506|NCT00282347|80101505|FG001|Safety Follow-up Period|Physician Decision|1|||
27521507|NCT00282347|80101504|FG000|Safety Follow-up Period|Protocol Deviation|0|||
27521508|NCT00282347|80101505|FG001|Safety Follow-up Period|Protocol Deviation|2|||
27521509|NCT00282347|80101504|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
27521510|NCT00282347|80101505|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
27521511|NCT00282347|80101504|FG000|B Cell Follow-up Period|Physician Decision|1|||
27521512|NCT00282347|80101505|FG001|B Cell Follow-up Period|Physician Decision|0|||
27521513|NCT00282347|80101504|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
27521514|NCT00282347|80101505|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
27521515|NCT00567255|80101506|FG000|Overall Study|Adverse Event|241|||
27521516|NCT00567255|80101507|FG001|Overall Study|Adverse Event|68|||
27521517|NCT00567255|80101506|FG000|Overall Study|Lost to Follow-up|77|||
27521518|NCT00567255|80101507|FG001|Overall Study|Lost to Follow-up|48|||
27521519|NCT00567255|80101506|FG000|Overall Study|Withdrawal by Subject|75|||
27521520|NCT00567255|80101507|FG001|Overall Study|Withdrawal by Subject|56|||
27521521|NCT00567255|80101506|FG000|Overall Study|Lack of Efficacy|19|||
27521522|NCT00567255|80101507|FG001|Overall Study|Lack of Efficacy|33|||
27521523|NCT00567255|80101506|FG000|Overall Study|Protocol Violation|20|||
27521524|NCT00567255|80101507|FG001|Overall Study|Protocol Violation|8|||
27521525|NCT00567255|80101506|FG000|Overall Study|Pregnancy|6|||
27521526|NCT00567255|80101507|FG001|Overall Study|Pregnancy|0|||
27521527|NCT00567255|80101506|FG000|Overall Study|Drug noncompliance,moved,other|25|||
27521528|NCT00567255|80101507|FG001|Overall Study|Drug noncompliance,moved,other|15|||
27521529|NCT05028361|80101513|FG000|Overall Study|Withdrawal by Subject|1|||
27620387|NCT00877851|80453207|FG000|Overall Study|Lost to Follow-up|5|||
27620388|NCT00877851|80453208|FG001|Overall Study|Lost to Follow-up|5|||
27620389|NCT00877851|80453207|FG000|Overall Study|computer problem|3|||
27620390|NCT00877851|80453208|FG001|Overall Study|computer problem|0|||
27854521|NCT01971970|81298804|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
27521530|NCT05028361|80101514|FG001|Overall Study|Withdrawal by Subject|0|||
27521531|NCT03005873|80101517|FG000|Overall Study|Prohibited medication use post radnomization|1|||
27521532|NCT03005873|80101518|FG001|Overall Study|Prohibited medication use post radnomization|1|||
27909264|NCT01051557|81506866|FG003|Overall Study|disease progression|2|||
27521533|NCT03005873|80101519|FG002|Overall Study|Prohibited medication use post radnomization|1|||
27521534|NCT03005873|80101517|FG000|Overall Study|Withdrew consent|0|||
27620391|NCT00877851|80453207|FG000|Overall Study|no longer interested in participating|1|||
27620392|NCT00877851|80453208|FG001|Overall Study|no longer interested in participating|0|||
27620393|NCT03639675|80453209|FG000|Overall Study|Withdrawal by Subject|1|||
27620394|NCT02559817|80453213|FG000|Treatment Period|Adverse Event|1|||
27620395|NCT02559817|80453214|FG001|Treatment Period|Adverse Event|0|||
27620396|NCT02559817|80453215|FG002|Treatment Period|Adverse Event|1|||
27620397|NCT02559817|80453216|FG003|Treatment Period|Adverse Event|0|||
27620398|NCT02559817|80453217|FG004|Treatment Period|Adverse Event|0|||
27620399|NCT02559817|80453213|FG000|Treatment Period|Lack of Efficacy|0|||
27620400|NCT02559817|80453214|FG001|Treatment Period|Lack of Efficacy|1|||
27620401|NCT02559817|80453215|FG002|Treatment Period|Lack of Efficacy|0|||
27620402|NCT02559817|80453216|FG003|Treatment Period|Lack of Efficacy|0|||
27620403|NCT02559817|80453217|FG004|Treatment Period|Lack of Efficacy|0|||
27620404|NCT02559817|80453213|FG000|Treatment Period|Lost to Follow-up|0|||
27521535|NCT03005873|80101518|FG001|Overall Study|Withdrew consent|1|||
27521536|NCT03005873|80101519|FG002|Overall Study|Withdrew consent|2|||
27521537|NCT03005873|80101517|FG000|Overall Study|Lost to Follow-up|0|||
27521538|NCT03005873|80101518|FG001|Overall Study|Lost to Follow-up|1|||
27521539|NCT03005873|80101519|FG002|Overall Study|Lost to Follow-up|0|||
27521540|NCT03005873|80101517|FG000|Overall Study|Ineligible post randomization|0|||
27521541|NCT03005873|80101518|FG001|Overall Study|Ineligible post randomization|0|||
27521542|NCT03005873|80101519|FG002|Overall Study|Ineligible post randomization|1|||
27521543|NCT02923921|80101520|FG000|Overall Study|Sponsor Decision|39|||
27521544|NCT02923921|80101521|FG001|Overall Study|Sponsor Decision|38|||
27521545|NCT02923921|80101520|FG000|Overall Study|Lost to Follow-up|1|||
27521546|NCT02923921|80101521|FG001|Overall Study|Lost to Follow-up|0|||
27521547|NCT02923921|80101520|FG000|Overall Study|Withdrawal by Subject|6|||
27521548|NCT02923921|80101521|FG001|Overall Study|Withdrawal by Subject|13|||
27521549|NCT02923921|80101520|FG000|Overall Study|Unknown, Not Collected|7|||
27521550|NCT02923921|80101521|FG001|Overall Study|Unknown, Not Collected|6|||
27521551|NCT03254108|80101522|FG000|Overall Study|Adverse Event|0|||
27521552|NCT03254108|80101523|FG001|Overall Study|Adverse Event|2|||
27521553|NCT03254108|80101524|FG002|Overall Study|Adverse Event|0|||
27521554|NCT03254108|80101525|FG003|Overall Study|Adverse Event|1|||
27521555|NCT03254108|80101526|FG004|Overall Study|Adverse Event|1|||
27521556|NCT03254108|80101522|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
27521557|NCT03254108|80101523|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
27521558|NCT03254108|80101524|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
27521559|NCT03254108|80101525|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
27521560|NCT03254108|80101526|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
27521561|NCT00435045|80101527|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
27521562|NCT00435045|80101528|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
27521563|NCT00435045|80101527|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
27521564|NCT00435045|80101528|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
27521565|NCT00435045|80101527|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
27521566|NCT00435045|80101528|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
27521567|NCT00435045|80101527|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
27521568|NCT00435045|80101528|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
27521569|NCT00435045|80101527|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
27521570|NCT00435045|80101528|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
27521571|NCT00435045|80101527|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
27521572|NCT00435045|80101528|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
27521573|NCT00435045|80101527|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
27521574|NCT00435045|80101528|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
27521575|NCT00435045|80101527|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
27521576|NCT00435045|80101528|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
27521577|NCT00435045|80101527|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
27521578|NCT00435045|80101528|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
27521579|NCT00435045|80101527|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
27521580|NCT00435045|80101528|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
27521581|NCT00435045|80101527|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
27521582|NCT00435045|80101528|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
27620405|NCT02559817|80453214|FG001|Treatment Period|Lost to Follow-up|1|||
27620406|NCT02559817|80453215|FG002|Treatment Period|Lost to Follow-up|0|||
27620407|NCT02559817|80453216|FG003|Treatment Period|Lost to Follow-up|1|||
27521583|NCT00653432|80101529|FG000|Overall Study|Adverse Event|4|||
27521584|NCT00653432|80101530|FG001|Overall Study|Adverse Event|1|||
27521585|NCT00653432|80101529|FG000|Overall Study|Withdrawal by Subject|4|||
27521586|NCT00653432|80101530|FG001|Overall Study|Withdrawal by Subject|5|||
27521587|NCT00653432|80101529|FG000|Overall Study|Lost to Follow-up|7|||
27620408|NCT02559817|80453217|FG004|Treatment Period|Lost to Follow-up|0|||
27620409|NCT02559817|80453213|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
27620410|NCT02559817|80453214|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
27731718|NCT01499290|80843011|FG000|Overall Study|Withdrawal by Subject|22|||
27521588|NCT00653432|80101530|FG001|Overall Study|Lost to Follow-up|6|||
27521589|NCT00653432|80101529|FG000|Overall Study|Use/Need of Con Therapy|2|||
27521590|NCT00653432|80101530|FG001|Overall Study|Use/Need of Con Therapy|1|||
27521591|NCT00653432|80101529|FG000|Overall Study|Other - Reason Not Provided|5|||
27620411|NCT02559817|80453215|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
27620412|NCT02559817|80453216|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
27620413|NCT02559817|80453217|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
27620414|NCT02559817|80453213|FG000|Treatment Period|Protocol Violation|0|||
27620415|NCT02559817|80453214|FG001|Treatment Period|Protocol Violation|0|||
27620416|NCT02559817|80453215|FG002|Treatment Period|Protocol Violation|0|||
27620417|NCT02559817|80453216|FG003|Treatment Period|Protocol Violation|1|||
27620418|NCT02559817|80453217|FG004|Treatment Period|Protocol Violation|0|||
27620419|NCT01822821|80453220|FG000|Overall Study|Eligible surgery cancelled|1|||
27909265|NCT01051557|81506867|FG004|Overall Study|disease progression|4|||
27909266|NCT01051557|81506868|FG005|Overall Study|disease progression|3|||
27909267|NCT01051557|81506869|FG006|Overall Study|disease progression|1|||
27909268|NCT01051557|81506863|FG000|Overall Study|Withdrawal by Subject|0|||
27909269|NCT01051557|81506864|FG001|Overall Study|Withdrawal by Subject|0|||
27521592|NCT00653432|80101530|FG001|Overall Study|Other - Reason Not Provided|3|||
27521593|NCT00436501|80101532|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
27521594|NCT00436501|80101533|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
27521595|NCT00436501|80101532|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
27521596|NCT00436501|80101533|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
27521597|NCT00275821|80101536|FG000|Overall Study|Adverse Event|4|||
27521598|NCT00275821|80101537|FG001|Overall Study|Adverse Event|12|||
27521599|NCT00275821|80101538|FG002|Overall Study|Adverse Event|5|||
27521600|NCT00275821|80101536|FG000|Overall Study|Administrative problems|3|||
27521601|NCT00275821|80101537|FG001|Overall Study|Administrative problems|4|||
27521602|NCT00275821|80101538|FG002|Overall Study|Administrative problems|4|||
27521603|NCT00275821|80101536|FG000|Overall Study|Withdrawal by Subject|0|||
27521604|NCT00275821|80101537|FG001|Overall Study|Withdrawal by Subject|2|||
27521605|NCT00275821|80101538|FG002|Overall Study|Withdrawal by Subject|1|||
27521606|NCT00275821|80101536|FG000|Overall Study|Lost to Follow-up|0|||
27521607|NCT00275821|80101537|FG001|Overall Study|Lost to Follow-up|1|||
27521608|NCT00275821|80101538|FG002|Overall Study|Lost to Follow-up|1|||
27521609|NCT00275821|80101536|FG000|Overall Study|Death|0|||
27521610|NCT00275821|80101537|FG001|Overall Study|Death|2|||
27521611|NCT00275821|80101538|FG002|Overall Study|Death|1|||
27521612|NCT00275821|80101536|FG000|Overall Study|Lack of Efficacy|2|||
27521613|NCT00275821|80101537|FG001|Overall Study|Lack of Efficacy|1|||
27521614|NCT00275821|80101538|FG002|Overall Study|Lack of Efficacy|0|||
27521615|NCT00275821|80101536|FG000|Overall Study|Protocol Violation|5|||
27521616|NCT00275821|80101537|FG001|Overall Study|Protocol Violation|1|||
27521617|NCT00275821|80101538|FG002|Overall Study|Protocol Violation|0|||
27521618|NCT00266864|80101541|FG000|Overall Study|Lost to Follow-up|4|||
27521619|NCT00266864|80101542|FG001|Overall Study|Lost to Follow-up|1|||
27521620|NCT00266864|80101541|FG000|Overall Study|Withdrawal by Subject|1|||
27521621|NCT00266864|80101542|FG001|Overall Study|Withdrawal by Subject|1|||
27521622|NCT02730195|80101545|FG000|Overall Study|Withdrawal by Subject|1|||
27521623|NCT00329901|80101546|FG000|Overall Study|Withdrawal by Subject|4|||
27521624|NCT00329901|80101547|FG001|Overall Study|Withdrawal by Subject|3|||
27620420|NCT01822821|80453221|FG001|Overall Study|Eligible surgery cancelled|1|||
27620421|NCT01822821|80453220|FG000|Overall Study|Other reasons|1|||
27620422|NCT01822821|80453221|FG001|Overall Study|Other reasons|0|||
27620423|NCT04212169|80453226|FG000|Overall Study|Adverse Event|0|||
27909270|NCT01051557|81506865|FG002|Overall Study|Withdrawal by Subject|1|||
27909271|NCT01051557|81506866|FG003|Overall Study|Withdrawal by Subject|0|||
27909272|NCT01051557|81506867|FG004|Overall Study|Withdrawal by Subject|2|||
27909273|NCT01051557|81506868|FG005|Overall Study|Withdrawal by Subject|0|||
27909274|NCT01051557|81506869|FG006|Overall Study|Withdrawal by Subject|1|||
27909275|NCT01051557|81506863|FG000|Overall Study|Adverse Event|0|||
27909276|NCT01051557|81506864|FG001|Overall Study|Adverse Event|0|||
27909277|NCT01051557|81506865|FG002|Overall Study|Adverse Event|0|||
27909278|NCT01051557|81506866|FG003|Overall Study|Adverse Event|1|||
27909279|NCT01051557|81506867|FG004|Overall Study|Adverse Event|1|||
27909280|NCT01051557|81506868|FG005|Overall Study|Adverse Event|3|||
27909281|NCT01051557|81506869|FG006|Overall Study|Adverse Event|4|||
27521625|NCT00329901|80101548|FG002|Overall Study|Withdrawal by Subject|2|||
27521626|NCT00329901|80101546|FG000|Overall Study|Lost to Follow-up|2|||
27521627|NCT00329901|80101547|FG001|Overall Study|Lost to Follow-up|0|||
27521628|NCT00329901|80101548|FG002|Overall Study|Lost to Follow-up|1|||
27521629|NCT00329901|80101546|FG000|Overall Study|Protocol Violation|1|||
27521630|NCT00329901|80101547|FG001|Overall Study|Protocol Violation|0|||
27521631|NCT00329901|80101548|FG002|Overall Study|Protocol Violation|1|||
27521632|NCT00329901|80101546|FG000|Overall Study|Unable to classify|2|||
27521633|NCT00329901|80101547|FG001|Overall Study|Unable to classify|2|||
27521634|NCT00329901|80101548|FG002|Overall Study|Unable to classify|0|||
27521635|NCT00995566|80101549|FG000|Overall Study|Adverse Event|2|||
27909282|NCT00547157|81506870|FG000|Overall Study|Other|1|||
27521636|NCT00995566|80101549|FG000|Overall Study|Early study termination|52|||
27521637|NCT03255629|80101552|FG000|Overall Study|Adverse Event|1|||
27854522|NCT01971970|81298803|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
27521638|NCT03255629|80101553|FG001|Overall Study|Adverse Event|0|||
27521639|NCT03255629|80101552|FG000|Overall Study|did not experience hypoglycemia|2|||
27521640|NCT03255629|80101553|FG001|Overall Study|did not experience hypoglycemia|1|||
27521641|NCT04740905|80101555|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
27521642|NCT04740905|80101556|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
27521643|NCT04740905|80101555|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
27521644|NCT04740905|80101556|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
27521645|NCT04740905|80101555|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
27521646|NCT04740905|80101556|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
27521647|NCT04740905|80101555|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
27521648|NCT04740905|80101556|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
27521649|NCT04740905|80101555|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
27521650|NCT04740905|80101556|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
27521651|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
27521652|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
27521653|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
27521654|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
27521655|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
27521656|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
27521657|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
27521658|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
27521659|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
27521660|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
27521661|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
27521662|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
27521663|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
27521664|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
27521665|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
27521666|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
27521667|NCT04740905|80101555|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
27521668|NCT04740905|80101556|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
27521669|NCT02745145|80101557|FG000|Overall Study|Adverse Event|1|||
27521670|NCT02745145|80101558|FG001|Overall Study|Adverse Event|0|||
27521671|NCT02745145|80101559|FG002|Overall Study|Adverse Event|0|||
27521672|NCT02745145|80101557|FG000|Overall Study|Death|0|||
27521673|NCT02745145|80101558|FG001|Overall Study|Death|1|||
27521674|NCT02745145|80101559|FG002|Overall Study|Death|0|||
27521675|NCT02745145|80101557|FG000|Overall Study|Progressive disease|0|||
27854523|NCT01971970|81298804|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
27854524|NCT01971970|81298803|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
27854525|NCT01971970|81298804|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
27854526|NCT01971970|81298803|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
27854527|NCT01971970|81298804|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
27854528|NCT01971970|81298803|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
27854529|NCT01971970|81298804|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
27909283|NCT00547157|81506871|FG001|Overall Study|Other|0|||
27909284|NCT00547157|81506870|FG000|Overall Study|Death|38|||
27909285|NCT00547157|81506871|FG001|Overall Study|Death|18|||
27909286|NCT00547157|81506870|FG000|Overall Study|Withdrawal by Subject|3|||
27909287|NCT00547157|81506871|FG001|Overall Study|Withdrawal by Subject|1|||
27521676|NCT02745145|80101558|FG001|Overall Study|Progressive disease|0|||
27521677|NCT02745145|80101559|FG002|Overall Study|Progressive disease|1|||
27521678|NCT02745145|80101557|FG000|Overall Study|Withdrew consent|1|||
27521679|NCT02745145|80101558|FG001|Overall Study|Withdrew consent|1|||
27521680|NCT02745145|80101559|FG002|Overall Study|Withdrew consent|1|||
27521681|NCT02745145|80101557|FG000|Overall Study|Study Termination|8|||
27521682|NCT02745145|80101558|FG001|Overall Study|Study Termination|3|||
27521683|NCT02745145|80101559|FG002|Overall Study|Study Termination|7|||
27521684|NCT00662532|80101563|FG000|Overall Study|Adverse Event|0|||
27521685|NCT00662532|80101564|FG001|Overall Study|Adverse Event|1|||
27521686|NCT00662532|80101563|FG000|Overall Study|Lost to Follow-up|0|||
27521687|NCT00662532|80101564|FG001|Overall Study|Lost to Follow-up|1|||
27521688|NCT00495040|80101567|FG000|Overall Study|Withdrawal by Subject|3|||
27521689|NCT00561977|80101568|FG000|Overall Study|Withdrawal by Subject|0|||
27521690|NCT00561977|80101569|FG001|Overall Study|Withdrawal by Subject|2|||
27521691|NCT00561977|80101570|FG002|Overall Study|Withdrawal by Subject|1|||
27521692|NCT00561977|80101568|FG000|Overall Study|Pregnancy|0|||
27521693|NCT00561977|80101569|FG001|Overall Study|Pregnancy|1|||
27521694|NCT00561977|80101570|FG002|Overall Study|Pregnancy|1|||
27521695|NCT01217307|80101571|FG000|Overall Study|Withdrawal by Subject|0|||
27521696|NCT01217307|80101572|FG001|Overall Study|Withdrawal by Subject|1|||
27521697|NCT01917656|80101575|FG000|Overall Study|Adverse Event|11|||
27521698|NCT01917656|80101576|FG001|Overall Study|Adverse Event|0|||
27521699|NCT01917656|80101575|FG000|Overall Study|Withdrawal criteria|8|||
27521700|NCT01917656|80101576|FG001|Overall Study|Withdrawal criteria|14|||
27521701|NCT01917656|80101575|FG000|Overall Study|Unclassified|0|||
27521702|NCT01917656|80101576|FG001|Overall Study|Unclassified|3|||
27521703|NCT01917656|80101575|FG000|Overall Study|Withdrawal by Subject|4|||
27521704|NCT01917656|80101576|FG001|Overall Study|Withdrawal by Subject|3|||
27521705|NCT01917656|80101575|FG000|Overall Study|Lost to Follow-up|3|||
27521706|NCT01917656|80101576|FG001|Overall Study|Lost to Follow-up|4|||
27521707|NCT00870103|80101578|FG000|Overall Study|Physician Decision|2|||
27521708|NCT00870103|80101578|FG000|Overall Study|Lost to Follow-up|2|||
27521709|NCT02207946|80101581|FG000|Overall Study|Lost to Follow-up|1|||
27521710|NCT02207946|80101582|FG001|Overall Study|Lost to Follow-up|0|||
27521711|NCT02207946|80101581|FG000|Overall Study|Adverse Event|0|||
27521712|NCT02207946|80101582|FG001|Overall Study|Adverse Event|1|||
27521713|NCT01989208|80101585|FG000|200 mg (7 Days)|Protocol Violation|0|||
27521714|NCT01989208|80101586|FG001|200 mg (7 Days)|Protocol Violation|1|||
27521715|NCT01888432|80101595|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
27521716|NCT01888432|80101596|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
27521717|NCT01888432|80101595|FG000|12-month Analysis (FAS)|Physician Decision|1|||
27521718|NCT01888432|80101596|FG001|12-month Analysis (FAS)|Physician Decision|1|||
27521719|NCT01888432|80101595|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
27521720|NCT01888432|80101596|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
27521721|NCT01888432|80101595|FG000|12-month Analysis (FAS)|Death|4|||
27521722|NCT01888432|80101596|FG001|12-month Analysis (FAS)|Death|3|||
27521723|NCT01888432|80101595|FG000|24-month Analysis (FAS)|Graft loss|0|||
27521724|NCT01888432|80101596|FG001|24-month Analysis (FAS)|Graft loss|1|||
27521725|NCT01888432|80101595|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
27521726|NCT01888432|80101596|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
27521727|NCT01888432|80101595|FG000|24-month Analysis (FAS)|Physician Decision|2|||
27521728|NCT01888432|80101596|FG001|24-month Analysis (FAS)|Physician Decision|4|||
27521729|NCT01888432|80101595|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
27521730|NCT01888432|80101596|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
27521731|NCT01888432|80101595|FG000|24-month Analysis (FAS)|Death|8|||
27521732|NCT01888432|80101596|FG001|24-month Analysis (FAS)|Death|4|||
27521733|NCT01888432|80101595|FG000|36-month Analysis (Extension)|Death|1|||
27521734|NCT01888432|80101596|FG001|36-month Analysis (Extension)|Death|0|||
27521735|NCT02168387|80104924|FG000|Overall Study|Planned exubation|6|||
27521736|NCT02168387|80104925|FG001|Overall Study|Planned exubation|3|||
27521737|NCT02168387|80104924|FG000|Overall Study|Death|1|||
27521738|NCT02168387|80104925|FG001|Overall Study|Death|0|||
27521739|NCT00770146|80104926|FG000|Treatment Period|Withdrawal by Subject|6|||
27521740|NCT00770146|80104927|FG001|Treatment Period|Withdrawal by Subject|13|||
27521741|NCT00770146|80104926|FG000|Treatment Period|Adverse Event|2|||
27521742|NCT00770146|80104927|FG001|Treatment Period|Adverse Event|26|||
27521743|NCT00770146|80104926|FG000|Treatment Period|Other|1|||
27521744|NCT00770146|80104927|FG001|Treatment Period|Other|5|||
27521745|NCT00770146|80104926|FG000|Treatment Period|Protocol non-compliance|0|||
27521746|NCT00770146|80104927|FG001|Treatment Period|Protocol non-compliance|1|||
27521747|NCT00770146|80104926|FG000|Follow-up Period|Withdrawal by Subject|7|||
27521748|NCT00770146|80104927|FG001|Follow-up Period|Withdrawal by Subject|13|||
27521749|NCT00770146|80104926|FG000|Follow-up Period|Adverse Event|0|||
27521750|NCT00770146|80104927|FG001|Follow-up Period|Adverse Event|2|||
27620424|NCT04212169|80453227|FG001|Overall Study|Adverse Event|0|||
27620425|NCT04212169|80453228|FG002|Overall Study|Adverse Event|0|||
27620426|NCT04212169|80453229|FG003|Overall Study|Adverse Event|2|||
27620427|NCT04212169|80453226|FG000|Overall Study|Lost to Follow-up|1|||
27620428|NCT04212169|80453227|FG001|Overall Study|Lost to Follow-up|0|||
27620429|NCT04212169|80453228|FG002|Overall Study|Lost to Follow-up|0|||
27620430|NCT04212169|80453229|FG003|Overall Study|Lost to Follow-up|2|||
27521751|NCT00770146|80104926|FG000|Follow-up Period|Other|4|||
27521752|NCT00770146|80104927|FG001|Follow-up Period|Other|5|||
27521753|NCT03874429|80104934|FG000|Overall Study|Adverse Event|2|||
27521754|NCT03874429|80104935|FG001|Overall Study|Adverse Event|2|||
27521755|NCT03874429|80104934|FG000|Overall Study|Lack of Efficacy|0|||
27521756|NCT03874429|80104935|FG001|Overall Study|Lack of Efficacy|1|||
27521757|NCT03874429|80104934|FG000|Overall Study|Covid-19 pandemic|4|||
27521758|NCT03874429|80104935|FG001|Overall Study|Covid-19 pandemic|2|||
27521759|NCT01029405|80104936|FG000|Overall Study|Withdrawal by Subject|0|||
27521760|NCT01029405|80104937|FG001|Overall Study|Withdrawal by Subject|1|||
27521761|NCT01029405|80104938|FG002|Overall Study|Withdrawal by Subject|2|||
27521762|NCT01029405|80104939|FG003|Overall Study|Withdrawal by Subject|0|||
27521763|NCT01029405|80104936|FG000|Overall Study|Protocol Violation|0|||
27521764|NCT01029405|80104937|FG001|Overall Study|Protocol Violation|0|||
27521765|NCT01029405|80104938|FG002|Overall Study|Protocol Violation|0|||
27521766|NCT01029405|80104939|FG003|Overall Study|Protocol Violation|1|||
27521767|NCT01029405|80104936|FG000|Overall Study|Adverse Event|0|||
27521768|NCT01029405|80104937|FG001|Overall Study|Adverse Event|0|||
27521769|NCT01029405|80104938|FG002|Overall Study|Adverse Event|1|||
27521770|NCT01029405|80104939|FG003|Overall Study|Adverse Event|1|||
27521771|NCT01029405|80104936|FG000|Overall Study|Lost to Follow-up|2|||
27521772|NCT01029405|80104937|FG001|Overall Study|Lost to Follow-up|1|||
27521773|NCT01029405|80104938|FG002|Overall Study|Lost to Follow-up|1|||
27521774|NCT01029405|80104939|FG003|Overall Study|Lost to Follow-up|2|||
27521775|NCT01029405|80104936|FG000|Overall Study|Other|0|||
27521776|NCT01029405|80104937|FG001|Overall Study|Other|1|||
27521777|NCT01029405|80104938|FG002|Overall Study|Other|0|||
27521778|NCT01029405|80104939|FG003|Overall Study|Other|1|||
27731719|NCT01499290|80843012|FG001|Overall Study|Withdrawal by Subject|15|||
27731720|NCT01499290|80843011|FG000|Overall Study|Not specified in study report|11|||
27731721|NCT01499290|80843012|FG001|Overall Study|Not specified in study report|5|||
27731722|NCT01499290|80843011|FG000|Overall Study|Condition improved/subject recovered|1|||
27731723|NCT01499290|80843012|FG001|Overall Study|Condition improved/subject recovered|0|||
27731724|NCT01499290|80843011|FG000|Overall Study|Lack of Efficacy|7|||
27731725|NCT01499290|80843012|FG001|Overall Study|Lack of Efficacy|8|||
27731726|NCT01499290|80843011|FG000|Overall Study|Adverse Event|14|||
27521779|NCT02285062|80104940|FG000|Pre-Treatment Period|Protocol Violation|0|||
27521780|NCT02285062|80104941|FG001|Pre-Treatment Period|Protocol Violation|2|||
27521781|NCT02285062|80104940|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
27521782|NCT02285062|80104941|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27521783|NCT00321646|80104943|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
27521784|NCT00321646|80104943|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
27521785|NCT00321646|80104943|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
27521786|NCT01700439|80104944|FG000|Overall Study|Lost to Follow-up|47|||
27521787|NCT01700439|80104944|FG000|Overall Study|Withdrawal by Subject|183|||
27521788|NCT01700439|80104944|FG000|Overall Study|Death|186|||
27521789|NCT02248675|80104945|FG000|Overall Study|Lost to Follow-up|3|||
27521790|NCT02248675|80104946|FG001|Overall Study|Lost to Follow-up|1|||
27521791|NCT03051620|80104949|FG000|Overall Study|Lost to Follow-up|6|||
27521792|NCT03051620|80104949|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
27521793|NCT01155167|80104954|FG000|Overall Study|Insufficient ultrasound data|2|||
27521794|NCT01155167|80104955|FG001|Overall Study|Insufficient ultrasound data|0|||
27521795|NCT01155167|80104954|FG000|Overall Study|Access site changed to femoral artery|1|||
27521796|NCT01155167|80104955|FG001|Overall Study|Access site changed to femoral artery|0|||
27521797|NCT00984620|80104958|FG000|Overall Study|Adverse Event|5|||
27521798|NCT00984620|80104959|FG001|Overall Study|Adverse Event|5|||
27521799|NCT00984620|80104958|FG000|Overall Study|Lost to Follow-up|1|||
27521800|NCT00984620|80104959|FG001|Overall Study|Lost to Follow-up|1|||
27521801|NCT00984620|80104958|FG000|Overall Study|Withdrawal by Subject|0|||
27521802|NCT00984620|80104959|FG001|Overall Study|Withdrawal by Subject|2|||
27521803|NCT00984620|80104958|FG000|Overall Study|reason other than listed above|0|||
27521804|NCT00984620|80104959|FG001|Overall Study|reason other than listed above|4|||
27521805|NCT03077087|80104962|FG000|Overall Study|Physician Decision|2|||
27521806|NCT01836276|80104966|FG000|Overall Study|Lost to Follow-up|28|||
27521807|NCT01836276|80104967|FG001|Overall Study|Lost to Follow-up|51|||
27521808|NCT00725842|80104968|FG000|Overall Study|Lost to Follow-up|19|||
27521809|NCT00725842|80104968|FG000|Overall Study|Death|1|||
27521810|NCT00725842|80104968|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
27521811|NCT00725842|80104968|FG000|Overall Study|Consent date prior to study start date|5|||
27521812|NCT00725842|80104968|FG000|Overall Study|Inclusion criterion not met|1|||
27521813|NCT00725842|80104968|FG000|Overall Study|No Visit 1 data|1|||
27521814|NCT01782469|80104969|FG000|Overall Study|Lost to Follow-up|1|||
27731727|NCT01499290|80843012|FG001|Overall Study|Adverse Event|7|||
27731728|NCT00275561|80843013|FG000|Overall Study|Withdrawal by Subject|0|||
27731729|NCT00275561|80843014|FG001|Overall Study|Withdrawal by Subject|1|||
27731730|NCT00275561|80843013|FG000|Overall Study|Travel|1|||
27521815|NCT03459690|80104970|FG000|Overall Study|Lost to Follow-up|0|||
27521816|NCT03459690|80104971|FG001|Overall Study|Lost to Follow-up|1|||
27521817|NCT03459690|80104970|FG000|Overall Study|Withdrawal by Subject|1|||
27521818|NCT03459690|80104971|FG001|Overall Study|Withdrawal by Subject|1|||
27521819|NCT01375075|80104974|FG000|Overall Study|Adverse Event|0|||
27521820|NCT01375075|80104975|FG001|Overall Study|Adverse Event|0|||
27521821|NCT01375075|80104976|FG002|Overall Study|Adverse Event|3|||
27521822|NCT01375075|80104977|FG003|Overall Study|Adverse Event|1|||
27521823|NCT01375075|80104978|FG004|Overall Study|Adverse Event|0|||
27521824|NCT01375075|80104979|FG005|Overall Study|Adverse Event|1|||
27521825|NCT01375075|80104974|FG000|Overall Study|Entry Criterion Not Met|1|||
27521826|NCT01375075|80104975|FG001|Overall Study|Entry Criterion Not Met|0|||
27521827|NCT01375075|80104976|FG002|Overall Study|Entry Criterion Not Met|0|||
27521828|NCT01375075|80104977|FG003|Overall Study|Entry Criterion Not Met|0|||
27521829|NCT01375075|80104978|FG004|Overall Study|Entry Criterion Not Met|0|||
27521830|NCT01375075|80104979|FG005|Overall Study|Entry Criterion Not Met|1|||
27521831|NCT01375075|80104974|FG000|Overall Study|Withdrawal by Subject|0|||
27521832|NCT01375075|80104975|FG001|Overall Study|Withdrawal by Subject|1|||
27521833|NCT01375075|80104976|FG002|Overall Study|Withdrawal by Subject|0|||
27521834|NCT01375075|80104977|FG003|Overall Study|Withdrawal by Subject|0|||
27521835|NCT01375075|80104978|FG004|Overall Study|Withdrawal by Subject|0|||
27521836|NCT01375075|80104979|FG005|Overall Study|Withdrawal by Subject|1|||
27521837|NCT00890045|80104982|FG000|Overall Study|Death|0|||
27521838|NCT00890045|80104983|FG001|Overall Study|Death|1|||
27521839|NCT00890045|80104982|FG000|Overall Study|Did not receive HeRO Graft|0|||
27521840|NCT00890045|80104983|FG001|Overall Study|Did not receive HeRO Graft|2|||
27521841|NCT00890045|80104982|FG000|Overall Study|Lost to Follow-up|5|||
27521842|NCT00890045|80104983|FG001|Overall Study|Lost to Follow-up|7|||
27521843|NCT04224688|80104984|FG000|Overall Study|Withdrawal by Subject|1|||
27521844|NCT04224688|80104985|FG001|Overall Study|Withdrawal by Subject|3|||
27521845|NCT04224688|80104984|FG000|Overall Study|Lack of Efficacy|1|||
27521846|NCT04224688|80104985|FG001|Overall Study|Lack of Efficacy|1|||
27521847|NCT04224688|80104984|FG000|Overall Study|Adverse event, not fatal|0|||
27521848|NCT04224688|80104985|FG001|Overall Study|Adverse event, not fatal|2|||
27521849|NCT04224688|80104984|FG000|Overall Study|COVID-19|0|||
27521850|NCT04224688|80104985|FG001|Overall Study|COVID-19|1|||
27521851|NCT02395302|80104986|FG000|Overall Study|Screen Failure|3|||
27521852|NCT02395302|80104986|FG000|Overall Study|Run In Failure|7|||
27521853|NCT02395302|80104986|FG000|Overall Study|Withdrawal by Subject|2|||
27521854|NCT02395302|80104986|FG000|Overall Study|Physician Decision|2|||
27521855|NCT02674854|80104995|FG000|Overall Study|Adverse Event|17|||
27521856|NCT02674854|80104996|FG001|Overall Study|Adverse Event|15|||
27521857|NCT02674854|80104997|FG002|Overall Study|Adverse Event|5|||
27521858|NCT02674854|80104995|FG000|Overall Study|Withdrawal by Subject|1|||
27521859|NCT02674854|80104996|FG001|Overall Study|Withdrawal by Subject|5|||
27521860|NCT02674854|80104997|FG002|Overall Study|Withdrawal by Subject|4|||
27521861|NCT02674854|80104995|FG000|Overall Study|No-compliant subject|1|||
27521862|NCT02674854|80104996|FG001|Overall Study|No-compliant subject|0|||
27521863|NCT02674854|80104997|FG002|Overall Study|No-compliant subject|1|||
27521864|NCT02674854|80104995|FG000|Overall Study|Lost to Follow-up|1|||
27521865|NCT02674854|80104996|FG001|Overall Study|Lost to Follow-up|0|||
27521866|NCT02674854|80104997|FG002|Overall Study|Lost to Follow-up|2|||
27521867|NCT02674854|80104995|FG000|Overall Study|Lack of Efficacy|0|||
27521868|NCT02674854|80104996|FG001|Overall Study|Lack of Efficacy|3|||
27521869|NCT02674854|80104997|FG002|Overall Study|Lack of Efficacy|0|||
27521870|NCT02674854|80104995|FG000|Overall Study|Disallowed Concurrent Medication|2|||
27521871|NCT02674854|80104996|FG001|Overall Study|Disallowed Concurrent Medication|2|||
27521872|NCT02674854|80104997|FG002|Overall Study|Disallowed Concurrent Medication|0|||
27521873|NCT02674854|80104995|FG000|Overall Study|Protocol Violation|1|||
27521874|NCT02674854|80104996|FG001|Overall Study|Protocol Violation|1|||
27521875|NCT02674854|80104997|FG002|Overall Study|Protocol Violation|2|||
27521876|NCT02674854|80104995|FG000|Overall Study|Death|0|||
27521877|NCT02674854|80104996|FG001|Overall Study|Death|1|||
27521878|NCT02674854|80104997|FG002|Overall Study|Death|0|||
27521879|NCT02674854|80104995|FG000|Overall Study|Subject missed V6.2|1|||
27521880|NCT02674854|80104996|FG001|Overall Study|Subject missed V6.2|0|||
27521881|NCT02674854|80104997|FG002|Overall Study|Subject missed V6.2|0|||
27521882|NCT00534313|80104998|FG000|Short-term Period|Adverse Event|1|||
27521883|NCT00534313|80104999|FG001|Short-term Period|Adverse Event|2|||
27521884|NCT00534313|80105000|FG002|Short-term Period|Adverse Event|1|||
27521885|NCT00534313|80105001|FG003|Short-term Period|Adverse Event|3|||
27521886|NCT00534313|80104998|FG000|Short-term Period|Lack of Efficacy|3|||
27521887|NCT00534313|80104999|FG001|Short-term Period|Lack of Efficacy|4|||
27620431|NCT04212169|80453226|FG000|Overall Study|Withdrawal by Subject|10|||
27521888|NCT00534313|80105000|FG002|Short-term Period|Lack of Efficacy|0|||
27620432|NCT04212169|80453227|FG001|Overall Study|Withdrawal by Subject|2|||
27620433|NCT04212169|80453228|FG002|Overall Study|Withdrawal by Subject|5|||
27521889|NCT00534313|80105001|FG003|Short-term Period|Lack of Efficacy|3|||
27521890|NCT00534313|80104998|FG000|Short-term Period|Participant not meeting study criteria|0|||
27521891|NCT00534313|80104999|FG001|Short-term Period|Participant not meeting study criteria|0|||
27521892|NCT00534313|80105000|FG002|Short-term Period|Participant not meeting study criteria|0|||
27521893|NCT00534313|80105001|FG003|Short-term Period|Participant not meeting study criteria|1|||
27521894|NCT00534313|80104998|FG000|Short-term Period|Participant withdrew consent|2|||
27521895|NCT00534313|80104999|FG001|Short-term Period|Participant withdrew consent|0|||
27521896|NCT00534313|80105000|FG002|Short-term Period|Participant withdrew consent|0|||
27521897|NCT00534313|80105001|FG003|Short-term Period|Participant withdrew consent|2|||
27521898|NCT00534313|80104998|FG000|Short-term Period|Pregnancy|0|||
27521899|NCT00534313|80104999|FG001|Short-term Period|Pregnancy|0|||
27521900|NCT00534313|80105000|FG002|Short-term Period|Pregnancy|1|||
27521901|NCT00534313|80105001|FG003|Short-term Period|Pregnancy|0|||
27521902|NCT00534313|80104998|FG000|Long-term Period|Adverse Event|2|||
27521903|NCT00534313|80104999|FG001|Long-term Period|Adverse Event|1|||
27521904|NCT00534313|80105000|FG002|Long-term Period|Adverse Event|0|||
27521905|NCT00534313|80105001|FG003|Long-term Period|Adverse Event|1|||
27521906|NCT00534313|80104998|FG000|Long-term Period|Lack of Efficacy|14|||
27521907|NCT00534313|80104999|FG001|Long-term Period|Lack of Efficacy|10|||
27521908|NCT00534313|80105000|FG002|Long-term Period|Lack of Efficacy|14|||
27521909|NCT00534313|80105001|FG003|Long-term Period|Lack of Efficacy|12|||
27521910|NCT00534313|80104998|FG000|Long-term Period|Lost to Follow-up|1|||
27521911|NCT00534313|80104999|FG001|Long-term Period|Lost to Follow-up|2|||
27521912|NCT00534313|80105000|FG002|Long-term Period|Lost to Follow-up|0|||
27521913|NCT00534313|80105001|FG003|Long-term Period|Lost to Follow-up|0|||
27620434|NCT04212169|80453229|FG003|Overall Study|Withdrawal by Subject|7|||
27620435|NCT04212169|80453226|FG000|Overall Study|Other reason, unspecified|3|||
27620436|NCT04212169|80453227|FG001|Overall Study|Other reason, unspecified|1|||
27620437|NCT04212169|80453228|FG002|Overall Study|Other reason, unspecified|0|||
27620438|NCT04212169|80453229|FG003|Overall Study|Other reason, unspecified|2|||
27620439|NCT00373295|80453232|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
27620440|NCT00373295|80453233|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
27620441|NCT00373295|80453234|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
27620442|NCT00373295|80453235|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
27620443|NCT00373295|80453236|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
27620444|NCT00373295|80453237|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
27620445|NCT00178256|80453239|FG000|Overall Study|Adverse Event|2|||
27620446|NCT00178256|80453240|FG001|Overall Study|Adverse Event|0|||
27521914|NCT00534313|80104998|FG000|Long-term Period|Withdrawal by Subject|2|||
27521915|NCT00534313|80104999|FG001|Long-term Period|Withdrawal by Subject|2|||
27521916|NCT00534313|80105000|FG002|Long-term Period|Withdrawal by Subject|0|||
27521917|NCT00534313|80105001|FG003|Long-term Period|Withdrawal by Subject|0|||
27521918|NCT00534313|80104998|FG000|Long-term Period|No longer meets study criteria|0|||
27521919|NCT00534313|80104999|FG001|Long-term Period|No longer meets study criteria|1|||
27521920|NCT00534313|80105000|FG002|Long-term Period|No longer meets study criteria|0|||
27521921|NCT00534313|80105001|FG003|Long-term Period|No longer meets study criteria|0|||
27521922|NCT00534313|80104998|FG000|Long-term Period|Poor compliance/noncompliance|0|||
27521923|NCT00534313|80104999|FG001|Long-term Period|Poor compliance/noncompliance|1|||
27521924|NCT00534313|80105000|FG002|Long-term Period|Poor compliance/noncompliance|1|||
27521925|NCT00534313|80105001|FG003|Long-term Period|Poor compliance/noncompliance|0|||
27521926|NCT00534313|80104998|FG000|Long-term Period|Administrative reason by sponsor|17|||
27521927|NCT00534313|80104999|FG001|Long-term Period|Administrative reason by sponsor|15|||
27521928|NCT00534313|80105000|FG002|Long-term Period|Administrative reason by sponsor|26|||
27521929|NCT00534313|80105001|FG003|Long-term Period|Administrative reason by sponsor|18|||
27521930|NCT00534313|80104998|FG000|Long-term Period|Other|1|||
27521931|NCT00534313|80104999|FG001|Long-term Period|Other|2|||
27521932|NCT00534313|80105000|FG002|Long-term Period|Other|2|||
27521933|NCT00534313|80105001|FG003|Long-term Period|Other|2|||
27521934|NCT01820260|80105002|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521935|NCT01820260|80105003|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521936|NCT01820260|80105004|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521937|NCT01820260|80105005|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521938|NCT01820260|80105006|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521939|NCT01820260|80105007|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521940|NCT01820260|80105008|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
27521941|NCT01820260|80105009|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521942|NCT01820260|80105010|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521943|NCT01820260|80105011|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521944|NCT01820260|80105012|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521945|NCT01820260|80105013|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521946|NCT01820260|80105014|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521947|NCT01820260|80105015|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
27521948|NCT01820260|80105002|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521949|NCT01820260|80105003|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521950|NCT01820260|80105004|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521951|NCT01820260|80105005|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521952|NCT01820260|80105006|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521953|NCT01820260|80105007|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521954|NCT01820260|80105008|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27620447|NCT00178256|80453241|FG002|Overall Study|Adverse Event|0|||
27620448|NCT00178256|80453242|FG003|Overall Study|Adverse Event|0|||
27620449|NCT00178256|80453239|FG000|Overall Study|Death|0|||
27620450|NCT00178256|80453240|FG001|Overall Study|Death|1|||
27620451|NCT00178256|80453241|FG002|Overall Study|Death|0|||
27620452|NCT00178256|80453242|FG003|Overall Study|Death|1|||
27620453|NCT00178256|80453239|FG000|Overall Study|Cancer progression|2|||
27620454|NCT00178256|80453240|FG001|Overall Study|Cancer progression|0|||
27620455|NCT00178256|80453241|FG002|Overall Study|Cancer progression|0|||
27620456|NCT00178256|80453242|FG003|Overall Study|Cancer progression|1|||
27620457|NCT02955277|80453243|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
27620458|NCT02955277|80453244|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
27620459|NCT02955277|80453243|FG000|Post to Follow-up|Lost to Follow-up|8|||
27620460|NCT02955277|80453244|FG001|Post to Follow-up|Lost to Follow-up|11|||
27620461|NCT01719861|80453247|FG000|Cycle 1|Death|4|||
27620462|NCT01719861|80453247|FG000|Cycle 2|Death|1|||
27620463|NCT01720797|80453248|FG000|Overall Study|Withdrawal by Subject|3|||
27620464|NCT01720797|80453249|FG001|Overall Study|Withdrawal by Subject|0|||
27620465|NCT01023308|80455852|FG000|Overall Study|Abnormal test proceedure results|3|||
27620466|NCT01023308|80455853|FG001|Overall Study|Abnormal test proceedure results|8|||
27620467|NCT01023308|80455852|FG000|Overall Study|Administrative problems|2|||
27620468|NCT01023308|80455853|FG001|Overall Study|Administrative problems|1|||
27620469|NCT01023308|80455852|FG000|Overall Study|Adverse Event|130|||
27620470|NCT01023308|80455853|FG001|Overall Study|Adverse Event|66|||
27620471|NCT01023308|80455852|FG000|Overall Study|Death|21|||
27620472|NCT01023308|80455853|FG001|Overall Study|Death|17|||
27620473|NCT01023308|80455852|FG000|Overall Study|Disease progression|82|||
27620474|NCT01023308|80455853|FG001|Overall Study|Disease progression|153|||
27620475|NCT01023308|80455852|FG000|Overall Study|New Cancer therapy|4|||
27620476|NCT01023308|80455853|FG001|Overall Study|New Cancer therapy|7|||
27620477|NCT01023308|80455852|FG000|Overall Study|Protocol Violation|3|||
27620478|NCT01023308|80455853|FG001|Overall Study|Protocol Violation|4|||
27620479|NCT01023308|80455852|FG000|Overall Study|Untreated|5|||
27620480|NCT01023308|80455853|FG001|Overall Study|Untreated|5|||
27620481|NCT01023308|80455852|FG000|Overall Study|Lost to Follow-up|1|||
27620482|NCT01023308|80455853|FG001|Overall Study|Lost to Follow-up|0|||
27620483|NCT01023308|80455852|FG000|Overall Study|Withdrawal by Subject|34|||
27620484|NCT01023308|80455853|FG001|Overall Study|Withdrawal by Subject|18|||
27620485|NCT01167023|80455854|FG000|Overall Study|Lost to Follow-up|0|||
27620486|NCT01167023|80455855|FG001|Overall Study|Lost to Follow-up|1|||
27620487|NCT01167023|80455856|FG002|Overall Study|Lost to Follow-up|1|||
27620488|NCT01167023|80455854|FG000|Overall Study|Screen Failure|0|||
27620489|NCT01167023|80455855|FG001|Overall Study|Screen Failure|1|||
27620490|NCT01167023|80455856|FG002|Overall Study|Screen Failure|0|||
27620491|NCT01167023|80455854|FG000|Overall Study|Sponsor Decision|0|||
27620492|NCT01167023|80455855|FG001|Overall Study|Sponsor Decision|1|||
27620493|NCT01167023|80455856|FG002|Overall Study|Sponsor Decision|0|||
27620494|NCT01167023|80455854|FG000|Overall Study|Withdrawal by Subject|0|||
27521955|NCT01820260|80105009|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521956|NCT01820260|80105010|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521957|NCT01820260|80105011|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
27521958|NCT01820260|80105012|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521959|NCT01820260|80105013|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521960|NCT01820260|80105014|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521961|NCT01820260|80105015|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
27521962|NCT04905498|80105016|FG000|Overall Study|Lost to Follow-up|0|||
27521963|NCT04905498|80105017|FG001|Overall Study|Lost to Follow-up|2|||
27521964|NCT04905498|80105016|FG000|Overall Study|COVID lockdown|1|||
27521965|NCT04905498|80105017|FG001|Overall Study|COVID lockdown|0|||
27521966|NCT04473235|80105023|FG000|Overall Study|Lost to Follow-up|6|||
27521967|NCT04473235|80105024|FG001|Overall Study|Lost to Follow-up|5|||
27521968|NCT04473235|80105023|FG000|Overall Study|Declined continuation|2|||
27521969|NCT04473235|80105024|FG001|Overall Study|Declined continuation|0|||
27521970|NCT04473235|80105023|FG000|Overall Study|Physician Decision|1|||
27521971|NCT04473235|80105024|FG001|Overall Study|Physician Decision|1|||
27521972|NCT04473235|80105023|FG000|Overall Study|Protocol Violation|10|||
27521973|NCT04473235|80105024|FG001|Overall Study|Protocol Violation|6|||
27521974|NCT00329849|80105028|FG000|Overall Study|Withdrawal by Subject|6|||
27521975|NCT00329849|80105029|FG001|Overall Study|Withdrawal by Subject|4|||
27521976|NCT00045942|80105030|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
27620495|NCT01167023|80455855|FG001|Overall Study|Withdrawal by Subject|0|||
27620496|NCT01167023|80455856|FG002|Overall Study|Withdrawal by Subject|1|||
27620497|NCT02696785|80455857|FG000|Blinded Treatment Period|Adverse Event|0|||
27620498|NCT02696785|80455858|FG001|Blinded Treatment Period|Adverse Event|1|||
27620499|NCT02696785|80455859|FG002|Blinded Treatment Period|Adverse Event|3|||
27521977|NCT00045942|80105031|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521978|NCT00045942|80105032|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521979|NCT00045942|80105033|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27620500|NCT02696785|80455860|FG003|Blinded Treatment Period|Adverse Event|0|||
27620501|NCT02696785|80455857|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
27620502|NCT02696785|80455858|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
27620503|NCT02696785|80455859|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
27620504|NCT02696785|80455860|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
27620505|NCT02696785|80455857|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
27620506|NCT02696785|80455858|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
27620507|NCT02696785|80455859|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
27620508|NCT02696785|80455860|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
27620509|NCT02696785|80455857|FG000|Blinded Treatment Period|Screen Failure|1|||
27620510|NCT02696785|80455858|FG001|Blinded Treatment Period|Screen Failure|0|||
27909288|NCT00547157|81506870|FG000|Overall Study|Administrative decision|3|||
27909289|NCT00547157|81506871|FG001|Overall Study|Administrative decision|2|||
27909290|NCT00547157|81506870|FG000|Overall Study|Lost to Follow-up|4|||
27909291|NCT00547157|81506871|FG001|Overall Study|Lost to Follow-up|2|||
27909292|NCT02697916|81506872|FG000|Overall Study|Death|357|||
27909293|NCT02697916|81506873|FG001|Overall Study|Death|315|||
27909294|NCT02697916|81506872|FG000|Overall Study|Withdrawal by Subject|221|||
27909295|NCT02697916|81506873|FG001|Overall Study|Withdrawal by Subject|393|||
27909296|NCT00003483|81506874|FG000|Overall Study|Not evaluable|1|||
27909297|NCT01004978|81506878|FG000|Overall Study|Disease progression|31|||
27909298|NCT01004978|81506879|FG001|Overall Study|Disease progression|48|||
27909299|NCT01004978|81506878|FG000|Overall Study|Adverse Event|42|||
27909300|NCT01004978|81506879|FG001|Overall Study|Adverse Event|22|||
27909301|NCT01004978|81506878|FG000|Overall Study|Death|3|||
27909302|NCT01004978|81506879|FG001|Overall Study|Death|2|||
27909303|NCT01004978|81506878|FG000|Overall Study|Withdrawal by Subject|16|||
27909304|NCT01004978|81506879|FG001|Overall Study|Withdrawal by Subject|16|||
27909305|NCT01004978|81506878|FG000|Overall Study|Alternative therapy|4|||
27909306|NCT01004978|81506879|FG001|Overall Study|Alternative therapy|8|||
27909307|NCT01004978|81506878|FG000|Overall Study|Physician Decision|6|||
27909308|NCT01004978|81506879|FG001|Overall Study|Physician Decision|3|||
27909309|NCT01004978|81506878|FG000|Overall Study|Other complicating disease|2|||
27909310|NCT01004978|81506879|FG001|Overall Study|Other complicating disease|2|||
27909311|NCT01004978|81506878|FG000|Overall Study|Protocol Violation|2|||
27909312|NCT01004978|81506879|FG001|Overall Study|Protocol Violation|3|||
27909313|NCT01004978|81506878|FG000|Overall Study|Non-compliance|3|||
27909314|NCT01004978|81506879|FG001|Overall Study|Non-compliance|2|||
27909315|NCT01004978|81506878|FG000|Overall Study|Ineligible|1|||
27909316|NCT01004978|81506879|FG001|Overall Study|Ineligible|0|||
27909317|NCT01004978|81506878|FG000|Overall Study|Unblinded|0|||
27909318|NCT01004978|81506879|FG001|Overall Study|Unblinded|1|||
27909319|NCT01004978|81506878|FG000|Overall Study|Performance status worsening|0|||
27909320|NCT01004978|81506879|FG001|Overall Study|Performance status worsening|1|||
27909321|NCT01004978|81506878|FG000|Overall Study|Never started treatment|8|||
27909322|NCT01004978|81506879|FG001|Overall Study|Never started treatment|9|||
27909323|NCT03311841|81506881|FG000|14-day Wash-out|Adverse Event|0|||
27909324|NCT03311841|81506882|FG001|14-day Wash-out|Adverse Event|1|||
27909325|NCT03311841|81506883|FG002|14-day Wash-out|Adverse Event|0|||
27909326|NCT03311841|81506884|FG003|14-day Wash-out|Adverse Event|0|||
27909327|NCT03311841|81506885|FG004|14-day Wash-out|Adverse Event|0|||
27909328|NCT03311841|81506881|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
27909329|NCT03311841|81506882|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
27909330|NCT03311841|81506883|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
27909331|NCT03311841|81506884|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
27909332|NCT03311841|81506885|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
27909333|NCT00686335|81506892|FG000|Run-in Period|Adverse Event|1|||
27909334|NCT00686335|81506892|FG000|Run-in Period|asthma exacerbation|1|||
27909335|NCT00686335|81506892|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
27909336|NCT00996034|81506896|FG000|Overall Study|Lost to Follow-up|2|||
27909337|NCT00996034|81506896|FG000|Overall Study|withdrawn by PI|1|||
27909338|NCT00621257|81506897|FG000|Overall Study|Lost to Follow-up|4|||
27909339|NCT00621257|81506898|FG001|Overall Study|Lost to Follow-up|0|||
27909340|NCT00621257|81506899|FG002|Overall Study|Lost to Follow-up|2|||
27909341|NCT00621257|81506900|FG003|Overall Study|Lost to Follow-up|4|||
27521980|NCT00045942|80105034|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521981|NCT00045942|80105035|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521982|NCT00045942|80105036|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521983|NCT00045942|80105037|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521984|NCT00045942|80105038|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
27521985|NCT00045942|80105030|FG000|PKC412A2104 (Core)|Adverse Event|5|||
27521986|NCT00045942|80105031|FG001|PKC412A2104 (Core)|Adverse Event|0|||
27521987|NCT00045942|80105032|FG002|PKC412A2104 (Core)|Adverse Event|0|||
27521988|NCT00045942|80105033|FG003|PKC412A2104 (Core)|Adverse Event|0|||
27909342|NCT00621257|81506901|FG004|Overall Study|Lost to Follow-up|7|||
27909343|NCT00621257|81506897|FG000|Overall Study|Adverse Event|0|||
27909344|NCT00621257|81506898|FG001|Overall Study|Adverse Event|1|||
27909345|NCT00621257|81506899|FG002|Overall Study|Adverse Event|1|||
27909346|NCT00621257|81506900|FG003|Overall Study|Adverse Event|0|||
27909347|NCT00621257|81506901|FG004|Overall Study|Adverse Event|0|||
27620511|NCT02696785|80455859|FG002|Blinded Treatment Period|Screen Failure|0|||
27909348|NCT00621257|81506897|FG000|Overall Study|Physician Decision|0|||
27909349|NCT00621257|81506898|FG001|Overall Study|Physician Decision|2|||
27909350|NCT00621257|81506899|FG002|Overall Study|Physician Decision|0|||
27909351|NCT00621257|81506900|FG003|Overall Study|Physician Decision|1|||
27909352|NCT00621257|81506901|FG004|Overall Study|Physician Decision|1|||
27620512|NCT02696785|80455860|FG003|Blinded Treatment Period|Screen Failure|0|||
27620513|NCT02696785|80455857|FG000|Washout Period|Withdrawal by Subject|0|||
27620514|NCT02696785|80455858|FG001|Washout Period|Withdrawal by Subject|1|||
27620515|NCT02696785|80455859|FG002|Washout Period|Withdrawal by Subject|0|||
27620516|NCT02696785|80455860|FG003|Washout Period|Withdrawal by Subject|0|||
27620517|NCT02696785|80455857|FG000|Washout Period|Lack of Efficacy|0|||
27620518|NCT02696785|80455858|FG001|Washout Period|Lack of Efficacy|1|||
27620519|NCT02696785|80455859|FG002|Washout Period|Lack of Efficacy|0|||
27620520|NCT02696785|80455860|FG003|Washout Period|Lack of Efficacy|0|||
27620521|NCT02696785|80455857|FG000|Extended Treatment Period|Adverse Event|2|||
27620522|NCT02696785|80455858|FG001|Extended Treatment Period|Adverse Event|3|||
27620523|NCT02696785|80455859|FG002|Extended Treatment Period|Adverse Event|2|||
27620524|NCT02696785|80455860|FG003|Extended Treatment Period|Adverse Event|1|||
27620525|NCT02696785|80455857|FG000|Extended Treatment Period|Lack of Efficacy|0|||
27620526|NCT02696785|80455858|FG001|Extended Treatment Period|Lack of Efficacy|1|||
27620527|NCT02696785|80455859|FG002|Extended Treatment Period|Lack of Efficacy|0|||
27620528|NCT02696785|80455860|FG003|Extended Treatment Period|Lack of Efficacy|0|||
27620529|NCT02696785|80455857|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
27620530|NCT02696785|80455858|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
27620531|NCT02696785|80455859|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
27620532|NCT02696785|80455860|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
27620533|NCT02696785|80455857|FG000|Follow-up Period|Adverse Event|0|||
27620534|NCT02696785|80455858|FG001|Follow-up Period|Adverse Event|0|||
27620535|NCT02696785|80455859|FG002|Follow-up Period|Adverse Event|8|||
27620536|NCT02696785|80455860|FG003|Follow-up Period|Adverse Event|2|||
27620537|NCT02696785|80455857|FG000|Follow-up Period|Lost to Follow-up|0|||
27620538|NCT02696785|80455858|FG001|Follow-up Period|Lost to Follow-up|0|||
27620539|NCT02696785|80455859|FG002|Follow-up Period|Lost to Follow-up|0|||
27620540|NCT02696785|80455860|FG003|Follow-up Period|Lost to Follow-up|1|||
27620541|NCT02696785|80455857|FG000|Follow-up Period|Lack of Efficacy|0|||
27620542|NCT02696785|80455858|FG001|Follow-up Period|Lack of Efficacy|0|||
27620543|NCT02696785|80455859|FG002|Follow-up Period|Lack of Efficacy|0|||
27620544|NCT02696785|80455860|FG003|Follow-up Period|Lack of Efficacy|1|||
27620545|NCT02696785|80455857|FG000|Follow-up Period|Withdrawal by Subject|1|||
27620546|NCT02696785|80455858|FG001|Follow-up Period|Withdrawal by Subject|0|||
27620547|NCT02696785|80455859|FG002|Follow-up Period|Withdrawal by Subject|5|||
27620548|NCT02696785|80455860|FG003|Follow-up Period|Withdrawal by Subject|4|||
27620549|NCT04296942|80455861|FG000|Overall Study|Study closure by sponsor|1|||
27909353|NCT00621257|81506897|FG000|Overall Study|Withdrawal by Subject|0|||
27909354|NCT00621257|81506898|FG001|Overall Study|Withdrawal by Subject|0|||
27909355|NCT00621257|81506899|FG002|Overall Study|Withdrawal by Subject|0|||
27909356|NCT00621257|81506900|FG003|Overall Study|Withdrawal by Subject|1|||
27909357|NCT00621257|81506901|FG004|Overall Study|Withdrawal by Subject|1|||
27909358|NCT02420119|81506902|FG000|Overall Study|insufficient laboratory data|5|||
27909359|NCT02983045|81506905|FG000|Overall Study|Withdrawal by Subject|0|||
27521989|NCT00045942|80105034|FG004|PKC412A2104 (Core)|Adverse Event|0|||
27521990|NCT00045942|80105035|FG005|PKC412A2104 (Core)|Adverse Event|0|||
27521991|NCT00045942|80105036|FG006|PKC412A2104 (Core)|Adverse Event|0|||
27521992|NCT00045942|80105037|FG007|PKC412A2104 (Core)|Adverse Event|0|||
27521993|NCT00045942|80105038|FG008|PKC412A2104 (Core)|Adverse Event|0|||
27521994|NCT00045942|80105030|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
27521995|NCT00045942|80105031|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
27521996|NCT00045942|80105032|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
27521997|NCT00045942|80105033|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
27521998|NCT00045942|80105034|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
27521999|NCT00045942|80105035|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
27522000|NCT00045942|80105036|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
27522001|NCT00045942|80105037|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
27522002|NCT00045942|80105038|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
27522003|NCT00045942|80105030|FG000|PKC412A2104 (Core)|Death|1|||
27522004|NCT00045942|80105031|FG001|PKC412A2104 (Core)|Death|0|||
27522005|NCT00045942|80105032|FG002|PKC412A2104 (Core)|Death|0|||
27522006|NCT00045942|80105033|FG003|PKC412A2104 (Core)|Death|0|||
27522007|NCT00045942|80105034|FG004|PKC412A2104 (Core)|Death|0|||
27620550|NCT04296942|80455862|FG001|Overall Study|Study closure by sponsor|0|||
27620551|NCT04296942|80455863|FG002|Overall Study|Study closure by sponsor|0|||
27620552|NCT02034435|80455866|FG000|Overall Study|Withdrawal by Subject|1|||
27620553|NCT02034435|80455867|FG001|Overall Study|Withdrawal by Subject|0|||
27620554|NCT02034435|80455868|FG002|Overall Study|Withdrawal by Subject|0|||
27620555|NCT02034435|80455869|FG003|Overall Study|Withdrawal by Subject|0|||
27620556|NCT02034435|80455866|FG000|Overall Study|Illness|0|||
27620557|NCT02034435|80455867|FG001|Overall Study|Illness|2|||
27522008|NCT00045942|80105035|FG005|PKC412A2104 (Core)|Death|0|||
27522009|NCT00045942|80105036|FG006|PKC412A2104 (Core)|Death|0|||
27522010|NCT00045942|80105037|FG007|PKC412A2104 (Core)|Death|0|||
27620558|NCT02034435|80455868|FG002|Overall Study|Illness|0|||
27909360|NCT02983045|81506906|FG001|Overall Study|Withdrawal by Subject|1|||
27620559|NCT02034435|80455869|FG003|Overall Study|Illness|0|||
27620560|NCT02034435|80455866|FG000|Overall Study|Inadequate IV access|1|||
27620561|NCT02034435|80455867|FG001|Overall Study|Inadequate IV access|0|||
27620562|NCT02034435|80455868|FG002|Overall Study|Inadequate IV access|0|||
27909361|NCT02983045|81506907|FG002|Overall Study|Withdrawal by Subject|0|||
27909362|NCT02983045|81506908|FG003|Overall Study|Withdrawal by Subject|5|||
27909363|NCT02983045|81506909|FG004|Overall Study|Withdrawal by Subject|0|||
27909364|NCT02983045|81506910|FG005|Overall Study|Withdrawal by Subject|72|||
27909365|NCT02983045|81506911|FG006|Overall Study|Withdrawal by Subject|0|||
27909366|NCT02983045|81506912|FG007|Overall Study|Withdrawal by Subject|0|||
27909367|NCT02983045|81506913|FG008|Overall Study|Withdrawal by Subject|0|||
27909368|NCT02983045|81506914|FG009|Overall Study|Withdrawal by Subject|2|||
27909369|NCT02983045|81506905|FG000|Overall Study|Lost to Follow-up|0|||
27909370|NCT02983045|81506906|FG001|Overall Study|Lost to Follow-up|0|||
27909371|NCT02983045|81506907|FG002|Overall Study|Lost to Follow-up|0|||
27909372|NCT02983045|81506908|FG003|Overall Study|Lost to Follow-up|0|||
27909373|NCT02983045|81506909|FG004|Overall Study|Lost to Follow-up|0|||
27909374|NCT02983045|81506910|FG005|Overall Study|Lost to Follow-up|10|||
27909375|NCT02983045|81506911|FG006|Overall Study|Lost to Follow-up|0|||
27909376|NCT02983045|81506912|FG007|Overall Study|Lost to Follow-up|0|||
27909377|NCT02983045|81506913|FG008|Overall Study|Lost to Follow-up|0|||
27909378|NCT02983045|81506914|FG009|Overall Study|Lost to Follow-up|0|||
27909379|NCT05279131|81506916|FG000|Overall Study|Lost to Follow-up|1|||
27909380|NCT05279131|81506916|FG000|Overall Study|Death|1|||
27909381|NCT05279131|81506916|FG000|Overall Study|Physician Decision|1|||
27909382|NCT04058028|81506917|FG000|Overall Study|Withdrawal of Consent from Study|12|||
27909383|NCT04058028|81506918|FG001|Overall Study|Withdrawal of Consent from Study|8|||
27909384|NCT04058028|81506919|FG002|Overall Study|Withdrawal of Consent from Study|6|||
27909385|NCT04058028|81506920|FG003|Overall Study|Withdrawal of Consent from Study|7|||
27909386|NCT04058028|81506917|FG000|Overall Study|Decision by Sponsor|13|||
27909387|NCT04058028|81506918|FG001|Overall Study|Decision by Sponsor|4|||
27909388|NCT04058028|81506919|FG002|Overall Study|Decision by Sponsor|1|||
27909389|NCT04058028|81506920|FG003|Overall Study|Decision by Sponsor|35|||
27909390|NCT04058028|81506917|FG000|Overall Study|Lost to Follow-up|1|||
27909391|NCT04058028|81506918|FG001|Overall Study|Lost to Follow-up|1|||
27909392|NCT04058028|81506919|FG002|Overall Study|Lost to Follow-up|1|||
27909393|NCT04058028|81506920|FG003|Overall Study|Lost to Follow-up|0|||
27909394|NCT04058028|81506917|FG000|Overall Study|Death|0|||
27909395|NCT04058028|81506918|FG001|Overall Study|Death|1|||
27909396|NCT04058028|81506919|FG002|Overall Study|Death|0|||
27909397|NCT04058028|81506920|FG003|Overall Study|Death|0|||
27909398|NCT01957579|81506921|FG000|Overall Study|Withdrawal of concent|0|||
27909399|NCT01957579|81506922|FG001|Overall Study|Withdrawal of concent|1|||
27909400|NCT01957579|81506923|FG002|Overall Study|Withdrawal of concent|0|||
27909401|NCT01957579|81506924|FG003|Overall Study|Withdrawal of concent|0|||
27909402|NCT01957579|81506921|FG000|Overall Study|Death|0|||
27909403|NCT01957579|81506922|FG001|Overall Study|Death|0|||
27909404|NCT01957579|81506923|FG002|Overall Study|Death|2|||
27909405|NCT01957579|81506924|FG003|Overall Study|Death|0|||
27909406|NCT04001803|81506927|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
27909407|NCT04001803|81506927|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
27909408|NCT04001803|81506927|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
27909409|NCT04001803|81506927|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
27909410|NCT04001803|81506927|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
27909411|NCT04001803|81506927|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
27909412|NCT04001803|81506927|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
27909413|NCT04001803|81506927|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
27909414|NCT04001803|81506927|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
27909415|NCT04001803|81506927|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
27909416|NCT03126786|81506928|FG000|Overall Study|Adverse Event|3|||
27909417|NCT03126786|81506929|FG001|Overall Study|Adverse Event|0|||
27909418|NCT03126786|81506928|FG000|Overall Study|Lost to Follow-up|0|||
27909419|NCT03126786|81506929|FG001|Overall Study|Lost to Follow-up|1|||
27909420|NCT03126786|81506928|FG000|Overall Study|Withdrawal by Subject|3|||
27909421|NCT03126786|81506929|FG001|Overall Study|Withdrawal by Subject|1|||
27620563|NCT02034435|80455869|FG003|Overall Study|Inadequate IV access|1|||
27909422|NCT05027815|81506930|FG000|Overall Study|Death|2|||
27909423|NCT05027815|81506931|FG001|Overall Study|Death|1|||
27909424|NCT01383018|81506932|FG000|Overall Study|Adverse Event|14|||
27909425|NCT01383018|81506932|FG000|Overall Study|Death|10|||
27909426|NCT01383018|81506932|FG000|Overall Study|Lost to Follow-up|5|||
27620564|NCT03379233|80455873|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
27909427|NCT01383018|81506932|FG000|Overall Study|Physician Decision|5|||
27909428|NCT01383018|81506932|FG000|Overall Study|Withdrawal by Subject|9|||
27522011|NCT00045942|80105038|FG008|PKC412A2104 (Core)|Death|0|||
27620565|NCT03379233|80455874|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
27909429|NCT01383018|81506932|FG000|Overall Study|Subject not implanted|76|||
27620566|NCT03670602|80455875|FG000|Overall Study|Lost to Follow-up|1|||
27620567|NCT03670602|80455876|FG001|Overall Study|Lost to Follow-up|0|||
27620568|NCT03670602|80455875|FG000|Overall Study|Withdrawal by Subject|0|||
27620569|NCT03670602|80455876|FG001|Overall Study|Withdrawal by Subject|3|||
27620570|NCT01272011|80455877|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
27620571|NCT01272011|80455878|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
27620572|NCT01272011|80455879|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
27620573|NCT02414828|80455884|FG000|Overall Study|Lost to Follow-up|0|||
27620574|NCT02414828|80455885|FG001|Overall Study|Lost to Follow-up|1|||
27620575|NCT02414828|80455886|FG002|Overall Study|Lost to Follow-up|1|||
27620576|NCT02414828|80455887|FG003|Overall Study|Lost to Follow-up|2|||
27620577|NCT00480441|80455889|FG000|Screening|Not Eligible|37|||
27620578|NCT00480441|80455890|FG001|Screening|Not Eligible|0|||
27620579|NCT00480441|80455891|FG002|Screening|Not Eligible|0|||
27620580|NCT00480441|80455889|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
27620581|NCT00480441|80455890|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
27620582|NCT00480441|80455891|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
27620583|NCT00480441|80455889|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
27620584|NCT00480441|80455890|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
27620585|NCT00480441|80455891|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
27522012|NCT00045942|80105030|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
27522013|NCT00045942|80105031|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
27620586|NCT00480441|80455889|FG000|Baseline Functional MRI|physical contraindication|4|||
27620587|NCT00480441|80455890|FG001|Baseline Functional MRI|physical contraindication|0|||
27620588|NCT00480441|80455891|FG002|Baseline Functional MRI|physical contraindication|0|||
27620589|NCT00480441|80455889|FG000|Randomization|Lost to Follow-up|0|||
27620590|NCT00480441|80455890|FG001|Randomization|Lost to Follow-up|7|||
27620591|NCT00480441|80455891|FG002|Randomization|Lost to Follow-up|2|||
27620592|NCT00999661|80455892|FG000|Overall Study|Lost to Follow-up|59|||
27620593|NCT00999661|80455892|FG000|Overall Study|Adverse Event|1|||
27620594|NCT00999661|80455892|FG000|Overall Study|Withdrawal by Subject|1|||
27620595|NCT00999661|80455892|FG000|Overall Study|Not meeting eligibility criteria|9|||
27620596|NCT02300311|80455899|FG000|Overall Study|Other than the reason specified|1|||
27620597|NCT02300311|80455900|FG001|Overall Study|Other than the reason specified|0|||
27620598|NCT02300311|80455899|FG000|Overall Study|Refused to continue taking medication|18|||
27620599|NCT02300311|80455900|FG001|Overall Study|Refused to continue taking medication|0|||
27620600|NCT01446003|80455901|FG000|Period 1|Protocol Violation|2|||
27620601|NCT01446003|80455902|FG001|Period 1|Protocol Violation|0|||
27620602|NCT01446003|80455901|FG000|Period 2|Adverse Event|1|||
27620603|NCT01446003|80455902|FG001|Period 2|Adverse Event|0|||
27620604|NCT03704298|80455906|FG000|Overall Study|Death|3|||
27620605|NCT03704298|80455907|FG001|Overall Study|Death|1|||
27620606|NCT03704298|80455908|FG002|Overall Study|Death|1|||
27620607|NCT03704298|80455909|FG003|Overall Study|Death|0|||
27522014|NCT00045942|80105032|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
27522015|NCT00045942|80105033|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
27522016|NCT00045942|80105034|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
27522017|NCT00045942|80105035|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
27522018|NCT00045942|80105036|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
27522019|NCT00045942|80105037|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
27522020|NCT00045942|80105038|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
27522021|NCT00045942|80105030|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
27522022|NCT00045942|80105031|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
27522023|NCT00045942|80105032|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
27522024|NCT00045942|80105033|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
27522025|NCT00045942|80105034|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
27522026|NCT00045942|80105035|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
27522027|NCT00045942|80105036|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
27522028|NCT00045942|80105037|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
27522029|NCT00045942|80105038|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
27522030|NCT00045942|80105030|FG000|PKC412A2104E1|Lack of Efficacy|0|||
27522031|NCT00045942|80105031|FG001|PKC412A2104E1|Lack of Efficacy|11|||
27522032|NCT00045942|80105032|FG002|PKC412A2104E1|Lack of Efficacy|11|||
27522033|NCT00045942|80105033|FG003|PKC412A2104E1|Lack of Efficacy|23|||
27522034|NCT00045942|80105034|FG004|PKC412A2104E1|Lack of Efficacy|17|||
27620608|NCT03704298|80455906|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
27522035|NCT00045942|80105035|FG005|PKC412A2104E1|Lack of Efficacy|0|||
27522036|NCT00045942|80105036|FG006|PKC412A2104E1|Lack of Efficacy|0|||
27522037|NCT00045942|80105037|FG007|PKC412A2104E1|Lack of Efficacy|0|||
27620609|NCT03704298|80455907|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
27620610|NCT03704298|80455908|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
27620611|NCT03704298|80455909|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
27620612|NCT03704298|80455906|FG000|Overall Study|Withdrawal by Subject|1|||
27620613|NCT03704298|80455907|FG001|Overall Study|Withdrawal by Subject|0|||
27522038|NCT00045942|80105038|FG008|PKC412A2104E1|Lack of Efficacy|0|||
27731731|NCT00275561|80843014|FG001|Overall Study|Travel|1|||
27909430|NCT01383018|81506932|FG000|Overall Study|Missed Visit|247|||
27522039|NCT00045942|80105030|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
27522040|NCT00045942|80105031|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
27522041|NCT00045942|80105032|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
27522042|NCT00045942|80105033|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
27522043|NCT00045942|80105034|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
27522044|NCT00045942|80105035|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
27522045|NCT00045942|80105036|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
27522046|NCT00045942|80105037|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
27522047|NCT00045942|80105038|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
27522048|NCT00045942|80105030|FG000|PKC412A2104E1|Adverse Event|0|||
27522049|NCT00045942|80105031|FG001|PKC412A2104E1|Adverse Event|1|||
27522050|NCT00045942|80105032|FG002|PKC412A2104E1|Adverse Event|1|||
27522051|NCT00045942|80105033|FG003|PKC412A2104E1|Adverse Event|3|||
27522052|NCT00045942|80105034|FG004|PKC412A2104E1|Adverse Event|6|||
27522053|NCT00045942|80105035|FG005|PKC412A2104E1|Adverse Event|0|||
27522054|NCT00045942|80105036|FG006|PKC412A2104E1|Adverse Event|0|||
27522055|NCT00045942|80105037|FG007|PKC412A2104E1|Adverse Event|0|||
27522056|NCT00045942|80105038|FG008|PKC412A2104E1|Adverse Event|0|||
27522057|NCT00045942|80105030|FG000|PKC412A2104E1|Death|0|||
27522058|NCT00045942|80105031|FG001|PKC412A2104E1|Death|4|||
27854530|NCT01971970|81298803|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
27909431|NCT01383018|81506932|FG000|Overall Study|Site closed early-not compliance related|7|||
27522059|NCT00045942|80105032|FG002|PKC412A2104E1|Death|1|||
27522060|NCT00045942|80105033|FG003|PKC412A2104E1|Death|1|||
27522061|NCT00045942|80105034|FG004|PKC412A2104E1|Death|1|||
27522062|NCT00045942|80105035|FG005|PKC412A2104E1|Death|0|||
27522063|NCT00045942|80105036|FG006|PKC412A2104E1|Death|0|||
27522064|NCT00045942|80105037|FG007|PKC412A2104E1|Death|0|||
27522065|NCT00045942|80105038|FG008|PKC412A2104E1|Death|0|||
27522066|NCT00045942|80105030|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522067|NCT00045942|80105031|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522068|NCT00045942|80105032|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
27522069|NCT00045942|80105033|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
27522070|NCT00045942|80105034|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522071|NCT00045942|80105035|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522072|NCT00045942|80105036|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522073|NCT00045942|80105037|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522074|NCT00045942|80105038|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
27522075|NCT00045942|80105030|FG000|PKC412A2104E2|Lost to Follow-up|0|||
27522076|NCT00045942|80105031|FG001|PKC412A2104E2|Lost to Follow-up|0|||
27522077|NCT00045942|80105032|FG002|PKC412A2104E2|Lost to Follow-up|0|||
27522078|NCT00045942|80105033|FG003|PKC412A2104E2|Lost to Follow-up|0|||
27522079|NCT00045942|80105034|FG004|PKC412A2104E2|Lost to Follow-up|0|||
27522080|NCT00045942|80105035|FG005|PKC412A2104E2|Lost to Follow-up|0|||
27522081|NCT00045942|80105036|FG006|PKC412A2104E2|Lost to Follow-up|0|||
27522082|NCT00045942|80105037|FG007|PKC412A2104E2|Lost to Follow-up|3|||
27909432|NCT01383018|81506932|FG000|Overall Study|Patient moved away from site|1|||
27909433|NCT01383018|81506932|FG000|Overall Study|Subject Incarcerated|1|||
27909434|NCT02609386|81506935|FG000|Overall Study|Withdrawal by Subject|6|||
27909435|NCT02609386|81506936|FG001|Overall Study|Withdrawal by Subject|1|||
27909436|NCT02609386|81506935|FG000|Overall Study|Lost to Follow-up|3|||
27909437|NCT02609386|81506936|FG001|Overall Study|Lost to Follow-up|5|||
27909438|NCT02609386|81506935|FG000|Overall Study|Death|19|||
27909439|NCT02609386|81506936|FG001|Overall Study|Death|9|||
27909440|NCT02609386|81506935|FG000|Overall Study|Physician Decision|0|||
27909441|NCT02609386|81506936|FG001|Overall Study|Physician Decision|2|||
27909442|NCT01535443|81506937|FG000|Overall Study|Physician Decision|3|||
27909443|NCT00215644|81506940|FG000|Overall Study|Disease Progression|28|||
27909444|NCT00215644|81506941|FG001|Overall Study|Disease Progression|10|||
27522083|NCT00045942|80105038|FG008|PKC412A2104E2|Lost to Follow-up|0|||
27522084|NCT00045942|80105030|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
27522085|NCT00045942|80105031|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
27522086|NCT00045942|80105032|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
27522087|NCT00045942|80105033|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
27522088|NCT00045942|80105034|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
27522089|NCT00045942|80105035|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
27522090|NCT00045942|80105036|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
27522091|NCT00045942|80105037|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
27909445|NCT00215644|81506940|FG000|Overall Study|Adverse Event|2|||
27909446|NCT00215644|81506941|FG001|Overall Study|Adverse Event|9|||
27909447|NCT00215644|81506940|FG000|Overall Study|Death|1|||
27909448|NCT00215644|81506941|FG001|Overall Study|Death|2|||
27909449|NCT00215644|81506940|FG000|Overall Study|Withdrawal by Subject|1|||
27909450|NCT00215644|81506941|FG001|Overall Study|Withdrawal by Subject|0|||
27909451|NCT00215644|81506940|FG000|Overall Study|Other|3|||
27909452|NCT00215644|81506941|FG001|Overall Study|Other|15|||
27522092|NCT00045942|80105038|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
27522093|NCT00045942|80105030|FG000|PKC412A2104E2|Lack of Efficacy|0|||
27522094|NCT00045942|80105031|FG001|PKC412A2104E2|Lack of Efficacy|0|||
27522095|NCT00045942|80105032|FG002|PKC412A2104E2|Lack of Efficacy|0|||
27522096|NCT00045942|80105033|FG003|PKC412A2104E2|Lack of Efficacy|0|||
27522097|NCT00045942|80105034|FG004|PKC412A2104E2|Lack of Efficacy|0|||
27522098|NCT00045942|80105035|FG005|PKC412A2104E2|Lack of Efficacy|3|||
27522099|NCT00045942|80105036|FG006|PKC412A2104E2|Lack of Efficacy|2|||
27522100|NCT00045942|80105037|FG007|PKC412A2104E2|Lack of Efficacy|2|||
27522101|NCT00045942|80105038|FG008|PKC412A2104E2|Lack of Efficacy|6|||
27522102|NCT00045942|80105030|FG000|PKC412A2104E2|Adverse Event|0|||
27522103|NCT00045942|80105031|FG001|PKC412A2104E2|Adverse Event|0|||
27522104|NCT00045942|80105032|FG002|PKC412A2104E2|Adverse Event|0|||
27522105|NCT00045942|80105033|FG003|PKC412A2104E2|Adverse Event|0|||
27522106|NCT00045942|80105034|FG004|PKC412A2104E2|Adverse Event|0|||
27620614|NCT03704298|80455908|FG002|Overall Study|Withdrawal by Subject|0|||
27620615|NCT03704298|80455909|FG003|Overall Study|Withdrawal by Subject|0|||
27620616|NCT03704298|80455906|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
27620617|NCT03704298|80455907|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
27620618|NCT03704298|80455908|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
27620619|NCT03704298|80455909|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
27620620|NCT03673098|80455910|FG000|Overall Study|Lost to Follow-up|2|||
27620621|NCT03673098|80455911|FG001|Overall Study|Lost to Follow-up|3|||
27620622|NCT03673098|80455910|FG000|Overall Study|Withdrawal by Subject|6|||
27620623|NCT03673098|80455911|FG001|Overall Study|Withdrawal by Subject|1|||
27620624|NCT03673098|80455910|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
27620625|NCT03673098|80455911|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
27620626|NCT01004263|80455923|FG000|Overall Study|Adverse Event|15|||
27620627|NCT01004263|80455923|FG000|Overall Study|Withdrawal by Subject|58|||
27620628|NCT01004263|80455923|FG000|Overall Study|Protocol Violation|10|||
27620629|NCT01004263|80455923|FG000|Overall Study|Lost to Follow-up|64|||
27620630|NCT01004263|80455923|FG000|Overall Study|Lack of Efficacy|13|||
27620631|NCT01004263|80455923|FG000|Overall Study|Pregnancy|2|||
27620632|NCT01004263|80455923|FG000|Overall Study|Physician Decision|15|||
27620633|NCT01004263|80455923|FG000|Overall Study|Lack of Qualifying Event|2|||
27620634|NCT04922021|80455924|FG000|Overall Study|Withdrawal by Subject|4|||
27620635|NCT04922021|80455925|FG001|Overall Study|Withdrawal by Subject|10|||
27620636|NCT04922021|80455924|FG000|Overall Study|Adverse Event|2|||
27620637|NCT04922021|80455925|FG001|Overall Study|Adverse Event|2|||
27620638|NCT04922021|80455924|FG000|Overall Study|Lack of Efficacy|0|||
27620639|NCT04922021|80455925|FG001|Overall Study|Lack of Efficacy|1|||
27620640|NCT04922021|80455924|FG000|Overall Study|Multiple reasons|1|||
27620641|NCT04922021|80455925|FG001|Overall Study|Multiple reasons|0|||
27620642|NCT01124617|80455926|FG000|Overall Study|Adverse Event|5|||
27620643|NCT01124617|80455927|FG001|Overall Study|Adverse Event|2|||
27620644|NCT01124617|80455926|FG000|Overall Study|Lack of Efficacy|2|||
27620645|NCT01124617|80455927|FG001|Overall Study|Lack of Efficacy|1|||
27620646|NCT01124617|80455926|FG000|Overall Study|Protocol Violation|1|||
27620647|NCT01124617|80455927|FG001|Overall Study|Protocol Violation|1|||
27620648|NCT01124617|80455926|FG000|Overall Study|Withdrawal by Subject|9|||
27620649|NCT01124617|80455927|FG001|Overall Study|Withdrawal by Subject|1|||
27620650|NCT01124617|80455926|FG000|Overall Study|Other|2|||
27620651|NCT01124617|80455927|FG001|Overall Study|Other|1|||
27620652|NCT01932996|80455928|FG000|Overall Study|Protocol Violation|2|||
27620653|NCT01932996|80455929|FG001|Overall Study|Protocol Violation|0|||
27620654|NCT03169361|80455930|FG000|Overall Study|Protocol Violation|32|||
27620655|NCT04155424|80455937|FG000|Overall Study|Other than specified|3|||
27620656|NCT04155424|80455937|FG000|Overall Study|Withdrawal by Subject|1|||
27620657|NCT04155424|80455937|FG000|Overall Study|Adverse Event|1|||
27620658|NCT02162732|80455942|FG000|Overall Study|Biopsy not performed.|18|||
27620659|NCT00445692|80455945|FG000|Overall Study|Adverse Event|11|||
27620660|NCT00445692|80455945|FG000|Overall Study|Lack of Efficacy|5|||
27620661|NCT01559090|80455946|FG000|Stage I|Withdrawal by Subject|2|||
27522107|NCT00045942|80105035|FG005|PKC412A2104E2|Adverse Event|4|||
27522108|NCT00045942|80105036|FG006|PKC412A2104E2|Adverse Event|3|||
27522109|NCT00045942|80105037|FG007|PKC412A2104E2|Adverse Event|1|||
27522110|NCT00045942|80105038|FG008|PKC412A2104E2|Adverse Event|0|||
27522111|NCT00045942|80105030|FG000|PKC412A2104E2|Death|0|||
27620662|NCT01559090|80455947|FG001|Stage I|Withdrawal by Subject|2|||
27620663|NCT01559090|80455948|FG002|Stage I|Withdrawal by Subject|3|||
27620664|NCT01559090|80455946|FG000|Stage II|Withdrawal by Subject|1|||
27620665|NCT01559090|80455947|FG001|Stage II|Withdrawal by Subject|0|||
27620666|NCT01559090|80455948|FG002|Stage II|Withdrawal by Subject|0|||
27620667|NCT00958009|80455949|FG000|Overall Study|Adverse Event|1|||
27620668|NCT00958009|80455949|FG000|Overall Study|Subject found device difficult to use|1|||
27522112|NCT00045942|80105031|FG001|PKC412A2104E2|Death|0|||
27522113|NCT00045942|80105032|FG002|PKC412A2104E2|Death|0|||
27522114|NCT00045942|80105033|FG003|PKC412A2104E2|Death|0|||
27854531|NCT01971970|81298804|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
27854532|NCT03071094|81298805|FG000|Overall Study|Death|1|||
27854533|NCT03071094|81298806|FG001|Overall Study|Death|1|||
27854534|NCT03071094|81298805|FG000|Overall Study|Adverse Event|1|||
27854535|NCT03071094|81298806|FG001|Overall Study|Adverse Event|0|||
27854536|NCT03573505|81298807|FG000|Overall Study|Adverse Event|1|||
27854537|NCT03573505|81298808|FG001|Overall Study|Adverse Event|1|||
27854538|NCT03573505|81298807|FG000|Overall Study|Consent withdrawn|0|||
27854539|NCT03573505|81298808|FG001|Overall Study|Consent withdrawn|1|||
27854540|NCT03573505|81298807|FG000|Overall Study|Disease progression|0|||
27854541|NCT03573505|81298808|FG001|Overall Study|Disease progression|1|||
27854542|NCT03573505|81298807|FG000|Overall Study|Site Terminated by Sponsor|1|||
27854543|NCT03573505|81298808|FG001|Overall Study|Site Terminated by Sponsor|1|||
27731732|NCT00275561|80843013|FG000|Overall Study|Scheduling|1|||
27731733|NCT00275561|80843014|FG001|Overall Study|Scheduling|2|||
27731734|NCT00275561|80843013|FG000|Overall Study|Family Issues|0|||
27731735|NCT00275561|80843014|FG001|Overall Study|Family Issues|2|||
27731736|NCT01111604|80843017|FG000|Overall Study|Lost to Follow-up|0|||
27522115|NCT00045942|80105034|FG004|PKC412A2104E2|Death|0|||
27522116|NCT00045942|80105035|FG005|PKC412A2104E2|Death|1|||
27522117|NCT00045942|80105036|FG006|PKC412A2104E2|Death|2|||
27522118|NCT00045942|80105037|FG007|PKC412A2104E2|Death|0|||
27522119|NCT00045942|80105038|FG008|PKC412A2104E2|Death|0|||
27522120|NCT01129583|80105039|FG000|Overall Study|Death|1|||
27522121|NCT01129583|80105040|FG001|Overall Study|Death|0|||
27522122|NCT01129583|80105039|FG000|Overall Study|Lost to Follow-up|1|||
27522123|NCT01129583|80105040|FG001|Overall Study|Lost to Follow-up|1|||
27522124|NCT01129583|80105039|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
27522125|NCT01129583|80105040|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
27522126|NCT01343901|80105041|FG000|Overall Study|Death|85|||
27522127|NCT01343901|80105041|FG000|Overall Study|Physician Decision|4|||
27522128|NCT01343901|80105041|FG000|Overall Study|Lost to Follow-up|12|||
27731737|NCT01111604|80843018|FG001|Overall Study|Lost to Follow-up|0|||
27731738|NCT01111604|80843019|FG002|Overall Study|Lost to Follow-up|1|||
27522129|NCT01343901|80105041|FG000|Overall Study|Management by another medical team|11|||
27731739|NCT01111604|80843017|FG000|Overall Study|Withdrew Consent|3|||
27731740|NCT01111604|80843018|FG001|Overall Study|Withdrew Consent|0|||
27731741|NCT01111604|80843019|FG002|Overall Study|Withdrew Consent|2|||
27731742|NCT01111604|80843017|FG000|Overall Study|Withdrawal by Subject|2|||
27731743|NCT01111604|80843018|FG001|Overall Study|Withdrawal by Subject|0|||
27731744|NCT01111604|80843019|FG002|Overall Study|Withdrawal by Subject|0|||
27731745|NCT01111604|80843017|FG000|Overall Study|Death|1|||
27731746|NCT01111604|80843018|FG001|Overall Study|Death|0|||
27731747|NCT01111604|80843019|FG002|Overall Study|Death|0|||
27731748|NCT01111604|80843017|FG000|Overall Study|Met Exclusion Criteria|2|||
27731749|NCT01111604|80843018|FG001|Overall Study|Met Exclusion Criteria|0|||
27731750|NCT01111604|80843019|FG002|Overall Study|Met Exclusion Criteria|0|||
27754905|NCT02065622|80929630|FG000|Maintenance Study|Lost to Follow-up|0|||
27754906|NCT02065622|80929631|FG001|Maintenance Study|Lost to Follow-up|0|||
27754907|NCT02065622|80929632|FG002|Maintenance Study|Lost to Follow-up|4|||
27754908|NCT02065622|80929633|FG003|Maintenance Study|Lost to Follow-up|1|||
27754909|NCT02065622|80929634|FG004|Maintenance Study|Lost to Follow-up|1|||
27754910|NCT02065622|80929630|FG000|Maintenance Study|Lack of Efficacy|0|||
27754911|NCT02065622|80929631|FG001|Maintenance Study|Lack of Efficacy|0|||
27754912|NCT02065622|80929632|FG002|Maintenance Study|Lack of Efficacy|70|||
27754913|NCT02065622|80929633|FG003|Maintenance Study|Lack of Efficacy|55|||
27754914|NCT02065622|80929634|FG004|Maintenance Study|Lack of Efficacy|19|||
27854544|NCT03573505|81298807|FG000|Overall Study|Study terminated by sponsor|50|||
27854545|NCT03573505|81298808|FG001|Overall Study|Study terminated by sponsor|45|||
27854546|NCT03573505|81298807|FG000|Overall Study|Reason not specified|0|||
27854547|NCT03573505|81298808|FG001|Overall Study|Reason not specified|1|||
27854548|NCT03573505|81298807|FG000|Overall Study|Death|0|||
27854549|NCT03573505|81298808|FG001|Overall Study|Death|4|||
27854550|NCT00968799|81298815|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
27522130|NCT01343901|80105041|FG000|Overall Study|Participant decision|1|||
27522131|NCT02518464|80105044|FG000|Overall Study|Adverse Event|2|||
27754915|NCT02065622|80929630|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
27754916|NCT02065622|80929631|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
27754917|NCT02065622|80929632|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
27522132|NCT01369329|80105045|FG000|Overall Study|Withdrawal by Subject|8|||
27522133|NCT01369329|80105046|FG001|Overall Study|Withdrawal by Subject|6|||
27522134|NCT01369329|80105047|FG002|Overall Study|Withdrawal by Subject|10|||
27754918|NCT02065622|80929633|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
27754919|NCT02065622|80929634|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
27754920|NCT02065622|80929630|FG000|Maintenance Study|Subject Non-Compliance|0|||
27854551|NCT03551496|81298816|FG000|Overall Study|Death|11|||
27854552|NCT03551496|81298817|FG001|Overall Study|Death|7|||
27522135|NCT01369329|80105045|FG000|Overall Study|Lost to Follow-up|2|||
27522136|NCT01369329|80105046|FG001|Overall Study|Lost to Follow-up|2|||
27522137|NCT01369329|80105047|FG002|Overall Study|Lost to Follow-up|2|||
27522138|NCT01369329|80105045|FG000|Overall Study|Other|2|||
27522139|NCT01369329|80105046|FG001|Overall Study|Other|3|||
27522140|NCT01369329|80105047|FG002|Overall Study|Other|2|||
27522141|NCT01101308|80105048|FG000|Period 1|Adverse Event|2|||
27522142|NCT01101308|80105049|FG001|Period 1|Adverse Event|1|||
27522143|NCT01101308|80105048|FG000|Period 1|Positive for cotinine|1|||
27522144|NCT01101308|80105049|FG001|Period 1|Positive for cotinine|0|||
27522145|NCT01909791|80105052|FG000|Overall Study|Death|9|||
27522146|NCT01909791|80105053|FG001|Overall Study|Death|8|||
27522147|NCT01909791|80105054|FG002|Overall Study|Death|4|||
27854553|NCT03551496|81298816|FG000|Overall Study|Withdrawal by Subject|4|||
27854554|NCT03551496|81298817|FG001|Overall Study|Withdrawal by Subject|3|||
27522148|NCT01909791|80105052|FG000|Overall Study|Withdrawal by Subject|5|||
27522149|NCT01909791|80105053|FG001|Overall Study|Withdrawal by Subject|9|||
27522150|NCT01909791|80105054|FG002|Overall Study|Withdrawal by Subject|13|||
27854555|NCT03551496|81298816|FG000|Overall Study|Other Reasons|1|||
27522151|NCT01909791|80105052|FG000|Overall Study|Lost to Follow-up|5|||
27522152|NCT01909791|80105053|FG001|Overall Study|Lost to Follow-up|11|||
27522153|NCT01909791|80105054|FG002|Overall Study|Lost to Follow-up|10|||
27522154|NCT01909791|80105052|FG000|Overall Study|Missed Visit|2|||
27522155|NCT01909791|80105053|FG001|Overall Study|Missed Visit|0|||
27522156|NCT01909791|80105054|FG002|Overall Study|Missed Visit|1|||
27522157|NCT03996369|80105057|FG000|Overall Study|Protocol deviation|1|||
27522158|NCT03996369|80105058|FG001|Overall Study|Protocol deviation|1|||
27522159|NCT03996369|80105057|FG000|Overall Study|Physician Decision|4|||
27522160|NCT03996369|80105058|FG001|Overall Study|Physician Decision|2|||
27522161|NCT03996369|80105057|FG000|Overall Study|Participant decision|0|||
27522162|NCT03996369|80105058|FG001|Overall Study|Participant decision|1|||
27522163|NCT03996369|80105057|FG000|Overall Study|Lack of Efficacy|4|||
27522164|NCT03996369|80105058|FG001|Overall Study|Lack of Efficacy|0|||
27522165|NCT03996369|80105057|FG000|Overall Study|Adverse Event|9|||
27522166|NCT03996369|80105058|FG001|Overall Study|Adverse Event|0|||
27522167|NCT03996369|80105057|FG000|Overall Study|Withdrawal by Subject|6|||
27522168|NCT03996369|80105058|FG001|Overall Study|Withdrawal by Subject|8|||
27522169|NCT03996369|80105057|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
27522170|NCT03996369|80105058|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
27522171|NCT03996369|80105057|FG000|Overall Study|Lost to Follow-up|0|||
27522172|NCT03996369|80105058|FG001|Overall Study|Lost to Follow-up|1|||
27522173|NCT04585009|80105061|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
27522174|NCT04585009|80105062|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522175|NCT04585009|80105063|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522176|NCT04585009|80105064|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522177|NCT04585009|80105065|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522178|NCT04585009|80105066|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522179|NCT04585009|80105067|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522180|NCT04585009|80105068|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522181|NCT04585009|80105069|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522182|NCT04585009|80105070|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522183|NCT04585009|80105071|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522184|NCT04585009|80105072|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
27522185|NCT04585009|80105061|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
27522186|NCT04585009|80105062|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522187|NCT04585009|80105063|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522188|NCT04585009|80105064|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522189|NCT04585009|80105065|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522190|NCT04585009|80105066|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522191|NCT04585009|80105067|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522192|NCT04585009|80105068|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522193|NCT04585009|80105069|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522194|NCT04585009|80105070|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522195|NCT04585009|80105071|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522196|NCT04585009|80105072|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
27522197|NCT04585009|80105061|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522198|NCT04585009|80105062|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522199|NCT04585009|80105063|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522200|NCT04585009|80105064|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522201|NCT04585009|80105065|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522202|NCT04585009|80105066|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522203|NCT04585009|80105067|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522204|NCT04585009|80105068|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
27522205|NCT04585009|80105069|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522206|NCT04585009|80105070|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522207|NCT04585009|80105071|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522208|NCT04585009|80105072|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
27522209|NCT04585009|80105061|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522210|NCT04585009|80105062|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522211|NCT04585009|80105063|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522212|NCT04585009|80105064|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522213|NCT04585009|80105065|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
27522214|NCT04585009|80105066|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522215|NCT04585009|80105067|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522216|NCT04585009|80105068|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522217|NCT04585009|80105069|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522218|NCT04585009|80105070|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522219|NCT04585009|80105071|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522220|NCT04585009|80105072|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
27522221|NCT04585009|80105061|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522222|NCT04585009|80105062|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522223|NCT04585009|80105063|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522224|NCT04585009|80105064|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522225|NCT04585009|80105065|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522226|NCT04585009|80105066|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522227|NCT04585009|80105067|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522228|NCT04585009|80105068|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522229|NCT04585009|80105069|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522230|NCT04585009|80105070|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
27522231|NCT04585009|80105071|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522232|NCT04585009|80105072|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
27522233|NCT04585009|80105061|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522234|NCT04585009|80105062|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522235|NCT04585009|80105063|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522236|NCT04585009|80105064|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522237|NCT04585009|80105065|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522238|NCT04585009|80105066|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522239|NCT04585009|80105067|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522240|NCT04585009|80105068|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522241|NCT04585009|80105069|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522242|NCT04585009|80105070|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522243|NCT04585009|80105071|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
27522244|NCT04585009|80105072|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
27522245|NCT04620798|80105073|FG000|Overall Study|Lost to Follow-up|126|||
27522246|NCT04620798|80105074|FG001|Overall Study|Lost to Follow-up|138|||
27522247|NCT00710762|80105080|FG000|Overall Study|Progressive disease|27|||
27522248|NCT00710762|80105081|FG001|Overall Study|Progressive disease|30|||
27522249|NCT00710762|80105080|FG000|Overall Study|Adverse Event other disease worsening|2|||
27522250|NCT00710762|80105081|FG001|Overall Study|Adverse Event other disease worsening|1|||
27522251|NCT00710762|80105080|FG000|Overall Study|Other Adverse Event|7|||
27522252|NCT00710762|80105081|FG001|Overall Study|Other Adverse Event|7|||
27522253|NCT00710762|80105080|FG000|Overall Study|Lost to Follow-up|1|||
27522254|NCT00710762|80105081|FG001|Overall Study|Lost to Follow-up|0|||
27522255|NCT00710762|80105080|FG000|Overall Study|Reason other than listed above|2|||
27522256|NCT00710762|80105081|FG001|Overall Study|Reason other than listed above|2|||
27522257|NCT01120782|80105082|FG000|Overall Study|Test article shipping error|11|||
27522258|NCT03985878|80105084|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
27522259|NCT03985878|80105084|FG000|Overall Study|Study Terminated by Sponsor|12|||
27522260|NCT03985878|80105084|FG000|Overall Study|Withdrawal by Subject|1|||
27522261|NCT00129311|80105088|FG000|Overall Study|Withdrawal by Subject|12|||
27522262|NCT00129311|80105089|FG001|Overall Study|Withdrawal by Subject|19|||
27522263|NCT00357760|80105090|FG000|Overall Study|Disease progression|44|||
27522264|NCT00357760|80105091|FG001|Overall Study|Disease progression|17|||
27522265|NCT00357760|80105090|FG000|Overall Study|Adverse Event|10|||
27522266|NCT00357760|80105091|FG001|Overall Study|Adverse Event|7|||
27522267|NCT00357760|80105090|FG000|Overall Study|Death|0|||
27522268|NCT00357760|80105091|FG001|Overall Study|Death|3|||
27522269|NCT00357760|80105090|FG000|Overall Study|Alternative therapy|1|||
27522270|NCT00357760|80105091|FG001|Overall Study|Alternative therapy|0|||
27522271|NCT00357760|80105090|FG000|Overall Study|Withdrawal by Subject|0|||
27522272|NCT00357760|80105091|FG001|Overall Study|Withdrawal by Subject|2|||
27522273|NCT00357760|80105090|FG000|Overall Study|Never started treatment|2|||
27522274|NCT00357760|80105091|FG001|Overall Study|Never started treatment|1|||
27522275|NCT00357760|80105090|FG000|Overall Study|Ineligible|0|||
27522276|NCT00357760|80105091|FG001|Overall Study|Ineligible|2|||
27522277|NCT00357760|80105090|FG000|Overall Study|Physician Decision|2|||
27522278|NCT00357760|80105091|FG001|Overall Study|Physician Decision|1|||
27522279|NCT00357760|80105090|FG000|Overall Study|Protocol Violation|0|||
27522280|NCT00357760|80105091|FG001|Overall Study|Protocol Violation|1|||
27522281|NCT00357760|80105090|FG000|Overall Study|To receive hospice care|0|||
27522282|NCT00357760|80105091|FG001|Overall Study|To receive hospice care|1|||
27522283|NCT01892384|80105092|FG000|Overall Study|Withdrawal by Subject|1|||
27522284|NCT01892384|80105093|FG001|Overall Study|Withdrawal by Subject|1|||
27522285|NCT01892384|80105094|FG002|Overall Study|Withdrawal by Subject|0|||
27522286|NCT01892384|80105095|FG003|Overall Study|Withdrawal by Subject|0|||
27522287|NCT00934843|80105096|FG000|Overall Study|Protocol Violation|0|||
27522288|NCT00934843|80105097|FG001|Overall Study|Protocol Violation|1|||
27522289|NCT01122264|80105100|FG000|Overall Study|Adverse Event|6|||
27731751|NCT03367871|80846056|FG000|Overall Study|Lost to Follow-up|1|||
27854556|NCT03551496|81298817|FG001|Overall Study|Other Reasons|0|||
27522290|NCT01122264|80105101|FG001|Overall Study|Adverse Event|5|||
27522291|NCT01122264|80105102|FG002|Overall Study|Adverse Event|7|||
27620669|NCT00681811|80455950|FG000|Overall Study|Adverse Event|1|||
27620670|NCT00681811|80455951|FG001|Overall Study|Adverse Event|1|||
27620671|NCT00681811|80455950|FG000|Overall Study|Withdrawal by Subject|2|||
27620672|NCT00681811|80455951|FG001|Overall Study|Withdrawal by Subject|2|||
27620673|NCT00681811|80455950|FG000|Overall Study|Non-compliance|0|||
27620674|NCT00681811|80455951|FG001|Overall Study|Non-compliance|1|||
27620675|NCT01474512|80455965|FG000|Induction Period|Adverse Event|6|||
27620676|NCT01474512|80455966|FG001|Induction Period|Adverse Event|10|||
27620677|NCT01474512|80455967|FG002|Induction Period|Adverse Event|10|||
27731752|NCT00723957|80846058|FG000|Overall Study|Adverse event unrelated to study drug|1|||
27731753|NCT00723957|80846059|FG001|Overall Study|Adverse event unrelated to study drug|4|||
27731754|NCT00723957|80846058|FG000|Overall Study|Death|3|||
27731755|NCT00723957|80846059|FG001|Overall Study|Death|4|||
27731756|NCT00723957|80846058|FG000|Overall Study|Disease progression|27|||
27731757|NCT00723957|80846059|FG001|Overall Study|Disease progression|25|||
27731758|NCT00723957|80846058|FG000|Overall Study|Maximum clinical benefit|4|||
27731759|NCT00723957|80846059|FG001|Overall Study|Maximum clinical benefit|5|||
27731760|NCT00723957|80846058|FG000|Overall Study|Investigator decision|1|||
27731761|NCT00723957|80846059|FG001|Overall Study|Investigator decision|1|||
27731762|NCT00723957|80846058|FG000|Overall Study|Study drug toxicity|4|||
27731763|NCT00723957|80846059|FG001|Overall Study|Study drug toxicity|6|||
27731764|NCT00723957|80846058|FG000|Overall Study|Withdrawal by Subject|7|||
27731765|NCT00723957|80846059|FG001|Overall Study|Withdrawal by Subject|5|||
27731766|NCT00723957|80846058|FG000|Overall Study|Reason not analyzed|1|||
27731767|NCT00723957|80846059|FG001|Overall Study|Reason not analyzed|0|||
27731768|NCT00723957|80846058|FG000|Overall Study|Never received treatment|3|||
27731769|NCT00723957|80846059|FG001|Overall Study|Never received treatment|3|||
27731770|NCT01032629|80846060|FG000|Overall Study|Closed Site|21|||
27731771|NCT01032629|80846061|FG001|Overall Study|Closed Site|18|||
27731772|NCT01032629|80846062|FG002|Overall Study|Closed Site|16|||
27731773|NCT01032629|80846060|FG000|Overall Study|Withdrawal by Subject|50|||
27731774|NCT01032629|80846061|FG001|Overall Study|Withdrawal by Subject|36|||
27731775|NCT01032629|80846062|FG002|Overall Study|Withdrawal by Subject|35|||
27522292|NCT01122264|80105100|FG000|Overall Study|Death|1|||
27522293|NCT01122264|80105101|FG001|Overall Study|Death|0|||
27522294|NCT01122264|80105102|FG002|Overall Study|Death|0|||
27522295|NCT01122264|80105100|FG000|Overall Study|Lost to Follow-up|5|||
27522296|NCT01122264|80105101|FG001|Overall Study|Lost to Follow-up|9|||
27522297|NCT01122264|80105102|FG002|Overall Study|Lost to Follow-up|13|||
27522298|NCT01122264|80105100|FG000|Overall Study|Entry Criteria Not Met|1|||
27522299|NCT01122264|80105101|FG001|Overall Study|Entry Criteria Not Met|0|||
27522300|NCT01122264|80105102|FG002|Overall Study|Entry Criteria Not Met|0|||
27522301|NCT01122264|80105100|FG000|Overall Study|Protocol Violation|7|||
27522302|NCT01122264|80105101|FG001|Overall Study|Protocol Violation|7|||
27522303|NCT01122264|80105102|FG002|Overall Study|Protocol Violation|9|||
27522304|NCT01122264|80105100|FG000|Overall Study|Withdrawal by Subject|6|||
27522305|NCT01122264|80105101|FG001|Overall Study|Withdrawal by Subject|6|||
27522306|NCT01122264|80105102|FG002|Overall Study|Withdrawal by Subject|16|||
27522307|NCT01122264|80105100|FG000|Overall Study|Physician Decision|3|||
27522308|NCT01122264|80105101|FG001|Overall Study|Physician Decision|1|||
27522309|NCT01122264|80105102|FG002|Overall Study|Physician Decision|1|||
27522310|NCT01122264|80105100|FG000|Overall Study|Lack of Efficacy|3|||
27522311|NCT01122264|80105101|FG001|Overall Study|Lack of Efficacy|1|||
27522312|NCT01122264|80105102|FG002|Overall Study|Lack of Efficacy|1|||
27522313|NCT02279407|80105103|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
27522314|NCT02279407|80105104|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
27522315|NCT02279407|80105105|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
27522316|NCT02279407|80105106|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
27522317|NCT02279407|80105103|FG000|Overall Study|Withdrawal by Subject|1|||
27522318|NCT02279407|80105104|FG001|Overall Study|Withdrawal by Subject|0|||
27522319|NCT02279407|80105105|FG002|Overall Study|Withdrawal by Subject|1|||
27522320|NCT02279407|80105106|FG003|Overall Study|Withdrawal by Subject|1|||
27522321|NCT02279407|80105103|FG000|Overall Study|Adverse Event|1|||
27522322|NCT02279407|80105104|FG001|Overall Study|Adverse Event|1|||
27522323|NCT02279407|80105105|FG002|Overall Study|Adverse Event|2|||
27522324|NCT02279407|80105106|FG003|Overall Study|Adverse Event|0|||
27731776|NCT01032629|80846060|FG000|Overall Study|Lost to Follow-up|74|||
27731777|NCT01032629|80846061|FG001|Overall Study|Lost to Follow-up|47|||
27522325|NCT00745849|80105111|FG000|First Intervention|Withdrawal by Subject|0|||
27522326|NCT00745849|80105112|FG001|First Intervention|Withdrawal by Subject|1|||
27620678|NCT01474512|80455968|FG003|Induction Period|Adverse Event|0|||
27620679|NCT01474512|80455969|FG004|Induction Period|Adverse Event|0|||
27620680|NCT01474512|80455970|FG005|Induction Period|Adverse Event|0|||
27620681|NCT01474512|80455971|FG006|Induction Period|Adverse Event|0|||
27731778|NCT01032629|80846062|FG002|Overall Study|Lost to Follow-up|37|||
27854557|NCT01806506|81298818|FG000|Overall Study|Lost to Follow-up|2|||
27522327|NCT00745849|80105111|FG000|First Intervention|Lost to Follow-up|1|||
27522328|NCT00745849|80105112|FG001|First Intervention|Lost to Follow-up|1|||
27522329|NCT00745849|80105111|FG000|Second Intervention|Lost to Follow-up|2|||
27522330|NCT00745849|80105112|FG001|Second Intervention|Lost to Follow-up|1|||
27522331|NCT01470989|80105115|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
27522332|NCT01470989|80105116|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
27522333|NCT01470989|80105115|FG000|Overall Study|Adverse Event|2|||
27522334|NCT01470989|80105116|FG001|Overall Study|Adverse Event|5|||
27854558|NCT01806506|81298819|FG001|Overall Study|Lost to Follow-up|1|||
27854559|NCT00838435|81298823|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
27522335|NCT01470989|80105115|FG000|Overall Study|Abnormal laboratory value|1|||
27522336|NCT01470989|80105116|FG001|Overall Study|Abnormal laboratory value|1|||
27522337|NCT01470989|80105115|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27522338|NCT01470989|80105116|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
27522339|NCT01470989|80105115|FG000|Overall Study|Withdrawal by Subject|19|||
27854560|NCT00838435|81298823|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
27854561|NCT00838435|81298823|FG000|Part 2 (7 Years)|Adverse Event|2|||
27854562|NCT00838435|81298823|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
27854563|NCT00838435|81298823|FG000|Part 2 (7 Years)|Physician Decision|1|||
27854564|NCT00838435|81298823|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
27854565|NCT00838435|81298823|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
27854566|NCT00821873|81298824|FG000|Overall Study|Lost to Follow-up|4|||
27854567|NCT00114166|81298825|FG000|Overall Study|Wrong primary|0|||
27854568|NCT00114166|81298826|FG001|Overall Study|Wrong primary|1|||
27854569|NCT02128217|81298836|FG000|Overall Study|Lost to Follow-up|0|||
27854570|NCT02128217|81298837|FG001|Overall Study|Lost to Follow-up|1|||
27522340|NCT01470989|80105116|FG001|Overall Study|Withdrawal by Subject|17|||
27522341|NCT01470989|80105115|FG000|Overall Study|Lost to Follow-up|18|||
27522342|NCT01470989|80105116|FG001|Overall Study|Lost to Follow-up|13|||
27522343|NCT01470989|80105115|FG000|Overall Study|Administrative problems|2|||
27522344|NCT01470989|80105116|FG001|Overall Study|Administrative problems|4|||
27522345|NCT01470989|80105115|FG000|Overall Study|Death|2|||
27522346|NCT01470989|80105116|FG001|Overall Study|Death|2|||
27522347|NCT01470989|80105115|FG000|Overall Study|Protocol deviation|1|||
27522348|NCT01470989|80105116|FG001|Overall Study|Protocol deviation|2|||
27522349|NCT02342418|80105117|FG000|Overall Study|Adverse Event|0|||
27522350|NCT02342418|80105118|FG001|Overall Study|Adverse Event|1|||
27522351|NCT02600871|80105119|FG000|Overall Study|Lost to Follow-up|13|||
27522352|NCT02600871|80105120|FG001|Overall Study|Lost to Follow-up|10|||
27522353|NCT00281658|80105121|FG000|Randomized Phase|Adverse Event|0|||
27522354|NCT00281658|80105122|FG001|Randomized Phase|Adverse Event|2|||
27522355|NCT00281658|80105123|FG002|Randomized Phase|Adverse Event|0|||
27522356|NCT00281658|80105124|FG003|Randomized Phase|Adverse Event|0|||
27522357|NCT00281658|80105121|FG000|Randomized Phase|Lost to Follow-up|34|||
27522358|NCT00281658|80105122|FG001|Randomized Phase|Lost to Follow-up|27|||
27522359|NCT00281658|80105123|FG002|Randomized Phase|Lost to Follow-up|0|||
27522360|NCT00281658|80105124|FG003|Randomized Phase|Lost to Follow-up|0|||
27522361|NCT00281658|80105121|FG000|Randomized Phase|Withdrawal by Subject|8|||
27522362|NCT00281658|80105122|FG001|Randomized Phase|Withdrawal by Subject|7|||
27522363|NCT00281658|80105123|FG002|Randomized Phase|Withdrawal by Subject|0|||
27522364|NCT00281658|80105124|FG003|Randomized Phase|Withdrawal by Subject|0|||
27522365|NCT00281658|80105121|FG000|Randomized Phase|Study closed/terminated|1|||
27522366|NCT00281658|80105122|FG001|Randomized Phase|Study closed/terminated|1|||
27522367|NCT00281658|80105123|FG002|Randomized Phase|Study closed/terminated|0|||
27522368|NCT00281658|80105124|FG003|Randomized Phase|Study closed/terminated|0|||
27522369|NCT00281658|80105121|FG000|Randomized Phase|Disease progression|36|||
27522370|NCT00281658|80105122|FG001|Randomized Phase|Disease progression|27|||
27522371|NCT00281658|80105123|FG002|Randomized Phase|Disease progression|0|||
27522372|NCT00281658|80105124|FG003|Randomized Phase|Disease progression|0|||
27522373|NCT00281658|80105121|FG000|Randomized Phase|Physician Decision|1|||
27522374|NCT00281658|80105122|FG001|Randomized Phase|Physician Decision|1|||
27522375|NCT00281658|80105123|FG002|Randomized Phase|Physician Decision|0|||
27522376|NCT00281658|80105124|FG003|Randomized Phase|Physician Decision|0|||
27522377|NCT00281658|80105121|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
27522378|NCT00281658|80105122|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
27522379|NCT00281658|80105123|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
27522380|NCT00281658|80105124|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
27522381|NCT00281658|80105121|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
27522382|NCT00281658|80105122|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
27522383|NCT00281658|80105123|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
27522384|NCT00281658|80105124|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
27522385|NCT00281658|80105121|FG000|Randomized Phase|Treatment ongoing|1|||
27522386|NCT00281658|80105122|FG001|Randomized Phase|Treatment ongoing|0|||
27522387|NCT00281658|80105123|FG002|Randomized Phase|Treatment ongoing|0|||
27731779|NCT00925600|80846063|FG000|Overall Study|Withdrawal by Subject|16|||
27854571|NCT00158600|81298839|FG000|Overall Study|unable to commit time to study|0|||
27522388|NCT00281658|80105124|FG003|Randomized Phase|Treatment ongoing|0|||
27731780|NCT00925600|80846064|FG001|Overall Study|Withdrawal by Subject|14|||
27731781|NCT00925600|80846063|FG000|Overall Study|Death|4|||
27731782|NCT00925600|80846064|FG001|Overall Study|Death|3|||
27731783|NCT00925600|80846063|FG000|Overall Study|Lost to Follow-up|2|||
27731784|NCT00925600|80846064|FG001|Overall Study|Lost to Follow-up|2|||
27731785|NCT00925600|80846063|FG000|Overall Study|Disease Progression|1|||
27731786|NCT00925600|80846064|FG001|Overall Study|Disease Progression|3|||
27522389|NCT00281658|80105121|FG000|Open Label Phase|Adverse Event|0|||
27522390|NCT00281658|80105122|FG001|Open Label Phase|Adverse Event|0|||
27522391|NCT00281658|80105123|FG002|Open Label Phase|Adverse Event|1|||
27522392|NCT00281658|80105124|FG003|Open Label Phase|Adverse Event|0|||
27522393|NCT00281658|80105121|FG000|Open Label Phase|Lost to Follow-up|0|||
27522394|NCT00281658|80105122|FG001|Open Label Phase|Lost to Follow-up|0|||
27522395|NCT00281658|80105123|FG002|Open Label Phase|Lost to Follow-up|16|||
27522396|NCT00281658|80105124|FG003|Open Label Phase|Lost to Follow-up|2|||
27522397|NCT00281658|80105121|FG000|Open Label Phase|Withdrawal by Subject|0|||
27522398|NCT00281658|80105122|FG001|Open Label Phase|Withdrawal by Subject|0|||
27522399|NCT00281658|80105123|FG002|Open Label Phase|Withdrawal by Subject|3|||
27522400|NCT00281658|80105124|FG003|Open Label Phase|Withdrawal by Subject|2|||
27522401|NCT00281658|80105121|FG000|Open Label Phase|Disease progression|0|||
27522402|NCT00281658|80105122|FG001|Open Label Phase|Disease progression|0|||
27522403|NCT00281658|80105123|FG002|Open Label Phase|Disease progression|18|||
27522404|NCT00281658|80105124|FG003|Open Label Phase|Disease progression|0|||
27522405|NCT00281658|80105121|FG000|Open Label Phase|Physician Decision|0|||
27522406|NCT00281658|80105122|FG001|Open Label Phase|Physician Decision|0|||
27522407|NCT00281658|80105123|FG002|Open Label Phase|Physician Decision|1|||
27522408|NCT00281658|80105124|FG003|Open Label Phase|Physician Decision|0|||
27522409|NCT00281658|80105121|FG000|Open Label Phase|Relocation of patient|0|||
27522410|NCT00281658|80105122|FG001|Open Label Phase|Relocation of patient|0|||
27522411|NCT00281658|80105123|FG002|Open Label Phase|Relocation of patient|1|||
27522412|NCT00281658|80105124|FG003|Open Label Phase|Relocation of patient|0|||
27522413|NCT00281658|80105121|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
27522414|NCT00281658|80105122|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
27522415|NCT00281658|80105123|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
27522416|NCT00281658|80105124|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
27522417|NCT05277337|80105126|FG000|Overall Study|Lost to Follow-up|2|||
27522418|NCT05277337|80105127|FG001|Overall Study|Lost to Follow-up|0|||
27522419|NCT05277337|80105126|FG000|Overall Study|Withdrawal by Subject|1|||
27522420|NCT05277337|80105127|FG001|Overall Study|Withdrawal by Subject|0|||
27522421|NCT02386189|80105132|FG000|Overall Study|Lost to Follow-up|2|||
27522422|NCT02386189|80105133|FG001|Overall Study|Lost to Follow-up|3|||
27522423|NCT02386189|80105132|FG000|Overall Study|Withdrawal by Subject|1|||
27522424|NCT02386189|80105133|FG001|Overall Study|Withdrawal by Subject|0|||
27522425|NCT02386189|80105132|FG000|Overall Study|Death|1|||
27522426|NCT02386189|80105133|FG001|Overall Study|Death|0|||
27522427|NCT04658940|80105135|FG000|Overall Study|Withdrawal by Subject|1|||
27522428|NCT02793622|80105136|FG000|Overall Study|Lost to Follow-up|31|||
27522429|NCT02793622|80105137|FG001|Overall Study|Lost to Follow-up|19|||
27522430|NCT02793622|80105136|FG000|Overall Study|Withdrawal by Subject|21|||
27522431|NCT02793622|80105137|FG001|Overall Study|Withdrawal by Subject|17|||
27522432|NCT02793622|80105136|FG000|Overall Study|Adverse Event|0|||
27522433|NCT02793622|80105137|FG001|Overall Study|Adverse Event|1|||
27522434|NCT02793622|80105136|FG000|Overall Study|Protocol Violation|1|||
27522435|NCT02793622|80105137|FG001|Overall Study|Protocol Violation|5|||
27522436|NCT00362180|80105138|FG000|Treated Period|Withdrawal by Subject|1|||
27522437|NCT00362180|80105139|FG001|Treated Period|Withdrawal by Subject|0|||
27522438|NCT00362180|80105140|FG002|Treated Period|Withdrawal by Subject|0|||
27522439|NCT00362180|80105141|FG003|Treated Period|Withdrawal by Subject|0|||
27522440|NCT00362180|80105142|FG004|Treated Period|Withdrawal by Subject|0|||
27522441|NCT00362180|80105143|FG005|Treated Period|Withdrawal by Subject|0|||
27522442|NCT00362180|80105144|FG006|Treated Period|Withdrawal by Subject|0|||
27620682|NCT01474512|80455972|FG007|Induction Period|Adverse Event|0|||
27731787|NCT00925600|80846063|FG000|Overall Study|Administrative Decision|1|||
27731788|NCT00925600|80846064|FG001|Overall Study|Administrative Decision|1|||
27522443|NCT00362180|80105145|FG007|Treated Period|Withdrawal by Subject|0|||
27522444|NCT00362180|80105146|FG008|Treated Period|Withdrawal by Subject|0|||
27522445|NCT00362180|80105138|FG000|Treated Period|Adverse Event|0|||
27522446|NCT00362180|80105139|FG001|Treated Period|Adverse Event|0|||
27522447|NCT00362180|80105140|FG002|Treated Period|Adverse Event|0|||
27522448|NCT00362180|80105141|FG003|Treated Period|Adverse Event|0|||
27522449|NCT00362180|80105142|FG004|Treated Period|Adverse Event|0|||
27522450|NCT00362180|80105143|FG005|Treated Period|Adverse Event|1|||
27522451|NCT00362180|80105144|FG006|Treated Period|Adverse Event|0|||
27522452|NCT00362180|80105145|FG007|Treated Period|Adverse Event|1|||
27522453|NCT00362180|80105146|FG008|Treated Period|Adverse Event|0|||
27522454|NCT01092832|80105147|FG000|Overall Study|Other|1|||
27620683|NCT01474512|80455973|FG008|Induction Period|Adverse Event|0|||
27620684|NCT01474512|80455974|FG009|Induction Period|Adverse Event|0|||
27620685|NCT01474512|80455975|FG010|Induction Period|Adverse Event|0|||
27620686|NCT01474512|80455976|FG011|Induction Period|Adverse Event|0|||
27620687|NCT01474512|80455977|FG012|Induction Period|Adverse Event|0|||
27620688|NCT01474512|80455978|FG013|Induction Period|Adverse Event|0|||
27620689|NCT01474512|80455979|FG014|Induction Period|Adverse Event|0|||
27620690|NCT01474512|80455980|FG015|Induction Period|Adverse Event|0|||
27620691|NCT01474512|80455981|FG016|Induction Period|Adverse Event|0|||
27620692|NCT01474512|80455982|FG017|Induction Period|Adverse Event|0|||
27620693|NCT01474512|80455965|FG000|Induction Period|Lack of Efficacy|7|||
27620694|NCT01474512|80455966|FG001|Induction Period|Lack of Efficacy|1|||
27620695|NCT01474512|80455967|FG002|Induction Period|Lack of Efficacy|0|||
27620696|NCT01474512|80455968|FG003|Induction Period|Lack of Efficacy|0|||
27620697|NCT01474512|80455969|FG004|Induction Period|Lack of Efficacy|0|||
27620698|NCT01474512|80455970|FG005|Induction Period|Lack of Efficacy|0|||
27620699|NCT01474512|80455971|FG006|Induction Period|Lack of Efficacy|0|||
27620700|NCT01474512|80455972|FG007|Induction Period|Lack of Efficacy|0|||
27731789|NCT00925600|80846063|FG000|Overall Study|Noncompliance|2|||
27731790|NCT00925600|80846064|FG001|Overall Study|Noncompliance|0|||
27731791|NCT00925600|80846063|FG000|Overall Study|Ineligibility Determined|2|||
27731792|NCT00925600|80846064|FG001|Overall Study|Ineligibility Determined|0|||
27909453|NCT00215644|81506940|FG000|Overall Study|Randomized but Not Treated|1|||
27909454|NCT00215644|81506941|FG001|Overall Study|Randomized but Not Treated|0|||
27909455|NCT01429298|81506942|FG000|Overall Study|Protocol Violation|4|||
27909456|NCT01429298|81506943|FG001|Overall Study|Protocol Violation|6|||
27909457|NCT02372383|81506944|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
27909458|NCT02372383|81506945|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
27909459|NCT02372383|81506946|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
27909460|NCT01091246|81506947|FG000|Overall Study|Lost to Follow-up|23|||
27909461|NCT01091246|81506948|FG001|Overall Study|Lost to Follow-up|11|||
27909462|NCT01091246|81506949|FG002|Overall Study|Lost to Follow-up|7|||
27909463|NCT01091246|81506947|FG000|Overall Study|Adverse Event|1|||
27909464|NCT01091246|81506948|FG001|Overall Study|Adverse Event|0|||
27909465|NCT01091246|81506949|FG002|Overall Study|Adverse Event|1|||
27909466|NCT01091246|81506947|FG000|Overall Study|Withdrawal by Subject|9|||
27909467|NCT01091246|81506948|FG001|Overall Study|Withdrawal by Subject|5|||
27909468|NCT01091246|81506949|FG002|Overall Study|Withdrawal by Subject|4|||
27909469|NCT01091246|81506947|FG000|Overall Study|Subject not dosed|2|||
27909470|NCT01091246|81506948|FG001|Overall Study|Subject not dosed|0|||
27909471|NCT01091246|81506949|FG002|Overall Study|Subject not dosed|1|||
27909472|NCT05176717|81506950|FG000|Overall Study|Sponsor Decision|1|||
27909473|NCT05176717|81506951|FG001|Overall Study|Sponsor Decision|2|||
27731793|NCT00925600|80846063|FG000|Overall Study|Protocol Deviation|0|||
27731794|NCT00925600|80846064|FG001|Overall Study|Protocol Deviation|1|||
27909474|NCT05176717|81506952|FG002|Overall Study|Sponsor Decision|2|||
27909475|NCT02335346|81506953|FG000|Overall Study|Adverse Event|11|||
27909476|NCT02335346|81506953|FG000|Overall Study|Withdrawal by Subject|1|||
27909477|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
27909478|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
27909479|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
27909480|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
27909481|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
27909482|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
27620701|NCT01474512|80455973|FG008|Induction Period|Lack of Efficacy|0|||
27731795|NCT00925600|80846063|FG000|Overall Study|Requirement for Alternative Therapy|0|||
27731796|NCT00925600|80846064|FG001|Overall Study|Requirement for Alternative Therapy|1|||
27731797|NCT00925600|80846063|FG000|Overall Study|Other|3|||
27731798|NCT00925600|80846064|FG001|Overall Study|Other|1|||
27731799|NCT00925600|80846063|FG000|Overall Study|Adverse Event|1|||
27731800|NCT00925600|80846064|FG001|Overall Study|Adverse Event|2|||
27731801|NCT00480857|80846065|FG000|Overall Study|Lack of Efficacy|2|||
27731802|NCT00840827|80846066|FG000|Overall Study|Adverse Event|1|||
27731803|NCT00840827|80846066|FG000|Overall Study|Lack of Efficacy|4|||
27731804|NCT00840827|80846066|FG000|Overall Study|Physician Decision|1|||
27731805|NCT01128387|80846067|FG000|Overall Study|Physician Decision|0|||
27731806|NCT01128387|80846068|FG001|Overall Study|Physician Decision|1|||
27620702|NCT01474512|80455974|FG009|Induction Period|Lack of Efficacy|0|||
27731807|NCT01409928|80846069|FG000|Overall Study|Physician Decision|12|||
27731808|NCT02786901|80846070|FG000|Overall Study|Adverse Event|1|||
27731809|NCT02786901|80846071|FG001|Overall Study|Adverse Event|1|||
27731810|NCT02786901|80846072|FG002|Overall Study|Adverse Event|2|||
27909483|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
27909484|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
27909485|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
27909486|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
27909487|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
27620703|NCT01474512|80455975|FG010|Induction Period|Lack of Efficacy|0|||
27620704|NCT01474512|80455976|FG011|Induction Period|Lack of Efficacy|0|||
27620705|NCT01474512|80455977|FG012|Induction Period|Lack of Efficacy|0|||
27620706|NCT01474512|80455978|FG013|Induction Period|Lack of Efficacy|0|||
27620707|NCT01474512|80455979|FG014|Induction Period|Lack of Efficacy|0|||
27620708|NCT01474512|80455980|FG015|Induction Period|Lack of Efficacy|0|||
27620709|NCT01474512|80455981|FG016|Induction Period|Lack of Efficacy|0|||
27620710|NCT01474512|80455982|FG017|Induction Period|Lack of Efficacy|0|||
27620711|NCT01474512|80455965|FG000|Induction Period|Withdrawal by Subject|6|||
27620712|NCT01474512|80455966|FG001|Induction Period|Withdrawal by Subject|6|||
27620713|NCT01474512|80455967|FG002|Induction Period|Withdrawal by Subject|5|||
27620714|NCT01474512|80455968|FG003|Induction Period|Withdrawal by Subject|0|||
27620715|NCT01474512|80455969|FG004|Induction Period|Withdrawal by Subject|0|||
27620716|NCT01474512|80455970|FG005|Induction Period|Withdrawal by Subject|0|||
27620717|NCT01474512|80455971|FG006|Induction Period|Withdrawal by Subject|0|||
27620718|NCT01474512|80455972|FG007|Induction Period|Withdrawal by Subject|0|||
27620719|NCT01474512|80455973|FG008|Induction Period|Withdrawal by Subject|0|||
27620720|NCT01474512|80455974|FG009|Induction Period|Withdrawal by Subject|0|||
27620721|NCT01474512|80455975|FG010|Induction Period|Withdrawal by Subject|0|||
27620722|NCT01474512|80455976|FG011|Induction Period|Withdrawal by Subject|0|||
27620723|NCT01474512|80455977|FG012|Induction Period|Withdrawal by Subject|0|||
27620724|NCT01474512|80455978|FG013|Induction Period|Withdrawal by Subject|0|||
27620725|NCT01474512|80455979|FG014|Induction Period|Withdrawal by Subject|0|||
27620726|NCT01474512|80455980|FG015|Induction Period|Withdrawal by Subject|0|||
27620727|NCT01474512|80455981|FG016|Induction Period|Withdrawal by Subject|0|||
27620728|NCT01474512|80455982|FG017|Induction Period|Withdrawal by Subject|0|||
27620729|NCT01474512|80455965|FG000|Induction Period|Protocol Violation|3|||
27620730|NCT01474512|80455966|FG001|Induction Period|Protocol Violation|6|||
27620731|NCT01474512|80455967|FG002|Induction Period|Protocol Violation|0|||
27620732|NCT01474512|80455968|FG003|Induction Period|Protocol Violation|0|||
27620733|NCT01474512|80455969|FG004|Induction Period|Protocol Violation|0|||
27620734|NCT01474512|80455970|FG005|Induction Period|Protocol Violation|0|||
27620735|NCT01474512|80455971|FG006|Induction Period|Protocol Violation|0|||
27620736|NCT01474512|80455972|FG007|Induction Period|Protocol Violation|0|||
27620737|NCT01474512|80455973|FG008|Induction Period|Protocol Violation|0|||
27620738|NCT01474512|80455974|FG009|Induction Period|Protocol Violation|0|||
27620739|NCT01474512|80455975|FG010|Induction Period|Protocol Violation|0|||
27620740|NCT01474512|80455976|FG011|Induction Period|Protocol Violation|0|||
27620741|NCT01474512|80455977|FG012|Induction Period|Protocol Violation|0|||
27620742|NCT01474512|80455978|FG013|Induction Period|Protocol Violation|0|||
27620743|NCT01474512|80455979|FG014|Induction Period|Protocol Violation|0|||
27620744|NCT01474512|80455980|FG015|Induction Period|Protocol Violation|0|||
27620745|NCT01474512|80455981|FG016|Induction Period|Protocol Violation|0|||
27620746|NCT01474512|80455982|FG017|Induction Period|Protocol Violation|0|||
27620747|NCT01474512|80455965|FG000|Induction Period|Sponsor Decision|1|||
27620748|NCT01474512|80455966|FG001|Induction Period|Sponsor Decision|1|||
27620749|NCT01474512|80455967|FG002|Induction Period|Sponsor Decision|1|||
27620750|NCT01474512|80455968|FG003|Induction Period|Sponsor Decision|0|||
27620751|NCT01474512|80455969|FG004|Induction Period|Sponsor Decision|0|||
27620752|NCT01474512|80455970|FG005|Induction Period|Sponsor Decision|0|||
27620753|NCT01474512|80455971|FG006|Induction Period|Sponsor Decision|0|||
27620754|NCT01474512|80455972|FG007|Induction Period|Sponsor Decision|0|||
27620755|NCT01474512|80455973|FG008|Induction Period|Sponsor Decision|0|||
27620756|NCT01474512|80455974|FG009|Induction Period|Sponsor Decision|0|||
27620757|NCT01474512|80455975|FG010|Induction Period|Sponsor Decision|0|||
27620758|NCT01474512|80455976|FG011|Induction Period|Sponsor Decision|0|||
27620759|NCT01474512|80455977|FG012|Induction Period|Sponsor Decision|0|||
27620760|NCT01474512|80455978|FG013|Induction Period|Sponsor Decision|0|||
27620761|NCT01474512|80455979|FG014|Induction Period|Sponsor Decision|0|||
27620762|NCT01474512|80455980|FG015|Induction Period|Sponsor Decision|0|||
27909488|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
27620763|NCT01474512|80455981|FG016|Induction Period|Sponsor Decision|0|||
27620764|NCT01474512|80455982|FG017|Induction Period|Sponsor Decision|0|||
27620765|NCT01474512|80455965|FG000|Induction Period|Lost to Follow-up|1|||
27620766|NCT01474512|80455966|FG001|Induction Period|Lost to Follow-up|0|||
27620767|NCT01474512|80455967|FG002|Induction Period|Lost to Follow-up|2|||
27620768|NCT01474512|80455968|FG003|Induction Period|Lost to Follow-up|0|||
27620769|NCT01474512|80455969|FG004|Induction Period|Lost to Follow-up|0|||
27620770|NCT01474512|80455970|FG005|Induction Period|Lost to Follow-up|0|||
27620771|NCT01474512|80455971|FG006|Induction Period|Lost to Follow-up|0|||
27620772|NCT01474512|80455972|FG007|Induction Period|Lost to Follow-up|0|||
27620773|NCT01474512|80455973|FG008|Induction Period|Lost to Follow-up|0|||
27620774|NCT01474512|80455974|FG009|Induction Period|Lost to Follow-up|0|||
27620775|NCT01474512|80455975|FG010|Induction Period|Lost to Follow-up|0|||
27620776|NCT01474512|80455976|FG011|Induction Period|Lost to Follow-up|0|||
27620777|NCT01474512|80455977|FG012|Induction Period|Lost to Follow-up|0|||
27522455|NCT01092832|80105148|FG001|Overall Study|Other|0|||
27522456|NCT01203852|80105149|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
27522457|NCT01203852|80105149|FG000|Washout 2 Weeks|Physician Decision|46|||
27522458|NCT03565367|80105152|FG000|Overall Study|No scan due to technical issues|4|||
27522459|NCT03565367|80105153|FG001|Overall Study|No scan due to technical issues|0|||
27522460|NCT02545543|80105154|FG000|Overall Study|Lost to Follow-up|67|||
27522461|NCT02545543|80105155|FG001|Overall Study|Lost to Follow-up|25|||
27522462|NCT02545543|80105154|FG000|Overall Study|Physician Decision|3|||
27522463|NCT02545543|80105155|FG001|Overall Study|Physician Decision|0|||
27522464|NCT02545543|80105154|FG000|Overall Study|Withdrawal by Subject|9|||
27522465|NCT02545543|80105155|FG001|Overall Study|Withdrawal by Subject|8|||
27522466|NCT02545543|80105154|FG000|Overall Study|Noncomplaince|1|||
27522467|NCT02545543|80105155|FG001|Overall Study|Noncomplaince|0|||
27522468|NCT02545543|80105154|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
27522469|NCT02545543|80105155|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
27522470|NCT03473548|80105156|FG000|Overall Study|Did not attempt HST testing|3|||
27522471|NCT03473548|80105157|FG001|Overall Study|Did not attempt HST testing|0|||
27522472|NCT04518995|80105158|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
27522473|NCT04518995|80105159|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
27522474|NCT04518995|80105160|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
27522475|NCT04518995|80105158|FG000|Overall Study|Lack of Efficacy|2|||
27522476|NCT04518995|80105159|FG001|Overall Study|Lack of Efficacy|1|||
27522477|NCT04518995|80105160|FG002|Overall Study|Lack of Efficacy|0|||
27522478|NCT04518995|80105158|FG000|Overall Study|Non-compliance With Study Drug|0|||
27522479|NCT04518995|80105159|FG001|Overall Study|Non-compliance With Study Drug|3|||
27522480|NCT04518995|80105160|FG002|Overall Study|Non-compliance With Study Drug|2|||
27522481|NCT04518995|80105158|FG000|Overall Study|Pregnancy|0|||
27522482|NCT04518995|80105159|FG001|Overall Study|Pregnancy|0|||
27522483|NCT04518995|80105160|FG002|Overall Study|Pregnancy|1|||
27522484|NCT04518995|80105158|FG000|Overall Study|Protocol Violation|2|||
27522485|NCT04518995|80105159|FG001|Overall Study|Protocol Violation|0|||
27522486|NCT04518995|80105160|FG002|Overall Study|Protocol Violation|1|||
27522487|NCT04518995|80105158|FG000|Overall Study|Reason not Specified|4|||
27522488|NCT04518995|80105159|FG001|Overall Study|Reason not Specified|11|||
27522489|NCT04518995|80105160|FG002|Overall Study|Reason not Specified|2|||
27522490|NCT04518995|80105158|FG000|Overall Study|Lost to Follow-up|1|||
27522491|NCT04518995|80105159|FG001|Overall Study|Lost to Follow-up|10|||
27522492|NCT04518995|80105160|FG002|Overall Study|Lost to Follow-up|6|||
27522493|NCT01268579|80105164|FG000|Overall Study|Adverse Event|1|||
27522494|NCT01268579|80105164|FG000|Overall Study|Withdrawal by Subject|2|||
27522495|NCT01328366|80105165|FG000|Overall Study|Death|1|||
27522496|NCT01328366|80105165|FG000|Overall Study|Withdrawal by Subject|2|||
27522497|NCT01328366|80105165|FG000|Overall Study|Lost to Follow-up|7|||
27522498|NCT00958438|80105166|FG000|Overall Study|Protocol Violation|3|||
27522499|NCT00958438|80105167|FG001|Overall Study|Protocol Violation|2|||
27522500|NCT00958438|80105168|FG002|Overall Study|Protocol Violation|2|||
27522501|NCT00958438|80105166|FG000|Overall Study|Withdrawal by Subject|4|||
27522502|NCT00958438|80105167|FG001|Overall Study|Withdrawal by Subject|2|||
27522503|NCT00958438|80105168|FG002|Overall Study|Withdrawal by Subject|1|||
27522504|NCT00958438|80105166|FG000|Overall Study|Adverse Event|0|||
27522505|NCT00958438|80105167|FG001|Overall Study|Adverse Event|3|||
27522506|NCT00958438|80105168|FG002|Overall Study|Adverse Event|0|||
27522507|NCT00958438|80105166|FG000|Overall Study|Physician Decision|1|||
27522508|NCT00958438|80105167|FG001|Overall Study|Physician Decision|0|||
27522509|NCT00958438|80105168|FG002|Overall Study|Physician Decision|1|||
27522510|NCT00958438|80105166|FG000|Overall Study|Other than specified above|2|||
27522511|NCT00958438|80105167|FG001|Overall Study|Other than specified above|3|||
27522512|NCT00958438|80105168|FG002|Overall Study|Other than specified above|2|||
27522513|NCT00535288|80105169|FG000|Overall Study|Adverse Event|20|||
27522514|NCT00535288|80105170|FG001|Overall Study|Adverse Event|19|||
27522515|NCT00535288|80105171|FG002|Overall Study|Adverse Event|25|||
27731811|NCT02786901|80846070|FG000|Overall Study|Physician Decision|1|||
27731812|NCT02786901|80846071|FG001|Overall Study|Physician Decision|0|||
27522516|NCT00535288|80105172|FG003|Overall Study|Adverse Event|20|||
27522517|NCT00535288|80105173|FG004|Overall Study|Adverse Event|30|||
27522518|NCT00535288|80105169|FG000|Overall Study|Lost to Follow-up|0|||
27522519|NCT00535288|80105170|FG001|Overall Study|Lost to Follow-up|3|||
27522520|NCT00535288|80105171|FG002|Overall Study|Lost to Follow-up|0|||
27522521|NCT00535288|80105172|FG003|Overall Study|Lost to Follow-up|0|||
27522522|NCT00535288|80105173|FG004|Overall Study|Lost to Follow-up|0|||
27522523|NCT00535288|80105169|FG000|Overall Study|Lack of Efficacy|26|||
27522524|NCT00535288|80105170|FG001|Overall Study|Lack of Efficacy|3|||
27522525|NCT00535288|80105171|FG002|Overall Study|Lack of Efficacy|4|||
27522526|NCT00535288|80105172|FG003|Overall Study|Lack of Efficacy|4|||
27522527|NCT00535288|80105173|FG004|Overall Study|Lack of Efficacy|7|||
27522528|NCT00535288|80105169|FG000|Overall Study|Unwilling to cooperate|6|||
27522529|NCT00535288|80105170|FG001|Overall Study|Unwilling to cooperate|6|||
27522530|NCT00535288|80105171|FG002|Overall Study|Unwilling to cooperate|3|||
27731813|NCT02786901|80846072|FG002|Overall Study|Physician Decision|0|||
27731814|NCT02786901|80846070|FG000|Overall Study|Rescue Therapy Use|71|||
27731815|NCT02786901|80846071|FG001|Overall Study|Rescue Therapy Use|49|||
27731816|NCT02786901|80846072|FG002|Overall Study|Rescue Therapy Use|33|||
27731817|NCT02786901|80846070|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
27731818|NCT02786901|80846071|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
27731819|NCT02786901|80846072|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
27731820|NCT02786901|80846070|FG000|Overall Study|Disallowed medication|1|||
27731821|NCT02786901|80846071|FG001|Overall Study|Disallowed medication|1|||
27731822|NCT02786901|80846072|FG002|Overall Study|Disallowed medication|0|||
27731823|NCT02786901|80846070|FG000|Overall Study|Randomized in error|2|||
27731824|NCT02786901|80846071|FG001|Overall Study|Randomized in error|0|||
27731825|NCT02786901|80846072|FG002|Overall Study|Randomized in error|1|||
27731826|NCT00522392|80846081|FG000|Overall Study|Disease progression|0|||
27731827|NCT00522392|80846082|FG001|Overall Study|Disease progression|3|||
27731828|NCT00522392|80846081|FG000|Overall Study|Adverse Event|7|||
27731829|NCT00522392|80846082|FG001|Overall Study|Adverse Event|7|||
27731830|NCT00522392|80846081|FG000|Overall Study|Withdrawal by Subject|1|||
27731831|NCT00522392|80846082|FG001|Overall Study|Withdrawal by Subject|1|||
27731832|NCT00522392|80846081|FG000|Overall Study|Physician Decision|0|||
27731833|NCT00522392|80846082|FG001|Overall Study|Physician Decision|1|||
27731834|NCT00522392|80846081|FG000|Overall Study|Non-compliance|0|||
27731835|NCT00522392|80846082|FG001|Overall Study|Non-compliance|1|||
27854572|NCT00158600|81298840|FG001|Overall Study|unable to commit time to study|1|||
27522531|NCT00535288|80105172|FG003|Overall Study|Unwilling to cooperate|3|||
27522532|NCT00535288|80105173|FG004|Overall Study|Unwilling to cooperate|4|||
27522533|NCT00535288|80105169|FG000|Overall Study|Other|2|||
27522534|NCT00535288|80105170|FG001|Overall Study|Other|1|||
27522535|NCT00535288|80105171|FG002|Overall Study|Other|1|||
27522536|NCT00535288|80105172|FG003|Overall Study|Other|2|||
27522537|NCT00535288|80105173|FG004|Overall Study|Other|1|||
27522538|NCT03739242|80105174|FG000|Overall Study|Withdrawal by Subject|1|||
27522539|NCT03739242|80105175|FG001|Overall Study|Withdrawal by Subject|1|||
27522540|NCT03739242|80105174|FG000|Overall Study|Protocol Violation|0|||
27522541|NCT03739242|80105175|FG001|Overall Study|Protocol Violation|1|||
27522542|NCT00130247|80105176|FG000|Overall Study|Pregnancy|1|||
27522543|NCT00130247|80105177|FG001|Overall Study|Pregnancy|0|||
27522544|NCT00130247|80105176|FG000|Overall Study|Post-randomization exclusion|1|||
27522545|NCT00130247|80105177|FG001|Overall Study|Post-randomization exclusion|2|||
27522546|NCT00130247|80105176|FG000|Overall Study|Not compliant with DOT|0|||
27522547|NCT00130247|80105177|FG001|Overall Study|Not compliant with DOT|2|||
27522548|NCT00395343|80105178|FG000|Overall Study|Adverse Event|13|||
27522549|NCT00395343|80105179|FG001|Overall Study|Adverse Event|5|||
27522550|NCT00395343|80105178|FG000|Overall Study|Lack of Efficacy|0|||
27522551|NCT00395343|80105179|FG001|Overall Study|Lack of Efficacy|1|||
27522552|NCT00395343|80105178|FG000|Overall Study|Lost to Follow-up|4|||
27522553|NCT00395343|80105179|FG001|Overall Study|Lost to Follow-up|4|||
27522554|NCT00395343|80105178|FG000|Overall Study|Physician Decision|2|||
27522555|NCT00395343|80105179|FG001|Overall Study|Physician Decision|4|||
27522556|NCT00395343|80105178|FG000|Overall Study|Protocol Violation|6|||
27522557|NCT00395343|80105179|FG001|Overall Study|Protocol Violation|8|||
27522558|NCT00395343|80105178|FG000|Overall Study|Withdrawal by Subject|11|||
27522559|NCT00395343|80105179|FG001|Overall Study|Withdrawal by Subject|12|||
27522560|NCT00395343|80105178|FG000|Overall Study|Other|5|||
27522561|NCT00395343|80105179|FG001|Overall Study|Other|2|||
27522562|NCT00711516|80105180|FG000|Overall Study|Adverse Event|1|||
27522563|NCT00711516|80105181|FG001|Overall Study|Adverse Event|1|||
27522564|NCT00711516|80105180|FG000|Overall Study|Withdrawal by Subject|0|||
27522565|NCT00711516|80105181|FG001|Overall Study|Withdrawal by Subject|1|||
27522566|NCT00711516|80105180|FG000|Overall Study|Protocol Violation|0|||
27522567|NCT00711516|80105181|FG001|Overall Study|Protocol Violation|1|||
27522568|NCT04022733|80105186|FG000|Overall Study|conversion to open surgery|3|||
27522569|NCT04022733|80105187|FG001|Overall Study|conversion to open surgery|2|||
27522570|NCT04022733|80105186|FG000|Overall Study|bradycardia|0|||
27522571|NCT04022733|80105187|FG001|Overall Study|bradycardia|1|||
27522572|NCT03254459|80105188|FG000|Overall Study|Adverse Event|7|||
27854573|NCT00158600|81298839|FG000|Overall Study|Adverse Event|2|||
27522573|NCT03254459|80105189|FG001|Overall Study|Adverse Event|20|||
27522574|NCT03254459|80105188|FG000|Overall Study|Withdrawal by Subject Consent|3|||
27522575|NCT03254459|80105189|FG001|Overall Study|Withdrawal by Subject Consent|1|||
27522576|NCT03254459|80105188|FG000|Overall Study|Lost to Follow-up|0|||
27522577|NCT03254459|80105189|FG001|Overall Study|Lost to Follow-up|1|||
27522578|NCT03254459|80105188|FG000|Overall Study|Miscellaneous|0|||
27522579|NCT03254459|80105189|FG001|Overall Study|Miscellaneous|1|||
27522580|NCT00402233|80105196|FG000|Overall Study|Adverse Event|1|||
27522581|NCT00402233|80105197|FG001|Overall Study|Adverse Event|7|||
27522582|NCT00402233|80105198|FG002|Overall Study|Adverse Event|9|||
27731836|NCT02661594|80846083|FG000|Overall Study|Protocol Violation|1|||
27731837|NCT02661594|80846084|FG001|Overall Study|Protocol Violation|0|||
27620778|NCT01474512|80455978|FG013|Induction Period|Lost to Follow-up|0|||
27620779|NCT01474512|80455979|FG014|Induction Period|Lost to Follow-up|0|||
27620780|NCT01474512|80455980|FG015|Induction Period|Lost to Follow-up|0|||
27620781|NCT01474512|80455981|FG016|Induction Period|Lost to Follow-up|0|||
27620782|NCT01474512|80455982|FG017|Induction Period|Lost to Follow-up|0|||
27620783|NCT01474512|80455965|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620784|NCT01474512|80455966|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620785|NCT01474512|80455967|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620786|NCT01474512|80455968|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
27620787|NCT01474512|80455969|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
27620788|NCT01474512|80455970|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
27620789|NCT01474512|80455971|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
27620790|NCT01474512|80455972|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620791|NCT01474512|80455973|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620792|NCT01474512|80455974|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620793|NCT01474512|80455975|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620794|NCT01474512|80455976|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620795|NCT01474512|80455977|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620796|NCT01474512|80455978|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620797|NCT01474512|80455979|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620798|NCT01474512|80455980|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620799|NCT01474512|80455981|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620800|NCT01474512|80455982|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
27620801|NCT01474512|80455965|FG000|Maintenance Period|Adverse Event|0|||
27620802|NCT01474512|80455966|FG001|Maintenance Period|Adverse Event|0|||
27620803|NCT01474512|80455967|FG002|Maintenance Period|Adverse Event|0|||
27620804|NCT01474512|80455968|FG003|Maintenance Period|Adverse Event|4|||
27620805|NCT01474512|80455969|FG004|Maintenance Period|Adverse Event|2|||
27620806|NCT01474512|80455970|FG005|Maintenance Period|Adverse Event|7|||
27620807|NCT01474512|80455971|FG006|Maintenance Period|Adverse Event|0|||
27620808|NCT01474512|80455972|FG007|Maintenance Period|Adverse Event|19|||
27620809|NCT01474512|80455973|FG008|Maintenance Period|Adverse Event|1|||
27620810|NCT01474512|80455974|FG009|Maintenance Period|Adverse Event|3|||
27620811|NCT01474512|80455975|FG010|Maintenance Period|Adverse Event|0|||
27620812|NCT01474512|80455976|FG011|Maintenance Period|Adverse Event|0|||
27620813|NCT01474512|80455977|FG012|Maintenance Period|Adverse Event|0|||
27620814|NCT01474512|80455978|FG013|Maintenance Period|Adverse Event|0|||
27620815|NCT01474512|80455979|FG014|Maintenance Period|Adverse Event|0|||
27620816|NCT01474512|80455980|FG015|Maintenance Period|Adverse Event|0|||
27620817|NCT01474512|80455981|FG016|Maintenance Period|Adverse Event|0|||
27620818|NCT01474512|80455982|FG017|Maintenance Period|Adverse Event|0|||
27620819|NCT01474512|80455965|FG000|Maintenance Period|Withdrawal by Subject|0|||
27909489|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
27909490|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
27909491|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Death|1|||
27909492|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Death|0|||
27909493|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
27620820|NCT01474512|80455966|FG001|Maintenance Period|Withdrawal by Subject|0|||
27620821|NCT01474512|80455967|FG002|Maintenance Period|Withdrawal by Subject|0|||
27620822|NCT01474512|80455968|FG003|Maintenance Period|Withdrawal by Subject|6|||
27620823|NCT01474512|80455969|FG004|Maintenance Period|Withdrawal by Subject|2|||
27620824|NCT01474512|80455970|FG005|Maintenance Period|Withdrawal by Subject|3|||
27620825|NCT01474512|80455971|FG006|Maintenance Period|Withdrawal by Subject|1|||
27620826|NCT01474512|80455972|FG007|Maintenance Period|Withdrawal by Subject|6|||
27620827|NCT01474512|80455973|FG008|Maintenance Period|Withdrawal by Subject|3|||
27620828|NCT01474512|80455974|FG009|Maintenance Period|Withdrawal by Subject|1|||
27620829|NCT01474512|80455975|FG010|Maintenance Period|Withdrawal by Subject|0|||
27620830|NCT01474512|80455976|FG011|Maintenance Period|Withdrawal by Subject|0|||
27731838|NCT02661594|80846085|FG002|Overall Study|Protocol Violation|1|||
27620831|NCT01474512|80455977|FG012|Maintenance Period|Withdrawal by Subject|0|||
27620832|NCT01474512|80455978|FG013|Maintenance Period|Withdrawal by Subject|0|||
27620833|NCT01474512|80455979|FG014|Maintenance Period|Withdrawal by Subject|0|||
27620834|NCT01474512|80455980|FG015|Maintenance Period|Withdrawal by Subject|0|||
27620835|NCT01474512|80455981|FG016|Maintenance Period|Withdrawal by Subject|0|||
27620836|NCT01474512|80455982|FG017|Maintenance Period|Withdrawal by Subject|0|||
27620837|NCT01474512|80455965|FG000|Maintenance Period|Lost to Follow-up|0|||
27620838|NCT01474512|80455966|FG001|Maintenance Period|Lost to Follow-up|0|||
27620839|NCT01474512|80455967|FG002|Maintenance Period|Lost to Follow-up|0|||
27620840|NCT01474512|80455968|FG003|Maintenance Period|Lost to Follow-up|3|||
27620841|NCT01474512|80455969|FG004|Maintenance Period|Lost to Follow-up|3|||
27620842|NCT01474512|80455970|FG005|Maintenance Period|Lost to Follow-up|0|||
27731839|NCT02661594|80846086|FG003|Overall Study|Protocol Violation|0|||
27731840|NCT01929083|80846087|FG000|Intervention 1|Lost to Follow-up|2|||
27731841|NCT01929083|80846088|FG001|Intervention 1|Lost to Follow-up|0|||
27731842|NCT01929083|80846087|FG000|Intervention 1|Nonadherent to study medications|1|||
27731843|NCT01929083|80846088|FG001|Intervention 1|Nonadherent to study medications|0|||
27731844|NCT01929083|80846087|FG000|Intervention 2|Adverse Event|0|||
27731845|NCT01929083|80846088|FG001|Intervention 2|Adverse Event|1|||
27731846|NCT03770403|80846090|FG000|Overall Study|Adverse Event|8|||
27731847|NCT03770403|80846090|FG000|Overall Study|Death|5|||
27731848|NCT03770403|80846090|FG000|Overall Study|Physician Decision|1|||
27731849|NCT03770403|80846090|FG000|Overall Study|Sponsor decision|1|||
27731850|NCT03770403|80846090|FG000|Overall Study|Study terminated by Sponsor|1|||
27731851|NCT03770403|80846090|FG000|Overall Study|Withdrawal by Subject|13|||
27731852|NCT03770403|80846090|FG000|Overall Study|Other|88|||
27731853|NCT01157117|80846094|FG000|Overall Study|Dosing Symptoms|0|||
27731854|NCT01157117|80846095|FG001|Overall Study|Dosing Symptoms|4|||
27731855|NCT01157117|80846096|FG002|Overall Study|Dosing Symptoms|0|||
27522583|NCT00402233|80105199|FG003|Overall Study|Adverse Event|9|||
27522584|NCT00402233|80105196|FG000|Overall Study|Protocol Violation|0|||
27522585|NCT00402233|80105197|FG001|Overall Study|Protocol Violation|1|||
27522586|NCT00402233|80105198|FG002|Overall Study|Protocol Violation|0|||
27522587|NCT00402233|80105199|FG003|Overall Study|Protocol Violation|0|||
27522588|NCT00402233|80105196|FG000|Overall Study|Withdrawal by Subject|2|||
27731856|NCT01157117|80846094|FG000|Overall Study|Withdrawal by Subject|4|||
27731857|NCT01157117|80846095|FG001|Overall Study|Withdrawal by Subject|1|||
27731858|NCT01157117|80846096|FG002|Overall Study|Withdrawal by Subject|1|||
27731859|NCT01157117|80846094|FG000|Overall Study|Lack of Efficacy|1|||
27731860|NCT01157117|80846095|FG001|Overall Study|Lack of Efficacy|1|||
27731861|NCT01157117|80846096|FG002|Overall Study|Lack of Efficacy|0|||
27731862|NCT01157117|80846094|FG000|Overall Study|Lost to Follow-up|0|||
27731863|NCT01157117|80846095|FG001|Overall Study|Lost to Follow-up|0|||
27731864|NCT01157117|80846096|FG002|Overall Study|Lost to Follow-up|1|||
27731865|NCT01157117|80846094|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
27731866|NCT01157117|80846095|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
27731867|NCT01157117|80846096|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
27731868|NCT01859403|80846097|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
27731869|NCT01859403|80846098|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
27731870|NCT01859403|80846097|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
27731871|NCT01859403|80846098|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
27731872|NCT01859403|80846097|FG000|Primary Endpoint Measure|Physician Decision|0|||
27731873|NCT01859403|80846098|FG001|Primary Endpoint Measure|Physician Decision|1|||
27731874|NCT01859403|80846097|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
27854574|NCT00158600|81298840|FG001|Overall Study|Adverse Event|1|||
27854575|NCT00158600|81298839|FG000|Overall Study|Death|1|||
27854576|NCT00158600|81298840|FG001|Overall Study|Death|0|||
27854577|NCT00158600|81298839|FG000|Overall Study|Withdrawal by Subject|2|||
27854578|NCT00158600|81298840|FG001|Overall Study|Withdrawal by Subject|2|||
27854579|NCT03276221|81298841|FG000|Overall Study|Lost to Follow-up|6|||
27854580|NCT03276221|81298842|FG001|Overall Study|Lost to Follow-up|2|||
27854581|NCT03276221|81298843|FG002|Overall Study|Lost to Follow-up|0|||
27854582|NCT03276221|81298841|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
27854583|NCT03276221|81298842|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
27854584|NCT03276221|81298843|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
27909494|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
27909495|NCT00105989|81506954|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
27909496|NCT00105989|81506955|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
27909497|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
27909498|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
27909499|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
27909500|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
27909501|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
27909502|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
27731875|NCT01859403|80846098|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
27731876|NCT00365989|80846099|FG000|Overall Study|Withdrawal by Subject|1|||
27854585|NCT04639713|81298846|FG000|Overall Study|Protocol Noncompliance|2|||
27854586|NCT04639713|81298846|FG000|Overall Study|Withdrawal by Subject|1|||
27854587|NCT01155024|81298847|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
27854588|NCT01155024|81298848|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
27522589|NCT00402233|80105197|FG001|Overall Study|Withdrawal by Subject|1|||
27620843|NCT01474512|80455971|FG006|Maintenance Period|Lost to Follow-up|0|||
27731877|NCT00365989|80846099|FG000|Overall Study|Non-compliance|1|||
27731878|NCT01238120|80846100|FG000|Overall Study|Withdrawal by Subject|4|||
27731879|NCT01238120|80846101|FG001|Overall Study|Withdrawal by Subject|1|||
27522590|NCT00402233|80105198|FG002|Overall Study|Withdrawal by Subject|2|||
27731880|NCT01238120|80846102|FG002|Overall Study|Withdrawal by Subject|2|||
27731881|NCT01238120|80846103|FG003|Overall Study|Withdrawal by Subject|5|||
27731882|NCT01238120|80846100|FG000|Overall Study|Lost to Follow-up|2|||
27731883|NCT01238120|80846101|FG001|Overall Study|Lost to Follow-up|0|||
27731884|NCT01238120|80846102|FG002|Overall Study|Lost to Follow-up|1|||
27731885|NCT01238120|80846103|FG003|Overall Study|Lost to Follow-up|1|||
27731886|NCT01238120|80846100|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
27731887|NCT01238120|80846101|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
27731888|NCT01238120|80846102|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
27731889|NCT01238120|80846103|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
27731890|NCT01309737|80846104|FG000|Week 0 to 16|Death|1|||
27731891|NCT01309737|80846105|FG001|Week 0 to 16|Death|0|||
27731892|NCT01309737|80846106|FG002|Week 0 to 16|Death|1|||
27731893|NCT01309737|80846107|FG003|Week 0 to 16|Death|0|||
27731894|NCT01309737|80846108|FG004|Week 0 to 16|Death|0|||
27731895|NCT01309737|80846104|FG000|Week 0 to 16|Adverse Event|11|||
27731896|NCT01309737|80846105|FG001|Week 0 to 16|Adverse Event|10|||
27731897|NCT01309737|80846106|FG002|Week 0 to 16|Adverse Event|5|||
27731898|NCT01309737|80846107|FG003|Week 0 to 16|Adverse Event|0|||
27731899|NCT01309737|80846108|FG004|Week 0 to 16|Adverse Event|0|||
27731900|NCT01309737|80846104|FG000|Week 0 to 16|Lack of Efficacy|15|||
27731901|NCT01309737|80846105|FG001|Week 0 to 16|Lack of Efficacy|2|||
27731902|NCT01309737|80846106|FG002|Week 0 to 16|Lack of Efficacy|24|||
27731903|NCT01309737|80846107|FG003|Week 0 to 16|Lack of Efficacy|0|||
27731904|NCT01309737|80846108|FG004|Week 0 to 16|Lack of Efficacy|0|||
27731905|NCT01309737|80846104|FG000|Week 0 to 16|Lost to Follow-up|7|||
27731906|NCT01309737|80846105|FG001|Week 0 to 16|Lost to Follow-up|8|||
27731907|NCT01309737|80846106|FG002|Week 0 to 16|Lost to Follow-up|3|||
27731908|NCT01309737|80846107|FG003|Week 0 to 16|Lost to Follow-up|0|||
27731909|NCT01309737|80846108|FG004|Week 0 to 16|Lost to Follow-up|0|||
27731910|NCT01309737|80846104|FG000|Week 0 to 16|Withdrawal by Subject|7|||
27731911|NCT01309737|80846105|FG001|Week 0 to 16|Withdrawal by Subject|6|||
27731912|NCT01309737|80846106|FG002|Week 0 to 16|Withdrawal by Subject|7|||
27731913|NCT01309737|80846107|FG003|Week 0 to 16|Withdrawal by Subject|0|||
27731914|NCT01309737|80846108|FG004|Week 0 to 16|Withdrawal by Subject|0|||
27731915|NCT01309737|80846104|FG000|Week 0 to 16|Other|10|||
27731916|NCT01309737|80846105|FG001|Week 0 to 16|Other|14|||
27731917|NCT01309737|80846106|FG002|Week 0 to 16|Other|4|||
27731918|NCT01309737|80846107|FG003|Week 0 to 16|Other|0|||
27731919|NCT01309737|80846108|FG004|Week 0 to 16|Other|0|||
27731920|NCT01309737|80846104|FG000|Week 0 to 16|Randomized, but not treated|1|||
27731921|NCT01309737|80846105|FG001|Week 0 to 16|Randomized, but not treated|0|||
27731922|NCT01309737|80846106|FG002|Week 0 to 16|Randomized, but not treated|0|||
27731923|NCT01309737|80846107|FG003|Week 0 to 16|Randomized, but not treated|0|||
27731924|NCT01309737|80846108|FG004|Week 0 to 16|Randomized, but not treated|0|||
27731925|NCT01309737|80846104|FG000|Week 16 to 52|Death|0|||
27731926|NCT01309737|80846105|FG001|Week 16 to 52|Death|0|||
27731927|NCT01309737|80846106|FG002|Week 16 to 52|Death|0|||
27731928|NCT01309737|80846107|FG003|Week 16 to 52|Death|0|||
27731929|NCT01309737|80846108|FG004|Week 16 to 52|Death|1|||
27731930|NCT01309737|80846104|FG000|Week 16 to 52|Adverse Event|7|||
27731931|NCT01309737|80846105|FG001|Week 16 to 52|Adverse Event|7|||
27854589|NCT01155024|81298847|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
27909503|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
27522591|NCT00402233|80105199|FG003|Overall Study|Withdrawal by Subject|2|||
27522592|NCT00402233|80105196|FG000|Overall Study|Worsening of disease under study|2|||
27522593|NCT00402233|80105197|FG001|Overall Study|Worsening of disease under study|0|||
27522594|NCT00402233|80105198|FG002|Overall Study|Worsening of disease under study|0|||
27522595|NCT00402233|80105199|FG003|Overall Study|Worsening of disease under study|0|||
27522596|NCT00402233|80105196|FG000|Overall Study|Worsening of other pre-existing disease|0|||
27522597|NCT00402233|80105197|FG001|Overall Study|Worsening of other pre-existing disease|1|||
27522598|NCT00402233|80105198|FG002|Overall Study|Worsening of other pre-existing disease|0|||
27522599|NCT00402233|80105199|FG003|Overall Study|Worsening of other pre-existing disease|0|||
27731932|NCT01309737|80846106|FG002|Week 16 to 52|Adverse Event|0|||
27731933|NCT01309737|80846107|FG003|Week 16 to 52|Adverse Event|6|||
27731934|NCT01309737|80846108|FG004|Week 16 to 52|Adverse Event|5|||
27731935|NCT01309737|80846104|FG000|Week 16 to 52|Lack of Efficacy|107|||
27731936|NCT01309737|80846105|FG001|Week 16 to 52|Lack of Efficacy|76|||
27731937|NCT01309737|80846106|FG002|Week 16 to 52|Lack of Efficacy|0|||
27731938|NCT01309737|80846107|FG003|Week 16 to 52|Lack of Efficacy|25|||
27731939|NCT01309737|80846108|FG004|Week 16 to 52|Lack of Efficacy|21|||
27731940|NCT01309737|80846104|FG000|Week 16 to 52|Lost to Follow-up|4|||
27522600|NCT02527200|80105200|FG000|Overall Study|Withdrawal by Subject|3|||
27731941|NCT01309737|80846105|FG001|Week 16 to 52|Lost to Follow-up|2|||
27731942|NCT01309737|80846106|FG002|Week 16 to 52|Lost to Follow-up|0|||
27731943|NCT01309737|80846107|FG003|Week 16 to 52|Lost to Follow-up|1|||
27731944|NCT01309737|80846108|FG004|Week 16 to 52|Lost to Follow-up|4|||
27731945|NCT01309737|80846104|FG000|Week 16 to 52|Withdrawal by Subject|5|||
27731946|NCT01309737|80846105|FG001|Week 16 to 52|Withdrawal by Subject|6|||
27731947|NCT01309737|80846106|FG002|Week 16 to 52|Withdrawal by Subject|0|||
27731948|NCT01309737|80846107|FG003|Week 16 to 52|Withdrawal by Subject|0|||
27731949|NCT01309737|80846108|FG004|Week 16 to 52|Withdrawal by Subject|2|||
27731950|NCT01309737|80846104|FG000|Week 16 to 52|Other|10|||
27731951|NCT01309737|80846105|FG001|Week 16 to 52|Other|12|||
27731952|NCT01309737|80846106|FG002|Week 16 to 52|Other|0|||
27731953|NCT01309737|80846107|FG003|Week 16 to 52|Other|2|||
27731954|NCT01309737|80846108|FG004|Week 16 to 52|Other|0|||
27731955|NCT02029976|80846111|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
27731956|NCT02029976|80846112|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
27731957|NCT02029976|80846111|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
27731958|NCT02029976|80846112|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
27522601|NCT02527200|80105201|FG001|Overall Study|Withdrawal by Subject|2|||
27620844|NCT01474512|80455972|FG007|Maintenance Period|Lost to Follow-up|2|||
27620845|NCT01474512|80455973|FG008|Maintenance Period|Lost to Follow-up|1|||
27620846|NCT01474512|80455974|FG009|Maintenance Period|Lost to Follow-up|1|||
27620847|NCT01474512|80455975|FG010|Maintenance Period|Lost to Follow-up|0|||
27620848|NCT01474512|80455976|FG011|Maintenance Period|Lost to Follow-up|0|||
27620849|NCT01474512|80455977|FG012|Maintenance Period|Lost to Follow-up|0|||
27620850|NCT01474512|80455978|FG013|Maintenance Period|Lost to Follow-up|0|||
27620851|NCT01474512|80455979|FG014|Maintenance Period|Lost to Follow-up|0|||
27620852|NCT01474512|80455980|FG015|Maintenance Period|Lost to Follow-up|0|||
27620853|NCT01474512|80455981|FG016|Maintenance Period|Lost to Follow-up|0|||
27620854|NCT01474512|80455982|FG017|Maintenance Period|Lost to Follow-up|0|||
27620855|NCT01474512|80455965|FG000|Maintenance Period|Death|0|||
27620856|NCT01474512|80455966|FG001|Maintenance Period|Death|0|||
27620857|NCT01474512|80455967|FG002|Maintenance Period|Death|0|||
27620858|NCT01474512|80455968|FG003|Maintenance Period|Death|0|||
27620859|NCT01474512|80455969|FG004|Maintenance Period|Death|0|||
27620860|NCT01474512|80455970|FG005|Maintenance Period|Death|2|||
27620861|NCT01474512|80455971|FG006|Maintenance Period|Death|0|||
27620862|NCT01474512|80455972|FG007|Maintenance Period|Death|0|||
27620863|NCT01474512|80455973|FG008|Maintenance Period|Death|0|||
27620864|NCT01474512|80455974|FG009|Maintenance Period|Death|0|||
27620865|NCT01474512|80455975|FG010|Maintenance Period|Death|0|||
27620866|NCT01474512|80455976|FG011|Maintenance Period|Death|0|||
27620867|NCT01474512|80455977|FG012|Maintenance Period|Death|0|||
27620868|NCT01474512|80455978|FG013|Maintenance Period|Death|0|||
27620869|NCT01474512|80455979|FG014|Maintenance Period|Death|0|||
27620870|NCT01474512|80455980|FG015|Maintenance Period|Death|0|||
27620871|NCT01474512|80455981|FG016|Maintenance Period|Death|0|||
27620872|NCT01474512|80455982|FG017|Maintenance Period|Death|0|||
27620873|NCT01474512|80455965|FG000|Maintenance Period|Physician Decision|0|||
27620874|NCT01474512|80455966|FG001|Maintenance Period|Physician Decision|0|||
27620875|NCT01474512|80455967|FG002|Maintenance Period|Physician Decision|0|||
27620876|NCT01474512|80455968|FG003|Maintenance Period|Physician Decision|0|||
27620877|NCT01474512|80455969|FG004|Maintenance Period|Physician Decision|0|||
27620878|NCT01474512|80455970|FG005|Maintenance Period|Physician Decision|1|||
27620879|NCT01474512|80455971|FG006|Maintenance Period|Physician Decision|0|||
27620880|NCT01474512|80455972|FG007|Maintenance Period|Physician Decision|2|||
27620881|NCT01474512|80455973|FG008|Maintenance Period|Physician Decision|0|||
27620882|NCT01474512|80455974|FG009|Maintenance Period|Physician Decision|0|||
27620883|NCT01474512|80455975|FG010|Maintenance Period|Physician Decision|0|||
27620884|NCT01474512|80455976|FG011|Maintenance Period|Physician Decision|0|||
27731959|NCT02029976|80846111|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
27522602|NCT02527200|80105202|FG002|Overall Study|Withdrawal by Subject|1|||
27522603|NCT02527200|80105203|FG003|Overall Study|Withdrawal by Subject|0|||
27522604|NCT02527200|80105200|FG000|Overall Study|Unclassified|0|||
27522605|NCT02527200|80105201|FG001|Overall Study|Unclassified|1|||
27522606|NCT02527200|80105202|FG002|Overall Study|Unclassified|0|||
27522607|NCT02527200|80105203|FG003|Overall Study|Unclassified|0|||
27522608|NCT02527200|80105200|FG000|Overall Study|Lost to Follow-up|0|||
27522609|NCT02527200|80105201|FG001|Overall Study|Lost to Follow-up|0|||
27522610|NCT02527200|80105202|FG002|Overall Study|Lost to Follow-up|1|||
27522611|NCT02527200|80105203|FG003|Overall Study|Lost to Follow-up|0|||
27620885|NCT01474512|80455977|FG012|Maintenance Period|Physician Decision|0|||
27620886|NCT01474512|80455978|FG013|Maintenance Period|Physician Decision|0|||
27731960|NCT02029976|80846112|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
27731961|NCT02029976|80846111|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
27620887|NCT01474512|80455979|FG014|Maintenance Period|Physician Decision|0|||
27522612|NCT03206788|80105206|FG000|Overall Study|Withdrawal by Subject|0|||
27522613|NCT03206788|80105207|FG001|Overall Study|Withdrawal by Subject|1|||
27620888|NCT01474512|80455980|FG015|Maintenance Period|Physician Decision|0|||
27620889|NCT01474512|80455981|FG016|Maintenance Period|Physician Decision|0|||
27620890|NCT01474512|80455982|FG017|Maintenance Period|Physician Decision|0|||
27620891|NCT01474512|80455965|FG000|Maintenance Period|Clinical Relapse|0|||
27522614|NCT03206788|80105206|FG000|Overall Study|Adverse Event|0|||
27522615|NCT03206788|80105207|FG001|Overall Study|Adverse Event|1|||
27522616|NCT03206788|80105206|FG000|Overall Study|Physician Decision|0|||
27522617|NCT03206788|80105207|FG001|Overall Study|Physician Decision|1|||
27731962|NCT02029976|80846112|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
27731963|NCT01381094|80846113|FG000|Overall Study|Adverse Event|1|||
27731964|NCT01381094|80846114|FG001|Overall Study|Adverse Event|2|||
27731965|NCT01381094|80846115|FG002|Overall Study|Adverse Event|0|||
27731966|NCT01381094|80846116|FG003|Overall Study|Adverse Event|1|||
27731967|NCT01381094|80846117|FG004|Overall Study|Adverse Event|0|||
27731968|NCT01381094|80846113|FG000|Overall Study|Lost to Follow-up|0|||
27731969|NCT01381094|80846114|FG001|Overall Study|Lost to Follow-up|0|||
27731970|NCT01381094|80846115|FG002|Overall Study|Lost to Follow-up|0|||
27731971|NCT01381094|80846116|FG003|Overall Study|Lost to Follow-up|0|||
27731972|NCT01381094|80846117|FG004|Overall Study|Lost to Follow-up|1|||
27731973|NCT01381094|80846113|FG000|Overall Study|Withdrawal of informed consent|0|||
27731974|NCT01381094|80846114|FG001|Overall Study|Withdrawal of informed consent|1|||
27731975|NCT01381094|80846115|FG002|Overall Study|Withdrawal of informed consent|0|||
27731976|NCT01381094|80846116|FG003|Overall Study|Withdrawal of informed consent|0|||
27731977|NCT01381094|80846117|FG004|Overall Study|Withdrawal of informed consent|0|||
27731978|NCT01381094|80846113|FG000|Overall Study|Participant given Aranesp injection|1|||
27731979|NCT01381094|80846114|FG001|Overall Study|Participant given Aranesp injection|0|||
27731980|NCT01381094|80846115|FG002|Overall Study|Participant given Aranesp injection|0|||
27731981|NCT01381094|80846116|FG003|Overall Study|Participant given Aranesp injection|0|||
27731982|NCT01381094|80846117|FG004|Overall Study|Participant given Aranesp injection|0|||
27731983|NCT02581995|80846122|FG000|Overall Study|Unspecified other|3|||
27731984|NCT02581995|80846122|FG000|Overall Study|Adverse Event|6|||
27731985|NCT02581995|80846122|FG000|Overall Study|Lost to Follow-up|5|||
27731986|NCT02581995|80846122|FG000|Overall Study|Withdrawal by participant|12|||
27731987|NCT02581995|80846122|FG000|Overall Study|Physician Decision|1|||
27731988|NCT02581995|80846122|FG000|Overall Study|Death|4|||
27731989|NCT00442598|80846125|FG000|Overall Study|Adverse Event|1|||
27731990|NCT00442598|80846126|FG001|Overall Study|Adverse Event|0|||
27731991|NCT00442598|80846127|FG002|Overall Study|Adverse Event|0|||
27731992|NCT00442598|80846125|FG000|Overall Study|Tumor progression|3|||
27731993|NCT00442598|80846126|FG001|Overall Study|Tumor progression|4|||
27731994|NCT00442598|80846127|FG002|Overall Study|Tumor progression|0|||
27731995|NCT00442598|80846125|FG000|Overall Study|Clinical deterioration|1|||
27731996|NCT00442598|80846126|FG001|Overall Study|Clinical deterioration|2|||
27731997|NCT00442598|80846127|FG002|Overall Study|Clinical deterioration|0|||
27731998|NCT00442598|80846125|FG000|Overall Study|CA125 progression|0|||
27731999|NCT00442598|80846126|FG001|Overall Study|CA125 progression|1|||
27732000|NCT00442598|80846127|FG002|Overall Study|CA125 progression|0|||
27732001|NCT00442598|80846125|FG000|Overall Study|Reduced creatinine clearance|1|||
27732002|NCT00442598|80846126|FG001|Overall Study|Reduced creatinine clearance|0|||
27732003|NCT00442598|80846127|FG002|Overall Study|Reduced creatinine clearance|0|||
27732004|NCT00442598|80846125|FG000|Overall Study|Death|0|||
27732005|NCT00442598|80846126|FG001|Overall Study|Death|1|||
27732006|NCT00442598|80846127|FG002|Overall Study|Death|0|||
27732007|NCT00103012|80846128|FG000|Overall Study|Withdrawal by Subject|2|||
27732008|NCT00103012|80846129|FG001|Overall Study|Withdrawal by Subject|1|||
27732009|NCT00103012|80846130|FG002|Overall Study|Withdrawal by Subject|2|||
27732010|NCT00103012|80846128|FG000|Overall Study|Pregnancy|1|||
27732011|NCT00103012|80846129|FG001|Overall Study|Pregnancy|0|||
27732012|NCT00103012|80846130|FG002|Overall Study|Pregnancy|0|||
27732013|NCT00103012|80846128|FG000|Overall Study|Adverse Event|0|||
27732014|NCT00103012|80846129|FG001|Overall Study|Adverse Event|0|||
27732015|NCT00103012|80846130|FG002|Overall Study|Adverse Event|1|||
27732016|NCT00103012|80846128|FG000|Overall Study|Subject non-compliant with medications|0|||
27732017|NCT00103012|80846129|FG001|Overall Study|Subject non-compliant with medications|0|||
27732018|NCT00103012|80846130|FG002|Overall Study|Subject non-compliant with medications|1|||
27732019|NCT02357420|80846136|FG000|Overall Study|Adverse Event|3|||
27732020|NCT02357420|80846137|FG001|Overall Study|Adverse Event|3|||
27522618|NCT01129024|80105208|FG000|Overall Study|Physician Decision|5|||
27522619|NCT01129024|80105208|FG000|Overall Study|Study Terminated by Sponsor|8|||
27522620|NCT01129024|80105208|FG000|Overall Study|Withdrawal by Subject|2|||
27522621|NCT01129024|80105208|FG000|Overall Study|Lack of Efficacy|3|||
27732021|NCT02357420|80846138|FG002|Overall Study|Adverse Event|8|||
27732022|NCT02357420|80846139|FG003|Overall Study|Adverse Event|9|||
27732023|NCT02357420|80846136|FG000|Overall Study|Investigator Decision|1|||
27732024|NCT02357420|80846137|FG001|Overall Study|Investigator Decision|0|||
27522622|NCT01129024|80105208|FG000|Overall Study|Needed a Platelet Transfusion|1|||
27522623|NCT00492063|80105209|FG000|Overall Study|Death|0|||
27620892|NCT01474512|80455966|FG001|Maintenance Period|Clinical Relapse|0|||
27732025|NCT02357420|80846138|FG002|Overall Study|Investigator Decision|0|||
27732026|NCT02357420|80846139|FG003|Overall Study|Investigator Decision|0|||
27732027|NCT02357420|80846136|FG000|Overall Study|Prohibited Medication|1|||
27732028|NCT02357420|80846137|FG001|Overall Study|Prohibited Medication|1|||
27732029|NCT02357420|80846138|FG002|Overall Study|Prohibited Medication|0|||
27732030|NCT02357420|80846139|FG003|Overall Study|Prohibited Medication|0|||
27732031|NCT02357420|80846136|FG000|Overall Study|Protocol Non-compliance|0|||
27732032|NCT02357420|80846137|FG001|Overall Study|Protocol Non-compliance|0|||
27732033|NCT02357420|80846138|FG002|Overall Study|Protocol Non-compliance|0|||
27732034|NCT02357420|80846139|FG003|Overall Study|Protocol Non-compliance|1|||
27522624|NCT00492063|80105210|FG001|Overall Study|Death|0|||
27522625|NCT00492063|80105211|FG002|Overall Study|Death|1|||
27522626|NCT00492063|80105212|FG003|Overall Study|Death|2|||
27732035|NCT02357420|80846136|FG000|Overall Study|Withdrawn Consent|4|||
27732036|NCT02357420|80846137|FG001|Overall Study|Withdrawn Consent|8|||
27732037|NCT02357420|80846138|FG002|Overall Study|Withdrawn Consent|6|||
27732038|NCT02357420|80846139|FG003|Overall Study|Withdrawn Consent|6|||
27732039|NCT02357420|80846136|FG000|Overall Study|Lost to Follow-up|3|||
27732040|NCT02357420|80846137|FG001|Overall Study|Lost to Follow-up|0|||
27732041|NCT02357420|80846138|FG002|Overall Study|Lost to Follow-up|2|||
27732042|NCT02357420|80846139|FG003|Overall Study|Lost to Follow-up|3|||
27732043|NCT02318784|80846140|FG000|Overall Study|Adverse Event|13|||
27732044|NCT02318784|80846140|FG000|Overall Study|Death|2|||
27732045|NCT02318784|80846140|FG000|Overall Study|Progressive Disease|37|||
27732046|NCT02318784|80846140|FG000|Overall Study|Withdrawal by Subject|10|||
27732047|NCT00737529|80846141|FG000|Overall Study|Disease Progression|95|||
27732048|NCT00737529|80846141|FG000|Overall Study|Adverse Event|24|||
27732049|NCT00737529|80846141|FG000|Overall Study|Withdrawal by Subject|5|||
27522627|NCT00492063|80105209|FG000|Overall Study|Withdrawal by Subject|4|||
27522628|NCT00492063|80105210|FG001|Overall Study|Withdrawal by Subject|3|||
27522629|NCT00492063|80105211|FG002|Overall Study|Withdrawal by Subject|5|||
27522630|NCT00492063|80105212|FG003|Overall Study|Withdrawal by Subject|4|||
27522631|NCT00492063|80105209|FG000|Overall Study|Lost to Follow-up|6|||
27522632|NCT00492063|80105210|FG001|Overall Study|Lost to Follow-up|11|||
27522633|NCT00492063|80105211|FG002|Overall Study|Lost to Follow-up|5|||
27522634|NCT00492063|80105212|FG003|Overall Study|Lost to Follow-up|3|||
27522635|NCT00492063|80105209|FG000|Overall Study|Protocol Violation|0|||
27522636|NCT00492063|80105210|FG001|Overall Study|Protocol Violation|0|||
27522637|NCT00492063|80105211|FG002|Overall Study|Protocol Violation|0|||
27522638|NCT00492063|80105212|FG003|Overall Study|Protocol Violation|1|||
27522639|NCT00412373|80105216|FG000|Overall Study|Adverse Event|8|||
27522640|NCT00412373|80105217|FG001|Overall Study|Adverse Event|13|||
27522641|NCT00412373|80105216|FG000|Overall Study|Lack of Efficacy|16|||
27522642|NCT00412373|80105217|FG001|Overall Study|Lack of Efficacy|22|||
27522643|NCT00412373|80105216|FG000|Overall Study|Lost to Follow-up|7|||
27522644|NCT00412373|80105217|FG001|Overall Study|Lost to Follow-up|13|||
27522645|NCT00412373|80105216|FG000|Overall Study|Withdrawal by Subject|8|||
27522646|NCT00412373|80105217|FG001|Overall Study|Withdrawal by Subject|27|||
27522647|NCT00412373|80105216|FG000|Overall Study|Other|2|||
27522648|NCT00412373|80105217|FG001|Overall Study|Other|2|||
27522649|NCT01444092|80105219|FG000|Overall Study|Adverse Event|8|||
27522650|NCT01444092|80105219|FG000|Overall Study|Protocol Violation|1|||
27522651|NCT01444092|80105219|FG000|Overall Study|Withdrawal by Subject|1|||
27522652|NCT01444092|80105219|FG000|Overall Study|Other Eligibility criteria|7|||
27522653|NCT02650921|80105220|FG000|Overall Study|Withdrawal by Subject|4|||
27522654|NCT02650921|80105220|FG000|Overall Study|Lost to Follow-up|2|||
27522655|NCT02650921|80105220|FG000|Overall Study|Adverse Event|1|||
27522656|NCT02650921|80105220|FG000|Overall Study|Due to Medical Condition|1|||
27522657|NCT01143389|80105221|FG000|Overall Study|Lost to Follow-up|26|||
27522658|NCT01143389|80105222|FG001|Overall Study|Lost to Follow-up|25|||
27522659|NCT00217464|80108322|FG000|Overall Study|Progression|15|||
27522660|NCT00217464|80108322|FG000|Overall Study|Other|2|||
27522661|NCT00459056|80108323|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
27522662|NCT00459056|80108324|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
27732050|NCT00737529|80846141|FG000|Overall Study|Death|4|||
27732051|NCT00737529|80846141|FG000|Overall Study|Protocol Violation|1|||
27732052|NCT00737529|80846141|FG000|Overall Study|Other|4|||
27732053|NCT03192904|80846142|FG000|Overall Study|Physician Decision|3|||
27522663|NCT00910624|80108332|FG000|Treatment Phase|Adverse Event|2|||
27522664|NCT00910624|80108333|FG001|Treatment Phase|Adverse Event|6|||
27522665|NCT00910624|80108334|FG002|Treatment Phase|Adverse Event|6|||
27522666|NCT00910624|80108335|FG003|Treatment Phase|Adverse Event|0|||
27522667|NCT00910624|80108332|FG000|Treatment Phase|Treatment Failure|23|||
27522668|NCT00910624|80108333|FG001|Treatment Phase|Treatment Failure|10|||
27522669|NCT00910624|80108334|FG002|Treatment Phase|Treatment Failure|0|||
27522670|NCT00910624|80108335|FG003|Treatment Phase|Treatment Failure|0|||
27522671|NCT00910624|80108332|FG000|Treatment Phase|Lost to Follow-up|0|||
27522672|NCT00910624|80108333|FG001|Treatment Phase|Lost to Follow-up|0|||
27522673|NCT00910624|80108334|FG002|Treatment Phase|Lost to Follow-up|1|||
27732054|NCT03192904|80846143|FG001|Overall Study|Physician Decision|1|||
27732055|NCT03192904|80846142|FG000|Overall Study|Lost to Follow-up|0|||
27732056|NCT03192904|80846143|FG001|Overall Study|Lost to Follow-up|1|||
27732057|NCT01400932|80846144|FG000|Overall Study|Adverse Event|10|||
27522674|NCT00910624|80108335|FG003|Treatment Phase|Lost to Follow-up|0|||
27522675|NCT00910624|80108332|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
27522676|NCT00910624|80108333|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
27522677|NCT00910624|80108334|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
27522678|NCT00910624|80108335|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
27522679|NCT00910624|80108332|FG000|Treatment Phase|Withdrawal by Subject|2|||
27522680|NCT00910624|80108333|FG001|Treatment Phase|Withdrawal by Subject|1|||
27522681|NCT00910624|80108334|FG002|Treatment Phase|Withdrawal by Subject|0|||
27522682|NCT00910624|80108335|FG003|Treatment Phase|Withdrawal by Subject|0|||
27522683|NCT00910624|80108332|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
27522684|NCT00910624|80108333|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
27522685|NCT00910624|80108334|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
27620893|NCT01474512|80455967|FG002|Maintenance Period|Clinical Relapse|0|||
27620894|NCT01474512|80455968|FG003|Maintenance Period|Clinical Relapse|1|||
27620895|NCT01474512|80455969|FG004|Maintenance Period|Clinical Relapse|0|||
27620896|NCT01474512|80455970|FG005|Maintenance Period|Clinical Relapse|0|||
27620897|NCT01474512|80455971|FG006|Maintenance Period|Clinical Relapse|0|||
27620898|NCT01474512|80455972|FG007|Maintenance Period|Clinical Relapse|0|||
27620899|NCT01474512|80455973|FG008|Maintenance Period|Clinical Relapse|0|||
27620900|NCT01474512|80455974|FG009|Maintenance Period|Clinical Relapse|0|||
27620901|NCT01474512|80455975|FG010|Maintenance Period|Clinical Relapse|0|||
27620902|NCT01474512|80455976|FG011|Maintenance Period|Clinical Relapse|0|||
27620903|NCT01474512|80455977|FG012|Maintenance Period|Clinical Relapse|0|||
27620904|NCT01474512|80455978|FG013|Maintenance Period|Clinical Relapse|0|||
27620905|NCT01474512|80455979|FG014|Maintenance Period|Clinical Relapse|0|||
27620906|NCT01474512|80455980|FG015|Maintenance Period|Clinical Relapse|0|||
27620907|NCT01474512|80455981|FG016|Maintenance Period|Clinical Relapse|0|||
27620908|NCT01474512|80455982|FG017|Maintenance Period|Clinical Relapse|0|||
27620909|NCT01474512|80455965|FG000|Maintenance Period|Lack of Efficacy|0|||
27620910|NCT01474512|80455966|FG001|Maintenance Period|Lack of Efficacy|0|||
27620911|NCT01474512|80455967|FG002|Maintenance Period|Lack of Efficacy|0|||
27620912|NCT01474512|80455968|FG003|Maintenance Period|Lack of Efficacy|1|||
27620913|NCT01474512|80455969|FG004|Maintenance Period|Lack of Efficacy|0|||
27620914|NCT01474512|80455970|FG005|Maintenance Period|Lack of Efficacy|0|||
27620915|NCT01474512|80455971|FG006|Maintenance Period|Lack of Efficacy|0|||
27620916|NCT01474512|80455972|FG007|Maintenance Period|Lack of Efficacy|11|||
27620917|NCT01474512|80455973|FG008|Maintenance Period|Lack of Efficacy|11|||
27620918|NCT01474512|80455974|FG009|Maintenance Period|Lack of Efficacy|12|||
27620919|NCT01474512|80455975|FG010|Maintenance Period|Lack of Efficacy|0|||
27620920|NCT01474512|80455976|FG011|Maintenance Period|Lack of Efficacy|0|||
27620921|NCT01474512|80455977|FG012|Maintenance Period|Lack of Efficacy|0|||
27620922|NCT01474512|80455978|FG013|Maintenance Period|Lack of Efficacy|0|||
27620923|NCT01474512|80455979|FG014|Maintenance Period|Lack of Efficacy|0|||
27620924|NCT01474512|80455980|FG015|Maintenance Period|Lack of Efficacy|0|||
27620925|NCT01474512|80455981|FG016|Maintenance Period|Lack of Efficacy|0|||
27620926|NCT01474512|80455982|FG017|Maintenance Period|Lack of Efficacy|0|||
27620927|NCT01474512|80455965|FG000|Maintenance Period|Protocol Violation|0|||
27620928|NCT01474512|80455966|FG001|Maintenance Period|Protocol Violation|0|||
27620929|NCT01474512|80455967|FG002|Maintenance Period|Protocol Violation|0|||
27620930|NCT01474512|80455968|FG003|Maintenance Period|Protocol Violation|1|||
27620931|NCT01474512|80455969|FG004|Maintenance Period|Protocol Violation|0|||
27620932|NCT01474512|80455970|FG005|Maintenance Period|Protocol Violation|0|||
27620933|NCT01474512|80455971|FG006|Maintenance Period|Protocol Violation|0|||
27909504|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
27909505|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
27909506|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
27909507|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
27909508|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
27909509|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
27909510|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
27909511|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Death|0|||
27909512|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Death|0|||
27620934|NCT01474512|80455972|FG007|Maintenance Period|Protocol Violation|1|||
27620935|NCT01474512|80455973|FG008|Maintenance Period|Protocol Violation|0|||
27620936|NCT01474512|80455974|FG009|Maintenance Period|Protocol Violation|1|||
27620937|NCT01474512|80455975|FG010|Maintenance Period|Protocol Violation|0|||
27909513|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
27620938|NCT01474512|80455976|FG011|Maintenance Period|Protocol Violation|0|||
27620939|NCT01474512|80455977|FG012|Maintenance Period|Protocol Violation|0|||
27620940|NCT01474512|80455978|FG013|Maintenance Period|Protocol Violation|0|||
27620941|NCT01474512|80455979|FG014|Maintenance Period|Protocol Violation|0|||
27522686|NCT00910624|80108335|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
27522687|NCT00910624|80108332|FG000|Follow-Up Phase|Adverse Event|0|||
27522688|NCT00910624|80108333|FG001|Follow-Up Phase|Adverse Event|0|||
27522689|NCT00910624|80108334|FG002|Follow-Up Phase|Adverse Event|1|||
27522690|NCT00910624|80108335|FG003|Follow-Up Phase|Adverse Event|0|||
27522691|NCT00910624|80108332|FG000|Follow-Up Phase|Lost to Follow-up|3|||
27522692|NCT00910624|80108333|FG001|Follow-Up Phase|Lost to Follow-up|1|||
27522693|NCT00910624|80108334|FG002|Follow-Up Phase|Lost to Follow-up|2|||
27620942|NCT01474512|80455980|FG015|Maintenance Period|Protocol Violation|0|||
27620943|NCT01474512|80455981|FG016|Maintenance Period|Protocol Violation|0|||
27620944|NCT01474512|80455982|FG017|Maintenance Period|Protocol Violation|0|||
27620945|NCT01474512|80455965|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
27620946|NCT01474512|80455966|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
27620947|NCT01474512|80455967|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
27620948|NCT01474512|80455968|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
27620949|NCT01474512|80455969|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
27620950|NCT01474512|80455970|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
27620951|NCT01474512|80455971|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
27620952|NCT01474512|80455972|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
27620953|NCT01474512|80455973|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
27522694|NCT00910624|80108335|FG003|Follow-Up Phase|Lost to Follow-up|0|||
27522695|NCT00910624|80108332|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
27522696|NCT00910624|80108333|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
27522697|NCT00910624|80108334|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
27522698|NCT00910624|80108335|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
27522699|NCT00910624|80108332|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
27522700|NCT00910624|80108333|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
27522701|NCT00910624|80108334|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
27522702|NCT00910624|80108335|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
27522703|NCT00910624|80108332|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
27522704|NCT00910624|80108333|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
27522705|NCT00910624|80108334|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
27522706|NCT00910624|80108335|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
27522707|NCT00910624|80108332|FG000|Follow-Up Phase|Administrative|0|||
27522708|NCT00910624|80108333|FG001|Follow-Up Phase|Administrative|1|||
27522709|NCT00910624|80108334|FG002|Follow-Up Phase|Administrative|1|||
27522710|NCT00910624|80108335|FG003|Follow-Up Phase|Administrative|0|||
27522711|NCT02969408|80108337|FG000|Overall Study|Adverse Event|2|||
27522712|NCT02969408|80108337|FG000|Overall Study|Withdrawal by Subject|8|||
27522713|NCT02969408|80108337|FG000|Overall Study|Lost to Follow-up|4|||
27522714|NCT02969408|80108337|FG000|Overall Study|Protocol Violation|1|||
27522715|NCT02969408|80108337|FG000|Overall Study|Other than specified|1|||
27522716|NCT02241889|80108338|FG000|Overall Study|device issues|0|||
27522717|NCT02241889|80108339|FG001|Overall Study|device issues|0|||
27522718|NCT02241889|80108340|FG002|Overall Study|device issues|1|||
27522719|NCT02241889|80108341|FG003|Overall Study|device issues|0|||
27522720|NCT02241889|80108342|FG004|Overall Study|device issues|0|||
27522721|NCT02241889|80108343|FG005|Overall Study|device issues|0|||
27522722|NCT02241889|80108338|FG000|Overall Study|Withdrawal by Subject|0|||
27522723|NCT02241889|80108339|FG001|Overall Study|Withdrawal by Subject|0|||
27522724|NCT02241889|80108340|FG002|Overall Study|Withdrawal by Subject|0|||
27522725|NCT02241889|80108341|FG003|Overall Study|Withdrawal by Subject|0|||
27522726|NCT02241889|80108342|FG004|Overall Study|Withdrawal by Subject|0|||
27522727|NCT02241889|80108343|FG005|Overall Study|Withdrawal by Subject|1|||
27522728|NCT00053898|80108344|FG000|Overall Study|No follow-up data from any source|9|||
27522729|NCT00053898|80108345|FG001|Overall Study|No follow-up data from any source|12|||
27522730|NCT00053898|80108344|FG000|Overall Study|Follow-up from telephone contact only|5|||
27522731|NCT00053898|80108345|FG001|Overall Study|Follow-up from telephone contact only|1|||
27522732|NCT01903252|80108348|FG000|Double-Blind Induction|Adverse Event|20|||
27522733|NCT01903252|80108349|FG001|Double-Blind Induction|Adverse Event|18|||
27522734|NCT01903252|80108350|FG002|Double-Blind Induction|Adverse Event|0|||
27522735|NCT01903252|80108351|FG003|Double-Blind Induction|Adverse Event|0|||
27522736|NCT01903252|80108352|FG004|Double-Blind Induction|Adverse Event|0|||
27522737|NCT01903252|80108353|FG005|Double-Blind Induction|Adverse Event|0|||
27522738|NCT01903252|80108348|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
27522739|NCT01903252|80108349|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
27620954|NCT01474512|80455974|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
27620955|NCT01474512|80455975|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
27620956|NCT01474512|80455976|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
27620957|NCT01474512|80455977|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
27620958|NCT01474512|80455978|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
27620959|NCT01474512|80455979|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
27620960|NCT01474512|80455980|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
27620961|NCT01474512|80455981|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
27620962|NCT01474512|80455982|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
27732058|NCT01400932|80846145|FG001|Overall Study|Adverse Event|5|||
27732059|NCT01400932|80846144|FG000|Overall Study|Lack of Efficacy|0|||
27909514|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
27909515|NCT00105989|81506954|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
27909516|NCT00105989|81506955|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
27909517|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
27909518|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
27909519|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
27909520|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
27909521|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
27909522|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
27909523|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
27909524|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
27909525|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
27909526|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
27909527|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
27732060|NCT01400932|80846145|FG001|Overall Study|Lack of Efficacy|3|||
27732061|NCT01400932|80846144|FG000|Overall Study|Withdrawal by Subject|2|||
27732062|NCT01400932|80846145|FG001|Overall Study|Withdrawal by Subject|6|||
27732063|NCT01400932|80846144|FG000|Overall Study|Lost to Follow-up|1|||
27732064|NCT01400932|80846145|FG001|Overall Study|Lost to Follow-up|0|||
27732065|NCT01400932|80846144|FG000|Overall Study|Protocol Deviation|0|||
27732066|NCT01400932|80846145|FG001|Overall Study|Protocol Deviation|1|||
27732067|NCT01400932|80846144|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27732068|NCT01400932|80846145|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
27854590|NCT01155024|81298848|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
27854591|NCT01155024|81298847|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
27854592|NCT01155024|81298848|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
27854593|NCT03760250|81298854|FG000|Overall Study|Withdrawal by Subject|1|||
27854594|NCT03760250|81298854|FG000|Overall Study|Physician Decision|1|||
27854595|NCT00505375|81298855|FG000|Overall Study|Death|1|||
27854596|NCT00505375|81298856|FG001|Overall Study|Death|0|||
27854597|NCT00505375|81298855|FG000|Overall Study|Withdrawal by Subject|2|||
27854598|NCT00505375|81298856|FG001|Overall Study|Withdrawal by Subject|2|||
27854599|NCT00505375|81298855|FG000|Overall Study|Lost to Follow-up|0|||
27854600|NCT00505375|81298856|FG001|Overall Study|Lost to Follow-up|2|||
27854601|NCT00505375|81298855|FG000|Overall Study|Pregnancy|1|||
27854602|NCT00505375|81298856|FG001|Overall Study|Pregnancy|0|||
27854603|NCT00505375|81298855|FG000|Overall Study|Travel issues|0|||
27854604|NCT00505375|81298856|FG001|Overall Study|Travel issues|1|||
27854605|NCT02534844|81298861|FG000|Part B|Withdrawal by Subject|0|||
27854606|NCT02534844|81298862|FG001|Part B|Withdrawal by Subject|0|||
27854607|NCT02534844|81298863|FG002|Part B|Withdrawal by Subject|0|||
27854608|NCT02534844|81298864|FG003|Part B|Withdrawal by Subject|0|||
27854609|NCT02534844|81298865|FG004|Part B|Withdrawal by Subject|2|||
27854610|NCT02534844|81298866|FG005|Part B|Withdrawal by Subject|1|||
27854611|NCT04421586|81298867|FG000|Overall Study|Death|0|||
27854612|NCT04421586|81298868|FG001|Overall Study|Death|1|||
27854613|NCT04421586|81298867|FG000|Overall Study|Lost to Follow-up|2|||
27854614|NCT04421586|81298868|FG001|Overall Study|Lost to Follow-up|2|||
27854615|NCT04421586|81298867|FG000|Overall Study|Withdrawn by PI|1|||
27854616|NCT04421586|81298868|FG001|Overall Study|Withdrawn by PI|0|||
27909528|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
27732069|NCT04401267|80846148|FG000|Overall Study|Death|0|||
27732070|NCT04401267|80846149|FG001|Overall Study|Death|1|||
27854617|NCT04421586|81298867|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
27854618|NCT04421586|81298868|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
27854619|NCT03251963|81298869|FG000|Overall Study|inappropriate Xa level timing|6|||
27854620|NCT03251963|81298870|FG001|Overall Study|inappropriate Xa level timing|3|||
27854621|NCT03251963|81298869|FG000|Overall Study|no peak Xa level drawn|2|||
27854622|NCT03251963|81298870|FG001|Overall Study|no peak Xa level drawn|0|||
27854623|NCT03251963|81298869|FG000|Overall Study|bled prior to Xa level|1|||
27854624|NCT03251963|81298870|FG001|Overall Study|bled prior to Xa level|2|||
27909529|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
27909530|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
27909531|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
27909532|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
27909533|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
27909534|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
27909535|NCT00105989|81506954|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
27909536|NCT00105989|81506955|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
27909537|NCT02091414|81506956|FG000|Overall Study|Withdrawal by Subject|2|||
27909538|NCT02091414|81506956|FG000|Overall Study|Death|2|||
27909539|NCT03052920|81506957|FG000|Overall Study|Withdrawal by Subject|1|||
27732071|NCT04401267|80846148|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
27732072|NCT04401267|80846149|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
27909540|NCT00762762|81506958|FG000|Overall Study|Did not return for appointments|6|||
27909541|NCT00762762|81506959|FG001|Overall Study|Did not return for appointments|8|||
27909542|NCT03252145|81506960|FG000|Overall Study|Withdrawal by Subject|1|||
27909543|NCT03252145|81506961|FG001|Overall Study|Withdrawal by Subject|0|||
27909544|NCT03252145|81506960|FG000|Overall Study|Complicating Disease|1|||
27909545|NCT03252145|81506961|FG001|Overall Study|Complicating Disease|2|||
27909546|NCT02105285|81506962|FG000|Overall Study|Adverse Event|1|||
27909547|NCT02105285|81506963|FG001|Overall Study|Adverse Event|1|||
27909548|NCT02105285|81506964|FG002|Overall Study|Adverse Event|0|||
27909549|NCT02105285|81506962|FG000|Overall Study|Protocol Violation|0|||
27909550|NCT02105285|81506963|FG001|Overall Study|Protocol Violation|1|||
27909551|NCT02105285|81506964|FG002|Overall Study|Protocol Violation|0|||
27909552|NCT02105285|81506962|FG000|Overall Study|Withdrawal by Subject|1|||
27909553|NCT02105285|81506963|FG001|Overall Study|Withdrawal by Subject|0|||
27909554|NCT02105285|81506964|FG002|Overall Study|Withdrawal by Subject|0|||
27909555|NCT00412932|81506970|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
27854625|NCT02351960|81298871|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
27854626|NCT02351960|81298872|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
27854627|NCT02351960|81298871|FG000|Overall Study|Voluntary Withdrawal|5|||
27854628|NCT02351960|81298872|FG001|Overall Study|Voluntary Withdrawal|4|||
27854629|NCT02351960|81298871|FG000|Overall Study|Significant Protocol Deviation|0|||
27854630|NCT02351960|81298872|FG001|Overall Study|Significant Protocol Deviation|5|||
27854631|NCT02669758|81298880|FG000|Overall Study|Withdrawal by Subject|43|||
27854632|NCT02669758|81298880|FG000|Overall Study|Lost to Follow-up|19|||
27854633|NCT02669758|81298880|FG000|Overall Study|Adverse Event|16|||
27854634|NCT02669758|81298880|FG000|Overall Study|Non-Compliance with Study Drug|8|||
27909556|NCT00412932|81506970|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
27909557|NCT00412932|81506970|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
27909558|NCT00412932|81506970|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
27909559|NCT00412932|81506970|FG000|Olmesartan (Olm) 20 mg|Other|1|||
27909560|NCT00412932|81506970|FG000|Olmesartan 40 mg|Adverse Event|4|||
27909561|NCT00412932|81506970|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
27909562|NCT00412932|81506970|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
27909563|NCT00412932|81506970|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
27909564|NCT00412932|81506970|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
27909565|NCT00412932|81506970|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
27909566|NCT00412932|81506970|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
27909567|NCT01473940|81506971|FG000|Induction Therapy|Death|0|||
27909568|NCT01473940|81506972|FG001|Induction Therapy|Death|0|||
27909569|NCT01473940|81506973|FG002|Induction Therapy|Death|1|||
27909570|NCT01473940|81506974|FG003|Induction Therapy|Death|1|||
27909571|NCT01473940|81506971|FG000|Induction Therapy|Progressive Disease|0|||
27909572|NCT01473940|81506972|FG001|Induction Therapy|Progressive Disease|1|||
27909573|NCT01473940|81506973|FG002|Induction Therapy|Progressive Disease|1|||
27854635|NCT02669758|81298880|FG000|Overall Study|Lack of Efficacy|5|||
27854636|NCT02669758|81298880|FG000|Overall Study|Pregnancy|1|||
27909574|NCT01473940|81506974|FG003|Induction Therapy|Progressive Disease|0|||
27909575|NCT01473940|81506971|FG000|Maintenance Therapy|Progressive Disease|1|||
27909576|NCT01473940|81506972|FG001|Maintenance Therapy|Progressive Disease|2|||
27732073|NCT04401267|80846148|FG000|Overall Study|Found to be Ineligible|1|||
27732074|NCT04401267|80846149|FG001|Overall Study|Found to be Ineligible|0|||
27732075|NCT01553149|80846150|FG000|Overall Study|Adverse Event|0|||
27732076|NCT01553149|80846151|FG001|Overall Study|Adverse Event|9|||
27854637|NCT02669758|81298880|FG000|Overall Study|Study noncompliance|1|||
27854638|NCT02669758|81298880|FG000|Overall Study|Protocol Violation|1|||
27909577|NCT01473940|81506973|FG002|Maintenance Therapy|Progressive Disease|1|||
27909578|NCT01473940|81506974|FG003|Maintenance Therapy|Progressive Disease|4|||
27909579|NCT01979523|81506980|FG000|Overall Study|Withdrawal by Subject|1|||
27909580|NCT01979523|81506981|FG001|Overall Study|Withdrawal by Subject|0|||
27909581|NCT00672633|81506983|FG000|Overall Study|Withdrawal by Subject|0|||
27909582|NCT00672633|81506984|FG001|Overall Study|Withdrawal by Subject|1|||
27909583|NCT04086121|81506989|FG000|Overall Study|Other than listed|8|||
27909584|NCT04086121|81506989|FG000|Overall Study|Withdrawal by Subject|3|||
27909585|NCT04086121|81506989|FG000|Overall Study|Lost to Follow-up|2|||
27909586|NCT04086121|81506989|FG000|Overall Study|Adverse Event|1|||
27909587|NCT00991289|81506990|FG000|Overall Study|Adverse Event|1|||
27909588|NCT00991289|81506990|FG000|Overall Study|Physician Decision|2|||
27909589|NCT00991289|81506990|FG000|Overall Study|Withdrawal by Subject|3|||
27909590|NCT00991289|81506990|FG000|Overall Study|Lost to Follow-up|4|||
27909591|NCT00991289|81506990|FG000|Overall Study|Protocol Violation|2|||
27909592|NCT02058589|81506991|FG000|Overall Study|Serious Adverse Event|1|||
27909593|NCT02058589|81506992|FG001|Overall Study|Serious Adverse Event|1|||
27909594|NCT02058589|81506991|FG000|Overall Study|Non-Serious Adverse Event|1|||
27909595|NCT02058589|81506992|FG001|Overall Study|Non-Serious Adverse Event|0|||
27909596|NCT02058589|81506991|FG000|Overall Study|Withdrawal by Subject|0|||
27909597|NCT02058589|81506992|FG001|Overall Study|Withdrawal by Subject|1|||
27854639|NCT00319982|81298881|FG000|Overall Study|Withdrawal by Subject|1|||
27854640|NCT00319982|81298882|FG001|Overall Study|Withdrawal by Subject|0|||
27909598|NCT02937740|81506993|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
27909599|NCT02937740|81506994|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
27909600|NCT02937740|81506993|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
27909601|NCT02937740|81506994|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
27909602|NCT02937740|81506993|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
27909603|NCT02937740|81506994|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
27909604|NCT02937740|81506993|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
27909605|NCT02937740|81506994|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
27909606|NCT02937740|81506993|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
27909607|NCT02937740|81506994|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
27854641|NCT01936623|81298883|FG000|Overall Study|Lost to Follow-up|0|||
27854642|NCT01936623|81298884|FG001|Overall Study|Lost to Follow-up|5|||
27854643|NCT04688931|81298885|FG000|Overall Study|Adverse Event|4|||
27854644|NCT04688931|81298886|FG001|Overall Study|Adverse Event|1|||
27854645|NCT04688931|81298885|FG000|Overall Study|Withdrawal by Subject|5|||
27854646|NCT04688931|81298886|FG001|Overall Study|Withdrawal by Subject|16|||
27854647|NCT04688931|81298885|FG000|Overall Study|Physician Decision|3|||
27854648|NCT04688931|81298886|FG001|Overall Study|Physician Decision|5|||
27854649|NCT04688931|81298885|FG000|Overall Study|Noncompliance|0|||
27854650|NCT04688931|81298886|FG001|Overall Study|Noncompliance|1|||
27854651|NCT04688931|81298885|FG000|Overall Study|Lost to Follow-up|1|||
27909608|NCT02937740|81506993|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
27909609|NCT02937740|81506994|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
27909610|NCT01254656|81506999|FG000|Overall Study|Discontinued due to termination of study|40|||
27909611|NCT01254656|81507000|FG001|Overall Study|Discontinued due to termination of study|39|||
27909612|NCT01254656|81507001|FG002|Overall Study|Discontinued due to termination of study|13|||
27909613|NCT01254656|81506999|FG000|Overall Study|Lack of Efficacy|3|||
27909614|NCT01254656|81507000|FG001|Overall Study|Lack of Efficacy|0|||
27909615|NCT01254656|81507001|FG002|Overall Study|Lack of Efficacy|0|||
27909616|NCT01254656|81506999|FG000|Overall Study|Lost to Follow-up|1|||
27909617|NCT01254656|81507000|FG001|Overall Study|Lost to Follow-up|0|||
27909618|NCT01254656|81507001|FG002|Overall Study|Lost to Follow-up|2|||
27909619|NCT01254656|81506999|FG000|Overall Study|Withdrawal by Subject|2|||
27909620|NCT01254656|81507000|FG001|Overall Study|Withdrawal by Subject|2|||
27909621|NCT01254656|81507001|FG002|Overall Study|Withdrawal by Subject|1|||
27909622|NCT01254656|81506999|FG000|Overall Study|Pregnancy|0|||
27909623|NCT01254656|81507000|FG001|Overall Study|Pregnancy|0|||
27909624|NCT01254656|81507001|FG002|Overall Study|Pregnancy|2|||
27909625|NCT01254656|81506999|FG000|Overall Study|Adverse Event|1|||
27909626|NCT01254656|81507000|FG001|Overall Study|Adverse Event|1|||
27909627|NCT01254656|81507001|FG002|Overall Study|Adverse Event|0|||
27909628|NCT01254656|81506999|FG000|Overall Study|Death|0|||
27854652|NCT04688931|81298886|FG001|Overall Study|Lost to Follow-up|3|||
27854653|NCT04688931|81298885|FG000|Overall Study|Randomization Error|3|||
27909629|NCT01254656|81507000|FG001|Overall Study|Death|1|||
27909630|NCT01254656|81507001|FG002|Overall Study|Death|0|||
27909631|NCT00735943|81507004|FG000|Overall Study|Lost to Follow-up|1|||
27909632|NCT00735943|81507004|FG000|Overall Study|Adverse Event|1|||
27909633|NCT05225389|81507005|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
27909634|NCT04878055|81507006|FG000|Overall Study|Patient transferred in another department|0|||
27909635|NCT04878055|81507007|FG001|Overall Study|Patient transferred in another department|2|||
27909636|NCT04878055|81507006|FG000|Overall Study|Physician Decision|1|||
27909637|NCT04878055|81507007|FG001|Overall Study|Physician Decision|1|||
27909638|NCT04878055|81507006|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
27909639|NCT04878055|81507007|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
27909640|NCT04878055|81507006|FG000|Overall Study|Adverse Event|12|||
27909641|NCT04878055|81507007|FG001|Overall Study|Adverse Event|7|||
27909642|NCT04878055|81507006|FG000|Overall Study|Other|5|||
27909643|NCT04878055|81507007|FG001|Overall Study|Other|0|||
27909644|NCT04878055|81507006|FG000|Overall Study|Withdrawal by Subject|7|||
27909645|NCT04878055|81507007|FG001|Overall Study|Withdrawal by Subject|3|||
27909646|NCT04878055|81507006|FG000|Overall Study|Lost to Follow-up|10|||
27909647|NCT04878055|81507007|FG001|Overall Study|Lost to Follow-up|1|||
27909648|NCT00905632|81507010|FG000|Overall Study|Adverse Event|0|||
27909649|NCT00905632|81507011|FG001|Overall Study|Adverse Event|0|||
27909650|NCT00905632|81507012|FG002|Overall Study|Adverse Event|0|||
27909651|NCT00905632|81507013|FG003|Overall Study|Adverse Event|0|||
27909652|NCT00905632|81507014|FG004|Overall Study|Adverse Event|0|||
27909653|NCT00905632|81507015|FG005|Overall Study|Adverse Event|1|||
27909654|NCT00905632|81507016|FG006|Overall Study|Adverse Event|4|||
27909655|NCT00110357|81507023|FG000|Overall Study|Deterioration without progression|2|||
27909656|NCT00110357|81507024|FG001|Overall Study|Deterioration without progression|0|||
27909657|NCT00110357|81507023|FG000|Overall Study|Disease progression/relapse|20|||
27909658|NCT00110357|81507024|FG001|Overall Study|Disease progression/relapse|15|||
27909659|NCT00110357|81507023|FG000|Overall Study|Study Closure|1|||
27909660|NCT00110357|81507024|FG001|Overall Study|Study Closure|0|||
27909661|NCT00110357|81507023|FG000|Overall Study|Study Drug Toxicity|1|||
27909662|NCT00110357|81507024|FG001|Overall Study|Study Drug Toxicity|3|||
27909663|NCT00110357|81507023|FG000|Overall Study|Withdrawal by Subject|3|||
27909664|NCT00110357|81507024|FG001|Overall Study|Withdrawal by Subject|1|||
27909665|NCT00960804|81507025|FG000|Overall Study|Adverse Event|1|||
27909666|NCT00960804|81507026|FG001|Overall Study|Adverse Event|0|||
27909667|NCT00960804|81507027|FG002|Overall Study|Adverse Event|0|||
27909668|NCT00960804|81507025|FG000|Overall Study|Withdrawal by Subject|1|||
27909669|NCT00960804|81507026|FG001|Overall Study|Withdrawal by Subject|0|||
27909670|NCT00960804|81507027|FG002|Overall Study|Withdrawal by Subject|0|||
27909671|NCT00960804|81507025|FG000|Overall Study|Study terminated by the sponsor|5|||
27909672|NCT00960804|81507026|FG001|Overall Study|Study terminated by the sponsor|4|||
27909673|NCT00960804|81507027|FG002|Overall Study|Study terminated by the sponsor|10|||
27909674|NCT00398047|81507028|FG000|Overall Study|all patient progressed before completion|3|||
27909675|NCT01964989|81507029|FG000|Overall Study|Protocol Violation|3|||
27909676|NCT01964989|81507030|FG001|Overall Study|Protocol Violation|4|||
27909677|NCT01964989|81507029|FG000|Overall Study|Administrative Reason|103|||
27909678|NCT01964989|81507030|FG001|Overall Study|Administrative Reason|95|||
27909679|NCT01964989|81507029|FG000|Overall Study|Adverse Event|0|||
27909680|NCT01964989|81507030|FG001|Overall Study|Adverse Event|1|||
27909681|NCT01964989|81507029|FG000|Overall Study|Death|1|||
27909682|NCT01964989|81507030|FG001|Overall Study|Death|3|||
27909683|NCT01964989|81507029|FG000|Overall Study|Withdrawal by Subject|156|||
27909684|NCT01964989|81507030|FG001|Overall Study|Withdrawal by Subject|160|||
27909685|NCT01964989|81507029|FG000|Overall Study|Lost to Follow-up|254|||
27909686|NCT01964989|81507030|FG001|Overall Study|Lost to Follow-up|232|||
27909687|NCT01964989|81507029|FG000|Overall Study|Other|267|||
27909688|NCT01964989|81507030|FG001|Overall Study|Other|252|||
27909689|NCT02155309|81507031|FG000|Overall Study|Protocol Violation|0|||
27909690|NCT02155309|81507032|FG001|Overall Study|Protocol Violation|0|||
27909691|NCT02155309|81507033|FG002|Overall Study|Protocol Violation|1|||
27909692|NCT03365934|81507034|FG000|Overall Study|Adverse Event|1|||
27909693|NCT03365934|81507034|FG000|Overall Study|Withdrawal by Subject|1|||
27522740|NCT01903252|80108350|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
27522741|NCT01903252|80108351|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
27522742|NCT01903252|80108352|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
27909694|NCT00807885|81507035|FG000|Overall Study|Lost to Follow-up|0|||
27909695|NCT00807885|81507036|FG001|Overall Study|Lost to Follow-up|0|||
27909696|NCT00807885|81507037|FG002|Overall Study|Lost to Follow-up|0|||
27909697|NCT00807885|81507038|FG003|Overall Study|Lost to Follow-up|0|||
27909698|NCT00807885|81507039|FG004|Overall Study|Lost to Follow-up|0|||
27909699|NCT00807885|81507040|FG005|Overall Study|Lost to Follow-up|1|||
27909700|NCT00807885|81507041|FG006|Overall Study|Lost to Follow-up|0|||
27909701|NCT00807885|81507042|FG007|Overall Study|Lost to Follow-up|0|||
27909702|NCT00807885|81507043|FG008|Overall Study|Lost to Follow-up|0|||
27909703|NCT00410072|81507044|FG000|Day 1 to Week 48|Adverse Event|1|||
27909704|NCT00410072|81507045|FG001|Day 1 to Week 48|Adverse Event|2|||
27909705|NCT00410072|81507044|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
27909706|NCT00410072|81507045|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
27909707|NCT00410072|81507044|FG000|Day 1 to Week 48|Other|0|||
27909708|NCT00410072|81507045|FG001|Day 1 to Week 48|Other|1|||
27909709|NCT00410072|81507044|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
27909710|NCT00410072|81507045|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
27909711|NCT00410072|81507044|FG000|Day 1 to Week 48|Pregnancy|0|||
27909712|NCT00410072|81507045|FG001|Day 1 to Week 48|Pregnancy|2|||
27909713|NCT00410072|81507044|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
27909714|NCT00410072|81507045|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
27909715|NCT00410072|81507044|FG000|After Week 48 to Week 96|Adverse Event|1|||
27522743|NCT01903252|80108353|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
27522744|NCT01903252|80108348|FG000|Double-Blind Induction|Physician Decision|2|||
27522745|NCT01903252|80108349|FG001|Double-Blind Induction|Physician Decision|3|||
27522746|NCT01903252|80108350|FG002|Double-Blind Induction|Physician Decision|0|||
27522747|NCT01903252|80108351|FG003|Double-Blind Induction|Physician Decision|0|||
27522748|NCT01903252|80108352|FG004|Double-Blind Induction|Physician Decision|0|||
27522749|NCT01903252|80108353|FG005|Double-Blind Induction|Physician Decision|0|||
27522750|NCT01903252|80108348|FG000|Double-Blind Induction|non-compliance,|7|||
27522751|NCT01903252|80108349|FG001|Double-Blind Induction|non-compliance,|7|||
27522752|NCT01903252|80108350|FG002|Double-Blind Induction|non-compliance,|0|||
27522753|NCT01903252|80108351|FG003|Double-Blind Induction|non-compliance,|0|||
27522754|NCT01903252|80108352|FG004|Double-Blind Induction|non-compliance,|0|||
27522755|NCT01903252|80108353|FG005|Double-Blind Induction|non-compliance,|0|||
27522756|NCT01903252|80108348|FG000|Extended Induction, Open-Label|Adverse Event|0|||
27522757|NCT01903252|80108349|FG001|Extended Induction, Open-Label|Adverse Event|0|||
27522758|NCT01903252|80108350|FG002|Extended Induction, Open-Label|Adverse Event|17|||
27522759|NCT01903252|80108351|FG003|Extended Induction, Open-Label|Adverse Event|0|||
27522760|NCT01903252|80108352|FG004|Extended Induction, Open-Label|Adverse Event|0|||
27522761|NCT01903252|80108353|FG005|Extended Induction, Open-Label|Adverse Event|0|||
27522762|NCT01903252|80108348|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27522763|NCT01903252|80108349|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27522764|NCT01903252|80108350|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
27522765|NCT01903252|80108351|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27522766|NCT01903252|80108352|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27854654|NCT04688931|81298886|FG001|Overall Study|Randomization Error|0|||
27854655|NCT04688931|81298885|FG000|Overall Study|Not Eligible|1|||
27854656|NCT04688931|81298886|FG001|Overall Study|Not Eligible|3|||
27854657|NCT04688931|81298885|FG000|Overall Study|Disease Progression|0|||
27854658|NCT04688931|81298886|FG001|Overall Study|Disease Progression|2|||
27854659|NCT04688931|81298885|FG000|Overall Study|Sponsor Requirement|1|||
27854660|NCT04688931|81298886|FG001|Overall Study|Sponsor Requirement|1|||
27854661|NCT04688931|81298885|FG000|Overall Study|Other Reason|1|||
27854662|NCT04688931|81298886|FG001|Overall Study|Other Reason|2|||
27854663|NCT02358343|81298887|FG000|Screening Intervention|Death|0|||
27854664|NCT02358343|81298888|FG001|Screening Intervention|Death|2|||
27854665|NCT02358343|81298889|FG002|Screening Intervention|Death|0|||
27854666|NCT02358343|81298890|FG003|Screening Intervention|Death|0|||
27854667|NCT02358343|81298891|FG004|Screening Intervention|Death|0|||
27854668|NCT02358343|81298887|FG000|Screening Intervention|Withdrawal by Subject|1|||
27854669|NCT02358343|81298888|FG001|Screening Intervention|Withdrawal by Subject|0|||
27854670|NCT02358343|81298889|FG002|Screening Intervention|Withdrawal by Subject|0|||
27854671|NCT02358343|81298890|FG003|Screening Intervention|Withdrawal by Subject|0|||
27854672|NCT02358343|81298891|FG004|Screening Intervention|Withdrawal by Subject|0|||
27854673|NCT02358343|81298887|FG000|Screening Intervention|Determined Ineligible|5|||
27854674|NCT02358343|81298888|FG001|Screening Intervention|Determined Ineligible|6|||
27854675|NCT02358343|81298889|FG002|Screening Intervention|Determined Ineligible|0|||
27854676|NCT02358343|81298890|FG003|Screening Intervention|Determined Ineligible|0|||
27854677|NCT02358343|81298891|FG004|Screening Intervention|Determined Ineligible|0|||
27854678|NCT02358343|81298887|FG000|Comparative Efficacy Trial / Observation|Death|0|||
27854679|NCT02358343|81298888|FG001|Comparative Efficacy Trial / Observation|Death|0|||
27854680|NCT02358343|81298889|FG002|Comparative Efficacy Trial / Observation|Death|2|||
27854681|NCT02358343|81298890|FG003|Comparative Efficacy Trial / Observation|Death|0|||
27854682|NCT02358343|81298891|FG004|Comparative Efficacy Trial / Observation|Death|0|||
27854683|NCT02358343|81298887|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
27854684|NCT02358343|81298888|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
27854685|NCT02358343|81298889|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
27854686|NCT02358343|81298890|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
27854687|NCT02358343|81298891|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
27854688|NCT02358343|81298887|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27854689|NCT02358343|81298888|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27854690|NCT02358343|81298889|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
27854691|NCT02358343|81298890|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27522767|NCT01903252|80108353|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
27522768|NCT01903252|80108348|FG000|Extended Induction, Open-Label|Physician Decision|0|||
27909716|NCT00410072|81507045|FG001|After Week 48 to Week 96|Adverse Event|2|||
27909717|NCT00410072|81507044|FG000|After Week 48 to Week 96|Death|0|||
27522769|NCT01903252|80108349|FG001|Extended Induction, Open-Label|Physician Decision|0|||
27522770|NCT01903252|80108350|FG002|Extended Induction, Open-Label|Physician Decision|1|||
27522771|NCT01903252|80108351|FG003|Extended Induction, Open-Label|Physician Decision|0|||
27522772|NCT01903252|80108352|FG004|Extended Induction, Open-Label|Physician Decision|0|||
27522773|NCT01903252|80108353|FG005|Extended Induction, Open-Label|Physician Decision|0|||
27522774|NCT01903252|80108348|FG000|Maintenance, Open-Label|Adverse Event|0|||
27522775|NCT01903252|80108349|FG001|Maintenance, Open-Label|Adverse Event|0|||
27522776|NCT01903252|80108350|FG002|Maintenance, Open-Label|Adverse Event|0|||
27620963|NCT01474512|80455965|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
27620964|NCT01474512|80455966|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
27620965|NCT01474512|80455967|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
27522777|NCT01903252|80108351|FG003|Maintenance, Open-Label|Adverse Event|3|||
27522778|NCT01903252|80108352|FG004|Maintenance, Open-Label|Adverse Event|9|||
27522779|NCT01903252|80108353|FG005|Maintenance, Open-Label|Adverse Event|14|||
27854692|NCT02358343|81298891|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
27522780|NCT01903252|80108348|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
27522781|NCT01903252|80108349|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
27522782|NCT01903252|80108350|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
27522783|NCT01903252|80108351|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
27522784|NCT01903252|80108352|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
27522785|NCT01903252|80108353|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
27522786|NCT01903252|80108348|FG000|Maintenance, Open-Label|Other|0|||
27522787|NCT01903252|80108349|FG001|Maintenance, Open-Label|Other|0|||
27522788|NCT01903252|80108350|FG002|Maintenance, Open-Label|Other|0|||
27522789|NCT01903252|80108351|FG003|Maintenance, Open-Label|Other|2|||
27522790|NCT01903252|80108352|FG004|Maintenance, Open-Label|Other|6|||
27522791|NCT01903252|80108353|FG005|Maintenance, Open-Label|Other|2|||
27522792|NCT00729469|80108354|FG000|Overall Study|Adverse Event|14|||
27522793|NCT00729469|80108355|FG001|Overall Study|Adverse Event|25|||
27522794|NCT00729469|80108354|FG000|Overall Study|Lost to Follow-up|9|||
27522795|NCT00729469|80108355|FG001|Overall Study|Lost to Follow-up|9|||
27522796|NCT00729469|80108354|FG000|Overall Study|Protocol Violation|2|||
27522797|NCT00729469|80108355|FG001|Overall Study|Protocol Violation|1|||
27522798|NCT00729469|80108354|FG000|Overall Study|Withdrawal by Subject|19|||
27522799|NCT00729469|80108355|FG001|Overall Study|Withdrawal by Subject|8|||
27522800|NCT00729469|80108354|FG000|Overall Study|Other-Not mentioned|9|||
27522801|NCT00729469|80108355|FG001|Overall Study|Other-Not mentioned|4|||
27522802|NCT00906971|80108360|FG000|Overall Study|Withdrawal by Subject|8|||
27522803|NCT00906971|80108361|FG001|Overall Study|Withdrawal by Subject|2|||
27522804|NCT00906971|80108360|FG000|Overall Study|Lost to Follow-up|0|||
27522805|NCT00906971|80108361|FG001|Overall Study|Lost to Follow-up|1|||
27522806|NCT00545129|80108362|FG000|Overall Study|Lack of Efficacy|2|||
27522807|NCT00545129|80108363|FG001|Overall Study|Lack of Efficacy|5|||
27522808|NCT00545129|80108362|FG000|Overall Study|Death|2|||
27522809|NCT00545129|80108363|FG001|Overall Study|Death|1|||
27522810|NCT00545129|80108362|FG000|Overall Study|Adverse Event|1|||
27522811|NCT00545129|80108363|FG001|Overall Study|Adverse Event|1|||
27522812|NCT00545129|80108362|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
27522813|NCT00545129|80108363|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
27522814|NCT00545129|80108362|FG000|Overall Study|Other|3|||
27522815|NCT00545129|80108363|FG001|Overall Study|Other|3|||
27522816|NCT00813943|80108364|FG000|Overall Study|Ongoing at cut-off date|5|||
27522817|NCT00813943|80108365|FG001|Overall Study|Ongoing at cut-off date|5|||
27522818|NCT00813943|80108366|FG002|Overall Study|Ongoing at cut-off date|3|||
27854693|NCT03484117|81298892|FG000|Overall Study|Lost to Follow-up|1|||
27854694|NCT03484117|81298893|FG001|Overall Study|Lost to Follow-up|3|||
27854695|NCT03484117|81298892|FG000|Overall Study|Declined participation in exit assess|1|||
27854696|NCT03484117|81298893|FG001|Overall Study|Declined participation in exit assess|1|||
27854697|NCT02394730|81298894|FG000|Overall Study|Lost to Follow-up|1|||
27854698|NCT02394730|81298895|FG001|Overall Study|Lost to Follow-up|0|||
27854699|NCT02394730|81298894|FG000|Overall Study|Withdrawal by Subject|0|||
27854700|NCT02394730|81298895|FG001|Overall Study|Withdrawal by Subject|1|||
27854701|NCT02987959|81298897|FG000|Overall Study|Grantor stopped supply of drugs|6|||
27909718|NCT00410072|81507045|FG001|After Week 48 to Week 96|Death|1|||
27522819|NCT02925416|80108367|FG000|Overall Study|Adverse Event|2|||
27522820|NCT02925416|80108368|FG001|Overall Study|Adverse Event|0|||
27522821|NCT03751657|80108369|FG000|Overall Study|Physician Decision|0|||
27522822|NCT03751657|80108370|FG001|Overall Study|Physician Decision|1|||
27522823|NCT03751657|80108369|FG000|Overall Study|Withdrawal by Subject|1|||
27522824|NCT03751657|80108370|FG001|Overall Study|Withdrawal by Subject|1|||
27522825|NCT03751657|80108369|FG000|Overall Study|Lost to Follow-up|2|||
27522826|NCT03751657|80108370|FG001|Overall Study|Lost to Follow-up|1|||
27522827|NCT03452527|80108371|FG000|Overall Study|Withdrawal by Subject|1|||
27522828|NCT03452527|80108372|FG001|Overall Study|Withdrawal by Subject|1|||
27522829|NCT03452527|80108371|FG000|Overall Study|Study Terminated|2|||
27522830|NCT03452527|80108372|FG001|Overall Study|Study Terminated|3|||
27522831|NCT01193257|80108373|FG000|Overall Study|Death|202|||
27522832|NCT01193257|80108374|FG001|Overall Study|Death|391|||
27522833|NCT01193257|80108373|FG000|Overall Study|Study termination by sponsor|0|||
27522834|NCT01193257|80108374|FG001|Overall Study|Study termination by sponsor|3|||
27522835|NCT01193257|80108373|FG000|Overall Study|Withdrawal by Subject|26|||
27522836|NCT01193257|80108374|FG001|Overall Study|Withdrawal by Subject|86|||
27522837|NCT01193257|80108373|FG000|Overall Study|Lost to Follow-up|2|||
27522838|NCT01193257|80108374|FG001|Overall Study|Lost to Follow-up|3|||
27522839|NCT01193257|80108373|FG000|Overall Study|Unblinded due to futility|135|||
27522840|NCT01193257|80108374|FG001|Overall Study|Unblinded due to futility|251|||
27522841|NCT00952380|80108375|FG000|Overall Study|Other|0|||
27522842|NCT00952380|80108376|FG001|Overall Study|Other|0|||
27522843|NCT00952380|80108377|FG002|Overall Study|Other|0|||
27522844|NCT00952380|80108378|FG003|Overall Study|Other|0|||
27522845|NCT00952380|80108379|FG004|Overall Study|Other|1|||
27522846|NCT00952380|80108375|FG000|Overall Study|Withdrawal by Subject|0|||
27522847|NCT00952380|80108376|FG001|Overall Study|Withdrawal by Subject|0|||
27522848|NCT00952380|80108377|FG002|Overall Study|Withdrawal by Subject|1|||
27522849|NCT00952380|80108378|FG003|Overall Study|Withdrawal by Subject|0|||
27522850|NCT00952380|80108379|FG004|Overall Study|Withdrawal by Subject|2|||
27522851|NCT00952380|80108375|FG000|Overall Study|Adverse Event|0|||
27522852|NCT00952380|80108376|FG001|Overall Study|Adverse Event|1|||
27522853|NCT00952380|80108377|FG002|Overall Study|Adverse Event|0|||
27522854|NCT00952380|80108378|FG003|Overall Study|Adverse Event|0|||
27522855|NCT00952380|80108379|FG004|Overall Study|Adverse Event|3|||
27522856|NCT00952380|80108375|FG000|Overall Study|Physician Decision|0|||
27522857|NCT00952380|80108376|FG001|Overall Study|Physician Decision|0|||
27522858|NCT00952380|80108377|FG002|Overall Study|Physician Decision|1|||
27522859|NCT00952380|80108378|FG003|Overall Study|Physician Decision|2|||
27522860|NCT00952380|80108379|FG004|Overall Study|Physician Decision|0|||
27522861|NCT00952380|80108375|FG000|Overall Study|Non-compliant to protocol|0|||
27522862|NCT00952380|80108376|FG001|Overall Study|Non-compliant to protocol|0|||
27522863|NCT00952380|80108377|FG002|Overall Study|Non-compliant to protocol|0|||
27522864|NCT00952380|80108378|FG003|Overall Study|Non-compliant to protocol|1|||
27620966|NCT01474512|80455968|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
27620967|NCT01474512|80455969|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
27620968|NCT01474512|80455970|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
27620969|NCT01474512|80455971|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
27620970|NCT01474512|80455972|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
27620971|NCT01474512|80455973|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
27620972|NCT01474512|80455974|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
27854702|NCT01565850|81298898|FG000|Overall Study|Adverse Event|0|||
27522865|NCT00952380|80108379|FG004|Overall Study|Non-compliant to protocol|0|||
27522866|NCT01566214|80108384|FG000|Overall Study|Lost to Follow-up|3|||
27522867|NCT01566214|80108385|FG001|Overall Study|Lost to Follow-up|0|||
27620973|NCT01474512|80455975|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
27620974|NCT01474512|80455976|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
27854703|NCT01565850|81298899|FG001|Overall Study|Adverse Event|1|||
27522868|NCT02635646|80108386|FG000|Overall Study|Lost to Follow-up|24|||
27522869|NCT02635646|80108387|FG001|Overall Study|Lost to Follow-up|25|||
27522870|NCT02635646|80108386|FG000|Overall Study|Pregnancy|1|||
27522871|NCT02635646|80108387|FG001|Overall Study|Pregnancy|1|||
27522872|NCT02656680|80108388|FG000|Overall Study|Lost to Follow-up|0|||
27522873|NCT02656680|80108389|FG001|Overall Study|Lost to Follow-up|1|||
27522874|NCT02656680|80108390|FG002|Overall Study|Lost to Follow-up|7|||
27522875|NCT04250077|80108392|FG000|Overall Study|Withdrawal by Subject|0|||
27522876|NCT04250077|80108393|FG001|Overall Study|Withdrawal by Subject|1|||
27522877|NCT04250077|80108394|FG002|Overall Study|Withdrawal by Subject|0|||
27522878|NCT04250077|80108392|FG000|Overall Study|Lost to Follow-up|2|||
27522879|NCT04250077|80108393|FG001|Overall Study|Lost to Follow-up|3|||
27522880|NCT04250077|80108394|FG002|Overall Study|Lost to Follow-up|0|||
27522881|NCT00528970|80108396|FG000|Overall Study|Adverse Event|6|||
27522882|NCT00528970|80108397|FG001|Overall Study|Adverse Event|8|||
27522883|NCT00528970|80108398|FG002|Overall Study|Adverse Event|5|||
27522884|NCT00528970|80108396|FG000|Overall Study|Lost to Follow-up|0|||
27522885|NCT00528970|80108397|FG001|Overall Study|Lost to Follow-up|0|||
27620975|NCT01474512|80455977|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
27620976|NCT01474512|80455978|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
27620977|NCT01474512|80455979|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
27620978|NCT01474512|80455980|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
27620979|NCT01474512|80455981|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
27620980|NCT01474512|80455982|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
27620981|NCT01474512|80455965|FG000|Long-Term Extension Period|Adverse Event|0|||
27620982|NCT01474512|80455966|FG001|Long-Term Extension Period|Adverse Event|0|||
27620983|NCT01474512|80455967|FG002|Long-Term Extension Period|Adverse Event|0|||
27620984|NCT01474512|80455968|FG003|Long-Term Extension Period|Adverse Event|0|||
27620985|NCT01474512|80455969|FG004|Long-Term Extension Period|Adverse Event|0|||
27620986|NCT01474512|80455970|FG005|Long-Term Extension Period|Adverse Event|0|||
27620987|NCT01474512|80455971|FG006|Long-Term Extension Period|Adverse Event|0|||
27620988|NCT01474512|80455972|FG007|Long-Term Extension Period|Adverse Event|0|||
27620989|NCT01474512|80455973|FG008|Long-Term Extension Period|Adverse Event|0|||
27620990|NCT01474512|80455974|FG009|Long-Term Extension Period|Adverse Event|0|||
27620991|NCT01474512|80455975|FG010|Long-Term Extension Period|Adverse Event|0|||
27620992|NCT01474512|80455976|FG011|Long-Term Extension Period|Adverse Event|1|||
27620993|NCT01474512|80455977|FG012|Long-Term Extension Period|Adverse Event|57|||
27620994|NCT01474512|80455978|FG013|Long-Term Extension Period|Adverse Event|58|||
27620995|NCT01474512|80455979|FG014|Long-Term Extension Period|Adverse Event|0|||
27620996|NCT01474512|80455980|FG015|Long-Term Extension Period|Adverse Event|0|||
27620997|NCT01474512|80455981|FG016|Long-Term Extension Period|Adverse Event|0|||
27620998|NCT01474512|80455982|FG017|Long-Term Extension Period|Adverse Event|0|||
27620999|NCT01474512|80455965|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
27621000|NCT01474512|80455966|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
27621001|NCT01474512|80455967|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
27621002|NCT01474512|80455968|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
27621003|NCT01474512|80455969|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
27621004|NCT01474512|80455970|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
27621005|NCT01474512|80455971|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
27621006|NCT01474512|80455972|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
27621007|NCT01474512|80455973|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
27621008|NCT01474512|80455974|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
27621009|NCT01474512|80455975|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
27621010|NCT01474512|80455976|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
27621011|NCT01474512|80455977|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
27621012|NCT01474512|80455978|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
27621013|NCT01474512|80455979|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
27621014|NCT01474512|80455980|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
27621015|NCT01474512|80455981|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
27621016|NCT01474512|80455982|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
27621017|NCT01474512|80455965|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
27621018|NCT01474512|80455966|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
27621019|NCT01474512|80455967|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
27621020|NCT01474512|80455968|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
27621021|NCT01474512|80455969|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
27621022|NCT01474512|80455970|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
27621023|NCT01474512|80455971|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
27621024|NCT01474512|80455972|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
27621025|NCT01474512|80455973|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
27621026|NCT01474512|80455974|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
27621027|NCT01474512|80455975|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
27621028|NCT01474512|80455976|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
27621029|NCT01474512|80455977|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
27621030|NCT01474512|80455978|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
27621031|NCT01474512|80455979|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
27621032|NCT01474512|80455980|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
27621033|NCT01474512|80455981|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
27621034|NCT01474512|80455982|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
27522886|NCT00528970|80108398|FG002|Overall Study|Lost to Follow-up|1|||
27522887|NCT00528970|80108396|FG000|Overall Study|Other than specified|2|||
27522888|NCT00528970|80108397|FG001|Overall Study|Other than specified|3|||
27522889|NCT00528970|80108398|FG002|Overall Study|Other than specified|3|||
27621035|NCT01474512|80455965|FG000|Long-Term Extension Period|Physician Decision|0|||
27621036|NCT01474512|80455966|FG001|Long-Term Extension Period|Physician Decision|0|||
27621037|NCT01474512|80455967|FG002|Long-Term Extension Period|Physician Decision|0|||
27621038|NCT01474512|80455968|FG003|Long-Term Extension Period|Physician Decision|0|||
27621039|NCT01474512|80455969|FG004|Long-Term Extension Period|Physician Decision|0|||
27621040|NCT01474512|80455970|FG005|Long-Term Extension Period|Physician Decision|0|||
27621041|NCT01474512|80455971|FG006|Long-Term Extension Period|Physician Decision|0|||
27621042|NCT01474512|80455972|FG007|Long-Term Extension Period|Physician Decision|0|||
27621043|NCT01474512|80455973|FG008|Long-Term Extension Period|Physician Decision|0|||
27621044|NCT01474512|80455974|FG009|Long-Term Extension Period|Physician Decision|0|||
27621045|NCT01474512|80455975|FG010|Long-Term Extension Period|Physician Decision|0|||
27621046|NCT01474512|80455976|FG011|Long-Term Extension Period|Physician Decision|0|||
27621047|NCT01474512|80455977|FG012|Long-Term Extension Period|Physician Decision|21|||
27621048|NCT01474512|80455978|FG013|Long-Term Extension Period|Physician Decision|21|||
27621049|NCT01474512|80455979|FG014|Long-Term Extension Period|Physician Decision|0|||
27621050|NCT01474512|80455980|FG015|Long-Term Extension Period|Physician Decision|0|||
27621051|NCT01474512|80455981|FG016|Long-Term Extension Period|Physician Decision|0|||
27732077|NCT01553149|80846150|FG000|Overall Study|Physician Decision|5|||
27732078|NCT01553149|80846151|FG001|Overall Study|Physician Decision|10|||
27732079|NCT01553149|80846150|FG000|Overall Study|Ineligible|0|||
27732080|NCT01553149|80846151|FG001|Overall Study|Ineligible|1|||
27732081|NCT03403192|80846152|FG000|Overall Study|Lost to Follow-up|1|||
27732082|NCT03403192|80846153|FG001|Overall Study|Lost to Follow-up|2|||
27732083|NCT03403192|80846154|FG002|Overall Study|Lost to Follow-up|0|||
27732084|NCT03403192|80846155|FG003|Overall Study|Lost to Follow-up|0|||
27732085|NCT03403192|80846152|FG000|Overall Study|Unable to respond|0|||
27732086|NCT03403192|80846153|FG001|Overall Study|Unable to respond|1|||
27732087|NCT03403192|80846154|FG002|Overall Study|Unable to respond|0|||
27854704|NCT01565850|81298898|FG000|Overall Study|Lost to Follow-up|12|||
27854705|NCT01565850|81298899|FG001|Overall Study|Lost to Follow-up|4|||
27854706|NCT01565850|81298898|FG000|Overall Study|Investigator's Discretion|2|||
27854707|NCT01565850|81298899|FG001|Overall Study|Investigator's Discretion|1|||
27854708|NCT01565850|81298898|FG000|Overall Study|Participant noncompliance|2|||
27854709|NCT01565850|81298899|FG001|Overall Study|Participant noncompliance|0|||
27854710|NCT01565850|81298898|FG000|Overall Study|Withdrew Consent|4|||
27854711|NCT01565850|81298899|FG001|Overall Study|Withdrew Consent|2|||
27854712|NCT00158756|81298900|FG000|Overall Study|Withdrawal by Subject|5|||
27854713|NCT00158756|81298901|FG001|Overall Study|Withdrawal by Subject|0|||
27854714|NCT00158756|81298902|FG002|Overall Study|Withdrawal by Subject|6|||
27854715|NCT00158756|81298903|FG003|Overall Study|Withdrawal by Subject|1|||
27854716|NCT00158756|81298904|FG004|Overall Study|Withdrawal by Subject|3|||
27854717|NCT00158756|81298900|FG000|Overall Study|Adverse Event|0|||
27854718|NCT00158756|81298901|FG001|Overall Study|Adverse Event|0|||
27854719|NCT00158756|81298902|FG002|Overall Study|Adverse Event|1|||
27854720|NCT00158756|81298903|FG003|Overall Study|Adverse Event|0|||
27854721|NCT00158756|81298904|FG004|Overall Study|Adverse Event|0|||
27854722|NCT00158756|81298900|FG000|Overall Study|Serious adverse event|0|||
27854723|NCT00158756|81298901|FG001|Overall Study|Serious adverse event|0|||
27854724|NCT00158756|81298902|FG002|Overall Study|Serious adverse event|1|||
27854725|NCT00158756|81298903|FG003|Overall Study|Serious adverse event|0|||
27854726|NCT00158756|81298904|FG004|Overall Study|Serious adverse event|0|||
27854727|NCT03246126|81298908|FG000|Overall Study|Withdrawal by Subject|0|||
27854728|NCT03246126|81298909|FG001|Overall Study|Withdrawal by Subject|1|||
27854729|NCT02387983|81298911|FG000|Overall Study|Adverse Event|4|||
27854730|NCT02387983|81298911|FG000|Overall Study|Protocol Violation|1|||
27854731|NCT02387983|81298911|FG000|Overall Study|Withdrawal by Subject|2|||
27854732|NCT00112866|81298912|FG000|Overall Study|Protocol Violation|1|||
27854733|NCT00112866|81298913|FG001|Overall Study|Protocol Violation|0|||
27854734|NCT00112866|81298912|FG000|Overall Study|did not start treatment post-op|1|||
27854735|NCT00112866|81298913|FG001|Overall Study|did not start treatment post-op|2|||
27854736|NCT00667810|81298914|FG000|Overall Study|Adverse Event|13|||
27854737|NCT00667810|81298915|FG001|Overall Study|Adverse Event|14|||
27854738|NCT00667810|81298916|FG002|Overall Study|Adverse Event|19|||
27854739|NCT00667810|81298917|FG003|Overall Study|Adverse Event|1|||
27909719|NCT00410072|81507044|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
27909720|NCT00410072|81507045|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
27909721|NCT00410072|81507044|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
27621052|NCT01474512|80455982|FG017|Long-Term Extension Period|Physician Decision|0|||
27732088|NCT03403192|80846155|FG003|Overall Study|Unable to respond|0|||
27732089|NCT03403192|80846152|FG000|Overall Study|Incomplete|3|||
27854740|NCT00667810|81298914|FG000|Overall Study|Death|1|||
27854741|NCT00667810|81298915|FG001|Overall Study|Death|1|||
27854742|NCT00667810|81298916|FG002|Overall Study|Death|3|||
27854743|NCT00667810|81298917|FG003|Overall Study|Death|0|||
27854744|NCT00667810|81298914|FG000|Overall Study|Lack of Efficacy|1|||
27854745|NCT00667810|81298915|FG001|Overall Study|Lack of Efficacy|0|||
27854746|NCT00667810|81298916|FG002|Overall Study|Lack of Efficacy|2|||
27621053|NCT01474512|80455965|FG000|Long-Term Extension Period|Clinical Relapse|0|||
27621054|NCT01474512|80455966|FG001|Long-Term Extension Period|Clinical Relapse|0|||
27621055|NCT01474512|80455967|FG002|Long-Term Extension Period|Clinical Relapse|0|||
27621056|NCT01474512|80455968|FG003|Long-Term Extension Period|Clinical Relapse|0|||
27621057|NCT01474512|80455969|FG004|Long-Term Extension Period|Clinical Relapse|0|||
27621058|NCT01474512|80455970|FG005|Long-Term Extension Period|Clinical Relapse|0|||
27621059|NCT01474512|80455971|FG006|Long-Term Extension Period|Clinical Relapse|0|||
27621060|NCT01474512|80455972|FG007|Long-Term Extension Period|Clinical Relapse|0|||
27621061|NCT01474512|80455973|FG008|Long-Term Extension Period|Clinical Relapse|0|||
27909722|NCT00410072|81507045|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
27909723|NCT00410072|81507044|FG000|After Week 48 to Week 96|Other|2|||
27909724|NCT00410072|81507045|FG001|After Week 48 to Week 96|Other|0|||
27909725|NCT00410072|81507044|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
27522890|NCT00528970|80108396|FG000|Overall Study|Protocol Violation|2|||
27522891|NCT00528970|80108397|FG001|Overall Study|Protocol Violation|1|||
27522892|NCT00528970|80108398|FG002|Overall Study|Protocol Violation|4|||
27522893|NCT00528970|80108396|FG000|Overall Study|Lack of Efficacy|0|||
27522894|NCT00528970|80108397|FG001|Overall Study|Lack of Efficacy|0|||
27522895|NCT00528970|80108398|FG002|Overall Study|Lack of Efficacy|1|||
27621062|NCT01474512|80455974|FG009|Long-Term Extension Period|Clinical Relapse|0|||
27621063|NCT01474512|80455975|FG010|Long-Term Extension Period|Clinical Relapse|0|||
27621064|NCT01474512|80455976|FG011|Long-Term Extension Period|Clinical Relapse|0|||
27621065|NCT01474512|80455977|FG012|Long-Term Extension Period|Clinical Relapse|9|||
27621066|NCT01474512|80455978|FG013|Long-Term Extension Period|Clinical Relapse|9|||
27621067|NCT01474512|80455979|FG014|Long-Term Extension Period|Clinical Relapse|0|||
27621068|NCT01474512|80455980|FG015|Long-Term Extension Period|Clinical Relapse|0|||
27621069|NCT01474512|80455981|FG016|Long-Term Extension Period|Clinical Relapse|0|||
27621070|NCT01474512|80455982|FG017|Long-Term Extension Period|Clinical Relapse|0|||
27621071|NCT01474512|80455965|FG000|Long-Term Extension Period|Death|0|||
27621072|NCT01474512|80455966|FG001|Long-Term Extension Period|Death|0|||
27854747|NCT00667810|81298917|FG003|Overall Study|Lack of Efficacy|0|||
27522896|NCT00528970|80108396|FG000|Overall Study|Withdrawal by Subject|4|||
27522897|NCT00528970|80108397|FG001|Overall Study|Withdrawal by Subject|3|||
27621073|NCT01474512|80455967|FG002|Long-Term Extension Period|Death|0|||
27621074|NCT01474512|80455968|FG003|Long-Term Extension Period|Death|0|||
27854748|NCT00667810|81298914|FG000|Overall Study|Lost to Follow-up|1|||
27854749|NCT00667810|81298915|FG001|Overall Study|Lost to Follow-up|4|||
27854750|NCT00667810|81298916|FG002|Overall Study|Lost to Follow-up|2|||
27854751|NCT00667810|81298917|FG003|Overall Study|Lost to Follow-up|0|||
27854752|NCT00667810|81298914|FG000|Overall Study|Physician Decision|1|||
27854753|NCT00667810|81298915|FG001|Overall Study|Physician Decision|1|||
27854754|NCT00667810|81298916|FG002|Overall Study|Physician Decision|2|||
27854755|NCT00667810|81298917|FG003|Overall Study|Physician Decision|0|||
27854756|NCT00667810|81298914|FG000|Overall Study|Protocol Violation|0|||
27854757|NCT00667810|81298915|FG001|Overall Study|Protocol Violation|2|||
27854758|NCT00667810|81298916|FG002|Overall Study|Protocol Violation|0|||
27854759|NCT00667810|81298917|FG003|Overall Study|Protocol Violation|0|||
27854760|NCT00667810|81298914|FG000|Overall Study|Withdrawal by Subject|14|||
27854761|NCT00667810|81298915|FG001|Overall Study|Withdrawal by Subject|20|||
27854762|NCT00667810|81298916|FG002|Overall Study|Withdrawal by Subject|29|||
27854763|NCT00667810|81298917|FG003|Overall Study|Withdrawal by Subject|1|||
27854764|NCT00667810|81298914|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
27854765|NCT00667810|81298915|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
27854766|NCT00667810|81298916|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
27854767|NCT00667810|81298917|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27854768|NCT00667810|81298914|FG000|Overall Study|Failed to Return|0|||
27854769|NCT00667810|81298915|FG001|Overall Study|Failed to Return|0|||
27854770|NCT00667810|81298916|FG002|Overall Study|Failed to Return|2|||
27854771|NCT00667810|81298917|FG003|Overall Study|Failed to Return|0|||
27854772|NCT00667810|81298914|FG000|Overall Study|Loss of Caregiver|0|||
27854773|NCT00667810|81298915|FG001|Overall Study|Loss of Caregiver|1|||
27854774|NCT00667810|81298916|FG002|Overall Study|Loss of Caregiver|3|||
27854775|NCT00667810|81298917|FG003|Overall Study|Loss of Caregiver|0|||
27854776|NCT00667810|81298914|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
27854777|NCT00667810|81298915|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
27854778|NCT00667810|81298916|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
27854779|NCT00667810|81298917|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
27909726|NCT00410072|81507045|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
27522898|NCT00528970|80108398|FG002|Overall Study|Withdrawal by Subject|5|||
27854780|NCT00667810|81298914|FG000|Overall Study|Other|6|||
27522899|NCT00528970|80108396|FG000|Overall Study|Randomized but not treated|0|||
27621075|NCT01474512|80455969|FG004|Long-Term Extension Period|Death|0|||
27621076|NCT01474512|80455970|FG005|Long-Term Extension Period|Death|0|||
27854781|NCT00667810|81298915|FG001|Overall Study|Other|6|||
27854782|NCT00667810|81298916|FG002|Overall Study|Other|5|||
27854783|NCT00667810|81298917|FG003|Overall Study|Other|0|||
27621077|NCT01474512|80455971|FG006|Long-Term Extension Period|Death|0|||
27621078|NCT01474512|80455972|FG007|Long-Term Extension Period|Death|0|||
27621079|NCT01474512|80455973|FG008|Long-Term Extension Period|Death|0|||
27522900|NCT00528970|80108397|FG001|Overall Study|Randomized but not treated|0|||
27522901|NCT00528970|80108398|FG002|Overall Study|Randomized but not treated|1|||
27522902|NCT02683746|80108399|FG000|Overall Study|Adverse Event|3|||
27522903|NCT02683746|80108400|FG001|Overall Study|Adverse Event|2|||
27522904|NCT02683746|80108399|FG000|Overall Study|Lost to Follow-up|5|||
27522905|NCT02683746|80108400|FG001|Overall Study|Lost to Follow-up|6|||
27522906|NCT02683746|80108399|FG000|Overall Study|Withdrawal by Subject|6|||
27522907|NCT02683746|80108400|FG001|Overall Study|Withdrawal by Subject|5|||
27522908|NCT02683746|80108399|FG000|Overall Study|Physician Decision|2|||
27522909|NCT02683746|80108400|FG001|Overall Study|Physician Decision|1|||
27522910|NCT01403948|80108401|FG000|Overall Study|Progressive disease|0|||
27522911|NCT01403948|80108402|FG001|Overall Study|Progressive disease|2|||
27621080|NCT01474512|80455974|FG009|Long-Term Extension Period|Death|0|||
27621081|NCT01474512|80455975|FG010|Long-Term Extension Period|Death|0|||
27621082|NCT01474512|80455976|FG011|Long-Term Extension Period|Death|0|||
27621083|NCT01474512|80455977|FG012|Long-Term Extension Period|Death|9|||
27854784|NCT02731326|81298918|FG000|Overall Study|Withdrawal by Subject|4|||
27854785|NCT02731326|81298919|FG001|Overall Study|Withdrawal by Subject|1|||
27854786|NCT02731326|81298918|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
27621084|NCT01474512|80455978|FG013|Long-Term Extension Period|Death|9|||
27621085|NCT01474512|80455979|FG014|Long-Term Extension Period|Death|0|||
27621086|NCT01474512|80455980|FG015|Long-Term Extension Period|Death|0|||
27621087|NCT01474512|80455981|FG016|Long-Term Extension Period|Death|0|||
27621088|NCT01474512|80455982|FG017|Long-Term Extension Period|Death|0|||
27621089|NCT01474512|80455965|FG000|Long-Term Extension Period|Sponsor Decision|0|||
27621090|NCT01474512|80455966|FG001|Long-Term Extension Period|Sponsor Decision|0|||
27621091|NCT01474512|80455967|FG002|Long-Term Extension Period|Sponsor Decision|0|||
27621092|NCT01474512|80455968|FG003|Long-Term Extension Period|Sponsor Decision|0|||
27621093|NCT01474512|80455969|FG004|Long-Term Extension Period|Sponsor Decision|0|||
27621094|NCT01474512|80455970|FG005|Long-Term Extension Period|Sponsor Decision|0|||
27621095|NCT01474512|80455971|FG006|Long-Term Extension Period|Sponsor Decision|0|||
27621096|NCT01474512|80455972|FG007|Long-Term Extension Period|Sponsor Decision|0|||
27621097|NCT01474512|80455973|FG008|Long-Term Extension Period|Sponsor Decision|0|||
27621098|NCT01474512|80455974|FG009|Long-Term Extension Period|Sponsor Decision|0|||
27621099|NCT01474512|80455975|FG010|Long-Term Extension Period|Sponsor Decision|0|||
27621100|NCT01474512|80455976|FG011|Long-Term Extension Period|Sponsor Decision|0|||
27621101|NCT01474512|80455977|FG012|Long-Term Extension Period|Sponsor Decision|6|||
27621102|NCT01474512|80455978|FG013|Long-Term Extension Period|Sponsor Decision|6|||
27621103|NCT01474512|80455979|FG014|Long-Term Extension Period|Sponsor Decision|0|||
27621104|NCT01474512|80455980|FG015|Long-Term Extension Period|Sponsor Decision|0|||
27621105|NCT01474512|80455981|FG016|Long-Term Extension Period|Sponsor Decision|0|||
27621106|NCT01474512|80455982|FG017|Long-Term Extension Period|Sponsor Decision|0|||
27621107|NCT01474512|80455965|FG000|Long-Term Extension Period|Protocol Violation|0|||
27621108|NCT01474512|80455966|FG001|Long-Term Extension Period|Protocol Violation|0|||
27621109|NCT01474512|80455967|FG002|Long-Term Extension Period|Protocol Violation|0|||
27621110|NCT01474512|80455968|FG003|Long-Term Extension Period|Protocol Violation|0|||
27621111|NCT01474512|80455969|FG004|Long-Term Extension Period|Protocol Violation|0|||
27621112|NCT01474512|80455970|FG005|Long-Term Extension Period|Protocol Violation|0|||
27621113|NCT01474512|80455971|FG006|Long-Term Extension Period|Protocol Violation|0|||
27621114|NCT01474512|80455972|FG007|Long-Term Extension Period|Protocol Violation|0|||
27621115|NCT01474512|80455973|FG008|Long-Term Extension Period|Protocol Violation|0|||
27621116|NCT01474512|80455974|FG009|Long-Term Extension Period|Protocol Violation|0|||
27621117|NCT01474512|80455975|FG010|Long-Term Extension Period|Protocol Violation|0|||
27621118|NCT01474512|80455976|FG011|Long-Term Extension Period|Protocol Violation|0|||
27621119|NCT01474512|80455977|FG012|Long-Term Extension Period|Protocol Violation|5|||
27621120|NCT01474512|80455978|FG013|Long-Term Extension Period|Protocol Violation|5|||
27621121|NCT01474512|80455979|FG014|Long-Term Extension Period|Protocol Violation|0|||
27621122|NCT01474512|80455980|FG015|Long-Term Extension Period|Protocol Violation|0|||
27621123|NCT01474512|80455981|FG016|Long-Term Extension Period|Protocol Violation|0|||
27854787|NCT02731326|81298919|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
27854788|NCT02731326|81298918|FG000|Overall Study|Discharged without AliveCor|10|||
27854789|NCT02731326|81298919|FG001|Overall Study|Discharged without AliveCor|0|||
27854790|NCT02731326|81298918|FG000|Overall Study|Duplicate Participant|1|||
27854791|NCT02731326|81298919|FG001|Overall Study|Duplicate Participant|1|||
27854792|NCT00321828|81298927|FG000|Overall Study|Ineligible|3|||
27854793|NCT00321828|81298927|FG000|Overall Study|No follow up data|1|||
27854794|NCT00846521|81298928|FG000|Overall Study|Withdrawal by Subject|5|||
27854795|NCT00846521|81298928|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
27854796|NCT00846521|81298928|FG000|Overall Study|Protocol Violation|1|||
27854797|NCT00725205|81298929|FG000|Overall Study|Adverse Event|22|||
27854798|NCT00725205|81298929|FG000|Overall Study|Investigator Discontinued|1|||
27854799|NCT00725205|81298929|FG000|Overall Study|Non-compliance With Protocol|14|||
27854800|NCT00725205|81298929|FG000|Overall Study|Other|8|||
27854801|NCT00725205|81298929|FG000|Overall Study|Protocol Defined Clinical Event|1|||
27854802|NCT00725205|81298929|FG000|Overall Study|Treatment Failure|41|||
27854803|NCT00616941|81298930|FG000|Overall Study|Progressive Disease|1|||
27854804|NCT00616941|81298931|FG001|Overall Study|Progressive Disease|2|||
27854805|NCT00616941|81298932|FG002|Overall Study|Progressive Disease|1|||
27854806|NCT00616941|81298930|FG000|Overall Study|Adverse Event|0|||
27854807|NCT00616941|81298931|FG001|Overall Study|Adverse Event|1|||
27854808|NCT00616941|81298932|FG002|Overall Study|Adverse Event|1|||
27621124|NCT01474512|80455982|FG017|Long-Term Extension Period|Protocol Violation|0|||
27854809|NCT00616941|81298930|FG000|Overall Study|Subject Non-compliance|0|||
27854810|NCT00616941|81298931|FG001|Overall Study|Subject Non-compliance|0|||
27621125|NCT01474512|80455965|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621126|NCT01474512|80455966|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621127|NCT01474512|80455967|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621128|NCT01474512|80455968|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27732090|NCT03403192|80846153|FG001|Overall Study|Incomplete|1|||
27732091|NCT03403192|80846154|FG002|Overall Study|Incomplete|3|||
27854811|NCT00616941|81298932|FG002|Overall Study|Subject Non-compliance|1|||
27854812|NCT00616941|81298930|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
27522912|NCT01403948|80108403|FG002|Overall Study|Progressive disease|2|||
27522913|NCT01403948|80108404|FG003|Overall Study|Progressive disease|4|||
27522914|NCT01403948|80108405|FG004|Overall Study|Progressive disease|2|||
27522915|NCT01403948|80108406|FG005|Overall Study|Progressive disease|6|||
27522916|NCT01403948|80108407|FG006|Overall Study|Progressive disease|2|||
27522917|NCT01403948|80108408|FG007|Overall Study|Progressive disease|4|||
27522918|NCT01403948|80108409|FG008|Overall Study|Progressive disease|5|||
27522919|NCT01403948|80108410|FG009|Overall Study|Progressive disease|5|||
27522920|NCT01403948|80108401|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522921|NCT01403948|80108402|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522922|NCT01403948|80108403|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522923|NCT01403948|80108404|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522924|NCT01403948|80108405|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
27522925|NCT01403948|80108406|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522926|NCT01403948|80108407|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
27522927|NCT01403948|80108408|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522928|NCT01403948|80108409|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
27522929|NCT01403948|80108410|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
27522930|NCT01403948|80108401|FG000|Overall Study|Lost to Follow-up|0|||
27522931|NCT01403948|80108402|FG001|Overall Study|Lost to Follow-up|0|||
27522932|NCT01403948|80108403|FG002|Overall Study|Lost to Follow-up|0|||
27522933|NCT01403948|80108404|FG003|Overall Study|Lost to Follow-up|0|||
27522934|NCT01403948|80108405|FG004|Overall Study|Lost to Follow-up|0|||
27522935|NCT01403948|80108406|FG005|Overall Study|Lost to Follow-up|0|||
27522936|NCT01403948|80108407|FG006|Overall Study|Lost to Follow-up|0|||
27522937|NCT01403948|80108408|FG007|Overall Study|Lost to Follow-up|0|||
27522938|NCT01403948|80108409|FG008|Overall Study|Lost to Follow-up|0|||
27522939|NCT01403948|80108410|FG009|Overall Study|Lost to Follow-up|1|||
27522940|NCT01403948|80108401|FG000|Overall Study|Refused cont. medication|0|||
27522941|NCT01403948|80108402|FG001|Overall Study|Refused cont. medication|0|||
27522942|NCT01403948|80108403|FG002|Overall Study|Refused cont. medication|0|||
27522943|NCT01403948|80108404|FG003|Overall Study|Refused cont. medication|0|||
27522944|NCT01403948|80108405|FG004|Overall Study|Refused cont. medication|1|||
27522945|NCT01403948|80108406|FG005|Overall Study|Refused cont. medication|0|||
27522946|NCT01403948|80108407|FG006|Overall Study|Refused cont. medication|0|||
27522947|NCT01403948|80108408|FG007|Overall Study|Refused cont. medication|0|||
27522948|NCT01403948|80108409|FG008|Overall Study|Refused cont. medication|0|||
27522949|NCT01403948|80108410|FG009|Overall Study|Refused cont. medication|1|||
27522950|NCT01403948|80108401|FG000|Overall Study|other than above|1|||
27522951|NCT01403948|80108402|FG001|Overall Study|other than above|2|||
27522952|NCT01403948|80108403|FG002|Overall Study|other than above|1|||
27522953|NCT01403948|80108404|FG003|Overall Study|other than above|0|||
27522954|NCT01403948|80108405|FG004|Overall Study|other than above|1|||
27522955|NCT01403948|80108406|FG005|Overall Study|other than above|1|||
27522956|NCT01403948|80108407|FG006|Overall Study|other than above|2|||
27522957|NCT01403948|80108408|FG007|Overall Study|other than above|0|||
27522958|NCT01403948|80108409|FG008|Overall Study|other than above|0|||
27522959|NCT01403948|80108410|FG009|Overall Study|other than above|0|||
27522960|NCT00538785|80108414|FG000|Overall Study|Death|9|||
27522961|NCT00538785|80108415|FG001|Overall Study|Death|10|||
27522962|NCT00538785|80108414|FG000|Overall Study|Withdrawal of consent|9|||
27522963|NCT00538785|80108415|FG001|Overall Study|Withdrawal of consent|7|||
27522964|NCT00538785|80108414|FG000|Overall Study|Lost to Follow-up|1|||
27522965|NCT00538785|80108415|FG001|Overall Study|Lost to Follow-up|0|||
27522966|NCT05347147|80108418|FG000|Overall Study|Lost to Follow-up|0|||
27522967|NCT05347147|80108419|FG001|Overall Study|Lost to Follow-up|1|||
27522968|NCT05347147|80108418|FG000|Overall Study|Sponsor request|3|||
27522969|NCT05347147|80108419|FG001|Overall Study|Sponsor request|3|||
27522970|NCT05347147|80108418|FG000|Overall Study|Study termination|2|||
27522971|NCT05347147|80108419|FG001|Overall Study|Study termination|1|||
27522972|NCT04140227|80108426|FG000|Overall Study|Withdrawal by Subject|26|||
27522973|NCT04140227|80108426|FG000|Overall Study|Lost to Follow-up|8|||
27522974|NCT04140227|80108426|FG000|Overall Study|Adverse Event|8|||
27854813|NCT00616941|81298931|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
27522975|NCT04140227|80108426|FG000|Overall Study|Death|1|||
27522976|NCT04140227|80108426|FG000|Overall Study|Other|3|||
27522977|NCT04140227|80108426|FG000|Overall Study|Protocol Violation|2|||
27522978|NCT04136444|80108427|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
27522979|NCT04136444|80108428|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
27522980|NCT00409175|80108429|FG000|Overall Study|Adverse Event|4|||
27522981|NCT00409175|80108430|FG001|Overall Study|Adverse Event|3|||
27522982|NCT00409175|80108429|FG000|Overall Study|Withdrawal by Subject|1|||
27522983|NCT00409175|80108430|FG001|Overall Study|Withdrawal by Subject|2|||
27522984|NCT00409175|80108429|FG000|Overall Study|Negative genotype|0|||
27522985|NCT00409175|80108430|FG001|Overall Study|Negative genotype|1|||
27522986|NCT00409175|80108429|FG000|Overall Study|Liver transplantation|13|||
27522987|NCT00409175|80108430|FG001|Overall Study|Liver transplantation|13|||
27621129|NCT01474512|80455969|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621130|NCT01474512|80455970|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621131|NCT01474512|80455971|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621132|NCT01474512|80455972|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621133|NCT01474512|80455973|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27522988|NCT01954927|80108431|FG000|Overall Study|Withdrawal by Subject|3|||
27522989|NCT01954927|80108432|FG001|Overall Study|Withdrawal by Subject|1|||
27522990|NCT00938886|80108441|FG000|Overall Study|Death|0|||
27522991|NCT00938886|80108442|FG001|Overall Study|Death|1|||
27522992|NCT00938886|80108441|FG000|Overall Study|Withdrawal by Subject|4|||
27522993|NCT00938886|80108442|FG001|Overall Study|Withdrawal by Subject|7|||
27522994|NCT00938886|80108441|FG000|Overall Study|Lost to Follow-up|3|||
27522995|NCT00938886|80108442|FG001|Overall Study|Lost to Follow-up|2|||
27522996|NCT01579812|80108451|FG000|Overall Study|Ineligible after treatment start|40|||
27522997|NCT01579812|80108451|FG000|Overall Study|Patient choice|3|||
27522998|NCT01579812|80108451|FG000|Overall Study|Noncompliance|3|||
27522999|NCT01579812|80108451|FG000|Overall Study|Withdrawal by Subject|6|||
27523000|NCT01120067|80108452|FG000|Overall Study|Lost to Follow-up|3|||
27523001|NCT01120067|80108453|FG001|Overall Study|Lost to Follow-up|1|||
27523002|NCT01120067|80108452|FG000|Overall Study|fail to engage >3 sessions|2|||
27523003|NCT01120067|80108453|FG001|Overall Study|fail to engage >3 sessions|0|||
27523004|NCT02692651|80108454|FG000|Study Treatment|Death|7|||
27523005|NCT02692651|80108455|FG001|Study Treatment|Death|3|||
27523006|NCT02692651|80108454|FG000|Study Treatment|comfort care|1|||
27523007|NCT02692651|80108455|FG001|Study Treatment|comfort care|1|||
27523008|NCT02692651|80108454|FG000|Study Treatment|Protocol violation per treating team preference|8|||
27523009|NCT02692651|80108455|FG001|Study Treatment|Protocol violation per treating team preference|6|||
27523010|NCT02692651|80108454|FG000|Post Study Treatment Follow-up|Death|4|||
27523011|NCT02692651|80108455|FG001|Post Study Treatment Follow-up|Death|4|||
27523012|NCT03339297|80108456|FG000|Overall Study|Relapse of Hematologic Disease|1|||
27523013|NCT03339297|80108457|FG001|Overall Study|Relapse of Hematologic Disease|0|||
27523014|NCT03339297|80108456|FG000|Overall Study|Death|10|||
27621134|NCT01474512|80455974|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621135|NCT01474512|80455975|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621136|NCT01474512|80455976|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621137|NCT01474512|80455977|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
27621138|NCT01474512|80455978|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
27621139|NCT01474512|80455979|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621140|NCT01474512|80455980|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621141|NCT01474512|80455981|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621142|NCT01474512|80455982|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
27621143|NCT01474512|80455965|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621144|NCT01474512|80455966|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621145|NCT01474512|80455967|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621146|NCT01474512|80455968|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621147|NCT01474512|80455969|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621148|NCT01474512|80455970|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621149|NCT01474512|80455971|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621150|NCT01474512|80455972|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621151|NCT01474512|80455973|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621152|NCT01474512|80455974|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621153|NCT01474512|80455975|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621154|NCT01474512|80455976|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
27621155|NCT01474512|80455977|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621156|NCT01474512|80455978|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621157|NCT01474512|80455979|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621158|NCT01474512|80455980|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27732092|NCT03403192|80846155|FG003|Overall Study|Incomplete|6|||
27523015|NCT03339297|80108457|FG001|Overall Study|Death|7|||
27523016|NCT03339297|80108456|FG000|Overall Study|Hepatic Candidosis|1|||
27523017|NCT03339297|80108457|FG001|Overall Study|Hepatic Candidosis|0|||
27523018|NCT03339297|80108456|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
27523019|NCT03339297|80108457|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
27523020|NCT03339297|80108456|FG000|Overall Study|Consent Withdrawn by Participant|3|||
27523021|NCT03339297|80108457|FG001|Overall Study|Consent Withdrawn by Participant|3|||
27523022|NCT03339297|80108456|FG000|Overall Study|Disease Relapse|2|||
27523023|NCT03339297|80108457|FG001|Overall Study|Disease Relapse|0|||
27523024|NCT03339297|80108456|FG000|Overall Study|Physician Decision|1|||
27523025|NCT03339297|80108457|FG001|Overall Study|Physician Decision|1|||
27523026|NCT03339297|80108456|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
27523027|NCT03339297|80108457|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
27621159|NCT01474512|80455981|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27621160|NCT01474512|80455982|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
27523028|NCT03339297|80108456|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
27523029|NCT03339297|80108457|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
27523030|NCT03339297|80108456|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
27523031|NCT03339297|80108457|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
27523032|NCT03339297|80108456|FG000|Overall Study|Adverse Event, Non-fatal|1|||
27523033|NCT03339297|80108457|FG001|Overall Study|Adverse Event, Non-fatal|0|||
27523034|NCT03339297|80108456|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
27523035|NCT03339297|80108457|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
27523036|NCT03339297|80108456|FG000|Overall Study|Patient Was Not Eligible|1|||
27523037|NCT03339297|80108457|FG001|Overall Study|Patient Was Not Eligible|0|||
27523038|NCT03104816|80108459|FG000|Overall Study|Lack of Efficacy|0|||
27523039|NCT03104816|80108460|FG001|Overall Study|Lack of Efficacy|2|||
27621161|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
27621162|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
27621163|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
27621164|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
27621165|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
27621166|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
27621167|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
27621168|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
27621169|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
27621170|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
27523040|NCT03104816|80108461|FG002|Overall Study|Lack of Efficacy|0|||
27523041|NCT03104816|80108459|FG000|Overall Study|Protocol Violation|2|||
27523042|NCT03104816|80108460|FG001|Overall Study|Protocol Violation|0|||
27523043|NCT03104816|80108461|FG002|Overall Study|Protocol Violation|2|||
27523044|NCT02483533|80108462|FG000|Overall Study|Lack of Efficacy|50|||
27523045|NCT02483533|80108463|FG001|Overall Study|Lack of Efficacy|50|||
27523046|NCT02915874|80108467|FG000|Overall Study|Lost to Follow-up|5|||
27523047|NCT02915874|80108468|FG001|Overall Study|Lost to Follow-up|4|||
27523048|NCT02915874|80108467|FG000|Overall Study|Withdrawal by Subject|1|||
27523049|NCT02915874|80108468|FG001|Overall Study|Withdrawal by Subject|1|||
27621171|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
27621172|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
27621173|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
27621174|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
27621175|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
27621176|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
27621177|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
27621178|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
27621179|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621180|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621181|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621182|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621183|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621184|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621185|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27732093|NCT00699192|80846156|FG000|Overall Study|Missing|1|||
27732094|NCT00699192|80846157|FG001|Overall Study|Missing|1|||
27732095|NCT00699192|80846158|FG002|Overall Study|Missing|1|||
27523050|NCT02915874|80108467|FG000|Overall Study|Started New Anxiety Medication|0|||
27523051|NCT02915874|80108468|FG001|Overall Study|Started New Anxiety Medication|1|||
27523052|NCT03387111|80108470|FG000|Overall Study|Progressive Disease|3|||
27523053|NCT03387111|80108470|FG000|Overall Study|Other|1|||
27523054|NCT02434471|80108471|FG000|Overall Study|Physician Decision|9|||
27523055|NCT01604278|80108472|FG000|Overall Study|Lack of Efficacy|0|||
27732096|NCT00699192|80846156|FG000|Overall Study|Adverse Event|9|||
27732097|NCT00699192|80846157|FG001|Overall Study|Adverse Event|4|||
27732098|NCT00699192|80846158|FG002|Overall Study|Adverse Event|3|||
27732099|NCT00699192|80846156|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27732100|NCT00699192|80846157|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27621186|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621187|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621188|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621189|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621190|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621191|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27732101|NCT00699192|80846158|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27732102|NCT00699192|80846156|FG000|Overall Study|Lack of Efficacy|0|||
27523056|NCT01604278|80108473|FG001|Overall Study|Lack of Efficacy|1|||
27523057|NCT01604278|80108472|FG000|Overall Study|Lost to Follow-up|1|||
27523058|NCT01604278|80108473|FG001|Overall Study|Lost to Follow-up|0|||
27732103|NCT00699192|80846157|FG001|Overall Study|Lack of Efficacy|0|||
27732104|NCT00699192|80846158|FG002|Overall Study|Lack of Efficacy|1|||
27732105|NCT00699192|80846156|FG000|Overall Study|Withdrawal by Subject|3|||
27732106|NCT00699192|80846157|FG001|Overall Study|Withdrawal by Subject|2|||
27621192|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
27621193|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
27621194|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
27621195|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
27621196|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
27621197|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621198|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621199|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621200|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621201|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621202|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621203|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621204|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621205|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621206|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621207|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621208|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621209|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621210|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
27621211|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
27621212|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
27621213|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
27621214|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
27621215|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621216|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621217|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621218|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621219|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621220|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621221|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621222|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621223|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621224|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621225|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621226|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621227|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621228|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621229|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621230|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
27621231|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
27621232|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
27621233|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
27621234|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
27621235|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
27621236|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
27621237|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
27621238|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
27621239|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
27621240|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
27621241|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
27621242|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
27621243|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
27621244|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
27621245|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
27621246|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
27621247|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
27621248|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
27621249|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
27621250|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
27621251|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621252|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
27732107|NCT00699192|80846158|FG002|Overall Study|Withdrawal by Subject|4|||
27909727|NCT00410072|81507044|FG000|After Week 48 to Week 96|Pregnancy|0|||
27621253|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621254|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621255|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621256|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
27909728|NCT00410072|81507045|FG001|After Week 48 to Week 96|Pregnancy|2|||
27621257|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621258|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621259|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621260|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621261|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621262|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621263|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621264|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621265|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621266|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
27621267|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
27621268|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
27621269|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
27621270|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
27621271|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
27621272|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
27621273|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
27621274|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
27621275|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
27621276|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
27621277|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
27621278|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
27621279|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
27621280|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
27621281|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
27909729|NCT00410072|81507044|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
27909730|NCT00410072|81507045|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
27909731|NCT02861664|81507048|FG000|Overall Study|Withdrawal of Consent|0|||
27909732|NCT02861664|81507049|FG001|Overall Study|Withdrawal of Consent|1|||
27909733|NCT00435461|81507050|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
27909734|NCT00435461|81507051|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
27909735|NCT00435461|81507052|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
27909736|NCT00435461|81507050|FG000|Overall Study|Protocol Violation|6|||
27909737|NCT00435461|81507051|FG001|Overall Study|Protocol Violation|9|||
27909738|NCT00435461|81507052|FG002|Overall Study|Protocol Violation|10|||
27909739|NCT00435461|81507050|FG000|Overall Study|Participant randomized(inadequate score)|1|||
27909740|NCT00435461|81507051|FG001|Overall Study|Participant randomized(inadequate score)|0|||
27909741|NCT00435461|81507052|FG002|Overall Study|Participant randomized(inadequate score)|0|||
27909742|NCT00435461|81507050|FG000|Overall Study|Compliance less than 80 percent|1|||
27909743|NCT00435461|81507051|FG001|Overall Study|Compliance less than 80 percent|0|||
27909744|NCT00435461|81507052|FG002|Overall Study|Compliance less than 80 percent|0|||
27909745|NCT00435461|81507050|FG000|Overall Study|In error, two study medications switched|1|||
27909746|NCT00435461|81507051|FG001|Overall Study|In error, two study medications switched|0|||
27909747|NCT00435461|81507052|FG002|Overall Study|In error, two study medications switched|0|||
27909748|NCT00435461|81507050|FG000|Overall Study|Lack of Efficacy|2|||
27909749|NCT00435461|81507051|FG001|Overall Study|Lack of Efficacy|1|||
27909750|NCT00435461|81507052|FG002|Overall Study|Lack of Efficacy|0|||
27909751|NCT00435461|81507050|FG000|Overall Study|Withdrawal by Subject|1|||
27909752|NCT00435461|81507051|FG001|Overall Study|Withdrawal by Subject|0|||
27909753|NCT00435461|81507052|FG002|Overall Study|Withdrawal by Subject|2|||
27909754|NCT00435461|81507050|FG000|Overall Study|Randomized in error|1|||
27909755|NCT00435461|81507051|FG001|Overall Study|Randomized in error|0|||
27909756|NCT00435461|81507052|FG002|Overall Study|Randomized in error|0|||
27523059|NCT01604278|80108472|FG000|Overall Study|Administrative problems|2|||
27523060|NCT01604278|80108473|FG001|Overall Study|Administrative problems|1|||
27523061|NCT01604278|80108472|FG000|Overall Study|Withdrawal by Subject|3|||
27523062|NCT01604278|80108473|FG001|Overall Study|Withdrawal by Subject|3|||
27523063|NCT01604278|80108472|FG000|Overall Study|Adverse Event|3|||
27523064|NCT01604278|80108473|FG001|Overall Study|Adverse Event|5|||
27523065|NCT01604278|80108472|FG000|Overall Study|Protocol Deviation|5|||
27523066|NCT01604278|80108473|FG001|Overall Study|Protocol Deviation|3|||
27523067|NCT01119937|80108475|FG000|Overall Study|Adverse Event|11|||
27523068|NCT01119937|80108476|FG001|Overall Study|Adverse Event|5|||
27523069|NCT01119937|80108475|FG000|Overall Study|Protocol deviation|3|||
27523070|NCT01119937|80108476|FG001|Overall Study|Protocol deviation|1|||
27523071|NCT01119937|80108475|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27621282|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
27621283|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
27621284|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
27621285|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
27909757|NCT00435461|81507050|FG000|Overall Study|Participant could not tolerate symptoms|0|||
27909758|NCT00435461|81507051|FG001|Overall Study|Participant could not tolerate symptoms|0|||
27909759|NCT00435461|81507052|FG002|Overall Study|Participant could not tolerate symptoms|1|||
27621286|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
27621287|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621288|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621289|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621290|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621291|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621292|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621293|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
27732108|NCT00699192|80846156|FG000|Overall Study|Administrative problems|1|||
27523072|NCT01119937|80108476|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27523073|NCT01119937|80108475|FG000|Overall Study|Withdrawal by Subject|2|||
27523074|NCT01119937|80108476|FG001|Overall Study|Withdrawal by Subject|1|||
27523075|NCT05615935|80108477|FG000|Overall Study|Lost to Follow-up|1|||
27523076|NCT05615935|80108478|FG001|Overall Study|Lost to Follow-up|1|||
27523077|NCT01945710|80108479|FG000|Overall Study|Progressive Disease|5|||
27523078|NCT01945710|80108480|FG001|Overall Study|Progressive Disease|4|||
27523079|NCT01945710|80108481|FG002|Overall Study|Progressive Disease|3|||
27732109|NCT00699192|80846157|FG001|Overall Study|Administrative problems|3|||
27732110|NCT00699192|80846158|FG002|Overall Study|Administrative problems|1|||
27732111|NCT00699192|80846156|FG000|Overall Study|Protocol Violation|2|||
27732112|NCT00699192|80846157|FG001|Overall Study|Protocol Violation|2|||
27732113|NCT00699192|80846158|FG002|Overall Study|Protocol Violation|0|||
27732114|NCT03371355|80846165|FG000|Overall Study|Investigator judgment|0|||
27732115|NCT03371355|80846166|FG001|Overall Study|Investigator judgment|0|||
27732116|NCT03371355|80846167|FG002|Overall Study|Investigator judgment|1|||
27732117|NCT03371355|80846168|FG003|Overall Study|Investigator judgment|1|||
27732118|NCT03371355|80846165|FG000|Overall Study|Voluntary withdrawal|1|||
27732119|NCT03371355|80846166|FG001|Overall Study|Voluntary withdrawal|0|||
27732120|NCT03371355|80846167|FG002|Overall Study|Voluntary withdrawal|1|||
27732121|NCT03371355|80846168|FG003|Overall Study|Voluntary withdrawal|2|||
27732122|NCT03371355|80846165|FG000|Overall Study|Adverse Event|0|||
27732123|NCT03371355|80846166|FG001|Overall Study|Adverse Event|1|||
27732124|NCT03371355|80846167|FG002|Overall Study|Adverse Event|2|||
27732125|NCT03371355|80846168|FG003|Overall Study|Adverse Event|3|||
27732126|NCT03371355|80846165|FG000|Overall Study|Reason not Specified|0|||
27732127|NCT03371355|80846166|FG001|Overall Study|Reason not Specified|1|||
27732128|NCT03371355|80846167|FG002|Overall Study|Reason not Specified|0|||
27732129|NCT03371355|80846168|FG003|Overall Study|Reason not Specified|1|||
27732130|NCT01454076|80846169|FG000|Overall Study|Other|2|||
27732131|NCT01454076|80846170|FG001|Overall Study|Other|0|||
27732132|NCT01454076|80846171|FG002|Overall Study|Other|0|||
27732133|NCT01454076|80846172|FG003|Overall Study|Other|1|||
27732134|NCT01454076|80846173|FG004|Overall Study|Other|2|||
27732135|NCT01454076|80846169|FG000|Overall Study|Withdrawal by Subject|3|||
27732136|NCT01454076|80846170|FG001|Overall Study|Withdrawal by Subject|4|||
27732137|NCT01454076|80846171|FG002|Overall Study|Withdrawal by Subject|2|||
27732138|NCT01454076|80846172|FG003|Overall Study|Withdrawal by Subject|1|||
27732139|NCT01454076|80846173|FG004|Overall Study|Withdrawal by Subject|2|||
27732140|NCT01454076|80846169|FG000|Overall Study|Adverse Event|8|||
27732141|NCT01454076|80846170|FG001|Overall Study|Adverse Event|2|||
27732142|NCT01454076|80846171|FG002|Overall Study|Adverse Event|7|||
27732143|NCT01454076|80846172|FG003|Overall Study|Adverse Event|0|||
27732144|NCT01454076|80846173|FG004|Overall Study|Adverse Event|2|||
27732145|NCT01169779|80846174|FG000|Overall Study|Adverse Event|3|||
27732146|NCT01169779|80846175|FG001|Overall Study|Adverse Event|11|||
27732147|NCT01169779|80846174|FG000|Overall Study|Lack of Efficacy|1|||
27732148|NCT01169779|80846175|FG001|Overall Study|Lack of Efficacy|0|||
27732149|NCT01169779|80846174|FG000|Overall Study|Protocol Violation|1|||
27732150|NCT01169779|80846175|FG001|Overall Study|Protocol Violation|1|||
27732151|NCT01169779|80846174|FG000|Overall Study|Withdrawal by Subject|3|||
27732152|NCT01169779|80846175|FG001|Overall Study|Withdrawal by Subject|2|||
27854814|NCT00616941|81298932|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
27854815|NCT00616941|81298930|FG000|Overall Study|Vaccination Suspended|0|||
27523080|NCT01945710|80108482|FG003|Overall Study|Progressive Disease|2|||
27621294|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
27732153|NCT01169779|80846174|FG000|Overall Study|Familial and personal reasons|3|||
27732154|NCT01169779|80846175|FG001|Overall Study|Familial and personal reasons|3|||
27732155|NCT03812510|80846176|FG000|Overall Study|Lost to Follow-up|39|||
27854816|NCT00616941|81298931|FG001|Overall Study|Vaccination Suspended|0|||
27854817|NCT00616941|81298932|FG002|Overall Study|Vaccination Suspended|3|||
27523081|NCT01945710|80108483|FG004|Overall Study|Progressive Disease|7|||
27523082|NCT01945710|80108484|FG005|Overall Study|Progressive Disease|3|||
27732156|NCT03812510|80846176|FG000|Overall Study|Withdrawal by Subject|42|||
27732157|NCT03812510|80846176|FG000|Overall Study|Physician Decision|2|||
27732158|NCT03812510|80846176|FG000|Overall Study|Study Terminated by Sponsor|9|||
27732159|NCT03812510|80846176|FG000|Overall Study|Did Not Start Study Medication|55|||
27523083|NCT01945710|80108485|FG006|Overall Study|Progressive Disease|19|||
27732160|NCT03812510|80846176|FG000|Overall Study|Adverse Event|5|||
27732161|NCT00501228|80846177|FG000|Overall Study|Withdrawal by Subject|1|||
27732162|NCT03968419|80846178|FG000|Treatment Period|Adverse Event|0|||
27732163|NCT03968419|80846179|FG001|Treatment Period|Adverse Event|0|||
27732164|NCT03968419|80846180|FG002|Treatment Period|Adverse Event|1|||
27732165|NCT03968419|80846178|FG000|Safety Follow-up Period|Death|3|||
27732166|NCT03968419|80846179|FG001|Safety Follow-up Period|Death|2|||
27732167|NCT03968419|80846180|FG002|Safety Follow-up Period|Death|1|||
27732168|NCT03968419|80846178|FG000|Safety Follow-up Period|Subject Decision|2|||
27732169|NCT03968419|80846179|FG001|Safety Follow-up Period|Subject Decision|1|||
27732170|NCT03968419|80846180|FG002|Safety Follow-up Period|Subject Decision|0|||
27732171|NCT00008385|80846185|FG000|Overall Study|Off treatment reasons not reported|79|||
27732172|NCT00008385|80846186|FG001|Overall Study|Off treatment reasons not reported|70|||
27732173|NCT00008385|80846185|FG000|Overall Study|Progressive disease|52|||
27732174|NCT00008385|80846186|FG001|Overall Study|Progressive disease|117|||
27732175|NCT00008385|80846185|FG000|Overall Study|Adverse Event|8|||
27732176|NCT00008385|80846186|FG001|Overall Study|Adverse Event|20|||
27732177|NCT00008385|80846185|FG000|Overall Study|Death|12|||
27732178|NCT00008385|80846186|FG001|Overall Study|Death|18|||
27732179|NCT00008385|80846185|FG000|Overall Study|Withdrawal by Subject|67|||
27732180|NCT00008385|80846186|FG001|Overall Study|Withdrawal by Subject|157|||
27732181|NCT00008385|80846185|FG000|Overall Study|Start non-protocol therapy|3|||
27732182|NCT00008385|80846186|FG001|Overall Study|Start non-protocol therapy|1|||
27732183|NCT00008385|80846185|FG000|Overall Study|Other complicating disease|17|||
27732184|NCT00008385|80846186|FG001|Overall Study|Other complicating disease|30|||
27732185|NCT00008385|80846185|FG000|Overall Study|Maximum dose reached|0|||
27732186|NCT00008385|80846186|FG001|Overall Study|Maximum dose reached|2|||
27732187|NCT00008385|80846185|FG000|Overall Study|Other|105|||
27732188|NCT00008385|80846186|FG001|Overall Study|Other|212|||
27732189|NCT00008385|80846185|FG000|Overall Study|Not start protocol therapy|44|||
27732190|NCT00008385|80846186|FG001|Overall Study|Not start protocol therapy|175|||
27732191|NCT00496366|80846187|FG000|Overall Study|Death|1|||
27732192|NCT05148884|80846188|FG000|Overall Study|Withdrawal by Subject|3|||
27732193|NCT05148884|80846189|FG001|Overall Study|Withdrawal by Subject|0|||
27732194|NCT05148884|80846188|FG000|Overall Study|Deep brain stimulation operation|0|||
27732195|NCT05148884|80846189|FG001|Overall Study|Deep brain stimulation operation|1|||
27732196|NCT04025632|80846196|FG000|Overall Study|Adverse Event|1|||
27732197|NCT04025632|80846197|FG001|Overall Study|Adverse Event|1|||
27732198|NCT04025632|80846196|FG000|Overall Study|Withdrawal by Subject|1|||
27732199|NCT04025632|80846197|FG001|Overall Study|Withdrawal by Subject|1|||
27732200|NCT04025632|80846196|FG000|Overall Study|Study Terminated by Sponsor|10|||
27732201|NCT04025632|80846197|FG001|Overall Study|Study Terminated by Sponsor|9|||
27732202|NCT04025632|80846196|FG000|Overall Study|Physician Decision|3|||
27732203|NCT04025632|80846197|FG001|Overall Study|Physician Decision|1|||
27732204|NCT01856114|80846198|FG000|Overall Study|Withdrawal by Subject|1|||
27732205|NCT01856114|80846199|FG001|Overall Study|Withdrawal by Subject|0|||
27732206|NCT01856114|80846198|FG000|Overall Study|Adverse Event|1|||
27732207|NCT01856114|80846199|FG001|Overall Study|Adverse Event|0|||
27732208|NCT00355121|80846200|FG000|Overall Study|Did not receive study vaccine|1|||
27732209|NCT00355121|80846201|FG001|Overall Study|Did not receive study vaccine|0|||
27732210|NCT00355121|80846202|FG002|Overall Study|Did not receive study vaccine|1|||
27732211|NCT00355121|80846200|FG000|Overall Study|Adverse Event|0|||
27732212|NCT00355121|80846201|FG001|Overall Study|Adverse Event|1|||
27732213|NCT00355121|80846202|FG002|Overall Study|Adverse Event|0|||
27732214|NCT00355121|80846200|FG000|Overall Study|Protocol Violation|7|||
27732215|NCT00355121|80846201|FG001|Overall Study|Protocol Violation|9|||
27732216|NCT00355121|80846202|FG002|Overall Study|Protocol Violation|1|||
27732217|NCT00355121|80846200|FG000|Overall Study|Lost to Follow-up|4|||
27732218|NCT00355121|80846201|FG001|Overall Study|Lost to Follow-up|7|||
27732219|NCT00355121|80846202|FG002|Overall Study|Lost to Follow-up|1|||
27732220|NCT00355121|80846200|FG000|Overall Study|Withdrawal by Subject|9|||
27732221|NCT00355121|80846201|FG001|Overall Study|Withdrawal by Subject|10|||
27732222|NCT00355121|80846202|FG002|Overall Study|Withdrawal by Subject|2|||
27732223|NCT00355121|80846200|FG000|Overall Study|Serious adverse events|0|||
27732224|NCT00355121|80846201|FG001|Overall Study|Serious adverse events|2|||
27732225|NCT00355121|80846202|FG002|Overall Study|Serious adverse events|0|||
27732226|NCT00502840|80846203|FG000|Overall Study|Adverse Event|5|||
27732227|NCT00502840|80846203|FG000|Overall Study|Additional or changed therapy|48|||
27732228|NCT00502840|80846203|FG000|Overall Study|Lack of Efficacy|11|||
27732229|NCT00502840|80846203|FG000|Overall Study|Protocol Violation|4|||
27732230|NCT00502840|80846203|FG000|Overall Study|Withdrawal by Subject|5|||
27909760|NCT00435461|81507050|FG000|Overall Study|Participant could not swallow capsule|0|||
27732231|NCT00502840|80846203|FG000|Overall Study|Lost to Follow-up|6|||
27732232|NCT00502840|80846203|FG000|Overall Study|Administrative problems|1|||
27732233|NCT00502840|80846203|FG000|Overall Study|Other|20|||
27732234|NCT00712348|80846204|FG000|Overall Study|Withdrawal by Subject|1|||
27732235|NCT02983604|80846206|FG000|Overall Study|Enrolled but not Treated|0|||
27523084|NCT01945710|80108479|FG000|Overall Study|Adverse Event|0|||
27523085|NCT01945710|80108480|FG001|Overall Study|Adverse Event|1|||
27523086|NCT01945710|80108481|FG002|Overall Study|Adverse Event|0|||
27523087|NCT01945710|80108482|FG003|Overall Study|Adverse Event|0|||
27523088|NCT01945710|80108483|FG004|Overall Study|Adverse Event|0|||
27523089|NCT01945710|80108484|FG005|Overall Study|Adverse Event|0|||
27523090|NCT01945710|80108485|FG006|Overall Study|Adverse Event|0|||
27523091|NCT01945710|80108479|FG000|Overall Study|Other|2|||
27523092|NCT01945710|80108480|FG001|Overall Study|Other|0|||
27523093|NCT01945710|80108481|FG002|Overall Study|Other|3|||
27523094|NCT01945710|80108482|FG003|Overall Study|Other|1|||
27523095|NCT01945710|80108483|FG004|Overall Study|Other|1|||
27523096|NCT01945710|80108484|FG005|Overall Study|Other|0|||
27523097|NCT01945710|80108485|FG006|Overall Study|Other|4|||
27523098|NCT01945710|80108479|FG000|Overall Study|Withdrawal by Subject|0|||
27523099|NCT01945710|80108480|FG001|Overall Study|Withdrawal by Subject|1|||
27523100|NCT01945710|80108481|FG002|Overall Study|Withdrawal by Subject|1|||
27523101|NCT01945710|80108482|FG003|Overall Study|Withdrawal by Subject|0|||
27523102|NCT01945710|80108483|FG004|Overall Study|Withdrawal by Subject|1|||
27523103|NCT01945710|80108484|FG005|Overall Study|Withdrawal by Subject|0|||
27523104|NCT01945710|80108485|FG006|Overall Study|Withdrawal by Subject|0|||
27523105|NCT01673347|80108488|FG000|Overall Study|failure of allograft|7|||
27523106|NCT01534182|80108489|FG000|Overall Study|Administrative problems|1|||
27523107|NCT01534182|80108490|FG001|Overall Study|Administrative problems|0|||
27523108|NCT01534182|80108489|FG000|Overall Study|Withdrawal by Subject|4|||
27523109|NCT01534182|80108490|FG001|Overall Study|Withdrawal by Subject|7|||
27523110|NCT01534182|80108489|FG000|Overall Study|Adverse Event|7|||
27523111|NCT01534182|80108490|FG001|Overall Study|Adverse Event|3|||
27523112|NCT01829243|80108491|FG000|First Intervention|Screen Failure|4|||
27523113|NCT01829243|80108492|FG001|First Intervention|Screen Failure|2|||
27523114|NCT00450385|80108493|FG000|Overall Study|Death|3|||
27523115|NCT00450385|80108493|FG000|Overall Study|Protocol Violation|1|||
27523116|NCT00450385|80108493|FG000|Overall Study|Withdrawal by Subject|2|||
27523117|NCT00450385|80108493|FG000|Overall Study|Lack of Efficacy|2|||
27523118|NCT00450385|80108493|FG000|Overall Study|Adverse Event|1|||
27523119|NCT00450385|80108493|FG000|Overall Study|Physician Decision|1|||
27523120|NCT00450385|80108493|FG000|Overall Study|Other|3|||
27523121|NCT01743001|80108494|FG000|Overall Study|Physician Decision|1|||
27523122|NCT01743001|80108495|FG001|Overall Study|Physician Decision|0|||
27523123|NCT01743001|80108494|FG000|Overall Study|Pregnancy|1|||
27523124|NCT01743001|80108495|FG001|Overall Study|Pregnancy|0|||
27523125|NCT01743001|80108494|FG000|Overall Study|Death|1|||
27523126|NCT01743001|80108495|FG001|Overall Study|Death|0|||
27523127|NCT01966432|80108496|FG000|Overall Study|Lost to Follow-up|3|||
27523128|NCT01966432|80108497|FG001|Overall Study|Lost to Follow-up|2|||
27523129|NCT01966432|80108498|FG002|Overall Study|Lost to Follow-up|5|||
27523130|NCT01966432|80108496|FG000|Overall Study|Withdrawal by Subject|1|||
27523131|NCT01966432|80108497|FG001|Overall Study|Withdrawal by Subject|3|||
27523132|NCT01966432|80108498|FG002|Overall Study|Withdrawal by Subject|0|||
27523133|NCT01966432|80108496|FG000|Overall Study|Subject Incarcerated|0|||
27523134|NCT01966432|80108497|FG001|Overall Study|Subject Incarcerated|0|||
27523135|NCT01966432|80108498|FG002|Overall Study|Subject Incarcerated|1|||
27523136|NCT01966432|80108496|FG000|Overall Study|SBIRT program ended|1|||
27523137|NCT01966432|80108497|FG001|Overall Study|SBIRT program ended|8|||
27523138|NCT01966432|80108498|FG002|Overall Study|SBIRT program ended|20|||
27523139|NCT02296138|80108499|FG000|Overall Study|Adverse Event|348|||
27523140|NCT02296138|80108500|FG001|Overall Study|Adverse Event|259|||
27523141|NCT02296138|80108499|FG000|Overall Study|Lack of Efficacy|59|||
27523142|NCT02296138|80108500|FG001|Overall Study|Lack of Efficacy|37|||
27523143|NCT02296138|80108499|FG000|Overall Study|Protocol Violation|35|||
27523144|NCT02296138|80108500|FG001|Overall Study|Protocol Violation|36|||
27523145|NCT02296138|80108499|FG000|Overall Study|Lost to Follow-up|9|||
27523146|NCT02296138|80108500|FG001|Overall Study|Lost to Follow-up|12|||
27523147|NCT02296138|80108499|FG000|Overall Study|Withdrawal by Subject|184|||
27732236|NCT02983604|80846207|FG001|Overall Study|Enrolled but not Treated|0|||
27621295|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
27732237|NCT02983604|80846208|FG002|Overall Study|Enrolled but not Treated|1|||
27523148|NCT02296138|80108500|FG001|Overall Study|Withdrawal by Subject|131|||
27523149|NCT02296138|80108499|FG000|Overall Study|Not Treated|1|||
27523150|NCT02296138|80108500|FG001|Overall Study|Not Treated|1|||
27523151|NCT02296138|80108499|FG000|Overall Study|Patients with data irregularities|10|||
27523152|NCT02296138|80108500|FG001|Overall Study|Patients with data irregularities|11|||
27523153|NCT02296138|80108499|FG000|Overall Study|Other than specified|15|||
27523154|NCT02296138|80108500|FG001|Overall Study|Other than specified|13|||
27523155|NCT00617669|80108501|FG000|Overall Study|Withdrawal by Subject|71|||
27523156|NCT00617669|80108502|FG001|Overall Study|Withdrawal by Subject|77|||
27523157|NCT00617669|80108501|FG000|Overall Study|Lost to Follow-up|3|||
27523158|NCT00617669|80108502|FG001|Overall Study|Lost to Follow-up|2|||
27523159|NCT00617669|80108501|FG000|Overall Study|Adverse Event|87|||
27523160|NCT00617669|80108502|FG001|Overall Study|Adverse Event|76|||
27732238|NCT02983604|80846209|FG003|Overall Study|Enrolled but not Treated|0|||
27732239|NCT00883493|80846210|FG000|Overall Study|Adverse Event|11|||
27732240|NCT00883493|80846211|FG001|Overall Study|Adverse Event|12|||
27732241|NCT00883493|80846210|FG000|Overall Study|Lack of Efficacy|4|||
27732242|NCT00883493|80846211|FG001|Overall Study|Lack of Efficacy|3|||
27732243|NCT00883493|80846210|FG000|Overall Study|Lost to Follow-up|7|||
27732244|NCT00883493|80846211|FG001|Overall Study|Lost to Follow-up|6|||
27732245|NCT00883493|80846210|FG000|Overall Study|Withdrawal by Subject|11|||
27732246|NCT00883493|80846211|FG001|Overall Study|Withdrawal by Subject|20|||
27732247|NCT00883493|80846210|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
27732248|NCT00883493|80846211|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
27732249|NCT00883493|80846210|FG000|Overall Study|Study specific disc. criteria|2|||
27732250|NCT00883493|80846211|FG001|Overall Study|Study specific disc. criteria|0|||
27732251|NCT00883493|80846210|FG000|Overall Study|Other|5|||
27732252|NCT00883493|80846211|FG001|Overall Study|Other|3|||
27732253|NCT00716976|80846212|FG000|Overall Study|Adverse Event|2|||
27732254|NCT00716976|80846213|FG001|Overall Study|Adverse Event|0|||
27732255|NCT00716976|80846212|FG000|Overall Study|Death|1|||
27732256|NCT00716976|80846213|FG001|Overall Study|Death|0|||
27909761|NCT00435461|81507051|FG001|Overall Study|Participant could not swallow capsule|0|||
27523161|NCT00617669|80108501|FG000|Overall Study|Protocol Violation|2|||
27523162|NCT00617669|80108502|FG001|Overall Study|Protocol Violation|3|||
27732257|NCT00716976|80846212|FG000|Overall Study|Physician Decision|2|||
27732258|NCT00716976|80846213|FG001|Overall Study|Physician Decision|2|||
27732259|NCT00716976|80846212|FG000|Overall Study|Withdrawal by Subject|5|||
27732260|NCT00716976|80846213|FG001|Overall Study|Withdrawal by Subject|1|||
27732261|NCT00716976|80846212|FG000|Overall Study|Premature discontinuation cisplatin|5|||
27732262|NCT00716976|80846213|FG001|Overall Study|Premature discontinuation cisplatin|4|||
27732263|NCT00716976|80846212|FG000|Overall Study|Radiation during protocol|1|||
27732264|NCT00716976|80846213|FG001|Overall Study|Radiation during protocol|0|||
27732265|NCT00716976|80846212|FG000|Overall Study|Ineligibles|4|||
27732266|NCT00716976|80846213|FG001|Overall Study|Ineligibles|2|||
27732267|NCT00619502|80846214|FG000|Overall Study|Lost to Follow-up|8|||
27732268|NCT00619502|80846215|FG001|Overall Study|Lost to Follow-up|10|||
27732269|NCT01511445|80846216|FG000|Overall Study|Lost to Follow-up|3|||
27732270|NCT01511445|80846217|FG001|Overall Study|Lost to Follow-up|1|||
27732271|NCT01511445|80846216|FG000|Overall Study|Protocol Violation|1|||
27732272|NCT01511445|80846217|FG001|Overall Study|Protocol Violation|3|||
27732273|NCT01511445|80846216|FG000|Overall Study|Protocol Violation|1|||
27732274|NCT01511445|80846217|FG001|Overall Study|Protocol Violation|0|||
27732275|NCT03502330|80846218|FG000|Overall Study|Adverse Event|2|||
27854818|NCT05304611|81298933|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
27854819|NCT05304611|81298934|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
27854820|NCT05304611|81298935|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
27854821|NCT05304611|81298936|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
27854822|NCT05304611|81298937|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
27854823|NCT05304611|81298938|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
27854824|NCT05304611|81298939|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
27854825|NCT05304611|81298940|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
27732276|NCT03502330|80846219|FG001|Overall Study|Adverse Event|1|||
27732277|NCT03502330|80846220|FG002|Overall Study|Adverse Event|0|||
27523163|NCT00617669|80108501|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
27523164|NCT00617669|80108502|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
27523165|NCT00617669|80108501|FG000|Overall Study|Patients randomized but not treated|2|||
27523166|NCT00617669|80108502|FG001|Overall Study|Patients randomized but not treated|3|||
27523167|NCT03338959|80108506|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
27523168|NCT03338959|80108506|FG000|Overall Study|Physician Decision|1|||
27523169|NCT04966910|80108515|FG000|Baseline|Participant did not complete measure|0|||
27523170|NCT04966910|80108516|FG001|Baseline|Participant did not complete measure|0|||
27523171|NCT04966910|80108517|FG002|Baseline|Participant did not complete measure|1|||
27523172|NCT04966910|80108518|FG003|Baseline|Participant did not complete measure|0|||
27523173|NCT04966910|80108515|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
27523174|NCT04966910|80108516|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
27732278|NCT03502330|80846221|FG003|Overall Study|Adverse Event|0|||
27909762|NCT00435461|81507052|FG002|Overall Study|Participant could not swallow capsule|1|||
27909763|NCT00435461|81507050|FG000|Overall Study|Pregnancy|2|||
27909764|NCT00435461|81507051|FG001|Overall Study|Pregnancy|0|||
27909765|NCT00435461|81507052|FG002|Overall Study|Pregnancy|0|||
27909766|NCT00435461|81507050|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
27909767|NCT00435461|81507051|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
27909768|NCT00435461|81507052|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
27909769|NCT00435461|81507050|FG000|Overall Study|Participant ended study one day early|1|||
27909770|NCT00435461|81507051|FG001|Overall Study|Participant ended study one day early|0|||
27909771|NCT00435461|81507052|FG002|Overall Study|Participant ended study one day early|0|||
27909772|NCT00435461|81507050|FG000|Overall Study|Noncompliance with study requirements|1|||
27909773|NCT00435461|81507051|FG001|Overall Study|Noncompliance with study requirements|1|||
27909774|NCT00435461|81507052|FG002|Overall Study|Noncompliance with study requirements|1|||
27909775|NCT00435461|81507050|FG000|Overall Study|Adverse Event|1|||
27909776|NCT00435461|81507051|FG001|Overall Study|Adverse Event|2|||
27909777|NCT00435461|81507052|FG002|Overall Study|Adverse Event|6|||
27909778|NCT00435461|81507050|FG000|Overall Study|Non-Compliance of diary|2|||
27909779|NCT00435461|81507051|FG001|Overall Study|Non-Compliance of diary|0|||
27909780|NCT00435461|81507052|FG002|Overall Study|Non-Compliance of diary|1|||
27909781|NCT00435461|81507050|FG000|Overall Study|Lost to Follow-up|1|||
27909782|NCT00435461|81507051|FG001|Overall Study|Lost to Follow-up|1|||
27909783|NCT00435461|81507052|FG002|Overall Study|Lost to Follow-up|2|||
27909784|NCT00972283|81507056|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
27909785|NCT00972283|81507057|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
27909786|NCT00972283|81507056|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
27909787|NCT00972283|81507057|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
27909788|NCT00972283|81507056|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
27909789|NCT00972283|81507057|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
27909790|NCT00972283|81507056|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
27909791|NCT00972283|81507057|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
27909792|NCT00972283|81507056|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
27909793|NCT00972283|81507057|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
27909794|NCT00972283|81507056|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
27909795|NCT00972283|81507057|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
27909796|NCT00972283|81507056|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
27909797|NCT00972283|81507057|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
27909798|NCT00972283|81507056|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
27909799|NCT00972283|81507057|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
27909800|NCT00972283|81507056|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
27909801|NCT00972283|81507057|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
27909802|NCT00972283|81507056|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
27909803|NCT00972283|81507057|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
27909804|NCT01854697|81507063|FG000|Overall Study|Adverse Event|1|||
27909805|NCT01854697|81507064|FG001|Overall Study|Adverse Event|0|||
27909806|NCT01854697|81507065|FG002|Overall Study|Adverse Event|0|||
27909807|NCT01854697|81507066|FG003|Overall Study|Adverse Event|0|||
27909808|NCT01854697|81507067|FG004|Overall Study|Adverse Event|1|||
27909809|NCT01854697|81507063|FG000|Overall Study|Lost to Follow-up|4|||
27909810|NCT01854697|81507064|FG001|Overall Study|Lost to Follow-up|1|||
27909811|NCT01854697|81507065|FG002|Overall Study|Lost to Follow-up|1|||
27732279|NCT03502330|80846222|FG004|Overall Study|Adverse Event|1|||
27732280|NCT03502330|80846223|FG005|Overall Study|Adverse Event|0|||
27732281|NCT03502330|80846224|FG006|Overall Study|Adverse Event|1|||
27732282|NCT03502330|80846225|FG007|Overall Study|Adverse Event|1|||
27732283|NCT03502330|80846226|FG008|Overall Study|Adverse Event|0|||
27732284|NCT03502330|80846218|FG000|Overall Study|Lack of Efficacy|1|||
27732285|NCT03502330|80846219|FG001|Overall Study|Lack of Efficacy|5|||
27732286|NCT03502330|80846220|FG002|Overall Study|Lack of Efficacy|3|||
27732287|NCT03502330|80846221|FG003|Overall Study|Lack of Efficacy|5|||
27732288|NCT03502330|80846222|FG004|Overall Study|Lack of Efficacy|1|||
27732289|NCT03502330|80846223|FG005|Overall Study|Lack of Efficacy|5|||
27732290|NCT03502330|80846224|FG006|Overall Study|Lack of Efficacy|5|||
27732291|NCT03502330|80846225|FG007|Overall Study|Lack of Efficacy|6|||
27732292|NCT03502330|80846226|FG008|Overall Study|Lack of Efficacy|0|||
27732293|NCT03502330|80846218|FG000|Overall Study|Physician Decision|0|||
27732294|NCT03502330|80846219|FG001|Overall Study|Physician Decision|0|||
27732295|NCT03502330|80846220|FG002|Overall Study|Physician Decision|0|||
27732296|NCT03502330|80846221|FG003|Overall Study|Physician Decision|0|||
27732297|NCT03502330|80846222|FG004|Overall Study|Physician Decision|1|||
27732298|NCT03502330|80846223|FG005|Overall Study|Physician Decision|0|||
27732299|NCT03502330|80846224|FG006|Overall Study|Physician Decision|0|||
27732300|NCT03502330|80846225|FG007|Overall Study|Physician Decision|0|||
27732301|NCT03502330|80846226|FG008|Overall Study|Physician Decision|0|||
27732302|NCT03502330|80846218|FG000|Overall Study|Withdrawal by Subject|0|||
27732303|NCT03502330|80846219|FG001|Overall Study|Withdrawal by Subject|0|||
27732304|NCT03502330|80846220|FG002|Overall Study|Withdrawal by Subject|0|||
27732305|NCT03502330|80846221|FG003|Overall Study|Withdrawal by Subject|0|||
27732306|NCT03502330|80846222|FG004|Overall Study|Withdrawal by Subject|0|||
27732307|NCT03502330|80846223|FG005|Overall Study|Withdrawal by Subject|1|||
27732308|NCT03502330|80846224|FG006|Overall Study|Withdrawal by Subject|0|||
27732309|NCT03502330|80846225|FG007|Overall Study|Withdrawal by Subject|1|||
27732310|NCT03502330|80846226|FG008|Overall Study|Withdrawal by Subject|0|||
27732311|NCT03502330|80846218|FG000|Overall Study|Death|0|||
27732312|NCT03502330|80846219|FG001|Overall Study|Death|0|||
27732313|NCT03502330|80846220|FG002|Overall Study|Death|0|||
27854826|NCT05304611|81298941|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
27854827|NCT05304611|81298933|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
27854828|NCT05304611|81298934|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
27854829|NCT05304611|81298935|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
27854830|NCT05304611|81298936|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
27854831|NCT05304611|81298937|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
27854832|NCT05304611|81298938|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
27854833|NCT05304611|81298939|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
27854834|NCT05304611|81298940|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
27854835|NCT05304611|81298941|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
27854836|NCT02448706|81298942|FG000|Overall Study|Withdrawal by Subject|4|||
27854837|NCT02448706|81298943|FG001|Overall Study|Withdrawal by Subject|3|||
27854838|NCT02448706|81298942|FG000|Overall Study|Protocol Violation|1|||
27854839|NCT02448706|81298943|FG001|Overall Study|Protocol Violation|1|||
27854840|NCT02054130|81298944|FG000|Overall Study|Withdrawal by Subject|4|||
27854841|NCT02054130|81298945|FG001|Overall Study|Withdrawal by Subject|4|||
27854842|NCT02054130|81298946|FG002|Overall Study|Withdrawal by Subject|7|||
27854843|NCT02054130|81298947|FG003|Overall Study|Withdrawal by Subject|10|||
27854844|NCT02054130|81298944|FG000|Overall Study|Death|0|||
27854845|NCT02054130|81298945|FG001|Overall Study|Death|1|||
27854846|NCT02054130|81298946|FG002|Overall Study|Death|0|||
27854847|NCT02054130|81298947|FG003|Overall Study|Death|0|||
27854848|NCT02054130|81298944|FG000|Overall Study|Lost to Follow-up|0|||
27854849|NCT02054130|81298945|FG001|Overall Study|Lost to Follow-up|0|||
27854850|NCT02054130|81298946|FG002|Overall Study|Lost to Follow-up|1|||
27854851|NCT02054130|81298947|FG003|Overall Study|Lost to Follow-up|2|||
27732314|NCT03502330|80846221|FG003|Overall Study|Death|0|||
27732315|NCT03502330|80846222|FG004|Overall Study|Death|0|||
27732316|NCT03502330|80846223|FG005|Overall Study|Death|0|||
27732317|NCT03502330|80846224|FG006|Overall Study|Death|2|||
27854852|NCT02054130|81298944|FG000|Overall Study|Missed dose|4|||
27854853|NCT02054130|81298945|FG001|Overall Study|Missed dose|6|||
27854854|NCT02054130|81298946|FG002|Overall Study|Missed dose|7|||
27854855|NCT02054130|81298947|FG003|Overall Study|Missed dose|10|||
27854856|NCT01193127|81298950|FG000|Randomized|Surgery Cancelled|0|||
27854857|NCT01193127|81298951|FG001|Randomized|Surgery Cancelled|0|||
27854858|NCT01193127|81298952|FG002|Randomized|Surgery Cancelled|0|||
27854859|NCT01193127|81298953|FG003|Randomized|Surgery Cancelled|1|||
27854860|NCT01193127|81298950|FG000|Treated|Withdrawal by Subject|0|||
27732318|NCT03502330|80846225|FG007|Overall Study|Death|0|||
27732319|NCT03502330|80846226|FG008|Overall Study|Death|0|||
27732320|NCT02162862|80846227|FG000|Overall Study|Lost to Follow-up|0|||
27732321|NCT02162862|80846228|FG001|Overall Study|Lost to Follow-up|11|||
27732322|NCT02162862|80846229|FG002|Overall Study|Lost to Follow-up|0|||
27732323|NCT02162862|80846227|FG000|Overall Study|Subject did not feel the med was needed|0|||
27909812|NCT01854697|81507066|FG003|Overall Study|Lost to Follow-up|2|||
27909813|NCT01854697|81507067|FG004|Overall Study|Lost to Follow-up|0|||
27909814|NCT01854697|81507063|FG000|Overall Study|To enter another AbbVie study|1|||
27909815|NCT01854697|81507064|FG001|Overall Study|To enter another AbbVie study|0|||
27909816|NCT01854697|81507065|FG002|Overall Study|To enter another AbbVie study|0|||
27909817|NCT01854697|81507066|FG003|Overall Study|To enter another AbbVie study|0|||
27909818|NCT01854697|81507067|FG004|Overall Study|To enter another AbbVie study|1|||
27909819|NCT01854697|81507063|FG000|Overall Study|Withdrew Consent|0|||
27909820|NCT01854697|81507064|FG001|Overall Study|Withdrew Consent|1|||
27909821|NCT01854697|81507065|FG002|Overall Study|Withdrew Consent|0|||
27909822|NCT01854697|81507066|FG003|Overall Study|Withdrew Consent|1|||
27909823|NCT01854697|81507067|FG004|Overall Study|Withdrew Consent|0|||
27909824|NCT01854697|81507063|FG000|Overall Study|Other|0|||
27909825|NCT01854697|81507064|FG001|Overall Study|Other|1|||
27854861|NCT01193127|81298951|FG001|Treated|Withdrawal by Subject|0|||
27854862|NCT01193127|81298952|FG002|Treated|Withdrawal by Subject|0|||
27854863|NCT01193127|81298953|FG003|Treated|Withdrawal by Subject|1|||
27854864|NCT00848107|81298954|FG000|Overall Study|Lost to Follow-up|2|||
27854865|NCT00848107|81298954|FG000|Overall Study|Withdrawal by Subject|8|||
27854866|NCT00848107|81298954|FG000|Overall Study|Adverse Event|9|||
27854867|NCT00848107|81298954|FG000|Overall Study|Death|1|||
27854868|NCT00848107|81298954|FG000|Overall Study|Pregnancy|1|||
27854869|NCT02196701|81298960|FG000|Overall Study|Adverse Event|1|||
27854870|NCT02196701|81298960|FG000|Overall Study|Lost to Follow-up|1|||
27854871|NCT02196701|81298960|FG000|Overall Study|Non-adherence to Protocol|1|||
27854872|NCT01941940|81298963|FG000|Overall Study|Adverse Event|11|||
27854873|NCT01941940|81298963|FG000|Overall Study|Lost to Follow-up|2|||
27854874|NCT01941940|81298963|FG000|Overall Study|Physician Decision|2|||
27854875|NCT01941940|81298963|FG000|Overall Study|Withdrawal by Subject|15|||
27854876|NCT01941940|81298963|FG000|Overall Study|Death|1|||
27854877|NCT01941940|81298963|FG000|Overall Study|Other|1|||
27854878|NCT01941940|81298963|FG000|Overall Study|Other|1|||
27854879|NCT01346774|81298964|FG000|Overall Study|Did not take a single dose|6|||
27854880|NCT01346774|81298965|FG001|Overall Study|Did not take a single dose|4|||
27854881|NCT01346774|81298964|FG000|Overall Study|Lost to Follow-up|3|||
27854882|NCT01346774|81298965|FG001|Overall Study|Lost to Follow-up|4|||
27854883|NCT01346774|81298964|FG000|Overall Study|Withdrawal by Subject|1|||
27854884|NCT01346774|81298965|FG001|Overall Study|Withdrawal by Subject|4|||
27854885|NCT01346774|81298964|FG000|Overall Study|Protocol Violation|2|||
27854886|NCT01346774|81298965|FG001|Overall Study|Protocol Violation|3|||
27854887|NCT01346774|81298964|FG000|Overall Study|Adverse Event|1|||
27854888|NCT01346774|81298965|FG001|Overall Study|Adverse Event|2|||
27854889|NCT02924727|81298971|FG000|Overall Study|Withdrawal by Subject|2|||
27854890|NCT02924727|81298972|FG001|Overall Study|Withdrawal by Subject|4|||
27854891|NCT02924727|81298971|FG000|Overall Study|Lost to Follow-up|2|||
27854892|NCT02924727|81298972|FG001|Overall Study|Lost to Follow-up|5|||
27854893|NCT02924727|81298971|FG000|Overall Study|Death|221|||
27854894|NCT02924727|81298972|FG001|Overall Study|Death|247|||
27854895|NCT02924727|81298971|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
27854896|NCT02924727|81298972|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
27854897|NCT01629966|81298977|FG000|Overall Study|Pregnancy|0|||
27854898|NCT01629966|81298978|FG001|Overall Study|Pregnancy|1|||
27854899|NCT01629966|81298979|FG002|Overall Study|Pregnancy|0|||
27854900|NCT01629966|81298977|FG000|Overall Study|Lost to Follow-up|10|||
27854901|NCT01629966|81298978|FG001|Overall Study|Lost to Follow-up|13|||
27854902|NCT01629966|81298979|FG002|Overall Study|Lost to Follow-up|9|||
27854903|NCT01629966|81298977|FG000|Overall Study|Withdrawal by Subject|8|||
27854904|NCT01629966|81298978|FG001|Overall Study|Withdrawal by Subject|9|||
27854905|NCT01629966|81298979|FG002|Overall Study|Withdrawal by Subject|16|||
27854906|NCT01629966|81298977|FG000|Overall Study|Protocol Violation|7|||
27854907|NCT01629966|81298978|FG001|Overall Study|Protocol Violation|9|||
27854908|NCT01629966|81298979|FG002|Overall Study|Protocol Violation|7|||
27854909|NCT01629966|81298977|FG000|Overall Study|Lack of Efficacy|5|||
27854910|NCT01629966|81298978|FG001|Overall Study|Lack of Efficacy|2|||
27854911|NCT01629966|81298979|FG002|Overall Study|Lack of Efficacy|4|||
27854912|NCT01629966|81298977|FG000|Overall Study|Adverse Event|11|||
27854913|NCT01629966|81298978|FG001|Overall Study|Adverse Event|18|||
27854914|NCT01629966|81298979|FG002|Overall Study|Adverse Event|30|||
27854915|NCT00450619|81298980|FG000|Overall Study|refused treatment after randomization|2|||
27854916|NCT00450619|81298981|FG001|Overall Study|refused treatment after randomization|0|||
27854917|NCT00450619|81298980|FG000|Overall Study|did not progress; refused further trmt|1|||
27854918|NCT00450619|81298981|FG001|Overall Study|did not progress; refused further trmt|1|||
27909826|NCT01854697|81507065|FG002|Overall Study|Other|1|||
27909827|NCT01854697|81507066|FG003|Overall Study|Other|0|||
27909828|NCT01854697|81507067|FG004|Overall Study|Other|0|||
27909829|NCT00770913|81507068|FG000|Overall Study|Adverse Event|1|||
27854919|NCT00450619|81298980|FG000|Overall Study|Adverse Event|1|||
27854920|NCT00450619|81298981|FG001|Overall Study|Adverse Event|0|||
27854921|NCT01083810|81302422|FG000|Overall Study|Lost to Follow-up|23|||
27909830|NCT00770913|81507069|FG001|Overall Study|Adverse Event|3|||
27909831|NCT00770913|81507070|FG002|Overall Study|Adverse Event|6|||
27909832|NCT00770913|81507068|FG000|Overall Study|Refusal to continue participation|6|||
27909833|NCT00770913|81507069|FG001|Overall Study|Refusal to continue participation|4|||
27523175|NCT04966910|80108517|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
27523176|NCT04966910|80108518|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
27523177|NCT04966910|80108515|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
27523178|NCT04966910|80108516|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
27523179|NCT04966910|80108517|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
27523180|NCT04966910|80108518|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
27523181|NCT04966910|80108515|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
27523182|NCT04966910|80108516|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
27523183|NCT04966910|80108517|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
27523184|NCT04966910|80108518|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
27523185|NCT01993836|80108523|FG000|Overall Study|Surgery Cancelled|3|||
27523186|NCT01993836|80108524|FG001|Overall Study|Surgery Cancelled|0|||
27523187|NCT01993836|80108525|FG002|Overall Study|Surgery Cancelled|0|||
27523188|NCT01993836|80108523|FG000|Overall Study|Physician Decision|2|||
27523189|NCT01993836|80108524|FG001|Overall Study|Physician Decision|1|||
27523190|NCT01993836|80108525|FG002|Overall Study|Physician Decision|0|||
27523191|NCT01993836|80108523|FG000|Overall Study|Death|0|||
27523192|NCT01993836|80108524|FG001|Overall Study|Death|2|||
27523193|NCT01993836|80108525|FG002|Overall Study|Death|0|||
27523194|NCT01993836|80108523|FG000|Overall Study|Withdrawal by Subject|12|||
27523195|NCT01993836|80108524|FG001|Overall Study|Withdrawal by Subject|10|||
27523196|NCT01993836|80108525|FG002|Overall Study|Withdrawal by Subject|5|||
27523197|NCT01030666|80108528|FG000|Overall Study|Lost to Follow-up|3|||
27523198|NCT01030666|80108529|FG001|Overall Study|Lost to Follow-up|2|||
27523199|NCT01642732|80108531|FG000|Overall Study|Withdrawal by Subject|1|||
27523200|NCT01144299|80108535|FG000|Overall Study|Lost to Follow-up|1|||
27523201|NCT01144299|80108536|FG001|Overall Study|Lost to Follow-up|0|||
27523202|NCT01144299|80108535|FG000|Overall Study|Withdrawal by Subject|1|||
27523203|NCT01144299|80108536|FG001|Overall Study|Withdrawal by Subject|0|||
27523204|NCT01357850|80108537|FG000|Overall Study|Lost to Follow-up|1|||
27854922|NCT01083810|81302423|FG001|Overall Study|Lost to Follow-up|11|||
27854923|NCT01083810|81302424|FG002|Overall Study|Lost to Follow-up|4|||
27854924|NCT01083810|81302422|FG000|Overall Study|Adverse Event|15|||
27854925|NCT01083810|81302423|FG001|Overall Study|Adverse Event|11|||
27854926|NCT01083810|81302424|FG002|Overall Study|Adverse Event|4|||
27854927|NCT01083810|81302422|FG000|Overall Study|Withdrawal by Subject|7|||
27854928|NCT01083810|81302423|FG001|Overall Study|Withdrawal by Subject|2|||
27854929|NCT01083810|81302424|FG002|Overall Study|Withdrawal by Subject|4|||
27854930|NCT01083810|81302422|FG000|Overall Study|Reason not reported|6|||
27854931|NCT01083810|81302423|FG001|Overall Study|Reason not reported|1|||
27854932|NCT01083810|81302424|FG002|Overall Study|Reason not reported|1|||
27854933|NCT01083810|81302422|FG000|Overall Study|Non-compliance|4|||
27854934|NCT01083810|81302423|FG001|Overall Study|Non-compliance|7|||
27854935|NCT01083810|81302424|FG002|Overall Study|Non-compliance|2|||
27854936|NCT01083810|81302422|FG000|Overall Study|Simplification|4|||
27854937|NCT01083810|81302423|FG001|Overall Study|Simplification|1|||
27854938|NCT01083810|81302424|FG002|Overall Study|Simplification|0|||
27854939|NCT01083810|81302422|FG000|Overall Study|Death|2|||
27854940|NCT01083810|81302423|FG001|Overall Study|Death|2|||
27854941|NCT01083810|81302424|FG002|Overall Study|Death|3|||
27854942|NCT01083810|81302422|FG000|Overall Study|Co-morbidities|1|||
27854943|NCT01083810|81302423|FG001|Overall Study|Co-morbidities|0|||
27854944|NCT01083810|81302424|FG002|Overall Study|Co-morbidities|0|||
27854945|NCT01083810|81302422|FG000|Overall Study|Participation in study|1|||
27854946|NCT01083810|81302423|FG001|Overall Study|Participation in study|0|||
27854947|NCT01083810|81302424|FG002|Overall Study|Participation in study|0|||
27854948|NCT01083810|81302422|FG000|Overall Study|Therapy break|1|||
27854949|NCT01083810|81302423|FG001|Overall Study|Therapy break|2|||
27909834|NCT00770913|81507070|FG002|Overall Study|Refusal to continue participation|5|||
27909835|NCT00770913|81507068|FG000|Overall Study|Physician Decision|0|||
27909836|NCT00770913|81507069|FG001|Overall Study|Physician Decision|1|||
27523205|NCT01357850|80108538|FG001|Overall Study|Lost to Follow-up|0|||
27523206|NCT01357850|80108539|FG002|Overall Study|Lost to Follow-up|0|||
27854950|NCT01083810|81302424|FG002|Overall Study|Therapy break|2|||
27854951|NCT01083810|81302422|FG000|Overall Study|Virologic failure|1|||
27909837|NCT00770913|81507070|FG002|Overall Study|Physician Decision|1|||
27909838|NCT00770913|81507068|FG000|Overall Study|Protocol Violation|3|||
27523207|NCT01357850|80108540|FG003|Overall Study|Lost to Follow-up|0|||
27523208|NCT00945906|80108542|FG000|Overall Study|Withdrawal by Subject|1|||
27523209|NCT00945906|80108542|FG000|Overall Study|Did not want to return for last visit|2|||
27854952|NCT01083810|81302423|FG001|Overall Study|Virologic failure|8|||
27854953|NCT01083810|81302424|FG002|Overall Study|Virologic failure|0|||
27854954|NCT00757848|81302425|FG000|Overall Study|Voluntary discontinuation|1|||
27854955|NCT00757848|81302426|FG001|Overall Study|Voluntary discontinuation|0|||
27909839|NCT00770913|81507069|FG001|Overall Study|Protocol Violation|0|||
27909840|NCT00770913|81507070|FG002|Overall Study|Protocol Violation|1|||
27909841|NCT00770913|81507068|FG000|Overall Study|Incorrect drug was allocated|1|||
27909842|NCT00770913|81507069|FG001|Overall Study|Incorrect drug was allocated|0|||
27909843|NCT00770913|81507070|FG002|Overall Study|Incorrect drug was allocated|0|||
27854956|NCT00757848|81302425|FG000|Overall Study|Adverse Event|1|||
27854957|NCT00757848|81302426|FG001|Overall Study|Adverse Event|2|||
27854958|NCT00757848|81302425|FG000|Overall Study|Incorrect enrolment|1|||
27854959|NCT00757848|81302426|FG001|Overall Study|Incorrect enrolment|0|||
27854960|NCT02288182|81302427|FG000|Overall Study|Adverse Event|0|||
27854961|NCT02288182|81302428|FG001|Overall Study|Adverse Event|1|||
27854962|NCT02288182|81302427|FG000|Overall Study|Lost to Follow-up|0|||
27909844|NCT04577794|81507071|FG000|Overall Study|Adverse Event|1|||
27909845|NCT04577794|81507072|FG001|Overall Study|Adverse Event|1|||
27909846|NCT02420262|81507073|FG000|Overall Study|Adverse Event|1|||
27909847|NCT02420262|81507074|FG001|Overall Study|Adverse Event|0|||
27909848|NCT02420262|81507073|FG000|Overall Study|Withdrawal by Subject|1|||
27909849|NCT02420262|81507074|FG001|Overall Study|Withdrawal by Subject|4|||
27621296|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621297|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621298|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621299|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621300|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621301|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
27621302|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621303|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
27621304|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
27621305|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621306|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621307|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621308|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621309|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621310|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621311|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621312|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621313|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621314|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621315|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621316|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621317|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621318|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621319|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
27621320|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621321|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
27621322|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
27621323|NCT01474512|80455965|FG000|Post-Treatment Follow-Up|Death|0|||
27621324|NCT01474512|80455966|FG001|Post-Treatment Follow-Up|Death|0|||
27621325|NCT01474512|80455967|FG002|Post-Treatment Follow-Up|Death|0|||
27621326|NCT01474512|80455968|FG003|Post-Treatment Follow-Up|Death|0|||
27621327|NCT01474512|80455969|FG004|Post-Treatment Follow-Up|Death|0|||
27621328|NCT01474512|80455970|FG005|Post-Treatment Follow-Up|Death|0|||
27621329|NCT01474512|80455971|FG006|Post-Treatment Follow-Up|Death|0|||
27621330|NCT01474512|80455972|FG007|Post-Treatment Follow-Up|Death|0|||
27621331|NCT01474512|80455973|FG008|Post-Treatment Follow-Up|Death|0|||
27732324|NCT02162862|80846228|FG001|Overall Study|Subject did not feel the med was needed|0|||
27854963|NCT02288182|81302428|FG001|Overall Study|Lost to Follow-up|1|||
27854964|NCT01780987|81302436|FG000|Overall Study|Adverse Event|0|||
27854965|NCT01780987|81302437|FG001|Overall Study|Adverse Event|4|||
27854966|NCT01780987|81302436|FG000|Overall Study|Withdrawal by Subject|2|||
27854967|NCT01780987|81302437|FG001|Overall Study|Withdrawal by Subject|0|||
27854968|NCT01780987|81302436|FG000|Overall Study|Request of Changing Hospital|0|||
27854969|NCT01780987|81302437|FG001|Overall Study|Request of Changing Hospital|1|||
27909850|NCT02420262|81507073|FG000|Overall Study|Unclassified|0|||
27909851|NCT02420262|81507074|FG001|Overall Study|Unclassified|1|||
27909852|NCT02097823|81507077|FG000|Overall Study|Withdrawal by Subject|1|||
27909853|NCT02097823|81507078|FG001|Overall Study|Withdrawal by Subject|1|||
27909854|NCT00810069|81507079|FG000|Lead-in Period I|Adverse Event|43|||
27621332|NCT01474512|80455974|FG009|Post-Treatment Follow-Up|Death|0|||
27621333|NCT01474512|80455975|FG010|Post-Treatment Follow-Up|Death|0|||
27621334|NCT01474512|80455976|FG011|Post-Treatment Follow-Up|Death|0|||
27621335|NCT01474512|80455977|FG012|Post-Treatment Follow-Up|Death|0|||
27621336|NCT01474512|80455978|FG013|Post-Treatment Follow-Up|Death|0|||
27621337|NCT01474512|80455979|FG014|Post-Treatment Follow-Up|Death|0|||
27854970|NCT01780987|81302436|FG000|Overall Study|Changing Residence|1|||
27854971|NCT01780987|81302437|FG001|Overall Study|Changing Residence|0|||
27621338|NCT01474512|80455980|FG015|Post-Treatment Follow-Up|Death|0|||
27621339|NCT01474512|80455981|FG016|Post-Treatment Follow-Up|Death|1|||
27621340|NCT01474512|80455982|FG017|Post-Treatment Follow-Up|Death|0|||
27621341|NCT01400893|80455985|FG000|Overall Study|Death|27|||
27621342|NCT01400893|80455986|FG001|Overall Study|Death|21|||
27621343|NCT01400893|80455985|FG000|Overall Study|Lost to Follow-up|0|||
27621344|NCT01400893|80455986|FG001|Overall Study|Lost to Follow-up|6|||
27621345|NCT04562779|80455991|FG000|Overall Study|Lost to Follow-up|7|||
27621346|NCT04562779|80455992|FG001|Overall Study|Lost to Follow-up|5|||
27621347|NCT04562779|80455993|FG002|Overall Study|Lost to Follow-up|10|||
27621348|NCT04562779|80455991|FG000|Overall Study|Protocol Violation|2|||
27621349|NCT04562779|80455992|FG001|Overall Study|Protocol Violation|2|||
27621350|NCT04562779|80455993|FG002|Overall Study|Protocol Violation|0|||
27621351|NCT01515319|80456006|FG000|Overall Study|Withdrawal by Subject|0|||
27621352|NCT01515319|80456007|FG001|Overall Study|Withdrawal by Subject|0|||
27621353|NCT01515319|80456008|FG002|Overall Study|Withdrawal by Subject|0|||
27621354|NCT01515319|80456009|FG003|Overall Study|Withdrawal by Subject|0|||
27621355|NCT01515319|80456010|FG004|Overall Study|Withdrawal by Subject|0|||
27621356|NCT01515319|80456011|FG005|Overall Study|Withdrawal by Subject|0|||
27621357|NCT01515319|80456012|FG006|Overall Study|Withdrawal by Subject|1|||
27621358|NCT01515319|80456013|FG007|Overall Study|Withdrawal by Subject|0|||
27621359|NCT01515319|80456014|FG008|Overall Study|Withdrawal by Subject|0|||
27621360|NCT01515319|80456015|FG009|Overall Study|Withdrawal by Subject|0|||
27621361|NCT01515319|80456006|FG000|Overall Study|Adverse Event|0|||
27621362|NCT01515319|80456007|FG001|Overall Study|Adverse Event|0|||
27621363|NCT01515319|80456008|FG002|Overall Study|Adverse Event|0|||
27621364|NCT01515319|80456009|FG003|Overall Study|Adverse Event|0|||
27621365|NCT01515319|80456010|FG004|Overall Study|Adverse Event|0|||
27621366|NCT01515319|80456011|FG005|Overall Study|Adverse Event|0|||
27621367|NCT01515319|80456012|FG006|Overall Study|Adverse Event|0|||
27523210|NCT00945906|80108542|FG000|Overall Study|Unable to return for last visit|2|||
27523211|NCT00945906|80108542|FG000|Overall Study|Moved to another country|2|||
27523212|NCT00274924|80108549|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
27523213|NCT00274924|80108550|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
27523214|NCT00274924|80108551|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
27523215|NCT00274924|80108549|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
27523216|NCT00274924|80108550|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
27523217|NCT00274924|80108551|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
27621368|NCT01515319|80456013|FG007|Overall Study|Adverse Event|0|||
27621369|NCT01515319|80456014|FG008|Overall Study|Adverse Event|3|||
27621370|NCT01515319|80456015|FG009|Overall Study|Adverse Event|0|||
27621371|NCT01515319|80456006|FG000|Overall Study|Protocol Violation|0|||
27621372|NCT01515319|80456007|FG001|Overall Study|Protocol Violation|0|||
27621373|NCT01515319|80456008|FG002|Overall Study|Protocol Violation|0|||
27621374|NCT01515319|80456009|FG003|Overall Study|Protocol Violation|0|||
27621375|NCT01515319|80456010|FG004|Overall Study|Protocol Violation|0|||
27621376|NCT01515319|80456011|FG005|Overall Study|Protocol Violation|0|||
27621377|NCT01515319|80456012|FG006|Overall Study|Protocol Violation|0|||
27621378|NCT01515319|80456013|FG007|Overall Study|Protocol Violation|0|||
27621379|NCT01515319|80456014|FG008|Overall Study|Protocol Violation|2|||
27621380|NCT01515319|80456015|FG009|Overall Study|Protocol Violation|0|||
27621381|NCT01118962|80456016|FG000|Overall Study|Adverse Event|2|||
27621382|NCT01118962|80456016|FG000|Overall Study|Lack of Efficacy|1|||
27621383|NCT01118962|80456016|FG000|Overall Study|Protocol Violation|1|||
27621384|NCT01118962|80456016|FG000|Overall Study|Withdrawal by Subject|4|||
27621385|NCT01118962|80456016|FG000|Overall Study|Pregnancy|1|||
27621386|NCT01118962|80456016|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
27621387|NCT00121199|80456017|FG000|Overall Study|Adverse Event|11|||
27621388|NCT00121199|80456017|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
27621389|NCT00121199|80456017|FG000|Overall Study|Progression/Relapse|1|||
27621390|NCT00121199|80456017|FG000|Overall Study|Death|3|||
27621391|NCT00121199|80456017|FG000|Overall Study|Other - Not Protocol Specified|3|||
27621392|NCT00121199|80456017|FG000|Overall Study|Ineligible|9|||
27621393|NCT02068885|80456018|FG000|Overall Study|Withdrew|3|||
27621394|NCT02068885|80456019|FG001|Overall Study|Withdrew|5|||
27621395|NCT02068885|80456020|FG002|Overall Study|Withdrew|8|||
27621396|NCT00333138|80456021|FG000|Core Study (6 Months)|Adverse Event|4|||
27621397|NCT00333138|80456022|FG001|Core Study (6 Months)|Adverse Event|5|||
27621398|NCT00333138|80456023|FG002|Core Study (6 Months)|Adverse Event|8|||
27523218|NCT00274924|80108549|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
27621399|NCT00333138|80456021|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
27621400|NCT00333138|80456022|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
27621401|NCT00333138|80456023|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
27621402|NCT00333138|80456021|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
27621403|NCT00333138|80456022|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
27621404|NCT00333138|80456023|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
27621405|NCT00333138|80456021|FG000|Core Study (6 Months)|Protocol Violation|1|||
27621406|NCT00333138|80456022|FG001|Core Study (6 Months)|Protocol Violation|0|||
27909855|NCT00810069|81507080|FG001|Lead-in Period I|Adverse Event|0|||
27909856|NCT00810069|81507081|FG002|Lead-in Period I|Adverse Event|0|||
27909857|NCT00810069|81507079|FG000|Lead-in Period I|Lack of Efficacy|1|||
27909858|NCT00810069|81507080|FG001|Lead-in Period I|Lack of Efficacy|0|||
27909859|NCT00810069|81507081|FG002|Lead-in Period I|Lack of Efficacy|0|||
27909860|NCT00810069|81507079|FG000|Lead-in Period I|Lost to Follow-up|19|||
27909861|NCT00810069|81507080|FG001|Lead-in Period I|Lost to Follow-up|0|||
27909862|NCT00810069|81507081|FG002|Lead-in Period I|Lost to Follow-up|0|||
27909863|NCT00810069|81507079|FG000|Lead-in Period I|Physician Decision|1|||
27909864|NCT00810069|81507080|FG001|Lead-in Period I|Physician Decision|0|||
27909865|NCT00810069|81507081|FG002|Lead-in Period I|Physician Decision|0|||
27909866|NCT00810069|81507079|FG000|Lead-in Period I|Protocol Violation|1|||
27621407|NCT00333138|80456023|FG002|Core Study (6 Months)|Protocol Violation|1|||
27621408|NCT00333138|80456021|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
27621409|NCT00333138|80456022|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
27621410|NCT00333138|80456023|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
27621411|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
27621412|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
27621413|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
27621414|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
27621415|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
27621416|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
27621417|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
27621418|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
27621419|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
27621420|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
27621421|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
27621422|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
27621423|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
27621424|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
27621425|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
27621426|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
27621427|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
27621428|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
27621429|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
27621430|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
27621431|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
27621432|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
27621433|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
27621434|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
27621435|NCT00333138|80456021|FG000|Extension Study (Month6 to End of Study)|Death|0|||
27621436|NCT00333138|80456022|FG001|Extension Study (Month6 to End of Study)|Death|1|||
27621437|NCT00333138|80456023|FG002|Extension Study (Month6 to End of Study)|Death|0|||
27621438|NCT00843882|80456027|FG000|Step 1|Lack of Efficacy|14|||
27621439|NCT00843882|80456028|FG001|Step 1|Lack of Efficacy|10|||
27621440|NCT00843882|80456029|FG002|Step 1|Lack of Efficacy|21|||
27621441|NCT00843882|80456027|FG000|Step 1|Adverse Event|8|||
27621442|NCT00843882|80456028|FG001|Step 1|Adverse Event|17|||
27621443|NCT00843882|80456029|FG002|Step 1|Adverse Event|20|||
27854972|NCT01780987|81302436|FG000|Overall Study|Not Receiving any Study Medication|0|||
27854973|NCT01780987|81302437|FG001|Overall Study|Not Receiving any Study Medication|1|||
27854974|NCT01246011|81302438|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
27854975|NCT01246011|81302439|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
27854976|NCT01246011|81302440|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
27854977|NCT01246011|81302438|FG000|Overall Study|Withdrawal by Subject|0|||
27854978|NCT01246011|81302439|FG001|Overall Study|Withdrawal by Subject|0|||
27854979|NCT01246011|81302440|FG002|Overall Study|Withdrawal by Subject|1|||
27854980|NCT00123955|81302443|FG000|Overall Study|Adverse Event|1|||
27854981|NCT00123955|81302444|FG001|Overall Study|Adverse Event|0|||
27854982|NCT00123955|81302443|FG000|Overall Study|Withdrawal by Subject|4|||
27854983|NCT00123955|81302444|FG001|Overall Study|Withdrawal by Subject|3|||
27854984|NCT00123955|81302443|FG000|Overall Study|Death|0|||
27854985|NCT00123955|81302444|FG001|Overall Study|Death|1|||
27909867|NCT00810069|81507080|FG001|Lead-in Period I|Protocol Violation|0|||
27909868|NCT00810069|81507081|FG002|Lead-in Period I|Protocol Violation|0|||
27909869|NCT00810069|81507079|FG000|Lead-in Period I|Withdrawal by Subject|46|||
27909870|NCT00810069|81507080|FG001|Lead-in Period I|Withdrawal by Subject|0|||
27854986|NCT01939496|81302448|FG000|Overall Study|Adverse Event|2|||
27854987|NCT01939496|81302449|FG001|Overall Study|Adverse Event|0|||
27909871|NCT00810069|81507081|FG002|Lead-in Period I|Withdrawal by Subject|0|||
27909872|NCT00810069|81507079|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
27909873|NCT00810069|81507080|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
27909874|NCT00810069|81507081|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
27909875|NCT00810069|81507079|FG000|Lead-in Period I|Randomization criteria not met|158|||
27909876|NCT00810069|81507080|FG001|Lead-in Period I|Randomization criteria not met|0|||
27909877|NCT00810069|81507081|FG002|Lead-in Period I|Randomization criteria not met|0|||
27854988|NCT01939496|81302450|FG002|Overall Study|Adverse Event|0|||
27523219|NCT00274924|80108550|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
27523220|NCT00274924|80108551|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
27523221|NCT00274924|80108549|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
27854989|NCT01939496|81302448|FG000|Overall Study|Lost to Follow-up|1|||
27854990|NCT01939496|81302449|FG001|Overall Study|Lost to Follow-up|1|||
27854991|NCT01939496|81302450|FG002|Overall Study|Lost to Follow-up|0|||
27854992|NCT01939496|81302448|FG000|Overall Study|Physician Decision|1|||
27854993|NCT01939496|81302449|FG001|Overall Study|Physician Decision|0|||
27854994|NCT01939496|81302450|FG002|Overall Study|Physician Decision|0|||
27854995|NCT01939496|81302448|FG000|Overall Study|Protocol Violation|3|||
27854996|NCT01939496|81302449|FG001|Overall Study|Protocol Violation|0|||
27854997|NCT01939496|81302450|FG002|Overall Study|Protocol Violation|0|||
27854998|NCT01939496|81302448|FG000|Overall Study|Withdrawal by Subject|0|||
27854999|NCT01939496|81302449|FG001|Overall Study|Withdrawal by Subject|1|||
27855000|NCT01939496|81302450|FG002|Overall Study|Withdrawal by Subject|1|||
27855001|NCT01939496|81302448|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
27855002|NCT01939496|81302449|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
27855003|NCT01939496|81302450|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
27855004|NCT01939496|81302448|FG000|Overall Study|Other|2|||
27855005|NCT01939496|81302449|FG001|Overall Study|Other|0|||
27855006|NCT01939496|81302450|FG002|Overall Study|Other|1|||
27855007|NCT03052959|81302451|FG000|Overall Study|Lost to Follow-up|4|||
27855008|NCT03052959|81302452|FG001|Overall Study|Lost to Follow-up|5|||
27855009|NCT00643565|81302453|FG000|Overall Study|Death|12|||
27855010|NCT00643565|81302454|FG001|Overall Study|Death|11|||
27855011|NCT00643565|81302453|FG000|Overall Study|Withdrawal by Subject|4|||
27855012|NCT00643565|81302454|FG001|Overall Study|Withdrawal by Subject|1|||
27855013|NCT00643565|81302453|FG000|Overall Study|Lost to Follow-up|0|||
27855014|NCT00643565|81302454|FG001|Overall Study|Lost to Follow-up|6|||
27855015|NCT00643565|81302453|FG000|Overall Study|Other|7|||
27855016|NCT00643565|81302454|FG001|Overall Study|Other|8|||
27909878|NCT00810069|81507079|FG000|Double-Blind Period II|Adverse Event|0|||
27909879|NCT00810069|81507080|FG001|Double-Blind Period II|Adverse Event|9|||
27909880|NCT00810069|81507081|FG002|Double-Blind Period II|Adverse Event|8|||
27909881|NCT00810069|81507079|FG000|Double-Blind Period II|Lack of Efficacy|0|||
27909882|NCT00810069|81507080|FG001|Double-Blind Period II|Lack of Efficacy|7|||
27909883|NCT00810069|81507081|FG002|Double-Blind Period II|Lack of Efficacy|12|||
27523222|NCT00274924|80108550|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
27523223|NCT00274924|80108551|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
27523224|NCT00274924|80108549|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
27523225|NCT00274924|80108550|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
27523226|NCT00274924|80108551|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
27621444|NCT00843882|80456027|FG000|Step 1|Death|1|||
27621445|NCT00843882|80456028|FG001|Step 1|Death|2|||
27621446|NCT00843882|80456029|FG002|Step 1|Death|4|||
27621447|NCT00843882|80456027|FG000|Step 1|Withdrawal by Subject|6|||
27621448|NCT00843882|80456028|FG001|Step 1|Withdrawal by Subject|12|||
27621449|NCT00843882|80456029|FG002|Step 1|Withdrawal by Subject|9|||
27621450|NCT00843882|80456027|FG000|Step 1|Physician Decision|0|||
27523227|NCT00274924|80108549|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
27523228|NCT00274924|80108550|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
27621451|NCT00843882|80456028|FG001|Step 1|Physician Decision|5|||
27621452|NCT00843882|80456029|FG002|Step 1|Physician Decision|1|||
27621453|NCT00843882|80456027|FG000|Step 1|Patient and physician's decision|0|||
27621454|NCT00843882|80456028|FG001|Step 1|Patient and physician's decision|0|||
27621455|NCT00843882|80456029|FG002|Step 1|Patient and physician's decision|1|||
27621456|NCT00843882|80456027|FG000|Step 1|Other complicating disease|1|||
27621457|NCT00843882|80456028|FG001|Step 1|Other complicating disease|3|||
27621458|NCT00843882|80456029|FG002|Step 1|Other complicating disease|4|||
27621459|NCT00843882|80456027|FG000|Step 1|Alternative therapy|0|||
27621460|NCT00843882|80456028|FG001|Step 1|Alternative therapy|1|||
27621461|NCT00843882|80456029|FG002|Step 1|Alternative therapy|1|||
27621462|NCT00843882|80456027|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
27523229|NCT00274924|80108551|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
27523230|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
27523231|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
27523232|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
27523233|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
27523234|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
27523235|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
27621463|NCT00843882|80456028|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
27621464|NCT00843882|80456029|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
27621465|NCT00843882|80456027|FG000|Step 1|Off treatment reason unknown|0|||
27621466|NCT00843882|80456028|FG001|Step 1|Off treatment reason unknown|1|||
27621467|NCT00843882|80456029|FG002|Step 1|Off treatment reason unknown|4|||
27621468|NCT00843882|80456027|FG000|Step 1|Never started treatment|2|||
27621469|NCT00843882|80456028|FG001|Step 1|Never started treatment|0|||
27621470|NCT00843882|80456029|FG002|Step 1|Never started treatment|0|||
27732325|NCT02162862|80846229|FG002|Overall Study|Subject did not feel the med was needed|4|||
27732326|NCT02185521|80846232|FG000|Overall Study|Withdrawal by Subject|1|||
27732327|NCT02185521|80846232|FG000|Overall Study|Protocol Violation|1|||
27732328|NCT01341457|80846235|FG000|Overall Study|Adverse Event|2|||
27732329|NCT01341457|80846236|FG001|Overall Study|Adverse Event|0|||
27732330|NCT04826900|80846237|FG000|Overall Study|Family factor|1|||
27732331|NCT04826900|80846238|FG001|Overall Study|Family factor|1|||
27732332|NCT00376961|80846239|FG000|Initial Registration|Adverse Event|1|||
27732333|NCT00376961|80846240|FG001|Initial Registration|Adverse Event|0|||
27732334|NCT00376961|80846239|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
27909884|NCT00810069|81507079|FG000|Double-Blind Period II|Lost to Follow-up|0|||
27909885|NCT00810069|81507080|FG001|Double-Blind Period II|Lost to Follow-up|9|||
27909886|NCT00810069|81507081|FG002|Double-Blind Period II|Lost to Follow-up|9|||
27909887|NCT00810069|81507079|FG000|Double-Blind Period II|Physician Decision|0|||
27909888|NCT00810069|81507080|FG001|Double-Blind Period II|Physician Decision|0|||
27909889|NCT00810069|81507081|FG002|Double-Blind Period II|Physician Decision|1|||
27909890|NCT00810069|81507079|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
27909891|NCT00810069|81507080|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
27909892|NCT00810069|81507081|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
27523236|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
27523237|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
27621471|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
27621472|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
27855017|NCT00643565|81302453|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
27909893|NCT00810069|81507079|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
27621473|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
27909894|NCT00810069|81507080|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
27621474|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
27621475|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
27621476|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
27621477|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
27621478|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
27621479|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
27523238|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
27523239|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
27523240|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
27523241|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
27523242|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
27523243|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
27523244|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
27621480|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
27621481|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
27621482|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
27621483|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
27621484|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
27523245|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
27523246|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
27523247|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
27523248|NCT00274924|80108549|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
27523249|NCT00274924|80108550|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
27523250|NCT00274924|80108551|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
27621485|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
27621486|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
27621487|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
27621488|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
27621489|NCT00843882|80456027|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
27621490|NCT00843882|80456028|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
27621491|NCT00843882|80456029|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
27621492|NCT00665561|80456033|FG000|Overall Study|Death recorded on subject summary pages|75|||
27855018|NCT00643565|81302454|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
27855019|NCT00643565|81302453|FG000|Overall Study|Recurrence of Disease|2|||
27855020|NCT00643565|81302454|FG001|Overall Study|Recurrence of Disease|1|||
27855021|NCT00643565|81302453|FG000|Overall Study|Progression of Disease|18|||
27523251|NCT00775203|80108552|FG000|Overall Study|Adverse Event|25|||
27523252|NCT00775203|80108553|FG001|Overall Study|Adverse Event|6|||
27523253|NCT00775203|80108552|FG000|Overall Study|Lack of Efficacy|8|||
27523254|NCT00775203|80108553|FG001|Overall Study|Lack of Efficacy|9|||
27523255|NCT00775203|80108552|FG000|Overall Study|Withdrawal by Subject|11|||
27523256|NCT00775203|80108553|FG001|Overall Study|Withdrawal by Subject|9|||
27523257|NCT00775203|80108552|FG000|Overall Study|Lost to Follow-up|11|||
27523258|NCT00775203|80108553|FG001|Overall Study|Lost to Follow-up|15|||
27523259|NCT00775203|80108552|FG000|Overall Study|Administrative reason|2|||
27523260|NCT00775203|80108553|FG001|Overall Study|Administrative reason|0|||
27523261|NCT00775203|80108552|FG000|Overall Study|Noncompliance|4|||
27523262|NCT00775203|80108553|FG001|Overall Study|Noncompliance|2|||
27523263|NCT00775203|80108552|FG000|Overall Study|Protocol Violation|0|||
27523264|NCT00775203|80108553|FG001|Overall Study|Protocol Violation|1|||
27523265|NCT00775203|80108552|FG000|Overall Study|Entered other study|1|||
27523266|NCT00775203|80108553|FG001|Overall Study|Entered other study|0|||
27523267|NCT00775203|80108552|FG000|Overall Study|Physician Decision|0|||
27523268|NCT00775203|80108553|FG001|Overall Study|Physician Decision|1|||
27523269|NCT02186301|80108554|FG000|Overall Study|Progressive Disease|7|||
27523270|NCT02186301|80108555|FG001|Overall Study|Progressive Disease|22|||
27523271|NCT02186301|80108556|FG002|Overall Study|Progressive Disease|27|||
27523272|NCT02186301|80108554|FG000|Overall Study|Adverse Event|5|||
27523273|NCT02186301|80108555|FG001|Overall Study|Adverse Event|5|||
27523274|NCT02186301|80108556|FG002|Overall Study|Adverse Event|5|||
27523275|NCT02186301|80108554|FG000|Overall Study|Death|1|||
27621493|NCT00665561|80456034|FG001|Overall Study|Death recorded on subject summary pages|75|||
27855022|NCT00643565|81302454|FG001|Overall Study|Progression of Disease|14|||
27523276|NCT02186301|80108555|FG001|Overall Study|Death|0|||
27523277|NCT02186301|80108556|FG002|Overall Study|Death|0|||
27523278|NCT02186301|80108554|FG000|Overall Study|Withdrawal by Subject|5|||
27523279|NCT02186301|80108555|FG001|Overall Study|Withdrawal by Subject|1|||
27732335|NCT00376961|80846240|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27523280|NCT02186301|80108556|FG002|Overall Study|Withdrawal by Subject|3|||
27523281|NCT02186301|80108554|FG000|Overall Study|Physician Decision|1|||
27732336|NCT00376961|80846239|FG000|Initial Registration|Progression/relapse|1|||
27523282|NCT02186301|80108555|FG001|Overall Study|Physician Decision|0|||
27523283|NCT02186301|80108556|FG002|Overall Study|Physician Decision|1|||
27909895|NCT00810069|81507081|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
27909896|NCT00810069|81507079|FG000|Double-Blind Period II|Clinical relapse|0|||
27909897|NCT00810069|81507080|FG001|Double-Blind Period II|Clinical relapse|3|||
27909898|NCT00810069|81507081|FG002|Double-Blind Period II|Clinical relapse|0|||
27909899|NCT00810069|81507079|FG000|Double-Blind Period II|Protocol Violation|0|||
27909900|NCT00810069|81507080|FG001|Double-Blind Period II|Protocol Violation|7|||
27909901|NCT00810069|81507081|FG002|Double-Blind Period II|Protocol Violation|6|||
27909902|NCT04162795|81507082|FG000|Overall Study|Other|16|||
27909903|NCT04162795|81507082|FG000|Overall Study|Screen failures|10|||
27523284|NCT02186301|80108554|FG000|Overall Study|Study Terminated by Sponsor|1|||
27523285|NCT02186301|80108555|FG001|Overall Study|Study Terminated by Sponsor|0|||
27523286|NCT02186301|80108556|FG002|Overall Study|Study Terminated by Sponsor|11|||
27523287|NCT02186301|80108554|FG000|Overall Study|Protocol Deviation|0|||
27523288|NCT02186301|80108555|FG001|Overall Study|Protocol Deviation|2|||
27523289|NCT02186301|80108556|FG002|Overall Study|Protocol Deviation|0|||
27523290|NCT02186301|80108554|FG000|Overall Study|Missing|0|||
27523291|NCT02186301|80108555|FG001|Overall Study|Missing|0|||
27523292|NCT02186301|80108556|FG002|Overall Study|Missing|2|||
27523293|NCT02186301|80108554|FG000|Overall Study|Other|0|||
27523294|NCT02186301|80108555|FG001|Overall Study|Other|0|||
27523295|NCT02186301|80108556|FG002|Overall Study|Other|1|||
27523296|NCT00927940|80108557|FG000|Overall Study|Death|1|||
27523297|NCT01073462|80108560|FG000|Overall Study|Death|14|||
27523298|NCT01073462|80108560|FG000|Overall Study|Kidney transplant|10|||
27523299|NCT01073462|80108560|FG000|Overall Study|Low parathyroid hormone levels|8|||
27523300|NCT01073462|80108560|FG000|Overall Study|Serious adverse event|2|||
27523301|NCT01073462|80108560|FG000|Overall Study|Lost to Follow-up|7|||
27523302|NCT00509262|80108561|FG000|Overall Study|Adverse Event|16|||
27523303|NCT00509262|80108562|FG001|Overall Study|Adverse Event|18|||
27523304|NCT00509262|80108561|FG000|Overall Study|Other|2|||
27523305|NCT00509262|80108562|FG001|Overall Study|Other|2|||
27523306|NCT00509262|80108561|FG000|Overall Study|Lack of Efficacy|1|||
27523307|NCT00509262|80108562|FG001|Overall Study|Lack of Efficacy|0|||
27523308|NCT00509262|80108561|FG000|Overall Study|Lost to Follow-up|1|||
27523309|NCT00509262|80108562|FG001|Overall Study|Lost to Follow-up|6|||
27523310|NCT00509262|80108561|FG000|Overall Study|Physician Decision|1|||
27523311|NCT00509262|80108562|FG001|Overall Study|Physician Decision|3|||
27523312|NCT00509262|80108561|FG000|Overall Study|Protocol Violation|2|||
27523313|NCT00509262|80108562|FG001|Overall Study|Protocol Violation|2|||
27523314|NCT00509262|80108561|FG000|Overall Study|Withdrawal by Subject|24|||
27523315|NCT00509262|80108562|FG001|Overall Study|Withdrawal by Subject|11|||
27523316|NCT01328444|80108566|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
27523317|NCT01328444|80108567|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
27523318|NCT01328444|80108568|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
27523319|NCT01328444|80108569|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
27523320|NCT01328444|80108570|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
27523321|NCT01328444|80108571|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
27523322|NCT01328444|80108566|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
27523323|NCT01328444|80108567|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
27523324|NCT01328444|80108568|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
27523325|NCT01328444|80108569|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
27523326|NCT01328444|80108570|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
27523327|NCT01328444|80108571|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
27523328|NCT01328444|80108566|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
27523329|NCT01328444|80108567|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
27523330|NCT01328444|80108568|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
27523331|NCT01328444|80108569|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27523332|NCT01328444|80108570|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
27523333|NCT01328444|80108571|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27523334|NCT01328444|80108566|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
27523335|NCT01328444|80108567|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
27523336|NCT01328444|80108568|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
27523337|NCT01328444|80108569|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
27523338|NCT01328444|80108570|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
27523339|NCT01328444|80108571|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
27523340|NCT01328444|80108566|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
27523341|NCT01328444|80108567|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27523342|NCT01328444|80108568|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27523343|NCT01328444|80108569|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27523344|NCT01328444|80108570|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27523345|NCT01328444|80108571|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27523346|NCT01328444|80108566|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27523347|NCT01328444|80108567|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
27855023|NCT00643565|81302453|FG000|Overall Study|Protocol Violation|3|||
27909904|NCT00149396|81507083|FG000|Overall Study|Death|15|||
27909905|NCT00149396|81507083|FG000|Overall Study|Withdrawal by Subject|1|||
27909906|NCT00149396|81507083|FG000|Overall Study|Subject noncompliance|2|||
27909907|NCT00149396|81507083|FG000|Overall Study|other treatment|5|||
27909908|NCT00463801|81507084|FG000|Overall Study|Protocol Violation|1|||
27909909|NCT00463801|81507084|FG000|Overall Study|Lack of Efficacy|2|||
27909910|NCT00463801|81507084|FG000|Overall Study|Adverse Event|4|||
27909911|NCT00463801|81507084|FG000|Overall Study|Lost to Follow-up|5|||
27909912|NCT00463801|81507084|FG000|Overall Study|No longer require therapy|1|||
27909913|NCT02757352|81507087|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
27909914|NCT02757352|81507088|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909915|NCT02757352|81507089|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
27909916|NCT02757352|81507090|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909917|NCT02757352|81507091|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909918|NCT02757352|81507092|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909919|NCT02757352|81507093|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909920|NCT02757352|81507094|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909921|NCT02757352|81507095|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909922|NCT02757352|81507096|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
27909923|NCT02757352|81507087|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909924|NCT02757352|81507088|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909925|NCT02757352|81507089|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
27909926|NCT02757352|81507090|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909927|NCT02757352|81507091|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909928|NCT02757352|81507092|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909929|NCT02757352|81507093|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909930|NCT02757352|81507094|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909931|NCT02757352|81507095|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909932|NCT02757352|81507096|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
27909933|NCT02757352|81507087|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
27909934|NCT02757352|81507088|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
27909935|NCT02757352|81507089|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
27523348|NCT01328444|80108568|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27523349|NCT01328444|80108569|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
27523350|NCT01328444|80108570|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27523351|NCT01328444|80108571|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27523352|NCT01328444|80108566|FG000|Washout Period (14 Days)|Adverse Event|1|||
27523353|NCT01328444|80108567|FG001|Washout Period (14 Days)|Adverse Event|1|||
27523354|NCT01328444|80108568|FG002|Washout Period (14 Days)|Adverse Event|0|||
27523355|NCT01328444|80108569|FG003|Washout Period (14 Days)|Adverse Event|1|||
27523356|NCT01328444|80108570|FG004|Washout Period (14 Days)|Adverse Event|1|||
27523357|NCT01328444|80108571|FG005|Washout Period (14 Days)|Adverse Event|2|||
27523358|NCT01328444|80108566|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
27523359|NCT01328444|80108567|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
27523360|NCT01328444|80108568|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
27523361|NCT01328444|80108569|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
27523362|NCT01328444|80108570|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
27523363|NCT01328444|80108571|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
27523364|NCT01328444|80108566|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
27523365|NCT01328444|80108567|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
27523366|NCT01328444|80108568|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
27523367|NCT01328444|80108569|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
27523368|NCT01328444|80108570|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
27523369|NCT01328444|80108571|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
27523370|NCT01328444|80108566|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
27523371|NCT01328444|80108567|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27523372|NCT01328444|80108568|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27523373|NCT01328444|80108569|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27523374|NCT01328444|80108570|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27523375|NCT01328444|80108571|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27523376|NCT01328444|80108566|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
27523377|NCT01328444|80108567|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
27523378|NCT01328444|80108568|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
27523379|NCT01328444|80108569|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
27523380|NCT01328444|80108570|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
27909936|NCT02757352|81507090|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27909937|NCT02757352|81507091|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27523381|NCT01328444|80108571|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
27523382|NCT01328444|80108566|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
27855024|NCT00643565|81302454|FG001|Overall Study|Protocol Violation|0|||
27523383|NCT01328444|80108567|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
27523384|NCT01328444|80108568|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
27909938|NCT02757352|81507092|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27909939|NCT02757352|81507093|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27909940|NCT02757352|81507094|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27909941|NCT02757352|81507095|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27909942|NCT02757352|81507096|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
27909943|NCT02757352|81507087|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909944|NCT02757352|81507088|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
27909945|NCT02757352|81507089|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909946|NCT02757352|81507090|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909947|NCT02757352|81507091|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909948|NCT02757352|81507092|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909949|NCT02757352|81507093|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909950|NCT02757352|81507094|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909951|NCT02757352|81507095|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909952|NCT02757352|81507096|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
27909953|NCT02757352|81507087|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909954|NCT02757352|81507088|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
27909955|NCT02757352|81507089|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909956|NCT02757352|81507090|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909957|NCT02757352|81507091|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909958|NCT02757352|81507092|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909959|NCT02757352|81507093|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27523385|NCT01328444|80108569|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
27523386|NCT01328444|80108570|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
27523387|NCT01328444|80108571|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
27523388|NCT01328444|80108566|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
27523389|NCT01328444|80108567|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
27523390|NCT01328444|80108568|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
27523391|NCT01328444|80108569|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
27523392|NCT01328444|80108570|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
27523393|NCT01328444|80108571|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
27523394|NCT01328444|80108566|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27621494|NCT00665561|80456033|FG000|Overall Study|Does not meet entrance criteria|19|||
27621495|NCT00665561|80456034|FG001|Overall Study|Does not meet entrance criteria|21|||
27621496|NCT00665561|80456033|FG000|Overall Study|Lost to Follow-up|203|||
27621497|NCT00665561|80456034|FG001|Overall Study|Lost to Follow-up|264|||
27621498|NCT00665561|80456033|FG000|Overall Study|Withdrawal by Subject|74|||
27621499|NCT00665561|80456034|FG001|Overall Study|Withdrawal by Subject|65|||
27621500|NCT00665561|80456033|FG000|Overall Study|Other|123|||
27621501|NCT00665561|80456034|FG001|Overall Study|Other|108|||
27621502|NCT00665561|80456033|FG000|Overall Study|Site closed|8|||
27621503|NCT00665561|80456034|FG001|Overall Study|Site closed|0|||
27621504|NCT00665561|80456033|FG000|Overall Study|Withdrawn due to pregnancy|0|||
27621505|NCT00665561|80456034|FG001|Overall Study|Withdrawn due to pregnancy|1|||
27523395|NCT01328444|80108567|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27523396|NCT01328444|80108568|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27523397|NCT01328444|80108569|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27523398|NCT01328444|80108570|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27523399|NCT01328444|80108571|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
27523400|NCT01328444|80108566|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27523401|NCT01328444|80108567|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27523402|NCT01328444|80108568|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27523403|NCT01328444|80108569|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27621506|NCT03283553|80456037|FG000|Patient Participant Flow|Death|5|||
27909960|NCT02757352|81507094|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27523404|NCT01328444|80108570|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27523405|NCT01328444|80108571|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27523406|NCT01715129|80108572|FG000|Overall Study|Adverse Event, fatal|1|||
27621507|NCT03283553|80456038|FG001|Patient Participant Flow|Death|10|||
27621508|NCT03283553|80456037|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
27523407|NCT01715129|80108572|FG000|Overall Study|Lack of Efficacy|3|||
27523408|NCT01715129|80108572|FG000|Overall Study|Protocol Violation|1|||
27621509|NCT03283553|80456038|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
27621510|NCT03283553|80456037|FG000|Patient Participant Flow|Lost to Follow-up|1|||
27909961|NCT02757352|81507095|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27621511|NCT03283553|80456038|FG001|Patient Participant Flow|Lost to Follow-up|1|||
27909962|NCT02757352|81507096|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909963|NCT02757352|81507087|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
27909964|NCT02757352|81507088|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
27909965|NCT02757352|81507089|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
27909966|NCT02757352|81507090|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27909967|NCT02757352|81507091|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27909968|NCT02757352|81507092|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27909969|NCT02757352|81507093|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27909970|NCT02757352|81507094|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27523409|NCT01715129|80108572|FG000|Overall Study|Consent Withdrawn|2|||
27523410|NCT01715129|80108572|FG000|Overall Study|Lost to Follow-up|1|||
27621512|NCT03283553|80456037|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
27621513|NCT03283553|80456038|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
27621514|NCT03283553|80456037|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
27621515|NCT03283553|80456038|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
27621516|NCT03283553|80456037|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
27523411|NCT01715129|80108572|FG000|Overall Study|Other|1|||
27523412|NCT01306929|80108573|FG000|Overall Study|Withdrawal by Subject|23|||
27523413|NCT01306929|80108573|FG000|Overall Study|Adverse Event|21|||
27523414|NCT01306929|80108573|FG000|Overall Study|Physician Decision|13|||
27523415|NCT01306929|80108573|FG000|Overall Study|Death|8|||
27523416|NCT01306929|80108573|FG000|Overall Study|Withdrawal by parent/guardian|5|||
27621517|NCT03283553|80456038|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
27621518|NCT04088409|80456041|FG000|Part A|Withdrawal by Subject|2|||
27621519|NCT04088409|80456042|FG001|Part A|Withdrawal by Subject|1|||
27621520|NCT04088409|80456041|FG000|Part A|Did Not Meet Randomization Criteria|2|||
27621521|NCT04088409|80456042|FG001|Part A|Did Not Meet Randomization Criteria|0|||
27732337|NCT00376961|80846240|FG001|Initial Registration|Progression/relapse|0|||
27732338|NCT00376961|80846239|FG000|Initial Registration|Ineligible|3|||
27732339|NCT00376961|80846240|FG001|Initial Registration|Ineligible|0|||
27732340|NCT00376961|80846239|FG000|Maintenance|Adverse Event|0|||
27732341|NCT00376961|80846240|FG001|Maintenance|Adverse Event|1|||
27732342|NCT00376961|80846239|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
27732343|NCT00376961|80846240|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
27732344|NCT00376961|80846239|FG000|Maintenance|Progression/relapse|0|||
27732345|NCT00376961|80846240|FG001|Maintenance|Progression/relapse|18|||
27732346|NCT00376961|80846239|FG000|Maintenance|Ineligible|0|||
27909971|NCT02757352|81507095|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27523417|NCT01306929|80108573|FG000|Overall Study|Protocol Violation|3|||
27523418|NCT01306929|80108573|FG000|Overall Study|Non-compliance with study drug|2|||
27523419|NCT01306929|80108573|FG000|Overall Study|Lost to Follow-up|2|||
27523420|NCT01306929|80108573|FG000|Overall Study|Various|17|||
27523421|NCT02815280|80108580|FG000|Double-Blind Phase|Adverse Event|1|||
27523422|NCT02815280|80108581|FG001|Double-Blind Phase|Adverse Event|1|||
27523423|NCT02815280|80108580|FG000|Double-Blind Phase|Lost to Follow-up|10|||
27523424|NCT02815280|80108581|FG001|Double-Blind Phase|Lost to Follow-up|9|||
27523425|NCT02815280|80108580|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
27523426|NCT02815280|80108581|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
27523427|NCT02815280|80108580|FG000|Double-Blind Phase|Protocol Violation|2|||
27523428|NCT02815280|80108581|FG001|Double-Blind Phase|Protocol Violation|2|||
27523429|NCT02815280|80108580|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
27523430|NCT02815280|80108581|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
27523431|NCT02815280|80108580|FG000|Open-Label Phase|Adverse Event|2|||
27523432|NCT02815280|80108581|FG001|Open-Label Phase|Adverse Event|3|||
27523433|NCT02815280|80108580|FG000|Open-Label Phase|Lost to Follow-up|18|||
27523434|NCT02815280|80108581|FG001|Open-Label Phase|Lost to Follow-up|9|||
27523435|NCT02815280|80108580|FG000|Open-Label Phase|Withdrawal by Subject|33|||
27523436|NCT02815280|80108581|FG001|Open-Label Phase|Withdrawal by Subject|18|||
27523437|NCT02815280|80108580|FG000|Open-Label Phase|Protocol Violation|3|||
27523438|NCT02815280|80108581|FG001|Open-Label Phase|Protocol Violation|0|||
27523439|NCT02815280|80108580|FG000|Open-Label Phase|Administrative|26|||
27523440|NCT02815280|80108581|FG001|Open-Label Phase|Administrative|12|||
27523441|NCT02815280|80108580|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
27909972|NCT02757352|81507096|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27523442|NCT02815280|80108581|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
27523443|NCT00833417|80108591|FG000|Overall Study|Adverse Event|5|||
27621522|NCT04088409|80456041|FG000|Part A|Lack of Efficacy|9|||
27621523|NCT04088409|80456042|FG001|Part A|Lack of Efficacy|0|||
27621524|NCT04088409|80456041|FG000|Part A|Lost to Follow-up|1|||
27732347|NCT00376961|80846240|FG001|Maintenance|Ineligible|3|||
27732348|NCT01147926|80846241|FG000|Overall Study|Subject Withdrew Consent|9|||
27909973|NCT02757352|81507087|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
27909974|NCT02757352|81507088|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
27909975|NCT02757352|81507089|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
27909976|NCT02757352|81507090|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27909977|NCT02757352|81507091|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27732349|NCT01147926|80846242|FG001|Overall Study|Subject Withdrew Consent|10|||
27732350|NCT01147926|80846241|FG000|Overall Study|Adverse Event|7|||
27732351|NCT01147926|80846242|FG001|Overall Study|Adverse Event|6|||
27732352|NCT01147926|80846241|FG000|Overall Study|Subject Non-Compliant|5|||
27732353|NCT01147926|80846242|FG001|Overall Study|Subject Non-Compliant|4|||
27732354|NCT01147926|80846241|FG000|Overall Study|Principal investigator left hospital|1|||
27732355|NCT01147926|80846242|FG001|Overall Study|Principal investigator left hospital|3|||
27732356|NCT01147926|80846241|FG000|Overall Study|Selection criteria not met|3|||
27732357|NCT01147926|80846242|FG001|Overall Study|Selection criteria not met|1|||
27732358|NCT01147926|80846241|FG000|Overall Study|Lost to Follow-up|0|||
27732359|NCT01147926|80846242|FG001|Overall Study|Lost to Follow-up|2|||
27732360|NCT01147926|80846241|FG000|Overall Study|Sponsor's Decision|0|||
27732361|NCT01147926|80846242|FG001|Overall Study|Sponsor's Decision|1|||
27732362|NCT01147926|80846241|FG000|Overall Study|Lack of Efficacy|1|||
27732363|NCT01147926|80846242|FG001|Overall Study|Lack of Efficacy|0|||
27732364|NCT01147926|80846241|FG000|Overall Study|Too busy, no time for study|1|||
27732365|NCT01147926|80846242|FG001|Overall Study|Too busy, no time for study|0|||
27732366|NCT01147926|80846241|FG000|Overall Study|Went on holiday|0|||
27732367|NCT01147926|80846242|FG001|Overall Study|Went on holiday|1|||
27732368|NCT01147926|80846241|FG000|Overall Study|Colonoscopy result|0|||
27732369|NCT01147926|80846242|FG001|Overall Study|Colonoscopy result|1|||
27732370|NCT02370121|80846244|FG000|Overall Study|Lost to Follow-up|1|||
27732371|NCT02370121|80846245|FG001|Overall Study|Lost to Follow-up|1|||
27732372|NCT00591734|80846246|FG000|Overall Study|Lack of Efficacy|35|||
27732373|NCT00591734|80846246|FG000|Overall Study|Adverse Event|5|||
27523444|NCT00833417|80108592|FG001|Overall Study|Adverse Event|16|||
27523445|NCT00833417|80108591|FG000|Overall Study|Death|1|||
27523446|NCT00833417|80108592|FG001|Overall Study|Death|3|||
27523447|NCT00833417|80108591|FG000|Overall Study|Lost to Follow-up|1|||
27523448|NCT00833417|80108592|FG001|Overall Study|Lost to Follow-up|2|||
27523449|NCT00833417|80108591|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
27732374|NCT00591734|80846246|FG000|Overall Study|Physician Decision|5|||
27732375|NCT00591734|80846246|FG000|Overall Study|Intercurrent Illness|8|||
27732376|NCT00609622|80846249|FG000|Overall Study|Adverse Event|14|||
27732377|NCT00609622|80846250|FG001|Overall Study|Adverse Event|10|||
27732378|NCT00609622|80846249|FG000|Overall Study|Withdrawal by Subject|4|||
27732379|NCT00609622|80846250|FG001|Overall Study|Withdrawal by Subject|20|||
27732380|NCT00609622|80846249|FG000|Overall Study|Death|1|||
27732381|NCT00609622|80846250|FG001|Overall Study|Death|4|||
27732382|NCT00609622|80846249|FG000|Overall Study|Protocol Violation|1|||
27732383|NCT00609622|80846250|FG001|Overall Study|Protocol Violation|1|||
27732384|NCT00609622|80846249|FG000|Overall Study|Objective progression or relapse|47|||
27732385|NCT00609622|80846250|FG001|Overall Study|Objective progression or relapse|41|||
27732386|NCT00609622|80846249|FG000|Overall Study|Study terminated by sponsor|16|||
27732387|NCT00609622|80846250|FG001|Overall Study|Study terminated by sponsor|3|||
27732388|NCT00609622|80846249|FG000|Overall Study|Other|7|||
27732389|NCT00609622|80846250|FG001|Overall Study|Other|14|||
27732390|NCT00609622|80846249|FG000|Overall Study|Global deterioration of health status|6|||
27732391|NCT00609622|80846250|FG001|Overall Study|Global deterioration of health status|2|||
27732392|NCT02006576|80846251|FG000|Overall Study|Withdrawal by Subject|4|||
27732393|NCT02006576|80846252|FG001|Overall Study|Withdrawal by Subject|6|||
27732394|NCT02006576|80846253|FG002|Overall Study|Withdrawal by Subject|2|||
27732395|NCT02006576|80846251|FG000|Overall Study|Death|0|||
27732396|NCT02006576|80846252|FG001|Overall Study|Death|0|||
27732397|NCT02006576|80846253|FG002|Overall Study|Death|1|||
27732398|NCT02006576|80846251|FG000|Overall Study|Lost to Follow-up|1|||
27732399|NCT02006576|80846252|FG001|Overall Study|Lost to Follow-up|0|||
27732400|NCT02006576|80846253|FG002|Overall Study|Lost to Follow-up|1|||
27732401|NCT02006576|80846251|FG000|Overall Study|Screen Failure, too sick, other|13|||
27909978|NCT02757352|81507092|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27958629|NCT01791517|81680065|FG007|Phase II|Lens Handling Difficulties|0|||
27523450|NCT00833417|80108592|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
27523451|NCT00833417|80108591|FG000|Overall Study|Patient Decision to Withdraw|4|||
27732402|NCT02006576|80846252|FG001|Overall Study|Screen Failure, too sick, other|1|||
27732403|NCT02006576|80846253|FG002|Overall Study|Screen Failure, too sick, other|13|||
27732404|NCT00484315|80846254|FG000|12-Month Clinical Follow-up|Death|6|||
27732405|NCT00484315|80846255|FG001|12-Month Clinical Follow-up|Death|2|||
27732406|NCT00484315|80846254|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
27732407|NCT00484315|80846255|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
27732408|NCT00484315|80846254|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
27523452|NCT00833417|80108592|FG001|Overall Study|Patient Decision to Withdraw|23|||
27523453|NCT00833417|80108591|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
27523454|NCT00833417|80108592|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
27523455|NCT00833417|80108591|FG000|Overall Study|Disease Progression|18|||
27523456|NCT00833417|80108592|FG001|Overall Study|Disease Progression|17|||
27523457|NCT00833417|80108591|FG000|Overall Study|Reason Not Specified|0|||
27523458|NCT00833417|80108592|FG001|Overall Study|Reason Not Specified|1|||
27523459|NCT00621621|80108593|FG000|Overall Study|Subjects were exited at EP study|30|||
27523460|NCT00621621|80108594|FG001|Overall Study|Subjects were exited at EP study|0|||
27523461|NCT00852371|80108595|FG000|Overall Study|Lost to Follow-up|2|||
27523462|NCT00852371|80108596|FG001|Overall Study|Lost to Follow-up|3|||
27523463|NCT00852371|80108597|FG002|Overall Study|Lost to Follow-up|4|||
27523464|NCT00852371|80108598|FG003|Overall Study|Lost to Follow-up|2|||
27523465|NCT00484185|80108600|FG000|Overall Study|Lost to Follow-up|44|||
27523466|NCT00484185|80108600|FG000|Overall Study|Other|20|||
27523467|NCT00484185|80108600|FG000|Overall Study|Randomized but not treated|5|||
27523468|NCT00484185|80108600|FG000|Overall Study|Death|2|||
27523469|NCT00475423|80108607|FG000|Overall Study|Protocol Violation|5|||
27523470|NCT00475423|80108607|FG000|Overall Study|Adverse Event|4|||
27523471|NCT00475423|80108607|FG000|Overall Study|Withdrawal by Subject|6|||
27523472|NCT00475423|80108607|FG000|Overall Study|Lack of Efficacy|8|||
27523473|NCT00475423|80108607|FG000|Overall Study|Death|1|||
27523474|NCT00475423|80108607|FG000|Overall Study|Reason not specified|1|||
27523475|NCT00475423|80108607|FG000|Overall Study|Lost to Follow-up|7|||
27523476|NCT02810444|80108611|FG000|Overall Study|Screen Failures|14|||
27523477|NCT02810444|80108611|FG000|Overall Study|Withdrawal by Subject|4|||
27523478|NCT02810444|80108611|FG000|Overall Study|Adverse Event|3|||
27523479|NCT02195011|80108612|FG000|Overall Study|Adverse Event|4|||
27523480|NCT02195011|80108613|FG001|Overall Study|Adverse Event|0|||
27523481|NCT02195011|80108612|FG000|Overall Study|Progressive Disease|18|||
27523482|NCT02195011|80108613|FG001|Overall Study|Progressive Disease|1|||
27523483|NCT02195011|80108612|FG000|Overall Study|Withdrawal by Subject|3|||
27523484|NCT02195011|80108613|FG001|Overall Study|Withdrawal by Subject|0|||
27523485|NCT00369629|80108614|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
27523486|NCT00369629|80108615|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
27523487|NCT00369629|80108616|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
27523488|NCT00369629|80108617|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
27523489|NCT00369629|80108614|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
27523490|NCT00369629|80108615|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
27523491|NCT00369629|80108616|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
27523492|NCT00369629|80108617|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
27523493|NCT00369629|80108614|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
27523494|NCT00369629|80108615|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
27523495|NCT00369629|80108616|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
27523496|NCT00369629|80108617|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
27523497|NCT00369629|80108614|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
27523498|NCT00369629|80108615|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
27523499|NCT00369629|80108616|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
27523500|NCT00369629|80108617|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
27523501|NCT00369629|80108614|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
27523502|NCT00369629|80108615|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
27523503|NCT00369629|80108616|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
27523504|NCT00369629|80108617|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
27523505|NCT00369629|80108614|FG000|Completed 4 More Cycles|Progressive disease|2|||
27523506|NCT00369629|80108615|FG001|Completed 4 More Cycles|Progressive disease|1|||
27523507|NCT00369629|80108616|FG002|Completed 4 More Cycles|Progressive disease|2|||
27523508|NCT00369629|80108617|FG003|Completed 4 More Cycles|Progressive disease|0|||
27523509|NCT00369629|80108614|FG000|Follow up for 1 Year|Death|2|||
27523510|NCT00369629|80108615|FG001|Follow up for 1 Year|Death|1|||
27523511|NCT00369629|80108616|FG002|Follow up for 1 Year|Death|1|||
27621525|NCT04088409|80456042|FG001|Part A|Lost to Follow-up|0|||
27621526|NCT04088409|80456041|FG000|Part A|Adverse Event|1|||
27621527|NCT04088409|80456042|FG001|Part A|Adverse Event|0|||
27621528|NCT04088409|80456041|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
27621529|NCT04088409|80456042|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
27621530|NCT04088409|80456041|FG000|Part B|Ongoing Treatment|10|||
27621531|NCT04088409|80456042|FG001|Part B|Ongoing Treatment|0|||
27621532|NCT01982760|80456043|FG000|Overall Study|Physician Decision|1|||
27621533|NCT01982760|80456044|FG001|Overall Study|Physician Decision|0|||
27523512|NCT00369629|80108617|FG003|Follow up for 1 Year|Death|0|||
27523513|NCT00369629|80108614|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
27621534|NCT02303574|80456045|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27523514|NCT00369629|80108615|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
27621535|NCT02303574|80456046|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27909979|NCT02757352|81507093|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27909980|NCT02757352|81507094|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27909981|NCT02757352|81507095|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27909982|NCT02757352|81507096|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
27909983|NCT02757352|81507087|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909984|NCT02757352|81507088|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909985|NCT02757352|81507089|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909986|NCT02757352|81507090|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
27909987|NCT02757352|81507091|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909988|NCT02757352|81507092|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
27909989|NCT02757352|81507093|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909990|NCT02757352|81507094|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909991|NCT02757352|81507095|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909992|NCT02757352|81507096|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
27909993|NCT02757352|81507087|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909994|NCT02757352|81507088|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909995|NCT02757352|81507089|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27909996|NCT02757352|81507090|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
27909997|NCT02757352|81507091|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
27909998|NCT02757352|81507092|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
27909999|NCT02757352|81507093|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27910000|NCT02757352|81507094|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27910001|NCT02757352|81507095|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27910002|NCT02757352|81507096|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
27910003|NCT02757352|81507087|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910004|NCT02757352|81507088|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910005|NCT02757352|81507089|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910006|NCT02757352|81507090|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910007|NCT02757352|81507091|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
27910008|NCT02757352|81507092|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910009|NCT02757352|81507093|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910010|NCT02757352|81507094|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910011|NCT02757352|81507095|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910012|NCT02757352|81507096|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
27910013|NCT02757352|81507087|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910014|NCT02757352|81507088|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910015|NCT02757352|81507089|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910016|NCT02757352|81507090|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910017|NCT02757352|81507091|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910018|NCT02757352|81507092|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
27910019|NCT02757352|81507093|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910020|NCT02757352|81507094|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910021|NCT02757352|81507095|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910022|NCT02757352|81507096|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
27910023|NCT02757352|81507087|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910024|NCT02757352|81507088|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910025|NCT02757352|81507089|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910026|NCT02757352|81507090|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
27910027|NCT02757352|81507091|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
27910028|NCT02757352|81507092|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
27910029|NCT02757352|81507093|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910030|NCT02757352|81507094|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910031|NCT02757352|81507095|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910032|NCT02757352|81507096|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
27910033|NCT02757352|81507087|FG000|Follow-Up Period|Adverse Event|0|||
27910034|NCT02757352|81507088|FG001|Follow-Up Period|Adverse Event|0|||
27910035|NCT02757352|81507089|FG002|Follow-Up Period|Adverse Event|0|||
27910036|NCT02757352|81507090|FG003|Follow-Up Period|Adverse Event|0|||
27910037|NCT02757352|81507091|FG004|Follow-Up Period|Adverse Event|0|||
27910038|NCT02757352|81507092|FG005|Follow-Up Period|Adverse Event|0|||
27910039|NCT02757352|81507093|FG006|Follow-Up Period|Adverse Event|1|||
27910040|NCT02757352|81507094|FG007|Follow-Up Period|Adverse Event|0|||
27910041|NCT02757352|81507095|FG008|Follow-Up Period|Adverse Event|2|||
27910042|NCT02757352|81507096|FG009|Follow-Up Period|Adverse Event|0|||
27910043|NCT02757352|81507087|FG000|Follow-Up Period|Lost to Follow-up|0|||
27910044|NCT02757352|81507088|FG001|Follow-Up Period|Lost to Follow-up|0|||
27523515|NCT00369629|80108616|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
27523516|NCT00369629|80108617|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
27523517|NCT00369629|80108614|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
27523518|NCT00369629|80108615|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
27523519|NCT00369629|80108616|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
27523520|NCT00369629|80108617|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
27523521|NCT02048241|80108623|FG000|Overall Study|Withdrawal by Subject|0|||
27523522|NCT02048241|80108624|FG001|Overall Study|Withdrawal by Subject|1|||
27523523|NCT01009840|80108625|FG000|Overall Study|Lost to Follow-up|1|||
27523524|NCT01009840|80108625|FG000|Overall Study|Adverse Event|4|||
27523525|NCT01009840|80108625|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
27523526|NCT01009840|80108625|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
27523527|NCT01009840|80108625|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
27523528|NCT01001299|80108629|FG000|Overall Study|Insufficient Therapeutic Response|20|||
27523529|NCT01001299|80108629|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
27523530|NCT01001299|80108629|FG000|Overall Study|Death|1|||
27523531|NCT01001299|80108629|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
27523532|NCT01001299|80108629|FG000|Overall Study|Withdrew Consent|1|||
27523533|NCT02617485|80108639|FG000|Treatment and Observation Period|Adverse Event|9|||
27523534|NCT02617485|80108640|FG001|Treatment and Observation Period|Adverse Event|1|||
27523535|NCT02617485|80108639|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
27523536|NCT02617485|80108640|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
27523537|NCT02617485|80108639|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
27523538|NCT02617485|80108640|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
27523539|NCT02617485|80108639|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
27523540|NCT02617485|80108640|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
27523541|NCT02617485|80108639|FG000|Treatment and Observation Period|Physician Decision|0|||
27523542|NCT02617485|80108640|FG001|Treatment and Observation Period|Physician Decision|1|||
27523543|NCT02617485|80108639|FG000|Follow-up Period|Adverse Event|1|||
27523544|NCT02617485|80108640|FG001|Follow-up Period|Adverse Event|0|||
27523545|NCT02617485|80108639|FG000|Follow-up Period|Withdrawal by Subject|1|||
27523546|NCT02617485|80108640|FG001|Follow-up Period|Withdrawal by Subject|0|||
27523547|NCT02617485|80108639|FG000|Follow-up Period|Disease progression|2|||
27523548|NCT02617485|80108640|FG001|Follow-up Period|Disease progression|1|||
27523549|NCT02617485|80108639|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
27523550|NCT02617485|80108640|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
27523551|NCT02617485|80108639|FG000|Follow-up Period|Patient needed radiotherapy|9|||
27523552|NCT02617485|80108640|FG001|Follow-up Period|Patient needed radiotherapy|5|||
27523553|NCT02617485|80108639|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
27523554|NCT02617485|80108640|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
27523555|NCT01589770|80108645|FG000|Overall Study|EGFR <60ml/min|6|||
27523556|NCT01589770|80108646|FG001|Overall Study|EGFR <60ml/min|4|||
27523557|NCT01589770|80108645|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
27523558|NCT01589770|80108646|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
27523559|NCT00265148|80108647|FG000|Overall Study|Adverse Event|2|||
27523560|NCT00265148|80108648|FG001|Overall Study|Adverse Event|2|||
27523561|NCT00265148|80108647|FG000|Overall Study|Lack of Efficacy|0|||
27523562|NCT00265148|80108648|FG001|Overall Study|Lack of Efficacy|2|||
27523563|NCT00265148|80108647|FG000|Overall Study|Protocol Violation|3|||
27523564|NCT00265148|80108648|FG001|Overall Study|Protocol Violation|2|||
27523565|NCT00265148|80108647|FG000|Overall Study|Lost to Follow-up|0|||
27523566|NCT00265148|80108648|FG001|Overall Study|Lost to Follow-up|1|||
27523567|NCT00265148|80108647|FG000|Overall Study|Withdrawal by Subject|2|||
27523568|NCT00265148|80108648|FG001|Overall Study|Withdrawal by Subject|1|||
27523569|NCT00265148|80108647|FG000|Overall Study|Physician Decision|1|||
27523570|NCT00265148|80108648|FG001|Overall Study|Physician Decision|0|||
27523571|NCT00265148|80108647|FG000|Overall Study|Increasing frailty|0|||
27523572|NCT00265148|80108648|FG001|Overall Study|Increasing frailty|1|||
27523573|NCT00265148|80108647|FG000|Overall Study|Subject chose to change of the dose|1|||
27523574|NCT00265148|80108648|FG001|Overall Study|Subject chose to change of the dose|0|||
27523575|NCT03678870|80108650|FG000|Overall Study|prescribed non- protocol medications|10|||
27523576|NCT03678870|80108651|FG001|Overall Study|prescribed non- protocol medications|6|||
27523577|NCT03678870|80108650|FG000|Overall Study|Lost to Follow-up|3|||
27523578|NCT03678870|80108651|FG001|Overall Study|Lost to Follow-up|2|||
27523579|NCT01106092|80108652|FG000|Overall Study|Withdrawal by Subject|0|||
27523580|NCT01106092|80108653|FG001|Overall Study|Withdrawal by Subject|0|||
27523581|NCT01106092|80108654|FG002|Overall Study|Withdrawal by Subject|0|||
27523582|NCT01106092|80108655|FG003|Overall Study|Withdrawal by Subject|1|||
27523583|NCT02519855|80112239|FG000|Overall Study|Adverse Event|0|||
27523584|NCT02519855|80112240|FG001|Overall Study|Adverse Event|1|||
27523585|NCT02519855|80112239|FG000|Overall Study|Lost to Follow-up|3|||
27523586|NCT02519855|80112240|FG001|Overall Study|Lost to Follow-up|3|||
27523587|NCT01904773|80112241|FG000|Screen|Screen failure|3|||
27523588|NCT01904773|80112242|FG001|Screen|Screen failure|0|||
27523589|NCT01904773|80112243|FG002|Screen|Screen failure|0|||
27523590|NCT01904773|80112244|FG003|Screen|Screen failure|0|||
27523591|NCT01904773|80112245|FG004|Screen|Screen failure|0|||
27523592|NCT01904773|80112246|FG005|Screen|Screen failure|0|||
27523593|NCT01904773|80112247|FG006|Screen|Screen failure|0|||
27523594|NCT01904773|80112248|FG007|Screen|Screen failure|0|||
27523595|NCT01904773|80112249|FG008|Screen|Screen failure|0|||
27523596|NCT01904773|80112241|FG000|Screen|Withdrawal by Subject|1|||
27523597|NCT01904773|80112242|FG001|Screen|Withdrawal by Subject|0|||
27523598|NCT01904773|80112243|FG002|Screen|Withdrawal by Subject|0|||
27523599|NCT01904773|80112244|FG003|Screen|Withdrawal by Subject|0|||
27523600|NCT01904773|80112245|FG004|Screen|Withdrawal by Subject|0|||
27523601|NCT01904773|80112246|FG005|Screen|Withdrawal by Subject|0|||
27523602|NCT01904773|80112247|FG006|Screen|Withdrawal by Subject|0|||
27523603|NCT01904773|80112248|FG007|Screen|Withdrawal by Subject|0|||
27523604|NCT01904773|80112249|FG008|Screen|Withdrawal by Subject|0|||
27523605|NCT01904773|80112241|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
27523606|NCT01904773|80112242|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523607|NCT01904773|80112243|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523608|NCT01904773|80112244|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523609|NCT01904773|80112245|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523610|NCT01904773|80112246|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523611|NCT01904773|80112247|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523612|NCT01904773|80112248|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523613|NCT01904773|80112249|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
27523614|NCT01904773|80112241|FG000|First Intervention|Adverse Event|0|||
27523615|NCT01904773|80112242|FG001|First Intervention|Adverse Event|0|||
27523616|NCT01904773|80112243|FG002|First Intervention|Adverse Event|0|||
27523617|NCT01904773|80112244|FG003|First Intervention|Adverse Event|0|||
27523618|NCT01904773|80112245|FG004|First Intervention|Adverse Event|0|||
27523619|NCT01904773|80112246|FG005|First Intervention|Adverse Event|0|||
27523620|NCT01904773|80112247|FG006|First Intervention|Adverse Event|1|||
27523621|NCT01904773|80112248|FG007|First Intervention|Adverse Event|0|||
27523622|NCT01904773|80112249|FG008|First Intervention|Adverse Event|0|||
27523623|NCT01904773|80112241|FG000|Placebo Washout First Intervention|Condition worsened|0|||
27523624|NCT01904773|80112242|FG001|Placebo Washout First Intervention|Condition worsened|1|||
27523625|NCT01904773|80112243|FG002|Placebo Washout First Intervention|Condition worsened|0|||
27523626|NCT01904773|80112244|FG003|Placebo Washout First Intervention|Condition worsened|0|||
27523627|NCT01904773|80112245|FG004|Placebo Washout First Intervention|Condition worsened|0|||
27523628|NCT01904773|80112246|FG005|Placebo Washout First Intervention|Condition worsened|0|||
27523629|NCT01904773|80112247|FG006|Placebo Washout First Intervention|Condition worsened|0|||
27523630|NCT01904773|80112248|FG007|Placebo Washout First Intervention|Condition worsened|0|||
27523631|NCT01904773|80112249|FG008|Placebo Washout First Intervention|Condition worsened|0|||
27523632|NCT01904773|80112241|FG000|Fifth Intervention|Adverse Event|0|||
27523633|NCT01904773|80112242|FG001|Fifth Intervention|Adverse Event|0|||
27523634|NCT01904773|80112243|FG002|Fifth Intervention|Adverse Event|0|||
27523635|NCT01904773|80112244|FG003|Fifth Intervention|Adverse Event|0|||
27523636|NCT01904773|80112245|FG004|Fifth Intervention|Adverse Event|0|||
27523637|NCT01904773|80112246|FG005|Fifth Intervention|Adverse Event|0|||
27523638|NCT01904773|80112247|FG006|Fifth Intervention|Adverse Event|0|||
27523639|NCT01904773|80112248|FG007|Fifth Intervention|Adverse Event|1|||
27523640|NCT01904773|80112249|FG008|Fifth Intervention|Adverse Event|0|||
27523641|NCT01904773|80112241|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523642|NCT01904773|80112242|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
27523643|NCT01904773|80112243|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523644|NCT01904773|80112244|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523645|NCT01904773|80112245|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523646|NCT01904773|80112246|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523647|NCT01904773|80112247|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523648|NCT01904773|80112248|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27523649|NCT01904773|80112249|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
27621536|NCT02303574|80456047|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
27621537|NCT02303574|80456048|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27621538|NCT02303574|80456049|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27621539|NCT02303574|80456050|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27855025|NCT00643565|81302453|FG000|Overall Study|Did Not Cooperate|0|||
27855026|NCT00643565|81302454|FG001|Overall Study|Did Not Cooperate|1|||
27855027|NCT00643565|81302453|FG000|Overall Study|Administrative|22|||
27523650|NCT02946931|80112253|FG000|Overall Study|Did not require collection of CRFs|588|||
27523651|NCT02946931|80112253|FG000|Overall Study|Other than listed|37|||
27523652|NCT02946931|80112253|FG000|Overall Study|Discharge from hospital|118|||
27855028|NCT00643565|81302454|FG001|Overall Study|Administrative|16|||
27523653|NCT02946931|80112253|FG000|Overall Study|Adverse Event|81|||
27523654|NCT02946931|80112253|FG000|Overall Study|CRFs not valid|1|||
27523655|NCT02946931|80112253|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
27523656|NCT00282464|80112260|FG000|Overall Study|Adverse Event|26|||
27523657|NCT00282464|80112261|FG001|Overall Study|Adverse Event|20|||
27523658|NCT00282464|80112260|FG000|Overall Study|Lack of Efficacy|8|||
27523659|NCT00282464|80112261|FG001|Overall Study|Lack of Efficacy|8|||
27523660|NCT00282464|80112260|FG000|Overall Study|Lost to Follow-up|10|||
27523661|NCT00282464|80112261|FG001|Overall Study|Lost to Follow-up|10|||
27523662|NCT00282464|80112260|FG000|Overall Study|Withdrawal by Subject|24|||
27523663|NCT00282464|80112261|FG001|Overall Study|Withdrawal by Subject|10|||
27523664|NCT00282464|80112260|FG000|Overall Study|laboratory abnormality|1|||
27523665|NCT00282464|80112261|FG001|Overall Study|laboratory abnormality|2|||
27523666|NCT00282464|80112260|FG000|Overall Study|Protocol Violation|0|||
27523667|NCT00282464|80112261|FG001|Overall Study|Protocol Violation|7|||
27523668|NCT00282464|80112260|FG000|Overall Study|Patient moved|1|||
27523669|NCT00282464|80112261|FG001|Overall Study|Patient moved|0|||
27523670|NCT00282464|80112260|FG000|Overall Study|patient non-compliant|3|||
27523671|NCT00282464|80112261|FG001|Overall Study|patient non-compliant|0|||
27523672|NCT00282464|80112260|FG000|Overall Study|patient no show|0|||
27523673|NCT00282464|80112261|FG001|Overall Study|patient no show|1|||
27523674|NCT00282464|80112260|FG000|Overall Study|patient incarcerated|0|||
27523675|NCT00282464|80112261|FG001|Overall Study|patient incarcerated|1|||
27523676|NCT00282464|80112260|FG000|Overall Study|family crisis|0|||
27523677|NCT00282464|80112261|FG001|Overall Study|family crisis|1|||
27523678|NCT00282464|80112260|FG000|Overall Study|dispensed wrong kit|0|||
27523679|NCT00282464|80112261|FG001|Overall Study|dispensed wrong kit|1|||
27523680|NCT00282464|80112260|FG000|Overall Study|dropped due to missed visits|0|||
27523681|NCT00282464|80112261|FG001|Overall Study|dropped due to missed visits|1|||
27523682|NCT00331552|80112262|FG000|Period 3: Phase II|Neurological Symptoms|1|||
27523683|NCT00331552|80112263|FG001|Period 3: Phase II|Neurological Symptoms|0|||
27523684|NCT00331552|80112262|FG000|Period 3: Phase II|Severe Nausea|1|||
27523685|NCT00331552|80112263|FG001|Period 3: Phase II|Severe Nausea|0|||
27523686|NCT00669409|80112264|FG000|Part 2|Withdrawal by Subject|0|||
27523687|NCT00669409|80112265|FG001|Part 2|Withdrawal by Subject|0|||
27523688|NCT00669409|80112266|FG002|Part 2|Withdrawal by Subject|0|||
27523689|NCT00669409|80112267|FG003|Part 2|Withdrawal by Subject|0|||
27523690|NCT00669409|80112268|FG004|Part 2|Withdrawal by Subject|0|||
27523691|NCT00669409|80112269|FG005|Part 2|Withdrawal by Subject|0|||
27523692|NCT00669409|80112270|FG006|Part 2|Withdrawal by Subject|0|||
27523693|NCT00669409|80112271|FG007|Part 2|Withdrawal by Subject|0|||
27523694|NCT00669409|80112272|FG008|Part 2|Withdrawal by Subject|0|||
27523695|NCT00669409|80112273|FG009|Part 2|Withdrawal by Subject|1|||
27523696|NCT00669409|80112274|FG010|Part 2|Withdrawal by Subject|0|||
27523697|NCT00348933|80112275|FG000|Overall Study|Withdrawal by Subject|10|||
27910045|NCT02757352|81507089|FG002|Follow-Up Period|Lost to Follow-up|0|||
27910046|NCT02757352|81507090|FG003|Follow-Up Period|Lost to Follow-up|0|||
27910047|NCT02757352|81507091|FG004|Follow-Up Period|Lost to Follow-up|0|||
27910048|NCT02757352|81507092|FG005|Follow-Up Period|Lost to Follow-up|0|||
27910049|NCT02757352|81507093|FG006|Follow-Up Period|Lost to Follow-up|0|||
27910050|NCT02757352|81507094|FG007|Follow-Up Period|Lost to Follow-up|0|||
27910051|NCT02757352|81507095|FG008|Follow-Up Period|Lost to Follow-up|1|||
27910052|NCT02757352|81507096|FG009|Follow-Up Period|Lost to Follow-up|0|||
27910053|NCT02757352|81507087|FG000|Follow-Up Period|Lack of Efficacy|0|||
27910054|NCT02757352|81507088|FG001|Follow-Up Period|Lack of Efficacy|0|||
27910055|NCT02757352|81507089|FG002|Follow-Up Period|Lack of Efficacy|0|||
27910056|NCT02757352|81507090|FG003|Follow-Up Period|Lack of Efficacy|0|||
27910057|NCT02757352|81507091|FG004|Follow-Up Period|Lack of Efficacy|0|||
27910058|NCT02757352|81507092|FG005|Follow-Up Period|Lack of Efficacy|0|||
27523698|NCT00348933|80112275|FG000|Overall Study|Lost to Follow-up|6|||
27523699|NCT00348933|80112275|FG000|Overall Study|Protocol Violation|2|||
27523700|NCT00348933|80112275|FG000|Overall Study|Adverse Event|7|||
27523701|NCT00266877|80112276|FG000|Overall Study|Death|1|||
27523702|NCT00266877|80112277|FG001|Overall Study|Death|1|||
27523703|NCT00266877|80112278|FG002|Overall Study|Death|1|||
27523704|NCT00266877|80112276|FG000|Overall Study|Adverse Event|6|||
27523705|NCT00266877|80112277|FG001|Overall Study|Adverse Event|4|||
27910059|NCT02757352|81507093|FG006|Follow-Up Period|Lack of Efficacy|0|||
27523706|NCT00266877|80112278|FG002|Overall Study|Adverse Event|1|||
27523707|NCT00266877|80112276|FG000|Overall Study|Physician Decision|2|||
27523708|NCT00266877|80112277|FG001|Overall Study|Physician Decision|1|||
27855029|NCT00643565|81302453|FG000|Overall Study|Adverse Event|5|||
27910060|NCT02757352|81507094|FG007|Follow-Up Period|Lack of Efficacy|0|||
27910061|NCT02757352|81507095|FG008|Follow-Up Period|Lack of Efficacy|1|||
27523709|NCT00266877|80112278|FG002|Overall Study|Physician Decision|1|||
27523710|NCT00266877|80112276|FG000|Overall Study|Withdrawal by Subject|3|||
27523711|NCT00266877|80112277|FG001|Overall Study|Withdrawal by Subject|1|||
27523712|NCT00266877|80112278|FG002|Overall Study|Withdrawal by Subject|1|||
27910062|NCT02757352|81507096|FG009|Follow-Up Period|Lack of Efficacy|1|||
27523713|NCT00266877|80112276|FG000|Overall Study|Disease Progression|72|||
27523714|NCT00266877|80112277|FG001|Overall Study|Disease Progression|37|||
27523715|NCT00266877|80112278|FG002|Overall Study|Disease Progression|23|||
27621540|NCT02303574|80456051|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27621541|NCT02303574|80456052|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27855030|NCT00643565|81302454|FG001|Overall Study|Adverse Event|8|||
27855031|NCT00678041|81302455|FG000|Overall Study|Physician Decision|5|||
27855032|NCT00678041|81302456|FG001|Overall Study|Physician Decision|5|||
27855033|NCT00080938|81302457|FG000|Overall Study|Adverse Event|3|||
27855034|NCT00080938|81302457|FG000|Overall Study|Withdrawal by Subject|6|||
27855035|NCT00080938|81302457|FG000|Overall Study|Death|2|||
27855036|NCT00080938|81302457|FG000|Overall Study|Lack of Efficacy|7|||
27855037|NCT00080938|81302457|FG000|Overall Study|other disease|1|||
27855038|NCT00080938|81302457|FG000|Overall Study|Not started protocol therapy|1|||
27855039|NCT00080938|81302457|FG000|Overall Study|Ineligible|4|||
27855040|NCT02034058|81302458|FG000|Overall Study|Death|3|||
27855041|NCT00918138|81302463|FG000|Overall Study|Subject withdrew consent|1|||
27855042|NCT00918138|81302464|FG001|Overall Study|Subject withdrew consent|1|||
27855043|NCT00918138|81302463|FG000|Overall Study|Death|1|||
27855044|NCT00918138|81302464|FG001|Overall Study|Death|0|||
27855045|NCT00658658|81302474|FG000|Overall Study|Withdrawal by Subject|0|||
27855046|NCT00658658|81302475|FG001|Overall Study|Withdrawal by Subject|1|||
27855047|NCT00658658|81302476|FG002|Overall Study|Withdrawal by Subject|0|||
27855048|NCT00658658|81302477|FG003|Overall Study|Withdrawal by Subject|0|||
27855049|NCT00658658|81302478|FG004|Overall Study|Withdrawal by Subject|0|||
27855050|NCT00658658|81302474|FG000|Overall Study|Death|4|||
27855051|NCT00658658|81302475|FG001|Overall Study|Death|0|||
27855052|NCT00658658|81302476|FG002|Overall Study|Death|0|||
27523716|NCT00266877|80112276|FG000|Overall Study|Symptomatic Deterioration|6|||
27523717|NCT00266877|80112277|FG001|Overall Study|Symptomatic Deterioration|3|||
27523718|NCT00266877|80112278|FG002|Overall Study|Symptomatic Deterioration|1|||
27523719|NCT00266877|80112276|FG000|Overall Study|Hospitalization|1|||
27523720|NCT00266877|80112277|FG001|Overall Study|Hospitalization|0|||
27523721|NCT00266877|80112278|FG002|Overall Study|Hospitalization|0|||
27523722|NCT00266877|80112276|FG000|Overall Study|Concomitant Radiotherapy|0|||
27523723|NCT00266877|80112277|FG001|Overall Study|Concomitant Radiotherapy|1|||
27523724|NCT00266877|80112278|FG002|Overall Study|Concomitant Radiotherapy|0|||
27523725|NCT01038869|80112280|FG000|Overall Study|Withdrawal by Subject|1|||
27523726|NCT01038869|80112280|FG000|Overall Study|Lost to Follow-up|6|||
27523727|NCT00159822|80112281|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
27523728|NCT00159822|80112281|FG000|Voriconazole Treatment Period|Adverse Event|9|||
27523729|NCT00159822|80112281|FG000|Voriconazole Treatment Period|Death|4|||
27523730|NCT00159822|80112281|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
27523731|NCT00159822|80112281|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
27523732|NCT00159822|80112281|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
27523733|NCT00159822|80112281|FG000|Post-treatment Follow-up Period|Death|1|||
27523734|NCT00159822|80112281|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
27523735|NCT00159822|80112281|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
27523736|NCT01235598|80112282|FG000|Overall Study|Adverse Event|0|||
27523737|NCT01235598|80112283|FG001|Overall Study|Adverse Event|3|||
27523738|NCT01235598|80112282|FG000|Overall Study|Lack of Efficacy|0|||
27523739|NCT01235598|80112283|FG001|Overall Study|Lack of Efficacy|1|||
27523740|NCT01235598|80112282|FG000|Overall Study|Withdrawal by Subject|1|||
27523741|NCT01235598|80112283|FG001|Overall Study|Withdrawal by Subject|0|||
27523742|NCT03390101|80112284|FG000|Weeks 0-12|Withdrawal by Subject|0|||
27523743|NCT03390101|80112285|FG001|Weeks 0-12|Withdrawal by Subject|1|||
27523744|NCT03390101|80112286|FG002|Weeks 0-12|Withdrawal by Subject|1|||
27523745|NCT03390101|80112284|FG000|Weeks 0-12|Lost to Follow-up|0|||
27523746|NCT03390101|80112285|FG001|Weeks 0-12|Lost to Follow-up|1|||
27523747|NCT03390101|80112286|FG002|Weeks 0-12|Lost to Follow-up|0|||
27523748|NCT03390101|80112284|FG000|Weeks 12-54|Withdrawal by Subject|0|||
27523749|NCT03390101|80112285|FG001|Weeks 12-54|Withdrawal by Subject|3|||
27523750|NCT03390101|80112286|FG002|Weeks 12-54|Withdrawal by Subject|1|||
27523751|NCT03390101|80112284|FG000|Weeks 12-54|Pregnancy|1|||
27855053|NCT00658658|81302477|FG003|Overall Study|Death|1|||
27855054|NCT00658658|81302478|FG004|Overall Study|Death|1|||
27523752|NCT03390101|80112285|FG001|Weeks 12-54|Pregnancy|0|||
27523753|NCT03390101|80112286|FG002|Weeks 12-54|Pregnancy|0|||
27523754|NCT03390101|80112284|FG000|Weeks 12-54|Adverse Event|2|||
27523755|NCT03390101|80112285|FG001|Weeks 12-54|Adverse Event|1|||
27523756|NCT03390101|80112286|FG002|Weeks 12-54|Adverse Event|1|||
27523757|NCT03911843|80112287|FG000|Overall Study|Adverse Event|2|||
27523758|NCT03911843|80112288|FG001|Overall Study|Adverse Event|0|||
27523759|NCT03911843|80112287|FG000|Overall Study|Protocol Violation|2|||
27855055|NCT00658658|81302474|FG000|Overall Study|Disease Progression|0|||
27855056|NCT00658658|81302475|FG001|Overall Study|Disease Progression|1|||
27855057|NCT00658658|81302476|FG002|Overall Study|Disease Progression|0|||
27523760|NCT03911843|80112288|FG001|Overall Study|Protocol Violation|0|||
27855058|NCT00658658|81302477|FG003|Overall Study|Disease Progression|1|||
27621542|NCT02303574|80456053|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27621543|NCT02303574|80456054|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
27621544|NCT02303574|80456045|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621545|NCT02303574|80456046|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621546|NCT02303574|80456047|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621547|NCT02303574|80456048|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621548|NCT02303574|80456049|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621549|NCT02303574|80456050|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621550|NCT02303574|80456051|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621551|NCT02303574|80456052|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
27621552|NCT02303574|80456053|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621553|NCT02303574|80456054|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
27621554|NCT00814489|80456055|FG000|Overall Study|Other|2|||
27621555|NCT00814489|80456056|FG001|Overall Study|Other|0|||
27621556|NCT00814489|80456057|FG002|Overall Study|Other|1|||
27621557|NCT01575860|80456058|FG000|Overall Study|Withdrawal by Subject|1|||
27621558|NCT01575860|80456058|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
27732409|NCT00484315|80846255|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
27732410|NCT00484315|80846254|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
27732411|NCT00484315|80846255|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
27732412|NCT00484315|80846254|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
27732413|NCT00484315|80846255|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
27732414|NCT00484315|80846254|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
27732415|NCT00484315|80846255|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
27910063|NCT02757352|81507087|FG000|Follow-Up Period|Withdrawal by Subject|0|||
27910064|NCT02757352|81507088|FG001|Follow-Up Period|Withdrawal by Subject|0|||
27621559|NCT04714216|80456059|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
27732416|NCT00484315|80846254|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
27732417|NCT00484315|80846255|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
27732418|NCT01822561|80846256|FG000|Overall Study|Withdrawal by Subject|2|||
27732419|NCT00924703|80846257|FG000|Overall Study|Withdrawal by Subject|11|||
27732420|NCT00924703|80846257|FG000|Overall Study|Physician Decision|5|||
27732421|NCT00924703|80846257|FG000|Overall Study|Lost to Follow-up|3|||
27732422|NCT00924703|80846257|FG000|Overall Study|Adverse Event|2|||
27732423|NCT00924703|80846257|FG000|Overall Study|Withdrawal by Sponsor|1|||
27732424|NCT03124459|80846260|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
27732425|NCT03124459|80846261|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
27732426|NCT03124459|80846262|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
27732427|NCT03124459|80846263|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
27732428|NCT03124459|80846264|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
27732429|NCT03124459|80846265|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
27732430|NCT03124459|80846260|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
27732431|NCT03124459|80846261|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
27732432|NCT03124459|80846262|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
27855059|NCT00658658|81302478|FG004|Overall Study|Disease Progression|3|||
27855060|NCT00658658|81302474|FG000|Overall Study|Protocol-specified Criteria|1|||
27855061|NCT00658658|81302475|FG001|Overall Study|Protocol-specified Criteria|0|||
27855062|NCT00658658|81302476|FG002|Overall Study|Protocol-specified Criteria|0|||
27855063|NCT00658658|81302477|FG003|Overall Study|Protocol-specified Criteria|0|||
27855064|NCT00658658|81302478|FG004|Overall Study|Protocol-specified Criteria|0|||
27855065|NCT00658658|81302474|FG000|Overall Study|Other|0|||
27855066|NCT00658658|81302475|FG001|Overall Study|Other|0|||
27855067|NCT00658658|81302476|FG002|Overall Study|Other|0|||
27855068|NCT00658658|81302477|FG003|Overall Study|Other|0|||
27855069|NCT00658658|81302478|FG004|Overall Study|Other|1|||
27855070|NCT02493777|81302486|FG000|Overall Study|Lost to Follow-up|0|||
27855071|NCT02493777|81302487|FG001|Overall Study|Lost to Follow-up|1|||
27855072|NCT02593773|81302488|FG000|Overall Study|Voluntary Withdrawal|3|||
27855073|NCT02593773|81302488|FG000|Overall Study|Study Terminated by Sponsor|31|||
27855074|NCT02593773|81302488|FG000|Overall Study|Death|1|||
27855075|NCT00380692|81302491|FG000|Study Period II - Double Blind|Adverse Event|1|||
27855076|NCT00380692|81302492|FG001|Study Period II - Double Blind|Adverse Event|0|||
27855077|NCT00380692|81302491|FG000|Study Period II - Double Blind|Protocol Violation|2|||
27855078|NCT00380692|81302492|FG001|Study Period II - Double Blind|Protocol Violation|2|||
27910065|NCT02757352|81507089|FG002|Follow-Up Period|Withdrawal by Subject|0|||
27621560|NCT04714216|80456059|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
27732433|NCT03124459|80846263|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
27732434|NCT03124459|80846264|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
27855079|NCT00380692|81302491|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
27855080|NCT00380692|81302492|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
27855081|NCT00380692|81302491|FG000|Study Period II - Double Blind|Physician Decision|0|||
27855082|NCT00380692|81302492|FG001|Study Period II - Double Blind|Physician Decision|1|||
27855083|NCT00380692|81302491|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
27855084|NCT00380692|81302492|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
27855085|NCT00380692|81302491|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
27855086|NCT00380692|81302492|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
27523761|NCT03911843|80112287|FG000|Overall Study|Lost to Follow-up|0|||
27523762|NCT03911843|80112288|FG001|Overall Study|Lost to Follow-up|1|||
27523763|NCT00869778|80112291|FG000|Overall Study|Adverse Event|2|||
27523764|NCT00869778|80112292|FG001|Overall Study|Adverse Event|0|||
27523765|NCT00869778|80112293|FG002|Overall Study|Adverse Event|0|||
27523766|NCT00869778|80112291|FG000|Overall Study|Withdrawal by Subject|3|||
27523767|NCT00869778|80112292|FG001|Overall Study|Withdrawal by Subject|4|||
27523768|NCT00869778|80112293|FG002|Overall Study|Withdrawal by Subject|5|||
27523769|NCT00869778|80112291|FG000|Overall Study|Pregnancy|1|||
27523770|NCT00869778|80112292|FG001|Overall Study|Pregnancy|0|||
27523771|NCT00869778|80112293|FG002|Overall Study|Pregnancy|0|||
27523772|NCT00869778|80112291|FG000|Overall Study|Protocol Violation|5|||
27523773|NCT00869778|80112292|FG001|Overall Study|Protocol Violation|3|||
27523774|NCT00869778|80112293|FG002|Overall Study|Protocol Violation|5|||
27523775|NCT00869778|80112291|FG000|Overall Study|Unblinding|1|||
27523776|NCT00869778|80112292|FG001|Overall Study|Unblinding|0|||
27523777|NCT00869778|80112293|FG002|Overall Study|Unblinding|0|||
27523778|NCT02052414|80112296|FG000|Overall Study|Adverse Event|12|||
27523779|NCT02052414|80112296|FG000|Overall Study|Lack of Efficacy|2|||
27523780|NCT02052414|80112296|FG000|Overall Study|Withdrawal by Subject|3|||
27523781|NCT01445548|80112303|FG000|Overall Study|Adverse Event|1|||
27523782|NCT02125604|80112304|FG000|Overall Study|Other|4|||
27523783|NCT02125604|80112304|FG000|Overall Study|Investigator Decision|1|||
27523784|NCT02125604|80112304|FG000|Overall Study|Lost to Follow-up|2|||
27523785|NCT02125604|80112304|FG000|Overall Study|Consent Withdrawn|4|||
27523786|NCT02125604|80112304|FG000|Overall Study|Adverse Event|20|||
27523787|NCT00075270|80112305|FG000|Overall Study|Withdrawal by Subject|28|||
27523788|NCT00075270|80112306|FG001|Overall Study|Withdrawal by Subject|21|||
27523789|NCT00075270|80112305|FG000|Overall Study|Lost to Follow-up|25|||
27523790|NCT00075270|80112306|FG001|Overall Study|Lost to Follow-up|28|||
27523791|NCT00075270|80112305|FG000|Overall Study|Protocol Violation|0|||
27523792|NCT00075270|80112306|FG001|Overall Study|Protocol Violation|2|||
27523793|NCT00075270|80112305|FG000|Overall Study|Death|198|||
27523794|NCT00075270|80112306|FG001|Overall Study|Death|215|||
27523795|NCT00075270|80112305|FG000|Overall Study|Other/Unknown|9|||
27523796|NCT00075270|80112306|FG001|Overall Study|Other/Unknown|5|||
27523797|NCT00075270|80112305|FG000|Overall Study|Missing|26|||
27523798|NCT00075270|80112306|FG001|Overall Study|Missing|13|||
27523799|NCT00555425|80112308|FG000|Overall Study|Missed Medication > 1 wk|34|||
27523800|NCT00555425|80112309|FG001|Overall Study|Missed Medication > 1 wk|15|||
27523801|NCT00555425|80112308|FG000|Overall Study|Missed 3 physician management visits|1|||
27523802|NCT00555425|80112309|FG001|Overall Study|Missed 3 physician management visits|0|||
27523803|NCT00555425|80112308|FG000|Overall Study|Met criteria for protective transfer|16|||
27523804|NCT00555425|80112309|FG001|Overall Study|Met criteria for protective transfer|3|||
27523805|NCT00555425|80112308|FG000|Overall Study|Became pregnant and transferred care|0|||
27523806|NCT00555425|80112309|FG001|Overall Study|Became pregnant and transferred care|1|||
27523807|NCT00570232|80112310|FG000|Overall Study|Adverse Event|10|||
27523808|NCT00570232|80112310|FG000|Overall Study|discontinued due to medical condition|3|||
27523809|NCT00570232|80112310|FG000|Overall Study|discontinued due to recurrence|8|||
27523810|NCT00570232|80112310|FG000|Overall Study|discontinued due to noncompliance|2|||
27523811|NCT01350544|80112313|FG000|Overall Study|Administrative Withdrawal|0|||
27523812|NCT01350544|80112314|FG001|Overall Study|Administrative Withdrawal|1|||
27523813|NCT01350544|80112313|FG000|Overall Study|Death|1|||
27732435|NCT03124459|80846265|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
27732436|NCT03124459|80846260|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
27732437|NCT03124459|80846261|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
27523814|NCT01350544|80112314|FG001|Overall Study|Death|2|||
27523815|NCT01350544|80112313|FG000|Overall Study|Moved out of LA County|2|||
27523816|NCT01350544|80112314|FG001|Overall Study|Moved out of LA County|2|||
27523817|NCT01350544|80112313|FG000|Overall Study|Medical Issues|1|||
27523818|NCT01350544|80112314|FG001|Overall Study|Medical Issues|1|||
27523819|NCT01350544|80112313|FG000|Overall Study|Withdrawal by Subject|0|||
27523820|NCT01350544|80112314|FG001|Overall Study|Withdrawal by Subject|1|||
27523821|NCT01350544|80112313|FG000|Overall Study|Incarceration|1|||
27523822|NCT01350544|80112314|FG001|Overall Study|Incarceration|0|||
27523823|NCT01350544|80112313|FG000|Overall Study|Lost to Follow-up|18|||
27523824|NCT01350544|80112314|FG001|Overall Study|Lost to Follow-up|15|||
27523825|NCT03400956|80112315|FG000|Treatment Period 1|Adverse Event|0|||
27523826|NCT03400956|80112316|FG001|Treatment Period 1|Adverse Event|1|||
27523827|NCT03400956|80112317|FG002|Treatment Period 1|Adverse Event|0|||
27523828|NCT03400956|80112315|FG000|Treatment Period 1|Lost to Follow-up|0|||
27523829|NCT03400956|80112316|FG001|Treatment Period 1|Lost to Follow-up|0|||
27910066|NCT02757352|81507090|FG003|Follow-Up Period|Withdrawal by Subject|0|||
27910067|NCT02757352|81507091|FG004|Follow-Up Period|Withdrawal by Subject|0|||
27910068|NCT02757352|81507092|FG005|Follow-Up Period|Withdrawal by Subject|0|||
27910069|NCT02757352|81507093|FG006|Follow-Up Period|Withdrawal by Subject|0|||
27910070|NCT02757352|81507094|FG007|Follow-Up Period|Withdrawal by Subject|1|||
27910071|NCT02757352|81507095|FG008|Follow-Up Period|Withdrawal by Subject|6|||
27910072|NCT02757352|81507096|FG009|Follow-Up Period|Withdrawal by Subject|2|||
27910073|NCT02169505|81510001|FG000|Overall Study|Withdrawal by Subject|1|||
27910074|NCT02768792|81510002|FG000|Overall Study|Adverse Event|1|||
27910075|NCT00760487|81510003|FG000|Overall Study|Unilateral implantation|3|||
27910076|NCT04668209|81510004|FG000|Overall Study|Withdrawal by Subject|2|||
27910077|NCT04668209|81510005|FG001|Overall Study|Withdrawal by Subject|2|||
27910078|NCT04668209|81510004|FG000|Overall Study|Lost to Follow-up|3|||
27910079|NCT04668209|81510005|FG001|Overall Study|Lost to Follow-up|4|||
27523830|NCT03400956|80112317|FG002|Treatment Period 1|Lost to Follow-up|1|||
27523831|NCT03400956|80112315|FG000|Treatment Period 1|Protocol Violation|0|||
27523832|NCT03400956|80112316|FG001|Treatment Period 1|Protocol Violation|2|||
27523833|NCT03400956|80112317|FG002|Treatment Period 1|Protocol Violation|0|||
27523834|NCT03400956|80112315|FG000|Treatment Period 1|Study terminated by sponsor|3|||
27523835|NCT03400956|80112316|FG001|Treatment Period 1|Study terminated by sponsor|1|||
27523836|NCT03400956|80112317|FG002|Treatment Period 1|Study terminated by sponsor|1|||
27523837|NCT03400956|80112315|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27523838|NCT03400956|80112316|FG001|Treatment Period 1|Withdrawal by Subject|2|||
27523839|NCT03400956|80112317|FG002|Treatment Period 1|Withdrawal by Subject|4|||
27523840|NCT03400956|80112315|FG000|Treatment Period 1|Other|1|||
27523841|NCT03400956|80112316|FG001|Treatment Period 1|Other|2|||
27523842|NCT03400956|80112317|FG002|Treatment Period 1|Other|3|||
27523843|NCT03400956|80112315|FG000|Post-treatment Period 1|Adverse Event|0|||
27523844|NCT03400956|80112316|FG001|Post-treatment Period 1|Adverse Event|0|||
27523845|NCT03400956|80112317|FG002|Post-treatment Period 1|Adverse Event|1|||
27523846|NCT03400956|80112315|FG000|Post-treatment Period 1|Physician Decision|2|||
27523847|NCT03400956|80112316|FG001|Post-treatment Period 1|Physician Decision|3|||
27523848|NCT03400956|80112317|FG002|Post-treatment Period 1|Physician Decision|0|||
27523849|NCT03400956|80112315|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
27523850|NCT03400956|80112316|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
27523851|NCT03400956|80112317|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
27523852|NCT03400956|80112315|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
27523853|NCT03400956|80112316|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
27523854|NCT03400956|80112317|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
27523855|NCT03400956|80112315|FG000|Post-treatment Period 1|Other|4|||
27523856|NCT03400956|80112316|FG001|Post-treatment Period 1|Other|3|||
27523857|NCT03400956|80112317|FG002|Post-treatment Period 1|Other|4|||
27523858|NCT03400956|80112315|FG000|Treatment Period 2|Adverse Event|2|||
27523859|NCT03400956|80112316|FG001|Treatment Period 2|Adverse Event|1|||
27523860|NCT03400956|80112317|FG002|Treatment Period 2|Adverse Event|1|||
27523861|NCT03400956|80112315|FG000|Treatment Period 2|Lost to Follow-up|1|||
27523862|NCT03400956|80112316|FG001|Treatment Period 2|Lost to Follow-up|1|||
27523863|NCT03400956|80112317|FG002|Treatment Period 2|Lost to Follow-up|0|||
27523864|NCT03400956|80112315|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27523865|NCT03400956|80112316|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27523866|NCT03400956|80112317|FG002|Treatment Period 2|Withdrawal by Subject|3|||
27523867|NCT03400956|80112315|FG000|Treatment Period 2|Other|1|||
27523868|NCT03400956|80112316|FG001|Treatment Period 2|Other|1|||
27523869|NCT03400956|80112317|FG002|Treatment Period 2|Other|0|||
27523870|NCT03400956|80112315|FG000|Follow-up Period|Withdrawal by Subject|0|||
27523871|NCT03400956|80112316|FG001|Follow-up Period|Withdrawal by Subject|0|||
27523872|NCT03400956|80112317|FG002|Follow-up Period|Withdrawal by Subject|1|||
27523873|NCT03400956|80112315|FG000|Follow-up Period|Other|0|||
27523874|NCT03400956|80112316|FG001|Follow-up Period|Other|0|||
27523875|NCT03400956|80112317|FG002|Follow-up Period|Other|1|||
27910080|NCT04668209|81510004|FG000|Overall Study|Subject Expired|2|||
27910081|NCT04668209|81510005|FG001|Overall Study|Subject Expired|0|||
27910082|NCT04668209|81510004|FG000|Overall Study|Withdrawn from study|0|||
27910083|NCT04668209|81510005|FG001|Overall Study|Withdrawn from study|1|||
27910084|NCT04668209|81510004|FG000|Overall Study|Adverse Event|0|||
27910085|NCT04668209|81510005|FG001|Overall Study|Adverse Event|1|||
27523876|NCT03467152|80112318|FG000|Overall Study|Adverse Event|4|||
27910086|NCT00397189|81510006|FG000|3 Weeks Period|Lost to Follow-up|5|||
27910087|NCT00397189|81510007|FG001|3 Weeks Period|Lost to Follow-up|4|||
27523877|NCT03467152|80112319|FG001|Overall Study|Adverse Event|5|||
27523878|NCT03467152|80112320|FG002|Overall Study|Adverse Event|0|||
27523879|NCT03467152|80112318|FG000|Overall Study|Subject Choice|1|||
27523880|NCT03467152|80112319|FG001|Overall Study|Subject Choice|3|||
27523881|NCT03467152|80112320|FG002|Overall Study|Subject Choice|0|||
27523882|NCT03467152|80112318|FG000|Overall Study|Lost to Follow-up|1|||
27910088|NCT00397189|81510006|FG000|3 Weeks Period|Adverse Event|3|||
27910089|NCT00397189|81510007|FG001|3 Weeks Period|Adverse Event|2|||
27523883|NCT03467152|80112319|FG001|Overall Study|Lost to Follow-up|0|||
27621561|NCT03424239|80456063|FG000|Overall Study|Withdrawal by Subject|2|||
27621562|NCT01244984|80456064|FG000|Overall Study|Adverse Event|2|||
27621563|NCT01244984|80456065|FG001|Overall Study|Adverse Event|11|||
27621564|NCT01244984|80456066|FG002|Overall Study|Adverse Event|2|||
27621565|NCT01244984|80456064|FG000|Overall Study|Protocol Violation|1|||
27621566|NCT01244984|80456065|FG001|Overall Study|Protocol Violation|0|||
27621567|NCT01244984|80456066|FG002|Overall Study|Protocol Violation|0|||
27621568|NCT01244984|80456064|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
27621569|NCT01244984|80456065|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
27621570|NCT01244984|80456066|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
27621571|NCT01244984|80456064|FG000|Overall Study|Withdrawal by Subject|1|||
27621572|NCT01244984|80456065|FG001|Overall Study|Withdrawal by Subject|2|||
27621573|NCT01244984|80456066|FG002|Overall Study|Withdrawal by Subject|2|||
27621574|NCT02688621|80456071|FG000|Overall Study|Pregnancy|1|||
27621575|NCT02688621|80456072|FG001|Overall Study|Pregnancy|3|||
27621576|NCT02688621|80456071|FG000|Overall Study|Lost to Follow-up|38|||
27621577|NCT02688621|80456072|FG001|Overall Study|Lost to Follow-up|15|||
27621578|NCT02688621|80456071|FG000|Overall Study|Withdrawal by Subject|1|||
27621579|NCT02688621|80456072|FG001|Overall Study|Withdrawal by Subject|0|||
27621580|NCT04668144|80456077|FG000|Overall Study|Protocol Violation|0|||
27621581|NCT04668144|80456078|FG001|Overall Study|Protocol Violation|1|||
27621582|NCT04668144|80456079|FG002|Overall Study|Protocol Violation|2|||
27621583|NCT03019458|80456080|FG000|Overall Study|Death|0|||
27621584|NCT03019458|80456081|FG001|Overall Study|Death|1|||
27621585|NCT00821236|80456082|FG000|Overall Study|Lost to Follow-up|3|||
27621586|NCT00708097|80456085|FG000|Period 1|Protocol Violation|0|||
27621587|NCT00708097|80456086|FG001|Period 1|Protocol Violation|1|||
27621588|NCT00708097|80456087|FG002|Period 1|Protocol Violation|0|||
27621589|NCT00708097|80456088|FG003|Period 1|Protocol Violation|2|||
27621590|NCT00708097|80456089|FG004|Period 1|Protocol Violation|0|||
27621591|NCT00708097|80456085|FG000|Period 1|Other Reason|0|||
27621592|NCT00708097|80456086|FG001|Period 1|Other Reason|0|||
27621593|NCT00708097|80456087|FG002|Period 1|Other Reason|0|||
27621594|NCT00708097|80456088|FG003|Period 1|Other Reason|0|||
27621595|NCT00708097|80456089|FG004|Period 1|Other Reason|1|||
27621596|NCT00708097|80456085|FG000|Period 2|Protocol Violation|0|||
27621597|NCT00708097|80456086|FG001|Period 2|Protocol Violation|1|||
27621598|NCT00708097|80456087|FG002|Period 2|Protocol Violation|1|||
27621599|NCT00708097|80456088|FG003|Period 2|Protocol Violation|1|||
27621600|NCT00708097|80456089|FG004|Period 2|Protocol Violation|0|||
27621601|NCT04076059|80456091|FG000|Double Blind Phase|Progressive disease|22|||
27621602|NCT04076059|80456092|FG001|Double Blind Phase|Progressive disease|26|||
27621603|NCT04076059|80456093|FG002|Double Blind Phase|Progressive disease|0|||
27621604|NCT04076059|80456091|FG000|Double Blind Phase|Withdrawal by Subject|4|||
27621605|NCT04076059|80456092|FG001|Double Blind Phase|Withdrawal by Subject|11|||
27621606|NCT04076059|80456093|FG002|Double Blind Phase|Withdrawal by Subject|0|||
27621607|NCT04076059|80456091|FG000|Double Blind Phase|Death|1|||
27621608|NCT04076059|80456092|FG001|Double Blind Phase|Death|1|||
27621609|NCT04076059|80456093|FG002|Double Blind Phase|Death|0|||
27621610|NCT04076059|80456091|FG000|Double Blind Phase|Lost to Follow-up|1|||
27621611|NCT04076059|80456092|FG001|Double Blind Phase|Lost to Follow-up|0|||
27621612|NCT04076059|80456093|FG002|Double Blind Phase|Lost to Follow-up|0|||
27621613|NCT04076059|80456091|FG000|Double Blind Phase|Adverse Event|5|||
27621614|NCT04076059|80456092|FG001|Double Blind Phase|Adverse Event|1|||
27621615|NCT04076059|80456093|FG002|Double Blind Phase|Adverse Event|0|||
27523884|NCT03467152|80112320|FG002|Overall Study|Lost to Follow-up|0|||
27523885|NCT03467152|80112318|FG000|Overall Study|Withdrawal by Subject|4|||
27523886|NCT03467152|80112319|FG001|Overall Study|Withdrawal by Subject|2|||
27523887|NCT03467152|80112320|FG002|Overall Study|Withdrawal by Subject|0|||
27523888|NCT03467152|80112318|FG000|Overall Study|Others|3|||
27523889|NCT03467152|80112319|FG001|Overall Study|Others|0|||
27523890|NCT03467152|80112320|FG002|Overall Study|Others|0|||
27523891|NCT03467152|80112318|FG000|Overall Study|Not treated|3|||
27523892|NCT03467152|80112319|FG001|Overall Study|Not treated|1|||
27621616|NCT04076059|80456091|FG000|Double Blind Phase|Ongoing Participants|82|||
27621617|NCT04076059|80456092|FG001|Double Blind Phase|Ongoing Participants|18|||
27621618|NCT04076059|80456093|FG002|Double Blind Phase|Ongoing Participants|0|||
27621619|NCT04076059|80456091|FG000|Double Blind Phase|Miscellaneous|3|||
27732438|NCT03124459|80846262|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
27621620|NCT04076059|80456092|FG001|Double Blind Phase|Miscellaneous|1|||
27621621|NCT04076059|80456093|FG002|Double Blind Phase|Miscellaneous|0|||
27621622|NCT04076059|80456091|FG000|Double Blind Phase|Protocol Deviation|1|||
27621623|NCT04076059|80456092|FG001|Double Blind Phase|Protocol Deviation|1|||
27523893|NCT03467152|80112320|FG002|Overall Study|Not treated|6|||
27523894|NCT00722371|80112321|FG000|Overall Study|Adverse Event|6|||
27523895|NCT00722371|80112322|FG001|Overall Study|Adverse Event|13|||
27621624|NCT04076059|80456093|FG002|Double Blind Phase|Protocol Deviation|0|||
27621625|NCT04076059|80456091|FG000|Double Blind Phase|Did not take study drug|1|||
27621626|NCT04076059|80456092|FG001|Double Blind Phase|Did not take study drug|1|||
27621627|NCT04076059|80456093|FG002|Double Blind Phase|Did not take study drug|0|||
27621628|NCT04076059|80456091|FG000|Open Label Phase|Progressive disease|0|||
27621629|NCT04076059|80456092|FG001|Open Label Phase|Progressive disease|0|||
27621630|NCT04076059|80456093|FG002|Open Label Phase|Progressive disease|7|||
27621631|NCT04076059|80456091|FG000|Open Label Phase|Withdrawal by Subject|0|||
27621632|NCT04076059|80456092|FG001|Open Label Phase|Withdrawal by Subject|0|||
27621633|NCT04076059|80456093|FG002|Open Label Phase|Withdrawal by Subject|3|||
27621634|NCT04076059|80456091|FG000|Open Label Phase|Death|0|||
27621635|NCT04076059|80456092|FG001|Open Label Phase|Death|0|||
27621636|NCT04076059|80456093|FG002|Open Label Phase|Death|2|||
27621637|NCT04076059|80456091|FG000|Open Label Phase|Ongoing Participants|0|||
27621638|NCT04076059|80456092|FG001|Open Label Phase|Ongoing Participants|0|||
27621639|NCT04076059|80456093|FG002|Open Label Phase|Ongoing Participants|11|||
27621640|NCT03568461|80456094|FG000|Overall Study|Death|7|||
27621641|NCT03568461|80456094|FG000|Overall Study|Physician Decision|5|||
27621642|NCT03568461|80456094|FG000|Overall Study|Subject decision|5|||
27621643|NCT03568461|80456094|FG000|Overall Study|Lost to Follow-up|1|||
27621644|NCT04319094|80456097|FG000|Baseline|Lost to Follow-up|4|||
27621645|NCT04319094|80456098|FG001|Baseline|Lost to Follow-up|5|||
27621646|NCT04319094|80456097|FG000|Baseline|Protocol Violation|0|||
27621647|NCT04319094|80456098|FG001|Baseline|Protocol Violation|3|||
27621648|NCT04319094|80456097|FG000|Baseline|Withdrawal by Subject|2|||
27621649|NCT04319094|80456098|FG001|Baseline|Withdrawal by Subject|1|||
27621650|NCT04319094|80456097|FG000|Post-Intervention|Death|0|||
27621651|NCT04319094|80456098|FG001|Post-Intervention|Death|1|||
27621652|NCT04319094|80456097|FG000|Post-Intervention|Lost to Follow-up|4|||
27621653|NCT04319094|80456098|FG001|Post-Intervention|Lost to Follow-up|4|||
27621654|NCT04319094|80456097|FG000|Post-Intervention|Withdrawal by Subject|8|||
27621655|NCT04319094|80456098|FG001|Post-Intervention|Withdrawal by Subject|5|||
27621656|NCT04319094|80456097|FG000|Post-Intervention|Incomplete Data Collection|1|||
27621657|NCT04319094|80456098|FG001|Post-Intervention|Incomplete Data Collection|3|||
27621658|NCT04319094|80456097|FG000|3-month|Death|1|||
27621659|NCT04319094|80456098|FG001|3-month|Death|0|||
27621660|NCT04319094|80456097|FG000|3-month|Lost to Follow-up|2|||
27621661|NCT04319094|80456098|FG001|3-month|Lost to Follow-up|2|||
27621662|NCT04319094|80456097|FG000|3-month|Withdrawal by Subject|0|||
27621663|NCT04319094|80456098|FG001|3-month|Withdrawal by Subject|3|||
27621664|NCT04319094|80456097|FG000|3-month|Incomplete data collection|9|||
27621665|NCT04319094|80456098|FG001|3-month|Incomplete data collection|7|||
27621666|NCT04319094|80456097|FG000|6-month|Lost to Follow-up|1|||
27621667|NCT04319094|80456098|FG001|6-month|Lost to Follow-up|1|||
27621668|NCT04319094|80456097|FG000|6-month|Withdrawal by Subject|0|||
27621669|NCT04319094|80456098|FG001|6-month|Withdrawal by Subject|3|||
27621670|NCT04319094|80456097|FG000|6-month|Incomplete data collection|14|||
27621671|NCT04319094|80456098|FG001|6-month|Incomplete data collection|9|||
27621672|NCT04319094|80456097|FG000|9-month|Lost to Follow-up|8|||
27621673|NCT04319094|80456098|FG001|9-month|Lost to Follow-up|4|||
27621674|NCT04319094|80456097|FG000|9-month|Withdrawal by Subject|0|||
27621675|NCT04319094|80456098|FG001|9-month|Withdrawal by Subject|1|||
27621676|NCT04319094|80456097|FG000|9-month|Incomplete data collection|8|||
27621677|NCT04319094|80456098|FG001|9-month|Incomplete data collection|5|||
27621678|NCT04319094|80456097|FG000|12-month|Lost to Follow-up|11|||
27621679|NCT04319094|80456098|FG001|12-month|Lost to Follow-up|8|||
27621680|NCT01321073|80456099|FG000|Overall Study|Did not attempt implant|4|||
27621681|NCT01321073|80456099|FG000|Overall Study|Death|3|||
27621682|NCT02223182|80456103|FG000|Double-Blind Period|Adverse Event|0|||
27621683|NCT02223182|80456104|FG001|Double-Blind Period|Adverse Event|2|||
27621684|NCT02223182|80456105|FG002|Double-Blind Period|Adverse Event|1|||
27621685|NCT02223182|80456106|FG003|Double-Blind Period|Adverse Event|0|||
27621686|NCT02223182|80456103|FG000|Double-Blind Period|Withdrawal by Subject|1|||
27621687|NCT02223182|80456104|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27621688|NCT02223182|80456105|FG002|Double-Blind Period|Withdrawal by Subject|1|||
27621689|NCT02223182|80456106|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27621690|NCT02223182|80456103|FG000|Double-Blind Period|Lost to Follow-up|0|||
27621691|NCT02223182|80456104|FG001|Double-Blind Period|Lost to Follow-up|1|||
27621692|NCT02223182|80456105|FG002|Double-Blind Period|Lost to Follow-up|0|||
27621693|NCT02223182|80456106|FG003|Double-Blind Period|Lost to Follow-up|0|||
27621694|NCT02223182|80456103|FG000|Double-Blind Period|Non Compliance|0|||
27621695|NCT02223182|80456104|FG001|Double-Blind Period|Non Compliance|0|||
27621696|NCT02223182|80456105|FG002|Double-Blind Period|Non Compliance|0|||
27621697|NCT02223182|80456106|FG003|Double-Blind Period|Non Compliance|1|||
27621698|NCT02223182|80456103|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
27621699|NCT02223182|80456104|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
27621700|NCT02223182|80456105|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
27621701|NCT02223182|80456106|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
27621702|NCT02223182|80456103|FG000|Open-Label 500 Period|Adverse Event|1|||
27621703|NCT02223182|80456104|FG001|Open-Label 500 Period|Adverse Event|0|||
27621704|NCT02223182|80456105|FG002|Open-Label 500 Period|Adverse Event|2|||
27621705|NCT02223182|80456106|FG003|Open-Label 500 Period|Adverse Event|1|||
27621706|NCT02223182|80456103|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
27621707|NCT02223182|80456104|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
27621708|NCT02223182|80456105|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
27621709|NCT02223182|80456106|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
27621710|NCT02223182|80456103|FG000|Open-Label 500 Period|Physician Decision|0|||
27621711|NCT02223182|80456104|FG001|Open-Label 500 Period|Physician Decision|0|||
27621712|NCT02223182|80456105|FG002|Open-Label 500 Period|Physician Decision|0|||
27621713|NCT02223182|80456106|FG003|Open-Label 500 Period|Physician Decision|1|||
27621714|NCT02223182|80456103|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
27621715|NCT02223182|80456104|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
27621716|NCT02223182|80456105|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
27621717|NCT02223182|80456106|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
27621718|NCT02223182|80456103|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
27621719|NCT02223182|80456104|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
27621720|NCT02223182|80456105|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
27621721|NCT02223182|80456106|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
27621722|NCT02223182|80456103|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
27621723|NCT02223182|80456104|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
27621724|NCT02223182|80456105|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
27621725|NCT02223182|80456106|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
27621726|NCT02223182|80456103|FG000|Open-Label 300 Period|Non Compliance|0|||
27621727|NCT02223182|80456104|FG001|Open-Label 300 Period|Non Compliance|2|||
27621728|NCT02223182|80456105|FG002|Open-Label 300 Period|Non Compliance|1|||
27621729|NCT02223182|80456106|FG003|Open-Label 300 Period|Non Compliance|0|||
27621730|NCT04529538|80456107|FG000|Overall Study|Lost to Follow-up|3|||
27621731|NCT04529538|80456108|FG001|Overall Study|Lost to Follow-up|2|||
27621732|NCT04529538|80456109|FG002|Overall Study|Lost to Follow-up|1|||
27523896|NCT00722371|80112323|FG002|Overall Study|Adverse Event|9|||
27523897|NCT00722371|80112324|FG003|Overall Study|Adverse Event|10|||
27523898|NCT00722371|80112325|FG004|Overall Study|Adverse Event|6|||
27523899|NCT00722371|80112326|FG005|Overall Study|Adverse Event|8|||
27523900|NCT00722371|80112327|FG006|Overall Study|Adverse Event|4|||
27523901|NCT00722371|80112321|FG000|Overall Study|Contraindication|0|||
27523902|NCT00722371|80112322|FG001|Overall Study|Contraindication|0|||
27523903|NCT00722371|80112323|FG002|Overall Study|Contraindication|1|||
27523904|NCT00722371|80112324|FG003|Overall Study|Contraindication|0|||
27523905|NCT00722371|80112325|FG004|Overall Study|Contraindication|0|||
27523906|NCT00722371|80112326|FG005|Overall Study|Contraindication|0|||
27523907|NCT00722371|80112327|FG006|Overall Study|Contraindication|0|||
27523908|NCT00722371|80112321|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
27523909|NCT00722371|80112322|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
27523910|NCT00722371|80112323|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
27523911|NCT00722371|80112324|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
27523912|NCT00722371|80112325|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
27523913|NCT00722371|80112326|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
27523914|NCT00722371|80112327|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
27523915|NCT00722371|80112321|FG000|Overall Study|Excluded medication|0|||
27523916|NCT00722371|80112322|FG001|Overall Study|Excluded medication|1|||
27523917|NCT00722371|80112323|FG002|Overall Study|Excluded medication|1|||
27523918|NCT00722371|80112324|FG003|Overall Study|Excluded medication|0|||
27523919|NCT00722371|80112325|FG004|Overall Study|Excluded medication|0|||
27523920|NCT00722371|80112326|FG005|Overall Study|Excluded medication|0|||
27523921|NCT00722371|80112327|FG006|Overall Study|Excluded medication|1|||
27523922|NCT00722371|80112321|FG000|Overall Study|Hyperglycemia|2|||
27523923|NCT00722371|80112322|FG001|Overall Study|Hyperglycemia|6|||
27621733|NCT04529538|80456110|FG003|Overall Study|Lost to Follow-up|0|||
27621734|NCT04529538|80456111|FG004|Overall Study|Lost to Follow-up|1|||
27621735|NCT04529538|80456112|FG005|Overall Study|Lost to Follow-up|1|||
27855087|NCT00380692|81302491|FG000|Study Period III - Open Label|Adverse Event|5|||
27855088|NCT00380692|81302492|FG001|Study Period III - Open Label|Adverse Event|3|||
27855089|NCT00380692|81302491|FG000|Study Period III - Open Label|Protocol Violation|0|||
27855090|NCT00380692|81302492|FG001|Study Period III - Open Label|Protocol Violation|0|||
27855091|NCT00380692|81302491|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
27855092|NCT00380692|81302492|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
27855093|NCT00380692|81302491|FG000|Study Period III - Open Label|Physician Decision|0|||
27855094|NCT00380692|81302492|FG001|Study Period III - Open Label|Physician Decision|3|||
27523924|NCT00722371|80112323|FG002|Overall Study|Hyperglycemia|4|||
27523925|NCT00722371|80112324|FG003|Overall Study|Hyperglycemia|2|||
27523926|NCT00722371|80112325|FG004|Overall Study|Hyperglycemia|5|||
27855095|NCT00380692|81302491|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
27523927|NCT00722371|80112326|FG005|Overall Study|Hyperglycemia|1|||
27523928|NCT00722371|80112327|FG006|Overall Study|Hyperglycemia|1|||
27523929|NCT00722371|80112321|FG000|Overall Study|Hypoglycemia|1|||
27523930|NCT00722371|80112322|FG001|Overall Study|Hypoglycemia|0|||
27523931|NCT00722371|80112323|FG002|Overall Study|Hypoglycemia|0|||
27523932|NCT00722371|80112324|FG003|Overall Study|Hypoglycemia|0|||
27621736|NCT04529538|80456113|FG006|Overall Study|Lost to Follow-up|2|||
27732439|NCT03124459|80846263|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
27732440|NCT03124459|80846264|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
27732441|NCT03124459|80846265|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
27732442|NCT03124459|80846260|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
27732443|NCT03124459|80846261|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
27855096|NCT00380692|81302492|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
27621737|NCT04529538|80456114|FG007|Overall Study|Lost to Follow-up|0|||
27621738|NCT04529538|80456107|FG000|Overall Study|Not eligible at enrollment|0|||
27621739|NCT04529538|80456108|FG001|Overall Study|Not eligible at enrollment|1|||
27621740|NCT04529538|80456109|FG002|Overall Study|Not eligible at enrollment|2|||
27523933|NCT00722371|80112325|FG004|Overall Study|Hypoglycemia|0|||
27523934|NCT00722371|80112326|FG005|Overall Study|Hypoglycemia|0|||
27523935|NCT00722371|80112327|FG006|Overall Study|Hypoglycemia|0|||
27523936|NCT00722371|80112321|FG000|Overall Study|Lack of Efficacy|4|||
27523937|NCT00722371|80112322|FG001|Overall Study|Lack of Efficacy|6|||
27855097|NCT00380692|81302491|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
27855098|NCT00380692|81302492|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
27523938|NCT00722371|80112323|FG002|Overall Study|Lack of Efficacy|6|||
27523939|NCT00722371|80112324|FG003|Overall Study|Lack of Efficacy|6|||
27523940|NCT00722371|80112325|FG004|Overall Study|Lack of Efficacy|2|||
27523941|NCT00722371|80112326|FG005|Overall Study|Lack of Efficacy|3|||
27523942|NCT00722371|80112327|FG006|Overall Study|Lack of Efficacy|0|||
27523943|NCT00722371|80112321|FG000|Overall Study|Lost to Follow-up|11|||
27523944|NCT00722371|80112322|FG001|Overall Study|Lost to Follow-up|14|||
27523945|NCT00722371|80112323|FG002|Overall Study|Lost to Follow-up|21|||
27523946|NCT00722371|80112324|FG003|Overall Study|Lost to Follow-up|13|||
27523947|NCT00722371|80112325|FG004|Overall Study|Lost to Follow-up|8|||
27523948|NCT00722371|80112326|FG005|Overall Study|Lost to Follow-up|16|||
27523949|NCT00722371|80112327|FG006|Overall Study|Lost to Follow-up|13|||
27523950|NCT00722371|80112321|FG000|Overall Study|Physician Decision|5|||
27523951|NCT00722371|80112322|FG001|Overall Study|Physician Decision|2|||
27523952|NCT00722371|80112323|FG002|Overall Study|Physician Decision|2|||
27523953|NCT00722371|80112324|FG003|Overall Study|Physician Decision|5|||
27523954|NCT00722371|80112325|FG004|Overall Study|Physician Decision|2|||
27523955|NCT00722371|80112326|FG005|Overall Study|Physician Decision|3|||
27523956|NCT00722371|80112327|FG006|Overall Study|Physician Decision|4|||
27523957|NCT00722371|80112321|FG000|Overall Study|Pregnancy|1|||
27523958|NCT00722371|80112322|FG001|Overall Study|Pregnancy|1|||
27523959|NCT00722371|80112323|FG002|Overall Study|Pregnancy|0|||
27523960|NCT00722371|80112324|FG003|Overall Study|Pregnancy|0|||
27523961|NCT00722371|80112325|FG004|Overall Study|Pregnancy|0|||
27523962|NCT00722371|80112326|FG005|Overall Study|Pregnancy|1|||
27523963|NCT00722371|80112327|FG006|Overall Study|Pregnancy|0|||
27523964|NCT00722371|80112321|FG000|Overall Study|Protocol Violation|6|||
27523965|NCT00722371|80112322|FG001|Overall Study|Protocol Violation|1|||
27523966|NCT00722371|80112323|FG002|Overall Study|Protocol Violation|0|||
27523967|NCT00722371|80112324|FG003|Overall Study|Protocol Violation|1|||
27523968|NCT00722371|80112325|FG004|Overall Study|Protocol Violation|4|||
27523969|NCT00722371|80112326|FG005|Overall Study|Protocol Violation|2|||
27523970|NCT00722371|80112327|FG006|Overall Study|Protocol Violation|1|||
27523971|NCT00722371|80112321|FG000|Overall Study|Withdrawal by Subject|18|||
27621741|NCT04529538|80456110|FG003|Overall Study|Not eligible at enrollment|1|||
27621742|NCT04529538|80456111|FG004|Overall Study|Not eligible at enrollment|0|||
27732444|NCT03124459|80846262|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
27855099|NCT00324649|81302498|FG000|Overall Study|Adverse Event|1|||
27855100|NCT00324649|81302499|FG001|Overall Study|Adverse Event|4|||
27621743|NCT04529538|80456112|FG005|Overall Study|Not eligible at enrollment|0|||
27523972|NCT00722371|80112322|FG001|Overall Study|Withdrawal by Subject|27|||
27523973|NCT00722371|80112323|FG002|Overall Study|Withdrawal by Subject|19|||
27523974|NCT00722371|80112324|FG003|Overall Study|Withdrawal by Subject|23|||
27523975|NCT00722371|80112325|FG004|Overall Study|Withdrawal by Subject|19|||
27523976|NCT00722371|80112326|FG005|Overall Study|Withdrawal by Subject|18|||
27523977|NCT00722371|80112327|FG006|Overall Study|Withdrawal by Subject|26|||
27910090|NCT00397189|81510006|FG000|3 Weeks Period|Withdrawal by Subject|13|||
27910091|NCT00397189|81510007|FG001|3 Weeks Period|Withdrawal by Subject|9|||
27910092|NCT00397189|81510006|FG000|3 Weeks Period|Physician Decision|0|||
27910093|NCT00397189|81510007|FG001|3 Weeks Period|Physician Decision|2|||
27910094|NCT00397189|81510006|FG000|3 Weeks Period|Protocol Violation|0|||
27910095|NCT00397189|81510007|FG001|3 Weeks Period|Protocol Violation|3|||
27910096|NCT00397189|81510006|FG000|3 Weeks Period|Other|0|||
27910097|NCT00397189|81510007|FG001|3 Weeks Period|Other|2|||
27910098|NCT00130689|81510008|FG000|Overall Study|Progressive Disease|29|||
27910099|NCT00130689|81510008|FG000|Overall Study|Death|1|||
27910100|NCT00130689|81510008|FG000|Overall Study|Clinical Deterioration|4|||
27910101|NCT00130689|81510008|FG000|Overall Study|Withdrawal by Subject|3|||
27910102|NCT00130689|81510008|FG000|Overall Study|Ineligible|6|||
27910103|NCT01556997|81510009|FG000|Overall Study|Adverse Event|10|||
27910104|NCT01556997|81510010|FG001|Overall Study|Adverse Event|12|||
27910105|NCT01556997|81510011|FG002|Overall Study|Adverse Event|12|||
27910106|NCT01556997|81510009|FG000|Overall Study|Lost to Follow-up|6|||
27910107|NCT01556997|81510010|FG001|Overall Study|Lost to Follow-up|6|||
27910108|NCT01556997|81510011|FG002|Overall Study|Lost to Follow-up|4|||
27910109|NCT01556997|81510009|FG000|Overall Study|Physician Decision|1|||
27910110|NCT01556997|81510010|FG001|Overall Study|Physician Decision|1|||
27910111|NCT01556997|81510011|FG002|Overall Study|Physician Decision|1|||
27910112|NCT01556997|81510009|FG000|Overall Study|Withdrawal by Subject|7|||
27910113|NCT01556997|81510010|FG001|Overall Study|Withdrawal by Subject|6|||
27910114|NCT01556997|81510011|FG002|Overall Study|Withdrawal by Subject|8|||
27910115|NCT01556997|81510009|FG000|Overall Study|Other|2|||
27523978|NCT01625260|80112328|FG000|Overall Study|Adverse Event|3|||
27523979|NCT01625260|80112329|FG001|Overall Study|Adverse Event|0|||
27855101|NCT00324649|81302498|FG000|Overall Study|Withdrawal by Subject|0|||
27523980|NCT01625260|80112328|FG000|Overall Study|Study Terminated by Investigator|2|||
27855102|NCT00324649|81302499|FG001|Overall Study|Withdrawal by Subject|1|||
27523981|NCT01625260|80112329|FG001|Overall Study|Study Terminated by Investigator|0|||
27523982|NCT01625260|80112328|FG000|Overall Study|Disease Progression|2|||
27523983|NCT01625260|80112329|FG001|Overall Study|Disease Progression|0|||
27523984|NCT01625260|80112328|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
27523985|NCT01625260|80112329|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
27523986|NCT03821844|80112330|FG000|Overall Study|Death|37|||
27523987|NCT03821844|80112331|FG001|Overall Study|Death|31|||
27523988|NCT03821844|80112330|FG000|Overall Study|Discharged|10|||
27523989|NCT03821844|80112331|FG001|Overall Study|Discharged|14|||
27523990|NCT03821844|80112330|FG000|Overall Study|Not present in facility at followup|2|||
27523991|NCT03821844|80112331|FG001|Overall Study|Not present in facility at followup|3|||
27523992|NCT03330002|80112332|FG000|Overall Study|Lost to Follow-up|15|||
27523993|NCT03330002|80112332|FG000|Overall Study|Death|7|||
27523994|NCT01879579|80112335|FG000|Overall Study|Phone incompatible with texting platform|3|||
27732445|NCT03124459|80846263|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
27855103|NCT00324649|81302498|FG000|Overall Study|Noncompliance|1|||
27855104|NCT00324649|81302499|FG001|Overall Study|Noncompliance|0|||
27855105|NCT03835221|81302500|FG000|Methafilcon A|Withdrawal by Subject|1|||
27855106|NCT01616953|81302505|FG000|Overall Study|Lost to Follow-up|1|||
27855107|NCT01616953|81302506|FG001|Overall Study|Lost to Follow-up|0|||
27855108|NCT01616953|81302505|FG000|Overall Study|lack of bone and soft tissue|1|||
27855109|NCT01616953|81302506|FG001|Overall Study|lack of bone and soft tissue|0|||
27855110|NCT00103311|81302507|FG000|Overall Study|Lost to Follow-up|1|||
27855111|NCT00103311|81302508|FG001|Overall Study|Lost to Follow-up|0|||
27855112|NCT00103311|81302507|FG000|Overall Study|Withdrawal by Subject|2|||
27855113|NCT00103311|81302508|FG001|Overall Study|Withdrawal by Subject|1|||
27855114|NCT00103311|81302507|FG000|Overall Study|Adverse Event|1|||
27855115|NCT00103311|81302508|FG001|Overall Study|Adverse Event|0|||
27855116|NCT01763684|81302509|FG000|Overall Study|Study terminated early due to low enrollment|126|||
27855117|NCT01763684|81302510|FG001|Overall Study|Study terminated early due to low enrollment|127|||
27855118|NCT01763684|81302509|FG000|Overall Study|Study surgery not performed|7|||
27855119|NCT01763684|81302510|FG001|Overall Study|Study surgery not performed|6|||
27910116|NCT01556997|81510010|FG001|Overall Study|Other|3|||
27855120|NCT03014180|81302511|FG000|Overall Study|Protocol Violation|2|||
27855121|NCT04319718|81302515|FG000|Overall Study|Adverse Event|0|||
27855122|NCT04319718|81302516|FG001|Overall Study|Adverse Event|2|||
27910117|NCT01556997|81510011|FG002|Overall Study|Other|7|||
27523995|NCT01879579|80112336|FG001|Overall Study|Phone incompatible with texting platform|0|||
27523996|NCT01879579|80112335|FG000|Overall Study|Did not enroll in texting platform|1|||
27523997|NCT01879579|80112336|FG001|Overall Study|Did not enroll in texting platform|0|||
27855123|NCT04319718|81302515|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
27910118|NCT02630563|81510012|FG000|Overall Study|Administrative|1|||
27910119|NCT01307891|81510013|FG000|Overall Study|Progressive Disease|3|||
27910120|NCT01307891|81510014|FG001|Overall Study|Progressive Disease|1|||
27910121|NCT00792909|81510015|FG000|Overall Study|Withdrawal by Subject|0|||
27910122|NCT00792909|81510016|FG001|Overall Study|Withdrawal by Subject|1|||
27732446|NCT03124459|80846264|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
27732447|NCT03124459|80846265|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
27732448|NCT03124459|80846260|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
27523998|NCT01879579|80112335|FG000|Overall Study|Did not initiate insulin treatment|1|||
27523999|NCT01879579|80112336|FG001|Overall Study|Did not initiate insulin treatment|0|||
27732449|NCT03124459|80846261|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
27732450|NCT03124459|80846262|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
27732451|NCT03124459|80846263|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
27732452|NCT03124459|80846264|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
27732453|NCT03124459|80846265|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
27732454|NCT03124459|80846260|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
27732455|NCT03124459|80846261|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
27732456|NCT03124459|80846262|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
27732457|NCT03124459|80846263|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
27732458|NCT03124459|80846264|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
27732459|NCT03124459|80846265|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
27732460|NCT00432809|80846268|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
27524000|NCT01879579|80112335|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
27732461|NCT00432809|80846269|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
27732462|NCT00432809|80846270|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
27732463|NCT00432809|80846268|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
27732464|NCT00432809|80846269|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
27732465|NCT00432809|80846270|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
27732466|NCT01705691|80846274|FG000|Overall Study|Death|1|||
27732467|NCT01705691|80846275|FG001|Overall Study|Death|2|||
27732468|NCT01705691|80846274|FG000|Overall Study|Withdrawal by Subject|1|||
27732469|NCT01705691|80846275|FG001|Overall Study|Withdrawal by Subject|2|||
27732470|NCT01705691|80846274|FG000|Overall Study|Lost to Follow-up|1|||
27524001|NCT01879579|80112336|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
27524002|NCT01879579|80112335|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
27524003|NCT01879579|80112336|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
27524004|NCT03709576|80112337|FG000|Overall Study|progression prior to enrollment|1|||
27524005|NCT02984943|80112339|FG000|Overall Study|Withdrawal by Subject|3|||
27524006|NCT02984943|80112339|FG000|Overall Study|Physician Decision|1|||
27524007|NCT02412488|80112340|FG000|Overall Study|Lost to Follow-up|10|||
27524008|NCT02412488|80112340|FG000|Overall Study|Withdrawal by Subject|5|||
27524009|NCT02412488|80112340|FG000|Overall Study|Physician Decision|1|||
27524010|NCT02412488|80112340|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
27524011|NCT02412488|80112340|FG000|Overall Study|Reveal LINQ explant|1|||
27524012|NCT00424255|80112345|FG000|Overall Study|Death|115|||
27524013|NCT00424255|80112346|FG001|Overall Study|Death|111|||
27524014|NCT00424255|80112345|FG000|Overall Study|Lost to Follow-up|26|||
27524015|NCT00424255|80112346|FG001|Overall Study|Lost to Follow-up|20|||
27524016|NCT00424255|80112345|FG000|Overall Study|Protocol Violation|0|||
27524017|NCT00424255|80112346|FG001|Overall Study|Protocol Violation|1|||
27524018|NCT00424255|80112345|FG000|Overall Study|Withdrawal by Subject|34|||
27524019|NCT00424255|80112346|FG001|Overall Study|Withdrawal by Subject|38|||
27524020|NCT00424255|80112345|FG000|Overall Study|Physician Decision|3|||
27524021|NCT00424255|80112346|FG001|Overall Study|Physician Decision|7|||
27524022|NCT00424255|80112345|FG000|Overall Study|Cognitive Disturbance|1|||
27524023|NCT00424255|80112346|FG001|Overall Study|Cognitive Disturbance|0|||
27524024|NCT00424255|80112345|FG000|Overall Study|Non-compliance by Participants|1|||
27524025|NCT00424255|80112346|FG001|Overall Study|Non-compliance by Participants|0|||
27524026|NCT00424255|80112345|FG000|Overall Study|Fatigue|1|||
27524027|NCT00424255|80112346|FG001|Overall Study|Fatigue|0|||
27524028|NCT00424255|80112345|FG000|Overall Study|Disease Progression|0|||
27524029|NCT00424255|80112346|FG001|Overall Study|Disease Progression|2|||
27732471|NCT01705691|80846275|FG001|Overall Study|Lost to Follow-up|1|||
27732472|NCT01705691|80846274|FG000|Overall Study|Other|0|||
27732473|NCT01705691|80846275|FG001|Overall Study|Other|1|||
27732474|NCT00702143|80846277|FG000|Overall Study|Lost to Follow-up|0|||
27732475|NCT00702143|80846278|FG001|Overall Study|Lost to Follow-up|0|||
27732476|NCT00702143|80846279|FG002|Overall Study|Lost to Follow-up|1|||
27732477|NCT04525703|80846288|FG000|Overall Study|Lost to Follow-up|6|||
27732478|NCT04525703|80846289|FG001|Overall Study|Lost to Follow-up|15|||
27732479|NCT04525703|80846290|FG002|Overall Study|Lost to Follow-up|8|||
27732480|NCT00891735|80846291|FG000|Overall Study|Adverse Event|2|||
27524030|NCT00424255|80112345|FG000|Overall Study|Sponsor Terminated Study|161|||
27524031|NCT00424255|80112346|FG001|Overall Study|Sponsor Terminated Study|167|||
27524032|NCT00043550|80112347|FG000|Overall Study|Withdrawal by Subject|22|||
27524033|NCT00043550|80112348|FG001|Overall Study|Withdrawal by Subject|12|||
27524034|NCT00043550|80112349|FG002|Overall Study|Withdrawal by Subject|20|||
27524035|NCT01104376|80112350|FG000|Overall Study|Withdrawal by Subject|15|||
27524036|NCT01104376|80112350|FG000|Overall Study|Consented but excluded after labs|13|||
27524037|NCT00409331|80112353|FG000|Overall Study|Physician Decision|1|||
27732481|NCT00891735|80846292|FG001|Overall Study|Adverse Event|0|||
27732482|NCT00891735|80846293|FG002|Overall Study|Adverse Event|2|||
27732483|NCT00891735|80846294|FG003|Overall Study|Adverse Event|0|||
27732484|NCT00891735|80846291|FG000|Overall Study|Death|8|||
27732485|NCT00891735|80846292|FG001|Overall Study|Death|5|||
27732486|NCT00891735|80846293|FG002|Overall Study|Death|4|||
27732487|NCT00891735|80846294|FG003|Overall Study|Death|5|||
27732488|NCT00891735|80846291|FG000|Overall Study|Lost to Follow-up|2|||
27732489|NCT00891735|80846292|FG001|Overall Study|Lost to Follow-up|2|||
27732490|NCT00891735|80846293|FG002|Overall Study|Lost to Follow-up|2|||
27732491|NCT00891735|80846294|FG003|Overall Study|Lost to Follow-up|2|||
27732492|NCT00891735|80846291|FG000|Overall Study|Physician's decision to withdraw patient|1|||
27732493|NCT00891735|80846292|FG001|Overall Study|Physician's decision to withdraw patient|0|||
27732494|NCT00891735|80846293|FG002|Overall Study|Physician's decision to withdraw patient|0|||
27732495|NCT00891735|80846294|FG003|Overall Study|Physician's decision to withdraw patient|0|||
27732496|NCT00891735|80846291|FG000|Overall Study|Patient's decision to withdraw|4|||
27732497|NCT00891735|80846292|FG001|Overall Study|Patient's decision to withdraw|9|||
27732498|NCT00891735|80846293|FG002|Overall Study|Patient's decision to withdraw|4|||
27732499|NCT00891735|80846294|FG003|Overall Study|Patient's decision to withdraw|8|||
27732500|NCT01243268|80846295|FG000|Overall Study|Lost to Follow-up|4|||
27732501|NCT01243268|80846295|FG000|Overall Study|Protocol Violation|51|||
27732502|NCT01243268|80846295|FG000|Overall Study|Deviation with contract date|7|||
27732503|NCT01243268|80846295|FG000|Overall Study|Duplicate subject|2|||
27732504|NCT00832819|80846296|FG000|Overall Study|Adverse Event|0|||
27732505|NCT00832819|80846297|FG001|Overall Study|Adverse Event|1|||
27732506|NCT00832819|80846298|FG002|Overall Study|Adverse Event|0|||
27732507|NCT00832819|80846296|FG000|Overall Study|Protocol Violation|0|||
27732508|NCT00832819|80846297|FG001|Overall Study|Protocol Violation|0|||
27732509|NCT00832819|80846298|FG002|Overall Study|Protocol Violation|1|||
27732510|NCT01245673|80846305|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
27732511|NCT00928070|80846312|FG000|Overall Study|Lost to Follow-up|1|||
27732512|NCT00928070|80846313|FG001|Overall Study|Lost to Follow-up|2|||
27732513|NCT00928070|80846312|FG000|Overall Study|Withdrawal by Subject|10|||
27732514|NCT00928070|80846313|FG001|Overall Study|Withdrawal by Subject|3|||
27732515|NCT00928070|80846312|FG000|Overall Study|Adverse Event|14|||
27732516|NCT00928070|80846313|FG001|Overall Study|Adverse Event|26|||
27732517|NCT00928070|80846312|FG000|Overall Study|Lack of Efficacy|9|||
27732518|NCT00928070|80846313|FG001|Overall Study|Lack of Efficacy|5|||
27732519|NCT00928070|80846312|FG000|Overall Study|Did not meet entrance criteria|16|||
27732520|NCT00928070|80846313|FG001|Overall Study|Did not meet entrance criteria|9|||
27732521|NCT00928070|80846312|FG000|Overall Study|Protocol Violation|6|||
27732522|NCT00928070|80846313|FG001|Overall Study|Protocol Violation|5|||
27732523|NCT00928070|80846312|FG000|Overall Study|Randomized but not treated|2|||
27732524|NCT00928070|80846313|FG001|Overall Study|Randomized but not treated|2|||
27732525|NCT00928070|80846312|FG000|Overall Study|Other|5|||
27732526|NCT00928070|80846313|FG001|Overall Study|Other|5|||
27732527|NCT02764541|80846316|FG000|Overall Study|Withdrawal by Subject|0|||
27732528|NCT02764541|80846317|FG001|Overall Study|Withdrawal by Subject|0|||
27732529|NCT02764541|80846318|FG002|Overall Study|Withdrawal by Subject|0|||
27732530|NCT02764541|80846319|FG003|Overall Study|Withdrawal by Subject|0|||
27732531|NCT02764541|80846320|FG004|Overall Study|Withdrawal by Subject|1|||
27732532|NCT02764541|80846321|FG005|Overall Study|Withdrawal by Subject|1|||
27732533|NCT02764541|80846322|FG006|Overall Study|Withdrawal by Subject|0|||
27732534|NCT02764541|80846323|FG007|Overall Study|Withdrawal by Subject|1|||
27732535|NCT02764541|80846316|FG000|Overall Study|Adverse Event|1|||
27732536|NCT02764541|80846317|FG001|Overall Study|Adverse Event|0|||
27732537|NCT02764541|80846318|FG002|Overall Study|Adverse Event|0|||
27732538|NCT02764541|80846319|FG003|Overall Study|Adverse Event|0|||
27732539|NCT02764541|80846320|FG004|Overall Study|Adverse Event|0|||
27732540|NCT02764541|80846321|FG005|Overall Study|Adverse Event|0|||
27621744|NCT04529538|80456113|FG006|Overall Study|Not eligible at enrollment|0|||
27732541|NCT02764541|80846322|FG006|Overall Study|Adverse Event|1|||
27732542|NCT02764541|80846323|FG007|Overall Study|Adverse Event|0|||
27732543|NCT02764541|80846316|FG000|Overall Study|Metastasis|1|||
27732544|NCT02764541|80846317|FG001|Overall Study|Metastasis|0|||
27732545|NCT02764541|80846318|FG002|Overall Study|Metastasis|0|||
27732546|NCT02764541|80846319|FG003|Overall Study|Metastasis|0|||
27732547|NCT02764541|80846320|FG004|Overall Study|Metastasis|0|||
27732548|NCT02764541|80846321|FG005|Overall Study|Metastasis|0|||
27732549|NCT02764541|80846322|FG006|Overall Study|Metastasis|0|||
27732550|NCT02764541|80846323|FG007|Overall Study|Metastasis|0|||
27732551|NCT02764541|80846316|FG000|Overall Study|Disease progression|1|||
27732552|NCT02764541|80846317|FG001|Overall Study|Disease progression|1|||
27732553|NCT02764541|80846318|FG002|Overall Study|Disease progression|0|||
27732554|NCT02764541|80846319|FG003|Overall Study|Disease progression|0|||
27732555|NCT02764541|80846320|FG004|Overall Study|Disease progression|0|||
27732556|NCT02764541|80846321|FG005|Overall Study|Disease progression|0|||
27732557|NCT02764541|80846322|FG006|Overall Study|Disease progression|0|||
27732558|NCT02764541|80846323|FG007|Overall Study|Disease progression|1|||
27524038|NCT00923364|80112354|FG000|Overall Study|Death|3|||
27524039|NCT00923364|80112355|FG001|Overall Study|Death|0|||
27524040|NCT00923364|80112354|FG000|Overall Study|Did not go to transplant|1|||
27524041|NCT00923364|80112355|FG001|Overall Study|Did not go to transplant|0|||
27524042|NCT00246571|80112358|FG000|Overall Study|Adverse Event|7|||
27524043|NCT00246571|80112359|FG001|Overall Study|Adverse Event|0|||
27524044|NCT00246571|80112358|FG000|Overall Study|Protocol Violation|0|||
27524045|NCT00246571|80112359|FG001|Overall Study|Protocol Violation|1|||
27524046|NCT00246571|80112358|FG000|Overall Study|Withdrawal by Subject|2|||
27524047|NCT00246571|80112359|FG001|Overall Study|Withdrawal by Subject|3|||
27524048|NCT00246571|80112358|FG000|Overall Study|Lack of Efficacy|84|||
27524049|NCT00246571|80112359|FG001|Overall Study|Lack of Efficacy|21|||
27524050|NCT00246571|80112358|FG000|Overall Study|Death|17|||
27524051|NCT00246571|80112359|FG001|Overall Study|Death|3|||
27524052|NCT00246571|80112358|FG000|Overall Study|Sponsor|0|||
27524053|NCT00246571|80112359|FG001|Overall Study|Sponsor|1|||
27910123|NCT00792909|81510017|FG002|Overall Study|Withdrawal by Subject|0|||
27910124|NCT01909804|81510018|FG000|Overall Study|Randomized but Never Treated|0|||
27910125|NCT01909804|81510019|FG001|Overall Study|Randomized but Never Treated|0|||
27910126|NCT01909804|81510020|FG002|Overall Study|Randomized but Never Treated|0|||
27910127|NCT01909804|81510021|FG003|Overall Study|Randomized but Never Treated|0|||
27910128|NCT01909804|81510022|FG004|Overall Study|Randomized but Never Treated|0|||
27910129|NCT01909804|81510023|FG005|Overall Study|Randomized but Never Treated|0|||
27910130|NCT01909804|81510024|FG006|Overall Study|Randomized but Never Treated|1|||
27910131|NCT01909804|81510025|FG007|Overall Study|Randomized but Never Treated|0|||
27910132|NCT01909804|81510026|FG008|Overall Study|Randomized but Never Treated|0|||
27910133|NCT01909804|81510027|FG009|Overall Study|Randomized but Never Treated|0|||
27910134|NCT01909804|81510028|FG010|Overall Study|Randomized but Never Treated|0|||
27910135|NCT01909804|81510029|FG011|Overall Study|Randomized but Never Treated|1|||
27910136|NCT01909804|81510018|FG000|Overall Study|Death|0|||
27910137|NCT01909804|81510019|FG001|Overall Study|Death|0|||
27910138|NCT01909804|81510020|FG002|Overall Study|Death|0|||
27910139|NCT01909804|81510021|FG003|Overall Study|Death|0|||
27910140|NCT01909804|81510022|FG004|Overall Study|Death|0|||
27910141|NCT01909804|81510023|FG005|Overall Study|Death|0|||
27910142|NCT01909804|81510024|FG006|Overall Study|Death|0|||
27910143|NCT01909804|81510025|FG007|Overall Study|Death|0|||
27910144|NCT01909804|81510026|FG008|Overall Study|Death|0|||
27524054|NCT00246571|80112358|FG000|Overall Study|Did not meet entrance criteria|2|||
27524055|NCT00246571|80112359|FG001|Overall Study|Did not meet entrance criteria|1|||
27524056|NCT00246571|80112358|FG000|Overall Study|Laboratory abnormalities|1|||
27524057|NCT00246571|80112359|FG001|Overall Study|Laboratory abnormalities|0|||
27524058|NCT00246571|80112358|FG000|Overall Study|Crossover participants|0|||
27524059|NCT00246571|80112359|FG001|Overall Study|Crossover participants|74|||
27524060|NCT03562767|80112360|FG000|Overall Study|Physician Decision|2|||
27524061|NCT03562767|80112361|FG001|Overall Study|Physician Decision|0|||
27524062|NCT03562767|80112362|FG002|Overall Study|Physician Decision|0|||
27524063|NCT03562767|80112360|FG000|Overall Study|Logistic Reason|1|||
27524064|NCT03562767|80112361|FG001|Overall Study|Logistic Reason|3|||
27524065|NCT03562767|80112362|FG002|Overall Study|Logistic Reason|0|||
27524066|NCT02216812|80112363|FG000|Overall Study|Lost to Follow-up|10|||
27524067|NCT02216812|80112364|FG001|Overall Study|Lost to Follow-up|5|||
27524068|NCT01576159|80112372|FG000|Overall Study|Withdrawal by Subject|0|||
27524069|NCT01576159|80112373|FG001|Overall Study|Withdrawal by Subject|1|||
27524070|NCT01576159|80112374|FG002|Overall Study|Withdrawal by Subject|0|||
27524071|NCT01576159|80112375|FG003|Overall Study|Withdrawal by Subject|0|||
27524072|NCT01576159|80112372|FG000|Overall Study|Physician Decision|0|||
27524073|NCT01576159|80112373|FG001|Overall Study|Physician Decision|0|||
27524074|NCT01576159|80112374|FG002|Overall Study|Physician Decision|1|||
27524075|NCT01576159|80112375|FG003|Overall Study|Physician Decision|0|||
27732559|NCT02764541|80846316|FG000|Overall Study|Protocol Violation|0|||
27910145|NCT01909804|81510027|FG009|Overall Study|Death|0|||
27910146|NCT01909804|81510028|FG010|Overall Study|Death|1|||
27910147|NCT01909804|81510029|FG011|Overall Study|Death|0|||
27910148|NCT01909804|81510018|FG000|Overall Study|Lack of Efficacy|4|||
27910149|NCT01909804|81510019|FG001|Overall Study|Lack of Efficacy|1|||
27524076|NCT01576159|80112372|FG000|Overall Study|Lost to Follow-up|0|||
27524077|NCT01576159|80112373|FG001|Overall Study|Lost to Follow-up|0|||
27524078|NCT01576159|80112374|FG002|Overall Study|Lost to Follow-up|0|||
27524079|NCT01576159|80112375|FG003|Overall Study|Lost to Follow-up|1|||
27524080|NCT01576159|80112372|FG000|Overall Study|Protocol Violation|1|||
27524081|NCT01576159|80112373|FG001|Overall Study|Protocol Violation|0|||
27524082|NCT01576159|80112374|FG002|Overall Study|Protocol Violation|0|||
27524083|NCT01576159|80112375|FG003|Overall Study|Protocol Violation|0|||
27524084|NCT00843778|80112376|FG000|Overall Study|Adverse Event|15|||
27524085|NCT00843778|80112376|FG000|Overall Study|Lack of Efficacy|14|||
27524086|NCT00843778|80112376|FG000|Overall Study|Loss of efficacy|2|||
27524087|NCT00843778|80112376|FG000|Overall Study|Withdrawal by Subject|4|||
27910150|NCT01909804|81510020|FG002|Overall Study|Lack of Efficacy|0|||
27524088|NCT03007888|80112377|FG000|First Intervention (14 Days)|Adverse Event|1|||
27524089|NCT03007888|80112378|FG001|First Intervention (14 Days)|Adverse Event|0|||
27524090|NCT02217527|80112383|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
27524091|NCT02217527|80112384|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
27524092|NCT02217527|80112383|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
27524093|NCT02217527|80112384|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
27910151|NCT01909804|81510021|FG003|Overall Study|Lack of Efficacy|0|||
27910152|NCT01909804|81510022|FG004|Overall Study|Lack of Efficacy|7|||
27524094|NCT01659554|80112385|FG000|Overall Study|Study Termination|4|||
27524095|NCT00807573|80112391|FG000|Overall Study|Withdrawal by Subject|1|||
27524096|NCT00807573|80112391|FG000|Overall Study|Adverse Event|1|||
27524097|NCT02312687|80112393|FG000|Overall Study|Other, Not Specified|1|||
27524098|NCT02009384|80112394|FG000|Overall Study|Death|2|||
27524099|NCT01658813|80112395|FG000|Overall Study|Disease progression|3|||
27524100|NCT01262352|80112401|FG000|Period 1|Illness after randomization|1|||
27524101|NCT01262352|80112402|FG001|Period 1|Illness after randomization|0|||
27524102|NCT01262352|80112401|FG000|Washout|Adverse Event|1|||
27524103|NCT01262352|80112402|FG001|Washout|Adverse Event|1|||
27524104|NCT01262352|80112401|FG000|Washout|Extended Washout|0|||
27524105|NCT01262352|80112402|FG001|Washout|Extended Washout|1|||
27524106|NCT03011892|80112403|FG000|Double Blind (DB) Period|Adverse Event|0|||
27524107|NCT03011892|80112404|FG001|Double Blind (DB) Period|Adverse Event|1|||
27524108|NCT03011892|80112405|FG002|Double Blind (DB) Period|Adverse Event|1|||
27524109|NCT03011892|80112406|FG003|Double Blind (DB) Period|Adverse Event|0|||
27524110|NCT03011892|80112407|FG004|Double Blind (DB) Period|Adverse Event|0|||
27524111|NCT03011892|80112408|FG005|Double Blind (DB) Period|Adverse Event|0|||
27524112|NCT03011892|80112409|FG006|Double Blind (DB) Period|Adverse Event|0|||
27524113|NCT03011892|80112410|FG007|Double Blind (DB) Period|Adverse Event|0|||
27524114|NCT03011892|80112411|FG008|Double Blind (DB) Period|Adverse Event|0|||
27524115|NCT03011892|80112412|FG009|Double Blind (DB) Period|Adverse Event|0|||
27524116|NCT03011892|80112413|FG010|Double Blind (DB) Period|Adverse Event|0|||
27524117|NCT03011892|80112414|FG011|Double Blind (DB) Period|Adverse Event|0|||
27524118|NCT03011892|80112403|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
27524119|NCT03011892|80112404|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
27524120|NCT03011892|80112405|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
27524121|NCT03011892|80112406|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
27524122|NCT03011892|80112407|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
27524123|NCT03011892|80112408|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
27524124|NCT03011892|80112409|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
27524125|NCT03011892|80112410|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
27524126|NCT03011892|80112411|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
27524127|NCT03011892|80112412|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
27524128|NCT03011892|80112413|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
27524129|NCT03011892|80112414|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
27524130|NCT03011892|80112403|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
27524131|NCT03011892|80112404|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
27524132|NCT03011892|80112405|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
27524133|NCT03011892|80112406|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
27524134|NCT03011892|80112407|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
27524135|NCT03011892|80112408|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
27524136|NCT03011892|80112409|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
27524137|NCT03011892|80112410|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
27524138|NCT03011892|80112411|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
27524139|NCT03011892|80112412|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
27524140|NCT03011892|80112413|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
27524141|NCT03011892|80112414|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
27524142|NCT03011892|80112403|FG000|Double Blind (DB) Period|Other|1|||
27524143|NCT03011892|80112404|FG001|Double Blind (DB) Period|Other|1|||
27524144|NCT03011892|80112405|FG002|Double Blind (DB) Period|Other|1|||
27524145|NCT03011892|80112406|FG003|Double Blind (DB) Period|Other|0|||
27524146|NCT03011892|80112407|FG004|Double Blind (DB) Period|Other|1|||
27855124|NCT04319718|81302516|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
27524147|NCT03011892|80112408|FG005|Double Blind (DB) Period|Other|0|||
27855125|NCT04647721|81302517|FG000|Overall Study|Withdrawal by Subject|0|||
27855126|NCT04647721|81302518|FG001|Overall Study|Withdrawal by Subject|2|||
27855127|NCT04647721|81302517|FG000|Overall Study|Lost to Follow-up|2|||
27910153|NCT01909804|81510023|FG005|Overall Study|Lack of Efficacy|3|||
27910154|NCT01909804|81510024|FG006|Overall Study|Lack of Efficacy|1|||
27910155|NCT01909804|81510025|FG007|Overall Study|Lack of Efficacy|1|||
27524148|NCT03011892|80112409|FG006|Double Blind (DB) Period|Other|0|||
27524149|NCT03011892|80112410|FG007|Double Blind (DB) Period|Other|0|||
27524150|NCT03011892|80112411|FG008|Double Blind (DB) Period|Other|0|||
27524151|NCT03011892|80112412|FG009|Double Blind (DB) Period|Other|0|||
27621745|NCT04529538|80456114|FG007|Overall Study|Not eligible at enrollment|1|||
27910156|NCT01909804|81510026|FG008|Overall Study|Lack of Efficacy|0|||
27524152|NCT03011892|80112413|FG010|Double Blind (DB) Period|Other|0|||
27524153|NCT03011892|80112414|FG011|Double Blind (DB) Period|Other|0|||
27524154|NCT03011892|80112403|FG000|Double Blind (DB) Period|Physician Decision|1|||
27524155|NCT03011892|80112404|FG001|Double Blind (DB) Period|Physician Decision|0|||
27524156|NCT03011892|80112405|FG002|Double Blind (DB) Period|Physician Decision|1|||
27524157|NCT03011892|80112406|FG003|Double Blind (DB) Period|Physician Decision|0|||
27621746|NCT04529538|80456107|FG000|Overall Study|Withdrawal by Subject|0|||
27621747|NCT04529538|80456108|FG001|Overall Study|Withdrawal by Subject|1|||
27621748|NCT04529538|80456109|FG002|Overall Study|Withdrawal by Subject|1|||
27621749|NCT04529538|80456110|FG003|Overall Study|Withdrawal by Subject|2|||
27621750|NCT04529538|80456111|FG004|Overall Study|Withdrawal by Subject|0|||
27621751|NCT04529538|80456112|FG005|Overall Study|Withdrawal by Subject|2|||
27621752|NCT04529538|80456113|FG006|Overall Study|Withdrawal by Subject|3|||
27621753|NCT04529538|80456114|FG007|Overall Study|Withdrawal by Subject|0|||
27621754|NCT04529538|80456107|FG000|Overall Study|Other|0|||
27621755|NCT04529538|80456108|FG001|Overall Study|Other|1|||
27621756|NCT04529538|80456109|FG002|Overall Study|Other|0|||
27621757|NCT04529538|80456110|FG003|Overall Study|Other|0|||
27621758|NCT04529538|80456111|FG004|Overall Study|Other|0|||
27621759|NCT04529538|80456112|FG005|Overall Study|Other|0|||
27621760|NCT04529538|80456113|FG006|Overall Study|Other|0|||
27732560|NCT02764541|80846317|FG001|Overall Study|Protocol Violation|0|||
27732561|NCT02764541|80846318|FG002|Overall Study|Protocol Violation|0|||
27732562|NCT02764541|80846319|FG003|Overall Study|Protocol Violation|1|||
27732563|NCT02764541|80846320|FG004|Overall Study|Protocol Violation|0|||
27732564|NCT02764541|80846321|FG005|Overall Study|Protocol Violation|1|||
27732565|NCT02764541|80846322|FG006|Overall Study|Protocol Violation|0|||
27732566|NCT02764541|80846323|FG007|Overall Study|Protocol Violation|0|||
27732567|NCT02764541|80846316|FG000|Overall Study|Physician Decision|0|||
27732568|NCT02764541|80846317|FG001|Overall Study|Physician Decision|0|||
27732569|NCT02764541|80846318|FG002|Overall Study|Physician Decision|0|||
27732570|NCT02764541|80846319|FG003|Overall Study|Physician Decision|1|||
27732571|NCT02764541|80846320|FG004|Overall Study|Physician Decision|0|||
27732572|NCT02764541|80846321|FG005|Overall Study|Physician Decision|0|||
27732573|NCT02764541|80846322|FG006|Overall Study|Physician Decision|0|||
27732574|NCT02764541|80846323|FG007|Overall Study|Physician Decision|1|||
27732575|NCT02764541|80846316|FG000|Overall Study|Three Cycles completed before surgery|0|||
27732576|NCT02764541|80846317|FG001|Overall Study|Three Cycles completed before surgery|0|||
27732577|NCT02764541|80846318|FG002|Overall Study|Three Cycles completed before surgery|0|||
27732578|NCT02764541|80846319|FG003|Overall Study|Three Cycles completed before surgery|1|||
27732579|NCT02764541|80846320|FG004|Overall Study|Three Cycles completed before surgery|0|||
27732580|NCT02764541|80846321|FG005|Overall Study|Three Cycles completed before surgery|0|||
27732581|NCT02764541|80846322|FG006|Overall Study|Three Cycles completed before surgery|0|||
27732582|NCT02764541|80846323|FG007|Overall Study|Three Cycles completed before surgery|0|||
27732583|NCT02764541|80846316|FG000|Overall Study|Patient Compliance|0|||
27732584|NCT02764541|80846317|FG001|Overall Study|Patient Compliance|0|||
27732585|NCT02764541|80846318|FG002|Overall Study|Patient Compliance|1|||
27732586|NCT02764541|80846319|FG003|Overall Study|Patient Compliance|0|||
27732587|NCT02764541|80846320|FG004|Overall Study|Patient Compliance|0|||
27732588|NCT02764541|80846321|FG005|Overall Study|Patient Compliance|0|||
27732589|NCT02764541|80846322|FG006|Overall Study|Patient Compliance|0|||
27732590|NCT02764541|80846323|FG007|Overall Study|Patient Compliance|0|||
27732591|NCT02764541|80846316|FG000|Overall Study|Death|0|||
27732592|NCT02764541|80846317|FG001|Overall Study|Death|0|||
27524158|NCT03011892|80112407|FG004|Double Blind (DB) Period|Physician Decision|0|||
27524159|NCT03011892|80112408|FG005|Double Blind (DB) Period|Physician Decision|0|||
27524160|NCT03011892|80112409|FG006|Double Blind (DB) Period|Physician Decision|0|||
27524161|NCT03011892|80112410|FG007|Double Blind (DB) Period|Physician Decision|0|||
27524162|NCT03011892|80112411|FG008|Double Blind (DB) Period|Physician Decision|0|||
27524163|NCT03011892|80112412|FG009|Double Blind (DB) Period|Physician Decision|0|||
27524164|NCT03011892|80112413|FG010|Double Blind (DB) Period|Physician Decision|0|||
27524165|NCT03011892|80112414|FG011|Double Blind (DB) Period|Physician Decision|0|||
27524166|NCT03011892|80112403|FG000|Double Blind (DB) Period|Pregnancy|0|||
27524167|NCT03011892|80112404|FG001|Double Blind (DB) Period|Pregnancy|0|||
27524168|NCT03011892|80112405|FG002|Double Blind (DB) Period|Pregnancy|0|||
27524169|NCT03011892|80112406|FG003|Double Blind (DB) Period|Pregnancy|0|||
27524170|NCT03011892|80112407|FG004|Double Blind (DB) Period|Pregnancy|1|||
27524171|NCT03011892|80112408|FG005|Double Blind (DB) Period|Pregnancy|0|||
27524172|NCT03011892|80112409|FG006|Double Blind (DB) Period|Pregnancy|0|||
27621761|NCT04529538|80456114|FG007|Overall Study|Other|0|||
27621762|NCT04529538|80456107|FG000|Overall Study|Adverse Event|0|||
27621763|NCT04529538|80456108|FG001|Overall Study|Adverse Event|0|||
27732593|NCT02764541|80846318|FG002|Overall Study|Death|0|||
27732594|NCT02764541|80846319|FG003|Overall Study|Death|0|||
27732595|NCT02764541|80846320|FG004|Overall Study|Death|0|||
27732596|NCT02764541|80846321|FG005|Overall Study|Death|0|||
27732597|NCT02764541|80846322|FG006|Overall Study|Death|1|||
27621764|NCT04529538|80456109|FG002|Overall Study|Adverse Event|0|||
27621765|NCT04529538|80456110|FG003|Overall Study|Adverse Event|1|||
27910157|NCT01909804|81510027|FG009|Overall Study|Lack of Efficacy|1|||
27524173|NCT03011892|80112410|FG007|Double Blind (DB) Period|Pregnancy|0|||
27524174|NCT03011892|80112411|FG008|Double Blind (DB) Period|Pregnancy|0|||
27621766|NCT04529538|80456111|FG004|Overall Study|Adverse Event|0|||
27621767|NCT04529538|80456112|FG005|Overall Study|Adverse Event|0|||
27621768|NCT04529538|80456113|FG006|Overall Study|Adverse Event|0|||
27621769|NCT04529538|80456114|FG007|Overall Study|Adverse Event|0|||
27621770|NCT04529538|80456107|FG000|Overall Study|Protocol Deviation|0|||
27621771|NCT04529538|80456108|FG001|Overall Study|Protocol Deviation|0|||
27621772|NCT04529538|80456109|FG002|Overall Study|Protocol Deviation|0|||
27621773|NCT04529538|80456110|FG003|Overall Study|Protocol Deviation|1|||
27621774|NCT04529538|80456111|FG004|Overall Study|Protocol Deviation|0|||
27621775|NCT04529538|80456112|FG005|Overall Study|Protocol Deviation|0|||
27621776|NCT04529538|80456113|FG006|Overall Study|Protocol Deviation|0|||
27621777|NCT04529538|80456114|FG007|Overall Study|Protocol Deviation|0|||
27621778|NCT04529538|80456107|FG000|Overall Study|Physician Decision|0|||
27621779|NCT04529538|80456108|FG001|Overall Study|Physician Decision|0|||
27621780|NCT04529538|80456109|FG002|Overall Study|Physician Decision|0|||
27621781|NCT04529538|80456110|FG003|Overall Study|Physician Decision|0|||
27621782|NCT04529538|80456111|FG004|Overall Study|Physician Decision|0|||
27621783|NCT04529538|80456112|FG005|Overall Study|Physician Decision|1|||
27621784|NCT04529538|80456113|FG006|Overall Study|Physician Decision|0|||
27621785|NCT04529538|80456114|FG007|Overall Study|Physician Decision|1|||
27621786|NCT01767909|80456116|FG000|Overall Study|Withdrawal by Subject|4|||
27621787|NCT01767909|80456117|FG001|Overall Study|Withdrawal by Subject|7|||
27621788|NCT01767909|80456116|FG000|Overall Study|Adverse Event|3|||
27621789|NCT01767909|80456117|FG001|Overall Study|Adverse Event|1|||
27621790|NCT01767909|80456116|FG000|Overall Study|Withdrawal by Study Partner|3|||
27621791|NCT01767909|80456117|FG001|Overall Study|Withdrawal by Study Partner|1|||
27621792|NCT01767909|80456116|FG000|Overall Study|Non-Compliance|2|||
27621793|NCT01767909|80456117|FG001|Overall Study|Non-Compliance|0|||
27621794|NCT01767909|80456116|FG000|Overall Study|Perceived Lack of Efficacy|1|||
27621795|NCT01767909|80456117|FG001|Overall Study|Perceived Lack of Efficacy|0|||
27621796|NCT01767909|80456116|FG000|Overall Study|Investigator Recommendation|0|||
27621797|NCT01767909|80456117|FG001|Overall Study|Investigator Recommendation|1|||
27621798|NCT01767909|80456116|FG000|Overall Study|Lost to Follow-up|0|||
27621799|NCT01767909|80456117|FG001|Overall Study|Lost to Follow-up|1|||
27621800|NCT01767909|80456116|FG000|Overall Study|LP uncessessful|0|||
27621801|NCT01767909|80456117|FG001|Overall Study|LP uncessessful|1|||
27621802|NCT04482855|80456122|FG000|Overall Study|Lost to Follow-up|1|||
27621803|NCT04482855|80456123|FG001|Overall Study|Lost to Follow-up|0|||
27621804|NCT04482855|80456122|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
27524175|NCT03011892|80112412|FG009|Double Blind (DB) Period|Pregnancy|0|||
27524176|NCT03011892|80112413|FG010|Double Blind (DB) Period|Pregnancy|0|||
27524177|NCT03011892|80112414|FG011|Double Blind (DB) Period|Pregnancy|0|||
27524178|NCT03011892|80112403|FG000|Double Blind (DB) Period|Protocol Violation|1|||
27524179|NCT03011892|80112404|FG001|Double Blind (DB) Period|Protocol Violation|0|||
27524180|NCT03011892|80112405|FG002|Double Blind (DB) Period|Protocol Violation|0|||
27524181|NCT03011892|80112406|FG003|Double Blind (DB) Period|Protocol Violation|0|||
27524182|NCT03011892|80112407|FG004|Double Blind (DB) Period|Protocol Violation|0|||
27524183|NCT03011892|80112408|FG005|Double Blind (DB) Period|Protocol Violation|0|||
27524184|NCT03011892|80112409|FG006|Double Blind (DB) Period|Protocol Violation|0|||
27524185|NCT03011892|80112410|FG007|Double Blind (DB) Period|Protocol Violation|0|||
27524186|NCT03011892|80112411|FG008|Double Blind (DB) Period|Protocol Violation|0|||
27524187|NCT03011892|80112412|FG009|Double Blind (DB) Period|Protocol Violation|0|||
27524188|NCT03011892|80112413|FG010|Double Blind (DB) Period|Protocol Violation|0|||
27524189|NCT03011892|80112414|FG011|Double Blind (DB) Period|Protocol Violation|0|||
27524190|NCT03011892|80112403|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
27524191|NCT03011892|80112404|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
27524192|NCT03011892|80112405|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
27524193|NCT03011892|80112406|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
27524194|NCT03011892|80112407|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
27524195|NCT03011892|80112408|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
27524196|NCT03011892|80112409|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
27621805|NCT04482855|80456123|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
27621806|NCT04482855|80456122|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
27621807|NCT04482855|80456123|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
27621808|NCT02573493|80456124|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
27621809|NCT02573493|80456125|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
27621810|NCT02573493|80456126|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
27732598|NCT02764541|80846323|FG007|Overall Study|Death|0|||
27621811|NCT02573493|80456127|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
27621812|NCT04170023|80456128|FG000|LTE Period|Withdrawal by Subject|1|||
27621813|NCT04170023|80456129|FG001|LTE Period|Withdrawal by Subject|0|||
27621814|NCT04170023|80456130|FG002|LTE Period|Withdrawal by Subject|0|||
27621815|NCT04170023|80456128|FG000|LTE Period|Study Termination|11|||
27621816|NCT04170023|80456129|FG001|LTE Period|Study Termination|11|||
27621817|NCT04170023|80456130|FG002|LTE Period|Study Termination|5|||
27621818|NCT04254679|80456131|FG000|Overall Study|Protocol Violation|1|||
27621819|NCT04254679|80456132|FG001|Overall Study|Protocol Violation|1|||
27621820|NCT04254679|80456131|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
27621821|NCT04254679|80456132|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
27621822|NCT02328014|80456133|FG000|Overall Study|Adverse Event|1|||
27621823|NCT02328014|80456134|FG001|Overall Study|Adverse Event|0|||
27621824|NCT02328014|80456135|FG002|Overall Study|Adverse Event|0|||
27621825|NCT02328014|80456136|FG003|Overall Study|Adverse Event|1|||
27621826|NCT02328014|80456133|FG000|Overall Study|Death|0|||
27621827|NCT02328014|80456134|FG001|Overall Study|Death|0|||
27621828|NCT02328014|80456135|FG002|Overall Study|Death|0|||
27621829|NCT02328014|80456136|FG003|Overall Study|Death|4|||
27621830|NCT02328014|80456133|FG000|Overall Study|Physician Decision|0|||
27621831|NCT02328014|80456134|FG001|Overall Study|Physician Decision|0|||
27621832|NCT02328014|80456135|FG002|Overall Study|Physician Decision|0|||
27621833|NCT02328014|80456136|FG003|Overall Study|Physician Decision|1|||
27621834|NCT02328014|80456133|FG000|Overall Study|Disease Progression|1|||
27621835|NCT02328014|80456134|FG001|Overall Study|Disease Progression|0|||
27621836|NCT02328014|80456135|FG002|Overall Study|Disease Progression|1|||
27621837|NCT02328014|80456136|FG003|Overall Study|Disease Progression|3|||
27910158|NCT01909804|81510028|FG010|Overall Study|Lack of Efficacy|0|||
27910159|NCT01909804|81510029|FG011|Overall Study|Lack of Efficacy|1|||
27910160|NCT01909804|81510018|FG000|Overall Study|Withdrew Consent|0|||
27910161|NCT01909804|81510019|FG001|Overall Study|Withdrew Consent|0|||
27621838|NCT02328014|80456133|FG000|Overall Study|Study Terminated by Sponsor|4|||
27621839|NCT02328014|80456134|FG001|Overall Study|Study Terminated by Sponsor|1|||
27855128|NCT04647721|81302518|FG001|Overall Study|Lost to Follow-up|0|||
27855129|NCT01287039|81302520|FG000|Overall Study|Noncompliance with study procedures|0|||
27855130|NCT01287039|81302521|FG001|Overall Study|Noncompliance with study procedures|1|||
27855131|NCT01287039|81302520|FG000|Overall Study|Change of location/residence|0|||
27855132|NCT01287039|81302521|FG001|Overall Study|Change of location/residence|3|||
27855133|NCT01287039|81302520|FG000|Overall Study|Elective surgery|0|||
27855134|NCT01287039|81302521|FG001|Overall Study|Elective surgery|1|||
27855135|NCT01287039|81302520|FG000|Overall Study|Protocol Violation|2|||
27855136|NCT01287039|81302521|FG001|Overall Study|Protocol Violation|3|||
27855137|NCT01287039|81302520|FG000|Overall Study|Excluded medication taken|1|||
27855138|NCT01287039|81302521|FG001|Overall Study|Excluded medication taken|0|||
27855139|NCT01287039|81302520|FG000|Overall Study|Noncompliance with study medication|0|||
27855140|NCT01287039|81302521|FG001|Overall Study|Noncompliance with study medication|1|||
27855141|NCT01287039|81302520|FG000|Overall Study|Problem with travel|0|||
27855142|NCT01287039|81302521|FG001|Overall Study|Problem with travel|1|||
27855143|NCT01287039|81302520|FG000|Overall Study|Death|1|||
27855144|NCT01287039|81302521|FG001|Overall Study|Death|0|||
27855145|NCT01287039|81302520|FG000|Overall Study|Change of residence|1|||
27855146|NCT01287039|81302521|FG001|Overall Study|Change of residence|0|||
27855147|NCT01287039|81302520|FG000|Overall Study|Adverse Event|7|||
27855148|NCT01287039|81302521|FG001|Overall Study|Adverse Event|4|||
27855149|NCT01287039|81302520|FG000|Overall Study|Withdrawal by Subject|14|||
27855150|NCT01287039|81302521|FG001|Overall Study|Withdrawal by Subject|11|||
27855151|NCT01287039|81302520|FG000|Overall Study|Lost to Follow-up|3|||
27855152|NCT01287039|81302521|FG001|Overall Study|Lost to Follow-up|2|||
27855153|NCT00160641|81302522|FG000|Overall Study|Adverse Event|102|||
27855154|NCT00160641|81302522|FG000|Overall Study|Withdrawal by Subject|87|||
27855155|NCT00160641|81302522|FG000|Overall Study|Lost to Follow-up|8|||
27855156|NCT00160641|81302522|FG000|Overall Study|Lack of Efficacy|12|||
27855157|NCT00160641|81302522|FG000|Overall Study|Protocol Violation|3|||
27855158|NCT00160641|81302522|FG000|Overall Study|Other|9|||
27855159|NCT01345175|81302528|FG000|Overall Study|Physician Decision|0|||
27855160|NCT01345175|81302529|FG001|Overall Study|Physician Decision|1|||
27855161|NCT01345175|81302528|FG000|Overall Study|Withdrawal by Subject|1|||
27621840|NCT02328014|80456135|FG002|Overall Study|Study Terminated by Sponsor|1|||
27621841|NCT02328014|80456136|FG003|Overall Study|Study Terminated by Sponsor|0|||
27621842|NCT02328014|80456133|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
27621843|NCT02328014|80456134|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
27621844|NCT02328014|80456135|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
27855162|NCT01345175|81302529|FG001|Overall Study|Withdrawal by Subject|1|||
27855163|NCT01345175|81302528|FG000|Overall Study|Failed to complete BFI|3|||
27855164|NCT01345175|81302529|FG001|Overall Study|Failed to complete BFI|2|||
27855165|NCT01345175|81302528|FG000|Overall Study|Stopped taking medication|2|||
27855166|NCT01345175|81302529|FG001|Overall Study|Stopped taking medication|2|||
27621845|NCT02328014|80456136|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
27621846|NCT02328014|80456133|FG000|Overall Study|Withdrawal by Subject|0|||
27621847|NCT02328014|80456134|FG001|Overall Study|Withdrawal by Subject|0|||
27621848|NCT02328014|80456135|FG002|Overall Study|Withdrawal by Subject|0|||
27621849|NCT02328014|80456136|FG003|Overall Study|Withdrawal by Subject|1|||
27621850|NCT04649359|80457766|FG000|Overall Study|Withdrawal by Subject|7|||
27621851|NCT04649359|80457767|FG001|Overall Study|Withdrawal by Subject|7|||
27910162|NCT01909804|81510020|FG002|Overall Study|Withdrew Consent|0|||
27910163|NCT01909804|81510021|FG003|Overall Study|Withdrew Consent|0|||
27910164|NCT01909804|81510022|FG004|Overall Study|Withdrew Consent|1|||
27910165|NCT01909804|81510023|FG005|Overall Study|Withdrew Consent|1|||
27910166|NCT01909804|81510024|FG006|Overall Study|Withdrew Consent|0|||
27910167|NCT01909804|81510025|FG007|Overall Study|Withdrew Consent|0|||
27910168|NCT01909804|81510026|FG008|Overall Study|Withdrew Consent|0|||
27910169|NCT01909804|81510027|FG009|Overall Study|Withdrew Consent|0|||
27621852|NCT04649359|80457766|FG000|Overall Study|Death|41|||
27621853|NCT04649359|80457767|FG001|Overall Study|Death|26|||
27621854|NCT04649359|80457766|FG000|Overall Study|Ongoing in the study|75|||
27621855|NCT04649359|80457767|FG001|Overall Study|Ongoing in the study|31|||
27621856|NCT02362035|80457768|FG000|Overall Study|Death|67|||
27621857|NCT02362035|80457768|FG000|Overall Study|Lost to Follow-up|3|||
27621858|NCT02362035|80457768|FG000|Overall Study|Adverse Event|1|||
27621859|NCT02362035|80457768|FG000|Overall Study|Physician Decision|1|||
27621860|NCT02362035|80457768|FG000|Overall Study|Subject started another cancer therapy|10|||
27621861|NCT02362035|80457768|FG000|Overall Study|Study terminated by sponsor|45|||
27621862|NCT02362035|80457768|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
27621863|NCT02362035|80457768|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
27621864|NCT02362035|80457768|FG000|Overall Study|Disease progression|11|||
27621865|NCT02362035|80457768|FG000|Overall Study|Withdrawal by Subject|20|||
27621866|NCT03976362|80457769|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
27621867|NCT03976362|80457770|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
27621868|NCT03976362|80457771|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
27621869|NCT03976362|80457769|FG000|Induction Phase|Death|62|||
27621870|NCT03976362|80457770|FG001|Induction Phase|Death|0|||
27621871|NCT03976362|80457771|FG002|Induction Phase|Death|0|||
27621872|NCT03976362|80457769|FG000|Maintenance Phase|Participants Ongoing|0|||
27621873|NCT03976362|80457770|FG001|Maintenance Phase|Participants Ongoing|106|||
27621874|NCT03976362|80457771|FG002|Maintenance Phase|Participants Ongoing|103|||
27621875|NCT03976362|80457769|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27621876|NCT03976362|80457770|FG001|Maintenance Phase|Withdrawal by Subject|4|||
27621877|NCT03976362|80457771|FG002|Maintenance Phase|Withdrawal by Subject|4|||
27621878|NCT03976362|80457769|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
27621879|NCT03976362|80457770|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
27621880|NCT03976362|80457771|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
27621881|NCT03976362|80457769|FG000|Maintenance Phase|Death|0|||
27621882|NCT03976362|80457770|FG001|Maintenance Phase|Death|186|||
27621883|NCT03976362|80457771|FG002|Maintenance Phase|Death|187|||
27621884|NCT04949399|80457772|FG000|Overall Study|Lost to Follow-up|11|||
27621885|NCT04949399|80457773|FG001|Overall Study|Lost to Follow-up|6|||
27621886|NCT04949399|80457772|FG000|Overall Study|Withdrawal by Subject|2|||
27621887|NCT04949399|80457773|FG001|Overall Study|Withdrawal by Subject|3|||
27621888|NCT00688688|80457774|FG000|Overall Study|Eligibility criterion not met|7|||
27621889|NCT00688688|80457775|FG001|Overall Study|Eligibility criterion not met|7|||
27621890|NCT00688688|80457776|FG002|Overall Study|Eligibility criterion not met|10|||
27621891|NCT00688688|80457774|FG000|Overall Study|Adverse Event|52|||
27910170|NCT01909804|81510028|FG010|Overall Study|Withdrew Consent|0|||
27910171|NCT01909804|81510029|FG011|Overall Study|Withdrew Consent|0|||
27910172|NCT01909804|81510018|FG000|Overall Study|Protocol Violation|0|||
27910173|NCT01909804|81510019|FG001|Overall Study|Protocol Violation|0|||
27621892|NCT00688688|80457775|FG001|Overall Study|Adverse Event|51|||
27621893|NCT00688688|80457776|FG002|Overall Study|Adverse Event|50|||
27621894|NCT00688688|80457774|FG000|Overall Study|Lack of Efficacy|34|||
27621895|NCT00688688|80457775|FG001|Overall Study|Lack of Efficacy|25|||
27910174|NCT01909804|81510020|FG002|Overall Study|Protocol Violation|0|||
27910175|NCT01909804|81510021|FG003|Overall Study|Protocol Violation|0|||
27621896|NCT00688688|80457776|FG002|Overall Study|Lack of Efficacy|45|||
27621897|NCT00688688|80457774|FG000|Overall Study|Withdrawal by Subject|66|||
27621898|NCT00688688|80457775|FG001|Overall Study|Withdrawal by Subject|75|||
27621899|NCT00688688|80457776|FG002|Overall Study|Withdrawal by Subject|65|||
27910176|NCT01909804|81510022|FG004|Overall Study|Protocol Violation|0|||
27621900|NCT00688688|80457774|FG000|Overall Study|Lost to Follow-up|14|||
27621901|NCT00688688|80457775|FG001|Overall Study|Lost to Follow-up|7|||
27621902|NCT00688688|80457776|FG002|Overall Study|Lost to Follow-up|7|||
27621903|NCT00688688|80457774|FG000|Overall Study|Protocol Violation|6|||
27621904|NCT00688688|80457775|FG001|Overall Study|Protocol Violation|9|||
27621905|NCT00688688|80457776|FG002|Overall Study|Protocol Violation|11|||
27910177|NCT01909804|81510023|FG005|Overall Study|Protocol Violation|0|||
27855167|NCT03028740|81302530|FG000|Overall Study|Did not Receive Study Drug|4|||
27910178|NCT01909804|81510024|FG006|Overall Study|Protocol Violation|0|||
27910179|NCT01909804|81510025|FG007|Overall Study|Protocol Violation|0|||
27910180|NCT01909804|81510026|FG008|Overall Study|Protocol Violation|0|||
27910181|NCT01909804|81510027|FG009|Overall Study|Protocol Violation|0|||
27910182|NCT01909804|81510028|FG010|Overall Study|Protocol Violation|0|||
27910183|NCT01909804|81510029|FG011|Overall Study|Protocol Violation|1|||
27910184|NCT02658669|81510032|FG000|Overall Study|Lost to Follow-up|7|||
27910185|NCT02658669|81510033|FG001|Overall Study|Lost to Follow-up|5|||
27910186|NCT00873730|81510034|FG000|Overall Study|Protocol Deviation|5|||
27910187|NCT00873730|81510035|FG001|Overall Study|Protocol Deviation|2|||
27910188|NCT00873730|81510034|FG000|Overall Study|Adverse Event|0|||
27910189|NCT00873730|81510035|FG001|Overall Study|Adverse Event|2|||
27910190|NCT00873730|81510034|FG000|Overall Study|Withdrawal by Subject|0|||
27910191|NCT00873730|81510035|FG001|Overall Study|Withdrawal by Subject|1|||
27910192|NCT00873730|81510034|FG000|Overall Study|Sponsor decision|1|||
27910193|NCT00873730|81510035|FG001|Overall Study|Sponsor decision|0|||
27910194|NCT00697593|81510038|FG000|Overall Study|Adverse Event|3|||
27910195|NCT00697593|81510038|FG000|Overall Study|Protocol Violation|1|||
27910196|NCT00697593|81510038|FG000|Overall Study|Lack of Efficacy|3|||
27524197|NCT03011892|80112410|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
27524198|NCT03011892|80112411|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
27524199|NCT03011892|80112412|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
27524200|NCT03011892|80112413|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
27524201|NCT03011892|80112414|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
27524202|NCT03011892|80112403|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
27524203|NCT03011892|80112404|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
27524204|NCT03011892|80112405|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
27524205|NCT03011892|80112406|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
27524206|NCT03011892|80112407|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
27524207|NCT03011892|80112408|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
27524208|NCT03011892|80112409|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
27524209|NCT03011892|80112410|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
27524210|NCT03011892|80112411|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
27524211|NCT03011892|80112412|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
27524212|NCT03011892|80112413|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
27524213|NCT03011892|80112414|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
27524214|NCT03011892|80112403|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
27524215|NCT03011892|80112404|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
27524216|NCT03011892|80112405|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
27524217|NCT03011892|80112406|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
27524218|NCT03011892|80112407|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
27524219|NCT03011892|80112408|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
27524220|NCT03011892|80112409|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
27524221|NCT03011892|80112410|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
27524222|NCT03011892|80112411|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
27524223|NCT03011892|80112412|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
27524224|NCT03011892|80112413|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
27524225|NCT03011892|80112414|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
27855168|NCT03028740|81302531|FG001|Overall Study|Did not Receive Study Drug|5|||
27855169|NCT03028740|81302530|FG000|Overall Study|Adverse Event|8|||
27855170|NCT03028740|81302531|FG001|Overall Study|Adverse Event|26|||
27855171|NCT03028740|81302530|FG000|Overall Study|Lack of Efficacy|0|||
27855172|NCT03028740|81302531|FG001|Overall Study|Lack of Efficacy|1|||
27855173|NCT03028740|81302530|FG000|Overall Study|Withdrawal by Subject|48|||
27855174|NCT03028740|81302531|FG001|Overall Study|Withdrawal by Subject|101|||
27855175|NCT03028740|81302530|FG000|Overall Study|Lost to Follow-up|30|||
27855176|NCT03028740|81302531|FG001|Overall Study|Lost to Follow-up|54|||
27855177|NCT03028740|81302530|FG000|Overall Study|Physician Decision|4|||
27855178|NCT03028740|81302531|FG001|Overall Study|Physician Decision|11|||
27855179|NCT03028740|81302530|FG000|Overall Study|Protocol Violation|4|||
27855180|NCT03028740|81302531|FG001|Overall Study|Protocol Violation|8|||
27855181|NCT03028740|81302530|FG000|Overall Study|Non-compliance with Study Drug|0|||
27855182|NCT03028740|81302531|FG001|Overall Study|Non-compliance with Study Drug|2|||
27910197|NCT00697593|81510038|FG000|Overall Study|Suspension of the study by sponsor|12|||
27524226|NCT03011892|80112403|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
27524227|NCT03011892|80112404|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
27524228|NCT03011892|80112405|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
27524229|NCT03011892|80112406|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
27524230|NCT03011892|80112407|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
27855183|NCT03028740|81302530|FG000|Overall Study|Study Terminated by Sponsor|467|||
27910198|NCT01968811|81510039|FG000|Overall Study|Protocol Violation|4|||
27910199|NCT01968811|81510039|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
27910200|NCT00096538|81510040|FG000|Overall Study|Withdrawal by Subject|1|||
27621906|NCT00688688|80457774|FG000|Overall Study|Randomized but never received study drug|1|||
27621907|NCT00688688|80457775|FG001|Overall Study|Randomized but never received study drug|0|||
27621908|NCT00688688|80457776|FG002|Overall Study|Randomized but never received study drug|0|||
27621909|NCT00688688|80457774|FG000|Overall Study|Non-compliance with study procedures|5|||
27621910|NCT00688688|80457775|FG001|Overall Study|Non-compliance with study procedures|3|||
27621911|NCT00688688|80457776|FG002|Overall Study|Non-compliance with study procedures|4|||
27621912|NCT00688688|80457774|FG000|Overall Study|Taking exclusionary medications|1|||
27621913|NCT00688688|80457775|FG001|Overall Study|Taking exclusionary medications|0|||
27621914|NCT00688688|80457776|FG002|Overall Study|Taking exclusionary medications|0|||
27621915|NCT00688688|80457774|FG000|Overall Study|Site closure|0|||
27621916|NCT00688688|80457775|FG001|Overall Study|Site closure|1|||
27621917|NCT00688688|80457776|FG002|Overall Study|Site closure|0|||
27621918|NCT00688688|80457774|FG000|Overall Study|Violation of exclusion criterion|0|||
27621919|NCT00688688|80457775|FG001|Overall Study|Violation of exclusion criterion|1|||
27621920|NCT00688688|80457776|FG002|Overall Study|Violation of exclusion criterion|0|||
27910201|NCT04978337|81510049|FG000|Overall Study|Withdrawal by Subject|0|||
27910202|NCT04978337|81510050|FG001|Overall Study|Withdrawal by Subject|1|||
27524231|NCT03011892|80112408|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
27524232|NCT03011892|80112409|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
27524233|NCT03011892|80112410|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
27621921|NCT04676022|80457777|FG000|Overall Study|Screen Failure/|1|||
27621922|NCT04676022|80457778|FG001|Overall Study|Screen Failure/|1|||
27621923|NCT04676022|80457779|FG002|Overall Study|Screen Failure/|85|||
27621924|NCT04676022|80457777|FG000|Overall Study|Lost to Follow-up|1|||
27621925|NCT04676022|80457778|FG001|Overall Study|Lost to Follow-up|1|||
27621926|NCT04676022|80457779|FG002|Overall Study|Lost to Follow-up|0|||
27621927|NCT04676022|80457777|FG000|Overall Study|Adverse Event|2|||
27621928|NCT04676022|80457778|FG001|Overall Study|Adverse Event|0|||
27621929|NCT04676022|80457779|FG002|Overall Study|Adverse Event|1|||
27621930|NCT04676022|80457777|FG000|Overall Study|Physician Decision|2|||
27621931|NCT04676022|80457778|FG001|Overall Study|Physician Decision|0|||
27621932|NCT04676022|80457779|FG002|Overall Study|Physician Decision|1|||
27621933|NCT04676022|80457777|FG000|Overall Study|Withdrawal by Subject|3|||
27621934|NCT04676022|80457778|FG001|Overall Study|Withdrawal by Subject|1|||
27621935|NCT04676022|80457779|FG002|Overall Study|Withdrawal by Subject|6|||
27621936|NCT04676022|80457777|FG000|Overall Study|Will not move forward with permanent implant|6|||
27621937|NCT04676022|80457778|FG001|Overall Study|Will not move forward with permanent implant|0|||
27621938|NCT04676022|80457779|FG002|Overall Study|Will not move forward with permanent implant|0|||
27621939|NCT04676022|80457777|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
27621940|NCT04676022|80457778|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
27524234|NCT03011892|80112411|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
27524235|NCT03011892|80112412|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
27524236|NCT03011892|80112413|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
27524237|NCT03011892|80112414|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
27524238|NCT03011892|80112403|FG000|Open Label (OL) Period|Reason not specified|0|||
27524239|NCT03011892|80112404|FG001|Open Label (OL) Period|Reason not specified|0|||
27524240|NCT03011892|80112405|FG002|Open Label (OL) Period|Reason not specified|0|||
27621941|NCT04676022|80457779|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
27621942|NCT05027971|80457780|FG000|Overall Study|Physician Decision|7|||
27621943|NCT05027971|80457781|FG001|Overall Study|Physician Decision|3|||
27621944|NCT05027971|80457780|FG000|Overall Study|Lost to Follow-up|1|||
27621945|NCT05027971|80457781|FG001|Overall Study|Lost to Follow-up|1|||
27621946|NCT05027971|80457780|FG000|Overall Study|Withdrawal by Subject|0|||
27621947|NCT05027971|80457781|FG001|Overall Study|Withdrawal by Subject|2|||
27621948|NCT05027971|80457780|FG000|Overall Study|Non-study fiber used.|0|||
27621949|NCT05027971|80457781|FG001|Overall Study|Non-study fiber used.|1|||
27524241|NCT03011892|80112406|FG003|Open Label (OL) Period|Reason not specified|0|||
27524242|NCT03011892|80112407|FG004|Open Label (OL) Period|Reason not specified|0|||
27524243|NCT03011892|80112408|FG005|Open Label (OL) Period|Reason not specified|0|||
27524244|NCT03011892|80112409|FG006|Open Label (OL) Period|Reason not specified|0|||
27524245|NCT03011892|80112410|FG007|Open Label (OL) Period|Reason not specified|1|||
27524246|NCT03011892|80112411|FG008|Open Label (OL) Period|Reason not specified|0|||
27621950|NCT05027971|80457780|FG000|Overall Study|Protocol Violation|0|||
27621951|NCT05027971|80457781|FG001|Overall Study|Protocol Violation|2|||
27732599|NCT02764541|80846316|FG000|Overall Study|Insurance reasons|0|||
27910203|NCT00667992|81510051|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
27621952|NCT03884231|80457783|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
27621953|NCT03884231|80457783|FG000|Overall Study|Subject Withdrew Consent|1|||
27621954|NCT03884231|80457783|FG000|Overall Study|MRI Scan Not Performed|1|||
27621955|NCT03682536|80457784|FG000|Randomization|Withdrawal by Subject|0|||
27621956|NCT03682536|80457785|FG001|Randomization|Withdrawal by Subject|2|||
27621957|NCT03682536|80457784|FG000|Treatment|Other Reasons|8|||
27621958|NCT03682536|80457785|FG001|Treatment|Other Reasons|7|||
27621959|NCT03682536|80457784|FG000|Treatment|Physician Decision|5|||
27621960|NCT03682536|80457785|FG001|Treatment|Physician Decision|5|||
27621961|NCT03682536|80457784|FG000|Treatment|Protocol Violation|1|||
27621962|NCT03682536|80457785|FG001|Treatment|Protocol Violation|0|||
27621963|NCT03682536|80457784|FG000|Treatment|Study Terminated by Sponsor|1|||
27621964|NCT03682536|80457785|FG001|Treatment|Study Terminated by Sponsor|2|||
27621965|NCT03682536|80457784|FG000|Treatment|Lost to Follow-up|0|||
27621966|NCT03682536|80457785|FG001|Treatment|Lost to Follow-up|1|||
27621967|NCT03682536|80457784|FG000|Treatment|Withdrawal by Subject|16|||
27621968|NCT03682536|80457785|FG001|Treatment|Withdrawal by Subject|18|||
27621969|NCT03682536|80457784|FG000|Treatment|Lack of Efficacy|41|||
27621970|NCT03682536|80457785|FG001|Treatment|Lack of Efficacy|68|||
27621971|NCT03682536|80457784|FG000|Treatment|Disease Progression|9|||
27621972|NCT03682536|80457785|FG001|Treatment|Disease Progression|7|||
27621973|NCT03682536|80457784|FG000|Treatment|Adverse Event|9|||
27621974|NCT03682536|80457785|FG001|Treatment|Adverse Event|5|||
27910204|NCT00667992|81510052|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
27524247|NCT03011892|80112412|FG009|Open Label (OL) Period|Reason not specified|0|||
27524248|NCT03011892|80112413|FG010|Open Label (OL) Period|Reason not specified|0|||
27524249|NCT03011892|80112414|FG011|Open Label (OL) Period|Reason not specified|0|||
27524250|NCT02108262|80112418|FG000|Overall Study|Non-compliance|0|||
27524251|NCT02108262|80112419|FG001|Overall Study|Non-compliance|2|||
27524252|NCT02108262|80112420|FG002|Overall Study|Non-compliance|1|||
27524253|NCT02108262|80112421|FG003|Overall Study|Non-compliance|1|||
27524254|NCT02108262|80112418|FG000|Overall Study|Randomized by error/screen failure|0|||
27524255|NCT02108262|80112419|FG001|Overall Study|Randomized by error/screen failure|0|||
27524256|NCT02108262|80112420|FG002|Overall Study|Randomized by error/screen failure|1|||
27524257|NCT02108262|80112421|FG003|Overall Study|Randomized by error/screen failure|0|||
27524258|NCT02108262|80112418|FG000|Overall Study|Distance to center|0|||
27524259|NCT02108262|80112419|FG001|Overall Study|Distance to center|1|||
27524260|NCT02108262|80112420|FG002|Overall Study|Distance to center|1|||
27524261|NCT02108262|80112421|FG003|Overall Study|Distance to center|0|||
27524262|NCT02108262|80112418|FG000|Overall Study|Adverse Event|0|||
27524263|NCT02108262|80112419|FG001|Overall Study|Adverse Event|11|||
27524264|NCT02108262|80112420|FG002|Overall Study|Adverse Event|6|||
27524265|NCT02108262|80112421|FG003|Overall Study|Adverse Event|12|||
27524266|NCT02108262|80112418|FG000|Overall Study|Death|0|||
27524267|NCT02108262|80112419|FG001|Overall Study|Death|2|||
27524268|NCT02108262|80112420|FG002|Overall Study|Death|2|||
27524269|NCT02108262|80112421|FG003|Overall Study|Death|1|||
27524270|NCT02108262|80112418|FG000|Overall Study|Lost to Follow-up|0|||
27524271|NCT02108262|80112419|FG001|Overall Study|Lost to Follow-up|0|||
27524272|NCT02108262|80112420|FG002|Overall Study|Lost to Follow-up|1|||
27524273|NCT02108262|80112421|FG003|Overall Study|Lost to Follow-up|0|||
27524274|NCT02108262|80112418|FG000|Overall Study|Physician Decision|0|||
27524275|NCT02108262|80112419|FG001|Overall Study|Physician Decision|0|||
27524276|NCT02108262|80112420|FG002|Overall Study|Physician Decision|2|||
27524277|NCT02108262|80112421|FG003|Overall Study|Physician Decision|0|||
27524278|NCT02108262|80112418|FG000|Overall Study|Withdrawal by Subject|0|||
27524279|NCT02108262|80112419|FG001|Overall Study|Withdrawal by Subject|7|||
27524280|NCT02108262|80112420|FG002|Overall Study|Withdrawal by Subject|3|||
27524281|NCT02108262|80112421|FG003|Overall Study|Withdrawal by Subject|4|||
27524282|NCT02108262|80112418|FG000|Overall Study|Due to key hepatic values|0|||
27524283|NCT02108262|80112419|FG001|Overall Study|Due to key hepatic values|1|||
27524284|NCT02108262|80112420|FG002|Overall Study|Due to key hepatic values|0|||
27524285|NCT02108262|80112421|FG003|Overall Study|Due to key hepatic values|0|||
27524286|NCT02108262|80112418|FG000|Overall Study|Unable to contact patient|0|||
27524287|NCT02108262|80112419|FG001|Overall Study|Unable to contact patient|3|||
27524288|NCT02108262|80112420|FG002|Overall Study|Unable to contact patient|1|||
27621975|NCT03682536|80457784|FG000|Treatment|Death|14|||
27910205|NCT00667992|81510051|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
27524289|NCT02108262|80112421|FG003|Overall Study|Unable to contact patient|2|||
27524290|NCT02108262|80112418|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
27524291|NCT02108262|80112419|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
27910206|NCT00667992|81510052|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
27524292|NCT02108262|80112420|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
27524293|NCT02108262|80112421|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
27524294|NCT02108262|80112418|FG000|Overall Study|Patient did not want another infusion|0|||
27524295|NCT02108262|80112419|FG001|Overall Study|Patient did not want another infusion|3|||
27524296|NCT02108262|80112420|FG002|Overall Study|Patient did not want another infusion|3|||
27621976|NCT03682536|80457785|FG001|Treatment|Death|13|||
27621977|NCT04565990|80457791|FG000|Overall Study|Death|5|||
27621978|NCT04565990|80457791|FG000|Overall Study|Lost to Follow-up|1|||
27621979|NCT04565990|80457791|FG000|Overall Study|Withdrawal by Subject|1|||
27621980|NCT04129580|80457792|FG000|Overall Study|Lost to Follow-up|14|||
27524297|NCT02108262|80112421|FG003|Overall Study|Patient did not want another infusion|2|||
27524298|NCT02108262|80112418|FG000|Overall Study|Vacation|0|||
27524299|NCT02108262|80112419|FG001|Overall Study|Vacation|1|||
27524300|NCT02108262|80112420|FG002|Overall Study|Vacation|0|||
27524301|NCT02108262|80112421|FG003|Overall Study|Vacation|0|||
27524302|NCT02108262|80112418|FG000|Overall Study|Patient decision|0|||
27524303|NCT02108262|80112419|FG001|Overall Study|Patient decision|7|||
27524304|NCT02108262|80112420|FG002|Overall Study|Patient decision|9|||
27524305|NCT02108262|80112421|FG003|Overall Study|Patient decision|14|||
27524306|NCT02108262|80112418|FG000|Overall Study|Missed IV due to pharmacy error|0|||
27524307|NCT02108262|80112419|FG001|Overall Study|Missed IV due to pharmacy error|0|||
27524308|NCT02108262|80112420|FG002|Overall Study|Missed IV due to pharmacy error|1|||
27524309|NCT02108262|80112421|FG003|Overall Study|Missed IV due to pharmacy error|0|||
27524310|NCT00592774|80112422|FG000|Overall Study|Adverse Event|5|||
27524311|NCT00592774|80112423|FG001|Overall Study|Adverse Event|19|||
27621981|NCT04129580|80457793|FG001|Overall Study|Lost to Follow-up|25|||
27621982|NCT05750745|80457796|FG000|Overall Study|Adverse Event|1|||
27621983|NCT05750745|80457797|FG001|Overall Study|Adverse Event|0|||
27621984|NCT05750745|80457798|FG002|Overall Study|Adverse Event|0|||
27621985|NCT05750745|80457796|FG000|Overall Study|Protocol Violation|1|||
27524312|NCT00592774|80112424|FG002|Overall Study|Adverse Event|2|||
27524313|NCT00592774|80112425|FG003|Overall Study|Adverse Event|14|||
27524314|NCT00592774|80112426|FG004|Overall Study|Adverse Event|8|||
27524315|NCT00592774|80112422|FG000|Overall Study|Protocol Violation|0|||
27524316|NCT00592774|80112423|FG001|Overall Study|Protocol Violation|1|||
27524317|NCT00592774|80112424|FG002|Overall Study|Protocol Violation|0|||
27524318|NCT00592774|80112425|FG003|Overall Study|Protocol Violation|0|||
27524319|NCT00592774|80112426|FG004|Overall Study|Protocol Violation|1|||
27524320|NCT00592774|80112422|FG000|Overall Study|Withdrawal by Subject|3|||
27524321|NCT00592774|80112423|FG001|Overall Study|Withdrawal by Subject|7|||
27524322|NCT00592774|80112424|FG002|Overall Study|Withdrawal by Subject|0|||
27524323|NCT00592774|80112425|FG003|Overall Study|Withdrawal by Subject|0|||
27524324|NCT00592774|80112426|FG004|Overall Study|Withdrawal by Subject|0|||
27524325|NCT00592774|80112422|FG000|Overall Study|Lack of Efficacy|3|||
27524326|NCT00592774|80112423|FG001|Overall Study|Lack of Efficacy|3|||
27524327|NCT00592774|80112424|FG002|Overall Study|Lack of Efficacy|0|||
27524328|NCT00592774|80112425|FG003|Overall Study|Lack of Efficacy|0|||
27524329|NCT00592774|80112426|FG004|Overall Study|Lack of Efficacy|2|||
27524330|NCT00592774|80112422|FG000|Overall Study|Physician Decision|0|||
27524331|NCT00592774|80112423|FG001|Overall Study|Physician Decision|1|||
27524332|NCT00592774|80112424|FG002|Overall Study|Physician Decision|1|||
27524333|NCT00592774|80112425|FG003|Overall Study|Physician Decision|0|||
27524334|NCT00592774|80112426|FG004|Overall Study|Physician Decision|1|||
27524335|NCT00592774|80112422|FG000|Overall Study|Other|0|||
27524336|NCT00592774|80112423|FG001|Overall Study|Other|1|||
27524337|NCT00592774|80112424|FG002|Overall Study|Other|1|||
27621986|NCT05750745|80457797|FG001|Overall Study|Protocol Violation|0|||
27621987|NCT05750745|80457798|FG002|Overall Study|Protocol Violation|0|||
27621988|NCT05750745|80457796|FG000|Overall Study|Withdrawal by Subject|0|||
27621989|NCT05750745|80457797|FG001|Overall Study|Withdrawal by Subject|1|||
27621990|NCT05750745|80457798|FG002|Overall Study|Withdrawal by Subject|0|||
27621991|NCT05257837|80457799|FG000|Overall Study|Excluded (did not find the guns)|4|||
27621992|NCT05257837|80457800|FG001|Overall Study|Excluded (did not find the guns)|2|||
27621993|NCT05257837|80457801|FG002|Overall Study|Excluded (did not find the guns)|4|||
27621994|NCT05257837|80457802|FG003|Overall Study|Excluded (did not find the guns)|0|||
27621995|NCT03302910|80457803|FG000|Overall Study|Protocol Violation|1|||
27621996|NCT03302910|80457804|FG001|Overall Study|Protocol Violation|0|||
27621997|NCT05196737|80457805|FG000|Non-intervention Week|Lost to Follow-up|2|||
27621998|NCT05196737|80457805|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
27621999|NCT04873817|80457806|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
27622000|NCT04873817|80457806|FG000|Overall Study|Lost to Follow-up|4|||
27622001|NCT04873817|80457806|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
27910207|NCT00667992|81510051|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
27524338|NCT00592774|80112425|FG003|Overall Study|Other|0|||
27524339|NCT00592774|80112426|FG004|Overall Study|Other|2|||
27524340|NCT04987944|80112427|FG000|Overall Study|Adverse Event|0|||
27524341|NCT04987944|80112428|FG001|Overall Study|Adverse Event|1|||
27622002|NCT04873817|80457806|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
27622003|NCT04873817|80457806|FG000|Overall Study|Other Reasons|3|||
27855184|NCT03028740|81302531|FG001|Overall Study|Study Terminated by Sponsor|917|||
27910208|NCT00667992|81510052|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
27524342|NCT04987944|80112427|FG000|Overall Study|Withdrawal by Subject|0|||
27524343|NCT04987944|80112428|FG001|Overall Study|Withdrawal by Subject|1|||
27524344|NCT02446171|80112429|FG000|Overall Study|Withdrawal by Subject|0|||
27524345|NCT02446171|80112430|FG001|Overall Study|Withdrawal by Subject|0|||
27524346|NCT02446171|80112431|FG002|Overall Study|Withdrawal by Subject|2|||
27524347|NCT02446171|80112432|FG003|Overall Study|Withdrawal by Subject|0|||
27524348|NCT02239120|80112433|FG000|Overall Study|Death|56|||
27524349|NCT02239120|80112434|FG001|Overall Study|Death|58|||
27524350|NCT02239120|80112433|FG000|Overall Study|Lost to Follow-up|19|||
27524351|NCT02239120|80112434|FG001|Overall Study|Lost to Follow-up|14|||
27524352|NCT02160002|80112435|FG000|Overall Study|Withdrawal by Subject|2|||
27524353|NCT02160002|80112436|FG001|Overall Study|Withdrawal by Subject|1|||
27524354|NCT01958827|80112437|FG000|Overall Study|Adverse Event|3|||
27524355|NCT01958827|80112437|FG000|Overall Study|Lack of Efficacy|6|||
27524356|NCT01958827|80112437|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
27524357|NCT01146860|80112438|FG000|Overall Study|Withdrawal by Subject|0|||
27524358|NCT01146860|80112439|FG001|Overall Study|Withdrawal by Subject|1|||
27524359|NCT01974765|80112440|FG000|Overall Study|Withdrawal by Subject|1|||
27524360|NCT01974765|80112440|FG000|Overall Study|Death|1|||
27524361|NCT01974765|80112440|FG000|Overall Study|Adverse Event|2|||
27524362|NCT00731042|80112441|FG000|Second Intervention|Did not meet inclusion criteria|0|||
27524363|NCT00731042|80112442|FG001|Second Intervention|Did not meet inclusion criteria|2|||
27524364|NCT02220998|80112457|FG000|Overall Study|Randomized but Never Treated|1|||
27524365|NCT02220998|80112458|FG001|Overall Study|Randomized but Never Treated|2|||
27524366|NCT02220998|80112457|FG000|Overall Study|Death|2|||
27524367|NCT02220998|80112458|FG001|Overall Study|Death|0|||
27524368|NCT02220998|80112457|FG000|Overall Study|Lack of Efficacy|0|||
27524369|NCT02220998|80112458|FG001|Overall Study|Lack of Efficacy|5|||
27524370|NCT02220998|80112457|FG000|Overall Study|Lost to Follow-up|4|||
27524371|NCT02220998|80112458|FG001|Overall Study|Lost to Follow-up|4|||
27524372|NCT05463198|80112459|FG000|Overall Study|Withdrawal by Subject|19|||
27524373|NCT05463198|80112459|FG000|Overall Study|Procedure Notes Missing|18|||
27524374|NCT01998984|80112460|FG000|Overall Study|Adverse Event|0|||
27524375|NCT01998984|80112461|FG001|Overall Study|Adverse Event|0|||
27524376|NCT01998984|80112462|FG002|Overall Study|Adverse Event|0|||
27524377|NCT01998984|80112463|FG003|Overall Study|Adverse Event|1|||
27524378|NCT01998984|80112460|FG000|Overall Study|Lost to Follow-up|0|||
27524379|NCT01998984|80112461|FG001|Overall Study|Lost to Follow-up|1|||
27524380|NCT01998984|80112462|FG002|Overall Study|Lost to Follow-up|0|||
27524381|NCT01998984|80112463|FG003|Overall Study|Lost to Follow-up|1|||
27524382|NCT01998984|80112460|FG000|Overall Study|Withdrawal by Subject|0|||
27524383|NCT01998984|80112461|FG001|Overall Study|Withdrawal by Subject|0|||
27524384|NCT01998984|80112462|FG002|Overall Study|Withdrawal by Subject|1|||
27524385|NCT01998984|80112463|FG003|Overall Study|Withdrawal by Subject|0|||
27524386|NCT01998984|80112460|FG000|Overall Study|Other|0|||
27524387|NCT01998984|80112461|FG001|Overall Study|Other|0|||
27524388|NCT01998984|80112462|FG002|Overall Study|Other|0|||
27524389|NCT01998984|80112463|FG003|Overall Study|Other|1|||
27622004|NCT02561455|80457807|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
27622005|NCT02561455|80457808|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
27622006|NCT02561455|80457809|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
27622007|NCT02561455|80457810|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
27622008|NCT02561455|80457807|FG000|Overall Study|Withdrawal by Subject|1|||
27622009|NCT02561455|80457808|FG001|Overall Study|Withdrawal by Subject|0|||
27622010|NCT02561455|80457809|FG002|Overall Study|Withdrawal by Subject|1|||
27622011|NCT02561455|80457810|FG003|Overall Study|Withdrawal by Subject|0|||
27622012|NCT02561455|80457807|FG000|Overall Study|Disease Progression|0|||
27622013|NCT02561455|80457808|FG001|Overall Study|Disease Progression|1|||
27622014|NCT02561455|80457809|FG002|Overall Study|Disease Progression|0|||
27622015|NCT02561455|80457810|FG003|Overall Study|Disease Progression|0|||
27622016|NCT02403674|80457811|FG000|Base Study|Death|1|||
27622017|NCT02403674|80457812|FG001|Base Study|Death|4|||
27622018|NCT02403674|80457811|FG000|Base Study|Adverse Event|11|||
27622019|NCT02403674|80457812|FG001|Base Study|Adverse Event|26|||
27732600|NCT02764541|80846317|FG001|Overall Study|Insurance reasons|0|||
27732601|NCT02764541|80846318|FG002|Overall Study|Insurance reasons|0|||
27524390|NCT00674154|80112464|FG000|Overall Study|Withdrawal by Subject|3|||
27524391|NCT00674154|80112465|FG001|Overall Study|Withdrawal by Subject|1|||
27524392|NCT00674154|80112464|FG000|Overall Study|Did not want parathyroidectomy|0|||
27524393|NCT00674154|80112465|FG001|Overall Study|Did not want parathyroidectomy|2|||
27524394|NCT02232880|80112474|FG000|Overall Study|study stopped prior to randomization|1|||
27524395|NCT01227629|80112478|FG000|Overall Study|Adverse Event|2|||
27524396|NCT01227629|80112479|FG001|Overall Study|Adverse Event|2|||
27524397|NCT01227629|80112480|FG002|Overall Study|Adverse Event|1|||
27622020|NCT02403674|80457811|FG000|Base Study|Lack of Efficacy|31|||
27622021|NCT02403674|80457812|FG001|Base Study|Lack of Efficacy|23|||
27622022|NCT02403674|80457811|FG000|Base Study|Lost to Follow-up|6|||
27622023|NCT02403674|80457812|FG001|Base Study|Lost to Follow-up|8|||
27732602|NCT02764541|80846319|FG003|Overall Study|Insurance reasons|0|||
27524398|NCT01227629|80112481|FG003|Overall Study|Adverse Event|6|||
27524399|NCT01227629|80112482|FG004|Overall Study|Adverse Event|1|||
27524400|NCT01227629|80112483|FG005|Overall Study|Adverse Event|1|||
27524401|NCT01227629|80112484|FG006|Overall Study|Adverse Event|6|||
27524402|NCT01227629|80112485|FG007|Overall Study|Adverse Event|6|||
27524403|NCT01227629|80112486|FG008|Overall Study|Adverse Event|4|||
27622024|NCT02403674|80457811|FG000|Base Study|Withdrawal by Subject|10|||
27622025|NCT02403674|80457812|FG001|Base Study|Withdrawal by Subject|17|||
27622026|NCT02403674|80457811|FG000|Base Study|Physician Decision|2|||
27622027|NCT02403674|80457812|FG001|Base Study|Physician Decision|2|||
27622028|NCT02403674|80457811|FG000|Base Study|Pregnancy|2|||
27622029|NCT02403674|80457812|FG001|Base Study|Pregnancy|2|||
27622030|NCT02403674|80457811|FG000|Base Study|Protocol Violation|8|||
27622031|NCT02403674|80457812|FG001|Base Study|Protocol Violation|4|||
27622032|NCT02403674|80457811|FG000|Base Study|Non-Compliance with study drug|1|||
27622033|NCT02403674|80457812|FG001|Base Study|Non-Compliance with study drug|4|||
27622034|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
27622035|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
27622036|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
27622037|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
27622038|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
27622039|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
27622040|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
27622041|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
27622042|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
27622043|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
27622044|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
27622045|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
27622046|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Death|1|||
27622047|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Death|0|||
27622048|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
27622049|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
27622050|NCT02403674|80457811|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
27622051|NCT02403674|80457812|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
27622052|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
27622053|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
27622054|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
27622055|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
27855185|NCT03028740|81302530|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
27855186|NCT03028740|81302531|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
27524404|NCT01227629|80112487|FG009|Overall Study|Adverse Event|0|||
27524405|NCT01227629|80112478|FG000|Overall Study|Protocol Violation|0|||
27524406|NCT01227629|80112479|FG001|Overall Study|Protocol Violation|0|||
27524407|NCT01227629|80112480|FG002|Overall Study|Protocol Violation|0|||
27524408|NCT01227629|80112481|FG003|Overall Study|Protocol Violation|1|||
27524409|NCT01227629|80112482|FG004|Overall Study|Protocol Violation|0|||
27524410|NCT01227629|80112483|FG005|Overall Study|Protocol Violation|0|||
27855187|NCT03028740|81302530|FG000|Overall Study|Reason not Specified|1|||
27910209|NCT00667992|81510051|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
27910210|NCT00667992|81510052|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
27910211|NCT00667992|81510051|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
27910212|NCT00667992|81510052|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
27910213|NCT00667992|81510051|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
27910214|NCT00667992|81510052|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
27910215|NCT00667992|81510051|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
27910216|NCT00667992|81510052|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
27910217|NCT00667992|81510051|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
27524411|NCT01227629|80112484|FG006|Overall Study|Protocol Violation|0|||
27524412|NCT01227629|80112485|FG007|Overall Study|Protocol Violation|0|||
27524413|NCT01227629|80112486|FG008|Overall Study|Protocol Violation|0|||
27524414|NCT01227629|80112487|FG009|Overall Study|Protocol Violation|0|||
27524415|NCT01227629|80112478|FG000|Overall Study|Lost to Follow-up|0|||
27524416|NCT01227629|80112479|FG001|Overall Study|Lost to Follow-up|0|||
27524417|NCT01227629|80112480|FG002|Overall Study|Lost to Follow-up|0|||
27855188|NCT03028740|81302531|FG001|Overall Study|Reason not Specified|5|||
27855189|NCT00536263|81302534|FG000|Overall Study|Adverse Event|5|||
27855190|NCT00536263|81302535|FG001|Overall Study|Adverse Event|5|||
27855191|NCT00536263|81302536|FG002|Overall Study|Adverse Event|7|||
27910218|NCT00667992|81510052|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
27524418|NCT01227629|80112481|FG003|Overall Study|Lost to Follow-up|0|||
27524419|NCT01227629|80112482|FG004|Overall Study|Lost to Follow-up|1|||
27524420|NCT01227629|80112483|FG005|Overall Study|Lost to Follow-up|0|||
27622056|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
27622057|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
27622058|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
27622059|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
27622060|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
27622061|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
27524421|NCT01227629|80112484|FG006|Overall Study|Lost to Follow-up|0|||
27910219|NCT00667992|81510051|FG000|Wash-out|Not within one doubling dilution|4|||
27910220|NCT00667992|81510052|FG001|Wash-out|Not within one doubling dilution|3|||
27910221|NCT00667992|81510051|FG000|Wash-out|Failure to wash-out|2|||
27524422|NCT01227629|80112485|FG007|Overall Study|Lost to Follow-up|0|||
27524423|NCT01227629|80112486|FG008|Overall Study|Lost to Follow-up|0|||
27622062|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Death|2|||
27622063|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Death|2|||
27622064|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
27622065|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
27622066|NCT02403674|80457811|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
27622067|NCT02403674|80457812|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
27622068|NCT02403674|80457811|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
27622069|NCT02403674|80457812|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
27622070|NCT02403674|80457811|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
27622071|NCT02403674|80457812|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
27622072|NCT02403674|80457811|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
27622073|NCT02403674|80457812|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
27622074|NCT02403674|80457811|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
27622075|NCT02403674|80457812|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
27622076|NCT02403674|80457811|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
27622077|NCT02403674|80457812|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
27622078|NCT01737268|80457817|FG000|Overall Study|Adverse Event|6|||
27622079|NCT01737268|80457817|FG000|Overall Study|Worsening of Target Disease|2|||
27622080|NCT01737268|80457817|FG000|Overall Study|In consideration of the patient's safety|1|||
27622081|NCT04060680|80457818|FG000|Overall Study|Unsuccessful implant|17|||
27622082|NCT04060680|80457819|FG001|Overall Study|Unsuccessful implant|2|||
27622083|NCT04060680|80457818|FG000|Overall Study|Adverse Event|3|||
27622084|NCT04060680|80457819|FG001|Overall Study|Adverse Event|0|||
27622085|NCT04060680|80457818|FG000|Overall Study|Death|2|||
27622086|NCT04060680|80457819|FG001|Overall Study|Death|0|||
27622087|NCT04060680|80457818|FG000|Overall Study|Study product no longer in use|1|||
27622088|NCT04060680|80457819|FG001|Overall Study|Study product no longer in use|0|||
27622089|NCT04060680|80457818|FG000|Overall Study|Withdrawal by Subject|1|||
27622090|NCT04060680|80457819|FG001|Overall Study|Withdrawal by Subject|0|||
27622091|NCT00689104|80457820|FG000|Overall Study|Eligibility criterion not met|5|||
27622092|NCT00689104|80457821|FG001|Overall Study|Eligibility criterion not met|8|||
27622093|NCT00689104|80457822|FG002|Overall Study|Eligibility criterion not met|0|||
27732603|NCT02764541|80846320|FG004|Overall Study|Insurance reasons|0|||
27524424|NCT01227629|80112487|FG009|Overall Study|Lost to Follow-up|0|||
27524425|NCT01227629|80112478|FG000|Overall Study|Withdrawal by Subject|0|||
27524426|NCT01227629|80112479|FG001|Overall Study|Withdrawal by Subject|0|||
27524427|NCT01227629|80112480|FG002|Overall Study|Withdrawal by Subject|0|||
27524428|NCT01227629|80112481|FG003|Overall Study|Withdrawal by Subject|0|||
27524429|NCT01227629|80112482|FG004|Overall Study|Withdrawal by Subject|0|||
27910222|NCT00667992|81510052|FG001|Wash-out|Failure to wash-out|2|||
27524430|NCT01227629|80112483|FG005|Overall Study|Withdrawal by Subject|0|||
27524431|NCT01227629|80112484|FG006|Overall Study|Withdrawal by Subject|2|||
27524432|NCT01227629|80112485|FG007|Overall Study|Withdrawal by Subject|0|||
27524433|NCT01227629|80112486|FG008|Overall Study|Withdrawal by Subject|0|||
27524434|NCT01227629|80112487|FG009|Overall Study|Withdrawal by Subject|1|||
27524435|NCT01227629|80112478|FG000|Overall Study|Other|0|||
27524436|NCT01227629|80112479|FG001|Overall Study|Other|0|||
27524437|NCT01227629|80112480|FG002|Overall Study|Other|0|||
27524438|NCT01227629|80112481|FG003|Overall Study|Other|1|||
27524439|NCT01227629|80112482|FG004|Overall Study|Other|0|||
27524440|NCT01227629|80112483|FG005|Overall Study|Other|0|||
27524441|NCT01227629|80112484|FG006|Overall Study|Other|0|||
27524442|NCT01227629|80112485|FG007|Overall Study|Other|0|||
27524443|NCT01227629|80112486|FG008|Overall Study|Other|2|||
27524444|NCT01227629|80112487|FG009|Overall Study|Other|1|||
27524445|NCT02213133|80112492|FG000|Overall Study|Participant discontinued study therapy|2|||
27524446|NCT02213133|80112493|FG001|Overall Study|Participant discontinued study therapy|0|||
27524447|NCT02213133|80112494|FG002|Overall Study|Participant discontinued study therapy|0|||
27524448|NCT02213133|80112492|FG000|Overall Study|Participant withdrew informed consent|2|||
27524449|NCT02213133|80112493|FG001|Overall Study|Participant withdrew informed consent|1|||
27524450|NCT02213133|80112494|FG002|Overall Study|Participant withdrew informed consent|2|||
27524451|NCT02213133|80112492|FG000|Overall Study|Disease progression|11|||
27524452|NCT02213133|80112493|FG001|Overall Study|Disease progression|2|||
27524453|NCT02213133|80112494|FG002|Overall Study|Disease progression|0|||
27622094|NCT00689104|80457823|FG003|Overall Study|Eligibility criterion not met|4|||
27622095|NCT00689104|80457820|FG000|Overall Study|Adverse Event|13|||
27622096|NCT00689104|80457821|FG001|Overall Study|Adverse Event|25|||
27622097|NCT00689104|80457822|FG002|Overall Study|Adverse Event|16|||
27910223|NCT00667992|81510051|FG000|Wash-out|Withdrawal by Subject|1|||
27622098|NCT00689104|80457823|FG003|Overall Study|Adverse Event|24|||
27622099|NCT00689104|80457820|FG000|Overall Study|Lack of Efficacy|5|||
27622100|NCT00689104|80457821|FG001|Overall Study|Lack of Efficacy|6|||
27622101|NCT00689104|80457822|FG002|Overall Study|Lack of Efficacy|2|||
27622102|NCT00689104|80457823|FG003|Overall Study|Lack of Efficacy|3|||
27732604|NCT02764541|80846321|FG005|Overall Study|Insurance reasons|0|||
27732605|NCT02764541|80846322|FG006|Overall Study|Insurance reasons|1|||
27732606|NCT02764541|80846323|FG007|Overall Study|Insurance reasons|0|||
27732607|NCT02658448|80846327|FG000|Overall Study|Lost to Follow-up|1|||
27732608|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
27732609|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
27732610|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
27732611|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
27732612|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
27732613|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
27732614|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
27732615|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
27732616|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
27732617|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
27732618|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
27732619|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
27732620|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
27732621|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
27732622|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
27732623|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
27732624|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
27732625|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
27732626|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
27732627|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
27732628|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
27732629|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
27732630|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
27732631|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
27732632|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
27732633|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
27732634|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
27732635|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
27732636|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
27732637|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
27732638|NCT00849017|80846328|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
27855192|NCT00536263|81302534|FG000|Overall Study|Lost to Follow-up|3|||
27524454|NCT02213133|80112492|FG000|Overall Study|Adverse Event (AE)|1|||
27524455|NCT02213133|80112493|FG001|Overall Study|Adverse Event (AE)|0|||
27524456|NCT02213133|80112494|FG002|Overall Study|Adverse Event (AE)|0|||
27524457|NCT02213133|80112492|FG000|Overall Study|Death|16|||
27524458|NCT02213133|80112493|FG001|Overall Study|Death|2|||
27524459|NCT02213133|80112494|FG002|Overall Study|Death|1|||
27524460|NCT02213133|80112492|FG000|Overall Study|Other|5|||
27524461|NCT02213133|80112493|FG001|Overall Study|Other|0|||
27524462|NCT02213133|80112494|FG002|Overall Study|Other|0|||
27524463|NCT02848729|80112497|FG000|Overall Study|Withdrawal by Subject|1|||
27524464|NCT02848729|80112498|FG001|Overall Study|Withdrawal by Subject|0|||
27524465|NCT02848729|80112497|FG000|Overall Study|Emesis|15|||
27524466|NCT02848729|80112498|FG001|Overall Study|Emesis|11|||
27524467|NCT00686634|80112499|FG000|Overall Study|Protocol Violation|6|||
27524468|NCT00393042|80112500|FG000|First Intervention|Withdrawal by Subject|1|||
27524469|NCT00393042|80112501|FG001|First Intervention|Withdrawal by Subject|2|||
27524470|NCT00393042|80112500|FG000|First Intervention|Lost to Follow-up|3|||
27524471|NCT00393042|80112501|FG001|First Intervention|Lost to Follow-up|3|||
27524472|NCT00393042|80112500|FG000|First Intervention|Protocol Violation|1|||
27524473|NCT00393042|80112501|FG001|First Intervention|Protocol Violation|0|||
27524474|NCT00393042|80112500|FG000|First Intervention|Adverse Event|0|||
27524475|NCT00393042|80112501|FG001|First Intervention|Adverse Event|1|||
27524476|NCT00393042|80112500|FG000|Second Intervetion|Adverse Event|0|||
27524477|NCT00393042|80112501|FG001|Second Intervetion|Adverse Event|3|||
27524478|NCT00393042|80112500|FG000|Second Intervetion|Withdrawal by Subject|0|||
27910224|NCT00667992|81510052|FG001|Wash-out|Withdrawal by Subject|0|||
27524479|NCT00393042|80112501|FG001|Second Intervetion|Withdrawal by Subject|2|||
27524480|NCT00393042|80112500|FG000|Second Intervetion|Lack of Efficacy|1|||
27524481|NCT00393042|80112501|FG001|Second Intervetion|Lack of Efficacy|0|||
27524482|NCT00393042|80112500|FG000|Second Intervetion|Lost to Follow-up|0|||
27524483|NCT00393042|80112501|FG001|Second Intervetion|Lost to Follow-up|2|||
27524484|NCT00393042|80112500|FG000|Second Intervetion|Protocol Violation|1|||
27622103|NCT00689104|80457820|FG000|Overall Study|Withdrawal by Subject|12|||
27524485|NCT00393042|80112501|FG001|Second Intervetion|Protocol Violation|1|||
27732639|NCT00849017|80846329|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
27732640|NCT00849017|80846330|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
27732641|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
27732642|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
27732643|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
27732644|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
27732645|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
27732646|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
27732647|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
27732648|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
27732649|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
27732650|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
27732651|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
27732652|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
27732653|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
27732654|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
27732655|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
27732656|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
27732657|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
27732658|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
27732659|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
27732660|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
27732661|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
27732662|NCT00849017|80846328|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
27732663|NCT00849017|80846329|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
27732664|NCT00849017|80846330|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
27732665|NCT01097044|80846334|FG000|Overall Study|Withdrawal by Subject|4|||
27732666|NCT01097044|80846335|FG001|Overall Study|Withdrawal by Subject|4|||
27732667|NCT01097044|80846334|FG000|Overall Study|Lost to Follow-up|1|||
27732668|NCT01097044|80846335|FG001|Overall Study|Lost to Follow-up|0|||
27732669|NCT01097044|80846334|FG000|Overall Study|Withdrawal by Sponsor|0|||
27732670|NCT01097044|80846335|FG001|Overall Study|Withdrawal by Sponsor|1|||
27524486|NCT02151773|80112510|FG000|Overall Study|Protocol Deviation|64|||
27524487|NCT04839562|80112516|FG000|Overall Study|Withdrawal by Subject|0|||
27524488|NCT04839562|80112517|FG001|Overall Study|Withdrawal by Subject|1|||
27524489|NCT04839562|80112516|FG000|Overall Study|Physician Decision|0|||
27524490|NCT04839562|80112517|FG001|Overall Study|Physician Decision|1|||
27524491|NCT00797966|80112518|FG000|Phase A|Lost to Follow-up|0|||
27524492|NCT00797966|80112519|FG001|Phase A|Lost to Follow-up|0|||
27524493|NCT00797966|80112520|FG002|Phase A|Lost to Follow-up|0|||
27524494|NCT00797966|80112521|FG003|Phase A|Lost to Follow-up|0|||
27524495|NCT00797966|80112522|FG004|Phase A|Lost to Follow-up|33|||
27524496|NCT00797966|80112523|FG005|Phase A|Lost to Follow-up|0|||
27524497|NCT00797966|80112518|FG000|Phase A|Adverse Event|0|||
27524498|NCT00797966|80112519|FG001|Phase A|Adverse Event|0|||
27524499|NCT00797966|80112520|FG002|Phase A|Adverse Event|0|||
27524500|NCT00797966|80112521|FG003|Phase A|Adverse Event|0|||
27524501|NCT00797966|80112522|FG004|Phase A|Adverse Event|46|||
27524502|NCT00797966|80112523|FG005|Phase A|Adverse Event|0|||
27524503|NCT00797966|80112518|FG000|Phase A|Met withdrawal criteria|0|||
27524504|NCT00797966|80112519|FG001|Phase A|Met withdrawal criteria|0|||
27524505|NCT00797966|80112520|FG002|Phase A|Met withdrawal criteria|0|||
27524506|NCT00797966|80112521|FG003|Phase A|Met withdrawal criteria|0|||
27524507|NCT00797966|80112522|FG004|Phase A|Met withdrawal criteria|4|||
27524508|NCT00797966|80112523|FG005|Phase A|Met withdrawal criteria|0|||
27524509|NCT00797966|80112518|FG000|Phase A|Physician Decision|0|||
27524510|NCT00797966|80112519|FG001|Phase A|Physician Decision|0|||
27524511|NCT00797966|80112520|FG002|Phase A|Physician Decision|0|||
27524512|NCT00797966|80112521|FG003|Phase A|Physician Decision|0|||
27524513|NCT00797966|80112522|FG004|Phase A|Physician Decision|13|||
27524514|NCT00797966|80112523|FG005|Phase A|Physician Decision|0|||
27524515|NCT00797966|80112518|FG000|Phase A|Withdrawal by Subject|0|||
27524516|NCT00797966|80112519|FG001|Phase A|Withdrawal by Subject|0|||
27732671|NCT04343651|80846338|FG000|Overall Study|Physician Decision|2|||
27732672|NCT04343651|80846339|FG001|Overall Study|Physician Decision|1|||
27732673|NCT04343651|80846338|FG000|Overall Study|Lost to Follow-up|2|||
27732674|NCT04343651|80846339|FG001|Overall Study|Lost to Follow-up|1|||
27732675|NCT04343651|80846338|FG000|Overall Study|Protocol Violation|4|||
27910225|NCT00667992|81510051|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
27910226|NCT00667992|81510052|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
27524517|NCT00797966|80112520|FG002|Phase A|Withdrawal by Subject|0|||
27524518|NCT00797966|80112521|FG003|Phase A|Withdrawal by Subject|0|||
27524519|NCT00797966|80112522|FG004|Phase A|Withdrawal by Subject|33|||
27524520|NCT00797966|80112523|FG005|Phase A|Withdrawal by Subject|0|||
27524521|NCT00797966|80112518|FG000|Phase A|Protocol deviation|0|||
27524522|NCT00797966|80112519|FG001|Phase A|Protocol deviation|0|||
27524523|NCT00797966|80112520|FG002|Phase A|Protocol deviation|0|||
27524524|NCT00797966|80112521|FG003|Phase A|Protocol deviation|0|||
27524525|NCT00797966|80112522|FG004|Phase A|Protocol deviation|56|||
27732676|NCT04343651|80846339|FG001|Overall Study|Protocol Violation|6|||
27732677|NCT04343651|80846338|FG000|Overall Study|Missing|3|||
27732678|NCT04343651|80846339|FG001|Overall Study|Missing|9|||
27732679|NCT04343651|80846338|FG000|Overall Study|Withdrawal by Subject|0|||
27732680|NCT04343651|80846339|FG001|Overall Study|Withdrawal by Subject|4|||
27732681|NCT04343651|80846338|FG000|Overall Study|Death|0|||
27732682|NCT04343651|80846339|FG001|Overall Study|Death|1|||
27732683|NCT04343651|80846338|FG000|Overall Study|Did not start treatment|1|||
27732684|NCT04343651|80846339|FG001|Overall Study|Did not start treatment|1|||
27732685|NCT04343651|80846338|FG000|Overall Study|Patient did not complete visits 3-6|0|||
27524526|NCT00797966|80112523|FG005|Phase A|Protocol deviation|0|||
27524527|NCT00797966|80112518|FG000|Phase B|Lost to Follow-up|0|||
27524528|NCT00797966|80112519|FG001|Phase B|Lost to Follow-up|1|||
27524529|NCT00797966|80112520|FG002|Phase B|Lost to Follow-up|3|||
27524530|NCT00797966|80112521|FG003|Phase B|Lost to Follow-up|0|||
27524531|NCT00797966|80112522|FG004|Phase B|Lost to Follow-up|0|||
27524532|NCT00797966|80112523|FG005|Phase B|Lost to Follow-up|0|||
27524533|NCT00797966|80112518|FG000|Phase B|Adverse Event|2|||
27524534|NCT00797966|80112519|FG001|Phase B|Adverse Event|1|||
27524535|NCT00797966|80112520|FG002|Phase B|Adverse Event|3|||
27524536|NCT00797966|80112521|FG003|Phase B|Adverse Event|1|||
27524537|NCT00797966|80112522|FG004|Phase B|Adverse Event|0|||
27732686|NCT04343651|80846339|FG001|Overall Study|Patient did not complete visits 3-6|1|||
27732687|NCT03133767|80846343|FG000|Overall Study|Lost to Follow-up|38|||
27732688|NCT03133767|80846344|FG001|Overall Study|Lost to Follow-up|24|||
27732689|NCT03133767|80846343|FG000|Overall Study|Protocol Violation|0|||
27732690|NCT03133767|80846344|FG001|Overall Study|Protocol Violation|1|||
27732691|NCT01276288|80846347|FG000|Overall Study|Adverse Event|1|||
27732692|NCT01276288|80846348|FG001|Overall Study|Adverse Event|1|||
27732693|NCT01276288|80846349|FG002|Overall Study|Adverse Event|0|||
27732694|NCT01276288|80846350|FG003|Overall Study|Adverse Event|0|||
27732695|NCT01276288|80846347|FG000|Overall Study|not treated|1|||
27732696|NCT01276288|80846348|FG001|Overall Study|not treated|0|||
27732697|NCT01276288|80846349|FG002|Overall Study|not treated|0|||
27732698|NCT01276288|80846350|FG003|Overall Study|not treated|0|||
27732699|NCT05499520|80846351|FG000|Overall Study|Lost to Follow-up|0|||
27732700|NCT05499520|80846352|FG001|Overall Study|Lost to Follow-up|0|||
27732701|NCT05499520|80846353|FG002|Overall Study|Lost to Follow-up|38|||
27855193|NCT00536263|81302535|FG001|Overall Study|Lost to Follow-up|4|||
27855194|NCT00536263|81302536|FG002|Overall Study|Lost to Follow-up|4|||
27855195|NCT00536263|81302534|FG000|Overall Study|Subject withdrew - not treatment related|2|||
27855196|NCT00536263|81302535|FG001|Overall Study|Subject withdrew - not treatment related|0|||
27855197|NCT00536263|81302536|FG002|Overall Study|Subject withdrew - not treatment related|5|||
27855198|NCT00536263|81302534|FG000|Overall Study|Subject withdrew - treatment related|0|||
27855199|NCT00536263|81302535|FG001|Overall Study|Subject withdrew - treatment related|3|||
27524538|NCT00797966|80112523|FG005|Phase B|Adverse Event|0|||
27524539|NCT00797966|80112518|FG000|Phase B|Met Withdrawal Criteria|3|||
27524540|NCT00797966|80112519|FG001|Phase B|Met Withdrawal Criteria|3|||
27524541|NCT00797966|80112520|FG002|Phase B|Met Withdrawal Criteria|6|||
27524542|NCT00797966|80112521|FG003|Phase B|Met Withdrawal Criteria|1|||
27524543|NCT00797966|80112522|FG004|Phase B|Met Withdrawal Criteria|0|||
27524544|NCT00797966|80112523|FG005|Phase B|Met Withdrawal Criteria|0|||
27524545|NCT00797966|80112518|FG000|Phase B|Physician Decision|1|||
27732702|NCT05499520|80846354|FG003|Overall Study|Lost to Follow-up|41|||
27732703|NCT05499520|80846355|FG004|Overall Study|Lost to Follow-up|46|||
27732704|NCT05499520|80846356|FG005|Overall Study|Lost to Follow-up|0|||
27855200|NCT00536263|81302536|FG002|Overall Study|Subject withdrew - treatment related|2|||
27855201|NCT00536263|81302534|FG000|Overall Study|Noncompliance with protocol|0|||
27855202|NCT00536263|81302535|FG001|Overall Study|Noncompliance with protocol|0|||
27855203|NCT00536263|81302536|FG002|Overall Study|Noncompliance with protocol|1|||
27732705|NCT05499520|80846357|FG006|Overall Study|Lost to Follow-up|31|||
27855204|NCT00536263|81302534|FG000|Overall Study|Did not meet protocol eligibility|1|||
27855205|NCT00536263|81302535|FG001|Overall Study|Did not meet protocol eligibility|2|||
27855206|NCT00536263|81302536|FG002|Overall Study|Did not meet protocol eligibility|2|||
27855207|NCT04234984|81302537|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
27910227|NCT00667992|81510051|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
27524546|NCT00797966|80112519|FG001|Phase B|Physician Decision|0|||
27524547|NCT00797966|80112520|FG002|Phase B|Physician Decision|3|||
27524548|NCT00797966|80112521|FG003|Phase B|Physician Decision|1|||
27524549|NCT00797966|80112522|FG004|Phase B|Physician Decision|0|||
27524550|NCT00797966|80112523|FG005|Phase B|Physician Decision|0|||
27732706|NCT05499520|80846358|FG007|Overall Study|Lost to Follow-up|45|||
27732707|NCT05499520|80846359|FG008|Overall Study|Lost to Follow-up|42|||
27732708|NCT05499520|80846360|FG009|Overall Study|Lost to Follow-up|0|||
27524551|NCT00797966|80112518|FG000|Phase B|Withdrawal by Subject|1|||
27732709|NCT05499520|80846361|FG010|Overall Study|Lost to Follow-up|0|||
27732710|NCT05499520|80846362|FG011|Overall Study|Lost to Follow-up|37|||
27524552|NCT00797966|80112519|FG001|Phase B|Withdrawal by Subject|4|||
27524553|NCT00797966|80112520|FG002|Phase B|Withdrawal by Subject|3|||
27524554|NCT00797966|80112521|FG003|Phase B|Withdrawal by Subject|3|||
27622104|NCT00689104|80457821|FG001|Overall Study|Withdrawal by Subject|11|||
27622105|NCT00689104|80457822|FG002|Overall Study|Withdrawal by Subject|18|||
27622106|NCT00689104|80457823|FG003|Overall Study|Withdrawal by Subject|11|||
27622107|NCT00689104|80457820|FG000|Overall Study|Lost to Follow-up|4|||
27622108|NCT00689104|80457821|FG001|Overall Study|Lost to Follow-up|3|||
27524555|NCT00797966|80112522|FG004|Phase B|Withdrawal by Subject|0|||
27524556|NCT00797966|80112523|FG005|Phase B|Withdrawal by Subject|0|||
27622109|NCT00689104|80457822|FG002|Overall Study|Lost to Follow-up|2|||
27524557|NCT00797966|80112518|FG000|Phase B|Protocol Deviation|4|||
27524558|NCT00797966|80112519|FG001|Phase B|Protocol Deviation|8|||
27524559|NCT00797966|80112520|FG002|Phase B|Protocol Deviation|2|||
27524560|NCT00797966|80112521|FG003|Phase B|Protocol Deviation|6|||
27524561|NCT00797966|80112522|FG004|Phase B|Protocol Deviation|0|||
27524562|NCT00797966|80112523|FG005|Phase B|Protocol Deviation|0|||
27524563|NCT00797966|80112518|FG000|Phase B|Lack of Efficacy|0|||
27524564|NCT00797966|80112519|FG001|Phase B|Lack of Efficacy|1|||
27524565|NCT00797966|80112520|FG002|Phase B|Lack of Efficacy|1|||
27524566|NCT00797966|80112521|FG003|Phase B|Lack of Efficacy|4|||
27524567|NCT00797966|80112522|FG004|Phase B|Lack of Efficacy|0|||
27524568|NCT00797966|80112523|FG005|Phase B|Lack of Efficacy|0|||
27524569|NCT00797966|80112518|FG000|Phase A+|Lost to Follow-up|0|||
27524570|NCT00797966|80112519|FG001|Phase A+|Lost to Follow-up|0|||
27524571|NCT00797966|80112520|FG002|Phase A+|Lost to Follow-up|0|||
27524572|NCT00797966|80112521|FG003|Phase A+|Lost to Follow-up|0|||
27524573|NCT00797966|80112522|FG004|Phase A+|Lost to Follow-up|0|||
27524574|NCT00797966|80112523|FG005|Phase A+|Lost to Follow-up|9|||
27524575|NCT00797966|80112518|FG000|Phase A+|Met withdrawal criteria|0|||
27524576|NCT00797966|80112519|FG001|Phase A+|Met withdrawal criteria|0|||
27524577|NCT00797966|80112520|FG002|Phase A+|Met withdrawal criteria|0|||
27524578|NCT00797966|80112521|FG003|Phase A+|Met withdrawal criteria|0|||
27524579|NCT00797966|80112522|FG004|Phase A+|Met withdrawal criteria|0|||
27524580|NCT00797966|80112523|FG005|Phase A+|Met withdrawal criteria|5|||
27524581|NCT00797966|80112518|FG000|Phase A+|Withdrawal by Subject|0|||
27524582|NCT00797966|80112519|FG001|Phase A+|Withdrawal by Subject|0|||
27524583|NCT00797966|80112520|FG002|Phase A+|Withdrawal by Subject|0|||
27524584|NCT00797966|80112521|FG003|Phase A+|Withdrawal by Subject|0|||
27524585|NCT00797966|80112522|FG004|Phase A+|Withdrawal by Subject|0|||
27524586|NCT00797966|80112523|FG005|Phase A+|Withdrawal by Subject|6|||
27524587|NCT00797966|80112518|FG000|Phase A+|Adverse Event|0|||
27524588|NCT00797966|80112519|FG001|Phase A+|Adverse Event|0|||
27524589|NCT00797966|80112520|FG002|Phase A+|Adverse Event|0|||
27524590|NCT00797966|80112521|FG003|Phase A+|Adverse Event|0|||
27524591|NCT00797966|80112522|FG004|Phase A+|Adverse Event|0|||
27524592|NCT00797966|80112523|FG005|Phase A+|Adverse Event|4|||
27524593|NCT00797966|80112518|FG000|Phase A+|Protocol deviation|0|||
27524594|NCT00797966|80112519|FG001|Phase A+|Protocol deviation|0|||
27910228|NCT00667992|81510052|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
27524595|NCT00797966|80112520|FG002|Phase A+|Protocol deviation|0|||
27524596|NCT00797966|80112521|FG003|Phase A+|Protocol deviation|0|||
27524597|NCT00797966|80112522|FG004|Phase A+|Protocol deviation|0|||
27524598|NCT00797966|80112523|FG005|Phase A+|Protocol deviation|4|||
27524599|NCT00991952|80112524|FG000|Overall Study|Adverse Event|0|||
27524600|NCT00991952|80112525|FG001|Overall Study|Adverse Event|1|||
27524601|NCT03859973|80112526|FG000|Overall Study|Other reason than listed|3|||
27524602|NCT03859973|80112527|FG001|Overall Study|Other reason than listed|2|||
27524603|NCT03859973|80112526|FG000|Overall Study|COVID-19 related, not due to AE|3|||
27524604|NCT03859973|80112527|FG001|Overall Study|COVID-19 related, not due to AE|4|||
27524605|NCT03859973|80112526|FG000|Overall Study|Withdrawal by Subject|8|||
27524606|NCT03859973|80112527|FG001|Overall Study|Withdrawal by Subject|9|||
27524607|NCT03859973|80112526|FG000|Overall Study|Lost to Follow-up|2|||
27524608|NCT03859973|80112527|FG001|Overall Study|Lost to Follow-up|3|||
27524609|NCT03859973|80112526|FG000|Overall Study|Protocol Violation|1|||
27524610|NCT03859973|80112527|FG001|Overall Study|Protocol Violation|3|||
27524611|NCT03859973|80112526|FG000|Overall Study|Adverse Event|3|||
27524612|NCT03859973|80112527|FG001|Overall Study|Adverse Event|5|||
27524613|NCT02047318|80112528|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
27524614|NCT02047318|80112528|FG000|Core Study Period|Adverse Event|1|||
27524615|NCT02047318|80112528|FG000|Core Study Period|Withdrawal by caregiver|3|||
27524616|NCT02047318|80112528|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
27524617|NCT00718237|80112533|FG000|Overall Study|Adverse Event|1|||
27524618|NCT00718237|80112534|FG001|Overall Study|Adverse Event|3|||
27524619|NCT00718237|80112533|FG000|Overall Study|Lost to Follow-up|2|||
27524620|NCT00718237|80112534|FG001|Overall Study|Lost to Follow-up|2|||
27524621|NCT00718237|80112533|FG000|Overall Study|Physician Decision|1|||
27524622|NCT00718237|80112534|FG001|Overall Study|Physician Decision|0|||
27524623|NCT00718237|80112533|FG000|Overall Study|Withdrawal by Subject|9|||
27524624|NCT00718237|80112534|FG001|Overall Study|Withdrawal by Subject|10|||
27524625|NCT02095132|80112535|FG000|Overall Study|Adverse Event|0|||
27524626|NCT02095132|80112536|FG001|Overall Study|Adverse Event|0|||
27524627|NCT02095132|80112537|FG002|Overall Study|Adverse Event|0|||
27524628|NCT02095132|80112538|FG003|Overall Study|Adverse Event|0|||
27524629|NCT02095132|80112539|FG004|Overall Study|Adverse Event|1|||
27910229|NCT01135524|81510059|FG000|Overall Study|Withdrawal by Subject|14|||
27910230|NCT01135524|81510059|FG000|Overall Study|Adverse Event|20|||
27524630|NCT02095132|80112540|FG005|Overall Study|Adverse Event|0|||
27524631|NCT02095132|80112541|FG006|Overall Study|Adverse Event|1|||
27524632|NCT02095132|80112542|FG007|Overall Study|Adverse Event|0|||
27524633|NCT02095132|80112543|FG008|Overall Study|Adverse Event|0|||
27524634|NCT02095132|80112535|FG000|Overall Study|Death|0|||
27524635|NCT02095132|80112536|FG001|Overall Study|Death|0|||
27524636|NCT02095132|80112537|FG002|Overall Study|Death|0|||
27524637|NCT02095132|80112538|FG003|Overall Study|Death|0|||
27524638|NCT02095132|80112539|FG004|Overall Study|Death|0|||
27524639|NCT02095132|80112540|FG005|Overall Study|Death|0|||
27524640|NCT02095132|80112541|FG006|Overall Study|Death|1|||
27524641|NCT02095132|80112542|FG007|Overall Study|Death|0|||
27524642|NCT02095132|80112543|FG008|Overall Study|Death|0|||
27524643|NCT02095132|80112535|FG000|Overall Study|Lack of Efficacy|3|||
27524644|NCT02095132|80112536|FG001|Overall Study|Lack of Efficacy|5|||
27524645|NCT02095132|80112537|FG002|Overall Study|Lack of Efficacy|2|||
27524646|NCT02095132|80112538|FG003|Overall Study|Lack of Efficacy|8|||
27524647|NCT02095132|80112539|FG004|Overall Study|Lack of Efficacy|3|||
27524648|NCT02095132|80112540|FG005|Overall Study|Lack of Efficacy|6|||
27524649|NCT02095132|80112541|FG006|Overall Study|Lack of Efficacy|10|||
27524650|NCT02095132|80112542|FG007|Overall Study|Lack of Efficacy|9|||
27524651|NCT02095132|80112543|FG008|Overall Study|Lack of Efficacy|8|||
27524652|NCT02095132|80112535|FG000|Overall Study|Physician Decision|1|||
27524653|NCT02095132|80112536|FG001|Overall Study|Physician Decision|0|||
27524654|NCT02095132|80112537|FG002|Overall Study|Physician Decision|0|||
27524655|NCT02095132|80112538|FG003|Overall Study|Physician Decision|0|||
27524656|NCT02095132|80112539|FG004|Overall Study|Physician Decision|0|||
27524657|NCT02095132|80112540|FG005|Overall Study|Physician Decision|0|||
27524658|NCT02095132|80112541|FG006|Overall Study|Physician Decision|1|||
27524659|NCT02095132|80112542|FG007|Overall Study|Physician Decision|0|||
27524660|NCT02095132|80112543|FG008|Overall Study|Physician Decision|2|||
27524661|NCT02095132|80112535|FG000|Overall Study|Withdrawal by Subject|0|||
27524662|NCT02095132|80112536|FG001|Overall Study|Withdrawal by Subject|0|||
27524663|NCT02095132|80112537|FG002|Overall Study|Withdrawal by Subject|2|||
27524664|NCT02095132|80112538|FG003|Overall Study|Withdrawal by Subject|2|||
27524665|NCT02095132|80112539|FG004|Overall Study|Withdrawal by Subject|3|||
27524666|NCT02095132|80112540|FG005|Overall Study|Withdrawal by Subject|0|||
27524667|NCT02095132|80112541|FG006|Overall Study|Withdrawal by Subject|5|||
27524668|NCT02095132|80112542|FG007|Overall Study|Withdrawal by Subject|0|||
27524669|NCT02095132|80112543|FG008|Overall Study|Withdrawal by Subject|0|||
27524670|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
27524671|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
27524672|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
27524673|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
27524674|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
27524675|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
27524676|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
27524677|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
27524678|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
27524679|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
27524680|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
27524681|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
27622110|NCT00689104|80457823|FG003|Overall Study|Lost to Follow-up|5|||
27524682|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
27524683|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
27524684|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
27524685|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
27524686|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
27524687|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
27524688|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
27524689|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
27524690|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
27524691|NCT01227824|80112550|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
27524692|NCT01227824|80112551|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
27524693|NCT01227824|80112552|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
27524694|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
27524695|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
27524696|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
27524697|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
27524698|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
27524699|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
27524700|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
27524701|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
27524702|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
27524703|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
27622111|NCT00689104|80457820|FG000|Overall Study|Protocol Violation|2|||
27524704|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
27524705|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
27524706|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
27524707|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
27524708|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
27524709|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
27524710|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
27524711|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
27524712|NCT01227824|80112550|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
27524713|NCT01227824|80112551|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
27524714|NCT01227824|80112552|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
27524715|NCT00527488|80112553|FG000|Overall Study|Withdrawn prior to dosing|0|||
27524716|NCT00527488|80112554|FG001|Overall Study|Withdrawn prior to dosing|1|||
27524717|NCT00527488|80112555|FG002|Overall Study|Withdrawn prior to dosing|1|||
27524718|NCT00527488|80112556|FG003|Overall Study|Withdrawn prior to dosing|0|||
27524719|NCT01752036|80112560|FG000|Overall Study|Death|2|||
27524720|NCT00322621|80112562|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
27524721|NCT00322621|80112563|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
27524722|NCT00322621|80112564|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
27524723|NCT00322621|80112562|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
27524724|NCT00322621|80112563|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
27524725|NCT00322621|80112564|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
27524726|NCT00322621|80112562|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
27524727|NCT00322621|80112563|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
27524728|NCT00322621|80112564|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
27524729|NCT00322621|80112562|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
27524730|NCT00322621|80112563|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
27524731|NCT00322621|80112564|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
27524732|NCT00322621|80112562|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
27524733|NCT00322621|80112563|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
27524734|NCT00322621|80112564|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
27524735|NCT00322621|80112562|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
27524736|NCT00322621|80112563|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
27524737|NCT00322621|80112564|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
27524738|NCT00322621|80112562|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
27524739|NCT00322621|80112563|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
27524740|NCT00322621|80112564|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
27855208|NCT04234984|81302537|FG000|Follow-up at the Second Time Point|Death|1|||
27855209|NCT04234984|81302537|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
27855210|NCT05142566|81302540|FG000|Overall Study|Protocol Violation|1|||
27855211|NCT01685073|81302543|FG000|Overall Study|Lost to Follow-up|6|||
27524741|NCT00322621|80112562|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
27524742|NCT00322621|80112563|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
27524743|NCT00322621|80112564|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
27524744|NCT00322621|80112562|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
27524745|NCT00322621|80112563|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
27524746|NCT00322621|80112564|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
27524747|NCT00322621|80112562|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
27524748|NCT00322621|80112563|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
27524749|NCT00322621|80112564|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
27524750|NCT00322621|80112562|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
27524751|NCT00322621|80112563|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
27524752|NCT00322621|80112564|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
27524753|NCT04381988|80112565|FG000|Overall Study|The study was terminated|4|||
27524754|NCT04381988|80112566|FG001|Overall Study|The study was terminated|0|||
27524755|NCT01975831|80115987|FG000|Overall Study|Adverse Event|1|||
27524756|NCT01975831|80115988|FG001|Overall Study|Adverse Event|2|||
27622112|NCT00689104|80457821|FG001|Overall Study|Protocol Violation|3|||
27622113|NCT00689104|80457822|FG002|Overall Study|Protocol Violation|5|||
27622114|NCT00689104|80457823|FG003|Overall Study|Protocol Violation|3|||
27622115|NCT00689104|80457820|FG000|Overall Study|Randomized but never received study drug|2|||
27622116|NCT00689104|80457821|FG001|Overall Study|Randomized but never received study drug|1|||
27910231|NCT01135524|81510059|FG000|Overall Study|Lost to Follow-up|3|||
27524757|NCT01975831|80115989|FG002|Overall Study|Adverse Event|2|||
27524758|NCT01975831|80115990|FG003|Overall Study|Adverse Event|0|||
27524759|NCT01975831|80115991|FG004|Overall Study|Adverse Event|1|||
27524760|NCT01975831|80115992|FG005|Overall Study|Adverse Event|1|||
27622117|NCT00689104|80457822|FG002|Overall Study|Randomized but never received study drug|1|||
27622118|NCT00689104|80457823|FG003|Overall Study|Randomized but never received study drug|0|||
27622119|NCT00689104|80457820|FG000|Overall Study|Physician Decision|1|||
27622120|NCT00689104|80457821|FG001|Overall Study|Physician Decision|0|||
27622121|NCT00689104|80457822|FG002|Overall Study|Physician Decision|0|||
27622122|NCT00689104|80457823|FG003|Overall Study|Physician Decision|0|||
27622123|NCT00689104|80457820|FG000|Overall Study|Non-compliance with study procedures|0|||
27622124|NCT00689104|80457821|FG001|Overall Study|Non-compliance with study procedures|0|||
27622125|NCT00689104|80457822|FG002|Overall Study|Non-compliance with study procedures|1|||
27622126|NCT00689104|80457823|FG003|Overall Study|Non-compliance with study procedures|0|||
27622127|NCT03282123|80457824|FG000|Overall Study|Withdrawal by Subject|5|||
27622128|NCT05008224|80457825|FG000|Overall Study|Death|3|||
27622129|NCT05008224|80457825|FG000|Overall Study|Lost to Follow-up|2|||
27622130|NCT05008224|80457825|FG000|Overall Study|Did Not Continue on Extension Study|39|||
27622131|NCT05008224|80457825|FG000|Overall Study|Transferred to Extension Study|100|||
27622132|NCT05008224|80457825|FG000|Overall Study|Withdrawal by Subject|2|||
27622133|NCT03474107|80457828|FG000|Overall Study|Adverse Event|42|||
27622134|NCT03474107|80457829|FG001|Overall Study|Adverse Event|46|||
27622135|NCT03474107|80457828|FG000|Overall Study|Death|2|||
27622136|NCT03474107|80457829|FG001|Overall Study|Death|2|||
27910232|NCT01135524|81510059|FG000|Overall Study|Administrative|151|||
27622137|NCT03474107|80457828|FG000|Overall Study|Lost to Follow-up|0|||
27622138|NCT03474107|80457829|FG001|Overall Study|Lost to Follow-up|1|||
27622139|NCT03474107|80457828|FG000|Overall Study|Progressive Disease|177|||
27622140|NCT03474107|80457829|FG001|Overall Study|Progressive Disease|180|||
27622141|NCT03474107|80457828|FG000|Overall Study|Protocol Violation|1|||
27622142|NCT03474107|80457829|FG001|Overall Study|Protocol Violation|1|||
27622143|NCT03474107|80457828|FG000|Overall Study|Withdrawal by Subject|15|||
27622144|NCT03474107|80457829|FG001|Overall Study|Withdrawal by Subject|27|||
27622145|NCT03474107|80457828|FG000|Overall Study|Physician Decision|7|||
27622146|NCT03474107|80457829|FG001|Overall Study|Physician Decision|22|||
27622147|NCT03474107|80457828|FG000|Overall Study|Miscellaneous|1|||
27622148|NCT03474107|80457829|FG001|Overall Study|Miscellaneous|6|||
27622149|NCT02323880|80457830|FG000|Overall Study|Adverse Event|2|||
27622150|NCT02323880|80457831|FG001|Overall Study|Adverse Event|0|||
27622151|NCT02323880|80457832|FG002|Overall Study|Adverse Event|1|||
27622152|NCT02323880|80457833|FG003|Overall Study|Adverse Event|1|||
27622153|NCT02323880|80457834|FG004|Overall Study|Adverse Event|1|||
27622154|NCT02323880|80457835|FG005|Overall Study|Adverse Event|0|||
27622155|NCT02323880|80457836|FG006|Overall Study|Adverse Event|1|||
27622156|NCT02323880|80457837|FG007|Overall Study|Adverse Event|0|||
27622157|NCT02323880|80457830|FG000|Overall Study|Death|0|||
27622158|NCT02323880|80457831|FG001|Overall Study|Death|0|||
27622159|NCT02323880|80457832|FG002|Overall Study|Death|0|||
27622160|NCT02323880|80457833|FG003|Overall Study|Death|0|||
27910233|NCT01135524|81510059|FG000|Overall Study|Lack of Efficacy|8|||
27622161|NCT02323880|80457834|FG004|Overall Study|Death|0|||
27855212|NCT01685073|81302544|FG001|Overall Study|Lost to Follow-up|8|||
27855213|NCT01685073|81302543|FG000|Overall Study|Withdrawal by Subject|24|||
27855214|NCT01685073|81302544|FG001|Overall Study|Withdrawal by Subject|24|||
27855215|NCT02072148|81302548|FG000|Overall Study|withdrew prior to surgery|23|||
27855216|NCT02072148|81302549|FG001|Overall Study|withdrew prior to surgery|0|||
27855217|NCT02072148|81302550|FG002|Overall Study|withdrew prior to surgery|0|||
27855218|NCT02072148|81302548|FG000|Overall Study|Death|0|||
27855219|NCT02072148|81302549|FG001|Overall Study|Death|0|||
27855220|NCT02072148|81302550|FG002|Overall Study|Death|1|||
27855221|NCT02072148|81302548|FG000|Overall Study|Withdrawal by Subject|0|||
27622162|NCT02323880|80457835|FG005|Overall Study|Death|1|||
27622163|NCT02323880|80457836|FG006|Overall Study|Death|0|||
27622164|NCT02323880|80457837|FG007|Overall Study|Death|0|||
27855222|NCT02072148|81302549|FG001|Overall Study|Withdrawal by Subject|13|||
27855223|NCT02072148|81302550|FG002|Overall Study|Withdrawal by Subject|12|||
27855224|NCT00228423|81302551|FG000|Overall Study|Adverse Event|2|||
27855225|NCT00228423|81302552|FG001|Overall Study|Adverse Event|5|||
27855226|NCT00228423|81302551|FG000|Overall Study|Withdrawal by Subject|7|||
27622165|NCT02323880|80457830|FG000|Overall Study|Lack of Efficacy|4|||
27855227|NCT00228423|81302552|FG001|Overall Study|Withdrawal by Subject|3|||
27622166|NCT02323880|80457831|FG001|Overall Study|Lack of Efficacy|11|||
27622167|NCT02323880|80457832|FG002|Overall Study|Lack of Efficacy|5|||
27622168|NCT02323880|80457833|FG003|Overall Study|Lack of Efficacy|5|||
27622169|NCT02323880|80457834|FG004|Overall Study|Lack of Efficacy|4|||
27622170|NCT02323880|80457835|FG005|Overall Study|Lack of Efficacy|8|||
27622171|NCT02323880|80457836|FG006|Overall Study|Lack of Efficacy|4|||
27622172|NCT02323880|80457837|FG007|Overall Study|Lack of Efficacy|6|||
27622173|NCT02323880|80457830|FG000|Overall Study|Physician Decision|0|||
27622174|NCT02323880|80457831|FG001|Overall Study|Physician Decision|0|||
27622175|NCT02323880|80457832|FG002|Overall Study|Physician Decision|0|||
27622176|NCT02323880|80457833|FG003|Overall Study|Physician Decision|0|||
27622177|NCT02323880|80457834|FG004|Overall Study|Physician Decision|1|||
27855228|NCT00228423|81302551|FG000|Overall Study|Protocol Violation|1|||
27910234|NCT01711983|81510063|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
27910235|NCT01711983|81510063|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
27910236|NCT01711983|81510063|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
27910237|NCT01711983|81510063|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
27910238|NCT03727841|81510075|FG000|Overall Study|Physician Decision|3|||
27910239|NCT03727841|81510076|FG001|Overall Study|Physician Decision|1|||
27910240|NCT02227784|81510077|FG000|Double-Blind Phase|Adverse Event|3|||
27910241|NCT02227784|81510078|FG001|Double-Blind Phase|Adverse Event|2|||
27910242|NCT02227784|81510079|FG002|Double-Blind Phase|Adverse Event|1|||
27910243|NCT02227784|81510080|FG003|Double-Blind Phase|Adverse Event|3|||
27910244|NCT02227784|81510081|FG004|Double-Blind Phase|Adverse Event|0|||
27910245|NCT02227784|81510077|FG000|Double-Blind Phase|Physician Decision|1|||
27524761|NCT01975831|80115993|FG006|Overall Study|Adverse Event|3|||
27524762|NCT01975831|80115994|FG007|Overall Study|Adverse Event|4|||
27524763|NCT01975831|80115995|FG008|Overall Study|Adverse Event|1|||
27524764|NCT01975831|80115987|FG000|Overall Study|Death|1|||
27524765|NCT01975831|80115988|FG001|Overall Study|Death|1|||
27524766|NCT01975831|80115989|FG002|Overall Study|Death|0|||
27910246|NCT02227784|81510078|FG001|Double-Blind Phase|Physician Decision|0|||
27910247|NCT02227784|81510079|FG002|Double-Blind Phase|Physician Decision|0|||
27524767|NCT01975831|80115990|FG003|Overall Study|Death|0|||
27524768|NCT01975831|80115991|FG004|Overall Study|Death|1|||
27524769|NCT01975831|80115992|FG005|Overall Study|Death|0|||
27524770|NCT01975831|80115993|FG006|Overall Study|Death|1|||
27524771|NCT01975831|80115994|FG007|Overall Study|Death|0|||
27524772|NCT01975831|80115995|FG008|Overall Study|Death|0|||
27910248|NCT02227784|81510080|FG003|Double-Blind Phase|Physician Decision|1|||
27910249|NCT02227784|81510081|FG004|Double-Blind Phase|Physician Decision|0|||
27910250|NCT02227784|81510077|FG000|Double-Blind Phase|Protocol Violation|0|||
27910251|NCT02227784|81510078|FG001|Double-Blind Phase|Protocol Violation|0|||
27910252|NCT02227784|81510079|FG002|Double-Blind Phase|Protocol Violation|1|||
27524773|NCT01975831|80115987|FG000|Overall Study|Progressive Disease|1|||
27524774|NCT01975831|80115988|FG001|Overall Study|Progressive Disease|3|||
27524775|NCT01975831|80115989|FG002|Overall Study|Progressive Disease|2|||
27524776|NCT01975831|80115990|FG003|Overall Study|Progressive Disease|4|||
27524777|NCT01975831|80115991|FG004|Overall Study|Progressive Disease|13|||
27524778|NCT01975831|80115992|FG005|Overall Study|Progressive Disease|9|||
27524779|NCT01975831|80115993|FG006|Overall Study|Progressive Disease|10|||
27524780|NCT01975831|80115994|FG007|Overall Study|Progressive Disease|8|||
27524781|NCT01975831|80115995|FG008|Overall Study|Progressive Disease|10|||
27524782|NCT01975831|80115987|FG000|Overall Study|Withdrawal by Subject|0|||
27524783|NCT01975831|80115988|FG001|Overall Study|Withdrawal by Subject|3|||
27524784|NCT01975831|80115989|FG002|Overall Study|Withdrawal by Subject|0|||
27524785|NCT01975831|80115990|FG003|Overall Study|Withdrawal by Subject|0|||
27524786|NCT01975831|80115991|FG004|Overall Study|Withdrawal by Subject|3|||
27524787|NCT01975831|80115992|FG005|Overall Study|Withdrawal by Subject|1|||
27524788|NCT01975831|80115993|FG006|Overall Study|Withdrawal by Subject|1|||
27524789|NCT01975831|80115994|FG007|Overall Study|Withdrawal by Subject|0|||
27524790|NCT01975831|80115995|FG008|Overall Study|Withdrawal by Subject|0|||
27524791|NCT01975831|80115987|FG000|Overall Study|Physician Decision|0|||
27524792|NCT01975831|80115988|FG001|Overall Study|Physician Decision|0|||
27524793|NCT01975831|80115989|FG002|Overall Study|Physician Decision|0|||
27524794|NCT01975831|80115990|FG003|Overall Study|Physician Decision|0|||
27524795|NCT01975831|80115991|FG004|Overall Study|Physician Decision|0|||
27524796|NCT01975831|80115992|FG005|Overall Study|Physician Decision|1|||
27524797|NCT01975831|80115993|FG006|Overall Study|Physician Decision|0|||
27524798|NCT01975831|80115994|FG007|Overall Study|Physician Decision|1|||
27524799|NCT01975831|80115995|FG008|Overall Study|Physician Decision|0|||
27524800|NCT01975831|80115987|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
27524801|NCT01975831|80115988|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
27524802|NCT01975831|80115989|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
27855229|NCT00228423|81302552|FG001|Overall Study|Protocol Violation|3|||
27910253|NCT02227784|81510080|FG003|Double-Blind Phase|Protocol Violation|1|||
27910254|NCT02227784|81510081|FG004|Double-Blind Phase|Protocol Violation|0|||
27910255|NCT02227784|81510077|FG000|Double-Blind Phase|Sponsor Decision|34|||
27910256|NCT02227784|81510078|FG001|Double-Blind Phase|Sponsor Decision|15|||
27524803|NCT01975831|80115990|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
27524804|NCT01975831|80115991|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
27524805|NCT01975831|80115992|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
27524806|NCT01975831|80115993|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
27524807|NCT01975831|80115994|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
27524808|NCT01975831|80115995|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
27524809|NCT01975831|80115987|FG000|Overall Study|Entered Hospice|0|||
27524810|NCT01975831|80115988|FG001|Overall Study|Entered Hospice|0|||
27524811|NCT01975831|80115989|FG002|Overall Study|Entered Hospice|0|||
27524812|NCT01975831|80115990|FG003|Overall Study|Entered Hospice|0|||
27524813|NCT01975831|80115991|FG004|Overall Study|Entered Hospice|0|||
27524814|NCT01975831|80115992|FG005|Overall Study|Entered Hospice|1|||
27910257|NCT02227784|81510079|FG002|Double-Blind Phase|Sponsor Decision|14|||
27910258|NCT02227784|81510080|FG003|Double-Blind Phase|Sponsor Decision|32|||
27910259|NCT02227784|81510081|FG004|Double-Blind Phase|Sponsor Decision|0|||
27910260|NCT02227784|81510077|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
27910261|NCT02227784|81510078|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
27910262|NCT02227784|81510079|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
27910263|NCT02227784|81510080|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
27910264|NCT02227784|81510081|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
27910265|NCT02227784|81510077|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27910266|NCT02227784|81510078|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27524815|NCT01975831|80115993|FG006|Overall Study|Entered Hospice|0|||
27524816|NCT01975831|80115994|FG007|Overall Study|Entered Hospice|0|||
27524817|NCT01975831|80115995|FG008|Overall Study|Entered Hospice|0|||
27524818|NCT01975831|80115987|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524819|NCT01975831|80115988|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524820|NCT01975831|80115989|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524821|NCT01975831|80115990|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524822|NCT01975831|80115991|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524823|NCT01975831|80115992|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524824|NCT01975831|80115993|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
27524825|NCT01975831|80115994|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
27524826|NCT01975831|80115995|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
27524827|NCT03044574|80115999|FG000|Overall Study|Lost to Follow-up|37|||
27524828|NCT03044574|80116000|FG001|Overall Study|Lost to Follow-up|45|||
27524829|NCT02106923|80116001|FG000|Overall Study|Protocol Violation|0|||
27524830|NCT02106923|80116002|FG001|Overall Study|Protocol Violation|0|||
27524831|NCT02106923|80116003|FG002|Overall Study|Protocol Violation|0|||
27524832|NCT02106923|80116004|FG003|Overall Study|Protocol Violation|0|||
27524833|NCT02106923|80116005|FG004|Overall Study|Protocol Violation|0|||
27524834|NCT02106923|80116006|FG005|Overall Study|Protocol Violation|1|||
27524835|NCT02937584|80116007|FG000|Period 1|Adverse Event|1|||
27524836|NCT02937584|80116008|FG001|Period 1|Adverse Event|2|||
27524837|NCT02937584|80116007|FG000|Washout|Adverse Event|0|||
27524838|NCT02937584|80116008|FG001|Washout|Adverse Event|1|||
27622178|NCT02323880|80457835|FG005|Overall Study|Physician Decision|1|||
27622179|NCT02323880|80457836|FG006|Overall Study|Physician Decision|1|||
27622180|NCT02323880|80457837|FG007|Overall Study|Physician Decision|0|||
27622181|NCT02323880|80457830|FG000|Overall Study|Withdrawal by Subject|0|||
27622182|NCT02323880|80457831|FG001|Overall Study|Withdrawal by Subject|2|||
27622183|NCT02323880|80457832|FG002|Overall Study|Withdrawal by Subject|0|||
27622184|NCT02323880|80457833|FG003|Overall Study|Withdrawal by Subject|0|||
27622185|NCT02323880|80457834|FG004|Overall Study|Withdrawal by Subject|0|||
27622186|NCT02323880|80457835|FG005|Overall Study|Withdrawal by Subject|0|||
27622187|NCT02323880|80457836|FG006|Overall Study|Withdrawal by Subject|0|||
27622188|NCT02323880|80457837|FG007|Overall Study|Withdrawal by Subject|0|||
27622189|NCT04394624|80457839|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
27622190|NCT04394624|80457839|FG000|Overall Study|Adverse Event|5|||
27622191|NCT04394624|80457839|FG000|Overall Study|Progressive disease|20|||
27622192|NCT03717194|80457842|FG000|Overall Study|Withdrawal by Subject|2|||
27622193|NCT03717194|80457843|FG001|Overall Study|Withdrawal by Subject|4|||
27622194|NCT03717194|80457842|FG000|Overall Study|Adverse Event|1|||
27622195|NCT03717194|80457843|FG001|Overall Study|Adverse Event|1|||
27622196|NCT04794179|80457844|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
27622197|NCT04794179|80457845|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
27622198|NCT04174560|80457846|FG000|Overall Study|Lost to Follow-up|1|||
27622199|NCT04174560|80457847|FG001|Overall Study|Lost to Follow-up|0|||
27622200|NCT04174560|80457848|FG002|Overall Study|Lost to Follow-up|0|||
27622201|NCT04174560|80457849|FG003|Overall Study|Lost to Follow-up|0|||
27732711|NCT05499520|80846363|FG012|Overall Study|Lost to Follow-up|53|||
27524839|NCT01244490|80116009|FG000|Overall Study|Lack of Efficacy|14|||
27524840|NCT01244490|80116010|FG001|Overall Study|Lack of Efficacy|5|||
27622202|NCT04174560|80457846|FG000|Overall Study|Withdrawal by Subject|0|||
27622203|NCT04174560|80457847|FG001|Overall Study|Withdrawal by Subject|0|||
27910267|NCT02227784|81510079|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27524841|NCT01244490|80116011|FG002|Overall Study|Lack of Efficacy|5|||
27524842|NCT01244490|80116009|FG000|Overall Study|Withdrawal by Subject|4|||
27524843|NCT01244490|80116010|FG001|Overall Study|Withdrawal by Subject|4|||
27524844|NCT01244490|80116011|FG002|Overall Study|Withdrawal by Subject|9|||
27524845|NCT01244490|80116009|FG000|Overall Study|Adverse Event|1|||
27524846|NCT01244490|80116010|FG001|Overall Study|Adverse Event|9|||
27524847|NCT01244490|80116011|FG002|Overall Study|Adverse Event|5|||
27524848|NCT01244490|80116009|FG000|Overall Study|Lost to Follow-up|0|||
27524849|NCT01244490|80116010|FG001|Overall Study|Lost to Follow-up|6|||
27524850|NCT01244490|80116011|FG002|Overall Study|Lost to Follow-up|3|||
27622204|NCT04174560|80457848|FG002|Overall Study|Withdrawal by Subject|2|||
27622205|NCT04174560|80457849|FG003|Overall Study|Withdrawal by Subject|0|||
27622206|NCT03015740|80457850|FG000|Overall Study|Adverse Event|1|||
27622207|NCT03015740|80457851|FG001|Overall Study|Adverse Event|0|||
27622208|NCT03015740|80457852|FG002|Overall Study|Adverse Event|0|||
27622209|NCT03015740|80457850|FG000|Overall Study|Death|3|||
27622210|NCT03015740|80457851|FG001|Overall Study|Death|5|||
27622211|NCT03015740|80457852|FG002|Overall Study|Death|0|||
27622212|NCT03015740|80457850|FG000|Overall Study|Withdrawal by Subject|2|||
27622213|NCT03015740|80457851|FG001|Overall Study|Withdrawal by Subject|0|||
27622214|NCT03015740|80457852|FG002|Overall Study|Withdrawal by Subject|0|||
27622215|NCT00798265|80457853|FG000|Overall Study|Lost to Follow-up|1|||
27622216|NCT00798265|80457854|FG001|Overall Study|Lost to Follow-up|10|||
27622217|NCT00798265|80457853|FG000|Overall Study|Study closing|7|||
27622218|NCT00798265|80457854|FG001|Overall Study|Study closing|6|||
27622219|NCT00798265|80457853|FG000|Overall Study|Withdrawal by Subject|0|||
27622220|NCT00798265|80457854|FG001|Overall Study|Withdrawal by Subject|1|||
27622221|NCT00798265|80457853|FG000|Overall Study|Screen failure|0|||
27622222|NCT00798265|80457854|FG001|Overall Study|Screen failure|1|||
27622223|NCT00662909|80457855|FG000|Overall Study|Adverse Event|17|||
27622224|NCT00662909|80457856|FG001|Overall Study|Adverse Event|18|||
27622225|NCT00662909|80457857|FG002|Overall Study|Adverse Event|19|||
27622226|NCT00662909|80457855|FG000|Overall Study|Lack of Efficacy|9|||
27622227|NCT00662909|80457856|FG001|Overall Study|Lack of Efficacy|1|||
27622228|NCT00662909|80457857|FG002|Overall Study|Lack of Efficacy|5|||
27622229|NCT00662909|80457855|FG000|Overall Study|Withdrawal by Subject|29|||
27622230|NCT00662909|80457856|FG001|Overall Study|Withdrawal by Subject|22|||
27622231|NCT00662909|80457857|FG002|Overall Study|Withdrawal by Subject|16|||
27622232|NCT00662909|80457855|FG000|Overall Study|Lost to Follow-up|2|||
27622233|NCT00662909|80457856|FG001|Overall Study|Lost to Follow-up|9|||
27622234|NCT00662909|80457857|FG002|Overall Study|Lost to Follow-up|3|||
27622235|NCT00662909|80457855|FG000|Overall Study|Protocol Violation|7|||
27622236|NCT00662909|80457856|FG001|Overall Study|Protocol Violation|4|||
27622237|NCT00662909|80457857|FG002|Overall Study|Protocol Violation|5|||
27622238|NCT00662909|80457855|FG000|Overall Study|Randomized- never received study drug|1|||
27622239|NCT00662909|80457856|FG001|Overall Study|Randomized- never received study drug|0|||
27732712|NCT05499520|80846364|FG013|Overall Study|Lost to Follow-up|49|||
27732713|NCT05499520|80846365|FG014|Overall Study|Lost to Follow-up|0|||
27732714|NCT05499520|80846366|FG015|Overall Study|Lost to Follow-up|36|||
27732715|NCT05499520|80846367|FG016|Overall Study|Lost to Follow-up|58|||
27732716|NCT05499520|80846368|FG017|Overall Study|Lost to Follow-up|53|||
27732717|NCT01934504|80849753|FG000|Overall Study|Protocol Deviation|0|||
27732718|NCT01934504|80849754|FG001|Overall Study|Protocol Deviation|0|||
27732719|NCT01934504|80849755|FG002|Overall Study|Protocol Deviation|0|||
27732720|NCT01934504|80849756|FG003|Overall Study|Protocol Deviation|2|||
27732721|NCT01934504|80849753|FG000|Overall Study|Study Terminated by Sponsor|1|||
27732722|NCT01934504|80849754|FG001|Overall Study|Study Terminated by Sponsor|0|||
27732723|NCT01934504|80849755|FG002|Overall Study|Study Terminated by Sponsor|5|||
27732724|NCT01934504|80849756|FG003|Overall Study|Study Terminated by Sponsor|5|||
27524851|NCT01244490|80116009|FG000|Overall Study|Other|0|||
27524852|NCT01244490|80116010|FG001|Overall Study|Other|0|||
27524853|NCT01244490|80116011|FG002|Overall Study|Other|1|||
27524854|NCT01185301|80116012|FG000|Overall Study|Adverse Event|3|||
27524855|NCT01185301|80116013|FG001|Overall Study|Adverse Event|0|||
27524856|NCT01185301|80116014|FG002|Overall Study|Adverse Event|2|||
27524857|NCT01185301|80116015|FG003|Overall Study|Adverse Event|3|||
27524858|NCT01185301|80116012|FG000|Overall Study|Withdrawal by Subject|7|||
27524859|NCT01185301|80116013|FG001|Overall Study|Withdrawal by Subject|5|||
27524860|NCT01185301|80116014|FG002|Overall Study|Withdrawal by Subject|2|||
27524861|NCT01185301|80116015|FG003|Overall Study|Withdrawal by Subject|3|||
27524862|NCT01185301|80116012|FG000|Overall Study|Lost to Follow-up|2|||
27524863|NCT01185301|80116013|FG001|Overall Study|Lost to Follow-up|0|||
27524864|NCT01185301|80116014|FG002|Overall Study|Lost to Follow-up|0|||
27524865|NCT01185301|80116015|FG003|Overall Study|Lost to Follow-up|1|||
27524866|NCT01185301|80116012|FG000|Overall Study|Other Reason|3|||
27524867|NCT01185301|80116013|FG001|Overall Study|Other Reason|2|||
27524868|NCT01185301|80116014|FG002|Overall Study|Other Reason|2|||
27524869|NCT01185301|80116015|FG003|Overall Study|Other Reason|2|||
27524870|NCT01343823|80116017|FG000|Overall Study|Study Terminated|1|||
27524871|NCT01343823|80116018|FG001|Overall Study|Study Terminated|0|||
27524872|NCT01343823|80116019|FG002|Overall Study|Study Terminated|0|||
27622240|NCT00662909|80457857|FG002|Overall Study|Randomized- never received study drug|0|||
27622241|NCT00662909|80457855|FG000|Overall Study|Non-compliance with study procedures|3|||
27622242|NCT00662909|80457856|FG001|Overall Study|Non-compliance with study procedures|3|||
27622243|NCT00662909|80457857|FG002|Overall Study|Non-compliance with study procedures|2|||
27732725|NCT02500537|80849757|FG000|Overall Study|Death|2|||
27732726|NCT02500537|80849758|FG001|Overall Study|Death|0|||
27732727|NCT02500537|80849757|FG000|Overall Study|Lost to Follow-up|0|||
27732728|NCT02500537|80849758|FG001|Overall Study|Lost to Follow-up|1|||
27732729|NCT02500537|80849757|FG000|Overall Study|Withdrawal by Subject|1|||
27524873|NCT01343823|80116020|FG003|Overall Study|Study Terminated|1|||
27622244|NCT00662909|80457855|FG000|Overall Study|Physician Decision|1|||
27622245|NCT00662909|80457856|FG001|Overall Study|Physician Decision|1|||
27622246|NCT00662909|80457857|FG002|Overall Study|Physician Decision|2|||
27622247|NCT00662909|80457855|FG000|Overall Study|Eligibility criterion not met|0|||
27622248|NCT00662909|80457856|FG001|Overall Study|Eligibility criterion not met|1|||
27622249|NCT00662909|80457857|FG002|Overall Study|Eligibility criterion not met|1|||
27622250|NCT01394991|80457858|FG000|Overall Study|Adverse Event|0|||
27622251|NCT01394991|80457859|FG001|Overall Study|Adverse Event|4|||
27622252|NCT01394991|80457858|FG000|Overall Study|Lack of Efficacy|5|||
27622253|NCT01394991|80457859|FG001|Overall Study|Lack of Efficacy|7|||
27622254|NCT01394991|80457858|FG000|Overall Study|Lost to Follow-up|6|||
27622255|NCT01394991|80457859|FG001|Overall Study|Lost to Follow-up|8|||
27622256|NCT01394991|80457858|FG000|Overall Study|Physician Decision|1|||
27622257|NCT01394991|80457859|FG001|Overall Study|Physician Decision|3|||
27622258|NCT01394991|80457858|FG000|Overall Study|Protocol Violation|1|||
27622259|NCT01394991|80457859|FG001|Overall Study|Protocol Violation|1|||
27622260|NCT01394991|80457858|FG000|Overall Study|Withdrawal by Subject|20|||
27622261|NCT01394991|80457859|FG001|Overall Study|Withdrawal by Subject|17|||
27622262|NCT01394991|80457858|FG000|Overall Study|Chemotherapy Termination|10|||
27622263|NCT01394991|80457859|FG001|Overall Study|Chemotherapy Termination|15|||
27622264|NCT01394991|80457858|FG000|Overall Study|Disease Progression|7|||
27622265|NCT01394991|80457859|FG001|Overall Study|Disease Progression|7|||
27622266|NCT01394991|80457858|FG000|Overall Study|Prematurely Termination of Trial|9|||
27622267|NCT01394991|80457859|FG001|Overall Study|Prematurely Termination of Trial|10|||
27910268|NCT02227784|81510080|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
27732730|NCT02500537|80849758|FG001|Overall Study|Withdrawal by Subject|0|||
27732731|NCT00733902|80849768|FG000|Overall Study|Death|0|||
27732732|NCT00733902|80849769|FG001|Overall Study|Death|0|||
27732733|NCT00733902|80849770|FG002|Overall Study|Death|0|||
27732734|NCT00733902|80849771|FG003|Overall Study|Death|1|||
27732735|NCT00733902|80849768|FG000|Overall Study|Adverse Event|3|||
27732736|NCT00733902|80849769|FG001|Overall Study|Adverse Event|4|||
27732737|NCT00733902|80849770|FG002|Overall Study|Adverse Event|7|||
27732738|NCT00733902|80849771|FG003|Overall Study|Adverse Event|11|||
27732739|NCT00733902|80849768|FG000|Overall Study|Lack of Efficacy|56|||
27732740|NCT00733902|80849769|FG001|Overall Study|Lack of Efficacy|21|||
27732741|NCT00733902|80849770|FG002|Overall Study|Lack of Efficacy|34|||
27732742|NCT00733902|80849771|FG003|Overall Study|Lack of Efficacy|23|||
27732743|NCT00733902|80849768|FG000|Overall Study|Protocol Violation|4|||
27732744|NCT00733902|80849769|FG001|Overall Study|Protocol Violation|6|||
27732745|NCT00733902|80849770|FG002|Overall Study|Protocol Violation|3|||
27732746|NCT00733902|80849771|FG003|Overall Study|Protocol Violation|3|||
27732747|NCT00733902|80849768|FG000|Overall Study|Withdrawal by Subject|10|||
27732748|NCT00733902|80849769|FG001|Overall Study|Withdrawal by Subject|5|||
27732749|NCT00733902|80849770|FG002|Overall Study|Withdrawal by Subject|4|||
27732750|NCT00733902|80849771|FG003|Overall Study|Withdrawal by Subject|16|||
27732751|NCT00733902|80849768|FG000|Overall Study|Entered extension study|89|||
27732752|NCT00733902|80849769|FG001|Overall Study|Entered extension study|124|||
27855230|NCT00228423|81302551|FG000|Overall Study|Physician Decision|0|||
27855231|NCT00228423|81302552|FG001|Overall Study|Physician Decision|1|||
27855232|NCT00861198|81302553|FG000|Overall Study|SpyGlass Failed|5|||
27855233|NCT04505293|81302554|FG000|Overall Study|Lost to Follow-up|2|||
27855234|NCT04505293|81302554|FG000|Overall Study|Withdrawal by Subject|6|||
27855235|NCT04505293|81302554|FG000|Overall Study|CT scan unreadable|277|||
27855236|NCT01183221|81302556|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
27855237|NCT01183221|81302557|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
27855238|NCT04168190|81302558|FG000|Overall Study|Lost to Follow-up|0|||
27855239|NCT04168190|81302559|FG001|Overall Study|Lost to Follow-up|1|||
27855240|NCT04168190|81302560|FG002|Overall Study|Lost to Follow-up|0|||
27855241|NCT04168190|81302561|FG003|Overall Study|Lost to Follow-up|7|||
27855242|NCT04168190|81302562|FG004|Overall Study|Lost to Follow-up|5|||
27855243|NCT04168190|81302558|FG000|Overall Study|Withdrawal by Subject|1|||
27855244|NCT04168190|81302559|FG001|Overall Study|Withdrawal by Subject|0|||
27622268|NCT03759366|80457863|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
27732753|NCT00733902|80849770|FG002|Overall Study|Entered extension study|111|||
27855245|NCT04168190|81302560|FG002|Overall Study|Withdrawal by Subject|0|||
27855246|NCT04168190|81302561|FG003|Overall Study|Withdrawal by Subject|2|||
27855247|NCT04168190|81302562|FG004|Overall Study|Withdrawal by Subject|4|||
27855248|NCT04168190|81302558|FG000|Overall Study|Death|0|||
27855249|NCT04168190|81302559|FG001|Overall Study|Death|0|||
27622269|NCT03759366|80457863|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
27622270|NCT01017120|80457866|FG000|Overall Study|Adverse Event|9|||
27732754|NCT00733902|80849771|FG003|Overall Study|Entered extension study|109|||
27622271|NCT01017120|80457867|FG001|Overall Study|Adverse Event|0|||
27622272|NCT01017120|80457866|FG000|Overall Study|Lost to Follow-up|13|||
27855250|NCT04168190|81302560|FG002|Overall Study|Death|0|||
27910269|NCT02227784|81510081|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
27910270|NCT02227784|81510077|FG000|Open-Label Extension Phase (OLE)|Death|0|||
27910271|NCT02227784|81510078|FG001|Open-Label Extension Phase (OLE)|Death|0|||
27910272|NCT02227784|81510079|FG002|Open-Label Extension Phase (OLE)|Death|0|||
27910273|NCT02227784|81510080|FG003|Open-Label Extension Phase (OLE)|Death|0|||
27910274|NCT02227784|81510081|FG004|Open-Label Extension Phase (OLE)|Death|1|||
27910275|NCT02227784|81510077|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27910276|NCT02227784|81510078|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27910277|NCT02227784|81510079|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27910278|NCT02227784|81510080|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
27910279|NCT02227784|81510081|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
27910280|NCT02227784|81510077|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27910281|NCT02227784|81510078|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27910282|NCT02227784|81510079|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27910283|NCT02227784|81510080|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
27910284|NCT02227784|81510081|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
27910285|NCT00401193|81510082|FG000|Overall Study|Adverse Event|1|||
27910286|NCT00401193|81510083|FG001|Overall Study|Adverse Event|3|||
27910287|NCT00401193|81510084|FG002|Overall Study|Adverse Event|1|||
27910288|NCT00401193|81510082|FG000|Overall Study|Protocol Violation|3|||
27910289|NCT00401193|81510083|FG001|Overall Study|Protocol Violation|1|||
27910290|NCT00401193|81510084|FG002|Overall Study|Protocol Violation|1|||
27910291|NCT00401193|81510082|FG000|Overall Study|Lost to Follow-up|6|||
27910292|NCT00401193|81510083|FG001|Overall Study|Lost to Follow-up|5|||
27910293|NCT00401193|81510084|FG002|Overall Study|Lost to Follow-up|1|||
27910294|NCT00401193|81510082|FG000|Overall Study|Withdrawal by Subject|2|||
27910295|NCT00401193|81510083|FG001|Overall Study|Withdrawal by Subject|0|||
27910296|NCT00401193|81510084|FG002|Overall Study|Withdrawal by Subject|1|||
27910297|NCT00401193|81510082|FG000|Overall Study|Other Event|3|||
27910298|NCT00401193|81510083|FG001|Overall Study|Other Event|2|||
27910299|NCT00401193|81510084|FG002|Overall Study|Other Event|2|||
27910300|NCT03300050|81510085|FG000|Overall Study|Lost to Follow-up|2|||
27910301|NCT03300050|81510086|FG001|Overall Study|Lost to Follow-up|1|||
27910302|NCT03300050|81510087|FG002|Overall Study|Lost to Follow-up|0|||
27910303|NCT03300050|81510088|FG003|Overall Study|Lost to Follow-up|0|||
27910304|NCT03300050|81510089|FG004|Overall Study|Lost to Follow-up|1|||
27910305|NCT03300050|81510085|FG000|Overall Study|Withdrawal by Subject|1|||
27910306|NCT03300050|81510086|FG001|Overall Study|Withdrawal by Subject|1|||
27910307|NCT03300050|81510087|FG002|Overall Study|Withdrawal by Subject|1|||
27910308|NCT03300050|81510088|FG003|Overall Study|Withdrawal by Subject|0|||
27910309|NCT03300050|81510089|FG004|Overall Study|Withdrawal by Subject|0|||
27910310|NCT03300050|81510085|FG000|Overall Study|Death|0|||
27910311|NCT03300050|81510086|FG001|Overall Study|Death|0|||
27910312|NCT03300050|81510087|FG002|Overall Study|Death|1|||
27910313|NCT03300050|81510088|FG003|Overall Study|Death|0|||
27910314|NCT03300050|81510089|FG004|Overall Study|Death|0|||
27910315|NCT03300050|81510085|FG000|Overall Study|Not Eligible at Randomization|0|||
27910316|NCT03300050|81510086|FG001|Overall Study|Not Eligible at Randomization|0|||
27910317|NCT03300050|81510087|FG002|Overall Study|Not Eligible at Randomization|1|||
27910318|NCT03300050|81510088|FG003|Overall Study|Not Eligible at Randomization|1|||
27910319|NCT03300050|81510089|FG004|Overall Study|Not Eligible at Randomization|0|||
27855251|NCT04168190|81302561|FG003|Overall Study|Death|1|||
27855252|NCT04168190|81302562|FG004|Overall Study|Death|0|||
27855253|NCT02528123|81302563|FG000|Overall Study|Lost to Follow-up|1|||
27855254|NCT02227147|81302564|FG000|Controlled Treatment Period|Adverse Event|4|||
27855255|NCT02227147|81302565|FG001|Controlled Treatment Period|Adverse Event|3|||
27855256|NCT02227147|81302564|FG000|Controlled Treatment Period|Other|2|||
27855257|NCT02227147|81302565|FG001|Controlled Treatment Period|Other|0|||
27855258|NCT02227147|81302564|FG000|Follow-up Period|Other|3|||
27524874|NCT01343823|80116017|FG000|Overall Study|Withdrawal by Subject|1|||
27524875|NCT01343823|80116018|FG001|Overall Study|Withdrawal by Subject|0|||
27524876|NCT01343823|80116019|FG002|Overall Study|Withdrawal by Subject|0|||
27524877|NCT01343823|80116020|FG003|Overall Study|Withdrawal by Subject|0|||
27855259|NCT02227147|81302565|FG001|Follow-up Period|Other|5|||
27910320|NCT02143024|81510090|FG000|Overall Study|Lost to Follow-up|1|||
27524878|NCT03505710|80116021|FG000|Overall Study|Progressive Disease|22|||
27524879|NCT03505710|80116022|FG001|Overall Study|Progressive Disease|9|||
27855260|NCT02699684|81302566|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
27910321|NCT02143024|81510091|FG001|Overall Study|Lost to Follow-up|1|||
27910322|NCT02143024|81510090|FG000|Overall Study|Withdrawal by Subject|1|||
27910323|NCT02143024|81510091|FG001|Overall Study|Withdrawal by Subject|0|||
27910324|NCT03046953|81510093|FG000|Overall Study|Relapse/progressive disease|21|||
27910325|NCT03046953|81510093|FG000|Overall Study|Death|2|||
27910326|NCT03046953|81510093|FG000|Overall Study|Withdrawal by Subject|3|||
27855261|NCT02699684|81302567|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
27910327|NCT00762034|81510094|FG000|Induction Period|Protocol Violation|1|||
27910328|NCT00762034|81510095|FG001|Induction Period|Protocol Violation|2|||
27910329|NCT00762034|81510094|FG000|Induction Period|Entry Criterion Not Met|12|||
27910330|NCT00762034|81510095|FG001|Induction Period|Entry Criterion Not Met|11|||
27910331|NCT00762034|81510094|FG000|Induction Period|Adverse Event|27|||
27910332|NCT00762034|81510095|FG001|Induction Period|Adverse Event|38|||
27910333|NCT00762034|81510094|FG000|Induction Period|Lost to Follow-up|1|||
27910334|NCT00762034|81510095|FG001|Induction Period|Lost to Follow-up|1|||
27910335|NCT00762034|81510094|FG000|Induction Period|Progressive Disease|73|||
27910336|NCT00762034|81510095|FG001|Induction Period|Progressive Disease|55|||
27910337|NCT00762034|81510094|FG000|Induction Period|Physician Decision|21|||
27910338|NCT00762034|81510095|FG001|Induction Period|Physician Decision|20|||
27910339|NCT00762034|81510094|FG000|Induction Period|Withdrawal by Subject|15|||
27910340|NCT00762034|81510095|FG001|Induction Period|Withdrawal by Subject|19|||
27910341|NCT00762034|81510094|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
27622273|NCT01017120|80457867|FG001|Overall Study|Lost to Follow-up|11|||
27622274|NCT01017120|80457866|FG000|Overall Study|Lack of Efficacy|1|||
27622275|NCT01017120|80457867|FG001|Overall Study|Lack of Efficacy|0|||
27622276|NCT01017120|80457866|FG000|Overall Study|Withdrawal by Subject|39|||
27622277|NCT01017120|80457867|FG001|Overall Study|Withdrawal by Subject|21|||
27622278|NCT01017120|80457866|FG000|Overall Study|Pregnancy|1|||
27622279|NCT01017120|80457867|FG001|Overall Study|Pregnancy|1|||
27622280|NCT01017120|80457866|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27622281|NCT01017120|80457867|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
27622282|NCT01017120|80457866|FG000|Overall Study|Relocated Out of Town|0|||
27732755|NCT00733902|80849768|FG000|Overall Study|Randomized but not treated|2|||
27855262|NCT00278889|81302568|FG000|Overall Study|Withdrawal by Subject|0|||
27855263|NCT00278889|81302569|FG001|Overall Study|Withdrawal by Subject|5|||
27855264|NCT00278889|81302570|FG002|Overall Study|Withdrawal by Subject|3|||
27855265|NCT00278889|81302568|FG000|Overall Study|Lost to Follow-up|1|||
27855266|NCT00278889|81302569|FG001|Overall Study|Lost to Follow-up|1|||
27855267|NCT00278889|81302570|FG002|Overall Study|Lost to Follow-up|0|||
27855268|NCT00278889|81302568|FG000|Overall Study|Death|24|||
27855269|NCT00278889|81302569|FG001|Overall Study|Death|21|||
27855270|NCT00278889|81302570|FG002|Overall Study|Death|17|||
27855271|NCT01403064|81302571|FG000|Overall Study|Death|0|||
27855272|NCT01403064|81302572|FG001|Overall Study|Death|0|||
27855273|NCT01403064|81302573|FG002|Overall Study|Death|1|||
27855274|NCT01403064|81302574|FG003|Overall Study|Death|1|||
27855275|NCT01403064|81302571|FG000|Overall Study|Withdrawal by Subject|0|||
27855276|NCT01403064|81302572|FG001|Overall Study|Withdrawal by Subject|0|||
27855277|NCT01403064|81302573|FG002|Overall Study|Withdrawal by Subject|1|||
27855278|NCT01403064|81302574|FG003|Overall Study|Withdrawal by Subject|1|||
27855279|NCT01403064|81302571|FG000|Overall Study|Other|1|||
27855280|NCT01403064|81302572|FG001|Overall Study|Other|0|||
27855281|NCT01403064|81302573|FG002|Overall Study|Other|2|||
27855282|NCT01403064|81302574|FG003|Overall Study|Other|1|||
27855283|NCT00251719|81302575|FG000|Overall Study|Adverse Event|14|||
27855284|NCT00251719|81302576|FG001|Overall Study|Adverse Event|8|||
27855285|NCT00251719|81302577|FG002|Overall Study|Adverse Event|7|||
27855286|NCT00251719|81302575|FG000|Overall Study|Protocol Violation|1|||
27855287|NCT00251719|81302576|FG001|Overall Study|Protocol Violation|1|||
27855288|NCT00251719|81302577|FG002|Overall Study|Protocol Violation|1|||
27855289|NCT00251719|81302575|FG000|Overall Study|Lost to Follow-up|5|||
27855290|NCT00251719|81302576|FG001|Overall Study|Lost to Follow-up|11|||
27855291|NCT00251719|81302577|FG002|Overall Study|Lost to Follow-up|8|||
27855292|NCT00251719|81302575|FG000|Overall Study|Withdrawal by Subject|14|||
27855293|NCT00251719|81302576|FG001|Overall Study|Withdrawal by Subject|12|||
27855294|NCT00251719|81302577|FG002|Overall Study|Withdrawal by Subject|11|||
27855295|NCT00251719|81302575|FG000|Overall Study|Lack of Efficacy|2|||
27855296|NCT00251719|81302576|FG001|Overall Study|Lack of Efficacy|1|||
27855297|NCT00251719|81302577|FG002|Overall Study|Lack of Efficacy|0|||
27855298|NCT00251719|81302575|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
27855299|NCT00251719|81302576|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
27855300|NCT00251719|81302577|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
27855301|NCT00251719|81302575|FG000|Overall Study|Investigator decision|1|||
27855302|NCT00251719|81302576|FG001|Overall Study|Investigator decision|1|||
27855303|NCT00251719|81302577|FG002|Overall Study|Investigator decision|0|||
27855304|NCT00251719|81302575|FG000|Overall Study|Noncompliance|2|||
27732756|NCT00733902|80849769|FG001|Overall Study|Randomized but not treated|2|||
27732757|NCT00733902|80849770|FG002|Overall Study|Randomized but not treated|2|||
27855305|NCT00251719|81302576|FG001|Overall Study|Noncompliance|3|||
27855306|NCT00251719|81302577|FG002|Overall Study|Noncompliance|1|||
27855307|NCT00251719|81302575|FG000|Overall Study|Barrett's esophagus|2|||
27855308|NCT00251719|81302576|FG001|Overall Study|Barrett's esophagus|2|||
27855309|NCT00251719|81302577|FG002|Overall Study|Barrett's esophagus|0|||
27855310|NCT01297465|81302582|FG000|Overall Study|Lack of Ovarian Response|1|||
27855311|NCT01297465|81302583|FG001|Overall Study|Lack of Ovarian Response|1|||
27910342|NCT00762034|81510095|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
27910343|NCT00762034|81510094|FG000|Induction Period|Deaths Due to Study Disease|9|||
27910344|NCT00762034|81510095|FG001|Induction Period|Deaths Due to Study Disease|9|||
27910345|NCT00762034|81510094|FG000|Maintenance Period|Protocol Violation|1|||
27910346|NCT00762034|81510095|FG001|Maintenance Period|Protocol Violation|3|||
27910347|NCT00762034|81510094|FG000|Maintenance Period|Entry Criterion Not Met|0|||
27910348|NCT00762034|81510095|FG001|Maintenance Period|Entry Criterion Not Met|2|||
27855312|NCT01297465|81302582|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
27855313|NCT01297465|81302583|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
27855314|NCT01297465|81302582|FG000|Overall Study|No Oocytes Retrieved|1|||
27855315|NCT01297465|81302583|FG001|Overall Study|No Oocytes Retrieved|1|||
27855316|NCT01297465|81302582|FG000|Overall Study|Poor oocyte quality|0|||
27855317|NCT01297465|81302583|FG001|Overall Study|Poor oocyte quality|1|||
27855318|NCT01297465|81302582|FG000|Overall Study|No Fertilization|6|||
27855319|NCT01297465|81302583|FG001|Overall Study|No Fertilization|4|||
27855320|NCT01297465|81302582|FG000|Overall Study|All Embryos Discarded|0|||
27855321|NCT01297465|81302583|FG001|Overall Study|All Embryos Discarded|1|||
27855322|NCT01297465|81302582|FG000|Overall Study|Intention to Freeze all Embryos|0|||
27855323|NCT01297465|81302583|FG001|Overall Study|Intention to Freeze all Embryos|1|||
27855324|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
27855325|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
27855326|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
27855327|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
27855328|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
27855329|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
27855330|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
27855331|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
27855332|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
27910349|NCT00762034|81510094|FG000|Maintenance Period|Adverse Event|42|||
27910350|NCT00762034|81510095|FG001|Maintenance Period|Adverse Event|26|||
27910351|NCT00762034|81510094|FG000|Maintenance Period|Progressive Disease|186|||
27910352|NCT00762034|81510095|FG001|Maintenance Period|Progressive Disease|224|||
27910353|NCT00762034|81510094|FG000|Maintenance Period|Physician Decision|25|||
27910354|NCT00762034|81510095|FG001|Maintenance Period|Physician Decision|20|||
27910355|NCT00762034|81510094|FG000|Maintenance Period|Withdrawal by Subject|34|||
27622283|NCT01017120|80457867|FG001|Overall Study|Relocated Out of Town|2|||
27855333|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
27855334|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
27855335|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
27855336|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
27855337|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
27855338|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
27855339|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
27855340|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
27855341|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
27855342|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
27855343|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
27855344|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
27855345|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
27855346|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
27855347|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
27855348|NCT03514641|81302584|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
27855349|NCT03514641|81302585|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
27524880|NCT03505710|80116023|FG002|Overall Study|Progressive Disease|34|||
27524881|NCT03505710|80116021|FG000|Overall Study|Clinical Progression|6|||
27524882|NCT03505710|80116022|FG001|Overall Study|Clinical Progression|6|||
27524883|NCT03505710|80116023|FG002|Overall Study|Clinical Progression|3|||
27524884|NCT03505710|80116021|FG000|Overall Study|Adverse Event|12|||
27622284|NCT01017120|80457866|FG000|Overall Study|Protocol Violation|1|||
27622285|NCT01017120|80457867|FG001|Overall Study|Protocol Violation|0|||
27524885|NCT03505710|80116022|FG001|Overall Study|Adverse Event|5|||
27524886|NCT03505710|80116023|FG002|Overall Study|Adverse Event|27|||
27524887|NCT03505710|80116021|FG000|Overall Study|Withdrawal by Subject|1|||
27524888|NCT03505710|80116022|FG001|Overall Study|Withdrawal by Subject|3|||
27524889|NCT03505710|80116023|FG002|Overall Study|Withdrawal by Subject|3|||
27524890|NCT03505710|80116021|FG000|Overall Study|Physician Decision|1|||
27622286|NCT01017120|80457866|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
27855350|NCT03514641|81302586|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
27855351|NCT03514641|81302587|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
27855352|NCT03514641|81302584|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
27855353|NCT03514641|81302585|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
27855354|NCT03514641|81302586|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
27910356|NCT00762034|81510095|FG001|Maintenance Period|Withdrawal by Subject|14|||
27910357|NCT00762034|81510094|FG000|Maintenance Period|Death not due to study disease|2|||
27732758|NCT00733902|80849771|FG003|Overall Study|Randomized but not treated|1|||
27732759|NCT00706628|80849775|FG000|Overall Study|Other Adverse Event|16|||
27732760|NCT00706628|80849776|FG001|Overall Study|Other Adverse Event|5|||
27732761|NCT00706628|80849777|FG002|Overall Study|Other Adverse Event|5|||
27732762|NCT00706628|80849778|FG003|Overall Study|Other Adverse Event|2|||
27732763|NCT00706628|80849775|FG000|Overall Study|Non compliant with protocol|0|||
27732764|NCT00706628|80849776|FG001|Overall Study|Non compliant with protocol|1|||
27732765|NCT00706628|80849777|FG002|Overall Study|Non compliant with protocol|0|||
27732766|NCT00706628|80849778|FG003|Overall Study|Non compliant with protocol|0|||
27732767|NCT00706628|80849775|FG000|Overall Study|Consent withdrawn|6|||
27732768|NCT00706628|80849776|FG001|Overall Study|Consent withdrawn|1|||
27732769|NCT00706628|80849777|FG002|Overall Study|Consent withdrawn|3|||
27732770|NCT00706628|80849778|FG003|Overall Study|Consent withdrawn|0|||
27732771|NCT00706628|80849775|FG000|Overall Study|Progressive disease|20|||
27732772|NCT00706628|80849776|FG001|Overall Study|Progressive disease|13|||
27732773|NCT00706628|80849777|FG002|Overall Study|Progressive disease|8|||
27732774|NCT00706628|80849778|FG003|Overall Study|Progressive disease|1|||
27732775|NCT00706628|80849775|FG000|Overall Study|Other than those stated above|4|||
27732776|NCT00706628|80849776|FG001|Overall Study|Other than those stated above|0|||
27732777|NCT00706628|80849777|FG002|Overall Study|Other than those stated above|0|||
27732778|NCT00706628|80849778|FG003|Overall Study|Other than those stated above|0|||
27732779|NCT00706628|80849775|FG000|Overall Study|Not treated|1|||
27732780|NCT00706628|80849776|FG001|Overall Study|Not treated|1|||
27732781|NCT00706628|80849777|FG002|Overall Study|Not treated|0|||
27732782|NCT00706628|80849778|FG003|Overall Study|Not treated|0|||
27732783|NCT03502187|80849779|FG000|Overall Study|Withdrawal by Subject|4|||
27732784|NCT03502187|80849780|FG001|Overall Study|Withdrawal by Subject|3|||
27732785|NCT03502187|80849781|FG002|Overall Study|Withdrawal by Subject|3|||
27732786|NCT03502187|80849779|FG000|Overall Study|Lost to Follow-up|5|||
27732787|NCT03502187|80849780|FG001|Overall Study|Lost to Follow-up|4|||
27732788|NCT03502187|80849781|FG002|Overall Study|Lost to Follow-up|5|||
27732789|NCT00398112|80849782|FG000|Overall Study|Adverse Event|4|||
27732790|NCT00398112|80849782|FG000|Overall Study|Disease progression|9|||
27732791|NCT00398112|80849782|FG000|Overall Study|Alternative treatment|1|||
27732792|NCT00398112|80849782|FG000|Overall Study|Withdrawal by Subject|3|||
27732793|NCT00398112|80849782|FG000|Overall Study|Death|1|||
27732794|NCT03377634|80849783|FG000|Study Period|Adverse Event|1|||
27732795|NCT03377634|80849784|FG001|Study Period|Adverse Event|0|||
27732796|NCT03377634|80849783|FG000|Study Period|Withdrawal by Subject|1|||
27732797|NCT03377634|80849784|FG001|Study Period|Withdrawal by Subject|0|||
27732798|NCT01085682|80849785|FG000|Overall Study|Withdrawal by Subject|25|||
27732799|NCT01085682|80849786|FG001|Overall Study|Withdrawal by Subject|25|||
27732800|NCT00345605|80849787|FG000|Arm 1|Adverse Event|0|||
27732801|NCT00345605|80849788|FG001|Arm 1|Adverse Event|1|||
27732802|NCT00345605|80849787|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
27732803|NCT00345605|80849788|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
27732804|NCT05300087|80849789|FG000|Overall Study|Withdrawal by Subject|0|||
27524891|NCT03505710|80116022|FG001|Overall Study|Physician Decision|0|||
27524892|NCT03505710|80116023|FG002|Overall Study|Physician Decision|2|||
27524893|NCT03505710|80116021|FG000|Overall Study|Death|4|||
27524894|NCT03505710|80116022|FG001|Overall Study|Death|3|||
27524895|NCT03505710|80116023|FG002|Overall Study|Death|6|||
27524896|NCT03505710|80116021|FG000|Overall Study|Other Reasons|1|||
27524897|NCT03505710|80116022|FG001|Overall Study|Other Reasons|1|||
27524898|NCT03505710|80116023|FG002|Overall Study|Other Reasons|1|||
27524899|NCT03189381|80116028|FG000|Overall Study|Death|1|||
27524900|NCT03189381|80116029|FG001|Overall Study|Death|0|||
27524901|NCT00713310|80116038|FG000|Overall Study|Adverse Event|5|||
27524902|NCT00713310|80116039|FG001|Overall Study|Adverse Event|2|||
27524903|NCT00713310|80116038|FG000|Overall Study|Lack of Efficacy|0|||
27524904|NCT00713310|80116039|FG001|Overall Study|Lack of Efficacy|2|||
27622287|NCT01017120|80457867|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
27732805|NCT05300087|80849790|FG001|Overall Study|Withdrawal by Subject|1|||
27732806|NCT00486902|80849792|FG000|Overall Study|Withdrawal by Subject|1|||
27732807|NCT00486902|80849793|FG001|Overall Study|Withdrawal by Subject|2|||
27732808|NCT00486902|80849792|FG000|Overall Study|decision for postpartum tubal ligation|3|||
27732809|NCT00486902|80849793|FG001|Overall Study|decision for postpartum tubal ligation|1|||
27732810|NCT00486902|80849792|FG000|Overall Study|spinal anesthetic protocal violation|1|||
27732811|NCT00486902|80849793|FG001|Overall Study|spinal anesthetic protocal violation|1|||
27732812|NCT00486902|80849792|FG000|Overall Study|Did not meet inclusion criteria|1|||
27524905|NCT00713310|80116038|FG000|Overall Study|Withdrawal by Subject|0|||
27524906|NCT00713310|80116039|FG001|Overall Study|Withdrawal by Subject|2|||
27524907|NCT04590248|80116049|FG000|Overall Study|Lost to Follow-up|1|||
27524908|NCT04590248|80116049|FG000|Overall Study|Withdrawal by Subject|16|||
27524909|NCT04590248|80116049|FG000|Overall Study|Other|2|||
27524910|NCT03915860|80116052|FG000|Overall Study|Adverse Event|3|||
27622288|NCT02687919|80457868|FG000|Overall Study|Withdrawal by Subject|6|||
27524911|NCT03915860|80116052|FG000|Overall Study|Withdrawal by Subject|6|||
27732813|NCT00486902|80849793|FG001|Overall Study|Did not meet inclusion criteria|0|||
27732814|NCT00486902|80849792|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
27732815|NCT00486902|80849793|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
27732816|NCT04317690|80849794|FG000|Overall Study|did not have complete information for primary outcome|0|||
27732817|NCT04317690|80849795|FG001|Overall Study|did not have complete information for primary outcome|4|||
27732818|NCT04317690|80849796|FG002|Overall Study|did not have complete information for primary outcome|0|||
27732819|NCT04317690|80849797|FG003|Overall Study|did not have complete information for primary outcome|2|||
27732820|NCT04317690|80849798|FG004|Overall Study|did not have complete information for primary outcome|0|||
27732821|NCT01850615|80849803|FG000|Overall Study|Protocol Violation|4|||
27732822|NCT01850615|80849804|FG001|Overall Study|Protocol Violation|1|||
27732823|NCT01850615|80849803|FG000|Overall Study|Adverse Event|2|||
27732824|NCT01850615|80849804|FG001|Overall Study|Adverse Event|1|||
27732825|NCT01850615|80849803|FG000|Overall Study|Withdrawal by Subject|3|||
27732826|NCT01850615|80849804|FG001|Overall Study|Withdrawal by Subject|1|||
27732827|NCT01850615|80849803|FG000|Overall Study|Lost to Follow-up|0|||
27732828|NCT01850615|80849804|FG001|Overall Study|Lost to Follow-up|1|||
27732829|NCT01850615|80849803|FG000|Overall Study|Unclassified|0|||
27732830|NCT01850615|80849804|FG001|Overall Study|Unclassified|1|||
27732831|NCT01228747|80849805|FG000|Overall Study|Adverse Event|8|||
27732832|NCT01228747|80849806|FG001|Overall Study|Adverse Event|4|||
27732833|NCT01228747|80849805|FG000|Overall Study|Lack of Efficacy|40|||
27732834|NCT01228747|80849806|FG001|Overall Study|Lack of Efficacy|27|||
27732835|NCT01228747|80849805|FG000|Overall Study|Protocol Violation|6|||
27732836|NCT01228747|80849806|FG001|Overall Study|Protocol Violation|5|||
27524912|NCT03915860|80116052|FG000|Overall Study|Lost to Follow-up|2|||
27524913|NCT03915860|80116052|FG000|Overall Study|Other than specified|3|||
27524914|NCT01107379|80116057|FG000|Overall Study|Withdrawal by Subject|18|||
27524915|NCT01107379|80116057|FG000|Overall Study|Lost to Follow-up|3|||
27524916|NCT02158364|80116058|FG000|Overall Study|Case report forms uncollected|10|||
27524917|NCT02158364|80116058|FG000|Overall Study|Protocol Deviation|50|||
27524918|NCT01547780|80116060|FG000|Baseline PET Scan|Physician Decision|1|||
27524919|NCT01547780|80116061|FG001|Baseline PET Scan|Physician Decision|0|||
27524920|NCT01547780|80116062|FG002|Baseline PET Scan|Physician Decision|1|||
27524921|NCT01547780|80116063|FG003|Baseline PET Scan|Physician Decision|0|||
27524922|NCT01547780|80116060|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
27524923|NCT01547780|80116061|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
27524924|NCT01547780|80116062|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
27524925|NCT01547780|80116063|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
27524926|NCT01133990|80116064|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
27524927|NCT01133990|80116065|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27524928|NCT01133990|80116066|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27524929|NCT01133990|80116067|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27524930|NCT01133990|80116068|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27524931|NCT01133990|80116069|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
27524932|NCT01133990|80116064|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
27524933|NCT01133990|80116065|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
27524934|NCT01133990|80116066|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
27524935|NCT01133990|80116067|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
27524936|NCT01133990|80116068|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
27524937|NCT01133990|80116069|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
27524938|NCT01133990|80116064|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
27524939|NCT01133990|80116065|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27524940|NCT01133990|80116066|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27524941|NCT01133990|80116067|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27524942|NCT01133990|80116068|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27524943|NCT01133990|80116069|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
27732837|NCT01228747|80849805|FG000|Overall Study|Lost to Follow-up|4|||
27732838|NCT01228747|80849806|FG001|Overall Study|Lost to Follow-up|3|||
27732839|NCT01228747|80849805|FG000|Overall Study|Withdrawal by Subject|5|||
27732840|NCT01228747|80849806|FG001|Overall Study|Withdrawal by Subject|1|||
27855355|NCT03514641|81302587|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
27524944|NCT01133990|80116064|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
27524945|NCT01133990|80116065|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
27524946|NCT01133990|80116066|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
27524947|NCT01133990|80116067|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
27524948|NCT01133990|80116068|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
27732841|NCT01228747|80849805|FG000|Overall Study|Other Reason|2|||
27732842|NCT01228747|80849806|FG001|Overall Study|Other Reason|5|||
27732843|NCT03851510|80849812|FG000|Overall Study|Screen Fail|1|||
27732844|NCT03851510|80849812|FG000|Overall Study|Adverse Event|1|||
27732845|NCT03851510|80849812|FG000|Overall Study|Withdrawal by Subject|1|||
27855356|NCT03514641|81302584|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
27732846|NCT00500266|80849813|FG000|Overall Study|Death|3|||
27732847|NCT00500266|80849813|FG000|Overall Study|Lost to Follow-up|3|||
27732848|NCT00500266|80849813|FG000|Overall Study|Withdrawal by Subject|3|||
27732849|NCT00500266|80849813|FG000|Overall Study|Assigned, not treated|4|||
27732850|NCT03514914|80849815|FG000|Overall Study|Death|3|||
27732851|NCT03514914|80849816|FG001|Overall Study|Death|3|||
27732852|NCT03514914|80849815|FG000|Overall Study|Lost to Follow-up|117|||
27732853|NCT03514914|80849816|FG001|Overall Study|Lost to Follow-up|89|||
27732854|NCT02770807|80849817|FG000|Overall Study|Adverse Event|3|||
27732855|NCT02770807|80849818|FG001|Overall Study|Adverse Event|3|||
27732856|NCT02770807|80849819|FG002|Overall Study|Adverse Event|1|||
27732857|NCT02770807|80849817|FG000|Overall Study|Withdrawal by Subject|7|||
27732858|NCT02770807|80849818|FG001|Overall Study|Withdrawal by Subject|3|||
27732859|NCT02770807|80849819|FG002|Overall Study|Withdrawal by Subject|4|||
27732860|NCT02770807|80849817|FG000|Overall Study|Other|0|||
27732861|NCT02770807|80849818|FG001|Overall Study|Other|1|||
27732862|NCT02770807|80849819|FG002|Overall Study|Other|0|||
27524949|NCT01133990|80116069|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
27524950|NCT01924429|80116070|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
27732863|NCT02770807|80849817|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
27732864|NCT02770807|80849818|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
27732865|NCT02770807|80849819|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
27732866|NCT02770807|80849817|FG000|Overall Study|Physician Decision|0|||
27732867|NCT02770807|80849818|FG001|Overall Study|Physician Decision|0|||
27732868|NCT02770807|80849819|FG002|Overall Study|Physician Decision|1|||
27732869|NCT00469079|80849823|FG000|Overall Study|Lack of Efficacy|3|||
27732870|NCT00469079|80849824|FG001|Overall Study|Lack of Efficacy|8|||
27732871|NCT00469079|80849825|FG002|Overall Study|Lack of Efficacy|5|||
27732872|NCT00469079|80849823|FG000|Overall Study|Adverse Event|1|||
27732873|NCT00469079|80849824|FG001|Overall Study|Adverse Event|3|||
27732874|NCT00469079|80849825|FG002|Overall Study|Adverse Event|2|||
27732875|NCT00469079|80849823|FG000|Overall Study|Lost to Follow-up|4|||
27732876|NCT00469079|80849824|FG001|Overall Study|Lost to Follow-up|8|||
27732877|NCT00469079|80849825|FG002|Overall Study|Lost to Follow-up|10|||
27732878|NCT00469079|80849823|FG000|Overall Study|Withdrawal by Subject|1|||
27732879|NCT00469079|80849824|FG001|Overall Study|Withdrawal by Subject|2|||
27732880|NCT00469079|80849825|FG002|Overall Study|Withdrawal by Subject|2|||
27732881|NCT00469079|80849823|FG000|Overall Study|Ineligible|0|||
27732882|NCT00469079|80849824|FG001|Overall Study|Ineligible|1|||
27732883|NCT00469079|80849825|FG002|Overall Study|Ineligible|0|||
27732884|NCT01551745|80849826|FG000|Overall Study|Withdrawal by Subject|1|||
27732885|NCT01551745|80849826|FG000|Overall Study|Disease Progression|2|||
27732886|NCT03195894|80849829|FG000|Overall Study|"An example is Started other treatment."|4|||
27732887|NCT03195894|80849830|FG001|Overall Study|"An example is Started other treatment."|5|||
27732888|NCT03195894|80849829|FG000|Overall Study|Withdrawal by Subject|15|||
27732889|NCT03195894|80849830|FG001|Overall Study|Withdrawal by Subject|4|||
27732890|NCT03195894|80849829|FG000|Overall Study|Lost to Follow-up|14|||
27732891|NCT03195894|80849830|FG001|Overall Study|Lost to Follow-up|19|||
27732892|NCT01445171|80849832|FG000|Overall Study|Lost to Follow-up|11|||
27732893|NCT01445171|80849832|FG000|Overall Study|Withdrawal by Subject|16|||
27732894|NCT01445171|80849832|FG000|Overall Study|Death|51|||
27732895|NCT01445171|80849832|FG000|Overall Study|Subjects declined to return for followup|9|||
27732896|NCT01445171|80849832|FG000|Overall Study|Consented but did not receive device|8|||
27732897|NCT00693706|80849833|FG000|Overall Study|Protocol Violation|0|||
27732898|NCT00693706|80849834|FG001|Overall Study|Protocol Violation|1|||
27732899|NCT01151137|80849835|FG000|Overall Study|Death|15|||
27732900|NCT01151137|80849836|FG001|Overall Study|Death|27|||
27732901|NCT01151137|80849835|FG000|Overall Study|Lost to Follow-up|1|||
27732902|NCT01151137|80849836|FG001|Overall Study|Lost to Follow-up|1|||
27732903|NCT00332202|80849837|FG000|Overall Study|Adverse Event|72|||
27732904|NCT00332202|80849838|FG001|Overall Study|Adverse Event|28|||
27732905|NCT00332202|80849837|FG000|Overall Study|Lost to Follow-up|2|||
27732906|NCT00332202|80849838|FG001|Overall Study|Lost to Follow-up|1|||
27732907|NCT00332202|80849837|FG000|Overall Study|Physician Decision|6|||
27732908|NCT00332202|80849838|FG001|Overall Study|Physician Decision|8|||
27732909|NCT00332202|80849837|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
27732910|NCT00332202|80849838|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
27732911|NCT00332202|80849837|FG000|Overall Study|Protocol Violation|7|||
27524951|NCT01924429|80116071|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
27732912|NCT00332202|80849838|FG001|Overall Study|Protocol Violation|2|||
27732913|NCT00332202|80849837|FG000|Overall Study|Sponsor Decision|1|||
27732914|NCT00332202|80849838|FG001|Overall Study|Sponsor Decision|2|||
27732915|NCT00332202|80849837|FG000|Overall Study|Withdrawal by Subject|36|||
27732916|NCT00332202|80849838|FG001|Overall Study|Withdrawal by Subject|17|||
27732917|NCT00332202|80849837|FG000|Overall Study|Progressive Disease|106|||
27524952|NCT02882152|80116072|FG000|Overall Study|Lost to Follow-up|1|||
27732918|NCT00332202|80849838|FG001|Overall Study|Progressive Disease|60|||
27732919|NCT00332202|80849837|FG000|Overall Study|Death|5|||
27732920|NCT00332202|80849838|FG001|Overall Study|Death|2|||
27732921|NCT04007159|80849839|FG000|Induction Phase|(missed study visits)|16|||
27732922|NCT04007159|80849839|FG000|Induction Phase|Withdrawal by Subject|4|||
27732923|NCT04007159|80849839|FG000|Induction Phase|Adverse Event|2|||
27732924|NCT04007159|80849839|FG000|Challenge Phase|missed study visits|3|||
27524953|NCT02882152|80116073|FG001|Overall Study|Lost to Follow-up|0|||
27732925|NCT00851903|80849840|FG000|Overall Study|Withdrawal by Subject|2|||
27732926|NCT01145560|80849841|FG000|Overall Study|Withdrawal by Subject|2|||
27732927|NCT01145560|80849842|FG001|Overall Study|Withdrawal by Subject|1|||
27732928|NCT01145560|80849843|FG002|Overall Study|Withdrawal by Subject|0|||
27732929|NCT01145560|80849841|FG000|Overall Study|Lost to Follow-up|1|||
27732930|NCT01145560|80849842|FG001|Overall Study|Lost to Follow-up|1|||
27732931|NCT01145560|80849843|FG002|Overall Study|Lost to Follow-up|1|||
27732932|NCT01145560|80849841|FG000|Overall Study|No study drug by 24h after organ failure|1|||
27732933|NCT01145560|80849842|FG001|Overall Study|No study drug by 24h after organ failure|0|||
27732934|NCT01145560|80849843|FG002|Overall Study|No study drug by 24h after organ failure|0|||
27732935|NCT01145560|80849841|FG000|Overall Study|Accidental unblinding of study treatment|0|||
27732936|NCT01145560|80849842|FG001|Overall Study|Accidental unblinding of study treatment|1|||
27732937|NCT01145560|80849843|FG002|Overall Study|Accidental unblinding of study treatment|0|||
27732938|NCT01145560|80849841|FG000|Overall Study|False insurance information|0|||
27732939|NCT01145560|80849842|FG001|Overall Study|False insurance information|1|||
27732940|NCT01145560|80849843|FG002|Overall Study|False insurance information|0|||
27732941|NCT01145560|80849841|FG000|Overall Study|Withdrawal of therapy|0|||
27732942|NCT01145560|80849842|FG001|Overall Study|Withdrawal of therapy|0|||
27732943|NCT01145560|80849843|FG002|Overall Study|Withdrawal of therapy|1|||
27732944|NCT00393718|80849861|FG000|Overall Study|Adverse Event|20|||
27732945|NCT00393718|80849862|FG001|Overall Study|Adverse Event|8|||
27732946|NCT00393718|80849861|FG000|Overall Study|Protocol Violation|1|||
27732947|NCT00393718|80849862|FG001|Overall Study|Protocol Violation|2|||
27732948|NCT00393718|80849861|FG000|Overall Study|Lack of Efficacy|10|||
27732949|NCT00393718|80849862|FG001|Overall Study|Lack of Efficacy|9|||
27732950|NCT00393718|80849861|FG000|Overall Study|Hypoglycaemia|3|||
27732951|NCT00393718|80849862|FG001|Overall Study|Hypoglycaemia|2|||
27732952|NCT00393718|80849861|FG000|Overall Study|Subject decision|5|||
27732953|NCT00393718|80849862|FG001|Overall Study|Subject decision|0|||
27732954|NCT00393718|80849861|FG000|Overall Study|Withdrawal of consent|2|||
27732955|NCT00393718|80849862|FG001|Overall Study|Withdrawal of consent|1|||
27732956|NCT00393718|80849861|FG000|Overall Study|Missed measurement|1|||
27732957|NCT00393718|80849862|FG001|Overall Study|Missed measurement|0|||
27732958|NCT00393718|80849861|FG000|Overall Study|Move|1|||
27732959|NCT00393718|80849862|FG001|Overall Study|Move|0|||
27732960|NCT02601573|80849863|FG000|Overall Study|Lost to Follow-up|0|||
27732961|NCT02601573|80849864|FG001|Overall Study|Lost to Follow-up|3|||
27732962|NCT02601573|80849865|FG002|Overall Study|Lost to Follow-up|1|||
27732963|NCT02601573|80849866|FG003|Overall Study|Lost to Follow-up|0|||
27732964|NCT02601573|80849867|FG004|Overall Study|Lost to Follow-up|2|||
27732965|NCT02601573|80849863|FG000|Overall Study|Withdrawal by Subject|0|||
27524954|NCT01238588|80116074|FG000|Overall Study|Withdrawal by Subject|1|||
27524955|NCT01238588|80116074|FG000|Overall Study|Physician Decision|2|||
27732966|NCT02601573|80849864|FG001|Overall Study|Withdrawal by Subject|1|||
27732967|NCT02601573|80849865|FG002|Overall Study|Withdrawal by Subject|0|||
27524956|NCT02093351|80116077|FG000|Part A|Adverse Event|0|||
27732968|NCT02601573|80849866|FG003|Overall Study|Withdrawal by Subject|1|||
27524957|NCT02093351|80116078|FG001|Part A|Adverse Event|1|||
27732969|NCT02601573|80849867|FG004|Overall Study|Withdrawal by Subject|0|||
27732970|NCT00686543|80849868|FG000|Overall Study|Adverse Event|9|||
27732971|NCT00686543|80849869|FG001|Overall Study|Adverse Event|1|||
27855357|NCT03514641|81302585|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
27855358|NCT03514641|81302586|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
27524958|NCT02093351|80116079|FG002|Part A|Adverse Event|1|||
27855359|NCT03514641|81302587|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
27855360|NCT03514641|81302584|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
27855361|NCT03514641|81302585|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
27855362|NCT03514641|81302586|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
27855363|NCT03514641|81302587|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
27855364|NCT03514641|81302584|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
27855365|NCT03514641|81302585|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
27855366|NCT03514641|81302586|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
27732972|NCT00686543|80849870|FG002|Overall Study|Adverse Event|3|||
27732973|NCT00686543|80849871|FG003|Overall Study|Adverse Event|2|||
27732974|NCT00686543|80849868|FG000|Overall Study|Withdrawal by Subject|2|||
27855367|NCT03514641|81302587|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
27524959|NCT02093351|80116080|FG003|Part A|Adverse Event|0|||
27524960|NCT02093351|80116077|FG000|Part A|Condition under investigation worsened|2|||
27732975|NCT00686543|80849869|FG001|Overall Study|Withdrawal by Subject|0|||
27732976|NCT00686543|80849870|FG002|Overall Study|Withdrawal by Subject|0|||
27524961|NCT02093351|80116078|FG001|Part A|Condition under investigation worsened|0|||
27732977|NCT00686543|80849871|FG003|Overall Study|Withdrawal by Subject|0|||
27732978|NCT00686543|80849868|FG000|Overall Study|Protocol Violation|3|||
27732979|NCT00686543|80849869|FG001|Overall Study|Protocol Violation|0|||
27732980|NCT00686543|80849870|FG002|Overall Study|Protocol Violation|2|||
27732981|NCT00686543|80849871|FG003|Overall Study|Protocol Violation|1|||
27732982|NCT00260208|80849872|FG000|Overall Study|Subject withdrew consent|11|||
27732983|NCT00260208|80849873|FG001|Overall Study|Subject withdrew consent|7|||
27732984|NCT00260208|80849872|FG000|Overall Study|Lost to Follow-up|6|||
27732985|NCT00260208|80849873|FG001|Overall Study|Lost to Follow-up|1|||
27524962|NCT02093351|80116079|FG002|Part A|Condition under investigation worsened|2|||
27524963|NCT02093351|80116080|FG003|Part A|Condition under investigation worsened|0|||
27524964|NCT02093351|80116077|FG000|Part A|Death|0|||
27524965|NCT02093351|80116078|FG001|Part A|Death|1|||
27524966|NCT02093351|80116079|FG002|Part A|Death|0|||
27524967|NCT02093351|80116080|FG003|Part A|Death|0|||
27524968|NCT02093351|80116077|FG000|Part B|Patient decision|0|||
27524969|NCT02093351|80116078|FG001|Part B|Patient decision|0|||
27524970|NCT02093351|80116079|FG002|Part B|Patient decision|0|||
27524971|NCT02093351|80116080|FG003|Part B|Patient decision|3|||
27524972|NCT02093351|80116077|FG000|Part B|Disease progression|0|||
27524973|NCT02093351|80116078|FG001|Part B|Disease progression|0|||
27524974|NCT02093351|80116079|FG002|Part B|Disease progression|0|||
27524975|NCT02093351|80116080|FG003|Part B|Disease progression|4|||
27524976|NCT02093351|80116077|FG000|Part B|Complete response|0|||
27524977|NCT02093351|80116078|FG001|Part B|Complete response|0|||
27524978|NCT02093351|80116079|FG002|Part B|Complete response|0|||
27524979|NCT02093351|80116080|FG003|Part B|Complete response|1|||
27524980|NCT02093351|80116077|FG000|Part B|Adverse event + disease progression|0|||
27524981|NCT02093351|80116078|FG001|Part B|Adverse event + disease progression|0|||
27524982|NCT02093351|80116079|FG002|Part B|Adverse event + disease progression|0|||
27524983|NCT02093351|80116080|FG003|Part B|Adverse event + disease progression|1|||
27524984|NCT02093351|80116077|FG000|Part B|Lack of therapeutic response|0|||
27524985|NCT02093351|80116078|FG001|Part B|Lack of therapeutic response|0|||
27524986|NCT02093351|80116079|FG002|Part B|Lack of therapeutic response|0|||
27524987|NCT02093351|80116080|FG003|Part B|Lack of therapeutic response|12|||
27524988|NCT02093351|80116077|FG000|Part B|Condition under investigation worsened|0|||
27524989|NCT02093351|80116078|FG001|Part B|Condition under investigation worsened|0|||
27524990|NCT02093351|80116079|FG002|Part B|Condition under investigation worsened|0|||
27524991|NCT02093351|80116080|FG003|Part B|Condition under investigation worsened|39|||
27524992|NCT02093351|80116077|FG000|Part B|Adverse Event|0|||
27524993|NCT02093351|80116078|FG001|Part B|Adverse Event|0|||
27524994|NCT02093351|80116079|FG002|Part B|Adverse Event|0|||
27524995|NCT02093351|80116080|FG003|Part B|Adverse Event|2|||
27732986|NCT00260208|80849872|FG000|Overall Study|Death|12|||
27732987|NCT00260208|80849873|FG001|Overall Study|Death|10|||
27855368|NCT03514641|81302584|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
27855369|NCT03514641|81302585|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
27855370|NCT03514641|81302586|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
27855371|NCT03514641|81302587|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
27855372|NCT00440466|81302588|FG000|Overall Study|Death|3|||
27855373|NCT00440466|81302589|FG001|Overall Study|Death|2|||
27855374|NCT00440466|81302590|FG002|Overall Study|Death|9|||
27855375|NCT00440466|81302588|FG000|Overall Study|Adverse Event|3|||
27855376|NCT00440466|81302589|FG001|Overall Study|Adverse Event|4|||
27855377|NCT00440466|81302590|FG002|Overall Study|Adverse Event|11|||
27855378|NCT00440466|81302588|FG000|Overall Study|Lost to Follow-up|1|||
27855379|NCT00440466|81302589|FG001|Overall Study|Lost to Follow-up|0|||
27855380|NCT00440466|81302590|FG002|Overall Study|Lost to Follow-up|2|||
27855381|NCT00440466|81302588|FG000|Overall Study|Physician Decision|2|||
27855382|NCT00440466|81302589|FG001|Overall Study|Physician Decision|0|||
27855383|NCT00440466|81302590|FG002|Overall Study|Physician Decision|1|||
27855384|NCT00440466|81302588|FG000|Overall Study|Protocol Violation|2|||
27855385|NCT00440466|81302589|FG001|Overall Study|Protocol Violation|0|||
27855386|NCT00440466|81302590|FG002|Overall Study|Protocol Violation|4|||
27524996|NCT02093351|80116077|FG000|Part B|Death|0|||
27524997|NCT02093351|80116078|FG001|Part B|Death|0|||
27524998|NCT02093351|80116079|FG002|Part B|Death|0|||
27524999|NCT02093351|80116080|FG003|Part B|Death|1|||
27525000|NCT00584740|80116081|FG000|Overall Study|Adverse Event|1|||
27732988|NCT00260208|80849872|FG000|Overall Study|Missing|18|||
27732989|NCT00260208|80849873|FG001|Overall Study|Missing|16|||
27855387|NCT00440466|81302588|FG000|Overall Study|Withdrawal by Subject|2|||
27855388|NCT00440466|81302589|FG001|Overall Study|Withdrawal by Subject|5|||
27855389|NCT00440466|81302590|FG002|Overall Study|Withdrawal by Subject|9|||
27855390|NCT00440466|81302588|FG000|Overall Study|Began Dialysis|0|||
27525001|NCT00584740|80116082|FG001|Overall Study|Adverse Event|1|||
27525002|NCT00584740|80116081|FG000|Overall Study|Lack of Efficacy|8|||
27525003|NCT00584740|80116082|FG001|Overall Study|Lack of Efficacy|2|||
27525004|NCT00584740|80116081|FG000|Overall Study|Withdrawal by Subject|3|||
27732990|NCT00316264|80849874|FG000|Overall Study|Lost to Follow-up|0|||
27525005|NCT00584740|80116082|FG001|Overall Study|Withdrawal by Subject|2|||
27525006|NCT00584740|80116081|FG000|Overall Study|Lost to Follow-up|0|||
27525007|NCT00584740|80116082|FG001|Overall Study|Lost to Follow-up|1|||
27525008|NCT00392379|80116083|FG000|Overall Study|Withdrawal by Subject|17|||
27525009|NCT00392379|80116084|FG001|Overall Study|Withdrawal by Subject|28|||
27525010|NCT00392379|80116083|FG000|Overall Study|Lost to Follow-up|4|||
27525011|NCT00392379|80116084|FG001|Overall Study|Lost to Follow-up|9|||
27525012|NCT00392379|80116083|FG000|Overall Study|Adverse Event|1|||
27525013|NCT00392379|80116084|FG001|Overall Study|Adverse Event|1|||
27525014|NCT00635024|80116091|FG000|Overall Study|Adverse Event|1|||
27525015|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
27525016|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
27525017|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
27525018|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
27525019|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
27525020|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
27525021|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
27525022|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
27525023|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
27525024|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
27525025|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
27525026|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
27525027|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
27525028|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
27525029|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
27525030|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
27525031|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
27525032|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
27525033|NCT00591578|80116099|FG000|Double-Blind Treatment Phase|Other|4|||
27525034|NCT00591578|80116100|FG001|Double-Blind Treatment Phase|Other|9|||
27525035|NCT00591578|80116101|FG002|Double-Blind Treatment Phase|Other|4|||
27525036|NCT00591578|80116099|FG000|Open-Label Extension Phase|Adverse Event|3|||
27525037|NCT00591578|80116100|FG001|Open-Label Extension Phase|Adverse Event|5|||
27525038|NCT00591578|80116101|FG002|Open-Label Extension Phase|Adverse Event|0|||
27525039|NCT00591578|80116099|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
27525040|NCT00591578|80116100|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
27525041|NCT00591578|80116101|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27525042|NCT00591578|80116099|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
27525043|NCT00591578|80116100|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
27525044|NCT00591578|80116101|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
27525045|NCT00591578|80116099|FG000|Open-Label Extension Phase|Other|1|||
27525046|NCT00591578|80116100|FG001|Open-Label Extension Phase|Other|0|||
27525047|NCT00591578|80116101|FG002|Open-Label Extension Phase|Other|0|||
27525048|NCT00924781|80116102|FG000|Overall Study|Study terminated by sponsor|12|||
27525049|NCT00924781|80116103|FG001|Overall Study|Study terminated by sponsor|10|||
27622289|NCT02687919|80457869|FG001|Overall Study|Withdrawal by Subject|6|||
27855391|NCT00440466|81302589|FG001|Overall Study|Began Dialysis|0|||
27855392|NCT00440466|81302590|FG002|Overall Study|Began Dialysis|1|||
27855393|NCT00440466|81302588|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
27855394|NCT00440466|81302589|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
27855395|NCT00440466|81302590|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
27855396|NCT04614246|81302601|FG000|Overall Study|Adverse Event|0|||
27855397|NCT04614246|81302602|FG001|Overall Study|Adverse Event|1|||
27855398|NCT04614246|81302603|FG002|Overall Study|Adverse Event|1|||
27855399|NCT04614246|81302604|FG003|Overall Study|Adverse Event|2|||
27855400|NCT04614246|81302605|FG004|Overall Study|Adverse Event|1|||
27855401|NCT04614246|81302601|FG000|Overall Study|Lost to Follow-up|0|||
27855402|NCT04614246|81302602|FG001|Overall Study|Lost to Follow-up|1|||
27910358|NCT00762034|81510095|FG001|Maintenance Period|Death not due to study disease|5|||
27910359|NCT00762034|81510094|FG000|Maintenance Period|Death due to study disease|3|||
27910360|NCT00762034|81510095|FG001|Maintenance Period|Death due to study disease|3|||
27910361|NCT00762034|81510094|FG000|Maintenance Period|Other|1|||
27910362|NCT00762034|81510095|FG001|Maintenance Period|Other|1|||
27910363|NCT01411319|81510096|FG000|Overall Study|Lost to Follow-up|1|||
27910364|NCT00436826|81510099|FG000|Double Blind Period (DBP)|Adverse Event|2|||
27525050|NCT01330017|80116104|FG000|Overall Study|Adverse Event|0|||
27525051|NCT01330017|80116105|FG001|Overall Study|Adverse Event|1|||
27622290|NCT02687919|80457868|FG000|Overall Study|Protocol Violation|2|||
27855403|NCT04614246|81302603|FG002|Overall Study|Lost to Follow-up|0|||
27525052|NCT01330017|80116106|FG002|Overall Study|Adverse Event|1|||
27622291|NCT02687919|80457869|FG001|Overall Study|Protocol Violation|0|||
27855404|NCT04614246|81302604|FG003|Overall Study|Lost to Follow-up|1|||
27525053|NCT01330017|80116107|FG003|Overall Study|Adverse Event|4|||
27525054|NCT01330017|80116108|FG004|Overall Study|Adverse Event|0|||
27855405|NCT04614246|81302605|FG004|Overall Study|Lost to Follow-up|3|||
27855406|NCT04614246|81302601|FG000|Overall Study|Other reason|0|||
27855407|NCT04614246|81302602|FG001|Overall Study|Other reason|1|||
27525055|NCT01330017|80116104|FG000|Overall Study|Withdrawal by Subject|0|||
27525056|NCT01330017|80116105|FG001|Overall Study|Withdrawal by Subject|0|||
27855408|NCT04614246|81302603|FG002|Overall Study|Other reason|2|||
27855409|NCT04614246|81302604|FG003|Overall Study|Other reason|0|||
27855410|NCT04614246|81302605|FG004|Overall Study|Other reason|0|||
27855411|NCT04614246|81302601|FG000|Overall Study|Withdrawal by Subject|4|||
27910365|NCT00436826|81510100|FG001|Double Blind Period (DBP)|Adverse Event|0|||
27525057|NCT01330017|80116106|FG002|Overall Study|Withdrawal by Subject|1|||
27525058|NCT01330017|80116107|FG003|Overall Study|Withdrawal by Subject|0|||
27525059|NCT01330017|80116108|FG004|Overall Study|Withdrawal by Subject|1|||
27622292|NCT03251378|80457874|FG000|Overall Study|Death|3|||
27622293|NCT03251378|80457875|FG001|Overall Study|Death|2|||
27622294|NCT03251378|80457876|FG002|Overall Study|Death|3|||
27622295|NCT03251378|80457877|FG003|Overall Study|Death|30|||
27622296|NCT03251378|80457878|FG004|Overall Study|Death|24|||
27622297|NCT03251378|80457879|FG005|Overall Study|Death|12|||
27622298|NCT03251378|80457880|FG006|Overall Study|Death|12|||
27622299|NCT03251378|80457874|FG000|Overall Study|Lost to Follow-up|0|||
27622300|NCT03251378|80457875|FG001|Overall Study|Lost to Follow-up|0|||
27622301|NCT03251378|80457876|FG002|Overall Study|Lost to Follow-up|1|||
27622302|NCT03251378|80457877|FG003|Overall Study|Lost to Follow-up|3|||
27622303|NCT03251378|80457878|FG004|Overall Study|Lost to Follow-up|0|||
27622304|NCT03251378|80457879|FG005|Overall Study|Lost to Follow-up|0|||
27525060|NCT01330017|80116104|FG000|Overall Study|Lost to Follow-up|0|||
27622305|NCT03251378|80457880|FG006|Overall Study|Lost to Follow-up|0|||
27622306|NCT03251378|80457874|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
27622307|NCT03251378|80457875|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
27622308|NCT03251378|80457876|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
27622309|NCT03251378|80457877|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
27622310|NCT03251378|80457878|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
27622311|NCT03251378|80457879|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
27622312|NCT03251378|80457880|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
27622313|NCT03251378|80457874|FG000|Overall Study|Progressive disease|2|||
27622314|NCT03251378|80457875|FG001|Overall Study|Progressive disease|0|||
27622315|NCT03251378|80457876|FG002|Overall Study|Progressive disease|0|||
27622316|NCT03251378|80457877|FG003|Overall Study|Progressive disease|1|||
27622317|NCT03251378|80457878|FG004|Overall Study|Progressive disease|0|||
27622318|NCT03251378|80457879|FG005|Overall Study|Progressive disease|0|||
27622319|NCT03251378|80457880|FG006|Overall Study|Progressive disease|0|||
27622320|NCT03251378|80457874|FG000|Overall Study|Physician Decision|0|||
27622321|NCT03251378|80457875|FG001|Overall Study|Physician Decision|2|||
27622322|NCT03251378|80457876|FG002|Overall Study|Physician Decision|0|||
27525061|NCT01330017|80116105|FG001|Overall Study|Lost to Follow-up|0|||
27525062|NCT01330017|80116106|FG002|Overall Study|Lost to Follow-up|1|||
27525063|NCT01330017|80116107|FG003|Overall Study|Lost to Follow-up|0|||
27525064|NCT01330017|80116108|FG004|Overall Study|Lost to Follow-up|0|||
27525065|NCT01330017|80116104|FG000|Overall Study|Protocol Violation|0|||
27525066|NCT01330017|80116105|FG001|Overall Study|Protocol Violation|0|||
27525067|NCT01330017|80116106|FG002|Overall Study|Protocol Violation|0|||
27525068|NCT01330017|80116107|FG003|Overall Study|Protocol Violation|1|||
27525069|NCT01330017|80116108|FG004|Overall Study|Protocol Violation|0|||
27525070|NCT01330017|80116104|FG000|Overall Study|Unknown Reason|5|||
27525071|NCT01330017|80116105|FG001|Overall Study|Unknown Reason|3|||
27525072|NCT01330017|80116106|FG002|Overall Study|Unknown Reason|5|||
27525073|NCT01330017|80116107|FG003|Overall Study|Unknown Reason|7|||
27525074|NCT01330017|80116108|FG004|Overall Study|Unknown Reason|2|||
27525075|NCT03614975|80116109|FG000|Overall Study|Physician Decision|7|||
27910366|NCT00436826|81510101|FG002|Double Blind Period (DBP)|Adverse Event|0|||
27525076|NCT03614975|80116110|FG001|Overall Study|Physician Decision|5|||
27525077|NCT03614975|80116109|FG000|Overall Study|Withdrawal by Subject|2|||
27525078|NCT03614975|80116110|FG001|Overall Study|Withdrawal by Subject|2|||
27525079|NCT03614975|80116109|FG000|Overall Study|Specimens not in lab batch shipment|1|||
27855412|NCT04614246|81302602|FG001|Overall Study|Withdrawal by Subject|2|||
27855413|NCT04614246|81302603|FG002|Overall Study|Withdrawal by Subject|4|||
27855414|NCT04614246|81302604|FG003|Overall Study|Withdrawal by Subject|3|||
27525080|NCT03614975|80116110|FG001|Overall Study|Specimens not in lab batch shipment|1|||
27732991|NCT00316264|80849875|FG001|Overall Study|Lost to Follow-up|1|||
27732992|NCT00316264|80849876|FG002|Overall Study|Lost to Follow-up|0|||
27732993|NCT00316264|80849874|FG000|Overall Study|Withdrawal of Consent|3|||
27732994|NCT00316264|80849875|FG001|Overall Study|Withdrawal of Consent|5|||
27732995|NCT00316264|80849876|FG002|Overall Study|Withdrawal of Consent|6|||
27732996|NCT00316264|80849874|FG000|Overall Study|Death|2|||
27732997|NCT00316264|80849875|FG001|Overall Study|Death|0|||
27732998|NCT00316264|80849876|FG002|Overall Study|Death|0|||
27732999|NCT00316264|80849874|FG000|Overall Study|Other|1|||
27733000|NCT00316264|80849875|FG001|Overall Study|Other|1|||
27733001|NCT00316264|80849876|FG002|Overall Study|Other|0|||
27733002|NCT02292849|80849877|FG000|Overall Study|Lost to Follow-up|0|||
27733003|NCT02292849|80849878|FG001|Overall Study|Lost to Follow-up|2|||
27733004|NCT02292849|80849879|FG002|Overall Study|Lost to Follow-up|2|||
27733005|NCT02292849|80849877|FG000|Overall Study|Physician Decision|4|||
27733006|NCT02292849|80849878|FG001|Overall Study|Physician Decision|0|||
27733007|NCT02292849|80849879|FG002|Overall Study|Physician Decision|0|||
27733008|NCT03440944|80849880|FG000|Overall Study|Physician Decision|1|||
27733009|NCT03440944|80849881|FG001|Overall Study|Physician Decision|0|||
27733010|NCT03440944|80849880|FG000|Overall Study|No Acceptable Vasculature|0|||
27733011|NCT03440944|80849881|FG001|Overall Study|No Acceptable Vasculature|1|||
27733012|NCT01412879|80849882|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
27733013|NCT01412879|80849883|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
27733014|NCT01412879|80849884|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
27733015|NCT01412879|80849882|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
27733016|NCT01412879|80849883|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
27733017|NCT01412879|80849884|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
27733018|NCT01412879|80849882|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
27733019|NCT01412879|80849883|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
27733020|NCT01412879|80849884|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
27733021|NCT01412879|80849882|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
27855415|NCT04614246|81302605|FG004|Overall Study|Withdrawal by Subject|4|||
27855416|NCT04614246|81302601|FG000|Overall Study|Physician Decision|0|||
27855417|NCT04614246|81302602|FG001|Overall Study|Physician Decision|2|||
27855418|NCT04614246|81302603|FG002|Overall Study|Physician Decision|1|||
27855419|NCT04614246|81302604|FG003|Overall Study|Physician Decision|0|||
27855420|NCT04614246|81302605|FG004|Overall Study|Physician Decision|0|||
27855421|NCT04614246|81302601|FG000|Overall Study|Study terminated by sponsor|10|||
27855422|NCT04614246|81302602|FG001|Overall Study|Study terminated by sponsor|15|||
27855423|NCT04614246|81302603|FG002|Overall Study|Study terminated by sponsor|12|||
27525081|NCT00727532|80116111|FG000|Overall Study|Adverse Event|1|||
27525082|NCT00727532|80116111|FG000|Overall Study|Withdrawal by Subject|1|||
27855424|NCT04614246|81302604|FG003|Overall Study|Study terminated by sponsor|13|||
27855425|NCT04614246|81302605|FG004|Overall Study|Study terminated by sponsor|9|||
27855426|NCT04614246|81302601|FG000|Overall Study|Pregnancy|2|||
27855427|NCT04614246|81302602|FG001|Overall Study|Pregnancy|0|||
27855428|NCT04614246|81302603|FG002|Overall Study|Pregnancy|1|||
27855429|NCT04614246|81302604|FG003|Overall Study|Pregnancy|0|||
27855430|NCT04614246|81302605|FG004|Overall Study|Pregnancy|0|||
27525083|NCT01461057|80116112|FG000|Overall Study|Death|10|||
27525084|NCT01461057|80116113|FG001|Overall Study|Death|9|||
27525085|NCT01461057|80116112|FG000|Overall Study|Withdrawal by Subject|2|||
27525086|NCT01461057|80116113|FG001|Overall Study|Withdrawal by Subject|3|||
27525087|NCT01461057|80116112|FG000|Overall Study|Physician Decision|0|||
27525088|NCT01461057|80116113|FG001|Overall Study|Physician Decision|2|||
27733022|NCT01412879|80849883|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
27733023|NCT01412879|80849884|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
27733024|NCT01412879|80849882|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
27733025|NCT01412879|80849883|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
27733026|NCT01412879|80849884|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
27855431|NCT02518919|81302606|FG000|Overall Study|Protocol Violation|1|||
27855432|NCT02518919|81302607|FG001|Overall Study|Protocol Violation|1|||
27855433|NCT02518919|81302608|FG002|Overall Study|Protocol Violation|2|||
27855434|NCT02005887|81302610|FG000|Overall Study|Protocol Violation|0|||
27855435|NCT02005887|81302611|FG001|Overall Study|Protocol Violation|2|||
27855436|NCT01103466|81302613|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
27525089|NCT01461057|80116112|FG000|Overall Study|Adverse Event|0|||
27525090|NCT01461057|80116113|FG001|Overall Study|Adverse Event|1|||
27525091|NCT01461057|80116112|FG000|Overall Study|Progression of Disease|1|||
27525092|NCT01461057|80116113|FG001|Overall Study|Progression of Disease|0|||
27622323|NCT03251378|80457877|FG003|Overall Study|Physician Decision|0|||
27622324|NCT03251378|80457878|FG004|Overall Study|Physician Decision|0|||
27622325|NCT03251378|80457879|FG005|Overall Study|Physician Decision|0|||
27622326|NCT03251378|80457880|FG006|Overall Study|Physician Decision|0|||
27622327|NCT03251378|80457874|FG000|Overall Study|Other|2|||
27622328|NCT03251378|80457875|FG001|Overall Study|Other|3|||
27622329|NCT03251378|80457876|FG002|Overall Study|Other|2|||
27622330|NCT03251378|80457877|FG003|Overall Study|Other|0|||
27622331|NCT03251378|80457878|FG004|Overall Study|Other|1|||
27622332|NCT03251378|80457879|FG005|Overall Study|Other|1|||
27622333|NCT03251378|80457880|FG006|Overall Study|Other|1|||
27622334|NCT03251378|80457874|FG000|Overall Study|Other|0|||
27622335|NCT03251378|80457875|FG001|Overall Study|Other|0|||
27622336|NCT03251378|80457876|FG002|Overall Study|Other|0|||
27622337|NCT03251378|80457877|FG003|Overall Study|Other|4|||
27622338|NCT03251378|80457878|FG004|Overall Study|Other|13|||
27622339|NCT03251378|80457879|FG005|Overall Study|Other|0|||
27622340|NCT03251378|80457880|FG006|Overall Study|Other|0|||
27525093|NCT01461057|80116112|FG000|Overall Study|Study Terminated by Sponsor|2|||
27525094|NCT01461057|80116113|FG001|Overall Study|Study Terminated by Sponsor|0|||
27525095|NCT00130442|80116114|FG000|Overall Study|Withdrawal by Subject|0|||
27525096|NCT00130442|80116115|FG001|Overall Study|Withdrawal by Subject|1|||
27525097|NCT00130442|80116114|FG000|Overall Study|did not meet criteria|1|||
27525098|NCT00130442|80116115|FG001|Overall Study|did not meet criteria|1|||
27525099|NCT00879879|80116116|FG000|Overall Study|Death|1|||
27525100|NCT00879879|80116116|FG000|Overall Study|Withdrawal by Subject|1|||
27525101|NCT00879879|80116116|FG000|Overall Study|Physician Decision|1|||
27622341|NCT01764386|80457881|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
27622342|NCT01764386|80457882|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
27622343|NCT01764386|80457881|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
27910367|NCT00436826|81510102|FG003|Double Blind Period (DBP)|Adverse Event|0|||
27910368|NCT00436826|81510103|FG004|Double Blind Period (DBP)|Adverse Event|0|||
27910369|NCT00436826|81510104|FG005|Double Blind Period (DBP)|Adverse Event|0|||
27910370|NCT00436826|81510099|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
27910371|NCT00436826|81510100|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
27910372|NCT00436826|81510101|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
27910373|NCT00436826|81510102|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
27910374|NCT00436826|81510103|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
27622344|NCT01764386|80457882|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
27622345|NCT01764386|80457881|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
27855437|NCT01103466|81302614|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
27855438|NCT01103466|81302615|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
27855439|NCT01103466|81302613|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
27855440|NCT01103466|81302614|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
27855441|NCT01103466|81302615|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
27855442|NCT01103466|81302613|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
27855443|NCT01103466|81302614|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
27855444|NCT01103466|81302615|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
27855445|NCT01103466|81302613|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
27855446|NCT01103466|81302614|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
27855447|NCT01103466|81302615|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
27855448|NCT01103466|81302613|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
27855449|NCT01103466|81302614|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
27855450|NCT01103466|81302615|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
27855451|NCT01103466|81302613|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
27855452|NCT01103466|81302614|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
27525102|NCT03234881|80116117|FG000|Overall Study|Lost to Follow-up|9|||
27622346|NCT01764386|80457882|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
27622347|NCT01764386|80457881|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
27622348|NCT01764386|80457882|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
27622349|NCT01764386|80457881|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
27622350|NCT01764386|80457882|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
27622351|NCT01764386|80457881|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
27622352|NCT01764386|80457882|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
27525103|NCT03234881|80116118|FG001|Overall Study|Lost to Follow-up|3|||
27622353|NCT01764386|80457881|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
27855453|NCT01103466|81302615|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
27855454|NCT01169532|81302616|FG000|Overall Study|Withdrawal by Subject|1|||
27855455|NCT01175811|81302617|FG000|Overall Study|Adverse Event|1|||
27855456|NCT01175811|81302618|FG001|Overall Study|Adverse Event|1|||
27910375|NCT00436826|81510104|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
27622354|NCT01764386|80457882|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
27622355|NCT01764386|80457881|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
27855457|NCT01175811|81302617|FG000|Overall Study|Entry criteria not met|3|||
27855458|NCT01175811|81302618|FG001|Overall Study|Entry criteria not met|1|||
27855459|NCT01175811|81302617|FG000|Overall Study|Lack of Efficacy|1|||
27855460|NCT01175811|81302618|FG001|Overall Study|Lack of Efficacy|0|||
27855461|NCT01175811|81302617|FG000|Overall Study|Lost to Follow-up|3|||
27855462|NCT01175811|81302618|FG001|Overall Study|Lost to Follow-up|2|||
27855463|NCT01175811|81302617|FG000|Overall Study|Physician Decision|1|||
27855464|NCT01175811|81302618|FG001|Overall Study|Physician Decision|1|||
27855465|NCT01175811|81302617|FG000|Overall Study|Protocol Violation|1|||
27855466|NCT01175811|81302618|FG001|Overall Study|Protocol Violation|2|||
27855467|NCT01175811|81302617|FG000|Overall Study|Withdrawal by Subject|6|||
27855468|NCT01175811|81302618|FG001|Overall Study|Withdrawal by Subject|7|||
27855469|NCT00857792|81302619|FG000|Overall Study|inadequate image quality for analysis|12|||
27855470|NCT04853992|81302624|FG000|Treatment Period A|Adverse Event|0|||
27855471|NCT04853992|81302625|FG001|Treatment Period A|Adverse Event|1|||
27855472|NCT04853992|81302624|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
27910376|NCT00436826|81510099|FG000|Double Blind Period (DBP)|Other|10|||
27910377|NCT00436826|81510100|FG001|Double Blind Period (DBP)|Other|11|||
27910378|NCT00436826|81510101|FG002|Double Blind Period (DBP)|Other|0|||
27910379|NCT00436826|81510102|FG003|Double Blind Period (DBP)|Other|0|||
27910380|NCT00436826|81510103|FG004|Double Blind Period (DBP)|Other|0|||
27910381|NCT00436826|81510104|FG005|Double Blind Period (DBP)|Other|0|||
27910382|NCT00436826|81510099|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
27910383|NCT00436826|81510100|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
27910384|NCT00436826|81510101|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
27910385|NCT00436826|81510102|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
27855473|NCT04853992|81302625|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
27855474|NCT01196078|81302626|FG000|Overall Study|Withdrawal by Subject|3|||
27855475|NCT01196078|81302627|FG001|Overall Study|Withdrawal by Subject|5|||
27855476|NCT01196078|81302626|FG000|Overall Study|Adverse Event|4|||
27910386|NCT00436826|81510103|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
27910387|NCT00436826|81510104|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
27910388|NCT00436826|81510099|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
27910389|NCT00436826|81510100|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
27910390|NCT00436826|81510101|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
27910391|NCT00436826|81510102|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
27525104|NCT00868517|80116119|FG000|Overall Study|Withdrawal by Subject|3|||
27525105|NCT00868517|80116120|FG001|Overall Study|Withdrawal by Subject|3|||
27622356|NCT01764386|80457882|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
27622357|NCT00940017|80460874|FG000|Overall Study|did not meet entrance criteria|3|||
27622358|NCT00940017|80460874|FG000|Overall Study|Adverse Event|1|||
27855477|NCT01196078|81302627|FG001|Overall Study|Adverse Event|4|||
27855478|NCT01196078|81302626|FG000|Overall Study|Protocol Violation|2|||
27855479|NCT01196078|81302627|FG001|Overall Study|Protocol Violation|1|||
27910392|NCT00436826|81510103|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
27910393|NCT00436826|81510104|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
27525106|NCT00868517|80116121|FG002|Overall Study|Withdrawal by Subject|2|||
27525107|NCT00868517|80116119|FG000|Overall Study|Protocol Violation|1|||
27622359|NCT02939183|80460875|FG000|Overall Study|Death|0|||
27622360|NCT02939183|80460876|FG001|Overall Study|Death|0|||
27525108|NCT00868517|80116120|FG001|Overall Study|Protocol Violation|1|||
27525109|NCT00868517|80116121|FG002|Overall Study|Protocol Violation|0|||
27525110|NCT03699475|80116124|FG000|Overall Study|Death|1|||
27525111|NCT01142089|80116127|FG000|Overall Study|Physician Decision|1|||
27525112|NCT01142089|80116128|FG001|Overall Study|Physician Decision|0|||
27525113|NCT01142089|80116127|FG000|Overall Study|Withdrawal by Subject|1|||
27525114|NCT01142089|80116128|FG001|Overall Study|Withdrawal by Subject|2|||
27525115|NCT01142089|80116127|FG000|Overall Study|Use of prohibited medications|0|||
27525116|NCT01142089|80116128|FG001|Overall Study|Use of prohibited medications|1|||
27525117|NCT01142089|80116127|FG000|Overall Study|Noncompliance with study procedures|2|||
27525118|NCT01142089|80116128|FG001|Overall Study|Noncompliance with study procedures|1|||
27525119|NCT01142089|80116127|FG000|Overall Study|Patient required rescue medication|8|||
27525120|NCT01142089|80116128|FG001|Overall Study|Patient required rescue medication|17|||
27622361|NCT02939183|80460877|FG002|Overall Study|Death|1|||
27525121|NCT00870233|80116135|FG000|Overall Study|Withdrawal by Subject|18|||
27525122|NCT00870233|80116135|FG000|Overall Study|Did not undergo laparotomy|3|||
27622362|NCT02939183|80460878|FG003|Overall Study|Death|0|||
27855480|NCT01196078|81302626|FG000|Overall Study|Lack of Efficacy|17|||
27855481|NCT01196078|81302627|FG001|Overall Study|Lack of Efficacy|23|||
27855482|NCT01196078|81302626|FG000|Overall Study|Lost to Follow-up|1|||
27855483|NCT01196078|81302627|FG001|Overall Study|Lost to Follow-up|0|||
27855484|NCT01196078|81302626|FG000|Overall Study|Death|6|||
27525123|NCT00870233|80116135|FG000|Overall Study|Incompatible internet browser|2|||
27622363|NCT02939183|80460879|FG004|Overall Study|Death|0|||
27622364|NCT02939183|80460880|FG005|Overall Study|Death|2|||
27855485|NCT01196078|81302627|FG001|Overall Study|Death|4|||
27855486|NCT01602965|81302628|FG000|Overall Study|Lost to Follow-up|4|||
27855487|NCT01602965|81302629|FG001|Overall Study|Lost to Follow-up|2|||
27855488|NCT00270257|81302630|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
27855489|NCT00270257|81302631|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
27855490|NCT05012163|81302637|FG000|Overall Study|Protocol Violation|0|||
27855491|NCT05012163|81302638|FG001|Overall Study|Protocol Violation|0|||
27855492|NCT05012163|81302639|FG002|Overall Study|Protocol Violation|1|||
27855493|NCT05012163|81302640|FG003|Overall Study|Protocol Violation|1|||
27855494|NCT02963441|81302641|FG000|Overall Study|Protocol violation or withdrawn|8|||
27855495|NCT02963441|81302641|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
27855496|NCT02963441|81302641|FG000|Overall Study|IDx-DR insufficient quality|33|||
27855497|NCT02791893|81302644|FG000|Blinded Phase|Lost to Follow-up|2|||
27855498|NCT02791893|81302645|FG001|Blinded Phase|Lost to Follow-up|2|||
27855499|NCT02791893|81302644|FG000|Blinded Phase|Withdrawal by Subject|1|||
27855500|NCT02791893|81302645|FG001|Blinded Phase|Withdrawal by Subject|2|||
27855501|NCT02791893|81302644|FG000|Open Label Phase|Lost to Follow-up|3|||
27855502|NCT02791893|81302645|FG001|Open Label Phase|Lost to Follow-up|0|||
27855503|NCT02791893|81302644|FG000|Open Label Phase|Withdrawal by Subject|0|||
27855504|NCT02791893|81302645|FG001|Open Label Phase|Withdrawal by Subject|2|||
27855505|NCT00856973|81302647|FG000|Overall Study|Adverse Event|5|||
27855506|NCT00856973|81302648|FG001|Overall Study|Adverse Event|5|||
27855507|NCT00856973|81302649|FG002|Overall Study|Adverse Event|3|||
27855508|NCT00856973|81302647|FG000|Overall Study|Lost to Follow-up|6|||
27855509|NCT00856973|81302648|FG001|Overall Study|Lost to Follow-up|3|||
27855510|NCT00856973|81302649|FG002|Overall Study|Lost to Follow-up|5|||
27855511|NCT00856973|81302647|FG000|Overall Study|Physician Decision|0|||
27855512|NCT00856973|81302648|FG001|Overall Study|Physician Decision|3|||
27855513|NCT00856973|81302649|FG002|Overall Study|Physician Decision|1|||
27855514|NCT00856973|81302647|FG000|Overall Study|Protocol Violation|1|||
27855515|NCT00856973|81302648|FG001|Overall Study|Protocol Violation|2|||
27910394|NCT00436826|81510099|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
27910395|NCT00436826|81510100|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
27910396|NCT00436826|81510101|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
27910397|NCT00436826|81510102|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
27910398|NCT00436826|81510103|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
27910399|NCT00436826|81510104|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
27910400|NCT02299388|81510114|FG000|Overall Study|Withdrawal by Subject|0|||
27910401|NCT02299388|81510115|FG001|Overall Study|Withdrawal by Subject|1|||
27910402|NCT03214679|81510116|FG000|Overall Study|Lost to Follow-up|12|||
27910403|NCT03214679|81510117|FG001|Overall Study|Lost to Follow-up|14|||
27910404|NCT03214679|81510116|FG000|Overall Study|not eligible|2|||
27910405|NCT03214679|81510117|FG001|Overall Study|not eligible|0|||
27910406|NCT00753675|81510119|FG000|Overall Study|other reason|11|||
27910407|NCT00753675|81510120|FG001|Overall Study|other reason|12|||
27910408|NCT00753675|81510121|FG002|Overall Study|other reason|13|||
27910409|NCT00753675|81510119|FG000|Overall Study|Death|1|||
27910410|NCT00753675|81510120|FG001|Overall Study|Death|2|||
27910411|NCT00753675|81510121|FG002|Overall Study|Death|4|||
27910412|NCT00753675|81510119|FG000|Overall Study|Adverse Event|11|||
27910413|NCT00753675|81510120|FG001|Overall Study|Adverse Event|9|||
27910414|NCT00753675|81510121|FG002|Overall Study|Adverse Event|4|||
27910415|NCT00753675|81510119|FG000|Overall Study|Objective progression of disease|35|||
27910416|NCT00753675|81510120|FG001|Overall Study|Objective progression of disease|35|||
27910417|NCT00753675|81510121|FG002|Overall Study|Objective progression of disease|35|||
27910418|NCT00753675|81510119|FG000|Overall Study|Withdrawal by Subject|0|||
27910419|NCT00753675|81510120|FG001|Overall Study|Withdrawal by Subject|1|||
27910420|NCT00753675|81510121|FG002|Overall Study|Withdrawal by Subject|0|||
27910421|NCT00753675|81510119|FG000|Overall Study|Lost to Follow-up|1|||
27525124|NCT00870233|80116135|FG000|Overall Study|Death|1|||
27525125|NCT02380690|80116140|FG000|Overall Study|Lost to Follow-up|14|||
27525126|NCT02380690|80116141|FG001|Overall Study|Lost to Follow-up|4|||
27525127|NCT02380690|80116140|FG000|Overall Study|Withdrawal by Subject|20|||
27525128|NCT02380690|80116141|FG001|Overall Study|Withdrawal by Subject|8|||
27525129|NCT01095094|80116142|FG000|Overall Study|Withdrawal by Subject|1|||
27622365|NCT02939183|80460881|FG006|Overall Study|Death|1|||
27622366|NCT02939183|80460882|FG007|Overall Study|Death|0|||
27855516|NCT00856973|81302649|FG002|Overall Study|Protocol Violation|1|||
27855517|NCT00856973|81302647|FG000|Overall Study|Withdrawal by Subject|13|||
27855518|NCT00856973|81302648|FG001|Overall Study|Withdrawal by Subject|16|||
27855519|NCT00856973|81302649|FG002|Overall Study|Withdrawal by Subject|15|||
27855520|NCT00856973|81302647|FG000|Overall Study|Other|11|||
27855521|NCT00856973|81302648|FG001|Overall Study|Other|12|||
27855522|NCT00856973|81302649|FG002|Overall Study|Other|13|||
27855523|NCT01388166|81302650|FG000|Overall Study|Adverse Event|16|||
27855524|NCT01388166|81302650|FG000|Overall Study|Lost to Follow-up|30|||
27525130|NCT01095094|80116142|FG000|Overall Study|Death|1|||
27525131|NCT01095094|80116142|FG000|Overall Study|Physician Decision|1|||
27525132|NCT00887744|80116143|FG000|Overall Study|Adverse Event|3|||
27525133|NCT00887744|80116143|FG000|Overall Study|Death|1|||
27525134|NCT00887744|80116143|FG000|Overall Study|Lost to Follow-up|3|||
27525135|NCT00887744|80116143|FG000|Overall Study|Withdrawal by Subject|18|||
27525136|NCT00887744|80116143|FG000|Overall Study|Various reasons|9|||
27525137|NCT00636987|80116148|FG000|Overall Study|Death|44|||
27525138|NCT00636987|80116148|FG000|Overall Study|Explanted|13|||
27525139|NCT00636987|80116148|FG000|Overall Study|Lost to Follow-up|63|||
27525140|NCT00636987|80116148|FG000|Overall Study|5 year visit window not complete|69|||
27525141|NCT04054947|80116149|FG000|Overall Study|Withdrawal by Subject|1|||
27525142|NCT04054947|80116150|FG001|Overall Study|Withdrawal by Subject|0|||
27525143|NCT04054947|80116149|FG000|Overall Study|Lost to Follow-up|2|||
27525144|NCT04054947|80116150|FG001|Overall Study|Lost to Follow-up|5|||
27525145|NCT00400153|80116151|FG000|Overall Study|AE due to study disease worsening|14|||
27525146|NCT00400153|80116152|FG001|Overall Study|AE due to study disease worsening|19|||
27910422|NCT00753675|81510120|FG001|Overall Study|Lost to Follow-up|0|||
27525147|NCT00400153|80116153|FG002|Overall Study|AE due to study disease worsening|20|||
27525148|NCT00400153|80116151|FG000|Overall Study|AE due to other disease worsening|2|||
27525149|NCT00400153|80116152|FG001|Overall Study|AE due to other disease worsening|1|||
27910423|NCT00753675|81510121|FG002|Overall Study|Lost to Follow-up|0|||
27910424|NCT02256917|81510122|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
27910425|NCT02256917|81510122|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
27622367|NCT02939183|80460883|FG008|Overall Study|Death|0|||
27622368|NCT02939183|80460875|FG000|Overall Study|Sponsor decision|0|||
27622369|NCT02939183|80460876|FG001|Overall Study|Sponsor decision|1|||
27622370|NCT02939183|80460877|FG002|Overall Study|Sponsor decision|0|||
27622371|NCT02939183|80460878|FG003|Overall Study|Sponsor decision|1|||
27622372|NCT02939183|80460879|FG004|Overall Study|Sponsor decision|2|||
27622373|NCT02939183|80460880|FG005|Overall Study|Sponsor decision|0|||
27622374|NCT02939183|80460881|FG006|Overall Study|Sponsor decision|3|||
27622375|NCT02939183|80460882|FG007|Overall Study|Sponsor decision|1|||
27622376|NCT02939183|80460883|FG008|Overall Study|Sponsor decision|4|||
27622377|NCT02939183|80460875|FG000|Overall Study|Withdrawal by Subject|0|||
27622378|NCT02939183|80460876|FG001|Overall Study|Withdrawal by Subject|2|||
27622379|NCT02939183|80460877|FG002|Overall Study|Withdrawal by Subject|0|||
27622380|NCT02939183|80460878|FG003|Overall Study|Withdrawal by Subject|1|||
27622381|NCT02939183|80460879|FG004|Overall Study|Withdrawal by Subject|0|||
27622382|NCT02939183|80460880|FG005|Overall Study|Withdrawal by Subject|0|||
27622383|NCT02939183|80460881|FG006|Overall Study|Withdrawal by Subject|2|||
27622384|NCT02939183|80460882|FG007|Overall Study|Withdrawal by Subject|2|||
27622385|NCT02939183|80460883|FG008|Overall Study|Withdrawal by Subject|2|||
27622386|NCT02939183|80460875|FG000|Overall Study|Not treated due to adverse event|0|||
27622387|NCT02939183|80460876|FG001|Overall Study|Not treated due to adverse event|0|||
27622388|NCT02939183|80460877|FG002|Overall Study|Not treated due to adverse event|0|||
27622389|NCT02939183|80460878|FG003|Overall Study|Not treated due to adverse event|1|||
27622390|NCT02939183|80460879|FG004|Overall Study|Not treated due to adverse event|0|||
27622391|NCT02939183|80460880|FG005|Overall Study|Not treated due to adverse event|0|||
27622392|NCT02939183|80460881|FG006|Overall Study|Not treated due to adverse event|1|||
27622393|NCT02939183|80460882|FG007|Overall Study|Not treated due to adverse event|0|||
27622394|NCT02939183|80460883|FG008|Overall Study|Not treated due to adverse event|0|||
27622395|NCT00087490|80460886|FG000|Overall Study|Death|6|||
27622396|NCT00087490|80460887|FG001|Overall Study|Death|4|||
27622397|NCT00087490|80460886|FG000|Overall Study|Adverse Event|3|||
27622398|NCT00087490|80460887|FG001|Overall Study|Adverse Event|8|||
27622399|NCT00087490|80460886|FG000|Overall Study|Lack of Efficacy|0|||
27622400|NCT00087490|80460887|FG001|Overall Study|Lack of Efficacy|2|||
27622401|NCT00087490|80460886|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
27622402|NCT00087490|80460887|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
27622403|NCT00087490|80460886|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
27622404|NCT00087490|80460887|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
27622405|NCT00087490|80460886|FG000|Overall Study|Randomized but not treated|7|||
27622406|NCT00087490|80460887|FG001|Overall Study|Randomized but not treated|18|||
27622407|NCT01354938|80460888|FG000|Overall Study|Lost to Follow-up|1|||
27622408|NCT01616563|80460889|FG000|Overall Study|Lost to Follow-up|40|||
27622409|NCT01598987|80460891|FG000|Baseline to Month 12|Administrative problems|2|||
27622410|NCT01598987|80460891|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
27622411|NCT01598987|80460891|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
27622412|NCT01598987|80460891|FG000|Baseline to 24 Month|Administrative problems|2|||
27622413|NCT01598987|80460891|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
27622414|NCT00329303|80460892|FG000|Overall Study|Lack of Efficacy|1|||
27622415|NCT00329303|80460893|FG001|Overall Study|Lack of Efficacy|0|||
27622416|NCT00329303|80460892|FG000|Overall Study|Decision of the sponsor|0|||
27622417|NCT00329303|80460893|FG001|Overall Study|Decision of the sponsor|1|||
27622418|NCT00329303|80460892|FG000|Overall Study|Patient no longer available|1|||
27622419|NCT00329303|80460893|FG001|Overall Study|Patient no longer available|0|||
27622420|NCT00329303|80460892|FG000|Overall Study|Patient relocated|0|||
27622421|NCT00329303|80460893|FG001|Overall Study|Patient relocated|1|||
27733027|NCT04026568|80849887|FG000|Overall Study|study terminated|0|||
27733028|NCT04026568|80849888|FG001|Overall Study|study terminated|1|||
27910426|NCT02256917|81510122|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
27622422|NCT00994279|80460894|FG000|Overall Study|Withdrawal by Subject|2|||
27622423|NCT00994279|80460895|FG001|Overall Study|Withdrawal by Subject|2|||
27622424|NCT00994279|80460894|FG000|Overall Study|Toxicity|1|||
27622425|NCT00994279|80460895|FG001|Overall Study|Toxicity|0|||
27622426|NCT00994279|80460894|FG000|Overall Study|Multiple reasons|1|||
27622427|NCT00994279|80460895|FG001|Overall Study|Multiple reasons|3|||
27910427|NCT02256917|81510122|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
27622428|NCT01686932|80460905|FG000|Period 1|Adverse Event|1|||
27622429|NCT01686932|80460906|FG001|Period 1|Adverse Event|1|||
27622430|NCT02485353|80460909|FG000|Overall Study|Death|1|||
27622431|NCT02485353|80460909|FG000|Overall Study|Disease Progression|1|||
27622432|NCT05349084|80460910|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
27622433|NCT00409708|80460911|FG000|Treatment|Abnormal test procedure result(s)|1|||
27622434|NCT00409708|80460912|FG001|Treatment|Abnormal test procedure result(s)|0|||
27910428|NCT02256917|81510122|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
27910429|NCT03479008|81510123|FG000|Overall Study|Withdrawal by Subject|3|||
27910430|NCT02035553|81510124|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
27910431|NCT02035553|81510125|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
27910432|NCT02035553|81510124|FG000|Overall Study|Adverse Event|10|||
27910433|NCT02035553|81510125|FG001|Overall Study|Adverse Event|6|||
27525150|NCT00400153|80116153|FG002|Overall Study|AE due to other disease worsening|0|||
27622435|NCT00409708|80460911|FG000|Treatment|Lack of Efficacy|0|||
27622436|NCT00409708|80460912|FG001|Treatment|Lack of Efficacy|1|||
27622437|NCT00409708|80460911|FG000|Treatment|Protocol Violation|6|||
27733029|NCT02921425|80849895|FG000|Overall Study|Protocol Violation|9|||
27622438|NCT00409708|80460912|FG001|Treatment|Protocol Violation|2|||
27622439|NCT00409708|80460911|FG000|Treatment|Withdrawal by Subject|3|||
27622440|NCT00409708|80460912|FG001|Treatment|Withdrawal by Subject|8|||
27622441|NCT00409708|80460911|FG000|Treatment|Lost to Follow-up|0|||
27622442|NCT00409708|80460912|FG001|Treatment|Lost to Follow-up|6|||
27622443|NCT00409708|80460911|FG000|Treatment|Administrative problems|5|||
27622444|NCT00409708|80460912|FG001|Treatment|Administrative problems|0|||
27622445|NCT00409708|80460911|FG000|Washout|Lack of Efficacy|9|||
27622446|NCT00409708|80460912|FG001|Washout|Lack of Efficacy|1|||
27622447|NCT00409708|80460911|FG000|Washout|Protocol Violation|0|||
27622448|NCT00409708|80460912|FG001|Washout|Protocol Violation|1|||
27622449|NCT00409708|80460911|FG000|Washout|Withdrawal by Subject|11|||
27622450|NCT00409708|80460912|FG001|Washout|Withdrawal by Subject|5|||
27622451|NCT00409708|80460911|FG000|Washout|Lost to Follow-up|1|||
27622452|NCT00409708|80460912|FG001|Washout|Lost to Follow-up|3|||
27622453|NCT03168438|80460916|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
27622454|NCT03168438|80460917|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
27622455|NCT01101542|80460918|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
27622456|NCT01101542|80460918|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
27622457|NCT01101542|80460918|FG000|Year 4 Surveillance Period|Other|287|||
27622458|NCT01101542|80460918|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
27622459|NCT01101542|80460918|FG000|Year 5 Surveillance Period|Pregnancy|1|||
27622460|NCT01101542|80460918|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
27622461|NCT01101542|80460918|FG000|Year 6 Surveillance Period|Pregnancy|1|||
27622462|NCT01101542|80460918|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
27733030|NCT00943683|80849896|FG000|Overall Study|Adverse Event|3|||
27733031|NCT00943683|80849897|FG001|Overall Study|Adverse Event|3|||
27733032|NCT00943683|80849896|FG000|Overall Study|Lost to Follow-up|1|||
27733033|NCT00943683|80849897|FG001|Overall Study|Lost to Follow-up|1|||
27733034|NCT00943683|80849896|FG000|Overall Study|Protocol Violation|1|||
27733035|NCT00943683|80849897|FG001|Overall Study|Protocol Violation|2|||
27733036|NCT00943683|80849896|FG000|Overall Study|Withdrawal by Subject|1|||
27733037|NCT00943683|80849897|FG001|Overall Study|Withdrawal by Subject|0|||
27910434|NCT02035553|81510124|FG000|Overall Study|Physician Decision|3|||
27910435|NCT02035553|81510125|FG001|Overall Study|Physician Decision|2|||
27910436|NCT02035553|81510124|FG000|Overall Study|Lack of Efficacy|1|||
27910437|NCT02035553|81510125|FG001|Overall Study|Lack of Efficacy|1|||
27525151|NCT00400153|80116151|FG000|Overall Study|AE due to other condition|3|||
27525152|NCT00400153|80116152|FG001|Overall Study|AE due to other condition|14|||
27525153|NCT00400153|80116153|FG002|Overall Study|AE due to other condition|15|||
27525154|NCT00400153|80116151|FG000|Overall Study|Protocol Violation|7|||
27525155|NCT00400153|80116152|FG001|Overall Study|Protocol Violation|4|||
27525156|NCT00400153|80116153|FG002|Overall Study|Protocol Violation|9|||
27525157|NCT00400153|80116151|FG000|Overall Study|Lost to Follow-up|2|||
27525158|NCT00400153|80116152|FG001|Overall Study|Lost to Follow-up|1|||
27525159|NCT00400153|80116153|FG002|Overall Study|Lost to Follow-up|4|||
27525160|NCT00400153|80116151|FG000|Overall Study|Withdrawal by Subject|12|||
27525161|NCT00400153|80116152|FG001|Overall Study|Withdrawal by Subject|11|||
27525162|NCT00400153|80116153|FG002|Overall Study|Withdrawal by Subject|10|||
27525163|NCT00400153|80116151|FG000|Overall Study|Other reasons - not mentioned above|8|||
27525164|NCT00400153|80116152|FG001|Overall Study|Other reasons - not mentioned above|5|||
27525165|NCT00400153|80116153|FG002|Overall Study|Other reasons - not mentioned above|3|||
27525166|NCT01289782|80116154|FG000|Overall Study|Lost to Follow-up|14|||
27622463|NCT00582790|80460920|FG000|Overall Study|Rapid progression of disease|1|||
27622464|NCT04610684|80460927|FG000|Study Treatment|Withdrawal by Subject|1|||
27910438|NCT02035553|81510124|FG000|Overall Study|Withdrawal by Subject|4|||
27622465|NCT04610684|80460927|FG000|Study Treatment|Disease Progression|2|||
27622466|NCT04610684|80460927|FG000|Follow up|Death|2|||
27622467|NCT04610684|80460927|FG000|Follow up|Withdrawal by Subject|1|||
27622468|NCT00162942|80460928|FG000|Overall Study|Adverse Event|10|||
27622469|NCT00162942|80460929|FG001|Overall Study|Adverse Event|6|||
27525167|NCT01289782|80116155|FG001|Overall Study|Lost to Follow-up|7|||
27525168|NCT01289782|80116154|FG000|Overall Study|Protocol Violation|1|||
27525169|NCT01289782|80116155|FG001|Overall Study|Protocol Violation|1|||
27622470|NCT00162942|80460928|FG000|Overall Study|Death|1|||
27622471|NCT00162942|80460929|FG001|Overall Study|Death|0|||
27733038|NCT00943683|80849896|FG000|Overall Study|Patient Moved|1|||
27855525|NCT01388166|81302650|FG000|Overall Study|Others than specified above|13|||
27855526|NCT00719849|81302651|FG000|Overall Study|Death|0|||
27855527|NCT00719849|81302652|FG001|Overall Study|Death|1|||
27855528|NCT02440568|81302653|FG000|Overall Study|Death|1|||
27855529|NCT02440568|81302654|FG001|Overall Study|Death|3|||
27855530|NCT02440568|81302655|FG002|Overall Study|Death|4|||
27855531|NCT02440568|81302656|FG003|Overall Study|Death|2|||
27855532|NCT02440568|81302653|FG000|Overall Study|Lack of Efficacy|2|||
27855533|NCT02440568|81302654|FG001|Overall Study|Lack of Efficacy|0|||
27855534|NCT02440568|81302655|FG002|Overall Study|Lack of Efficacy|1|||
27855535|NCT02440568|81302656|FG003|Overall Study|Lack of Efficacy|0|||
27855536|NCT02440568|81302653|FG000|Overall Study|Lost to Follow-up|1|||
27855537|NCT02440568|81302654|FG001|Overall Study|Lost to Follow-up|0|||
27855538|NCT02440568|81302655|FG002|Overall Study|Lost to Follow-up|0|||
27855539|NCT02440568|81302656|FG003|Overall Study|Lost to Follow-up|0|||
27855540|NCT02906930|81302657|FG000|Overall Study|Withdrawal by Subject|0|||
27855541|NCT02906930|81302658|FG001|Overall Study|Withdrawal by Subject|5|||
27910439|NCT02035553|81510125|FG001|Overall Study|Withdrawal by Subject|7|||
27910440|NCT02035553|81510124|FG000|Overall Study|Non-compliance with Study Drug|0|||
27910441|NCT02035553|81510125|FG001|Overall Study|Non-compliance with Study Drug|1|||
27910442|NCT02035553|81510124|FG000|Overall Study|Lost to Follow-up|0|||
27910443|NCT02035553|81510125|FG001|Overall Study|Lost to Follow-up|1|||
27910444|NCT02035553|81510124|FG000|Overall Study|Other Reason|0|||
27910445|NCT02035553|81510125|FG001|Overall Study|Other Reason|4|||
27910446|NCT03293394|81510127|FG000|Follow-up (6 Months)|Adverse Event|4|||
27910447|NCT03293394|81510128|FG001|Follow-up (6 Months)|Adverse Event|2|||
27910448|NCT03243305|81510129|FG000|Overall Study|Lost to Follow-up|250|||
27910449|NCT03243305|81510129|FG000|Overall Study|Withdrawal by Subject|170|||
27910450|NCT03243305|81510129|FG000|Overall Study|Pregnancy|104|||
27910451|NCT03243305|81510129|FG000|Overall Study|Non-Compliance with Study Drug|38|||
27910452|NCT03243305|81510129|FG000|Overall Study|Adverse Event|23|||
27910453|NCT03243305|81510129|FG000|Overall Study|No sexually active|26|||
27910454|NCT03243305|81510129|FG000|Overall Study|Physician Decision|22|||
27910455|NCT03243305|81510129|FG000|Overall Study|Protocol Violation|22|||
27910456|NCT03243305|81510129|FG000|Overall Study|Study method no longer primary method|12|||
27910457|NCT03243305|81510129|FG000|Overall Study|Study Terminated by Sponsor|1|||
27910458|NCT03243305|81510129|FG000|Overall Study|Early terminations|267|||
27910459|NCT01733121|81510130|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
27910460|NCT01733121|81510131|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
27910461|NCT01733121|81510130|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
27910462|NCT01733121|81510131|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
27910463|NCT01733121|81510130|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
27910464|NCT01733121|81510131|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
27910465|NCT01733121|81510130|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
27910466|NCT01733121|81510131|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
27910467|NCT00540644|81510132|FG000|Overall Study|Adverse Event|3|||
27910468|NCT00540644|81510133|FG001|Overall Study|Adverse Event|1|||
27910469|NCT00540644|81510132|FG000|Overall Study|Disease Progression|3|||
27910470|NCT00540644|81510133|FG001|Overall Study|Disease Progression|1|||
27910471|NCT00540644|81510132|FG000|Overall Study|Physician Decision|0|||
27910472|NCT00540644|81510133|FG001|Overall Study|Physician Decision|5|||
27910473|NCT00540644|81510132|FG000|Overall Study|Withdrawal by Subject|2|||
27910474|NCT00540644|81510133|FG001|Overall Study|Withdrawal by Subject|2|||
27910475|NCT00540644|81510132|FG000|Overall Study|Noncomplilance|1|||
27525170|NCT01289782|80116154|FG000|Overall Study|Withdrawal by Subject|8|||
27525171|NCT01289782|80116155|FG001|Overall Study|Withdrawal by Subject|2|||
27525172|NCT01289782|80116154|FG000|Overall Study|Sponsor's Decision|1|||
27525173|NCT01289782|80116155|FG001|Overall Study|Sponsor's Decision|0|||
27525174|NCT01289782|80116154|FG000|Overall Study|Reason not specified|1|||
27525175|NCT01289782|80116155|FG001|Overall Study|Reason not specified|2|||
27525176|NCT01115803|80116160|FG000|Overall Study|Withdrawal by Subject|0|||
27525177|NCT01115803|80116161|FG001|Overall Study|Withdrawal by Subject|0|||
27525178|NCT01115803|80116162|FG002|Overall Study|Withdrawal by Subject|0|||
27525179|NCT01115803|80116163|FG003|Overall Study|Withdrawal by Subject|0|||
27525180|NCT01115803|80116164|FG004|Overall Study|Withdrawal by Subject|0|||
27622472|NCT00162942|80460928|FG000|Overall Study|Withdrawal by Subject|3|||
27855542|NCT02906930|81302659|FG002|Overall Study|Withdrawal by Subject|5|||
27910476|NCT00540644|81510133|FG001|Overall Study|Noncomplilance|0|||
27910477|NCT02748057|81510134|FG000|Overall Study|Adverse Event|1|||
27855543|NCT02906930|81302660|FG003|Overall Study|Withdrawal by Subject|4|||
27910478|NCT02748057|81510135|FG001|Overall Study|Adverse Event|0|||
27910479|NCT02748057|81510134|FG000|Overall Study|Physician Decision|0|||
27910480|NCT02748057|81510135|FG001|Overall Study|Physician Decision|1|||
27910481|NCT02748057|81510134|FG000|Overall Study|Protocol Violation|2|||
27910482|NCT02748057|81510135|FG001|Overall Study|Protocol Violation|1|||
27525181|NCT01115803|80116165|FG005|Overall Study|Withdrawal by Subject|0|||
27855544|NCT02906930|81302657|FG000|Overall Study|Lost to Follow-up|5|||
27855545|NCT02906930|81302658|FG001|Overall Study|Lost to Follow-up|7|||
27910483|NCT02748057|81510134|FG000|Overall Study|Participant Moved|1|||
27910484|NCT02748057|81510135|FG001|Overall Study|Participant Moved|0|||
27910485|NCT02748057|81510134|FG000|Overall Study|Withdrawal by Subject|1|||
27910486|NCT02748057|81510135|FG001|Overall Study|Withdrawal by Subject|0|||
27910487|NCT01673984|81510136|FG000|Overall Study|Adverse Event|1|||
27910488|NCT01673984|81510137|FG001|Overall Study|Adverse Event|0|||
27910489|NCT01673984|81510136|FG000|Overall Study|Study termination|9|||
27910490|NCT01673984|81510137|FG001|Overall Study|Study termination|6|||
27910491|NCT03518086|81510138|FG000|Overall Study|Adverse Event|23|||
27910492|NCT03518086|81510139|FG001|Overall Study|Adverse Event|15|||
27910493|NCT03518086|81510140|FG002|Overall Study|Adverse Event|0|||
27910494|NCT03518086|81510141|FG003|Overall Study|Adverse Event|0|||
27910495|NCT03518086|81510138|FG000|Overall Study|Withdrawal by Subject|8|||
27910496|NCT03518086|81510139|FG001|Overall Study|Withdrawal by Subject|5|||
27910497|NCT03518086|81510140|FG002|Overall Study|Withdrawal by Subject|0|||
27910498|NCT03518086|81510141|FG003|Overall Study|Withdrawal by Subject|0|||
27910499|NCT03518086|81510138|FG000|Overall Study|Lack of Efficacy|5|||
27910500|NCT03518086|81510139|FG001|Overall Study|Lack of Efficacy|5|||
27910501|NCT03518086|81510140|FG002|Overall Study|Lack of Efficacy|0|||
27910502|NCT03518086|81510141|FG003|Overall Study|Lack of Efficacy|0|||
27910503|NCT03518086|81510138|FG000|Overall Study|Protocol Violation|1|||
27910504|NCT03518086|81510139|FG001|Overall Study|Protocol Violation|5|||
27855546|NCT02906930|81302659|FG002|Overall Study|Lost to Follow-up|5|||
27855547|NCT02906930|81302660|FG003|Overall Study|Lost to Follow-up|2|||
27855548|NCT02906930|81302657|FG000|Overall Study|Death|0|||
27855549|NCT02906930|81302658|FG001|Overall Study|Death|0|||
27855550|NCT02906930|81302659|FG002|Overall Study|Death|1|||
27855551|NCT02906930|81302660|FG003|Overall Study|Death|0|||
27855552|NCT02906930|81302657|FG000|Overall Study|Other|1|||
27855553|NCT02906930|81302658|FG001|Overall Study|Other|2|||
27855554|NCT02906930|81302659|FG002|Overall Study|Other|1|||
27855555|NCT02906930|81302660|FG003|Overall Study|Other|2|||
27855556|NCT02143583|81302661|FG000|Overall Study|Withdrawal by Subject|1|||
27855557|NCT02143583|81302662|FG001|Overall Study|Withdrawal by Subject|0|||
27855558|NCT02143583|81302663|FG002|Overall Study|Withdrawal by Subject|1|||
27855559|NCT02143583|81302661|FG000|Overall Study|husband illness|0|||
27855560|NCT02143583|81302662|FG001|Overall Study|husband illness|0|||
27855561|NCT02143583|81302663|FG002|Overall Study|husband illness|1|||
27855562|NCT02669940|81302672|FG000|Overall Study|Failure to return|0|||
27855563|NCT02669940|81302673|FG001|Overall Study|Failure to return|3|||
27855564|NCT02669940|81302672|FG000|Overall Study|Insufficient follow-up data|1|||
27855565|NCT02669940|81302673|FG001|Overall Study|Insufficient follow-up data|0|||
27855566|NCT01394952|81302674|FG000|Overall Study|Lost to Follow-up|0|||
27855567|NCT01394952|81302675|FG001|Overall Study|Lost to Follow-up|5|||
27855568|NCT01394952|81302674|FG000|Overall Study|Withdrawal by Subject|10|||
27855569|NCT01394952|81302675|FG001|Overall Study|Withdrawal by Subject|5|||
27855570|NCT01394952|81302674|FG000|Overall Study|Physician Decision|2|||
27855571|NCT01394952|81302675|FG001|Overall Study|Physician Decision|0|||
27855572|NCT01394952|81302674|FG000|Overall Study|Sponsor Decision|5|||
27855573|NCT01394952|81302675|FG001|Overall Study|Sponsor Decision|7|||
27855574|NCT01059539|81302676|FG000|Overall Study|Adverse Event|66|||
27855575|NCT01059539|81302676|FG000|Overall Study|Insufficient Therapeutic Response|26|||
27855576|NCT01059539|81302676|FG000|Overall Study|Protocol Violation|55|||
27855577|NCT01059539|81302676|FG000|Overall Study|Withdrawal of Consent|80|||
27855578|NCT01059539|81302676|FG000|Overall Study|Lost to Follow-up|42|||
27855579|NCT01059539|81302676|FG000|Overall Study|Reason Not Specified|2|||
27855580|NCT02119286|81302677|FG000|Overall Study|Adverse Event|9|||
27855581|NCT02119286|81302678|FG001|Overall Study|Adverse Event|7|||
27855582|NCT02119286|81302679|FG002|Overall Study|Adverse Event|2|||
27855583|NCT02119286|81302677|FG000|Overall Study|Lack of Efficacy|11|||
27855584|NCT02119286|81302678|FG001|Overall Study|Lack of Efficacy|3|||
27855585|NCT02119286|81302679|FG002|Overall Study|Lack of Efficacy|4|||
27855586|NCT02119286|81302677|FG000|Overall Study|Lost to Follow-up|2|||
27855587|NCT02119286|81302678|FG001|Overall Study|Lost to Follow-up|0|||
27855588|NCT02119286|81302679|FG002|Overall Study|Lost to Follow-up|1|||
27855589|NCT02119286|81302677|FG000|Overall Study|Withdrawal by Subject|4|||
27855590|NCT02119286|81302678|FG001|Overall Study|Withdrawal by Subject|1|||
27733039|NCT00943683|80849897|FG001|Overall Study|Patient Moved|0|||
27855591|NCT02119286|81302679|FG002|Overall Study|Withdrawal by Subject|0|||
27855592|NCT04498403|81302680|FG000|Overall Study|Adverse Event|1|||
27855593|NCT04498403|81302681|FG001|Overall Study|Adverse Event|0|||
27855594|NCT04498403|81302680|FG000|Overall Study|Study Terminated By Sponsor|29|||
27910505|NCT03518086|81510140|FG002|Overall Study|Protocol Violation|0|||
27910506|NCT03518086|81510141|FG003|Overall Study|Protocol Violation|0|||
27855595|NCT04498403|81302681|FG001|Overall Study|Study Terminated By Sponsor|10|||
27855596|NCT04442490|81302682|FG000|Overall Study|Withdrawal by Subject|18|||
27910507|NCT03518086|81510138|FG000|Overall Study|Lost to Follow-up|0|||
27910508|NCT03518086|81510139|FG001|Overall Study|Lost to Follow-up|3|||
27910509|NCT03518086|81510140|FG002|Overall Study|Lost to Follow-up|0|||
27855597|NCT04442490|81302683|FG001|Overall Study|Withdrawal by Subject|10|||
27855598|NCT04442490|81302682|FG000|Overall Study|Lost to Follow-up|7|||
27855599|NCT04442490|81302683|FG001|Overall Study|Lost to Follow-up|7|||
27855600|NCT04442490|81302682|FG000|Overall Study|Adverse Event|2|||
27855601|NCT04442490|81302683|FG001|Overall Study|Adverse Event|6|||
27855602|NCT04442490|81302682|FG000|Overall Study|Noncompliance|3|||
27855603|NCT04442490|81302683|FG001|Overall Study|Noncompliance|1|||
27855604|NCT04442490|81302682|FG000|Overall Study|Physician Decision|2|||
27855605|NCT04442490|81302683|FG001|Overall Study|Physician Decision|1|||
27855606|NCT04442490|81302682|FG000|Overall Study|Reason not Specified|2|||
27622473|NCT00162942|80460929|FG001|Overall Study|Withdrawal by Subject|6|||
27622474|NCT00162942|80460928|FG000|Overall Study|Physician Decision|1|||
27622475|NCT00162942|80460929|FG001|Overall Study|Physician Decision|0|||
27622476|NCT00162942|80460928|FG000|Overall Study|Enter Open-Label Study|76|||
27622477|NCT00162942|80460929|FG001|Overall Study|Enter Open-Label Study|35|||
27622478|NCT00162942|80460928|FG000|Overall Study|Alternate Therapy|6|||
27622479|NCT00162942|80460929|FG001|Overall Study|Alternate Therapy|2|||
27622480|NCT00162942|80460928|FG000|Overall Study|Lack of Efficacy|1|||
27855607|NCT04442490|81302683|FG001|Overall Study|Reason not Specified|1|||
27855608|NCT04442490|81302682|FG000|Overall Study|Randomized but not Treated|3|||
27855609|NCT04442490|81302683|FG001|Overall Study|Randomized but not Treated|3|||
27855610|NCT01523457|81302685|FG000|Overall Study|Withdrawal by Subject|7|||
27855611|NCT01523457|81302686|FG001|Overall Study|Withdrawal by Subject|2|||
27855612|NCT01584843|81302687|FG000|First Treatment Period|Adverse Event|0|||
27855613|NCT01584843|81302688|FG001|First Treatment Period|Adverse Event|0|||
27855614|NCT01584843|81302689|FG002|First Treatment Period|Adverse Event|1|||
27855615|NCT01584843|81302690|FG003|First Treatment Period|Adverse Event|0|||
27855616|NCT01584843|81302691|FG004|First Treatment Period|Adverse Event|0|||
27855617|NCT01584843|81302692|FG005|First Treatment Period|Adverse Event|0|||
27855618|NCT01584843|81302687|FG000|First Treatment Period|Protocol Violation|0|||
27855619|NCT01584843|81302688|FG001|First Treatment Period|Protocol Violation|0|||
27855620|NCT01584843|81302689|FG002|First Treatment Period|Protocol Violation|0|||
27855621|NCT01584843|81302690|FG003|First Treatment Period|Protocol Violation|0|||
27855622|NCT01584843|81302691|FG004|First Treatment Period|Protocol Violation|0|||
27855623|NCT01584843|81302692|FG005|First Treatment Period|Protocol Violation|1|||
27855624|NCT01584843|81302687|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27855625|NCT01584843|81302688|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27855626|NCT01584843|81302689|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27855627|NCT01584843|81302690|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27855628|NCT01584843|81302691|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
27622481|NCT00162942|80460929|FG001|Overall Study|Lack of Efficacy|0|||
27855629|NCT01584843|81302692|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
27855630|NCT01584843|81302687|FG000|Second Treatment Period|Withdrawal by Subject|0|||
27855631|NCT01584843|81302688|FG001|Second Treatment Period|Withdrawal by Subject|0|||
27855632|NCT01584843|81302689|FG002|Second Treatment Period|Withdrawal by Subject|0|||
27855633|NCT01584843|81302690|FG003|Second Treatment Period|Withdrawal by Subject|0|||
27855634|NCT01584843|81302691|FG004|Second Treatment Period|Withdrawal by Subject|0|||
27855635|NCT01584843|81302692|FG005|Second Treatment Period|Withdrawal by Subject|1|||
27855636|NCT04112173|81302693|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
27855637|NCT02317614|81302695|FG000|Overall Study|Lost to Follow-up|1|||
27855638|NCT02317614|81302696|FG001|Overall Study|Lost to Follow-up|1|||
27855639|NCT02317614|81302695|FG000|Overall Study|Withdrawal by Subject|1|||
27855640|NCT02317614|81302696|FG001|Overall Study|Withdrawal by Subject|0|||
27855641|NCT02317614|81302695|FG000|Overall Study|Death|1|||
27855642|NCT02317614|81302696|FG001|Overall Study|Death|1|||
27622482|NCT00162942|80460928|FG000|Overall Study|Flare During Active Treatment|7|||
27622483|NCT00162942|80460929|FG001|Overall Study|Flare During Active Treatment|3|||
27622484|NCT00162942|80460928|FG000|Overall Study|2 or more consecutive treatments missed|1|||
27622485|NCT00162942|80460929|FG001|Overall Study|2 or more consecutive treatments missed|0|||
27622486|NCT02459587|80460933|FG000|3-Month Follow-up Assessment|Death|0|||
27622487|NCT02459587|80460934|FG001|3-Month Follow-up Assessment|Death|2|||
27622488|NCT02459587|80460933|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
27622489|NCT02459587|80460934|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
27622490|NCT02459587|80460933|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
27622491|NCT02459587|80460934|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
27622492|NCT02459587|80460933|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
27622493|NCT02459587|80460934|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
27855643|NCT04280705|81302697|FG000|Overall Study|Enrolled but not treated|4|||
27910510|NCT03518086|81510141|FG003|Overall Study|Lost to Follow-up|0|||
27855644|NCT04280705|81302698|FG001|Overall Study|Enrolled but not treated|10|||
27855645|NCT04280705|81302697|FG000|Overall Study|Physician Decision|1|||
27622494|NCT02459587|80460933|FG000|6-month Follow-up Assessment|Death|2|||
27622495|NCT02459587|80460934|FG001|6-month Follow-up Assessment|Death|1|||
27733040|NCT02945657|80849898|FG000|Overall Study|Adverse Event|1|||
27855646|NCT04280705|81302698|FG001|Overall Study|Physician Decision|0|||
27855647|NCT04280705|81302697|FG000|Overall Study|Withdrawal by Subject|7|||
27855648|NCT04280705|81302698|FG001|Overall Study|Withdrawal by Subject|9|||
27855649|NCT04280705|81302697|FG000|Overall Study|Adverse Event|0|||
27855650|NCT04280705|81302698|FG001|Overall Study|Adverse Event|4|||
27855651|NCT04280705|81302697|FG000|Overall Study|Transferred to another hospital|1|||
27855652|NCT04280705|81302698|FG001|Overall Study|Transferred to another hospital|1|||
27855653|NCT02585934|81302699|FG000|Overall Study|Lost to Follow-up|2|||
27855654|NCT02585934|81302700|FG001|Overall Study|Lost to Follow-up|2|||
27855655|NCT02585934|81302699|FG000|Overall Study|Protocol Violation|14|||
27855656|NCT02585934|81302700|FG001|Overall Study|Protocol Violation|11|||
27855657|NCT02585934|81302699|FG000|Overall Study|Adverse Event|21|||
27855658|NCT02585934|81302700|FG001|Overall Study|Adverse Event|22|||
27855659|NCT02585934|81302699|FG000|Overall Study|Physician Decision|3|||
27855660|NCT02585934|81302700|FG001|Overall Study|Physician Decision|2|||
27855661|NCT02585934|81302699|FG000|Overall Study|Withdrawal by Subject|7|||
27855662|NCT02585934|81302700|FG001|Overall Study|Withdrawal by Subject|21|||
27855663|NCT02585934|81302699|FG000|Overall Study|Lack of Efficacy|2|||
27855664|NCT02585934|81302700|FG001|Overall Study|Lack of Efficacy|1|||
27855665|NCT02585934|81302699|FG000|Overall Study|Death|2|||
27910511|NCT03518086|81510138|FG000|Overall Study|Insufficient Diary Data|0|||
27910512|NCT03518086|81510139|FG001|Overall Study|Insufficient Diary Data|2|||
27910513|NCT03518086|81510140|FG002|Overall Study|Insufficient Diary Data|0|||
27910514|NCT03518086|81510141|FG003|Overall Study|Insufficient Diary Data|0|||
27910515|NCT03518086|81510138|FG000|Overall Study|Non- compliance to Protocol|0|||
27910516|NCT03518086|81510139|FG001|Overall Study|Non- compliance to Protocol|1|||
27733041|NCT02945657|80849898|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
27733042|NCT00623831|80849899|FG000|Overall Study|Withdrawal by Subject|1|||
27733043|NCT00623831|80849900|FG001|Overall Study|Withdrawal by Subject|0|||
27733044|NCT00623831|80849899|FG000|Overall Study|Progressive Disease|0|||
27910517|NCT03518086|81510140|FG002|Overall Study|Non- compliance to Protocol|0|||
27910518|NCT03518086|81510141|FG003|Overall Study|Non- compliance to Protocol|0|||
27910519|NCT03518086|81510138|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
27910520|NCT03518086|81510139|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
27910521|NCT03518086|81510140|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
27910522|NCT03518086|81510141|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
27910523|NCT03518086|81510138|FG000|Overall Study|Site Terminated by Sponsor|0|||
27910524|NCT03518086|81510139|FG001|Overall Study|Site Terminated by Sponsor|1|||
27910525|NCT03518086|81510140|FG002|Overall Study|Site Terminated by Sponsor|0|||
27622496|NCT02459587|80460933|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
27622497|NCT02459587|80460934|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
27622498|NCT02459587|80460933|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
27622499|NCT02459587|80460934|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
27622500|NCT02459587|80460933|FG000|12-month Follow-up Assessment|Death|2|||
27622501|NCT02459587|80460934|FG001|12-month Follow-up Assessment|Death|0|||
27622502|NCT02459587|80460933|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
27622503|NCT02459587|80460934|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
27622504|NCT02459587|80460933|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
27622505|NCT02459587|80460934|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
27622506|NCT02459587|80460933|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
27622507|NCT02459587|80460934|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
27622508|NCT03382821|80460935|FG000|Overall Study|Did not receive allocated intervention.|0|||
27622509|NCT03382821|80460936|FG001|Overall Study|Did not receive allocated intervention.|3|||
27622510|NCT02825043|80460937|FG000|Overall Study|Lost to Follow-up|4|||
27622511|NCT00811187|80460938|FG000|Overall Study|Unable to place device / procedure abort|3|||
27622512|NCT00811187|80460939|FG001|Overall Study|Unable to place device / procedure abort|3|||
27622513|NCT01641861|80460940|FG000|Overall Study|Lost to Follow-up|21|||
27622514|NCT01641861|80460941|FG001|Overall Study|Lost to Follow-up|16|||
27622515|NCT01641861|80460940|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
27622516|NCT01641861|80460941|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
27622517|NCT01641861|80460940|FG000|Overall Study|Died due to drowning|0|||
27622518|NCT01641861|80460941|FG001|Overall Study|Died due to drowning|1|||
27622519|NCT00495469|80460942|FG000|Overall Study|Adverse Event|0|||
27910526|NCT03518086|81510141|FG003|Overall Study|Site Terminated by Sponsor|0|||
27622520|NCT00495469|80460943|FG001|Overall Study|Adverse Event|1|||
27622521|NCT00495469|80460944|FG002|Overall Study|Adverse Event|3|||
27622522|NCT00495469|80460945|FG003|Overall Study|Adverse Event|0|||
27622523|NCT00495469|80460946|FG004|Overall Study|Adverse Event|1|||
27855666|NCT02585934|81302700|FG001|Overall Study|Death|0|||
27855667|NCT02585934|81302699|FG000|Overall Study|Caregiver Withdrew Consent|7|||
27855668|NCT02585934|81302700|FG001|Overall Study|Caregiver Withdrew Consent|7|||
27910527|NCT01073163|81510142|FG000|Overall Study|Adverse Event|1|||
27910528|NCT01073163|81510142|FG000|Overall Study|Disease Progression|1|||
27855669|NCT02585934|81302699|FG000|Overall Study|Sponsor Termination|1|||
27910529|NCT01073163|81510142|FG000|Overall Study|Early termination|1|||
27622524|NCT00495469|80460947|FG005|Overall Study|Adverse Event|1|||
27622525|NCT00495469|80460948|FG006|Overall Study|Adverse Event|1|||
27622526|NCT00495469|80460942|FG000|Overall Study|Lost to Follow-up|1|||
27622527|NCT00495469|80460943|FG001|Overall Study|Lost to Follow-up|1|||
27622528|NCT00495469|80460944|FG002|Overall Study|Lost to Follow-up|3|||
27622529|NCT00495469|80460945|FG003|Overall Study|Lost to Follow-up|1|||
27622530|NCT00495469|80460946|FG004|Overall Study|Lost to Follow-up|0|||
27622531|NCT00495469|80460947|FG005|Overall Study|Lost to Follow-up|0|||
27622532|NCT00495469|80460948|FG006|Overall Study|Lost to Follow-up|0|||
27622533|NCT00495469|80460942|FG000|Overall Study|Protocol Violation|0|||
27622534|NCT00495469|80460943|FG001|Overall Study|Protocol Violation|0|||
27622535|NCT00495469|80460944|FG002|Overall Study|Protocol Violation|0|||
27622536|NCT00495469|80460945|FG003|Overall Study|Protocol Violation|0|||
27622537|NCT00495469|80460946|FG004|Overall Study|Protocol Violation|1|||
27622538|NCT00495469|80460947|FG005|Overall Study|Protocol Violation|2|||
27733045|NCT00623831|80849900|FG001|Overall Study|Progressive Disease|1|||
27525182|NCT01115803|80116166|FG006|Overall Study|Withdrawal by Subject|1|||
27525183|NCT01115803|80116160|FG000|Overall Study|Lost to Follow-up|0|||
27525184|NCT01115803|80116161|FG001|Overall Study|Lost to Follow-up|0|||
27525185|NCT01115803|80116162|FG002|Overall Study|Lost to Follow-up|1|||
27525186|NCT01115803|80116163|FG003|Overall Study|Lost to Follow-up|0|||
27525187|NCT01115803|80116164|FG004|Overall Study|Lost to Follow-up|0|||
27525188|NCT01115803|80116165|FG005|Overall Study|Lost to Follow-up|0|||
27525189|NCT01115803|80116166|FG006|Overall Study|Lost to Follow-up|0|||
27525190|NCT01115803|80116160|FG000|Overall Study|Progressive Disease during Cycle1|0|||
27525191|NCT01115803|80116161|FG001|Overall Study|Progressive Disease during Cycle1|0|||
27525192|NCT01115803|80116162|FG002|Overall Study|Progressive Disease during Cycle1|0|||
27525193|NCT01115803|80116163|FG003|Overall Study|Progressive Disease during Cycle1|0|||
27525194|NCT01115803|80116164|FG004|Overall Study|Progressive Disease during Cycle1|0|||
27525195|NCT01115803|80116165|FG005|Overall Study|Progressive Disease during Cycle1|0|||
27525196|NCT01115803|80116166|FG006|Overall Study|Progressive Disease during Cycle1|1|||
27525197|NCT02764190|80116173|FG000|Overall Study|Lost to Follow-up|17|||
27525198|NCT02764190|80116174|FG001|Overall Study|Lost to Follow-up|13|||
27525199|NCT01006603|80116175|FG000|Overall Study|Withdrawal by Subject|17|||
27525200|NCT01006603|80116176|FG001|Overall Study|Withdrawal by Subject|19|||
27525201|NCT01006603|80116175|FG000|Overall Study|Lost to Follow-up|0|||
27525202|NCT01006603|80116176|FG001|Overall Study|Lost to Follow-up|1|||
27525203|NCT01006603|80116175|FG000|Overall Study|Safety reason|1|||
27525204|NCT01006603|80116176|FG001|Overall Study|Safety reason|1|||
27525205|NCT01006603|80116175|FG000|Overall Study|Protocol Violation|1|||
27622539|NCT00495469|80460948|FG006|Overall Study|Protocol Violation|0|||
27622540|NCT00495469|80460942|FG000|Overall Study|Withdrawal by Subject|5|||
27622541|NCT00495469|80460943|FG001|Overall Study|Withdrawal by Subject|3|||
27622542|NCT00495469|80460944|FG002|Overall Study|Withdrawal by Subject|1|||
27622543|NCT00495469|80460945|FG003|Overall Study|Withdrawal by Subject|3|||
27622544|NCT00495469|80460946|FG004|Overall Study|Withdrawal by Subject|3|||
27622545|NCT00495469|80460947|FG005|Overall Study|Withdrawal by Subject|2|||
27622546|NCT00495469|80460948|FG006|Overall Study|Withdrawal by Subject|3|||
27622547|NCT00495469|80460942|FG000|Overall Study|Lack of Efficacy|0|||
27622548|NCT00495469|80460943|FG001|Overall Study|Lack of Efficacy|0|||
27622549|NCT00495469|80460944|FG002|Overall Study|Lack of Efficacy|0|||
27622550|NCT00495469|80460945|FG003|Overall Study|Lack of Efficacy|0|||
27622551|NCT00495469|80460946|FG004|Overall Study|Lack of Efficacy|0|||
27622552|NCT00495469|80460947|FG005|Overall Study|Lack of Efficacy|0|||
27622553|NCT00495469|80460948|FG006|Overall Study|Lack of Efficacy|1|||
27622554|NCT00495469|80460942|FG000|Overall Study|Liver function test abnormality|0|||
27622555|NCT00495469|80460943|FG001|Overall Study|Liver function test abnormality|1|||
27622556|NCT00495469|80460944|FG002|Overall Study|Liver function test abnormality|0|||
27622557|NCT00495469|80460945|FG003|Overall Study|Liver function test abnormality|0|||
27622558|NCT00495469|80460946|FG004|Overall Study|Liver function test abnormality|0|||
27622559|NCT00495469|80460947|FG005|Overall Study|Liver function test abnormality|0|||
27622560|NCT00495469|80460948|FG006|Overall Study|Liver function test abnormality|0|||
27622561|NCT00495469|80460942|FG000|Overall Study|ST depression at randomisation in ECG|0|||
27622562|NCT00495469|80460943|FG001|Overall Study|ST depression at randomisation in ECG|1|||
27622563|NCT00495469|80460944|FG002|Overall Study|ST depression at randomisation in ECG|0|||
27622564|NCT00495469|80460945|FG003|Overall Study|ST depression at randomisation in ECG|0|||
27622565|NCT00495469|80460946|FG004|Overall Study|ST depression at randomisation in ECG|0|||
27733046|NCT00389207|80849901|FG000|Overall Study|Adverse Event|26|||
27733047|NCT00389207|80849902|FG001|Overall Study|Adverse Event|32|||
27525206|NCT01006603|80116176|FG001|Overall Study|Protocol Violation|3|||
27525207|NCT01006603|80116175|FG000|Overall Study|Incorrect enrolment|0|||
27525208|NCT01006603|80116176|FG001|Overall Study|Incorrect enrolment|2|||
27622566|NCT00495469|80460947|FG005|Overall Study|ST depression at randomisation in ECG|0|||
27622567|NCT00495469|80460948|FG006|Overall Study|ST depression at randomisation in ECG|0|||
27525209|NCT01006603|80116175|FG000|Overall Study|Adverse Event|15|||
27525210|NCT01006603|80116176|FG001|Overall Study|Adverse Event|7|||
27855670|NCT02585934|81302700|FG001|Overall Study|Sponsor Termination|2|||
27525211|NCT01006603|80116175|FG000|Overall Study|Death|1|||
27525212|NCT01006603|80116176|FG001|Overall Study|Death|1|||
27525213|NCT01006603|80116175|FG000|Overall Study|Study specific discontinuation criteria|33|||
27525214|NCT01006603|80116176|FG001|Overall Study|Study specific discontinuation criteria|34|||
27525215|NCT01006603|80116175|FG000|Overall Study|Other|3|||
27525216|NCT01006603|80116176|FG001|Overall Study|Other|7|||
27525217|NCT03780400|80116178|FG000|Overall Study|Lost to Follow-up|5|||
27525218|NCT03780400|80116178|FG000|Overall Study|Withdrawal by Subject|2|||
27525219|NCT01565343|80116179|FG000|Overall Study|Administrative decision/technical issues|1|||
27525220|NCT01565343|80116180|FG001|Overall Study|Administrative decision/technical issues|0|||
27525221|NCT01565343|80116181|FG002|Overall Study|Administrative decision/technical issues|0|||
27525222|NCT02742246|80116182|FG000|Overall Study|Never initiated treatment|5|||
27525223|NCT02742246|80116183|FG001|Overall Study|Never initiated treatment|3|||
27525224|NCT02742246|80116184|FG002|Overall Study|Never initiated treatment|1|||
27525225|NCT02742246|80116182|FG000|Overall Study|dropped out during treatment|7|||
27525226|NCT02742246|80116183|FG001|Overall Study|dropped out during treatment|13|||
27525227|NCT02742246|80116184|FG002|Overall Study|dropped out during treatment|10|||
27525228|NCT02742246|80116182|FG000|Overall Study|Death|1|||
27525229|NCT02742246|80116183|FG001|Overall Study|Death|0|||
27525230|NCT02742246|80116184|FG002|Overall Study|Death|0|||
27525231|NCT02661178|80116185|FG000|Part 1|Protocol Violation|1|||
27525232|NCT02661178|80116186|FG001|Part 1|Protocol Violation|0|||
27525233|NCT02661178|80116187|FG002|Part 1|Protocol Violation|0|||
27525234|NCT02661178|80116188|FG003|Part 1|Protocol Violation|0|||
27525235|NCT02661178|80116189|FG004|Part 1|Protocol Violation|0|||
27525236|NCT02661178|80116190|FG005|Part 1|Protocol Violation|0|||
27525237|NCT02661178|80116191|FG006|Part 1|Protocol Violation|0|||
27525238|NCT02661178|80116192|FG007|Part 1|Protocol Violation|0|||
27525239|NCT02661178|80116193|FG008|Part 1|Protocol Violation|0|||
27525240|NCT02661178|80116194|FG009|Part 1|Protocol Violation|0|||
27525241|NCT02661178|80116195|FG010|Part 1|Protocol Violation|0|||
27525242|NCT02661178|80116196|FG011|Part 1|Protocol Violation|0|||
27525243|NCT02661178|80116197|FG012|Part 1|Protocol Violation|0|||
27525244|NCT02661178|80116198|FG013|Part 1|Protocol Violation|0|||
27525245|NCT02661178|80116199|FG014|Part 1|Protocol Violation|0|||
27525246|NCT03963401|80116202|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
27525247|NCT03963401|80116203|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
27525248|NCT03963401|80116204|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
27525249|NCT03963401|80116205|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
27525250|NCT03963401|80116206|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
27525251|NCT03963401|80116207|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
27525252|NCT03963401|80116202|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
27525253|NCT03963401|80116203|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
27525254|NCT03963401|80116204|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
27525255|NCT03963401|80116205|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
27525256|NCT03963401|80116206|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
27525257|NCT03963401|80116207|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
27525258|NCT03963401|80116202|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
27525259|NCT03963401|80116203|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
27525260|NCT03963401|80116204|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
27525261|NCT03963401|80116205|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
27525262|NCT03963401|80116206|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
27525263|NCT03963401|80116207|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
27525264|NCT03963401|80116202|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
27525265|NCT03963401|80116203|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
27525266|NCT03963401|80116204|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
27525267|NCT03963401|80116205|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
27525268|NCT03963401|80116206|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
27525269|NCT03963401|80116207|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
27525270|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
27525271|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
27855671|NCT02585934|81302699|FG000|Overall Study|Another Reason|10|||
27855672|NCT02585934|81302700|FG001|Overall Study|Another Reason|5|||
27525272|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
27525273|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
27525274|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
27525275|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
27525276|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
27525277|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
27525278|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
27525279|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
27855673|NCT01367665|81302701|FG000|Overall Study|Death|102|||
27525280|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
27525281|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
27733048|NCT00389207|80849903|FG002|Overall Study|Adverse Event|10|||
27733049|NCT00389207|80849901|FG000|Overall Study|Protocol Violation|3|||
27733050|NCT00389207|80849902|FG001|Overall Study|Protocol Violation|1|||
27733051|NCT00389207|80849903|FG002|Overall Study|Protocol Violation|4|||
27733052|NCT00389207|80849901|FG000|Overall Study|Lost to Follow-up|12|||
27733053|NCT00389207|80849902|FG001|Overall Study|Lost to Follow-up|9|||
27733054|NCT00389207|80849903|FG002|Overall Study|Lost to Follow-up|7|||
27733055|NCT00389207|80849901|FG000|Overall Study|Withdrawal by Subject|5|||
27733056|NCT00389207|80849902|FG001|Overall Study|Withdrawal by Subject|7|||
27733057|NCT00389207|80849903|FG002|Overall Study|Withdrawal by Subject|11|||
27733058|NCT00389207|80849901|FG000|Overall Study|Other|17|||
27733059|NCT00389207|80849902|FG001|Overall Study|Other|23|||
27733060|NCT00389207|80849903|FG002|Overall Study|Other|9|||
27733061|NCT00809133|80849906|FG000|Overall Study|Progressive disease|2|||
27733062|NCT00809133|80849907|FG001|Overall Study|Progressive disease|5|||
27733063|NCT00809133|80849908|FG002|Overall Study|Progressive disease|5|||
27733064|NCT00809133|80849909|FG003|Overall Study|Progressive disease|3|||
27733065|NCT00809133|80849910|FG004|Overall Study|Progressive disease|4|||
27733066|NCT00809133|80849911|FG005|Overall Study|Progressive disease|1|||
27733067|NCT00809133|80849912|FG006|Overall Study|Progressive disease|3|||
27733068|NCT00809133|80849913|FG007|Overall Study|Progressive disease|3|||
27733069|NCT00809133|80849914|FG008|Overall Study|Progressive disease|3|||
27733070|NCT00809133|80849915|FG009|Overall Study|Progressive disease|9|||
27733071|NCT00809133|80849916|FG010|Overall Study|Progressive disease|5|||
27733072|NCT00809133|80849917|FG011|Overall Study|Progressive disease|7|||
27733073|NCT00809133|80849918|FG012|Overall Study|Progressive disease|5|||
27733074|NCT00809133|80849919|FG013|Overall Study|Progressive disease|4|||
27733075|NCT00809133|80849906|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733076|NCT00809133|80849907|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733077|NCT00809133|80849908|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733078|NCT00809133|80849909|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733079|NCT00809133|80849910|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733080|NCT00809133|80849911|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27910530|NCT02489448|81510143|FG000|Overall Study|Death|3|||
27910531|NCT02489448|81510143|FG000|Overall Study|Withdrawal by Subject|2|||
27910532|NCT03283930|81510144|FG000|Overall Study|Scheduling conflict|8|||
27910533|NCT03283930|81510145|FG001|Overall Study|Scheduling conflict|10|||
27910534|NCT03283930|81510144|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
27910535|NCT03283930|81510145|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
27733081|NCT00809133|80849912|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27733082|NCT00809133|80849913|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
27733083|NCT00809133|80849914|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733084|NCT00809133|80849915|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733085|NCT00809133|80849916|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733086|NCT00809133|80849917|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733087|NCT00809133|80849918|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
27733088|NCT00809133|80849919|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
27733089|NCT00809133|80849906|FG000|Overall Study|Other adverse event|1|||
27733090|NCT00809133|80849907|FG001|Overall Study|Other adverse event|1|||
27733091|NCT00809133|80849908|FG002|Overall Study|Other adverse event|1|||
27525282|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
27733092|NCT00809133|80849909|FG003|Overall Study|Other adverse event|0|||
27910536|NCT03283930|81510144|FG000|Overall Study|Technical software issue|2|||
27733093|NCT00809133|80849910|FG004|Overall Study|Other adverse event|0|||
27733094|NCT00809133|80849911|FG005|Overall Study|Other adverse event|3|||
27733095|NCT00809133|80849912|FG006|Overall Study|Other adverse event|2|||
27733096|NCT00809133|80849913|FG007|Overall Study|Other adverse event|4|||
27733097|NCT00809133|80849914|FG008|Overall Study|Other adverse event|0|||
27733098|NCT00809133|80849915|FG009|Overall Study|Other adverse event|0|||
27733099|NCT00809133|80849916|FG010|Overall Study|Other adverse event|1|||
27733100|NCT00809133|80849917|FG011|Overall Study|Other adverse event|1|||
27733101|NCT00809133|80849918|FG012|Overall Study|Other adverse event|0|||
27733102|NCT00809133|80849919|FG013|Overall Study|Other adverse event|1|||
27733103|NCT00809133|80849906|FG000|Overall Study|Lost to Follow-up|0|||
27733104|NCT00809133|80849907|FG001|Overall Study|Lost to Follow-up|0|||
27733105|NCT00809133|80849908|FG002|Overall Study|Lost to Follow-up|0|||
27733106|NCT00809133|80849909|FG003|Overall Study|Lost to Follow-up|0|||
27733107|NCT00809133|80849910|FG004|Overall Study|Lost to Follow-up|0|||
27733108|NCT00809133|80849911|FG005|Overall Study|Lost to Follow-up|1|||
27910537|NCT03283930|81510145|FG001|Overall Study|Technical software issue|2|||
27733109|NCT00809133|80849912|FG006|Overall Study|Lost to Follow-up|0|||
27733110|NCT00809133|80849913|FG007|Overall Study|Lost to Follow-up|0|||
27733111|NCT00809133|80849914|FG008|Overall Study|Lost to Follow-up|0|||
27733112|NCT00809133|80849915|FG009|Overall Study|Lost to Follow-up|0|||
27733113|NCT00809133|80849916|FG010|Overall Study|Lost to Follow-up|0|||
27733114|NCT00809133|80849917|FG011|Overall Study|Lost to Follow-up|0|||
27733115|NCT00809133|80849918|FG012|Overall Study|Lost to Follow-up|0|||
27733116|NCT00809133|80849919|FG013|Overall Study|Lost to Follow-up|0|||
27910538|NCT01001520|81510146|FG000|Medication Period 1|Withdrawal by Subject|2|||
27910539|NCT01001520|81510147|FG001|Medication Period 1|Withdrawal by Subject|2|||
27910540|NCT01001520|81510146|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
27910541|NCT01001520|81510147|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
27910542|NCT01001520|81510146|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
27910543|NCT01001520|81510147|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
27910544|NCT01001520|81510146|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
27910545|NCT01001520|81510147|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
27910546|NCT01001520|81510146|FG000|Washout Period|Withdrawal by Subject|2|||
27910547|NCT01001520|81510147|FG001|Washout Period|Withdrawal by Subject|1|||
27910548|NCT01001520|81510146|FG000|Medication Period 2|Withdrawal by Subject|0|||
27910549|NCT01001520|81510147|FG001|Medication Period 2|Withdrawal by Subject|3|||
27910550|NCT02030119|81510148|FG000|Overall Study|Withdrawal by Subject|3|||
27910551|NCT02030119|81510149|FG001|Overall Study|Withdrawal by Subject|1|||
27910552|NCT02030119|81510150|FG002|Overall Study|Withdrawal by Subject|5|||
27910553|NCT02030119|81510151|FG003|Overall Study|Withdrawal by Subject|3|||
27910554|NCT02030119|81510148|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
27910555|NCT02030119|81510149|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
27910556|NCT02030119|81510150|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
27910557|NCT02030119|81510151|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
27910558|NCT05259163|81510154|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
27910559|NCT05259163|81510155|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
27910560|NCT02131064|81510161|FG000|Overall Study|Death|5|||
27910561|NCT02131064|81510162|FG001|Overall Study|Death|6|||
27910562|NCT02131064|81510161|FG000|Overall Study|Lost to Follow-up|4|||
27910563|NCT02131064|81510162|FG001|Overall Study|Lost to Follow-up|8|||
27910564|NCT02131064|81510161|FG000|Overall Study|Withdrawal by Subject|14|||
27910565|NCT02131064|81510162|FG001|Overall Study|Withdrawal by Subject|18|||
27910566|NCT02131064|81510161|FG000|Overall Study|Other|2|||
27910567|NCT02131064|81510162|FG001|Overall Study|Other|2|||
27910568|NCT04877990|81510164|FG000|Treatment|Other reasons|3|||
27910569|NCT04877990|81510165|FG001|Treatment|Other reasons|1|||
27910570|NCT04877990|81510164|FG000|Treatment|Administrative reasons by sponsor|17|||
27910571|NCT04877990|81510165|FG001|Treatment|Administrative reasons by sponsor|33|||
27910572|NCT04877990|81510164|FG000|Treatment|Withdrawal by Subject|2|||
27910573|NCT04877990|81510165|FG001|Treatment|Withdrawal by Subject|6|||
27910574|NCT04877990|81510164|FG000|Treatment|Adverse Event|2|||
27910575|NCT04877990|81510165|FG001|Treatment|Adverse Event|1|||
27910576|NCT02964338|81510166|FG000|Overall Study|Sponsor terminated study for futility|12|||
27910577|NCT02964338|81510167|FG001|Overall Study|Sponsor terminated study for futility|15|||
27910578|NCT02964338|81510168|FG002|Overall Study|Sponsor terminated study for futility|14|||
27910579|NCT02964338|81510166|FG000|Overall Study|Lack of Efficacy|0|||
27910580|NCT02964338|81510167|FG001|Overall Study|Lack of Efficacy|3|||
27733117|NCT00809133|80849906|FG000|Overall Study|Consent withdrawn|0|||
27733118|NCT00809133|80849907|FG001|Overall Study|Consent withdrawn|0|||
27733119|NCT00809133|80849908|FG002|Overall Study|Consent withdrawn|0|||
27733120|NCT00809133|80849909|FG003|Overall Study|Consent withdrawn|0|||
27733121|NCT00809133|80849910|FG004|Overall Study|Consent withdrawn|1|||
27733122|NCT00809133|80849911|FG005|Overall Study|Consent withdrawn|0|||
27733123|NCT00809133|80849912|FG006|Overall Study|Consent withdrawn|0|||
27733124|NCT00809133|80849913|FG007|Overall Study|Consent withdrawn|0|||
27733125|NCT00809133|80849914|FG008|Overall Study|Consent withdrawn|0|||
27733126|NCT00809133|80849915|FG009|Overall Study|Consent withdrawn|0|||
27733127|NCT00809133|80849916|FG010|Overall Study|Consent withdrawn|0|||
27733128|NCT00809133|80849917|FG011|Overall Study|Consent withdrawn|0|||
27733129|NCT00809133|80849918|FG012|Overall Study|Consent withdrawn|0|||
27733130|NCT00809133|80849919|FG013|Overall Study|Consent withdrawn|0|||
27733131|NCT00809133|80849906|FG000|Overall Study|Other not mentioned above|0|||
27733132|NCT00809133|80849907|FG001|Overall Study|Other not mentioned above|1|||
27733133|NCT00809133|80849908|FG002|Overall Study|Other not mentioned above|0|||
27733134|NCT00809133|80849909|FG003|Overall Study|Other not mentioned above|0|||
27733135|NCT00809133|80849910|FG004|Overall Study|Other not mentioned above|0|||
27733136|NCT00809133|80849911|FG005|Overall Study|Other not mentioned above|1|||
27733137|NCT00809133|80849912|FG006|Overall Study|Other not mentioned above|0|||
27733138|NCT00809133|80849913|FG007|Overall Study|Other not mentioned above|0|||
27733139|NCT00809133|80849914|FG008|Overall Study|Other not mentioned above|0|||
27733140|NCT00809133|80849915|FG009|Overall Study|Other not mentioned above|0|||
27733141|NCT00809133|80849916|FG010|Overall Study|Other not mentioned above|0|||
27733142|NCT00809133|80849917|FG011|Overall Study|Other not mentioned above|0|||
27733143|NCT00809133|80849918|FG012|Overall Study|Other not mentioned above|0|||
27733144|NCT00809133|80849919|FG013|Overall Study|Other not mentioned above|0|||
27733145|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
27733146|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
27733147|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
27910581|NCT02964338|81510168|FG002|Overall Study|Lack of Efficacy|0|||
27910582|NCT02964338|81510166|FG000|Overall Study|Lost to Follow-up|1|||
27910583|NCT02964338|81510167|FG001|Overall Study|Lost to Follow-up|0|||
27910584|NCT02964338|81510168|FG002|Overall Study|Lost to Follow-up|3|||
27910585|NCT02964338|81510166|FG000|Overall Study|Protocol Violation|0|||
27910586|NCT02964338|81510167|FG001|Overall Study|Protocol Violation|1|||
27910587|NCT02964338|81510168|FG002|Overall Study|Protocol Violation|0|||
27910588|NCT02964338|81510166|FG000|Overall Study|Withdrawal by Subject|1|||
27910589|NCT02964338|81510167|FG001|Overall Study|Withdrawal by Subject|3|||
27910590|NCT02964338|81510168|FG002|Overall Study|Withdrawal by Subject|1|||
27910591|NCT02964338|81510166|FG000|Overall Study|Adverse Event|2|||
27733148|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27733149|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27733150|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27733151|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27525283|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
27525284|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
27525285|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
27525286|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
27525287|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
27525288|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
27525289|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
27525290|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
27525291|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
27525292|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
27525293|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
27525294|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
27525295|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
27525296|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
27733152|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27733153|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27733154|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
27910592|NCT02964338|81510167|FG001|Overall Study|Adverse Event|1|||
27910593|NCT02964338|81510168|FG002|Overall Study|Adverse Event|1|||
27910594|NCT02964338|81510166|FG000|Overall Study|Non-compliant with e-diary|0|||
27525297|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
27525298|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
27525299|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
27622568|NCT01890967|80460951|FG000|Overall Study|Adverse Event|3|||
27622569|NCT01890967|80460952|FG001|Overall Study|Adverse Event|3|||
27622570|NCT01890967|80460953|FG002|Overall Study|Adverse Event|3|||
27622571|NCT01890967|80460954|FG003|Overall Study|Adverse Event|2|||
27622572|NCT01890967|80460955|FG004|Overall Study|Adverse Event|1|||
27622573|NCT01890967|80460956|FG005|Overall Study|Adverse Event|7|||
27622574|NCT01890967|80460951|FG000|Overall Study|Death|1|||
27622575|NCT01890967|80460952|FG001|Overall Study|Death|0|||
27622576|NCT01890967|80460953|FG002|Overall Study|Death|0|||
27733155|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
27910595|NCT02964338|81510167|FG001|Overall Study|Non-compliant with e-diary|1|||
27910596|NCT02964338|81510168|FG002|Overall Study|Non-compliant with e-diary|0|||
27910597|NCT02964338|81510166|FG000|Overall Study|Did not meet criteria|1|||
27910598|NCT02964338|81510167|FG001|Overall Study|Did not meet criteria|0|||
27910599|NCT02964338|81510168|FG002|Overall Study|Did not meet criteria|0|||
27910600|NCT02710084|81510173|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
27910601|NCT02710084|81510174|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
27910602|NCT02421419|81510181|FG000|Overall Study|Physician Decision|0|||
27910603|NCT02421419|81510182|FG001|Overall Study|Physician Decision|0|||
27910604|NCT02421419|81510183|FG002|Overall Study|Physician Decision|1|||
27910605|NCT03012841|81510187|FG000|Overall Study|Protocol Violation|0|||
27910606|NCT03012841|81510188|FG001|Overall Study|Protocol Violation|10|||
27910607|NCT03012841|81510187|FG000|Overall Study|Lost to Follow-up|6|||
27910608|NCT03012841|81510188|FG001|Overall Study|Lost to Follow-up|1|||
27910609|NCT03012841|81510187|FG000|Overall Study|Withdrawal by Subject|6|||
27910610|NCT03012841|81510188|FG001|Overall Study|Withdrawal by Subject|0|||
27910611|NCT03012841|81510187|FG000|Overall Study|Unable to complete 12 month visit|6|||
27910612|NCT03012841|81510188|FG001|Overall Study|Unable to complete 12 month visit|0|||
27910613|NCT03012841|81510187|FG000|Overall Study|Subject relocation|1|||
27910614|NCT03012841|81510188|FG001|Overall Study|Subject relocation|0|||
27910615|NCT03012841|81510187|FG000|Overall Study|Seasonal winter travel|1|||
27910616|NCT03012841|81510188|FG001|Overall Study|Seasonal winter travel|0|||
27910617|NCT03012841|81510187|FG000|Overall Study|Physician Decision|0|||
27910618|NCT03012841|81510188|FG001|Overall Study|Physician Decision|2|||
27910619|NCT03012841|81510187|FG000|Overall Study|No ablation performed|0|||
27910620|NCT03012841|81510188|FG001|Overall Study|No ablation performed|2|||
27910621|NCT03012841|81510187|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
27910622|NCT03012841|81510188|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
27910623|NCT03012841|81510187|FG000|Overall Study|Insurance change|0|||
27733156|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
27525300|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
27525301|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
27525302|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
27525303|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
27525304|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
27525305|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
27525306|NCT03963401|80116202|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
27525307|NCT03963401|80116203|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
27525308|NCT03963401|80116204|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
27525309|NCT03963401|80116205|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
27525310|NCT03963401|80116206|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
27525311|NCT03963401|80116207|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
27525312|NCT04473482|80116210|FG000|Overall Study|Death|0|||
27525313|NCT04473482|80116211|FG001|Overall Study|Death|3|||
27525314|NCT04473482|80116210|FG000|Overall Study|Lost to Follow-up|9|||
27525315|NCT04473482|80116211|FG001|Overall Study|Lost to Follow-up|7|||
27525316|NCT04473482|80116210|FG000|Overall Study|Withdrawal by Subject|2|||
27525317|NCT04473482|80116211|FG001|Overall Study|Withdrawal by Subject|1|||
27525318|NCT01215916|80116213|FG000|Overall Study|Progressive Disease|0|||
27525319|NCT01215916|80116214|FG001|Overall Study|Progressive Disease|2|||
27525320|NCT01215916|80116215|FG002|Overall Study|Progressive Disease|1|||
27525321|NCT01215916|80116216|FG003|Overall Study|Progressive Disease|2|||
27525322|NCT01215916|80116217|FG004|Overall Study|Progressive Disease|5|||
27525323|NCT01215916|80116218|FG005|Overall Study|Progressive Disease|4|||
27525324|NCT01215916|80116219|FG006|Overall Study|Progressive Disease|5|||
27622577|NCT01890967|80460954|FG003|Overall Study|Death|0|||
27910624|NCT03012841|81510188|FG001|Overall Study|Insurance change|1|||
27910625|NCT01768559|81510189|FG000|Overall Study|Randomized but not treated|0|||
27910626|NCT01768559|81510190|FG001|Overall Study|Randomized but not treated|0|||
27525325|NCT01215916|80116220|FG007|Overall Study|Progressive Disease|3|||
27525326|NCT01215916|80116221|FG008|Overall Study|Progressive Disease|1|||
27622578|NCT01890967|80460955|FG004|Overall Study|Death|0|||
27622579|NCT01890967|80460956|FG005|Overall Study|Death|0|||
27622580|NCT01890967|80460951|FG000|Overall Study|Lost to Follow-up|1|||
27622581|NCT01890967|80460952|FG001|Overall Study|Lost to Follow-up|1|||
27622582|NCT01890967|80460953|FG002|Overall Study|Lost to Follow-up|1|||
27622583|NCT01890967|80460954|FG003|Overall Study|Lost to Follow-up|1|||
27622584|NCT01890967|80460955|FG004|Overall Study|Lost to Follow-up|0|||
27622585|NCT01890967|80460956|FG005|Overall Study|Lost to Follow-up|1|||
27622586|NCT01890967|80460951|FG000|Overall Study|Protocol Violation|0|||
27622587|NCT01890967|80460952|FG001|Overall Study|Protocol Violation|3|||
27622588|NCT01890967|80460953|FG002|Overall Study|Protocol Violation|3|||
27622589|NCT01890967|80460954|FG003|Overall Study|Protocol Violation|2|||
27622590|NCT01890967|80460955|FG004|Overall Study|Protocol Violation|4|||
27622591|NCT01890967|80460956|FG005|Overall Study|Protocol Violation|1|||
27622592|NCT01890967|80460951|FG000|Overall Study|Sponsor Decision|2|||
27622593|NCT01890967|80460952|FG001|Overall Study|Sponsor Decision|0|||
27855674|NCT01367665|81302702|FG001|Overall Study|Death|19|||
27855675|NCT01367665|81302701|FG000|Overall Study|Lost to Follow-up|222|||
27855676|NCT01367665|81302702|FG001|Overall Study|Lost to Follow-up|22|||
27910627|NCT01768559|81510191|FG002|Overall Study|Randomized but not treated|1|||
27910628|NCT01768559|81510189|FG000|Overall Study|Adverse Event|15|||
27910629|NCT01768559|81510190|FG001|Overall Study|Adverse Event|2|||
27910630|NCT01768559|81510191|FG002|Overall Study|Adverse Event|5|||
27910631|NCT01768559|81510189|FG000|Overall Study|Lack of Efficacy|6|||
27910632|NCT01768559|81510190|FG001|Overall Study|Lack of Efficacy|4|||
27910633|NCT01768559|81510191|FG002|Overall Study|Lack of Efficacy|0|||
27910634|NCT01768559|81510189|FG000|Overall Study|Poor compliance to protocol|0|||
27910635|NCT01768559|81510190|FG001|Overall Study|Poor compliance to protocol|3|||
27910636|NCT01768559|81510191|FG002|Overall Study|Poor compliance to protocol|2|||
27910637|NCT01768559|81510189|FG000|Overall Study|Other than specified|9|||
27910638|NCT01768559|81510190|FG001|Overall Study|Other than specified|8|||
27910639|NCT01768559|81510191|FG002|Overall Study|Other than specified|5|||
27910640|NCT00613366|81510194|FG000|Overall Study|Withdrawal by Subject|3|||
27910641|NCT00613366|81510195|FG001|Overall Study|Withdrawal by Subject|2|||
27910642|NCT02714036|81510198|FG000|Overall Study|Adverse Event|9|||
27910643|NCT02714036|81510199|FG001|Overall Study|Adverse Event|2|||
27910644|NCT02714036|81510198|FG000|Overall Study|Withdrawal by Subject|3|||
27910645|NCT02714036|81510199|FG001|Overall Study|Withdrawal by Subject|2|||
27910646|NCT03915626|81510200|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
27910647|NCT03318003|81510201|FG000|Overall Study|Withdrawal by Subject|1|||
27910648|NCT03318003|81510202|FG001|Overall Study|Withdrawal by Subject|1|||
27910649|NCT03318003|81510201|FG000|Overall Study|fetal loss|0|||
27910650|NCT03318003|81510202|FG001|Overall Study|fetal loss|1|||
27910651|NCT01826981|81510204|FG000|Overall Study|Lack of Efficacy|0|||
27910652|NCT01826981|81510205|FG001|Overall Study|Lack of Efficacy|1|||
27855677|NCT01367665|81302701|FG000|Overall Study|Not Done|118|||
27855678|NCT01367665|81302702|FG001|Overall Study|Not Done|14|||
27855679|NCT03493386|81302705|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27855680|NCT03493386|81302706|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
27855681|NCT03493386|81302707|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27855682|NCT03493386|81302708|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27855683|NCT03107026|81302709|FG000|Overall Study|Adverse Event|2|||
27855684|NCT03107026|81302710|FG001|Overall Study|Adverse Event|14|||
27855685|NCT03107026|81302711|FG002|Overall Study|Adverse Event|23|||
27855686|NCT03107026|81302709|FG000|Overall Study|Lost to Follow-up|12|||
27855687|NCT03107026|81302710|FG001|Overall Study|Lost to Follow-up|12|||
27855688|NCT03107026|81302711|FG002|Overall Study|Lost to Follow-up|13|||
27855689|NCT03107026|81302709|FG000|Overall Study|Protocol Violation|1|||
27855690|NCT03107026|81302710|FG001|Overall Study|Protocol Violation|2|||
27910653|NCT01826981|81510206|FG002|Overall Study|Lack of Efficacy|0|||
27855691|NCT03107026|81302711|FG002|Overall Study|Protocol Violation|0|||
27855692|NCT03107026|81302709|FG000|Overall Study|Pregnancy|1|||
27855693|NCT03107026|81302710|FG001|Overall Study|Pregnancy|0|||
27855694|NCT03107026|81302711|FG002|Overall Study|Pregnancy|0|||
27855695|NCT03107026|81302709|FG000|Overall Study|Withdrawal by Subject|13|||
27622594|NCT01890967|80460953|FG002|Overall Study|Sponsor Decision|1|||
27622595|NCT01890967|80460954|FG003|Overall Study|Sponsor Decision|3|||
27855696|NCT03107026|81302710|FG001|Overall Study|Withdrawal by Subject|5|||
27855697|NCT03107026|81302711|FG002|Overall Study|Withdrawal by Subject|17|||
27910654|NCT01826981|81510207|FG003|Overall Study|Lack of Efficacy|0|||
27910655|NCT01826981|81510208|FG004|Overall Study|Lack of Efficacy|5|||
27622596|NCT01890967|80460955|FG004|Overall Study|Sponsor Decision|2|||
27622597|NCT01890967|80460956|FG005|Overall Study|Sponsor Decision|3|||
27622598|NCT01890967|80460951|FG000|Overall Study|Withdrawal by Subject|3|||
27855698|NCT03107026|81302709|FG000|Overall Study|non compliance with study visits|1|||
27855699|NCT03107026|81302710|FG001|Overall Study|non compliance with study visits|2|||
27855700|NCT03107026|81302711|FG002|Overall Study|non compliance with study visits|0|||
27855701|NCT03107026|81302709|FG000|Overall Study|non-compliance with study drug|2|||
27855702|NCT03107026|81302710|FG001|Overall Study|non-compliance with study drug|2|||
27855703|NCT03107026|81302711|FG002|Overall Study|non-compliance with study drug|3|||
27855704|NCT03107026|81302709|FG000|Overall Study|Physician Decision|0|||
27855705|NCT03107026|81302710|FG001|Overall Study|Physician Decision|1|||
27855706|NCT03107026|81302711|FG002|Overall Study|Physician Decision|0|||
27855707|NCT00003875|81302716|FG000|Overall Study|Screen Failed|1|||
27855708|NCT00369317|81302717|FG000|Overall Study|Adverse Event|3|||
27855709|NCT00369317|81302717|FG000|Overall Study|Death|1|||
27855710|NCT00369317|81302717|FG000|Overall Study|Lack of Efficacy|5|||
27855711|NCT00369317|81302717|FG000|Overall Study|Physician Decision|2|||
27855712|NCT00369317|81302717|FG000|Overall Study|Withdrawal by Subject|8|||
27855713|NCT00369317|81302717|FG000|Overall Study|Ineligible|1|||
27855714|NCT03321630|81302721|FG000|Overall Study|Adverse Event|1|||
27855715|NCT03321630|81302721|FG000|Overall Study|Investigator Discretion|2|||
27855716|NCT03321630|81302721|FG000|Overall Study|Withdrawal by Subject|1|||
27855717|NCT00988065|81302723|FG000|Overall Study|Adverse Event|4|||
27855718|NCT00988065|81302724|FG001|Overall Study|Adverse Event|10|||
27855719|NCT00988065|81302725|FG002|Overall Study|Adverse Event|2|||
27855720|NCT00988065|81302723|FG000|Overall Study|Lost to Follow-up|1|||
27855721|NCT00988065|81302724|FG001|Overall Study|Lost to Follow-up|2|||
27855722|NCT00988065|81302725|FG002|Overall Study|Lost to Follow-up|2|||
27910656|NCT01826981|81510209|FG005|Overall Study|Lack of Efficacy|0|||
27910657|NCT01826981|81510210|FG006|Overall Study|Lack of Efficacy|0|||
27910658|NCT01826981|81510211|FG007|Overall Study|Lack of Efficacy|8|||
27525327|NCT01215916|80116213|FG000|Overall Study|Adverse Event|1|||
27525328|NCT01215916|80116214|FG001|Overall Study|Adverse Event|1|||
27525329|NCT01215916|80116215|FG002|Overall Study|Adverse Event|0|||
27525330|NCT01215916|80116216|FG003|Overall Study|Adverse Event|1|||
27525331|NCT01215916|80116217|FG004|Overall Study|Adverse Event|0|||
27525332|NCT01215916|80116218|FG005|Overall Study|Adverse Event|0|||
27525333|NCT01215916|80116219|FG006|Overall Study|Adverse Event|3|||
27525334|NCT01215916|80116220|FG007|Overall Study|Adverse Event|0|||
27525335|NCT01215916|80116221|FG008|Overall Study|Adverse Event|0|||
27855723|NCT00988065|81302723|FG000|Overall Study|Subject withdrew consent|3|||
27910659|NCT01826981|81510212|FG008|Overall Study|Lack of Efficacy|7|||
27910660|NCT01826981|81510213|FG009|Overall Study|Lack of Efficacy|0|||
27910661|NCT01826981|81510214|FG010|Overall Study|Lack of Efficacy|1|||
27910662|NCT01826981|81510215|FG011|Overall Study|Lack of Efficacy|0|||
27910663|NCT01826981|81510216|FG012|Overall Study|Lack of Efficacy|0|||
27910664|NCT01826981|81510217|FG013|Overall Study|Lack of Efficacy|3|||
27910665|NCT01826981|81510218|FG014|Overall Study|Lack of Efficacy|0|||
27910666|NCT01826981|81510204|FG000|Overall Study|Lost to Follow-up|0|||
27910667|NCT01826981|81510205|FG001|Overall Study|Lost to Follow-up|0|||
27910668|NCT01826981|81510206|FG002|Overall Study|Lost to Follow-up|0|||
27910669|NCT01826981|81510207|FG003|Overall Study|Lost to Follow-up|0|||
27910670|NCT01826981|81510208|FG004|Overall Study|Lost to Follow-up|1|||
27910671|NCT01826981|81510209|FG005|Overall Study|Lost to Follow-up|1|||
27910672|NCT01826981|81510210|FG006|Overall Study|Lost to Follow-up|0|||
27910673|NCT01826981|81510211|FG007|Overall Study|Lost to Follow-up|1|||
27910674|NCT01826981|81510212|FG008|Overall Study|Lost to Follow-up|0|||
27910675|NCT01826981|81510213|FG009|Overall Study|Lost to Follow-up|1|||
27910676|NCT01826981|81510214|FG010|Overall Study|Lost to Follow-up|1|||
27910677|NCT01826981|81510215|FG011|Overall Study|Lost to Follow-up|1|||
27910678|NCT01826981|81510216|FG012|Overall Study|Lost to Follow-up|1|||
27910679|NCT01826981|81510217|FG013|Overall Study|Lost to Follow-up|0|||
27910680|NCT01826981|81510218|FG014|Overall Study|Lost to Follow-up|0|||
27910681|NCT01826981|81510204|FG000|Overall Study|Withdrew Consent|0|||
27910682|NCT01826981|81510205|FG001|Overall Study|Withdrew Consent|0|||
27910683|NCT01826981|81510206|FG002|Overall Study|Withdrew Consent|0|||
27910684|NCT01826981|81510207|FG003|Overall Study|Withdrew Consent|0|||
27910685|NCT01826981|81510208|FG004|Overall Study|Withdrew Consent|0|||
27910686|NCT01826981|81510209|FG005|Overall Study|Withdrew Consent|0|||
27910687|NCT01826981|81510210|FG006|Overall Study|Withdrew Consent|1|||
27855724|NCT00988065|81302724|FG001|Overall Study|Subject withdrew consent|5|||
27855725|NCT00988065|81302725|FG002|Overall Study|Subject withdrew consent|2|||
27910688|NCT01826981|81510211|FG007|Overall Study|Withdrew Consent|1|||
27910689|NCT01826981|81510212|FG008|Overall Study|Withdrew Consent|0|||
27910690|NCT01826981|81510213|FG009|Overall Study|Withdrew Consent|0|||
27855726|NCT00988065|81302723|FG000|Overall Study|Noncompliance with protocol|5|||
27910691|NCT01826981|81510214|FG010|Overall Study|Withdrew Consent|0|||
27910692|NCT01826981|81510215|FG011|Overall Study|Withdrew Consent|1|||
27910693|NCT01826981|81510216|FG012|Overall Study|Withdrew Consent|0|||
27525336|NCT01215916|80116213|FG000|Overall Study|Withdrawal by Subject|0|||
27525337|NCT01215916|80116214|FG001|Overall Study|Withdrawal by Subject|1|||
27855727|NCT00988065|81302724|FG001|Overall Study|Noncompliance with protocol|6|||
27855728|NCT00988065|81302725|FG002|Overall Study|Noncompliance with protocol|9|||
27910694|NCT01826981|81510217|FG013|Overall Study|Withdrew Consent|1|||
27910695|NCT01826981|81510218|FG014|Overall Study|Withdrew Consent|0|||
27910696|NCT01826981|81510204|FG000|Overall Study|Adverse Event|0|||
27525338|NCT01215916|80116215|FG002|Overall Study|Withdrawal by Subject|1|||
27525339|NCT01215916|80116216|FG003|Overall Study|Withdrawal by Subject|2|||
27525340|NCT01215916|80116217|FG004|Overall Study|Withdrawal by Subject|0|||
27910697|NCT01826981|81510205|FG001|Overall Study|Adverse Event|0|||
27910698|NCT01826981|81510206|FG002|Overall Study|Adverse Event|0|||
27910699|NCT01826981|81510207|FG003|Overall Study|Adverse Event|0|||
27910700|NCT01826981|81510208|FG004|Overall Study|Adverse Event|1|||
27910701|NCT01826981|81510209|FG005|Overall Study|Adverse Event|0|||
27910702|NCT01826981|81510210|FG006|Overall Study|Adverse Event|0|||
27910703|NCT01826981|81510211|FG007|Overall Study|Adverse Event|0|||
27910704|NCT01826981|81510212|FG008|Overall Study|Adverse Event|0|||
27910705|NCT01826981|81510213|FG009|Overall Study|Adverse Event|0|||
27910706|NCT01826981|81510214|FG010|Overall Study|Adverse Event|0|||
27910707|NCT01826981|81510215|FG011|Overall Study|Adverse Event|0|||
27910708|NCT01826981|81510216|FG012|Overall Study|Adverse Event|0|||
27910709|NCT01826981|81510217|FG013|Overall Study|Adverse Event|0|||
27910710|NCT01826981|81510218|FG014|Overall Study|Adverse Event|0|||
27910711|NCT01826981|81510204|FG000|Overall Study|Upper G-I Haemorrhage|0|||
27910712|NCT01826981|81510205|FG001|Overall Study|Upper G-I Haemorrhage|0|||
27910713|NCT01826981|81510206|FG002|Overall Study|Upper G-I Haemorrhage|0|||
27910714|NCT01826981|81510207|FG003|Overall Study|Upper G-I Haemorrhage|0|||
27910715|NCT01826981|81510208|FG004|Overall Study|Upper G-I Haemorrhage|0|||
27910716|NCT01826981|81510209|FG005|Overall Study|Upper G-I Haemorrhage|0|||
27910717|NCT01826981|81510210|FG006|Overall Study|Upper G-I Haemorrhage|0|||
27910718|NCT01826981|81510211|FG007|Overall Study|Upper G-I Haemorrhage|0|||
27525341|NCT01215916|80116218|FG005|Overall Study|Withdrawal by Subject|0|||
27525342|NCT01215916|80116219|FG006|Overall Study|Withdrawal by Subject|1|||
27525343|NCT01215916|80116220|FG007|Overall Study|Withdrawal by Subject|0|||
27525344|NCT01215916|80116221|FG008|Overall Study|Withdrawal by Subject|0|||
27525345|NCT01215916|80116213|FG000|Overall Study|Death|0|||
27525346|NCT01215916|80116214|FG001|Overall Study|Death|1|||
27525347|NCT01215916|80116215|FG002|Overall Study|Death|0|||
27525348|NCT01215916|80116216|FG003|Overall Study|Death|0|||
27525349|NCT01215916|80116217|FG004|Overall Study|Death|1|||
27525350|NCT01215916|80116218|FG005|Overall Study|Death|0|||
27525351|NCT01215916|80116219|FG006|Overall Study|Death|0|||
27525352|NCT01215916|80116220|FG007|Overall Study|Death|0|||
27525353|NCT01215916|80116221|FG008|Overall Study|Death|1|||
27525354|NCT01215916|80116213|FG000|Overall Study|Physician Decision|0|||
27525355|NCT01215916|80116214|FG001|Overall Study|Physician Decision|0|||
27525356|NCT01215916|80116215|FG002|Overall Study|Physician Decision|1|||
27910719|NCT01826981|81510212|FG008|Overall Study|Upper G-I Haemorrhage|0|||
27525357|NCT01215916|80116216|FG003|Overall Study|Physician Decision|1|||
27525358|NCT01215916|80116217|FG004|Overall Study|Physician Decision|0|||
27525359|NCT01215916|80116218|FG005|Overall Study|Physician Decision|0|||
27525360|NCT01215916|80116219|FG006|Overall Study|Physician Decision|0|||
27525361|NCT01215916|80116220|FG007|Overall Study|Physician Decision|0|||
27525362|NCT01215916|80116221|FG008|Overall Study|Physician Decision|0|||
27525363|NCT01585584|80116222|FG000|Overall Study|Lack of Efficacy|1|||
27525364|NCT01585584|80116222|FG000|Overall Study|Withdrawal by Subject|1|||
27525365|NCT01585584|80116222|FG000|Overall Study|Physician Decision|2|||
27525366|NCT00420641|80116224|FG000|Overall Study|Adverse Event|3|||
27525367|NCT00420641|80116225|FG001|Overall Study|Adverse Event|25|||
27525368|NCT00420641|80116226|FG002|Overall Study|Adverse Event|10|||
27525369|NCT00420641|80116224|FG000|Overall Study|Lost to Follow-up|2|||
27525370|NCT00420641|80116225|FG001|Overall Study|Lost to Follow-up|4|||
27525371|NCT00420641|80116226|FG002|Overall Study|Lost to Follow-up|2|||
27525372|NCT00420641|80116224|FG000|Overall Study|Protocol Violation|8|||
27525373|NCT00420641|80116225|FG001|Overall Study|Protocol Violation|8|||
27525374|NCT00420641|80116226|FG002|Overall Study|Protocol Violation|7|||
27525375|NCT00420641|80116224|FG000|Overall Study|Withdrawal by Subject|15|||
27525376|NCT00420641|80116225|FG001|Overall Study|Withdrawal by Subject|21|||
27525377|NCT00420641|80116226|FG002|Overall Study|Withdrawal by Subject|14|||
27525378|NCT00420641|80116224|FG000|Overall Study|Lack of Efficacy|6|||
27525379|NCT00420641|80116225|FG001|Overall Study|Lack of Efficacy|5|||
27525380|NCT00420641|80116226|FG002|Overall Study|Lack of Efficacy|4|||
27525381|NCT00420641|80116224|FG000|Overall Study|Non-compliance|7|||
27525382|NCT00420641|80116225|FG001|Overall Study|Non-compliance|5|||
27525383|NCT00420641|80116226|FG002|Overall Study|Non-compliance|4|||
27525384|NCT00420641|80116224|FG000|Overall Study|Other|4|||
27525385|NCT00420641|80116225|FG001|Overall Study|Other|4|||
27525386|NCT00420641|80116226|FG002|Overall Study|Other|3|||
27525387|NCT03680742|80116227|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
27910720|NCT01826981|81510213|FG009|Overall Study|Upper G-I Haemorrhage|0|||
27910721|NCT01826981|81510214|FG010|Overall Study|Upper G-I Haemorrhage|0|||
27525388|NCT03761797|80116228|FG000|Overall Study|Changing hospital|11|||
27525389|NCT03761797|80116228|FG000|Overall Study|Improvement/remission|6|||
27910722|NCT01826981|81510215|FG011|Overall Study|Upper G-I Haemorrhage|0|||
27910723|NCT01826981|81510216|FG012|Overall Study|Upper G-I Haemorrhage|0|||
27910724|NCT01826981|81510217|FG013|Overall Study|Upper G-I Haemorrhage|1|||
27910725|NCT01826981|81510218|FG014|Overall Study|Upper G-I Haemorrhage|0|||
27910726|NCT01826981|81510204|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910727|NCT01826981|81510205|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910728|NCT01826981|81510206|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910729|NCT01826981|81510207|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910730|NCT01826981|81510208|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910731|NCT01826981|81510209|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910732|NCT01826981|81510210|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910733|NCT01826981|81510211|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
27910734|NCT01826981|81510212|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910735|NCT01826981|81510213|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
27525390|NCT03761797|80116228|FG000|Overall Study|Withdrawal by Subject|19|||
27525391|NCT03761797|80116228|FG000|Overall Study|Lost to Follow-up|33|||
27525392|NCT03761797|80116228|FG000|Overall Study|Adverse Event|37|||
27525393|NCT03761797|80116228|FG000|Overall Study|Case report form (CRF) not collected|5|||
27525394|NCT03761797|80116228|FG000|Overall Study|No patient visit after entry|13|||
27525395|NCT03761797|80116228|FG000|Overall Study|Switch to other diabetes medication|10|||
27525396|NCT03761797|80116228|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
27525397|NCT03761797|80116228|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
27525398|NCT03761797|80116228|FG000|Overall Study|Insufficient effectives|2|||
27622599|NCT01890967|80460952|FG001|Overall Study|Withdrawal by Subject|4|||
27910736|NCT01826981|81510214|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910737|NCT01826981|81510215|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910738|NCT01826981|81510216|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910739|NCT01826981|81510217|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910740|NCT01826981|81510218|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
27910741|NCT02329327|81510220|FG000|Overall Study|Death|78|||
27525399|NCT03761797|80116228|FG000|Overall Study|Excessive alcohol intake|1|||
27525400|NCT01185834|80116229|FG000|Overall Study|Lost to Follow-up|2|||
27525401|NCT01185834|80116229|FG000|Overall Study|Discomfort|4|||
27525402|NCT01185834|80116229|FG000|Overall Study|Biomicroscopy|4|||
27525403|NCT01185834|80116229|FG000|Overall Study|Time/Job Conflict|2|||
27525404|NCT01185834|80116229|FG000|Overall Study|Early exit - Site error|2|||
27622600|NCT01890967|80460953|FG002|Overall Study|Withdrawal by Subject|2|||
27622601|NCT01890967|80460954|FG003|Overall Study|Withdrawal by Subject|3|||
27622602|NCT01890967|80460955|FG004|Overall Study|Withdrawal by Subject|3|||
27622603|NCT01890967|80460956|FG005|Overall Study|Withdrawal by Subject|1|||
27622604|NCT01543685|80460957|FG000|Overall Study|Lack of Efficacy|1|||
27622605|NCT01543685|80460958|FG001|Overall Study|Lack of Efficacy|2|||
27622606|NCT01543685|80460959|FG002|Overall Study|Lack of Efficacy|2|||
27622607|NCT01543685|80460960|FG003|Overall Study|Lack of Efficacy|0|||
27622608|NCT01543685|80460961|FG004|Overall Study|Lack of Efficacy|2|||
27622609|NCT01543685|80460957|FG000|Overall Study|Adverse Event|2|||
27622610|NCT01543685|80460958|FG001|Overall Study|Adverse Event|1|||
27622611|NCT01543685|80460959|FG002|Overall Study|Adverse Event|0|||
27622612|NCT01543685|80460960|FG003|Overall Study|Adverse Event|0|||
27525405|NCT01436162|80116232|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
27525406|NCT01436162|80116233|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
27525407|NCT01436162|80116234|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
27525408|NCT01436162|80116232|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
27525409|NCT01436162|80116233|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
27525410|NCT01436162|80116234|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
27525411|NCT01436162|80116232|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
27525412|NCT01436162|80116233|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
27525413|NCT01436162|80116234|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
27525414|NCT01436162|80116232|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
27525415|NCT01436162|80116233|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
27622613|NCT01543685|80460961|FG004|Overall Study|Adverse Event|2|||
27910742|NCT02329327|81510221|FG001|Overall Study|Death|0|||
27910743|NCT02329327|81510220|FG000|Overall Study|Withdrawal by Subject|3|||
27525416|NCT01436162|80116234|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
27525417|NCT01436162|80116232|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
27525418|NCT01436162|80116233|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910744|NCT02329327|81510221|FG001|Overall Study|Withdrawal by Subject|0|||
27910745|NCT02329327|81510220|FG000|Overall Study|Lost to Follow-up|4|||
27910746|NCT02329327|81510221|FG001|Overall Study|Lost to Follow-up|0|||
27910747|NCT03512353|81510222|FG000|Overall Study|Sponsor Decision|3|||
27910748|NCT03512353|81510222|FG000|Overall Study|Death|1|||
27525419|NCT01436162|80116234|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27525420|NCT01436162|80116232|FG000|Single-blind Lead-in Phase|Other|107|||
27622614|NCT00318656|80460962|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
27622615|NCT00318656|80460963|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
27622616|NCT00318656|80460962|FG000|Overall Study|Did not receive any treatment|0|||
27622617|NCT00318656|80460963|FG001|Overall Study|Did not receive any treatment|1|||
27525421|NCT01436162|80116233|FG001|Single-blind Lead-in Phase|Other|0|||
27525422|NCT01436162|80116234|FG002|Single-blind Lead-in Phase|Other|0|||
27525423|NCT01436162|80116232|FG000|Randomized Phase|Adverse Event|1|||
27525424|NCT01436162|80116233|FG001|Randomized Phase|Adverse Event|5|||
27525425|NCT01436162|80116234|FG002|Randomized Phase|Adverse Event|6|||
27525426|NCT01436162|80116232|FG000|Randomized Phase|Protocol Violation|4|||
27525427|NCT01436162|80116233|FG001|Randomized Phase|Protocol Violation|4|||
27525428|NCT01436162|80116234|FG002|Randomized Phase|Protocol Violation|2|||
27525429|NCT01436162|80116232|FG000|Randomized Phase|Withdrawal by Subject|16|||
27525430|NCT01436162|80116233|FG001|Randomized Phase|Withdrawal by Subject|9|||
27525431|NCT01436162|80116234|FG002|Randomized Phase|Withdrawal by Subject|8|||
27525432|NCT01436162|80116232|FG000|Randomized Phase|Lost to Follow-up|17|||
27525433|NCT01436162|80116233|FG001|Randomized Phase|Lost to Follow-up|5|||
27525434|NCT01436162|80116234|FG002|Randomized Phase|Lost to Follow-up|4|||
27622618|NCT00051311|80460968|FG000|Overall Study|Starting new study|0|||
27622619|NCT00051311|80460969|FG001|Overall Study|Starting new study|1|||
27622620|NCT00051311|80460968|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
27622621|NCT00051311|80460969|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
27622622|NCT00051311|80460968|FG000|Overall Study|Death of recipient|8|||
27622623|NCT00051311|80460969|FG001|Overall Study|Death of recipient|8|||
27622624|NCT00051311|80460968|FG000|Overall Study|Recipient taken off study|4|||
27622625|NCT00051311|80460969|FG001|Overall Study|Recipient taken off study|4|||
27622626|NCT02264574|80460973|FG000|Overall Study|Death|21|||
27622627|NCT02264574|80460974|FG001|Overall Study|Death|21|||
27622628|NCT02264574|80460973|FG000|Overall Study|Withdrawal by Subject|8|||
27622629|NCT02264574|80460974|FG001|Overall Study|Withdrawal by Subject|6|||
27622630|NCT02264574|80460973|FG000|Overall Study|Other, Not Specified|0|||
27622631|NCT02264574|80460974|FG001|Overall Study|Other, Not Specified|3|||
27622632|NCT03459729|80460977|FG000|Overall Study|Physician Decision|2|||
27622633|NCT01232556|80460978|FG000|Overall Study|Withdrawal by Subject|21|||
27525435|NCT01436162|80116232|FG000|Randomized Phase|Lack of Efficacy|0|||
27525436|NCT01436162|80116233|FG001|Randomized Phase|Lack of Efficacy|1|||
27525437|NCT01436162|80116234|FG002|Randomized Phase|Lack of Efficacy|1|||
27525438|NCT01436162|80116232|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
27525439|NCT01436162|80116233|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
27525440|NCT01436162|80116234|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
27525441|NCT01436162|80116232|FG000|Randomized Phase|Other|2|||
27525442|NCT01436162|80116233|FG001|Randomized Phase|Other|5|||
27525443|NCT01436162|80116234|FG002|Randomized Phase|Other|4|||
27525444|NCT00969280|80116235|FG000|Overall Study|Protocol Violation|2|||
27525445|NCT00969280|80116236|FG001|Overall Study|Protocol Violation|1|||
27622634|NCT01232556|80460979|FG001|Overall Study|Withdrawal by Subject|17|||
27622635|NCT01232556|80460978|FG000|Overall Study|Death|97|||
27622636|NCT01232556|80460979|FG001|Overall Study|Death|97|||
27622637|NCT01232556|80460978|FG000|Overall Study|Lost to Follow-up|0|||
27622638|NCT01232556|80460979|FG001|Overall Study|Lost to Follow-up|2|||
27622639|NCT01232556|80460978|FG000|Overall Study|Terminated by Sponsor|35|||
27622640|NCT01232556|80460979|FG001|Overall Study|Terminated by Sponsor|51|||
27622641|NCT01232556|80460978|FG000|Overall Study|Other|6|||
27622642|NCT01232556|80460979|FG001|Overall Study|Other|4|||
27622643|NCT03289455|80460986|FG000|Overall Study|Death|1|||
27622644|NCT03289455|80460987|FG001|Overall Study|Death|0|||
27622645|NCT03289455|80460988|FG002|Overall Study|Death|0|||
27622646|NCT03289455|80460986|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
27622647|NCT03289455|80460987|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
27622648|NCT03289455|80460988|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
27622649|NCT03289455|80460986|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
27525446|NCT00969280|80116235|FG000|Overall Study|Withdrawal by Subject|0|||
27525447|NCT00969280|80116236|FG001|Overall Study|Withdrawal by Subject|1|||
27525448|NCT00969280|80116235|FG000|Overall Study|infection of influenza A(H1N1)|0|||
27525449|NCT00969280|80116236|FG001|Overall Study|infection of influenza A(H1N1)|1|||
27525450|NCT03584373|80116237|FG000|Overall Study|Lost to Follow-up|7|||
27525451|NCT03584373|80116238|FG001|Overall Study|Lost to Follow-up|8|||
27525452|NCT02276027|80116242|FG000|Overall Study|Death|1|||
27525453|NCT02276027|80116243|FG001|Overall Study|Death|0|||
27525454|NCT02276027|80116244|FG002|Overall Study|Death|0|||
27525455|NCT02276027|80116245|FG003|Overall Study|Death|2|||
27525456|NCT02276027|80116242|FG000|Overall Study|Physician Decision|0|||
27525457|NCT02276027|80116243|FG001|Overall Study|Physician Decision|0|||
27622650|NCT03289455|80460987|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
27622651|NCT03289455|80460988|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
27525458|NCT02276027|80116244|FG002|Overall Study|Physician Decision|0|||
27525459|NCT02276027|80116245|FG003|Overall Study|Physician Decision|1|||
27525460|NCT02276027|80116242|FG000|Overall Study|Progressive disease|1|||
27525461|NCT02276027|80116243|FG001|Overall Study|Progressive disease|13|||
27622652|NCT03289455|80460986|FG000|Overall Study|Progressive disease|3|||
27622653|NCT03289455|80460987|FG001|Overall Study|Progressive disease|4|||
27622654|NCT03289455|80460988|FG002|Overall Study|Progressive disease|5|||
27622655|NCT02100722|80460989|FG000|Overall Study|Withdrawal pre-procedure|4|||
27622656|NCT02100722|80460990|FG001|Overall Study|Withdrawal pre-procedure|9|||
27622657|NCT02100722|80460989|FG000|Overall Study|Withdrawal post-procedure|0|||
27622658|NCT02100722|80460990|FG001|Overall Study|Withdrawal post-procedure|3|||
27622659|NCT02100722|80460989|FG000|Overall Study|Lost to Follow-up|2|||
27622660|NCT02100722|80460990|FG001|Overall Study|Lost to Follow-up|2|||
27622661|NCT02100722|80460989|FG000|Overall Study|Continuing on study|751|||
27622662|NCT02100722|80460990|FG001|Overall Study|Continuing on study|729|||
27622663|NCT02065245|80460991|FG000|Infusion 1|Lost to Follow-up|0|||
27622664|NCT02065245|80460992|FG001|Infusion 1|Lost to Follow-up|0|||
27622665|NCT02065245|80460993|FG002|Infusion 1|Lost to Follow-up|0|||
27622666|NCT02065245|80460994|FG003|Infusion 1|Lost to Follow-up|0|||
27622667|NCT02065245|80460995|FG004|Infusion 1|Lost to Follow-up|0|||
27622668|NCT02065245|80460996|FG005|Infusion 1|Lost to Follow-up|0|||
27622669|NCT02065245|80460997|FG006|Infusion 1|Lost to Follow-up|1|||
27622670|NCT02065245|80460991|FG000|Infusion 1|Death|0|||
27622671|NCT02065245|80460992|FG001|Infusion 1|Death|0|||
27622672|NCT02065245|80460993|FG002|Infusion 1|Death|1|||
27622673|NCT02065245|80460994|FG003|Infusion 1|Death|0|||
27622674|NCT02065245|80460995|FG004|Infusion 1|Death|1|||
27622675|NCT02065245|80460996|FG005|Infusion 1|Death|0|||
27622676|NCT02065245|80460997|FG006|Infusion 1|Death|0|||
27622677|NCT02065245|80460991|FG000|Infusion 2|Death|0|||
27622678|NCT02065245|80460992|FG001|Infusion 2|Death|0|||
27622679|NCT02065245|80460993|FG002|Infusion 2|Death|0|||
27622680|NCT02065245|80460994|FG003|Infusion 2|Death|0|||
27622681|NCT02065245|80460995|FG004|Infusion 2|Death|0|||
27622682|NCT02065245|80460996|FG005|Infusion 2|Death|0|||
27622683|NCT02065245|80460997|FG006|Infusion 2|Death|1|||
27525462|NCT02276027|80116244|FG002|Overall Study|Progressive disease|12|||
27525463|NCT02276027|80116245|FG003|Overall Study|Progressive disease|14|||
27525464|NCT02276027|80116242|FG000|Overall Study|Subject/guardian decision|0|||
27525465|NCT02276027|80116243|FG001|Overall Study|Subject/guardian decision|1|||
27525466|NCT02276027|80116244|FG002|Overall Study|Subject/guardian decision|0|||
27622684|NCT02065245|80460991|FG000|Infusion 3|Lost to Follow-up|1|||
27622685|NCT02065245|80460992|FG001|Infusion 3|Lost to Follow-up|1|||
27622686|NCT02065245|80460993|FG002|Infusion 3|Lost to Follow-up|0|||
27622687|NCT02065245|80460994|FG003|Infusion 3|Lost to Follow-up|0|||
27622688|NCT02065245|80460995|FG004|Infusion 3|Lost to Follow-up|0|||
27622689|NCT02065245|80460996|FG005|Infusion 3|Lost to Follow-up|0|||
27622690|NCT02065245|80460997|FG006|Infusion 3|Lost to Follow-up|0|||
27622691|NCT02926937|80460998|FG000|Overall Study|Adverse Event|0|||
27622692|NCT02926937|80460999|FG001|Overall Study|Adverse Event|1|||
27622693|NCT02926937|80461000|FG002|Overall Study|Adverse Event|1|||
27622694|NCT02926937|80460998|FG000|Overall Study|Poor Compliance to Protocol|1|||
27525467|NCT02276027|80116245|FG003|Overall Study|Subject/guardian decision|3|||
27525468|NCT02276027|80116242|FG000|Overall Study|Adverse Event|0|||
27525469|NCT02276027|80116243|FG001|Overall Study|Adverse Event|2|||
27525470|NCT02276027|80116244|FG002|Overall Study|Adverse Event|8|||
27525471|NCT02276027|80116245|FG003|Overall Study|Adverse Event|2|||
27525472|NCT00913692|80116246|FG000|Screening (4 Months)|Physician Decision|3|||
27525473|NCT00913692|80116246|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
27525474|NCT00913692|80116246|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
27622695|NCT02926937|80460999|FG001|Overall Study|Poor Compliance to Protocol|0|||
27855729|NCT00852969|81302726|FG000|Overall Study|Adverse Event|0|||
27855730|NCT00852969|81302727|FG001|Overall Study|Adverse Event|1|||
27855731|NCT00852969|81302726|FG000|Overall Study|Lost to Follow-up|0|||
27855732|NCT00852969|81302727|FG001|Overall Study|Lost to Follow-up|1|||
27855733|NCT03596151|81302728|FG000|Overall Study|Withdrawal by Subject|1|||
27855734|NCT01561430|81302734|FG000|Overall Study|Adverse Event|0|||
27855735|NCT01561430|81302735|FG001|Overall Study|Adverse Event|0|||
27525475|NCT01401959|80116249|FG000|Enrolled|Withdrawal by Subject|1|||
27525476|NCT01401959|80116250|FG001|Enrolled|Withdrawal by Subject|0|||
27855736|NCT01561430|81302736|FG002|Overall Study|Adverse Event|3|||
27855737|NCT01561430|81302737|FG003|Overall Study|Adverse Event|1|||
27525477|NCT01401959|80116251|FG002|Enrolled|Withdrawal by Subject|0|||
27525478|NCT01401959|80116249|FG000|Treated|Disease Progression|2|||
27525479|NCT01401959|80116250|FG001|Treated|Disease Progression|2|||
27855738|NCT01561430|81302734|FG000|Overall Study|Withdrawal by Subject|0|||
27622696|NCT02926937|80461000|FG002|Overall Study|Poor Compliance to Protocol|0|||
27622697|NCT02926937|80460998|FG000|Overall Study|Lost to Follow-up|4|||
27622698|NCT02926937|80460999|FG001|Overall Study|Lost to Follow-up|5|||
27622699|NCT02926937|80461000|FG002|Overall Study|Lost to Follow-up|0|||
27622700|NCT02926937|80460998|FG000|Overall Study|At the Participant's own Request|11|||
27622701|NCT02926937|80460999|FG001|Overall Study|At the Participant's own Request|5|||
27622702|NCT02926937|80461000|FG002|Overall Study|At the Participant's own Request|8|||
27622703|NCT02926937|80460998|FG000|Overall Study|Reason not Specified|3|||
27622704|NCT02926937|80460999|FG001|Overall Study|Reason not Specified|4|||
27622705|NCT02926937|80461000|FG002|Overall Study|Reason not Specified|2|||
27622706|NCT00335153|80461002|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
27622707|NCT00335153|80461002|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
27622708|NCT00335153|80461002|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
27622709|NCT00335153|80461002|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
27622710|NCT00335153|80461002|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
27525480|NCT01401959|80116251|FG002|Treated|Disease Progression|1|||
27525481|NCT01401959|80116249|FG000|Treated|Adverse Event|4|||
27622711|NCT00335153|80461002|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
27622712|NCT00335153|80461002|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
27622713|NCT00335153|80461002|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
27622714|NCT00335153|80461002|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
27622715|NCT00335153|80461002|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
27622716|NCT00031447|80461003|FG000|Overall Study|Lost to Follow-up|0|||
27622717|NCT00031447|80461004|FG001|Overall Study|Lost to Follow-up|1|||
27622718|NCT00031447|80461003|FG000|Overall Study|Non-compliant|1|||
27622719|NCT00031447|80461004|FG001|Overall Study|Non-compliant|1|||
27622720|NCT00031447|80461003|FG000|Overall Study|Re-activation of Disease|2|||
27622721|NCT00031447|80461004|FG001|Overall Study|Re-activation of Disease|1|||
27622722|NCT00031447|80461003|FG000|Overall Study|Disruption of blinded study drug supply|7|||
27622723|NCT00031447|80461004|FG001|Overall Study|Disruption of blinded study drug supply|4|||
27622724|NCT02790606|80461007|FG000|Overall Study|Death|27|||
27622725|NCT02790606|80461007|FG000|Overall Study|Lost to Follow-up|4|||
27622726|NCT02790606|80461007|FG000|Overall Study|Physician Decision|3|||
27622727|NCT02790606|80461007|FG000|Overall Study|Withdrawal by Subject|1|||
27622728|NCT00630864|80461009|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
27525482|NCT01401959|80116250|FG001|Treated|Adverse Event|3|||
27525483|NCT01401959|80116251|FG002|Treated|Adverse Event|2|||
27525484|NCT01401959|80116249|FG000|Treated|Withdrawal by Subject|1|||
27525485|NCT01401959|80116250|FG001|Treated|Withdrawal by Subject|2|||
27525486|NCT01401959|80116251|FG002|Treated|Withdrawal by Subject|2|||
27525487|NCT01401959|80116249|FG000|Treated|Protocol Violation|0|||
27525488|NCT01401959|80116250|FG001|Treated|Protocol Violation|1|||
27525489|NCT01401959|80116251|FG002|Treated|Protocol Violation|0|||
27525490|NCT00859638|80116252|FG000|Overall Study|Lost to Follow-up|6|||
27525491|NCT00859638|80116253|FG001|Overall Study|Lost to Follow-up|1|||
27525492|NCT00859638|80116252|FG000|Overall Study|Withdrawal by Subject|3|||
27525493|NCT00859638|80116253|FG001|Overall Study|Withdrawal by Subject|2|||
27525494|NCT00859638|80116252|FG000|Overall Study|Ill health|1|||
27525495|NCT00859638|80116253|FG001|Overall Study|Ill health|1|||
27525496|NCT00169442|80116259|FG000|Overall Study|Withdrawal by Subject|0|||
27525497|NCT00169442|80116260|FG001|Overall Study|Withdrawal by Subject|0|||
27525498|NCT00169442|80116261|FG002|Overall Study|Withdrawal by Subject|1|||
27525499|NCT00169442|80116262|FG003|Overall Study|Withdrawal by Subject|0|||
27622729|NCT00630864|80461009|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
27622730|NCT01101165|80461012|FG000|Period 1|Adverse Event|1|||
27622731|NCT01101165|80461013|FG001|Period 1|Adverse Event|2|||
27622732|NCT01101165|80461012|FG000|Period 1|Withdrawal by Subject|0|||
27525500|NCT00169442|80116263|FG004|Overall Study|Withdrawal by Subject|0|||
27525501|NCT00169442|80116264|FG005|Overall Study|Withdrawal by Subject|0|||
27525502|NCT00169442|80116259|FG000|Overall Study|Migrated/moved from study area|0|||
27525503|NCT00169442|80116260|FG001|Overall Study|Migrated/moved from study area|0|||
27525504|NCT00169442|80116261|FG002|Overall Study|Migrated/moved from study area|0|||
27622733|NCT01101165|80461013|FG001|Period 1|Withdrawal by Subject|2|||
27622734|NCT01101165|80461012|FG000|Period 1|Positive Drug Screen|0|||
27733157|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27855739|NCT01561430|81302735|FG001|Overall Study|Withdrawal by Subject|0|||
27855740|NCT01561430|81302736|FG002|Overall Study|Withdrawal by Subject|1|||
27855741|NCT01561430|81302737|FG003|Overall Study|Withdrawal by Subject|0|||
27855742|NCT01561430|81302734|FG000|Overall Study|Physician Decision|0|||
27855743|NCT01561430|81302735|FG001|Overall Study|Physician Decision|1|||
27910749|NCT00101868|81510223|FG000|Overall Study|Death|10|||
27910750|NCT00101868|81510224|FG001|Overall Study|Death|10|||
27910751|NCT00101868|81510223|FG000|Overall Study|Withdrawal by Subject|8|||
27910752|NCT00101868|81510224|FG001|Overall Study|Withdrawal by Subject|9|||
27910753|NCT00101868|81510223|FG000|Overall Study|Protocol Violation|3|||
27525505|NCT00169442|80116262|FG003|Overall Study|Migrated/moved from study area|0|||
27525506|NCT00169442|80116263|FG004|Overall Study|Migrated/moved from study area|0|||
27525507|NCT00169442|80116264|FG005|Overall Study|Migrated/moved from study area|2|||
27525508|NCT00169442|80116259|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27525509|NCT00169442|80116260|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27622735|NCT01101165|80461013|FG001|Period 1|Positive Drug Screen|1|||
27622736|NCT01101165|80461012|FG000|Period 1|Lost to Follow-up|1|||
27622737|NCT01101165|80461013|FG001|Period 1|Lost to Follow-up|0|||
27525510|NCT00169442|80116261|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27622738|NCT01101165|80461012|FG000|Period 2|Withdrawal by Subject|3|||
27622739|NCT01101165|80461013|FG001|Period 2|Withdrawal by Subject|1|||
27622740|NCT01101165|80461012|FG000|Period 2|Adverse Event|1|||
27525511|NCT00169442|80116262|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27525512|NCT00169442|80116263|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
27525513|NCT00169442|80116264|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
27525514|NCT00169442|80116259|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
27525515|NCT00169442|80116260|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
27525516|NCT00169442|80116261|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
27525517|NCT00169442|80116262|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
27525518|NCT00169442|80116263|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
27525519|NCT00169442|80116264|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
27525520|NCT01307020|80116265|FG000|Overall Study|Lost to Follow-up|0|||
27525521|NCT01307020|80116266|FG001|Overall Study|Lost to Follow-up|0|||
27855744|NCT01561430|81302736|FG002|Overall Study|Physician Decision|0|||
27910754|NCT00101868|81510224|FG001|Overall Study|Protocol Violation|0|||
27622741|NCT01101165|80461013|FG001|Period 2|Adverse Event|0|||
27622742|NCT02056119|80461016|FG000|Overall Study|Death|1|||
27622743|NCT02056119|80461017|FG001|Overall Study|Death|2|||
27622744|NCT02056119|80461016|FG000|Overall Study|Intubated for less than 24 hrs|2|||
27622745|NCT02056119|80461017|FG001|Overall Study|Intubated for less than 24 hrs|7|||
27622746|NCT02056119|80461016|FG000|Overall Study|No aerosol treatments were given.|3|||
27622747|NCT02056119|80461017|FG001|Overall Study|No aerosol treatments were given.|2|||
27622748|NCT02056119|80461016|FG000|Overall Study|Received Metaneb treatment|0|||
27910755|NCT00101868|81510223|FG000|Overall Study|Lost to Follow-up|8|||
27910756|NCT00101868|81510224|FG001|Overall Study|Lost to Follow-up|13|||
27910757|NCT00369343|81510225|FG000|Double-blind Phase|Adverse Event|19|||
27910758|NCT00369343|81510226|FG001|Double-blind Phase|Adverse Event|4|||
27525522|NCT01307020|80116267|FG002|Overall Study|Lost to Follow-up|1|||
27525523|NCT01307020|80116268|FG003|Overall Study|Lost to Follow-up|1|||
27525524|NCT01307020|80116269|FG004|Overall Study|Lost to Follow-up|0|||
27525525|NCT01307020|80116270|FG005|Overall Study|Lost to Follow-up|0|||
27525526|NCT01307020|80116271|FG006|Overall Study|Lost to Follow-up|1|||
27525527|NCT01307020|80116272|FG007|Overall Study|Lost to Follow-up|0|||
27525528|NCT01307020|80116273|FG008|Overall Study|Lost to Follow-up|0|||
27525529|NCT01307020|80116274|FG009|Overall Study|Lost to Follow-up|0|||
27525530|NCT01307020|80116265|FG000|Overall Study|Electronic data capture failure|0|||
27525531|NCT01307020|80116266|FG001|Overall Study|Electronic data capture failure|1|||
27525532|NCT01307020|80116267|FG002|Overall Study|Electronic data capture failure|0|||
27525533|NCT01307020|80116268|FG003|Overall Study|Electronic data capture failure|0|||
27525534|NCT01307020|80116269|FG004|Overall Study|Electronic data capture failure|0|||
27525535|NCT01307020|80116270|FG005|Overall Study|Electronic data capture failure|0|||
27525536|NCT01307020|80116271|FG006|Overall Study|Electronic data capture failure|0|||
27525537|NCT01307020|80116272|FG007|Overall Study|Electronic data capture failure|0|||
27525538|NCT01307020|80116273|FG008|Overall Study|Electronic data capture failure|0|||
27525539|NCT01307020|80116274|FG009|Overall Study|Electronic data capture failure|0|||
27525540|NCT00829933|80116276|FG000|Overall Study|Adverse Event|2|||
27525541|NCT00829933|80116277|FG001|Overall Study|Adverse Event|3|||
27525542|NCT00829933|80116278|FG002|Overall Study|Adverse Event|2|||
27525543|NCT00829933|80116279|FG003|Overall Study|Adverse Event|1|||
27525544|NCT00829933|80116276|FG000|Overall Study|Death|0|||
27525545|NCT00829933|80116277|FG001|Overall Study|Death|0|||
27525546|NCT00829933|80116278|FG002|Overall Study|Death|1|||
27525547|NCT00829933|80116279|FG003|Overall Study|Death|1|||
27525548|NCT00829933|80116276|FG000|Overall Study|Lack of Efficacy|0|||
27525549|NCT00829933|80116277|FG001|Overall Study|Lack of Efficacy|1|||
27525550|NCT00829933|80116278|FG002|Overall Study|Lack of Efficacy|0|||
27622749|NCT02056119|80461017|FG001|Overall Study|Received Metaneb treatment|2|||
27855745|NCT01561430|81302737|FG003|Overall Study|Physician Decision|0|||
27855746|NCT01561430|81302734|FG000|Overall Study|Sponsor Decision|1|||
27855747|NCT01561430|81302735|FG001|Overall Study|Sponsor Decision|14|||
27855748|NCT01561430|81302736|FG002|Overall Study|Sponsor Decision|13|||
27855749|NCT01561430|81302737|FG003|Overall Study|Sponsor Decision|12|||
27855750|NCT01831765|81302738|FG000|Overall Study|Lack of Efficacy|1|||
27855751|NCT01831765|81302739|FG001|Overall Study|Lack of Efficacy|0|||
27855752|NCT01831765|81302740|FG002|Overall Study|Lack of Efficacy|0|||
27855753|NCT01831765|81302738|FG000|Overall Study|Other, sponsor withdrew subject|0|||
27855754|NCT01831765|81302739|FG001|Overall Study|Other, sponsor withdrew subject|1|||
27855755|NCT01831765|81302740|FG002|Overall Study|Other, sponsor withdrew subject|0|||
27855756|NCT01831765|81302738|FG000|Overall Study|Pregnancy|1|||
27855757|NCT01831765|81302739|FG001|Overall Study|Pregnancy|1|||
27525551|NCT00829933|80116279|FG003|Overall Study|Lack of Efficacy|0|||
27525552|NCT00829933|80116276|FG000|Overall Study|Physician Decision|5|||
27525553|NCT00829933|80116277|FG001|Overall Study|Physician Decision|7|||
27525554|NCT00829933|80116278|FG002|Overall Study|Physician Decision|8|||
27622750|NCT02056119|80461016|FG000|Overall Study|Protocol Violation|4|||
27855758|NCT01831765|81302740|FG002|Overall Study|Pregnancy|2|||
27855759|NCT01831765|81302738|FG000|Overall Study|Death|0|||
27855760|NCT01831765|81302739|FG001|Overall Study|Death|1|||
27855761|NCT01831765|81302740|FG002|Overall Study|Death|1|||
27622751|NCT02056119|80461017|FG001|Overall Study|Protocol Violation|7|||
27622752|NCT02153788|80461018|FG000|Overall Study|Physician Decision|2|||
27622753|NCT02153788|80461019|FG001|Overall Study|Physician Decision|1|||
27622754|NCT01657032|80461020|FG000|Overall Study|Lost to Follow-up|0|||
27622755|NCT01657032|80461021|FG001|Overall Study|Lost to Follow-up|7|||
27622756|NCT05550337|80461022|FG000|Overall Study|Lack of Efficacy|0|||
27622757|NCT05550337|80461023|FG001|Overall Study|Lack of Efficacy|0|||
27622758|NCT05550337|80461024|FG002|Overall Study|Lack of Efficacy|1|||
27622759|NCT05550337|80461022|FG000|Overall Study|Adverse Event|1|||
27622760|NCT05550337|80461023|FG001|Overall Study|Adverse Event|5|||
27622761|NCT05550337|80461024|FG002|Overall Study|Adverse Event|0|||
27622762|NCT05550337|80461022|FG000|Overall Study|Withdrawal by Subject|8|||
27622763|NCT05550337|80461023|FG001|Overall Study|Withdrawal by Subject|14|||
27622764|NCT05550337|80461024|FG002|Overall Study|Withdrawal by Subject|10|||
27622765|NCT05550337|80461022|FG000|Overall Study|Pregnancy|0|||
27622766|NCT05550337|80461023|FG001|Overall Study|Pregnancy|0|||
27622767|NCT05550337|80461024|FG002|Overall Study|Pregnancy|1|||
27910759|NCT00369343|81510225|FG000|Double-blind Phase|Failed to return|2|||
27910760|NCT00369343|81510226|FG001|Double-blind Phase|Failed to return|0|||
27525555|NCT00829933|80116279|FG003|Overall Study|Physician Decision|1|||
27525556|NCT00829933|80116276|FG000|Overall Study|Pregnancy|0|||
27525557|NCT00829933|80116277|FG001|Overall Study|Pregnancy|0|||
27910761|NCT00369343|81510225|FG000|Double-blind Phase|Lost to Follow-up|9|||
27910762|NCT00369343|81510226|FG001|Double-blind Phase|Lost to Follow-up|2|||
27910763|NCT00369343|81510225|FG000|Double-blind Phase|Protocol Violation|2|||
27910764|NCT00369343|81510226|FG001|Double-blind Phase|Protocol Violation|0|||
27910765|NCT00369343|81510225|FG000|Double-blind Phase|Withdrawal by Subject|8|||
27622768|NCT05550337|80461022|FG000|Overall Study|Protocol Violation|1|||
27622769|NCT05550337|80461023|FG001|Overall Study|Protocol Violation|3|||
27622770|NCT05550337|80461024|FG002|Overall Study|Protocol Violation|4|||
27622771|NCT05550337|80461022|FG000|Overall Study|Physician Decision|2|||
27622772|NCT05550337|80461023|FG001|Overall Study|Physician Decision|1|||
27622773|NCT05550337|80461024|FG002|Overall Study|Physician Decision|1|||
27622774|NCT05550337|80461022|FG000|Overall Study|Lost to Follow-up|16|||
27622775|NCT05550337|80461023|FG001|Overall Study|Lost to Follow-up|11|||
27622776|NCT05550337|80461024|FG002|Overall Study|Lost to Follow-up|11|||
27622777|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
27622778|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
27622779|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
27622780|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
27622781|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
27622782|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
27622783|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
27622784|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
27622785|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27622786|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27910766|NCT00369343|81510226|FG001|Double-blind Phase|Withdrawal by Subject|6|||
27622787|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27622788|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
27525558|NCT00829933|80116278|FG002|Overall Study|Pregnancy|0|||
27525559|NCT00829933|80116279|FG003|Overall Study|Pregnancy|2|||
27525560|NCT00829933|80116276|FG000|Overall Study|Protocol Violation|2|||
27525561|NCT00829933|80116277|FG001|Overall Study|Protocol Violation|1|||
27525562|NCT00829933|80116278|FG002|Overall Study|Protocol Violation|0|||
27525563|NCT00829933|80116279|FG003|Overall Study|Protocol Violation|0|||
27525564|NCT00829933|80116276|FG000|Overall Study|withdrew before treatment started|5|||
27622789|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
27622790|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
27622791|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27622792|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27910767|NCT00369343|81510225|FG000|Double-blind Phase|Lack of Efficacy|0|||
27525565|NCT00829933|80116277|FG001|Overall Study|withdrew before treatment started|1|||
27525566|NCT00829933|80116278|FG002|Overall Study|withdrew before treatment started|2|||
27525567|NCT00829933|80116279|FG003|Overall Study|withdrew before treatment started|9|||
27525568|NCT03729362|80116281|FG000|Overall Study|Withdrawal by Subject|2|||
27525569|NCT03729362|80116282|FG001|Overall Study|Withdrawal by Subject|0|||
27525570|NCT03729362|80116281|FG000|Overall Study|Physician Decision|1|||
27622793|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27622794|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
27622795|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27622796|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
27622797|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27622798|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27622799|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27855762|NCT01831765|81302738|FG000|Overall Study|Other, site closed|1|||
27855763|NCT01831765|81302739|FG001|Overall Study|Other, site closed|1|||
27622800|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
27622801|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
27622802|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
27622803|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
27622804|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
27622805|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
27622806|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
27525571|NCT03729362|80116282|FG001|Overall Study|Physician Decision|0|||
27525572|NCT03729362|80116281|FG000|Overall Study|COVID-19 Pandemic|1|||
27525573|NCT03729362|80116282|FG001|Overall Study|COVID-19 Pandemic|0|||
27525574|NCT03729362|80116281|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
27525575|NCT03729362|80116282|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
27525576|NCT03729362|80116281|FG000|Overall Study|Adverse Event|0|||
27525577|NCT03729362|80116282|FG001|Overall Study|Adverse Event|1|||
27525578|NCT03729362|80116281|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
27525579|NCT03729362|80116282|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
27622807|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
27622808|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
27622809|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27622810|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27622811|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27622812|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
27622813|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
27622814|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
27622815|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27622816|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27622817|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27622818|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
27622819|NCT01089556|80461029|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
27622820|NCT01089556|80461030|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
27622821|NCT01089556|80461031|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27622822|NCT01089556|80461032|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27622823|NCT01089556|80461033|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27525580|NCT02290431|80116285|FG000|Overall Study|Adverse Event|20|||
27525581|NCT02290431|80116285|FG000|Overall Study|Progressive disease|4|||
27622824|NCT01089556|80461034|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
27525582|NCT02290431|80116285|FG000|Overall Study|Study terminated by Sponsor|1|||
27525583|NCT02290431|80116285|FG000|Overall Study|Physician Decision|2|||
27622825|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
27525584|NCT04322539|80116286|FG000|Overall Study|Withdrawal of consent|14|||
27525585|NCT04322539|80116287|FG001|Overall Study|Withdrawal of consent|8|||
27525586|NCT04322539|80116286|FG000|Overall Study|Death|317|||
27525587|NCT04322539|80116287|FG001|Overall Study|Death|173|||
27525588|NCT04322539|80116286|FG000|Overall Study|Adverse Event|1|||
27525589|NCT04322539|80116287|FG001|Overall Study|Adverse Event|0|||
27525590|NCT04322539|80116286|FG000|Overall Study|Lost to Follow-up|3|||
27525591|NCT04322539|80116287|FG001|Overall Study|Lost to Follow-up|0|||
27525592|NCT04322539|80116286|FG000|Overall Study|Other|2|||
27525593|NCT04322539|80116287|FG001|Overall Study|Other|3|||
27525594|NCT04322539|80116286|FG000|Overall Study|Ongoing|124|||
27525595|NCT04322539|80116287|FG001|Overall Study|Ongoing|46|||
27525596|NCT01653132|80116288|FG000|First Intervention|Protocol Violation|1|||
27525597|NCT01653132|80116289|FG001|First Intervention|Protocol Violation|0|||
27525598|NCT02522871|80116290|FG000|Overall Study|Protocol Violation|1|||
27525599|NCT02522871|80116291|FG001|Overall Study|Protocol Violation|4|||
27525600|NCT02522871|80116290|FG000|Overall Study|Treated without randomization|1|||
27525601|NCT02522871|80116291|FG001|Overall Study|Treated without randomization|0|||
27525602|NCT02522871|80116290|FG000|Overall Study|Death|9|||
27525603|NCT02522871|80116291|FG001|Overall Study|Death|9|||
27525604|NCT02522871|80116290|FG000|Overall Study|Died in operating room prior to transplant|0|||
27525605|NCT02522871|80116291|FG001|Overall Study|Died in operating room prior to transplant|1|||
27525606|NCT01894568|80116292|FG000|Overall Study|Adverse Event|2|||
27525607|NCT01894568|80116293|FG001|Overall Study|Adverse Event|3|||
27525608|NCT01894568|80116292|FG000|Overall Study|Protocol required discontinuation|2|||
27622826|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
27525609|NCT01894568|80116293|FG001|Overall Study|Protocol required discontinuation|1|||
27525610|NCT01894568|80116292|FG000|Overall Study|Withdrawal by Subject|5|||
27622827|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
27525611|NCT01894568|80116293|FG001|Overall Study|Withdrawal by Subject|5|||
27525612|NCT01894568|80116292|FG000|Overall Study|Physician Decision|1|||
27525613|NCT01894568|80116293|FG001|Overall Study|Physician Decision|0|||
27525614|NCT01894568|80116292|FG000|Overall Study|Lost to Follow-up|0|||
27855764|NCT01831765|81302740|FG002|Overall Study|Other, site closed|0|||
27525615|NCT01894568|80116293|FG001|Overall Study|Lost to Follow-up|1|||
27525616|NCT00327470|80116296|FG000|Overall Study|Randomized, but not treated|0|||
27525617|NCT00327470|80116297|FG001|Overall Study|Randomized, but not treated|2|||
27525618|NCT00327470|80116296|FG000|Overall Study|Adverse Event|9|||
27525619|NCT00327470|80116297|FG001|Overall Study|Adverse Event|14|||
27525620|NCT00327470|80116296|FG000|Overall Study|Lack of Efficacy|7|||
27525621|NCT00327470|80116297|FG001|Overall Study|Lack of Efficacy|19|||
27525622|NCT00327470|80116296|FG000|Overall Study|Other|5|||
27525623|NCT00327470|80116297|FG001|Overall Study|Other|9|||
27525624|NCT00327470|80116296|FG000|Overall Study|Lost to Follow-up|1|||
27525625|NCT00327470|80116297|FG001|Overall Study|Lost to Follow-up|3|||
27525626|NCT00327470|80116296|FG000|Overall Study|Withdrawal by Subject|6|||
27525627|NCT00327470|80116297|FG001|Overall Study|Withdrawal by Subject|12|||
27525628|NCT00327470|80116296|FG000|Overall Study|Death|1|||
27525629|NCT00327470|80116297|FG001|Overall Study|Death|4|||
27525630|NCT04575597|80116298|FG000|Overall Study|Death|0|||
27525631|NCT04575597|80116299|FG001|Overall Study|Death|0|||
27525632|NCT04575597|80116300|FG002|Overall Study|Death|0|||
27525633|NCT04575597|80116301|FG003|Overall Study|Death|1|||
27525634|NCT04575597|80116302|FG004|Overall Study|Death|3|||
27525635|NCT04575597|80116303|FG005|Overall Study|Death|14|||
27525636|NCT04575597|80116298|FG000|Overall Study|Lost to Follow-up|2|||
27525637|NCT04575597|80116299|FG001|Overall Study|Lost to Follow-up|1|||
27525638|NCT04575597|80116300|FG002|Overall Study|Lost to Follow-up|1|||
27525639|NCT04575597|80116301|FG003|Overall Study|Lost to Follow-up|2|||
27525640|NCT04575597|80116302|FG004|Overall Study|Lost to Follow-up|10|||
27525641|NCT04575597|80116303|FG005|Overall Study|Lost to Follow-up|8|||
27525642|NCT04575597|80116298|FG000|Overall Study|Withdrawal by Subject|2|||
27525643|NCT04575597|80116299|FG001|Overall Study|Withdrawal by Subject|2|||
27525644|NCT04575597|80116300|FG002|Overall Study|Withdrawal by Subject|4|||
27525645|NCT04575597|80116301|FG003|Overall Study|Withdrawal by Subject|2|||
27525646|NCT04575597|80116302|FG004|Overall Study|Withdrawal by Subject|25|||
27525647|NCT04575597|80116303|FG005|Overall Study|Withdrawal by Subject|28|||
27525648|NCT04575597|80116298|FG000|Overall Study|Not Recorded|0|||
27525649|NCT04575597|80116299|FG001|Overall Study|Not Recorded|0|||
27525650|NCT04575597|80116300|FG002|Overall Study|Not Recorded|0|||
27525651|NCT04575597|80116301|FG003|Overall Study|Not Recorded|0|||
27525652|NCT04575597|80116302|FG004|Overall Study|Not Recorded|0|||
27525653|NCT04575597|80116303|FG005|Overall Study|Not Recorded|2|||
27525654|NCT04575597|80116298|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27525655|NCT04575597|80116299|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27525656|NCT04575597|80116300|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27525657|NCT04575597|80116301|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27525658|NCT04575597|80116302|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
27525659|NCT04575597|80116303|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
27525660|NCT00821509|80116304|FG000|Overall Study|Withdrawal by Subject|12|||
27525661|NCT00821509|80116305|FG001|Overall Study|Withdrawal by Subject|11|||
27525662|NCT00821509|80116306|FG002|Overall Study|Withdrawal by Subject|34|||
27525663|NCT00816023|80116307|FG000|Overall Study|Lost to Follow-up|1|||
27525664|NCT00816023|80116308|FG001|Overall Study|Lost to Follow-up|1|||
27525665|NCT00816023|80116309|FG002|Overall Study|Lost to Follow-up|0|||
27525666|NCT00816023|80116310|FG003|Overall Study|Lost to Follow-up|0|||
27525667|NCT00816023|80116307|FG000|Overall Study|Withdrawal by Subject|1|||
27525668|NCT00816023|80116308|FG001|Overall Study|Withdrawal by Subject|0|||
27525669|NCT00816023|80116309|FG002|Overall Study|Withdrawal by Subject|0|||
27525670|NCT00816023|80116310|FG003|Overall Study|Withdrawal by Subject|0|||
27525671|NCT00816023|80116307|FG000|Overall Study|Physician Decision|0|||
27525672|NCT00816023|80116308|FG001|Overall Study|Physician Decision|0|||
27525673|NCT00816023|80116309|FG002|Overall Study|Physician Decision|1|||
27525674|NCT00816023|80116310|FG003|Overall Study|Physician Decision|0|||
27525675|NCT00816023|80116307|FG000|Overall Study|assessments complete prior to window|1|||
27525676|NCT00816023|80116308|FG001|Overall Study|assessments complete prior to window|1|||
27525677|NCT00816023|80116309|FG002|Overall Study|assessments complete prior to window|2|||
27525678|NCT00816023|80116310|FG003|Overall Study|assessments complete prior to window|1|||
27525679|NCT00816023|80116307|FG000|Overall Study|Randomized Not Treated|6|||
27525680|NCT00816023|80116308|FG001|Overall Study|Randomized Not Treated|4|||
27525681|NCT00816023|80116309|FG002|Overall Study|Randomized Not Treated|6|||
27525682|NCT00816023|80116310|FG003|Overall Study|Randomized Not Treated|11|||
27525683|NCT03149848|80116311|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
27525684|NCT03149848|80116311|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
27525685|NCT03309046|80119311|FG000|Overall Study|Withdrawal by Subject|4|||
27525686|NCT03309046|80119312|FG001|Overall Study|Withdrawal by Subject|17|||
27525687|NCT03603509|80119313|FG000|Overall Study|Lost to Follow-up|3|||
27525688|NCT03603509|80119314|FG001|Overall Study|Lost to Follow-up|4|||
27525689|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
27525690|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
27525691|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Other|2|||
27525692|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Other|2|||
27525693|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Personal reasons|2|||
27525694|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Personal reasons|2|||
27525695|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
27525696|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
27525697|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
27525698|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
27525699|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
27525700|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
27525701|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
27525702|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
27525703|NCT00667446|80119317|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
27525704|NCT00667446|80119318|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
27525705|NCT00667446|80119317|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
27525706|NCT00667446|80119318|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
27525707|NCT00827931|80119319|FG000|Overall Study|Death|3|||
27525708|NCT00827931|80119320|FG001|Overall Study|Death|5|||
27525709|NCT00827931|80119319|FG000|Overall Study|Adverse Event|1|||
27525710|NCT00827931|80119320|FG001|Overall Study|Adverse Event|0|||
27525711|NCT00827931|80119319|FG000|Overall Study|Lost to Follow-up|1|||
27525712|NCT00827931|80119320|FG001|Overall Study|Lost to Follow-up|0|||
27525713|NCT00827931|80119319|FG000|Overall Study|Withdrawal by Subject|0|||
27525714|NCT00827931|80119320|FG001|Overall Study|Withdrawal by Subject|1|||
27525715|NCT00827931|80119319|FG000|Overall Study|Other|1|||
27525716|NCT00827931|80119320|FG001|Overall Study|Other|0|||
27525717|NCT00791076|80119321|FG000|Overall Study|Study was terminated,PI left institution|8|||
27525718|NCT00136604|80119322|FG000|Overall Study|Lost to Follow-up|1|||
27525719|NCT00136604|80119323|FG001|Overall Study|Lost to Follow-up|0|||
27525720|NCT00136604|80119324|FG002|Overall Study|Lost to Follow-up|0|||
27525721|NCT00136604|80119325|FG003|Overall Study|Lost to Follow-up|0|||
27525722|NCT00136604|80119326|FG004|Overall Study|Lost to Follow-up|1|||
27525723|NCT00136604|80119322|FG000|Overall Study|Migrated/moved from study area|0|||
27525724|NCT00136604|80119323|FG001|Overall Study|Migrated/moved from study area|1|||
27525725|NCT00136604|80119324|FG002|Overall Study|Migrated/moved from study area|0|||
27525726|NCT00136604|80119325|FG003|Overall Study|Migrated/moved from study area|0|||
27525727|NCT00136604|80119326|FG004|Overall Study|Migrated/moved from study area|0|||
27525728|NCT00256282|80119327|FG000|Overall Study|Disease progression, relapse during acti|12|||
27525729|NCT00256282|80119327|FG000|Overall Study|Adverse Event|3|||
27525730|NCT00256282|80119327|FG000|Overall Study|Physician Decision|1|||
27525731|NCT03188042|80119328|FG000|Overall Study|Withdrawal by Subject|1|||
27525732|NCT03188042|80119329|FG001|Overall Study|Withdrawal by Subject|1|||
27525733|NCT02325791|80119332|FG000|Overall Study|Adverse Event|0|||
27525734|NCT02325791|80119333|FG001|Overall Study|Adverse Event|1|||
27525735|NCT02325791|80119334|FG002|Overall Study|Adverse Event|1|||
27525736|NCT02325791|80119335|FG003|Overall Study|Adverse Event|0|||
27525737|NCT02325791|80119332|FG000|Overall Study|Death|0|||
27525738|NCT02325791|80119333|FG001|Overall Study|Death|3|||
27525739|NCT02325791|80119334|FG002|Overall Study|Death|0|||
27525740|NCT02325791|80119335|FG003|Overall Study|Death|1|||
27525741|NCT02325791|80119332|FG000|Overall Study|Lost to Follow-up|0|||
27525742|NCT02325791|80119333|FG001|Overall Study|Lost to Follow-up|15|||
27525743|NCT02325791|80119334|FG002|Overall Study|Lost to Follow-up|14|||
27525744|NCT02325791|80119335|FG003|Overall Study|Lost to Follow-up|9|||
27525745|NCT02325791|80119332|FG000|Overall Study|Physician Decision|0|||
27525746|NCT02325791|80119333|FG001|Overall Study|Physician Decision|1|||
27525747|NCT02325791|80119334|FG002|Overall Study|Physician Decision|1|||
27525748|NCT02325791|80119335|FG003|Overall Study|Physician Decision|0|||
27525749|NCT02325791|80119332|FG000|Overall Study|Protocol Violation|0|||
27733158|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27525750|NCT02325791|80119333|FG001|Overall Study|Protocol Violation|0|||
27525751|NCT02325791|80119334|FG002|Overall Study|Protocol Violation|1|||
27525752|NCT02325791|80119335|FG003|Overall Study|Protocol Violation|0|||
27525753|NCT02325791|80119332|FG000|Overall Study|Withdrawal by Subject|0|||
27525754|NCT02325791|80119333|FG001|Overall Study|Withdrawal by Subject|5|||
27525755|NCT02325791|80119334|FG002|Overall Study|Withdrawal by Subject|8|||
27855765|NCT01831765|81302738|FG000|Overall Study|Adverse Event|5|||
27525756|NCT02325791|80119335|FG003|Overall Study|Withdrawal by Subject|16|||
27525757|NCT01027273|80119336|FG000|Overall Study|Lost to Follow-up|57|||
27525758|NCT01027273|80119337|FG001|Overall Study|Lost to Follow-up|31|||
27525759|NCT01027273|80119336|FG000|Overall Study|Death|2|||
27525760|NCT01027273|80119337|FG001|Overall Study|Death|2|||
27525761|NCT02616601|80119338|FG000|Overall Study|Withdrawal by Subject|4|||
27525762|NCT02616601|80119339|FG001|Overall Study|Withdrawal by Subject|4|||
27525763|NCT02616601|80119340|FG002|Overall Study|Withdrawal by Subject|3|||
27525764|NCT02616601|80119338|FG000|Overall Study|Adverse Event|2|||
27525765|NCT02616601|80119339|FG001|Overall Study|Adverse Event|0|||
27525766|NCT02616601|80119340|FG002|Overall Study|Adverse Event|2|||
27525767|NCT02616601|80119338|FG000|Overall Study|Death|1|||
27525768|NCT02616601|80119339|FG001|Overall Study|Death|0|||
27525769|NCT02616601|80119340|FG002|Overall Study|Death|0|||
27525770|NCT02616601|80119338|FG000|Overall Study|Lost to Follow-up|1|||
27525771|NCT02616601|80119339|FG001|Overall Study|Lost to Follow-up|0|||
27525772|NCT02616601|80119340|FG002|Overall Study|Lost to Follow-up|1|||
27525773|NCT02616601|80119338|FG000|Overall Study|Non-Compliance with Test Article|1|||
27525774|NCT02616601|80119339|FG001|Overall Study|Non-Compliance with Test Article|0|||
27525775|NCT02616601|80119340|FG002|Overall Study|Non-Compliance with Test Article|1|||
27525776|NCT00830869|80119345|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
27525777|NCT00830869|80119346|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
27525778|NCT00830869|80119347|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
27525779|NCT00830869|80119348|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
27525780|NCT00830869|80119349|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
27525781|NCT00830869|80119350|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
27525782|NCT00830869|80119351|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
27525783|NCT00830869|80119352|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
27525784|NCT00830869|80119353|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
27525785|NCT00830869|80119354|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
27525786|NCT00830869|80119355|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
27525787|NCT00830869|80119356|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
27525788|NCT00830869|80119345|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
27525789|NCT00830869|80119346|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
27525790|NCT00830869|80119347|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
27525791|NCT00830869|80119348|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
27525792|NCT00830869|80119349|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
27525793|NCT00830869|80119350|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
27525794|NCT00830869|80119351|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
27525795|NCT00830869|80119352|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
27525796|NCT00830869|80119353|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
27525797|NCT00830869|80119354|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
27525798|NCT00830869|80119355|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
27525799|NCT00830869|80119356|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
27525800|NCT00830869|80119345|FG000|Period 1: Part 1|Adverse Event|0|||
27525801|NCT00830869|80119346|FG001|Period 1: Part 1|Adverse Event|0|||
27525802|NCT00830869|80119347|FG002|Period 1: Part 1|Adverse Event|0|||
27525803|NCT00830869|80119348|FG003|Period 1: Part 1|Adverse Event|0|||
27525804|NCT00830869|80119349|FG004|Period 1: Part 1|Adverse Event|0|||
27525805|NCT00830869|80119350|FG005|Period 1: Part 1|Adverse Event|1|||
27525806|NCT00830869|80119351|FG006|Period 1: Part 1|Adverse Event|1|||
27525807|NCT00830869|80119352|FG007|Period 1: Part 1|Adverse Event|0|||
27525808|NCT00830869|80119353|FG008|Period 1: Part 1|Adverse Event|0|||
27525809|NCT00830869|80119354|FG009|Period 1: Part 1|Adverse Event|0|||
27525810|NCT00830869|80119355|FG010|Period 1: Part 1|Adverse Event|0|||
27525811|NCT00830869|80119356|FG011|Period 1: Part 1|Adverse Event|0|||
27525812|NCT00830869|80119345|FG000|Period 1: Part 1|Progressive disease|1|||
27855766|NCT01831765|81302739|FG001|Overall Study|Adverse Event|3|||
27855767|NCT01831765|81302740|FG002|Overall Study|Adverse Event|3|||
27855768|NCT01831765|81302738|FG000|Overall Study|Withdrawal by Subject|22|||
27855769|NCT01831765|81302739|FG001|Overall Study|Withdrawal by Subject|7|||
27855770|NCT01831765|81302740|FG002|Overall Study|Withdrawal by Subject|17|||
27855771|NCT01831765|81302738|FG000|Overall Study|Withdrawal criteria|12|||
27855772|NCT01831765|81302739|FG001|Overall Study|Withdrawal criteria|10|||
27855773|NCT01831765|81302740|FG002|Overall Study|Withdrawal criteria|16|||
27855774|NCT01831765|81302738|FG000|Overall Study|Lost to Follow-up|2|||
27855775|NCT01831765|81302739|FG001|Overall Study|Lost to Follow-up|3|||
27855776|NCT01831765|81302740|FG002|Overall Study|Lost to Follow-up|3|||
27855777|NCT03127644|81302741|FG000|Overall Study|Study-specific withdrawal criteria|0|||
27855778|NCT03127644|81302742|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27855779|NCT03127644|81302743|FG002|Overall Study|Study-specific withdrawal criteria|2|||
27855780|NCT02923674|81306548|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
27855781|NCT02923674|81306549|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
27855782|NCT02923674|81306550|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
27525813|NCT00830869|80119346|FG001|Period 1: Part 1|Progressive disease|0|||
27525814|NCT00830869|80119347|FG002|Period 1: Part 1|Progressive disease|1|||
27525815|NCT00830869|80119348|FG003|Period 1: Part 1|Progressive disease|6|||
27525816|NCT00830869|80119349|FG004|Period 1: Part 1|Progressive disease|4|||
27525817|NCT00830869|80119350|FG005|Period 1: Part 1|Progressive disease|4|||
27525818|NCT00830869|80119351|FG006|Period 1: Part 1|Progressive disease|1|||
27525819|NCT00830869|80119352|FG007|Period 1: Part 1|Progressive disease|0|||
27525820|NCT00830869|80119353|FG008|Period 1: Part 1|Progressive disease|0|||
27525821|NCT00830869|80119354|FG009|Period 1: Part 1|Progressive disease|0|||
27525822|NCT00830869|80119355|FG010|Period 1: Part 1|Progressive disease|0|||
27525823|NCT00830869|80119356|FG011|Period 1: Part 1|Progressive disease|0|||
27525824|NCT00830869|80119345|FG000|Period 2: Part 2|Protocol Violation|0|||
27525825|NCT00830869|80119346|FG001|Period 2: Part 2|Protocol Violation|0|||
27525826|NCT00830869|80119347|FG002|Period 2: Part 2|Protocol Violation|0|||
27525827|NCT00830869|80119348|FG003|Period 2: Part 2|Protocol Violation|0|||
27525828|NCT00830869|80119349|FG004|Period 2: Part 2|Protocol Violation|0|||
27525829|NCT00830869|80119350|FG005|Period 2: Part 2|Protocol Violation|0|||
27525830|NCT00830869|80119351|FG006|Period 2: Part 2|Protocol Violation|0|||
27525831|NCT00830869|80119352|FG007|Period 2: Part 2|Protocol Violation|1|||
27525832|NCT00830869|80119353|FG008|Period 2: Part 2|Protocol Violation|0|||
27525833|NCT00830869|80119354|FG009|Period 2: Part 2|Protocol Violation|1|||
27525834|NCT00830869|80119355|FG010|Period 2: Part 2|Protocol Violation|0|||
27525835|NCT00830869|80119356|FG011|Period 2: Part 2|Protocol Violation|0|||
27525836|NCT00830869|80119345|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
27525837|NCT00830869|80119346|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
27525838|NCT00830869|80119347|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
27525839|NCT00830869|80119348|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
27525840|NCT00830869|80119349|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
27525841|NCT00830869|80119350|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
27525842|NCT00830869|80119351|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
27525843|NCT00830869|80119352|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
27525844|NCT00830869|80119353|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
27525845|NCT00830869|80119354|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
27525846|NCT00830869|80119355|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
27525847|NCT00830869|80119356|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
27525848|NCT00830869|80119345|FG000|Period 2: Part 2|Adverse Event|0|||
27525849|NCT00830869|80119346|FG001|Period 2: Part 2|Adverse Event|0|||
27525850|NCT00830869|80119347|FG002|Period 2: Part 2|Adverse Event|0|||
27525851|NCT00830869|80119348|FG003|Period 2: Part 2|Adverse Event|0|||
27525852|NCT00830869|80119349|FG004|Period 2: Part 2|Adverse Event|0|||
27525853|NCT00830869|80119350|FG005|Period 2: Part 2|Adverse Event|0|||
27525854|NCT00830869|80119351|FG006|Period 2: Part 2|Adverse Event|0|||
27525855|NCT00830869|80119352|FG007|Period 2: Part 2|Adverse Event|4|||
27525856|NCT00830869|80119353|FG008|Period 2: Part 2|Adverse Event|3|||
27525857|NCT00830869|80119354|FG009|Period 2: Part 2|Adverse Event|2|||
27525858|NCT00830869|80119355|FG010|Period 2: Part 2|Adverse Event|2|||
27525859|NCT00830869|80119356|FG011|Period 2: Part 2|Adverse Event|0|||
27525860|NCT00830869|80119345|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
27525861|NCT00830869|80119346|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
27525862|NCT00830869|80119347|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
27525863|NCT00830869|80119348|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
27525864|NCT00830869|80119349|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
27525865|NCT00830869|80119350|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
27525866|NCT00830869|80119351|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
27525867|NCT00830869|80119352|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
27525868|NCT00830869|80119353|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
27525869|NCT00830869|80119354|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
27525870|NCT00830869|80119355|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
27525871|NCT00830869|80119356|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
27525872|NCT00830869|80119345|FG000|Period 2: Part 2|Progressive disease|0|||
27525873|NCT00830869|80119346|FG001|Period 2: Part 2|Progressive disease|0|||
27525874|NCT00830869|80119347|FG002|Period 2: Part 2|Progressive disease|0|||
27525875|NCT00830869|80119348|FG003|Period 2: Part 2|Progressive disease|0|||
27525876|NCT00830869|80119349|FG004|Period 2: Part 2|Progressive disease|0|||
27525877|NCT00830869|80119350|FG005|Period 2: Part 2|Progressive disease|0|||
27525878|NCT00830869|80119351|FG006|Period 2: Part 2|Progressive disease|0|||
27525879|NCT00830869|80119352|FG007|Period 2: Part 2|Progressive disease|14|||
27525880|NCT00830869|80119353|FG008|Period 2: Part 2|Progressive disease|11|||
27525881|NCT00830869|80119354|FG009|Period 2: Part 2|Progressive disease|12|||
27525882|NCT00830869|80119355|FG010|Period 2: Part 2|Progressive disease|8|||
27525883|NCT00830869|80119356|FG011|Period 2: Part 2|Progressive disease|15|||
27525884|NCT00830869|80119345|FG000|Period 2: Part 2|Other|0|||
27525885|NCT00830869|80119346|FG001|Period 2: Part 2|Other|0|||
27525886|NCT00830869|80119347|FG002|Period 2: Part 2|Other|0|||
27525887|NCT00830869|80119348|FG003|Period 2: Part 2|Other|0|||
27525888|NCT00830869|80119349|FG004|Period 2: Part 2|Other|0|||
27910768|NCT00369343|81510226|FG001|Double-blind Phase|Lack of Efficacy|4|||
27525889|NCT00830869|80119350|FG005|Period 2: Part 2|Other|0|||
27525890|NCT00830869|80119351|FG006|Period 2: Part 2|Other|0|||
27525891|NCT00830869|80119352|FG007|Period 2: Part 2|Other|0|||
27525892|NCT00830869|80119353|FG008|Period 2: Part 2|Other|0|||
27525893|NCT00830869|80119354|FG009|Period 2: Part 2|Other|1|||
27525894|NCT00830869|80119355|FG010|Period 2: Part 2|Other|0|||
27525895|NCT00830869|80119356|FG011|Period 2: Part 2|Other|0|||
27525896|NCT01895361|80119359|FG000|Overall Study|Adverse Event|1|||
27525897|NCT01895361|80119360|FG001|Overall Study|Adverse Event|1|||
27525898|NCT01895361|80119361|FG002|Overall Study|Adverse Event|3|||
27525899|NCT01895361|80119359|FG000|Overall Study|Death|2|||
27525900|NCT01895361|80119360|FG001|Overall Study|Death|1|||
27525901|NCT01895361|80119361|FG002|Overall Study|Death|2|||
27525902|NCT01895361|80119359|FG000|Overall Study|Lost to Follow-up|4|||
27525903|NCT01895361|80119360|FG001|Overall Study|Lost to Follow-up|4|||
27525904|NCT01895361|80119361|FG002|Overall Study|Lost to Follow-up|6|||
27525905|NCT01895361|80119359|FG000|Overall Study|Non-compliance with study|1|||
27525906|NCT01895361|80119360|FG001|Overall Study|Non-compliance with study|3|||
27525907|NCT01895361|80119361|FG002|Overall Study|Non-compliance with study|1|||
27525908|NCT01895361|80119359|FG000|Overall Study|Physician Decision|2|||
27525909|NCT01895361|80119360|FG001|Overall Study|Physician Decision|2|||
27525910|NCT01895361|80119361|FG002|Overall Study|Physician Decision|2|||
27525911|NCT01895361|80119359|FG000|Overall Study|Withdrawal by Subject|7|||
27525912|NCT01895361|80119360|FG001|Overall Study|Withdrawal by Subject|6|||
27525913|NCT01895361|80119361|FG002|Overall Study|Withdrawal by Subject|6|||
27525914|NCT01895361|80119359|FG000|Overall Study|Lack of Efficacy|0|||
27525915|NCT01895361|80119360|FG001|Overall Study|Lack of Efficacy|1|||
27525916|NCT01895361|80119361|FG002|Overall Study|Lack of Efficacy|0|||
27525917|NCT01895361|80119359|FG000|Overall Study|Reasons different from categories above|7|||
27525918|NCT01895361|80119360|FG001|Overall Study|Reasons different from categories above|3|||
27525919|NCT01895361|80119361|FG002|Overall Study|Reasons different from categories above|4|||
27525920|NCT00817479|80119364|FG000|Overall Study|Physician Decision|1|||
27525921|NCT00817479|80119365|FG001|Overall Study|Physician Decision|1|||
27525922|NCT00877773|80119366|FG000|Overall Study|Disease Progression|44|||
27525923|NCT03433339|80119367|FG000|Overall Study|Lost to Follow-up|2|||
27525924|NCT03433339|80119368|FG001|Overall Study|Lost to Follow-up|0|||
27525925|NCT03433339|80119367|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
27525926|NCT03433339|80119368|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
27525927|NCT03433339|80119367|FG000|Overall Study|Withdrawal by Subject|0|||
27525928|NCT03433339|80119368|FG001|Overall Study|Withdrawal by Subject|2|||
27525929|NCT00251004|80119371|FG000|Overall Study|Withdrawal by Subject|23|||
27525930|NCT00251004|80119372|FG001|Overall Study|Withdrawal by Subject|16|||
27525931|NCT00251004|80119373|FG002|Overall Study|Withdrawal by Subject|14|||
27525932|NCT00251004|80119371|FG000|Overall Study|Death|9|||
27525933|NCT00251004|80119372|FG001|Overall Study|Death|10|||
27525934|NCT00251004|80119373|FG002|Overall Study|Death|8|||
27525935|NCT00251004|80119371|FG000|Overall Study|Lost to Follow-up|1|||
27525936|NCT00251004|80119372|FG001|Overall Study|Lost to Follow-up|2|||
27525937|NCT00251004|80119373|FG002|Overall Study|Lost to Follow-up|1|||
27525938|NCT00251004|80119371|FG000|Overall Study|Graft Loss|12|||
27525939|NCT00251004|80119372|FG001|Overall Study|Graft Loss|13|||
27525940|NCT00251004|80119373|FG002|Overall Study|Graft Loss|8|||
27525941|NCT01275339|80119374|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
27525942|NCT01275339|80119375|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
27525943|NCT01275339|80119376|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
27525944|NCT01275339|80119377|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
27525945|NCT01275339|80119374|FG000|Overall Study|Withdrawal by Subject|0|||
27525946|NCT01275339|80119375|FG001|Overall Study|Withdrawal by Subject|0|||
27525947|NCT01275339|80119376|FG002|Overall Study|Withdrawal by Subject|1|||
27525948|NCT01275339|80119377|FG003|Overall Study|Withdrawal by Subject|0|||
27525949|NCT02282345|80119381|FG000|Overall Study|Progression|0|||
27525950|NCT02282345|80119382|FG001|Overall Study|Progression|1|||
27525951|NCT00829283|80119383|FG000|Overall Study|Lost to Follow-up|7|||
27525952|NCT00829283|80119384|FG001|Overall Study|Lost to Follow-up|25|||
27525953|NCT04559529|80119385|FG000|First Intervention (1 Day)|Adverse Event|0|||
27525954|NCT04559529|80119386|FG001|First Intervention (1 Day)|Adverse Event|0|||
27525955|NCT04559529|80119387|FG002|First Intervention (1 Day)|Adverse Event|0|||
27525956|NCT04559529|80119388|FG003|First Intervention (1 Day)|Adverse Event|1|||
27525957|NCT04559529|80119385|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
27525958|NCT04559529|80119386|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
27525959|NCT04559529|80119387|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
27525960|NCT04559529|80119388|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
27525961|NCT04559529|80119385|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
27525962|NCT04559529|80119386|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
27525963|NCT04559529|80119387|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
27525964|NCT04559529|80119388|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
27525965|NCT00134784|80119389|FG000|Overall Study|Withdrawal by Subject|2|||
27525966|NCT00134784|80119390|FG001|Overall Study|Withdrawal by Subject|2|||
27525967|NCT00134784|80119391|FG002|Overall Study|Withdrawal by Subject|2|||
27525968|NCT00134784|80119392|FG003|Overall Study|Withdrawal by Subject|1|||
27525969|NCT03745820|80119396|FG000|Overall Study|Adverse Event|0|||
27525970|NCT03745820|80119397|FG001|Overall Study|Adverse Event|3|||
27855783|NCT02923674|81306548|FG000|Overall Study|Lost to Follow-up|7|||
27525971|NCT03745820|80119398|FG002|Overall Study|Adverse Event|2|||
27525972|NCT03745820|80119396|FG000|Overall Study|Non-Compliance with Study Drug|4|||
27525973|NCT03745820|80119397|FG001|Overall Study|Non-Compliance with Study Drug|3|||
27525974|NCT03745820|80119398|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27622828|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
27622829|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
27622830|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
27622831|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
27622832|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
27622833|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27622834|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27622835|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27622836|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
27622837|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27622838|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27622839|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27622840|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
27622841|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
27622842|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
27622843|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27622844|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27622845|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
27622846|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27622847|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27622848|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
27622849|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
27622850|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
27622851|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
27622852|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
27622853|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
27622854|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
27622855|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
27622856|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
27622857|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
27525975|NCT03745820|80119396|FG000|Overall Study|Withdrawal by Subject|4|||
27525976|NCT03745820|80119397|FG001|Overall Study|Withdrawal by Subject|4|||
27525977|NCT03745820|80119398|FG002|Overall Study|Withdrawal by Subject|4|||
27525978|NCT03745820|80119396|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
27525979|NCT03745820|80119397|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
27525980|NCT03745820|80119398|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
27525981|NCT03745820|80119396|FG000|Overall Study|Lost to Follow-up|2|||
27525982|NCT03745820|80119397|FG001|Overall Study|Lost to Follow-up|0|||
27525983|NCT03745820|80119398|FG002|Overall Study|Lost to Follow-up|3|||
27525984|NCT03745820|80119396|FG000|Overall Study|Reason not Specified|2|||
27525985|NCT03745820|80119397|FG001|Overall Study|Reason not Specified|4|||
27525986|NCT03745820|80119398|FG002|Overall Study|Reason not Specified|1|||
27525987|NCT01423604|80119399|FG000|Safety Run-In|Adverse Event|3|||
27525988|NCT01423604|80119400|FG001|Safety Run-In|Adverse Event|0|||
27525989|NCT01423604|80119399|FG000|Safety Run-In|Death|1|||
27525990|NCT01423604|80119400|FG001|Safety Run-In|Death|0|||
27525991|NCT01423604|80119399|FG000|Safety Run-In|Physician Decision|1|||
27525992|NCT01423604|80119400|FG001|Safety Run-In|Physician Decision|0|||
27525993|NCT01423604|80119399|FG000|Safety Run-In|Disease progression|3|||
27525994|NCT01423604|80119400|FG001|Safety Run-In|Disease progression|0|||
27622858|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
27622859|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
27622860|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
27622861|NCT01089556|80461029|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
27622862|NCT01089556|80461030|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
27622863|NCT01089556|80461031|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
27622864|NCT01089556|80461032|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
27622865|NCT01089556|80461033|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
27622866|NCT01089556|80461034|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
27622867|NCT01555762|80461035|FG000|Overall Study|No information on Bevacizumab intake|11|||
27622868|NCT01555762|80461035|FG000|Overall Study|Missing start date of infusion|8|||
27910769|NCT00369343|81510225|FG000|Double-blind Phase|Protocol deviation|4|||
27910770|NCT00369343|81510226|FG001|Double-blind Phase|Protocol deviation|0|||
27910771|NCT00369343|81510225|FG000|Open-label Phase|Adverse Event|19|||
27525995|NCT01423604|80119399|FG000|Safety Run-In|Patient decision|1|||
27622869|NCT01555762|80461035|FG000|Overall Study|75 years old or more ticked No|1|||
27525996|NCT01423604|80119400|FG001|Safety Run-In|Patient decision|0|||
27525997|NCT01423604|80119399|FG000|Randomized|Adverse Event|4|||
27525998|NCT01423604|80119400|FG001|Randomized|Adverse Event|10|||
27525999|NCT01423604|80119399|FG000|Randomized|Death|1|||
27526000|NCT01423604|80119400|FG001|Randomized|Death|0|||
27526001|NCT01423604|80119399|FG000|Randomized|Physician Decision|16|||
27910772|NCT00369343|81510226|FG001|Open-label Phase|Adverse Event|7|||
27910773|NCT00369343|81510225|FG000|Open-label Phase|Failed to return|4|||
27910774|NCT00369343|81510226|FG001|Open-label Phase|Failed to return|0|||
27910775|NCT00369343|81510225|FG000|Open-label Phase|Physician Decision|2|||
27910776|NCT00369343|81510226|FG001|Open-label Phase|Physician Decision|0|||
27910777|NCT00369343|81510225|FG000|Open-label Phase|Lost to Follow-up|5|||
27910778|NCT00369343|81510226|FG001|Open-label Phase|Lost to Follow-up|3|||
27910779|NCT00369343|81510225|FG000|Open-label Phase|inadvertently reported study completers|3|||
27910780|NCT00369343|81510226|FG001|Open-label Phase|inadvertently reported study completers|2|||
27910781|NCT00369343|81510225|FG000|Open-label Phase|Protocol Violation|1|||
27910782|NCT00369343|81510226|FG001|Open-label Phase|Protocol Violation|3|||
27910783|NCT00369343|81510225|FG000|Open-label Phase|Withdrawal by Subject|15|||
27910784|NCT00369343|81510226|FG001|Open-label Phase|Withdrawal by Subject|6|||
27910785|NCT00369343|81510225|FG000|Open-label Phase|Lack of Efficacy|4|||
27910786|NCT00369343|81510226|FG001|Open-label Phase|Lack of Efficacy|3|||
27910787|NCT00369343|81510225|FG000|Open-label Phase|Lack of continuance tolerability|3|||
27910788|NCT00369343|81510226|FG001|Open-label Phase|Lack of continuance tolerability|4|||
27910789|NCT00369343|81510225|FG000|Open-label Phase|did not take study drug|1|||
27526002|NCT01423604|80119400|FG001|Randomized|Physician Decision|13|||
27526003|NCT01423604|80119399|FG000|Randomized|Other - unspecified|37|||
27526004|NCT01423604|80119400|FG001|Randomized|Other - unspecified|31|||
27526005|NCT01423604|80119399|FG000|Randomized|Patient decision|5|||
27910790|NCT00369343|81510226|FG001|Open-label Phase|did not take study drug|2|||
27910791|NCT01585246|81510227|FG000|Overall Study|Lost to Follow-up|0|||
27910792|NCT01585246|81510228|FG001|Overall Study|Lost to Follow-up|0|||
27910793|NCT01585246|81510229|FG002|Overall Study|Lost to Follow-up|2|||
27910794|NCT01585246|81510230|FG003|Overall Study|Lost to Follow-up|1|||
27526006|NCT01423604|80119400|FG001|Randomized|Patient decision|9|||
27526007|NCT02230527|80119401|FG000|Overall Study|Withdrawal by Subject|1|||
27526008|NCT02230527|80119402|FG001|Overall Study|Withdrawal by Subject|1|||
27526009|NCT02230527|80119401|FG000|Overall Study|Death|1|||
27526010|NCT02230527|80119402|FG001|Overall Study|Death|0|||
27526011|NCT02230527|80119401|FG000|Overall Study|Lost to Follow-up|2|||
27526012|NCT02230527|80119402|FG001|Overall Study|Lost to Follow-up|1|||
27526013|NCT02230527|80119401|FG000|Overall Study|Other|1|||
27526014|NCT02230527|80119402|FG001|Overall Study|Other|0|||
27526015|NCT00783302|80119405|FG000|Overall Study|Lost to Follow-up|17|||
27526016|NCT00783302|80119405|FG000|Overall Study|Technical Problems|11|||
27526017|NCT00783302|80119405|FG000|Overall Study|Protocol Violation|3|||
27526018|NCT00783302|80119405|FG000|Overall Study|Physician Decision|1|||
27526019|NCT00783302|80119405|FG000|Overall Study|Withdrawal by Subject|3|||
27526020|NCT05093790|80119406|FG000|Overall Study|Failure to meet continuation criteria|0|||
27526021|NCT05093790|80119407|FG001|Overall Study|Failure to meet continuation criteria|0|||
27526022|NCT05093790|80119408|FG002|Overall Study|Failure to meet continuation criteria|1|||
27526023|NCT05093790|80119409|FG003|Overall Study|Failure to meet continuation criteria|0|||
27526024|NCT05093790|80119406|FG000|Overall Study|Adverse Event|1|||
27526025|NCT05093790|80119407|FG001|Overall Study|Adverse Event|0|||
27910795|NCT01585246|81510231|FG004|Overall Study|Lost to Follow-up|0|||
27910796|NCT01585246|81510227|FG000|Overall Study|Protocol Violation|0|||
27910797|NCT01585246|81510228|FG001|Overall Study|Protocol Violation|0|||
27910798|NCT01585246|81510229|FG002|Overall Study|Protocol Violation|0|||
27910799|NCT01585246|81510230|FG003|Overall Study|Protocol Violation|0|||
27526026|NCT05093790|80119408|FG002|Overall Study|Adverse Event|0|||
27526027|NCT05093790|80119409|FG003|Overall Study|Adverse Event|0|||
27526028|NCT00706849|80119412|FG000|Treatment Period|Adverse Event|0|||
27526029|NCT00706849|80119413|FG001|Treatment Period|Adverse Event|9|||
27526030|NCT00706849|80119412|FG000|Treatment Period|Other|0|||
27526031|NCT00706849|80119413|FG001|Treatment Period|Other|1|||
27526032|NCT00706849|80119412|FG000|Follow-up Period|Withdrawal by Subject|0|||
27526033|NCT00706849|80119413|FG001|Follow-up Period|Withdrawal by Subject|2|||
27526034|NCT00706849|80119412|FG000|Follow-up Period|Protocol non-compliance|0|||
27526035|NCT00706849|80119413|FG001|Follow-up Period|Protocol non-compliance|1|||
27526036|NCT00137839|80119414|FG000|Overall Study|Adverse Event|7|||
27526037|NCT00137839|80119414|FG000|Overall Study|Physician Decision|7|||
27526038|NCT00137839|80119414|FG000|Overall Study|Death|8|||
27526039|NCT00137839|80119414|FG000|Overall Study|Disease Progression|60|||
27622870|NCT01555762|80461035|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
27526040|NCT00137839|80119414|FG000|Overall Study|Not Start Treatment|1|||
27526041|NCT00137839|80119414|FG000|Overall Study|Prolonged Treatment Delay|1|||
27526042|NCT02478398|80119415|FG000|Overall Study|Adverse Event|20|||
27526043|NCT02478398|80119416|FG001|Overall Study|Adverse Event|5|||
27910800|NCT01585246|81510231|FG004|Overall Study|Protocol Violation|1|||
27526044|NCT02478398|80119415|FG000|Overall Study|Lost to Follow-up|5|||
27526045|NCT02478398|80119416|FG001|Overall Study|Lost to Follow-up|4|||
27526046|NCT02478398|80119415|FG000|Overall Study|Non-Compliance With Study Drug|5|||
27855784|NCT02923674|81306549|FG001|Overall Study|Lost to Follow-up|12|||
27910801|NCT01585246|81510227|FG000|Overall Study|Withdrawal by Subject|0|||
27910802|NCT01585246|81510228|FG001|Overall Study|Withdrawal by Subject|0|||
27526047|NCT02478398|80119416|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27526048|NCT02478398|80119415|FG000|Overall Study|Protocol Violation|3|||
27526049|NCT02478398|80119416|FG001|Overall Study|Protocol Violation|1|||
27526050|NCT02478398|80119415|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
27526051|NCT02478398|80119416|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
27526052|NCT02478398|80119415|FG000|Overall Study|Withdrawal By Participant|10|||
27526053|NCT02478398|80119416|FG001|Overall Study|Withdrawal By Participant|4|||
27526054|NCT05498701|80119422|FG000|Period 3|Adverse Event|1|||
27526055|NCT05498701|80119423|FG001|Period 3|Adverse Event|0|||
27526056|NCT00397943|80119424|FG000|Overall Study|Unspecified reasons|12|||
27526057|NCT00397943|80119425|FG001|Overall Study|Unspecified reasons|9|||
27526058|NCT00397943|80119426|FG002|Overall Study|Unspecified reasons|0|||
27526059|NCT00397943|80119427|FG003|Overall Study|Unspecified reasons|0|||
27526060|NCT00397943|80119428|FG004|Overall Study|Unspecified reasons|0|||
27526061|NCT02652767|80119432|FG000|Overall Study|Death|2|||
27526062|NCT02652767|80119432|FG000|Overall Study|Lost to Follow-up|1|||
27526063|NCT02652767|80119432|FG000|Overall Study|Withdrawal by Subject|1|||
27526064|NCT00384111|80119433|FG000|Overall Study|Disease Progression|3|||
27526065|NCT00384111|80119433|FG000|Overall Study|Adverse Event|1|||
27526066|NCT00384111|80119433|FG000|Overall Study|Investigator Decision|3|||
27526067|NCT00384111|80119433|FG000|Overall Study|Study Terminated by the Sponsor|19|||
27526068|NCT00761150|80119441|FG000|Open-label Period|Adverse Event|36|||
27526069|NCT00761150|80119442|FG001|Open-label Period|Adverse Event|0|||
27526070|NCT00761150|80119443|FG002|Open-label Period|Adverse Event|0|||
27526071|NCT00761150|80119441|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
27526072|NCT00761150|80119442|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
27526073|NCT00761150|80119443|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
27526074|NCT00761150|80119441|FG000|Open-label Period|Lost to Follow-up|7|||
27526075|NCT00761150|80119442|FG001|Open-label Period|Lost to Follow-up|0|||
27526076|NCT00761150|80119443|FG002|Open-label Period|Lost to Follow-up|0|||
27526077|NCT00761150|80119441|FG000|Open-label Period|Lack of Efficacy|4|||
27526078|NCT00761150|80119442|FG001|Open-label Period|Lack of Efficacy|0|||
27733159|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27910803|NCT01585246|81510229|FG002|Overall Study|Withdrawal by Subject|1|||
27622871|NCT01555762|80461035|FG000|Overall Study|Death linked to progression of disease|165|||
27733160|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27733161|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27733162|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27733163|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
27910804|NCT01585246|81510230|FG003|Overall Study|Withdrawal by Subject|2|||
27910805|NCT01585246|81510231|FG004|Overall Study|Withdrawal by Subject|1|||
27910806|NCT01585246|81510227|FG000|Overall Study|Other|0|||
27910807|NCT01585246|81510228|FG001|Overall Study|Other|1|||
27910808|NCT01585246|81510229|FG002|Overall Study|Other|1|||
27910809|NCT01585246|81510230|FG003|Overall Study|Other|1|||
27910810|NCT01585246|81510231|FG004|Overall Study|Other|0|||
27910811|NCT04235504|81510232|FG000|Study Phase|Withdrawal by Subject|5|||
27910812|NCT04235504|81510233|FG001|Study Phase|Withdrawal by Subject|2|||
27910813|NCT04235504|81510234|FG002|Study Phase|Withdrawal by Subject|0|||
27910814|NCT04235504|81510235|FG003|Study Phase|Withdrawal by Subject|0|||
27910815|NCT04235504|81510232|FG000|Continuation Phase|Withdrawal by Subject|0|||
27910816|NCT04235504|81510233|FG001|Continuation Phase|Withdrawal by Subject|4|||
27910817|NCT04235504|81510234|FG002|Continuation Phase|Withdrawal by Subject|0|||
27910818|NCT04235504|81510235|FG003|Continuation Phase|Withdrawal by Subject|0|||
27910819|NCT04235504|81510232|FG000|Continuation Phase|Adverse Event|0|||
27910820|NCT04235504|81510233|FG001|Continuation Phase|Adverse Event|1|||
27910821|NCT04235504|81510234|FG002|Continuation Phase|Adverse Event|0|||
27910822|NCT04235504|81510235|FG003|Continuation Phase|Adverse Event|0|||
27910823|NCT04235504|81510232|FG000|Continuation Phase|Physician Decision|1|||
27910824|NCT04235504|81510233|FG001|Continuation Phase|Physician Decision|2|||
27910825|NCT04235504|81510234|FG002|Continuation Phase|Physician Decision|1|||
27910826|NCT04235504|81510235|FG003|Continuation Phase|Physician Decision|0|||
27910827|NCT04826484|81510241|FG000|Overall Study|Lost to Follow-up|2|||
27910828|NCT04826484|81510242|FG001|Overall Study|Lost to Follow-up|0|||
27910829|NCT00673257|81510245|FG000|Overall Study|Withdrawal by Subject|4|||
27910830|NCT00673257|81510245|FG000|Overall Study|Unable to obtain specimen|1|||
27526079|NCT00761150|80119443|FG002|Open-label Period|Lack of Efficacy|0|||
27526080|NCT00761150|80119441|FG000|Open-label Period|Withdrawal by Subject|5|||
27526081|NCT00761150|80119442|FG001|Open-label Period|Withdrawal by Subject|0|||
27526082|NCT00761150|80119443|FG002|Open-label Period|Withdrawal by Subject|0|||
27910831|NCT05415462|81510259|FG000|Overall Study|Death|18|||
27910832|NCT05415462|81510260|FG001|Overall Study|Death|10|||
27910833|NCT05415462|81510259|FG000|Overall Study|Lost to Follow-up|72|||
27526083|NCT00761150|80119441|FG000|Open-label Period|Noncompliance|2|||
27910834|NCT05415462|81510260|FG001|Overall Study|Lost to Follow-up|64|||
27910835|NCT05415462|81510259|FG000|Overall Study|Physician Decision|5|||
27910836|NCT05415462|81510260|FG001|Overall Study|Physician Decision|5|||
27910837|NCT05415462|81510259|FG000|Overall Study|Protocol Deviation|1|||
27910838|NCT05415462|81510260|FG001|Overall Study|Protocol Deviation|0|||
27910839|NCT05415462|81510259|FG000|Overall Study|Withdrawal by Subject|129|||
27910840|NCT05415462|81510260|FG001|Overall Study|Withdrawal by Subject|101|||
27910841|NCT05415462|81510259|FG000|Overall Study|Other Than Specified|8|||
27910842|NCT05415462|81510260|FG001|Overall Study|Other Than Specified|8|||
27910843|NCT02111174|81510261|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
27910844|NCT02111174|81510262|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
27910845|NCT02111174|81510261|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
27910846|NCT02111174|81510262|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
27910847|NCT02111174|81510261|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
27910848|NCT02111174|81510262|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
27910849|NCT02111174|81510261|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
27910850|NCT02111174|81510262|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
27910851|NCT01465230|81510263|FG000|Overall Study|Withdrawal by Subject|2|||
27910852|NCT01639144|81510271|FG000|Overall Study|Withdrawal by Subject|4|||
27910853|NCT01639144|81510272|FG001|Overall Study|Withdrawal by Subject|2|||
27910854|NCT01639144|81510271|FG000|Overall Study|Physician Decision|2|||
27855785|NCT02923674|81306550|FG002|Overall Study|Lost to Follow-up|7|||
27855786|NCT02923674|81306548|FG000|Overall Study|Problem with intervention|2|||
27855787|NCT02923674|81306549|FG001|Overall Study|Problem with intervention|2|||
27855788|NCT02923674|81306550|FG002|Overall Study|Problem with intervention|1|||
27855789|NCT02923674|81306548|FG000|Overall Study|Adverse Event|3|||
27855790|NCT02923674|81306549|FG001|Overall Study|Adverse Event|1|||
27855791|NCT02923674|81306550|FG002|Overall Study|Adverse Event|1|||
27855792|NCT02923674|81306548|FG000|Overall Study|Withdrawal by Subject|2|||
27855793|NCT02923674|81306549|FG001|Overall Study|Withdrawal by Subject|2|||
27855794|NCT02923674|81306550|FG002|Overall Study|Withdrawal by Subject|2|||
27855795|NCT03400943|81306553|FG000|Treatment Period 1|Adverse Event|0|||
27855796|NCT03400943|81306554|FG001|Treatment Period 1|Adverse Event|0|||
27855797|NCT03400943|81306555|FG002|Treatment Period 1|Adverse Event|0|||
27855798|NCT03400943|81306556|FG003|Treatment Period 1|Adverse Event|1|||
27855799|NCT03400943|81306553|FG000|Treatment Period 1|Lost to Follow-up|1|||
27855800|NCT03400943|81306554|FG001|Treatment Period 1|Lost to Follow-up|0|||
27855801|NCT03400943|81306555|FG002|Treatment Period 1|Lost to Follow-up|0|||
27855802|NCT03400943|81306556|FG003|Treatment Period 1|Lost to Follow-up|0|||
27855803|NCT03400943|81306553|FG000|Treatment Period 1|Protocol Violation|0|||
27855804|NCT03400943|81306554|FG001|Treatment Period 1|Protocol Violation|1|||
27855805|NCT03400943|81306555|FG002|Treatment Period 1|Protocol Violation|1|||
27855806|NCT03400943|81306556|FG003|Treatment Period 1|Protocol Violation|0|||
27910855|NCT01639144|81510272|FG001|Overall Study|Physician Decision|0|||
27910856|NCT01639144|81510271|FG000|Overall Study|Met postoperative exclusion criteria|4|||
27910857|NCT01639144|81510272|FG001|Overall Study|Met postoperative exclusion criteria|3|||
27910858|NCT00943397|81510277|FG000|Overall Study|Adverse Event|0|||
27910859|NCT00943397|81510278|FG001|Overall Study|Adverse Event|6|||
27910860|NCT00943397|81510277|FG000|Overall Study|Lost to Follow-up|0|||
27910861|NCT00943397|81510278|FG001|Overall Study|Lost to Follow-up|4|||
27910862|NCT00943397|81510277|FG000|Overall Study|Protocol Violation|2|||
27910863|NCT00943397|81510278|FG001|Overall Study|Protocol Violation|5|||
27910864|NCT00943397|81510277|FG000|Overall Study|Withdrawal by Subject|1|||
27910865|NCT00943397|81510278|FG001|Overall Study|Withdrawal by Subject|1|||
27910866|NCT00943397|81510277|FG000|Overall Study|Site terminated and other|12|||
27910867|NCT00943397|81510278|FG001|Overall Study|Site terminated and other|56|||
27526084|NCT00761150|80119442|FG001|Open-label Period|Noncompliance|0|||
27526085|NCT00761150|80119443|FG002|Open-label Period|Noncompliance|0|||
27526086|NCT00761150|80119441|FG000|Open-label Period|Other|5|||
27526087|NCT00761150|80119442|FG001|Open-label Period|Other|0|||
27526088|NCT00761150|80119443|FG002|Open-label Period|Other|0|||
27526089|NCT00761150|80119441|FG000|Double-blind Period|Lack of Efficacy|0|||
27526090|NCT00761150|80119442|FG001|Double-blind Period|Lack of Efficacy|2|||
27526091|NCT00761150|80119443|FG002|Double-blind Period|Lack of Efficacy|19|||
27526092|NCT00761150|80119441|FG000|Double-blind Period|Adverse Event|0|||
27855807|NCT03400943|81306553|FG000|Treatment Period 1|Study terminated by sponsor|2|||
27855808|NCT03400943|81306554|FG001|Treatment Period 1|Study terminated by sponsor|0|||
27910868|NCT00758498|81510279|FG000|Overall Study|Adverse Event|2|||
27910869|NCT00758498|81510280|FG001|Overall Study|Adverse Event|2|||
27910870|NCT00758498|81510281|FG002|Overall Study|Adverse Event|3|||
27910871|NCT00758498|81510279|FG000|Overall Study|Subject legally detained out of state|1|||
27910872|NCT00758498|81510280|FG001|Overall Study|Subject legally detained out of state|0|||
27910873|NCT00758498|81510281|FG002|Overall Study|Subject legally detained out of state|0|||
27910874|NCT00758498|81510279|FG000|Overall Study|Withdrawal by Subject|0|||
27910875|NCT00758498|81510280|FG001|Overall Study|Withdrawal by Subject|0|||
27526093|NCT00761150|80119442|FG001|Double-blind Period|Adverse Event|3|||
27855809|NCT03400943|81306555|FG002|Treatment Period 1|Study terminated by sponsor|0|||
27855810|NCT03400943|81306556|FG003|Treatment Period 1|Study terminated by sponsor|1|||
27622872|NCT01555762|80461035|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
27622873|NCT01555762|80461035|FG000|Overall Study|Investigator's decision|10|||
27622874|NCT01555762|80461035|FG000|Overall Study|Participant not wishing to continue|5|||
27622875|NCT01555762|80461035|FG000|Overall Study|Missing data|1|||
27622876|NCT01555762|80461035|FG000|Overall Study|Death linked to an adverse event|14|||
27622877|NCT00551213|80461036|FG000|Overall Study|Adverse Event|6|||
27622878|NCT00551213|80461037|FG001|Overall Study|Adverse Event|3|||
27622879|NCT00551213|80461036|FG000|Overall Study|Progressive Disease|41|||
27622880|NCT00551213|80461037|FG001|Overall Study|Progressive Disease|12|||
27622881|NCT00551213|80461036|FG000|Overall Study|Withdrawal by Subject|2|||
27622882|NCT00551213|80461037|FG001|Overall Study|Withdrawal by Subject|0|||
27622883|NCT00551213|80461036|FG000|Overall Study|Not Treated|1|||
27622884|NCT00551213|80461037|FG001|Overall Study|Not Treated|2|||
27622885|NCT00465361|80461038|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
27622886|NCT05233085|80461041|FG000|Overall Study|Adverse Event|1|||
27622887|NCT05233085|80461042|FG001|Overall Study|Adverse Event|0|||
27622888|NCT05233085|80461043|FG002|Overall Study|Adverse Event|0|||
27622889|NCT05233085|80461044|FG003|Overall Study|Adverse Event|0|||
27733164|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
27855811|NCT03400943|81306553|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27855812|NCT03400943|81306554|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27855813|NCT03400943|81306555|FG002|Treatment Period 1|Withdrawal by Subject|3|||
27855814|NCT03400943|81306556|FG003|Treatment Period 1|Withdrawal by Subject|1|||
27855815|NCT03400943|81306553|FG000|Treatment Period 1|Other|2|||
27855816|NCT03400943|81306554|FG001|Treatment Period 1|Other|1|||
27855817|NCT03400943|81306555|FG002|Treatment Period 1|Other|2|||
27855818|NCT03400943|81306556|FG003|Treatment Period 1|Other|2|||
27855819|NCT03400943|81306553|FG000|Post-treatment Period 1|Adverse Event|2|||
27855820|NCT03400943|81306554|FG001|Post-treatment Period 1|Adverse Event|0|||
27855821|NCT03400943|81306555|FG002|Post-treatment Period 1|Adverse Event|0|||
27855822|NCT03400943|81306556|FG003|Post-treatment Period 1|Adverse Event|0|||
27855823|NCT03400943|81306553|FG000|Post-treatment Period 1|Protocol Violation|1|||
27855824|NCT03400943|81306554|FG001|Post-treatment Period 1|Protocol Violation|0|||
27855825|NCT03400943|81306555|FG002|Post-treatment Period 1|Protocol Violation|0|||
27855826|NCT03400943|81306556|FG003|Post-treatment Period 1|Protocol Violation|0|||
27855827|NCT03400943|81306553|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
27855828|NCT03400943|81306554|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
27855829|NCT03400943|81306555|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
27855830|NCT03400943|81306556|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
27855831|NCT03400943|81306553|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
27855832|NCT03400943|81306554|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
27855833|NCT03400943|81306555|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
27855834|NCT03400943|81306556|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
27855835|NCT03400943|81306553|FG000|Post-treatment Period 1|Other|2|||
27855836|NCT03400943|81306554|FG001|Post-treatment Period 1|Other|0|||
27855837|NCT03400943|81306555|FG002|Post-treatment Period 1|Other|4|||
27855838|NCT03400943|81306556|FG003|Post-treatment Period 1|Other|5|||
27855839|NCT03400943|81306553|FG000|Treatment Period 2|Study terminated by sponsor|0|||
27855840|NCT03400943|81306554|FG001|Treatment Period 2|Study terminated by sponsor|1|||
27855841|NCT03400943|81306555|FG002|Treatment Period 2|Study terminated by sponsor|0|||
27855842|NCT03400943|81306556|FG003|Treatment Period 2|Study terminated by sponsor|0|||
27526094|NCT00761150|80119443|FG002|Double-blind Period|Adverse Event|3|||
27526095|NCT00761150|80119441|FG000|Double-blind Period|Withdrawal by Subject|0|||
27526096|NCT00761150|80119442|FG001|Double-blind Period|Withdrawal by Subject|3|||
27526097|NCT00761150|80119443|FG002|Double-blind Period|Withdrawal by Subject|2|||
27526098|NCT00761150|80119441|FG000|Double-blind Period|Lost to Follow-up|0|||
27526099|NCT00761150|80119442|FG001|Double-blind Period|Lost to Follow-up|2|||
27526100|NCT00761150|80119443|FG002|Double-blind Period|Lost to Follow-up|1|||
27526101|NCT00761150|80119441|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
27526102|NCT00761150|80119442|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
27526103|NCT00761150|80119443|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
27526104|NCT00761150|80119441|FG000|Double-blind Period|Noncompliance|0|||
27526105|NCT00761150|80119442|FG001|Double-blind Period|Noncompliance|1|||
27526106|NCT00761150|80119443|FG002|Double-blind Period|Noncompliance|0|||
27526107|NCT00761150|80119441|FG000|Double-blind Period|Other|0|||
27526108|NCT00761150|80119442|FG001|Double-blind Period|Other|3|||
27526109|NCT00761150|80119443|FG002|Double-blind Period|Other|3|||
27622890|NCT00724061|80461051|FG000|Dose Escalation Phase|Adverse Event|2|||
27622891|NCT00724061|80461051|FG000|Dose Escalation Phase|Disease Progression|3|||
27855843|NCT03400943|81306553|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27622892|NCT02851511|80461057|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
27622893|NCT02851511|80461058|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
27622894|NCT02851511|80461059|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
27622895|NCT02851511|80461060|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
27526110|NCT00321893|80119444|FG000|Overall Study|Non-Compliance/Refusal|16|||
27910876|NCT00758498|81510281|FG002|Overall Study|Withdrawal by Subject|1|||
27910877|NCT00758498|81510279|FG000|Overall Study|Noncompliance to study procedures|0|||
27910878|NCT00758498|81510280|FG001|Overall Study|Noncompliance to study procedures|0|||
27910879|NCT00758498|81510281|FG002|Overall Study|Noncompliance to study procedures|1|||
27910880|NCT02542397|81510283|FG000|Overall Study|Death|2|||
27910881|NCT02542397|81510283|FG000|Overall Study|Physician Decision|6|||
27910882|NCT02542397|81510283|FG000|Overall Study|Withdrawal by Subject|6|||
27855844|NCT03400943|81306554|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27855845|NCT03400943|81306555|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27855846|NCT03400943|81306556|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27855847|NCT03400943|81306553|FG000|Treatment Period 2|Other|1|||
27622896|NCT02851511|80461057|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
27622897|NCT02851511|80461058|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
27622898|NCT02851511|80461059|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
27622899|NCT02851511|80461060|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
27622900|NCT02851511|80461057|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
27622901|NCT02851511|80461058|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
27622902|NCT02851511|80461059|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
27622903|NCT02851511|80461060|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
27622904|NCT02851511|80461057|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
27622905|NCT02851511|80461058|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
27622906|NCT02851511|80461059|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
27622907|NCT02851511|80461060|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
27622908|NCT02851511|80461057|FG000|Phase I|Physician Decision|0|||
27733165|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
27733166|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27733167|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27855848|NCT03400943|81306554|FG001|Treatment Period 2|Other|6|||
27733168|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27733169|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27733170|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27733171|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27733172|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733173|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733174|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
27733175|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733176|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733177|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733178|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733179|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733180|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27733181|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
27733182|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27733183|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
27733184|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27733185|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27733186|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27733187|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27733188|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27733189|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27733190|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27733191|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733192|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733193|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733194|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733195|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733196|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733197|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27733198|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27855849|NCT03400943|81306555|FG002|Treatment Period 2|Other|0|||
27855850|NCT03400943|81306556|FG003|Treatment Period 2|Other|0|||
27855851|NCT03400943|81306553|FG000|Follow-up Period|Withdrawal by Subject|1|||
27910883|NCT02542397|81510283|FG000|Overall Study|Lost to Follow-up|2|||
27910884|NCT05227118|81510284|FG000|Overall Study|Adverse Event|0|||
27910885|NCT05227118|81510285|FG001|Overall Study|Adverse Event|0|||
27622909|NCT02851511|80461058|FG001|Phase I|Physician Decision|0|||
27622910|NCT02851511|80461059|FG002|Phase I|Physician Decision|0|||
27855852|NCT03400943|81306554|FG001|Follow-up Period|Withdrawal by Subject|0|||
27855853|NCT03400943|81306555|FG002|Follow-up Period|Withdrawal by Subject|0|||
27855854|NCT03400943|81306556|FG003|Follow-up Period|Withdrawal by Subject|0|||
27855855|NCT03255655|81306559|FG000|Overall Study|Lost to Follow-up|7|||
27855856|NCT03255655|81306560|FG001|Overall Study|Lost to Follow-up|4|||
27855857|NCT00706095|81306561|FG000|Overall Study|Progressive Disease|4|||
27855858|NCT00706095|81306562|FG001|Overall Study|Progressive Disease|5|||
27855859|NCT00706095|81306563|FG002|Overall Study|Progressive Disease|3|||
27855860|NCT00706095|81306561|FG000|Overall Study|Clinical Progression|1|||
27855861|NCT00706095|81306562|FG001|Overall Study|Clinical Progression|2|||
27855862|NCT00706095|81306563|FG002|Overall Study|Clinical Progression|2|||
27855863|NCT00706095|81306561|FG000|Overall Study|Withdrawal by Subject|1|||
27855864|NCT00706095|81306562|FG001|Overall Study|Withdrawal by Subject|0|||
27733199|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
27855865|NCT00706095|81306563|FG002|Overall Study|Withdrawal by Subject|0|||
27910886|NCT05227118|81510286|FG002|Overall Study|Adverse Event|1|||
27910887|NCT05227118|81510287|FG003|Overall Study|Adverse Event|0|||
27526111|NCT00321893|80119445|FG001|Overall Study|Non-Compliance/Refusal|10|||
27733200|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
27733201|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733202|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733203|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733204|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733205|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733206|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733207|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27733208|NCT01307423|80849930|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27733209|NCT01307423|80849931|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
27733210|NCT01307423|80849932|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
27526112|NCT00321893|80119444|FG000|Overall Study|Lost to Follow-up|2|||
27526113|NCT00321893|80119445|FG001|Overall Study|Lost to Follow-up|1|||
27526114|NCT00321893|80119444|FG000|Overall Study|Adverse Event|6|||
27526115|NCT00321893|80119445|FG001|Overall Study|Adverse Event|3|||
27526116|NCT02486627|80119446|FG000|Overall Study|Death|1|||
27526117|NCT02486627|80119447|FG001|Overall Study|Death|0|||
27526118|NCT02486627|80119446|FG000|Overall Study|Other Unspecified|0|||
27526119|NCT02486627|80119447|FG001|Overall Study|Other Unspecified|2|||
27526120|NCT02486627|80119446|FG000|Overall Study|Consent Withdrawn by Participant|4|||
27526121|NCT02486627|80119447|FG001|Overall Study|Consent Withdrawn by Participant|3|||
27526122|NCT02486627|80119446|FG000|Overall Study|Significant Participant Noncompliance|1|||
27526123|NCT02486627|80119447|FG001|Overall Study|Significant Participant Noncompliance|1|||
27526124|NCT02486627|80119446|FG000|Overall Study|Lost to Follow-up|1|||
27526125|NCT02486627|80119447|FG001|Overall Study|Lost to Follow-up|3|||
27526126|NCT01574079|80119451|FG000|Overall Study|Physician Decision|0|||
27526127|NCT01574079|80119452|FG001|Overall Study|Physician Decision|2|||
27526128|NCT01574079|80119451|FG000|Overall Study|Lost to Follow-up|1|||
27526129|NCT01574079|80119452|FG001|Overall Study|Lost to Follow-up|0|||
27526130|NCT01606878|80119456|FG000|Overall Study|Adverse Event|1|||
27526131|NCT01606878|80119457|FG001|Overall Study|Adverse Event|1|||
27526132|NCT01606878|80119458|FG002|Overall Study|Adverse Event|0|||
27526133|NCT01606878|80119459|FG003|Overall Study|Adverse Event|0|||
27526134|NCT01606878|80119460|FG004|Overall Study|Adverse Event|0|||
27526135|NCT01606878|80119461|FG005|Overall Study|Adverse Event|0|||
27526136|NCT01606878|80119462|FG006|Overall Study|Adverse Event|1|||
27526137|NCT01606878|80119463|FG007|Overall Study|Adverse Event|0|||
27526138|NCT01606878|80119464|FG008|Overall Study|Adverse Event|1|||
27526139|NCT01606878|80119465|FG009|Overall Study|Adverse Event|3|||
27526140|NCT01606878|80119466|FG010|Overall Study|Adverse Event|0|||
27526141|NCT01606878|80119456|FG000|Overall Study|Lack of Efficacy|1|||
27526142|NCT01606878|80119457|FG001|Overall Study|Lack of Efficacy|1|||
27733211|NCT01307423|80849933|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27855866|NCT01868893|81306567|FG000|Overall Study|Adverse Event|2|||
27855867|NCT01868893|81306567|FG000|Overall Study|Commercial availability of study drug|17|||
27855868|NCT01868893|81306567|FG000|Overall Study|Neutropenia|1|||
27855869|NCT01167257|81306570|FG000|Overall Study|Lost to Follow-up|2|||
27910888|NCT05227118|81510284|FG000|Overall Study|Withdrawal by Subject|0|||
27526143|NCT01606878|80119458|FG002|Overall Study|Lack of Efficacy|1|||
27526144|NCT01606878|80119459|FG003|Overall Study|Lack of Efficacy|2|||
27526145|NCT01606878|80119460|FG004|Overall Study|Lack of Efficacy|1|||
27526146|NCT01606878|80119461|FG005|Overall Study|Lack of Efficacy|2|||
27526147|NCT01606878|80119462|FG006|Overall Study|Lack of Efficacy|1|||
27526148|NCT01606878|80119463|FG007|Overall Study|Lack of Efficacy|2|||
27526149|NCT01606878|80119464|FG008|Overall Study|Lack of Efficacy|2|||
27526150|NCT01606878|80119465|FG009|Overall Study|Lack of Efficacy|0|||
27526151|NCT01606878|80119466|FG010|Overall Study|Lack of Efficacy|1|||
27733212|NCT01307423|80849934|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27855870|NCT01167257|81306571|FG001|Overall Study|Lost to Follow-up|2|||
27855871|NCT01167257|81306570|FG000|Overall Study|Withdrew consent|1|||
27855872|NCT01167257|81306571|FG001|Overall Study|Withdrew consent|1|||
27855873|NCT03837743|81306572|FG000|Overall Study|Adverse Event|1|||
27855874|NCT03837743|81306572|FG000|Overall Study|Withdrawal by Subject|2|||
27855875|NCT00259272|81306575|FG000|Overall Study|Adverse Event|2|||
27855876|NCT00259272|81306576|FG001|Overall Study|Adverse Event|1|||
27855877|NCT00259272|81306577|FG002|Overall Study|Adverse Event|0|||
27855878|NCT00259272|81306578|FG003|Overall Study|Adverse Event|3|||
27855879|NCT00259272|81306575|FG000|Overall Study|Lack of Efficacy|5|||
27855880|NCT00259272|81306576|FG001|Overall Study|Lack of Efficacy|1|||
27855881|NCT00259272|81306577|FG002|Overall Study|Lack of Efficacy|2|||
27855882|NCT00259272|81306578|FG003|Overall Study|Lack of Efficacy|6|||
27910889|NCT05227118|81510285|FG001|Overall Study|Withdrawal by Subject|0|||
27910890|NCT05227118|81510286|FG002|Overall Study|Withdrawal by Subject|2|||
27910891|NCT05227118|81510287|FG003|Overall Study|Withdrawal by Subject|0|||
27910892|NCT02090283|81510288|FG000|Overall Study|Withdrawal by Subject|6|||
27910893|NCT02090283|81510289|FG001|Overall Study|Withdrawal by Subject|6|||
27910894|NCT02090283|81510290|FG002|Overall Study|Withdrawal by Subject|6|||
27910895|NCT02090283|81510288|FG000|Overall Study|Sponsor Terminated Study|6|||
27910896|NCT02090283|81510289|FG001|Overall Study|Sponsor Terminated Study|6|||
27910897|NCT02090283|81510290|FG002|Overall Study|Sponsor Terminated Study|1|||
27910898|NCT02090283|81510288|FG000|Overall Study|Lost to Follow-up|2|||
27910899|NCT02090283|81510289|FG001|Overall Study|Lost to Follow-up|2|||
27910900|NCT02090283|81510290|FG002|Overall Study|Lost to Follow-up|3|||
27910901|NCT02090283|81510288|FG000|Overall Study|Adverse Event|1|||
27910902|NCT02090283|81510289|FG001|Overall Study|Adverse Event|1|||
27910903|NCT02090283|81510290|FG002|Overall Study|Adverse Event|0|||
27910904|NCT02090283|81510288|FG000|Overall Study|Protocol Violation|2|||
27910905|NCT02090283|81510289|FG001|Overall Study|Protocol Violation|0|||
27910906|NCT02090283|81510290|FG002|Overall Study|Protocol Violation|0|||
27910907|NCT00837967|81513439|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
27910908|NCT00837967|81513440|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
27910909|NCT02472886|81513442|FG000|Overall Study|Lack of Efficacy|0|||
27910910|NCT02472886|81513443|FG001|Overall Study|Lack of Efficacy|2|||
27910911|NCT02472886|81513444|FG002|Overall Study|Lack of Efficacy|1|||
27910912|NCT01435759|81513445|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
27910913|NCT01435759|81513446|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
27910914|NCT01435759|81513447|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
27910915|NCT01435759|81513448|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
27910916|NCT01435759|81513449|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
27910917|NCT01435759|81513450|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
27910918|NCT01435759|81513445|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
27910919|NCT01435759|81513446|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
27910920|NCT01435759|81513447|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
27910921|NCT01435759|81513448|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
27910922|NCT01435759|81513449|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
27910923|NCT01435759|81513450|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
27910924|NCT01435759|81513445|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
27910925|NCT01435759|81513446|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27910926|NCT01435759|81513447|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27910927|NCT01435759|81513448|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27910928|NCT01435759|81513449|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27910929|NCT01435759|81513450|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
27910930|NCT01435759|81513445|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
27910931|NCT01435759|81513446|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27910932|NCT01435759|81513447|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27910933|NCT01435759|81513448|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27910934|NCT01435759|81513449|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27526152|NCT01606878|80119456|FG000|Overall Study|Physician Decision|1|||
27855883|NCT00259272|81306575|FG000|Overall Study|Physician Decision|1|||
27910935|NCT01435759|81513450|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
27910936|NCT01435759|81513445|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
27910937|NCT01435759|81513446|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910938|NCT01435759|81513447|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910939|NCT01435759|81513448|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910940|NCT01435759|81513449|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910941|NCT01435759|81513450|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
27526153|NCT01606878|80119457|FG001|Overall Study|Physician Decision|0|||
27855884|NCT00259272|81306576|FG001|Overall Study|Physician Decision|2|||
27910942|NCT01435759|81513445|FG000|Antidepressant Lead-in Phase|Other|119|||
27910943|NCT01435759|81513446|FG001|Antidepressant Lead-in Phase|Other|0|||
27526154|NCT01606878|80119458|FG002|Overall Study|Physician Decision|2|||
27910944|NCT01435759|81513447|FG002|Antidepressant Lead-in Phase|Other|0|||
27910945|NCT01435759|81513448|FG003|Antidepressant Lead-in Phase|Other|0|||
27910946|NCT01435759|81513449|FG004|Antidepressant Lead-in Phase|Other|0|||
27910947|NCT01435759|81513450|FG005|Antidepressant Lead-in Phase|Other|0|||
27910948|NCT01435759|81513445|FG000|Double-blind Phase|Adverse Event|7|||
27910949|NCT01435759|81513446|FG001|Double-blind Phase|Adverse Event|0|||
27910950|NCT01435759|81513447|FG002|Double-blind Phase|Adverse Event|1|||
27910951|NCT01435759|81513448|FG003|Double-blind Phase|Adverse Event|1|||
27910952|NCT01435759|81513449|FG004|Double-blind Phase|Adverse Event|1|||
27910953|NCT01435759|81513450|FG005|Double-blind Phase|Adverse Event|3|||
27910954|NCT01435759|81513445|FG000|Double-blind Phase|Protocol Violation|2|||
27910955|NCT01435759|81513446|FG001|Double-blind Phase|Protocol Violation|0|||
27910956|NCT01435759|81513447|FG002|Double-blind Phase|Protocol Violation|1|||
27910957|NCT01435759|81513448|FG003|Double-blind Phase|Protocol Violation|2|||
27910958|NCT01435759|81513449|FG004|Double-blind Phase|Protocol Violation|0|||
27910959|NCT01435759|81513450|FG005|Double-blind Phase|Protocol Violation|1|||
27910960|NCT01435759|81513445|FG000|Double-blind Phase|Withdrawal by Subject|17|||
27910961|NCT01435759|81513446|FG001|Double-blind Phase|Withdrawal by Subject|4|||
27910962|NCT01435759|81513447|FG002|Double-blind Phase|Withdrawal by Subject|3|||
27910963|NCT01435759|81513448|FG003|Double-blind Phase|Withdrawal by Subject|4|||
27910964|NCT01435759|81513449|FG004|Double-blind Phase|Withdrawal by Subject|2|||
27910965|NCT01435759|81513450|FG005|Double-blind Phase|Withdrawal by Subject|2|||
27910966|NCT01435759|81513445|FG000|Double-blind Phase|Lost to Follow-up|31|||
27910967|NCT01435759|81513446|FG001|Double-blind Phase|Lost to Follow-up|1|||
27910968|NCT01435759|81513447|FG002|Double-blind Phase|Lost to Follow-up|2|||
27910969|NCT01435759|81513448|FG003|Double-blind Phase|Lost to Follow-up|0|||
27910970|NCT01435759|81513449|FG004|Double-blind Phase|Lost to Follow-up|3|||
27910971|NCT01435759|81513450|FG005|Double-blind Phase|Lost to Follow-up|3|||
27910972|NCT01435759|81513445|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
27910973|NCT01435759|81513446|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910974|NCT01435759|81513447|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910975|NCT01435759|81513448|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27910976|NCT01435759|81513449|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
27526155|NCT01606878|80119459|FG003|Overall Study|Physician Decision|1|||
27526156|NCT01606878|80119460|FG004|Overall Study|Physician Decision|1|||
27526157|NCT01606878|80119461|FG005|Overall Study|Physician Decision|1|||
27526158|NCT01606878|80119462|FG006|Overall Study|Physician Decision|2|||
27526159|NCT01606878|80119463|FG007|Overall Study|Physician Decision|0|||
27526160|NCT01606878|80119464|FG008|Overall Study|Physician Decision|1|||
27526161|NCT01606878|80119465|FG009|Overall Study|Physician Decision|0|||
27526162|NCT01606878|80119466|FG010|Overall Study|Physician Decision|0|||
27526163|NCT01606878|80119456|FG000|Overall Study|Withdrawal by Subject|3|||
27526164|NCT01606878|80119457|FG001|Overall Study|Withdrawal by Subject|2|||
27526165|NCT01606878|80119458|FG002|Overall Study|Withdrawal by Subject|2|||
27526166|NCT01606878|80119459|FG003|Overall Study|Withdrawal by Subject|0|||
27526167|NCT01606878|80119460|FG004|Overall Study|Withdrawal by Subject|1|||
27526168|NCT01606878|80119461|FG005|Overall Study|Withdrawal by Subject|1|||
27526169|NCT01606878|80119462|FG006|Overall Study|Withdrawal by Subject|2|||
27526170|NCT01606878|80119463|FG007|Overall Study|Withdrawal by Subject|1|||
27526171|NCT01606878|80119464|FG008|Overall Study|Withdrawal by Subject|2|||
27526172|NCT01606878|80119465|FG009|Overall Study|Withdrawal by Subject|0|||
27526173|NCT01606878|80119466|FG010|Overall Study|Withdrawal by Subject|2|||
27526174|NCT01551420|80119467|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
27526175|NCT01551420|80119468|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
27526176|NCT01551420|80119467|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
27526177|NCT01551420|80119468|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
27526178|NCT01551420|80119467|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
27526179|NCT01551420|80119468|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
27526180|NCT01551420|80119467|FG000|Screened for Part B Eligibility|Declined participation|8|||
27526181|NCT01551420|80119468|FG001|Screened for Part B Eligibility|Declined participation|1|||
27526182|NCT01551420|80119467|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
27526183|NCT01551420|80119468|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
27910977|NCT01435759|81513450|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
27526184|NCT01551420|80119467|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
27526185|NCT01551420|80119468|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
27526186|NCT01551420|80119467|FG000|Home Use (Part B)|Withdrawal by staff|0|||
27526187|NCT01551420|80119468|FG001|Home Use (Part B)|Withdrawal by staff|1|||
27526188|NCT04738318|80119469|FG000|Overall Study|Protocol Violation|1|||
27526189|NCT04738318|80119470|FG001|Overall Study|Protocol Violation|0|||
27526190|NCT04761627|80119471|FG000|Run-in Period|Death|1|||
27910978|NCT01435759|81513445|FG000|Double-blind Phase|Other|8|||
27910979|NCT01435759|81513446|FG001|Double-blind Phase|Other|2|||
27910980|NCT01435759|81513447|FG002|Double-blind Phase|Other|0|||
27910981|NCT01435759|81513448|FG003|Double-blind Phase|Other|2|||
27910982|NCT01435759|81513449|FG004|Double-blind Phase|Other|0|||
27910983|NCT01435759|81513450|FG005|Double-blind Phase|Other|0|||
27910984|NCT00571662|81513459|FG000|Overall Study|Withdrawal by Subject|2|||
27910985|NCT00571662|81513459|FG000|Overall Study|psychiatric instability|1|||
27910986|NCT00571662|81513459|FG000|Overall Study|Adverse Event|5|||
27910987|NCT02007720|81513460|FG000|Overall Study|Withdrawal by Subject|9|||
27910988|NCT02007720|81513461|FG001|Overall Study|Withdrawal by Subject|11|||
27910989|NCT02007720|81513460|FG000|Overall Study|study terminated by sponsor|58|||
27910990|NCT02007720|81513461|FG001|Overall Study|study terminated by sponsor|54|||
27910991|NCT02007720|81513460|FG000|Overall Study|technical problem|4|||
27910992|NCT02007720|81513461|FG001|Overall Study|technical problem|2|||
27910993|NCT02007720|81513460|FG000|Overall Study|patient followd less than 165 days|11|||
27910994|NCT02007720|81513461|FG001|Overall Study|patient followd less than 165 days|5|||
27910995|NCT01249417|81513468|FG000|Randomised Population|Study treatment not received|0|||
27910996|NCT01249417|81513469|FG001|Randomised Population|Study treatment not received|0|||
27910997|NCT01249417|81513470|FG002|Randomised Population|Study treatment not received|2|||
27910998|NCT01249417|81513468|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
27910999|NCT01249417|81513469|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
27911000|NCT01249417|81513470|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
27911001|NCT01249417|81513468|FG000|Treatment Phase - ITT Population|Other|0|||
27911002|NCT01249417|81513469|FG001|Treatment Phase - ITT Population|Other|0|||
27911003|NCT01249417|81513470|FG002|Treatment Phase - ITT Population|Other|1|||
27911004|NCT01249417|81513468|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
27911005|NCT01249417|81513469|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
27911006|NCT01249417|81513470|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
27911007|NCT01249417|81513468|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
27911008|NCT01249417|81513469|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
27911009|NCT01249417|81513470|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
27911010|NCT01249417|81513468|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
27911011|NCT01249417|81513469|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
27911012|NCT01249417|81513470|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
27911013|NCT03654729|81513474|FG000|Overall Study|Death|9|||
27911014|NCT03654729|81513475|FG001|Overall Study|Death|9|||
27911015|NCT03654729|81513476|FG002|Overall Study|Death|16|||
27911016|NCT03654729|81513474|FG000|Overall Study|Withdrawal by Subject|8|||
27911017|NCT03654729|81513475|FG001|Overall Study|Withdrawal by Subject|6|||
27911018|NCT03654729|81513476|FG002|Overall Study|Withdrawal by Subject|4|||
27911019|NCT03654729|81513474|FG000|Overall Study|Study terminated by Sponsor|3|||
27911020|NCT03654729|81513475|FG001|Overall Study|Study terminated by Sponsor|5|||
27911021|NCT03654729|81513476|FG002|Overall Study|Study terminated by Sponsor|4|||
27911022|NCT03654729|81513474|FG000|Overall Study|Not reported|2|||
27911023|NCT03654729|81513475|FG001|Overall Study|Not reported|4|||
27911024|NCT03654729|81513476|FG002|Overall Study|Not reported|5|||
27526191|NCT04761627|80119472|FG001|Run-in Period|Death|0|||
27526192|NCT04761627|80119473|FG002|Run-in Period|Death|0|||
27526193|NCT04761627|80119471|FG000|Run-in Period|Required alternative therapy|2|||
27526194|NCT04761627|80119472|FG001|Run-in Period|Required alternative therapy|0|||
27622911|NCT02851511|80461060|FG003|Phase I|Physician Decision|1|||
27622912|NCT02851511|80461057|FG000|Phase I|Withdrawal by Subject|2|||
27622913|NCT02851511|80461058|FG001|Phase I|Withdrawal by Subject|1|||
27622914|NCT02851511|80461059|FG002|Phase I|Withdrawal by Subject|0|||
27622915|NCT02851511|80461060|FG003|Phase I|Withdrawal by Subject|3|||
27622916|NCT02851511|80461057|FG000|Phase II|Physician Decision|18|||
27622917|NCT02851511|80461058|FG001|Phase II|Physician Decision|16|||
27622918|NCT02851511|80461059|FG002|Phase II|Physician Decision|0|||
27622919|NCT02851511|80461060|FG003|Phase II|Physician Decision|0|||
27622920|NCT02851511|80461057|FG000|Phase II|Withdrawal by Subject|18|||
27622921|NCT02851511|80461058|FG001|Phase II|Withdrawal by Subject|16|||
27622922|NCT02851511|80461059|FG002|Phase II|Withdrawal by Subject|0|||
27526195|NCT04761627|80119473|FG002|Run-in Period|Required alternative therapy|0|||
27526196|NCT04761627|80119471|FG000|Run-in Period|Lost to Follow-up|2|||
27526197|NCT04761627|80119472|FG001|Run-in Period|Lost to Follow-up|0|||
27526198|NCT04761627|80119473|FG002|Run-in Period|Lost to Follow-up|0|||
27526199|NCT04761627|80119471|FG000|Run-in Period|Protocol Violation|3|||
27526200|NCT04761627|80119472|FG001|Run-in Period|Protocol Violation|0|||
27526201|NCT04761627|80119473|FG002|Run-in Period|Protocol Violation|0|||
27526202|NCT04761627|80119471|FG000|Run-in Period|Abnormal liver function|1|||
27526203|NCT04761627|80119472|FG001|Run-in Period|Abnormal liver function|0|||
27911025|NCT03654729|81513474|FG000|Overall Study|Progressive disease|3|||
27911026|NCT03654729|81513475|FG001|Overall Study|Progressive disease|0|||
27911027|NCT03654729|81513476|FG002|Overall Study|Progressive disease|0|||
27911028|NCT03654729|81513474|FG000|Overall Study|Lost to Follow-up|2|||
27911029|NCT03654729|81513475|FG001|Overall Study|Lost to Follow-up|0|||
27911030|NCT03654729|81513476|FG002|Overall Study|Lost to Follow-up|0|||
27911031|NCT03654729|81513474|FG000|Overall Study|Physician Decision|2|||
27911032|NCT03654729|81513475|FG001|Overall Study|Physician Decision|0|||
27911033|NCT03654729|81513476|FG002|Overall Study|Physician Decision|0|||
27622923|NCT02851511|80461060|FG003|Phase II|Withdrawal by Subject|0|||
27622924|NCT02851511|80461057|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
27622925|NCT02851511|80461058|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
27622926|NCT02851511|80461059|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
27622927|NCT02851511|80461060|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
27855885|NCT00259272|81306577|FG002|Overall Study|Physician Decision|1|||
27855886|NCT00259272|81306578|FG003|Overall Study|Physician Decision|3|||
27855887|NCT00259272|81306575|FG000|Overall Study|Protocol Violation|2|||
27855888|NCT00259272|81306576|FG001|Overall Study|Protocol Violation|0|||
27855889|NCT00259272|81306577|FG002|Overall Study|Protocol Violation|0|||
27855890|NCT00259272|81306578|FG003|Overall Study|Protocol Violation|1|||
27855891|NCT00259272|81306575|FG000|Overall Study|Sponsor Decision|0|||
27855892|NCT00259272|81306576|FG001|Overall Study|Sponsor Decision|1|||
27855893|NCT00259272|81306577|FG002|Overall Study|Sponsor Decision|0|||
27526204|NCT04761627|80119473|FG002|Run-in Period|Abnormal liver function|0|||
27526205|NCT04761627|80119471|FG000|Run-in Period|Adverse Event|6|||
27526206|NCT04761627|80119472|FG001|Run-in Period|Adverse Event|0|||
27526207|NCT04761627|80119473|FG002|Run-in Period|Adverse Event|0|||
27526208|NCT04761627|80119471|FG000|Run-in Period|Withdrawal by Subject|7|||
27526209|NCT04761627|80119472|FG001|Run-in Period|Withdrawal by Subject|0|||
27526210|NCT04761627|80119473|FG002|Run-in Period|Withdrawal by Subject|0|||
27526211|NCT04761627|80119471|FG000|Run-in Period|Did not meet PASI 50|15|||
27526212|NCT04761627|80119472|FG001|Run-in Period|Did not meet PASI 50|0|||
27526213|NCT04761627|80119473|FG002|Run-in Period|Did not meet PASI 50|0|||
27526214|NCT04761627|80119471|FG000|Run-in Period|Study site closure|2|||
27526215|NCT04761627|80119472|FG001|Run-in Period|Study site closure|0|||
27526216|NCT04761627|80119473|FG002|Run-in Period|Study site closure|0|||
27526217|NCT04761627|80119471|FG000|Run-in Period|Pregnancy|2|||
27526218|NCT04761627|80119472|FG001|Run-in Period|Pregnancy|0|||
27526219|NCT04761627|80119473|FG002|Run-in Period|Pregnancy|0|||
27526220|NCT04761627|80119471|FG000|Post-randomization Period|Military service|0|||
27526221|NCT04761627|80119472|FG001|Post-randomization Period|Military service|1|||
27526222|NCT04761627|80119473|FG002|Post-randomization Period|Military service|0|||
27526223|NCT04761627|80119471|FG000|Post-randomization Period|Adverse Event|0|||
27526224|NCT04761627|80119472|FG001|Post-randomization Period|Adverse Event|4|||
27526225|NCT04761627|80119473|FG002|Post-randomization Period|Adverse Event|2|||
27526226|NCT04761627|80119471|FG000|Post-randomization Period|Lost to Follow-up|0|||
27526227|NCT04761627|80119472|FG001|Post-randomization Period|Lost to Follow-up|6|||
27526228|NCT04761627|80119473|FG002|Post-randomization Period|Lost to Follow-up|6|||
27526229|NCT04761627|80119471|FG000|Post-randomization Period|Withdrawal by Subject|0|||
27526230|NCT04761627|80119472|FG001|Post-randomization Period|Withdrawal by Subject|7|||
27526231|NCT04761627|80119473|FG002|Post-randomization Period|Withdrawal by Subject|6|||
27526232|NCT04761627|80119471|FG000|Post-randomization Period|Pregnancy|0|||
27526233|NCT04761627|80119472|FG001|Post-randomization Period|Pregnancy|0|||
27526234|NCT04761627|80119473|FG002|Post-randomization Period|Pregnancy|1|||
27526235|NCT04761627|80119471|FG000|Post-randomization Period|Study site closure|0|||
27526236|NCT04761627|80119472|FG001|Post-randomization Period|Study site closure|0|||
27526237|NCT04761627|80119473|FG002|Post-randomization Period|Study site closure|1|||
27526238|NCT04761627|80119471|FG000|Post-randomization Period|Family planning|0|||
27526239|NCT04761627|80119472|FG001|Post-randomization Period|Family planning|1|||
27526240|NCT04761627|80119473|FG002|Post-randomization Period|Family planning|0|||
27526241|NCT04706416|80119474|FG000|Overall Study|Lost to Follow-up|2|||
27526242|NCT04706416|80119475|FG001|Overall Study|Lost to Follow-up|0|||
27526243|NCT01077375|80119476|FG000|Overall Study|Adverse Event|2|||
27526244|NCT01077375|80119477|FG001|Overall Study|Adverse Event|15|||
27526245|NCT01077375|80119476|FG000|Overall Study|Lack of Efficacy|6|||
27526246|NCT01077375|80119477|FG001|Overall Study|Lack of Efficacy|8|||
27526247|NCT01077375|80119476|FG000|Overall Study|Withdrawal by Subject|0|||
27526248|NCT01077375|80119477|FG001|Overall Study|Withdrawal by Subject|6|||
27526249|NCT01077375|80119476|FG000|Overall Study|Lost to Follow-up|2|||
27526250|NCT01077375|80119477|FG001|Overall Study|Lost to Follow-up|5|||
27622928|NCT02851511|80461057|FG000|Phase II|Lost to Follow-up|0|||
27622929|NCT02851511|80461058|FG001|Phase II|Lost to Follow-up|1|||
27622930|NCT02851511|80461059|FG002|Phase II|Lost to Follow-up|0|||
27855894|NCT00259272|81306578|FG003|Overall Study|Sponsor Decision|0|||
27526251|NCT01077375|80119476|FG000|Overall Study|Other Reason|0|||
27526252|NCT01077375|80119477|FG001|Overall Study|Other Reason|1|||
27526253|NCT00586664|80119481|FG000|Overall Study|Withdrawal by Subject|3|||
27526254|NCT00586664|80119482|FG001|Overall Study|Withdrawal by Subject|7|||
27526255|NCT00586664|80119483|FG002|Overall Study|Withdrawal by Subject|1|||
27526256|NCT00586664|80119481|FG000|Overall Study|Exclusion criteria met|2|||
27526257|NCT00586664|80119482|FG001|Overall Study|Exclusion criteria met|0|||
27526258|NCT00586664|80119483|FG002|Overall Study|Exclusion criteria met|0|||
27622931|NCT02851511|80461060|FG003|Phase II|Lost to Follow-up|0|||
27855895|NCT00259272|81306575|FG000|Overall Study|Withdrawal by Subject|4|||
27855896|NCT00259272|81306576|FG001|Overall Study|Withdrawal by Subject|2|||
27855897|NCT00259272|81306577|FG002|Overall Study|Withdrawal by Subject|2|||
27622932|NCT04096365|80461061|FG000|Overall Study|Adverse Event|1|||
27622933|NCT00764868|80461062|FG000|Overall Study|Adverse Event|18|||
27622934|NCT00764868|80461062|FG000|Overall Study|Withdrawal by Subject|31|||
27622935|NCT00764868|80461062|FG000|Overall Study|Non-compliance|16|||
27622936|NCT00764868|80461062|FG000|Overall Study|Lost to Follow-up|25|||
27622937|NCT00764868|80461062|FG000|Overall Study|Lack of Efficacy|5|||
27622938|NCT00764868|80461062|FG000|Overall Study|Subject moved|7|||
27622939|NCT00764868|80461062|FG000|Overall Study|Pregnancy|3|||
27622940|NCT00764868|80461062|FG000|Overall Study|Prohibited medication|1|||
27622941|NCT00764868|80461062|FG000|Overall Study|Out of town|1|||
27622942|NCT00764868|80461062|FG000|Overall Study|Misuse and compliance of study drug|1|||
27622943|NCT00764868|80461062|FG000|Overall Study|Subject sent to boarding school|1|||
27622944|NCT00764868|80461062|FG000|Overall Study|Met an exclusion criteria|1|||
27622945|NCT00764868|80461062|FG000|Overall Study|Positive drug screen|2|||
27622946|NCT00764868|80461062|FG000|Overall Study|Sponsor requested withdrawal|1|||
27855898|NCT00259272|81306578|FG003|Overall Study|Withdrawal by Subject|7|||
27855899|NCT00259272|81306575|FG000|Overall Study|Lost to Follow-up|1|||
27855900|NCT00259272|81306576|FG001|Overall Study|Lost to Follow-up|0|||
27855901|NCT00259272|81306577|FG002|Overall Study|Lost to Follow-up|0|||
27855902|NCT00259272|81306578|FG003|Overall Study|Lost to Follow-up|1|||
27855903|NCT00960115|81306579|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
27855904|NCT00960115|81306580|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
27911034|NCT03654729|81513474|FG000|Overall Study|Protocol Violation|1|||
27526259|NCT00895011|80119484|FG000|Overall Study|Withdrawal by Subject|14|||
27526260|NCT00895011|80119485|FG001|Overall Study|Withdrawal by Subject|7|||
27526261|NCT00895011|80119486|FG002|Overall Study|Withdrawal by Subject|2|||
27911035|NCT03654729|81513475|FG001|Overall Study|Protocol Violation|1|||
27911036|NCT03654729|81513476|FG002|Overall Study|Protocol Violation|0|||
27911037|NCT03654729|81513474|FG000|Overall Study|Non-compliance with study drug|0|||
27855905|NCT01777620|81306587|FG000|Overall Study|Subject Withdrawal|1|||
27855906|NCT01777620|81306588|FG001|Overall Study|Subject Withdrawal|0|||
27911038|NCT03654729|81513475|FG001|Overall Study|Non-compliance with study drug|1|||
27911039|NCT03654729|81513476|FG002|Overall Study|Non-compliance with study drug|0|||
27911040|NCT03654729|81513474|FG000|Overall Study|Site terminated by Sponsor|1|||
27526262|NCT00895011|80119484|FG000|Overall Study|Lost to Follow-up|5|||
27526263|NCT00895011|80119485|FG001|Overall Study|Lost to Follow-up|4|||
27526264|NCT00895011|80119486|FG002|Overall Study|Lost to Follow-up|1|||
27526265|NCT00895011|80119484|FG000|Overall Study|Protocol Violation|3|||
27526266|NCT00895011|80119485|FG001|Overall Study|Protocol Violation|1|||
27526267|NCT00895011|80119486|FG002|Overall Study|Protocol Violation|3|||
27526268|NCT00895011|80119484|FG000|Overall Study|Adverse Event|1|||
27526269|NCT00895011|80119485|FG001|Overall Study|Adverse Event|2|||
27526270|NCT00895011|80119486|FG002|Overall Study|Adverse Event|2|||
27526271|NCT00895011|80119484|FG000|Overall Study|schedule conflict|1|||
27526272|NCT00895011|80119485|FG001|Overall Study|schedule conflict|0|||
27526273|NCT00895011|80119486|FG002|Overall Study|schedule conflict|0|||
27526274|NCT04535167|80119487|FG000|Treatment|Adverse Event|0|||
27526275|NCT04535167|80119488|FG001|Treatment|Adverse Event|0|||
27526276|NCT04535167|80119489|FG002|Treatment|Adverse Event|0|||
27526277|NCT04535167|80119490|FG003|Treatment|Adverse Event|0|||
27526278|NCT04535167|80119491|FG004|Treatment|Adverse Event|0|||
27526279|NCT04535167|80119492|FG005|Treatment|Adverse Event|0|||
27622947|NCT01687270|80461063|FG000|Overall Study|Lack of Efficacy|11|||
27855907|NCT01986010|81306593|FG000|Overall Study|Adverse Event|0|||
27855908|NCT01986010|81306594|FG001|Overall Study|Adverse Event|1|||
27855909|NCT01986010|81306595|FG002|Overall Study|Adverse Event|0|||
27855910|NCT01986010|81306596|FG003|Overall Study|Adverse Event|0|||
27855911|NCT01986010|81306597|FG004|Overall Study|Adverse Event|0|||
27855912|NCT01986010|81306598|FG005|Overall Study|Adverse Event|0|||
27855913|NCT01986010|81306599|FG006|Overall Study|Adverse Event|0|||
27855914|NCT01986010|81306600|FG007|Overall Study|Adverse Event|0|||
27855915|NCT01986010|81306601|FG008|Overall Study|Adverse Event|0|||
27855916|NCT01986010|81306602|FG009|Overall Study|Adverse Event|0|||
27855917|NCT01986010|81306603|FG010|Overall Study|Adverse Event|0|||
27855918|NCT01986010|81306604|FG011|Overall Study|Adverse Event|0|||
27855919|NCT01986010|81306605|FG012|Overall Study|Adverse Event|0|||
27855920|NCT01986010|81306606|FG013|Overall Study|Adverse Event|0|||
27855921|NCT01986010|81306607|FG014|Overall Study|Adverse Event|0|||
27855922|NCT01986010|81306608|FG015|Overall Study|Adverse Event|1|||
27911041|NCT03654729|81513475|FG001|Overall Study|Site terminated by Sponsor|0|||
27526280|NCT04535167|80119493|FG006|Treatment|Adverse Event|1|||
27526281|NCT04535167|80119487|FG000|Follow-Up|Death|0|||
27622948|NCT01687270|80461063|FG000|Overall Study|Lost to Follow-up|1|||
27622949|NCT01094743|80461064|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
27911042|NCT03654729|81513476|FG002|Overall Study|Site terminated by Sponsor|0|||
27911043|NCT02532257|81513477|FG000|Overall Study|Adverse Event|2|||
27526282|NCT04535167|80119488|FG001|Follow-Up|Death|0|||
27526283|NCT04535167|80119489|FG002|Follow-Up|Death|0|||
27526284|NCT04535167|80119490|FG003|Follow-Up|Death|0|||
27526285|NCT04535167|80119491|FG004|Follow-Up|Death|0|||
27526286|NCT04535167|80119492|FG005|Follow-Up|Death|0|||
27526287|NCT04535167|80119493|FG006|Follow-Up|Death|1|||
27526288|NCT04535167|80119487|FG000|Follow-Up|Lost to Follow-up|0|||
27526289|NCT04535167|80119488|FG001|Follow-Up|Lost to Follow-up|0|||
27526290|NCT04535167|80119489|FG002|Follow-Up|Lost to Follow-up|0|||
27526291|NCT04535167|80119490|FG003|Follow-Up|Lost to Follow-up|1|||
27526292|NCT04535167|80119491|FG004|Follow-Up|Lost to Follow-up|0|||
27526293|NCT04535167|80119492|FG005|Follow-Up|Lost to Follow-up|0|||
27526294|NCT04535167|80119493|FG006|Follow-Up|Lost to Follow-up|0|||
27526295|NCT03560739|80119496|FG000|Overall Study|Adverse Event|0|||
27526296|NCT03560739|80119497|FG001|Overall Study|Adverse Event|1|||
27526297|NCT03560739|80119498|FG002|Overall Study|Adverse Event|0|||
27526298|NCT03560739|80119499|FG003|Overall Study|Adverse Event|0|||
27526299|NCT03726996|80119506|FG000|Overall Study|Parent's decision|2|||
27526300|NCT03726996|80119506|FG000|Overall Study|Study early termination|2|||
27526301|NCT03774823|80119507|FG000|Overall Study|Withdrawal by Subject|1|||
27622950|NCT03850444|80461065|FG000|Overall Study|Adverse Event|16|||
27622951|NCT03850444|80461066|FG001|Overall Study|Adverse Event|10|||
27622952|NCT03850444|80461065|FG000|Overall Study|Death|87|||
27911044|NCT02532257|81513477|FG000|Overall Study|Physician Decision|4|||
27911045|NCT02532257|81513477|FG000|Overall Study|Withdrawal by Subject|3|||
27911046|NCT02532257|81513477|FG000|Overall Study|Progressive Disease|10|||
27911047|NCT00509899|81513478|FG000|Overall Study|Progressive disease|1|||
27911048|NCT00509899|81513479|FG001|Overall Study|Progressive disease|3|||
27911049|NCT00509899|81513480|FG002|Overall Study|Progressive disease|5|||
27911050|NCT00509899|81513481|FG003|Overall Study|Progressive disease|1|||
27911051|NCT00509899|81513482|FG004|Overall Study|Progressive disease|0|||
27911052|NCT00509899|81513483|FG005|Overall Study|Progressive disease|1|||
27911053|NCT00509899|81513484|FG006|Overall Study|Progressive disease|0|||
27911054|NCT00509899|81513485|FG007|Overall Study|Progressive disease|0|||
27911055|NCT00509899|81513478|FG000|Overall Study|Unacceptable Toxicity|1|||
27911056|NCT00509899|81513479|FG001|Overall Study|Unacceptable Toxicity|0|||
27911057|NCT00509899|81513480|FG002|Overall Study|Unacceptable Toxicity|0|||
27911058|NCT00509899|81513481|FG003|Overall Study|Unacceptable Toxicity|2|||
27911059|NCT00509899|81513482|FG004|Overall Study|Unacceptable Toxicity|0|||
27911060|NCT00509899|81513483|FG005|Overall Study|Unacceptable Toxicity|0|||
27911061|NCT00509899|81513484|FG006|Overall Study|Unacceptable Toxicity|0|||
27911062|NCT00509899|81513485|FG007|Overall Study|Unacceptable Toxicity|0|||
27911063|NCT00509899|81513478|FG000|Overall Study|Withdrawal by Subject|6|||
27526302|NCT03774823|80119508|FG001|Overall Study|Withdrawal by Subject|1|||
27526303|NCT00976508|80119518|FG000|Overall Study|Death|7|||
27526304|NCT00976508|80119519|FG001|Overall Study|Death|1|||
27526305|NCT00976508|80119518|FG000|Overall Study|Lost to Follow-up|1|||
27526306|NCT00976508|80119519|FG001|Overall Study|Lost to Follow-up|0|||
27526307|NCT00976508|80119518|FG000|Overall Study|Withdrawal by Subject|1|||
27526308|NCT00976508|80119519|FG001|Overall Study|Withdrawal by Subject|0|||
27526309|NCT00976508|80119518|FG000|Overall Study|Disease Progression|4|||
27526310|NCT00976508|80119519|FG001|Overall Study|Disease Progression|4|||
27526311|NCT00976508|80119518|FG000|Overall Study|Subject Enrolled in Hospice|1|||
27526312|NCT00976508|80119519|FG001|Overall Study|Subject Enrolled in Hospice|0|||
27526313|NCT00976508|80119518|FG000|Overall Study|Terminated by the Sponsor|0|||
27526314|NCT00976508|80119519|FG001|Overall Study|Terminated by the Sponsor|1|||
27526315|NCT05672667|80119520|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
27526316|NCT01226121|80119521|FG000|Overall Study|Lost to Follow-up|2|||
27526317|NCT01226121|80119522|FG001|Overall Study|Lost to Follow-up|0|||
27526318|NCT01226121|80119523|FG002|Overall Study|Lost to Follow-up|1|||
27526319|NCT01002820|80119524|FG000|Overall Study|Adverse Event|1|||
27526320|NCT01002820|80119524|FG000|Overall Study|Withdrawal by Subject|2|||
27526321|NCT01002820|80119524|FG000|Overall Study|Lack of Efficacy|1|||
27526322|NCT01634178|80119525|FG000|Treatment Period 1|Adverse Event|0|||
27526323|NCT01634178|80119526|FG001|Treatment Period 1|Adverse Event|1|||
27526324|NCT01634178|80119525|FG000|Treatment Period 2|Adverse Event|1|||
27526325|NCT01634178|80119526|FG001|Treatment Period 2|Adverse Event|0|||
27526326|NCT02677324|80119530|FG000|Overall Study|Disease Progression|6|||
27526327|NCT02677324|80119530|FG000|Overall Study|Inability to Swallow pills|1|||
27526328|NCT02677324|80119530|FG000|Overall Study|Non-compliance|1|||
27526329|NCT02677324|80119530|FG000|Overall Study|Lack of Efficacy|1|||
27526330|NCT02677324|80119530|FG000|Overall Study|Medical insurance coverage|1|||
27526331|NCT02677324|80119530|FG000|Overall Study|Adverse Event|1|||
27526332|NCT02677324|80119530|FG000|Overall Study|IgM Myeloma diagnosis|1|||
27526333|NCT00973349|80119533|FG000|Overall Study|Adverse Event|0|||
27526334|NCT00973349|80119534|FG001|Overall Study|Adverse Event|0|||
27526335|NCT00973349|80119535|FG002|Overall Study|Adverse Event|0|||
27526336|NCT00973349|80119536|FG003|Overall Study|Adverse Event|0|||
27526337|NCT00973349|80119537|FG004|Overall Study|Adverse Event|1|||
27526338|NCT00973349|80119538|FG005|Overall Study|Adverse Event|0|||
27526339|NCT00973349|80119539|FG006|Overall Study|Adverse Event|0|||
27526340|NCT00973349|80119540|FG007|Overall Study|Adverse Event|0|||
27526341|NCT00973349|80119541|FG008|Overall Study|Adverse Event|1|||
27526342|NCT00973349|80119542|FG009|Overall Study|Adverse Event|0|||
27526343|NCT00973349|80119543|FG010|Overall Study|Adverse Event|0|||
27526344|NCT00973349|80119544|FG011|Overall Study|Adverse Event|0|||
27526345|NCT00973349|80119545|FG012|Overall Study|Adverse Event|0|||
27526346|NCT00973349|80119546|FG013|Overall Study|Adverse Event|0|||
27911064|NCT00509899|81513479|FG001|Overall Study|Withdrawal by Subject|2|||
27911065|NCT00509899|81513480|FG002|Overall Study|Withdrawal by Subject|3|||
27911066|NCT00509899|81513481|FG003|Overall Study|Withdrawal by Subject|0|||
27911067|NCT00509899|81513482|FG004|Overall Study|Withdrawal by Subject|3|||
27911068|NCT00509899|81513483|FG005|Overall Study|Withdrawal by Subject|2|||
27526347|NCT00973349|80119547|FG014|Overall Study|Adverse Event|1|||
27526348|NCT00973349|80119548|FG015|Overall Study|Adverse Event|0|||
27526349|NCT00973349|80119533|FG000|Overall Study|Withdrawal by Subject|1|||
27526350|NCT00973349|80119534|FG001|Overall Study|Withdrawal by Subject|2|||
27526351|NCT00973349|80119535|FG002|Overall Study|Withdrawal by Subject|2|||
27526352|NCT00973349|80119536|FG003|Overall Study|Withdrawal by Subject|3|||
27526353|NCT00973349|80119537|FG004|Overall Study|Withdrawal by Subject|2|||
27526354|NCT00973349|80119538|FG005|Overall Study|Withdrawal by Subject|0|||
27911069|NCT00509899|81513484|FG006|Overall Study|Withdrawal by Subject|0|||
27911070|NCT00509899|81513485|FG007|Overall Study|Withdrawal by Subject|0|||
27911071|NCT00509899|81513478|FG000|Overall Study|Physician Decision|4|||
27911072|NCT00509899|81513479|FG001|Overall Study|Physician Decision|2|||
27911073|NCT00509899|81513480|FG002|Overall Study|Physician Decision|7|||
27911074|NCT00509899|81513481|FG003|Overall Study|Physician Decision|0|||
27911075|NCT00509899|81513482|FG004|Overall Study|Physician Decision|1|||
27911076|NCT00509899|81513483|FG005|Overall Study|Physician Decision|4|||
27911077|NCT00509899|81513484|FG006|Overall Study|Physician Decision|0|||
27911078|NCT00509899|81513485|FG007|Overall Study|Physician Decision|0|||
27911079|NCT00509899|81513478|FG000|Overall Study|Intercurrent Illness|1|||
27911080|NCT00509899|81513479|FG001|Overall Study|Intercurrent Illness|0|||
27911081|NCT00509899|81513480|FG002|Overall Study|Intercurrent Illness|0|||
27911082|NCT00509899|81513481|FG003|Overall Study|Intercurrent Illness|1|||
27911083|NCT00509899|81513482|FG004|Overall Study|Intercurrent Illness|0|||
27911084|NCT00509899|81513483|FG005|Overall Study|Intercurrent Illness|1|||
27911085|NCT00509899|81513484|FG006|Overall Study|Intercurrent Illness|0|||
27911086|NCT00509899|81513485|FG007|Overall Study|Intercurrent Illness|0|||
27911087|NCT00509899|81513478|FG000|Overall Study|Death|2|||
27911088|NCT00509899|81513479|FG001|Overall Study|Death|2|||
27911089|NCT00509899|81513480|FG002|Overall Study|Death|3|||
27911090|NCT00509899|81513481|FG003|Overall Study|Death|0|||
27911091|NCT00509899|81513482|FG004|Overall Study|Death|1|||
27911092|NCT00509899|81513483|FG005|Overall Study|Death|1|||
27911093|NCT00509899|81513484|FG006|Overall Study|Death|1|||
27911094|NCT00509899|81513485|FG007|Overall Study|Death|1|||
27911095|NCT00509899|81513478|FG000|Overall Study|Lack of Efficacy|1|||
27911096|NCT00509899|81513479|FG001|Overall Study|Lack of Efficacy|0|||
27911097|NCT00509899|81513480|FG002|Overall Study|Lack of Efficacy|2|||
27911098|NCT00509899|81513481|FG003|Overall Study|Lack of Efficacy|0|||
27911099|NCT00509899|81513482|FG004|Overall Study|Lack of Efficacy|0|||
27911100|NCT00509899|81513483|FG005|Overall Study|Lack of Efficacy|1|||
27911101|NCT00509899|81513484|FG006|Overall Study|Lack of Efficacy|0|||
27911102|NCT00509899|81513485|FG007|Overall Study|Lack of Efficacy|0|||
27911103|NCT03560869|81513486|FG000|Overall Study|Withdrawal by Subject|3|||
27911104|NCT03560869|81513487|FG001|Overall Study|Withdrawal by Subject|4|||
27911105|NCT03560869|81513486|FG000|Overall Study|Screening failure|4|||
27911106|NCT03560869|81513487|FG001|Overall Study|Screening failure|4|||
27911107|NCT03560869|81513486|FG000|Overall Study|Withdrawal by PI|0|||
27911108|NCT03560869|81513487|FG001|Overall Study|Withdrawal by PI|1|||
27911109|NCT00943592|81513488|FG000|Overall Study|Death|3|||
27911110|NCT01211145|81513490|FG000|Overall Study|Reason not specified|3|||
27911111|NCT01211145|81513491|FG001|Overall Study|Reason not specified|2|||
27911112|NCT01211145|81513492|FG002|Overall Study|Reason not specified|2|||
27911113|NCT01211145|81513493|FG003|Overall Study|Reason not specified|1|||
27911114|NCT01211145|81513490|FG000|Overall Study|Lost to Follow-up|3|||
27911115|NCT01211145|81513491|FG001|Overall Study|Lost to Follow-up|2|||
27911116|NCT01211145|81513492|FG002|Overall Study|Lost to Follow-up|1|||
27911117|NCT01211145|81513493|FG003|Overall Study|Lost to Follow-up|2|||
27911118|NCT01211145|81513490|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27911119|NCT01211145|81513491|FG001|Overall Study|Study-specific withdrawal criteria|0|||
27911120|NCT01211145|81513492|FG002|Overall Study|Study-specific withdrawal criteria|0|||
27911121|NCT01211145|81513493|FG003|Overall Study|Study-specific withdrawal criteria|0|||
27911122|NCT01211145|81513490|FG000|Overall Study|Severe noncompliance to protocol|1|||
27911123|NCT01211145|81513491|FG001|Overall Study|Severe noncompliance to protocol|0|||
27911124|NCT01211145|81513492|FG002|Overall Study|Severe noncompliance to protocol|0|||
27911125|NCT01211145|81513493|FG003|Overall Study|Severe noncompliance to protocol|0|||
27911126|NCT01211145|81513490|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
27911127|NCT01211145|81513491|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
27911128|NCT01211145|81513492|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
27911129|NCT01211145|81513493|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
27911130|NCT01211145|81513490|FG000|Overall Study|Patient decision|2|||
27911131|NCT01211145|81513491|FG001|Overall Study|Patient decision|1|||
27911132|NCT01211145|81513492|FG002|Overall Study|Patient decision|0|||
27911133|NCT01211145|81513493|FG003|Overall Study|Patient decision|2|||
27911134|NCT03284853|81513494|FG000|Overall Study|Adverse Event|40|||
27911135|NCT03284853|81513495|FG001|Overall Study|Adverse Event|4|||
27911136|NCT03284853|81513494|FG000|Overall Study|Withdrawal by Subject|5|||
27911137|NCT03284853|81513495|FG001|Overall Study|Withdrawal by Subject|1|||
27911138|NCT03284853|81513494|FG000|Overall Study|Lost to Follow-up|1|||
27911139|NCT03284853|81513495|FG001|Overall Study|Lost to Follow-up|0|||
27911140|NCT03284853|81513494|FG000|Overall Study|Lack of Efficacy|1|||
27911141|NCT03284853|81513495|FG001|Overall Study|Lack of Efficacy|0|||
27911142|NCT03284853|81513494|FG000|Overall Study|Disallowed Concurrent Medication|1|||
27911143|NCT03284853|81513495|FG001|Overall Study|Disallowed Concurrent Medication|1|||
27911144|NCT03284853|81513494|FG000|Overall Study|Protocol Violation|3|||
27911145|NCT03284853|81513495|FG001|Overall Study|Protocol Violation|3|||
27911146|NCT03284853|81513494|FG000|Overall Study|Death|0|||
27911147|NCT03284853|81513495|FG001|Overall Study|Death|1|||
27911148|NCT03284853|81513494|FG000|Overall Study|Other - Reason not reported in CSR|4|||
27911149|NCT03284853|81513495|FG001|Overall Study|Other - Reason not reported in CSR|3|||
27911150|NCT03839394|81513499|FG000|Overall Study|Lost to Follow-up|6|||
27911151|NCT03839394|81513500|FG001|Overall Study|Lost to Follow-up|8|||
27911152|NCT03839394|81513499|FG000|Overall Study|Withdrawal by Subject|0|||
27911153|NCT03839394|81513500|FG001|Overall Study|Withdrawal by Subject|2|||
27911154|NCT04633226|81513501|FG000|Overall Study|Withdrawal by parent/guardian|4|||
27911155|NCT04633226|81513501|FG000|Overall Study|Randomized by mistake without study treatment|1|||
27911156|NCT02019550|81513505|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27911157|NCT02019550|81513506|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
27911158|NCT02384538|81513507|FG000|Overall Study|Adverse Event|1|||
27911159|NCT02384538|81513508|FG001|Overall Study|Adverse Event|4|||
27911160|NCT02384538|81513507|FG000|Overall Study|Lack of Efficacy|4|||
27526355|NCT00973349|80119539|FG006|Overall Study|Withdrawal by Subject|2|||
27526356|NCT00973349|80119540|FG007|Overall Study|Withdrawal by Subject|2|||
27526357|NCT00973349|80119541|FG008|Overall Study|Withdrawal by Subject|0|||
27526358|NCT00973349|80119542|FG009|Overall Study|Withdrawal by Subject|2|||
27526359|NCT00973349|80119543|FG010|Overall Study|Withdrawal by Subject|0|||
27526360|NCT00973349|80119544|FG011|Overall Study|Withdrawal by Subject|1|||
27526361|NCT00973349|80119545|FG012|Overall Study|Withdrawal by Subject|0|||
27526362|NCT00973349|80119546|FG013|Overall Study|Withdrawal by Subject|0|||
27526363|NCT00973349|80119547|FG014|Overall Study|Withdrawal by Subject|0|||
27526364|NCT00973349|80119548|FG015|Overall Study|Withdrawal by Subject|0|||
27526365|NCT00973349|80119533|FG000|Overall Study|Lost to Follow-up|3|||
27526366|NCT00973349|80119534|FG001|Overall Study|Lost to Follow-up|1|||
27526367|NCT00973349|80119535|FG002|Overall Study|Lost to Follow-up|2|||
27526368|NCT00973349|80119536|FG003|Overall Study|Lost to Follow-up|2|||
27526369|NCT00973349|80119537|FG004|Overall Study|Lost to Follow-up|1|||
27526370|NCT00973349|80119538|FG005|Overall Study|Lost to Follow-up|3|||
27526371|NCT00973349|80119539|FG006|Overall Study|Lost to Follow-up|0|||
27855923|NCT01986010|81306609|FG016|Overall Study|Adverse Event|0|||
27855924|NCT01986010|81306593|FG000|Overall Study|Lost to Follow-up|2|||
27855925|NCT01986010|81306594|FG001|Overall Study|Lost to Follow-up|1|||
27855926|NCT01986010|81306595|FG002|Overall Study|Lost to Follow-up|2|||
27855927|NCT01986010|81306596|FG003|Overall Study|Lost to Follow-up|2|||
27855928|NCT01986010|81306597|FG004|Overall Study|Lost to Follow-up|2|||
27855929|NCT01986010|81306598|FG005|Overall Study|Lost to Follow-up|2|||
27855930|NCT01986010|81306599|FG006|Overall Study|Lost to Follow-up|0|||
27855931|NCT01986010|81306600|FG007|Overall Study|Lost to Follow-up|0|||
27855932|NCT01986010|81306601|FG008|Overall Study|Lost to Follow-up|4|||
27855933|NCT01986010|81306602|FG009|Overall Study|Lost to Follow-up|2|||
27855934|NCT01986010|81306603|FG010|Overall Study|Lost to Follow-up|0|||
27855935|NCT01986010|81306604|FG011|Overall Study|Lost to Follow-up|1|||
27855936|NCT01986010|81306605|FG012|Overall Study|Lost to Follow-up|1|||
27855937|NCT01986010|81306606|FG013|Overall Study|Lost to Follow-up|1|||
27855938|NCT01986010|81306607|FG014|Overall Study|Lost to Follow-up|2|||
27855939|NCT01986010|81306608|FG015|Overall Study|Lost to Follow-up|0|||
27855940|NCT01986010|81306609|FG016|Overall Study|Lost to Follow-up|0|||
27855941|NCT01986010|81306593|FG000|Overall Study|Physician Decision|0|||
27855942|NCT01986010|81306594|FG001|Overall Study|Physician Decision|0|||
27855943|NCT01986010|81306595|FG002|Overall Study|Physician Decision|0|||
27855944|NCT01986010|81306596|FG003|Overall Study|Physician Decision|0|||
27855945|NCT01986010|81306597|FG004|Overall Study|Physician Decision|0|||
27855946|NCT01986010|81306598|FG005|Overall Study|Physician Decision|0|||
27855947|NCT01986010|81306599|FG006|Overall Study|Physician Decision|0|||
27855948|NCT01986010|81306600|FG007|Overall Study|Physician Decision|0|||
27855949|NCT01986010|81306601|FG008|Overall Study|Physician Decision|0|||
27855950|NCT01986010|81306602|FG009|Overall Study|Physician Decision|0|||
27855951|NCT01986010|81306603|FG010|Overall Study|Physician Decision|0|||
27855952|NCT01986010|81306604|FG011|Overall Study|Physician Decision|0|||
27855953|NCT01986010|81306605|FG012|Overall Study|Physician Decision|0|||
27855954|NCT01986010|81306606|FG013|Overall Study|Physician Decision|0|||
27911161|NCT02384538|81513508|FG001|Overall Study|Lack of Efficacy|4|||
27911162|NCT02384538|81513507|FG000|Overall Study|Withdrew Consent|0|||
27911163|NCT02384538|81513508|FG001|Overall Study|Withdrew Consent|4|||
27911164|NCT02384538|81513507|FG000|Overall Study|Other|1|||
27526372|NCT00973349|80119540|FG007|Overall Study|Lost to Follow-up|1|||
27526373|NCT00973349|80119541|FG008|Overall Study|Lost to Follow-up|2|||
27526374|NCT00973349|80119542|FG009|Overall Study|Lost to Follow-up|1|||
27526375|NCT00973349|80119543|FG010|Overall Study|Lost to Follow-up|0|||
27855955|NCT01986010|81306607|FG014|Overall Study|Physician Decision|1|||
27855956|NCT01986010|81306608|FG015|Overall Study|Physician Decision|0|||
27855957|NCT01986010|81306609|FG016|Overall Study|Physician Decision|0|||
27855958|NCT01986010|81306593|FG000|Overall Study|Withdrawal by Subject|2|||
27855959|NCT01986010|81306594|FG001|Overall Study|Withdrawal by Subject|2|||
27855960|NCT01986010|81306595|FG002|Overall Study|Withdrawal by Subject|3|||
27855961|NCT01986010|81306596|FG003|Overall Study|Withdrawal by Subject|0|||
27911165|NCT02384538|81513508|FG001|Overall Study|Other|3|||
27911166|NCT00385918|81513509|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
27911167|NCT00385918|81513510|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
27911168|NCT00385918|81513511|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
27911169|NCT00385918|81513509|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
27911170|NCT00385918|81513510|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
27911171|NCT00385918|81513511|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
27911172|NCT00385918|81513509|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
27911173|NCT00385918|81513510|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
27911174|NCT00385918|81513511|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
27911175|NCT00385918|81513509|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
27855962|NCT01986010|81306597|FG004|Overall Study|Withdrawal by Subject|2|||
27855963|NCT01986010|81306598|FG005|Overall Study|Withdrawal by Subject|4|||
27855964|NCT01986010|81306599|FG006|Overall Study|Withdrawal by Subject|0|||
27855965|NCT01986010|81306600|FG007|Overall Study|Withdrawal by Subject|0|||
27855966|NCT01986010|81306601|FG008|Overall Study|Withdrawal by Subject|0|||
27855967|NCT01986010|81306602|FG009|Overall Study|Withdrawal by Subject|0|||
27622953|NCT03850444|80461066|FG001|Overall Study|Death|107|||
27622954|NCT03850444|80461065|FG000|Overall Study|Lost to Follow-up|1|||
27622955|NCT03850444|80461066|FG001|Overall Study|Lost to Follow-up|1|||
27622956|NCT03850444|80461065|FG000|Overall Study|Withdrawal by Subject|1|||
27622957|NCT03850444|80461066|FG001|Overall Study|Withdrawal by Subject|5|||
27622958|NCT03850444|80461065|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
27622959|NCT03850444|80461066|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
27622960|NCT01033643|80461067|FG000|Overall Study|Withdrew Consent|0|||
27622961|NCT01033643|80461068|FG001|Overall Study|Withdrew Consent|3|||
27622962|NCT01033643|80461069|FG002|Overall Study|Withdrew Consent|0|||
27622963|NCT01033643|80461070|FG003|Overall Study|Withdrew Consent|0|||
27622964|NCT01033643|80461071|FG004|Overall Study|Withdrew Consent|0|||
27622965|NCT01033643|80461072|FG005|Overall Study|Withdrew Consent|1|||
27622966|NCT00770211|80461073|FG000|Overall Study|Lost to Follow-up|1|||
27622967|NCT00770211|80461074|FG001|Overall Study|Lost to Follow-up|0|||
27622968|NCT00770211|80461073|FG000|Overall Study|Withdrawal by Subject|0|||
27622969|NCT00770211|80461074|FG001|Overall Study|Withdrawal by Subject|2|||
27622970|NCT01036087|80461075|FG000|Overall Study|Adverse Event|2|||
27622971|NCT01036087|80461075|FG000|Overall Study|Lack of Efficacy|1|||
27622972|NCT04541186|80461076|FG000|Main Study|Adverse Event|0|||
27622973|NCT04541186|80461077|FG001|Main Study|Adverse Event|0|||
27622974|NCT04541186|80461078|FG002|Main Study|Adverse Event|4|||
27622975|NCT04541186|80461079|FG003|Main Study|Adverse Event|0|||
27622976|NCT04541186|80461080|FG004|Main Study|Adverse Event|0|||
27622977|NCT04541186|80461076|FG000|Main Study|Investigator Decision|0|||
27622978|NCT04541186|80461077|FG001|Main Study|Investigator Decision|0|||
27855968|NCT01986010|81306603|FG010|Overall Study|Withdrawal by Subject|0|||
27855969|NCT01986010|81306604|FG011|Overall Study|Withdrawal by Subject|2|||
27855970|NCT01986010|81306605|FG012|Overall Study|Withdrawal by Subject|0|||
27855971|NCT01986010|81306606|FG013|Overall Study|Withdrawal by Subject|1|||
27855972|NCT01986010|81306607|FG014|Overall Study|Withdrawal by Subject|2|||
27855973|NCT01986010|81306608|FG015|Overall Study|Withdrawal by Subject|0|||
27855974|NCT01986010|81306609|FG016|Overall Study|Withdrawal by Subject|0|||
27855975|NCT01986010|81306593|FG000|Overall Study|Status Not Recorded|2|||
27855976|NCT01986010|81306594|FG001|Overall Study|Status Not Recorded|4|||
27855977|NCT01986010|81306595|FG002|Overall Study|Status Not Recorded|2|||
27855978|NCT01986010|81306596|FG003|Overall Study|Status Not Recorded|0|||
27855979|NCT01986010|81306597|FG004|Overall Study|Status Not Recorded|1|||
27855980|NCT01986010|81306598|FG005|Overall Study|Status Not Recorded|2|||
27855981|NCT01986010|81306599|FG006|Overall Study|Status Not Recorded|0|||
27855982|NCT01986010|81306600|FG007|Overall Study|Status Not Recorded|0|||
27855983|NCT01986010|81306601|FG008|Overall Study|Status Not Recorded|2|||
27855984|NCT01986010|81306602|FG009|Overall Study|Status Not Recorded|1|||
27855985|NCT01986010|81306603|FG010|Overall Study|Status Not Recorded|7|||
27855986|NCT01986010|81306604|FG011|Overall Study|Status Not Recorded|7|||
27855987|NCT01986010|81306605|FG012|Overall Study|Status Not Recorded|9|||
27855988|NCT01986010|81306606|FG013|Overall Study|Status Not Recorded|9|||
27855989|NCT01986010|81306607|FG014|Overall Study|Status Not Recorded|5|||
27622979|NCT04541186|80461078|FG002|Main Study|Investigator Decision|1|||
27855990|NCT01986010|81306608|FG015|Overall Study|Status Not Recorded|10|||
27855991|NCT01986010|81306609|FG016|Overall Study|Status Not Recorded|4|||
27855992|NCT00121134|81306614|FG000|Overall Study|Progression of Disease|5|||
27855993|NCT00121134|81306615|FG001|Overall Study|Progression of Disease|3|||
27855994|NCT00121134|81306616|FG002|Overall Study|Progression of Disease|4|||
27855995|NCT00121134|81306617|FG003|Overall Study|Progression of Disease|2|||
27622980|NCT04541186|80461079|FG003|Main Study|Investigator Decision|1|||
27622981|NCT04541186|80461080|FG004|Main Study|Investigator Decision|0|||
27622982|NCT04541186|80461076|FG000|Main Study|Withdrawal by Subject|1|||
27911176|NCT00385918|81513510|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
27911177|NCT00385918|81513511|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
27911178|NCT00385918|81513509|FG000|Intervention Phase After Randomization|Physician Decision|1|||
27911179|NCT00385918|81513510|FG001|Intervention Phase After Randomization|Physician Decision|0|||
27911180|NCT00385918|81513511|FG002|Intervention Phase After Randomization|Physician Decision|0|||
27911181|NCT00385918|81513509|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
27911182|NCT00385918|81513510|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
27911183|NCT00385918|81513511|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
27911184|NCT04202497|81513514|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
27911185|NCT04202497|81513515|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
27526376|NCT00973349|80119544|FG011|Overall Study|Lost to Follow-up|1|||
27526377|NCT00973349|80119545|FG012|Overall Study|Lost to Follow-up|0|||
27526378|NCT00973349|80119546|FG013|Overall Study|Lost to Follow-up|0|||
27526379|NCT00973349|80119547|FG014|Overall Study|Lost to Follow-up|0|||
27526380|NCT00973349|80119548|FG015|Overall Study|Lost to Follow-up|1|||
27526381|NCT00973349|80119533|FG000|Overall Study|Inappropriate enrolment|0|||
27526382|NCT00973349|80119534|FG001|Overall Study|Inappropriate enrolment|0|||
27526383|NCT00973349|80119535|FG002|Overall Study|Inappropriate enrolment|1|||
27526384|NCT00973349|80119536|FG003|Overall Study|Inappropriate enrolment|0|||
27526385|NCT00973349|80119537|FG004|Overall Study|Inappropriate enrolment|0|||
27526386|NCT00973349|80119538|FG005|Overall Study|Inappropriate enrolment|0|||
27526387|NCT00973349|80119539|FG006|Overall Study|Inappropriate enrolment|0|||
27526388|NCT00973349|80119540|FG007|Overall Study|Inappropriate enrolment|0|||
27526389|NCT00973349|80119541|FG008|Overall Study|Inappropriate enrolment|0|||
27855996|NCT00121134|81306614|FG000|Overall Study|Toxicity|4|||
27855997|NCT00121134|81306615|FG001|Overall Study|Toxicity|7|||
27855998|NCT00121134|81306616|FG002|Overall Study|Toxicity|13|||
27855999|NCT00121134|81306617|FG003|Overall Study|Toxicity|5|||
27526390|NCT00973349|80119542|FG009|Overall Study|Inappropriate enrolment|2|||
27526391|NCT00973349|80119543|FG010|Overall Study|Inappropriate enrolment|0|||
27526392|NCT00973349|80119544|FG011|Overall Study|Inappropriate enrolment|0|||
27526393|NCT00973349|80119545|FG012|Overall Study|Inappropriate enrolment|1|||
27526394|NCT00973349|80119546|FG013|Overall Study|Inappropriate enrolment|0|||
27622983|NCT04541186|80461077|FG001|Main Study|Withdrawal by Subject|1|||
27856000|NCT00121134|81306614|FG000|Overall Study|Physician Decision|6|||
27856001|NCT00121134|81306615|FG001|Overall Study|Physician Decision|4|||
27856002|NCT00121134|81306616|FG002|Overall Study|Physician Decision|4|||
27856003|NCT00121134|81306617|FG003|Overall Study|Physician Decision|1|||
27856004|NCT00121134|81306614|FG000|Overall Study|Treatment Delay|1|||
27856005|NCT00121134|81306615|FG001|Overall Study|Treatment Delay|0|||
27856006|NCT00121134|81306616|FG002|Overall Study|Treatment Delay|0|||
27856007|NCT00121134|81306617|FG003|Overall Study|Treatment Delay|0|||
27856008|NCT00121134|81306614|FG000|Overall Study|Intercurrent Illness|0|||
27856009|NCT00121134|81306615|FG001|Overall Study|Intercurrent Illness|0|||
27856010|NCT00121134|81306616|FG002|Overall Study|Intercurrent Illness|0|||
27856011|NCT00121134|81306617|FG003|Overall Study|Intercurrent Illness|1|||
27856012|NCT00121134|81306614|FG000|Overall Study|Patient Personal Reasons|0|||
27856013|NCT00121134|81306615|FG001|Overall Study|Patient Personal Reasons|1|||
27856014|NCT00121134|81306616|FG002|Overall Study|Patient Personal Reasons|0|||
27856015|NCT00121134|81306617|FG003|Overall Study|Patient Personal Reasons|0|||
27856016|NCT00895947|81306618|FG000|Overall Study|Adverse Event|3|||
27856017|NCT00895947|81306619|FG001|Overall Study|Adverse Event|4|||
27856018|NCT00895947|81306618|FG000|Overall Study|Lost to Follow-up|3|||
27856019|NCT00895947|81306619|FG001|Overall Study|Lost to Follow-up|4|||
27856020|NCT00895947|81306618|FG000|Overall Study|Protocol Violation|4|||
27856021|NCT00895947|81306619|FG001|Overall Study|Protocol Violation|2|||
27856022|NCT00895947|81306618|FG000|Overall Study|Withdrawal by Subject|2|||
27856023|NCT00895947|81306619|FG001|Overall Study|Withdrawal by Subject|0|||
27856024|NCT03233230|81306620|FG000|Overall Study|Adverse Event|6|||
27856025|NCT03233230|81306621|FG001|Overall Study|Adverse Event|3|||
27856026|NCT03233230|81306622|FG002|Overall Study|Adverse Event|6|||
27856027|NCT03233230|81306623|FG003|Overall Study|Adverse Event|3|||
27856028|NCT03233230|81306620|FG000|Overall Study|Protocol Violation|1|||
27856029|NCT03233230|81306621|FG001|Overall Study|Protocol Violation|2|||
27856030|NCT03233230|81306622|FG002|Overall Study|Protocol Violation|1|||
27856031|NCT03233230|81306623|FG003|Overall Study|Protocol Violation|1|||
27856032|NCT03233230|81306620|FG000|Overall Study|Lack of Efficacy|1|||
27856033|NCT03233230|81306621|FG001|Overall Study|Lack of Efficacy|0|||
27526395|NCT00973349|80119547|FG014|Overall Study|Inappropriate enrolment|1|||
27856034|NCT03233230|81306622|FG002|Overall Study|Lack of Efficacy|0|||
27856035|NCT03233230|81306623|FG003|Overall Study|Lack of Efficacy|0|||
27856036|NCT03233230|81306620|FG000|Overall Study|Other|5|||
27856037|NCT03233230|81306621|FG001|Overall Study|Other|5|||
27856038|NCT03233230|81306622|FG002|Overall Study|Other|5|||
27856039|NCT03233230|81306623|FG003|Overall Study|Other|3|||
27856040|NCT03233230|81306620|FG000|Overall Study|Withdrawal by Subject|2|||
27856041|NCT03233230|81306621|FG001|Overall Study|Withdrawal by Subject|2|||
27911186|NCT04202497|81513516|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
27911187|NCT04202497|81513517|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
27911188|NCT00497146|81513520|FG000|Treatment Period|Adverse Event|6|||
27911189|NCT00497146|81513521|FG001|Treatment Period|Adverse Event|2|||
27911190|NCT00497146|81513520|FG000|Treatment Period|Withdrawal by Subject|5|||
27911191|NCT00497146|81513521|FG001|Treatment Period|Withdrawal by Subject|9|||
27911192|NCT00497146|81513520|FG000|Treatment Period|Lost to Follow-up|1|||
27911193|NCT00497146|81513521|FG001|Treatment Period|Lost to Follow-up|3|||
27911194|NCT00497146|81513520|FG000|Treatment Period|Required dialysis|4|||
27911195|NCT00497146|81513521|FG001|Treatment Period|Required dialysis|1|||
27911196|NCT00497146|81513520|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
27911197|NCT00497146|81513521|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
27911198|NCT00497146|81513520|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
27911199|NCT00497146|81513521|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
27911200|NCT00497146|81513520|FG000|Treatment Period|Other Reason|2|||
27911201|NCT00497146|81513521|FG001|Treatment Period|Other Reason|3|||
27911202|NCT00497146|81513520|FG000|Long-term Follow-up Period|Adverse Event|2|||
27911203|NCT00497146|81513521|FG001|Long-term Follow-up Period|Adverse Event|2|||
27911204|NCT00497146|81513520|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
27911205|NCT00497146|81513521|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
27911206|NCT00497146|81513520|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
27911207|NCT00497146|81513521|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
27911208|NCT00497146|81513520|FG000|Long-term Follow-up Period|Other|0|||
27911209|NCT00497146|81513521|FG001|Long-term Follow-up Period|Other|1|||
27911210|NCT04613739|81513522|FG000|Overall Study|Lost to Follow-up|6|||
27911211|NCT04613739|81513523|FG001|Overall Study|Lost to Follow-up|9|||
27911212|NCT04613739|81513522|FG000|Overall Study|potentially duplicative/fraudulent|1|||
27911213|NCT04613739|81513523|FG001|Overall Study|potentially duplicative/fraudulent|3|||
27911214|NCT02155985|81513526|FG000|Overall Study|Withdrawal by Subject|0|||
27911215|NCT02155985|81513527|FG001|Overall Study|Withdrawal by Subject|0|||
27911216|NCT02155985|81513528|FG002|Overall Study|Withdrawal by Subject|1|||
27911217|NCT02155985|81513526|FG000|Overall Study|Lost to Follow-up|1|||
27911218|NCT02155985|81513527|FG001|Overall Study|Lost to Follow-up|0|||
27911219|NCT02155985|81513528|FG002|Overall Study|Lost to Follow-up|0|||
27911220|NCT03280056|81513529|FG000|Overall Study|Withdrawal by Subject|12|||
27911221|NCT03280056|81513530|FG001|Overall Study|Withdrawal by Subject|14|||
27911222|NCT03280056|81513529|FG000|Overall Study|Death|9|||
27911223|NCT03280056|81513530|FG001|Overall Study|Death|2|||
27911224|NCT03280056|81513529|FG000|Overall Study|Adverse Event|1|||
27911225|NCT03280056|81513530|FG001|Overall Study|Adverse Event|3|||
27911226|NCT03280056|81513529|FG000|Overall Study|Lost to Follow-up|1|||
27911227|NCT03280056|81513530|FG001|Overall Study|Lost to Follow-up|1|||
27911228|NCT03280056|81513529|FG000|Overall Study|Physician Decision|0|||
27911229|NCT03280056|81513530|FG001|Overall Study|Physician Decision|1|||
27911230|NCT03280056|81513529|FG000|Overall Study|Early Discontinuation|1|||
27911231|NCT03280056|81513530|FG001|Overall Study|Early Discontinuation|0|||
27911232|NCT01421641|81513531|FG000|Overall Study|Protocol Violation|2|||
27526396|NCT00973349|80119548|FG015|Overall Study|Inappropriate enrolment|1|||
27733213|NCT01307423|80849935|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27911233|NCT01421641|81513532|FG001|Overall Study|Protocol Violation|2|||
27911234|NCT01266824|81513535|FG000|Overall Study|Study terminated prior to completion|2|||
27911235|NCT01266824|81513536|FG001|Overall Study|Study terminated prior to completion|3|||
27911236|NCT02213380|81513537|FG000|Underwent Randomization|Withdrawal by Subject|2|||
27911237|NCT02213380|81513538|FG001|Underwent Randomization|Withdrawal by Subject|0|||
27526397|NCT00973349|80119533|FG000|Overall Study|Protocol Violation|0|||
27526398|NCT00973349|80119534|FG001|Overall Study|Protocol Violation|0|||
27526399|NCT00973349|80119535|FG002|Overall Study|Protocol Violation|0|||
27526400|NCT00973349|80119536|FG003|Overall Study|Protocol Violation|0|||
27526401|NCT00973349|80119537|FG004|Overall Study|Protocol Violation|0|||
27526402|NCT00973349|80119538|FG005|Overall Study|Protocol Violation|0|||
27526403|NCT00973349|80119539|FG006|Overall Study|Protocol Violation|0|||
27526404|NCT00973349|80119540|FG007|Overall Study|Protocol Violation|0|||
27526405|NCT00973349|80119541|FG008|Overall Study|Protocol Violation|1|||
27526406|NCT00973349|80119542|FG009|Overall Study|Protocol Violation|0|||
27526407|NCT00973349|80119543|FG010|Overall Study|Protocol Violation|0|||
27526408|NCT00973349|80119544|FG011|Overall Study|Protocol Violation|0|||
27526409|NCT00973349|80119545|FG012|Overall Study|Protocol Violation|0|||
27526410|NCT00973349|80119546|FG013|Overall Study|Protocol Violation|0|||
27911238|NCT02213380|81513537|FG000|Underwent Randomization|Not treated|3|||
27911239|NCT02213380|81513538|FG001|Underwent Randomization|Not treated|3|||
27911240|NCT02213380|81513537|FG000|Per-protocol Analysis|Protocol Violation|32|||
27526411|NCT00973349|80119547|FG014|Overall Study|Protocol Violation|0|||
27526412|NCT00973349|80119548|FG015|Overall Study|Protocol Violation|0|||
27526413|NCT00973349|80119533|FG000|Overall Study|Unable to classify|0|||
27526414|NCT00973349|80119534|FG001|Overall Study|Unable to classify|0|||
27526415|NCT00973349|80119535|FG002|Overall Study|Unable to classify|0|||
27622984|NCT04541186|80461078|FG002|Main Study|Withdrawal by Subject|0|||
27622985|NCT04541186|80461079|FG003|Main Study|Withdrawal by Subject|0|||
27622986|NCT04541186|80461080|FG004|Main Study|Withdrawal by Subject|0|||
27622987|NCT04541186|80461076|FG000|Main Study|COVID-19-related Dose Interruption|0|||
27622988|NCT04541186|80461077|FG001|Main Study|COVID-19-related Dose Interruption|0|||
27622989|NCT04541186|80461078|FG002|Main Study|COVID-19-related Dose Interruption|0|||
27622990|NCT04541186|80461079|FG003|Main Study|COVID-19-related Dose Interruption|0|||
27622991|NCT04541186|80461080|FG004|Main Study|COVID-19-related Dose Interruption|1|||
27622992|NCT04541186|80461076|FG000|Main Study|Randomized in Error Not Treated|0|||
27622993|NCT04541186|80461077|FG001|Main Study|Randomized in Error Not Treated|0|||
27622994|NCT04541186|80461078|FG002|Main Study|Randomized in Error Not Treated|1|||
27622995|NCT04541186|80461079|FG003|Main Study|Randomized in Error Not Treated|0|||
27622996|NCT04541186|80461080|FG004|Main Study|Randomized in Error Not Treated|0|||
27622997|NCT04541186|80461076|FG000|Fibrate Expansion Study|Other than Specified|0|||
27622998|NCT04541186|80461077|FG001|Fibrate Expansion Study|Other than Specified|0|||
27622999|NCT04541186|80461078|FG002|Fibrate Expansion Study|Other than Specified|0|||
27623000|NCT04541186|80461079|FG003|Fibrate Expansion Study|Other than Specified|0|||
27623001|NCT04541186|80461080|FG004|Fibrate Expansion Study|Other than Specified|1|||
27623002|NCT01417000|80461081|FG000|Overall Study|Death|59|||
27623003|NCT01417000|80461082|FG001|Overall Study|Death|28|||
27623004|NCT01417000|80461081|FG000|Overall Study|Lost to Follow-up|1|||
27623005|NCT01417000|80461082|FG001|Overall Study|Lost to Follow-up|0|||
27623006|NCT01417000|80461081|FG000|Overall Study|Study Terminated by Sponsor|1|||
27623007|NCT01417000|80461082|FG001|Overall Study|Study Terminated by Sponsor|1|||
27623008|NCT01734811|80461085|FG000|Overall Study|Lost to Follow-up|2|||
27623009|NCT01734811|80461086|FG001|Overall Study|Lost to Follow-up|3|||
27623010|NCT01734811|80461085|FG000|Overall Study|Withdrawal by Subject|2|||
27623011|NCT01734811|80461086|FG001|Overall Study|Withdrawal by Subject|0|||
27623012|NCT02498613|80461088|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
27623013|NCT02498613|80461089|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
27623014|NCT02498613|80461090|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
27623015|NCT02498613|80461091|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
27623016|NCT02498613|80461088|FG000|Overall Study|Withdrawal by Subject|3|||
27623017|NCT02498613|80461089|FG001|Overall Study|Withdrawal by Subject|1|||
27623018|NCT02498613|80461090|FG002|Overall Study|Withdrawal by Subject|0|||
27623019|NCT02498613|80461091|FG003|Overall Study|Withdrawal by Subject|0|||
27623020|NCT04226495|80461096|FG000|Overall Study|Withdrawal by Subject|3|||
27623021|NCT04226495|80461097|FG001|Overall Study|Withdrawal by Subject|3|||
27623022|NCT04226495|80461096|FG000|Overall Study|PI discretion|2|||
27623023|NCT04226495|80461097|FG001|Overall Study|PI discretion|4|||
27623024|NCT01072929|80461098|FG000|Overall Study|Adverse Event|8|||
27623025|NCT01072929|80461099|FG001|Overall Study|Adverse Event|11|||
27623026|NCT01072929|80461100|FG002|Overall Study|Adverse Event|2|||
27623027|NCT01072929|80461098|FG000|Overall Study|Lack of Efficacy|7|||
27623028|NCT01072929|80461099|FG001|Overall Study|Lack of Efficacy|4|||
27623029|NCT01072929|80461100|FG002|Overall Study|Lack of Efficacy|0|||
27623030|NCT01072929|80461098|FG000|Overall Study|Withdrawal by Subject|7|||
27623031|NCT01072929|80461099|FG001|Overall Study|Withdrawal by Subject|15|||
27623032|NCT01072929|80461100|FG002|Overall Study|Withdrawal by Subject|3|||
27623033|NCT01072929|80461098|FG000|Overall Study|Protocol Violation|13|||
27623034|NCT01072929|80461099|FG001|Overall Study|Protocol Violation|11|||
27623035|NCT01072929|80461100|FG002|Overall Study|Protocol Violation|2|||
27623036|NCT01072929|80461098|FG000|Overall Study|Lost to Follow-up|8|||
27623037|NCT01072929|80461099|FG001|Overall Study|Lost to Follow-up|4|||
27623038|NCT01072929|80461100|FG002|Overall Study|Lost to Follow-up|1|||
27623039|NCT01072929|80461098|FG000|Overall Study|Noncompliance with study medication|0|||
27623040|NCT01072929|80461099|FG001|Overall Study|Noncompliance with study medication|3|||
27623041|NCT01072929|80461100|FG002|Overall Study|Noncompliance with study medication|0|||
27623042|NCT01072929|80461098|FG000|Overall Study|Noncompliance with study procedures|1|||
27623043|NCT01072929|80461099|FG001|Overall Study|Noncompliance with study procedures|0|||
27623044|NCT01072929|80461100|FG002|Overall Study|Noncompliance with study procedures|1|||
27623045|NCT01072929|80461098|FG000|Overall Study|Other|0|||
27623046|NCT01072929|80461099|FG001|Overall Study|Other|3|||
27733214|NCT01307423|80849936|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27733215|NCT01307423|80849937|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27856042|NCT03233230|81306622|FG002|Overall Study|Withdrawal by Subject|0|||
27623047|NCT01072929|80461100|FG002|Overall Study|Other|0|||
27623048|NCT05177848|80461102|FG000|Overall Study|Lost to Follow-up|1|||
27623049|NCT05177848|80461103|FG001|Overall Study|Lost to Follow-up|4|||
27623050|NCT05177848|80461102|FG000|Overall Study|Discontinued|2|||
27623051|NCT05177848|80461103|FG001|Overall Study|Discontinued|1|||
27623052|NCT00783718|80461104|FG000|Induction Phase|Adverse Event|4|||
27623053|NCT00783718|80461105|FG001|Induction Phase|Adverse Event|0|||
27856043|NCT03233230|81306623|FG003|Overall Study|Withdrawal by Subject|1|||
27623054|NCT00783718|80461106|FG002|Induction Phase|Adverse Event|7|||
27623055|NCT00783718|80461107|FG003|Induction Phase|Adverse Event|0|||
27623056|NCT00783718|80461108|FG004|Induction Phase|Adverse Event|0|||
27623057|NCT00783718|80461109|FG005|Induction Phase|Adverse Event|0|||
27623058|NCT00783718|80461110|FG006|Induction Phase|Adverse Event|0|||
27623059|NCT00783718|80461104|FG000|Induction Phase|Protocol Violation|1|||
27623060|NCT00783718|80461105|FG001|Induction Phase|Protocol Violation|1|||
27623061|NCT00783718|80461106|FG002|Induction Phase|Protocol Violation|6|||
27623062|NCT00783718|80461107|FG003|Induction Phase|Protocol Violation|0|||
27623063|NCT00783718|80461108|FG004|Induction Phase|Protocol Violation|0|||
27623064|NCT00783718|80461109|FG005|Induction Phase|Protocol Violation|0|||
27623065|NCT00783718|80461110|FG006|Induction Phase|Protocol Violation|0|||
27623066|NCT00783718|80461104|FG000|Induction Phase|Lack of Efficacy|5|||
27623067|NCT00783718|80461105|FG001|Induction Phase|Lack of Efficacy|2|||
27623068|NCT00783718|80461106|FG002|Induction Phase|Lack of Efficacy|14|||
27623069|NCT00783718|80461107|FG003|Induction Phase|Lack of Efficacy|0|||
27623070|NCT00783718|80461108|FG004|Induction Phase|Lack of Efficacy|0|||
27623071|NCT00783718|80461109|FG005|Induction Phase|Lack of Efficacy|0|||
27623072|NCT00783718|80461110|FG006|Induction Phase|Lack of Efficacy|0|||
27623073|NCT00783718|80461104|FG000|Induction Phase|Withdrawal by Subject|3|||
27623074|NCT00783718|80461105|FG001|Induction Phase|Withdrawal by Subject|4|||
27623075|NCT00783718|80461106|FG002|Induction Phase|Withdrawal by Subject|8|||
27623076|NCT00783718|80461107|FG003|Induction Phase|Withdrawal by Subject|0|||
27623077|NCT00783718|80461108|FG004|Induction Phase|Withdrawal by Subject|0|||
27623078|NCT00783718|80461109|FG005|Induction Phase|Withdrawal by Subject|0|||
27623079|NCT00783718|80461110|FG006|Induction Phase|Withdrawal by Subject|0|||
27623080|NCT00783718|80461104|FG000|Induction Phase|Lost to Follow-up|1|||
27623081|NCT00783718|80461105|FG001|Induction Phase|Lost to Follow-up|0|||
27623082|NCT00783718|80461106|FG002|Induction Phase|Lost to Follow-up|1|||
27623083|NCT00783718|80461107|FG003|Induction Phase|Lost to Follow-up|0|||
27623084|NCT00783718|80461108|FG004|Induction Phase|Lost to Follow-up|0|||
27623085|NCT00783718|80461109|FG005|Induction Phase|Lost to Follow-up|0|||
27623086|NCT00783718|80461110|FG006|Induction Phase|Lost to Follow-up|0|||
27623087|NCT00783718|80461104|FG000|Maintenance Phase|Adverse Event|12|||
27623088|NCT00783718|80461105|FG001|Maintenance Phase|Adverse Event|0|||
27623089|NCT00783718|80461106|FG002|Maintenance Phase|Adverse Event|0|||
27623090|NCT00783718|80461107|FG003|Maintenance Phase|Adverse Event|15|||
27623091|NCT00783718|80461108|FG004|Maintenance Phase|Adverse Event|7|||
27623092|NCT00783718|80461109|FG005|Maintenance Phase|Adverse Event|6|||
27623093|NCT00783718|80461110|FG006|Maintenance Phase|Adverse Event|16|||
27623094|NCT00783718|80461104|FG000|Maintenance Phase|Protocol Violation|1|||
27623095|NCT00783718|80461105|FG001|Maintenance Phase|Protocol Violation|0|||
27623096|NCT00783718|80461106|FG002|Maintenance Phase|Protocol Violation|0|||
27623097|NCT00783718|80461107|FG003|Maintenance Phase|Protocol Violation|0|||
27623098|NCT00783718|80461108|FG004|Maintenance Phase|Protocol Violation|0|||
27623099|NCT00783718|80461109|FG005|Maintenance Phase|Protocol Violation|0|||
27623100|NCT00783718|80461110|FG006|Maintenance Phase|Protocol Violation|2|||
27623101|NCT00783718|80461104|FG000|Maintenance Phase|Lack of Efficacy|83|||
27623102|NCT00783718|80461105|FG001|Maintenance Phase|Lack of Efficacy|0|||
27623103|NCT00783718|80461106|FG002|Maintenance Phase|Lack of Efficacy|0|||
27623104|NCT00783718|80461107|FG003|Maintenance Phase|Lack of Efficacy|61|||
27623105|NCT00783718|80461108|FG004|Maintenance Phase|Lack of Efficacy|31|||
27623106|NCT00783718|80461109|FG005|Maintenance Phase|Lack of Efficacy|33|||
27623107|NCT00783718|80461110|FG006|Maintenance Phase|Lack of Efficacy|155|||
27623108|NCT00783718|80461104|FG000|Maintenance Phase|Withdrawal by Subject|6|||
27623109|NCT00783718|80461105|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27623110|NCT00783718|80461106|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27623111|NCT00783718|80461107|FG003|Maintenance Phase|Withdrawal by Subject|2|||
27623112|NCT00783718|80461108|FG004|Maintenance Phase|Withdrawal by Subject|5|||
27623113|NCT00783718|80461109|FG005|Maintenance Phase|Withdrawal by Subject|2|||
27623114|NCT00783718|80461110|FG006|Maintenance Phase|Withdrawal by Subject|20|||
27623115|NCT00783718|80461104|FG000|Maintenance Phase|Lost to Follow-up|3|||
27733216|NCT01307423|80849938|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
27733217|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
27733218|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
27733219|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
27911241|NCT02213380|81513538|FG001|Per-protocol Analysis|Protocol Violation|36|||
27623116|NCT00783718|80461105|FG001|Maintenance Phase|Lost to Follow-up|0|||
27623117|NCT00783718|80461106|FG002|Maintenance Phase|Lost to Follow-up|0|||
27623118|NCT00783718|80461107|FG003|Maintenance Phase|Lost to Follow-up|0|||
27623119|NCT00783718|80461108|FG004|Maintenance Phase|Lost to Follow-up|2|||
27623120|NCT00783718|80461109|FG005|Maintenance Phase|Lost to Follow-up|0|||
27623121|NCT00783718|80461110|FG006|Maintenance Phase|Lost to Follow-up|2|||
27623122|NCT02373813|80461111|FG000|Run-In Period|Other, Not Specified|5|||
27623123|NCT02373813|80461112|FG001|Run-In Period|Other, Not Specified|0|||
27623124|NCT02373813|80461113|FG002|Run-In Period|Other, Not Specified|0|||
27623125|NCT02373813|80461114|FG003|Run-In Period|Other, Not Specified|0|||
27623126|NCT02373813|80461111|FG000|Run-In Period|Withdrawal by Subject|16|||
27623127|NCT02373813|80461112|FG001|Run-In Period|Withdrawal by Subject|0|||
27623128|NCT02373813|80461113|FG002|Run-In Period|Withdrawal by Subject|0|||
27623129|NCT02373813|80461114|FG003|Run-In Period|Withdrawal by Subject|0|||
27623130|NCT02373813|80461111|FG000|Run-In Period|Decision by Sponsor|11|||
27623131|NCT02373813|80461112|FG001|Run-In Period|Decision by Sponsor|0|||
27623132|NCT02373813|80461113|FG002|Run-In Period|Decision by Sponsor|0|||
27623133|NCT02373813|80461114|FG003|Run-In Period|Decision by Sponsor|0|||
27623134|NCT02373813|80461111|FG000|Run-In Period|Protocol Violation|75|||
27623135|NCT02373813|80461112|FG001|Run-In Period|Protocol Violation|0|||
27623136|NCT02373813|80461113|FG002|Run-In Period|Protocol Violation|0|||
27623137|NCT02373813|80461114|FG003|Run-In Period|Protocol Violation|0|||
27623138|NCT02373813|80461111|FG000|Run-In Period|Lost to Follow-up|2|||
27733220|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
27733221|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
27733222|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
27733223|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
27733224|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
27733225|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
27733226|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
27733227|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
27733228|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
27733229|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
27733230|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
27733231|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
27733232|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
27856044|NCT03233230|81306620|FG000|Overall Study|Lost to Follow-up|0|||
27856045|NCT03233230|81306621|FG001|Overall Study|Lost to Follow-up|3|||
27911242|NCT01419535|81513539|FG000|Overall Study|could not maintain iv line|1|||
27911243|NCT01419535|81513540|FG001|Overall Study|could not maintain iv line|1|||
27911244|NCT01419535|81513539|FG000|Overall Study|Withdrawal by Subject|0|||
27911245|NCT01419535|81513540|FG001|Overall Study|Withdrawal by Subject|1|||
27911246|NCT01081626|81513541|FG000|Overall Study|Dosing error|1|||
27911247|NCT01081626|81513542|FG001|Overall Study|Dosing error|1|||
27911248|NCT01081626|81513541|FG000|Overall Study|Missing Estradiol|25|||
27911249|NCT01081626|81513542|FG001|Overall Study|Missing Estradiol|28|||
27911250|NCT01081626|81513541|FG000|Overall Study|Low antral follicle count|1|||
27911251|NCT01081626|81513542|FG001|Overall Study|Low antral follicle count|0|||
27911252|NCT01081626|81513541|FG000|Overall Study|Overstimulation|0|||
27911253|NCT01081626|81513542|FG001|Overall Study|Overstimulation|1|||
27911254|NCT01081626|81513541|FG000|Overall Study|Lost to Follow-up|0|||
27911255|NCT01081626|81513542|FG001|Overall Study|Lost to Follow-up|1|||
27911256|NCT01081626|81513541|FG000|Overall Study|Other|33|||
27911257|NCT01081626|81513542|FG001|Overall Study|Other|30|||
27911258|NCT01845597|81513546|FG000|Overall Study|Death|8|||
27911259|NCT01845597|81513546|FG000|Overall Study|Lost to Follow-up|22|||
27911260|NCT02258659|81513552|FG000|Overall Study|Withdrawal by Subject|1|||
27911261|NCT00357877|81513556|FG000|Overall Study|Death|2|||
27911262|NCT00357877|81513557|FG001|Overall Study|Death|1|||
27911263|NCT00357877|81513556|FG000|Overall Study|Lost to Follow-up|20|||
27911264|NCT00357877|81513557|FG001|Overall Study|Lost to Follow-up|23|||
27911265|NCT00357877|81513556|FG000|Overall Study|Withdrawal by Subject|3|||
27856046|NCT03233230|81306622|FG002|Overall Study|Lost to Follow-up|0|||
27856047|NCT03233230|81306623|FG003|Overall Study|Lost to Follow-up|0|||
27856048|NCT04620135|81306625|FG000|Study Completion|Adverse Event|2|||
27856049|NCT04620135|81306626|FG001|Study Completion|Adverse Event|3|||
27856050|NCT04620135|81306625|FG000|Study Completion|Withdrawal by Subject|2|||
27856051|NCT04620135|81306626|FG001|Study Completion|Withdrawal by Subject|0|||
27856052|NCT00742924|81306628|FG000|Overall Study|Adverse Event|0|||
27856053|NCT00742924|81306629|FG001|Overall Study|Adverse Event|0|||
27856054|NCT00742924|81306630|FG002|Overall Study|Adverse Event|1|||
27856055|NCT00742924|81306631|FG003|Overall Study|Adverse Event|1|||
27623139|NCT02373813|80461112|FG001|Run-In Period|Lost to Follow-up|0|||
27856056|NCT00742924|81306628|FG000|Overall Study|Lack of Efficacy|5|||
27856057|NCT00742924|81306629|FG001|Overall Study|Lack of Efficacy|1|||
27856058|NCT00742924|81306630|FG002|Overall Study|Lack of Efficacy|2|||
27623140|NCT02373813|80461113|FG002|Run-In Period|Lost to Follow-up|0|||
27623141|NCT02373813|80461114|FG003|Run-In Period|Lost to Follow-up|0|||
27623142|NCT02373813|80461111|FG000|Run-In Period|Adverse Event|3|||
27623143|NCT02373813|80461112|FG001|Run-In Period|Adverse Event|0|||
27911266|NCT00357877|81513557|FG001|Overall Study|Withdrawal by Subject|3|||
27911267|NCT00357877|81513556|FG000|Overall Study|Administrative withdrawal|1|||
27911268|NCT00357877|81513557|FG001|Overall Study|Administrative withdrawal|1|||
27911269|NCT00357877|81513556|FG000|Overall Study|Other|0|||
27911270|NCT00357877|81513557|FG001|Overall Study|Other|2|||
27911271|NCT04399889|81513558|FG000|Overall Study|Death|5|||
27911272|NCT04399889|81513559|FG001|Overall Study|Death|1|||
27911273|NCT04399889|81513560|FG002|Overall Study|Death|1|||
27911274|NCT00618826|81513561|FG000|Overall Study|Adverse Event|1|||
27911275|NCT00424593|81513562|FG000|Acute Double-Blind Period|Adverse Event|16|||
27911276|NCT00424593|81513563|FG001|Acute Double-Blind Period|Adverse Event|7|||
27911277|NCT00424593|81513562|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
27911278|NCT00424593|81513563|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
27911279|NCT00424593|81513562|FG000|Acute Double-Blind Period|Protocol Violation|2|||
27623144|NCT02373813|80461113|FG002|Run-In Period|Adverse Event|0|||
27623145|NCT02373813|80461114|FG003|Run-In Period|Adverse Event|0|||
27623146|NCT02373813|80461111|FG000|Run-In Period|Noncompliance|1|||
27623147|NCT02373813|80461112|FG001|Run-In Period|Noncompliance|0|||
27623148|NCT02373813|80461113|FG002|Run-In Period|Noncompliance|0|||
27623149|NCT02373813|80461114|FG003|Run-In Period|Noncompliance|0|||
27623150|NCT02373813|80461111|FG000|Run-In Period|Ineligibility Determined|3|||
27623151|NCT02373813|80461112|FG001|Run-In Period|Ineligibility Determined|0|||
27623152|NCT02373813|80461113|FG002|Run-In Period|Ineligibility Determined|0|||
27623153|NCT02373813|80461114|FG003|Run-In Period|Ineligibility Determined|0|||
27623154|NCT02373813|80461111|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
27623155|NCT02373813|80461112|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
27623156|NCT02373813|80461113|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
27623157|NCT02373813|80461114|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
27623158|NCT02373813|80461111|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27623159|NCT02373813|80461112|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
27623160|NCT02373813|80461113|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
27623161|NCT02373813|80461114|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
27623162|NCT02373813|80461111|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27623163|NCT02373813|80461112|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
27623164|NCT02373813|80461113|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
27623165|NCT02373813|80461114|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
27623166|NCT02373813|80461111|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27623167|NCT02373813|80461112|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
27623168|NCT02373813|80461113|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
27623169|NCT02373813|80461114|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
27623170|NCT01140347|80461115|FG000|Overall Study|Lost to Follow-up|5|||
27623171|NCT01140347|80461116|FG001|Overall Study|Lost to Follow-up|6|||
27623172|NCT01140347|80461115|FG000|Overall Study|Withdrawal by Subject|13|||
27623173|NCT01140347|80461116|FG001|Overall Study|Withdrawal by Subject|8|||
27623174|NCT00859014|80461119|FG000|Overall Study|Death|4|||
27623175|NCT00859014|80461119|FG000|Overall Study|Lost to Follow-up|1|||
27623176|NCT00953160|80461127|FG000|Overall Study|Lost to Follow-up|23|||
27623177|NCT00953160|80461127|FG000|Overall Study|Withdrawal by Subject|4|||
27623178|NCT02724020|80461128|FG000|Overall Study|Death|16|||
27623179|NCT02724020|80461129|FG001|Overall Study|Death|18|||
27623180|NCT02724020|80461130|FG002|Overall Study|Death|19|||
27623181|NCT02724020|80461128|FG000|Overall Study|Lost to Follow-up|0|||
27623182|NCT02724020|80461129|FG001|Overall Study|Lost to Follow-up|3|||
27623183|NCT02724020|80461130|FG002|Overall Study|Lost to Follow-up|0|||
27623184|NCT02724020|80461128|FG000|Overall Study|Site Terminated by Sponsor|15|||
27623185|NCT02724020|80461129|FG001|Overall Study|Site Terminated by Sponsor|8|||
27623186|NCT02724020|80461130|FG002|Overall Study|Site Terminated by Sponsor|8|||
27623187|NCT02724020|80461128|FG000|Overall Study|Withdrawal by Subject|1|||
27623188|NCT02724020|80461129|FG001|Overall Study|Withdrawal by Subject|3|||
27623189|NCT02724020|80461130|FG002|Overall Study|Withdrawal by Subject|5|||
27623190|NCT00761774|80461131|FG000|Overall Study|Adverse Event|17|||
27623191|NCT00761774|80461131|FG000|Overall Study|Lack of Efficacy|37|||
27623192|NCT00761774|80461131|FG000|Overall Study|Lost to Follow-up|2|||
27623193|NCT00761774|80461131|FG000|Overall Study|Withdrawal by Subject|9|||
27623194|NCT00761774|80461131|FG000|Overall Study|Non-compliance|4|||
27623195|NCT00761774|80461131|FG000|Overall Study|End of study|2|||
27623196|NCT00761774|80461131|FG000|Overall Study|Reclassification of seizures|1|||
27623197|NCT00761774|80461131|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
27911280|NCT00424593|81513563|FG001|Acute Double-Blind Period|Protocol Violation|2|||
27623198|NCT00761774|80461131|FG000|Overall Study|Sponsor decision|1|||
27623199|NCT00761774|80461131|FG000|Overall Study|Investigator clinical judgement|1|||
27623200|NCT00761774|80461131|FG000|Overall Study|Patient moved out of study area|1|||
27623201|NCT00761774|80461131|FG000|Overall Study|Coordinator leaving site|1|||
27623202|NCT00761774|80461131|FG000|Overall Study|Subject IP non-compliance|1|||
27623203|NCT00761774|80461131|FG000|Overall Study|IP stopped by hospital physician|1|||
27623204|NCT01238575|80461132|FG000|Overall Study|Lack of Efficacy|2|||
27623205|NCT01238575|80461133|FG001|Overall Study|Lack of Efficacy|4|||
27623206|NCT01238575|80461132|FG000|Overall Study|Adverse Event|2|||
27623207|NCT01238575|80461133|FG001|Overall Study|Adverse Event|0|||
27623208|NCT01636362|80461134|FG000|Overall Study|Physician Decision|6|||
27911281|NCT00424593|81513562|FG000|Acute Double-Blind Period|Physician Decision|1|||
27911282|NCT00424593|81513563|FG001|Acute Double-Blind Period|Physician Decision|2|||
27733233|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
27733234|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
27733235|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733236|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27856059|NCT00742924|81306631|FG003|Overall Study|Lack of Efficacy|4|||
27856060|NCT00742924|81306628|FG000|Overall Study|Physician Decision|0|||
27856061|NCT00742924|81306629|FG001|Overall Study|Physician Decision|0|||
27856062|NCT00742924|81306630|FG002|Overall Study|Physician Decision|0|||
27856063|NCT00742924|81306631|FG003|Overall Study|Physician Decision|1|||
27856064|NCT00742924|81306628|FG000|Overall Study|Withdrawal by Subject|0|||
27856065|NCT00742924|81306629|FG001|Overall Study|Withdrawal by Subject|1|||
27526416|NCT00973349|80119536|FG003|Overall Study|Unable to classify|0|||
27526417|NCT00973349|80119537|FG004|Overall Study|Unable to classify|1|||
27526418|NCT00973349|80119538|FG005|Overall Study|Unable to classify|1|||
27526419|NCT00973349|80119539|FG006|Overall Study|Unable to classify|0|||
27526420|NCT00973349|80119540|FG007|Overall Study|Unable to classify|0|||
27526421|NCT00973349|80119541|FG008|Overall Study|Unable to classify|0|||
27526422|NCT00973349|80119542|FG009|Overall Study|Unable to classify|1|||
27526423|NCT00973349|80119543|FG010|Overall Study|Unable to classify|0|||
27526424|NCT00973349|80119544|FG011|Overall Study|Unable to classify|0|||
27526425|NCT00973349|80119545|FG012|Overall Study|Unable to classify|0|||
27526426|NCT00973349|80119546|FG013|Overall Study|Unable to classify|0|||
27526427|NCT00973349|80119547|FG014|Overall Study|Unable to classify|0|||
27526428|NCT00973349|80119548|FG015|Overall Study|Unable to classify|0|||
27623209|NCT01636362|80461134|FG000|Overall Study|Subject healed, not returning|1|||
27623210|NCT01636362|80461134|FG000|Overall Study|Withdrawal by Subject|1|||
27623211|NCT02531438|80461136|FG000|Overall Study|Adverse Event|7|||
27623212|NCT02531438|80461137|FG001|Overall Study|Adverse Event|9|||
27623213|NCT02531438|80461136|FG000|Overall Study|Lost to Follow-up|0|||
27623214|NCT02531438|80461137|FG001|Overall Study|Lost to Follow-up|3|||
27623215|NCT02531438|80461136|FG000|Overall Study|Withdrawal by Subject|7|||
27623216|NCT02531438|80461137|FG001|Overall Study|Withdrawal by Subject|8|||
27623217|NCT02531438|80461136|FG000|Overall Study|Physician Decision|0|||
27623218|NCT02531438|80461137|FG001|Overall Study|Physician Decision|1|||
27623219|NCT02531438|80461136|FG000|Overall Study|Death|6|||
27623220|NCT02531438|80461137|FG001|Overall Study|Death|3|||
27623221|NCT02531438|80461136|FG000|Overall Study|Randomized, but Not Treated|4|||
27623222|NCT02531438|80461137|FG001|Overall Study|Randomized, but Not Treated|0|||
27623223|NCT02531438|80461136|FG000|Overall Study|Missed EOT/PTE Visit|5|||
27623224|NCT02531438|80461137|FG001|Overall Study|Missed EOT/PTE Visit|2|||
27623225|NCT02531438|80461136|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
27623226|NCT02531438|80461137|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
27623227|NCT00562965|80461138|FG000|Overall Study|Withdrawal by Subject|0|||
27623228|NCT00562965|80461139|FG001|Overall Study|Withdrawal by Subject|1|||
27623229|NCT00562965|80461138|FG000|Overall Study|Death|2|||
27623230|NCT00562965|80461139|FG001|Overall Study|Death|4|||
27623231|NCT00562965|80461138|FG000|Overall Study|Lost to Follow-up|1|||
27623232|NCT00562965|80461139|FG001|Overall Study|Lost to Follow-up|0|||
27623233|NCT00562965|80461138|FG000|Overall Study|Other|0|||
27623234|NCT00562965|80461139|FG001|Overall Study|Other|1|||
27623235|NCT02368886|80461142|FG000|Overall Study|Cancel|1|||
27623236|NCT02368886|80461143|FG001|Overall Study|Cancel|1|||
27623237|NCT02368886|80461144|FG002|Overall Study|Cancel|1|||
27856066|NCT00742924|81306630|FG002|Overall Study|Withdrawal by Subject|1|||
27856067|NCT00742924|81306631|FG003|Overall Study|Withdrawal by Subject|0|||
27856068|NCT00714493|81306633|FG000|Overall Study|Adverse Event|11|||
27856069|NCT00714493|81306633|FG000|Overall Study|Death|3|||
27856070|NCT00714493|81306633|FG000|Overall Study|Lack of Efficacy|10|||
27856071|NCT00714493|81306633|FG000|Overall Study|Lost to Follow-up|3|||
27856072|NCT00714493|81306633|FG000|Overall Study|Protocol Violation|12|||
27856073|NCT00714493|81306633|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
27856074|NCT00714493|81306633|FG000|Overall Study|OTHER|2|||
27856075|NCT00574912|81306639|FG000|Overall Study|Could not place IV lines.|3|||
27911283|NCT00424593|81513562|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
27856076|NCT00574912|81306639|FG000|Overall Study|scheduling conflicts|3|||
27526429|NCT02101112|80119553|FG000|Overall Study|Adverse Event|0|||
27526430|NCT02101112|80119554|FG001|Overall Study|Adverse Event|0|||
27526431|NCT02101112|80119555|FG002|Overall Study|Adverse Event|1|||
27623238|NCT02368886|80461145|FG003|Overall Study|Cancel|3|||
27623239|NCT02368886|80461142|FG000|Overall Study|Ineligible|0|||
27623240|NCT02368886|80461143|FG001|Overall Study|Ineligible|0|||
27623241|NCT02368886|80461144|FG002|Overall Study|Ineligible|0|||
27623242|NCT02368886|80461145|FG003|Overall Study|Ineligible|1|||
27623243|NCT00430677|80461146|FG000|Short-term Period|Death|1|||
27526432|NCT02101112|80119556|FG003|Overall Study|Adverse Event|0|||
27623244|NCT00430677|80461147|FG001|Short-term Period|Death|1|||
27623245|NCT00430677|80461148|FG002|Short-term Period|Death|5|||
27733237|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733238|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733239|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733240|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
27733241|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733242|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733243|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
27733244|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
27733245|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
27733246|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
27733247|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
27733248|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
27733249|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
27733250|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
27733251|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
27733252|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
27733253|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733254|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733255|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733256|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
27733257|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733258|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733259|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733260|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733261|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
27733262|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
27733263|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
27733264|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
27733265|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
27733266|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
27733267|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
27733268|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
27733269|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
27733270|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
27733271|NCT01307423|80849930|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733272|NCT01307423|80849931|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733273|NCT01307423|80849932|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733274|NCT01307423|80849933|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733275|NCT01307423|80849934|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733276|NCT01307423|80849935|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
27733277|NCT01307423|80849936|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733278|NCT01307423|80849937|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733279|NCT01307423|80849938|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
27733280|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27733281|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
27733282|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
27733283|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27733284|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27733285|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27733286|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
27733287|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
27733288|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
27733289|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27733290|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
27733291|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
27733292|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27733293|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27733294|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27733295|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
27733296|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
27733297|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
27733298|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27911284|NCT00424593|81513563|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
27911285|NCT00424593|81513562|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
27733299|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27733300|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
27733301|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27623246|NCT00430677|80461146|FG000|Short-term Period|Adverse Event|15|||
27623247|NCT00430677|80461147|FG001|Short-term Period|Adverse Event|13|||
27623248|NCT00430677|80461148|FG002|Short-term Period|Adverse Event|9|||
27623249|NCT00430677|80461146|FG000|Short-term Period|Lack of Efficacy|5|||
27623250|NCT00430677|80461147|FG001|Short-term Period|Lack of Efficacy|6|||
27623251|NCT00430677|80461148|FG002|Short-term Period|Lack of Efficacy|4|||
27623252|NCT00430677|80461146|FG000|Short-term Period|Withdrawal by Subject|1|||
27623253|NCT00430677|80461147|FG001|Short-term Period|Withdrawal by Subject|1|||
27623254|NCT00430677|80461148|FG002|Short-term Period|Withdrawal by Subject|2|||
27623255|NCT00430677|80461146|FG000|Short-term Period|Participant no longer met study criteria|1|||
27623256|NCT00430677|80461147|FG001|Short-term Period|Participant no longer met study criteria|1|||
27623257|NCT00430677|80461148|FG002|Short-term Period|Participant no longer met study criteria|2|||
27623258|NCT00430677|80461146|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
27623259|NCT00430677|80461147|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
27623260|NCT00430677|80461148|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
27623261|NCT00430677|80461146|FG000|Short-term Period|Pregnancy|0|||
27623262|NCT00430677|80461147|FG001|Short-term Period|Pregnancy|2|||
27623263|NCT00430677|80461148|FG002|Short-term Period|Pregnancy|0|||
27623264|NCT00430677|80461146|FG000|Long-term Extension Period|Death|1|||
27623265|NCT00430677|80461147|FG001|Long-term Extension Period|Death|0|||
27623266|NCT00430677|80461148|FG002|Long-term Extension Period|Death|0|||
27623267|NCT00430677|80461146|FG000|Long-term Extension Period|Adverse Event|3|||
27623268|NCT00430677|80461147|FG001|Long-term Extension Period|Adverse Event|2|||
27623269|NCT00430677|80461148|FG002|Long-term Extension Period|Adverse Event|5|||
27623270|NCT00430677|80461146|FG000|Long-term Extension Period|Lack of Efficacy|5|||
27623271|NCT00430677|80461147|FG001|Long-term Extension Period|Lack of Efficacy|3|||
27623272|NCT00430677|80461148|FG002|Long-term Extension Period|Lack of Efficacy|8|||
27623273|NCT00430677|80461146|FG000|Long-term Extension Period|Lost to Follow-up|1|||
27623274|NCT00430677|80461147|FG001|Long-term Extension Period|Lost to Follow-up|1|||
27623275|NCT00430677|80461148|FG002|Long-term Extension Period|Lost to Follow-up|1|||
27623276|NCT00430677|80461146|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
27623277|NCT00430677|80461147|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
27623278|NCT00430677|80461148|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
27623279|NCT00430677|80461146|FG000|Long-term Extension Period|Pregnancy|1|||
27623280|NCT00430677|80461147|FG001|Long-term Extension Period|Pregnancy|1|||
27623281|NCT00430677|80461148|FG002|Long-term Extension Period|Pregnancy|0|||
27623282|NCT00430677|80461146|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
27623283|NCT00430677|80461147|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
27623284|NCT00430677|80461148|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
27623285|NCT00430677|80461146|FG000|Long-term Extension Period|Other|2|||
27623286|NCT00430677|80461147|FG001|Long-term Extension Period|Other|1|||
27623287|NCT00430677|80461148|FG002|Long-term Extension Period|Other|1|||
27623288|NCT00430677|80461146|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
27623289|NCT00430677|80461147|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
27623290|NCT00430677|80461148|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
27623291|NCT00530777|80461149|FG000|Overall Study|Lost to Follow-up|0|||
27623292|NCT00530777|80461150|FG001|Overall Study|Lost to Follow-up|1|||
27623293|NCT00530777|80461149|FG000|Overall Study|Death|1|||
27623294|NCT00530777|80461150|FG001|Overall Study|Death|2|||
27623295|NCT00530777|80461149|FG000|Overall Study|Physician Decision|1|||
27623296|NCT00530777|80461150|FG001|Overall Study|Physician Decision|0|||
27623297|NCT00530777|80461149|FG000|Overall Study|Withdrawal by Subject|0|||
27623298|NCT00530777|80461150|FG001|Overall Study|Withdrawal by Subject|1|||
27623299|NCT00530777|80461149|FG000|Overall Study|Unable to adhere to visit schedule|5|||
27623300|NCT00530777|80461150|FG001|Overall Study|Unable to adhere to visit schedule|1|||
27623301|NCT00184028|80461151|FG000|Overall Study|Death|1|||
27623302|NCT00184028|80461151|FG000|Overall Study|Lack of Efficacy|4|||
27623303|NCT00184028|80461151|FG000|Overall Study|Adverse Event|2|||
27623304|NCT00184028|80461151|FG000|Overall Study|Withdrawal by Subject|1|||
27623305|NCT00184028|80461151|FG000|Overall Study|Non-compliance|2|||
27623306|NCT01244828|80461153|FG000|Overall Study|Adverse Event|37|||
27623307|NCT01244828|80461153|FG000|Overall Study|Withdrawal by Subject|31|||
27623308|NCT01244828|80461153|FG000|Overall Study|Lack of Efficacy|7|||
27623309|NCT01244828|80461153|FG000|Overall Study|Lost to Follow-up|2|||
27623310|NCT01244828|80461153|FG000|Overall Study|Other reason (not specified)|1|||
27623311|NCT01876043|80461154|FG000|Overall Study|Death|1|||
27623312|NCT01876043|80461154|FG000|Overall Study|Withdrawal by Subject|1|||
27623313|NCT03782727|80461156|FG000|Overall Study|Lost to Follow-up|32|||
27623314|NCT02107274|80461157|FG000|Treatment vs. Placebo|Adverse Event|3|||
27623315|NCT02107274|80461158|FG001|Treatment vs. Placebo|Adverse Event|0|||
27623316|NCT02107274|80461157|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
27623317|NCT02107274|80461158|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
27623318|NCT02107274|80461157|FG000|Control Phase|Lost to Follow-up|1|||
27623319|NCT02107274|80461158|FG001|Control Phase|Lost to Follow-up|1|||
27623320|NCT02107274|80461157|FG000|Control Phase|Death|2|||
27526433|NCT02101112|80119557|FG004|Overall Study|Adverse Event|0|||
27526434|NCT02101112|80119558|FG005|Overall Study|Adverse Event|0|||
27526435|NCT02101112|80119553|FG000|Overall Study|Withdrawal by Subject|0|||
27526436|NCT02101112|80119554|FG001|Overall Study|Withdrawal by Subject|0|||
27526437|NCT02101112|80119555|FG002|Overall Study|Withdrawal by Subject|0|||
27526438|NCT02101112|80119556|FG003|Overall Study|Withdrawal by Subject|0|||
27526439|NCT02101112|80119557|FG004|Overall Study|Withdrawal by Subject|1|||
27526440|NCT02101112|80119558|FG005|Overall Study|Withdrawal by Subject|0|||
27526441|NCT03533686|80119559|FG000|Overall Study|Withdrawal by Subject|1|||
27526442|NCT03533686|80119560|FG001|Overall Study|Withdrawal by Subject|0|||
27526443|NCT03533686|80119561|FG002|Overall Study|Withdrawal by Subject|0|||
27526444|NCT03533686|80119562|FG003|Overall Study|Withdrawal by Subject|3|||
27526445|NCT03533686|80119563|FG004|Overall Study|Withdrawal by Subject|5|||
27526446|NCT03533686|80119564|FG005|Overall Study|Withdrawal by Subject|1|||
27526447|NCT03533686|80119559|FG000|Overall Study|Lost to Follow-up|0|||
27526448|NCT03533686|80119560|FG001|Overall Study|Lost to Follow-up|1|||
27526449|NCT03533686|80119561|FG002|Overall Study|Lost to Follow-up|0|||
27526450|NCT03533686|80119562|FG003|Overall Study|Lost to Follow-up|0|||
27526451|NCT03533686|80119563|FG004|Overall Study|Lost to Follow-up|2|||
27526452|NCT03533686|80119564|FG005|Overall Study|Lost to Follow-up|0|||
27623321|NCT02107274|80461158|FG001|Control Phase|Death|0|||
27623322|NCT02107274|80461157|FG000|Control Phase|Adverse Event|0|||
27623323|NCT02107274|80461158|FG001|Control Phase|Adverse Event|1|||
27623324|NCT01427907|80461159|FG000|Overall Study|Withdrawal by Subject|3|||
27623325|NCT01427907|80461160|FG001|Overall Study|Withdrawal by Subject|4|||
27623326|NCT01268059|80464095|FG000|Overall Study|Lost to Follow-up|0|||
27911286|NCT00424593|81513563|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
27623327|NCT01268059|80464096|FG001|Overall Study|Lost to Follow-up|1|||
27623328|NCT01268059|80464097|FG002|Overall Study|Lost to Follow-up|0|||
27623329|NCT01268059|80464098|FG003|Overall Study|Lost to Follow-up|0|||
27623330|NCT01268059|80464095|FG000|Overall Study|Withdrawal by Subject|7|||
27623331|NCT01268059|80464096|FG001|Overall Study|Withdrawal by Subject|4|||
27623332|NCT01268059|80464097|FG002|Overall Study|Withdrawal by Subject|0|||
27623333|NCT01268059|80464098|FG003|Overall Study|Withdrawal by Subject|0|||
27623334|NCT01268059|80464095|FG000|Overall Study|Death|20|||
27623335|NCT01268059|80464096|FG001|Overall Study|Death|30|||
27623336|NCT01268059|80464097|FG002|Overall Study|Death|3|||
27623337|NCT01268059|80464098|FG003|Overall Study|Death|5|||
27623338|NCT01268059|80464095|FG000|Overall Study|Progression of disease|1|||
27623339|NCT01268059|80464096|FG001|Overall Study|Progression of disease|0|||
27623340|NCT01268059|80464097|FG002|Overall Study|Progression of disease|0|||
27623341|NCT01268059|80464098|FG003|Overall Study|Progression of disease|0|||
27623342|NCT01304147|80464099|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
27623343|NCT01304147|80464100|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
27623344|NCT03432533|80464101|FG000|Overall Study|Lost to Follow-up|1|||
27623345|NCT03432533|80464102|FG001|Overall Study|Lost to Follow-up|2|||
27911287|NCT00424593|81513562|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
27623346|NCT03432533|80464101|FG000|Overall Study|Withdrawal by Subject|14|||
27623347|NCT03432533|80464102|FG001|Overall Study|Withdrawal by Subject|9|||
27623348|NCT02692235|80464105|FG000|Overall Study|Withdrawal by Subject|2|||
27623349|NCT02692235|80464106|FG001|Overall Study|Withdrawal by Subject|1|||
27856077|NCT00574912|81306639|FG000|Overall Study|Physician Decision|2|||
27856078|NCT03201250|81306644|FG000|Overall Study|screen failures|3|||
27856079|NCT03201250|81306645|FG001|Overall Study|screen failures|0|||
27856080|NCT03201250|81306646|FG002|Overall Study|screen failures|0|||
27856081|NCT04188301|81306649|FG000|Month 3|Lost to Follow-up|0|||
27856082|NCT04188301|81306650|FG001|Month 3|Lost to Follow-up|0|||
27856083|NCT04188301|81306651|FG002|Month 3|Lost to Follow-up|1|||
27856084|NCT04188301|81306649|FG000|Month 12|Lost to Follow-up|0|||
27856085|NCT04188301|81306650|FG001|Month 12|Lost to Follow-up|0|||
27856086|NCT04188301|81306651|FG002|Month 12|Lost to Follow-up|2|||
27856087|NCT04188301|81306649|FG000|Month 12|Death|1|||
27526453|NCT03533686|80119559|FG000|Overall Study|Screen Failure|0|||
27526454|NCT03533686|80119560|FG001|Overall Study|Screen Failure|0|||
27526455|NCT03533686|80119561|FG002|Overall Study|Screen Failure|0|||
27526456|NCT03533686|80119562|FG003|Overall Study|Screen Failure|2|||
27526457|NCT03533686|80119563|FG004|Overall Study|Screen Failure|0|||
27526458|NCT03533686|80119564|FG005|Overall Study|Screen Failure|0|||
27526459|NCT01074047|80119565|FG000|Treatment Phase|Adverse Event|89|||
27623350|NCT02692235|80464105|FG000|Overall Study|Adverse Event|1|||
27623351|NCT02692235|80464106|FG001|Overall Study|Adverse Event|2|||
27623352|NCT01653743|80464112|FG000|Overall Study|Withdrawal by Subject|1|||
27623353|NCT01653743|80464113|FG001|Overall Study|Withdrawal by Subject|0|||
27623354|NCT01653743|80464112|FG000|Overall Study|Investigator discretion|3|||
27623355|NCT01653743|80464113|FG001|Overall Study|Investigator discretion|0|||
27623356|NCT04236986|80464115|FG000|Overall Study|Withdrawal by Subject|3|||
27856088|NCT04188301|81306650|FG001|Month 12|Death|1|||
27856089|NCT04188301|81306651|FG002|Month 12|Death|0|||
27856090|NCT04188301|81306649|FG000|Month 18|Lost to Follow-up|6|||
27623357|NCT04236986|80464116|FG001|Overall Study|Withdrawal by Subject|1|||
27623358|NCT02099539|80464117|FG000|Overall Study|Progressive Disease|3|||
27623359|NCT02099539|80464118|FG001|Overall Study|Progressive Disease|2|||
27623360|NCT02099539|80464119|FG002|Overall Study|Progressive Disease|2|||
27623361|NCT02099539|80464120|FG003|Overall Study|Progressive Disease|1|||
27623362|NCT02099539|80464121|FG004|Overall Study|Progressive Disease|4|||
27623363|NCT02099539|80464122|FG005|Overall Study|Progressive Disease|2|||
27623364|NCT02099539|80464123|FG006|Overall Study|Progressive Disease|0|||
27623365|NCT02099539|80464117|FG000|Overall Study|Adverse Event|0|||
27623366|NCT02099539|80464118|FG001|Overall Study|Adverse Event|0|||
27623367|NCT02099539|80464119|FG002|Overall Study|Adverse Event|1|||
27623368|NCT02099539|80464120|FG003|Overall Study|Adverse Event|1|||
27623369|NCT02099539|80464121|FG004|Overall Study|Adverse Event|0|||
27623370|NCT02099539|80464122|FG005|Overall Study|Adverse Event|0|||
27623371|NCT02099539|80464123|FG006|Overall Study|Adverse Event|0|||
27623372|NCT02099539|80464117|FG000|Overall Study|Physician Decision|0|||
27623373|NCT02099539|80464118|FG001|Overall Study|Physician Decision|0|||
27623374|NCT02099539|80464119|FG002|Overall Study|Physician Decision|0|||
27623375|NCT02099539|80464120|FG003|Overall Study|Physician Decision|0|||
27623376|NCT02099539|80464121|FG004|Overall Study|Physician Decision|0|||
27623377|NCT02099539|80464122|FG005|Overall Study|Physician Decision|1|||
27623378|NCT02099539|80464123|FG006|Overall Study|Physician Decision|0|||
27623379|NCT02271594|80464124|FG000|Overall Study|Study closed; recruiting failure|19|||
27623380|NCT02271594|80464125|FG001|Overall Study|Study closed; recruiting failure|12|||
27623381|NCT00670540|80464130|FG000|Overall Study|ineligible|17|||
27623382|NCT00670540|80464130|FG000|Overall Study|not living in France|348|||
27623383|NCT00670540|80464130|FG000|Overall Study|refused to participate|189|||
27623384|NCT00670540|80464130|FG000|Overall Study|controls randomised for no follow up|2770|||
27623385|NCT00670540|80464130|FG000|Overall Study|missing information inclusion criteria|1|||
27623386|NCT00367237|80464133|FG000|Overall Study|Adverse Event|7|||
27623387|NCT00367237|80464134|FG001|Overall Study|Adverse Event|2|||
27623388|NCT00367237|80464133|FG000|Overall Study|Lost to Follow-up|1|||
27623389|NCT00367237|80464134|FG001|Overall Study|Lost to Follow-up|0|||
27733302|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27856091|NCT04188301|81306650|FG001|Month 18|Lost to Follow-up|0|||
27856092|NCT04188301|81306651|FG002|Month 18|Lost to Follow-up|0|||
27856093|NCT03050060|81306659|FG000|Overall Study|Adverse Event|7|||
27856094|NCT03050060|81306659|FG000|Overall Study|Withdrawal by Subject|1|||
27856095|NCT03050060|81306659|FG000|Overall Study|Progression|7|||
27856096|NCT02119819|81306660|FG000|Overall Study|Adverse Event|3|||
27856097|NCT02119819|81306661|FG001|Overall Study|Adverse Event|1|||
27856098|NCT02119819|81306662|FG002|Overall Study|Adverse Event|2|||
27856099|NCT02119819|81306663|FG003|Overall Study|Adverse Event|3|||
27856100|NCT02119819|81306664|FG004|Overall Study|Adverse Event|0|||
27856101|NCT02119819|81306665|FG005|Overall Study|Adverse Event|1|||
27856102|NCT02119819|81306660|FG000|Overall Study|Lack of Efficacy|0|||
27856103|NCT02119819|81306661|FG001|Overall Study|Lack of Efficacy|0|||
27856104|NCT02119819|81306662|FG002|Overall Study|Lack of Efficacy|0|||
27856105|NCT02119819|81306663|FG003|Overall Study|Lack of Efficacy|0|||
27856106|NCT02119819|81306664|FG004|Overall Study|Lack of Efficacy|0|||
27856107|NCT02119819|81306665|FG005|Overall Study|Lack of Efficacy|1|||
27856108|NCT02119819|81306660|FG000|Overall Study|Lost to Follow-up|0|||
27856109|NCT02119819|81306661|FG001|Overall Study|Lost to Follow-up|0|||
27856110|NCT02119819|81306662|FG002|Overall Study|Lost to Follow-up|1|||
27856111|NCT02119819|81306663|FG003|Overall Study|Lost to Follow-up|2|||
27856112|NCT02119819|81306664|FG004|Overall Study|Lost to Follow-up|1|||
27856113|NCT02119819|81306665|FG005|Overall Study|Lost to Follow-up|2|||
27856114|NCT02119819|81306660|FG000|Overall Study|Physician Decision|1|||
27856115|NCT02119819|81306661|FG001|Overall Study|Physician Decision|1|||
27856116|NCT02119819|81306662|FG002|Overall Study|Physician Decision|0|||
27856117|NCT02119819|81306663|FG003|Overall Study|Physician Decision|0|||
27856118|NCT02119819|81306664|FG004|Overall Study|Physician Decision|0|||
27856119|NCT02119819|81306665|FG005|Overall Study|Physician Decision|1|||
27856120|NCT02119819|81306660|FG000|Overall Study|Withdrawal by Subject|5|||
27911288|NCT00424593|81513563|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
27856121|NCT02119819|81306661|FG001|Overall Study|Withdrawal by Subject|3|||
27856122|NCT02119819|81306662|FG002|Overall Study|Withdrawal by Subject|0|||
27856123|NCT02119819|81306663|FG003|Overall Study|Withdrawal by Subject|0|||
27623390|NCT00367237|80464133|FG000|Overall Study|Withdrawal by Subject|0|||
27623391|NCT00367237|80464134|FG001|Overall Study|Withdrawal by Subject|4|||
27623392|NCT00367237|80464133|FG000|Overall Study|Protocol Violation|2|||
27623393|NCT00367237|80464134|FG001|Overall Study|Protocol Violation|5|||
27623394|NCT04011384|80464143|FG000|Overall Study|Withdrawal by Subject|2|||
27623395|NCT04011384|80464144|FG001|Overall Study|Withdrawal by Subject|0|||
27623396|NCT02338609|80464145|FG000|Overall Study|Physician Decision|1|||
27623397|NCT02338609|80464145|FG000|Overall Study|Death|1|||
27623398|NCT00819234|80464148|FG000|Overall Study|Withdrawal by Subject|8|||
27856124|NCT02119819|81306664|FG004|Overall Study|Withdrawal by Subject|6|||
27856125|NCT02119819|81306665|FG005|Overall Study|Withdrawal by Subject|10|||
27911289|NCT00424593|81513562|FG000|Dose-Blind Extension Period|Adverse Event|18|||
27911290|NCT00424593|81513563|FG001|Dose-Blind Extension Period|Adverse Event|0|||
27911291|NCT00424593|81513562|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
27911292|NCT00424593|81513563|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
27911293|NCT00424593|81513562|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
27911294|NCT00424593|81513563|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
27911295|NCT00424593|81513562|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
27526460|NCT01074047|80119566|FG001|Treatment Phase|Adverse Event|66|||
27526461|NCT01074047|80119565|FG000|Treatment Phase|Disease Progression|16|||
27526462|NCT01074047|80119566|FG001|Treatment Phase|Disease Progression|21|||
27526463|NCT01074047|80119565|FG000|Treatment Phase|Withdrawal by Subject|27|||
27526464|NCT01074047|80119566|FG001|Treatment Phase|Withdrawal by Subject|48|||
27526465|NCT01074047|80119565|FG000|Treatment Phase|Death|53|||
27526466|NCT01074047|80119566|FG001|Treatment Phase|Death|58|||
27526467|NCT01074047|80119565|FG000|Treatment Phase|Lost to Follow-up|0|||
27526468|NCT01074047|80119566|FG001|Treatment Phase|Lost to Follow-up|1|||
27526469|NCT01074047|80119565|FG000|Treatment Phase|Protocol Violation|0|||
27526470|NCT01074047|80119566|FG001|Treatment Phase|Protocol Violation|1|||
27526471|NCT01074047|80119565|FG000|Treatment Phase|Miscellaneous|32|||
27526472|NCT01074047|80119566|FG001|Treatment Phase|Miscellaneous|39|||
27526473|NCT01074047|80119565|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
27526474|NCT01074047|80119566|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
27526475|NCT01074047|80119565|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
27526476|NCT01074047|80119566|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
27526477|NCT01074047|80119565|FG000|Survival Follow-Up Phase|Death|116|||
27526478|NCT01074047|80119566|FG001|Survival Follow-Up Phase|Death|124|||
27526479|NCT01074047|80119565|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
27526480|NCT01074047|80119566|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
27526481|NCT01074047|80119565|FG000|Extension Phase|Physician Decision|1|||
27526482|NCT01074047|80119566|FG001|Extension Phase|Physician Decision|0|||
27526483|NCT01074047|80119565|FG000|Extension Phase|Adverse Event|5|||
27526484|NCT01074047|80119566|FG001|Extension Phase|Adverse Event|0|||
27526485|NCT01074047|80119565|FG000|Extension Phase|Disease Progression|9|||
27526486|NCT01074047|80119566|FG001|Extension Phase|Disease Progression|0|||
27526487|NCT01074047|80119565|FG000|Extension Phase|Withdrawal by Subject|2|||
27526488|NCT01074047|80119566|FG001|Extension Phase|Withdrawal by Subject|0|||
27526489|NCT01074047|80119565|FG000|Extension Phase|Death|5|||
27526490|NCT01074047|80119566|FG001|Extension Phase|Death|0|||
27526491|NCT02604017|80119567|FG000|Overall Study|Withdrew Consent|0|||
27526492|NCT02604017|80119568|FG001|Overall Study|Withdrew Consent|2|||
27526493|NCT02604017|80119567|FG000|Overall Study|Lost to Follow-up|5|||
27526494|NCT02604017|80119568|FG001|Overall Study|Lost to Follow-up|6|||
27526495|NCT02604017|80119567|FG000|Overall Study|Other|1|||
27526496|NCT02604017|80119568|FG001|Overall Study|Other|0|||
27526497|NCT01758289|80119576|FG000|Overall Study|Premature Study Termination|44|||
27526498|NCT01758289|80119576|FG000|Overall Study|Adverse Event|9|||
27526499|NCT01099709|80119577|FG000|Period 1|Withdrawal by Subject|0|||
27526500|NCT01099709|80119578|FG001|Period 1|Withdrawal by Subject|1|||
27526501|NCT01099709|80119577|FG000|Period 1|Positive cotinine test|0|||
27526502|NCT01099709|80119578|FG001|Period 1|Positive cotinine test|1|||
27856126|NCT02119819|81306660|FG000|Overall Study|Jury Duty|0|||
27856127|NCT02119819|81306661|FG001|Overall Study|Jury Duty|0|||
27856128|NCT02119819|81306662|FG002|Overall Study|Jury Duty|1|||
27856129|NCT02119819|81306663|FG003|Overall Study|Jury Duty|0|||
27856130|NCT02119819|81306664|FG004|Overall Study|Jury Duty|0|||
27856131|NCT02119819|81306665|FG005|Overall Study|Jury Duty|0|||
27856132|NCT02119819|81306660|FG000|Overall Study|Protocol Violation|0|||
27856133|NCT02119819|81306661|FG001|Overall Study|Protocol Violation|0|||
27856134|NCT02119819|81306662|FG002|Overall Study|Protocol Violation|0|||
27856135|NCT02119819|81306663|FG003|Overall Study|Protocol Violation|1|||
27856136|NCT02119819|81306664|FG004|Overall Study|Protocol Violation|0|||
27856137|NCT02119819|81306665|FG005|Overall Study|Protocol Violation|0|||
27856138|NCT02119819|81306660|FG000|Overall Study|Left the city to get a job|0|||
27856139|NCT02119819|81306661|FG001|Overall Study|Left the city to get a job|0|||
27856140|NCT02119819|81306662|FG002|Overall Study|Left the city to get a job|0|||
27856141|NCT02119819|81306663|FG003|Overall Study|Left the city to get a job|1|||
27856142|NCT02119819|81306664|FG004|Overall Study|Left the city to get a job|0|||
27856143|NCT02119819|81306665|FG005|Overall Study|Left the city to get a job|0|||
27856144|NCT00302081|81306669|FG000|Overall Study|Adverse Event|6|||
27856145|NCT00302081|81306670|FG001|Overall Study|Adverse Event|5|||
27856146|NCT00302081|81306671|FG002|Overall Study|Adverse Event|4|||
27856147|NCT00302081|81306669|FG000|Overall Study|Lost to Follow-up|21|||
27526503|NCT01099709|80119577|FG000|Period 1|Adverse Event|1|||
27856148|NCT00302081|81306670|FG001|Overall Study|Lost to Follow-up|18|||
27856149|NCT00302081|81306671|FG002|Overall Study|Lost to Follow-up|28|||
27856150|NCT00302081|81306669|FG000|Overall Study|Withdrawal by Subject|8|||
27911296|NCT00424593|81513563|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
27911297|NCT00424593|81513562|FG000|Dose-Blind Extension Period|Physician Decision|3|||
27623399|NCT00819234|80464149|FG001|Overall Study|Withdrawal by Subject|13|||
27623400|NCT00819234|80464150|FG002|Overall Study|Withdrawal by Subject|6|||
27623401|NCT00819234|80464151|FG003|Overall Study|Withdrawal by Subject|3|||
27623402|NCT00819234|80464152|FG004|Overall Study|Withdrawal by Subject|0|||
27623403|NCT00819234|80464153|FG005|Overall Study|Withdrawal by Subject|4|||
27623404|NCT00819234|80464154|FG006|Overall Study|Withdrawal by Subject|4|||
27623405|NCT00819234|80464155|FG007|Overall Study|Withdrawal by Subject|8|||
27623406|NCT00819234|80464156|FG008|Overall Study|Withdrawal by Subject|5|||
27623407|NCT00819234|80464157|FG009|Overall Study|Withdrawal by Subject|3|||
27623408|NCT00819234|80464148|FG000|Overall Study|Adverse Event|0|||
27911298|NCT00424593|81513563|FG001|Dose-Blind Extension Period|Physician Decision|0|||
27911299|NCT00587795|81513568|FG000|Overall Study|Withdrawal by Subject|1|||
27911300|NCT00587795|81513569|FG001|Overall Study|Withdrawal by Subject|0|||
27526504|NCT01099709|80119578|FG001|Period 1|Adverse Event|0|||
27526505|NCT01923168|80119580|FG000|Overall Study|Protocol Violation|1|||
27526506|NCT01923168|80119581|FG001|Overall Study|Protocol Violation|1|||
27526507|NCT01923168|80119582|FG002|Overall Study|Protocol Violation|0|||
27526508|NCT01923168|80119580|FG000|Overall Study|Subject/guardian decision|14|||
27526509|NCT01923168|80119581|FG001|Overall Study|Subject/guardian decision|14|||
27526510|NCT01923168|80119582|FG002|Overall Study|Subject/guardian decision|4|||
27526511|NCT01923168|80119580|FG000|Overall Study|Adverse Event|12|||
27526512|NCT01923168|80119581|FG001|Overall Study|Adverse Event|12|||
27526513|NCT01923168|80119582|FG002|Overall Study|Adverse Event|0|||
27526514|NCT01923168|80119580|FG000|Overall Study|Physician Decision|6|||
27623409|NCT00819234|80464149|FG001|Overall Study|Adverse Event|0|||
27623410|NCT00819234|80464150|FG002|Overall Study|Adverse Event|1|||
27623411|NCT00819234|80464151|FG003|Overall Study|Adverse Event|0|||
27623412|NCT00819234|80464152|FG004|Overall Study|Adverse Event|0|||
27623413|NCT00819234|80464153|FG005|Overall Study|Adverse Event|2|||
27623414|NCT00819234|80464154|FG006|Overall Study|Adverse Event|0|||
27623415|NCT00819234|80464155|FG007|Overall Study|Adverse Event|0|||
27623416|NCT00819234|80464156|FG008|Overall Study|Adverse Event|0|||
27623417|NCT00819234|80464157|FG009|Overall Study|Adverse Event|0|||
27623418|NCT00819234|80464148|FG000|Overall Study|Physician Decision|0|||
27623419|NCT00819234|80464149|FG001|Overall Study|Physician Decision|0|||
27623420|NCT00819234|80464150|FG002|Overall Study|Physician Decision|0|||
27623421|NCT00819234|80464151|FG003|Overall Study|Physician Decision|1|||
27623422|NCT00819234|80464152|FG004|Overall Study|Physician Decision|0|||
27623423|NCT00819234|80464153|FG005|Overall Study|Physician Decision|0|||
27623424|NCT00819234|80464154|FG006|Overall Study|Physician Decision|0|||
27623425|NCT00819234|80464155|FG007|Overall Study|Physician Decision|0|||
27623426|NCT00819234|80464156|FG008|Overall Study|Physician Decision|0|||
27623427|NCT00819234|80464157|FG009|Overall Study|Physician Decision|2|||
27623428|NCT00819234|80464148|FG000|Overall Study|Protocol Violation|0|||
27623429|NCT00819234|80464149|FG001|Overall Study|Protocol Violation|0|||
27623430|NCT00819234|80464150|FG002|Overall Study|Protocol Violation|1|||
27623431|NCT00819234|80464151|FG003|Overall Study|Protocol Violation|0|||
27623432|NCT00819234|80464152|FG004|Overall Study|Protocol Violation|0|||
27623433|NCT00819234|80464153|FG005|Overall Study|Protocol Violation|0|||
27623434|NCT00819234|80464154|FG006|Overall Study|Protocol Violation|0|||
27623435|NCT00819234|80464155|FG007|Overall Study|Protocol Violation|0|||
27623436|NCT00819234|80464156|FG008|Overall Study|Protocol Violation|0|||
27623437|NCT00819234|80464157|FG009|Overall Study|Protocol Violation|0|||
27623438|NCT00819234|80464148|FG000|Overall Study|Lost to Follow-up|2|||
27623439|NCT00819234|80464149|FG001|Overall Study|Lost to Follow-up|2|||
27623440|NCT00819234|80464150|FG002|Overall Study|Lost to Follow-up|0|||
27623441|NCT00819234|80464151|FG003|Overall Study|Lost to Follow-up|2|||
27623442|NCT00819234|80464152|FG004|Overall Study|Lost to Follow-up|1|||
27623443|NCT00819234|80464153|FG005|Overall Study|Lost to Follow-up|1|||
27623444|NCT00819234|80464154|FG006|Overall Study|Lost to Follow-up|1|||
27623445|NCT00819234|80464155|FG007|Overall Study|Lost to Follow-up|1|||
27856151|NCT00302081|81306670|FG001|Overall Study|Withdrawal by Subject|12|||
27526515|NCT01923168|80119581|FG001|Overall Study|Physician Decision|9|||
27623446|NCT00819234|80464156|FG008|Overall Study|Lost to Follow-up|1|||
27623447|NCT00819234|80464157|FG009|Overall Study|Lost to Follow-up|2|||
27623448|NCT01700530|80464158|FG000|Overall Study|Withdrawal by Subject|0|||
27623449|NCT01700530|80464159|FG001|Overall Study|Withdrawal by Subject|3|||
27623450|NCT01700530|80464160|FG002|Overall Study|Withdrawal by Subject|1|||
27623451|NCT04530344|80464163|FG000|Overall Study|Lost to Follow-up|3|||
27623452|NCT04530344|80464164|FG001|Overall Study|Lost to Follow-up|3|||
27623453|NCT04530344|80464165|FG002|Overall Study|Lost to Follow-up|3|||
27623454|NCT04530344|80464166|FG003|Overall Study|Lost to Follow-up|10|||
27623455|NCT04530344|80464163|FG000|Overall Study|Withdrawal by Subject|14|||
27623456|NCT04530344|80464164|FG001|Overall Study|Withdrawal by Subject|5|||
27623457|NCT04530344|80464165|FG002|Overall Study|Withdrawal by Subject|18|||
27623458|NCT04530344|80464166|FG003|Overall Study|Withdrawal by Subject|33|||
27911301|NCT00872521|81513570|FG000|Completed PAD Induction|Patient choice|0|||
27623459|NCT04530344|80464163|FG000|Overall Study|Adverse Event|0|||
27911302|NCT00872521|81513571|FG001|Completed PAD Induction|Patient choice|1|||
27526516|NCT01923168|80119582|FG002|Overall Study|Physician Decision|5|||
27526517|NCT01923168|80119580|FG000|Overall Study|Progressive disease|4|||
27526518|NCT01923168|80119581|FG001|Overall Study|Progressive disease|3|||
27526519|NCT01923168|80119582|FG002|Overall Study|Progressive disease|7|||
27526520|NCT01923168|80119580|FG000|Overall Study|Death|0|||
27526521|NCT01923168|80119581|FG001|Overall Study|Death|0|||
27526522|NCT01923168|80119582|FG002|Overall Study|Death|1|||
27526523|NCT02273739|80119583|FG000|Overall Study|Progression of Disease|3|||
27526524|NCT02273739|80119584|FG001|Overall Study|Progression of Disease|4|||
27526525|NCT02273739|80119585|FG002|Overall Study|Progression of Disease|5|||
27526526|NCT02273739|80119586|FG003|Overall Study|Progression of Disease|2|||
27526527|NCT02273739|80119583|FG000|Overall Study|Death|0|||
27526528|NCT02273739|80119584|FG001|Overall Study|Death|0|||
27526529|NCT02273739|80119585|FG002|Overall Study|Death|0|||
27526530|NCT02273739|80119586|FG003|Overall Study|Death|2|||
27526531|NCT02273739|80119583|FG000|Overall Study|Adverse Event|0|||
27526532|NCT02273739|80119584|FG001|Overall Study|Adverse Event|0|||
27526533|NCT02273739|80119585|FG002|Overall Study|Adverse Event|0|||
27526534|NCT02273739|80119586|FG003|Overall Study|Adverse Event|1|||
27526535|NCT02273739|80119583|FG000|Overall Study|Withdrawal by Subject|0|||
27526536|NCT02273739|80119584|FG001|Overall Study|Withdrawal by Subject|0|||
27526537|NCT02273739|80119585|FG002|Overall Study|Withdrawal by Subject|2|||
27526538|NCT02273739|80119586|FG003|Overall Study|Withdrawal by Subject|1|||
27526539|NCT02273739|80119583|FG000|Overall Study|Physician Decision|0|||
27526540|NCT02273739|80119584|FG001|Overall Study|Physician Decision|0|||
27526541|NCT02273739|80119585|FG002|Overall Study|Physician Decision|0|||
27526542|NCT02273739|80119586|FG003|Overall Study|Physician Decision|1|||
27526543|NCT02925793|80119587|FG000|Overall Study|Adverse Event|3|||
27526544|NCT02925793|80119588|FG001|Overall Study|Adverse Event|3|||
27526545|NCT02925793|80119589|FG002|Overall Study|Adverse Event|6|||
27526546|NCT02925793|80119587|FG000|Overall Study|Withdrawal by Subject|16|||
27526547|NCT02925793|80119588|FG001|Overall Study|Withdrawal by Subject|15|||
27526548|NCT02925793|80119589|FG002|Overall Study|Withdrawal by Subject|13|||
27526549|NCT02925793|80119587|FG000|Overall Study|Investigator Discretion|0|||
27526550|NCT02925793|80119588|FG001|Overall Study|Investigator Discretion|1|||
27526551|NCT02925793|80119589|FG002|Overall Study|Investigator Discretion|1|||
27526552|NCT02925793|80119587|FG000|Overall Study|Lost to Follow-up|2|||
27526553|NCT02925793|80119588|FG001|Overall Study|Lost to Follow-up|3|||
27526554|NCT02925793|80119589|FG002|Overall Study|Lost to Follow-up|1|||
27526555|NCT02925793|80119587|FG000|Overall Study|Lack of Efficacy|2|||
27526556|NCT02925793|80119588|FG001|Overall Study|Lack of Efficacy|6|||
27526557|NCT02925793|80119589|FG002|Overall Study|Lack of Efficacy|4|||
27526558|NCT02925793|80119587|FG000|Overall Study|Other:|2|||
27526559|NCT02925793|80119588|FG001|Overall Study|Other:|1|||
27526560|NCT02925793|80119589|FG002|Overall Study|Other:|3|||
27526561|NCT02554279|80119592|FG000|Overall Study|Adverse Event|2|||
27623460|NCT04530344|80464164|FG001|Overall Study|Adverse Event|0|||
27623461|NCT04530344|80464165|FG002|Overall Study|Adverse Event|0|||
27623462|NCT04530344|80464166|FG003|Overall Study|Adverse Event|1|||
27623463|NCT04530344|80464163|FG000|Overall Study|Lack of Efficacy|0|||
27623464|NCT04530344|80464164|FG001|Overall Study|Lack of Efficacy|0|||
27623465|NCT04530344|80464165|FG002|Overall Study|Lack of Efficacy|0|||
27623466|NCT04530344|80464166|FG003|Overall Study|Lack of Efficacy|1|||
27623467|NCT04530344|80464163|FG000|Overall Study|Physician Decision|0|||
27623468|NCT04530344|80464164|FG001|Overall Study|Physician Decision|0|||
27623469|NCT04530344|80464165|FG002|Overall Study|Physician Decision|1|||
27623470|NCT04530344|80464166|FG003|Overall Study|Physician Decision|1|||
27526562|NCT02554279|80119593|FG001|Overall Study|Adverse Event|5|||
27623471|NCT04530344|80464163|FG000|Overall Study|Pregnancy|0|||
27623472|NCT04530344|80464164|FG001|Overall Study|Pregnancy|0|||
27526563|NCT02554279|80119592|FG000|Overall Study|Lost to Follow-up|3|||
27526564|NCT02554279|80119593|FG001|Overall Study|Lost to Follow-up|2|||
27526565|NCT02554279|80119592|FG000|Overall Study|Withdrawal by Subject|6|||
27526566|NCT02554279|80119593|FG001|Overall Study|Withdrawal by Subject|4|||
27526567|NCT02554279|80119592|FG000|Overall Study|Protocol Violation|2|||
27526568|NCT02554279|80119593|FG001|Overall Study|Protocol Violation|1|||
27623473|NCT04530344|80464165|FG002|Overall Study|Pregnancy|2|||
27623474|NCT04530344|80464166|FG003|Overall Study|Pregnancy|1|||
27623475|NCT04530344|80464163|FG000|Overall Study|Protocol Violation|0|||
27623476|NCT04530344|80464164|FG001|Overall Study|Protocol Violation|0|||
27623477|NCT04530344|80464165|FG002|Overall Study|Protocol Violation|0|||
27623478|NCT04530344|80464166|FG003|Overall Study|Protocol Violation|1|||
27526569|NCT02554279|80119592|FG000|Overall Study|Other reason|19|||
27526570|NCT02554279|80119593|FG001|Overall Study|Other reason|6|||
27526571|NCT02694718|80119595|FG000|Overall Study|Death|1|||
27526572|NCT02694718|80119595|FG000|Overall Study|Withdrawal by Subject|1|||
27526573|NCT00089674|80119596|FG000|Overall Study|Physician Decision|4|||
27623479|NCT04530344|80464163|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
27623480|NCT04530344|80464164|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
27526574|NCT00089674|80119597|FG001|Overall Study|Physician Decision|2|||
27526575|NCT00089674|80119596|FG000|Overall Study|Adverse Event|23|||
27623481|NCT04530344|80464165|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
27623482|NCT04530344|80464166|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
27623483|NCT04530344|80464163|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
27623484|NCT04530344|80464164|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
27623485|NCT04530344|80464165|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
27623486|NCT04530344|80464166|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
27623487|NCT04530344|80464163|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
27623488|NCT04530344|80464164|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
27623489|NCT04530344|80464165|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
27623490|NCT04530344|80464166|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
27623491|NCT04530344|80464163|FG000|Overall Study|Personal Reasons|0|||
27623492|NCT04530344|80464164|FG001|Overall Study|Personal Reasons|0|||
27623493|NCT04530344|80464165|FG002|Overall Study|Personal Reasons|0|||
27623494|NCT04530344|80464166|FG003|Overall Study|Personal Reasons|1|||
27623495|NCT04530344|80464163|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
27623496|NCT04530344|80464164|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
27623497|NCT04530344|80464165|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
27623498|NCT04530344|80464166|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
27623499|NCT00594932|80464167|FG000|First 3 Months|Withdrawal by Subject|1|||
27623500|NCT00594932|80464168|FG001|First 3 Months|Withdrawal by Subject|3|||
27623501|NCT00594932|80464167|FG000|Final 3 Months|Withdrawal by Subject|4|||
27623502|NCT00594932|80464168|FG001|Final 3 Months|Withdrawal by Subject|3|||
27623503|NCT01642186|80464169|FG000|Overall Study|Death|0|||
27623504|NCT01642186|80464170|FG001|Overall Study|Death|2|||
27623505|NCT01642186|80464171|FG002|Overall Study|Death|2|||
27623506|NCT01642186|80464169|FG000|Overall Study|Lost to Follow-up|0|||
27623507|NCT01642186|80464170|FG001|Overall Study|Lost to Follow-up|0|||
27623508|NCT01642186|80464171|FG002|Overall Study|Lost to Follow-up|1|||
27623509|NCT00748969|80464173|FG000|Overall Study|Withdrawal by Subject|1|||
27623510|NCT00748969|80464174|FG001|Overall Study|Withdrawal by Subject|0|||
27623511|NCT00748969|80464173|FG000|Overall Study|Withdrawal by Subject|0|||
27623512|NCT00748969|80464174|FG001|Overall Study|Withdrawal by Subject|1|||
27623513|NCT00601640|80464177|FG000|Overall Study|Withdrawal by Subject|3|||
27623514|NCT00601640|80464178|FG001|Overall Study|Withdrawal by Subject|0|||
27623515|NCT00601640|80464179|FG002|Overall Study|Withdrawal by Subject|7|||
27526576|NCT00089674|80119597|FG001|Overall Study|Adverse Event|29|||
27526577|NCT00089674|80119596|FG000|Overall Study|Withdrawal by Subject|143|||
27526578|NCT00089674|80119597|FG001|Overall Study|Withdrawal by Subject|127|||
27526579|NCT00089674|80119596|FG000|Overall Study|Death|43|||
27526580|NCT00089674|80119597|FG001|Overall Study|Death|43|||
27526581|NCT00089674|80119596|FG000|Overall Study|Disease progression|21|||
27526582|NCT00089674|80119597|FG001|Overall Study|Disease progression|23|||
27526583|NCT00089674|80119596|FG000|Overall Study|Ineligibility determined|8|||
27526584|NCT00089674|80119597|FG001|Overall Study|Ineligibility determined|10|||
27526585|NCT00089674|80119596|FG000|Overall Study|Lost to Follow-up|21|||
27526586|NCT00089674|80119597|FG001|Overall Study|Lost to Follow-up|17|||
27526587|NCT00089674|80119596|FG000|Overall Study|Noncompliance|7|||
27526588|NCT00089674|80119597|FG001|Overall Study|Noncompliance|3|||
27526589|NCT00089674|80119596|FG000|Overall Study|Other|5|||
27526590|NCT00089674|80119597|FG001|Overall Study|Other|9|||
27623516|NCT00601640|80464177|FG000|Overall Study|Death|1|||
27733303|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27733304|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27733305|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27733306|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
27526591|NCT00089674|80119596|FG000|Overall Study|Requirement for alternative therapy|14|||
27526592|NCT00089674|80119597|FG001|Overall Study|Requirement for alternative therapy|4|||
27526593|NCT01487577|80119598|FG000|Overall Study|Became ineligible after signing consent|1|||
27526594|NCT03328182|80119601|FG000|Overall Study|Withdrawal by Subject|1|||
27526595|NCT03328182|80119601|FG000|Overall Study|Protocol Violation|2|||
27526596|NCT03328182|80119601|FG000|Overall Study|No Product Evaluated|1|||
27526597|NCT00998764|80119602|FG000|Overall Study|Lack of Efficacy|3|||
27526598|NCT00998764|80119603|FG001|Overall Study|Lack of Efficacy|6|||
27623517|NCT00601640|80464178|FG001|Overall Study|Death|0|||
27623518|NCT00601640|80464179|FG002|Overall Study|Death|0|||
27526599|NCT00998764|80119602|FG000|Overall Study|Adverse Event|17|||
27526600|NCT00998764|80119603|FG001|Overall Study|Adverse Event|12|||
27526601|NCT00998764|80119602|FG000|Overall Study|Withdrawal by Subject|19|||
27623519|NCT00601640|80464177|FG000|Overall Study|Adverse Event|0|||
27623520|NCT00601640|80464178|FG001|Overall Study|Adverse Event|4|||
27623521|NCT00601640|80464179|FG002|Overall Study|Adverse Event|2|||
27623522|NCT00601640|80464177|FG000|Overall Study|intercurrent illness|1|||
27623523|NCT00601640|80464178|FG001|Overall Study|intercurrent illness|0|||
27526602|NCT00998764|80119603|FG001|Overall Study|Withdrawal by Subject|25|||
27526603|NCT00998764|80119602|FG000|Overall Study|Physician Decision|3|||
27623524|NCT00601640|80464179|FG002|Overall Study|intercurrent illness|0|||
27623525|NCT00601640|80464177|FG000|Overall Study|change in eligibility status|0|||
27623526|NCT00601640|80464178|FG001|Overall Study|change in eligibility status|1|||
27623527|NCT00601640|80464179|FG002|Overall Study|change in eligibility status|1|||
27911303|NCT00872521|81513572|FG002|Completed PAD Induction|Patient choice|0|||
27911304|NCT00872521|81513570|FG000|Completed PAD Induction|Disease progression|0|||
27911305|NCT00872521|81513571|FG001|Completed PAD Induction|Disease progression|2|||
27911306|NCT00872521|81513572|FG002|Completed PAD Induction|Disease progression|0|||
27911307|NCT00872521|81513570|FG000|Completed PAD Induction|Adverse Event|4|||
27911308|NCT00872521|81513571|FG001|Completed PAD Induction|Adverse Event|0|||
27911309|NCT00872521|81513572|FG002|Completed PAD Induction|Adverse Event|0|||
27911310|NCT00872521|81513570|FG000|Completed PAD Induction|Death|1|||
27911311|NCT00872521|81513571|FG001|Completed PAD Induction|Death|1|||
27911312|NCT00872521|81513572|FG002|Completed PAD Induction|Death|0|||
27911313|NCT00872521|81513570|FG000|Primary Endpoint Analysis|Other|1|||
27526604|NCT00998764|80119603|FG001|Overall Study|Physician Decision|3|||
27526605|NCT00998764|80119602|FG000|Overall Study|Death|3|||
27911314|NCT00872521|81513571|FG001|Primary Endpoint Analysis|Other|2|||
27911315|NCT00872521|81513572|FG002|Primary Endpoint Analysis|Other|0|||
27911316|NCT00872521|81513570|FG000|Primary Endpoint Analysis|Patient choice|0|||
27911317|NCT00872521|81513571|FG001|Primary Endpoint Analysis|Patient choice|1|||
27911318|NCT00872521|81513572|FG002|Primary Endpoint Analysis|Patient choice|0|||
27911319|NCT00872521|81513570|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
27911320|NCT00872521|81513571|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
27911321|NCT00872521|81513572|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
27911322|NCT00872521|81513570|FG000|Primary Endpoint Analysis|Patient response missing|0|||
27911323|NCT00872521|81513571|FG001|Primary Endpoint Analysis|Patient response missing|0|||
27911324|NCT00872521|81513572|FG002|Primary Endpoint Analysis|Patient response missing|1|||
27911325|NCT00872521|81513570|FG000|Completed 3-month Follow up|Other|0|||
27911326|NCT00872521|81513571|FG001|Completed 3-month Follow up|Other|2|||
27911327|NCT00872521|81513572|FG002|Completed 3-month Follow up|Other|0|||
27911328|NCT00872521|81513570|FG000|Completed 3-month Follow up|Physician Decision|0|||
27911329|NCT00872521|81513571|FG001|Completed 3-month Follow up|Physician Decision|1|||
27911330|NCT00872521|81513572|FG002|Completed 3-month Follow up|Physician Decision|0|||
27911331|NCT00872521|81513570|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
27911332|NCT00872521|81513571|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
27911333|NCT00872521|81513572|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
27911334|NCT02039778|81513573|FG000|Overall Study|Death|2|||
27911335|NCT02039778|81513573|FG000|Overall Study|Withdrawal by Subject|1|||
27911336|NCT02039778|81513573|FG000|Overall Study|Never started the protocol treatment|1|||
27911337|NCT00803712|81513580|FG000|Overall Study|Noncompliance|3|||
27911338|NCT00803712|81513581|FG001|Overall Study|Noncompliance|0|||
27911339|NCT00803712|81513580|FG000|Overall Study|Adverse Event|5|||
27911340|NCT00803712|81513581|FG001|Overall Study|Adverse Event|0|||
27911341|NCT00803712|81513580|FG000|Overall Study|Death|8|||
27911342|NCT00803712|81513581|FG001|Overall Study|Death|7|||
27911343|NCT00803712|81513580|FG000|Overall Study|Lost to Follow-up|3|||
27911344|NCT00803712|81513581|FG001|Overall Study|Lost to Follow-up|1|||
27911345|NCT00803712|81513580|FG000|Overall Study|Withdrawal by Subject|2|||
27911346|NCT00803712|81513581|FG001|Overall Study|Withdrawal by Subject|4|||
27911347|NCT00803712|81513580|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
27911348|NCT00803712|81513581|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
27911349|NCT00803712|81513580|FG000|Overall Study|Protocol criteria (other)|0|||
27911350|NCT00803712|81513581|FG001|Overall Study|Protocol criteria (other)|2|||
27526606|NCT00998764|80119603|FG001|Overall Study|Death|1|||
27526607|NCT00998764|80119602|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
27526608|NCT00998764|80119603|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
27526609|NCT00998764|80119602|FG000|Overall Study|Protocol Violation|0|||
27526610|NCT00998764|80119603|FG001|Overall Study|Protocol Violation|1|||
27526611|NCT00998764|80119602|FG000|Overall Study|Failed to Return|1|||
27526612|NCT00998764|80119603|FG001|Overall Study|Failed to Return|1|||
27526613|NCT00998764|80119602|FG000|Overall Study|Lost to Follow-up|1|||
27526614|NCT00998764|80119603|FG001|Overall Study|Lost to Follow-up|1|||
27526615|NCT00998764|80119602|FG000|Overall Study|Loss of Caregiver|0|||
27526616|NCT00998764|80119603|FG001|Overall Study|Loss of Caregiver|3|||
27526617|NCT00998764|80119602|FG000|Overall Study|Other|4|||
27526618|NCT00998764|80119603|FG001|Overall Study|Other|4|||
27526619|NCT00998764|80119602|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
27526620|NCT00998764|80119603|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
27623528|NCT03176134|80464180|FG000|Overall Study|Lost to Follow-up|0|||
27623529|NCT03176134|80464181|FG001|Overall Study|Lost to Follow-up|2|||
27911351|NCT00803712|81513580|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
27911352|NCT00803712|81513581|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
27911353|NCT00803712|81513580|FG000|Overall Study|Administrative decision|2|||
27911354|NCT00803712|81513581|FG001|Overall Study|Administrative decision|3|||
27526621|NCT00219544|80119604|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
27526622|NCT00219544|80119605|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
27526623|NCT00219544|80119604|FG000|Single Blind Treatment Period|Adverse Event|9|||
27526624|NCT00219544|80119605|FG001|Single Blind Treatment Period|Adverse Event|0|||
27526625|NCT00219544|80119604|FG000|Single Blind Treatment Period|Protocol Violation|4|||
27526626|NCT00219544|80119605|FG001|Single Blind Treatment Period|Protocol Violation|0|||
27526627|NCT00219544|80119604|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
27526628|NCT00219544|80119605|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
27526629|NCT00219544|80119604|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
27526630|NCT00219544|80119605|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
27526631|NCT00219544|80119604|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
27526632|NCT00219544|80119605|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
27526633|NCT01569464|80119606|FG000|Overall Study|Adverse Event|4|||
27526634|NCT01569464|80119607|FG001|Overall Study|Adverse Event|0|||
27733307|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27733308|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
27733309|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
27733310|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27733311|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27733312|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27733313|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27733314|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
27733315|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
27733316|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27733317|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27733318|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27733319|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27733320|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27733321|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27733322|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
27856152|NCT00302081|81306671|FG002|Overall Study|Withdrawal by Subject|8|||
27856153|NCT00302081|81306669|FG000|Overall Study|Protocol Violation|5|||
27856154|NCT00302081|81306670|FG001|Overall Study|Protocol Violation|1|||
27526635|NCT01569464|80119606|FG000|Overall Study|Lack of Efficacy|1|||
27526636|NCT01569464|80119607|FG001|Overall Study|Lack of Efficacy|0|||
27526637|NCT01569464|80119606|FG000|Overall Study|Protocol Violation|1|||
27526638|NCT01569464|80119607|FG001|Overall Study|Protocol Violation|0|||
27526639|NCT01569464|80119606|FG000|Overall Study|Lost to Follow-up|2|||
27526640|NCT01569464|80119607|FG001|Overall Study|Lost to Follow-up|3|||
27526641|NCT01569464|80119606|FG000|Overall Study|Withdrawal by Subject|1|||
27526642|NCT01569464|80119607|FG001|Overall Study|Withdrawal by Subject|1|||
27526643|NCT01569464|80119606|FG000|Overall Study|Other|1|||
27526644|NCT01569464|80119607|FG001|Overall Study|Other|1|||
27526645|NCT01309893|80119612|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
27526646|NCT01309893|80119613|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
27526647|NCT01309893|80119612|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
27526648|NCT01309893|80119613|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
27526649|NCT00604214|80119614|FG000|Baseline to Day 28|Death|223|||
27526650|NCT00604214|80119615|FG001|Baseline to Day 28|Death|202|||
27526651|NCT00604214|80119614|FG000|Baseline to Day 28|Lost to Follow-up|2|||
27526652|NCT00604214|80119615|FG001|Baseline to Day 28|Lost to Follow-up|4|||
27526653|NCT00604214|80119614|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
27526654|NCT00604214|80119615|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
27526655|NCT00604214|80119614|FG000|Day 29 to Day 90|Death|64|||
27526656|NCT00604214|80119615|FG001|Day 29 to Day 90|Death|67|||
27526657|NCT00604214|80119614|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
27526658|NCT00604214|80119615|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
27526659|NCT00604214|80119614|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
27526660|NCT00604214|80119615|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
27526661|NCT00604214|80119614|FG000|Day 91 to Day 180|Death|19|||
27526662|NCT00604214|80119615|FG001|Day 91 to Day 180|Death|23|||
27526663|NCT00604214|80119614|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
27526664|NCT00604214|80119615|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
27526665|NCT00604214|80119614|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
27526666|NCT00604214|80119615|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
27526667|NCT01246466|80119616|FG000|Overall Study|Death|1|||
27526668|NCT01246466|80119616|FG000|Overall Study|Withdrawal by Subject|1|||
27526669|NCT00064298|80119620|FG000|Overall Study|Withdrawal by Subject|2|||
27526670|NCT00064298|80119621|FG001|Overall Study|Withdrawal by Subject|1|||
27526671|NCT00064298|80119620|FG000|Overall Study|Lost to Follow-up|2|||
27526672|NCT00064298|80119621|FG001|Overall Study|Lost to Follow-up|2|||
27526673|NCT00064298|80119620|FG000|Overall Study|Death|0|||
27526674|NCT00064298|80119621|FG001|Overall Study|Death|1|||
27733323|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27526675|NCT00064298|80119620|FG000|Overall Study|Disease Progression|2|||
27526676|NCT00064298|80119621|FG001|Overall Study|Disease Progression|1|||
27911355|NCT00803712|81513580|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
27911356|NCT00803712|81513581|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
27911357|NCT01025284|81513582|FG000|Overall Study|Investigator Decision|0|||
27911358|NCT01025284|81513583|FG001|Overall Study|Investigator Decision|1|||
27911359|NCT01025284|81513584|FG002|Overall Study|Investigator Decision|0|||
27911360|NCT01025284|81513582|FG000|Overall Study|Withdrawal by Subject|0|||
27911361|NCT01025284|81513583|FG001|Overall Study|Withdrawal by Subject|1|||
27911362|NCT01025284|81513584|FG002|Overall Study|Withdrawal by Subject|0|||
27911363|NCT02959918|81513585|FG000|Overall Study|Adverse Event|1|||
27911364|NCT02959918|81513586|FG001|Overall Study|Adverse Event|1|||
27526677|NCT02456103|80119622|FG000|Overall Study|Study Closure|207|||
27526678|NCT02456103|80119622|FG000|Overall Study|Physician Decision|1|||
27526679|NCT02456103|80119622|FG000|Overall Study|Required prohibited medications|5|||
27526680|NCT02456103|80119622|FG000|Overall Study|Protocol Violation|1|||
27526681|NCT02456103|80119622|FG000|Overall Study|Adverse Event|5|||
27526682|NCT02456103|80119622|FG000|Overall Study|Abnormal Laboratory Value|2|||
27526683|NCT02456103|80119622|FG000|Overall Study|Lost to Follow-up|1|||
27526684|NCT02456103|80119622|FG000|Overall Study|Withdrawal by Subject|24|||
27526685|NCT01489111|80122991|FG000|Overall Study|Withdrawal criterion|1|||
27526686|NCT01224782|80122992|FG000|Overall Study|Lost to Follow-up|177|||
27526687|NCT01224782|80122992|FG000|Overall Study|Withdrawal by Subject|16|||
27526688|NCT01224782|80122992|FG000|Overall Study|Death|14|||
27526689|NCT01224782|80122992|FG000|Overall Study|Improvement|13|||
27526690|NCT01224782|80122992|FG000|Overall Study|Adverse Event|12|||
27526691|NCT01224782|80122992|FG000|Overall Study|Adverse Reaction|11|||
27526692|NCT01224782|80122992|FG000|Overall Study|Noncompliance|10|||
27526693|NCT01224782|80122992|FG000|Overall Study|Other|4|||
27526694|NCT01224782|80122992|FG000|Overall Study|Start of Dialysis|3|||
27526695|NCT01224782|80122992|FG000|Overall Study|Change of Treatment|1|||
27526696|NCT01224782|80122992|FG000|Overall Study|Financial Reasons|1|||
27526697|NCT01224782|80122992|FG000|Overall Study|Deterioration|1|||
27526698|NCT01224782|80122992|FG000|Overall Study|Transplantation|1|||
27526699|NCT01426789|80122993|FG000|Part 1|Protocol deviation|0|||
27526700|NCT01426789|80122994|FG001|Part 1|Protocol deviation|1|||
27526701|NCT01426789|80122995|FG002|Part 1|Protocol deviation|0|||
27526702|NCT01426789|80122996|FG003|Part 1|Protocol deviation|0|||
27526703|NCT01426789|80122997|FG004|Part 1|Protocol deviation|0|||
27526704|NCT01426789|80122998|FG005|Part 1|Protocol deviation|0|||
27526705|NCT01426789|80122993|FG000|Part 1|Lost to Follow-up|1|||
27526706|NCT01426789|80122994|FG001|Part 1|Lost to Follow-up|2|||
27526707|NCT01426789|80122995|FG002|Part 1|Lost to Follow-up|0|||
27526708|NCT01426789|80122996|FG003|Part 1|Lost to Follow-up|0|||
27526709|NCT01426789|80122997|FG004|Part 1|Lost to Follow-up|0|||
27526710|NCT01426789|80122998|FG005|Part 1|Lost to Follow-up|0|||
27526711|NCT01426789|80122993|FG000|Part 1|Lack of Efficacy|2|||
27526712|NCT01426789|80122994|FG001|Part 1|Lack of Efficacy|1|||
27733324|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
27733325|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27733326|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
27733327|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
27733328|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27526713|NCT01426789|80122995|FG002|Part 1|Lack of Efficacy|0|||
27526714|NCT01426789|80122996|FG003|Part 1|Lack of Efficacy|0|||
27526715|NCT01426789|80122997|FG004|Part 1|Lack of Efficacy|0|||
27526716|NCT01426789|80122998|FG005|Part 1|Lack of Efficacy|0|||
27526717|NCT01426789|80122993|FG000|Part 1|Adverse Event|3|||
27526718|NCT01426789|80122994|FG001|Part 1|Adverse Event|0|||
27623530|NCT03176134|80464182|FG002|Overall Study|Lost to Follow-up|0|||
27733329|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27733330|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27911365|NCT02959918|81513587|FG002|Overall Study|Adverse Event|2|||
27911366|NCT02959918|81513588|FG003|Overall Study|Adverse Event|0|||
27526719|NCT01426789|80122995|FG002|Part 1|Adverse Event|0|||
27623531|NCT03176134|80464183|FG003|Overall Study|Lost to Follow-up|0|||
27526720|NCT01426789|80122996|FG003|Part 1|Adverse Event|0|||
27623532|NCT03176134|80464184|FG004|Overall Study|Lost to Follow-up|0|||
27623533|NCT03176134|80464185|FG005|Overall Study|Lost to Follow-up|0|||
27733331|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
27526721|NCT01426789|80122997|FG004|Part 1|Adverse Event|0|||
27526722|NCT01426789|80122998|FG005|Part 1|Adverse Event|0|||
27526723|NCT01426789|80122993|FG000|Part 2|Protocol deviation|0|||
27526724|NCT01426789|80122994|FG001|Part 2|Protocol deviation|0|||
27526725|NCT01426789|80122995|FG002|Part 2|Protocol deviation|1|||
27526726|NCT01426789|80122996|FG003|Part 2|Protocol deviation|0|||
27526727|NCT01426789|80122997|FG004|Part 2|Protocol deviation|0|||
27526728|NCT01426789|80122998|FG005|Part 2|Protocol deviation|0|||
27526729|NCT01426789|80122993|FG000|Part 2|Death|0|||
27526730|NCT01426789|80122994|FG001|Part 2|Death|0|||
27856155|NCT00302081|81306671|FG002|Overall Study|Protocol Violation|2|||
27526731|NCT01426789|80122995|FG002|Part 2|Death|1|||
27526732|NCT01426789|80122996|FG003|Part 2|Death|0|||
27526733|NCT01426789|80122997|FG004|Part 2|Death|1|||
27526734|NCT01426789|80122998|FG005|Part 2|Death|0|||
27526735|NCT01426789|80122993|FG000|Part 2|Administrative problems|0|||
27526736|NCT01426789|80122994|FG001|Part 2|Administrative problems|0|||
27526737|NCT01426789|80122995|FG002|Part 2|Administrative problems|2|||
27526738|NCT01426789|80122996|FG003|Part 2|Administrative problems|0|||
27526739|NCT01426789|80122997|FG004|Part 2|Administrative problems|1|||
27526740|NCT01426789|80122998|FG005|Part 2|Administrative problems|0|||
27526741|NCT01426789|80122993|FG000|Part 2|Lost to Follow-up|0|||
27526742|NCT01426789|80122994|FG001|Part 2|Lost to Follow-up|0|||
27526743|NCT01426789|80122995|FG002|Part 2|Lost to Follow-up|4|||
27526744|NCT01426789|80122996|FG003|Part 2|Lost to Follow-up|0|||
27526745|NCT01426789|80122997|FG004|Part 2|Lost to Follow-up|1|||
27526746|NCT01426789|80122998|FG005|Part 2|Lost to Follow-up|0|||
27526747|NCT01426789|80122993|FG000|Part 2|Withdrawal by Subject|0|||
27526748|NCT01426789|80122994|FG001|Part 2|Withdrawal by Subject|0|||
27526749|NCT01426789|80122995|FG002|Part 2|Withdrawal by Subject|0|||
27526750|NCT01426789|80122996|FG003|Part 2|Withdrawal by Subject|1|||
27526751|NCT01426789|80122997|FG004|Part 2|Withdrawal by Subject|2|||
27526752|NCT01426789|80122998|FG005|Part 2|Withdrawal by Subject|0|||
27526753|NCT01426789|80122993|FG000|Part 2|Lack of Efficacy|0|||
27526754|NCT01426789|80122994|FG001|Part 2|Lack of Efficacy|0|||
27526755|NCT01426789|80122995|FG002|Part 2|Lack of Efficacy|5|||
27526756|NCT01426789|80122996|FG003|Part 2|Lack of Efficacy|0|||
27526757|NCT01426789|80122997|FG004|Part 2|Lack of Efficacy|2|||
27526758|NCT01426789|80122998|FG005|Part 2|Lack of Efficacy|0|||
27526759|NCT01426789|80122993|FG000|Part 2|Adverse Event|0|||
27526760|NCT01426789|80122994|FG001|Part 2|Adverse Event|0|||
27526761|NCT01426789|80122995|FG002|Part 2|Adverse Event|2|||
27526762|NCT01426789|80122996|FG003|Part 2|Adverse Event|0|||
27526763|NCT01426789|80122997|FG004|Part 2|Adverse Event|1|||
27526764|NCT01426789|80122998|FG005|Part 2|Adverse Event|0|||
27526765|NCT03021564|80122999|FG000|Overall Study|Death|84|||
27526766|NCT03021564|80123000|FG001|Overall Study|Death|466|||
27526767|NCT03021564|80122999|FG000|Overall Study|Lost to Follow-up|0|||
27911367|NCT02959918|81513589|FG004|Overall Study|Adverse Event|0|||
27911368|NCT02959918|81513590|FG005|Overall Study|Adverse Event|2|||
27911369|NCT02959918|81513591|FG006|Overall Study|Adverse Event|2|||
27911370|NCT02959918|81513592|FG007|Overall Study|Adverse Event|1|||
27911371|NCT02959918|81513593|FG008|Overall Study|Adverse Event|2|||
27911372|NCT02959918|81513594|FG009|Overall Study|Adverse Event|1|||
27911373|NCT02959918|81513595|FG010|Overall Study|Adverse Event|1|||
27911374|NCT02959918|81513596|FG011|Overall Study|Adverse Event|3|||
27911375|NCT02959918|81513597|FG012|Overall Study|Adverse Event|2|||
27911376|NCT02959918|81513598|FG013|Overall Study|Adverse Event|4|||
27911377|NCT02959918|81513585|FG000|Overall Study|Lost to Follow-up|0|||
27911378|NCT02959918|81513586|FG001|Overall Study|Lost to Follow-up|0|||
27911379|NCT02959918|81513587|FG002|Overall Study|Lost to Follow-up|0|||
27911380|NCT02959918|81513588|FG003|Overall Study|Lost to Follow-up|0|||
27911381|NCT02959918|81513589|FG004|Overall Study|Lost to Follow-up|0|||
27911382|NCT02959918|81513590|FG005|Overall Study|Lost to Follow-up|0|||
27911383|NCT02959918|81513591|FG006|Overall Study|Lost to Follow-up|0|||
27911384|NCT02959918|81513592|FG007|Overall Study|Lost to Follow-up|0|||
27911385|NCT02959918|81513593|FG008|Overall Study|Lost to Follow-up|0|||
27911386|NCT02959918|81513594|FG009|Overall Study|Lost to Follow-up|1|||
27911387|NCT02959918|81513595|FG010|Overall Study|Lost to Follow-up|0|||
27911388|NCT02959918|81513596|FG011|Overall Study|Lost to Follow-up|0|||
27911389|NCT02959918|81513597|FG012|Overall Study|Lost to Follow-up|1|||
27526768|NCT03021564|80123000|FG001|Overall Study|Lost to Follow-up|2|||
27856156|NCT00302081|81306669|FG000|Overall Study|Lack of Efficacy|1|||
27911390|NCT02959918|81513598|FG013|Overall Study|Lost to Follow-up|0|||
27911391|NCT02959918|81513585|FG000|Overall Study|Withdrawal by Subject|0|||
27911392|NCT02959918|81513586|FG001|Overall Study|Withdrawal by Subject|0|||
27911393|NCT02959918|81513587|FG002|Overall Study|Withdrawal by Subject|1|||
27526769|NCT03269552|80123001|FG000|Overall Study|Adverse Event|2|||
27526770|NCT00622739|80123002|FG000|Overall Study|Physician Decision|1|||
27911394|NCT02959918|81513588|FG003|Overall Study|Withdrawal by Subject|2|||
27911395|NCT02959918|81513589|FG004|Overall Study|Withdrawal by Subject|0|||
27911396|NCT02959918|81513590|FG005|Overall Study|Withdrawal by Subject|0|||
27526771|NCT00622739|80123003|FG001|Overall Study|Physician Decision|0|||
27526772|NCT00622739|80123002|FG000|Overall Study|Adverse Event|1|||
27526773|NCT00622739|80123003|FG001|Overall Study|Adverse Event|2|||
27526774|NCT00622739|80123002|FG000|Overall Study|Lack of Efficacy|0|||
27526775|NCT00622739|80123003|FG001|Overall Study|Lack of Efficacy|2|||
27526776|NCT00622739|80123002|FG000|Overall Study|Withdrawal by Subject|0|||
27526777|NCT00622739|80123003|FG001|Overall Study|Withdrawal by Subject|1|||
27526778|NCT00622739|80123002|FG000|Overall Study|Lost to Follow-up|0|||
27526779|NCT00622739|80123003|FG001|Overall Study|Lost to Follow-up|1|||
27526780|NCT03170232|80123004|FG000|Overall Study|Adverse Event|0|||
27911397|NCT02959918|81513591|FG006|Overall Study|Withdrawal by Subject|1|||
27911398|NCT02959918|81513592|FG007|Overall Study|Withdrawal by Subject|0|||
27911399|NCT02959918|81513593|FG008|Overall Study|Withdrawal by Subject|1|||
27911400|NCT02959918|81513594|FG009|Overall Study|Withdrawal by Subject|1|||
27911401|NCT02959918|81513595|FG010|Overall Study|Withdrawal by Subject|2|||
27911402|NCT02959918|81513596|FG011|Overall Study|Withdrawal by Subject|3|||
27911403|NCT02959918|81513597|FG012|Overall Study|Withdrawal by Subject|1|||
27911404|NCT02959918|81513598|FG013|Overall Study|Withdrawal by Subject|1|||
27526781|NCT03170232|80123005|FG001|Overall Study|Adverse Event|1|||
27526782|NCT03170232|80123004|FG000|Overall Study|Protocol Violation|0|||
27526783|NCT03170232|80123005|FG001|Overall Study|Protocol Violation|1|||
27526784|NCT03170232|80123004|FG000|Overall Study|Lack of Efficacy|0|||
27526785|NCT03170232|80123005|FG001|Overall Study|Lack of Efficacy|1|||
27526786|NCT03170232|80123004|FG000|Overall Study|Study closed/terminated|26|||
27526787|NCT03170232|80123005|FG001|Overall Study|Study closed/terminated|23|||
27526788|NCT03170232|80123004|FG000|Overall Study|Lost to Follow-up|1|||
27911405|NCT02959918|81513585|FG000|Overall Study|Protocol Violation|0|||
27911406|NCT02959918|81513586|FG001|Overall Study|Protocol Violation|0|||
27911407|NCT02959918|81513587|FG002|Overall Study|Protocol Violation|1|||
27911408|NCT02959918|81513588|FG003|Overall Study|Protocol Violation|0|||
27911409|NCT02959918|81513589|FG004|Overall Study|Protocol Violation|0|||
27911410|NCT02959918|81513590|FG005|Overall Study|Protocol Violation|1|||
27911411|NCT02959918|81513591|FG006|Overall Study|Protocol Violation|0|||
27911412|NCT02959918|81513592|FG007|Overall Study|Protocol Violation|0|||
27911413|NCT02959918|81513593|FG008|Overall Study|Protocol Violation|2|||
27911414|NCT02959918|81513594|FG009|Overall Study|Protocol Violation|1|||
27911415|NCT02959918|81513595|FG010|Overall Study|Protocol Violation|0|||
27911416|NCT02959918|81513596|FG011|Overall Study|Protocol Violation|1|||
27526789|NCT03170232|80123005|FG001|Overall Study|Lost to Follow-up|0|||
27526790|NCT03170232|80123004|FG000|Overall Study|Withdrawal by Subject|0|||
27526791|NCT03170232|80123005|FG001|Overall Study|Withdrawal by Subject|1|||
27526792|NCT01362595|80123006|FG000|Overall Study|Screen failure|10|||
27526793|NCT01362595|80123006|FG000|Overall Study|Withdrawal by Subject|2|||
27526794|NCT03490981|80123007|FG000|Overall Study|Lost to Follow-up|1|||
27526795|NCT03490981|80123008|FG001|Overall Study|Lost to Follow-up|2|||
27526796|NCT00476047|80123013|FG000|Overall Study|Lost to Follow-up|1|||
27526797|NCT00459979|80123014|FG000|Overall Study|Withdrawal by Subject|1|||
27526798|NCT00459979|80123014|FG000|Overall Study|Protocol Violation|1|||
27526799|NCT00993044|80123015|FG000|Irinotecan 50 mg|Physician Decision|1|||
27526800|NCT00366340|80123016|FG000|Infant Series|Protocol Violation|3|||
27526801|NCT00366340|80123017|FG001|Infant Series|Protocol Violation|4|||
27526802|NCT00366340|80123016|FG000|Infant Series|Withdrawal by Subject|3|||
27526803|NCT00366340|80123017|FG001|Infant Series|Withdrawal by Subject|3|||
27526804|NCT00366340|80123016|FG000|Infant Series|Adverse Event|0|||
27526805|NCT00366340|80123017|FG001|Infant Series|Adverse Event|2|||
27526806|NCT00366340|80123016|FG000|Infant Series|Lost to Follow-up|1|||
27526807|NCT00366340|80123017|FG001|Infant Series|Lost to Follow-up|1|||
27526808|NCT00366340|80123016|FG000|Infant Series|Failure to return|1|||
27526809|NCT00366340|80123017|FG001|Infant Series|Failure to return|0|||
27526810|NCT00366340|80123016|FG000|After the Infant Series|Parent/legal guardian request|1|||
27526811|NCT00366340|80123017|FG001|After the Infant Series|Parent/legal guardian request|1|||
27526812|NCT00366340|80123016|FG000|After the Infant Series|Failed to return|0|||
27526813|NCT00366340|80123017|FG001|After the Infant Series|Failed to return|1|||
27526814|NCT00366340|80123016|FG000|After the Infant Series|Protocol Violation|2|||
27526815|NCT00366340|80123017|FG001|After the Infant Series|Protocol Violation|2|||
27526816|NCT00366340|80123016|FG000|After the Infant Series|Adverse Event|0|||
27526817|NCT00366340|80123017|FG001|After the Infant Series|Adverse Event|1|||
27526818|NCT00366340|80123016|FG000|After the Infant Series|Lost to Follow-up|0|||
27526819|NCT00366340|80123017|FG001|After the Infant Series|Lost to Follow-up|1|||
27526820|NCT00366340|80123016|FG000|Toddler Dose|Failed to return|1|||
27526821|NCT00366340|80123017|FG001|Toddler Dose|Failed to return|0|||
27526822|NCT00366340|80123016|FG000|Toddler Dose|Parent/legal guardian request|0|||
27526823|NCT00366340|80123017|FG001|Toddler Dose|Parent/legal guardian request|1|||
27526824|NCT01011478|80123021|FG000|Overall Study|No follow up data|12|||
27733332|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
27911417|NCT02959918|81513597|FG012|Overall Study|Protocol Violation|1|||
27911418|NCT02959918|81513598|FG013|Overall Study|Protocol Violation|0|||
27526825|NCT01011478|80123022|FG001|Overall Study|No follow up data|7|||
27526826|NCT01251146|80123023|FG000|Overall Study|Lost to Follow-up|3|||
27526827|NCT01251146|80123024|FG001|Overall Study|Lost to Follow-up|10|||
27526828|NCT02068768|80123027|FG000|Overall Study|Lost to Follow-up|5|||
27526829|NCT02068768|80123027|FG000|Overall Study|Early Termination by Sponsor|2|||
27526830|NCT03945175|80123028|FG000|Overall Study|Did not meet inclusion criteria|31|||
27526831|NCT03945175|80123028|FG000|Overall Study|Withdrew consent|2|||
27526832|NCT03945175|80123028|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
27911419|NCT02959918|81513585|FG000|Overall Study|Stopping Rule Met|1|||
27911420|NCT02959918|81513586|FG001|Overall Study|Stopping Rule Met|0|||
27911421|NCT02959918|81513587|FG002|Overall Study|Stopping Rule Met|3|||
27911422|NCT02959918|81513588|FG003|Overall Study|Stopping Rule Met|4|||
27526833|NCT03945175|80123028|FG000|Overall Study|Early termination during Mydayis treatment|1|||
27526834|NCT01611454|80123030|FG000|Overall Study|Lack of Efficacy|18|||
27526835|NCT01611454|80123031|FG001|Overall Study|Lack of Efficacy|10|||
27526836|NCT00719264|80123032|FG000|Overall Study|Adverse Event|41|||
27526837|NCT00719264|80123033|FG001|Overall Study|Adverse Event|49|||
27526838|NCT00719264|80123032|FG000|Overall Study|Death|13|||
27526839|NCT00719264|80123033|FG001|Overall Study|Death|10|||
27526840|NCT00719264|80123032|FG000|Overall Study|Administrative Problems|6|||
27526841|NCT00719264|80123033|FG001|Overall Study|Administrative Problems|4|||
27526842|NCT00719264|80123032|FG000|Overall Study|Lost to Follow-up|1|||
27526843|NCT00719264|80123033|FG001|Overall Study|Lost to Follow-up|1|||
27526844|NCT00719264|80123032|FG000|Overall Study|Withdrawal by Subject|12|||
27526845|NCT00719264|80123033|FG001|Overall Study|Withdrawal by Subject|7|||
27526846|NCT00719264|80123032|FG000|Overall Study|Protocol Deviation|1|||
27526847|NCT00719264|80123033|FG001|Overall Study|Protocol Deviation|3|||
27526848|NCT00719264|80123032|FG000|Overall Study|New Cancer Therapy|4|||
27526849|NCT00719264|80123033|FG001|Overall Study|New Cancer Therapy|2|||
27526850|NCT00719264|80123032|FG000|Overall Study|Disease Progression|104|||
27526851|NCT00719264|80123033|FG001|Overall Study|Disease Progression|107|||
27526852|NCT05070546|80123034|FG000|Overall Study|Death|0|||
27526853|NCT05070546|80123035|FG001|Overall Study|Death|0|||
27526854|NCT05070546|80123036|FG002|Overall Study|Death|0|||
27526855|NCT05070546|80123037|FG003|Overall Study|Death|0|||
27526856|NCT05070546|80123038|FG004|Overall Study|Death|0|||
27911423|NCT02959918|81513589|FG004|Overall Study|Stopping Rule Met|5|||
27911424|NCT02959918|81513590|FG005|Overall Study|Stopping Rule Met|3|||
27911425|NCT02959918|81513591|FG006|Overall Study|Stopping Rule Met|2|||
27911426|NCT02959918|81513592|FG007|Overall Study|Stopping Rule Met|4|||
27911427|NCT02959918|81513593|FG008|Overall Study|Stopping Rule Met|1|||
27911428|NCT02959918|81513594|FG009|Overall Study|Stopping Rule Met|1|||
27911429|NCT02959918|81513595|FG010|Overall Study|Stopping Rule Met|3|||
27911430|NCT02959918|81513596|FG011|Overall Study|Stopping Rule Met|5|||
27911431|NCT02959918|81513597|FG012|Overall Study|Stopping Rule Met|2|||
27911432|NCT02959918|81513598|FG013|Overall Study|Stopping Rule Met|1|||
27911433|NCT02959918|81513585|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
27911434|NCT02959918|81513586|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
27911435|NCT02959918|81513587|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
27526857|NCT05070546|80123039|FG005|Overall Study|Death|1|||
27526858|NCT05070546|80123034|FG000|Overall Study|Lost to Follow-up|8|||
27526859|NCT05070546|80123035|FG001|Overall Study|Lost to Follow-up|2|||
27526860|NCT05070546|80123036|FG002|Overall Study|Lost to Follow-up|7|||
27526861|NCT05070546|80123037|FG003|Overall Study|Lost to Follow-up|1|||
27526862|NCT05070546|80123038|FG004|Overall Study|Lost to Follow-up|2|||
27526863|NCT05070546|80123039|FG005|Overall Study|Lost to Follow-up|0|||
27526864|NCT05070546|80123034|FG000|Overall Study|Withdrawal by Subject|1|||
27526865|NCT05070546|80123035|FG001|Overall Study|Withdrawal by Subject|1|||
27526866|NCT05070546|80123036|FG002|Overall Study|Withdrawal by Subject|3|||
27526867|NCT05070546|80123037|FG003|Overall Study|Withdrawal by Subject|0|||
27526868|NCT05070546|80123038|FG004|Overall Study|Withdrawal by Subject|0|||
27526869|NCT05070546|80123039|FG005|Overall Study|Withdrawal by Subject|0|||
27526870|NCT05070546|80123034|FG000|Overall Study|Other|0|||
27526871|NCT05070546|80123035|FG001|Overall Study|Other|0|||
27526872|NCT05070546|80123036|FG002|Overall Study|Other|0|||
27526873|NCT05070546|80123037|FG003|Overall Study|Other|0|||
27526874|NCT05070546|80123038|FG004|Overall Study|Other|3|||
27526875|NCT05070546|80123039|FG005|Overall Study|Other|0|||
27526876|NCT05070546|80123034|FG000|Overall Study|Randomized but not vaccinated|1|||
27526877|NCT05070546|80123035|FG001|Overall Study|Randomized but not vaccinated|0|||
27526878|NCT05070546|80123036|FG002|Overall Study|Randomized but not vaccinated|1|||
27526879|NCT05070546|80123037|FG003|Overall Study|Randomized but not vaccinated|1|||
27526880|NCT05070546|80123038|FG004|Overall Study|Randomized but not vaccinated|3|||
27526881|NCT05070546|80123039|FG005|Overall Study|Randomized but not vaccinated|0|||
27526882|NCT00880165|80123040|FG000|Overall Study|Withdrawal by Subject|27|||
27526883|NCT00880165|80123041|FG001|Overall Study|Withdrawal by Subject|23|||
27526884|NCT00880165|80123040|FG000|Overall Study|Not diagnosed with OSA|14|||
27526885|NCT00880165|80123041|FG001|Overall Study|Not diagnosed with OSA|8|||
27526886|NCT00880165|80123040|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
27526887|NCT00880165|80123041|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
27911436|NCT02959918|81513588|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
27911437|NCT02959918|81513589|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27526888|NCT00880165|80123040|FG000|Overall Study|Lost to follow|9|||
27526889|NCT00880165|80123041|FG001|Overall Study|Lost to follow|15|||
27526890|NCT02793128|80123042|FG000|Overall Study|Death|4|||
27526891|NCT02793128|80123042|FG000|Overall Study|Withdrawal by Subject|2|||
27526892|NCT02793128|80123042|FG000|Overall Study|Physician Decision|1|||
27526893|NCT02793128|80123042|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
27911438|NCT02959918|81513590|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911439|NCT02959918|81513591|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911440|NCT02959918|81513592|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27526894|NCT02793128|80123042|FG000|Overall Study|Patient elected nephroureterectomy|1|||
27526895|NCT03860935|80123058|FG000|Overall Study|Withdrawal of Consent|15|||
27526896|NCT03860935|80123059|FG001|Overall Study|Withdrawal of Consent|6|||
27526897|NCT03860935|80123058|FG000|Overall Study|Death|75|||
27526898|NCT03860935|80123059|FG001|Overall Study|Death|51|||
27526899|NCT02628769|80123066|FG000|First Intervention|Adverse Event|1|||
27526900|NCT02628769|80123067|FG001|First Intervention|Adverse Event|0|||
27526901|NCT02628769|80123066|FG000|First Intervention|Withdrawal by Subject|0|||
27526902|NCT02628769|80123067|FG001|First Intervention|Withdrawal by Subject|1|||
27526903|NCT02628769|80123066|FG000|Second Intervention|Adverse Event|2|||
27526904|NCT02628769|80123067|FG001|Second Intervention|Adverse Event|0|||
27526905|NCT02628769|80123066|FG000|Second Intervention|Physician Decision|0|||
27526906|NCT02628769|80123067|FG001|Second Intervention|Physician Decision|1|||
27526907|NCT03442764|80123070|FG000|Overall Study|Adverse Event|1|||
27526908|NCT03442764|80123071|FG001|Overall Study|Adverse Event|0|||
27526909|NCT03442764|80123072|FG002|Overall Study|Adverse Event|0|||
27526910|NCT02718300|80123075|FG000|Overall Study|Death|4|||
27526911|NCT02718300|80123076|FG001|Overall Study|Death|5|||
27526912|NCT02718300|80123077|FG002|Overall Study|Death|17|||
27526913|NCT02718300|80123075|FG000|Overall Study|Lost to Follow-up|1|||
27526914|NCT02718300|80123076|FG001|Overall Study|Lost to Follow-up|0|||
27526915|NCT02718300|80123077|FG002|Overall Study|Lost to Follow-up|2|||
27526916|NCT02718300|80123075|FG000|Overall Study|Physician Decision|1|||
27526917|NCT02718300|80123076|FG001|Overall Study|Physician Decision|0|||
27526918|NCT02718300|80123077|FG002|Overall Study|Physician Decision|2|||
27526919|NCT02718300|80123075|FG000|Overall Study|Study Terminated by Sponsor|6|||
27526920|NCT02718300|80123076|FG001|Overall Study|Study Terminated by Sponsor|3|||
27526921|NCT02718300|80123077|FG002|Overall Study|Study Terminated by Sponsor|4|||
27526922|NCT02718300|80123075|FG000|Overall Study|Withdrawal by Subject|0|||
27526923|NCT02718300|80123076|FG001|Overall Study|Withdrawal by Subject|4|||
27526924|NCT02718300|80123077|FG002|Overall Study|Withdrawal by Subject|3|||
27526925|NCT02718300|80123075|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
27526926|NCT02718300|80123076|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
27526927|NCT02718300|80123077|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
27526928|NCT04010539|80123078|FG000|Overall Study|Withdrawal by Subject|4|||
27526929|NCT04010539|80123079|FG001|Overall Study|Withdrawal by Subject|1|||
27526930|NCT04010539|80123078|FG000|Overall Study|Physician Decision|0|||
27623534|NCT03176134|80464186|FG006|Overall Study|Lost to Follow-up|0|||
27623535|NCT03176134|80464187|FG007|Overall Study|Lost to Follow-up|0|||
27623536|NCT03176134|80464180|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27623537|NCT03176134|80464181|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27623538|NCT03176134|80464182|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
27623539|NCT03176134|80464183|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27623540|NCT03176134|80464184|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27623541|NCT03176134|80464185|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27623542|NCT03176134|80464186|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
27623543|NCT03176134|80464187|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
27623544|NCT04730947|80464189|FG000|Overall Study|Withdrawal by Subject|0|||
27623545|NCT04730947|80464190|FG001|Overall Study|Withdrawal by Subject|1|||
27623546|NCT02652130|80464192|FG000|Overall Study|Death|1|||
27623547|NCT04523181|80464193|FG000|Overall Study|Withdrawal by Subject|4|||
27623548|NCT04523181|80464194|FG001|Overall Study|Withdrawal by Subject|5|||
27526931|NCT04010539|80123079|FG001|Overall Study|Physician Decision|2|||
27526932|NCT04010539|80123078|FG000|Overall Study|Lost to Follow-up|10|||
27526933|NCT04010539|80123079|FG001|Overall Study|Lost to Follow-up|14|||
27526934|NCT04010539|80123078|FG000|Overall Study|Adverse Event|3|||
27623549|NCT04523181|80464193|FG000|Overall Study|Lost to Follow-up|2|||
27623550|NCT04523181|80464194|FG001|Overall Study|Lost to Follow-up|3|||
27623551|NCT04523181|80464193|FG000|Overall Study|Physician Decision|1|||
27623552|NCT04523181|80464194|FG001|Overall Study|Physician Decision|0|||
27623553|NCT04523181|80464193|FG000|Overall Study|Transferred to external facility.|1|||
27526935|NCT04010539|80123079|FG001|Overall Study|Adverse Event|0|||
27623554|NCT04523181|80464194|FG001|Overall Study|Transferred to external facility.|1|||
27623555|NCT04159506|80464195|FG000|Overall Study|Lost to Follow-up|2|||
27733333|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
27526936|NCT04010539|80123078|FG000|Overall Study|Participant Did Not Receive IP|0|||
27526937|NCT04010539|80123079|FG001|Overall Study|Participant Did Not Receive IP|1|||
27526938|NCT04010539|80123078|FG000|Overall Study|Protocol Deviation|0|||
27526939|NCT04010539|80123079|FG001|Overall Study|Protocol Deviation|1|||
27526940|NCT04010539|80123078|FG000|Overall Study|Randomized in Error/ Mistake|2|||
27623556|NCT04159506|80464196|FG001|Overall Study|Lost to Follow-up|5|||
27623557|NCT00578227|80464197|FG000|Overall Study|Lost to Follow-up|0|||
27526941|NCT04010539|80123079|FG001|Overall Study|Randomized in Error/ Mistake|0|||
27623558|NCT00578227|80464198|FG001|Overall Study|Lost to Follow-up|1|||
27623559|NCT00578227|80464199|FG002|Overall Study|Lost to Follow-up|1|||
27623560|NCT00578227|80464197|FG000|Overall Study|Withdrawal by Subject|5|||
27623561|NCT00578227|80464198|FG001|Overall Study|Withdrawal by Subject|1|||
27623562|NCT00578227|80464199|FG002|Overall Study|Withdrawal by Subject|3|||
27623563|NCT01556243|80464200|FG000|Overall Study|Ineligible|34|||
27623564|NCT01556243|80464200|FG000|Overall Study|Converted to mastectomy|14|||
27623565|NCT01556243|80464200|FG000|Overall Study|Unable to achieve negative margins|2|||
27623566|NCT01556243|80464200|FG000|Overall Study|Withdrawal by Subject|16|||
27623567|NCT04034238|80464205|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
27623568|NCT04034238|80464206|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27623569|NCT04034238|80464207|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
27623570|NCT04034238|80464208|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27623571|NCT04034238|80464205|FG000|Dose Escalation Phase|Screen failures|0|||
27623572|NCT04034238|80464206|FG001|Dose Escalation Phase|Screen failures|0|||
27623573|NCT04034238|80464207|FG002|Dose Escalation Phase|Screen failures|0|||
27526942|NCT04010539|80123078|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
27526943|NCT04010539|80123079|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
27526944|NCT01155479|80123083|FG000|Part I|Adverse Event|13|||
27526945|NCT01155479|80123084|FG001|Part I|Adverse Event|8|||
27526946|NCT01155479|80123085|FG002|Part I|Adverse Event|18|||
27526947|NCT01155479|80123086|FG003|Part I|Adverse Event|7|||
27526948|NCT01155479|80123087|FG004|Part I|Adverse Event|6|||
27526949|NCT01155479|80123083|FG000|Part I|Administrative|2|||
27526950|NCT01155479|80123084|FG001|Part I|Administrative|2|||
27526951|NCT01155479|80123085|FG002|Part I|Administrative|2|||
27526952|NCT01155479|80123086|FG003|Part I|Administrative|0|||
27526953|NCT01155479|80123087|FG004|Part I|Administrative|0|||
27526954|NCT01155479|80123083|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
27526955|NCT01155479|80123084|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
27526956|NCT01155479|80123085|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
27526957|NCT01155479|80123086|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
27526958|NCT01155479|80123087|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
27526959|NCT01155479|80123083|FG000|Part I|Withdrawal by Subject|11|||
27526960|NCT01155479|80123084|FG001|Part I|Withdrawal by Subject|13|||
27526961|NCT01155479|80123085|FG002|Part I|Withdrawal by Subject|8|||
27526962|NCT01155479|80123086|FG003|Part I|Withdrawal by Subject|8|||
27526963|NCT01155479|80123087|FG004|Part I|Withdrawal by Subject|9|||
27526964|NCT01155479|80123083|FG000|Part I|Lost to Follow-up|0|||
27526965|NCT01155479|80123084|FG001|Part I|Lost to Follow-up|0|||
27526966|NCT01155479|80123085|FG002|Part I|Lost to Follow-up|1|||
27526967|NCT01155479|80123086|FG003|Part I|Lost to Follow-up|1|||
27526968|NCT01155479|80123087|FG004|Part I|Lost to Follow-up|0|||
27526969|NCT01155479|80123083|FG000|Part I|Treatment Failure|3|||
27526970|NCT01155479|80123084|FG001|Part I|Treatment Failure|0|||
27526971|NCT01155479|80123085|FG002|Part I|Treatment Failure|3|||
27526972|NCT01155479|80123086|FG003|Part I|Treatment Failure|1|||
27623574|NCT04034238|80464208|FG003|Dose Escalation Phase|Screen failures|2|||
27623575|NCT04034238|80464205|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
27733334|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27733335|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
27623576|NCT04034238|80464206|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
27526973|NCT01155479|80123087|FG004|Part I|Treatment Failure|2|||
27526974|NCT01155479|80123083|FG000|Part I|Did Not Receive Treatment|4|||
27526975|NCT01155479|80123084|FG001|Part I|Did Not Receive Treatment|2|||
27526976|NCT01155479|80123085|FG002|Part I|Did Not Receive Treatment|2|||
27526977|NCT01155479|80123086|FG003|Part I|Did Not Receive Treatment|6|||
27526978|NCT01155479|80123087|FG004|Part I|Did Not Receive Treatment|1|||
27623577|NCT04034238|80464207|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
27623578|NCT04034238|80464208|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
27623579|NCT04034238|80464205|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
27911441|NCT02959918|81513593|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911442|NCT02959918|81513594|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911443|NCT02959918|81513595|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911444|NCT02959918|81513596|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911445|NCT02959918|81513597|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911446|NCT02959918|81513598|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
27911447|NCT02959918|81513585|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911448|NCT02959918|81513586|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911449|NCT02959918|81513587|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911450|NCT02959918|81513588|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911451|NCT02959918|81513589|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911452|NCT02959918|81513590|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27526979|NCT01155479|80123083|FG000|Part I|Non-Compliance with Protocol|2|||
27526980|NCT01155479|80123084|FG001|Part I|Non-Compliance with Protocol|1|||
27526981|NCT01155479|80123085|FG002|Part I|Non-Compliance with Protocol|3|||
27526982|NCT01155479|80123086|FG003|Part I|Non-Compliance with Protocol|3|||
27526983|NCT01155479|80123087|FG004|Part I|Non-Compliance with Protocol|2|||
27526984|NCT01155479|80123083|FG000|Part II|Adverse Event|7|||
27911453|NCT02959918|81513591|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911454|NCT02959918|81513592|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
27911455|NCT02959918|81513593|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911456|NCT02959918|81513594|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911457|NCT02959918|81513595|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27526985|NCT01155479|80123084|FG001|Part II|Adverse Event|6|||
27526986|NCT01155479|80123085|FG002|Part II|Adverse Event|8|||
27526987|NCT01155479|80123086|FG003|Part II|Adverse Event|3|||
27526988|NCT01155479|80123087|FG004|Part II|Adverse Event|4|||
27526989|NCT01155479|80123083|FG000|Part II|Administrative|43|||
27526990|NCT01155479|80123084|FG001|Part II|Administrative|49|||
27526991|NCT01155479|80123085|FG002|Part II|Administrative|36|||
27526992|NCT01155479|80123086|FG003|Part II|Administrative|38|||
27526993|NCT01155479|80123087|FG004|Part II|Administrative|46|||
27526994|NCT01155479|80123083|FG000|Part II|Withdrawal by Subject|8|||
27526995|NCT01155479|80123084|FG001|Part II|Withdrawal by Subject|4|||
27526996|NCT01155479|80123085|FG002|Part II|Withdrawal by Subject|12|||
27526997|NCT01155479|80123086|FG003|Part II|Withdrawal by Subject|7|||
27526998|NCT01155479|80123087|FG004|Part II|Withdrawal by Subject|3|||
27526999|NCT01155479|80123083|FG000|Part II|Lost to Follow-up|1|||
27527000|NCT01155479|80123084|FG001|Part II|Lost to Follow-up|0|||
27527001|NCT01155479|80123085|FG002|Part II|Lost to Follow-up|0|||
27527002|NCT01155479|80123086|FG003|Part II|Lost to Follow-up|0|||
27527003|NCT01155479|80123087|FG004|Part II|Lost to Follow-up|1|||
27527004|NCT01155479|80123083|FG000|Part II|Treatment Failure|0|||
27527005|NCT01155479|80123084|FG001|Part II|Treatment Failure|1|||
27856157|NCT00302081|81306670|FG001|Overall Study|Lack of Efficacy|0|||
27527006|NCT01155479|80123085|FG002|Part II|Treatment Failure|2|||
27527007|NCT01155479|80123086|FG003|Part II|Treatment Failure|0|||
27527008|NCT01155479|80123087|FG004|Part II|Treatment Failure|1|||
27527009|NCT01155479|80123083|FG000|Part II|Non-Compliance with Protocol|0|||
27527010|NCT01155479|80123084|FG001|Part II|Non-Compliance with Protocol|1|||
27527011|NCT01155479|80123085|FG002|Part II|Non-Compliance with Protocol|0|||
27527012|NCT01155479|80123086|FG003|Part II|Non-Compliance with Protocol|2|||
27527013|NCT01155479|80123087|FG004|Part II|Non-Compliance with Protocol|0|||
27527014|NCT02025556|80123095|FG000|Overall Study|Adverse Event|0|||
27527015|NCT02025556|80123096|FG001|Overall Study|Adverse Event|4|||
27527016|NCT02025556|80123097|FG002|Overall Study|Adverse Event|2|||
27527017|NCT02025556|80123095|FG000|Overall Study|Lack of Efficacy|2|||
27527018|NCT02025556|80123096|FG001|Overall Study|Lack of Efficacy|1|||
27527019|NCT02025556|80123097|FG002|Overall Study|Lack of Efficacy|0|||
27527020|NCT02025556|80123095|FG000|Overall Study|Protocol Violation|2|||
27527021|NCT02025556|80123096|FG001|Overall Study|Protocol Violation|1|||
27527022|NCT02025556|80123097|FG002|Overall Study|Protocol Violation|0|||
27527023|NCT02025556|80123095|FG000|Overall Study|Withdrawal by Subject|0|||
27527024|NCT02025556|80123096|FG001|Overall Study|Withdrawal by Subject|3|||
27527025|NCT02025556|80123097|FG002|Overall Study|Withdrawal by Subject|6|||
27527026|NCT02025556|80123095|FG000|Overall Study|Lost to Follow-up|2|||
27527027|NCT02025556|80123096|FG001|Overall Study|Lost to Follow-up|4|||
27527028|NCT02025556|80123097|FG002|Overall Study|Lost to Follow-up|0|||
27527029|NCT02025556|80123095|FG000|Overall Study|Reason not reported|0|||
27527030|NCT02025556|80123096|FG001|Overall Study|Reason not reported|0|||
27527031|NCT02025556|80123097|FG002|Overall Study|Reason not reported|1|||
27527032|NCT03891667|80123098|FG000|Overall Study|Physician Decision|1|||
27527033|NCT03891667|80123099|FG001|Overall Study|Physician Decision|0|||
27527034|NCT03891667|80123098|FG000|Overall Study|COVID related pause|1|||
27527035|NCT03891667|80123099|FG001|Overall Study|COVID related pause|1|||
27527036|NCT03891667|80123098|FG000|Overall Study|Withdrawal by Subject|0|||
27527037|NCT03891667|80123099|FG001|Overall Study|Withdrawal by Subject|1|||
27527038|NCT03891667|80123098|FG000|Overall Study|Adverse Event|0|||
27527039|NCT03891667|80123099|FG001|Overall Study|Adverse Event|1|||
27527040|NCT01736657|80123100|FG000|Overall Study|insufficient vascular access|1|||
27527041|NCT01209832|80123106|FG000|Period 1|Sponsor Decision and was not dosed|1|||
27527042|NCT01209832|80123106|FG000|Period 2|Sponsor Decision|1|||
27527043|NCT01992159|80123107|FG000|Overall Study|Withdrawal by Subject|4|||
27527044|NCT01992159|80123108|FG001|Overall Study|Withdrawal by Subject|7|||
27527045|NCT01992159|80123109|FG002|Overall Study|Withdrawal by Subject|0|||
27527046|NCT01992159|80123110|FG003|Overall Study|Withdrawal by Subject|3|||
27527047|NCT01992159|80123107|FG000|Overall Study|Adverse Event|0|||
27527048|NCT01992159|80123108|FG001|Overall Study|Adverse Event|1|||
27527049|NCT01992159|80123109|FG002|Overall Study|Adverse Event|0|||
27527050|NCT01992159|80123110|FG003|Overall Study|Adverse Event|1|||
27527051|NCT01992159|80123107|FG000|Overall Study|Death|0|||
27527052|NCT01992159|80123108|FG001|Overall Study|Death|0|||
27527053|NCT01992159|80123109|FG002|Overall Study|Death|1|||
27527054|NCT01992159|80123110|FG003|Overall Study|Death|0|||
27527055|NCT00924170|80123116|FG000|Overall Study|Refused further treatment|0|||
27527056|NCT00924170|80123117|FG001|Overall Study|Refused further treatment|1|||
27527057|NCT00924170|80123116|FG000|Overall Study|Physician Decision|0|||
27527058|NCT00924170|80123117|FG001|Overall Study|Physician Decision|1|||
27527059|NCT00924170|80123116|FG000|Overall Study|Progressive disease|3|||
27856158|NCT00302081|81306671|FG002|Overall Study|Lack of Efficacy|5|||
27527060|NCT00924170|80123117|FG001|Overall Study|Progressive disease|6|||
27527061|NCT00924170|80123116|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
27623580|NCT04034238|80464206|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
27623581|NCT04034238|80464207|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
27623582|NCT04034238|80464208|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
27623583|NCT02049437|80464214|FG000|Period 1|Adverse Event|1|||
27911458|NCT02959918|81513596|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911459|NCT02959918|81513597|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911460|NCT02959918|81513598|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
27911461|NCT02959918|81513585|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911462|NCT02959918|81513586|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911463|NCT02959918|81513587|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911464|NCT02959918|81513588|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911465|NCT02959918|81513589|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911466|NCT02959918|81513590|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911467|NCT02959918|81513591|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911468|NCT02959918|81513592|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911469|NCT02959918|81513593|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
27527062|NCT00924170|80123117|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
27527063|NCT00924170|80123116|FG000|Overall Study|Death|1|||
27527064|NCT00924170|80123117|FG001|Overall Study|Death|0|||
27527065|NCT03324581|80123122|FG000|Overall Study|Adverse Event|18|||
27527066|NCT03324581|80123123|FG001|Overall Study|Adverse Event|11|||
27527067|NCT03324581|80123124|FG002|Overall Study|Adverse Event|7|||
27527068|NCT03324581|80123122|FG000|Overall Study|Lack of Efficacy|0|||
27527069|NCT03324581|80123123|FG001|Overall Study|Lack of Efficacy|1|||
27527070|NCT03324581|80123124|FG002|Overall Study|Lack of Efficacy|0|||
27527071|NCT03324581|80123122|FG000|Overall Study|Lost to Follow-up|5|||
27527072|NCT03324581|80123123|FG001|Overall Study|Lost to Follow-up|3|||
27527073|NCT03324581|80123124|FG002|Overall Study|Lost to Follow-up|6|||
27527074|NCT03324581|80123122|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
27527075|NCT03324581|80123123|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
27527076|NCT03324581|80123124|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
27527077|NCT03324581|80123122|FG000|Overall Study|Physician Decision|0|||
27527078|NCT03324581|80123123|FG001|Overall Study|Physician Decision|1|||
27527079|NCT03324581|80123124|FG002|Overall Study|Physician Decision|2|||
27527080|NCT03324581|80123122|FG000|Overall Study|Protocol Deviation|8|||
27527081|NCT03324581|80123123|FG001|Overall Study|Protocol Deviation|9|||
27527082|NCT03324581|80123124|FG002|Overall Study|Protocol Deviation|4|||
27527083|NCT03324581|80123122|FG000|Overall Study|Withdrawal by Subject|6|||
27527084|NCT03324581|80123123|FG001|Overall Study|Withdrawal by Subject|8|||
27527085|NCT03324581|80123124|FG002|Overall Study|Withdrawal by Subject|6|||
27527086|NCT03324581|80123122|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
27527087|NCT03324581|80123123|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
27527088|NCT03324581|80123124|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
27527089|NCT03025789|80123125|FG000|Overall Study|Lack of Efficacy|6|||
27527090|NCT03025789|80123126|FG001|Overall Study|Lack of Efficacy|1|||
27527091|NCT03025789|80123125|FG000|Overall Study|Death|1|||
27527092|NCT03025789|80123126|FG001|Overall Study|Death|0|||
27527093|NCT03025789|80123125|FG000|Overall Study|Withdrawal by Subject|0|||
27527094|NCT03025789|80123126|FG001|Overall Study|Withdrawal by Subject|2|||
27527095|NCT00740051|80123127|FG000|Overall Study|Lack of Efficacy|2|||
27527096|NCT00740051|80123128|FG001|Overall Study|Lack of Efficacy|5|||
27623584|NCT02049437|80464215|FG001|Period 1|Adverse Event|1|||
27527097|NCT00740051|80123127|FG000|Overall Study|Adverse Event|1|||
27623585|NCT02049437|80464214|FG000|Period 1|Adverse Event|1|||
27623586|NCT02049437|80464215|FG001|Period 1|Adverse Event|0|||
27623587|NCT01348854|80464216|FG000|Overall Study|Lost to Follow-up|2|||
27527098|NCT00740051|80123128|FG001|Overall Study|Adverse Event|4|||
27527099|NCT00740051|80123127|FG000|Overall Study|Protocol Violation|2|||
27527100|NCT00740051|80123128|FG001|Overall Study|Protocol Violation|6|||
27527101|NCT00740051|80123127|FG000|Overall Study|Lost to Follow-up|3|||
27527102|NCT00740051|80123128|FG001|Overall Study|Lost to Follow-up|8|||
27527103|NCT00740051|80123127|FG000|Overall Study|Withdrawal by Subject|6|||
27623588|NCT01348854|80464217|FG001|Overall Study|Lost to Follow-up|1|||
27623589|NCT01348854|80464216|FG000|Overall Study|Withdrawal by Subject|1|||
27623590|NCT01348854|80464217|FG001|Overall Study|Withdrawal by Subject|0|||
27623591|NCT04776213|80464219|FG000|Overall Study|Other|1|||
27623592|NCT04776213|80464219|FG000|Overall Study|Withdrawal by Subject|7|||
27623593|NCT04776213|80464219|FG000|Overall Study|Protocol Violation|1|||
27623594|NCT04776213|80464219|FG000|Overall Study|Lost to Follow-up|2|||
27623595|NCT04438785|80464220|FG000|Overall Study|change of weight, give up intervention|2|||
27623596|NCT04438785|80464221|FG001|Overall Study|change of weight, give up intervention|10|||
27623597|NCT00795132|80464228|FG000|Overall Study|Death|1|||
27623598|NCT00795132|80464228|FG000|Overall Study|Relapse|2|||
27623599|NCT01562743|80464229|FG000|Overall Study|Adverse Event|29|||
27623600|NCT01562743|80464229|FG000|Overall Study|Lack of Efficacy|3|||
27623601|NCT01562743|80464229|FG000|Overall Study|Withdrawal by Subject|13|||
27623602|NCT01562743|80464229|FG000|Overall Study|Protocol Violation|1|||
27623603|NCT01562743|80464229|FG000|Overall Study|Discontinuation criteria|2|||
27623604|NCT01562743|80464229|FG000|Overall Study|Lost to Follow-up|2|||
27623605|NCT01562743|80464229|FG000|Overall Study|Physician Decision|2|||
27623606|NCT01536262|80464233|FG000|Overall Study|Adverse Event|6|||
27623607|NCT01536262|80464234|FG001|Overall Study|Adverse Event|1|||
27623608|NCT01536262|80464235|FG002|Overall Study|Adverse Event|2|||
27623609|NCT01536262|80464233|FG000|Overall Study|Withdrawal by Subject|1|||
27623610|NCT01536262|80464234|FG001|Overall Study|Withdrawal by Subject|1|||
27623611|NCT01536262|80464235|FG002|Overall Study|Withdrawal by Subject|0|||
27527104|NCT00740051|80123128|FG001|Overall Study|Withdrawal by Subject|8|||
27527105|NCT00740051|80123127|FG000|Overall Study|Other reason (not specified)|4|||
27527106|NCT00740051|80123128|FG001|Overall Study|Other reason (not specified)|1|||
27527107|NCT00588952|80123129|FG000|Overall Study|Adverse Event|0|||
27527108|NCT00588952|80123130|FG001|Overall Study|Adverse Event|2|||
27527109|NCT00588952|80123129|FG000|Overall Study|Withdrawal by Subject|3|||
27527110|NCT00588952|80123130|FG001|Overall Study|Withdrawal by Subject|5|||
27527111|NCT02663687|80123133|FG000|Overall Study|Adverse Event|1|||
27527112|NCT02663687|80123134|FG001|Overall Study|Adverse Event|0|||
27527113|NCT02663687|80123135|FG002|Overall Study|Adverse Event|0|||
27527114|NCT02663687|80123136|FG003|Overall Study|Adverse Event|0|||
27527115|NCT02663687|80123137|FG004|Overall Study|Adverse Event|0|||
27623612|NCT01536262|80464233|FG000|Overall Study|Other than stated above|1|||
27623613|NCT01536262|80464234|FG001|Overall Study|Other than stated above|0|||
27623614|NCT01536262|80464235|FG002|Overall Study|Other than stated above|0|||
27623615|NCT00432159|80464236|FG000|Overall Study|Death|0|||
27623616|NCT00432159|80464237|FG001|Overall Study|Death|1|||
27733336|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
27527116|NCT02663687|80123133|FG000|Overall Study|Other|1|||
27527117|NCT02663687|80123134|FG001|Overall Study|Other|0|||
27527118|NCT02663687|80123135|FG002|Overall Study|Other|1|||
27527119|NCT02663687|80123136|FG003|Overall Study|Other|0|||
27527120|NCT02663687|80123137|FG004|Overall Study|Other|0|||
27527121|NCT02361580|80123138|FG000|Overall Study|Lost to Follow-up|6|||
27527122|NCT02361580|80123139|FG001|Overall Study|Lost to Follow-up|3|||
27527123|NCT00910247|80123140|FG000|Overall Study|Adverse Event|15|||
27527124|NCT00910247|80123140|FG000|Overall Study|Death|2|||
27527125|NCT00910247|80123140|FG000|Overall Study|Lost to Follow-up|10|||
27527126|NCT00910247|80123140|FG000|Overall Study|Physician Decision|3|||
27527127|NCT00910247|80123140|FG000|Overall Study|Protocol Violation|10|||
27527128|NCT00910247|80123140|FG000|Overall Study|Withdrawal by Subject|25|||
27527129|NCT00910247|80123140|FG000|Overall Study|Not collected|4|||
27527130|NCT03355664|80123141|FG000|Overall Study|Adverse Event|1|||
27527131|NCT03355664|80123142|FG001|Overall Study|Adverse Event|2|||
27856159|NCT00302081|81306669|FG000|Overall Study|Death|2|||
27911470|NCT02959918|81513594|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27527132|NCT03355664|80123141|FG000|Overall Study|Lost to Follow-up|11|||
27527133|NCT03355664|80123142|FG001|Overall Study|Lost to Follow-up|7|||
27527134|NCT03355664|80123141|FG000|Overall Study|Protocol Violation|1|||
27527135|NCT03355664|80123142|FG001|Overall Study|Protocol Violation|2|||
27527136|NCT03355664|80123141|FG000|Overall Study|Withdrawal by Subject|2|||
27527137|NCT03355664|80123142|FG001|Overall Study|Withdrawal by Subject|1|||
27527138|NCT02292784|80123143|FG000|Overall Study|Lost to Follow-up|1|||
27623617|NCT00432159|80464238|FG002|Overall Study|Death|0|||
27623618|NCT00432159|80464239|FG003|Overall Study|Death|0|||
27623619|NCT00432159|80464240|FG004|Overall Study|Death|0|||
27623620|NCT00432159|80464236|FG000|Overall Study|Failure|9|||
27527139|NCT02292784|80123144|FG001|Overall Study|Lost to Follow-up|17|||
27527140|NCT02292784|80123145|FG002|Overall Study|Lost to Follow-up|18|||
27527141|NCT02292784|80123143|FG000|Overall Study|Withdrawal by Subject|0|||
27527142|NCT02292784|80123144|FG001|Overall Study|Withdrawal by Subject|3|||
27623621|NCT00432159|80464237|FG001|Overall Study|Failure|5|||
27623622|NCT00432159|80464238|FG002|Overall Study|Failure|3|||
27623623|NCT00432159|80464239|FG003|Overall Study|Failure|2|||
27623624|NCT00432159|80464240|FG004|Overall Study|Failure|3|||
27623625|NCT00432159|80464236|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
27527143|NCT02292784|80123145|FG002|Overall Study|Withdrawal by Subject|3|||
27527144|NCT00214500|80123148|FG000|Treatment Period|Adverse Event|1|||
27527145|NCT00214500|80123148|FG000|Extension Period|Withdrawal by Subject|2|||
27527146|NCT00058539|80123149|FG000|Overall Study|Disease progression|24|||
27527147|NCT00058539|80123149|FG000|Overall Study|Adverse Event|3|||
27527148|NCT00058539|80123149|FG000|Overall Study|Withdrawal by Subject|5|||
27527149|NCT00058539|80123149|FG000|Overall Study|Physician Decision|9|||
27527150|NCT00058539|80123149|FG000|Overall Study|Death|1|||
27527151|NCT00290407|80123150|FG000|Overall Study|Physician Decision|2|||
27527152|NCT02119676|80123152|FG000|Overall Study|Adverse Event|9|||
27527153|NCT02119676|80123153|FG001|Overall Study|Adverse Event|17|||
27527154|NCT02119676|80123154|FG002|Overall Study|Adverse Event|10|||
27527155|NCT02119676|80123155|FG003|Overall Study|Adverse Event|10|||
27527156|NCT02119676|80123152|FG000|Overall Study|Disease progression|53|||
27527157|NCT02119676|80123153|FG001|Overall Study|Disease progression|55|||
27527158|NCT02119676|80123154|FG002|Overall Study|Disease progression|68|||
27527159|NCT02119676|80123155|FG003|Overall Study|Disease progression|73|||
27527160|NCT02119676|80123152|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
27527161|NCT02119676|80123153|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
27527162|NCT02119676|80123154|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
27527163|NCT02119676|80123155|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
27527164|NCT02119676|80123152|FG000|Overall Study|Physician Decision|4|||
27527165|NCT02119676|80123153|FG001|Overall Study|Physician Decision|2|||
27527166|NCT02119676|80123154|FG002|Overall Study|Physician Decision|3|||
27527167|NCT02119676|80123155|FG003|Overall Study|Physician Decision|2|||
27527168|NCT02119676|80123152|FG000|Overall Study|Death|9|||
27527169|NCT02119676|80123153|FG001|Overall Study|Death|3|||
27623626|NCT00432159|80464237|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
27623627|NCT00432159|80464238|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
27623628|NCT00432159|80464239|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
27623629|NCT00432159|80464240|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
27623630|NCT00797225|80464241|FG000|Weeks 1 to 12|Adverse Event|0|||
27623631|NCT00797225|80464242|FG001|Weeks 1 to 12|Adverse Event|0|||
27623632|NCT00797225|80464243|FG002|Weeks 1 to 12|Adverse Event|1|||
27623633|NCT00797225|80464244|FG003|Weeks 1 to 12|Adverse Event|0|||
27623634|NCT00797225|80464245|FG004|Weeks 1 to 12|Adverse Event|0|||
27623635|NCT00797225|80464246|FG005|Weeks 1 to 12|Adverse Event|0|||
27623636|NCT00797225|80464247|FG006|Weeks 1 to 12|Adverse Event|0|||
27623637|NCT00797225|80464248|FG007|Weeks 1 to 12|Adverse Event|0|||
27623638|NCT00797225|80464241|FG000|Weeks 1 to 12|Non-compliance|0|||
27623639|NCT00797225|80464242|FG001|Weeks 1 to 12|Non-compliance|1|||
27623640|NCT00797225|80464243|FG002|Weeks 1 to 12|Non-compliance|0|||
27623641|NCT00797225|80464244|FG003|Weeks 1 to 12|Non-compliance|0|||
27623642|NCT00797225|80464245|FG004|Weeks 1 to 12|Non-compliance|0|||
27623643|NCT00797225|80464246|FG005|Weeks 1 to 12|Non-compliance|0|||
27623644|NCT00797225|80464247|FG006|Weeks 1 to 12|Non-compliance|0|||
27623645|NCT00797225|80464248|FG007|Weeks 1 to 12|Non-compliance|0|||
27623646|NCT00797225|80464241|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
27623647|NCT00797225|80464242|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
27856160|NCT00302081|81306670|FG001|Overall Study|Death|1|||
27856161|NCT00302081|81306671|FG002|Overall Study|Death|0|||
27856162|NCT00302081|81306669|FG000|Overall Study|Other|13|||
27856163|NCT00302081|81306670|FG001|Overall Study|Other|6|||
27856164|NCT00302081|81306671|FG002|Overall Study|Other|5|||
27856165|NCT02408068|81306672|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
27856166|NCT02408068|81306673|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
27856167|NCT02408068|81306674|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
27856168|NCT02408068|81306675|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
27856169|NCT02408068|81306676|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
27856170|NCT02408068|81306677|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
27856171|NCT04295135|81306681|FG000|Overall Study|Withdrawal by Subject|2|||
27856172|NCT04295135|81306682|FG001|Overall Study|Withdrawal by Subject|1|||
27856173|NCT04295135|81306681|FG000|Overall Study|Subject left organization|8|||
27856174|NCT04295135|81306682|FG001|Overall Study|Subject left organization|4|||
27856175|NCT02944383|81306687|FG000|Overall Study|Lost to Follow-up|0|||
27856176|NCT02944383|81306688|FG001|Overall Study|Lost to Follow-up|0|||
27856177|NCT02944383|81306689|FG002|Overall Study|Lost to Follow-up|1|||
27527170|NCT02119676|80123154|FG002|Overall Study|Death|2|||
27527171|NCT02119676|80123155|FG003|Overall Study|Death|1|||
27527172|NCT02119676|80123152|FG000|Overall Study|Noncompliance|0|||
27623648|NCT00797225|80464243|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
27856178|NCT02944383|81306687|FG000|Overall Study|Withdrawal by Subject|1|||
27856179|NCT02944383|81306688|FG001|Overall Study|Withdrawal by Subject|0|||
27527173|NCT02119676|80123153|FG001|Overall Study|Noncompliance|1|||
27527174|NCT02119676|80123154|FG002|Overall Study|Noncompliance|0|||
27623649|NCT00797225|80464244|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
27623650|NCT00797225|80464245|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
27623651|NCT00797225|80464246|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
27623652|NCT00797225|80464247|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
27623653|NCT00797225|80464248|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
27623654|NCT00797225|80464241|FG000|Weeks 1 to 12|Sponsor Decision|1|||
27623655|NCT00797225|80464242|FG001|Weeks 1 to 12|Sponsor Decision|0|||
27623656|NCT00797225|80464243|FG002|Weeks 1 to 12|Sponsor Decision|0|||
27623657|NCT00797225|80464244|FG003|Weeks 1 to 12|Sponsor Decision|0|||
27623658|NCT00797225|80464245|FG004|Weeks 1 to 12|Sponsor Decision|0|||
27623659|NCT00797225|80464246|FG005|Weeks 1 to 12|Sponsor Decision|0|||
27623660|NCT00797225|80464247|FG006|Weeks 1 to 12|Sponsor Decision|0|||
27623661|NCT00797225|80464248|FG007|Weeks 1 to 12|Sponsor Decision|0|||
27623662|NCT00797225|80464241|FG000|Weeks 13 to 24|Non-compliance|0|||
27623663|NCT00797225|80464242|FG001|Weeks 13 to 24|Non-compliance|2|||
27623664|NCT00797225|80464243|FG002|Weeks 13 to 24|Non-compliance|0|||
27623665|NCT00797225|80464244|FG003|Weeks 13 to 24|Non-compliance|0|||
27623666|NCT00797225|80464245|FG004|Weeks 13 to 24|Non-compliance|0|||
27527175|NCT02119676|80123155|FG003|Overall Study|Noncompliance|0|||
27527176|NCT02119676|80123152|FG000|Overall Study|Lost to Follow-up|0|||
27527177|NCT02119676|80123153|FG001|Overall Study|Lost to Follow-up|0|||
27527178|NCT02119676|80123154|FG002|Overall Study|Lost to Follow-up|1|||
27527179|NCT02119676|80123155|FG003|Overall Study|Lost to Follow-up|0|||
27527180|NCT02119676|80123152|FG000|Overall Study|Protocol deviation|0|||
27623667|NCT00797225|80464246|FG005|Weeks 13 to 24|Non-compliance|0|||
27623668|NCT00797225|80464247|FG006|Weeks 13 to 24|Non-compliance|0|||
27623669|NCT00797225|80464248|FG007|Weeks 13 to 24|Non-compliance|0|||
27623670|NCT00797225|80464241|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
27856180|NCT02944383|81306689|FG002|Overall Study|Withdrawal by Subject|0|||
27856181|NCT02488330|81306690|FG000|Overall Study|Adverse Event|1|||
27856182|NCT02488330|81306690|FG000|Overall Study|Physician Decision|2|||
27856183|NCT02488330|81306690|FG000|Overall Study|Death|2|||
27856184|NCT02488330|81306690|FG000|Overall Study|Disease Progression|3|||
27856185|NCT02488330|81306690|FG000|Overall Study|Study Termination by Sponsor|4|||
27856186|NCT01732484|81306691|FG000|Overall Study|Death|7|||
27856187|NCT01732484|81306691|FG000|Overall Study|Lost to Follow-up|14|||
27856188|NCT01732484|81306691|FG000|Overall Study|chronical illness|5|||
27911471|NCT02959918|81513595|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911472|NCT02959918|81513596|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911473|NCT02959918|81513597|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911474|NCT02959918|81513598|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
27911475|NCT02959918|81513585|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911476|NCT02959918|81513586|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911477|NCT02959918|81513587|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911478|NCT02959918|81513588|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911479|NCT02959918|81513589|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911480|NCT02959918|81513590|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27856189|NCT03861481|81306692|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
27856190|NCT03861481|81306693|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
27856191|NCT03861481|81306692|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
27856192|NCT03861481|81306693|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
27856193|NCT03861481|81306692|FG000|Overall Study|Relapse|1|||
27856194|NCT03861481|81306693|FG001|Overall Study|Relapse|0|||
27856195|NCT03861481|81306692|FG000|Overall Study|Withdrawal by Subject|0|||
27856196|NCT03861481|81306693|FG001|Overall Study|Withdrawal by Subject|1|||
27856197|NCT03861481|81306692|FG000|Overall Study|Lack of Efficacy|4|||
27527181|NCT02119676|80123153|FG001|Overall Study|Protocol deviation|0|||
27527182|NCT02119676|80123154|FG002|Overall Study|Protocol deviation|1|||
27527183|NCT02119676|80123155|FG003|Overall Study|Protocol deviation|0|||
27527184|NCT02119676|80123152|FG000|Overall Study|Other, unspecified|2|||
27527185|NCT02119676|80123153|FG001|Overall Study|Other, unspecified|1|||
27527186|NCT02119676|80123154|FG002|Overall Study|Other, unspecified|3|||
27527187|NCT02119676|80123155|FG003|Overall Study|Other, unspecified|4|||
27527188|NCT02119676|80123152|FG000|Overall Study|Did not receive study med|2|||
27527189|NCT02119676|80123153|FG001|Overall Study|Did not receive study med|2|||
27527190|NCT02119676|80123154|FG002|Overall Study|Did not receive study med|4|||
27527191|NCT02119676|80123155|FG003|Overall Study|Did not receive study med|5|||
27527192|NCT04461600|80123156|FG000|Overall Study|Death|6|||
27527193|NCT04461600|80123157|FG001|Overall Study|Death|5|||
27856198|NCT03861481|81306693|FG001|Overall Study|Lack of Efficacy|5|||
27527194|NCT04461600|80123156|FG000|Overall Study|Withdrawal by Subject|0|||
27623671|NCT00797225|80464242|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
27623672|NCT00797225|80464243|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
27527195|NCT04461600|80123157|FG001|Overall Study|Withdrawal by Subject|1|||
27527196|NCT00645788|80123158|FG000|Overall Study|Did not receive study drug|1|||
27623673|NCT00797225|80464244|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
27623674|NCT00797225|80464245|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
27623675|NCT00797225|80464246|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
27856199|NCT02603393|81306695|FG000|Overall Study|Patient/guardian decision|32|||
27527197|NCT00645788|80123159|FG001|Overall Study|Did not receive study drug|1|||
27527198|NCT00645788|80123160|FG002|Overall Study|Did not receive study drug|0|||
27527199|NCT00645788|80123161|FG003|Overall Study|Did not receive study drug|0|||
27527200|NCT00645788|80123158|FG000|Overall Study|Adverse Event|4|||
27527201|NCT00645788|80123159|FG001|Overall Study|Adverse Event|9|||
27527202|NCT00645788|80123160|FG002|Overall Study|Adverse Event|5|||
27527203|NCT00645788|80123161|FG003|Overall Study|Adverse Event|3|||
27527204|NCT00645788|80123158|FG000|Overall Study|Lost to Follow-up|1|||
27527205|NCT00645788|80123159|FG001|Overall Study|Lost to Follow-up|0|||
27527206|NCT00645788|80123160|FG002|Overall Study|Lost to Follow-up|0|||
27527207|NCT00645788|80123161|FG003|Overall Study|Lost to Follow-up|0|||
27527208|NCT00645788|80123158|FG000|Overall Study|Protocol Violation|1|||
27527209|NCT00645788|80123159|FG001|Overall Study|Protocol Violation|0|||
27527210|NCT00645788|80123160|FG002|Overall Study|Protocol Violation|2|||
27527211|NCT00645788|80123161|FG003|Overall Study|Protocol Violation|0|||
27527212|NCT00645788|80123158|FG000|Overall Study|Withdrawal by Subject|0|||
27527213|NCT00645788|80123159|FG001|Overall Study|Withdrawal by Subject|1|||
27527214|NCT00645788|80123160|FG002|Overall Study|Withdrawal by Subject|0|||
27733337|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27733338|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27733339|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27733340|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
27733341|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
27733342|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
27733343|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733344|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
27733345|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
27733346|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733347|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733348|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733349|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733350|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733351|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
27733352|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27733353|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
27733354|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
27733355|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27733356|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27733357|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27733358|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27733359|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
27733360|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
27733361|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27733362|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
27733363|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
27733364|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27733365|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27733366|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27733367|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
27733368|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
27733369|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
27733370|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733371|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27733372|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733373|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733374|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733375|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733376|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733377|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
27733378|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
27733379|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27733380|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
27733381|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27733382|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27733383|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27527215|NCT00645788|80123161|FG003|Overall Study|Withdrawal by Subject|2|||
27527216|NCT00645788|80123158|FG000|Overall Study|Pulmonary exacerbation|13|||
27527217|NCT00645788|80123159|FG001|Overall Study|Pulmonary exacerbation|16|||
27527218|NCT00645788|80123160|FG002|Overall Study|Pulmonary exacerbation|11|||
27527219|NCT00645788|80123161|FG003|Overall Study|Pulmonary exacerbation|9|||
27527220|NCT02353143|80123162|FG000|Overall Study|Withdrawal by Subject|1|||
27527221|NCT02353143|80123163|FG001|Overall Study|Withdrawal by Subject|0|||
27527222|NCT02353143|80123164|FG002|Overall Study|Withdrawal by Subject|0|||
27527223|NCT02353143|80123165|FG003|Overall Study|Withdrawal by Subject|0|||
27527224|NCT02353143|80123166|FG004|Overall Study|Withdrawal by Subject|1|||
27527225|NCT02353143|80123167|FG005|Overall Study|Withdrawal by Subject|0|||
27527226|NCT02353143|80123168|FG006|Overall Study|Withdrawal by Subject|0|||
27527227|NCT02353143|80123169|FG007|Overall Study|Withdrawal by Subject|1|||
27527228|NCT02353143|80123170|FG008|Overall Study|Withdrawal by Subject|1|||
27527229|NCT02353143|80123162|FG000|Overall Study|Lack of Efficacy|2|||
27527230|NCT02353143|80123163|FG001|Overall Study|Lack of Efficacy|1|||
27527231|NCT02353143|80123164|FG002|Overall Study|Lack of Efficacy|2|||
27527232|NCT02353143|80123165|FG003|Overall Study|Lack of Efficacy|4|||
27527233|NCT02353143|80123166|FG004|Overall Study|Lack of Efficacy|13|||
27527234|NCT02353143|80123167|FG005|Overall Study|Lack of Efficacy|2|||
27527235|NCT02353143|80123168|FG006|Overall Study|Lack of Efficacy|2|||
27527236|NCT02353143|80123169|FG007|Overall Study|Lack of Efficacy|2|||
27527237|NCT02353143|80123170|FG008|Overall Study|Lack of Efficacy|1|||
27527238|NCT02353143|80123162|FG000|Overall Study|reason not specified|1|||
27527239|NCT02353143|80123163|FG001|Overall Study|reason not specified|2|||
27527240|NCT02353143|80123164|FG002|Overall Study|reason not specified|0|||
27527241|NCT02353143|80123165|FG003|Overall Study|reason not specified|0|||
27527242|NCT02353143|80123166|FG004|Overall Study|reason not specified|6|||
27527243|NCT02353143|80123167|FG005|Overall Study|reason not specified|1|||
27527244|NCT02353143|80123168|FG006|Overall Study|reason not specified|0|||
27527245|NCT02353143|80123169|FG007|Overall Study|reason not specified|3|||
27527246|NCT02353143|80123170|FG008|Overall Study|reason not specified|1|||
27527247|NCT02353143|80123162|FG000|Overall Study|Physician Decision|0|||
27527248|NCT02353143|80123163|FG001|Overall Study|Physician Decision|4|||
27527249|NCT02353143|80123164|FG002|Overall Study|Physician Decision|2|||
27527250|NCT02353143|80123165|FG003|Overall Study|Physician Decision|3|||
27527251|NCT02353143|80123166|FG004|Overall Study|Physician Decision|4|||
27527252|NCT02353143|80123167|FG005|Overall Study|Physician Decision|0|||
27527253|NCT02353143|80123168|FG006|Overall Study|Physician Decision|1|||
27527254|NCT02353143|80123169|FG007|Overall Study|Physician Decision|2|||
27527255|NCT02353143|80123170|FG008|Overall Study|Physician Decision|0|||
27527256|NCT02353143|80123162|FG000|Overall Study|Adverse Event|0|||
27527257|NCT02353143|80123163|FG001|Overall Study|Adverse Event|0|||
27527258|NCT02353143|80123164|FG002|Overall Study|Adverse Event|1|||
27527259|NCT02353143|80123165|FG003|Overall Study|Adverse Event|0|||
27527260|NCT02353143|80123166|FG004|Overall Study|Adverse Event|1|||
27527261|NCT02353143|80123167|FG005|Overall Study|Adverse Event|1|||
27527262|NCT02353143|80123168|FG006|Overall Study|Adverse Event|0|||
27527263|NCT02353143|80123169|FG007|Overall Study|Adverse Event|0|||
27527264|NCT02353143|80123170|FG008|Overall Study|Adverse Event|0|||
27527265|NCT02353143|80123162|FG000|Overall Study|patient receiving other treatment for AML|0|||
27527266|NCT02353143|80123163|FG001|Overall Study|patient receiving other treatment for AML|0|||
27527267|NCT02353143|80123164|FG002|Overall Study|patient receiving other treatment for AML|1|||
27527268|NCT02353143|80123165|FG003|Overall Study|patient receiving other treatment for AML|0|||
27527269|NCT02353143|80123166|FG004|Overall Study|patient receiving other treatment for AML|0|||
27527270|NCT02353143|80123167|FG005|Overall Study|patient receiving other treatment for AML|0|||
27527271|NCT02353143|80123168|FG006|Overall Study|patient receiving other treatment for AML|0|||
27527272|NCT02353143|80123169|FG007|Overall Study|patient receiving other treatment for AML|0|||
27911481|NCT02959918|81513591|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911482|NCT02959918|81513592|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911483|NCT02959918|81513593|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911484|NCT02959918|81513594|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
27911485|NCT02959918|81513595|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911486|NCT02959918|81513596|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911487|NCT02959918|81513597|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27527273|NCT02353143|80123170|FG008|Overall Study|patient receiving other treatment for AML|0|||
27527274|NCT02353143|80123162|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
27527275|NCT02353143|80123163|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
27527276|NCT02353143|80123164|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
27527277|NCT02353143|80123165|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
27527278|NCT02353143|80123166|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
27527279|NCT02353143|80123167|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
27527280|NCT02353143|80123168|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
27527281|NCT02353143|80123169|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
27527282|NCT02353143|80123170|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
27527283|NCT00171054|80123172|FG000|Overall Study|Protocol Violation|1|||
27527284|NCT00171054|80123173|FG001|Overall Study|Protocol Violation|2|||
27527285|NCT00171054|80123172|FG000|Overall Study|Patient withdrew consent|1|||
27527286|NCT00171054|80123173|FG001|Overall Study|Patient withdrew consent|0|||
27527287|NCT00171054|80123172|FG000|Overall Study|Lost to Follow-up|0|||
27527288|NCT00171054|80123173|FG001|Overall Study|Lost to Follow-up|1|||
27527289|NCT00171054|80123172|FG000|Overall Study|Adverse Event|8|||
27527290|NCT00171054|80123173|FG001|Overall Study|Adverse Event|8|||
27527291|NCT00171054|80123172|FG000|Overall Study|Condition no longer required study drug|0|||
27527292|NCT00171054|80123173|FG001|Overall Study|Condition no longer required study drug|1|||
27527293|NCT02496676|80123174|FG000|Phase 1 - Period 1|Adverse Event|0|||
27527294|NCT02496676|80123175|FG001|Phase 1 - Period 1|Adverse Event|1|||
27527295|NCT02496676|80123174|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
27527296|NCT02496676|80123175|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
27527297|NCT01323920|80123176|FG000|Overall Study|Death|5|||
27527298|NCT01323920|80123176|FG000|Overall Study|Withdrawal by Subject|1|||
27527299|NCT03036800|80123177|FG000|Overall Study|Protocol Violation|1|||
27527300|NCT03036800|80123178|FG001|Overall Study|Protocol Violation|0|||
27527301|NCT03036800|80123177|FG000|Overall Study|Non-compliance|1|||
27527302|NCT03036800|80123178|FG001|Overall Study|Non-compliance|0|||
27527303|NCT03036800|80123177|FG000|Overall Study|Lost to Follow-up|1|||
27527304|NCT03036800|80123178|FG001|Overall Study|Lost to Follow-up|0|||
27527305|NCT03036800|80123177|FG000|Overall Study|Death|1|||
27527306|NCT03036800|80123178|FG001|Overall Study|Death|0|||
27527307|NCT03036800|80123177|FG000|Overall Study|Tolerance|5|||
27527308|NCT03036800|80123178|FG001|Overall Study|Tolerance|0|||
27527309|NCT03036800|80123177|FG000|Overall Study|Unknown/no reason given|50|||
27527310|NCT03036800|80123178|FG001|Overall Study|Unknown/no reason given|39|||
27527311|NCT02274038|80123182|FG000|Overall Study|Death|1|||
27527312|NCT00466687|80123183|FG000|Overall Study|Adverse Event|1|||
27527313|NCT00466687|80123183|FG000|Overall Study|Other complicating illness|3|||
27527314|NCT00466687|80123183|FG000|Overall Study|Withdrawal by Subject|1|||
27527315|NCT00466687|80123183|FG000|Overall Study|Disease progression|29|||
27527316|NCT02320903|80123184|FG000|Overall Study|Withdrawal by Subject|0|||
27527317|NCT02320903|80123185|FG001|Overall Study|Withdrawal by Subject|9|||
27527318|NCT02320903|80123186|FG002|Overall Study|Withdrawal by Subject|9|||
27527319|NCT02320903|80123184|FG000|Overall Study|Exited therapy; no longer eligible|8|||
27527320|NCT02320903|80123185|FG001|Overall Study|Exited therapy; no longer eligible|2|||
27527321|NCT02320903|80123186|FG002|Overall Study|Exited therapy; no longer eligible|2|||
27527322|NCT02320903|80123184|FG000|Overall Study|Lost to Follow-up|0|||
27527323|NCT02320903|80123185|FG001|Overall Study|Lost to Follow-up|5|||
27623676|NCT00797225|80464247|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
27623677|NCT00797225|80464248|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
27623678|NCT00797225|80464241|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
27623679|NCT00797225|80464242|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
27623680|NCT00797225|80464243|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
27623681|NCT00797225|80464244|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
27623682|NCT00797225|80464245|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
27623683|NCT00797225|80464246|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
27623684|NCT00797225|80464247|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
27623685|NCT00797225|80464248|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
27623686|NCT00797225|80464241|FG000|Weeks 13 to 24|Adverse Event|0|||
27623687|NCT00797225|80464242|FG001|Weeks 13 to 24|Adverse Event|1|||
27623688|NCT00797225|80464243|FG002|Weeks 13 to 24|Adverse Event|0|||
27623689|NCT00797225|80464244|FG003|Weeks 13 to 24|Adverse Event|0|||
27623690|NCT00797225|80464245|FG004|Weeks 13 to 24|Adverse Event|0|||
27623691|NCT00797225|80464246|FG005|Weeks 13 to 24|Adverse Event|0|||
27623692|NCT00797225|80464247|FG006|Weeks 13 to 24|Adverse Event|1|||
27856200|NCT02603393|81306696|FG001|Overall Study|Patient/guardian decision|18|||
27911488|NCT02959918|81513598|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
27911489|NCT01188668|81513603|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
27911490|NCT01188668|81513603|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
27911491|NCT01188668|81513603|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
27911492|NCT01158261|81513606|FG000|Overall Study|Lost to Follow-up|9|||
27527324|NCT02320903|80123186|FG002|Overall Study|Lost to Follow-up|5|||
27911493|NCT01158261|81513606|FG000|Overall Study|Death|7|||
27911494|NCT01158261|81513606|FG000|Overall Study|Withdrawal by Subject|1|||
27527325|NCT01505647|80123187|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
27527326|NCT01505647|80123188|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
27527327|NCT01505647|80123187|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
27527328|NCT01505647|80123188|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
27527329|NCT01505647|80123187|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
27527330|NCT01505647|80123188|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
27527331|NCT01505647|80123187|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
27623693|NCT00797225|80464248|FG007|Weeks 13 to 24|Adverse Event|0|||
27623694|NCT00797225|80464241|FG000|Weeks 13 to 24|Sponsor Decision|0|||
27527332|NCT01505647|80123188|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
27623695|NCT00797225|80464242|FG001|Weeks 13 to 24|Sponsor Decision|0|||
27623696|NCT00797225|80464243|FG002|Weeks 13 to 24|Sponsor Decision|0|||
27623697|NCT00797225|80464244|FG003|Weeks 13 to 24|Sponsor Decision|0|||
27623698|NCT00797225|80464245|FG004|Weeks 13 to 24|Sponsor Decision|0|||
27623699|NCT00797225|80464246|FG005|Weeks 13 to 24|Sponsor Decision|0|||
27623700|NCT00797225|80464247|FG006|Weeks 13 to 24|Sponsor Decision|1|||
27623701|NCT00797225|80464248|FG007|Weeks 13 to 24|Sponsor Decision|0|||
27623702|NCT01253200|80464249|FG000|Overall Study|Death|1|||
27623703|NCT01253200|80464250|FG001|Overall Study|Death|0|||
27623704|NCT01253200|80464251|FG002|Overall Study|Death|0|||
27623705|NCT01253200|80464252|FG003|Overall Study|Death|0|||
27623706|NCT01253200|80464253|FG004|Overall Study|Death|0|||
27623707|NCT01253200|80464249|FG000|Overall Study|Lost to Follow-up|1|||
27623708|NCT01253200|80464250|FG001|Overall Study|Lost to Follow-up|1|||
27623709|NCT01253200|80464251|FG002|Overall Study|Lost to Follow-up|0|||
27623710|NCT01253200|80464252|FG003|Overall Study|Lost to Follow-up|0|||
27623711|NCT01253200|80464253|FG004|Overall Study|Lost to Follow-up|0|||
27623712|NCT01253200|80464249|FG000|Overall Study|Withdrawal by Subject|2|||
27623713|NCT01253200|80464250|FG001|Overall Study|Withdrawal by Subject|0|||
27623714|NCT01253200|80464251|FG002|Overall Study|Withdrawal by Subject|0|||
27623715|NCT01253200|80464252|FG003|Overall Study|Withdrawal by Subject|0|||
27623716|NCT01253200|80464253|FG004|Overall Study|Withdrawal by Subject|0|||
27623717|NCT01253200|80464249|FG000|Overall Study|Protocol Violation|1|||
27733384|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27733385|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27856201|NCT02603393|81306695|FG000|Overall Study|Adverse Event|17|||
27527333|NCT01505647|80123187|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
27527334|NCT01505647|80123188|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
27527335|NCT01089361|80123189|FG000|Overall Study|Death|1|||
27527336|NCT01089361|80123190|FG001|Overall Study|Death|0|||
27527337|NCT02045303|80123193|FG000|Overall Study|Protocol Violation|2|||
27527338|NCT02045303|80123194|FG001|Overall Study|Protocol Violation|1|||
27527339|NCT02045303|80123195|FG002|Overall Study|Protocol Violation|0|||
27527340|NCT02045303|80123193|FG000|Overall Study|Withdrawal by Subject|0|||
27527341|NCT02045303|80123194|FG001|Overall Study|Withdrawal by Subject|2|||
27527342|NCT02045303|80123195|FG002|Overall Study|Withdrawal by Subject|0|||
27527343|NCT03222492|80123196|FG000|Overall Study|Withdrawal by Subject|0|||
27527344|NCT03222492|80123197|FG001|Overall Study|Withdrawal by Subject|0|||
27527345|NCT03222492|80123198|FG002|Overall Study|Withdrawal by Subject|1|||
27527346|NCT03222492|80123199|FG003|Overall Study|Withdrawal by Subject|0|||
27527347|NCT03222492|80123196|FG000|Overall Study|COVID-19 related|0|||
27527348|NCT03222492|80123197|FG001|Overall Study|COVID-19 related|0|||
27527349|NCT03222492|80123198|FG002|Overall Study|COVID-19 related|1|||
27527350|NCT03222492|80123199|FG003|Overall Study|COVID-19 related|0|||
27527351|NCT01214174|80123200|FG000|Overall Study|Withdrawal by Subject|0|||
27527352|NCT01214174|80123201|FG001|Overall Study|Withdrawal by Subject|0|||
27527353|NCT01214174|80123202|FG002|Overall Study|Withdrawal by Subject|1|||
27527354|NCT01288976|80123204|FG000|Overall Study|Withdrawal by Subject|58|||
27527355|NCT01288976|80123205|FG001|Overall Study|Withdrawal by Subject|12|||
27527356|NCT01288976|80123206|FG002|Overall Study|Withdrawal by Subject|9|||
27527357|NCT01288976|80123204|FG000|Overall Study|Death|98|||
27527358|NCT01288976|80123205|FG001|Overall Study|Death|6|||
27527359|NCT01288976|80123206|FG002|Overall Study|Death|4|||
27527360|NCT01288976|80123204|FG000|Overall Study|Data unavailable|22|||
27527361|NCT01288976|80123205|FG001|Overall Study|Data unavailable|9|||
27527362|NCT01288976|80123206|FG002|Overall Study|Data unavailable|7|||
27527363|NCT01369485|80123207|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
27527364|NCT01369485|80123208|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
27527365|NCT01369485|80123207|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
27527366|NCT01369485|80123208|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
27527367|NCT01369485|80123207|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
27527368|NCT01369485|80123208|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
27527369|NCT01369485|80123207|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
27527370|NCT01369485|80123208|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
27527371|NCT01369485|80123207|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
27527372|NCT01369485|80123208|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
27623718|NCT01253200|80464250|FG001|Overall Study|Protocol Violation|4|||
27623719|NCT01253200|80464251|FG002|Overall Study|Protocol Violation|0|||
27623720|NCT01253200|80464252|FG003|Overall Study|Protocol Violation|0|||
27527373|NCT01369485|80123207|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
27527374|NCT01369485|80123208|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
27527375|NCT01369485|80123207|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
27527376|NCT01369485|80123208|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
27527377|NCT01369485|80123207|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
27623721|NCT01253200|80464253|FG004|Overall Study|Protocol Violation|5|||
27623722|NCT01253200|80464249|FG000|Overall Study|intents|10|||
27623723|NCT01253200|80464250|FG001|Overall Study|intents|10|||
27623724|NCT01253200|80464251|FG002|Overall Study|intents|1|||
27623725|NCT01253200|80464252|FG003|Overall Study|intents|3|||
27623726|NCT01253200|80464253|FG004|Overall Study|intents|0|||
27623727|NCT01253200|80464249|FG000|Overall Study|Attempts|6|||
27623728|NCT01253200|80464250|FG001|Overall Study|Attempts|4|||
27623729|NCT01253200|80464251|FG002|Overall Study|Attempts|1|||
27623730|NCT01253200|80464252|FG003|Overall Study|Attempts|2|||
27856202|NCT02603393|81306696|FG001|Overall Study|Adverse Event|15|||
27856203|NCT02603393|81306695|FG000|Overall Study|Technical problems|4|||
27856204|NCT02603393|81306696|FG001|Overall Study|Technical problems|7|||
27856205|NCT02603393|81306695|FG000|Overall Study|Lack of Efficacy|7|||
27856206|NCT02603393|81306696|FG001|Overall Study|Lack of Efficacy|2|||
27911495|NCT03872843|81513607|FG000|Overall Study|Lost to Follow-up|5|||
27911496|NCT03872843|81513608|FG001|Overall Study|Lost to Follow-up|7|||
27856207|NCT02603393|81306695|FG000|Overall Study|Death|3|||
27856208|NCT02603393|81306696|FG001|Overall Study|Death|4|||
27856209|NCT02603393|81306695|FG000|Overall Study|Physician Decision|3|||
27856210|NCT02603393|81306696|FG001|Overall Study|Physician Decision|3|||
27911497|NCT00931632|81513611|FG000|Overall Study|Withdrawal by Subject|2|||
27911498|NCT00931632|81513612|FG001|Overall Study|Withdrawal by Subject|3|||
27911499|NCT00931632|81513611|FG000|Overall Study|Adverse Event|19|||
27911500|NCT00931632|81513612|FG001|Overall Study|Adverse Event|15|||
27911501|NCT00169104|81513619|FG000|Overall Study|Withdrawal by Subject|2|||
27911502|NCT00169104|81513620|FG001|Overall Study|Withdrawal by Subject|0|||
27911503|NCT00169104|81513619|FG000|Overall Study|Protocol Violation|0|||
27911504|NCT00169104|81513620|FG001|Overall Study|Protocol Violation|1|||
27911505|NCT00169104|81513619|FG000|Overall Study|Physician Decision|0|||
27911506|NCT00169104|81513620|FG001|Overall Study|Physician Decision|1|||
27911507|NCT00534248|81513621|FG000|Overall Study|Adverse Event|19|||
27911508|NCT00534248|81513622|FG001|Overall Study|Adverse Event|29|||
27911509|NCT00534248|81513621|FG000|Overall Study|Lost to Follow-up|353|||
27856211|NCT02603393|81306695|FG000|Overall Study|Protocol deviation|2|||
27856212|NCT02603393|81306696|FG001|Overall Study|Protocol deviation|3|||
27856213|NCT02603393|81306695|FG000|Overall Study|Lost to Follow-up|1|||
27856214|NCT02603393|81306696|FG001|Overall Study|Lost to Follow-up|2|||
27856215|NCT02603393|81306695|FG000|Overall Study|Non-compliance with study treatment|1|||
27856216|NCT02603393|81306696|FG001|Overall Study|Non-compliance with study treatment|0|||
27527378|NCT01369485|80123208|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
27527379|NCT01369485|80123207|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
27527380|NCT01369485|80123208|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
27527381|NCT01369485|80123207|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
27527382|NCT01369485|80123208|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
27527383|NCT00609362|80123209|FG000|Overall Study|Withdrawal by Subject|2|||
27527384|NCT00609362|80123210|FG001|Overall Study|Withdrawal by Subject|1|||
27527385|NCT00609362|80123209|FG000|Overall Study|Adverse Event|1|||
27527386|NCT00609362|80123210|FG001|Overall Study|Adverse Event|0|||
27527387|NCT03361176|80123211|FG000|Overall Study|Lost to Follow-up|1|||
27527388|NCT03361176|80123212|FG001|Overall Study|Lost to Follow-up|2|||
27527389|NCT03361176|80123211|FG000|Overall Study|Adverse Event|0|||
27527390|NCT03361176|80123212|FG001|Overall Study|Adverse Event|2|||
27527391|NCT03361176|80123211|FG000|Overall Study|Withdrawal by Subject|0|||
27527392|NCT03361176|80123212|FG001|Overall Study|Withdrawal by Subject|1|||
27527393|NCT04449029|80123213|FG000|Overall Study|Adverse Event|0|||
27527394|NCT04449029|80123214|FG001|Overall Study|Adverse Event|1|||
27527395|NCT04449029|80123215|FG002|Overall Study|Adverse Event|1|||
27527396|NCT04449029|80123216|FG003|Overall Study|Adverse Event|0|||
27527397|NCT04449029|80123217|FG004|Overall Study|Adverse Event|1|||
27527398|NCT04449029|80123218|FG005|Overall Study|Adverse Event|0|||
27527399|NCT04449029|80123219|FG006|Overall Study|Adverse Event|1|||
27527400|NCT04449029|80123220|FG007|Overall Study|Adverse Event|0|||
27527401|NCT04449029|80123213|FG000|Overall Study|Lost to Follow-up|0|||
27527402|NCT04449029|80123214|FG001|Overall Study|Lost to Follow-up|1|||
27527403|NCT04449029|80123215|FG002|Overall Study|Lost to Follow-up|0|||
27527404|NCT04449029|80123216|FG003|Overall Study|Lost to Follow-up|0|||
27623731|NCT01253200|80464253|FG004|Overall Study|Attempts|0|||
27623732|NCT02401529|80464254|FG000|Overall Study|Lost to Follow-up|2|||
27856217|NCT02603393|81306695|FG000|Overall Study|Sponsor decision|1|||
27911510|NCT00534248|81513622|FG001|Overall Study|Lost to Follow-up|375|||
27527405|NCT04449029|80123217|FG004|Overall Study|Lost to Follow-up|0|||
27527406|NCT04449029|80123218|FG005|Overall Study|Lost to Follow-up|0|||
27527407|NCT04449029|80123219|FG006|Overall Study|Lost to Follow-up|0|||
27527408|NCT04449029|80123220|FG007|Overall Study|Lost to Follow-up|0|||
27623733|NCT02401529|80464255|FG001|Overall Study|Lost to Follow-up|1|||
27911511|NCT00534248|81513621|FG000|Overall Study|Other protocol specified criteria|13|||
27911512|NCT00534248|81513622|FG001|Overall Study|Other protocol specified criteria|3|||
27527409|NCT04449029|80123213|FG000|Overall Study|Protocol Violation|0|||
27527410|NCT04449029|80123214|FG001|Overall Study|Protocol Violation|1|||
27527411|NCT04449029|80123215|FG002|Overall Study|Protocol Violation|0|||
27623734|NCT02401529|80464254|FG000|Overall Study|Physician Decision|2|||
27856218|NCT02603393|81306696|FG001|Overall Study|Sponsor decision|0|||
27856219|NCT02802631|81306697|FG000|Overall Study|Withdrawal by Subject|1|||
27623735|NCT02401529|80464255|FG001|Overall Study|Physician Decision|6|||
27623736|NCT02401529|80464254|FG000|Overall Study|Protocol Violation|5|||
27623737|NCT02401529|80464255|FG001|Overall Study|Protocol Violation|0|||
27623738|NCT00557505|80464256|FG000|Overall Study|Death|0|||
27623739|NCT00557505|80464257|FG001|Overall Study|Death|0|||
27623740|NCT00557505|80464258|FG002|Overall Study|Death|0|||
27623741|NCT00557505|80464259|FG003|Overall Study|Death|0|||
27623742|NCT00557505|80464260|FG004|Overall Study|Death|0|||
27623743|NCT00557505|80464261|FG005|Overall Study|Death|0|||
27623744|NCT00557505|80464262|FG006|Overall Study|Death|0|||
27623745|NCT00557505|80464263|FG007|Overall Study|Death|0|||
27623746|NCT00557505|80464264|FG008|Overall Study|Death|1|||
27623747|NCT00557505|80464256|FG000|Overall Study|Adverse Event|0|||
27623748|NCT00557505|80464257|FG001|Overall Study|Adverse Event|0|||
27623749|NCT00557505|80464258|FG002|Overall Study|Adverse Event|1|||
27623750|NCT00557505|80464259|FG003|Overall Study|Adverse Event|0|||
27623751|NCT00557505|80464260|FG004|Overall Study|Adverse Event|0|||
27623752|NCT00557505|80464261|FG005|Overall Study|Adverse Event|0|||
27623753|NCT00557505|80464262|FG006|Overall Study|Adverse Event|1|||
27623754|NCT00557505|80464263|FG007|Overall Study|Adverse Event|0|||
27623755|NCT00557505|80464264|FG008|Overall Study|Adverse Event|0|||
27623756|NCT00557505|80464256|FG000|Overall Study|Global deterioration of health|1|||
27623757|NCT00557505|80464257|FG001|Overall Study|Global deterioration of health|0|||
27623758|NCT00557505|80464258|FG002|Overall Study|Global deterioration of health|0|||
27623759|NCT00557505|80464259|FG003|Overall Study|Global deterioration of health|0|||
27623760|NCT00557505|80464260|FG004|Overall Study|Global deterioration of health|0|||
27623761|NCT00557505|80464261|FG005|Overall Study|Global deterioration of health|0|||
27623762|NCT00557505|80464262|FG006|Overall Study|Global deterioration of health|0|||
27623763|NCT00557505|80464263|FG007|Overall Study|Global deterioration of health|0|||
27623764|NCT00557505|80464264|FG008|Overall Study|Global deterioration of health|0|||
27623765|NCT00557505|80464256|FG000|Overall Study|Objective progression or relapse|2|||
27623766|NCT00557505|80464257|FG001|Overall Study|Objective progression or relapse|3|||
27623767|NCT00557505|80464258|FG002|Overall Study|Objective progression or relapse|3|||
27623768|NCT00557505|80464259|FG003|Overall Study|Objective progression or relapse|2|||
27623769|NCT00557505|80464260|FG004|Overall Study|Objective progression or relapse|2|||
27623770|NCT00557505|80464261|FG005|Overall Study|Objective progression or relapse|3|||
27623771|NCT00557505|80464262|FG006|Overall Study|Objective progression or relapse|2|||
27623772|NCT00557505|80464263|FG007|Overall Study|Objective progression or relapse|5|||
27623773|NCT00557505|80464264|FG008|Overall Study|Objective progression or relapse|15|||
27623774|NCT00557505|80464256|FG000|Overall Study|Withdrawal by Subject|0|||
27623775|NCT00557505|80464257|FG001|Overall Study|Withdrawal by Subject|0|||
27623776|NCT00557505|80464258|FG002|Overall Study|Withdrawal by Subject|0|||
27623777|NCT00557505|80464259|FG003|Overall Study|Withdrawal by Subject|1|||
27623778|NCT00557505|80464260|FG004|Overall Study|Withdrawal by Subject|0|||
27623779|NCT00557505|80464261|FG005|Overall Study|Withdrawal by Subject|0|||
27911513|NCT00534248|81513621|FG000|Overall Study|Physician Decision|10|||
27911514|NCT00534248|81513622|FG001|Overall Study|Physician Decision|7|||
27911515|NCT00534248|81513621|FG000|Overall Study|Protocol Violation|3|||
27911516|NCT00534248|81513622|FG001|Overall Study|Protocol Violation|4|||
27527412|NCT04449029|80123216|FG003|Overall Study|Protocol Violation|0|||
27527413|NCT04449029|80123217|FG004|Overall Study|Protocol Violation|0|||
27527414|NCT04449029|80123218|FG005|Overall Study|Protocol Violation|0|||
27527415|NCT04449029|80123219|FG006|Overall Study|Protocol Violation|0|||
27527416|NCT04449029|80123220|FG007|Overall Study|Protocol Violation|0|||
27527417|NCT04449029|80123213|FG000|Overall Study|Physician Decision|0|||
27527418|NCT04449029|80123214|FG001|Overall Study|Physician Decision|0|||
27527419|NCT04449029|80123215|FG002|Overall Study|Physician Decision|0|||
27527420|NCT04449029|80123216|FG003|Overall Study|Physician Decision|0|||
27527421|NCT04449029|80123217|FG004|Overall Study|Physician Decision|0|||
27527422|NCT04449029|80123218|FG005|Overall Study|Physician Decision|1|||
27527423|NCT04449029|80123219|FG006|Overall Study|Physician Decision|0|||
27527424|NCT04449029|80123220|FG007|Overall Study|Physician Decision|0|||
27527425|NCT04449029|80123213|FG000|Overall Study|Withdrawal by Subject|3|||
27527426|NCT04449029|80123214|FG001|Overall Study|Withdrawal by Subject|0|||
27623780|NCT00557505|80464262|FG006|Overall Study|Withdrawal by Subject|0|||
27623781|NCT00557505|80464263|FG007|Overall Study|Withdrawal by Subject|0|||
27623782|NCT00557505|80464264|FG008|Overall Study|Withdrawal by Subject|1|||
27623783|NCT03905135|80464277|FG000|Dose Escalation|Adverse Event|1|||
27623784|NCT03905135|80464278|FG001|Dose Escalation|Adverse Event|1|||
27623785|NCT03905135|80464277|FG000|Dose Escalation|Progressive disease|3|||
27623786|NCT03905135|80464278|FG001|Dose Escalation|Progressive disease|1|||
27623787|NCT03905135|80464277|FG000|Dose Escalation|Intercurrent illness|1|||
27911517|NCT00534248|81513621|FG000|Overall Study|Withdrawal by Subject|263|||
27527427|NCT04449029|80123215|FG002|Overall Study|Withdrawal by Subject|1|||
27623788|NCT03905135|80464278|FG001|Dose Escalation|Intercurrent illness|0|||
27623789|NCT00783692|80464279|FG000|Induction Phase|Adverse Event|7|||
27623790|NCT00783692|80464280|FG001|Induction Phase|Adverse Event|9|||
27623791|NCT00783692|80464281|FG002|Induction Phase|Adverse Event|24|||
27623792|NCT00783692|80464282|FG003|Induction Phase|Adverse Event|0|||
27623793|NCT00783692|80464283|FG004|Induction Phase|Adverse Event|0|||
27623794|NCT00783692|80464284|FG005|Induction Phase|Adverse Event|0|||
27623795|NCT00783692|80464285|FG006|Induction Phase|Adverse Event|0|||
27623796|NCT00783692|80464279|FG000|Induction Phase|Protocol Violation|0|||
27623797|NCT00783692|80464280|FG001|Induction Phase|Protocol Violation|0|||
27623798|NCT00783692|80464281|FG002|Induction Phase|Protocol Violation|1|||
27623799|NCT00783692|80464282|FG003|Induction Phase|Protocol Violation|0|||
27623800|NCT00783692|80464283|FG004|Induction Phase|Protocol Violation|0|||
27856220|NCT02802631|81306698|FG001|Overall Study|Withdrawal by Subject|0|||
27856221|NCT02802631|81306699|FG002|Overall Study|Withdrawal by Subject|0|||
27527428|NCT04449029|80123216|FG003|Overall Study|Withdrawal by Subject|1|||
27527429|NCT04449029|80123217|FG004|Overall Study|Withdrawal by Subject|5|||
27527430|NCT04449029|80123218|FG005|Overall Study|Withdrawal by Subject|1|||
27527431|NCT04449029|80123219|FG006|Overall Study|Withdrawal by Subject|4|||
27527432|NCT04449029|80123220|FG007|Overall Study|Withdrawal by Subject|0|||
27527433|NCT01609478|80123221|FG000|Overall Study|Adverse Event|3|||
27527434|NCT01609478|80123222|FG001|Overall Study|Adverse Event|1|||
27527435|NCT01609478|80123223|FG002|Overall Study|Adverse Event|5|||
27527436|NCT01609478|80123221|FG000|Overall Study|Protocol Deviation|0|||
27527437|NCT01609478|80123222|FG001|Overall Study|Protocol Deviation|1|||
27527438|NCT01609478|80123223|FG002|Overall Study|Protocol Deviation|1|||
27527439|NCT01609478|80123221|FG000|Overall Study|Non-Compliance with study treatment|1|||
27527440|NCT01609478|80123222|FG001|Overall Study|Non-Compliance with study treatment|0|||
27527441|NCT01609478|80123223|FG002|Overall Study|Non-Compliance with study treatment|0|||
27527442|NCT01609478|80123221|FG000|Overall Study|Physician Decision|1|||
27527443|NCT01609478|80123222|FG001|Overall Study|Physician Decision|0|||
27527444|NCT01609478|80123223|FG002|Overall Study|Physician Decision|1|||
27527445|NCT01609478|80123221|FG000|Overall Study|Withdrawal by Subject|2|||
27527446|NCT01609478|80123222|FG001|Overall Study|Withdrawal by Subject|0|||
27527447|NCT01609478|80123223|FG002|Overall Study|Withdrawal by Subject|2|||
27527448|NCT01525901|80123227|FG000|Period 2: 12 Weeks|Adverse Event|0|||
27527449|NCT01525901|80123228|FG001|Period 2: 12 Weeks|Adverse Event|1|||
27527450|NCT01525901|80123229|FG002|Period 2: 12 Weeks|Adverse Event|0|||
27527451|NCT01525901|80123230|FG003|Period 2: 12 Weeks|Adverse Event|0|||
27527452|NCT01925989|80123232|FG000|Period 1|Sponsor Decision|1|||
27527453|NCT01925989|80123233|FG001|Period 1|Sponsor Decision|1|||
27527454|NCT01925989|80123234|FG002|Period 1|Sponsor Decision|0|||
27527455|NCT01925989|80123232|FG000|Period 1|Withdrawal by Subject|0|||
27527456|NCT01925989|80123233|FG001|Period 1|Withdrawal by Subject|1|||
27527457|NCT01925989|80123234|FG002|Period 1|Withdrawal by Subject|0|||
27527458|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
27527459|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
27527460|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
27527461|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
27527462|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
27527463|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
27527464|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
27527465|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
27527466|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
27527467|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
27527468|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
27527469|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
27527470|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
27527471|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
27527472|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
27527473|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
27527474|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
27527475|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
27527476|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
27527477|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
27527478|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
27527479|NCT02431247|80123235|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
27527480|NCT02431247|80123236|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
27527481|NCT02431247|80123237|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
27527482|NCT02431247|80123235|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
27527483|NCT02431247|80123236|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
27527484|NCT02431247|80123237|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
27527485|NCT02431247|80123235|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
27527486|NCT02431247|80123236|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
27527487|NCT02431247|80123237|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
27527488|NCT02431247|80123235|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27623801|NCT00783692|80464284|FG005|Induction Phase|Protocol Violation|0|||
27623802|NCT00783692|80464285|FG006|Induction Phase|Protocol Violation|0|||
27623803|NCT00783692|80464279|FG000|Induction Phase|Lack of Efficacy|1|||
27623804|NCT00783692|80464280|FG001|Induction Phase|Lack of Efficacy|3|||
27623805|NCT00783692|80464281|FG002|Induction Phase|Lack of Efficacy|28|||
27623806|NCT00783692|80464282|FG003|Induction Phase|Lack of Efficacy|0|||
27623807|NCT00783692|80464283|FG004|Induction Phase|Lack of Efficacy|0|||
27623808|NCT00783692|80464284|FG005|Induction Phase|Lack of Efficacy|0|||
27623809|NCT00783692|80464285|FG006|Induction Phase|Lack of Efficacy|0|||
27911518|NCT00534248|81513622|FG001|Overall Study|Withdrawal by Subject|255|||
27911519|NCT02256839|81513623|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
27911520|NCT02256839|81513624|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
27527489|NCT02431247|80123236|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
27527490|NCT02431247|80123237|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
27527491|NCT02431247|80123235|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27527492|NCT02431247|80123236|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
27527493|NCT02431247|80123237|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
27527494|NCT02431247|80123235|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
27527495|NCT02431247|80123236|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
27527496|NCT02431247|80123237|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
27527497|NCT02431247|80123235|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
27623810|NCT00783692|80464279|FG000|Induction Phase|Withdrawal by Subject|3|||
27623811|NCT00783692|80464280|FG001|Induction Phase|Withdrawal by Subject|9|||
27623812|NCT00783692|80464281|FG002|Induction Phase|Withdrawal by Subject|16|||
27623813|NCT00783692|80464282|FG003|Induction Phase|Withdrawal by Subject|0|||
27527498|NCT02431247|80123236|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
27527499|NCT02431247|80123237|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
27527500|NCT01445886|80123240|FG000|Overall Study|Lost to Follow-up|2|||
27527501|NCT01445886|80123240|FG000|Overall Study|Protocol Violation|3|||
27623814|NCT00783692|80464283|FG004|Induction Phase|Withdrawal by Subject|0|||
27623815|NCT00783692|80464284|FG005|Induction Phase|Withdrawal by Subject|0|||
27623816|NCT00783692|80464285|FG006|Induction Phase|Withdrawal by Subject|0|||
27623817|NCT00783692|80464279|FG000|Induction Phase|Lost to Follow-up|0|||
27623818|NCT00783692|80464280|FG001|Induction Phase|Lost to Follow-up|0|||
27623819|NCT00783692|80464281|FG002|Induction Phase|Lost to Follow-up|3|||
27623820|NCT00783692|80464282|FG003|Induction Phase|Lost to Follow-up|0|||
27623821|NCT00783692|80464283|FG004|Induction Phase|Lost to Follow-up|0|||
27623822|NCT00783692|80464284|FG005|Induction Phase|Lost to Follow-up|0|||
27623823|NCT00783692|80464285|FG006|Induction Phase|Lost to Follow-up|0|||
27623824|NCT00783692|80464279|FG000|Induction Phase|Other|0|||
27623825|NCT00783692|80464280|FG001|Induction Phase|Other|0|||
27623826|NCT00783692|80464281|FG002|Induction Phase|Other|2|||
27623827|NCT00783692|80464282|FG003|Induction Phase|Other|0|||
27623828|NCT00783692|80464283|FG004|Induction Phase|Other|0|||
27623829|NCT00783692|80464284|FG005|Induction Phase|Other|0|||
27623830|NCT00783692|80464285|FG006|Induction Phase|Other|0|||
27623831|NCT00783692|80464279|FG000|Maintenance Phase|Adverse Event|7|||
27623832|NCT00783692|80464280|FG001|Maintenance Phase|Adverse Event|0|||
27623833|NCT00783692|80464281|FG002|Maintenance Phase|Adverse Event|0|||
27623834|NCT00783692|80464282|FG003|Maintenance Phase|Adverse Event|15|||
27623835|NCT00783692|80464283|FG004|Maintenance Phase|Adverse Event|12|||
27623836|NCT00783692|80464284|FG005|Maintenance Phase|Adverse Event|9|||
27623837|NCT00783692|80464285|FG006|Maintenance Phase|Adverse Event|38|||
27623838|NCT00783692|80464279|FG000|Maintenance Phase|Protocol Violation|0|||
27623839|NCT00783692|80464280|FG001|Maintenance Phase|Protocol Violation|0|||
27623840|NCT00783692|80464281|FG002|Maintenance Phase|Protocol Violation|0|||
27623841|NCT00783692|80464282|FG003|Maintenance Phase|Protocol Violation|1|||
27733386|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27911521|NCT01890759|81513627|FG000|Overall Study|Protocol Violation|0|||
27911522|NCT01890759|81513628|FG001|Overall Study|Protocol Violation|2|||
27527502|NCT00999921|80123241|FG000|Overall Study|Lost to Follow-up|10|||
27527503|NCT00999921|80123242|FG001|Overall Study|Lost to Follow-up|19|||
27527504|NCT01511055|80123243|FG000|Overall Study|Withdrawal by Subject|6|||
27623842|NCT00783692|80464283|FG004|Maintenance Phase|Protocol Violation|2|||
27623843|NCT00783692|80464284|FG005|Maintenance Phase|Protocol Violation|3|||
27527505|NCT00586326|80123251|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
27527506|NCT00586326|80123251|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
27527507|NCT00586326|80123251|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
27623844|NCT00783692|80464285|FG006|Maintenance Phase|Protocol Violation|4|||
27623845|NCT00783692|80464279|FG000|Maintenance Phase|Lack of Efficacy|79|||
27623846|NCT00783692|80464280|FG001|Maintenance Phase|Lack of Efficacy|0|||
27623847|NCT00783692|80464281|FG002|Maintenance Phase|Lack of Efficacy|0|||
27623848|NCT00783692|80464282|FG003|Maintenance Phase|Lack of Efficacy|64|||
27527508|NCT00586326|80123251|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
27623849|NCT00783692|80464283|FG004|Maintenance Phase|Lack of Efficacy|58|||
27623850|NCT00783692|80464284|FG005|Maintenance Phase|Lack of Efficacy|48|||
27623851|NCT00783692|80464285|FG006|Maintenance Phase|Lack of Efficacy|177|||
27623852|NCT00783692|80464279|FG000|Maintenance Phase|Withdrawal by Subject|7|||
27623853|NCT00783692|80464280|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27623854|NCT00783692|80464281|FG002|Maintenance Phase|Withdrawal by Subject|0|||
27623855|NCT00783692|80464282|FG003|Maintenance Phase|Withdrawal by Subject|7|||
27623856|NCT00783692|80464283|FG004|Maintenance Phase|Withdrawal by Subject|6|||
27911523|NCT01890759|81513627|FG000|Overall Study|Lost to Follow-up|0|||
27911524|NCT01890759|81513628|FG001|Overall Study|Lost to Follow-up|2|||
27911525|NCT01890759|81513627|FG000|Overall Study|Withdrawal by Subject|2|||
27911526|NCT01890759|81513628|FG001|Overall Study|Withdrawal by Subject|8|||
27911527|NCT02620787|81513629|FG000|Overall Study|Adverse Event|1|||
27911528|NCT02620787|81513630|FG001|Overall Study|Adverse Event|0|||
27911529|NCT02620787|81513629|FG000|Overall Study|Eligibility Criteria Not Met|1|||
27911530|NCT02620787|81513630|FG001|Overall Study|Eligibility Criteria Not Met|0|||
27623857|NCT00783692|80464284|FG005|Maintenance Phase|Withdrawal by Subject|9|||
27623858|NCT00783692|80464285|FG006|Maintenance Phase|Withdrawal by Subject|24|||
27623859|NCT00783692|80464279|FG000|Maintenance Phase|Lost to Follow-up|2|||
27623860|NCT00783692|80464280|FG001|Maintenance Phase|Lost to Follow-up|0|||
27623861|NCT00783692|80464281|FG002|Maintenance Phase|Lost to Follow-up|0|||
27623862|NCT00783692|80464282|FG003|Maintenance Phase|Lost to Follow-up|1|||
27623863|NCT00783692|80464283|FG004|Maintenance Phase|Lost to Follow-up|3|||
27623864|NCT00783692|80464284|FG005|Maintenance Phase|Lost to Follow-up|2|||
27623865|NCT00783692|80464285|FG006|Maintenance Phase|Lost to Follow-up|5|||
27623866|NCT00783692|80464279|FG000|Maintenance Phase|Other|0|||
27623867|NCT00783692|80464280|FG001|Maintenance Phase|Other|0|||
27623868|NCT00783692|80464281|FG002|Maintenance Phase|Other|0|||
27623869|NCT00783692|80464282|FG003|Maintenance Phase|Other|1|||
27623870|NCT00783692|80464283|FG004|Maintenance Phase|Other|0|||
27623871|NCT00783692|80464284|FG005|Maintenance Phase|Other|1|||
27623872|NCT00783692|80464285|FG006|Maintenance Phase|Other|1|||
27623873|NCT01929993|80464288|FG000|Overall Study|Protocol Violation|4|||
27623874|NCT01929993|80464289|FG001|Overall Study|Protocol Violation|6|||
27623875|NCT01929993|80464288|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
27623876|NCT01929993|80464289|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
27623877|NCT02788656|80464304|FG000|Overall Study|Withdrawal by Subject|1|||
27623878|NCT02788656|80464305|FG001|Overall Study|Withdrawal by Subject|0|||
27623879|NCT01582243|80464312|FG000|Overall Study|Withdrawal by Subject|1|||
27623880|NCT01582243|80464312|FG000|Overall Study|Adverse Event|1|||
27623881|NCT01582243|80464312|FG000|Overall Study|Lost to Follow-up|1|||
27623882|NCT01369355|80464314|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
27623883|NCT01369355|80464315|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
27623884|NCT01369355|80464316|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
27623885|NCT01369355|80464317|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
27623886|NCT01369355|80464318|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
27623887|NCT01369355|80464319|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
27623888|NCT01369355|80464320|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
27623889|NCT01369355|80464321|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
27623890|NCT01369355|80464322|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
27623891|NCT01369355|80464314|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
27856222|NCT02802631|81306700|FG003|Overall Study|Withdrawal by Subject|0|||
27856223|NCT02802631|81306701|FG004|Overall Study|Withdrawal by Subject|0|||
27856224|NCT02802631|81306702|FG005|Overall Study|Withdrawal by Subject|0|||
27856225|NCT02802631|81306703|FG006|Overall Study|Withdrawal by Subject|0|||
27856226|NCT02802631|81306704|FG007|Overall Study|Withdrawal by Subject|0|||
27856227|NCT02802631|81306697|FG000|Overall Study|Physician Decision|1|||
27856228|NCT02802631|81306698|FG001|Overall Study|Physician Decision|0|||
27856229|NCT02802631|81306699|FG002|Overall Study|Physician Decision|0|||
27856230|NCT02802631|81306700|FG003|Overall Study|Physician Decision|0|||
27856231|NCT02802631|81306701|FG004|Overall Study|Physician Decision|0|||
27856232|NCT02802631|81306702|FG005|Overall Study|Physician Decision|0|||
27856233|NCT02802631|81306703|FG006|Overall Study|Physician Decision|1|||
27856234|NCT02802631|81306704|FG007|Overall Study|Physician Decision|0|||
27856235|NCT02802631|81306697|FG000|Overall Study|Adverse Event|0|||
27856236|NCT02802631|81306698|FG001|Overall Study|Adverse Event|2|||
27856237|NCT02802631|81306699|FG002|Overall Study|Adverse Event|0|||
27856238|NCT02802631|81306700|FG003|Overall Study|Adverse Event|1|||
27623892|NCT01369355|80464315|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
27623893|NCT01369355|80464316|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
27623894|NCT01369355|80464317|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
27623895|NCT01369355|80464318|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
27623896|NCT01369355|80464319|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
27856239|NCT02802631|81306701|FG004|Overall Study|Adverse Event|6|||
27856240|NCT02802631|81306702|FG005|Overall Study|Adverse Event|1|||
27911531|NCT01419314|81513631|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
27911532|NCT01419314|81513632|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
27911533|NCT01419314|81513631|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
27623897|NCT01369355|80464320|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
27623898|NCT01369355|80464321|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
27623899|NCT01369355|80464322|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
27623900|NCT01369355|80464314|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27623901|NCT01369355|80464315|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
27527509|NCT00586326|80123251|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
27527510|NCT00586326|80123251|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
27527511|NCT00586326|80123251|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
27527512|NCT00586326|80123251|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
27527513|NCT00586326|80123251|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
27527514|NCT00586326|80123251|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
27527515|NCT00586326|80123251|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
27527516|NCT00586326|80123251|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
27527517|NCT00586326|80123251|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
27527518|NCT00586326|80123251|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
27527519|NCT00586326|80123251|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
27623902|NCT01369355|80464316|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
27623903|NCT01369355|80464317|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27623904|NCT01369355|80464318|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27527520|NCT00586326|80123251|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
27527521|NCT00586326|80123251|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
27527522|NCT03123185|80123252|FG000|Overall Study|Withdrawal by Subject|0|||
27911534|NCT01419314|81513632|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
27911535|NCT01419314|81513631|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
27911536|NCT01419314|81513632|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
27911537|NCT00707057|81513633|FG000|Overall Study|Withdrawal by Subject|8|||
27911538|NCT00707057|81513634|FG001|Overall Study|Withdrawal by Subject|3|||
27911539|NCT00707057|81513633|FG000|Overall Study|Dosed incorrectly|0|||
27911540|NCT00707057|81513634|FG001|Overall Study|Dosed incorrectly|1|||
27911541|NCT01676012|81513635|FG000|Overall Study|Adverse Event|2|||
27911542|NCT01676012|81513635|FG000|Overall Study|incomplete set of videos|1|||
27911543|NCT02370511|81513636|FG000|Overall Study|Death|10|||
27911544|NCT02370511|81513637|FG001|Overall Study|Death|7|||
27911545|NCT02370511|81513638|FG002|Overall Study|Death|1|||
27911546|NCT02370511|81513636|FG000|Overall Study|Withdrawal by Subject|2|||
27911547|NCT02370511|81513637|FG001|Overall Study|Withdrawal by Subject|0|||
27527523|NCT03123185|80123253|FG001|Overall Study|Withdrawal by Subject|0|||
27527524|NCT03123185|80123254|FG002|Overall Study|Withdrawal by Subject|0|||
27527525|NCT03123185|80123255|FG003|Overall Study|Withdrawal by Subject|0|||
27527526|NCT03123185|80123256|FG004|Overall Study|Withdrawal by Subject|0|||
27527527|NCT03123185|80123257|FG005|Overall Study|Withdrawal by Subject|0|||
27527528|NCT03123185|80123258|FG006|Overall Study|Withdrawal by Subject|0|||
27527529|NCT03123185|80123259|FG007|Overall Study|Withdrawal by Subject|0|||
27527530|NCT03123185|80123260|FG008|Overall Study|Withdrawal by Subject|0|||
27623905|NCT01369355|80464319|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
27623906|NCT01369355|80464320|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27623907|NCT01369355|80464321|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27623908|NCT01369355|80464322|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
27623909|NCT01369355|80464314|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
27911548|NCT02370511|81513638|FG002|Overall Study|Withdrawal by Subject|0|||
27911549|NCT02370511|81513636|FG000|Overall Study|Lost to Follow-up|0|||
27911550|NCT02370511|81513637|FG001|Overall Study|Lost to Follow-up|4|||
27911551|NCT02370511|81513638|FG002|Overall Study|Lost to Follow-up|0|||
27911552|NCT02155699|81513639|FG000|Overall Study|Withdrawal by Subject|0|||
27911553|NCT02155699|81513640|FG001|Overall Study|Withdrawal by Subject|3|||
27911554|NCT02155699|81513641|FG002|Overall Study|Withdrawal by Subject|6|||
27911555|NCT02155699|81513642|FG003|Overall Study|Withdrawal by Subject|1|||
27911556|NCT02155699|81513639|FG000|Overall Study|Lost to Follow-up|0|||
27911557|NCT02155699|81513640|FG001|Overall Study|Lost to Follow-up|0|||
27911558|NCT02155699|81513641|FG002|Overall Study|Lost to Follow-up|0|||
27911559|NCT02155699|81513642|FG003|Overall Study|Lost to Follow-up|3|||
27623910|NCT01369355|80464315|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27911560|NCT02155699|81513639|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
27527531|NCT03123185|80123261|FG009|Overall Study|Withdrawal by Subject|0|||
27527532|NCT03123185|80123262|FG010|Overall Study|Withdrawal by Subject|0|||
27856241|NCT02802631|81306703|FG006|Overall Study|Adverse Event|4|||
27911561|NCT02155699|81513640|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
27911562|NCT02155699|81513641|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
27911563|NCT02155699|81513642|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
27911564|NCT05404711|81513643|FG000|Completed Study Visit|Withdrawal by Subject|1|||
27911565|NCT05404711|81513643|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
27911566|NCT05404711|81513643|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
27623911|NCT01369355|80464316|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
27623912|NCT01369355|80464317|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
27623913|NCT01369355|80464318|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
27856242|NCT02802631|81306704|FG007|Overall Study|Adverse Event|0|||
27527533|NCT03123185|80123263|FG011|Overall Study|Withdrawal by Subject|0|||
27527534|NCT03123185|80123264|FG012|Overall Study|Withdrawal by Subject|1|||
27527535|NCT03123185|80123265|FG013|Overall Study|Withdrawal by Subject|0|||
27527536|NCT00548405|80123266|FG000|Overall Study|Adverse Event|6|||
27527537|NCT00548405|80123267|FG001|Overall Study|Adverse Event|2|||
27527538|NCT00548405|80123268|FG002|Overall Study|Adverse Event|0|||
27527539|NCT00548405|80123266|FG000|Overall Study|Lack of Efficacy|6|||
27527540|NCT00548405|80123267|FG001|Overall Study|Lack of Efficacy|0|||
27527541|NCT00548405|80123268|FG002|Overall Study|Lack of Efficacy|0|||
27527542|NCT00548405|80123266|FG000|Overall Study|Physician Decision|3|||
27527543|NCT00548405|80123267|FG001|Overall Study|Physician Decision|4|||
27527544|NCT00548405|80123268|FG002|Overall Study|Physician Decision|1|||
27527545|NCT00548405|80123266|FG000|Overall Study|Pregnancy|1|||
27527546|NCT00548405|80123267|FG001|Overall Study|Pregnancy|0|||
27527547|NCT00548405|80123268|FG002|Overall Study|Pregnancy|0|||
27527548|NCT00548405|80123266|FG000|Overall Study|Protocol Violation|1|||
27527549|NCT00548405|80123267|FG001|Overall Study|Protocol Violation|0|||
27527550|NCT00548405|80123268|FG002|Overall Study|Protocol Violation|0|||
27527551|NCT00548405|80123266|FG000|Overall Study|Withdrawal by Subject|36|||
27527552|NCT00548405|80123267|FG001|Overall Study|Withdrawal by Subject|12|||
27527553|NCT00548405|80123268|FG002|Overall Study|Withdrawal by Subject|5|||
27527554|NCT00548405|80123266|FG000|Overall Study|Lost to Follow-up|1|||
27527555|NCT00548405|80123267|FG001|Overall Study|Lost to Follow-up|1|||
27527556|NCT00548405|80123268|FG002|Overall Study|Lost to Follow-up|2|||
27527557|NCT00548405|80123266|FG000|Overall Study|Death|0|||
27527558|NCT00548405|80123267|FG001|Overall Study|Death|1|||
27527559|NCT00548405|80123268|FG002|Overall Study|Death|1|||
27527560|NCT00548405|80123266|FG000|Overall Study|Sponsor decision|1|||
27527561|NCT00548405|80123267|FG001|Overall Study|Sponsor decision|0|||
27527562|NCT00548405|80123268|FG002|Overall Study|Sponsor decision|0|||
27527563|NCT00548405|80123266|FG000|Overall Study|Randomized but not treated|1|||
27527564|NCT00548405|80123267|FG001|Overall Study|Randomized but not treated|0|||
27527565|NCT00548405|80123268|FG002|Overall Study|Randomized but not treated|0|||
27527566|NCT01527357|80123271|FG000|Overall Study|Death|8|||
27527567|NCT01527357|80123272|FG001|Overall Study|Death|2|||
27527568|NCT01527357|80123271|FG000|Overall Study|Lost to Follow-up|6|||
27527569|NCT01527357|80123272|FG001|Overall Study|Lost to Follow-up|4|||
27527570|NCT01527357|80123271|FG000|Overall Study|Withdrew Consent|1|||
27527571|NCT01527357|80123272|FG001|Overall Study|Withdrew Consent|1|||
27527572|NCT01527357|80123271|FG000|Overall Study|Non-compliance|0|||
27527573|NCT01527357|80123272|FG001|Overall Study|Non-compliance|1|||
27527574|NCT01527357|80123271|FG000|Overall Study|No Day 29 Visit|0|||
27527575|NCT01527357|80123272|FG001|Overall Study|No Day 29 Visit|1|||
27527576|NCT01527357|80123271|FG000|Overall Study|Did Not Receive Treatment|2|||
27527577|NCT01527357|80123272|FG001|Overall Study|Did Not Receive Treatment|0|||
27527578|NCT00278915|80123273|FG000|Overall Study|Disease progression|1|||
27527579|NCT01888003|80123275|FG000|Overall Study|Study Terminated|5|||
27527580|NCT01888003|80123276|FG001|Overall Study|Study Terminated|6|||
27527581|NCT01888003|80123277|FG002|Overall Study|Study Terminated|40|||
27527582|NCT02093026|80123278|FG000|Overall Study|Adverse Event|26|||
27527583|NCT02093026|80123278|FG000|Overall Study|Death|10|||
27527584|NCT02093026|80123278|FG000|Overall Study|Other|157|||
27527585|NCT00739596|80123285|FG000|Overall Study|Adverse Event|12|||
27527586|NCT00739596|80123286|FG001|Overall Study|Adverse Event|6|||
27527587|NCT00739596|80123285|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
27527588|NCT00739596|80123286|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
27527589|NCT00739596|80123285|FG000|Overall Study|Patient Withdrew Consent|8|||
27527590|NCT00739596|80123286|FG001|Overall Study|Patient Withdrew Consent|8|||
27527591|NCT00739596|80123285|FG000|Overall Study|Lost to Follow-up|0|||
27527592|NCT00739596|80123286|FG001|Overall Study|Lost to Follow-up|2|||
27527593|NCT00739596|80123285|FG000|Overall Study|Protocol Deviation|1|||
27527594|NCT00739596|80123286|FG001|Overall Study|Protocol Deviation|1|||
27527595|NCT01150474|80123287|FG000|Overall Study|Withdrawal by Subject|5|||
27527596|NCT01150474|80123288|FG001|Overall Study|Withdrawal by Subject|2|||
27527597|NCT01150474|80123287|FG000|Overall Study|Cancer found|1|||
27527598|NCT01150474|80123288|FG001|Overall Study|Cancer found|0|||
27527599|NCT01150474|80123287|FG000|Overall Study|Multiple Studies|0|||
27527600|NCT01150474|80123288|FG001|Overall Study|Multiple Studies|1|||
27527601|NCT01150474|80123287|FG000|Overall Study|Rectotomy|1|||
27527602|NCT01150474|80123288|FG001|Overall Study|Rectotomy|0|||
27527603|NCT01150474|80123287|FG000|Overall Study|Drug did not arrive in time|1|||
27527604|NCT01150474|80123288|FG001|Overall Study|Drug did not arrive in time|0|||
27527605|NCT01150474|80123287|FG000|Overall Study|Drug not administered|1|||
27527606|NCT01150474|80123288|FG001|Overall Study|Drug not administered|0|||
27527607|NCT01150474|80123287|FG000|Overall Study|Surgery Changed|1|||
27527608|NCT01150474|80123288|FG001|Overall Study|Surgery Changed|0|||
27623914|NCT01369355|80464319|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
27623915|NCT01369355|80464320|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27623916|NCT01369355|80464321|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27623917|NCT01369355|80464322|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
27623918|NCT01369355|80464314|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
27623919|NCT01369355|80464315|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
27623920|NCT01369355|80464316|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
27623921|NCT01369355|80464317|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
27623922|NCT01369355|80464318|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
27623923|NCT01369355|80464319|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
27623924|NCT01369355|80464320|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
27623925|NCT01369355|80464321|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
27623926|NCT01369355|80464322|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
27623927|NCT01369355|80464314|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
27623928|NCT01369355|80464315|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
27623929|NCT01369355|80464316|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
27623930|NCT01369355|80464317|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
27623931|NCT01369355|80464318|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
27623932|NCT01369355|80464319|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
27623933|NCT01369355|80464320|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
27623934|NCT01369355|80464321|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
27623935|NCT01369355|80464322|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
27623936|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
27623937|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
27623938|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
27623939|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
27623940|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
27623941|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
27623942|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
27623943|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
27623944|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
27623945|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Death|0|||
27623946|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Death|0|||
27623947|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Death|0|||
27623948|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Death|0|||
27623949|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Death|0|||
27623950|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Death|0|||
27623951|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Death|0|||
27623952|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Death|1|||
27623953|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Death|3|||
27623954|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27623955|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27623956|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27623957|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27623958|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27623959|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
27623960|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
27623961|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
27623962|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
27623963|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623964|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623965|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623966|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623967|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623968|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623969|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
27623970|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
27623971|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
27623972|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
27623973|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
27623974|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
27623975|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
27623976|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
27623977|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
27856243|NCT02802631|81306697|FG000|Overall Study|Sponsor Decision|0|||
27856244|NCT02802631|81306698|FG001|Overall Study|Sponsor Decision|0|||
27623978|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
27623979|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
27623980|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
27623981|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27623982|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27623983|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27623984|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27623985|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27623986|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
27623987|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
27623988|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
27623989|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
27623990|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27623991|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27623992|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27623993|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27623994|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27623995|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
27623996|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
27623997|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
27623998|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
27623999|NCT01369355|80464314|FG000|Long-term Extension (Week 44-272)|Other|0|||
27624000|NCT01369355|80464315|FG001|Long-term Extension (Week 44-272)|Other|0|||
27624001|NCT01369355|80464316|FG002|Long-term Extension (Week 44-272)|Other|0|||
27624002|NCT01369355|80464317|FG003|Long-term Extension (Week 44-272)|Other|0|||
27624003|NCT01369355|80464318|FG004|Long-term Extension (Week 44-272)|Other|0|||
27624004|NCT01369355|80464319|FG005|Long-term Extension (Week 44-272)|Other|0|||
27624005|NCT01369355|80464320|FG006|Long-term Extension (Week 44-272)|Other|110|||
27624006|NCT01369355|80464321|FG007|Long-term Extension (Week 44-272)|Other|9|||
27624007|NCT01369355|80464322|FG008|Long-term Extension (Week 44-272)|Other|17|||
27624008|NCT04550039|80464324|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
27624009|NCT04550039|80464325|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
27624010|NCT04550039|80464324|FG000|Overall Study|patient self-withdrew from study|0|||
27624011|NCT04550039|80464325|FG001|Overall Study|patient self-withdrew from study|1|||
27624012|NCT01878890|80464326|FG000|Overall Study|Protocol Violation|0|||
27624013|NCT01878890|80464327|FG001|Overall Study|Protocol Violation|1|||
27624014|NCT01878890|80464328|FG002|Overall Study|Protocol Violation|0|||
27624015|NCT01878890|80464329|FG003|Overall Study|Protocol Violation|0|||
27624016|NCT01251614|80464330|FG000|Overall Study|Adverse Event|1|||
27624017|NCT01251614|80464331|FG001|Overall Study|Adverse Event|0|||
27624018|NCT01251614|80464332|FG002|Overall Study|Adverse Event|1|||
27624019|NCT01251614|80464330|FG000|Overall Study|Lack of Efficacy|1|||
27624020|NCT01251614|80464331|FG001|Overall Study|Lack of Efficacy|9|||
27624021|NCT01251614|80464332|FG002|Overall Study|Lack of Efficacy|4|||
27624022|NCT01251614|80464330|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
27624023|NCT01251614|80464331|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
27624024|NCT01251614|80464332|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
27624025|NCT01251614|80464330|FG000|Overall Study|Pregnancy|0|||
27624026|NCT01251614|80464331|FG001|Overall Study|Pregnancy|0|||
27624027|NCT01251614|80464332|FG002|Overall Study|Pregnancy|2|||
27624028|NCT01251614|80464330|FG000|Overall Study|Loss of Disease Control|0|||
27624029|NCT01251614|80464331|FG001|Overall Study|Loss of Disease Control|1|||
27624030|NCT01251614|80464332|FG002|Overall Study|Loss of Disease Control|0|||
27624031|NCT01251614|80464330|FG000|Overall Study|Withdrawal by Subject|0|||
27624032|NCT01251614|80464331|FG001|Overall Study|Withdrawal by Subject|2|||
27624033|NCT01251614|80464332|FG002|Overall Study|Withdrawal by Subject|1|||
27624034|NCT01251614|80464330|FG000|Overall Study|Lost to Follow-up|0|||
27624035|NCT01251614|80464331|FG001|Overall Study|Lost to Follow-up|1|||
27624036|NCT01251614|80464332|FG002|Overall Study|Lost to Follow-up|0|||
27624037|NCT00088465|80464333|FG000|Overall Study|Withdrawal by Subject|290|||
27624038|NCT00088465|80464333|FG000|Overall Study|Adverse Event|77|||
27624039|NCT00088465|80464333|FG000|Overall Study|Lost to Follow-up|57|||
27624040|NCT00088465|80464333|FG000|Overall Study|Physician Decision|45|||
27624041|NCT00088465|80464333|FG000|Overall Study|Sponsor Decision|37|||
27624042|NCT00088465|80464333|FG000|Overall Study|Lack of Efficacy|27|||
27733387|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
27856245|NCT02802631|81306699|FG002|Overall Study|Sponsor Decision|6|||
27856246|NCT02802631|81306700|FG003|Overall Study|Sponsor Decision|0|||
27624043|NCT00088465|80464333|FG000|Overall Study|Protocol Violation|17|||
27624044|NCT00088465|80464333|FG000|Overall Study|Death|11|||
27624045|NCT02424344|80464336|FG000|Overall Study|Lack of Efficacy|0|||
27624046|NCT02424344|80464337|FG001|Overall Study|Lack of Efficacy|1|||
27624047|NCT02424344|80464336|FG000|Overall Study|Withdrawal by Subject|2|||
27624048|NCT02424344|80464337|FG001|Overall Study|Withdrawal by Subject|1|||
27624049|NCT02424344|80464336|FG000|Overall Study|Lost to Follow-up|1|||
27624050|NCT02424344|80464337|FG001|Overall Study|Lost to Follow-up|0|||
27624051|NCT02424344|80464336|FG000|Overall Study|Adverse Event|4|||
27624052|NCT02424344|80464337|FG001|Overall Study|Adverse Event|8|||
27624053|NCT00354029|80464338|FG000|Overall Study|Protocol Violation|4|||
27624054|NCT00354029|80464339|FG001|Overall Study|Protocol Violation|2|||
27624055|NCT00836810|80464341|FG000|Overall Study|New diagnosis|1|||
27624056|NCT00836810|80464342|FG001|Overall Study|New diagnosis|0|||
27624057|NCT02906683|80464348|FG000|Overall Study|Adverse Event|0|||
27624058|NCT02906683|80464349|FG001|Overall Study|Adverse Event|1|||
27624059|NCT02906683|80464350|FG002|Overall Study|Adverse Event|0|||
27624060|NCT02906683|80464348|FG000|Overall Study|Physician Decision|0|||
27624061|NCT02906683|80464349|FG001|Overall Study|Physician Decision|1|||
27624062|NCT02906683|80464350|FG002|Overall Study|Physician Decision|1|||
27624063|NCT02906683|80464348|FG000|Overall Study|Withdrawal by Subject|0|||
27624064|NCT02906683|80464349|FG001|Overall Study|Withdrawal by Subject|2|||
27624065|NCT02906683|80464350|FG002|Overall Study|Withdrawal by Subject|1|||
27624066|NCT02906683|80464348|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
27624067|NCT02906683|80464349|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
27624068|NCT02906683|80464350|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
27624069|NCT02906683|80464348|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
27624070|NCT02906683|80464349|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
27624071|NCT02906683|80464350|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
27624072|NCT05780047|80464351|FG000|Overall Study|Did not submit baseline urine test kit|226|||
27624073|NCT05780047|80464351|FG000|Overall Study|Lost to Follow-up|34|||
27624074|NCT05780047|80464351|FG000|Overall Study|Did not submit second urine test kit|124|||
27624075|NCT01021878|80464352|FG000|Overall Study|Lost to Follow-up|4|||
27624076|NCT01021878|80464353|FG001|Overall Study|Lost to Follow-up|3|||
27624077|NCT01021878|80464352|FG000|Overall Study|Death|0|||
27624078|NCT01021878|80464353|FG001|Overall Study|Death|1|||
27624079|NCT01021878|80464352|FG000|Overall Study|Adverse Event|6|||
27624080|NCT01021878|80464353|FG001|Overall Study|Adverse Event|5|||
27624081|NCT01021878|80464352|FG000|Overall Study|Transplantation|6|||
27624082|NCT01021878|80464353|FG001|Overall Study|Transplantation|1|||
27624083|NCT02320253|80464354|FG000|Overall Study|Withdrawal by Subject|3|||
27624084|NCT02320253|80464355|FG001|Overall Study|Withdrawal by Subject|0|||
27624085|NCT02320253|80464356|FG002|Overall Study|Withdrawal by Subject|0|||
27624086|NCT02320253|80464354|FG000|Overall Study|Lost to Follow-up|2|||
27624087|NCT02320253|80464355|FG001|Overall Study|Lost to Follow-up|2|||
27624088|NCT02320253|80464356|FG002|Overall Study|Lost to Follow-up|1|||
27624089|NCT02320253|80464354|FG000|Overall Study|Death|1|||
27624090|NCT02320253|80464355|FG001|Overall Study|Death|0|||
27624091|NCT02320253|80464356|FG002|Overall Study|Death|1|||
27624092|NCT04172987|80464359|FG000|Lead In Period|Adverse Event|1|||
27624093|NCT04172987|80464359|FG000|Lead In Period|Protocol Violation|1|||
27624094|NCT04172987|80464359|FG000|Period 1|Physician Decision|1|||
27624095|NCT04172987|80464359|FG000|Period 2|Adverse Event|5|||
27624096|NCT04172987|80464359|FG000|Period 2|Dosing Termination by Sponsor|4|||
27624097|NCT00224133|80464361|FG000|Overall Study|Adverse Event|93|||
27624098|NCT00224133|80464361|FG000|Overall Study|Protocol Violation|6|||
27624099|NCT00224133|80464361|FG000|Overall Study|Withdrawal by Subject|33|||
27624100|NCT00224133|80464361|FG000|Overall Study|Lack of Efficacy|58|||
27624101|NCT00224133|80464361|FG000|Overall Study|Lost to Follow-up|21|||
27624102|NCT00224133|80464361|FG000|Overall Study|Physician Decision|1|||
27624103|NCT00224133|80464361|FG000|Overall Study|Other|14|||
27624104|NCT01606189|80464362|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
27624105|NCT01606189|80464363|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
27624106|NCT01606189|80464364|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
27624107|NCT01606189|80464365|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
27624108|NCT01606189|80464366|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
27624109|NCT01606189|80464367|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
27527609|NCT01465191|80123293|FG000|Overall Study|Protocol Violation|6|||
27527610|NCT01465191|80123294|FG001|Overall Study|Protocol Violation|3|||
27527611|NCT01465191|80123295|FG002|Overall Study|Protocol Violation|3|||
27527612|NCT01465191|80123293|FG000|Overall Study|Lost to Follow-up|3|||
27527613|NCT01465191|80123294|FG001|Overall Study|Lost to Follow-up|6|||
27527614|NCT01465191|80123295|FG002|Overall Study|Lost to Follow-up|4|||
27527615|NCT02314143|80123296|FG000|Overall Study|Adverse Event|0|||
27527616|NCT02314143|80123297|FG001|Overall Study|Adverse Event|6|||
27624110|NCT01606189|80464362|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27624111|NCT01606189|80464363|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27624112|NCT01606189|80464364|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27624113|NCT01606189|80464365|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27527617|NCT02314143|80123298|FG002|Overall Study|Adverse Event|4|||
27527618|NCT02314143|80123296|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
27624114|NCT01606189|80464366|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
27624115|NCT01606189|80464367|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
27624116|NCT00335556|80464370|FG000|Overall Study|Death|0|||
27624117|NCT00335556|80464371|FG001|Overall Study|Death|5|||
27624118|NCT00335556|80464372|FG002|Overall Study|Death|0|||
27624119|NCT00335556|80464373|FG003|Overall Study|Death|0|||
27624120|NCT00335556|80464374|FG004|Overall Study|Death|1|||
27624121|NCT00335556|80464375|FG005|Overall Study|Death|0|||
27624122|NCT00335556|80464370|FG000|Overall Study|Lack of Efficacy|0|||
27624123|NCT00335556|80464371|FG001|Overall Study|Lack of Efficacy|19|||
27624124|NCT00335556|80464372|FG002|Overall Study|Lack of Efficacy|3|||
27624125|NCT00335556|80464373|FG003|Overall Study|Lack of Efficacy|3|||
27624126|NCT00335556|80464374|FG004|Overall Study|Lack of Efficacy|0|||
27624127|NCT00335556|80464375|FG005|Overall Study|Lack of Efficacy|1|||
27624128|NCT00335556|80464370|FG000|Overall Study|Physician Decision|0|||
27624129|NCT00335556|80464371|FG001|Overall Study|Physician Decision|6|||
27624130|NCT00335556|80464372|FG002|Overall Study|Physician Decision|2|||
27527619|NCT02314143|80123297|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
27527620|NCT02314143|80123298|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
27527621|NCT02314143|80123296|FG000|Overall Study|Physician Decision|2|||
27527622|NCT02314143|80123297|FG001|Overall Study|Physician Decision|1|||
27527623|NCT02314143|80123298|FG002|Overall Study|Physician Decision|0|||
27527624|NCT02314143|80123296|FG000|Overall Study|Withdrawal by Subject|1|||
27527625|NCT02314143|80123297|FG001|Overall Study|Withdrawal by Subject|0|||
27527626|NCT02314143|80123298|FG002|Overall Study|Withdrawal by Subject|1|||
27527627|NCT02195687|80123299|FG000|Overall Study|Personal Reasons|1|||
27527628|NCT02195687|80123300|FG001|Overall Study|Personal Reasons|1|||
27527629|NCT02195687|80123299|FG000|Overall Study|Lost to Follow-up|4|||
27527630|NCT02195687|80123300|FG001|Overall Study|Lost to Follow-up|1|||
27527631|NCT01101191|80123301|FG000|Period 1|Withdrawal by Subject|1|||
27527632|NCT01101191|80123302|FG001|Period 1|Withdrawal by Subject|0|||
27527633|NCT01101191|80123301|FG000|Period 1|Adverse Event|1|||
27527634|NCT01101191|80123302|FG001|Period 1|Adverse Event|2|||
27527635|NCT03631355|80123303|FG000|Overall Study|Lost to Follow-up|1|||
27527636|NCT03631355|80123304|FG001|Overall Study|Lost to Follow-up|2|||
27624131|NCT00335556|80464373|FG003|Overall Study|Physician Decision|1|||
27624132|NCT00335556|80464374|FG004|Overall Study|Physician Decision|0|||
27624133|NCT00335556|80464375|FG005|Overall Study|Physician Decision|0|||
27624134|NCT00335556|80464370|FG000|Overall Study|Ineligible|2|||
27624135|NCT00335556|80464371|FG001|Overall Study|Ineligible|0|||
27624136|NCT00335556|80464372|FG002|Overall Study|Ineligible|0|||
27624137|NCT00335556|80464373|FG003|Overall Study|Ineligible|0|||
27733388|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733389|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
27733390|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733391|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733392|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733393|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733394|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733395|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
27733396|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
27733397|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27733398|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
27733399|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
27733400|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27733401|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27733402|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27733403|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27733404|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
27733405|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
27733406|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27733407|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27733408|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
27733409|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27733410|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27624138|NCT00335556|80464374|FG004|Overall Study|Ineligible|0|||
27624139|NCT00335556|80464375|FG005|Overall Study|Ineligible|0|||
27624140|NCT00335556|80464370|FG000|Overall Study|Refusal of further protocol therapy|0|||
27733411|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27733412|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27733413|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27624141|NCT00335556|80464371|FG001|Overall Study|Refusal of further protocol therapy|4|||
27624142|NCT00335556|80464372|FG002|Overall Study|Refusal of further protocol therapy|0|||
27624143|NCT00335556|80464373|FG003|Overall Study|Refusal of further protocol therapy|1|||
27624144|NCT00335556|80464374|FG004|Overall Study|Refusal of further protocol therapy|0|||
27624145|NCT00335556|80464375|FG005|Overall Study|Refusal of further protocol therapy|0|||
27624146|NCT02138916|80464376|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
27624147|NCT02138916|80464377|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
27624148|NCT02138916|80464378|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
27624149|NCT02138916|80464376|FG000|Overall Study|Death|14|||
27624150|NCT02138916|80464377|FG001|Overall Study|Death|11|||
27624151|NCT02138916|80464378|FG002|Overall Study|Death|12|||
27624152|NCT02138916|80464376|FG000|Overall Study|Withdrawal by Subject|27|||
27624153|NCT02138916|80464377|FG001|Overall Study|Withdrawal by Subject|31|||
27624154|NCT02138916|80464378|FG002|Overall Study|Withdrawal by Subject|32|||
27624155|NCT02138916|80464376|FG000|Overall Study|Study specific withdrawal criteria|0|||
27624156|NCT02138916|80464377|FG001|Overall Study|Study specific withdrawal criteria|0|||
27624157|NCT02138916|80464378|FG002|Overall Study|Study specific withdrawal criteria|1|||
27624158|NCT02138916|80464376|FG000|Overall Study|incorrect enrolment|1|||
27624159|NCT02138916|80464377|FG001|Overall Study|incorrect enrolment|1|||
27624160|NCT02138916|80464378|FG002|Overall Study|incorrect enrolment|0|||
27624161|NCT02138916|80464376|FG000|Overall Study|Severe non-compliance|1|||
27624162|NCT02138916|80464377|FG001|Overall Study|Severe non-compliance|2|||
27624163|NCT02138916|80464378|FG002|Overall Study|Severe non-compliance|1|||
27624164|NCT02138916|80464376|FG000|Overall Study|Lost to Follow-up|4|||
27624165|NCT02138916|80464377|FG001|Overall Study|Lost to Follow-up|2|||
27624166|NCT02138916|80464378|FG002|Overall Study|Lost to Follow-up|3|||
27624167|NCT02138916|80464376|FG000|Overall Study|Adverse Event|4|||
27624168|NCT02138916|80464377|FG001|Overall Study|Adverse Event|4|||
27624169|NCT02138916|80464378|FG002|Overall Study|Adverse Event|3|||
27624170|NCT00550732|80464380|FG000|Overall Study|Death|4|||
27624171|NCT00550732|80464380|FG000|Overall Study|Withdrawal by Subject|2|||
27624172|NCT00550732|80464380|FG000|Overall Study|Physician Decision|2|||
27624173|NCT00550732|80464380|FG000|Overall Study|Lost to Follow-up|1|||
27624174|NCT00550732|80464380|FG000|Overall Study|Palliative care|1|||
27624175|NCT00550732|80464380|FG000|Overall Study|Adverse Event|1|||
27624176|NCT00490555|80464392|FG000|Overall Study|noncompliant with drug administration|0|||
27624177|NCT00490555|80464393|FG001|Overall Study|noncompliant with drug administration|0|||
27624178|NCT00490555|80464394|FG002|Overall Study|noncompliant with drug administration|2|||
27624179|NCT00490555|80464395|FG003|Overall Study|noncompliant with drug administration|0|||
27624180|NCT02123966|80464400|FG000|Overall Study|Intercurrent Illness|1|||
27624181|NCT00410384|80464401|FG000|Overall Study|Withdrawal by Subject|28|||
27624182|NCT00410384|80464402|FG001|Overall Study|Withdrawal by Subject|17|||
27624183|NCT00410384|80464403|FG002|Overall Study|Withdrawal by Subject|20|||
27624184|NCT00410384|80464401|FG000|Overall Study|Adverse Event|23|||
27624185|NCT00410384|80464402|FG001|Overall Study|Adverse Event|18|||
27624186|NCT00410384|80464403|FG002|Overall Study|Adverse Event|23|||
27624187|NCT00410384|80464401|FG000|Overall Study|Lack of Efficacy|20|||
27624188|NCT00410384|80464402|FG001|Overall Study|Lack of Efficacy|12|||
27624189|NCT00410384|80464403|FG002|Overall Study|Lack of Efficacy|17|||
27624190|NCT00410384|80464401|FG000|Overall Study|Lack of Compliance|2|||
27624191|NCT00410384|80464402|FG001|Overall Study|Lack of Compliance|2|||
27624192|NCT00410384|80464403|FG002|Overall Study|Lack of Compliance|2|||
27624193|NCT00410384|80464401|FG000|Overall Study|Lost to Follow-up|4|||
27624194|NCT00410384|80464402|FG001|Overall Study|Lost to Follow-up|6|||
27624195|NCT00410384|80464403|FG002|Overall Study|Lost to Follow-up|6|||
27624196|NCT00410384|80464401|FG000|Overall Study|Protocol Violation|6|||
27624197|NCT00410384|80464402|FG001|Overall Study|Protocol Violation|6|||
27624198|NCT00410384|80464403|FG002|Overall Study|Protocol Violation|6|||
27624199|NCT00410384|80464401|FG000|Overall Study|Physician Decision|3|||
27624200|NCT00410384|80464402|FG001|Overall Study|Physician Decision|3|||
27624201|NCT00410384|80464403|FG002|Overall Study|Physician Decision|4|||
27624202|NCT00410384|80464401|FG000|Overall Study|Other|3|||
27624203|NCT00410384|80464402|FG001|Overall Study|Other|8|||
27624204|NCT00410384|80464403|FG002|Overall Study|Other|4|||
27624205|NCT03836664|80464407|FG000|Overall Study|Didn't complete forms and lost drug|3|||
27624206|NCT03836664|80464408|FG001|Overall Study|Didn't complete forms and lost drug|3|||
27856247|NCT02802631|81306701|FG004|Overall Study|Sponsor Decision|2|||
27856248|NCT02802631|81306702|FG005|Overall Study|Sponsor Decision|0|||
27624207|NCT01388543|80464409|FG000|Day 14|Adverse Event|1|||
27624208|NCT01388543|80464410|FG001|Day 14|Adverse Event|4|||
27624209|NCT00519779|80466839|FG000|Overall Study|Withdrawal by Subject|0|||
27624210|NCT00519779|80466840|FG001|Overall Study|Withdrawal by Subject|1|||
27624211|NCT01106287|80466849|FG000|Overall Study|Adverse Event|1|||
27624212|NCT01106287|80466850|FG001|Overall Study|Adverse Event|0|||
27624213|NCT01106287|80466851|FG002|Overall Study|Adverse Event|0|||
27624214|NCT01106287|80466852|FG003|Overall Study|Adverse Event|0|||
27624215|NCT00531479|80466853|FG000|Overall Study|Death|68|||
27624216|NCT00531479|80466854|FG001|Overall Study|Death|71|||
27624217|NCT00531479|80466853|FG000|Overall Study|Lost to Follow-up|0|||
27624218|NCT00531479|80466854|FG001|Overall Study|Lost to Follow-up|2|||
27624219|NCT00531479|80466853|FG000|Overall Study|Other|0|||
27624220|NCT00531479|80466854|FG001|Overall Study|Other|1|||
27624221|NCT00531479|80466853|FG000|Overall Study|Withdrawal by Subject|6|||
27624222|NCT00531479|80466854|FG001|Overall Study|Withdrawal by Subject|6|||
27624223|NCT00531479|80466853|FG000|Overall Study|Did not receive treatment|2|||
27624224|NCT00531479|80466854|FG001|Overall Study|Did not receive treatment|3|||
27911567|NCT05404711|81513643|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
27911568|NCT05404711|81513643|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
27911569|NCT05404711|81513643|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
27911570|NCT01619878|81513655|FG000|6 Week Follow-up Phase|Adverse Event|1|||
27911571|NCT01619878|81513655|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
27911572|NCT01619878|81513655|FG000|Follow-up at 12 Months of Age|Death|2|||
27911573|NCT00807365|81513656|FG000|Overall Study|Study Terminated|5|||
27911574|NCT02864407|81513657|FG000|Overall Study|Protocol Violation|3|||
27911575|NCT02864407|81513657|FG000|Overall Study|Lost to Follow-up|115|||
27911576|NCT02864407|81513657|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
27911577|NCT02864407|81513657|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
27911578|NCT02864407|81513657|FG000|Overall Study|Consent prior to the contract date|1|||
27527637|NCT01439347|80126076|FG000|Overall Study|Death|10|||
27527638|NCT01439347|80126077|FG001|Overall Study|Death|9|||
27527639|NCT01439347|80126076|FG000|Overall Study|Withdrawal by Subject|0|||
27527640|NCT01439347|80126077|FG001|Overall Study|Withdrawal by Subject|1|||
27527641|NCT01439347|80126076|FG000|Overall Study|Physician Decision|1|||
27527642|NCT01439347|80126077|FG001|Overall Study|Physician Decision|0|||
27527643|NCT01439347|80126076|FG000|Overall Study|Sponsor Terminated Study|2|||
27527644|NCT01439347|80126077|FG001|Overall Study|Sponsor Terminated Study|3|||
27527645|NCT03783702|80126078|FG000|Overall Study|Lost to Follow-up|6|||
27527646|NCT03783702|80126079|FG001|Overall Study|Lost to Follow-up|8|||
27527647|NCT03783702|80126078|FG000|Overall Study|Protocol Violation|1|||
27527648|NCT03783702|80126079|FG001|Overall Study|Protocol Violation|3|||
27527649|NCT00381381|80126082|FG000|Overall Study|Adverse Event|3|||
27527650|NCT00381381|80126082|FG000|Overall Study|Lost to Follow-up|52|||
27527651|NCT00381381|80126082|FG000|Overall Study|Withdrawal by Subject|9|||
27527652|NCT01028378|80126084|FG000|Overall Study|Lost to Follow-up|12|||
27527653|NCT01028378|80126084|FG000|Overall Study|Withdrawal by Subject|1|||
27527654|NCT01028378|80126084|FG000|Overall Study|Adminstrative Reasons|4|||
27527655|NCT00873860|80126085|FG000|Overall Study|Lost to Follow-up|1|||
27527656|NCT00873860|80126086|FG001|Overall Study|Lost to Follow-up|0|||
27527657|NCT00873860|80126087|FG002|Overall Study|Lost to Follow-up|0|||
27527658|NCT00873860|80126088|FG003|Overall Study|Lost to Follow-up|1|||
27527659|NCT00873860|80126085|FG000|Overall Study|Withdrawal by Subject|1|||
27527660|NCT00873860|80126086|FG001|Overall Study|Withdrawal by Subject|0|||
27527661|NCT00873860|80126087|FG002|Overall Study|Withdrawal by Subject|2|||
27527662|NCT00873860|80126088|FG003|Overall Study|Withdrawal by Subject|0|||
27527663|NCT00873860|80126085|FG000|Overall Study|Death|1|||
27527664|NCT00873860|80126086|FG001|Overall Study|Death|0|||
27527665|NCT00873860|80126087|FG002|Overall Study|Death|0|||
27527666|NCT00873860|80126088|FG003|Overall Study|Death|0|||
27527667|NCT00873860|80126085|FG000|Overall Study|Other|1|||
27527668|NCT00873860|80126086|FG001|Overall Study|Other|0|||
27527669|NCT00873860|80126087|FG002|Overall Study|Other|1|||
27527670|NCT00873860|80126088|FG003|Overall Study|Other|0|||
27527671|NCT03612856|80126091|FG000|Pre-dose Period|Physician Decision|0|||
27527672|NCT03612856|80126092|FG001|Pre-dose Period|Physician Decision|1|||
27527673|NCT03612856|80126093|FG002|Pre-dose Period|Physician Decision|1|||
27527674|NCT03612856|80126091|FG000|Pre-dose Period|Withdrawal by Subject|0|||
27527675|NCT03612856|80126092|FG001|Pre-dose Period|Withdrawal by Subject|1|||
27527676|NCT03612856|80126093|FG002|Pre-dose Period|Withdrawal by Subject|0|||
27527677|NCT00769483|80126094|FG000|Overall Study|Withdrawal by Subject|0|||
27527678|NCT00769483|80126095|FG001|Overall Study|Withdrawal by Subject|1|||
27527679|NCT00769483|80126096|FG002|Overall Study|Withdrawal by Subject|0|||
27527680|NCT00769483|80126097|FG003|Overall Study|Withdrawal by Subject|0|||
27527681|NCT00769483|80126098|FG004|Overall Study|Withdrawal by Subject|1|||
27527682|NCT00769483|80126099|FG005|Overall Study|Withdrawal by Subject|0|||
27527683|NCT04271280|80126101|FG000|Overall Study|Lost to Follow-up|300|||
27733414|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
27911579|NCT00751140|81513663|FG000|Overall Study|benign angioma excluded from analysis|1|||
27911580|NCT02493517|81513664|FG000|Overall Study|Protocol Violation|1|||
27911581|NCT02493517|81513665|FG001|Overall Study|Protocol Violation|2|||
27911582|NCT02493517|81513664|FG000|Overall Study|Withdrawal by Subject|1|||
27911583|NCT02493517|81513665|FG001|Overall Study|Withdrawal by Subject|2|||
27911584|NCT02493517|81513664|FG000|Overall Study|Adverse Event|0|||
27527684|NCT04271280|80126101|FG000|Overall Study|Death|153|||
27527685|NCT04271280|80126101|FG000|Overall Study|Withdrawal of consent by patient|59|||
27527686|NCT04271280|80126101|FG000|Overall Study|Other|51|||
27527687|NCT04271280|80126101|FG000|Overall Study|No end of study information|42|||
27527688|NCT02011893|80126102|FG000|Enrollment to Randomization|Adverse Event|2|||
27527689|NCT02011893|80126103|FG001|Enrollment to Randomization|Adverse Event|0|||
27527690|NCT02011893|80126104|FG002|Enrollment to Randomization|Adverse Event|0|||
27527691|NCT02011893|80126102|FG000|Enrollment to Randomization|Physician Decision|10|||
27527692|NCT02011893|80126103|FG001|Enrollment to Randomization|Physician Decision|0|||
27527693|NCT02011893|80126104|FG002|Enrollment to Randomization|Physician Decision|0|||
27624225|NCT05310084|80466855|FG000|Overall Study|Withdrawal by Subject|2|||
27624226|NCT05310084|80466856|FG001|Overall Study|Withdrawal by Subject|3|||
27624227|NCT05310084|80466855|FG000|Overall Study|Participant availability|0|||
27624228|NCT05310084|80466856|FG001|Overall Study|Participant availability|4|||
27624229|NCT05310084|80466855|FG000|Overall Study|Lost to Follow-up|1|||
27624230|NCT05310084|80466856|FG001|Overall Study|Lost to Follow-up|1|||
27624231|NCT05310084|80466855|FG000|Overall Study|Adverse Event|1|||
27624232|NCT05310084|80466856|FG001|Overall Study|Adverse Event|1|||
27624233|NCT05310084|80466855|FG000|Overall Study|Randomized but not vaccinated|4|||
27624234|NCT05310084|80466856|FG001|Overall Study|Randomized but not vaccinated|2|||
27624235|NCT00819910|80466859|FG000|Overall Study|Adverse Event|0|||
27624236|NCT00819910|80466860|FG001|Overall Study|Adverse Event|0|||
27624237|NCT00819910|80466861|FG002|Overall Study|Adverse Event|2|||
27624238|NCT00819910|80466862|FG003|Overall Study|Adverse Event|1|||
27624239|NCT00819910|80466859|FG000|Overall Study|Withdrawal by Subject|1|||
27624240|NCT00819910|80466860|FG001|Overall Study|Withdrawal by Subject|1|||
27624241|NCT00819910|80466861|FG002|Overall Study|Withdrawal by Subject|1|||
27624242|NCT00819910|80466862|FG003|Overall Study|Withdrawal by Subject|0|||
27624243|NCT00819910|80466859|FG000|Overall Study|Lost to Follow-up|1|||
27624244|NCT00819910|80466860|FG001|Overall Study|Lost to Follow-up|0|||
27624245|NCT00819910|80466861|FG002|Overall Study|Lost to Follow-up|0|||
27624246|NCT00819910|80466862|FG003|Overall Study|Lost to Follow-up|0|||
27624247|NCT04939428|80466865|FG000|Overall Study|Death|0|||
27624248|NCT04939428|80466866|FG001|Overall Study|Death|1|||
27624249|NCT04939428|80466867|FG002|Overall Study|Death|0|||
27624250|NCT04939428|80466865|FG000|Overall Study|Lost to Follow-up|0|||
27624251|NCT04939428|80466866|FG001|Overall Study|Lost to Follow-up|5|||
27624252|NCT04939428|80466867|FG002|Overall Study|Lost to Follow-up|0|||
27624253|NCT04939428|80466865|FG000|Overall Study|Physician Decision|1|||
27624254|NCT04939428|80466866|FG001|Overall Study|Physician Decision|0|||
27624255|NCT04939428|80466867|FG002|Overall Study|Physician Decision|0|||
27624256|NCT04939428|80466865|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
27624257|NCT04939428|80466866|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27624258|NCT04939428|80466867|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
27624259|NCT04939428|80466865|FG000|Overall Study|Withdrawal by Subject|10|||
27624260|NCT04939428|80466866|FG001|Overall Study|Withdrawal by Subject|11|||
27624261|NCT04939428|80466867|FG002|Overall Study|Withdrawal by Subject|0|||
27624262|NCT04939428|80466865|FG000|Overall Study|Unkown|6|||
27624263|NCT04939428|80466866|FG001|Overall Study|Unkown|3|||
27624264|NCT04939428|80466867|FG002|Overall Study|Unkown|0|||
27624265|NCT04939428|80466865|FG000|Overall Study|Discotinued per protocol|0|||
27624266|NCT04939428|80466866|FG001|Overall Study|Discotinued per protocol|0|||
27624267|NCT04939428|80466867|FG002|Overall Study|Discotinued per protocol|902|||
27624268|NCT03582137|80466873|FG000|Overall Study|Adverse Event|1|||
27624269|NCT03582137|80466874|FG001|Overall Study|Adverse Event|0|||
27624270|NCT00832780|80466882|FG000|Overall Study|Death|16|||
27624271|NCT00832780|80466882|FG000|Overall Study|Lost to Follow-up|4|||
27624272|NCT00832780|80466882|FG000|Overall Study|no reason given|2|||
27624273|NCT00832780|80466882|FG000|Overall Study|other complicating condition|2|||
27624274|NCT00832780|80466882|FG000|Overall Study|Physician Decision|1|||
27624275|NCT00558753|80466883|FG000|Overall Study|Lost to Follow-up|5|||
27624276|NCT00558753|80466884|FG001|Overall Study|Lost to Follow-up|7|||
27624277|NCT04305912|80466890|FG000|First Intervention|COVID-19 Suspension|2|||
27624278|NCT04305912|80466891|FG001|First Intervention|COVID-19 Suspension|0|||
27624279|NCT04305912|80466890|FG000|First Intervention|Withdrawal by Subject|0|||
27624280|NCT04305912|80466891|FG001|First Intervention|Withdrawal by Subject|1|||
27624281|NCT04305912|80466890|FG000|Second Intervention|Adverse Event|0|||
27624282|NCT04305912|80466891|FG001|Second Intervention|Adverse Event|1|||
27624283|NCT00462943|80466892|FG000|Overall Study|Failure to achieve a response|5|||
27624284|NCT00462943|80466893|FG001|Overall Study|Failure to achieve a response|5|||
27624285|NCT00462943|80466894|FG002|Overall Study|Failure to achieve a response|1|||
27624286|NCT00462943|80466892|FG000|Overall Study|Adverse Event|6|||
27624287|NCT00462943|80466893|FG001|Overall Study|Adverse Event|4|||
27624288|NCT00462943|80466894|FG002|Overall Study|Adverse Event|1|||
27624289|NCT00462943|80466892|FG000|Overall Study|Protocol Violation|1|||
27624290|NCT00462943|80466893|FG001|Overall Study|Protocol Violation|0|||
27624291|NCT00462943|80466894|FG002|Overall Study|Protocol Violation|0|||
27624292|NCT00462943|80466892|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
27624293|NCT00462943|80466893|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
27624294|NCT00462943|80466894|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
27624295|NCT00462943|80466892|FG000|Overall Study|Disease Progression|15|||
27624296|NCT00462943|80466893|FG001|Overall Study|Disease Progression|15|||
27624297|NCT00462943|80466894|FG002|Overall Study|Disease Progression|9|||
27624298|NCT00462943|80466892|FG000|Overall Study|Death|5|||
27624299|NCT00462943|80466893|FG001|Overall Study|Death|2|||
27624300|NCT00462943|80466894|FG002|Overall Study|Death|7|||
27624301|NCT00462943|80466892|FG000|Overall Study|Stem Cell Transplant|1|||
27624302|NCT00462943|80466893|FG001|Overall Study|Stem Cell Transplant|1|||
27624303|NCT00462943|80466894|FG002|Overall Study|Stem Cell Transplant|0|||
27624304|NCT00462943|80466892|FG000|Overall Study|Bone Marrow Transplant|1|||
27624305|NCT00462943|80466893|FG001|Overall Study|Bone Marrow Transplant|0|||
27624306|NCT00462943|80466894|FG002|Overall Study|Bone Marrow Transplant|0|||
27624307|NCT00462943|80466892|FG000|Overall Study|Required Lymphocyte Infusion|1|||
27624308|NCT00462943|80466893|FG001|Overall Study|Required Lymphocyte Infusion|0|||
27624309|NCT00462943|80466894|FG002|Overall Study|Required Lymphocyte Infusion|0|||
27624310|NCT00462943|80466892|FG000|Overall Study|Transplant - not specified|1|||
27624311|NCT00462943|80466893|FG001|Overall Study|Transplant - not specified|0|||
27624312|NCT00462943|80466894|FG002|Overall Study|Transplant - not specified|1|||
27624313|NCT00462943|80466892|FG000|Overall Study|Physician Decision|1|||
27624314|NCT00462943|80466893|FG001|Overall Study|Physician Decision|0|||
27624315|NCT00462943|80466894|FG002|Overall Study|Physician Decision|0|||
27624316|NCT00462943|80466892|FG000|Overall Study|Withdrawal by Subject|0|||
27624317|NCT00462943|80466893|FG001|Overall Study|Withdrawal by Subject|1|||
27624318|NCT00462943|80466894|FG002|Overall Study|Withdrawal by Subject|0|||
27624319|NCT03115346|80466897|FG000|Overall Study|Did not have AAA surgery|28|||
27624320|NCT03115346|80466898|FG001|Overall Study|Did not have AAA surgery|15|||
27624321|NCT03115346|80466897|FG000|Overall Study|Death|3|||
27527694|NCT02011893|80126102|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
27527695|NCT02011893|80126103|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
27624322|NCT03115346|80466898|FG001|Overall Study|Death|1|||
27624323|NCT03115346|80466897|FG000|Overall Study|Withdrawal by Subject|0|||
27624324|NCT03115346|80466898|FG001|Overall Study|Withdrawal by Subject|3|||
27527696|NCT02011893|80126104|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
27527697|NCT02011893|80126102|FG000|Enrollment to Randomization|Screening Failure|29|||
27527698|NCT02011893|80126103|FG001|Enrollment to Randomization|Screening Failure|0|||
27624325|NCT03115346|80466897|FG000|Overall Study|Lost to Follow-up|0|||
27624326|NCT03115346|80466898|FG001|Overall Study|Lost to Follow-up|3|||
27624327|NCT02263885|80466899|FG000|Overall Study|Withdrawal by Subject|7|||
27624328|NCT02263885|80466899|FG000|Overall Study|Alternative Treatment|3|||
27624329|NCT00577629|80466903|FG000|Treatment Period|Death|1|||
27624330|NCT00577629|80466903|FG000|Long Term Follow-Up|Death|15|||
27624331|NCT00577629|80466903|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
27624332|NCT00577629|80466903|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
27733415|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27527699|NCT02011893|80126104|FG002|Enrollment to Randomization|Screening Failure|0|||
27527700|NCT02011893|80126102|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
27527701|NCT02011893|80126103|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
27527702|NCT02011893|80126104|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
27527703|NCT02011893|80126102|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
27527704|NCT02011893|80126103|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
27527705|NCT02011893|80126104|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
27624333|NCT00577629|80466903|FG000|Long Term Follow-Up|Physician Decision|1|||
27733416|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733417|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733418|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733419|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733420|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733421|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733422|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
27733423|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
27733424|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27733425|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
27733426|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
27856249|NCT02802631|81306703|FG006|Overall Study|Sponsor Decision|0|||
27856250|NCT02802631|81306704|FG007|Overall Study|Sponsor Decision|4|||
27856251|NCT00540293|81306707|FG000|Overall Study|Adverse event related to study drug|10|||
27856252|NCT00540293|81306707|FG000|Overall Study|Adverse event not related to study drug|7|||
27856253|NCT00540293|81306707|FG000|Overall Study|Withdrawal by Subject|6|||
27856254|NCT00540293|81306707|FG000|Overall Study|Protocol violation, & subject schedule|12|||
27856255|NCT01121666|81306708|FG000|Overall Study|Protocol Violation|29|||
27624334|NCT01648283|80466909|FG000|Overall Study|Withdrawal by Subject|14|||
27527706|NCT02011893|80126102|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
27527707|NCT02011893|80126103|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
27624335|NCT00079937|80466917|FG000|Overall Study|Adverse Event|2|||
27624336|NCT00079937|80466918|FG001|Overall Study|Adverse Event|1|||
27624337|NCT00079937|80466917|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27733427|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27733428|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27733429|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27856256|NCT01121666|81306709|FG001|Overall Study|Protocol Violation|10|||
27624338|NCT00079937|80466918|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27911585|NCT02493517|81513665|FG001|Overall Study|Adverse Event|2|||
27911586|NCT02493517|81513664|FG000|Overall Study|Missed study visit|0|||
27911587|NCT02493517|81513665|FG001|Overall Study|Missed study visit|1|||
27911588|NCT01051817|81513670|FG000|Overall Study|Adverse Event|0|||
27911589|NCT01051817|81513671|FG001|Overall Study|Adverse Event|2|||
27911590|NCT01051817|81513670|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
27911591|NCT01051817|81513671|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
27911592|NCT01051817|81513670|FG000|Overall Study|Withdrawal by Subject|3|||
27911593|NCT01051817|81513671|FG001|Overall Study|Withdrawal by Subject|5|||
27911594|NCT01051817|81513670|FG000|Overall Study|Protocol Violation|0|||
27911595|NCT01051817|81513671|FG001|Overall Study|Protocol Violation|1|||
27911596|NCT00522548|81513674|FG000|Overall Study|Adverse Event|2|||
27911597|NCT00522548|81513675|FG001|Overall Study|Adverse Event|2|||
27911598|NCT00522548|81513674|FG000|Overall Study|Withdrawal by Subject|0|||
27911599|NCT00522548|81513675|FG001|Overall Study|Withdrawal by Subject|2|||
27911600|NCT01152996|81513676|FG000|Overall Study|Withdrawal by Subject|142|||
27911601|NCT01152996|81513676|FG000|Overall Study|Adverse Event|115|||
27911602|NCT01152996|81513676|FG000|Overall Study|Lost to Follow-up|112|||
27911603|NCT01152996|81513676|FG000|Overall Study|Lack of Efficacy|68|||
27911604|NCT01152996|81513676|FG000|Overall Study|Noncompliance|41|||
27911605|NCT01152996|81513676|FG000|Overall Study|Other|36|||
27911606|NCT01152996|81513676|FG000|Overall Study|Protocol Violation|22|||
27911607|NCT01152996|81513676|FG000|Overall Study|Elevated liver enzymes|1|||
27911608|NCT01938846|81513679|FG000|Overall Study|Progressive disease|26|||
27911609|NCT01938846|81513680|FG001|Overall Study|Progressive disease|18|||
27911610|NCT01938846|81513681|FG002|Overall Study|Progressive disease|16|||
27911611|NCT01938846|81513679|FG000|Overall Study|Adverse Event|8|||
27911612|NCT01938846|81513680|FG001|Overall Study|Adverse Event|4|||
27911613|NCT01938846|81513681|FG002|Overall Study|Adverse Event|3|||
27911614|NCT01938846|81513679|FG000|Overall Study|Withdrawal by Subject|2|||
27911615|NCT01938846|81513680|FG001|Overall Study|Withdrawal by Subject|2|||
27911616|NCT01938846|81513681|FG002|Overall Study|Withdrawal by Subject|1|||
27911617|NCT01938846|81513679|FG000|Overall Study|Other than listed|5|||
27911618|NCT01938846|81513680|FG001|Overall Study|Other than listed|1|||
27911619|NCT01938846|81513681|FG002|Overall Study|Other than listed|4|||
27911620|NCT00048035|81513686|FG000|Core Period|Early Withdrawals|4|||
27911621|NCT00048035|81513687|FG001|Core Period|Early Withdrawals|2|||
27911622|NCT00048035|81513688|FG002|Core Period|Early Withdrawals|1|||
27911623|NCT00048035|81513689|FG003|Core Period|Early Withdrawals|1|||
27911624|NCT00048035|81513690|FG004|Core Period|Early Withdrawals|1|||
27911625|NCT00048035|81513691|FG005|Core Period|Early Withdrawals|1|||
27911626|NCT00048035|81513692|FG006|Core Period|Early Withdrawals|0|||
27911627|NCT00048035|81513693|FG007|Core Period|Early Withdrawals|0|||
27911628|NCT00048035|81513686|FG000|Extension Year 1|Early Withdrawals|0|||
27624339|NCT00079937|80466917|FG000|Overall Study|Subject no longer requires study drug|3|||
27624340|NCT00079937|80466918|FG001|Overall Study|Subject no longer requires study drug|0|||
27624341|NCT00079937|80466917|FG000|Overall Study|Protocol Violation|8|||
27733430|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27856257|NCT03188666|81306712|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
27624342|NCT00079937|80466918|FG001|Overall Study|Protocol Violation|6|||
27733431|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
27856258|NCT03188666|81306713|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
27856259|NCT03188666|81306714|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
27856260|NCT03188666|81306715|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
27856261|NCT03188666|81306712|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
27856262|NCT03188666|81306713|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
27856263|NCT03188666|81306714|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
27856264|NCT03188666|81306715|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
27856265|NCT03188666|81306712|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
27856266|NCT03188666|81306713|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
27856267|NCT03188666|81306714|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
27856268|NCT03188666|81306715|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
27856269|NCT03188666|81306712|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
27856270|NCT03188666|81306713|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
27856271|NCT03188666|81306714|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
27856272|NCT03188666|81306715|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
27856273|NCT01172821|81306716|FG000|Overall Study|Adverse Event|5|||
27856274|NCT01172821|81306717|FG001|Overall Study|Adverse Event|2|||
27911629|NCT00048035|81513687|FG001|Extension Year 1|Early Withdrawals|0|||
27911630|NCT00048035|81513688|FG002|Extension Year 1|Early Withdrawals|0|||
27911631|NCT00048035|81513689|FG003|Extension Year 1|Early Withdrawals|0|||
27911632|NCT00048035|81513690|FG004|Extension Year 1|Early Withdrawals|0|||
27911633|NCT00048035|81513691|FG005|Extension Year 1|Early Withdrawals|0|||
27911634|NCT00048035|81513692|FG006|Extension Year 1|Early Withdrawals|11|||
27911635|NCT00048035|81513693|FG007|Extension Year 1|Early Withdrawals|11|||
27911636|NCT00048035|81513686|FG000|Extension Year 2|Early Withdrawals|0|||
27733432|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
27733433|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27733434|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
27733435|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
27733436|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27733437|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27733438|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27733439|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27733440|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27733441|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
27624343|NCT00079937|80466917|FG000|Overall Study|Withdrawal by Subject|21|||
27624344|NCT00079937|80466918|FG001|Overall Study|Withdrawal by Subject|7|||
27624345|NCT00079937|80466917|FG000|Overall Study|Lost to Follow-up|12|||
27624346|NCT00079937|80466918|FG001|Overall Study|Lost to Follow-up|5|||
27624347|NCT00079937|80466917|FG000|Overall Study|Administrative problems|22|||
27624348|NCT00079937|80466918|FG001|Overall Study|Administrative problems|11|||
27624349|NCT01008748|80466919|FG000|Overall Study|Lost to Follow-up|80|||
27624350|NCT01008748|80466919|FG000|Overall Study|Other|1|||
27624351|NCT01838551|80466931|FG000|Overall Study|Adverse Event|16|||
27733442|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27733443|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
27733444|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
27733445|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27733446|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27733447|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27733448|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27733449|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27733450|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27733451|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733452|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
27733453|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733454|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733455|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733456|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733457|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733458|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733459|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
27733460|NCT01307423|80849930|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27856275|NCT01172821|81306718|FG002|Overall Study|Adverse Event|2|||
27911637|NCT00048035|81513687|FG001|Extension Year 2|Early Withdrawals|0|||
27911638|NCT00048035|81513688|FG002|Extension Year 2|Early Withdrawals|0|||
27911639|NCT00048035|81513689|FG003|Extension Year 2|Early Withdrawals|0|||
27527708|NCT02011893|80126104|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
27527709|NCT02011893|80126102|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
27527710|NCT02011893|80126103|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
27527711|NCT02011893|80126104|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
27527712|NCT02011893|80126102|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
27527713|NCT02011893|80126103|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
27527714|NCT02011893|80126104|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
27527715|NCT02497976|80126105|FG000|Overall Study|Withdrawal by Subject|2|||
27527716|NCT02497976|80126106|FG001|Overall Study|Withdrawal by Subject|0|||
27527717|NCT02497976|80126105|FG000|Overall Study|Moved out of area|0|||
27624352|NCT01838551|80466931|FG000|Overall Study|Death|1|||
27624353|NCT01838551|80466931|FG000|Overall Study|Lack of Efficacy|10|||
27527718|NCT02497976|80126106|FG001|Overall Study|Moved out of area|1|||
27733461|NCT01307423|80849931|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27733462|NCT01307423|80849932|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
27733463|NCT01307423|80849933|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27733464|NCT01307423|80849934|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27733465|NCT01307423|80849935|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27733466|NCT01307423|80849936|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
27733467|NCT01307423|80849937|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
27733468|NCT01307423|80849938|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
27856276|NCT01172821|81306719|FG003|Overall Study|Adverse Event|7|||
27856277|NCT01172821|81306716|FG000|Overall Study|Protocol Violation|0|||
27527719|NCT02992132|80126108|FG000|Overall Study|Adverse Event|4|||
27624354|NCT01838551|80466931|FG000|Overall Study|Physician Decision|4|||
27624355|NCT01838551|80466931|FG000|Overall Study|Withdrawal by Subject|10|||
27624356|NCT01838551|80466931|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
27856278|NCT01172821|81306717|FG001|Overall Study|Protocol Violation|2|||
27911640|NCT00048035|81513690|FG004|Extension Year 2|Early Withdrawals|0|||
27733469|NCT00603239|80849939|FG000|Overall Study|Adverse Event|4|||
27733470|NCT00603239|80849940|FG001|Overall Study|Adverse Event|1|||
27733471|NCT00603239|80849939|FG000|Overall Study|Entry criteria not met|0|||
27733472|NCT00603239|80849940|FG001|Overall Study|Entry criteria not met|1|||
27733473|NCT00603239|80849939|FG000|Overall Study|Loss of glucose control|3|||
27733474|NCT00603239|80849940|FG001|Overall Study|Loss of glucose control|0|||
27733475|NCT00603239|80849939|FG000|Overall Study|Lost to Follow-up|2|||
27733476|NCT00603239|80849940|FG001|Overall Study|Lost to Follow-up|1|||
27733477|NCT00603239|80849939|FG000|Overall Study|Physician Decision|2|||
27733478|NCT00603239|80849940|FG001|Overall Study|Physician Decision|0|||
27733479|NCT00603239|80849939|FG000|Overall Study|Protocol Violation|2|||
27733480|NCT00603239|80849940|FG001|Overall Study|Protocol Violation|0|||
27733481|NCT00603239|80849939|FG000|Overall Study|Subject decision|2|||
27733482|NCT00603239|80849940|FG001|Overall Study|Subject decision|1|||
27733483|NCT00749190|80849941|FG000|Overall Study|Adverse Event|0|||
27733484|NCT00749190|80849942|FG001|Overall Study|Adverse Event|2|||
27733485|NCT00749190|80849943|FG002|Overall Study|Adverse Event|0|||
27733486|NCT00749190|80849944|FG003|Overall Study|Adverse Event|4|||
27733487|NCT00749190|80849945|FG004|Overall Study|Adverse Event|0|||
27733488|NCT00749190|80849946|FG005|Overall Study|Adverse Event|3|||
27733489|NCT00749190|80849947|FG006|Overall Study|Adverse Event|0|||
27733490|NCT00749190|80849941|FG000|Overall Study|Lack of Efficacy|3|||
27733491|NCT00749190|80849942|FG001|Overall Study|Lack of Efficacy|1|||
27733492|NCT00749190|80849943|FG002|Overall Study|Lack of Efficacy|1|||
27733493|NCT00749190|80849944|FG003|Overall Study|Lack of Efficacy|0|||
27733494|NCT00749190|80849945|FG004|Overall Study|Lack of Efficacy|0|||
27733495|NCT00749190|80849946|FG005|Overall Study|Lack of Efficacy|1|||
27733496|NCT00749190|80849947|FG006|Overall Study|Lack of Efficacy|0|||
27733497|NCT00749190|80849941|FG000|Overall Study|Withdrawal by Subject|2|||
27733498|NCT00749190|80849942|FG001|Overall Study|Withdrawal by Subject|1|||
27733499|NCT00749190|80849943|FG002|Overall Study|Withdrawal by Subject|0|||
27733500|NCT00749190|80849944|FG003|Overall Study|Withdrawal by Subject|0|||
27733501|NCT00749190|80849945|FG004|Overall Study|Withdrawal by Subject|0|||
27733502|NCT00749190|80849946|FG005|Overall Study|Withdrawal by Subject|1|||
27733503|NCT00749190|80849947|FG006|Overall Study|Withdrawal by Subject|0|||
27733504|NCT00749190|80849941|FG000|Overall Study|Protocol Violation|0|||
27733505|NCT00749190|80849942|FG001|Overall Study|Protocol Violation|1|||
27733506|NCT00749190|80849943|FG002|Overall Study|Protocol Violation|0|||
27733507|NCT00749190|80849944|FG003|Overall Study|Protocol Violation|0|||
27733508|NCT00749190|80849945|FG004|Overall Study|Protocol Violation|0|||
27733509|NCT00749190|80849946|FG005|Overall Study|Protocol Violation|0|||
27733510|NCT00749190|80849947|FG006|Overall Study|Protocol Violation|1|||
27733511|NCT00749190|80849941|FG000|Overall Study|Other reason not defined above|0|||
27733512|NCT00749190|80849942|FG001|Overall Study|Other reason not defined above|0|||
27733513|NCT00749190|80849943|FG002|Overall Study|Other reason not defined above|0|||
27733514|NCT00749190|80849944|FG003|Overall Study|Other reason not defined above|1|||
27733515|NCT00749190|80849945|FG004|Overall Study|Other reason not defined above|0|||
27733516|NCT00749190|80849946|FG005|Overall Study|Other reason not defined above|0|||
27733517|NCT00749190|80849947|FG006|Overall Study|Other reason not defined above|0|||
27733518|NCT00833092|80849948|FG000|Overall Study|Withdrawal by Subject|2|||
27733519|NCT00833092|80849949|FG001|Overall Study|Withdrawal by Subject|3|||
27733520|NCT00833092|80849948|FG000|Overall Study|Protocol Violation|2|||
27733521|NCT00833092|80849949|FG001|Overall Study|Protocol Violation|1|||
27733522|NCT00833092|80849948|FG000|Overall Study|Diarrhea|0|||
27733523|NCT00833092|80849949|FG001|Overall Study|Diarrhea|2|||
27733524|NCT00833092|80849948|FG000|Overall Study|constipation|0|||
27527720|NCT02992132|80126109|FG001|Overall Study|Adverse Event|1|||
27527721|NCT02992132|80126110|FG002|Overall Study|Adverse Event|3|||
27527722|NCT02992132|80126108|FG000|Overall Study|Lack of Efficacy|2|||
27527723|NCT02992132|80126109|FG001|Overall Study|Lack of Efficacy|0|||
27527724|NCT02992132|80126110|FG002|Overall Study|Lack of Efficacy|0|||
27527725|NCT02992132|80126108|FG000|Overall Study|Non-compliance with study drug|2|||
27624357|NCT00828945|80466932|FG000|Overall Study|Death|4|||
27733525|NCT00833092|80849949|FG001|Overall Study|constipation|1|||
27733526|NCT00781365|80849950|FG000|Overall Study|Withdrawal by Subject|13|||
27733527|NCT00781365|80849951|FG001|Overall Study|Withdrawal by Subject|8|||
27733528|NCT00781365|80849950|FG000|Overall Study|Did Not Attend Visit|20|||
27733529|NCT00781365|80849951|FG001|Overall Study|Did Not Attend Visit|28|||
27733530|NCT00781365|80849950|FG000|Overall Study|Language barrier|1|||
27733531|NCT00781365|80849951|FG001|Overall Study|Language barrier|0|||
27733532|NCT02722044|80849954|FG000|Overall Study|Adverse Event|2|||
27733533|NCT02722044|80849954|FG000|Overall Study|Physician Decision|1|||
27733534|NCT02722044|80849954|FG000|Overall Study|Withdrawal by Subject|1|||
27624358|NCT00828945|80466932|FG000|Overall Study|Participant was missing|1|||
27624359|NCT00828945|80466932|FG000|Overall Study|Other|36|||
27527726|NCT02992132|80126109|FG001|Overall Study|Non-compliance with study drug|0|||
27733535|NCT02722044|80849954|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
27733536|NCT04325503|80849955|FG000|Overall Study|Withdrawal by Subject|1|||
27733537|NCT04325503|80849955|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
27733538|NCT01237951|80849958|FG000|Overall Study|Death|1|||
27733539|NCT00087438|80849959|FG000|Overall Study|Ineligible / No protocol treatment|4|||
27733540|NCT03213665|80849960|FG000|Overall Study|Adverse Event|1|||
27733541|NCT03213665|80849960|FG000|Overall Study|Physician Decision|2|||
27733542|NCT03213665|80849960|FG000|Overall Study|Withdrawal by Subject|3|||
27733543|NCT03213665|80849960|FG000|Overall Study|Progressive Disease|13|||
27733544|NCT01287104|80849961|FG000|Overall Study|Patient developed progressive disease|1|||
27733545|NCT01287104|80849962|FG001|Overall Study|Patient developed progressive disease|1|||
27733546|NCT01287104|80849963|FG002|Overall Study|Patient developed progressive disease|3|||
27733547|NCT01287104|80849964|FG003|Overall Study|Patient developed progressive disease|2|||
27733548|NCT01287104|80849961|FG000|Overall Study|Donor anaphylaxis|0|||
27733549|NCT01287104|80849962|FG001|Overall Study|Donor anaphylaxis|1|||
27527727|NCT02992132|80126110|FG002|Overall Study|Non-compliance with study drug|0|||
27733550|NCT01287104|80849963|FG002|Overall Study|Donor anaphylaxis|0|||
27733551|NCT01287104|80849964|FG003|Overall Study|Donor anaphylaxis|1|||
27733552|NCT01287104|80849961|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
27733553|NCT01287104|80849962|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
27733554|NCT01287104|80849963|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
27733555|NCT01287104|80849964|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
27733556|NCT01287104|80849961|FG000|Overall Study|Low donor chimerism|0|||
27733557|NCT01287104|80849962|FG001|Overall Study|Low donor chimerism|1|||
27733558|NCT01287104|80849963|FG002|Overall Study|Low donor chimerism|0|||
27733559|NCT01287104|80849964|FG003|Overall Study|Low donor chimerism|0|||
27733560|NCT01287104|80849961|FG000|Overall Study|NK cells did not meet release criteria|0|||
27733561|NCT01287104|80849962|FG001|Overall Study|NK cells did not meet release criteria|1|||
27733562|NCT01287104|80849963|FG002|Overall Study|NK cells did not meet release criteria|0|||
27733563|NCT01287104|80849964|FG003|Overall Study|NK cells did not meet release criteria|0|||
27733564|NCT01990261|80849965|FG000|Overall Study|Death Before Treatment Start|2|||
27733565|NCT01990261|80849965|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
27733566|NCT01990261|80849965|FG000|Overall Study|Death From other Causes|1|||
27733567|NCT01990261|80849965|FG000|Overall Study|Disease Progression (PD)|8|||
27733568|NCT01990261|80849965|FG000|Overall Study|PD Before Treatment Start|1|||
27733569|NCT01990261|80849965|FG000|Overall Study|Dossier not Approved|1|||
27733570|NCT01990261|80849965|FG000|Overall Study|Lost to Follow-up|2|||
27733571|NCT02485717|80849968|FG000|Overall Study|Lost to Follow-up|6|||
27733572|NCT02485717|80849969|FG001|Overall Study|Lost to Follow-up|0|||
27733573|NCT02485717|80849970|FG002|Overall Study|Lost to Follow-up|0|||
27733574|NCT02485717|80849968|FG000|Overall Study|Withdrawal by Subject|0|||
27733575|NCT02485717|80849969|FG001|Overall Study|Withdrawal by Subject|0|||
27733576|NCT02485717|80849970|FG002|Overall Study|Withdrawal by Subject|1|||
27733577|NCT02485717|80849968|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
27733578|NCT02485717|80849969|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
27733579|NCT02485717|80849970|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
27733580|NCT02485717|80849968|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
27733581|NCT02485717|80849969|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
27733582|NCT02485717|80849970|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
27733583|NCT00666562|80849973|FG000|Overall Study|Withdrawal by Subject|0|||
27733584|NCT00666562|80849974|FG001|Overall Study|Withdrawal by Subject|1|||
27733585|NCT00666562|80849975|FG002|Overall Study|Withdrawal by Subject|0|||
27733586|NCT00666562|80849973|FG000|Overall Study|Concomitant Medication|0|||
27733587|NCT00666562|80849974|FG001|Overall Study|Concomitant Medication|1|||
27733588|NCT00666562|80849975|FG002|Overall Study|Concomitant Medication|0|||
27733589|NCT02115308|80849978|FG000|Overall Study|Safety Screening|2|||
27733590|NCT02115308|80849979|FG001|Overall Study|Safety Screening|2|||
27733591|NCT00880750|80849980|FG000|First Intervention|Adverse Event|1|||
27733592|NCT00880750|80849981|FG001|First Intervention|Adverse Event|0|||
27733593|NCT00880750|80849980|FG000|First Intervention|Unable to collect urine|4|||
27733594|NCT00880750|80849981|FG001|First Intervention|Unable to collect urine|0|||
27733595|NCT00880750|80849980|FG000|First Intervention|Non-compliance with meals|0|||
27733596|NCT00880750|80849981|FG001|First Intervention|Non-compliance with meals|1|||
27733597|NCT00880750|80849980|FG000|First Intervention|Withdrawal by Subject|2|||
27733598|NCT00880750|80849981|FG001|First Intervention|Withdrawal by Subject|0|||
27911641|NCT00048035|81513691|FG005|Extension Year 2|Early Withdrawals|0|||
27733599|NCT00880750|80849980|FG000|First Intervention|Lost to Follow-up|2|||
27733600|NCT00880750|80849981|FG001|First Intervention|Lost to Follow-up|0|||
27733601|NCT00880750|80849980|FG000|Second Intervention|Withdrawal by Subject|2|||
27733602|NCT00880750|80849981|FG001|Second Intervention|Withdrawal by Subject|2|||
27733603|NCT00880750|80849980|FG000|Second Intervention|Protocol Violation|1|||
27733604|NCT00880750|80849981|FG001|Second Intervention|Protocol Violation|0|||
27733605|NCT00880750|80849980|FG000|Second Intervention|Unable to collect urine|1|||
27733606|NCT00880750|80849981|FG001|Second Intervention|Unable to collect urine|0|||
27733607|NCT01361711|80849982|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
27733608|NCT01361711|80849982|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
27733609|NCT01361711|80849982|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
27733610|NCT01361711|80849982|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
27733611|NCT01361711|80849982|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
27733612|NCT01361711|80849982|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
27733613|NCT01361711|80849982|FG000|Completed Week 18 of Treatment|Other|9|||
27733614|NCT01361711|80849982|FG000|10 Year Follow-up|Still in follow-up|22|||
27733615|NCT01361711|80849982|FG000|10 Year Follow-up|Death|7|||
27733616|NCT01361711|80849982|FG000|10 Year Follow-up|Developed new cancer|1|||
27733617|NCT01361711|80849982|FG000|10 Year Follow-up|Lost to Follow-up|2|||
27733618|NCT01361711|80849982|FG000|10 Year Follow-up|New treatment started|6|||
27733619|NCT01361711|80849982|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
27733620|NCT01361711|80849982|FG000|10 Year Follow-up|Progressive Disease|1|||
27733621|NCT02041962|80849988|FG000|Overall Study|Lost Aetna Coverage|43|||
27733622|NCT02041962|80849989|FG001|Overall Study|Lost Aetna Coverage|40|||
27733623|NCT02041962|80849988|FG000|Overall Study|Death|1|||
27733624|NCT02041962|80849989|FG001|Overall Study|Death|1|||
27733625|NCT02041962|80849988|FG000|Overall Study|Lost to Follow-up|37|||
27733626|NCT02041962|80849989|FG001|Overall Study|Lost to Follow-up|32|||
27733627|NCT02041962|80849988|FG000|Overall Study|Withdrawal by Subject|0|||
27733628|NCT02041962|80849989|FG001|Overall Study|Withdrawal by Subject|11|||
27733629|NCT00158184|80849990|FG000|Overall Study|personal issues|3|||
27733630|NCT00158184|80849991|FG001|Overall Study|personal issues|1|||
27733631|NCT00158184|80849990|FG000|Overall Study|failed for follow unit/study rules|2|||
27733632|NCT00158184|80849991|FG001|Overall Study|failed for follow unit/study rules|0|||
27733633|NCT00158184|80849990|FG000|Overall Study|Adverse Event|1|||
27733634|NCT00158184|80849991|FG001|Overall Study|Adverse Event|1|||
27733635|NCT03041311|80849992|FG000|Overall Study|Death|39|||
27733636|NCT03041311|80849993|FG001|Overall Study|Death|42|||
27733637|NCT03041311|80849992|FG000|Overall Study|Lost to Follow-up|0|||
27733638|NCT03041311|80849993|FG001|Overall Study|Lost to Follow-up|1|||
27733639|NCT03041311|80849992|FG000|Overall Study|Withdrawal by Subject|8|||
27733640|NCT03041311|80849993|FG001|Overall Study|Withdrawal by Subject|5|||
27733641|NCT03041311|80849992|FG000|Overall Study|Sponsor Terminated Study|2|||
27733642|NCT03041311|80849993|FG001|Overall Study|Sponsor Terminated Study|4|||
27733643|NCT03041311|80849992|FG000|Overall Study|Disease Progression|3|||
27733644|NCT03041311|80849993|FG001|Overall Study|Disease Progression|1|||
27733645|NCT03041311|80849992|FG000|Overall Study|Randomized in error, did not receive drug|2|||
27733646|NCT03041311|80849993|FG001|Overall Study|Randomized in error, did not receive drug|0|||
27733647|NCT02318095|80849994|FG000|Overall Study|Adverse Event|1|||
27733648|NCT02013544|80849997|FG000|Overall Study|Adverse Event|5|||
27733649|NCT02013544|80849998|FG001|Overall Study|Adverse Event|5|||
27733650|NCT02013544|80849997|FG000|Overall Study|Lost to Follow-up|2|||
27733651|NCT02013544|80849998|FG001|Overall Study|Lost to Follow-up|3|||
27733652|NCT02013544|80849997|FG000|Overall Study|Withdrawal by Subject|2|||
27733653|NCT02013544|80849998|FG001|Overall Study|Withdrawal by Subject|8|||
27733654|NCT02013544|80849997|FG000|Overall Study|Physician Decision|0|||
27733655|NCT02013544|80849998|FG001|Overall Study|Physician Decision|1|||
27733656|NCT02013544|80849997|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
27733657|NCT02013544|80849998|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
27733658|NCT02537678|80850006|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
27733659|NCT02537678|80850007|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
27733660|NCT02537678|80850006|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
27733661|NCT02537678|80850007|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
27733662|NCT02537678|80850006|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
27733663|NCT02537678|80850007|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
27733664|NCT02537678|80850006|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
27733665|NCT02537678|80850007|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
27733666|NCT02537678|80850006|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
27733667|NCT02537678|80850007|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
27733668|NCT02537678|80850006|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
27733669|NCT02537678|80850007|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
27733670|NCT02537678|80850006|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
27733671|NCT02537678|80850007|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
27733672|NCT02698189|80850008|FG000|Overall Study|Physician Decision|3|||
27733673|NCT02698189|80850009|FG001|Overall Study|Physician Decision|0|||
27733674|NCT02698189|80850008|FG000|Overall Study|Progressive disease|0|||
27733675|NCT02698189|80850009|FG001|Overall Study|Progressive disease|5|||
27733676|NCT02698189|80850008|FG000|Overall Study|Study terminated by sponsor|0|||
27733677|NCT02698189|80850009|FG001|Overall Study|Study terminated by sponsor|1|||
27733678|NCT01974817|80850022|FG000|Overall Study|Death|4|||
27527728|NCT02992132|80126108|FG000|Overall Study|Progressive disease|1|||
27733679|NCT01974817|80850022|FG000|Overall Study|Lost to Follow-up|2|||
27733680|NCT01974817|80850022|FG000|Overall Study|Protocol Violation|2|||
27733681|NCT03304522|80850023|FG000|Overall Study|Adverse Event|0|||
27733682|NCT03304522|80850024|FG001|Overall Study|Adverse Event|4|||
27733683|NCT03304522|80850023|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
27733684|NCT03304522|80850024|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
27733685|NCT03304522|80850023|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
27733686|NCT03304522|80850024|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
27733687|NCT03304522|80850023|FG000|Overall Study|Other|0|||
27733688|NCT03304522|80850024|FG001|Overall Study|Other|1|||
27733689|NCT00927485|80850025|FG000|Overall Study|Adverse Event|4|||
27733690|NCT00927485|80850026|FG001|Overall Study|Adverse Event|2|||
27733691|NCT00927485|80850025|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
27733692|NCT00927485|80850026|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
27733693|NCT00104871|80850031|FG000|Overall Study|Not evaluable|1|||
27733694|NCT02612909|80850032|FG000|Phase 2|Withdrawal by Subject|2|||
27733695|NCT02612909|80850033|FG001|Phase 2|Withdrawal by Subject|5|||
27733696|NCT02612909|80850034|FG002|Phase 2|Withdrawal by Subject|0|||
27733697|NCT02612909|80850035|FG003|Phase 2|Withdrawal by Subject|0|||
27733698|NCT02612909|80850036|FG004|Phase 2|Withdrawal by Subject|0|||
27733699|NCT02612909|80850032|FG000|Phase 2|Pregnancy|0|||
27733700|NCT02612909|80850033|FG001|Phase 2|Pregnancy|0|||
27733701|NCT02612909|80850034|FG002|Phase 2|Pregnancy|1|||
27733702|NCT02612909|80850035|FG003|Phase 2|Pregnancy|0|||
27733703|NCT02612909|80850036|FG004|Phase 2|Pregnancy|0|||
27733704|NCT02612909|80850032|FG000|Phase 3|Withdrawal by Subject|0|||
27733705|NCT02612909|80850033|FG001|Phase 3|Withdrawal by Subject|0|||
27733706|NCT02612909|80850034|FG002|Phase 3|Withdrawal by Subject|0|||
27733707|NCT02612909|80850035|FG003|Phase 3|Withdrawal by Subject|1|||
27733708|NCT02612909|80850036|FG004|Phase 3|Withdrawal by Subject|0|||
27733709|NCT03430310|80850039|FG000|Overall Study|Protocol Violation|2|||
27733710|NCT03430310|80850040|FG001|Overall Study|Protocol Violation|0|||
27733711|NCT03430310|80850039|FG000|Overall Study|Withdrawal by Subject|3|||
27733712|NCT03430310|80850040|FG001|Overall Study|Withdrawal by Subject|2|||
27733713|NCT03430310|80850039|FG000|Overall Study|COVID shutdown March 2020|0|||
27733714|NCT03430310|80850040|FG001|Overall Study|COVID shutdown March 2020|1|||
27733715|NCT01475734|80850045|FG000|Overall Study|Withdrawal by Subject|1|||
27733716|NCT01475734|80850046|FG001|Overall Study|Withdrawal by Subject|0|||
27733717|NCT01475734|80850045|FG000|Overall Study|Protocol Violation|1|||
27733718|NCT01475734|80850046|FG001|Overall Study|Protocol Violation|0|||
27733719|NCT01475734|80850045|FG000|Overall Study|Physician Decision|0|||
27733720|NCT01475734|80850046|FG001|Overall Study|Physician Decision|1|||
27733721|NCT02498821|80850047|FG000|Overall Study|Screen failure|3|||
27733722|NCT02498821|80850048|FG001|Overall Study|Screen failure|5|||
27733723|NCT03593915|80850051|FG000|Overall Study|Adverse Event|0|||
27733724|NCT03593915|80850052|FG001|Overall Study|Adverse Event|0|||
27733725|NCT03593915|80850053|FG002|Overall Study|Adverse Event|0|||
27733726|NCT03593915|80850054|FG003|Overall Study|Adverse Event|1|||
27733727|NCT03593915|80850055|FG004|Overall Study|Adverse Event|0|||
27733728|NCT03593915|80850056|FG005|Overall Study|Adverse Event|0|||
27733729|NCT03593915|80850051|FG000|Overall Study|Physician Decision|0|||
27733730|NCT03593915|80850052|FG001|Overall Study|Physician Decision|0|||
27733731|NCT03593915|80850053|FG002|Overall Study|Physician Decision|0|||
27733732|NCT03593915|80850054|FG003|Overall Study|Physician Decision|0|||
27733733|NCT03593915|80850055|FG004|Overall Study|Physician Decision|0|||
27733734|NCT03593915|80850056|FG005|Overall Study|Physician Decision|1|||
27733735|NCT00749203|80850057|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
27733736|NCT00749203|80850058|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
27733737|NCT00749203|80850057|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
27733738|NCT00749203|80850058|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
27733739|NCT00749203|80850057|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
27733740|NCT00749203|80850058|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
27733741|NCT00749203|80850057|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
27733742|NCT00749203|80850058|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
27733743|NCT00749203|80850057|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
27733744|NCT00749203|80850058|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
27733745|NCT00749203|80850057|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
27733746|NCT00749203|80850058|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
27733747|NCT00778830|80850061|FG000|Overall Study|Ongoing at data cut-off|0|||
27733748|NCT00778830|80850062|FG001|Overall Study|Ongoing at data cut-off|1|||
27733749|NCT03521791|80850063|FG000|Overall Study|Protocol Violation|7|||
27733750|NCT03521791|80850064|FG001|Overall Study|Protocol Violation|17|||
27733751|NCT00828451|80850065|FG000|Overall Study|Death|2|||
27733752|NCT00828451|80850065|FG000|Overall Study|Lack of intravenous line|7|||
27733753|NCT00828451|80850065|FG000|Overall Study|Withdrawal by Subject|1|||
27733754|NCT00828451|80850065|FG000|Overall Study|Deterioration in clinical status|1|||
27527729|NCT02992132|80126109|FG001|Overall Study|Progressive disease|0|||
27527730|NCT02992132|80126110|FG002|Overall Study|Progressive disease|0|||
27527731|NCT02992132|80126108|FG000|Overall Study|Protocol Violation|2|||
27527732|NCT02992132|80126109|FG001|Overall Study|Protocol Violation|2|||
27527733|NCT02992132|80126110|FG002|Overall Study|Protocol Violation|0|||
27527734|NCT02992132|80126108|FG000|Overall Study|Caregiver withdrew consent|2|||
27527735|NCT02992132|80126109|FG001|Overall Study|Caregiver withdrew consent|3|||
27527736|NCT02992132|80126110|FG002|Overall Study|Caregiver withdrew consent|2|||
27527737|NCT02992132|80126108|FG000|Overall Study|Withdrawal by Subject|0|||
27527738|NCT02992132|80126109|FG001|Overall Study|Withdrawal by Subject|2|||
27527739|NCT02992132|80126110|FG002|Overall Study|Withdrawal by Subject|1|||
27527740|NCT02992132|80126108|FG000|Overall Study|Physician Decision|0|||
27527741|NCT02992132|80126109|FG001|Overall Study|Physician Decision|0|||
27527742|NCT02992132|80126110|FG002|Overall Study|Physician Decision|1|||
27527743|NCT02536833|80126111|FG000|Overall Study|Discontinued Before Treatment|0|||
27527744|NCT02536833|80126112|FG001|Overall Study|Discontinued Before Treatment|0|||
27527745|NCT02536833|80126113|FG002|Overall Study|Discontinued Before Treatment|1|||
27527746|NCT02536833|80126114|FG003|Overall Study|Discontinued Before Treatment|2|||
27527747|NCT02536833|80126111|FG000|Overall Study|Adverse Event|1|||
27527748|NCT02536833|80126112|FG001|Overall Study|Adverse Event|3|||
27527749|NCT02536833|80126113|FG002|Overall Study|Adverse Event|4|||
27527750|NCT02536833|80126114|FG003|Overall Study|Adverse Event|1|||
27527751|NCT02536833|80126111|FG000|Overall Study|Lost to Follow-up|2|||
27527752|NCT02536833|80126112|FG001|Overall Study|Lost to Follow-up|1|||
27527753|NCT02536833|80126113|FG002|Overall Study|Lost to Follow-up|2|||
27527754|NCT02536833|80126114|FG003|Overall Study|Lost to Follow-up|2|||
27527755|NCT02536833|80126111|FG000|Overall Study|Physician Decision|0|||
27527756|NCT02536833|80126112|FG001|Overall Study|Physician Decision|0|||
27527757|NCT02536833|80126113|FG002|Overall Study|Physician Decision|0|||
27527758|NCT02536833|80126114|FG003|Overall Study|Physician Decision|1|||
27527759|NCT02536833|80126111|FG000|Overall Study|Site Terminated by Sponsor|2|||
27527760|NCT02536833|80126112|FG001|Overall Study|Site Terminated by Sponsor|2|||
27527761|NCT02536833|80126113|FG002|Overall Study|Site Terminated by Sponsor|2|||
27527762|NCT02536833|80126114|FG003|Overall Study|Site Terminated by Sponsor|2|||
27527763|NCT02536833|80126111|FG000|Overall Study|Subject Non-Compliance|0|||
27527764|NCT02536833|80126112|FG001|Overall Study|Subject Non-Compliance|1|||
27527765|NCT02536833|80126113|FG002|Overall Study|Subject Non-Compliance|1|||
27527766|NCT02536833|80126114|FG003|Overall Study|Subject Non-Compliance|0|||
27527767|NCT02536833|80126111|FG000|Overall Study|Withdrawal by Subject|4|||
27527768|NCT02536833|80126112|FG001|Overall Study|Withdrawal by Subject|3|||
27527769|NCT02536833|80126113|FG002|Overall Study|Withdrawal by Subject|5|||
27527770|NCT02536833|80126114|FG003|Overall Study|Withdrawal by Subject|11|||
27527771|NCT02117427|80126115|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
27527772|NCT02117427|80126116|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
27527773|NCT02117427|80126117|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
27527774|NCT02117427|80126115|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
27527775|NCT02117427|80126116|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
27527776|NCT02117427|80126117|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
27527777|NCT02117427|80126115|FG000|Overall Study|Physician Decision|0|||
27527778|NCT02117427|80126116|FG001|Overall Study|Physician Decision|2|||
27527779|NCT02117427|80126117|FG002|Overall Study|Physician Decision|0|||
27527780|NCT02117427|80126115|FG000|Overall Study|No longer meets inclusion criteria|0|||
27527781|NCT02117427|80126116|FG001|Overall Study|No longer meets inclusion criteria|1|||
27527782|NCT02117427|80126117|FG002|Overall Study|No longer meets inclusion criteria|0|||
27527783|NCT02117427|80126115|FG000|Overall Study|Death|0|||
27856279|NCT01172821|81306718|FG002|Overall Study|Protocol Violation|1|||
27856280|NCT01172821|81306719|FG003|Overall Study|Protocol Violation|2|||
27856281|NCT01172821|81306716|FG000|Overall Study|Lost to Follow-up|4|||
27856282|NCT01172821|81306717|FG001|Overall Study|Lost to Follow-up|1|||
27856283|NCT01172821|81306718|FG002|Overall Study|Lost to Follow-up|2|||
27856284|NCT01172821|81306719|FG003|Overall Study|Lost to Follow-up|2|||
27856285|NCT01172821|81306716|FG000|Overall Study|Withdrawal by Subject|2|||
27856286|NCT01172821|81306717|FG001|Overall Study|Withdrawal by Subject|3|||
27527784|NCT02117427|80126116|FG001|Overall Study|Death|1|||
27527785|NCT02117427|80126117|FG002|Overall Study|Death|0|||
27527786|NCT04389970|80126118|FG000|Overall Study|Lost to Follow-up|1|||
27527787|NCT00718081|80126119|FG000|Overall Study|Adverse Event|0|||
27527788|NCT00718081|80126120|FG001|Overall Study|Adverse Event|1|||
27527789|NCT00718081|80126121|FG002|Overall Study|Adverse Event|0|||
27527790|NCT00718081|80126119|FG000|Overall Study|Lack of Efficacy|7|||
27527791|NCT00718081|80126120|FG001|Overall Study|Lack of Efficacy|3|||
27527792|NCT00718081|80126121|FG002|Overall Study|Lack of Efficacy|21|||
27527793|NCT03112590|80126122|FG000|Overall Study|Adverse Event|0|||
27527794|NCT03112590|80126123|FG001|Overall Study|Adverse Event|1|||
27527795|NCT03112590|80126124|FG002|Overall Study|Adverse Event|0|||
27527796|NCT01172275|80126132|FG000|Overall Study|Lost to Follow-up|1|||
27527797|NCT01172275|80126133|FG001|Overall Study|Lost to Follow-up|0|||
27527798|NCT01172275|80126132|FG000|Overall Study|Protocol Violation|1|||
27527799|NCT01172275|80126133|FG001|Overall Study|Protocol Violation|0|||
27527800|NCT02862600|80126134|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
27527801|NCT02862600|80126134|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
27527802|NCT02862600|80126134|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
27527803|NCT02862600|80126134|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
27527804|NCT01475071|80126141|FG000|Overall Study|Physician Decision|1|||
27527805|NCT01475071|80126141|FG000|Overall Study|Withdrawal by Subject|6|||
27527806|NCT01475071|80126141|FG000|Overall Study|Lost to Follow-up|1|||
27527807|NCT00371761|80126142|FG000|Overall Study|Adverse Event|1|||
27527808|NCT00371761|80126143|FG001|Overall Study|Adverse Event|1|||
27527809|NCT00371761|80126142|FG000|Overall Study|Withdrawal by Subject|1|||
27527810|NCT00371761|80126143|FG001|Overall Study|Withdrawal by Subject|3|||
27527811|NCT00371761|80126142|FG000|Overall Study|Investigator Judgment|2|||
27527812|NCT00371761|80126143|FG001|Overall Study|Investigator Judgment|3|||
27527813|NCT00371761|80126142|FG000|Overall Study|Study termination|4|||
27527814|NCT00371761|80126143|FG001|Overall Study|Study termination|3|||
27527815|NCT01721577|80126144|FG000|Overall Study|Lack of Efficacy|1|||
27527816|NCT01721577|80126145|FG001|Overall Study|Lack of Efficacy|0|||
27527817|NCT01721577|80126144|FG000|Overall Study|Death|1|||
27527818|NCT01721577|80126145|FG001|Overall Study|Death|0|||
27527819|NCT01721577|80126144|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
27527820|NCT01721577|80126145|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
27527821|NCT01721577|80126144|FG000|Overall Study|Adverse Event|0|||
27527822|NCT01721577|80126145|FG001|Overall Study|Adverse Event|2|||
27527823|NCT01007253|80126146|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
27527824|NCT01007253|80126147|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
27527825|NCT01007253|80126148|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
27527826|NCT01007253|80126149|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
27527827|NCT02021656|80126150|FG000|Overall Study|Adverse Event|1|||
27527828|NCT02021656|80126150|FG000|Overall Study|Lack of Efficacy|2|||
27527829|NCT02021656|80126150|FG000|Overall Study|Lost to Follow-up|1|||
27527830|NCT02021656|80126150|FG000|Overall Study|Withdrew Consent|2|||
27527831|NCT01673282|80126151|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
27527832|NCT01673282|80126152|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
27527833|NCT01673282|80126151|FG000|Overall Study|Lack of Efficacy|9|||
27527834|NCT01673282|80126152|FG001|Overall Study|Lack of Efficacy|2|||
27527835|NCT01673282|80126151|FG000|Overall Study|Lost to Follow-up|11|||
27527836|NCT01673282|80126152|FG001|Overall Study|Lost to Follow-up|10|||
27527837|NCT01673282|80126151|FG000|Overall Study|Withdrawal by Subject|3|||
27527838|NCT01673282|80126152|FG001|Overall Study|Withdrawal by Subject|3|||
27527839|NCT01673282|80126151|FG000|Overall Study|Other|1|||
27527840|NCT01673282|80126152|FG001|Overall Study|Other|6|||
27527841|NCT00730028|80126153|FG000|Overall Study|Adverse Event|23|||
27527842|NCT00730028|80126154|FG001|Overall Study|Adverse Event|26|||
27527843|NCT00730028|80126155|FG002|Overall Study|Adverse Event|16|||
27527844|NCT00730028|80126156|FG003|Overall Study|Adverse Event|20|||
27527845|NCT00730028|80126157|FG004|Overall Study|Adverse Event|43|||
27527846|NCT00730028|80126153|FG000|Overall Study|Lost to Follow-up|13|||
27527847|NCT00730028|80126154|FG001|Overall Study|Lost to Follow-up|26|||
27527848|NCT00730028|80126155|FG002|Overall Study|Lost to Follow-up|22|||
27527849|NCT00730028|80126156|FG003|Overall Study|Lost to Follow-up|26|||
27527850|NCT00730028|80126157|FG004|Overall Study|Lost to Follow-up|25|||
27527851|NCT00730028|80126153|FG000|Overall Study|Protocol Violation|6|||
27527852|NCT00730028|80126154|FG001|Overall Study|Protocol Violation|1|||
27527853|NCT00730028|80126155|FG002|Overall Study|Protocol Violation|1|||
27527854|NCT00730028|80126156|FG003|Overall Study|Protocol Violation|2|||
27527855|NCT00730028|80126157|FG004|Overall Study|Protocol Violation|0|||
27527856|NCT00730028|80126153|FG000|Overall Study|Withdrawal by Subject|9|||
27527857|NCT00730028|80126154|FG001|Overall Study|Withdrawal by Subject|5|||
27527858|NCT00730028|80126155|FG002|Overall Study|Withdrawal by Subject|4|||
27624360|NCT02042443|80466933|FG000|Overall Study|Adverse Event|2|||
27733755|NCT04672083|80850068|FG000|Overall Study|Lost to Follow-up|1|||
27733756|NCT04672083|80850069|FG001|Overall Study|Lost to Follow-up|0|||
27527859|NCT00730028|80126156|FG003|Overall Study|Withdrawal by Subject|5|||
27527860|NCT00730028|80126157|FG004|Overall Study|Withdrawal by Subject|9|||
27527861|NCT00730028|80126153|FG000|Overall Study|Physician Decision|3|||
27527862|NCT00730028|80126154|FG001|Overall Study|Physician Decision|3|||
27527863|NCT00730028|80126155|FG002|Overall Study|Physician Decision|2|||
27527864|NCT00730028|80126156|FG003|Overall Study|Physician Decision|3|||
27527865|NCT00730028|80126157|FG004|Overall Study|Physician Decision|2|||
27527866|NCT00730028|80126153|FG000|Overall Study|Treatment Failure|5|||
27527867|NCT00730028|80126154|FG001|Overall Study|Treatment Failure|5|||
27527868|NCT00730028|80126155|FG002|Overall Study|Treatment Failure|0|||
27624361|NCT02042443|80466934|FG001|Overall Study|Adverse Event|1|||
27733757|NCT04672083|80850070|FG002|Overall Study|Lost to Follow-up|0|||
27527869|NCT00730028|80126156|FG003|Overall Study|Treatment Failure|0|||
27527870|NCT00730028|80126157|FG004|Overall Study|Treatment Failure|1|||
27733758|NCT04672083|80850071|FG003|Overall Study|Lost to Follow-up|0|||
27733759|NCT04672083|80850072|FG004|Overall Study|Lost to Follow-up|0|||
27733760|NCT00768222|80853377|FG000|Overall Study|Lost to Follow-up|1|||
27733761|NCT00768222|80853378|FG001|Overall Study|Lost to Follow-up|1|||
27733762|NCT00768222|80853377|FG000|Overall Study|Withdrawal by Subject|3|||
27733763|NCT00768222|80853378|FG001|Overall Study|Withdrawal by Subject|1|||
27733764|NCT00768222|80853377|FG000|Overall Study|Protocol Violation|0|||
27733765|NCT00768222|80853378|FG001|Overall Study|Protocol Violation|2|||
27733766|NCT00960076|80853379|FG000|Overall Study|Adverse Event|1|||
27733767|NCT00960076|80853380|FG001|Overall Study|Adverse Event|7|||
27733768|NCT00960076|80853379|FG000|Overall Study|No longer met study criteria|1|||
27733769|NCT00960076|80853380|FG001|Overall Study|No longer met study criteria|5|||
27733770|NCT00960076|80853379|FG000|Overall Study|Withdrawal by Subject|1|||
27911642|NCT00048035|81513692|FG006|Extension Year 2|Early Withdrawals|3|||
27911643|NCT00048035|81513693|FG007|Extension Year 2|Early Withdrawals|3|||
27527871|NCT00730028|80126153|FG000|Overall Study|Randomization Error|1|||
27856287|NCT01172821|81306718|FG002|Overall Study|Withdrawal by Subject|3|||
27856288|NCT01172821|81306719|FG003|Overall Study|Withdrawal by Subject|3|||
27856289|NCT01172821|81306716|FG000|Overall Study|Other|3|||
27856290|NCT01172821|81306717|FG001|Overall Study|Other|4|||
27856291|NCT01172821|81306718|FG002|Overall Study|Other|5|||
27856292|NCT01172821|81306719|FG003|Overall Study|Other|3|||
27856293|NCT04126213|81306720|FG000|Overall Study|Lost to Follow-up|9|||
27856294|NCT04126213|81306721|FG001|Overall Study|Lost to Follow-up|1|||
27856295|NCT04126213|81306722|FG002|Overall Study|Lost to Follow-up|5|||
27856296|NCT04126213|81306723|FG003|Overall Study|Lost to Follow-up|10|||
27856297|NCT04126213|81306724|FG004|Overall Study|Lost to Follow-up|4|||
27856298|NCT04126213|81306725|FG005|Overall Study|Lost to Follow-up|7|||
27856299|NCT04126213|81306720|FG000|Overall Study|Withdrawal by Subject|3|||
27856300|NCT04126213|81306721|FG001|Overall Study|Withdrawal by Subject|2|||
27856301|NCT04126213|81306722|FG002|Overall Study|Withdrawal by Subject|1|||
27856302|NCT04126213|81306723|FG003|Overall Study|Withdrawal by Subject|1|||
27856303|NCT04126213|81306724|FG004|Overall Study|Withdrawal by Subject|1|||
27856304|NCT04126213|81306725|FG005|Overall Study|Withdrawal by Subject|1|||
27856305|NCT04126213|81306720|FG000|Overall Study|Other|0|||
27856306|NCT04126213|81306721|FG001|Overall Study|Other|0|||
27856307|NCT04126213|81306722|FG002|Overall Study|Other|2|||
27856308|NCT04126213|81306723|FG003|Overall Study|Other|2|||
27856309|NCT04126213|81306724|FG004|Overall Study|Other|0|||
27856310|NCT04126213|81306725|FG005|Overall Study|Other|1|||
27856311|NCT04126213|81306720|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27856312|NCT04126213|81306721|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
27856313|NCT04126213|81306722|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27856314|NCT04126213|81306723|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
27856315|NCT04126213|81306724|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27856316|NCT04126213|81306725|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
27856317|NCT01732874|81306726|FG000|Overall Study|Withdrawal by Subject|5|||
27856318|NCT01732874|81306727|FG001|Overall Study|Withdrawal by Subject|1|||
27856319|NCT01732874|81306726|FG000|Overall Study|Death of Infant|3|||
27856320|NCT01732874|81306727|FG001|Overall Study|Death of Infant|2|||
27856321|NCT02032706|81306733|FG000|Overall Study|Did not qualify|5|||
27856322|NCT02032706|81306733|FG000|Overall Study|Protocol Violation|1|||
27856323|NCT04078126|81306734|FG000|Washout|Study put on hold due to COVID-19|0|||
27856324|NCT04078126|81306735|FG001|Washout|Study put on hold due to COVID-19|2|||
27856325|NCT04078126|81306734|FG000|Period 2|Study put on hold due to COVID-19|1|||
27856326|NCT04078126|81306735|FG001|Period 2|Study put on hold due to COVID-19|1|||
27856327|NCT01642914|81306736|FG000|Overall Study|Adverse Event|11|||
27856328|NCT01642914|81306737|FG001|Overall Study|Adverse Event|7|||
27856329|NCT01642914|81306738|FG002|Overall Study|Adverse Event|15|||
27856330|NCT01642914|81306736|FG000|Overall Study|Lack of Efficacy|9|||
27856331|NCT01642914|81306737|FG001|Overall Study|Lack of Efficacy|4|||
27856332|NCT01642914|81306738|FG002|Overall Study|Lack of Efficacy|2|||
27856333|NCT01642914|81306736|FG000|Overall Study|Protocol Violation|15|||
27856334|NCT01642914|81306737|FG001|Overall Study|Protocol Violation|13|||
27856335|NCT01642914|81306738|FG002|Overall Study|Protocol Violation|6|||
27856336|NCT01642914|81306736|FG000|Overall Study|Withdrawal by Subject|5|||
27856337|NCT01642914|81306737|FG001|Overall Study|Withdrawal by Subject|5|||
27856338|NCT01642914|81306738|FG002|Overall Study|Withdrawal by Subject|10|||
27856339|NCT01642914|81306736|FG000|Overall Study|Lost to Follow-up|5|||
27856340|NCT01642914|81306737|FG001|Overall Study|Lost to Follow-up|3|||
27856341|NCT01642914|81306738|FG002|Overall Study|Lost to Follow-up|7|||
27856342|NCT01642914|81306736|FG000|Overall Study|Other Reason|1|||
27733771|NCT00960076|80853380|FG001|Overall Study|Withdrawal by Subject|2|||
27733772|NCT00960076|80853379|FG000|Overall Study|Lost to Follow-up|3|||
27733773|NCT00960076|80853380|FG001|Overall Study|Lost to Follow-up|3|||
27733774|NCT00960076|80853379|FG000|Overall Study|Severe non-compliance to protocol|1|||
27856343|NCT01642914|81306737|FG001|Overall Study|Other Reason|0|||
27856344|NCT01642914|81306738|FG002|Overall Study|Other Reason|0|||
27856345|NCT00655876|81306750|FG000|Overall Study|Protocol Violation|9|||
27733775|NCT00960076|80853380|FG001|Overall Study|Severe non-compliance to protocol|2|||
27733776|NCT00960076|80853379|FG000|Overall Study|Hyperglycemia|1|||
27733777|NCT00960076|80853380|FG001|Overall Study|Hyperglycemia|5|||
27733778|NCT00960076|80853379|FG000|Overall Study|Did not attend the termination visit|0|||
27733779|NCT00960076|80853380|FG001|Overall Study|Did not attend the termination visit|1|||
27733780|NCT02210780|80853381|FG000|Overall Study|Adverse Event|0|||
27733781|NCT02210780|80853382|FG001|Overall Study|Adverse Event|5|||
27733782|NCT02210780|80853381|FG000|Overall Study|Lost to Follow-up|2|||
27733783|NCT02210780|80853382|FG001|Overall Study|Lost to Follow-up|1|||
27733784|NCT02210780|80853381|FG000|Overall Study|Withdrawal by Subject|1|||
27733785|NCT02210780|80853382|FG001|Overall Study|Withdrawal by Subject|1|||
27733786|NCT02210780|80853381|FG000|Overall Study|Physician Decision|1|||
27733787|NCT02210780|80853382|FG001|Overall Study|Physician Decision|0|||
27733788|NCT02210780|80853381|FG000|Overall Study|Protocol Violation|1|||
27733789|NCT02210780|80853382|FG001|Overall Study|Protocol Violation|0|||
27733790|NCT02210780|80853381|FG000|Overall Study|Other than specified above|0|||
27733791|NCT02210780|80853382|FG001|Overall Study|Other than specified above|1|||
27733792|NCT01276821|80853384|FG000|Overall Study|Protocol Violation|0|||
27733793|NCT01276821|80853385|FG001|Overall Study|Protocol Violation|1|||
27733794|NCT01389245|80853389|FG000|Overall Study|Protocol Violation|10|||
27733795|NCT01389245|80853389|FG000|Overall Study|Lost to Follow-up|3|||
27733796|NCT01389245|80853389|FG000|Overall Study|Withdrawal by Subject|2|||
27733797|NCT00246259|80853394|FG000|Overall Study|Other|3|||
27733798|NCT00246259|80853395|FG001|Overall Study|Other|3|||
27733799|NCT00246259|80853394|FG000|Overall Study|Not stable by Week 18|2|||
27733800|NCT00246259|80853395|FG001|Overall Study|Not stable by Week 18|1|||
27733801|NCT00246259|80853394|FG000|Overall Study|Participant non-compliant|4|||
27733802|NCT00246259|80853395|FG001|Overall Study|Participant non-compliant|9|||
27733803|NCT00246259|80853394|FG000|Overall Study|Lack of Efficacy|2|||
27733804|NCT00246259|80853395|FG001|Overall Study|Lack of Efficacy|2|||
27733805|NCT00246259|80853394|FG000|Overall Study|Investigator withdrew participant|2|||
27733806|NCT00246259|80853395|FG001|Overall Study|Investigator withdrew participant|0|||
27733807|NCT00246259|80853394|FG000|Overall Study|Adverse Event|5|||
27733808|NCT00246259|80853395|FG001|Overall Study|Adverse Event|0|||
27733809|NCT00246259|80853394|FG000|Overall Study|Lost to Follow-up|3|||
27733810|NCT00246259|80853395|FG001|Overall Study|Lost to Follow-up|4|||
27733811|NCT00246259|80853394|FG000|Overall Study|Withdrawal by Subject|5|||
27733812|NCT00246259|80853395|FG001|Overall Study|Withdrawal by Subject|1|||
27733813|NCT00246259|80853394|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
27733814|NCT00246259|80853395|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
27733815|NCT00541307|80853396|FG000|Overall Study|Death|5|||
27733816|NCT00541307|80853396|FG000|Overall Study|Physician Decision|3|||
27733817|NCT00541307|80853396|FG000|Overall Study|Withdrawal by Subject|6|||
27733818|NCT00541307|80853396|FG000|Overall Study|Lost to Follow-up|4|||
27733819|NCT00541307|80853396|FG000|Overall Study|Subject returned early (outside window)|1|||
27733820|NCT00541307|80853396|FG000|Overall Study|Surgical Bypass|5|||
27733821|NCT01355289|80853397|FG000|Core Study|Adverse Event, Non-Fatal|1|||
27733822|NCT01355289|80853398|FG001|Core Study|Adverse Event, Non-Fatal|0|||
27733823|NCT01355289|80853399|FG002|Core Study|Adverse Event, Non-Fatal|0|||
27733824|NCT01355289|80853400|FG003|Core Study|Adverse Event, Non-Fatal|0|||
27733825|NCT01355289|80853401|FG004|Core Study|Adverse Event, Non-Fatal|0|||
27733826|NCT01355289|80853397|FG000|Core Study|Inadequate Therapeutic Effect|0|||
27733827|NCT01355289|80853398|FG001|Core Study|Inadequate Therapeutic Effect|0|||
27733828|NCT01355289|80853399|FG002|Core Study|Inadequate Therapeutic Effect|0|||
27733829|NCT01355289|80853400|FG003|Core Study|Inadequate Therapeutic Effect|1|||
27733830|NCT01355289|80853401|FG004|Core Study|Inadequate Therapeutic Effect|0|||
27733831|NCT01355289|80853397|FG000|Core Study|Other|0|||
27733832|NCT01355289|80853398|FG001|Core Study|Other|0|||
27733833|NCT01355289|80853399|FG002|Core Study|Other|0|||
27733834|NCT01355289|80853400|FG003|Core Study|Other|1|||
27733835|NCT01355289|80853401|FG004|Core Study|Other|0|||
27733836|NCT01355289|80853397|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
27733837|NCT01355289|80853398|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
27733838|NCT01355289|80853399|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
27733839|NCT01355289|80853400|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
27733840|NCT01355289|80853401|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
27733841|NCT01355289|80853397|FG000|Open Label Extension|Lost to Follow-up|0|||
27733842|NCT01355289|80853398|FG001|Open Label Extension|Lost to Follow-up|0|||
27733843|NCT01355289|80853399|FG002|Open Label Extension|Lost to Follow-up|0|||
27733844|NCT01355289|80853400|FG003|Open Label Extension|Lost to Follow-up|0|||
27733845|NCT01355289|80853401|FG004|Open Label Extension|Lost to Follow-up|1|||
27733846|NCT01355289|80853397|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
27733847|NCT01355289|80853398|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
27733848|NCT01355289|80853399|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
27733849|NCT01355289|80853400|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
27733850|NCT01355289|80853401|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
27527872|NCT00730028|80126154|FG001|Overall Study|Randomization Error|0|||
27527873|NCT00730028|80126155|FG002|Overall Study|Randomization Error|0|||
27527874|NCT00730028|80126156|FG003|Overall Study|Randomization Error|0|||
27527875|NCT00730028|80126157|FG004|Overall Study|Randomization Error|2|||
27527876|NCT02054481|80126159|FG000|Overall Study|Adverse Event|1|||
27527877|NCT02054481|80126160|FG001|Overall Study|Adverse Event|1|||
27527878|NCT02054481|80126161|FG002|Overall Study|Adverse Event|0|||
27527879|NCT02054481|80126162|FG003|Overall Study|Adverse Event|1|||
27527880|NCT02054481|80126159|FG000|Overall Study|Lost to Follow-up|1|||
27527881|NCT02054481|80126160|FG001|Overall Study|Lost to Follow-up|0|||
27527882|NCT02054481|80126161|FG002|Overall Study|Lost to Follow-up|0|||
27527883|NCT02054481|80126162|FG003|Overall Study|Lost to Follow-up|0|||
27527884|NCT02054481|80126159|FG000|Overall Study|Other reason|2|||
27527885|NCT02054481|80126160|FG001|Overall Study|Other reason|1|||
27527886|NCT02054481|80126161|FG002|Overall Study|Other reason|2|||
27527887|NCT02054481|80126162|FG003|Overall Study|Other reason|0|||
27527888|NCT00194675|80126163|FG000|Overall Study|Lost to Follow-up|1|||
27527889|NCT00194675|80126164|FG001|Overall Study|Lost to Follow-up|1|||
27527890|NCT00194675|80126163|FG000|Overall Study|lack of interest|1|||
27527891|NCT00194675|80126164|FG001|Overall Study|lack of interest|1|||
27527892|NCT00194675|80126163|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
27527893|NCT00194675|80126164|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
27527894|NCT00194675|80126163|FG000|Overall Study|Protocol Violation|1|||
27527895|NCT00194675|80126164|FG001|Overall Study|Protocol Violation|0|||
27527896|NCT00194675|80126163|FG000|Overall Study|Death|1|||
27527897|NCT00194675|80126164|FG001|Overall Study|Death|0|||
27527898|NCT04285580|80126165|FG000|Overall Study|Protocol Violation|0|||
27527899|NCT04285580|80126166|FG001|Overall Study|Protocol Violation|1|||
27527900|NCT00908011|80126167|FG000|Overall Study|Withdrawal by Subject|2|||
27527901|NCT00908011|80126168|FG001|Overall Study|Withdrawal by Subject|2|||
27527902|NCT00245583|80126169|FG000|Overall Study|Lost to Follow-up|1|||
27527903|NCT00245583|80126170|FG001|Overall Study|Lost to Follow-up|5|||
27527904|NCT00245583|80126169|FG000|Overall Study|Adverse Event|2|||
27527905|NCT00245583|80126170|FG001|Overall Study|Adverse Event|1|||
27527906|NCT00245583|80126169|FG000|Overall Study|Lack of Efficacy|1|||
27527907|NCT00245583|80126170|FG001|Overall Study|Lack of Efficacy|0|||
27527908|NCT00245583|80126169|FG000|Overall Study|Withdrawal by Subject|2|||
27527909|NCT00245583|80126170|FG001|Overall Study|Withdrawal by Subject|3|||
27527910|NCT02716896|80126171|FG000|Overall Study|Physician Decision|0|||
27527911|NCT02716896|80126172|FG001|Overall Study|Physician Decision|1|||
27527912|NCT02632838|80126174|FG000|Overall Study|Withdrawal by Subject|3|||
27527913|NCT02632838|80126175|FG001|Overall Study|Withdrawal by Subject|0|||
27527914|NCT02632838|80126174|FG000|Overall Study|Lost to Follow-up|0|||
27527915|NCT02632838|80126175|FG001|Overall Study|Lost to Follow-up|2|||
27527916|NCT00686998|80126176|FG000|Overall Study|Adverse Event|3|||
27527917|NCT00686998|80126177|FG001|Overall Study|Adverse Event|2|||
27527918|NCT00686998|80126178|FG002|Overall Study|Adverse Event|1|||
27527919|NCT00686998|80126176|FG000|Overall Study|Withdrawal by Subject|2|||
27527920|NCT00686998|80126177|FG001|Overall Study|Withdrawal by Subject|1|||
27527921|NCT00686998|80126178|FG002|Overall Study|Withdrawal by Subject|2|||
27527922|NCT00686998|80126176|FG000|Overall Study|Lack of Efficacy|7|||
27527923|NCT00686998|80126177|FG001|Overall Study|Lack of Efficacy|5|||
27527924|NCT00686998|80126178|FG002|Overall Study|Lack of Efficacy|0|||
27527925|NCT00686998|80126176|FG000|Overall Study|Other|0|||
27527926|NCT00686998|80126177|FG001|Overall Study|Other|0|||
27527927|NCT00686998|80126178|FG002|Overall Study|Other|1|||
27527928|NCT00686998|80126176|FG000|Overall Study|Safety Reasons|1|||
27527929|NCT00686998|80126177|FG001|Overall Study|Safety Reasons|0|||
27527930|NCT00686998|80126178|FG002|Overall Study|Safety Reasons|0|||
27527931|NCT04179890|80126179|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
27527932|NCT04179890|80126180|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
27527933|NCT04179890|80126179|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
27527934|NCT04179890|80126180|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
27624362|NCT02042443|80466933|FG000|Overall Study|Withdrawal by Subject|0|||
27527935|NCT04179890|80126179|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
27527936|NCT04179890|80126180|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
27527937|NCT04179890|80126179|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
27527938|NCT04179890|80126180|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
27527939|NCT04179890|80126179|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
27527940|NCT04179890|80126180|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
27527941|NCT04179890|80126179|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
27527942|NCT04179890|80126180|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
27624363|NCT02042443|80466934|FG001|Overall Study|Withdrawal by Subject|1|||
27624364|NCT02042443|80466933|FG000|Overall Study|Progression|21|||
27527943|NCT04179890|80126179|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
27527944|NCT04179890|80126180|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
27527945|NCT04179890|80126179|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
27527946|NCT04179890|80126180|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
27527947|NCT04179890|80126179|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
27527948|NCT04179890|80126180|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
27527949|NCT00773383|80126181|FG000|Overall Study|Adverse Event|4|||
27527950|NCT00773383|80126181|FG000|Overall Study|Death|1|||
27527951|NCT00773383|80126181|FG000|Overall Study|Progression of Disease|23|||
27527952|NCT00773383|80126181|FG000|Overall Study|Other|2|||
27527953|NCT00773383|80126181|FG000|Overall Study|No study dose received|1|||
27527954|NCT01854944|80126184|FG000|Overall Study|Withdrawal by Subject|0|||
27527955|NCT01854944|80126185|FG001|Overall Study|Withdrawal by Subject|0|||
27527956|NCT01854944|80126186|FG002|Overall Study|Withdrawal by Subject|1|||
27527957|NCT01117792|80126195|FG000|Overall Study|Death|1|||
27527958|NCT01117792|80126195|FG000|Overall Study|Adverse Event|3|||
27527959|NCT02117414|80126196|FG000|Overall Study|Death|5|||
27527960|NCT02117414|80126197|FG001|Overall Study|Death|2|||
27527961|NCT02117414|80126196|FG000|Overall Study|Withdrawal by Subject|10|||
27527962|NCT02117414|80126197|FG001|Overall Study|Withdrawal by Subject|4|||
27527963|NCT00760084|80126198|FG000|Overall Study|Physician Decision|5|||
27527964|NCT00760084|80126198|FG000|Overall Study|Withdrawal by Subject|2|||
27527965|NCT00760084|80126198|FG000|Overall Study|Progressive Disease|3|||
27527966|NCT00542451|80126202|FG000|Overall Study|Adverse Event|31|||
27527967|NCT00542451|80126202|FG000|Overall Study|Withdrawal by Subject|30|||
27527968|NCT00542451|80126202|FG000|Overall Study|Physician Decision|4|||
27527969|NCT00542451|80126202|FG000|Overall Study|Recurrent disease|1|||
27527970|NCT00542451|80126202|FG000|Overall Study|unknown reason|1|||
27527971|NCT00542451|80126202|FG000|Overall Study|Death|2|||
27527972|NCT00542451|80126202|FG000|Overall Study|Lost to Follow-up|10|||
27527973|NCT01751802|80126207|FG000|Overall Study|Adverse Event|4|||
27527974|NCT01751802|80126208|FG001|Overall Study|Adverse Event|2|||
27527975|NCT00249288|80126209|FG000|Overall Study|Lost to Follow-up|3|||
27527976|NCT00249288|80126210|FG001|Overall Study|Lost to Follow-up|3|||
27527977|NCT00249288|80126209|FG000|Overall Study|Withdrawal by Subject|2|||
27527978|NCT00249288|80126210|FG001|Overall Study|Withdrawal by Subject|2|||
27527979|NCT02582255|80126211|FG000|Overall Study|Protocol Violation|0|||
27527980|NCT02582255|80126212|FG001|Overall Study|Protocol Violation|3|||
27527981|NCT03059446|80126214|FG000|Overall Study|Adverse Event|11|||
27527982|NCT03059446|80126214|FG000|Overall Study|Withdrawal of Consent|16|||
27527983|NCT03059446|80126214|FG000|Overall Study|Lost to Follow-up|3|||
27527984|NCT03059446|80126214|FG000|Overall Study|Protocol Violation|1|||
27527985|NCT03059446|80126214|FG000|Overall Study|Study Terminated by Sponsor|131|||
27527986|NCT03059446|80126214|FG000|Overall Study|Reason not Specified|5|||
27527987|NCT03119701|80126215|FG000|6-day Dosing|Death|4|||
27527988|NCT03119701|80126216|FG001|6-day Dosing|Death|1|||
27527989|NCT03119701|80126215|FG000|6-day Dosing|Adverse Event|3|||
27527990|NCT03119701|80126216|FG001|6-day Dosing|Adverse Event|0|||
27527991|NCT03119701|80126215|FG000|6-day Dosing|Physician Decision|0|||
27527992|NCT03119701|80126216|FG001|6-day Dosing|Physician Decision|1|||
27527993|NCT03119701|80126215|FG000|6-day Dosing|Withdrawal by Subject|0|||
27527994|NCT03119701|80126216|FG001|6-day Dosing|Withdrawal by Subject|1|||
27527995|NCT03119701|80126215|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
27527996|NCT03119701|80126216|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
27527997|NCT01222403|80126217|FG000|Overall Study|Inappropriate enrollment|0|||
27527998|NCT01222403|80126218|FG001|Overall Study|Inappropriate enrollment|2|||
27527999|NCT05342532|80126221|FG000|Overall Study|Adverse Event|5|||
27528000|NCT05342532|80126222|FG001|Overall Study|Adverse Event|20|||
27528001|NCT05342532|80126221|FG000|Overall Study|Lost to Follow-up|10|||
27528002|NCT05342532|80126222|FG001|Overall Study|Lost to Follow-up|15|||
27528003|NCT01466595|80126223|FG000|Overall Study|Withdrawal by Subject|0|||
27528004|NCT01466595|80126224|FG001|Overall Study|Withdrawal by Subject|1|||
27528005|NCT02414139|80126225|FG000|Treatment Period|Adverse Event|11|||
27528006|NCT02414139|80126226|FG001|Treatment Period|Adverse Event|6|||
27528007|NCT02414139|80126227|FG002|Treatment Period|Adverse Event|8|||
27528008|NCT02414139|80126228|FG003|Treatment Period|Adverse Event|5|||
27528009|NCT02414139|80126229|FG004|Treatment Period|Adverse Event|14|||
27856346|NCT00655876|81306751|FG001|Overall Study|Protocol Violation|7|||
27856347|NCT01315132|81306752|FG000|Overall Study|not treated due to disease progression|1|||
27528010|NCT02414139|80126230|FG005|Treatment Period|Adverse Event|3|||
27528011|NCT02414139|80126231|FG006|Treatment Period|Adverse Event|6|||
27528012|NCT02414139|80126232|FG007|Treatment Period|Adverse Event|1|||
27528013|NCT02414139|80126233|FG008|Treatment Period|Adverse Event|6|||
27528014|NCT02414139|80126234|FG009|Treatment Period|Adverse Event|8|||
27528015|NCT02414139|80126225|FG000|Treatment Period|Death|0|||
27528016|NCT02414139|80126226|FG001|Treatment Period|Death|0|||
27528017|NCT02414139|80126227|FG002|Treatment Period|Death|1|||
27528018|NCT02414139|80126228|FG003|Treatment Period|Death|1|||
27528019|NCT02414139|80126229|FG004|Treatment Period|Death|0|||
27528020|NCT02414139|80126230|FG005|Treatment Period|Death|0|||
27528021|NCT02414139|80126231|FG006|Treatment Period|Death|0|||
27528022|NCT02414139|80126232|FG007|Treatment Period|Death|0|||
27528023|NCT02414139|80126233|FG008|Treatment Period|Death|0|||
27528024|NCT02414139|80126234|FG009|Treatment Period|Death|1|||
27528025|NCT02414139|80126225|FG000|Treatment Period|Physician Decision|5|||
27528026|NCT02414139|80126226|FG001|Treatment Period|Physician Decision|4|||
27528027|NCT02414139|80126227|FG002|Treatment Period|Physician Decision|6|||
27528028|NCT02414139|80126228|FG003|Treatment Period|Physician Decision|1|||
27528029|NCT02414139|80126229|FG004|Treatment Period|Physician Decision|4|||
27528030|NCT02414139|80126230|FG005|Treatment Period|Physician Decision|0|||
27528031|NCT02414139|80126231|FG006|Treatment Period|Physician Decision|2|||
27528032|NCT02414139|80126232|FG007|Treatment Period|Physician Decision|0|||
27624365|NCT02042443|80466934|FG001|Overall Study|Progression|17|||
27624366|NCT02042443|80466933|FG000|Overall Study|not protocol specified|1|||
27624367|NCT02042443|80466934|FG001|Overall Study|not protocol specified|1|||
27624368|NCT02042443|80466933|FG000|Overall Study|Not eligible/not analyzable|3|||
27624369|NCT02042443|80466934|FG001|Overall Study|Not eligible/not analyzable|6|||
27624370|NCT02347943|80466935|FG000|Overall Study|Study was cancelled|140|||
27624371|NCT02347943|80466936|FG001|Overall Study|Study was cancelled|67|||
27624372|NCT02347943|80466937|FG002|Overall Study|Study was cancelled|45|||
27624373|NCT00498186|80466938|FG000|Overall Study|Protocol Violation|10|||
27624374|NCT00498186|80466938|FG000|Overall Study|Lack of Efficacy|31|||
27624375|NCT00498186|80466938|FG000|Overall Study|Adverse Event|89|||
27624376|NCT00498186|80466938|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
27733851|NCT01355289|80853397|FG000|Open Label Extension|Other|0|||
27733852|NCT01355289|80853398|FG001|Open Label Extension|Other|0|||
27733853|NCT01355289|80853399|FG002|Open Label Extension|Other|0|||
27733854|NCT01355289|80853400|FG003|Open Label Extension|Other|0|||
27733855|NCT01355289|80853401|FG004|Open Label Extension|Other|3|||
27733856|NCT02054702|80853402|FG000|Overall Study|Lost to Follow-up|3|||
27733857|NCT02054702|80853403|FG001|Overall Study|Lost to Follow-up|5|||
27733858|NCT02054702|80853402|FG000|Overall Study|Adverse Event|3|||
27733859|NCT02054702|80853403|FG001|Overall Study|Adverse Event|1|||
27733860|NCT02054702|80853402|FG000|Overall Study|Met Withdrawal Criteria|4|||
27733861|NCT02054702|80853403|FG001|Overall Study|Met Withdrawal Criteria|1|||
27733862|NCT02054702|80853402|FG000|Overall Study|Physician Decision|0|||
27733863|NCT02054702|80853403|FG001|Overall Study|Physician Decision|1|||
27733864|NCT02054702|80853402|FG000|Overall Study|Withdrawal by Subject|14|||
27733865|NCT02054702|80853403|FG001|Overall Study|Withdrawal by Subject|4|||
27733866|NCT03542682|80853413|FG000|Overall Study|COVID-19 Protocol|0|||
27733867|NCT03542682|80853414|FG001|Overall Study|COVID-19 Protocol|1|||
27733868|NCT04574999|80853415|FG000|Overall Study|Adverse Event|1|||
27733869|NCT04574999|80853416|FG001|Overall Study|Adverse Event|0|||
27733870|NCT04574999|80853415|FG000|Overall Study|Lack of Efficacy|2|||
27733871|NCT04574999|80853416|FG001|Overall Study|Lack of Efficacy|3|||
27733872|NCT04574999|80853415|FG000|Overall Study|Protocol Violation|1|||
27733873|NCT04574999|80853416|FG001|Overall Study|Protocol Violation|0|||
27733874|NCT04574999|80853415|FG000|Overall Study|Withdrawal by Subject|2|||
27733875|NCT04574999|80853416|FG001|Overall Study|Withdrawal by Subject|2|||
27733876|NCT04574999|80853415|FG000|Overall Study|Lost to Follow-up|1|||
27733877|NCT04574999|80853416|FG001|Overall Study|Lost to Follow-up|0|||
27733878|NCT04574999|80853415|FG000|Overall Study|Personal problems|1|||
27733879|NCT04574999|80853416|FG001|Overall Study|Personal problems|0|||
27856348|NCT00123474|81306753|FG000|Randomized to Treatment|Randomized, never treated|1|||
27528033|NCT02414139|80126233|FG008|Treatment Period|Physician Decision|1|||
27528034|NCT02414139|80126234|FG009|Treatment Period|Physician Decision|4|||
27528035|NCT02414139|80126225|FG000|Treatment Period|Progressive disease|48|||
27528036|NCT02414139|80126226|FG001|Treatment Period|Progressive disease|31|||
27528037|NCT02414139|80126227|FG002|Treatment Period|Progressive disease|37|||
27528038|NCT02414139|80126228|FG003|Treatment Period|Progressive disease|21|||
27528039|NCT02414139|80126229|FG004|Treatment Period|Progressive disease|43|||
27624377|NCT00498186|80466938|FG000|Overall Study|Withdrawal by Subject|18|||
27733880|NCT04574999|80853415|FG000|Overall Study|Previous planned surgery|1|||
27733881|NCT04574999|80853416|FG001|Overall Study|Previous planned surgery|0|||
27733882|NCT00628355|80853419|FG000|Overall Study|Withdrawal by Subject|1|||
27733883|NCT00628355|80853420|FG001|Overall Study|Withdrawal by Subject|1|||
27624378|NCT00498186|80466938|FG000|Overall Study|Lost to Follow-up|3|||
27624379|NCT00498186|80466938|FG000|Overall Study|Other|10|||
27733884|NCT00432237|80853423|FG000|Overall Study|Adverse Event|0|||
27733885|NCT00432237|80853424|FG001|Overall Study|Adverse Event|0|||
27733886|NCT00432237|80853425|FG002|Overall Study|Adverse Event|0|||
27733887|NCT00432237|80853426|FG003|Overall Study|Adverse Event|1|||
27733888|NCT00432237|80853423|FG000|Overall Study|Lack of Efficacy|0|||
27733889|NCT00432237|80853424|FG001|Overall Study|Lack of Efficacy|0|||
27624380|NCT00448864|80466945|FG000|Overall Study|Death|1|||
27624381|NCT00448864|80466946|FG001|Overall Study|Death|0|||
27624382|NCT00448864|80466947|FG002|Overall Study|Death|0|||
27624383|NCT00448864|80466945|FG000|Overall Study|Lost to Follow-up|3|||
27624384|NCT00448864|80466946|FG001|Overall Study|Lost to Follow-up|1|||
27624385|NCT00448864|80466947|FG002|Overall Study|Lost to Follow-up|0|||
27624386|NCT00448864|80466945|FG000|Overall Study|Physician Decision|1|||
27624387|NCT00448864|80466946|FG001|Overall Study|Physician Decision|0|||
27624388|NCT00448864|80466947|FG002|Overall Study|Physician Decision|1|||
27624389|NCT00448864|80466945|FG000|Overall Study|Withdrawal by Subject|0|||
27624390|NCT00448864|80466946|FG001|Overall Study|Withdrawal by Subject|2|||
27911644|NCT02824224|81513694|FG000|Overall Study|Discontinued, IUS expulsion|0|||
27911645|NCT02824224|81513695|FG001|Overall Study|Discontinued, IUS expulsion|1|||
27911646|NCT02824224|81513694|FG000|Overall Study|Did not show up for allocation visit|2|||
27911647|NCT02824224|81513695|FG001|Overall Study|Did not show up for allocation visit|0|||
27911648|NCT02750332|81513696|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27911649|NCT02750332|81513697|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27911650|NCT01395810|81513698|FG000|Overall Study|Adverse Event|0|||
27911651|NCT01395810|81513699|FG001|Overall Study|Adverse Event|1|||
27911652|NCT01395810|81513700|FG002|Overall Study|Adverse Event|0|||
27911653|NCT01395810|81513701|FG003|Overall Study|Adverse Event|0|||
27911654|NCT01395810|81513698|FG000|Overall Study|Lack of Efficacy|0|||
27911655|NCT01395810|81513699|FG001|Overall Study|Lack of Efficacy|1|||
27911656|NCT01395810|81513700|FG002|Overall Study|Lack of Efficacy|0|||
27911657|NCT01395810|81513701|FG003|Overall Study|Lack of Efficacy|0|||
27911658|NCT01395810|81513698|FG000|Overall Study|Withdrawal criteria|0|||
27911659|NCT01395810|81513699|FG001|Overall Study|Withdrawal criteria|2|||
27911660|NCT01395810|81513700|FG002|Overall Study|Withdrawal criteria|0|||
27911661|NCT01395810|81513701|FG003|Overall Study|Withdrawal criteria|0|||
27911662|NCT01395810|81513698|FG000|Overall Study|Unclassified|2|||
27911663|NCT01395810|81513699|FG001|Overall Study|Unclassified|0|||
27911664|NCT01395810|81513700|FG002|Overall Study|Unclassified|0|||
27911665|NCT01395810|81513701|FG003|Overall Study|Unclassified|0|||
27911666|NCT01922258|81513702|FG000|Overall Study|Lost to Follow-up|1|||
27528040|NCT02414139|80126230|FG005|Treatment Period|Progressive disease|12|||
27528041|NCT02414139|80126231|FG006|Treatment Period|Progressive disease|16|||
27528042|NCT02414139|80126232|FG007|Treatment Period|Progressive disease|2|||
27528043|NCT02414139|80126233|FG008|Treatment Period|Progressive disease|20|||
27528044|NCT02414139|80126234|FG009|Treatment Period|Progressive disease|14|||
27528045|NCT02414139|80126225|FG000|Treatment Period|Protocol deviation|0|||
27528046|NCT02414139|80126226|FG001|Treatment Period|Protocol deviation|0|||
27528047|NCT02414139|80126227|FG002|Treatment Period|Protocol deviation|1|||
27528048|NCT02414139|80126228|FG003|Treatment Period|Protocol deviation|0|||
27528049|NCT02414139|80126229|FG004|Treatment Period|Protocol deviation|0|||
27528050|NCT02414139|80126230|FG005|Treatment Period|Protocol deviation|0|||
27528051|NCT02414139|80126231|FG006|Treatment Period|Protocol deviation|0|||
27528052|NCT02414139|80126232|FG007|Treatment Period|Protocol deviation|0|||
27528053|NCT02414139|80126233|FG008|Treatment Period|Protocol deviation|0|||
27528054|NCT02414139|80126234|FG009|Treatment Period|Protocol deviation|0|||
27528055|NCT02414139|80126225|FG000|Treatment Period|Subject/Guardian decision|5|||
27528056|NCT02414139|80126226|FG001|Treatment Period|Subject/Guardian decision|1|||
27528057|NCT02414139|80126227|FG002|Treatment Period|Subject/Guardian decision|1|||
27528058|NCT02414139|80126228|FG003|Treatment Period|Subject/Guardian decision|2|||
27528059|NCT02414139|80126229|FG004|Treatment Period|Subject/Guardian decision|5|||
27528060|NCT02414139|80126230|FG005|Treatment Period|Subject/Guardian decision|0|||
27528061|NCT02414139|80126231|FG006|Treatment Period|Subject/Guardian decision|2|||
27528062|NCT02414139|80126232|FG007|Treatment Period|Subject/Guardian decision|0|||
27528063|NCT02414139|80126233|FG008|Treatment Period|Subject/Guardian decision|1|||
27528064|NCT02414139|80126234|FG009|Treatment Period|Subject/Guardian decision|1|||
27528065|NCT02414139|80126225|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
27528066|NCT02414139|80126226|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
27528067|NCT02414139|80126227|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
27528068|NCT02414139|80126228|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
27528069|NCT02414139|80126229|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
27528070|NCT02414139|80126230|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
27528071|NCT02414139|80126231|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
27528072|NCT02414139|80126232|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
27528073|NCT02414139|80126233|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
27528074|NCT02414139|80126234|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
27528075|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
27528076|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27624391|NCT00448864|80466947|FG002|Overall Study|Withdrawal by Subject|0|||
27624392|NCT00448864|80466945|FG000|Overall Study|Protocol Violation|0|||
27624393|NCT00448864|80466946|FG001|Overall Study|Protocol Violation|2|||
27911667|NCT01922258|81513703|FG001|Overall Study|Lost to Follow-up|1|||
27624394|NCT00448864|80466947|FG002|Overall Study|Protocol Violation|0|||
27624395|NCT02491411|80466948|FG000|Overall Study|Physician Decision|4|||
27624396|NCT00852475|80466951|FG000|Overall Study|Lost to Follow-up|3|||
27624397|NCT00852475|80466952|FG001|Overall Study|Lost to Follow-up|4|||
27624398|NCT04531540|80466955|FG000|Overall Study|Adverse Event|1|||
27624399|NCT04531540|80466955|FG000|Overall Study|Protocol Violation|3|||
27624400|NCT04531540|80466955|FG000|Overall Study|Withdrawal by Subject|4|||
27624401|NCT04531540|80466955|FG000|Overall Study|Found to be Ineligible|1|||
27624402|NCT00672256|80466956|FG000|Overall Study|PI dropped, bad data|44|||
27624403|NCT04978363|80466957|FG000|Overall Study|Other medical issues unrelated to the study|0|||
27624404|NCT04978363|80466958|FG001|Overall Study|Other medical issues unrelated to the study|0|||
27624405|NCT04978363|80466959|FG002|Overall Study|Other medical issues unrelated to the study|0|||
27624406|NCT04978363|80466960|FG003|Overall Study|Other medical issues unrelated to the study|0|||
27624407|NCT04978363|80466961|FG004|Overall Study|Other medical issues unrelated to the study|1|||
27624408|NCT04978363|80466962|FG005|Overall Study|Other medical issues unrelated to the study|0|||
27624409|NCT04978363|80466963|FG006|Overall Study|Other medical issues unrelated to the study|0|||
27624410|NCT04978363|80466964|FG007|Overall Study|Other medical issues unrelated to the study|0|||
27624411|NCT04978363|80466965|FG008|Overall Study|Other medical issues unrelated to the study|0|||
27624412|NCT04978363|80466966|FG009|Overall Study|Other medical issues unrelated to the study|0|||
27624413|NCT04978363|80466967|FG010|Overall Study|Other medical issues unrelated to the study|0|||
27624414|NCT04978363|80466957|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
27624415|NCT04978363|80466958|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
27624416|NCT04978363|80466959|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
27624417|NCT04978363|80466960|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
27624418|NCT04978363|80466961|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
27624419|NCT04978363|80466962|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
27624420|NCT04978363|80466963|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
27624421|NCT04978363|80466964|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
27624422|NCT04978363|80466965|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
27624423|NCT04978363|80466966|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
27624424|NCT04978363|80466967|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
27624425|NCT04978363|80466957|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624426|NCT04978363|80466958|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
27624427|NCT04978363|80466959|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624428|NCT04978363|80466960|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624429|NCT04978363|80466961|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624430|NCT04978363|80466962|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624431|NCT04978363|80466963|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624432|NCT04978363|80466964|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624433|NCT04978363|80466965|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624434|NCT04978363|80466966|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624435|NCT04978363|80466967|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
27624436|NCT04476043|80466970|FG000|Overall Study|Withdrawal by Subject|1|||
27624437|NCT04476043|80466971|FG001|Overall Study|Withdrawal by Subject|3|||
27624438|NCT04476043|80466972|FG002|Overall Study|Withdrawal by Subject|4|||
27624439|NCT04476043|80466973|FG003|Overall Study|Withdrawal by Subject|1|||
27624440|NCT04476043|80466970|FG000|Overall Study|Lost to Follow-up|1|||
27624441|NCT04476043|80466971|FG001|Overall Study|Lost to Follow-up|1|||
27624442|NCT04476043|80466972|FG002|Overall Study|Lost to Follow-up|2|||
27624443|NCT04476043|80466973|FG003|Overall Study|Lost to Follow-up|1|||
27624444|NCT04476043|80466970|FG000|Overall Study|Adverse Event|2|||
27624445|NCT04476043|80466971|FG001|Overall Study|Adverse Event|0|||
27624446|NCT04476043|80466972|FG002|Overall Study|Adverse Event|1|||
27624447|NCT04476043|80466973|FG003|Overall Study|Adverse Event|0|||
27624448|NCT04476043|80466970|FG000|Overall Study|Protocol Violation|0|||
27624449|NCT04476043|80466971|FG001|Overall Study|Protocol Violation|1|||
27624450|NCT04476043|80466972|FG002|Overall Study|Protocol Violation|0|||
27624451|NCT04476043|80466973|FG003|Overall Study|Protocol Violation|0|||
27624452|NCT01268566|80466977|FG000|Overall Study|Lost to Follow-up|1|||
27624453|NCT01268566|80466977|FG000|Overall Study|Withdrawal by Subject|12|||
27624454|NCT01268566|80466977|FG000|Overall Study|Death|30|||
27624455|NCT05355805|80466979|FG000|Overall Study|Lost to Follow-up|6|||
27624456|NCT05355805|80466980|FG001|Overall Study|Lost to Follow-up|5|||
27624457|NCT05355805|80466981|FG002|Overall Study|Lost to Follow-up|6|||
27624458|NCT05355805|80466982|FG003|Overall Study|Lost to Follow-up|2|||
27624459|NCT05355805|80466979|FG000|Overall Study|Decision by Sponsor|0|||
27624460|NCT05355805|80466980|FG001|Overall Study|Decision by Sponsor|0|||
27624461|NCT05355805|80466981|FG002|Overall Study|Decision by Sponsor|0|||
27624462|NCT05355805|80466982|FG003|Overall Study|Decision by Sponsor|1|||
27856349|NCT00123474|81306754|FG001|Randomized to Treatment|Randomized, never treated|4|||
27624463|NCT05355805|80466979|FG000|Overall Study|Withdrawal by Subject|7|||
27624464|NCT05355805|80466980|FG001|Overall Study|Withdrawal by Subject|10|||
27624465|NCT05355805|80466981|FG002|Overall Study|Withdrawal by Subject|9|||
27624466|NCT05355805|80466982|FG003|Overall Study|Withdrawal by Subject|2|||
27624467|NCT05355805|80466979|FG000|Overall Study|Missing|0|||
27624468|NCT05355805|80466980|FG001|Overall Study|Missing|0|||
27624469|NCT05355805|80466981|FG002|Overall Study|Missing|1|||
27624470|NCT05355805|80466982|FG003|Overall Study|Missing|0|||
27624471|NCT05355805|80466979|FG000|Overall Study|Ongoing|0|||
27624472|NCT05355805|80466980|FG001|Overall Study|Ongoing|41|||
27624473|NCT05355805|80466981|FG002|Overall Study|Ongoing|38|||
27624474|NCT05355805|80466982|FG003|Overall Study|Ongoing|48|||
27624475|NCT01192295|80466983|FG000|Overall Study|Adverse Event|3|||
27624476|NCT01192295|80466984|FG001|Overall Study|Adverse Event|7|||
27624477|NCT01192295|80466983|FG000|Overall Study|Withdrawal by Subject|3|||
27528077|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27624478|NCT01192295|80466984|FG001|Overall Study|Withdrawal by Subject|4|||
27624479|NCT01192295|80466983|FG000|Overall Study|Lost to Follow-up|0|||
27624480|NCT01192295|80466984|FG001|Overall Study|Lost to Follow-up|1|||
27624481|NCT01192295|80466983|FG000|Overall Study|Lack of Efficacy|0|||
27624482|NCT01192295|80466984|FG001|Overall Study|Lack of Efficacy|5|||
27624483|NCT01192295|80466983|FG000|Overall Study|Administrative|4|||
27624484|NCT01192295|80466984|FG001|Overall Study|Administrative|6|||
27624485|NCT04639947|80466985|FG000|Overall Study|Screen fail|1|||
27624486|NCT02365298|80466986|FG000|Period 2|incorrect Rx dispensed|1|||
27624487|NCT02365298|80466987|FG001|Period 2|incorrect Rx dispensed|0|||
27624488|NCT02365298|80466986|FG000|Period 2|Discontinued at request of Sponsor|1|||
27624489|NCT02365298|80466987|FG001|Period 2|Discontinued at request of Sponsor|0|||
27624490|NCT02365298|80466986|FG000|Period 2|Test Article longer available|0|||
27624491|NCT02365298|80466987|FG001|Period 2|Test Article longer available|1|||
27624492|NCT02365298|80466986|FG000|Period 2|Protocol Violation|0|||
27624493|NCT02365298|80466987|FG001|Period 2|Protocol Violation|1|||
27733890|NCT00432237|80853425|FG002|Overall Study|Lack of Efficacy|0|||
27733891|NCT00432237|80853426|FG003|Overall Study|Lack of Efficacy|1|||
27733892|NCT00432237|80853423|FG000|Overall Study|Lost to Follow-up|10|||
27733893|NCT00432237|80853424|FG001|Overall Study|Lost to Follow-up|10|||
27733894|NCT00432237|80853425|FG002|Overall Study|Lost to Follow-up|18|||
27733895|NCT00432237|80853426|FG003|Overall Study|Lost to Follow-up|18|||
27733896|NCT00432237|80853423|FG000|Overall Study|Physician Decision|1|||
27733897|NCT00432237|80853424|FG001|Overall Study|Physician Decision|3|||
27733898|NCT00432237|80853425|FG002|Overall Study|Physician Decision|2|||
27856350|NCT00123474|81306755|FG002|Randomized to Treatment|Randomized, never treated|2|||
27528078|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27528079|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
27528080|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27528081|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27528082|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27528083|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27528084|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27528085|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Death|0|||
27528086|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Death|1|||
27528087|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Death|0|||
27528088|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Death|0|||
27528089|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Death|1|||
27528090|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Death|0|||
27528091|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Death|0|||
27528092|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Death|0|||
27528093|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Death|0|||
27528094|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Death|1|||
27528095|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
27528096|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528097|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528098|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528099|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528100|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27624494|NCT01833065|80466988|FG000|Overall Study|Adverse Event|6|||
27624495|NCT01833065|80466989|FG001|Overall Study|Adverse Event|1|||
27733899|NCT00432237|80853426|FG003|Overall Study|Physician Decision|1|||
27733900|NCT00432237|80853423|FG000|Overall Study|Pregnancy|0|||
27856351|NCT00123474|81306756|FG003|Randomized to Treatment|Randomized, never treated|1|||
27624496|NCT01833065|80466990|FG002|Overall Study|Adverse Event|0|||
27624497|NCT01833065|80466991|FG003|Overall Study|Adverse Event|2|||
27624498|NCT01833065|80466992|FG004|Overall Study|Adverse Event|3|||
27733901|NCT00432237|80853424|FG001|Overall Study|Pregnancy|1|||
27624499|NCT01833065|80466988|FG000|Overall Study|Protocol Violation|1|||
27733902|NCT00432237|80853425|FG002|Overall Study|Pregnancy|0|||
27856352|NCT00123474|81306753|FG000|As Treated at Study Closure|not reported when site closed|1|||
27528101|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528102|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528103|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528104|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
27528105|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
27528106|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
27528107|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
27528108|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
27528109|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
27528110|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27528111|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27528112|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27528113|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27528114|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27528115|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
27528116|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
27624500|NCT01833065|80466989|FG001|Overall Study|Protocol Violation|0|||
27624501|NCT01833065|80466990|FG002|Overall Study|Protocol Violation|0|||
27624502|NCT01833065|80466991|FG003|Overall Study|Protocol Violation|0|||
27624503|NCT01833065|80466992|FG004|Overall Study|Protocol Violation|2|||
27624504|NCT01833065|80466988|FG000|Overall Study|Lost to Follow-up|1|||
27624505|NCT01833065|80466989|FG001|Overall Study|Lost to Follow-up|0|||
27624506|NCT01833065|80466990|FG002|Overall Study|Lost to Follow-up|0|||
27624507|NCT01833065|80466991|FG003|Overall Study|Lost to Follow-up|0|||
27528117|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
27528118|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
27528119|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
27528120|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
27528121|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
27528122|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
27528123|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
27528124|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
27528125|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528126|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
27528127|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528128|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528129|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528130|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528131|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528132|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528133|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
27528134|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
27528135|NCT02414139|80126225|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
27528136|NCT02414139|80126226|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
27528137|NCT02414139|80126227|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
27528138|NCT02414139|80126228|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
27624508|NCT01833065|80466992|FG004|Overall Study|Lost to Follow-up|3|||
27624509|NCT01833065|80466988|FG000|Overall Study|Withdrawal by Subject|6|||
27911668|NCT01922258|81513702|FG000|Overall Study|Adverse Event|9|||
27624510|NCT01833065|80466989|FG001|Overall Study|Withdrawal by Subject|2|||
27624511|NCT01833065|80466990|FG002|Overall Study|Withdrawal by Subject|4|||
27624512|NCT01833065|80466991|FG003|Overall Study|Withdrawal by Subject|3|||
27624513|NCT01833065|80466992|FG004|Overall Study|Withdrawal by Subject|11|||
27624514|NCT01833065|80466988|FG000|Overall Study|Subject's substantial non-compliance|0|||
27624515|NCT01833065|80466989|FG001|Overall Study|Subject's substantial non-compliance|1|||
27624516|NCT01833065|80466990|FG002|Overall Study|Subject's substantial non-compliance|0|||
27624517|NCT01833065|80466991|FG003|Overall Study|Subject's substantial non-compliance|0|||
27624518|NCT01833065|80466992|FG004|Overall Study|Subject's substantial non-compliance|0|||
27624519|NCT01833065|80466988|FG000|Overall Study|Trial terminated by sponsor|8|||
27624520|NCT01833065|80466989|FG001|Overall Study|Trial terminated by sponsor|8|||
27624521|NCT01833065|80466990|FG002|Overall Study|Trial terminated by sponsor|7|||
27624522|NCT01833065|80466991|FG003|Overall Study|Trial terminated by sponsor|3|||
27624523|NCT01833065|80466992|FG004|Overall Study|Trial terminated by sponsor|13|||
27624524|NCT01833065|80466988|FG000|Overall Study|Others|2|||
27624525|NCT01833065|80466989|FG001|Overall Study|Others|1|||
27624526|NCT01833065|80466990|FG002|Overall Study|Others|1|||
27624527|NCT01833065|80466991|FG003|Overall Study|Others|1|||
27624528|NCT01833065|80466992|FG004|Overall Study|Others|4|||
27911669|NCT01922258|81513703|FG001|Overall Study|Adverse Event|2|||
27528139|NCT02414139|80126229|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
27528140|NCT02414139|80126230|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
27528141|NCT02414139|80126231|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
27624529|NCT00871429|80466993|FG000|Overall Study|Lost to Follow-up|6|||
27624530|NCT00871429|80466993|FG000|Overall Study|Withdrawal by Subject|17|||
27624531|NCT00871429|80466993|FG000|Overall Study|Questionnaire not completed|1|||
27624532|NCT01390857|80466995|FG000|Overall Study|Protocol Violation|2|||
27624533|NCT01390857|80466995|FG000|Overall Study|Lost to Follow-up|1|||
27624534|NCT01390857|80466995|FG000|Overall Study|No Visit after the First Visit|7|||
27624535|NCT03246672|80467000|FG000|Overall Study|Lost to Follow-up|2|||
27624536|NCT01941316|80467005|FG000|Overall Study|Adverse Event|0|||
27624537|NCT01941316|80467006|FG001|Overall Study|Adverse Event|1|||
27624538|NCT01941316|80467007|FG002|Overall Study|Adverse Event|0|||
27624539|NCT01941316|80467008|FG003|Overall Study|Adverse Event|7|||
27624540|NCT01941316|80467005|FG000|Overall Study|Progressive Disease|3|||
27624541|NCT01941316|80467006|FG001|Overall Study|Progressive Disease|6|||
27624542|NCT01941316|80467007|FG002|Overall Study|Progressive Disease|2|||
27624543|NCT01941316|80467008|FG003|Overall Study|Progressive Disease|29|||
27624544|NCT01941316|80467005|FG000|Overall Study|Withdrawal by Subject|0|||
27624545|NCT01941316|80467006|FG001|Overall Study|Withdrawal by Subject|2|||
27624546|NCT01941316|80467007|FG002|Overall Study|Withdrawal by Subject|1|||
27624547|NCT01941316|80467008|FG003|Overall Study|Withdrawal by Subject|8|||
27911670|NCT01922258|81513702|FG000|Overall Study|Met Withdrawal Criteria|0|||
27911671|NCT01922258|81513703|FG001|Overall Study|Met Withdrawal Criteria|4|||
27911672|NCT01922258|81513702|FG000|Overall Study|Withdrawn by the Investigator|1|||
27911673|NCT01922258|81513703|FG001|Overall Study|Withdrawn by the Investigator|4|||
27911674|NCT01922258|81513702|FG000|Overall Study|Withdrawal by participant|5|||
27911675|NCT01922258|81513703|FG001|Overall Study|Withdrawal by participant|5|||
27911676|NCT03014206|81513704|FG000|Overall Study|Registration Violation|12|||
27911677|NCT02557399|81513708|FG000|Overall Study|Adverse Event|6|||
27911678|NCT02557399|81513709|FG001|Overall Study|Adverse Event|5|||
27911679|NCT02557399|81513708|FG000|Overall Study|Protocol Violation|0|||
27911680|NCT02557399|81513709|FG001|Overall Study|Protocol Violation|1|||
27911681|NCT02557399|81513708|FG000|Overall Study|Protocol-defined stopping criteria|0|||
27911682|NCT02557399|81513709|FG001|Overall Study|Protocol-defined stopping criteria|1|||
27911683|NCT02557399|81513708|FG000|Overall Study|Withdrawal by Subject|1|||
27911684|NCT02557399|81513709|FG001|Overall Study|Withdrawal by Subject|1|||
27911685|NCT02576977|81513710|FG000|Overall Study|Adverse Event|13|||
27911686|NCT02576977|81513711|FG001|Overall Study|Adverse Event|2|||
27911687|NCT02576977|81513710|FG000|Overall Study|Death|73|||
27911688|NCT02576977|81513711|FG001|Overall Study|Death|60|||
27911689|NCT02576977|81513710|FG000|Overall Study|Screen failure|1|||
27911690|NCT02576977|81513711|FG001|Overall Study|Screen failure|0|||
27911691|NCT02576977|81513710|FG000|Overall Study|Study Terminated at Selected Sites|27|||
27911692|NCT02576977|81513711|FG001|Overall Study|Study Terminated at Selected Sites|50|||
27911693|NCT02576977|81513710|FG000|Overall Study|Withdrawal by Subject|11|||
27911694|NCT02576977|81513711|FG001|Overall Study|Withdrawal by Subject|11|||
27911695|NCT02576977|81513710|FG000|Overall Study|Final Disposition Unknown|0|||
27528142|NCT02414139|80126232|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
27528143|NCT02414139|80126233|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
27528144|NCT02414139|80126234|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
27528145|NCT00814879|80126235|FG000|By Week 24|Cancer Diagnosis|1|||
27528146|NCT00814879|80126236|FG001|By Week 24|Cancer Diagnosis|0|||
27528147|NCT00814879|80126235|FG000|By Week 24|Incarceration|0|||
27528148|NCT00814879|80126236|FG001|By Week 24|Incarceration|1|||
27528149|NCT00814879|80126235|FG000|By Week 48|Lost to Follow-up|2|||
27528150|NCT00814879|80126236|FG001|By Week 48|Lost to Follow-up|2|||
27528151|NCT00814879|80126235|FG000|By Week 48|Death|0|||
27528152|NCT00814879|80126236|FG001|By Week 48|Death|1|||
27528153|NCT01850602|80126237|FG000|Overall Study|Adverse Event|7|||
27528154|NCT01850602|80126238|FG001|Overall Study|Adverse Event|10|||
27528155|NCT01850602|80126237|FG000|Overall Study|Physician Decision|2|||
27624548|NCT01941316|80467005|FG000|Overall Study|Death|0|||
27624549|NCT01941316|80467006|FG001|Overall Study|Death|0|||
27624550|NCT01941316|80467007|FG002|Overall Study|Death|0|||
27624551|NCT01941316|80467008|FG003|Overall Study|Death|3|||
27624552|NCT01941316|80467005|FG000|Overall Study|Physician Decision|0|||
27624553|NCT01941316|80467006|FG001|Overall Study|Physician Decision|0|||
27624554|NCT01941316|80467007|FG002|Overall Study|Physician Decision|0|||
27624555|NCT01941316|80467008|FG003|Overall Study|Physician Decision|3|||
27624556|NCT01941316|80467005|FG000|Overall Study|Protocol Violation|0|||
27624557|NCT01941316|80467006|FG001|Overall Study|Protocol Violation|0|||
27624558|NCT01941316|80467007|FG002|Overall Study|Protocol Violation|0|||
27624559|NCT01941316|80467008|FG003|Overall Study|Protocol Violation|3|||
27911696|NCT02576977|81513711|FG001|Overall Study|Final Disposition Unknown|1|||
27911697|NCT02576977|81513710|FG000|Overall Study|Lost to Follow-up|1|||
27911698|NCT02576977|81513711|FG001|Overall Study|Lost to Follow-up|0|||
27911699|NCT02576977|81513710|FG000|Overall Study|Progressive Disease|0|||
27733903|NCT00432237|80853426|FG003|Overall Study|Pregnancy|0|||
27733904|NCT00432237|80853423|FG000|Overall Study|Protocol Violation|13|||
27733905|NCT00432237|80853424|FG001|Overall Study|Protocol Violation|10|||
27733906|NCT00432237|80853425|FG002|Overall Study|Protocol Violation|11|||
27733907|NCT00432237|80853426|FG003|Overall Study|Protocol Violation|8|||
27733908|NCT00432237|80853423|FG000|Overall Study|Withdrawal by Subject|5|||
27733909|NCT00432237|80853424|FG001|Overall Study|Withdrawal by Subject|6|||
27733910|NCT00432237|80853425|FG002|Overall Study|Withdrawal by Subject|9|||
27733911|NCT00432237|80853426|FG003|Overall Study|Withdrawal by Subject|11|||
27911700|NCT02576977|81513711|FG001|Overall Study|Progressive Disease|1|||
27911701|NCT04110314|81513712|FG000|Overall Study|Did not meet inclusion criteria|35255|||
27911702|NCT04110314|81513713|FG001|Overall Study|Did not meet inclusion criteria|35104|||
27911703|NCT04110314|81513714|FG002|Overall Study|Did not meet inclusion criteria|35636|||
27911704|NCT04110314|81513715|FG003|Overall Study|Did not meet inclusion criteria|35135|||
27911705|NCT04110314|81513716|FG004|Overall Study|Did not meet inclusion criteria|35247|||
27911706|NCT04110314|81513717|FG005|Overall Study|Did not meet inclusion criteria|35727|||
27911707|NCT02686164|81513718|FG000|Overall Study|Adverse Event|1|||
27911708|NCT02686164|81513718|FG000|Overall Study|Withdrawal of consent|1|||
27911709|NCT02686164|81513718|FG000|Overall Study|Clinical progression|1|||
27911710|NCT00493012|81513719|FG000|Overall Study|Lost to Follow-up|18|||
27911711|NCT00493012|81513720|FG001|Overall Study|Lost to Follow-up|17|||
27911712|NCT04004260|81513721|FG000|Overall Study|Withdrawal by Subject|7|||
27911713|NCT04004260|81513722|FG001|Overall Study|Withdrawal by Subject|3|||
27911714|NCT04004260|81513721|FG000|Overall Study|Lost to Follow-up|22|||
27911715|NCT04004260|81513722|FG001|Overall Study|Lost to Follow-up|12|||
27911716|NCT04004260|81513721|FG000|Overall Study|Did not engage in intervention|13|||
27911717|NCT04004260|81513722|FG001|Overall Study|Did not engage in intervention|17|||
27911718|NCT02989402|81513723|FG000|Overall Study|Adverse event, or serious adverse event|4|||
27911719|NCT02989402|81513723|FG000|Overall Study|Death|2|||
27911720|NCT02989402|81513723|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
27911721|NCT02989402|81513723|FG000|Overall Study|Lost to Follow-up|8|||
27911722|NCT02989402|81513723|FG000|Overall Study|Patient no longer on monotherapy|1|||
27911723|NCT02989402|81513723|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
27911724|NCT02989402|81513723|FG000|Overall Study|Withdrawal by Subject|7|||
27911725|NCT02989402|81513723|FG000|Overall Study|Other|2|||
27911726|NCT00402727|81513724|FG000|Overall Study|Adverse Event|10|||
27911727|NCT00402727|81513725|FG001|Overall Study|Adverse Event|6|||
27911728|NCT00402727|81513724|FG000|Overall Study|Death|1|||
27911729|NCT00402727|81513725|FG001|Overall Study|Death|0|||
27911730|NCT00402727|81513724|FG000|Overall Study|Lack of Efficacy|1|||
27911731|NCT00402727|81513725|FG001|Overall Study|Lack of Efficacy|3|||
27911732|NCT00402727|81513724|FG000|Overall Study|Lost to Follow-up|24|||
27911733|NCT00402727|81513725|FG001|Overall Study|Lost to Follow-up|11|||
27911734|NCT00402727|81513724|FG000|Overall Study|Physician Decision|1|||
27911735|NCT00402727|81513725|FG001|Overall Study|Physician Decision|1|||
27528156|NCT01850602|80126238|FG001|Overall Study|Physician Decision|1|||
27528157|NCT01850602|80126237|FG000|Overall Study|Withdrawal by Subject|2|||
27528158|NCT01850602|80126238|FG001|Overall Study|Withdrawal by Subject|4|||
27528159|NCT01850602|80126237|FG000|Overall Study|Decrease in serum calcium|2|||
27528160|NCT01850602|80126238|FG001|Overall Study|Decrease in serum calcium|3|||
27528161|NCT01850602|80126237|FG000|Overall Study|Increase in serum ferritin|1|||
27733912|NCT00432237|80853423|FG000|Overall Study|Lack of Qualifying Event|38|||
27733913|NCT00432237|80853424|FG001|Overall Study|Lack of Qualifying Event|71|||
27911736|NCT00402727|81513724|FG000|Overall Study|Protocol Violation|0|||
27911737|NCT00402727|81513725|FG001|Overall Study|Protocol Violation|4|||
27911738|NCT00402727|81513724|FG000|Overall Study|Withdrawal by Subject|3|||
27733914|NCT00432237|80853425|FG002|Overall Study|Lack of Qualifying Event|69|||
27733915|NCT00432237|80853426|FG003|Overall Study|Lack of Qualifying Event|84|||
27733916|NCT00870688|80853427|FG000|Overall Study|Lost to Follow-up|2|||
27733917|NCT00870688|80853427|FG000|Overall Study|Death, Unrelated|1|||
27733918|NCT00870688|80853427|FG000|Overall Study|Granules in the Stools|1|||
27733919|NCT03715465|80853428|FG000|Overall Study|Withdrawal by Subject|1|||
27733920|NCT03715465|80853429|FG001|Overall Study|Withdrawal by Subject|2|||
27733921|NCT01802281|80853431|FG000|Overall Study|Death|1|||
27733922|NCT01802281|80853432|FG001|Overall Study|Death|2|||
27733923|NCT01802281|80853431|FG000|Overall Study|Withdrawal by Subject|2|||
27911739|NCT00402727|81513725|FG001|Overall Study|Withdrawal by Subject|7|||
27528162|NCT01850602|80126238|FG001|Overall Study|Increase in serum ferritin|0|||
27528163|NCT02448680|80126243|FG000|Overall Study|Physician Decision|1|||
27528164|NCT02448680|80126244|FG001|Overall Study|Physician Decision|1|||
27528165|NCT02448680|80126243|FG000|Overall Study|Withdrawal by Subject|0|||
27528166|NCT02448680|80126244|FG001|Overall Study|Withdrawal by Subject|2|||
27528167|NCT00589784|80126245|FG000|Overall Study|Withdrawal by Subject|0|||
27528168|NCT00589784|80126246|FG001|Overall Study|Withdrawal by Subject|6|||
27528169|NCT00589784|80126245|FG000|Overall Study|Patient inevaluable|1|||
27528170|NCT00589784|80126246|FG001|Overall Study|Patient inevaluable|0|||
27528171|NCT00589784|80126245|FG000|Overall Study|Adverse Event|0|||
27528172|NCT00589784|80126246|FG001|Overall Study|Adverse Event|4|||
27528173|NCT01653782|80126247|FG000|Overall Study|Withdrawal by Subject|9|||
27528174|NCT01653782|80126248|FG001|Overall Study|Withdrawal by Subject|15|||
27528175|NCT01653782|80126249|FG002|Overall Study|Withdrawal by Subject|4|||
27528176|NCT01653782|80126247|FG000|Overall Study|Lost to Follow-up|7|||
27528177|NCT01653782|80126248|FG001|Overall Study|Lost to Follow-up|3|||
27528178|NCT01653782|80126249|FG002|Overall Study|Lost to Follow-up|2|||
27528179|NCT00938964|80126250|FG000|Overall Study|Death|3|||
27528180|NCT00938964|80126251|FG001|Overall Study|Death|3|||
27528181|NCT00938964|80126250|FG000|Overall Study|Lost to Follow-up|2|||
27528182|NCT00938964|80126251|FG001|Overall Study|Lost to Follow-up|3|||
27528183|NCT00938964|80126250|FG000|Overall Study|Withdrawal by Subject|22|||
27528184|NCT00938964|80126251|FG001|Overall Study|Withdrawal by Subject|18|||
27528185|NCT00938964|80126250|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
27528186|NCT00938964|80126251|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
27528187|NCT01484938|80126252|FG000|Overall Study|Adverse Event|2|||
27528188|NCT01484938|80126252|FG000|Overall Study|Lost to Follow-up|1|||
27528189|NCT01484938|80126252|FG000|Overall Study|Noncompliance|1|||
27528190|NCT04369924|80126253|FG000|Overall Study|Lost to Follow-up|302|||
27528191|NCT04369924|80126254|FG001|Overall Study|Lost to Follow-up|339|||
27528192|NCT01117051|80126255|FG000|Overall Study|Withdrawal by Subject|5|||
27528193|NCT01117051|80126256|FG001|Overall Study|Withdrawal by Subject|3|||
27528194|NCT01117051|80126255|FG000|Overall Study|Adverse Event|4|||
27528195|NCT01117051|80126256|FG001|Overall Study|Adverse Event|3|||
27528196|NCT01117051|80126255|FG000|Overall Study|Lost to Follow-up|0|||
27528197|NCT01117051|80126256|FG001|Overall Study|Lost to Follow-up|1|||
27528198|NCT01117051|80126255|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
27528199|NCT01117051|80126256|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
27528200|NCT01117051|80126255|FG000|Overall Study|Sponsor's decision|3|||
27528201|NCT01117051|80126256|FG001|Overall Study|Sponsor's decision|1|||
27528202|NCT01117051|80126255|FG000|Overall Study|Surgical procedure|0|||
27528203|NCT01117051|80126256|FG001|Overall Study|Surgical procedure|1|||
27528204|NCT01117051|80126255|FG000|Overall Study|Randomized by mistake|0|||
27528205|NCT01117051|80126256|FG001|Overall Study|Randomized by mistake|1|||
27528206|NCT01117051|80126255|FG000|Overall Study|Convenience issue|1|||
27528207|NCT01117051|80126256|FG001|Overall Study|Convenience issue|0|||
27528208|NCT03091777|80126257|FG000|Overall Study|Pregnancy|2|||
27528209|NCT03091777|80126258|FG001|Overall Study|Pregnancy|1|||
27528210|NCT03091777|80126259|FG002|Overall Study|Pregnancy|0|||
27528211|NCT03091777|80126257|FG000|Overall Study|Adverse Event|2|||
27528212|NCT03091777|80126258|FG001|Overall Study|Adverse Event|1|||
27528213|NCT03091777|80126259|FG002|Overall Study|Adverse Event|4|||
27528214|NCT03091777|80126257|FG000|Overall Study|Withdrawal by Subject|4|||
27528215|NCT03091777|80126258|FG001|Overall Study|Withdrawal by Subject|2|||
27528216|NCT03091777|80126259|FG002|Overall Study|Withdrawal by Subject|6|||
27528217|NCT03091777|80126257|FG000|Overall Study|Protocol Violation|2|||
27528218|NCT03091777|80126258|FG001|Overall Study|Protocol Violation|1|||
27911740|NCT00402727|81513724|FG000|Overall Study|supply problems|2|||
27528219|NCT03091777|80126259|FG002|Overall Study|Protocol Violation|1|||
27528220|NCT03091777|80126257|FG000|Overall Study|Lost to Follow-up|12|||
27528221|NCT03091777|80126258|FG001|Overall Study|Lost to Follow-up|14|||
27528222|NCT03091777|80126259|FG002|Overall Study|Lost to Follow-up|7|||
27733924|NCT01802281|80853432|FG001|Overall Study|Withdrawal by Subject|1|||
27733925|NCT01802281|80853431|FG000|Overall Study|Ineligible|5|||
27528223|NCT03091777|80126257|FG000|Overall Study|Lack of Efficacy|0|||
27528224|NCT03091777|80126258|FG001|Overall Study|Lack of Efficacy|0|||
27528225|NCT03091777|80126259|FG002|Overall Study|Lack of Efficacy|5|||
27733926|NCT01802281|80853432|FG001|Overall Study|Ineligible|3|||
27733927|NCT04426630|80853433|FG000|Overall Study|Death|4|||
27733928|NCT04426630|80853433|FG000|Overall Study|Lost to Follow-up|2|||
27733929|NCT04125680|80853438|FG000|Overall Study|Lost to Follow-up|15|||
27733930|NCT00811252|80853442|FG000|Overall Study|Adverse Event|6|||
27733931|NCT00811252|80853443|FG001|Overall Study|Adverse Event|10|||
27733932|NCT00811252|80853444|FG002|Overall Study|Adverse Event|15|||
27733933|NCT00811252|80853442|FG000|Overall Study|Lack of Efficacy|7|||
27733934|NCT00811252|80853443|FG001|Overall Study|Lack of Efficacy|2|||
27733935|NCT00811252|80853444|FG002|Overall Study|Lack of Efficacy|0|||
27733936|NCT00811252|80853442|FG000|Overall Study|Protocol Violation|3|||
27733937|NCT00811252|80853443|FG001|Overall Study|Protocol Violation|3|||
27733938|NCT00811252|80853444|FG002|Overall Study|Protocol Violation|2|||
27733939|NCT00811252|80853442|FG000|Overall Study|Withdrawal of Consent|1|||
27733940|NCT00811252|80853443|FG001|Overall Study|Withdrawal of Consent|2|||
27733941|NCT00811252|80853444|FG002|Overall Study|Withdrawal of Consent|2|||
27733942|NCT00811252|80853442|FG000|Overall Study|Lost to Follow-up|0|||
27733943|NCT00811252|80853443|FG001|Overall Study|Lost to Follow-up|0|||
27733944|NCT00811252|80853444|FG002|Overall Study|Lost to Follow-up|2|||
27733945|NCT00811252|80853442|FG000|Overall Study|Administrative or Other Reasons|0|||
27733946|NCT00811252|80853443|FG001|Overall Study|Administrative or Other Reasons|3|||
27733947|NCT00811252|80853444|FG002|Overall Study|Administrative or Other Reasons|2|||
27733948|NCT00619229|80853445|FG000|Overall Study|Withdrawal by Subject|1|||
27733949|NCT00619229|80853446|FG001|Overall Study|Withdrawal by Subject|1|||
27733950|NCT00619229|80853445|FG000|Overall Study|Lost to Follow-up|1|||
27733951|NCT00619229|80853446|FG001|Overall Study|Lost to Follow-up|0|||
27733952|NCT00619229|80853445|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
27911741|NCT00402727|81513725|FG001|Overall Study|supply problems|1|||
27911742|NCT00402727|81513724|FG000|Overall Study|non-compliance|0|||
27528226|NCT03091777|80126257|FG000|Overall Study|Noncompliance with study drug|2|||
27528227|NCT03091777|80126258|FG001|Overall Study|Noncompliance with study drug|3|||
27528228|NCT03091777|80126259|FG002|Overall Study|Noncompliance with study drug|1|||
27528229|NCT03091777|80126257|FG000|Overall Study|Physician Decision|1|||
27528230|NCT03091777|80126258|FG001|Overall Study|Physician Decision|0|||
27528231|NCT03091777|80126259|FG002|Overall Study|Physician Decision|1|||
27528232|NCT03091777|80126257|FG000|Overall Study|Abnormal Laboratory Value|7|||
27528233|NCT03091777|80126258|FG001|Overall Study|Abnormal Laboratory Value|11|||
27528234|NCT03091777|80126259|FG002|Overall Study|Abnormal Laboratory Value|12|||
27528235|NCT02734433|80126260|FG000|Overall Study|Disease progression|1|||
27528236|NCT02734433|80126261|FG001|Overall Study|Disease progression|5|||
27528237|NCT02734433|80126260|FG000|Overall Study|Clinical progression|0|||
27528238|NCT02734433|80126261|FG001|Overall Study|Clinical progression|1|||
27528239|NCT02734433|80126260|FG000|Overall Study|Withdrawal by Subject|1|||
27528240|NCT02734433|80126261|FG001|Overall Study|Withdrawal by Subject|2|||
27528241|NCT02446743|80126264|FG000|Overall Study|Withdrawal by Subject|1|||
27528242|NCT02446743|80126265|FG001|Overall Study|Withdrawal by Subject|1|||
27528243|NCT02446743|80126264|FG000|Overall Study|Lost to Follow-up|1|||
27528244|NCT02446743|80126265|FG001|Overall Study|Lost to Follow-up|0|||
27528245|NCT02446743|80126264|FG000|Overall Study|Adverse Event|1|||
27528246|NCT02446743|80126265|FG001|Overall Study|Adverse Event|1|||
27528247|NCT02446743|80126264|FG000|Overall Study|Other|2|||
27528248|NCT02446743|80126265|FG001|Overall Study|Other|3|||
27528249|NCT01227564|80126266|FG000|Overall Study|No Longer Willing to Participate|4|||
27528250|NCT01227564|80126267|FG001|Overall Study|No Longer Willing to Participate|2|||
27528251|NCT01227564|80126268|FG002|Overall Study|No Longer Willing to Participate|5|||
27528252|NCT01227564|80126266|FG000|Overall Study|Participant moved to another town|0|||
27528253|NCT01227564|80126267|FG001|Overall Study|Participant moved to another town|0|||
27528254|NCT01227564|80126268|FG002|Overall Study|Participant moved to another town|1|||
27528255|NCT01629706|80126269|FG000|Phase 1 PureVision|Screen Failure|4|||
27528256|NCT01629706|80126269|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
27528257|NCT01629706|80126269|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
27528258|NCT01629706|80126269|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
27528259|NCT01629706|80126269|FG000|Phase 2 Habitual|Screen Failure|6|||
27528260|NCT01629706|80126269|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
27911743|NCT00402727|81513725|FG001|Overall Study|non-compliance|1|||
27528261|NCT01629706|80126269|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
27528262|NCT01629706|80126269|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
27528263|NCT01629706|80126269|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
27528264|NCT01565499|80126271|FG000|Overall Study|Physician Decision|1|||
27624560|NCT01941316|80467005|FG000|Overall Study|Intercurrent illness|0|||
27733953|NCT00619229|80853446|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
27528265|NCT01565499|80126271|FG000|Overall Study|Adverse Event|5|||
27528266|NCT01565499|80126271|FG000|Overall Study|Withdrawal by Subject|2|||
27624561|NCT01941316|80467006|FG001|Overall Study|Intercurrent illness|0|||
27733954|NCT00619229|80853445|FG000|Overall Study|Investigator planned Cataract Operation|1|||
27911744|NCT02324361|81513734|FG000|Overall Study|Lost to Follow-up|5|||
27733955|NCT00619229|80853446|FG001|Overall Study|Investigator planned Cataract Operation|0|||
27528267|NCT01233687|80126275|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
27528268|NCT01233687|80126275|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
27528269|NCT01233687|80126275|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
27528270|NCT03312751|80126278|FG000|Overall Study|Death|7|||
27528271|NCT03312751|80126279|FG001|Overall Study|Death|9|||
27528272|NCT03312751|80126278|FG000|Overall Study|Study discontinuation due to other reason|0|||
27528273|NCT03312751|80126279|FG001|Overall Study|Study discontinuation due to other reason|1|||
27528274|NCT03475875|80126280|FG000|Period 1|Lost to Follow-up|1|||
27528275|NCT03475875|80126281|FG001|Period 1|Lost to Follow-up|0|||
27528276|NCT03475875|80126280|FG000|Period 1|Adverse Event|2|||
27528277|NCT03475875|80126281|FG001|Period 1|Adverse Event|1|||
27528278|NCT03475875|80126280|FG000|Period 2|Adverse Event|3|||
27528279|NCT03475875|80126281|FG001|Period 2|Adverse Event|0|||
27856353|NCT00123474|81306754|FG001|As Treated at Study Closure|not reported when site closed|0|||
27856354|NCT00123474|81306755|FG002|As Treated at Study Closure|not reported when site closed|1|||
27856355|NCT00123474|81306756|FG003|As Treated at Study Closure|not reported when site closed|0|||
27856356|NCT00123474|81306753|FG000|As Treated at Study Closure|Adverse Event|10|||
27856357|NCT00123474|81306754|FG001|As Treated at Study Closure|Adverse Event|4|||
27856358|NCT00123474|81306755|FG002|As Treated at Study Closure|Adverse Event|10|||
27856359|NCT00123474|81306756|FG003|As Treated at Study Closure|Adverse Event|8|||
27856360|NCT00123474|81306753|FG000|As Treated at Study Closure|Disease Progression|35|||
27856361|NCT00123474|81306754|FG001|As Treated at Study Closure|Disease Progression|42|||
27856362|NCT00123474|81306755|FG002|As Treated at Study Closure|Disease Progression|29|||
27856363|NCT00123474|81306756|FG003|As Treated at Study Closure|Disease Progression|27|||
27856364|NCT00123474|81306753|FG000|As Treated at Study Closure|Investigator Request|12|||
27528280|NCT03475875|80126280|FG000|Period 2|Protocol Violation|0|||
27528281|NCT03475875|80126281|FG001|Period 2|Protocol Violation|1|||
27528282|NCT00821327|80126283|FG000|Overall Study|Adverse Event|13|||
27528283|NCT00821327|80126283|FG000|Overall Study|Patient Request|1|||
27528284|NCT00821327|80126283|FG000|Overall Study|Investigator Request|2|||
27528285|NCT00821327|80126283|FG000|Overall Study|Sponsor Request|1|||
27528286|NCT00821327|80126283|FG000|Overall Study|Disease Progression|13|||
27528287|NCT00821327|80126283|FG000|Overall Study|Other/Unknown|5|||
27528288|NCT00704522|80126284|FG000|Overall Study|Lack of Efficacy|65|||
27528289|NCT00704522|80126285|FG001|Overall Study|Lack of Efficacy|17|||
27528290|NCT00704522|80126284|FG000|Overall Study|Failure to appear again at hospital|56|||
27528291|NCT00704522|80126285|FG001|Overall Study|Failure to appear again at hospital|10|||
27528292|NCT00704522|80126284|FG000|Overall Study|Withdrawal by Subject|17|||
27528293|NCT00704522|80126285|FG001|Overall Study|Withdrawal by Subject|8|||
27528294|NCT00704522|80126284|FG000|Overall Study|Adverse Event|9|||
27528295|NCT00704522|80126285|FG001|Overall Study|Adverse Event|1|||
27528296|NCT00704522|80126284|FG000|Overall Study|Undefined causes|9|||
27528297|NCT00704522|80126285|FG001|Overall Study|Undefined causes|7|||
27733956|NCT04725682|80853447|FG000|Overall Study|Withdrawal by Subject|7|||
27733957|NCT04725682|80853448|FG001|Overall Study|Withdrawal by Subject|5|||
27733958|NCT04725682|80853447|FG000|Overall Study|Failed to comply with the requirements|2|||
27733959|NCT04725682|80853448|FG001|Overall Study|Failed to comply with the requirements|1|||
27733960|NCT04725682|80853447|FG000|Overall Study|Adverse Event|1|||
27733961|NCT04725682|80853448|FG001|Overall Study|Adverse Event|1|||
27733962|NCT04725682|80853447|FG000|Overall Study|Death|0|||
27733963|NCT04725682|80853448|FG001|Overall Study|Death|1|||
27733964|NCT00935883|80853449|FG000|Treatment Period|Physician Decision|1|||
27733965|NCT00935883|80853450|FG001|Treatment Period|Physician Decision|0|||
27733966|NCT00935883|80853449|FG000|Treatment Period|Withdrawal by Subject|0|||
27733967|NCT00935883|80853450|FG001|Treatment Period|Withdrawal by Subject|2|||
27733968|NCT01147809|80853453|FG000|Phase I (168 Days)|Adverse Event|0|||
27733969|NCT01147809|80853454|FG001|Phase I (168 Days)|Adverse Event|0|||
27733970|NCT01147809|80853455|FG002|Phase I (168 Days)|Adverse Event|0|||
27733971|NCT01147809|80853456|FG003|Phase I (168 Days)|Adverse Event|1|||
27733972|NCT01147809|80853457|FG004|Phase I (168 Days)|Adverse Event|0|||
27733973|NCT01147809|80853458|FG005|Phase I (168 Days)|Adverse Event|0|||
27733974|NCT01147809|80853453|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
27733975|NCT01147809|80853454|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
27733976|NCT01147809|80853455|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
27733977|NCT01147809|80853456|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
27733978|NCT01147809|80853457|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
27733979|NCT01147809|80853458|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
27733980|NCT01147809|80853453|FG000|Phase I (168 Days)|Physician Decision|0|||
27733981|NCT01147809|80853454|FG001|Phase I (168 Days)|Physician Decision|1|||
27733982|NCT01147809|80853455|FG002|Phase I (168 Days)|Physician Decision|2|||
27733983|NCT01147809|80853456|FG003|Phase I (168 Days)|Physician Decision|0|||
27733984|NCT01147809|80853457|FG004|Phase I (168 Days)|Physician Decision|0|||
27528298|NCT00704522|80126284|FG000|Overall Study|No information on therapy end|27|||
27733985|NCT01147809|80853458|FG005|Phase I (168 Days)|Physician Decision|0|||
27733986|NCT01147809|80853453|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
27733987|NCT01147809|80853454|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
27733988|NCT01147809|80853455|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
27733989|NCT01147809|80853456|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
27733990|NCT01147809|80853457|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
27733991|NCT01147809|80853458|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
27733992|NCT01147809|80853453|FG000|Phase II (168 Days)|Adverse Event|0|||
27733993|NCT01147809|80853454|FG001|Phase II (168 Days)|Adverse Event|0|||
27733994|NCT01147809|80853455|FG002|Phase II (168 Days)|Adverse Event|0|||
27733995|NCT01147809|80853456|FG003|Phase II (168 Days)|Adverse Event|0|||
27733996|NCT01147809|80853457|FG004|Phase II (168 Days)|Adverse Event|3|||
27733997|NCT01147809|80853458|FG005|Phase II (168 Days)|Adverse Event|6|||
27733998|NCT01147809|80853453|FG000|Phase II (168 Days)|Protocol Violation|0|||
27733999|NCT01147809|80853454|FG001|Phase II (168 Days)|Protocol Violation|0|||
27734000|NCT01147809|80853455|FG002|Phase II (168 Days)|Protocol Violation|0|||
27734001|NCT01147809|80853456|FG003|Phase II (168 Days)|Protocol Violation|0|||
27734002|NCT01147809|80853457|FG004|Phase II (168 Days)|Protocol Violation|0|||
27734003|NCT01147809|80853458|FG005|Phase II (168 Days)|Protocol Violation|1|||
27734004|NCT01147809|80853453|FG000|Phase II (168 Days)|Physician Decision|0|||
27734005|NCT01147809|80853454|FG001|Phase II (168 Days)|Physician Decision|0|||
27734006|NCT01147809|80853455|FG002|Phase II (168 Days)|Physician Decision|0|||
27734007|NCT01147809|80853456|FG003|Phase II (168 Days)|Physician Decision|0|||
27734008|NCT01147809|80853457|FG004|Phase II (168 Days)|Physician Decision|5|||
27734009|NCT01147809|80853458|FG005|Phase II (168 Days)|Physician Decision|11|||
27734010|NCT01147809|80853453|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
27734011|NCT01147809|80853454|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
27734012|NCT01147809|80853455|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
27734013|NCT01147809|80853456|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
27734014|NCT01147809|80853457|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
27734015|NCT01147809|80853458|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
27734016|NCT01147809|80853453|FG000|Phase II (168 Days)|Ongoing|0|||
27734017|NCT01147809|80853454|FG001|Phase II (168 Days)|Ongoing|0|||
27734018|NCT01147809|80853455|FG002|Phase II (168 Days)|Ongoing|0|||
27734019|NCT01147809|80853456|FG003|Phase II (168 Days)|Ongoing|0|||
27734020|NCT01147809|80853457|FG004|Phase II (168 Days)|Ongoing|1|||
27734021|NCT01147809|80853458|FG005|Phase II (168 Days)|Ongoing|0|||
27734022|NCT00270894|80853459|FG000|Overall Study|Adverse Event|1|||
27734023|NCT00270894|80853459|FG000|Overall Study|Withdrawal by Subject|1|||
27734024|NCT01950819|80853469|FG000|Overall Study|Graft Loss|35|||
27734025|NCT01950819|80853470|FG001|Overall Study|Graft Loss|30|||
27856365|NCT00123474|81306754|FG001|As Treated at Study Closure|Investigator Request|6|||
27856366|NCT00123474|81306755|FG002|As Treated at Study Closure|Investigator Request|7|||
27856367|NCT00123474|81306756|FG003|As Treated at Study Closure|Investigator Request|5|||
27856368|NCT00123474|81306753|FG000|As Treated at Study Closure|non-specified|54|||
27856369|NCT00123474|81306754|FG001|As Treated at Study Closure|non-specified|47|||
27856370|NCT00123474|81306755|FG002|As Treated at Study Closure|non-specified|57|||
27856371|NCT00123474|81306756|FG003|As Treated at Study Closure|non-specified|60|||
27856372|NCT00123474|81306753|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
27856373|NCT00123474|81306754|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
27528299|NCT00704522|80126285|FG001|Overall Study|No information on therapy end|2|||
27528300|NCT00378079|80126300|FG000|Overall Study|Lost to Follow-up|6|||
27528301|NCT00378079|80126301|FG001|Overall Study|Lost to Follow-up|1|||
27528302|NCT00378079|80126302|FG002|Overall Study|Lost to Follow-up|0|||
27528303|NCT03828370|80126307|FG000|3 Month Follow-up|Lost to Follow-up|4|||
27528304|NCT03828370|80126308|FG001|3 Month Follow-up|Lost to Follow-up|12|||
27528305|NCT03828370|80126307|FG000|9 Month Follow up|Lost to Follow-up|12|||
27528306|NCT03828370|80126308|FG001|9 Month Follow up|Lost to Follow-up|20|||
27528307|NCT01514370|80126309|FG000|Overall Study|Protocol Violation|2|||
27528308|NCT01514370|80126310|FG001|Overall Study|Protocol Violation|3|||
27528309|NCT01514370|80126309|FG000|Overall Study|Lost to Follow-up|0|||
27528310|NCT01514370|80126310|FG001|Overall Study|Lost to Follow-up|2|||
27528311|NCT01514370|80126309|FG000|Overall Study|Withdrawal by Subject|2|||
27528312|NCT01514370|80126310|FG001|Overall Study|Withdrawal by Subject|1|||
27528313|NCT01514370|80126309|FG000|Overall Study|Adverse Event|1|||
27624562|NCT01941316|80467007|FG002|Overall Study|Intercurrent illness|0|||
27734026|NCT01950819|80853469|FG000|Overall Study|Death|29|||
27734027|NCT01950819|80853470|FG001|Overall Study|Death|34|||
27734028|NCT01950819|80853469|FG000|Overall Study|Subject / Gardian decision|54|||
27734029|NCT01950819|80853470|FG001|Overall Study|Subject / Gardian decision|51|||
27734030|NCT01950819|80853469|FG000|Overall Study|technical problems|2|||
27528314|NCT01514370|80126310|FG001|Overall Study|Adverse Event|3|||
27528315|NCT01514370|80126309|FG000|Overall Study|Other|6|||
27734031|NCT01950819|80853470|FG001|Overall Study|technical problems|0|||
27734032|NCT01950819|80853469|FG000|Overall Study|Pregnancy|0|||
27734033|NCT01950819|80853470|FG001|Overall Study|Pregnancy|2|||
27734034|NCT01950819|80853469|FG000|Overall Study|Lost to Follow-up|9|||
27734035|NCT01950819|80853470|FG001|Overall Study|Lost to Follow-up|17|||
27856374|NCT00123474|81306755|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
27528316|NCT01514370|80126310|FG001|Overall Study|Other|7|||
27734036|NCT02209506|80853471|FG000|Overall Study|Withdrawal by Subject|0|||
27528317|NCT00206076|80126312|FG000|Overall Study|Physician Decision|2|||
27528318|NCT00206076|80126313|FG001|Overall Study|Physician Decision|0|||
27528319|NCT00206076|80126312|FG000|Overall Study|Withdrawal by Subject|1|||
27528320|NCT00206076|80126313|FG001|Overall Study|Withdrawal by Subject|1|||
27528321|NCT02017171|80126314|FG000|Overall Study|Death|10|||
27528322|NCT02017171|80126315|FG001|Overall Study|Death|4|||
27528323|NCT02017171|80126314|FG000|Overall Study|Withdrawal by Subject|23|||
27528324|NCT02017171|80126315|FG001|Overall Study|Withdrawal by Subject|17|||
27528325|NCT02017171|80126314|FG000|Overall Study|Lost to Follow-up|21|||
27528326|NCT02017171|80126315|FG001|Overall Study|Lost to Follow-up|20|||
27528327|NCT02017171|80126314|FG000|Overall Study|ESKD|6|||
27528328|NCT02017171|80126315|FG001|Overall Study|ESKD|2|||
27528329|NCT02017171|80126314|FG000|Overall Study|Miscellaneous|2|||
27528330|NCT02017171|80126315|FG001|Overall Study|Miscellaneous|3|||
27528331|NCT02514473|80128591|FG000|Overall Study|Adverse Event|0|||
27528332|NCT02514473|80128592|FG001|Overall Study|Adverse Event|2|||
27528333|NCT02514473|80128591|FG000|Overall Study|Withdrawal by Subject|2|||
27528334|NCT02514473|80128592|FG001|Overall Study|Withdrawal by Subject|1|||
27528335|NCT02514473|80128591|FG000|Overall Study|Lost to Follow-up|0|||
27528336|NCT02514473|80128592|FG001|Overall Study|Lost to Follow-up|1|||
27528337|NCT02514473|80128591|FG000|Overall Study|Other|1|||
27528338|NCT02514473|80128592|FG001|Overall Study|Other|1|||
27528339|NCT02730208|80128595|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
27528340|NCT02730208|80128596|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
27528341|NCT01562873|80128597|FG000|Overall Study|Disease Progression per RECIST|10|||
27528342|NCT01562873|80128598|FG001|Overall Study|Disease Progression per RECIST|0|||
27528343|NCT01562873|80128597|FG000|Overall Study|Adverse Event|1|||
27528344|NCT01562873|80128598|FG001|Overall Study|Adverse Event|0|||
27528345|NCT01562873|80128597|FG000|Overall Study|Clinical Disease Progression|9|||
27528346|NCT01562873|80128598|FG001|Overall Study|Clinical Disease Progression|0|||
27528347|NCT01562873|80128597|FG000|Overall Study|Clinical PD and adverse event|1|||
27528348|NCT01562873|80128598|FG001|Overall Study|Clinical PD and adverse event|0|||
27528349|NCT03418571|80128600|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
27528350|NCT03418571|80128601|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
27528351|NCT01017575|80128602|FG000|Overall Study|Lack of Efficacy|0|||
27528352|NCT01017575|80128603|FG001|Overall Study|Lack of Efficacy|1|||
27528353|NCT01017575|80128604|FG002|Overall Study|Lack of Efficacy|0|||
27528354|NCT01017575|80128605|FG003|Overall Study|Lack of Efficacy|1|||
27528355|NCT01017575|80128606|FG004|Overall Study|Lack of Efficacy|1|||
27528356|NCT01017575|80128602|FG000|Overall Study|Adverse Event|0|||
27528357|NCT01017575|80128603|FG001|Overall Study|Adverse Event|1|||
27528358|NCT01017575|80128604|FG002|Overall Study|Adverse Event|0|||
27528359|NCT01017575|80128605|FG003|Overall Study|Adverse Event|0|||
27528360|NCT01017575|80128606|FG004|Overall Study|Adverse Event|2|||
27528361|NCT01017575|80128602|FG000|Overall Study|Withdrawal by Subject|1|||
27528362|NCT01017575|80128603|FG001|Overall Study|Withdrawal by Subject|0|||
27528363|NCT01017575|80128604|FG002|Overall Study|Withdrawal by Subject|0|||
27528364|NCT01017575|80128605|FG003|Overall Study|Withdrawal by Subject|0|||
27528365|NCT01017575|80128606|FG004|Overall Study|Withdrawal by Subject|0|||
27528366|NCT01739400|80128607|FG000|Overall Study|Physician Decision|3|||
27528367|NCT01739400|80128608|FG001|Overall Study|Physician Decision|0|||
27528368|NCT01739400|80128607|FG000|Overall Study|Lost to Follow-up|2|||
27528369|NCT01739400|80128608|FG001|Overall Study|Lost to Follow-up|0|||
27528370|NCT01739400|80128607|FG000|Overall Study|Death|5|||
27528371|NCT01739400|80128608|FG001|Overall Study|Death|2|||
27528372|NCT01739400|80128607|FG000|Overall Study|Withdrawal by Subject|7|||
27528373|NCT01739400|80128608|FG001|Overall Study|Withdrawal by Subject|7|||
27528374|NCT04352127|80128611|FG000|Overall Study|Unable to obtain readings|4|||
27528375|NCT04352127|80128612|FG001|Overall Study|Unable to obtain readings|1|||
27528376|NCT04571515|80128613|FG000|Overall Study|Physician Decision|0|||
27528377|NCT04571515|80128614|FG001|Overall Study|Physician Decision|0|||
27528378|NCT04571515|80128615|FG002|Overall Study|Physician Decision|0|||
27528379|NCT04571515|80128616|FG003|Overall Study|Physician Decision|0|||
27528380|NCT04571515|80128617|FG004|Overall Study|Physician Decision|1|||
27528381|NCT04571515|80128613|FG000|Overall Study|Withdrawal by Subject|0|||
27528382|NCT04571515|80128614|FG001|Overall Study|Withdrawal by Subject|0|||
27734037|NCT02209506|80853472|FG001|Overall Study|Withdrawal by Subject|0|||
27528383|NCT04571515|80128615|FG002|Overall Study|Withdrawal by Subject|0|||
27528384|NCT04571515|80128616|FG003|Overall Study|Withdrawal by Subject|0|||
27528385|NCT04571515|80128617|FG004|Overall Study|Withdrawal by Subject|1|||
27734038|NCT02209506|80853473|FG002|Overall Study|Withdrawal by Subject|0|||
27528386|NCT04571515|80128613|FG000|Overall Study|insufficient pain|1|||
27528387|NCT04571515|80128614|FG001|Overall Study|insufficient pain|0|||
27528388|NCT04571515|80128615|FG002|Overall Study|insufficient pain|0|||
27528389|NCT04571515|80128616|FG003|Overall Study|insufficient pain|0|||
27528390|NCT04571515|80128617|FG004|Overall Study|insufficient pain|1|||
27528391|NCT03523000|80128618|FG000|Overall Study|Withdrawal by Subject|3|||
27528392|NCT03523000|80128619|FG001|Overall Study|Withdrawal by Subject|0|||
27528393|NCT03523000|80128618|FG000|Overall Study|Unsuccessful trial|2|||
27528394|NCT03523000|80128619|FG001|Overall Study|Unsuccessful trial|0|||
27528395|NCT01390220|80128620|FG000|Test Dose Phase|Adverse Event|17|||
27528396|NCT01390220|80128621|FG001|Test Dose Phase|Adverse Event|0|||
27528397|NCT01390220|80128622|FG002|Test Dose Phase|Adverse Event|0|||
27528398|NCT01390220|80128620|FG000|Test Dose Phase|Withdrawal by Subject|8|||
27528399|NCT01390220|80128621|FG001|Test Dose Phase|Withdrawal by Subject|0|||
27528400|NCT01390220|80128622|FG002|Test Dose Phase|Withdrawal by Subject|0|||
27528401|NCT01390220|80128620|FG000|Test Dose Phase|Lost to Follow-up|2|||
27528402|NCT01390220|80128621|FG001|Test Dose Phase|Lost to Follow-up|0|||
27528403|NCT01390220|80128622|FG002|Test Dose Phase|Lost to Follow-up|0|||
27528404|NCT01390220|80128620|FG000|Test Dose Phase|Protocol Violation|8|||
27528405|NCT01390220|80128621|FG001|Test Dose Phase|Protocol Violation|0|||
27528406|NCT01390220|80128622|FG002|Test Dose Phase|Protocol Violation|0|||
27528407|NCT01390220|80128620|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
27528408|NCT01390220|80128621|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
27528409|NCT01390220|80128622|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
27528410|NCT01390220|80128620|FG000|Test Dose Phase|Study/Site closure|6|||
27528411|NCT01390220|80128621|FG001|Test Dose Phase|Study/Site closure|0|||
27528412|NCT01390220|80128622|FG002|Test Dose Phase|Study/Site closure|0|||
27528413|NCT01390220|80128620|FG000|Test Dose Phase|Caregiver no longer available|5|||
27528414|NCT01390220|80128621|FG001|Test Dose Phase|Caregiver no longer available|0|||
27528415|NCT01390220|80128622|FG002|Test Dose Phase|Caregiver no longer available|0|||
27528416|NCT01390220|80128620|FG000|Test Dose Phase|Noncompliance|2|||
27528417|NCT01390220|80128621|FG001|Test Dose Phase|Noncompliance|0|||
27528418|NCT01390220|80128622|FG002|Test Dose Phase|Noncompliance|0|||
27528419|NCT01390220|80128620|FG000|Test Dose Phase|Logistical|6|||
27528420|NCT01390220|80128621|FG001|Test Dose Phase|Logistical|0|||
27528421|NCT01390220|80128622|FG002|Test Dose Phase|Logistical|0|||
27528422|NCT01390220|80128620|FG000|Comparative Phase|Withdrawal by Subject|0|||
27528423|NCT01390220|80128621|FG001|Comparative Phase|Withdrawal by Subject|1|||
27528424|NCT01390220|80128622|FG002|Comparative Phase|Withdrawal by Subject|0|||
27528425|NCT02605837|80128627|FG000|Overall Study|Adverse Event|3|||
27528426|NCT02605837|80128628|FG001|Overall Study|Adverse Event|1|||
27528427|NCT02605837|80128627|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27528428|NCT02605837|80128628|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27528429|NCT02605837|80128627|FG000|Overall Study|Withdrawal by Subject|8|||
27528430|NCT02605837|80128628|FG001|Overall Study|Withdrawal by Subject|8|||
27528431|NCT02605837|80128627|FG000|Overall Study|Physician Decision|0|||
27528432|NCT02605837|80128628|FG001|Overall Study|Physician Decision|1|||
27528433|NCT01058265|80128629|FG000|Overall Study|Lost to Follow-up|11|||
27528434|NCT01058265|80128630|FG001|Overall Study|Lost to Follow-up|12|||
27528435|NCT01277042|80128631|FG000|Overall Study|Adverse Event|4|||
27528436|NCT01277042|80128632|FG001|Overall Study|Adverse Event|3|||
27528437|NCT01277042|80128631|FG000|Overall Study|Lost to Follow-up|2|||
27528438|NCT01277042|80128632|FG001|Overall Study|Lost to Follow-up|2|||
27528439|NCT01277042|80128631|FG000|Overall Study|Withdrawal by Subject|2|||
27528440|NCT01277042|80128632|FG001|Overall Study|Withdrawal by Subject|0|||
27528441|NCT00323869|80128633|FG000|Overall Study|Death|1|||
27528442|NCT03687970|80128635|FG000|Overall Study|visit scheduling conflicts|2|||
27528443|NCT03687970|80128636|FG001|Overall Study|visit scheduling conflicts|0|||
27528444|NCT01860846|80128637|FG000|Overall Study|Lost to Follow-up|33|||
27528445|NCT02301988|80128638|FG000|Overall Study|Withdrawal by Subject|2|||
27528446|NCT02301988|80128639|FG001|Overall Study|Withdrawal by Subject|1|||
27528447|NCT02301988|80128638|FG000|Overall Study|Physician Decision|2|||
27528448|NCT02301988|80128639|FG001|Overall Study|Physician Decision|2|||
27528449|NCT02301988|80128638|FG000|Overall Study|Unknown Reason|1|||
27528450|NCT02301988|80128639|FG001|Overall Study|Unknown Reason|3|||
27528451|NCT02301988|80128638|FG000|Overall Study|Lack of Efficacy|3|||
27528452|NCT02301988|80128639|FG001|Overall Study|Lack of Efficacy|2|||
27528453|NCT02301988|80128638|FG000|Overall Study|Death|1|||
27528454|NCT02301988|80128639|FG001|Overall Study|Death|0|||
27528455|NCT02301988|80128638|FG000|Overall Study|Adverse Event|1|||
27528456|NCT02301988|80128639|FG001|Overall Study|Adverse Event|1|||
27528457|NCT00768469|80128640|FG000|Overall Study|Adverse Event|0|||
27528458|NCT00768469|80128641|FG001|Overall Study|Adverse Event|2|||
27528459|NCT00768469|80128640|FG000|Overall Study|Disease Progression|3|||
27528460|NCT00768469|80128641|FG001|Overall Study|Disease Progression|4|||
27528461|NCT00768469|80128640|FG000|Overall Study|Withdrawal by Subject|0|||
27528462|NCT00768469|80128641|FG001|Overall Study|Withdrawal by Subject|1|||
27528463|NCT00812487|80128644|FG000|Overall Study|Lost to Follow-up|2|||
27528464|NCT00812487|80128645|FG001|Overall Study|Lost to Follow-up|0|||
27528465|NCT00812487|80128644|FG000|Overall Study|Withdrawal by Subject|3|||
27528466|NCT00812487|80128645|FG001|Overall Study|Withdrawal by Subject|2|||
27528467|NCT00812487|80128644|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
27528468|NCT00812487|80128645|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
27528469|NCT00812487|80128644|FG000|Overall Study|Protocol Violation|0|||
27528470|NCT00812487|80128645|FG001|Overall Study|Protocol Violation|1|||
27528471|NCT01624870|80128649|FG000|Overall Study|Death|19|||
27528472|NCT01624870|80128649|FG000|Overall Study|Withdrawal by Subject|1|||
27528473|NCT01624870|80128649|FG000|Overall Study|CoreValve not implanted|6|||
27528474|NCT01624870|80128649|FG000|Overall Study|Lost to follow up|1|||
27528475|NCT02711345|80128650|FG000|Overall Study|Adverse Event|0|||
27528476|NCT02711345|80128651|FG001|Overall Study|Adverse Event|0|||
27528477|NCT02711345|80128652|FG002|Overall Study|Adverse Event|0|||
27528478|NCT02711345|80128653|FG003|Overall Study|Adverse Event|1|||
27528479|NCT02711345|80128654|FG004|Overall Study|Adverse Event|1|||
27528480|NCT02711345|80128655|FG005|Overall Study|Adverse Event|2|||
27528481|NCT02711345|80128656|FG006|Overall Study|Adverse Event|1|||
27528482|NCT02711345|80128657|FG007|Overall Study|Adverse Event|0|||
27528483|NCT02711345|80128658|FG008|Overall Study|Adverse Event|0|||
27528484|NCT02711345|80128659|FG009|Overall Study|Adverse Event|2|||
27528485|NCT02711345|80128650|FG000|Overall Study|Physician Decision|0|||
27528486|NCT02711345|80128651|FG001|Overall Study|Physician Decision|0|||
27528487|NCT02711345|80128652|FG002|Overall Study|Physician Decision|1|||
27528488|NCT02711345|80128653|FG003|Overall Study|Physician Decision|0|||
27528489|NCT02711345|80128654|FG004|Overall Study|Physician Decision|0|||
27528490|NCT02711345|80128655|FG005|Overall Study|Physician Decision|0|||
27528491|NCT02711345|80128656|FG006|Overall Study|Physician Decision|0|||
27528492|NCT02711345|80128657|FG007|Overall Study|Physician Decision|0|||
27528493|NCT02711345|80128658|FG008|Overall Study|Physician Decision|1|||
27528494|NCT02711345|80128659|FG009|Overall Study|Physician Decision|0|||
27528495|NCT02711345|80128650|FG000|Overall Study|Progressive disease|1|||
27528496|NCT02711345|80128651|FG001|Overall Study|Progressive disease|3|||
27528497|NCT02711345|80128652|FG002|Overall Study|Progressive disease|5|||
27528498|NCT02711345|80128653|FG003|Overall Study|Progressive disease|3|||
27528499|NCT02711345|80128654|FG004|Overall Study|Progressive disease|7|||
27528500|NCT02711345|80128655|FG005|Overall Study|Progressive disease|2|||
27528501|NCT02711345|80128656|FG006|Overall Study|Progressive disease|8|||
27528502|NCT02711345|80128657|FG007|Overall Study|Progressive disease|4|||
27528503|NCT02711345|80128658|FG008|Overall Study|Progressive disease|5|||
27528504|NCT02711345|80128659|FG009|Overall Study|Progressive disease|6|||
27528505|NCT02711345|80128650|FG000|Overall Study|Subject/guardian decision|0|||
27528506|NCT02711345|80128651|FG001|Overall Study|Subject/guardian decision|0|||
27528507|NCT02711345|80128652|FG002|Overall Study|Subject/guardian decision|0|||
27528508|NCT02711345|80128653|FG003|Overall Study|Subject/guardian decision|0|||
27528509|NCT02711345|80128654|FG004|Overall Study|Subject/guardian decision|0|||
27528510|NCT02711345|80128655|FG005|Overall Study|Subject/guardian decision|2|||
27528511|NCT02711345|80128656|FG006|Overall Study|Subject/guardian decision|3|||
27528512|NCT02711345|80128657|FG007|Overall Study|Subject/guardian decision|1|||
27528513|NCT02711345|80128658|FG008|Overall Study|Subject/guardian decision|0|||
27528514|NCT02711345|80128659|FG009|Overall Study|Subject/guardian decision|4|||
27528515|NCT02711345|80128650|FG000|Overall Study|Death|1|||
27528516|NCT02711345|80128651|FG001|Overall Study|Death|0|||
27528517|NCT02711345|80128652|FG002|Overall Study|Death|0|||
27528518|NCT02711345|80128653|FG003|Overall Study|Death|0|||
27528519|NCT02711345|80128654|FG004|Overall Study|Death|0|||
27528520|NCT02711345|80128655|FG005|Overall Study|Death|0|||
27528521|NCT02711345|80128656|FG006|Overall Study|Death|0|||
27528522|NCT02711345|80128657|FG007|Overall Study|Death|1|||
27528523|NCT02711345|80128658|FG008|Overall Study|Death|0|||
27528524|NCT02711345|80128659|FG009|Overall Study|Death|0|||
27528525|NCT01205581|80128660|FG000|Overall Study|Withdrawal by Subject|1|||
27528526|NCT01205581|80128661|FG001|Overall Study|Withdrawal by Subject|0|||
27528527|NCT01205581|80128662|FG002|Overall Study|Withdrawal by Subject|0|||
27528528|NCT01205581|80128663|FG003|Overall Study|Withdrawal by Subject|0|||
27528529|NCT01205581|80128664|FG004|Overall Study|Withdrawal by Subject|0|||
27528530|NCT01205581|80128665|FG005|Overall Study|Withdrawal by Subject|0|||
27624563|NCT01941316|80467008|FG003|Overall Study|Intercurrent illness|1|||
27624564|NCT01941316|80467005|FG000|Overall Study|Other, not specified|0|||
27624565|NCT01941316|80467006|FG001|Overall Study|Other, not specified|0|||
27528531|NCT02927067|80128670|FG000|Overall Study|Withdrawn Consent|20|||
27528532|NCT02927067|80128671|FG001|Overall Study|Withdrawn Consent|12|||
27528533|NCT02927067|80128670|FG000|Overall Study|Death|18|||
27528534|NCT02927067|80128671|FG001|Overall Study|Death|31|||
27528535|NCT02927067|80128670|FG000|Overall Study|Adverse Event|13|||
27528536|NCT02927067|80128671|FG001|Overall Study|Adverse Event|10|||
27528537|NCT02927067|80128670|FG000|Overall Study|Noncompliance|5|||
27528538|NCT02927067|80128671|FG001|Overall Study|Noncompliance|2|||
27528539|NCT02927067|80128670|FG000|Overall Study|Reason not Specified|4|||
27528540|NCT02927067|80128671|FG001|Overall Study|Reason not Specified|6|||
27528541|NCT01142128|80128676|FG000|Overall Study|Physician Decision|1|||
27528542|NCT01142128|80128676|FG000|Overall Study|Lost to Follow-up|1|||
27528543|NCT01142128|80128676|FG000|Overall Study|Withdrawal by Subject|2|||
27528544|NCT01856023|80128679|FG000|Overall Study|Death|1|||
27528545|NCT01856023|80128680|FG001|Overall Study|Death|2|||
27528546|NCT01856023|80128679|FG000|Overall Study|Adverse Event|2|||
27528547|NCT01856023|80128680|FG001|Overall Study|Adverse Event|1|||
27528548|NCT01856023|80128679|FG000|Overall Study|Lack of Efficacy|5|||
27528549|NCT01856023|80128680|FG001|Overall Study|Lack of Efficacy|5|||
27528550|NCT01856023|80128679|FG000|Overall Study|non compliance, study closure|1|||
27528551|NCT01856023|80128680|FG001|Overall Study|non compliance, study closure|3|||
27528552|NCT01856023|80128679|FG000|Overall Study|Withdrawal by Subject|1|||
27528553|NCT01856023|80128680|FG001|Overall Study|Withdrawal by Subject|1|||
27528554|NCT02278471|80128681|FG000|Overall Study|Lost to Follow-up|6|||
27528555|NCT02278471|80128682|FG001|Overall Study|Lost to Follow-up|15|||
27528556|NCT02278471|80128681|FG000|Overall Study|Death|2|||
27528557|NCT02278471|80128682|FG001|Overall Study|Death|2|||
27528558|NCT02278471|80128681|FG000|Overall Study|Withdrawal by Subject|0|||
27528559|NCT02278471|80128682|FG001|Overall Study|Withdrawal by Subject|3|||
27528560|NCT01711879|80128687|FG000|Overall Study|Death|1|||
27528561|NCT01711879|80128688|FG001|Overall Study|Death|0|||
27528562|NCT00814801|80128689|FG000|Overall Study|Adverse Event|15|||
27528563|NCT00814801|80128690|FG001|Overall Study|Adverse Event|16|||
27528564|NCT00814801|80128691|FG002|Overall Study|Adverse Event|19|||
27528565|NCT00814801|80128689|FG000|Overall Study|Withdrawal by Subject|9|||
27528566|NCT00814801|80128690|FG001|Overall Study|Withdrawal by Subject|11|||
27528567|NCT00814801|80128691|FG002|Overall Study|Withdrawal by Subject|14|||
27528568|NCT00814801|80128689|FG000|Overall Study|Inappropriate as a subject|1|||
27528569|NCT00814801|80128690|FG001|Overall Study|Inappropriate as a subject|1|||
27528570|NCT00814801|80128691|FG002|Overall Study|Inappropriate as a subject|1|||
27528571|NCT00814801|80128689|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
27528572|NCT00814801|80128690|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
27528573|NCT00814801|80128691|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
27528574|NCT00814801|80128689|FG000|Overall Study|Missing or change of caregiver|6|||
27528575|NCT00814801|80128690|FG001|Overall Study|Missing or change of caregiver|2|||
27528576|NCT00814801|80128691|FG002|Overall Study|Missing or change of caregiver|4|||
27528577|NCT00814801|80128689|FG000|Overall Study|Non-compliance|0|||
27528578|NCT00814801|80128690|FG001|Overall Study|Non-compliance|1|||
27528579|NCT00814801|80128691|FG002|Overall Study|Non-compliance|1|||
27528580|NCT00814801|80128689|FG000|Overall Study|Other|2|||
27528581|NCT00814801|80128690|FG001|Overall Study|Other|6|||
27528582|NCT00814801|80128691|FG002|Overall Study|Other|4|||
27528583|NCT04085367|80128694|FG000|Overall Study|Adverse Event|1|||
27528584|NCT04085367|80128695|FG001|Overall Study|Adverse Event|1|||
27528585|NCT04085367|80128694|FG000|Overall Study|Withdrawal by Subject|13|||
27528586|NCT04085367|80128695|FG001|Overall Study|Withdrawal by Subject|4|||
27528587|NCT04085367|80128694|FG000|Overall Study|Lost to Follow-up|3|||
27528588|NCT04085367|80128695|FG001|Overall Study|Lost to Follow-up|1|||
27528589|NCT04085367|80128694|FG000|Overall Study|Other unspecified|2|||
27528590|NCT04085367|80128695|FG001|Overall Study|Other unspecified|1|||
27528591|NCT04085367|80128694|FG000|Overall Study|Status Unknown|1|||
27528592|NCT04085367|80128695|FG001|Overall Study|Status Unknown|1|||
27528593|NCT01315236|80128699|FG000|Double-blind Phase|Death|1|||
27528594|NCT01315236|80128700|FG001|Double-blind Phase|Death|0|||
27528595|NCT01315236|80128699|FG000|Double-blind Phase|Adverse Event|1|||
27528596|NCT01315236|80128700|FG001|Double-blind Phase|Adverse Event|0|||
27528597|NCT01315236|80128699|FG000|Double-blind Phase|Withdrawal of Consent|1|||
27528598|NCT01315236|80128700|FG001|Double-blind Phase|Withdrawal of Consent|0|||
27528599|NCT01315236|80128699|FG000|Double-blind Phase|Lost to Follow-up|1|||
27528600|NCT01315236|80128700|FG001|Double-blind Phase|Lost to Follow-up|0|||
27528601|NCT01315236|80128699|FG000|Open-label Phase|Death|1|||
27528602|NCT01315236|80128700|FG001|Open-label Phase|Death|0|||
27528603|NCT01315236|80128699|FG000|Open-label Phase|Adverse Event|0|||
27528604|NCT01315236|80128700|FG001|Open-label Phase|Adverse Event|1|||
27528605|NCT01315236|80128699|FG000|Open-label Phase|Other|0|||
27856375|NCT00123474|81306756|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
27856376|NCT00123474|81306753|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
27528606|NCT01315236|80128700|FG001|Open-label Phase|Other|1|||
27528607|NCT01315236|80128699|FG000|12-Month Follow-up Period|Death|0|||
27528608|NCT01315236|80128700|FG001|12-Month Follow-up Period|Death|1|||
27528609|NCT01315236|80128699|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
27528610|NCT01315236|80128700|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
27528611|NCT03055858|80128701|FG000|Overall Study|Death|9|||
27528612|NCT03055858|80128701|FG000|Overall Study|Withdrawal by Subject|11|||
27528613|NCT03055858|80128701|FG000|Overall Study|Lost to Follow-up|6|||
27528614|NCT03055858|80128701|FG000|Overall Study|Missed Follow-Up Visits|18|||
27528615|NCT01467427|80128702|FG000|Overall Study|Withdrawal by Subject|1|||
27528616|NCT01467427|80128703|FG001|Overall Study|Withdrawal by Subject|0|||
27734039|NCT02209506|80853474|FG003|Overall Study|Withdrawal by Subject|0|||
27528617|NCT01467427|80128702|FG000|Overall Study|Entered extension phase|11|||
27528618|NCT01467427|80128703|FG001|Overall Study|Entered extension phase|11|||
27528619|NCT01467427|80128702|FG000|Overall Study|Not continuing in extension phase|0|||
27528620|NCT01467427|80128703|FG001|Overall Study|Not continuing in extension phase|2|||
27528621|NCT01163032|80128704|FG000|Randomization Phase|Withdrawal by Subject|2|||
27624566|NCT01941316|80467007|FG002|Overall Study|Other, not specified|0|||
27624567|NCT01941316|80467008|FG003|Overall Study|Other, not specified|1|||
27624568|NCT05576662|80467011|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
27624569|NCT05576662|80467012|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
27624570|NCT05576662|80467011|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
27624571|NCT05576662|80467012|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
27528622|NCT01163032|80128705|FG001|Randomization Phase|Withdrawal by Subject|3|||
27528623|NCT01163032|80128706|FG002|Randomization Phase|Withdrawal by Subject|0|||
27528624|NCT01163032|80128704|FG000|Randomization Phase|Adverse Event|3|||
27528625|NCT01163032|80128705|FG001|Randomization Phase|Adverse Event|3|||
27624572|NCT05576662|80467011|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
27624573|NCT05576662|80467012|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
27624574|NCT05576662|80467011|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
27624575|NCT05576662|80467012|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
27624576|NCT04213846|80467013|FG000|Overall Study|Withdrawal by Subject|7|||
27624577|NCT04213846|80467014|FG001|Overall Study|Withdrawal by Subject|6|||
27624578|NCT04213846|80467013|FG000|Overall Study|Lost to Follow-up|15|||
27624579|NCT04213846|80467014|FG001|Overall Study|Lost to Follow-up|21|||
27624580|NCT01123161|80467015|FG000|Overall Study|Lost to Follow-up|1|||
27624581|NCT01123161|80467016|FG001|Overall Study|Lost to Follow-up|0|||
27624582|NCT01123161|80467015|FG000|Overall Study|Withdrawal by Subject|1|||
27624583|NCT01123161|80467016|FG001|Overall Study|Withdrawal by Subject|0|||
27624584|NCT02335268|80467018|FG000|Overall Study|Physician Decision|5|||
27624585|NCT02335268|80467019|FG001|Overall Study|Physician Decision|1|||
27624586|NCT02335268|80467018|FG000|Overall Study|Lack of Efficacy|2|||
27624587|NCT02335268|80467019|FG001|Overall Study|Lack of Efficacy|1|||
27624588|NCT02335268|80467018|FG000|Overall Study|Adverse Event|5|||
27624589|NCT02335268|80467019|FG001|Overall Study|Adverse Event|2|||
27624590|NCT02335268|80467018|FG000|Overall Study|increase blasts|2|||
27624591|NCT02335268|80467019|FG001|Overall Study|increase blasts|0|||
27624592|NCT02335268|80467018|FG000|Overall Study|Withdrawal by Subject|3|||
27624593|NCT02335268|80467019|FG001|Overall Study|Withdrawal by Subject|2|||
27734040|NCT02209506|80853475|FG004|Overall Study|Withdrawal by Subject|1|||
27734041|NCT00195650|80853478|FG000|Overall Study|Adverse Event|194|||
27734042|NCT00195650|80853478|FG000|Overall Study|Lack of Efficacy|99|||
27856377|NCT00123474|81306754|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
27856378|NCT00123474|81306755|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
27856379|NCT00123474|81306756|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
27856380|NCT02348723|81306757|FG000|Overall Study|No ablation|21|||
27856381|NCT02348723|81306758|FG001|Overall Study|No ablation|20|||
27856382|NCT02348723|81306757|FG000|Overall Study|Non-compliant with Protocol|1|||
27856383|NCT02348723|81306758|FG001|Overall Study|Non-compliant with Protocol|0|||
27856384|NCT02348723|81306757|FG000|Overall Study|Lost to Follow-up|1|||
27856385|NCT02348723|81306758|FG001|Overall Study|Lost to Follow-up|1|||
27856386|NCT02348723|81306757|FG000|Overall Study|Consent withdrawn|1|||
27856387|NCT02348723|81306758|FG001|Overall Study|Consent withdrawn|3|||
27856388|NCT02348723|81306757|FG000|Overall Study|Reason other than specified|1|||
27856389|NCT02348723|81306758|FG001|Overall Study|Reason other than specified|1|||
27856390|NCT02348723|81306757|FG000|Overall Study|Adverse Event|3|||
27856391|NCT02348723|81306758|FG001|Overall Study|Adverse Event|1|||
27856392|NCT00085423|81306759|FG000|Overall Study|Withdrawal by Subject|1|||
27856393|NCT00085423|81306759|FG000|Overall Study|screen failure|1|||
27856394|NCT00128830|81306760|FG000|Overall Study|Adverse Event|10|||
27856395|NCT00128830|81306760|FG000|Overall Study|Withdrawal by Subject|14|||
27856396|NCT00128830|81306760|FG000|Overall Study|Lost to Follow-up|4|||
27911745|NCT02324361|81513735|FG001|Overall Study|Lost to Follow-up|2|||
27911746|NCT02581488|81513738|FG000|Overall Study|Adverse Event|6|||
27911747|NCT02581488|81513739|FG001|Overall Study|Adverse Event|7|||
27528626|NCT01163032|80128706|FG002|Randomization Phase|Adverse Event|0|||
27624594|NCT00945477|80467020|FG000|Overall Study|Adverse Event|3|||
27624595|NCT00945477|80467020|FG000|Overall Study|Lack of Efficacy|2|||
27624596|NCT00945477|80467020|FG000|Overall Study|Withdrawal by Subject|1|||
27624597|NCT00797862|80467021|FG000|Overall Study|Adverse Event|86|||
27624598|NCT00797862|80467022|FG001|Overall Study|Adverse Event|44|||
27624599|NCT00797862|80467023|FG002|Overall Study|Adverse Event|58|||
27624600|NCT00797862|80467021|FG000|Overall Study|Abnormal Test Procedure Result|0|||
27624601|NCT00797862|80467022|FG001|Overall Study|Abnormal Test Procedure Result|1|||
27624602|NCT00797862|80467023|FG002|Overall Study|Abnormal Test Procedure Result|1|||
27734043|NCT00195650|80853478|FG000|Overall Study|Withdrawal by Subject|67|||
27734044|NCT00195650|80853478|FG000|Overall Study|Lost to Follow-up|44|||
27911748|NCT02581488|81513738|FG000|Overall Study|Lost to Follow-up|1|||
27624603|NCT00797862|80467021|FG000|Overall Study|Lack of Efficacy|1|||
27624604|NCT00797862|80467022|FG001|Overall Study|Lack of Efficacy|7|||
27624605|NCT00797862|80467023|FG002|Overall Study|Lack of Efficacy|6|||
27624606|NCT00797862|80467021|FG000|Overall Study|No longer required study medication|1|||
27624607|NCT00797862|80467022|FG001|Overall Study|No longer required study medication|0|||
27624608|NCT00797862|80467023|FG002|Overall Study|No longer required study medication|0|||
27624609|NCT00797862|80467021|FG000|Overall Study|Withdrawal by Subject|14|||
27624610|NCT00797862|80467022|FG001|Overall Study|Withdrawal by Subject|7|||
27624611|NCT00797862|80467023|FG002|Overall Study|Withdrawal by Subject|7|||
27624612|NCT00797862|80467021|FG000|Overall Study|Lost to Follow-up|11|||
27624613|NCT00797862|80467022|FG001|Overall Study|Lost to Follow-up|0|||
27624614|NCT00797862|80467023|FG002|Overall Study|Lost to Follow-up|5|||
27624615|NCT00797862|80467021|FG000|Overall Study|Administrative Problem|4|||
27624616|NCT00797862|80467022|FG001|Overall Study|Administrative Problem|0|||
27624617|NCT00797862|80467023|FG002|Overall Study|Administrative Problem|0|||
27624618|NCT00797862|80467021|FG000|Overall Study|Protocol Violation|4|||
27624619|NCT00797862|80467022|FG001|Overall Study|Protocol Violation|6|||
27624620|NCT00797862|80467023|FG002|Overall Study|Protocol Violation|8|||
27624621|NCT00797862|80467021|FG000|Overall Study|Mis-randomized|3|||
27624622|NCT00797862|80467022|FG001|Overall Study|Mis-randomized|3|||
27624623|NCT00797862|80467023|FG002|Overall Study|Mis-randomized|1|||
27624624|NCT02179918|80467025|FG000|Overall Study|Death|0|||
27624625|NCT02179918|80467026|FG001|Overall Study|Death|0|||
27624626|NCT02179918|80467027|FG002|Overall Study|Death|0|||
27624627|NCT02179918|80467028|FG003|Overall Study|Death|1|||
27624628|NCT02179918|80467029|FG004|Overall Study|Death|0|||
27624629|NCT02179918|80467025|FG000|Overall Study|Lost to Follow-up|0|||
27624630|NCT02179918|80467026|FG001|Overall Study|Lost to Follow-up|0|||
27624631|NCT02179918|80467027|FG002|Overall Study|Lost to Follow-up|1|||
27624632|NCT02179918|80467028|FG003|Overall Study|Lost to Follow-up|0|||
27624633|NCT02179918|80467029|FG004|Overall Study|Lost to Follow-up|0|||
27624634|NCT02179918|80467025|FG000|Overall Study|Progressive Disease|4|||
27624635|NCT02179918|80467026|FG001|Overall Study|Progressive Disease|1|||
27624636|NCT02179918|80467027|FG002|Overall Study|Progressive Disease|1|||
27624637|NCT02179918|80467028|FG003|Overall Study|Progressive Disease|2|||
27624638|NCT02179918|80467029|FG004|Overall Study|Progressive Disease|6|||
27624639|NCT02179918|80467025|FG000|Overall Study|Other|0|||
27624640|NCT02179918|80467026|FG001|Overall Study|Other|1|||
27624641|NCT02179918|80467027|FG002|Overall Study|Other|0|||
27624642|NCT02179918|80467028|FG003|Overall Study|Other|0|||
27624643|NCT02179918|80467029|FG004|Overall Study|Other|1|||
27624644|NCT02179918|80467025|FG000|Overall Study|Subject refused further follow-up|0|||
27624645|NCT02179918|80467026|FG001|Overall Study|Subject refused further follow-up|1|||
27624646|NCT02179918|80467027|FG002|Overall Study|Subject refused further follow-up|0|||
27624647|NCT02179918|80467028|FG003|Overall Study|Subject refused further follow-up|0|||
27624648|NCT02179918|80467029|FG004|Overall Study|Subject refused further follow-up|1|||
27624649|NCT03566680|80467031|FG000|Overall Study|Pregnancy|1|||
27624650|NCT03566680|80467031|FG000|Overall Study|Lost to Follow-up|13|||
27624651|NCT03566680|80467031|FG000|Overall Study|Withdrawal by Subject|3|||
27624652|NCT01518257|80467032|FG000|Overall Study|Lost to Follow-up|1|||
27624653|NCT01518257|80467033|FG001|Overall Study|Lost to Follow-up|0|||
27624654|NCT01518257|80467032|FG000|Overall Study|Other Miscellaneous Reason|1|||
27624655|NCT01518257|80467033|FG001|Overall Study|Other Miscellaneous Reason|0|||
27624656|NCT00916006|80467034|FG000|Overall Study|Adverse Event|1|||
27624657|NCT00916006|80467035|FG001|Overall Study|Adverse Event|1|||
27624658|NCT00916006|80467034|FG000|Overall Study|Withdrawal by Subject|2|||
27624659|NCT00916006|80467035|FG001|Overall Study|Withdrawal by Subject|5|||
27624660|NCT00916006|80467034|FG000|Overall Study|Protocol Violation|0|||
27624661|NCT00916006|80467035|FG001|Overall Study|Protocol Violation|1|||
27624662|NCT01094171|80467038|FG000|Overall Study|Lost to Follow-up|2|||
27624663|NCT01094171|80467038|FG000|Overall Study|Informed consent withdrawal|4|||
27624664|NCT01094171|80467038|FG000|Overall Study|Migration from the study area|3|||
27624665|NCT01094171|80467038|FG000|Overall Study|Other|1|||
27624666|NCT01872611|80467042|FG000|Overall Study|Adverse Event|3|||
27624667|NCT01872611|80467043|FG001|Overall Study|Adverse Event|1|||
27624668|NCT01872611|80467042|FG000|Overall Study|Adverse Event, prior to treatment|0|||
27624669|NCT01872611|80467043|FG001|Overall Study|Adverse Event, prior to treatment|1|||
27624670|NCT01872611|80467042|FG000|Overall Study|Death|0|||
27624671|NCT01872611|80467043|FG001|Overall Study|Death|1|||
27624672|NCT01872611|80467042|FG000|Overall Study|Death, prior to treatment|0|||
27624673|NCT01872611|80467043|FG001|Overall Study|Death, prior to treatment|1|||
27624674|NCT01872611|80467042|FG000|Overall Study|Lost to Follow-up|8|||
27624675|NCT01872611|80467043|FG001|Overall Study|Lost to Follow-up|1|||
27624676|NCT01872611|80467042|FG000|Overall Study|Physician Decision|1|||
27856397|NCT00128830|81306760|FG000|Overall Study|Reached a virologic endpoint|29|||
27624677|NCT01872611|80467043|FG001|Overall Study|Physician Decision|0|||
27624678|NCT01872611|80467042|FG000|Overall Study|Withdrawal by Subject|6|||
27624679|NCT01872611|80467043|FG001|Overall Study|Withdrawal by Subject|1|||
27624680|NCT01872611|80467042|FG000|Overall Study|Reason not provided|6|||
27624681|NCT01872611|80467043|FG001|Overall Study|Reason not provided|6|||
27624682|NCT01928940|80467044|FG000|Overall Study|Adverse Event|0|||
27624683|NCT01928940|80467045|FG001|Overall Study|Adverse Event|1|||
27624684|NCT01141660|80467046|FG000|Overall Study|Physician Decision|0|||
27624685|NCT01141660|80467047|FG001|Overall Study|Physician Decision|12|||
27624686|NCT02846415|80467051|FG000|Overall Study|Lost to Follow-up|2|||
27624687|NCT02846415|80467052|FG001|Overall Study|Lost to Follow-up|0|||
27624688|NCT02846415|80467051|FG000|Overall Study|Withdrawal by Subject|1|||
27624689|NCT02846415|80467052|FG001|Overall Study|Withdrawal by Subject|1|||
27624690|NCT01729871|80467053|FG000|Overall Study|Adverse Event|7|||
27624691|NCT01729871|80467054|FG001|Overall Study|Adverse Event|7|||
27624692|NCT01729871|80467053|FG000|Overall Study|Death|0|||
27624693|NCT01729871|80467054|FG001|Overall Study|Death|1|||
27624694|NCT01729871|80467053|FG000|Overall Study|Lack of Efficacy|0|||
27624695|NCT01729871|80467054|FG001|Overall Study|Lack of Efficacy|1|||
27624696|NCT01729871|80467053|FG000|Overall Study|Physician Decision|0|||
27624697|NCT01729871|80467054|FG001|Overall Study|Physician Decision|2|||
27624698|NCT01729871|80467053|FG000|Overall Study|Protocol Violation|1|||
27624699|NCT01729871|80467054|FG001|Overall Study|Protocol Violation|0|||
27624700|NCT01729871|80467053|FG000|Overall Study|Withdrawal by Subject|0|||
27624701|NCT01729871|80467054|FG001|Overall Study|Withdrawal by Subject|3|||
27624702|NCT01729871|80467053|FG000|Overall Study|Other|4|||
27624703|NCT01729871|80467054|FG001|Overall Study|Other|9|||
27528627|NCT01163032|80128704|FG000|Randomization Phase|Protocol Violation|0|||
27528628|NCT01163032|80128705|FG001|Randomization Phase|Protocol Violation|1|||
27528629|NCT01163032|80128706|FG002|Randomization Phase|Protocol Violation|0|||
27528630|NCT01163032|80128704|FG000|Randomization Phase|Various*|5|||
27528631|NCT01163032|80128705|FG001|Randomization Phase|Various*|4|||
27528632|NCT01163032|80128706|FG002|Randomization Phase|Various*|0|||
27528633|NCT01163032|80128704|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
27528634|NCT01163032|80128705|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
27528635|NCT01163032|80128706|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
27528636|NCT01163032|80128704|FG000|Open Label Extension Phase|Adverse Event|0|||
27528637|NCT01163032|80128705|FG001|Open Label Extension Phase|Adverse Event|0|||
27528638|NCT01163032|80128706|FG002|Open Label Extension Phase|Adverse Event|3|||
27528639|NCT01163032|80128704|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
27528640|NCT01163032|80128705|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
27528641|NCT01163032|80128706|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
27528642|NCT01163032|80128704|FG000|Open Label Extension Phase|Protocol Violation|0|||
27528643|NCT01163032|80128705|FG001|Open Label Extension Phase|Protocol Violation|0|||
27528644|NCT01163032|80128706|FG002|Open Label Extension Phase|Protocol Violation|1|||
27528645|NCT01163032|80128704|FG000|Open Label Extension Phase|Study Termination|0|||
27528646|NCT01163032|80128705|FG001|Open Label Extension Phase|Study Termination|0|||
27528647|NCT01163032|80128706|FG002|Open Label Extension Phase|Study Termination|7|||
27528648|NCT01163032|80128704|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
27528649|NCT01163032|80128705|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
27528650|NCT01163032|80128706|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
27528651|NCT02376829|80128707|FG000|Overall Study|Withdrawal by Subject|27|||
27528652|NCT02376829|80128708|FG001|Overall Study|Withdrawal by Subject|44|||
27528653|NCT00708201|80128722|FG000|Overall Study|Adverse Event|4|||
27528654|NCT00708201|80128723|FG001|Overall Study|Adverse Event|4|||
27528655|NCT00708201|80128722|FG000|Overall Study|Withdrawal by Subject|1|||
27528656|NCT00708201|80128723|FG001|Overall Study|Withdrawal by Subject|1|||
27528657|NCT00708201|80128722|FG000|Overall Study|Lost to Follow-up|2|||
27528658|NCT00708201|80128723|FG001|Overall Study|Lost to Follow-up|0|||
27528659|NCT00708201|80128722|FG000|Overall Study|Protocol Violation|0|||
27528660|NCT00708201|80128723|FG001|Overall Study|Protocol Violation|1|||
27528661|NCT02829944|80128724|FG000|Overall Study|Physician Decision|0|||
27528662|NCT02829944|80128725|FG001|Overall Study|Physician Decision|1|||
27528663|NCT02829944|80128724|FG000|Overall Study|Screen Failure|2|||
27624704|NCT00561574|80467055|FG000|Overall Study|Adverse Event|21|||
27624705|NCT00561574|80467056|FG001|Overall Study|Adverse Event|24|||
27624706|NCT00561574|80467055|FG000|Overall Study|Lack of Efficacy|11|||
27528664|NCT02829944|80128725|FG001|Overall Study|Screen Failure|2|||
27528665|NCT02829944|80128724|FG000|Overall Study|Inadequate Neuraxial Block|1|||
27528666|NCT02829944|80128725|FG001|Overall Study|Inadequate Neuraxial Block|1|||
27528667|NCT02829944|80128724|FG000|Overall Study|Withdrawal by Subject|2|||
27528668|NCT02829944|80128725|FG001|Overall Study|Withdrawal by Subject|1|||
27528669|NCT02829944|80128724|FG000|Overall Study|Catheter Displacement|1|||
27624707|NCT00561574|80467056|FG001|Overall Study|Lack of Efficacy|21|||
27624708|NCT00561574|80467055|FG000|Overall Study|Withdrawal by Subject|4|||
27528670|NCT02829944|80128725|FG001|Overall Study|Catheter Displacement|0|||
27528671|NCT02829944|80128724|FG000|Overall Study|Catheter broke|0|||
27528672|NCT02829944|80128725|FG001|Overall Study|Catheter broke|1|||
27624709|NCT00561574|80467056|FG001|Overall Study|Withdrawal by Subject|4|||
27624710|NCT00561574|80467055|FG000|Overall Study|Reason Unrelated to Trial|6|||
27734045|NCT00195650|80853478|FG000|Overall Study|Death|23|||
27624711|NCT00561574|80467056|FG001|Overall Study|Reason Unrelated to Trial|2|||
27624712|NCT00561574|80467055|FG000|Overall Study|Lost to Follow-up|1|||
27624713|NCT00561574|80467056|FG001|Overall Study|Lost to Follow-up|0|||
27624714|NCT00561574|80467055|FG000|Overall Study|Other|5|||
27624715|NCT00561574|80467056|FG001|Overall Study|Other|7|||
27624716|NCT01143077|80467057|FG000|Overall Study|Lack of Efficacy|0|||
27624717|NCT01143077|80467058|FG001|Overall Study|Lack of Efficacy|2|||
27624718|NCT01143077|80467059|FG002|Overall Study|Lack of Efficacy|1|||
27624719|NCT01143077|80467057|FG000|Overall Study|Adverse Event|5|||
27624720|NCT01143077|80467058|FG001|Overall Study|Adverse Event|6|||
27624721|NCT01143077|80467059|FG002|Overall Study|Adverse Event|5|||
27624722|NCT01143077|80467057|FG000|Overall Study|Lost to Follow-up|2|||
27624723|NCT01143077|80467058|FG001|Overall Study|Lost to Follow-up|3|||
27624724|NCT01143077|80467059|FG002|Overall Study|Lost to Follow-up|4|||
27624725|NCT01143077|80467057|FG000|Overall Study|Protocol Violation|2|||
27624726|NCT01143077|80467058|FG001|Overall Study|Protocol Violation|0|||
27624727|NCT01143077|80467059|FG002|Overall Study|Protocol Violation|0|||
27624728|NCT01143077|80467057|FG000|Overall Study|Withdrawal by Subject|4|||
27624729|NCT01143077|80467058|FG001|Overall Study|Withdrawal by Subject|3|||
27624730|NCT01143077|80467059|FG002|Overall Study|Withdrawal by Subject|3|||
27624731|NCT01143077|80467057|FG000|Overall Study|Non-compliance with study drug|0|||
27624732|NCT01143077|80467058|FG001|Overall Study|Non-compliance with study drug|1|||
27624733|NCT01143077|80467059|FG002|Overall Study|Non-compliance with study drug|1|||
27624734|NCT01143077|80467057|FG000|Overall Study|Administrative|1|||
27624735|NCT01143077|80467058|FG001|Overall Study|Administrative|0|||
27624736|NCT01143077|80467059|FG002|Overall Study|Administrative|0|||
27624737|NCT01143077|80467057|FG000|Overall Study|Principal Investigator Decision|2|||
27624738|NCT01143077|80467058|FG001|Overall Study|Principal Investigator Decision|0|||
27624739|NCT01143077|80467059|FG002|Overall Study|Principal Investigator Decision|1|||
27624740|NCT02949271|80467063|FG000|Overall Study|Lack of Efficacy|5|||
27624741|NCT02949271|80467064|FG001|Overall Study|Lack of Efficacy|4|||
27624742|NCT02949271|80467063|FG000|Overall Study|Lost to Follow-up|3|||
27624743|NCT02949271|80467064|FG001|Overall Study|Lost to Follow-up|6|||
27624744|NCT02949271|80467063|FG000|Overall Study|Physician Decision|5|||
27624745|NCT02949271|80467064|FG001|Overall Study|Physician Decision|5|||
27624746|NCT02949271|80467063|FG000|Overall Study|Protocol Violation|6|||
27624747|NCT02949271|80467064|FG001|Overall Study|Protocol Violation|3|||
27624748|NCT02949271|80467063|FG000|Overall Study|Withdrawal by Subject|1|||
27624749|NCT02949271|80467064|FG001|Overall Study|Withdrawal by Subject|0|||
27624750|NCT02949271|80467063|FG000|Overall Study|Delivered prior to intervention|7|||
27624751|NCT02949271|80467064|FG001|Overall Study|Delivered prior to intervention|9|||
27624752|NCT02949271|80467063|FG000|Overall Study|Outside the window for cervical dilation|2|||
27624753|NCT02949271|80467064|FG001|Overall Study|Outside the window for cervical dilation|3|||
27624754|NCT01789203|80467067|FG000|Overall Study|Adverse Event|2|||
27624755|NCT01789203|80467068|FG001|Overall Study|Adverse Event|2|||
27624756|NCT01789203|80467067|FG000|Overall Study|Withdrawal by Subject|1|||
27624757|NCT01789203|80467068|FG001|Overall Study|Withdrawal by Subject|0|||
27624758|NCT01789203|80467067|FG000|Overall Study|Death|1|||
27624759|NCT01789203|80467068|FG001|Overall Study|Death|0|||
27624760|NCT01789203|80467067|FG000|Overall Study|Protocol Violation|2|||
27624761|NCT01789203|80467068|FG001|Overall Study|Protocol Violation|1|||
27528673|NCT02829944|80128724|FG000|Overall Study|Staff unavailable|0|||
27528674|NCT02829944|80128725|FG001|Overall Study|Staff unavailable|1|||
27528675|NCT03455764|80128727|FG000|Overall Study|Adverse Event|1|||
27528676|NCT03455764|80128728|FG001|Overall Study|Adverse Event|0|||
27528677|NCT03455764|80128729|FG002|Overall Study|Adverse Event|0|||
27528678|NCT03455764|80128730|FG003|Overall Study|Adverse Event|0|||
27528679|NCT03455764|80128731|FG004|Overall Study|Adverse Event|0|||
27528680|NCT03455764|80128727|FG000|Overall Study|Disease Progression|4|||
27528681|NCT03455764|80128728|FG001|Overall Study|Disease Progression|0|||
27528682|NCT03455764|80128729|FG002|Overall Study|Disease Progression|0|||
27624762|NCT01789203|80467067|FG000|Overall Study|Other|1|||
27624763|NCT01789203|80467068|FG001|Overall Study|Other|1|||
27624764|NCT01789203|80467067|FG000|Overall Study|patient non-adherent|2|||
27624765|NCT01789203|80467068|FG001|Overall Study|patient non-adherent|0|||
27624766|NCT01027871|80467071|FG000|Overall Study|Physician Decision|1|||
27624767|NCT01027871|80467072|FG001|Overall Study|Physician Decision|5|||
27624768|NCT01027871|80467073|FG002|Overall Study|Physician Decision|0|||
27528683|NCT03455764|80128730|FG003|Overall Study|Disease Progression|0|||
27528684|NCT03455764|80128731|FG004|Overall Study|Disease Progression|0|||
27528685|NCT03455764|80128727|FG000|Overall Study|On Treatment|1|||
27624769|NCT01027871|80467071|FG000|Overall Study|Protocol Violation|0|||
27624770|NCT01027871|80467072|FG001|Overall Study|Protocol Violation|2|||
27528686|NCT03455764|80128728|FG001|Overall Study|On Treatment|0|||
27624771|NCT01027871|80467073|FG002|Overall Study|Protocol Violation|2|||
27624772|NCT01027871|80467071|FG000|Overall Study|Withdrawal by Subject|1|||
27624773|NCT01027871|80467072|FG001|Overall Study|Withdrawal by Subject|2|||
27624774|NCT01027871|80467073|FG002|Overall Study|Withdrawal by Subject|2|||
27528687|NCT03455764|80128729|FG002|Overall Study|On Treatment|0|||
27624775|NCT01027871|80467071|FG000|Overall Study|Adverse Event|0|||
27624776|NCT01027871|80467072|FG001|Overall Study|Adverse Event|2|||
27624777|NCT01027871|80467073|FG002|Overall Study|Adverse Event|2|||
27624778|NCT01027871|80467071|FG000|Overall Study|Sponsor Decision|0|||
27624779|NCT01027871|80467072|FG001|Overall Study|Sponsor Decision|2|||
27624780|NCT01027871|80467073|FG002|Overall Study|Sponsor Decision|0|||
27624781|NCT01027871|80467071|FG000|Overall Study|Discontinued Prior to Treatment|0|||
27624782|NCT01027871|80467072|FG001|Overall Study|Discontinued Prior to Treatment|0|||
27528688|NCT03455764|80128730|FG003|Overall Study|On Treatment|0|||
27528689|NCT03455764|80128731|FG004|Overall Study|On Treatment|0|||
27528690|NCT01727700|80128732|FG000|Overall Study|Adverse Event|0|||
27528691|NCT01727700|80128733|FG001|Overall Study|Adverse Event|7|||
27528692|NCT01727700|80128734|FG002|Overall Study|Adverse Event|1|||
27528693|NCT01727700|80128732|FG000|Overall Study|Particpant withdrew consent|0|||
27528694|NCT01727700|80128733|FG001|Overall Study|Particpant withdrew consent|3|||
27528695|NCT01727700|80128734|FG002|Overall Study|Particpant withdrew consent|1|||
27528696|NCT01727700|80128732|FG000|Overall Study|Protocol Violation|2|||
27528697|NCT01727700|80128733|FG001|Overall Study|Protocol Violation|0|||
27528698|NCT01727700|80128734|FG002|Overall Study|Protocol Violation|0|||
27528699|NCT00521001|80128735|FG000|Overall Study|Ineligible|1|||
27528700|NCT02889562|80128736|FG000|Overall Study|Physician Decision|0|||
27528701|NCT02889562|80128737|FG001|Overall Study|Physician Decision|1|||
27528702|NCT02889562|80128736|FG000|Overall Study|Withdrawal by Subject|0|||
27528703|NCT02889562|80128737|FG001|Overall Study|Withdrawal by Subject|1|||
27528704|NCT00473746|80128738|FG000|Period 1 (Phase 1)|Adverse Event|1|||
27528705|NCT00473746|80128739|FG001|Period 1 (Phase 1)|Adverse Event|0|||
27528706|NCT00473746|80128740|FG002|Period 1 (Phase 1)|Adverse Event|0|||
27528707|NCT00473746|80128741|FG003|Period 1 (Phase 1)|Adverse Event|0|||
27528708|NCT00473746|80128742|FG004|Period 1 (Phase 1)|Adverse Event|0|||
27528709|NCT00473746|80128738|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27528710|NCT00473746|80128739|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
27528711|NCT00473746|80128740|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27528712|NCT00473746|80128741|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27528713|NCT00473746|80128742|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
27528714|NCT00473746|80128738|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
27528715|NCT00473746|80128739|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
27528716|NCT00473746|80128740|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
27528717|NCT00473746|80128741|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
27528718|NCT00473746|80128742|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
27528719|NCT00473746|80128738|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27528720|NCT00473746|80128739|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
27528721|NCT00473746|80128740|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27528722|NCT00473746|80128741|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27528723|NCT00473746|80128742|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
27528724|NCT00473746|80128738|FG000|Period 1 (Phase 1)|Reason not specified|0|||
27528725|NCT00473746|80128739|FG001|Period 1 (Phase 1)|Reason not specified|1|||
27528726|NCT00473746|80128740|FG002|Period 1 (Phase 1)|Reason not specified|0|||
27528727|NCT00473746|80128741|FG003|Period 1 (Phase 1)|Reason not specified|0|||
27528728|NCT00473746|80128742|FG004|Period 1 (Phase 1)|Reason not specified|0|||
27528729|NCT00473746|80128738|FG000|Period 2 (Phase 2)|Adverse Event|0|||
27528730|NCT00473746|80128739|FG001|Period 2 (Phase 2)|Adverse Event|0|||
27528731|NCT00473746|80128740|FG002|Period 2 (Phase 2)|Adverse Event|0|||
27528732|NCT00473746|80128741|FG003|Period 2 (Phase 2)|Adverse Event|0|||
27528733|NCT00473746|80128742|FG004|Period 2 (Phase 2)|Adverse Event|3|||
27528734|NCT00473746|80128738|FG000|Period 2 (Phase 2)|Death|0|||
27528735|NCT00473746|80128739|FG001|Period 2 (Phase 2)|Death|0|||
27528736|NCT00473746|80128740|FG002|Period 2 (Phase 2)|Death|0|||
27528737|NCT00473746|80128741|FG003|Period 2 (Phase 2)|Death|0|||
27528738|NCT00473746|80128742|FG004|Period 2 (Phase 2)|Death|1|||
27528739|NCT00473746|80128738|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
27528740|NCT00473746|80128739|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
27528741|NCT00473746|80128740|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
27528742|NCT00473746|80128741|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
27528743|NCT00473746|80128742|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
27528744|NCT00473746|80128738|FG000|Period 2 (Phase 2)|Reason not specified|0|||
27528745|NCT00473746|80128739|FG001|Period 2 (Phase 2)|Reason not specified|0|||
27624783|NCT01027871|80467073|FG002|Overall Study|Discontinued Prior to Treatment|1|||
27624784|NCT03239210|80467074|FG000|Overall Study|Lost to Follow-up|2|||
27624785|NCT03239210|80467075|FG001|Overall Study|Lost to Follow-up|2|||
27624786|NCT03239210|80467074|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
27528746|NCT00473746|80128740|FG002|Period 2 (Phase 2)|Reason not specified|0|||
27528747|NCT00473746|80128741|FG003|Period 2 (Phase 2)|Reason not specified|0|||
27528748|NCT00473746|80128742|FG004|Period 2 (Phase 2)|Reason not specified|3|||
27528749|NCT00322153|80128743|FG000|Overall Study|Adverse Event|21|||
27528750|NCT00322153|80128744|FG001|Overall Study|Adverse Event|34|||
27734046|NCT00195650|80853478|FG000|Overall Study|Protocol Violation|15|||
27528751|NCT00322153|80128743|FG000|Overall Study|Protocol Violation|6|||
27528752|NCT00322153|80128744|FG001|Overall Study|Protocol Violation|14|||
27624787|NCT03239210|80467075|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
27624788|NCT03239210|80467074|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
27624789|NCT03239210|80467075|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
27624790|NCT01174550|80467076|FG000|Overall Study|Death|75|||
27624791|NCT01174550|80467077|FG001|Overall Study|Death|74|||
27624792|NCT01174550|80467076|FG000|Overall Study|Lost to Follow-up|652|||
27624793|NCT01174550|80467077|FG001|Overall Study|Lost to Follow-up|510|||
27624794|NCT01174550|80467076|FG000|Overall Study|Withdrawal by Subject|543|||
27624795|NCT01174550|80467077|FG001|Overall Study|Withdrawal by Subject|289|||
27624796|NCT01304706|80467080|FG000|Overall Study|Adverse Event|2|||
27624797|NCT01304706|80467080|FG000|Overall Study|Lack of Efficacy|1|||
27624798|NCT01304706|80467080|FG000|Overall Study|Death|3|||
27624799|NCT01304706|80467080|FG000|Overall Study|Withdrawal by Subject|3|||
27624800|NCT01304706|80467080|FG000|Overall Study|Lost to Follow-up|7|||
27624801|NCT01304706|80467080|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
27624802|NCT01688973|80467081|FG000|Overall Study|Ineligible|2|||
27624803|NCT01688973|80467082|FG001|Overall Study|Ineligible|3|||
27624804|NCT05567159|80467083|FG000|Overall Study|Adverse Event|4|||
27624805|NCT05567159|80467083|FG000|Overall Study|Physician Decision|3|||
27624806|NCT05567159|80467083|FG000|Overall Study|Protocol deviation|1|||
27624807|NCT01097655|80467084|FG000|Overall Study|Withdrawal by Subject|1|||
27624808|NCT01097655|80467084|FG000|Overall Study|Subject Documented Twice|1|||
27624809|NCT01097655|80467084|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
27624810|NCT02724878|80467093|FG000|Overall Study|Still on Active Therapy|15|||
27624811|NCT02724878|80467093|FG000|Overall Study|Disease Progression|31|||
27624812|NCT02724878|80467093|FG000|Overall Study|Toxicity|5|||
27624813|NCT02724878|80467093|FG000|Overall Study|Death|1|||
27624814|NCT02724878|80467093|FG000|Overall Study|Withdrawal by Subject|4|||
27624815|NCT02724878|80467093|FG000|Overall Study|Lost to Follow-up|2|||
27624816|NCT02724878|80467093|FG000|Overall Study|Protocol Violation|1|||
27624817|NCT02724878|80467093|FG000|Overall Study|Ineligible for Study Drug|5|||
27624818|NCT02724878|80467093|FG000|Overall Study|not started|1|||
27624819|NCT00477412|80469195|FG000|Overall Study|Death|0|||
27624820|NCT00477412|80469196|FG001|Overall Study|Death|0|||
27624821|NCT00477412|80469197|FG002|Overall Study|Death|0|||
27624822|NCT00477412|80469198|FG003|Overall Study|Death|4|||
27624823|NCT00477412|80469195|FG000|Overall Study|Lost to Follow-up|0|||
27624824|NCT00477412|80469196|FG001|Overall Study|Lost to Follow-up|0|||
27624825|NCT00477412|80469197|FG002|Overall Study|Lost to Follow-up|0|||
27528753|NCT00322153|80128743|FG000|Overall Study|Withdrawal by Subject|18|||
27528754|NCT00322153|80128744|FG001|Overall Study|Withdrawal by Subject|10|||
27528755|NCT00322153|80128743|FG000|Overall Study|Lack of Efficacy|8|||
27528756|NCT00322153|80128744|FG001|Overall Study|Lack of Efficacy|3|||
27528757|NCT00322153|80128743|FG000|Overall Study|Lost to Follow-up|5|||
27528758|NCT00322153|80128744|FG001|Overall Study|Lost to Follow-up|4|||
27528759|NCT00322153|80128743|FG000|Overall Study|Withdrawn for other reasons|5|||
27528760|NCT00322153|80128744|FG001|Overall Study|Withdrawn for other reasons|4|||
27528761|NCT04618770|80128746|FG000|Overall Study|Censored from Analysis|12|||
27528762|NCT04618770|80128746|FG000|Overall Study|Early Termination|25|||
27528763|NCT02233946|80128747|FG000|Baseline|Withdrawal by Subject|2|||
27528764|NCT02233946|80128748|FG001|Baseline|Withdrawal by Subject|0|||
27528765|NCT02233946|80128747|FG000|3-months Follow-up|Lost to Follow-up|53|||
27528766|NCT02233946|80128748|FG001|3-months Follow-up|Lost to Follow-up|29|||
27528767|NCT02233946|80128747|FG000|6-months Follow-up|Lost to Follow-up|21|||
27528768|NCT02233946|80128748|FG001|6-months Follow-up|Lost to Follow-up|2|||
27528769|NCT02233946|80128747|FG000|9-month Follow-up|Lost to Follow-up|20|||
27624826|NCT00477412|80469198|FG003|Overall Study|Lost to Follow-up|1|||
27624827|NCT00477412|80469195|FG000|Overall Study|Withdrawal by Subject|0|||
27624828|NCT00477412|80469196|FG001|Overall Study|Withdrawal by Subject|0|||
27734047|NCT00195650|80853478|FG000|Overall Study|Administrative reasons|83|||
27624829|NCT00477412|80469197|FG002|Overall Study|Withdrawal by Subject|0|||
27734048|NCT04800315|80853481|FG000|Randomization|Did not receive study treatment|1|||
27734049|NCT04800315|80853482|FG001|Randomization|Did not receive study treatment|0|||
27528770|NCT02233946|80128748|FG001|9-month Follow-up|Lost to Follow-up|11|||
27528771|NCT02233946|80128747|FG000|12-month Follow-up|Lost to Follow-up|28|||
27528772|NCT02233946|80128748|FG001|12-month Follow-up|Lost to Follow-up|11|||
27528773|NCT01285960|80128751|FG000|Overall Study|Withdrawal by Subject|2|||
27528774|NCT01285960|80128751|FG000|Overall Study|Lost to Follow-up|2|||
27528775|NCT01285960|80128751|FG000|Overall Study|2 subjects received less 10 sonications|2|||
27624830|NCT00477412|80469198|FG003|Overall Study|Withdrawal by Subject|2|||
27624831|NCT00477412|80469195|FG000|Overall Study|Second Malignancy|0|||
27624832|NCT00477412|80469196|FG001|Overall Study|Second Malignancy|0|||
27528776|NCT00543855|80128753|FG000|Overall Study|Adverse Event|3|||
27528777|NCT00543855|80128754|FG001|Overall Study|Adverse Event|1|||
27528778|NCT00543855|80128755|FG002|Overall Study|Adverse Event|3|||
27624833|NCT00477412|80469197|FG002|Overall Study|Second Malignancy|0|||
27624834|NCT00477412|80469198|FG003|Overall Study|Second Malignancy|1|||
27624835|NCT00477412|80469195|FG000|Overall Study|Adverse Event|1|||
27624836|NCT00477412|80469196|FG001|Overall Study|Adverse Event|0|||
27624837|NCT00477412|80469197|FG002|Overall Study|Adverse Event|1|||
27624838|NCT00477412|80469198|FG003|Overall Study|Adverse Event|0|||
27624839|NCT00991276|80469201|FG000|First Intervention Period|Adverse Event|0|||
27624840|NCT00991276|80469202|FG001|First Intervention Period|Adverse Event|1|||
27624841|NCT00991276|80469203|FG002|First Intervention Period|Adverse Event|0|||
27624842|NCT00991276|80469204|FG003|First Intervention Period|Adverse Event|1|||
27624843|NCT00991276|80469205|FG004|First Intervention Period|Adverse Event|0|||
27624844|NCT00991276|80469206|FG005|First Intervention Period|Adverse Event|0|||
27624845|NCT00991276|80469201|FG000|First Intervention Period|Protocol Violation|0|||
27624846|NCT00991276|80469202|FG001|First Intervention Period|Protocol Violation|0|||
27624847|NCT00991276|80469203|FG002|First Intervention Period|Protocol Violation|0|||
27624848|NCT00991276|80469204|FG003|First Intervention Period|Protocol Violation|0|||
27624849|NCT00991276|80469205|FG004|First Intervention Period|Protocol Violation|2|||
27624850|NCT00991276|80469206|FG005|First Intervention Period|Protocol Violation|0|||
27624851|NCT00991276|80469201|FG000|First Intervention Period|Insufficient clinical response|0|||
27624852|NCT00991276|80469202|FG001|First Intervention Period|Insufficient clinical response|0|||
27624853|NCT00991276|80469203|FG002|First Intervention Period|Insufficient clinical response|0|||
27624854|NCT00991276|80469204|FG003|First Intervention Period|Insufficient clinical response|0|||
27624855|NCT00991276|80469205|FG004|First Intervention Period|Insufficient clinical response|1|||
27624856|NCT00991276|80469206|FG005|First Intervention Period|Insufficient clinical response|0|||
27624857|NCT00991276|80469201|FG000|First Intervention Period|Other|0|||
27624858|NCT00991276|80469202|FG001|First Intervention Period|Other|0|||
27624859|NCT00991276|80469203|FG002|First Intervention Period|Other|0|||
27624860|NCT00991276|80469204|FG003|First Intervention Period|Other|1|||
27624861|NCT00991276|80469205|FG004|First Intervention Period|Other|1|||
27528779|NCT00543855|80128756|FG003|Overall Study|Adverse Event|4|||
27528780|NCT00543855|80128753|FG000|Overall Study|Lost to Follow-up|0|||
27624862|NCT00991276|80469206|FG005|First Intervention Period|Other|0|||
27624863|NCT00991276|80469201|FG000|First Intervention Period|Withdrawal by Subject|0|||
27624864|NCT00991276|80469202|FG001|First Intervention Period|Withdrawal by Subject|1|||
27624865|NCT00991276|80469203|FG002|First Intervention Period|Withdrawal by Subject|0|||
27528781|NCT00543855|80128754|FG001|Overall Study|Lost to Follow-up|0|||
27528782|NCT00543855|80128755|FG002|Overall Study|Lost to Follow-up|1|||
27528783|NCT00543855|80128756|FG003|Overall Study|Lost to Follow-up|0|||
27528784|NCT00543855|80128753|FG000|Overall Study|Withdrawal by Subject|0|||
27528785|NCT00543855|80128754|FG001|Overall Study|Withdrawal by Subject|1|||
27528786|NCT00543855|80128755|FG002|Overall Study|Withdrawal by Subject|2|||
27528787|NCT00543855|80128756|FG003|Overall Study|Withdrawal by Subject|0|||
27528788|NCT00543855|80128753|FG000|Overall Study|Protocol Violation|1|||
27528789|NCT00543855|80128754|FG001|Overall Study|Protocol Violation|0|||
27528790|NCT00543855|80128755|FG002|Overall Study|Protocol Violation|0|||
27528791|NCT00543855|80128756|FG003|Overall Study|Protocol Violation|0|||
27528792|NCT01306877|80128760|FG000|Overall Study|Lost to Follow-up|3|||
27528793|NCT01306877|80128761|FG001|Overall Study|Lost to Follow-up|3|||
27528794|NCT01306877|80128760|FG000|Overall Study|Physician Decision|0|||
27528795|NCT01306877|80128761|FG001|Overall Study|Physician Decision|1|||
27528796|NCT01056380|80128762|FG000|Overall Study|Lost to Follow-up|2|||
27528797|NCT01056380|80128763|FG001|Overall Study|Lost to Follow-up|3|||
27528798|NCT02359851|80128764|FG000|Overall Study|Death|1|||
27528799|NCT02359851|80128764|FG000|Overall Study|Disease progression|1|||
27528800|NCT00976573|80128765|FG000|Overall Study|Ineligible|0|||
27528801|NCT00976573|80128766|FG001|Overall Study|Ineligible|1|||
27528802|NCT00976573|80128765|FG000|Overall Study|Cancel prior to receiving treatment|4|||
27528803|NCT00976573|80128766|FG001|Overall Study|Cancel prior to receiving treatment|2|||
27528804|NCT03345342|80128771|FG000|Open-Label Phase|Adverse Event|30|||
27528805|NCT03345342|80128772|FG001|Open-Label Phase|Adverse Event|0|||
27528806|NCT03345342|80128773|FG002|Open-Label Phase|Adverse Event|0|||
27528807|NCT03345342|80128774|FG003|Open-Label Phase|Adverse Event|0|||
27624866|NCT00991276|80469204|FG003|First Intervention Period|Withdrawal by Subject|1|||
27624867|NCT00991276|80469205|FG004|First Intervention Period|Withdrawal by Subject|0|||
27624868|NCT00991276|80469206|FG005|First Intervention Period|Withdrawal by Subject|1|||
27624869|NCT00991276|80469201|FG000|First Intervention Period|Lost to Follow-up|0|||
27624870|NCT00991276|80469202|FG001|First Intervention Period|Lost to Follow-up|1|||
27624871|NCT00991276|80469203|FG002|First Intervention Period|Lost to Follow-up|0|||
27528808|NCT03345342|80128775|FG004|Open-Label Phase|Adverse Event|0|||
27528809|NCT03345342|80128771|FG000|Open-Label Phase|Death|1|||
27528810|NCT03345342|80128772|FG001|Open-Label Phase|Death|0|||
27528811|NCT03345342|80128773|FG002|Open-Label Phase|Death|0|||
27528812|NCT03345342|80128774|FG003|Open-Label Phase|Death|0|||
27528813|NCT03345342|80128775|FG004|Open-Label Phase|Death|0|||
27528814|NCT03345342|80128771|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
27528815|NCT03345342|80128772|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
27528816|NCT03345342|80128773|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
27528817|NCT03345342|80128774|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
27528818|NCT03345342|80128775|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
27624872|NCT00991276|80469204|FG003|First Intervention Period|Lost to Follow-up|1|||
27624873|NCT00991276|80469205|FG004|First Intervention Period|Lost to Follow-up|0|||
27624874|NCT00991276|80469206|FG005|First Intervention Period|Lost to Follow-up|0|||
27624875|NCT00991276|80469201|FG000|Second Intervention Period|Adverse Event|0|||
27624876|NCT00991276|80469202|FG001|Second Intervention Period|Adverse Event|2|||
27624877|NCT00991276|80469203|FG002|Second Intervention Period|Adverse Event|0|||
27528819|NCT03345342|80128771|FG000|Open-Label Phase|Lack of Efficacy|6|||
27528820|NCT03345342|80128772|FG001|Open-Label Phase|Lack of Efficacy|0|||
27528821|NCT03345342|80128773|FG002|Open-Label Phase|Lack of Efficacy|0|||
27528822|NCT03345342|80128774|FG003|Open-Label Phase|Lack of Efficacy|0|||
27528823|NCT03345342|80128775|FG004|Open-Label Phase|Lack of Efficacy|0|||
27528824|NCT03345342|80128771|FG000|Open-Label Phase|Lost to Follow-up|9|||
27528825|NCT03345342|80128772|FG001|Open-Label Phase|Lost to Follow-up|0|||
27528826|NCT03345342|80128773|FG002|Open-Label Phase|Lost to Follow-up|0|||
27734050|NCT04800315|80853483|FG002|Randomization|Did not receive study treatment|0|||
27734051|NCT04800315|80853484|FG003|Randomization|Did not receive study treatment|0|||
27734052|NCT04800315|80853481|FG000|Treatment Period|Adverse Event|4|||
27734053|NCT04800315|80853482|FG001|Treatment Period|Adverse Event|2|||
27734054|NCT04800315|80853483|FG002|Treatment Period|Adverse Event|1|||
27734055|NCT04800315|80853484|FG003|Treatment Period|Adverse Event|2|||
27734056|NCT04800315|80853481|FG000|Treatment Period|Lack of Efficacy|1|||
27734057|NCT04800315|80853482|FG001|Treatment Period|Lack of Efficacy|0|||
27734058|NCT04800315|80853483|FG002|Treatment Period|Lack of Efficacy|0|||
27734059|NCT04800315|80853484|FG003|Treatment Period|Lack of Efficacy|3|||
27734060|NCT04800315|80853481|FG000|Treatment Period|Lost to Follow-up|0|||
27734061|NCT04800315|80853482|FG001|Treatment Period|Lost to Follow-up|1|||
27734062|NCT04800315|80853483|FG002|Treatment Period|Lost to Follow-up|2|||
27734063|NCT04800315|80853484|FG003|Treatment Period|Lost to Follow-up|2|||
27734064|NCT04800315|80853481|FG000|Treatment Period|Withdrawal by participant|0|||
27734065|NCT04800315|80853482|FG001|Treatment Period|Withdrawal by participant|0|||
27734066|NCT04800315|80853483|FG002|Treatment Period|Withdrawal by participant|0|||
27734067|NCT04800315|80853484|FG003|Treatment Period|Withdrawal by participant|4|||
27734068|NCT04800315|80853481|FG000|Treatment Period|Other Reasons|0|||
27734069|NCT04800315|80853482|FG001|Treatment Period|Other Reasons|2|||
27734070|NCT04800315|80853483|FG002|Treatment Period|Other Reasons|0|||
27734071|NCT04800315|80853484|FG003|Treatment Period|Other Reasons|1|||
27734072|NCT03617705|80853485|FG000|Overall Study|Withdrawal by Subject|2|||
27734073|NCT03617705|80853485|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
27734074|NCT03617705|80853485|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
27734075|NCT00635102|80853492|FG000|Overall Study|Withdrawal by Subject|7|||
27734076|NCT00635102|80853493|FG001|Overall Study|Withdrawal by Subject|8|||
27734077|NCT02338843|80853494|FG000|Overall Study|Adverse Event|2|||
27734078|NCT02338843|80853495|FG001|Overall Study|Adverse Event|1|||
27734079|NCT02338843|80853494|FG000|Overall Study|Death|40|||
27734080|NCT02338843|80853495|FG001|Overall Study|Death|53|||
27734081|NCT02338843|80853494|FG000|Overall Study|Physician Decision|1|||
27624878|NCT00991276|80469204|FG003|Second Intervention Period|Adverse Event|1|||
27624879|NCT00991276|80469205|FG004|Second Intervention Period|Adverse Event|1|||
27624880|NCT00991276|80469206|FG005|Second Intervention Period|Adverse Event|0|||
27624881|NCT00991276|80469201|FG000|Second Intervention Period|Protocol Violation|1|||
27624882|NCT00991276|80469202|FG001|Second Intervention Period|Protocol Violation|0|||
27624883|NCT00991276|80469203|FG002|Second Intervention Period|Protocol Violation|0|||
27624884|NCT00991276|80469204|FG003|Second Intervention Period|Protocol Violation|0|||
27624885|NCT00991276|80469205|FG004|Second Intervention Period|Protocol Violation|0|||
27528827|NCT03345342|80128774|FG003|Open-Label Phase|Lost to Follow-up|0|||
27528828|NCT03345342|80128775|FG004|Open-Label Phase|Lost to Follow-up|0|||
27528829|NCT03345342|80128771|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
27528830|NCT03345342|80128772|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
27528831|NCT03345342|80128773|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
27528832|NCT03345342|80128774|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
27528833|NCT03345342|80128775|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
27528834|NCT03345342|80128771|FG000|Open-Label Phase|Physician Decision|4|||
27624886|NCT00991276|80469206|FG005|Second Intervention Period|Protocol Violation|0|||
27624887|NCT00991276|80469201|FG000|Second Intervention Period|Other|0|||
27624888|NCT00991276|80469202|FG001|Second Intervention Period|Other|0|||
27734082|NCT02338843|80853495|FG001|Overall Study|Physician Decision|0|||
27734083|NCT02338843|80853494|FG000|Overall Study|Withdrawal by Subject|0|||
27528835|NCT03345342|80128772|FG001|Open-Label Phase|Physician Decision|0|||
27528836|NCT03345342|80128773|FG002|Open-Label Phase|Physician Decision|0|||
27528837|NCT03345342|80128774|FG003|Open-Label Phase|Physician Decision|0|||
27624889|NCT00991276|80469203|FG002|Second Intervention Period|Other|0|||
27734084|NCT02338843|80853495|FG001|Overall Study|Withdrawal by Subject|2|||
27734085|NCT02338843|80853494|FG000|Overall Study|Subject Recovered|0|||
27734086|NCT02338843|80853495|FG001|Overall Study|Subject Recovered|2|||
27911749|NCT02581488|81513739|FG001|Overall Study|Lost to Follow-up|0|||
27911750|NCT02581488|81513738|FG000|Overall Study|Withdrawal by Subject|1|||
27911751|NCT02581488|81513739|FG001|Overall Study|Withdrawal by Subject|0|||
27911752|NCT02581488|81513738|FG000|Overall Study|Non-Compliance|1|||
27911753|NCT02581488|81513739|FG001|Overall Study|Non-Compliance|0|||
27911754|NCT02581488|81513738|FG000|Overall Study|Protocol Violation|0|||
27528838|NCT03345342|80128775|FG004|Open-Label Phase|Physician Decision|0|||
27528839|NCT03345342|80128771|FG000|Open-Label Phase|Protocol Violation|8|||
27528840|NCT03345342|80128772|FG001|Open-Label Phase|Protocol Violation|0|||
27528841|NCT03345342|80128773|FG002|Open-Label Phase|Protocol Violation|0|||
27528842|NCT03345342|80128774|FG003|Open-Label Phase|Protocol Violation|0|||
27528843|NCT03345342|80128775|FG004|Open-Label Phase|Protocol Violation|0|||
27528844|NCT03345342|80128771|FG000|Open-Label Phase|Withdrawal by Subject|57|||
27528845|NCT03345342|80128772|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27528846|NCT03345342|80128773|FG002|Open-Label Phase|Withdrawal by Subject|0|||
27528847|NCT03345342|80128774|FG003|Open-Label Phase|Withdrawal by Subject|0|||
27528848|NCT03345342|80128775|FG004|Open-Label Phase|Withdrawal by Subject|0|||
27528849|NCT03345342|80128771|FG000|Open-Label Phase|Other|15|||
27528850|NCT03345342|80128772|FG001|Open-Label Phase|Other|0|||
27528851|NCT03345342|80128773|FG002|Open-Label Phase|Other|0|||
27528852|NCT03345342|80128774|FG003|Open-Label Phase|Other|0|||
27528853|NCT03345342|80128775|FG004|Open-Label Phase|Other|0|||
27528854|NCT03345342|80128771|FG000|Double-Blind Phase|Adverse Event|0|||
27528855|NCT03345342|80128772|FG001|Double-Blind Phase|Adverse Event|1|||
27528856|NCT03345342|80128773|FG002|Double-Blind Phase|Adverse Event|6|||
27528857|NCT03345342|80128774|FG003|Double-Blind Phase|Adverse Event|0|||
27624890|NCT00991276|80469204|FG003|Second Intervention Period|Other|1|||
27624891|NCT00991276|80469205|FG004|Second Intervention Period|Other|0|||
27624892|NCT00991276|80469206|FG005|Second Intervention Period|Other|1|||
27624893|NCT00991276|80469201|FG000|Third Intervention Period|Protocol Violation|1|||
27624894|NCT00991276|80469202|FG001|Third Intervention Period|Protocol Violation|0|||
27624895|NCT00991276|80469203|FG002|Third Intervention Period|Protocol Violation|0|||
27624896|NCT00991276|80469204|FG003|Third Intervention Period|Protocol Violation|0|||
27624897|NCT00991276|80469205|FG004|Third Intervention Period|Protocol Violation|0|||
27624898|NCT00991276|80469206|FG005|Third Intervention Period|Protocol Violation|0|||
27624899|NCT00991276|80469201|FG000|Third Intervention Period|Other|0|||
27624900|NCT00991276|80469202|FG001|Third Intervention Period|Other|0|||
27624901|NCT00991276|80469203|FG002|Third Intervention Period|Other|0|||
27624902|NCT00991276|80469204|FG003|Third Intervention Period|Other|0|||
27624903|NCT00991276|80469205|FG004|Third Intervention Period|Other|0|||
27624904|NCT00991276|80469206|FG005|Third Intervention Period|Other|1|||
27624905|NCT00991276|80469201|FG000|Third Intervention Period|Adverse Event|0|||
27624906|NCT00991276|80469202|FG001|Third Intervention Period|Adverse Event|0|||
27624907|NCT00991276|80469203|FG002|Third Intervention Period|Adverse Event|1|||
27624908|NCT00991276|80469204|FG003|Third Intervention Period|Adverse Event|0|||
27624909|NCT00991276|80469205|FG004|Third Intervention Period|Adverse Event|0|||
27624910|NCT00991276|80469206|FG005|Third Intervention Period|Adverse Event|0|||
27624911|NCT00991276|80469201|FG000|Third Intervention Period|Withdrawal by Subject|0|||
27624912|NCT00991276|80469202|FG001|Third Intervention Period|Withdrawal by Subject|0|||
27624913|NCT00991276|80469203|FG002|Third Intervention Period|Withdrawal by Subject|0|||
27624914|NCT00991276|80469204|FG003|Third Intervention Period|Withdrawal by Subject|1|||
27624915|NCT00991276|80469205|FG004|Third Intervention Period|Withdrawal by Subject|0|||
27624916|NCT00991276|80469206|FG005|Third Intervention Period|Withdrawal by Subject|0|||
27624917|NCT03178201|80469207|FG000|Overall Study|Off study|5|||
27624918|NCT02321540|80469211|FG000|Overall Study|Death|0|||
27624919|NCT02321540|80469212|FG001|Overall Study|Death|1|||
27624920|NCT02321540|80469211|FG000|Overall Study|Progression|3|||
27624921|NCT02321540|80469212|FG001|Overall Study|Progression|9|||
27624922|NCT02459964|80469215|FG000|Overall Study|Withdrawal by Subject|0|||
27624923|NCT02459964|80469216|FG001|Overall Study|Withdrawal by Subject|0|||
27624924|NCT02459964|80469217|FG002|Overall Study|Withdrawal by Subject|1|||
27624925|NCT02459964|80469215|FG000|Overall Study|Abnormal EKG changes|0|||
27624926|NCT02459964|80469216|FG001|Overall Study|Abnormal EKG changes|0|||
27624927|NCT02459964|80469217|FG002|Overall Study|Abnormal EKG changes|1|||
27624928|NCT00248287|80469218|FG000|Overall Study|Adverse Event|11|||
27624929|NCT00248287|80469219|FG001|Overall Study|Adverse Event|10|||
27624930|NCT00248287|80469218|FG000|Overall Study|Death|1|||
27624931|NCT00248287|80469219|FG001|Overall Study|Death|0|||
27624932|NCT00248287|80469218|FG000|Overall Study|Lost to Follow-up|0|||
27624933|NCT00248287|80469219|FG001|Overall Study|Lost to Follow-up|1|||
27734087|NCT02338843|80853494|FG000|Overall Study|Discontinued prior to randomizat|1|||
27911755|NCT02581488|81513739|FG001|Overall Study|Protocol Violation|4|||
27528858|NCT03345342|80128775|FG004|Double-Blind Phase|Adverse Event|0|||
27528859|NCT03345342|80128771|FG000|Double-Blind Phase|Death|0|||
27528860|NCT03345342|80128772|FG001|Double-Blind Phase|Death|2|||
27528861|NCT03345342|80128773|FG002|Double-Blind Phase|Death|1|||
27624934|NCT00248287|80469218|FG000|Overall Study|Investigator Request|4|||
27624935|NCT00248287|80469219|FG001|Overall Study|Investigator Request|3|||
27528862|NCT03345342|80128774|FG003|Double-Blind Phase|Death|0|||
27528863|NCT03345342|80128775|FG004|Double-Blind Phase|Death|0|||
27528864|NCT03345342|80128771|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
27734088|NCT02338843|80853495|FG001|Overall Study|Discontinued prior to randomizat|0|||
27734089|NCT01059448|80853496|FG000|Overall Study|Adverse Event|1|||
27734090|NCT01059448|80853497|FG001|Overall Study|Adverse Event|3|||
27734091|NCT01059448|80853498|FG002|Overall Study|Adverse Event|0|||
27734092|NCT01059448|80853499|FG003|Overall Study|Adverse Event|1|||
27734093|NCT01059448|80853496|FG000|Overall Study|Withdrawal by Subject|2|||
27734094|NCT01059448|80853497|FG001|Overall Study|Withdrawal by Subject|0|||
27734095|NCT01059448|80853498|FG002|Overall Study|Withdrawal by Subject|2|||
27734096|NCT01059448|80853499|FG003|Overall Study|Withdrawal by Subject|4|||
27734097|NCT01059448|80853496|FG000|Overall Study|Disease Progression|2|||
27734098|NCT01059448|80853497|FG001|Overall Study|Disease Progression|1|||
27734099|NCT01059448|80853498|FG002|Overall Study|Disease Progression|4|||
27734100|NCT01059448|80853499|FG003|Overall Study|Disease Progression|2|||
27734101|NCT01059448|80853496|FG000|Overall Study|Administrative Decision|43|||
27734102|NCT01059448|80853497|FG001|Overall Study|Administrative Decision|49|||
27734103|NCT01059448|80853498|FG002|Overall Study|Administrative Decision|45|||
27734104|NCT01059448|80853499|FG003|Overall Study|Administrative Decision|46|||
27734105|NCT01059448|80853496|FG000|Overall Study|Lost to Follow-up|0|||
27734106|NCT01059448|80853497|FG001|Overall Study|Lost to Follow-up|0|||
27734107|NCT01059448|80853498|FG002|Overall Study|Lost to Follow-up|2|||
27734108|NCT01059448|80853499|FG003|Overall Study|Lost to Follow-up|0|||
27734109|NCT01059448|80853496|FG000|Overall Study|Death|0|||
27734110|NCT01059448|80853497|FG001|Overall Study|Death|1|||
27734111|NCT01059448|80853498|FG002|Overall Study|Death|0|||
27734112|NCT01059448|80853499|FG003|Overall Study|Death|0|||
27734113|NCT01059448|80853496|FG000|Overall Study|Other|1|||
27734114|NCT01059448|80853497|FG001|Overall Study|Other|1|||
27734115|NCT01059448|80853498|FG002|Overall Study|Other|0|||
27734116|NCT01059448|80853499|FG003|Overall Study|Other|1|||
27734117|NCT00486603|80853501|FG000|Overall Study|Withdrawal by Subject|1|||
27734118|NCT00486603|80853502|FG001|Overall Study|Withdrawal by Subject|0|||
27734119|NCT00486603|80853503|FG002|Overall Study|Withdrawal by Subject|0|||
27734120|NCT00486603|80853504|FG003|Overall Study|Withdrawal by Subject|0|||
27734121|NCT00486603|80853505|FG004|Overall Study|Withdrawal by Subject|0|||
27734122|NCT00486603|80853501|FG000|Overall Study|Physician Decision|0|||
27734123|NCT00486603|80853502|FG001|Overall Study|Physician Decision|1|||
27734124|NCT00486603|80853503|FG002|Overall Study|Physician Decision|0|||
27734125|NCT00486603|80853504|FG003|Overall Study|Physician Decision|0|||
27734126|NCT00486603|80853505|FG004|Overall Study|Physician Decision|0|||
27734127|NCT02388295|80853506|FG000|Dose Escalation Week 1|Adverse Event|1|||
27734128|NCT02388295|80853507|FG001|Dose Escalation Week 1|Adverse Event|2|||
27734129|NCT02388295|80853508|FG002|Dose Escalation Week 1|Adverse Event|1|||
27734130|NCT02388295|80853506|FG000|Dose Escalation Week 1|Determined not eligible|1|||
27734131|NCT02388295|80853507|FG001|Dose Escalation Week 1|Determined not eligible|1|||
27734132|NCT02388295|80853508|FG002|Dose Escalation Week 1|Determined not eligible|1|||
27734133|NCT02388295|80853506|FG000|Dose Escalation Week 2|Protocol Violation|0|||
27734134|NCT02388295|80853507|FG001|Dose Escalation Week 2|Protocol Violation|1|||
27734135|NCT02388295|80853508|FG002|Dose Escalation Week 2|Protocol Violation|0|||
27734136|NCT02388295|80853506|FG000|Dose Escalation Week 2|Determined not eligible|1|||
27734137|NCT02388295|80853507|FG001|Dose Escalation Week 2|Determined not eligible|1|||
27734138|NCT02388295|80853508|FG002|Dose Escalation Week 2|Determined not eligible|1|||
27734139|NCT02388295|80853506|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
27734140|NCT02388295|80853507|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
27734141|NCT02388295|80853508|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
27734142|NCT02599402|80853509|FG000|Overall Study|Disease progression|153|||
27734143|NCT02599402|80853509|FG000|Overall Study|Study drug toxicity|201|||
27734144|NCT02599402|80853509|FG000|Overall Study|Death|26|||
27734145|NCT02599402|80853509|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
27734146|NCT02599402|80853509|FG000|Overall Study|Participant request to discontinue study treatment|13|||
27734147|NCT02599402|80853509|FG000|Overall Study|Participant withdrew consent|5|||
27734148|NCT02599402|80853509|FG000|Overall Study|Lost to Follow-up|1|||
27734149|NCT02599402|80853509|FG000|Overall Study|Maximum Clinical Benefit|7|||
27734150|NCT02599402|80853509|FG000|Overall Study|Poor/non-compliance|1|||
27734151|NCT02599402|80853509|FG000|Overall Study|Pregnancy|1|||
27734152|NCT02599402|80853509|FG000|Overall Study|Participant no longer met study criteria|7|||
27528865|NCT03345342|80128772|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
27734153|NCT02599402|80853509|FG000|Overall Study|Other Reasons|95|||
27734154|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
27734155|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
27734156|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
27734157|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
27734158|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
27734159|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27734160|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27734161|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27734162|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27734163|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
27734164|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27734165|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27734166|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27734167|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
27734168|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
27734169|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
27734170|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
27734171|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
27734172|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
27734173|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
27734174|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
27734175|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
27734176|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
27734177|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
27734178|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
27734179|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
27734180|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
27734181|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
27734182|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
27911756|NCT02849743|81513740|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
27911757|NCT02849743|81513741|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
27911758|NCT02849743|81513740|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
27911759|NCT02849743|81513741|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27911760|NCT00490919|81513742|FG000|Open-label Run-in Period|Adverse Event|239|||
27911761|NCT00490919|81513743|FG001|Open-label Run-in Period|Adverse Event|0|||
27528866|NCT03345342|80128773|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
27528867|NCT03345342|80128774|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
27528868|NCT03345342|80128775|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
27528869|NCT03345342|80128771|FG000|Double-Blind Phase|Lost to Follow-up|0|||
27528870|NCT03345342|80128772|FG001|Double-Blind Phase|Lost to Follow-up|1|||
27528871|NCT03345342|80128773|FG002|Double-Blind Phase|Lost to Follow-up|7|||
27528872|NCT03345342|80128774|FG003|Double-Blind Phase|Lost to Follow-up|0|||
27528873|NCT03345342|80128775|FG004|Double-Blind Phase|Lost to Follow-up|0|||
27528874|NCT03345342|80128771|FG000|Double-Blind Phase|Physician Decision|0|||
27528875|NCT03345342|80128772|FG001|Double-Blind Phase|Physician Decision|1|||
27528876|NCT03345342|80128773|FG002|Double-Blind Phase|Physician Decision|4|||
27528877|NCT03345342|80128774|FG003|Double-Blind Phase|Physician Decision|0|||
27528878|NCT03345342|80128775|FG004|Double-Blind Phase|Physician Decision|0|||
27528879|NCT03345342|80128771|FG000|Double-Blind Phase|Protocol Violation|0|||
27528880|NCT03345342|80128772|FG001|Double-Blind Phase|Protocol Violation|0|||
27528881|NCT03345342|80128773|FG002|Double-Blind Phase|Protocol Violation|1|||
27528882|NCT03345342|80128774|FG003|Double-Blind Phase|Protocol Violation|0|||
27528883|NCT03345342|80128775|FG004|Double-Blind Phase|Protocol Violation|0|||
27528884|NCT03345342|80128771|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
27528885|NCT03345342|80128772|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
27528886|NCT03345342|80128773|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
27528887|NCT03345342|80128774|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
27528888|NCT03345342|80128775|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
27528889|NCT03345342|80128771|FG000|Double-Blind Phase|Other|0|||
27528890|NCT03345342|80128772|FG001|Double-Blind Phase|Other|1|||
27528891|NCT03345342|80128773|FG002|Double-Blind Phase|Other|3|||
27528892|NCT03345342|80128774|FG003|Double-Blind Phase|Other|0|||
27528893|NCT03345342|80128775|FG004|Double-Blind Phase|Other|0|||
27528894|NCT03345342|80128771|FG000|Follow-Up Phase|Adverse Event|0|||
27528895|NCT03345342|80128772|FG001|Follow-Up Phase|Adverse Event|0|||
27528896|NCT03345342|80128773|FG002|Follow-Up Phase|Adverse Event|0|||
27528897|NCT03345342|80128774|FG003|Follow-Up Phase|Adverse Event|0|||
27528898|NCT03345342|80128775|FG004|Follow-Up Phase|Adverse Event|4|||
27528899|NCT03345342|80128771|FG000|Follow-Up Phase|Lost to Follow-up|0|||
27856398|NCT00128830|81306760|FG000|Overall Study|Non-compliant|4|||
27528900|NCT03345342|80128772|FG001|Follow-Up Phase|Lost to Follow-up|0|||
27528901|NCT03345342|80128773|FG002|Follow-Up Phase|Lost to Follow-up|0|||
27528902|NCT03345342|80128774|FG003|Follow-Up Phase|Lost to Follow-up|0|||
27528903|NCT03345342|80128775|FG004|Follow-Up Phase|Lost to Follow-up|6|||
27528904|NCT03345342|80128771|FG000|Follow-Up Phase|Physician Decision|0|||
27528905|NCT03345342|80128772|FG001|Follow-Up Phase|Physician Decision|0|||
27528906|NCT03345342|80128773|FG002|Follow-Up Phase|Physician Decision|0|||
27734183|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
27734184|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
27624936|NCT00248287|80469218|FG000|Overall Study|Patient Request|5|||
27528907|NCT03345342|80128774|FG003|Follow-Up Phase|Physician Decision|0|||
27528908|NCT03345342|80128775|FG004|Follow-Up Phase|Physician Decision|5|||
27528909|NCT03345342|80128771|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
27528910|NCT03345342|80128772|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
27528911|NCT03345342|80128773|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
27528912|NCT03345342|80128774|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
27528913|NCT03345342|80128775|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
27528914|NCT03345342|80128771|FG000|Follow-Up Phase|Other|0|||
27528915|NCT03345342|80128772|FG001|Follow-Up Phase|Other|0|||
27528916|NCT03345342|80128773|FG002|Follow-Up Phase|Other|0|||
27856399|NCT00128830|81306760|FG000|Overall Study|Discontinued or ineligible for study|2|||
27528917|NCT03345342|80128774|FG003|Follow-Up Phase|Other|3|||
27528918|NCT03345342|80128775|FG004|Follow-Up Phase|Other|1|||
27528919|NCT01280955|80128777|FG000|Overall Study|Death|2|||
27528920|NCT01280955|80128777|FG000|Overall Study|Withdrawal by Subject|1|||
27528921|NCT00450112|80128781|FG000|Overall Study|Other Treatment Required|5|||
27528922|NCT00450112|80128782|FG001|Overall Study|Other Treatment Required|1|||
27528923|NCT00450112|80128781|FG000|Overall Study|Withdrawal by Subject|4|||
27528924|NCT00450112|80128782|FG001|Overall Study|Withdrawal by Subject|1|||
27528925|NCT00450112|80128781|FG000|Overall Study|Lost to Follow-up|2|||
27528926|NCT00450112|80128782|FG001|Overall Study|Lost to Follow-up|1|||
27528927|NCT00450112|80128781|FG000|Overall Study|Others|2|||
27528928|NCT00450112|80128782|FG001|Overall Study|Others|3|||
27528929|NCT02283177|80128783|FG000|Overall Study|Withdrawal by Subject|1|||
27528930|NCT02283177|80128784|FG001|Overall Study|Withdrawal by Subject|1|||
27528931|NCT01055496|80128787|FG000|Overall Study|Withdrawal by Subject|2|||
27528932|NCT01055496|80128788|FG001|Overall Study|Withdrawal by Subject|4|||
27528933|NCT01055496|80128787|FG000|Overall Study|Death|13|||
27528934|NCT01055496|80128788|FG001|Overall Study|Death|23|||
27528935|NCT01055496|80128787|FG000|Overall Study|Lost to Follow-up|0|||
27528936|NCT01055496|80128788|FG001|Overall Study|Lost to Follow-up|2|||
27528937|NCT01055496|80128787|FG000|Overall Study|Other - Unspecified|0|||
27528938|NCT01055496|80128788|FG001|Overall Study|Other - Unspecified|1|||
27528939|NCT02942576|80128795|FG000|Overall Study|Adverse Event|28|||
27528940|NCT02942576|80128796|FG001|Overall Study|Adverse Event|6|||
27528941|NCT02942576|80128795|FG000|Overall Study|Withdrawal by Subject|7|||
27528942|NCT02942576|80128796|FG001|Overall Study|Withdrawal by Subject|5|||
27528943|NCT02942576|80128795|FG000|Overall Study|Physician Decision|1|||
27528944|NCT02942576|80128796|FG001|Overall Study|Physician Decision|4|||
27528945|NCT02942576|80128795|FG000|Overall Study|Other|10|||
27528946|NCT02942576|80128796|FG001|Overall Study|Other|8|||
27528947|NCT00442468|80128797|FG000|Overall Study|Adverse Event|4|||
27528948|NCT00442468|80128797|FG000|Overall Study|Withdrawal by Subject|91|||
27528949|NCT00442468|80128797|FG000|Overall Study|Did not complete all study procedures|88|||
27528950|NCT04041700|80128798|FG000|Overall Study|Pregnancy|1|||
27528951|NCT04041700|80128798|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
27528952|NCT00417482|80128801|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
27528953|NCT00417482|80128802|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
27528954|NCT00417482|80128803|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
27528955|NCT00417482|80128801|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
27528956|NCT00417482|80128802|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
27528957|NCT00417482|80128803|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
27528958|NCT00417482|80128801|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
27528959|NCT00417482|80128802|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
27528960|NCT00417482|80128803|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
27528961|NCT00417482|80128801|FG000|Phase B 1st 16 Weeks|Death|1|||
27528962|NCT00417482|80128802|FG001|Phase B 1st 16 Weeks|Death|0|||
27528963|NCT00417482|80128803|FG002|Phase B 1st 16 Weeks|Death|0|||
27856400|NCT00128830|81306760|FG000|Overall Study|Other|9|||
27734185|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
27856401|NCT00117325|81306761|FG000|Overall Study|Adverse Event|3|||
27856402|NCT00117325|81306762|FG001|Overall Study|Adverse Event|3|||
27856403|NCT00117325|81306761|FG000|Overall Study|Lost to Follow-up|1|||
27856404|NCT00117325|81306762|FG001|Overall Study|Lost to Follow-up|1|||
27856405|NCT00117325|81306761|FG000|Overall Study|Protocol Violation|2|||
27528964|NCT00417482|80128801|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
27528965|NCT00417482|80128802|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
27528966|NCT00417482|80128803|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
27528967|NCT00417482|80128801|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
27528968|NCT00417482|80128802|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
27528969|NCT00417482|80128803|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
27528970|NCT00417482|80128801|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
27528971|NCT00417482|80128802|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
27734186|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
27528972|NCT00417482|80128803|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
27528973|NCT00417482|80128801|FG000|Phase B 2nd 16 Weeks|Death|1|||
27528974|NCT00417482|80128802|FG001|Phase B 2nd 16 Weeks|Death|1|||
27856406|NCT00117325|81306762|FG001|Overall Study|Protocol Violation|3|||
27734187|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
27734188|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
27734189|NCT00785577|80853510|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
27734190|NCT00785577|80853511|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
27734191|NCT00785577|80853512|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
27734192|NCT00785577|80853513|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
27734193|NCT00785577|80853514|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
27734194|NCT00785577|80853510|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27734195|NCT00785577|80853511|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27856407|NCT00117325|81306761|FG000|Overall Study|Withdrawal by Subject|3|||
27856408|NCT00117325|81306762|FG001|Overall Study|Withdrawal by Subject|2|||
27911762|NCT00490919|81513744|FG002|Open-label Run-in Period|Adverse Event|0|||
27911763|NCT00490919|81513742|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
27911764|NCT00490919|81513743|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
27911765|NCT00490919|81513744|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
27911766|NCT00490919|81513742|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
27911767|NCT00490919|81513743|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
27911768|NCT00490919|81513744|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
27911769|NCT00490919|81513742|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
27911770|NCT00490919|81513743|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
27911771|NCT00490919|81513744|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
27911772|NCT00490919|81513742|FG000|Open-label Run-in Period|Administrative|40|||
27911773|NCT00490919|81513743|FG001|Open-label Run-in Period|Administrative|0|||
27911774|NCT00490919|81513744|FG002|Open-label Run-in Period|Administrative|0|||
27911775|NCT00490919|81513742|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
27856409|NCT00117325|81306761|FG000|Overall Study|Lack of Efficacy|1|||
27856410|NCT00117325|81306762|FG001|Overall Study|Lack of Efficacy|0|||
27856411|NCT00117325|81306761|FG000|Overall Study|Use of prohibited medicine|1|||
27856412|NCT00117325|81306762|FG001|Overall Study|Use of prohibited medicine|2|||
27856413|NCT00117325|81306761|FG000|Overall Study|Early termination|1|||
27856414|NCT00117325|81306762|FG001|Overall Study|Early termination|1|||
27856415|NCT00117325|81306761|FG000|Overall Study|Admisnitrative|1|||
27856416|NCT00117325|81306762|FG001|Overall Study|Admisnitrative|0|||
27856417|NCT02516553|81306769|FG000|Overall Study|Progressive disease|2|||
27856418|NCT02516553|81306770|FG001|Overall Study|Progressive disease|2|||
27911776|NCT00490919|81513743|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
27911777|NCT00490919|81513744|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
27911778|NCT00490919|81513742|FG000|Double-blind Phase|Adverse Event|0|||
27624937|NCT00248287|80469219|FG001|Overall Study|Patient Request|3|||
27528975|NCT00417482|80128803|FG002|Phase B 2nd 16 Weeks|Death|0|||
27528976|NCT01347580|80128804|FG000|Overall Study|Withdrawal by Subject|13|||
27624938|NCT00248287|80469218|FG000|Overall Study|Other|3|||
27624939|NCT00248287|80469219|FG001|Overall Study|Other|2|||
27624940|NCT04697069|80469220|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
27624941|NCT04697069|80469221|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
27734196|NCT00785577|80853512|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27856419|NCT02516553|81306771|FG002|Overall Study|Progressive disease|3|||
27734197|NCT00785577|80853513|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
27528977|NCT01347580|80128805|FG001|Overall Study|Withdrawal by Subject|23|||
27624942|NCT04697069|80469220|FG000|Overall Study|Study termination|2|||
27624943|NCT04697069|80469221|FG001|Overall Study|Study termination|1|||
27624944|NCT01096056|80469226|FG000|Overall Study|Lost to Follow-up|0|||
27624945|NCT01096056|80469227|FG001|Overall Study|Lost to Follow-up|1|||
27624946|NCT03415022|80469228|FG000|Overall Study|Withdrawal by Subject|1|||
27624947|NCT03415022|80469229|FG001|Overall Study|Withdrawal by Subject|2|||
27624948|NCT03415022|80469228|FG000|Overall Study|COVID-19 Suspension|2|||
27624949|NCT03415022|80469229|FG001|Overall Study|COVID-19 Suspension|3|||
27624950|NCT03415022|80469228|FG000|Overall Study|Lost to Follow-up|2|||
27624951|NCT03415022|80469229|FG001|Overall Study|Lost to Follow-up|0|||
27624952|NCT02374957|80469234|FG000|Overall Study|Patient did not complete forms correctly|1|||
27624953|NCT02374957|80469235|FG001|Overall Study|Patient did not complete forms correctly|0|||
27624954|NCT01460381|80469236|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
27624955|NCT01460381|80469237|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
27624956|NCT01773122|80469242|FG000|Overall Study|Due to amended age eligibility criteria|3|||
27624957|NCT01773122|80469243|FG001|Overall Study|Due to amended age eligibility criteria|1|||
27624958|NCT01773122|80469244|FG002|Overall Study|Due to amended age eligibility criteria|0|||
27624959|NCT01773122|80469245|FG003|Overall Study|Due to amended age eligibility criteria|1|||
27624960|NCT02322216|80469246|FG000|Overall Study|Adverse Event|1|||
27624961|NCT02322216|80469247|FG001|Overall Study|Adverse Event|0|||
27624962|NCT02322216|80469246|FG000|Overall Study|Withdrawal by Subject|1|||
27624963|NCT02322216|80469247|FG001|Overall Study|Withdrawal by Subject|4|||
27624964|NCT02735915|80469249|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
27624965|NCT02735915|80469249|FG000|Overall Study|Withdrawal following SAE|2|||
27624966|NCT02735915|80469249|FG000|Overall Study|Withdrawal by Subject|1|||
27624967|NCT03201809|80469250|FG000|Overall Study|Lost to Follow-up|2|||
27624968|NCT03201809|80469251|FG001|Overall Study|Lost to Follow-up|0|||
27624969|NCT01720043|80469252|FG000|Overall Study|Withdrawal by Subject|1|||
27624970|NCT02317705|80469253|FG000|Overall Study|Withdrawal by Subject|3|||
27624971|NCT02317705|80469253|FG000|Overall Study|Physician Decision|1|||
27624972|NCT02317705|80469253|FG000|Overall Study|Drug not usable|1|||
27624973|NCT01195675|80469258|FG000|Overall Study|Adverse Event|1|||
27624974|NCT01195675|80469258|FG000|Overall Study|Withdrawal by Subject|2|||
27624975|NCT01656304|80469259|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
27624976|NCT00926393|80469260|FG000|Overall Study|Withdrawal by Subject|1|||
27624977|NCT00926393|80469261|FG001|Overall Study|Withdrawal by Subject|2|||
27624978|NCT00926393|80469260|FG000|Overall Study|Adverse Event|1|||
27911779|NCT00490919|81513743|FG001|Double-blind Phase|Adverse Event|40|||
27911780|NCT00490919|81513744|FG002|Double-blind Phase|Adverse Event|20|||
27911781|NCT00490919|81513742|FG000|Double-blind Phase|Withdrawal by Subject|0|||
27911782|NCT00490919|81513743|FG001|Double-blind Phase|Withdrawal by Subject|10|||
27624979|NCT00926393|80469261|FG001|Overall Study|Adverse Event|1|||
27624980|NCT01763047|80469262|FG000|Period 1|Test Article Not Available|4|||
27624981|NCT01763047|80469263|FG001|Period 1|Test Article Not Available|1|||
27624982|NCT01763047|80469262|FG000|Period 1|Protocol Violation|4|||
27624983|NCT01763047|80469263|FG001|Period 1|Protocol Violation|4|||
27624984|NCT01763047|80469262|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
27624985|NCT01763047|80469263|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
27624986|NCT01763047|80469262|FG000|Period 1|Adverse Event|0|||
27624987|NCT01763047|80469263|FG001|Period 1|Adverse Event|1|||
27624988|NCT01763047|80469262|FG000|Period 1|Unsatisfactory Visual Response|0|||
27624989|NCT01763047|80469263|FG001|Period 1|Unsatisfactory Visual Response|3|||
27624990|NCT01763047|80469262|FG000|Period 1|Lens Power Not Available|0|||
27734198|NCT00785577|80853514|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
27734199|NCT00785577|80853510|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
27624991|NCT01763047|80469263|FG001|Period 1|Lens Power Not Available|1|||
27624992|NCT01763047|80469262|FG000|Period 1|Study Site office Closed|0|||
27624993|NCT01763047|80469263|FG001|Period 1|Study Site office Closed|1|||
27624994|NCT01763047|80469262|FG000|Period 2|Lens Discomfort|1|||
27624995|NCT01763047|80469263|FG001|Period 2|Lens Discomfort|0|||
27624996|NCT01763047|80469262|FG000|Period 2|No longer meets Eligibility Criteria|1|||
27624997|NCT01763047|80469263|FG001|Period 2|No longer meets Eligibility Criteria|0|||
27911783|NCT00490919|81513744|FG002|Double-blind Phase|Withdrawal by Subject|11|||
27624998|NCT01763047|80469262|FG000|Period 2|Study Site office Closed|1|||
27624999|NCT01763047|80469263|FG001|Period 2|Study Site office Closed|1|||
27625000|NCT01763047|80469262|FG000|Period 2|Unsatisfactory Visual Response|1|||
27734200|NCT00785577|80853511|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
27911784|NCT00490919|81513742|FG000|Double-blind Phase|Lost to Follow-up|0|||
27625001|NCT01763047|80469263|FG001|Period 2|Unsatisfactory Visual Response|1|||
27625002|NCT01763047|80469262|FG000|Period 2|Protocol Violation|0|||
27625003|NCT01763047|80469263|FG001|Period 2|Protocol Violation|2|||
27625004|NCT01763047|80469262|FG000|Period 2|Unsatisfactory lens Fitting|0|||
27625005|NCT01763047|80469263|FG001|Period 2|Unsatisfactory lens Fitting|1|||
27911785|NCT00490919|81513743|FG001|Double-blind Phase|Lost to Follow-up|8|||
27911786|NCT00490919|81513744|FG002|Double-blind Phase|Lost to Follow-up|11|||
27911787|NCT00490919|81513742|FG000|Double-blind Phase|Lack of Efficacy|0|||
27734201|NCT00785577|80853512|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
27734202|NCT00785577|80853513|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
27734203|NCT00785577|80853514|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
27734204|NCT03822884|80853515|FG000|Overall Study|Withdrawal by Subject|0|||
27734205|NCT03822884|80853516|FG001|Overall Study|Withdrawal by Subject|0|||
27734206|NCT03822884|80853517|FG002|Overall Study|Withdrawal by Subject|0|||
27734207|NCT03822884|80853518|FG003|Overall Study|Withdrawal by Subject|0|||
27734208|NCT03822884|80853519|FG004|Overall Study|Withdrawal by Subject|1|||
27734209|NCT03822884|80853520|FG005|Overall Study|Withdrawal by Subject|0|||
27734210|NCT01244737|80853524|FG000|Overall Study|Physician Decision|2|||
27734211|NCT01244737|80853525|FG001|Overall Study|Physician Decision|18|||
27734212|NCT01244737|80853526|FG002|Overall Study|Physician Decision|5|||
27734213|NCT01244737|80853524|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
27734214|NCT01244737|80853525|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
27734215|NCT01244737|80853526|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
27528978|NCT01347580|80128804|FG000|Overall Study|Death|30|||
27528979|NCT01347580|80128805|FG001|Overall Study|Death|19|||
27528980|NCT01347580|80128804|FG000|Overall Study|Protocol Violation|10|||
27528981|NCT01347580|80128805|FG001|Overall Study|Protocol Violation|7|||
27528982|NCT01347580|80128804|FG000|Overall Study|Lost to Follow-up|3|||
27528983|NCT01347580|80128805|FG001|Overall Study|Lost to Follow-up|1|||
27734216|NCT01244737|80853524|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
27528984|NCT01347580|80128804|FG000|Overall Study|Had other reason|9|||
27528985|NCT01347580|80128805|FG001|Overall Study|Had other reason|6|||
27856420|NCT02516553|81306772|FG003|Overall Study|Progressive disease|5|||
27625006|NCT03085017|80469264|FG000|Overall Study|Death|0|||
27625007|NCT03085017|80469265|FG001|Overall Study|Death|3|||
27625008|NCT02206685|80469266|FG000|Overall Study|Surgery cancelled/changed|2|||
27625009|NCT02206685|80469267|FG001|Overall Study|Surgery cancelled/changed|3|||
27625010|NCT02206685|80469266|FG000|Overall Study|Withdrawal by Subject|1|||
27625011|NCT02206685|80469267|FG001|Overall Study|Withdrawal by Subject|2|||
27625012|NCT02206685|80469266|FG000|Overall Study|Protocol Violation|2|||
27625013|NCT02206685|80469267|FG001|Overall Study|Protocol Violation|2|||
27625014|NCT03686683|80469271|FG000|Overall Study|Withdrawal by Subject|52|||
27625015|NCT03686683|80469272|FG001|Overall Study|Withdrawal by Subject|32|||
27625016|NCT03686683|80469271|FG000|Overall Study|Lost to Follow-up|23|||
27625017|NCT03686683|80469272|FG001|Overall Study|Lost to Follow-up|19|||
27625018|NCT03686683|80469271|FG000|Overall Study|Adverse Event|1|||
27625019|NCT03686683|80469272|FG001|Overall Study|Adverse Event|0|||
27625020|NCT03686683|80469271|FG000|Overall Study|Death|10|||
27625021|NCT03686683|80469272|FG001|Overall Study|Death|5|||
27528986|NCT01151098|80128806|FG000|Overall Study|Adverse Event|82|||
27625022|NCT03686683|80469271|FG000|Overall Study|Progressive Disease|1|||
27528987|NCT01151098|80128806|FG000|Overall Study|Lost to Follow-up|6|||
27528988|NCT01151098|80128806|FG000|Overall Study|Lack of Efficacy|15|||
27528989|NCT01151098|80128806|FG000|Overall Study|Protocol Violation|1|||
27528990|NCT01151098|80128806|FG000|Overall Study|Miscellaneous|13|||
27528991|NCT01076075|80128807|FG000|Overall Study|Adverse Event|3|||
27528992|NCT01076075|80128808|FG001|Overall Study|Adverse Event|9|||
27528993|NCT01076075|80128807|FG000|Overall Study|Lack of Efficacy|5|||
27528994|NCT01076075|80128808|FG001|Overall Study|Lack of Efficacy|4|||
27528995|NCT01076075|80128807|FG000|Overall Study|Lost to Follow-up|6|||
27528996|NCT01076075|80128808|FG001|Overall Study|Lost to Follow-up|5|||
27528997|NCT01076075|80128807|FG000|Overall Study|other|19|||
27528998|NCT01076075|80128808|FG001|Overall Study|other|9|||
27528999|NCT01076075|80128807|FG000|Overall Study|Protocol Violation|0|||
27529000|NCT01076075|80128808|FG001|Overall Study|Protocol Violation|1|||
27529001|NCT01076075|80128807|FG000|Overall Study|Withdrawal by Subject|8|||
27529002|NCT01076075|80128808|FG001|Overall Study|Withdrawal by Subject|19|||
27625023|NCT03686683|80469272|FG001|Overall Study|Progressive Disease|1|||
27625024|NCT03686683|80469271|FG000|Overall Study|Noncompliance|1|||
27529003|NCT00470184|80128809|FG000|Overall Study|Not Treated(became ineligible)|4|||
27529004|NCT00470184|80128809|FG000|Overall Study|Not treated (other)|1|||
27529005|NCT00470184|80128809|FG000|Overall Study|disease Progression|4|||
27529006|NCT00470184|80128809|FG000|Overall Study|Adverse Event|3|||
27529007|NCT00470184|80128809|FG000|Overall Study|Withdrawal by Subject|4|||
27529008|NCT00470184|80128809|FG000|Overall Study|other|5|||
27529009|NCT00470184|80128809|FG000|Overall Study|recurrence|1|||
27529010|NCT00510952|80128810|FG000|Overall Study|Adverse Event|1|||
27529011|NCT00510952|80128811|FG001|Overall Study|Adverse Event|0|||
27529012|NCT00510952|80128810|FG000|Overall Study|Entry Criteria Not Met|3|||
27625025|NCT03686683|80469272|FG001|Overall Study|Noncompliance|0|||
27734217|NCT01244737|80853525|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
27734218|NCT01244737|80853526|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
27734219|NCT01244737|80853524|FG000|Overall Study|MIB immunopathology results not available|3|||
27734220|NCT01244737|80853525|FG001|Overall Study|MIB immunopathology results not available|2|||
27734221|NCT01244737|80853526|FG002|Overall Study|MIB immunopathology results not available|0|||
27734222|NCT01244737|80853524|FG000|Overall Study|PET data failure|0|||
27734223|NCT01244737|80853525|FG001|Overall Study|PET data failure|1|||
27734224|NCT01244737|80853526|FG002|Overall Study|PET data failure|0|||
27734225|NCT01244737|80853524|FG000|Overall Study|Withdrawal by Subject|0|||
27734226|NCT01244737|80853525|FG001|Overall Study|Withdrawal by Subject|0|||
27734227|NCT01244737|80853526|FG002|Overall Study|Withdrawal by Subject|1|||
27734228|NCT01264939|80853531|FG000|Overall Study|Adverse Event|1|||
27734229|NCT01264939|80853532|FG001|Overall Study|Adverse Event|3|||
27734230|NCT01264939|80853531|FG000|Overall Study|Lost to Follow-up|0|||
27734231|NCT01264939|80853532|FG001|Overall Study|Lost to Follow-up|3|||
27734232|NCT01264939|80853531|FG000|Overall Study|Physician Decision|1|||
27734233|NCT01264939|80853532|FG001|Overall Study|Physician Decision|1|||
27734234|NCT01264939|80853531|FG000|Overall Study|Patient/Guardian Decision|8|||
27529013|NCT00510952|80128811|FG001|Overall Study|Entry Criteria Not Met|1|||
27529014|NCT00510952|80128810|FG000|Overall Study|Lost to Follow-up|5|||
27529015|NCT00510952|80128811|FG001|Overall Study|Lost to Follow-up|3|||
27529016|NCT00510952|80128810|FG000|Overall Study|Physician Decision|1|||
27529017|NCT00510952|80128811|FG001|Overall Study|Physician Decision|1|||
27529018|NCT00510952|80128810|FG000|Overall Study|Protocol Violation|7|||
27529019|NCT00510952|80128811|FG001|Overall Study|Protocol Violation|4|||
27625026|NCT03686683|80469271|FG000|Overall Study|Physician Decision|1|||
27625027|NCT03686683|80469272|FG001|Overall Study|Physician Decision|1|||
27625028|NCT03686683|80469271|FG000|Overall Study|Screen fail post-randomization|1|||
27734235|NCT01264939|80853532|FG001|Overall Study|Patient/Guardian Decision|10|||
27734236|NCT01264939|80853531|FG000|Overall Study|Disease Progression|8|||
27734237|NCT01264939|80853532|FG001|Overall Study|Disease Progression|11|||
27734238|NCT01717638|80853533|FG000|Overall Study|Lost to Follow-up|0|||
27529020|NCT00510952|80128810|FG000|Overall Study|Sponsor Decision|1|||
27529021|NCT00510952|80128811|FG001|Overall Study|Sponsor Decision|0|||
27529022|NCT00510952|80128810|FG000|Overall Study|Withdrawal by Subject|6|||
27529023|NCT00510952|80128811|FG001|Overall Study|Withdrawal by Subject|7|||
27529024|NCT00510952|80128810|FG000|Overall Study|Did Not Receive Study Drug|2|||
27529025|NCT00510952|80128811|FG001|Overall Study|Did Not Receive Study Drug|0|||
27529026|NCT00367770|80128812|FG000|Overall Study|Adverse Event|1|||
27529027|NCT00367770|80128812|FG000|Overall Study|Withdrawal by Subject|1|||
27529028|NCT01931670|80128817|FG000|Treatment Period|Exclusionary Medication Received|1|||
27529029|NCT01931670|80128818|FG001|Treatment Period|Exclusionary Medication Received|1|||
27529030|NCT01931670|80128819|FG002|Treatment Period|Exclusionary Medication Received|1|||
27529031|NCT01931670|80128817|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
27529032|NCT01931670|80128818|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
27529033|NCT01931670|80128819|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
27529034|NCT01931670|80128817|FG000|Treatment Period|Subject Noncompliant|4|||
27529035|NCT01931670|80128818|FG001|Treatment Period|Subject Noncompliant|9|||
27529036|NCT01931670|80128819|FG002|Treatment Period|Subject Noncompliant|5|||
27529037|NCT01931670|80128817|FG000|Treatment Period|Adverse Event|19|||
27529038|NCT01931670|80128818|FG001|Treatment Period|Adverse Event|8|||
27529039|NCT01931670|80128819|FG002|Treatment Period|Adverse Event|21|||
27529040|NCT01931670|80128817|FG000|Treatment Period|Lack of Efficacy|11|||
27529041|NCT01931670|80128818|FG001|Treatment Period|Lack of Efficacy|2|||
27529042|NCT01931670|80128819|FG002|Treatment Period|Lack of Efficacy|2|||
27529043|NCT01931670|80128817|FG000|Treatment Period|Pregnancy|7|||
27529044|NCT01931670|80128818|FG001|Treatment Period|Pregnancy|2|||
27529045|NCT01931670|80128819|FG002|Treatment Period|Pregnancy|0|||
27529046|NCT01931670|80128817|FG000|Treatment Period|Other|8|||
27529047|NCT01931670|80128818|FG001|Treatment Period|Other|7|||
27529048|NCT01931670|80128819|FG002|Treatment Period|Other|2|||
27529049|NCT01931670|80128817|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
27529050|NCT01931670|80128818|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
27529051|NCT01931670|80128819|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
27529052|NCT01931670|80128817|FG000|Treatment Period|Lost to Follow-up|19|||
27529053|NCT01931670|80128818|FG001|Treatment Period|Lost to Follow-up|5|||
27529054|NCT01931670|80128819|FG002|Treatment Period|Lost to Follow-up|7|||
27529055|NCT01931670|80128817|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
27529056|NCT01931670|80128818|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
27529057|NCT01931670|80128819|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
27529058|NCT01931670|80128817|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
27529059|NCT01931670|80128818|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
27529060|NCT01931670|80128819|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
27625029|NCT03686683|80469272|FG001|Overall Study|Screen fail post-randomization|0|||
27625030|NCT03686683|80469271|FG000|Overall Study|Protocol Violation|3|||
27625031|NCT03686683|80469272|FG001|Overall Study|Protocol Violation|0|||
27625032|NCT03686683|80469271|FG000|Overall Study|No data available|1|||
27625033|NCT03686683|80469272|FG001|Overall Study|No data available|0|||
27625034|NCT02775435|80469273|FG000|Overall Study|Adverse Event|32|||
27625035|NCT02775435|80469274|FG001|Overall Study|Adverse Event|27|||
27625036|NCT02775435|80469273|FG000|Overall Study|Lost to Follow-up|2|||
27625037|NCT02775435|80469274|FG001|Overall Study|Lost to Follow-up|2|||
27625038|NCT02775435|80469273|FG000|Overall Study|Sponsor decision|44|||
27625039|NCT02775435|80469274|FG001|Overall Study|Sponsor decision|19|||
27625040|NCT02775435|80469273|FG000|Overall Study|Withdrawal by Subject|4|||
27625041|NCT02775435|80469274|FG001|Overall Study|Withdrawal by Subject|9|||
27625042|NCT02775435|80469273|FG000|Overall Study|Death|196|||
27625043|NCT02775435|80469274|FG001|Overall Study|Death|224|||
27625044|NCT02757885|80469275|FG000|Overall Study|Screen Failures|4|||
27625045|NCT01649427|80469276|FG000|Overall Study|Adverse Event|1|||
27625046|NCT01649427|80469277|FG001|Overall Study|Adverse Event|1|||
27625047|NCT01649427|80469276|FG000|Overall Study|Withdrawal by Subject|8|||
27625048|NCT01649427|80469277|FG001|Overall Study|Withdrawal by Subject|7|||
27625049|NCT01649427|80469276|FG000|Overall Study|Lost to Follow-up|0|||
27625050|NCT01649427|80469277|FG001|Overall Study|Lost to Follow-up|1|||
27625051|NCT01649427|80469276|FG000|Overall Study|Graft loss|0|||
27529061|NCT01931670|80128817|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
27529062|NCT01931670|80128818|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
27529063|NCT01931670|80128819|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
27529064|NCT01931670|80128817|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
27856421|NCT02516553|81306773|FG004|Overall Study|Progressive disease|3|||
27529065|NCT01931670|80128818|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
27625052|NCT01649427|80469277|FG001|Overall Study|Graft loss|1|||
27625053|NCT01649427|80469276|FG000|Overall Study|Surgical problems during nephrectomy|2|||
27625054|NCT01649427|80469277|FG001|Overall Study|Surgical problems during nephrectomy|2|||
27625055|NCT02812966|80469284|FG000|Overall Study|Death|1|||
27625056|NCT02812966|80469285|FG001|Overall Study|Death|0|||
27734239|NCT01717638|80853534|FG001|Overall Study|Lost to Follow-up|0|||
27734240|NCT01717638|80853535|FG002|Overall Study|Lost to Follow-up|0|||
27734241|NCT01717638|80853536|FG003|Overall Study|Lost to Follow-up|0|||
27734242|NCT01717638|80853537|FG004|Overall Study|Lost to Follow-up|0|||
27734243|NCT01717638|80853538|FG005|Overall Study|Lost to Follow-up|1|||
27734244|NCT01717638|80853539|FG006|Overall Study|Lost to Follow-up|0|||
27734245|NCT01717638|80853540|FG007|Overall Study|Lost to Follow-up|0|||
27734246|NCT01717638|80853541|FG008|Overall Study|Lost to Follow-up|0|||
27734247|NCT01717638|80853542|FG009|Overall Study|Lost to Follow-up|0|||
27734248|NCT01717638|80853543|FG010|Overall Study|Lost to Follow-up|0|||
27734249|NCT01717638|80853544|FG011|Overall Study|Lost to Follow-up|0|||
27734250|NCT01717638|80853545|FG012|Overall Study|Lost to Follow-up|0|||
27734251|NCT01717638|80853533|FG000|Overall Study|Father in hospital|0|||
27734252|NCT01717638|80853534|FG001|Overall Study|Father in hospital|0|||
27734253|NCT01717638|80853535|FG002|Overall Study|Father in hospital|0|||
27734254|NCT01717638|80853536|FG003|Overall Study|Father in hospital|0|||
27734255|NCT01717638|80853537|FG004|Overall Study|Father in hospital|0|||
27734256|NCT01717638|80853538|FG005|Overall Study|Father in hospital|0|||
27734257|NCT01717638|80853539|FG006|Overall Study|Father in hospital|0|||
27734258|NCT01717638|80853540|FG007|Overall Study|Father in hospital|0|||
27734259|NCT01717638|80853541|FG008|Overall Study|Father in hospital|0|||
27734260|NCT01717638|80853542|FG009|Overall Study|Father in hospital|0|||
27734261|NCT01717638|80853543|FG010|Overall Study|Father in hospital|0|||
27734262|NCT01717638|80853544|FG011|Overall Study|Father in hospital|0|||
27734263|NCT01717638|80853545|FG012|Overall Study|Father in hospital|1|||
27734264|NCT01717638|80853533|FG000|Overall Study|Withdrawal by Subject|0|||
27734265|NCT01717638|80853534|FG001|Overall Study|Withdrawal by Subject|1|||
27734266|NCT01717638|80853535|FG002|Overall Study|Withdrawal by Subject|1|||
27734267|NCT01717638|80853536|FG003|Overall Study|Withdrawal by Subject|0|||
27734268|NCT01717638|80853537|FG004|Overall Study|Withdrawal by Subject|1|||
27734269|NCT01717638|80853538|FG005|Overall Study|Withdrawal by Subject|0|||
27734270|NCT01717638|80853539|FG006|Overall Study|Withdrawal by Subject|2|||
27734271|NCT01717638|80853540|FG007|Overall Study|Withdrawal by Subject|1|||
27734272|NCT01717638|80853541|FG008|Overall Study|Withdrawal by Subject|2|||
27734273|NCT01717638|80853542|FG009|Overall Study|Withdrawal by Subject|1|||
27625057|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
27625058|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
27625059|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
27625060|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
27625061|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
27625062|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
27625063|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
27625064|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
27625065|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
27625066|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
27734274|NCT01717638|80853543|FG010|Overall Study|Withdrawal by Subject|0|||
27734275|NCT01717638|80853544|FG011|Overall Study|Withdrawal by Subject|0|||
27734276|NCT01717638|80853545|FG012|Overall Study|Withdrawal by Subject|18|||
27734277|NCT00592683|80853546|FG000|Overall Study|Found ineligible|0|||
27734278|NCT00592683|80853547|FG001|Overall Study|Found ineligible|1|||
27734279|NCT00592683|80853546|FG000|Overall Study|Withdrawal by Subject|1|||
27734280|NCT00592683|80853547|FG001|Overall Study|Withdrawal by Subject|0|||
27734281|NCT00592683|80853546|FG000|Overall Study|Adverse Event|0|||
27529066|NCT01931670|80128819|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
27529067|NCT01931670|80128817|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
27625067|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
27625068|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
27734282|NCT00592683|80853547|FG001|Overall Study|Adverse Event|2|||
27529068|NCT01931670|80128818|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
27529069|NCT01931670|80128819|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
27529070|NCT01931670|80128817|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
27529071|NCT01931670|80128818|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
27529072|NCT01931670|80128819|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
27529073|NCT01920555|80128825|FG000|Overall Study|Physician Decision|1|||
27529074|NCT01920555|80128826|FG001|Overall Study|Physician Decision|2|||
27529075|NCT01920555|80128827|FG002|Overall Study|Physician Decision|1|||
27529076|NCT01920555|80128828|FG003|Overall Study|Physician Decision|2|||
27734283|NCT00592683|80853546|FG000|Overall Study|Protocol Violation|1|||
27734284|NCT00592683|80853547|FG001|Overall Study|Protocol Violation|0|||
27734285|NCT00592683|80853546|FG000|Overall Study|Study drug expired|1|||
27734286|NCT00592683|80853547|FG001|Overall Study|Study drug expired|0|||
27734287|NCT00592683|80853546|FG000|Overall Study|Other|1|||
27734288|NCT00592683|80853547|FG001|Overall Study|Other|0|||
27734289|NCT00592683|80853546|FG000|Overall Study|Lost to Follow-up|0|||
27734290|NCT00592683|80853547|FG001|Overall Study|Lost to Follow-up|1|||
27734291|NCT01914679|80853551|FG000|Overall Study|Lack of Efficacy|1|||
27734292|NCT01914679|80853551|FG000|Overall Study|Sponsor terminated study|4|||
27734293|NCT04398732|80853554|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
27734294|NCT03539432|80853555|FG000|Overall Study|Lost to Follow-up|0|||
27734295|NCT03539432|80853556|FG001|Overall Study|Lost to Follow-up|1|||
27734296|NCT01591330|80853572|FG000|Period 1|Adverse Event|1|||
27734297|NCT01591330|80853573|FG001|Period 1|Adverse Event|0|||
27529077|NCT01920555|80128829|FG004|Overall Study|Physician Decision|0|||
27529078|NCT01920555|80128825|FG000|Overall Study|Lack of Efficacy|2|||
27529079|NCT01920555|80128826|FG001|Overall Study|Lack of Efficacy|0|||
27529080|NCT01920555|80128827|FG002|Overall Study|Lack of Efficacy|0|||
27529081|NCT01920555|80128828|FG003|Overall Study|Lack of Efficacy|0|||
27734298|NCT01591330|80853574|FG002|Period 1|Adverse Event|0|||
27734299|NCT01591330|80853575|FG003|Period 1|Adverse Event|0|||
27734300|NCT01591330|80853572|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
27734301|NCT01591330|80853573|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
27734302|NCT01591330|80853574|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
27734303|NCT01591330|80853575|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
27734304|NCT01591330|80853572|FG000|Period 2|Adverse Event|1|||
27734305|NCT01591330|80853573|FG001|Period 2|Adverse Event|0|||
27734306|NCT01591330|80853574|FG002|Period 2|Adverse Event|0|||
27734307|NCT01591330|80853575|FG003|Period 2|Adverse Event|0|||
27734308|NCT00222105|80853576|FG000|Overall Study|Removed due to wrong diagnosis|1|||
27734309|NCT00222105|80853576|FG000|Overall Study|Withdrawal by Subject|1|||
27734310|NCT00222105|80853576|FG000|Overall Study|Adverse Event|8|||
27734311|NCT00222105|80853576|FG000|Overall Study|Treatment delays|2|||
27734312|NCT00222105|80853576|FG000|Overall Study|Death|2|||
27734313|NCT03358472|80853583|FG000|Overall Study|Death|6|||
27734314|NCT03358472|80853584|FG001|Overall Study|Death|3|||
27734315|NCT03358472|80853585|FG002|Overall Study|Death|10|||
27734316|NCT03358472|80853583|FG000|Overall Study|Physician Decision|0|||
27734317|NCT03358472|80853584|FG001|Overall Study|Physician Decision|1|||
27734318|NCT03358472|80853585|FG002|Overall Study|Physician Decision|0|||
27734319|NCT03358472|80853583|FG000|Overall Study|Withdrawal by Subject|0|||
27734320|NCT03358472|80853584|FG001|Overall Study|Withdrawal by Subject|0|||
27734321|NCT03358472|80853585|FG002|Overall Study|Withdrawal by Subject|1|||
27734322|NCT03358472|80853583|FG000|Overall Study|On-going at clinical cut off date|9|||
27734323|NCT03358472|80853584|FG001|Overall Study|On-going at clinical cut off date|6|||
27734324|NCT03358472|80853585|FG002|Overall Study|On-going at clinical cut off date|5|||
27734325|NCT02706938|80853586|FG000|First Period, 6 Weeks|Adverse Event|8|||
27734326|NCT02706938|80853587|FG001|First Period, 6 Weeks|Adverse Event|0|||
27734327|NCT02706938|80853586|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
27734328|NCT02706938|80853587|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
27734329|NCT02706938|80853586|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
27734330|NCT02706938|80853587|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
27734331|NCT02706938|80853586|FG000|Second Period, 6 Weeks|Adverse Event|0|||
27734332|NCT02706938|80853587|FG001|Second Period, 6 Weeks|Adverse Event|7|||
27734333|NCT02706938|80853586|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
27734334|NCT02706938|80853587|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
27529082|NCT01920555|80128829|FG004|Overall Study|Lack of Efficacy|0|||
27529083|NCT01920555|80128825|FG000|Overall Study|Travel Difficulties|1|||
27529084|NCT01920555|80128826|FG001|Overall Study|Travel Difficulties|1|||
27529085|NCT01920555|80128827|FG002|Overall Study|Travel Difficulties|0|||
27529086|NCT01920555|80128828|FG003|Overall Study|Travel Difficulties|0|||
27529087|NCT01920555|80128829|FG004|Overall Study|Travel Difficulties|1|||
27529088|NCT01920555|80128825|FG000|Overall Study|Lost to Follow-up|0|||
27529089|NCT01920555|80128826|FG001|Overall Study|Lost to Follow-up|1|||
27529090|NCT01920555|80128827|FG002|Overall Study|Lost to Follow-up|0|||
27529091|NCT01920555|80128828|FG003|Overall Study|Lost to Follow-up|1|||
27625069|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
27625070|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
27625071|NCT04672460|80469288|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
27734335|NCT01892722|80853588|FG000|Overall Study|Protocol deviation|0|||
27734336|NCT01892722|80853589|FG001|Overall Study|Protocol deviation|1|||
27734337|NCT01892722|80853588|FG000|Overall Study|Administrative problems|0|||
27529092|NCT01920555|80128829|FG004|Overall Study|Lost to Follow-up|0|||
27529093|NCT00930982|80132197|FG000|Overall Study|Adverse Event|19|||
27734338|NCT01892722|80853589|FG001|Overall Study|Administrative problems|1|||
27734339|NCT01892722|80853588|FG000|Overall Study|Patient/guardian decision|0|||
27734340|NCT01892722|80853589|FG001|Overall Study|Patient/guardian decision|2|||
27734341|NCT01892722|80853588|FG000|Overall Study|Physician Decision|1|||
27734342|NCT01892722|80853589|FG001|Overall Study|Physician Decision|2|||
27529094|NCT00930982|80132198|FG001|Overall Study|Adverse Event|23|||
27529095|NCT00930982|80132197|FG000|Overall Study|Protocol Violation|1|||
27734343|NCT01892722|80853588|FG000|Overall Study|Adverse Event|3|||
27734344|NCT01892722|80853589|FG001|Overall Study|Adverse Event|2|||
27734345|NCT01892722|80853588|FG000|Overall Study|Lack of Efficacy|0|||
27734346|NCT01892722|80853589|FG001|Overall Study|Lack of Efficacy|7|||
27529096|NCT00930982|80132198|FG001|Overall Study|Protocol Violation|5|||
27529097|NCT00930982|80132197|FG000|Overall Study|Withdrawal by Subject|1|||
27529098|NCT00930982|80132198|FG001|Overall Study|Withdrawal by Subject|1|||
27529099|NCT03435640|80132199|FG000|Overall Study|Withdrawal by Subject|0|||
27529100|NCT03435640|80132200|FG001|Overall Study|Withdrawal by Subject|1|||
27529101|NCT03435640|80132201|FG002|Overall Study|Withdrawal by Subject|0|||
27529102|NCT03435640|80132202|FG003|Overall Study|Withdrawal by Subject|2|||
27529103|NCT03435640|80132203|FG004|Overall Study|Withdrawal by Subject|0|||
27529104|NCT03435640|80132204|FG005|Overall Study|Withdrawal by Subject|0|||
27529105|NCT03435640|80132205|FG006|Overall Study|Withdrawal by Subject|3|||
27529106|NCT03435640|80132206|FG007|Overall Study|Withdrawal by Subject|0|||
27529107|NCT03435640|80132207|FG008|Overall Study|Withdrawal by Subject|0|||
27529108|NCT03435640|80132208|FG009|Overall Study|Withdrawal by Subject|2|||
27529109|NCT03435640|80132209|FG010|Overall Study|Withdrawal by Subject|3|||
27529110|NCT03435640|80132199|FG000|Overall Study|Lost to Follow-up|0|||
27529111|NCT03435640|80132200|FG001|Overall Study|Lost to Follow-up|0|||
27529112|NCT03435640|80132201|FG002|Overall Study|Lost to Follow-up|1|||
27529113|NCT03435640|80132202|FG003|Overall Study|Lost to Follow-up|0|||
27529114|NCT03435640|80132203|FG004|Overall Study|Lost to Follow-up|0|||
27529115|NCT03435640|80132204|FG005|Overall Study|Lost to Follow-up|0|||
27529116|NCT03435640|80132205|FG006|Overall Study|Lost to Follow-up|0|||
27529117|NCT03435640|80132206|FG007|Overall Study|Lost to Follow-up|0|||
27529118|NCT03435640|80132207|FG008|Overall Study|Lost to Follow-up|0|||
27911788|NCT00490919|81513743|FG001|Double-blind Phase|Lack of Efficacy|22|||
27911789|NCT00490919|81513744|FG002|Double-blind Phase|Lack of Efficacy|36|||
27911790|NCT00490919|81513742|FG000|Double-blind Phase|Administrative|0|||
27911791|NCT00490919|81513743|FG001|Double-blind Phase|Administrative|6|||
27911792|NCT00490919|81513744|FG002|Double-blind Phase|Administrative|6|||
27911793|NCT00846053|81513751|FG000|Overall Study|Physician Decision|3|||
27911794|NCT00846053|81513752|FG001|Overall Study|Physician Decision|0|||
27911795|NCT02283658|81513753|FG000|Overall Study|Withdrawal by Subject|1|||
27911796|NCT01801111|81513754|FG000|Overall Study|Adverse Event|12|||
27911797|NCT01801111|81513754|FG000|Overall Study|Death|8|||
27911798|NCT01801111|81513754|FG000|Overall Study|Physician Decision|5|||
27911799|NCT01801111|81513754|FG000|Overall Study|Other|1|||
27911800|NCT01801111|81513754|FG000|Overall Study|Withdrawal by Subject|4|||
27911801|NCT01801111|81513754|FG000|Overall Study|Study Terminated by Sponsor|27|||
27911802|NCT01801111|81513754|FG000|Overall Study|Progressive Disease|81|||
27911803|NCT01247350|81513755|FG000|Overall Study|Adverse Event|0|||
27911804|NCT01247350|81513756|FG001|Overall Study|Adverse Event|0|||
27911805|NCT01247350|81513757|FG002|Overall Study|Adverse Event|1|||
27911806|NCT01247350|81513758|FG003|Overall Study|Adverse Event|0|||
27529119|NCT03435640|80132208|FG009|Overall Study|Lost to Follow-up|0|||
27529120|NCT03435640|80132209|FG010|Overall Study|Lost to Follow-up|0|||
27529121|NCT03023046|80132218|FG000|Overall Study|Withdrawal by Subject|1|||
27529122|NCT02398227|80132219|FG000|Overall Study|Lost to Follow-up|21|||
27529123|NCT02398227|80132220|FG001|Overall Study|Lost to Follow-up|12|||
27529124|NCT02398227|80132219|FG000|Overall Study|Withdrawal by Subject|5|||
27529125|NCT02398227|80132220|FG001|Overall Study|Withdrawal by Subject|6|||
27529126|NCT02398227|80132219|FG000|Overall Study|Removed from treatment and dropped out|1|||
27529127|NCT02398227|80132220|FG001|Overall Study|Removed from treatment and dropped out|0|||
27529128|NCT03194490|80132225|FG000|Overall Study|Lost to Follow-up|1|||
27529129|NCT03194490|80132226|FG001|Overall Study|Lost to Follow-up|3|||
27529130|NCT03194490|80132225|FG000|Overall Study|participant developed specific neck pain|1|||
27529131|NCT03194490|80132226|FG001|Overall Study|participant developed specific neck pain|0|||
27529132|NCT00745615|80132227|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
27529133|NCT00745615|80132228|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
27529134|NCT00745615|80132229|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
27625072|NCT04672460|80469289|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
27529135|NCT00745615|80132230|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
27529136|NCT00745615|80132231|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
27529137|NCT00745615|80132232|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
27529138|NCT00745615|80132227|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27529139|NCT00745615|80132228|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
27625073|NCT04672460|80469288|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
27625074|NCT04672460|80469289|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
27911807|NCT01247350|81513759|FG004|Overall Study|Adverse Event|0|||
27529140|NCT00745615|80132229|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27529141|NCT00745615|80132230|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27856422|NCT02516553|81306774|FG005|Overall Study|Progressive disease|0|||
27911808|NCT01247350|81513755|FG000|Overall Study|Withdrawal by Subject|0|||
27911809|NCT01247350|81513756|FG001|Overall Study|Withdrawal by Subject|0|||
27911810|NCT01247350|81513757|FG002|Overall Study|Withdrawal by Subject|0|||
27911811|NCT01247350|81513758|FG003|Overall Study|Withdrawal by Subject|1|||
27911812|NCT01247350|81513759|FG004|Overall Study|Withdrawal by Subject|0|||
27529142|NCT00745615|80132231|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27529143|NCT00745615|80132232|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
27529144|NCT00745615|80132227|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
27529145|NCT00745615|80132228|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
27529146|NCT00745615|80132229|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
27529147|NCT00745615|80132230|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
27529148|NCT00745615|80132231|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
27529149|NCT00745615|80132232|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
27529150|NCT00745615|80132227|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27529151|NCT00745615|80132228|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
27529152|NCT00745615|80132229|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27529153|NCT00745615|80132230|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27529154|NCT00745615|80132231|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27529155|NCT00745615|80132232|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
27529156|NCT00745615|80132227|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27529157|NCT00745615|80132228|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
27529158|NCT00745615|80132229|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27529159|NCT00745615|80132230|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27529160|NCT00745615|80132231|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27529161|NCT00745615|80132232|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
27529162|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27529163|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27529164|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27529165|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
27529166|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
27529167|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
27529168|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27529169|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27529170|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27529171|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
27529172|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
27529173|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
27529174|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27529175|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27529176|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27529177|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
27529178|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
27529179|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
27529180|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27529181|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27529182|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27529183|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
27529184|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
27529185|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
27529186|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27529187|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27529188|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27529189|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
27529190|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
27529191|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
27529192|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27529193|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27529194|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27529195|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
27529196|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
27529197|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
27529198|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27529199|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27529200|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27529201|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27529202|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
27529203|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
27856423|NCT02516553|81306775|FG006|Overall Study|Progressive disease|5|||
27529204|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
27734347|NCT01892722|80853588|FG000|Overall Study|Withdrawal by Subject|3|||
27856424|NCT02516553|81306776|FG007|Overall Study|Progressive disease|5|||
27529205|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
27529206|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
27529207|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
27529208|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
27529209|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
27529210|NCT00745615|80132227|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27529211|NCT00745615|80132228|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27529212|NCT00745615|80132229|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27529213|NCT00745615|80132230|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
27529214|NCT00745615|80132231|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
27529215|NCT00745615|80132232|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
27529216|NCT05867342|80132233|FG000|Overall Study|Investigator Decision|3|||
27529217|NCT05867342|80132234|FG001|Overall Study|Investigator Decision|3|||
27529218|NCT03463031|80132235|FG000|Overall Study|Withdrawal by Subject|4|||
27529219|NCT03463031|80132236|FG001|Overall Study|Withdrawal by Subject|2|||
27529220|NCT03463031|80132235|FG000|Overall Study|Investigator/Sponsor Decision|0|||
27529221|NCT03463031|80132236|FG001|Overall Study|Investigator/Sponsor Decision|1|||
27529222|NCT03463031|80132235|FG000|Overall Study|Lost to Follow-up|1|||
27529223|NCT03463031|80132236|FG001|Overall Study|Lost to Follow-up|1|||
27529224|NCT03463031|80132235|FG000|Overall Study|Adverse Event|4|||
27529225|NCT03463031|80132236|FG001|Overall Study|Adverse Event|1|||
27529226|NCT03463031|80132235|FG000|Overall Study|Use of prohibited medication by subject|1|||
27529227|NCT03463031|80132236|FG001|Overall Study|Use of prohibited medication by subject|0|||
27529228|NCT00336583|80132244|FG000|Overall Study|Lost to Follow-up|1|||
27529229|NCT00336583|80132244|FG000|Overall Study|Death|1|||
27529230|NCT01249118|80132245|FG000|First Washout Period|Physician Decision|0|||
27529231|NCT01249118|80132246|FG001|First Washout Period|Physician Decision|1|||
27529232|NCT01249118|80132247|FG002|First Washout Period|Physician Decision|0|||
27529233|NCT00640835|80132263|FG000|Overall Study|Adverse Event|5|||
27529234|NCT00640835|80132264|FG001|Overall Study|Adverse Event|3|||
27529235|NCT00640835|80132263|FG000|Overall Study|Withdrawal by Subject|12|||
27529236|NCT00640835|80132264|FG001|Overall Study|Withdrawal by Subject|14|||
27911813|NCT01247350|81513755|FG000|Overall Study|Entry criteria not met|0|||
27911814|NCT01247350|81513756|FG001|Overall Study|Entry criteria not met|0|||
27911815|NCT01247350|81513757|FG002|Overall Study|Entry criteria not met|0|||
27911816|NCT01247350|81513758|FG003|Overall Study|Entry criteria not met|0|||
27911817|NCT01247350|81513759|FG004|Overall Study|Entry criteria not met|1|||
27958630|NCT01791517|81680066|FG008|Phase II|Lens Handling Difficulties|1|||
27958631|NCT01791517|81680067|FG009|Phase II|Lens Handling Difficulties|0|||
27958632|NCT01791517|81680068|FG010|Phase II|Lens Handling Difficulties|0|||
27958633|NCT01791517|81680069|FG011|Phase II|Lens Handling Difficulties|0|||
27958634|NCT01791517|81680058|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
27958635|NCT01791517|81680059|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
27958636|NCT01791517|81680060|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
27958637|NCT01791517|81680061|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
27958638|NCT01791517|81680062|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
27958639|NCT01791517|81680063|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
27958640|NCT01791517|81680064|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
27529237|NCT00640835|80132263|FG000|Overall Study|Physician Decision|10|||
27529238|NCT00640835|80132264|FG001|Overall Study|Physician Decision|14|||
27529239|NCT00640835|80132263|FG000|Overall Study|Sponsor's Decision|11|||
27529240|NCT00640835|80132264|FG001|Overall Study|Sponsor's Decision|7|||
27529241|NCT00640835|80132263|FG000|Overall Study|Protocol Violation|2|||
27529242|NCT00640835|80132264|FG001|Overall Study|Protocol Violation|2|||
27529243|NCT00640835|80132263|FG000|Overall Study|Lost to Follow-up|17|||
27529244|NCT00640835|80132264|FG001|Overall Study|Lost to Follow-up|13|||
27625075|NCT04672460|80469288|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
27625076|NCT04672460|80469289|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
27625077|NCT04672460|80469288|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
27625078|NCT04672460|80469289|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
27625079|NCT04672460|80469288|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
27625080|NCT04672460|80469289|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
27625081|NCT04672460|80469288|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
27958641|NCT01791517|81680065|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
27958642|NCT01791517|81680066|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
27958643|NCT01791517|81680067|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
27625082|NCT04672460|80469289|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
27625083|NCT04672460|80469288|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
27625084|NCT04672460|80469289|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
27625085|NCT04672460|80469288|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
27625086|NCT04672460|80469289|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
27625087|NCT04672460|80469288|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
27625088|NCT04672460|80469289|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
27625089|NCT04672460|80469288|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
27625090|NCT04672460|80469289|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
27625091|NCT03971357|80469292|FG000|Overall Study|Lack of Efficacy|0|||
27625092|NCT03971357|80469293|FG001|Overall Study|Lack of Efficacy|1|||
27625093|NCT02096003|80469296|FG000|Overall Study|Protocol Violation|0|||
27625094|NCT02096003|80469297|FG001|Overall Study|Protocol Violation|2|||
27625095|NCT02096003|80469296|FG000|Overall Study|additional surgery|2|||
27625096|NCT02096003|80469297|FG001|Overall Study|additional surgery|1|||
27625097|NCT01684046|80469298|FG000|Period 1, First 30 Days|Adverse Event|0|||
27625098|NCT01684046|80469299|FG001|Period 1, First 30 Days|Adverse Event|2|||
27911818|NCT05137717|81517946|FG000|Overall Study|Death|2|||
27911819|NCT05137717|81517946|FG000|Overall Study|Withdrawal by Subject|6|||
27911820|NCT02895295|81517947|FG000|Overall Study|Survey Non-response|71|||
27911821|NCT02895295|81517948|FG001|Overall Study|Survey Non-response|94|||
27911822|NCT02895295|81517949|FG002|Overall Study|Survey Non-response|92|||
27911823|NCT04249362|81517957|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|34|||
27911824|NCT04249362|81517958|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|25|||
27911825|NCT02573259|81517966|FG000|Overall Study|Death|1|||
27911826|NCT02573259|81517967|FG001|Overall Study|Death|6|||
27911827|NCT02573259|81517968|FG002|Overall Study|Death|5|||
27911828|NCT02573259|81517969|FG003|Overall Study|Death|6|||
27911829|NCT02573259|81517970|FG004|Overall Study|Death|9|||
27911830|NCT02573259|81517971|FG005|Overall Study|Death|32|||
27911831|NCT02573259|81517972|FG006|Overall Study|Death|21|||
27911832|NCT02573259|81517966|FG000|Overall Study|Lost to Follow-up|0|||
27911833|NCT02573259|81517967|FG001|Overall Study|Lost to Follow-up|0|||
27911834|NCT02573259|81517968|FG002|Overall Study|Lost to Follow-up|0|||
27911835|NCT02573259|81517969|FG003|Overall Study|Lost to Follow-up|0|||
27911836|NCT02573259|81517970|FG004|Overall Study|Lost to Follow-up|0|||
27625099|NCT05650333|80469300|FG000|Treatment Period (7 Days)|Adverse Event|1|||
27625100|NCT02501629|80469303|FG000|Overall Study|Death|0|||
27625101|NCT02501629|80469304|FG001|Overall Study|Death|1|||
27625102|NCT02501629|80469303|FG000|Overall Study|Withdrawn from study by sponsor|1|||
27625103|NCT02501629|80469304|FG001|Overall Study|Withdrawn from study by sponsor|0|||
27625104|NCT02501629|80469303|FG000|Overall Study|Early termination by sponsor|1|||
27625105|NCT02501629|80469304|FG001|Overall Study|Early termination by sponsor|0|||
27625106|NCT02501629|80469303|FG000|Overall Study|Withdrawal by Subject|3|||
27625107|NCT02501629|80469304|FG001|Overall Study|Withdrawal by Subject|5|||
27625108|NCT02501629|80469303|FG000|Overall Study|Subject did not return to site|0|||
27625109|NCT02501629|80469304|FG001|Overall Study|Subject did not return to site|1|||
27625110|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
27625111|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
27625112|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
27625113|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
27625114|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
27625115|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
27625116|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
27625117|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
27625118|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
27625119|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
27625120|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
27625121|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
27625122|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
27625123|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
27625124|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
27734348|NCT01892722|80853589|FG001|Overall Study|Withdrawal by Subject|5|||
27734349|NCT02333227|80853591|FG000|Overall Study|Lost to Follow-up|137|||
27734350|NCT02333227|80853592|FG001|Overall Study|Lost to Follow-up|106|||
27911837|NCT02573259|81517971|FG005|Overall Study|Lost to Follow-up|2|||
27911838|NCT02573259|81517972|FG006|Overall Study|Lost to Follow-up|1|||
27911839|NCT02573259|81517966|FG000|Overall Study|Participant refused further follow-up|0|||
27911840|NCT02573259|81517967|FG001|Overall Study|Participant refused further follow-up|2|||
27625125|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
27625126|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
27625127|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
27625128|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
27625129|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
27625130|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
27625131|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
27625132|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
27625133|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
27625134|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
27625135|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
27625136|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
27625137|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
27625138|NCT00241644|80469305|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
27625139|NCT00241644|80469306|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
27625140|NCT00241644|80469307|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
27625141|NCT00241644|80469308|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
27625142|NCT00241644|80469305|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
27625143|NCT00241644|80469306|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
27625144|NCT00241644|80469307|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
27625145|NCT00241644|80469308|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
27625146|NCT00241644|80469305|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
27625147|NCT00241644|80469306|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
27625148|NCT00241644|80469307|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
27625149|NCT00241644|80469308|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
27625150|NCT00241644|80469305|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
27625151|NCT00241644|80469306|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
27625152|NCT00241644|80469307|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
27625153|NCT00241644|80469308|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
27734351|NCT02333227|80853591|FG000|Overall Study|Pregnancy Interrupted|42|||
27734352|NCT02333227|80853592|FG001|Overall Study|Pregnancy Interrupted|89|||
27734353|NCT02333227|80853591|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
27734354|NCT02333227|80853592|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
27734355|NCT01891643|80853605|FG000|Overall Study|Adverse event unrelated to study drug|2|||
27529245|NCT00640835|80132263|FG000|Overall Study|Other Reason|19|||
27529246|NCT00640835|80132264|FG001|Overall Study|Other Reason|4|||
27529247|NCT00679055|80132265|FG000|Overall Study|Adverse Event|0|||
27529248|NCT00679055|80132266|FG001|Overall Study|Adverse Event|1|||
27529249|NCT00679055|80132265|FG000|Overall Study|Other|0|||
27529250|NCT00679055|80132266|FG001|Overall Study|Other|3|||
27529251|NCT00679055|80132265|FG000|Overall Study|Study Terminated|2|||
27529252|NCT00679055|80132266|FG001|Overall Study|Study Terminated|1|||
27529253|NCT01255787|80132267|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
27529254|NCT01255787|80132268|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
27529255|NCT01255787|80132269|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
27529256|NCT01255787|80132270|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
27529257|NCT01255787|80132267|FG000|Overall Study|Major Protocol Deviation|1|||
27529258|NCT01255787|80132268|FG001|Overall Study|Major Protocol Deviation|1|||
27529259|NCT01255787|80132269|FG002|Overall Study|Major Protocol Deviation|0|||
27529260|NCT01255787|80132270|FG003|Overall Study|Major Protocol Deviation|4|||
27529261|NCT01255787|80132267|FG000|Overall Study|Lost to Follow-up|1|||
27529262|NCT01255787|80132268|FG001|Overall Study|Lost to Follow-up|2|||
27529263|NCT01255787|80132269|FG002|Overall Study|Lost to Follow-up|4|||
27529264|NCT01255787|80132270|FG003|Overall Study|Lost to Follow-up|2|||
27529265|NCT01255787|80132267|FG000|Overall Study|Withdrawal of Consent|3|||
27529266|NCT01255787|80132268|FG001|Overall Study|Withdrawal of Consent|9|||
27529267|NCT01255787|80132269|FG002|Overall Study|Withdrawal of Consent|3|||
27529268|NCT01255787|80132270|FG003|Overall Study|Withdrawal of Consent|4|||
27529269|NCT01255787|80132267|FG000|Overall Study|Pregnancy|0|||
27529270|NCT01255787|80132268|FG001|Overall Study|Pregnancy|0|||
27529271|NCT01255787|80132269|FG002|Overall Study|Pregnancy|0|||
27529272|NCT01255787|80132270|FG003|Overall Study|Pregnancy|1|||
27529273|NCT01255787|80132267|FG000|Overall Study|Lack of Efficacy|2|||
27529274|NCT01255787|80132268|FG001|Overall Study|Lack of Efficacy|2|||
27529275|NCT01255787|80132269|FG002|Overall Study|Lack of Efficacy|2|||
27734356|NCT01891643|80853606|FG001|Overall Study|Adverse event unrelated to study drug|5|||
27529276|NCT01255787|80132270|FG003|Overall Study|Lack of Efficacy|2|||
27529277|NCT01255787|80132267|FG000|Overall Study|Noncompliance with Study Drug|3|||
27529278|NCT01255787|80132268|FG001|Overall Study|Noncompliance with Study Drug|1|||
27529279|NCT01255787|80132269|FG002|Overall Study|Noncompliance with Study Drug|0|||
27529280|NCT01255787|80132270|FG003|Overall Study|Noncompliance with Study Drug|0|||
27529281|NCT01479985|80132271|FG000|Overall Study|Tablet malfunction, no data saved|1|||
27529282|NCT01479985|80132272|FG001|Overall Study|Tablet malfunction, no data saved|1|||
27529283|NCT01479985|80132271|FG000|Overall Study|No decisional conflict scale responses|0|||
27529284|NCT01479985|80132272|FG001|Overall Study|No decisional conflict scale responses|2|||
27625154|NCT00241644|80469305|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
27625155|NCT00241644|80469306|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
27625156|NCT00241644|80469307|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
27625157|NCT00241644|80469308|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
27625158|NCT00241644|80469305|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
27625159|NCT00241644|80469306|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
27625160|NCT00241644|80469307|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
27625161|NCT00241644|80469308|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
27625162|NCT01772719|80469309|FG000|Overall Study|Withdrawal by Subject|3|||
27625163|NCT01772719|80469309|FG000|Overall Study|Adverse Event|2|||
27625164|NCT01772719|80469309|FG000|Overall Study|Protocol Violation|1|||
27625165|NCT01772719|80469309|FG000|Overall Study|Lost to Follow-up|1|||
27625166|NCT03383887|80469311|FG000|Overall Study|Lost to Follow-up|0|||
27625167|NCT03383887|80469312|FG001|Overall Study|Lost to Follow-up|1|||
27625168|NCT02892409|80469313|FG000|Overall Study|Adverse Event|1|||
27625169|NCT02892409|80469314|FG001|Overall Study|Adverse Event|0|||
27625170|NCT02892409|80469313|FG000|Overall Study|Withdrawal by Subject|2|||
27625171|NCT02892409|80469314|FG001|Overall Study|Withdrawal by Subject|1|||
27625172|NCT02028884|80469318|FG000|Double-blind Period|Adverse Event|5|||
27625173|NCT02028884|80469319|FG001|Double-blind Period|Adverse Event|3|||
27625174|NCT02028884|80469320|FG002|Double-blind Period|Adverse Event|0|||
27625175|NCT02028884|80469318|FG000|Double-blind Period|Eligibility Violation|1|||
27625176|NCT02028884|80469319|FG001|Double-blind Period|Eligibility Violation|0|||
27625177|NCT02028884|80469320|FG002|Double-blind Period|Eligibility Violation|0|||
27625178|NCT02028884|80469318|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
27625179|NCT02028884|80469319|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
27625180|NCT02028884|80469320|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
27625181|NCT02028884|80469318|FG000|Double-blind Period|Withdrawal by Subject|2|||
27625182|NCT02028884|80469319|FG001|Double-blind Period|Withdrawal by Subject|0|||
27625183|NCT02028884|80469320|FG002|Double-blind Period|Withdrawal by Subject|0|||
27625184|NCT02028884|80469318|FG000|Open-label Extension Period|Adverse Event|3|||
27625185|NCT02028884|80469319|FG001|Open-label Extension Period|Adverse Event|1|||
27625186|NCT02028884|80469320|FG002|Open-label Extension Period|Adverse Event|0|||
27625187|NCT02028884|80469318|FG000|Open-label Extension Period|Lack of Efficacy|3|||
27625188|NCT02028884|80469319|FG001|Open-label Extension Period|Lack of Efficacy|0|||
27625189|NCT02028884|80469320|FG002|Open-label Extension Period|Lack of Efficacy|0|||
27625190|NCT02028884|80469318|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
27625191|NCT02028884|80469319|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
27625192|NCT02028884|80469320|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
27625193|NCT02028884|80469318|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
27625194|NCT02028884|80469319|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
27625195|NCT02028884|80469320|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
27625196|NCT02028884|80469318|FG000|Open-label Extension Period|Switched to another treatment option|3|||
27625197|NCT02028884|80469319|FG001|Open-label Extension Period|Switched to another treatment option|0|||
27625198|NCT02028884|80469320|FG002|Open-label Extension Period|Switched to another treatment option|0|||
27625199|NCT04091672|80469321|FG000|Overall Study|Death|6|||
27625200|NCT04091672|80469322|FG001|Overall Study|Death|6|||
27625201|NCT04091672|80469321|FG000|Overall Study|Lost to Follow-up|7|||
27625202|NCT04091672|80469322|FG001|Overall Study|Lost to Follow-up|7|||
27625203|NCT04091672|80469321|FG000|Overall Study|Withdrawal by Subject|3|||
27625204|NCT04091672|80469322|FG001|Overall Study|Withdrawal by Subject|3|||
27625205|NCT04091672|80469321|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
27625206|NCT04091672|80469322|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
27625207|NCT00603447|80469326|FG000|Overall Study|Adverse Event|0|||
27625208|NCT00603447|80469327|FG001|Overall Study|Adverse Event|1|||
27625209|NCT00603447|80469328|FG002|Overall Study|Adverse Event|1|||
27625210|NCT00603447|80469329|FG003|Overall Study|Adverse Event|2|||
27625211|NCT00603447|80469330|FG004|Overall Study|Adverse Event|1|||
27625212|NCT00603447|80469331|FG005|Overall Study|Adverse Event|2|||
27625213|NCT00603447|80469332|FG006|Overall Study|Adverse Event|10|||
27625214|NCT00603447|80469326|FG000|Overall Study|Other|0|||
27625215|NCT00603447|80469327|FG001|Overall Study|Other|0|||
27625216|NCT00603447|80469328|FG002|Overall Study|Other|1|||
27625217|NCT00603447|80469329|FG003|Overall Study|Other|0|||
27625218|NCT00603447|80469330|FG004|Overall Study|Other|3|||
27625219|NCT00603447|80469331|FG005|Overall Study|Other|0|||
27625220|NCT00603447|80469332|FG006|Overall Study|Other|13|||
27625221|NCT00603447|80469326|FG000|Overall Study|Withdrew Consent|0|||
27625222|NCT00603447|80469327|FG001|Overall Study|Withdrew Consent|2|||
27625223|NCT00603447|80469328|FG002|Overall Study|Withdrew Consent|0|||
27625224|NCT00603447|80469329|FG003|Overall Study|Withdrew Consent|0|||
27625225|NCT00603447|80469330|FG004|Overall Study|Withdrew Consent|1|||
27625226|NCT00603447|80469331|FG005|Overall Study|Withdrew Consent|0|||
27625227|NCT00603447|80469332|FG006|Overall Study|Withdrew Consent|1|||
27625228|NCT02397889|80469333|FG000|Overall Study|Physician Decision|1|||
27625229|NCT02397889|80469334|FG001|Overall Study|Physician Decision|0|||
27625230|NCT04391309|80469335|FG000|Overall Study|Death|1|||
27625231|NCT04391309|80469336|FG001|Overall Study|Death|1|||
27625232|NCT04391309|80469335|FG000|Overall Study|Lost to Follow-up|3|||
27625233|NCT04391309|80469336|FG001|Overall Study|Lost to Follow-up|2|||
27625234|NCT04391309|80469335|FG000|Overall Study|Withdrawal by Subject|2|||
27625235|NCT04391309|80469336|FG001|Overall Study|Withdrawal by Subject|2|||
27625236|NCT05489224|80469337|FG000|Treatment Period I|Withdrawal by Subject|6|||
27625237|NCT05489224|80469338|FG001|Treatment Period I|Withdrawal by Subject|5|||
27625238|NCT05489224|80469339|FG002|Treatment Period I|Withdrawal by Subject|0|||
27625239|NCT05489224|80469337|FG000|Treatment Period I|Adverse Event|3|||
27625240|NCT05489224|80469338|FG001|Treatment Period I|Adverse Event|11|||
27625241|NCT05489224|80469339|FG002|Treatment Period I|Adverse Event|0|||
27625242|NCT05489224|80469337|FG000|Treatment Period I|Lost to Follow-up|0|||
27625243|NCT05489224|80469338|FG001|Treatment Period I|Lost to Follow-up|1|||
27625244|NCT05489224|80469339|FG002|Treatment Period I|Lost to Follow-up|0|||
27625245|NCT05489224|80469337|FG000|Treatment Period I|Physician Decision|0|||
27625246|NCT05489224|80469338|FG001|Treatment Period I|Physician Decision|1|||
27625247|NCT05489224|80469339|FG002|Treatment Period I|Physician Decision|0|||
27625248|NCT05489224|80469337|FG000|Treatment Period II up to Week 32|Ongoing|222|||
27625249|NCT05489224|80469338|FG001|Treatment Period II up to Week 32|Ongoing|107|||
27625250|NCT05489224|80469339|FG002|Treatment Period II up to Week 32|Ongoing|107|||
27625251|NCT05489224|80469337|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
27625252|NCT05489224|80469338|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
27625253|NCT05489224|80469339|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
27625254|NCT05489224|80469337|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
27625255|NCT05489224|80469338|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
27625256|NCT05489224|80469339|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
27625257|NCT00052962|80469340|FG000|Overall Study|Not evaluable|0|||
27625258|NCT00052962|80469341|FG001|Overall Study|Not evaluable|2|||
27625259|NCT00052962|80469340|FG000|Overall Study|Not randomized/not evaluable|1|||
27625260|NCT00052962|80469341|FG001|Overall Study|Not randomized/not evaluable|0|||
27625261|NCT00868231|80469343|FG000|Treatment Period 1|Adverse Event|0|||
27625262|NCT00868231|80469344|FG001|Treatment Period 1|Adverse Event|0|||
27625263|NCT00868231|80469345|FG002|Treatment Period 1|Adverse Event|0|||
27625264|NCT00868231|80469346|FG003|Treatment Period 1|Adverse Event|0|||
27625265|NCT00868231|80469347|FG004|Treatment Period 1|Adverse Event|1|||
27625266|NCT00868231|80469348|FG005|Treatment Period 1|Adverse Event|0|||
27625267|NCT00868231|80469343|FG000|Treatment Period 2|Adverse Event|1|||
27625268|NCT00868231|80469344|FG001|Treatment Period 2|Adverse Event|0|||
27625269|NCT00868231|80469345|FG002|Treatment Period 2|Adverse Event|0|||
27625270|NCT00868231|80469346|FG003|Treatment Period 2|Adverse Event|0|||
27625271|NCT00868231|80469347|FG004|Treatment Period 2|Adverse Event|0|||
27625272|NCT00868231|80469348|FG005|Treatment Period 2|Adverse Event|0|||
27625273|NCT00868231|80469343|FG000|Treatment Period 3|Adverse Event|0|||
27625274|NCT00868231|80469344|FG001|Treatment Period 3|Adverse Event|0|||
27625275|NCT00868231|80469345|FG002|Treatment Period 3|Adverse Event|1|||
27625276|NCT00868231|80469346|FG003|Treatment Period 3|Adverse Event|0|||
27625277|NCT00868231|80469347|FG004|Treatment Period 3|Adverse Event|0|||
27625278|NCT00868231|80469348|FG005|Treatment Period 3|Adverse Event|0|||
27625279|NCT00072475|80469349|FG000|Overall Study|Adverse Event|44|||
27625280|NCT00072475|80469349|FG000|Overall Study|Death|3|||
27625281|NCT00072475|80469349|FG000|Overall Study|Withdrawal by Subject|46|||
27625282|NCT00072475|80469349|FG000|Overall Study|Patient/Investigator Decision|4|||
27625283|NCT02929108|80469350|FG000|Overall Study|Hospice patient death|100|||
27625284|NCT02929108|80469351|FG001|Overall Study|Hospice patient death|64|||
27625285|NCT02929108|80469352|FG002|Overall Study|Hospice patient death|28|||
27625286|NCT02929108|80469353|FG003|Overall Study|Hospice patient death|46|||
27625287|NCT02929108|80469354|FG004|Overall Study|Hospice patient death|55|||
27625288|NCT02929108|80469355|FG005|Overall Study|Hospice patient death|28|||
27625289|NCT02929108|80469356|FG006|Overall Study|Hospice patient death|78|||
27625290|NCT02223793|80469357|FG000|Overall Study|Lost to Follow-up|10|||
27625291|NCT02223793|80469358|FG001|Overall Study|Lost to Follow-up|1|||
27625292|NCT02223793|80469359|FG002|Overall Study|Lost to Follow-up|2|||
27625293|NCT02223793|80469357|FG000|Overall Study|Withdrawal by Subject|3|||
27625294|NCT02223793|80469358|FG001|Overall Study|Withdrawal by Subject|2|||
27625295|NCT02223793|80469359|FG002|Overall Study|Withdrawal by Subject|3|||
27625296|NCT02223793|80469357|FG000|Overall Study|Moved/studycenter unable to participate|4|||
27625297|NCT02223793|80469358|FG001|Overall Study|Moved/studycenter unable to participate|6|||
27625298|NCT02223793|80469359|FG002|Overall Study|Moved/studycenter unable to participate|8|||
27625299|NCT00946192|80469360|FG000|Overall Study|Lost to Follow-up|6|||
27625300|NCT00946192|80469361|FG001|Overall Study|Lost to Follow-up|11|||
27625301|NCT00946192|80469362|FG002|Overall Study|Lost to Follow-up|9|||
27625302|NCT00946192|80469360|FG000|Overall Study|Withdrawal by Subject|10|||
27625303|NCT00946192|80469361|FG001|Overall Study|Withdrawal by Subject|7|||
27625304|NCT00946192|80469362|FG002|Overall Study|Withdrawal by Subject|3|||
27625305|NCT00946192|80469360|FG000|Overall Study|Did not start medication|2|||
27625306|NCT00946192|80469361|FG001|Overall Study|Did not start medication|0|||
27625307|NCT00946192|80469362|FG002|Overall Study|Did not start medication|0|||
27625308|NCT01744691|80469363|FG000|Overall Study|Progressive Disease|18|||
27625309|NCT01744691|80469363|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
27856425|NCT02516553|81306777|FG008|Overall Study|Progressive disease|11|||
27911841|NCT02573259|81517968|FG002|Overall Study|Participant refused further follow-up|1|||
27911842|NCT02573259|81517969|FG003|Overall Study|Participant refused further follow-up|0|||
27911843|NCT02573259|81517970|FG004|Overall Study|Participant refused further follow-up|3|||
27911844|NCT02573259|81517971|FG005|Overall Study|Participant refused further follow-up|20|||
27911845|NCT02573259|81517972|FG006|Overall Study|Participant refused further follow-up|7|||
27911846|NCT02573259|81517966|FG000|Overall Study|Other|0|||
27911847|NCT02573259|81517967|FG001|Overall Study|Other|0|||
27911848|NCT02573259|81517968|FG002|Overall Study|Other|0|||
27911849|NCT02573259|81517969|FG003|Overall Study|Other|0|||
27911850|NCT02573259|81517970|FG004|Overall Study|Other|1|||
27911851|NCT02573259|81517971|FG005|Overall Study|Other|4|||
27911852|NCT02573259|81517972|FG006|Overall Study|Other|5|||
27911853|NCT00327717|81517974|FG000|Overall Study|Adverse Event|6|||
27911854|NCT00327717|81517975|FG001|Overall Study|Adverse Event|6|||
27911855|NCT00327717|81517974|FG000|Overall Study|Lack of Efficacy|0|||
27911856|NCT00327717|81517975|FG001|Overall Study|Lack of Efficacy|1|||
27911857|NCT00327717|81517974|FG000|Overall Study|Withdrawal by Subject|3|||
27911858|NCT00327717|81517975|FG001|Overall Study|Withdrawal by Subject|7|||
27911859|NCT00685360|81517976|FG000|Overall Study|Lost to Follow-up|0|||
27911860|NCT00685360|81517977|FG001|Overall Study|Lost to Follow-up|1|||
27911861|NCT00685360|81517978|FG002|Overall Study|Lost to Follow-up|2|||
27911862|NCT00685360|81517976|FG000|Overall Study|Adverse Event|4|||
27911863|NCT00685360|81517977|FG001|Overall Study|Adverse Event|6|||
27911864|NCT00685360|81517978|FG002|Overall Study|Adverse Event|4|||
27529285|NCT01479985|80132271|FG000|Overall Study|No post-visit survey|5|||
27529286|NCT01479985|80132272|FG001|Overall Study|No post-visit survey|3|||
27529287|NCT02360605|80132273|FG000|Overall Study|Withdrawal by Subject|4|||
27529288|NCT02360605|80132274|FG001|Overall Study|Withdrawal by Subject|9|||
27529289|NCT02360605|80132273|FG000|Overall Study|Lost to Follow-up|7|||
27529290|NCT02360605|80132274|FG001|Overall Study|Lost to Follow-up|8|||
27529291|NCT02360605|80132273|FG000|Overall Study|Death|0|||
27529292|NCT02360605|80132274|FG001|Overall Study|Death|1|||
27529293|NCT02280473|80132276|FG000|Overall Study|Adverse Event|1|||
27529294|NCT02280473|80132277|FG001|Overall Study|Adverse Event|1|||
27529295|NCT02280473|80132276|FG000|Overall Study|Lack of Efficacy|0|||
27529296|NCT02280473|80132277|FG001|Overall Study|Lack of Efficacy|1|||
27529297|NCT02280473|80132276|FG000|Overall Study|Lost to Follow-up|0|||
27529298|NCT02280473|80132277|FG001|Overall Study|Lost to Follow-up|1|||
27529299|NCT03481660|80132282|FG000|Overall Study|Adverse Event|5|||
27529300|NCT03481660|80132283|FG001|Overall Study|Adverse Event|4|||
27529301|NCT03481660|80132282|FG000|Overall Study|Death|13|||
27529302|NCT03481660|80132283|FG001|Overall Study|Death|9|||
27529303|NCT03481660|80132282|FG000|Overall Study|Lost to Follow-up|2|||
27529304|NCT03481660|80132283|FG001|Overall Study|Lost to Follow-up|2|||
27529305|NCT03481660|80132282|FG000|Overall Study|Physician Decision|2|||
27529306|NCT03481660|80132283|FG001|Overall Study|Physician Decision|3|||
27529307|NCT03481660|80132282|FG000|Overall Study|Withdrawal by Subject|14|||
27529308|NCT03481660|80132283|FG001|Overall Study|Withdrawal by Subject|7|||
27529309|NCT03026088|80132288|FG000|Overall Study|Study termination|20|||
27529310|NCT04050371|80132289|FG000|Overall Study|Withdrawal by Subject|1|||
27625310|NCT01744691|80469363|FG000|Overall Study|Withdrawal of consent for treatment|3|||
27625311|NCT01744691|80469363|FG000|Overall Study|Physician Decision|4|||
27625312|NCT03303105|80469364|FG000|Overall Study|Adverse Event|0|||
27625313|NCT03303105|80469365|FG001|Overall Study|Adverse Event|2|||
27856426|NCT02516553|81306778|FG009|Overall Study|Progressive disease|3|||
27856427|NCT02516553|81306779|FG010|Overall Study|Progressive disease|10|||
27856428|NCT02516553|81306780|FG011|Overall Study|Progressive disease|8|||
27856429|NCT02516553|81306781|FG012|Overall Study|Progressive disease|8|||
27856430|NCT02516553|81306782|FG013|Overall Study|Progressive disease|2|||
27856431|NCT02516553|81306783|FG014|Overall Study|Progressive disease|2|||
27856432|NCT02516553|81306784|FG015|Overall Study|Progressive disease|2|||
27856433|NCT02516553|81306785|FG016|Overall Study|Progressive disease|1|||
27856434|NCT02516553|81306786|FG017|Overall Study|Progressive disease|9|||
27856435|NCT02516553|81306787|FG018|Overall Study|Progressive disease|12|||
27856436|NCT02516553|81306788|FG019|Overall Study|Progressive disease|7|||
27856437|NCT02516553|81306789|FG020|Overall Study|Progressive disease|16|||
27856438|NCT02516553|81306790|FG021|Overall Study|Progressive disease|18|||
27856439|NCT02516553|81306769|FG000|Overall Study|Dose limiting toxicity|0|||
27856440|NCT02516553|81306770|FG001|Overall Study|Dose limiting toxicity|0|||
27911865|NCT00685360|81517976|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
27911866|NCT00685360|81517977|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
27625314|NCT03303105|80469364|FG000|Overall Study|Lack of Efficacy|1|||
27625315|NCT03303105|80469365|FG001|Overall Study|Lack of Efficacy|0|||
27625316|NCT03303105|80469364|FG000|Overall Study|Protocol Violation|1|||
27625317|NCT03303105|80469365|FG001|Overall Study|Protocol Violation|0|||
27625318|NCT03303105|80469364|FG000|Overall Study|Withdrawal by Subject|0|||
27625319|NCT03303105|80469365|FG001|Overall Study|Withdrawal by Subject|2|||
27625320|NCT02952261|80469366|FG000|Overall Study|Withdrawal by Subject|4|||
27625321|NCT02952261|80469367|FG001|Overall Study|Withdrawal by Subject|5|||
27625322|NCT02952261|80469366|FG000|Overall Study|Protocol Violation|1|||
27625323|NCT02952261|80469367|FG001|Overall Study|Protocol Violation|0|||
27625324|NCT00389519|80469368|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
27625325|NCT00389519|80469369|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
27625326|NCT00389519|80469370|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
27625327|NCT00389519|80469371|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
27625328|NCT00389519|80469368|FG000|Placebo Run-In|Withdrawal by Subject|19|||
27625329|NCT00389519|80469369|FG001|Placebo Run-In|Withdrawal by Subject|0|||
27625330|NCT00389519|80469370|FG002|Placebo Run-In|Withdrawal by Subject|0|||
27625331|NCT00389519|80469371|FG003|Placebo Run-In|Withdrawal by Subject|0|||
27625332|NCT00389519|80469368|FG000|Placebo Run-In|Reason not specified|40|||
27625333|NCT00389519|80469369|FG001|Placebo Run-In|Reason not specified|0|||
27625334|NCT00389519|80469370|FG002|Placebo Run-In|Reason not specified|0|||
27625335|NCT00389519|80469371|FG003|Placebo Run-In|Reason not specified|0|||
27625336|NCT00389519|80469368|FG000|Randomized|Did not receive study drug|2|||
27625337|NCT00389519|80469369|FG001|Randomized|Did not receive study drug|0|||
27625338|NCT00389519|80469370|FG002|Randomized|Did not receive study drug|0|||
27625339|NCT00389519|80469371|FG003|Randomized|Did not receive study drug|0|||
27625340|NCT00389519|80469368|FG000|Treated|Adverse Event|1|||
27625341|NCT00389519|80469369|FG001|Treated|Adverse Event|0|||
27625342|NCT00389519|80469370|FG002|Treated|Adverse Event|0|||
27625343|NCT00389519|80469371|FG003|Treated|Adverse Event|2|||
27625344|NCT00389519|80469368|FG000|Treated|Reason not specified|1|||
27734357|NCT01891643|80853605|FG000|Overall Study|Disease Progression|4|||
27734358|NCT01891643|80853606|FG001|Overall Study|Disease Progression|3|||
27734359|NCT01891643|80853605|FG000|Overall Study|Study Drug Toxicity|3|||
27734360|NCT01891643|80853606|FG001|Overall Study|Study Drug Toxicity|0|||
27734361|NCT01891643|80853605|FG000|Overall Study|Maximum Clinical Benefit|0|||
27734362|NCT01891643|80853606|FG001|Overall Study|Maximum Clinical Benefit|1|||
27734363|NCT01891643|80853605|FG000|Overall Study|Poor/Non-compliance|0|||
27734364|NCT01891643|80853606|FG001|Overall Study|Poor/Non-compliance|1|||
27734365|NCT01891643|80853605|FG000|Overall Study|Participant request to discontinue|1|||
27734366|NCT01891643|80853606|FG001|Overall Study|Participant request to discontinue|0|||
27734367|NCT00023322|80853611|FG000|Overall Study|Lost to Follow-up|1|||
27734368|NCT02209766|80853612|FG000|Overall Study|Withdrawal by Subject|0|||
27734369|NCT02209766|80853613|FG001|Overall Study|Withdrawal by Subject|0|||
27734370|NCT02209766|80853614|FG002|Overall Study|Withdrawal by Subject|0|||
27734371|NCT02209766|80853615|FG003|Overall Study|Withdrawal by Subject|1|||
27734372|NCT02209766|80853616|FG004|Overall Study|Withdrawal by Subject|0|||
27734373|NCT05047523|80853617|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
27734374|NCT05047523|80853618|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
27734375|NCT05047523|80853619|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
27734376|NCT05047523|80853620|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
27734377|NCT05047523|80853621|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
27734378|NCT05047523|80853622|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
27734379|NCT05047523|80853617|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27734380|NCT05047523|80853618|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
27856441|NCT02516553|81306771|FG002|Overall Study|Dose limiting toxicity|0|||
27856442|NCT02516553|81306772|FG003|Overall Study|Dose limiting toxicity|0|||
27856443|NCT02516553|81306773|FG004|Overall Study|Dose limiting toxicity|3|||
27856444|NCT02516553|81306774|FG005|Overall Study|Dose limiting toxicity|1|||
27856445|NCT02516553|81306775|FG006|Overall Study|Dose limiting toxicity|1|||
27911867|NCT00685360|81517978|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
27911868|NCT00685360|81517976|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
27625345|NCT00389519|80469369|FG001|Treated|Reason not specified|1|||
27625346|NCT00389519|80469370|FG002|Treated|Reason not specified|0|||
27625347|NCT00389519|80469371|FG003|Treated|Reason not specified|2|||
27625348|NCT04337489|80469372|FG000|Overall Study|Withdrawal by Subject|1|||
27625349|NCT00567164|80469373|FG000|Overall Study|Withdrawal by Subject|171|||
27625350|NCT00567164|80469374|FG001|Overall Study|Withdrawal by Subject|21|||
27625351|NCT00567164|80469375|FG002|Overall Study|Withdrawal by Subject|17|||
27625352|NCT00567164|80469373|FG000|Overall Study|Protocol Violation|23|||
27625353|NCT00567164|80469374|FG001|Overall Study|Protocol Violation|4|||
27625354|NCT00567164|80469375|FG002|Overall Study|Protocol Violation|2|||
27625355|NCT00567164|80469373|FG000|Overall Study|Adverse Event|92|||
27625356|NCT00567164|80469374|FG001|Overall Study|Adverse Event|13|||
27625357|NCT00567164|80469375|FG002|Overall Study|Adverse Event|9|||
27625358|NCT00567164|80469373|FG000|Overall Study|Death|0|||
27625359|NCT00567164|80469374|FG001|Overall Study|Death|0|||
27625360|NCT00567164|80469375|FG002|Overall Study|Death|1|||
27625361|NCT00567164|80469373|FG000|Overall Study|Lost to Follow-up|202|||
27625362|NCT00567164|80469374|FG001|Overall Study|Lost to Follow-up|23|||
27625363|NCT00567164|80469375|FG002|Overall Study|Lost to Follow-up|21|||
27625364|NCT00567164|80469373|FG000|Overall Study|Pregnancy|20|||
27734381|NCT05047523|80853619|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27734382|NCT05047523|80853620|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27529311|NCT04050371|80132290|FG001|Overall Study|Withdrawal by Subject|0|||
27529312|NCT00667420|80132291|FG000|Overall Study|Adverse Event|2|||
27529313|NCT00667420|80132291|FG000|Overall Study|Lack of Efficacy|5|||
27529314|NCT00667420|80132291|FG000|Overall Study|Physician Decision|1|||
27529315|NCT00667420|80132291|FG000|Overall Study|Withdrawal by Subject|2|||
27529316|NCT02469038|80132301|FG000|Overall Study|Physician Decision|4|||
27529317|NCT02469038|80132302|FG001|Overall Study|Physician Decision|5|||
27529318|NCT03823378|80132308|FG000|Overall Study|Adverse Event|2|||
27529319|NCT03823378|80132309|FG001|Overall Study|Adverse Event|2|||
27529320|NCT03823378|80132310|FG002|Overall Study|Adverse Event|0|||
27529321|NCT03823378|80132311|FG003|Overall Study|Adverse Event|0|||
27529322|NCT03823378|80132312|FG004|Overall Study|Adverse Event|0|||
27529323|NCT03823378|80132313|FG005|Overall Study|Adverse Event|0|||
27529324|NCT03823378|80132308|FG000|Overall Study|Lost to Follow-up|0|||
27529325|NCT03823378|80132309|FG001|Overall Study|Lost to Follow-up|1|||
27529326|NCT03823378|80132310|FG002|Overall Study|Lost to Follow-up|0|||
27529327|NCT03823378|80132311|FG003|Overall Study|Lost to Follow-up|0|||
27856446|NCT02516553|81306776|FG007|Overall Study|Dose limiting toxicity|0|||
27529328|NCT03823378|80132312|FG004|Overall Study|Lost to Follow-up|1|||
27529329|NCT03823378|80132313|FG005|Overall Study|Lost to Follow-up|0|||
27529330|NCT03823378|80132308|FG000|Overall Study|Withdrawal by Subject|0|||
27529331|NCT03823378|80132309|FG001|Overall Study|Withdrawal by Subject|1|||
27529332|NCT03823378|80132310|FG002|Overall Study|Withdrawal by Subject|4|||
27529333|NCT03823378|80132311|FG003|Overall Study|Withdrawal by Subject|2|||
27529334|NCT03823378|80132312|FG004|Overall Study|Withdrawal by Subject|0|||
27529335|NCT03823378|80132313|FG005|Overall Study|Withdrawal by Subject|1|||
27529336|NCT03823378|80132308|FG000|Overall Study|Other, not specified|19|||
27529337|NCT03823378|80132309|FG001|Overall Study|Other, not specified|12|||
27529338|NCT03823378|80132310|FG002|Overall Study|Other, not specified|6|||
27529339|NCT03823378|80132311|FG003|Overall Study|Other, not specified|8|||
27529340|NCT03823378|80132312|FG004|Overall Study|Other, not specified|17|||
27529341|NCT03823378|80132313|FG005|Overall Study|Other, not specified|7|||
27529342|NCT03500679|80132325|FG000|Overall Study|Lost to Follow-up|6|||
27529343|NCT03500679|80132326|FG001|Overall Study|Lost to Follow-up|3|||
27529344|NCT03500679|80132325|FG000|Overall Study|Withdrawal by Subject|3|||
27529345|NCT03500679|80132326|FG001|Overall Study|Withdrawal by Subject|0|||
27529346|NCT01912963|80132333|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
27529347|NCT01912963|80132334|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
27529348|NCT01912963|80132335|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
27529349|NCT01912963|80132333|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
27529350|NCT01912963|80132334|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
27529351|NCT01912963|80132335|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
27529352|NCT01912963|80132333|FG000|Overall Study|Adverse Event|0|||
27529353|NCT01912963|80132334|FG001|Overall Study|Adverse Event|1|||
27529354|NCT01912963|80132335|FG002|Overall Study|Adverse Event|1|||
27529355|NCT01912963|80132333|FG000|Overall Study|Withdrawal by Subject|0|||
27529356|NCT01912963|80132334|FG001|Overall Study|Withdrawal by Subject|1|||
27856447|NCT02516553|81306777|FG008|Overall Study|Dose limiting toxicity|1|||
27529357|NCT01912963|80132335|FG002|Overall Study|Withdrawal by Subject|0|||
27529358|NCT01912963|80132333|FG000|Overall Study|Sought treatment locally|0|||
27529359|NCT01912963|80132334|FG001|Overall Study|Sought treatment locally|1|||
27529360|NCT01912963|80132335|FG002|Overall Study|Sought treatment locally|0|||
27529361|NCT00761748|80132338|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
27529362|NCT00761748|80132339|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
27529363|NCT00761748|80132338|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
27529364|NCT00761748|80132339|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
27529365|NCT00046891|80132340|FG000|Overall Study|Cancels|5|||
27529366|NCT00046891|80132341|FG001|Overall Study|Cancels|9|||
27529367|NCT00046891|80132340|FG000|Overall Study|Ineligible|1|||
27625365|NCT00567164|80469374|FG001|Overall Study|Pregnancy|4|||
27529368|NCT00046891|80132341|FG001|Overall Study|Ineligible|1|||
27529369|NCT00046891|80132340|FG000|Overall Study|Withdrawal by Subject|18|||
27529370|NCT00046891|80132341|FG001|Overall Study|Withdrawal by Subject|15|||
27529371|NCT00046891|80132340|FG000|Overall Study|Adverse Event|5|||
27625366|NCT00567164|80469375|FG002|Overall Study|Pregnancy|6|||
27625367|NCT00567164|80469373|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
27625368|NCT00567164|80469374|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
27529372|NCT00046891|80132341|FG001|Overall Study|Adverse Event|5|||
27529373|NCT01298193|80132342|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
27529374|NCT01298193|80132342|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
27529375|NCT01298193|80132342|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
27529376|NCT01298193|80132342|FG000|Efficacy Phase (Second Cycle)|Death|1|||
27529377|NCT02775903|80132344|FG000|Overall Study|Death|7|||
27529378|NCT02775903|80132345|FG001|Overall Study|Death|11|||
27529379|NCT02775903|80132346|FG002|Overall Study|Death|12|||
27529380|NCT02775903|80132347|FG003|Overall Study|Death|11|||
27529381|NCT02775903|80132344|FG000|Overall Study|Adverse Event|0|||
27529382|NCT02775903|80132345|FG001|Overall Study|Adverse Event|1|||
27529383|NCT02775903|80132346|FG002|Overall Study|Adverse Event|12|||
27529384|NCT02775903|80132347|FG003|Overall Study|Adverse Event|3|||
27529385|NCT02775903|80132344|FG000|Overall Study|Progressive disease|15|||
27625369|NCT00567164|80469375|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
27625370|NCT00567164|80469373|FG000|Overall Study|Missing|1|||
27625371|NCT00567164|80469374|FG001|Overall Study|Missing|0|||
27625372|NCT00567164|80469375|FG002|Overall Study|Missing|0|||
27625373|NCT00751790|80469376|FG000|Overall Study|Lost to Follow-up|1|||
27625374|NCT00751790|80469376|FG000|Overall Study|Death|3|||
27625375|NCT00751790|80469376|FG000|Overall Study|Withdrawal by Subject|1|||
27625376|NCT02256969|80469377|FG000|Overall Study|Screenfailed or withdrew|2|||
27625377|NCT02256969|80469378|FG001|Overall Study|Screenfailed or withdrew|1|||
27625378|NCT02256969|80469379|FG002|Overall Study|Screenfailed or withdrew|1|||
27625379|NCT03120676|80469386|FG000|Overall Study|Not treated|1|||
27625380|NCT01645111|80469387|FG000|Overall Study|Did not require Clevidipine|15|||
27625381|NCT01120275|80469396|FG000|Overall Study|Adverse Event|3|||
27625382|NCT01120275|80469396|FG000|Overall Study|Progression|27|||
27625383|NCT01120275|80469396|FG000|Overall Study|Ineligible|3|||
27625384|NCT01120275|80469396|FG000|Overall Study|Withdrawal by Subject|1|||
27625385|NCT01120275|80469396|FG000|Overall Study|Refusal|1|||
27856448|NCT02516553|81306778|FG009|Overall Study|Dose limiting toxicity|0|||
27856449|NCT02516553|81306779|FG010|Overall Study|Dose limiting toxicity|0|||
27856450|NCT02516553|81306780|FG011|Overall Study|Dose limiting toxicity|1|||
27856451|NCT02516553|81306781|FG012|Overall Study|Dose limiting toxicity|0|||
27856452|NCT02516553|81306782|FG013|Overall Study|Dose limiting toxicity|1|||
27856453|NCT02516553|81306783|FG014|Overall Study|Dose limiting toxicity|0|||
27856454|NCT02516553|81306784|FG015|Overall Study|Dose limiting toxicity|0|||
27856455|NCT02516553|81306785|FG016|Overall Study|Dose limiting toxicity|1|||
27856456|NCT02516553|81306786|FG017|Overall Study|Dose limiting toxicity|1|||
27856457|NCT02516553|81306787|FG018|Overall Study|Dose limiting toxicity|0|||
27856458|NCT02516553|81306788|FG019|Overall Study|Dose limiting toxicity|2|||
27856459|NCT02516553|81306789|FG020|Overall Study|Dose limiting toxicity|0|||
27856460|NCT02516553|81306790|FG021|Overall Study|Dose limiting toxicity|0|||
27856461|NCT02516553|81306769|FG000|Overall Study|Other Adverse Events|0|||
27856462|NCT02516553|81306770|FG001|Overall Study|Other Adverse Events|0|||
27856463|NCT02516553|81306771|FG002|Overall Study|Other Adverse Events|0|||
27856464|NCT02516553|81306772|FG003|Overall Study|Other Adverse Events|1|||
27856465|NCT02516553|81306773|FG004|Overall Study|Other Adverse Events|0|||
27856466|NCT02516553|81306774|FG005|Overall Study|Other Adverse Events|1|||
27856467|NCT02516553|81306775|FG006|Overall Study|Other Adverse Events|0|||
27856468|NCT02516553|81306776|FG007|Overall Study|Other Adverse Events|0|||
27856469|NCT02516553|81306777|FG008|Overall Study|Other Adverse Events|0|||
27856470|NCT02516553|81306778|FG009|Overall Study|Other Adverse Events|1|||
27856471|NCT02516553|81306779|FG010|Overall Study|Other Adverse Events|3|||
27856472|NCT02516553|81306780|FG011|Overall Study|Other Adverse Events|2|||
27856473|NCT02516553|81306781|FG012|Overall Study|Other Adverse Events|0|||
27856474|NCT02516553|81306782|FG013|Overall Study|Other Adverse Events|1|||
27856475|NCT02516553|81306783|FG014|Overall Study|Other Adverse Events|0|||
27856476|NCT02516553|81306784|FG015|Overall Study|Other Adverse Events|0|||
27856477|NCT02516553|81306785|FG016|Overall Study|Other Adverse Events|0|||
27856478|NCT02516553|81306786|FG017|Overall Study|Other Adverse Events|2|||
27856479|NCT02516553|81306787|FG018|Overall Study|Other Adverse Events|1|||
27529386|NCT02775903|80132345|FG001|Overall Study|Progressive disease|14|||
27529387|NCT02775903|80132346|FG002|Overall Study|Progressive disease|30|||
27625386|NCT01120275|80469396|FG000|Overall Study|Not specific|1|||
27856480|NCT02516553|81306788|FG019|Overall Study|Other Adverse Events|2|||
27856481|NCT02516553|81306789|FG020|Overall Study|Other Adverse Events|2|||
27856482|NCT02516553|81306790|FG021|Overall Study|Other Adverse Events|1|||
27856483|NCT02516553|81306769|FG000|Overall Study|Refused to continue trial medication|0|||
27856484|NCT02516553|81306770|FG001|Overall Study|Refused to continue trial medication|0|||
27856485|NCT02516553|81306771|FG002|Overall Study|Refused to continue trial medication|0|||
27529388|NCT02775903|80132347|FG003|Overall Study|Progressive disease|20|||
27625387|NCT00723294|80469399|FG000|Overall Study|Lobular histology|2|||
27625388|NCT00723294|80469399|FG000|Overall Study|>25% intraductal component|1|||
27529389|NCT02775903|80132344|FG000|Overall Study|Lack of Efficacy|2|||
27625389|NCT00723294|80469399|FG000|Overall Study|No MRI tumor enhancement|1|||
27625390|NCT00723294|80469399|FG000|Overall Study|1.0-Tesla MRI|1|||
27625391|NCT00723294|80469399|FG000|Overall Study|No cryoabalation|2|||
27625392|NCT00723294|80469399|FG000|Overall Study|Did not undergo surgery|1|||
27625393|NCT00723294|80469399|FG000|Overall Study|Treated prior to registration|1|||
27625394|NCT00723294|80469399|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
27625395|NCT00723294|80469399|FG000|Overall Study|Benign lesion|1|||
27625396|NCT00723294|80469399|FG000|Overall Study|Withdrawal by Subject|1|||
27625397|NCT00723294|80469399|FG000|Overall Study|No treatment due to probe failure|1|||
27625398|NCT01257503|80469400|FG000|Overall Study|Lost to Follow-up|7|||
27625399|NCT01257503|80469401|FG001|Overall Study|Lost to Follow-up|10|||
27625400|NCT01257503|80469400|FG000|Overall Study|Over 5 years old at enrollment|0|||
27625401|NCT01257503|80469401|FG001|Overall Study|Over 5 years old at enrollment|1|||
27625402|NCT01257503|80469400|FG000|Overall Study|strep culture positive at enrollment|1|||
27625403|NCT01257503|80469401|FG001|Overall Study|strep culture positive at enrollment|0|||
27625404|NCT01674569|80469407|FG000|Overall Study|Adverse Event|0|||
27625405|NCT01674569|80469408|FG001|Overall Study|Adverse Event|2|||
27625406|NCT01674569|80469409|FG002|Overall Study|Adverse Event|0|||
27625407|NCT01674569|80469410|FG003|Overall Study|Adverse Event|1|||
27625408|NCT01674569|80469411|FG004|Overall Study|Adverse Event|2|||
27625409|NCT01674569|80469412|FG005|Overall Study|Adverse Event|2|||
27625410|NCT01674569|80469407|FG000|Overall Study|Protocol Violation|0|||
27625411|NCT01674569|80469408|FG001|Overall Study|Protocol Violation|1|||
27625412|NCT01674569|80469409|FG002|Overall Study|Protocol Violation|1|||
27625413|NCT01674569|80469410|FG003|Overall Study|Protocol Violation|0|||
27625414|NCT01674569|80469411|FG004|Overall Study|Protocol Violation|0|||
27625415|NCT01674569|80469412|FG005|Overall Study|Protocol Violation|0|||
27625416|NCT01674569|80469407|FG000|Overall Study|Withdrawal by Subject|0|||
27625417|NCT01674569|80469408|FG001|Overall Study|Withdrawal by Subject|0|||
27625418|NCT01674569|80469409|FG002|Overall Study|Withdrawal by Subject|1|||
27734383|NCT05047523|80853621|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27734384|NCT05047523|80853622|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
27734385|NCT05047523|80853617|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
27529390|NCT02775903|80132345|FG001|Overall Study|Lack of Efficacy|2|||
27529391|NCT02775903|80132346|FG002|Overall Study|Lack of Efficacy|2|||
27529392|NCT02775903|80132347|FG003|Overall Study|Lack of Efficacy|6|||
27529393|NCT02775903|80132344|FG000|Overall Study|Withdrawal by Subject|7|||
27529394|NCT02775903|80132345|FG001|Overall Study|Withdrawal by Subject|5|||
27529395|NCT02775903|80132346|FG002|Overall Study|Withdrawal by Subject|5|||
27529396|NCT02775903|80132347|FG003|Overall Study|Withdrawal by Subject|8|||
27529397|NCT02775903|80132344|FG000|Overall Study|Other reasons|7|||
27529398|NCT02775903|80132345|FG001|Overall Study|Other reasons|8|||
27529399|NCT02775903|80132346|FG002|Overall Study|Other reasons|2|||
27529400|NCT02775903|80132347|FG003|Overall Study|Other reasons|12|||
27529401|NCT01857310|80132348|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
27529402|NCT01857310|80132349|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
27529403|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27529404|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27529405|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27529406|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
27529407|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
27529408|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27529409|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27529410|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27529411|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
27529412|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
27529413|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27529414|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27529415|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27529416|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
27529417|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
27529418|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27529419|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27734386|NCT05047523|80853618|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
27734387|NCT05047523|80853619|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
27734388|NCT05047523|80853620|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
27734389|NCT05047523|80853621|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
27734390|NCT05047523|80853622|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
27734391|NCT05047523|80853617|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
27734392|NCT05047523|80853618|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27734393|NCT05047523|80853619|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27734394|NCT05047523|80853620|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27734395|NCT05047523|80853621|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27734396|NCT05047523|80853622|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
27911869|NCT00685360|81517977|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
27911870|NCT00685360|81517978|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
27911871|NCT00685360|81517976|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
27911872|NCT00685360|81517977|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
27911873|NCT00685360|81517978|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
27911874|NCT00685360|81517976|FG000|Overall Study|Protocol Deviation|0|||
27911875|NCT00685360|81517977|FG001|Overall Study|Protocol Deviation|1|||
27734397|NCT05047523|80853617|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
27734398|NCT05047523|80853618|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
27911876|NCT00685360|81517978|FG002|Overall Study|Protocol Deviation|1|||
27911877|NCT04194489|81517979|FG000|Overall Study|Withdrawal by Subject|5|||
27911878|NCT04194489|81517979|FG000|Overall Study|Lost to Follow-up|48|||
27911879|NCT00485069|81517981|FG000|Overall Study|Adverse Event|10|||
27911880|NCT00485069|81517982|FG001|Overall Study|Adverse Event|4|||
27911881|NCT00485069|81517981|FG000|Overall Study|Lack of Efficacy|2|||
27529420|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27529421|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
27734399|NCT05047523|80853619|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
27529422|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
27529423|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27529424|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27529425|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27529426|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
27529427|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
27734400|NCT05047523|80853620|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
27734401|NCT05047523|80853621|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
27734402|NCT05047523|80853622|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
27734403|NCT05047523|80853617|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
27734404|NCT05047523|80853618|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
27734405|NCT05047523|80853619|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
27734406|NCT05047523|80853620|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
27734407|NCT05047523|80853621|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
27529428|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27529429|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27529430|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27529431|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
27529432|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
27529433|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27529434|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27529435|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27529436|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
27529437|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
27529438|NCT01898494|80132353|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27529439|NCT01898494|80132354|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27529440|NCT01898494|80132355|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27734408|NCT05047523|80853622|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
27734409|NCT01193335|80853623|FG000|After Infant Series|Lost to Follow-up|1|||
27911882|NCT00485069|81517982|FG001|Overall Study|Lack of Efficacy|1|||
27911883|NCT00485069|81517981|FG000|Overall Study|Protocol Violation|0|||
27911884|NCT00485069|81517982|FG001|Overall Study|Protocol Violation|1|||
27911885|NCT00485069|81517981|FG000|Overall Study|Withdrawal by Subject|6|||
27911886|NCT00485069|81517982|FG001|Overall Study|Withdrawal by Subject|6|||
27911887|NCT02948829|81517987|FG000|Overall Study|Lost to Follow-up|2|||
27911888|NCT02948829|81517987|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
27911889|NCT02948829|81517987|FG000|Overall Study|Pregnancy|1|||
27911890|NCT02948829|81517987|FG000|Overall Study|Other: Reason not Specified|8|||
27911891|NCT03143101|81517990|FG000|Overall Study|Withdrawal by Subject|0|||
27911892|NCT03143101|81517991|FG001|Overall Study|Withdrawal by Subject|1|||
27529441|NCT01898494|80132356|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
27529442|NCT01898494|80132357|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
27529443|NCT01898494|80132353|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
27529444|NCT01898494|80132354|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
27911893|NCT03143101|81517992|FG002|Overall Study|Withdrawal by Subject|0|||
27911894|NCT03143101|81517990|FG000|Overall Study|Lost to Follow-up|2|||
27911895|NCT03143101|81517991|FG001|Overall Study|Lost to Follow-up|2|||
27911896|NCT03143101|81517992|FG002|Overall Study|Lost to Follow-up|0|||
27911897|NCT04131712|81518001|FG000|Overall Study|COVID related|0|||
27734410|NCT01193335|80853624|FG001|After Infant Series|Lost to Follow-up|2|||
27625419|NCT01674569|80469410|FG003|Overall Study|Withdrawal by Subject|0|||
27625420|NCT01674569|80469411|FG004|Overall Study|Withdrawal by Subject|0|||
27625421|NCT01674569|80469412|FG005|Overall Study|Withdrawal by Subject|0|||
27625422|NCT01456780|80469413|FG000|Overall Study|Lost to Follow-up|3|||
27625423|NCT01456780|80469414|FG001|Overall Study|Lost to Follow-up|3|||
27625424|NCT01456780|80469415|FG002|Overall Study|Lost to Follow-up|0|||
27625425|NCT05305040|80469416|FG000|Overall Study|Not Dosed|37|||
27625426|NCT05305040|80469417|FG001|Overall Study|Not Dosed|37|||
27625427|NCT05305040|80469416|FG000|Overall Study|Study Closure|34|||
27625428|NCT05305040|80469417|FG001|Overall Study|Study Closure|46|||
27625429|NCT05305040|80469416|FG000|Overall Study|Death|14|||
27625430|NCT05305040|80469417|FG001|Overall Study|Death|13|||
27625431|NCT05305040|80469416|FG000|Overall Study|Withdrawal by Subject|15|||
27625432|NCT05305040|80469417|FG001|Overall Study|Withdrawal by Subject|10|||
27734411|NCT01193335|80853623|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
27734412|NCT01193335|80853624|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
27734413|NCT01193335|80853623|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
27734414|NCT01193335|80853624|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
27734415|NCT01193335|80853623|FG000|1-Year Follow-up|Lost to Follow-up|4|||
27734416|NCT01193335|80853624|FG001|1-Year Follow-up|Lost to Follow-up|0|||
27734417|NCT01193335|80853623|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
27734418|NCT01193335|80853624|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
27734419|NCT01193335|80853623|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
27734420|NCT01193335|80853624|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
27734421|NCT03926143|80853628|FG000|Overall Study|Physician Decision|3|||
27734422|NCT03926143|80853628|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
27734423|NCT03926143|80853628|FG000|Overall Study|Adverse Event|2|||
27734424|NCT03926143|80853628|FG000|Overall Study|Progressive disease|3|||
27734425|NCT02443402|80853629|FG000|Overall Study|Withdrawal by Subject|3|||
27734426|NCT02443402|80853630|FG001|Overall Study|Withdrawal by Subject|1|||
27734427|NCT02443402|80853629|FG000|Overall Study|Screen Failure|1|||
27734428|NCT02443402|80853630|FG001|Overall Study|Screen Failure|2|||
27734429|NCT00097539|80853632|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
27734430|NCT00097539|80853633|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
27734431|NCT00097539|80853634|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
27734432|NCT00097539|80853635|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
27734433|NCT00097539|80853636|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
27734434|NCT00097539|80853637|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
27734435|NCT00097539|80853638|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
27734436|NCT00097539|80853632|FG000|Overall Study|Withdrawal by Subject|925|||
27734437|NCT00097539|80853633|FG001|Overall Study|Withdrawal by Subject|323|||
27734438|NCT00097539|80853634|FG002|Overall Study|Withdrawal by Subject|346|||
27734439|NCT00097539|80853635|FG003|Overall Study|Withdrawal by Subject|217|||
27734440|NCT00097539|80853636|FG004|Overall Study|Withdrawal by Subject|68|||
27734441|NCT00097539|80853637|FG005|Overall Study|Withdrawal by Subject|229|||
27734442|NCT00097539|80853638|FG006|Overall Study|Withdrawal by Subject|3|||
27734443|NCT00097539|80853632|FG000|Overall Study|Participant Non-compliant|2140|||
27734444|NCT00097539|80853633|FG001|Overall Study|Participant Non-compliant|567|||
27734445|NCT00097539|80853634|FG002|Overall Study|Participant Non-compliant|1067|||
27734446|NCT00097539|80853635|FG003|Overall Study|Participant Non-compliant|353|||
27734447|NCT00097539|80853636|FG004|Overall Study|Participant Non-compliant|136|||
27734448|NCT00097539|80853637|FG005|Overall Study|Participant Non-compliant|543|||
27734449|NCT00097539|80853638|FG006|Overall Study|Participant Non-compliant|18|||
27734450|NCT00097539|80853632|FG000|Overall Study|Lack of Efficacy|249|||
27734451|NCT00097539|80853633|FG001|Overall Study|Lack of Efficacy|122|||
27734452|NCT00097539|80853634|FG002|Overall Study|Lack of Efficacy|202|||
27734453|NCT00097539|80853635|FG003|Overall Study|Lack of Efficacy|105|||
27734454|NCT00097539|80853636|FG004|Overall Study|Lack of Efficacy|45|||
27625433|NCT05305040|80469416|FG000|Overall Study|Other|13|||
27734455|NCT00097539|80853637|FG005|Overall Study|Lack of Efficacy|228|||
27734456|NCT00097539|80853638|FG006|Overall Study|Lack of Efficacy|5|||
27734457|NCT00097539|80853632|FG000|Overall Study|Adverse Event|78|||
27734458|NCT00097539|80853633|FG001|Overall Study|Adverse Event|133|||
27734459|NCT00097539|80853634|FG002|Overall Study|Adverse Event|37|||
27734460|NCT00097539|80853635|FG003|Overall Study|Adverse Event|27|||
27734461|NCT00097539|80853636|FG004|Overall Study|Adverse Event|30|||
27856486|NCT02516553|81306772|FG003|Overall Study|Refused to continue trial medication|0|||
27625434|NCT05305040|80469417|FG001|Overall Study|Other|10|||
27625435|NCT05305040|80469416|FG000|Overall Study|Primary Malignancy Relapse|3|||
27625436|NCT05305040|80469417|FG001|Overall Study|Primary Malignancy Relapse|4|||
27625437|NCT05305040|80469416|FG000|Overall Study|Adverse Event|3|||
27625438|NCT05305040|80469417|FG001|Overall Study|Adverse Event|3|||
27625439|NCT05305040|80469416|FG000|Overall Study|Lost to Follow-up|2|||
27625440|NCT05305040|80469417|FG001|Overall Study|Lost to Follow-up|1|||
27625441|NCT05305040|80469416|FG000|Overall Study|Graft versus host disease|2|||
27734462|NCT00097539|80853637|FG005|Overall Study|Adverse Event|59|||
27734463|NCT00097539|80853638|FG006|Overall Study|Adverse Event|1|||
27734464|NCT00097539|80853632|FG000|Overall Study|Death|2|||
27734465|NCT00097539|80853633|FG001|Overall Study|Death|7|||
27734466|NCT00097539|80853634|FG002|Overall Study|Death|0|||
27734467|NCT00097539|80853635|FG003|Overall Study|Death|0|||
27734468|NCT00097539|80853636|FG004|Overall Study|Death|1|||
27734469|NCT00097539|80853637|FG005|Overall Study|Death|3|||
27734470|NCT00097539|80853638|FG006|Overall Study|Death|0|||
27734471|NCT00097539|80853632|FG000|Overall Study|Reasons Other Than Above|3602|||
27734472|NCT00097539|80853633|FG001|Overall Study|Reasons Other Than Above|1382|||
27734473|NCT00097539|80853634|FG002|Overall Study|Reasons Other Than Above|1757|||
27734474|NCT00097539|80853635|FG003|Overall Study|Reasons Other Than Above|692|||
27734475|NCT00097539|80853636|FG004|Overall Study|Reasons Other Than Above|361|||
27734476|NCT00097539|80853637|FG005|Overall Study|Reasons Other Than Above|1244|||
27734477|NCT00097539|80853638|FG006|Overall Study|Reasons Other Than Above|34|||
27734478|NCT00097539|80853632|FG000|Overall Study|Reason not Specified|111|||
27911898|NCT04131712|81518002|FG001|Overall Study|COVID related|0|||
27911899|NCT04131712|81518003|FG002|Overall Study|COVID related|2|||
27911900|NCT04131712|81518004|FG003|Overall Study|COVID related|0|||
27911901|NCT04131712|81518001|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
27911902|NCT04131712|81518002|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
27911903|NCT04131712|81518003|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
27911904|NCT04131712|81518004|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
27911905|NCT02829047|81518005|FG000|Overall Study|Withdrawal by Subject|1|||
27911906|NCT02689804|81518006|FG000|Overall Study|Withdrawal by Subject|2|||
27911907|NCT02689804|81518007|FG001|Overall Study|Withdrawal by Subject|0|||
27911908|NCT01275144|81518008|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
27911909|NCT01275144|81518009|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
27911910|NCT04157088|81518010|FG000|Overall Study|Study terminated by sponsor|23|||
27911911|NCT04157088|81518010|FG000|Overall Study|Withdrawal by Subject|4|||
27911912|NCT04157088|81518010|FG000|Overall Study|Lost to Follow-up|2|||
27529445|NCT01898494|80132355|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
27911913|NCT04157088|81518010|FG000|Overall Study|Death|1|||
27529446|NCT01898494|80132356|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
27529447|NCT01898494|80132357|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
27529448|NCT01898494|80132353|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
27529449|NCT01898494|80132354|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
27529450|NCT01898494|80132355|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
27529451|NCT01898494|80132356|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
27529452|NCT01898494|80132357|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
27529453|NCT01898494|80132353|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
27529454|NCT01898494|80132354|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
27529455|NCT01898494|80132355|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
27529456|NCT01898494|80132356|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
27529457|NCT01898494|80132357|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
27529458|NCT01898494|80132353|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27529459|NCT01898494|80132354|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
27529460|NCT01898494|80132355|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27529461|NCT01898494|80132356|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27529462|NCT01898494|80132357|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
27529463|NCT01898494|80132353|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27529464|NCT01898494|80132354|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27529465|NCT01898494|80132355|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
27529466|NCT01898494|80132356|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27529467|NCT01898494|80132357|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
27529468|NCT01898494|80132353|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
27529469|NCT01898494|80132354|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
27529470|NCT01898494|80132355|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
27529471|NCT01898494|80132356|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
27529472|NCT01898494|80132357|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
27529473|NCT01082640|80132359|FG000|Overall Study|Adverse Event|9|||
27529474|NCT01082640|80132360|FG001|Overall Study|Adverse Event|5|||
27529475|NCT01082640|80132361|FG002|Overall Study|Adverse Event|3|||
27529476|NCT01082640|80132359|FG000|Overall Study|Withdrawal by Subject|3|||
27734479|NCT00097539|80853633|FG001|Overall Study|Reason not Specified|49|||
27734480|NCT00097539|80853634|FG002|Overall Study|Reason not Specified|53|||
27734481|NCT00097539|80853635|FG003|Overall Study|Reason not Specified|21|||
27734482|NCT00097539|80853636|FG004|Overall Study|Reason not Specified|11|||
27734483|NCT00097539|80853637|FG005|Overall Study|Reason not Specified|40|||
27734484|NCT00097539|80853638|FG006|Overall Study|Reason not Specified|2|||
27911914|NCT00666211|81518011|FG000|Overall Study|Withdrawal by Subject|10|||
27911915|NCT00666211|81518012|FG001|Overall Study|Withdrawal by Subject|13|||
27911916|NCT00666211|81518011|FG000|Overall Study|went off medication, no more pain|1|||
27529477|NCT01082640|80132360|FG001|Overall Study|Withdrawal by Subject|3|||
27529478|NCT01082640|80132361|FG002|Overall Study|Withdrawal by Subject|2|||
27529479|NCT01082640|80132359|FG000|Overall Study|Major protocol deviation|3|||
27529480|NCT01082640|80132360|FG001|Overall Study|Major protocol deviation|3|||
27529481|NCT01082640|80132361|FG002|Overall Study|Major protocol deviation|0|||
27529482|NCT01082640|80132359|FG000|Overall Study|Lost to Follow-up|0|||
27529483|NCT01082640|80132360|FG001|Overall Study|Lost to Follow-up|3|||
27529484|NCT01082640|80132361|FG002|Overall Study|Lost to Follow-up|0|||
27529485|NCT01082640|80132359|FG000|Overall Study|Other|2|||
27529486|NCT01082640|80132360|FG001|Overall Study|Other|1|||
27529487|NCT01082640|80132361|FG002|Overall Study|Other|3|||
27529488|NCT01858636|80132364|FG000|Overall Study|No Device Deployment Attempted|24|||
27529489|NCT01858636|80132364|FG000|Overall Study|Physician Decision|1|||
27529490|NCT01858636|80132364|FG000|Overall Study|Death|1|||
27529491|NCT01858636|80132364|FG000|Overall Study|Lost to Follow-up|1|||
27529492|NCT01858636|80132364|FG000|Overall Study|Withdrawal by Subject|1|||
27529493|NCT01009281|80132366|FG000|Overall Study|Administrative problems|7|||
27529494|NCT00510874|80132367|FG000|Overall Study|Withdrawal by Subject|1|||
27529495|NCT00510874|80132368|FG001|Overall Study|Withdrawal by Subject|1|||
27529496|NCT00510874|80132369|FG002|Overall Study|Withdrawal by Subject|0|||
27529497|NCT00510874|80132370|FG003|Overall Study|Withdrawal by Subject|0|||
27529498|NCT00510874|80132371|FG004|Overall Study|Withdrawal by Subject|3|||
27529499|NCT00510874|80132372|FG005|Overall Study|Withdrawal by Subject|0|||
27529500|NCT00510874|80132373|FG006|Overall Study|Withdrawal by Subject|0|||
27529501|NCT00510874|80132367|FG000|Overall Study|Lost to Follow-up|2|||
27529502|NCT00510874|80132368|FG001|Overall Study|Lost to Follow-up|3|||
27529503|NCT00510874|80132369|FG002|Overall Study|Lost to Follow-up|1|||
27529504|NCT00510874|80132370|FG003|Overall Study|Lost to Follow-up|3|||
27529505|NCT00510874|80132371|FG004|Overall Study|Lost to Follow-up|4|||
27529506|NCT00510874|80132372|FG005|Overall Study|Lost to Follow-up|0|||
27625442|NCT05305040|80469417|FG001|Overall Study|Graft versus host disease|0|||
27625443|NCT05305040|80469416|FG000|Overall Study|Investigator's Decision|1|||
27625444|NCT05305040|80469417|FG001|Overall Study|Investigator's Decision|1|||
27625445|NCT05305040|80469416|FG000|Overall Study|COVID-19 Reasons|1|||
27625446|NCT05305040|80469417|FG001|Overall Study|COVID-19 Reasons|0|||
27625447|NCT00256308|80469418|FG000|Overall Study|Death|2|||
27625448|NCT00151996|80469422|FG000|Overall Study|Adverse Event|3|||
27625449|NCT00151996|80469423|FG001|Overall Study|Adverse Event|2|||
27625450|NCT00151996|80469422|FG000|Overall Study|Withdrawal by Subject|1|||
27625451|NCT00151996|80469423|FG001|Overall Study|Withdrawal by Subject|1|||
27625452|NCT00151996|80469422|FG000|Overall Study|Protocol Violation|1|||
27625453|NCT00151996|80469423|FG001|Overall Study|Protocol Violation|2|||
27625454|NCT00151996|80469422|FG000|Overall Study|Sponsor's decision|0|||
27625455|NCT00151996|80469423|FG001|Overall Study|Sponsor's decision|2|||
27625456|NCT00823979|80469428|FG000|Overall Study|Lack of Efficacy|13|||
27625457|NCT00823979|80469429|FG001|Overall Study|Lack of Efficacy|16|||
27625458|NCT00823979|80469430|FG002|Overall Study|Lack of Efficacy|9|||
27625459|NCT00823979|80469428|FG000|Overall Study|Lost to Follow-up|2|||
27625460|NCT00823979|80469429|FG001|Overall Study|Lost to Follow-up|1|||
27625461|NCT00823979|80469430|FG002|Overall Study|Lost to Follow-up|0|||
27625462|NCT00823979|80469428|FG000|Overall Study|Withdrawal by Subject|2|||
27625463|NCT00823979|80469429|FG001|Overall Study|Withdrawal by Subject|3|||
27625464|NCT00823979|80469430|FG002|Overall Study|Withdrawal by Subject|2|||
27625465|NCT00823979|80469428|FG000|Overall Study|Protocol Violation|1|||
27625466|NCT00823979|80469429|FG001|Overall Study|Protocol Violation|1|||
27625467|NCT00823979|80469430|FG002|Overall Study|Protocol Violation|0|||
27625468|NCT00823979|80469428|FG000|Overall Study|Pregnancy|0|||
27625469|NCT00823979|80469429|FG001|Overall Study|Pregnancy|1|||
27625470|NCT00823979|80469430|FG002|Overall Study|Pregnancy|0|||
27625471|NCT00823979|80469428|FG000|Overall Study|Adverse Event|0|||
27625472|NCT00823979|80469429|FG001|Overall Study|Adverse Event|2|||
27734485|NCT01122927|80853639|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
27529507|NCT00510874|80132373|FG006|Overall Study|Lost to Follow-up|1|||
27529508|NCT03116347|80132374|FG000|Overall Study|Withdrawal by Subject|1|||
27529509|NCT03116347|80132375|FG001|Overall Study|Withdrawal by Subject|2|||
27529510|NCT03718299|80132382|FG000|Overall Study|Adverse Event|1|||
27529511|NCT03718299|80132382|FG000|Overall Study|Withdrawal by Subject|6|||
27529512|NCT03718299|80132382|FG000|Overall Study|Physician Decision|2|||
27529513|NCT03718299|80132382|FG000|Overall Study|Lost to Follow-up|1|||
27529514|NCT01757691|80132386|FG000|Overall Study|Administrative problems|2|||
27529515|NCT01757691|80132387|FG001|Overall Study|Administrative problems|0|||
27529516|NCT01367119|80132388|FG000|Overall Study|Adverse Event|1|||
27625473|NCT00823979|80469430|FG002|Overall Study|Adverse Event|4|||
27625474|NCT00823979|80469428|FG000|Overall Study|Other|2|||
27625475|NCT00823979|80469429|FG001|Overall Study|Other|0|||
27625476|NCT00823979|80469430|FG002|Overall Study|Other|1|||
27529517|NCT01367119|80132389|FG001|Overall Study|Adverse Event|0|||
27625477|NCT00823979|80469428|FG000|Overall Study|Randomized but not Treated|4|||
27625478|NCT00823979|80469429|FG001|Overall Study|Randomized but not Treated|3|||
27529518|NCT01367119|80132388|FG000|Overall Study|Withdrawal by Subject|1|||
27529519|NCT01367119|80132389|FG001|Overall Study|Withdrawal by Subject|1|||
27529520|NCT01916967|80132390|FG000|Overall Study|Adverse Event|0|||
27529521|NCT01916967|80132391|FG001|Overall Study|Adverse Event|0|||
27529522|NCT01916967|80132392|FG002|Overall Study|Adverse Event|2|||
27529523|NCT01916967|80132390|FG000|Overall Study|Lack of Efficacy|0|||
27529524|NCT01916967|80132391|FG001|Overall Study|Lack of Efficacy|0|||
27529525|NCT01916967|80132392|FG002|Overall Study|Lack of Efficacy|6|||
27529526|NCT01916967|80132390|FG000|Overall Study|Physician Decision|0|||
27529527|NCT01916967|80132391|FG001|Overall Study|Physician Decision|0|||
27529528|NCT01916967|80132392|FG002|Overall Study|Physician Decision|1|||
27911917|NCT00666211|81518012|FG001|Overall Study|went off medication, no more pain|0|||
27911918|NCT00666211|81518011|FG000|Overall Study|patient non-compliant|6|||
27911919|NCT00666211|81518012|FG001|Overall Study|patient non-compliant|6|||
27911920|NCT00666211|81518011|FG000|Overall Study|disease progression|1|||
27911921|NCT00666211|81518012|FG001|Overall Study|disease progression|8|||
27911922|NCT00666211|81518011|FG000|Overall Study|Lost to Follow-up|2|||
27911923|NCT00666211|81518012|FG001|Overall Study|Lost to Follow-up|0|||
27911924|NCT00666211|81518011|FG000|Overall Study|toxicity|0|||
27911925|NCT00666211|81518012|FG001|Overall Study|toxicity|2|||
27911926|NCT00666211|81518011|FG000|Overall Study|hospital admission|0|||
27911927|NCT00666211|81518012|FG001|Overall Study|hospital admission|5|||
27911928|NCT00666211|81518011|FG000|Overall Study|Death|0|||
27911929|NCT00666211|81518012|FG001|Overall Study|Death|2|||
27911930|NCT00666211|81518011|FG000|Overall Study|off tx for other complicating disease|0|||
27911931|NCT00666211|81518012|FG001|Overall Study|off tx for other complicating disease|1|||
27911932|NCT00666211|81518011|FG000|Overall Study|Physician Decision|0|||
27911933|NCT00666211|81518012|FG001|Overall Study|Physician Decision|1|||
27911934|NCT01302418|81518013|FG000|Overall Study|Protocol Violation|9|||
27911935|NCT01302418|81518013|FG000|Overall Study|Non-evaluable|9|||
27911936|NCT01935089|81518019|FG000|Overall Study|Adverse Event|2|||
27911937|NCT01935089|81518019|FG000|Overall Study|Withdrawal by Subject|1|||
27911938|NCT00766597|81518020|FG000|Overall Study|Unexpected closure of study|4|||
27911939|NCT00766597|81518020|FG000|Overall Study|Without CCR5-tropic virus|5|||
27911940|NCT02317991|81518027|FG000|Overall Study|Adverse Event|12|||
27911941|NCT02317991|81518027|FG000|Overall Study|Death|4|||
27911942|NCT02317991|81518027|FG000|Overall Study|Withdrawal by Subject|8|||
27911943|NCT02317991|81518027|FG000|Overall Study|Progressive Disease|41|||
27911944|NCT00715559|81518028|FG000|Overall Study|medication not tolerated - nausea|1|||
27911945|NCT04613518|81518031|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
27529529|NCT01916967|80132390|FG000|Overall Study|Protocol Violation|0|||
27529530|NCT01916967|80132391|FG001|Overall Study|Protocol Violation|1|||
27529531|NCT01916967|80132392|FG002|Overall Study|Protocol Violation|0|||
27529532|NCT00596362|80132393|FG000|Overall Study|Progressive Disease|1|||
27529533|NCT02140775|80132394|FG000|Overall Study|Withdrawal by Subject|30|||
27529534|NCT02140775|80132395|FG001|Overall Study|Withdrawal by Subject|7|||
27529535|NCT01903525|80132396|FG000|Overall Study|Lost to Follow-up|5|||
27529536|NCT01903525|80132397|FG001|Overall Study|Lost to Follow-up|9|||
27911946|NCT04613518|81518032|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
27911947|NCT04613518|81518033|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
27911948|NCT04613518|81518031|FG000|Double-Blind Treatment Period|Adverse Event|2|||
27911949|NCT04613518|81518032|FG001|Double-Blind Treatment Period|Adverse Event|0|||
27911950|NCT04613518|81518033|FG002|Double-Blind Treatment Period|Adverse Event|1|||
27911951|NCT04613518|81518031|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
27911952|NCT04613518|81518032|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
27911953|NCT04613518|81518033|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
27911954|NCT04613518|81518031|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
27911955|NCT04613518|81518032|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
27911956|NCT04613518|81518033|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
27911957|NCT04613518|81518031|FG000|Double-Blind Treatment Period|Other Reasons|2|||
27911958|NCT04613518|81518032|FG001|Double-Blind Treatment Period|Other Reasons|0|||
27911959|NCT04613518|81518033|FG002|Double-Blind Treatment Period|Other Reasons|0|||
27911960|NCT04613518|81518031|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
27911961|NCT04613518|81518032|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
27911962|NCT04613518|81518033|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
27911963|NCT04613518|81518031|FG000|Open-Label Treatment Period|Adverse Event|1|||
27911964|NCT04613518|81518032|FG001|Open-Label Treatment Period|Adverse Event|0|||
27529537|NCT01903525|80132396|FG000|Overall Study|Adverse Event|0|||
27529538|NCT01903525|80132397|FG001|Overall Study|Adverse Event|1|||
27911965|NCT04613518|81518033|FG002|Open-Label Treatment Period|Adverse Event|3|||
27911966|NCT04613518|81518031|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
27911967|NCT04613518|81518032|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
27529539|NCT00920829|80132398|FG000|Allocation|No post randomization data|3|||
27529540|NCT00920829|80132399|FG001|Allocation|No post randomization data|1|||
27734486|NCT01122927|80853640|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
27734487|NCT01122927|80853639|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
27734488|NCT01122927|80853640|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27734489|NCT01122927|80853639|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
27734490|NCT01122927|80853640|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
27734491|NCT01122927|80853639|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
27734492|NCT01122927|80853640|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27734493|NCT01122927|80853639|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
27734494|NCT01122927|80853640|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
27734495|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
27734496|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
27734497|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
27734498|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
27734499|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
27734500|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
27734501|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
27734502|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
27734503|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
27734504|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
27734505|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
27734506|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
27734507|NCT01122927|80853639|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
27734508|NCT01122927|80853640|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
27734509|NCT00190775|80853644|FG000|Overall Study|Adverse Event|57|||
27734510|NCT00190775|80853645|FG001|Overall Study|Adverse Event|22|||
27734511|NCT00190775|80853644|FG000|Overall Study|Satisfactory Response|1|||
27734512|NCT00190775|80853645|FG001|Overall Study|Satisfactory Response|0|||
27734513|NCT00190775|80853644|FG000|Overall Study|Lack of Efficacy|28|||
27734514|NCT00190775|80853645|FG001|Overall Study|Lack of Efficacy|32|||
27734515|NCT00190775|80853644|FG000|Overall Study|Lost to Follow-up|31|||
27734516|NCT00190775|80853645|FG001|Overall Study|Lost to Follow-up|23|||
27734517|NCT00190775|80853644|FG000|Overall Study|Participant Moved|0|||
27734518|NCT00190775|80853645|FG001|Overall Study|Participant Moved|1|||
27734519|NCT00190775|80853644|FG000|Overall Study|Withdrawal by Subject|24|||
27734520|NCT00190775|80853645|FG001|Overall Study|Withdrawal by Subject|13|||
27734521|NCT00190775|80853644|FG000|Overall Study|Sponsor Decision|1|||
27734522|NCT00190775|80853645|FG001|Overall Study|Sponsor Decision|0|||
27734523|NCT00190775|80853644|FG000|Overall Study|Physician Decision|3|||
27734524|NCT00190775|80853645|FG001|Overall Study|Physician Decision|0|||
27734525|NCT00190775|80853644|FG000|Overall Study|Noncompliance|3|||
27734526|NCT00190775|80853645|FG001|Overall Study|Noncompliance|5|||
27734527|NCT00190775|80853644|FG000|Overall Study|Protocol Violation|0|||
27734528|NCT00190775|80853645|FG001|Overall Study|Protocol Violation|1|||
27734529|NCT00190775|80853644|FG000|Overall Study|Exclusion Criteria Met|1|||
27734530|NCT00190775|80853645|FG001|Overall Study|Exclusion Criteria Met|3|||
27734531|NCT00110305|80853646|FG000|Overall Study|Adverse Event|46|||
27734532|NCT00110305|80853647|FG001|Overall Study|Adverse Event|13|||
27734533|NCT00110305|80853646|FG000|Overall Study|Sponsors Decision|1|||
27734534|NCT00110305|80853647|FG001|Overall Study|Sponsors Decision|0|||
27734535|NCT00110305|80853646|FG000|Overall Study|Subject Non-Compliant|9|||
27734536|NCT00110305|80853647|FG001|Overall Study|Subject Non-Compliant|2|||
27734537|NCT00110305|80853646|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
27734538|NCT00110305|80853647|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
27734539|NCT00110305|80853646|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
27734540|NCT00110305|80853647|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
27734541|NCT00110305|80853646|FG000|Overall Study|Protocol Violation|0|||
27734542|NCT00110305|80853647|FG001|Overall Study|Protocol Violation|1|||
27734543|NCT00110305|80853646|FG000|Overall Study|Withdrawal by Subject|7|||
27734544|NCT00110305|80853647|FG001|Overall Study|Withdrawal by Subject|7|||
27734545|NCT00110305|80853646|FG000|Overall Study|Lost to Follow-up|20|||
27734546|NCT00110305|80853647|FG001|Overall Study|Lost to Follow-up|3|||
27734547|NCT00110305|80853646|FG000|Overall Study|Other|8|||
27734548|NCT00110305|80853647|FG001|Overall Study|Other|2|||
27734549|NCT00813748|80853648|FG000|Skin Test Substudy|Physician Decision|0|||
27734550|NCT00813748|80853649|FG001|Skin Test Substudy|Physician Decision|1|||
27911968|NCT04613518|81518033|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
27734551|NCT03871491|80853650|FG000|Overall Study|Withdrawal by Subject|14|||
27734552|NCT03871491|80853651|FG001|Overall Study|Withdrawal by Subject|14|||
27734553|NCT03871491|80853652|FG002|Overall Study|Withdrawal by Subject|14|||
27734554|NCT03871491|80853653|FG003|Overall Study|Withdrawal by Subject|14|||
27734555|NCT03871491|80853650|FG000|Overall Study|Physician Decision|0|||
27734556|NCT03871491|80853651|FG001|Overall Study|Physician Decision|0|||
27734557|NCT03871491|80853652|FG002|Overall Study|Physician Decision|1|||
27911969|NCT04613518|81518031|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
27911970|NCT04613518|81518032|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
27911971|NCT04613518|81518033|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
27911972|NCT04613518|81518031|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
27625479|NCT00823979|80469430|FG002|Overall Study|Randomized but not Treated|1|||
27625480|NCT00823979|80469428|FG000|Overall Study|Study Terminated by Sponsor|5|||
27625481|NCT00823979|80469429|FG001|Overall Study|Study Terminated by Sponsor|5|||
27625482|NCT00823979|80469430|FG002|Overall Study|Study Terminated by Sponsor|7|||
27625483|NCT02040844|80469431|FG000|Overall Study|Adverse Event|0|||
27625484|NCT02040844|80469432|FG001|Overall Study|Adverse Event|0|||
27625485|NCT02040844|80469433|FG002|Overall Study|Adverse Event|1|||
27625486|NCT02040844|80469431|FG000|Overall Study|Withdrawal by Subject|16|||
27625487|NCT02040844|80469432|FG001|Overall Study|Withdrawal by Subject|22|||
27625488|NCT02040844|80469433|FG002|Overall Study|Withdrawal by Subject|25|||
27625489|NCT02040844|80469431|FG000|Overall Study|Lost to Follow-up|12|||
27625490|NCT02040844|80469432|FG001|Overall Study|Lost to Follow-up|9|||
27625491|NCT02040844|80469433|FG002|Overall Study|Lost to Follow-up|13|||
27734558|NCT03871491|80853653|FG003|Overall Study|Physician Decision|1|||
27734559|NCT03871491|80853650|FG000|Overall Study|Lost to Follow-up|50|||
27734560|NCT03871491|80853651|FG001|Overall Study|Lost to Follow-up|15|||
27734561|NCT03871491|80853652|FG002|Overall Study|Lost to Follow-up|36|||
27734562|NCT03871491|80853653|FG003|Overall Study|Lost to Follow-up|11|||
27911973|NCT04613518|81518032|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
27911974|NCT04613518|81518033|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
27911975|NCT04613518|81518031|FG000|Open-Label Treatment Period|Other reasons|1|||
27911976|NCT04613518|81518032|FG001|Open-Label Treatment Period|Other reasons|0|||
27911977|NCT04613518|81518033|FG002|Open-Label Treatment Period|Other reasons|0|||
27911978|NCT00227539|81518034|FG000|Overall Study|Protocol Violation|1|||
27911979|NCT02735980|81518041|FG000|Overall Study|Adverse Event|0|||
27911980|NCT02735980|81518042|FG001|Overall Study|Adverse Event|4|||
27911981|NCT02735980|81518043|FG002|Overall Study|Adverse Event|1|||
27911982|NCT02735980|81518041|FG000|Overall Study|Death|5|||
27911983|NCT02735980|81518042|FG001|Overall Study|Death|4|||
27911984|NCT02735980|81518043|FG002|Overall Study|Death|0|||
27911985|NCT02735980|81518041|FG000|Overall Study|Physician Decision|3|||
27911986|NCT02735980|81518042|FG001|Overall Study|Physician Decision|1|||
27911987|NCT02735980|81518043|FG002|Overall Study|Physician Decision|0|||
27911988|NCT02735980|81518041|FG000|Overall Study|Screen failure|1|||
27911989|NCT02735980|81518042|FG001|Overall Study|Screen failure|0|||
27911990|NCT02735980|81518043|FG002|Overall Study|Screen failure|0|||
27911991|NCT02735980|81518041|FG000|Overall Study|Withdrawal by Subject|1|||
27911992|NCT02735980|81518042|FG001|Overall Study|Withdrawal by Subject|2|||
27911993|NCT02735980|81518043|FG002|Overall Study|Withdrawal by Subject|0|||
27911994|NCT01166750|81518044|FG000|Overall Study|Lost to Follow-up|1|||
27911995|NCT01166750|81518045|FG001|Overall Study|Lost to Follow-up|0|||
27911996|NCT02753816|81518053|FG000|Overall Study|Protocol Violation|0|||
27911997|NCT02753816|81518054|FG001|Overall Study|Protocol Violation|1|||
27911998|NCT02753816|81518055|FG002|Overall Study|Protocol Violation|0|||
27911999|NCT04980014|81518056|FG000|Overall Study|Participants who are Duplicated|1|||
27912000|NCT04980014|81518056|FG000|Overall Study|Follow-up Failure|13|||
27529541|NCT00920829|80132400|FG002|Allocation|No post randomization data|0|||
27529542|NCT00920829|80132401|FG003|Allocation|No post randomization data|2|||
27529543|NCT00920829|80132398|FG000|Available for Analysis|Withdrawal by Subject|6|||
27529544|NCT00920829|80132399|FG001|Available for Analysis|Withdrawal by Subject|6|||
27529545|NCT00920829|80132400|FG002|Available for Analysis|Withdrawal by Subject|6|||
27529546|NCT00920829|80132401|FG003|Available for Analysis|Withdrawal by Subject|10|||
27529547|NCT00920829|80132398|FG000|Available for Analysis|Required Medical Treatment|0|||
27529548|NCT00920829|80132399|FG001|Available for Analysis|Required Medical Treatment|1|||
27529549|NCT00920829|80132400|FG002|Available for Analysis|Required Medical Treatment|2|||
27529550|NCT00920829|80132401|FG003|Available for Analysis|Required Medical Treatment|0|||
27529551|NCT00920829|80132398|FG000|Available for Analysis|Adverse Event|1|||
27529552|NCT00920829|80132399|FG001|Available for Analysis|Adverse Event|2|||
27529553|NCT00920829|80132400|FG002|Available for Analysis|Adverse Event|1|||
27529554|NCT00920829|80132401|FG003|Available for Analysis|Adverse Event|0|||
27529555|NCT00920829|80132398|FG000|Available for Analysis|Death|1|||
27529556|NCT00920829|80132399|FG001|Available for Analysis|Death|0|||
27625492|NCT02040844|80469431|FG000|Overall Study|Missing|13|||
27912001|NCT04980014|81518056|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
27912002|NCT04980014|81518056|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
27912003|NCT04980014|81518056|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
27625493|NCT02040844|80469432|FG001|Overall Study|Missing|3|||
27625494|NCT02040844|80469433|FG002|Overall Study|Missing|2|||
27625495|NCT02040844|80469431|FG000|Overall Study|Non-specified|8|||
27625496|NCT02040844|80469432|FG001|Overall Study|Non-specified|2|||
27734563|NCT04178590|80853654|FG000|Overall Study|Pregnancy|1|||
27734564|NCT04178590|80853654|FG000|Overall Study|Lost to Follow-up|1|||
27625497|NCT02040844|80469433|FG002|Overall Study|Non-specified|5|||
27625498|NCT02040844|80469431|FG000|Overall Study|Concomitant medication|1|||
27625499|NCT02040844|80469432|FG001|Overall Study|Concomitant medication|3|||
27625500|NCT02040844|80469433|FG002|Overall Study|Concomitant medication|1|||
27625501|NCT02027935|80473303|FG000|Overall Study|Death|1|||
27625502|NCT02027935|80473303|FG000|Overall Study|Lack of Efficacy|5|||
27625503|NCT02027935|80473303|FG000|Overall Study|Study Closure|1|||
27625504|NCT01264718|80473304|FG000|Overall Study|Lost to Follow-up|3|||
27625505|NCT01264718|80473305|FG001|Overall Study|Lost to Follow-up|2|||
27625506|NCT01264718|80473304|FG000|Overall Study|Withdrawal by Subject|9|||
27625507|NCT01264718|80473305|FG001|Overall Study|Withdrawal by Subject|15|||
27625508|NCT01264718|80473304|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
27625509|NCT01264718|80473305|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
27625510|NCT03829332|80473308|FG000|Overall Study|Death|145|||
27625511|NCT03829332|80473309|FG001|Overall Study|Death|135|||
27625512|NCT03829332|80473308|FG000|Overall Study|Withdrawal by Subject|10|||
27625513|NCT03829332|80473309|FG001|Overall Study|Withdrawal by Subject|4|||
27625514|NCT03829332|80473308|FG000|Overall Study|Ongoing in Study|154|||
27625515|NCT03829332|80473309|FG001|Overall Study|Ongoing in Study|175|||
27625516|NCT02465359|80473310|FG000|Overall Study|Lack of Efficacy|1|||
27625517|NCT02465359|80473310|FG000|Overall Study|Withdrawal by Subject|1|||
27625518|NCT02465359|80473310|FG000|Overall Study|Adverse Event|1|||
27625519|NCT00058058|80473311|FG000|Overall Study|Withdrawal by Subject|4|||
27625520|NCT00058058|80473311|FG000|Overall Study|Ineligible|20|||
27625521|NCT00058058|80473311|FG000|Overall Study|Claustrophobic|5|||
27625522|NCT00058058|80473311|FG000|Overall Study|technical issues|6|||
27625523|NCT00058058|80473311|FG000|Overall Study|Poor positioning, illness,pain|3|||
27625524|NCT05052983|80473323|FG000|Overall Study|Lack of Efficacy|3|||
27625525|NCT05052983|80473324|FG001|Overall Study|Lack of Efficacy|12|||
27625526|NCT05052983|80473323|FG000|Overall Study|Adverse Event|1|||
27625527|NCT05052983|80473324|FG001|Overall Study|Adverse Event|0|||
27625528|NCT03111095|80473325|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
27625529|NCT03111095|80473326|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
27625530|NCT03111095|80473325|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
27625531|NCT03111095|80473326|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
27625532|NCT03531905|80473327|FG000|Overall Study|Withdrawal by Subject|3|||
27625533|NCT03531905|80473328|FG001|Overall Study|Withdrawal by Subject|3|||
27625534|NCT03531905|80473329|FG002|Overall Study|Withdrawal by Subject|2|||
27625535|NCT03531905|80473327|FG000|Overall Study|Lost to Follow-up|2|||
27625536|NCT03531905|80473328|FG001|Overall Study|Lost to Follow-up|2|||
27625537|NCT03531905|80473329|FG002|Overall Study|Lost to Follow-up|1|||
27625538|NCT03531905|80473327|FG000|Overall Study|Participant was out of town|1|||
27625539|NCT03531905|80473328|FG001|Overall Study|Participant was out of town|0|||
27625540|NCT03531905|80473329|FG002|Overall Study|Participant was out of town|0|||
27625541|NCT03531905|80473327|FG000|Overall Study|Could not speak with the participant|1|||
27625542|NCT03531905|80473328|FG001|Overall Study|Could not speak with the participant|0|||
27625543|NCT03531905|80473329|FG002|Overall Study|Could not speak with the participant|0|||
27625544|NCT05824351|80473333|FG000|Overall Study|Adverse Event|6|||
27625545|NCT04133363|80473338|FG000|Overall Study|Lost to Follow-up|2|||
27625546|NCT04133363|80473339|FG001|Overall Study|Lost to Follow-up|1|||
27625547|NCT04133363|80473340|FG002|Overall Study|Lost to Follow-up|4|||
27625548|NCT03781804|80473342|FG000|Overall Study|Adverse Event|2|||
27625549|NCT03781804|80473343|FG001|Overall Study|Adverse Event|2|||
27625550|NCT03781804|80473344|FG002|Overall Study|Adverse Event|3|||
27625551|NCT03781804|80473342|FG000|Overall Study|Lost to Follow-up|1|||
27625552|NCT03781804|80473343|FG001|Overall Study|Lost to Follow-up|1|||
27625553|NCT03781804|80473344|FG002|Overall Study|Lost to Follow-up|2|||
27625554|NCT03781804|80473342|FG000|Overall Study|Lack of Efficacy|4|||
27625555|NCT03781804|80473343|FG001|Overall Study|Lack of Efficacy|2|||
27856487|NCT02516553|81306773|FG004|Overall Study|Refused to continue trial medication|0|||
27625556|NCT03781804|80473344|FG002|Overall Study|Lack of Efficacy|9|||
27856488|NCT02516553|81306774|FG005|Overall Study|Refused to continue trial medication|0|||
27856489|NCT02516553|81306775|FG006|Overall Study|Refused to continue trial medication|0|||
27856490|NCT02516553|81306776|FG007|Overall Study|Refused to continue trial medication|0|||
27625557|NCT03781804|80473342|FG000|Overall Study|Protocol Violation|0|||
27734565|NCT05900115|80853655|FG000|Overall Study|Lost to Follow-up|129|||
27625558|NCT03781804|80473343|FG001|Overall Study|Protocol Violation|0|||
27625559|NCT03781804|80473344|FG002|Overall Study|Protocol Violation|1|||
27625560|NCT03781804|80473342|FG000|Overall Study|Withdrawal by Subject|0|||
27625561|NCT03781804|80473343|FG001|Overall Study|Withdrawal by Subject|1|||
27625562|NCT03781804|80473344|FG002|Overall Study|Withdrawal by Subject|1|||
27625563|NCT03781804|80473342|FG000|Overall Study|Reason not provided|2|||
27625564|NCT03781804|80473343|FG001|Overall Study|Reason not provided|2|||
27625565|NCT03781804|80473344|FG002|Overall Study|Reason not provided|0|||
27625566|NCT00542386|80473345|FG000|Overall Study|Adverse Event|1|||
27625567|NCT00542386|80473346|FG001|Overall Study|Adverse Event|7|||
27625568|NCT00542386|80473347|FG002|Overall Study|Adverse Event|7|||
27625569|NCT00542386|80473348|FG003|Overall Study|Adverse Event|8|||
27625570|NCT00542386|80473349|FG004|Overall Study|Adverse Event|13|||
27625571|NCT00542386|80473350|FG005|Overall Study|Adverse Event|4|||
27625572|NCT00542386|80473345|FG000|Overall Study|Death|0|||
27625573|NCT00542386|80473346|FG001|Overall Study|Death|0|||
27625574|NCT00542386|80473347|FG002|Overall Study|Death|1|||
27625575|NCT00542386|80473348|FG003|Overall Study|Death|2|||
27625576|NCT00542386|80473349|FG004|Overall Study|Death|1|||
27625577|NCT00542386|80473350|FG005|Overall Study|Death|2|||
27625578|NCT00542386|80473345|FG000|Overall Study|Lack of Efficacy|32|||
27625579|NCT00542386|80473346|FG001|Overall Study|Lack of Efficacy|12|||
27625580|NCT00542386|80473347|FG002|Overall Study|Lack of Efficacy|10|||
27625581|NCT00542386|80473348|FG003|Overall Study|Lack of Efficacy|13|||
27625582|NCT00542386|80473349|FG004|Overall Study|Lack of Efficacy|7|||
27625583|NCT00542386|80473350|FG005|Overall Study|Lack of Efficacy|31|||
27625584|NCT00542386|80473345|FG000|Overall Study|Physician Decision|1|||
27625585|NCT00542386|80473346|FG001|Overall Study|Physician Decision|0|||
27625586|NCT00542386|80473347|FG002|Overall Study|Physician Decision|0|||
27625587|NCT00542386|80473348|FG003|Overall Study|Physician Decision|1|||
27625588|NCT00542386|80473349|FG004|Overall Study|Physician Decision|0|||
27625589|NCT00542386|80473350|FG005|Overall Study|Physician Decision|0|||
27625590|NCT00542386|80473345|FG000|Overall Study|Protocol Violation|0|||
27625591|NCT00542386|80473346|FG001|Overall Study|Protocol Violation|0|||
27625592|NCT00542386|80473347|FG002|Overall Study|Protocol Violation|1|||
27912004|NCT03586050|81518059|FG000|Overall Study|Death|3|||
27912005|NCT03586050|81518059|FG000|Overall Study|Withdrawal by Subject|2|||
27912006|NCT01038687|81518062|FG000|Overall Study|Adverse Event|0|||
27912007|NCT01038687|81518063|FG001|Overall Study|Adverse Event|2|||
27912008|NCT01038687|81518064|FG002|Overall Study|Adverse Event|1|||
27529557|NCT00920829|80132400|FG002|Available for Analysis|Death|0|||
27529558|NCT00920829|80132401|FG003|Available for Analysis|Death|0|||
27529559|NCT00920829|80132398|FG000|Available for Analysis|Protocol Violation|0|||
27529560|NCT00920829|80132399|FG001|Available for Analysis|Protocol Violation|0|||
27529561|NCT00920829|80132400|FG002|Available for Analysis|Protocol Violation|1|||
27529562|NCT00920829|80132401|FG003|Available for Analysis|Protocol Violation|0|||
27529563|NCT00920829|80132398|FG000|Available for Analysis|Required more treatment|0|||
27529564|NCT00920829|80132399|FG001|Available for Analysis|Required more treatment|2|||
27529565|NCT00920829|80132400|FG002|Available for Analysis|Required more treatment|0|||
27529566|NCT00920829|80132401|FG003|Available for Analysis|Required more treatment|1|||
27529567|NCT00495131|80132402|FG000|Overall Study|Adverse Event|6|||
27529568|NCT00495131|80132403|FG001|Overall Study|Adverse Event|2|||
27529569|NCT00495131|80132402|FG000|Overall Study|Lack of Efficacy|0|||
27529570|NCT00495131|80132403|FG001|Overall Study|Lack of Efficacy|2|||
27625593|NCT00542386|80473348|FG003|Overall Study|Protocol Violation|0|||
27856491|NCT02516553|81306777|FG008|Overall Study|Refused to continue trial medication|0|||
27856492|NCT02516553|81306778|FG009|Overall Study|Refused to continue trial medication|0|||
27856493|NCT02516553|81306779|FG010|Overall Study|Refused to continue trial medication|1|||
27856494|NCT02516553|81306780|FG011|Overall Study|Refused to continue trial medication|0|||
27856495|NCT02516553|81306781|FG012|Overall Study|Refused to continue trial medication|0|||
27856496|NCT02516553|81306782|FG013|Overall Study|Refused to continue trial medication|0|||
27856497|NCT02516553|81306783|FG014|Overall Study|Refused to continue trial medication|0|||
27856498|NCT02516553|81306784|FG015|Overall Study|Refused to continue trial medication|0|||
27856499|NCT02516553|81306785|FG016|Overall Study|Refused to continue trial medication|0|||
27856500|NCT02516553|81306786|FG017|Overall Study|Refused to continue trial medication|0|||
27856501|NCT02516553|81306787|FG018|Overall Study|Refused to continue trial medication|1|||
27856502|NCT02516553|81306788|FG019|Overall Study|Refused to continue trial medication|0|||
27856503|NCT02516553|81306789|FG020|Overall Study|Refused to continue trial medication|0|||
27856504|NCT02516553|81306790|FG021|Overall Study|Refused to continue trial medication|1|||
27856505|NCT02516553|81306769|FG000|Overall Study|other reasons than listed|0|||
27856506|NCT02516553|81306770|FG001|Overall Study|other reasons than listed|0|||
27856507|NCT02516553|81306771|FG002|Overall Study|other reasons than listed|0|||
27856508|NCT02516553|81306772|FG003|Overall Study|other reasons than listed|0|||
27856509|NCT02516553|81306773|FG004|Overall Study|other reasons than listed|0|||
27856510|NCT02516553|81306774|FG005|Overall Study|other reasons than listed|0|||
27856511|NCT02516553|81306775|FG006|Overall Study|other reasons than listed|0|||
27856512|NCT02516553|81306776|FG007|Overall Study|other reasons than listed|1|||
27529571|NCT00495131|80132402|FG000|Overall Study|Lost to Follow-up|0|||
27529572|NCT00495131|80132403|FG001|Overall Study|Lost to Follow-up|2|||
27529573|NCT00495131|80132402|FG000|Overall Study|Withdrawal by Subject|1|||
27625594|NCT00542386|80473349|FG004|Overall Study|Protocol Violation|0|||
27625595|NCT00542386|80473350|FG005|Overall Study|Protocol Violation|4|||
27625596|NCT00542386|80473345|FG000|Overall Study|Withdrawal by Subject|5|||
27625597|NCT00542386|80473346|FG001|Overall Study|Withdrawal by Subject|8|||
27625598|NCT00542386|80473347|FG002|Overall Study|Withdrawal by Subject|10|||
27625599|NCT00542386|80473348|FG003|Overall Study|Withdrawal by Subject|11|||
27625600|NCT00542386|80473349|FG004|Overall Study|Withdrawal by Subject|15|||
27625601|NCT00542386|80473350|FG005|Overall Study|Withdrawal by Subject|7|||
27625602|NCT00542386|80473345|FG000|Overall Study|Other Reasons|4|||
27625603|NCT00542386|80473346|FG001|Overall Study|Other Reasons|1|||
27529574|NCT00495131|80132403|FG001|Overall Study|Withdrawal by Subject|0|||
27529575|NCT00920907|80132404|FG000|Induction Period|Adverse Event|0|||
27625604|NCT00542386|80473347|FG002|Overall Study|Other Reasons|4|||
27625605|NCT00542386|80473348|FG003|Overall Study|Other Reasons|3|||
27625606|NCT00542386|80473349|FG004|Overall Study|Other Reasons|4|||
27625607|NCT00542386|80473350|FG005|Overall Study|Other Reasons|2|||
27625608|NCT01769391|80473351|FG000|Overall Study|Death|10|||
27625609|NCT01769391|80473352|FG001|Overall Study|Death|1|||
27625610|NCT01769391|80473351|FG000|Overall Study|Adverse Event|0|||
27625611|NCT01769391|80473352|FG001|Overall Study|Adverse Event|3|||
27625612|NCT01769391|80473351|FG000|Overall Study|Progressive Disease|1|||
27625613|NCT01769391|80473352|FG001|Overall Study|Progressive Disease|2|||
27625614|NCT01769391|80473351|FG000|Overall Study|Withdrawal by Subject|4|||
27625615|NCT01769391|80473352|FG001|Overall Study|Withdrawal by Subject|3|||
27625616|NCT01769391|80473351|FG000|Overall Study|Investigator Decision|2|||
27529576|NCT00920907|80132405|FG001|Induction Period|Adverse Event|2|||
27529577|NCT00920907|80132404|FG000|Induction Period|Death|1|||
27529578|NCT00920907|80132405|FG001|Induction Period|Death|1|||
27625617|NCT01769391|80473352|FG001|Overall Study|Investigator Decision|0|||
27625618|NCT00349908|80473355|FG000|Overall Study|Withdrawal by Subject|0|||
27625619|NCT00349908|80473356|FG001|Overall Study|Withdrawal by Subject|4|||
27625620|NCT03368001|80473358|FG000|Allocation|Lost to Pretest|16|||
27625621|NCT03368001|80473359|FG001|Allocation|Lost to Pretest|25|||
27625622|NCT03368001|80473358|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
27625623|NCT03368001|80473359|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
27625624|NCT03368001|80473358|FG000|Posttest|Lost to Posttest|7|||
27625625|NCT03368001|80473359|FG001|Posttest|Lost to Posttest|11|||
27625626|NCT03368001|80473358|FG000|Posttest|Discontinued Intervention|6|||
27625627|NCT03368001|80473359|FG001|Posttest|Discontinued Intervention|19|||
27625628|NCT03368001|80473358|FG000|Follow-up|Lost to Follow-up|6|||
27625629|NCT03368001|80473359|FG001|Follow-up|Lost to Follow-up|3|||
27625630|NCT01474538|80473362|FG000|Treatment Period 1|Death|1|||
27625631|NCT01474538|80473363|FG001|Treatment Period 1|Death|0|||
27625632|NCT01474538|80473362|FG000|Treatment Period 1|Physician Decision|1|||
27625633|NCT01474538|80473363|FG001|Treatment Period 1|Physician Decision|0|||
27625634|NCT01474538|80473362|FG000|Treatment Period 1|Withdrawal by Subject|1|||
27625635|NCT01474538|80473363|FG001|Treatment Period 1|Withdrawal by Subject|3|||
27625636|NCT01474538|80473362|FG000|Treatment Period 1|Protocol Violation|0|||
27529579|NCT00920907|80132404|FG000|Induction Period|Disease Progression|12|||
27529580|NCT00920907|80132405|FG001|Induction Period|Disease Progression|11|||
27529581|NCT00920907|80132404|FG000|Induction Period|Study Drug Toxicity|8|||
27529582|NCT00920907|80132405|FG001|Induction Period|Study Drug Toxicity|6|||
27529583|NCT00920907|80132404|FG000|Induction Period|No longer meets study criteria|0|||
27529584|NCT00920907|80132405|FG001|Induction Period|No longer meets study criteria|1|||
27529585|NCT00920907|80132404|FG000|Induction Period|Withdrawal by Subject|1|||
27529586|NCT00920907|80132405|FG001|Induction Period|Withdrawal by Subject|1|||
27529587|NCT00920907|80132404|FG000|Maintenance Period|Disease Progression|3|||
27529588|NCT00920907|80132405|FG001|Maintenance Period|Disease Progression|7|||
27529589|NCT00920907|80132404|FG000|Maintenance Period|Administrative (study closure)|7|||
27529590|NCT00920907|80132405|FG001|Maintenance Period|Administrative (study closure)|2|||
27529591|NCT00920907|80132404|FG000|Maintenance Period|Study Drug Toxicity|0|||
27529592|NCT00920907|80132405|FG001|Maintenance Period|Study Drug Toxicity|2|||
27529593|NCT00920907|80132404|FG000|Maintenance Period|Death|1|||
27529594|NCT00920907|80132405|FG001|Maintenance Period|Death|1|||
27529595|NCT00920907|80132404|FG000|Maintenance Period|Withdrawal by Subject|1|||
27529596|NCT00920907|80132405|FG001|Maintenance Period|Withdrawal by Subject|0|||
27529597|NCT00920907|80132404|FG000|Maintenance Period|Adverse Event|0|||
27529598|NCT00920907|80132405|FG001|Maintenance Period|Adverse Event|1|||
27625637|NCT01474538|80473363|FG001|Treatment Period 1|Protocol Violation|1|||
27625638|NCT01474538|80473362|FG000|Treatment Period 2|Death|1|||
27625639|NCT01474538|80473363|FG001|Treatment Period 2|Death|0|||
27625640|NCT01474538|80473362|FG000|Treatment Period 2|Adverse Event|1|||
27529599|NCT02961218|80132406|FG000|Overall Study|Lost to Follow-up|0|||
27529600|NCT02961218|80132407|FG001|Overall Study|Lost to Follow-up|2|||
27529601|NCT02961218|80132406|FG000|Overall Study|Physician Decision|0|||
27529602|NCT02961218|80132407|FG001|Overall Study|Physician Decision|2|||
27529603|NCT02961218|80132406|FG000|Overall Study|Subject/Guardian Decision|3|||
27529604|NCT02961218|80132407|FG001|Overall Study|Subject/Guardian Decision|1|||
27529605|NCT01606254|80132408|FG000|Overall Study|Withdrawal by Subject|1|||
27625641|NCT01474538|80473363|FG001|Treatment Period 2|Adverse Event|1|||
27625642|NCT01474538|80473362|FG000|Treatment Period 2|Withdrawal by Subject|2|||
27625643|NCT01474538|80473363|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27625644|NCT01474538|80473362|FG000|Treatment Period 2|Sponsor decision|1|||
27625645|NCT01474538|80473363|FG001|Treatment Period 2|Sponsor decision|0|||
27625646|NCT01474538|80473362|FG000|Treatment Period 2|Physician Decision|0|||
27625647|NCT01474538|80473363|FG001|Treatment Period 2|Physician Decision|1|||
27625648|NCT01474538|80473362|FG000|Treatment Period 2|Protocol Violation|1|||
27625649|NCT01474538|80473363|FG001|Treatment Period 2|Protocol Violation|0|||
27625650|NCT02781584|80473364|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
27625651|NCT02781584|80473365|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
27625652|NCT02781584|80473366|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
27625653|NCT02781584|80473367|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
27625654|NCT02781584|80473368|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
27625655|NCT02781584|80473369|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
27625656|NCT02781584|80473370|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
27625657|NCT02781584|80473371|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
27625658|NCT02781584|80473372|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
27625659|NCT02781584|80473373|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
27625660|NCT02781584|80473374|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
27625661|NCT02781584|80473375|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
27625662|NCT02781584|80473376|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
27625663|NCT02781584|80473364|FG000|Pre-treatment Phase|Adverse Event|0|||
27625664|NCT02781584|80473365|FG001|Pre-treatment Phase|Adverse Event|0|||
27625665|NCT02781584|80473366|FG002|Pre-treatment Phase|Adverse Event|0|||
27625666|NCT02781584|80473367|FG003|Pre-treatment Phase|Adverse Event|0|||
27625667|NCT02781584|80473368|FG004|Pre-treatment Phase|Adverse Event|0|||
27625668|NCT02781584|80473369|FG005|Pre-treatment Phase|Adverse Event|0|||
27625669|NCT02781584|80473370|FG006|Pre-treatment Phase|Adverse Event|0|||
27625670|NCT02781584|80473371|FG007|Pre-treatment Phase|Adverse Event|0|||
27625671|NCT02781584|80473372|FG008|Pre-treatment Phase|Adverse Event|0|||
27625672|NCT02781584|80473373|FG009|Pre-treatment Phase|Adverse Event|0|||
27625673|NCT02781584|80473374|FG010|Pre-treatment Phase|Adverse Event|0|||
27625674|NCT02781584|80473375|FG011|Pre-treatment Phase|Adverse Event|1|||
27625675|NCT02781584|80473376|FG012|Pre-treatment Phase|Adverse Event|0|||
27625676|NCT02781584|80473364|FG000|Treatment Phase|Withdrew Consent|0|||
27625677|NCT02781584|80473365|FG001|Treatment Phase|Withdrew Consent|0|||
27625678|NCT02781584|80473366|FG002|Treatment Phase|Withdrew Consent|0|||
27625679|NCT02781584|80473367|FG003|Treatment Phase|Withdrew Consent|0|||
27625680|NCT02781584|80473368|FG004|Treatment Phase|Withdrew Consent|0|||
27625681|NCT02781584|80473369|FG005|Treatment Phase|Withdrew Consent|1|||
27625682|NCT02781584|80473370|FG006|Treatment Phase|Withdrew Consent|0|||
27625683|NCT02781584|80473371|FG007|Treatment Phase|Withdrew Consent|0|||
27625684|NCT02781584|80473372|FG008|Treatment Phase|Withdrew Consent|0|||
27625685|NCT02781584|80473373|FG009|Treatment Phase|Withdrew Consent|0|||
27625686|NCT02781584|80473374|FG010|Treatment Phase|Withdrew Consent|1|||
27625687|NCT02781584|80473375|FG011|Treatment Phase|Withdrew Consent|2|||
27625688|NCT02781584|80473376|FG012|Treatment Phase|Withdrew Consent|0|||
27625689|NCT02781584|80473364|FG000|Treatment Phase|Adverse Event|0|||
27625690|NCT02781584|80473365|FG001|Treatment Phase|Adverse Event|0|||
27625691|NCT02781584|80473366|FG002|Treatment Phase|Adverse Event|0|||
27625692|NCT02781584|80473367|FG003|Treatment Phase|Adverse Event|0|||
27625693|NCT02781584|80473368|FG004|Treatment Phase|Adverse Event|0|||
27625694|NCT02781584|80473369|FG005|Treatment Phase|Adverse Event|0|||
27625695|NCT02781584|80473370|FG006|Treatment Phase|Adverse Event|0|||
27625696|NCT02781584|80473371|FG007|Treatment Phase|Adverse Event|1|||
27625697|NCT02781584|80473372|FG008|Treatment Phase|Adverse Event|0|||
27625698|NCT02781584|80473373|FG009|Treatment Phase|Adverse Event|0|||
27625699|NCT02781584|80473374|FG010|Treatment Phase|Adverse Event|0|||
27625700|NCT02781584|80473375|FG011|Treatment Phase|Adverse Event|0|||
27625701|NCT02781584|80473376|FG012|Treatment Phase|Adverse Event|0|||
27625702|NCT03721016|80473377|FG000|Overall Study|Adverse Event|0|||
27625703|NCT03721016|80473378|FG001|Overall Study|Adverse Event|1|||
27625704|NCT03721016|80473379|FG002|Overall Study|Adverse Event|1|||
27625705|NCT03721016|80473377|FG000|Overall Study|Withdrawal by Subject|8|||
27734566|NCT05900115|80853656|FG001|Overall Study|Lost to Follow-up|98|||
27734567|NCT02318602|80853659|FG000|Overall Study|Adverse Event|0|||
27625706|NCT03721016|80473378|FG001|Overall Study|Withdrawal by Subject|16|||
27625707|NCT03721016|80473379|FG002|Overall Study|Withdrawal by Subject|13|||
27625708|NCT03721016|80473377|FG000|Overall Study|Lost to Follow-up|4|||
27856513|NCT02516553|81306777|FG008|Overall Study|other reasons than listed|1|||
27856514|NCT02516553|81306778|FG009|Overall Study|other reasons than listed|0|||
27625709|NCT03721016|80473378|FG001|Overall Study|Lost to Follow-up|6|||
27625710|NCT03721016|80473379|FG002|Overall Study|Lost to Follow-up|5|||
27625711|NCT03721016|80473377|FG000|Overall Study|Physician Decision|0|||
27625712|NCT03721016|80473378|FG001|Overall Study|Physician Decision|1|||
27625713|NCT03721016|80473379|FG002|Overall Study|Physician Decision|2|||
27625714|NCT03721016|80473377|FG000|Overall Study|Protocol Violation|0|||
27625715|NCT03721016|80473378|FG001|Overall Study|Protocol Violation|1|||
27625716|NCT03721016|80473379|FG002|Overall Study|Protocol Violation|0|||
27625717|NCT03721016|80473377|FG000|Overall Study|Site terminated by sponsor|3|||
27625718|NCT03721016|80473378|FG001|Overall Study|Site terminated by sponsor|7|||
27625719|NCT03721016|80473379|FG002|Overall Study|Site terminated by sponsor|6|||
27625720|NCT03721016|80473377|FG000|Overall Study|Subject exited early due to COVID-19|1|||
27625721|NCT03721016|80473378|FG001|Overall Study|Subject exited early due to COVID-19|0|||
27625722|NCT03721016|80473379|FG002|Overall Study|Subject exited early due to COVID-19|0|||
27625723|NCT03425539|80473380|FG000|Overall Study|Randomized but not treated|0|||
27625724|NCT03425539|80473381|FG001|Overall Study|Randomized but not treated|1|||
27625725|NCT03425539|80473380|FG000|Overall Study|Adverse Event|2|||
27625726|NCT03425539|80473381|FG001|Overall Study|Adverse Event|2|||
27625727|NCT03425539|80473380|FG000|Overall Study|Withdrawal by Subject|3|||
27625728|NCT03425539|80473381|FG001|Overall Study|Withdrawal by Subject|0|||
27625729|NCT03425539|80473380|FG000|Overall Study|Lost to Follow-up|0|||
27625730|NCT03425539|80473381|FG001|Overall Study|Lost to Follow-up|1|||
27625731|NCT01124162|80473382|FG000|First Intervention|Adverse Event|2|||
27625732|NCT01124162|80473383|FG001|First Intervention|Adverse Event|0|||
27625733|NCT01124162|80473382|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27625734|NCT01124162|80473383|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27625735|NCT04927975|80473384|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
27625736|NCT04927975|80473385|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
27625737|NCT04927975|80473386|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
27625738|NCT04927975|80473387|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
27625739|NCT04927975|80473388|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
27625740|NCT04927975|80473389|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
27625741|NCT04927975|80473384|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
27625742|NCT04927975|80473385|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
27625743|NCT04927975|80473386|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
27625744|NCT04927975|80473387|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
27625745|NCT04927975|80473388|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
27625746|NCT04927975|80473389|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
27625747|NCT04927975|80473384|FG000|Period 1 (Baseline-Week 24)|Death|0|||
27625748|NCT04927975|80473385|FG001|Period 1 (Baseline-Week 24)|Death|0|||
27625749|NCT04927975|80473386|FG002|Period 1 (Baseline-Week 24)|Death|0|||
27625750|NCT04927975|80473387|FG003|Period 1 (Baseline-Week 24)|Death|0|||
27625751|NCT04927975|80473388|FG004|Period 1 (Baseline-Week 24)|Death|0|||
27734568|NCT02318602|80853660|FG001|Overall Study|Adverse Event|1|||
27734569|NCT02318602|80853661|FG002|Overall Study|Adverse Event|1|||
27856515|NCT02516553|81306779|FG010|Overall Study|other reasons than listed|1|||
27856516|NCT02516553|81306780|FG011|Overall Study|other reasons than listed|1|||
27529606|NCT01606254|80132409|FG001|Overall Study|Withdrawal by Subject|3|||
27529607|NCT01606254|80132410|FG002|Overall Study|Withdrawal by Subject|0|||
27529608|NCT01606254|80132411|FG003|Overall Study|Withdrawal by Subject|2|||
27529609|NCT01606254|80132408|FG000|Overall Study|Adverse Event|1|||
27529610|NCT01606254|80132409|FG001|Overall Study|Adverse Event|1|||
27529611|NCT01606254|80132410|FG002|Overall Study|Adverse Event|0|||
27529612|NCT01606254|80132411|FG003|Overall Study|Adverse Event|1|||
27529613|NCT02821910|80132412|FG000|Overall Study|Withdrawal by Subject|0|||
27529614|NCT02821910|80132413|FG001|Overall Study|Withdrawal by Subject|0|||
27529615|NCT02821910|80132414|FG002|Overall Study|Withdrawal by Subject|1|||
27529616|NCT02821910|80132415|FG003|Overall Study|Withdrawal by Subject|0|||
27529617|NCT02821910|80132416|FG004|Overall Study|Withdrawal by Subject|0|||
27529618|NCT02821910|80132417|FG005|Overall Study|Withdrawal by Subject|1|||
27529619|NCT02821910|80132412|FG000|Overall Study|Other than specified|1|||
27529620|NCT02821910|80132413|FG001|Overall Study|Other than specified|0|||
27529621|NCT02821910|80132414|FG002|Overall Study|Other than specified|1|||
27529622|NCT02821910|80132415|FG003|Overall Study|Other than specified|0|||
27529623|NCT02821910|80132416|FG004|Overall Study|Other than specified|0|||
27529624|NCT02821910|80132417|FG005|Overall Study|Other than specified|0|||
27529625|NCT01933789|80132418|FG000|Overall Study|Death|0|||
27529626|NCT01933789|80132419|FG001|Overall Study|Death|0|||
27529627|NCT01933789|80132420|FG002|Overall Study|Death|0|||
27529628|NCT01933789|80132421|FG003|Overall Study|Death|0|||
27529629|NCT01933789|80132422|FG004|Overall Study|Death|21|||
27529630|NCT01933789|80132423|FG005|Overall Study|Death|32|||
27529631|NCT01933789|80132424|FG006|Overall Study|Death|0|||
27529632|NCT01933789|80132425|FG007|Overall Study|Death|0|||
27529633|NCT01933789|80132426|FG008|Overall Study|Death|0|||
27529634|NCT01933789|80132418|FG000|Overall Study|Lost to Follow-up|0|||
27529635|NCT01933789|80132419|FG001|Overall Study|Lost to Follow-up|0|||
27529636|NCT01933789|80132420|FG002|Overall Study|Lost to Follow-up|0|||
27529637|NCT01933789|80132421|FG003|Overall Study|Lost to Follow-up|1|||
27529638|NCT01933789|80132422|FG004|Overall Study|Lost to Follow-up|8|||
27529639|NCT01933789|80132423|FG005|Overall Study|Lost to Follow-up|9|||
27529640|NCT01933789|80132424|FG006|Overall Study|Lost to Follow-up|1|||
27529641|NCT01933789|80132425|FG007|Overall Study|Lost to Follow-up|4|||
27529642|NCT01933789|80132426|FG008|Overall Study|Lost to Follow-up|0|||
27529643|NCT01933789|80132418|FG000|Overall Study|Withdrawal by Subject|2|||
27529644|NCT01933789|80132419|FG001|Overall Study|Withdrawal by Subject|1|||
27529645|NCT01933789|80132420|FG002|Overall Study|Withdrawal by Subject|0|||
27529646|NCT01933789|80132421|FG003|Overall Study|Withdrawal by Subject|0|||
27734570|NCT02318602|80853659|FG000|Overall Study|Withdrawal by Subject|0|||
27734571|NCT02318602|80853660|FG001|Overall Study|Withdrawal by Subject|3|||
27734572|NCT02318602|80853661|FG002|Overall Study|Withdrawal by Subject|0|||
27734573|NCT02318602|80853659|FG000|Overall Study|Death|1|||
27734574|NCT02318602|80853660|FG001|Overall Study|Death|0|||
27734575|NCT02318602|80853661|FG002|Overall Study|Death|0|||
27734576|NCT02318602|80853659|FG000|Overall Study|Guardian decision to withdraw|0|||
27734577|NCT02318602|80853660|FG001|Overall Study|Guardian decision to withdraw|0|||
27734578|NCT02318602|80853661|FG002|Overall Study|Guardian decision to withdraw|1|||
27734579|NCT01254344|80853662|FG000|Overall Study|Adverse Event|2|||
27734580|NCT01254344|80853663|FG001|Overall Study|Adverse Event|5|||
27734581|NCT01254344|80853662|FG000|Overall Study|Physician Decision|7|||
27734582|NCT01254344|80853663|FG001|Overall Study|Physician Decision|4|||
27734583|NCT01254344|80853662|FG000|Overall Study|Protocol Violation|1|||
27734584|NCT01254344|80853663|FG001|Overall Study|Protocol Violation|4|||
27734585|NCT01254344|80853662|FG000|Overall Study|Withdrawal by Subject|3|||
27734586|NCT01254344|80853663|FG001|Overall Study|Withdrawal by Subject|6|||
27734587|NCT00002850|80857051|FG000|Overall Study|Death|4|||
27734588|NCT00002850|80857052|FG001|Overall Study|Death|1|||
27734589|NCT00002850|80857053|FG002|Overall Study|Death|3|||
27734590|NCT00002850|80857051|FG000|Overall Study|Protocol Violation|1|||
27734591|NCT00002850|80857052|FG001|Overall Study|Protocol Violation|0|||
27734592|NCT00002850|80857053|FG002|Overall Study|Protocol Violation|1|||
27734593|NCT00002850|80857051|FG000|Overall Study|Withdrawal by Subject|0|||
27734594|NCT00002850|80857052|FG001|Overall Study|Withdrawal by Subject|1|||
27734595|NCT00002850|80857053|FG002|Overall Study|Withdrawal by Subject|0|||
27734596|NCT01028352|80857062|FG000|Overall Study|Ineligible due to baseline average pain|5|||
27734597|NCT01028352|80857062|FG000|Overall Study|Withdrawal by Subject|1|||
27734598|NCT04429022|80857063|FG000|Overall Study|Protocol Violation|18|||
27734599|NCT04429022|80857064|FG001|Overall Study|Protocol Violation|1|||
27734600|NCT03417440|80857065|FG000|Overall Study|Lost to Follow-up|0|||
27734601|NCT03417440|80857066|FG001|Overall Study|Lost to Follow-up|1|||
27734602|NCT03417440|80857067|FG002|Overall Study|Lost to Follow-up|0|||
27734603|NCT03417440|80857068|FG003|Overall Study|Lost to Follow-up|0|||
27734604|NCT03417440|80857069|FG004|Overall Study|Lost to Follow-up|1|||
27734605|NCT03417440|80857070|FG005|Overall Study|Lost to Follow-up|0|||
27734606|NCT03417440|80857071|FG006|Overall Study|Lost to Follow-up|0|||
27734607|NCT03417440|80857072|FG007|Overall Study|Lost to Follow-up|0|||
27734608|NCT03417440|80857065|FG000|Overall Study|Withdrawal by Subject|2|||
27734609|NCT03417440|80857066|FG001|Overall Study|Withdrawal by Subject|0|||
27734610|NCT03417440|80857067|FG002|Overall Study|Withdrawal by Subject|2|||
27734611|NCT03417440|80857068|FG003|Overall Study|Withdrawal by Subject|1|||
27734612|NCT03417440|80857069|FG004|Overall Study|Withdrawal by Subject|1|||
27734613|NCT03417440|80857070|FG005|Overall Study|Withdrawal by Subject|0|||
27734614|NCT03417440|80857071|FG006|Overall Study|Withdrawal by Subject|0|||
27734615|NCT03417440|80857072|FG007|Overall Study|Withdrawal by Subject|1|||
27734616|NCT00900796|80857073|FG000|Phase 1|Lacked sufficient information|4|||
27734617|NCT00900796|80857073|FG000|Phase 1|Missing information at Week 16|7|||
27734618|NCT00900796|80857073|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
27734619|NCT00900796|80857073|FG000|Phase 2|Lost to Follow-up|5|||
27734620|NCT03075839|80857074|FG000|Overall Study|Lost to Follow-up|4|||
27734621|NCT02504541|80857075|FG000|Overall Study|Adverse Event|4|||
27734622|NCT02504541|80857075|FG000|Overall Study|Withdrawal by Subject|4|||
27734623|NCT02504541|80857075|FG000|Overall Study|Lost to Follow-up|1|||
27734624|NCT02504541|80857075|FG000|Overall Study|Met Stopping Criteria|1|||
27734625|NCT02504541|80857075|FG000|Overall Study|Protocol Violation|2|||
27734626|NCT02504541|80857075|FG000|Overall Study|Termination by Sponsor|1|||
27734627|NCT02504541|80857075|FG000|Overall Study|Other|2|||
27734628|NCT02504541|80857075|FG000|Overall Study|Multiple|5|||
27734629|NCT02360098|80857077|FG000|Overall Study|Physician Decision|7|||
27734630|NCT03668223|80857078|FG000|Overall Study|Death|10|||
27734631|NCT03668223|80857079|FG001|Overall Study|Death|5|||
27734632|NCT03668223|80857078|FG000|Overall Study|Lost to Follow-up|12|||
27734633|NCT03668223|80857079|FG001|Overall Study|Lost to Follow-up|12|||
27734634|NCT03668223|80857078|FG000|Overall Study|Withdrawal by Subject|8|||
27734635|NCT03668223|80857079|FG001|Overall Study|Withdrawal by Subject|3|||
27734636|NCT01491178|80857082|FG000|Overall Study|Adverse Event|1016|||
27734637|NCT01491178|80857082|FG000|Overall Study|Improvement of NVAF|210|||
27734638|NCT01491178|80857082|FG000|Overall Study|To conduct invasive treatment|59|||
27734639|NCT01491178|80857082|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
27734640|NCT01491178|80857082|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
27734641|NCT01491178|80857082|FG000|Overall Study|To take a contraindication|20|||
27734642|NCT01491178|80857082|FG000|Overall Study|Other than specified above|657|||
27734643|NCT01607892|80857084|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
27734644|NCT01607892|80857085|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
27734645|NCT01607892|80857086|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
27734646|NCT01607892|80857087|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
27734647|NCT01607892|80857088|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
27734648|NCT01607892|80857084|FG000|Overall Study|Death|4|||
27734649|NCT01607892|80857085|FG001|Overall Study|Death|2|||
27734650|NCT01607892|80857086|FG002|Overall Study|Death|8|||
27734651|NCT01607892|80857087|FG003|Overall Study|Death|10|||
27734652|NCT01607892|80857088|FG004|Overall Study|Death|3|||
27734653|NCT01607892|80857084|FG000|Overall Study|Investigator discretion|2|||
27734654|NCT01607892|80857085|FG001|Overall Study|Investigator discretion|4|||
27734655|NCT01607892|80857086|FG002|Overall Study|Investigator discretion|4|||
27734656|NCT01607892|80857087|FG003|Overall Study|Investigator discretion|8|||
27734657|NCT01607892|80857088|FG004|Overall Study|Investigator discretion|0|||
27734658|NCT01607892|80857084|FG000|Overall Study|Other treatments became available|1|||
27734659|NCT01607892|80857085|FG001|Overall Study|Other treatments became available|1|||
27734660|NCT01607892|80857086|FG002|Overall Study|Other treatments became available|0|||
27734661|NCT01607892|80857087|FG003|Overall Study|Other treatments became available|0|||
27734662|NCT01607892|80857088|FG004|Overall Study|Other treatments became available|2|||
27734663|NCT01607892|80857084|FG000|Overall Study|Intercurrent illness|1|||
27734664|NCT01607892|80857085|FG001|Overall Study|Intercurrent illness|0|||
27734665|NCT01607892|80857086|FG002|Overall Study|Intercurrent illness|0|||
27734666|NCT01607892|80857087|FG003|Overall Study|Intercurrent illness|3|||
27734667|NCT01607892|80857088|FG004|Overall Study|Intercurrent illness|0|||
27734668|NCT01607892|80857084|FG000|Overall Study|Non-Compliance with study procedures|0|||
27734669|NCT01607892|80857085|FG001|Overall Study|Non-Compliance with study procedures|0|||
27734670|NCT01607892|80857086|FG002|Overall Study|Non-Compliance with study procedures|1|||
27734671|NCT01607892|80857087|FG003|Overall Study|Non-Compliance with study procedures|0|||
27734672|NCT01607892|80857088|FG004|Overall Study|Non-Compliance with study procedures|0|||
27734673|NCT01607892|80857084|FG000|Overall Study|Consent withdrawn by participant|9|||
27734674|NCT01607892|80857085|FG001|Overall Study|Consent withdrawn by participant|4|||
27734675|NCT01607892|80857086|FG002|Overall Study|Consent withdrawn by participant|24|||
27734676|NCT01607892|80857087|FG003|Overall Study|Consent withdrawn by participant|14|||
27734677|NCT01607892|80857088|FG004|Overall Study|Consent withdrawn by participant|4|||
27734678|NCT01607892|80857084|FG000|Overall Study|Disease progression|38|||
27734679|NCT01607892|80857085|FG001|Overall Study|Disease progression|13|||
27734680|NCT01607892|80857086|FG002|Overall Study|Disease progression|37|||
27734681|NCT01607892|80857087|FG003|Overall Study|Disease progression|57|||
27734682|NCT01607892|80857088|FG004|Overall Study|Disease progression|9|||
27734683|NCT01607892|80857084|FG000|Overall Study|Incidence or severity of Adverse events|3|||
27734684|NCT01607892|80857085|FG001|Overall Study|Incidence or severity of Adverse events|3|||
27734685|NCT01607892|80857086|FG002|Overall Study|Incidence or severity of Adverse events|7|||
27734686|NCT01607892|80857087|FG003|Overall Study|Incidence or severity of Adverse events|2|||
27734687|NCT01607892|80857088|FG004|Overall Study|Incidence or severity of Adverse events|6|||
27734688|NCT03245814|80857089|FG000|Overall Study|Lost to Follow-up|5|||
27734689|NCT03245814|80857090|FG001|Overall Study|Lost to Follow-up|8|||
27734690|NCT03245814|80857089|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
27734691|NCT03245814|80857090|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
27734692|NCT00618722|80857091|FG000|Overall Study|Refusal of Treatment|0|||
27734693|NCT00618722|80857092|FG001|Overall Study|Refusal of Treatment|0|||
27734694|NCT00618722|80857093|FG002|Overall Study|Refusal of Treatment|1|||
27734695|NCT00618722|80857094|FG003|Overall Study|Refusal of Treatment|0|||
27734696|NCT00618722|80857091|FG000|Overall Study|Patient Request|1|||
27734697|NCT00618722|80857092|FG001|Overall Study|Patient Request|1|||
27734698|NCT00618722|80857093|FG002|Overall Study|Patient Request|1|||
27734699|NCT00618722|80857094|FG003|Overall Study|Patient Request|1|||
27734700|NCT00618722|80857091|FG000|Overall Study|Inability to Complete Study Procedure|0|||
27734701|NCT00618722|80857092|FG001|Overall Study|Inability to Complete Study Procedure|1|||
27734702|NCT00618722|80857093|FG002|Overall Study|Inability to Complete Study Procedure|0|||
27734703|NCT00618722|80857094|FG003|Overall Study|Inability to Complete Study Procedure|0|||
27734704|NCT00618722|80857091|FG000|Overall Study|Lost to Follow-up|2|||
27734705|NCT00618722|80857092|FG001|Overall Study|Lost to Follow-up|0|||
27734706|NCT00618722|80857093|FG002|Overall Study|Lost to Follow-up|0|||
27734707|NCT00618722|80857094|FG003|Overall Study|Lost to Follow-up|2|||
27734708|NCT00618722|80857091|FG000|Overall Study|Miscellaneous Reasons|0|||
27734709|NCT00618722|80857092|FG001|Overall Study|Miscellaneous Reasons|0|||
27734710|NCT00618722|80857093|FG002|Overall Study|Miscellaneous Reasons|1|||
27529647|NCT01933789|80132422|FG004|Overall Study|Withdrawal by Subject|17|||
27529648|NCT01933789|80132423|FG005|Overall Study|Withdrawal by Subject|16|||
27734711|NCT00618722|80857094|FG003|Overall Study|Miscellaneous Reasons|1|||
27529649|NCT01933789|80132424|FG006|Overall Study|Withdrawal by Subject|1|||
27734712|NCT00817414|80857095|FG000|Overall Study|Adverse Event|1|||
27529650|NCT01933789|80132425|FG007|Overall Study|Withdrawal by Subject|4|||
27529651|NCT01933789|80132426|FG008|Overall Study|Withdrawal by Subject|0|||
27529652|NCT01933789|80132418|FG000|Overall Study|Became Ineligible|4|||
27734713|NCT00817414|80857096|FG001|Overall Study|Adverse Event|1|||
27734714|NCT00817414|80857097|FG002|Overall Study|Adverse Event|1|||
27734715|NCT00817414|80857098|FG003|Overall Study|Adverse Event|0|||
27734716|NCT00817414|80857099|FG004|Overall Study|Adverse Event|0|||
27734717|NCT00817414|80857095|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
27734718|NCT00817414|80857096|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
27734719|NCT00817414|80857097|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
27734720|NCT00817414|80857098|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
27734721|NCT00817414|80857099|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
27734722|NCT00817414|80857095|FG000|Overall Study|Withdrawal by Subject|1|||
27912009|NCT00490971|81518072|FG000|Acute/Continuation|Adverse Event|62|||
27912010|NCT00490971|81518073|FG001|Acute/Continuation|Adverse Event|13|||
27912011|NCT00490971|81518074|FG002|Acute/Continuation|Adverse Event|0|||
27912012|NCT00490971|81518075|FG003|Acute/Continuation|Adverse Event|0|||
27912013|NCT00490971|81518076|FG004|Acute/Continuation|Adverse Event|0|||
27912014|NCT00490971|81518072|FG000|Acute/Continuation|Death|2|||
27912015|NCT00490971|81518073|FG001|Acute/Continuation|Death|0|||
27912016|NCT00490971|81518074|FG002|Acute/Continuation|Death|0|||
27912017|NCT00490971|81518075|FG003|Acute/Continuation|Death|0|||
27912018|NCT00490971|81518076|FG004|Acute/Continuation|Death|0|||
27912019|NCT00490971|81518072|FG000|Acute/Continuation|Lack of Efficacy|106|||
27912020|NCT00490971|81518073|FG001|Acute/Continuation|Lack of Efficacy|12|||
27912021|NCT00490971|81518074|FG002|Acute/Continuation|Lack of Efficacy|0|||
27912022|NCT00490971|81518075|FG003|Acute/Continuation|Lack of Efficacy|0|||
27912023|NCT00490971|81518076|FG004|Acute/Continuation|Lack of Efficacy|0|||
27912024|NCT00490971|81518072|FG000|Acute/Continuation|Lost to Follow-up|23|||
27912025|NCT00490971|81518073|FG001|Acute/Continuation|Lost to Follow-up|7|||
27912026|NCT00490971|81518074|FG002|Acute/Continuation|Lost to Follow-up|0|||
27912027|NCT00490971|81518075|FG003|Acute/Continuation|Lost to Follow-up|0|||
27912028|NCT00490971|81518076|FG004|Acute/Continuation|Lost to Follow-up|0|||
27912029|NCT00490971|81518072|FG000|Acute/Continuation|Protocol Violation|10|||
27912030|NCT00490971|81518073|FG001|Acute/Continuation|Protocol Violation|2|||
27912031|NCT00490971|81518074|FG002|Acute/Continuation|Protocol Violation|0|||
27912032|NCT00490971|81518075|FG003|Acute/Continuation|Protocol Violation|0|||
27912033|NCT00490971|81518076|FG004|Acute/Continuation|Protocol Violation|0|||
27912034|NCT00490971|81518072|FG000|Acute/Continuation|Withdrawal by Subject|92|||
27912035|NCT00490971|81518073|FG001|Acute/Continuation|Withdrawal by Subject|24|||
27912036|NCT00490971|81518074|FG002|Acute/Continuation|Withdrawal by Subject|0|||
27912037|NCT00490971|81518075|FG003|Acute/Continuation|Withdrawal by Subject|0|||
27912038|NCT00490971|81518076|FG004|Acute/Continuation|Withdrawal by Subject|0|||
27912039|NCT00490971|81518072|FG000|Acute/Continuation|Other|11|||
27912040|NCT00490971|81518073|FG001|Acute/Continuation|Other|4|||
27912041|NCT00490971|81518074|FG002|Acute/Continuation|Other|0|||
27912042|NCT00490971|81518075|FG003|Acute/Continuation|Other|0|||
27912043|NCT00490971|81518076|FG004|Acute/Continuation|Other|0|||
27912044|NCT00490971|81518072|FG000|Maintenance|Adverse Event|0|||
27912045|NCT00490971|81518073|FG001|Maintenance|Adverse Event|0|||
27912046|NCT00490971|81518074|FG002|Maintenance|Adverse Event|4|||
27912047|NCT00490971|81518075|FG003|Maintenance|Adverse Event|5|||
27912048|NCT00490971|81518076|FG004|Maintenance|Adverse Event|7|||
27912049|NCT00490971|81518072|FG000|Maintenance|Death|0|||
27529653|NCT01933789|80132419|FG001|Overall Study|Became Ineligible|0|||
27529654|NCT01933789|80132420|FG002|Overall Study|Became Ineligible|0|||
27529655|NCT01933789|80132421|FG003|Overall Study|Became Ineligible|0|||
27529656|NCT01933789|80132422|FG004|Overall Study|Became Ineligible|13|||
27734723|NCT00817414|80857096|FG001|Overall Study|Withdrawal by Subject|1|||
27734724|NCT00817414|80857097|FG002|Overall Study|Withdrawal by Subject|0|||
27734725|NCT00817414|80857098|FG003|Overall Study|Withdrawal by Subject|0|||
27734726|NCT00817414|80857099|FG004|Overall Study|Withdrawal by Subject|0|||
27734727|NCT00817414|80857095|FG000|Overall Study|Lost to Follow-up|0|||
27734728|NCT00817414|80857096|FG001|Overall Study|Lost to Follow-up|0|||
27734729|NCT00817414|80857097|FG002|Overall Study|Lost to Follow-up|1|||
27734730|NCT00817414|80857098|FG003|Overall Study|Lost to Follow-up|1|||
27734731|NCT00817414|80857099|FG004|Overall Study|Lost to Follow-up|1|||
27734732|NCT00817414|80857095|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27912050|NCT00490971|81518073|FG001|Maintenance|Death|0|||
27912051|NCT00490971|81518074|FG002|Maintenance|Death|0|||
27912052|NCT00490971|81518075|FG003|Maintenance|Death|2|||
27912053|NCT00490971|81518076|FG004|Maintenance|Death|0|||
27734733|NCT00817414|80857096|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27734734|NCT00817414|80857097|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27912054|NCT00490971|81518072|FG000|Maintenance|Lost to Follow-up|0|||
27625752|NCT04927975|80473389|FG005|Period 1 (Baseline-Week 24)|Death|1|||
27625753|NCT04927975|80473384|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
27912055|NCT00490971|81518073|FG001|Maintenance|Lost to Follow-up|0|||
27912056|NCT00490971|81518074|FG002|Maintenance|Lost to Follow-up|5|||
27529657|NCT01933789|80132423|FG005|Overall Study|Became Ineligible|10|||
27912057|NCT00490971|81518075|FG003|Maintenance|Lost to Follow-up|8|||
27912058|NCT00490971|81518076|FG004|Maintenance|Lost to Follow-up|10|||
27912059|NCT00490971|81518072|FG000|Maintenance|Pregnancy|0|||
27734735|NCT00817414|80857098|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
27734736|NCT00817414|80857099|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
27734737|NCT00817414|80857095|FG000|Overall Study|Protocol Violation|0|||
27734738|NCT00817414|80857096|FG001|Overall Study|Protocol Violation|0|||
27734739|NCT00817414|80857097|FG002|Overall Study|Protocol Violation|0|||
27734740|NCT00817414|80857098|FG003|Overall Study|Protocol Violation|0|||
27734741|NCT00817414|80857099|FG004|Overall Study|Protocol Violation|1|||
27734742|NCT03459040|80857100|FG000|Overall Study|Death|8|||
27734743|NCT03459040|80857100|FG000|Overall Study|Withdrawal by Subject|1|||
27734744|NCT02582671|80857101|FG000|Overall Study|Failure to return|1|||
27734745|NCT02582671|80857101|FG000|Overall Study|Other, not specified|1|||
27734746|NCT01925703|80857102|FG000|Overall Study|Physician Decision|1|||
27734747|NCT01925703|80857102|FG000|Overall Study|Lost to Follow-up|2|||
27734748|NCT01925703|80857102|FG000|Overall Study|Discharge prior to full iron repletion|1|||
27734749|NCT01390389|80857103|FG000|Overall Study|Withdrawal by Subject|2|||
27734750|NCT01390389|80857104|FG001|Overall Study|Withdrawal by Subject|0|||
27734751|NCT01390389|80857103|FG000|Overall Study|Screen Fail|2|||
27734752|NCT01390389|80857104|FG001|Overall Study|Screen Fail|1|||
27734753|NCT04488822|80857107|FG000|Overall Study|Adverse Event|8|||
27734754|NCT04488822|80857107|FG000|Overall Study|Withdrawal by Subject|1|||
27734755|NCT03106779|80857108|FG000|Overall Study|Lack of Efficacy|33|||
27734756|NCT03106779|80857109|FG001|Overall Study|Lack of Efficacy|24|||
27734757|NCT03106779|80857108|FG000|Overall Study|Adverse Event|8|||
27734758|NCT03106779|80857109|FG001|Overall Study|Adverse Event|16|||
27734759|NCT03106779|80857108|FG000|Overall Study|Physician Decision|10|||
27734760|NCT03106779|80857109|FG001|Overall Study|Physician Decision|6|||
27734761|NCT03106779|80857108|FG000|Overall Study|Patient/guardian decision|4|||
27734762|NCT03106779|80857109|FG001|Overall Study|Patient/guardian decision|3|||
27734763|NCT03106779|80857108|FG000|Overall Study|Progressive disease|1|||
27734764|NCT03106779|80857109|FG001|Overall Study|Progressive disease|3|||
27734765|NCT03106779|80857108|FG000|Overall Study|Lost to Follow-up|1|||
27734766|NCT03106779|80857109|FG001|Overall Study|Lost to Follow-up|2|||
27734767|NCT03106779|80857108|FG000|Overall Study|Death|1|||
27734768|NCT03106779|80857109|FG001|Overall Study|Death|0|||
27734769|NCT03106779|80857108|FG000|Overall Study|Protocol Violation|1|||
27734770|NCT03106779|80857109|FG001|Overall Study|Protocol Violation|0|||
27734771|NCT03106779|80857108|FG000|Overall Study|Not treated|1|||
27734772|NCT03106779|80857109|FG001|Overall Study|Not treated|0|||
27734773|NCT03138564|80857118|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
27734774|NCT03138564|80857119|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
27734775|NCT03138564|80857118|FG000|Overall Study|Lost to Follow-up|16|||
27734776|NCT03138564|80857119|FG001|Overall Study|Lost to Follow-up|2|||
27734777|NCT03138564|80857118|FG000|Overall Study|Withdrawal by Subject|48|||
27734778|NCT03138564|80857119|FG001|Overall Study|Withdrawal by Subject|4|||
27734779|NCT03138564|80857118|FG000|Overall Study|No longer met eligibility criteria|2|||
27734780|NCT03138564|80857119|FG001|Overall Study|No longer met eligibility criteria|0|||
27734781|NCT03138564|80857118|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
27734782|NCT03138564|80857119|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
27734783|NCT03138564|80857118|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
27734784|NCT03138564|80857119|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
27625754|NCT04927975|80473385|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
27625755|NCT04927975|80473386|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
27625756|NCT04927975|80473387|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
27625757|NCT04927975|80473388|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
27625758|NCT04927975|80473389|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
27625759|NCT04927975|80473384|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
27625760|NCT04927975|80473385|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
27625761|NCT04927975|80473386|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
27625762|NCT04927975|80473387|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
27625763|NCT04927975|80473388|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
27625764|NCT04927975|80473389|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
27625765|NCT03302156|80473390|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
27625766|NCT03302156|80473391|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
27625767|NCT03302156|80473392|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
27625768|NCT01119950|80473393|FG000|Overall Study|Adverse Event|25|||
27625769|NCT01119950|80473393|FG000|Overall Study|Withdrawal by Subject|9|||
27625770|NCT01119950|80473393|FG000|Overall Study|Protocol Violation|5|||
27625771|NCT01119950|80473393|FG000|Overall Study|Lost to Follow-up|4|||
27625772|NCT01119950|80473393|FG000|Overall Study|Administrative|2|||
27625773|NCT01119950|80473393|FG000|Overall Study|Abnormal lab value|1|||
27625774|NCT01119950|80473393|FG000|Overall Study|Death|1|||
27734785|NCT03138564|80857118|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
27734786|NCT03138564|80857119|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
27734787|NCT03138564|80857118|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
27912060|NCT00490971|81518073|FG001|Maintenance|Pregnancy|0|||
27912061|NCT00490971|81518074|FG002|Maintenance|Pregnancy|1|||
27912062|NCT00490971|81518075|FG003|Maintenance|Pregnancy|0|||
27912063|NCT00490971|81518076|FG004|Maintenance|Pregnancy|0|||
27912064|NCT00490971|81518072|FG000|Maintenance|Protocol Violation|0|||
27912065|NCT00490971|81518073|FG001|Maintenance|Protocol Violation|0|||
27912066|NCT00490971|81518074|FG002|Maintenance|Protocol Violation|4|||
27912067|NCT00490971|81518075|FG003|Maintenance|Protocol Violation|1|||
27912068|NCT00490971|81518076|FG004|Maintenance|Protocol Violation|1|||
27912069|NCT00490971|81518072|FG000|Maintenance|Withdrawal by Subject|0|||
27912070|NCT00490971|81518073|FG001|Maintenance|Withdrawal by Subject|0|||
27529658|NCT01933789|80132424|FG006|Overall Study|Became Ineligible|13|||
27529659|NCT01933789|80132425|FG007|Overall Study|Became Ineligible|6|||
27529660|NCT01933789|80132426|FG008|Overall Study|Became Ineligible|0|||
27529661|NCT02537574|80132431|FG000|Overall Study|Adverse Event|1|||
27529662|NCT02537574|80132432|FG001|Overall Study|Adverse Event|3|||
27529663|NCT02537574|80132433|FG002|Overall Study|Adverse Event|2|||
27529664|NCT02537574|80132431|FG000|Overall Study|Lost to Follow-up|40|||
27529665|NCT02537574|80132432|FG001|Overall Study|Lost to Follow-up|51|||
27529666|NCT02537574|80132433|FG002|Overall Study|Lost to Follow-up|55|||
27529667|NCT02537574|80132431|FG000|Overall Study|Noncompliance with study drug|0|||
27529668|NCT02537574|80132432|FG001|Overall Study|Noncompliance with study drug|1|||
27529669|NCT02537574|80132433|FG002|Overall Study|Noncompliance with study drug|1|||
27529670|NCT02537574|80132431|FG000|Overall Study|Physician Decision|2|||
27529671|NCT02537574|80132432|FG001|Overall Study|Physician Decision|0|||
27529672|NCT02537574|80132433|FG002|Overall Study|Physician Decision|0|||
27529673|NCT02537574|80132431|FG000|Overall Study|Protocol Violation|4|||
27529674|NCT02537574|80132432|FG001|Overall Study|Protocol Violation|2|||
27529675|NCT02537574|80132433|FG002|Overall Study|Protocol Violation|3|||
27529676|NCT02537574|80132431|FG000|Overall Study|Withdrawal by Subject|37|||
27529677|NCT02537574|80132432|FG001|Overall Study|Withdrawal by Subject|27|||
27529678|NCT02537574|80132433|FG002|Overall Study|Withdrawal by Subject|29|||
27529679|NCT02537574|80132431|FG000|Overall Study|Lack of Efficacy|14|||
27529680|NCT02537574|80132432|FG001|Overall Study|Lack of Efficacy|16|||
27529681|NCT02537574|80132433|FG002|Overall Study|Lack of Efficacy|15|||
27529682|NCT02537574|80132431|FG000|Overall Study|Duplicate Patient|1|||
27529683|NCT02537574|80132432|FG001|Overall Study|Duplicate Patient|0|||
27529684|NCT02537574|80132433|FG002|Overall Study|Duplicate Patient|0|||
27529685|NCT02537574|80132431|FG000|Overall Study|Patient not Stable|0|||
27529686|NCT02537574|80132432|FG001|Overall Study|Patient not Stable|1|||
27529687|NCT02537574|80132433|FG002|Overall Study|Patient not Stable|0|||
27529688|NCT02537574|80132431|FG000|Overall Study|Incarceration|0|||
27529689|NCT02537574|80132432|FG001|Overall Study|Incarceration|1|||
27529690|NCT02537574|80132433|FG002|Overall Study|Incarceration|0|||
27529691|NCT02537574|80132431|FG000|Overall Study|Failed Naloxone Challenge|0|||
27529692|NCT02537574|80132432|FG001|Overall Study|Failed Naloxone Challenge|1|||
27529693|NCT02537574|80132433|FG002|Overall Study|Failed Naloxone Challenge|0|||
27529694|NCT02537574|80132431|FG000|Overall Study|Transportation Issues|0|||
27529695|NCT02537574|80132432|FG001|Overall Study|Transportation Issues|0|||
27529696|NCT02537574|80132433|FG002|Overall Study|Transportation Issues|1|||
27529697|NCT02537574|80132431|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
27625775|NCT02908464|80473394|FG000|Overall Study|Withdrawal by Subject|2|||
27625776|NCT02908464|80473395|FG001|Overall Study|Withdrawal by Subject|1|||
27625777|NCT02908464|80473394|FG000|Overall Study|Found ineligible after randomization|0|||
27625778|NCT02908464|80473395|FG001|Overall Study|Found ineligible after randomization|2|||
27625779|NCT00049517|80473396|FG000|Induction|Disease progression|0|||
27625780|NCT00049517|80473397|FG001|Induction|Disease progression|0|||
27625781|NCT00049517|80473398|FG002|Induction|Disease progression|0|||
27625782|NCT00049517|80473399|FG003|Induction|Disease progression|0|||
27625783|NCT00049517|80473400|FG004|Induction|Disease progression|18|||
27625784|NCT00049517|80473401|FG005|Induction|Disease progression|11|||
27912071|NCT00490971|81518074|FG002|Maintenance|Withdrawal by Subject|26|||
27912072|NCT00490971|81518075|FG003|Maintenance|Withdrawal by Subject|28|||
27529698|NCT02537574|80132432|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
27529699|NCT02537574|80132433|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
27625785|NCT00049517|80473396|FG000|Induction|Adverse Event|0|||
27625786|NCT00049517|80473397|FG001|Induction|Adverse Event|0|||
27625787|NCT00049517|80473398|FG002|Induction|Adverse Event|0|||
27625788|NCT00049517|80473399|FG003|Induction|Adverse Event|0|||
27625789|NCT00049517|80473400|FG004|Induction|Adverse Event|5|||
27912073|NCT00490971|81518076|FG004|Maintenance|Withdrawal by Subject|18|||
27912074|NCT00490971|81518072|FG000|Maintenance|Other|0|||
27529700|NCT02537574|80132431|FG000|Overall Study|Noncompliance with Protocol|0|||
27529701|NCT02537574|80132432|FG001|Overall Study|Noncompliance with Protocol|0|||
27529702|NCT02537574|80132433|FG002|Overall Study|Noncompliance with Protocol|1|||
27529703|NCT01962922|80132436|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
27625790|NCT00049517|80473401|FG005|Induction|Adverse Event|7|||
27912075|NCT00490971|81518073|FG001|Maintenance|Other|0|||
27912076|NCT00490971|81518074|FG002|Maintenance|Other|11|||
27912077|NCT00490971|81518075|FG003|Maintenance|Other|9|||
27734788|NCT03138564|80857119|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
27734789|NCT00140855|80857125|FG000|Overall Study|Progressive disease|2|||
27734790|NCT00629083|80857126|FG000|Overall Study|Adverse Event|0|||
27734791|NCT00629083|80857127|FG001|Overall Study|Adverse Event|2|||
27734792|NCT00629083|80857126|FG000|Overall Study|Lack of Efficacy|3|||
27734793|NCT00629083|80857127|FG001|Overall Study|Lack of Efficacy|1|||
27734794|NCT00629083|80857126|FG000|Overall Study|Withdrawal by Subject|10|||
27734795|NCT00629083|80857127|FG001|Overall Study|Withdrawal by Subject|2|||
27734796|NCT00629083|80857126|FG000|Overall Study|Lost to Follow-up|12|||
27734797|NCT00629083|80857127|FG001|Overall Study|Lost to Follow-up|8|||
27734798|NCT00629083|80857126|FG000|Overall Study|Moved out of country/state|2|||
27734799|NCT00629083|80857127|FG001|Overall Study|Moved out of country/state|1|||
27734800|NCT00629083|80857126|FG000|Overall Study|Refused to return for 12 month visit|1|||
27734801|NCT00629083|80857127|FG001|Overall Study|Refused to return for 12 month visit|0|||
27734802|NCT03874234|80857128|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734803|NCT03874234|80857129|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734804|NCT03874234|80857130|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734805|NCT03874234|80857131|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
27734806|NCT03874234|80857132|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734807|NCT03874234|80857133|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734808|NCT03874234|80857134|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734809|NCT03874234|80857135|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734810|NCT03874234|80857136|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734811|NCT03874234|80857137|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734812|NCT03874234|80857138|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27529704|NCT01962922|80132437|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
27529705|NCT01962922|80132436|FG000|PK Portion Day 7|non-compliance|1|||
27529706|NCT01962922|80132437|FG001|PK Portion Day 7|non-compliance|0|||
27529707|NCT01962922|80132436|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
27529708|NCT01962922|80132437|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
27529709|NCT01962922|80132436|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
27734813|NCT03874234|80857139|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734814|NCT03874234|80857140|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
27734815|NCT03874234|80857128|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
27734816|NCT03874234|80857129|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734817|NCT03874234|80857130|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734818|NCT03874234|80857131|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734819|NCT03874234|80857132|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734820|NCT03874234|80857133|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734821|NCT03874234|80857134|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734822|NCT03874234|80857135|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734823|NCT03874234|80857136|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734824|NCT03874234|80857137|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734825|NCT03874234|80857138|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734826|NCT03874234|80857139|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734827|NCT03874234|80857140|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
27734828|NCT03874234|80857128|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734829|NCT03874234|80857129|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734830|NCT03874234|80857130|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734831|NCT03874234|80857131|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
27734832|NCT03874234|80857132|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734833|NCT03874234|80857133|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734834|NCT03874234|80857134|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27856517|NCT02516553|81306781|FG012|Overall Study|other reasons than listed|0|||
27529710|NCT01962922|80132437|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
27529711|NCT01931202|80132441|FG000|Overall Study|Withdrawal by Subject|0|||
27529712|NCT01931202|80132442|FG001|Overall Study|Withdrawal by Subject|0|||
27529713|NCT01931202|80132443|FG002|Overall Study|Withdrawal by Subject|2|||
27529714|NCT01931202|80132441|FG000|Overall Study|Lost to Follow-up|0|||
27529715|NCT01931202|80132442|FG001|Overall Study|Lost to Follow-up|5|||
27529716|NCT01931202|80132443|FG002|Overall Study|Lost to Follow-up|2|||
27529717|NCT00095628|80132444|FG000|Overall Study|Disease progression prior to treatment|1|||
27529718|NCT00076024|80132446|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
27529719|NCT00076024|80132447|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
27734835|NCT03874234|80857135|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27529720|NCT00076024|80132448|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
27529721|NCT00076024|80132449|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
27529722|NCT00076024|80132446|FG000|Phase 1, Lead-in|Adverse Event|1|||
27734836|NCT03874234|80857136|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27856518|NCT02516553|81306782|FG013|Overall Study|other reasons than listed|0|||
27529723|NCT00076024|80132447|FG001|Phase 1, Lead-in|Adverse Event|0|||
27529724|NCT00076024|80132448|FG002|Phase 1, Lead-in|Adverse Event|0|||
27529725|NCT00076024|80132449|FG003|Phase 1, Lead-in|Adverse Event|0|||
27529726|NCT00076024|80132446|FG000|Phase 1, Lead-in|Clinical progression|1|||
27529727|NCT00076024|80132447|FG001|Phase 1, Lead-in|Clinical progression|0|||
27529728|NCT00076024|80132448|FG002|Phase 1, Lead-in|Clinical progression|0|||
27529729|NCT00076024|80132449|FG003|Phase 1, Lead-in|Clinical progression|0|||
27529730|NCT00076024|80132446|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
27529731|NCT00076024|80132447|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
27529732|NCT00076024|80132448|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
27529733|NCT00076024|80132449|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
27529734|NCT00076024|80132446|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
27529735|NCT00076024|80132447|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
27529736|NCT00076024|80132448|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
27529737|NCT00076024|80132449|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
27529738|NCT00076024|80132446|FG000|Phase 2, Double-blind|Adverse Event|0|||
27529739|NCT00076024|80132447|FG001|Phase 2, Double-blind|Adverse Event|25|||
27529740|NCT00076024|80132448|FG002|Phase 2, Double-blind|Adverse Event|6|||
27529741|NCT00076024|80132449|FG003|Phase 2, Double-blind|Adverse Event|0|||
27529742|NCT00076024|80132446|FG000|Phase 2, Double-blind|Un-specified|0|||
27529743|NCT00076024|80132447|FG001|Phase 2, Double-blind|Un-specified|14|||
27529744|NCT00076024|80132448|FG002|Phase 2, Double-blind|Un-specified|6|||
27529745|NCT00076024|80132449|FG003|Phase 2, Double-blind|Un-specified|0|||
27529746|NCT00076024|80132446|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
27529747|NCT00076024|80132447|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
27529748|NCT00076024|80132448|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
27529749|NCT00076024|80132449|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
27529750|NCT00076024|80132446|FG000|Phase 2, Open-label|Adverse Event|0|||
27529751|NCT00076024|80132447|FG001|Phase 2, Open-label|Adverse Event|0|||
27529752|NCT00076024|80132448|FG002|Phase 2, Open-label|Adverse Event|0|||
27529753|NCT00076024|80132449|FG003|Phase 2, Open-label|Adverse Event|2|||
27529754|NCT00076024|80132446|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
27529755|NCT00076024|80132447|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
27529756|NCT00076024|80132448|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
27529757|NCT00076024|80132449|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
27529758|NCT00076024|80132446|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
27529759|NCT00076024|80132447|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
27529760|NCT00076024|80132448|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
27529761|NCT00076024|80132449|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
27529762|NCT00076024|80132446|FG000|Phase 2, Open-label|Other|0|||
27529763|NCT00076024|80132447|FG001|Phase 2, Open-label|Other|0|||
27529764|NCT00076024|80132448|FG002|Phase 2, Open-label|Other|0|||
27529765|NCT00076024|80132449|FG003|Phase 2, Open-label|Other|2|||
27529766|NCT02676466|80132450|FG000|Overall Study|Death|0|||
27529767|NCT02676466|80132451|FG001|Overall Study|Death|2|||
27529768|NCT02676466|80132452|FG002|Overall Study|Death|1|||
27529769|NCT02676466|80132453|FG003|Overall Study|Death|0|||
27529770|NCT02676466|80132454|FG004|Overall Study|Death|0|||
27529771|NCT02676466|80132455|FG005|Overall Study|Death|0|||
27529772|NCT02676466|80132456|FG006|Overall Study|Death|0|||
27529773|NCT02676466|80132457|FG007|Overall Study|Death|0|||
27529774|NCT02676466|80132450|FG000|Overall Study|Withdrawal by Subject|4|||
27529775|NCT02676466|80132451|FG001|Overall Study|Withdrawal by Subject|3|||
27529776|NCT02676466|80132452|FG002|Overall Study|Withdrawal by Subject|1|||
27529777|NCT02676466|80132453|FG003|Overall Study|Withdrawal by Subject|0|||
27529778|NCT02676466|80132454|FG004|Overall Study|Withdrawal by Subject|3|||
27529779|NCT02676466|80132455|FG005|Overall Study|Withdrawal by Subject|1|||
27529780|NCT02676466|80132456|FG006|Overall Study|Withdrawal by Subject|1|||
27529781|NCT02676466|80132457|FG007|Overall Study|Withdrawal by Subject|1|||
27529782|NCT02425644|80132458|FG000|Overall Study|Lost to Follow-up|2|||
27529783|NCT02425644|80132459|FG001|Overall Study|Lost to Follow-up|3|||
27529784|NCT02425644|80132458|FG000|Overall Study|Withdrawal by Subject|41|||
27625791|NCT00049517|80473396|FG000|Induction|Death|0|||
27625792|NCT00049517|80473397|FG001|Induction|Death|0|||
27625793|NCT00049517|80473398|FG002|Induction|Death|0|||
27734837|NCT03874234|80857137|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734838|NCT03874234|80857138|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27856519|NCT02516553|81306783|FG014|Overall Study|other reasons than listed|0|||
27856520|NCT02516553|81306784|FG015|Overall Study|other reasons than listed|0|||
27529785|NCT02425644|80132459|FG001|Overall Study|Withdrawal by Subject|36|||
27529786|NCT02425644|80132458|FG000|Overall Study|Lack of Efficacy|3|||
27529787|NCT02425644|80132459|FG001|Overall Study|Lack of Efficacy|10|||
27529788|NCT02425644|80132458|FG000|Overall Study|Adverse Event|13|||
27529789|NCT02425644|80132459|FG001|Overall Study|Adverse Event|3|||
27529790|NCT02425644|80132458|FG000|Overall Study|Death|0|||
27529791|NCT02425644|80132459|FG001|Overall Study|Death|2|||
27529792|NCT02425644|80132458|FG000|Overall Study|Other|18|||
27529793|NCT02425644|80132459|FG001|Overall Study|Other|17|||
27625794|NCT00049517|80473399|FG003|Induction|Death|0|||
27529794|NCT02480712|80132460|FG000|Overall Study|Enrolled but Never Treated|1|||
27734839|NCT03874234|80857139|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734840|NCT03874234|80857140|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
27734841|NCT03874234|80857128|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734842|NCT03874234|80857129|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734843|NCT03874234|80857130|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734844|NCT03874234|80857131|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734845|NCT03874234|80857132|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
27734846|NCT03874234|80857133|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734847|NCT03874234|80857134|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734848|NCT03874234|80857135|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734849|NCT03874234|80857136|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734850|NCT03874234|80857137|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734851|NCT03874234|80857138|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734852|NCT03874234|80857139|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734853|NCT03874234|80857140|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
27734854|NCT03874234|80857128|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734855|NCT03874234|80857129|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27912078|NCT00490971|81518076|FG004|Maintenance|Other|3|||
27912079|NCT02250300|81518080|FG000|Expansion Phase|Death|6|||
27912080|NCT02250300|81518081|FG001|Expansion Phase|Death|7|||
27912081|NCT02250300|81518082|FG002|Expansion Phase|Death|0|||
27912082|NCT02250300|81518083|FG003|Expansion Phase|Death|0|||
27912083|NCT03755518|81518084|FG000|Overall Study|Adverse Event|6|||
27912084|NCT03755518|81518084|FG000|Overall Study|Lack of Efficacy|6|||
27912085|NCT03755518|81518084|FG000|Overall Study|Bone Marrow Transplant|4|||
27912086|NCT03755518|81518084|FG000|Overall Study|Withdrawal by participant|4|||
27912087|NCT03755518|81518084|FG000|Overall Study|Progressive Disease|2|||
27912088|NCT03755518|81518084|FG000|Overall Study|Death|1|||
27529795|NCT02480712|80132460|FG000|Overall Study|Lost to Follow-up|5|||
27734856|NCT03874234|80857130|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734857|NCT03874234|80857131|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734858|NCT03874234|80857132|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27529796|NCT02480712|80132460|FG000|Overall Study|Withdrew Consent|3|||
27529797|NCT02480712|80132460|FG000|Overall Study|Death|1|||
27529798|NCT02480712|80132460|FG000|Overall Study|Lack of Efficacy|1|||
27529799|NCT02284178|80132461|FG000|Overall Study|Met exclusion criteria|49|||
27529800|NCT02284178|80132462|FG001|Overall Study|Met exclusion criteria|54|||
27529801|NCT04163718|80132464|FG000|Overall Study|Study terminated|12|||
27529802|NCT00117286|80132471|FG000|Overall Study|Adverse Event|12|||
27734859|NCT03874234|80857133|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734860|NCT03874234|80857134|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734861|NCT03874234|80857135|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
27734862|NCT03874234|80857136|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734863|NCT03874234|80857137|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734864|NCT03874234|80857138|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734865|NCT03874234|80857139|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734866|NCT03874234|80857140|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
27734867|NCT03874234|80857128|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734868|NCT03874234|80857129|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734869|NCT03874234|80857130|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734870|NCT03874234|80857131|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734871|NCT03874234|80857132|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
27912089|NCT03755518|81518084|FG000|Overall Study|Physician Decision|1|||
27912090|NCT03755518|81518084|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
27912091|NCT01675492|81518085|FG000|Overall Study|study completed early - product approval|42|||
27529803|NCT00117286|80132472|FG001|Overall Study|Adverse Event|6|||
27529804|NCT00117286|80132471|FG000|Overall Study|Lost to Follow-up|2|||
27529805|NCT00117286|80132472|FG001|Overall Study|Lost to Follow-up|0|||
27529806|NCT00117286|80132471|FG000|Overall Study|Protocol Violation|3|||
27529807|NCT00117286|80132472|FG001|Overall Study|Protocol Violation|3|||
27529808|NCT00117286|80132471|FG000|Overall Study|Withdrawal by Subject|6|||
27529809|NCT00117286|80132472|FG001|Overall Study|Withdrawal by Subject|2|||
27529810|NCT00117286|80132471|FG000|Overall Study|Physician Decision|3|||
27529811|NCT00117286|80132472|FG001|Overall Study|Physician Decision|7|||
27529812|NCT00117286|80132471|FG000|Overall Study|Lack of Efficacy|2|||
27912092|NCT02291029|81518086|FG000|Overall Study|Withdrawal by Subject|0|||
27912093|NCT02291029|81518087|FG001|Overall Study|Withdrawal by Subject|0|||
27529813|NCT00117286|80132472|FG001|Overall Study|Lack of Efficacy|1|||
27529814|NCT00117286|80132471|FG000|Overall Study|Research site closing|0|||
27912094|NCT02291029|81518088|FG002|Overall Study|Withdrawal by Subject|1|||
27529815|NCT00117286|80132472|FG001|Overall Study|Research site closing|2|||
27625795|NCT00049517|80473400|FG004|Induction|Death|9|||
27625796|NCT00049517|80473401|FG005|Induction|Death|6|||
27625797|NCT00049517|80473396|FG000|Induction|Withdrawal by Subject|0|||
27625798|NCT00049517|80473397|FG001|Induction|Withdrawal by Subject|0|||
27625799|NCT00049517|80473398|FG002|Induction|Withdrawal by Subject|0|||
27625800|NCT00049517|80473399|FG003|Induction|Withdrawal by Subject|0|||
27625801|NCT00049517|80473400|FG004|Induction|Withdrawal by Subject|1|||
27625802|NCT00049517|80473401|FG005|Induction|Withdrawal by Subject|3|||
27625803|NCT00049517|80473396|FG000|Induction|Alternative therapy|0|||
27734872|NCT03874234|80857133|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
27734873|NCT03874234|80857134|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734874|NCT03874234|80857135|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734875|NCT03874234|80857136|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734876|NCT03874234|80857137|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27912095|NCT02291029|81518089|FG003|Overall Study|Withdrawal by Subject|0|||
27529816|NCT00504582|80132473|FG000|Overall Study|Lost to Follow-up|1|||
27625804|NCT00049517|80473397|FG001|Induction|Alternative therapy|0|||
27625805|NCT00049517|80473398|FG002|Induction|Alternative therapy|0|||
27625806|NCT00049517|80473399|FG003|Induction|Alternative therapy|0|||
27625807|NCT00049517|80473400|FG004|Induction|Alternative therapy|2|||
27625808|NCT00049517|80473401|FG005|Induction|Alternative therapy|2|||
27625809|NCT00049517|80473396|FG000|Induction|Other complicating disease|0|||
27625810|NCT00049517|80473397|FG001|Induction|Other complicating disease|0|||
27625811|NCT00049517|80473398|FG002|Induction|Other complicating disease|0|||
27625812|NCT00049517|80473399|FG003|Induction|Other complicating disease|0|||
27625813|NCT00049517|80473400|FG004|Induction|Other complicating disease|3|||
27625814|NCT00049517|80473401|FG005|Induction|Other complicating disease|0|||
27625815|NCT00049517|80473396|FG000|Induction|Reasons not reported|0|||
27625816|NCT00049517|80473397|FG001|Induction|Reasons not reported|0|||
27625817|NCT00049517|80473398|FG002|Induction|Reasons not reported|0|||
27625818|NCT00049517|80473399|FG003|Induction|Reasons not reported|0|||
27625819|NCT00049517|80473400|FG004|Induction|Reasons not reported|22|||
27625820|NCT00049517|80473401|FG005|Induction|Reasons not reported|25|||
27625821|NCT00049517|80473396|FG000|Conditioning/Transplant|Disease progression|14|||
27625822|NCT00049517|80473397|FG001|Conditioning/Transplant|Disease progression|6|||
27529817|NCT00504582|80132474|FG001|Overall Study|Lost to Follow-up|0|||
27529818|NCT00504582|80132475|FG002|Overall Study|Lost to Follow-up|0|||
27529819|NCT01467583|80132476|FG000|Overall Study|Death|1|||
27529820|NCT01467583|80132477|FG001|Overall Study|Death|1|||
27529821|NCT01467583|80132478|FG002|Overall Study|Death|0|||
27529822|NCT01467583|80132476|FG000|Overall Study|Withdrawal by Subject|1|||
27529823|NCT01467583|80132477|FG001|Overall Study|Withdrawal by Subject|0|||
27529824|NCT01467583|80132478|FG002|Overall Study|Withdrawal by Subject|0|||
27529825|NCT01467583|80132476|FG000|Overall Study|Protocol Violation|0|||
27529826|NCT01467583|80132477|FG001|Overall Study|Protocol Violation|0|||
27529827|NCT01467583|80132478|FG002|Overall Study|Protocol Violation|2|||
27529828|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
27529829|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
27529830|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
27529831|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
27529832|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27529833|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
27529834|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
27529835|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
27529836|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
27529837|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
27529838|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
27529839|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
27529840|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
27529841|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
27625823|NCT00049517|80473398|FG002|Conditioning/Transplant|Disease progression|10|||
27625824|NCT00049517|80473399|FG003|Conditioning/Transplant|Disease progression|6|||
27625825|NCT00049517|80473400|FG004|Conditioning/Transplant|Disease progression|0|||
27625826|NCT00049517|80473401|FG005|Conditioning/Transplant|Disease progression|0|||
27625827|NCT00049517|80473396|FG000|Conditioning/Transplant|Adverse Event|2|||
27625828|NCT00049517|80473397|FG001|Conditioning/Transplant|Adverse Event|1|||
27625829|NCT00049517|80473398|FG002|Conditioning/Transplant|Adverse Event|4|||
27734877|NCT03874234|80857138|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27529842|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
27529843|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
27529844|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Program Termination|3|||
27625830|NCT00049517|80473399|FG003|Conditioning/Transplant|Adverse Event|8|||
27625831|NCT00049517|80473400|FG004|Conditioning/Transplant|Adverse Event|0|||
27625832|NCT00049517|80473401|FG005|Conditioning/Transplant|Adverse Event|0|||
27625833|NCT00049517|80473396|FG000|Conditioning/Transplant|Death|1|||
27625834|NCT00049517|80473397|FG001|Conditioning/Transplant|Death|0|||
27625835|NCT00049517|80473398|FG002|Conditioning/Transplant|Death|0|||
27625836|NCT00049517|80473399|FG003|Conditioning/Transplant|Death|2|||
27625837|NCT00049517|80473400|FG004|Conditioning/Transplant|Death|0|||
27625838|NCT00049517|80473401|FG005|Conditioning/Transplant|Death|0|||
27625839|NCT00049517|80473396|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
27625840|NCT00049517|80473397|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
27625841|NCT00049517|80473398|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
27625842|NCT00049517|80473399|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
27625843|NCT00049517|80473400|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
27625844|NCT00049517|80473401|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
27625845|NCT00049517|80473396|FG000|Conditioning/Transplant|Alternative therapy|4|||
27625846|NCT00049517|80473397|FG001|Conditioning/Transplant|Alternative therapy|4|||
27625847|NCT00049517|80473398|FG002|Conditioning/Transplant|Alternative therapy|2|||
27625848|NCT00049517|80473399|FG003|Conditioning/Transplant|Alternative therapy|1|||
27625849|NCT00049517|80473400|FG004|Conditioning/Transplant|Alternative therapy|1|||
27625850|NCT00049517|80473401|FG005|Conditioning/Transplant|Alternative therapy|0|||
27625851|NCT00049517|80473396|FG000|Conditioning/Transplant|Other complicating disease|2|||
27625852|NCT00049517|80473397|FG001|Conditioning/Transplant|Other complicating disease|0|||
27625853|NCT00049517|80473398|FG002|Conditioning/Transplant|Other complicating disease|0|||
27625854|NCT00049517|80473399|FG003|Conditioning/Transplant|Other complicating disease|4|||
27625855|NCT00049517|80473400|FG004|Conditioning/Transplant|Other complicating disease|0|||
27625856|NCT00049517|80473401|FG005|Conditioning/Transplant|Other complicating disease|1|||
27625857|NCT00049517|80473396|FG000|Conditioning/Transplant|Reasons not reported|25|||
27625858|NCT00049517|80473397|FG001|Conditioning/Transplant|Reasons not reported|31|||
27625859|NCT00049517|80473398|FG002|Conditioning/Transplant|Reasons not reported|18|||
27625860|NCT00049517|80473399|FG003|Conditioning/Transplant|Reasons not reported|15|||
27625861|NCT00049517|80473400|FG004|Conditioning/Transplant|Reasons not reported|5|||
27625862|NCT00049517|80473401|FG005|Conditioning/Transplant|Reasons not reported|5|||
27625863|NCT03310983|80473402|FG000|Overall Study|Lost to Follow-up|15|||
27625864|NCT03310983|80473403|FG001|Overall Study|Lost to Follow-up|17|||
27625865|NCT00290706|80473405|FG000|Overall Study|Withdrawal by Subject|2|||
27625866|NCT00290706|80473406|FG001|Overall Study|Withdrawal by Subject|0|||
27625867|NCT00290706|80473407|FG002|Overall Study|Withdrawal by Subject|0|||
27625868|NCT00290706|80473408|FG003|Overall Study|Withdrawal by Subject|0|||
27625869|NCT00290706|80473405|FG000|Overall Study|Progressive Disease|3|||
27625870|NCT00290706|80473406|FG001|Overall Study|Progressive Disease|5|||
27529845|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Program Termination|0|||
27529846|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Program Termination|1|||
27529847|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Program Termination|1|||
27529848|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
27529849|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
27529850|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
27529851|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
27529852|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
27529853|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
27529854|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
27529855|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
27529856|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
27529857|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
27625871|NCT00290706|80473407|FG002|Overall Study|Progressive Disease|4|||
27625872|NCT00290706|80473408|FG003|Overall Study|Progressive Disease|10|||
27625873|NCT00290706|80473405|FG000|Overall Study|Adverse Event|0|||
27625874|NCT00290706|80473406|FG001|Overall Study|Adverse Event|1|||
27625875|NCT00290706|80473407|FG002|Overall Study|Adverse Event|2|||
27625876|NCT00290706|80473408|FG003|Overall Study|Adverse Event|0|||
27734878|NCT03874234|80857139|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27529858|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
27529859|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
27625877|NCT00290706|80473405|FG000|Overall Study|Receive auto transplant or radiation|0|||
27625878|NCT00290706|80473406|FG001|Overall Study|Receive auto transplant or radiation|0|||
27625879|NCT00290706|80473407|FG002|Overall Study|Receive auto transplant or radiation|0|||
27625880|NCT00290706|80473408|FG003|Overall Study|Receive auto transplant or radiation|1|||
27625881|NCT00290706|80473405|FG000|Overall Study|Physician Decision|0|||
27625882|NCT00290706|80473406|FG001|Overall Study|Physician Decision|0|||
27625883|NCT00290706|80473407|FG002|Overall Study|Physician Decision|0|||
27625884|NCT00290706|80473408|FG003|Overall Study|Physician Decision|1|||
27625885|NCT00282438|80473410|FG000|Overall Study|Lack of Efficacy|1|||
27625886|NCT00282438|80473411|FG001|Overall Study|Lack of Efficacy|0|||
27625887|NCT00282438|80473410|FG000|Overall Study|Death|0|||
27625888|NCT00282438|80473411|FG001|Overall Study|Death|1|||
27734879|NCT03874234|80857140|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
27734880|NCT03874234|80857128|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27625889|NCT00849147|80473412|FG000|Overall Study|Withdrawal by Subject|1|||
27625890|NCT00849147|80473412|FG000|Overall Study|Protocol Violation|2|||
27625891|NCT00849147|80473412|FG000|Overall Study|Disease Relapse/Progression|2|||
27625892|NCT02469064|80473413|FG000|Overall Study|Request not to receive intervention.|1|||
27625893|NCT02469064|80473414|FG001|Overall Study|Request not to receive intervention.|3|||
27625894|NCT02334306|80473415|FG000|Double-blind Period|Adverse Event|0|||
27625895|NCT02334306|80473416|FG001|Double-blind Period|Adverse Event|1|||
27625896|NCT02334306|80473415|FG000|Double-blind Period|Withdrawal by Subject|1|||
27625897|NCT02334306|80473416|FG001|Double-blind Period|Withdrawal by Subject|1|||
27625898|NCT01323660|80473417|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
27625899|NCT01323660|80473418|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
27625900|NCT01323660|80473419|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
27625901|NCT01323660|80473420|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
27625902|NCT01323660|80473421|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
27625903|NCT01323660|80473422|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
27625904|NCT01323660|80473417|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
27625905|NCT01323660|80473418|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
27625906|NCT01323660|80473419|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
27625907|NCT01323660|80473420|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
27625908|NCT01323660|80473421|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
27625909|NCT01323660|80473422|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
27625910|NCT01323660|80473417|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27625911|NCT01323660|80473418|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
27625912|NCT01323660|80473419|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27625913|NCT01323660|80473420|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27625914|NCT01323660|80473421|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
27625915|NCT01323660|80473422|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
27625916|NCT01323660|80473417|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27625917|NCT01323660|80473418|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27625918|NCT01323660|80473419|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27625919|NCT01323660|80473420|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27625920|NCT01323660|80473421|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
27625921|NCT01323660|80473422|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
27625922|NCT01323660|80473417|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27625923|NCT01323660|80473418|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27625924|NCT01323660|80473419|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27625925|NCT01323660|80473420|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27625926|NCT01323660|80473421|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
27625927|NCT01323660|80473422|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
27625928|NCT01323660|80473417|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
27625929|NCT01323660|80473418|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27625930|NCT01323660|80473419|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27625931|NCT01323660|80473420|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
27625932|NCT01323660|80473421|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
27625933|NCT01323660|80473422|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
27625934|NCT01323660|80473417|FG000|Washout Period (14 Days)|Adverse Event|0|||
27625935|NCT01323660|80473418|FG001|Washout Period (14 Days)|Adverse Event|0|||
27625936|NCT01323660|80473419|FG002|Washout Period (14 Days)|Adverse Event|0|||
27625937|NCT01323660|80473420|FG003|Washout Period (14 Days)|Adverse Event|0|||
27625938|NCT01323660|80473421|FG004|Washout Period (14 Days)|Adverse Event|1|||
27625939|NCT01323660|80473422|FG005|Washout Period (14 Days)|Adverse Event|0|||
27625940|NCT01323660|80473417|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
27625941|NCT01323660|80473418|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
27625942|NCT01323660|80473419|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
27625943|NCT01323660|80473420|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
27625944|NCT01323660|80473421|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
27625945|NCT01323660|80473422|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
27625946|NCT01323660|80473417|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27625947|NCT01323660|80473418|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27625948|NCT01323660|80473419|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
27625949|NCT01323660|80473420|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27625950|NCT01323660|80473421|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
27625951|NCT01323660|80473422|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
27625952|NCT01323660|80473417|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
27625953|NCT01323660|80473418|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
27625954|NCT01323660|80473419|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
27625955|NCT01323660|80473420|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
27625956|NCT01323660|80473421|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
27625957|NCT01323660|80473422|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
27625958|NCT01323660|80473417|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27529860|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
27529861|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
27529862|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
27529863|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
27529864|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
27529865|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
27529866|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
27529867|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
27529868|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
27529869|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
27529870|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
27529871|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
27529872|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
27529873|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
27529874|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
27529875|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
27529876|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
27529877|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
27529878|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
27529879|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
27529880|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
27529881|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
27529882|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
27529883|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
27529884|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
27529885|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
27529886|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
27529887|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
27529888|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
27529889|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
27529890|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
27529891|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
27529892|NCT03739840|80132485|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
27529893|NCT03739840|80132486|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
27529894|NCT03739840|80132487|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
27529895|NCT03739840|80132488|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
27529896|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
27529897|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
27529898|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
27529899|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
27529900|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
27529901|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
27625959|NCT01323660|80473418|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27625960|NCT01323660|80473419|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27625961|NCT01323660|80473420|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27625962|NCT01323660|80473421|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
27625963|NCT01323660|80473422|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
27625964|NCT01323660|80473417|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27625965|NCT01323660|80473418|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27625966|NCT01323660|80473419|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27625967|NCT01323660|80473420|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27625968|NCT01323660|80473421|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
27625969|NCT01323660|80473422|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
27625970|NCT01323660|80473417|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27625971|NCT01323660|80473418|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27625972|NCT01323660|80473419|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27625973|NCT01323660|80473420|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27625974|NCT01323660|80473421|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
27625975|NCT01323660|80473422|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27625976|NCT03736785|80473423|FG000|Overall Study|Adverse Event|1|||
27625977|NCT03736785|80473424|FG001|Overall Study|Adverse Event|1|||
27625978|NCT03736785|80473425|FG002|Overall Study|Adverse Event|1|||
27625979|NCT03736785|80473423|FG000|Overall Study|Death|1|||
27625980|NCT03736785|80473424|FG001|Overall Study|Death|0|||
27625981|NCT03736785|80473425|FG002|Overall Study|Death|1|||
27625982|NCT03736785|80473423|FG000|Overall Study|Lost to Follow-up|0|||
27625983|NCT03736785|80473424|FG001|Overall Study|Lost to Follow-up|2|||
27625984|NCT03736785|80473425|FG002|Overall Study|Lost to Follow-up|3|||
27625985|NCT03736785|80473423|FG000|Overall Study|Non compliance with study drug|1|||
27625986|NCT03736785|80473424|FG001|Overall Study|Non compliance with study drug|1|||
27625987|NCT03736785|80473425|FG002|Overall Study|Non compliance with study drug|0|||
27625988|NCT03736785|80473423|FG000|Overall Study|Physician Decision|0|||
27625989|NCT03736785|80473424|FG001|Overall Study|Physician Decision|1|||
27625990|NCT03736785|80473425|FG002|Overall Study|Physician Decision|1|||
27625991|NCT03736785|80473423|FG000|Overall Study|Protocol Violation|1|||
27625992|NCT03736785|80473424|FG001|Overall Study|Protocol Violation|4|||
27625993|NCT03736785|80473425|FG002|Overall Study|Protocol Violation|3|||
27625994|NCT03736785|80473423|FG000|Overall Study|Sponsor Decision|1|||
27625995|NCT03736785|80473424|FG001|Overall Study|Sponsor Decision|0|||
27625996|NCT03736785|80473425|FG002|Overall Study|Sponsor Decision|0|||
27625997|NCT03736785|80473423|FG000|Overall Study|Unknown/Missing data|3|||
27625998|NCT03736785|80473424|FG001|Overall Study|Unknown/Missing data|2|||
27625999|NCT03736785|80473425|FG002|Overall Study|Unknown/Missing data|1|||
27626000|NCT03736785|80473423|FG000|Overall Study|Withdrawal by Subject|9|||
27626001|NCT03736785|80473424|FG001|Overall Study|Withdrawal by Subject|6|||
27626002|NCT03736785|80473425|FG002|Overall Study|Withdrawal by Subject|4|||
27626003|NCT01240356|80473426|FG000|Overall Study|Withdrawal by Subject|2|||
27626004|NCT01240356|80473427|FG001|Overall Study|Withdrawal by Subject|0|||
27626005|NCT01240356|80473426|FG000|Overall Study|MRI contraindication|1|||
27626006|NCT01240356|80473427|FG001|Overall Study|MRI contraindication|0|||
27626007|NCT01414166|80473428|FG000|Overall Study|Adverse Event|10|||
27626008|NCT01414166|80473429|FG001|Overall Study|Adverse Event|2|||
27626009|NCT01414166|80473428|FG000|Overall Study|Lost to Follow-up|4|||
27626010|NCT01414166|80473429|FG001|Overall Study|Lost to Follow-up|1|||
27626011|NCT01414166|80473428|FG000|Overall Study|Non-compliance with study drug|2|||
27626012|NCT01414166|80473429|FG001|Overall Study|Non-compliance with study drug|0|||
27626013|NCT01414166|80473428|FG000|Overall Study|Physician Decision|2|||
27626014|NCT01414166|80473429|FG001|Overall Study|Physician Decision|0|||
27626015|NCT01414166|80473428|FG000|Overall Study|Protocol Violation|2|||
27626016|NCT01414166|80473429|FG001|Overall Study|Protocol Violation|0|||
27626017|NCT01414166|80473428|FG000|Overall Study|Study terminated by Sponsor|68|||
27626018|NCT01414166|80473429|FG001|Overall Study|Study terminated by Sponsor|75|||
27626019|NCT01414166|80473428|FG000|Overall Study|Withdrawal by Subject|3|||
27626020|NCT01414166|80473429|FG001|Overall Study|Withdrawal by Subject|5|||
27626021|NCT00093795|80473430|FG000|Overall Study|No follow up data|20|||
27626022|NCT00093795|80473431|FG001|Overall Study|No follow up data|16|||
27626023|NCT00093795|80473432|FG002|Overall Study|No follow up data|17|||
27626024|NCT03523091|80473433|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
27626025|NCT03523091|80473434|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
27626026|NCT03523091|80473433|FG000|Overall Study|Withdrawal by Subject|0|||
27626027|NCT03523091|80473434|FG001|Overall Study|Withdrawal by Subject|3|||
27626028|NCT03523091|80473433|FG000|Overall Study|Increase Botox dose|0|||
27626029|NCT03523091|80473434|FG001|Overall Study|Increase Botox dose|1|||
27626030|NCT04536077|80473435|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
27626031|NCT04536077|80473436|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
27734881|NCT03874234|80857129|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27734882|NCT03874234|80857130|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27734883|NCT03874234|80857131|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27912096|NCT02291029|81518090|FG004|Overall Study|Withdrawal by Subject|0|||
27912097|NCT02291029|81518091|FG005|Overall Study|Withdrawal by Subject|0|||
27912098|NCT02291029|81518086|FG000|Overall Study|Adverse Event|0|||
27912099|NCT02291029|81518087|FG001|Overall Study|Adverse Event|1|||
27912100|NCT02291029|81518088|FG002|Overall Study|Adverse Event|0|||
27912101|NCT02291029|81518089|FG003|Overall Study|Adverse Event|0|||
27912102|NCT02291029|81518090|FG004|Overall Study|Adverse Event|0|||
27529902|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
27529903|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
27529904|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
27529905|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
27529906|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
27529907|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
27529908|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
27529909|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
27529910|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
27529911|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
27529912|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
27529913|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
27529914|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
27529915|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
27529916|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
27529917|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
27529918|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
27529919|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
27529920|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
27529921|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
27529922|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
27529923|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
27529924|NCT03739840|80132485|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
27529925|NCT03739840|80132486|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
27529926|NCT03739840|80132487|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
27529927|NCT03739840|80132488|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
27529928|NCT03224546|80132489|FG000|Overall Study|Lost to Follow-up|9|||
27529929|NCT03224546|80132490|FG001|Overall Study|Lost to Follow-up|8|||
27529930|NCT03224546|80132491|FG002|Overall Study|Lost to Follow-up|3|||
27529931|NCT03224546|80132489|FG000|Overall Study|Withdrawal by Subject|7|||
27529932|NCT03224546|80132490|FG001|Overall Study|Withdrawal by Subject|14|||
27529933|NCT03224546|80132491|FG002|Overall Study|Withdrawal by Subject|12|||
27529934|NCT02435069|80132492|FG000|Dose Response - First Intervention|Adverse Event|0|||
27529935|NCT02435069|80132493|FG001|Dose Response - First Intervention|Adverse Event|1|||
27529936|NCT02435069|80132494|FG002|Dose Response - First Intervention|Adverse Event|1|||
27529937|NCT02435069|80132495|FG003|Dose Response - First Intervention|Adverse Event|0|||
27529938|NCT02435069|80132496|FG004|Dose Response - First Intervention|Adverse Event|0|||
27529939|NCT02435069|80132492|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27529940|NCT02435069|80132493|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27529941|NCT02435069|80132494|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27529942|NCT02435069|80132495|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
27529943|NCT02435069|80132496|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
27529944|NCT00772070|80132497|FG000|Overall Study|Lost to Follow-up|0|||
27529945|NCT00772070|80132498|FG001|Overall Study|Lost to Follow-up|8|||
27529946|NCT00772070|80132497|FG000|Overall Study|Withdrawal by Subject|0|||
27529947|NCT00772070|80132498|FG001|Overall Study|Withdrawal by Subject|2|||
27529948|NCT00772070|80132497|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
27529949|NCT00772070|80132498|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
27529950|NCT01314911|80132499|FG000|Overall Study|Lost to Follow-up|3|||
27529951|NCT01314911|80132500|FG001|Overall Study|Lost to Follow-up|2|||
27529952|NCT01314911|80132499|FG000|Overall Study|Withdrawal by Subject|1|||
27529953|NCT01314911|80132500|FG001|Overall Study|Withdrawal by Subject|3|||
27529954|NCT01314911|80132499|FG000|Overall Study|Received Non-randomized Study Drug|0|||
27734884|NCT03874234|80857132|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27734885|NCT03874234|80857133|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27734886|NCT03874234|80857134|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
27734887|NCT03874234|80857135|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27734888|NCT03874234|80857136|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27912103|NCT02291029|81518091|FG005|Overall Study|Adverse Event|0|||
27734889|NCT03874234|80857137|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27529955|NCT01314911|80132500|FG001|Overall Study|Received Non-randomized Study Drug|1|||
27529956|NCT01314911|80132499|FG000|Overall Study|Never Started Treatment|1|||
27529957|NCT01314911|80132500|FG001|Overall Study|Never Started Treatment|0|||
27529958|NCT01336569|80132501|FG000|Overall Study|Lost to Follow-up|4|||
27529959|NCT03882008|80132507|FG000|Overall Study|Withdrawal by Subject|1|||
27529960|NCT03882008|80132507|FG000|Overall Study|Lost to Follow-up|1|||
27529961|NCT02059005|80132508|FG000|Overall Study|Death|1|||
27529962|NCT02059005|80132509|FG001|Overall Study|Death|3|||
27529963|NCT02059005|80132508|FG000|Overall Study|Lost to Follow-up|19|||
27529964|NCT02059005|80132509|FG001|Overall Study|Lost to Follow-up|19|||
27529965|NCT02059005|80132508|FG000|Overall Study|Incarceration|0|||
27529966|NCT02059005|80132509|FG001|Overall Study|Incarceration|1|||
27529967|NCT02059005|80132508|FG000|Overall Study|Inpatient|0|||
27529968|NCT02059005|80132509|FG001|Overall Study|Inpatient|1|||
27529969|NCT00989573|80134737|FG000|Overall Study|Adverse Event|8|||
27529970|NCT00989573|80134738|FG001|Overall Study|Adverse Event|12|||
27529971|NCT00989573|80134739|FG002|Overall Study|Adverse Event|4|||
27529972|NCT00989573|80134737|FG000|Overall Study|Physician Decision|0|||
27529973|NCT00989573|80134738|FG001|Overall Study|Physician Decision|2|||
27529974|NCT00989573|80134739|FG002|Overall Study|Physician Decision|0|||
27529975|NCT00989573|80134737|FG000|Overall Study|Protocol Violation|1|||
27529976|NCT00989573|80134738|FG001|Overall Study|Protocol Violation|1|||
27529977|NCT00989573|80134739|FG002|Overall Study|Protocol Violation|1|||
27529978|NCT00989573|80134737|FG000|Overall Study|Withdrawal by Subject|4|||
27529979|NCT00989573|80134738|FG001|Overall Study|Withdrawal by Subject|7|||
27529980|NCT00989573|80134739|FG002|Overall Study|Withdrawal by Subject|3|||
27529981|NCT01756300|80134742|FG000|Overall Study|Death|1|||
27529982|NCT01756300|80134742|FG000|Overall Study|Withdrawal by Subject|1|||
27529983|NCT01278160|80134746|FG000|Overall Study|Adverse Event|1|||
27529984|NCT01278160|80134747|FG001|Overall Study|Adverse Event|1|||
27529985|NCT01278160|80134746|FG000|Overall Study|Lost to Follow-up|0|||
27529986|NCT01278160|80134747|FG001|Overall Study|Lost to Follow-up|1|||
27529987|NCT01278160|80134746|FG000|Overall Study|Withdrawal by Subject|3|||
27529988|NCT01278160|80134747|FG001|Overall Study|Withdrawal by Subject|2|||
27529989|NCT01278160|80134746|FG000|Overall Study|Unclassified|1|||
27529990|NCT01278160|80134747|FG001|Overall Study|Unclassified|2|||
27529991|NCT02581943|80134748|FG000|Overall Study|Death|5|||
27529992|NCT02581943|80134749|FG001|Overall Study|Death|2|||
27529993|NCT02581943|80134748|FG000|Overall Study|Disease Progression|12|||
27529994|NCT02581943|80134749|FG001|Overall Study|Disease Progression|15|||
27529995|NCT02581943|80134748|FG000|Overall Study|Withdrawal by Subject|1|||
27529996|NCT02581943|80134749|FG001|Overall Study|Withdrawal by Subject|2|||
27529997|NCT02028871|80134756|FG000|Overall Study|Positive urine drug screen|1|||
27529998|NCT02028871|80134757|FG001|Overall Study|Positive urine drug screen|1|||
27529999|NCT02028871|80134756|FG000|Overall Study|Withdrawal by Subject|1|||
27530000|NCT02028871|80134757|FG001|Overall Study|Withdrawal by Subject|2|||
27530001|NCT02028871|80134756|FG000|Overall Study|IV placement difficulty|1|||
27530002|NCT02028871|80134757|FG001|Overall Study|IV placement difficulty|0|||
27530003|NCT02028871|80134756|FG000|Overall Study|Current Illness|1|||
27530004|NCT02028871|80134757|FG001|Overall Study|Current Illness|0|||
27530005|NCT00174291|80134760|FG000|Overall Study|Lost to Follow-up|1|||
27530006|NCT00174291|80134761|FG001|Overall Study|Lost to Follow-up|1|||
27530007|NCT00174291|80134760|FG000|Overall Study|Protocol Violation|0|||
27530008|NCT00174291|80134761|FG001|Overall Study|Protocol Violation|2|||
27530009|NCT00174291|80134760|FG000|Overall Study|Study terminated by sponsor|1|||
27530010|NCT00174291|80134761|FG001|Overall Study|Study terminated by sponsor|0|||
27530011|NCT00174291|80134760|FG000|Overall Study|Withdrawal by Subject|3|||
27530012|NCT00174291|80134761|FG001|Overall Study|Withdrawal by Subject|3|||
27530013|NCT00566501|80134765|FG000|Overall Study|Adverse Event|68|||
27530014|NCT00566501|80134766|FG001|Overall Study|Adverse Event|59|||
27530015|NCT00566501|80134765|FG000|Overall Study|Medication Non-compliance|5|||
27530016|NCT00566501|80134766|FG001|Overall Study|Medication Non-compliance|0|||
27530017|NCT00566501|80134765|FG000|Overall Study|Protocol Violation|2|||
27530018|NCT00566501|80134766|FG001|Overall Study|Protocol Violation|2|||
27530019|NCT00566501|80134765|FG000|Overall Study|Request of Investigator or Sponsor|6|||
27530020|NCT00566501|80134766|FG001|Overall Study|Request of Investigator or Sponsor|7|||
27530021|NCT00566501|80134765|FG000|Overall Study|Withdrawal by Subject|33|||
27530022|NCT00566501|80134766|FG001|Overall Study|Withdrawal by Subject|30|||
27530023|NCT00566501|80134765|FG000|Overall Study|Lack of Efficacy|8|||
27530024|NCT00566501|80134766|FG001|Overall Study|Lack of Efficacy|3|||
27734890|NCT03874234|80857138|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27530025|NCT00566501|80134765|FG000|Overall Study|Other|25|||
27530026|NCT00566501|80134766|FG001|Overall Study|Other|21|||
27530027|NCT00723203|80134767|FG000|Overall Study|Withdrawal by Subject|3|||
27530028|NCT02634710|80134771|FG000|Overall Study|Death|4|||
27530029|NCT00144027|80134772|FG000|Overall Study|Lost to Follow-up|1|||
27530030|NCT00144027|80134773|FG001|Overall Study|Lost to Follow-up|3|||
27530031|NCT00144027|80134772|FG000|Overall Study|Withdrawal by Subject|2|||
27530032|NCT00144027|80134773|FG001|Overall Study|Withdrawal by Subject|2|||
27530033|NCT00144027|80134772|FG000|Overall Study|did not complete baseline assessment|0|||
27530034|NCT00144027|80134773|FG001|Overall Study|did not complete baseline assessment|6|||
27530035|NCT01272661|80134774|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
27530036|NCT01272661|80134775|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
27530037|NCT01272661|80134776|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
27530038|NCT02987660|80134777|FG000|Overall Study|Study terminated by sponsor|10|||
27530039|NCT02987660|80134778|FG001|Overall Study|Study terminated by sponsor|10|||
27530040|NCT03384693|80134783|FG000|Overall Study|Adverse Event|3|||
27530041|NCT03370289|80134784|FG000|Overall Study|Screen Failure|1|||
27530042|NCT03370289|80134784|FG000|Overall Study|Sample Size Sufficient|4|||
27530043|NCT02750943|80134787|FG000|Overall Study|Lost to Follow-up|1|||
27530044|NCT02750943|80134788|FG001|Overall Study|Lost to Follow-up|2|||
27530045|NCT02750943|80134787|FG000|Overall Study|Withdrawal by Subject|5|||
27530046|NCT02750943|80134788|FG001|Overall Study|Withdrawal by Subject|7|||
27530047|NCT02579928|80134791|FG000|Overall Study|Withdrawal by Subject|1|||
27530048|NCT02579928|80134792|FG001|Overall Study|Withdrawal by Subject|0|||
27530049|NCT00995865|80134793|FG000|Overall Study|Protocol Violation|2|||
27530050|NCT00995865|80134794|FG001|Overall Study|Protocol Violation|0|||
27530051|NCT00995865|80134795|FG002|Overall Study|Protocol Violation|0|||
27530052|NCT00995865|80134793|FG000|Overall Study|Lost to Follow-up|0|||
27530053|NCT00995865|80134794|FG001|Overall Study|Lost to Follow-up|0|||
27530054|NCT00995865|80134795|FG002|Overall Study|Lost to Follow-up|1|||
27530055|NCT00586846|80134797|FG000|Overall Study|Physician Decision|1|||
27530056|NCT00586846|80134797|FG000|Overall Study|Death|1|||
27530057|NCT00586846|80134797|FG000|Overall Study|Evaluable for Toxicity Only|4|||
27530058|NCT05442775|80134800|FG000|Overall Study|Trial terminated|61|||
27530059|NCT05442775|80134800|FG000|Overall Study|Lack of Efficacy|4|||
27530060|NCT05442775|80134800|FG000|Overall Study|Withdrawal by Subject|4|||
27530061|NCT05442775|80134800|FG000|Overall Study|Death|1|||
27530062|NCT05442775|80134800|FG000|Overall Study|Participant removed at Sponsor request|1|||
27530063|NCT04854642|80134801|FG000|Overall Study|Adverse Event|1|||
27530064|NCT04854642|80134802|FG001|Overall Study|Adverse Event|2|||
27530065|NCT04854642|80134801|FG000|Overall Study|Withdrawal by Subject|0|||
27530066|NCT04854642|80134802|FG001|Overall Study|Withdrawal by Subject|1|||
27530067|NCT00815516|80134803|FG000|Overall Study|Death|3|||
27530068|NCT00815516|80134804|FG001|Overall Study|Death|1|||
27530069|NCT00815516|80134803|FG000|Overall Study|Physician Decision|1|||
27530070|NCT00815516|80134804|FG001|Overall Study|Physician Decision|0|||
27530071|NCT00568685|80134807|FG000|Overall Study|Adverse Event|2|||
27530072|NCT00568685|80134808|FG001|Overall Study|Adverse Event|3|||
27530073|NCT00568685|80134809|FG002|Overall Study|Adverse Event|3|||
27530074|NCT00568685|80134807|FG000|Overall Study|Withdrawal by Subject|7|||
27530075|NCT00568685|80134808|FG001|Overall Study|Withdrawal by Subject|2|||
27530076|NCT00568685|80134809|FG002|Overall Study|Withdrawal by Subject|2|||
27530077|NCT00568685|80134807|FG000|Overall Study|Protocol Violation|1|||
27530078|NCT00568685|80134808|FG001|Overall Study|Protocol Violation|0|||
27530079|NCT00568685|80134809|FG002|Overall Study|Protocol Violation|0|||
27530080|NCT00395538|80134810|FG000|Overall Study|Did not re-consent to revised protocol|1|||
27530081|NCT00395538|80134811|FG001|Overall Study|Did not re-consent to revised protocol|10|||
27530082|NCT00395538|80134812|FG002|Overall Study|Did not re-consent to revised protocol|0|||
27530083|NCT00395538|80134810|FG000|Overall Study|FDA partial hold on PTH|0|||
27530084|NCT00395538|80134811|FG001|Overall Study|FDA partial hold on PTH|0|||
27530085|NCT00395538|80134812|FG002|Overall Study|FDA partial hold on PTH|11|||
27530086|NCT00395538|80134810|FG000|Overall Study|Failed screening|0|||
27530087|NCT00395538|80134811|FG001|Overall Study|Failed screening|0|||
27530088|NCT00395538|80134812|FG002|Overall Study|Failed screening|4|||
27530089|NCT00395538|80134810|FG000|Overall Study|Switch to Natpara|0|||
27530090|NCT00395538|80134811|FG001|Overall Study|Switch to Natpara|0|||
27530091|NCT00395538|80134812|FG002|Overall Study|Switch to Natpara|3|||
27530092|NCT00395538|80134810|FG000|Overall Study|Adverse Event|1|||
27530093|NCT00395538|80134811|FG001|Overall Study|Adverse Event|0|||
27530094|NCT00395538|80134812|FG002|Overall Study|Adverse Event|2|||
27530095|NCT00395538|80134810|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
27530096|NCT00395538|80134811|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
27530097|NCT00395538|80134812|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
27530098|NCT00395538|80134810|FG000|Overall Study|Non-compliance with study protocol|0|||
27530099|NCT00395538|80134811|FG001|Overall Study|Non-compliance with study protocol|1|||
27530100|NCT00395538|80134812|FG002|Overall Study|Non-compliance with study protocol|0|||
27530101|NCT00395538|80134810|FG000|Overall Study|PTH resistance|0|||
27530102|NCT00395538|80134811|FG001|Overall Study|PTH resistance|0|||
27530103|NCT00395538|80134812|FG002|Overall Study|PTH resistance|1|||
27530104|NCT00395538|80134810|FG000|Overall Study|Pregnancy|1|||
27734891|NCT03874234|80857139|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27530105|NCT00395538|80134811|FG001|Overall Study|Pregnancy|0|||
27530106|NCT00395538|80134812|FG002|Overall Study|Pregnancy|0|||
27912104|NCT01005901|81518092|FG000|Overall Study|Withdrawal by Subject|38|||
27912105|NCT01005901|81518093|FG001|Overall Study|Withdrawal by Subject|14|||
27912106|NCT01005901|81518092|FG000|Overall Study|Adverse Event|30|||
27912107|NCT01005901|81518093|FG001|Overall Study|Adverse Event|16|||
27912108|NCT01005901|81518092|FG000|Overall Study|Administrative problems|21|||
27912109|NCT01005901|81518093|FG001|Overall Study|Administrative problems|13|||
27912110|NCT01005901|81518092|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
27912111|NCT01005901|81518093|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
27912112|NCT01005901|81518092|FG000|Overall Study|Protocol Violation|4|||
27912113|NCT01005901|81518093|FG001|Overall Study|Protocol Violation|3|||
27912114|NCT01005901|81518092|FG000|Overall Study|Death|2|||
27912115|NCT01005901|81518093|FG001|Overall Study|Death|3|||
27912116|NCT01005901|81518092|FG000|Overall Study|Lost to Follow-up|1|||
27912117|NCT01005901|81518093|FG001|Overall Study|Lost to Follow-up|2|||
27912118|NCT01005901|81518092|FG000|Overall Study|Patient's inability to use the device|1|||
27912119|NCT01005901|81518093|FG001|Overall Study|Patient's inability to use the device|1|||
27912120|NCT01005901|81518092|FG000|Overall Study|No longer requires study drug|0|||
27912121|NCT01005901|81518093|FG001|Overall Study|No longer requires study drug|1|||
27912122|NCT03421379|81518094|FG000|Period 1|Withdrawal by Subject|0|||
27912123|NCT03421379|81518095|FG001|Period 1|Withdrawal by Subject|1|||
27912124|NCT03421379|81518094|FG000|Period 1|Physician Decision|1|||
27912125|NCT03421379|81518095|FG001|Period 1|Physician Decision|1|||
27912126|NCT03421379|81518094|FG000|Period 1|Did not receive treatment|1|||
27912127|NCT03421379|81518095|FG001|Period 1|Did not receive treatment|2|||
27912128|NCT01265394|81518096|FG000|Overall Study|Subjects withdrawn|37|||
27912129|NCT00588146|81518098|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
27912130|NCT00588146|81518099|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
27912131|NCT05502302|81518107|FG000|Overall Study|Lost to Follow-up|6|||
27912132|NCT05502302|81518107|FG000|Overall Study|Death|2|||
27912133|NCT00715299|81518110|FG000|Overall Study|Withdrawal by Subject|1|||
27912134|NCT00715299|81518110|FG000|Overall Study|Adverse Event|3|||
27912135|NCT00715299|81518110|FG000|Overall Study|failed the pre-screen exercise test|2|||
27912136|NCT00103285|81518113|FG000|Induction|Adverse Event|14|||
27912137|NCT00103285|81518114|FG001|Induction|Adverse Event|0|||
27912138|NCT00103285|81518115|FG002|Induction|Adverse Event|0|||
27912139|NCT00103285|81518116|FG003|Induction|Adverse Event|0|||
27912140|NCT00103285|81518117|FG004|Induction|Adverse Event|0|||
27912141|NCT00103285|81518118|FG005|Induction|Adverse Event|0|||
27912142|NCT00103285|81518119|FG006|Induction|Adverse Event|0|||
27912143|NCT00103285|81518120|FG007|Induction|Adverse Event|0|||
27912144|NCT00103285|81518113|FG000|Induction|Death|24|||
27530107|NCT00395538|80134810|FG000|Overall Study|Partial recovery of parathyroid function|0|||
27530108|NCT00395538|80134811|FG001|Overall Study|Partial recovery of parathyroid function|0|||
27530109|NCT00395538|80134812|FG002|Overall Study|Partial recovery of parathyroid function|1|||
27530110|NCT00395538|80134810|FG000|Overall Study|Participant elected to discontinue|0|||
27530111|NCT00395538|80134811|FG001|Overall Study|Participant elected to discontinue|0|||
27530112|NCT00395538|80134812|FG002|Overall Study|Participant elected to discontinue|1|||
27530113|NCT00267189|80134813|FG000|Overall Study|Patient withdrew consent|1|||
27530114|NCT00267189|80134814|FG001|Overall Study|Patient withdrew consent|1|||
27530115|NCT00267189|80134813|FG000|Overall Study|Death|1|||
27530116|NCT00267189|80134814|FG001|Overall Study|Death|0|||
27530117|NCT00267189|80134813|FG000|Overall Study|Missing|3|||
27530118|NCT00267189|80134814|FG001|Overall Study|Missing|0|||
27530119|NCT03350984|80134815|FG000|Overall Study|Death|1|||
27530120|NCT03350984|80134816|FG001|Overall Study|Death|0|||
27530121|NCT03350984|80134815|FG000|Overall Study|Lost to Follow-up|5|||
27530122|NCT03350984|80134816|FG001|Overall Study|Lost to Follow-up|6|||
27530123|NCT03350984|80134815|FG000|Overall Study|Protocol Violation|1|||
27530124|NCT03350984|80134816|FG001|Overall Study|Protocol Violation|2|||
27530125|NCT03350984|80134815|FG000|Overall Study|Physician Decision|1|||
27530126|NCT03350984|80134816|FG001|Overall Study|Physician Decision|0|||
27530127|NCT02038829|80134820|FG000|Washout Period 1|Death|0|||
27530128|NCT02038829|80134821|FG001|Washout Period 1|Death|0|||
27530129|NCT02038829|80134822|FG002|Washout Period 1|Death|0|||
27530130|NCT02038829|80134823|FG003|Washout Period 1|Death|0|||
27530131|NCT02038829|80134824|FG004|Washout Period 1|Death|1|||
27530132|NCT02038829|80134825|FG005|Washout Period 1|Death|0|||
27530133|NCT02038829|80134826|FG006|Washout Period 1|Death|0|||
27530134|NCT02038829|80134827|FG007|Washout Period 1|Death|0|||
27530135|NCT02038829|80134828|FG008|Washout Period 1|Death|0|||
27530136|NCT02038829|80134829|FG009|Washout Period 1|Death|0|||
27912145|NCT00103285|81518114|FG001|Induction|Death|0|||
27912146|NCT00103285|81518115|FG002|Induction|Death|0|||
27912147|NCT00103285|81518116|FG003|Induction|Death|0|||
27912148|NCT00103285|81518117|FG004|Induction|Death|0|||
27912149|NCT00103285|81518118|FG005|Induction|Death|0|||
27912150|NCT00103285|81518119|FG006|Induction|Death|0|||
27912151|NCT00103285|81518120|FG007|Induction|Death|0|||
27530137|NCT02038829|80134830|FG010|Washout Period 1|Death|0|||
27530138|NCT02038829|80134831|FG011|Washout Period 1|Death|0|||
27912152|NCT00103285|81518113|FG000|Induction|Physician Decision|103|||
27626032|NCT04536077|80473435|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
27626033|NCT04536077|80473436|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
27626034|NCT00359619|80473437|FG000|Overall Study|Adverse Event|0|||
27530139|NCT02038829|80134820|FG000|Treatment Period 2|Adverse Event|0|||
27530140|NCT02038829|80134821|FG001|Treatment Period 2|Adverse Event|0|||
27530141|NCT02038829|80134822|FG002|Treatment Period 2|Adverse Event|0|||
27530142|NCT02038829|80134823|FG003|Treatment Period 2|Adverse Event|0|||
27530143|NCT02038829|80134824|FG004|Treatment Period 2|Adverse Event|0|||
27530144|NCT02038829|80134825|FG005|Treatment Period 2|Adverse Event|0|||
27530145|NCT02038829|80134826|FG006|Treatment Period 2|Adverse Event|0|||
27530146|NCT02038829|80134827|FG007|Treatment Period 2|Adverse Event|0|||
27530147|NCT02038829|80134828|FG008|Treatment Period 2|Adverse Event|0|||
27530148|NCT02038829|80134829|FG009|Treatment Period 2|Adverse Event|0|||
27626035|NCT00359619|80473438|FG001|Overall Study|Adverse Event|0|||
27626036|NCT00359619|80473439|FG002|Overall Study|Adverse Event|1|||
27626037|NCT00359619|80473440|FG003|Overall Study|Adverse Event|0|||
27626038|NCT00359619|80473441|FG004|Overall Study|Adverse Event|0|||
27626039|NCT00359619|80473442|FG005|Overall Study|Adverse Event|0|||
27626040|NCT00359619|80473443|FG006|Overall Study|Adverse Event|1|||
27626041|NCT00359619|80473437|FG000|Overall Study|Withdrawal by Subject|3|||
27626042|NCT00359619|80473438|FG001|Overall Study|Withdrawal by Subject|1|||
27626043|NCT00359619|80473439|FG002|Overall Study|Withdrawal by Subject|4|||
27626044|NCT00359619|80473440|FG003|Overall Study|Withdrawal by Subject|2|||
27626045|NCT00359619|80473441|FG004|Overall Study|Withdrawal by Subject|2|||
27626046|NCT00359619|80473442|FG005|Overall Study|Withdrawal by Subject|0|||
27626047|NCT00359619|80473443|FG006|Overall Study|Withdrawal by Subject|3|||
27626048|NCT00359619|80473437|FG000|Overall Study|Other|1|||
27626049|NCT00359619|80473438|FG001|Overall Study|Other|0|||
27626050|NCT00359619|80473439|FG002|Overall Study|Other|0|||
27626051|NCT00359619|80473440|FG003|Overall Study|Other|0|||
27626052|NCT00359619|80473441|FG004|Overall Study|Other|0|||
27626053|NCT00359619|80473442|FG005|Overall Study|Other|0|||
27626054|NCT00359619|80473443|FG006|Overall Study|Other|0|||
27626055|NCT00359619|80473437|FG000|Overall Study|Lost to Follow-up|4|||
27626056|NCT00359619|80473438|FG001|Overall Study|Lost to Follow-up|4|||
27626057|NCT00359619|80473439|FG002|Overall Study|Lost to Follow-up|2|||
27626058|NCT00359619|80473440|FG003|Overall Study|Lost to Follow-up|1|||
27626059|NCT00359619|80473441|FG004|Overall Study|Lost to Follow-up|1|||
27626060|NCT00359619|80473442|FG005|Overall Study|Lost to Follow-up|5|||
27626061|NCT00359619|80473443|FG006|Overall Study|Lost to Follow-up|0|||
27626062|NCT04011033|80473444|FG000|Overall Study|Physician Decision|2|||
27626063|NCT04011033|80473445|FG001|Overall Study|Physician Decision|3|||
27626064|NCT04011033|80473444|FG000|Overall Study|Withdrawal by Subject|1|||
27626065|NCT04011033|80473445|FG001|Overall Study|Withdrawal by Subject|0|||
27626066|NCT04454567|80473448|FG000|Overall Study|Study Terminated by Sponsor|1|||
27626067|NCT04454567|80473449|FG001|Overall Study|Study Terminated by Sponsor|1|||
27626068|NCT01168401|80473450|FG000|Overall Study|Lost to Follow-up|1|||
27626069|NCT01168401|80473451|FG001|Overall Study|Lost to Follow-up|1|||
27626070|NCT01168401|80473452|FG002|Overall Study|Lost to Follow-up|2|||
27626071|NCT01168401|80473453|FG003|Overall Study|Lost to Follow-up|1|||
27626072|NCT01168401|80473454|FG004|Overall Study|Lost to Follow-up|0|||
27626073|NCT01168401|80473455|FG005|Overall Study|Lost to Follow-up|0|||
27626074|NCT01168401|80473456|FG006|Overall Study|Lost to Follow-up|0|||
27626075|NCT01168401|80473457|FG007|Overall Study|Lost to Follow-up|0|||
27626076|NCT01168401|80473458|FG008|Overall Study|Lost to Follow-up|0|||
27626077|NCT01168401|80473459|FG009|Overall Study|Lost to Follow-up|0|||
27626078|NCT01168401|80473460|FG010|Overall Study|Lost to Follow-up|0|||
27626079|NCT01168401|80473450|FG000|Overall Study|Withdrawal by Subject|0|||
27626080|NCT01168401|80473451|FG001|Overall Study|Withdrawal by Subject|0|||
27626081|NCT01168401|80473452|FG002|Overall Study|Withdrawal by Subject|0|||
27626082|NCT01168401|80473453|FG003|Overall Study|Withdrawal by Subject|1|||
27626083|NCT01168401|80473454|FG004|Overall Study|Withdrawal by Subject|0|||
27626084|NCT01168401|80473455|FG005|Overall Study|Withdrawal by Subject|0|||
27626085|NCT01168401|80473456|FG006|Overall Study|Withdrawal by Subject|0|||
27626086|NCT01168401|80473457|FG007|Overall Study|Withdrawal by Subject|0|||
27530149|NCT02038829|80134830|FG010|Treatment Period 2|Adverse Event|1|||
27626087|NCT01168401|80473458|FG008|Overall Study|Withdrawal by Subject|0|||
27530150|NCT02038829|80134831|FG011|Treatment Period 2|Adverse Event|0|||
27626088|NCT01168401|80473459|FG009|Overall Study|Withdrawal by Subject|0|||
27626089|NCT01168401|80473460|FG010|Overall Study|Withdrawal by Subject|0|||
27626090|NCT04984876|80473463|FG000|Overall Study|Subject decision|2|||
27626091|NCT04984876|80473464|FG001|Overall Study|Subject decision|10|||
27626092|NCT04984876|80473465|FG002|Overall Study|Subject decision|3|||
27530151|NCT02038829|80134820|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27530152|NCT02038829|80134821|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27530153|NCT02038829|80134822|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27626093|NCT04984876|80473466|FG003|Overall Study|Subject decision|3|||
27626094|NCT04984876|80473467|FG004|Overall Study|Subject decision|3|||
27626095|NCT04984876|80473468|FG005|Overall Study|Subject decision|0|||
27626096|NCT04984876|80473463|FG000|Overall Study|Guardian decision|0|||
27626097|NCT04984876|80473464|FG001|Overall Study|Guardian decision|1|||
27626098|NCT04984876|80473465|FG002|Overall Study|Guardian decision|0|||
27626099|NCT04984876|80473466|FG003|Overall Study|Guardian decision|2|||
27626100|NCT04984876|80473467|FG004|Overall Study|Guardian decision|0|||
27626101|NCT04984876|80473468|FG005|Overall Study|Guardian decision|1|||
27626102|NCT04984876|80473463|FG000|Overall Study|Lost to Follow-up|0|||
27626103|NCT04984876|80473464|FG001|Overall Study|Lost to Follow-up|0|||
27626104|NCT04984876|80473465|FG002|Overall Study|Lost to Follow-up|1|||
27626105|NCT04984876|80473466|FG003|Overall Study|Lost to Follow-up|1|||
27626106|NCT04984876|80473467|FG004|Overall Study|Lost to Follow-up|0|||
27626107|NCT04984876|80473468|FG005|Overall Study|Lost to Follow-up|0|||
27626108|NCT04984876|80473463|FG000|Overall Study|Physician Decision|1|||
27626109|NCT04984876|80473464|FG001|Overall Study|Physician Decision|0|||
27626110|NCT04984876|80473465|FG002|Overall Study|Physician Decision|0|||
27626111|NCT04984876|80473466|FG003|Overall Study|Physician Decision|1|||
27626112|NCT04984876|80473467|FG004|Overall Study|Physician Decision|0|||
27626113|NCT04984876|80473468|FG005|Overall Study|Physician Decision|0|||
27626114|NCT04984876|80473463|FG000|Overall Study|Adverse Event|0|||
27626115|NCT04984876|80473464|FG001|Overall Study|Adverse Event|0|||
27626116|NCT04984876|80473465|FG002|Overall Study|Adverse Event|1|||
27626117|NCT04984876|80473466|FG003|Overall Study|Adverse Event|0|||
27626118|NCT04984876|80473467|FG004|Overall Study|Adverse Event|0|||
27626119|NCT04984876|80473468|FG005|Overall Study|Adverse Event|0|||
27626120|NCT03441984|80473470|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626121|NCT03441984|80473471|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626122|NCT03441984|80473472|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
27626123|NCT03441984|80473473|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626124|NCT03441984|80473474|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626125|NCT03441984|80473475|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626126|NCT03441984|80473476|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626127|NCT03441984|80473477|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626128|NCT03441984|80473478|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626129|NCT03441984|80473479|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626130|NCT03441984|80473480|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626131|NCT03441984|80473481|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
27626132|NCT01027286|80473482|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
27626133|NCT01027286|80473483|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
27626134|NCT01027286|80473482|FG000|Overall Study|Lost to Follow-up|0|||
27626135|NCT01027286|80473483|FG001|Overall Study|Lost to Follow-up|1|||
27626136|NCT02062827|80473484|FG000|Overall Study|Death|1|||
27626137|NCT02062827|80473485|FG001|Overall Study|Death|0|||
27626138|NCT02062827|80473486|FG002|Overall Study|Death|0|||
27626139|NCT02062827|80473487|FG003|Overall Study|Death|0|||
27626140|NCT02062827|80473488|FG004|Overall Study|Death|0|||
27626141|NCT02062827|80473489|FG005|Overall Study|Death|0|||
27626142|NCT02062827|80473490|FG006|Overall Study|Death|0|||
27626143|NCT02062827|80473491|FG007|Overall Study|Death|0|||
27626144|NCT02062827|80473484|FG000|Overall Study|Withdrawal by Subject|3|||
27626145|NCT02062827|80473485|FG001|Overall Study|Withdrawal by Subject|1|||
27626146|NCT02062827|80473486|FG002|Overall Study|Withdrawal by Subject|1|||
27626147|NCT02062827|80473487|FG003|Overall Study|Withdrawal by Subject|2|||
27626148|NCT02062827|80473488|FG004|Overall Study|Withdrawal by Subject|6|||
27626149|NCT02062827|80473489|FG005|Overall Study|Withdrawal by Subject|0|||
27626150|NCT02062827|80473490|FG006|Overall Study|Withdrawal by Subject|5|||
27626151|NCT02062827|80473491|FG007|Overall Study|Withdrawal by Subject|0|||
27626152|NCT02062827|80473484|FG000|Overall Study|Screen Fail|0|||
27626153|NCT02062827|80473485|FG001|Overall Study|Screen Fail|0|||
27626154|NCT02062827|80473486|FG002|Overall Study|Screen Fail|0|||
27626155|NCT02062827|80473487|FG003|Overall Study|Screen Fail|0|||
27626156|NCT02062827|80473488|FG004|Overall Study|Screen Fail|0|||
27626157|NCT02062827|80473489|FG005|Overall Study|Screen Fail|0|||
27626158|NCT02062827|80473490|FG006|Overall Study|Screen Fail|0|||
27626159|NCT02062827|80473491|FG007|Overall Study|Screen Fail|8|||
27626160|NCT03771898|80473492|FG000|Overall Study|Adverse Event|1|||
27626161|NCT03771898|80473493|FG001|Overall Study|Adverse Event|0|||
27626162|NCT03771898|80473494|FG002|Overall Study|Adverse Event|0|||
27626163|NCT03771898|80473495|FG003|Overall Study|Adverse Event|0|||
27626164|NCT03771898|80473496|FG004|Overall Study|Adverse Event|0|||
27626165|NCT03771898|80473492|FG000|Overall Study|Lost to Follow-up|1|||
27626166|NCT03771898|80473493|FG001|Overall Study|Lost to Follow-up|1|||
27626167|NCT03771898|80473494|FG002|Overall Study|Lost to Follow-up|1|||
27626168|NCT03771898|80473495|FG003|Overall Study|Lost to Follow-up|0|||
27626169|NCT03771898|80473496|FG004|Overall Study|Lost to Follow-up|0|||
27626170|NCT03771898|80473492|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27626171|NCT03771898|80473493|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27626172|NCT03771898|80473494|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27626173|NCT03771898|80473495|FG003|Overall Study|Withdrawal by parent/guardian|0|||
27626174|NCT03771898|80473496|FG004|Overall Study|Withdrawal by parent/guardian|0|||
27626175|NCT03771898|80473492|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
27626176|NCT03771898|80473493|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
27626177|NCT03771898|80473494|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
27626178|NCT03771898|80473495|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
27626179|NCT03771898|80473496|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
27626180|NCT00515086|80473497|FG000|Overall Study|Adverse Event|1|||
27626181|NCT00515086|80473498|FG001|Overall Study|Adverse Event|1|||
27626182|NCT00515086|80473499|FG002|Overall Study|Adverse Event|2|||
27626183|NCT00515086|80473500|FG003|Overall Study|Adverse Event|3|||
27626184|NCT00515086|80473497|FG000|Overall Study|Administrative|1|||
27626185|NCT00515086|80473498|FG001|Overall Study|Administrative|1|||
27626186|NCT00515086|80473499|FG002|Overall Study|Administrative|0|||
27626187|NCT00515086|80473500|FG003|Overall Study|Administrative|0|||
27626188|NCT00515086|80473497|FG000|Overall Study|Withdrawal by Subject|1|||
27626189|NCT00515086|80473498|FG001|Overall Study|Withdrawal by Subject|0|||
27626190|NCT00515086|80473499|FG002|Overall Study|Withdrawal by Subject|0|||
27626191|NCT00515086|80473500|FG003|Overall Study|Withdrawal by Subject|1|||
27626192|NCT00515086|80473497|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
27626193|NCT00515086|80473498|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27626194|NCT00515086|80473499|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
27626195|NCT00515086|80473500|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27626196|NCT00515086|80473497|FG000|Overall Study|Lost to Follow-up|1|||
27626197|NCT00515086|80473498|FG001|Overall Study|Lost to Follow-up|0|||
27626198|NCT00515086|80473499|FG002|Overall Study|Lost to Follow-up|0|||
27626199|NCT00515086|80473500|FG003|Overall Study|Lost to Follow-up|0|||
27626200|NCT00515086|80473497|FG000|Overall Study|Study drug no longer required|0|||
27626201|NCT00515086|80473498|FG001|Overall Study|Study drug no longer required|1|||
27626202|NCT00515086|80473499|FG002|Overall Study|Study drug no longer required|0|||
27626203|NCT00515086|80473500|FG003|Overall Study|Study drug no longer required|0|||
27626204|NCT00515086|80473497|FG000|Overall Study|Death|2|||
27530154|NCT02038829|80134823|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27530155|NCT02038829|80134824|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27530156|NCT02038829|80134825|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27530157|NCT02038829|80134826|FG006|Treatment Period 2|Withdrawal by Subject|0|||
27530158|NCT02038829|80134827|FG007|Treatment Period 2|Withdrawal by Subject|0|||
27530159|NCT02038829|80134828|FG008|Treatment Period 2|Withdrawal by Subject|0|||
27530160|NCT02038829|80134829|FG009|Treatment Period 2|Withdrawal by Subject|0|||
27530161|NCT02038829|80134830|FG010|Treatment Period 2|Withdrawal by Subject|0|||
27530162|NCT02038829|80134831|FG011|Treatment Period 2|Withdrawal by Subject|0|||
27530163|NCT02038829|80134820|FG000|Washout Period 2|Adverse Event|0|||
27530164|NCT02038829|80134821|FG001|Washout Period 2|Adverse Event|0|||
27530165|NCT02038829|80134822|FG002|Washout Period 2|Adverse Event|0|||
27530166|NCT02038829|80134823|FG003|Washout Period 2|Adverse Event|0|||
27530167|NCT02038829|80134824|FG004|Washout Period 2|Adverse Event|0|||
27530168|NCT02038829|80134825|FG005|Washout Period 2|Adverse Event|0|||
27530169|NCT02038829|80134826|FG006|Washout Period 2|Adverse Event|0|||
27530170|NCT02038829|80134827|FG007|Washout Period 2|Adverse Event|0|||
27530171|NCT02038829|80134828|FG008|Washout Period 2|Adverse Event|1|||
27530172|NCT02038829|80134829|FG009|Washout Period 2|Adverse Event|0|||
27530173|NCT02038829|80134830|FG010|Washout Period 2|Adverse Event|0|||
27530174|NCT02038829|80134831|FG011|Washout Period 2|Adverse Event|0|||
27530175|NCT02038829|80134820|FG000|Washout Period 2|Withdrawal by Subject|0|||
27530176|NCT02038829|80134821|FG001|Washout Period 2|Withdrawal by Subject|0|||
27626205|NCT00515086|80473498|FG001|Overall Study|Death|0|||
27626206|NCT00515086|80473499|FG002|Overall Study|Death|0|||
27626207|NCT00515086|80473500|FG003|Overall Study|Death|0|||
27626208|NCT01565928|80473503|FG000|Overall Study|Adverse Event|3|||
27530177|NCT02038829|80134822|FG002|Washout Period 2|Withdrawal by Subject|0|||
27530178|NCT02038829|80134823|FG003|Washout Period 2|Withdrawal by Subject|0|||
27530179|NCT02038829|80134824|FG004|Washout Period 2|Withdrawal by Subject|0|||
27626209|NCT01565928|80473503|FG000|Overall Study|Other|3|||
27626210|NCT01565928|80473503|FG000|Overall Study|Progressive Disease|13|||
27626211|NCT01565928|80473503|FG000|Overall Study|Withdrawal by Subject|1|||
27626212|NCT01565928|80473503|FG000|Overall Study|Death|2|||
27626213|NCT05487703|80473504|FG000|Overall Study|Other|19|||
27626214|NCT05487703|80473504|FG000|Overall Study|Participant not well|5|||
27626215|NCT05487703|80473504|FG000|Overall Study|Insurance Reasons|6|||
27626216|NCT05487703|80473504|FG000|Overall Study|Physician Decision|19|||
27626217|NCT05487703|80473504|FG000|Overall Study|Lack of Efficacy|60|||
27626218|NCT02540213|80473505|FG000|Overall Study|Death/adverse event|18|||
27626219|NCT02540213|80473505|FG000|Overall Study|Administrative reasons|3|||
27626220|NCT02540213|80473505|FG000|Overall Study|Kidney transplant|3|||
27626221|NCT02540213|80473505|FG000|Overall Study|Lack of Efficacy|6|||
27626222|NCT02540213|80473505|FG000|Overall Study|Consent withdrawn|7|||
27626223|NCT02540213|80473505|FG000|Overall Study|Enrolled but not treated|2|||
27626224|NCT03201757|80473509|FG000|Overall Study|Withdrawal by Subject|133|||
27626225|NCT03201757|80473509|FG000|Overall Study|Adverse Event|44|||
27626226|NCT03201757|80473509|FG000|Overall Study|Lost to Follow-up|37|||
27626227|NCT03201757|80473509|FG000|Overall Study|Pregnancy|2|||
27626228|NCT03201757|80473509|FG000|Overall Study|Lack of Efficacy|1|||
27626229|NCT03201757|80473509|FG000|Overall Study|Protocol Violation|20|||
27626230|NCT03201757|80473509|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
27626231|NCT03201757|80473509|FG000|Overall Study|Not Yet Determined|5|||
27626232|NCT03201757|80473509|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
27626233|NCT03201757|80473509|FG000|Overall Study|Other|20|||
27626234|NCT02095158|80473510|FG000|Overall Study|Adverse Event|14|||
27626235|NCT02095158|80473510|FG000|Overall Study|Lack of Efficacy|3|||
27626236|NCT02095158|80473510|FG000|Overall Study|Pregnancy|1|||
27626237|NCT02095158|80473510|FG000|Overall Study|Lost to Follow-up|20|||
27626238|NCT02095158|80473510|FG000|Overall Study|Personal Reasons|35|||
27626239|NCT02095158|80473510|FG000|Overall Study|Protocol Violation|1|||
27626240|NCT02095158|80473510|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27626241|NCT02289560|80473511|FG000|Overall Study|Lost to Follow-up|6|||
27626242|NCT02289560|80473511|FG000|Overall Study|Alternative Treatment|4|||
27626243|NCT02289560|80473511|FG000|Overall Study|Inadequate Treatment|2|||
27626244|NCT02289560|80473511|FG000|Overall Study|Withdrawal by Subject|23|||
27626245|NCT03095508|80473517|FG000|Overall Study|Adverse Event|0|||
27626246|NCT03095508|80473518|FG001|Overall Study|Adverse Event|1|||
27626247|NCT00569946|80473519|FG000|Overall Study|Adverse Event|16|||
27626248|NCT00569946|80473519|FG000|Overall Study|Objective Progression or Relapse|42|||
27626249|NCT00569946|80473519|FG000|Overall Study|Global Deterioration of Health Status|1|||
27626250|NCT01582945|80473520|FG000|Overall Study|Intolerable side-effects|1|||
27626251|NCT01582945|80473520|FG000|Overall Study|Scheduling conflicts|1|||
27626252|NCT01450943|80473521|FG000|Overall Study|Screen failure, loss to follow-up|2|||
27626253|NCT01450943|80473522|FG001|Overall Study|Screen failure, loss to follow-up|7|||
27626254|NCT01450943|80473523|FG002|Overall Study|Screen failure, loss to follow-up|6|||
27626255|NCT02624778|80473524|FG000|Overall Study|Lost to Follow-up|0|||
27626256|NCT02624778|80473525|FG001|Overall Study|Lost to Follow-up|0|||
27626257|NCT02624778|80473526|FG002|Overall Study|Lost to Follow-up|1|||
27626258|NCT02624778|80473527|FG003|Overall Study|Lost to Follow-up|0|||
27626259|NCT02624778|80473528|FG004|Overall Study|Lost to Follow-up|0|||
27626260|NCT02624778|80473529|FG005|Overall Study|Lost to Follow-up|0|||
27626261|NCT02624778|80473530|FG006|Overall Study|Lost to Follow-up|0|||
27626262|NCT02624778|80473531|FG007|Overall Study|Lost to Follow-up|0|||
27626263|NCT02624778|80473532|FG008|Overall Study|Lost to Follow-up|0|||
27626264|NCT02624778|80473524|FG000|Overall Study|Withdrawal by Subject|0|||
27626265|NCT02624778|80473525|FG001|Overall Study|Withdrawal by Subject|1|||
27626266|NCT02624778|80473526|FG002|Overall Study|Withdrawal by Subject|0|||
27626267|NCT02624778|80473527|FG003|Overall Study|Withdrawal by Subject|0|||
27626268|NCT02624778|80473528|FG004|Overall Study|Withdrawal by Subject|0|||
27626269|NCT02624778|80473529|FG005|Overall Study|Withdrawal by Subject|1|||
27626270|NCT02624778|80473530|FG006|Overall Study|Withdrawal by Subject|1|||
27626271|NCT02624778|80473531|FG007|Overall Study|Withdrawal by Subject|1|||
27626272|NCT02624778|80473532|FG008|Overall Study|Withdrawal by Subject|1|||
27626273|NCT02624778|80473524|FG000|Overall Study|Adverse Event|0|||
27626274|NCT02624778|80473525|FG001|Overall Study|Adverse Event|0|||
27626275|NCT02624778|80473526|FG002|Overall Study|Adverse Event|0|||
27626276|NCT02624778|80473527|FG003|Overall Study|Adverse Event|0|||
27626277|NCT02624778|80473528|FG004|Overall Study|Adverse Event|0|||
27626278|NCT02624778|80473529|FG005|Overall Study|Adverse Event|0|||
27626279|NCT02624778|80473530|FG006|Overall Study|Adverse Event|0|||
27626280|NCT02624778|80473531|FG007|Overall Study|Adverse Event|0|||
27626281|NCT02624778|80473532|FG008|Overall Study|Adverse Event|2|||
27626282|NCT02624778|80473524|FG000|Overall Study|Death|0|||
27626283|NCT02624778|80473525|FG001|Overall Study|Death|0|||
27626284|NCT02624778|80473526|FG002|Overall Study|Death|0|||
27626285|NCT02624778|80473527|FG003|Overall Study|Death|0|||
27626286|NCT02624778|80473528|FG004|Overall Study|Death|0|||
27626287|NCT02624778|80473529|FG005|Overall Study|Death|0|||
27626288|NCT02624778|80473530|FG006|Overall Study|Death|1|||
27626289|NCT02624778|80473531|FG007|Overall Study|Death|0|||
27626290|NCT02624778|80473532|FG008|Overall Study|Death|0|||
27626291|NCT02624778|80473524|FG000|Overall Study|Physician Decision|0|||
27626292|NCT02624778|80473525|FG001|Overall Study|Physician Decision|0|||
27626293|NCT02624778|80473526|FG002|Overall Study|Physician Decision|0|||
27626294|NCT02624778|80473527|FG003|Overall Study|Physician Decision|0|||
27626295|NCT02624778|80473528|FG004|Overall Study|Physician Decision|0|||
27626296|NCT02624778|80473529|FG005|Overall Study|Physician Decision|0|||
27626297|NCT02624778|80473530|FG006|Overall Study|Physician Decision|0|||
27626298|NCT02624778|80473531|FG007|Overall Study|Physician Decision|3|||
27626299|NCT02624778|80473532|FG008|Overall Study|Physician Decision|3|||
27626300|NCT04423393|80473533|FG000|Overall Study|Withdrawal by Subject|0|||
27626301|NCT04423393|80473534|FG001|Overall Study|Withdrawal by Subject|0|||
27626302|NCT04423393|80473535|FG002|Overall Study|Withdrawal by Subject|0|||
27626303|NCT04423393|80473536|FG003|Overall Study|Withdrawal by Subject|0|||
27626304|NCT04423393|80473537|FG004|Overall Study|Withdrawal by Subject|0|||
27626305|NCT04423393|80473538|FG005|Overall Study|Withdrawal by Subject|1|||
27626306|NCT04423393|80473539|FG006|Overall Study|Withdrawal by Subject|0|||
27626307|NCT04423393|80473540|FG007|Overall Study|Withdrawal by Subject|0|||
27626308|NCT04423393|80473541|FG008|Overall Study|Withdrawal by Subject|0|||
27626309|NCT04423393|80473542|FG009|Overall Study|Withdrawal by Subject|0|||
27626310|NCT04423393|80473543|FG010|Overall Study|Withdrawal by Subject|0|||
27626311|NCT04423393|80473544|FG011|Overall Study|Withdrawal by Subject|0|||
27626312|NCT04423393|80473545|FG012|Overall Study|Withdrawal by Subject|0|||
27626313|NCT04423393|80473546|FG013|Overall Study|Withdrawal by Subject|1|||
27626314|NCT04423393|80473547|FG014|Overall Study|Withdrawal by Subject|0|||
27626315|NCT04423393|80473548|FG015|Overall Study|Withdrawal by Subject|0|||
27626316|NCT04423393|80473549|FG016|Overall Study|Withdrawal by Subject|0|||
27626317|NCT04423393|80473550|FG017|Overall Study|Withdrawal by Subject|0|||
27626318|NCT04423393|80473533|FG000|Overall Study|Sponsor Decision|0|||
27626319|NCT04423393|80473534|FG001|Overall Study|Sponsor Decision|0|||
27626320|NCT04423393|80473535|FG002|Overall Study|Sponsor Decision|0|||
27626321|NCT04423393|80473536|FG003|Overall Study|Sponsor Decision|0|||
27626322|NCT04423393|80473537|FG004|Overall Study|Sponsor Decision|0|||
27626323|NCT04423393|80473538|FG005|Overall Study|Sponsor Decision|0|||
27626324|NCT04423393|80473539|FG006|Overall Study|Sponsor Decision|0|||
27626325|NCT04423393|80473540|FG007|Overall Study|Sponsor Decision|0|||
27626326|NCT04423393|80473541|FG008|Overall Study|Sponsor Decision|0|||
27626327|NCT04423393|80473542|FG009|Overall Study|Sponsor Decision|0|||
27626328|NCT04423393|80473543|FG010|Overall Study|Sponsor Decision|0|||
27626329|NCT04423393|80473544|FG011|Overall Study|Sponsor Decision|0|||
27626330|NCT04423393|80473545|FG012|Overall Study|Sponsor Decision|0|||
27626331|NCT04423393|80473546|FG013|Overall Study|Sponsor Decision|1|||
27626332|NCT04423393|80473547|FG014|Overall Study|Sponsor Decision|0|||
27626333|NCT04423393|80473548|FG015|Overall Study|Sponsor Decision|0|||
27626334|NCT04423393|80473549|FG016|Overall Study|Sponsor Decision|0|||
27626335|NCT04423393|80473550|FG017|Overall Study|Sponsor Decision|0|||
27626336|NCT00303303|80473553|FG000|Overall Study|Withdrawal by Subject|0|||
27626337|NCT00303303|80473554|FG001|Overall Study|Withdrawal by Subject|0|||
27626338|NCT00303303|80473555|FG002|Overall Study|Withdrawal by Subject|1|||
27626339|NCT05349864|80473556|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
27626340|NCT05349864|80473557|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
27626341|NCT01268891|80473563|FG000|Overall Study|Adverse Event|3|||
27626342|NCT01268891|80473564|FG001|Overall Study|Adverse Event|7|||
27626343|NCT01268891|80473563|FG000|Overall Study|Lack of Efficacy|1|||
27626344|NCT01268891|80473564|FG001|Overall Study|Lack of Efficacy|0|||
27626345|NCT01268891|80473563|FG000|Overall Study|Withdrawal of Consent|3|||
27626346|NCT01268891|80473564|FG001|Overall Study|Withdrawal of Consent|1|||
27626347|NCT01268891|80473563|FG000|Overall Study|Administrative or other reason(s)|1|||
27626348|NCT01268891|80473564|FG001|Overall Study|Administrative or other reason(s)|0|||
27626349|NCT03732820|80473567|FG000|Overall Study|Death|168|||
27626350|NCT03732820|80473568|FG001|Overall Study|Death|203|||
27626351|NCT03732820|80473567|FG000|Overall Study|Other|2|||
27626352|NCT03732820|80473568|FG001|Overall Study|Other|2|||
27626353|NCT03732820|80473567|FG000|Overall Study|Failure to meet randomisation criteria|1|||
27626354|NCT03732820|80473568|FG001|Overall Study|Failure to meet randomisation criteria|1|||
27626355|NCT03732820|80473567|FG000|Overall Study|Patient decision|14|||
27912153|NCT00103285|81518114|FG001|Induction|Physician Decision|0|||
27626356|NCT03732820|80473568|FG001|Overall Study|Patient decision|10|||
27626357|NCT03732820|80473567|FG000|Overall Study|Screen failure|0|||
27626358|NCT03732820|80473568|FG001|Overall Study|Screen failure|1|||
27626359|NCT03732820|80473567|FG000|Overall Study|Patients ongoing study at data cut off|210|||
27912154|NCT00103285|81518115|FG002|Induction|Physician Decision|0|||
27626360|NCT03732820|80473568|FG001|Overall Study|Patients ongoing study at data cut off|178|||
27626361|NCT03732820|80473567|FG000|Overall Study|Lost to Follow-up|4|||
27626362|NCT03732820|80473568|FG001|Overall Study|Lost to Follow-up|2|||
27626363|NCT00881335|80473569|FG000|Overall Study|Lost to Follow-up|3|||
27626364|NCT00881335|80473570|FG001|Overall Study|Lost to Follow-up|2|||
27626365|NCT00543725|80473573|FG000|Overall Study|Adverse Event|18|||
27626366|NCT00543725|80473574|FG001|Overall Study|Adverse Event|27|||
27626367|NCT00543725|80473573|FG000|Overall Study|Sponsor's Decision|0|||
27626368|NCT00543725|80473574|FG001|Overall Study|Sponsor's Decision|1|||
27626369|NCT00543725|80473573|FG000|Overall Study|Subject Non-Compliant|4|||
27626370|NCT00543725|80473574|FG001|Overall Study|Subject Non-Compliant|4|||
27626371|NCT00543725|80473573|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
27626372|NCT00543725|80473574|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
27626373|NCT00543725|80473573|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
27626374|NCT00543725|80473574|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
27626375|NCT00543725|80473573|FG000|Overall Study|Protocol Violation|0|||
27626376|NCT00543725|80473574|FG001|Overall Study|Protocol Violation|1|||
27626377|NCT00543725|80473573|FG000|Overall Study|Withdrawal by Subject|4|||
27626378|NCT00543725|80473574|FG001|Overall Study|Withdrawal by Subject|13|||
27856521|NCT02516553|81306785|FG016|Overall Study|other reasons than listed|0|||
27856522|NCT02516553|81306786|FG017|Overall Study|other reasons than listed|0|||
27856523|NCT02516553|81306787|FG018|Overall Study|other reasons than listed|0|||
27912155|NCT00103285|81518116|FG003|Induction|Physician Decision|0|||
27530180|NCT02038829|80134825|FG005|Washout Period 2|Withdrawal by Subject|1|||
27530181|NCT02038829|80134826|FG006|Washout Period 2|Withdrawal by Subject|0|||
27530182|NCT02038829|80134827|FG007|Washout Period 2|Withdrawal by Subject|0|||
27530183|NCT02038829|80134828|FG008|Washout Period 2|Withdrawal by Subject|0|||
27530184|NCT02038829|80134829|FG009|Washout Period 2|Withdrawal by Subject|0|||
27530185|NCT02038829|80134830|FG010|Washout Period 2|Withdrawal by Subject|0|||
27530186|NCT02038829|80134831|FG011|Washout Period 2|Withdrawal by Subject|0|||
27530187|NCT02038829|80134820|FG000|Treatment Period 4|Adverse Event|0|||
27530188|NCT02038829|80134821|FG001|Treatment Period 4|Adverse Event|1|||
27530189|NCT02038829|80134822|FG002|Treatment Period 4|Adverse Event|0|||
27530190|NCT02038829|80134823|FG003|Treatment Period 4|Adverse Event|0|||
27530191|NCT02038829|80134824|FG004|Treatment Period 4|Adverse Event|0|||
27626379|NCT00543725|80473573|FG000|Overall Study|Lost to Follow-up|15|||
27626380|NCT00543725|80473574|FG001|Overall Study|Lost to Follow-up|11|||
27856524|NCT02516553|81306788|FG019|Overall Study|other reasons than listed|0|||
27530192|NCT02038829|80134825|FG005|Treatment Period 4|Adverse Event|0|||
27530193|NCT02038829|80134826|FG006|Treatment Period 4|Adverse Event|0|||
27530194|NCT02038829|80134827|FG007|Treatment Period 4|Adverse Event|0|||
27530195|NCT02038829|80134828|FG008|Treatment Period 4|Adverse Event|0|||
27626381|NCT00543725|80473573|FG000|Overall Study|Other|3|||
27626382|NCT00543725|80473574|FG001|Overall Study|Other|3|||
27626383|NCT05074498|80473579|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
27626384|NCT05074498|80473580|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
27626385|NCT05074498|80473581|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
27626386|NCT05074498|80473582|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
27626387|NCT05074498|80473583|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
27626388|NCT05074498|80473584|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
27626389|NCT05074498|80473579|FG000|Part 1 (Upto Day 104)|Other|1|||
27626390|NCT05074498|80473580|FG001|Part 1 (Upto Day 104)|Other|0|||
27626391|NCT05074498|80473581|FG002|Part 1 (Upto Day 104)|Other|0|||
27626392|NCT05074498|80473582|FG003|Part 1 (Upto Day 104)|Other|0|||
27626393|NCT05074498|80473583|FG004|Part 1 (Upto Day 104)|Other|0|||
27626394|NCT05074498|80473584|FG005|Part 1 (Upto Day 104)|Other|0|||
27626395|NCT05074498|80473579|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
27626396|NCT05074498|80473580|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
27626397|NCT05074498|80473581|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
27626398|NCT05074498|80473582|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
27626399|NCT05074498|80473583|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
27626400|NCT05074498|80473584|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
27626401|NCT05074498|80473579|FG000|Part 2 (Upto Day 104)|Death|0|||
27626402|NCT05074498|80473580|FG001|Part 2 (Upto Day 104)|Death|0|||
27626403|NCT05074498|80473581|FG002|Part 2 (Upto Day 104)|Death|0|||
27626404|NCT05074498|80473582|FG003|Part 2 (Upto Day 104)|Death|0|||
27626405|NCT05074498|80473583|FG004|Part 2 (Upto Day 104)|Death|1|||
27626406|NCT05074498|80473584|FG005|Part 2 (Upto Day 104)|Death|0|||
27626407|NCT05074498|80473579|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
27626408|NCT05074498|80473580|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
27626409|NCT05074498|80473581|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
27626410|NCT05074498|80473582|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
27626411|NCT05074498|80473583|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
27626412|NCT05074498|80473584|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
27626413|NCT05074498|80473579|FG000|Part 2 (Upto Day 104)|Other|0|||
27626414|NCT05074498|80473580|FG001|Part 2 (Upto Day 104)|Other|0|||
27626415|NCT05074498|80473581|FG002|Part 2 (Upto Day 104)|Other|0|||
27626416|NCT05074498|80473582|FG003|Part 2 (Upto Day 104)|Other|0|||
27626417|NCT05074498|80473583|FG004|Part 2 (Upto Day 104)|Other|1|||
27626418|NCT05074498|80473584|FG005|Part 2 (Upto Day 104)|Other|0|||
27626419|NCT01242085|80473587|FG000|Overall Study|Withdrawal by Subject|4|||
27626420|NCT01242085|80473588|FG001|Overall Study|Withdrawal by Subject|2|||
27626421|NCT01242085|80473589|FG002|Overall Study|Withdrawal by Subject|0|||
27626422|NCT01242085|80473587|FG000|Overall Study|medically unable to have surgery|4|||
27626423|NCT01242085|80473588|FG001|Overall Study|medically unable to have surgery|5|||
27626424|NCT01242085|80473589|FG002|Overall Study|medically unable to have surgery|0|||
27626425|NCT00536380|80473590|FG000|Overall Study|Adverse Event|0|||
27626426|NCT00536380|80473591|FG001|Overall Study|Adverse Event|2|||
27626427|NCT00536380|80473592|FG002|Overall Study|Adverse Event|2|||
27626428|NCT00536380|80473590|FG000|Overall Study|Lost to Follow-up|0|||
27734892|NCT03874234|80857140|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
27734893|NCT03874234|80857128|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734894|NCT03874234|80857129|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734895|NCT03874234|80857130|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734896|NCT03874234|80857131|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734897|NCT03874234|80857132|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
27734898|NCT03874234|80857133|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734899|NCT03874234|80857134|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734900|NCT03874234|80857135|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734901|NCT03874234|80857136|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734902|NCT03874234|80857137|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734903|NCT03874234|80857138|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734904|NCT03874234|80857139|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27912156|NCT00103285|81518117|FG004|Induction|Physician Decision|0|||
27626429|NCT00536380|80473591|FG001|Overall Study|Lost to Follow-up|0|||
27626430|NCT00536380|80473592|FG002|Overall Study|Lost to Follow-up|1|||
27626431|NCT00536380|80473590|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
27734905|NCT03874234|80857140|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
27734906|NCT01478958|80857142|FG000|Overall Study|Withdrawal by Subject|1|||
27626432|NCT00536380|80473591|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
27626433|NCT00536380|80473592|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
27626434|NCT00536380|80473590|FG000|Overall Study|Withdrawal related to study drug|7|||
27626435|NCT00536380|80473591|FG001|Overall Study|Withdrawal related to study drug|5|||
27626436|NCT00536380|80473592|FG002|Overall Study|Withdrawal related to study drug|2|||
27626437|NCT00536380|80473590|FG000|Overall Study|Noncompliance with protocol|3|||
27626438|NCT00536380|80473591|FG001|Overall Study|Noncompliance with protocol|2|||
27856525|NCT02516553|81306789|FG020|Overall Study|other reasons than listed|2|||
27856526|NCT02516553|81306790|FG021|Overall Study|other reasons than listed|2|||
27856527|NCT02038907|81306791|FG000|Overall Study|Protocol Violation|0|||
27530196|NCT02038829|80134829|FG009|Treatment Period 4|Adverse Event|0|||
27530197|NCT02038829|80134830|FG010|Treatment Period 4|Adverse Event|0|||
27530198|NCT02038829|80134831|FG011|Treatment Period 4|Adverse Event|0|||
27530199|NCT02038829|80134820|FG000|Washout Period 4|Adverse Event|0|||
27530200|NCT02038829|80134821|FG001|Washout Period 4|Adverse Event|0|||
27530201|NCT02038829|80134822|FG002|Washout Period 4|Adverse Event|0|||
27530202|NCT02038829|80134823|FG003|Washout Period 4|Adverse Event|0|||
27530203|NCT02038829|80134824|FG004|Washout Period 4|Adverse Event|0|||
27530204|NCT02038829|80134825|FG005|Washout Period 4|Adverse Event|0|||
27530205|NCT02038829|80134826|FG006|Washout Period 4|Adverse Event|1|||
27530206|NCT02038829|80134827|FG007|Washout Period 4|Adverse Event|0|||
27530207|NCT02038829|80134828|FG008|Washout Period 4|Adverse Event|0|||
27530208|NCT02038829|80134829|FG009|Washout Period 4|Adverse Event|0|||
27530209|NCT02038829|80134830|FG010|Washout Period 4|Adverse Event|0|||
27530210|NCT02038829|80134831|FG011|Washout Period 4|Adverse Event|0|||
27530211|NCT02038829|80134820|FG000|Treatment Period 6|Adverse Event|0|||
27530212|NCT02038829|80134821|FG001|Treatment Period 6|Adverse Event|0|||
27530213|NCT02038829|80134822|FG002|Treatment Period 6|Adverse Event|1|||
27530214|NCT02038829|80134823|FG003|Treatment Period 6|Adverse Event|0|||
27530215|NCT02038829|80134824|FG004|Treatment Period 6|Adverse Event|0|||
27530216|NCT02038829|80134825|FG005|Treatment Period 6|Adverse Event|0|||
27530217|NCT02038829|80134826|FG006|Treatment Period 6|Adverse Event|0|||
27530218|NCT02038829|80134827|FG007|Treatment Period 6|Adverse Event|0|||
27530219|NCT02038829|80134828|FG008|Treatment Period 6|Adverse Event|0|||
27530220|NCT02038829|80134829|FG009|Treatment Period 6|Adverse Event|0|||
27530221|NCT02038829|80134830|FG010|Treatment Period 6|Adverse Event|0|||
27626439|NCT00536380|80473592|FG002|Overall Study|Noncompliance with protocol|2|||
27856528|NCT02038907|81306792|FG001|Overall Study|Protocol Violation|0|||
27626440|NCT00536380|80473590|FG000|Overall Study|Did not meet protocol eligibility|0|||
27626441|NCT00536380|80473591|FG001|Overall Study|Did not meet protocol eligibility|0|||
27626442|NCT00536380|80473592|FG002|Overall Study|Did not meet protocol eligibility|1|||
27626443|NCT00536380|80473590|FG000|Overall Study|Administrative|0|||
27626444|NCT00536380|80473591|FG001|Overall Study|Administrative|0|||
27626445|NCT00536380|80473592|FG002|Overall Study|Administrative|1|||
27626446|NCT02377362|80473593|FG000|Part A Second Treatment|Protocol Violation|0|||
27626447|NCT02377362|80473594|FG001|Part A Second Treatment|Protocol Violation|0|||
27626448|NCT02377362|80473595|FG002|Part A Second Treatment|Protocol Violation|0|||
27626449|NCT02377362|80473596|FG003|Part A Second Treatment|Protocol Violation|0|||
27626450|NCT02377362|80473597|FG004|Part A Second Treatment|Protocol Violation|1|||
27626451|NCT02377362|80473598|FG005|Part A Second Treatment|Protocol Violation|0|||
27626452|NCT02377362|80473599|FG006|Part A Second Treatment|Protocol Violation|0|||
27626453|NCT02377362|80473600|FG007|Part A Second Treatment|Protocol Violation|0|||
27626454|NCT02377362|80473601|FG008|Part A Second Treatment|Protocol Violation|0|||
27626455|NCT02377362|80473602|FG009|Part A Second Treatment|Protocol Violation|0|||
27626456|NCT02377362|80473603|FG010|Part A Second Treatment|Protocol Violation|0|||
27626457|NCT02377362|80473604|FG011|Part A Second Treatment|Protocol Violation|0|||
27626458|NCT02377362|80473605|FG012|Part A Second Treatment|Protocol Violation|0|||
27626459|NCT02377362|80473593|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626460|NCT02377362|80473594|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626461|NCT02377362|80473595|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626462|NCT02377362|80473596|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
27626463|NCT02377362|80473597|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
27626464|NCT02377362|80473598|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
27626465|NCT02377362|80473599|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626466|NCT02377362|80473600|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626467|NCT02377362|80473601|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626468|NCT02377362|80473602|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626469|NCT02377362|80473603|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626470|NCT02377362|80473604|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626471|NCT02377362|80473605|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
27626472|NCT02377362|80473593|FG000|Part B Overall|Protocol Violation|0|||
27856529|NCT02038907|81306793|FG002|Overall Study|Protocol Violation|0|||
27856530|NCT02038907|81306794|FG003|Overall Study|Protocol Violation|0|||
27856531|NCT02038907|81306795|FG004|Overall Study|Protocol Violation|0|||
27856532|NCT02038907|81306796|FG005|Overall Study|Protocol Violation|0|||
27856533|NCT02038907|81306797|FG006|Overall Study|Protocol Violation|0|||
27530222|NCT02038829|80134831|FG011|Treatment Period 6|Adverse Event|0|||
27530223|NCT00048061|80134832|FG000|Overall Study|Adverse Event|41|||
27530224|NCT00048061|80134833|FG001|Overall Study|Adverse Event|32|||
27530225|NCT00048061|80134834|FG002|Overall Study|Adverse Event|44|||
27530226|NCT00048061|80134835|FG003|Overall Study|Adverse Event|37|||
27530227|NCT00048061|80134832|FG000|Overall Study|Lost to Follow-up|3|||
27734907|NCT01478958|80857143|FG001|Overall Study|Withdrawal by Subject|1|||
27734908|NCT01478958|80857144|FG002|Overall Study|Withdrawal by Subject|1|||
27734909|NCT01478958|80857142|FG000|Overall Study|Weight loss|1|||
27734910|NCT01478958|80857143|FG001|Overall Study|Weight loss|0|||
27734911|NCT01478958|80857144|FG002|Overall Study|Weight loss|0|||
27734912|NCT01478958|80857142|FG000|Overall Study|Re-located|0|||
27734913|NCT01478958|80857143|FG001|Overall Study|Re-located|1|||
27734914|NCT01478958|80857144|FG002|Overall Study|Re-located|0|||
27734915|NCT01478958|80857142|FG000|Overall Study|Unable to comply|0|||
27734916|NCT01478958|80857143|FG001|Overall Study|Unable to comply|0|||
27734917|NCT01478958|80857144|FG002|Overall Study|Unable to comply|2|||
27734918|NCT02966314|80857147|FG000|Overall Study|Lost to Follow-up|1|||
27734919|NCT02966314|80857148|FG001|Overall Study|Lost to Follow-up|0|||
27734920|NCT02034123|80857152|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734921|NCT02034123|80857153|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734922|NCT02034123|80857154|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734923|NCT02034123|80857155|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734924|NCT02034123|80857156|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
27734925|NCT02034123|80857157|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734926|NCT02034123|80857158|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734927|NCT02034123|80857159|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
27734928|NCT02034123|80857160|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
27734929|NCT02034123|80857161|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734930|NCT02034123|80857162|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734931|NCT02034123|80857163|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734932|NCT02034123|80857164|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734933|NCT02034123|80857165|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734934|NCT02034123|80857166|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734935|NCT02034123|80857167|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734936|NCT02034123|80857168|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734937|NCT02034123|80857169|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
27734938|NCT02034123|80857152|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734939|NCT02034123|80857153|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734940|NCT02034123|80857154|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734941|NCT02034123|80857155|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
27734942|NCT02034123|80857156|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734943|NCT02034123|80857157|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734944|NCT02034123|80857158|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734945|NCT02034123|80857159|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734946|NCT02034123|80857160|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734947|NCT02034123|80857161|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734948|NCT02034123|80857162|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734949|NCT02034123|80857163|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734950|NCT02034123|80857164|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734951|NCT02034123|80857165|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734952|NCT02034123|80857166|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734953|NCT02034123|80857167|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27530228|NCT00048061|80134833|FG001|Overall Study|Lost to Follow-up|2|||
27530229|NCT00048061|80134834|FG002|Overall Study|Lost to Follow-up|4|||
27530230|NCT00048061|80134835|FG003|Overall Study|Lost to Follow-up|5|||
27626473|NCT02377362|80473594|FG001|Part B Overall|Protocol Violation|0|||
27734954|NCT02034123|80857168|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734955|NCT02034123|80857169|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
27734956|NCT02034123|80857152|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734957|NCT02034123|80857153|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734958|NCT02034123|80857154|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734959|NCT02034123|80857155|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734960|NCT02034123|80857156|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734961|NCT02034123|80857157|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734962|NCT02034123|80857158|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734963|NCT02034123|80857159|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734964|NCT02034123|80857160|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
27734965|NCT02034123|80857161|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734966|NCT02034123|80857162|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734967|NCT02034123|80857163|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734968|NCT02034123|80857164|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27626474|NCT02377362|80473595|FG002|Part B Overall|Protocol Violation|0|||
27734969|NCT02034123|80857165|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734970|NCT02034123|80857166|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734971|NCT02034123|80857167|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734972|NCT02034123|80857168|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734973|NCT02034123|80857169|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
27734974|NCT02034123|80857152|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734975|NCT02034123|80857153|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734976|NCT02034123|80857154|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734977|NCT02034123|80857155|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
27734978|NCT02034123|80857156|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
27856534|NCT02038907|81306798|FG007|Overall Study|Protocol Violation|0|||
27856535|NCT02038907|81306799|FG008|Overall Study|Protocol Violation|0|||
27856536|NCT02038907|81306800|FG009|Overall Study|Protocol Violation|0|||
27856537|NCT02038907|81306801|FG010|Overall Study|Protocol Violation|1|||
27856538|NCT02038907|81306802|FG011|Overall Study|Protocol Violation|0|||
27530231|NCT00048061|80134832|FG000|Overall Study|Withdrawal by Subject|20|||
27530232|NCT00048061|80134833|FG001|Overall Study|Withdrawal by Subject|29|||
27530233|NCT00048061|80134834|FG002|Overall Study|Withdrawal by Subject|29|||
27734979|NCT02034123|80857157|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734980|NCT02034123|80857158|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734981|NCT02034123|80857159|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734982|NCT02034123|80857160|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734983|NCT02034123|80857161|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734984|NCT02034123|80857162|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734985|NCT02034123|80857163|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734986|NCT02034123|80857164|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734987|NCT02034123|80857165|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734988|NCT02034123|80857166|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734989|NCT02034123|80857167|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734990|NCT02034123|80857168|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734991|NCT02034123|80857169|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
27734992|NCT03311126|80857170|FG000|Induction|Death|1|||
27734993|NCT03311126|80857170|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
27734994|NCT02909153|80857171|FG000|Overall Study|Withdrawal by Subject|0|||
27734995|NCT02909153|80857172|FG001|Overall Study|Withdrawal by Subject|1|||
27856539|NCT02038907|81306803|FG012|Overall Study|Protocol Violation|0|||
27856540|NCT02038907|81306804|FG013|Overall Study|Protocol Violation|0|||
27856541|NCT02038907|81306791|FG000|Overall Study|Withdrawal by Subject|0|||
27530234|NCT00048061|80134835|FG003|Overall Study|Withdrawal by Subject|32|||
27530235|NCT00048061|80134832|FG000|Overall Study|Did not follow-up|5|||
27530236|NCT00048061|80134833|FG001|Overall Study|Did not follow-up|5|||
27530237|NCT00048061|80134834|FG002|Overall Study|Did not follow-up|4|||
27530238|NCT00048061|80134835|FG003|Overall Study|Did not follow-up|5|||
27530239|NCT00048061|80134832|FG000|Overall Study|Early improvement|6|||
27530240|NCT00048061|80134833|FG001|Overall Study|Early improvement|5|||
27530241|NCT00048061|80134834|FG002|Overall Study|Early improvement|3|||
27530242|NCT00048061|80134835|FG003|Overall Study|Early improvement|0|||
27626475|NCT02377362|80473596|FG003|Part B Overall|Protocol Violation|0|||
27626476|NCT02377362|80473597|FG004|Part B Overall|Protocol Violation|0|||
27856542|NCT02038907|81306792|FG001|Overall Study|Withdrawal by Subject|0|||
27530243|NCT00764504|80134836|FG000|Overall Study|Death|12|||
27530244|NCT00764504|80134837|FG001|Overall Study|Death|6|||
27530245|NCT00764504|80134838|FG002|Overall Study|Death|13|||
27530246|NCT00764504|80134836|FG000|Overall Study|Revision of Device|12|||
27530247|NCT00764504|80134837|FG001|Overall Study|Revision of Device|23|||
27530248|NCT00764504|80134838|FG002|Overall Study|Revision of Device|14|||
27530249|NCT00764504|80134836|FG000|Overall Study|Physician Decision|1|||
27530250|NCT00764504|80134837|FG001|Overall Study|Physician Decision|0|||
27530251|NCT00764504|80134838|FG002|Overall Study|Physician Decision|0|||
27530252|NCT00764504|80134836|FG000|Overall Study|Withdrawal by Subject|1|||
27530253|NCT00764504|80134837|FG001|Overall Study|Withdrawal by Subject|7|||
27530254|NCT00764504|80134838|FG002|Overall Study|Withdrawal by Subject|4|||
27530255|NCT00764504|80134836|FG000|Overall Study|Lost to Follow-up|40|||
27626477|NCT02377362|80473598|FG005|Part B Overall|Protocol Violation|0|||
27530256|NCT00764504|80134837|FG001|Overall Study|Lost to Follow-up|34|||
27530257|NCT00764504|80134838|FG002|Overall Study|Lost to Follow-up|72|||
27530258|NCT03505671|80134848|FG000|Overall Study|Withdrawal by Subject|2|||
27530259|NCT03505671|80134849|FG001|Overall Study|Withdrawal by Subject|1|||
27530260|NCT03505671|80134848|FG000|Overall Study|Lost to Follow-up|1|||
27530261|NCT03505671|80134849|FG001|Overall Study|Lost to Follow-up|0|||
27530262|NCT01476644|80134851|FG000|Overall Study|Death|5|||
27530263|NCT01476644|80134851|FG000|Overall Study|moved to another state|2|||
27626478|NCT02377362|80473599|FG006|Part B Overall|Protocol Violation|0|||
27626479|NCT02377362|80473600|FG007|Part B Overall|Protocol Violation|0|||
27626480|NCT02377362|80473601|FG008|Part B Overall|Protocol Violation|0|||
27626481|NCT02377362|80473602|FG009|Part B Overall|Protocol Violation|1|||
27626482|NCT02377362|80473603|FG010|Part B Overall|Protocol Violation|0|||
27530264|NCT01476644|80134851|FG000|Overall Study|Lost to Follow-up|19|||
27530265|NCT01476644|80134851|FG000|Overall Study|Withdrawal by Subject|13|||
27530266|NCT02898116|80134854|FG000|Overall Study|Adverse Event|1|||
27530267|NCT02898116|80134854|FG000|Overall Study|Progressive disease|1|||
27530268|NCT00597701|80134855|FG000|Overall Study|Withdrawal by Subject|5|||
27530269|NCT00597701|80134856|FG001|Overall Study|Withdrawal by Subject|5|||
27530270|NCT00597701|80134855|FG000|Overall Study|Death|0|||
27530271|NCT00597701|80134856|FG001|Overall Study|Death|1|||
27530272|NCT00597701|80134855|FG000|Overall Study|Physician Decision|2|||
27530273|NCT00597701|80134856|FG001|Overall Study|Physician Decision|0|||
27530274|NCT00597701|80134855|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
27530275|NCT00597701|80134856|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
27530276|NCT00107952|80134863|FG000|Overall Study|Death|75|||
27530277|NCT00107952|80134864|FG001|Overall Study|Death|61|||
27530278|NCT00107952|80134863|FG000|Overall Study|Lost to Follow-up|0|||
27530279|NCT00107952|80134864|FG001|Overall Study|Lost to Follow-up|3|||
27530280|NCT00107952|80134863|FG000|Overall Study|Withdrawal by Subject|9|||
27530281|NCT00107952|80134864|FG001|Overall Study|Withdrawal by Subject|6|||
27530282|NCT00107952|80134863|FG000|Overall Study|Other|2|||
27530283|NCT00107952|80134864|FG001|Overall Study|Other|5|||
27530284|NCT00107952|80134863|FG000|Overall Study|Never received study treatment|9|||
27530285|NCT00107952|80134864|FG001|Overall Study|Never received study treatment|6|||
27530286|NCT03960554|80134865|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
27530287|NCT03960554|80134866|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
27530288|NCT00560885|80134868|FG000|Overall Study|Death|7|||
27530289|NCT00560885|80134868|FG000|Overall Study|Withdrawal by Subject|1|||
27530290|NCT00433654|80134869|FG000|Overall Study|Death|4|||
27530291|NCT00433654|80134870|FG001|Overall Study|Death|0|||
27530292|NCT00433654|80134869|FG000|Overall Study|Missed visit|6|||
27530293|NCT00433654|80134870|FG001|Overall Study|Missed visit|3|||
27530294|NCT00433654|80134869|FG000|Overall Study|Subject not yet due for visit|4|||
27530295|NCT00433654|80134870|FG001|Overall Study|Subject not yet due for visit|0|||
27530296|NCT00433654|80134869|FG000|Overall Study|Withdrawal by Subject|1|||
27530297|NCT00433654|80134870|FG001|Overall Study|Withdrawal by Subject|2|||
27530298|NCT02445391|80134871|FG000|Overall Study|No active protocol treatment|3|||
27530299|NCT02445391|80134872|FG001|Overall Study|No active protocol treatment|0|||
27530300|NCT02445391|80134873|FG002|Overall Study|No active protocol treatment|0|||
27530301|NCT02445391|80134871|FG000|Overall Study|Adverse Event|0|||
27530302|NCT02445391|80134872|FG001|Overall Study|Adverse Event|21|||
27530303|NCT02445391|80134873|FG002|Overall Study|Adverse Event|12|||
27530304|NCT02445391|80134871|FG000|Overall Study|Alternative therapy|0|||
27530305|NCT02445391|80134872|FG001|Overall Study|Alternative therapy|0|||
27530306|NCT02445391|80134873|FG002|Overall Study|Alternative therapy|1|||
27530307|NCT02445391|80134871|FG000|Overall Study|Disease progression|0|||
27530308|NCT02445391|80134872|FG001|Overall Study|Disease progression|7|||
27530309|NCT02445391|80134873|FG002|Overall Study|Disease progression|22|||
27530310|NCT02445391|80134871|FG000|Overall Study|Complicating disease|0|||
27530311|NCT02445391|80134872|FG001|Overall Study|Complicating disease|2|||
27530312|NCT02445391|80134873|FG002|Overall Study|Complicating disease|1|||
27530313|NCT02445391|80134871|FG000|Overall Study|Withdrawal by Subject|0|||
27530314|NCT02445391|80134872|FG001|Overall Study|Withdrawal by Subject|4|||
27530315|NCT02445391|80134873|FG002|Overall Study|Withdrawal by Subject|9|||
27530316|NCT02445391|80134871|FG000|Overall Study|Financial issue|0|||
27530317|NCT02445391|80134872|FG001|Overall Study|Financial issue|0|||
27530318|NCT02445391|80134873|FG002|Overall Study|Financial issue|2|||
27530319|NCT02445391|80134871|FG000|Overall Study|Still on treatment|0|||
27530320|NCT02445391|80134872|FG001|Overall Study|Still on treatment|7|||
27626483|NCT02377362|80473604|FG011|Part B Overall|Protocol Violation|0|||
27626484|NCT02377362|80473605|FG012|Part B Overall|Protocol Violation|0|||
27626485|NCT02377362|80473593|FG000|Part B Overall|Adverse Event|0|||
27626486|NCT02377362|80473594|FG001|Part B Overall|Adverse Event|0|||
27530321|NCT02445391|80134873|FG002|Overall Study|Still on treatment|16|||
27530322|NCT02445391|80134871|FG000|Overall Study|Not start protocol therapy|0|||
27530323|NCT02445391|80134872|FG001|Overall Study|Not start protocol therapy|12|||
27530324|NCT02445391|80134873|FG002|Overall Study|Not start protocol therapy|9|||
27530325|NCT03977454|80134876|FG000|Overall Study|immediate postoperative revision|2|||
27530326|NCT03977454|80134877|FG001|Overall Study|immediate postoperative revision|2|||
27626487|NCT02377362|80473595|FG002|Part B Overall|Adverse Event|0|||
27530327|NCT04250714|80134878|FG000|Overall Study|Treatment - withdrawal by subject|14|||
27530328|NCT04250714|80134878|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
27530329|NCT04250714|80134878|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
27530330|NCT04250714|80134878|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
27734996|NCT02909153|80857173|FG002|Overall Study|Withdrawal by Subject|0|||
27734997|NCT02909153|80857174|FG003|Overall Study|Withdrawal by Subject|0|||
27734998|NCT02909153|80857175|FG004|Overall Study|Withdrawal by Subject|0|||
27734999|NCT00768560|80857176|FG000|Intervention Set 1|Adverse Event|0|||
27735000|NCT00768560|80857177|FG001|Intervention Set 1|Adverse Event|1|||
27735001|NCT00768560|80857178|FG002|Intervention Set 1|Adverse Event|0|||
27735002|NCT00768560|80857179|FG003|Intervention Set 1|Adverse Event|0|||
27735003|NCT00768560|80857180|FG004|Intervention Set 1|Adverse Event|0|||
27735004|NCT00768560|80857181|FG005|Intervention Set 1|Adverse Event|0|||
27735005|NCT00238264|80857184|FG000|Overall Study|Death|7|||
27735006|NCT00238264|80857184|FG000|Overall Study|Lost to Follow-up|18|||
27735007|NCT00238264|80857184|FG000|Overall Study|Withdrawal by Subject|4|||
27735008|NCT00238264|80857184|FG000|Overall Study|Ineligible|7|||
27735009|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
27735010|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
27735011|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
27735012|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
27735013|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
27735014|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
27735015|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
27735016|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
27735017|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
27735018|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
27735019|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
27735020|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
27735021|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
27735022|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
27735023|NCT00446030|80857185|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
27735024|NCT00446030|80857186|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
27735025|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
27735026|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
27735027|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
27735028|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
27735029|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
27735030|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
27735031|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
27530331|NCT04250714|80134878|FG000|Overall Study|Treatment - Death|1|||
27530332|NCT04250714|80134878|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
27530333|NCT04250714|80134878|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
27530334|NCT04250714|80134878|FG000|Overall Study|Attempt|2|||
27530335|NCT04250714|80134878|FG000|Overall Study|Intent|7|||
27530336|NCT00843726|80134879|FG000|Overall Study|Death|1|||
27530337|NCT00843726|80134880|FG001|Overall Study|Death|0|||
27530338|NCT00843726|80134879|FG000|Overall Study|Withdrawal by Subject|0|||
27530339|NCT00843726|80134880|FG001|Overall Study|Withdrawal by Subject|1|||
27530340|NCT00084838|80134882|FG000|Overall Study|Death|1|||
27735032|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
27735033|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
27735034|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
27735035|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
27735036|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
27735037|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
27735038|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
27735039|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
27530341|NCT00084838|80134882|FG000|Overall Study|Adverse Event|2|||
27530342|NCT00084838|80134882|FG000|Overall Study|Withdrawal by Subject|1|||
27530343|NCT00084838|80134882|FG000|Overall Study|Progressive Disease|4|||
27530344|NCT00084838|80134882|FG000|Overall Study|Pt Non-Compliance|1|||
27530345|NCT00084838|80134882|FG000|Overall Study|Ineligible|4|||
27530346|NCT01155219|80134883|FG000|Overall Study|Adverse Event|3|||
27626488|NCT02377362|80473596|FG003|Part B Overall|Adverse Event|0|||
27626489|NCT02377362|80473597|FG004|Part B Overall|Adverse Event|0|||
27626490|NCT02377362|80473598|FG005|Part B Overall|Adverse Event|0|||
27735040|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
27735041|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
27626491|NCT02377362|80473599|FG006|Part B Overall|Adverse Event|1|||
27735042|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
27735043|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
27735044|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
27530347|NCT01155219|80134884|FG001|Overall Study|Adverse Event|1|||
27530348|NCT01155219|80134883|FG000|Overall Study|non-medical reason|1|||
27530349|NCT01155219|80134884|FG001|Overall Study|non-medical reason|2|||
27530350|NCT00364130|80134886|FG000|Intervention Period|Lost to Follow-up|4|||
27530351|NCT00364130|80134887|FG001|Intervention Period|Lost to Follow-up|3|||
27530352|NCT00364130|80134886|FG000|Intervention Period|Pregnancy|1|||
27530353|NCT00364130|80134887|FG001|Intervention Period|Pregnancy|0|||
27530354|NCT00364130|80134886|FG000|Intervention Period|Withdrawal by Subject|4|||
27530355|NCT00364130|80134887|FG001|Intervention Period|Withdrawal by Subject|5|||
27856543|NCT02038907|81306793|FG002|Overall Study|Withdrawal by Subject|0|||
27856544|NCT02038907|81306794|FG003|Overall Study|Withdrawal by Subject|0|||
27856545|NCT02038907|81306795|FG004|Overall Study|Withdrawal by Subject|0|||
27856546|NCT02038907|81306796|FG005|Overall Study|Withdrawal by Subject|0|||
27856547|NCT02038907|81306797|FG006|Overall Study|Withdrawal by Subject|0|||
27856548|NCT02038907|81306798|FG007|Overall Study|Withdrawal by Subject|0|||
27530356|NCT00364130|80134886|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
27530357|NCT00364130|80134887|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
27530358|NCT00997438|80134894|FG000|Overall Study|Blood draw difficulty|2|||
27530359|NCT00997438|80134895|FG001|Overall Study|Blood draw difficulty|0|||
27530360|NCT00997438|80134896|FG002|Overall Study|Blood draw difficulty|1|||
27530361|NCT00997438|80134894|FG000|Overall Study|Withdrawal by Subject|1|||
27530362|NCT00997438|80134895|FG001|Overall Study|Withdrawal by Subject|1|||
27530363|NCT00997438|80134896|FG002|Overall Study|Withdrawal by Subject|0|||
27530364|NCT00997438|80134894|FG000|Overall Study|Exclusion criteria at visit 1|2|||
27530365|NCT00997438|80134895|FG001|Overall Study|Exclusion criteria at visit 1|2|||
27530366|NCT00997438|80134896|FG002|Overall Study|Exclusion criteria at visit 1|3|||
27530367|NCT00901927|80134897|FG000|Overall Study|Lack of Efficacy|1|||
27530368|NCT00901927|80134897|FG000|Overall Study|Protocol Violation|3|||
27530369|NCT00901927|80134897|FG000|Overall Study|Withdrawal by Subject|2|||
27530370|NCT01483690|80134898|FG000|Overall Study|Adverse Event|1|||
27530371|NCT01483690|80134899|FG001|Overall Study|Adverse Event|2|||
27530372|NCT01483690|80134898|FG000|Overall Study|clinical deterioration|1|||
27530373|NCT01483690|80134899|FG001|Overall Study|clinical deterioration|0|||
27530374|NCT01483690|80134898|FG000|Overall Study|Physician Decision|0|||
27530375|NCT01483690|80134899|FG001|Overall Study|Physician Decision|2|||
27530376|NCT01483690|80134898|FG000|Overall Study|exclusionary procedure|0|||
27530377|NCT01483690|80134899|FG001|Overall Study|exclusionary procedure|1|||
27530378|NCT03052764|80134900|FG000|Double-Blind Treatment Period|Adverse Event|2|||
27530379|NCT03052764|80134901|FG001|Double-Blind Treatment Period|Adverse Event|0|||
27530380|NCT03052764|80134900|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
27530381|NCT03052764|80134901|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
27530382|NCT03052764|80134900|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
27530383|NCT03052764|80134901|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
27530384|NCT03052764|80134900|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
27530385|NCT03052764|80134901|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27530386|NCT03052764|80134900|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
27530387|NCT03052764|80134901|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
27530388|NCT03332771|80134904|FG000|Overall Study|Adverse Event|6|||
27530389|NCT03332771|80134905|FG001|Overall Study|Adverse Event|4|||
27856549|NCT02038907|81306799|FG008|Overall Study|Withdrawal by Subject|0|||
27856550|NCT02038907|81306800|FG009|Overall Study|Withdrawal by Subject|0|||
27856551|NCT02038907|81306801|FG010|Overall Study|Withdrawal by Subject|1|||
27856552|NCT02038907|81306802|FG011|Overall Study|Withdrawal by Subject|0|||
27856553|NCT02038907|81306803|FG012|Overall Study|Withdrawal by Subject|0|||
27856554|NCT02038907|81306804|FG013|Overall Study|Withdrawal by Subject|0|||
27856555|NCT03469336|81306809|FG000|Overall Study|Adverse Event|1|||
27856556|NCT02331368|81306810|FG000|Overall Study|Withdrawal by Subject|3|||
27912157|NCT00103285|81518118|FG005|Induction|Physician Decision|0|||
27912158|NCT00103285|81518119|FG006|Induction|Physician Decision|0|||
27912159|NCT00103285|81518120|FG007|Induction|Physician Decision|0|||
27912160|NCT00103285|81518113|FG000|Induction|Withdrawal by Subject|1|||
27912161|NCT00103285|81518114|FG001|Induction|Withdrawal by Subject|0|||
27912162|NCT00103285|81518115|FG002|Induction|Withdrawal by Subject|0|||
27912163|NCT00103285|81518116|FG003|Induction|Withdrawal by Subject|0|||
27912164|NCT00103285|81518117|FG004|Induction|Withdrawal by Subject|0|||
27912165|NCT00103285|81518118|FG005|Induction|Withdrawal by Subject|0|||
27912166|NCT00103285|81518119|FG006|Induction|Withdrawal by Subject|0|||
27912167|NCT00103285|81518120|FG007|Induction|Withdrawal by Subject|0|||
27530390|NCT03332771|80134906|FG002|Overall Study|Adverse Event|1|||
27856557|NCT00616629|81306813|FG000|Overall Study|Protocol Violation|1|||
27912168|NCT00103285|81518113|FG000|Induction|Ineligible|43|||
27530391|NCT03332771|80134907|FG003|Overall Study|Adverse Event|3|||
27626492|NCT02377362|80473600|FG007|Part B Overall|Adverse Event|1|||
27856558|NCT00616629|81306814|FG001|Overall Study|Protocol Violation|2|||
27856559|NCT00616629|81306815|FG002|Overall Study|Protocol Violation|1|||
27912169|NCT00103285|81518114|FG001|Induction|Ineligible|0|||
27912170|NCT00103285|81518115|FG002|Induction|Ineligible|0|||
27530392|NCT03332771|80134904|FG000|Overall Study|Poor Compliance to Protocol|0|||
27530393|NCT03332771|80134905|FG001|Overall Study|Poor Compliance to Protocol|1|||
27530394|NCT03332771|80134906|FG002|Overall Study|Poor Compliance to Protocol|0|||
27856560|NCT00616629|81306816|FG003|Overall Study|Protocol Violation|0|||
27912171|NCT00103285|81518116|FG003|Induction|Ineligible|0|||
27530395|NCT03332771|80134907|FG003|Overall Study|Poor Compliance to Protocol|1|||
27912172|NCT00103285|81518117|FG004|Induction|Ineligible|0|||
27912173|NCT00103285|81518118|FG005|Induction|Ineligible|0|||
27912174|NCT00103285|81518119|FG006|Induction|Ineligible|0|||
27912175|NCT00103285|81518120|FG007|Induction|Ineligible|0|||
27912176|NCT00103285|81518113|FG000|Induction|Refusal|906|||
27912177|NCT00103285|81518114|FG001|Induction|Refusal|0|||
27912178|NCT00103285|81518115|FG002|Induction|Refusal|0|||
27530396|NCT03332771|80134904|FG000|Overall Study|Lost to Follow-up|2|||
27530397|NCT03332771|80134905|FG001|Overall Study|Lost to Follow-up|2|||
27530398|NCT03332771|80134906|FG002|Overall Study|Lost to Follow-up|1|||
27530399|NCT03332771|80134907|FG003|Overall Study|Lost to Follow-up|2|||
27530400|NCT03332771|80134904|FG000|Overall Study|At the Participant's own request|20|||
27530401|NCT03332771|80134905|FG001|Overall Study|At the Participant's own request|26|||
27530402|NCT03332771|80134906|FG002|Overall Study|At the Participant's own request|14|||
27530403|NCT03332771|80134907|FG003|Overall Study|At the Participant's own request|23|||
27530404|NCT03332771|80134904|FG000|Overall Study|Reason Not Specified|6|||
27530405|NCT03332771|80134905|FG001|Overall Study|Reason Not Specified|18|||
27530406|NCT03332771|80134906|FG002|Overall Study|Reason Not Specified|16|||
27530407|NCT03332771|80134907|FG003|Overall Study|Reason Not Specified|19|||
27530408|NCT03416374|80134908|FG000|Between Treatment Period I and II|Other|0|||
27530409|NCT03416374|80134909|FG001|Between Treatment Period I and II|Other|9|||
27530410|NCT03416374|80134908|FG000|Treatment Period II|Lack of Efficacy|3|||
27530411|NCT03416374|80134909|FG001|Treatment Period II|Lack of Efficacy|11|||
27530412|NCT03416374|80134908|FG000|Treatment Period II|Adverse Event|1|||
27530413|NCT03416374|80134909|FG001|Treatment Period II|Adverse Event|4|||
27530414|NCT03416374|80134908|FG000|Treatment Period II|Death|0|||
27530415|NCT03416374|80134909|FG001|Treatment Period II|Death|1|||
27530416|NCT03416374|80134908|FG000|Treatment Period II|Other|0|||
27530417|NCT03416374|80134909|FG001|Treatment Period II|Other|2|||
27530418|NCT02567552|80134911|FG000|Overall Study|Adverse Event|0|||
27530419|NCT02567552|80134912|FG001|Overall Study|Adverse Event|1|||
27530420|NCT03206073|80134913|FG000|Overall Study|Participant Noncompliance|0|||
27530421|NCT03206073|80134914|FG001|Overall Study|Participant Noncompliance|1|||
27530422|NCT03206073|80134915|FG002|Overall Study|Participant Noncompliance|0|||
27530423|NCT03206073|80134916|FG003|Overall Study|Participant Noncompliance|0|||
27530424|NCT03206073|80134913|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
27626493|NCT02377362|80473601|FG008|Part B Overall|Adverse Event|0|||
27626494|NCT02377362|80473602|FG009|Part B Overall|Adverse Event|0|||
27626495|NCT02377362|80473603|FG010|Part B Overall|Adverse Event|0|||
27626496|NCT02377362|80473604|FG011|Part B Overall|Adverse Event|0|||
27626497|NCT02377362|80473605|FG012|Part B Overall|Adverse Event|0|||
27626498|NCT02377362|80473593|FG000|Part B Overall|Withdrawal by Subject|0|||
27626499|NCT02377362|80473594|FG001|Part B Overall|Withdrawal by Subject|0|||
27626500|NCT02377362|80473595|FG002|Part B Overall|Withdrawal by Subject|0|||
27626501|NCT02377362|80473596|FG003|Part B Overall|Withdrawal by Subject|0|||
27626502|NCT02377362|80473597|FG004|Part B Overall|Withdrawal by Subject|0|||
27626503|NCT02377362|80473598|FG005|Part B Overall|Withdrawal by Subject|0|||
27626504|NCT02377362|80473599|FG006|Part B Overall|Withdrawal by Subject|1|||
27626505|NCT02377362|80473600|FG007|Part B Overall|Withdrawal by Subject|0|||
27626506|NCT02377362|80473601|FG008|Part B Overall|Withdrawal by Subject|0|||
27626507|NCT02377362|80473602|FG009|Part B Overall|Withdrawal by Subject|0|||
27626508|NCT02377362|80473603|FG010|Part B Overall|Withdrawal by Subject|0|||
27626509|NCT02377362|80473604|FG011|Part B Overall|Withdrawal by Subject|1|||
27626510|NCT02377362|80473605|FG012|Part B Overall|Withdrawal by Subject|0|||
27626511|NCT04109118|80473606|FG000|Overall Study|Lost to Follow-up|3|||
27626512|NCT02219490|80473611|FG000|Overall Study|Adverse Event|24|||
27626513|NCT02219490|80473611|FG000|Overall Study|Withdrew consent|96|||
27626514|NCT02219490|80473611|FG000|Overall Study|Lost to Follow-up|126|||
27626515|NCT02219490|80473611|FG000|Overall Study|COVID-19 infection|2|||
27626516|NCT02219490|80473611|FG000|Overall Study|COVID-19 logistical restrictions|33|||
27912179|NCT00103285|81518116|FG003|Induction|Refusal|0|||
27912180|NCT00103285|81518117|FG004|Induction|Refusal|0|||
27912181|NCT00103285|81518118|FG005|Induction|Refusal|0|||
27626517|NCT02219490|80473611|FG000|Overall Study|Other, not specified|57|||
27626518|NCT03643211|80473612|FG000|Overall Study|Contract violation/deficiency|12|||
27626519|NCT03643211|80473612|FG000|Overall Study|Invalid registration|3|||
27735045|NCT00446030|80857185|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
27912182|NCT00103285|81518119|FG006|Induction|Refusal|0|||
27626520|NCT03643211|80473612|FG000|Overall Study|No treatment information|2|||
27912183|NCT00103285|81518120|FG007|Induction|Refusal|0|||
27912184|NCT00103285|81518113|FG000|Induction|Other|258|||
27530425|NCT03206073|80134914|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
27530426|NCT03206073|80134915|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
27530427|NCT03206073|80134916|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
27530428|NCT03206073|80134913|FG000|Overall Study|Death|0|||
27912185|NCT00103285|81518114|FG001|Induction|Other|0|||
27912186|NCT00103285|81518115|FG002|Induction|Other|0|||
27626521|NCT03643211|80473612|FG000|Overall Study|No adverse event information - No revisit|4|||
27626522|NCT00938340|80473614|FG000|Overall Study|Withdrawal by Subject|3|||
27626523|NCT00938340|80473614|FG000|Overall Study|Protocol Violation|1|||
27626524|NCT00938340|80473614|FG000|Overall Study|Adverse Event|1|||
27626525|NCT02430532|80473615|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
27626526|NCT02430532|80473616|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
27626527|NCT02430532|80473615|FG000|Overall Study|Consent Withdrawn|0|||
27626528|NCT02430532|80473616|FG001|Overall Study|Consent Withdrawn|2|||
27626529|NCT02430532|80473615|FG000|Overall Study|Adverse Event|0|||
27626530|NCT02430532|80473616|FG001|Overall Study|Adverse Event|1|||
27626531|NCT03158948|80473617|FG000|Overall Study|Death|1|||
27626532|NCT03158948|80473618|FG001|Overall Study|Death|1|||
27626533|NCT03158948|80473619|FG002|Overall Study|Death|3|||
27626534|NCT03158948|80473620|FG003|Overall Study|Death|2|||
27626535|NCT03158948|80473617|FG000|Overall Study|Physician Decision|0|||
27626536|NCT03158948|80473618|FG001|Overall Study|Physician Decision|0|||
27626537|NCT03158948|80473619|FG002|Overall Study|Physician Decision|0|||
27626538|NCT03158948|80473620|FG003|Overall Study|Physician Decision|1|||
27626539|NCT00941031|80473623|FG000|Induction Period|Lack of Efficacy|2|||
27626540|NCT00941031|80473624|FG001|Induction Period|Lack of Efficacy|1|||
27626541|NCT00941031|80473625|FG002|Induction Period|Lack of Efficacy|0|||
27626542|NCT00941031|80473626|FG003|Induction Period|Lack of Efficacy|5|||
27626543|NCT00941031|80473627|FG004|Induction Period|Lack of Efficacy|0|||
27626544|NCT00941031|80473628|FG005|Induction Period|Lack of Efficacy|0|||
27626545|NCT00941031|80473629|FG006|Induction Period|Lack of Efficacy|0|||
27626546|NCT00941031|80473623|FG000|Induction Period|Withdrawal by Subject|1|||
27626547|NCT00941031|80473624|FG001|Induction Period|Withdrawal by Subject|2|||
27626548|NCT00941031|80473625|FG002|Induction Period|Withdrawal by Subject|2|||
27626549|NCT00941031|80473626|FG003|Induction Period|Withdrawal by Subject|2|||
27626550|NCT00941031|80473627|FG004|Induction Period|Withdrawal by Subject|0|||
27626551|NCT00941031|80473628|FG005|Induction Period|Withdrawal by Subject|0|||
27626552|NCT00941031|80473629|FG006|Induction Period|Withdrawal by Subject|0|||
27626553|NCT00941031|80473623|FG000|Induction Period|Adminstative Problems|1|||
27626554|NCT00941031|80473624|FG001|Induction Period|Adminstative Problems|1|||
27626555|NCT00941031|80473625|FG002|Induction Period|Adminstative Problems|1|||
27626556|NCT00941031|80473626|FG003|Induction Period|Adminstative Problems|0|||
27626557|NCT00941031|80473627|FG004|Induction Period|Adminstative Problems|0|||
27626558|NCT00941031|80473628|FG005|Induction Period|Adminstative Problems|0|||
27626559|NCT00941031|80473629|FG006|Induction Period|Adminstative Problems|0|||
27626560|NCT00941031|80473623|FG000|Induction Period|Adverse Event|1|||
27626561|NCT00941031|80473624|FG001|Induction Period|Adverse Event|0|||
27626562|NCT00941031|80473625|FG002|Induction Period|Adverse Event|3|||
27626563|NCT00941031|80473626|FG003|Induction Period|Adverse Event|2|||
27626564|NCT00941031|80473627|FG004|Induction Period|Adverse Event|0|||
27626565|NCT00941031|80473628|FG005|Induction Period|Adverse Event|0|||
27626566|NCT00941031|80473629|FG006|Induction Period|Adverse Event|0|||
27626567|NCT00941031|80473623|FG000|Maintenance Period|Withdrawal by Subject|0|||
27626568|NCT00941031|80473624|FG001|Maintenance Period|Withdrawal by Subject|0|||
27626569|NCT00941031|80473625|FG002|Maintenance Period|Withdrawal by Subject|0|||
27626570|NCT00941031|80473626|FG003|Maintenance Period|Withdrawal by Subject|0|||
27626571|NCT00941031|80473627|FG004|Maintenance Period|Withdrawal by Subject|6|||
27626572|NCT00941031|80473628|FG005|Maintenance Period|Withdrawal by Subject|2|||
27626573|NCT00941031|80473629|FG006|Maintenance Period|Withdrawal by Subject|13|||
27626574|NCT00941031|80473623|FG000|Maintenance Period|Administrative Problems|0|||
27626575|NCT00941031|80473624|FG001|Maintenance Period|Administrative Problems|0|||
27626576|NCT00941031|80473625|FG002|Maintenance Period|Administrative Problems|0|||
27626577|NCT00941031|80473626|FG003|Maintenance Period|Administrative Problems|0|||
27626578|NCT00941031|80473627|FG004|Maintenance Period|Administrative Problems|1|||
27626579|NCT00941031|80473628|FG005|Maintenance Period|Administrative Problems|0|||
27626580|NCT00941031|80473629|FG006|Maintenance Period|Administrative Problems|1|||
27626581|NCT00941031|80473623|FG000|Maintenance Period|Protocol Violation|0|||
27626582|NCT00941031|80473624|FG001|Maintenance Period|Protocol Violation|0|||
27626583|NCT00941031|80473625|FG002|Maintenance Period|Protocol Violation|0|||
27626584|NCT00941031|80473626|FG003|Maintenance Period|Protocol Violation|0|||
27626585|NCT00941031|80473627|FG004|Maintenance Period|Protocol Violation|0|||
27626586|NCT00941031|80473628|FG005|Maintenance Period|Protocol Violation|0|||
27626587|NCT00941031|80473629|FG006|Maintenance Period|Protocol Violation|1|||
27626588|NCT00941031|80473623|FG000|Maintenance Period|Adverse Event|0|||
27626589|NCT00941031|80473624|FG001|Maintenance Period|Adverse Event|0|||
27626590|NCT00941031|80473625|FG002|Maintenance Period|Adverse Event|0|||
27626591|NCT00941031|80473626|FG003|Maintenance Period|Adverse Event|0|||
27626592|NCT00941031|80473627|FG004|Maintenance Period|Adverse Event|0|||
27626593|NCT00941031|80473628|FG005|Maintenance Period|Adverse Event|2|||
27626594|NCT00941031|80473629|FG006|Maintenance Period|Adverse Event|8|||
27626595|NCT00941031|80473623|FG000|Maintenance Period|Lost to Follow-up|0|||
27626596|NCT00941031|80473624|FG001|Maintenance Period|Lost to Follow-up|0|||
27626597|NCT00941031|80473625|FG002|Maintenance Period|Lost to Follow-up|0|||
27626598|NCT00941031|80473626|FG003|Maintenance Period|Lost to Follow-up|0|||
27626599|NCT00941031|80473627|FG004|Maintenance Period|Lost to Follow-up|2|||
27626600|NCT00941031|80473628|FG005|Maintenance Period|Lost to Follow-up|2|||
27626601|NCT00941031|80473629|FG006|Maintenance Period|Lost to Follow-up|7|||
27626602|NCT00941031|80473623|FG000|Maintenance Period|Lack of Efficacy|0|||
27626603|NCT00941031|80473624|FG001|Maintenance Period|Lack of Efficacy|0|||
27626604|NCT00941031|80473625|FG002|Maintenance Period|Lack of Efficacy|0|||
27626605|NCT00941031|80473626|FG003|Maintenance Period|Lack of Efficacy|0|||
27626606|NCT00941031|80473627|FG004|Maintenance Period|Lack of Efficacy|0|||
27626607|NCT00941031|80473628|FG005|Maintenance Period|Lack of Efficacy|0|||
27626608|NCT00941031|80473629|FG006|Maintenance Period|Lack of Efficacy|13|||
27626609|NCT02359435|80473630|FG000|Overall Study|Lost to Follow-up|4|||
27626610|NCT02359435|80473631|FG001|Overall Study|Lost to Follow-up|4|||
27626611|NCT03822351|80473632|FG000|Overall Study|Death|27|||
27626612|NCT03822351|80473633|FG001|Overall Study|Death|23|||
27626613|NCT03822351|80473634|FG002|Overall Study|Death|24|||
27626614|NCT03822351|80473632|FG000|Overall Study|Lost to Follow-up|6|||
27626615|NCT03822351|80473633|FG001|Overall Study|Lost to Follow-up|2|||
27626616|NCT03822351|80473634|FG002|Overall Study|Lost to Follow-up|1|||
27626617|NCT03822351|80473632|FG000|Overall Study|Withdrawal by Subject|10|||
27626618|NCT03822351|80473633|FG001|Overall Study|Withdrawal by Subject|4|||
27626619|NCT03822351|80473634|FG002|Overall Study|Withdrawal by Subject|6|||
27626620|NCT03822351|80473632|FG000|Overall Study|Progressive Disease|2|||
27626621|NCT03822351|80473633|FG001|Overall Study|Progressive Disease|1|||
27626622|NCT03822351|80473634|FG002|Overall Study|Progressive Disease|0|||
27626623|NCT03822351|80473632|FG000|Overall Study|Not Treated|1|||
27626624|NCT03822351|80473633|FG001|Overall Study|Not Treated|1|||
27626625|NCT03822351|80473634|FG002|Overall Study|Not Treated|1|||
27626626|NCT00506519|80473636|FG000|Overall Study|Death|4|||
27626627|NCT00506519|80473637|FG001|Overall Study|Death|6|||
27626628|NCT00506519|80473638|FG002|Overall Study|Death|0|||
27626629|NCT00506519|80473636|FG000|Overall Study|Adverse Event|1|||
27626630|NCT00506519|80473637|FG001|Overall Study|Adverse Event|0|||
27626631|NCT00506519|80473638|FG002|Overall Study|Adverse Event|0|||
27626632|NCT01333514|80473639|FG000|Overall Study|Withdrawal by Subject|1|||
27626633|NCT01333514|80473640|FG001|Overall Study|Withdrawal by Subject|0|||
27626634|NCT00554801|80473643|FG000|Overall Study|left area before completion|5|||
27626635|NCT00554801|80473644|FG001|Overall Study|left area before completion|0|||
27626636|NCT00554801|80473643|FG000|Overall Study|Withdrawal by Subject|14|||
27626637|NCT00554801|80473644|FG001|Overall Study|Withdrawal by Subject|0|||
27626638|NCT01784068|80476732|FG000|NTCS Phase|Adverse Event|5|||
27626639|NCT01784068|80476733|FG001|NTCS Phase|Adverse Event|0|||
27626640|NCT01784068|80476732|FG000|NTCS Phase|Physician Decision|2|||
27626641|NCT01784068|80476733|FG001|NTCS Phase|Physician Decision|0|||
27626642|NCT01784068|80476732|FG000|NTCS Phase|Patient/guardian decision|3|||
27626643|NCT01784068|80476733|FG001|NTCS Phase|Patient/guardian decision|0|||
27626644|NCT01784068|80476732|FG000|NTCS Phase|Death|2|||
27626645|NCT01784068|80476733|FG001|NTCS Phase|Death|0|||
27626646|NCT01784068|80476732|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
27626647|NCT01784068|80476733|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
27626648|NCT01784068|80476732|FG000|TFR Phase|Physician Decision|0|||
27626649|NCT01784068|80476733|FG001|TFR Phase|Physician Decision|1|||
27626650|NCT01784068|80476732|FG000|TFR Phase|Patient/guardian decision|0|||
27626651|NCT01784068|80476733|FG001|TFR Phase|Patient/guardian decision|3|||
27626652|NCT01784068|80476732|FG000|TFR Phase|Death|0|||
27626653|NCT01784068|80476733|FG001|TFR Phase|Death|1|||
27626654|NCT01784068|80476732|FG000|TFR Phase|Lack of Efficacy|0|||
27626655|NCT01784068|80476733|FG001|TFR Phase|Lack of Efficacy|88|||
27626656|NCT01007149|80476734|FG000|Overall Study|Administrative problems|0|||
27626657|NCT01007149|80476735|FG001|Overall Study|Administrative problems|1|||
27626658|NCT03563053|80476736|FG000|Overall Study|Withdrawal by Subject|17|||
27912187|NCT00103285|81518116|FG003|Induction|Other|0|||
27626659|NCT03563053|80476736|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
27626660|NCT03563053|80476736|FG000|Overall Study|Adverse Event|3|||
27626661|NCT03563053|80476736|FG000|Overall Study|Physician Decision|1|||
27626662|NCT03563053|80476736|FG000|Overall Study|study terminated by sponsor|71|||
27626663|NCT01704846|80476737|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27626664|NCT01704846|80476738|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27626665|NCT03852433|80476743|FG000|Overall Study|Withdrawal of consent|5|||
27626666|NCT03852433|80476744|FG001|Overall Study|Withdrawal of consent|8|||
27626667|NCT03852433|80476745|FG002|Overall Study|Withdrawal of consent|1|||
27626668|NCT03852433|80476746|FG003|Overall Study|Withdrawal of consent|1|||
27626669|NCT03852433|80476743|FG000|Overall Study|Adverse Event|1|||
27626670|NCT03852433|80476744|FG001|Overall Study|Adverse Event|1|||
27626671|NCT03852433|80476745|FG002|Overall Study|Adverse Event|1|||
27626672|NCT03852433|80476746|FG003|Overall Study|Adverse Event|1|||
27626673|NCT03852433|80476743|FG000|Overall Study|Lost to Follow-up|0|||
27626674|NCT03852433|80476744|FG001|Overall Study|Lost to Follow-up|1|||
27626675|NCT03852433|80476745|FG002|Overall Study|Lost to Follow-up|0|||
27626676|NCT03852433|80476746|FG003|Overall Study|Lost to Follow-up|1|||
27626677|NCT03852433|80476743|FG000|Overall Study|Pregnancy|0|||
27626678|NCT03852433|80476744|FG001|Overall Study|Pregnancy|1|||
27626679|NCT03852433|80476745|FG002|Overall Study|Pregnancy|1|||
27626680|NCT03852433|80476746|FG003|Overall Study|Pregnancy|0|||
27626681|NCT03852433|80476743|FG000|Overall Study|Protocol Violation|0|||
27626682|NCT03852433|80476744|FG001|Overall Study|Protocol Violation|0|||
27626683|NCT03852433|80476745|FG002|Overall Study|Protocol Violation|1|||
27626684|NCT03852433|80476746|FG003|Overall Study|Protocol Violation|1|||
27626685|NCT03852433|80476743|FG000|Overall Study|Death|0|||
27626686|NCT03852433|80476744|FG001|Overall Study|Death|0|||
27626687|NCT03852433|80476745|FG002|Overall Study|Death|1|||
27626688|NCT03852433|80476746|FG003|Overall Study|Death|0|||
27626689|NCT03852433|80476743|FG000|Overall Study|Lack of Efficacy|0|||
27626690|NCT03852433|80476744|FG001|Overall Study|Lack of Efficacy|1|||
27626691|NCT03852433|80476745|FG002|Overall Study|Lack of Efficacy|0|||
27626692|NCT03852433|80476746|FG003|Overall Study|Lack of Efficacy|0|||
27912188|NCT00103285|81518117|FG004|Induction|Other|0|||
27912189|NCT00103285|81518118|FG005|Induction|Other|0|||
27626693|NCT03852433|80476743|FG000|Overall Study|Non-compliance with study drug|0|||
27626694|NCT03852433|80476744|FG001|Overall Study|Non-compliance with study drug|0|||
27626695|NCT03852433|80476745|FG002|Overall Study|Non-compliance with study drug|0|||
27626696|NCT03852433|80476746|FG003|Overall Study|Non-compliance with study drug|1|||
27626697|NCT03852433|80476743|FG000|Overall Study|Physician Decision|1|||
27626698|NCT03852433|80476744|FG001|Overall Study|Physician Decision|0|||
27735046|NCT00446030|80857186|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
27735047|NCT00846742|80857196|FG000|Overall Study|Withdrawal by Subject|1|||
27626699|NCT03852433|80476745|FG002|Overall Study|Physician Decision|0|||
27626700|NCT03852433|80476746|FG003|Overall Study|Physician Decision|0|||
27626701|NCT03852433|80476743|FG000|Overall Study|Randomized but never treated|1|||
27626702|NCT03852433|80476744|FG001|Overall Study|Randomized but never treated|0|||
27626703|NCT03852433|80476745|FG002|Overall Study|Randomized but never treated|0|||
27626704|NCT03852433|80476746|FG003|Overall Study|Randomized but never treated|0|||
27626705|NCT05460663|80476755|FG000|Overall Study|Withdrawal by Subject|2|||
27626706|NCT05460663|80476756|FG001|Overall Study|Withdrawal by Subject|5|||
27626707|NCT01599325|80476758|FG000|Primary Parent Phase|Adverse Event|5|||
27530429|NCT03206073|80134914|FG001|Overall Study|Death|0|||
27626708|NCT01599325|80476758|FG000|Primary Parent Phase|Disease Progression|7|||
27856561|NCT00616629|81306817|FG004|Overall Study|Protocol Violation|0|||
27856562|NCT00616629|81306813|FG000|Overall Study|AV-block|1|||
27856563|NCT00616629|81306814|FG001|Overall Study|AV-block|0|||
27856564|NCT00616629|81306815|FG002|Overall Study|AV-block|0|||
27856565|NCT00616629|81306816|FG003|Overall Study|AV-block|0|||
27856566|NCT00616629|81306817|FG004|Overall Study|AV-block|0|||
27856567|NCT02338193|81306831|FG000|Overall Study|Withdrawal by Subject|0|||
27856568|NCT02338193|81306832|FG001|Overall Study|Withdrawal by Subject|0|||
27856569|NCT02338193|81306833|FG002|Overall Study|Withdrawal by Subject|2|||
27856570|NCT02338193|81306831|FG000|Overall Study|Pregnancy|0|||
27856571|NCT02338193|81306832|FG001|Overall Study|Pregnancy|1|||
27856572|NCT02338193|81306833|FG002|Overall Study|Pregnancy|1|||
27856573|NCT02338193|81306831|FG000|Overall Study|Noncompliant with visits|2|||
27856574|NCT02338193|81306832|FG001|Overall Study|Noncompliant with visits|2|||
27856575|NCT02338193|81306833|FG002|Overall Study|Noncompliant with visits|7|||
27912190|NCT00103285|81518119|FG006|Induction|Other|0|||
27626709|NCT01599325|80476758|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
27735048|NCT02048904|80857197|FG000|Overall Study|Withdrawal by Subject|7|||
27856576|NCT02338193|81306831|FG000|Overall Study|moved out of state|0|||
27912191|NCT00103285|81518120|FG007|Induction|Other|0|||
27912192|NCT00103285|81518113|FG000|Response Assignment|Adverse Event|0|||
27530430|NCT03206073|80134915|FG002|Overall Study|Death|1|||
27530431|NCT03206073|80134916|FG003|Overall Study|Death|0|||
27530432|NCT03206073|80134913|FG000|Overall Study|Taken off active treatment|0|||
27530433|NCT03206073|80134914|FG001|Overall Study|Taken off active treatment|0|||
27530434|NCT03206073|80134915|FG002|Overall Study|Taken off active treatment|3|||
27530435|NCT03206073|80134916|FG003|Overall Study|Taken off active treatment|0|||
27530436|NCT00749580|80134921|FG000|Overall Study|Lost to Follow-up|4|||
27530437|NCT00749580|80134922|FG001|Overall Study|Lost to Follow-up|8|||
27530438|NCT00749580|80134921|FG000|Overall Study|Adverse Event|0|||
27530439|NCT00749580|80134922|FG001|Overall Study|Adverse Event|1|||
27530440|NCT05128773|80134923|FG000|Overall Study|Sponsor decision to terminate study|3|||
27530441|NCT00055471|80134924|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
27530442|NCT00055471|80134925|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
27530443|NCT00055471|80134926|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
27530444|NCT00055471|80134924|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
27530445|NCT00055471|80134925|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
27530446|NCT00055471|80134926|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
27530447|NCT00055471|80134924|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
27530448|NCT00055471|80134925|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
27530449|NCT00055471|80134926|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
27530450|NCT00301821|80134927|FG000|Overall Study|Ineligible|25|||
27530451|NCT00301821|80134927|FG000|Overall Study|Cancel|1|||
27530452|NCT00072176|80134932|FG000|Overall Study|Withdrawal by Subject|1|||
27530453|NCT00072176|80134933|FG001|Overall Study|Withdrawal by Subject|0|||
27530454|NCT00072176|80134932|FG000|Overall Study|Protocol Violation|0|||
27530455|NCT00072176|80134933|FG001|Overall Study|Protocol Violation|1|||
27530456|NCT01002482|80134940|FG000|Overall Study|Withdrawal by Subject|14|||
27530457|NCT01002482|80134941|FG001|Overall Study|Withdrawal by Subject|21|||
27530458|NCT01002482|80134940|FG000|Overall Study|Included twice|1|||
27530459|NCT01002482|80134941|FG001|Overall Study|Included twice|0|||
27530460|NCT04123665|80134944|FG000|Overall Study|Withdrawal by Subject|7|||
27530461|NCT04123665|80134945|FG001|Overall Study|Withdrawal by Subject|0|||
27530462|NCT04123665|80134944|FG000|Overall Study|Lost to Follow-up|1|||
27530463|NCT04123665|80134945|FG001|Overall Study|Lost to Follow-up|0|||
27530464|NCT00625742|80134952|FG000|Overall Study|Disease Progression|2|||
27530465|NCT00625742|80134952|FG000|Overall Study|Withdrawal by Subject|1|||
27530466|NCT00625742|80134952|FG000|Overall Study|Adverse Event|4|||
27530467|NCT00625742|80134952|FG000|Overall Study|Lost to Follow-up|4|||
27530468|NCT00625742|80134952|FG000|Overall Study|Ineligible|1|||
27530469|NCT01709578|80134958|FG000|Overall Study|Rescued and entered in long term safety|63|||
27530470|NCT01709578|80134959|FG001|Overall Study|Rescued and entered in long term safety|25|||
27530471|NCT01709578|80134960|FG002|Overall Study|Rescued and entered in long term safety|26|||
27530472|NCT01709578|80134958|FG000|Overall Study|Adverse Event|9|||
27530473|NCT01709578|80134959|FG001|Overall Study|Adverse Event|18|||
27530474|NCT01709578|80134960|FG002|Overall Study|Adverse Event|17|||
27530475|NCT01709578|80134958|FG000|Overall Study|Lack of Efficacy|5|||
27530476|NCT01709578|80134959|FG001|Overall Study|Lack of Efficacy|4|||
27530477|NCT01709578|80134960|FG002|Overall Study|Lack of Efficacy|2|||
27530478|NCT01709578|80134958|FG000|Overall Study|Poor compliance to protocol|1|||
27530479|NCT01709578|80134959|FG001|Overall Study|Poor compliance to protocol|2|||
27530480|NCT01709578|80134960|FG002|Overall Study|Poor compliance to protocol|1|||
27530481|NCT01709578|80134958|FG000|Overall Study|Other, not related to safety or efficacy|2|||
27530482|NCT01709578|80134959|FG001|Overall Study|Other, not related to safety or efficacy|7|||
27530483|NCT01709578|80134960|FG002|Overall Study|Other, not related to safety or efficacy|5|||
27530484|NCT03468543|80134961|FG000|Overall Study|Protocol stopping rules met|3|||
27530485|NCT04263454|80134964|FG000|Overall Study|Adverse Event|0|||
27530486|NCT04263454|80134965|FG001|Overall Study|Adverse Event|2|||
27530487|NCT04263454|80134964|FG000|Overall Study|Physician Decision|3|||
27530488|NCT04263454|80134965|FG001|Overall Study|Physician Decision|5|||
27530489|NCT04263454|80134964|FG000|Overall Study|Poor Data Quality|0|||
27530490|NCT04263454|80134965|FG001|Overall Study|Poor Data Quality|1|||
27530491|NCT03711266|80134972|FG000|Overall Study|Lost to Follow-up|10|||
27530492|NCT04099251|80134979|FG000|Pre-Treatment|Other reasons|1|||
27530493|NCT04099251|80134980|FG001|Pre-Treatment|Other reasons|0|||
27530494|NCT04099251|80134979|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
27530495|NCT04099251|80134980|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
27530496|NCT04099251|80134979|FG000|Blinded Treatment Phase|Other reasons|16|||
27530497|NCT04099251|80134980|FG001|Blinded Treatment Phase|Other reasons|7|||
27530498|NCT04099251|80134979|FG000|Blinded Treatment Phase|Disease recurrence|26|||
27530499|NCT04099251|80134980|FG001|Blinded Treatment Phase|Disease recurrence|41|||
27530500|NCT04099251|80134979|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
27530501|NCT04099251|80134980|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
27530502|NCT04099251|80134979|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
27530503|NCT04099251|80134980|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
27626710|NCT01599325|80476758|FG000|Primary Parent Phase|Death|13|||
27626711|NCT01599325|80476758|FG000|Primary Parent Phase|Protocol Violation|1|||
27626712|NCT01599325|80476758|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
27626713|NCT01599325|80476758|FG000|Primary Parent Phase|Other|2|||
27626714|NCT01599325|80476758|FG000|Extension Phase|Study Closure|1|||
27626715|NCT01599325|80476758|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
27626716|NCT01599325|80476758|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
27626717|NCT01599325|80476758|FG000|Extension Phase|Disease Progression|1|||
27626718|NCT01599325|80476758|FG000|Extension Phase|Withdrawal by Subject|8|||
27626719|NCT01311648|80476760|FG000|Main Study|Protocol Violation|0|||
27735049|NCT02048904|80857197|FG000|Overall Study|Physician Decision|70|||
27735050|NCT02091440|80857200|FG000|Overall Study|Death|2|||
27735051|NCT01120626|80857201|FG000|Overall Study|Withdrawal by Subject|1|||
27735052|NCT01120626|80857202|FG001|Overall Study|Withdrawal by Subject|0|||
27735053|NCT03814746|80857204|FG000|Overall Study|Participant decision|9|||
27735054|NCT03814746|80857205|FG001|Overall Study|Participant decision|6|||
27735055|NCT03814746|80857206|FG002|Overall Study|Participant decision|15|||
27735056|NCT03814746|80857204|FG000|Overall Study|Physician Decision|2|||
27735057|NCT03814746|80857205|FG001|Overall Study|Physician Decision|2|||
27735058|NCT03814746|80857206|FG002|Overall Study|Physician Decision|4|||
27735059|NCT03814746|80857204|FG000|Overall Study|Death|2|||
27735060|NCT03814746|80857205|FG001|Overall Study|Death|2|||
27735061|NCT03814746|80857206|FG002|Overall Study|Death|2|||
27735062|NCT03814746|80857204|FG000|Overall Study|Adverse Event|2|||
27735063|NCT03814746|80857205|FG001|Overall Study|Adverse Event|2|||
27735064|NCT03814746|80857206|FG002|Overall Study|Adverse Event|1|||
27735065|NCT03814746|80857204|FG000|Overall Study|Lost to Follow-up|2|||
27735066|NCT03814746|80857205|FG001|Overall Study|Lost to Follow-up|1|||
27735067|NCT03814746|80857206|FG002|Overall Study|Lost to Follow-up|2|||
27735068|NCT03814746|80857204|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27735069|NCT03814746|80857205|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27735070|NCT03814746|80857206|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27735071|NCT03814746|80857204|FG000|Overall Study|Pregnancy|0|||
27735072|NCT03814746|80857205|FG001|Overall Study|Pregnancy|1|||
27735073|NCT03814746|80857206|FG002|Overall Study|Pregnancy|1|||
27735074|NCT03814746|80857204|FG000|Overall Study|Protocol Violation|1|||
27735075|NCT03814746|80857205|FG001|Overall Study|Protocol Violation|0|||
27735076|NCT03814746|80857206|FG002|Overall Study|Protocol Violation|0|||
27735077|NCT05408858|80857207|FG000|Overall Study|no longer met eligibility criteria|1|||
27735078|NCT00476086|80857208|FG000|Overall Study|Alternative therapy|1|||
27735079|NCT00476086|80857208|FG000|Overall Study|Progressive Disease|4|||
27735080|NCT00684814|80857209|FG000|Washout Period of 7 Days|Adverse Event|1|||
27735081|NCT00684814|80857210|FG001|Washout Period of 7 Days|Adverse Event|2|||
27735082|NCT00684814|80857209|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27735083|NCT00684814|80857210|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
27735084|NCT00684814|80857209|FG000|Second Intervention|Adverse Event|1|||
27735085|NCT00684814|80857210|FG001|Second Intervention|Adverse Event|0|||
27735086|NCT00374556|80857211|FG000|Overall Study|Lost to Follow-up|1|||
27735087|NCT00374556|80857212|FG001|Overall Study|Lost to Follow-up|0|||
27735088|NCT00374556|80857211|FG000|Overall Study|Removed at baseline due to medical cond|0|||
27735089|NCT00374556|80857212|FG001|Overall Study|Removed at baseline due to medical cond|1|||
27735090|NCT04052139|80857213|FG000|Overall Study|Lost to Follow-up|2|||
27735091|NCT04052139|80857214|FG001|Overall Study|Lost to Follow-up|0|||
27735092|NCT04052139|80857215|FG002|Overall Study|Lost to Follow-up|0|||
27856577|NCT02338193|81306832|FG001|Overall Study|moved out of state|1|||
27626720|NCT01311648|80476761|FG001|Main Study|Protocol Violation|1|||
27626721|NCT01311648|80476760|FG000|Main Study|Adverse Event|0|||
27626722|NCT01311648|80476761|FG001|Main Study|Adverse Event|1|||
27626723|NCT01311648|80476760|FG000|Main Study|Inhibitor management|0|||
27626724|NCT01311648|80476761|FG001|Main Study|Inhibitor management|17|||
27626725|NCT01311648|80476760|FG000|Main Study|Withdrawal by Subject|0|||
27626726|NCT01311648|80476761|FG001|Main Study|Withdrawal by Subject|2|||
27626727|NCT01311648|80476760|FG000|Extension Study|Physician Decision|0|||
27626728|NCT01311648|80476761|FG001|Extension Study|Physician Decision|1|||
27626729|NCT01311648|80476760|FG000|Extension Study|ITI therapy with marketed product|0|||
27626730|NCT01311648|80476761|FG001|Extension Study|ITI therapy with marketed product|1|||
27735093|NCT04052139|80857213|FG000|Overall Study|Withdrawal by Subject|1|||
27735094|NCT04052139|80857214|FG001|Overall Study|Withdrawal by Subject|0|||
27735095|NCT04052139|80857215|FG002|Overall Study|Withdrawal by Subject|0|||
27735096|NCT02665689|80857216|FG000|Overall Study|Adverse Event|1|||
27626731|NCT01311648|80476760|FG000|Extension Study|Incorrect visit planning|0|||
27626732|NCT01311648|80476761|FG001|Extension Study|Incorrect visit planning|1|||
27626733|NCT01311648|80476760|FG000|Extension Study|Family's decision|0|||
27735097|NCT02665689|80857217|FG001|Overall Study|Adverse Event|0|||
27735098|NCT02665689|80857216|FG000|Overall Study|Trial termination|1|||
27735099|NCT02665689|80857217|FG001|Overall Study|Trial termination|1|||
27735100|NCT02665689|80857216|FG000|Overall Study|Lost to Follow-up|0|||
27735101|NCT02665689|80857217|FG001|Overall Study|Lost to Follow-up|1|||
27735102|NCT01903876|80857222|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
27735103|NCT01903876|80857223|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
27735104|NCT01903876|80857222|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
27735105|NCT01903876|80857223|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
27735106|NCT04433117|80857224|FG000|Overall Study|Withdrawal by Subject|1|||
27735107|NCT04433117|80857225|FG001|Overall Study|Withdrawal by Subject|0|||
27735108|NCT01931865|80857226|FG000|Overall Study|Lost to Follow-up|2|||
27735109|NCT01931865|80857226|FG000|Overall Study|Withdrawal by Subject|2|||
27735110|NCT02317510|80857227|FG000|Overall Study|Adverse Event|0|||
27735111|NCT02317510|80857228|FG001|Overall Study|Adverse Event|1|||
27735112|NCT03180736|80857229|FG000|Overall Study|Adverse Event|3|||
27735113|NCT03180736|80857230|FG001|Overall Study|Adverse Event|4|||
27912193|NCT00103285|81518114|FG001|Response Assignment|Adverse Event|8|||
27912194|NCT00103285|81518115|FG002|Response Assignment|Adverse Event|3|||
27912195|NCT00103285|81518116|FG003|Response Assignment|Adverse Event|2|||
27912196|NCT00103285|81518117|FG004|Response Assignment|Adverse Event|3|||
27912197|NCT00103285|81518118|FG005|Response Assignment|Adverse Event|1|||
27912198|NCT00103285|81518119|FG006|Response Assignment|Adverse Event|1|||
27912199|NCT00103285|81518120|FG007|Response Assignment|Adverse Event|2|||
27912200|NCT00103285|81518113|FG000|Response Assignment|Death|0|||
27912201|NCT00103285|81518114|FG001|Response Assignment|Death|5|||
27626734|NCT01311648|80476761|FG001|Extension Study|Family's decision|1|||
27626735|NCT01311648|80476760|FG000|Extension Study|Failure of ITI therapy|0|||
27626736|NCT01311648|80476761|FG001|Extension Study|Failure of ITI therapy|3|||
27626737|NCT01311648|80476760|FG000|Extension Study|Long travel|0|||
27626738|NCT01311648|80476761|FG001|Extension Study|Long travel|1|||
27626739|NCT01311648|80476760|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
27626740|NCT01311648|80476761|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
27626741|NCT01311648|80476760|FG000|Extension Study|Withdrawal by Subject|0|||
27626742|NCT01311648|80476761|FG001|Extension Study|Withdrawal by Subject|1|||
27626743|NCT01311648|80476760|FG000|Extension Study|Inhibitor management|0|||
27626744|NCT01311648|80476761|FG001|Extension Study|Inhibitor management|2|||
27626745|NCT03768206|80476764|FG000|Overall Study|Lost to Follow-up|2|||
27626746|NCT03768206|80476765|FG001|Overall Study|Lost to Follow-up|1|||
27626747|NCT03768206|80476764|FG000|Overall Study|Withdrawal by Subject|0|||
27626748|NCT03768206|80476765|FG001|Overall Study|Withdrawal by Subject|1|||
27626749|NCT00631475|80476766|FG000|Overall Study|Death|18|||
27626750|NCT00631475|80476766|FG000|Overall Study|Adverse Event|14|||
27626751|NCT00631475|80476766|FG000|Overall Study|Withdrew consent|5|||
27735114|NCT03180736|80857229|FG000|Overall Study|Death|10|||
27912202|NCT00103285|81518115|FG002|Response Assignment|Death|2|||
27912203|NCT00103285|81518116|FG003|Response Assignment|Death|2|||
27912204|NCT00103285|81518117|FG004|Response Assignment|Death|3|||
27912205|NCT00103285|81518118|FG005|Response Assignment|Death|1|||
27912206|NCT00103285|81518119|FG006|Response Assignment|Death|0|||
27912207|NCT00103285|81518120|FG007|Response Assignment|Death|8|||
27912208|NCT00103285|81518113|FG000|Response Assignment|Lost to Follow-up|0|||
27912209|NCT00103285|81518114|FG001|Response Assignment|Lost to Follow-up|9|||
27912210|NCT00103285|81518115|FG002|Response Assignment|Lost to Follow-up|5|||
27912211|NCT00103285|81518116|FG003|Response Assignment|Lost to Follow-up|5|||
27912212|NCT00103285|81518117|FG004|Response Assignment|Lost to Follow-up|1|||
27912213|NCT00103285|81518118|FG005|Response Assignment|Lost to Follow-up|2|||
27912214|NCT00103285|81518119|FG006|Response Assignment|Lost to Follow-up|2|||
27912215|NCT00103285|81518120|FG007|Response Assignment|Lost to Follow-up|5|||
27912216|NCT00103285|81518113|FG000|Response Assignment|Physician Decision|0|||
27912217|NCT00103285|81518114|FG001|Response Assignment|Physician Decision|13|||
27912218|NCT00103285|81518115|FG002|Response Assignment|Physician Decision|14|||
27912219|NCT00103285|81518116|FG003|Response Assignment|Physician Decision|9|||
27912220|NCT00103285|81518117|FG004|Response Assignment|Physician Decision|13|||
27912221|NCT00103285|81518118|FG005|Response Assignment|Physician Decision|7|||
27912222|NCT00103285|81518119|FG006|Response Assignment|Physician Decision|4|||
27912223|NCT00103285|81518120|FG007|Response Assignment|Physician Decision|35|||
27912224|NCT00103285|81518113|FG000|Response Assignment|Protocol Violation|0|||
27912225|NCT00103285|81518114|FG001|Response Assignment|Protocol Violation|2|||
27626752|NCT00631475|80476766|FG000|Overall Study|Preparation for lung transplant|8|||
27626753|NCT00906698|80476769|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
27626754|NCT00906698|80476770|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
27735115|NCT03180736|80857230|FG001|Overall Study|Death|7|||
27735116|NCT03180736|80857229|FG000|Overall Study|Withdrawal by Subject|5|||
27912226|NCT00103285|81518115|FG002|Response Assignment|Protocol Violation|0|||
27735117|NCT03180736|80857230|FG001|Overall Study|Withdrawal by Subject|12|||
27735118|NCT03180736|80857229|FG000|Overall Study|Lost to Follow-up|1|||
27735119|NCT03180736|80857230|FG001|Overall Study|Lost to Follow-up|0|||
27912227|NCT00103285|81518116|FG003|Response Assignment|Protocol Violation|0|||
27912228|NCT00103285|81518117|FG004|Response Assignment|Protocol Violation|0|||
27912229|NCT00103285|81518118|FG005|Response Assignment|Protocol Violation|0|||
27912230|NCT00103285|81518119|FG006|Response Assignment|Protocol Violation|0|||
27912231|NCT00103285|81518120|FG007|Response Assignment|Protocol Violation|0|||
27912232|NCT00103285|81518113|FG000|Response Assignment|Withdrawal by Subject|0|||
27912233|NCT00103285|81518114|FG001|Response Assignment|Withdrawal by Subject|4|||
27912234|NCT00103285|81518115|FG002|Response Assignment|Withdrawal by Subject|1|||
27912235|NCT00103285|81518116|FG003|Response Assignment|Withdrawal by Subject|1|||
27912236|NCT00103285|81518117|FG004|Response Assignment|Withdrawal by Subject|2|||
27912237|NCT00103285|81518118|FG005|Response Assignment|Withdrawal by Subject|2|||
27912238|NCT00103285|81518119|FG006|Response Assignment|Withdrawal by Subject|0|||
27856578|NCT02338193|81306833|FG002|Overall Study|moved out of state|0|||
27856579|NCT02338193|81306831|FG000|Overall Study|intolerant of side effects|1|||
27856580|NCT02338193|81306832|FG001|Overall Study|intolerant of side effects|0|||
27856581|NCT02338193|81306833|FG002|Overall Study|intolerant of side effects|0|||
27856582|NCT00506129|81306834|FG000|Overall Study|Disease Progression/Relapse|15|||
27856583|NCT00506129|81306834|FG000|Overall Study|Death|7|||
27912239|NCT00103285|81518120|FG007|Response Assignment|Withdrawal by Subject|2|||
27912240|NCT00103285|81518113|FG000|Response Assignment|Ineligible|0|||
27530504|NCT04099251|80134979|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
27530505|NCT04099251|80134980|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
27530506|NCT04099251|80134979|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
27530507|NCT04099251|80134980|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
27530508|NCT04099251|80134979|FG000|Blinded Treatment Phase|Death|6|||
27530509|NCT04099251|80134980|FG001|Blinded Treatment Phase|Death|2|||
27856584|NCT02677714|81306841|FG000|Overall Study|Withdrawal by Subject|2|||
27530510|NCT04099251|80134979|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
27530511|NCT04099251|80134980|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
27530512|NCT04099251|80134979|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
27530513|NCT04099251|80134980|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
27530514|NCT04099251|80134979|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
27530515|NCT04099251|80134980|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
27530516|NCT04099251|80134979|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
27530517|NCT04099251|80134980|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
27530518|NCT04099251|80134979|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
27530519|NCT04099251|80134980|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
27530520|NCT04099251|80134979|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
27530521|NCT04099251|80134980|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
27530522|NCT04099251|80134979|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
27530523|NCT04099251|80134980|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
27530524|NCT04099251|80134979|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
27530525|NCT04099251|80134980|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
27530526|NCT04099251|80134979|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
27530527|NCT04099251|80134980|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
27530528|NCT01178073|80134981|FG000|Overall Study|Adverse Event|34|||
27530529|NCT01178073|80134982|FG001|Overall Study|Adverse Event|27|||
27530530|NCT01178073|80134983|FG002|Overall Study|Adverse Event|24|||
27530531|NCT01178073|80134981|FG000|Overall Study|Protocol Violation|1|||
27530532|NCT01178073|80134982|FG001|Overall Study|Protocol Violation|1|||
27530533|NCT01178073|80134983|FG002|Overall Study|Protocol Violation|1|||
27530534|NCT01178073|80134981|FG000|Overall Study|Lost to Follow-up|2|||
27530535|NCT01178073|80134982|FG001|Overall Study|Lost to Follow-up|0|||
27530536|NCT01178073|80134983|FG002|Overall Study|Lost to Follow-up|3|||
27530537|NCT01178073|80134981|FG000|Overall Study|Physician Decision|14|||
27530538|NCT01178073|80134982|FG001|Overall Study|Physician Decision|10|||
27530539|NCT01178073|80134983|FG002|Overall Study|Physician Decision|10|||
27530540|NCT01178073|80134981|FG000|Overall Study|Withdrawal by Subject|10|||
27530541|NCT01178073|80134982|FG001|Overall Study|Withdrawal by Subject|6|||
27530542|NCT01178073|80134983|FG002|Overall Study|Withdrawal by Subject|8|||
27530543|NCT01178073|80134981|FG000|Overall Study|Missing Completion Status|1|||
27530544|NCT01178073|80134982|FG001|Overall Study|Missing Completion Status|0|||
27530545|NCT01178073|80134983|FG002|Overall Study|Missing Completion Status|0|||
27530546|NCT01325623|80137506|FG000|Overall Study|Withdrawal by Subject|3|||
27856585|NCT02677714|81306842|FG001|Overall Study|Withdrawal by Subject|0|||
27856586|NCT04392583|81306858|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
27530547|NCT00880685|80137512|FG000|Memantine 10mg|Lost to Follow-up|2|||
27530548|NCT00880685|80137512|FG000|Memantine 20mg|Withdrawal by Subject|1|||
27530549|NCT00478881|80137513|FG000|Overall Study|Adverse Event|31|||
27530550|NCT00478881|80137514|FG001|Overall Study|Adverse Event|12|||
27530551|NCT00478881|80137513|FG000|Overall Study|Lack of Efficacy|0|||
27626755|NCT00906698|80476771|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
27530552|NCT00478881|80137514|FG001|Overall Study|Lack of Efficacy|3|||
27735120|NCT03180736|80857229|FG000|Overall Study|Lack of Efficacy|66|||
27912241|NCT00103285|81518114|FG001|Response Assignment|Ineligible|8|||
27912242|NCT00103285|81518115|FG002|Response Assignment|Ineligible|6|||
27530553|NCT00478881|80137513|FG000|Overall Study|Lost to Follow-up|0|||
27530554|NCT00478881|80137514|FG001|Overall Study|Lost to Follow-up|1|||
27530555|NCT00478881|80137513|FG000|Overall Study|Protocol Violation|2|||
27530556|NCT00478881|80137514|FG001|Overall Study|Protocol Violation|2|||
27530557|NCT00478881|80137513|FG000|Overall Study|Withdrawal by Subject|6|||
27530558|NCT00478881|80137514|FG001|Overall Study|Withdrawal by Subject|2|||
27530559|NCT00478881|80137513|FG000|Overall Study|Non-Compliance with Study Medication|0|||
27530560|NCT00478881|80137514|FG001|Overall Study|Non-Compliance with Study Medication|2|||
27530561|NCT01610271|80137516|FG000|Overall Study|Surgery not complete|0|||
27530562|NCT01610271|80137517|FG001|Overall Study|Surgery not complete|1|||
27530563|NCT01610271|80137516|FG000|Overall Study|Prosthesis not implanted|2|||
27530564|NCT01610271|80137517|FG001|Overall Study|Prosthesis not implanted|3|||
27530565|NCT03766685|80137518|FG000|Overall Study|Lost to Follow-up|1|||
27530566|NCT03766685|80137519|FG001|Overall Study|Lost to Follow-up|1|||
27530567|NCT03766685|80137520|FG002|Overall Study|Lost to Follow-up|0|||
27530568|NCT03766685|80137521|FG003|Overall Study|Lost to Follow-up|0|||
27530569|NCT03766685|80137518|FG000|Overall Study|Adverse Event, not fatal|0|||
27530570|NCT03766685|80137519|FG001|Overall Study|Adverse Event, not fatal|1|||
27530571|NCT03766685|80137520|FG002|Overall Study|Adverse Event, not fatal|0|||
27530572|NCT03766685|80137521|FG003|Overall Study|Adverse Event, not fatal|1|||
27530573|NCT03766685|80137518|FG000|Overall Study|Withdrawal by Subject|0|||
27530574|NCT03766685|80137519|FG001|Overall Study|Withdrawal by Subject|2|||
27530575|NCT03766685|80137520|FG002|Overall Study|Withdrawal by Subject|0|||
27530576|NCT03766685|80137521|FG003|Overall Study|Withdrawal by Subject|0|||
27530577|NCT03766685|80137518|FG000|Overall Study|Protocol Violation|0|||
27530578|NCT03766685|80137519|FG001|Overall Study|Protocol Violation|1|||
27530579|NCT03766685|80137520|FG002|Overall Study|Protocol Violation|0|||
27530580|NCT03766685|80137521|FG003|Overall Study|Protocol Violation|0|||
27530581|NCT03766685|80137518|FG000|Overall Study|Non-compliance|0|||
27530582|NCT03766685|80137519|FG001|Overall Study|Non-compliance|2|||
27530583|NCT03766685|80137520|FG002|Overall Study|Non-compliance|0|||
27530584|NCT03766685|80137521|FG003|Overall Study|Non-compliance|0|||
27530585|NCT02393690|80137522|FG000|Overall Study|Ineligible|0|||
27530586|NCT02393690|80137523|FG001|Overall Study|Ineligible|1|||
27530587|NCT00737464|80137524|FG000|Overall Study|Adverse Event|1|||
27530588|NCT00737464|80137524|FG000|Overall Study|Death|6|||
27530589|NCT00737464|80137524|FG000|Overall Study|Other - Failure to Return|1|||
27530590|NCT00737464|80137524|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
27530591|NCT00737464|80137524|FG000|Overall Study|Other reasons|4|||
27530592|NCT01721070|80137525|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
27530593|NCT02962765|80137526|FG000|Overall Study|Protocol Violation|9|||
27530594|NCT02962765|80137526|FG000|Overall Study|Withdrawal by Subject|3|||
27530595|NCT02962765|80137526|FG000|Overall Study|Lost to Follow-up|1|||
27530596|NCT02962765|80137526|FG000|Overall Study|Death|1|||
27530597|NCT02962765|80137526|FG000|Overall Study|Limited access to study medication|3|||
27530598|NCT01394718|80137527|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
27530599|NCT01394718|80137528|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
27530600|NCT00427960|80137530|FG000|Overall Study|Adverse Event|2|||
27530601|NCT00427960|80137531|FG001|Overall Study|Adverse Event|0|||
27530602|NCT00427960|80137530|FG000|Overall Study|Withdrawal by Subject|0|||
27530603|NCT00427960|80137531|FG001|Overall Study|Withdrawal by Subject|3|||
27530604|NCT00427960|80137530|FG000|Overall Study|Other|0|||
27530605|NCT00427960|80137531|FG001|Overall Study|Other|1|||
27530606|NCT01309308|80137532|FG000|Overall Study|Lost to Follow-up|6|||
27530607|NCT01309308|80137533|FG001|Overall Study|Lost to Follow-up|4|||
27530608|NCT01822496|80137534|FG000|Overall Study|Protocol Violation|2|||
27530609|NCT01822496|80137535|FG001|Overall Study|Protocol Violation|2|||
27530610|NCT01822496|80137536|FG002|Overall Study|Protocol Violation|0|||
27530611|NCT01822496|80137537|FG003|Overall Study|Protocol Violation|1|||
27530612|NCT01822496|80137534|FG000|Overall Study|Withdrawal by Subject|0|||
27530613|NCT01822496|80137535|FG001|Overall Study|Withdrawal by Subject|0|||
27530614|NCT01822496|80137536|FG002|Overall Study|Withdrawal by Subject|0|||
27530615|NCT01822496|80137537|FG003|Overall Study|Withdrawal by Subject|3|||
27530616|NCT00978432|80137544|FG000|Overall Study|Withdrawal by Subject|0|||
27530617|NCT00978432|80137545|FG001|Overall Study|Withdrawal by Subject|0|||
27530618|NCT00978432|80137546|FG002|Overall Study|Withdrawal by Subject|1|||
27530619|NCT00978432|80137544|FG000|Overall Study|Lack of Efficacy|1|||
27530620|NCT00978432|80137545|FG001|Overall Study|Lack of Efficacy|1|||
27530621|NCT00978432|80137546|FG002|Overall Study|Lack of Efficacy|3|||
27530622|NCT00978432|80137544|FG000|Overall Study|Adverse Event|2|||
27735121|NCT03180736|80857230|FG001|Overall Study|Lack of Efficacy|87|||
27912243|NCT00103285|81518116|FG003|Response Assignment|Ineligible|2|||
27530623|NCT00978432|80137545|FG001|Overall Study|Adverse Event|0|||
27530624|NCT00978432|80137546|FG002|Overall Study|Adverse Event|1|||
27530625|NCT00704808|80137548|FG000|Overall Study|Discontinued prior to starting treatment|14|||
27530626|NCT00704808|80137548|FG000|Overall Study|Death|7|||
27530627|NCT00704808|80137548|FG000|Overall Study|Tumor progression|80|||
27530628|NCT00704808|80137548|FG000|Overall Study|Patient's decision|11|||
27530629|NCT00704808|80137548|FG000|Overall Study|Early therapy discontinuation|16|||
27626756|NCT00906698|80476772|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
27626757|NCT00906698|80476773|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
27626758|NCT00906698|80476774|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
27626759|NCT00906698|80476769|FG000|Overall Study|Adverse Event|0|||
27626760|NCT00906698|80476770|FG001|Overall Study|Adverse Event|0|||
27626761|NCT00906698|80476771|FG002|Overall Study|Adverse Event|2|||
27626762|NCT00906698|80476772|FG003|Overall Study|Adverse Event|0|||
27626763|NCT00906698|80476773|FG004|Overall Study|Adverse Event|4|||
27626764|NCT00906698|80476774|FG005|Overall Study|Adverse Event|1|||
27626765|NCT00906698|80476769|FG000|Overall Study|Disease progression|3|||
27626766|NCT00906698|80476770|FG001|Overall Study|Disease progression|12|||
27626767|NCT00906698|80476771|FG002|Overall Study|Disease progression|4|||
27626768|NCT00906698|80476772|FG003|Overall Study|Disease progression|4|||
27626769|NCT00906698|80476773|FG004|Overall Study|Disease progression|12|||
27626770|NCT00906698|80476774|FG005|Overall Study|Disease progression|4|||
27626771|NCT00906698|80476769|FG000|Overall Study|Withdrawal by Subject|0|||
27626772|NCT00906698|80476770|FG001|Overall Study|Withdrawal by Subject|0|||
27626773|NCT00906698|80476771|FG002|Overall Study|Withdrawal by Subject|0|||
27626774|NCT00906698|80476772|FG003|Overall Study|Withdrawal by Subject|0|||
27626775|NCT00906698|80476773|FG004|Overall Study|Withdrawal by Subject|1|||
27626776|NCT00906698|80476774|FG005|Overall Study|Withdrawal by Subject|0|||
27626777|NCT00906698|80476769|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
27626778|NCT00906698|80476770|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
27626779|NCT00906698|80476771|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
27626780|NCT00906698|80476772|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
27626781|NCT00906698|80476773|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
27626782|NCT00906698|80476774|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
27626783|NCT04759131|80476775|FG000|Overall Study|Investigator's discretion|1|||
27626784|NCT04759131|80476776|FG001|Overall Study|Investigator's discretion|0|||
27530630|NCT00704808|80137548|FG000|Overall Study|Adverse Event|1|||
27530631|NCT00704808|80137548|FG000|Overall Study|Lost to Follow-up|1|||
27530632|NCT00704808|80137548|FG000|Overall Study|Treatment change|1|||
27530633|NCT00925990|80137549|FG000|Overall Study|Adverse Event|1|||
27530634|NCT00925990|80137550|FG001|Overall Study|Adverse Event|3|||
27530635|NCT00925990|80137549|FG000|Overall Study|Withdrawal by Subject|2|||
27530636|NCT00925990|80137550|FG001|Overall Study|Withdrawal by Subject|2|||
27530637|NCT00925990|80137549|FG000|Overall Study|Lost to Follow-up|1|||
27530638|NCT00925990|80137550|FG001|Overall Study|Lost to Follow-up|3|||
27530639|NCT00925990|80137549|FG000|Overall Study|Physician Decision|1|||
27530640|NCT00925990|80137550|FG001|Overall Study|Physician Decision|1|||
27530641|NCT00925990|80137549|FG000|Overall Study|moved out of state, missed medication|0|||
27530642|NCT00925990|80137550|FG001|Overall Study|moved out of state, missed medication|2|||
27530643|NCT04597918|80137551|FG000|Overall Study|Withdrawal by Subject|6|||
27530644|NCT04597918|80137551|FG000|Overall Study|Lost to Follow-up|3|||
27530645|NCT04597918|80137551|FG000|Overall Study|Death|1|||
27530646|NCT02237911|80137555|FG000|Overall Study|Withdrawal by Subject|4|||
27530647|NCT02237911|80137556|FG001|Overall Study|Withdrawal by Subject|7|||
27530648|NCT02237911|80137557|FG002|Overall Study|Withdrawal by Subject|2|||
27530649|NCT02237911|80137555|FG000|Overall Study|Lost to Follow-up|3|||
27530650|NCT02237911|80137556|FG001|Overall Study|Lost to Follow-up|1|||
27530651|NCT02237911|80137557|FG002|Overall Study|Lost to Follow-up|1|||
27530652|NCT00006389|80137564|FG000|Overall Study|Adverse Event|1|||
27530653|NCT01236118|80137565|FG000|Overall Study|Adverse Event|2|||
27530654|NCT01236118|80137566|FG001|Overall Study|Adverse Event|0|||
27530655|NCT01236118|80137567|FG002|Overall Study|Adverse Event|2|||
27530656|NCT01236118|80137565|FG000|Overall Study|Physician Decision|0|||
27530657|NCT01236118|80137566|FG001|Overall Study|Physician Decision|1|||
27530658|NCT01236118|80137567|FG002|Overall Study|Physician Decision|0|||
27530659|NCT01236118|80137565|FG000|Overall Study|Withdrawal by Subject|0|||
27530660|NCT01236118|80137566|FG001|Overall Study|Withdrawal by Subject|0|||
27530661|NCT01236118|80137567|FG002|Overall Study|Withdrawal by Subject|1|||
27626785|NCT04759131|80476775|FG000|Overall Study|Subject withdrawal|1|||
27626786|NCT04759131|80476776|FG001|Overall Study|Subject withdrawal|0|||
27530662|NCT01638819|80137568|FG000|Overall Study|Lost to Follow-up|1|||
27626787|NCT02451943|80476777|FG000|Overall Study|On Treatment|4|||
27626788|NCT02451943|80476778|FG001|Overall Study|On Treatment|4|||
27626789|NCT02451943|80476777|FG000|Overall Study|Withdrawal by Subject|13|||
27626790|NCT02451943|80476778|FG001|Overall Study|Withdrawal by Subject|16|||
27626791|NCT02451943|80476777|FG000|Overall Study|Lost to Follow-up|3|||
27626792|NCT02451943|80476778|FG001|Overall Study|Lost to Follow-up|4|||
27626793|NCT05419557|80476782|FG000|Overall Study|Lost to Follow-up|11|||
27530663|NCT01638819|80137569|FG001|Overall Study|Lost to Follow-up|0|||
27530664|NCT03282565|80137570|FG000|Overall Study|COVID-19 Research Shutdown|0|||
27530665|NCT03282565|80137571|FG001|Overall Study|COVID-19 Research Shutdown|2|||
27626794|NCT05419557|80476783|FG001|Overall Study|Lost to Follow-up|4|||
27626795|NCT02132702|80476784|FG000|Overall Study|Protocol Violation|2|||
27626796|NCT02132702|80476784|FG000|Overall Study|Adverse Event|3|||
27626797|NCT02132702|80476784|FG000|Overall Study|Withdrawal by Subject|3|||
27626798|NCT04886596|80476785|FG000|Overall Study|Adverse Event|73|||
27626799|NCT04886596|80476786|FG001|Overall Study|Adverse Event|78|||
27626800|NCT04886596|80476785|FG000|Overall Study|Lost to Follow-up|104|||
27626801|NCT04886596|80476786|FG001|Overall Study|Lost to Follow-up|104|||
27626802|NCT04886596|80476785|FG000|Overall Study|Ongoing|12095|||
27530666|NCT03282565|80137572|FG002|Overall Study|COVID-19 Research Shutdown|2|||
27530667|NCT03901456|80137573|FG000|Overall Study|Withdrawal by Subject|0|||
27530668|NCT03901456|80137574|FG001|Overall Study|Withdrawal by Subject|0|||
27530669|NCT03901456|80137575|FG002|Overall Study|Withdrawal by Subject|1|||
27530670|NCT03901456|80137573|FG000|Overall Study|Lost to Follow-up|0|||
27530671|NCT03901456|80137574|FG001|Overall Study|Lost to Follow-up|1|||
27530672|NCT03901456|80137575|FG002|Overall Study|Lost to Follow-up|0|||
27530673|NCT00191646|80137586|FG000|Overall Study|Toxicity|26|||
27530674|NCT00191646|80137587|FG001|Overall Study|Toxicity|37|||
27530675|NCT00191646|80137586|FG000|Overall Study|Disease Progression|5|||
27530676|NCT00191646|80137587|FG001|Overall Study|Disease Progression|6|||
27530677|NCT00191646|80137586|FG000|Overall Study|Physician Decision|20|||
27530678|NCT00191646|80137587|FG001|Overall Study|Physician Decision|11|||
27530679|NCT00191646|80137586|FG000|Overall Study|Withdrawal by Subject|58|||
27530680|NCT00191646|80137587|FG001|Overall Study|Withdrawal by Subject|39|||
27530681|NCT00191646|80137586|FG000|Overall Study|Protocol Violation|5|||
27530682|NCT00191646|80137587|FG001|Overall Study|Protocol Violation|7|||
27530683|NCT00191646|80137586|FG000|Overall Study|Death|6|||
27530684|NCT00191646|80137587|FG001|Overall Study|Death|8|||
27530685|NCT00191646|80137586|FG000|Overall Study|Other|33|||
27530686|NCT00191646|80137587|FG001|Overall Study|Other|34|||
27530687|NCT00191646|80137586|FG000|Overall Study|Missing Data|18|||
27530688|NCT00191646|80137587|FG001|Overall Study|Missing Data|11|||
27530689|NCT03150485|80137588|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
27530690|NCT03150485|80137589|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
27530691|NCT03150485|80137590|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
27530692|NCT03150485|80137591|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
27530693|NCT03150485|80137592|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
27530694|NCT03150485|80137593|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
27530695|NCT01859143|80137594|FG000|Overall Study|Lost to Follow-up|2|||
27530696|NCT01859143|80137595|FG001|Overall Study|Lost to Follow-up|0|||
27530697|NCT00470158|80137596|FG000|Overall Study|Death|0|||
27530698|NCT00470158|80137597|FG001|Overall Study|Death|0|||
27530699|NCT00470158|80137598|FG002|Overall Study|Death|0|||
27530700|NCT00470158|80137599|FG003|Overall Study|Death|0|||
27530701|NCT00470158|80137600|FG004|Overall Study|Death|2|||
27530702|NCT00470158|80137596|FG000|Overall Study|Lost to Follow-up|7|||
27530703|NCT00470158|80137597|FG001|Overall Study|Lost to Follow-up|8|||
27530704|NCT00470158|80137598|FG002|Overall Study|Lost to Follow-up|8|||
27530705|NCT00470158|80137599|FG003|Overall Study|Lost to Follow-up|5|||
27530706|NCT00470158|80137600|FG004|Overall Study|Lost to Follow-up|4|||
27530707|NCT00470158|80137596|FG000|Overall Study|Protocol Violation|1|||
27530708|NCT00470158|80137597|FG001|Overall Study|Protocol Violation|0|||
27530709|NCT00470158|80137598|FG002|Overall Study|Protocol Violation|0|||
27530710|NCT00470158|80137599|FG003|Overall Study|Protocol Violation|0|||
27530711|NCT00470158|80137600|FG004|Overall Study|Protocol Violation|0|||
27530712|NCT00426231|80137608|FG000|Overall Study|Withdrawal by Subject|9|||
27530713|NCT00426231|80137609|FG001|Overall Study|Withdrawal by Subject|12|||
27530714|NCT02787551|80137610|FG000|Core Period: 26 Weeks|Adverse Event|10|||
27626803|NCT04886596|80476786|FG001|Overall Study|Ongoing|12107|||
27626804|NCT04886596|80476785|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
27626805|NCT04886596|80476786|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
27626806|NCT04886596|80476785|FG000|Overall Study|Migrated / Moved from the study area|17|||
27626807|NCT04886596|80476786|FG001|Overall Study|Migrated / Moved from the study area|14|||
27626808|NCT04886596|80476785|FG000|Overall Study|Unknown reason|16|||
27626809|NCT04886596|80476786|FG001|Overall Study|Unknown reason|23|||
27626810|NCT00777556|80476787|FG000|Overall Study|Inappropriate self-selection|34|||
27530715|NCT02787551|80137611|FG001|Core Period: 26 Weeks|Adverse Event|0|||
27530716|NCT02787551|80137610|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
27530717|NCT02787551|80137611|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
27530718|NCT02787551|80137610|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
27626811|NCT00777556|80476787|FG000|Overall Study|Dispensed but did not use product|12|||
27626812|NCT00777556|80476787|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
27626813|NCT03586167|80476788|FG000|Overall Study|Other|1|||
27530719|NCT02787551|80137611|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
27530720|NCT02787551|80137610|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
27626814|NCT03586167|80476789|FG001|Overall Study|Other|0|||
27530721|NCT02787551|80137611|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
27530722|NCT02787551|80137610|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
27530723|NCT02787551|80137611|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
27530724|NCT02787551|80137610|FG000|Core Period: 26 Weeks|Other than specified|3|||
27530725|NCT02787551|80137611|FG001|Core Period: 26 Weeks|Other than specified|1|||
27530726|NCT02787551|80137610|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
27530727|NCT02787551|80137611|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
27530728|NCT02787551|80137610|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
27530729|NCT02787551|80137611|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
27530730|NCT02787551|80137610|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
27530731|NCT02787551|80137611|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
27530732|NCT01528215|80137613|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
27530733|NCT01528215|80137614|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
27530734|NCT01528215|80137613|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
27530735|NCT01528215|80137614|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
27530736|NCT01528215|80137613|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
27530737|NCT01528215|80137614|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
27530738|NCT01528215|80137613|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
27912244|NCT00103285|81518117|FG004|Response Assignment|Ineligible|0|||
27912245|NCT00103285|81518118|FG005|Response Assignment|Ineligible|3|||
27912246|NCT00103285|81518119|FG006|Response Assignment|Ineligible|1|||
27912247|NCT00103285|81518120|FG007|Response Assignment|Ineligible|5|||
27912248|NCT00103285|81518113|FG000|Response Assignment|Refusal|0|||
27912249|NCT00103285|81518114|FG001|Response Assignment|Refusal|53|||
27912250|NCT00103285|81518115|FG002|Response Assignment|Refusal|5|||
27912251|NCT00103285|81518116|FG003|Response Assignment|Refusal|3|||
27912252|NCT00103285|81518117|FG004|Response Assignment|Refusal|25|||
27912253|NCT00103285|81518118|FG005|Response Assignment|Refusal|15|||
27912254|NCT00103285|81518119|FG006|Response Assignment|Refusal|30|||
27912255|NCT00103285|81518120|FG007|Response Assignment|Refusal|10|||
27912256|NCT00103285|81518113|FG000|Response Assignment|Other|0|||
27912257|NCT00103285|81518114|FG001|Response Assignment|Other|30|||
27912258|NCT00103285|81518115|FG002|Response Assignment|Other|48|||
27912259|NCT00103285|81518116|FG003|Response Assignment|Other|38|||
27912260|NCT00103285|81518117|FG004|Response Assignment|Other|37|||
27912261|NCT00103285|81518118|FG005|Response Assignment|Other|17|||
27912262|NCT00103285|81518119|FG006|Response Assignment|Other|11|||
27912263|NCT00103285|81518120|FG007|Response Assignment|Other|53|||
27912264|NCT05401565|81518126|FG000|Overall Study|Lost to Follow-up|1|||
27912265|NCT05401565|81518127|FG001|Overall Study|Lost to Follow-up|0|||
27912266|NCT05401565|81518126|FG000|Overall Study|Adverse Event|2|||
27912267|NCT05401565|81518127|FG001|Overall Study|Adverse Event|0|||
27912268|NCT03193047|81518128|FG000|Overall Study|Physician Decision|1|||
27912269|NCT03193047|81518129|FG001|Overall Study|Physician Decision|0|||
27912270|NCT03193047|81518128|FG000|Overall Study|Participant Left State|1|||
27912271|NCT03193047|81518129|FG001|Overall Study|Participant Left State|0|||
27912272|NCT01683604|81518133|FG000|Overall Study|Adverse Event|2|||
27912273|NCT01683604|81518133|FG000|Overall Study|Lack of Efficacy|1|||
27912274|NCT01683604|81518133|FG000|Overall Study|Other|2|||
27912275|NCT04158219|81518134|FG000|Overall Study|Lost to Follow-up|1|||
27626815|NCT03396913|80476790|FG000|Overall Study|Lost to Follow-up|0|||
27912276|NCT02718911|81518135|FG000|Overall Study|Adverse Event|0|||
27912277|NCT02718911|81518136|FG001|Overall Study|Adverse Event|0|||
27912278|NCT02718911|81518137|FG002|Overall Study|Adverse Event|0|||
27912279|NCT02718911|81518138|FG003|Overall Study|Adverse Event|0|||
27912280|NCT02718911|81518139|FG004|Overall Study|Adverse Event|0|||
27912281|NCT02718911|81518140|FG005|Overall Study|Adverse Event|0|||
27912282|NCT02718911|81518141|FG006|Overall Study|Adverse Event|0|||
27530739|NCT01528215|80137614|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
27530740|NCT00096954|80137615|FG000|Overall Study|Adverse Event|3|||
27530741|NCT00096954|80137616|FG001|Overall Study|Adverse Event|1|||
27530742|NCT00096954|80137615|FG000|Overall Study|Withdrawal by Subject|9|||
27912283|NCT02718911|81518142|FG007|Overall Study|Adverse Event|0|||
27912284|NCT02718911|81518143|FG008|Overall Study|Adverse Event|0|||
27530743|NCT00096954|80137616|FG001|Overall Study|Withdrawal by Subject|8|||
27530744|NCT00096954|80137615|FG000|Overall Study|Physician Decision|1|||
27626816|NCT03396913|80476791|FG001|Overall Study|Lost to Follow-up|6|||
27626817|NCT03210402|80476792|FG000|Overall Study|Withdrawal by Subject|0|||
27626818|NCT03210402|80476793|FG001|Overall Study|Withdrawal by Subject|1|||
27626819|NCT02824432|80476794|FG000|Overall Study|Major Protocol Deviation|1|||
27626820|NCT02824432|80476795|FG001|Overall Study|Major Protocol Deviation|0|||
27626821|NCT03404843|80476800|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
27626822|NCT03404843|80476801|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
27626823|NCT01740557|80476807|FG000|Overall Study|Ineligible|1|||
27626824|NCT01740557|80476807|FG000|Overall Study|Screen failure|1|||
27626825|NCT01348087|80476808|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
27626826|NCT01348087|80476808|FG000|Overall Study|Administrative problems|79|||
27626827|NCT01348087|80476808|FG000|Overall Study|protocol deviation|1|||
27626828|NCT01348087|80476808|FG000|Overall Study|Lost to Follow-up|1|||
27626829|NCT01348087|80476808|FG000|Overall Study|Subject withdrew consent|7|||
27626830|NCT01348087|80476808|FG000|Overall Study|Adverse Event|25|||
27626831|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
27626832|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
27735122|NCT03180736|80857229|FG000|Overall Study|Physician Decision|4|||
27735123|NCT03180736|80857230|FG001|Overall Study|Physician Decision|7|||
27735124|NCT03180736|80857229|FG000|Overall Study|randomized but not treated|2|||
27735125|NCT03180736|80857230|FG001|Overall Study|randomized but not treated|3|||
27735126|NCT03258814|80857233|FG000|Overall Study|Early Termination|4|||
27735127|NCT03258814|80857234|FG001|Overall Study|Early Termination|3|||
27735128|NCT03258814|80857235|FG002|Overall Study|Early Termination|10|||
27735129|NCT01564784|80857236|FG000|Overall Study|Other|1|||
27735130|NCT01564784|80857237|FG001|Overall Study|Other|0|||
27735131|NCT01564784|80857236|FG000|Overall Study|Subject refused further follow-up|1|||
27735132|NCT01564784|80857237|FG001|Overall Study|Subject refused further follow-up|6|||
27735133|NCT01564784|80857236|FG000|Overall Study|Lost to Follow-up|1|||
27735134|NCT01564784|80857237|FG001|Overall Study|Lost to Follow-up|1|||
27735135|NCT01564784|80857236|FG000|Overall Study|Death|131|||
27735136|NCT01564784|80857237|FG001|Overall Study|Death|126|||
27735137|NCT01624142|80857243|FG000|Overall Study|Withdrawal by Subject|14|||
27735138|NCT01624142|80857244|FG001|Overall Study|Withdrawal by Subject|4|||
27735139|NCT01624142|80857243|FG000|Overall Study|Death|3|||
27735140|NCT01624142|80857244|FG001|Overall Study|Death|6|||
27735141|NCT01624142|80857243|FG000|Overall Study|Study Closure|12|||
27735142|NCT01624142|80857244|FG001|Overall Study|Study Closure|6|||
27735143|NCT01624142|80857243|FG000|Overall Study|Lost to Follow-up|2|||
27735144|NCT01624142|80857244|FG001|Overall Study|Lost to Follow-up|0|||
27912285|NCT02718911|81518144|FG009|Overall Study|Adverse Event|2|||
27912286|NCT02718911|81518135|FG000|Overall Study|Death|2|||
27912287|NCT02718911|81518136|FG001|Overall Study|Death|3|||
27912288|NCT02718911|81518137|FG002|Overall Study|Death|1|||
27912289|NCT02718911|81518138|FG003|Overall Study|Death|0|||
27912290|NCT02718911|81518139|FG004|Overall Study|Death|1|||
27912291|NCT02718911|81518140|FG005|Overall Study|Death|3|||
27912292|NCT02718911|81518141|FG006|Overall Study|Death|1|||
27912293|NCT02718911|81518142|FG007|Overall Study|Death|1|||
27530745|NCT00096954|80137616|FG001|Overall Study|Physician Decision|1|||
27530746|NCT00096954|80137615|FG000|Overall Study|Sponsors Decision|1|||
27530747|NCT00096954|80137616|FG001|Overall Study|Sponsors Decision|1|||
27530748|NCT00096954|80137615|FG000|Overall Study|Pregnancy|1|||
27530749|NCT00096954|80137616|FG001|Overall Study|Pregnancy|1|||
27530750|NCT00096954|80137615|FG000|Overall Study|Initiation of immunotherapy|1|||
27530751|NCT00096954|80137616|FG001|Overall Study|Initiation of immunotherapy|0|||
27530752|NCT00096954|80137615|FG000|Overall Study|Non-compliance|0|||
27530753|NCT00096954|80137616|FG001|Overall Study|Non-compliance|3|||
27530754|NCT00096954|80137615|FG000|Overall Study|Lost to Follow-up|8|||
27530755|NCT00096954|80137616|FG001|Overall Study|Lost to Follow-up|5|||
27735145|NCT01624142|80857243|FG000|Overall Study|Other|1|||
27912294|NCT02718911|81518143|FG008|Overall Study|Death|4|||
27530756|NCT02063880|80137620|FG000|Overall Study|Death|21|||
27626833|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
27626834|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
27735146|NCT01624142|80857244|FG001|Overall Study|Other|0|||
27735147|NCT00162773|80857245|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
27735148|NCT00613626|80857248|FG000|Overall Study|Ineligible|0|||
27735149|NCT00613626|80857249|FG001|Overall Study|Ineligible|1|||
27735150|NCT00613626|80857250|FG002|Overall Study|Ineligible|0|||
27735151|NCT01287754|80857254|FG000|Overall Study|Death|2|||
27912295|NCT02718911|81518144|FG009|Overall Study|Death|3|||
27735152|NCT01287754|80857255|FG001|Overall Study|Death|12|||
27735153|NCT01287754|80857254|FG000|Overall Study|Lost to Follow-up|1|||
27735154|NCT01287754|80857255|FG001|Overall Study|Lost to Follow-up|6|||
27735155|NCT01287754|80857254|FG000|Overall Study|Protocol Violation|0|||
27735156|NCT01287754|80857255|FG001|Overall Study|Protocol Violation|3|||
27735157|NCT03367156|80857261|FG000|Overall Study|Lack of interest|3|||
27735158|NCT03367156|80857262|FG001|Overall Study|Lack of interest|1|||
27735159|NCT03367156|80857261|FG000|Overall Study|Death|2|||
27735160|NCT03367156|80857262|FG001|Overall Study|Death|0|||
27735161|NCT03367156|80857261|FG000|Overall Study|Lost to Follow-up|2|||
27735162|NCT03367156|80857262|FG001|Overall Study|Lost to Follow-up|1|||
27735163|NCT03367156|80857261|FG000|Overall Study|Became ineligible|1|||
27735164|NCT03367156|80857262|FG001|Overall Study|Became ineligible|2|||
27735165|NCT03367156|80857261|FG000|Overall Study|Hospitalization|1|||
27735166|NCT03367156|80857262|FG001|Overall Study|Hospitalization|0|||
27735167|NCT03367156|80857261|FG000|Overall Study|Concerned about Treatment|11|||
27735168|NCT03367156|80857262|FG001|Overall Study|Concerned about Treatment|3|||
27735169|NCT03367156|80857261|FG000|Overall Study|Started new treatment|4|||
27735170|NCT03367156|80857262|FG001|Overall Study|Started new treatment|1|||
27735171|NCT00917384|80857263|FG000|Overall Study|Lost to Follow-up|4|||
27735172|NCT00917384|80857264|FG001|Overall Study|Lost to Follow-up|2|||
27735173|NCT00917384|80857263|FG000|Overall Study|Withdrawal by Subject|10|||
27735174|NCT00917384|80857264|FG001|Overall Study|Withdrawal by Subject|2|||
27735175|NCT00317044|80857268|FG000|Overall Study|Protocol Violation|28|||
27735176|NCT00317044|80857269|FG001|Overall Study|Protocol Violation|22|||
27735177|NCT00317044|80857270|FG002|Overall Study|Protocol Violation|20|||
27735178|NCT00317044|80857268|FG000|Overall Study|Adverse Event|4|||
27735179|NCT00317044|80857269|FG001|Overall Study|Adverse Event|7|||
27735180|NCT00317044|80857270|FG002|Overall Study|Adverse Event|4|||
27735181|NCT00317044|80857268|FG000|Overall Study|Withdrawal by Subject|10|||
27735182|NCT00317044|80857269|FG001|Overall Study|Withdrawal by Subject|7|||
27735183|NCT00317044|80857270|FG002|Overall Study|Withdrawal by Subject|12|||
27735184|NCT00317044|80857268|FG000|Overall Study|Lost to Follow-up|0|||
27735185|NCT00317044|80857269|FG001|Overall Study|Lost to Follow-up|2|||
27735186|NCT00317044|80857270|FG002|Overall Study|Lost to Follow-up|3|||
27735187|NCT00317044|80857268|FG000|Overall Study|Multiple Reasons|6|||
27735188|NCT00317044|80857269|FG001|Overall Study|Multiple Reasons|2|||
27735189|NCT00317044|80857270|FG002|Overall Study|Multiple Reasons|6|||
27735190|NCT02207907|80857276|FG000|Overall Study|Lost to Follow-up|3|||
27735191|NCT02207907|80857277|FG001|Overall Study|Lost to Follow-up|1|||
27735192|NCT02207907|80857276|FG000|Overall Study|Withdrawal by Subject|5|||
27735193|NCT02207907|80857277|FG001|Overall Study|Withdrawal by Subject|6|||
27735194|NCT02207907|80857276|FG000|Overall Study|Did not meet study criteria|3|||
27735195|NCT02207907|80857277|FG001|Overall Study|Did not meet study criteria|0|||
27735196|NCT02207907|80857276|FG000|Overall Study|Pregnancy|0|||
27735197|NCT02207907|80857277|FG001|Overall Study|Pregnancy|1|||
27735198|NCT00752986|80857280|FG000|Overall Study|Withdrawal by Subject|2|||
27735199|NCT00752986|80857281|FG001|Overall Study|Withdrawal by Subject|1|||
27735200|NCT00752986|80857282|FG002|Overall Study|Withdrawal by Subject|2|||
27735201|NCT00752986|80857280|FG000|Overall Study|Protocol Violation|3|||
27735202|NCT00752986|80857281|FG001|Overall Study|Protocol Violation|0|||
27735203|NCT00752986|80857282|FG002|Overall Study|Protocol Violation|0|||
27735204|NCT00885365|80857286|FG000|4 Weeks ON Treatment|Adverse Event|2|||
27735205|NCT00885365|80857287|FG001|4 Weeks ON Treatment|Adverse Event|4|||
27735206|NCT00885365|80857286|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
27735207|NCT00885365|80857287|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
27735208|NCT00885365|80857286|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
27735209|NCT00885365|80857287|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
27735210|NCT00761215|80857293|FG000|Overall Study|Randomized but didn't receive drug|1|||
27735211|NCT00761215|80857294|FG001|Overall Study|Randomized but didn't receive drug|1|||
27530757|NCT02063880|80137621|FG001|Overall Study|Death|18|||
27530758|NCT02063880|80137620|FG000|Overall Study|Lost to Follow-up|7|||
27735212|NCT00761215|80857295|FG002|Overall Study|Randomized but didn't receive drug|2|||
27530759|NCT02063880|80137621|FG001|Overall Study|Lost to Follow-up|7|||
27530760|NCT02063880|80137620|FG000|Overall Study|Ineligible|0|||
27735213|NCT00761215|80857293|FG000|Overall Study|Lost to Follow-up|6|||
27735214|NCT00761215|80857294|FG001|Overall Study|Lost to Follow-up|3|||
27735215|NCT00761215|80857295|FG002|Overall Study|Lost to Follow-up|6|||
27735216|NCT00761215|80857293|FG000|Overall Study|Withdrawal by Subject|1|||
27735217|NCT00761215|80857294|FG001|Overall Study|Withdrawal by Subject|0|||
27735218|NCT00761215|80857295|FG002|Overall Study|Withdrawal by Subject|0|||
27735219|NCT00761215|80857293|FG000|Overall Study|Bacteremia|1|||
27735220|NCT00761215|80857294|FG001|Overall Study|Bacteremia|0|||
27735221|NCT00761215|80857295|FG002|Overall Study|Bacteremia|0|||
27530761|NCT02063880|80137621|FG001|Overall Study|Ineligible|2|||
27735222|NCT01360996|80857300|FG000|Overall Study|Withdrawal by Subject|4|||
27735223|NCT01360996|80857301|FG001|Overall Study|Withdrawal by Subject|3|||
27735224|NCT01360996|80857302|FG002|Overall Study|Withdrawal by Subject|2|||
27735225|NCT01360996|80857300|FG000|Overall Study|Noncompliant|2|||
27530762|NCT02452697|80137622|FG000|Overall Study|Physician Decision|4|||
27530763|NCT02452697|80137623|FG001|Overall Study|Physician Decision|4|||
27530764|NCT02452697|80137624|FG002|Overall Study|Physician Decision|3|||
27530765|NCT02452697|80137625|FG003|Overall Study|Physician Decision|2|||
27530766|NCT02452697|80137622|FG000|Overall Study|Withdrawal by Subject|1|||
27530767|NCT02452697|80137623|FG001|Overall Study|Withdrawal by Subject|0|||
27530768|NCT02452697|80137624|FG002|Overall Study|Withdrawal by Subject|0|||
27530769|NCT02452697|80137625|FG003|Overall Study|Withdrawal by Subject|0|||
27530770|NCT02452697|80137622|FG000|Overall Study|still in follow-up|2|||
27735226|NCT01360996|80857301|FG001|Overall Study|Noncompliant|0|||
27735227|NCT01360996|80857302|FG002|Overall Study|Noncompliant|0|||
27735228|NCT03191786|80857303|FG000|Overall Study|Death|236|||
27735229|NCT03191786|80857304|FG001|Overall Study|Death|127|||
27735230|NCT03191786|80857303|FG000|Overall Study|Lost to Follow-up|9|||
27735231|NCT03191786|80857304|FG001|Overall Study|Lost to Follow-up|3|||
27735232|NCT03191786|80857303|FG000|Overall Study|Physician Decision|1|||
27735233|NCT03191786|80857304|FG001|Overall Study|Physician Decision|0|||
27735234|NCT03191786|80857303|FG000|Overall Study|Moved to Post Trial Access Program|30|||
27735235|NCT03191786|80857304|FG001|Overall Study|Moved to Post Trial Access Program|5|||
27735236|NCT03191786|80857303|FG000|Overall Study|Withdrawal by Subject|26|||
27735237|NCT03191786|80857304|FG001|Overall Study|Withdrawal by Subject|16|||
27735238|NCT03545282|80857307|FG000|Overall Study|Lost to Follow-up|15|||
27735239|NCT03545282|80857308|FG001|Overall Study|Lost to Follow-up|10|||
27735240|NCT03545282|80857307|FG000|Overall Study|Withdrawal by Subject|2|||
27735241|NCT03545282|80857308|FG001|Overall Study|Withdrawal by Subject|2|||
27735242|NCT00886938|80857309|FG000|Overall Study|Adverse Event|1|||
27735243|NCT00886938|80857309|FG000|Overall Study|Withdrawal by Subject|1|||
27735244|NCT04030195|80857310|FG000|Overall Study|Withdrawal by Subject|2|||
27735245|NCT04030195|80857311|FG001|Overall Study|Withdrawal by Subject|0|||
27735246|NCT04030195|80857312|FG002|Overall Study|Withdrawal by Subject|0|||
27735247|NCT05089708|80857313|FG000|Overall Study|Lost to Follow-up|9|||
27735248|NCT05089708|80857314|FG001|Overall Study|Lost to Follow-up|7|||
27735249|NCT05089708|80857313|FG000|Overall Study|Withdrawal by Subject|3|||
27735250|NCT05089708|80857314|FG001|Overall Study|Withdrawal by Subject|1|||
27735251|NCT05089708|80857313|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
27735252|NCT05089708|80857314|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
27735253|NCT05089708|80857313|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
27735254|NCT05089708|80857314|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
27735255|NCT00947349|80857316|FG000|Triple Treatment Combination Period|Adverse Event|0|||
27735256|NCT00947349|80857317|FG001|Triple Treatment Combination Period|Adverse Event|1|||
27735257|NCT00947349|80857318|FG002|Triple Treatment Combination Period|Adverse Event|0|||
27735258|NCT00947349|80857319|FG003|Triple Treatment Combination Period|Adverse Event|0|||
27735259|NCT00947349|80857316|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
27735260|NCT00947349|80857317|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
27735261|NCT00947349|80857318|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
27735262|NCT00947349|80857319|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
27735263|NCT00947349|80857316|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
27735264|NCT00947349|80857317|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
27735265|NCT00947349|80857318|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
27735266|NCT00947349|80857319|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
27735267|NCT00947349|80857316|FG000|Overall Study Standard of Care|Other|0|||
27735268|NCT00947349|80857317|FG001|Overall Study Standard of Care|Other|0|||
27735269|NCT00947349|80857318|FG002|Overall Study Standard of Care|Other|0|||
27735270|NCT00947349|80857319|FG003|Overall Study Standard of Care|Other|1|||
27735271|NCT03596164|80857320|FG000|Overall Study|Adverse Event|0|||
27735272|NCT03596164|80857321|FG001|Overall Study|Adverse Event|1|||
27735273|NCT03596164|80857320|FG000|Overall Study|Death|1|||
27735274|NCT03596164|80857321|FG001|Overall Study|Death|0|||
27735275|NCT02951052|80857322|FG000|Overall Study|Adverse Event|13|||
27735276|NCT02951052|80857323|FG001|Overall Study|Adverse Event|5|||
27735277|NCT02951052|80857322|FG000|Overall Study|Withdrawal by Subject|1|||
27735278|NCT02951052|80857323|FG001|Overall Study|Withdrawal by Subject|5|||
27735279|NCT02951052|80857322|FG000|Overall Study|Physician Decision|2|||
27735280|NCT02951052|80857323|FG001|Overall Study|Physician Decision|0|||
27735281|NCT02951052|80857322|FG000|Overall Study|Lost to Follow-up|1|||
27735282|NCT02951052|80857323|FG001|Overall Study|Lost to Follow-up|1|||
27735283|NCT02951052|80857322|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
27735284|NCT02951052|80857323|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
27735285|NCT02951052|80857322|FG000|Overall Study|Protocol Violation|5|||
27735286|NCT02951052|80857323|FG001|Overall Study|Protocol Violation|3|||
27735287|NCT02951052|80857322|FG000|Overall Study|Lack of Efficacy|3|||
27735288|NCT02951052|80857323|FG001|Overall Study|Lack of Efficacy|4|||
27735289|NCT02951052|80857322|FG000|Overall Study|Ongoing|1|||
27735290|NCT02951052|80857323|FG001|Overall Study|Ongoing|0|||
27626835|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Adverse Event|198|||
27735291|NCT00098787|80857325|FG000|Overall Study|Never started treatment|3|||
27735292|NCT00098787|80857326|FG001|Overall Study|Never started treatment|2|||
27735293|NCT00098787|80857327|FG002|Overall Study|Never started treatment|1|||
27735294|NCT00098787|80857325|FG000|Overall Study|Ineligible|9|||
27735295|NCT00098787|80857326|FG001|Overall Study|Ineligible|7|||
27735296|NCT00098787|80857327|FG002|Overall Study|Ineligible|3|||
27735297|NCT00098787|80857325|FG000|Overall Study|Disease progression|28|||
27735298|NCT00098787|80857326|FG001|Overall Study|Disease progression|17|||
27735299|NCT00098787|80857327|FG002|Overall Study|Disease progression|23|||
27735300|NCT00098787|80857325|FG000|Overall Study|Adverse Event|8|||
27735301|NCT00098787|80857326|FG001|Overall Study|Adverse Event|17|||
27735302|NCT00098787|80857327|FG002|Overall Study|Adverse Event|8|||
27735303|NCT00098787|80857325|FG000|Overall Study|Death|6|||
27735304|NCT00098787|80857326|FG001|Overall Study|Death|1|||
27735305|NCT00098787|80857327|FG002|Overall Study|Death|0|||
27735306|NCT00098787|80857325|FG000|Overall Study|Withdrawal by Subject|4|||
27735307|NCT00098787|80857326|FG001|Overall Study|Withdrawal by Subject|12|||
27735308|NCT00098787|80857327|FG002|Overall Study|Withdrawal by Subject|6|||
27735309|NCT00098787|80857325|FG000|Overall Study|Alternative therapy|8|||
27735310|NCT00098787|80857326|FG001|Overall Study|Alternative therapy|13|||
27735311|NCT00098787|80857327|FG002|Overall Study|Alternative therapy|13|||
27735312|NCT00098787|80857325|FG000|Overall Study|Other|7|||
27735313|NCT00098787|80857326|FG001|Overall Study|Other|6|||
27735314|NCT00098787|80857327|FG002|Overall Study|Other|9|||
27735315|NCT04358458|80857328|FG000|Overall Study|Death|1|||
27735316|NCT04358458|80857329|FG001|Overall Study|Death|1|||
27735317|NCT04358458|80857330|FG002|Overall Study|Death|3|||
27735318|NCT04358458|80857331|FG003|Overall Study|Death|8|||
27735319|NCT04358458|80857332|FG004|Overall Study|Death|1|||
27735320|NCT04358458|80857333|FG005|Overall Study|Death|6|||
27735321|NCT04358458|80857334|FG006|Overall Study|Death|2|||
27735322|NCT04358458|80857335|FG007|Overall Study|Death|3|||
27735323|NCT04358458|80857328|FG000|Overall Study|Lost to Follow-up|0|||
27735324|NCT04358458|80857329|FG001|Overall Study|Lost to Follow-up|0|||
27735325|NCT04358458|80857330|FG002|Overall Study|Lost to Follow-up|0|||
27735326|NCT04358458|80857331|FG003|Overall Study|Lost to Follow-up|0|||
27735327|NCT04358458|80857332|FG004|Overall Study|Lost to Follow-up|0|||
27735328|NCT04358458|80857333|FG005|Overall Study|Lost to Follow-up|0|||
27735329|NCT04358458|80857334|FG006|Overall Study|Lost to Follow-up|0|||
27735330|NCT04358458|80857335|FG007|Overall Study|Lost to Follow-up|1|||
27735331|NCT04358458|80857328|FG000|Overall Study|Site is closing study participation|0|||
27735332|NCT04358458|80857329|FG001|Overall Study|Site is closing study participation|0|||
27735333|NCT04358458|80857330|FG002|Overall Study|Site is closing study participation|0|||
27735334|NCT04358458|80857331|FG003|Overall Study|Site is closing study participation|1|||
27735335|NCT04358458|80857332|FG004|Overall Study|Site is closing study participation|0|||
27735336|NCT04358458|80857333|FG005|Overall Study|Site is closing study participation|0|||
27735337|NCT04358458|80857334|FG006|Overall Study|Site is closing study participation|0|||
27735338|NCT04358458|80857335|FG007|Overall Study|Site is closing study participation|0|||
27735339|NCT04358458|80857328|FG000|Overall Study|Sponsor request|2|||
27735340|NCT04358458|80857329|FG001|Overall Study|Sponsor request|3|||
27735341|NCT04358458|80857330|FG002|Overall Study|Sponsor request|3|||
27735342|NCT04358458|80857331|FG003|Overall Study|Sponsor request|0|||
27735343|NCT04358458|80857332|FG004|Overall Study|Sponsor request|2|||
27735344|NCT04358458|80857333|FG005|Overall Study|Sponsor request|3|||
27735345|NCT04358458|80857334|FG006|Overall Study|Sponsor request|1|||
27735346|NCT04358458|80857335|FG007|Overall Study|Sponsor request|1|||
27735347|NCT04358458|80857328|FG000|Overall Study|Withdrawal by Subject|0|||
27735348|NCT04358458|80857329|FG001|Overall Study|Withdrawal by Subject|0|||
27735349|NCT04358458|80857330|FG002|Overall Study|Withdrawal by Subject|1|||
27735350|NCT04358458|80857331|FG003|Overall Study|Withdrawal by Subject|1|||
27735351|NCT04358458|80857332|FG004|Overall Study|Withdrawal by Subject|0|||
27735352|NCT04358458|80857333|FG005|Overall Study|Withdrawal by Subject|1|||
27735353|NCT04358458|80857334|FG006|Overall Study|Withdrawal by Subject|0|||
27735354|NCT04358458|80857335|FG007|Overall Study|Withdrawal by Subject|1|||
27735355|NCT05369806|80857336|FG000|Overall Study|Lost to Follow-up|1|||
27735356|NCT01299025|80857337|FG000|Overall Study|Withdrawal by Subject|2|||
27735357|NCT01299025|80857338|FG001|Overall Study|Withdrawal by Subject|1|||
27735358|NCT01299025|80857337|FG000|Overall Study|Lost to Follow-up|1|||
27735359|NCT01299025|80857338|FG001|Overall Study|Lost to Follow-up|0|||
27735360|NCT01966731|80857339|FG000|Overall Study|Death|2|||
27735361|NCT01966731|80857339|FG000|Overall Study|Lost to Follow-up|1|||
27735362|NCT01966731|80857339|FG000|Overall Study|Physician Decision|2|||
27735363|NCT01966731|80857339|FG000|Overall Study|Follow up is not complete|600|||
27735364|NCT01966731|80857339|FG000|Overall Study|Screening Failure|29|||
27735365|NCT01966731|80857339|FG000|Overall Study|Found to be ineligible|1|||
27735366|NCT01171612|80857342|FG000|Overall Study|Lost to Follow-up|51|||
27735367|NCT02580058|80857343|FG000|Overall Study|Adverse Event|16|||
27735368|NCT02580058|80857344|FG001|Overall Study|Adverse Event|30|||
27735369|NCT02580058|80857345|FG002|Overall Study|Adverse Event|20|||
27735370|NCT02580058|80857343|FG000|Overall Study|Death|4|||
27735371|NCT02580058|80857344|FG001|Overall Study|Death|4|||
27735372|NCT02580058|80857345|FG002|Overall Study|Death|5|||
27735373|NCT02580058|80857343|FG000|Overall Study|Physician Decision|1|||
27735374|NCT02580058|80857344|FG001|Overall Study|Physician Decision|3|||
27735375|NCT02580058|80857345|FG002|Overall Study|Physician Decision|11|||
27735376|NCT02580058|80857343|FG000|Overall Study|Other|5|||
27735377|NCT02580058|80857344|FG001|Overall Study|Other|1|||
27735378|NCT02580058|80857345|FG002|Overall Study|Other|3|||
27735379|NCT02580058|80857343|FG000|Overall Study|Withdrawal by Subject|4|||
27735380|NCT02580058|80857344|FG001|Overall Study|Withdrawal by Subject|7|||
27735381|NCT02580058|80857345|FG002|Overall Study|Withdrawal by Subject|31|||
27735382|NCT02580058|80857343|FG000|Overall Study|Global Deterioration of Health Status|19|||
27735383|NCT02580058|80857344|FG001|Overall Study|Global Deterioration of Health Status|18|||
27735384|NCT02580058|80857345|FG002|Overall Study|Global Deterioration of Health Status|24|||
27735385|NCT02580058|80857343|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
27735386|NCT02580058|80857344|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27735387|NCT02580058|80857345|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
27735388|NCT02580058|80857343|FG000|Overall Study|Progressive Disease|137|||
27735389|NCT02580058|80857344|FG001|Overall Study|Progressive Disease|125|||
27735390|NCT02580058|80857345|FG002|Overall Study|Progressive Disease|94|||
27735391|NCT02580058|80857343|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27735392|NCT02580058|80857344|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27735393|NCT02580058|80857345|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27735394|NCT02635204|80857346|FG000|Overall Study|Adverse Event|1|||
27735395|NCT02635204|80857347|FG001|Overall Study|Adverse Event|0|||
27735396|NCT02635204|80857346|FG000|Overall Study|Lost to Follow-up|1|||
27735397|NCT02635204|80857347|FG001|Overall Study|Lost to Follow-up|1|||
27735398|NCT00488631|80857349|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
27735399|NCT00488631|80857350|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
27735400|NCT00488631|80857351|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
27735401|NCT00488631|80857352|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
27735402|NCT00488631|80857353|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
27735403|NCT00488631|80857354|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
27735404|NCT00488631|80857355|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
27735405|NCT00488631|80857356|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
27735406|NCT00488631|80857357|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
27735407|NCT00488631|80857358|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
27735408|NCT00488631|80857349|FG000|Double Blind Period (Week 0-54)|Death|0|||
27735409|NCT00488631|80857350|FG001|Double Blind Period (Week 0-54)|Death|0|||
27735410|NCT00488631|80857351|FG002|Double Blind Period (Week 0-54)|Death|0|||
27735411|NCT00488631|80857352|FG003|Double Blind Period (Week 0-54)|Death|0|||
27735412|NCT00488631|80857353|FG004|Double Blind Period (Week 0-54)|Death|0|||
27735413|NCT00488631|80857354|FG005|Double Blind Period (Week 0-54)|Death|1|||
27735414|NCT00488631|80857355|FG006|Double Blind Period (Week 0-54)|Death|0|||
27735415|NCT00488631|80857356|FG007|Double Blind Period (Week 0-54)|Death|0|||
27735416|NCT00488631|80857357|FG008|Double Blind Period (Week 0-54)|Death|0|||
27735417|NCT00488631|80857358|FG009|Double Blind Period (Week 0-54)|Death|0|||
27735418|NCT00488631|80857349|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
27735419|NCT00488631|80857350|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
27735420|NCT00488631|80857351|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
27735421|NCT00488631|80857352|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
27735422|NCT00488631|80857353|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
27735423|NCT00488631|80857354|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
27735424|NCT00488631|80857355|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
27735425|NCT00488631|80857356|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
27735426|NCT00488631|80857357|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
27735427|NCT00488631|80857358|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
27735428|NCT00488631|80857349|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
27735429|NCT00488631|80857350|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
27735430|NCT00488631|80857351|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
27735431|NCT00488631|80857352|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
27735432|NCT00488631|80857353|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
27735433|NCT00488631|80857354|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
27735434|NCT00488631|80857355|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
27735435|NCT00488631|80857356|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
27735436|NCT00488631|80857357|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
27735437|NCT00488631|80857358|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
27735438|NCT00488631|80857349|FG000|Double Blind Period (Week 0-54)|Other|6|||
27735439|NCT00488631|80857350|FG001|Double Blind Period (Week 0-54)|Other|12|||
27735440|NCT00488631|80857351|FG002|Double Blind Period (Week 0-54)|Other|10|||
27735441|NCT00488631|80857352|FG003|Double Blind Period (Week 0-54)|Other|11|||
27735442|NCT00488631|80857353|FG004|Double Blind Period (Week 0-54)|Other|14|||
27735443|NCT00488631|80857354|FG005|Double Blind Period (Week 0-54)|Other|34|||
27735444|NCT00488631|80857355|FG006|Double Blind Period (Week 0-54)|Other|0|||
27735445|NCT00488631|80857356|FG007|Double Blind Period (Week 0-54)|Other|0|||
27735446|NCT00488631|80857357|FG008|Double Blind Period (Week 0-54)|Other|0|||
27735447|NCT00488631|80857358|FG009|Double Blind Period (Week 0-54)|Other|0|||
27912296|NCT02718911|81518135|FG000|Overall Study|Lost to Follow-up|0|||
27735448|NCT00488631|80857349|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27735449|NCT00488631|80857350|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27856587|NCT02011386|81306863|FG000|Overall Study|Non-compliance|2|||
27735450|NCT00488631|80857351|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27735451|NCT00488631|80857352|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27735452|NCT00488631|80857353|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27735453|NCT00488631|80857354|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27735454|NCT00488631|80857355|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
27735455|NCT00488631|80857356|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
27530771|NCT02452697|80137623|FG001|Overall Study|still in follow-up|2|||
27530772|NCT02452697|80137624|FG002|Overall Study|still in follow-up|1|||
27530773|NCT02452697|80137625|FG003|Overall Study|still in follow-up|3|||
27530774|NCT00589290|80137629|FG000|Overall Study|Withdrawal by Subject|1|||
27530775|NCT01865084|80137630|FG000|Double Blind Period (DB)|Adverse Event|2|||
27530776|NCT01865084|80137631|FG001|Double Blind Period (DB)|Adverse Event|2|||
27530777|NCT01865084|80137632|FG002|Double Blind Period (DB)|Adverse Event|1|||
27530778|NCT01865084|80137630|FG000|Double Blind Period (DB)|Protocol Violation|0|||
27530779|NCT01865084|80137631|FG001|Double Blind Period (DB)|Protocol Violation|0|||
27530780|NCT01865084|80137632|FG002|Double Blind Period (DB)|Protocol Violation|1|||
27530781|NCT01865084|80137630|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
27530782|NCT01865084|80137631|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
27530783|NCT01865084|80137632|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
27530784|NCT01865084|80137630|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
27530785|NCT01865084|80137631|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
27530786|NCT01865084|80137632|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
27530787|NCT01865084|80137630|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
27530788|NCT01865084|80137631|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
27530789|NCT01865084|80137632|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
27530790|NCT01865084|80137630|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
27530791|NCT01865084|80137631|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
27530792|NCT01865084|80137632|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
27530793|NCT01865084|80137630|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
27530794|NCT01865084|80137631|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
27530795|NCT01865084|80137632|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
27530796|NCT01865084|80137630|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
27530797|NCT01865084|80137631|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
27530798|NCT01865084|80137632|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
27530799|NCT01865084|80137630|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
27530800|NCT01865084|80137631|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
27530801|NCT01865084|80137632|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
27530802|NCT01143207|80137637|FG000|Overall Study|Lost to Follow-up|2|||
27530803|NCT00089284|80137638|FG000|Overall Study|Adverse event before starting treatment|0|||
27530804|NCT00089284|80137639|FG001|Overall Study|Adverse event before starting treatment|0|||
27530805|NCT00089284|80137640|FG002|Overall Study|Adverse event before starting treatment|0|||
27530806|NCT00089284|80137641|FG003|Overall Study|Adverse event before starting treatment|0|||
27530807|NCT00089284|80137642|FG004|Overall Study|Adverse event before starting treatment|0|||
27530808|NCT00089284|80137643|FG005|Overall Study|Adverse event before starting treatment|0|||
27530809|NCT00089284|80137644|FG006|Overall Study|Adverse event before starting treatment|1|||
27530810|NCT00751621|80137645|FG000|Overall Study|Adverse Event|1|||
27530811|NCT00751621|80137645|FG000|Overall Study|Withdrawal by Subject|1|||
27530812|NCT00751621|80137645|FG000|Overall Study|Subject moved to another country|1|||
27530813|NCT00751621|80137645|FG000|Overall Study|Poor adherence to asthma treatment|1|||
27530814|NCT03488927|80137648|FG000|Overall Study|Withdrawal by Subject|44|||
27530815|NCT03488927|80137649|FG001|Overall Study|Withdrawal by Subject|118|||
27530816|NCT03488927|80137650|FG002|Overall Study|Withdrawal by Subject|217|||
27530817|NCT02939079|80137651|FG000|Overall Study|Adverse Event|2|||
27530818|NCT02939079|80137652|FG001|Overall Study|Adverse Event|1|||
27530819|NCT02939079|80137651|FG000|Overall Study|Lost to Follow-up|0|||
27530820|NCT02939079|80137652|FG001|Overall Study|Lost to Follow-up|2|||
27530821|NCT02939079|80137651|FG000|Overall Study|Protocol Violation|1|||
27530822|NCT02939079|80137652|FG001|Overall Study|Protocol Violation|0|||
27735456|NCT00488631|80857357|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
27735457|NCT00488631|80857358|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
27735458|NCT00488631|80857349|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
27530823|NCT02939079|80137651|FG000|Overall Study|Withdrawal by Subject|0|||
27530824|NCT02939079|80137652|FG001|Overall Study|Withdrawal by Subject|1|||
27530825|NCT02939079|80137651|FG000|Overall Study|relapse during the study|1|||
27530826|NCT02939079|80137652|FG001|Overall Study|relapse during the study|1|||
27530827|NCT05036369|80137653|FG000|Overall Study|Run In non compliance|1|||
27530828|NCT05036369|80137654|FG001|Overall Study|Run In non compliance|2|||
27530829|NCT05036369|80137653|FG000|Overall Study|Change in eligibility criteria|0|||
27530830|NCT05036369|80137654|FG001|Overall Study|Change in eligibility criteria|1|||
27530831|NCT03183778|80137657|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
27530832|NCT00237185|80137658|FG000|Core|Adverse Event|3|||
27530833|NCT00237185|80137659|FG001|Core|Adverse Event|4|||
27530834|NCT00237185|80137658|FG000|Core|Abnormal laboratory value|0|||
27530835|NCT00237185|80137659|FG001|Core|Abnormal laboratory value|4|||
27530836|NCT00237185|80137658|FG000|Core|Abnormal test procedure results|1|||
27530837|NCT00237185|80137659|FG001|Core|Abnormal test procedure results|0|||
27530838|NCT00237185|80137658|FG000|Core|Lack of Efficacy|30|||
27530839|NCT00237185|80137659|FG001|Core|Lack of Efficacy|23|||
27530840|NCT00237185|80137658|FG000|Core|Protocol Violation|1|||
27530841|NCT00237185|80137659|FG001|Core|Protocol Violation|1|||
27530842|NCT00237185|80137658|FG000|Core|Withdrawal by Subject|4|||
27530843|NCT00237185|80137659|FG001|Core|Withdrawal by Subject|4|||
27530844|NCT00237185|80137658|FG000|Core|Administrative problems|0|||
27530845|NCT00237185|80137659|FG001|Core|Administrative problems|1|||
27530846|NCT00237185|80137658|FG000|Core|Death|4|||
27530847|NCT00237185|80137659|FG001|Core|Death|0|||
27530848|NCT00237185|80137658|FG000|Core|Determined ineligible post randomization|1|||
27530849|NCT00237185|80137659|FG001|Core|Determined ineligible post randomization|0|||
27530850|NCT00237185|80137658|FG000|Extension|Adverse Event|1|||
27530851|NCT00237185|80137659|FG001|Extension|Adverse Event|0|||
27530852|NCT00237185|80137658|FG000|Extension|Abnormal laboratory value|0|||
27530853|NCT00237185|80137659|FG001|Extension|Abnormal laboratory value|1|||
27530854|NCT00237185|80137658|FG000|Extension|Lack of Efficacy|9|||
27530855|NCT00237185|80137659|FG001|Extension|Lack of Efficacy|14|||
27530856|NCT00237185|80137658|FG000|Extension|Condition no longer required study drug|0|||
27530857|NCT00237185|80137659|FG001|Extension|Condition no longer required study drug|1|||
27530858|NCT00237185|80137658|FG000|Extension|Withdrawal by Subject|3|||
27530859|NCT00237185|80137659|FG001|Extension|Withdrawal by Subject|2|||
27530860|NCT00237185|80137658|FG000|Extension|Lost to Follow-up|1|||
27530861|NCT00237185|80137659|FG001|Extension|Lost to Follow-up|0|||
27530862|NCT00237185|80137658|FG000|Extension|Administrative problems|1|||
27530863|NCT00237185|80137659|FG001|Extension|Administrative problems|0|||
27530864|NCT00237185|80137658|FG000|Extension|Death|1|||
27530865|NCT00237185|80137659|FG001|Extension|Death|1|||
27530866|NCT02713204|80137660|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
27530867|NCT02713204|80137661|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27530868|NCT02713204|80137662|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
27530869|NCT02713204|80137663|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27626836|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Adverse Event|0|||
27626837|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Adverse Event|0|||
27912297|NCT02718911|81518136|FG001|Overall Study|Lost to Follow-up|0|||
27912298|NCT02718911|81518137|FG002|Overall Study|Lost to Follow-up|0|||
27912299|NCT02718911|81518138|FG003|Overall Study|Lost to Follow-up|0|||
27912300|NCT02718911|81518139|FG004|Overall Study|Lost to Follow-up|0|||
27912301|NCT02718911|81518140|FG005|Overall Study|Lost to Follow-up|0|||
27912302|NCT02718911|81518141|FG006|Overall Study|Lost to Follow-up|0|||
27912303|NCT02718911|81518142|FG007|Overall Study|Lost to Follow-up|0|||
27912304|NCT02718911|81518143|FG008|Overall Study|Lost to Follow-up|1|||
27912305|NCT02718911|81518144|FG009|Overall Study|Lost to Follow-up|0|||
27912306|NCT02718911|81518135|FG000|Overall Study|Physician Decision|2|||
27912307|NCT02718911|81518136|FG001|Overall Study|Physician Decision|0|||
27912308|NCT02718911|81518137|FG002|Overall Study|Physician Decision|1|||
27912309|NCT02718911|81518138|FG003|Overall Study|Physician Decision|1|||
27530870|NCT02713204|80137664|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27530871|NCT02713204|80137665|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27626838|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Adverse Event|0|||
27626839|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Death|62|||
27626840|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Death|0|||
27626841|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Death|0|||
27626842|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Death|0|||
27626843|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
27626844|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
27626845|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
27626846|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
27626847|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Complicating disease|13|||
27626848|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Complicating disease|0|||
27626849|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Complicating disease|0|||
27626850|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Complicating disease|0|||
27626851|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
27626852|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
27626853|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
27626854|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
27626855|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
27626856|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
27626857|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
27626858|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
27626859|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Non-compliance|4|||
27626860|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Non-compliance|0|||
27626861|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Non-compliance|0|||
27626862|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Non-compliance|0|||
27626863|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Pain|4|||
27626864|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Pain|0|||
27626865|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Pain|0|||
27626866|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Pain|0|||
27626867|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
27856588|NCT02011386|81306863|FG000|Overall Study|Lack of Efficacy|3|||
27856589|NCT00758680|81310165|FG000|Overall Study|Adverse Event|0|||
27856590|NCT00758680|81310166|FG001|Overall Study|Adverse Event|0|||
27856591|NCT00758680|81310167|FG002|Overall Study|Adverse Event|0|||
27856592|NCT00758680|81310168|FG003|Overall Study|Adverse Event|0|||
27856593|NCT00758680|81310169|FG004|Overall Study|Adverse Event|0|||
27856594|NCT00758680|81310170|FG005|Overall Study|Adverse Event|0|||
27856595|NCT00758680|81310171|FG006|Overall Study|Adverse Event|0|||
27856596|NCT00758680|81310172|FG007|Overall Study|Adverse Event|1|||
27856597|NCT00758680|81310173|FG008|Overall Study|Adverse Event|0|||
27856598|NCT00758680|81310174|FG009|Overall Study|Adverse Event|1|||
27856599|NCT00758680|81310165|FG000|Overall Study|Laboratory Adverse Event|0|||
27856600|NCT00758680|81310166|FG001|Overall Study|Laboratory Adverse Event|0|||
27856601|NCT00758680|81310167|FG002|Overall Study|Laboratory Adverse Event|0|||
27856602|NCT00758680|81310168|FG003|Overall Study|Laboratory Adverse Event|0|||
27856603|NCT00758680|81310169|FG004|Overall Study|Laboratory Adverse Event|0|||
27856604|NCT00758680|81310170|FG005|Overall Study|Laboratory Adverse Event|0|||
27856605|NCT00758680|81310171|FG006|Overall Study|Laboratory Adverse Event|0|||
27856606|NCT00758680|81310172|FG007|Overall Study|Laboratory Adverse Event|0|||
27856607|NCT00758680|81310173|FG008|Overall Study|Laboratory Adverse Event|1|||
27856608|NCT00758680|81310174|FG009|Overall Study|Laboratory Adverse Event|0|||
27856609|NCT00758680|81310165|FG000|Overall Study|Withdrawal by Subject|0|||
27856610|NCT00758680|81310166|FG001|Overall Study|Withdrawal by Subject|0|||
27856611|NCT00758680|81310167|FG002|Overall Study|Withdrawal by Subject|0|||
27856612|NCT00758680|81310168|FG003|Overall Study|Withdrawal by Subject|0|||
27856613|NCT00758680|81310169|FG004|Overall Study|Withdrawal by Subject|0|||
27856614|NCT00758680|81310170|FG005|Overall Study|Withdrawal by Subject|0|||
27856615|NCT00758680|81310171|FG006|Overall Study|Withdrawal by Subject|1|||
27856616|NCT00758680|81310172|FG007|Overall Study|Withdrawal by Subject|0|||
27856617|NCT00758680|81310173|FG008|Overall Study|Withdrawal by Subject|1|||
27856618|NCT00758680|81310174|FG009|Overall Study|Withdrawal by Subject|0|||
27626868|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
27626869|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
27626870|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
27626871|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Hospice care|1|||
27856619|NCT02563106|81310175|FG000|Overall Study|Withdrawal by Subject|7|||
27856620|NCT02563106|81310176|FG001|Overall Study|Withdrawal by Subject|8|||
27856621|NCT02563106|81310175|FG000|Overall Study|Adverse Event|17|||
27856622|NCT02563106|81310176|FG001|Overall Study|Adverse Event|15|||
27856623|NCT02563106|81310175|FG000|Overall Study|Protocol Violation|1|||
27856624|NCT02563106|81310176|FG001|Overall Study|Protocol Violation|0|||
27856625|NCT02563106|81310175|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
27856626|NCT02563106|81310176|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
27856627|NCT02563106|81310175|FG000|Overall Study|Lost to Follow-up|3|||
27626872|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Hospice care|0|||
27530872|NCT02713204|80137666|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27530873|NCT02713204|80137667|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
27530874|NCT02713204|80137660|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530875|NCT02713204|80137661|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530876|NCT02713204|80137662|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
27530877|NCT02713204|80137663|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530878|NCT02713204|80137664|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530879|NCT02713204|80137665|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530880|NCT02713204|80137666|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530881|NCT02713204|80137667|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
27530882|NCT02713204|80137660|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530883|NCT02713204|80137661|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
27530884|NCT02713204|80137662|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530885|NCT02713204|80137663|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530886|NCT02713204|80137664|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530887|NCT02713204|80137665|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530888|NCT02713204|80137666|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530889|NCT02713204|80137667|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
27530890|NCT02713204|80137660|FG000|From Week 12 up to Week 36|Adverse Event|1|||
27530891|NCT02713204|80137661|FG001|From Week 12 up to Week 36|Adverse Event|0|||
27530892|NCT02713204|80137662|FG002|From Week 12 up to Week 36|Adverse Event|0|||
27530893|NCT02713204|80137663|FG003|From Week 12 up to Week 36|Adverse Event|1|||
27530894|NCT02713204|80137664|FG004|From Week 12 up to Week 36|Adverse Event|1|||
27530895|NCT02713204|80137665|FG005|From Week 12 up to Week 36|Adverse Event|0|||
27530896|NCT02713204|80137666|FG006|From Week 12 up to Week 36|Adverse Event|2|||
27530897|NCT02713204|80137667|FG007|From Week 12 up to Week 36|Adverse Event|1|||
27530898|NCT02713204|80137660|FG000|From Week 12 up to Week 36|Death|0|||
27530899|NCT02713204|80137661|FG001|From Week 12 up to Week 36|Death|0|||
27530900|NCT02713204|80137662|FG002|From Week 12 up to Week 36|Death|0|||
27530901|NCT02713204|80137663|FG003|From Week 12 up to Week 36|Death|1|||
27530902|NCT02713204|80137664|FG004|From Week 12 up to Week 36|Death|0|||
27530903|NCT02713204|80137665|FG005|From Week 12 up to Week 36|Death|1|||
27530904|NCT02713204|80137666|FG006|From Week 12 up to Week 36|Death|0|||
27530905|NCT02713204|80137667|FG007|From Week 12 up to Week 36|Death|3|||
27530906|NCT02713204|80137660|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530907|NCT02713204|80137661|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530908|NCT02713204|80137662|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530909|NCT02713204|80137663|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
27530910|NCT02713204|80137664|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530911|NCT02713204|80137665|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530912|NCT02713204|80137666|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530913|NCT02713204|80137667|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
27530914|NCT02713204|80137660|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
27530915|NCT02713204|80137661|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
27530916|NCT02713204|80137662|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
27530917|NCT02713204|80137663|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
27530918|NCT02713204|80137664|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
27530919|NCT02713204|80137665|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
27530920|NCT02713204|80137666|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
27530921|NCT02713204|80137667|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
27530922|NCT00945555|80137676|FG000|Overall Study|Referred to another hospital|5|||
27530923|NCT00945555|80137676|FG000|Overall Study|Worsening condition, intensive care unit|1|||
27530924|NCT00945555|80137676|FG000|Overall Study|Withdrawal by Subject|2|||
27530925|NCT00945555|80137676|FG000|Overall Study|Participant continued treatment at home|1|||
27856628|NCT02563106|81310176|FG001|Overall Study|Lost to Follow-up|2|||
27856629|NCT02563106|81310175|FG000|Overall Study|Physician Decision|3|||
27856630|NCT02563106|81310176|FG001|Overall Study|Physician Decision|1|||
27856631|NCT02563106|81310175|FG000|Overall Study|Other reason - not specified|2|||
27530926|NCT00945555|80137676|FG000|Overall Study|Death|18|||
27530927|NCT00945555|80137676|FG000|Overall Study|Other|1|||
27530928|NCT00900601|80137677|FG000|Overall Study|Physician Decision|1|||
27530929|NCT01230710|80137678|FG000|Overall Study|Disease Progression|41|||
27856632|NCT02563106|81310176|FG001|Overall Study|Other reason - not specified|1|||
27856633|NCT03623386|81310177|FG000|Overall Study|Protocol Violation|3|||
27530930|NCT01230710|80137678|FG000|Overall Study|Lost to Follow-up|3|||
27530931|NCT01230710|80137678|FG000|Overall Study|Death|4|||
27856634|NCT03623386|81310178|FG001|Overall Study|Protocol Violation|2|||
27856635|NCT03623386|81310179|FG002|Overall Study|Protocol Violation|0|||
27530932|NCT01230710|80137678|FG000|Overall Study|Withdrawal of Consent|1|||
27530933|NCT01697358|80137679|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
27530934|NCT01697358|80137680|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
27530935|NCT01697358|80137679|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
27530936|NCT01697358|80137680|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
27626873|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Hospice care|0|||
27626874|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Hospice care|0|||
27626875|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Physician Decision|1|||
27626876|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Physician Decision|0|||
27626877|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Physician Decision|0|||
27626878|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Physician Decision|0|||
27626879|NCT01107626|80476809|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
27626880|NCT01107626|80476810|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
27626881|NCT01107626|80476811|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
27626882|NCT01107626|80476812|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
27626883|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
27626884|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
27626885|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
27626886|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
27626887|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
27626888|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
27626889|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
27626890|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
27626891|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Death|0|||
27626892|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Death|8|||
27626893|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Death|2|||
27626894|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Death|13|||
27626895|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
27626896|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
27626897|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
27626898|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
27626899|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
27626900|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
27626901|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
27626902|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
27626903|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
27626904|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
27626905|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
27626906|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
27626907|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
27626908|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
27626909|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
27626910|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
27626911|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
27626912|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
27626913|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
27626914|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
27626915|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
27626916|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
27626917|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
27626918|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
27626919|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
27626920|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
27626921|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
27626922|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
27626923|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
27626924|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
27626925|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
27626926|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
27626927|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
27626928|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
27626929|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
27626930|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
27626931|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
27626932|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
27626933|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
27626934|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
27626935|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Pain|0|||
27626936|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Pain|0|||
27626937|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Pain|0|||
27626938|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Pain|1|||
27735459|NCT00488631|80857350|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
27735460|NCT00488631|80857351|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
27735461|NCT00488631|80857352|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
27626939|NCT01107626|80476809|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
27626940|NCT01107626|80476810|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
27626941|NCT01107626|80476811|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
27626942|NCT01107626|80476812|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
27626943|NCT03503773|80476813|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
27626944|NCT03503773|80476814|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
27626945|NCT03503773|80476813|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
27626946|NCT03503773|80476814|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
27626947|NCT03503773|80476813|FG000|Overall Study|Not completing the primary ABPM|3|||
27626948|NCT03503773|80476814|FG001|Overall Study|Not completing the primary ABPM|1|||
27626949|NCT03503773|80476813|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27626950|NCT03503773|80476814|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27626951|NCT00975806|80476815|FG000|Overall Study|Adverse Event|2|||
27626952|NCT00975806|80476816|FG001|Overall Study|Adverse Event|1|||
27626953|NCT00975806|80476817|FG002|Overall Study|Adverse Event|2|||
27626954|NCT00975806|80476815|FG000|Overall Study|Disease Progression|1|||
27626955|NCT00975806|80476816|FG001|Overall Study|Disease Progression|5|||
27626956|NCT00975806|80476817|FG002|Overall Study|Disease Progression|1|||
27626957|NCT00975806|80476815|FG000|Overall Study|Withdrawal by Subject|1|||
27626958|NCT00975806|80476816|FG001|Overall Study|Withdrawal by Subject|0|||
27626959|NCT00975806|80476817|FG002|Overall Study|Withdrawal by Subject|0|||
27626960|NCT00975806|80476815|FG000|Overall Study|Death|0|||
27626961|NCT00975806|80476816|FG001|Overall Study|Death|1|||
27626962|NCT00975806|80476817|FG002|Overall Study|Death|0|||
27626963|NCT00975806|80476815|FG000|Overall Study|Physician decision and disease related|1|||
27626964|NCT00975806|80476816|FG001|Overall Study|Physician decision and disease related|0|||
27626965|NCT00975806|80476817|FG002|Overall Study|Physician decision and disease related|1|||
27626966|NCT01311713|80476820|FG000|Overall Study|Death|0|||
27626967|NCT01311713|80476821|FG001|Overall Study|Death|0|||
27626968|NCT01311713|80476822|FG002|Overall Study|Death|1|||
27626969|NCT01311713|80476823|FG003|Overall Study|Death|1|||
27626970|NCT01311713|80476824|FG004|Overall Study|Death|0|||
27626971|NCT01311713|80476825|FG005|Overall Study|Death|1|||
27626972|NCT01311713|80476826|FG006|Overall Study|Death|0|||
27626973|NCT01311713|80476820|FG000|Overall Study|Adverse Event|0|||
27626974|NCT01311713|80476821|FG001|Overall Study|Adverse Event|1|||
27626975|NCT01311713|80476822|FG002|Overall Study|Adverse Event|0|||
27626976|NCT01311713|80476823|FG003|Overall Study|Adverse Event|2|||
27626977|NCT01311713|80476824|FG004|Overall Study|Adverse Event|0|||
27626978|NCT01311713|80476825|FG005|Overall Study|Adverse Event|0|||
27626979|NCT01311713|80476826|FG006|Overall Study|Adverse Event|2|||
27626980|NCT01311713|80476820|FG000|Overall Study|Withdrawal by Subject|0|||
27626981|NCT01311713|80476821|FG001|Overall Study|Withdrawal by Subject|1|||
27626982|NCT01311713|80476822|FG002|Overall Study|Withdrawal by Subject|1|||
27626983|NCT01311713|80476823|FG003|Overall Study|Withdrawal by Subject|0|||
27626984|NCT01311713|80476824|FG004|Overall Study|Withdrawal by Subject|0|||
27626985|NCT01311713|80476825|FG005|Overall Study|Withdrawal by Subject|1|||
27626986|NCT01311713|80476826|FG006|Overall Study|Withdrawal by Subject|2|||
27626987|NCT01311713|80476820|FG000|Overall Study|Disease progression|3|||
27626988|NCT01311713|80476821|FG001|Overall Study|Disease progression|4|||
27626989|NCT01311713|80476822|FG002|Overall Study|Disease progression|3|||
27626990|NCT01311713|80476823|FG003|Overall Study|Disease progression|2|||
27626991|NCT01311713|80476824|FG004|Overall Study|Disease progression|4|||
27626992|NCT01311713|80476825|FG005|Overall Study|Disease progression|4|||
27626993|NCT01311713|80476826|FG006|Overall Study|Disease progression|5|||
27626994|NCT01311713|80476820|FG000|Overall Study|Lost to Follow-up|0|||
27626995|NCT01311713|80476821|FG001|Overall Study|Lost to Follow-up|0|||
27626996|NCT01311713|80476822|FG002|Overall Study|Lost to Follow-up|1|||
27626997|NCT01311713|80476823|FG003|Overall Study|Lost to Follow-up|0|||
27626998|NCT01311713|80476824|FG004|Overall Study|Lost to Follow-up|0|||
27626999|NCT01311713|80476825|FG005|Overall Study|Lost to Follow-up|0|||
27627000|NCT01311713|80476826|FG006|Overall Study|Lost to Follow-up|0|||
27627001|NCT01311713|80476820|FG000|Overall Study|Stopped taking study medication|0|||
27627002|NCT01311713|80476821|FG001|Overall Study|Stopped taking study medication|0|||
27856636|NCT03623386|81310177|FG000|Overall Study|Physician Decision|1|||
27856637|NCT03623386|81310178|FG001|Overall Study|Physician Decision|1|||
27627003|NCT01311713|80476822|FG002|Overall Study|Stopped taking study medication|0|||
27627004|NCT01311713|80476823|FG003|Overall Study|Stopped taking study medication|1|||
27627005|NCT01311713|80476824|FG004|Overall Study|Stopped taking study medication|1|||
27627006|NCT01311713|80476825|FG005|Overall Study|Stopped taking study medication|0|||
27627007|NCT01311713|80476826|FG006|Overall Study|Stopped taking study medication|0|||
27627008|NCT01311713|80476820|FG000|Overall Study|Enrolled but not treated|0|||
27627009|NCT01311713|80476821|FG001|Overall Study|Enrolled but not treated|0|||
27627010|NCT01311713|80476822|FG002|Overall Study|Enrolled but not treated|1|||
27627011|NCT01311713|80476823|FG003|Overall Study|Enrolled but not treated|0|||
27627012|NCT01311713|80476824|FG004|Overall Study|Enrolled but not treated|0|||
27627013|NCT01311713|80476825|FG005|Overall Study|Enrolled but not treated|0|||
27627014|NCT01311713|80476826|FG006|Overall Study|Enrolled but not treated|0|||
27627015|NCT01311713|80476820|FG000|Overall Study|Other than specified|0|||
27627016|NCT01311713|80476821|FG001|Overall Study|Other than specified|1|||
27627017|NCT01311713|80476822|FG002|Overall Study|Other than specified|2|||
27627018|NCT01311713|80476823|FG003|Overall Study|Other than specified|0|||
27627019|NCT01311713|80476824|FG004|Overall Study|Other than specified|0|||
27627020|NCT01311713|80476825|FG005|Overall Study|Other than specified|0|||
27627021|NCT01311713|80476826|FG006|Overall Study|Other than specified|0|||
27735462|NCT00488631|80857353|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
27735463|NCT00488631|80857354|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
27735464|NCT00488631|80857355|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
27735465|NCT00488631|80857356|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
27530937|NCT01697358|80137679|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
27530938|NCT01697358|80137680|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
27530939|NCT01697358|80137679|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
27530940|NCT01697358|80137680|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
27530941|NCT01697358|80137679|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
27530942|NCT01697358|80137680|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
27530943|NCT01697358|80137679|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
27530944|NCT01697358|80137680|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
27530945|NCT01697358|80137679|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
27530946|NCT01697358|80137680|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
27530947|NCT01697358|80137679|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
27530948|NCT01697358|80137680|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
27530949|NCT01697358|80137679|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
27530950|NCT01697358|80137680|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
27530951|NCT01697358|80137679|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
27530952|NCT01697358|80137680|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
27530953|NCT02460458|80137683|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
27530954|NCT02460458|80137683|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
27530955|NCT02460458|80137683|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
27530956|NCT02460458|80137683|FG000|First Prospective Phase|Lost to Follow-up|16|||
27530957|NCT02460458|80137683|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
27530958|NCT00736879|80137684|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
27530959|NCT00736879|80137685|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
27530960|NCT00736879|80137686|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
27530961|NCT00736879|80137687|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
27530962|NCT00736879|80137684|FG000|Double Blind Treatment Period|Adverse Event|0|||
27530963|NCT00736879|80137685|FG001|Double Blind Treatment Period|Adverse Event|1|||
27530964|NCT00736879|80137686|FG002|Double Blind Treatment Period|Adverse Event|1|||
27530965|NCT00736879|80137687|FG003|Double Blind Treatment Period|Adverse Event|0|||
27530966|NCT00736879|80137684|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
27530967|NCT00736879|80137685|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
27530968|NCT00736879|80137686|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
27530969|NCT00736879|80137687|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
27530970|NCT00736879|80137684|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
27530971|NCT00736879|80137685|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
27530972|NCT00736879|80137686|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
27530973|NCT00736879|80137687|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
27530974|NCT00736879|80137684|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
27530975|NCT00736879|80137685|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
27530976|NCT00736879|80137686|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
27530977|NCT00736879|80137687|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
27530978|NCT00736879|80137684|FG000|Double Blind Treatment Period|No longer met criteria|0|||
27530979|NCT00736879|80137685|FG001|Double Blind Treatment Period|No longer met criteria|1|||
27530980|NCT00736879|80137686|FG002|Double Blind Treatment Period|No longer met criteria|0|||
27530981|NCT00736879|80137687|FG003|Double Blind Treatment Period|No longer met criteria|0|||
27530982|NCT00736879|80137684|FG000|Double Blind Treatment Period|non-specified|0|||
27530983|NCT00736879|80137685|FG001|Double Blind Treatment Period|non-specified|1|||
27530984|NCT00736879|80137686|FG002|Double Blind Treatment Period|non-specified|0|||
27530985|NCT00736879|80137687|FG003|Double Blind Treatment Period|non-specified|0|||
27530986|NCT00736879|80137684|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
27627022|NCT03532178|80476828|FG000|First Period|Withdrawal by Subject|1|||
27627023|NCT03532178|80476829|FG001|First Period|Withdrawal by Subject|3|||
27627024|NCT03532178|80476828|FG000|First Period|technical issues in data collection Technical issues|0|||
27912310|NCT02718911|81518139|FG004|Overall Study|Physician Decision|0|||
27912311|NCT02718911|81518140|FG005|Overall Study|Physician Decision|0|||
27912312|NCT02718911|81518141|FG006|Overall Study|Physician Decision|0|||
27912313|NCT02718911|81518142|FG007|Overall Study|Physician Decision|1|||
27912314|NCT02718911|81518143|FG008|Overall Study|Physician Decision|2|||
27912315|NCT02718911|81518144|FG009|Overall Study|Physician Decision|1|||
27912316|NCT02718911|81518135|FG000|Overall Study|Withdrawal by Subject|0|||
27912317|NCT02718911|81518136|FG001|Overall Study|Withdrawal by Subject|0|||
27912318|NCT02718911|81518137|FG002|Overall Study|Withdrawal by Subject|0|||
27912319|NCT02718911|81518138|FG003|Overall Study|Withdrawal by Subject|0|||
27912320|NCT02718911|81518139|FG004|Overall Study|Withdrawal by Subject|1|||
27912321|NCT02718911|81518140|FG005|Overall Study|Withdrawal by Subject|0|||
27912322|NCT02718911|81518141|FG006|Overall Study|Withdrawal by Subject|0|||
27912323|NCT02718911|81518142|FG007|Overall Study|Withdrawal by Subject|0|||
27912324|NCT02718911|81518143|FG008|Overall Study|Withdrawal by Subject|1|||
27912325|NCT02718911|81518144|FG009|Overall Study|Withdrawal by Subject|4|||
27912326|NCT02718911|81518135|FG000|Overall Study|Reason Not Collected|0|||
27912327|NCT02718911|81518136|FG001|Overall Study|Reason Not Collected|0|||
27912328|NCT02718911|81518137|FG002|Overall Study|Reason Not Collected|1|||
27912329|NCT02718911|81518138|FG003|Overall Study|Reason Not Collected|0|||
27912330|NCT02718911|81518139|FG004|Overall Study|Reason Not Collected|0|||
27912331|NCT02718911|81518140|FG005|Overall Study|Reason Not Collected|0|||
27912332|NCT02718911|81518141|FG006|Overall Study|Reason Not Collected|2|||
27912333|NCT02718911|81518142|FG007|Overall Study|Reason Not Collected|1|||
27912334|NCT02718911|81518143|FG008|Overall Study|Reason Not Collected|4|||
27912335|NCT02718911|81518144|FG009|Overall Study|Reason Not Collected|9|||
27912336|NCT02003144|81518165|FG000|Open Label Maintenance Phase|Other than specified|2|||
27912337|NCT02003144|81518166|FG001|Open Label Maintenance Phase|Other than specified|4|||
27912338|NCT02003144|81518165|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
27912339|NCT02003144|81518166|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
27856638|NCT03623386|81310179|FG002|Overall Study|Physician Decision|0|||
27856639|NCT03623386|81310177|FG000|Overall Study|Lost to Follow-up|0|||
27856640|NCT03623386|81310178|FG001|Overall Study|Lost to Follow-up|2|||
27856641|NCT03623386|81310179|FG002|Overall Study|Lost to Follow-up|0|||
27856642|NCT03623386|81310177|FG000|Overall Study|COVID-19|0|||
27856643|NCT03623386|81310178|FG001|Overall Study|COVID-19|1|||
27856644|NCT03623386|81310179|FG002|Overall Study|COVID-19|0|||
27856645|NCT01957176|81310180|FG000|Overall Study|Adverse Event|2|||
27856646|NCT01957176|81310181|FG001|Overall Study|Adverse Event|0|||
27856647|NCT01957176|81310180|FG000|Overall Study|Physician Decision|2|||
27856648|NCT01957176|81310181|FG001|Overall Study|Physician Decision|1|||
27856649|NCT01957176|81310180|FG000|Overall Study|Withdrawal by Subject|1|||
27856650|NCT01957176|81310181|FG001|Overall Study|Withdrawal by Subject|0|||
27856651|NCT02828241|81310182|FG000|Overall Study|Adverse Event|7|||
27856652|NCT02828241|81310183|FG001|Overall Study|Adverse Event|2|||
27856653|NCT02828241|81310182|FG000|Overall Study|Protocol Violation|1|||
27856654|NCT02828241|81310183|FG001|Overall Study|Protocol Violation|0|||
27856655|NCT00515541|81310184|FG000|Overall Study|Physician Decision|0|||
27856656|NCT00515541|81310185|FG001|Overall Study|Physician Decision|2|||
27856657|NCT00515541|81310186|FG002|Overall Study|Physician Decision|0|||
27856658|NCT00515541|81310187|FG003|Overall Study|Physician Decision|1|||
27856659|NCT00515541|81310184|FG000|Overall Study|No show for appointments|0|||
27856660|NCT00515541|81310185|FG001|Overall Study|No show for appointments|1|||
27856661|NCT00515541|81310186|FG002|Overall Study|No show for appointments|0|||
27856662|NCT00515541|81310187|FG003|Overall Study|No show for appointments|2|||
27856663|NCT00515541|81310184|FG000|Overall Study|Withdrawal by Subject|0|||
27856664|NCT00515541|81310185|FG001|Overall Study|Withdrawal by Subject|2|||
27856665|NCT00515541|81310186|FG002|Overall Study|Withdrawal by Subject|0|||
27856666|NCT00515541|81310187|FG003|Overall Study|Withdrawal by Subject|2|||
27856667|NCT00686075|81310190|FG000|Overall Study|Withdrawal by Subject|4|||
27856668|NCT00686075|81310191|FG001|Overall Study|Withdrawal by Subject|3|||
27856669|NCT00686075|81310192|FG002|Overall Study|Withdrawal by Subject|3|||
27856670|NCT00686075|81310193|FG003|Overall Study|Withdrawal by Subject|7|||
27912340|NCT02003144|81518165|FG000|Open Label Maintenance Phase|Pregnancy|0|||
27912341|NCT02003144|81518166|FG001|Open Label Maintenance Phase|Pregnancy|2|||
27912342|NCT02003144|81518165|FG000|Open Label Maintenance Phase|Physician Decision|1|||
27912343|NCT02003144|81518166|FG001|Open Label Maintenance Phase|Physician Decision|1|||
27856671|NCT00686075|81310194|FG004|Overall Study|Withdrawal by Subject|1|||
27856672|NCT00686075|81310195|FG005|Overall Study|Withdrawal by Subject|0|||
27856673|NCT00686075|81310196|FG006|Overall Study|Withdrawal by Subject|0|||
27856674|NCT00686075|81310197|FG007|Overall Study|Withdrawal by Subject|2|||
27912344|NCT02003144|81518165|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
27912345|NCT02003144|81518166|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
27912346|NCT02003144|81518165|FG000|Open Label Maintenance Phase|Adverse Event|2|||
27912347|NCT02003144|81518166|FG001|Open Label Maintenance Phase|Adverse Event|1|||
27912348|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27856675|NCT00686075|81310198|FG008|Overall Study|Withdrawal by Subject|4|||
27856676|NCT00686075|81310199|FG009|Overall Study|Withdrawal by Subject|6|||
27856677|NCT00686075|81310190|FG000|Overall Study|Lost to Follow-up|3|||
27856678|NCT00686075|81310191|FG001|Overall Study|Lost to Follow-up|6|||
27856679|NCT00686075|81310192|FG002|Overall Study|Lost to Follow-up|3|||
27856680|NCT00686075|81310193|FG003|Overall Study|Lost to Follow-up|2|||
27856681|NCT00686075|81310194|FG004|Overall Study|Lost to Follow-up|3|||
27856682|NCT00686075|81310195|FG005|Overall Study|Lost to Follow-up|3|||
27856683|NCT00686075|81310196|FG006|Overall Study|Lost to Follow-up|0|||
27856684|NCT00686075|81310197|FG007|Overall Study|Lost to Follow-up|0|||
27856685|NCT00686075|81310198|FG008|Overall Study|Lost to Follow-up|2|||
27856686|NCT00686075|81310199|FG009|Overall Study|Lost to Follow-up|3|||
27856687|NCT00686075|81310190|FG000|Overall Study|Other|1|||
27856688|NCT00686075|81310191|FG001|Overall Study|Other|1|||
27856689|NCT00686075|81310192|FG002|Overall Study|Other|0|||
27856690|NCT00686075|81310193|FG003|Overall Study|Other|0|||
27856691|NCT00686075|81310194|FG004|Overall Study|Other|0|||
27856692|NCT00686075|81310195|FG005|Overall Study|Other|0|||
27856693|NCT00686075|81310196|FG006|Overall Study|Other|0|||
27856694|NCT00686075|81310197|FG007|Overall Study|Other|0|||
27856695|NCT00686075|81310198|FG008|Overall Study|Other|0|||
27856696|NCT00686075|81310199|FG009|Overall Study|Other|1|||
27856697|NCT01433549|81310202|FG000|Phase 2: Second Study Product|Adverse Event|0|||
27856698|NCT01433549|81310203|FG001|Phase 2: Second Study Product|Adverse Event|1|||
27856699|NCT02455050|81310204|FG000|Treatment Period 1|Lost to Follow-up|1|||
27856700|NCT02455050|81310205|FG001|Treatment Period 1|Lost to Follow-up|1|||
27856701|NCT02455050|81310206|FG002|Treatment Period 1|Lost to Follow-up|1|||
27856702|NCT02455050|81310207|FG003|Treatment Period 1|Lost to Follow-up|2|||
27856703|NCT02455050|81310204|FG000|Treatment Period 2|Lost to Follow-up|1|||
27856704|NCT02455050|81310205|FG001|Treatment Period 2|Lost to Follow-up|0|||
27856705|NCT02455050|81310206|FG002|Treatment Period 2|Lost to Follow-up|2|||
27856706|NCT02455050|81310207|FG003|Treatment Period 2|Lost to Follow-up|1|||
27856707|NCT02492880|81310210|FG000|Overall Study|Lost to Follow-up|1|||
27856708|NCT02492880|81310210|FG000|Overall Study|Protocol Violation|1|||
27856709|NCT02836496|81310211|FG000|Overall Study|Adverse Event|2|||
27856710|NCT02836496|81310212|FG001|Overall Study|Adverse Event|1|||
27856711|NCT02836496|81310211|FG000|Overall Study|Withdrawal by Subject|0|||
27856712|NCT02836496|81310212|FG001|Overall Study|Withdrawal by Subject|1|||
27856713|NCT00599521|81310216|FG000|Overall Study|Lack of Efficacy|4|||
27856714|NCT00599521|81310217|FG001|Overall Study|Lack of Efficacy|8|||
27856715|NCT00599521|81310216|FG000|Overall Study|Adverse Event|4|||
27856716|NCT00599521|81310217|FG001|Overall Study|Adverse Event|1|||
27856717|NCT00599521|81310216|FG000|Overall Study|Withdrawal by Subject|28|||
27856718|NCT00599521|81310217|FG001|Overall Study|Withdrawal by Subject|34|||
27856719|NCT00599521|81310216|FG000|Overall Study|Protocol Violation|1|||
27856720|NCT00599521|81310217|FG001|Overall Study|Protocol Violation|1|||
27912349|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
27530987|NCT00736879|80137685|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
27530988|NCT00736879|80137686|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
27530989|NCT00736879|80137687|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
27530990|NCT00736879|80137684|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
27530991|NCT00736879|80137685|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
27530992|NCT00736879|80137686|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
27530993|NCT00736879|80137687|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
27530994|NCT00760214|80137688|FG000|Overall Study|Adverse Event|8|||
27530995|NCT00760214|80137689|FG001|Overall Study|Adverse Event|9|||
27530996|NCT00760214|80137690|FG002|Overall Study|Adverse Event|12|||
27530997|NCT00760214|80137688|FG000|Overall Study|Protocol Violation|3|||
27530998|NCT00760214|80137689|FG001|Overall Study|Protocol Violation|0|||
27530999|NCT00760214|80137690|FG002|Overall Study|Protocol Violation|3|||
27531000|NCT00760214|80137688|FG000|Overall Study|Lost to Follow-up|0|||
27531001|NCT00760214|80137689|FG001|Overall Study|Lost to Follow-up|0|||
27531002|NCT00760214|80137690|FG002|Overall Study|Lost to Follow-up|1|||
27531003|NCT00760214|80137688|FG000|Overall Study|Withdrawal by Subject|12|||
27531004|NCT00760214|80137689|FG001|Overall Study|Withdrawal by Subject|14|||
27531005|NCT00760214|80137690|FG002|Overall Study|Withdrawal by Subject|13|||
27531006|NCT00760214|80137688|FG000|Overall Study|Lack of Efficacy|3|||
27531007|NCT00760214|80137689|FG001|Overall Study|Lack of Efficacy|2|||
27856721|NCT00599521|81310216|FG000|Overall Study|Lost to Follow-up|23|||
27856722|NCT00599521|81310217|FG001|Overall Study|Lost to Follow-up|23|||
27856723|NCT00599521|81310216|FG000|Overall Study|Pregnancy|0|||
27856724|NCT00599521|81310217|FG001|Overall Study|Pregnancy|2|||
27856725|NCT03579966|81310220|FG000|Overall Study|Adverse Event|6|||
27856726|NCT03579966|81310220|FG000|Overall Study|Lost to Follow-up|4|||
27856727|NCT03579966|81310220|FG000|Overall Study|Physician Decision|10|||
27856728|NCT03579966|81310220|FG000|Overall Study|Pregnancy|1|||
27531008|NCT00760214|80137690|FG002|Overall Study|Lack of Efficacy|4|||
27856729|NCT03579966|81310220|FG000|Overall Study|Withdrawal by Subject|16|||
27912350|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
27912351|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912352|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912353|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912354|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912355|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912356|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912357|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912358|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912359|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27531009|NCT00760214|80137688|FG000|Overall Study|Pregnancy|0|||
27531010|NCT00760214|80137689|FG001|Overall Study|Pregnancy|0|||
27531011|NCT00760214|80137690|FG002|Overall Study|Pregnancy|1|||
27531012|NCT00760214|80137688|FG000|Overall Study|Physician Decision|1|||
27531013|NCT00760214|80137689|FG001|Overall Study|Physician Decision|1|||
27531014|NCT00760214|80137690|FG002|Overall Study|Physician Decision|1|||
27531015|NCT00760214|80137688|FG000|Overall Study|Other|3|||
27531016|NCT00760214|80137689|FG001|Overall Study|Other|4|||
27531017|NCT00760214|80137690|FG002|Overall Study|Other|6|||
27531018|NCT02923427|80137691|FG000|Overall Study|convert to laparatomy|2|||
27531019|NCT02923427|80137692|FG001|Overall Study|convert to laparatomy|2|||
27531020|NCT02923427|80137691|FG000|Overall Study|destaturation|1|||
27531021|NCT02923427|80137692|FG001|Overall Study|destaturation|0|||
27531022|NCT02923427|80137691|FG000|Overall Study|can not replace LMA|1|||
27531023|NCT02923427|80137692|FG001|Overall Study|can not replace LMA|0|||
27531024|NCT01994590|80137709|FG000|Overall Study|Adverse Event|1|||
27531025|NCT01994590|80137709|FG000|Overall Study|Trial Terminated|1|||
27531026|NCT00923936|80137710|FG000|Overall Study|progressive disease on study|2|||
27531027|NCT00923936|80137711|FG001|Overall Study|progressive disease on study|1|||
27531028|NCT00923936|80137710|FG000|Overall Study|Adverse Event|2|||
27531029|NCT00923936|80137711|FG001|Overall Study|Adverse Event|1|||
27531030|NCT00923936|80137710|FG000|Overall Study|Lost to follow up|2|||
27531031|NCT00923936|80137711|FG001|Overall Study|Lost to follow up|0|||
27531032|NCT00923936|80137710|FG000|Overall Study|Continuing in follow up period|2|||
27531033|NCT00923936|80137711|FG001|Overall Study|Continuing in follow up period|1|||
27531034|NCT00122278|80137722|FG000|Overall Study|Lost to Follow-up|2|||
27531035|NCT00122278|80137723|FG001|Overall Study|Lost to Follow-up|0|||
27531036|NCT03053271|80137728|FG000|Overall Study|Did not meet randomization criteria|3|||
27531037|NCT03053271|80137728|FG000|Overall Study|Withdrawal by Subject|1|||
27735466|NCT00488631|80857357|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
27735467|NCT00488631|80857358|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
27735468|NCT00488631|80857349|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
27531038|NCT02788474|80137732|FG000|Double Blind Treatment Period|Not treated|1|||
27531039|NCT02788474|80137733|FG001|Double Blind Treatment Period|Not treated|0|||
27531040|NCT02788474|80137732|FG000|Double Blind Treatment Period|Patient's refusal|3|||
27531041|NCT02788474|80137733|FG001|Double Blind Treatment Period|Patient's refusal|0|||
27531042|NCT02788474|80137732|FG000|Double Blind Treatment Period|Adverse Event|6|||
27531043|NCT02788474|80137733|FG001|Double Blind Treatment Period|Adverse Event|4|||
27531044|NCT02788474|80137732|FG000|Open Label Treatment Period|Adverse Event|29|||
27531045|NCT02788474|80137733|FG001|Open Label Treatment Period|Adverse Event|9|||
27627025|NCT03532178|80476829|FG001|First Period|technical issues in data collection Technical issues|1|||
27627026|NCT03532178|80476828|FG000|Second Period|Withdrawal by Subject|1|||
27627027|NCT03532178|80476829|FG001|Second Period|Withdrawal by Subject|1|||
27627028|NCT03532178|80476828|FG000|Second Period|Technical issues|0|||
27627029|NCT03532178|80476829|FG001|Second Period|Technical issues|1|||
27627030|NCT03593070|80476830|FG000|Overall Study|administrative withdrawal|1|||
27735469|NCT00488631|80857350|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
27735470|NCT00488631|80857351|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
27735471|NCT00488631|80857352|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
27735472|NCT00488631|80857353|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
27735473|NCT00488631|80857354|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
27735474|NCT00488631|80857355|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
27735475|NCT00488631|80857356|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
27735476|NCT00488631|80857357|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
27735477|NCT00488631|80857358|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
27735478|NCT00488631|80857349|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735479|NCT00488631|80857350|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735480|NCT00488631|80857351|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735481|NCT00488631|80857352|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735482|NCT00488631|80857353|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735483|NCT00488631|80857354|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735484|NCT00488631|80857355|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
27735485|NCT00488631|80857356|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735486|NCT00488631|80857357|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
27735487|NCT00488631|80857358|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
27735488|NCT00488631|80857349|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735489|NCT00488631|80857350|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735490|NCT00488631|80857351|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735491|NCT00488631|80857352|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735492|NCT00488631|80857353|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735493|NCT00488631|80857354|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735494|NCT00488631|80857355|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
27735495|NCT00488631|80857356|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
27735496|NCT00488631|80857357|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
27735497|NCT00488631|80857358|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
27735498|NCT02432807|80857359|FG000|Overall Study|Adverse Event|0|||
27735499|NCT02432807|80857360|FG001|Overall Study|Adverse Event|2|||
27735500|NCT02432807|80857359|FG000|Overall Study|Lost to Follow-up|1|||
27735501|NCT02432807|80857360|FG001|Overall Study|Lost to Follow-up|0|||
27735502|NCT02432807|80857359|FG000|Overall Study|Withdrawal by Subject|1|||
27735503|NCT02432807|80857360|FG001|Overall Study|Withdrawal by Subject|1|||
27735504|NCT02432807|80857359|FG000|Overall Study|Other|1|||
27735505|NCT02432807|80857360|FG001|Overall Study|Other|1|||
27735506|NCT03584009|80857361|FG000|Overall Study|Death|25|||
27735507|NCT03584009|80857362|FG001|Overall Study|Death|18|||
27735508|NCT03584009|80857361|FG000|Overall Study|Lost to Follow-up|0|||
27735509|NCT03584009|80857362|FG001|Overall Study|Lost to Follow-up|1|||
27735510|NCT03584009|80857361|FG000|Overall Study|Physician Decision|1|||
27735511|NCT03584009|80857362|FG001|Overall Study|Physician Decision|1|||
27735512|NCT03584009|80857361|FG000|Overall Study|Study Terminated by Sponsor|22|||
27735513|NCT03584009|80857362|FG001|Overall Study|Study Terminated by Sponsor|30|||
27735514|NCT03584009|80857361|FG000|Overall Study|Withdrawal by Subject|3|||
27735515|NCT03584009|80857362|FG001|Overall Study|Withdrawal by Subject|2|||
27735516|NCT01877655|80859954|FG000|Overall Study|Death|57|||
27856730|NCT03579966|81310220|FG000|Overall Study|Study terminated by Sponsor|22|||
27856731|NCT03579966|81310220|FG000|Overall Study|Protocol Violation|1|||
27856732|NCT03246646|81310227|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
27627031|NCT03593070|80476831|FG001|Overall Study|administrative withdrawal|1|||
27627032|NCT03124108|80476833|FG000|Overall Study|Adverse Event|0|||
27627033|NCT03124108|80476834|FG001|Overall Study|Adverse Event|1|||
27627034|NCT03124108|80476835|FG002|Overall Study|Adverse Event|0|||
27627035|NCT03646669|80476838|FG000|Overall Study|Withdrawal by Subject|5|||
27735517|NCT01877655|80859955|FG001|Overall Study|Death|52|||
27735518|NCT01877655|80859954|FG000|Overall Study|Withdrawal by Subject|18|||
27856733|NCT03246646|81310228|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
27627036|NCT03646669|80476839|FG001|Overall Study|Withdrawal by Subject|0|||
27627037|NCT03064074|80476847|FG000|Overall Study|Physician Decision|0|||
27627038|NCT03064074|80476848|FG001|Overall Study|Physician Decision|0|||
27627039|NCT03064074|80476849|FG002|Overall Study|Physician Decision|0|||
27735519|NCT01877655|80859955|FG001|Overall Study|Withdrawal by Subject|26|||
27735520|NCT01877655|80859954|FG000|Overall Study|Physician Decision|11|||
27735521|NCT01877655|80859955|FG001|Overall Study|Physician Decision|10|||
27735522|NCT01877655|80859954|FG000|Overall Study|Miscellaneous|4|||
27735523|NCT01877655|80859955|FG001|Overall Study|Miscellaneous|4|||
27735524|NCT01877655|80859954|FG000|Overall Study|Randomized but Never Received Drug|8|||
27735525|NCT01877655|80859955|FG001|Overall Study|Randomized but Never Received Drug|5|||
27735526|NCT00845429|80859956|FG000|Overall Study|Protocol Violation|5|||
27735527|NCT00845429|80859957|FG001|Overall Study|Protocol Violation|4|||
27735528|NCT00845429|80859958|FG002|Overall Study|Protocol Violation|7|||
27531046|NCT02788474|80137732|FG000|Open Label Treatment Period|Other than reason specified|1|||
27531047|NCT02788474|80137733|FG001|Open Label Treatment Period|Other than reason specified|0|||
27531048|NCT02788474|80137732|FG000|Open Label Treatment Period|Patient's refusal|1|||
27735529|NCT00845429|80859956|FG000|Overall Study|Lost to Follow-up|7|||
27735530|NCT00845429|80859957|FG001|Overall Study|Lost to Follow-up|9|||
27735531|NCT00845429|80859958|FG002|Overall Study|Lost to Follow-up|10|||
27735532|NCT00845429|80859956|FG000|Overall Study|Withdrawal by Subject|2|||
27735533|NCT00845429|80859957|FG001|Overall Study|Withdrawal by Subject|2|||
27735534|NCT00845429|80859958|FG002|Overall Study|Withdrawal by Subject|2|||
27735535|NCT00845429|80859956|FG000|Overall Study|Serious adverse event|0|||
27735536|NCT00845429|80859957|FG001|Overall Study|Serious adverse event|0|||
27735537|NCT00845429|80859958|FG002|Overall Study|Serious adverse event|1|||
27735538|NCT01573442|80859965|FG000|Overall Study|Cancels|9|||
27735539|NCT01573442|80859966|FG001|Overall Study|Cancels|10|||
27735540|NCT01748071|80859967|FG000|Overall Study|Adverse Event|2|||
27735541|NCT01748071|80859968|FG001|Overall Study|Adverse Event|2|||
27735542|NCT01748071|80859969|FG002|Overall Study|Adverse Event|0|||
27735543|NCT03293654|80859970|FG000|Overall Study|Lost to Follow-up|0|||
27735544|NCT03293654|80859971|FG001|Overall Study|Lost to Follow-up|1|||
27735545|NCT03293654|80859972|FG002|Overall Study|Lost to Follow-up|0|||
27735546|NCT03567187|80859973|FG000|Overall Study|Lost to Follow-up|18|||
27735547|NCT01021007|80859974|FG000|Overall Study|Lost to Follow-up|1|||
27735548|NCT01021007|80859975|FG001|Overall Study|Lost to Follow-up|1|||
27735549|NCT01021007|80859974|FG000|Overall Study|Adverse Event|1|||
27531049|NCT02788474|80137733|FG001|Open Label Treatment Period|Patient's refusal|3|||
27531050|NCT02788474|80137732|FG000|Open Label Treatment Period|Non-compliance|1|||
27531051|NCT02788474|80137733|FG001|Open Label Treatment Period|Non-compliance|0|||
27531052|NCT00777205|80137736|FG000|Overall Study|Lost to Follow-up|25|||
27531053|NCT00777205|80137737|FG001|Overall Study|Lost to Follow-up|9|||
27531054|NCT00777205|80137736|FG000|Overall Study|Withdrawal by Subject|6|||
27531055|NCT00777205|80137737|FG001|Overall Study|Withdrawal by Subject|4|||
27531056|NCT00777205|80137736|FG000|Overall Study|Death|0|||
27531057|NCT00777205|80137737|FG001|Overall Study|Death|2|||
27531058|NCT00777205|80137736|FG000|Overall Study|Protocol Violation|0|||
27531059|NCT00777205|80137737|FG001|Overall Study|Protocol Violation|56|||
27531060|NCT01741012|80137744|FG000|Overall Study|Lost to Follow-up|1|||
27531061|NCT01741012|80137744|FG000|Overall Study|Withdrawal by Subject|2|||
27531062|NCT03179761|80137745|FG000|Overall Study|Death|2|||
27531063|NCT03179761|80137746|FG001|Overall Study|Death|5|||
27531064|NCT03179761|80137745|FG000|Overall Study|Lost to Follow-up|2|||
27531065|NCT03179761|80137746|FG001|Overall Study|Lost to Follow-up|2|||
27531066|NCT03179761|80137745|FG000|Overall Study|Protocol Violation|1|||
27531067|NCT03179761|80137746|FG001|Overall Study|Protocol Violation|0|||
27531068|NCT03179761|80137745|FG000|Overall Study|Withdrawal by Subject|1|||
27531069|NCT03179761|80137746|FG001|Overall Study|Withdrawal by Subject|4|||
27531070|NCT03179761|80137745|FG000|Overall Study|Investigator Request|0|||
27531071|NCT03179761|80137746|FG001|Overall Study|Investigator Request|2|||
27531072|NCT01674634|80137748|FG000|Overall Study|Withdrawal by Subject|3|||
27531073|NCT01674634|80137748|FG000|Overall Study|Lost to Follow-up|3|||
27531074|NCT01982331|80137749|FG000|Received Vaccination 2|Adverse Event|1|||
27531075|NCT01982331|80137750|FG001|Received Vaccination 2|Adverse Event|2|||
27531076|NCT01982331|80137749|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
27531077|NCT01982331|80137750|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
27735550|NCT01021007|80859975|FG001|Overall Study|Adverse Event|3|||
27531078|NCT01982331|80137749|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
27735551|NCT02272790|80859977|FG000|Overall Study|Physician Decision|0|||
27735552|NCT02272790|80859978|FG001|Overall Study|Physician Decision|1|||
27735553|NCT02272790|80859979|FG002|Overall Study|Physician Decision|0|||
27735554|NCT02272790|80859980|FG003|Overall Study|Physician Decision|0|||
27531079|NCT01982331|80137750|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
27735555|NCT02272790|80859981|FG004|Overall Study|Physician Decision|0|||
27531080|NCT03131453|80137751|FG000|Overall Study|Study terminated by Sponsor|424|||
27531081|NCT03131453|80137752|FG001|Overall Study|Study terminated by Sponsor|222|||
27531082|NCT03131453|80137753|FG002|Overall Study|Study terminated by Sponsor|438|||
27735556|NCT02272790|80859982|FG005|Overall Study|Physician Decision|0|||
27735557|NCT03277196|80859983|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
27735558|NCT03277196|80859983|FG000|Overall Study|Lost to Follow-up|3|||
27531083|NCT03131453|80137751|FG000|Overall Study|Withdrawal by Subject|18|||
27735559|NCT03277196|80859983|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
27735560|NCT03277196|80859983|FG000|Overall Study|Other|2|||
27735561|NCT00282243|80859984|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
27735562|NCT00282243|80859984|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
27735563|NCT00282243|80859984|FG000|Extension Treatment Period|Adverse Event|15|||
27735564|NCT00282243|80859984|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
27735565|NCT00282243|80859984|FG000|Extension Treatment Period|Non-compliance|2|||
27735566|NCT00282243|80859984|FG000|Extension Treatment Period|Physician Decision|1|||
27735567|NCT03487445|80859985|FG000|Randomization|Not treated for administrative reasons|1|||
27735568|NCT03487445|80859986|FG001|Randomization|Not treated for administrative reasons|0|||
27735569|NCT01262898|80859987|FG000|Overall Study|Protocol Violation|1|||
27735570|NCT01262898|80859988|FG001|Overall Study|Protocol Violation|1|||
27735571|NCT01262898|80859989|FG002|Overall Study|Protocol Violation|0|||
27735572|NCT01262898|80859990|FG003|Overall Study|Protocol Violation|0|||
27735573|NCT01262898|80859987|FG000|Overall Study|Lost to Follow-up|1|||
27735574|NCT01262898|80859988|FG001|Overall Study|Lost to Follow-up|0|||
27735575|NCT01262898|80859989|FG002|Overall Study|Lost to Follow-up|0|||
27735576|NCT01262898|80859990|FG003|Overall Study|Lost to Follow-up|0|||
27735577|NCT01262898|80859987|FG000|Overall Study|Withdrawal by Subject|1|||
27735578|NCT01262898|80859988|FG001|Overall Study|Withdrawal by Subject|1|||
27735579|NCT01262898|80859989|FG002|Overall Study|Withdrawal by Subject|0|||
27735580|NCT01262898|80859990|FG003|Overall Study|Withdrawal by Subject|0|||
27735581|NCT05502289|80859991|FG000|Period 1|Out Of Window|1|||
27735582|NCT05502289|80859992|FG001|Period 1|Out Of Window|0|||
27735583|NCT03323749|80859993|FG000|Double-blind Period|Lost to Follow-up|4|||
27735584|NCT03323749|80859994|FG001|Double-blind Period|Lost to Follow-up|5|||
27735585|NCT03323749|80859993|FG000|Double-blind Period|Adverse Event|3|||
27735586|NCT03323749|80859994|FG001|Double-blind Period|Adverse Event|1|||
27735587|NCT03323749|80859993|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
27735588|NCT03323749|80859994|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
27735589|NCT03323749|80859993|FG000|Open-Label Period|Adverse Event|3|||
27735590|NCT03323749|80859994|FG001|Open-Label Period|Adverse Event|10|||
27735591|NCT03323749|80859993|FG000|Open-Label Period|Withdrawal by Subject|7|||
27735592|NCT03323749|80859994|FG001|Open-Label Period|Withdrawal by Subject|5|||
27735593|NCT01217606|80859995|FG000|Initial Treatment Phase|Other Reasons|0|||
27735594|NCT01217606|80859996|FG001|Initial Treatment Phase|Other Reasons|2|||
27735595|NCT01217606|80859995|FG000|Initial Treatment Phase|Protocol Violation|3|||
27735596|NCT01217606|80859996|FG001|Initial Treatment Phase|Protocol Violation|2|||
27735597|NCT01217606|80859995|FG000|Initial Treatment Phase|Personal Reasons|0|||
27735598|NCT01217606|80859996|FG001|Initial Treatment Phase|Personal Reasons|2|||
27856734|NCT03246646|81310227|FG000|Overall Study|Withdrawal by Subject|3|||
27856735|NCT03246646|81310228|FG001|Overall Study|Withdrawal by Subject|0|||
27531084|NCT03131453|80137752|FG001|Overall Study|Withdrawal by Subject|7|||
27531085|NCT03131453|80137753|FG002|Overall Study|Withdrawal by Subject|13|||
27531086|NCT03131453|80137751|FG000|Overall Study|Adverse Event|10|||
27735599|NCT01217606|80859995|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
27735600|NCT01217606|80859996|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
27735601|NCT01217606|80859995|FG000|Initial Treatment Phase|Adverse Event|10|||
27735602|NCT01217606|80859996|FG001|Initial Treatment Phase|Adverse Event|6|||
27735603|NCT01217606|80859995|FG000|9-Month Masked Extension|Adverse Event|3|||
27735604|NCT01217606|80859996|FG001|9-Month Masked Extension|Adverse Event|6|||
27735605|NCT01217606|80859995|FG000|9-Month Masked Extension|Other Reasons|4|||
27856736|NCT03246646|81310227|FG000|Overall Study|Lost to Follow-up|7|||
27856737|NCT03246646|81310228|FG001|Overall Study|Lost to Follow-up|0|||
27856738|NCT01197755|81310229|FG000|Overall Study|Adverse Event|8|||
27856739|NCT01197755|81310230|FG001|Overall Study|Adverse Event|10|||
27856740|NCT01197755|81310231|FG002|Overall Study|Adverse Event|10|||
27856741|NCT01197755|81310229|FG000|Overall Study|Study-specific discontinuation criteria|2|||
27856742|NCT01197755|81310230|FG001|Overall Study|Study-specific discontinuation criteria|1|||
27856743|NCT01197755|81310231|FG002|Overall Study|Study-specific discontinuation criteria|0|||
27856744|NCT01197755|81310229|FG000|Overall Study|Entered the long-term extension study|18|||
27735606|NCT01217606|80859996|FG001|9-Month Masked Extension|Other Reasons|4|||
27856745|NCT01197755|81310230|FG001|Overall Study|Entered the long-term extension study|21|||
27735607|NCT01217606|80859995|FG000|9-Month Masked Extension|Personal Reasons|2|||
27735608|NCT01217606|80859996|FG001|9-Month Masked Extension|Personal Reasons|1|||
27735609|NCT01217606|80859995|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
27735610|NCT01217606|80859996|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
27735611|NCT01217606|80859995|FG000|9-Month Masked Extension|Pregnancy|1|||
27735612|NCT01217606|80859996|FG001|9-Month Masked Extension|Pregnancy|0|||
27735613|NCT01217606|80859995|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
27735614|NCT01217606|80859996|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
27735615|NCT00384956|80859997|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
27735616|NCT02936752|80859998|FG000|Overall Study|Death|2|||
27735617|NCT02936752|80859999|FG001|Overall Study|Death|1|||
27735618|NCT02936752|80859998|FG000|Overall Study|Physician Decision|4|||
27735619|NCT02936752|80859999|FG001|Overall Study|Physician Decision|0|||
27735620|NCT02936752|80859998|FG000|Overall Study|Withdrawal by Subject|0|||
27735621|NCT02936752|80859999|FG001|Overall Study|Withdrawal by Subject|2|||
27735622|NCT01526148|80860000|FG000|Overall Study|Adverse Event|6|||
27735623|NCT01526148|80860001|FG001|Overall Study|Adverse Event|5|||
27735624|NCT01526148|80860000|FG000|Overall Study|Lost to Follow-up|3|||
27735625|NCT01526148|80860001|FG001|Overall Study|Lost to Follow-up|6|||
27735626|NCT01526148|80860000|FG000|Overall Study|Withdrawal by Subject|2|||
27735627|NCT01526148|80860001|FG001|Overall Study|Withdrawal by Subject|0|||
27735628|NCT01526148|80860000|FG000|Overall Study|Unstable Medical Condition|1|||
27531087|NCT03131453|80137752|FG001|Overall Study|Adverse Event|3|||
27531088|NCT03131453|80137753|FG002|Overall Study|Adverse Event|3|||
27531089|NCT03131453|80137751|FG000|Overall Study|Lost to Follow-up|1|||
27531090|NCT03131453|80137752|FG001|Overall Study|Lost to Follow-up|0|||
27531091|NCT03131453|80137753|FG002|Overall Study|Lost to Follow-up|1|||
27531092|NCT03131453|80137751|FG000|Overall Study|Physician Decision|1|||
27531093|NCT03131453|80137752|FG001|Overall Study|Physician Decision|0|||
27531094|NCT03131453|80137753|FG002|Overall Study|Physician Decision|1|||
27531095|NCT03131453|80137751|FG000|Overall Study|Non-compliance with study treatment|1|||
27531096|NCT03131453|80137752|FG001|Overall Study|Non-compliance with study treatment|0|||
27531097|NCT03131453|80137753|FG002|Overall Study|Non-compliance with study treatment|0|||
27531098|NCT03131453|80137751|FG000|Overall Study|Technical problems|1|||
27531099|NCT03131453|80137752|FG001|Overall Study|Technical problems|0|||
27531100|NCT03131453|80137753|FG002|Overall Study|Technical problems|0|||
27531101|NCT03131453|80137751|FG000|Overall Study|Protocol deviation|0|||
27531102|NCT03131453|80137752|FG001|Overall Study|Protocol deviation|1|||
27531103|NCT03131453|80137753|FG002|Overall Study|Protocol deviation|0|||
27531104|NCT05080660|80137754|FG000|Overall Study|Adverse Event|4|||
27531105|NCT05080660|80137755|FG001|Overall Study|Adverse Event|0|||
27531106|NCT05080660|80137754|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
27531107|NCT05080660|80137755|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
27531108|NCT05080660|80137754|FG000|Overall Study|Physician Decision|1|||
27531109|NCT05080660|80137755|FG001|Overall Study|Physician Decision|0|||
27531110|NCT05080660|80137754|FG000|Overall Study|Protocol Deviation|2|||
27531111|NCT05080660|80137755|FG001|Overall Study|Protocol Deviation|0|||
27531112|NCT05080660|80137754|FG000|Overall Study|Withdrawal by Subject|5|||
27531113|NCT05080660|80137755|FG001|Overall Study|Withdrawal by Subject|2|||
27531114|NCT03489551|80137756|FG000|Overall Study|Withdrawal by Subject|2|||
27531115|NCT03611010|80137759|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
27531116|NCT03611010|80137760|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
27531117|NCT03611010|80137761|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
27531118|NCT03611010|80137762|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
27531119|NCT03187756|80137763|FG000|Overall Study|Termination of study|4|||
27531120|NCT01437878|80137764|FG000|Overall Study|Withdrawal by Subject|1|||
27531121|NCT01437878|80137765|FG001|Overall Study|Withdrawal by Subject|0|||
27531122|NCT00937391|80137766|FG000|Stage 2|Withdrawal by Subject|1|||
27735629|NCT01526148|80860001|FG001|Overall Study|Unstable Medical Condition|0|||
27735630|NCT01526148|80860000|FG000|Overall Study|Unable to discontinue concomitant med|1|||
27735631|NCT01526148|80860001|FG001|Overall Study|Unable to discontinue concomitant med|0|||
27735632|NCT01526148|80860000|FG000|Overall Study|Moved out of state|1|||
27735633|NCT01526148|80860001|FG001|Overall Study|Moved out of state|0|||
27735634|NCT01526148|80860000|FG000|Overall Study|Incarcerated|0|||
27735635|NCT01526148|80860001|FG001|Overall Study|Incarcerated|2|||
27856746|NCT01197755|81310231|FG002|Overall Study|Entered the long-term extension study|35|||
27531123|NCT03953183|80137767|FG000|Overall Study|Physician Decision|0|||
27531124|NCT03953183|80137768|FG001|Overall Study|Physician Decision|1|||
27531125|NCT03953183|80137767|FG000|Overall Study|Withdrawal by Subject|0|||
27531126|NCT03953183|80137768|FG001|Overall Study|Withdrawal by Subject|1|||
27531127|NCT01539317|80137772|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
27531128|NCT01539317|80137773|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
27531129|NCT02131532|80137774|FG000|Overall Study|Withdrawal by Subject|1|||
27531130|NCT02131532|80137774|FG000|Overall Study|Physician Decision|1|||
27531131|NCT02131532|80137774|FG000|Overall Study|Other health conditions|2|||
27531132|NCT02038452|80137775|FG000|Overall Study|Withdrawal by Subject|7|||
27531133|NCT02038452|80137776|FG001|Overall Study|Withdrawal by Subject|9|||
27531134|NCT02038452|80137775|FG000|Overall Study|Lost to Follow-up|31|||
27531135|NCT02038452|80137776|FG001|Overall Study|Lost to Follow-up|28|||
27531136|NCT00700570|80137778|FG000|Overall Study|Adverse Event|2|||
27531137|NCT00700570|80137779|FG001|Overall Study|Adverse Event|6|||
27531138|NCT00700570|80137778|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
27531139|NCT00700570|80137779|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
27531140|NCT00700570|80137778|FG000|Overall Study|Disease Progression|8|||
27531141|NCT00700570|80137779|FG001|Overall Study|Disease Progression|11|||
27531142|NCT00700570|80137778|FG000|Overall Study|Withdrawal by Subject|1|||
27531143|NCT00700570|80137779|FG001|Overall Study|Withdrawal by Subject|6|||
27531144|NCT00744471|80137780|FG000|Overall Study|Randomized but not treated|1|||
27531145|NCT00744471|80137781|FG001|Overall Study|Randomized but not treated|1|||
27531146|NCT00744471|80137782|FG002|Overall Study|Randomized but not treated|4|||
27531147|NCT00744471|80137783|FG003|Overall Study|Randomized but not treated|0|||
27531148|NCT00744471|80137780|FG000|Overall Study|Death|0|||
27627040|NCT03064074|80476850|FG003|Overall Study|Physician Decision|1|||
27627041|NCT01939158|80476852|FG000|Overall Study|Adverse Event|1|||
27912360|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27627042|NCT01939158|80476853|FG001|Overall Study|Adverse Event|0|||
27627043|NCT01939158|80476854|FG002|Overall Study|Adverse Event|0|||
27627044|NCT01939158|80476855|FG003|Overall Study|Adverse Event|0|||
27627045|NCT01939158|80476852|FG000|Overall Study|Withdrawal by Subject|22|||
27627046|NCT01939158|80476853|FG001|Overall Study|Withdrawal by Subject|25|||
27627047|NCT01939158|80476854|FG002|Overall Study|Withdrawal by Subject|15|||
27627048|NCT01939158|80476855|FG003|Overall Study|Withdrawal by Subject|17|||
27627049|NCT01939158|80476852|FG000|Overall Study|Migrated/moved from study area|5|||
27627050|NCT01939158|80476853|FG001|Overall Study|Migrated/moved from study area|7|||
27627051|NCT01939158|80476854|FG002|Overall Study|Migrated/moved from study area|3|||
27627052|NCT01939158|80476855|FG003|Overall Study|Migrated/moved from study area|6|||
27627053|NCT01939158|80476852|FG000|Overall Study|Lost to Follow-up|18|||
27627054|NCT01939158|80476853|FG001|Overall Study|Lost to Follow-up|17|||
27627055|NCT01939158|80476854|FG002|Overall Study|Lost to Follow-up|17|||
27627056|NCT01939158|80476855|FG003|Overall Study|Lost to Follow-up|17|||
27627057|NCT01939158|80476852|FG000|Overall Study|Death|0|||
27627058|NCT01939158|80476853|FG001|Overall Study|Death|0|||
27627059|NCT01939158|80476854|FG002|Overall Study|Death|1|||
27627060|NCT01939158|80476855|FG003|Overall Study|Death|1|||
27627061|NCT01939158|80476852|FG000|Overall Study|No longer meets eligibility criteria|0|||
27627062|NCT01939158|80476853|FG001|Overall Study|No longer meets eligibility criteria|0|||
27627063|NCT01939158|80476854|FG002|Overall Study|No longer meets eligibility criteria|1|||
27627064|NCT01939158|80476855|FG003|Overall Study|No longer meets eligibility criteria|0|||
27627065|NCT01939158|80476852|FG000|Overall Study|Other|1|||
27627066|NCT01939158|80476853|FG001|Overall Study|Other|3|||
27627067|NCT01939158|80476854|FG002|Overall Study|Other|4|||
27627068|NCT01939158|80476855|FG003|Overall Study|Other|3|||
27627069|NCT03681691|80476858|FG000|Overall Study|COVID|1|||
27627070|NCT03681691|80476859|FG001|Overall Study|COVID|0|||
27627071|NCT03681691|80476858|FG000|Overall Study|prolonged bleeding|1|||
27627072|NCT03681691|80476859|FG001|Overall Study|prolonged bleeding|0|||
27627073|NCT03681691|80476858|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
27627074|NCT03681691|80476859|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
27627075|NCT04858425|80476860|FG000|Overall Study|Adverse Event|2|||
27627076|NCT04858425|80476861|FG001|Overall Study|Adverse Event|2|||
27627077|NCT04858425|80476860|FG000|Overall Study|Withdrawal by Subject|3|||
27627078|NCT04858425|80476861|FG001|Overall Study|Withdrawal by Subject|1|||
27627079|NCT04858425|80476860|FG000|Overall Study|Lost to Follow-up|4|||
27627080|NCT04858425|80476861|FG001|Overall Study|Lost to Follow-up|2|||
27627081|NCT04858425|80476860|FG000|Overall Study|Lost to Follow-up|1|||
27627082|NCT04858425|80476861|FG001|Overall Study|Lost to Follow-up|0|||
27627083|NCT04088188|80476865|FG000|Overall Study|Withdrawal by Subject|2|||
27735636|NCT04964258|80860010|FG000|Overall Study|Lost to Follow-up|1|||
27912361|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27912362|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
27531149|NCT00744471|80137781|FG001|Overall Study|Death|0|||
27531150|NCT00744471|80137782|FG002|Overall Study|Death|0|||
27531151|NCT00744471|80137783|FG003|Overall Study|Death|1|||
27627084|NCT04088188|80476866|FG001|Overall Study|Withdrawal by Subject|0|||
27627085|NCT04088188|80476865|FG000|Overall Study|Adverse Event|2|||
27627086|NCT04088188|80476866|FG001|Overall Study|Adverse Event|0|||
27627087|NCT03098030|80476867|FG000|Overall Study|Death|10|||
27627088|NCT03098030|80476868|FG001|Overall Study|Death|156|||
27627089|NCT03098030|80476869|FG002|Overall Study|Death|156|||
27627090|NCT03098030|80476870|FG003|Overall Study|Death|82|||
27627091|NCT03098030|80476867|FG000|Overall Study|Withdrawal by Subject|0|||
27627092|NCT03098030|80476868|FG001|Overall Study|Withdrawal by Subject|7|||
27627093|NCT03098030|80476869|FG002|Overall Study|Withdrawal by Subject|8|||
27912363|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
27912364|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
27912365|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912366|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27627094|NCT03098030|80476870|FG003|Overall Study|Withdrawal by Subject|2|||
27627095|NCT03098030|80476867|FG000|Overall Study|Lost to Follow-up|0|||
27627096|NCT03098030|80476868|FG001|Overall Study|Lost to Follow-up|0|||
27627097|NCT03098030|80476869|FG002|Overall Study|Lost to Follow-up|2|||
27627098|NCT03098030|80476870|FG003|Overall Study|Lost to Follow-up|1|||
27627099|NCT00015457|80476871|FG000|First Intervention|Adverse Event|0|||
27627100|NCT00015457|80476872|FG001|First Intervention|Adverse Event|2|||
27627101|NCT00015457|80476871|FG000|First Intervention|Lack of Efficacy|0|||
27627102|NCT00015457|80476872|FG001|First Intervention|Lack of Efficacy|1|||
27912367|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912368|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912369|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912370|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912371|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912372|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912373|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912374|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912375|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912376|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912377|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
27912378|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
27912379|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
27912380|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
27912381|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27627103|NCT00015457|80476871|FG000|Second Intervention|Withdrawal by Subject|1|||
27627104|NCT00015457|80476872|FG001|Second Intervention|Withdrawal by Subject|0|||
27627105|NCT03722446|80476873|FG000|Overall Study|Protocol Violation|15|||
27627106|NCT03722446|80476874|FG001|Overall Study|Protocol Violation|2|||
27627107|NCT01167426|80476889|FG000|Overall Study|Lost to Follow-up|6|||
27627108|NCT01167426|80476889|FG000|Overall Study|Protocol Violation|1|||
27627109|NCT01167426|80476889|FG000|Overall Study|Withdrawal by Subject|2|||
27627110|NCT01167426|80476889|FG000|Overall Study|Sponsor Decision|1|||
27627111|NCT00771667|80476893|FG000|Induction Phase|Adverse Event|5|||
27627112|NCT00771667|80476894|FG001|Induction Phase|Adverse Event|2|||
27627113|NCT00771667|80476895|FG002|Induction Phase|Adverse Event|4|||
27627114|NCT00771667|80476896|FG003|Induction Phase|Adverse Event|1|||
27627115|NCT00771667|80476897|FG004|Induction Phase|Adverse Event|0|||
27627116|NCT00771667|80476898|FG005|Induction Phase|Adverse Event|0|||
27627117|NCT00771667|80476899|FG006|Induction Phase|Adverse Event|0|||
27627118|NCT00771667|80476900|FG007|Induction Phase|Adverse Event|0|||
27627119|NCT00771667|80476901|FG008|Induction Phase|Adverse Event|0|||
27627120|NCT00771667|80476902|FG009|Induction Phase|Adverse Event|0|||
27627121|NCT00771667|80476893|FG000|Induction Phase|Lack of Efficacy|9|||
27627122|NCT00771667|80476894|FG001|Induction Phase|Lack of Efficacy|2|||
27627123|NCT00771667|80476895|FG002|Induction Phase|Lack of Efficacy|4|||
27627124|NCT00771667|80476896|FG003|Induction Phase|Lack of Efficacy|3|||
27912382|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912383|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912384|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912385|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912386|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912387|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912388|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912389|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27627125|NCT00771667|80476897|FG004|Induction Phase|Lack of Efficacy|0|||
27856747|NCT01197755|81310229|FG000|Overall Study|Lack of therapeutic response|0|||
27856748|NCT01197755|81310230|FG001|Overall Study|Lack of therapeutic response|7|||
27856749|NCT01197755|81310231|FG002|Overall Study|Lack of therapeutic response|4|||
27856750|NCT01197755|81310229|FG000|Overall Study|Severe non-compliance to the protocol|2|||
27856751|NCT01197755|81310230|FG001|Overall Study|Severe non-compliance to the protocol|1|||
27856752|NCT01197755|81310231|FG002|Overall Study|Severe non-compliance to the protocol|2|||
27627126|NCT00771667|80476898|FG005|Induction Phase|Lack of Efficacy|0|||
27627127|NCT00771667|80476899|FG006|Induction Phase|Lack of Efficacy|0|||
27627128|NCT00771667|80476900|FG007|Induction Phase|Lack of Efficacy|0|||
27627129|NCT00771667|80476901|FG008|Induction Phase|Lack of Efficacy|0|||
27627130|NCT00771667|80476902|FG009|Induction Phase|Lack of Efficacy|0|||
27627131|NCT00771667|80476893|FG000|Induction Phase|Lost to Follow-up|1|||
27627132|NCT00771667|80476894|FG001|Induction Phase|Lost to Follow-up|0|||
27627133|NCT00771667|80476895|FG002|Induction Phase|Lost to Follow-up|1|||
27627134|NCT00771667|80476896|FG003|Induction Phase|Lost to Follow-up|0|||
27912390|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912391|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912392|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
27912393|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912394|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912395|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
27912396|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912397|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912398|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912399|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912400|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912401|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912402|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912403|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912404|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912405|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912406|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912407|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
27912408|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912409|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912410|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
27912411|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912412|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912413|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912414|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912415|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912416|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912417|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912418|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912419|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912420|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912421|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912422|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
27912423|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912424|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912425|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
27912426|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912427|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27531152|NCT00744471|80137780|FG000|Overall Study|Adverse Event|6|||
27531153|NCT00744471|80137781|FG001|Overall Study|Adverse Event|7|||
27531154|NCT00744471|80137782|FG002|Overall Study|Adverse Event|5|||
27531155|NCT00744471|80137783|FG003|Overall Study|Adverse Event|9|||
27531156|NCT00744471|80137780|FG000|Overall Study|Withdrawal by Subject|9|||
27531157|NCT00744471|80137781|FG001|Overall Study|Withdrawal by Subject|9|||
27531158|NCT00744471|80137782|FG002|Overall Study|Withdrawal by Subject|15|||
27627135|NCT00771667|80476897|FG004|Induction Phase|Lost to Follow-up|0|||
27627136|NCT00771667|80476898|FG005|Induction Phase|Lost to Follow-up|0|||
27856753|NCT01197755|81310229|FG000|Overall Study|Withdrawal by Subject|1|||
27856754|NCT01197755|81310230|FG001|Overall Study|Withdrawal by Subject|0|||
27856755|NCT01197755|81310231|FG002|Overall Study|Withdrawal by Subject|0|||
27856756|NCT01197755|81310229|FG000|Overall Study|Lost to Follow-up|0|||
27856757|NCT01197755|81310230|FG001|Overall Study|Lost to Follow-up|0|||
27856758|NCT01197755|81310231|FG002|Overall Study|Lost to Follow-up|1|||
27856759|NCT01197755|81310229|FG000|Overall Study|eg, change in circumstances|7|||
27856760|NCT01197755|81310230|FG001|Overall Study|eg, change in circumstances|3|||
27856761|NCT01197755|81310231|FG002|Overall Study|eg, change in circumstances|2|||
27856762|NCT04268316|81310232|FG000|Overall Study|Withdrawal by Subject|2|||
27856763|NCT04268316|81310233|FG001|Overall Study|Withdrawal by Subject|1|||
27856764|NCT04268316|81310234|FG002|Overall Study|Withdrawal by Subject|0|||
27856765|NCT00210249|81310235|FG000|Overall Study|Lost to Follow-up|5|||
27856766|NCT00210249|81310235|FG000|Overall Study|Protocol Violation|11|||
27856767|NCT03301623|81310245|FG000|Overall Study|Death|3|||
27856768|NCT03301623|81310246|FG001|Overall Study|Death|1|||
27856769|NCT03301623|81310245|FG000|Overall Study|Withdrawal by Subject|11|||
27856770|NCT03301623|81310246|FG001|Overall Study|Withdrawal by Subject|13|||
27856771|NCT03301623|81310245|FG000|Overall Study|Lost to Follow-up|3|||
27627137|NCT00771667|80476899|FG006|Induction Phase|Lost to Follow-up|0|||
27856772|NCT03301623|81310246|FG001|Overall Study|Lost to Follow-up|1|||
27627138|NCT00771667|80476900|FG007|Induction Phase|Lost to Follow-up|0|||
27627139|NCT00771667|80476901|FG008|Induction Phase|Lost to Follow-up|0|||
27735637|NCT04964258|80860011|FG001|Overall Study|Lost to Follow-up|0|||
27735638|NCT04964258|80860012|FG002|Overall Study|Lost to Follow-up|0|||
27735639|NCT04964258|80860013|FG003|Overall Study|Lost to Follow-up|0|||
27735640|NCT04964258|80860014|FG004|Overall Study|Lost to Follow-up|0|||
27735641|NCT04964258|80860015|FG005|Overall Study|Lost to Follow-up|1|||
27735642|NCT04964258|80860016|FG006|Overall Study|Lost to Follow-up|0|||
27735643|NCT04964258|80860017|FG007|Overall Study|Lost to Follow-up|0|||
27735644|NCT04964258|80860018|FG008|Overall Study|Lost to Follow-up|0|||
27735645|NCT04964258|80860019|FG009|Overall Study|Lost to Follow-up|0|||
27735646|NCT04964258|80860020|FG010|Overall Study|Lost to Follow-up|0|||
27735647|NCT01650805|80860021|FG000|Overall Study|Withdrawal by Subject|1|||
27735648|NCT01650805|80860022|FG001|Overall Study|Withdrawal by Subject|0|||
27735649|NCT05292755|80860029|FG000|Overall Study|Lost to Follow-up|5|||
27735650|NCT05292755|80860030|FG001|Overall Study|Lost to Follow-up|9|||
27735651|NCT02111811|80860034|FG000|Treatment Phase|Lost to Follow-up|22|||
27735652|NCT02111811|80860035|FG001|Treatment Phase|Lost to Follow-up|18|||
27735653|NCT02111811|80860034|FG000|Treatment Phase|Death|2|||
27735654|NCT02111811|80860035|FG001|Treatment Phase|Death|0|||
27735655|NCT02111811|80860034|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
27735656|NCT02111811|80860035|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
27735657|NCT02111811|80860034|FG000|Follow up Period (Aim 2)|Death|2|||
27735658|NCT02111811|80860035|FG001|Follow up Period (Aim 2)|Death|0|||
27735659|NCT00775021|80860036|FG000|First Intervention|Lost to Follow-up|1|||
27735660|NCT00775021|80860037|FG001|First Intervention|Lost to Follow-up|0|||
27735661|NCT00775021|80860036|FG000|Second Intervention|Adverse Event|0|||
27735662|NCT00775021|80860037|FG001|Second Intervention|Adverse Event|1|||
27735663|NCT02286102|80860040|FG000|Overall Study|Screen Failure|1|||
27735664|NCT02286102|80860041|FG001|Overall Study|Screen Failure|1|||
27735665|NCT02717507|80860042|FG000|Overall Study|Lost to Follow-up|5|||
27735666|NCT02717507|80860043|FG001|Overall Study|Lost to Follow-up|8|||
27735667|NCT02717507|80860042|FG000|Overall Study|Pregnancy|1|||
27735668|NCT02717507|80860043|FG001|Overall Study|Pregnancy|1|||
27735669|NCT02717507|80860042|FG000|Overall Study|Protocol Violation|2|||
27735670|NCT02717507|80860043|FG001|Overall Study|Protocol Violation|2|||
27735671|NCT02717507|80860042|FG000|Overall Study|Withdrawal by Subject|20|||
27735672|NCT02717507|80860043|FG001|Overall Study|Withdrawal by Subject|20|||
27735673|NCT02717507|80860042|FG000|Overall Study|Relapse|1|||
27735674|NCT02717507|80860043|FG001|Overall Study|Relapse|1|||
27735675|NCT02717507|80860042|FG000|Overall Study|Cardiac Event|2|||
27735676|NCT02717507|80860043|FG001|Overall Study|Cardiac Event|6|||
27735677|NCT00942162|80860044|FG000|Overall Study|Death|45|||
27735678|NCT00942162|80860045|FG001|Overall Study|Death|35|||
27735679|NCT00942162|80860046|FG002|Overall Study|Death|0|||
27735680|NCT00942162|80860044|FG000|Overall Study|Withdrawal by Subject|7|||
27735681|NCT00942162|80860045|FG001|Overall Study|Withdrawal by Subject|2|||
27735682|NCT00942162|80860046|FG002|Overall Study|Withdrawal by Subject|0|||
27735683|NCT00942162|80860044|FG000|Overall Study|Lost to Follow-up|4|||
27735684|NCT00942162|80860045|FG001|Overall Study|Lost to Follow-up|0|||
27735685|NCT00942162|80860046|FG002|Overall Study|Lost to Follow-up|0|||
27735686|NCT00942162|80860044|FG000|Overall Study|Other|14|||
27735687|NCT00942162|80860045|FG001|Overall Study|Other|13|||
27735688|NCT00942162|80860046|FG002|Overall Study|Other|2|||
27735689|NCT01974323|80860047|FG000|Overall Study|Other Reasons|25|||
27735690|NCT01974323|80860048|FG001|Overall Study|Other Reasons|28|||
27735691|NCT01974323|80860047|FG000|Overall Study|Protocol Violation|2|||
27735692|NCT01974323|80860048|FG001|Overall Study|Protocol Violation|2|||
27735693|NCT01974323|80860047|FG000|Overall Study|Personal Reasons|15|||
27735694|NCT01974323|80860048|FG001|Overall Study|Personal Reasons|19|||
27735695|NCT01974323|80860047|FG000|Overall Study|Lost to Follow-up|45|||
27735696|NCT01974323|80860048|FG001|Overall Study|Lost to Follow-up|40|||
27735697|NCT01974323|80860047|FG000|Overall Study|Pregnancy|2|||
27735698|NCT01974323|80860048|FG001|Overall Study|Pregnancy|1|||
27735699|NCT01974323|80860047|FG000|Overall Study|Lack of Efficacy|1|||
27735700|NCT01974323|80860048|FG001|Overall Study|Lack of Efficacy|1|||
27735701|NCT01974323|80860047|FG000|Overall Study|Adverse Event|2|||
27735702|NCT01974323|80860048|FG001|Overall Study|Adverse Event|2|||
27735703|NCT03022461|80860050|FG000|Overall Study|Death|3|||
27735704|NCT00283387|80860053|FG000|First Intervention|Subject non-compliant|1|||
27735705|NCT00283387|80860054|FG001|First Intervention|Subject non-compliant|1|||
27735706|NCT00283387|80860053|FG000|First Intervention|Withdrawal by Subject|0|||
27735707|NCT00283387|80860054|FG001|First Intervention|Withdrawal by Subject|1|||
27735708|NCT00195351|80860055|FG000|Overall Study|Lost to Follow-up|9|||
27735709|NCT00195351|80860056|FG001|Overall Study|Lost to Follow-up|9|||
27735710|NCT00195351|80860055|FG000|Overall Study|Withdrawal by Subject|6|||
27735711|NCT00195351|80860056|FG001|Overall Study|Withdrawal by Subject|3|||
27735712|NCT00195351|80860055|FG000|Overall Study|Protocol Deviation|3|||
27735713|NCT00195351|80860056|FG001|Overall Study|Protocol Deviation|2|||
27735714|NCT00195351|80860055|FG000|Overall Study|Death|3|||
27735715|NCT00195351|80860056|FG001|Overall Study|Death|1|||
27627140|NCT00771667|80476902|FG009|Induction Phase|Lost to Follow-up|0|||
27627141|NCT00771667|80476893|FG000|Induction Phase|Other|4|||
27627142|NCT00771667|80476894|FG001|Induction Phase|Other|6|||
27627143|NCT00771667|80476895|FG002|Induction Phase|Other|3|||
27627144|NCT00771667|80476896|FG003|Induction Phase|Other|4|||
27627145|NCT00771667|80476897|FG004|Induction Phase|Other|0|||
27627146|NCT00771667|80476898|FG005|Induction Phase|Other|0|||
27627147|NCT00771667|80476899|FG006|Induction Phase|Other|0|||
27627148|NCT00771667|80476900|FG007|Induction Phase|Other|0|||
27627149|NCT00771667|80476901|FG008|Induction Phase|Other|0|||
27627150|NCT00771667|80476902|FG009|Induction Phase|Other|0|||
27627151|NCT00771667|80476893|FG000|Maintenance Phase|Adverse Event|0|||
27627152|NCT00771667|80476894|FG001|Maintenance Phase|Adverse Event|0|||
27627153|NCT00771667|80476895|FG002|Maintenance Phase|Adverse Event|0|||
27627154|NCT00771667|80476896|FG003|Maintenance Phase|Adverse Event|0|||
27627155|NCT00771667|80476897|FG004|Maintenance Phase|Adverse Event|1|||
27627156|NCT00771667|80476898|FG005|Maintenance Phase|Adverse Event|3|||
27627157|NCT00771667|80476899|FG006|Maintenance Phase|Adverse Event|5|||
27627158|NCT00771667|80476900|FG007|Maintenance Phase|Adverse Event|1|||
27627159|NCT00771667|80476901|FG008|Maintenance Phase|Adverse Event|8|||
27627160|NCT00771667|80476902|FG009|Maintenance Phase|Adverse Event|7|||
27627161|NCT00771667|80476893|FG000|Maintenance Phase|Lack of Efficacy|0|||
27627162|NCT00771667|80476894|FG001|Maintenance Phase|Lack of Efficacy|0|||
27627163|NCT00771667|80476895|FG002|Maintenance Phase|Lack of Efficacy|0|||
27627164|NCT00771667|80476896|FG003|Maintenance Phase|Lack of Efficacy|0|||
27627165|NCT00771667|80476897|FG004|Maintenance Phase|Lack of Efficacy|1|||
27627166|NCT00771667|80476898|FG005|Maintenance Phase|Lack of Efficacy|3|||
27627167|NCT00771667|80476899|FG006|Maintenance Phase|Lack of Efficacy|3|||
27627168|NCT00771667|80476900|FG007|Maintenance Phase|Lack of Efficacy|2|||
27627169|NCT00771667|80476901|FG008|Maintenance Phase|Lack of Efficacy|11|||
27627170|NCT00771667|80476902|FG009|Maintenance Phase|Lack of Efficacy|7|||
27627171|NCT00771667|80476893|FG000|Maintenance Phase|Other|0|||
27627172|NCT00771667|80476894|FG001|Maintenance Phase|Other|0|||
27627173|NCT00771667|80476895|FG002|Maintenance Phase|Other|0|||
27627174|NCT00771667|80476896|FG003|Maintenance Phase|Other|0|||
27627175|NCT00771667|80476897|FG004|Maintenance Phase|Other|0|||
27627176|NCT00771667|80476898|FG005|Maintenance Phase|Other|1|||
27627177|NCT00771667|80476899|FG006|Maintenance Phase|Other|2|||
27627178|NCT00771667|80476900|FG007|Maintenance Phase|Other|2|||
27627179|NCT00771667|80476901|FG008|Maintenance Phase|Other|3|||
27627180|NCT00771667|80476902|FG009|Maintenance Phase|Other|3|||
27627181|NCT02333630|80476905|FG000|Overall Study|Lost to Follow-up|5|||
27627182|NCT02333630|80476906|FG001|Overall Study|Lost to Follow-up|2|||
27627183|NCT00580801|80476915|FG000|Overall Study|Physician Decision|1|||
27627184|NCT00580801|80476916|FG001|Overall Study|Physician Decision|0|||
27627185|NCT00580801|80476917|FG002|Overall Study|Physician Decision|0|||
27627186|NCT00580801|80476915|FG000|Overall Study|Adverse Event|2|||
27627187|NCT00580801|80476916|FG001|Overall Study|Adverse Event|0|||
27627188|NCT00580801|80476917|FG002|Overall Study|Adverse Event|0|||
27627189|NCT00580801|80476915|FG000|Overall Study|Lost to Follow-up|2|||
27627190|NCT00580801|80476916|FG001|Overall Study|Lost to Follow-up|0|||
27627191|NCT00580801|80476917|FG002|Overall Study|Lost to Follow-up|0|||
27627192|NCT00580801|80476915|FG000|Overall Study|Reached a virologic endpoint|0|||
27627193|NCT00580801|80476916|FG001|Overall Study|Reached a virologic endpoint|1|||
27856773|NCT01910389|81310247|FG000|Overall Study|Withdrawal by Subject|2|||
27856774|NCT01910389|81310248|FG001|Overall Study|Withdrawal by Subject|0|||
27856775|NCT01910389|81310247|FG000|Overall Study|Study Closed|13|||
27856776|NCT01910389|81310248|FG001|Overall Study|Study Closed|8|||
27856777|NCT02730351|81310249|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
27856778|NCT02730351|81310250|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
27856779|NCT02730351|81310249|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
27856780|NCT02730351|81310250|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
27856781|NCT02730351|81310249|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
27912428|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27627194|NCT00580801|80476917|FG002|Overall Study|Reached a virologic endpoint|2|||
27627195|NCT00580801|80476915|FG000|Overall Study|Participant non-compliant|0|||
27627196|NCT00580801|80476916|FG001|Overall Study|Participant non-compliant|0|||
27627197|NCT00580801|80476917|FG002|Overall Study|Participant non-compliant|1|||
27627198|NCT00580801|80476915|FG000|Overall Study|Travel|1|||
27627199|NCT00580801|80476916|FG001|Overall Study|Travel|0|||
27627200|NCT00580801|80476917|FG002|Overall Study|Travel|0|||
27627201|NCT02701361|80476918|FG000|Overall Study|Lost to Follow-up|5|||
27627202|NCT02701361|80476919|FG001|Overall Study|Lost to Follow-up|2|||
27627203|NCT02701361|80476920|FG002|Overall Study|Lost to Follow-up|1|||
27627204|NCT02701361|80476918|FG000|Overall Study|Withdrawal by Subject|4|||
27627205|NCT02701361|80476919|FG001|Overall Study|Withdrawal by Subject|0|||
27627206|NCT02701361|80476920|FG002|Overall Study|Withdrawal by Subject|0|||
27627207|NCT02701361|80476918|FG000|Overall Study|timed out in rehab center|0|||
27627208|NCT02701361|80476919|FG001|Overall Study|timed out in rehab center|1|||
27912429|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912430|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912431|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912432|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912433|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912434|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912435|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27912436|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27531159|NCT00744471|80137783|FG003|Overall Study|Withdrawal by Subject|12|||
27531160|NCT00744471|80137780|FG000|Overall Study|Protocol Violation|1|||
27531161|NCT00744471|80137781|FG001|Overall Study|Protocol Violation|4|||
27627209|NCT02701361|80476920|FG002|Overall Study|timed out in rehab center|0|||
27627210|NCT02701361|80476918|FG000|Overall Study|incarceration|0|||
27627211|NCT02701361|80476919|FG001|Overall Study|incarceration|0|||
27627212|NCT02701361|80476920|FG002|Overall Study|incarceration|1|||
27627213|NCT02246621|80476921|FG000|Overall Study|Withdrawal by Subject|28|||
27627214|NCT02246621|80476922|FG001|Overall Study|Withdrawal by Subject|16|||
27627215|NCT02246621|80476921|FG000|Overall Study|Lost to Follow-up|1|||
27627216|NCT02246621|80476922|FG001|Overall Study|Lost to Follow-up|0|||
27627217|NCT02246621|80476921|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
27627218|NCT02246621|80476922|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
27627219|NCT04163458|80476923|FG000|Overall Study|Protocol Deviation|7|||
27627220|NCT04163458|80476924|FG001|Overall Study|Protocol Deviation|13|||
27627221|NCT04163458|80476923|FG000|Overall Study|Adverse Event|5|||
27627222|NCT04163458|80476924|FG001|Overall Study|Adverse Event|8|||
27627223|NCT04163458|80476923|FG000|Overall Study|Due to COVID-19 pandemic|4|||
27627224|NCT04163458|80476924|FG001|Overall Study|Due to COVID-19 pandemic|2|||
27627225|NCT04163458|80476923|FG000|Overall Study|Participant withdrew consent|2|||
27627226|NCT04163458|80476924|FG001|Overall Study|Participant withdrew consent|3|||
27627227|NCT04163458|80476923|FG000|Overall Study|Randomization failure|2|||
27627228|NCT04163458|80476924|FG001|Overall Study|Randomization failure|2|||
27627229|NCT04163458|80476923|FG000|Overall Study|Other|4|||
27627230|NCT04163458|80476924|FG001|Overall Study|Other|2|||
27531162|NCT00744471|80137782|FG002|Overall Study|Protocol Violation|1|||
27531163|NCT00744471|80137783|FG003|Overall Study|Protocol Violation|2|||
27531164|NCT00744471|80137780|FG000|Overall Study|Entered extension study|41|||
27531165|NCT00744471|80137781|FG001|Overall Study|Entered extension study|84|||
27531166|NCT00744471|80137782|FG002|Overall Study|Entered extension study|100|||
27531167|NCT00744471|80137783|FG003|Overall Study|Entered extension study|91|||
27531168|NCT00744471|80137780|FG000|Overall Study|Other|2|||
27531169|NCT00744471|80137781|FG001|Overall Study|Other|3|||
27531170|NCT00744471|80137782|FG002|Overall Study|Other|6|||
27531171|NCT00744471|80137783|FG003|Overall Study|Other|2|||
27531172|NCT00744471|80137780|FG000|Overall Study|Lack of Efficacy|83|||
27531173|NCT00744471|80137781|FG001|Overall Study|Lack of Efficacy|37|||
27531174|NCT00744471|80137782|FG002|Overall Study|Lack of Efficacy|19|||
27531175|NCT00744471|80137783|FG003|Overall Study|Lack of Efficacy|31|||
27531176|NCT00744471|80137780|FG000|Overall Study|Lost to Follow-up|0|||
27531177|NCT00744471|80137781|FG001|Overall Study|Lost to Follow-up|0|||
27531178|NCT00744471|80137782|FG002|Overall Study|Lost to Follow-up|2|||
27531179|NCT00744471|80137783|FG003|Overall Study|Lost to Follow-up|0|||
27531180|NCT01631812|80141317|FG000|Overall Study|Adverse Event|25|||
27531181|NCT01631812|80141317|FG000|Overall Study|Lack of Efficacy|5|||
27531182|NCT01631812|80141317|FG000|Overall Study|Withdrawal by Subject|4|||
27531183|NCT01631812|80141317|FG000|Overall Study|Physician Decision|3|||
27531184|NCT01925274|80141319|FG000|Overall Study|Death|1|||
27627231|NCT02974010|80476925|FG000|Overall Study|Lost to Follow-up|3|||
27531185|NCT01925274|80141320|FG001|Overall Study|Death|0|||
27531186|NCT01925274|80141321|FG002|Overall Study|Death|0|||
27531187|NCT01925274|80141319|FG000|Overall Study|Lost to Follow-up|0|||
27531188|NCT01925274|80141320|FG001|Overall Study|Lost to Follow-up|1|||
27627232|NCT02974010|80476926|FG001|Overall Study|Lost to Follow-up|1|||
27627233|NCT02974010|80476927|FG002|Overall Study|Lost to Follow-up|0|||
27627234|NCT02974010|80476928|FG003|Overall Study|Lost to Follow-up|0|||
27531189|NCT01925274|80141321|FG002|Overall Study|Lost to Follow-up|0|||
27531190|NCT01925274|80141319|FG000|Overall Study|Withdrawal by Subject|1|||
27531191|NCT01925274|80141320|FG001|Overall Study|Withdrawal by Subject|2|||
27627235|NCT02974010|80476925|FG000|Overall Study|Withdrawal by Subject|2|||
27627236|NCT02974010|80476926|FG001|Overall Study|Withdrawal by Subject|1|||
27627237|NCT02974010|80476927|FG002|Overall Study|Withdrawal by Subject|0|||
27627238|NCT02974010|80476928|FG003|Overall Study|Withdrawal by Subject|0|||
27531192|NCT01925274|80141321|FG002|Overall Study|Withdrawal by Subject|0|||
27531193|NCT01925274|80141319|FG000|Overall Study|Study terminated by sponsor|4|||
27627239|NCT02974010|80476925|FG000|Overall Study|Adverse Event|0|||
27627240|NCT02974010|80476926|FG001|Overall Study|Adverse Event|1|||
27531194|NCT01925274|80141320|FG001|Overall Study|Study terminated by sponsor|0|||
27531195|NCT01925274|80141321|FG002|Overall Study|Study terminated by sponsor|0|||
27531196|NCT01925274|80141319|FG000|Overall Study|Protocol amendment|1|||
27531197|NCT01925274|80141320|FG001|Overall Study|Protocol amendment|3|||
27531198|NCT01925274|80141321|FG002|Overall Study|Protocol amendment|6|||
27531199|NCT01484054|80141322|FG000|Period 1|Withdrawal by Subject|0|||
27531200|NCT01484054|80141323|FG001|Period 1|Withdrawal by Subject|1|||
27531201|NCT04073368|80141324|FG000|Overall Study|Adverse Event|2|||
27531202|NCT04073368|80141325|FG001|Overall Study|Adverse Event|0|||
27531203|NCT04073368|80141326|FG002|Overall Study|Adverse Event|1|||
27531204|NCT04073368|80141327|FG003|Overall Study|Adverse Event|1|||
27531205|NCT04073368|80141324|FG000|Overall Study|Withdrawal by Subject|2|||
27531206|NCT04073368|80141325|FG001|Overall Study|Withdrawal by Subject|2|||
27531207|NCT04073368|80141326|FG002|Overall Study|Withdrawal by Subject|1|||
27912437|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
27531208|NCT04073368|80141327|FG003|Overall Study|Withdrawal by Subject|1|||
27531209|NCT04073368|80141324|FG000|Overall Study|Lost to Follow-up|1|||
27531210|NCT04073368|80141325|FG001|Overall Study|Lost to Follow-up|1|||
27531211|NCT04073368|80141326|FG002|Overall Study|Lost to Follow-up|1|||
27531212|NCT04073368|80141327|FG003|Overall Study|Lost to Follow-up|0|||
27531213|NCT04073368|80141324|FG000|Overall Study|Protocol Violation|0|||
27531214|NCT04073368|80141325|FG001|Overall Study|Protocol Violation|1|||
27531215|NCT04073368|80141326|FG002|Overall Study|Protocol Violation|0|||
27531216|NCT04073368|80141327|FG003|Overall Study|Protocol Violation|0|||
27531217|NCT04073368|80141324|FG000|Overall Study|Subject noncompliance|7|||
27531218|NCT04073368|80141325|FG001|Overall Study|Subject noncompliance|4|||
27531219|NCT04073368|80141326|FG002|Overall Study|Subject noncompliance|0|||
27531220|NCT04073368|80141327|FG003|Overall Study|Subject noncompliance|0|||
27531221|NCT03161093|80141328|FG000|Overall Study|Protocol Violation|11|||
27531222|NCT03161093|80141329|FG001|Overall Study|Protocol Violation|14|||
27531223|NCT03161093|80141330|FG002|Overall Study|Protocol Violation|6|||
27531224|NCT03161093|80141331|FG003|Overall Study|Protocol Violation|13|||
27531225|NCT03161093|80141332|FG004|Overall Study|Protocol Violation|1|||
27531226|NCT03161093|80141333|FG005|Overall Study|Protocol Violation|0|||
27531227|NCT03161093|80141328|FG000|Overall Study|Adverse Event|5|||
27531228|NCT03161093|80141329|FG001|Overall Study|Adverse Event|21|||
27531229|NCT03161093|80141330|FG002|Overall Study|Adverse Event|16|||
27531230|NCT03161093|80141331|FG003|Overall Study|Adverse Event|35|||
27531231|NCT03161093|80141332|FG004|Overall Study|Adverse Event|2|||
27531232|NCT03161093|80141333|FG005|Overall Study|Adverse Event|1|||
27531233|NCT03161093|80141328|FG000|Overall Study|Lack of Efficacy|9|||
27735716|NCT00195351|80860055|FG000|Overall Study|Lack of Efficacy|0|||
27735717|NCT00195351|80860056|FG001|Overall Study|Lack of Efficacy|1|||
27735718|NCT03885284|80860057|FG000|Overall Study|Disease Progression|1|||
27735719|NCT03885284|80860058|FG001|Overall Study|Disease Progression|3|||
27735720|NCT03885284|80860057|FG000|Overall Study|Physician Decision|0|||
27735721|NCT03885284|80860058|FG001|Overall Study|Physician Decision|1|||
27735722|NCT03815175|80860061|FG000|Overall Study|Subject Lost to Follow-up|6|||
27735723|NCT03815175|80860061|FG000|Overall Study|Subject Withdrew Consent|48|||
27735724|NCT03815175|80860061|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
27735725|NCT03815175|80860061|FG000|Overall Study|Death|86|||
27735726|NCT03815175|80860061|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
27856782|NCT02730351|81310250|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
27856783|NCT02730351|81310249|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
27856784|NCT02730351|81310250|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
27856785|NCT02730351|81310249|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
27856786|NCT02730351|81310250|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
27856787|NCT01177059|81310251|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
27856788|NCT01177059|81310251|FG000|Overall Study|Withdrew consent|2|||
27856789|NCT01177059|81310251|FG000|Overall Study|Lost to Follow-up|18|||
27856790|NCT01884311|81310252|FG000|Overall Study|Withdrawal by Subject|3|||
27912438|NCT02326272|81518167|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27531234|NCT03161093|80141329|FG001|Overall Study|Lack of Efficacy|13|||
27531235|NCT03161093|80141330|FG002|Overall Study|Lack of Efficacy|9|||
27735727|NCT03815175|80860061|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
27735728|NCT03815175|80860061|FG000|Overall Study|Other Status Change Reason|1|||
27856791|NCT01884311|81310252|FG000|Overall Study|withdrew consent due to AEs|1|||
27912439|NCT02326272|81518168|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27531236|NCT03161093|80141331|FG003|Overall Study|Lack of Efficacy|24|||
27531237|NCT03161093|80141332|FG004|Overall Study|Lack of Efficacy|4|||
27531238|NCT03161093|80141333|FG005|Overall Study|Lack of Efficacy|1|||
27531239|NCT03161093|80141328|FG000|Overall Study|Physician Decision|0|||
27531240|NCT03161093|80141329|FG001|Overall Study|Physician Decision|1|||
27531241|NCT03161093|80141330|FG002|Overall Study|Physician Decision|0|||
27531242|NCT03161093|80141331|FG003|Overall Study|Physician Decision|2|||
27531243|NCT03161093|80141332|FG004|Overall Study|Physician Decision|17|||
27531244|NCT03161093|80141333|FG005|Overall Study|Physician Decision|15|||
27735729|NCT03815175|80860061|FG000|Overall Study|Missed Visit|12|||
27735730|NCT01686568|80860063|FG000|Main Study|Withdrawal by Subject|1|||
27735731|NCT01686568|80860064|FG001|Main Study|Withdrawal by Subject|3|||
27735732|NCT01686568|80860063|FG000|Main Study|Noncompliance with protocol|0|||
27735733|NCT01686568|80860064|FG001|Main Study|Noncompliance with protocol|1|||
27735734|NCT01686568|80860063|FG000|Main Study|Liver enzymes above range of exclusion|1|||
27735735|NCT01686568|80860064|FG001|Main Study|Liver enzymes above range of exclusion|0|||
27735736|NCT01686568|80860063|FG000|Sub-Study|Not consented for sub-study|2|||
27735737|NCT01686568|80860064|FG001|Sub-Study|Not consented for sub-study|2|||
27735738|NCT02040142|80860065|FG000|Overall Study|Lost to Follow-up|5|||
27735739|NCT02040142|80860065|FG000|Overall Study|Death|17|||
27735740|NCT02040142|80860065|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
27735741|NCT02782715|80860067|FG000|Overall Study|Withdrawal by Subject|1|||
27735742|NCT02868892|80860068|FG000|Overall Study|Investigator left site and no follow-up|6|||
27735743|NCT03233048|80860069|FG000|Overall Study|Withdrawal by Subject|1|||
27735744|NCT01670500|80860070|FG000|Overall Study|Withdrawal by Subject|1|||
27735745|NCT01670500|80860071|FG001|Overall Study|Withdrawal by Subject|0|||
27735746|NCT00004980|80860072|FG000|Overall Study|Withdrawal by Subject|1|||
27735747|NCT00004980|80860073|FG001|Overall Study|Withdrawal by Subject|0|||
27735748|NCT00004980|80860072|FG000|Overall Study|memory difficulties|1|||
27735749|NCT00004980|80860073|FG001|Overall Study|memory difficulties|1|||
27735750|NCT00004980|80860072|FG000|Overall Study|Physician Decision|0|||
27531245|NCT03161093|80141328|FG000|Overall Study|Withdrawal by Subject|24|||
27531246|NCT03161093|80141329|FG001|Overall Study|Withdrawal by Subject|73|||
27531247|NCT03161093|80141330|FG002|Overall Study|Withdrawal by Subject|44|||
27531248|NCT03161093|80141331|FG003|Overall Study|Withdrawal by Subject|97|||
27531249|NCT03161093|80141332|FG004|Overall Study|Withdrawal by Subject|11|||
27531250|NCT03161093|80141333|FG005|Overall Study|Withdrawal by Subject|10|||
27531251|NCT03161093|80141328|FG000|Overall Study|Lost to Follow-up|3|||
27531252|NCT03161093|80141329|FG001|Overall Study|Lost to Follow-up|12|||
27531253|NCT03161093|80141330|FG002|Overall Study|Lost to Follow-up|4|||
27531254|NCT03161093|80141331|FG003|Overall Study|Lost to Follow-up|7|||
27735751|NCT00004980|80860073|FG001|Overall Study|Physician Decision|1|||
27735752|NCT02978222|80860075|FG000|Overall Study|Withdrawal by Subject|2|||
27735753|NCT02978222|80860076|FG001|Overall Study|Withdrawal by Subject|2|||
27735754|NCT02978222|80860075|FG000|Overall Study|Physician Decision|2|||
27735755|NCT02978222|80860076|FG001|Overall Study|Physician Decision|0|||
27735756|NCT02978222|80860075|FG000|Overall Study|Adverse Event|0|||
27735757|NCT02978222|80860076|FG001|Overall Study|Adverse Event|1|||
27735758|NCT02978222|80860075|FG000|Overall Study|Death|1|||
27735759|NCT02978222|80860076|FG001|Overall Study|Death|0|||
27735760|NCT02978222|80860075|FG000|Overall Study|Disease Progression|32|||
27735761|NCT02978222|80860076|FG001|Overall Study|Disease Progression|32|||
27735762|NCT02978222|80860075|FG000|Overall Study|Early Study Termination|24|||
27735763|NCT02978222|80860076|FG001|Overall Study|Early Study Termination|21|||
27735764|NCT04538664|80860077|FG000|Overall Study|Withdrawal by Subject|5|||
27735765|NCT04538664|80860078|FG001|Overall Study|Withdrawal by Subject|9|||
27735766|NCT04538664|80860077|FG000|Overall Study|Lost to Follow-up|2|||
27735767|NCT04538664|80860078|FG001|Overall Study|Lost to Follow-up|1|||
27735768|NCT04538664|80860077|FG000|Overall Study|Ongoing|106|||
27735769|NCT04538664|80860078|FG001|Overall Study|Ongoing|115|||
27735770|NCT05127486|80860079|FG000|Overall Study|Adverse Event|2|||
27735771|NCT05127486|80860080|FG001|Overall Study|Adverse Event|4|||
27735772|NCT05127486|80860079|FG000|Overall Study|Lack of Efficacy|1|||
27735773|NCT05127486|80860080|FG001|Overall Study|Lack of Efficacy|0|||
27735774|NCT05127486|80860079|FG000|Overall Study|Pregnancy|0|||
27735775|NCT05127486|80860080|FG001|Overall Study|Pregnancy|1|||
27735776|NCT05127486|80860079|FG000|Overall Study|Physician Decision|4|||
27531255|NCT03161093|80141332|FG004|Overall Study|Lost to Follow-up|8|||
27531256|NCT03161093|80141333|FG005|Overall Study|Lost to Follow-up|13|||
27531257|NCT03161093|80141328|FG000|Overall Study|Death|3|||
27531258|NCT03161093|80141329|FG001|Overall Study|Death|9|||
27531259|NCT03161093|80141330|FG002|Overall Study|Death|7|||
27735777|NCT05127486|80860080|FG001|Overall Study|Physician Decision|1|||
27735778|NCT05127486|80860079|FG000|Overall Study|Withdrawal by Subject|14|||
27735779|NCT05127486|80860080|FG001|Overall Study|Withdrawal by Subject|13|||
27735780|NCT05127486|80860079|FG000|Overall Study|Lost to Follow-up|5|||
27735781|NCT05127486|80860080|FG001|Overall Study|Lost to Follow-up|8|||
27735782|NCT00586690|80860083|FG000|Overall Study|Death|2|||
27912440|NCT02326272|81518169|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
27958644|NCT01791517|81680068|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
27531260|NCT03161093|80141331|FG003|Overall Study|Death|9|||
27735783|NCT00586690|80860084|FG001|Overall Study|Death|0|||
27735784|NCT00586690|80860083|FG000|Overall Study|Disease Progression|10|||
27735785|NCT00586690|80860084|FG001|Overall Study|Disease Progression|0|||
27531261|NCT03161093|80141332|FG004|Overall Study|Death|0|||
27531262|NCT03161093|80141333|FG005|Overall Study|Death|0|||
27735786|NCT00586690|80860083|FG000|Overall Study|Adverse Event|1|||
27735787|NCT00586690|80860084|FG001|Overall Study|Adverse Event|0|||
27735788|NCT00586690|80860083|FG000|Overall Study|Lack of Efficacy|2|||
27735789|NCT00586690|80860084|FG001|Overall Study|Lack of Efficacy|0|||
27735790|NCT00586690|80860083|FG000|Overall Study|Lab can't accommodate|1|||
27735791|NCT00586690|80860084|FG001|Overall Study|Lab can't accommodate|0|||
27735792|NCT03312218|80860085|FG000|Overall Study|Never signed in to access the app|54|||
27735793|NCT03312218|80860086|FG001|Overall Study|Never signed in to access the app|58|||
27735794|NCT01725165|80860092|FG000|Overall Study|Death|11|||
27735795|NCT01725165|80860093|FG001|Overall Study|Death|18|||
27735796|NCT04927312|80860097|FG000|Overall Study|Adverse Event|1|||
27735797|NCT04927312|80860097|FG000|Overall Study|Death|1|||
27735798|NCT04927312|80860097|FG000|Overall Study|Withdrawal by Subject|1|||
27735799|NCT04927312|80860097|FG000|Overall Study|Other|1|||
27735800|NCT04513158|80860098|FG000|Overall Study|Screen Failure|1|||
27735801|NCT03830281|80860101|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
27735802|NCT03830281|80860102|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
27735803|NCT03830281|80860101|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
27735804|NCT03830281|80860102|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
27735805|NCT03830281|80860101|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
27735806|NCT03830281|80860102|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
27735807|NCT03830281|80860101|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
27735808|NCT03830281|80860102|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
27735809|NCT03830281|80860101|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
27735810|NCT03830281|80860102|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
27735811|NCT03830281|80860101|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
27735812|NCT03830281|80860102|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
27735813|NCT03830281|80860101|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
27735814|NCT03830281|80860102|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
27735815|NCT03830281|80860101|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
27735816|NCT03830281|80860102|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
27735817|NCT03830281|80860101|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
27735818|NCT03830281|80860102|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
27735819|NCT03406962|80860110|FG000|Overall Study|Death|2|||
27735820|NCT03406962|80860110|FG000|Overall Study|Adverse Event|1|||
27735821|NCT01331161|80860111|FG000|Overall Study|Physician Decision|1|||
27735822|NCT01331161|80860112|FG001|Overall Study|Physician Decision|0|||
27735823|NCT01331161|80860111|FG000|Overall Study|Lost to Follow-up|0|||
27735824|NCT01331161|80860112|FG001|Overall Study|Lost to Follow-up|1|||
27856792|NCT01884311|81310252|FG000|Overall Study|Precautionary measure|1|||
27856793|NCT04740814|81310253|FG000|Overall Study|Adverse Event|3|||
27856794|NCT04740814|81310253|FG000|Overall Study|Protocol Violation|2|||
27856795|NCT04740814|81310253|FG000|Overall Study|Lost to Follow-up|2|||
27856796|NCT04740814|81310253|FG000|Overall Study|Withdrawal by Subject|3|||
27735825|NCT01331161|80860111|FG000|Overall Study|Pregnancy|0|||
27735826|NCT01331161|80860112|FG001|Overall Study|Pregnancy|1|||
27735827|NCT04091217|80860113|FG000|Overall Study|Lost to Follow-up|2|||
27735828|NCT00538681|80860118|FG000|Overall Study|Progressive Disease|7|||
27735829|NCT00538681|80860119|FG001|Overall Study|Progressive Disease|0|||
27735830|NCT00538681|80860120|FG002|Overall Study|Progressive Disease|1|||
27735831|NCT00538681|80860121|FG003|Overall Study|Progressive Disease|0|||
27735832|NCT00538681|80860118|FG000|Overall Study|Sponsor Decision|1|||
27735833|NCT00538681|80860119|FG001|Overall Study|Sponsor Decision|3|||
27735834|NCT00538681|80860120|FG002|Overall Study|Sponsor Decision|8|||
27735835|NCT00538681|80860121|FG003|Overall Study|Sponsor Decision|9|||
27735836|NCT00538681|80860118|FG000|Overall Study|Adverse Event|1|||
27735837|NCT00538681|80860119|FG001|Overall Study|Adverse Event|1|||
27735838|NCT00538681|80860120|FG002|Overall Study|Adverse Event|1|||
27735839|NCT00538681|80860121|FG003|Overall Study|Adverse Event|0|||
27735840|NCT00538681|80860118|FG000|Overall Study|Death|0|||
27735841|NCT00538681|80860119|FG001|Overall Study|Death|0|||
27735842|NCT00538681|80860120|FG002|Overall Study|Death|1|||
27735843|NCT00538681|80860121|FG003|Overall Study|Death|1|||
27735844|NCT00538681|80860118|FG000|Overall Study|Investigator Decision|0|||
27856797|NCT01288053|81310254|FG000|Overall Study|Death|1|||
27531263|NCT03161093|80141328|FG000|Overall Study|Unknown - Not reported|0|||
27735845|NCT00538681|80860119|FG001|Overall Study|Investigator Decision|0|||
27735846|NCT00538681|80860120|FG002|Overall Study|Investigator Decision|0|||
27735847|NCT00538681|80860121|FG003|Overall Study|Investigator Decision|1|||
27735848|NCT00816036|80860122|FG000|Overall Study|Death|47|||
27531264|NCT03161093|80141329|FG001|Overall Study|Unknown - Not reported|1|||
27531265|NCT03161093|80141330|FG002|Overall Study|Unknown - Not reported|0|||
27735849|NCT00816036|80860123|FG001|Overall Study|Death|28|||
27735850|NCT00816036|80860122|FG000|Overall Study|Lost to Follow-up|75|||
27735851|NCT00816036|80860123|FG001|Overall Study|Lost to Follow-up|57|||
27735852|NCT00816036|80860122|FG000|Overall Study|Withdrawal by Subject|54|||
27735853|NCT00816036|80860123|FG001|Overall Study|Withdrawal by Subject|23|||
27735854|NCT00503399|80860124|FG000|Overall Study|Death|2|||
27735855|NCT00503399|80860125|FG001|Overall Study|Death|1|||
27735856|NCT00503399|80860124|FG000|Overall Study|Protocol Violation|1|||
27735857|NCT00503399|80860125|FG001|Overall Study|Protocol Violation|0|||
27735858|NCT00503399|80860124|FG000|Overall Study|Withdrawal by Subject|4|||
27735859|NCT00503399|80860125|FG001|Overall Study|Withdrawal by Subject|2|||
27735860|NCT00503399|80860124|FG000|Overall Study|Adverse Event|0|||
27735861|NCT00503399|80860125|FG001|Overall Study|Adverse Event|3|||
27735862|NCT00503399|80860124|FG000|Overall Study|Lost to Follow-up|0|||
27735863|NCT00503399|80860125|FG001|Overall Study|Lost to Follow-up|2|||
27735864|NCT00957853|80860127|FG000|Overall Study|Withdrawal by Subject|1|||
27735865|NCT00957853|80860128|FG001|Overall Study|Withdrawal by Subject|0|||
27735866|NCT00957853|80860129|FG002|Overall Study|Withdrawal by Subject|0|||
27735867|NCT02120417|80860130|FG000|Overall Study|Death|5|||
27735868|NCT02120417|80860131|FG001|Overall Study|Death|1|||
27735869|NCT02120417|80860130|FG000|Overall Study|Adverse Event|3|||
27735870|NCT02120417|80860131|FG001|Overall Study|Adverse Event|9|||
27735871|NCT02120417|80860130|FG000|Overall Study|Participant decision|4|||
27735872|NCT02120417|80860131|FG001|Overall Study|Participant decision|4|||
27735873|NCT02120417|80860130|FG000|Overall Study|Disease progression|41|||
27735874|NCT02120417|80860131|FG001|Overall Study|Disease progression|45|||
27735875|NCT02120417|80860130|FG000|Overall Study|Noncompliance with study treatment|0|||
27735876|NCT02120417|80860131|FG001|Overall Study|Noncompliance with study treatment|2|||
27735877|NCT02120417|80860130|FG000|Overall Study|Physician Decision|2|||
27735878|NCT02120417|80860131|FG001|Overall Study|Physician Decision|3|||
27735879|NCT02120417|80860130|FG000|Overall Study|Other unspecified|5|||
27735880|NCT02120417|80860131|FG001|Overall Study|Other unspecified|4|||
27735881|NCT03577990|80860132|FG000|Overall Study|Lost to Follow-up|4|||
27735882|NCT03577990|80860133|FG001|Overall Study|Lost to Follow-up|6|||
27735883|NCT03577990|80860132|FG000|Overall Study|Withdrawal by Subject|4|||
27735884|NCT03577990|80860133|FG001|Overall Study|Withdrawal by Subject|7|||
27735885|NCT03716726|80860134|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
27735886|NCT03716726|80860135|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
27735887|NCT03716726|80860134|FG000|12 Months Followup|Lost to Follow-up|10|||
27735888|NCT03716726|80860135|FG001|12 Months Followup|Lost to Follow-up|17|||
27735889|NCT03263091|80860136|FG000|OL Component|Withdrawal by Subject|1|||
27735890|NCT03263091|80860137|FG001|OL Component|Withdrawal by Subject|1|||
27735891|NCT03263091|80860138|FG002|OL Component|Withdrawal by Subject|0|||
27735892|NCT03263091|80860139|FG003|OL Component|Withdrawal by Subject|0|||
27735893|NCT03263091|80860140|FG004|OL Component|Withdrawal by Subject|0|||
27735894|NCT03263091|80860141|FG005|OL Component|Withdrawal by Subject|0|||
27735895|NCT03263091|80860136|FG000|OL Component|Physician Decision|0|||
27735896|NCT03263091|80860137|FG001|OL Component|Physician Decision|1|||
27735897|NCT03263091|80860138|FG002|OL Component|Physician Decision|2|||
27735898|NCT03263091|80860139|FG003|OL Component|Physician Decision|0|||
27735899|NCT03263091|80860140|FG004|OL Component|Physician Decision|0|||
27735900|NCT03263091|80860141|FG005|OL Component|Physician Decision|0|||
27735901|NCT03263091|80860136|FG000|OL Component|Death|1|||
27735902|NCT03263091|80860137|FG001|OL Component|Death|0|||
27735903|NCT03263091|80860138|FG002|OL Component|Death|0|||
27735904|NCT03263091|80860139|FG003|OL Component|Death|0|||
27735905|NCT03263091|80860140|FG004|OL Component|Death|0|||
27735906|NCT03263091|80860141|FG005|OL Component|Death|0|||
27735907|NCT03263091|80860136|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
27735908|NCT03263091|80860137|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
27735909|NCT03263091|80860138|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
27735910|NCT03263091|80860139|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
27735911|NCT03263091|80860140|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
27735912|NCT03263091|80860141|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
27735913|NCT03263091|80860136|FG000|OL High-EPO Component|Physician Decision|0|||
27735914|NCT03263091|80860137|FG001|OL High-EPO Component|Physician Decision|0|||
27735915|NCT03263091|80860138|FG002|OL High-EPO Component|Physician Decision|0|||
27735916|NCT03263091|80860139|FG003|OL High-EPO Component|Physician Decision|1|||
27856798|NCT00688376|81310255|FG000|Double-Blind Phase|Adverse Event|4|||
27856799|NCT00688376|81310256|FG001|Double-Blind Phase|Adverse Event|4|||
27856800|NCT00688376|81310255|FG000|Double-Blind Phase|Protocol Violation|1|||
27735917|NCT03263091|80860140|FG004|OL High-EPO Component|Physician Decision|0|||
27735918|NCT03263091|80860141|FG005|OL High-EPO Component|Physician Decision|0|||
27735919|NCT03263091|80860136|FG000|OL High-EPO Component|Death|0|||
27735920|NCT03263091|80860137|FG001|OL High-EPO Component|Death|0|||
27735921|NCT03263091|80860138|FG002|OL High-EPO Component|Death|0|||
27735922|NCT03263091|80860139|FG003|OL High-EPO Component|Death|3|||
27735923|NCT03263091|80860140|FG004|OL High-EPO Component|Death|0|||
27735924|NCT03263091|80860141|FG005|OL High-EPO Component|Death|0|||
27735925|NCT03263091|80860136|FG000|DB Component|Withdrawal by Subject|0|||
27735926|NCT03263091|80860137|FG001|DB Component|Withdrawal by Subject|0|||
27735927|NCT03263091|80860138|FG002|DB Component|Withdrawal by Subject|0|||
27735928|NCT03263091|80860139|FG003|DB Component|Withdrawal by Subject|0|||
27856801|NCT00688376|81310256|FG001|Double-Blind Phase|Protocol Violation|2|||
27735929|NCT03263091|80860140|FG004|DB Component|Withdrawal by Subject|22|||
27735930|NCT03263091|80860141|FG005|DB Component|Withdrawal by Subject|8|||
27735931|NCT03263091|80860136|FG000|DB Component|Physician Decision|0|||
27735932|NCT03263091|80860137|FG001|DB Component|Physician Decision|0|||
27735933|NCT03263091|80860138|FG002|DB Component|Physician Decision|0|||
27735934|NCT03263091|80860139|FG003|DB Component|Physician Decision|0|||
27735935|NCT03263091|80860140|FG004|DB Component|Physician Decision|3|||
27735936|NCT03263091|80860141|FG005|DB Component|Physician Decision|1|||
27856802|NCT00688376|81310255|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
27958645|NCT01791517|81680069|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
27627241|NCT02974010|80476927|FG002|Overall Study|Adverse Event|0|||
27627242|NCT02974010|80476928|FG003|Overall Study|Adverse Event|0|||
27627243|NCT02974010|80476925|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
27627244|NCT02974010|80476926|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
27627245|NCT02974010|80476927|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
27627246|NCT02974010|80476928|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
27627247|NCT02974010|80476925|FG000|Overall Study|Lack of Efficacy|0|||
27627248|NCT02974010|80476926|FG001|Overall Study|Lack of Efficacy|0|||
27627249|NCT02974010|80476927|FG002|Overall Study|Lack of Efficacy|1|||
27627250|NCT02974010|80476928|FG003|Overall Study|Lack of Efficacy|0|||
27627251|NCT01068249|80476929|FG000|Overall Study|Death|1|||
27627252|NCT01068249|80476929|FG000|Overall Study|Withdrawal by Subject|3|||
27627253|NCT02140554|80476930|FG000|Overall Study|Withdrawal of consent|1|||
27627254|NCT02140554|80476931|FG001|Overall Study|Withdrawal of consent|0|||
27627255|NCT02140554|80476932|FG002|Overall Study|Withdrawal of consent|4|||
27627256|NCT02140554|80476930|FG000|Overall Study|Physician Decision|1|||
27627257|NCT02140554|80476931|FG001|Overall Study|Physician Decision|0|||
27627258|NCT02140554|80476932|FG002|Overall Study|Physician Decision|2|||
27627259|NCT02140554|80476930|FG000|Overall Study|Death|0|||
27627260|NCT02140554|80476931|FG001|Overall Study|Death|0|||
27627261|NCT02140554|80476932|FG002|Overall Study|Death|1|||
27627262|NCT02140554|80476930|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
27627263|NCT02140554|80476931|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
27627264|NCT02140554|80476932|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
27627265|NCT05025449|80476933|FG000|Overall Study|Withdrawal by Subject|1|||
27627266|NCT05025449|80476933|FG000|Overall Study|Patient emergently taken to operating room|1|||
27627267|NCT01249092|80476934|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
27627268|NCT01249092|80476934|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
27627269|NCT00763282|80476935|FG000|Overall Study|Withdrawal by Subject|6|||
27627270|NCT00763282|80476936|FG001|Overall Study|Withdrawal by Subject|5|||
27627271|NCT00763282|80476935|FG000|Overall Study|Death|4|||
27627272|NCT00763282|80476936|FG001|Overall Study|Death|3|||
27627273|NCT00763282|80476935|FG000|Overall Study|Lost to Follow-up|22|||
27627274|NCT00763282|80476936|FG001|Overall Study|Lost to Follow-up|26|||
27627275|NCT00768066|80476937|FG000|Overall Study|Did not receive study product injection.|3|||
27627276|NCT00768066|80476938|FG001|Overall Study|Did not receive study product injection.|3|||
27627277|NCT00768066|80476939|FG002|Overall Study|Did not receive study product injection.|0|||
27627278|NCT00831792|80476940|FG000|Overall Study|Not Eligible|3|||
27627279|NCT00831792|80476940|FG000|Overall Study|Adverse Event|1|||
27627280|NCT00831792|80476940|FG000|Overall Study|Death|1|||
27627281|NCT00831792|80476940|FG000|Overall Study|Lack of Efficacy|1|||
27627282|NCT01549652|80476941|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
27627283|NCT01549652|80476942|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
27627284|NCT01549652|80476943|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
27627285|NCT01549652|80476944|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
27627286|NCT01549652|80476941|FG000|Overall Study|Study Drug Titration Failure|5|||
27627287|NCT01549652|80476942|FG001|Overall Study|Study Drug Titration Failure|6|||
27627288|NCT01549652|80476943|FG002|Overall Study|Study Drug Titration Failure|0|||
27627289|NCT01549652|80476944|FG003|Overall Study|Study Drug Titration Failure|0|||
27627290|NCT01549652|80476941|FG000|Overall Study|Withdrawal Effect|0|||
27627291|NCT01549652|80476942|FG001|Overall Study|Withdrawal Effect|2|||
27735937|NCT03263091|80860136|FG000|DB Component|Adverse Event|0|||
27735938|NCT03263091|80860137|FG001|DB Component|Adverse Event|0|||
27735939|NCT03263091|80860138|FG002|DB Component|Adverse Event|0|||
27627292|NCT01549652|80476943|FG002|Overall Study|Withdrawal Effect|0|||
27627293|NCT01549652|80476944|FG003|Overall Study|Withdrawal Effect|0|||
27627294|NCT01549652|80476941|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
27627295|NCT01549652|80476942|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
27627296|NCT01549652|80476943|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
27627297|NCT01549652|80476944|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
27627298|NCT01549652|80476941|FG000|Overall Study|Problem with Infusion|1|||
27735940|NCT03263091|80860139|FG003|DB Component|Adverse Event|0|||
27735941|NCT03263091|80860140|FG004|DB Component|Adverse Event|2|||
27735942|NCT03263091|80860141|FG005|DB Component|Adverse Event|1|||
27735943|NCT03263091|80860136|FG000|DB Component|Lost to Follow-up|0|||
27735944|NCT03263091|80860137|FG001|DB Component|Lost to Follow-up|0|||
27735945|NCT03263091|80860138|FG002|DB Component|Lost to Follow-up|0|||
27735946|NCT03263091|80860139|FG003|DB Component|Lost to Follow-up|0|||
27735947|NCT03263091|80860140|FG004|DB Component|Lost to Follow-up|2|||
27735948|NCT03263091|80860141|FG005|DB Component|Lost to Follow-up|1|||
27735949|NCT03263091|80860136|FG000|DB Component|Death|0|||
27735950|NCT03263091|80860137|FG001|DB Component|Death|0|||
27735951|NCT03263091|80860138|FG002|DB Component|Death|0|||
27735952|NCT03263091|80860139|FG003|DB Component|Death|0|||
27735953|NCT03263091|80860140|FG004|DB Component|Death|7|||
27735954|NCT03263091|80860141|FG005|DB Component|Death|4|||
27735955|NCT03263091|80860136|FG000|DB Component|Other than specified|0|||
27735956|NCT03263091|80860137|FG001|DB Component|Other than specified|0|||
27735957|NCT03263091|80860138|FG002|DB Component|Other than specified|0|||
27735958|NCT03263091|80860139|FG003|DB Component|Other than specified|0|||
27735959|NCT03263091|80860140|FG004|DB Component|Other than specified|8|||
27735960|NCT03263091|80860141|FG005|DB Component|Other than specified|6|||
27735961|NCT00587223|80860144|FG000|Overall Study|Adverse Event|1|||
27735962|NCT01061008|80860145|FG000|Overall Study|Badiocephalic fistula failed|3|||
27735963|NCT01061008|80860146|FG001|Overall Study|Badiocephalic fistula failed|2|||
27735964|NCT01061008|80860145|FG000|Overall Study|Death|1|||
27735965|NCT01061008|80860146|FG001|Overall Study|Death|0|||
27735966|NCT01061008|80860145|FG000|Overall Study|Withdrawal by Subject|1|||
27735967|NCT01061008|80860146|FG001|Overall Study|Withdrawal by Subject|3|||
27735968|NCT01061008|80860145|FG000|Overall Study|Unable to exercise following surgery|1|||
27735969|NCT01061008|80860146|FG001|Overall Study|Unable to exercise following surgery|0|||
27735970|NCT01061008|80860145|FG000|Overall Study|Adverse Event|0|||
27735971|NCT01061008|80860146|FG001|Overall Study|Adverse Event|1|||
27735972|NCT05139030|80860149|FG000|Overall Study|Withdrawal by Subject|1|||
27735973|NCT05139030|80860150|FG001|Overall Study|Withdrawal by Subject|3|||
27856803|NCT00688376|81310256|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
27856804|NCT00688376|81310255|FG000|Double-Blind Phase|Not treated|0|||
27856805|NCT00688376|81310256|FG001|Double-Blind Phase|Not treated|1|||
27856806|NCT00688376|81310255|FG000|Blinded Extension Phase|Adverse Event|3|||
27856807|NCT00688376|81310256|FG001|Blinded Extension Phase|Adverse Event|4|||
27856808|NCT00688376|81310255|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
27856809|NCT00688376|81310256|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
27856810|NCT00688376|81310255|FG000|Blinded Extension Phase|Physician Decision|1|||
27856811|NCT00688376|81310256|FG001|Blinded Extension Phase|Physician Decision|0|||
27856812|NCT00688376|81310255|FG000|Blinded Extension Phase|Other|1|||
27531266|NCT03161093|80141331|FG003|Overall Study|Unknown - Not reported|0|||
27531267|NCT03161093|80141332|FG004|Overall Study|Unknown - Not reported|0|||
27531268|NCT03161093|80141333|FG005|Overall Study|Unknown - Not reported|1|||
27735974|NCT05139030|80860149|FG000|Overall Study|Adverse Event|0|||
27856813|NCT00688376|81310256|FG001|Blinded Extension Phase|Other|0|||
27856814|NCT00893737|81310259|FG000|Overall Study|Adverse Event|4|||
27856815|NCT00893737|81310259|FG000|Overall Study|Withdrawal by Subject|2|||
27856816|NCT00893737|81310259|FG000|Overall Study|Lost to Follow-up|6|||
27856817|NCT02524730|81310260|FG000|Overall Study|Lost to Follow-up|5|||
27856818|NCT02524730|81310260|FG000|Overall Study|Withdrawal by Subject|18|||
27856819|NCT02524730|81310260|FG000|Overall Study|Death|10|||
27856820|NCT02524730|81310260|FG000|Overall Study|Adverse Event|8|||
27856821|NCT02524730|81310260|FG000|Overall Study|Protocol Violation|1|||
27856822|NCT02524730|81310260|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
27856823|NCT01770392|81310261|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
27856824|NCT00706511|81310263|FG000|Overall Study|Withdrawal by Subject|1|||
27856825|NCT00706511|81310264|FG001|Overall Study|Withdrawal by Subject|0|||
27856826|NCT00706511|81310265|FG002|Overall Study|Withdrawal by Subject|0|||
27856827|NCT00706511|81310266|FG003|Overall Study|Withdrawal by Subject|0|||
27856828|NCT00191113|81310267|FG000|Core Study|Withdrawal by Subject|25|||
27856829|NCT00191113|81310268|FG001|Core Study|Withdrawal by Subject|9|||
27856830|NCT00191113|81310267|FG000|Core Study|Protocol Violation|6|||
27856831|NCT00191113|81310268|FG001|Core Study|Protocol Violation|2|||
27856832|NCT00191113|81310267|FG000|Core Study|Lost to Follow-up|3|||
27856833|NCT00191113|81310268|FG001|Core Study|Lost to Follow-up|0|||
27627299|NCT01549652|80476942|FG001|Overall Study|Problem with Infusion|0|||
27735975|NCT05139030|80860150|FG001|Overall Study|Adverse Event|1|||
27735976|NCT05139030|80860149|FG000|Overall Study|Failure to meet continuation criteria|0|||
27735977|NCT05139030|80860150|FG001|Overall Study|Failure to meet continuation criteria|1|||
27735978|NCT00364793|80860151|FG000|Overall Study|Adverse Event|2|||
27856834|NCT00191113|81310267|FG000|Core Study|Adverse Event|0|||
27856835|NCT00191113|81310268|FG001|Core Study|Adverse Event|2|||
27856836|NCT00191113|81310267|FG000|Core Study|Lack of Efficacy|0|||
27856837|NCT00191113|81310268|FG001|Core Study|Lack of Efficacy|2|||
27856838|NCT00191113|81310267|FG000|Core Study|Death|1|||
27856839|NCT00191113|81310268|FG001|Core Study|Death|0|||
27856840|NCT02149108|81310270|FG000|Overall Study|Not treated|1|||
27735979|NCT00364793|80860152|FG001|Overall Study|Adverse Event|0|||
27856841|NCT02149108|81310271|FG001|Overall Study|Not treated|2|||
27735980|NCT00364793|80860153|FG002|Overall Study|Adverse Event|0|||
27735981|NCT00364793|80860154|FG003|Overall Study|Adverse Event|0|||
27735982|NCT00364793|80860151|FG000|Overall Study|Death|1|||
27735983|NCT00364793|80860152|FG001|Overall Study|Death|0|||
27735984|NCT00364793|80860153|FG002|Overall Study|Death|1|||
27735985|NCT00364793|80860154|FG003|Overall Study|Death|0|||
27735986|NCT00364793|80860151|FG000|Overall Study|Lack of Efficacy|3|||
27735987|NCT00364793|80860152|FG001|Overall Study|Lack of Efficacy|3|||
27735988|NCT00364793|80860153|FG002|Overall Study|Lack of Efficacy|1|||
27735989|NCT00364793|80860154|FG003|Overall Study|Lack of Efficacy|1|||
27735990|NCT00364793|80860151|FG000|Overall Study|Lost to Follow-up|1|||
27735991|NCT00364793|80860152|FG001|Overall Study|Lost to Follow-up|0|||
27735992|NCT00364793|80860153|FG002|Overall Study|Lost to Follow-up|2|||
27531269|NCT01052844|80141336|FG000|Overall Study|Adverse Event|0|||
27531270|NCT01052844|80141337|FG001|Overall Study|Adverse Event|1|||
27735993|NCT00364793|80860154|FG003|Overall Study|Lost to Follow-up|0|||
27735994|NCT00364793|80860151|FG000|Overall Study|Poor or non-compliance|1|||
27735995|NCT00364793|80860152|FG001|Overall Study|Poor or non-compliance|1|||
27735996|NCT00364793|80860153|FG002|Overall Study|Poor or non-compliance|0|||
27735997|NCT00364793|80860154|FG003|Overall Study|Poor or non-compliance|1|||
27735998|NCT00364793|80860151|FG000|Overall Study|No longer meets criteria|0|||
27735999|NCT00364793|80860152|FG001|Overall Study|No longer meets criteria|0|||
27736000|NCT00364793|80860153|FG002|Overall Study|No longer meets criteria|0|||
27736001|NCT00364793|80860154|FG003|Overall Study|No longer meets criteria|1|||
27736002|NCT00364793|80860151|FG000|Overall Study|Withdrawal by Subject|0|||
27736003|NCT00364793|80860152|FG001|Overall Study|Withdrawal by Subject|1|||
27736004|NCT00364793|80860153|FG002|Overall Study|Withdrawal by Subject|0|||
27736005|NCT00364793|80860154|FG003|Overall Study|Withdrawal by Subject|0|||
27736006|NCT00826748|80860164|FG000|Overall Study|Withdrawal by Subject|0|||
27736007|NCT00826748|80860165|FG001|Overall Study|Withdrawal by Subject|0|||
27736008|NCT00826748|80860166|FG002|Overall Study|Withdrawal by Subject|2|||
27736009|NCT00826748|80860164|FG000|Overall Study|Physician Decision|0|||
27736010|NCT00826748|80860165|FG001|Overall Study|Physician Decision|0|||
27736011|NCT00826748|80860166|FG002|Overall Study|Physician Decision|1|||
27856842|NCT02149108|81310270|FG000|Overall Study|Progressive Disease (PD)|324|||
27912441|NCT02326272|81518170|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912442|NCT02326272|81518171|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912443|NCT02326272|81518172|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912444|NCT02326272|81518173|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912445|NCT02326272|81518174|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912446|NCT02326272|81518175|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912447|NCT02326272|81518176|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27958646|NCT01791517|81680058|FG000|Phase II|Pre-Existing Ocular Issue|0|||
27856843|NCT02149108|81310271|FG001|Overall Study|Progressive Disease (PD)|318|||
27856844|NCT02149108|81310270|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
27856845|NCT02149108|81310271|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
27856846|NCT02149108|81310270|FG000|Overall Study|Other Adverse Event (AE)|8|||
27856847|NCT02149108|81310271|FG001|Overall Study|Other Adverse Event (AE)|18|||
27856848|NCT02149108|81310270|FG000|Overall Study|Other not defined above|0|||
27856849|NCT02149108|81310271|FG001|Overall Study|Other not defined above|2|||
27856850|NCT02149108|81310270|FG000|Overall Study|Refusal to continue trial medication|15|||
27856851|NCT02149108|81310271|FG001|Overall Study|Refusal to continue trial medication|11|||
27531271|NCT04068610|80141338|FG000|Overall Study|Death|4|||
27531272|NCT04068610|80141339|FG001|Overall Study|Death|8|||
27531273|NCT04068610|80141340|FG002|Overall Study|Death|13|||
27531274|NCT04068610|80141338|FG000|Overall Study|Lost to Follow-up|0|||
27531275|NCT04068610|80141339|FG001|Overall Study|Lost to Follow-up|2|||
27531276|NCT04068610|80141340|FG002|Overall Study|Lost to Follow-up|0|||
27531277|NCT04068610|80141338|FG000|Overall Study|Withdrawal by Subject|0|||
27531278|NCT04068610|80141339|FG001|Overall Study|Withdrawal by Subject|4|||
27531279|NCT04068610|80141340|FG002|Overall Study|Withdrawal by Subject|2|||
27531280|NCT04068610|80141338|FG000|Overall Study|Other|3|||
27531281|NCT04068610|80141339|FG001|Overall Study|Other|12|||
27531282|NCT04068610|80141340|FG002|Overall Study|Other|11|||
27736012|NCT00826748|80860164|FG000|Overall Study|Samples Did Not pass QC|0|||
27736013|NCT00826748|80860165|FG001|Overall Study|Samples Did Not pass QC|0|||
27736014|NCT00826748|80860166|FG002|Overall Study|Samples Did Not pass QC|1|||
27736015|NCT02032524|80860167|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
27736016|NCT02032524|80860168|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
27531283|NCT00116168|80141342|FG000|Overall Study|Lost to Follow-up|6|||
27531284|NCT00116168|80141343|FG001|Overall Study|Lost to Follow-up|5|||
27531285|NCT00116168|80141344|FG002|Overall Study|Lost to Follow-up|0|||
27736017|NCT02032524|80860169|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
27736018|NCT02032524|80860170|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
27531286|NCT00116168|80141345|FG003|Overall Study|Lost to Follow-up|0|||
27736019|NCT02032524|80860171|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
27736020|NCT02032524|80860172|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
27736021|NCT02032524|80860167|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
27736022|NCT02032524|80860168|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
27736023|NCT02032524|80860169|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
27736024|NCT02032524|80860170|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
27736025|NCT02032524|80860171|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
27736026|NCT02032524|80860172|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
27736027|NCT02032524|80860167|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
27736028|NCT02032524|80860168|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
27736029|NCT02032524|80860169|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
27736030|NCT02032524|80860170|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
27736031|NCT02032524|80860171|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
27912448|NCT02326272|81518177|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912449|NCT02326272|81518178|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912450|NCT02326272|81518179|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912451|NCT02326272|81518180|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912452|NCT02326272|81518181|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
27912453|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912454|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912455|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27531287|NCT01484132|80141349|FG000|Overall Study|Lost to Follow-up|8|||
27531288|NCT01484132|80141349|FG000|Overall Study|Difficulty with time commitment|2|||
27531289|NCT01484132|80141349|FG000|Overall Study|Ineligible|1|||
27531290|NCT01484132|80141349|FG000|Overall Study|No pre-treatment urine sample collected|1|||
27531291|NCT01484132|80141349|FG000|Overall Study|No post-treatment urine sample collected|10|||
27531292|NCT02106910|80141350|FG000|Overall Study|Lost to Follow-up|1|||
27531293|NCT02106910|80141351|FG001|Overall Study|Lost to Follow-up|1|||
27531294|NCT01070043|80141353|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
27531295|NCT01070043|80141354|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
27531296|NCT01070043|80141355|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
27531297|NCT01070043|80141353|FG000|Double-Blind Treatment|Adverse Event|0|||
27531298|NCT01070043|80141354|FG001|Double-Blind Treatment|Adverse Event|0|||
27531299|NCT01070043|80141355|FG002|Double-Blind Treatment|Adverse Event|2|||
27531300|NCT03538431|80141359|FG000|Overall Study|Physician Decision|0|||
27531301|NCT03538431|80141360|FG001|Overall Study|Physician Decision|1|||
27531302|NCT03538431|80141359|FG000|Overall Study|Withdrawal by Subject|1|||
27531303|NCT03538431|80141360|FG001|Overall Study|Withdrawal by Subject|0|||
27531304|NCT00292318|80141361|FG000|Overall Study|Study terminated by officials|2|||
27531305|NCT00292318|80141362|FG001|Overall Study|Study terminated by officials|1|||
27531306|NCT00932737|80141365|FG000|Overall Study|Not treated in second episode|1|||
27531307|NCT00932737|80141366|FG001|Overall Study|Not treated in second episode|0|||
27531308|NCT00932737|80141365|FG000|Overall Study|Adverse Event|0|||
27531309|NCT00932737|80141366|FG001|Overall Study|Adverse Event|1|||
27531310|NCT01869725|80141367|FG000|Overall Study|ineligible after registration|1|||
27531311|NCT01869725|80141367|FG000|Overall Study|Death|1|||
27531312|NCT01869725|80141367|FG000|Overall Study|Lost to Follow-up|2|||
27531313|NCT00764491|80141368|FG000|Overall Study|Lost to Follow-up|35|||
27531314|NCT00764491|80141369|FG001|Overall Study|Lost to Follow-up|17|||
27736032|NCT02032524|80860172|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
27736033|NCT02032524|80860167|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
27736034|NCT02032524|80860168|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
27856852|NCT02149108|81310270|FG000|Overall Study|Lost to Follow-up|1|||
27856853|NCT02149108|81310271|FG001|Overall Study|Lost to Follow-up|0|||
27856854|NCT02065700|81310272|FG000|Overall Study|Adverse Event|165|||
27856855|NCT02065700|81310273|FG001|Overall Study|Adverse Event|101|||
27856856|NCT02065700|81310272|FG000|Overall Study|Withdrawal by Subject|90|||
27856857|NCT02065700|81310273|FG001|Overall Study|Withdrawal by Subject|29|||
27856858|NCT02065700|81310272|FG000|Overall Study|Lost to Follow-up|12|||
27856859|NCT02065700|81310273|FG001|Overall Study|Lost to Follow-up|9|||
27856860|NCT02065700|81310272|FG000|Overall Study|Physician Decision|2|||
27856861|NCT02065700|81310273|FG001|Overall Study|Physician Decision|0|||
27856862|NCT02065700|81310272|FG000|Overall Study|Sponsor Request|38|||
27856863|NCT02065700|81310273|FG001|Overall Study|Sponsor Request|15|||
27856864|NCT02065700|81310272|FG000|Overall Study|Treatment Failure|3|||
27856865|NCT02065700|81310273|FG001|Overall Study|Treatment Failure|2|||
27856866|NCT02065700|81310272|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
27856867|NCT02065700|81310273|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
27856868|NCT02065700|81310272|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
27856869|NCT02065700|81310273|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
27531315|NCT00145600|80141370|FG000|Overall Study|Death|1|||
27531316|NCT00145600|80141371|FG001|Overall Study|Death|2|||
27531317|NCT00145600|80141372|FG002|Overall Study|Death|2|||
27531318|NCT00145600|80141373|FG003|Overall Study|Death|6|||
27531319|NCT00145600|80141370|FG000|Overall Study|Ineligible|3|||
27531320|NCT00145600|80141371|FG001|Overall Study|Ineligible|0|||
27531321|NCT00145600|80141372|FG002|Overall Study|Ineligible|1|||
27531322|NCT00145600|80141373|FG003|Overall Study|Ineligible|5|||
27531323|NCT00145600|80141370|FG000|Overall Study|Lost to Follow-up|2|||
27531324|NCT00145600|80141371|FG001|Overall Study|Lost to Follow-up|6|||
27627300|NCT01549652|80476943|FG002|Overall Study|Problem with Infusion|0|||
27627301|NCT01549652|80476944|FG003|Overall Study|Problem with Infusion|0|||
27912456|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912457|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27912458|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
27912459|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
27912460|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
27912461|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
27912462|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912463|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912464|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912465|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912466|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912467|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
27912468|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912469|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912470|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912471|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912472|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912473|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
27912474|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27912475|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912476|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27912477|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
27912478|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912479|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912480|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912481|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912482|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
27912483|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912484|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912485|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912486|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912487|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912488|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
27912489|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912490|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
27627302|NCT01549652|80476941|FG000|Overall Study|Titration Non-Compliance|1|||
27912491|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912492|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912493|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912494|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912495|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912496|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912497|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
27912498|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912499|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912500|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912501|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27912502|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912503|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
27912504|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27627303|NCT01549652|80476942|FG001|Overall Study|Titration Non-Compliance|3|||
27627304|NCT01549652|80476943|FG002|Overall Study|Titration Non-Compliance|4|||
27912505|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27912506|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27627305|NCT01549652|80476944|FG003|Overall Study|Titration Non-Compliance|5|||
27531325|NCT00145600|80141372|FG002|Overall Study|Lost to Follow-up|2|||
27627306|NCT01549652|80476941|FG000|Overall Study|Titration Side Effects|0|||
27627307|NCT01549652|80476942|FG001|Overall Study|Titration Side Effects|0|||
27627308|NCT01549652|80476943|FG002|Overall Study|Titration Side Effects|6|||
27627309|NCT01549652|80476944|FG003|Overall Study|Titration Side Effects|3|||
27627310|NCT01549652|80476941|FG000|Overall Study|Withdrawal by Subject|0|||
27627311|NCT01549652|80476942|FG001|Overall Study|Withdrawal by Subject|0|||
27627312|NCT01549652|80476943|FG002|Overall Study|Withdrawal by Subject|5|||
27627313|NCT01549652|80476944|FG003|Overall Study|Withdrawal by Subject|3|||
27627314|NCT03568162|80476945|FG000|Overall Study|Adverse Event|0|||
27627315|NCT03568162|80476946|FG001|Overall Study|Adverse Event|1|||
27627316|NCT03568162|80476947|FG002|Overall Study|Adverse Event|2|||
27627317|NCT03568162|80476948|FG003|Overall Study|Adverse Event|0|||
27627318|NCT03568162|80476949|FG004|Overall Study|Adverse Event|0|||
27627319|NCT03568162|80476950|FG005|Overall Study|Adverse Event|1|||
27627320|NCT03568162|80476945|FG000|Overall Study|Death|0|||
27627321|NCT03568162|80476946|FG001|Overall Study|Death|0|||
27531326|NCT00145600|80141373|FG003|Overall Study|Lost to Follow-up|4|||
27531327|NCT00145600|80141370|FG000|Overall Study|Noncompliance|1|||
27627322|NCT03568162|80476947|FG002|Overall Study|Death|0|||
27627323|NCT03568162|80476948|FG003|Overall Study|Death|0|||
27627324|NCT03568162|80476949|FG004|Overall Study|Death|1|||
27627325|NCT03568162|80476950|FG005|Overall Study|Death|0|||
27627326|NCT03568162|80476945|FG000|Overall Study|Lost to Follow-up|3|||
27627327|NCT03568162|80476946|FG001|Overall Study|Lost to Follow-up|2|||
27627328|NCT03568162|80476947|FG002|Overall Study|Lost to Follow-up|4|||
27627329|NCT03568162|80476948|FG003|Overall Study|Lost to Follow-up|2|||
27627330|NCT03568162|80476949|FG004|Overall Study|Lost to Follow-up|3|||
27627331|NCT03568162|80476950|FG005|Overall Study|Lost to Follow-up|2|||
27627332|NCT03568162|80476945|FG000|Overall Study|Physician Decision|0|||
27627333|NCT03568162|80476946|FG001|Overall Study|Physician Decision|1|||
27627334|NCT03568162|80476947|FG002|Overall Study|Physician Decision|1|||
27627335|NCT03568162|80476948|FG003|Overall Study|Physician Decision|0|||
27627336|NCT03568162|80476949|FG004|Overall Study|Physician Decision|1|||
27627337|NCT03568162|80476950|FG005|Overall Study|Physician Decision|0|||
27627338|NCT03568162|80476945|FG000|Overall Study|Pregnancy|0|||
27627339|NCT03568162|80476946|FG001|Overall Study|Pregnancy|0|||
27627340|NCT03568162|80476947|FG002|Overall Study|Pregnancy|0|||
27736035|NCT02032524|80860169|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
27856870|NCT02065700|81310272|FG000|Overall Study|Non-compliance with Study Procedures|2|||
27531328|NCT00145600|80141371|FG001|Overall Study|Noncompliance|0|||
27531329|NCT00145600|80141372|FG002|Overall Study|Noncompliance|0|||
27531330|NCT00145600|80141373|FG003|Overall Study|Noncompliance|0|||
27531331|NCT00145600|80141370|FG000|Overall Study|Withdrawal by Subject|1|||
27531332|NCT00145600|80141371|FG001|Overall Study|Withdrawal by Subject|2|||
27531333|NCT00145600|80141372|FG002|Overall Study|Withdrawal by Subject|0|||
27531334|NCT00145600|80141373|FG003|Overall Study|Withdrawal by Subject|1|||
27531335|NCT01083173|80141374|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
27531336|NCT01083173|80141375|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
27531337|NCT01083173|80141374|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
27531338|NCT01083173|80141375|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
27531339|NCT01083173|80141374|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
27627341|NCT03568162|80476948|FG003|Overall Study|Pregnancy|1|||
27627342|NCT03568162|80476949|FG004|Overall Study|Pregnancy|0|||
27627343|NCT03568162|80476950|FG005|Overall Study|Pregnancy|0|||
27627344|NCT03568162|80476945|FG000|Overall Study|Protocol Violation|1|||
27627345|NCT03568162|80476946|FG001|Overall Study|Protocol Violation|0|||
27627346|NCT03568162|80476947|FG002|Overall Study|Protocol Violation|1|||
27627347|NCT03568162|80476948|FG003|Overall Study|Protocol Violation|1|||
27627348|NCT03568162|80476949|FG004|Overall Study|Protocol Violation|1|||
27627349|NCT03568162|80476950|FG005|Overall Study|Protocol Violation|1|||
27627350|NCT03568162|80476945|FG000|Overall Study|Withdrawal by Subject|15|||
27627351|NCT03568162|80476946|FG001|Overall Study|Withdrawal by Subject|15|||
27627352|NCT03568162|80476947|FG002|Overall Study|Withdrawal by Subject|26|||
27627353|NCT03568162|80476948|FG003|Overall Study|Withdrawal by Subject|22|||
27856871|NCT02065700|81310273|FG001|Overall Study|Non-compliance with Study Procedures|0|||
27856872|NCT02065700|81310272|FG000|Overall Study|Not Defined|21|||
27856873|NCT02065700|81310273|FG001|Overall Study|Not Defined|3|||
27856874|NCT00977379|81310274|FG000|Overall Study|Withdrawal by Subject|1|||
27856875|NCT00977379|81310275|FG001|Overall Study|Withdrawal by Subject|1|||
27856876|NCT00977379|81310274|FG000|Overall Study|Death|7|||
27856877|NCT00977379|81310275|FG001|Overall Study|Death|9|||
27856878|NCT00977379|81310274|FG000|Overall Study|Premature Study Termination|4|||
27627354|NCT03568162|80476949|FG004|Overall Study|Withdrawal by Subject|6|||
27627355|NCT03568162|80476950|FG005|Overall Study|Withdrawal by Subject|9|||
27627356|NCT03568162|80476945|FG000|Overall Study|Others|3|||
27627357|NCT03568162|80476946|FG001|Overall Study|Others|4|||
27627358|NCT03568162|80476947|FG002|Overall Study|Others|1|||
27856879|NCT00977379|81310275|FG001|Overall Study|Premature Study Termination|0|||
27856880|NCT00977379|81310274|FG000|Overall Study|Participant Moving House|0|||
27627359|NCT03568162|80476948|FG003|Overall Study|Others|4|||
27627360|NCT03568162|80476949|FG004|Overall Study|Others|2|||
27627361|NCT03568162|80476950|FG005|Overall Study|Others|1|||
27627362|NCT00465985|80476951|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
27627363|NCT00465985|80476952|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
27627364|NCT00465985|80476951|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
27627365|NCT00465985|80476952|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
27531340|NCT01083173|80141375|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
27531341|NCT01083173|80141374|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
27531342|NCT01083173|80141375|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
27531343|NCT01083173|80141374|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
27531344|NCT01083173|80141375|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
27531345|NCT01083173|80141374|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
27531346|NCT01083173|80141375|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
27531347|NCT01083173|80141374|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
27531348|NCT01083173|80141375|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
27531349|NCT01083173|80141374|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
27531350|NCT01083173|80141375|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
27531351|NCT01083173|80141374|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
27531352|NCT01083173|80141375|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
27531353|NCT01083173|80141374|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
27531354|NCT01083173|80141375|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
27531355|NCT01083173|80141374|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
27531356|NCT01083173|80141375|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
27627366|NCT00465985|80476951|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
27627367|NCT00465985|80476952|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
27627368|NCT00465985|80476951|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
27627369|NCT00465985|80476952|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
27627370|NCT01839877|80476954|FG000|Overall Study|Protocol Violation|1|||
27627371|NCT03538054|80476955|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
27627372|NCT03538054|80476955|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
27627373|NCT03538054|80476955|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
27627374|NCT03635567|80476956|FG000|Overall Study|Lost to Follow-up|0|||
27627375|NCT03635567|80476957|FG001|Overall Study|Lost to Follow-up|2|||
27627376|NCT03635567|80476956|FG000|Overall Study|Withdrawal by Subject|9|||
27627377|NCT03635567|80476957|FG001|Overall Study|Withdrawal by Subject|10|||
27627378|NCT03635567|80476956|FG000|Overall Study|Ongoing in Study|125|||
27627379|NCT03635567|80476957|FG001|Overall Study|Ongoing in Study|76|||
27627380|NCT03635567|80476956|FG000|Overall Study|Death|174|||
27856881|NCT00977379|81310275|FG001|Overall Study|Participant Moving House|1|||
27856882|NCT00977379|81310274|FG000|Overall Study|Randomization Error|0|||
27856883|NCT00977379|81310275|FG001|Overall Study|Randomization Error|1|||
27856884|NCT03768726|81310279|FG000|Treatment Phase|Adverse Event|2|||
27856885|NCT03768726|81310280|FG001|Treatment Phase|Adverse Event|2|||
27856886|NCT03768726|81310279|FG000|Treatment Phase|Lost to Follow-up|1|||
27856887|NCT03768726|81310280|FG001|Treatment Phase|Lost to Follow-up|0|||
27856888|NCT03768726|81310279|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
27856889|NCT03768726|81310280|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
27856890|NCT03768726|81310279|FG000|Treatment Phase|Withdrawal by Subject|3|||
27856891|NCT03768726|81310280|FG001|Treatment Phase|Withdrawal by Subject|1|||
27856892|NCT03768726|81310279|FG000|Follow-Up|Adverse Event|2|||
27856893|NCT03768726|81310280|FG001|Follow-Up|Adverse Event|2|||
27856894|NCT03768726|81310279|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
27856895|NCT03768726|81310280|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
27856896|NCT03768726|81310279|FG000|Follow-Up|Withdrawal by Subject|2|||
27856897|NCT03768726|81310280|FG001|Follow-Up|Withdrawal by Subject|0|||
27856898|NCT03768726|81310279|FG000|Follow-Up|Other|1|||
27856899|NCT03768726|81310280|FG001|Follow-Up|Other|0|||
27856900|NCT00587990|81310281|FG000|Overall Study|Death|0|||
27856901|NCT00587990|81310282|FG001|Overall Study|Death|0|||
27856902|NCT00587990|81310283|FG002|Overall Study|Death|1|||
27856903|NCT00988442|81310284|FG000|Overall Study|Death|1|||
27856904|NCT00988442|81310285|FG001|Overall Study|Death|2|||
27856905|NCT00988442|81310284|FG000|Overall Study|Lost to Follow-up|0|||
27856906|NCT00988442|81310285|FG001|Overall Study|Lost to Follow-up|1|||
27627381|NCT03635567|80476957|FG001|Overall Study|Death|221|||
27856907|NCT00988442|81310284|FG000|Overall Study|Early Study Closure|29|||
27856908|NCT00988442|81310285|FG001|Overall Study|Early Study Closure|25|||
27856909|NCT03402750|81310286|FG000|Overall Study|Lost to Follow-up|2|||
27856910|NCT03402750|81310287|FG001|Overall Study|Lost to Follow-up|1|||
27856911|NCT01032018|81310288|FG000|Overall Study|Lost to Follow-up|6|||
27627382|NCT02857283|80476958|FG000|First Exposure|Withdrawal by Subject|1|||
27627383|NCT02857283|80476959|FG001|First Exposure|Withdrawal by Subject|0|||
27627384|NCT04084769|80476960|FG000|Overall Study|Protocol Violation|1|||
27627385|NCT04084769|80476961|FG001|Overall Study|Protocol Violation|3|||
27627386|NCT04084769|80476962|FG002|Overall Study|Protocol Violation|0|||
27627387|NCT04084769|80476963|FG003|Overall Study|Protocol Violation|1|||
27627388|NCT04084769|80476960|FG000|Overall Study|Withdrawal by Subject|0|||
27736036|NCT02032524|80860170|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
27736037|NCT02032524|80860171|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
27736038|NCT02032524|80860172|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
27736039|NCT02032524|80860167|FG000|Period 2: LTS13769 Study|Other|0|||
27736040|NCT02032524|80860168|FG001|Period 2: LTS13769 Study|Other|0|||
27736041|NCT02032524|80860169|FG002|Period 2: LTS13769 Study|Other|0|||
27736042|NCT02032524|80860170|FG003|Period 2: LTS13769 Study|Other|0|||
27736043|NCT02032524|80860171|FG004|Period 2: LTS13769 Study|Other|0|||
27736044|NCT02032524|80860172|FG005|Period 2: LTS13769 Study|Other|1|||
27736045|NCT03293680|80860173|FG000|Overall Study|Death|1|||
27736046|NCT03293680|80860173|FG000|Overall Study|Did not meet inclusion criteria|8|||
27736047|NCT03301857|80860177|FG000|Overall Study|Death|0|||
27736048|NCT03301857|80860178|FG001|Overall Study|Death|2|||
27736049|NCT03301857|80860177|FG000|Overall Study|Lost to Follow-up|4|||
27736050|NCT03301857|80860178|FG001|Overall Study|Lost to Follow-up|2|||
27736051|NCT03301857|80860177|FG000|Overall Study|Decision by Sponsor|6|||
27736052|NCT03301857|80860178|FG001|Overall Study|Decision by Sponsor|0|||
27912507|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
27912508|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912509|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912510|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912511|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27912512|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
27627389|NCT04084769|80476961|FG001|Overall Study|Withdrawal by Subject|1|||
27627390|NCT04084769|80476962|FG002|Overall Study|Withdrawal by Subject|0|||
27627391|NCT04084769|80476963|FG003|Overall Study|Withdrawal by Subject|0|||
27531357|NCT01614600|80141376|FG000|Overall Study|Unacceptable fit|1|||
27531358|NCT01614600|80141376|FG000|Overall Study|Discomfort|1|||
27531359|NCT01614600|80141376|FG000|Overall Study|Unable to remove lens at the end of day|1|||
27531360|NCT01614600|80141376|FG000|Overall Study|Protocol deviation|1|||
27531361|NCT01555983|80141377|FG000|Overall Study|Withdrawal by Subject|1|||
27531362|NCT01555983|80141378|FG001|Overall Study|Withdrawal by Subject|0|||
27531363|NCT01555983|80141379|FG002|Overall Study|Withdrawal by Subject|0|||
27531364|NCT01555983|80141380|FG003|Overall Study|Withdrawal by Subject|0|||
27531365|NCT01555983|80141381|FG004|Overall Study|Withdrawal by Subject|1|||
27531366|NCT01555983|80141382|FG005|Overall Study|Withdrawal by Subject|1|||
27531367|NCT00761579|80141383|FG000|Overall Study|Adverse Event|10|||
27531368|NCT00761579|80141383|FG000|Overall Study|Death|2|||
27531369|NCT00761579|80141383|FG000|Overall Study|Lack of Efficacy|21|||
27531370|NCT00761579|80141383|FG000|Overall Study|Lost to Follow-up|16|||
27531371|NCT00761579|80141383|FG000|Overall Study|Pregnancy|1|||
27531372|NCT00761579|80141383|FG000|Overall Study|Withdrawal by Subject|34|||
27531373|NCT00761579|80141383|FG000|Overall Study|Lack of compliance|2|||
27531374|NCT00761579|80141383|FG000|Overall Study|Protocol deviation|1|||
27531375|NCT00761579|80141383|FG000|Overall Study|Drug overdose|1|||
27531376|NCT00761579|80141383|FG000|Overall Study|Aggravation of depression|1|||
27531377|NCT00761579|80141383|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
27531378|NCT00761579|80141383|FG000|Overall Study|Lost survey form|1|||
27531379|NCT00761579|80141383|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
27531380|NCT04502979|80141384|FG000|Overall Study|Lost to Follow-up|1|||
27531381|NCT04502979|80141385|FG001|Overall Study|Lost to Follow-up|3|||
27531382|NCT04502979|80141384|FG000|Overall Study|Withdrawal by Subject|2|||
27531383|NCT04502979|80141385|FG001|Overall Study|Withdrawal by Subject|1|||
27531384|NCT02203071|80141386|FG000|Overall Study|Lost to Follow-up|3|||
27531385|NCT02203071|80141387|FG001|Overall Study|Lost to Follow-up|1|||
27531386|NCT00287079|80141388|FG000|Overall Study|Qualifying relapse|12|||
27531387|NCT00287079|80141389|FG001|Overall Study|Qualifying relapse|1|||
27627392|NCT04084769|80476960|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27627393|NCT04084769|80476961|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27736053|NCT03301857|80860177|FG000|Overall Study|Withdrawal by Subject|12|||
27736054|NCT03301857|80860178|FG001|Overall Study|Withdrawal by Subject|4|||
27736055|NCT03040024|80860179|FG000|Overall Study|Adverse Event|0|||
27736056|NCT03040024|80860180|FG001|Overall Study|Adverse Event|1|||
27531388|NCT00287079|80141388|FG000|Overall Study|Non-qualifying relapse|1|||
27736057|NCT03040024|80860181|FG002|Overall Study|Adverse Event|0|||
27736058|NCT03040024|80860179|FG000|Overall Study|Death|0|||
27531389|NCT00287079|80141389|FG001|Overall Study|Non-qualifying relapse|0|||
27531390|NCT00287079|80141388|FG000|Overall Study|Adverse Event|5|||
27627394|NCT04084769|80476962|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27627395|NCT04084769|80476963|FG003|Overall Study|Withdrawal by parent/guardian|1|||
27627396|NCT04084769|80476960|FG000|Overall Study|Lost to Follow-up|2|||
27627397|NCT04084769|80476961|FG001|Overall Study|Lost to Follow-up|0|||
27627398|NCT04084769|80476962|FG002|Overall Study|Lost to Follow-up|0|||
27627399|NCT04084769|80476963|FG003|Overall Study|Lost to Follow-up|0|||
27627400|NCT00906282|80476965|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
27627401|NCT00906282|80476965|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
27627402|NCT00906282|80476965|FG000|Preoperative Chemotherapy|Progressive disease|6|||
27627403|NCT00906282|80476965|FG000|Preoperative Chemotherapy|Toxicity|1|||
27627404|NCT00425503|80476966|FG000|Overall Study|Adverse Event|2|||
27627405|NCT00425503|80476966|FG000|Overall Study|Protocol Violation|1|||
27627406|NCT00712166|80476969|FG000|Overall Study|Noncompliance|0|||
27627407|NCT00712166|80476970|FG001|Overall Study|Noncompliance|1|||
27627408|NCT01720446|80476974|FG000|Overall Study|Lost to Follow-up|12|||
27627409|NCT01720446|80476975|FG001|Overall Study|Lost to Follow-up|6|||
27627410|NCT01720446|80476976|FG002|Overall Study|Lost to Follow-up|16|||
27627411|NCT01720446|80476977|FG003|Overall Study|Lost to Follow-up|16|||
27627412|NCT01720446|80476974|FG000|Overall Study|Withdrawal by Subject|2|||
27627413|NCT01720446|80476975|FG001|Overall Study|Withdrawal by Subject|5|||
27627414|NCT01720446|80476976|FG002|Overall Study|Withdrawal by Subject|4|||
27627415|NCT01720446|80476977|FG003|Overall Study|Withdrawal by Subject|4|||
27627416|NCT00613301|80476980|FG000|Overall Study|Adverse Event|49|||
27627417|NCT00613301|80476980|FG000|Overall Study|Lost to Follow-up|88|||
27627418|NCT00613301|80476980|FG000|Overall Study|Withdrawal by Subject|5|||
27627419|NCT00613301|80476980|FG000|Overall Study|Death|6|||
27627420|NCT00613301|80476980|FG000|Overall Study|Lack of Efficacy|13|||
27627421|NCT00613301|80476980|FG000|Overall Study|Physician Decision|2|||
27627422|NCT00613301|80476980|FG000|Overall Study|No data was collected|53|||
27627423|NCT00613301|80476980|FG000|Overall Study|Irregularly enrolled patients|12|||
27627424|NCT03213678|80476981|FG000|Overall Study|Death|1|||
27627425|NCT03213678|80476981|FG000|Overall Study|Physician Decision|1|||
27627426|NCT03213678|80476981|FG000|Overall Study|Progressive disease|16|||
27627427|NCT01516892|80476982|FG000|Overall Study|Adverse Event|25|||
27627428|NCT01516892|80476982|FG000|Overall Study|Lack of Efficacy|35|||
27627429|NCT01516892|80476982|FG000|Overall Study|Pregnancy|5|||
27627430|NCT01516892|80476982|FG000|Overall Study|Lost to Follow-up|82|||
27627431|NCT01516892|80476982|FG000|Overall Study|Subject Withdrew Consent|92|||
27627432|NCT01516892|80476982|FG000|Overall Study|Protocol Violation|60|||
27627433|NCT01516892|80476982|FG000|Overall Study|Other Miscellaneous Reasons|43|||
27627434|NCT01516892|80476982|FG000|Overall Study|Missing|1|||
27627435|NCT01670019|80476983|FG000|Overall Study|Adverse Event|3|||
27627436|NCT01670019|80476984|FG001|Overall Study|Adverse Event|0|||
27627437|NCT01670019|80476983|FG000|Overall Study|Withdrawal by Subject|6|||
27627438|NCT01670019|80476984|FG001|Overall Study|Withdrawal by Subject|0|||
27627439|NCT02750709|80476985|FG000|Treatment Period 1|Adverse Event|0|||
27627440|NCT02750709|80476986|FG001|Treatment Period 1|Adverse Event|0|||
27627441|NCT02750709|80476987|FG002|Treatment Period 1|Adverse Event|0|||
27627442|NCT02750709|80476988|FG003|Treatment Period 1|Adverse Event|0|||
27627443|NCT02750709|80476989|FG004|Treatment Period 1|Adverse Event|0|||
27627444|NCT02750709|80476990|FG005|Treatment Period 1|Adverse Event|1|||
27627445|NCT01090024|80476995|FG000|Period 1|Met exclusion criteria|0|||
27627446|NCT01090024|80476996|FG001|Period 1|Met exclusion criteria|0|||
27627447|NCT01090024|80476997|FG002|Period 1|Met exclusion criteria|0|||
27736059|NCT03040024|80860180|FG001|Overall Study|Death|1|||
27736060|NCT03040024|80860181|FG002|Overall Study|Death|0|||
27736061|NCT03040024|80860179|FG000|Overall Study|Physician Decision|0|||
27736062|NCT03040024|80860180|FG001|Overall Study|Physician Decision|0|||
27736063|NCT03040024|80860181|FG002|Overall Study|Physician Decision|1|||
27736064|NCT05593432|80860182|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
27736065|NCT05593432|80860183|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
27736066|NCT05593432|80860184|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
27736067|NCT05593432|80860185|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
27736068|NCT05593432|80860182|FG000|16-Week OLE Period|Lack of Efficacy|0|||
27736069|NCT05593432|80860183|FG001|16-Week OLE Period|Lack of Efficacy|0|||
27736070|NCT05593432|80860184|FG002|16-Week OLE Period|Lack of Efficacy|0|||
27958647|NCT01791517|81680059|FG001|Phase II|Pre-Existing Ocular Issue|0|||
27627448|NCT01090024|80476998|FG003|Period 1|Met exclusion criteria|0|||
27627449|NCT01090024|80476999|FG004|Period 1|Met exclusion criteria|0|||
27736071|NCT05593432|80860185|FG003|16-Week OLE Period|Lack of Efficacy|1|||
27736072|NCT05593432|80860182|FG000|16-Week OLE Period|Lost to Follow-up|0|||
27736073|NCT05593432|80860183|FG001|16-Week OLE Period|Lost to Follow-up|0|||
27627450|NCT01090024|80477000|FG005|Period 1|Met exclusion criteria|0|||
27627451|NCT01090024|80477001|FG006|Period 1|Met exclusion criteria|0|||
27627452|NCT01090024|80477002|FG007|Period 1|Met exclusion criteria|0|||
27627453|NCT01090024|80477003|FG008|Period 1|Met exclusion criteria|0|||
27627454|NCT01090024|80477004|FG009|Period 1|Met exclusion criteria|0|||
27627455|NCT01090024|80477005|FG010|Period 1|Met exclusion criteria|0|||
27627456|NCT01090024|80477006|FG011|Period 1|Met exclusion criteria|0|||
27736074|NCT05593432|80860184|FG002|16-Week OLE Period|Lost to Follow-up|1|||
27736075|NCT05593432|80860185|FG003|16-Week OLE Period|Lost to Follow-up|2|||
27736076|NCT05593432|80860182|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
27736077|NCT05593432|80860183|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
27736078|NCT05593432|80860184|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
27736079|NCT05593432|80860185|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
27736080|NCT02725788|80860186|FG000|Overall Study|Lost to Follow-up|1|||
27736081|NCT02725788|80860187|FG001|Overall Study|Lost to Follow-up|1|||
27736082|NCT02725788|80860186|FG000|Overall Study|Protocol Violation|0|||
27736083|NCT02725788|80860187|FG001|Overall Study|Protocol Violation|1|||
27736084|NCT02031679|80860190|FG000|Overall Study|Protocol Violation|0|||
27736085|NCT02031679|80860191|FG001|Overall Study|Protocol Violation|1|||
27736086|NCT02031679|80860190|FG000|Overall Study|Lack of Efficacy|0|||
27736087|NCT02031679|80860191|FG001|Overall Study|Lack of Efficacy|1|||
27736088|NCT00963807|80860192|FG000|Overall Study|Physician Decision|2|||
27736089|NCT00963807|80860192|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
27736090|NCT00963807|80860192|FG000|Overall Study|Disease progression|15|||
27736091|NCT03212261|80860193|FG000|Overall Study|Became ineligible d/t tech|2|||
27736092|NCT03212261|80860193|FG000|Overall Study|Tech Trouble- No first study visit|1|||
27736093|NCT03212261|80860193|FG000|Overall Study|Lost to Follow-up|7|||
27736094|NCT03212261|80860193|FG000|Overall Study|Family Emergency|1|||
27736095|NCT03212261|80860193|FG000|Overall Study|Too busy/ No time|5|||
27736096|NCT03263806|80860197|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
27736097|NCT03263806|80860198|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
27736098|NCT03263806|80860197|FG000|Overall Study|Withdrawal by Subject|0|||
27736099|NCT03263806|80860198|FG001|Overall Study|Withdrawal by Subject|1|||
27736100|NCT03263806|80860197|FG000|Overall Study|Study Termination|5|||
27736101|NCT03263806|80860198|FG001|Overall Study|Study Termination|6|||
27736102|NCT01009294|80860202|FG000|Overall Study|Study discontinued by Sponsor|6|||
27736103|NCT05817045|80860203|FG000|Overall Study|Protocol Violation|0|||
27736104|NCT05817045|80860204|FG001|Overall Study|Protocol Violation|3|||
27736105|NCT05817045|80860203|FG000|Overall Study|Withdrawal by Subject|10|||
27736106|NCT05817045|80860204|FG001|Overall Study|Withdrawal by Subject|7|||
27736107|NCT05817045|80860203|FG000|Overall Study|Physician Decision|3|||
27736108|NCT05817045|80860204|FG001|Overall Study|Physician Decision|0|||
27736109|NCT05817045|80860203|FG000|Overall Study|Lost to Follow-up|0|||
27736110|NCT05817045|80860204|FG001|Overall Study|Lost to Follow-up|1|||
27736111|NCT05817045|80860203|FG000|Overall Study|Device Deficiency|1|||
27736112|NCT05817045|80860204|FG001|Overall Study|Device Deficiency|0|||
27736113|NCT05817045|80860203|FG000|Overall Study|System Error|1|||
27736114|NCT05817045|80860204|FG001|Overall Study|System Error|0|||
27736115|NCT01739595|80860206|FG000|Overall Study|Adverse Event|3|||
27736116|NCT01739595|80860207|FG001|Overall Study|Adverse Event|0|||
27736117|NCT01739595|80860208|FG002|Overall Study|Adverse Event|0|||
27736118|NCT01739595|80860206|FG000|Overall Study|Lost to Follow-up|2|||
27736119|NCT01739595|80860207|FG001|Overall Study|Lost to Follow-up|0|||
27736120|NCT01739595|80860208|FG002|Overall Study|Lost to Follow-up|0|||
27736121|NCT01739595|80860206|FG000|Overall Study|Withdrawal by Subject|2|||
27736122|NCT01739595|80860207|FG001|Overall Study|Withdrawal by Subject|1|||
27736123|NCT01739595|80860208|FG002|Overall Study|Withdrawal by Subject|2|||
27736124|NCT01739595|80860206|FG000|Overall Study|Eligibility issue|3|||
27736125|NCT01739595|80860207|FG001|Overall Study|Eligibility issue|0|||
27736126|NCT01739595|80860208|FG002|Overall Study|Eligibility issue|0|||
27736127|NCT01739595|80860206|FG000|Overall Study|Protocol Violation|1|||
27736128|NCT01739595|80860207|FG001|Overall Study|Protocol Violation|0|||
27736129|NCT01739595|80860208|FG002|Overall Study|Protocol Violation|0|||
27736130|NCT01739595|80860206|FG000|Overall Study|Lab assessment|1|||
27736131|NCT01739595|80860207|FG001|Overall Study|Lab assessment|0|||
27736132|NCT01739595|80860208|FG002|Overall Study|Lab assessment|0|||
27736133|NCT01739595|80860206|FG000|Overall Study|Drug discrepancy|1|||
27736134|NCT01739595|80860207|FG001|Overall Study|Drug discrepancy|0|||
27736135|NCT01739595|80860208|FG002|Overall Study|Drug discrepancy|0|||
27736136|NCT00278629|80860209|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
27736137|NCT02224664|80860214|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
27736138|NCT02224664|80860215|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27736139|NCT02224664|80860216|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27736140|NCT02224664|80860217|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27736141|NCT02224664|80860218|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
27736142|NCT02224664|80860214|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
27736143|NCT02224664|80860215|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
27736144|NCT02224664|80860216|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
27736145|NCT02224664|80860217|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
27736146|NCT02224664|80860218|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
27736147|NCT02224664|80860214|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
27736148|NCT02224664|80860215|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
27736149|NCT02224664|80860216|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
27736150|NCT02224664|80860217|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
27736151|NCT02224664|80860218|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
27736152|NCT00509106|80860219|FG000|Overall Study|Adverse Event|3|||
27736153|NCT00509106|80860220|FG001|Overall Study|Adverse Event|2|||
27736154|NCT00509106|80860219|FG000|Overall Study|Noncompliance|0|||
27736155|NCT00509106|80860220|FG001|Overall Study|Noncompliance|1|||
27736156|NCT00509106|80860219|FG000|Overall Study|At the request of sponsor/investigator|1|||
27736157|NCT00509106|80860220|FG001|Overall Study|At the request of sponsor/investigator|2|||
27736158|NCT00509106|80860219|FG000|Overall Study|Withdrew consent|4|||
27736159|NCT00509106|80860220|FG001|Overall Study|Withdrew consent|8|||
27736160|NCT00509106|80860219|FG000|Overall Study|Lost to Follow-up|16|||
27736161|NCT00509106|80860220|FG001|Overall Study|Lost to Follow-up|10|||
27736162|NCT00509106|80860219|FG000|Overall Study|Other|1|||
27736163|NCT00509106|80860220|FG001|Overall Study|Other|0|||
27736164|NCT00509106|80860219|FG000|Overall Study|Death|6|||
27736165|NCT00509106|80860220|FG001|Overall Study|Death|6|||
27736166|NCT02886715|80860221|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27736167|NCT02886715|80860222|FG001|Overall Study|Non-Compliance With Study Drug|2|||
27736168|NCT02886715|80860223|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27736169|NCT02886715|80860221|FG000|Overall Study|Adverse Event|4|||
27736170|NCT02886715|80860222|FG001|Overall Study|Adverse Event|2|||
27736171|NCT02886715|80860223|FG002|Overall Study|Adverse Event|0|||
27736172|NCT02886715|80860221|FG000|Overall Study|Lack of Efficacy|0|||
27736173|NCT02886715|80860222|FG001|Overall Study|Lack of Efficacy|2|||
27736174|NCT02886715|80860223|FG002|Overall Study|Lack of Efficacy|1|||
27736175|NCT02886715|80860221|FG000|Overall Study|Lost to Follow-up|29|||
27736176|NCT02886715|80860222|FG001|Overall Study|Lost to Follow-up|26|||
27736177|NCT02886715|80860223|FG002|Overall Study|Lost to Follow-up|10|||
27736178|NCT02886715|80860221|FG000|Overall Study|Pregnancy|1|||
27736179|NCT02886715|80860222|FG001|Overall Study|Pregnancy|1|||
27736180|NCT02886715|80860223|FG002|Overall Study|Pregnancy|1|||
27736181|NCT02886715|80860221|FG000|Overall Study|Protocol Violation|3|||
27736182|NCT02886715|80860222|FG001|Overall Study|Protocol Violation|2|||
27736183|NCT02886715|80860223|FG002|Overall Study|Protocol Violation|1|||
27736184|NCT02886715|80860221|FG000|Overall Study|Withdrawal by Subject|20|||
27736185|NCT02886715|80860222|FG001|Overall Study|Withdrawal by Subject|18|||
27736186|NCT02886715|80860223|FG002|Overall Study|Withdrawal by Subject|5|||
27736187|NCT02886715|80860221|FG000|Overall Study|missing|7|||
27736188|NCT02886715|80860222|FG001|Overall Study|missing|2|||
27736189|NCT02886715|80860223|FG002|Overall Study|missing|2|||
27736190|NCT00742781|80864706|FG000|Overall Study|Withdrawal by Subject|3|||
27736191|NCT00327444|80864708|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
27736192|NCT00327444|80864709|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
27736193|NCT00327444|80864708|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
27736194|NCT00327444|80864709|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
27736195|NCT00327444|80864708|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
27736196|NCT00327444|80864709|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
27736197|NCT00327444|80864708|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
27736198|NCT00327444|80864709|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
27736199|NCT00327444|80864708|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
27736200|NCT00327444|80864709|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
27736201|NCT00327444|80864708|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
27736202|NCT00327444|80864709|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
27736203|NCT00327444|80864708|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
27736204|NCT00327444|80864709|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
27736205|NCT00327444|80864708|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
27736206|NCT00327444|80864709|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
27736207|NCT04246047|80864710|FG000|Overall Study|Death|50|||
27736208|NCT04246047|80864711|FG001|Overall Study|Death|77|||
27736209|NCT04246047|80864710|FG000|Overall Study|Lost to Follow-up|1|||
27736210|NCT04246047|80864711|FG001|Overall Study|Lost to Follow-up|3|||
27736211|NCT04246047|80864710|FG000|Overall Study|Physician Decision|4|||
27736212|NCT04246047|80864711|FG001|Overall Study|Physician Decision|10|||
27736213|NCT04246047|80864710|FG000|Overall Study|Withdrawal by Subject|19|||
27736214|NCT04246047|80864711|FG001|Overall Study|Withdrawal by Subject|26|||
27736215|NCT04246047|80864710|FG000|Overall Study|Ongoing|169|||
27736216|NCT04246047|80864711|FG001|Overall Study|Ongoing|135|||
27736217|NCT00049127|80864715|FG000|Overall Study|Withdrawal by Subject|0|||
27736218|NCT00049127|80864716|FG001|Overall Study|Withdrawal by Subject|0|||
27736219|NCT00049127|80864717|FG002|Overall Study|Withdrawal by Subject|1|||
27958648|NCT01791517|81680060|FG002|Phase II|Pre-Existing Ocular Issue|0|||
27736220|NCT00049127|80864718|FG003|Overall Study|Withdrawal by Subject|0|||
27736221|NCT00049127|80864719|FG004|Overall Study|Withdrawal by Subject|0|||
27736222|NCT02732951|80864720|FG000|Overall Study|Other than listed|1|||
27736223|NCT02732951|80864721|FG001|Overall Study|Other than listed|0|||
27736224|NCT02732951|80864720|FG000|Overall Study|Lost to Follow-up|0|||
27736225|NCT02732951|80864721|FG001|Overall Study|Lost to Follow-up|1|||
27736226|NCT02732951|80864720|FG000|Overall Study|Adverse Event|4|||
27736227|NCT02732951|80864721|FG001|Overall Study|Adverse Event|4|||
27736228|NCT02732951|80864720|FG000|Overall Study|Protocol Violation|0|||
27736229|NCT02732951|80864721|FG001|Overall Study|Protocol Violation|1|||
27736230|NCT00805207|80864722|FG000|Overall Study|Protocol Violation|0|||
27736231|NCT00805207|80864723|FG001|Overall Study|Protocol Violation|0|||
27736232|NCT00805207|80864724|FG002|Overall Study|Protocol Violation|1|||
27736233|NCT00805207|80864725|FG003|Overall Study|Protocol Violation|0|||
27736234|NCT00805207|80864726|FG004|Overall Study|Protocol Violation|0|||
27736235|NCT00805207|80864727|FG005|Overall Study|Protocol Violation|0|||
27736236|NCT00805207|80864728|FG006|Overall Study|Protocol Violation|0|||
27736237|NCT00805207|80864729|FG007|Overall Study|Protocol Violation|0|||
27736238|NCT00805207|80864730|FG008|Overall Study|Protocol Violation|0|||
27736239|NCT00805207|80864722|FG000|Overall Study|Physician Decision|0|||
27736240|NCT00805207|80864723|FG001|Overall Study|Physician Decision|1|||
27736241|NCT00805207|80864724|FG002|Overall Study|Physician Decision|0|||
27736242|NCT00805207|80864725|FG003|Overall Study|Physician Decision|0|||
27736243|NCT00805207|80864726|FG004|Overall Study|Physician Decision|0|||
27736244|NCT00805207|80864727|FG005|Overall Study|Physician Decision|1|||
27736245|NCT00805207|80864728|FG006|Overall Study|Physician Decision|0|||
27736246|NCT00805207|80864729|FG007|Overall Study|Physician Decision|0|||
27736247|NCT00805207|80864730|FG008|Overall Study|Physician Decision|0|||
27736248|NCT00805207|80864722|FG000|Overall Study|Withdrawal by Subject|0|||
27736249|NCT00805207|80864723|FG001|Overall Study|Withdrawal by Subject|1|||
27736250|NCT00805207|80864724|FG002|Overall Study|Withdrawal by Subject|0|||
27736251|NCT00805207|80864725|FG003|Overall Study|Withdrawal by Subject|0|||
27736252|NCT00805207|80864726|FG004|Overall Study|Withdrawal by Subject|1|||
27736253|NCT00805207|80864727|FG005|Overall Study|Withdrawal by Subject|2|||
27736254|NCT00805207|80864728|FG006|Overall Study|Withdrawal by Subject|0|||
27736255|NCT00805207|80864729|FG007|Overall Study|Withdrawal by Subject|0|||
27736256|NCT00805207|80864730|FG008|Overall Study|Withdrawal by Subject|0|||
27736257|NCT02017444|80864732|FG000|Overall Study|Physician Decision|1|||
27736258|NCT02017444|80864733|FG001|Overall Study|Physician Decision|0|||
27531391|NCT00287079|80141389|FG001|Overall Study|Adverse Event|0|||
27531392|NCT00287079|80141388|FG000|Overall Study|Protocol Violation|1|||
27531393|NCT00287079|80141389|FG001|Overall Study|Protocol Violation|0|||
27531394|NCT00287079|80141388|FG000|Overall Study|Other|3|||
27531395|NCT00287079|80141389|FG001|Overall Study|Other|0|||
27531396|NCT02595970|80141390|FG000|Overall Study|Withdrawal by Subject|2|||
27531397|NCT02595970|80141390|FG000|Overall Study|Physician Decision|2|||
27531398|NCT02595970|80141390|FG000|Overall Study|Protocol Violation|4|||
27531399|NCT02595970|80141390|FG000|Overall Study|Adverse Event|5|||
27531400|NCT02595970|80141390|FG000|Overall Study|Lack of Efficacy|7|||
27531401|NCT00608543|80141392|FG000|Overall Study|Adverse Event|4|||
27627457|NCT01090024|80477007|FG012|Period 1|Met exclusion criteria|0|||
27627458|NCT01090024|80477008|FG013|Period 1|Met exclusion criteria|0|||
27627459|NCT01090024|80477009|FG014|Period 1|Met exclusion criteria|1|||
27736259|NCT02017444|80864732|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
27736260|NCT02017444|80864733|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
27856912|NCT01032018|81310289|FG001|Overall Study|Lost to Follow-up|5|||
27856913|NCT01032018|81310288|FG000|Overall Study|Death|0|||
27856914|NCT01032018|81310289|FG001|Overall Study|Death|1|||
27856915|NCT02885181|81310290|FG000|Overall Study|Investigator's Discretion|0|||
27856916|NCT02885181|81310291|FG001|Overall Study|Investigator's Discretion|1|||
27856917|NCT02885181|81310292|FG002|Overall Study|Investigator's Discretion|0|||
27856918|NCT02885181|81310293|FG003|Overall Study|Investigator's Discretion|1|||
27856919|NCT02885181|81310290|FG000|Overall Study|Adverse Event|0|||
27856920|NCT02885181|81310291|FG001|Overall Study|Adverse Event|0|||
27856921|NCT02885181|81310292|FG002|Overall Study|Adverse Event|0|||
27856922|NCT02885181|81310293|FG003|Overall Study|Adverse Event|1|||
27856923|NCT02885181|81310290|FG000|Overall Study|Withdrawal by Subject|0|||
27856924|NCT02885181|81310291|FG001|Overall Study|Withdrawal by Subject|0|||
27856925|NCT02885181|81310292|FG002|Overall Study|Withdrawal by Subject|0|||
27856926|NCT02885181|81310293|FG003|Overall Study|Withdrawal by Subject|1|||
27531402|NCT02694523|80141393|FG000|Part A|Adverse Event|7|||
27531403|NCT02694523|80141394|FG001|Part A|Adverse Event|3|||
27531404|NCT02694523|80141395|FG002|Part A|Adverse Event|0|||
27531405|NCT02694523|80141396|FG003|Part A|Adverse Event|0|||
27531406|NCT02694523|80141397|FG004|Part A|Adverse Event|0|||
27531407|NCT02694523|80141398|FG005|Part A|Adverse Event|0|||
27531408|NCT02694523|80141399|FG006|Part A|Adverse Event|0|||
27627460|NCT01090024|80477010|FG015|Period 1|Met exclusion criteria|0|||
27736261|NCT05847881|80864734|FG000|Overall Study|Principal Investigator Decision|8|||
27736262|NCT05847881|80864734|FG000|Overall Study|Withdrawal by Subject|2|||
27736263|NCT03615222|80864735|FG000|Overall Study|Ineligible|26|||
27736264|NCT03615222|80864735|FG000|Overall Study|Withdrawal by Subject|7|||
27736265|NCT03615222|80864735|FG000|Overall Study|Death|1|||
27856927|NCT01908816|81310294|FG000|Overall Study|Subject's no longer requires study drug|0|||
27531409|NCT02694523|80141393|FG000|Part A|Protocol Violation|1|||
27531410|NCT02694523|80141394|FG001|Part A|Protocol Violation|0|||
27531411|NCT02694523|80141395|FG002|Part A|Protocol Violation|0|||
27531412|NCT02694523|80141396|FG003|Part A|Protocol Violation|0|||
27531413|NCT02694523|80141397|FG004|Part A|Protocol Violation|0|||
27531414|NCT02694523|80141398|FG005|Part A|Protocol Violation|0|||
27531415|NCT02694523|80141399|FG006|Part A|Protocol Violation|0|||
27531416|NCT02694523|80141393|FG000|Part A|Lost to Follow-up|1|||
27531417|NCT02694523|80141394|FG001|Part A|Lost to Follow-up|2|||
27531418|NCT02694523|80141395|FG002|Part A|Lost to Follow-up|0|||
27531419|NCT02694523|80141396|FG003|Part A|Lost to Follow-up|0|||
27531420|NCT02694523|80141397|FG004|Part A|Lost to Follow-up|0|||
27531421|NCT02694523|80141398|FG005|Part A|Lost to Follow-up|0|||
27531422|NCT02694523|80141399|FG006|Part A|Lost to Follow-up|0|||
27531423|NCT02694523|80141393|FG000|Part A|Withdrawal by Subject|3|||
27531424|NCT02694523|80141394|FG001|Part A|Withdrawal by Subject|1|||
27531425|NCT02694523|80141395|FG002|Part A|Withdrawal by Subject|0|||
27531426|NCT02694523|80141396|FG003|Part A|Withdrawal by Subject|0|||
27531427|NCT02694523|80141397|FG004|Part A|Withdrawal by Subject|0|||
27531428|NCT02694523|80141398|FG005|Part A|Withdrawal by Subject|0|||
27531429|NCT02694523|80141399|FG006|Part A|Withdrawal by Subject|0|||
27531430|NCT02694523|80141393|FG000|Part A|Other|1|||
27531431|NCT02694523|80141394|FG001|Part A|Other|1|||
27531432|NCT02694523|80141395|FG002|Part A|Other|0|||
27531433|NCT02694523|80141396|FG003|Part A|Other|0|||
27531434|NCT02694523|80141397|FG004|Part A|Other|0|||
27531435|NCT02694523|80141398|FG005|Part A|Other|0|||
27531436|NCT02694523|80141399|FG006|Part A|Other|0|||
27531437|NCT02694523|80141393|FG000|Part B|Adverse Event|0|||
27531438|NCT02694523|80141394|FG001|Part B|Adverse Event|0|||
27531439|NCT02694523|80141395|FG002|Part B|Adverse Event|7|||
27531440|NCT02694523|80141396|FG003|Part B|Adverse Event|1|||
27531441|NCT02694523|80141397|FG004|Part B|Adverse Event|1|||
27531442|NCT02694523|80141398|FG005|Part B|Adverse Event|2|||
27531443|NCT02694523|80141399|FG006|Part B|Adverse Event|0|||
27531444|NCT02694523|80141393|FG000|Part B|Protocol Violation|0|||
27531445|NCT02694523|80141394|FG001|Part B|Protocol Violation|0|||
27531446|NCT02694523|80141395|FG002|Part B|Protocol Violation|1|||
27531447|NCT02694523|80141396|FG003|Part B|Protocol Violation|0|||
27531448|NCT02694523|80141397|FG004|Part B|Protocol Violation|0|||
27531449|NCT02694523|80141398|FG005|Part B|Protocol Violation|0|||
27531450|NCT02694523|80141399|FG006|Part B|Protocol Violation|0|||
27531451|NCT02694523|80141393|FG000|Part B|Lost to Follow-up|0|||
27531452|NCT02694523|80141394|FG001|Part B|Lost to Follow-up|0|||
27531453|NCT02694523|80141395|FG002|Part B|Lost to Follow-up|2|||
27531454|NCT02694523|80141396|FG003|Part B|Lost to Follow-up|3|||
27531455|NCT02694523|80141397|FG004|Part B|Lost to Follow-up|2|||
27531456|NCT02694523|80141398|FG005|Part B|Lost to Follow-up|0|||
27531457|NCT02694523|80141399|FG006|Part B|Lost to Follow-up|1|||
27531458|NCT02694523|80141393|FG000|Part B|Withdrawal by Subject|0|||
27531459|NCT02694523|80141394|FG001|Part B|Withdrawal by Subject|0|||
27531460|NCT02694523|80141395|FG002|Part B|Withdrawal by Subject|9|||
27531461|NCT02694523|80141396|FG003|Part B|Withdrawal by Subject|0|||
27531462|NCT02694523|80141397|FG004|Part B|Withdrawal by Subject|1|||
27531463|NCT02694523|80141398|FG005|Part B|Withdrawal by Subject|3|||
27531464|NCT02694523|80141399|FG006|Part B|Withdrawal by Subject|0|||
27531465|NCT02694523|80141393|FG000|Part B|Other|0|||
27531466|NCT02694523|80141394|FG001|Part B|Other|0|||
27531467|NCT02694523|80141395|FG002|Part B|Other|1|||
27531468|NCT02694523|80141396|FG003|Part B|Other|0|||
27531469|NCT02694523|80141397|FG004|Part B|Other|0|||
27531470|NCT02694523|80141398|FG005|Part B|Other|0|||
27531471|NCT02694523|80141399|FG006|Part B|Other|1|||
27531472|NCT02963831|80141400|FG000|Overall Study|Progressive Disease|3|||
27531473|NCT02963831|80141401|FG001|Overall Study|Progressive Disease|3|||
27531474|NCT02963831|80141402|FG002|Overall Study|Progressive Disease|16|||
27531475|NCT02963831|80141403|FG003|Overall Study|Progressive Disease|27|||
27531476|NCT02963831|80141400|FG000|Overall Study|Withdrawal by Subject|1|||
27531477|NCT02963831|80141401|FG001|Overall Study|Withdrawal by Subject|0|||
27531478|NCT02963831|80141402|FG002|Overall Study|Withdrawal by Subject|2|||
27531479|NCT02963831|80141403|FG003|Overall Study|Withdrawal by Subject|4|||
27531480|NCT02963831|80141400|FG000|Overall Study|Adverse Event|0|||
27531481|NCT02963831|80141401|FG001|Overall Study|Adverse Event|1|||
27531482|NCT02963831|80141402|FG002|Overall Study|Adverse Event|1|||
27531483|NCT02963831|80141403|FG003|Overall Study|Adverse Event|2|||
27531484|NCT02963831|80141400|FG000|Overall Study|Death|0|||
27531485|NCT02963831|80141401|FG001|Overall Study|Death|0|||
27531486|NCT02963831|80141402|FG002|Overall Study|Death|0|||
27531487|NCT02963831|80141403|FG003|Overall Study|Death|2|||
27531488|NCT04738734|80141404|FG000|Overall Study|Withdrawal by Subject|2|||
27531489|NCT04738734|80141405|FG001|Overall Study|Withdrawal by Subject|4|||
27531490|NCT04738734|80141404|FG000|Overall Study|Lost to Follow-up|5|||
27531491|NCT04738734|80141405|FG001|Overall Study|Lost to Follow-up|2|||
27531492|NCT04738734|80141404|FG000|Overall Study|Physician Decision|0|||
27531493|NCT04738734|80141405|FG001|Overall Study|Physician Decision|1|||
27531494|NCT04738734|80141404|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
27627461|NCT01090024|80477011|FG016|Period 1|Met exclusion criteria|0|||
27627462|NCT01090024|80477012|FG017|Period 1|Met exclusion criteria|0|||
27627463|NCT01090024|80476995|FG000|Period 1|Adverse Event|0|||
27627464|NCT01090024|80476996|FG001|Period 1|Adverse Event|0|||
27627465|NCT01090024|80476997|FG002|Period 1|Adverse Event|0|||
27627466|NCT01090024|80476998|FG003|Period 1|Adverse Event|0|||
27627467|NCT01090024|80476999|FG004|Period 1|Adverse Event|0|||
27627468|NCT01090024|80477000|FG005|Period 1|Adverse Event|0|||
27627469|NCT01090024|80477001|FG006|Period 1|Adverse Event|0|||
27627470|NCT01090024|80477002|FG007|Period 1|Adverse Event|0|||
27627471|NCT01090024|80477003|FG008|Period 1|Adverse Event|0|||
27627472|NCT01090024|80477004|FG009|Period 1|Adverse Event|1|||
27627473|NCT01090024|80477005|FG010|Period 1|Adverse Event|0|||
27627474|NCT01090024|80477006|FG011|Period 1|Adverse Event|1|||
27627475|NCT01090024|80477007|FG012|Period 1|Adverse Event|0|||
27627476|NCT01090024|80477008|FG013|Period 1|Adverse Event|0|||
27627477|NCT01090024|80477009|FG014|Period 1|Adverse Event|0|||
27627478|NCT01090024|80477010|FG015|Period 1|Adverse Event|0|||
27627479|NCT01090024|80477011|FG016|Period 1|Adverse Event|0|||
27627480|NCT01090024|80477012|FG017|Period 1|Adverse Event|1|||
27627481|NCT01090024|80476995|FG000|Period 1|Withdrawal by Subject|0|||
27627482|NCT01090024|80476996|FG001|Period 1|Withdrawal by Subject|0|||
27627483|NCT01090024|80476997|FG002|Period 1|Withdrawal by Subject|0|||
27627484|NCT01090024|80476998|FG003|Period 1|Withdrawal by Subject|1|||
27627485|NCT01090024|80476999|FG004|Period 1|Withdrawal by Subject|0|||
27627486|NCT01090024|80477000|FG005|Period 1|Withdrawal by Subject|0|||
27627487|NCT01090024|80477001|FG006|Period 1|Withdrawal by Subject|0|||
27627488|NCT01090024|80477002|FG007|Period 1|Withdrawal by Subject|0|||
27627489|NCT01090024|80477003|FG008|Period 1|Withdrawal by Subject|0|||
27627490|NCT01090024|80477004|FG009|Period 1|Withdrawal by Subject|0|||
27627491|NCT01090024|80477005|FG010|Period 1|Withdrawal by Subject|0|||
27627492|NCT01090024|80477006|FG011|Period 1|Withdrawal by Subject|0|||
27627493|NCT01090024|80477007|FG012|Period 1|Withdrawal by Subject|0|||
27627494|NCT01090024|80477008|FG013|Period 1|Withdrawal by Subject|0|||
27627495|NCT01090024|80477009|FG014|Period 1|Withdrawal by Subject|0|||
27856928|NCT01908816|81310295|FG001|Overall Study|Subject's no longer requires study drug|0|||
27856929|NCT01908816|81310296|FG002|Overall Study|Subject's no longer requires study drug|0|||
27856930|NCT01908816|81310297|FG003|Overall Study|Subject's no longer requires study drug|1|||
27856931|NCT01908816|81310294|FG000|Overall Study|Protocol deviation|1|||
27856932|NCT01908816|81310295|FG001|Overall Study|Protocol deviation|2|||
27856933|NCT01908816|81310296|FG002|Overall Study|Protocol deviation|1|||
27912513|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912514|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912515|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912516|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912517|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27531495|NCT04738734|80141405|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
27856934|NCT01908816|81310297|FG003|Overall Study|Protocol deviation|1|||
27531496|NCT00857415|80141406|FG000|Overall Study|Image acquisition failure|2|||
27531497|NCT00857415|80141407|FG001|Overall Study|Image acquisition failure|0|||
27531498|NCT00857415|80141406|FG000|Overall Study|Invalid image or not imaged|3|||
27531499|NCT00857415|80141407|FG001|Overall Study|Invalid image or not imaged|0|||
27531500|NCT00857415|80141406|FG000|Overall Study|Subject still living at end of study|110|||
27531501|NCT00857415|80141407|FG001|Overall Study|Subject still living at end of study|0|||
27531502|NCT00857415|80141406|FG000|Overall Study|Deceased with no autopsy|2|||
27531503|NCT00857415|80141407|FG001|Overall Study|Deceased with no autopsy|0|||
27531504|NCT01672736|80141408|FG000|Overall Study|Available drug expired on 31 May 16|3|||
27856935|NCT01908816|81310294|FG000|Overall Study|Withdrawal by Subject|0|||
27856936|NCT01908816|81310295|FG001|Overall Study|Withdrawal by Subject|4|||
27856937|NCT01908816|81310296|FG002|Overall Study|Withdrawal by Subject|2|||
27627496|NCT01090024|80477010|FG015|Period 1|Withdrawal by Subject|0|||
27627497|NCT01090024|80477011|FG016|Period 1|Withdrawal by Subject|0|||
27856938|NCT01908816|81310297|FG003|Overall Study|Withdrawal by Subject|2|||
27531505|NCT00057876|80141409|FG000|Overall Study|Adverse Event|8|||
27627498|NCT01090024|80477012|FG017|Period 1|Withdrawal by Subject|0|||
27627499|NCT01090024|80476995|FG000|Period 1|Lost to Follow-up|0|||
27627500|NCT01090024|80476996|FG001|Period 1|Lost to Follow-up|1|||
27627501|NCT01090024|80476997|FG002|Period 1|Lost to Follow-up|0|||
27627502|NCT01090024|80476998|FG003|Period 1|Lost to Follow-up|0|||
27627503|NCT01090024|80476999|FG004|Period 1|Lost to Follow-up|0|||
27627504|NCT01090024|80477000|FG005|Period 1|Lost to Follow-up|0|||
27627505|NCT01090024|80477001|FG006|Period 1|Lost to Follow-up|0|||
27627506|NCT01090024|80477002|FG007|Period 1|Lost to Follow-up|0|||
27627507|NCT01090024|80477003|FG008|Period 1|Lost to Follow-up|0|||
27912518|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912519|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912520|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
27912521|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912522|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912523|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912524|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912525|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912526|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27912527|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
27627508|NCT01090024|80477004|FG009|Period 1|Lost to Follow-up|0|||
27627509|NCT01090024|80477005|FG010|Period 1|Lost to Follow-up|0|||
27627510|NCT01090024|80477006|FG011|Period 1|Lost to Follow-up|0|||
27627511|NCT01090024|80477007|FG012|Period 1|Lost to Follow-up|0|||
27627512|NCT01090024|80477008|FG013|Period 1|Lost to Follow-up|0|||
27627513|NCT01090024|80477009|FG014|Period 1|Lost to Follow-up|0|||
27627514|NCT01090024|80477010|FG015|Period 1|Lost to Follow-up|0|||
27627515|NCT01090024|80477011|FG016|Period 1|Lost to Follow-up|0|||
27627516|NCT01090024|80477012|FG017|Period 1|Lost to Follow-up|0|||
27627517|NCT01090024|80476995|FG000|Period 2|Lost to Follow-up|0|||
27912528|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27627518|NCT01090024|80476996|FG001|Period 2|Lost to Follow-up|0|||
27627519|NCT01090024|80476997|FG002|Period 2|Lost to Follow-up|0|||
27627520|NCT01090024|80476998|FG003|Period 2|Lost to Follow-up|1|||
27627521|NCT01090024|80476999|FG004|Period 2|Lost to Follow-up|0|||
27627522|NCT01090024|80477000|FG005|Period 2|Lost to Follow-up|0|||
27627523|NCT01090024|80477001|FG006|Period 2|Lost to Follow-up|0|||
27736266|NCT00491530|80864753|FG000|Overall Study|Adverse Event|6|||
27736267|NCT00491530|80864754|FG001|Overall Study|Adverse Event|1|||
27736268|NCT00491530|80864755|FG002|Overall Study|Adverse Event|2|||
27736269|NCT00491530|80864753|FG000|Overall Study|Withdrawal by Subject|3|||
27736270|NCT00491530|80864754|FG001|Overall Study|Withdrawal by Subject|0|||
27736271|NCT00491530|80864755|FG002|Overall Study|Withdrawal by Subject|0|||
27736272|NCT00491530|80864753|FG000|Overall Study|Lost to Follow-up|3|||
27736273|NCT00491530|80864754|FG001|Overall Study|Lost to Follow-up|2|||
27736274|NCT00491530|80864755|FG002|Overall Study|Lost to Follow-up|2|||
27856939|NCT01908816|81310294|FG000|Overall Study|Lost to Follow-up|3|||
27856940|NCT01908816|81310295|FG001|Overall Study|Lost to Follow-up|5|||
27912529|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912530|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27627524|NCT01090024|80477002|FG007|Period 2|Lost to Follow-up|0|||
27627525|NCT01090024|80477003|FG008|Period 2|Lost to Follow-up|0|||
27627526|NCT01090024|80477004|FG009|Period 2|Lost to Follow-up|0|||
27912531|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27627527|NCT01090024|80477005|FG010|Period 2|Lost to Follow-up|0|||
27627528|NCT01090024|80477006|FG011|Period 2|Lost to Follow-up|0|||
27627529|NCT01090024|80477007|FG012|Period 2|Lost to Follow-up|0|||
27736275|NCT00491530|80864753|FG000|Overall Study|Lack of Efficacy|0|||
27736276|NCT00491530|80864754|FG001|Overall Study|Lack of Efficacy|1|||
27736277|NCT00491530|80864755|FG002|Overall Study|Lack of Efficacy|0|||
27627530|NCT01090024|80477008|FG013|Period 2|Lost to Follow-up|0|||
27627531|NCT01090024|80477009|FG014|Period 2|Lost to Follow-up|0|||
27627532|NCT01090024|80477010|FG015|Period 2|Lost to Follow-up|0|||
27627533|NCT01090024|80477011|FG016|Period 2|Lost to Follow-up|0|||
27627534|NCT01090024|80477012|FG017|Period 2|Lost to Follow-up|0|||
27627535|NCT01090024|80476995|FG000|Period 2|Adverse Event|1|||
27627536|NCT01090024|80476996|FG001|Period 2|Adverse Event|0|||
27627537|NCT01090024|80476997|FG002|Period 2|Adverse Event|0|||
27627538|NCT01090024|80476998|FG003|Period 2|Adverse Event|0|||
27627539|NCT01090024|80476999|FG004|Period 2|Adverse Event|0|||
27627540|NCT01090024|80477000|FG005|Period 2|Adverse Event|0|||
27627541|NCT01090024|80477001|FG006|Period 2|Adverse Event|0|||
27627542|NCT01090024|80477002|FG007|Period 2|Adverse Event|0|||
27627543|NCT01090024|80477003|FG008|Period 2|Adverse Event|0|||
27627544|NCT01090024|80477004|FG009|Period 2|Adverse Event|0|||
27627545|NCT01090024|80477005|FG010|Period 2|Adverse Event|0|||
27627546|NCT01090024|80477006|FG011|Period 2|Adverse Event|0|||
27627547|NCT01090024|80477007|FG012|Period 2|Adverse Event|0|||
27627548|NCT01090024|80477008|FG013|Period 2|Adverse Event|0|||
27627549|NCT01090024|80477009|FG014|Period 2|Adverse Event|0|||
27627550|NCT01090024|80477010|FG015|Period 2|Adverse Event|0|||
27627551|NCT01090024|80477011|FG016|Period 2|Adverse Event|0|||
27627552|NCT01090024|80477012|FG017|Period 2|Adverse Event|0|||
27627553|NCT01090024|80476995|FG000|Period 3|Withdrawal by Subject|0|||
27627554|NCT01090024|80476996|FG001|Period 3|Withdrawal by Subject|0|||
27627555|NCT01090024|80476997|FG002|Period 3|Withdrawal by Subject|0|||
27627556|NCT01090024|80476998|FG003|Period 3|Withdrawal by Subject|0|||
27627557|NCT01090024|80476999|FG004|Period 3|Withdrawal by Subject|0|||
27627558|NCT01090024|80477000|FG005|Period 3|Withdrawal by Subject|0|||
27627559|NCT01090024|80477001|FG006|Period 3|Withdrawal by Subject|0|||
27627560|NCT01090024|80477002|FG007|Period 3|Withdrawal by Subject|0|||
27627561|NCT01090024|80477003|FG008|Period 3|Withdrawal by Subject|0|||
27627562|NCT01090024|80477004|FG009|Period 3|Withdrawal by Subject|0|||
27627563|NCT01090024|80477005|FG010|Period 3|Withdrawal by Subject|0|||
27627564|NCT01090024|80477006|FG011|Period 3|Withdrawal by Subject|0|||
27627565|NCT01090024|80477007|FG012|Period 3|Withdrawal by Subject|0|||
27627566|NCT01090024|80477008|FG013|Period 3|Withdrawal by Subject|0|||
27627567|NCT01090024|80477009|FG014|Period 3|Withdrawal by Subject|0|||
27627568|NCT01090024|80477010|FG015|Period 3|Withdrawal by Subject|1|||
27627569|NCT01090024|80477011|FG016|Period 3|Withdrawal by Subject|0|||
27627570|NCT01090024|80477012|FG017|Period 3|Withdrawal by Subject|0|||
27627571|NCT01090024|80476995|FG000|Period 3|Protocol Violation|0|||
27627572|NCT01090024|80476996|FG001|Period 3|Protocol Violation|0|||
27627573|NCT01090024|80476997|FG002|Period 3|Protocol Violation|0|||
27627574|NCT01090024|80476998|FG003|Period 3|Protocol Violation|0|||
27627575|NCT01090024|80476999|FG004|Period 3|Protocol Violation|0|||
27627576|NCT01090024|80477000|FG005|Period 3|Protocol Violation|0|||
27627577|NCT01090024|80477001|FG006|Period 3|Protocol Violation|0|||
27627578|NCT01090024|80477002|FG007|Period 3|Protocol Violation|0|||
27627579|NCT01090024|80477003|FG008|Period 3|Protocol Violation|1|||
27627580|NCT01090024|80477004|FG009|Period 3|Protocol Violation|0|||
27627581|NCT01090024|80477005|FG010|Period 3|Protocol Violation|0|||
27627582|NCT01090024|80477006|FG011|Period 3|Protocol Violation|0|||
27627583|NCT01090024|80477007|FG012|Period 3|Protocol Violation|0|||
27627584|NCT01090024|80477008|FG013|Period 3|Protocol Violation|0|||
27627585|NCT01090024|80477009|FG014|Period 3|Protocol Violation|0|||
27627586|NCT01090024|80477010|FG015|Period 3|Protocol Violation|0|||
27627587|NCT01090024|80477011|FG016|Period 3|Protocol Violation|0|||
27627588|NCT01090024|80477012|FG017|Period 3|Protocol Violation|0|||
27627589|NCT01090024|80476995|FG000|Period 3|Adverse Event|0|||
27627590|NCT01090024|80476996|FG001|Period 3|Adverse Event|0|||
27627591|NCT01090024|80476997|FG002|Period 3|Adverse Event|0|||
27627592|NCT01090024|80476998|FG003|Period 3|Adverse Event|0|||
27627593|NCT01090024|80476999|FG004|Period 3|Adverse Event|0|||
27856941|NCT01908816|81310296|FG002|Overall Study|Lost to Follow-up|4|||
27627594|NCT01090024|80477000|FG005|Period 3|Adverse Event|1|||
27627595|NCT01090024|80477001|FG006|Period 3|Adverse Event|0|||
27627596|NCT01090024|80477002|FG007|Period 3|Adverse Event|0|||
27627597|NCT01090024|80477003|FG008|Period 3|Adverse Event|0|||
27627598|NCT01090024|80477004|FG009|Period 3|Adverse Event|0|||
27627599|NCT01090024|80477005|FG010|Period 3|Adverse Event|0|||
27627600|NCT01090024|80477006|FG011|Period 3|Adverse Event|0|||
27627601|NCT01090024|80477007|FG012|Period 3|Adverse Event|0|||
27627602|NCT01090024|80477008|FG013|Period 3|Adverse Event|0|||
27627603|NCT01090024|80477009|FG014|Period 3|Adverse Event|0|||
27627604|NCT01090024|80477010|FG015|Period 3|Adverse Event|0|||
27627605|NCT01090024|80477011|FG016|Period 3|Adverse Event|0|||
27627606|NCT01090024|80477012|FG017|Period 3|Adverse Event|0|||
27627607|NCT03102242|80477018|FG000|Overall Study|Adverse Event|2|||
27627608|NCT01080131|80477019|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
27627609|NCT01080131|80477020|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
27627610|NCT01080131|80477019|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
27531506|NCT00057876|80141410|FG001|Overall Study|Adverse Event|8|||
27531507|NCT00057876|80141409|FG000|Overall Study|Death|2|||
27627611|NCT01080131|80477020|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
27627612|NCT01080131|80477019|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
27627613|NCT01080131|80477020|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
27627614|NCT01080131|80477019|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
27627615|NCT01080131|80477020|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
27627616|NCT01080131|80477019|FG000|Core Study (0- 12 Weeks)|Death|1|||
27627617|NCT01080131|80477020|FG001|Core Study (0- 12 Weeks)|Death|0|||
27627618|NCT01080131|80477019|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
27627619|NCT01080131|80477020|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
27627620|NCT01080131|80477019|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
27627621|NCT01080131|80477020|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
27531508|NCT00057876|80141410|FG001|Overall Study|Death|1|||
27531509|NCT00057876|80141409|FG000|Overall Study|Withdrawal by Subject|5|||
27531510|NCT00057876|80141410|FG001|Overall Study|Withdrawal by Subject|6|||
27531511|NCT00057876|80141409|FG000|Overall Study|Lack of Efficacy|10|||
27531512|NCT00057876|80141410|FG001|Overall Study|Lack of Efficacy|8|||
27531513|NCT00057876|80141409|FG000|Overall Study|Ineligible|1|||
27531514|NCT00057876|80141410|FG001|Overall Study|Ineligible|2|||
27531515|NCT00057876|80141409|FG000|Overall Study|other reason|2|||
27531516|NCT00057876|80141410|FG001|Overall Study|other reason|2|||
27531517|NCT00057876|80141409|FG000|Overall Study|other complicating disease|1|||
27531518|NCT00057876|80141410|FG001|Overall Study|other complicating disease|0|||
27531519|NCT04223232|80141420|FG000|Overall Study|Withdrawal by Subject|1|||
27531520|NCT01462227|80141421|FG000|Second Assignment|Lost to Follow-up|1|||
27531521|NCT01462227|80141422|FG001|Second Assignment|Lost to Follow-up|0|||
27531522|NCT01462227|80141423|FG002|Second Assignment|Lost to Follow-up|0|||
27531523|NCT01462227|80141424|FG003|Second Assignment|Lost to Follow-up|0|||
27531524|NCT01462227|80141421|FG000|Second Assignment|Protocol Violation|0|||
27531525|NCT01462227|80141422|FG001|Second Assignment|Protocol Violation|1|||
27531526|NCT01462227|80141423|FG002|Second Assignment|Protocol Violation|1|||
27531527|NCT01462227|80141424|FG003|Second Assignment|Protocol Violation|0|||
27531528|NCT03583164|80141427|FG000|Overall Study|Death in Main Phase|35|||
27531529|NCT03583164|80141427|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
27531530|NCT03583164|80141427|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
27531531|NCT03583164|80141427|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
27531532|NCT03583164|80141427|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
27531533|NCT03583164|80141427|FG000|Overall Study|Physician decision in Main Phase|1|||
27531534|NCT03583164|80141427|FG000|Overall Study|Physician decision in Extended Phase|2|||
27531535|NCT03583164|80141427|FG000|Overall Study|Death in Extended Phase|13|||
27531536|NCT03583164|80141427|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
27531537|NCT03583164|80141427|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
27531538|NCT03583164|80141427|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
27531539|NCT03583164|80141427|FG000|Overall Study|Treatment failure in Main Phase|2|||
27531540|NCT03583164|80141427|FG000|Overall Study|Treatment failure in Extended Phase|4|||
27531541|NCT03583164|80141427|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
27531542|NCT03583164|80141427|FG000|Overall Study|Other not specified reason in Main Phase|2|||
27531543|NCT00386607|80141430|FG000|Core|Adverse Event|40|||
27531544|NCT00386607|80141431|FG001|Core|Adverse Event|0|||
27531545|NCT00386607|80141430|FG000|Core|Abnormal laboratory value(s)|3|||
27531546|NCT00386607|80141431|FG001|Core|Abnormal laboratory value(s)|0|||
27531547|NCT00386607|80141430|FG000|Core|Unsatisfactory therapeutic effect|23|||
27531548|NCT00386607|80141431|FG001|Core|Unsatisfactory therapeutic effect|0|||
27531549|NCT00386607|80141430|FG000|Core|Condition no longer requires study drug|4|||
27531550|NCT00386607|80141431|FG001|Core|Condition no longer requires study drug|0|||
27531551|NCT00386607|80141430|FG000|Core|Patient withdrew consent|15|||
27531552|NCT00386607|80141431|FG001|Core|Patient withdrew consent|0|||
27531553|NCT00386607|80141430|FG000|Core|Lost to Follow-up|23|||
27531554|NCT00386607|80141431|FG001|Core|Lost to Follow-up|0|||
27531555|NCT00386607|80141430|FG000|Core|Administrative problems|1|||
27627622|NCT01080131|80477019|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
27627623|NCT01080131|80477020|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
27736278|NCT00491530|80864753|FG000|Overall Study|Investigator Discretion|0|||
27531556|NCT00386607|80141431|FG001|Core|Administrative problems|0|||
27531557|NCT00386607|80141430|FG000|Core|Protocol Deviation|6|||
27531558|NCT00386607|80141431|FG001|Core|Protocol Deviation|0|||
27531559|NCT00386607|80141430|FG000|Extension|Adverse Event|0|||
27531560|NCT00386607|80141431|FG001|Extension|Adverse Event|6|||
27531561|NCT00386607|80141430|FG000|Extension|Abnormal laboratory value(s)|0|||
27531562|NCT00386607|80141431|FG001|Extension|Abnormal laboratory value(s)|1|||
27531563|NCT00386607|80141430|FG000|Extension|Administrative problems|0|||
27531564|NCT00386607|80141431|FG001|Extension|Administrative problems|1|||
27531565|NCT00386607|80141430|FG000|Extension|Lost to Follow-up|0|||
27531566|NCT00386607|80141431|FG001|Extension|Lost to Follow-up|3|||
27627624|NCT01080131|80477019|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
27627625|NCT01080131|80477020|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
27627626|NCT01080131|80477019|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
27627627|NCT01080131|80477020|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
27627628|NCT01080131|80477019|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
27627629|NCT01080131|80477020|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
27627630|NCT01080131|80477019|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
27627631|NCT01080131|80477020|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
27627632|NCT01080131|80477019|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
27627633|NCT01080131|80477020|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
27627634|NCT00864682|80477021|FG000|Overall Study|Protocol Violation|2|||
27627635|NCT00864682|80477022|FG001|Overall Study|Protocol Violation|1|||
27627636|NCT00864682|80477023|FG002|Overall Study|Protocol Violation|2|||
27627637|NCT04310579|80477028|FG000|Overall Study|Adverse Event|0|||
27627638|NCT04310579|80477029|FG001|Overall Study|Adverse Event|0|||
27627639|NCT04310579|80477030|FG002|Overall Study|Adverse Event|0|||
27627640|NCT04310579|80477031|FG003|Overall Study|Adverse Event|0|||
27627641|NCT04310579|80477032|FG004|Overall Study|Adverse Event|0|||
27627642|NCT04310579|80477033|FG005|Overall Study|Adverse Event|0|||
27627643|NCT04310579|80477034|FG006|Overall Study|Adverse Event|2|||
27627644|NCT04310579|80477035|FG007|Overall Study|Adverse Event|0|||
27627645|NCT04310579|80477036|FG008|Overall Study|Adverse Event|1|||
27627646|NCT04310579|80477037|FG009|Overall Study|Adverse Event|1|||
27627647|NCT04310579|80477038|FG010|Overall Study|Adverse Event|0|||
27627648|NCT04310579|80477028|FG000|Overall Study|Withdrawal by Subject|0|||
27627649|NCT04310579|80477029|FG001|Overall Study|Withdrawal by Subject|0|||
27627650|NCT04310579|80477030|FG002|Overall Study|Withdrawal by Subject|0|||
27627651|NCT04310579|80477031|FG003|Overall Study|Withdrawal by Subject|0|||
27627652|NCT04310579|80477032|FG004|Overall Study|Withdrawal by Subject|0|||
27627653|NCT04310579|80477033|FG005|Overall Study|Withdrawal by Subject|1|||
27627654|NCT04310579|80477034|FG006|Overall Study|Withdrawal by Subject|0|||
27627655|NCT04310579|80477035|FG007|Overall Study|Withdrawal by Subject|0|||
27627656|NCT04310579|80477036|FG008|Overall Study|Withdrawal by Subject|0|||
27627657|NCT04310579|80477037|FG009|Overall Study|Withdrawal by Subject|0|||
27627658|NCT04310579|80477038|FG010|Overall Study|Withdrawal by Subject|0|||
27627659|NCT04310579|80477028|FG000|Overall Study|Positive COVID-19 test|0|||
27627660|NCT04310579|80477029|FG001|Overall Study|Positive COVID-19 test|0|||
27627661|NCT04310579|80477030|FG002|Overall Study|Positive COVID-19 test|0|||
27627662|NCT04310579|80477031|FG003|Overall Study|Positive COVID-19 test|0|||
27627663|NCT04310579|80477032|FG004|Overall Study|Positive COVID-19 test|0|||
27627664|NCT04310579|80477033|FG005|Overall Study|Positive COVID-19 test|0|||
27627665|NCT04310579|80477034|FG006|Overall Study|Positive COVID-19 test|0|||
27627666|NCT04310579|80477035|FG007|Overall Study|Positive COVID-19 test|0|||
27627667|NCT04310579|80477036|FG008|Overall Study|Positive COVID-19 test|0|||
27627668|NCT04310579|80477037|FG009|Overall Study|Positive COVID-19 test|0|||
27627669|NCT04310579|80477038|FG010|Overall Study|Positive COVID-19 test|1|||
27627670|NCT02534896|80477040|FG000|Overall Study|Adverse Event|2|||
27627671|NCT02534896|80477041|FG001|Overall Study|Adverse Event|1|||
27627672|NCT02534896|80477042|FG002|Overall Study|Adverse Event|1|||
27627673|NCT02534896|80477040|FG000|Overall Study|Insufficient therapeutic response|2|||
27627674|NCT02534896|80477041|FG001|Overall Study|Insufficient therapeutic response|0|||
27627675|NCT02534896|80477042|FG002|Overall Study|Insufficient therapeutic response|0|||
27627676|NCT03834493|80477050|FG000|Overall Study|Participants Ongoing|311|||
27627677|NCT03834493|80477051|FG001|Overall Study|Participants Ongoing|324|||
27627678|NCT03834493|80477050|FG000|Overall Study|Withdrawal by Subject|20|||
27627679|NCT03834493|80477051|FG001|Overall Study|Withdrawal by Subject|17|||
27627680|NCT03834493|80477050|FG000|Overall Study|Physician Decision|1|||
27627681|NCT03834493|80477051|FG001|Overall Study|Physician Decision|0|||
27627682|NCT03834493|80477050|FG000|Overall Study|Death|289|||
27627683|NCT03834493|80477051|FG001|Overall Study|Death|282|||
27627684|NCT02689349|80480193|FG000|Overall Study|Not implanted|4|||
27627685|NCT02689349|80480194|FG001|Overall Study|Not implanted|0|||
27627686|NCT02689349|80480193|FG000|Overall Study|Withdrawal by Subject|9|||
27627687|NCT02689349|80480194|FG001|Overall Study|Withdrawal by Subject|0|||
27627688|NCT01605136|80480195|FG000|Study Period|Withdrawal by Subject|2|||
27627689|NCT01605136|80480196|FG001|Study Period|Withdrawal by Subject|0|||
27627690|NCT01605136|80480195|FG000|Study Period|Physician Decision|1|||
27627691|NCT01605136|80480196|FG001|Study Period|Physician Decision|1|||
27627692|NCT01605136|80480195|FG000|Study Period|Lost to Follow-up|0|||
27627693|NCT01605136|80480196|FG001|Study Period|Lost to Follow-up|2|||
27627694|NCT01605136|80480195|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
27627695|NCT01605136|80480196|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
27627696|NCT02380742|80480202|FG000|Overall Study|Withdrawal by Subject|1|||
27627697|NCT02380742|80480203|FG001|Overall Study|Withdrawal by Subject|0|||
27627698|NCT00038103|80480209|FG000|Overall Study|Adverse Event|5|||
27627699|NCT00038103|80480210|FG001|Overall Study|Adverse Event|6|||
27627700|NCT00038103|80480209|FG000|Overall Study|Lack of Efficacy|48|||
27627701|NCT00038103|80480210|FG001|Overall Study|Lack of Efficacy|41|||
27627702|NCT00038103|80480209|FG000|Overall Study|Withdrawal by Subject|0|||
27627703|NCT00038103|80480210|FG001|Overall Study|Withdrawal by Subject|3|||
27627704|NCT00038103|80480209|FG000|Overall Study|Lost to Follow-up|0|||
27627705|NCT00038103|80480210|FG001|Overall Study|Lost to Follow-up|3|||
27627706|NCT00038103|80480209|FG000|Overall Study|Protocol Violation|0|||
27627707|NCT00038103|80480210|FG001|Overall Study|Protocol Violation|2|||
27627708|NCT00038103|80480209|FG000|Overall Study|Sponsor Decision|0|||
27627709|NCT00038103|80480210|FG001|Overall Study|Sponsor Decision|1|||
27627710|NCT00038103|80480209|FG000|Overall Study|Randomized/never treated|2|||
27627711|NCT00038103|80480210|FG001|Overall Study|Randomized/never treated|0|||
27627712|NCT04335591|80480211|FG000|Overall Study|Adverse Event|5|||
27627713|NCT04335591|80480212|FG001|Overall Study|Adverse Event|2|||
27627714|NCT04335591|80480213|FG002|Overall Study|Adverse Event|3|||
27627715|NCT04335591|80480214|FG003|Overall Study|Adverse Event|2|||
27627716|NCT04335591|80480211|FG000|Overall Study|Protocol Violation|1|||
27627717|NCT04335591|80480212|FG001|Overall Study|Protocol Violation|0|||
27627718|NCT04335591|80480213|FG002|Overall Study|Protocol Violation|0|||
27627719|NCT04335591|80480214|FG003|Overall Study|Protocol Violation|0|||
27627720|NCT04335591|80480211|FG000|Overall Study|Withdrawal by Subject|8|||
27627721|NCT04335591|80480212|FG001|Overall Study|Withdrawal by Subject|4|||
27627722|NCT04335591|80480213|FG002|Overall Study|Withdrawal by Subject|4|||
27627723|NCT04335591|80480214|FG003|Overall Study|Withdrawal by Subject|5|||
27627724|NCT04335591|80480211|FG000|Overall Study|Subject planning pregnancy|0|||
27627725|NCT04335591|80480212|FG001|Overall Study|Subject planning pregnancy|1|||
27627726|NCT04335591|80480213|FG002|Overall Study|Subject planning pregnancy|0|||
27531567|NCT00386607|80141430|FG000|Extension|Patient withdrew consent|0|||
27531568|NCT00386607|80141431|FG001|Extension|Patient withdrew consent|5|||
27531569|NCT00386607|80141430|FG000|Extension|Unsatisfactory therapeutic effect|0|||
27531570|NCT00386607|80141431|FG001|Extension|Unsatisfactory therapeutic effect|1|||
27531571|NCT01400815|80141432|FG000|Overall Study|Adverse Event|3|||
27531572|NCT01400815|80141433|FG001|Overall Study|Adverse Event|0|||
27531573|NCT01400815|80141432|FG000|Overall Study|Death|0|||
27627727|NCT04335591|80480214|FG003|Overall Study|Subject planning pregnancy|0|||
27627728|NCT04335591|80480211|FG000|Overall Study|Ukrainian Russian war conflict|4|||
27531574|NCT01400815|80141433|FG001|Overall Study|Death|1|||
27531575|NCT01400815|80141432|FG000|Overall Study|Lost to Follow-up|18|||
27531576|NCT01400815|80141433|FG001|Overall Study|Lost to Follow-up|11|||
27531577|NCT01400815|80141432|FG000|Overall Study|Protocol Violation|0|||
27627729|NCT04335591|80480212|FG001|Overall Study|Ukrainian Russian war conflict|5|||
27627730|NCT04335591|80480213|FG002|Overall Study|Ukrainian Russian war conflict|2|||
27627731|NCT04335591|80480214|FG003|Overall Study|Ukrainian Russian war conflict|0|||
27627732|NCT03121950|80480215|FG000|Overall Study|Withdrawal by Subject|11|||
27627733|NCT03121950|80480216|FG001|Overall Study|Withdrawal by Subject|2|||
27627734|NCT01156116|80480217|FG000|Overall Study|Withdrawal by Subject|3|||
27627735|NCT01156116|80480218|FG001|Overall Study|Withdrawal by Subject|1|||
27627736|NCT01156116|80480217|FG000|Overall Study|CPAP intolerance|2|||
27627737|NCT01156116|80480218|FG001|Overall Study|CPAP intolerance|0|||
27627738|NCT03545984|80480220|FG000|Overall Study|CSF cases not present during rotation|11|||
27627739|NCT03545984|80480221|FG001|Overall Study|CSF cases not present during rotation|9|||
27627740|NCT01119703|80480224|FG000|Overall Study|Adverse Event|0|||
27627741|NCT01119703|80480225|FG001|Overall Study|Adverse Event|1|||
27627742|NCT00404079|80480227|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
27627743|NCT00404079|80480228|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
27627744|NCT01178762|80480231|FG000|Overall Study|Lost to Follow-up|15|||
27627745|NCT02046616|80480237|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
27627746|NCT02046616|80480237|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
27627747|NCT02046616|80480237|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
27627748|NCT02046616|80480237|FG000|24-Week Treatment Period|Physician Decision|3|||
27627749|NCT02046616|80480237|FG000|24-Week Treatment Period|Other|1|||
27627750|NCT02046616|80480237|FG000|8-Week FU Period|Lost to Follow-up|1|||
27627751|NCT04555044|80480238|FG000|Overall Study|Adverse Event|0|||
27627752|NCT04555044|80480239|FG001|Overall Study|Adverse Event|1|||
27627753|NCT00099437|80480240|FG000|Overall Study|Lost to Follow-up|30|||
27627754|NCT00099437|80480241|FG001|Overall Study|Lost to Follow-up|33|||
27627755|NCT00099437|80480240|FG000|Overall Study|Death|293|||
27627756|NCT00099437|80480241|FG001|Overall Study|Death|261|||
27627757|NCT00099437|80480240|FG000|Overall Study|Withdrawal by Subject|6|||
27627758|NCT00099437|80480241|FG001|Overall Study|Withdrawal by Subject|10|||
27627759|NCT00099437|80480240|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
27627760|NCT00099437|80480241|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
27531578|NCT01400815|80141433|FG001|Overall Study|Protocol Violation|1|||
27531579|NCT01400815|80141432|FG000|Overall Study|Physician Decision|1|||
27531580|NCT01400815|80141433|FG001|Overall Study|Physician Decision|0|||
27531581|NCT01400815|80141432|FG000|Overall Study|Withdrawal by Subject|15|||
27856942|NCT01908816|81310297|FG003|Overall Study|Lost to Follow-up|2|||
27627761|NCT03113487|80480242|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
27627762|NCT00502593|80480244|FG000|Overall Study|Withdrawn unspecified reason|1|||
27627763|NCT00502593|80480245|FG001|Overall Study|Withdrawn unspecified reason|1|||
27627764|NCT00502593|80480246|FG002|Overall Study|Withdrawn unspecified reason|3|||
27627765|NCT00502593|80480247|FG003|Overall Study|Withdrawn unspecified reason|1|||
27627766|NCT00502593|80480248|FG004|Overall Study|Withdrawn unspecified reason|2|||
27627767|NCT00502593|80480249|FG005|Overall Study|Withdrawn unspecified reason|0|||
27627768|NCT00502593|80480250|FG006|Overall Study|Withdrawn unspecified reason|2|||
27627769|NCT00502593|80480251|FG007|Overall Study|Withdrawn unspecified reason|0|||
27627770|NCT00502593|80480252|FG008|Overall Study|Withdrawn unspecified reason|0|||
27627771|NCT00502593|80480253|FG009|Overall Study|Withdrawn unspecified reason|0|||
27627772|NCT00502593|80480254|FG010|Overall Study|Withdrawn unspecified reason|0|||
27627773|NCT00502593|80480255|FG011|Overall Study|Withdrawn unspecified reason|0|||
27627774|NCT00502593|80480244|FG000|Overall Study|Withdrawal by Subject|0|||
27627775|NCT00502593|80480245|FG001|Overall Study|Withdrawal by Subject|0|||
27627776|NCT00502593|80480246|FG002|Overall Study|Withdrawal by Subject|6|||
27627777|NCT00502593|80480247|FG003|Overall Study|Withdrawal by Subject|2|||
27627778|NCT00502593|80480248|FG004|Overall Study|Withdrawal by Subject|2|||
27627779|NCT00502593|80480249|FG005|Overall Study|Withdrawal by Subject|0|||
27627780|NCT00502593|80480250|FG006|Overall Study|Withdrawal by Subject|3|||
27627781|NCT00502593|80480251|FG007|Overall Study|Withdrawal by Subject|0|||
27627782|NCT00502593|80480252|FG008|Overall Study|Withdrawal by Subject|3|||
27627783|NCT00502593|80480253|FG009|Overall Study|Withdrawal by Subject|0|||
27627784|NCT00502593|80480254|FG010|Overall Study|Withdrawal by Subject|1|||
27627785|NCT00502593|80480255|FG011|Overall Study|Withdrawal by Subject|0|||
27627786|NCT00502593|80480244|FG000|Overall Study|Lost to Follow-up|2|||
27627787|NCT00502593|80480245|FG001|Overall Study|Lost to Follow-up|1|||
27627788|NCT00502593|80480246|FG002|Overall Study|Lost to Follow-up|1|||
27627789|NCT00502593|80480247|FG003|Overall Study|Lost to Follow-up|1|||
27627790|NCT00502593|80480248|FG004|Overall Study|Lost to Follow-up|0|||
27627791|NCT00502593|80480249|FG005|Overall Study|Lost to Follow-up|0|||
27627792|NCT00502593|80480250|FG006|Overall Study|Lost to Follow-up|0|||
27627793|NCT00502593|80480251|FG007|Overall Study|Lost to Follow-up|0|||
27627794|NCT00502593|80480252|FG008|Overall Study|Lost to Follow-up|3|||
27627795|NCT00502593|80480253|FG009|Overall Study|Lost to Follow-up|0|||
27627796|NCT00502593|80480254|FG010|Overall Study|Lost to Follow-up|1|||
27627797|NCT00502593|80480255|FG011|Overall Study|Lost to Follow-up|0|||
27627798|NCT02968004|80480264|FG000|Overall Study|Adverse Event|1|||
27627799|NCT02968004|80480265|FG001|Overall Study|Adverse Event|0|||
27627800|NCT02968004|80480264|FG000|Overall Study|Withdrawal by Subject|0|||
27627801|NCT02968004|80480265|FG001|Overall Study|Withdrawal by Subject|1|||
27627802|NCT00817635|80480266|FG000|Overall Study|Adverse Event|1|||
27627803|NCT00817635|80480267|FG001|Overall Study|Adverse Event|0|||
27627804|NCT00817635|80480268|FG002|Overall Study|Adverse Event|0|||
27627805|NCT00817635|80480269|FG003|Overall Study|Adverse Event|1|||
27627806|NCT00817635|80480270|FG004|Overall Study|Adverse Event|1|||
27627807|NCT00817635|80480266|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
27627808|NCT00817635|80480267|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
27627809|NCT00817635|80480268|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
27627810|NCT00817635|80480269|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
27627811|NCT00817635|80480270|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
27627812|NCT00817635|80480266|FG000|Overall Study|Withdrawal by Subject|2|||
27627813|NCT00817635|80480267|FG001|Overall Study|Withdrawal by Subject|1|||
27627814|NCT00817635|80480268|FG002|Overall Study|Withdrawal by Subject|0|||
27627815|NCT00817635|80480269|FG003|Overall Study|Withdrawal by Subject|1|||
27627816|NCT00817635|80480270|FG004|Overall Study|Withdrawal by Subject|2|||
27627817|NCT00817635|80480266|FG000|Overall Study|Lost to Follow-up|0|||
27627818|NCT00817635|80480267|FG001|Overall Study|Lost to Follow-up|1|||
27627819|NCT00817635|80480268|FG002|Overall Study|Lost to Follow-up|0|||
27627820|NCT00817635|80480269|FG003|Overall Study|Lost to Follow-up|1|||
27627821|NCT00817635|80480270|FG004|Overall Study|Lost to Follow-up|0|||
27627822|NCT00817635|80480266|FG000|Overall Study|Administrative Problems|0|||
27627823|NCT00817635|80480267|FG001|Overall Study|Administrative Problems|0|||
27627824|NCT00817635|80480268|FG002|Overall Study|Administrative Problems|0|||
27627825|NCT00817635|80480269|FG003|Overall Study|Administrative Problems|0|||
27627826|NCT00817635|80480270|FG004|Overall Study|Administrative Problems|1|||
27627827|NCT00817635|80480266|FG000|Overall Study|Protocol Violation|5|||
27627828|NCT00817635|80480267|FG001|Overall Study|Protocol Violation|1|||
27627829|NCT00817635|80480268|FG002|Overall Study|Protocol Violation|3|||
27627830|NCT00817635|80480269|FG003|Overall Study|Protocol Violation|2|||
27856943|NCT01908816|81310294|FG000|Overall Study|Death|1|||
27856944|NCT01908816|81310295|FG001|Overall Study|Death|0|||
27856945|NCT01908816|81310296|FG002|Overall Study|Death|7|||
27856946|NCT01908816|81310297|FG003|Overall Study|Death|1|||
27627831|NCT00817635|80480270|FG004|Overall Study|Protocol Violation|3|||
27627832|NCT01419717|80480272|FG000|Overall Study|Protocol-specified Criteria|62|||
27627833|NCT01419717|80480272|FG000|Overall Study|Adverse Event|19|||
27627834|NCT01419717|80480272|FG000|Overall Study|Death|17|||
27627835|NCT01419717|80480272|FG000|Overall Study|Withdrawal by Subject|10|||
27627836|NCT01419717|80480272|FG000|Overall Study|Disease Progression|9|||
27627837|NCT01419717|80480272|FG000|Overall Study|Other|4|||
27627838|NCT01419717|80480272|FG000|Overall Study|Lost to Follow-up|2|||
27627839|NCT01419717|80480272|FG000|Overall Study|Administrative Decision|1|||
27627840|NCT01419717|80480272|FG000|Overall Study|Noncompliance|1|||
27627841|NCT00357396|80480273|FG000|Overall Study|Adverse Event|1|||
27627842|NCT00357396|80480274|FG001|Overall Study|Adverse Event|0|||
27627843|NCT00984282|80480275|FG000|Double Blind Treatment|Adverse Event|40|||
27627844|NCT00984282|80480276|FG001|Double Blind Treatment|Adverse Event|6|||
27627845|NCT00984282|80480275|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
27627846|NCT00984282|80480276|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
27627847|NCT00984282|80480275|FG000|Double Blind Treatment|Physician Decision|1|||
27627848|NCT00984282|80480276|FG001|Double Blind Treatment|Physician Decision|2|||
27627849|NCT00984282|80480275|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
27627850|NCT00984282|80480276|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
27627851|NCT00984282|80480275|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
27627852|NCT00984282|80480276|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
27627853|NCT00984282|80480275|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
27627854|NCT00984282|80480276|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
27627855|NCT00984282|80480275|FG000|Double Blind Treatment|Lost to Follow-up|3|||
27627856|NCT00984282|80480276|FG001|Double Blind Treatment|Lost to Follow-up|0|||
27627857|NCT00984282|80480275|FG000|Double Blind Treatment|Death|8|||
27627858|NCT00984282|80480276|FG001|Double Blind Treatment|Death|4|||
27627859|NCT00984282|80480275|FG000|Double Blind Treatment|Not treated|0|||
27627860|NCT00984282|80480276|FG001|Double Blind Treatment|Not treated|1|||
27627861|NCT00984282|80480275|FG000|Double Blind Treatment|Switched to commercial drug|6|||
27627862|NCT00984282|80480276|FG001|Double Blind Treatment|Switched to commercial drug|1|||
27627863|NCT00984282|80480275|FG000|Double Blind Treatment|protocol driven decision point|1|||
27627864|NCT00984282|80480276|FG001|Double Blind Treatment|protocol driven decision point|1|||
27627865|NCT00984282|80480275|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
27912532|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912533|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912534|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
27912535|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912536|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912537|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912538|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912539|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912540|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912541|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912542|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
27912543|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912544|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912545|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912546|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912547|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912548|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912549|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912550|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912551|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
27912552|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912553|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27627866|NCT00984282|80480276|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
27627867|NCT00984282|80480275|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
27627868|NCT00984282|80480276|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
27627869|NCT00984282|80480275|FG000|Open-label Treatment|Adverse Event|20|||
27627870|NCT00984282|80480276|FG001|Open-label Treatment|Adverse Event|30|||
27627871|NCT00984282|80480275|FG000|Open-label Treatment|Withdrawal by Subject|6|||
27627872|NCT00984282|80480276|FG001|Open-label Treatment|Withdrawal by Subject|21|||
27627873|NCT00984282|80480275|FG000|Open-label Treatment|Death|7|||
27627874|NCT00984282|80480276|FG001|Open-label Treatment|Death|15|||
27627875|NCT00984282|80480275|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
27627876|NCT00984282|80480276|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
27627877|NCT00984282|80480275|FG000|Open-label Treatment|Lost to Follow-up|1|||
27627878|NCT00984282|80480276|FG001|Open-label Treatment|Lost to Follow-up|1|||
27627879|NCT00984282|80480275|FG000|Open-label Treatment|Patient convenience|1|||
27856947|NCT01908816|81310294|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27736279|NCT00491530|80864754|FG001|Overall Study|Investigator Discretion|1|||
27736280|NCT00491530|80864755|FG002|Overall Study|Investigator Discretion|0|||
27531582|NCT01400815|80141433|FG001|Overall Study|Withdrawal by Subject|8|||
27531583|NCT01400815|80141432|FG000|Overall Study|Subject in jail|1|||
27531584|NCT01400815|80141433|FG001|Overall Study|Subject in jail|0|||
27531585|NCT00943124|80141434|FG000|Period 1|Withdrawal by Subject|1|||
27531586|NCT00943124|80141435|FG001|Period 1|Withdrawal by Subject|1|||
27736281|NCT00491530|80864753|FG000|Overall Study|Patient Request|0|||
27736282|NCT00491530|80864754|FG001|Overall Study|Patient Request|1|||
27736283|NCT00491530|80864755|FG002|Overall Study|Patient Request|0|||
27736284|NCT00491530|80864753|FG000|Overall Study|Use of Prohibited Medication|0|||
27736285|NCT00491530|80864754|FG001|Overall Study|Use of Prohibited Medication|0|||
27736286|NCT00491530|80864755|FG002|Overall Study|Use of Prohibited Medication|1|||
27856948|NCT01908816|81310295|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27856949|NCT01908816|81310296|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
27856950|NCT01908816|81310297|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
27912554|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912555|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912556|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912557|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
27912558|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912559|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912560|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912561|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912562|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912563|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
27912564|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
27912565|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
27912566|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
27912567|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912568|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912569|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27531587|NCT00943124|80141434|FG000|Period 1|Did Not Follow Study Procedures|1|||
27912570|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912571|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27531588|NCT00943124|80141435|FG001|Period 1|Did Not Follow Study Procedures|0|||
27531589|NCT00943124|80141434|FG000|Period 1|Personal Reasons|0|||
27531590|NCT00943124|80141435|FG001|Period 1|Personal Reasons|1|||
27531591|NCT01954342|80141436|FG000|Overall Study|Missing data from 13-16week study visit|0|||
27531592|NCT01954342|80141437|FG001|Overall Study|Missing data from 13-16week study visit|0|||
27531593|NCT01954342|80141438|FG002|Overall Study|Missing data from 13-16week study visit|0|||
27531594|NCT01954342|80141439|FG003|Overall Study|Missing data from 13-16week study visit|1|||
27531595|NCT01954342|80141436|FG000|Overall Study|Miscarriage|0|||
27531596|NCT01954342|80141437|FG001|Overall Study|Miscarriage|0|||
27531597|NCT01954342|80141438|FG002|Overall Study|Miscarriage|0|||
27531598|NCT01954342|80141439|FG003|Overall Study|Miscarriage|3|||
27531599|NCT01954342|80141436|FG000|Overall Study|Lost to Follow-up|0|||
27531600|NCT01954342|80141437|FG001|Overall Study|Lost to Follow-up|0|||
27531601|NCT01954342|80141438|FG002|Overall Study|Lost to Follow-up|0|||
27531602|NCT01954342|80141439|FG003|Overall Study|Lost to Follow-up|5|||
27531603|NCT01954342|80141436|FG000|Overall Study|Preterm delivery|0|||
27531604|NCT01954342|80141437|FG001|Overall Study|Preterm delivery|0|||
27531605|NCT01954342|80141438|FG002|Overall Study|Preterm delivery|0|||
27531606|NCT01954342|80141439|FG003|Overall Study|Preterm delivery|3|||
27531607|NCT01954342|80141436|FG000|Overall Study|Pre-eclampsia|0|||
27531608|NCT01954342|80141437|FG001|Overall Study|Pre-eclampsia|0|||
27531609|NCT01954342|80141438|FG002|Overall Study|Pre-eclampsia|0|||
27531610|NCT01954342|80141439|FG003|Overall Study|Pre-eclampsia|4|||
27531611|NCT01954342|80141436|FG000|Overall Study|Unreliable Data|0|||
27531612|NCT01954342|80141437|FG001|Overall Study|Unreliable Data|0|||
27531613|NCT01954342|80141438|FG002|Overall Study|Unreliable Data|0|||
27531614|NCT01954342|80141439|FG003|Overall Study|Unreliable Data|2|||
27531615|NCT00697073|80141447|FG000|Overall Study|Withdrawal by Subject|2|||
27531616|NCT00697073|80141447|FG000|Overall Study|Pregnancy|1|||
27531617|NCT00697073|80141447|FG000|Overall Study|non compliance and other|6|||
27531618|NCT03139279|80141448|FG000|Overall Study|Physician Decision|2|||
27531619|NCT03139279|80141449|FG001|Overall Study|Physician Decision|0|||
27531620|NCT03139279|80141448|FG000|Overall Study|Protocol Violation|5|||
27531621|NCT03139279|80141449|FG001|Overall Study|Protocol Violation|4|||
27531622|NCT03139279|80141448|FG000|Overall Study|Withdrawal by Subject|0|||
27736287|NCT00117312|80864758|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
27736288|NCT00117312|80864759|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
27736289|NCT00117312|80864760|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
27736290|NCT00117312|80864761|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
27736291|NCT00117312|80864758|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
27736292|NCT00117312|80864759|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
27736293|NCT00117312|80864760|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
27736294|NCT00117312|80864761|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
27736295|NCT00117312|80864758|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
27736296|NCT00117312|80864759|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
27736297|NCT00117312|80864760|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
27736298|NCT00117312|80864761|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
27736299|NCT00117312|80864758|FG000|Overall Study|Other|0|||
27736300|NCT00117312|80864759|FG001|Overall Study|Other|1|||
27736301|NCT00117312|80864760|FG002|Overall Study|Other|3|||
27736302|NCT00117312|80864761|FG003|Overall Study|Other|1|||
27736303|NCT00117312|80864758|FG000|Overall Study|Patient choice|0|||
27736304|NCT00117312|80864759|FG001|Overall Study|Patient choice|0|||
27736305|NCT00117312|80864760|FG002|Overall Study|Patient choice|2|||
27736306|NCT00117312|80864761|FG003|Overall Study|Patient choice|1|||
27736307|NCT00117312|80864758|FG000|Overall Study|Adverse Event|0|||
27736308|NCT00117312|80864759|FG001|Overall Study|Adverse Event|2|||
27736309|NCT00117312|80864760|FG002|Overall Study|Adverse Event|0|||
27736310|NCT00117312|80864761|FG003|Overall Study|Adverse Event|0|||
27736311|NCT00117312|80864758|FG000|Overall Study|Protocol Violation|0|||
27736312|NCT00117312|80864759|FG001|Overall Study|Protocol Violation|1|||
27736313|NCT00117312|80864760|FG002|Overall Study|Protocol Violation|3|||
27736314|NCT00117312|80864761|FG003|Overall Study|Protocol Violation|0|||
27736315|NCT00117312|80864758|FG000|Overall Study|PSA decrease <=50%|0|||
27736316|NCT00117312|80864759|FG001|Overall Study|PSA decrease <=50%|2|||
27736317|NCT00117312|80864760|FG002|Overall Study|PSA decrease <=50%|2|||
27736318|NCT00117312|80864761|FG003|Overall Study|PSA decrease <=50%|4|||
27736319|NCT00117312|80864758|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
27736320|NCT00117312|80864759|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
27736321|NCT00117312|80864760|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
27736322|NCT00117312|80864761|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
27736323|NCT00117312|80864758|FG000|Overall Study|Hepatic abnormality|0|||
27736324|NCT00117312|80864759|FG001|Overall Study|Hepatic abnormality|1|||
27736325|NCT00117312|80864760|FG002|Overall Study|Hepatic abnormality|0|||
27736326|NCT00117312|80864761|FG003|Overall Study|Hepatic abnormality|1|||
27736327|NCT00117312|80864758|FG000|Overall Study|Withdrawal by Subject|0|||
27736328|NCT00117312|80864759|FG001|Overall Study|Withdrawal by Subject|2|||
27736329|NCT00117312|80864760|FG002|Overall Study|Withdrawal by Subject|0|||
27736330|NCT00117312|80864761|FG003|Overall Study|Withdrawal by Subject|0|||
27736331|NCT03022422|80864766|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
27736332|NCT03022422|80864767|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
27736333|NCT03022422|80864768|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
27736334|NCT03022422|80864769|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
27736335|NCT03022422|80864770|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
27736336|NCT03022422|80864771|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
27736337|NCT03517436|80864772|FG000|Overall Study|Death|3|||
27736338|NCT03517436|80864772|FG000|Overall Study|Withdrawal by Subject|4|||
27736339|NCT03517436|80864772|FG000|Overall Study|Did not receive study valve.|1|||
27736340|NCT02112448|80864773|FG000|Overall Study|lab values precluding use of ketorolac|2|||
27736341|NCT02112448|80864774|FG001|Overall Study|lab values precluding use of ketorolac|2|||
27856951|NCT01908816|81310294|FG000|Overall Study|Early termination|87|||
27856952|NCT01908816|81310295|FG001|Overall Study|Early termination|60|||
27856953|NCT01908816|81310296|FG002|Overall Study|Early termination|43|||
27856954|NCT01908816|81310297|FG003|Overall Study|Early termination|28|||
27856955|NCT01524679|81310299|FG000|Overall Study|Lost to Follow-up|1|||
27856956|NCT01524679|81310300|FG001|Overall Study|Lost to Follow-up|4|||
27856957|NCT01524679|81310299|FG000|Overall Study|Withdrawal by Subject|4|||
27856958|NCT01524679|81310300|FG001|Overall Study|Withdrawal by Subject|4|||
27856959|NCT01524679|81310299|FG000|Overall Study|Adverse Event|9|||
27856960|NCT01524679|81310300|FG001|Overall Study|Adverse Event|0|||
27856961|NCT01524679|81310299|FG000|Overall Study|Protocol Violation|1|||
27856962|NCT01524679|81310300|FG001|Overall Study|Protocol Violation|0|||
27856963|NCT01524679|81310299|FG000|Overall Study|Lack of Efficacy|2|||
27856964|NCT01524679|81310300|FG001|Overall Study|Lack of Efficacy|0|||
27856965|NCT01524679|81310299|FG000|Overall Study|e.g.wish for children, relocation|6|||
27856966|NCT01524679|81310300|FG001|Overall Study|e.g.wish for children, relocation|1|||
27736342|NCT02112448|80864773|FG000|Overall Study|Protocol Violation|1|||
27736343|NCT02112448|80864774|FG001|Overall Study|Protocol Violation|2|||
27736344|NCT02112448|80864773|FG000|Overall Study|Physician Decision|4|||
27736345|NCT02112448|80864774|FG001|Overall Study|Physician Decision|6|||
27736346|NCT02112448|80864773|FG000|Overall Study|required heparin so could not use ketoro|1|||
27736347|NCT02112448|80864774|FG001|Overall Study|required heparin so could not use ketoro|0|||
27736348|NCT04925570|80864781|FG000|Overall Study|Protocol Violation|24|||
27736349|NCT04925570|80864782|FG001|Overall Study|Protocol Violation|30|||
27531623|NCT03139279|80141449|FG001|Overall Study|Withdrawal by Subject|2|||
27531624|NCT04209348|80141450|FG000|Overall Study|Lost to Follow-up|1|||
27531625|NCT04209348|80141451|FG001|Overall Study|Lost to Follow-up|0|||
27531626|NCT01008150|80141452|FG000|Overall Study|did not receive study drug|1|||
27531627|NCT01008150|80141453|FG001|Overall Study|did not receive study drug|1|||
27531628|NCT01008150|80141454|FG002|Overall Study|did not receive study drug|1|||
27531629|NCT01008150|80141455|FG003|Overall Study|did not receive study drug|0|||
27531630|NCT02294773|80141456|FG000|Overall Study|Withdrawal by Subject|0|||
27531631|NCT02294773|80141457|FG001|Overall Study|Withdrawal by Subject|2|||
27531632|NCT00853073|80141458|FG000|Overall Study|Withdrawal by Subject|3|||
27531633|NCT00853073|80141459|FG001|Overall Study|Withdrawal by Subject|2|||
27531634|NCT01986907|80141460|FG000|Overall Study|Adverse Event|11|||
27531635|NCT01986907|80141460|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
27531636|NCT01986907|80141460|FG000|Overall Study|Protocol Violation|4|||
27531637|NCT01986907|80141460|FG000|Overall Study|Withdrawal by Subject|76|||
27531638|NCT01986907|80141460|FG000|Overall Study|Lost to Follow-up|38|||
27531639|NCT01986907|80141460|FG000|Overall Study|Death|9|||
27531640|NCT01226043|80141473|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
27531641|NCT01226043|80141474|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
27531642|NCT01226043|80141475|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
27736350|NCT04925570|80864781|FG000|Overall Study|Withdrawal by Subject|0|||
27736351|NCT04925570|80864782|FG001|Overall Study|Withdrawal by Subject|2|||
27736352|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
27736353|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
27736354|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
27736355|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
27736356|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
27531643|NCT01226043|80141476|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
27531644|NCT01226043|80141473|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
27531645|NCT01226043|80141474|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
27531646|NCT01226043|80141475|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
27531647|NCT01226043|80141476|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
27627880|NCT00984282|80480276|FG001|Open-label Treatment|Patient convenience|0|||
27627881|NCT00984282|80480275|FG000|Open-label Treatment|Non-compliant with study medication|1|||
27627882|NCT00984282|80480276|FG001|Open-label Treatment|Non-compliant with study medication|0|||
27627883|NCT00984282|80480275|FG000|Open-label Treatment|Target lesion removed|0|||
27627884|NCT00984282|80480276|FG001|Open-label Treatment|Target lesion removed|1|||
27627885|NCT00984282|80480275|FG000|Open-label Treatment|Protocol driven decision point|1|||
27627886|NCT00984282|80480276|FG001|Open-label Treatment|Protocol driven decision point|1|||
27627887|NCT00984282|80480275|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
27627888|NCT00984282|80480276|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
27627889|NCT00984282|80480275|FG000|Open-label Treatment|Switched to commercial drug|6|||
27627890|NCT00984282|80480276|FG001|Open-label Treatment|Switched to commercial drug|7|||
27627891|NCT00984282|80480275|FG000|Open-label Treatment|Physician Decision|1|||
27627892|NCT00984282|80480276|FG001|Open-label Treatment|Physician Decision|0|||
27627893|NCT00984282|80480275|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
27627894|NCT00984282|80480276|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
27627895|NCT00984282|80480275|FG000|Long Term Follow-up|Death|27|||
27627896|NCT00984282|80480276|FG001|Long Term Follow-up|Death|68|||
27627897|NCT00984282|80480275|FG000|Long Term Follow-up|Lost to Follow-up|3|||
27627898|NCT00984282|80480276|FG001|Long Term Follow-up|Lost to Follow-up|6|||
27627899|NCT00984282|80480275|FG000|Long Term Follow-up|Protocol driven decision point|25|||
27736357|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
27736358|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
27736359|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
27627900|NCT00984282|80480276|FG001|Long Term Follow-up|Protocol driven decision point|26|||
27627901|NCT00984282|80480275|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
27736360|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
27736361|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
27736362|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
27736363|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
27736364|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
27856967|NCT02272634|81310313|FG000|Overall Study|Adverse Event|1|||
27531648|NCT01226043|80141473|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
27531649|NCT01226043|80141474|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
27531650|NCT01226043|80141475|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
27531651|NCT01226043|80141476|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
27531652|NCT01226043|80141473|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
27531653|NCT01226043|80141474|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
27531654|NCT01226043|80141475|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
27736365|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
27736366|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
27736367|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
27736368|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
27736369|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
27736370|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
27736371|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
27736372|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Death|0|||
27736373|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Death|1|||
27856968|NCT02272634|81310314|FG001|Overall Study|Adverse Event|0|||
27856969|NCT02272634|81310315|FG002|Overall Study|Adverse Event|0|||
27856970|NCT02272634|81310313|FG000|Overall Study|Protocol Violation|0|||
27856971|NCT02272634|81310314|FG001|Overall Study|Protocol Violation|0|||
27856972|NCT02272634|81310315|FG002|Overall Study|Protocol Violation|1|||
27856973|NCT02272634|81310313|FG000|Overall Study|Withdrawal by Subject|0|||
27856974|NCT02272634|81310314|FG001|Overall Study|Withdrawal by Subject|1|||
27856975|NCT02272634|81310315|FG002|Overall Study|Withdrawal by Subject|0|||
27856976|NCT03222583|81310321|FG000|Overall Study|Withdrawal by Subject|3|||
27856977|NCT03222583|81310322|FG001|Overall Study|Withdrawal by Subject|3|||
27856978|NCT03222583|81310321|FG000|Overall Study|Lost to Follow-up|1|||
27856979|NCT03222583|81310322|FG001|Overall Study|Lost to Follow-up|0|||
27856980|NCT03222583|81310321|FG000|Overall Study|Other|1|||
27531655|NCT01226043|80141476|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
27531656|NCT01226043|80141473|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
27531657|NCT01226043|80141474|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
27531658|NCT01226043|80141475|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
27531659|NCT01226043|80141476|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
27531660|NCT01226043|80141473|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
27531661|NCT01226043|80141474|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
27531662|NCT01226043|80141475|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
27531663|NCT01226043|80141476|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
27531664|NCT01226043|80141473|FG000|6-week Re-randomization Phase|Adverse Event|0|||
27531665|NCT01226043|80141474|FG001|6-week Re-randomization Phase|Adverse Event|0|||
27531666|NCT01226043|80141475|FG002|6-week Re-randomization Phase|Adverse Event|1|||
27531667|NCT01226043|80141476|FG003|6-week Re-randomization Phase|Adverse Event|1|||
27531668|NCT01226043|80141473|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
27531669|NCT01226043|80141474|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
27531670|NCT01226043|80141475|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
27531671|NCT01226043|80141476|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
27531672|NCT01226043|80141473|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
27531673|NCT01226043|80141474|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
27531674|NCT01226043|80141475|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
27531675|NCT01226043|80141476|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
27531676|NCT01226043|80141473|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
27531677|NCT01226043|80141474|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
27531678|NCT01226043|80141475|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
27531679|NCT01226043|80141476|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
27531680|NCT01226043|80141473|FG000|6-week Re-randomization Phase|Physician Decision|0|||
27531681|NCT01226043|80141474|FG001|6-week Re-randomization Phase|Physician Decision|0|||
27531682|NCT01226043|80141475|FG002|6-week Re-randomization Phase|Physician Decision|3|||
27531683|NCT01226043|80141476|FG003|6-week Re-randomization Phase|Physician Decision|2|||
27531684|NCT01226043|80141473|FG000|6-week Re-randomization Phase|completed in error|0|||
27531685|NCT01226043|80141474|FG001|6-week Re-randomization Phase|completed in error|0|||
27531686|NCT01226043|80141475|FG002|6-week Re-randomization Phase|completed in error|0|||
27531687|NCT01226043|80141476|FG003|6-week Re-randomization Phase|completed in error|1|||
27531688|NCT01226043|80141473|FG000|30-week Observational Phase|Adverse Event|0|||
27531689|NCT01226043|80141474|FG001|30-week Observational Phase|Adverse Event|0|||
27531690|NCT01226043|80141475|FG002|30-week Observational Phase|Adverse Event|1|||
27531691|NCT01226043|80141476|FG003|30-week Observational Phase|Adverse Event|1|||
27531692|NCT01226043|80141473|FG000|30-week Observational Phase|Protocol Violation|0|||
27736374|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Death|0|||
27736375|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Death|0|||
27531693|NCT01226043|80141474|FG001|30-week Observational Phase|Protocol Violation|0|||
27531694|NCT01226043|80141475|FG002|30-week Observational Phase|Protocol Violation|0|||
27531695|NCT01226043|80141476|FG003|30-week Observational Phase|Protocol Violation|1|||
27531696|NCT01226043|80141473|FG000|30-week Observational Phase|Lost to Follow-up|0|||
27627902|NCT00984282|80480276|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
27736376|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Death|0|||
27856981|NCT03222583|81310322|FG001|Overall Study|Other|3|||
27856982|NCT04091659|81310323|FG000|Overall Study|Protocol Violation|3|||
27856983|NCT04091659|81310324|FG001|Overall Study|Protocol Violation|0|||
27531697|NCT01226043|80141474|FG001|30-week Observational Phase|Lost to Follow-up|0|||
27531698|NCT01226043|80141475|FG002|30-week Observational Phase|Lost to Follow-up|2|||
27531699|NCT01226043|80141476|FG003|30-week Observational Phase|Lost to Follow-up|2|||
27531700|NCT01226043|80141473|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
27531701|NCT01226043|80141474|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
27531702|NCT01226043|80141475|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
27531703|NCT01226043|80141476|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
27531704|NCT01226043|80141473|FG000|30-week Observational Phase|Physician Decision|0|||
27531705|NCT01226043|80141474|FG001|30-week Observational Phase|Physician Decision|0|||
27531706|NCT01226043|80141475|FG002|30-week Observational Phase|Physician Decision|2|||
27531707|NCT01226043|80141476|FG003|30-week Observational Phase|Physician Decision|2|||
27531708|NCT02808650|80141477|FG000|Overall Study|Death|0|||
27531709|NCT02808650|80141478|FG001|Overall Study|Death|0|||
27531710|NCT02808650|80141479|FG002|Overall Study|Death|0|||
27531711|NCT02808650|80141480|FG003|Overall Study|Death|0|||
27531712|NCT02808650|80141481|FG004|Overall Study|Death|1|||
27531713|NCT02808650|80141477|FG000|Overall Study|Lack of Efficacy|5|||
27531714|NCT02808650|80141478|FG001|Overall Study|Lack of Efficacy|5|||
27531715|NCT02808650|80141479|FG002|Overall Study|Lack of Efficacy|6|||
27531716|NCT02808650|80141480|FG003|Overall Study|Lack of Efficacy|5|||
27531717|NCT02808650|80141481|FG004|Overall Study|Lack of Efficacy|4|||
27531718|NCT02808650|80141477|FG000|Overall Study|Physician Decision|1|||
27531719|NCT02808650|80141478|FG001|Overall Study|Physician Decision|1|||
27531720|NCT02808650|80141479|FG002|Overall Study|Physician Decision|0|||
27531721|NCT02808650|80141480|FG003|Overall Study|Physician Decision|0|||
27531722|NCT02808650|80141481|FG004|Overall Study|Physician Decision|0|||
27531723|NCT02808650|80141477|FG000|Overall Study|Withdrawal by Subject|0|||
27531724|NCT02808650|80141478|FG001|Overall Study|Withdrawal by Subject|0|||
27531725|NCT02808650|80141479|FG002|Overall Study|Withdrawal by Subject|0|||
27531726|NCT02808650|80141480|FG003|Overall Study|Withdrawal by Subject|1|||
27531727|NCT02808650|80141481|FG004|Overall Study|Withdrawal by Subject|1|||
27531728|NCT04365257|80141486|FG000|Overall Study|Physician Decision|1|||
27531729|NCT04365257|80141487|FG001|Overall Study|Physician Decision|0|||
27531730|NCT04365257|80141486|FG000|Overall Study|Patient Noncompliance|1|||
27531731|NCT04365257|80141487|FG001|Overall Study|Patient Noncompliance|0|||
27531732|NCT04365257|80141486|FG000|Overall Study|Withdrawal by Subject|0|||
27627903|NCT00984282|80480275|FG000|Long Term Follow-up|Switched to commercial drug|4|||
27627904|NCT00984282|80480276|FG001|Long Term Follow-up|Switched to commercial drug|2|||
27736377|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
27736378|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
27736379|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
27736380|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
27736381|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
27736382|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
27736383|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
27736384|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
27736385|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
27736386|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
27736387|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
27736388|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
27736389|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
27736390|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
27736391|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
27736392|NCT05087030|80864785|FG000|Main Period (Week 0 to Week 52)|Other|1|||
27736393|NCT05087030|80864786|FG001|Main Period (Week 0 to Week 52)|Other|2|||
27736394|NCT05087030|80864787|FG002|Main Period (Week 0 to Week 52)|Other|0|||
27736395|NCT05087030|80864788|FG003|Main Period (Week 0 to Week 52)|Other|0|||
27736396|NCT05087030|80864789|FG004|Main Period (Week 0 to Week 52)|Other|0|||
27736397|NCT05087030|80864785|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
27736398|NCT05087030|80864786|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
27736399|NCT05087030|80864787|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
27736400|NCT05087030|80864788|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
27736401|NCT05087030|80864789|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
27736402|NCT02500550|80864794|FG000|Overall Study|Death|7|||
27736403|NCT02468193|80864795|FG000|Overall Study|Adverse Event|4|||
27531733|NCT04365257|80141487|FG001|Overall Study|Withdrawal by Subject|1|||
27531734|NCT02024529|80141489|FG000|Overall Study|Withdrawal by Subject|11|||
27531735|NCT02024529|80141490|FG001|Overall Study|Withdrawal by Subject|21|||
27531736|NCT02024529|80141489|FG000|Overall Study|Lost to Follow-up|2|||
27531737|NCT02024529|80141490|FG001|Overall Study|Lost to Follow-up|4|||
27531738|NCT00054717|80141491|FG000|Overall Study|Randomized but not treated|2|||
27856984|NCT04091659|81310323|FG000|Overall Study|Lost to Follow-up|0|||
27856985|NCT04091659|81310324|FG001|Overall Study|Lost to Follow-up|1|||
27856986|NCT04730349|81310325|FG000|Overall Study|Participant withdrew consent|1|||
27856987|NCT04730349|81310326|FG001|Overall Study|Participant withdrew consent|0|||
27531739|NCT00054717|80141492|FG001|Overall Study|Randomized but not treated|8|||
27531740|NCT00054717|80141491|FG000|Overall Study|Adverse Event|70|||
27531741|NCT00054717|80141492|FG001|Overall Study|Adverse Event|22|||
27531742|NCT00054717|80141491|FG000|Overall Study|Protocol Violation|18|||
27531743|NCT00054717|80141492|FG001|Overall Study|Protocol Violation|19|||
27531744|NCT00054717|80141491|FG000|Overall Study|Lost to Follow-up|23|||
27531745|NCT00054717|80141492|FG001|Overall Study|Lost to Follow-up|13|||
27531746|NCT00054717|80141491|FG000|Overall Study|Withdrawal by Subject|32|||
27531747|NCT00054717|80141492|FG001|Overall Study|Withdrawal by Subject|20|||
27531748|NCT00054717|80141491|FG000|Overall Study|Other reason not defined above|117|||
27531749|NCT00054717|80141492|FG001|Overall Study|Other reason not defined above|217|||
27736404|NCT02468193|80864795|FG000|Overall Study|Subject/ Guardian decision|2|||
27736405|NCT03240081|80864796|FG000|Overall Study|Withdrawal by Subject|0|||
27736406|NCT03240081|80864797|FG001|Overall Study|Withdrawal by Subject|2|||
27736407|NCT03240081|80864796|FG000|Overall Study|Lost to Follow-up|0|||
27736408|NCT03240081|80864797|FG001|Overall Study|Lost to Follow-up|1|||
27736409|NCT00998738|80864800|FG000|Overall Study|Uknown|1|||
27736410|NCT03486314|80864801|FG000|Part A|Adverse Event|1|||
27736411|NCT03486314|80864802|FG001|Part A|Adverse Event|0|||
27736412|NCT03486314|80864803|FG002|Part A|Adverse Event|0|||
27736413|NCT03486314|80864801|FG000|Part A|Symptomatic Deterioration|2|||
27736414|NCT03486314|80864802|FG001|Part A|Symptomatic Deterioration|0|||
27736415|NCT03486314|80864803|FG002|Part A|Symptomatic Deterioration|0|||
27736416|NCT00892437|80864804|FG000|Randomized Phase|Randomized but not treated|6|||
27736417|NCT00892437|80864805|FG001|Randomized Phase|Randomized but not treated|0|||
27736418|NCT00892437|80864804|FG000|Randomized Phase|Adverse Event|2|||
27736419|NCT00892437|80864805|FG001|Randomized Phase|Adverse Event|2|||
27736420|NCT00892437|80864804|FG000|Randomized Phase|Lost to Follow-up|1|||
27736421|NCT00892437|80864805|FG001|Randomized Phase|Lost to Follow-up|3|||
27736422|NCT00892437|80864804|FG000|Randomized Phase|Investigator's Discretion|1|||
27736423|NCT00892437|80864805|FG001|Randomized Phase|Investigator's Discretion|0|||
27736424|NCT00892437|80864804|FG000|Randomized Phase|Withdrew Consent|1|||
27736425|NCT00892437|80864805|FG001|Randomized Phase|Withdrew Consent|0|||
27736426|NCT00892437|80864804|FG000|Open-Label Extension Phase|Adverse Event|4|||
27736427|NCT00892437|80864805|FG001|Open-Label Extension Phase|Adverse Event|2|||
27736428|NCT00892437|80864804|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
27736429|NCT00892437|80864805|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
27736430|NCT00892437|80864804|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
27736431|NCT00892437|80864805|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
27736432|NCT00892437|80864804|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
27736433|NCT00892437|80864805|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
27736434|NCT00892437|80864804|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
27736435|NCT00892437|80864805|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
27736436|NCT01241786|80864806|FG000|Overall Study|Lack of Efficacy|5|||
27736437|NCT02649634|80864809|FG000|Overall Study|Withdrawal by Subject|3|||
27736438|NCT02649634|80864810|FG001|Overall Study|Withdrawal by Subject|5|||
27736439|NCT02649634|80864809|FG000|Overall Study|Lost to Follow-up|0|||
27736440|NCT02649634|80864810|FG001|Overall Study|Lost to Follow-up|1|||
27736441|NCT01073943|80864818|FG000|Overall Study|Withdrawal by Subject|8|||
27736442|NCT01073943|80864819|FG001|Overall Study|Withdrawal by Subject|2|||
27736443|NCT01073943|80864818|FG000|Overall Study|Protocol Violation|2|||
27736444|NCT01073943|80864819|FG001|Overall Study|Protocol Violation|1|||
27736445|NCT01073943|80864818|FG000|Overall Study|Adverse Event|1|||
27736446|NCT01073943|80864819|FG001|Overall Study|Adverse Event|1|||
27736447|NCT01073943|80864818|FG000|Overall Study|Lost to Follow-up|0|||
27736448|NCT01073943|80864819|FG001|Overall Study|Lost to Follow-up|2|||
27736449|NCT01073943|80864818|FG000|Overall Study|Power outage; colonoscopy not done|1|||
27736450|NCT01073943|80864819|FG001|Overall Study|Power outage; colonoscopy not done|0|||
27856988|NCT04730349|81310325|FG000|Overall Study|Disease progression|6|||
27531750|NCT01907100|80141493|FG000|Overall Study|PD based on modified RECIST criteria|31|||
27531751|NCT01907100|80141494|FG001|Overall Study|PD based on modified RECIST criteria|32|||
27736451|NCT01073943|80864818|FG000|Overall Study|Subject forgot|0|||
27736452|NCT01073943|80864819|FG001|Overall Study|Subject forgot|1|||
27736453|NCT01073943|80864818|FG000|Overall Study|Unable to return for follow-up|0|||
27736454|NCT01073943|80864819|FG001|Overall Study|Unable to return for follow-up|1|||
27736455|NCT01073943|80864818|FG000|Overall Study|Could not tolerate prep|1|||
27736456|NCT01073943|80864819|FG001|Overall Study|Could not tolerate prep|0|||
27736457|NCT02863848|80864822|FG000|Overall Study|Lost to Follow-up|1|||
27736458|NCT02863848|80864823|FG001|Overall Study|Lost to Follow-up|1|||
27736459|NCT02863848|80864822|FG000|Overall Study|Protocol Violation|1|||
27736460|NCT02863848|80864823|FG001|Overall Study|Protocol Violation|2|||
27736461|NCT01662999|80864827|FG000|Period 3|Withdrawal by Subject|0|||
27736462|NCT01662999|80864828|FG001|Period 3|Withdrawal by Subject|1|||
27736463|NCT01662999|80864829|FG002|Period 3|Withdrawal by Subject|0|||
27736464|NCT01662999|80864830|FG003|Period 3|Withdrawal by Subject|0|||
27736465|NCT01662999|80864831|FG004|Period 3|Withdrawal by Subject|0|||
27736466|NCT01662999|80864832|FG005|Period 3|Withdrawal by Subject|0|||
27736467|NCT00986349|80864835|FG000|Overall Study|Unsuccessful implant procedure|3|||
27736468|NCT00986349|80864835|FG000|Overall Study|Adverse Event|2|||
27736469|NCT00986349|80864835|FG000|Overall Study|Physician Decision|1|||
27736470|NCT00986349|80864835|FG000|Overall Study|device migration|1|||
27736471|NCT01051739|80864836|FG000|Overall Study|Death|3|||
27736472|NCT01051739|80864837|FG001|Overall Study|Death|3|||
27736473|NCT01051739|80864836|FG000|Overall Study|Withdrawal by Subject|25|||
27736474|NCT01051739|80864837|FG001|Overall Study|Withdrawal by Subject|10|||
27736475|NCT01973283|80864838|FG000|Overall Study|Lost to Follow-up|4|||
27736476|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
27736477|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
27736478|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
27736479|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
27736480|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
27736481|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
27736482|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Personal issues|2|||
27736483|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Personal issues|0|||
27736484|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Personal issues|0|||
27736485|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Too busy|7|||
27736486|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Too busy|1|||
27736487|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Too busy|0|||
27736488|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Pain|2|||
27736489|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Pain|0|||
27736490|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Pain|0|||
27736491|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Moved|1|||
27736492|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Moved|0|||
27736493|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Moved|0|||
27736494|NCT00594399|80864839|FG000|Initial 3 Month Counseling|Family illness|1|||
27736495|NCT00594399|80864840|FG001|Initial 3 Month Counseling|Family illness|0|||
27736496|NCT00594399|80864841|FG002|Initial 3 Month Counseling|Family illness|0|||
27736497|NCT00594399|80864839|FG000|Rerandomization Arm 1 Only|Death|2|||
27912572|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
27912573|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912574|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912575|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912576|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912577|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912578|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
27912579|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912580|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912581|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27736498|NCT00594399|80864840|FG001|Rerandomization Arm 1 Only|Death|1|||
27736499|NCT00594399|80864841|FG002|Rerandomization Arm 1 Only|Death|0|||
27736500|NCT00594399|80864839|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
27736501|NCT00594399|80864840|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
27736502|NCT00594399|80864841|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
27856989|NCT04730349|81310326|FG001|Overall Study|Disease progression|4|||
27856990|NCT04730349|81310325|FG000|Overall Study|Study drug toxicity|0|||
27856991|NCT04730349|81310326|FG001|Overall Study|Study drug toxicity|1|||
27856992|NCT00807248|81310329|FG000|Overall Study|Adverse Event|1|||
27856993|NCT00807248|81310330|FG001|Overall Study|Adverse Event|2|||
27856994|NCT00807248|81310331|FG002|Overall Study|Adverse Event|2|||
27856995|NCT00807248|81310332|FG003|Overall Study|Adverse Event|6|||
27856996|NCT00807248|81310329|FG000|Overall Study|Lack of Efficacy|14|||
27856997|NCT00807248|81310330|FG001|Overall Study|Lack of Efficacy|4|||
27856998|NCT00807248|81310331|FG002|Overall Study|Lack of Efficacy|8|||
27736503|NCT04321343|80864842|FG000|Overall Study|Adverse Event|0|||
27736504|NCT04321343|80864843|FG001|Overall Study|Adverse Event|0|||
27736505|NCT04321343|80864844|FG002|Overall Study|Adverse Event|1|||
27736506|NCT04321343|80864845|FG003|Overall Study|Adverse Event|0|||
27736507|NCT04321343|80864842|FG000|Overall Study|Death|0|||
27736508|NCT04321343|80864843|FG001|Overall Study|Death|0|||
27856999|NCT00807248|81310332|FG003|Overall Study|Lack of Efficacy|3|||
27736509|NCT04321343|80864844|FG002|Overall Study|Death|0|||
27857000|NCT00807248|81310329|FG000|Overall Study|Protocol Violation|0|||
27736510|NCT04321343|80864845|FG003|Overall Study|Death|1|||
27857001|NCT00807248|81310330|FG001|Overall Study|Protocol Violation|1|||
27857002|NCT00807248|81310331|FG002|Overall Study|Protocol Violation|1|||
27531752|NCT01907100|80141495|FG002|Overall Study|PD based on modified RECIST criteria|95|||
27531753|NCT01907100|80141496|FG003|Overall Study|PD based on modified RECIST criteria|92|||
27531754|NCT01907100|80141493|FG000|Overall Study|Withdrawal by Subject|2|||
27531755|NCT01907100|80141494|FG001|Overall Study|Withdrawal by Subject|5|||
27531756|NCT01907100|80141495|FG002|Overall Study|Withdrawal by Subject|10|||
27531757|NCT01907100|80141496|FG003|Overall Study|Withdrawal by Subject|13|||
27531758|NCT01907100|80141493|FG000|Overall Study|Protocol Violation|0|||
27531759|NCT01907100|80141494|FG001|Overall Study|Protocol Violation|0|||
27531760|NCT01907100|80141495|FG002|Overall Study|Protocol Violation|1|||
27531761|NCT01907100|80141496|FG003|Overall Study|Protocol Violation|1|||
27531762|NCT01907100|80141493|FG000|Overall Study|Lost to Follow-up|0|||
27531763|NCT01907100|80141494|FG001|Overall Study|Lost to Follow-up|0|||
27531764|NCT01907100|80141495|FG002|Overall Study|Lost to Follow-up|0|||
27531765|NCT01907100|80141496|FG003|Overall Study|Lost to Follow-up|1|||
27531766|NCT01907100|80141493|FG000|Overall Study|Not treated|2|||
27531767|NCT01907100|80141494|FG001|Overall Study|Not treated|0|||
27531768|NCT01907100|80141495|FG002|Overall Study|Not treated|1|||
27531769|NCT01907100|80141496|FG003|Overall Study|Not treated|2|||
27531770|NCT01907100|80141493|FG000|Overall Study|Other than reasons specified|1|||
27531771|NCT01907100|80141494|FG001|Overall Study|Other than reasons specified|0|||
27531772|NCT01907100|80141495|FG002|Overall Study|Other than reasons specified|10|||
27531773|NCT01907100|80141496|FG003|Overall Study|Other than reasons specified|6|||
27531774|NCT01907100|80141493|FG000|Overall Study|Adverse event (AE)|6|||
27531775|NCT01907100|80141494|FG001|Overall Study|Adverse event (AE)|3|||
27531776|NCT01907100|80141495|FG002|Overall Study|Adverse event (AE)|22|||
27531777|NCT01907100|80141496|FG003|Overall Study|Adverse event (AE)|23|||
27531778|NCT01907100|80141493|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
27531779|NCT01907100|80141494|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
27531780|NCT01907100|80141495|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
27531781|NCT01907100|80141496|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
27531782|NCT02966873|80141502|FG000|Overall Study|Lost to Follow-up|16|||
27531783|NCT02966873|80141503|FG001|Overall Study|Lost to Follow-up|15|||
27531784|NCT00423670|80141504|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
27531785|NCT00423670|80141505|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531786|NCT00423670|80141506|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531787|NCT00423670|80141507|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531788|NCT00423670|80141508|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531789|NCT00423670|80141509|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531790|NCT00423670|80141510|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531791|NCT00423670|80141511|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
27531792|NCT00423670|80141504|FG000|Treatment Period|Adverse Event|8|||
27531793|NCT00423670|80141505|FG001|Treatment Period|Adverse Event|12|||
27531794|NCT00423670|80141506|FG002|Treatment Period|Adverse Event|15|||
27531795|NCT00423670|80141507|FG003|Treatment Period|Adverse Event|20|||
27531796|NCT00423670|80141508|FG004|Treatment Period|Adverse Event|9|||
27531797|NCT00423670|80141509|FG005|Treatment Period|Adverse Event|4|||
27531798|NCT00423670|80141510|FG006|Treatment Period|Adverse Event|7|||
27531799|NCT00423670|80141511|FG007|Treatment Period|Adverse Event|2|||
27531800|NCT00423670|80141504|FG000|Treatment Period|Protocol-defined clinical event|0|||
27531801|NCT00423670|80141505|FG001|Treatment Period|Protocol-defined clinical event|7|||
27531802|NCT00423670|80141506|FG002|Treatment Period|Protocol-defined clinical event|4|||
27531803|NCT00423670|80141507|FG003|Treatment Period|Protocol-defined clinical event|12|||
27531804|NCT00423670|80141508|FG004|Treatment Period|Protocol-defined clinical event|5|||
27531805|NCT00423670|80141509|FG005|Treatment Period|Protocol-defined clinical event|4|||
27531806|NCT00423670|80141510|FG006|Treatment Period|Protocol-defined clinical event|16|||
27531807|NCT00423670|80141511|FG007|Treatment Period|Protocol-defined clinical event|15|||
27531808|NCT00423670|80141504|FG000|Treatment Period|Lost to Follow-up|2|||
27531809|NCT00423670|80141505|FG001|Treatment Period|Lost to Follow-up|1|||
27531810|NCT00423670|80141506|FG002|Treatment Period|Lost to Follow-up|3|||
27531811|NCT00423670|80141507|FG003|Treatment Period|Lost to Follow-up|1|||
27531812|NCT00423670|80141508|FG004|Treatment Period|Lost to Follow-up|6|||
27531813|NCT00423670|80141509|FG005|Treatment Period|Lost to Follow-up|0|||
27531814|NCT00423670|80141510|FG006|Treatment Period|Lost to Follow-up|3|||
27531815|NCT00423670|80141511|FG007|Treatment Period|Lost to Follow-up|1|||
27531816|NCT00423670|80141504|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
27531817|NCT00423670|80141505|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
27857003|NCT00807248|81310332|FG003|Overall Study|Protocol Violation|0|||
27857004|NCT00807248|81310329|FG000|Overall Study|Withdrawal of Consent|5|||
27531818|NCT00423670|80141506|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
27531819|NCT00423670|80141507|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
27531820|NCT00423670|80141508|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
27531821|NCT00423670|80141509|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
27531822|NCT00423670|80141510|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
27531823|NCT00423670|80141511|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
27627905|NCT00984282|80480275|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
27627906|NCT00984282|80480276|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
27736511|NCT04321343|80864842|FG000|Overall Study|Pregnancy|1|||
27736512|NCT04321343|80864843|FG001|Overall Study|Pregnancy|0|||
27736513|NCT04321343|80864844|FG002|Overall Study|Pregnancy|0|||
27736514|NCT04321343|80864845|FG003|Overall Study|Pregnancy|0|||
27736515|NCT04321343|80864842|FG000|Overall Study|Protocol Violation|1|||
27857005|NCT00807248|81310330|FG001|Overall Study|Withdrawal of Consent|5|||
27857006|NCT00807248|81310331|FG002|Overall Study|Withdrawal of Consent|5|||
27912582|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912583|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912584|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912585|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912586|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912587|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
27912588|NCT02326272|81518167|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912589|NCT02326272|81518168|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912590|NCT02326272|81518169|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912591|NCT02326272|81518170|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912592|NCT02326272|81518171|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912593|NCT02326272|81518172|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912594|NCT02326272|81518173|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
27912595|NCT02326272|81518174|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912596|NCT02326272|81518175|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912597|NCT02326272|81518176|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27531824|NCT00423670|80141504|FG000|Treatment Period|Investigator decision|0|||
27531825|NCT00423670|80141505|FG001|Treatment Period|Investigator decision|0|||
27531826|NCT00423670|80141506|FG002|Treatment Period|Investigator decision|0|||
27531827|NCT00423670|80141507|FG003|Treatment Period|Investigator decision|0|||
27531828|NCT00423670|80141508|FG004|Treatment Period|Investigator decision|0|||
27531829|NCT00423670|80141509|FG005|Treatment Period|Investigator decision|0|||
27531830|NCT00423670|80141510|FG006|Treatment Period|Investigator decision|0|||
27531831|NCT00423670|80141511|FG007|Treatment Period|Investigator decision|1|||
27531832|NCT00423670|80141504|FG000|Treatment Period|Non-compliance with protocol|3|||
27857007|NCT00807248|81310332|FG003|Overall Study|Withdrawal of Consent|5|||
27857008|NCT00807248|81310329|FG000|Overall Study|Lost to Follow-up|1|||
27857009|NCT00807248|81310330|FG001|Overall Study|Lost to Follow-up|0|||
27857010|NCT00807248|81310331|FG002|Overall Study|Lost to Follow-up|0|||
27857011|NCT00807248|81310332|FG003|Overall Study|Lost to Follow-up|0|||
27857012|NCT00807248|81310329|FG000|Overall Study|Other Reason|0|||
27857013|NCT00807248|81310330|FG001|Overall Study|Other Reason|0|||
27857014|NCT00807248|81310331|FG002|Overall Study|Other Reason|2|||
27857015|NCT00807248|81310332|FG003|Overall Study|Other Reason|0|||
27627907|NCT04565249|80480279|FG000|Overall Study|Death|0|||
27736516|NCT04321343|80864843|FG001|Overall Study|Protocol Violation|1|||
27736517|NCT04321343|80864844|FG002|Overall Study|Protocol Violation|1|||
27857016|NCT01268501|81310333|FG000|Overall Study|Lost to Follow-up|1|||
27857017|NCT01268501|81310333|FG000|Overall Study|Withdrawal by Subject|3|||
27857018|NCT01268501|81310333|FG000|Overall Study|Unacceptable Subjective Vision|3|||
27857019|NCT01268501|81310333|FG000|Overall Study|Handling Difficulties|2|||
27857020|NCT01195103|81310335|FG000|Overall Study|Withdrawal by Subject|1|||
27857021|NCT01195103|81310336|FG001|Overall Study|Withdrawal by Subject|0|||
27857022|NCT01195103|81310337|FG002|Overall Study|Withdrawal by Subject|0|||
27857023|NCT02588950|81310338|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
27857024|NCT02588950|81310339|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
27857025|NCT02588950|81310340|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
27857026|NCT02588950|81310341|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
27857027|NCT02588950|81310338|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
27857028|NCT02588950|81310339|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
27857029|NCT02588950|81310340|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
27857030|NCT02588950|81310341|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
27857031|NCT02303041|81310345|FG000|Overall Study|Adverse Event|1|||
27857032|NCT02303041|81310346|FG001|Overall Study|Adverse Event|2|||
27857033|NCT01372774|81310347|FG000|Overall Study|Withdrawal prior to treatment|4|||
27857034|NCT01372774|81310348|FG001|Overall Study|Withdrawal prior to treatment|5|||
27857035|NCT02365558|81310354|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
27857036|NCT02365558|81310355|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
27857037|NCT02365558|81310354|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
27857038|NCT02365558|81310355|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
27857039|NCT01214915|81310356|FG000|Overall Study|Adverse Event|8|||
27857040|NCT01214915|81310356|FG000|Overall Study|Lack of Efficacy|3|||
27627908|NCT04565249|80480280|FG001|Overall Study|Death|0|||
27627909|NCT04565249|80480281|FG002|Overall Study|Death|0|||
27627910|NCT04565249|80480282|FG003|Overall Study|Death|1|||
27531833|NCT00423670|80141505|FG001|Treatment Period|Non-compliance with protocol|1|||
27531834|NCT00423670|80141506|FG002|Treatment Period|Non-compliance with protocol|1|||
27531835|NCT00423670|80141507|FG003|Treatment Period|Non-compliance with protocol|3|||
27531836|NCT00423670|80141508|FG004|Treatment Period|Non-compliance with protocol|2|||
27531837|NCT00423670|80141509|FG005|Treatment Period|Non-compliance with protocol|0|||
27531838|NCT00423670|80141510|FG006|Treatment Period|Non-compliance with protocol|2|||
27531839|NCT00423670|80141511|FG007|Treatment Period|Non-compliance with protocol|2|||
27531840|NCT00423670|80141504|FG000|Follow-up Period|Lost to Follow-up|0|||
27531841|NCT00423670|80141505|FG001|Follow-up Period|Lost to Follow-up|12|||
27531842|NCT00423670|80141506|FG002|Follow-up Period|Lost to Follow-up|8|||
27531843|NCT00423670|80141507|FG003|Follow-up Period|Lost to Follow-up|3|||
27531844|NCT00423670|80141508|FG004|Follow-up Period|Lost to Follow-up|1|||
27531845|NCT00423670|80141509|FG005|Follow-up Period|Lost to Follow-up|0|||
27531846|NCT00423670|80141510|FG006|Follow-up Period|Lost to Follow-up|5|||
27531847|NCT00423670|80141511|FG007|Follow-up Period|Lost to Follow-up|0|||
27531848|NCT00423670|80141504|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
27531849|NCT00423670|80141505|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
27627911|NCT05567952|80480283|FG000|Overall Study|Lost to Follow-up|3|||
27627912|NCT05567952|80480284|FG001|Overall Study|Lost to Follow-up|2|||
27627913|NCT05567952|80480283|FG000|Overall Study|Withdrawal by Subject|6|||
27912598|NCT02326272|81518177|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912599|NCT02326272|81518178|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912600|NCT02326272|81518179|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27627914|NCT05567952|80480284|FG001|Overall Study|Withdrawal by Subject|3|||
27627915|NCT05567952|80480283|FG000|Overall Study|Other|3|||
27627916|NCT05567952|80480284|FG001|Overall Study|Other|1|||
27627917|NCT00631917|80480285|FG000|Overall Study|Adverse Event|34|||
27627918|NCT00631917|80480286|FG001|Overall Study|Adverse Event|45|||
27627919|NCT00631917|80480285|FG000|Overall Study|Abnormal laboratory value(s)|2|||
27627920|NCT00631917|80480286|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27627921|NCT00631917|80480285|FG000|Overall Study|Abnormal test procedure result(s)|3|||
27627922|NCT00631917|80480286|FG001|Overall Study|Abnormal test procedure result(s)|2|||
27627923|NCT00631917|80480285|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
27912601|NCT02326272|81518180|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27627924|NCT00631917|80480286|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
27627925|NCT00631917|80480285|FG000|Overall Study|No longer required study drug|0|||
27627926|NCT00631917|80480286|FG001|Overall Study|No longer required study drug|1|||
27627927|NCT00631917|80480285|FG000|Overall Study|Protocol deviation|6|||
27627928|NCT00631917|80480286|FG001|Overall Study|Protocol deviation|5|||
27627929|NCT00631917|80480285|FG000|Overall Study|Subject withdrew consent|25|||
27627930|NCT00631917|80480286|FG001|Overall Study|Subject withdrew consent|33|||
27627931|NCT00631917|80480285|FG000|Overall Study|Lost to Follow-up|7|||
27627932|NCT00631917|80480286|FG001|Overall Study|Lost to Follow-up|7|||
27627933|NCT00631917|80480285|FG000|Overall Study|Administrative problems|2|||
27912602|NCT02326272|81518181|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
27912603|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
27912604|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
27912605|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
27912606|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
27912607|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
27912608|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
27912609|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
27912610|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
27912611|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
27912612|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
27912613|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
27912614|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
27912615|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
27912616|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
27912617|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
27531850|NCT00423670|80141506|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
27531851|NCT00423670|80141507|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
27531852|NCT00423670|80141508|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
27627934|NCT00631917|80480286|FG001|Overall Study|Administrative problems|0|||
27627935|NCT00631917|80480285|FG000|Overall Study|Death|1|||
27627936|NCT00631917|80480286|FG001|Overall Study|Death|0|||
27627937|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
27627938|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
27627939|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27912618|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912619|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912620|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912621|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912622|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912623|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912624|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912625|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912626|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912627|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912628|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
27912629|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
27912630|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
27912631|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
27912632|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
27912633|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912634|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912635|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912636|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912637|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912638|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912639|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27531853|NCT00423670|80141509|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
27531854|NCT00423670|80141510|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
27531855|NCT00423670|80141511|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
27531856|NCT00423670|80141504|FG000|Follow-up Period|Non-compliance with protocol|2|||
27531857|NCT00423670|80141505|FG001|Follow-up Period|Non-compliance with protocol|0|||
27531858|NCT00423670|80141506|FG002|Follow-up Period|Non-compliance with protocol|1|||
27531859|NCT00423670|80141507|FG003|Follow-up Period|Non-compliance with protocol|1|||
27531860|NCT00423670|80141508|FG004|Follow-up Period|Non-compliance with protocol|0|||
27531861|NCT00423670|80141509|FG005|Follow-up Period|Non-compliance with protocol|0|||
27531862|NCT00423670|80141510|FG006|Follow-up Period|Non-compliance with protocol|3|||
27627940|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27857041|NCT01447420|81310357|FG000|Overall Study|Adverse Event|2|||
27857042|NCT01447420|81310358|FG001|Overall Study|Adverse Event|4|||
27857043|NCT01447420|81310359|FG002|Overall Study|Adverse Event|2|||
27857044|NCT01447420|81310357|FG000|Overall Study|Protocol Violation|3|||
27857045|NCT01447420|81310358|FG001|Overall Study|Protocol Violation|3|||
27857046|NCT01447420|81310359|FG002|Overall Study|Protocol Violation|0|||
27857047|NCT01447420|81310357|FG000|Overall Study|Withdrawal by Subject|4|||
27857048|NCT01447420|81310358|FG001|Overall Study|Withdrawal by Subject|1|||
27857049|NCT01447420|81310359|FG002|Overall Study|Withdrawal by Subject|0|||
27857050|NCT01447420|81310357|FG000|Overall Study|Lack of Efficacy|1|||
27857051|NCT01447420|81310358|FG001|Overall Study|Lack of Efficacy|19|||
27531863|NCT00423670|80141511|FG007|Follow-up Period|Non-compliance with protocol|2|||
27857052|NCT01447420|81310359|FG002|Overall Study|Lack of Efficacy|8|||
27531864|NCT01282203|80141512|FG000|Overall Study|Adverse Event|1|||
27736518|NCT04321343|80864845|FG003|Overall Study|Protocol Violation|1|||
27736519|NCT04321343|80864842|FG000|Overall Study|Withdrawal by Subject|0|||
27736520|NCT04321343|80864843|FG001|Overall Study|Withdrawal by Subject|6|||
27736521|NCT04321343|80864844|FG002|Overall Study|Withdrawal by Subject|0|||
27736522|NCT04321343|80864845|FG003|Overall Study|Withdrawal by Subject|2|||
27736523|NCT04321343|80864842|FG000|Overall Study|Lost to Follow-up|2|||
27736524|NCT04321343|80864843|FG001|Overall Study|Lost to Follow-up|2|||
27736525|NCT04321343|80864844|FG002|Overall Study|Lost to Follow-up|1|||
27736526|NCT04321343|80864845|FG003|Overall Study|Lost to Follow-up|3|||
27736527|NCT01856673|80864846|FG000|Overall Study|Withdrawal by Subject|44|||
27736528|NCT01856673|80864847|FG001|Overall Study|Withdrawal by Subject|50|||
27736529|NCT01856673|80864848|FG002|Overall Study|Withdrawal by Subject|33|||
27736530|NCT01856673|80864846|FG000|Overall Study|Lost to Follow-up|31|||
27736531|NCT01856673|80864847|FG001|Overall Study|Lost to Follow-up|34|||
27736532|NCT01856673|80864848|FG002|Overall Study|Lost to Follow-up|0|||
27736533|NCT01856673|80864846|FG000|Overall Study|Unknown reasons|9|||
27736534|NCT01856673|80864847|FG001|Overall Study|Unknown reasons|0|||
27736535|NCT01856673|80864848|FG002|Overall Study|Unknown reasons|0|||
27736536|NCT01856673|80864846|FG000|Overall Study|Psychologist decision|1|||
27736537|NCT01856673|80864847|FG001|Overall Study|Psychologist decision|0|||
27736538|NCT01856673|80864848|FG002|Overall Study|Psychologist decision|0|||
27736539|NCT01856673|80864846|FG000|Overall Study|Paperwork errors|8|||
27736540|NCT01856673|80864847|FG001|Overall Study|Paperwork errors|0|||
27736541|NCT01856673|80864848|FG002|Overall Study|Paperwork errors|0|||
27736542|NCT01856673|80864846|FG000|Overall Study|Death|1|||
27736543|NCT01856673|80864847|FG001|Overall Study|Death|1|||
27736544|NCT01856673|80864848|FG002|Overall Study|Death|0|||
27736545|NCT01856673|80864846|FG000|Overall Study|Protocol Violation|1|||
27736546|NCT01856673|80864847|FG001|Overall Study|Protocol Violation|0|||
27736547|NCT01856673|80864848|FG002|Overall Study|Protocol Violation|1|||
27736548|NCT00561353|80864849|FG000|Overall Study|Subject reached a virologic endpoint|2|||
27736549|NCT00561353|80864850|FG001|Overall Study|Subject reached a virologic endpoint|1|||
27736550|NCT00561353|80864851|FG002|Overall Study|Subject reached a virologic endpoint|1|||
27736551|NCT00561353|80864852|FG003|Overall Study|Subject reached a virologic endpoint|4|||
27736552|NCT00561353|80864853|FG004|Overall Study|Subject reached a virologic endpoint|1|||
27736553|NCT00561353|80864854|FG005|Overall Study|Subject reached a virologic endpoint|3|||
27736554|NCT00561353|80864855|FG006|Overall Study|Subject reached a virologic endpoint|4|||
27736555|NCT00561353|80864856|FG007|Overall Study|Subject reached a virologic endpoint|4|||
27736556|NCT00561353|80864857|FG008|Overall Study|Subject reached a virologic endpoint|5|||
27736557|NCT00561353|80864858|FG009|Overall Study|Subject reached a virologic endpoint|0|||
27736558|NCT00561353|80864849|FG000|Overall Study|Subject ineligible to continue the trial|0|||
27736559|NCT00561353|80864850|FG001|Overall Study|Subject ineligible to continue the trial|0|||
27736560|NCT00561353|80864851|FG002|Overall Study|Subject ineligible to continue the trial|0|||
27736561|NCT00561353|80864852|FG003|Overall Study|Subject ineligible to continue the trial|0|||
27736562|NCT00561353|80864853|FG004|Overall Study|Subject ineligible to continue the trial|0|||
27736563|NCT00561353|80864854|FG005|Overall Study|Subject ineligible to continue the trial|1|||
27736564|NCT00561353|80864855|FG006|Overall Study|Subject ineligible to continue the trial|1|||
27736565|NCT00561353|80864856|FG007|Overall Study|Subject ineligible to continue the trial|0|||
27736566|NCT00561353|80864857|FG008|Overall Study|Subject ineligible to continue the trial|2|||
27736567|NCT00561353|80864858|FG009|Overall Study|Subject ineligible to continue the trial|1|||
27736568|NCT00561353|80864849|FG000|Overall Study|Other|1|||
27736569|NCT00561353|80864850|FG001|Overall Study|Other|0|||
27736570|NCT00561353|80864851|FG002|Overall Study|Other|1|||
27531865|NCT03114488|80141513|FG000|Time Period 2|Withdrawal by Subject|1|||
27531866|NCT03114488|80141514|FG001|Time Period 2|Withdrawal by Subject|3|||
27531867|NCT05274165|80141515|FG000|Overall Study|Withdrawal by Subject|3|||
27531868|NCT05274165|80141516|FG001|Overall Study|Withdrawal by Subject|3|||
27531869|NCT03956056|80141517|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
27531870|NCT03956056|80141517|FG000|Overall Study|Lack of Efficacy|1|||
27531871|NCT04761822|80141518|FG000|Overall Study|Adverse Event|3|||
27531872|NCT04761822|80141519|FG001|Overall Study|Adverse Event|1|||
27531873|NCT04761822|80141520|FG002|Overall Study|Adverse Event|1|||
27531874|NCT04761822|80141521|FG003|Overall Study|Adverse Event|3|||
27736571|NCT00561353|80864852|FG003|Overall Study|Other|0|||
27736572|NCT00561353|80864853|FG004|Overall Study|Other|0|||
27736573|NCT00561353|80864854|FG005|Overall Study|Other|2|||
27736574|NCT00561353|80864855|FG006|Overall Study|Other|0|||
27736575|NCT00561353|80864856|FG007|Overall Study|Other|0|||
27736576|NCT00561353|80864857|FG008|Overall Study|Other|0|||
27736577|NCT00561353|80864858|FG009|Overall Study|Other|0|||
27736578|NCT00561353|80864849|FG000|Overall Study|Adverse Event|0|||
27736579|NCT00561353|80864850|FG001|Overall Study|Adverse Event|0|||
27531875|NCT04761822|80141518|FG000|Overall Study|Lost to Follow-up|1|||
27531876|NCT04761822|80141519|FG001|Overall Study|Lost to Follow-up|0|||
27912640|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912641|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912642|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912643|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27912644|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912645|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
27912646|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912647|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
27912648|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912649|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912650|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912651|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912652|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912653|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912654|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912655|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27531877|NCT04761822|80141520|FG002|Overall Study|Lost to Follow-up|2|||
27531878|NCT04761822|80141521|FG003|Overall Study|Lost to Follow-up|3|||
27531879|NCT04761822|80141518|FG000|Overall Study|Physician Decision|0|||
27531880|NCT04761822|80141519|FG001|Overall Study|Physician Decision|1|||
27531881|NCT04761822|80141520|FG002|Overall Study|Physician Decision|0|||
27531882|NCT04761822|80141521|FG003|Overall Study|Physician Decision|0|||
27531883|NCT04761822|80141518|FG000|Overall Study|Withdrawal by Subject|3|||
27531884|NCT04761822|80141519|FG001|Overall Study|Withdrawal by Subject|8|||
27531885|NCT04761822|80141520|FG002|Overall Study|Withdrawal by Subject|1|||
27531886|NCT04761822|80141521|FG003|Overall Study|Withdrawal by Subject|11|||
27531887|NCT04761822|80141518|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
27531888|NCT04761822|80141519|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
27531889|NCT04761822|80141520|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
27531890|NCT04761822|80141521|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
27531891|NCT04761822|80141518|FG000|Overall Study|Participant requested unblinding|0|||
27531892|NCT04761822|80141519|FG001|Overall Study|Participant requested unblinding|0|||
27531893|NCT04761822|80141520|FG002|Overall Study|Participant requested unblinding|0|||
27531894|NCT04761822|80141521|FG003|Overall Study|Participant requested unblinding|1|||
27531895|NCT01067976|80141522|FG000|Overall Study|Study drug never administered|20|||
27531896|NCT01067976|80141522|FG000|Overall Study|Study prematurely discontinued|2|||
27531897|NCT01368432|80141523|FG000|Overall Study|Lost to Follow-up|0|||
27531898|NCT01368432|80141524|FG001|Overall Study|Lost to Follow-up|1|||
27531899|NCT04545554|80141525|FG000|Overall Study|Withdrawal by Subject|0|||
27531900|NCT04545554|80141526|FG001|Overall Study|Withdrawal by Subject|0|||
27531901|NCT04545554|80141527|FG002|Overall Study|Withdrawal by Subject|0|||
27531902|NCT04545554|80141528|FG003|Overall Study|Withdrawal by Subject|1|||
27531903|NCT04545554|80141529|FG004|Overall Study|Withdrawal by Subject|0|||
27531904|NCT04545554|80141530|FG005|Overall Study|Withdrawal by Subject|0|||
27627941|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627942|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627943|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627944|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627945|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627946|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627947|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627948|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627949|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627950|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
27627951|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
27627952|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
27627953|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627954|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627955|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627956|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627957|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627958|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627959|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27857053|NCT03511326|81310360|FG000|Overall Study|Withdrawal by Subject|1|||
27857054|NCT02283294|81310365|FG000|Overall Study|Lost to Follow-up|1|||
27857055|NCT02283294|81310366|FG001|Overall Study|Lost to Follow-up|1|||
27531905|NCT02853344|80141533|FG000|Overall Study|Lost to Follow-up|1|||
27531906|NCT02853344|80141534|FG001|Overall Study|Lost to Follow-up|1|||
27531907|NCT02853344|80141533|FG000|Overall Study|Withdrawal by Subject|2|||
27531908|NCT02853344|80141534|FG001|Overall Study|Withdrawal by Subject|4|||
27736580|NCT00561353|80864851|FG002|Overall Study|Adverse Event|0|||
27736581|NCT00561353|80864852|FG003|Overall Study|Adverse Event|2|||
27736582|NCT00561353|80864853|FG004|Overall Study|Adverse Event|0|||
27736583|NCT00561353|80864854|FG005|Overall Study|Adverse Event|0|||
27736584|NCT00561353|80864855|FG006|Overall Study|Adverse Event|1|||
27736585|NCT00561353|80864856|FG007|Overall Study|Adverse Event|0|||
27736586|NCT00561353|80864857|FG008|Overall Study|Adverse Event|0|||
27736587|NCT00561353|80864858|FG009|Overall Study|Adverse Event|1|||
27736588|NCT00561353|80864849|FG000|Overall Study|Lost to Follow-up|2|||
27736589|NCT00561353|80864850|FG001|Overall Study|Lost to Follow-up|0|||
27736590|NCT00561353|80864851|FG002|Overall Study|Lost to Follow-up|1|||
27736591|NCT00561353|80864852|FG003|Overall Study|Lost to Follow-up|0|||
27736592|NCT00561353|80864853|FG004|Overall Study|Lost to Follow-up|0|||
27736593|NCT00561353|80864854|FG005|Overall Study|Lost to Follow-up|0|||
27736594|NCT00561353|80864855|FG006|Overall Study|Lost to Follow-up|0|||
27736595|NCT00561353|80864856|FG007|Overall Study|Lost to Follow-up|0|||
27736596|NCT00561353|80864857|FG008|Overall Study|Lost to Follow-up|0|||
27736597|NCT00561353|80864858|FG009|Overall Study|Lost to Follow-up|0|||
27736598|NCT00561353|80864849|FG000|Overall Study|Withdrawal by Subject|0|||
27736599|NCT00561353|80864850|FG001|Overall Study|Withdrawal by Subject|2|||
27736600|NCT00561353|80864851|FG002|Overall Study|Withdrawal by Subject|0|||
27736601|NCT00561353|80864852|FG003|Overall Study|Withdrawal by Subject|0|||
27736602|NCT00561353|80864853|FG004|Overall Study|Withdrawal by Subject|0|||
27736603|NCT00561353|80864854|FG005|Overall Study|Withdrawal by Subject|0|||
27736604|NCT00561353|80864855|FG006|Overall Study|Withdrawal by Subject|0|||
27736605|NCT00561353|80864856|FG007|Overall Study|Withdrawal by Subject|0|||
27736606|NCT00561353|80864857|FG008|Overall Study|Withdrawal by Subject|0|||
27736607|NCT00561353|80864858|FG009|Overall Study|Withdrawal by Subject|0|||
27736608|NCT01829048|80864861|FG000|Overall Study|Withdrawal by Subject|0|||
27736609|NCT01829048|80864862|FG001|Overall Study|Withdrawal by Subject|0|||
27736610|NCT01829048|80864863|FG002|Overall Study|Withdrawal by Subject|0|||
27736611|NCT01829048|80864864|FG003|Overall Study|Withdrawal by Subject|2|||
27736612|NCT01829048|80864865|FG004|Overall Study|Withdrawal by Subject|0|||
27736613|NCT02582515|80864866|FG000|Overall Study|Withdrawal by Subject|0|||
27736614|NCT02582515|80864867|FG001|Overall Study|Withdrawal by Subject|1|||
27736615|NCT01697345|80864879|FG000|Overall Study|Withdrawal by Subject|1|||
27736616|NCT02698410|80864894|FG000|Overall Study|Adverse Event|2|||
27736617|NCT02698410|80864894|FG000|Overall Study|Withdrawal by Subject|1|||
27736618|NCT02698410|80864894|FG000|Overall Study|Other|1|||
27736619|NCT00519077|80864895|FG000|Overall Study|Death|6|||
27736620|NCT00519077|80864895|FG000|Overall Study|Other|2|||
27736621|NCT00609609|80864896|FG000|Overall Study|Withdrawal by Subject|2|||
27736622|NCT00609609|80864897|FG001|Overall Study|Withdrawal by Subject|0|||
27736623|NCT00609609|80864896|FG000|Overall Study|Progression|4|||
27736624|NCT00609609|80864897|FG001|Overall Study|Progression|2|||
27736625|NCT00356915|80864898|FG000|Overall Study|Non compliance|1|||
27736626|NCT00356915|80864899|FG001|Overall Study|Non compliance|2|||
27736627|NCT00356915|80864900|FG002|Overall Study|Non compliance|1|||
27736628|NCT00356915|80864898|FG000|Overall Study|Protocol Violation|2|||
27736629|NCT00356915|80864899|FG001|Overall Study|Protocol Violation|3|||
27736630|NCT00356915|80864900|FG002|Overall Study|Protocol Violation|2|||
27736631|NCT00356915|80864898|FG000|Overall Study|Withdrawal by Subject|14|||
27736632|NCT00356915|80864899|FG001|Overall Study|Withdrawal by Subject|14|||
27736633|NCT00356915|80864900|FG002|Overall Study|Withdrawal by Subject|10|||
27736634|NCT00356915|80864898|FG000|Overall Study|Lack of Efficacy|0|||
27736635|NCT00356915|80864899|FG001|Overall Study|Lack of Efficacy|0|||
27736636|NCT00356915|80864900|FG002|Overall Study|Lack of Efficacy|3|||
27736637|NCT00356915|80864898|FG000|Overall Study|Lost to Follow-up|27|||
27736638|NCT00356915|80864899|FG001|Overall Study|Lost to Follow-up|34|||
27857056|NCT02283294|81310365|FG000|Overall Study|Withdrawal by Subject|1|||
27857057|NCT02283294|81310366|FG001|Overall Study|Withdrawal by Subject|6|||
27736639|NCT00356915|80864900|FG002|Overall Study|Lost to Follow-up|14|||
27912656|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27736640|NCT00356915|80864898|FG000|Overall Study|Administrative Decision|0|||
27736641|NCT00356915|80864899|FG001|Overall Study|Administrative Decision|0|||
27736642|NCT00356915|80864900|FG002|Overall Study|Administrative Decision|1|||
27736643|NCT00356915|80864898|FG000|Overall Study|Physician Decision|0|||
27736644|NCT00356915|80864899|FG001|Overall Study|Physician Decision|2|||
27736645|NCT00356915|80864900|FG002|Overall Study|Physician Decision|0|||
27736646|NCT00356915|80864898|FG000|Overall Study|Adverse Event|21|||
27857058|NCT02283294|81310365|FG000|Overall Study|Protocol Violation|1|||
27736647|NCT00356915|80864899|FG001|Overall Study|Adverse Event|31|||
27736648|NCT00356915|80864900|FG002|Overall Study|Adverse Event|8|||
27736649|NCT00356915|80864898|FG000|Overall Study|Miscellaneous reasons|11|||
27736650|NCT00356915|80864899|FG001|Overall Study|Miscellaneous reasons|8|||
27857059|NCT02283294|81310366|FG001|Overall Study|Protocol Violation|0|||
27736651|NCT00356915|80864900|FG002|Overall Study|Miscellaneous reasons|3|||
27736652|NCT05113940|80864901|FG000|Part A (18 Days)|Adverse Event|0|||
27736653|NCT05113940|80864902|FG001|Part A (18 Days)|Adverse Event|0|||
27736654|NCT05113940|80864903|FG002|Part A (18 Days)|Adverse Event|1|||
27736655|NCT05113940|80864904|FG003|Part A (18 Days)|Adverse Event|1|||
27736656|NCT05113940|80864905|FG004|Part A (18 Days)|Adverse Event|1|||
27736657|NCT05113940|80864906|FG005|Part A (18 Days)|Adverse Event|0|||
27736658|NCT05113940|80864907|FG006|Part A (18 Days)|Adverse Event|0|||
27736659|NCT05113940|80864908|FG007|Part A (18 Days)|Adverse Event|0|||
27736660|NCT05113940|80864909|FG008|Part A (18 Days)|Adverse Event|0|||
27736661|NCT05113940|80864910|FG009|Part A (18 Days)|Adverse Event|0|||
27736662|NCT05113940|80864911|FG010|Part A (18 Days)|Adverse Event|0|||
27736663|NCT05113940|80864912|FG011|Part A (18 Days)|Adverse Event|2|||
27736664|NCT05113940|80864913|FG012|Part A (18 Days)|Adverse Event|0|||
27736665|NCT05113940|80864914|FG013|Part A (18 Days)|Adverse Event|0|||
27736666|NCT05113940|80864915|FG014|Part A (18 Days)|Adverse Event|0|||
27736667|NCT05113940|80864901|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736668|NCT05113940|80864902|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736669|NCT05113940|80864903|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736670|NCT05113940|80864904|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736671|NCT05113940|80864905|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736672|NCT05113940|80864906|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736673|NCT05113940|80864907|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736674|NCT05113940|80864908|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736675|NCT05113940|80864909|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736676|NCT05113940|80864910|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736677|NCT05113940|80864911|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736678|NCT05113940|80864912|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736679|NCT05113940|80864913|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
27912657|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27531909|NCT02853344|80141533|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
27531910|NCT02853344|80141534|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
27531911|NCT02853344|80141533|FG000|Overall Study|Death|70|||
27531912|NCT02853344|80141534|FG001|Overall Study|Death|112|||
27531913|NCT03422627|80141537|FG000|Overall Study|Protocol-specified Criteria|1|||
27531914|NCT03422627|80141538|FG001|Overall Study|Protocol-specified Criteria|1|||
27531915|NCT03422627|80141539|FG002|Overall Study|Protocol-specified Criteria|0|||
27531916|NCT03422627|80141540|FG003|Overall Study|Protocol-specified Criteria|0|||
27531917|NCT03422627|80141541|FG004|Overall Study|Protocol-specified Criteria|2|||
27531918|NCT03422627|80141537|FG000|Overall Study|Requirement for Alternative Therapy|1|||
27531919|NCT03422627|80141538|FG001|Overall Study|Requirement for Alternative Therapy|1|||
27531920|NCT03422627|80141539|FG002|Overall Study|Requirement for Alternative Therapy|2|||
27531921|NCT03422627|80141540|FG003|Overall Study|Requirement for Alternative Therapy|0|||
27531922|NCT03422627|80141541|FG004|Overall Study|Requirement for Alternative Therapy|0|||
27531923|NCT03422627|80141537|FG000|Overall Study|Disease Progression|1|||
27531924|NCT03422627|80141538|FG001|Overall Study|Disease Progression|0|||
27531925|NCT03422627|80141539|FG002|Overall Study|Disease Progression|1|||
27531926|NCT03422627|80141540|FG003|Overall Study|Disease Progression|2|||
27531927|NCT03422627|80141541|FG004|Overall Study|Disease Progression|0|||
27531928|NCT03422627|80141537|FG000|Overall Study|Adverse Event|2|||
27531929|NCT03422627|80141538|FG001|Overall Study|Adverse Event|1|||
27531930|NCT03422627|80141539|FG002|Overall Study|Adverse Event|0|||
27531931|NCT03422627|80141540|FG003|Overall Study|Adverse Event|0|||
27531932|NCT03422627|80141541|FG004|Overall Study|Adverse Event|2|||
27531933|NCT03422627|80141537|FG000|Overall Study|Ineligibility Determined|0|||
27531934|NCT03422627|80141538|FG001|Overall Study|Ineligibility Determined|1|||
27531935|NCT03422627|80141539|FG002|Overall Study|Ineligibility Determined|0|||
27531936|NCT03422627|80141540|FG003|Overall Study|Ineligibility Determined|0|||
27531937|NCT03422627|80141541|FG004|Overall Study|Ineligibility Determined|0|||
27531938|NCT03422627|80141537|FG000|Overall Study|Death|0|||
27531939|NCT03422627|80141538|FG001|Overall Study|Death|1|||
27531940|NCT03422627|80141539|FG002|Overall Study|Death|1|||
27531941|NCT03422627|80141540|FG003|Overall Study|Death|0|||
27531942|NCT03422627|80141541|FG004|Overall Study|Death|0|||
27531943|NCT03422627|80141537|FG000|Overall Study|Withdrawal by Subject|0|||
27531944|NCT03422627|80141538|FG001|Overall Study|Withdrawal by Subject|0|||
27736680|NCT05113940|80864914|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
27736681|NCT05113940|80864915|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
27736682|NCT04197713|80864916|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
27736683|NCT04197713|80864917|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
27736684|NCT01295125|80864918|FG000|Overall Study|Study stopped prematurely|9|||
27531945|NCT03422627|80141539|FG002|Overall Study|Withdrawal by Subject|0|||
27531946|NCT03422627|80141540|FG003|Overall Study|Withdrawal by Subject|1|||
27531947|NCT03422627|80141541|FG004|Overall Study|Withdrawal by Subject|0|||
27531948|NCT01977651|80141542|FG000|4 Month Treatment Period|Adverse Event|34|||
27531949|NCT01977651|80141542|FG000|4 Month Treatment Period|Death|3|||
27531950|NCT01977651|80141542|FG000|4 Month Treatment Period|Progressive Disease|43|||
27531951|NCT01977651|80141542|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
27531952|NCT01977651|80141542|FG000|4 Month Treatment Period|Physician Decision|4|||
27531953|NCT01977651|80141542|FG000|1 Year Extension Period|Adverse Event|14|||
27531954|NCT01977651|80141542|FG000|1 Year Extension Period|Death|10|||
27531955|NCT01977651|80141542|FG000|1 Year Extension Period|Lost to Follow-up|2|||
27531956|NCT01977651|80141542|FG000|1 Year Extension Period|Progressive Disease|86|||
27531957|NCT01977651|80141542|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
27531958|NCT01977651|80141542|FG000|1 Year Extension Period|Physician Decision|6|||
27531959|NCT01977651|80141542|FG000|1 Year Extension Period|Miscellaneous|1|||
27531960|NCT01977651|80141542|FG000|Post 1 Year Extension Period|Adverse Event|5|||
27531961|NCT01977651|80141542|FG000|Post 1 Year Extension Period|Death|13|||
27531962|NCT01977651|80141542|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
27531963|NCT01977651|80141542|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
27531964|NCT01977651|80141542|FG000|Post 1 Year Extension Period|Physician Decision|4|||
27531965|NCT01977651|80141542|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
27531966|NCT03875118|80141543|FG000|Overall Study|Withdrawal by Subject|4|||
27531967|NCT03875118|80141544|FG001|Overall Study|Withdrawal by Subject|4|||
27531968|NCT01225887|80141550|FG000|Overall Study|Ineligible:required test not done|2|||
27531969|NCT01225887|80141550|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
27531970|NCT01225887|80141550|FG000|Overall Study|Ineligible:inadequate pathology|2|||
27531971|NCT03693170|80141553|FG000|Overall Study|Disease Progression|48|||
27531972|NCT03693170|80141553|FG000|Overall Study|Adverse Event|16|||
27531973|NCT03693170|80141553|FG000|Overall Study|Physician Decision|6|||
27531974|NCT03693170|80141553|FG000|Overall Study|Protocol Violation|2|||
27531975|NCT03693170|80141553|FG000|Overall Study|Death|1|||
27531976|NCT03693170|80141553|FG000|Overall Study|Non compliance with study drug|1|||
27531977|NCT03693170|80141553|FG000|Overall Study|Withdrawal by Subject|1|||
27531978|NCT02545075|80141557|FG000|Randomization|Lost to Follow-up|0|||
27531979|NCT02545075|80141558|FG001|Randomization|Lost to Follow-up|1|||
27531980|NCT02545075|80141557|FG000|Randomization|Withdrawal by Subject|0|||
27531981|NCT02545075|80141558|FG001|Randomization|Withdrawal by Subject|6|||
27531982|NCT02545075|80141557|FG000|Treatment|Disease progression|71|||
27531983|NCT02545075|80141558|FG001|Treatment|Disease progression|32|||
27531984|NCT02545075|80141557|FG000|Treatment|Participant dicontinued study treatment|7|||
27627960|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627961|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627962|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627963|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627964|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
27627965|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
27627966|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
27627967|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627968|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27531985|NCT02545075|80141558|FG001|Treatment|Participant dicontinued study treatment|9|||
27531986|NCT02545075|80141557|FG000|Treatment|Withdrawal by Subject|1|||
27531987|NCT02545075|80141558|FG001|Treatment|Withdrawal by Subject|0|||
27531988|NCT02545075|80141557|FG000|Treatment|Adverse event not related to study drug|1|||
27531989|NCT02545075|80141558|FG001|Treatment|Adverse event not related to study drug|0|||
27531990|NCT02545075|80141557|FG000|Treatment|Death|1|||
27531991|NCT02545075|80141558|FG001|Treatment|Death|0|||
27531992|NCT02545075|80141557|FG000|Treatment|Participant drug toxicity|1|||
27531993|NCT02545075|80141558|FG001|Treatment|Participant drug toxicity|0|||
27531994|NCT02545075|80141557|FG000|Treatment|Completed treatment|40|||
27531995|NCT02545075|80141558|FG001|Treatment|Completed treatment|12|||
27531996|NCT01229397|80141559|FG000|Overall Study|Withdrawal by Subject|3|||
27531997|NCT01229397|80141560|FG001|Overall Study|Withdrawal by Subject|3|||
27531998|NCT01229397|80141559|FG000|Overall Study|Lost to Follow-up|7|||
27531999|NCT01229397|80141560|FG001|Overall Study|Lost to Follow-up|6|||
27532000|NCT01229397|80141559|FG000|Overall Study|Migrated/moved from study area|1|||
27532001|NCT01229397|80141560|FG001|Overall Study|Migrated/moved from study area|0|||
27532002|NCT01163266|80141561|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
27532003|NCT01163266|80141562|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
27532004|NCT01163266|80141563|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
27532005|NCT01163266|80141561|FG000|Overall Study|Lack of Efficacy|1|||
27532006|NCT01163266|80141562|FG001|Overall Study|Lack of Efficacy|3|||
27532007|NCT01163266|80141563|FG002|Overall Study|Lack of Efficacy|1|||
27627969|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627970|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627971|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27532008|NCT01163266|80141561|FG000|Overall Study|Noncompliance with Study Drug|0|||
27532009|NCT01163266|80141562|FG001|Overall Study|Noncompliance with Study Drug|2|||
27532010|NCT01163266|80141563|FG002|Overall Study|Noncompliance with Study Drug|0|||
27532011|NCT01163266|80141561|FG000|Overall Study|Protocol Deviations|2|||
27627972|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627973|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627974|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627975|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627976|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627977|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627978|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
27627979|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
27627980|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
27627981|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627982|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27532012|NCT01163266|80141562|FG001|Overall Study|Protocol Deviations|2|||
27532013|NCT01163266|80141563|FG002|Overall Study|Protocol Deviations|5|||
27532014|NCT01163266|80141561|FG000|Overall Study|Withdrawal of Consent|5|||
27532015|NCT01163266|80141562|FG001|Overall Study|Withdrawal of Consent|7|||
27627983|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627984|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627985|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627986|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627987|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627988|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627989|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27532016|NCT01163266|80141563|FG002|Overall Study|Withdrawal of Consent|3|||
27532017|NCT01163266|80141561|FG000|Overall Study|Lost to Follow-up|7|||
27532018|NCT01163266|80141562|FG001|Overall Study|Lost to Follow-up|7|||
27532019|NCT01163266|80141563|FG002|Overall Study|Lost to Follow-up|10|||
27532020|NCT01163266|80141561|FG000|Overall Study|Other|1|||
27532021|NCT01163266|80141562|FG001|Overall Study|Other|1|||
27532022|NCT01163266|80141563|FG002|Overall Study|Other|2|||
27532023|NCT01107418|80141570|FG000|Overall Study|Disease Progression|45|||
27532024|NCT01107418|80141570|FG000|Overall Study|Adverse Event|3|||
27532025|NCT01107418|80141570|FG000|Overall Study|Withdrawal by Subject|1|||
27532026|NCT01107418|80141570|FG000|Overall Study|Study Closing|1|||
27532027|NCT01107418|80141570|FG000|Overall Study|Started Other Therapy|1|||
27627990|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627991|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627992|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
27627993|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
27627994|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
27627995|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27627996|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27627997|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27627998|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27627999|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628000|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628001|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628002|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628003|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628004|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628005|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628006|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
27628007|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
27628008|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
27628009|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628010|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628011|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628012|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628013|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628014|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628015|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27532028|NCT01107418|80141570|FG000|Overall Study|Entered Extension Study|1|||
27628016|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27736685|NCT01333189|80864922|FG000|Overall Study|Time constraints|1|||
27736686|NCT01333189|80864923|FG001|Overall Study|Time constraints|0|||
27736687|NCT01333189|80864922|FG000|Overall Study|Adverse Event|1|||
27857060|NCT02283294|81310365|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
27857061|NCT02283294|81310366|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
27532029|NCT01130103|80141572|FG000|Randomized Treatment|Adverse Event|1|||
27532030|NCT01130103|80141573|FG001|Randomized Treatment|Adverse Event|1|||
27628017|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628018|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628019|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628020|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
27628021|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
27532031|NCT01130103|80141572|FG000|Randomized Treatment|Lost to Follow-up|1|||
27532032|NCT01130103|80141573|FG001|Randomized Treatment|Lost to Follow-up|0|||
27532033|NCT01130103|80141572|FG000|Randomized Treatment|Protocol Violation|3|||
27532034|NCT01130103|80141573|FG001|Randomized Treatment|Protocol Violation|2|||
27532035|NCT01130103|80141572|FG000|Randomized Treatment|Withdrawal by Subject|1|||
27532036|NCT01130103|80141573|FG001|Randomized Treatment|Withdrawal by Subject|2|||
27532037|NCT01130103|80141572|FG000|Maintenance Treatment|Lack of Efficacy|0|||
27532038|NCT01130103|80141573|FG001|Maintenance Treatment|Lack of Efficacy|1|||
27532039|NCT01130103|80141572|FG000|Maintenance Treatment|Lost to Follow-up|1|||
27532040|NCT01130103|80141573|FG001|Maintenance Treatment|Lost to Follow-up|1|||
27628022|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
27628023|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628024|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628025|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628026|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628027|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628028|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628029|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628030|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628031|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628032|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628033|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628034|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
27628035|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
27628036|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
27628037|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628038|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628039|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628040|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628041|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628042|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628043|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628044|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628045|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628046|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628047|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628048|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
27628049|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
27628050|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
27628051|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628052|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628053|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628054|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628055|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628056|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628057|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628058|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628059|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628060|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628061|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628062|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
27628063|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
27628064|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
27628065|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628066|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628067|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628068|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628069|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628070|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27532041|NCT01130103|80141572|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
27532042|NCT01130103|80141573|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
27532043|NCT01347307|80141577|FG000|Overall Study|Death|0|||
27532044|NCT01347307|80141578|FG001|Overall Study|Death|4|||
27532045|NCT01347307|80141577|FG000|Overall Study|Physician Decision|0|||
27532046|NCT01347307|80141578|FG001|Overall Study|Physician Decision|1|||
27628071|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27532047|NCT01675427|80141579|FG000|Overall Study|Withdrawal by Subject|7|||
27532048|NCT01675427|80141579|FG000|Overall Study|Participant Refused Sample Collection|18|||
27532049|NCT01675427|80141579|FG000|Overall Study|Sample not Collected by Mistake|2|||
27532050|NCT01675427|80141579|FG000|Overall Study|Lost to Follow-up|5|||
27532051|NCT01675427|80141579|FG000|Overall Study|Other|2|||
27532052|NCT03911154|80141582|FG000|Overall Study|Withdrawal by Subject|1|||
27532053|NCT00620464|80141583|FG000|Overall Study|Adverse Event|15|||
27532054|NCT00620464|80141584|FG001|Overall Study|Adverse Event|17|||
27532055|NCT00620464|80141583|FG000|Overall Study|Lost to Follow-up|1|||
27532056|NCT00620464|80141584|FG001|Overall Study|Lost to Follow-up|1|||
27532057|NCT00620464|80141583|FG000|Overall Study|Planning Pregnancy|1|||
27532058|NCT00620464|80141584|FG001|Overall Study|Planning Pregnancy|4|||
27628072|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628073|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628074|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628075|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628076|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
27628077|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
27628078|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
27628079|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628080|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27532059|NCT00620464|80141583|FG000|Overall Study|Personal|2|||
27532060|NCT00620464|80141584|FG001|Overall Study|Personal|2|||
27532061|NCT00620464|80141583|FG000|Overall Study|Used prohibited medication|1|||
27532062|NCT00620464|80141584|FG001|Overall Study|Used prohibited medication|0|||
27532063|NCT00116428|80141587|FG000|Overall Study|Withdrawal by Subject|2|||
27532064|NCT00116428|80141588|FG001|Overall Study|Withdrawal by Subject|5|||
27532065|NCT00116428|80141587|FG000|Overall Study|Did not meet inclusion criteria|1|||
27532066|NCT00116428|80141588|FG001|Overall Study|Did not meet inclusion criteria|0|||
27532067|NCT03923738|80141589|FG000|Period 1|Adverse Event|1|||
27532068|NCT03923738|80141589|FG000|Period 1|Withdrawal by Subject|1|||
27532069|NCT00910988|80141590|FG000|Overall Study|Lost to Follow-up|2|||
27532070|NCT00910988|80141591|FG001|Overall Study|Lost to Follow-up|4|||
27532071|NCT00910988|80141592|FG002|Overall Study|Lost to Follow-up|3|||
27532072|NCT00910988|80141593|FG003|Overall Study|Lost to Follow-up|0|||
27532073|NCT01243671|80141600|FG000|Overall Study|Adverse Event|3|||
27628081|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628082|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27532074|NCT01243671|80141600|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
27736688|NCT01333189|80864923|FG001|Overall Study|Adverse Event|0|||
27532075|NCT01243671|80141600|FG000|Overall Study|Other|1|||
27532076|NCT02305888|80141601|FG000|Overall Study|Lost to Follow-up|0|||
27532077|NCT02305888|80141602|FG001|Overall Study|Lost to Follow-up|0|||
27532078|NCT02305888|80141603|FG002|Overall Study|Lost to Follow-up|1|||
27532079|NCT02305888|80141601|FG000|Overall Study|Adverse Event|0|||
27532080|NCT02305888|80141602|FG001|Overall Study|Adverse Event|1|||
27532081|NCT02305888|80141603|FG002|Overall Study|Adverse Event|0|||
27532082|NCT01539642|80141604|FG000|Overall Study|Lack of Efficacy|20|||
27532083|NCT01539642|80141605|FG001|Overall Study|Lack of Efficacy|18|||
27532084|NCT01539642|80141604|FG000|Overall Study|Patient ready for early discharge|8|||
27532085|NCT01539642|80141605|FG001|Overall Study|Patient ready for early discharge|7|||
27532086|NCT01539642|80141604|FG000|Overall Study|Adverse Event|6|||
27532087|NCT01539642|80141605|FG001|Overall Study|Adverse Event|4|||
27532088|NCT01539642|80141604|FG000|Overall Study|Withdrawal by Subject|2|||
27532089|NCT01539642|80141605|FG001|Overall Study|Withdrawal by Subject|2|||
27532090|NCT01369615|80141606|FG000|Overall Study|Withdrawal by Subject|0|||
27532091|NCT01369615|80141607|FG001|Overall Study|Withdrawal by Subject|1|||
27628083|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628084|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628085|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628086|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628087|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628088|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27532092|NCT01369615|80141606|FG000|Overall Study|Lost to Follow-up|0|||
27532093|NCT01369615|80141607|FG001|Overall Study|Lost to Follow-up|1|||
27532094|NCT00562627|80141612|FG000|Overall Study|Protocol Violation|1|||
27532095|NCT00562627|80141613|FG001|Overall Study|Protocol Violation|1|||
27532096|NCT00562627|80141614|FG002|Overall Study|Protocol Violation|1|||
27532097|NCT01986140|80141615|FG000|Overall Study|Withdrawal by Subject|31|||
27532098|NCT01986140|80141616|FG001|Overall Study|Withdrawal by Subject|25|||
27532099|NCT01986140|80141615|FG000|Overall Study|alternative treatment|1|||
27532100|NCT01986140|80141616|FG001|Overall Study|alternative treatment|1|||
27532101|NCT01986140|80141615|FG000|Overall Study|found not eligible|3|||
27628089|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628090|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
27628091|NCT03982199|80480288|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
27628092|NCT03982199|80480289|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
27628093|NCT03982199|80480290|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628094|NCT03982199|80480291|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628095|NCT03982199|80480292|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628096|NCT03982199|80480293|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628097|NCT03982199|80480294|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628098|NCT03982199|80480295|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628099|NCT03982199|80480296|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27532102|NCT01986140|80141616|FG001|Overall Study|found not eligible|0|||
27532103|NCT01986140|80141615|FG000|Overall Study|Adverse Event|0|||
27532104|NCT01986140|80141616|FG001|Overall Study|Adverse Event|1|||
27532105|NCT01986140|80141615|FG000|Overall Study|progression disease|0|||
27532106|NCT01986140|80141616|FG001|Overall Study|progression disease|1|||
27532107|NCT04533880|80141617|FG000|Overall Study|Lost to Follow-up|0|||
27532108|NCT04533880|80141618|FG001|Overall Study|Lost to Follow-up|1|||
27532109|NCT04533880|80141619|FG002|Overall Study|Lost to Follow-up|1|||
27532110|NCT00642473|80141620|FG000|Overall Study|Withdrawal by Subject|0|||
27532111|NCT00642473|80141621|FG001|Overall Study|Withdrawal by Subject|5|||
27532112|NCT00642473|80141620|FG000|Overall Study|Progression or death|2|||
27532113|NCT00642473|80141621|FG001|Overall Study|Progression or death|4|||
27532114|NCT00642473|80141620|FG000|Overall Study|Other|2|||
27532115|NCT00642473|80141621|FG001|Overall Study|Other|2|||
27532116|NCT01570868|80141622|FG000|Overall Study|Adverse Event|8|||
27532117|NCT01570868|80141623|FG001|Overall Study|Adverse Event|1|||
27532118|NCT01570868|80141622|FG000|Overall Study|FDA Recommendation|23|||
27532119|NCT01570868|80141623|FG001|Overall Study|FDA Recommendation|3|||
27532120|NCT01570868|80141622|FG000|Overall Study|Physician Decision|10|||
27532121|NCT01570868|80141623|FG001|Overall Study|Physician Decision|4|||
27532122|NCT01570868|80141622|FG000|Overall Study|Lost to Follow-up|1|||
27532123|NCT01570868|80141623|FG001|Overall Study|Lost to Follow-up|0|||
27532124|NCT01570868|80141622|FG000|Overall Study|Withdrawal by Subject|1|||
27532125|NCT01570868|80141623|FG001|Overall Study|Withdrawal by Subject|0|||
27532126|NCT00567593|80141624|FG000|Overall Study|Adverse Event|1|||
27532127|NCT00567593|80141624|FG000|Overall Study|Physician Decision|1|||
27532128|NCT04228783|80141625|FG000|Overall Study|Adverse Event|1|||
27532129|NCT04228783|80141626|FG001|Overall Study|Adverse Event|0|||
27532130|NCT04228783|80141627|FG002|Overall Study|Adverse Event|2|||
27532131|NCT04228783|80141628|FG003|Overall Study|Adverse Event|0|||
27532132|NCT04228783|80141629|FG004|Overall Study|Adverse Event|0|||
27532133|NCT04228783|80141630|FG005|Overall Study|Adverse Event|1|||
27532134|NCT04228783|80141625|FG000|Overall Study|Death|0|||
27532135|NCT04228783|80141626|FG001|Overall Study|Death|0|||
27532136|NCT04228783|80141627|FG002|Overall Study|Death|0|||
27532137|NCT04228783|80141628|FG003|Overall Study|Death|0|||
27532138|NCT04228783|80141629|FG004|Overall Study|Death|1|||
27532139|NCT04228783|80141630|FG005|Overall Study|Death|0|||
27532140|NCT04228783|80141625|FG000|Overall Study|Lost to Follow-up|36|||
27532141|NCT04228783|80141626|FG001|Overall Study|Lost to Follow-up|36|||
27532142|NCT04228783|80141627|FG002|Overall Study|Lost to Follow-up|28|||
27532143|NCT04228783|80141628|FG003|Overall Study|Lost to Follow-up|6|||
27532144|NCT04228783|80141629|FG004|Overall Study|Lost to Follow-up|14|||
27532145|NCT04228783|80141630|FG005|Overall Study|Lost to Follow-up|3|||
27532146|NCT04228783|80141625|FG000|Overall Study|Physician Decision|1|||
27532147|NCT04228783|80141626|FG001|Overall Study|Physician Decision|2|||
27532148|NCT04228783|80141627|FG002|Overall Study|Physician Decision|0|||
27532149|NCT04228783|80141628|FG003|Overall Study|Physician Decision|0|||
27532150|NCT04228783|80141629|FG004|Overall Study|Physician Decision|0|||
27532151|NCT04228783|80141630|FG005|Overall Study|Physician Decision|0|||
27532152|NCT04228783|80141625|FG000|Overall Study|Protocol Violation|0|||
27532153|NCT04228783|80141626|FG001|Overall Study|Protocol Violation|0|||
27532154|NCT04228783|80141627|FG002|Overall Study|Protocol Violation|0|||
27736689|NCT01333189|80864922|FG000|Overall Study|Transportation difficulties|0|||
27532155|NCT04228783|80141628|FG003|Overall Study|Protocol Violation|1|||
27532156|NCT04228783|80141629|FG004|Overall Study|Protocol Violation|0|||
27532157|NCT04228783|80141630|FG005|Overall Study|Protocol Violation|0|||
27532158|NCT04228783|80141625|FG000|Overall Study|Withdrawal by Subject|6|||
27532159|NCT04228783|80141626|FG001|Overall Study|Withdrawal by Subject|10|||
27532160|NCT04228783|80141627|FG002|Overall Study|Withdrawal by Subject|19|||
27532161|NCT04228783|80141628|FG003|Overall Study|Withdrawal by Subject|1|||
27532162|NCT04228783|80141629|FG004|Overall Study|Withdrawal by Subject|2|||
27532163|NCT04228783|80141630|FG005|Overall Study|Withdrawal by Subject|0|||
27532164|NCT04228783|80141625|FG000|Overall Study|Other|4|||
27532165|NCT04228783|80141626|FG001|Overall Study|Other|3|||
27532166|NCT04228783|80141627|FG002|Overall Study|Other|2|||
27532167|NCT04228783|80141628|FG003|Overall Study|Other|1|||
27532168|NCT04228783|80141629|FG004|Overall Study|Other|0|||
27532169|NCT04228783|80141630|FG005|Overall Study|Other|0|||
27532170|NCT02869438|80141631|FG000|Overall Study|Lost to Follow-up|1|||
27532171|NCT02869438|80141632|FG001|Overall Study|Lost to Follow-up|0|||
27532172|NCT02869438|80141631|FG000|Overall Study|Adverse Event|1|||
27532173|NCT02869438|80141632|FG001|Overall Study|Adverse Event|0|||
27532174|NCT02869438|80141631|FG000|Overall Study|Withdrawal by Subject|1|||
27532175|NCT02869438|80141632|FG001|Overall Study|Withdrawal by Subject|2|||
27532176|NCT00950911|80141635|FG000|Overall Study|Adverse Event|0|||
27532177|NCT00950911|80141636|FG001|Overall Study|Adverse Event|2|||
27532178|NCT00950911|80141635|FG000|Overall Study|Death|4|||
27532179|NCT00950911|80141636|FG001|Overall Study|Death|6|||
27532180|NCT00950911|80141635|FG000|Overall Study|Disease progression|2|||
27532181|NCT00950911|80141636|FG001|Overall Study|Disease progression|2|||
27532182|NCT00950911|80141635|FG000|Overall Study|Consent withdrawn|1|||
27532183|NCT00950911|80141636|FG001|Overall Study|Consent withdrawn|3|||
27532184|NCT00950911|80141635|FG000|Overall Study|Administrative decision|3|||
27628100|NCT03982199|80480297|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628101|NCT03982199|80480298|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628102|NCT03982199|80480299|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628103|NCT03982199|80480300|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628104|NCT03982199|80480301|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
27628105|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628106|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628107|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628108|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
27628109|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628110|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628111|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628112|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628113|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628114|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628115|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628116|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628117|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628118|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
27628119|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628120|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628121|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
27628122|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628123|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628124|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27532185|NCT00950911|80141636|FG001|Overall Study|Administrative decision|1|||
27532186|NCT00950911|80141635|FG000|Overall Study|Ineligibility determined|1|||
27532187|NCT00950911|80141636|FG001|Overall Study|Ineligibility determined|0|||
27532188|NCT00950911|80141635|FG000|Overall Study|Noncompliance|1|||
27532189|NCT00950911|80141636|FG001|Overall Study|Noncompliance|0|||
27532190|NCT00950911|80141635|FG000|Overall Study|Poor performance status|0|||
27532191|NCT00950911|80141636|FG001|Overall Study|Poor performance status|1|||
27532192|NCT02517866|80141640|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27532193|NCT02517866|80141641|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
27532194|NCT02517866|80141642|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27532195|NCT02517866|80141640|FG000|Overall Study|Significant Protocol Deviation|4|||
27532196|NCT02517866|80141641|FG001|Overall Study|Significant Protocol Deviation|1|||
27532197|NCT02517866|80141642|FG002|Overall Study|Significant Protocol Deviation|0|||
27532198|NCT02517866|80141640|FG000|Overall Study|Lost to Follow-up|1|||
27532199|NCT02517866|80141641|FG001|Overall Study|Lost to Follow-up|0|||
27628125|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628126|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628127|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628128|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628129|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27532200|NCT02517866|80141642|FG002|Overall Study|Lost to Follow-up|0|||
27532201|NCT02517866|80141640|FG000|Overall Study|Voluntary Withdrawal|2|||
27532202|NCT02517866|80141641|FG001|Overall Study|Voluntary Withdrawal|2|||
27532203|NCT02517866|80141642|FG002|Overall Study|Voluntary Withdrawal|0|||
27532204|NCT02517866|80141640|FG000|Overall Study|Investigator Decision|2|||
27532205|NCT02517866|80141641|FG001|Overall Study|Investigator Decision|1|||
27532206|NCT02517866|80141642|FG002|Overall Study|Investigator Decision|0|||
27532207|NCT02517866|80141640|FG000|Overall Study|Reason not specified|2|||
27532208|NCT02517866|80141641|FG001|Overall Study|Reason not specified|0|||
27532209|NCT02517866|80141642|FG002|Overall Study|Reason not specified|0|||
27532210|NCT00131508|80145186|FG000|Overall Study|Disease progression|0|||
27532211|NCT00131508|80145187|FG001|Overall Study|Disease progression|2|||
27532212|NCT00131508|80145186|FG000|Overall Study|Non-Compliance|2|||
27532213|NCT00131508|80145187|FG001|Overall Study|Non-Compliance|4|||
27532214|NCT00131508|80145186|FG000|Overall Study|Withdrawal by Subject|1|||
27532215|NCT00131508|80145187|FG001|Overall Study|Withdrawal by Subject|2|||
27532216|NCT01264016|80145188|FG000|Overall Study|Withdrawal by Subject|1|||
27532217|NCT01264016|80145188|FG000|Overall Study|Felt faint at sight of blood|1|||
27532218|NCT04137224|80145189|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
27532219|NCT04137224|80145190|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
27532220|NCT04137224|80145189|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
27532221|NCT04137224|80145190|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
27532222|NCT04137224|80145189|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
27532223|NCT04137224|80145190|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
27532224|NCT01104155|80145193|FG000|Overall Study|Adverse Event|15|||
27532225|NCT01104155|80145194|FG001|Overall Study|Adverse Event|8|||
27532226|NCT01104155|80145193|FG000|Overall Study|Participant choice|6|||
27532227|NCT01104155|80145194|FG001|Overall Study|Participant choice|5|||
27532228|NCT01104155|80145193|FG000|Overall Study|Withdrawal of consent|1|||
27532229|NCT01104155|80145194|FG001|Overall Study|Withdrawal of consent|1|||
27532230|NCT01104155|80145193|FG000|Overall Study|Other|3|||
27532231|NCT01104155|80145194|FG001|Overall Study|Other|4|||
27532232|NCT01904058|80145195|FG000|Overall Study|Adverse Event|2|||
27532233|NCT01904058|80145196|FG001|Overall Study|Adverse Event|0|||
27532234|NCT01904058|80145197|FG002|Overall Study|Adverse Event|0|||
27532235|NCT01904058|80145198|FG003|Overall Study|Adverse Event|0|||
27532236|NCT01904058|80145195|FG000|Overall Study|Withdrawal by Subject|1|||
27532237|NCT01904058|80145196|FG001|Overall Study|Withdrawal by Subject|0|||
27532238|NCT01904058|80145197|FG002|Overall Study|Withdrawal by Subject|1|||
27628130|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628131|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628132|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
27628133|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628134|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628135|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
27628136|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628137|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628138|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628139|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628140|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628141|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628142|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628143|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628144|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628145|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628146|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
27628147|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628148|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628149|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
27628150|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
27628151|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27736690|NCT01333189|80864923|FG001|Overall Study|Transportation difficulties|1|||
27736691|NCT01333189|80864922|FG000|Overall Study|Moved from region|0|||
27736692|NCT01333189|80864923|FG001|Overall Study|Moved from region|1|||
27736693|NCT02919306|80864924|FG000|Overall Study|Withdrawal by Subject|1|||
27736694|NCT02919306|80864925|FG001|Overall Study|Withdrawal by Subject|0|||
27736695|NCT02919306|80864924|FG000|Overall Study|Protocol Violation|1|||
27736696|NCT02919306|80864925|FG001|Overall Study|Protocol Violation|0|||
27736697|NCT04285723|80864926|FG000|Overall Study|Subject decision|1|||
27736698|NCT04285723|80864927|FG001|Overall Study|Subject decision|2|||
27736699|NCT04285723|80864926|FG000|Overall Study|Physician Decision|1|||
27532239|NCT01904058|80145198|FG003|Overall Study|Withdrawal by Subject|0|||
27857062|NCT00895414|81310371|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
27857063|NCT00895414|81310372|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
27532240|NCT01904058|80145195|FG000|Overall Study|Pregnancy|0|||
27532241|NCT01904058|80145196|FG001|Overall Study|Pregnancy|0|||
27736700|NCT04285723|80864927|FG001|Overall Study|Physician Decision|0|||
27736701|NCT04285723|80864926|FG000|Overall Study|No efficiency|1|||
27736702|NCT04285723|80864927|FG001|Overall Study|No efficiency|0|||
27857064|NCT00895414|81310371|FG000|First Intervention (14 Days)|Physician Decision|0|||
27736703|NCT01672892|80864936|FG000|Overall Study|Protocol Violation|7|||
27736704|NCT01672892|80864937|FG001|Overall Study|Protocol Violation|3|||
27736705|NCT02498652|80864944|FG000|Overall Study|Protocol Violation|0|||
27736706|NCT02498652|80864945|FG001|Overall Study|Protocol Violation|1|||
27736707|NCT02499952|80864952|FG000|Overall Study|Lost to Follow-up|1|||
27736708|NCT02499952|80864952|FG000|Overall Study|Death|9|||
27736709|NCT00472303|80864953|FG000|Titration Phase|Adverse Event|22|||
27736710|NCT00472303|80864954|FG001|Titration Phase|Adverse Event|12|||
27857065|NCT00895414|81310372|FG001|First Intervention (14 Days)|Physician Decision|1|||
27857066|NCT01671332|81310373|FG000|Overall Study|Withdrawal by Subject|1|||
27857067|NCT01671332|81310374|FG001|Overall Study|Withdrawal by Subject|1|||
27857068|NCT01199471|81310380|FG000|Overall Study|Protocol Violation|4|||
27857069|NCT01199471|81310380|FG000|Overall Study|Withdrawal by Subject|1|||
27857070|NCT01199471|81310380|FG000|Overall Study|Physician Decision|1|||
27857071|NCT01267994|81310381|FG000|Overall Study|Adverse Event|2|||
27857072|NCT00470067|81310382|FG000|Overall Study|Death|1|||
27857073|NCT00470067|81310382|FG000|Overall Study|Disease Progression|6|||
27857074|NCT01682863|81310383|FG000|Overall Study|Subject/guardian decision|19|||
27857075|NCT01682863|81310384|FG001|Overall Study|Subject/guardian decision|12|||
27857076|NCT01682863|81310385|FG002|Overall Study|Subject/guardian decision|10|||
27857077|NCT01682863|81310383|FG000|Overall Study|Lost to Follow-up|5|||
27857078|NCT01682863|81310384|FG001|Overall Study|Lost to Follow-up|1|||
27857079|NCT01682863|81310385|FG002|Overall Study|Lost to Follow-up|6|||
27857080|NCT01682863|81310383|FG000|Overall Study|Death|1|||
27857081|NCT01682863|81310384|FG001|Overall Study|Death|3|||
27857082|NCT01682863|81310385|FG002|Overall Study|Death|4|||
27857083|NCT01682863|81310383|FG000|Overall Study|Protocol deviation|1|||
27857084|NCT01682863|81310384|FG001|Overall Study|Protocol deviation|0|||
27857085|NCT01682863|81310385|FG002|Overall Study|Protocol deviation|1|||
27857086|NCT01682863|81310383|FG000|Overall Study|Technical problems|1|||
27857087|NCT01682863|81310384|FG001|Overall Study|Technical problems|0|||
27857088|NCT01682863|81310385|FG002|Overall Study|Technical problems|0|||
27857089|NCT01682863|81310383|FG000|Overall Study|Adverse Event|0|||
27857090|NCT01682863|81310384|FG001|Overall Study|Adverse Event|1|||
27857091|NCT01682863|81310385|FG002|Overall Study|Adverse Event|2|||
27857092|NCT01682863|81310383|FG000|Overall Study|Physician Decision|0|||
27857093|NCT01682863|81310384|FG001|Overall Study|Physician Decision|0|||
27857094|NCT01682863|81310385|FG002|Overall Study|Physician Decision|1|||
27857095|NCT01156142|81310386|FG000|Overall Study|Withdrawal by Subject|8|||
27857096|NCT01156142|81310387|FG001|Overall Study|Withdrawal by Subject|6|||
27857097|NCT01156142|81310386|FG000|Overall Study|Ineligible|0|||
27857098|NCT01156142|81310387|FG001|Overall Study|Ineligible|1|||
27857099|NCT02130882|81310388|FG000|Overall Study|Withdrawal by Subject|0|||
27857100|NCT02130882|81310389|FG001|Overall Study|Withdrawal by Subject|1|||
27857101|NCT00171301|81310390|FG000|Overall Study|Death|1|||
27857102|NCT00171301|81310391|FG001|Overall Study|Death|2|||
27857103|NCT00171301|81310390|FG000|Overall Study|Adverse Event|1|||
27532242|NCT01904058|80145197|FG002|Overall Study|Pregnancy|0|||
27532243|NCT01904058|80145198|FG003|Overall Study|Pregnancy|1|||
27532244|NCT02367131|80145200|FG000|Overall Study|Adverse Event|64|||
27532245|NCT02367131|80145200|FG000|Overall Study|No visit since the first visit|3|||
27532246|NCT02367131|80145200|FG000|Overall Study|Request by patient|53|||
27532247|NCT02367131|80145200|FG000|Overall Study|Improvement/remission|2|||
27532248|NCT02367131|80145200|FG000|Overall Study|No change/progressive disease|78|||
27532249|NCT02367131|80145200|FG000|Overall Study|Other than stated above|20|||
27532250|NCT02367131|80145200|FG000|Overall Study|Not treated|2|||
27532251|NCT01104701|80145201|FG000|Overall Study|Withdrawal by Subject|0|||
27532252|NCT01104701|80145202|FG001|Overall Study|Withdrawal by Subject|1|||
27532253|NCT01104701|80145203|FG002|Overall Study|Withdrawal by Subject|2|||
27532254|NCT01104701|80145204|FG003|Overall Study|Withdrawal by Subject|1|||
27532255|NCT01104701|80145201|FG000|Overall Study|Adverse Event|0|||
27532256|NCT01104701|80145202|FG001|Overall Study|Adverse Event|0|||
27532257|NCT01104701|80145203|FG002|Overall Study|Adverse Event|0|||
27857104|NCT00171301|81310391|FG001|Overall Study|Adverse Event|2|||
27857105|NCT00171301|81310390|FG000|Overall Study|Lost to Follow-up|6|||
27857106|NCT00171301|81310391|FG001|Overall Study|Lost to Follow-up|2|||
27857107|NCT00171301|81310390|FG000|Overall Study|Protocol Violation|0|||
27857108|NCT00171301|81310391|FG001|Overall Study|Protocol Violation|2|||
27857109|NCT00171301|81310390|FG000|Overall Study|Withdrawal by Subject|0|||
27857110|NCT00171301|81310391|FG001|Overall Study|Withdrawal by Subject|1|||
27532258|NCT01104701|80145204|FG003|Overall Study|Adverse Event|1|||
27857111|NCT02447744|81310392|FG000|Overall Study|Withdrawal by Subject|3|||
27532259|NCT01104701|80145201|FG000|Overall Study|Physician Decision|0|||
27532260|NCT01104701|80145202|FG001|Overall Study|Physician Decision|2|||
27736711|NCT00472303|80864955|FG002|Titration Phase|Adverse Event|0|||
27736712|NCT00472303|80864953|FG000|Titration Phase|Death|4|||
27857112|NCT02447744|81310393|FG001|Overall Study|Withdrawal by Subject|1|||
27857113|NCT02447744|81310392|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
27857114|NCT02447744|81310393|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
27857115|NCT02307266|81310395|FG000|Overall Study|Adverse Event|3|||
27532261|NCT01104701|80145203|FG002|Overall Study|Physician Decision|0|||
27532262|NCT01104701|80145204|FG003|Overall Study|Physician Decision|0|||
27532263|NCT03387150|80145205|FG000|Overall Study|Withdrawal by Subject|3|||
27532264|NCT03387150|80145206|FG001|Overall Study|Withdrawal by Subject|0|||
27532265|NCT03387150|80145207|FG002|Overall Study|Withdrawal by Subject|3|||
27532266|NCT03387150|80145208|FG003|Overall Study|Withdrawal by Subject|4|||
27532267|NCT03387150|80145209|FG004|Overall Study|Withdrawal by Subject|1|||
27532268|NCT03387150|80145210|FG005|Overall Study|Withdrawal by Subject|2|||
27532269|NCT03387150|80145211|FG006|Overall Study|Withdrawal by Subject|0|||
27532270|NCT03387150|80145205|FG000|Overall Study|Lost to Follow-up|3|||
27532271|NCT03387150|80145206|FG001|Overall Study|Lost to Follow-up|2|||
27532272|NCT03387150|80145207|FG002|Overall Study|Lost to Follow-up|2|||
27532273|NCT03387150|80145208|FG003|Overall Study|Lost to Follow-up|3|||
27532274|NCT03387150|80145209|FG004|Overall Study|Lost to Follow-up|3|||
27532275|NCT03387150|80145210|FG005|Overall Study|Lost to Follow-up|3|||
27532276|NCT03387150|80145211|FG006|Overall Study|Lost to Follow-up|0|||
27532277|NCT03387150|80145205|FG000|Overall Study|Participant unable to adhere to visit|0|||
27532278|NCT03387150|80145206|FG001|Overall Study|Participant unable to adhere to visit|1|||
27532279|NCT03387150|80145207|FG002|Overall Study|Participant unable to adhere to visit|0|||
27532280|NCT03387150|80145208|FG003|Overall Study|Participant unable to adhere to visit|0|||
27532281|NCT03387150|80145209|FG004|Overall Study|Participant unable to adhere to visit|2|||
27532282|NCT03387150|80145210|FG005|Overall Study|Participant unable to adhere to visit|2|||
27532283|NCT03387150|80145211|FG006|Overall Study|Participant unable to adhere to visit|0|||
27532284|NCT02611960|80145215|FG000|Overall Study|Adverse Event|7|||
27532285|NCT02611960|80145216|FG001|Overall Study|Adverse Event|8|||
27532286|NCT02611960|80145215|FG000|Overall Study|Death|98|||
27532287|NCT02611960|80145216|FG001|Overall Study|Death|92|||
27532288|NCT02611960|80145215|FG000|Overall Study|Withdrawal by Subject|1|||
27532289|NCT02611960|80145216|FG001|Overall Study|Withdrawal by Subject|5|||
27628152|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27532290|NCT02611960|80145215|FG000|Overall Study|Sponsor Decision|11|||
27532291|NCT02611960|80145216|FG001|Overall Study|Sponsor Decision|11|||
27532292|NCT02484690|80145217|FG000|Overall Study|Adverse Event|1|||
27532293|NCT02484690|80145218|FG001|Overall Study|Adverse Event|3|||
27628153|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628154|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628155|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628156|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628157|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628158|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628159|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628160|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
27628161|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628162|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628163|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628164|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
27628165|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628166|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628167|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628168|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628169|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628170|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628171|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628172|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628173|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628174|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
27628175|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628176|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628177|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
27628178|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
27628179|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628180|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628181|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628182|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628183|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27532294|NCT02484690|80145219|FG002|Overall Study|Adverse Event|0|||
27532295|NCT02484690|80145220|FG003|Overall Study|Adverse Event|0|||
27532296|NCT02484690|80145221|FG004|Overall Study|Adverse Event|5|||
27532297|NCT02484690|80145217|FG000|Overall Study|Death|0|||
27532298|NCT02484690|80145218|FG001|Overall Study|Death|0|||
27532299|NCT02484690|80145219|FG002|Overall Study|Death|0|||
27532300|NCT02484690|80145220|FG003|Overall Study|Death|0|||
27532301|NCT02484690|80145221|FG004|Overall Study|Death|1|||
27532302|NCT02484690|80145217|FG000|Overall Study|Withdrawal by Subject|1|||
27532303|NCT02484690|80145218|FG001|Overall Study|Withdrawal by Subject|3|||
27532304|NCT02484690|80145219|FG002|Overall Study|Withdrawal by Subject|1|||
27532305|NCT02484690|80145220|FG003|Overall Study|Withdrawal by Subject|2|||
27532306|NCT02484690|80145221|FG004|Overall Study|Withdrawal by Subject|0|||
27532307|NCT02484690|80145217|FG000|Overall Study|Physician Decision|2|||
27532308|NCT02484690|80145218|FG001|Overall Study|Physician Decision|0|||
27532309|NCT02484690|80145219|FG002|Overall Study|Physician Decision|1|||
27532310|NCT02484690|80145220|FG003|Overall Study|Physician Decision|0|||
27532311|NCT02484690|80145221|FG004|Overall Study|Physician Decision|0|||
27532312|NCT02484690|80145217|FG000|Overall Study|Lost to Follow-up|0|||
27532313|NCT02484690|80145218|FG001|Overall Study|Lost to Follow-up|0|||
27532314|NCT02484690|80145219|FG002|Overall Study|Lost to Follow-up|1|||
27532315|NCT02484690|80145220|FG003|Overall Study|Lost to Follow-up|0|||
27532316|NCT02484690|80145221|FG004|Overall Study|Lost to Follow-up|0|||
27532317|NCT01927341|80145222|FG000|Phase 1b|Lost to Follow-up|1|||
27532318|NCT01927341|80145223|FG001|Phase 1b|Lost to Follow-up|0|||
27532319|NCT01927341|80145224|FG002|Phase 1b|Lost to Follow-up|0|||
27532320|NCT01927341|80145225|FG003|Phase 1b|Lost to Follow-up|0|||
27532321|NCT01927341|80145226|FG004|Phase 1b|Lost to Follow-up|0|||
27532322|NCT01927341|80145222|FG000|Phase 1b|Death|2|||
27628184|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628185|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628186|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628187|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628188|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
27628189|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628190|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628191|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628192|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628193|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628194|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628195|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628196|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628197|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
27628198|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628199|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628200|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628201|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628202|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
27628203|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628204|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628205|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628206|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628207|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628208|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628209|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628210|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628211|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
27628212|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628213|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27736713|NCT00472303|80864954|FG001|Titration Phase|Death|2|||
27736714|NCT00472303|80864955|FG002|Titration Phase|Death|0|||
27736715|NCT00472303|80864953|FG000|Titration Phase|Lack of Efficacy|10|||
27736716|NCT00472303|80864954|FG001|Titration Phase|Lack of Efficacy|0|||
27736717|NCT00472303|80864955|FG002|Titration Phase|Lack of Efficacy|0|||
27532323|NCT01927341|80145223|FG001|Phase 1b|Death|0|||
27532324|NCT01927341|80145224|FG002|Phase 1b|Death|0|||
27532325|NCT01927341|80145225|FG003|Phase 1b|Death|0|||
27532326|NCT01927341|80145226|FG004|Phase 1b|Death|0|||
27532327|NCT01927341|80145222|FG000|Phase 1b|Follow-up completed|7|||
27532328|NCT01927341|80145223|FG001|Phase 1b|Follow-up completed|0|||
27532329|NCT01927341|80145224|FG002|Phase 1b|Follow-up completed|0|||
27532330|NCT01927341|80145225|FG003|Phase 1b|Follow-up completed|0|||
27532331|NCT01927341|80145226|FG004|Phase 1b|Follow-up completed|0|||
27532332|NCT01927341|80145222|FG000|Phase 2|Lost to Follow-up|0|||
27532333|NCT01927341|80145223|FG001|Phase 2|Lost to Follow-up|1|||
27532334|NCT01927341|80145224|FG002|Phase 2|Lost to Follow-up|0|||
27532335|NCT01927341|80145225|FG003|Phase 2|Lost to Follow-up|0|||
27532336|NCT01927341|80145226|FG004|Phase 2|Lost to Follow-up|0|||
27628214|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628215|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628216|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
27628217|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628218|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628219|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628220|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628221|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628222|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628223|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628224|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628225|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
27628226|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628227|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628228|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628229|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628230|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
27628231|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628232|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628233|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628234|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628235|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628236|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628237|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27736718|NCT00472303|80864953|FG000|Titration Phase|Withdrawal by Subject|16|||
27532337|NCT01927341|80145222|FG000|Phase 2|Participant withdrew consent|0|||
27532338|NCT01927341|80145223|FG001|Phase 2|Participant withdrew consent|2|||
27736719|NCT00472303|80864954|FG001|Titration Phase|Withdrawal by Subject|13|||
27736720|NCT00472303|80864955|FG002|Titration Phase|Withdrawal by Subject|0|||
27736721|NCT00472303|80864953|FG000|Titration Phase|Trial Medication non-compliant|4|||
27736722|NCT00472303|80864954|FG001|Titration Phase|Trial Medication non-compliant|1|||
27736723|NCT00472303|80864955|FG002|Titration Phase|Trial Medication non-compliant|0|||
27736724|NCT00472303|80864953|FG000|Titration Phase|Other|3|||
27736725|NCT00472303|80864954|FG001|Titration Phase|Other|1|||
27736726|NCT00472303|80864955|FG002|Titration Phase|Other|0|||
27857116|NCT02307266|81310396|FG001|Overall Study|Adverse Event|1|||
27857117|NCT02307266|81310397|FG002|Overall Study|Adverse Event|5|||
27532339|NCT01927341|80145224|FG002|Phase 2|Participant withdrew consent|1|||
27532340|NCT01927341|80145225|FG003|Phase 2|Participant withdrew consent|2|||
27532341|NCT01927341|80145226|FG004|Phase 2|Participant withdrew consent|3|||
27532342|NCT01927341|80145222|FG000|Phase 2|Death|0|||
27532343|NCT01927341|80145223|FG001|Phase 2|Death|4|||
27532344|NCT01927341|80145224|FG002|Phase 2|Death|0|||
27532345|NCT01927341|80145225|FG003|Phase 2|Death|3|||
27532346|NCT01927341|80145226|FG004|Phase 2|Death|2|||
27532347|NCT01927341|80145222|FG000|Phase 2|New cancer therapy|0|||
27532348|NCT01927341|80145223|FG001|Phase 2|New cancer therapy|1|||
27532349|NCT01927341|80145224|FG002|Phase 2|New cancer therapy|0|||
27532350|NCT01927341|80145225|FG003|Phase 2|New cancer therapy|4|||
27532351|NCT01927341|80145226|FG004|Phase 2|New cancer therapy|1|||
27532352|NCT01927341|80145222|FG000|Phase 2|Disease progression|0|||
27532353|NCT01927341|80145223|FG001|Phase 2|Disease progression|1|||
27532354|NCT01927341|80145224|FG002|Phase 2|Disease progression|1|||
27532355|NCT01927341|80145225|FG003|Phase 2|Disease progression|1|||
27532356|NCT01927341|80145226|FG004|Phase 2|Disease progression|0|||
27532357|NCT01927341|80145222|FG000|Phase 2|Follow-up completed|0|||
27532358|NCT01927341|80145223|FG001|Phase 2|Follow-up completed|6|||
27532359|NCT01927341|80145224|FG002|Phase 2|Follow-up completed|3|||
27532360|NCT01927341|80145225|FG003|Phase 2|Follow-up completed|5|||
27532361|NCT01927341|80145226|FG004|Phase 2|Follow-up completed|2|||
27532362|NCT02319837|80145227|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
27532363|NCT02319837|80145228|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
27532364|NCT02319837|80145229|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
27857118|NCT02307266|81310395|FG000|Overall Study|Withdrawal by Subject|2|||
27532365|NCT02319837|80145227|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
27532366|NCT02319837|80145228|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
27532367|NCT02319837|80145229|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
27532368|NCT02319837|80145227|FG000|Study Treatment Phase|Adverse Event|73|||
27532369|NCT02319837|80145228|FG001|Study Treatment Phase|Adverse Event|36|||
27532370|NCT02319837|80145229|FG002|Study Treatment Phase|Adverse Event|63|||
27628238|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628239|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
27628240|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628241|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628242|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628243|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628244|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
27628245|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628246|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628247|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628248|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628249|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628250|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628251|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628252|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628253|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
27628254|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628255|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628256|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628257|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27736727|NCT00472303|80864953|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
27628258|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
27628259|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628260|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628261|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27532371|NCT02319837|80145227|FG000|Study Treatment Phase|Development of castration resistance|0|||
27532372|NCT02319837|80145228|FG001|Study Treatment Phase|Development of castration resistance|2|||
27736728|NCT00472303|80864954|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
27736729|NCT00472303|80864955|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
27532373|NCT02319837|80145229|FG002|Study Treatment Phase|Development of castration resistance|0|||
27532374|NCT02319837|80145227|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
27532375|NCT02319837|80145228|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
27532376|NCT02319837|80145229|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
27532377|NCT02319837|80145227|FG000|Study Treatment Phase|Protocol Violation|2|||
27532378|NCT02319837|80145228|FG001|Study Treatment Phase|Protocol Violation|2|||
27532379|NCT02319837|80145229|FG002|Study Treatment Phase|Protocol Violation|1|||
27736730|NCT00472303|80864953|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
27736731|NCT00472303|80864954|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
27736732|NCT00472303|80864955|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
27736733|NCT00472303|80864953|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
27736734|NCT00472303|80864954|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
27736735|NCT00472303|80864955|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
27736736|NCT00472303|80864953|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
27736737|NCT00472303|80864954|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
27736738|NCT00472303|80864955|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
27736739|NCT00472303|80864953|FG000|Discontinuations After Titration Phase|Other|5|||
27736740|NCT00472303|80864954|FG001|Discontinuations After Titration Phase|Other|0|||
27736741|NCT00472303|80864955|FG002|Discontinuations After Titration Phase|Other|0|||
27736742|NCT00472303|80864953|FG000|Maintenance Phase|Adverse Event|5|||
27736743|NCT00472303|80864954|FG001|Maintenance Phase|Adverse Event|6|||
27736744|NCT00472303|80864955|FG002|Maintenance Phase|Adverse Event|6|||
27736745|NCT00472303|80864953|FG000|Maintenance Phase|Death|3|||
27736746|NCT00472303|80864954|FG001|Maintenance Phase|Death|0|||
27736747|NCT00472303|80864955|FG002|Maintenance Phase|Death|2|||
27736748|NCT00472303|80864953|FG000|Maintenance Phase|Lack of Efficacy|2|||
27736749|NCT00472303|80864954|FG001|Maintenance Phase|Lack of Efficacy|2|||
27736750|NCT00472303|80864955|FG002|Maintenance Phase|Lack of Efficacy|4|||
27736751|NCT00472303|80864953|FG000|Maintenance Phase|Withdrawal by Subject|6|||
27736752|NCT00472303|80864954|FG001|Maintenance Phase|Withdrawal by Subject|7|||
27736753|NCT00472303|80864955|FG002|Maintenance Phase|Withdrawal by Subject|3|||
27736754|NCT00472303|80864953|FG000|Maintenance Phase|Trial medication non-compliant|0|||
27736755|NCT00472303|80864954|FG001|Maintenance Phase|Trial medication non-compliant|0|||
27736756|NCT00472303|80864955|FG002|Maintenance Phase|Trial medication non-compliant|1|||
27736757|NCT00472303|80864953|FG000|Maintenance Phase|Resolution of pain|0|||
27736758|NCT00472303|80864954|FG001|Maintenance Phase|Resolution of pain|0|||
27532380|NCT02319837|80145227|FG000|Study Treatment Phase|Lost to Follow-up|0|||
27532381|NCT02319837|80145228|FG001|Study Treatment Phase|Lost to Follow-up|1|||
27532382|NCT02319837|80145229|FG002|Study Treatment Phase|Lost to Follow-up|0|||
27628262|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628263|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628264|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
27628265|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628266|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
27628267|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
27628268|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628269|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628270|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628271|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628272|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
27628273|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628274|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628275|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628276|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628277|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628278|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628279|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628280|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628281|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
27857119|NCT02307266|81310396|FG001|Overall Study|Withdrawal by Subject|0|||
27857120|NCT02307266|81310397|FG002|Overall Study|Withdrawal by Subject|1|||
27857121|NCT02307266|81310395|FG000|Overall Study|Lost to Follow-up|3|||
27857122|NCT02307266|81310396|FG001|Overall Study|Lost to Follow-up|0|||
27857123|NCT02307266|81310397|FG002|Overall Study|Lost to Follow-up|0|||
27857124|NCT03310411|81310398|FG000|Period 1|Adverse Event|0|||
27628282|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27532383|NCT02319837|80145227|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
27532384|NCT02319837|80145228|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
27532385|NCT02319837|80145229|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
27532386|NCT02319837|80145227|FG000|Study Treatment Phase|Other|0|||
27532387|NCT02319837|80145228|FG001|Study Treatment Phase|Other|1|||
27532388|NCT02319837|80145229|FG002|Study Treatment Phase|Other|0|||
27532389|NCT02319837|80145227|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
27532390|NCT02319837|80145228|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
27532391|NCT02319837|80145229|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
27532392|NCT02319837|80145227|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
27532393|NCT02319837|80145228|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
27532394|NCT02319837|80145229|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
27532395|NCT02319837|80145227|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
27532396|NCT02319837|80145228|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
27532397|NCT02319837|80145229|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
27532398|NCT02319837|80145227|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
27532399|NCT02319837|80145228|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
27532400|NCT02319837|80145229|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
27532401|NCT02319837|80145227|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
27532402|NCT02319837|80145228|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
27532403|NCT02319837|80145229|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
27532404|NCT02319837|80145227|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
27628283|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628284|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628285|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27736759|NCT00472303|80864955|FG002|Maintenance Phase|Resolution of pain|1|||
27857125|NCT03310411|81310399|FG001|Period 1|Adverse Event|0|||
27857126|NCT03310411|81310400|FG002|Period 1|Adverse Event|0|||
27857127|NCT03310411|81310401|FG003|Period 1|Adverse Event|1|||
27857128|NCT00658021|81310402|FG000|28-Week Treatment Period|Adverse Event|3|||
27857129|NCT00658021|81310403|FG001|28-Week Treatment Period|Adverse Event|1|||
27857130|NCT00658021|81310404|FG002|28-Week Treatment Period|Adverse Event|0|||
27857131|NCT00658021|81310402|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
27736760|NCT00472303|80864953|FG000|Maintenance Phase|Other|1|||
27628286|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
27628287|NCT03982199|80480288|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628288|NCT03982199|80480289|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27736761|NCT00472303|80864954|FG001|Maintenance Phase|Other|1|||
27736762|NCT00472303|80864955|FG002|Maintenance Phase|Other|0|||
27532405|NCT02319837|80145228|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
27532406|NCT02319837|80145229|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
27532407|NCT02319837|80145227|FG000|Long-Term Follow-Up Phase|Death|33|||
27532408|NCT02319837|80145228|FG001|Long-Term Follow-Up Phase|Death|54|||
27532409|NCT02319837|80145229|FG002|Long-Term Follow-Up Phase|Death|42|||
27532410|NCT03799211|80145230|FG000|Overall Study|Lost to Follow-up|2|||
27532411|NCT03799211|80145231|FG001|Overall Study|Lost to Follow-up|13|||
27532412|NCT03799211|80145230|FG000|Overall Study|Withdrawal by Subject|2|||
27532413|NCT03799211|80145231|FG001|Overall Study|Withdrawal by Subject|0|||
27532414|NCT03509467|80145238|FG000|Overall Study|Withdrawal by Subject|5|||
27532415|NCT03509467|80145239|FG001|Overall Study|Withdrawal by Subject|1|||
27532416|NCT03509467|80145240|FG002|Overall Study|Withdrawal by Subject|6|||
27532417|NCT03509467|80145241|FG003|Overall Study|Withdrawal by Subject|7|||
27532418|NCT03509467|80145242|FG004|Overall Study|Withdrawal by Subject|10|||
27532419|NCT03509467|80145243|FG005|Overall Study|Withdrawal by Subject|10|||
27532420|NCT03509467|80145244|FG006|Overall Study|Withdrawal by Subject|10|||
27532421|NCT03509467|80145245|FG007|Overall Study|Withdrawal by Subject|10|||
27912658|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912659|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
27532422|NCT03509467|80145238|FG000|Overall Study|Death|0|||
27532423|NCT03509467|80145239|FG001|Overall Study|Death|0|||
27532424|NCT03509467|80145240|FG002|Overall Study|Death|2|||
27532425|NCT03509467|80145241|FG003|Overall Study|Death|2|||
27532426|NCT03509467|80145242|FG004|Overall Study|Death|1|||
27532427|NCT03509467|80145243|FG005|Overall Study|Death|0|||
27857132|NCT00658021|81310403|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
27857133|NCT00658021|81310404|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
27857134|NCT00658021|81310402|FG000|28-Week Treatment Period|Protocol Violation|0|||
27857135|NCT00658021|81310403|FG001|28-Week Treatment Period|Protocol Violation|2|||
27857136|NCT00658021|81310404|FG002|28-Week Treatment Period|Protocol Violation|1|||
27857137|NCT00658021|81310402|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
27912660|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27532428|NCT03509467|80145244|FG006|Overall Study|Death|1|||
27532429|NCT03509467|80145245|FG007|Overall Study|Death|0|||
27532430|NCT03509467|80145238|FG000|Overall Study|Proxy Withdrawal|0|||
27532431|NCT03509467|80145239|FG001|Overall Study|Proxy Withdrawal|0|||
27532432|NCT03509467|80145240|FG002|Overall Study|Proxy Withdrawal|0|||
27532433|NCT03509467|80145241|FG003|Overall Study|Proxy Withdrawal|0|||
27532434|NCT03509467|80145242|FG004|Overall Study|Proxy Withdrawal|0|||
27532435|NCT03509467|80145243|FG005|Overall Study|Proxy Withdrawal|0|||
27532436|NCT03509467|80145244|FG006|Overall Study|Proxy Withdrawal|0|||
27532437|NCT03509467|80145245|FG007|Overall Study|Proxy Withdrawal|1|||
27532438|NCT04447755|80145246|FG000|Overall Study|Death|8|||
27532439|NCT04447755|80145247|FG001|Overall Study|Death|14|||
27532440|NCT04447755|80145248|FG002|Overall Study|Death|8|||
27532441|NCT04447755|80145249|FG003|Overall Study|Death|9|||
27532442|NCT04447755|80145250|FG004|Overall Study|Death|7|||
27532443|NCT04447755|80145251|FG005|Overall Study|Death|7|||
27532444|NCT04447755|80145252|FG006|Overall Study|Death|40|||
27532445|NCT04447755|80145246|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27532446|NCT04447755|80145247|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27532447|NCT04447755|80145248|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27532448|NCT04447755|80145249|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27532449|NCT04447755|80145250|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27532450|NCT04447755|80145251|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
27532451|NCT04447755|80145252|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
27532452|NCT04447755|80145246|FG000|Overall Study|Ongoing in Study|1|||
27532453|NCT04447755|80145247|FG001|Overall Study|Ongoing in Study|2|||
27532454|NCT04447755|80145248|FG002|Overall Study|Ongoing in Study|0|||
27532455|NCT04447755|80145249|FG003|Overall Study|Ongoing in Study|0|||
27532456|NCT04447755|80145250|FG004|Overall Study|Ongoing in Study|2|||
27532457|NCT04447755|80145251|FG005|Overall Study|Ongoing in Study|2|||
27532458|NCT04447755|80145252|FG006|Overall Study|Ongoing in Study|26|||
27532459|NCT02204007|80145254|FG000|Overall Study|Surgery Canceled|1|||
27532460|NCT02204007|80145255|FG001|Overall Study|Surgery Canceled|1|||
27628289|NCT03982199|80480290|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628290|NCT03982199|80480291|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628291|NCT03982199|80480292|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628292|NCT03982199|80480293|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
27628293|NCT03982199|80480294|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628294|NCT03982199|80480295|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
27628295|NCT03982199|80480296|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
27628296|NCT03982199|80480297|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628297|NCT03982199|80480298|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628298|NCT03982199|80480299|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628299|NCT03982199|80480300|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628300|NCT03982199|80480301|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
27628301|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628302|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628303|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27912661|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27912662|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
27532461|NCT03347188|80145257|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
27532462|NCT03347188|80145258|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
27628304|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628305|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27912663|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912664|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912665|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912666|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912667|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912668|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912669|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912670|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27532463|NCT03347188|80145257|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
27532464|NCT03347188|80145258|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
27532465|NCT03347188|80145257|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
27532466|NCT03347188|80145258|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
27532467|NCT03347188|80145257|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
27532468|NCT03347188|80145258|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
27532469|NCT03347188|80145257|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
27532470|NCT03347188|80145258|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
27532471|NCT03347188|80145257|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
27532472|NCT03347188|80145258|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
27532473|NCT03347188|80145257|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
27532474|NCT03347188|80145258|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
27532475|NCT03347188|80145257|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
27532476|NCT03347188|80145258|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
27532477|NCT03911713|80145259|FG000|Overall Study|Lost to Follow-up|0|||
27532478|NCT03911713|80145260|FG001|Overall Study|Lost to Follow-up|2|||
27628306|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628307|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628308|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628309|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
27628310|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
27628311|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
27628312|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
27628313|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
27628314|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
27628315|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628316|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628317|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628318|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628319|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628320|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628321|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628322|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628323|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628324|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
27628325|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628326|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628327|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628328|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
27628329|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628330|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628331|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628332|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628333|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628334|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628335|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628336|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628337|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628338|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628339|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628340|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628341|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
27628342|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
27628343|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27736763|NCT00813995|80864956|FG000|Overall Study|Clinical adverse event|9|||
27736764|NCT00813995|80864957|FG001|Overall Study|Clinical adverse event|3|||
27736765|NCT00813995|80864956|FG000|Overall Study|Laboratory adverse event|0|||
27736766|NCT00813995|80864957|FG001|Overall Study|Laboratory adverse event|2|||
27532479|NCT03911713|80145261|FG002|Overall Study|Lost to Follow-up|0|||
27532480|NCT03911713|80145262|FG003|Overall Study|Lost to Follow-up|0|||
27532481|NCT03911713|80145263|FG004|Overall Study|Lost to Follow-up|0|||
27532482|NCT03911713|80145259|FG000|Overall Study|Other|0|||
27532483|NCT03911713|80145260|FG001|Overall Study|Other|0|||
27532484|NCT03911713|80145261|FG002|Overall Study|Other|0|||
27532485|NCT03911713|80145262|FG003|Overall Study|Other|1|||
27532486|NCT03911713|80145263|FG004|Overall Study|Other|0|||
27532487|NCT03911713|80145259|FG000|Overall Study|Randomized, Never Dosed|1|||
27532488|NCT03911713|80145260|FG001|Overall Study|Randomized, Never Dosed|0|||
27532489|NCT03911713|80145261|FG002|Overall Study|Randomized, Never Dosed|0|||
27532490|NCT03911713|80145262|FG003|Overall Study|Randomized, Never Dosed|1|||
27532491|NCT03911713|80145263|FG004|Overall Study|Randomized, Never Dosed|0|||
27532492|NCT01933217|80145268|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
27532493|NCT01933217|80145269|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
27532494|NCT01933217|80145268|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
27532495|NCT01933217|80145269|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
27532496|NCT01241240|80145270|FG000|Overall Study|Adverse Event|5|||
27532497|NCT01241240|80145271|FG001|Overall Study|Adverse Event|4|||
27532498|NCT01241240|80145270|FG000|Overall Study|Lost to Follow-up|2|||
27532499|NCT01241240|80145271|FG001|Overall Study|Lost to Follow-up|4|||
27532500|NCT01241240|80145270|FG000|Overall Study|Personal Reasons|1|||
27532501|NCT01241240|80145271|FG001|Overall Study|Personal Reasons|1|||
27532502|NCT02057393|80145277|FG000|Overall Study|Withdrawal by Subject|1|||
27532503|NCT02057393|80145277|FG000|Overall Study|Patient did not meet criteria|1|||
27532504|NCT03360747|80145278|FG000|Overall Study|Voluntary Withdrawal|1|||
27628344|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628345|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628346|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628347|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628348|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628349|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628350|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628351|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628352|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628353|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
27628354|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
27628355|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
27628356|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
27628357|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628358|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628359|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628360|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628361|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628362|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628363|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628364|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628365|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628366|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628367|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628368|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628369|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
27628370|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
27628371|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628372|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628373|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628374|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628375|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628376|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628377|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628378|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628379|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628380|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628381|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628382|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
27628383|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
27628384|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
27628385|NCT03982199|80480288|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628386|NCT03982199|80480289|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628387|NCT03982199|80480290|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628388|NCT03982199|80480291|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628389|NCT03982199|80480292|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628390|NCT03982199|80480293|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628391|NCT03982199|80480294|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628392|NCT03982199|80480295|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628393|NCT03982199|80480296|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628394|NCT03982199|80480297|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628395|NCT03982199|80480298|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628396|NCT03982199|80480299|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628397|NCT03982199|80480300|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
27628398|NCT03982199|80480301|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
27628399|NCT01155869|80480302|FG000|Overall Study|Lost to Follow-up|3|||
27628400|NCT01155869|80480303|FG001|Overall Study|Lost to Follow-up|1|||
27628401|NCT02784704|80480305|FG000|Overall Study|Adverse Event|4|||
27628402|NCT02784704|80480306|FG001|Overall Study|Adverse Event|2|||
27628403|NCT02784704|80480305|FG000|Overall Study|Lost to Follow-up|6|||
27628404|NCT02784704|80480306|FG001|Overall Study|Lost to Follow-up|4|||
27628405|NCT02784704|80480305|FG000|Overall Study|Withdrawal by Subject|1|||
27628406|NCT02784704|80480306|FG001|Overall Study|Withdrawal by Subject|3|||
27628407|NCT02784704|80480305|FG000|Overall Study|Subject Non Compliance|2|||
27912671|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27532505|NCT02395016|80145279|FG000|Overall Study|Adverse Event|4|||
27912672|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912673|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
27912674|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912675|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
27912676|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
27912677|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
27912678|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912679|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912680|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912681|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912682|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912683|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912684|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912685|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912686|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27532506|NCT02395016|80145280|FG001|Overall Study|Adverse Event|3|||
27532507|NCT02395016|80145279|FG000|Overall Study|Withdrawal by Subject|9|||
27532508|NCT02395016|80145280|FG001|Overall Study|Withdrawal by Subject|6|||
27532509|NCT02395016|80145279|FG000|Overall Study|Protocol Violation|2|||
27532510|NCT02395016|80145280|FG001|Overall Study|Protocol Violation|3|||
27532511|NCT04447417|80145285|FG000|Overall Study|Withdrawal by Subject|1|||
27857138|NCT00658021|81310403|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
27857139|NCT00658021|81310404|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
27857140|NCT00658021|81310402|FG000|28-Week Treatment Period|Physician Decision|1|||
27857141|NCT00658021|81310403|FG001|28-Week Treatment Period|Physician Decision|2|||
27857142|NCT00658021|81310404|FG002|28-Week Treatment Period|Physician Decision|1|||
27857143|NCT00658021|81310402|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
27857144|NCT00658021|81310403|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
27857145|NCT00658021|81310404|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
27857146|NCT00658021|81310402|FG000|28-Week Treatment Period|Loss of glucose control|1|||
27857147|NCT00658021|81310403|FG001|28-Week Treatment Period|Loss of glucose control|1|||
27857148|NCT00658021|81310404|FG002|28-Week Treatment Period|Loss of glucose control|10|||
27857149|NCT00658021|81310402|FG000|28-Week Treatment Period|Other|2|||
27857150|NCT00658021|81310403|FG001|28-Week Treatment Period|Other|3|||
27857151|NCT00658021|81310404|FG002|28-Week Treatment Period|Other|1|||
27857152|NCT00658021|81310402|FG000|28-Week Treatment Period|Did not receive treatment|2|||
27857153|NCT00658021|81310403|FG001|28-Week Treatment Period|Did not receive treatment|0|||
27857154|NCT00658021|81310404|FG002|28-Week Treatment Period|Did not receive treatment|0|||
27857155|NCT00658021|81310402|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
27857156|NCT00658021|81310403|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
27857157|NCT00658021|81310404|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
27857158|NCT00658021|81310402|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
27857159|NCT00658021|81310403|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
27857160|NCT00658021|81310404|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
27857161|NCT01675661|81310405|FG000|Overall Study|Lost to Follow-up|22|||
27857162|NCT01675661|81310406|FG001|Overall Study|Lost to Follow-up|23|||
27857163|NCT01675661|81310405|FG000|Overall Study|Practical problems|9|||
27857164|NCT01675661|81310406|FG001|Overall Study|Practical problems|5|||
27857165|NCT01675661|81310405|FG000|Overall Study|Moved away|5|||
27857166|NCT01675661|81310406|FG001|Overall Study|Moved away|6|||
27857167|NCT01675661|81310405|FG000|Overall Study|Withdrawal by Subject|3|||
27857168|NCT01675661|81310406|FG001|Overall Study|Withdrawal by Subject|7|||
27857169|NCT01675661|81310405|FG000|Overall Study|Physician Decision|0|||
27857170|NCT01675661|81310406|FG001|Overall Study|Physician Decision|2|||
27857171|NCT01675661|81310405|FG000|Overall Study|Death|0|||
27857172|NCT01675661|81310406|FG001|Overall Study|Death|1|||
27857173|NCT01675661|81310405|FG000|Overall Study|Other reason|1|||
27857174|NCT01675661|81310406|FG001|Overall Study|Other reason|2|||
27857175|NCT02605993|81310418|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
27857176|NCT02605993|81310419|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
27857177|NCT02605993|81310420|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
27857178|NCT02605993|81310421|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
27857179|NCT02105974|81310422|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
27857180|NCT02105974|81310423|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
27912687|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27532512|NCT04447417|80145286|FG001|Overall Study|Withdrawal by Subject|0|||
27857181|NCT02105974|81310424|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
27912688|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912689|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
27912690|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912691|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
27912692|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
27912693|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912694|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912695|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27532513|NCT04447417|80145285|FG000|Overall Study|Failure to meet inclusion criteria|1|||
27532514|NCT04447417|80145286|FG001|Overall Study|Failure to meet inclusion criteria|0|||
27532515|NCT04447417|80145285|FG000|Overall Study|Lost to Follow-up|1|||
27532516|NCT04447417|80145286|FG001|Overall Study|Lost to Follow-up|0|||
27532517|NCT01323946|80145295|FG000|Overall Study|Lost to Follow-up|0|||
27532518|NCT01323946|80145296|FG001|Overall Study|Lost to Follow-up|1|||
27532519|NCT01323946|80145297|FG002|Overall Study|Lost to Follow-up|0|||
27532520|NCT01323946|80145295|FG000|Overall Study|Parents refused the last blood draw|1|||
27532521|NCT01323946|80145296|FG001|Overall Study|Parents refused the last blood draw|0|||
27532522|NCT01323946|80145297|FG002|Overall Study|Parents refused the last blood draw|0|||
27532523|NCT01323946|80145295|FG000|Overall Study|Withdrawal by Subject|2|||
27532524|NCT01323946|80145296|FG001|Overall Study|Withdrawal by Subject|2|||
27532525|NCT01323946|80145297|FG002|Overall Study|Withdrawal by Subject|0|||
27532526|NCT01066000|80145300|FG000|Overall Study|Protocol Violation|4|||
27532527|NCT01066000|80145300|FG000|Overall Study|Death|3|||
27532528|NCT01066000|80145300|FG000|Overall Study|Withdrawal by Subject|1|||
27532529|NCT01066000|80145300|FG000|Overall Study|Adverse Event|1|||
27532530|NCT02520661|80145301|FG000|Overall Study|Lost to Follow-up|7|||
27532531|NCT02520661|80145302|FG001|Overall Study|Lost to Follow-up|3|||
27532532|NCT02520661|80145301|FG000|Overall Study|Admitted from ED|49|||
27532533|NCT02520661|80145302|FG001|Overall Study|Admitted from ED|48|||
27532534|NCT02520661|80145301|FG000|Overall Study|ED greater than 24 hours|29|||
27532535|NCT02520661|80145302|FG001|Overall Study|ED greater than 24 hours|38|||
27532536|NCT02520661|80145301|FG000|Overall Study|other ineligibility|14|||
27532537|NCT02520661|80145302|FG001|Overall Study|other ineligibility|22|||
27532538|NCT02520661|80145301|FG000|Overall Study|Withdrawal by Subject|7|||
27532539|NCT02520661|80145302|FG001|Overall Study|Withdrawal by Subject|16|||
27532540|NCT00573248|80145305|FG000|Overall Study|scheduling conflicts|15|||
27532541|NCT00573248|80145306|FG001|Overall Study|scheduling conflicts|11|||
27532542|NCT01702571|80145307|FG000|Overall Study|Death|1067|||
27532543|NCT01702571|80145308|FG001|Overall Study|Death|76|||
27532544|NCT01702571|80145307|FG000|Overall Study|Lost to Follow-up|144|||
27532545|NCT01702571|80145308|FG001|Overall Study|Lost to Follow-up|10|||
27532546|NCT01702571|80145307|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
27532547|NCT01702571|80145308|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
27532548|NCT01702571|80145307|FG000|Overall Study|Investigator Decision|5|||
27532549|NCT01702571|80145308|FG001|Overall Study|Investigator Decision|0|||
27532550|NCT01702571|80145307|FG000|Overall Study|Not Classifiable|1|||
27532551|NCT01702571|80145308|FG001|Overall Study|Not Classifiable|0|||
27857182|NCT02105974|81310422|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
27857183|NCT02105974|81310423|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
27857184|NCT02105974|81310424|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
27857185|NCT02105974|81310422|FG000|2 Week Run-in Period|Adverse Event|6|||
27857186|NCT02105974|81310423|FG001|2 Week Run-in Period|Adverse Event|0|||
27857187|NCT02105974|81310424|FG002|2 Week Run-in Period|Adverse Event|0|||
27857188|NCT02105974|81310422|FG000|2 Week Run-in Period|Study closed/terminated|1|||
27857189|NCT02105974|81310423|FG001|2 Week Run-in Period|Study closed/terminated|0|||
27857190|NCT02105974|81310424|FG002|2 Week Run-in Period|Study closed/terminated|0|||
27857191|NCT02105974|81310422|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
27857192|NCT02105974|81310423|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
27857193|NCT02105974|81310424|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
27857194|NCT02105974|81310422|FG000|2 Week Run-in Period|Withdrew consent|23|||
27857195|NCT02105974|81310423|FG001|2 Week Run-in Period|Withdrew consent|0|||
27857196|NCT02105974|81310424|FG002|2 Week Run-in Period|Withdrew consent|0|||
27857197|NCT02105974|81310422|FG000|2 Week Run-in Period|Investigator discretion|8|||
27857198|NCT02105974|81310423|FG001|2 Week Run-in Period|Investigator discretion|0|||
27857199|NCT02105974|81310424|FG002|2 Week Run-in Period|Investigator discretion|0|||
27857200|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
27857201|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
27857202|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
27912696|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27532552|NCT01702571|80145307|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
27532553|NCT01702571|80145308|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
27532554|NCT01702571|80145307|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
27532555|NCT01702571|80145308|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
27628408|NCT02784704|80480306|FG001|Overall Study|Subject Non Compliance|0|||
27628409|NCT04044664|80480309|FG000|Stage 1|Adverse Event|3|||
27628410|NCT04044664|80480310|FG001|Stage 1|Adverse Event|3|||
27628411|NCT04044664|80480311|FG002|Stage 1|Adverse Event|1|||
27628412|NCT04044664|80480309|FG000|Stage 1|Lost to Follow-up|3|||
27628413|NCT04044664|80480310|FG001|Stage 1|Lost to Follow-up|2|||
27532556|NCT01702571|80145307|FG000|Overall Study|Progressive Disease|3|||
27532557|NCT01702571|80145308|FG001|Overall Study|Progressive Disease|0|||
27532558|NCT01702571|80145307|FG000|Overall Study|Protocol Violation|2|||
27532559|NCT01702571|80145308|FG001|Overall Study|Protocol Violation|0|||
27532560|NCT01702571|80145307|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
27532561|NCT01702571|80145308|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
27532562|NCT01702571|80145307|FG000|Overall Study|Termination By Sponsor|4|||
27532563|NCT01702571|80145308|FG001|Overall Study|Termination By Sponsor|0|||
27532564|NCT01702571|80145307|FG000|Overall Study|Withdrawal by Subject|177|||
27532565|NCT01702571|80145308|FG001|Overall Study|Withdrawal by Subject|29|||
27532566|NCT01646073|80145309|FG000|Period A (12 Weeks)|Adverse Event|0|||
27532567|NCT01646073|80145310|FG001|Period A (12 Weeks)|Adverse Event|2|||
27628414|NCT04044664|80480311|FG002|Stage 1|Lost to Follow-up|2|||
27628415|NCT04044664|80480309|FG000|Stage 1|Withdrawal by Subject|9|||
27628416|NCT04044664|80480310|FG001|Stage 1|Withdrawal by Subject|1|||
27628417|NCT04044664|80480311|FG002|Stage 1|Withdrawal by Subject|0|||
27628418|NCT04044664|80480309|FG000|Stage 1|noncompliance, personal reason|2|||
27628419|NCT04044664|80480310|FG001|Stage 1|noncompliance, personal reason|0|||
27628420|NCT04044664|80480311|FG002|Stage 1|noncompliance, personal reason|0|||
27628421|NCT04044664|80480309|FG000|Stage 1|randomization error|0|||
27628422|NCT04044664|80480310|FG001|Stage 1|randomization error|1|||
27628423|NCT04044664|80480311|FG002|Stage 1|randomization error|0|||
27628424|NCT04044664|80480309|FG000|Stage 2|Adverse Event|2|||
27628425|NCT04044664|80480310|FG001|Stage 2|Adverse Event|0|||
27912697|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912698|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27628426|NCT04044664|80480311|FG002|Stage 2|Adverse Event|0|||
27628427|NCT04044664|80480309|FG000|Stage 2|Lost to Follow-up|3|||
27736767|NCT00813995|80864956|FG000|Overall Study|Lack of Efficacy|1|||
27736768|NCT00813995|80864957|FG001|Overall Study|Lack of Efficacy|0|||
27736769|NCT00813995|80864956|FG000|Overall Study|Lost to Follow-up|4|||
27736770|NCT00813995|80864957|FG001|Overall Study|Lost to Follow-up|2|||
27736771|NCT00813995|80864956|FG000|Overall Study|Other reason|2|||
27736772|NCT00813995|80864957|FG001|Overall Study|Other reason|2|||
27736773|NCT00813995|80864956|FG000|Overall Study|Protocol Violation|3|||
27736774|NCT00813995|80864957|FG001|Overall Study|Protocol Violation|2|||
27736775|NCT00813995|80864956|FG000|Overall Study|Subject moved|4|||
27736776|NCT00813995|80864957|FG001|Overall Study|Subject moved|0|||
27736777|NCT00813995|80864956|FG000|Overall Study|Withdrawal by Subject|0|||
27736778|NCT00813995|80864957|FG001|Overall Study|Withdrawal by Subject|5|||
27736779|NCT00659438|80864958|FG000|Overall Study|Withdrawal by Subject|2|||
27736780|NCT00659438|80864959|FG001|Overall Study|Withdrawal by Subject|2|||
27736781|NCT00659438|80864958|FG000|Overall Study|Death|11|||
27736782|NCT00659438|80864959|FG001|Overall Study|Death|6|||
27736783|NCT00659438|80864958|FG000|Overall Study|Lost to Follow-up|1|||
27736784|NCT00659438|80864959|FG001|Overall Study|Lost to Follow-up|0|||
27736785|NCT01173653|80864964|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
27736786|NCT01173653|80864965|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
27736787|NCT00686127|80864971|FG000|Overall Study|Withdrawal by Subject|14|||
27736788|NCT00686127|80864972|FG001|Overall Study|Withdrawal by Subject|6|||
27736789|NCT02609399|80864973|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
27736790|NCT02609399|80864974|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
27736791|NCT02609399|80864973|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
27736792|NCT02609399|80864974|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
27736793|NCT02609399|80864973|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
27736794|NCT02609399|80864974|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
27857203|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
27857204|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
27857205|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
27857206|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
27857207|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
27912699|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27532568|NCT01646073|80145309|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
27628428|NCT04044664|80480310|FG001|Stage 2|Lost to Follow-up|2|||
27628429|NCT04044664|80480311|FG002|Stage 2|Lost to Follow-up|1|||
27628430|NCT04044664|80480309|FG000|Stage 2|Withdrawal by Subject|3|||
27628431|NCT04044664|80480310|FG001|Stage 2|Withdrawal by Subject|0|||
27736795|NCT00730236|80864975|FG000|Overall Study|Adverse Event|4|||
27736796|NCT00730236|80864975|FG000|Overall Study|Withdrawal by Subject|1|||
27736797|NCT00730236|80864975|FG000|Overall Study|Non-compliance|1|||
27736798|NCT05299892|80864976|FG000|Overall Study|Withdrawal by Subject|2|||
27736799|NCT02424149|80864983|FG000|Overall Study|surgery cancelled|2|||
27736800|NCT02424149|80864984|FG001|Overall Study|surgery cancelled|0|||
27736801|NCT02424149|80864983|FG000|Overall Study|Withdrawal by Subject|0|||
27736802|NCT02424149|80864984|FG001|Overall Study|Withdrawal by Subject|1|||
27736803|NCT01937312|80864989|FG000|Overall Study|Adverse Event|10|||
27736804|NCT01937312|80864990|FG001|Overall Study|Adverse Event|1|||
27736805|NCT01937312|80864989|FG000|Overall Study|Lack of Efficacy|0|||
27736806|NCT01937312|80864990|FG001|Overall Study|Lack of Efficacy|1|||
27736807|NCT01937312|80864989|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
27736808|NCT01937312|80864990|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
27736809|NCT00824564|80864991|FG000|Overall Study|Lost to Follow-up|5|||
27736810|NCT00824564|80864992|FG001|Overall Study|Lost to Follow-up|7|||
27736811|NCT00824564|80864991|FG000|Overall Study|Withdrawal by Subject|1|||
27736812|NCT00824564|80864992|FG001|Overall Study|Withdrawal by Subject|1|||
27736813|NCT00824564|80864991|FG000|Overall Study|Other|1|||
27736814|NCT00824564|80864992|FG001|Overall Study|Other|2|||
27736815|NCT00824564|80864991|FG000|Overall Study|Randomized, but not treated|1|||
27736816|NCT00824564|80864992|FG001|Overall Study|Randomized, but not treated|0|||
27736817|NCT00075881|80864995|FG000|Overall Study|Lack of Efficacy|18|||
27736818|NCT00075881|80864995|FG000|Overall Study|Adverse Event|7|||
27736819|NCT00075881|80864995|FG000|Overall Study|Death|1|||
27736820|NCT00075881|80864995|FG000|Overall Study|Withdrawal by Subject|2|||
27736821|NCT00075881|80864995|FG000|Overall Study|Protocol Violation|4|||
27736822|NCT00075881|80864995|FG000|Overall Study|other complicating disease|3|||
27736823|NCT00075881|80864995|FG000|Overall Study|other|4|||
27736824|NCT00075881|80864995|FG000|Overall Study|missing data|2|||
27736825|NCT00075881|80864995|FG000|Overall Study|Ineligible|1|||
27736826|NCT00075881|80864995|FG000|Overall Study|never start protocol therapy|1|||
27736827|NCT02397655|80864996|FG000|Overall Study|data not completed|1301|||
27736828|NCT01486264|80864997|FG000|Overall Study|Death|1|||
27532569|NCT01646073|80145310|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
27532570|NCT01646073|80145309|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
27532571|NCT01646073|80145310|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
27736829|NCT01486264|80864998|FG001|Overall Study|Death|1|||
27736830|NCT01486264|80864997|FG000|Overall Study|Adverse Event|3|||
27736831|NCT01486264|80864998|FG001|Overall Study|Adverse Event|3|||
27736832|NCT01486264|80864997|FG000|Overall Study|Lack of Efficacy|6|||
27736833|NCT01486264|80864998|FG001|Overall Study|Lack of Efficacy|10|||
27736834|NCT01486264|80864997|FG000|Overall Study|Withdrawal by Subject|7|||
27736835|NCT01486264|80864998|FG001|Overall Study|Withdrawal by Subject|18|||
27736836|NCT01486264|80864997|FG000|Overall Study|Physician Decision|1|||
27736837|NCT01486264|80864998|FG001|Overall Study|Physician Decision|1|||
27736838|NCT01486264|80864997|FG000|Overall Study|Protocol Violation|3|||
27736839|NCT01486264|80864998|FG001|Overall Study|Protocol Violation|0|||
27736840|NCT01486264|80864997|FG000|Overall Study|Lost to Follow-up|3|||
27736841|NCT01486264|80864998|FG001|Overall Study|Lost to Follow-up|2|||
27736842|NCT01486264|80864997|FG000|Overall Study|Other|5|||
27736843|NCT01486264|80864998|FG001|Overall Study|Other|11|||
27736844|NCT01486264|80864997|FG000|Overall Study|Not treated|0|||
27736845|NCT01486264|80864998|FG001|Overall Study|Not treated|1|||
27736846|NCT01451515|80864999|FG000|Overall Study|Death|0|||
27736847|NCT01451515|80865000|FG001|Overall Study|Death|1|||
27736848|NCT01451515|80865001|FG002|Overall Study|Death|0|||
27736849|NCT01451515|80864999|FG000|Overall Study|Withdrawal by Subject|0|||
27736850|NCT01451515|80865000|FG001|Overall Study|Withdrawal by Subject|1|||
27736851|NCT01451515|80865001|FG002|Overall Study|Withdrawal by Subject|0|||
27736852|NCT01451515|80864999|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
27736853|NCT01451515|80865000|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
27857208|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
27532572|NCT01646073|80145309|FG000|Period A (12 Weeks)|Protocol Violation|0|||
27532573|NCT01646073|80145310|FG001|Period A (12 Weeks)|Protocol Violation|1|||
27532574|NCT01646073|80145309|FG000|Period A (12 Weeks)|Other|0|||
27532575|NCT01646073|80145310|FG001|Period A (12 Weeks)|Other|1|||
27736854|NCT01451515|80865001|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
27857209|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
27532576|NCT01646073|80145309|FG000|Period B (12 Weeks)|Adverse Event|0|||
27736855|NCT01451515|80864999|FG000|Overall Study|Relapse (except CNS)|1|||
27736856|NCT01451515|80865000|FG001|Overall Study|Relapse (except CNS)|1|||
27736857|NCT01451515|80865001|FG002|Overall Study|Relapse (except CNS)|0|||
27736858|NCT00995371|80865002|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
27736859|NCT00995371|80865003|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
27736860|NCT01252966|80865004|FG000|Overall Study|Lost to Follow-up|16|||
27736861|NCT01252966|80865005|FG001|Overall Study|Lost to Follow-up|10|||
27736862|NCT01252966|80865004|FG000|Overall Study|Withdrawal by Subject|7|||
27736863|NCT01252966|80865005|FG001|Overall Study|Withdrawal by Subject|3|||
27736864|NCT03401749|80865006|FG000|Overall Study|Lost to Follow-up|20|||
27736865|NCT03401749|80865007|FG001|Overall Study|Lost to Follow-up|16|||
27736866|NCT03401749|80865008|FG002|Overall Study|Lost to Follow-up|26|||
27736867|NCT00957372|80865009|FG000|PART I|Lost to Follow-up|0|||
27736868|NCT00957372|80865010|FG001|PART I|Lost to Follow-up|0|||
27736869|NCT00957372|80865011|FG002|PART I|Lost to Follow-up|1|||
27736870|NCT00957372|80865012|FG003|PART I|Lost to Follow-up|0|||
27736871|NCT00957372|80865009|FG000|PART II|Withdrawal by Subject|0|||
27736872|NCT00957372|80865010|FG001|PART II|Withdrawal by Subject|0|||
27736873|NCT00957372|80865011|FG002|PART II|Withdrawal by Subject|0|||
27736874|NCT00957372|80865012|FG003|PART II|Withdrawal by Subject|8|||
27736875|NCT00957372|80865009|FG000|PART II|Physician Decision|0|||
27736876|NCT00957372|80865010|FG001|PART II|Physician Decision|0|||
27736877|NCT00957372|80865011|FG002|PART II|Physician Decision|0|||
27736878|NCT00957372|80865012|FG003|PART II|Physician Decision|1|||
27912700|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912701|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912702|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912703|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27912704|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
27912705|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
27736879|NCT00957372|80865009|FG000|PART II|Pregnancy|0|||
27736880|NCT00957372|80865010|FG001|PART II|Pregnancy|0|||
27736881|NCT00957372|80865011|FG002|PART II|Pregnancy|0|||
27736882|NCT00957372|80865012|FG003|PART II|Pregnancy|1|||
27736883|NCT00957372|80865009|FG000|PART II|Not Know|0|||
27736884|NCT00957372|80865010|FG001|PART II|Not Know|0|||
27736885|NCT00957372|80865011|FG002|PART II|Not Know|0|||
27736886|NCT00957372|80865012|FG003|PART II|Not Know|20|||
27736887|NCT00957372|80865009|FG000|PART II|Adverse Event|0|||
27736888|NCT00957372|80865010|FG001|PART II|Adverse Event|0|||
27736889|NCT00957372|80865011|FG002|PART II|Adverse Event|0|||
27736890|NCT00957372|80865012|FG003|PART II|Adverse Event|10|||
27736891|NCT00957372|80865009|FG000|PART II|Patient non-compliance|0|||
27736892|NCT00957372|80865010|FG001|PART II|Patient non-compliance|0|||
27736893|NCT00957372|80865011|FG002|PART II|Patient non-compliance|0|||
27736894|NCT00957372|80865012|FG003|PART II|Patient non-compliance|4|||
27736895|NCT03794986|80865013|FG000|Overall Study|0 Sessions Attended|34|||
27736896|NCT03794986|80865014|FG001|Overall Study|0 Sessions Attended|37|||
27736897|NCT03794986|80865013|FG000|Overall Study|Withdrawal by Subject|4|||
27736898|NCT03794986|80865014|FG001|Overall Study|Withdrawal by Subject|6|||
27736899|NCT03794986|80865013|FG000|Overall Study|Protocol Violation|1|||
27736900|NCT03794986|80865014|FG001|Overall Study|Protocol Violation|0|||
27736901|NCT00200057|80865016|FG000|Overall Study|Lack of Efficacy|3|||
27736902|NCT00200057|80865016|FG000|Overall Study|Exited due to terminal illness of PI|2|||
27736903|NCT00200057|80865016|FG000|Overall Study|Withdrawal by Subject|1|||
27736904|NCT00200057|80865016|FG000|Overall Study|Change in medical condition|1|||
27736905|NCT00200057|80865016|FG000|Overall Study|Infection|1|||
27736906|NCT00200057|80865016|FG000|Overall Study|Death|1|||
27736907|NCT05029622|80865017|FG000|Overall Study|Lost to Follow-up|1|||
27736908|NCT03633331|80865018|FG000|Overall Study|Withdrawal by Subject|1|||
27736909|NCT02143414|80865019|FG000|Induction|Adverse Event|1|||
27736910|NCT02143414|80865020|FG001|Induction|Adverse Event|2|||
27736911|NCT02143414|80865019|FG000|Induction|Death|1|||
27736912|NCT02143414|80865020|FG001|Induction|Death|2|||
27736913|NCT02143414|80865019|FG000|Induction|Patient refusal|1|||
27736914|NCT02143414|80865020|FG001|Induction|Patient refusal|1|||
27736915|NCT02143414|80865019|FG000|Induction|Refractory|1|||
27736916|NCT02143414|80865020|FG001|Induction|Refractory|0|||
27736917|NCT02143414|80865019|FG000|Induction|Began alternative treatment|1|||
27736918|NCT02143414|80865020|FG001|Induction|Began alternative treatment|0|||
27736919|NCT02143414|80865019|FG000|Induction|Ineligible for postremission|5|||
27736920|NCT02143414|80865020|FG001|Induction|Ineligible for postremission|1|||
27736921|NCT02143414|80865019|FG000|Post-remission|Adverse Event|0|||
27736922|NCT02143414|80865020|FG001|Post-remission|Adverse Event|2|||
27736923|NCT02143414|80865019|FG000|Post-remission|Disease progression/relapse|5|||
27736924|NCT02143414|80865020|FG001|Post-remission|Disease progression/relapse|0|||
27736925|NCT02143414|80865019|FG000|Maintenance|Adverse Event|4|||
27736926|NCT02143414|80865020|FG001|Maintenance|Adverse Event|6|||
27736927|NCT02143414|80865019|FG000|Maintenance|Disease progression/relapse|3|||
27736928|NCT02143414|80865020|FG001|Maintenance|Disease progression/relapse|2|||
27736929|NCT02143414|80865019|FG000|Maintenance|Patient refusal|2|||
27736930|NCT02143414|80865020|FG001|Maintenance|Patient refusal|1|||
27736931|NCT02143414|80865019|FG000|Maintenance|Physician Decision|1|||
27736932|NCT02143414|80865020|FG001|Maintenance|Physician Decision|0|||
27736933|NCT02143414|80865019|FG000|Maintenance|Death|0|||
27736934|NCT02143414|80865020|FG001|Maintenance|Death|1|||
27736935|NCT02143414|80865019|FG000|Maintenance|On protocol treatment|0|||
27736936|NCT02143414|80865020|FG001|Maintenance|On protocol treatment|6|||
27736937|NCT00504257|80865021|FG000|Overall Study|Withdrawal by Subject|2|||
27736938|NCT00504257|80865021|FG000|Overall Study|ineligible histology|2|||
27736939|NCT01719757|80865022|FG000|Overall Study|Adverse Event|38|||
27736940|NCT01719757|80865022|FG000|Overall Study|Withdrawal by Subject|15|||
27736941|NCT01719757|80865022|FG000|Overall Study|Lost to Follow-up|20|||
27736942|NCT01719757|80865022|FG000|Overall Study|Protocol Violation|1|||
27736943|NCT01719757|80865022|FG000|Overall Study|well controlled pain|27|||
27736944|NCT02300129|80865023|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
27736945|NCT02300129|80865024|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
27736946|NCT02300129|80865025|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
27736947|NCT02300129|80865026|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
27736948|NCT02300129|80865023|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
27736949|NCT02300129|80865024|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
27736950|NCT02300129|80865025|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
27736951|NCT02300129|80865026|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
27736952|NCT02300129|80865023|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
27736953|NCT02300129|80865024|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
27736954|NCT02300129|80865025|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
27736955|NCT02300129|80865026|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
27736956|NCT00144170|80865027|FG000|Overall Study|Adverse Event|84|||
27736957|NCT00144170|80865028|FG001|Overall Study|Adverse Event|41|||
27736958|NCT00144170|80865027|FG000|Overall Study|Protocol Violation|23|||
27736959|NCT00144170|80865028|FG001|Overall Study|Protocol Violation|16|||
27736960|NCT00144170|80865027|FG000|Overall Study|Lost to Follow-up|5|||
27736961|NCT00144170|80865028|FG001|Overall Study|Lost to Follow-up|10|||
27736962|NCT00144170|80865027|FG000|Overall Study|Withdrawal by Subject|29|||
27736963|NCT00144170|80865028|FG001|Overall Study|Withdrawal by Subject|13|||
27736964|NCT00144170|80865027|FG000|Overall Study|Other reason not defined above|211|||
27736965|NCT00144170|80865028|FG001|Overall Study|Other reason not defined above|316|||
27736966|NCT03095703|80865036|FG000|Overall Study|Withdrawal by Subject|1|||
27736967|NCT02561156|80865037|FG000|Part 2|Adverse Event|0|||
27736968|NCT02561156|80865038|FG001|Part 2|Adverse Event|0|||
27736969|NCT02561156|80865039|FG002|Part 2|Adverse Event|0|||
27736970|NCT02561156|80865040|FG003|Part 2|Adverse Event|0|||
27736971|NCT02561156|80865041|FG004|Part 2|Adverse Event|0|||
27736972|NCT02561156|80865042|FG005|Part 2|Adverse Event|0|||
27736973|NCT02561156|80865043|FG006|Part 2|Adverse Event|0|||
27736974|NCT02561156|80865044|FG007|Part 2|Adverse Event|0|||
27736975|NCT02561156|80865045|FG008|Part 2|Adverse Event|0|||
27736976|NCT02561156|80865046|FG009|Part 2|Adverse Event|0|||
27857210|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
27532577|NCT01646073|80145310|FG001|Period B (12 Weeks)|Adverse Event|7|||
27532578|NCT01646073|80145309|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
27532579|NCT01646073|80145310|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
27532580|NCT01646073|80145309|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
27532581|NCT01646073|80145310|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
27532582|NCT00591344|80145311|FG000|Overall Study|Transportation issues|1|||
27532583|NCT00591344|80145312|FG001|Overall Study|Transportation issues|0|||
27628432|NCT04044664|80480311|FG002|Stage 2|Withdrawal by Subject|0|||
27628433|NCT04044664|80480309|FG000|Stage 2|protocol deviation|1|||
27736977|NCT02561156|80865047|FG010|Part 2|Adverse Event|0|||
27736978|NCT02561156|80865048|FG011|Part 2|Adverse Event|1|||
27736979|NCT02561156|80865049|FG012|Part 2|Adverse Event|0|||
27736980|NCT01123889|80865050|FG000|Overall Study|Lost to Follow-up|3|||
27857211|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
27857212|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
27857213|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
27857214|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
27857215|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
27857216|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
27857217|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
27857218|NCT02105974|81310422|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
27857219|NCT02105974|81310423|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
27857220|NCT02105974|81310424|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
27857221|NCT00554606|81310425|FG000|Overall Study|Adverse Event|3|||
27857222|NCT00554606|81310425|FG000|Overall Study|Abnormal laboratory values|1|||
27857223|NCT00554606|81310425|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
27857224|NCT00554606|81310425|FG000|Overall Study|Subject withdrew consent|2|||
27857225|NCT00554606|81310425|FG000|Overall Study|Lost to Follow-up|2|||
27912706|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
27532584|NCT00591344|80145311|FG000|Overall Study|Moved out of state|1|||
27532585|NCT00591344|80145312|FG001|Overall Study|Moved out of state|0|||
27532586|NCT00591344|80145311|FG000|Overall Study|Medical complications|1|||
27532587|NCT00591344|80145312|FG001|Overall Study|Medical complications|3|||
27628434|NCT04044664|80480310|FG001|Stage 2|protocol deviation|0|||
27736981|NCT01123889|80865051|FG001|Overall Study|Lost to Follow-up|1|||
27736982|NCT01273818|80865052|FG000|Overall Study|Physician Decision|13|||
27857226|NCT00554606|81310425|FG000|Overall Study|Administrative problems|60|||
27628435|NCT04044664|80480311|FG002|Stage 2|protocol deviation|0|||
27628436|NCT00771849|80480314|FG000|Overall Study|Lost to Follow-up|1|||
27628437|NCT00771849|80480315|FG001|Overall Study|Lost to Follow-up|2|||
27628438|NCT00771849|80480314|FG000|Overall Study|Withdrawal by Subject|1|||
27912707|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
27912708|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912709|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912710|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912711|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912712|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912713|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912714|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912715|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912716|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912717|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912718|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912719|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
27912720|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912721|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912722|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
27912723|NCT02326272|81518167|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27532588|NCT00591344|80145311|FG000|Overall Study|Underwent DBS|2|||
27532589|NCT00591344|80145312|FG001|Overall Study|Underwent DBS|2|||
27532590|NCT00591344|80145311|FG000|Overall Study|Death|0|||
27532591|NCT00591344|80145312|FG001|Overall Study|Death|1|||
27532592|NCT00591344|80145311|FG000|Overall Study|Lost to Follow-up|0|||
27532593|NCT00591344|80145312|FG001|Overall Study|Lost to Follow-up|1|||
27532594|NCT00591344|80145311|FG000|Overall Study|Did not want to come off medication|0|||
27532595|NCT00591344|80145312|FG001|Overall Study|Did not want to come off medication|1|||
27532596|NCT02360111|80145313|FG000|Overall Study|Death|2|||
27532597|NCT02497612|80145314|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
27532598|NCT02497612|80145315|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
27532599|NCT02497612|80145316|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
27532600|NCT02497612|80145317|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
27628439|NCT00771849|80480315|FG001|Overall Study|Withdrawal by Subject|1|||
27628440|NCT00771849|80480314|FG000|Overall Study|Not vaccinated|0|||
27628441|NCT00771849|80480315|FG001|Overall Study|Not vaccinated|1|||
27628442|NCT02013037|80480316|FG000|Overall Study|Death|6|||
27628443|NCT02013037|80480316|FG000|Overall Study|Withdrawal by Subject|1|||
27628444|NCT02013037|80480316|FG000|Overall Study|Awaiting Transplantation|7|||
27628445|NCT02013037|80480316|FG000|Overall Study|Transplanted without DSA|2|||
27628446|NCT02155829|80480317|FG000|Overall Study|Adverse Event|1|||
27628447|NCT02155829|80480318|FG001|Overall Study|Adverse Event|0|||
27628448|NCT02155829|80480317|FG000|Overall Study|Withdrawal by Subject|3|||
27628449|NCT02155829|80480318|FG001|Overall Study|Withdrawal by Subject|3|||
27628450|NCT02155829|80480317|FG000|Overall Study|Protocol Violation|2|||
27628451|NCT02155829|80480318|FG001|Overall Study|Protocol Violation|0|||
27532601|NCT02497612|80145314|FG000|Overall Study|Participant's request|2|||
27532602|NCT02497612|80145315|FG001|Overall Study|Participant's request|3|||
27532603|NCT02497612|80145316|FG002|Overall Study|Participant's request|4|||
27532604|NCT02497612|80145317|FG003|Overall Study|Participant's request|1|||
27532605|NCT02497612|80145314|FG000|Overall Study|Investigator's judgement|1|||
27628452|NCT02711826|80480320|FG000|Overall Study|Physician Decision|0|||
27628453|NCT02711826|80480321|FG001|Overall Study|Physician Decision|0|||
27628454|NCT02711826|80480322|FG002|Overall Study|Physician Decision|0|||
27628455|NCT02711826|80480323|FG003|Overall Study|Physician Decision|1|||
27628456|NCT02711826|80480324|FG004|Overall Study|Physician Decision|0|||
27628457|NCT02711826|80480320|FG000|Overall Study|Withdrawal by Subject|0|||
27857227|NCT00554606|81310425|FG000|Overall Study|Death|1|||
27857228|NCT00554606|81310425|FG000|Overall Study|Protocol deviation|2|||
27857229|NCT00950963|81310426|FG000|Overall Study|Lost to Follow-up|29|||
27857230|NCT00950963|81310427|FG001|Overall Study|Lost to Follow-up|24|||
27857231|NCT03393806|81310430|FG000|Overall Study|Physician Decision|1|||
27857232|NCT03393806|81310431|FG001|Overall Study|Physician Decision|0|||
27857233|NCT01259115|81310440|FG000|Period 1|Adverse Event|1|||
27857234|NCT01259115|81310441|FG001|Period 1|Adverse Event|0|||
27857235|NCT01259115|81310440|FG000|Period 1|Protocol Violation|2|||
27857236|NCT01259115|81310441|FG001|Period 1|Protocol Violation|0|||
27857237|NCT01259115|81310440|FG000|Period 1|Lost to Follow-up|0|||
27857238|NCT01259115|81310441|FG001|Period 1|Lost to Follow-up|1|||
27857239|NCT01259115|81310440|FG000|Period 2|Adverse Event|1|||
27857240|NCT01259115|81310441|FG001|Period 2|Adverse Event|0|||
27857241|NCT03397771|81310442|FG000|Overall Study|2 erroneously randomized, never treated|3|||
27857242|NCT03397771|81310443|FG001|Overall Study|2 erroneously randomized, never treated|1|||
27857243|NCT03397771|81310442|FG000|Overall Study|Withdrawal by Subject|1|||
27912724|NCT02326272|81518168|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912725|NCT02326272|81518169|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912726|NCT02326272|81518170|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912727|NCT02326272|81518171|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912728|NCT02326272|81518172|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912729|NCT02326272|81518173|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912730|NCT02326272|81518174|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912731|NCT02326272|81518175|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912732|NCT02326272|81518176|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912733|NCT02326272|81518177|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912734|NCT02326272|81518178|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912735|NCT02326272|81518179|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
27532606|NCT02497612|80145315|FG001|Overall Study|Investigator's judgement|0|||
27532607|NCT02497612|80145316|FG002|Overall Study|Investigator's judgement|0|||
27532608|NCT02497612|80145317|FG003|Overall Study|Investigator's judgement|2|||
27532609|NCT02497612|80145314|FG000|Overall Study|Adverse Event|3|||
27532610|NCT02497612|80145315|FG001|Overall Study|Adverse Event|1|||
27532611|NCT02497612|80145316|FG002|Overall Study|Adverse Event|4|||
27532612|NCT02497612|80145317|FG003|Overall Study|Adverse Event|1|||
27532613|NCT02497612|80145314|FG000|Overall Study|Lost to Follow-up|1|||
27532614|NCT02497612|80145315|FG001|Overall Study|Lost to Follow-up|1|||
27532615|NCT02497612|80145316|FG002|Overall Study|Lost to Follow-up|0|||
27532616|NCT02497612|80145317|FG003|Overall Study|Lost to Follow-up|1|||
27532617|NCT02497612|80145314|FG000|Overall Study|Other unspecified|1|||
27532618|NCT02497612|80145315|FG001|Overall Study|Other unspecified|1|||
27532619|NCT02497612|80145316|FG002|Overall Study|Other unspecified|2|||
27736983|NCT01273818|80865053|FG001|Overall Study|Physician Decision|2|||
27736984|NCT01273818|80865054|FG002|Overall Study|Physician Decision|9|||
27532620|NCT02497612|80145317|FG003|Overall Study|Other unspecified|0|||
27532621|NCT02497612|80145314|FG000|Overall Study|Not eligible|1|||
27532622|NCT02497612|80145315|FG001|Overall Study|Not eligible|0|||
27532623|NCT02497612|80145316|FG002|Overall Study|Not eligible|0|||
27532624|NCT02497612|80145317|FG003|Overall Study|Not eligible|1|||
27532625|NCT00410202|80145318|FG000|On-Treatment|Continuing treatment|69|||
27532626|NCT00410202|80145319|FG001|On-Treatment|Continuing treatment|71|||
27736985|NCT00524303|80865057|FG000|Overall Study|Lost to Follow-up|6|||
27736986|NCT00524303|80865058|FG001|Overall Study|Lost to Follow-up|0|||
27912736|NCT02326272|81518180|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27532627|NCT00410202|80145320|FG002|On-Treatment|Continuing treatment|66|||
27912737|NCT02326272|81518181|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
27912738|NCT01178125|81518182|FG000|Overall Study|Lost to Follow-up|397|||
27912739|NCT01178125|81518182|FG000|Overall Study|Adverse Event|244|||
27912740|NCT01178125|81518182|FG000|Overall Study|Withdrawal by Subject|209|||
27912741|NCT01178125|81518182|FG000|Overall Study|Noncompliance|184|||
27912742|NCT01178125|81518182|FG000|Overall Study|Pregnancy|55|||
27912743|NCT01178125|81518182|FG000|Overall Study|Other Reason|39|||
27912744|NCT01178125|81518182|FG000|Overall Study|Sponsor Decision|28|||
27912745|NCT01178125|81518182|FG000|Overall Study|Protocol Violation|17|||
27912746|NCT01178125|81518182|FG000|Overall Study|Investigator Decision|5|||
27912747|NCT01724177|81518183|FG000|Overall Study|Adverse Event|8|||
27912748|NCT01724177|81518183|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
27912749|NCT01724177|81518183|FG000|Overall Study|Nervous participant|1|||
27912750|NCT01724177|81518183|FG000|Overall Study|Serious Adverse Event Related|1|||
27912751|NCT01367249|81518185|FG000|Overall Study|Withdrawal by Subject|6|||
27912752|NCT01367249|81518186|FG001|Overall Study|Withdrawal by Subject|6|||
27912753|NCT01367249|81518185|FG000|Overall Study|Other|3|||
27912754|NCT01367249|81518186|FG001|Overall Study|Other|10|||
27912755|NCT00527826|81518190|FG000|Overall Study|Adverse Event|10|||
27912756|NCT00527826|81518191|FG001|Overall Study|Adverse Event|10|||
27912757|NCT00527826|81518190|FG000|Overall Study|Lost to Follow-up|3|||
27912758|NCT00527826|81518191|FG001|Overall Study|Lost to Follow-up|2|||
27912759|NCT00527826|81518190|FG000|Overall Study|Withdrawal by Subject|5|||
27912760|NCT00527826|81518191|FG001|Overall Study|Withdrawal by Subject|8|||
27912761|NCT00527826|81518190|FG000|Overall Study|Inclusion Criteria Not Met|3|||
27912762|NCT00527826|81518191|FG001|Overall Study|Inclusion Criteria Not Met|3|||
27912763|NCT00527826|81518190|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
27912764|NCT00527826|81518191|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
27912765|NCT00527826|81518190|FG000|Overall Study|Additional Intake of Viani forte|0|||
27912766|NCT00527826|81518191|FG001|Overall Study|Additional Intake of Viani forte|1|||
27912767|NCT00527826|81518190|FG000|Overall Study|Participant moved away|0|||
27912768|NCT00527826|81518191|FG001|Overall Study|Participant moved away|1|||
27912769|NCT02171429|81518192|FG000|Overall Study|Other|0|||
27912770|NCT02171429|81518193|FG001|Overall Study|Other|1|||
27912771|NCT02171429|81518194|FG002|Overall Study|Other|1|||
27912772|NCT02171429|81518192|FG000|Overall Study|Non-Compliance|0|||
27912773|NCT02171429|81518193|FG001|Overall Study|Non-Compliance|0|||
27532628|NCT00410202|80145318|FG000|On-Treatment|Adverse Event|1|||
27532629|NCT00410202|80145319|FG001|On-Treatment|Adverse Event|3|||
27532630|NCT00410202|80145320|FG002|On-Treatment|Adverse Event|2|||
27532631|NCT00410202|80145318|FG000|On-Treatment|Death|1|||
27532632|NCT00410202|80145319|FG001|On-Treatment|Death|0|||
27532633|NCT00410202|80145320|FG002|On-Treatment|Death|0|||
27532634|NCT00410202|80145318|FG000|On-Treatment|Lost to Follow-up|1|||
27532635|NCT00410202|80145319|FG001|On-Treatment|Lost to Follow-up|0|||
27532636|NCT00410202|80145320|FG002|On-Treatment|Lost to Follow-up|1|||
27532637|NCT00410202|80145318|FG000|On-Treatment|Lack of Efficacy|1|||
27532638|NCT00410202|80145319|FG001|On-Treatment|Lack of Efficacy|4|||
27532639|NCT00410202|80145320|FG002|On-Treatment|Lack of Efficacy|0|||
27532640|NCT00410202|80145318|FG000|On-Treatment|Withdrawal by Subject|2|||
27532641|NCT00410202|80145319|FG001|On-Treatment|Withdrawal by Subject|1|||
27532642|NCT00410202|80145320|FG002|On-Treatment|Withdrawal by Subject|1|||
27532643|NCT00410202|80145318|FG000|On-Treatment|Other Reason|0|||
27532644|NCT00410202|80145319|FG001|On-Treatment|Other Reason|0|||
27532645|NCT00410202|80145320|FG002|On-Treatment|Other Reason|1|||
27532646|NCT00410202|80145318|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
27532647|NCT00410202|80145319|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
27532648|NCT00410202|80145320|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
27532649|NCT00410202|80145318|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
27736987|NCT00524303|80865059|FG002|Overall Study|Lost to Follow-up|3|||
27857244|NCT03397771|81310443|FG001|Overall Study|Withdrawal by Subject|3|||
27857245|NCT03397771|81310442|FG000|Overall Study|Protocol Violation|2|||
27857246|NCT03397771|81310443|FG001|Overall Study|Protocol Violation|2|||
27857247|NCT03397771|81310442|FG000|Overall Study|Adverse Event|2|||
27857248|NCT03397771|81310443|FG001|Overall Study|Adverse Event|1|||
27857249|NCT04625725|81310444|FG000|Overall Study|Adverse Event|2|||
27857250|NCT04625725|81310445|FG001|Overall Study|Adverse Event|1|||
27857251|NCT04625725|81310444|FG000|Overall Study|Death|22|||
27857252|NCT04625725|81310445|FG001|Overall Study|Death|10|||
27912774|NCT02171429|81518194|FG002|Overall Study|Non-Compliance|1|||
27857253|NCT04625725|81310444|FG000|Overall Study|Lost to Follow-up|357|||
27857254|NCT04625725|81310445|FG001|Overall Study|Lost to Follow-up|200|||
27857255|NCT04625725|81310444|FG000|Overall Study|Dosed in sub-study|310|||
27912775|NCT02171429|81518192|FG000|Overall Study|Physician Decision|0|||
27532650|NCT00410202|80145319|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
27912776|NCT02171429|81518193|FG001|Overall Study|Physician Decision|0|||
27912777|NCT02171429|81518194|FG002|Overall Study|Physician Decision|1|||
27912778|NCT02171429|81518192|FG000|Overall Study|Withdrawal by Subject|1|||
27912779|NCT02171429|81518193|FG001|Overall Study|Withdrawal by Subject|1|||
27912780|NCT02171429|81518194|FG002|Overall Study|Withdrawal by Subject|1|||
27912781|NCT02171429|81518192|FG000|Overall Study|Lost to Follow-up|0|||
27912782|NCT02171429|81518193|FG001|Overall Study|Lost to Follow-up|1|||
27912783|NCT02171429|81518194|FG002|Overall Study|Lost to Follow-up|0|||
27912784|NCT02171429|81518192|FG000|Overall Study|Death|0|||
27912785|NCT02171429|81518193|FG001|Overall Study|Death|0|||
27912786|NCT02171429|81518194|FG002|Overall Study|Death|1|||
27912787|NCT00447902|81518195|FG000|Overall Study|Adverse Event|0|||
27912788|NCT00447902|81518196|FG001|Overall Study|Adverse Event|3|||
27912789|NCT00447902|81518195|FG000|Overall Study|Protocol Violation|1|||
27912790|NCT00447902|81518196|FG001|Overall Study|Protocol Violation|0|||
27912791|NCT00447902|81518195|FG000|Overall Study|Withdrawal by Subject|0|||
27912792|NCT00447902|81518196|FG001|Overall Study|Withdrawal by Subject|1|||
27857256|NCT04625725|81310445|FG001|Overall Study|Dosed in sub-study|193|||
27857257|NCT04625725|81310444|FG000|Overall Study|Physician Decision|5|||
27857258|NCT04625725|81310445|FG001|Overall Study|Physician Decision|0|||
27857259|NCT04625725|81310444|FG000|Overall Study|Protocol Violation|1|||
27857260|NCT04625725|81310445|FG001|Overall Study|Protocol Violation|0|||
27857261|NCT04625725|81310444|FG000|Overall Study|Withdrawal by Subject|242|||
27857262|NCT04625725|81310445|FG001|Overall Study|Withdrawal by Subject|144|||
27857263|NCT04625725|81310444|FG000|Overall Study|Not specified otherwise|31|||
27857264|NCT04625725|81310445|FG001|Overall Study|Not specified otherwise|9|||
27857265|NCT04625725|81310444|FG000|Overall Study|Missing|0|||
27857266|NCT04625725|81310445|FG001|Overall Study|Missing|1|||
27857267|NCT04492020|81310446|FG000|Overall Study|Adverse Event|1|||
27857268|NCT04492020|81310447|FG001|Overall Study|Adverse Event|3|||
27857269|NCT04492020|81310446|FG000|Overall Study|Withdrawal by Subject|4|||
27857270|NCT04492020|81310447|FG001|Overall Study|Withdrawal by Subject|3|||
27857271|NCT04492020|81310446|FG000|Overall Study|Lost to Follow-up|4|||
27857272|NCT04492020|81310447|FG001|Overall Study|Lost to Follow-up|3|||
27857273|NCT04492020|81310446|FG000|Overall Study|Protocol Violation|5|||
27912793|NCT00447902|81518195|FG000|Overall Study|included patients who discontinued|1|||
27912794|NCT00447902|81518196|FG001|Overall Study|included patients who discontinued|1|||
27912795|NCT00447902|81518195|FG000|Overall Study|Lack of Efficacy|2|||
27857274|NCT04492020|81310447|FG001|Overall Study|Protocol Violation|2|||
27857275|NCT04492020|81310446|FG000|Overall Study|Lack of Qualifying Event|25|||
27857276|NCT04492020|81310447|FG001|Overall Study|Lack of Qualifying Event|27|||
27857277|NCT04492020|81310446|FG000|Overall Study|Non-compliance with Study Drug|2|||
27857278|NCT04492020|81310447|FG001|Overall Study|Non-compliance with Study Drug|1|||
27857279|NCT04495283|81310456|FG000|Overall Study|Physician Decision|0|||
27857280|NCT04495283|81310457|FG001|Overall Study|Physician Decision|0|||
27857281|NCT04495283|81310458|FG002|Overall Study|Physician Decision|1|||
27912796|NCT00447902|81518196|FG001|Overall Study|Lack of Efficacy|1|||
27912797|NCT00379899|81518197|FG000|Overall Study|Adverse Event|7|||
27857282|NCT04495283|81310456|FG000|Overall Study|Withdrawal by Subject|0|||
27857283|NCT04495283|81310457|FG001|Overall Study|Withdrawal by Subject|1|||
27857284|NCT04495283|81310458|FG002|Overall Study|Withdrawal by Subject|1|||
27857285|NCT04495283|81310456|FG000|Overall Study|Other|1|||
27857286|NCT04495283|81310457|FG001|Overall Study|Other|0|||
27857287|NCT04495283|81310458|FG002|Overall Study|Other|1|||
27857288|NCT04271735|81310459|FG000|Overall Study|Physician Decision|2|||
27857289|NCT04271735|81310460|FG001|Overall Study|Physician Decision|0|||
27857290|NCT04713553|81310465|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
27857291|NCT04713553|81310466|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
27857292|NCT04713553|81310467|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
27857293|NCT04713553|81310468|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
27857294|NCT04713553|81310469|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
27857295|NCT04713553|81310470|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
27912798|NCT00379899|81518198|FG001|Overall Study|Adverse Event|3|||
27912799|NCT00379899|81518197|FG000|Overall Study|Death|10|||
27912800|NCT00379899|81518198|FG001|Overall Study|Death|10|||
27912801|NCT00379899|81518197|FG000|Overall Study|Lost to Follow-up|2|||
27912802|NCT00379899|81518198|FG001|Overall Study|Lost to Follow-up|4|||
27857296|NCT04713553|81310471|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
27857297|NCT04713553|81310465|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27857298|NCT04713553|81310466|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27857299|NCT04713553|81310467|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27912803|NCT00379899|81518197|FG000|Overall Study|Physician Decision|3|||
27857300|NCT04713553|81310468|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
27857301|NCT04713553|81310469|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27857302|NCT04713553|81310470|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27857303|NCT04713553|81310471|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
27912804|NCT00379899|81518198|FG001|Overall Study|Physician Decision|4|||
27912805|NCT00379899|81518197|FG000|Overall Study|Withdrawal by Subject|5|||
27912806|NCT00379899|81518198|FG001|Overall Study|Withdrawal by Subject|5|||
27912807|NCT00379899|81518197|FG000|Overall Study|Ineligibility determined|0|||
27628458|NCT02711826|80480321|FG001|Overall Study|Withdrawal by Subject|1|||
27628459|NCT02711826|80480322|FG002|Overall Study|Withdrawal by Subject|0|||
27628460|NCT02711826|80480323|FG003|Overall Study|Withdrawal by Subject|4|||
27857304|NCT04713553|81310465|FG000|Primary Study (2 Months)|Other|1|||
27628461|NCT02711826|80480324|FG004|Overall Study|Withdrawal by Subject|0|||
27628462|NCT02711826|80480320|FG000|Overall Study|Failure to manufacture cellular product|0|||
27628463|NCT02711826|80480321|FG001|Overall Study|Failure to manufacture cellular product|0|||
27628464|NCT02711826|80480322|FG002|Overall Study|Failure to manufacture cellular product|5|||
27628465|NCT02711826|80480323|FG003|Overall Study|Failure to manufacture cellular product|0|||
27628466|NCT02711826|80480324|FG004|Overall Study|Failure to manufacture cellular product|0|||
27628467|NCT02711826|80480320|FG000|Overall Study|Infusion canceled for active infection|0|||
27628468|NCT02711826|80480321|FG001|Overall Study|Infusion canceled for active infection|1|||
27628469|NCT02711826|80480322|FG002|Overall Study|Infusion canceled for active infection|0|||
27628470|NCT02711826|80480323|FG003|Overall Study|Infusion canceled for active infection|0|||
27628471|NCT02711826|80480324|FG004|Overall Study|Infusion canceled for active infection|0|||
27628472|NCT02711826|80480320|FG000|Overall Study|Screen failures|0|||
27628473|NCT02711826|80480321|FG001|Overall Study|Screen failures|0|||
27628474|NCT02711826|80480322|FG002|Overall Study|Screen failures|0|||
27628475|NCT02711826|80480323|FG003|Overall Study|Screen failures|4|||
27628476|NCT02711826|80480324|FG004|Overall Study|Screen failures|0|||
27628477|NCT01211665|80480326|FG000|Overall Study|Withdrawal by Subject|1|||
27628478|NCT01211665|80480327|FG001|Overall Study|Withdrawal by Subject|0|||
27628479|NCT01211665|80480326|FG000|Overall Study|Death|1|||
27628480|NCT01211665|80480327|FG001|Overall Study|Death|0|||
27628481|NCT04888585|80480328|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
27628482|NCT04888585|80480329|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
27628483|NCT04888585|80480330|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
27628484|NCT04888585|80480331|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
27628485|NCT04888585|80480332|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
27628486|NCT04888585|80480333|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
27628487|NCT04888585|80480334|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
27628488|NCT04888585|80480335|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
27628489|NCT04888585|80480336|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
27628490|NCT04888585|80480337|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
27628491|NCT04888585|80480338|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
27628492|NCT04888585|80480328|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27628493|NCT04888585|80480329|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
27628494|NCT04888585|80480330|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
27628495|NCT04888585|80480331|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
27628496|NCT04888585|80480332|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
27628497|NCT04888585|80480333|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27628498|NCT04888585|80480334|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27628499|NCT04888585|80480335|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27628500|NCT04888585|80480336|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27628501|NCT04888585|80480337|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27857305|NCT04713553|81310466|FG001|Primary Study (2 Months)|Other|2|||
27857306|NCT04713553|81310467|FG002|Primary Study (2 Months)|Other|0|||
27857307|NCT04713553|81310468|FG003|Primary Study (2 Months)|Other|0|||
27857308|NCT04713553|81310469|FG004|Primary Study (2 Months)|Other|1|||
27857309|NCT04713553|81310470|FG005|Primary Study (2 Months)|Other|0|||
27857310|NCT04713553|81310471|FG006|Primary Study (2 Months)|Other|0|||
27857311|NCT04713553|81310465|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
27857312|NCT04713553|81310466|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
27857313|NCT04713553|81310467|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
27532651|NCT00410202|80145320|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
27532652|NCT00410202|80145318|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
27532653|NCT00410202|80145319|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
27532654|NCT00410202|80145320|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
27532655|NCT04478123|80145321|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
27532656|NCT04478123|80145321|FG000|Overall Study|NE|1|||
27532657|NCT02806973|80145324|FG000|Period 1|Withdrawal by Subject|0|||
27532658|NCT02806973|80145325|FG001|Period 1|Withdrawal by Subject|2|||
27532659|NCT02806973|80145326|FG002|Period 1|Withdrawal by Subject|1|||
27532660|NCT02806973|80145327|FG003|Period 1|Withdrawal by Subject|1|||
27532661|NCT02806973|80145324|FG000|Period 1|Adverse Event|0|||
27628502|NCT04888585|80480338|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
27628503|NCT04888585|80480328|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628504|NCT04888585|80480329|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628505|NCT04888585|80480330|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
27857314|NCT04713553|81310468|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
27532662|NCT02806973|80145325|FG001|Period 1|Adverse Event|0|||
27628506|NCT04888585|80480331|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628507|NCT04888585|80480332|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
27628508|NCT04888585|80480333|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628509|NCT04888585|80480334|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628510|NCT04888585|80480335|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628511|NCT04888585|80480336|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628512|NCT04888585|80480337|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27628513|NCT04888585|80480338|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
27532663|NCT02806973|80145326|FG002|Period 1|Adverse Event|0|||
27532664|NCT02806973|80145327|FG003|Period 1|Adverse Event|1|||
27532665|NCT02806973|80145324|FG000|Period 3|Withdrawal by Subject|0|||
27532666|NCT02806973|80145325|FG001|Period 3|Withdrawal by Subject|0|||
27532667|NCT02806973|80145326|FG002|Period 3|Withdrawal by Subject|0|||
27532668|NCT02806973|80145327|FG003|Period 3|Withdrawal by Subject|3|||
27532669|NCT02806973|80145324|FG000|Period 3|Adverse Event|0|||
27532670|NCT02806973|80145325|FG001|Period 3|Adverse Event|0|||
27532671|NCT02806973|80145326|FG002|Period 3|Adverse Event|1|||
27532672|NCT02806973|80145327|FG003|Period 3|Adverse Event|0|||
27532673|NCT00674973|80145329|FG000|Overall Study|Insufficient Therapeutic Response|77|||
27532674|NCT00674973|80145330|FG001|Overall Study|Insufficient Therapeutic Response|72|||
27532675|NCT00674973|80145329|FG000|Overall Study|Refused Treatment|1|||
27532676|NCT00674973|80145330|FG001|Overall Study|Refused Treatment|5|||
27532677|NCT00674973|80145329|FG000|Overall Study|Failure to Return|1|||
27532678|NCT00674973|80145330|FG001|Overall Study|Failure to Return|0|||
27532679|NCT00674973|80145329|FG000|Overall Study|Adverse Event|2|||
27532680|NCT00674973|80145330|FG001|Overall Study|Adverse Event|9|||
27532681|NCT00674973|80145329|FG000|Overall Study|Death|19|||
27532682|NCT00674973|80145330|FG001|Overall Study|Death|15|||
27532683|NCT00674973|80145329|FG000|Overall Study|Protocol Violation|0|||
27532684|NCT00674973|80145330|FG001|Overall Study|Protocol Violation|1|||
27532685|NCT00537238|80145333|FG000|Overall Study|Death|1|||
27532686|NCT00537238|80145334|FG001|Overall Study|Death|2|||
27532687|NCT00537238|80145333|FG000|Overall Study|Adverse Event|31|||
27532688|NCT00537238|80145334|FG001|Overall Study|Adverse Event|22|||
27532689|NCT00537238|80145333|FG000|Overall Study|Lack of Efficacy|20|||
27532690|NCT00537238|80145334|FG001|Overall Study|Lack of Efficacy|21|||
27532691|NCT00537238|80145333|FG000|Overall Study|Lost to Follow-up|12|||
27532692|NCT00537238|80145334|FG001|Overall Study|Lost to Follow-up|8|||
27532693|NCT00537238|80145333|FG000|Overall Study|Withdrawal by Subject|51|||
27532694|NCT00537238|80145334|FG001|Overall Study|Withdrawal by Subject|47|||
27532695|NCT00537238|80145333|FG000|Overall Study|Protocol Violation|15|||
27532696|NCT00537238|80145334|FG001|Overall Study|Protocol Violation|19|||
27532697|NCT00537238|80145333|FG000|Overall Study|Does not meet entrance criteria|0|||
27532698|NCT00537238|80145334|FG001|Overall Study|Does not meet entrance criteria|2|||
27532699|NCT00537238|80145333|FG000|Overall Study|Other|44|||
27532700|NCT00537238|80145334|FG001|Overall Study|Other|52|||
27532701|NCT01251744|80145337|FG000|Overall Study|Lost to Follow-up|1|||
27532702|NCT01251744|80145338|FG001|Overall Study|Lost to Follow-up|0|||
27532703|NCT01676727|80145339|FG000|Overall Study|Death|18|||
27532704|NCT01676727|80145339|FG000|Overall Study|Withdrawal by Subject|6|||
27532705|NCT01676727|80145339|FG000|Overall Study|Screening failure|5|||
27532706|NCT01676727|80145339|FG000|Overall Study|Not willing to attend 1-year visit|2|||
27532707|NCT01676727|80145339|FG000|Overall Study|Valve explanted|1|||
27532708|NCT00750880|80145340|FG000|Overall Study|Adverse Event|76|||
27532709|NCT00750880|80145340|FG000|Overall Study|Death|4|||
27532710|NCT00750880|80145340|FG000|Overall Study|Lack of Efficacy|46|||
27532711|NCT00750880|80145340|FG000|Overall Study|Lost to Follow-up|10|||
27532712|NCT00750880|80145340|FG000|Overall Study|Protocol Violation|15|||
27532713|NCT00750880|80145340|FG000|Overall Study|Withdrawal by Subject|33|||
27532714|NCT00750880|80145340|FG000|Overall Study|Physician Decision|20|||
27532715|NCT00750880|80145340|FG000|Overall Study|Administrative|11|||
27532716|NCT00471146|80145341|FG000|Overall Study|Adverse Event|32|||
27532717|NCT00471146|80145342|FG001|Overall Study|Adverse Event|33|||
27532718|NCT00471146|80145341|FG000|Overall Study|Withdrawal by Subject|14|||
27532719|NCT00471146|80145342|FG001|Overall Study|Withdrawal by Subject|11|||
27532720|NCT00471146|80145341|FG000|Overall Study|Death|11|||
27532721|NCT00471146|80145342|FG001|Overall Study|Death|12|||
27532722|NCT00471146|80145341|FG000|Overall Study|Lost to Follow-up|4|||
27532723|NCT00471146|80145342|FG001|Overall Study|Lost to Follow-up|2|||
27532724|NCT00471146|80145341|FG000|Overall Study|Protocol Violation|2|||
27532725|NCT00471146|80145342|FG001|Overall Study|Protocol Violation|2|||
27532726|NCT00471146|80145341|FG000|Overall Study|Objective progression or relapse|84|||
27532727|NCT00471146|80145342|FG001|Overall Study|Objective progression or relapse|87|||
27532728|NCT00471146|80145341|FG000|Overall Study|Global deterioration of health status|12|||
27532729|NCT00471146|80145342|FG001|Overall Study|Global deterioration of health status|14|||
27532730|NCT00471146|80145341|FG000|Overall Study|Randomized but not treated|9|||
27532731|NCT00471146|80145342|FG001|Overall Study|Randomized but not treated|8|||
27532732|NCT00471146|80145341|FG000|Overall Study|Other|4|||
27912808|NCT00379899|81518198|FG001|Overall Study|Ineligibility determined|1|||
27912809|NCT00379899|81518197|FG000|Overall Study|Noncompliance|1|||
27912810|NCT00379899|81518198|FG001|Overall Study|Noncompliance|1|||
27912811|NCT00379899|81518197|FG000|Overall Study|Parathyroidectomy|0|||
27912812|NCT00379899|81518198|FG001|Overall Study|Parathyroidectomy|2|||
27912813|NCT00379899|81518197|FG000|Overall Study|Renal transplantation|5|||
27912814|NCT00379899|81518198|FG001|Overall Study|Renal transplantation|4|||
27912815|NCT00379899|81518197|FG000|Overall Study|Coronary artery bypass graft|1|||
27912816|NCT00379899|81518198|FG001|Overall Study|Coronary artery bypass graft|1|||
27912817|NCT00379899|81518197|FG000|Overall Study|Other protocol-specified criteria|3|||
27912818|NCT00379899|81518198|FG001|Overall Study|Other protocol-specified criteria|4|||
27912819|NCT00379899|81518197|FG000|Overall Study|Other|3|||
27912820|NCT00379899|81518198|FG001|Overall Study|Other|1|||
27912821|NCT00482170|81518199|FG000|Overall Study|Adverse Event|5|||
27912822|NCT00482170|81518200|FG001|Overall Study|Adverse Event|14|||
27912823|NCT00482170|81518199|FG000|Overall Study|Withdrawal by Subject|6|||
27912824|NCT00482170|81518200|FG001|Overall Study|Withdrawal by Subject|1|||
27912825|NCT00482170|81518199|FG000|Overall Study|Protocol Violation|2|||
27912826|NCT00482170|81518200|FG001|Overall Study|Protocol Violation|3|||
27912827|NCT00482170|81518199|FG000|Overall Study|Lost to Follow-up|2|||
27912828|NCT00482170|81518200|FG001|Overall Study|Lost to Follow-up|0|||
27912829|NCT00482170|81518199|FG000|Overall Study|Unspecified reason|0|||
27912830|NCT00482170|81518200|FG001|Overall Study|Unspecified reason|2|||
27912831|NCT02485483|81518201|FG000|Overall Study|Depression at baseline|15|||
27912832|NCT02485483|81518202|FG001|Overall Study|Depression at baseline|0|||
27912833|NCT02485483|81518201|FG000|Overall Study|Discontinued after baseline|39|||
27912834|NCT02485483|81518202|FG001|Overall Study|Discontinued after baseline|0|||
27912835|NCT00752089|81518203|FG000|Overall Study|Adverse Event|1|||
27912836|NCT00752089|81518203|FG000|Overall Study|Protocol Deviation|2|||
27857315|NCT04713553|81310469|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
27857316|NCT04713553|81310470|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
27857317|NCT04713553|81310471|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
27857318|NCT04713553|81310465|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
27857319|NCT04713553|81310466|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
27857320|NCT04713553|81310467|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
27857321|NCT04713553|81310468|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
27857322|NCT04713553|81310469|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
27857323|NCT04713553|81310470|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
27857324|NCT04713553|81310471|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
27857325|NCT01070771|81310472|FG000|Overall Study|Adverse Event|2|||
27857326|NCT01070771|81310472|FG000|Overall Study|Protocol Violation|1|||
27857327|NCT00311402|81310473|FG000|Overall Study|Adverse Event|118|||
27857328|NCT00311402|81310474|FG001|Overall Study|Adverse Event|105|||
27857329|NCT00311402|81310473|FG000|Overall Study|Lost to Follow-up|0|||
27857330|NCT00311402|81310474|FG001|Overall Study|Lost to Follow-up|3|||
27857331|NCT00311402|81310473|FG000|Overall Study|Withdrawal by Subject|17|||
27857332|NCT00311402|81310474|FG001|Overall Study|Withdrawal by Subject|18|||
27857333|NCT00311402|81310473|FG000|Overall Study|Lack of Efficacy|58|||
27857334|NCT00311402|81310474|FG001|Overall Study|Lack of Efficacy|42|||
27857335|NCT00311402|81310473|FG000|Overall Study|Protocol Violation|7|||
27857336|NCT00311402|81310474|FG001|Overall Study|Protocol Violation|6|||
27857337|NCT00311402|81310473|FG000|Overall Study|IRB's rejection etc.|10|||
27857338|NCT00311402|81310474|FG001|Overall Study|IRB's rejection etc.|3|||
27857339|NCT02266134|81310475|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
27857340|NCT02266134|81310476|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
27857341|NCT02266134|81310477|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
27857342|NCT02266134|81310478|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
27857343|NCT02266134|81310475|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
27857344|NCT02266134|81310476|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
27857345|NCT02266134|81310477|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
27857346|NCT02266134|81310478|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
27857347|NCT02266134|81310475|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
27857348|NCT02266134|81310476|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
27857349|NCT02266134|81310477|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
27857350|NCT02266134|81310478|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
27857351|NCT02266134|81310475|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
27857352|NCT02266134|81310476|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
27857353|NCT02266134|81310477|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
27857354|NCT02266134|81310478|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
27912837|NCT00752089|81518203|FG000|Overall Study|Could not attend visit 9|1|||
27912838|NCT00752089|81518203|FG000|Overall Study|Not capable of wearing partial denture|1|||
27857355|NCT02266134|81310475|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
27912839|NCT00752089|81518203|FG000|Overall Study|Cannot continue the study|1|||
27628514|NCT04888585|80480328|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628515|NCT04888585|80480329|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628516|NCT04888585|80480330|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628517|NCT04888585|80480331|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628518|NCT04888585|80480332|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628519|NCT04888585|80480333|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628520|NCT04888585|80480334|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628521|NCT04888585|80480335|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
27628522|NCT04888585|80480336|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628523|NCT04888585|80480337|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
27628524|NCT04888585|80480338|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
27857356|NCT02266134|81310476|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
27857357|NCT02266134|81310477|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
27857358|NCT02266134|81310478|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
27857359|NCT02266134|81310475|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
27857360|NCT02266134|81310476|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
27532733|NCT00471146|80145342|FG001|Overall Study|Other|5|||
27532734|NCT00470847|80145346|FG000|Overall Study|Pt still receiving treatment|1|||
27532735|NCT01385371|80145347|FG000|Overall Study|Adverse Event|54|||
27628525|NCT04888585|80480328|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
27628526|NCT04888585|80480329|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
27628527|NCT04888585|80480330|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
27628528|NCT04888585|80480331|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
27628529|NCT04888585|80480332|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
27628530|NCT04888585|80480333|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
27628531|NCT04888585|80480334|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
27628532|NCT04888585|80480335|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
27628533|NCT04888585|80480336|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
27532736|NCT01385371|80145348|FG001|Overall Study|Adverse Event|19|||
27532737|NCT01385371|80145347|FG000|Overall Study|Lost to Follow-up|16|||
27532738|NCT01385371|80145348|FG001|Overall Study|Lost to Follow-up|16|||
27532739|NCT01385371|80145347|FG000|Overall Study|Withdrawal by Subject|52|||
27532740|NCT01385371|80145348|FG001|Overall Study|Withdrawal by Subject|39|||
27532741|NCT01385371|80145347|FG000|Overall Study|Protocol Violation|25|||
27532742|NCT01385371|80145348|FG001|Overall Study|Protocol Violation|21|||
27532743|NCT01385371|80145347|FG000|Overall Study|Administrative|2|||
27532744|NCT01385371|80145348|FG001|Overall Study|Administrative|2|||
27532745|NCT01134315|80145349|FG000|Overall Study|Adverse Event|1|||
27532746|NCT01134315|80145350|FG001|Overall Study|Adverse Event|2|||
27532747|NCT01134315|80145349|FG000|Overall Study|Other Reason|8|||
27532748|NCT01134315|80145350|FG001|Overall Study|Other Reason|17|||
27532749|NCT03190369|80145351|FG000|Overall Study|Poor compliance to protocol|0|||
27532750|NCT03190369|80145352|FG001|Overall Study|Poor compliance to protocol|1|||
27532751|NCT03190369|80145351|FG000|Overall Study|Withdraw before treatment|1|||
27532752|NCT03190369|80145352|FG001|Overall Study|Withdraw before treatment|5|||
27532753|NCT03190369|80145351|FG000|Overall Study|Randomized but not treated|0|||
27532754|NCT03190369|80145352|FG001|Overall Study|Randomized but not treated|2|||
27532755|NCT00915356|80145357|FG000|Overall Study|Withdrawal by Subject|1|||
27532756|NCT00915356|80145358|FG001|Overall Study|Withdrawal by Subject|0|||
27532757|NCT00915356|80145359|FG002|Overall Study|Withdrawal by Subject|0|||
27532758|NCT00915356|80145360|FG003|Overall Study|Withdrawal by Subject|0|||
27532759|NCT00915356|80145361|FG004|Overall Study|Withdrawal by Subject|0|||
27532760|NCT01977937|80145362|FG000|Overall Study|Withdrawal by Subject|2|||
27532761|NCT01977937|80145363|FG001|Overall Study|Withdrawal by Subject|1|||
27532762|NCT01977937|80145362|FG000|Overall Study|Adverse Event|1|||
27532763|NCT01977937|80145363|FG001|Overall Study|Adverse Event|0|||
27532764|NCT01977937|80145362|FG000|Overall Study|Physician Decision|0|||
27532765|NCT01977937|80145363|FG001|Overall Study|Physician Decision|1|||
27532766|NCT01886716|80145366|FG000|Week 1|Lost to Follow-up|0|||
27532767|NCT01886716|80145367|FG001|Week 1|Lost to Follow-up|0|||
27532768|NCT01886716|80145368|FG002|Week 1|Lost to Follow-up|2|||
27532769|NCT01886716|80145369|FG003|Week 1|Lost to Follow-up|2|||
27532770|NCT01886716|80145366|FG000|Week 2|Lost to Follow-up|3|||
27532771|NCT01886716|80145367|FG001|Week 2|Lost to Follow-up|2|||
27532772|NCT01886716|80145368|FG002|Week 2|Lost to Follow-up|1|||
27532773|NCT01886716|80145369|FG003|Week 2|Lost to Follow-up|3|||
27532774|NCT01886716|80145366|FG000|Week 3|Lost to Follow-up|1|||
27628534|NCT04888585|80480337|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
27736988|NCT00524303|80865057|FG000|Overall Study|Protocol Violation|0|||
27736989|NCT00524303|80865058|FG001|Overall Study|Protocol Violation|1|||
27532775|NCT01886716|80145367|FG001|Week 3|Lost to Follow-up|1|||
27532776|NCT01886716|80145368|FG002|Week 3|Lost to Follow-up|0|||
27532777|NCT01886716|80145369|FG003|Week 3|Lost to Follow-up|1|||
27532778|NCT01199731|80145374|FG000|Overall Study|Adverse Event|0|||
27532779|NCT01199731|80145375|FG001|Overall Study|Adverse Event|1|||
27532780|NCT01199731|80145376|FG002|Overall Study|Adverse Event|0|||
27628535|NCT04888585|80480338|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
27628536|NCT04888585|80480328|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
27628537|NCT04888585|80480329|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
27628538|NCT04888585|80480330|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
27628539|NCT04888585|80480331|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
27628540|NCT04888585|80480332|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
27628541|NCT04888585|80480333|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
27628542|NCT04888585|80480334|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
27628543|NCT04888585|80480335|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
27628544|NCT04888585|80480336|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
27857361|NCT02266134|81310477|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
27857362|NCT02266134|81310478|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
27857363|NCT04771403|81310480|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
27857364|NCT04771403|81310481|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
27857365|NCT04771403|81310480|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
27857366|NCT04771403|81310481|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
27857367|NCT04771403|81310480|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
27857368|NCT04771403|81310481|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
27857369|NCT04771403|81310480|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
27857370|NCT04771403|81310481|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
27857371|NCT04771403|81310480|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
27912840|NCT00003471|81518204|FG000|Overall Study|Not evaluable|4|||
27912841|NCT01951417|81518207|FG000|Overall Study|Withdrawal by Subject|1|||
27912842|NCT01951417|81518207|FG000|Overall Study|Protocol Violation|2|||
27912843|NCT01951417|81518207|FG000|Overall Study|Lost to Follow-up|6|||
27912844|NCT02895347|81518208|FG000|Overall Study|Withdrawal by Subject|3|||
27912845|NCT02895347|81518209|FG001|Overall Study|Withdrawal by Subject|1|||
27912846|NCT02360280|81518210|FG000|Overall Study|Withdrawal by Subject|2|||
27912847|NCT02360280|81518211|FG001|Overall Study|Withdrawal by Subject|0|||
27912848|NCT02360280|81518210|FG000|Overall Study|Adverse Event|0|||
27912849|NCT02360280|81518211|FG001|Overall Study|Adverse Event|1|||
27912850|NCT02360280|81518210|FG000|Overall Study|Lost to Follow-up|1|||
27912851|NCT02360280|81518211|FG001|Overall Study|Lost to Follow-up|0|||
27532781|NCT01199731|80145374|FG000|Overall Study|Study closed/terminated|7|||
27532782|NCT01199731|80145375|FG001|Overall Study|Study closed/terminated|9|||
27532783|NCT01199731|80145376|FG002|Overall Study|Study closed/terminated|7|||
27532784|NCT01199731|80145374|FG000|Overall Study|Lost to Follow-up|0|||
27532785|NCT01199731|80145375|FG001|Overall Study|Lost to Follow-up|0|||
27532786|NCT01199731|80145376|FG002|Overall Study|Lost to Follow-up|2|||
27532787|NCT01199731|80145374|FG000|Overall Study|Physician Decision|0|||
27912852|NCT03113968|81518212|FG000|Overall Study|Withdrawal by Subject|31|||
27532788|NCT01199731|80145375|FG001|Overall Study|Physician Decision|1|||
27532789|NCT01199731|80145376|FG002|Overall Study|Physician Decision|1|||
27532790|NCT01199731|80145374|FG000|Overall Study|Withdrawal by Subject|2|||
27532791|NCT01199731|80145375|FG001|Overall Study|Withdrawal by Subject|0|||
27532792|NCT01199731|80145376|FG002|Overall Study|Withdrawal by Subject|0|||
27532793|NCT00467610|80145379|FG000|Overall Study|Withdrawal by Subject|1|||
27532794|NCT01736124|80145384|FG000|Post-intervention Assessment|Death|2|||
27532795|NCT01736124|80145385|FG001|Post-intervention Assessment|Death|2|||
27532796|NCT01736124|80145384|FG000|Post-intervention Assessment|lost computer access|1|||
27532797|NCT01736124|80145385|FG001|Post-intervention Assessment|lost computer access|1|||
27532798|NCT01736124|80145384|FG000|Post-intervention Assessment|Moved away|3|||
27532799|NCT01736124|80145385|FG001|Post-intervention Assessment|Moved away|1|||
27532800|NCT01736124|80145384|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
27532801|NCT01736124|80145385|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
27532802|NCT01736124|80145384|FG000|Post-intervention Assessment|Illness|3|||
27532803|NCT01736124|80145385|FG001|Post-intervention Assessment|Illness|2|||
27532804|NCT01736124|80145384|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
27532805|NCT01736124|80145385|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
27532806|NCT01736124|80145384|FG000|Post-intervention Assessment|Temporarily away|3|||
27912853|NCT03113968|81518213|FG001|Overall Study|Withdrawal by Subject|4|||
27912854|NCT01450813|81518214|FG000|Overall Study|Physician Decision|1|||
27532807|NCT01736124|80145385|FG001|Post-intervention Assessment|Temporarily away|1|||
27532808|NCT01736124|80145384|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
27532809|NCT01736124|80145385|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
27628545|NCT04888585|80480337|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
27628546|NCT04888585|80480338|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
27628547|NCT04888585|80480328|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
27628548|NCT04888585|80480329|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
27628549|NCT04888585|80480330|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
27628550|NCT04888585|80480331|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
27628551|NCT04888585|80480332|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
27628552|NCT04888585|80480333|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
27628553|NCT04888585|80480334|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
27628554|NCT04888585|80480335|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
27628555|NCT04888585|80480336|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
27628556|NCT04888585|80480337|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
27628557|NCT04888585|80480338|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
27628558|NCT04888585|80480328|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628559|NCT04888585|80480329|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628560|NCT04888585|80480330|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628561|NCT04888585|80480331|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628562|NCT04888585|80480332|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628563|NCT04888585|80480333|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628564|NCT04888585|80480334|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
27628565|NCT04888585|80480335|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
27628566|NCT04888585|80480336|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
27628567|NCT04888585|80480337|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
27628568|NCT04888585|80480338|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
27628569|NCT05512949|80480339|FG000|Overall Study|Lost to Follow-up|4|||
27628570|NCT05512949|80480340|FG001|Overall Study|Lost to Follow-up|6|||
27628571|NCT05512949|80480341|FG002|Overall Study|Lost to Follow-up|2|||
27628572|NCT05512949|80480339|FG000|Overall Study|Protocol Violation|0|||
27628573|NCT05512949|80480340|FG001|Overall Study|Protocol Violation|0|||
27628574|NCT05512949|80480341|FG002|Overall Study|Protocol Violation|1|||
27628575|NCT05512949|80480339|FG000|Overall Study|Withdrawal by Subject|1|||
27628576|NCT05512949|80480340|FG001|Overall Study|Withdrawal by Subject|1|||
27628577|NCT05512949|80480341|FG002|Overall Study|Withdrawal by Subject|2|||
27628578|NCT05512949|80480339|FG000|Overall Study|Completion status unknown|1|||
27628579|NCT05512949|80480340|FG001|Overall Study|Completion status unknown|3|||
27628580|NCT05512949|80480341|FG002|Overall Study|Completion status unknown|0|||
27628581|NCT01981356|80480342|FG000|Overall Study|Lost to Follow-up|4|||
27628582|NCT01981356|80480343|FG001|Overall Study|Lost to Follow-up|1|||
27628583|NCT01981356|80480342|FG000|Overall Study|Withdrawal by Subject|1|||
27628584|NCT01981356|80480343|FG001|Overall Study|Withdrawal by Subject|1|||
27628585|NCT01981356|80480342|FG000|Overall Study|Protocol Violation|2|||
27628586|NCT01981356|80480343|FG001|Overall Study|Protocol Violation|0|||
27628587|NCT00149630|80480347|FG000|Overall Study|Incarceration|2|||
27628588|NCT00149630|80480348|FG001|Overall Study|Incarceration|0|||
27532810|NCT01736124|80145384|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
27532811|NCT01736124|80145385|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
27532812|NCT01736124|80145384|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
27532813|NCT01736124|80145385|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
27532814|NCT01736124|80145384|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
27532815|NCT01736124|80145385|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
27532816|NCT01736124|80145384|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
27532817|NCT01736124|80145385|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
27532818|NCT01736124|80145384|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
27532819|NCT01736124|80145385|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
27532820|NCT01736124|80145384|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
27532821|NCT01736124|80145385|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
27532822|NCT01736124|80145384|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
27532823|NCT01736124|80145385|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
27532824|NCT01736124|80145384|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
27532825|NCT01736124|80145385|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
27532826|NCT01822678|80145386|FG000|Overall Study|Withdrawal by Subject|5|||
27532827|NCT01822678|80145387|FG001|Overall Study|Withdrawal by Subject|4|||
27532828|NCT01822678|80145388|FG002|Overall Study|Withdrawal by Subject|4|||
27628589|NCT00149630|80480347|FG000|Overall Study|Treatment Programs|4|||
27628590|NCT00149630|80480348|FG001|Overall Study|Treatment Programs|5|||
27628591|NCT00149630|80480347|FG000|Overall Study|Adverse Event|2|||
27628592|NCT00149630|80480348|FG001|Overall Study|Adverse Event|0|||
27628593|NCT00545844|80480349|FG000|Overall Study|Lost to Follow-up|9|||
27628594|NCT00545844|80480349|FG000|Overall Study|Protocol Violation|1|||
27628595|NCT00545844|80480349|FG000|Overall Study|Withdrawal by Subject|2|||
27532829|NCT01822678|80145386|FG000|Overall Study|Adverse Event|4|||
27628596|NCT01191086|80480350|FG000|Overall Study|Adverse Event|20|||
27628597|NCT01191086|80480350|FG000|Overall Study|Lack of Efficacy|10|||
27628598|NCT01191086|80480350|FG000|Overall Study|Lost to Follow-up|4|||
27628599|NCT01191086|80480350|FG000|Overall Study|Physician Decision|2|||
27628600|NCT01191086|80480350|FG000|Overall Study|Withdrawal by Subject|24|||
27628601|NCT01191086|80480350|FG000|Overall Study|Discontinuation criterion met|1|||
27628602|NCT01191086|80480350|FG000|Overall Study|Other|1|||
27628603|NCT00320489|80480358|FG000|Overall Study|Adverse Event|26|||
27628604|NCT00320489|80480359|FG001|Overall Study|Adverse Event|25|||
27628605|NCT00320489|80480358|FG000|Overall Study|Clinical Relapse|26|||
27628606|NCT00320489|80480359|FG001|Overall Study|Clinical Relapse|20|||
27628607|NCT00320489|80480358|FG000|Overall Study|Death|0|||
27628608|NCT00320489|80480359|FG001|Overall Study|Death|2|||
27628609|NCT00320489|80480358|FG000|Overall Study|Entry Criteria Exclusion|2|||
27628610|NCT00320489|80480359|FG001|Overall Study|Entry Criteria Exclusion|4|||
27628611|NCT00320489|80480358|FG000|Overall Study|Lack of Efficacy|16|||
27628612|NCT00320489|80480359|FG001|Overall Study|Lack of Efficacy|7|||
27628613|NCT00320489|80480358|FG000|Overall Study|Lost to Follow-up|21|||
27628614|NCT00320489|80480359|FG001|Overall Study|Lost to Follow-up|22|||
27628615|NCT00320489|80480358|FG000|Overall Study|Physician Decision|8|||
27628616|NCT00320489|80480359|FG001|Overall Study|Physician Decision|8|||
27628617|NCT00320489|80480358|FG000|Overall Study|Protocol Violation|4|||
27628618|NCT00320489|80480359|FG001|Overall Study|Protocol Violation|4|||
27628619|NCT00320489|80480358|FG000|Overall Study|Sponsor Decision|3|||
27628620|NCT00320489|80480359|FG001|Overall Study|Sponsor Decision|3|||
27628621|NCT00320489|80480358|FG000|Overall Study|Withdrawal by Subject|39|||
27628622|NCT00320489|80480359|FG001|Overall Study|Withdrawal by Subject|41|||
27628623|NCT01648140|80480362|FG000|Overall Study|Physician Decision|1|||
27628624|NCT01648140|80480363|FG001|Overall Study|Physician Decision|0|||
27628625|NCT01648140|80480364|FG002|Overall Study|Physician Decision|0|||
27628626|NCT01648140|80480365|FG003|Overall Study|Physician Decision|0|||
27628627|NCT01648140|80480362|FG000|Overall Study|Lack of Efficacy|4|||
27628628|NCT01648140|80480363|FG001|Overall Study|Lack of Efficacy|7|||
27628629|NCT01648140|80480364|FG002|Overall Study|Lack of Efficacy|1|||
27736990|NCT00524303|80865059|FG002|Overall Study|Protocol Violation|1|||
27532830|NCT01822678|80145387|FG001|Overall Study|Adverse Event|3|||
27532831|NCT01822678|80145388|FG002|Overall Study|Adverse Event|1|||
27532832|NCT01822678|80145386|FG000|Overall Study|Lack of Efficacy|3|||
27532833|NCT01822678|80145387|FG001|Overall Study|Lack of Efficacy|6|||
27532834|NCT01822678|80145388|FG002|Overall Study|Lack of Efficacy|5|||
27532835|NCT01822678|80145386|FG000|Overall Study|Lost to Follow-up|0|||
27532836|NCT01822678|80145387|FG001|Overall Study|Lost to Follow-up|2|||
27532837|NCT01822678|80145388|FG002|Overall Study|Lost to Follow-up|1|||
27532838|NCT00667602|80145389|FG000|Overall Study|Withdrawal by Subject|4|||
27532839|NCT00667602|80145390|FG001|Overall Study|Withdrawal by Subject|9|||
27532840|NCT00667602|80145391|FG002|Overall Study|Withdrawal by Subject|10|||
27532841|NCT00667602|80145389|FG000|Overall Study|Lost to Follow-up|4|||
27532842|NCT00667602|80145390|FG001|Overall Study|Lost to Follow-up|5|||
27532843|NCT00667602|80145391|FG002|Overall Study|Lost to Follow-up|6|||
27628630|NCT01648140|80480365|FG003|Overall Study|Lack of Efficacy|0|||
27628631|NCT01648140|80480362|FG000|Overall Study|Adverse Event|3|||
27628632|NCT01648140|80480363|FG001|Overall Study|Adverse Event|1|||
27628633|NCT01648140|80480364|FG002|Overall Study|Adverse Event|2|||
27628634|NCT01648140|80480365|FG003|Overall Study|Adverse Event|0|||
27628635|NCT01648140|80480362|FG000|Overall Study|Withdrawal by Subject|2|||
27912855|NCT01450813|81518215|FG001|Overall Study|Physician Decision|1|||
27628636|NCT01648140|80480363|FG001|Overall Study|Withdrawal by Subject|3|||
27628637|NCT01648140|80480364|FG002|Overall Study|Withdrawal by Subject|3|||
27628638|NCT01648140|80480365|FG003|Overall Study|Withdrawal by Subject|2|||
27628639|NCT01648140|80480362|FG000|Overall Study|Lost to Follow-up|2|||
27628640|NCT01648140|80480363|FG001|Overall Study|Lost to Follow-up|1|||
27628641|NCT01648140|80480364|FG002|Overall Study|Lost to Follow-up|2|||
27736991|NCT00524303|80865057|FG000|Overall Study|Withdrawal by Subject|3|||
27736992|NCT00524303|80865058|FG001|Overall Study|Withdrawal by Subject|0|||
27736993|NCT00524303|80865059|FG002|Overall Study|Withdrawal by Subject|4|||
27736994|NCT00524303|80865057|FG000|Overall Study|Death|0|||
27736995|NCT00524303|80865058|FG001|Overall Study|Death|2|||
27736996|NCT00524303|80865059|FG002|Overall Study|Death|3|||
27736997|NCT00524303|80865057|FG000|Overall Study|Adverse Event|1|||
27736998|NCT00524303|80865058|FG001|Overall Study|Adverse Event|2|||
27736999|NCT00524303|80865059|FG002|Overall Study|Adverse Event|3|||
27737000|NCT00524303|80865057|FG000|Overall Study|Did not Complete Study Dosing|1|||
27737001|NCT00524303|80865058|FG001|Overall Study|Did not Complete Study Dosing|0|||
27737002|NCT00524303|80865059|FG002|Overall Study|Did not Complete Study Dosing|0|||
27737003|NCT00524303|80865057|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
27628642|NCT01648140|80480365|FG003|Overall Study|Lost to Follow-up|0|||
27628643|NCT02351180|80480366|FG000|Overall Study|Withdrawal by Subject|1|||
27628644|NCT02351180|80480367|FG001|Overall Study|Withdrawal by Subject|0|||
27628645|NCT03523962|80480368|FG000|Closed Fractures|Death|86|||
27628646|NCT03523962|80480369|FG001|Closed Fractures|Death|71|||
27628647|NCT03523962|80480370|FG002|Closed Fractures|Death|0|||
27628648|NCT03523962|80480371|FG003|Closed Fractures|Death|0|||
27628649|NCT03523962|80480368|FG000|Closed Fractures|Lost to Follow-up|62|||
27628650|NCT03523962|80480369|FG001|Closed Fractures|Lost to Follow-up|36|||
27628651|NCT03523962|80480370|FG002|Closed Fractures|Lost to Follow-up|0|||
27628652|NCT03523962|80480371|FG003|Closed Fractures|Lost to Follow-up|0|||
27628653|NCT03523962|80480368|FG000|Closed Fractures|Withdrawal by Subject|19|||
27628654|NCT03523962|80480369|FG001|Closed Fractures|Withdrawal by Subject|29|||
27628655|NCT03523962|80480370|FG002|Closed Fractures|Withdrawal by Subject|0|||
27912856|NCT01450813|81518216|FG002|Overall Study|Physician Decision|0|||
27912857|NCT01450813|81518217|FG003|Overall Study|Physician Decision|3|||
27912858|NCT02053493|81518219|FG000|Overall Study|Withdrawal by Subject|1|||
27912859|NCT02053493|81518220|FG001|Overall Study|Withdrawal by Subject|1|||
27912860|NCT00325819|81518221|FG000|Overall Study|Study product lost in mail|2|||
27912861|NCT00325819|81518222|FG001|Overall Study|Study product lost in mail|1|||
27532844|NCT00667602|80145389|FG000|Overall Study|Administrative reason|0|||
27532845|NCT00667602|80145390|FG001|Overall Study|Administrative reason|0|||
27532846|NCT00667602|80145391|FG002|Overall Study|Administrative reason|2|||
27532847|NCT00667602|80145389|FG000|Overall Study|Protocol Violation|0|||
27532848|NCT00667602|80145390|FG001|Overall Study|Protocol Violation|1|||
27532849|NCT00667602|80145391|FG002|Overall Study|Protocol Violation|0|||
27532850|NCT00771316|80145392|FG000|Overall Study|Adverse Event|0|||
27532851|NCT00771316|80145393|FG001|Overall Study|Adverse Event|1|||
27532852|NCT00771316|80145392|FG000|Overall Study|Patient withdrew consent|1|||
27532853|NCT00771316|80145393|FG001|Overall Study|Patient withdrew consent|0|||
27532854|NCT00771316|80145392|FG000|Overall Study|Discontinued due to early termination|1|||
27532855|NCT00771316|80145393|FG001|Overall Study|Discontinued due to early termination|0|||
27532856|NCT02035475|80145395|FG000|Overall Study|Withdrawal by Subject|4|||
27532857|NCT02035475|80145395|FG000|Overall Study|Physician Decision|1|||
27532858|NCT02035475|80145395|FG000|Overall Study|Equipment Error|1|||
27532859|NCT02337738|80145398|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
27532860|NCT02337738|80145399|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
27532861|NCT02337738|80145400|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
27532862|NCT02337738|80145398|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27532863|NCT02337738|80145399|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
27532864|NCT02337738|80145400|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
27532865|NCT02337738|80145398|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
27532866|NCT02337738|80145399|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
27628656|NCT03523962|80480371|FG003|Closed Fractures|Withdrawal by Subject|0|||
27912862|NCT00325819|81518221|FG000|Overall Study|Did not take a dose of study product|4|||
27532867|NCT02337738|80145400|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
27532868|NCT02337738|80145398|FG000|Overall Study|Voluntary Withdrawal|10|||
27532869|NCT02337738|80145399|FG001|Overall Study|Voluntary Withdrawal|5|||
27628657|NCT03523962|80480368|FG000|Closed Fractures|Incarceration|1|||
27628658|NCT03523962|80480369|FG001|Closed Fractures|Incarceration|4|||
27628659|NCT03523962|80480370|FG002|Closed Fractures|Incarceration|0|||
27628660|NCT03523962|80480371|FG003|Closed Fractures|Incarceration|0|||
27628661|NCT03523962|80480368|FG000|Open Fractures|Death|0|||
27628662|NCT03523962|80480369|FG001|Open Fractures|Death|0|||
27628663|NCT03523962|80480370|FG002|Open Fractures|Death|11|||
27737004|NCT00524303|80865058|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
27737005|NCT00524303|80865059|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
27532870|NCT02337738|80145400|FG002|Overall Study|Voluntary Withdrawal|2|||
27532871|NCT02337738|80145398|FG000|Overall Study|Lack of Efficacy|2|||
27532872|NCT02337738|80145399|FG001|Overall Study|Lack of Efficacy|4|||
27532873|NCT02337738|80145400|FG002|Overall Study|Lack of Efficacy|0|||
27532874|NCT02337738|80145398|FG000|Overall Study|Investigator's Judgment|1|||
27532875|NCT02337738|80145399|FG001|Overall Study|Investigator's Judgment|1|||
27532876|NCT02337738|80145400|FG002|Overall Study|Investigator's Judgment|3|||
27532877|NCT03181893|80145401|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532878|NCT03181893|80145402|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
27532879|NCT03181893|80145403|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532880|NCT03181893|80145404|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532881|NCT03181893|80145405|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532882|NCT03181893|80145406|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532883|NCT03181893|80145407|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532884|NCT03181893|80145408|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532885|NCT03181893|80145409|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532886|NCT03181893|80145410|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532887|NCT03181893|80145411|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
27532888|NCT03181893|80145401|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
27532889|NCT03181893|80145402|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
27532890|NCT03181893|80145403|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532891|NCT03181893|80145404|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532892|NCT03181893|80145405|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532893|NCT03181893|80145406|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532894|NCT03181893|80145407|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532895|NCT03181893|80145408|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532896|NCT03181893|80145409|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532897|NCT03181893|80145410|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532898|NCT03181893|80145411|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
27532899|NCT03181893|80145401|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532900|NCT03181893|80145402|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532901|NCT03181893|80145403|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532902|NCT03181893|80145404|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532903|NCT03181893|80145405|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27857372|NCT04771403|81310481|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
27857373|NCT04771403|81310480|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
27857374|NCT04771403|81310481|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
27857375|NCT04771403|81310480|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
27857376|NCT04771403|81310481|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
27857377|NCT04771403|81310480|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
27857378|NCT04771403|81310481|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
27857379|NCT01593696|81310482|FG000|Dose Escalation|Progressive Disease|2|||
27857380|NCT01593696|81310483|FG001|Dose Escalation|Progressive Disease|0|||
27857381|NCT01593696|81310484|FG002|Dose Escalation|Progressive Disease|0|||
27857382|NCT01593696|81310485|FG003|Dose Escalation|Progressive Disease|0|||
27857383|NCT01593696|81310482|FG000|Dose Expansion|Fungal infection|0|||
27857384|NCT01593696|81310483|FG001|Dose Expansion|Fungal infection|0|||
27857385|NCT01593696|81310484|FG002|Dose Expansion|Fungal infection|1|||
27857386|NCT01593696|81310485|FG003|Dose Expansion|Fungal infection|0|||
27912863|NCT00325819|81518222|FG001|Overall Study|Did not take a dose of study product|9|||
27912864|NCT00325819|81518221|FG000|Overall Study|Lost to Follow-up|3|||
27912865|NCT00325819|81518222|FG001|Overall Study|Lost to Follow-up|3|||
27912866|NCT01971567|81518223|FG000|Overall Study|Withdrawal by Subject|3|||
27912867|NCT01971567|81518224|FG001|Overall Study|Withdrawal by Subject|2|||
27912868|NCT01971567|81518223|FG000|Overall Study|Lost to Follow-up|1|||
27912869|NCT01971567|81518224|FG001|Overall Study|Lost to Follow-up|0|||
27912870|NCT00784719|81518225|FG000|Overall Study|Adverse Event|0|||
27912871|NCT00784719|81518226|FG001|Overall Study|Adverse Event|2|||
27912872|NCT00784719|81518227|FG002|Overall Study|Adverse Event|0|||
27912873|NCT00784719|81518228|FG003|Overall Study|Adverse Event|0|||
27912874|NCT00784719|81518229|FG004|Overall Study|Adverse Event|1|||
27912875|NCT00784719|81518230|FG005|Overall Study|Adverse Event|1|||
27912876|NCT00784719|81518231|FG006|Overall Study|Adverse Event|1|||
27628664|NCT03523962|80480371|FG003|Open Fractures|Death|6|||
27737006|NCT00524303|80865057|FG000|Overall Study|Disease Progression|0|||
27737007|NCT00524303|80865058|FG001|Overall Study|Disease Progression|4|||
27737008|NCT00524303|80865059|FG002|Overall Study|Disease Progression|1|||
27737009|NCT00524303|80865057|FG000|Overall Study|Disease Recurrence|0|||
27912877|NCT00784719|81518225|FG000|Overall Study|Lost to Follow-up|0|||
27912878|NCT00784719|81518226|FG001|Overall Study|Lost to Follow-up|0|||
27912879|NCT00784719|81518227|FG002|Overall Study|Lost to Follow-up|0|||
27912880|NCT00784719|81518228|FG003|Overall Study|Lost to Follow-up|0|||
27912881|NCT00784719|81518229|FG004|Overall Study|Lost to Follow-up|1|||
27912882|NCT00784719|81518230|FG005|Overall Study|Lost to Follow-up|1|||
27912883|NCT00784719|81518231|FG006|Overall Study|Lost to Follow-up|0|||
27912884|NCT00784719|81518225|FG000|Overall Study|Other|2|||
27912885|NCT00784719|81518226|FG001|Overall Study|Other|1|||
27912886|NCT00784719|81518227|FG002|Overall Study|Other|1|||
27912887|NCT00784719|81518228|FG003|Overall Study|Other|0|||
27912888|NCT00784719|81518229|FG004|Overall Study|Other|2|||
27912889|NCT00784719|81518230|FG005|Overall Study|Other|1|||
27912890|NCT00784719|81518231|FG006|Overall Study|Other|3|||
27912891|NCT00784719|81518225|FG000|Overall Study|Withdrawal by Subject|1|||
27912892|NCT00784719|81518226|FG001|Overall Study|Withdrawal by Subject|0|||
27912893|NCT00784719|81518227|FG002|Overall Study|Withdrawal by Subject|0|||
27912894|NCT00784719|81518228|FG003|Overall Study|Withdrawal by Subject|0|||
27912895|NCT00784719|81518229|FG004|Overall Study|Withdrawal by Subject|2|||
27912896|NCT00784719|81518230|FG005|Overall Study|Withdrawal by Subject|0|||
27912897|NCT00784719|81518231|FG006|Overall Study|Withdrawal by Subject|1|||
27912898|NCT00828113|81518232|FG000|Overall Study|Withdrawal by Subject|27|||
27912899|NCT00828113|81518233|FG001|Overall Study|Withdrawal by Subject|26|||
27912900|NCT00828113|81518232|FG000|Overall Study|Lost to Follow-up|3|||
27912901|NCT00828113|81518233|FG001|Overall Study|Lost to Follow-up|5|||
27912902|NCT02849080|81518238|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
27912903|NCT02849080|81518239|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
27912904|NCT02849080|81518240|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
27912905|NCT02849080|81518241|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
27912906|NCT02849080|81518238|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
27912907|NCT02849080|81518239|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
27912908|NCT02849080|81518240|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
27912909|NCT02849080|81518241|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
27912910|NCT02849080|81518238|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
27912911|NCT02849080|81518239|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
27912912|NCT02849080|81518240|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
27912913|NCT02849080|81518241|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
27912914|NCT02849080|81518238|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
27912915|NCT02849080|81518239|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
27912916|NCT02849080|81518240|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
27912917|NCT02849080|81518241|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
27912918|NCT02849080|81518238|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
27912919|NCT02849080|81518239|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
27912920|NCT02849080|81518240|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
27912921|NCT02849080|81518241|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
27628665|NCT03523962|80480368|FG000|Open Fractures|Lost to Follow-up|0|||
27628666|NCT03523962|80480369|FG001|Open Fractures|Lost to Follow-up|0|||
27628667|NCT03523962|80480370|FG002|Open Fractures|Lost to Follow-up|15|||
27628668|NCT03523962|80480371|FG003|Open Fractures|Lost to Follow-up|8|||
27628669|NCT03523962|80480368|FG000|Open Fractures|Withdrawal by Subject|0|||
27628670|NCT03523962|80480369|FG001|Open Fractures|Withdrawal by Subject|0|||
27628671|NCT03523962|80480370|FG002|Open Fractures|Withdrawal by Subject|6|||
27628672|NCT03523962|80480371|FG003|Open Fractures|Withdrawal by Subject|2|||
27628673|NCT03523962|80480368|FG000|Open Fractures|Incarceration|0|||
27628674|NCT03523962|80480369|FG001|Open Fractures|Incarceration|0|||
27628675|NCT03523962|80480370|FG002|Open Fractures|Incarceration|1|||
27628676|NCT03523962|80480371|FG003|Open Fractures|Incarceration|0|||
27628677|NCT01362491|80480372|FG000|Overall Study|Ineligible|1|||
27628678|NCT01362491|80480373|FG001|Overall Study|Ineligible|0|||
27628679|NCT01362491|80480374|FG002|Overall Study|Ineligible|0|||
27628680|NCT01329328|80480376|FG000|Overall Study|Withdrawal by Subject|2|||
27628681|NCT01329328|80480377|FG001|Overall Study|Withdrawal by Subject|4|||
27628682|NCT01329328|80480378|FG002|Overall Study|Withdrawal by Subject|3|||
27912922|NCT02849080|81518238|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
27912923|NCT02849080|81518239|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
27912924|NCT02849080|81518240|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
27912925|NCT02849080|81518241|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
27912926|NCT00956839|81518242|FG000|Overall Study|Lost to Follow-up|3|||
27912927|NCT00956839|81518243|FG001|Overall Study|Lost to Follow-up|0|||
27912928|NCT00956839|81518244|FG002|Overall Study|Lost to Follow-up|3|||
27628683|NCT01908634|80480380|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
27628684|NCT01908634|80480380|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
27912929|NCT02259400|81518245|FG000|Overall Study|Death|0|||
27912930|NCT02259400|81518246|FG001|Overall Study|Death|2|||
27912931|NCT02104895|81518247|FG000|Overall Study|Withdrawal by Subject|0|||
27912932|NCT02104895|81518248|FG001|Overall Study|Withdrawal by Subject|14|||
27628685|NCT00919763|80480381|FG000|Overall Study|Adverse Event|7|||
27628686|NCT00919763|80480382|FG001|Overall Study|Adverse Event|1|||
27628687|NCT00919763|80480381|FG000|Overall Study|Lost to Follow-up|1|||
27628688|NCT00919763|80480382|FG001|Overall Study|Lost to Follow-up|0|||
27628689|NCT00919763|80480381|FG000|Overall Study|Protocol Violation|1|||
27628690|NCT00919763|80480382|FG001|Overall Study|Protocol Violation|1|||
27628691|NCT00919763|80480381|FG000|Overall Study|Withdrawal by Subject|3|||
27628692|NCT00919763|80480382|FG001|Overall Study|Withdrawal by Subject|1|||
27628693|NCT00919763|80480381|FG000|Overall Study|Non-compliance|0|||
27628694|NCT00919763|80480382|FG001|Overall Study|Non-compliance|1|||
27628695|NCT04716933|80480383|FG000|Overall Study|Ongoing|46|||
27628696|NCT04716933|80480384|FG001|Overall Study|Ongoing|37|||
27628697|NCT04716933|80480383|FG000|Overall Study|Sponsor Decision|55|||
27628698|NCT04716933|80480384|FG001|Overall Study|Sponsor Decision|63|||
27628699|NCT00886613|80480385|FG000|Overall Study|Protocol deviation (Part B)|1|||
27628700|NCT00886613|80480386|FG001|Overall Study|Protocol deviation (Part B)|0|||
27628701|NCT00886613|80480387|FG002|Overall Study|Protocol deviation (Part B)|0|||
27628702|NCT00886613|80480385|FG000|Overall Study|Lost to follow-up (Part B)|1|||
27628703|NCT00886613|80480386|FG001|Overall Study|Lost to follow-up (Part B)|0|||
27628704|NCT00886613|80480387|FG002|Overall Study|Lost to follow-up (Part B)|1|||
27628705|NCT00886613|80480385|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
27912933|NCT01628848|81518251|FG000|Overall Study|Adverse Event|9|||
27912934|NCT01628848|81518252|FG001|Overall Study|Adverse Event|7|||
27912935|NCT01628848|81518251|FG000|Overall Study|Lack of Efficacy|0|||
27912936|NCT01628848|81518252|FG001|Overall Study|Lack of Efficacy|4|||
27912937|NCT01628848|81518251|FG000|Overall Study|Withdrawal by Subject|0|||
27912938|NCT01628848|81518252|FG001|Overall Study|Withdrawal by Subject|2|||
27532904|NCT03181893|80145406|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532905|NCT03181893|80145407|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27628706|NCT00886613|80480386|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
27628707|NCT00886613|80480387|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
27628708|NCT05526911|80480388|FG000|Overall Study|Adverse Event|2|||
27912939|NCT01628848|81518251|FG000|Overall Study|Physician Decision|3|||
27532906|NCT03181893|80145408|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
27532907|NCT03181893|80145409|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
27532908|NCT03181893|80145410|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532909|NCT03181893|80145411|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
27532910|NCT03181893|80145401|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532911|NCT03181893|80145402|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532912|NCT03181893|80145403|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532913|NCT03181893|80145404|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532914|NCT03181893|80145405|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532915|NCT03181893|80145406|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532916|NCT03181893|80145407|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532917|NCT03181893|80145408|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532918|NCT03181893|80145409|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532919|NCT03181893|80145410|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
27532920|NCT03181893|80145411|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
27532921|NCT03181893|80145401|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532922|NCT03181893|80145402|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532923|NCT03181893|80145403|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532924|NCT03181893|80145404|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532925|NCT03181893|80145405|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532926|NCT03181893|80145406|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532927|NCT03181893|80145407|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532928|NCT03181893|80145408|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532929|NCT03181893|80145409|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532930|NCT03181893|80145410|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
27532931|NCT03181893|80145411|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
27532932|NCT00053365|80145412|FG000|Overall Study|Incorrect cell type|1|||
27532933|NCT00053365|80145412|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
27532934|NCT00053365|80145412|FG000|Overall Study|Never treated|4|||
27628709|NCT02282527|80480390|FG000|Overall Study|Lost to Follow-up|0|||
27912940|NCT01628848|81518252|FG001|Overall Study|Physician Decision|1|||
27532935|NCT00884377|80145413|FG000|Overall Study|Withdrawal by Subject|1|||
27532936|NCT00884377|80145414|FG001|Overall Study|Withdrawal by Subject|0|||
27532937|NCT00884377|80145413|FG000|Overall Study|Could not confirm diagnosis|1|||
27628710|NCT02282527|80480391|FG001|Overall Study|Lost to Follow-up|1|||
27628711|NCT02282527|80480390|FG000|Overall Study|Lack of home health aid|1|||
27628712|NCT02282527|80480391|FG001|Overall Study|Lack of home health aid|0|||
27628713|NCT01494662|80480392|FG000|Overall Study|Withdrawal by Subject|0|||
27737010|NCT00524303|80865058|FG001|Overall Study|Disease Recurrence|1|||
27912941|NCT00613821|81518255|FG000|Overall Study|Withdrawal by Subject|1|||
27912942|NCT00613821|81518256|FG001|Overall Study|Withdrawal by Subject|0|||
27532938|NCT00884377|80145414|FG001|Overall Study|Could not confirm diagnosis|0|||
27532939|NCT00884377|80145413|FG000|Overall Study|Physician Decision|0|||
27532940|NCT00884377|80145414|FG001|Overall Study|Physician Decision|1|||
27532941|NCT04521777|80145417|FG000|Overall Study|Death|2|||
27532942|NCT04521777|80145417|FG000|Overall Study|Withdrawal by Subject|2|||
27532943|NCT04399837|80145425|FG000|Overall Study|Other than listed|0|||
27912943|NCT00613821|81518255|FG000|Overall Study|Physician Decision|1|||
27912944|NCT00613821|81518256|FG001|Overall Study|Physician Decision|1|||
27912945|NCT01673178|81518257|FG000|Overall Study|Lost to Follow-up|0|||
27912946|NCT01673178|81518258|FG001|Overall Study|Lost to Follow-up|1|||
27912947|NCT01673178|81518259|FG002|Overall Study|Lost to Follow-up|0|||
27912948|NCT01673178|81518260|FG003|Overall Study|Lost to Follow-up|0|||
27912949|NCT01673178|81518261|FG004|Overall Study|Lost to Follow-up|0|||
27532944|NCT04399837|80145426|FG001|Overall Study|Other than listed|2|||
27532945|NCT04399837|80145427|FG002|Overall Study|Other than listed|2|||
27532946|NCT04399837|80145428|FG003|Overall Study|Other than listed|3|||
27532947|NCT04399837|80145425|FG000|Overall Study|Withdrawal by Subject|1|||
27532948|NCT04399837|80145426|FG001|Overall Study|Withdrawal by Subject|2|||
27532949|NCT04399837|80145427|FG002|Overall Study|Withdrawal by Subject|1|||
27532950|NCT04399837|80145428|FG003|Overall Study|Withdrawal by Subject|1|||
27532951|NCT01086423|80145429|FG000|Overall Study|Protocol Violation|0|||
27532952|NCT01086423|80145430|FG001|Overall Study|Protocol Violation|0|||
27532953|NCT01086423|80145431|FG002|Overall Study|Protocol Violation|1|||
27532954|NCT01086423|80145429|FG000|Overall Study|Migrated/moved from study area|2|||
27532955|NCT01086423|80145430|FG001|Overall Study|Migrated/moved from study area|0|||
27532956|NCT01086423|80145431|FG002|Overall Study|Migrated/moved from study area|4|||
27532957|NCT01086423|80145429|FG000|Overall Study|Adverse event, fatal|1|||
27532958|NCT01086423|80145430|FG001|Overall Study|Adverse event, fatal|1|||
27532959|NCT01086423|80145431|FG002|Overall Study|Adverse event, fatal|0|||
27532960|NCT01086423|80145429|FG000|Overall Study|Adverse event, non-fatal|2|||
27532961|NCT01086423|80145430|FG001|Overall Study|Adverse event, non-fatal|1|||
27532962|NCT01086423|80145431|FG002|Overall Study|Adverse event, non-fatal|0|||
27532963|NCT01086423|80145429|FG000|Overall Study|Withdrawal by Subject|5|||
27532964|NCT01086423|80145430|FG001|Overall Study|Withdrawal by Subject|1|||
27532965|NCT01086423|80145431|FG002|Overall Study|Withdrawal by Subject|3|||
27532966|NCT01086423|80145429|FG000|Overall Study|Lost to Follow-up|0|||
27532967|NCT01086423|80145430|FG001|Overall Study|Lost to Follow-up|0|||
27532968|NCT01086423|80145431|FG002|Overall Study|Lost to Follow-up|1|||
27532969|NCT01795638|80145432|FG000|Overall Study|Death|0|||
27532970|NCT01795638|80145433|FG001|Overall Study|Death|3|||
27532971|NCT01795638|80145432|FG000|Overall Study|transferred to quaternary hospital|2|||
27532972|NCT01795638|80145433|FG001|Overall Study|transferred to quaternary hospital|3|||
27532973|NCT01795638|80145432|FG000|Overall Study|Protocol Violation|3|||
27532974|NCT01795638|80145433|FG001|Overall Study|Protocol Violation|0|||
27532975|NCT01795638|80145432|FG000|Overall Study|discharged from hospital|7|||
27532976|NCT01795638|80145433|FG001|Overall Study|discharged from hospital|5|||
27532977|NCT01795638|80145432|FG000|Overall Study|Withdrawal by Subject|1|||
27532978|NCT01795638|80145433|FG001|Overall Study|Withdrawal by Subject|0|||
27912950|NCT01673178|81518257|FG000|Overall Study|Withdrawal by Subject|0|||
27912951|NCT01673178|81518258|FG001|Overall Study|Withdrawal by Subject|0|||
27912952|NCT01673178|81518259|FG002|Overall Study|Withdrawal by Subject|1|||
27912953|NCT01673178|81518260|FG003|Overall Study|Withdrawal by Subject|4|||
27532979|NCT00586066|80145436|FG000|Overall Study|Lost to Follow-up|6|||
27532980|NCT00586066|80145437|FG001|Overall Study|Lost to Follow-up|3|||
27532981|NCT00586066|80145436|FG000|Overall Study|Lack of Efficacy|5|||
27532982|NCT00586066|80145437|FG001|Overall Study|Lack of Efficacy|3|||
27532983|NCT00586066|80145436|FG000|Overall Study|Adverse Event|2|||
27532984|NCT00586066|80145437|FG001|Overall Study|Adverse Event|2|||
27532985|NCT00586066|80145436|FG000|Overall Study|Physician Decision|1|||
27532986|NCT00586066|80145437|FG001|Overall Study|Physician Decision|0|||
27532987|NCT00586066|80145436|FG000|Overall Study|Withdrawal of consent|4|||
27532988|NCT00586066|80145437|FG001|Overall Study|Withdrawal of consent|2|||
27532989|NCT03265665|80145438|FG000|24-week Data Collection|Withdrawal by Subject|2|||
27532990|NCT03265665|80145439|FG001|24-week Data Collection|Withdrawal by Subject|2|||
27912954|NCT01673178|81518261|FG004|Overall Study|Withdrawal by Subject|2|||
27912955|NCT01673178|81518257|FG000|Overall Study|Protocol Violation|1|||
27912956|NCT01673178|81518258|FG001|Overall Study|Protocol Violation|1|||
27912957|NCT01673178|81518259|FG002|Overall Study|Protocol Violation|0|||
27912958|NCT01673178|81518260|FG003|Overall Study|Protocol Violation|1|||
27912959|NCT01673178|81518261|FG004|Overall Study|Protocol Violation|0|||
27912960|NCT01673178|81518257|FG000|Overall Study|Adverse Event|1|||
27912961|NCT01673178|81518258|FG001|Overall Study|Adverse Event|0|||
27912962|NCT01673178|81518259|FG002|Overall Study|Adverse Event|0|||
27532991|NCT03265665|80145438|FG000|24-week Data Collection|Lost to Follow-up|4|||
27532992|NCT03265665|80145439|FG001|24-week Data Collection|Lost to Follow-up|5|||
27532993|NCT03265665|80145438|FG000|36-week Data Collection|Lost to Follow-up|6|||
27912963|NCT01673178|81518260|FG003|Overall Study|Adverse Event|2|||
27912964|NCT01673178|81518261|FG004|Overall Study|Adverse Event|0|||
27628714|NCT01494662|80480393|FG001|Overall Study|Withdrawal by Subject|0|||
27628715|NCT01494662|80480394|FG002|Overall Study|Withdrawal by Subject|1|||
27628716|NCT01494662|80480395|FG003|Overall Study|Withdrawal by Subject|0|||
27628717|NCT01494662|80480396|FG004|Overall Study|Withdrawal by Subject|0|||
27628718|NCT01494662|80480397|FG005|Overall Study|Withdrawal by Subject|0|||
27628719|NCT01494662|80480398|FG006|Overall Study|Withdrawal by Subject|0|||
27628720|NCT01494662|80480392|FG000|Overall Study|Physician Decision|0|||
27628721|NCT01494662|80480393|FG001|Overall Study|Physician Decision|0|||
27628722|NCT01494662|80480394|FG002|Overall Study|Physician Decision|1|||
27628723|NCT01494662|80480395|FG003|Overall Study|Physician Decision|0|||
27628724|NCT01494662|80480396|FG004|Overall Study|Physician Decision|0|||
27628725|NCT01494662|80480397|FG005|Overall Study|Physician Decision|0|||
27628726|NCT01494662|80480398|FG006|Overall Study|Physician Decision|0|||
27628727|NCT00470626|80480399|FG000|Overall Study|Lost to Follow-up|10|||
27628728|NCT00470626|80480399|FG000|Overall Study|Withdrawal by Subject|7|||
27628729|NCT01913340|80480400|FG000|Overall Study|Death|2|||
27628730|NCT01913340|80480401|FG001|Overall Study|Death|5|||
27628731|NCT01913340|80480400|FG000|Overall Study|Lost to Follow-up|1|||
27628732|NCT01913340|80480401|FG001|Overall Study|Lost to Follow-up|1|||
27628733|NCT01823341|80480402|FG000|Overall Study|Failed run-in|7|||
27628734|NCT01823341|80480402|FG000|Overall Study|Withdrawal by Subject|7|||
27628735|NCT01823341|80480402|FG000|Overall Study|Adverse Event|1|||
27628736|NCT01191788|80480407|FG000|Overall Study|Lost to Follow-up|21|||
27628737|NCT01191788|80480408|FG001|Overall Study|Lost to Follow-up|22|||
27628738|NCT02195479|80480409|FG000|Overall Study|Lost to Follow-up|3|||
27628739|NCT02195479|80480410|FG001|Overall Study|Lost to Follow-up|0|||
27628740|NCT02195479|80480409|FG000|Overall Study|Death|48|||
27628741|NCT02195479|80480410|FG001|Overall Study|Death|45|||
27628742|NCT02195479|80480409|FG000|Overall Study|Physician Decision|1|||
27628743|NCT02195479|80480410|FG001|Overall Study|Physician Decision|0|||
27628744|NCT02195479|80480409|FG000|Overall Study|Withdrawal by Subject|11|||
27628745|NCT02195479|80480410|FG001|Overall Study|Withdrawal by Subject|6|||
27628746|NCT02195479|80480409|FG000|Overall Study|Other|2|||
27628747|NCT02195479|80480410|FG001|Overall Study|Other|2|||
27628748|NCT02195479|80480409|FG000|Overall Study|Ongoing|291|||
27628749|NCT02195479|80480410|FG001|Overall Study|Ongoing|297|||
27628750|NCT01137292|80480411|FG000|Overall Study|Death|30|||
27628751|NCT01137292|80480411|FG000|Overall Study|Adverse Event|3|||
27628752|NCT01137292|80480411|FG000|Overall Study|Lack of Efficacy|13|||
27628753|NCT01137292|80480411|FG000|Overall Study|Lost to Follow-up|1|||
27628754|NCT01137292|80480411|FG000|Overall Study|Other|7|||
27628755|NCT03586544|80480412|FG000|First Intervention|Adverse Event|0|||
27628756|NCT03586544|80480413|FG001|First Intervention|Adverse Event|1|||
27628757|NCT03586544|80480412|FG000|Second Intervention|Withdrawal by Subject|0|||
27628758|NCT03586544|80480413|FG001|Second Intervention|Withdrawal by Subject|1|||
27628759|NCT01123083|80480414|FG000|Overall Study|Investigator recommendation|1|||
27628760|NCT01123083|80480415|FG001|Overall Study|Investigator recommendation|1|||
27628761|NCT01123083|80480414|FG000|Overall Study|Administrative reasons|0|||
27628762|NCT01123083|80480415|FG001|Overall Study|Administrative reasons|4|||
27628763|NCT01123083|80480414|FG000|Overall Study|Lost to Follow-up|2|||
27628764|NCT01123083|80480415|FG001|Overall Study|Lost to Follow-up|6|||
27628765|NCT01123083|80480414|FG000|Overall Study|Adverse Event|1|||
27912965|NCT01673178|81518257|FG000|Overall Study|Other|1|||
27912966|NCT01673178|81518258|FG001|Overall Study|Other|0|||
27912967|NCT01673178|81518259|FG002|Overall Study|Other|2|||
27912968|NCT01673178|81518260|FG003|Overall Study|Other|1|||
27912969|NCT01673178|81518261|FG004|Overall Study|Other|0|||
27912970|NCT00398216|81518262|FG000|Overall Study|Adverse Event|4|||
27912971|NCT00398216|81518263|FG001|Overall Study|Adverse Event|2|||
27912972|NCT00398216|81518264|FG002|Overall Study|Adverse Event|5|||
27912973|NCT00398216|81518265|FG003|Overall Study|Adverse Event|7|||
27912974|NCT00398216|81518266|FG004|Overall Study|Adverse Event|2|||
27912975|NCT00398216|81518262|FG000|Overall Study|Protocol Violation|2|||
27912976|NCT00398216|81518263|FG001|Overall Study|Protocol Violation|4|||
27628766|NCT01123083|80480415|FG001|Overall Study|Adverse Event|0|||
27912977|NCT00398216|81518264|FG002|Overall Study|Protocol Violation|5|||
27912978|NCT00398216|81518265|FG003|Overall Study|Protocol Violation|7|||
27628767|NCT01123083|80480414|FG000|Overall Study|Withdrew for another reason not covered|0|||
27628768|NCT01123083|80480415|FG001|Overall Study|Withdrew for another reason not covered|1|||
27628769|NCT01123083|80480414|FG000|Overall Study|Participant/legal representative request|7|||
27628770|NCT01123083|80480415|FG001|Overall Study|Participant/legal representative request|3|||
27628771|NCT03613129|80480416|FG000|Pre-treatment Assessment|Protocol Violation|2|||
27628772|NCT03613129|80480417|FG001|Pre-treatment Assessment|Protocol Violation|0|||
27628773|NCT03613129|80480418|FG002|Pre-treatment Assessment|Protocol Violation|0|||
27628774|NCT03613129|80480419|FG003|Pre-treatment Assessment|Protocol Violation|0|||
27912979|NCT00398216|81518266|FG004|Overall Study|Protocol Violation|5|||
27912980|NCT00398216|81518262|FG000|Overall Study|Lost to Follow-up|1|||
27912981|NCT00398216|81518263|FG001|Overall Study|Lost to Follow-up|6|||
27912982|NCT00398216|81518264|FG002|Overall Study|Lost to Follow-up|4|||
27912983|NCT00398216|81518265|FG003|Overall Study|Lost to Follow-up|4|||
27628775|NCT03613129|80480420|FG004|Pre-treatment Assessment|Protocol Violation|0|||
27912984|NCT00398216|81518266|FG004|Overall Study|Lost to Follow-up|1|||
27912985|NCT00398216|81518262|FG000|Overall Study|Death|0|||
27912986|NCT00398216|81518263|FG001|Overall Study|Death|3|||
27912987|NCT00398216|81518264|FG002|Overall Study|Death|0|||
27912988|NCT00398216|81518265|FG003|Overall Study|Death|0|||
27912989|NCT00398216|81518266|FG004|Overall Study|Death|0|||
27912990|NCT00398216|81518262|FG000|Overall Study|Withdrawal by Subject|1|||
27912991|NCT00398216|81518263|FG001|Overall Study|Withdrawal by Subject|0|||
27912992|NCT00398216|81518264|FG002|Overall Study|Withdrawal by Subject|3|||
27912993|NCT00398216|81518265|FG003|Overall Study|Withdrawal by Subject|1|||
27912994|NCT00398216|81518266|FG004|Overall Study|Withdrawal by Subject|2|||
27912995|NCT00398216|81518262|FG000|Overall Study|administrative reasons|3|||
27912996|NCT00398216|81518263|FG001|Overall Study|administrative reasons|4|||
27912997|NCT00398216|81518264|FG002|Overall Study|administrative reasons|4|||
27912998|NCT00398216|81518265|FG003|Overall Study|administrative reasons|3|||
27912999|NCT00398216|81518266|FG004|Overall Study|administrative reasons|3|||
27913000|NCT00398216|81518262|FG000|Overall Study|entrance criteria|0|||
27913001|NCT00398216|81518263|FG001|Overall Study|entrance criteria|0|||
27913002|NCT00398216|81518264|FG002|Overall Study|entrance criteria|0|||
27913003|NCT00398216|81518265|FG003|Overall Study|entrance criteria|0|||
27913004|NCT00398216|81518266|FG004|Overall Study|entrance criteria|2|||
27913005|NCT00268983|81518267|FG000|Overall Study|Death|3|||
27913006|NCT00268983|81518268|FG001|Overall Study|Death|0|||
27913007|NCT02688933|81518269|FG000|Overall Study|Adverse Event|3|||
27913008|NCT02688933|81518270|FG001|Overall Study|Adverse Event|1|||
27913009|NCT02688933|81518269|FG000|Overall Study|Lack of Efficacy|2|||
27913010|NCT02688933|81518270|FG001|Overall Study|Lack of Efficacy|2|||
27913011|NCT02688933|81518269|FG000|Overall Study|Poor compliance to protocol|7|||
27913012|NCT02688933|81518270|FG001|Overall Study|Poor compliance to protocol|4|||
27913013|NCT02688933|81518269|FG000|Overall Study|Hypoglycemia|2|||
27913014|NCT02688933|81518270|FG001|Overall Study|Hypoglycemia|0|||
27913015|NCT02688933|81518269|FG000|Overall Study|Other than Specified|14|||
27913016|NCT02688933|81518270|FG001|Overall Study|Other than Specified|25|||
27913017|NCT02688933|81518269|FG000|Overall Study|Lost to Follow-up|1|||
27628776|NCT03613129|80480416|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
27737011|NCT00524303|80865059|FG002|Overall Study|Disease Recurrence|0|||
27913018|NCT02688933|81518270|FG001|Overall Study|Lost to Follow-up|5|||
27913019|NCT01869777|81518271|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
27913020|NCT01212094|81518274|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
27913021|NCT01212094|81518275|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
27913022|NCT01212094|81518276|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
27913023|NCT01212094|81518274|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
27913024|NCT01212094|81518275|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
27913025|NCT01212094|81518276|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
27913026|NCT01212094|81518274|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
27913027|NCT01212094|81518275|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
27913028|NCT01212094|81518276|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
27913029|NCT01212094|81518274|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
27913030|NCT01212094|81518275|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
27913031|NCT01212094|81518276|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
27913032|NCT01212094|81518274|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
27913033|NCT01212094|81518275|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
27913034|NCT01212094|81518276|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
27913035|NCT01212094|81518274|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
27913036|NCT01212094|81518275|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
27913037|NCT01212094|81518276|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
27913038|NCT00919633|81518279|FG000|Overall Study|Adverse Event|1|||
27913039|NCT00919633|81518280|FG001|Overall Study|Adverse Event|9|||
27913040|NCT00919633|81518281|FG002|Overall Study|Adverse Event|12|||
27913041|NCT00919633|81518282|FG003|Overall Study|Adverse Event|10|||
27913042|NCT00919633|81518279|FG000|Overall Study|Death|0|||
27913043|NCT00919633|81518280|FG001|Overall Study|Death|0|||
27913044|NCT00919633|81518281|FG002|Overall Study|Death|2|||
27913045|NCT00919633|81518282|FG003|Overall Study|Death|0|||
27913046|NCT00919633|81518279|FG000|Overall Study|Lack of Efficacy|17|||
27913047|NCT00919633|81518280|FG001|Overall Study|Lack of Efficacy|3|||
27913048|NCT00919633|81518281|FG002|Overall Study|Lack of Efficacy|2|||
27913049|NCT00919633|81518282|FG003|Overall Study|Lack of Efficacy|3|||
27913050|NCT00919633|81518279|FG000|Overall Study|Withdrawal by Subject|1|||
27628777|NCT03613129|80480417|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
27628778|NCT03613129|80480418|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
27913051|NCT00919633|81518280|FG001|Overall Study|Withdrawal by Subject|2|||
27913052|NCT00919633|81518281|FG002|Overall Study|Withdrawal by Subject|4|||
27913053|NCT00919633|81518282|FG003|Overall Study|Withdrawal by Subject|3|||
27913054|NCT00919633|81518279|FG000|Overall Study|Lost to Follow-up|3|||
27628779|NCT03613129|80480419|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
27628780|NCT03613129|80480420|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
27628781|NCT04304534|80480421|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
27628782|NCT04304534|80480422|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
27628783|NCT04304534|80480423|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
27628784|NCT04304534|80480424|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
27628785|NCT04304534|80480421|FG000|Overall Study|Non-Compliance with study drug|0|||
27628786|NCT04304534|80480422|FG001|Overall Study|Non-Compliance with study drug|1|||
27628787|NCT04304534|80480423|FG002|Overall Study|Non-Compliance with study drug|1|||
27628788|NCT04304534|80480424|FG003|Overall Study|Non-Compliance with study drug|1|||
27628789|NCT04304534|80480421|FG000|Overall Study|Lost to Follow-up|0|||
27628790|NCT04304534|80480422|FG001|Overall Study|Lost to Follow-up|1|||
27628791|NCT04304534|80480423|FG002|Overall Study|Lost to Follow-up|2|||
27628792|NCT04304534|80480424|FG003|Overall Study|Lost to Follow-up|3|||
27628793|NCT04304534|80480421|FG000|Overall Study|Unspecific|4|||
27628794|NCT04304534|80480422|FG001|Overall Study|Unspecific|2|||
27628795|NCT04304534|80480423|FG002|Overall Study|Unspecific|2|||
27628796|NCT04304534|80480424|FG003|Overall Study|Unspecific|2|||
27628797|NCT04304534|80480421|FG000|Overall Study|Technical Problems|2|||
27628798|NCT04304534|80480422|FG001|Overall Study|Technical Problems|2|||
27628799|NCT04304534|80480423|FG002|Overall Study|Technical Problems|3|||
27628800|NCT04304534|80480424|FG003|Overall Study|Technical Problems|4|||
27628801|NCT04304534|80480421|FG000|Overall Study|Death|7|||
27628802|NCT04304534|80480422|FG001|Overall Study|Death|2|||
27628803|NCT04304534|80480423|FG002|Overall Study|Death|4|||
27628804|NCT04304534|80480424|FG003|Overall Study|Death|3|||
27628805|NCT04304534|80480421|FG000|Overall Study|Withdrawal by Subject|7|||
27628806|NCT04304534|80480422|FG001|Overall Study|Withdrawal by Subject|2|||
27628807|NCT04304534|80480423|FG002|Overall Study|Withdrawal by Subject|7|||
27628808|NCT04304534|80480424|FG003|Overall Study|Withdrawal by Subject|4|||
27628809|NCT04304534|80480421|FG000|Overall Study|Physician Decision|4|||
27628810|NCT04304534|80480422|FG001|Overall Study|Physician Decision|9|||
27628811|NCT04304534|80480423|FG002|Overall Study|Physician Decision|9|||
27628812|NCT04304534|80480424|FG003|Overall Study|Physician Decision|5|||
27628813|NCT04304534|80480421|FG000|Overall Study|Subject Decision|34|||
27628814|NCT04304534|80480422|FG001|Overall Study|Subject Decision|25|||
27628815|NCT04304534|80480423|FG002|Overall Study|Subject Decision|25|||
27628816|NCT04304534|80480424|FG003|Overall Study|Subject Decision|26|||
27628817|NCT04304534|80480421|FG000|Overall Study|Adverse Event|35|||
27737012|NCT00524303|80865057|FG000|Overall Study|Sponsor Request|0|||
27737013|NCT00524303|80865058|FG001|Overall Study|Sponsor Request|0|||
27737014|NCT00524303|80865059|FG002|Overall Study|Sponsor Request|1|||
27737015|NCT00524303|80865057|FG000|Overall Study|Physician Decision|0|||
27737016|NCT00524303|80865058|FG001|Overall Study|Physician Decision|0|||
27737017|NCT00524303|80865059|FG002|Overall Study|Physician Decision|1|||
27737018|NCT00524303|80865057|FG000|Overall Study|Completed 5 years|0|||
27737019|NCT00524303|80865058|FG001|Overall Study|Completed 5 years|0|||
27737020|NCT00524303|80865059|FG002|Overall Study|Completed 5 years|1|||
27737021|NCT03427073|80865060|FG000|Overall Study|Disease Progression|1|||
27737022|NCT03427073|80865061|FG001|Overall Study|Disease Progression|1|||
27737023|NCT03427073|80865062|FG002|Overall Study|Disease Progression|1|||
27737024|NCT03427073|80865063|FG003|Overall Study|Disease Progression|3|||
27737025|NCT03427073|80865064|FG004|Overall Study|Disease Progression|3|||
27737026|NCT03427073|80865065|FG005|Overall Study|Disease Progression|4|||
27737027|NCT03427073|80865066|FG006|Overall Study|Disease Progression|2|||
27737028|NCT03427073|80865067|FG007|Overall Study|Disease Progression|3|||
27737029|NCT03427073|80865060|FG000|Overall Study|Physician Decision|0|||
27737030|NCT03427073|80865061|FG001|Overall Study|Physician Decision|0|||
27737031|NCT03427073|80865062|FG002|Overall Study|Physician Decision|0|||
27913055|NCT00919633|81518280|FG001|Overall Study|Lost to Follow-up|1|||
27628818|NCT04304534|80480422|FG001|Overall Study|Adverse Event|40|||
27628819|NCT04304534|80480423|FG002|Overall Study|Adverse Event|39|||
27628820|NCT04304534|80480424|FG003|Overall Study|Adverse Event|44|||
27628821|NCT00946114|80480425|FG000|Overall Study|Death|5|||
27628822|NCT00946114|80480426|FG001|Overall Study|Death|2|||
27628823|NCT00946114|80480425|FG000|Overall Study|Other|1|||
27628824|NCT00946114|80480426|FG001|Overall Study|Other|0|||
27628825|NCT00946114|80480425|FG000|Overall Study|Withdrawal by Subject|2|||
27628826|NCT00946114|80480426|FG001|Overall Study|Withdrawal by Subject|0|||
27628827|NCT01280591|80480429|FG000|Overall Study|Withdrawal by Subject|0|||
27628828|NCT01280591|80480430|FG001|Overall Study|Withdrawal by Subject|0|||
27628829|NCT01280591|80480431|FG002|Overall Study|Withdrawal by Subject|0|||
27628830|NCT01280591|80480432|FG003|Overall Study|Withdrawal by Subject|2|||
27628831|NCT01280591|80480429|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
27628832|NCT01280591|80480430|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
27737032|NCT03427073|80865063|FG003|Overall Study|Physician Decision|0|||
27737033|NCT03427073|80865064|FG004|Overall Study|Physician Decision|0|||
27737034|NCT03427073|80865065|FG005|Overall Study|Physician Decision|0|||
27737035|NCT03427073|80865066|FG006|Overall Study|Physician Decision|1|||
27628833|NCT01280591|80480431|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
27628834|NCT01280591|80480432|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
27628835|NCT02759731|80480433|FG000|Overall Study|Did not complete treatment.|8|||
27628836|NCT01250002|80480434|FG000|Overall Study|Change to open surgical procedure|4|||
27628837|NCT01250002|80480435|FG001|Overall Study|Change to open surgical procedure|3|||
27628838|NCT02577523|80480436|FG000|Overall Study|Adverse Event|1|||
27628839|NCT02577523|80480437|FG001|Overall Study|Adverse Event|1|||
27628840|NCT02577523|80480436|FG000|Overall Study|Lack of Efficacy|1|||
27628841|NCT02577523|80480437|FG001|Overall Study|Lack of Efficacy|1|||
27628842|NCT02577523|80480436|FG000|Overall Study|Withdrawal by Subject|1|||
27628843|NCT02577523|80480437|FG001|Overall Study|Withdrawal by Subject|0|||
27628844|NCT00567879|80480438|FG000|Overall Study|Adverse Event|2|||
27628845|NCT00567879|80480439|FG001|Overall Study|Adverse Event|0|||
27628846|NCT00567879|80480440|FG002|Overall Study|Adverse Event|1|||
27628847|NCT00567879|80480441|FG003|Overall Study|Adverse Event|0|||
27628848|NCT00567879|80480442|FG004|Overall Study|Adverse Event|1|||
27628849|NCT00567879|80480443|FG005|Overall Study|Adverse Event|0|||
27628850|NCT00567879|80480438|FG000|Overall Study|Abnormal test procedure(s)|0|||
27628851|NCT00567879|80480439|FG001|Overall Study|Abnormal test procedure(s)|0|||
27628852|NCT00567879|80480440|FG002|Overall Study|Abnormal test procedure(s)|1|||
27628853|NCT00567879|80480441|FG003|Overall Study|Abnormal test procedure(s)|0|||
27628854|NCT00567879|80480442|FG004|Overall Study|Abnormal test procedure(s)|0|||
27628855|NCT00567879|80480443|FG005|Overall Study|Abnormal test procedure(s)|0|||
27628856|NCT00567879|80480438|FG000|Overall Study|Withdrawal by Subject|0|||
27628857|NCT00567879|80480439|FG001|Overall Study|Withdrawal by Subject|0|||
27628858|NCT00567879|80480440|FG002|Overall Study|Withdrawal by Subject|3|||
27628859|NCT00567879|80480441|FG003|Overall Study|Withdrawal by Subject|1|||
27628860|NCT00567879|80480442|FG004|Overall Study|Withdrawal by Subject|0|||
27628861|NCT00567879|80480443|FG005|Overall Study|Withdrawal by Subject|0|||
27628862|NCT00567879|80480438|FG000|Overall Study|New cancer therapy|0|||
27628863|NCT00567879|80480439|FG001|Overall Study|New cancer therapy|0|||
27628864|NCT00567879|80480440|FG002|Overall Study|New cancer therapy|1|||
27628865|NCT00567879|80480441|FG003|Overall Study|New cancer therapy|0|||
27628866|NCT00567879|80480442|FG004|Overall Study|New cancer therapy|0|||
27628867|NCT00567879|80480443|FG005|Overall Study|New cancer therapy|0|||
27628868|NCT00567879|80480438|FG000|Overall Study|Disease progression|5|||
27628869|NCT00567879|80480439|FG001|Overall Study|Disease progression|7|||
27628870|NCT00567879|80480440|FG002|Overall Study|Disease progression|15|||
27628871|NCT00567879|80480441|FG003|Overall Study|Disease progression|5|||
27628872|NCT00567879|80480442|FG004|Overall Study|Disease progression|11|||
27628873|NCT00567879|80480443|FG005|Overall Study|Disease progression|3|||
27628874|NCT01511250|80480444|FG000|Overall Study|Withdrawal of Consent|1|||
27628875|NCT01511250|80480445|FG001|Overall Study|Withdrawal of Consent|0|||
27628876|NCT01511250|80480446|FG002|Overall Study|Withdrawal of Consent|0|||
27628877|NCT01511250|80480447|FG003|Overall Study|Withdrawal of Consent|0|||
27628878|NCT01511250|80480448|FG004|Overall Study|Withdrawal of Consent|0|||
27628879|NCT01511250|80480449|FG005|Overall Study|Withdrawal of Consent|0|||
27628880|NCT01511250|80480450|FG006|Overall Study|Withdrawal of Consent|0|||
27628881|NCT01511250|80480451|FG007|Overall Study|Withdrawal of Consent|1|||
27628882|NCT01511250|80480452|FG008|Overall Study|Withdrawal of Consent|1|||
27628883|NCT01511250|80480453|FG009|Overall Study|Withdrawal of Consent|0|||
27628884|NCT01511250|80480444|FG000|Overall Study|Sponsor/Investigator Decision|1|||
27628885|NCT01511250|80480445|FG001|Overall Study|Sponsor/Investigator Decision|0|||
27628886|NCT01511250|80480446|FG002|Overall Study|Sponsor/Investigator Decision|0|||
27628887|NCT01511250|80480447|FG003|Overall Study|Sponsor/Investigator Decision|0|||
27628888|NCT01511250|80480448|FG004|Overall Study|Sponsor/Investigator Decision|0|||
27628889|NCT01511250|80480449|FG005|Overall Study|Sponsor/Investigator Decision|0|||
27628890|NCT01511250|80480450|FG006|Overall Study|Sponsor/Investigator Decision|0|||
27628891|NCT01511250|80480451|FG007|Overall Study|Sponsor/Investigator Decision|0|||
27628892|NCT01511250|80480452|FG008|Overall Study|Sponsor/Investigator Decision|0|||
27628893|NCT01511250|80480453|FG009|Overall Study|Sponsor/Investigator Decision|0|||
27628894|NCT01511250|80480444|FG000|Overall Study|Lost to Follow-up|7|||
27628895|NCT01511250|80480445|FG001|Overall Study|Lost to Follow-up|3|||
27628896|NCT01511250|80480446|FG002|Overall Study|Lost to Follow-up|3|||
27628897|NCT01511250|80480447|FG003|Overall Study|Lost to Follow-up|3|||
27628898|NCT01511250|80480448|FG004|Overall Study|Lost to Follow-up|0|||
27628899|NCT01511250|80480449|FG005|Overall Study|Lost to Follow-up|0|||
27628900|NCT01511250|80480450|FG006|Overall Study|Lost to Follow-up|2|||
27628901|NCT01511250|80480451|FG007|Overall Study|Lost to Follow-up|3|||
27628902|NCT01511250|80480452|FG008|Overall Study|Lost to Follow-up|13|||
27628903|NCT01511250|80480453|FG009|Overall Study|Lost to Follow-up|5|||
27628904|NCT01511250|80480444|FG000|Overall Study|Protocol Violation|0|||
27628905|NCT01511250|80480445|FG001|Overall Study|Protocol Violation|2|||
27737036|NCT03427073|80865067|FG007|Overall Study|Physician Decision|1|||
27628906|NCT01511250|80480446|FG002|Overall Study|Protocol Violation|1|||
27628907|NCT01511250|80480447|FG003|Overall Study|Protocol Violation|0|||
27628908|NCT01511250|80480448|FG004|Overall Study|Protocol Violation|0|||
27913056|NCT00919633|81518281|FG002|Overall Study|Lost to Follow-up|0|||
27913057|NCT00919633|81518282|FG003|Overall Study|Lost to Follow-up|2|||
27913058|NCT00919633|81518279|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
27913059|NCT00919633|81518280|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
27913060|NCT00919633|81518281|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
27913061|NCT00919633|81518282|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
27913062|NCT00919633|81518279|FG000|Overall Study|Protocol Violation|0|||
27913063|NCT00919633|81518280|FG001|Overall Study|Protocol Violation|0|||
27913064|NCT00919633|81518281|FG002|Overall Study|Protocol Violation|0|||
27913065|NCT00919633|81518282|FG003|Overall Study|Protocol Violation|1|||
27913066|NCT00919633|81518279|FG000|Overall Study|Physician Decision|0|||
27913067|NCT00919633|81518280|FG001|Overall Study|Physician Decision|0|||
27913068|NCT00919633|81518281|FG002|Overall Study|Physician Decision|0|||
27913069|NCT00919633|81518282|FG003|Overall Study|Physician Decision|1|||
27913070|NCT00919633|81518279|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
27913071|NCT00919633|81518280|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
27913072|NCT00919633|81518281|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
27913073|NCT00919633|81518282|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
27913074|NCT00919633|81518279|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
27913075|NCT00919633|81518280|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
27913076|NCT00919633|81518281|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
27913077|NCT00919633|81518282|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
27913078|NCT03382418|81518283|FG000|Overall Study|Withdrawal by Subject|1|||
27913079|NCT03382418|81518284|FG001|Overall Study|Withdrawal by Subject|0|||
27913080|NCT03382418|81518285|FG002|Overall Study|Withdrawal by Subject|0|||
27913081|NCT03382418|81518283|FG000|Overall Study|Lost to Follow-up|2|||
27913082|NCT03382418|81518284|FG001|Overall Study|Lost to Follow-up|3|||
27913083|NCT03382418|81518285|FG002|Overall Study|Lost to Follow-up|0|||
27913084|NCT01076543|81518286|FG000|Overall Study|Withdrawal by Subject|2|||
27913085|NCT01076543|81518287|FG001|Overall Study|Withdrawal by Subject|0|||
27913086|NCT01076543|81518288|FG002|Overall Study|Withdrawal by Subject|0|||
27913087|NCT01076543|81518289|FG003|Overall Study|Withdrawal by Subject|0|||
27913088|NCT01076543|81518290|FG004|Overall Study|Withdrawal by Subject|0|||
27913089|NCT01076543|81518291|FG005|Overall Study|Withdrawal by Subject|0|||
27913090|NCT02907463|81518292|FG000|Overall Study|Lost to Follow-up|17|||
27913091|NCT02907463|81518292|FG000|Overall Study|Death|10|||
27913092|NCT02907463|81518292|FG000|Overall Study|Withdrawal by Subject|4|||
27913093|NCT02907463|81518292|FG000|Overall Study|MIS Approach was not used|2|||
27913094|NCT02907463|81518292|FG000|Overall Study|Not Implanted with Study Device|2|||
27913095|NCT02907463|81518292|FG000|Overall Study|Device Explanted|1|||
27913096|NCT02907463|81518292|FG000|Overall Study|Missing Exit Form|1|||
27913097|NCT01214668|81518293|FG000|Overall Study|Adverse Event|0|||
27913098|NCT01214668|81518294|FG001|Overall Study|Adverse Event|1|||
27913099|NCT01214668|81518295|FG002|Overall Study|Adverse Event|0|||
27913100|NCT01214668|81518296|FG003|Overall Study|Adverse Event|2|||
27913101|NCT01214668|81518297|FG004|Overall Study|Adverse Event|1|||
27913102|NCT01214668|81518298|FG005|Overall Study|Adverse Event|1|||
27913103|NCT01214668|81518293|FG000|Overall Study|Death|0|||
27532994|NCT03265665|80145439|FG001|36-week Data Collection|Lost to Follow-up|8|||
27532995|NCT00518973|80145440|FG000|Overall Study|Withdrawal by Subject|3|||
27913104|NCT01214668|81518294|FG001|Overall Study|Death|0|||
27913105|NCT01214668|81518295|FG002|Overall Study|Death|1|||
27913106|NCT01214668|81518296|FG003|Overall Study|Death|0|||
27913107|NCT01214668|81518297|FG004|Overall Study|Death|0|||
27913108|NCT01214668|81518298|FG005|Overall Study|Death|0|||
27913109|NCT01214668|81518293|FG000|Overall Study|Progressive Disease|4|||
27913110|NCT01214668|81518294|FG001|Overall Study|Progressive Disease|2|||
27913111|NCT01214668|81518295|FG002|Overall Study|Progressive Disease|5|||
27913112|NCT01214668|81518296|FG003|Overall Study|Progressive Disease|4|||
27913113|NCT01214668|81518297|FG004|Overall Study|Progressive Disease|4|||
27913114|NCT01214668|81518298|FG005|Overall Study|Progressive Disease|5|||
27913115|NCT01214668|81518293|FG000|Overall Study|Withdrawal by Subject|0|||
27913116|NCT01214668|81518294|FG001|Overall Study|Withdrawal by Subject|0|||
27913117|NCT01214668|81518295|FG002|Overall Study|Withdrawal by Subject|0|||
27913118|NCT01214668|81518296|FG003|Overall Study|Withdrawal by Subject|0|||
27913119|NCT01214668|81518297|FG004|Overall Study|Withdrawal by Subject|1|||
27913120|NCT01214668|81518298|FG005|Overall Study|Withdrawal by Subject|0|||
27913121|NCT00206427|81518300|FG000|Overall Study|Adverse Event|2|||
27913122|NCT02526160|81518301|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
27913123|NCT02526160|81518302|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
27913124|NCT02526160|81518301|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
27913125|NCT02526160|81518302|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
27532996|NCT00518973|80145441|FG001|Overall Study|Withdrawal by Subject|2|||
27913126|NCT02526160|81518301|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
27913127|NCT02526160|81518302|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
27628909|NCT01511250|80480449|FG005|Overall Study|Protocol Violation|0|||
27628910|NCT01511250|80480450|FG006|Overall Study|Protocol Violation|0|||
27628911|NCT01511250|80480451|FG007|Overall Study|Protocol Violation|0|||
27628912|NCT01511250|80480452|FG008|Overall Study|Protocol Violation|0|||
27628913|NCT01511250|80480453|FG009|Overall Study|Protocol Violation|0|||
27628914|NCT01345292|80480456|FG000|Overall Study|Withdrawal by Subject|2|||
27628915|NCT01345292|80480457|FG001|Overall Study|Withdrawal by Subject|0|||
27628916|NCT01345292|80480458|FG002|Overall Study|Withdrawal by Subject|1|||
27628917|NCT03256344|80480459|FG000|Overall Study|Death|6|||
27628918|NCT03256344|80480460|FG001|Overall Study|Death|22|||
27628919|NCT03256344|80480459|FG000|Overall Study|Withdrawal by Subject|3|||
27628920|NCT03256344|80480460|FG001|Overall Study|Withdrawal by Subject|3|||
27628921|NCT03256344|80480459|FG000|Overall Study|Sponsor Decision|1|||
27628922|NCT03256344|80480460|FG001|Overall Study|Sponsor Decision|0|||
27628923|NCT03603717|80480463|FG000|Overall Study|Lost to Follow-up|20|||
27628924|NCT03603717|80480464|FG001|Overall Study|Lost to Follow-up|20|||
27628925|NCT03603717|80480463|FG000|Overall Study|Withdrawal by Subject|16|||
27628926|NCT03603717|80480464|FG001|Overall Study|Withdrawal by Subject|10|||
27628927|NCT01803646|80480465|FG000|Overall Study|Protocol Violation|1|||
27628928|NCT01803646|80480466|FG001|Overall Study|Protocol Violation|0|||
27628929|NCT01803646|80480465|FG000|Overall Study|Adverse Event|1|||
27628930|NCT01803646|80480466|FG001|Overall Study|Adverse Event|1|||
27628931|NCT01803646|80480465|FG000|Overall Study|Withdrawal by Subject|9|||
27628932|NCT01803646|80480466|FG001|Overall Study|Withdrawal by Subject|6|||
27628933|NCT01803646|80480465|FG000|Overall Study|Randomization error|1|||
27628934|NCT01803646|80480466|FG001|Overall Study|Randomization error|2|||
27628935|NCT01803646|80480465|FG000|Overall Study|Lost to Follow-up|5|||
27737037|NCT01982630|80865068|FG000|Overall Study|Adverse Event|2|||
27737038|NCT01982630|80865069|FG001|Overall Study|Adverse Event|0|||
27737039|NCT01982630|80865070|FG002|Overall Study|Adverse Event|1|||
27737040|NCT01982630|80865071|FG003|Overall Study|Adverse Event|0|||
27737041|NCT01982630|80865072|FG004|Overall Study|Adverse Event|1|||
27737042|NCT01982630|80865073|FG005|Overall Study|Adverse Event|2|||
27737043|NCT01982630|80865074|FG006|Overall Study|Adverse Event|1|||
27737044|NCT01982630|80865075|FG007|Overall Study|Adverse Event|0|||
27737045|NCT01982630|80865068|FG000|Overall Study|Physician Decision|1|||
27737046|NCT01982630|80865069|FG001|Overall Study|Physician Decision|0|||
27737047|NCT01982630|80865070|FG002|Overall Study|Physician Decision|2|||
27628936|NCT01803646|80480466|FG001|Overall Study|Lost to Follow-up|1|||
27628937|NCT00290732|80480467|FG000|Overall Study|Inability to instill drug intraductally.|0|||
27737048|NCT01982630|80865071|FG003|Overall Study|Physician Decision|1|||
27737049|NCT01982630|80865072|FG004|Overall Study|Physician Decision|2|||
27737050|NCT01982630|80865073|FG005|Overall Study|Physician Decision|0|||
27737051|NCT01982630|80865074|FG006|Overall Study|Physician Decision|0|||
27737052|NCT01982630|80865075|FG007|Overall Study|Physician Decision|0|||
27737053|NCT01982630|80865068|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27737054|NCT01982630|80865069|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27737055|NCT01982630|80865070|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
27737056|NCT01982630|80865071|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27628938|NCT00290732|80480468|FG001|Overall Study|Inability to instill drug intraductally.|1|||
27628939|NCT00290732|80480469|FG002|Overall Study|Inability to instill drug intraductally.|1|||
27628940|NCT00290732|80480470|FG003|Overall Study|Inability to instill drug intraductally.|0|||
27628941|NCT00290732|80480471|FG004|Overall Study|Inability to instill drug intraductally.|0|||
27628942|NCT02680756|80480472|FG000|Overall Study|Adverse Event|10|||
27628943|NCT02680756|80480473|FG001|Overall Study|Adverse Event|2|||
27628944|NCT02680756|80480472|FG000|Overall Study|Lost to Follow-up|7|||
27628945|NCT02680756|80480473|FG001|Overall Study|Lost to Follow-up|6|||
27628946|NCT02680756|80480472|FG000|Overall Study|Withdrawal by Subject|5|||
27628947|NCT02680756|80480473|FG001|Overall Study|Withdrawal by Subject|5|||
27628948|NCT02680756|80480472|FG000|Overall Study|Physician Decision|4|||
27628949|NCT02680756|80480473|FG001|Overall Study|Physician Decision|1|||
27628950|NCT02680756|80480472|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
27737057|NCT01982630|80865072|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27737058|NCT01982630|80865073|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27737059|NCT01982630|80865074|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27737060|NCT01982630|80865075|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
27628951|NCT02680756|80480473|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
27628952|NCT02680756|80480472|FG000|Overall Study|Blood transfusion for any reason|0|||
27628953|NCT02680756|80480473|FG001|Overall Study|Blood transfusion for any reason|1|||
27628954|NCT02680756|80480472|FG000|Overall Study|Death|1|||
27628955|NCT02680756|80480473|FG001|Overall Study|Death|0|||
27628956|NCT02680756|80480472|FG000|Overall Study|Protocol Violation|1|||
27628957|NCT02680756|80480473|FG001|Overall Study|Protocol Violation|0|||
27628958|NCT02680756|80480472|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
27628959|NCT02680756|80480473|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
27737061|NCT01982630|80865068|FG000|Overall Study|Withdrawal by Subject|0|||
27737062|NCT01982630|80865069|FG001|Overall Study|Withdrawal by Subject|0|||
27737063|NCT01982630|80865070|FG002|Overall Study|Withdrawal by Subject|0|||
27737064|NCT01982630|80865071|FG003|Overall Study|Withdrawal by Subject|0|||
27737065|NCT01982630|80865072|FG004|Overall Study|Withdrawal by Subject|0|||
27737066|NCT01982630|80865073|FG005|Overall Study|Withdrawal by Subject|1|||
27737067|NCT01982630|80865074|FG006|Overall Study|Withdrawal by Subject|0|||
27737068|NCT01982630|80865075|FG007|Overall Study|Withdrawal by Subject|0|||
27737069|NCT01687673|80865078|FG000|Overall Study|Physician Decision|1|||
27737070|NCT01773473|80865079|FG000|Overall Study|Adverse Event|3|||
27737071|NCT01773473|80865080|FG001|Overall Study|Adverse Event|2|||
27737072|NCT01773473|80865079|FG000|Overall Study|Protocol Violation|0|||
27737073|NCT01773473|80865080|FG001|Overall Study|Protocol Violation|4|||
27737074|NCT01773473|80865079|FG000|Overall Study|Physician Decision|3|||
27737075|NCT01773473|80865080|FG001|Overall Study|Physician Decision|5|||
27737076|NCT01773473|80865079|FG000|Overall Study|Sponsor Decision|2|||
27737077|NCT01773473|80865080|FG001|Overall Study|Sponsor Decision|0|||
27737078|NCT01773473|80865079|FG000|Overall Study|Lack of Efficacy|0|||
27737079|NCT01773473|80865080|FG001|Overall Study|Lack of Efficacy|1|||
27737080|NCT01773473|80865079|FG000|Overall Study|Non-Compliance with study drug|1|||
27737081|NCT01773473|80865080|FG001|Overall Study|Non-Compliance with study drug|4|||
27737082|NCT01773473|80865079|FG000|Overall Study|Withdrawal by Subject|5|||
27737083|NCT01773473|80865080|FG001|Overall Study|Withdrawal by Subject|3|||
27737084|NCT01773473|80865079|FG000|Overall Study|Lost to Follow-up|2|||
27737085|NCT01773473|80865080|FG001|Overall Study|Lost to Follow-up|0|||
27737086|NCT01733329|80865081|FG000|Overall Study|Protocol Violation|1|||
27737087|NCT01733329|80865082|FG001|Overall Study|Protocol Violation|1|||
27737088|NCT01733329|80865081|FG000|Overall Study|Uterine artery injury|1|||
27737089|NCT01733329|80865082|FG001|Overall Study|Uterine artery injury|0|||
27737090|NCT03116113|80865084|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737091|NCT03116113|80865085|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737092|NCT03116113|80865086|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737093|NCT03116113|80865087|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737094|NCT03116113|80865088|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737095|NCT03116113|80865089|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737096|NCT03116113|80865090|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
27737097|NCT03116113|80865091|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
27737098|NCT03116113|80865092|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
27737099|NCT02986373|80865093|FG000|Overall Study|Adverse Event|4|||
27737100|NCT02986373|80865093|FG000|Overall Study|Lost to Follow-up|1|||
27737101|NCT02986373|80865093|FG000|Overall Study|Withdrawal by Subject|10|||
27737102|NCT02986373|80865093|FG000|Overall Study|Other|24|||
27737103|NCT01901224|80868212|FG000|Overall Study|study was not funded and terminated|2|||
27737104|NCT02704429|80868217|FG000|Part A: 24 Weeks|Adverse Event|3|||
27737105|NCT02704429|80868218|FG001|Part A: 24 Weeks|Adverse Event|0|||
27737106|NCT02704429|80868217|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
27737107|NCT02704429|80868218|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
27737108|NCT01440101|80868219|FG000|Overall Study|Adverse Event|2|||
27737109|NCT01440101|80868220|FG001|Overall Study|Adverse Event|0|||
27737110|NCT01440101|80868221|FG002|Overall Study|Adverse Event|0|||
27737111|NCT01440101|80868219|FG000|Overall Study|Withdrawal by Subject|0|||
27737112|NCT01440101|80868220|FG001|Overall Study|Withdrawal by Subject|3|||
27737113|NCT01440101|80868221|FG002|Overall Study|Withdrawal by Subject|1|||
27737114|NCT01440101|80868219|FG000|Overall Study|Other|0|||
27737115|NCT01440101|80868220|FG001|Overall Study|Other|1|||
27737116|NCT01440101|80868221|FG002|Overall Study|Other|0|||
27737117|NCT02286960|80868222|FG000|Overall Study|Lost to Follow-up|3|||
27737118|NCT02286960|80868223|FG001|Overall Study|Lost to Follow-up|3|||
27737119|NCT00095121|80868224|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
27737120|NCT00095121|80868225|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
27737121|NCT00095121|80868224|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
27737122|NCT00095121|80868225|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
27737123|NCT02835495|80868226|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
27737124|NCT02835495|80868227|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
27737125|NCT02835495|80868226|FG000|Overall Study|Declined in-person follow-up visit|4|||
27737126|NCT02835495|80868227|FG001|Overall Study|Declined in-person follow-up visit|2|||
27737127|NCT01844076|80868228|FG000|Overall Study|Adverse Event|1|||
27737128|NCT01844076|80868229|FG001|Overall Study|Adverse Event|0|||
27737129|NCT01844076|80868230|FG002|Overall Study|Adverse Event|0|||
27737130|NCT01844076|80868231|FG003|Overall Study|Adverse Event|0|||
27737131|NCT01844076|80868228|FG000|Overall Study|Withdrawal by Subject|1|||
27737132|NCT01844076|80868229|FG001|Overall Study|Withdrawal by Subject|0|||
27532997|NCT04850313|80145442|FG000|Overall Study|Withdrawal by Subject|0|||
27737133|NCT01844076|80868230|FG002|Overall Study|Withdrawal by Subject|0|||
27737134|NCT01844076|80868231|FG003|Overall Study|Withdrawal by Subject|0|||
27737135|NCT03832387|80868233|FG000|Overall Study|Protocol Violation|2|||
27532998|NCT04850313|80145443|FG001|Overall Study|Withdrawal by Subject|1|||
27532999|NCT03971071|80145444|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
27533000|NCT03971071|80145445|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
27533001|NCT03971071|80145446|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
27533002|NCT03971071|80145447|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
27533003|NCT03971071|80145448|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
27737136|NCT03832387|80868234|FG001|Overall Study|Protocol Violation|6|||
27737137|NCT03832387|80868233|FG000|Overall Study|EXCLUSION CRITERIA|3|||
27737138|NCT03832387|80868234|FG001|Overall Study|EXCLUSION CRITERIA|1|||
27737139|NCT00942409|80868235|FG000|Overall Study|Lack of Efficacy|1|||
27737140|NCT00942409|80868235|FG000|Overall Study|study drug unavailable|2|||
27737141|NCT00860470|80868236|FG000|Overall Study|Death|6|||
27737142|NCT00860470|80868237|FG001|Overall Study|Death|10|||
27737143|NCT00860470|80868236|FG000|Overall Study|Moved away|8|||
27737144|NCT00860470|80868237|FG001|Overall Study|Moved away|10|||
27737145|NCT00860470|80868236|FG000|Overall Study|Lost to Follow-up|34|||
27737146|NCT00860470|80868237|FG001|Overall Study|Lost to Follow-up|39|||
27737147|NCT01154101|80868240|FG000|Overall Study|Adverse Event|0|||
27533004|NCT03971071|80145444|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
27533005|NCT03971071|80145445|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
27533006|NCT03971071|80145446|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
27737148|NCT01154101|80868241|FG001|Overall Study|Adverse Event|2|||
27737149|NCT01154101|80868242|FG002|Overall Study|Adverse Event|1|||
27737150|NCT01154101|80868243|FG003|Overall Study|Adverse Event|1|||
27737151|NCT01154101|80868244|FG004|Overall Study|Adverse Event|0|||
27737152|NCT01154101|80868240|FG000|Overall Study|Lost to Follow-up|0|||
27737153|NCT01154101|80868241|FG001|Overall Study|Lost to Follow-up|1|||
27737154|NCT01154101|80868242|FG002|Overall Study|Lost to Follow-up|0|||
27913128|NCT02526160|81518301|FG000|Open-Label Treatment Extension Period I|Death|0|||
27913129|NCT02526160|81518302|FG001|Open-Label Treatment Extension Period I|Death|1|||
27913130|NCT02526160|81518301|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
27913131|NCT02526160|81518302|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
27913132|NCT02526160|81518301|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
27913133|NCT02526160|81518302|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
27913134|NCT02526160|81518301|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
27913135|NCT02526160|81518302|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
27913136|NCT02526160|81518301|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
27913137|NCT02526160|81518302|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
27913138|NCT02346877|81518303|FG000|Overall Study|Adverse Event|1|||
27913139|NCT02346877|81518304|FG001|Overall Study|Adverse Event|0|||
27913140|NCT02346877|81518303|FG000|Overall Study|Administrative Decision|1|||
27913141|NCT02346877|81518304|FG001|Overall Study|Administrative Decision|0|||
27913142|NCT02346877|81518303|FG000|Overall Study|Sponsor Decision|12|||
27913143|NCT02346877|81518304|FG001|Overall Study|Sponsor Decision|0|||
27913144|NCT02346877|81518303|FG000|Overall Study|Missing|5|||
27913145|NCT02346877|81518304|FG001|Overall Study|Missing|0|||
27913146|NCT01223404|81518305|FG000|First Intervention (1 Day)|Adverse Event|0|||
27913147|NCT01223404|81518306|FG001|First Intervention (1 Day)|Adverse Event|0|||
27913148|NCT01223404|81518307|FG002|First Intervention (1 Day)|Adverse Event|0|||
27913149|NCT01223404|81518308|FG003|First Intervention (1 Day)|Adverse Event|1|||
27913150|NCT01223404|81518309|FG004|First Intervention (1 Day)|Adverse Event|0|||
27913151|NCT01223404|81518310|FG005|First Intervention (1 Day)|Adverse Event|0|||
27913152|NCT01223404|81518305|FG000|Second Intervention (1 Day)|Adverse Event|1|||
27913153|NCT01223404|81518306|FG001|Second Intervention (1 Day)|Adverse Event|0|||
27913154|NCT01223404|81518307|FG002|Second Intervention (1 Day)|Adverse Event|0|||
27913155|NCT01223404|81518308|FG003|Second Intervention (1 Day)|Adverse Event|0|||
27913156|NCT01223404|81518309|FG004|Second Intervention (1 Day)|Adverse Event|0|||
27913157|NCT01223404|81518310|FG005|Second Intervention (1 Day)|Adverse Event|0|||
27913158|NCT01223404|81518305|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27913159|NCT01223404|81518306|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27913160|NCT01223404|81518307|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27913161|NCT01223404|81518308|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
27737155|NCT01154101|80868243|FG003|Overall Study|Lost to Follow-up|1|||
27737156|NCT01154101|80868244|FG004|Overall Study|Lost to Follow-up|0|||
27737157|NCT01154101|80868240|FG000|Overall Study|Withdrawal by Subject|0|||
27913162|NCT01223404|81518309|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27533007|NCT03971071|80145447|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27913163|NCT01223404|81518310|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
27913164|NCT04147247|81518315|FG000|Overall Study|Progressive disease|3|||
27737158|NCT01154101|80868241|FG001|Overall Study|Withdrawal by Subject|1|||
27737159|NCT01154101|80868242|FG002|Overall Study|Withdrawal by Subject|2|||
27737160|NCT01154101|80868243|FG003|Overall Study|Withdrawal by Subject|0|||
27737161|NCT01154101|80868244|FG004|Overall Study|Withdrawal by Subject|1|||
27737162|NCT02240706|80868245|FG000|Overall Study|Lack of Efficacy|2|||
27737163|NCT02240706|80868246|FG001|Overall Study|Lack of Efficacy|2|||
27737164|NCT02240706|80868247|FG002|Overall Study|Lack of Efficacy|2|||
27737165|NCT02240706|80868248|FG003|Overall Study|Lack of Efficacy|2|||
27737166|NCT02240706|80868249|FG004|Overall Study|Lack of Efficacy|5|||
27737167|NCT02240706|80868250|FG005|Overall Study|Lack of Efficacy|0|||
27737168|NCT02240706|80868251|FG006|Overall Study|Lack of Efficacy|0|||
27737169|NCT02240706|80868245|FG000|Overall Study|Adverse Event|1|||
27737170|NCT02240706|80868246|FG001|Overall Study|Adverse Event|0|||
27737171|NCT02240706|80868247|FG002|Overall Study|Adverse Event|1|||
27737172|NCT02240706|80868248|FG003|Overall Study|Adverse Event|0|||
27737173|NCT02240706|80868249|FG004|Overall Study|Adverse Event|2|||
27737174|NCT02240706|80868250|FG005|Overall Study|Adverse Event|0|||
27737175|NCT02240706|80868251|FG006|Overall Study|Adverse Event|0|||
27737176|NCT02240706|80868245|FG000|Overall Study|Progressive disease|0|||
27737177|NCT02240706|80868246|FG001|Overall Study|Progressive disease|0|||
27737178|NCT02240706|80868247|FG002|Overall Study|Progressive disease|0|||
27737179|NCT02240706|80868248|FG003|Overall Study|Progressive disease|0|||
27737180|NCT02240706|80868249|FG004|Overall Study|Progressive disease|1|||
27737181|NCT02240706|80868250|FG005|Overall Study|Progressive disease|0|||
27737182|NCT02240706|80868251|FG006|Overall Study|Progressive disease|0|||
27737183|NCT02240706|80868245|FG000|Overall Study|Dose limiting toxicity|0|||
27737184|NCT02240706|80868246|FG001|Overall Study|Dose limiting toxicity|0|||
27737185|NCT02240706|80868247|FG002|Overall Study|Dose limiting toxicity|0|||
27737186|NCT02240706|80868248|FG003|Overall Study|Dose limiting toxicity|0|||
27737187|NCT02240706|80868249|FG004|Overall Study|Dose limiting toxicity|1|||
27737188|NCT02240706|80868250|FG005|Overall Study|Dose limiting toxicity|0|||
27737189|NCT02240706|80868251|FG006|Overall Study|Dose limiting toxicity|0|||
27737190|NCT02240706|80868245|FG000|Overall Study|Refused to continue taking medication|0|||
27737191|NCT02240706|80868246|FG001|Overall Study|Refused to continue taking medication|1|||
27737192|NCT02240706|80868247|FG002|Overall Study|Refused to continue taking medication|3|||
27737193|NCT02240706|80868248|FG003|Overall Study|Refused to continue taking medication|1|||
27737194|NCT02240706|80868249|FG004|Overall Study|Refused to continue taking medication|2|||
27737195|NCT02240706|80868250|FG005|Overall Study|Refused to continue taking medication|0|||
27737196|NCT02240706|80868251|FG006|Overall Study|Refused to continue taking medication|0|||
27737197|NCT02240706|80868245|FG000|Overall Study|Insurance billing concerns|0|||
27737198|NCT02240706|80868246|FG001|Overall Study|Insurance billing concerns|0|||
27737199|NCT02240706|80868247|FG002|Overall Study|Insurance billing concerns|0|||
27737200|NCT02240706|80868248|FG003|Overall Study|Insurance billing concerns|1|||
27737201|NCT02240706|80868249|FG004|Overall Study|Insurance billing concerns|0|||
27737202|NCT02240706|80868250|FG005|Overall Study|Insurance billing concerns|0|||
27737203|NCT02240706|80868251|FG006|Overall Study|Insurance billing concerns|0|||
27737204|NCT01357239|80868254|FG000|Stratum: All Patients|Adverse Event|0|||
27737205|NCT01357239|80868255|FG001|Stratum: All Patients|Adverse Event|0|||
27737206|NCT01357239|80868256|FG002|Stratum: All Patients|Adverse Event|1|||
27737207|NCT01357239|80868257|FG003|Stratum: All Patients|Adverse Event|1|||
27737208|NCT01357239|80868254|FG000|Stratum: All Patients|Subject withdrew consent|0|||
27737209|NCT01357239|80868255|FG001|Stratum: All Patients|Subject withdrew consent|0|||
27737210|NCT01357239|80868256|FG002|Stratum: All Patients|Subject withdrew consent|1|||
27737211|NCT01357239|80868257|FG003|Stratum: All Patients|Subject withdrew consent|1|||
27737212|NCT01357239|80868254|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
27737213|NCT01357239|80868255|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
27737214|NCT01357239|80868256|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
27737215|NCT01357239|80868257|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
27737216|NCT01357239|80868254|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
27737217|NCT01357239|80868255|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
27737218|NCT01357239|80868256|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
27737219|NCT01357239|80868257|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
27737220|NCT01357239|80868254|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
27737221|NCT01357239|80868255|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
27737222|NCT01357239|80868256|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
27737223|NCT01357239|80868257|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
27737224|NCT04112914|80868258|FG000|Overall Study|Lost to Follow-up|13|||
27737225|NCT04112914|80868259|FG001|Overall Study|Lost to Follow-up|9|||
27628960|NCT02680756|80480472|FG000|Overall Study|None of above or not recorded|3|||
27737226|NCT04112914|80868258|FG000|Overall Study|Withdrawal by Subject|1|||
27737227|NCT04112914|80868259|FG001|Overall Study|Withdrawal by Subject|0|||
27737228|NCT03846947|80868260|FG000|Overall Study|technical issues with imaging sequence|2|||
27737229|NCT00847613|80868270|FG000|Overall Study|Ongoing at cut-off date|250|||
27628961|NCT02680756|80480473|FG001|Overall Study|None of above or not recorded|2|||
27628962|NCT03518112|80480474|FG000|Overall Study|Withdrawal by Subject|1|||
27737230|NCT00847613|80868271|FG001|Overall Study|Ongoing at cut-off date|265|||
27737231|NCT00847613|80868272|FG002|Overall Study|Ongoing at cut-off date|64|||
27737232|NCT00847613|80868273|FG003|Overall Study|Ongoing at cut-off date|64|||
27737233|NCT00847613|80868270|FG000|Overall Study|Death|1|||
27737234|NCT00847613|80868271|FG001|Overall Study|Death|1|||
27737235|NCT00847613|80868272|FG002|Overall Study|Death|0|||
27737236|NCT00847613|80868273|FG003|Overall Study|Death|0|||
27737237|NCT00847613|80868270|FG000|Overall Study|Adverse Event|36|||
27737238|NCT00847613|80868271|FG001|Overall Study|Adverse Event|26|||
27737239|NCT00847613|80868272|FG002|Overall Study|Adverse Event|5|||
27737240|NCT00847613|80868273|FG003|Overall Study|Adverse Event|6|||
27737241|NCT00847613|80868270|FG000|Overall Study|Lack of Efficacy|7|||
27737242|NCT00847613|80868271|FG001|Overall Study|Lack of Efficacy|3|||
27737243|NCT00847613|80868272|FG002|Overall Study|Lack of Efficacy|3|||
27737244|NCT00847613|80868273|FG003|Overall Study|Lack of Efficacy|1|||
27737245|NCT00847613|80868270|FG000|Overall Study|Study terminated by Sponsor|1|||
27737246|NCT00847613|80868271|FG001|Overall Study|Study terminated by Sponsor|0|||
27737247|NCT00847613|80868272|FG002|Overall Study|Study terminated by Sponsor|2|||
27737248|NCT00847613|80868273|FG003|Overall Study|Study terminated by Sponsor|1|||
27737249|NCT00847613|80868270|FG000|Overall Study|Lost to Follow-up|5|||
27737250|NCT00847613|80868271|FG001|Overall Study|Lost to Follow-up|0|||
27737251|NCT00847613|80868272|FG002|Overall Study|Lost to Follow-up|0|||
27737252|NCT00847613|80868273|FG003|Overall Study|Lost to Follow-up|3|||
27737253|NCT00847613|80868270|FG000|Overall Study|Protocol Violation|6|||
27737254|NCT00847613|80868271|FG001|Overall Study|Protocol Violation|6|||
27737255|NCT00847613|80868272|FG002|Overall Study|Protocol Violation|3|||
27737256|NCT00847613|80868273|FG003|Overall Study|Protocol Violation|1|||
27737257|NCT00847613|80868270|FG000|Overall Study|Pregnancy|1|||
27737258|NCT00847613|80868271|FG001|Overall Study|Pregnancy|1|||
27737259|NCT00847613|80868272|FG002|Overall Study|Pregnancy|0|||
27737260|NCT00847613|80868273|FG003|Overall Study|Pregnancy|0|||
27737261|NCT00847613|80868270|FG000|Overall Study|Site closure|1|||
27737262|NCT00847613|80868271|FG001|Overall Study|Site closure|0|||
27737263|NCT00847613|80868272|FG002|Overall Study|Site closure|0|||
27737264|NCT00847613|80868273|FG003|Overall Study|Site closure|1|||
27737265|NCT00847613|80868270|FG000|Overall Study|Withdrawal by Subject|8|||
27737266|NCT00847613|80868271|FG001|Overall Study|Withdrawal by Subject|11|||
27737267|NCT00847613|80868272|FG002|Overall Study|Withdrawal by Subject|2|||
27737268|NCT00847613|80868273|FG003|Overall Study|Withdrawal by Subject|2|||
27737269|NCT00847613|80868270|FG000|Overall Study|Participant moved|4|||
27737270|NCT00847613|80868271|FG001|Overall Study|Participant moved|1|||
27737271|NCT00847613|80868272|FG002|Overall Study|Participant moved|0|||
27737272|NCT00847613|80868273|FG003|Overall Study|Participant moved|0|||
27737273|NCT00847613|80868270|FG000|Overall Study|Sponsor request|0|||
27737274|NCT00847613|80868271|FG001|Overall Study|Sponsor request|1|||
27737275|NCT00847613|80868272|FG002|Overall Study|Sponsor request|0|||
27737276|NCT00847613|80868273|FG003|Overall Study|Sponsor request|0|||
27737277|NCT00847613|80868270|FG000|Overall Study|Randomized, but not treated|0|||
27737278|NCT00847613|80868271|FG001|Overall Study|Randomized, but not treated|3|||
27737279|NCT00847613|80868272|FG002|Overall Study|Randomized, but not treated|0|||
27737280|NCT00847613|80868273|FG003|Overall Study|Randomized, but not treated|0|||
27737281|NCT00847613|80868270|FG000|Overall Study|Other|1|||
27737282|NCT00847613|80868271|FG001|Overall Study|Other|1|||
27737283|NCT00847613|80868272|FG002|Overall Study|Other|2|||
27737284|NCT00847613|80868273|FG003|Overall Study|Other|0|||
27737285|NCT01076179|80868275|FG000|Overall Study|Withdrawal by Subject|1|||
27737286|NCT00815308|80868276|FG000|Overall Study|Adverse Event|4|||
27737287|NCT00815308|80868276|FG000|Overall Study|Withdrawal by Subject|0|||
27737288|NCT00815308|80868276|FG000|Overall Study|Protocol Violation|6|||
27737289|NCT01682044|80868277|FG000|Overall Study|Death|1|||
27737290|NCT01682044|80868277|FG000|Overall Study|Progression|3|||
27737291|NCT01503021|80868278|FG000|Overall Study|Adverse Event|7|||
27737292|NCT01503021|80868279|FG001|Overall Study|Adverse Event|6|||
27737293|NCT01503021|80868278|FG000|Overall Study|Death|0|||
27533008|NCT03971071|80145448|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
27533009|NCT03971071|80145444|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
27533010|NCT03971071|80145445|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
27737294|NCT01503021|80868279|FG001|Overall Study|Death|2|||
27737295|NCT01503021|80868278|FG000|Overall Study|Lost to Follow-up|2|||
27737296|NCT01503021|80868279|FG001|Overall Study|Lost to Follow-up|0|||
27737297|NCT01503021|80868278|FG000|Overall Study|Physician Decision|3|||
27737298|NCT01503021|80868279|FG001|Overall Study|Physician Decision|0|||
27737299|NCT01503021|80868278|FG000|Overall Study|Protocol Violation|1|||
27737300|NCT01503021|80868279|FG001|Overall Study|Protocol Violation|3|||
27533011|NCT03971071|80145446|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
27533012|NCT03971071|80145447|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
27737301|NCT01503021|80868278|FG000|Overall Study|Withdrawal by Subject|9|||
27737302|NCT01503021|80868279|FG001|Overall Study|Withdrawal by Subject|8|||
27737303|NCT01503021|80868278|FG000|Overall Study|Moved, received transplant, etc.|5|||
27737304|NCT01503021|80868279|FG001|Overall Study|Moved, received transplant, etc.|7|||
27737305|NCT03748641|80868282|FG000|Overall Study|Ongoing|155|||
27737306|NCT03748641|80868283|FG001|Overall Study|Ongoing|148|||
27737307|NCT03748641|80868284|FG002|Overall Study|Ongoing|66|||
27628963|NCT03006341|80480479|FG000|Overall Study|Not linked in the EMR|25069|||
27628964|NCT03006341|80480480|FG001|Overall Study|Not linked in the EMR|67505|||
27628965|NCT03006341|80480481|FG002|Overall Study|Not linked in the EMR|30993|||
27628966|NCT03006341|80480482|FG003|Overall Study|Not linked in the EMR|10685|||
27628967|NCT02107014|80480483|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
27628968|NCT00591838|80480485|FG000|Overall Study|Withdrawal by Subject|0|||
27628969|NCT00591838|80480486|FG001|Overall Study|Withdrawal by Subject|0|||
27628970|NCT00591838|80480487|FG002|Overall Study|Withdrawal by Subject|0|||
27628971|NCT00591838|80480488|FG003|Overall Study|Withdrawal by Subject|1|||
27628972|NCT00591838|80480489|FG004|Overall Study|Withdrawal by Subject|0|||
27737308|NCT03748641|80868285|FG003|Overall Study|Ongoing|79|||
27737309|NCT03748641|80868286|FG004|Overall Study|Ongoing|84|||
27737310|NCT03748641|80868282|FG000|Overall Study|Death|54|||
27737311|NCT03748641|80868283|FG001|Overall Study|Death|59|||
27533013|NCT03971071|80145448|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
27533014|NCT03971071|80145444|FG000|Open-label Treatment Period|Sponsor decision|0|||
27533015|NCT03971071|80145445|FG001|Open-label Treatment Period|Sponsor decision|0|||
27533016|NCT03971071|80145446|FG002|Open-label Treatment Period|Sponsor decision|0|||
27533017|NCT03971071|80145447|FG003|Open-label Treatment Period|Sponsor decision|0|||
27533018|NCT03971071|80145448|FG004|Open-label Treatment Period|Sponsor decision|1|||
27533019|NCT03971071|80145444|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
27533020|NCT03971071|80145445|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27533021|NCT03971071|80145446|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
27533022|NCT03971071|80145447|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
27533023|NCT03971071|80145448|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
27533024|NCT03971071|80145444|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27533025|NCT03971071|80145445|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
27533026|NCT03971071|80145446|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
27533027|NCT03971071|80145447|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
27533028|NCT03971071|80145448|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
27533029|NCT01147172|80145451|FG000|Overall Study|Withdrawal by Subject|2|||
27533030|NCT01147172|80145451|FG000|Overall Study|Lost to Follow-up|2|||
27533031|NCT02963935|80145452|FG000|Overall Study|Adverse Event|12|||
27533032|NCT02963935|80145453|FG001|Overall Study|Adverse Event|6|||
27533033|NCT02963935|80145452|FG000|Overall Study|Protocol Violation|2|||
27533034|NCT02963935|80145453|FG001|Overall Study|Protocol Violation|1|||
27533035|NCT02963935|80145452|FG000|Overall Study|Lack of Efficacy|0|||
27533036|NCT02963935|80145453|FG001|Overall Study|Lack of Efficacy|2|||
27533037|NCT02963935|80145452|FG000|Overall Study|Lost to Follow-up|1|||
27533038|NCT02963935|80145453|FG001|Overall Study|Lost to Follow-up|6|||
27533039|NCT02963935|80145452|FG000|Overall Study|Unclassified|13|||
27533040|NCT02963935|80145453|FG001|Overall Study|Unclassified|22|||
27533041|NCT01439568|80145455|FG000|Overall Study|Lost to Follow-up|1|||
27533042|NCT01439568|80145456|FG001|Overall Study|Lost to Follow-up|0|||
27533043|NCT01439568|80145455|FG000|Overall Study|Withdrawal by Subject|2|||
27533044|NCT01439568|80145456|FG001|Overall Study|Withdrawal by Subject|2|||
27533045|NCT03575897|80145459|FG000|Overall Study|Lost to Follow-up|12|||
27533046|NCT03575897|80145460|FG001|Overall Study|Lost to Follow-up|13|||
27533047|NCT04072575|80145467|FG000|Overall Study|Physician Decision|1|||
27533048|NCT04072575|80145467|FG000|Overall Study|Adverse Event|7|||
27533049|NCT04072575|80145467|FG000|Overall Study|Withdrawal by Subject|14|||
27533050|NCT04072575|80145467|FG000|Overall Study|Other|2|||
27533051|NCT02047227|80145468|FG000|Overall Study|Adverse Event|2|||
27533052|NCT02047227|80145469|FG001|Overall Study|Adverse Event|4|||
27533053|NCT02047227|80145468|FG000|Overall Study|Lost to Follow-up|0|||
27533054|NCT02047227|80145469|FG001|Overall Study|Lost to Follow-up|3|||
27533055|NCT02047227|80145468|FG000|Overall Study|Protocol Violation|1|||
27533056|NCT02047227|80145469|FG001|Overall Study|Protocol Violation|0|||
27533057|NCT02047227|80145468|FG000|Overall Study|Spontaneous pregnancy|1|||
27533058|NCT02047227|80145469|FG001|Overall Study|Spontaneous pregnancy|0|||
27533059|NCT02047227|80145468|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
27533060|NCT02047227|80145469|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
27533061|NCT02047227|80145468|FG000|Overall Study|No oocytes retrieved|21|||
27533062|NCT02047227|80145469|FG001|Overall Study|No oocytes retrieved|20|||
27533063|NCT02047227|80145468|FG000|Overall Study|No fertilization|61|||
27533064|NCT02047227|80145469|FG001|Overall Study|No fertilization|51|||
27533065|NCT02047227|80145468|FG000|Overall Study|Intention to freeze all embryos|1|||
27533066|NCT02047227|80145469|FG001|Overall Study|Intention to freeze all embryos|0|||
27533067|NCT02047227|80145468|FG000|Overall Study|All embryos discarded|12|||
27737312|NCT03748641|80868284|FG002|Overall Study|Death|51|||
27737313|NCT03748641|80868285|FG003|Overall Study|Death|42|||
27737314|NCT03748641|80868286|FG004|Overall Study|Death|9|||
27533068|NCT02047227|80145469|FG001|Overall Study|All embryos discarded|11|||
27533069|NCT02047227|80145468|FG000|Overall Study|Other|10|||
27533070|NCT02047227|80145469|FG001|Overall Study|Other|9|||
27533071|NCT03698331|80148029|FG000|Overall Study|Adverse Event|2|||
27737315|NCT03748641|80868282|FG000|Overall Study|Lost to Follow-up|0|||
27913165|NCT04147247|81518316|FG001|Overall Study|Progressive disease|3|||
27913166|NCT04147247|81518317|FG002|Overall Study|Progressive disease|4|||
27913167|NCT04147247|81518318|FG003|Overall Study|Progressive disease|4|||
27913168|NCT04147247|81518319|FG004|Overall Study|Progressive disease|3|||
27913169|NCT04147247|81518315|FG000|Overall Study|Physician Decision|0|||
27913170|NCT04147247|81518316|FG001|Overall Study|Physician Decision|1|||
27913171|NCT04147247|81518317|FG002|Overall Study|Physician Decision|0|||
27913172|NCT04147247|81518318|FG003|Overall Study|Physician Decision|0|||
27913173|NCT04147247|81518319|FG004|Overall Study|Physician Decision|0|||
27913174|NCT04147247|81518315|FG000|Overall Study|Clinical Disease Progression|0|||
27913175|NCT04147247|81518316|FG001|Overall Study|Clinical Disease Progression|0|||
27913176|NCT04147247|81518317|FG002|Overall Study|Clinical Disease Progression|0|||
27913177|NCT04147247|81518318|FG003|Overall Study|Clinical Disease Progression|0|||
27913178|NCT04147247|81518319|FG004|Overall Study|Clinical Disease Progression|1|||
27913179|NCT04147247|81518315|FG000|Overall Study|Adverse Event|0|||
27913180|NCT04147247|81518316|FG001|Overall Study|Adverse Event|0|||
27913181|NCT04147247|81518317|FG002|Overall Study|Adverse Event|1|||
27913182|NCT04147247|81518318|FG003|Overall Study|Adverse Event|0|||
27913183|NCT04147247|81518319|FG004|Overall Study|Adverse Event|1|||
27913184|NCT01607593|81518324|FG000|Overall Study|Adverse Event|15|||
27913185|NCT01607593|81518324|FG000|Overall Study|Lack of Efficacy|16|||
27913186|NCT01607593|81518324|FG000|Overall Study|Lost to Follow-up|25|||
27913187|NCT01607593|81518324|FG000|Overall Study|Continuation|33|||
27913188|NCT01607593|81518324|FG000|Overall Study|Other|4|||
27913189|NCT02492165|81518325|FG000|Overall Study|Withdrawal by Subject|0|||
27913190|NCT02492165|81518326|FG001|Overall Study|Withdrawal by Subject|1|||
27913191|NCT02492165|81518327|FG002|Overall Study|Withdrawal by Subject|0|||
27913192|NCT02492165|81518328|FG003|Overall Study|Withdrawal by Subject|0|||
27913193|NCT02221648|81518329|FG000|Overall Study|Withdrawal by Subject|3|||
27913194|NCT02221648|81518330|FG001|Overall Study|Withdrawal by Subject|3|||
27913195|NCT00181883|81518331|FG000|Overall Study|Lack of Efficacy|2|||
27913196|NCT00181883|81518331|FG000|Overall Study|Treatment Limiting AEs|3|||
27913197|NCT00181883|81518331|FG000|Overall Study|Withdrawal by Subject|4|||
27913198|NCT00181883|81518331|FG000|Overall Study|Lost to Follow-up|1|||
27913199|NCT02896569|81518332|FG000|Overall Study|Lost to Follow-up|2|||
27913200|NCT02896569|81518333|FG001|Overall Study|Lost to Follow-up|1|||
27913201|NCT02896569|81518332|FG000|Overall Study|Physician Decision|1|||
27913202|NCT02896569|81518333|FG001|Overall Study|Physician Decision|3|||
27913203|NCT02896569|81518332|FG000|Overall Study|Adverse Event|0|||
27913204|NCT02896569|81518333|FG001|Overall Study|Adverse Event|1|||
27913205|NCT02896569|81518332|FG000|Overall Study|Withdrawal by Subject|1|||
27533072|NCT03698331|80148030|FG001|Overall Study|Adverse Event|3|||
27533073|NCT03698331|80148029|FG000|Overall Study|Withdrawal by Subject|1|||
27533074|NCT03698331|80148030|FG001|Overall Study|Withdrawal by Subject|1|||
27533075|NCT03698331|80148029|FG000|Overall Study|Lost to Follow-up|0|||
27533076|NCT03698331|80148030|FG001|Overall Study|Lost to Follow-up|2|||
27533077|NCT03698331|80148029|FG000|Overall Study|Non-compliance with study drug|1|||
27533078|NCT03698331|80148030|FG001|Overall Study|Non-compliance with study drug|0|||
27533079|NCT01609231|80148031|FG000|Overall Study|Adverse Event|1|||
27533080|NCT01609231|80148032|FG001|Overall Study|Adverse Event|3|||
27533081|NCT01609231|80148031|FG000|Overall Study|Physician Decision|1|||
27533082|NCT01609231|80148032|FG001|Overall Study|Physician Decision|0|||
27533083|NCT01609231|80148031|FG000|Overall Study|Withdrawal by Subject|1|||
27533084|NCT01609231|80148032|FG001|Overall Study|Withdrawal by Subject|0|||
27533085|NCT03589469|80148033|FG000|Overall Study|Withdrawal by Subject|8|||
27737316|NCT03748641|80868283|FG001|Overall Study|Lost to Follow-up|2|||
27737317|NCT03748641|80868284|FG002|Overall Study|Lost to Follow-up|1|||
27737318|NCT03748641|80868285|FG003|Overall Study|Lost to Follow-up|0|||
27737319|NCT03748641|80868286|FG004|Overall Study|Lost to Follow-up|0|||
27737320|NCT03748641|80868282|FG000|Overall Study|Withdrawal by Subject|3|||
27737321|NCT03748641|80868283|FG001|Overall Study|Withdrawal by Subject|2|||
27737322|NCT03748641|80868284|FG002|Overall Study|Withdrawal by Subject|5|||
27737323|NCT03748641|80868285|FG003|Overall Study|Withdrawal by Subject|3|||
27913206|NCT02896569|81518333|FG001|Overall Study|Withdrawal by Subject|0|||
27913207|NCT01945944|81518337|FG000|Overall Study|Adverse Event|0|||
27913208|NCT01945944|81518338|FG001|Overall Study|Adverse Event|2|||
27913209|NCT01945944|81518337|FG000|Overall Study|Physician Decision|1|||
27913210|NCT01945944|81518338|FG001|Overall Study|Physician Decision|0|||
27913211|NCT01945944|81518337|FG000|Overall Study|Withdrawal by Subject|0|||
27913212|NCT01945944|81518338|FG001|Overall Study|Withdrawal by Subject|1|||
27913213|NCT04552132|81518339|FG000|Overall Study|Lost to Follow-up|4|||
27533086|NCT03589469|80148033|FG000|Overall Study|Physician Decision|20|||
27533087|NCT03589469|80148033|FG000|Overall Study|Death|97|||
27913214|NCT04552132|81518340|FG001|Overall Study|Lost to Follow-up|3|||
27913215|NCT04552132|81518339|FG000|Overall Study|Protocol Violation|1|||
27913216|NCT04552132|81518340|FG001|Overall Study|Protocol Violation|0|||
27913217|NCT02417753|81521953|FG000|Overall Study|Death|1|||
27913218|NCT01298700|81521958|FG000|Overall Study|Adverse Event|50|||
27913219|NCT01298700|81521959|FG001|Overall Study|Adverse Event|51|||
27533088|NCT03589469|80148033|FG000|Overall Study|Lost to Follow-up|8|||
27533089|NCT03589469|80148033|FG000|Overall Study|Miscellaneous|1|||
27533090|NCT05314478|80148034|FG000|Overall Study|Physician Decision|1|||
27533091|NCT04963231|80148035|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
27737324|NCT03748641|80868286|FG004|Overall Study|Withdrawal by Subject|2|||
27737325|NCT03368859|80868287|FG000|Overall Study|Withdrew Consent|5|||
27737326|NCT03368859|80868288|FG001|Overall Study|Withdrew Consent|4|||
27533092|NCT04963231|80148036|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
27533093|NCT04963231|80148037|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
27533094|NCT04963231|80148035|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
27533095|NCT04963231|80148036|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
27533096|NCT04963231|80148037|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
27533097|NCT04963231|80148035|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
27533098|NCT04963231|80148036|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
27533099|NCT04963231|80148037|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
27533100|NCT04963231|80148035|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
27533101|NCT04963231|80148036|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
27533102|NCT04963231|80148037|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
27533103|NCT04963231|80148035|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
27533104|NCT04963231|80148036|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
27533105|NCT04963231|80148037|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
27533106|NCT04963231|80148035|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
27533107|NCT04963231|80148036|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
27533108|NCT04963231|80148037|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
27533109|NCT04963231|80148035|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
27533110|NCT04963231|80148036|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
27533111|NCT04963231|80148037|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
27533112|NCT02130024|80148042|FG000|Overall Study|Adverse Event|10|||
27533113|NCT02130024|80148043|FG001|Overall Study|Adverse Event|11|||
27533114|NCT02130024|80148042|FG000|Overall Study|Death|2|||
27533115|NCT02130024|80148043|FG001|Overall Study|Death|2|||
27533116|NCT02130024|80148042|FG000|Overall Study|Lost to Follow-up|1|||
27533117|NCT02130024|80148043|FG001|Overall Study|Lost to Follow-up|1|||
27533118|NCT02130024|80148042|FG000|Overall Study|Physician Decision|1|||
27533119|NCT02130024|80148043|FG001|Overall Study|Physician Decision|3|||
27533120|NCT02130024|80148042|FG000|Overall Study|Protocol Deviation|4|||
27533121|NCT02130024|80148043|FG001|Overall Study|Protocol Deviation|0|||
27533122|NCT02130024|80148042|FG000|Overall Study|Site Administration Problems|1|||
27533123|NCT02130024|80148043|FG001|Overall Study|Site Administration Problems|0|||
27533124|NCT02130024|80148042|FG000|Overall Study|Subject Withdrew Consent|6|||
27533125|NCT02130024|80148043|FG001|Overall Study|Subject Withdrew Consent|14|||
27533126|NCT05490771|80148046|FG000|Overall Study|Disease progression|18|||
27533127|NCT05490771|80148046|FG000|Overall Study|Adverse Event|3|||
27533128|NCT05490771|80148046|FG000|Overall Study|Other complicating disease|1|||
27533129|NCT05490771|80148046|FG000|Overall Study|Withdrawal by Subject|3|||
27533130|NCT05490771|80148046|FG000|Overall Study|Physician Decision|1|||
27533131|NCT05490771|80148046|FG000|Overall Study|Still on treatment|2|||
27533132|NCT05490771|80148046|FG000|Overall Study|Never start protocol therapy|5|||
27533133|NCT05490771|80148046|FG000|Overall Study|Ineligible|2|||
27533134|NCT01281137|80148048|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
27533135|NCT01281137|80148049|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
27533136|NCT01281137|80148048|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
27533137|NCT01281137|80148049|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
27737327|NCT03368859|80868287|FG000|Overall Study|Death|12|||
27737328|NCT03368859|80868288|FG001|Overall Study|Death|6|||
27913220|NCT01298700|81521958|FG000|Overall Study|Lack of Efficacy|9|||
27913221|NCT01298700|81521959|FG001|Overall Study|Lack of Efficacy|14|||
27913222|NCT01298700|81521958|FG000|Overall Study|Lost to Follow-up|5|||
27913223|NCT01298700|81521959|FG001|Overall Study|Lost to Follow-up|2|||
27913224|NCT01298700|81521958|FG000|Overall Study|Withdrawal by Subject|12|||
27913225|NCT01298700|81521959|FG001|Overall Study|Withdrawal by Subject|9|||
27913226|NCT01298700|81521958|FG000|Overall Study|Protocol Violation|6|||
27533138|NCT01281137|80148048|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
27533139|NCT01281137|80148049|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
27533140|NCT01281137|80148048|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
27737329|NCT03368859|80868287|FG000|Overall Study|Study terminated by Sponsor|18|||
27737330|NCT03368859|80868288|FG001|Overall Study|Study terminated by Sponsor|23|||
27737331|NCT03368859|80868287|FG000|Overall Study|Other|1|||
27737332|NCT03368859|80868288|FG001|Overall Study|Other|1|||
27913227|NCT01298700|81521959|FG001|Overall Study|Protocol Violation|4|||
27913228|NCT01298700|81521958|FG000|Overall Study|Other Miscellaneous Reasons|16|||
27913229|NCT01298700|81521959|FG001|Overall Study|Other Miscellaneous Reasons|15|||
27913230|NCT01298700|81521958|FG000|Overall Study|Did not Receive Study Drug|3|||
27913231|NCT01298700|81521959|FG001|Overall Study|Did not Receive Study Drug|5|||
27913232|NCT01697800|81521960|FG000|Overall Study|Death|0|||
27533141|NCT01281137|80148049|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
27533142|NCT01281137|80148048|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
27737333|NCT02638012|80868291|FG000|Overall Study|Lost to Follow-up|1|||
27737334|NCT00754390|80868295|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
27737335|NCT00754390|80868295|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
27737336|NCT00754390|80868295|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
27737337|NCT00754390|80868295|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
27737338|NCT00820040|80868296|FG000|Overall Study|Death|1|||
27737339|NCT00820040|80868296|FG000|Overall Study|Sponsor terminated study|1|||
27737340|NCT00820040|80868296|FG000|Overall Study|Screen failure|1|||
27533143|NCT01281137|80148049|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
27533144|NCT02435147|80148050|FG000|Overall Study|non-evaluable DXA scan|11|||
27533145|NCT02423772|80148055|FG000|Overall Study|Lost to Follow-up|3|||
27533146|NCT02423772|80148056|FG001|Overall Study|Lost to Follow-up|3|||
27533147|NCT02423772|80148055|FG000|Overall Study|Did not begin intervention|2|||
27533148|NCT02423772|80148056|FG001|Overall Study|Did not begin intervention|5|||
27533149|NCT01927627|80148059|FG000|Overall Study|Adverse Event|3|||
27628973|NCT01193153|80483570|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
27628974|NCT01193153|80483571|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
27628975|NCT01193153|80483570|FG000|Open-label Lead in Period|Pregnancy|1|||
27628976|NCT01193153|80483571|FG001|Open-label Lead in Period|Pregnancy|0|||
27628977|NCT01193153|80483570|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
27628978|NCT01193153|80483571|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
27628979|NCT01193153|80483570|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
27628980|NCT01193153|80483571|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
27628981|NCT01193153|80483570|FG000|Open-label Lead in Period|Other|14|||
27628982|NCT01193153|80483571|FG001|Open-label Lead in Period|Other|0|||
27628983|NCT01193153|80483570|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
27628984|NCT01193153|80483571|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
27628985|NCT01193153|80483570|FG000|Open-label Lead in Period|Adverse Event|41|||
27628986|NCT01193153|80483571|FG001|Open-label Lead in Period|Adverse Event|0|||
27628987|NCT01193153|80483570|FG000|Open-label Lead in Period|Death|1|||
27628988|NCT01193153|80483571|FG001|Open-label Lead in Period|Death|0|||
27628989|NCT01193153|80483570|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
27628990|NCT01193153|80483571|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
27628991|NCT01193153|80483570|FG000|Open-label Stabilization Period|Adverse Event|9|||
27628992|NCT01193153|80483571|FG001|Open-label Stabilization Period|Adverse Event|0|||
27628993|NCT01193153|80483570|FG000|Open-label Stabilization Period|Death|2|||
27628994|NCT01193153|80483571|FG001|Open-label Stabilization Period|Death|0|||
27628995|NCT01193153|80483570|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
27628996|NCT01193153|80483571|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
27628997|NCT01193153|80483570|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
27628998|NCT01193153|80483571|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
27628999|NCT01193153|80483570|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
27629000|NCT01193153|80483571|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
27629001|NCT01193153|80483570|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
27629002|NCT01193153|80483571|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
27629003|NCT01193153|80483570|FG000|Open-label Stabilization Period|Other|8|||
27629004|NCT01193153|80483571|FG001|Open-label Stabilization Period|Other|0|||
27629005|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Other|2|||
27629006|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Other|3|||
27629007|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
27629008|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
27629009|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Death|2|||
27629010|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Death|0|||
27737341|NCT02371629|80868298|FG000|Overall Study|Patient decision|14|||
27913233|NCT01697800|81521961|FG001|Overall Study|Death|1|||
27913234|NCT02219685|81521965|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
27533150|NCT01927627|80148059|FG000|Overall Study|Lack of Efficacy|1|||
27629011|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
27629012|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
27629013|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
27737342|NCT02371629|80868299|FG001|Overall Study|Patient decision|10|||
27737343|NCT02371629|80868298|FG000|Overall Study|Adverse Event|8|||
27629014|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
27629015|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
27629016|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
27629017|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
27629018|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
27629019|NCT01193153|80483570|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
27629020|NCT01193153|80483571|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
27629021|NCT01585038|80483576|FG000|Overall Study|Adverse Event|2|||
27629022|NCT01585038|80483577|FG001|Overall Study|Adverse Event|2|||
27629023|NCT03107611|80483578|FG000|Overall Study|Adverse Event|1|||
27629024|NCT03107611|80483579|FG001|Overall Study|Adverse Event|0|||
27629025|NCT03107611|80483580|FG002|Overall Study|Adverse Event|2|||
27629026|NCT03107611|80483578|FG000|Overall Study|Lost to Follow-up|3|||
27629027|NCT03107611|80483579|FG001|Overall Study|Lost to Follow-up|3|||
27629028|NCT03107611|80483580|FG002|Overall Study|Lost to Follow-up|3|||
27629029|NCT03107611|80483578|FG000|Overall Study|Protocol Violation|0|||
27629030|NCT03107611|80483579|FG001|Overall Study|Protocol Violation|0|||
27629031|NCT03107611|80483580|FG002|Overall Study|Protocol Violation|1|||
27629032|NCT03107611|80483578|FG000|Overall Study|Withdrawal by Subject|1|||
27629033|NCT03107611|80483579|FG001|Overall Study|Withdrawal by Subject|0|||
27629034|NCT03107611|80483580|FG002|Overall Study|Withdrawal by Subject|1|||
27629035|NCT03107611|80483578|FG000|Overall Study|Worsening signs/symptoms|2|||
27629036|NCT03107611|80483579|FG001|Overall Study|Worsening signs/symptoms|1|||
27629037|NCT03107611|80483580|FG002|Overall Study|Worsening signs/symptoms|2|||
27737344|NCT02371629|80868299|FG001|Overall Study|Adverse Event|8|||
27737345|NCT02371629|80868298|FG000|Overall Study|Physician Decision|2|||
27737346|NCT02371629|80868299|FG001|Overall Study|Physician Decision|3|||
27737347|NCT02371629|80868298|FG000|Overall Study|Death|1|||
27737348|NCT02371629|80868299|FG001|Overall Study|Death|1|||
27737349|NCT02371629|80868298|FG000|Overall Study|Noncompliance with study treatment|1|||
27737350|NCT02371629|80868299|FG001|Overall Study|Noncompliance with study treatment|0|||
27629038|NCT01726023|80483581|FG000|Overall Study|Death|1|||
27629039|NCT01726023|80483582|FG001|Overall Study|Death|1|||
27629040|NCT01726023|80483581|FG000|Overall Study|Lost to Follow-up|5|||
27629041|NCT01726023|80483582|FG001|Overall Study|Lost to Follow-up|10|||
27629042|NCT01726023|80483581|FG000|Overall Study|Other Eligibility criteria|7|||
27913235|NCT02219685|81521966|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
27913236|NCT02219685|81521965|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
27913237|NCT02219685|81521966|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
27913238|NCT00115778|81521967|FG000|Overall Study|Withdrawal by Subject|0|||
27913239|NCT00115778|81521968|FG001|Overall Study|Withdrawal by Subject|1|||
27913240|NCT02922153|81521969|FG000|Overall Study|Death|8|||
27913241|NCT02922153|81521970|FG001|Overall Study|Death|1|||
27913242|NCT02922153|81521969|FG000|Overall Study|Lost to Follow-up|1|||
27913243|NCT02922153|81521970|FG001|Overall Study|Lost to Follow-up|0|||
27913244|NCT02922153|81521969|FG000|Overall Study|Physician Decision|1|||
27913245|NCT02922153|81521970|FG001|Overall Study|Physician Decision|1|||
27913246|NCT01128400|81521974|FG000|Overall Study|Lost to Follow-up|1|||
27913247|NCT01128400|81521975|FG001|Overall Study|Lost to Follow-up|0|||
27913248|NCT01128400|81521976|FG002|Overall Study|Lost to Follow-up|1|||
27737351|NCT02371629|80868298|FG000|Overall Study|Lack of Efficacy|0|||
27913249|NCT01128400|81521974|FG000|Overall Study|Screening failure|1|||
27913250|NCT01128400|81521975|FG001|Overall Study|Screening failure|0|||
27913251|NCT01128400|81521976|FG002|Overall Study|Screening failure|0|||
27533151|NCT01927627|80148059|FG000|Overall Study|Financial Concerns|1|||
27533152|NCT00464269|80148060|FG000|Overall Study|Lack of Efficacy|1|||
27533153|NCT00464269|80148061|FG001|Overall Study|Lack of Efficacy|0|||
27533154|NCT00464269|80148062|FG002|Overall Study|Lack of Efficacy|0|||
27533155|NCT00464269|80148063|FG003|Overall Study|Lack of Efficacy|0|||
27533156|NCT00464269|80148060|FG000|Overall Study|Lost to Follow-up|0|||
27533157|NCT00464269|80148061|FG001|Overall Study|Lost to Follow-up|4|||
27533158|NCT00464269|80148062|FG002|Overall Study|Lost to Follow-up|0|||
27533159|NCT00464269|80148063|FG003|Overall Study|Lost to Follow-up|1|||
27533160|NCT00464269|80148060|FG000|Overall Study|Withdrawal by Subject|0|||
27533161|NCT00464269|80148061|FG001|Overall Study|Withdrawal by Subject|2|||
27533162|NCT00464269|80148062|FG002|Overall Study|Withdrawal by Subject|1|||
27533163|NCT00464269|80148063|FG003|Overall Study|Withdrawal by Subject|1|||
27533164|NCT00464269|80148060|FG000|Overall Study|Other reason|3|||
27629043|NCT01726023|80483582|FG001|Overall Study|Other Eligibility criteria|7|||
27629044|NCT01726023|80483581|FG000|Overall Study|Withdrawal by Subject|16|||
27737352|NCT02371629|80868299|FG001|Overall Study|Lack of Efficacy|2|||
27913252|NCT01128400|81521974|FG000|Overall Study|were not invited to participate on taste|0|||
27533165|NCT00464269|80148061|FG001|Overall Study|Other reason|3|||
27533166|NCT00464269|80148062|FG002|Overall Study|Other reason|1|||
27737353|NCT02371629|80868298|FG000|Overall Study|Protocol deviation|0|||
27737354|NCT02371629|80868299|FG001|Overall Study|Protocol deviation|1|||
27913253|NCT01128400|81521975|FG001|Overall Study|were not invited to participate on taste|0|||
27533167|NCT00464269|80148063|FG003|Overall Study|Other reason|1|||
27533168|NCT00464269|80148060|FG000|Overall Study|AE, serious fatal|0|||
27533169|NCT00464269|80148061|FG001|Overall Study|AE, serious fatal|0|||
27533170|NCT00464269|80148062|FG002|Overall Study|AE, serious fatal|1|||
27533171|NCT00464269|80148063|FG003|Overall Study|AE, serious fatal|1|||
27533172|NCT00464269|80148060|FG000|Overall Study|SAE, non-fatal|0|||
27533173|NCT00464269|80148061|FG001|Overall Study|SAE, non-fatal|0|||
27533174|NCT00464269|80148062|FG002|Overall Study|SAE, non-fatal|0|||
27533175|NCT00464269|80148063|FG003|Overall Study|SAE, non-fatal|1|||
27533176|NCT00464269|80148060|FG000|Overall Study|AE, non-serious non-fatal|2|||
27533177|NCT00464269|80148061|FG001|Overall Study|AE, non-serious non-fatal|8|||
27533178|NCT00464269|80148062|FG002|Overall Study|AE, non-serious non-fatal|3|||
27533179|NCT00464269|80148063|FG003|Overall Study|AE, non-serious non-fatal|4|||
27533180|NCT00464269|80148060|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27533181|NCT00464269|80148061|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27533182|NCT00464269|80148062|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
27533183|NCT00464269|80148063|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
27533184|NCT00753766|80148068|FG000|Overall Study|Physician Decision|1|||
27533185|NCT00753766|80148069|FG001|Overall Study|Physician Decision|0|||
27533186|NCT00902668|80148070|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
27533187|NCT01200524|80148071|FG000|Overall Study|Withdrawal by Subject|1|||
27533188|NCT01200524|80148072|FG001|Overall Study|Withdrawal by Subject|1|||
27533189|NCT01200524|80148073|FG002|Overall Study|Withdrawal by Subject|3|||
27533190|NCT01200524|80148071|FG000|Overall Study|Adverse Event|1|||
27533191|NCT01200524|80148072|FG001|Overall Study|Adverse Event|0|||
27533192|NCT01200524|80148073|FG002|Overall Study|Adverse Event|0|||
27533193|NCT01200524|80148071|FG000|Overall Study|Non availability of study nurse|0|||
27913254|NCT01128400|81521976|FG002|Overall Study|were not invited to participate on taste|15|||
27533194|NCT01200524|80148072|FG001|Overall Study|Non availability of study nurse|0|||
27533195|NCT01200524|80148073|FG002|Overall Study|Non availability of study nurse|1|||
27533196|NCT02913612|80148074|FG000|Overall Study|Lost to Follow-up|6|||
27533197|NCT02913612|80148075|FG001|Overall Study|Lost to Follow-up|5|||
27533198|NCT02913612|80148076|FG002|Overall Study|Lost to Follow-up|2|||
27629045|NCT01726023|80483582|FG001|Overall Study|Withdrawal by Subject|8|||
27913255|NCT01128400|81521974|FG000|Overall Study|Excluded due to sinus problems|0|||
27913256|NCT01128400|81521975|FG001|Overall Study|Excluded due to sinus problems|1|||
27913257|NCT01128400|81521976|FG002|Overall Study|Excluded due to sinus problems|0|||
27913258|NCT02504320|81521977|FG000|Treatment Period 1|Positive Drug Screen|0|||
27913259|NCT02504320|81521978|FG001|Treatment Period 1|Positive Drug Screen|0|||
27913260|NCT02504320|81521979|FG002|Treatment Period 1|Positive Drug Screen|1|||
27913261|NCT02504320|81521980|FG003|Treatment Period 1|Positive Drug Screen|0|||
27913262|NCT02504320|81521977|FG000|Treatment Period 2|Positive Drug Screen|0|||
27913263|NCT02504320|81521978|FG001|Treatment Period 2|Positive Drug Screen|1|||
27913264|NCT02504320|81521979|FG002|Treatment Period 2|Positive Drug Screen|0|||
27913265|NCT02504320|81521980|FG003|Treatment Period 2|Positive Drug Screen|0|||
27913266|NCT02504320|81521977|FG000|Treatment Period 3|Positive Drug Screen|0|||
27913267|NCT02504320|81521978|FG001|Treatment Period 3|Positive Drug Screen|0|||
27913268|NCT02504320|81521979|FG002|Treatment Period 3|Positive Drug Screen|0|||
27913269|NCT02504320|81521980|FG003|Treatment Period 3|Positive Drug Screen|1|||
27913270|NCT02504320|81521977|FG000|Treatment Period 3|Adverse Event|0|||
27913271|NCT02504320|81521978|FG001|Treatment Period 3|Adverse Event|0|||
27913272|NCT02504320|81521979|FG002|Treatment Period 3|Adverse Event|1|||
27913273|NCT02504320|81521980|FG003|Treatment Period 3|Adverse Event|0|||
27913274|NCT00810199|81521981|FG000|Overall Study|Adverse Event|24|||
27913275|NCT00810199|81521982|FG001|Overall Study|Adverse Event|26|||
27913276|NCT00810199|81521981|FG000|Overall Study|Death|4|||
27913277|NCT00810199|81521982|FG001|Overall Study|Death|6|||
27913278|NCT00810199|81521981|FG000|Overall Study|Withdrew consent|9|||
27913279|NCT00810199|81521982|FG001|Overall Study|Withdrew consent|12|||
27913280|NCT00810199|81521981|FG000|Overall Study|Insufficient therapeutic response|5|||
27913281|NCT00810199|81521982|FG001|Overall Study|Insufficient therapeutic response|14|||
27913282|NCT00810199|81521981|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
27913283|NCT00810199|81521982|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
27913284|NCT00810199|81521981|FG000|Overall Study|Administrative/Other|5|||
27913285|NCT00810199|81521982|FG001|Overall Study|Administrative/Other|6|||
27913286|NCT00810199|81521981|FG000|Overall Study|Protocol Violation|2|||
27913287|NCT00810199|81521982|FG001|Overall Study|Protocol Violation|6|||
27913288|NCT00810199|81521981|FG000|Overall Study|Failure to return|1|||
27913289|NCT00810199|81521982|FG001|Overall Study|Failure to return|4|||
27913290|NCT00810199|81521981|FG000|Overall Study|Did not receive study drug|2|||
27533199|NCT02913612|80148077|FG003|Overall Study|Lost to Follow-up|0|||
27533200|NCT02913612|80148074|FG000|Overall Study|Physician Decision|1|||
27533201|NCT02913612|80148075|FG001|Overall Study|Physician Decision|4|||
27533202|NCT02913612|80148076|FG002|Overall Study|Physician Decision|1|||
27533203|NCT02913612|80148077|FG003|Overall Study|Physician Decision|0|||
27629046|NCT01710514|80483586|FG000|Overall Study|Adverse Event|6|||
27913291|NCT00810199|81521982|FG001|Overall Study|Did not receive study drug|1|||
27913292|NCT00248651|81521988|FG000|Overall Study|Withdrawal by Subject|28|||
27913293|NCT00248651|81521989|FG001|Overall Study|Withdrawal by Subject|40|||
27913294|NCT00248651|81521990|FG002|Overall Study|Withdrawal by Subject|32|||
27913295|NCT03771963|81521993|FG000|Overall Study|Lost to Follow-up|22|||
27533204|NCT02913612|80148074|FG000|Overall Study|Withdrawal by Subject|2|||
27533205|NCT02913612|80148075|FG001|Overall Study|Withdrawal by Subject|4|||
27533206|NCT02913612|80148076|FG002|Overall Study|Withdrawal by Subject|0|||
27533207|NCT02913612|80148077|FG003|Overall Study|Withdrawal by Subject|0|||
27533208|NCT02913612|80148074|FG000|Overall Study|Hemangioma resolved|1|||
27533209|NCT02913612|80148075|FG001|Overall Study|Hemangioma resolved|0|||
27533210|NCT02913612|80148076|FG002|Overall Study|Hemangioma resolved|0|||
27533211|NCT02913612|80148077|FG003|Overall Study|Hemangioma resolved|0|||
27533212|NCT02913612|80148074|FG000|Overall Study|Local IRB decision|1|||
27533213|NCT02913612|80148075|FG001|Overall Study|Local IRB decision|0|||
27533214|NCT02913612|80148076|FG002|Overall Study|Local IRB decision|0|||
27533215|NCT02913612|80148077|FG003|Overall Study|Local IRB decision|0|||
27533216|NCT02913612|80148074|FG000|Overall Study|Study drug non-compliance|1|||
27533217|NCT02913612|80148075|FG001|Overall Study|Study drug non-compliance|1|||
27533218|NCT02913612|80148076|FG002|Overall Study|Study drug non-compliance|0|||
27533219|NCT02913612|80148077|FG003|Overall Study|Study drug non-compliance|0|||
27737355|NCT01071070|80868304|FG000|Overall Study|Adverse Event|0|||
27737356|NCT01071070|80868305|FG001|Overall Study|Adverse Event|3|||
27737357|NCT01071070|80868304|FG000|Overall Study|Withdrawal by Subject|1|||
27737358|NCT01071070|80868305|FG001|Overall Study|Withdrawal by Subject|0|||
27737359|NCT01071070|80868304|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
27737360|NCT01071070|80868305|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
27737361|NCT01071070|80868304|FG000|Overall Study|Hypercalcemia|1|||
27737362|NCT01071070|80868305|FG001|Overall Study|Hypercalcemia|0|||
27913296|NCT03771963|81521993|FG000|Overall Study|Withdrawal of Consent|10|||
27913297|NCT02521792|81521994|FG000|Overall Study|Study Terminated|6|||
27913298|NCT01921517|81522005|FG000|Overall Study|Lost to Follow-up|5|||
27913299|NCT01921517|81522006|FG001|Overall Study|Lost to Follow-up|0|||
27913300|NCT01921517|81522005|FG000|Overall Study|Newly diagnosed health concern|2|||
27913301|NCT01921517|81522006|FG001|Overall Study|Newly diagnosed health concern|0|||
27913302|NCT01921517|81522005|FG000|Overall Study|Physician Decision|0|||
27913303|NCT01921517|81522006|FG001|Overall Study|Physician Decision|2|||
27913304|NCT01921517|81522005|FG000|Overall Study|Withdrawal by Subject|7|||
27913305|NCT01921517|81522006|FG001|Overall Study|Withdrawal by Subject|3|||
27913306|NCT01921517|81522005|FG000|Overall Study|Subject missed final imaging|1|||
27913307|NCT01921517|81522006|FG001|Overall Study|Subject missed final imaging|4|||
27913308|NCT01587885|81522008|FG000|Treatment Period 1|Failure to Return|0|||
27913309|NCT01587885|81522009|FG001|Treatment Period 1|Failure to Return|1|||
27913310|NCT01587885|81522008|FG000|Treatment Period 1|Protocol Violation|0|||
27913311|NCT01587885|81522009|FG001|Treatment Period 1|Protocol Violation|2|||
27913312|NCT04534517|81522010|FG000|Overall Study|Adverse Event|1|||
27913313|NCT04534517|81522010|FG000|Overall Study|Withdrawal by Subject|1|||
27913314|NCT04534517|81522010|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
27913315|NCT04534517|81522010|FG000|Overall Study|COVID-19 Related|1|||
27913316|NCT02322749|81522018|FG000|Period 2|Adverse Event|0|||
27913317|NCT02322749|81522019|FG001|Period 2|Adverse Event|0|||
27913318|NCT02322749|81522020|FG002|Period 2|Adverse Event|0|||
27913319|NCT02322749|81522021|FG003|Period 2|Adverse Event|1|||
27533220|NCT02913612|80148074|FG000|Overall Study|Insurance issues|0|||
27533221|NCT02913612|80148075|FG001|Overall Study|Insurance issues|1|||
27533222|NCT02913612|80148076|FG002|Overall Study|Insurance issues|0|||
27533223|NCT02913612|80148077|FG003|Overall Study|Insurance issues|0|||
27533224|NCT02913612|80148074|FG000|Overall Study|Needed to treat second hemangioma|0|||
27533225|NCT02913612|80148075|FG001|Overall Study|Needed to treat second hemangioma|1|||
27533226|NCT02913612|80148076|FG002|Overall Study|Needed to treat second hemangioma|0|||
27533227|NCT02913612|80148077|FG003|Overall Study|Needed to treat second hemangioma|0|||
27533228|NCT02913612|80148074|FG000|Overall Study|Study completion criteria not met|0|||
27533229|NCT02913612|80148075|FG001|Overall Study|Study completion criteria not met|1|||
27533230|NCT02913612|80148076|FG002|Overall Study|Study completion criteria not met|0|||
27533231|NCT02913612|80148077|FG003|Overall Study|Study completion criteria not met|0|||
27533232|NCT02913612|80148074|FG000|Overall Study|Ineligible|0|||
27533233|NCT02913612|80148075|FG001|Overall Study|Ineligible|1|||
27533234|NCT02913612|80148076|FG002|Overall Study|Ineligible|0|||
27533235|NCT02913612|80148077|FG003|Overall Study|Ineligible|0|||
27533236|NCT04916769|80148078|FG000|Period 1|Physician Decision|0|||
27533237|NCT04916769|80148079|FG001|Period 1|Physician Decision|0|||
27533238|NCT04916769|80148080|FG002|Period 1|Physician Decision|0|||
27533239|NCT04916769|80148081|FG003|Period 1|Physician Decision|0|||
27533240|NCT04916769|80148082|FG004|Period 1|Physician Decision|0|||
27913320|NCT02322749|81522022|FG004|Period 2|Adverse Event|0|||
27913321|NCT02322749|81522023|FG005|Period 2|Adverse Event|0|||
27913322|NCT02322749|81522018|FG000|Period 2|Withdrawal by Subject|0|||
27913323|NCT02322749|81522019|FG001|Period 2|Withdrawal by Subject|0|||
27629047|NCT01710514|80483587|FG001|Overall Study|Adverse Event|7|||
27629048|NCT01710514|80483586|FG000|Overall Study|Withdrawal by Subject|1|||
27629049|NCT01710514|80483587|FG001|Overall Study|Withdrawal by Subject|0|||
27629050|NCT01145885|80483588|FG000|Overall Study|Progressive Disease|7|||
27629051|NCT02503202|80483589|FG000|Base Study: Up to Month 6|Death|1|||
27737363|NCT02104180|80868306|FG000|Overall Study|Protocol Violation|1|||
27629052|NCT02503202|80483590|FG001|Base Study: Up to Month 6|Death|1|||
27737364|NCT02104180|80868307|FG001|Overall Study|Protocol Violation|0|||
27737365|NCT04938648|80868308|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
27737366|NCT04938648|80868309|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
27737367|NCT04938648|80868308|FG000|Overall Study|Patient too ill|0|||
27737368|NCT04938648|80868309|FG001|Overall Study|Patient too ill|1|||
27737369|NCT04938648|80868308|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
27737370|NCT04938648|80868309|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
27737371|NCT04938648|80868308|FG000|Overall Study|Patient did not have memory problems|1|||
27737372|NCT04938648|80868309|FG001|Overall Study|Patient did not have memory problems|1|||
27737373|NCT04938648|80868308|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
27737374|NCT04938648|80868309|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
27737375|NCT04938648|80868308|FG000|Overall Study|Care partner could not be reached|0|||
27737376|NCT04938648|80868309|FG001|Overall Study|Care partner could not be reached|1|||
27737377|NCT04938648|80868308|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
27737378|NCT04938648|80868309|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
27737379|NCT04938648|80868308|FG000|Overall Study|Withdrawal by Subject|2|||
27737380|NCT04938648|80868309|FG001|Overall Study|Withdrawal by Subject|1|||
27737381|NCT03717922|80868312|FG000|Overall Study|Lost to Follow-up|2|||
27737382|NCT03717922|80868313|FG001|Overall Study|Lost to Follow-up|2|||
27737383|NCT02626338|80868314|FG000|Overall Study|Lack of Efficacy|3|||
27737384|NCT02626338|80868315|FG001|Overall Study|Lack of Efficacy|2|||
27737385|NCT02626338|80868316|FG002|Overall Study|Lack of Efficacy|0|||
27533241|NCT04916769|80148083|FG005|Period 1|Physician Decision|1|||
27533242|NCT04916769|80148078|FG000|Period 2|Physician Decision|0|||
27533243|NCT04916769|80148079|FG001|Period 2|Physician Decision|1|||
27533244|NCT04916769|80148080|FG002|Period 2|Physician Decision|0|||
27533245|NCT04916769|80148081|FG003|Period 2|Physician Decision|0|||
27533246|NCT04916769|80148082|FG004|Period 2|Physician Decision|0|||
27629053|NCT02503202|80483591|FG002|Base Study: Up to Month 6|Death|0|||
27629054|NCT02503202|80483592|FG003|Base Study: Up to Month 6|Death|0|||
27629055|NCT02503202|80483593|FG004|Base Study: Up to Month 6|Death|0|||
27629056|NCT02503202|80483589|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
27629057|NCT02503202|80483590|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
27629058|NCT02503202|80483591|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
27629059|NCT02503202|80483592|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
27629060|NCT02503202|80483593|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
27629061|NCT02503202|80483589|FG000|Base Study: Up to Month 6|Physician Decision|0|||
27737386|NCT00624338|80868317|FG000|Overall Study|Adverse Event|14|||
27737387|NCT00624338|80868318|FG001|Overall Study|Adverse Event|14|||
27737388|NCT00624338|80868319|FG002|Overall Study|Adverse Event|18|||
27533247|NCT04916769|80148083|FG005|Period 2|Physician Decision|0|||
27533248|NCT00334815|80148088|FG000|Overall Study|Adverse Event|3|||
27533249|NCT00334815|80148089|FG001|Overall Study|Adverse Event|2|||
27533250|NCT00334815|80148088|FG000|Overall Study|Death|0|||
27533251|NCT00334815|80148089|FG001|Overall Study|Death|2|||
27533252|NCT00334815|80148088|FG000|Overall Study|Progression|1|||
27533253|NCT00334815|80148089|FG001|Overall Study|Progression|0|||
27533254|NCT00334815|80148088|FG000|Overall Study|ineligible|1|||
27533255|NCT00334815|80148089|FG001|Overall Study|ineligible|1|||
27533256|NCT00334815|80148088|FG000|Overall Study|patient refused treatment|0|||
27533257|NCT00334815|80148089|FG001|Overall Study|patient refused treatment|1|||
27533258|NCT00334815|80148088|FG000|Overall Study|Physician Decision|2|||
27533259|NCT00334815|80148089|FG001|Overall Study|Physician Decision|4|||
27533260|NCT03217266|80148090|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
27533261|NCT03217266|80148091|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
27533262|NCT03217266|80148092|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
27533263|NCT03217266|80148093|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
27533264|NCT03217266|80148090|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
27533265|NCT03217266|80148091|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
27533266|NCT03217266|80148092|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
27533267|NCT03217266|80148093|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
27533268|NCT03217266|80148090|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
27629062|NCT02503202|80483590|FG001|Base Study: Up to Month 6|Physician Decision|0|||
27533269|NCT03217266|80148091|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
27629063|NCT02503202|80483591|FG002|Base Study: Up to Month 6|Physician Decision|0|||
27629064|NCT02503202|80483592|FG003|Base Study: Up to Month 6|Physician Decision|0|||
27737389|NCT00624338|80868317|FG000|Overall Study|Lost to Follow-up|1|||
27629065|NCT02503202|80483593|FG004|Base Study: Up to Month 6|Physician Decision|1|||
27629066|NCT02503202|80483589|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
27533270|NCT03217266|80148092|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
27533271|NCT03217266|80148093|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
27533272|NCT05430022|80148095|FG000|Overall Study|Withdrawal by Subject|4|||
27629067|NCT02503202|80483590|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
27913324|NCT02322749|81522020|FG002|Period 2|Withdrawal by Subject|0|||
27629068|NCT02503202|80483591|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
27629069|NCT02503202|80483592|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
27629070|NCT02503202|80483593|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
27629071|NCT02503202|80483589|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
27913325|NCT02322749|81522021|FG003|Period 2|Withdrawal by Subject|1|||
27913326|NCT02322749|81522022|FG004|Period 2|Withdrawal by Subject|0|||
27913327|NCT02322749|81522023|FG005|Period 2|Withdrawal by Subject|0|||
27913328|NCT02322749|81522018|FG000|Period 3|Withdrawal by Subject|0|||
27913329|NCT02322749|81522019|FG001|Period 3|Withdrawal by Subject|0|||
27913330|NCT02322749|81522020|FG002|Period 3|Withdrawal by Subject|1|||
27913331|NCT02322749|81522021|FG003|Period 3|Withdrawal by Subject|0|||
27913332|NCT02322749|81522022|FG004|Period 3|Withdrawal by Subject|0|||
27913333|NCT02322749|81522023|FG005|Period 3|Withdrawal by Subject|0|||
27913334|NCT02699996|81522024|FG000|Overall Study|Withdrawal by Subject|5|||
27913335|NCT02699996|81522025|FG001|Overall Study|Withdrawal by Subject|2|||
27913336|NCT05417412|81522029|FG000|Overall Study|Lost to Follow-up|2|||
27913337|NCT02824627|81522033|FG000|Overall Study|Adverse Event|1|||
27913338|NCT02824627|81522034|FG001|Overall Study|Adverse Event|2|||
27913339|NCT02824627|81522033|FG000|Overall Study|Lost to Follow-up|2|||
27913340|NCT02824627|81522034|FG001|Overall Study|Lost to Follow-up|1|||
27913341|NCT02061813|81522035|FG000|Overall Study|Withdrawal by Subject|1|||
27913342|NCT02061813|81522035|FG000|Overall Study|Protocol Violation|2|||
27533273|NCT05430022|80148096|FG001|Overall Study|Withdrawal by Subject|4|||
27533274|NCT05394350|80148097|FG000|Overall Study|Death|2|||
27533275|NCT05394350|80148098|FG001|Overall Study|Death|2|||
27533276|NCT05394350|80148099|FG002|Overall Study|Death|4|||
27629072|NCT02503202|80483590|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
27629073|NCT02503202|80483591|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
27629074|NCT02503202|80483592|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
27629075|NCT02503202|80483593|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
27629076|NCT02503202|80483589|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
27629077|NCT02503202|80483590|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
27629078|NCT02503202|80483591|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
27629079|NCT02503202|80483592|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
27629080|NCT02503202|80483593|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
27629081|NCT02503202|80483589|FG000|Extension: Month 6 to 24|Death|1|||
27629082|NCT02503202|80483590|FG001|Extension: Month 6 to 24|Death|0|||
27629083|NCT02503202|80483591|FG002|Extension: Month 6 to 24|Death|0|||
27629084|NCT02503202|80483592|FG003|Extension: Month 6 to 24|Death|0|||
27629085|NCT02503202|80483593|FG004|Extension: Month 6 to 24|Death|0|||
27629086|NCT02503202|80483589|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
27737390|NCT00624338|80868318|FG001|Overall Study|Lost to Follow-up|0|||
27913343|NCT00954122|81522039|FG000|Overall Study|Withdrawal by Subject|5|||
27913344|NCT00954122|81522039|FG000|Overall Study|Adverse Event|1|||
27913345|NCT00954122|81522039|FG000|Overall Study|Safety Reason|1|||
27913346|NCT02915159|81522052|FG000|Overall Study|Participant no longer meets criteria|2|||
27913347|NCT02915159|81522053|FG001|Overall Study|Participant no longer meets criteria|0|||
27913348|NCT02915159|81522052|FG000|Overall Study|poor/non-compliance|1|||
27913349|NCT02915159|81522053|FG001|Overall Study|poor/non-compliance|0|||
27913350|NCT02915159|81522052|FG000|Overall Study|Participant withdrew consent|5|||
27913351|NCT02915159|81522053|FG001|Overall Study|Participant withdrew consent|1|||
27913352|NCT02915159|81522052|FG000|Overall Study|Request to discontinue treatment|1|||
27913353|NCT02915159|81522053|FG001|Overall Study|Request to discontinue treatment|2|||
27913354|NCT02915159|81522052|FG000|Overall Study|Adverse Event|2|||
27913355|NCT02915159|81522053|FG001|Overall Study|Adverse Event|2|||
27913356|NCT02915159|81522052|FG000|Overall Study|Lack of Efficacy|0|||
27913357|NCT02915159|81522053|FG001|Overall Study|Lack of Efficacy|3|||
27913358|NCT03066830|81522060|FG000|Overall Study|At the Participant's own Request|16|||
27629087|NCT02503202|80483590|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
27629088|NCT02503202|80483591|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
27737391|NCT00624338|80868319|FG002|Overall Study|Lost to Follow-up|0|||
27737392|NCT00624338|80868317|FG000|Overall Study|Lack of Efficacy|11|||
27913359|NCT03066830|81522061|FG001|Overall Study|At the Participant's own Request|17|||
27913360|NCT03066830|81522060|FG000|Overall Study|Other|3|||
27913361|NCT03066830|81522061|FG001|Overall Study|Other|0|||
27913362|NCT03066830|81522060|FG000|Overall Study|Poor Compliance to Protocol|1|||
27913363|NCT03066830|81522061|FG001|Overall Study|Poor Compliance to Protocol|0|||
27913364|NCT03066830|81522060|FG000|Overall Study|Adverse Event|2|||
27533277|NCT05394350|80148100|FG003|Overall Study|Death|0|||
27533278|NCT05394350|80148101|FG004|Overall Study|Death|1|||
27533279|NCT05394350|80148102|FG005|Overall Study|Death|0|||
27533280|NCT05394350|80148097|FG000|Overall Study|Study terminated by sponsor|1|||
27533281|NCT05394350|80148098|FG001|Overall Study|Study terminated by sponsor|1|||
27533282|NCT05394350|80148099|FG002|Overall Study|Study terminated by sponsor|7|||
27533283|NCT05394350|80148100|FG003|Overall Study|Study terminated by sponsor|3|||
27533284|NCT05394350|80148101|FG004|Overall Study|Study terminated by sponsor|2|||
27533285|NCT05394350|80148102|FG005|Overall Study|Study terminated by sponsor|4|||
27629089|NCT02503202|80483592|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
27629090|NCT02503202|80483593|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
27629091|NCT02503202|80483589|FG000|Extension: Month 6 to 24|Physician Decision|1|||
27629092|NCT02503202|80483590|FG001|Extension: Month 6 to 24|Physician Decision|0|||
27629093|NCT02503202|80483591|FG002|Extension: Month 6 to 24|Physician Decision|1|||
27629094|NCT02503202|80483592|FG003|Extension: Month 6 to 24|Physician Decision|3|||
27629095|NCT02503202|80483593|FG004|Extension: Month 6 to 24|Physician Decision|0|||
27629096|NCT02503202|80483589|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
27629097|NCT02503202|80483590|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
27629098|NCT02503202|80483591|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
27629099|NCT02503202|80483592|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
27629100|NCT02503202|80483593|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
27629101|NCT04567615|80483594|FG000|Randomization|Participant withdrew consent|1|||
27629102|NCT04567615|80483595|FG001|Randomization|Participant withdrew consent|0|||
27629103|NCT04567615|80483596|FG002|Randomization|Participant withdrew consent|0|||
27737393|NCT00624338|80868318|FG001|Overall Study|Lack of Efficacy|3|||
27737394|NCT00624338|80868319|FG002|Overall Study|Lack of Efficacy|14|||
27913365|NCT03066830|81522061|FG001|Overall Study|Adverse Event|2|||
27913366|NCT03066830|81522060|FG000|Overall Study|Lost to Follow-up|11|||
27533286|NCT00986479|80148103|FG000|Period 1|Improved mood|1|||
27533287|NCT00986479|80148104|FG001|Period 1|Improved mood|0|||
27533288|NCT00986479|80148103|FG000|Period 1|Administrative reasons|1|||
27533289|NCT00986479|80148104|FG001|Period 1|Administrative reasons|0|||
27533290|NCT01810432|80148105|FG000|Washout|Protocol Violation|0|||
27533291|NCT01810432|80148106|FG001|Washout|Protocol Violation|1|||
27533292|NCT01810432|80148105|FG000|Washout|Adverse Event|1|||
27533293|NCT01810432|80148106|FG001|Washout|Adverse Event|0|||
27913367|NCT03066830|81522061|FG001|Overall Study|Lost to Follow-up|3|||
27913368|NCT02848664|81522071|FG000|Overall Study|Withdrawal by Subject|2|||
27913369|NCT02848664|81522071|FG000|Overall Study|Adverse Event|1|||
27913370|NCT02848664|81522071|FG000|Overall Study|no assistance for device training|1|||
27913371|NCT03146741|81522072|FG000|Overall Study|Txp with non-HCV+ heart|4|||
27913372|NCT03146741|81522072|FG000|Overall Study|Listeted for MOT|2|||
27913373|NCT03146741|81522072|FG000|Overall Study|Physician Decision|2|||
27913374|NCT03146741|81522072|FG000|Overall Study|Awaiting txp|2|||
27913375|NCT01839916|81522075|FG000|Overall Study|Death|9|||
27913376|NCT01839916|81522075|FG000|Overall Study|Physician Decision|17|||
27913377|NCT01839916|81522075|FG000|Overall Study|Relapse|12|||
27913378|NCT01839916|81522075|FG000|Overall Study|GVHD|2|||
27913379|NCT01839916|81522075|FG000|Overall Study|Graft Failure|1|||
27913380|NCT01000974|81522079|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
27913381|NCT01000974|81522080|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
27913382|NCT01000974|81522081|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
27913383|NCT01000974|81522079|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
27913384|NCT01000974|81522080|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
27913385|NCT01000974|81522081|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
27913386|NCT01000974|81522079|FG000|Primary Vaccination Phase|Protocol Violation|40|||
27913387|NCT01000974|81522080|FG001|Primary Vaccination Phase|Protocol Violation|3|||
27913388|NCT01000974|81522081|FG002|Primary Vaccination Phase|Protocol Violation|2|||
27913389|NCT01000974|81522079|FG000|Primary Vaccination Phase|Adverse Event|14|||
27913390|NCT01000974|81522080|FG001|Primary Vaccination Phase|Adverse Event|2|||
27913391|NCT01000974|81522081|FG002|Primary Vaccination Phase|Adverse Event|2|||
27913392|NCT01000974|81522079|FG000|Primary Vaccination Phase|Other|4|||
27913393|NCT01000974|81522080|FG001|Primary Vaccination Phase|Other|9|||
27913394|NCT01000974|81522081|FG002|Primary Vaccination Phase|Other|12|||
27913395|NCT01000974|81522079|FG000|Booster Vaccination Phase|Protocol Violation|0|||
27533294|NCT01810432|80148105|FG000|Period 2|Withdrawal by Subject|2|||
27533295|NCT01810432|80148106|FG001|Period 2|Withdrawal by Subject|1|||
27629104|NCT04567615|80483594|FG000|Randomization|Adverse event unrelated to study drug|0|||
27737395|NCT00624338|80868317|FG000|Overall Study|Protocol Violation|3|||
27913396|NCT01000974|81522080|FG001|Booster Vaccination Phase|Protocol Violation|0|||
27913397|NCT01000974|81522081|FG002|Booster Vaccination Phase|Protocol Violation|2|||
27913398|NCT01000974|81522079|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
27913399|NCT01000974|81522080|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
27913400|NCT01000974|81522081|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
27913401|NCT01000974|81522079|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
27533296|NCT01810432|80148105|FG000|Period 2|Physician Decision|1|||
27629105|NCT04567615|80483595|FG001|Randomization|Adverse event unrelated to study drug|1|||
27629106|NCT04567615|80483596|FG002|Randomization|Adverse event unrelated to study drug|0|||
27629107|NCT04567615|80483594|FG000|Treatment Period|Participant Withdrew Consent|2|||
27629108|NCT04567615|80483595|FG001|Treatment Period|Participant Withdrew Consent|5|||
27629109|NCT04567615|80483596|FG002|Treatment Period|Participant Withdrew Consent|1|||
27629110|NCT04567615|80483594|FG000|Treatment Period|Death|1|||
27629111|NCT04567615|80483595|FG001|Treatment Period|Death|2|||
27629112|NCT04567615|80483596|FG002|Treatment Period|Death|0|||
27629113|NCT04567615|80483594|FG000|Treatment Period|Lost to Follow-up|0|||
27629114|NCT04567615|80483595|FG001|Treatment Period|Lost to Follow-up|1|||
27629115|NCT04567615|80483596|FG002|Treatment Period|Lost to Follow-up|0|||
27629116|NCT04567615|80483594|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
27629117|NCT04567615|80483595|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
27629118|NCT04567615|80483596|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
27629119|NCT04567615|80483594|FG000|Treatment Period|Disease Progression|85|||
27629120|NCT04567615|80483595|FG001|Treatment Period|Disease Progression|63|||
27629121|NCT04567615|80483596|FG002|Treatment Period|Disease Progression|16|||
27629122|NCT04567615|80483594|FG000|Treatment Period|Study Drug Toxicity|3|||
27629123|NCT04567615|80483595|FG001|Treatment Period|Study Drug Toxicity|10|||
27629124|NCT04567615|80483596|FG002|Treatment Period|Study Drug Toxicity|4|||
27629125|NCT04567615|80483594|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
27629126|NCT04567615|80483595|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
27629127|NCT04567615|80483596|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
27629128|NCT04567615|80483594|FG000|Treatment Period|Other Reasons|1|||
27629129|NCT04567615|80483595|FG001|Treatment Period|Other Reasons|2|||
27629130|NCT04567615|80483596|FG002|Treatment Period|Other Reasons|0|||
27629131|NCT04567615|80483594|FG000|Treatment Period|Still On-going Treatment|21|||
27629132|NCT04567615|80483595|FG001|Treatment Period|Still On-going Treatment|22|||
27629133|NCT04567615|80483596|FG002|Treatment Period|Still On-going Treatment|2|||
27629134|NCT03612804|80483597|FG000|Overall Study|Death|0|||
27629135|NCT03612804|80483598|FG001|Overall Study|Death|7|||
27629136|NCT03612804|80483599|FG002|Overall Study|Death|0|||
27629137|NCT03612804|80483600|FG003|Overall Study|Death|8|||
27629138|NCT03612804|80483597|FG000|Overall Study|Medication copay coverage issues|0|||
27629139|NCT03612804|80483598|FG001|Overall Study|Medication copay coverage issues|0|||
27629140|NCT03612804|80483599|FG002|Overall Study|Medication copay coverage issues|0|||
27629141|NCT03612804|80483600|FG003|Overall Study|Medication copay coverage issues|17|||
27629142|NCT03612804|80483597|FG000|Overall Study|Not current smoker at time of screening|0|||
27629143|NCT03612804|80483598|FG001|Overall Study|Not current smoker at time of screening|1|||
27629144|NCT03612804|80483599|FG002|Overall Study|Not current smoker at time of screening|0|||
27629145|NCT03612804|80483600|FG003|Overall Study|Not current smoker at time of screening|3|||
27629146|NCT03612804|80483597|FG000|Overall Study|Non-veteran status|0|||
27629147|NCT03612804|80483598|FG001|Overall Study|Non-veteran status|1|||
27629148|NCT03612804|80483599|FG002|Overall Study|Non-veteran status|0|||
27629149|NCT03612804|80483600|FG003|Overall Study|Non-veteran status|0|||
27629150|NCT03612804|80483597|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
27629151|NCT03612804|80483598|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
27629152|NCT03612804|80483599|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
27629153|NCT03612804|80483600|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
27629154|NCT03612804|80483597|FG000|Overall Study|Provider retired from VA|0|||
27629155|NCT03612804|80483598|FG001|Overall Study|Provider retired from VA|0|||
27629156|NCT03612804|80483599|FG002|Overall Study|Provider retired from VA|2|||
27629157|NCT03612804|80483600|FG003|Overall Study|Provider retired from VA|0|||
27629158|NCT03612804|80483597|FG000|Overall Study|Withdrawal by Subject|0|||
27629159|NCT03612804|80483598|FG001|Overall Study|Withdrawal by Subject|0|||
27629160|NCT03612804|80483599|FG002|Overall Study|Withdrawal by Subject|7|||
27629161|NCT03612804|80483600|FG003|Overall Study|Withdrawal by Subject|0|||
27629162|NCT03612804|80483597|FG000|Overall Study|Provider involved with study activities|1|||
27629163|NCT03612804|80483598|FG001|Overall Study|Provider involved with study activities|0|||
27629164|NCT03612804|80483599|FG002|Overall Study|Provider involved with study activities|0|||
27629165|NCT03612804|80483600|FG003|Overall Study|Provider involved with study activities|0|||
27629166|NCT00603538|80483601|FG000|Overall Study|Adverse Event|0|||
27629167|NCT00603538|80483602|FG001|Overall Study|Adverse Event|4|||
27629168|NCT00603538|80483603|FG002|Overall Study|Adverse Event|2|||
27629169|NCT00603538|80483601|FG000|Overall Study|Objective progression or relapse|3|||
27629170|NCT00603538|80483602|FG001|Overall Study|Objective progression or relapse|0|||
27629171|NCT00603538|80483603|FG002|Overall Study|Objective progression or relapse|0|||
27629172|NCT03784963|80483607|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
27629173|NCT03784963|80483608|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
27629174|NCT03784963|80483609|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
27737396|NCT00624338|80868318|FG001|Overall Study|Protocol Violation|3|||
27629175|NCT03784963|80483610|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
27629176|NCT02512042|80483612|FG000|Overall Study|Adverse Event|0|||
27629177|NCT02512042|80483613|FG001|Overall Study|Adverse Event|4|||
27629178|NCT02512042|80483612|FG000|Overall Study|Withdrawal by Subject|6|||
27629179|NCT02512042|80483613|FG001|Overall Study|Withdrawal by Subject|6|||
27629180|NCT02512042|80483612|FG000|Overall Study|Non-compliance with study drug|1|||
27629181|NCT02512042|80483613|FG001|Overall Study|Non-compliance with study drug|2|||
27629182|NCT02512042|80483612|FG000|Overall Study|Lost to Follow-up|5|||
27629183|NCT02512042|80483613|FG001|Overall Study|Lost to Follow-up|2|||
27629184|NCT02512042|80483612|FG000|Overall Study|Other|11|||
27629185|NCT02512042|80483613|FG001|Overall Study|Other|11|||
27629186|NCT01751724|80483614|FG000|Overall Study|extubated bef.start assigned treatment|1|||
27629187|NCT01751724|80483615|FG001|Overall Study|extubated bef.start assigned treatment|0|||
27629188|NCT01751724|80483614|FG000|Overall Study|withdrawn by parent|0|||
27629189|NCT01751724|80483615|FG001|Overall Study|withdrawn by parent|2|||
27629190|NCT00587288|80483616|FG000|Overall Study|Adverse Event|0|||
27629191|NCT00587288|80483617|FG001|Overall Study|Adverse Event|1|||
27629192|NCT00587288|80483616|FG000|Overall Study|Lack of Efficacy|2|||
27629193|NCT00587288|80483617|FG001|Overall Study|Lack of Efficacy|8|||
27629194|NCT00587288|80483616|FG000|Overall Study|Protocol Violation|1|||
27629195|NCT00587288|80483617|FG001|Overall Study|Protocol Violation|0|||
27629196|NCT00891618|80483618|FG000|Overall Study|Withdrawal by Subject|1|||
27629197|NCT00315055|80483621|FG000|Overall Study|Protocol Violation|2|||
27629198|NCT00315055|80483622|FG001|Overall Study|Protocol Violation|4|||
27629199|NCT00315055|80483621|FG000|Overall Study|Lost to Follow-up|1|||
27629200|NCT00315055|80483622|FG001|Overall Study|Lost to Follow-up|1|||
27629201|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
27629202|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
27629203|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
27629204|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
27629205|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
27629206|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
27629207|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
27629208|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
27629209|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
27629210|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
27629211|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
27629212|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
27629213|NCT02057718|80483623|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
27629214|NCT02057718|80483624|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
27629215|NCT02057718|80483623|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
27629216|NCT02057718|80483624|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
27629217|NCT02057718|80483623|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
27629218|NCT02057718|80483624|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
27629219|NCT02057718|80483623|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
27629220|NCT02057718|80483624|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
27629221|NCT02057718|80483623|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
27629222|NCT02057718|80483624|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
27629223|NCT01451814|80483625|FG000|Overall Study|Withdrawal by Subject|1|||
27629224|NCT01451814|80483626|FG001|Overall Study|Withdrawal by Subject|1|||
27629225|NCT01451814|80483625|FG000|Overall Study|Lost to Follow-up|5|||
27629226|NCT01451814|80483626|FG001|Overall Study|Lost to Follow-up|4|||
27629227|NCT01616654|80483629|FG000|Overall Study|Lack of Efficacy|1|||
27629228|NCT01616654|80483630|FG001|Overall Study|Lack of Efficacy|0|||
27629229|NCT01616654|80483631|FG002|Overall Study|Lack of Efficacy|0|||
27629230|NCT01616654|80483632|FG003|Overall Study|Lack of Efficacy|0|||
27629231|NCT01616654|80483633|FG004|Overall Study|Lack of Efficacy|1|||
27629232|NCT01616654|80483629|FG000|Overall Study|Adverse Event|0|||
27629233|NCT01616654|80483630|FG001|Overall Study|Adverse Event|1|||
27629234|NCT01616654|80483631|FG002|Overall Study|Adverse Event|2|||
27737397|NCT00624338|80868319|FG002|Overall Study|Protocol Violation|2|||
27737398|NCT00624338|80868317|FG000|Overall Study|Death|0|||
27629235|NCT01616654|80483632|FG003|Overall Study|Adverse Event|1|||
27629236|NCT01616654|80483633|FG004|Overall Study|Adverse Event|0|||
27629237|NCT01616654|80483629|FG000|Overall Study|Withdrawal by Subject|2|||
27629238|NCT01616654|80483630|FG001|Overall Study|Withdrawal by Subject|2|||
27629239|NCT01616654|80483631|FG002|Overall Study|Withdrawal by Subject|3|||
27629240|NCT01616654|80483632|FG003|Overall Study|Withdrawal by Subject|1|||
27629241|NCT01616654|80483633|FG004|Overall Study|Withdrawal by Subject|5|||
27629242|NCT01616654|80483629|FG000|Overall Study|Protocol Violation|0|||
27737399|NCT00624338|80868318|FG001|Overall Study|Death|2|||
27737400|NCT00624338|80868319|FG002|Overall Study|Death|0|||
27629243|NCT01616654|80483630|FG001|Overall Study|Protocol Violation|5|||
27629244|NCT01616654|80483631|FG002|Overall Study|Protocol Violation|2|||
27629245|NCT01616654|80483632|FG003|Overall Study|Protocol Violation|4|||
27629246|NCT01616654|80483633|FG004|Overall Study|Protocol Violation|4|||
27629247|NCT01616654|80483629|FG000|Overall Study|Lost to Follow-up|1|||
27629248|NCT01616654|80483630|FG001|Overall Study|Lost to Follow-up|0|||
27629249|NCT01616654|80483631|FG002|Overall Study|Lost to Follow-up|3|||
27629250|NCT01616654|80483632|FG003|Overall Study|Lost to Follow-up|2|||
27629251|NCT01616654|80483633|FG004|Overall Study|Lost to Follow-up|1|||
27629252|NCT01616654|80483629|FG000|Overall Study|Pregnancy|1|||
27629253|NCT01616654|80483630|FG001|Overall Study|Pregnancy|0|||
27629254|NCT01616654|80483631|FG002|Overall Study|Pregnancy|0|||
27533297|NCT01810432|80148106|FG001|Period 2|Physician Decision|0|||
27533298|NCT01810432|80148105|FG000|Period 2|Lost to Follow-up|1|||
27533299|NCT01810432|80148106|FG001|Period 2|Lost to Follow-up|1|||
27533300|NCT01068652|80148107|FG000|Overall Study|Adverse Event|4|||
27533301|NCT01068652|80148108|FG001|Overall Study|Adverse Event|0|||
27533302|NCT01068652|80148107|FG000|Overall Study|Lack of Efficacy|0|||
27629255|NCT01616654|80483632|FG003|Overall Study|Pregnancy|0|||
27629256|NCT01616654|80483633|FG004|Overall Study|Pregnancy|1|||
27629257|NCT00139737|80483634|FG000|Overall Study|Withdrawal by Subject|190|||
27629258|NCT00139737|80483634|FG000|Overall Study|Adverse Event|58|||
27629259|NCT00139737|80483634|FG000|Overall Study|Lack of Efficacy|40|||
27629260|NCT00139737|80483634|FG000|Overall Study|Lost to Follow-up|8|||
27629261|NCT00139737|80483634|FG000|Overall Study|Death|3|||
27629262|NCT00139737|80483634|FG000|Overall Study|Laboratory Abnormality|2|||
27629263|NCT00139737|80483634|FG000|Overall Study|Protocol Violation|18|||
27629264|NCT00139737|80483634|FG000|Overall Study|Withdrew During Screening Phase|8|||
27629265|NCT00139737|80483634|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
27629266|NCT00139737|80483634|FG000|Overall Study|Screened, Not Treated|13|||
27629267|NCT00920686|80483637|FG000|Overall Study|Lost to Follow-up|2|||
27629268|NCT00920686|80483638|FG001|Overall Study|Lost to Follow-up|3|||
27629269|NCT00920686|80483639|FG002|Overall Study|Lost to Follow-up|1|||
27629270|NCT00920686|80483637|FG000|Overall Study|Study drug dosing criteria not met|17|||
27629271|NCT00920686|80483638|FG001|Overall Study|Study drug dosing criteria not met|19|||
27913402|NCT01000974|81522080|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
27913403|NCT01000974|81522081|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
27913404|NCT01000974|81522079|FG000|Booster Vaccination Phase|Other|24|||
27913405|NCT01000974|81522080|FG001|Booster Vaccination Phase|Other|6|||
27913406|NCT01000974|81522081|FG002|Booster Vaccination Phase|Other|4|||
27913407|NCT02302846|81522082|FG000|Overall Study|Withdrawal by Subject|1|||
27913408|NCT03669549|81522096|FG000|Overall Study|Adverse Event|4|||
27533303|NCT01068652|80148108|FG001|Overall Study|Lack of Efficacy|2|||
27533304|NCT01068652|80148107|FG000|Overall Study|Lost to Follow-up|2|||
27533305|NCT01068652|80148108|FG001|Overall Study|Lost to Follow-up|1|||
27533306|NCT01068652|80148107|FG000|Overall Study|Protocol Violation|3|||
27533307|NCT01068652|80148108|FG001|Overall Study|Protocol Violation|6|||
27533308|NCT01068652|80148107|FG000|Overall Study|Withdrawal criteria|1|||
27533309|NCT01068652|80148108|FG001|Overall Study|Withdrawal criteria|2|||
27533310|NCT01068652|80148107|FG000|Overall Study|Patient was not eligible|1|||
27533311|NCT01068652|80148108|FG001|Overall Study|Patient was not eligible|0|||
27533312|NCT01068652|80148107|FG000|Overall Study|Unclassified|7|||
27533313|NCT01068652|80148108|FG001|Overall Study|Unclassified|4|||
27533314|NCT02027376|80148111|FG000|Overall Study|Death|1|||
27533315|NCT02027376|80148112|FG001|Overall Study|Death|0|||
27533316|NCT02027376|80148113|FG002|Overall Study|Death|0|||
27533317|NCT04950166|80148118|FG000|Overall Study|Withdrawal by Subject|1|||
27533318|NCT01691898|80148119|FG000|Overall Study|Death|34|||
27533319|NCT01691898|80148120|FG001|Overall Study|Death|32|||
27533320|NCT01691898|80148121|FG002|Overall Study|Death|6|||
27533321|NCT01691898|80148122|FG003|Overall Study|Death|3|||
27533322|NCT01691898|80148123|FG004|Overall Study|Death|8|||
27533323|NCT01691898|80148124|FG005|Overall Study|Death|31|||
27533324|NCT01691898|80148119|FG000|Overall Study|Adverse Event|0|||
27629272|NCT00920686|80483639|FG002|Overall Study|Study drug dosing criteria not met|12|||
27913409|NCT03669549|81522096|FG000|Overall Study|Withdrawal by Subject|1|||
27533325|NCT01691898|80148120|FG001|Overall Study|Adverse Event|1|||
27533326|NCT01691898|80148121|FG002|Overall Study|Adverse Event|0|||
27533327|NCT01691898|80148122|FG003|Overall Study|Adverse Event|1|||
27533328|NCT01691898|80148123|FG004|Overall Study|Adverse Event|1|||
27533329|NCT01691898|80148124|FG005|Overall Study|Adverse Event|0|||
27533330|NCT01691898|80148119|FG000|Overall Study|Progression of Disease|1|||
27629273|NCT00906035|80483640|FG000|Overall Study|Withdrawal by Subject|2|||
27629274|NCT00906035|80483641|FG001|Overall Study|Withdrawal by Subject|3|||
27629275|NCT00906035|80483642|FG002|Overall Study|Withdrawal by Subject|0|||
27629276|NCT02174562|80483643|FG000|Overall Study|Withdrawal by Subject|7|||
27629277|NCT02174562|80483644|FG001|Overall Study|Withdrawal by Subject|2|||
27629278|NCT02174562|80483643|FG000|Overall Study|Death|2|||
27533331|NCT01691898|80148120|FG001|Overall Study|Progression of Disease|2|||
27533332|NCT01691898|80148121|FG002|Overall Study|Progression of Disease|1|||
27533333|NCT01691898|80148122|FG003|Overall Study|Progression of Disease|0|||
27533334|NCT01691898|80148123|FG004|Overall Study|Progression of Disease|0|||
27533335|NCT01691898|80148124|FG005|Overall Study|Progression of Disease|1|||
27533336|NCT01691898|80148119|FG000|Overall Study|Lost to Follow-up|3|||
27533337|NCT01691898|80148120|FG001|Overall Study|Lost to Follow-up|1|||
27533338|NCT01691898|80148121|FG002|Overall Study|Lost to Follow-up|0|||
27533339|NCT01691898|80148122|FG003|Overall Study|Lost to Follow-up|0|||
27533340|NCT01691898|80148123|FG004|Overall Study|Lost to Follow-up|1|||
27533341|NCT01691898|80148124|FG005|Overall Study|Lost to Follow-up|0|||
27533342|NCT01691898|80148119|FG000|Overall Study|Withdrawal by Subject|9|||
27533343|NCT01691898|80148120|FG001|Overall Study|Withdrawal by Subject|8|||
27533344|NCT01691898|80148121|FG002|Overall Study|Withdrawal by Subject|2|||
27533345|NCT01691898|80148122|FG003|Overall Study|Withdrawal by Subject|1|||
27533346|NCT01691898|80148123|FG004|Overall Study|Withdrawal by Subject|3|||
27533347|NCT01691898|80148124|FG005|Overall Study|Withdrawal by Subject|3|||
27533348|NCT01691898|80148119|FG000|Overall Study|Non-Compliance|0|||
27533349|NCT01691898|80148120|FG001|Overall Study|Non-Compliance|0|||
27533350|NCT01691898|80148121|FG002|Overall Study|Non-Compliance|0|||
27533351|NCT01691898|80148122|FG003|Overall Study|Non-Compliance|0|||
27533352|NCT01691898|80148123|FG004|Overall Study|Non-Compliance|1|||
27533353|NCT01691898|80148124|FG005|Overall Study|Non-Compliance|0|||
27533354|NCT04889222|80148125|FG000|Overall Study|Did not meet eligibility criteria|8|||
27533355|NCT04889222|80148125|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
27533356|NCT04889222|80148125|FG000|Overall Study|Did not proceed due to time constraints|5|||
27533357|NCT01193660|80148126|FG000|Overall Study|Withdrawal by Subject|2|||
27533358|NCT01193660|80148127|FG001|Overall Study|Withdrawal by Subject|3|||
27533359|NCT01193660|80148128|FG002|Overall Study|Withdrawal by Subject|1|||
27533360|NCT01193660|80148126|FG000|Overall Study|Death|1|||
27533361|NCT01193660|80148127|FG001|Overall Study|Death|0|||
27533362|NCT01193660|80148128|FG002|Overall Study|Death|0|||
27533363|NCT01193660|80148126|FG000|Overall Study|Physician Decision|1|||
27533364|NCT01193660|80148127|FG001|Overall Study|Physician Decision|0|||
27629279|NCT02174562|80483644|FG001|Overall Study|Death|0|||
27629280|NCT02174562|80483643|FG000|Overall Study|Lost to Follow-up|0|||
27737401|NCT00624338|80868317|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
27737402|NCT00624338|80868318|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
27737403|NCT00624338|80868319|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
27737404|NCT00624338|80868317|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
27737405|NCT00624338|80868318|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
27737406|NCT00624338|80868319|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
27737407|NCT00624338|80868317|FG000|Overall Study|Other|15|||
27737408|NCT00624338|80868318|FG001|Overall Study|Other|5|||
27737409|NCT00624338|80868319|FG002|Overall Study|Other|9|||
27737410|NCT00624338|80868317|FG000|Overall Study|Randomized but not treated|2|||
27913410|NCT03669549|81522096|FG000|Overall Study|Study terminated by the Sponsor|1|||
27533365|NCT01193660|80148128|FG002|Overall Study|Physician Decision|1|||
27629281|NCT02174562|80483644|FG001|Overall Study|Lost to Follow-up|3|||
27629282|NCT04176458|80483647|FG000|Overall Study|Covid 19|4|||
27629283|NCT00619645|80483651|FG000|Overall Study|Adverse Event|1|||
27629284|NCT03264456|80483653|FG000|Overall Study|Withdrawal by Subject|3|||
27629285|NCT03264456|80483653|FG000|Overall Study|Lost to Follow-up|1|||
27629286|NCT02930343|80483659|FG000|Overall Study|Lost to Follow-up|9|||
27629287|NCT02930343|80483660|FG001|Overall Study|Lost to Follow-up|7|||
27629288|NCT00197015|80483661|FG000|Overall Study|Adverse Event|3|||
27629289|NCT00197015|80483662|FG001|Overall Study|Adverse Event|0|||
27629290|NCT00197015|80483663|FG002|Overall Study|Adverse Event|1|||
27629291|NCT00197015|80483661|FG000|Overall Study|Protocol Violation|0|||
27629292|NCT00197015|80483662|FG001|Overall Study|Protocol Violation|3|||
27629293|NCT00197015|80483663|FG002|Overall Study|Protocol Violation|3|||
27629294|NCT00197015|80483661|FG000|Overall Study|Withdrawal by Subject|17|||
27629295|NCT00197015|80483662|FG001|Overall Study|Withdrawal by Subject|37|||
27629296|NCT00197015|80483663|FG002|Overall Study|Withdrawal by Subject|34|||
27629297|NCT00197015|80483661|FG000|Overall Study|Lost to Follow-up|28|||
27629298|NCT00197015|80483662|FG001|Overall Study|Lost to Follow-up|46|||
27913411|NCT01657162|81522097|FG000|Overall Study|Adverse Event|26|||
27533366|NCT00437320|80148131|FG000|Overall Study|Participant request|2|||
27533367|NCT00437320|80148132|FG001|Overall Study|Participant request|1|||
27533368|NCT00437320|80148133|FG002|Overall Study|Participant request|4|||
27533369|NCT02046733|80148143|FG000|Overall Study|never initiated 'treatment visits'|6|||
27533370|NCT02046733|80148144|FG001|Overall Study|never initiated 'treatment visits'|0|||
27533371|NCT04041375|80148145|FG000|Intervention Phase|Withdrawal by Subject|2|||
27629299|NCT00197015|80483663|FG002|Overall Study|Lost to Follow-up|37|||
27629300|NCT00197015|80483661|FG000|Overall Study|Other|2|||
27629301|NCT00197015|80483662|FG001|Overall Study|Other|3|||
27629302|NCT00197015|80483663|FG002|Overall Study|Other|2|||
27737411|NCT00624338|80868318|FG001|Overall Study|Randomized but not treated|1|||
27533372|NCT04041375|80148146|FG001|Intervention Phase|Withdrawal by Subject|2|||
27533373|NCT04041375|80148145|FG000|Follow-up Phase|Death|2|||
27913412|NCT01657162|81522098|FG001|Overall Study|Adverse Event|36|||
27913413|NCT01657162|81522097|FG000|Overall Study|Withdrawal by Subject|13|||
27913414|NCT01657162|81522098|FG001|Overall Study|Withdrawal by Subject|13|||
27913415|NCT01657162|81522097|FG000|Overall Study|Continuing Significant Deterioration|9|||
27913416|NCT01657162|81522098|FG001|Overall Study|Continuing Significant Deterioration|3|||
27913417|NCT01657162|81522097|FG000|Overall Study|Refusal of Treatment|4|||
27913418|NCT01657162|81522098|FG001|Overall Study|Refusal of Treatment|6|||
27913419|NCT01657162|81522097|FG000|Overall Study|Lost to Follow-up|3|||
27913420|NCT01657162|81522098|FG001|Overall Study|Lost to Follow-up|4|||
27533374|NCT04041375|80148146|FG001|Follow-up Phase|Death|0|||
27533375|NCT04041375|80148145|FG000|Follow-up Phase|Lost to Follow-up|2|||
27533376|NCT04041375|80148146|FG001|Follow-up Phase|Lost to Follow-up|1|||
27533377|NCT04041375|80148145|FG000|Follow-up Phase|Too ill|3|||
27533378|NCT04041375|80148146|FG001|Follow-up Phase|Too ill|0|||
27533379|NCT01442038|80148148|FG000|Overall Study|Death|35|||
27533380|NCT01442038|80148149|FG001|Overall Study|Death|29|||
27533381|NCT01442038|80148148|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
27533382|NCT01442038|80148149|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
27533383|NCT01442038|80148148|FG000|Overall Study|Participant Withdrew Consent|137|||
27533384|NCT01442038|80148149|FG001|Overall Study|Participant Withdrew Consent|102|||
27533385|NCT01442038|80148148|FG000|Overall Study|Lost to Follow-up|37|||
27533386|NCT01442038|80148149|FG001|Overall Study|Lost to Follow-up|51|||
27533387|NCT01442038|80148148|FG000|Overall Study|Adverse Event|26|||
27533388|NCT01442038|80148149|FG001|Overall Study|Adverse Event|15|||
27533389|NCT01442038|80148148|FG000|Overall Study|Protocol Deviation|9|||
27533390|NCT01442038|80148149|FG001|Overall Study|Protocol Deviation|20|||
27533391|NCT01442038|80148148|FG000|Overall Study|Investigator's Discretion|13|||
27533392|NCT01442038|80148149|FG001|Overall Study|Investigator's Discretion|16|||
27533393|NCT01442038|80148148|FG000|Overall Study|Study Terminated By Sponsor|2|||
27533394|NCT01442038|80148149|FG001|Overall Study|Study Terminated By Sponsor|3|||
27533395|NCT03845543|80148160|FG000|Overall Study|Death|25|||
27533396|NCT03845543|80148160|FG000|Overall Study|Withdrawal by Subject|2|||
27533397|NCT03845543|80148160|FG000|Overall Study|Lost to Follow-up|12|||
27533398|NCT03845543|80148160|FG000|Overall Study|Adverse Event|17|||
27533399|NCT01231347|80148161|FG000|Overall Study|Full Consent withdrawn|19|||
27533400|NCT01231347|80148162|FG001|Overall Study|Full Consent withdrawn|19|||
27533401|NCT01231347|80148163|FG002|Overall Study|Full Consent withdrawn|11|||
27533402|NCT01231347|80148161|FG000|Overall Study|Lost to Follow-up|4|||
27533403|NCT01231347|80148162|FG001|Overall Study|Lost to Follow-up|2|||
27533404|NCT01231347|80148163|FG002|Overall Study|Lost to Follow-up|2|||
27533405|NCT01231347|80148161|FG000|Overall Study|Death|202|||
27533406|NCT01231347|80148162|FG001|Overall Study|Death|210|||
27533407|NCT01231347|80148163|FG002|Overall Study|Death|101|||
27533408|NCT01231347|80148161|FG000|Overall Study|other event|7|||
27533409|NCT01231347|80148162|FG001|Overall Study|other event|9|||
27533410|NCT01231347|80148163|FG002|Overall Study|other event|3|||
27533411|NCT00532155|80148167|FG000|Overall Study|Adverse Event|66|||
27533412|NCT00532155|80148168|FG001|Overall Study|Adverse Event|123|||
27533413|NCT00532155|80148167|FG000|Overall Study|Lack of Efficacy|332|||
27533414|NCT00532155|80148168|FG001|Overall Study|Lack of Efficacy|255|||
27533415|NCT00532155|80148167|FG000|Overall Study|Protocol Violation|1|||
27533416|NCT00532155|80148168|FG001|Overall Study|Protocol Violation|3|||
27533417|NCT00532155|80148167|FG000|Overall Study|Lost to Follow-up|2|||
27533418|NCT00532155|80148168|FG001|Overall Study|Lost to Follow-up|0|||
27533419|NCT00532155|80148167|FG000|Overall Study|Physician Decision|16|||
27533420|NCT00532155|80148168|FG001|Overall Study|Physician Decision|15|||
27533421|NCT00532155|80148167|FG000|Overall Study|Withdrawal by Subject|23|||
27533422|NCT00532155|80148168|FG001|Overall Study|Withdrawal by Subject|44|||
27533423|NCT00532155|80148167|FG000|Overall Study|Consent withdrawn|5|||
27533424|NCT00532155|80148168|FG001|Overall Study|Consent withdrawn|7|||
27533425|NCT00532155|80148167|FG000|Overall Study|Moved|1|||
27533426|NCT00532155|80148168|FG001|Overall Study|Moved|0|||
27533427|NCT00532155|80148167|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
27913421|NCT01657162|81522097|FG000|Overall Study|Death|2|||
27913422|NCT01657162|81522098|FG001|Overall Study|Death|3|||
27913423|NCT01657162|81522097|FG000|Overall Study|Inability to Complete Study Procedures|1|||
27913424|NCT01657162|81522098|FG001|Overall Study|Inability to Complete Study Procedures|7|||
27533428|NCT00532155|80148168|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
27533429|NCT00532155|80148167|FG000|Overall Study|Occurence of a second cancer|0|||
27533430|NCT00532155|80148168|FG001|Overall Study|Occurence of a second cancer|1|||
27533431|NCT00532155|80148167|FG000|Overall Study|Occurence of a secondary cancer|0|||
27533432|NCT00532155|80148168|FG001|Overall Study|Occurence of a secondary cancer|1|||
27533433|NCT00532155|80148167|FG000|Overall Study|Promotor ended study|1|||
27533434|NCT00532155|80148168|FG001|Overall Study|Promotor ended study|0|||
27533435|NCT00532155|80148167|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
27533436|NCT00532155|80148168|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
27629303|NCT02839330|80483664|FG000|Overall Study|Adverse Event|0|||
27913425|NCT01657162|81522097|FG000|Overall Study|Protocol Violation|1|||
27533437|NCT00532155|80148167|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
27533438|NCT00532155|80148168|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
27533439|NCT00532155|80148167|FG000|Overall Study|Study stopped|1|||
27533440|NCT00532155|80148168|FG001|Overall Study|Study stopped|0|||
27533441|NCT00532155|80148167|FG000|Overall Study|Study terminated by sponsor|1|||
27533442|NCT00532155|80148168|FG001|Overall Study|Study terminated by sponsor|0|||
27533443|NCT00532155|80148167|FG000|Overall Study|Study termination stop further treatment|4|||
27533444|NCT00532155|80148168|FG001|Overall Study|Study termination stop further treatment|0|||
27533445|NCT00532155|80148167|FG000|Overall Study|Did not receive study medication|2|||
27533446|NCT00532155|80148168|FG001|Overall Study|Did not receive study medication|6|||
27533447|NCT00598702|80148169|FG000|Overall Study|Other|0|||
27629304|NCT02839330|80483665|FG001|Overall Study|Adverse Event|1|||
27629305|NCT02839330|80483666|FG002|Overall Study|Adverse Event|2|||
27629306|NCT02839330|80483667|FG003|Overall Study|Adverse Event|2|||
27629307|NCT02839330|80483664|FG000|Overall Study|Death|4|||
27629308|NCT02839330|80483665|FG001|Overall Study|Death|6|||
27533448|NCT00598702|80148170|FG001|Overall Study|Other|2|||
27629309|NCT02839330|80483666|FG002|Overall Study|Death|1|||
27629310|NCT02839330|80483667|FG003|Overall Study|Death|1|||
27629311|NCT02839330|80483664|FG000|Overall Study|Withdrawal by Subject|27|||
27629312|NCT02839330|80483665|FG001|Overall Study|Withdrawal by Subject|19|||
27629313|NCT02839330|80483666|FG002|Overall Study|Withdrawal by Subject|11|||
27629314|NCT02839330|80483667|FG003|Overall Study|Withdrawal by Subject|13|||
27629315|NCT02839330|80483664|FG000|Overall Study|Lost to Follow-up|22|||
27737412|NCT00624338|80868319|FG002|Overall Study|Randomized but not treated|3|||
27737413|NCT01006356|80868320|FG000|Overall Study|Adverse Event|6|||
27737414|NCT01006356|80868320|FG000|Overall Study|Physician Decision|1|||
27737415|NCT01006356|80868320|FG000|Overall Study|Paticipants did not cooperate|6|||
27737416|NCT01006356|80868320|FG000|Overall Study|Withdrawal by Subject|1|||
27737417|NCT01006356|80868320|FG000|Overall Study|Choice by participants|2|||
27737418|NCT01006356|80868320|FG000|Overall Study|Protocol Violation|3|||
27737419|NCT01006356|80868320|FG000|Overall Study|Other|23|||
27737420|NCT02900092|80868330|FG000|Overall Study|Adverse Event|1|||
27737421|NCT02299934|80868335|FG000|Overall Study|Termination of study|13|||
27737422|NCT01676961|80868336|FG000|Overall Study|Death|3|||
27737423|NCT01676961|80868336|FG000|Overall Study|Lost to Follow-up|1|||
27737424|NCT01676961|80868336|FG000|Overall Study|Withdrawal by Subject|1|||
27737425|NCT01025635|80868344|FG000|Overall Study|Withdrawal by Subject|6|||
27737426|NCT01025635|80868345|FG001|Overall Study|Withdrawal by Subject|7|||
27737427|NCT01025635|80868344|FG000|Overall Study|Protocol Violation|4|||
27737428|NCT01025635|80868345|FG001|Overall Study|Protocol Violation|2|||
27737429|NCT01025635|80868344|FG000|Overall Study|Lack of Efficacy|0|||
27737430|NCT01025635|80868345|FG001|Overall Study|Lack of Efficacy|1|||
27737431|NCT01025635|80868344|FG000|Overall Study|Lost to Follow-up|9|||
27737432|NCT01025635|80868345|FG001|Overall Study|Lost to Follow-up|13|||
27737433|NCT01025635|80868344|FG000|Overall Study|Reason not known|4|||
27737434|NCT01025635|80868345|FG001|Overall Study|Reason not known|2|||
27737435|NCT03185130|80868346|FG000|Overall Study|Withdrawal by Subject|0|||
27737436|NCT03185130|80868347|FG001|Overall Study|Withdrawal by Subject|2|||
27737437|NCT02015819|80868348|FG000|Overall Study|Rickham catheter was misaligned|0|||
27737438|NCT02015819|80868349|FG001|Overall Study|Rickham catheter was misaligned|0|||
27737439|NCT02015819|80868350|FG002|Overall Study|Rickham catheter was misaligned|0|||
27533449|NCT00598702|80148171|FG002|Overall Study|Other|0|||
27533450|NCT00598702|80148172|FG003|Overall Study|Other|0|||
27533451|NCT00598702|80148173|FG004|Overall Study|Other|0|||
27533452|NCT00598702|80148174|FG005|Overall Study|Other|1|||
27533453|NCT00598702|80148175|FG006|Overall Study|Other|0|||
27533454|NCT00598702|80148176|FG007|Overall Study|Other|0|||
27533455|NCT00598702|80148169|FG000|Overall Study|Early discharge from hospital|0|||
27533456|NCT00598702|80148170|FG001|Overall Study|Early discharge from hospital|0|||
27629316|NCT02839330|80483665|FG001|Overall Study|Lost to Follow-up|27|||
27629317|NCT02839330|80483666|FG002|Overall Study|Lost to Follow-up|29|||
27629318|NCT02839330|80483667|FG003|Overall Study|Lost to Follow-up|25|||
27629319|NCT02839330|80483664|FG000|Overall Study|Administrative Reason|0|||
27737440|NCT02015819|80868351|FG003|Overall Study|Rickham catheter was misaligned|1|||
27737444|NCT02251743|80868355|FG000|Overall Study|Withdrawal by Subject|1|||
27737445|NCT02251743|80868356|FG001|Overall Study|Withdrawal by Subject|1|||
27737446|NCT02201940|80868357|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
27737447|NCT02201940|80868358|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
27737448|NCT02201940|80868357|FG000|Overall Study|Lack of Efficacy|2|||
27737449|NCT02201940|80868358|FG001|Overall Study|Lack of Efficacy|113|||
27533457|NCT00598702|80148171|FG002|Overall Study|Early discharge from hospital|2|||
27533458|NCT00598702|80148172|FG003|Overall Study|Early discharge from hospital|5|||
27533459|NCT00598702|80148173|FG004|Overall Study|Early discharge from hospital|0|||
27533460|NCT00598702|80148174|FG005|Overall Study|Early discharge from hospital|10|||
27533461|NCT00598702|80148175|FG006|Overall Study|Early discharge from hospital|1|||
27533462|NCT00598702|80148176|FG007|Overall Study|Early discharge from hospital|0|||
27533463|NCT00598702|80148169|FG000|Overall Study|Adverse Event|0|||
27533464|NCT00598702|80148170|FG001|Overall Study|Adverse Event|0|||
27533465|NCT00598702|80148171|FG002|Overall Study|Adverse Event|0|||
27533466|NCT00598702|80148172|FG003|Overall Study|Adverse Event|1|||
27533467|NCT00598702|80148173|FG004|Overall Study|Adverse Event|0|||
27533468|NCT00598702|80148174|FG005|Overall Study|Adverse Event|0|||
27533469|NCT00598702|80148175|FG006|Overall Study|Adverse Event|0|||
27533470|NCT00598702|80148176|FG007|Overall Study|Adverse Event|0|||
27533471|NCT00598702|80148169|FG000|Overall Study|Withdrawal by Subject|0|||
27629320|NCT02839330|80483665|FG001|Overall Study|Administrative Reason|0|||
27629321|NCT02839330|80483666|FG002|Overall Study|Administrative Reason|0|||
27629322|NCT02839330|80483667|FG003|Overall Study|Administrative Reason|1|||
27629323|NCT02839330|80483664|FG000|Overall Study|Protocol Violation|1|||
27629324|NCT02839330|80483665|FG001|Overall Study|Protocol Violation|2|||
27629325|NCT02839330|80483666|FG002|Overall Study|Protocol Violation|2|||
27629326|NCT02839330|80483667|FG003|Overall Study|Protocol Violation|3|||
27629327|NCT02839330|80483664|FG000|Overall Study|Other reason, not specified|4|||
27629328|NCT02839330|80483665|FG001|Overall Study|Other reason, not specified|3|||
27629329|NCT02839330|80483666|FG002|Overall Study|Other reason, not specified|3|||
27629330|NCT02839330|80483667|FG003|Overall Study|Other reason, not specified|6|||
27629331|NCT01570751|80483668|FG000|Period A (16 Weeks)|Protocol Violation|1|||
27629332|NCT01570751|80483669|FG001|Period A (16 Weeks)|Protocol Violation|1|||
27629333|NCT01570751|80483668|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
27629334|NCT01570751|80483669|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
27629335|NCT01570751|80483668|FG000|Period A (16 Weeks)|Unclassified|2|||
27629336|NCT01570751|80483669|FG001|Period A (16 Weeks)|Unclassified|3|||
27629337|NCT01570751|80483668|FG000|Period B (16 Weeks)|Adverse Event|1|||
27629338|NCT01570751|80483669|FG001|Period B (16 Weeks)|Adverse Event|0|||
27629339|NCT01570751|80483668|FG000|Period B (16 Weeks)|Protocol Violation|0|||
27629340|NCT01570751|80483669|FG001|Period B (16 Weeks)|Protocol Violation|1|||
27629341|NCT03467724|80483672|FG000|Overall Study|Lost to Follow-up|5|||
27629342|NCT03467724|80483672|FG000|Overall Study|Withdrawal by Subject|1|||
27629343|NCT03467724|80483672|FG000|Overall Study|Protocol Violation|1|||
27629344|NCT03467724|80483672|FG000|Overall Study|Adverse Event|1|||
27629345|NCT03055767|80483673|FG000|Open-Label Period|Lost to Follow-up|0|||
27629346|NCT03055767|80483674|FG001|Open-Label Period|Lost to Follow-up|0|||
27629347|NCT03055767|80483675|FG002|Open-Label Period|Lost to Follow-up|2|||
27629348|NCT03055767|80483676|FG003|Open-Label Period|Lost to Follow-up|0|||
27629349|NCT03055767|80483673|FG000|Open-Label Period|Withdrawal by Subject|0|||
27629350|NCT03055767|80483674|FG001|Open-Label Period|Withdrawal by Subject|0|||
27629351|NCT03055767|80483675|FG002|Open-Label Period|Withdrawal by Subject|0|||
27629352|NCT03055767|80483676|FG003|Open-Label Period|Withdrawal by Subject|1|||
27629353|NCT00256243|80483679|FG000|Overall Study|Lost to Follow-up|2|||
27629354|NCT00256243|80483679|FG000|Overall Study|Death|7|||
27629355|NCT00256243|80483679|FG000|Overall Study|Not treated|1|||
27629356|NCT01664104|80483680|FG000|Overall Study|Adverse Event|6|||
27629357|NCT01664104|80483680|FG000|Overall Study|Lack of Efficacy|2|||
27629358|NCT01664104|80483680|FG000|Overall Study|Withdrawal by Subject|1|||
27629359|NCT01664104|80483680|FG000|Overall Study|Lost to Follow-up|4|||
27629360|NCT01664104|80483680|FG000|Overall Study|Other|1|||
27629361|NCT01664104|80483680|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
27629362|NCT01306331|80483683|FG000|Overall Study|Adverse Event|28|||
27629363|NCT01306331|80483684|FG001|Overall Study|Adverse Event|25|||
27629364|NCT01306331|80483683|FG000|Overall Study|Lost to Follow-up|321|||
27629365|NCT01306331|80483684|FG001|Overall Study|Lost to Follow-up|323|||
27629366|NCT01306331|80483683|FG000|Overall Study|Physician Decision|26|||
27629367|NCT01306331|80483684|FG001|Overall Study|Physician Decision|22|||
27629368|NCT01306331|80483683|FG000|Overall Study|Pregnancy|136|||
27629369|NCT01306331|80483684|FG001|Overall Study|Pregnancy|151|||
27629370|NCT01306331|80483683|FG000|Overall Study|Protocol Violation|154|||
27629371|NCT01306331|80483684|FG001|Overall Study|Protocol Violation|124|||
27629372|NCT01306331|80483683|FG000|Overall Study|Withdrawal by Subject|163|||
27629373|NCT01306331|80483684|FG001|Overall Study|Withdrawal by Subject|152|||
27629374|NCT01306331|80483683|FG000|Overall Study|Not sexually active|29|||
27533472|NCT00598702|80148170|FG001|Overall Study|Withdrawal by Subject|0|||
27533473|NCT00598702|80148171|FG002|Overall Study|Withdrawal by Subject|0|||
27629375|NCT01306331|80483684|FG001|Overall Study|Not sexually active|28|||
27629376|NCT01306331|80483683|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
27629377|NCT01306331|80483684|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
27533474|NCT00598702|80148172|FG003|Overall Study|Withdrawal by Subject|1|||
27533475|NCT00598702|80148173|FG004|Overall Study|Withdrawal by Subject|1|||
27629378|NCT01306331|80483683|FG000|Overall Study|Other|34|||
27629379|NCT01306331|80483684|FG001|Overall Study|Other|32|||
27629380|NCT05298111|80483685|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
27629381|NCT05298111|80483686|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
27737450|NCT02201940|80868357|FG000|Overall Study|Lost to Follow-up|5|||
27737451|NCT02201940|80868358|FG001|Overall Study|Lost to Follow-up|0|||
27737452|NCT02201940|80868357|FG000|Overall Study|Withdrew Consent|2|||
27737453|NCT02201940|80868358|FG001|Overall Study|Withdrew Consent|1|||
27737454|NCT02201940|80868357|FG000|Overall Study|Investigator's Discretion|1|||
27737455|NCT02201940|80868358|FG001|Overall Study|Investigator's Discretion|1|||
27737456|NCT02201940|80868357|FG000|Overall Study|Death|1|||
27629382|NCT03631199|80483687|FG000|Overall Study|Progressive disease|9|||
27629383|NCT03631199|80483688|FG001|Overall Study|Progressive disease|5|||
27629384|NCT03631199|80483689|FG002|Overall Study|Progressive disease|5|||
27629385|NCT03631199|80483690|FG003|Overall Study|Progressive disease|149|||
27629386|NCT03631199|80483691|FG004|Overall Study|Progressive disease|148|||
27629387|NCT03631199|80483687|FG000|Overall Study|Physician Decision|0|||
27629388|NCT03631199|80483688|FG001|Overall Study|Physician Decision|2|||
27629389|NCT03631199|80483689|FG002|Overall Study|Physician Decision|3|||
27629390|NCT03631199|80483690|FG003|Overall Study|Physician Decision|19|||
27629391|NCT03631199|80483691|FG004|Overall Study|Physician Decision|13|||
27629392|NCT03631199|80483687|FG000|Overall Study|Adverse Event|1|||
27629393|NCT03631199|80483688|FG001|Overall Study|Adverse Event|1|||
27629394|NCT03631199|80483689|FG002|Overall Study|Adverse Event|0|||
27629395|NCT03631199|80483690|FG003|Overall Study|Adverse Event|28|||
27629396|NCT03631199|80483691|FG004|Overall Study|Adverse Event|29|||
27737457|NCT02201940|80868358|FG001|Overall Study|Death|0|||
27737458|NCT02201940|80868357|FG000|Overall Study|Adverse Event|0|||
27737459|NCT02201940|80868358|FG001|Overall Study|Adverse Event|1|||
27737460|NCT01826214|80868359|FG000|Overall Study|Adverse Event|7|||
27737461|NCT01826214|80868360|FG001|Overall Study|Adverse Event|6|||
27737462|NCT01826214|80868359|FG000|Overall Study|Death|3|||
27737463|NCT01826214|80868360|FG001|Overall Study|Death|1|||
27737464|NCT01826214|80868359|FG000|Overall Study|Lost to Follow-up|1|||
27737465|NCT01826214|80868360|FG001|Overall Study|Lost to Follow-up|0|||
27629397|NCT03631199|80483687|FG000|Overall Study|Death|0|||
27629398|NCT03631199|80483688|FG001|Overall Study|Death|1|||
27629399|NCT03631199|80483689|FG002|Overall Study|Death|0|||
27629400|NCT03631199|80483690|FG003|Overall Study|Death|35|||
27629401|NCT03631199|80483691|FG004|Overall Study|Death|48|||
27629402|NCT03631199|80483687|FG000|Overall Study|Subject decision|0|||
27629403|NCT03631199|80483688|FG001|Overall Study|Subject decision|1|||
27629404|NCT03631199|80483689|FG002|Overall Study|Subject decision|0|||
27629405|NCT03631199|80483690|FG003|Overall Study|Subject decision|12|||
27629406|NCT03631199|80483691|FG004|Overall Study|Subject decision|12|||
27629407|NCT03631199|80483687|FG000|Overall Study|No treated|0|||
27629408|NCT03631199|80483688|FG001|Overall Study|No treated|0|||
27629409|NCT03631199|80483689|FG002|Overall Study|No treated|0|||
27629410|NCT03631199|80483690|FG003|Overall Study|No treated|0|||
27629411|NCT03631199|80483691|FG004|Overall Study|No treated|1|||
27629412|NCT03631199|80483687|FG000|Overall Study|Treatment ongoing|0|||
27629413|NCT03631199|80483688|FG001|Overall Study|Treatment ongoing|1|||
27629414|NCT03631199|80483689|FG002|Overall Study|Treatment ongoing|1|||
27629415|NCT03631199|80483690|FG003|Overall Study|Treatment ongoing|76|||
27629416|NCT03631199|80483691|FG004|Overall Study|Treatment ongoing|71|||
27629417|NCT03631199|80483687|FG000|Overall Study|Guardian decision|0|||
27629418|NCT03631199|80483688|FG001|Overall Study|Guardian decision|0|||
27629419|NCT03631199|80483689|FG002|Overall Study|Guardian decision|0|||
27629420|NCT03631199|80483690|FG003|Overall Study|Guardian decision|1|||
27629421|NCT03631199|80483691|FG004|Overall Study|Guardian decision|1|||
27629422|NCT04511650|80483692|FG000|Overall Study|Lost to Follow-up|1|||
27629423|NCT04511650|80483693|FG001|Overall Study|Lost to Follow-up|0|||
27629424|NCT04511650|80483694|FG002|Overall Study|Lost to Follow-up|0|||
27737466|NCT01826214|80868359|FG000|Overall Study|Physician Decision|0|||
27913426|NCT01657162|81522098|FG001|Overall Study|Protocol Violation|0|||
27913427|NCT01657162|81522097|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
27913428|NCT01657162|81522098|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
27629425|NCT04511650|80483692|FG000|Overall Study|Withdrawal by Subject|1|||
27629426|NCT04511650|80483693|FG001|Overall Study|Withdrawal by Subject|0|||
27629427|NCT04511650|80483694|FG002|Overall Study|Withdrawal by Subject|0|||
27737467|NCT01826214|80868360|FG001|Overall Study|Physician Decision|2|||
27737468|NCT01826214|80868359|FG000|Overall Study|Progressive disease|22|||
27737469|NCT01826214|80868360|FG001|Overall Study|Progressive disease|21|||
27629428|NCT04511650|80483692|FG000|Overall Study|reason not provided|0|||
27629429|NCT04511650|80483693|FG001|Overall Study|reason not provided|0|||
27629430|NCT04511650|80483694|FG002|Overall Study|reason not provided|1|||
27629431|NCT04511650|80483692|FG000|Overall Study|Death|1|||
27629432|NCT04511650|80483693|FG001|Overall Study|Death|1|||
27629433|NCT04511650|80483694|FG002|Overall Study|Death|1|||
27629434|NCT00995709|80483699|FG000|Overall Study|Adverse Event|4|||
27629435|NCT00995709|80483700|FG001|Overall Study|Adverse Event|2|||
27629436|NCT00995709|80483701|FG002|Overall Study|Adverse Event|0|||
27629437|NCT00995709|80483699|FG000|Overall Study|Lack of Efficacy|0|||
27629438|NCT00995709|80483700|FG001|Overall Study|Lack of Efficacy|1|||
27629439|NCT00995709|80483701|FG002|Overall Study|Lack of Efficacy|4|||
27913429|NCT01657162|81522097|FG000|Overall Study|Other than Specified|0|||
27533476|NCT00598702|80148174|FG005|Overall Study|Withdrawal by Subject|0|||
27533477|NCT00598702|80148175|FG006|Overall Study|Withdrawal by Subject|0|||
27533478|NCT00598702|80148176|FG007|Overall Study|Withdrawal by Subject|0|||
27533479|NCT00598702|80148169|FG000|Overall Study|Physician Decision|0|||
27533480|NCT00598702|80148170|FG001|Overall Study|Physician Decision|0|||
27533481|NCT00598702|80148171|FG002|Overall Study|Physician Decision|0|||
27533482|NCT00598702|80148172|FG003|Overall Study|Physician Decision|0|||
27533483|NCT00598702|80148173|FG004|Overall Study|Physician Decision|1|||
27533484|NCT00598702|80148174|FG005|Overall Study|Physician Decision|0|||
27533485|NCT00598702|80148175|FG006|Overall Study|Physician Decision|0|||
27629440|NCT00995709|80483699|FG000|Overall Study|Withdrawal by Subject|0|||
27629441|NCT00995709|80483700|FG001|Overall Study|Withdrawal by Subject|4|||
27629442|NCT00995709|80483701|FG002|Overall Study|Withdrawal by Subject|1|||
27629443|NCT00995709|80483699|FG000|Overall Study|Lost to Follow-up|1|||
27533486|NCT00598702|80148176|FG007|Overall Study|Physician Decision|0|||
27533487|NCT00598702|80148169|FG000|Overall Study|Dose limiting toxicity|0|||
27533488|NCT00598702|80148170|FG001|Overall Study|Dose limiting toxicity|0|||
27533489|NCT00598702|80148171|FG002|Overall Study|Dose limiting toxicity|0|||
27533490|NCT00598702|80148172|FG003|Overall Study|Dose limiting toxicity|1|||
27629444|NCT00995709|80483700|FG001|Overall Study|Lost to Follow-up|0|||
27629445|NCT00995709|80483701|FG002|Overall Study|Lost to Follow-up|0|||
27629446|NCT00995709|80483699|FG000|Overall Study|Death|0|||
27629447|NCT00995709|80483700|FG001|Overall Study|Death|1|||
27629448|NCT00995709|80483701|FG002|Overall Study|Death|0|||
27629449|NCT00995709|80483699|FG000|Overall Study|Protocol Violation|2|||
27533491|NCT00598702|80148173|FG004|Overall Study|Dose limiting toxicity|1|||
27533492|NCT00598702|80148174|FG005|Overall Study|Dose limiting toxicity|1|||
27533493|NCT00598702|80148175|FG006|Overall Study|Dose limiting toxicity|0|||
27533494|NCT00598702|80148176|FG007|Overall Study|Dose limiting toxicity|0|||
27533495|NCT04439266|80148177|FG000|Overall Study|Ineligible|1|||
27533496|NCT04439266|80148177|FG000|Overall Study|Adverse Event|1|||
27533497|NCT04439266|80148177|FG000|Overall Study|Death|1|||
27533498|NCT04439266|80148177|FG000|Overall Study|Disease progression|1|||
27533499|NCT04439266|80148177|FG000|Overall Study|Still on treatment|1|||
27629450|NCT00995709|80483700|FG001|Overall Study|Protocol Violation|1|||
27629451|NCT00995709|80483701|FG002|Overall Study|Protocol Violation|0|||
27629452|NCT02595398|80483710|FG000|Overall Study|Non-compliance|1|||
27629453|NCT02595398|80483711|FG001|Overall Study|Non-compliance|0|||
27629454|NCT02595398|80483710|FG000|Overall Study|Withdrawal by Subject|2|||
27629455|NCT02595398|80483711|FG001|Overall Study|Withdrawal by Subject|1|||
27629456|NCT02595398|80483710|FG000|Overall Study|Lost to Follow-up|1|||
27629457|NCT02595398|80483711|FG001|Overall Study|Lost to Follow-up|0|||
27629458|NCT01837641|80483712|FG000|Overall Study|Sponsor decision|1|||
27629459|NCT01837641|80483713|FG001|Overall Study|Sponsor decision|0|||
27629460|NCT01837641|80483714|FG002|Overall Study|Sponsor decision|0|||
27629461|NCT01837641|80483715|FG003|Overall Study|Sponsor decision|0|||
27629462|NCT01837641|80483716|FG004|Overall Study|Sponsor decision|0|||
27629463|NCT01837641|80483717|FG005|Overall Study|Sponsor decision|1|||
27629464|NCT01837641|80483718|FG006|Overall Study|Sponsor decision|0|||
27629465|NCT01837641|80483719|FG007|Overall Study|Sponsor decision|0|||
27629466|NCT01837641|80483712|FG000|Overall Study|Adverse Event|0|||
27629467|NCT01837641|80483713|FG001|Overall Study|Adverse Event|0|||
27629468|NCT01837641|80483714|FG002|Overall Study|Adverse Event|0|||
27629469|NCT01837641|80483715|FG003|Overall Study|Adverse Event|0|||
27629470|NCT01837641|80483716|FG004|Overall Study|Adverse Event|0|||
27629471|NCT01837641|80483717|FG005|Overall Study|Adverse Event|1|||
27629472|NCT01837641|80483718|FG006|Overall Study|Adverse Event|0|||
27533500|NCT00057954|80148182|FG000|Overall Study|Death|1|||
27533501|NCT00057954|80148182|FG000|Overall Study|Disease progression|1|||
27629473|NCT01837641|80483719|FG007|Overall Study|Adverse Event|0|||
27629474|NCT01837641|80483712|FG000|Overall Study|Withdrawal by Subject|0|||
27629475|NCT01837641|80483713|FG001|Overall Study|Withdrawal by Subject|0|||
27629476|NCT01837641|80483714|FG002|Overall Study|Withdrawal by Subject|0|||
27629477|NCT01837641|80483715|FG003|Overall Study|Withdrawal by Subject|0|||
27629478|NCT01837641|80483716|FG004|Overall Study|Withdrawal by Subject|1|||
27629479|NCT01837641|80483717|FG005|Overall Study|Withdrawal by Subject|0|||
27629480|NCT01837641|80483718|FG006|Overall Study|Withdrawal by Subject|1|||
27629481|NCT01837641|80483719|FG007|Overall Study|Withdrawal by Subject|0|||
27629482|NCT00711646|80483720|FG000|Overall Study|Adverse Event|6|||
27629483|NCT00711646|80483721|FG001|Overall Study|Adverse Event|1|||
27629484|NCT00711646|80483720|FG000|Overall Study|Withdrawal by Subject|4|||
27629485|NCT00711646|80483721|FG001|Overall Study|Withdrawal by Subject|0|||
27629486|NCT00711646|80483720|FG000|Overall Study|Protocol Violation|0|||
27629487|NCT00711646|80483721|FG001|Overall Study|Protocol Violation|1|||
27533502|NCT02642029|80148183|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
27533503|NCT02642029|80148184|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
27533504|NCT02642029|80148185|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
27533505|NCT02642029|80148186|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
27629488|NCT00711646|80483720|FG000|Overall Study|Lost to Follow-up|1|||
27629489|NCT00711646|80483721|FG001|Overall Study|Lost to Follow-up|0|||
27629490|NCT00711646|80483720|FG000|Overall Study|administrative decision|0|||
27629491|NCT00711646|80483721|FG001|Overall Study|administrative decision|1|||
27629492|NCT00711646|80483720|FG000|Overall Study|patient non-compliance|1|||
27629493|NCT00711646|80483721|FG001|Overall Study|patient non-compliance|0|||
27629494|NCT01972152|80483722|FG000|First Treatment Visit|Lost to Follow-up|0|||
27629495|NCT01972152|80483723|FG001|First Treatment Visit|Lost to Follow-up|1|||
27629496|NCT01972152|80483724|FG002|First Treatment Visit|Lost to Follow-up|0|||
27629497|NCT01972152|80483725|FG003|First Treatment Visit|Lost to Follow-up|0|||
27629498|NCT01972152|80483726|FG004|First Treatment Visit|Lost to Follow-up|0|||
27629499|NCT01972152|80483727|FG005|First Treatment Visit|Lost to Follow-up|0|||
27629500|NCT01972152|80483722|FG000|Second Treatment Visit|Protocol Violation|0|||
27629501|NCT01972152|80483723|FG001|Second Treatment Visit|Protocol Violation|1|||
27629502|NCT01972152|80483724|FG002|Second Treatment Visit|Protocol Violation|0|||
27629503|NCT01972152|80483725|FG003|Second Treatment Visit|Protocol Violation|0|||
27629504|NCT01972152|80483726|FG004|Second Treatment Visit|Protocol Violation|0|||
27629505|NCT01972152|80483727|FG005|Second Treatment Visit|Protocol Violation|0|||
27629506|NCT02954055|80483728|FG000|Overall Study|Did not initiate therapy|6|||
27629507|NCT02954055|80483729|FG001|Overall Study|Did not initiate therapy|1|||
27629508|NCT01235949|80483732|FG000|Primary Phase|Migrated/moved from study area|1|||
27629509|NCT01235949|80483733|FG001|Primary Phase|Migrated/moved from study area|1|||
27629510|NCT01235949|80483734|FG002|Primary Phase|Migrated/moved from study area|0|||
27629511|NCT01235949|80483735|FG003|Primary Phase|Migrated/moved from study area|0|||
27629512|NCT01235949|80483736|FG004|Primary Phase|Migrated/moved from study area|1|||
27629513|NCT01235949|80483737|FG005|Primary Phase|Migrated/moved from study area|2|||
27629514|NCT01235949|80483738|FG006|Primary Phase|Migrated/moved from study area|0|||
27629515|NCT01235949|80483739|FG007|Primary Phase|Migrated/moved from study area|0|||
27629516|NCT01235949|80483740|FG008|Primary Phase|Migrated/moved from study area|0|||
27629517|NCT01235949|80483741|FG009|Primary Phase|Migrated/moved from study area|0|||
27629518|NCT01235949|80483742|FG010|Primary Phase|Migrated/moved from study area|0|||
27629519|NCT01235949|80483743|FG011|Primary Phase|Migrated/moved from study area|0|||
27629520|NCT01235949|80483744|FG012|Primary Phase|Migrated/moved from study area|0|||
27629521|NCT01235949|80483745|FG013|Primary Phase|Migrated/moved from study area|0|||
27629522|NCT01235949|80483746|FG014|Primary Phase|Migrated/moved from study area|0|||
27629523|NCT01235949|80483747|FG015|Primary Phase|Migrated/moved from study area|0|||
27629524|NCT01235949|80483748|FG016|Primary Phase|Migrated/moved from study area|0|||
27629525|NCT01235949|80483749|FG017|Primary Phase|Migrated/moved from study area|0|||
27629526|NCT01235949|80483732|FG000|Primary Phase|Adverse Event|0|||
27629527|NCT01235949|80483733|FG001|Primary Phase|Adverse Event|0|||
27629528|NCT01235949|80483734|FG002|Primary Phase|Adverse Event|0|||
27629529|NCT01235949|80483735|FG003|Primary Phase|Adverse Event|1|||
27629530|NCT01235949|80483736|FG004|Primary Phase|Adverse Event|0|||
27629531|NCT01235949|80483737|FG005|Primary Phase|Adverse Event|0|||
27629532|NCT01235949|80483738|FG006|Primary Phase|Adverse Event|0|||
27629533|NCT01235949|80483739|FG007|Primary Phase|Adverse Event|0|||
27629534|NCT01235949|80483740|FG008|Primary Phase|Adverse Event|0|||
27629535|NCT01235949|80483741|FG009|Primary Phase|Adverse Event|0|||
27629536|NCT01235949|80483742|FG010|Primary Phase|Adverse Event|0|||
27629537|NCT01235949|80483743|FG011|Primary Phase|Adverse Event|0|||
27629538|NCT01235949|80483744|FG012|Primary Phase|Adverse Event|0|||
27629539|NCT01235949|80483745|FG013|Primary Phase|Adverse Event|0|||
27533506|NCT02642029|80148187|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
27533507|NCT02642029|80148188|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
27533508|NCT02642029|80148183|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
27533509|NCT02642029|80148184|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
27533510|NCT02642029|80148185|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
27533511|NCT02642029|80148186|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
27533512|NCT02642029|80148187|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
27533513|NCT02642029|80148188|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
27533514|NCT02642029|80148183|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
27629540|NCT01235949|80483746|FG014|Primary Phase|Adverse Event|0|||
27629541|NCT01235949|80483747|FG015|Primary Phase|Adverse Event|0|||
27629542|NCT01235949|80483748|FG016|Primary Phase|Adverse Event|0|||
27629543|NCT01235949|80483749|FG017|Primary Phase|Adverse Event|0|||
27629544|NCT01235949|80483732|FG000|Primary Phase|Withdrawal by Subject|3|||
27629545|NCT01235949|80483733|FG001|Primary Phase|Withdrawal by Subject|2|||
27629546|NCT01235949|80483734|FG002|Primary Phase|Withdrawal by Subject|2|||
27629547|NCT01235949|80483735|FG003|Primary Phase|Withdrawal by Subject|0|||
27629548|NCT01235949|80483736|FG004|Primary Phase|Withdrawal by Subject|0|||
27629549|NCT01235949|80483737|FG005|Primary Phase|Withdrawal by Subject|3|||
27629550|NCT01235949|80483738|FG006|Primary Phase|Withdrawal by Subject|0|||
27629551|NCT01235949|80483739|FG007|Primary Phase|Withdrawal by Subject|0|||
27629552|NCT01235949|80483740|FG008|Primary Phase|Withdrawal by Subject|0|||
27629553|NCT01235949|80483741|FG009|Primary Phase|Withdrawal by Subject|0|||
27629554|NCT01235949|80483742|FG010|Primary Phase|Withdrawal by Subject|0|||
27629555|NCT01235949|80483743|FG011|Primary Phase|Withdrawal by Subject|0|||
27629556|NCT01235949|80483744|FG012|Primary Phase|Withdrawal by Subject|0|||
27629557|NCT01235949|80483745|FG013|Primary Phase|Withdrawal by Subject|0|||
27629558|NCT01235949|80483746|FG014|Primary Phase|Withdrawal by Subject|0|||
27629559|NCT01235949|80483747|FG015|Primary Phase|Withdrawal by Subject|0|||
27629560|NCT01235949|80483748|FG016|Primary Phase|Withdrawal by Subject|0|||
27629561|NCT01235949|80483749|FG017|Primary Phase|Withdrawal by Subject|0|||
27629562|NCT01235949|80483732|FG000|Primary Phase|Lost to Follow-up|0|||
27629563|NCT01235949|80483733|FG001|Primary Phase|Lost to Follow-up|0|||
27629564|NCT01235949|80483734|FG002|Primary Phase|Lost to Follow-up|1|||
27629565|NCT01235949|80483735|FG003|Primary Phase|Lost to Follow-up|1|||
27629566|NCT01235949|80483736|FG004|Primary Phase|Lost to Follow-up|0|||
27629567|NCT01235949|80483737|FG005|Primary Phase|Lost to Follow-up|2|||
27629568|NCT01235949|80483738|FG006|Primary Phase|Lost to Follow-up|0|||
27629569|NCT01235949|80483739|FG007|Primary Phase|Lost to Follow-up|0|||
27629570|NCT01235949|80483740|FG008|Primary Phase|Lost to Follow-up|0|||
27629571|NCT01235949|80483741|FG009|Primary Phase|Lost to Follow-up|0|||
27629572|NCT01235949|80483742|FG010|Primary Phase|Lost to Follow-up|0|||
27629573|NCT01235949|80483743|FG011|Primary Phase|Lost to Follow-up|0|||
27629574|NCT01235949|80483744|FG012|Primary Phase|Lost to Follow-up|0|||
27629575|NCT01235949|80483745|FG013|Primary Phase|Lost to Follow-up|0|||
27629576|NCT01235949|80483746|FG014|Primary Phase|Lost to Follow-up|0|||
27629577|NCT01235949|80483747|FG015|Primary Phase|Lost to Follow-up|0|||
27629578|NCT01235949|80483748|FG016|Primary Phase|Lost to Follow-up|0|||
27629579|NCT01235949|80483749|FG017|Primary Phase|Lost to Follow-up|0|||
27629580|NCT01235949|80483732|FG000|Booster Phase|Migrated/moved from study area|0|||
27629581|NCT01235949|80483733|FG001|Booster Phase|Migrated/moved from study area|0|||
27629582|NCT01235949|80483734|FG002|Booster Phase|Migrated/moved from study area|0|||
27629583|NCT01235949|80483735|FG003|Booster Phase|Migrated/moved from study area|0|||
27533515|NCT02642029|80148184|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
27533516|NCT02642029|80148185|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
27533517|NCT02642029|80148186|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
27533518|NCT02642029|80148187|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
27533519|NCT02642029|80148188|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
27533520|NCT02642029|80148183|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
27533521|NCT02642029|80148184|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
27533522|NCT02642029|80148185|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
27533523|NCT02642029|80148186|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
27533524|NCT02642029|80148187|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
27629584|NCT01235949|80483736|FG004|Booster Phase|Migrated/moved from study area|0|||
27629585|NCT01235949|80483737|FG005|Booster Phase|Migrated/moved from study area|0|||
27629586|NCT01235949|80483738|FG006|Booster Phase|Migrated/moved from study area|0|||
27629587|NCT01235949|80483739|FG007|Booster Phase|Migrated/moved from study area|0|||
27629588|NCT01235949|80483740|FG008|Booster Phase|Migrated/moved from study area|0|||
27629589|NCT01235949|80483741|FG009|Booster Phase|Migrated/moved from study area|0|||
27629590|NCT01235949|80483742|FG010|Booster Phase|Migrated/moved from study area|0|||
27629591|NCT01235949|80483743|FG011|Booster Phase|Migrated/moved from study area|1|||
27629592|NCT01235949|80483744|FG012|Booster Phase|Migrated/moved from study area|1|||
27629593|NCT01235949|80483745|FG013|Booster Phase|Migrated/moved from study area|0|||
27629594|NCT01235949|80483746|FG014|Booster Phase|Migrated/moved from study area|0|||
27629595|NCT01235949|80483747|FG015|Booster Phase|Migrated/moved from study area|0|||
27629596|NCT01235949|80483748|FG016|Booster Phase|Migrated/moved from study area|0|||
27629597|NCT01235949|80483749|FG017|Booster Phase|Migrated/moved from study area|1|||
27629598|NCT01235949|80483732|FG000|Booster Phase|Adverse Event|0|||
27629599|NCT01235949|80483733|FG001|Booster Phase|Adverse Event|0|||
27629600|NCT01235949|80483734|FG002|Booster Phase|Adverse Event|0|||
27629601|NCT01235949|80483735|FG003|Booster Phase|Adverse Event|0|||
27629602|NCT01235949|80483736|FG004|Booster Phase|Adverse Event|0|||
27913430|NCT01657162|81522098|FG001|Overall Study|Other than Specified|2|||
27913431|NCT01059773|81522099|FG000|Overall Study|Adverse Event|2|||
27913432|NCT01059773|81522100|FG001|Overall Study|Adverse Event|2|||
27629603|NCT01235949|80483737|FG005|Booster Phase|Adverse Event|0|||
27629604|NCT01235949|80483738|FG006|Booster Phase|Adverse Event|0|||
27629605|NCT01235949|80483739|FG007|Booster Phase|Adverse Event|0|||
27913433|NCT01059773|81522099|FG000|Overall Study|Withdrawal by Subject|1|||
27629606|NCT01235949|80483740|FG008|Booster Phase|Adverse Event|0|||
27629607|NCT01235949|80483741|FG009|Booster Phase|Adverse Event|0|||
27629608|NCT01235949|80483742|FG010|Booster Phase|Adverse Event|0|||
27629609|NCT01235949|80483743|FG011|Booster Phase|Adverse Event|0|||
27629610|NCT01235949|80483744|FG012|Booster Phase|Adverse Event|0|||
27629611|NCT01235949|80483745|FG013|Booster Phase|Adverse Event|0|||
27629612|NCT01235949|80483746|FG014|Booster Phase|Adverse Event|0|||
27913434|NCT01059773|81522100|FG001|Overall Study|Withdrawal by Subject|5|||
27533525|NCT02642029|80148188|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
27533526|NCT02642029|80148183|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
27533527|NCT02642029|80148184|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
27533528|NCT02642029|80148185|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
27533529|NCT02642029|80148186|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
27533530|NCT02642029|80148187|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
27533531|NCT02642029|80148188|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
27533532|NCT02642029|80148183|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
27533533|NCT02642029|80148184|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
27533534|NCT02642029|80148185|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
27533535|NCT02642029|80148186|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
27533536|NCT02642029|80148187|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
27533537|NCT02642029|80148188|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
27533538|NCT04543409|80148191|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27533539|NCT04543409|80148192|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27533540|NCT04543409|80148191|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
27533541|NCT04543409|80148192|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
27533542|NCT04543409|80148191|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
27533543|NCT04543409|80148192|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
27533544|NCT04543409|80148191|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
27533545|NCT04543409|80148192|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
27533546|NCT04543409|80148191|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
27533547|NCT04543409|80148192|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
27533548|NCT04543409|80148191|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
27533549|NCT04543409|80148192|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
27533550|NCT04543409|80148191|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
27533551|NCT04543409|80148192|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
27533552|NCT04543409|80148191|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
27533553|NCT04543409|80148192|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
27533554|NCT04543409|80148191|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
27533555|NCT04543409|80148192|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
27533556|NCT04543409|80148191|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
27533557|NCT04543409|80148192|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
27533558|NCT04543409|80148191|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
27533559|NCT04543409|80148192|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
27533560|NCT03793556|80148194|FG000|Overall Study|Withdrawal by Subject|12|||
27533561|NCT03793556|80148195|FG001|Overall Study|Withdrawal by Subject|1|||
27533562|NCT03793556|80148194|FG000|Overall Study|Lost to Follow-up|1|||
27533563|NCT03793556|80148195|FG001|Overall Study|Lost to Follow-up|1|||
27533564|NCT00629772|80148196|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
27533565|NCT00629772|80148197|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
27533566|NCT00629772|80148196|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
27533567|NCT00629772|80148197|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
27533568|NCT02169284|80148199|FG000|Overall Study|Physician Decision|0|||
27533569|NCT02169284|80148200|FG001|Overall Study|Physician Decision|1|||
27533570|NCT04251273|80148201|FG000|Overall Study|Lost to Follow-up|331|||
27533571|NCT04251273|80148202|FG001|Overall Study|Lost to Follow-up|290|||
27533572|NCT04416633|80148205|FG000|Overall Study|Death|1|||
27533573|NCT04416633|80148205|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
27533574|NCT04416633|80148205|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
27533575|NCT04416633|80148205|FG000|Overall Study|Adverse Event|6|||
27533576|NCT04416633|80148205|FG000|Overall Study|Withdrawal by Subject|6|||
27533577|NCT02770170|80148208|FG000|Overall Study|Withdrawal by Subject|0|||
27533578|NCT02770170|80148209|FG001|Overall Study|Withdrawal by Subject|0|||
27533579|NCT02770170|80148210|FG002|Overall Study|Withdrawal by Subject|0|||
27533580|NCT02770170|80148211|FG003|Overall Study|Withdrawal by Subject|2|||
27533581|NCT02770170|80148208|FG000|Overall Study|due to pregnancy|1|||
27533582|NCT02770170|80148209|FG001|Overall Study|due to pregnancy|0|||
27533583|NCT02770170|80148210|FG002|Overall Study|due to pregnancy|0|||
27533584|NCT02770170|80148211|FG003|Overall Study|due to pregnancy|0|||
27533585|NCT02770170|80148208|FG000|Overall Study|Lack of Efficacy|2|||
27533586|NCT02770170|80148209|FG001|Overall Study|Lack of Efficacy|0|||
27533587|NCT02770170|80148210|FG002|Overall Study|Lack of Efficacy|0|||
27533588|NCT02770170|80148211|FG003|Overall Study|Lack of Efficacy|1|||
27533589|NCT02770170|80148208|FG000|Overall Study|Adverse Event|4|||
27533590|NCT02770170|80148209|FG001|Overall Study|Adverse Event|3|||
27533591|NCT02770170|80148210|FG002|Overall Study|Adverse Event|5|||
27533592|NCT02770170|80148211|FG003|Overall Study|Adverse Event|3|||
27533593|NCT02770170|80148208|FG000|Overall Study|due to disease worsening|0|||
27629613|NCT01235949|80483747|FG015|Booster Phase|Adverse Event|1|||
27629614|NCT01235949|80483748|FG016|Booster Phase|Adverse Event|0|||
27629615|NCT01235949|80483749|FG017|Booster Phase|Adverse Event|0|||
27629616|NCT01235949|80483732|FG000|Booster Phase|Withdrawal by Subject|0|||
27629617|NCT01235949|80483733|FG001|Booster Phase|Withdrawal by Subject|0|||
27629618|NCT01235949|80483734|FG002|Booster Phase|Withdrawal by Subject|0|||
27629619|NCT01235949|80483735|FG003|Booster Phase|Withdrawal by Subject|0|||
27629620|NCT01235949|80483736|FG004|Booster Phase|Withdrawal by Subject|0|||
27629621|NCT01235949|80483737|FG005|Booster Phase|Withdrawal by Subject|0|||
27629622|NCT01235949|80483738|FG006|Booster Phase|Withdrawal by Subject|0|||
27629623|NCT01235949|80483739|FG007|Booster Phase|Withdrawal by Subject|1|||
27629624|NCT01235949|80483740|FG008|Booster Phase|Withdrawal by Subject|1|||
27629625|NCT01235949|80483741|FG009|Booster Phase|Withdrawal by Subject|0|||
27629626|NCT01235949|80483742|FG010|Booster Phase|Withdrawal by Subject|1|||
27629627|NCT01235949|80483743|FG011|Booster Phase|Withdrawal by Subject|1|||
27629628|NCT01235949|80483744|FG012|Booster Phase|Withdrawal by Subject|2|||
27629629|NCT01235949|80483745|FG013|Booster Phase|Withdrawal by Subject|0|||
27629630|NCT01235949|80483746|FG014|Booster Phase|Withdrawal by Subject|2|||
27629631|NCT01235949|80483747|FG015|Booster Phase|Withdrawal by Subject|0|||
27629632|NCT01235949|80483748|FG016|Booster Phase|Withdrawal by Subject|0|||
27629633|NCT01235949|80483749|FG017|Booster Phase|Withdrawal by Subject|0|||
27629634|NCT01235949|80483732|FG000|Booster Phase|Lost to Follow-up|0|||
27629635|NCT01235949|80483733|FG001|Booster Phase|Lost to Follow-up|0|||
27629636|NCT01235949|80483734|FG002|Booster Phase|Lost to Follow-up|0|||
27629637|NCT01235949|80483735|FG003|Booster Phase|Lost to Follow-up|0|||
27629638|NCT01235949|80483736|FG004|Booster Phase|Lost to Follow-up|0|||
27629639|NCT01235949|80483737|FG005|Booster Phase|Lost to Follow-up|0|||
27629640|NCT01235949|80483738|FG006|Booster Phase|Lost to Follow-up|0|||
27629641|NCT01235949|80483739|FG007|Booster Phase|Lost to Follow-up|0|||
27629642|NCT01235949|80483740|FG008|Booster Phase|Lost to Follow-up|1|||
27629643|NCT01235949|80483741|FG009|Booster Phase|Lost to Follow-up|1|||
27629644|NCT01235949|80483742|FG010|Booster Phase|Lost to Follow-up|1|||
27629645|NCT01235949|80483743|FG011|Booster Phase|Lost to Follow-up|1|||
27629646|NCT01235949|80483744|FG012|Booster Phase|Lost to Follow-up|0|||
27629647|NCT01235949|80483745|FG013|Booster Phase|Lost to Follow-up|0|||
27629648|NCT01235949|80483746|FG014|Booster Phase|Lost to Follow-up|0|||
27629649|NCT01235949|80483747|FG015|Booster Phase|Lost to Follow-up|0|||
27629650|NCT01235949|80483748|FG016|Booster Phase|Lost to Follow-up|0|||
27629651|NCT01235949|80483749|FG017|Booster Phase|Lost to Follow-up|1|||
27629652|NCT01649791|80483754|FG000|Overall Study|Disease Progression|2|||
27629653|NCT01649791|80483754|FG000|Overall Study|Adverse Event|1|||
27629654|NCT03761784|80483757|FG000|Overall Study|Adverse Event|4|||
27629655|NCT03761784|80483758|FG001|Overall Study|Adverse Event|0|||
27629656|NCT03761784|80483757|FG000|Overall Study|Lost to Follow-up|10|||
27629657|NCT03761784|80483758|FG001|Overall Study|Lost to Follow-up|7|||
27629658|NCT03761784|80483757|FG000|Overall Study|Pregnancy|1|||
27913435|NCT01059773|81522099|FG000|Overall Study|Lost to Follow-up|1|||
27913436|NCT01059773|81522100|FG001|Overall Study|Lost to Follow-up|1|||
27533594|NCT02770170|80148209|FG001|Overall Study|due to disease worsening|0|||
27533595|NCT02770170|80148210|FG002|Overall Study|due to disease worsening|0|||
27533596|NCT02770170|80148211|FG003|Overall Study|due to disease worsening|1|||
27533597|NCT01180634|80148212|FG000|Overall Study|Adverse Event|4|||
27533598|NCT01180634|80148213|FG001|Overall Study|Adverse Event|1|||
27533599|NCT01180634|80148212|FG000|Overall Study|Miscellaneous|2|||
27533600|NCT01180634|80148213|FG001|Overall Study|Miscellaneous|0|||
27533601|NCT01180634|80148212|FG000|Overall Study|Withdrawal by Subject|4|||
27533602|NCT01180634|80148213|FG001|Overall Study|Withdrawal by Subject|0|||
27533603|NCT02810340|80148214|FG000|Overall Study|Withdrawal by Subject|1|||
27533604|NCT02810340|80148215|FG001|Overall Study|Withdrawal by Subject|0|||
27533605|NCT02810340|80148216|FG002|Overall Study|Withdrawal by Subject|0|||
27533606|NCT02810340|80148214|FG000|Overall Study|Incarceration|0|||
27533607|NCT02810340|80148215|FG001|Overall Study|Incarceration|1|||
27533608|NCT02810340|80148216|FG002|Overall Study|Incarceration|0|||
27533609|NCT02810340|80148214|FG000|Overall Study|Lost to Follow-up|0|||
27533610|NCT02810340|80148215|FG001|Overall Study|Lost to Follow-up|0|||
27533611|NCT02810340|80148216|FG002|Overall Study|Lost to Follow-up|1|||
27533612|NCT02239224|80148217|FG000|Overall Study|Administrative|0|||
27533613|NCT02239224|80148218|FG001|Overall Study|Administrative|0|||
27629659|NCT03761784|80483758|FG001|Overall Study|Pregnancy|0|||
27629660|NCT03761784|80483757|FG000|Overall Study|Protocol Violation|2|||
27629661|NCT03761784|80483758|FG001|Overall Study|Protocol Violation|0|||
27629662|NCT03761784|80483757|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
27629663|NCT03761784|80483758|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
27629664|NCT03761784|80483757|FG000|Overall Study|Withdrawal by Subject|9|||
27913437|NCT01059773|81522099|FG000|Overall Study|Pregnancy|1|||
27629665|NCT03761784|80483758|FG001|Overall Study|Withdrawal by Subject|4|||
27629666|NCT03761784|80483757|FG000|Overall Study|Physician Decision|1|||
27629667|NCT03761784|80483758|FG001|Overall Study|Physician Decision|0|||
27533614|NCT02239224|80148219|FG002|Overall Study|Administrative|3|||
27533615|NCT02239224|80148220|FG003|Overall Study|Administrative|1|||
27533616|NCT02943460|80148221|FG000|Blinded Study Phase|Adverse Event|3|||
27533617|NCT02943460|80148222|FG001|Blinded Study Phase|Adverse Event|0|||
27533618|NCT02943460|80148223|FG002|Blinded Study Phase|Adverse Event|0|||
27533619|NCT02943460|80148221|FG000|Blinded Study Phase|Withdrew Consent|0|||
27533620|NCT02943460|80148222|FG001|Blinded Study Phase|Withdrew Consent|1|||
27533621|NCT02943460|80148223|FG002|Blinded Study Phase|Withdrew Consent|0|||
27913438|NCT01059773|81522100|FG001|Overall Study|Pregnancy|1|||
27913439|NCT01059773|81522099|FG000|Overall Study|Protocol Violation|6|||
27533622|NCT02943460|80148221|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
27533623|NCT02943460|80148222|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
27913440|NCT01059773|81522100|FG001|Overall Study|Protocol Violation|2|||
27913441|NCT01059773|81522099|FG000|Overall Study|Physician Decision|5|||
27913442|NCT01059773|81522100|FG001|Overall Study|Physician Decision|4|||
27913443|NCT01059773|81522099|FG000|Overall Study|Lack of Efficacy|3|||
27913444|NCT01059773|81522100|FG001|Overall Study|Lack of Efficacy|3|||
27913445|NCT01059773|81522099|FG000|Overall Study|Death|0|||
27913446|NCT01059773|81522100|FG001|Overall Study|Death|1|||
27913447|NCT01059773|81522099|FG000|Overall Study|Malignancy including squamous cell skin|0|||
27913448|NCT01059773|81522100|FG001|Overall Study|Malignancy including squamous cell skin|1|||
27913449|NCT01059773|81522099|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
27913450|NCT01059773|81522100|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
27913451|NCT01059773|81522099|FG000|Overall Study|Other|1|||
27913452|NCT01059773|81522100|FG001|Overall Study|Other|3|||
27913453|NCT04010461|81522102|FG000|Overall Study|COVID based withdrawal|5|||
27913454|NCT04010461|81522102|FG000|Overall Study|Withdrawal by Subject|5|||
27913455|NCT04010461|81522102|FG000|Overall Study|Adverse Event|1|||
27913456|NCT04010461|81522102|FG000|Overall Study|No Motor Threshold obtainable|1|||
27913457|NCT04010461|81522102|FG000|Overall Study|Physician Decision|1|||
27533624|NCT02943460|80148223|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
27533625|NCT02943460|80148221|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
27533626|NCT02943460|80148222|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
27533627|NCT02943460|80148223|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
27533628|NCT02943460|80148221|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
27533629|NCT02943460|80148222|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
27533630|NCT02943460|80148223|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
27533631|NCT02160782|80148224|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
27913458|NCT02782741|81522103|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
27913459|NCT02782741|81522104|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
27913460|NCT02782741|81522105|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
27913461|NCT02782741|81522103|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
27913462|NCT02782741|81522104|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
27913463|NCT02782741|81522105|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
27913464|NCT02782741|81522103|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
27913465|NCT02782741|81522104|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
27913466|NCT02782741|81522105|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
27913467|NCT02782741|81522103|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
27913468|NCT02782741|81522104|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
27913469|NCT02782741|81522105|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
27913470|NCT02782741|81522103|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
27913471|NCT02782741|81522104|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
27913472|NCT02782741|81522105|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
27533632|NCT02160782|80148225|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
27533633|NCT02160782|80148226|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
27533634|NCT02160782|80148227|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
27533635|NCT02160782|80148228|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
27533636|NCT02160782|80148224|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27533637|NCT02160782|80148225|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27533638|NCT02160782|80148226|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27533639|NCT02160782|80148227|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
27533640|NCT02160782|80148228|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
27533641|NCT02160782|80148224|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27533642|NCT02160782|80148225|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27533643|NCT02160782|80148226|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27533644|NCT02160782|80148227|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
27533645|NCT02160782|80148228|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
27533646|NCT02160782|80148224|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27533647|NCT02160782|80148225|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27533648|NCT02160782|80148226|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27533649|NCT02160782|80148227|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
27533650|NCT02160782|80148228|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
27533651|NCT02160782|80148224|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27533652|NCT02160782|80148225|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27533653|NCT02160782|80148226|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27533654|NCT02160782|80148227|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
27533655|NCT02160782|80148228|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
27533656|NCT02160782|80148224|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27533657|NCT02160782|80148225|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27533658|NCT02160782|80148226|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27533659|NCT02160782|80148227|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
27533660|NCT02160782|80148228|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
27533661|NCT02160782|80148224|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27533662|NCT02160782|80148225|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27533663|NCT02160782|80148226|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27533664|NCT02160782|80148227|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
27533665|NCT02160782|80148228|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
27533666|NCT04093414|80148229|FG000|3 Month Follow up|Physician Decision|0|||
27533667|NCT04093414|80148230|FG001|3 Month Follow up|Physician Decision|1|||
27533668|NCT04093414|80148229|FG000|6month Follow up|Physician Decision|1|||
27533669|NCT04093414|80148230|FG001|6month Follow up|Physician Decision|3|||
27533670|NCT00591266|80148233|FG000|Overall Study|Adverse Event|2|||
27533671|NCT00591266|80148234|FG001|Overall Study|Adverse Event|2|||
27533672|NCT00591266|80148235|FG002|Overall Study|Adverse Event|3|||
27533673|NCT00591266|80148233|FG000|Overall Study|Lost to Follow-up|0|||
27533674|NCT00591266|80148234|FG001|Overall Study|Lost to Follow-up|1|||
27533675|NCT00591266|80148235|FG002|Overall Study|Lost to Follow-up|0|||
27533676|NCT00591266|80148233|FG000|Overall Study|Protocol Violation|0|||
27533677|NCT00591266|80148234|FG001|Overall Study|Protocol Violation|0|||
27533678|NCT00591266|80148235|FG002|Overall Study|Protocol Violation|1|||
27629668|NCT03761784|80483757|FG000|Overall Study|Other Than Specified|1|||
27629669|NCT03761784|80483758|FG001|Overall Study|Other Than Specified|0|||
27629670|NCT02987543|80483759|FG000|Overall Study|Ongoing study at data cut off|49|||
27737470|NCT01826214|80868359|FG000|Overall Study|Study terminated by Sponsor|0|||
27737471|NCT01826214|80868360|FG001|Overall Study|Study terminated by Sponsor|1|||
27737472|NCT01826214|80868359|FG000|Overall Study|Subject/guardian decision|2|||
27737473|NCT01826214|80868360|FG001|Overall Study|Subject/guardian decision|3|||
27737474|NCT04840667|80868361|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
27737475|NCT01242111|80868362|FG000|Overall Study|Adverse Event|1|||
27737476|NCT01242111|80868362|FG000|Overall Study|Withdrawal by Subject|1|||
27737477|NCT01242111|80868362|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
27737478|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
27737479|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
27737480|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
27737481|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
27737482|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
27737483|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
27737484|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
27737485|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
27737486|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
27737487|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
27737488|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
27737489|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
27737490|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
27737491|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
27737492|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
27737493|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
27737494|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
27737495|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
27737496|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
27737497|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
27737498|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
27737499|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
27737500|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
27737501|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
27737502|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
27737503|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
27737504|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
27737505|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
27737506|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
27737507|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
27737508|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
27737509|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
27737510|NCT03818035|80868363|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
27737511|NCT03818035|80868364|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
27737512|NCT03818035|80868365|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
27737513|NCT03818035|80868366|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
27737514|NCT03818035|80868363|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
27737515|NCT03818035|80868364|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
27737516|NCT03818035|80868365|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
27737517|NCT03818035|80868366|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
27737518|NCT03818035|80868363|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
27737519|NCT03818035|80868364|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
27533679|NCT00591266|80148233|FG000|Overall Study|Withdrawal by Subject|6|||
27533680|NCT00591266|80148234|FG001|Overall Study|Withdrawal by Subject|2|||
27533681|NCT00591266|80148235|FG002|Overall Study|Withdrawal by Subject|5|||
27533682|NCT00591266|80148233|FG000|Overall Study|Lack of Efficacy|0|||
27533683|NCT00591266|80148234|FG001|Overall Study|Lack of Efficacy|2|||
27533684|NCT00591266|80148235|FG002|Overall Study|Lack of Efficacy|0|||
27533685|NCT00591266|80148233|FG000|Overall Study|Other|1|||
27533686|NCT00591266|80148234|FG001|Overall Study|Other|4|||
27533687|NCT00591266|80148235|FG002|Overall Study|Other|5|||
27533688|NCT02600351|80148241|FG000|Overall Study|Lack of Efficacy|3|||
27533689|NCT02600351|80148242|FG001|Overall Study|Lack of Efficacy|0|||
27533690|NCT02600351|80148243|FG002|Overall Study|Lack of Efficacy|5|||
27533691|NCT02600351|80148244|FG003|Overall Study|Lack of Efficacy|2|||
27533692|NCT02600351|80148241|FG000|Overall Study|Lost to Follow-up|1|||
27737520|NCT03818035|80868365|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
27737521|NCT03818035|80868366|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
27737522|NCT03818035|80868363|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
27533693|NCT02600351|80148242|FG001|Overall Study|Lost to Follow-up|0|||
27533694|NCT02600351|80148243|FG002|Overall Study|Lost to Follow-up|0|||
27737523|NCT03818035|80868364|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
27913473|NCT00780975|81522109|FG000|Overall Study|Progressive disease|3|||
27533695|NCT02600351|80148244|FG003|Overall Study|Lost to Follow-up|0|||
27533696|NCT02600351|80148241|FG000|Overall Study|Randomized but Not Treated|1|||
27533697|NCT02600351|80148242|FG001|Overall Study|Randomized but Not Treated|0|||
27737524|NCT03818035|80868365|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
27737525|NCT03818035|80868366|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
27737526|NCT03818035|80868363|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
27737527|NCT03818035|80868364|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
27737528|NCT03818035|80868365|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
27737529|NCT03818035|80868366|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
27737530|NCT03818035|80868363|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
27737531|NCT03818035|80868364|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
27737532|NCT03818035|80868365|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
27737533|NCT03818035|80868366|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
27737534|NCT03818035|80868363|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
27737535|NCT03818035|80868364|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
27737536|NCT03818035|80868365|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
27737537|NCT03818035|80868366|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
27737538|NCT00532259|80868367|FG000|Overall Study|Withdrawal by Subject|2|||
27737539|NCT00532259|80868367|FG000|Overall Study|Adverse Event|1|||
27737540|NCT00532259|80868367|FG000|Overall Study|Death|1|||
27737541|NCT00532259|80868367|FG000|Overall Study|Lack of Efficacy|21|||
27737542|NCT00532259|80868367|FG000|Overall Study|Lost to Follow-up|3|||
27737543|NCT00532259|80868367|FG000|Overall Study|Physician Decision|3|||
27737544|NCT00532259|80868367|FG000|Overall Study|Protocol Violation|1|||
27737545|NCT00363415|80868371|FG000|Overall Study|Progressive Disease|196|||
27737546|NCT00363415|80868372|FG001|Overall Study|Progressive Disease|107|||
27737547|NCT00363415|80868371|FG000|Overall Study|Sponsor Decision|67|||
27737548|NCT00363415|80868372|FG001|Overall Study|Sponsor Decision|31|||
27737549|NCT00363415|80868371|FG000|Overall Study|Death|32|||
27737550|NCT00363415|80868372|FG001|Overall Study|Death|29|||
27737551|NCT00363415|80868371|FG000|Overall Study|Adverse Event|24|||
27737552|NCT00363415|80868372|FG001|Overall Study|Adverse Event|15|||
27737553|NCT00363415|80868371|FG000|Overall Study|Physician Decision|18|||
27737554|NCT00363415|80868372|FG001|Overall Study|Physician Decision|35|||
27737555|NCT00363415|80868371|FG000|Overall Study|Entry Criteria Not Met|11|||
27737556|NCT00363415|80868372|FG001|Overall Study|Entry Criteria Not Met|10|||
27737557|NCT00363415|80868371|FG000|Overall Study|Withdrawal by Subject|9|||
27737558|NCT00363415|80868372|FG001|Overall Study|Withdrawal by Subject|15|||
27737559|NCT00363415|80868371|FG000|Overall Study|Lost to Follow-up|3|||
27737560|NCT00363415|80868372|FG001|Overall Study|Lost to Follow-up|3|||
27737561|NCT00363415|80868371|FG000|Overall Study|Protocol Violation|1|||
27737562|NCT00363415|80868372|FG001|Overall Study|Protocol Violation|4|||
27737563|NCT04331899|80868374|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
27737564|NCT04331899|80868375|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
27737565|NCT00883753|80868376|FG000|Overall Study|Adverse Event|37|||
27737566|NCT00883753|80868376|FG000|Overall Study|Death|2|||
27737567|NCT00883753|80868376|FG000|Overall Study|Insufficient therapeutic response|16|||
27737568|NCT00883753|80868376|FG000|Overall Study|Lost to Follow-up|4|||
27737569|NCT00883753|80868376|FG000|Overall Study|Violation of selection criteria at entry|7|||
27737570|NCT00883753|80868376|FG000|Overall Study|Protocol Violation|2|||
27737571|NCT00883753|80868376|FG000|Overall Study|Refused treatment|4|||
27737572|NCT00883753|80868376|FG000|Overall Study|Withdrew consent|10|||
27737573|NCT00883753|80868376|FG000|Overall Study|Investigator's decision|17|||
27533698|NCT02600351|80148243|FG002|Overall Study|Randomized but Not Treated|1|||
27533699|NCT02600351|80148244|FG003|Overall Study|Randomized but Not Treated|3|||
27533700|NCT04043728|80148245|FG000|Overall Study|Lost to Follow-up|1|||
27533701|NCT04043728|80148246|FG001|Overall Study|Lost to Follow-up|2|||
27533702|NCT04043728|80148247|FG002|Overall Study|Lost to Follow-up|0|||
27533703|NCT03063203|80148248|FG000|Overall Study|Chose alternative therapy|3|||
27533704|NCT03063203|80148248|FG000|Overall Study|Death|2|||
27533705|NCT03063203|80148248|FG000|Overall Study|Disease progression|4|||
27533706|NCT03063203|80148248|FG000|Overall Study|Physician Decision|5|||
27533707|NCT03078907|80148249|FG000|Overall Study|Adverse Event|2|||
27533708|NCT03078907|80148250|FG001|Overall Study|Adverse Event|0|||
27533709|NCT03078907|80148249|FG000|Overall Study|Other|1|||
27737574|NCT00883753|80868376|FG000|Overall Study|Administrative/Other|8|||
27737575|NCT01157169|80868389|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
27737576|NCT01157169|80868390|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
27737577|NCT01157169|80868389|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
27737578|NCT01157169|80868390|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
27737579|NCT02453841|80868392|FG000|Overall Study|Protocol Violation|1|||
27737580|NCT02453841|80868392|FG000|Overall Study|Unable to obtain blood samples|2|||
27737581|NCT00996840|80868395|FG000|Overall Study|Adverse Event|0|||
27737582|NCT00996840|80868396|FG001|Overall Study|Adverse Event|1|||
27533710|NCT03078907|80148250|FG001|Overall Study|Other|0|||
27533711|NCT03078907|80148249|FG000|Overall Study|Protocol Violation|0|||
27533712|NCT03078907|80148250|FG001|Overall Study|Protocol Violation|1|||
27533713|NCT02322021|80148251|FG000|Core Phase|Adverse Event|1|||
27533714|NCT02322021|80148252|FG001|Core Phase|Adverse Event|3|||
27533715|NCT02322021|80148253|FG002|Core Phase|Adverse Event|4|||
27533716|NCT02322021|80148254|FG003|Core Phase|Adverse Event|2|||
27533717|NCT02322021|80148255|FG004|Core Phase|Adverse Event|0|||
27533718|NCT02322021|80148251|FG000|Core Phase|Participant Choice|4|||
27533719|NCT02322021|80148252|FG001|Core Phase|Participant Choice|5|||
27533720|NCT02322021|80148253|FG002|Core Phase|Participant Choice|4|||
27533721|NCT02322021|80148254|FG003|Core Phase|Participant Choice|2|||
27533722|NCT02322021|80148255|FG004|Core Phase|Participant Choice|0|||
27533723|NCT02322021|80148251|FG000|Core Phase|Lost to Follow-up|0|||
27533724|NCT02322021|80148252|FG001|Core Phase|Lost to Follow-up|0|||
27533725|NCT02322021|80148253|FG002|Core Phase|Lost to Follow-up|0|||
27533726|NCT02322021|80148254|FG003|Core Phase|Lost to Follow-up|1|||
27533727|NCT02322021|80148255|FG004|Core Phase|Lost to Follow-up|0|||
27533728|NCT02322021|80148251|FG000|Core Phase|Other|0|||
27533729|NCT02322021|80148252|FG001|Core Phase|Other|0|||
27533730|NCT02322021|80148253|FG002|Core Phase|Other|1|||
27533731|NCT02322021|80148254|FG003|Core Phase|Other|0|||
27533732|NCT02322021|80148255|FG004|Core Phase|Other|0|||
27533733|NCT02322021|80148251|FG000|Extension Phase|Adverse Event|0|||
27533734|NCT02322021|80148252|FG001|Extension Phase|Adverse Event|0|||
27533735|NCT02322021|80148253|FG002|Extension Phase|Adverse Event|0|||
27533736|NCT02322021|80148254|FG003|Extension Phase|Adverse Event|0|||
27533737|NCT02322021|80148255|FG004|Extension Phase|Adverse Event|3|||
27533738|NCT02322021|80148251|FG000|Extension Phase|Participant Choice|0|||
27533739|NCT02322021|80148252|FG001|Extension Phase|Participant Choice|0|||
27533740|NCT02322021|80148253|FG002|Extension Phase|Participant Choice|0|||
27533741|NCT02322021|80148254|FG003|Extension Phase|Participant Choice|0|||
27533742|NCT02322021|80148255|FG004|Extension Phase|Participant Choice|6|||
27533743|NCT02322021|80148251|FG000|Extension Phase|Other|0|||
27533744|NCT02322021|80148252|FG001|Extension Phase|Other|0|||
27737583|NCT00996840|80868397|FG002|Overall Study|Adverse Event|0|||
27737584|NCT00996840|80868398|FG003|Overall Study|Adverse Event|0|||
27737585|NCT00996840|80868399|FG004|Overall Study|Adverse Event|0|||
27737586|NCT00996840|80868395|FG000|Overall Study|Physician Decision|0|||
27737587|NCT00996840|80868396|FG001|Overall Study|Physician Decision|0|||
27737588|NCT00996840|80868397|FG002|Overall Study|Physician Decision|1|||
27737589|NCT00996840|80868398|FG003|Overall Study|Physician Decision|1|||
27737590|NCT00996840|80868399|FG004|Overall Study|Physician Decision|2|||
27737591|NCT00996840|80868395|FG000|Overall Study|Withdrawal by Subject|1|||
27737592|NCT00996840|80868396|FG001|Overall Study|Withdrawal by Subject|1|||
27737593|NCT00996840|80868397|FG002|Overall Study|Withdrawal by Subject|0|||
27737594|NCT00996840|80868398|FG003|Overall Study|Withdrawal by Subject|0|||
27737595|NCT00996840|80868399|FG004|Overall Study|Withdrawal by Subject|0|||
27737596|NCT01794780|80868401|FG000|Overall Study|Adverse Event|0|||
27737597|NCT01794780|80868402|FG001|Overall Study|Adverse Event|1|||
27737598|NCT01794780|80868403|FG002|Overall Study|Adverse Event|2|||
27737599|NCT01794780|80868404|FG003|Overall Study|Adverse Event|0|||
27737600|NCT01794780|80868405|FG004|Overall Study|Adverse Event|0|||
27737601|NCT01794780|80868406|FG005|Overall Study|Adverse Event|0|||
27737602|NCT01794780|80868407|FG006|Overall Study|Adverse Event|0|||
27737603|NCT01794780|80868408|FG007|Overall Study|Adverse Event|0|||
27737604|NCT01794780|80868401|FG000|Overall Study|Death|0|||
27737605|NCT01794780|80868402|FG001|Overall Study|Death|2|||
27737606|NCT01794780|80868403|FG002|Overall Study|Death|14|||
27737607|NCT01794780|80868404|FG003|Overall Study|Death|1|||
27737608|NCT01794780|80868405|FG004|Overall Study|Death|0|||
27737609|NCT01794780|80868406|FG005|Overall Study|Death|9|||
27737610|NCT01794780|80868407|FG006|Overall Study|Death|4|||
27737611|NCT01794780|80868408|FG007|Overall Study|Death|0|||
27737612|NCT01794780|80868401|FG000|Overall Study|Lost to Follow-up|10|||
27737613|NCT01794780|80868402|FG001|Overall Study|Lost to Follow-up|64|||
27737614|NCT01794780|80868403|FG002|Overall Study|Lost to Follow-up|165|||
27737615|NCT01794780|80868404|FG003|Overall Study|Lost to Follow-up|53|||
27737616|NCT01794780|80868405|FG004|Overall Study|Lost to Follow-up|2|||
27533745|NCT02322021|80148253|FG002|Extension Phase|Other|0|||
27737617|NCT01794780|80868406|FG005|Overall Study|Lost to Follow-up|99|||
27737618|NCT01794780|80868407|FG006|Overall Study|Lost to Follow-up|30|||
27737619|NCT01794780|80868408|FG007|Overall Study|Lost to Follow-up|5|||
27533746|NCT02322021|80148254|FG003|Extension Phase|Other|0|||
27737620|NCT01794780|80868401|FG000|Overall Study|Withdrew informed consent|7|||
27533747|NCT02322021|80148255|FG004|Extension Phase|Other|3|||
27533748|NCT02322021|80148251|FG000|Extension Phase|Lost to Follow-up|0|||
27737621|NCT01794780|80868402|FG001|Overall Study|Withdrew informed consent|17|||
27737622|NCT01794780|80868403|FG002|Overall Study|Withdrew informed consent|36|||
27737623|NCT01794780|80868404|FG003|Overall Study|Withdrew informed consent|9|||
27737624|NCT01794780|80868405|FG004|Overall Study|Withdrew informed consent|0|||
27533749|NCT02322021|80148252|FG001|Extension Phase|Lost to Follow-up|0|||
27533750|NCT02322021|80148253|FG002|Extension Phase|Lost to Follow-up|0|||
27533751|NCT02322021|80148254|FG003|Extension Phase|Lost to Follow-up|0|||
27533752|NCT02322021|80148255|FG004|Extension Phase|Lost to Follow-up|1|||
27533753|NCT02322021|80148251|FG000|Extension Phase|Study terminated by sponsor|0|||
27533754|NCT02322021|80148252|FG001|Extension Phase|Study terminated by sponsor|0|||
27913474|NCT00780975|81522109|FG000|Overall Study|Toxicity|5|||
27913475|NCT00377637|81522114|FG000|Induction Phase|Adverse Event|12|||
27629671|NCT02987543|80483760|FG001|Overall Study|Ongoing study at data cut off|21|||
27629672|NCT02987543|80483761|FG002|Overall Study|Ongoing study at data cut off|19|||
27629673|NCT02987543|80483762|FG003|Overall Study|Ongoing study at data cut off|12|||
27629674|NCT02987543|80483759|FG000|Overall Study|Death|88|||
27629675|NCT02987543|80483760|FG001|Overall Study|Death|54|||
27629676|NCT02987543|80483761|FG002|Overall Study|Death|67|||
27629677|NCT02987543|80483762|FG003|Overall Study|Death|28|||
27629678|NCT02987543|80483759|FG000|Overall Study|Lost to Follow-up|3|||
27629679|NCT02987543|80483760|FG001|Overall Study|Lost to Follow-up|0|||
27629680|NCT02987543|80483761|FG002|Overall Study|Lost to Follow-up|1|||
27629681|NCT02987543|80483762|FG003|Overall Study|Lost to Follow-up|0|||
27629682|NCT02987543|80483759|FG000|Overall Study|Screen failure|0|||
27629683|NCT02987543|80483760|FG001|Overall Study|Screen failure|0|||
27629684|NCT02987543|80483761|FG002|Overall Study|Screen failure|0|||
27629685|NCT02987543|80483762|FG003|Overall Study|Screen failure|1|||
27629686|NCT02987543|80483759|FG000|Overall Study|Withdrawal by Subject|21|||
27629687|NCT02987543|80483760|FG001|Overall Study|Withdrawal by Subject|7|||
27629688|NCT02987543|80483761|FG002|Overall Study|Withdrawal by Subject|7|||
27629689|NCT02987543|80483762|FG003|Overall Study|Withdrawal by Subject|6|||
27629690|NCT02987543|80483759|FG000|Overall Study|Study terminated by sponsor|1|||
27629691|NCT02987543|80483760|FG001|Overall Study|Study terminated by sponsor|0|||
27629692|NCT02987543|80483761|FG002|Overall Study|Study terminated by sponsor|0|||
27629693|NCT02987543|80483762|FG003|Overall Study|Study terminated by sponsor|0|||
27629694|NCT02987543|80483759|FG000|Overall Study|Investigator decision|0|||
27629695|NCT02987543|80483760|FG001|Overall Study|Investigator decision|1|||
27629696|NCT02987543|80483761|FG002|Overall Study|Investigator decision|0|||
27629697|NCT02987543|80483762|FG003|Overall Study|Investigator decision|0|||
27629698|NCT02987543|80483759|FG000|Overall Study|Disease progression|0|||
27629699|NCT02987543|80483760|FG001|Overall Study|Disease progression|0|||
27629700|NCT02987543|80483761|FG002|Overall Study|Disease progression|0|||
27629701|NCT02987543|80483762|FG003|Overall Study|Disease progression|1|||
27629702|NCT02499328|80483765|FG000|Overall Study|Withdrawal by Subject|1|||
27629703|NCT02499328|80483766|FG001|Overall Study|Withdrawal by Subject|1|||
27629704|NCT02499328|80483767|FG002|Overall Study|Withdrawal by Subject|5|||
27737625|NCT01794780|80868406|FG005|Overall Study|Withdrew informed consent|48|||
27737626|NCT01794780|80868407|FG006|Overall Study|Withdrew informed consent|4|||
27533755|NCT02322021|80148253|FG002|Extension Phase|Study terminated by sponsor|0|||
27533756|NCT02322021|80148254|FG003|Extension Phase|Study terminated by sponsor|0|||
27533757|NCT02322021|80148255|FG004|Extension Phase|Study terminated by sponsor|28|||
27533758|NCT02764697|80148256|FG000|Overall Study|Lack of Efficacy|3|||
27533759|NCT02001181|80148260|FG000|Overall Study|Adverse Event|0|||
27533760|NCT02001181|80148261|FG001|Overall Study|Adverse Event|2|||
27533761|NCT02001181|80148260|FG000|Overall Study|Lost to Follow-up|1|||
27533762|NCT02001181|80148261|FG001|Overall Study|Lost to Follow-up|0|||
27533763|NCT02001181|80148260|FG000|Overall Study|Withdrawal by Subject|0|||
27533764|NCT02001181|80148261|FG001|Overall Study|Withdrawal by Subject|1|||
27533765|NCT03004443|80148263|FG000|Overall Study|Pregnancy|0|||
27533766|NCT03004443|80148264|FG001|Overall Study|Pregnancy|1|||
27533777|NCT01460368|80148268|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27533778|NCT01460368|80148269|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27533779|NCT01460368|80148270|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27533780|NCT01460368|80148271|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27533781|NCT01460368|80148272|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
27629705|NCT02499328|80483768|FG003|Overall Study|Withdrawal by Subject|3|||
27629706|NCT02499328|80483769|FG004|Overall Study|Withdrawal by Subject|5|||
27913476|NCT00377637|81522115|FG001|Induction Phase|Adverse Event|21|||
27533782|NCT01460368|80148273|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27533783|NCT01460368|80148274|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
27629707|NCT02499328|80483770|FG005|Overall Study|Withdrawal by Subject|0|||
27629708|NCT02499328|80483771|FG006|Overall Study|Withdrawal by Subject|0|||
27533784|NCT01460368|80148268|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27629709|NCT02499328|80483772|FG007|Overall Study|Withdrawal by Subject|0|||
27629710|NCT02499328|80483773|FG008|Overall Study|Withdrawal by Subject|2|||
27629711|NCT02499328|80483774|FG009|Overall Study|Withdrawal by Subject|2|||
27913477|NCT00377637|81522116|FG002|Induction Phase|Adverse Event|0|||
27913478|NCT00377637|81522117|FG003|Induction Phase|Adverse Event|0|||
27737627|NCT01794780|80868408|FG007|Overall Study|Withdrew informed consent|3|||
27913479|NCT00377637|81522114|FG000|Induction Phase|Deterioration/serum creatinine|2|||
27913480|NCT00377637|81522115|FG001|Induction Phase|Deterioration/serum creatinine|0|||
27913481|NCT00377637|81522116|FG002|Induction Phase|Deterioration/serum creatinine|0|||
27913482|NCT00377637|81522117|FG003|Induction Phase|Deterioration/serum creatinine|0|||
27913483|NCT00377637|81522114|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
27913484|NCT00377637|81522115|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
27913485|NCT00377637|81522116|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
27913486|NCT00377637|81522117|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
27913487|NCT00377637|81522114|FG000|Induction Phase|Lost to Follow-up|2|||
27913488|NCT00377637|81522115|FG001|Induction Phase|Lost to Follow-up|1|||
27913489|NCT00377637|81522116|FG002|Induction Phase|Lost to Follow-up|0|||
27913490|NCT00377637|81522117|FG003|Induction Phase|Lost to Follow-up|0|||
27913491|NCT00377637|81522114|FG000|Induction Phase|Death|1|||
27913492|NCT00377637|81522115|FG001|Induction Phase|Death|3|||
27913493|NCT00377637|81522116|FG002|Induction Phase|Death|0|||
27913494|NCT00377637|81522117|FG003|Induction Phase|Death|0|||
27913495|NCT00377637|81522114|FG000|Induction Phase|Withdrawal by Subject|5|||
27913496|NCT00377637|81522115|FG001|Induction Phase|Withdrawal by Subject|6|||
27913497|NCT00377637|81522116|FG002|Induction Phase|Withdrawal by Subject|0|||
27913498|NCT00377637|81522117|FG003|Induction Phase|Withdrawal by Subject|0|||
27913499|NCT00377637|81522114|FG000|Induction Phase|Physician Decision|3|||
27913500|NCT00377637|81522115|FG001|Induction Phase|Physician Decision|1|||
27913501|NCT00377637|81522116|FG002|Induction Phase|Physician Decision|0|||
27913502|NCT00377637|81522117|FG003|Induction Phase|Physician Decision|0|||
27913503|NCT00377637|81522114|FG000|Induction Phase|Sponsor decision|1|||
27913504|NCT00377637|81522115|FG001|Induction Phase|Sponsor decision|2|||
27913505|NCT00377637|81522116|FG002|Induction Phase|Sponsor decision|0|||
27913506|NCT00377637|81522117|FG003|Induction Phase|Sponsor decision|0|||
27913507|NCT00377637|81522114|FG000|Induction Phase|Non-Compliance|1|||
27913508|NCT00377637|81522115|FG001|Induction Phase|Non-Compliance|0|||
27913509|NCT00377637|81522116|FG002|Induction Phase|Non-Compliance|0|||
27913510|NCT00377637|81522117|FG003|Induction Phase|Non-Compliance|0|||
27913511|NCT00377637|81522114|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
27913512|NCT00377637|81522115|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
27913513|NCT00377637|81522116|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
27913514|NCT00377637|81522117|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
27913515|NCT00377637|81522114|FG000|Maintenance Phase|Adverse Event|0|||
27913516|NCT00377637|81522115|FG001|Maintenance Phase|Adverse Event|0|||
27913517|NCT00377637|81522116|FG002|Maintenance Phase|Adverse Event|29|||
27913518|NCT00377637|81522117|FG003|Maintenance Phase|Adverse Event|43|||
27913519|NCT00377637|81522114|FG000|Maintenance Phase|Physician Decision|0|||
27913520|NCT00377637|81522115|FG001|Maintenance Phase|Physician Decision|0|||
27913521|NCT00377637|81522116|FG002|Maintenance Phase|Physician Decision|5|||
27913522|NCT00377637|81522117|FG003|Maintenance Phase|Physician Decision|4|||
27913523|NCT00377637|81522114|FG000|Maintenance Phase|Lost to Follow-up|0|||
27913524|NCT00377637|81522115|FG001|Maintenance Phase|Lost to Follow-up|0|||
27913525|NCT00377637|81522116|FG002|Maintenance Phase|Lost to Follow-up|3|||
27913526|NCT00377637|81522117|FG003|Maintenance Phase|Lost to Follow-up|1|||
27913527|NCT00377637|81522114|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27913528|NCT00377637|81522115|FG001|Maintenance Phase|Withdrawal by Subject|0|||
27913529|NCT00377637|81522116|FG002|Maintenance Phase|Withdrawal by Subject|3|||
27913530|NCT00377637|81522117|FG003|Maintenance Phase|Withdrawal by Subject|3|||
27913531|NCT00377637|81522114|FG000|Maintenance Phase|Sponsor decision|0|||
27913532|NCT00377637|81522115|FG001|Maintenance Phase|Sponsor decision|0|||
27913533|NCT00377637|81522116|FG002|Maintenance Phase|Sponsor decision|2|||
27913534|NCT00377637|81522117|FG003|Maintenance Phase|Sponsor decision|3|||
27913535|NCT00377637|81522114|FG000|Maintenance Phase|Non-compliance|0|||
27913536|NCT00377637|81522115|FG001|Maintenance Phase|Non-compliance|0|||
27913537|NCT00377637|81522116|FG002|Maintenance Phase|Non-compliance|1|||
27913538|NCT00377637|81522117|FG003|Maintenance Phase|Non-compliance|1|||
27913539|NCT00377637|81522114|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
27913540|NCT00377637|81522115|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
27913541|NCT00377637|81522116|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
27913542|NCT00377637|81522117|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
27913543|NCT00377637|81522114|FG000|Maintenance Phase|Death|0|||
27913544|NCT00377637|81522115|FG001|Maintenance Phase|Death|0|||
27913545|NCT00377637|81522116|FG002|Maintenance Phase|Death|0|||
27913546|NCT00377637|81522117|FG003|Maintenance Phase|Death|1|||
27913547|NCT03677869|81522128|FG000|Overall Study|Withdrawal by Subject|1|||
27913548|NCT03372798|81522129|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
27913549|NCT03372798|81522130|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
27913550|NCT03372798|81522129|FG000|Overall Study|Failure of imaging probe|0|||
27737628|NCT01794780|80868401|FG000|Overall Study|Other|0|||
27913551|NCT03372798|81522130|FG001|Overall Study|Failure of imaging probe|1|||
27913552|NCT03904420|81522131|FG000|Overall Study|Study terminated|2|||
27913553|NCT03904420|81522132|FG001|Overall Study|Study terminated|2|||
27913554|NCT01029262|81522133|FG000|Overall Study|Adverse Event|9|||
27913555|NCT01029262|81522134|FG001|Overall Study|Adverse Event|52|||
27913556|NCT01029262|81522133|FG000|Overall Study|Lack of therapeutic effect|57|||
27913557|NCT01029262|81522134|FG001|Overall Study|Lack of therapeutic effect|76|||
27913558|NCT01029262|81522133|FG000|Overall Study|Withdrawal by Subject|10|||
27913559|NCT01029262|81522134|FG001|Overall Study|Withdrawal by Subject|17|||
27913560|NCT01029262|81522133|FG000|Overall Study|Protocol Violation|2|||
27913561|NCT01029262|81522134|FG001|Overall Study|Protocol Violation|3|||
27913562|NCT01029262|81522133|FG000|Overall Study|Miscellaneous|1|||
27737629|NCT01794780|80868402|FG001|Overall Study|Other|12|||
27737630|NCT01794780|80868403|FG002|Overall Study|Other|25|||
27737631|NCT01794780|80868404|FG003|Overall Study|Other|20|||
27737632|NCT01794780|80868405|FG004|Overall Study|Other|1|||
27737633|NCT01794780|80868406|FG005|Overall Study|Other|24|||
27737634|NCT01794780|80868407|FG006|Overall Study|Other|4|||
27737635|NCT01794780|80868408|FG007|Overall Study|Other|1|||
27737636|NCT03658889|80868411|FG000|Overall Study|Protocol Violation|2|||
27737637|NCT03658889|80868412|FG001|Overall Study|Protocol Violation|0|||
27737638|NCT03853694|80868413|FG000|Overall Study|Protocol Violation|3|||
27737639|NCT03853694|80868414|FG001|Overall Study|Protocol Violation|5|||
27737640|NCT03853694|80868415|FG002|Overall Study|Protocol Violation|3|||
27737641|NCT03853694|80868413|FG000|Overall Study|Delivered early|0|||
27737642|NCT03853694|80868414|FG001|Overall Study|Delivered early|1|||
27913563|NCT01029262|81522134|FG001|Overall Study|Miscellaneous|9|||
27913564|NCT01029262|81522133|FG000|Overall Study|Death|0|||
27913565|NCT01029262|81522134|FG001|Overall Study|Death|3|||
27913566|NCT02021292|81522137|FG000|Overall Study|Physician Decision|0|||
27913567|NCT02021292|81522138|FG001|Overall Study|Physician Decision|1|||
27913568|NCT02021292|81522137|FG000|Overall Study|Lost to Follow-up|0|||
27913569|NCT02021292|81522138|FG001|Overall Study|Lost to Follow-up|1|||
27913570|NCT02021292|81522137|FG000|Overall Study|Death|0|||
27913571|NCT02021292|81522138|FG001|Overall Study|Death|1|||
27913572|NCT04435808|81522141|FG000|Overall Study|Study stopped by DSMB|0|||
27913573|NCT04435808|81522142|FG001|Overall Study|Study stopped by DSMB|1|||
27913574|NCT03589807|81522144|FG000|Overall Study|Lost to Follow-up|0|||
27913575|NCT03589807|81522145|FG001|Overall Study|Lost to Follow-up|2|||
27913576|NCT03589807|81522146|FG002|Overall Study|Lost to Follow-up|2|||
27913577|NCT03589807|81522147|FG003|Overall Study|Lost to Follow-up|3|||
27913578|NCT03589807|81522148|FG004|Overall Study|Lost to Follow-up|1|||
27913579|NCT03589807|81522149|FG005|Overall Study|Lost to Follow-up|1|||
27913580|NCT03589807|81522144|FG000|Overall Study|Withdrawal by Subject|0|||
27913581|NCT03589807|81522145|FG001|Overall Study|Withdrawal by Subject|5|||
27913582|NCT03589807|81522146|FG002|Overall Study|Withdrawal by Subject|0|||
27913583|NCT03589807|81522147|FG003|Overall Study|Withdrawal by Subject|0|||
27913584|NCT03589807|81522148|FG004|Overall Study|Withdrawal by Subject|0|||
27913585|NCT03589807|81522149|FG005|Overall Study|Withdrawal by Subject|0|||
27913586|NCT03589807|81522144|FG000|Overall Study|Protocol Violation|0|||
27913587|NCT03589807|81522145|FG001|Overall Study|Protocol Violation|0|||
27913588|NCT03589807|81522146|FG002|Overall Study|Protocol Violation|0|||
27913589|NCT03589807|81522147|FG003|Overall Study|Protocol Violation|1|||
27913590|NCT03589807|81522148|FG004|Overall Study|Protocol Violation|0|||
27913591|NCT03589807|81522149|FG005|Overall Study|Protocol Violation|0|||
27913592|NCT03589807|81522144|FG000|Overall Study|Enrolled but treatment not administered|0|||
27913593|NCT03589807|81522145|FG001|Overall Study|Enrolled but treatment not administered|0|||
27913594|NCT03589807|81522146|FG002|Overall Study|Enrolled but treatment not administered|0|||
27913595|NCT03589807|81522147|FG003|Overall Study|Enrolled but treatment not administered|0|||
27913596|NCT03589807|81522148|FG004|Overall Study|Enrolled but treatment not administered|1|||
27913597|NCT03589807|81522149|FG005|Overall Study|Enrolled but treatment not administered|0|||
27913598|NCT00610168|81522150|FG000|Overall Study|Withdrawal by Subject|2|||
27913599|NCT00610168|81522151|FG001|Overall Study|Withdrawal by Subject|0|||
27533785|NCT01460368|80148269|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
27533786|NCT01460368|80148270|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27533787|NCT01460368|80148271|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27913600|NCT00305227|81522152|FG000|Overall Study|Lost to Follow-up|7|||
27533788|NCT01460368|80148272|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27913601|NCT00305227|81522153|FG001|Overall Study|Lost to Follow-up|6|||
27737643|NCT03853694|80868415|FG002|Overall Study|Delivered early|0|||
27737644|NCT03853694|80868413|FG000|Overall Study|not suitable to proceed|0|||
27737645|NCT03853694|80868414|FG001|Overall Study|not suitable to proceed|1|||
27737646|NCT03853694|80868415|FG002|Overall Study|not suitable to proceed|0|||
27737647|NCT03853694|80868413|FG000|Overall Study|difficult surgery|0|||
27737648|NCT03853694|80868414|FG001|Overall Study|difficult surgery|0|||
27913602|NCT02168491|81522154|FG000|Overall Study|Withdrawal by Subject|1|||
27913603|NCT03478371|81522158|FG000|Overall Study|non-compliance|1|||
27913604|NCT03478371|81522158|FG000|Overall Study|Lost to Follow-up|4|||
27533789|NCT01460368|80148273|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
27533790|NCT01460368|80148274|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
27533791|NCT01460368|80148268|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27533792|NCT01460368|80148269|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
27533793|NCT01460368|80148270|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27533794|NCT01460368|80148271|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27533795|NCT01460368|80148272|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27533796|NCT01460368|80148273|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27533797|NCT01460368|80148274|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
27737649|NCT03853694|80868415|FG002|Overall Study|difficult surgery|1|||
27737650|NCT03853694|80868413|FG000|Overall Study|Lost to Follow-up|0|||
27737651|NCT03853694|80868414|FG001|Overall Study|Lost to Follow-up|1|||
27737652|NCT03853694|80868415|FG002|Overall Study|Lost to Follow-up|0|||
27737653|NCT03853694|80868413|FG000|Overall Study|Withdrawal by Subject|0|||
27737654|NCT03853694|80868414|FG001|Overall Study|Withdrawal by Subject|1|||
27737655|NCT03853694|80868415|FG002|Overall Study|Withdrawal by Subject|0|||
27737656|NCT00658333|80868416|FG000|Overall Study|Adverse Event|2|||
27533798|NCT01460368|80148268|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27533799|NCT01460368|80148269|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27533800|NCT01460368|80148270|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
27533801|NCT01460368|80148271|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27533802|NCT01460368|80148272|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27533803|NCT01460368|80148273|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27533804|NCT01460368|80148274|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
27533805|NCT01460368|80148268|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27533806|NCT01460368|80148269|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27533807|NCT01460368|80148270|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
27533808|NCT01460368|80148271|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
27533809|NCT01460368|80148272|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27533810|NCT01460368|80148273|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
27533811|NCT01460368|80148274|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
27533812|NCT01147640|80148275|FG000|Overall Study|Adverse Event|2|||
27533813|NCT01147640|80148276|FG001|Overall Study|Adverse Event|0|||
27533814|NCT01147640|80148275|FG000|Overall Study|Physician Decision|1|||
27533815|NCT01147640|80148276|FG001|Overall Study|Physician Decision|0|||
27533816|NCT01147640|80148275|FG000|Overall Study|Withdrawal by Subject|1|||
27533817|NCT01147640|80148276|FG001|Overall Study|Withdrawal by Subject|0|||
27533818|NCT01147640|80148275|FG000|Overall Study|Lost to Follow-up|0|||
27533819|NCT01147640|80148276|FG001|Overall Study|Lost to Follow-up|1|||
27533820|NCT01147640|80148275|FG000|Overall Study|Didn't meet eligibility criteria|1|||
27533821|NCT01147640|80148276|FG001|Overall Study|Didn't meet eligibility criteria|0|||
27533822|NCT01262573|80148277|FG000|Overall Study|Withdrawal by Subject|0|||
27533823|NCT01262573|80148278|FG001|Overall Study|Withdrawal by Subject|1|||
27533824|NCT04060862|80148279|FG000|Overall Study|Symptomatic Deterioration|1|||
27533825|NCT04060862|80148279|FG000|Overall Study|Un-specified|6|||
27533826|NCT04060862|80148279|FG000|Overall Study|Progressive disease|12|||
27533827|NCT04060862|80148279|FG000|Overall Study|Physician Decision|1|||
27533828|NCT04171765|80148281|FG000|Overall Study|Adverse Event|2|||
27533829|NCT04171765|80148282|FG001|Overall Study|Adverse Event|0|||
27533830|NCT04171765|80148283|FG002|Overall Study|Adverse Event|1|||
27533831|NCT04171765|80148284|FG003|Overall Study|Adverse Event|0|||
27533832|NCT04171765|80148281|FG000|Overall Study|Lost to Follow-up|0|||
27533833|NCT04171765|80148282|FG001|Overall Study|Lost to Follow-up|2|||
27737657|NCT00658333|80868417|FG001|Overall Study|Adverse Event|1|||
27737658|NCT01059812|80868423|FG000|Overall Study|Adverse Event|9|||
27737659|NCT01059812|80868424|FG001|Overall Study|Adverse Event|5|||
27737660|NCT01059812|80868423|FG000|Overall Study|Lack of Efficacy|2|||
27737661|NCT01059812|80868424|FG001|Overall Study|Lack of Efficacy|2|||
27737662|NCT01059812|80868423|FG000|Overall Study|Protocol Violation|3|||
27737663|NCT01059812|80868424|FG001|Overall Study|Protocol Violation|1|||
27737664|NCT01059812|80868423|FG000|Overall Study|Withdrawal Criteria|9|||
27737665|NCT01059812|80868424|FG001|Overall Study|Withdrawal Criteria|4|||
27737666|NCT01059812|80868423|FG000|Overall Study|Unclassified|14|||
27737667|NCT01059812|80868424|FG001|Overall Study|Unclassified|4|||
27737668|NCT04734873|80868425|FG000|Overall Study|Lost to Follow-up|1|||
27533834|NCT04171765|80148283|FG002|Overall Study|Lost to Follow-up|2|||
27533835|NCT04171765|80148284|FG003|Overall Study|Lost to Follow-up|2|||
27737669|NCT04734873|80868426|FG001|Overall Study|Lost to Follow-up|3|||
27737670|NCT04734873|80868427|FG002|Overall Study|Lost to Follow-up|2|||
27737671|NCT04734873|80868425|FG000|Overall Study|Randomized but not dosed|1|||
27737672|NCT04734873|80868426|FG001|Overall Study|Randomized but not dosed|0|||
27737673|NCT04734873|80868427|FG002|Overall Study|Randomized but not dosed|1|||
27737674|NCT00466505|80868428|FG000|Overall Study|disease progression|13|||
27737675|NCT00466505|80868428|FG000|Overall Study|Adverse Event|4|||
27913605|NCT01932697|81522159|FG000|Overall Study|Received a different amount of tx|1|||
27913606|NCT01932697|81522160|FG001|Overall Study|Received a different amount of tx|0|||
27913607|NCT01932697|81522159|FG000|Overall Study|Ineligible|1|||
27913608|NCT01932697|81522160|FG001|Overall Study|Ineligible|0|||
27913609|NCT00732069|81522165|FG000|Washout After First Study Drug|Adverse Event|1|||
27913610|NCT00732069|81522166|FG001|Washout After First Study Drug|Adverse Event|0|||
27913611|NCT00732069|81522167|FG002|Washout After First Study Drug|Adverse Event|0|||
27913612|NCT00732069|81522168|FG003|Washout After First Study Drug|Adverse Event|0|||
27913613|NCT00732069|81522169|FG004|Washout After First Study Drug|Adverse Event|0|||
27913614|NCT00732069|81522170|FG005|Washout After First Study Drug|Adverse Event|0|||
27913615|NCT01441973|81522171|FG000|Overall Study|Disease progression|8|||
27913616|NCT01441973|81522172|FG001|Overall Study|Disease progression|6|||
27913617|NCT01441973|81522171|FG000|Overall Study|Adverse event unrelated to study drug|3|||
27913618|NCT01441973|81522172|FG001|Overall Study|Adverse event unrelated to study drug|2|||
27913619|NCT01441973|81522171|FG000|Overall Study|Participant request to discontinue|1|||
27913620|NCT01441973|81522172|FG001|Overall Study|Participant request to discontinue|1|||
27913621|NCT01441973|81522171|FG000|Overall Study|Poor compliance/noncompliance|0|||
27913622|NCT01441973|81522172|FG001|Overall Study|Poor compliance/noncompliance|1|||
27913623|NCT01441973|81522171|FG000|Overall Study|Administrative reason by sponsor|3|||
27913624|NCT01441973|81522172|FG001|Overall Study|Administrative reason by sponsor|5|||
27913625|NCT01441973|81522171|FG000|Overall Study|Participant withdrew consent|0|||
27913626|NCT01441973|81522172|FG001|Overall Study|Participant withdrew consent|1|||
27913627|NCT00411450|81522175|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
27913628|NCT01468454|81522178|FG000|Overall Study|Did not have surgery after PET|9|||
27913629|NCT03498313|81522182|FG000|Experimental Period 1|Adverse Event|1|||
27913630|NCT03498313|81522183|FG001|Experimental Period 1|Adverse Event|0|||
27913631|NCT03498313|81522184|FG002|Experimental Period 1|Adverse Event|0|||
27913632|NCT03498313|81522185|FG003|Experimental Period 1|Adverse Event|1|||
27913633|NCT03498313|81522186|FG004|Experimental Period 1|Adverse Event|0|||
27913634|NCT03498313|81522187|FG005|Experimental Period 1|Adverse Event|0|||
27913635|NCT03498313|81522182|FG000|Experimental Period 1|Withdrawal by Subject|0|||
27913636|NCT03498313|81522183|FG001|Experimental Period 1|Withdrawal by Subject|1|||
27913637|NCT03498313|81522184|FG002|Experimental Period 1|Withdrawal by Subject|0|||
27913638|NCT03498313|81522185|FG003|Experimental Period 1|Withdrawal by Subject|0|||
27913639|NCT03498313|81522186|FG004|Experimental Period 1|Withdrawal by Subject|0|||
27913640|NCT03498313|81522187|FG005|Experimental Period 1|Withdrawal by Subject|0|||
27913641|NCT03498313|81522182|FG000|Washout Period 1|Anovulation|1|||
27913642|NCT03498313|81522183|FG001|Washout Period 1|Anovulation|0|||
27913643|NCT03498313|81522184|FG002|Washout Period 1|Anovulation|0|||
27913644|NCT03498313|81522185|FG003|Washout Period 1|Anovulation|0|||
27913645|NCT03498313|81522186|FG004|Washout Period 1|Anovulation|0|||
27913646|NCT03498313|81522187|FG005|Washout Period 1|Anovulation|0|||
27913647|NCT03498313|81522182|FG000|Washout Period 1|Withdrawal by Subject|0|||
27913648|NCT03498313|81522183|FG001|Washout Period 1|Withdrawal by Subject|3|||
27913649|NCT03498313|81522184|FG002|Washout Period 1|Withdrawal by Subject|0|||
27913650|NCT03498313|81522185|FG003|Washout Period 1|Withdrawal by Subject|1|||
27913651|NCT03498313|81522186|FG004|Washout Period 1|Withdrawal by Subject|0|||
27913652|NCT03498313|81522187|FG005|Washout Period 1|Withdrawal by Subject|1|||
27913653|NCT03498313|81522182|FG000|Experimental Period 2|Adverse Event|0|||
27913654|NCT03498313|81522183|FG001|Experimental Period 2|Adverse Event|0|||
27913655|NCT03498313|81522184|FG002|Experimental Period 2|Adverse Event|0|||
27913656|NCT03498313|81522185|FG003|Experimental Period 2|Adverse Event|0|||
27913657|NCT03498313|81522186|FG004|Experimental Period 2|Adverse Event|1|||
27913658|NCT03498313|81522187|FG005|Experimental Period 2|Adverse Event|2|||
27913659|NCT03498313|81522182|FG000|Washout Period 2|Physician Decision|1|||
27913660|NCT03498313|81522183|FG001|Washout Period 2|Physician Decision|0|||
27913661|NCT03498313|81522184|FG002|Washout Period 2|Physician Decision|0|||
27913662|NCT03498313|81522185|FG003|Washout Period 2|Physician Decision|1|||
27913663|NCT03498313|81522186|FG004|Washout Period 2|Physician Decision|0|||
27913664|NCT03498313|81522187|FG005|Washout Period 2|Physician Decision|1|||
27913665|NCT03498313|81522182|FG000|Washout Period 2|Withdrawal by Subject|3|||
27913666|NCT03498313|81522183|FG001|Washout Period 2|Withdrawal by Subject|2|||
27913667|NCT03498313|81522184|FG002|Washout Period 2|Withdrawal by Subject|0|||
27533836|NCT04171765|80148281|FG000|Overall Study|Week 58 visit missed|0|||
27913668|NCT03498313|81522185|FG003|Washout Period 2|Withdrawal by Subject|0|||
27913669|NCT03498313|81522186|FG004|Washout Period 2|Withdrawal by Subject|2|||
27913670|NCT03498313|81522187|FG005|Washout Period 2|Withdrawal by Subject|0|||
27913671|NCT03498313|81522182|FG000|Washout Period 2|Anovulation|0|||
27913672|NCT03498313|81522183|FG001|Washout Period 2|Anovulation|0|||
27913673|NCT03498313|81522184|FG002|Washout Period 2|Anovulation|0|||
27913674|NCT03498313|81522185|FG003|Washout Period 2|Anovulation|0|||
27533837|NCT04171765|80148282|FG001|Overall Study|Week 58 visit missed|0|||
27533838|NCT04171765|80148283|FG002|Overall Study|Week 58 visit missed|1|||
27533839|NCT04171765|80148284|FG003|Overall Study|Week 58 visit missed|0|||
27533840|NCT04171765|80148281|FG000|Overall Study|Study terminated by sponsor|2|||
27533841|NCT04171765|80148282|FG001|Overall Study|Study terminated by sponsor|0|||
27533842|NCT04171765|80148283|FG002|Overall Study|Study terminated by sponsor|0|||
27533843|NCT04171765|80148284|FG003|Overall Study|Study terminated by sponsor|0|||
27533844|NCT04171765|80148281|FG000|Overall Study|Withdrawal by Subject|1|||
27533845|NCT04171765|80148282|FG001|Overall Study|Withdrawal by Subject|0|||
27533846|NCT04171765|80148283|FG002|Overall Study|Withdrawal by Subject|0|||
27533847|NCT04171765|80148284|FG003|Overall Study|Withdrawal by Subject|3|||
27533848|NCT02544074|80148285|FG000|Overall Study|Withdrawal by Subject|0|||
27533849|NCT02544074|80148286|FG001|Overall Study|Withdrawal by Subject|1|||
27533850|NCT02544074|80148287|FG002|Overall Study|Withdrawal by Subject|0|||
27533851|NCT02544074|80148288|FG003|Overall Study|Withdrawal by Subject|0|||
27533852|NCT02544074|80148289|FG004|Overall Study|Withdrawal by Subject|0|||
27533853|NCT02544074|80148290|FG005|Overall Study|Withdrawal by Subject|0|||
27533854|NCT02544074|80148291|FG006|Overall Study|Withdrawal by Subject|0|||
27533855|NCT02544074|80148292|FG007|Overall Study|Withdrawal by Subject|0|||
27533856|NCT02544074|80148293|FG008|Overall Study|Withdrawal by Subject|0|||
27533857|NCT02544074|80148294|FG009|Overall Study|Withdrawal by Subject|0|||
27533858|NCT02544074|80148295|FG010|Overall Study|Withdrawal by Subject|0|||
27533859|NCT02544074|80148296|FG011|Overall Study|Withdrawal by Subject|0|||
27533860|NCT02544074|80148297|FG012|Overall Study|Withdrawal by Subject|0|||
27533861|NCT02544074|80148298|FG013|Overall Study|Withdrawal by Subject|0|||
27533862|NCT02544074|80148299|FG014|Overall Study|Withdrawal by Subject|0|||
27533863|NCT02544074|80148300|FG015|Overall Study|Withdrawal by Subject|0|||
27533864|NCT02544074|80148301|FG016|Overall Study|Withdrawal by Subject|0|||
27533865|NCT02544074|80148302|FG017|Overall Study|Withdrawal by Subject|0|||
27629712|NCT02499328|80483775|FG010|Overall Study|Withdrawal by Subject|0|||
27629713|NCT02499328|80483776|FG011|Overall Study|Withdrawal by Subject|3|||
27629714|NCT02499328|80483777|FG012|Overall Study|Withdrawal by Subject|7|||
27629715|NCT02499328|80483778|FG013|Overall Study|Withdrawal by Subject|3|||
27629716|NCT02499328|80483779|FG014|Overall Study|Withdrawal by Subject|1|||
27629717|NCT02499328|80483780|FG015|Overall Study|Withdrawal by Subject|0|||
27629718|NCT02499328|80483781|FG016|Overall Study|Withdrawal by Subject|0|||
27629719|NCT02499328|80483782|FG017|Overall Study|Withdrawal by Subject|3|||
27629720|NCT02499328|80483783|FG018|Overall Study|Withdrawal by Subject|0|||
27629721|NCT02499328|80483765|FG000|Overall Study|Lost to Follow-up|0|||
27629722|NCT02499328|80483766|FG001|Overall Study|Lost to Follow-up|1|||
27629723|NCT02499328|80483767|FG002|Overall Study|Lost to Follow-up|1|||
27629724|NCT02499328|80483768|FG003|Overall Study|Lost to Follow-up|2|||
27629725|NCT02499328|80483769|FG004|Overall Study|Lost to Follow-up|0|||
27629726|NCT02499328|80483770|FG005|Overall Study|Lost to Follow-up|0|||
27629727|NCT02499328|80483771|FG006|Overall Study|Lost to Follow-up|0|||
27629728|NCT02499328|80483772|FG007|Overall Study|Lost to Follow-up|2|||
27629729|NCT02499328|80483773|FG008|Overall Study|Lost to Follow-up|3|||
27629730|NCT02499328|80483774|FG009|Overall Study|Lost to Follow-up|0|||
27629731|NCT02499328|80483775|FG010|Overall Study|Lost to Follow-up|0|||
27629732|NCT02499328|80483776|FG011|Overall Study|Lost to Follow-up|0|||
27629733|NCT02499328|80483777|FG012|Overall Study|Lost to Follow-up|0|||
27629734|NCT02499328|80483778|FG013|Overall Study|Lost to Follow-up|0|||
27629735|NCT02499328|80483779|FG014|Overall Study|Lost to Follow-up|0|||
27629736|NCT02499328|80483780|FG015|Overall Study|Lost to Follow-up|0|||
27629737|NCT02499328|80483781|FG016|Overall Study|Lost to Follow-up|0|||
27629738|NCT02499328|80483782|FG017|Overall Study|Lost to Follow-up|0|||
27629739|NCT02499328|80483783|FG018|Overall Study|Lost to Follow-up|1|||
27629740|NCT02499328|80483765|FG000|Overall Study|Death|0|||
27629741|NCT02499328|80483766|FG001|Overall Study|Death|3|||
27629742|NCT02499328|80483767|FG002|Overall Study|Death|3|||
27629743|NCT02499328|80483768|FG003|Overall Study|Death|2|||
27629744|NCT02499328|80483769|FG004|Overall Study|Death|4|||
27629745|NCT02499328|80483770|FG005|Overall Study|Death|7|||
27629746|NCT02499328|80483771|FG006|Overall Study|Death|3|||
27629747|NCT02499328|80483772|FG007|Overall Study|Death|0|||
27629748|NCT02499328|80483773|FG008|Overall Study|Death|2|||
27629749|NCT02499328|80483774|FG009|Overall Study|Death|6|||
27629750|NCT02499328|80483775|FG010|Overall Study|Death|6|||
27629751|NCT02499328|80483776|FG011|Overall Study|Death|20|||
27629752|NCT02499328|80483777|FG012|Overall Study|Death|9|||
27629753|NCT02499328|80483778|FG013|Overall Study|Death|7|||
27629754|NCT02499328|80483779|FG014|Overall Study|Death|3|||
27533866|NCT02544074|80148303|FG018|Overall Study|Withdrawal by Subject|0|||
27533867|NCT02544074|80148304|FG019|Overall Study|Withdrawal by Subject|0|||
27533868|NCT02544074|80148305|FG020|Overall Study|Withdrawal by Subject|0|||
27533869|NCT02544074|80148285|FG000|Overall Study|Tablet error|0|||
27629755|NCT02499328|80483780|FG015|Overall Study|Death|1|||
27629756|NCT02499328|80483781|FG016|Overall Study|Death|1|||
27629757|NCT02499328|80483782|FG017|Overall Study|Death|16|||
27629758|NCT02499328|80483783|FG018|Overall Study|Death|5|||
27629759|NCT02499328|80483765|FG000|Overall Study|"Other"|2|||
27629760|NCT02499328|80483766|FG001|Overall Study|"Other"|2|||
27629761|NCT02499328|80483767|FG002|Overall Study|"Other"|1|||
27737676|NCT00201201|80868431|FG000|Overall Study|Death|0|||
27737677|NCT00201201|80868432|FG001|Overall Study|Death|2|||
27737678|NCT00201201|80868431|FG000|Overall Study|Withdrawal by Subject|5|||
27737679|NCT00201201|80868432|FG001|Overall Study|Withdrawal by Subject|5|||
27737680|NCT00630032|80868442|FG000|Overall Study|Death|55|||
27737681|NCT00630032|80868443|FG001|Overall Study|Death|49|||
27737682|NCT00630032|80868442|FG000|Overall Study|Withdrawal by Subject|3|||
27737683|NCT00630032|80868443|FG001|Overall Study|Withdrawal by Subject|2|||
27737684|NCT00630032|80868442|FG000|Overall Study|Lost to Follow-up|18|||
27737685|NCT00630032|80868443|FG001|Overall Study|Lost to Follow-up|31|||
27737686|NCT00630032|80868442|FG000|Overall Study|Protocol Violation|1|||
27737687|NCT00630032|80868443|FG001|Overall Study|Protocol Violation|0|||
27737688|NCT00630032|80868442|FG000|Overall Study|Patient has moved|1|||
27533870|NCT02544074|80148286|FG001|Overall Study|Tablet error|0|||
27737689|NCT00630032|80868443|FG001|Overall Study|Patient has moved|1|||
27737690|NCT00630032|80868442|FG000|Overall Study|Disease progression|1|||
27737691|NCT00630032|80868443|FG001|Overall Study|Disease progression|1|||
27737692|NCT00630032|80868442|FG000|Overall Study|End of monitoring in US centers|11|||
27737693|NCT00630032|80868443|FG001|Overall Study|End of monitoring in US centers|11|||
27737694|NCT01938625|80868444|FG000|Overall Study|Withdrawal by Subject|0|||
27737695|NCT01938625|80868445|FG001|Overall Study|Withdrawal by Subject|1|||
27737696|NCT01938625|80868444|FG000|Overall Study|Adverse Event|0|||
27737697|NCT01938625|80868445|FG001|Overall Study|Adverse Event|1|||
27737698|NCT01389128|80868446|FG000|Overall Study|Fetal distress|1|||
27737699|NCT01389128|80868447|FG001|Overall Study|Fetal distress|0|||
27737700|NCT01389128|80868446|FG000|Overall Study|Cervix dilation stop|1|||
27737701|NCT01389128|80868447|FG001|Overall Study|Cervix dilation stop|2|||
27737702|NCT01389128|80868446|FG000|Overall Study|Rapid labor evolution|3|||
27737703|NCT01389128|80868447|FG001|Overall Study|Rapid labor evolution|2|||
27737704|NCT01389128|80868446|FG000|Overall Study|Intolerance to procedure|0|||
27737705|NCT01389128|80868447|FG001|Overall Study|Intolerance to procedure|2|||
27737706|NCT00215150|80868448|FG000|Open Label Phase|Lost to Follow-up|7|||
27737707|NCT00215150|80868448|FG000|Open Label Phase|Withdrawal by Subject|1|||
27737708|NCT00215150|80868448|FG000|Open Label Phase|Did not complete a post base visit|13|||
27737709|NCT00215150|80868448|FG000|Open Label Phase|Did not meet randomization criteria|9|||
27737710|NCT00215150|80868448|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
27737711|NCT00215150|80868448|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
27737712|NCT00215150|80868448|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
27737713|NCT03455543|80868449|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
27737714|NCT03455543|80868450|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
27737715|NCT03455543|80868451|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
27737716|NCT03455543|80868449|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
27737717|NCT03455543|80868450|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
27737718|NCT03455543|80868451|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
27737719|NCT03455543|80868449|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
27737720|NCT03455543|80868450|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
27737721|NCT03455543|80868451|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
27737722|NCT03455543|80868449|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
27737723|NCT03455543|80868450|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
27533871|NCT02544074|80148287|FG002|Overall Study|Tablet error|0|||
27533872|NCT02544074|80148288|FG003|Overall Study|Tablet error|0|||
27533873|NCT02544074|80148289|FG004|Overall Study|Tablet error|0|||
27533874|NCT02544074|80148290|FG005|Overall Study|Tablet error|1|||
27533875|NCT02544074|80148291|FG006|Overall Study|Tablet error|0|||
27533876|NCT02544074|80148292|FG007|Overall Study|Tablet error|0|||
27533877|NCT02544074|80148293|FG008|Overall Study|Tablet error|0|||
27533878|NCT02544074|80148294|FG009|Overall Study|Tablet error|1|||
27533879|NCT02544074|80148295|FG010|Overall Study|Tablet error|0|||
27533880|NCT02544074|80148296|FG011|Overall Study|Tablet error|0|||
27533881|NCT02544074|80148297|FG012|Overall Study|Tablet error|0|||
27533882|NCT02544074|80148298|FG013|Overall Study|Tablet error|0|||
27737724|NCT03455543|80868451|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
27737725|NCT03455543|80868449|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
27737726|NCT03455543|80868450|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
27737727|NCT03455543|80868451|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
27737728|NCT03455543|80868449|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
27737729|NCT03455543|80868450|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
27913675|NCT03498313|81522186|FG004|Washout Period 2|Anovulation|0|||
27533883|NCT02544074|80148299|FG014|Overall Study|Tablet error|0|||
27533884|NCT02544074|80148300|FG015|Overall Study|Tablet error|0|||
27533885|NCT02544074|80148301|FG016|Overall Study|Tablet error|0|||
27533886|NCT02544074|80148302|FG017|Overall Study|Tablet error|0|||
27533887|NCT02544074|80148303|FG018|Overall Study|Tablet error|0|||
27533888|NCT02544074|80148304|FG019|Overall Study|Tablet error|0|||
27737730|NCT03455543|80868451|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
27737731|NCT03455543|80868449|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
27737732|NCT03455543|80868450|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
27737733|NCT03455543|80868451|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
27737734|NCT03455543|80868449|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
27737735|NCT03455543|80868450|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
27737736|NCT03455543|80868451|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
27737737|NCT03455543|80868449|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
27737738|NCT03455543|80868450|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
27737739|NCT03455543|80868451|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
27737740|NCT00473694|80868453|FG000|Overall Study|Adverse Event|0|||
27913676|NCT03498313|81522187|FG005|Washout Period 2|Anovulation|1|||
27913677|NCT01704755|81522188|FG000|Overall Study|Adverse Event|4|||
27913678|NCT01704755|81522189|FG001|Overall Study|Adverse Event|1|||
27533889|NCT02544074|80148305|FG020|Overall Study|Tablet error|0|||
27533890|NCT00736957|80148306|FG000|Overall Study|Adverse Event|43|||
27533891|NCT00736957|80148306|FG000|Overall Study|Withdrawal by Subject|49|||
27533892|NCT00736957|80148306|FG000|Overall Study|violation of eligibility criteria|2|||
27533893|NCT00736957|80148306|FG000|Overall Study|did not attend hospital appointments|1|||
27533894|NCT00736957|80148306|FG000|Overall Study|not eligible for Treatment Period I|22|||
27533895|NCT00736957|80148306|FG000|Overall Study|Physician Decision|5|||
27533896|NCT02805972|80148307|FG000|Washout Period|Lost to Follow-up|3|||
27533897|NCT02805972|80148308|FG001|Washout Period|Lost to Follow-up|0|||
27533898|NCT03439657|80148309|FG000|Overall Study|Adverse Event|2|||
27533899|NCT03439657|80148310|FG001|Overall Study|Adverse Event|3|||
27533900|NCT03439657|80148309|FG000|Overall Study|Lost to Follow-up|1|||
27533901|NCT03439657|80148310|FG001|Overall Study|Lost to Follow-up|0|||
27533902|NCT03439657|80148309|FG000|Overall Study|Protocol Violation|1|||
27533903|NCT03439657|80148310|FG001|Overall Study|Protocol Violation|1|||
27533904|NCT03439657|80148309|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
27533905|NCT03439657|80148310|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
27629762|NCT02499328|80483768|FG003|Overall Study|"Other"|3|||
27629763|NCT02499328|80483769|FG004|Overall Study|"Other"|6|||
27629764|NCT02499328|80483770|FG005|Overall Study|"Other"|2|||
27629765|NCT02499328|80483771|FG006|Overall Study|"Other"|3|||
27629766|NCT02499328|80483772|FG007|Overall Study|"Other"|4|||
27629767|NCT02499328|80483773|FG008|Overall Study|"Other"|6|||
27629768|NCT02499328|80483774|FG009|Overall Study|"Other"|16|||
27629769|NCT02499328|80483775|FG010|Overall Study|"Other"|13|||
27629770|NCT02499328|80483776|FG011|Overall Study|"Other"|31|||
27629771|NCT02499328|80483777|FG012|Overall Study|"Other"|8|||
27629772|NCT02499328|80483778|FG013|Overall Study|"Other"|7|||
27629773|NCT02499328|80483779|FG014|Overall Study|"Other"|6|||
27629774|NCT02499328|80483780|FG015|Overall Study|"Other"|0|||
27629775|NCT02499328|80483781|FG016|Overall Study|"Other"|0|||
27629776|NCT02499328|80483782|FG017|Overall Study|"Other"|34|||
27629777|NCT02499328|80483783|FG018|Overall Study|"Other"|43|||
27629778|NCT02499328|80483765|FG000|Overall Study|Disease Progression|0|||
27629779|NCT02499328|80483766|FG001|Overall Study|Disease Progression|0|||
27629780|NCT02499328|80483767|FG002|Overall Study|Disease Progression|0|||
27629781|NCT02499328|80483768|FG003|Overall Study|Disease Progression|0|||
27629782|NCT02499328|80483769|FG004|Overall Study|Disease Progression|0|||
27629783|NCT02499328|80483770|FG005|Overall Study|Disease Progression|0|||
27629784|NCT02499328|80483771|FG006|Overall Study|Disease Progression|1|||
27629785|NCT02499328|80483772|FG007|Overall Study|Disease Progression|0|||
27629786|NCT02499328|80483773|FG008|Overall Study|Disease Progression|1|||
27629787|NCT02499328|80483774|FG009|Overall Study|Disease Progression|0|||
27629788|NCT02499328|80483775|FG010|Overall Study|Disease Progression|1|||
27629789|NCT02499328|80483776|FG011|Overall Study|Disease Progression|0|||
27629790|NCT02499328|80483777|FG012|Overall Study|Disease Progression|0|||
27629791|NCT02499328|80483778|FG013|Overall Study|Disease Progression|0|||
27629792|NCT02499328|80483779|FG014|Overall Study|Disease Progression|0|||
27629793|NCT02499328|80483780|FG015|Overall Study|Disease Progression|0|||
27629794|NCT02499328|80483781|FG016|Overall Study|Disease Progression|0|||
27533906|NCT00299182|80150460|FG000|Overall Study|Withdrawal by Subject|0|||
27629795|NCT02499328|80483782|FG017|Overall Study|Disease Progression|2|||
27629796|NCT02499328|80483783|FG018|Overall Study|Disease Progression|0|||
27629797|NCT02499328|80483765|FG000|Overall Study|Adverse Event|1|||
27533907|NCT00299182|80150461|FG001|Overall Study|Withdrawal by Subject|0|||
27533908|NCT00299182|80150462|FG002|Overall Study|Withdrawal by Subject|1|||
27533909|NCT00299182|80150463|FG003|Overall Study|Withdrawal by Subject|0|||
27533910|NCT00299182|80150464|FG004|Overall Study|Withdrawal by Subject|1|||
27629798|NCT02499328|80483766|FG001|Overall Study|Adverse Event|0|||
27629799|NCT02499328|80483767|FG002|Overall Study|Adverse Event|0|||
27629800|NCT02499328|80483768|FG003|Overall Study|Adverse Event|1|||
27629801|NCT02499328|80483769|FG004|Overall Study|Adverse Event|0|||
27629802|NCT02499328|80483770|FG005|Overall Study|Adverse Event|0|||
27737741|NCT00473694|80868454|FG001|Overall Study|Adverse Event|1|||
27737742|NCT00473694|80868455|FG002|Overall Study|Adverse Event|0|||
27737743|NCT00473694|80868456|FG003|Overall Study|Adverse Event|0|||
27737744|NCT00473694|80868453|FG000|Overall Study|Participants did not receive treatment|11|||
27737745|NCT00473694|80868454|FG001|Overall Study|Participants did not receive treatment|3|||
27737746|NCT00473694|80868455|FG002|Overall Study|Participants did not receive treatment|5|||
27737747|NCT00473694|80868456|FG003|Overall Study|Participants did not receive treatment|6|||
27737748|NCT00473694|80868453|FG000|Overall Study|Lost to Follow-up|0|||
27737749|NCT00473694|80868454|FG001|Overall Study|Lost to Follow-up|0|||
27737750|NCT00473694|80868455|FG002|Overall Study|Lost to Follow-up|0|||
27737751|NCT00473694|80868456|FG003|Overall Study|Lost to Follow-up|1|||
27737752|NCT03015532|80868461|FG000|Overall Study|Adverse Event|0|||
27737753|NCT03015532|80868462|FG001|Overall Study|Adverse Event|0|||
27913679|NCT01704755|81522188|FG000|Overall Study|Lost to Follow-up|3|||
27913680|NCT01704755|81522189|FG001|Overall Study|Lost to Follow-up|4|||
27533911|NCT00299182|80150465|FG005|Overall Study|Withdrawal by Subject|2|||
27533912|NCT00299182|80150466|FG006|Overall Study|Withdrawal by Subject|0|||
27533913|NCT00299182|80150460|FG000|Overall Study|Chemotherapy Changed|0|||
27533914|NCT00299182|80150461|FG001|Overall Study|Chemotherapy Changed|0|||
27533915|NCT00299182|80150462|FG002|Overall Study|Chemotherapy Changed|1|||
27533916|NCT00299182|80150463|FG003|Overall Study|Chemotherapy Changed|0|||
27533917|NCT00299182|80150464|FG004|Overall Study|Chemotherapy Changed|1|||
27533918|NCT00299182|80150465|FG005|Overall Study|Chemotherapy Changed|0|||
27533919|NCT00299182|80150466|FG006|Overall Study|Chemotherapy Changed|1|||
27533920|NCT00299182|80150460|FG000|Overall Study|Adverse Event|0|||
27533921|NCT00299182|80150461|FG001|Overall Study|Adverse Event|0|||
27533922|NCT00299182|80150462|FG002|Overall Study|Adverse Event|0|||
27533923|NCT00299182|80150463|FG003|Overall Study|Adverse Event|0|||
27533924|NCT00299182|80150464|FG004|Overall Study|Adverse Event|0|||
27533925|NCT00299182|80150465|FG005|Overall Study|Adverse Event|1|||
27629803|NCT02499328|80483771|FG006|Overall Study|Adverse Event|0|||
27737754|NCT03015532|80868463|FG002|Overall Study|Adverse Event|0|||
27913681|NCT01704755|81522188|FG000|Overall Study|Withdrew consent|1|||
27913682|NCT01704755|81522189|FG001|Overall Study|Withdrew consent|1|||
27913683|NCT01704755|81522188|FG000|Overall Study|Other (not specified)|3|||
27913684|NCT01704755|81522189|FG001|Overall Study|Other (not specified)|1|||
27913685|NCT01704755|81522188|FG000|Overall Study|Withdrew consent and personal issues|1|||
27913686|NCT01704755|81522189|FG001|Overall Study|Withdrew consent and personal issues|0|||
27913687|NCT01519817|81522190|FG000|Overall Study|Withdrawal by Subject|1|||
27913688|NCT01519817|81522191|FG001|Overall Study|Withdrawal by Subject|0|||
27913689|NCT01519817|81522192|FG002|Overall Study|Withdrawal by Subject|0|||
27913690|NCT01519817|81522193|FG003|Overall Study|Withdrawal by Subject|0|||
27913691|NCT01519817|81522190|FG000|Overall Study|Off study due to infection|0|||
27913692|NCT01519817|81522191|FG001|Overall Study|Off study due to infection|0|||
27913693|NCT01519817|81522192|FG002|Overall Study|Off study due to infection|0|||
27913694|NCT01519817|81522193|FG003|Overall Study|Off study due to infection|1|||
27913695|NCT00698815|81522194|FG000|Overall Study|Death|1|||
27913696|NCT00698815|81522195|FG001|Overall Study|Death|2|||
27913697|NCT00698815|81522196|FG002|Overall Study|Death|4|||
27913698|NCT00698815|81522194|FG000|Overall Study|Withdrawal by Subject|6|||
27913699|NCT00698815|81522195|FG001|Overall Study|Withdrawal by Subject|3|||
27913700|NCT00698815|81522196|FG002|Overall Study|Withdrawal by Subject|2|||
27913701|NCT00698815|81522194|FG000|Overall Study|MD discretion|2|||
27913702|NCT00698815|81522195|FG001|Overall Study|MD discretion|7|||
27913703|NCT00698815|81522196|FG002|Overall Study|MD discretion|2|||
27629804|NCT02499328|80483772|FG007|Overall Study|Adverse Event|0|||
27629805|NCT02499328|80483773|FG008|Overall Study|Adverse Event|0|||
27629806|NCT02499328|80483774|FG009|Overall Study|Adverse Event|0|||
27629807|NCT02499328|80483775|FG010|Overall Study|Adverse Event|0|||
27629808|NCT02499328|80483776|FG011|Overall Study|Adverse Event|0|||
27629809|NCT02499328|80483777|FG012|Overall Study|Adverse Event|1|||
27629810|NCT02499328|80483778|FG013|Overall Study|Adverse Event|0|||
27629811|NCT02499328|80483779|FG014|Overall Study|Adverse Event|0|||
27629812|NCT02499328|80483780|FG015|Overall Study|Adverse Event|0|||
27629813|NCT02499328|80483781|FG016|Overall Study|Adverse Event|0|||
27629814|NCT02499328|80483782|FG017|Overall Study|Adverse Event|0|||
27629815|NCT02499328|80483783|FG018|Overall Study|Adverse Event|0|||
27629816|NCT01806714|80483787|FG000|Overall Study|No functioning phone number|200|||
27629817|NCT01806714|80483788|FG001|Overall Study|No functioning phone number|170|||
27629818|NCT01175707|80483791|FG000|Overall Study|Adverse Event|4|||
27629819|NCT01175707|80483792|FG001|Overall Study|Adverse Event|6|||
27629820|NCT02993471|80483793|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
27629821|NCT02993471|80483793|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
27629822|NCT01227707|80483794|FG000|Overall Study|Adverse Event|10|||
27629823|NCT01227707|80483794|FG000|Overall Study|Progression of disease|3|||
27629824|NCT01227707|80483794|FG000|Overall Study|Withdrawal by Subject|1|||
27629825|NCT01227707|80483794|FG000|Overall Study|Patient non-compliance|3|||
27629826|NCT01227707|80483794|FG000|Overall Study|Medical decision|6|||
27629827|NCT01227707|80483794|FG000|Overall Study|Death|1|||
27629828|NCT03034915|80483803|FG000|Overall Study|Adverse Event|29|||
27629829|NCT03034915|80483804|FG001|Overall Study|Adverse Event|32|||
27629830|NCT03034915|80483805|FG002|Overall Study|Adverse Event|22|||
27629831|NCT03034915|80483803|FG000|Overall Study|Lost to Follow-up|5|||
27629832|NCT03034915|80483804|FG001|Overall Study|Lost to Follow-up|13|||
27629833|NCT03034915|80483805|FG002|Overall Study|Lost to Follow-up|3|||
27629834|NCT03034915|80483803|FG000|Overall Study|Withdrawal by Subject|29|||
27629835|NCT03034915|80483804|FG001|Overall Study|Withdrawal by Subject|46|||
27629836|NCT03034915|80483805|FG002|Overall Study|Withdrawal by Subject|41|||
27629837|NCT03034915|80483803|FG000|Overall Study|Protocol Deviation|2|||
27629838|NCT03034915|80483804|FG001|Overall Study|Protocol Deviation|14|||
27629839|NCT03034915|80483805|FG002|Overall Study|Protocol Deviation|7|||
27629840|NCT03034915|80483803|FG000|Overall Study|Lack of Efficacy|8|||
27629841|NCT03034915|80483804|FG001|Overall Study|Lack of Efficacy|16|||
27629842|NCT03034915|80483805|FG002|Overall Study|Lack of Efficacy|18|||
27629843|NCT03034915|80483803|FG000|Overall Study|Site closed|2|||
27629844|NCT03034915|80483804|FG001|Overall Study|Site closed|2|||
27629845|NCT03034915|80483805|FG002|Overall Study|Site closed|4|||
27629846|NCT03034915|80483803|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
27629847|NCT03034915|80483804|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
27629848|NCT03034915|80483805|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
27629849|NCT03034915|80483803|FG000|Overall Study|Physician Decision|1|||
27629850|NCT03034915|80483804|FG001|Overall Study|Physician Decision|5|||
27629851|NCT03034915|80483805|FG002|Overall Study|Physician Decision|2|||
27629852|NCT01695317|80483806|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
27629853|NCT01695317|80483807|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
27629854|NCT01695317|80483806|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
27629855|NCT01695317|80483807|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
27629856|NCT01560949|80483809|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
27629857|NCT01560949|80483809|FG000|Surgery Phase|Physician Decision|3|||
27629858|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Other|4|||
27629859|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Other|0|||
27629860|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
27629861|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
27629862|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
27629863|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
27629864|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
27629865|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
27629866|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
27629867|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
27629868|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
27629869|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
27629870|NCT00853827|80483810|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
27629871|NCT00853827|80483811|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
27629872|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
27629873|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
27629874|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
27629875|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
27629876|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
27629877|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
27737755|NCT03015532|80868464|FG003|Overall Study|Adverse Event|0|||
27533926|NCT00299182|80150466|FG006|Overall Study|Adverse Event|0|||
27533927|NCT00299182|80150460|FG000|Overall Study|Not Eligible|0|||
27533928|NCT00299182|80150461|FG001|Overall Study|Not Eligible|0|||
27533929|NCT00299182|80150462|FG002|Overall Study|Not Eligible|0|||
27533930|NCT00299182|80150463|FG003|Overall Study|Not Eligible|0|||
27533931|NCT00299182|80150464|FG004|Overall Study|Not Eligible|1|||
27533932|NCT00299182|80150465|FG005|Overall Study|Not Eligible|0|||
27533933|NCT00299182|80150466|FG006|Overall Study|Not Eligible|0|||
27533934|NCT03331250|80150467|FG000|Overall Study|Withdrawal by Subject|1|||
27533935|NCT03894046|80150468|FG000|Overall Study|Protocol Violation|1|||
27533936|NCT03894046|80150469|FG001|Overall Study|Protocol Violation|0|||
27533937|NCT03894046|80150470|FG002|Overall Study|Protocol Violation|0|||
27533938|NCT03894046|80150468|FG000|Overall Study|Adverse Event|0|||
27533939|NCT03894046|80150469|FG001|Overall Study|Adverse Event|1|||
27533940|NCT03894046|80150470|FG002|Overall Study|Adverse Event|0|||
27533941|NCT03894046|80150468|FG000|Overall Study|Withdrawal by Subject|2|||
27533942|NCT03894046|80150469|FG001|Overall Study|Withdrawal by Subject|3|||
27533943|NCT03894046|80150470|FG002|Overall Study|Withdrawal by Subject|1|||
27533944|NCT03894046|80150468|FG000|Overall Study|Death|15|||
27533945|NCT03894046|80150469|FG001|Overall Study|Death|21|||
27533946|NCT03894046|80150470|FG002|Overall Study|Death|4|||
27533947|NCT03894046|80150468|FG000|Overall Study|No growth of ABC|2|||
27533948|NCT03894046|80150469|FG001|Overall Study|No growth of ABC|1|||
27533949|NCT03894046|80150470|FG002|Overall Study|No growth of ABC|0|||
27533950|NCT03894046|80150468|FG000|Overall Study|Physician Decision|1|||
27533951|NCT03894046|80150469|FG001|Overall Study|Physician Decision|1|||
27533952|NCT03894046|80150470|FG002|Overall Study|Physician Decision|1|||
27533953|NCT03894046|80150468|FG000|Overall Study|Prohibited concomitant medication|1|||
27533954|NCT03894046|80150469|FG001|Overall Study|Prohibited concomitant medication|0|||
27533955|NCT03894046|80150470|FG002|Overall Study|Prohibited concomitant medication|0|||
27533956|NCT03894046|80150468|FG000|Overall Study|Transferred to other arm/group|1|||
27533957|NCT03894046|80150469|FG001|Overall Study|Transferred to other arm/group|1|||
27533958|NCT03894046|80150470|FG002|Overall Study|Transferred to other arm/group|0|||
27629878|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
27629879|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
27629880|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
27629881|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
27629882|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
27629883|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
27629884|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
27629885|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
27629886|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
27629887|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
27629888|NCT00853827|80483810|FG000|Double Blind Period (103 Weeks)|Death|1|||
27629889|NCT00853827|80483811|FG001|Double Blind Period (103 Weeks)|Death|6|||
27629890|NCT02163915|80483817|FG000|Overall Study|Withdrawal by Subject|2|||
27629891|NCT02163915|80483818|FG001|Overall Study|Withdrawal by Subject|0|||
27629892|NCT02163915|80483819|FG002|Overall Study|Withdrawal by Subject|2|||
27629893|NCT02163915|80483820|FG003|Overall Study|Withdrawal by Subject|2|||
27629894|NCT02163915|80483821|FG004|Overall Study|Withdrawal by Subject|2|||
27629895|NCT02163915|80483817|FG000|Overall Study|Study termination|1|||
27629896|NCT02163915|80483818|FG001|Overall Study|Study termination|0|||
27629897|NCT02163915|80483819|FG002|Overall Study|Study termination|0|||
27629898|NCT02163915|80483820|FG003|Overall Study|Study termination|0|||
27629899|NCT02163915|80483821|FG004|Overall Study|Study termination|2|||
27629900|NCT02163915|80483817|FG000|Overall Study|Physician Decision|0|||
27629901|NCT02163915|80483818|FG001|Overall Study|Physician Decision|0|||
27629902|NCT02163915|80483819|FG002|Overall Study|Physician Decision|0|||
27629903|NCT02163915|80483820|FG003|Overall Study|Physician Decision|1|||
27629904|NCT02163915|80483821|FG004|Overall Study|Physician Decision|0|||
27737756|NCT03015532|80868465|FG004|Overall Study|Adverse Event|0|||
27533959|NCT03270644|80150471|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
27533960|NCT03270644|80150471|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
27533961|NCT01756053|80150472|FG000|Period 1 (10 Days)|Protocol Violation|1|||
27533962|NCT01756053|80150473|FG001|Period 1 (10 Days)|Protocol Violation|1|||
27533963|NCT01756053|80150472|FG000|Period 2 (10 Days)|Protocol Violation|0|||
27533964|NCT01756053|80150473|FG001|Period 2 (10 Days)|Protocol Violation|2|||
27629905|NCT00464672|80483822|FG000|Overall Study|withdrawal of consent|0|||
27629906|NCT00464672|80483823|FG001|Overall Study|withdrawal of consent|0|||
27629907|NCT00464672|80483824|FG002|Overall Study|withdrawal of consent|0|||
27629908|NCT00464672|80483825|FG003|Overall Study|withdrawal of consent|1|||
27629909|NCT00464672|80483826|FG004|Overall Study|withdrawal of consent|9|||
27533965|NCT01011738|80150474|FG000|Overall Study|Death|12|||
27533966|NCT01011738|80150475|FG001|Overall Study|Death|3|||
27533967|NCT01011738|80150476|FG002|Overall Study|Death|0|||
27533968|NCT01011738|80150474|FG000|Overall Study|Unknown reasons|312|||
27533969|NCT01011738|80150475|FG001|Overall Study|Unknown reasons|291|||
27533970|NCT01011738|80150476|FG002|Overall Study|Unknown reasons|17|||
27629910|NCT00464672|80483827|FG005|Overall Study|withdrawal of consent|4|||
27629911|NCT00464672|80483822|FG000|Overall Study|Lost to Follow-up|25|||
27629912|NCT00464672|80483823|FG001|Overall Study|Lost to Follow-up|10|||
27629913|NCT00464672|80483824|FG002|Overall Study|Lost to Follow-up|0|||
27913704|NCT00698815|81522194|FG000|Overall Study|Did not receive protocol treatment|1|||
27533971|NCT01856907|80150477|FG000|Overall Study|Pregnancy|0|||
27913705|NCT00698815|81522195|FG001|Overall Study|Did not receive protocol treatment|2|||
27913706|NCT00698815|81522196|FG002|Overall Study|Did not receive protocol treatment|2|||
27913707|NCT04386902|81522197|FG000|Overall Study|Withdrawal by Subject|5|||
27913708|NCT04386902|81522197|FG000|Overall Study|Technical problems in the recording|5|||
27913709|NCT01484951|81522198|FG000|Overall Study|Adverse Event|3|||
27913710|NCT01484951|81522198|FG000|Overall Study|Personal Reasons|1|||
27913711|NCT01484951|81522198|FG000|Overall Study|Non-Compliance|1|||
27913712|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
27913713|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
27913714|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
27913715|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
27913716|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
27913717|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
27913718|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
27913719|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
27913720|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
27913721|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
27533972|NCT01856907|80150478|FG001|Overall Study|Pregnancy|1|||
27533973|NCT01856907|80150479|FG002|Overall Study|Pregnancy|0|||
27533974|NCT01856907|80150477|FG000|Overall Study|Pregnancy|0|||
27533975|NCT01856907|80150478|FG001|Overall Study|Pregnancy|1|||
27533976|NCT01856907|80150479|FG002|Overall Study|Pregnancy|0|||
27533977|NCT01856907|80150477|FG000|Overall Study|Withdrawal by Subject|0|||
27533978|NCT01856907|80150478|FG001|Overall Study|Withdrawal by Subject|1|||
27533979|NCT01856907|80150479|FG002|Overall Study|Withdrawal by Subject|0|||
27533980|NCT01309165|80150484|FG000|Overall Study|Lost to Follow-up|4|||
27533981|NCT01309165|80150485|FG001|Overall Study|Lost to Follow-up|3|||
27533982|NCT01309165|80150484|FG000|Overall Study|Return to work|1|||
27533983|NCT01309165|80150485|FG001|Overall Study|Return to work|2|||
27533984|NCT01309165|80150484|FG000|Overall Study|Left country|0|||
27533985|NCT01309165|80150485|FG001|Overall Study|Left country|1|||
27533986|NCT01309165|80150484|FG000|Overall Study|No transportation|0|||
27533987|NCT01309165|80150485|FG001|Overall Study|No transportation|1|||
27533988|NCT01309165|80150484|FG000|Overall Study|Admitted to hospital for second stroke|1|||
27533989|NCT01309165|80150485|FG001|Overall Study|Admitted to hospital for second stroke|0|||
27533990|NCT02955797|80150487|FG000|Overall Study|Protocol Violation|1|||
27533991|NCT02955797|80150488|FG001|Overall Study|Protocol Violation|0|||
27533992|NCT02955797|80150489|FG002|Overall Study|Protocol Violation|0|||
27533993|NCT02955797|80150490|FG003|Overall Study|Protocol Violation|1|||
27533994|NCT02955797|80150487|FG000|Overall Study|Withdrawal by Subject|2|||
27533995|NCT02955797|80150488|FG001|Overall Study|Withdrawal by Subject|2|||
27533996|NCT02955797|80150489|FG002|Overall Study|Withdrawal by Subject|0|||
27533997|NCT02955797|80150490|FG003|Overall Study|Withdrawal by Subject|1|||
27533998|NCT02955797|80150487|FG000|Overall Study|Lost to Follow-up|0|||
27533999|NCT02955797|80150488|FG001|Overall Study|Lost to Follow-up|1|||
27534000|NCT02955797|80150489|FG002|Overall Study|Lost to Follow-up|0|||
27534001|NCT02955797|80150490|FG003|Overall Study|Lost to Follow-up|0|||
27534002|NCT01123850|80150491|FG000|Overall Study|Slow enrollment|45|||
27534003|NCT05061966|80150492|FG000|Overall Study|Lost to Follow-up|13|||
27629914|NCT00464672|80483825|FG003|Overall Study|Lost to Follow-up|0|||
27629915|NCT00464672|80483826|FG004|Overall Study|Lost to Follow-up|1|||
27629916|NCT00464672|80483827|FG005|Overall Study|Lost to Follow-up|0|||
27629917|NCT03357341|80483833|FG000|Overall Study|Withdrawal by Subject|3|||
27913722|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
27913723|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
27913724|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
27913725|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
27913726|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
27913727|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
27534004|NCT05061966|80150493|FG001|Overall Study|Lost to Follow-up|13|||
27534005|NCT02965716|80150494|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
27534006|NCT02965716|80150495|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
27534007|NCT02965716|80150494|FG000|Overall Study|Progression/Relapse|8|||
27534008|NCT02965716|80150495|FG001|Overall Study|Progression/Relapse|16|||
27534009|NCT02965716|80150494|FG000|Overall Study|Death|1|||
27629918|NCT03357341|80483834|FG001|Overall Study|Withdrawal by Subject|6|||
27534010|NCT02965716|80150495|FG001|Overall Study|Death|0|||
27629919|NCT03357341|80483833|FG000|Overall Study|Lost to Follow-up|4|||
27629920|NCT03357341|80483834|FG001|Overall Study|Lost to Follow-up|5|||
27629921|NCT03357341|80483833|FG000|Overall Study|Death|0|||
27629922|NCT03357341|80483834|FG001|Overall Study|Death|1|||
27629923|NCT00770965|80483835|FG000|Safety Set|Withdrawal by Subject|0|||
27629924|NCT00770965|80483836|FG001|Safety Set|Withdrawal by Subject|0|||
27629925|NCT00770965|80483837|FG002|Safety Set|Withdrawal by Subject|0|||
27629926|NCT00770965|80483838|FG003|Safety Set|Withdrawal by Subject|1|||
27629927|NCT00770965|80483835|FG000|Safety Set|Protocol deviation|0|||
27629928|NCT00770965|80483836|FG001|Safety Set|Protocol deviation|0|||
27629929|NCT00770965|80483837|FG002|Safety Set|Protocol deviation|1|||
27629930|NCT00770965|80483838|FG003|Safety Set|Protocol deviation|0|||
27629931|NCT00770965|80483835|FG000|Excluded Set|Administrative problems|14|||
27629932|NCT00770965|80483836|FG001|Excluded Set|Administrative problems|12|||
27629933|NCT00770965|80483837|FG002|Excluded Set|Administrative problems|12|||
27629934|NCT00770965|80483838|FG003|Excluded Set|Administrative problems|10|||
27629935|NCT00770965|80483835|FG000|Excluded Set|Withdrawal by Subject|1|||
27629936|NCT00770965|80483836|FG001|Excluded Set|Withdrawal by Subject|1|||
27913728|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
27913729|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
27913730|NCT03569098|81522202|FG000|Double-Blind Treatment Cycle 1|Other|1|||
27534011|NCT02965716|80150494|FG000|Overall Study|Not Protocol Specified|1|||
27534012|NCT02965716|80150495|FG001|Overall Study|Not Protocol Specified|3|||
27534013|NCT02589405|80150499|FG000|Overall Study|Adverse Event|3|||
27534014|NCT02589405|80150499|FG000|Overall Study|Withdrawal by Subject|1|||
27534015|NCT01051466|80150500|FG000|Overall Study|Adverse Event|1|||
27534016|NCT01051466|80150501|FG001|Overall Study|Adverse Event|0|||
27534017|NCT01051466|80150500|FG000|Overall Study|Lost to Follow-up|1|||
27534018|NCT01051466|80150501|FG001|Overall Study|Lost to Follow-up|1|||
27534019|NCT01051466|80150500|FG000|Overall Study|Withdrawal by Subject|5|||
27534020|NCT01051466|80150501|FG001|Overall Study|Withdrawal by Subject|1|||
27534021|NCT01051466|80150500|FG000|Overall Study|Entry Criteria Not Met|0|||
27534022|NCT01051466|80150501|FG001|Overall Study|Entry Criteria Not Met|3|||
27534023|NCT01051466|80150500|FG000|Overall Study|Physician Decision|1|||
27534024|NCT01051466|80150501|FG001|Overall Study|Physician Decision|0|||
27534025|NCT00580970|80150502|FG000|Pre-treatment|Non-compliance|1|||
27534026|NCT00580970|80150502|FG000|Treatment (Lovastatin)|Non-compliance|6|||
27534027|NCT00580970|80150502|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
27534028|NCT00580970|80150502|FG000|Treatment (Lovastatin)|Physician Decision|4|||
27534029|NCT00580970|80150502|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
27534030|NCT00580970|80150502|FG000|Treatment (Lovastatin)|Death|1|||
27534031|NCT00215683|80150505|FG000|Overall Study|Adverse Event|15|||
27534032|NCT00215683|80150506|FG001|Overall Study|Adverse Event|16|||
27534033|NCT00215683|80150507|FG002|Overall Study|Adverse Event|15|||
27534034|NCT00215683|80150505|FG000|Overall Study|Lack of Efficacy|5|||
27534035|NCT00215683|80150506|FG001|Overall Study|Lack of Efficacy|1|||
27534036|NCT00215683|80150507|FG002|Overall Study|Lack of Efficacy|2|||
27534037|NCT00215683|80150505|FG000|Overall Study|Lost to Follow-up|0|||
27534038|NCT00215683|80150506|FG001|Overall Study|Lost to Follow-up|2|||
27534039|NCT00215683|80150507|FG002|Overall Study|Lost to Follow-up|1|||
27534040|NCT00215683|80150505|FG000|Overall Study|Withdrawal by Subject|9|||
27534041|NCT00215683|80150506|FG001|Overall Study|Withdrawal by Subject|4|||
27534042|NCT00215683|80150507|FG002|Overall Study|Withdrawal by Subject|13|||
27534043|NCT00215683|80150505|FG000|Overall Study|Physician Decision|0|||
27534044|NCT00215683|80150506|FG001|Overall Study|Physician Decision|0|||
27534045|NCT00215683|80150507|FG002|Overall Study|Physician Decision|1|||
27534046|NCT00215683|80150505|FG000|Overall Study|Difficult to attend visits|0|||
27534047|NCT00215683|80150506|FG001|Overall Study|Difficult to attend visits|1|||
27629937|NCT00770965|80483837|FG002|Excluded Set|Withdrawal by Subject|2|||
27629938|NCT00770965|80483838|FG003|Excluded Set|Withdrawal by Subject|3|||
27629939|NCT00608907|80483839|FG000|Overall Study|Adverse Event|6|||
27913731|NCT03569098|81522203|FG001|Double-Blind Treatment Cycle 1|Other|0|||
27534048|NCT00215683|80150507|FG002|Overall Study|Difficult to attend visits|0|||
27534049|NCT00215683|80150505|FG000|Overall Study|No study drug available|0|||
27534050|NCT00215683|80150506|FG001|Overall Study|No study drug available|1|||
27534051|NCT00215683|80150507|FG002|Overall Study|No study drug available|0|||
27534052|NCT00215683|80150505|FG000|Overall Study|Intermittent therapy required|0|||
27534053|NCT00215683|80150506|FG001|Overall Study|Intermittent therapy required|1|||
27534054|NCT00215683|80150507|FG002|Overall Study|Intermittent therapy required|0|||
27534055|NCT02979197|80150510|FG000|Overall Study|Adverse Event|4|||
27534056|NCT02979197|80150511|FG001|Overall Study|Adverse Event|2|||
27534057|NCT02979197|80150512|FG002|Overall Study|Adverse Event|0|||
27534058|NCT02979197|80150510|FG000|Overall Study|Protocol Violation|0|||
27534059|NCT02979197|80150511|FG001|Overall Study|Protocol Violation|1|||
27534060|NCT02979197|80150512|FG002|Overall Study|Protocol Violation|0|||
27629940|NCT00608907|80483840|FG001|Overall Study|Adverse Event|0|||
27629941|NCT00608907|80483841|FG002|Overall Study|Adverse Event|1|||
27629942|NCT00608907|80483839|FG000|Overall Study|Death|1|||
27629943|NCT00608907|80483840|FG001|Overall Study|Death|0|||
27534061|NCT02979197|80150510|FG000|Overall Study|Subject unable to commit to study dates|0|||
27534062|NCT02979197|80150511|FG001|Overall Study|Subject unable to commit to study dates|1|||
27534063|NCT02979197|80150512|FG002|Overall Study|Subject unable to commit to study dates|0|||
27534064|NCT02556203|80150513|FG000|Overall Study|Withdrawal by Subject|21|||
27534065|NCT02556203|80150514|FG001|Overall Study|Withdrawal by Subject|21|||
27534066|NCT02556203|80150513|FG000|Overall Study|Lost to Follow-up|5|||
27534067|NCT02556203|80150514|FG001|Overall Study|Lost to Follow-up|5|||
27534068|NCT02556203|80150513|FG000|Overall Study|Adverse Event|1|||
27534069|NCT02556203|80150514|FG001|Overall Study|Adverse Event|0|||
27534070|NCT00737438|80150516|FG000|Overall Study|Withdrawal by Subject|2|||
27534071|NCT00737438|80150516|FG000|Overall Study|Patient ineligible|1|||
27534072|NCT02413372|80150517|FG000|Treatment|Lost to Follow-up|0|||
27534073|NCT02413372|80150518|FG001|Treatment|Lost to Follow-up|2|||
27534074|NCT02413372|80150519|FG002|Treatment|Lost to Follow-up|1|||
27534075|NCT02413372|80150517|FG000|Treatment|Withdrawal by Subject|1|||
27534076|NCT02413372|80150518|FG001|Treatment|Withdrawal by Subject|0|||
27534077|NCT02413372|80150519|FG002|Treatment|Withdrawal by Subject|0|||
27534078|NCT02413372|80150517|FG000|Follow-up|Lost to Follow-up|1|||
27534079|NCT02413372|80150518|FG001|Follow-up|Lost to Follow-up|1|||
27534080|NCT02413372|80150519|FG002|Follow-up|Lost to Follow-up|0|||
27534081|NCT02413372|80150517|FG000|Follow-up|Subject Withdrew Consent|1|||
27534082|NCT02413372|80150518|FG001|Follow-up|Subject Withdrew Consent|0|||
27534083|NCT02413372|80150519|FG002|Follow-up|Subject Withdrew Consent|1|||
27534084|NCT02413372|80150517|FG000|Follow-up|Subject unable to return for visit|0|||
27534085|NCT02413372|80150518|FG001|Follow-up|Subject unable to return for visit|0|||
27534086|NCT02413372|80150519|FG002|Follow-up|Subject unable to return for visit|1|||
27534087|NCT02231918|80150520|FG000|Overall Study|Withdrawal by Subject|0|||
27534088|NCT02231918|80150521|FG001|Overall Study|Withdrawal by Subject|1|||
27534089|NCT02231918|80150522|FG002|Overall Study|Withdrawal by Subject|0|||
27534090|NCT02231918|80150520|FG000|Overall Study|Adverse Event|0|||
27534091|NCT02231918|80150521|FG001|Overall Study|Adverse Event|0|||
27534092|NCT02231918|80150522|FG002|Overall Study|Adverse Event|1|||
27534093|NCT04676412|80150526|FG000|Overall Study|Death|17|||
27534094|NCT04676412|80150527|FG001|Overall Study|Death|23|||
27534095|NCT04676412|80150526|FG000|Overall Study|Withdrawal by Subject|0|||
27534096|NCT04676412|80150527|FG001|Overall Study|Withdrawal by Subject|2|||
27534097|NCT04676412|80150526|FG000|Overall Study|Participants ongoing|32|||
27534098|NCT04676412|80150527|FG001|Overall Study|Participants ongoing|33|||
27534099|NCT04795622|80150528|FG000|Overall Study|Adverse Event|1|||
27534100|NCT04795622|80150529|FG001|Overall Study|Adverse Event|0|||
27534101|NCT04795622|80150528|FG000|Overall Study|Withdrawal by Subject|3|||
27534102|NCT04795622|80150529|FG001|Overall Study|Withdrawal by Subject|3|||
27534103|NCT04795622|80150528|FG000|Overall Study|Protocol Violation|0|||
27534104|NCT04795622|80150529|FG001|Overall Study|Protocol Violation|2|||
27534105|NCT04795622|80150528|FG000|Overall Study|Lost to Follow-up|2|||
27534106|NCT04795622|80150529|FG001|Overall Study|Lost to Follow-up|3|||
27534107|NCT04795622|80150528|FG000|Overall Study|Other|7|||
27534108|NCT04795622|80150529|FG001|Overall Study|Other|8|||
27534109|NCT01824342|80150531|FG000|Overall Study|Withdrawal by Subject|0|||
27534110|NCT01824342|80150532|FG001|Overall Study|Withdrawal by Subject|3|||
27534111|NCT01824342|80150531|FG000|Overall Study|Adverse Event|1|||
27534112|NCT01824342|80150532|FG001|Overall Study|Adverse Event|1|||
27534113|NCT01824342|80150531|FG000|Overall Study|Disease Progression|1|||
27534114|NCT01824342|80150532|FG001|Overall Study|Disease Progression|1|||
27534115|NCT01824342|80150531|FG000|Overall Study|Physician Decision|5|||
27534116|NCT01824342|80150532|FG001|Overall Study|Physician Decision|0|||
27534117|NCT01824342|80150531|FG000|Overall Study|Death|2|||
27534118|NCT01824342|80150532|FG001|Overall Study|Death|0|||
27534119|NCT01090973|80150533|FG000|Overall Study|Disease progression|1|||
27534120|NCT01626495|80150537|FG000|Overall Study|Adverse Event|3|||
27534121|NCT01626495|80150537|FG000|Overall Study|Disease progression|27|||
27534122|NCT01626495|80150537|FG000|Overall Study|Withdrawal by Subject|1|||
27534123|NCT01626495|80150537|FG000|Overall Study|Administrative problem|1|||
27629944|NCT00608907|80483841|FG002|Overall Study|Death|0|||
27737757|NCT03015532|80868466|FG005|Overall Study|Adverse Event|2|||
27534124|NCT01626495|80150537|FG000|Overall Study|Death|2|||
27737758|NCT03015532|80868467|FG006|Overall Study|Adverse Event|1|||
27737759|NCT03015532|80868468|FG007|Overall Study|Adverse Event|0|||
27534125|NCT01626495|80150537|FG000|Overall Study|Physician Decision|1|||
27534126|NCT01626495|80150537|FG000|Overall Study|New cancer therapy|16|||
27534127|NCT01626495|80150537|FG000|Overall Study|Manufacturing failure|1|||
27534128|NCT00678080|80150538|FG000|Overall Study|Physician Decision|2|||
27534129|NCT00678080|80150539|FG001|Overall Study|Physician Decision|0|||
27534130|NCT00678080|80150538|FG000|Overall Study|Lost to Follow-up|1|||
27534131|NCT00678080|80150539|FG001|Overall Study|Lost to Follow-up|0|||
27534132|NCT00678080|80150538|FG000|Overall Study|Withdrawal by Subject|0|||
27534133|NCT00678080|80150539|FG001|Overall Study|Withdrawal by Subject|1|||
27534134|NCT00569270|80150540|FG000|Period: First Intervention|Protocol Violation|0|||
27629945|NCT00608907|80483839|FG000|Overall Study|Withdrawal by Subject|4|||
27629946|NCT00608907|80483840|FG001|Overall Study|Withdrawal by Subject|0|||
27629947|NCT00608907|80483841|FG002|Overall Study|Withdrawal by Subject|0|||
27629948|NCT00608907|80483839|FG000|Overall Study|Progressive Disease|1|||
27629949|NCT00608907|80483840|FG001|Overall Study|Progressive Disease|0|||
27629950|NCT00608907|80483841|FG002|Overall Study|Progressive Disease|0|||
27629951|NCT03395353|80483842|FG000|Overall Study|Adverse Event|20|||
27629952|NCT03395353|80483842|FG000|Overall Study|Protocol Violation|1|||
27629953|NCT03395353|80483842|FG000|Overall Study|Lack of Efficacy|3|||
27629954|NCT03395353|80483842|FG000|Overall Study|Withdrawal by Subject|24|||
27629955|NCT03395353|80483842|FG000|Overall Study|Discontinued visit|1|||
27629956|NCT03395353|80483842|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
27629957|NCT03395353|80483842|FG000|Overall Study|Physician Decision|4|||
27629958|NCT03395353|80483842|FG000|Overall Study|Early termination of overall study|33|||
27629959|NCT02385669|80486536|FG000|Overall Study|Adverse Event|2|||
27629960|NCT01190150|80486544|FG000|First Treatment|Withdrawal by Subject|1|||
27629961|NCT01190150|80486545|FG001|First Treatment|Withdrawal by Subject|0|||
27629962|NCT01190150|80486544|FG000|Washout|Withdrawal by Subject|0|||
27629963|NCT01190150|80486545|FG001|Washout|Withdrawal by Subject|1|||
27629964|NCT01190150|80486544|FG000|Washout|Difficulty in adherence|0|||
27629965|NCT01190150|80486545|FG001|Washout|Difficulty in adherence|1|||
27629966|NCT01876511|80486548|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
27629967|NCT01876511|80486549|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
27629968|NCT01876511|80486550|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
27629969|NCT01876511|80486548|FG000|Overall Study|Death (unrelated)|3|||
27629970|NCT01876511|80486549|FG001|Overall Study|Death (unrelated)|0|||
27629971|NCT01876511|80486550|FG002|Overall Study|Death (unrelated)|2|||
27629972|NCT01876511|80486548|FG000|Overall Study|Drug-related Toxicity|5|||
27629973|NCT01876511|80486549|FG001|Overall Study|Drug-related Toxicity|1|||
27629974|NCT01876511|80486550|FG002|Overall Study|Drug-related Toxicity|6|||
27629975|NCT01876511|80486548|FG000|Overall Study|Patient Decision|3|||
27629976|NCT01876511|80486549|FG001|Overall Study|Patient Decision|0|||
27629977|NCT01876511|80486550|FG002|Overall Study|Patient Decision|6|||
27629978|NCT01876511|80486548|FG000|Overall Study|Physician Decision|1|||
27629979|NCT01876511|80486549|FG001|Overall Study|Physician Decision|0|||
27629980|NCT01876511|80486550|FG002|Overall Study|Physician Decision|1|||
27629981|NCT00930813|80486554|FG000|Overall Study|Death|4|||
27629982|NCT00930813|80486555|FG001|Overall Study|Death|5|||
27629983|NCT00930813|80486554|FG000|Overall Study|Withdrawal by Subject|2|||
27629984|NCT00930813|80486555|FG001|Overall Study|Withdrawal by Subject|5|||
27629985|NCT00930813|80486554|FG000|Overall Study|Lost to Follow-up|2|||
27629986|NCT00930813|80486555|FG001|Overall Study|Lost to Follow-up|4|||
27629987|NCT00741988|80486564|FG000|Overall Study|Adverse Event|2|||
27629988|NCT00741988|80486565|FG001|Overall Study|Adverse Event|4|||
27629989|NCT00741988|80486564|FG000|Overall Study|Lack of Efficacy|2|||
27913732|NCT03569098|81522204|FG002|Double-Blind Treatment Cycle 1|Other|1|||
27913733|NCT03569098|81522202|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
27913734|NCT03569098|81522203|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
27913735|NCT03569098|81522204|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
27913736|NCT03569098|81522202|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
27913737|NCT03569098|81522203|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
27913738|NCT03569098|81522204|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
27913739|NCT03569098|81522202|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
27913740|NCT03569098|81522203|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
27913741|NCT03569098|81522204|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
27913742|NCT03569098|81522202|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
27913743|NCT03569098|81522203|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
27913744|NCT03569098|81522204|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
27913745|NCT03569098|81522202|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
27913746|NCT03569098|81522203|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
27913747|NCT03569098|81522204|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
27913748|NCT03569098|81522202|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
27629990|NCT00741988|80486565|FG001|Overall Study|Lack of Efficacy|0|||
27913749|NCT03569098|81522203|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
27629991|NCT00530335|80486566|FG000|Overall Study|Adverse Event|3|||
27629992|NCT00530335|80486566|FG000|Overall Study|Protocol Violation|1|||
27629993|NCT00530335|80486566|FG000|Overall Study|Withdrawal by Subject|1|||
27629994|NCT00530335|80486566|FG000|Overall Study|Physician Decision|1|||
27629995|NCT01185522|80486569|FG000|Overall Study|Lack of Efficacy|28|||
27629996|NCT01185522|80486569|FG000|Overall Study|Lost to Follow-up|19|||
27629997|NCT01185522|80486569|FG000|Overall Study|Withdrawal by Subject|10|||
27629998|NCT01185522|80486569|FG000|Overall Study|Poor tolerance|39|||
27629999|NCT01185522|80486569|FG000|Overall Study|Other reasons|12|||
27630000|NCT02943993|80486570|FG000|Overall Study|Withdrawal by Subject|52|||
27630001|NCT02943993|80486570|FG000|Overall Study|Transfer to another institution|6|||
27630002|NCT02943993|80486570|FG000|Overall Study|Lost to Follow-up|135|||
27913750|NCT03569098|81522204|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
27913751|NCT03797898|81522205|FG000|Overall Study|Lost to Follow-up|60|||
27913752|NCT03797898|81522206|FG001|Overall Study|Lost to Follow-up|69|||
27913753|NCT03797898|81522205|FG000|Overall Study|Withdrawal by Subject|9|||
27913754|NCT03797898|81522206|FG001|Overall Study|Withdrawal by Subject|7|||
27913755|NCT03797898|81522205|FG000|Overall Study|Became ineligible|5|||
27913756|NCT03797898|81522206|FG001|Overall Study|Became ineligible|2|||
27913757|NCT01255904|81522207|FG000|Overall Study|Physician Decision|1|||
27913758|NCT01255904|81522208|FG001|Overall Study|Physician Decision|4|||
27913759|NCT03118518|81522209|FG000|Overall Study|Early Exit after treatment|2|||
27913760|NCT03118518|81522210|FG001|Overall Study|Early Exit after treatment|8|||
27913761|NCT03118518|81522209|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
27913762|NCT03118518|81522210|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
27913763|NCT03225170|81522212|FG000|Overall Study|Lost to Follow-up|4|||
27913764|NCT03225170|81522213|FG001|Overall Study|Lost to Follow-up|4|||
27913765|NCT03225170|81522214|FG002|Overall Study|Lost to Follow-up|0|||
27913766|NCT03225170|81522212|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
27913767|NCT03225170|81522213|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
27913768|NCT03225170|81522214|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
27913769|NCT00237692|81522223|FG000|Overall Study|Lost to Follow-up|9|||
27913770|NCT00237692|81522224|FG001|Overall Study|Lost to Follow-up|3|||
27913771|NCT00237692|81522225|FG002|Overall Study|Lost to Follow-up|5|||
27913772|NCT00237692|81522226|FG003|Overall Study|Lost to Follow-up|3|||
27534135|NCT00569270|80150541|FG001|Period: First Intervention|Protocol Violation|1|||
27534136|NCT02395666|80150542|FG000|Overall Study|Physician Decision|3|||
27534137|NCT02395666|80150543|FG001|Overall Study|Physician Decision|0|||
27534138|NCT02395666|80150542|FG000|Overall Study|Lost to Follow-up|1|||
27534139|NCT02395666|80150543|FG001|Overall Study|Lost to Follow-up|0|||
27534140|NCT02395666|80150542|FG000|Overall Study|Withdrawal by Subject|2|||
27534141|NCT02395666|80150543|FG001|Overall Study|Withdrawal by Subject|1|||
27534142|NCT01845818|80150544|FG000|Overall Study|Withdrawal by Subject|0|||
27534143|NCT01845818|80150545|FG001|Overall Study|Withdrawal by Subject|1|||
27534144|NCT01845818|80150544|FG000|Overall Study|Lost to Follow-up|7|||
27534145|NCT01845818|80150545|FG001|Overall Study|Lost to Follow-up|5|||
27534146|NCT01845818|80150544|FG000|Overall Study|Administrative Reasons|3|||
27534147|NCT01845818|80150545|FG001|Overall Study|Administrative Reasons|1|||
27534148|NCT01845818|80150544|FG000|Overall Study|Serious Adverse Event|1|||
27534149|NCT01845818|80150545|FG001|Overall Study|Serious Adverse Event|1|||
27534150|NCT01845818|80150544|FG000|Overall Study|Other|25|||
27534151|NCT01845818|80150545|FG001|Overall Study|Other|8|||
27534152|NCT01845818|80150544|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
27534153|NCT01845818|80150545|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
27534154|NCT01845818|80150544|FG000|Overall Study|No Follow-Up Data Available|4|||
27534155|NCT01845818|80150545|FG001|Overall Study|No Follow-Up Data Available|1|||
27534156|NCT01461980|80150546|FG000|Overall Study|Other|9|||
27534157|NCT01461980|80150547|FG001|Overall Study|Other|8|||
27534158|NCT01461980|80150548|FG002|Overall Study|Other|6|||
27534159|NCT01461980|80150546|FG000|Overall Study|Medication error|7|||
27534160|NCT01461980|80150547|FG001|Overall Study|Medication error|5|||
27630003|NCT02943993|80486570|FG000|Overall Study|Death|98|||
27630004|NCT02943993|80486570|FG000|Overall Study|Other reason for premature termination|32|||
27630005|NCT02943993|80486570|FG000|Overall Study|Missing reason for termination|7|||
27630006|NCT00646451|80486571|FG000|Overall Study|Adverse Event|3|||
27630007|NCT00646451|80486572|FG001|Overall Study|Adverse Event|0|||
27630008|NCT00646451|80486571|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
27630009|NCT00646451|80486572|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
27630010|NCT03478696|80486573|FG000|Overall Study|Adverse Event|1|||
27630011|NCT03478696|80486574|FG001|Overall Study|Adverse Event|5|||
27630012|NCT03478696|80486573|FG000|Overall Study|Lost to Follow-up|1|||
27630013|NCT03478696|80486574|FG001|Overall Study|Lost to Follow-up|0|||
27630014|NCT03478696|80486573|FG000|Overall Study|Physician Decision|6|||
27630015|NCT03478696|80486574|FG001|Overall Study|Physician Decision|3|||
27630016|NCT03478696|80486573|FG000|Overall Study|Withdrawal by Subject|9|||
27913773|NCT00237692|81522223|FG000|Overall Study|Death|1|||
27913774|NCT00237692|81522224|FG001|Overall Study|Death|2|||
27913775|NCT00237692|81522225|FG002|Overall Study|Death|2|||
27913776|NCT00237692|81522226|FG003|Overall Study|Death|3|||
27913777|NCT00237692|81522223|FG000|Overall Study|Excluded - did not meet criteria|4|||
27913778|NCT00237692|81522224|FG001|Overall Study|Excluded - did not meet criteria|3|||
27913779|NCT00237692|81522225|FG002|Overall Study|Excluded - did not meet criteria|5|||
27913780|NCT00237692|81522226|FG003|Overall Study|Excluded - did not meet criteria|9|||
27534161|NCT01461980|80150548|FG002|Overall Study|Medication error|6|||
27534162|NCT01461980|80150546|FG000|Overall Study|Adverse Event|12|||
27534163|NCT01461980|80150547|FG001|Overall Study|Adverse Event|5|||
27534164|NCT01461980|80150548|FG002|Overall Study|Adverse Event|6|||
27534165|NCT01461980|80150546|FG000|Overall Study|Protocol Violation|12|||
27913781|NCT00237692|81522223|FG000|Overall Study|Withdrawal by Subject|4|||
27913782|NCT00237692|81522224|FG001|Overall Study|Withdrawal by Subject|6|||
27913783|NCT00237692|81522225|FG002|Overall Study|Withdrawal by Subject|10|||
27913784|NCT00237692|81522226|FG003|Overall Study|Withdrawal by Subject|4|||
27913785|NCT00689338|81522227|FG000|Overall Study|Death|65|||
27913786|NCT00689338|81522227|FG000|Overall Study|Adverse Event|13|||
27913787|NCT00689338|81522227|FG000|Overall Study|Insufficient Clinical Response|1|||
27913788|NCT00689338|81522227|FG000|Overall Study|Lack of Efficacy|6|||
27913789|NCT00689338|81522227|FG000|Overall Study|Other|8|||
27913790|NCT00689338|81522227|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
27913791|NCT00689338|81522227|FG000|Overall Study|Lost to Follow-up|5|||
27913792|NCT00689338|81522227|FG000|Overall Study|Withdrawal by Subject|3|||
27913793|NCT00689338|81522227|FG000|Overall Study|Protocol Violation|15|||
27913794|NCT00809445|81522230|FG000|1 Month Follow-up|Lost contact|1|||
27913795|NCT00809445|81522231|FG001|1 Month Follow-up|Lost contact|2|||
27913796|NCT00809445|81522232|FG002|1 Month Follow-up|Lost contact|1|||
27913797|NCT00809445|81522230|FG000|1 Month Follow-up|Withdrew consent|1|||
27913798|NCT00809445|81522231|FG001|1 Month Follow-up|Withdrew consent|1|||
27913799|NCT00809445|81522232|FG002|1 Month Follow-up|Withdrew consent|1|||
27913800|NCT00809445|81522230|FG000|1 Month Follow-up|Death|0|||
27913801|NCT00809445|81522231|FG001|1 Month Follow-up|Death|1|||
27913802|NCT00809445|81522232|FG002|1 Month Follow-up|Death|1|||
27913803|NCT00809445|81522230|FG000|1 Month Follow-up|Incarcerated|0|||
27913804|NCT00809445|81522231|FG001|1 Month Follow-up|Incarcerated|0|||
27913805|NCT00809445|81522232|FG002|1 Month Follow-up|Incarcerated|1|||
27913806|NCT00809445|81522230|FG000|6 Month Follow-up|Lost contact|16|||
27913807|NCT00809445|81522231|FG001|6 Month Follow-up|Lost contact|14|||
27913808|NCT00809445|81522232|FG002|6 Month Follow-up|Lost contact|14|||
27913809|NCT00809445|81522230|FG000|6 Month Follow-up|Death|2|||
27913810|NCT00809445|81522231|FG001|6 Month Follow-up|Death|1|||
27913811|NCT00809445|81522232|FG002|6 Month Follow-up|Death|1|||
27913812|NCT00809445|81522230|FG000|6 Month Follow-up|Incarcerated|6|||
27913813|NCT00809445|81522231|FG001|6 Month Follow-up|Incarcerated|8|||
27913814|NCT00809445|81522232|FG002|6 Month Follow-up|Incarcerated|8|||
27913815|NCT00809445|81522230|FG000|6 Month Follow-up|Withdrew consent|0|||
27913816|NCT00809445|81522231|FG001|6 Month Follow-up|Withdrew consent|0|||
27913817|NCT00809445|81522232|FG002|6 Month Follow-up|Withdrew consent|1|||
27913818|NCT03075267|81522235|FG000|Overall Study|Protocol Violation|1|||
27913819|NCT03075267|81522236|FG001|Overall Study|Protocol Violation|0|||
27913820|NCT03075267|81522237|FG002|Overall Study|Protocol Violation|0|||
27913821|NCT00715403|81522238|FG000|Overall Study|Progressive disease|0|||
27913822|NCT00715403|81522239|FG001|Overall Study|Progressive disease|1|||
27913823|NCT00715403|81522240|FG002|Overall Study|Progressive disease|3|||
27913824|NCT00715403|81522241|FG003|Overall Study|Progressive disease|9|||
27913825|NCT00715403|81522242|FG004|Overall Study|Progressive disease|5|||
27913826|NCT00715403|81522243|FG005|Overall Study|Progressive disease|14|||
27913827|NCT00715403|81522244|FG006|Overall Study|Progressive disease|1|||
27913828|NCT00715403|81522238|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
27630017|NCT03478696|80486574|FG001|Overall Study|Withdrawal by Subject|4|||
27913829|NCT00715403|81522239|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
27913830|NCT00715403|81522240|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
27913831|NCT00715403|81522241|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
27913832|NCT00715403|81522242|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
27913833|NCT00715403|81522243|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
27913834|NCT00715403|81522244|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
27913835|NCT00715403|81522238|FG000|Overall Study|Other Adverse Event than DLT|1|||
27630018|NCT00927823|80486575|FG000|Continuous Dosing Period|Death|0|||
27630019|NCT00927823|80486576|FG001|Continuous Dosing Period|Death|0|||
27913836|NCT00715403|81522239|FG001|Overall Study|Other Adverse Event than DLT|0|||
27913837|NCT00715403|81522240|FG002|Overall Study|Other Adverse Event than DLT|0|||
27913838|NCT00715403|81522241|FG003|Overall Study|Other Adverse Event than DLT|0|||
27913839|NCT00715403|81522242|FG004|Overall Study|Other Adverse Event than DLT|0|||
27913840|NCT00715403|81522243|FG005|Overall Study|Other Adverse Event than DLT|2|||
27913841|NCT00715403|81522244|FG006|Overall Study|Other Adverse Event than DLT|0|||
27913842|NCT00715403|81522238|FG000|Overall Study|Protocol Violation|0|||
27913843|NCT00715403|81522239|FG001|Overall Study|Protocol Violation|0|||
27913844|NCT00715403|81522240|FG002|Overall Study|Protocol Violation|0|||
27913845|NCT00715403|81522241|FG003|Overall Study|Protocol Violation|0|||
27913846|NCT00715403|81522242|FG004|Overall Study|Protocol Violation|0|||
27913847|NCT00715403|81522243|FG005|Overall Study|Protocol Violation|1|||
27913848|NCT00715403|81522244|FG006|Overall Study|Protocol Violation|0|||
27913849|NCT00715403|81522238|FG000|Overall Study|Other reason not defined above|0|||
27913850|NCT00715403|81522239|FG001|Overall Study|Other reason not defined above|0|||
27913851|NCT00715403|81522240|FG002|Overall Study|Other reason not defined above|1|||
27913852|NCT00715403|81522241|FG003|Overall Study|Other reason not defined above|0|||
27913853|NCT00715403|81522242|FG004|Overall Study|Other reason not defined above|1|||
27913854|NCT00715403|81522243|FG005|Overall Study|Other reason not defined above|1|||
27913855|NCT00715403|81522244|FG006|Overall Study|Other reason not defined above|0|||
27913856|NCT01747499|81522245|FG000|Overall Study|Steroid refractory aGvHD|1|||
27913857|NCT01747499|81522246|FG001|Overall Study|Steroid refractory aGvHD|0|||
27913858|NCT01747499|81522247|FG002|Overall Study|Steroid refractory aGvHD|0|||
27913859|NCT01747499|81522248|FG003|Overall Study|Steroid refractory aGvHD|1|||
27913860|NCT01747499|81522249|FG004|Overall Study|Steroid refractory aGvHD|4|||
27913861|NCT01747499|81522245|FG000|Overall Study|Physician Decision|0|||
27913862|NCT01747499|81522246|FG001|Overall Study|Physician Decision|1|||
27913863|NCT01747499|81522247|FG002|Overall Study|Physician Decision|0|||
27913864|NCT01747499|81522248|FG003|Overall Study|Physician Decision|0|||
27913865|NCT01747499|81522249|FG004|Overall Study|Physician Decision|2|||
27913866|NCT01747499|81522245|FG000|Overall Study|Death|0|||
27630020|NCT00927823|80486577|FG002|Continuous Dosing Period|Death|6|||
27630021|NCT00927823|80486578|FG003|Continuous Dosing Period|Death|0|||
27630022|NCT00927823|80486575|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
27630023|NCT00927823|80486576|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
27630024|NCT00927823|80486577|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
27630025|NCT00927823|80486578|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
27630026|NCT00927823|80486575|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
27630027|NCT00927823|80486576|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
27630028|NCT00927823|80486577|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
27630029|NCT00927823|80486578|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
27630030|NCT00927823|80486575|FG000|Continuous Dosing Period|Other|1|||
27630031|NCT00927823|80486576|FG001|Continuous Dosing Period|Other|2|||
27630032|NCT00927823|80486577|FG002|Continuous Dosing Period|Other|9|||
27630033|NCT00927823|80486578|FG003|Continuous Dosing Period|Other|3|||
27630034|NCT01909336|80486580|FG000|Overall Study|Lost to Follow-up|4|||
27630035|NCT01909336|80486581|FG001|Overall Study|Lost to Follow-up|2|||
27630036|NCT01909336|80486582|FG002|Overall Study|Lost to Follow-up|2|||
27630037|NCT01909336|80486580|FG000|Overall Study|Physician Decision|0|||
27630038|NCT01909336|80486581|FG001|Overall Study|Physician Decision|1|||
27630039|NCT01909336|80486582|FG002|Overall Study|Physician Decision|1|||
27630040|NCT03396835|80486583|FG000|Overall Study|Withdrawn prior to completion|1|||
27630041|NCT03396835|80486583|FG000|Overall Study|Did not meet criteria for data analysis|1|||
27630042|NCT05019729|80486584|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
27630043|NCT05019729|80486585|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
27630044|NCT05019729|80486586|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
27630045|NCT05019729|80486587|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
27630046|NCT05019729|80486588|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
27630047|NCT05019729|80486589|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
27630048|NCT00299702|80486591|FG000|Overall Study|Death|1|||
27630049|NCT00299702|80486592|FG001|Overall Study|Death|0|||
27630050|NCT00299702|80486591|FG000|Overall Study|Adverse Event|0|||
27630051|NCT00299702|80486592|FG001|Overall Study|Adverse Event|4|||
27630052|NCT00299702|80486591|FG000|Overall Study|Lost to Follow-up|18|||
27630053|NCT00299702|80486592|FG001|Overall Study|Lost to Follow-up|10|||
27630054|NCT00299702|80486591|FG000|Overall Study|Withdrawal by Subject|25|||
27630055|NCT00299702|80486592|FG001|Overall Study|Withdrawal by Subject|23|||
27630056|NCT00299702|80486591|FG000|Overall Study|Pregnancy|0|||
27630057|NCT00299702|80486592|FG001|Overall Study|Pregnancy|1|||
27630058|NCT00299702|80486591|FG000|Overall Study|Insufficient Response|4|||
27630059|NCT00299702|80486592|FG001|Overall Study|Insufficient Response|3|||
27630060|NCT00299702|80486591|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
27913867|NCT01747499|81522246|FG001|Overall Study|Death|0|||
27913868|NCT01747499|81522247|FG002|Overall Study|Death|0|||
27913869|NCT01747499|81522248|FG003|Overall Study|Death|1|||
27913870|NCT01747499|81522249|FG004|Overall Study|Death|1|||
27913871|NCT01747499|81522245|FG000|Overall Study|Withdrawal by Subject|0|||
27630061|NCT00299702|80486592|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
27630062|NCT02317016|80486593|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
27630063|NCT02317016|80486593|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
27630064|NCT02317016|80486593|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
27630065|NCT02317016|80486593|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
27630066|NCT02317016|80486593|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
27630067|NCT02317016|80486593|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
27913872|NCT01747499|81522246|FG001|Overall Study|Withdrawal by Subject|0|||
27913873|NCT01747499|81522247|FG002|Overall Study|Withdrawal by Subject|0|||
27913874|NCT01747499|81522248|FG003|Overall Study|Withdrawal by Subject|0|||
27913875|NCT01747499|81522249|FG004|Overall Study|Withdrawal by Subject|6|||
27913876|NCT01747499|81522245|FG000|Overall Study|Developed AML and death|0|||
27913877|NCT01747499|81522246|FG001|Overall Study|Developed AML and death|0|||
27913878|NCT01747499|81522247|FG002|Overall Study|Developed AML and death|0|||
27630068|NCT02317016|80486593|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
27630069|NCT00751036|80486594|FG000|Overall Study|Disease Progression|28|||
27630070|NCT00751036|80486595|FG001|Overall Study|Disease Progression|29|||
27630071|NCT00751036|80486594|FG000|Overall Study|Adverse Event|6|||
27630072|NCT00751036|80486595|FG001|Overall Study|Adverse Event|4|||
27630073|NCT00751036|80486594|FG000|Overall Study|Administrative Problems|3|||
27630074|NCT00751036|80486595|FG001|Overall Study|Administrative Problems|4|||
27630075|NCT00751036|80486594|FG000|Overall Study|Withdrawal by Subject|5|||
27630076|NCT00751036|80486595|FG001|Overall Study|Withdrawal by Subject|2|||
27630077|NCT00751036|80486594|FG000|Overall Study|Death|3|||
27630078|NCT00751036|80486595|FG001|Overall Study|Death|3|||
27630079|NCT00751036|80486594|FG000|Overall Study|Lost to Follow-up|0|||
27630080|NCT00751036|80486595|FG001|Overall Study|Lost to Follow-up|1|||
27630081|NCT00751036|80486594|FG000|Overall Study|Protocol Violation|1|||
27630082|NCT00751036|80486595|FG001|Overall Study|Protocol Violation|0|||
27630083|NCT00751036|80486594|FG000|Overall Study|Missing end of Treatment Page|2|||
27630084|NCT00751036|80486595|FG001|Overall Study|Missing end of Treatment Page|3|||
27630085|NCT03942042|80486596|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
27630086|NCT03942042|80486597|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
27630087|NCT03942042|80486596|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
27630088|NCT03942042|80486597|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
27630089|NCT02357784|80486602|FG000|Overall Study|Withdrawal by Subject|1|||
27630090|NCT03635112|80486603|FG000|Overall Study|Adverse Event|5|||
27630091|NCT03635112|80486604|FG001|Overall Study|Adverse Event|9|||
27630092|NCT03635112|80486605|FG002|Overall Study|Adverse Event|14|||
27630093|NCT03635112|80486603|FG000|Overall Study|Lost to Follow-up|1|||
27630094|NCT03635112|80486604|FG001|Overall Study|Lost to Follow-up|0|||
27630095|NCT03635112|80486605|FG002|Overall Study|Lost to Follow-up|1|||
27630096|NCT03635112|80486603|FG000|Overall Study|Physician Decision|5|||
27630097|NCT03635112|80486604|FG001|Overall Study|Physician Decision|7|||
27630098|NCT03635112|80486605|FG002|Overall Study|Physician Decision|5|||
27630099|NCT03635112|80486603|FG000|Overall Study|Protocol Violation|0|||
27630100|NCT03635112|80486604|FG001|Overall Study|Protocol Violation|0|||
27630101|NCT03635112|80486605|FG002|Overall Study|Protocol Violation|1|||
27630102|NCT03635112|80486603|FG000|Overall Study|Study Terminated by Sponsor|11|||
27630103|NCT03635112|80486604|FG001|Overall Study|Study Terminated by Sponsor|17|||
27630104|NCT03635112|80486605|FG002|Overall Study|Study Terminated by Sponsor|21|||
27630105|NCT03635112|80486603|FG000|Overall Study|Withdrawal by Subject|4|||
27630106|NCT03635112|80486604|FG001|Overall Study|Withdrawal by Subject|9|||
27630107|NCT03635112|80486605|FG002|Overall Study|Withdrawal by Subject|7|||
27630108|NCT03635112|80486603|FG000|Overall Study|Miscellaneous|0|||
27630109|NCT03635112|80486604|FG001|Overall Study|Miscellaneous|0|||
27630110|NCT03635112|80486605|FG002|Overall Study|Miscellaneous|1|||
27630111|NCT01149681|80486606|FG000|Overall Study|Withdrawal by Subject|7|||
27630112|NCT01149681|80486606|FG000|Overall Study|Progressive disease|1|||
27630113|NCT01149681|80486606|FG000|Overall Study|Physician Decision|2|||
27630114|NCT01149681|80486606|FG000|Overall Study|adverse events nonrelated study drug|2|||
27630115|NCT03061474|80486610|FG000|Overall Study|Adverse Event|2|||
27630116|NCT03061474|80486611|FG001|Overall Study|Adverse Event|0|||
27630117|NCT03061474|80486610|FG000|Overall Study|Safety Risk|0|||
27630118|NCT03061474|80486611|FG001|Overall Study|Safety Risk|1|||
27630119|NCT03061474|80486610|FG000|Overall Study|Participant unwilling or unable to participate|0|||
27630120|NCT03061474|80486611|FG001|Overall Study|Participant unwilling or unable to participate|2|||
27630121|NCT03061474|80486610|FG000|Overall Study|Lost to Follow-up|0|||
27630122|NCT03061474|80486611|FG001|Overall Study|Lost to Follow-up|1|||
27630123|NCT02486588|80486612|FG000|Overall Study|Randomized in error- ineligible|738|||
27630124|NCT02486588|80486613|FG001|Overall Study|Randomized in error- ineligible|750|||
27534166|NCT01461980|80150547|FG001|Overall Study|Protocol Violation|19|||
27534167|NCT01461980|80150548|FG002|Overall Study|Protocol Violation|16|||
27534168|NCT01461980|80150546|FG000|Overall Study|No longer meets eligibility criteria|18|||
27534169|NCT01461980|80150547|FG001|Overall Study|No longer meets eligibility criteria|9|||
27534170|NCT01461980|80150548|FG002|Overall Study|No longer meets eligibility criteria|19|||
27534171|NCT01461980|80150546|FG000|Overall Study|Lost to Follow-up|52|||
27534172|NCT01461980|80150547|FG001|Overall Study|Lost to Follow-up|53|||
27534173|NCT01461980|80150548|FG002|Overall Study|Lost to Follow-up|51|||
27534174|NCT01461980|80150546|FG000|Overall Study|No longer willing to participate|52|||
27630125|NCT02486588|80486614|FG002|Overall Study|Randomized in error- ineligible|755|||
27630126|NCT02486588|80486615|FG003|Overall Study|Randomized in error- ineligible|738|||
27630127|NCT02486588|80486616|FG004|Overall Study|Randomized in error- ineligible|746|||
27630128|NCT02486588|80486617|FG005|Overall Study|Randomized in error- ineligible|746|||
27630129|NCT01537133|80486618|FG000|Overall Study|Withdrawal by Subject|2|||
27630130|NCT01537133|80486619|FG001|Overall Study|Withdrawal by Subject|0|||
27630131|NCT01537133|80486620|FG002|Overall Study|Withdrawal by Subject|0|||
27534175|NCT01461980|80150547|FG001|Overall Study|No longer willing to participate|38|||
27534176|NCT01461980|80150548|FG002|Overall Study|No longer willing to participate|54|||
27630132|NCT01537133|80486621|FG003|Overall Study|Withdrawal by Subject|0|||
27630133|NCT01537133|80486618|FG000|Overall Study|Lost to Follow-up|1|||
27630134|NCT01537133|80486619|FG001|Overall Study|Lost to Follow-up|0|||
27630135|NCT01537133|80486620|FG002|Overall Study|Lost to Follow-up|0|||
27630136|NCT01537133|80486621|FG003|Overall Study|Lost to Follow-up|0|||
27630137|NCT03179787|80486624|FG000|Overall Study|Lost to Follow-up|15|||
27630138|NCT03179787|80486624|FG000|Overall Study|Case report failures|2|||
27630139|NCT03179787|80486624|FG000|Overall Study|Treatment not administered|1|||
27630140|NCT00324038|80486627|FG000|Overall Study|Adverse Event|38|||
27630141|NCT00324038|80486628|FG001|Overall Study|Adverse Event|23|||
27630142|NCT00324038|80486627|FG000|Overall Study|Lack of Efficacy|5|||
27630143|NCT00324038|80486628|FG001|Overall Study|Lack of Efficacy|13|||
27630144|NCT00324038|80486627|FG000|Overall Study|Lost to Follow-up|0|||
27630145|NCT00324038|80486628|FG001|Overall Study|Lost to Follow-up|2|||
27630146|NCT00324038|80486627|FG000|Overall Study|Other|6|||
27630147|NCT00324038|80486628|FG001|Overall Study|Other|13|||
27630148|NCT04173572|80486629|FG000|Overall Study|Withdrawal by Subject|1|||
27630149|NCT04173572|80486630|FG001|Overall Study|Withdrawal by Subject|5|||
27630150|NCT04173572|80486629|FG000|Overall Study|Lost to Follow-up|3|||
27630151|NCT04173572|80486630|FG001|Overall Study|Lost to Follow-up|1|||
27737760|NCT03015532|80868461|FG000|Overall Study|Withdrawal by Subject|0|||
27534177|NCT01461980|80150546|FG000|Overall Study|Randomized but not vaccinated|4|||
27534178|NCT01461980|80150547|FG001|Overall Study|Randomized but not vaccinated|8|||
27534179|NCT01461980|80150548|FG002|Overall Study|Randomized but not vaccinated|7|||
27534180|NCT01710046|80150549|FG000|Overall Study|Lost to Follow-up|1|||
27534181|NCT01710046|80150550|FG001|Overall Study|Lost to Follow-up|0|||
27534182|NCT00147251|80150551|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
27534183|NCT00147251|80150552|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
27534184|NCT01528033|80150553|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
27534185|NCT01528033|80150554|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
27534186|NCT01528033|80150553|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
27534187|NCT01528033|80150554|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
27534188|NCT01528033|80150553|FG000|Primary Endpoint Assessment ITT|Death|2|||
27534189|NCT01528033|80150554|FG001|Primary Endpoint Assessment ITT|Death|2|||
27534190|NCT01528033|80150553|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
27534191|NCT01528033|80150554|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
27534192|NCT01528033|80150553|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
27534193|NCT01528033|80150554|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
27630152|NCT01467700|80486631|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
27737761|NCT03015532|80868462|FG001|Overall Study|Withdrawal by Subject|0|||
27737762|NCT03015532|80868463|FG002|Overall Study|Withdrawal by Subject|0|||
27737763|NCT03015532|80868464|FG003|Overall Study|Withdrawal by Subject|0|||
27737764|NCT03015532|80868465|FG004|Overall Study|Withdrawal by Subject|0|||
27737765|NCT03015532|80868466|FG005|Overall Study|Withdrawal by Subject|0|||
27737766|NCT03015532|80868467|FG006|Overall Study|Withdrawal by Subject|1|||
27737767|NCT03015532|80868468|FG007|Overall Study|Withdrawal by Subject|0|||
27737768|NCT01025336|80868472|FG000|Overall Study|Protocol Violation|0|||
27737769|NCT01025336|80868473|FG001|Overall Study|Protocol Violation|0|||
27737770|NCT01025336|80868474|FG002|Overall Study|Protocol Violation|0|||
27737771|NCT01025336|80868475|FG003|Overall Study|Protocol Violation|2|||
27913879|NCT01747499|81522248|FG003|Overall Study|Developed AML and death|0|||
27913880|NCT01747499|81522249|FG004|Overall Study|Developed AML and death|1|||
27913881|NCT01747499|81522245|FG000|Overall Study|Determined not to be eligible|0|||
27913882|NCT01747499|81522246|FG001|Overall Study|Determined not to be eligible|0|||
27913883|NCT01747499|81522247|FG002|Overall Study|Determined not to be eligible|0|||
27737772|NCT01025336|80868476|FG004|Overall Study|Protocol Violation|0|||
27913884|NCT01747499|81522248|FG003|Overall Study|Determined not to be eligible|0|||
27913885|NCT01747499|81522249|FG004|Overall Study|Determined not to be eligible|1|||
27913886|NCT00941304|81522252|FG000|Overall Study|Lost to Follow-up|1|||
27913887|NCT00941304|81522253|FG001|Overall Study|Lost to Follow-up|0|||
27913888|NCT00941304|81522254|FG002|Overall Study|Lost to Follow-up|0|||
27913889|NCT00941304|81522255|FG003|Overall Study|Lost to Follow-up|0|||
27534194|NCT01528033|80150553|FG000|Follow Up|No data available|46|||
27534195|NCT01528033|80150554|FG001|Follow Up|No data available|44|||
27534196|NCT01565642|80150559|FG000|Overall Study|Withdrawal by Subject|2|||
27534197|NCT01565642|80150560|FG001|Overall Study|Withdrawal by Subject|1|||
27534198|NCT00611533|80150563|FG000|First Intervention (6 Weeks)|Never started study|0|||
27630153|NCT01467700|80486632|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
27737773|NCT01967225|80868477|FG000|Overall Study|Adverse Event|3|||
27737774|NCT01967225|80868478|FG001|Overall Study|Adverse Event|1|||
27913890|NCT00941304|81522256|FG004|Overall Study|Lost to Follow-up|0|||
27630154|NCT01467700|80486633|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
27630155|NCT01467700|80486634|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
27913891|NCT04030598|81522257|FG000|Overall Study|Voluntary Withdrawal|0|||
27630156|NCT01467700|80486631|FG000|Overall Study|Major Protocol Deviation|3|||
27534199|NCT00611533|80150564|FG001|First Intervention (6 Weeks)|Never started study|1|||
27913892|NCT04030598|81522258|FG001|Overall Study|Voluntary Withdrawal|1|||
27913893|NCT04030598|81522259|FG002|Overall Study|Voluntary Withdrawal|0|||
27630157|NCT01467700|80486632|FG001|Overall Study|Major Protocol Deviation|3|||
27630158|NCT01467700|80486633|FG002|Overall Study|Major Protocol Deviation|2|||
27630159|NCT01467700|80486634|FG003|Overall Study|Major Protocol Deviation|3|||
27913894|NCT00846586|81522260|FG000|Overall Study|Adverse Event|20|||
27913895|NCT00846586|81522261|FG001|Overall Study|Adverse Event|10|||
27913896|NCT00846586|81522260|FG000|Overall Study|Subject withdrew consent|8|||
27913897|NCT00846586|81522261|FG001|Overall Study|Subject withdrew consent|10|||
27913898|NCT00846586|81522260|FG000|Overall Study|Administrative problems|5|||
27913899|NCT00846586|81522261|FG001|Overall Study|Administrative problems|4|||
27913900|NCT00846586|81522260|FG000|Overall Study|Death|2|||
27913901|NCT00846586|81522261|FG001|Overall Study|Death|0|||
27913902|NCT00846586|81522260|FG000|Overall Study|Protocol deviation|2|||
27913903|NCT00846586|81522261|FG001|Overall Study|Protocol deviation|6|||
27913904|NCT00846586|81522260|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27913905|NCT00846586|81522261|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27913906|NCT00846586|81522260|FG000|Overall Study|Lost to Follow-up|1|||
27913907|NCT00846586|81522261|FG001|Overall Study|Lost to Follow-up|4|||
27534200|NCT00611533|80150563|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
27534201|NCT00611533|80150564|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
27534202|NCT00611533|80150563|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
27534203|NCT00611533|80150564|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
27630160|NCT01467700|80486631|FG000|Overall Study|Lost to Follow-up|6|||
27630161|NCT01467700|80486632|FG001|Overall Study|Lost to Follow-up|5|||
27630162|NCT01467700|80486633|FG002|Overall Study|Lost to Follow-up|2|||
27630163|NCT01467700|80486634|FG003|Overall Study|Lost to Follow-up|3|||
27630164|NCT01467700|80486631|FG000|Overall Study|Voluntary Withdrawal|5|||
27630165|NCT01467700|80486632|FG001|Overall Study|Voluntary Withdrawal|7|||
27630166|NCT01467700|80486633|FG002|Overall Study|Voluntary Withdrawal|6|||
27630167|NCT01467700|80486634|FG003|Overall Study|Voluntary Withdrawal|2|||
27630168|NCT01467700|80486631|FG000|Overall Study|Study Termination|6|||
27630169|NCT01467700|80486632|FG001|Overall Study|Study Termination|5|||
27534204|NCT02635776|80150565|FG000|Overall Study|Physician Decision|1|||
27534205|NCT02635776|80150566|FG001|Overall Study|Physician Decision|0|||
27534206|NCT02635776|80150565|FG000|Overall Study|Adverse Event|51|||
27534207|NCT02635776|80150566|FG001|Overall Study|Adverse Event|3|||
27534208|NCT02635776|80150565|FG000|Overall Study|Withdrawal by Subject|41|||
27534209|NCT02635776|80150566|FG001|Overall Study|Withdrawal by Subject|7|||
27534210|NCT02635776|80150565|FG000|Overall Study|Lost to Follow-up|4|||
27534211|NCT02635776|80150566|FG001|Overall Study|Lost to Follow-up|0|||
27534212|NCT02635776|80150565|FG000|Overall Study|Other reasons|5|||
27534213|NCT02635776|80150566|FG001|Overall Study|Other reasons|1|||
27534214|NCT03438383|80150567|FG000|Overall Study|Protocol Violation|9|||
27534215|NCT03438383|80150568|FG001|Overall Study|Protocol Violation|3|||
27534216|NCT00977574|80150569|FG000|Overall Study|Never Treated|4|||
27534217|NCT00977574|80150570|FG001|Overall Study|Never Treated|2|||
27534218|NCT00977574|80150571|FG002|Overall Study|Never Treated|4|||
27534219|NCT01031706|80150572|FG000|Overall Study|Adverse Event|1|||
27534220|NCT01031706|80150573|FG001|Overall Study|Adverse Event|0|||
27534221|NCT01031706|80150572|FG000|Overall Study|Withdrawal by Subject|1|||
27534222|NCT01031706|80150573|FG001|Overall Study|Withdrawal by Subject|1|||
27534223|NCT01683019|80150574|FG000|Overall Study|Withdrawal by Subject|2|||
27534224|NCT01683019|80150575|FG001|Overall Study|Withdrawal by Subject|1|||
27534225|NCT01683019|80150576|FG002|Overall Study|Withdrawal by Subject|4|||
27534226|NCT00484094|80150580|FG000|Overall Study|Discontinued|39|||
27534227|NCT00484094|80150580|FG000|Overall Study|Other|3|||
27534228|NCT04128371|80150585|FG000|Overall Study|Lack of Efficacy|1|||
27534229|NCT03540030|80150588|FG000|Overall Study|Withdrawal by Subject|2|||
27630170|NCT01467700|80486633|FG002|Overall Study|Study Termination|10|||
27630171|NCT01467700|80486634|FG003|Overall Study|Study Termination|7|||
27913908|NCT00846586|81522260|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27913909|NCT00846586|81522261|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27913910|NCT04794751|81525665|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
27913911|NCT04794751|81525666|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
27913912|NCT04794751|81525665|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
27534230|NCT03540030|80150589|FG001|Overall Study|Withdrawal by Subject|1|||
27534231|NCT03540030|80150588|FG000|Overall Study|screen fail|7|||
27534232|NCT03540030|80150589|FG001|Overall Study|screen fail|1|||
27534233|NCT03540030|80150588|FG000|Overall Study|never had surgery after signing consent|9|||
27534234|NCT03540030|80150589|FG001|Overall Study|never had surgery after signing consent|1|||
27534235|NCT03553927|80150592|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
27534236|NCT03553927|80150593|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
27534237|NCT03553927|80150592|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
27534238|NCT03553927|80150593|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
27534239|NCT03672643|80150598|FG000|Overall Study|Adverse Event|3|||
27737775|NCT01967225|80868477|FG000|Overall Study|Withdrawal by Subject|2|||
27737776|NCT01967225|80868478|FG001|Overall Study|Withdrawal by Subject|1|||
27737777|NCT01967225|80868477|FG000|Overall Study|Lack of Efficacy|1|||
27737778|NCT01967225|80868478|FG001|Overall Study|Lack of Efficacy|1|||
27534240|NCT03672643|80150598|FG000|Overall Study|Death|2|||
27534241|NCT03672643|80150598|FG000|Overall Study|Withdrawal by Subject|1|||
27534242|NCT03672643|80150598|FG000|Overall Study|Progressive disease|11|||
27534243|NCT03672643|80150598|FG000|Overall Study|Global deterioration of health status|1|||
27534244|NCT03672643|80150598|FG000|Overall Study|Refused further treatment|7|||
27534245|NCT03672643|80150598|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
27534246|NCT02633501|80150604|FG000|Overall Study|Adverse Event|0|||
27534247|NCT02633501|80150605|FG001|Overall Study|Adverse Event|0|||
27534248|NCT02633501|80150606|FG002|Overall Study|Adverse Event|1|||
27534249|NCT02633501|80150607|FG003|Overall Study|Adverse Event|0|||
27534250|NCT02633501|80150608|FG004|Overall Study|Adverse Event|1|||
27534251|NCT02633501|80150609|FG005|Overall Study|Adverse Event|1|||
27534252|NCT02633501|80150604|FG000|Overall Study|Withdrawal by Subject|2|||
27534253|NCT02633501|80150605|FG001|Overall Study|Withdrawal by Subject|1|||
27534254|NCT02633501|80150606|FG002|Overall Study|Withdrawal by Subject|2|||
27534255|NCT02633501|80150607|FG003|Overall Study|Withdrawal by Subject|2|||
27534256|NCT02633501|80150608|FG004|Overall Study|Withdrawal by Subject|1|||
27534257|NCT02633501|80150609|FG005|Overall Study|Withdrawal by Subject|3|||
27737779|NCT01967225|80868477|FG000|Overall Study|Switching to other therapy|2|||
27737780|NCT01967225|80868478|FG001|Overall Study|Switching to other therapy|0|||
27737781|NCT01967225|80868477|FG000|Overall Study|Protocol driven decision point|1|||
27737782|NCT01967225|80868478|FG001|Overall Study|Protocol driven decision point|0|||
27737783|NCT01967225|80868477|FG000|Overall Study|Logistical difficulties|1|||
27737784|NCT01967225|80868478|FG001|Overall Study|Logistical difficulties|0|||
27737785|NCT01967225|80868477|FG000|Overall Study|Protocol Violation|2|||
27737786|NCT01967225|80868478|FG001|Overall Study|Protocol Violation|0|||
27630172|NCT01467700|80486631|FG000|Overall Study|Pregnancy|0|||
27737787|NCT02469246|80868479|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
27737788|NCT02469246|80868480|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
27737789|NCT02469246|80868479|FG000|Double-Blind Phase|Adverse Event|12|||
27737790|NCT02469246|80868480|FG001|Double-Blind Phase|Adverse Event|9|||
27737791|NCT02469246|80868479|FG000|Double-Blind Phase|Death|2|||
27737792|NCT02469246|80868480|FG001|Double-Blind Phase|Death|0|||
27737793|NCT02469246|80868479|FG000|Double-Blind Phase|Lack of Efficacy|2|||
27737794|NCT02469246|80868480|FG001|Double-Blind Phase|Lack of Efficacy|1|||
27737795|NCT02469246|80868479|FG000|Double-Blind Phase|Investigator's Discretion|8|||
27737796|NCT02469246|80868480|FG001|Double-Blind Phase|Investigator's Discretion|8|||
27737797|NCT02469246|80868479|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
27737798|NCT02469246|80868480|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27737799|NCT02469246|80868479|FG000|Double-Blind Phase|Protocol Violation|1|||
27737800|NCT02469246|80868480|FG001|Double-Blind Phase|Protocol Violation|1|||
27737801|NCT02469246|80868479|FG000|Double-Blind Phase|Withdrew Consent|25|||
27737802|NCT02469246|80868480|FG001|Double-Blind Phase|Withdrew Consent|25|||
27737803|NCT02469246|80868479|FG000|Double-Blind Phase|Lost to Follow-up|9|||
27737804|NCT02469246|80868480|FG001|Double-Blind Phase|Lost to Follow-up|5|||
27737805|NCT02707757|80868481|FG000|Overall Study|Protocol Violation|3|||
27737806|NCT02707757|80868482|FG001|Overall Study|Protocol Violation|2|||
27737807|NCT02707757|80868481|FG000|Overall Study|Withdrawal by Subject|2|||
27737808|NCT02707757|80868482|FG001|Overall Study|Withdrawal by Subject|0|||
27737809|NCT02707757|80868481|FG000|Overall Study|Death|0|||
27737810|NCT02707757|80868482|FG001|Overall Study|Death|1|||
27737811|NCT02707757|80868481|FG000|Overall Study|Adverse Event|6|||
27737812|NCT02707757|80868482|FG001|Overall Study|Adverse Event|4|||
27737813|NCT02707757|80868481|FG000|Overall Study|Renal transplant/elective operation|1|||
27737814|NCT02707757|80868482|FG001|Overall Study|Renal transplant/elective operation|5|||
27737815|NCT01531725|80868483|FG000|Overall Study|Protocol Violation|5|||
27737816|NCT00844883|80868493|FG000|Overall Study|Bridged to liver transplant|3|||
27737817|NCT00844883|80868493|FG000|Overall Study|Bridged to resection|1|||
27737818|NCT01896232|80868494|FG000|Overall Study|Death|6|||
27737819|NCT01896232|80868495|FG001|Overall Study|Death|10|||
27737820|NCT01896232|80868494|FG000|Overall Study|Withdrawal by Subject|32|||
27737821|NCT01896232|80868495|FG001|Overall Study|Withdrawal by Subject|31|||
27737822|NCT01896232|80868494|FG000|Overall Study|Sponsor Decision|2|||
27534258|NCT02633501|80150604|FG000|Overall Study|Various other reasons|0|||
27737823|NCT01896232|80868495|FG001|Overall Study|Sponsor Decision|0|||
27737824|NCT01896232|80868494|FG000|Overall Study|Lost to Follow-up|9|||
27534259|NCT02633501|80150605|FG001|Overall Study|Various other reasons|2|||
27630173|NCT01467700|80486632|FG001|Overall Study|Pregnancy|1|||
27737825|NCT01896232|80868495|FG001|Overall Study|Lost to Follow-up|12|||
27737826|NCT02591615|80868496|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
27737827|NCT02591615|80868497|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
27534260|NCT02633501|80150606|FG002|Overall Study|Various other reasons|4|||
27534261|NCT02633501|80150607|FG003|Overall Study|Various other reasons|1|||
27737828|NCT02591615|80868498|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
27737829|NCT02591615|80868499|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
27737830|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
27737831|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
27737832|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
27913913|NCT04794751|81525666|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
27913914|NCT04794751|81525665|FG000|Period 1|Protocol Violation|0|||
27534262|NCT02633501|80150608|FG004|Overall Study|Various other reasons|7|||
27534263|NCT02633501|80150609|FG005|Overall Study|Various other reasons|11|||
27534264|NCT02633501|80150604|FG000|Overall Study|Lost to Follow-up|0|||
27534265|NCT02633501|80150605|FG001|Overall Study|Lost to Follow-up|0|||
27534266|NCT02633501|80150606|FG002|Overall Study|Lost to Follow-up|0|||
27534267|NCT02633501|80150607|FG003|Overall Study|Lost to Follow-up|1|||
27534268|NCT02633501|80150608|FG004|Overall Study|Lost to Follow-up|2|||
27534269|NCT02633501|80150609|FG005|Overall Study|Lost to Follow-up|0|||
27534270|NCT04357782|80150610|FG000|Overall Study|Discharged from hospital|1|||
27534271|NCT04357782|80150611|FG001|Overall Study|Discharged from hospital|0|||
27534272|NCT04357782|80150610|FG000|Overall Study|Death|0|||
27630174|NCT01467700|80486633|FG002|Overall Study|Pregnancy|1|||
27630175|NCT01467700|80486634|FG003|Overall Study|Pregnancy|0|||
27630176|NCT01467700|80486631|FG000|Overall Study|Lack of Efficacy|2|||
27630177|NCT01467700|80486632|FG001|Overall Study|Lack of Efficacy|0|||
27630178|NCT01467700|80486633|FG002|Overall Study|Lack of Efficacy|2|||
27630179|NCT01467700|80486634|FG003|Overall Study|Lack of Efficacy|1|||
27630180|NCT01467700|80486631|FG000|Overall Study|Reason not Specified|1|||
27630181|NCT01467700|80486632|FG001|Overall Study|Reason not Specified|3|||
27630182|NCT01467700|80486633|FG002|Overall Study|Reason not Specified|2|||
27630183|NCT01467700|80486634|FG003|Overall Study|Reason not Specified|8|||
27630184|NCT00197236|80486638|FG000|Overall Study|Adverse Event|1|||
27630185|NCT00197236|80486639|FG001|Overall Study|Adverse Event|0|||
27630186|NCT00197236|80486640|FG002|Overall Study|Adverse Event|1|||
27630187|NCT00197236|80486638|FG000|Overall Study|Lost to Follow-up|5|||
27630188|NCT00197236|80486639|FG001|Overall Study|Lost to Follow-up|14|||
27630189|NCT00197236|80486640|FG002|Overall Study|Lost to Follow-up|6|||
27630190|NCT00197236|80486638|FG000|Overall Study|Protocol Violation|0|||
27630191|NCT00197236|80486639|FG001|Overall Study|Protocol Violation|0|||
27630192|NCT00197236|80486640|FG002|Overall Study|Protocol Violation|1|||
27630193|NCT00197236|80486638|FG000|Overall Study|Withdrawal by Subject|7|||
27630194|NCT00197236|80486639|FG001|Overall Study|Withdrawal by Subject|3|||
27913915|NCT04794751|81525666|FG001|Period 1|Protocol Violation|2|||
27913916|NCT04794751|81525665|FG000|Period 1|Withdrawal by Subject|0|||
27913917|NCT04794751|81525666|FG001|Period 1|Withdrawal by Subject|1|||
27913918|NCT04794751|81525665|FG000|Period 2|Withdrawal by Subject|0|||
27913919|NCT04794751|81525666|FG001|Period 2|Withdrawal by Subject|1|||
27913920|NCT04794751|81525665|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
27913921|NCT04794751|81525666|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
27913922|NCT04794751|81525665|FG000|Period 2|Protocol Violation|1|||
27913923|NCT04794751|81525666|FG001|Period 2|Protocol Violation|0|||
27913924|NCT02157519|81525667|FG000|Overall Study|Death|3|||
27913925|NCT02157519|81525668|FG001|Overall Study|Death|1|||
27913926|NCT02157519|81525667|FG000|Overall Study|Withdrawal by Subject|7|||
27913927|NCT02157519|81525668|FG001|Overall Study|Withdrawal by Subject|0|||
27913928|NCT02157519|81525667|FG000|Overall Study|Lost to Follow-up|1|||
27913929|NCT02157519|81525668|FG001|Overall Study|Lost to Follow-up|0|||
27913930|NCT02106351|81525669|FG000|Treatment Cycle 1|Adverse Event|2|||
27913931|NCT02106351|81525670|FG001|Treatment Cycle 1|Adverse Event|0|||
27913932|NCT02106351|81525671|FG002|Treatment Cycle 1|Adverse Event|0|||
27913933|NCT02106351|81525669|FG000|Treatment Cycle 1|Consent withdrawn|1|||
27913934|NCT02106351|81525670|FG001|Treatment Cycle 1|Consent withdrawn|0|||
27913935|NCT02106351|81525671|FG002|Treatment Cycle 1|Consent withdrawn|2|||
27913936|NCT02106351|81525669|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
27913937|NCT02106351|81525670|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
27913938|NCT02106351|81525671|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
27913939|NCT02106351|81525669|FG000|Treatment Cycle 1|Other|0|||
27913940|NCT02106351|81525670|FG001|Treatment Cycle 1|Other|3|||
27913941|NCT02106351|81525671|FG002|Treatment Cycle 1|Other|1|||
27913942|NCT02106351|81525669|FG000|Treatment Cycle 1|Randomised but not treated|1|||
27913943|NCT02106351|81525670|FG001|Treatment Cycle 1|Randomised but not treated|0|||
27913944|NCT02106351|81525671|FG002|Treatment Cycle 1|Randomised but not treated|1|||
27913945|NCT02106351|81525669|FG000|Treatment Cycle 2|Adverse Event|0|||
27630195|NCT00197236|80486640|FG002|Overall Study|Withdrawal by Subject|11|||
27630196|NCT00197236|80486638|FG000|Overall Study|Study drug/medication expiration|1|||
27630197|NCT00197236|80486639|FG001|Overall Study|Study drug/medication expiration|0|||
27630198|NCT00197236|80486640|FG002|Overall Study|Study drug/medication expiration|3|||
27737833|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
27534273|NCT04357782|80150611|FG001|Overall Study|Death|2|||
27630199|NCT00197236|80486638|FG000|Overall Study|Returned out of specified time window|0|||
27630200|NCT00197236|80486639|FG001|Overall Study|Returned out of specified time window|0|||
27630201|NCT00197236|80486640|FG002|Overall Study|Returned out of specified time window|1|||
27630202|NCT00269399|80486641|FG000|Overall Study|Lack of Efficacy|27|||
27630203|NCT00269399|80486642|FG001|Overall Study|Lack of Efficacy|10|||
27630204|NCT00269399|80486641|FG000|Overall Study|Adverse Event|10|||
27630205|NCT00269399|80486642|FG001|Overall Study|Adverse Event|4|||
27630206|NCT00269399|80486641|FG000|Overall Study|Withdrawal by Subject|2|||
27630207|NCT00269399|80486642|FG001|Overall Study|Withdrawal by Subject|5|||
27630208|NCT00269399|80486641|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
27630209|NCT00269399|80486642|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
27913946|NCT02106351|81525670|FG001|Treatment Cycle 2|Adverse Event|2|||
27913947|NCT02106351|81525671|FG002|Treatment Cycle 2|Adverse Event|0|||
27913948|NCT02106351|81525669|FG000|Treatment Cycle 2|Consent withdrawn|0|||
27913949|NCT02106351|81525670|FG001|Treatment Cycle 2|Consent withdrawn|1|||
27913950|NCT02106351|81525671|FG002|Treatment Cycle 2|Consent withdrawn|1|||
27913951|NCT02106351|81525669|FG000|Treatment Cycle 2|Other|0|||
27913952|NCT02106351|81525670|FG001|Treatment Cycle 2|Other|2|||
27630210|NCT00269399|80486641|FG000|Overall Study|Other|0|||
27630211|NCT00269399|80486642|FG001|Overall Study|Other|4|||
27630212|NCT00269399|80486641|FG000|Overall Study|Development of exclusion criteria|0|||
27630213|NCT00269399|80486642|FG001|Overall Study|Development of exclusion criteria|1|||
27630214|NCT02030028|80486645|FG000|Overall Study|Withdrawal by Subject|4|||
27630215|NCT02030028|80486645|FG000|Overall Study|lack of transportation|1|||
27630216|NCT04072822|80486646|FG000|Treatment|Adverse Event|9|||
27630217|NCT04072822|80486647|FG001|Treatment|Adverse Event|5|||
27630218|NCT04072822|80486646|FG000|Treatment|Met Stopping Criteria|13|||
27630219|NCT04072822|80486647|FG001|Treatment|Met Stopping Criteria|24|||
27630220|NCT04072822|80486646|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
27630221|NCT04072822|80486647|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
27630222|NCT04072822|80486646|FG000|Treatment|Withdrawal by Subject|0|||
27630223|NCT04072822|80486647|FG001|Treatment|Withdrawal by Subject|2|||
27630224|NCT04072822|80486646|FG000|Treatment|Death|0|||
27630225|NCT04072822|80486647|FG001|Treatment|Death|2|||
27630226|NCT04072822|80486646|FG000|Treatment|Lost to Follow-up|11|||
27630227|NCT04072822|80486647|FG001|Treatment|Lost to Follow-up|3|||
27630228|NCT04072822|80486646|FG000|Treatment|Physician Decision|1|||
27630229|NCT04072822|80486647|FG001|Treatment|Physician Decision|0|||
27630230|NCT04072822|80486646|FG000|Treatment|Other|7|||
27737834|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
27913953|NCT02106351|81525671|FG002|Treatment Cycle 2|Other|2|||
27913954|NCT02106351|81525669|FG000|Treatment Cycle 3|Adverse Event|0|||
27913955|NCT02106351|81525670|FG001|Treatment Cycle 3|Adverse Event|1|||
27913956|NCT02106351|81525671|FG002|Treatment Cycle 3|Adverse Event|0|||
27913957|NCT02106351|81525669|FG000|Treatment Cycle 3|Consent withdrawn|0|||
27913958|NCT02106351|81525670|FG001|Treatment Cycle 3|Consent withdrawn|0|||
27913959|NCT02106351|81525671|FG002|Treatment Cycle 3|Consent withdrawn|2|||
27913960|NCT02106351|81525669|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
27913961|NCT02106351|81525670|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
27913962|NCT02106351|81525671|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
27913963|NCT02106351|81525669|FG000|Treatment Cycle 3|Other|0|||
27913964|NCT02106351|81525670|FG001|Treatment Cycle 3|Other|2|||
27913965|NCT02106351|81525671|FG002|Treatment Cycle 3|Other|3|||
27913966|NCT02106351|81525669|FG000|Treatment Cycle 4|Consent withdrawn|0|||
27913967|NCT02106351|81525670|FG001|Treatment Cycle 4|Consent withdrawn|0|||
27913968|NCT02106351|81525671|FG002|Treatment Cycle 4|Consent withdrawn|2|||
27913969|NCT02106351|81525669|FG000|Treatment Cycle 4|Other|0|||
27913970|NCT02106351|81525670|FG001|Treatment Cycle 4|Other|1|||
27913971|NCT02106351|81525671|FG002|Treatment Cycle 4|Other|0|||
27913972|NCT01405898|81525672|FG000|Overall Study|Withdrawal by Subject|2|||
27913973|NCT01405898|81525673|FG001|Overall Study|Withdrawal by Subject|2|||
27913974|NCT00458003|81525674|FG000|Overall Study|Non protocol spinal anesthesia|1|||
27913975|NCT00458003|81525675|FG001|Overall Study|Non protocol spinal anesthesia|1|||
27913976|NCT03786380|81525685|FG000|Overall Study|Adverse Event|1|||
27913977|NCT03786380|81525686|FG001|Overall Study|Adverse Event|0|||
27913978|NCT03786380|81525687|FG002|Overall Study|Adverse Event|0|||
27913979|NCT03786380|81525688|FG003|Overall Study|Adverse Event|3|||
27913980|NCT03786380|81525689|FG004|Overall Study|Adverse Event|1|||
27913981|NCT03786380|81525685|FG000|Overall Study|Lack of Efficacy|0|||
27630231|NCT04072822|80486647|FG001|Treatment|Other|9|||
27630232|NCT04072822|80486646|FG000|Follow-up|Withdrawal by Subject|1|||
27630233|NCT04072822|80486647|FG001|Follow-up|Withdrawal by Subject|0|||
27630234|NCT04072822|80486646|FG000|Follow-up|Lost to Follow-up|5|||
27630235|NCT04072822|80486647|FG001|Follow-up|Lost to Follow-up|4|||
27630236|NCT01460342|80486654|FG000|Overall Study|Adverse Event|5|||
27630237|NCT01460342|80486655|FG001|Overall Study|Adverse Event|4|||
27630238|NCT01460342|80486654|FG000|Overall Study|Lost to Follow-up|1|||
27630239|NCT01460342|80486655|FG001|Overall Study|Lost to Follow-up|2|||
27913982|NCT03786380|81525686|FG001|Overall Study|Lack of Efficacy|0|||
27913983|NCT03786380|81525687|FG002|Overall Study|Lack of Efficacy|0|||
27630240|NCT01460342|80486654|FG000|Overall Study|Protocol Violation|0|||
27630241|NCT01460342|80486655|FG001|Overall Study|Protocol Violation|1|||
27630242|NCT01460342|80486654|FG000|Overall Study|Withdrawal by Subject|3|||
27630243|NCT01460342|80486655|FG001|Overall Study|Withdrawal by Subject|4|||
27630244|NCT01460342|80486654|FG000|Overall Study|Physician Decision|1|||
27630245|NCT01460342|80486655|FG001|Overall Study|Physician Decision|3|||
27630246|NCT01460342|80486654|FG000|Overall Study|Lack of Efficacy|1|||
27630247|NCT01460342|80486655|FG001|Overall Study|Lack of Efficacy|0|||
27630248|NCT03255018|80486656|FG000|Overall Study|Death on study|0|||
27630249|NCT03255018|80486657|FG001|Overall Study|Death on study|5|||
27630250|NCT03255018|80486656|FG000|Overall Study|Withdrawal by Subject|0|||
27630251|NCT03255018|80486657|FG001|Overall Study|Withdrawal by Subject|2|||
27630252|NCT03987451|80486658|FG000|Overall Study|Lost to Follow-up|1|||
27630253|NCT03987451|80486659|FG001|Overall Study|Lost to Follow-up|0|||
27630254|NCT03987451|80486658|FG000|Overall Study|Withdrawal by Subject|1|||
27630255|NCT03987451|80486659|FG001|Overall Study|Withdrawal by Subject|1|||
27630256|NCT00837616|80486660|FG000|Overall Study|Withdrawal by Subject|0|||
27630257|NCT00837616|80486661|FG001|Overall Study|Withdrawal by Subject|1|||
27630258|NCT04889664|80486662|FG000|Screen|Lost to Follow-up|1|||
27630259|NCT04889664|80486662|FG000|Screen|Failed to meet screening criteria|1|||
27630260|NCT04889664|80486662|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
27630261|NCT03140176|80486667|FG000|Overall Study|Reason missing|23|||
27630262|NCT03140176|80486667|FG000|Overall Study|Death|33|||
27630263|NCT03140176|80486667|FG000|Overall Study|Disease progression|1|||
27630264|NCT03140176|80486667|FG000|Overall Study|Physician Decision|1|||
27630265|NCT03140176|80486667|FG000|Overall Study|Withdrawal by Subject|1|||
27630266|NCT03140176|80486667|FG000|Overall Study|Lost to Follow-up|15|||
27630267|NCT00586339|80486670|FG000|Overall Study|Withdrawal by Subject|1|||
27630268|NCT00586339|80486671|FG001|Overall Study|Withdrawal by Subject|3|||
27630269|NCT00586339|80486672|FG002|Overall Study|Withdrawal by Subject|1|||
27630270|NCT00586339|80486670|FG000|Overall Study|Migrated/moved from study area|3|||
27630271|NCT00586339|80486671|FG001|Overall Study|Migrated/moved from study area|2|||
27630272|NCT00586339|80486672|FG002|Overall Study|Migrated/moved from study area|4|||
27630273|NCT00586339|80486670|FG000|Overall Study|Lost to Follow-up|3|||
27630274|NCT00586339|80486671|FG001|Overall Study|Lost to Follow-up|2|||
27630275|NCT00586339|80486672|FG002|Overall Study|Lost to Follow-up|1|||
27630276|NCT01833832|80486673|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
27630277|NCT00371566|80486677|FG000|Treatment Phase|Withdrawal by Subject|0|||
27630278|NCT00371566|80486678|FG001|Treatment Phase|Withdrawal by Subject|1|||
27630279|NCT00371566|80486677|FG000|Treatment Phase|Adverse Event|0|||
27630280|NCT00371566|80486678|FG001|Treatment Phase|Adverse Event|1|||
27630281|NCT00371566|80486677|FG000|Treatment Phase|Protocol Violation|0|||
27913984|NCT03786380|81525688|FG003|Overall Study|Lack of Efficacy|0|||
27913985|NCT03786380|81525689|FG004|Overall Study|Lack of Efficacy|1|||
27913986|NCT03786380|81525685|FG000|Overall Study|Withdrawal by Subject|1|||
27913987|NCT03786380|81525686|FG001|Overall Study|Withdrawal by Subject|2|||
27913988|NCT03786380|81525687|FG002|Overall Study|Withdrawal by Subject|2|||
27913989|NCT03786380|81525688|FG003|Overall Study|Withdrawal by Subject|1|||
27913990|NCT03786380|81525689|FG004|Overall Study|Withdrawal by Subject|2|||
27913991|NCT03786380|81525685|FG000|Overall Study|Lost to Follow-up|3|||
27913992|NCT03786380|81525686|FG001|Overall Study|Lost to Follow-up|0|||
27913993|NCT03786380|81525687|FG002|Overall Study|Lost to Follow-up|1|||
27913994|NCT03786380|81525688|FG003|Overall Study|Lost to Follow-up|2|||
27913995|NCT03786380|81525689|FG004|Overall Study|Lost to Follow-up|0|||
27913996|NCT03786380|81525685|FG000|Overall Study|Physician Decision|0|||
27913997|NCT03786380|81525686|FG001|Overall Study|Physician Decision|0|||
27913998|NCT03786380|81525687|FG002|Overall Study|Physician Decision|1|||
27913999|NCT03786380|81525688|FG003|Overall Study|Physician Decision|0|||
27914000|NCT03786380|81525689|FG004|Overall Study|Physician Decision|0|||
27914001|NCT03786380|81525685|FG000|Overall Study|Study Terminated by the Sponsor|30|||
27914002|NCT03786380|81525686|FG001|Overall Study|Study Terminated by the Sponsor|20|||
27914003|NCT03786380|81525687|FG002|Overall Study|Study Terminated by the Sponsor|50|||
27630282|NCT00371566|80486678|FG001|Treatment Phase|Protocol Violation|1|||
27914004|NCT03786380|81525688|FG003|Overall Study|Study Terminated by the Sponsor|57|||
27914005|NCT03786380|81525689|FG004|Overall Study|Study Terminated by the Sponsor|23|||
27914006|NCT03786380|81525685|FG000|Overall Study|Reason Not Specified|0|||
27914007|NCT03786380|81525686|FG001|Overall Study|Reason Not Specified|0|||
27914008|NCT03786380|81525687|FG002|Overall Study|Reason Not Specified|0|||
27630283|NCT00371566|80486677|FG000|Chemoradiation Phase|Physician Decision|2|||
27630284|NCT00371566|80486678|FG001|Chemoradiation Phase|Physician Decision|0|||
27630285|NCT00371566|80486677|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
27630286|NCT00371566|80486678|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
27630287|NCT00371566|80486677|FG000|Chemoradiation Phase|Non compliant|0|||
27630288|NCT00371566|80486678|FG001|Chemoradiation Phase|Non compliant|1|||
27630289|NCT00371566|80486677|FG000|Chemoradiation Phase|Progressive Disease|1|||
27630290|NCT00371566|80486678|FG001|Chemoradiation Phase|Progressive Disease|1|||
27630291|NCT00371566|80486677|FG000|Chemoradiation Phase|Death|2|||
27914009|NCT03786380|81525688|FG003|Overall Study|Reason Not Specified|0|||
27914010|NCT03786380|81525689|FG004|Overall Study|Reason Not Specified|1|||
27914011|NCT00902577|81525690|FG000|Overall Study|Withdrawal by Subject|6|||
27914012|NCT00902577|81525690|FG000|Overall Study|FMISO production failure|2|||
27914013|NCT00249873|81525695|FG000|Overall Study|Not treated|7|||
27914014|NCT00249873|81525696|FG001|Overall Study|Not treated|8|||
27914015|NCT00249873|81525695|FG000|Overall Study|Significant thrombocytopenia|9|||
27914016|NCT00249873|81525696|FG001|Overall Study|Significant thrombocytopenia|8|||
27914017|NCT00249873|81525695|FG000|Overall Study|Severe allergic reaction|8|||
27914018|NCT00249873|81525696|FG001|Overall Study|Severe allergic reaction|1|||
27914019|NCT00249873|81525695|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
27914020|NCT00249873|81525696|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
27914021|NCT00249873|81525695|FG000|Overall Study|Other Serious Adverse Event|86|||
27914022|NCT00249873|81525696|FG001|Overall Study|Other Serious Adverse Event|97|||
27914023|NCT00249873|81525695|FG000|Overall Study|Qualifying condition not present|20|||
27914024|NCT00249873|81525696|FG001|Overall Study|Qualifying condition not present|23|||
27914025|NCT00249873|81525695|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
27534274|NCT04439175|80150613|FG000|Overall Study|Never started treatment|4|||
27534275|NCT04439175|80150613|FG000|Overall Study|Ineligible|5|||
27534276|NCT04439175|80150613|FG000|Overall Study|Adverse Event|6|||
27534277|NCT04439175|80150613|FG000|Overall Study|Death|4|||
27534278|NCT04439175|80150613|FG000|Overall Study|Disease progression|44|||
27534279|NCT04439175|80150613|FG000|Overall Study|Withdrawal by Subject|4|||
27630292|NCT00371566|80486678|FG001|Chemoradiation Phase|Death|0|||
27630293|NCT00371566|80486677|FG000|Follow Up Phase|Death|0|||
27630294|NCT00371566|80486678|FG001|Follow Up Phase|Death|5|||
27630295|NCT00371566|80486677|FG000|Follow Up Phase|Disease progression|1|||
27630296|NCT00371566|80486678|FG001|Follow Up Phase|Disease progression|0|||
27630297|NCT00371566|80486677|FG000|Follow Up Phase|Withdrawal by Subject|0|||
27630298|NCT00371566|80486678|FG001|Follow Up Phase|Withdrawal by Subject|1|||
27630299|NCT00371566|80486677|FG000|Follow Up Phase|Physician Decision|1|||
27630300|NCT00371566|80486678|FG001|Follow Up Phase|Physician Decision|1|||
27630301|NCT00371566|80486677|FG000|Follow Up Phase|Lost to Follow-up|1|||
27630302|NCT00371566|80486678|FG001|Follow Up Phase|Lost to Follow-up|0|||
27630303|NCT00387465|80486679|FG000|Overall Study|Withdrawal by Subject|0|||
27630304|NCT00387465|80486680|FG001|Overall Study|Withdrawal by Subject|1|||
27630305|NCT00387465|80486681|FG002|Overall Study|Withdrawal by Subject|0|||
27630306|NCT03254394|80486709|FG000|Overall Study|Withdrawal by Subject|0|||
27630307|NCT03254394|80486710|FG001|Overall Study|Withdrawal by Subject|2|||
27630308|NCT03184558|80486715|FG000|Overall Study|Withdrawal by Subject|2|||
27737835|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
27737836|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
27737837|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
27737838|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
27534280|NCT04439175|80150613|FG000|Overall Study|Alternative Therapy|1|||
27534281|NCT04439175|80150613|FG000|Overall Study|Other|2|||
27534282|NCT04439344|80150617|FG000|Overall Study|Never started threapy|3|||
27534283|NCT04439344|80150617|FG000|Overall Study|Ineligible|3|||
27534284|NCT04439344|80150617|FG000|Overall Study|Adverse Event|13|||
27534285|NCT04439344|80150617|FG000|Overall Study|Death|2|||
27534286|NCT04439344|80150617|FG000|Overall Study|Disease progression|29|||
27534287|NCT04439344|80150617|FG000|Overall Study|Withdrawal by Subject|2|||
27534288|NCT04439344|80150617|FG000|Overall Study|Alternative therapy|1|||
27534289|NCT05055128|80150618|FG000|Overall Study|Adverse Event|0|||
27534290|NCT05055128|80150619|FG001|Overall Study|Adverse Event|0|||
27534291|NCT05055128|80150620|FG002|Overall Study|Adverse Event|0|||
27534292|NCT05055128|80150621|FG003|Overall Study|Adverse Event|1|||
27534293|NCT05055128|80150622|FG004|Overall Study|Adverse Event|1|||
27534294|NCT05055128|80150618|FG000|Overall Study|Protocol Violation|0|||
27534295|NCT05055128|80150619|FG001|Overall Study|Protocol Violation|0|||
27737839|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
27737840|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
27737841|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
27737842|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
27737843|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
27630309|NCT03184558|80486715|FG000|Overall Study|Death|16|||
27737844|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
27914026|NCT00249873|81525696|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
27914027|NCT00249873|81525695|FG000|Overall Study|Withdrawal by Subject|504|||
27914028|NCT00249873|81525696|FG001|Overall Study|Withdrawal by Subject|466|||
27534296|NCT05055128|80150620|FG002|Overall Study|Protocol Violation|0|||
27534297|NCT05055128|80150621|FG003|Overall Study|Protocol Violation|1|||
27534298|NCT05055128|80150622|FG004|Overall Study|Protocol Violation|0|||
27630310|NCT03184558|80486715|FG000|Overall Study|Lost to Follow-up|2|||
27630311|NCT03184558|80486715|FG000|Overall Study|Other|9|||
27630312|NCT00094809|80486716|FG000|Overall Study|Protocol deviation|2|||
27630313|NCT00094809|80486717|FG001|Overall Study|Protocol deviation|2|||
27630314|NCT00094809|80486716|FG000|Overall Study|Noncompliance|1|||
27630315|NCT00094809|80486717|FG001|Overall Study|Noncompliance|0|||
27630316|NCT00094809|80486716|FG000|Overall Study|Adverse Event|3|||
27630317|NCT00094809|80486717|FG001|Overall Study|Adverse Event|1|||
27630318|NCT00094809|80486716|FG000|Overall Study|Withdrawal by Subject|8|||
27630319|NCT00094809|80486717|FG001|Overall Study|Withdrawal by Subject|9|||
27630320|NCT00094809|80486716|FG000|Overall Study|Disease progression|3|||
27630321|NCT00094809|80486717|FG001|Overall Study|Disease progression|3|||
27737845|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
27737846|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
27737847|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
27737848|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
27737849|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
27737850|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
27737851|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
27737852|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
27737853|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
27737854|NCT02591615|80868496|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
27737855|NCT02591615|80868497|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
27737856|NCT02591615|80868498|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
27737857|NCT02591615|80868499|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
27737858|NCT02591615|80868496|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
27737859|NCT02591615|80868497|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
27737860|NCT02591615|80868498|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
27737861|NCT02591615|80868499|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
27737862|NCT02591615|80868496|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
27737863|NCT02591615|80868497|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
27737864|NCT02591615|80868498|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
27737865|NCT02591615|80868499|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
27737866|NCT02591615|80868496|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
27737867|NCT02591615|80868497|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
27737868|NCT02591615|80868498|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
27737869|NCT02591615|80868499|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
27737870|NCT02591615|80868496|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
27737871|NCT02591615|80868497|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
27737872|NCT02591615|80868498|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
27737873|NCT02591615|80868499|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
27737874|NCT02591615|80868496|FG000|Maintenance MK-3475|Adverse Event|0|||
27737875|NCT02591615|80868497|FG001|Maintenance MK-3475|Adverse Event|3|||
27737876|NCT02591615|80868498|FG002|Maintenance MK-3475|Adverse Event|1|||
27737877|NCT02591615|80868499|FG003|Maintenance MK-3475|Adverse Event|2|||
27737878|NCT02591615|80868496|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
27737879|NCT02591615|80868497|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
27737880|NCT02591615|80868498|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
27737881|NCT02591615|80868499|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
27737882|NCT02591615|80868496|FG000|Maintenance MK-3475|Death|0|||
27737883|NCT02591615|80868497|FG001|Maintenance MK-3475|Death|1|||
27737884|NCT02591615|80868498|FG002|Maintenance MK-3475|Death|1|||
27737885|NCT02591615|80868499|FG003|Maintenance MK-3475|Death|0|||
27737886|NCT02591615|80868496|FG000|Maintenance MK-3475|Physician discretion|0|||
27737887|NCT02591615|80868497|FG001|Maintenance MK-3475|Physician discretion|0|||
27737888|NCT02591615|80868498|FG002|Maintenance MK-3475|Physician discretion|1|||
27737889|NCT02591615|80868499|FG003|Maintenance MK-3475|Physician discretion|0|||
27737890|NCT02591615|80868496|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
27737891|NCT02591615|80868497|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
27737892|NCT02591615|80868498|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
27737893|NCT02591615|80868499|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
27737894|NCT02591615|80868496|FG000|Maintenance MK-3475|In active treatment|2|||
27737895|NCT02591615|80868497|FG001|Maintenance MK-3475|In active treatment|0|||
27737896|NCT02591615|80868498|FG002|Maintenance MK-3475|In active treatment|0|||
27737897|NCT02591615|80868499|FG003|Maintenance MK-3475|In active treatment|1|||
27737898|NCT01096667|80868503|FG000|Overall Study|Lost to Follow-up|1|||
27737899|NCT01096667|80868504|FG001|Overall Study|Lost to Follow-up|1|||
27737900|NCT01096667|80868505|FG002|Overall Study|Lost to Follow-up|1|||
27737901|NCT01096667|80868506|FG003|Overall Study|Lost to Follow-up|0|||
27737902|NCT01096667|80868507|FG004|Overall Study|Lost to Follow-up|0|||
27737903|NCT01096667|80868503|FG000|Overall Study|Withdrawal by Subject|1|||
27737904|NCT01096667|80868504|FG001|Overall Study|Withdrawal by Subject|0|||
27737905|NCT01096667|80868505|FG002|Overall Study|Withdrawal by Subject|0|||
27737906|NCT01096667|80868506|FG003|Overall Study|Withdrawal by Subject|1|||
27630322|NCT00094809|80486716|FG000|Overall Study|Physician Decision|3|||
27630323|NCT00094809|80486717|FG001|Overall Study|Physician Decision|5|||
27630324|NCT00094809|80486716|FG000|Overall Study|Lost to Follow-up|6|||
27630325|NCT00094809|80486717|FG001|Overall Study|Lost to Follow-up|6|||
27630326|NCT00094809|80486716|FG000|Overall Study|Death|19|||
27630327|NCT00094809|80486717|FG001|Overall Study|Death|25|||
27630328|NCT00094809|80486716|FG000|Overall Study|Protocol-specified criteria|1|||
27630329|NCT00094809|80486717|FG001|Overall Study|Protocol-specified criteria|1|||
27630330|NCT00094809|80486716|FG000|Overall Study|Other|2|||
27630331|NCT00094809|80486717|FG001|Overall Study|Other|4|||
27630332|NCT00094809|80486716|FG000|Overall Study|Informed consent signed after treatment|1|||
27630333|NCT00094809|80486717|FG001|Overall Study|Informed consent signed after treatment|0|||
27630334|NCT00094809|80486716|FG000|Overall Study|Study drug not received|2|||
27630335|NCT00094809|80486717|FG001|Overall Study|Study drug not received|8|||
27630336|NCT00094809|80486716|FG000|Overall Study|Other|1|||
27630337|NCT00094809|80486717|FG001|Overall Study|Other|1|||
27630338|NCT01360840|80486720|FG000|Overall Study|Ongoing at data cut-off|10|||
27914029|NCT00249873|81525695|FG000|Overall Study|Lost to Follow-up|4|||
27914030|NCT00249873|81525696|FG001|Overall Study|Lost to Follow-up|7|||
27914031|NCT00249873|81525695|FG000|Overall Study|Minor bleeding|99|||
27914032|NCT00249873|81525696|FG001|Overall Study|Minor bleeding|37|||
27914033|NCT00249873|81525695|FG000|Overall Study|Non-compliance|41|||
27914034|NCT00249873|81525696|FG001|Overall Study|Non-compliance|46|||
27914035|NCT00249873|81525695|FG000|Overall Study|Other non serious Adverse Event|112|||
27914036|NCT00249873|81525696|FG001|Overall Study|Other non serious Adverse Event|108|||
27914037|NCT00249873|81525695|FG000|Overall Study|Other contraindicated medication|1|||
27534299|NCT05055128|80150618|FG000|Overall Study|Withdrawal by Subject|5|||
27534300|NCT05055128|80150619|FG001|Overall Study|Withdrawal by Subject|2|||
27534301|NCT05055128|80150620|FG002|Overall Study|Withdrawal by Subject|2|||
27534302|NCT05055128|80150621|FG003|Overall Study|Withdrawal by Subject|4|||
27534303|NCT05055128|80150622|FG004|Overall Study|Withdrawal by Subject|2|||
27630339|NCT01360840|80486721|FG001|Overall Study|Ongoing at data cut-off|10|||
27630340|NCT01360840|80486722|FG002|Overall Study|Ongoing at data cut-off|9|||
27630341|NCT02236559|80486731|FG000|Overall Study|Met Exclusion|3|||
27534304|NCT05055128|80150618|FG000|Overall Study|Randomized By Mistake|0|||
27534305|NCT05055128|80150619|FG001|Overall Study|Randomized By Mistake|1|||
27534306|NCT05055128|80150620|FG002|Overall Study|Randomized By Mistake|0|||
27534307|NCT05055128|80150621|FG003|Overall Study|Randomized By Mistake|0|||
27534308|NCT05055128|80150622|FG004|Overall Study|Randomized By Mistake|0|||
27534309|NCT05055128|80150618|FG000|Overall Study|Other|1|||
27534310|NCT05055128|80150619|FG001|Overall Study|Other|0|||
27534311|NCT05055128|80150620|FG002|Overall Study|Other|0|||
27534312|NCT05055128|80150621|FG003|Overall Study|Other|0|||
27534313|NCT05055128|80150622|FG004|Overall Study|Other|0|||
27534314|NCT02476422|80150623|FG000|Overall Study|Subject/guardian decision|0|||
27534315|NCT02476422|80150624|FG001|Overall Study|Subject/guardian decision|1|||
27534316|NCT00694707|80150640|FG000|Overall Study|Did Not Receive Treatment|0|||
27534317|NCT00694707|80150641|FG001|Overall Study|Did Not Receive Treatment|0|||
27630342|NCT02236559|80486732|FG001|Overall Study|Met Exclusion|6|||
27630343|NCT02236559|80486731|FG000|Overall Study|Did not Meet Inclusion|3|||
27630344|NCT02236559|80486732|FG001|Overall Study|Did not Meet Inclusion|3|||
27534318|NCT00694707|80150642|FG002|Overall Study|Did Not Receive Treatment|1|||
27534319|NCT00694707|80150643|FG003|Overall Study|Did Not Receive Treatment|1|||
27534320|NCT00694707|80150644|FG004|Overall Study|Did Not Receive Treatment|1|||
27534321|NCT00694707|80150640|FG000|Overall Study|Adverse Event|22|||
27534322|NCT00694707|80150641|FG001|Overall Study|Adverse Event|14|||
27534323|NCT00694707|80150642|FG002|Overall Study|Adverse Event|8|||
27534324|NCT00694707|80150643|FG003|Overall Study|Adverse Event|12|||
27534325|NCT00694707|80150644|FG004|Overall Study|Adverse Event|13|||
27534326|NCT00694707|80150640|FG000|Overall Study|Insufficient Therapeutic Response|33|||
27534327|NCT00694707|80150641|FG001|Overall Study|Insufficient Therapeutic Response|18|||
27534328|NCT00694707|80150642|FG002|Overall Study|Insufficient Therapeutic Response|17|||
27534329|NCT00694707|80150643|FG003|Overall Study|Insufficient Therapeutic Response|15|||
27630345|NCT02236559|80486731|FG000|Overall Study|Subject Did Not Consent|4|||
27914038|NCT00249873|81525696|FG001|Overall Study|Other contraindicated medication|0|||
27914039|NCT00249873|81525695|FG000|Overall Study|Patient not wish to continue after May08|3|||
27914040|NCT00249873|81525696|FG001|Overall Study|Patient not wish to continue after May08|4|||
27914041|NCT00249873|81525695|FG000|Overall Study|Physician withdrew consent|59|||
27914042|NCT00249873|81525696|FG001|Overall Study|Physician withdrew consent|60|||
27914043|NCT00249873|81525695|FG000|Overall Study|Open label clopidogrel required|31|||
27914044|NCT00249873|81525696|FG001|Overall Study|Open label clopidogrel required|42|||
27914045|NCT00249873|81525695|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
27914046|NCT00249873|81525696|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
27534330|NCT00694707|80150644|FG004|Overall Study|Insufficient Therapeutic Response|10|||
27630346|NCT02236559|80486732|FG001|Overall Study|Subject Did Not Consent|2|||
27630347|NCT02236559|80486731|FG000|Overall Study|Physician Decision|1|||
27630348|NCT02236559|80486732|FG001|Overall Study|Physician Decision|1|||
27914047|NCT00249873|81525695|FG000|Overall Study|Oral anticoagulant required|159|||
27914048|NCT00249873|81525696|FG001|Overall Study|Oral anticoagulant required|157|||
27914049|NCT00249873|81525695|FG000|Overall Study|Study drug intolerance|5|||
27914050|NCT00249873|81525696|FG001|Overall Study|Study drug intolerance|0|||
27914051|NCT00249873|81525695|FG000|Overall Study|Surgery/ procedure|9|||
27914052|NCT00249873|81525696|FG001|Overall Study|Surgery/ procedure|9|||
27914053|NCT00249873|81525695|FG000|Overall Study|Event related to cardiac condition|12|||
27914054|NCT00249873|81525696|FG001|Overall Study|Event related to cardiac condition|21|||
27914055|NCT00249873|81525695|FG000|Overall Study|Thromboembolic/outcome event|82|||
27914056|NCT00249873|81525696|FG001|Overall Study|Thromboembolic/outcome event|122|||
27914057|NCT03177148|81525697|FG000|Overall Study|Lost to Follow-up|50|||
27914058|NCT03177148|81525698|FG001|Overall Study|Lost to Follow-up|1|||
27914059|NCT03177148|81525697|FG000|Overall Study|Death|1|||
27914060|NCT03177148|81525698|FG001|Overall Study|Death|0|||
27914061|NCT04346199|81525699|FG000|Overall Study|Death|8|||
27914062|NCT04346199|81525700|FG001|Overall Study|Death|9|||
27914063|NCT04346199|81525699|FG000|Overall Study|Lost to Follow-up|0|||
27914064|NCT04346199|81525700|FG001|Overall Study|Lost to Follow-up|1|||
27914065|NCT04346199|81525699|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
27914066|NCT04346199|81525700|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
27914067|NCT04346199|81525699|FG000|Overall Study|Withdrawal by Subject|5|||
27914068|NCT04346199|81525700|FG001|Overall Study|Withdrawal by Subject|1|||
27534331|NCT00694707|80150640|FG000|Overall Study|Protocol Violation|1|||
27534332|NCT00694707|80150641|FG001|Overall Study|Protocol Violation|2|||
27534333|NCT00694707|80150642|FG002|Overall Study|Protocol Violation|1|||
27534334|NCT00694707|80150643|FG003|Overall Study|Protocol Violation|3|||
27534335|NCT00694707|80150644|FG004|Overall Study|Protocol Violation|1|||
27534336|NCT00694707|80150640|FG000|Overall Study|Withdrawal of Consent|14|||
27534337|NCT00694707|80150641|FG001|Overall Study|Withdrawal of Consent|18|||
27534338|NCT00694707|80150642|FG002|Overall Study|Withdrawal of Consent|22|||
27534339|NCT00694707|80150643|FG003|Overall Study|Withdrawal of Consent|16|||
27534340|NCT00694707|80150644|FG004|Overall Study|Withdrawal of Consent|15|||
27534341|NCT00694707|80150640|FG000|Overall Study|Lost to Follow-up|0|||
27534342|NCT00694707|80150641|FG001|Overall Study|Lost to Follow-up|1|||
27534343|NCT00694707|80150642|FG002|Overall Study|Lost to Follow-up|2|||
27534344|NCT00694707|80150643|FG003|Overall Study|Lost to Follow-up|0|||
27534345|NCT00694707|80150644|FG004|Overall Study|Lost to Follow-up|0|||
27534346|NCT00694707|80150640|FG000|Overall Study|Jeopardizing Parole Status|1|||
27534347|NCT00694707|80150641|FG001|Overall Study|Jeopardizing Parole Status|0|||
27534348|NCT00694707|80150642|FG002|Overall Study|Jeopardizing Parole Status|0|||
27534349|NCT00694707|80150643|FG003|Overall Study|Jeopardizing Parole Status|0|||
27534350|NCT00694707|80150644|FG004|Overall Study|Jeopardizing Parole Status|0|||
27630349|NCT02236559|80486731|FG000|Overall Study|Withdrawal by Subject|1|||
27630350|NCT02236559|80486732|FG001|Overall Study|Withdrawal by Subject|0|||
27630351|NCT01020838|80486733|FG000|Overall Study|Death|90|||
27630352|NCT01020838|80486733|FG000|Overall Study|Adverse Event|1|||
27630353|NCT01020838|80486733|FG000|Overall Study|Withdrawal by Subject|9|||
27630354|NCT01020838|80486733|FG000|Overall Study|Lost to Follow-up|6|||
27630355|NCT01020838|80486733|FG000|Overall Study|Most common: Study ended by sponsor|77|||
27630356|NCT00208767|80486734|FG000|Overall Study|Adverse Event|9|||
27630357|NCT00208767|80486735|FG001|Overall Study|Adverse Event|1|||
27630358|NCT00208767|80486734|FG000|Overall Study|Withdrawal by Subject|14|||
27914069|NCT00823264|81525701|FG000|Overall Study|Protocol Violation|2|||
27914070|NCT00823264|81525702|FG001|Overall Study|Protocol Violation|0|||
27914071|NCT00465517|81525703|FG000|Overall Study|Adverse Event|7|||
27914072|NCT00465517|81525704|FG001|Overall Study|Adverse Event|3|||
27914073|NCT00465517|81525703|FG000|Overall Study|Lost to Follow-up|1|||
27630359|NCT00208767|80486735|FG001|Overall Study|Withdrawal by Subject|3|||
27630360|NCT00208767|80486734|FG000|Overall Study|Death|1|||
27630361|NCT00208767|80486735|FG001|Overall Study|Death|0|||
27630362|NCT00208767|80486734|FG000|Overall Study|Lost to Follow-up|3|||
27914074|NCT00465517|81525704|FG001|Overall Study|Lost to Follow-up|0|||
27914075|NCT00465517|81525703|FG000|Overall Study|Withdrawal by Subject|4|||
27534351|NCT00694707|80150640|FG000|Overall Study|Death in the Family|1|||
27534352|NCT00694707|80150641|FG001|Overall Study|Death in the Family|0|||
27534353|NCT00694707|80150642|FG002|Overall Study|Death in the Family|0|||
27534354|NCT00694707|80150643|FG003|Overall Study|Death in the Family|0|||
27534355|NCT00694707|80150644|FG004|Overall Study|Death in the Family|0|||
27630363|NCT00208767|80486735|FG001|Overall Study|Lost to Follow-up|3|||
27630364|NCT01466881|80486736|FG000|Overall Study|Ineligible|5|||
27914076|NCT00465517|81525704|FG001|Overall Study|Withdrawal by Subject|1|||
27914077|NCT02949947|81525708|FG000|Overall Study|Non Compliance|0|||
27914078|NCT02949947|81525709|FG001|Overall Study|Non Compliance|1|||
27914079|NCT02949947|81525708|FG000|Overall Study|Insurance change|1|||
27914080|NCT02949947|81525709|FG001|Overall Study|Insurance change|0|||
27914081|NCT00669318|81525710|FG000|Overall Study|Withdrawal by Subject|2|||
27534356|NCT00694707|80150640|FG000|Overall Study|Arrest by Police|0|||
27630365|NCT01466881|80486736|FG000|Overall Study|Adverse Event|6|||
27534357|NCT00694707|80150641|FG001|Overall Study|Arrest by Police|1|||
27534358|NCT00694707|80150642|FG002|Overall Study|Arrest by Police|0|||
27534359|NCT00694707|80150643|FG003|Overall Study|Arrest by Police|0|||
27534360|NCT00694707|80150644|FG004|Overall Study|Arrest by Police|0|||
27534361|NCT00694707|80150640|FG000|Overall Study|Administrative Reasons|0|||
27534362|NCT00694707|80150641|FG001|Overall Study|Administrative Reasons|1|||
27737907|NCT01096667|80868507|FG004|Overall Study|Withdrawal by Subject|0|||
27737908|NCT01096667|80868503|FG000|Overall Study|Reason not available|0|||
27737909|NCT01096667|80868504|FG001|Overall Study|Reason not available|1|||
27737910|NCT01096667|80868505|FG002|Overall Study|Reason not available|1|||
27737911|NCT01096667|80868506|FG003|Overall Study|Reason not available|1|||
27737912|NCT01096667|80868507|FG004|Overall Study|Reason not available|0|||
27737913|NCT01096667|80868503|FG000|Overall Study|Protocol Violation|0|||
27737914|NCT01096667|80868504|FG001|Overall Study|Protocol Violation|0|||
27737915|NCT01096667|80868505|FG002|Overall Study|Protocol Violation|0|||
27737916|NCT01096667|80868506|FG003|Overall Study|Protocol Violation|1|||
27737917|NCT01096667|80868507|FG004|Overall Study|Protocol Violation|0|||
27737918|NCT01096667|80868503|FG000|Overall Study|Not treated|1|||
27737919|NCT01096667|80868504|FG001|Overall Study|Not treated|0|||
27737920|NCT01096667|80868505|FG002|Overall Study|Not treated|0|||
27737921|NCT01096667|80868506|FG003|Overall Study|Not treated|0|||
27737922|NCT01096667|80868507|FG004|Overall Study|Not treated|0|||
27737923|NCT00826514|80868510|FG000|Overall Study|Adverse Event|1|||
27737924|NCT00826514|80868511|FG001|Overall Study|Adverse Event|1|||
27737925|NCT00826514|80868510|FG000|Overall Study|Lack of Efficacy|0|||
27737926|NCT00826514|80868511|FG001|Overall Study|Lack of Efficacy|1|||
27737927|NCT00826514|80868510|FG000|Overall Study|Withdrawal by Subject|2|||
27737928|NCT00826514|80868511|FG001|Overall Study|Withdrawal by Subject|3|||
27737929|NCT02750410|80868512|FG000|Double-Blind Treatment Period|Adverse Event|2|||
27737930|NCT02750410|80868513|FG001|Double-Blind Treatment Period|Adverse Event|2|||
27737931|NCT02750410|80868512|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27737932|NCT02750410|80868513|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
27737933|NCT02750410|80868512|FG000|Open-Label Extension Period|Adverse Event|5|||
27737934|NCT02750410|80868513|FG001|Open-Label Extension Period|Adverse Event|3|||
27737935|NCT02750410|80868512|FG000|Open-Label Extension Period|Protocol Violation|0|||
27737936|NCT02750410|80868513|FG001|Open-Label Extension Period|Protocol Violation|1|||
27737937|NCT02750410|80868512|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
27737938|NCT02750410|80868513|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
27737939|NCT00613314|80868514|FG000|Overall Study|Adverse Event|5|||
27737940|NCT00613314|80868514|FG000|Overall Study|Protocol Violation|14|||
27737941|NCT00613314|80868514|FG000|Overall Study|Lost to Follow-up|46|||
27737942|NCT00613314|80868514|FG000|Overall Study|Other reason not defined above|90|||
27737943|NCT00408681|80868515|FG000|Overall Study|Lack of Efficacy|2|||
27737944|NCT00408681|80868515|FG000|Overall Study|Adverse Event|7|||
27737945|NCT01137435|80868516|FG000|Overall Study|Lost to Follow-up|24|||
27737946|NCT01137435|80868516|FG000|Overall Study|Off label usage|4|||
27737947|NCT01985321|80868528|FG000|Overall Study|Protocol Violation|4|||
27737948|NCT01985321|80868529|FG001|Overall Study|Protocol Violation|3|||
27737949|NCT01985321|80868528|FG000|Overall Study|Withdrawal by Subject|1|||
27737950|NCT01985321|80868529|FG001|Overall Study|Withdrawal by Subject|0|||
27737951|NCT01985321|80868528|FG000|Overall Study|Lost to Follow-up|5|||
27737952|NCT01985321|80868529|FG001|Overall Study|Lost to Follow-up|2|||
27737953|NCT01985321|80868528|FG000|Overall Study|Subject treated wrong type of sore|1|||
27534363|NCT00694707|80150642|FG002|Overall Study|Administrative Reasons|0|||
27737954|NCT01985321|80868529|FG001|Overall Study|Subject treated wrong type of sore|0|||
27737955|NCT01548638|80868530|FG000|Overall Study|Protocol Violation|3|||
27737956|NCT01548638|80868530|FG000|Overall Study|Withdrawal by Subject|1|||
27737957|NCT00849212|80868531|FG000|Overall Study|Lack of Efficacy|1|||
27737958|NCT00849212|80868531|FG000|Overall Study|Withdrawal by Subject|3|||
27737959|NCT00849212|80868531|FG000|Overall Study|Adverse Event|2|||
27737960|NCT00849212|80868531|FG000|Overall Study|Miscellaneous|1|||
27737961|NCT03215277|80868532|FG000|Overall Study|Adverse Event|2|||
27737962|NCT03215277|80868533|FG001|Overall Study|Adverse Event|3|||
27737963|NCT03215277|80868532|FG000|Overall Study|Death|1|||
27737964|NCT03215277|80868533|FG001|Overall Study|Death|0|||
27737965|NCT03215277|80868532|FG000|Overall Study|Lost to Follow-up|0|||
27737966|NCT03215277|80868533|FG001|Overall Study|Lost to Follow-up|1|||
27737967|NCT03215277|80868532|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
27737968|NCT03215277|80868533|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
27737969|NCT04375878|80868534|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
27914082|NCT01061606|81525711|FG000|Overall Study|Adverse Event|1|||
27534364|NCT00694707|80150643|FG003|Overall Study|Administrative Reasons|2|||
27737970|NCT04375878|80868535|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
27737971|NCT04375878|80868536|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
27737972|NCT04375878|80868537|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
27737973|NCT04375878|80868538|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
27737974|NCT04375878|80868539|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
27737975|NCT04375878|80868534|FG000|Crossover First and Second Interventions|Adverse Event|0|||
27737976|NCT04375878|80868535|FG001|Crossover First and Second Interventions|Adverse Event|0|||
27737977|NCT04375878|80868536|FG002|Crossover First and Second Interventions|Adverse Event|1|||
27737978|NCT04375878|80868537|FG003|Crossover First and Second Interventions|Adverse Event|0|||
27737979|NCT04375878|80868538|FG004|Crossover First and Second Interventions|Adverse Event|0|||
27737980|NCT04375878|80868539|FG005|Crossover First and Second Interventions|Adverse Event|0|||
27737981|NCT04375878|80868534|FG000|Extension Phase|Withdrawal by Subject|0|||
27914083|NCT01061606|81525711|FG000|Overall Study|Death|1|||
27914084|NCT01061606|81525711|FG000|Overall Study|Disease Progression|4|||
27914085|NCT01061606|81525711|FG000|Overall Study|alternative therapy|2|||
27914086|NCT00970489|81525712|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
27914087|NCT00970489|81525713|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
27914088|NCT00737100|81525714|FG000|Overall Study|Adverse Event|6|||
27914089|NCT00737100|81525715|FG001|Overall Study|Adverse Event|5|||
27914090|NCT00737100|81525716|FG002|Overall Study|Adverse Event|3|||
27914091|NCT00737100|81525714|FG000|Overall Study|Lost to Follow-up|0|||
27914092|NCT00737100|81525715|FG001|Overall Study|Lost to Follow-up|1|||
27914093|NCT00737100|81525716|FG002|Overall Study|Lost to Follow-up|0|||
27914094|NCT00737100|81525714|FG000|Overall Study|Withdrawal by Subject|0|||
27914095|NCT00737100|81525715|FG001|Overall Study|Withdrawal by Subject|0|||
27914096|NCT00737100|81525716|FG002|Overall Study|Withdrawal by Subject|3|||
27914097|NCT00737100|81525714|FG000|Overall Study|Reason discontinued not explained above|1|||
27914098|NCT00737100|81525715|FG001|Overall Study|Reason discontinued not explained above|1|||
27914099|NCT00737100|81525716|FG002|Overall Study|Reason discontinued not explained above|1|||
27914100|NCT00917124|81525730|FG000|Overall Study|Protocol Violation|4|||
27914101|NCT00917124|81525731|FG001|Overall Study|Protocol Violation|6|||
27914102|NCT01687218|81525732|FG000|Overall Study|Withdrawal by Subject|2|||
27914103|NCT01687218|81525733|FG001|Overall Study|Withdrawal by Subject|3|||
27914104|NCT01687218|81525734|FG002|Overall Study|Withdrawal by Subject|0|||
27914105|NCT01687218|81525735|FG003|Overall Study|Withdrawal by Subject|1|||
27534365|NCT00694707|80150644|FG004|Overall Study|Administrative Reasons|0|||
27534366|NCT00694707|80150640|FG000|Overall Study|Notification of Past Head Injury|0|||
27534367|NCT00694707|80150641|FG001|Overall Study|Notification of Past Head Injury|0|||
27534368|NCT00694707|80150642|FG002|Overall Study|Notification of Past Head Injury|0|||
27534369|NCT00694707|80150643|FG003|Overall Study|Notification of Past Head Injury|1|||
27630366|NCT01466881|80486736|FG000|Overall Study|Progression/relapse|20|||
27737982|NCT04375878|80868535|FG001|Extension Phase|Withdrawal by Subject|0|||
27914106|NCT01687218|81525736|FG004|Overall Study|Withdrawal by Subject|1|||
27914107|NCT01687218|81525737|FG005|Overall Study|Withdrawal by Subject|0|||
27914108|NCT01687218|81525732|FG000|Overall Study|Relocated, no follow-up planned|1|||
27914109|NCT01687218|81525733|FG001|Overall Study|Relocated, no follow-up planned|0|||
27914110|NCT01687218|81525734|FG002|Overall Study|Relocated, no follow-up planned|1|||
27914111|NCT01687218|81525735|FG003|Overall Study|Relocated, no follow-up planned|1|||
27914112|NCT01687218|81525736|FG004|Overall Study|Relocated, no follow-up planned|0|||
27914113|NCT01687218|81525737|FG005|Overall Study|Relocated, no follow-up planned|0|||
27914114|NCT02616783|81525738|FG000|Overall Study|Randomized but Not Treated|1|||
27914115|NCT02616783|81525739|FG001|Overall Study|Randomized but Not Treated|0|||
27914116|NCT02616783|81525738|FG000|Overall Study|Adverse Event|1|||
27914117|NCT02616783|81525739|FG001|Overall Study|Adverse Event|0|||
27914118|NCT02616783|81525738|FG000|Overall Study|Death|1|||
27914119|NCT02616783|81525739|FG001|Overall Study|Death|0|||
27914120|NCT02616783|81525738|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27914121|NCT02616783|81525739|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27914122|NCT02616783|81525738|FG000|Overall Study|Protocol Violation|1|||
27914123|NCT02616783|81525739|FG001|Overall Study|Protocol Violation|1|||
27914124|NCT02616783|81525738|FG000|Overall Study|Withdrew Consent|1|||
27914125|NCT02616783|81525739|FG001|Overall Study|Withdrew Consent|1|||
27914126|NCT00723229|81525740|FG000|First Intervention|Lost to Follow-up|7|||
27914127|NCT00723229|81525741|FG001|First Intervention|Lost to Follow-up|3|||
27914128|NCT02810418|81525747|FG000|Arm A Dose Escalation|Adverse Event|2|||
27914129|NCT02810418|81525748|FG001|Arm A Dose Escalation|Adverse Event|1|||
27914130|NCT02810418|81525749|FG002|Arm A Dose Escalation|Adverse Event|0|||
27914131|NCT02810418|81525750|FG003|Arm A Dose Escalation|Adverse Event|0|||
27914132|NCT02810418|81525751|FG004|Arm A Dose Escalation|Adverse Event|0|||
27914133|NCT02810418|81525752|FG005|Arm A Dose Escalation|Adverse Event|0|||
27914134|NCT02810418|81525753|FG006|Arm A Dose Escalation|Adverse Event|0|||
27914135|NCT02810418|81525747|FG000|Dose Expansion|Adverse Event|0|||
27914136|NCT02810418|81525748|FG001|Dose Expansion|Adverse Event|1|||
27914137|NCT02810418|81525749|FG002|Dose Expansion|Adverse Event|1|||
27914138|NCT02810418|81525750|FG003|Dose Expansion|Adverse Event|0|||
27914139|NCT02810418|81525751|FG004|Dose Expansion|Adverse Event|0|||
27914140|NCT02810418|81525752|FG005|Dose Expansion|Adverse Event|0|||
27914141|NCT02810418|81525753|FG006|Dose Expansion|Adverse Event|0|||
27914142|NCT02810418|81525747|FG000|Dose Expansion|Physician Decision|0|||
27534370|NCT00694707|80150644|FG004|Overall Study|Notification of Past Head Injury|0|||
27534371|NCT04996797|80150649|FG000|Overall Study|Adverse Event|0|||
27534372|NCT04996797|80150650|FG001|Overall Study|Adverse Event|2|||
27534373|NCT04996797|80150651|FG002|Overall Study|Adverse Event|0|||
27534374|NCT04996797|80150652|FG003|Overall Study|Adverse Event|1|||
27534375|NCT04996797|80150649|FG000|Overall Study|Lack of Efficacy|0|||
27534376|NCT04996797|80150650|FG001|Overall Study|Lack of Efficacy|2|||
27534377|NCT04996797|80150651|FG002|Overall Study|Lack of Efficacy|0|||
27534378|NCT04996797|80150652|FG003|Overall Study|Lack of Efficacy|0|||
27534379|NCT04996797|80150649|FG000|Overall Study|Prohibited Medication|0|||
27534380|NCT04996797|80150650|FG001|Overall Study|Prohibited Medication|1|||
27534381|NCT04996797|80150651|FG002|Overall Study|Prohibited Medication|0|||
27534382|NCT04996797|80150652|FG003|Overall Study|Prohibited Medication|0|||
27534383|NCT04996797|80150649|FG000|Overall Study|Ongoing|68|||
27534384|NCT04996797|80150650|FG001|Overall Study|Ongoing|60|||
27534385|NCT04996797|80150651|FG002|Overall Study|Ongoing|22|||
27630367|NCT01466881|80486736|FG000|Overall Study|Death|4|||
27630368|NCT01466881|80486736|FG000|Overall Study|Other reason not protocol specified|5|||
27630369|NCT04364269|80486737|FG000|Overall Study|Adverse Event|1|||
27630370|NCT04364269|80486738|FG001|Overall Study|Adverse Event|0|||
27630371|NCT04364269|80486739|FG002|Overall Study|Adverse Event|0|||
27630372|NCT04364269|80486737|FG000|Overall Study|Withdrawal by Subject|0|||
27630373|NCT04364269|80486738|FG001|Overall Study|Withdrawal by Subject|1|||
27630374|NCT04364269|80486739|FG002|Overall Study|Withdrawal by Subject|0|||
27630375|NCT04880733|80486740|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
27630376|NCT04880733|80486741|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
27630377|NCT04880733|80486742|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
27630378|NCT04880733|80486740|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
27630379|NCT04880733|80486741|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
27630380|NCT04880733|80486742|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
27630381|NCT04880733|80486740|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
27630382|NCT04880733|80486741|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
27630383|NCT04880733|80486742|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
27630384|NCT04880733|80486740|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
27630385|NCT04880733|80486741|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
27630386|NCT04880733|80486742|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
27630387|NCT04880733|80486740|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
27630388|NCT04880733|80486741|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
27630389|NCT04880733|80486742|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
27630390|NCT02962674|80486743|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
27630391|NCT02982213|80486746|FG000|Overall Study|Did not complete follow up questionnaire|5|||
27630392|NCT02982213|80486747|FG001|Overall Study|Did not complete follow up questionnaire|1|||
27630393|NCT02390557|80486749|FG000|Wave 2|Survey non-respondent|72|||
27630394|NCT02390557|80486750|FG001|Wave 2|Survey non-respondent|41|||
27630395|NCT02390557|80486751|FG002|Wave 2|Survey non-respondent|23|||
27630396|NCT03601507|80486754|FG000|Overall Study|Adverse Event|1|||
27630397|NCT03537651|80486757|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
27630398|NCT03537651|80486757|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
27630399|NCT03537651|80486757|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
27630400|NCT03537651|80486757|FG000|Part A (Up to 96 Weeks)|Other|1|||
27630401|NCT03537651|80486757|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
27630402|NCT03537651|80486757|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
27630403|NCT03537651|80486757|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
27630404|NCT03537651|80486757|FG000|Part B (Up to 192 Weeks)|Other|1|||
27630405|NCT00880906|80486766|FG000|Overall Study|Lost to Follow-up|0|||
27630406|NCT00880906|80486767|FG001|Overall Study|Lost to Follow-up|1|||
27630407|NCT00880906|80486766|FG000|Overall Study|Did not meet criteria following patholog|12|||
27630408|NCT00880906|80486767|FG001|Overall Study|Did not meet criteria following patholog|6|||
27630409|NCT01076335|80486772|FG000|Overall Study|Withdrawal by Subject|3|||
27630410|NCT01076335|80486772|FG000|Overall Study|Withdrawal without treatment|1|||
27630411|NCT00130637|80486773|FG000|Overall Study|Adverse Event|2|||
27630412|NCT00130637|80486773|FG000|Overall Study|Withdrawal by Subject|1|||
27630413|NCT03235349|80486775|FG000|Overall Study|Adverse Event|1|||
27630414|NCT03235349|80486775|FG000|Overall Study|Other|1|||
27630415|NCT01977612|80486776|FG000|Overall Study|Lost to Follow-up|1|||
27534386|NCT04996797|80150652|FG003|Overall Study|Ongoing|20|||
27630416|NCT01977612|80486777|FG001|Overall Study|Lost to Follow-up|1|||
27630417|NCT02596035|80486778|FG000|Overall Study|Disease Progression|64|||
27630418|NCT02596035|80486779|FG001|Overall Study|Disease Progression|32|||
27630419|NCT02596035|80486780|FG002|Overall Study|Disease Progression|1|||
27630420|NCT02596035|80486778|FG000|Overall Study|study drug toxicity|12|||
27534387|NCT04996797|80150649|FG000|Overall Study|Withdrawal by Subject|0|||
27534388|NCT04996797|80150650|FG001|Overall Study|Withdrawal by Subject|2|||
27534389|NCT04996797|80150651|FG002|Overall Study|Withdrawal by Subject|0|||
27534390|NCT04996797|80150652|FG003|Overall Study|Withdrawal by Subject|0|||
27534391|NCT01180647|80150653|FG000|Overall Study|Lost to Follow-up|5|||
27534392|NCT01180647|80150654|FG001|Overall Study|Lost to Follow-up|6|||
27534393|NCT02900976|80150665|FG000|Overall Study|Adverse Event|0|||
27534394|NCT02900976|80150666|FG001|Overall Study|Adverse Event|1|||
27534395|NCT02900976|80150665|FG000|Overall Study|Physician Decision|0|||
27534396|NCT02900976|80150666|FG001|Overall Study|Physician Decision|2|||
27534397|NCT02900976|80150665|FG000|Overall Study|Progressive disease|0|||
27534398|NCT02900976|80150666|FG001|Overall Study|Progressive disease|6|||
27534399|NCT03491215|80150667|FG000|Overall Study|Death|6|||
27534400|NCT03491215|80150668|FG001|Overall Study|Death|2|||
27534401|NCT03491215|80150669|FG002|Overall Study|Death|1|||
27534402|NCT03491215|80150670|FG003|Overall Study|Death|0|||
27534403|NCT03491215|80150667|FG000|Overall Study|Physician Decision|1|||
27534404|NCT03491215|80150668|FG001|Overall Study|Physician Decision|0|||
27534405|NCT03491215|80150669|FG002|Overall Study|Physician Decision|0|||
27534406|NCT03491215|80150670|FG003|Overall Study|Physician Decision|0|||
27534407|NCT00559754|80150671|FG000|Overall Study|Disease progression|1|||
27534408|NCT00559754|80150671|FG000|Overall Study|Adverse Event|5|||
27534409|NCT00559754|80150671|FG000|Overall Study|Protocol Violation|1|||
27534410|NCT00559754|80150671|FG000|Overall Study|Investigator criteria|2|||
27534411|NCT00559754|80150671|FG000|Overall Study|Withdrawal by Subject|2|||
27534412|NCT04439279|80150672|FG000|Overall Study|Adverse Event|7|||
27534413|NCT04439279|80150672|FG000|Overall Study|Death|4|||
27534414|NCT04439279|80150672|FG000|Overall Study|Disease progression|17|||
27534415|NCT04439279|80150672|FG000|Overall Study|Complicating disease|3|||
27534416|NCT04439279|80150672|FG000|Overall Study|Withdrawal by Subject|2|||
27534417|NCT04439279|80150672|FG000|Overall Study|Ineligible|1|||
27534418|NCT04439279|80150672|FG000|Overall Study|Treatment still ongoing|1|||
27534419|NCT00071396|80150673|FG000|Overall Study|Withdrawal by Subject|1|||
27534420|NCT00071396|80150673|FG000|Overall Study|Physician Decision|2|||
27534421|NCT03516812|80150674|FG000|Overall Study|Adverse Event|4|||
27534422|NCT03516812|80150674|FG000|Overall Study|Lack of Efficacy|2|||
27534423|NCT02149875|80150681|FG000|Overall Study|Lost to Follow-up|3|||
27534424|NCT02149875|80150682|FG001|Overall Study|Lost to Follow-up|4|||
27534425|NCT02149875|80150683|FG002|Overall Study|Lost to Follow-up|5|||
27534426|NCT02149875|80150681|FG000|Overall Study|Withdrawal by Subject|3|||
27534427|NCT02149875|80150682|FG001|Overall Study|Withdrawal by Subject|2|||
27534428|NCT02149875|80150683|FG002|Overall Study|Withdrawal by Subject|2|||
27534429|NCT02149875|80150681|FG000|Overall Study|Physician Decision|1|||
27534430|NCT02149875|80150682|FG001|Overall Study|Physician Decision|2|||
27534431|NCT02149875|80150683|FG002|Overall Study|Physician Decision|2|||
27534432|NCT02791594|80150684|FG000|Overall Study|Physician Decision|2|||
27534433|NCT01134731|80150685|FG000|Overall Study|Adverse Event|3|||
27534434|NCT01134731|80150686|FG001|Overall Study|Adverse Event|2|||
27534435|NCT01134731|80150687|FG002|Overall Study|Adverse Event|1|||
27534436|NCT01134731|80150685|FG000|Overall Study|Physician Decision|2|||
27534437|NCT01134731|80150686|FG001|Overall Study|Physician Decision|2|||
27534438|NCT01134731|80150687|FG002|Overall Study|Physician Decision|2|||
27534439|NCT01134731|80150685|FG000|Overall Study|Lack of Efficacy|0|||
27534440|NCT01134731|80150686|FG001|Overall Study|Lack of Efficacy|0|||
27534441|NCT01134731|80150687|FG002|Overall Study|Lack of Efficacy|1|||
27534442|NCT01134731|80150685|FG000|Overall Study|Withdrawal by Subject|3|||
27534443|NCT01134731|80150686|FG001|Overall Study|Withdrawal by Subject|3|||
27534444|NCT01134731|80150687|FG002|Overall Study|Withdrawal by Subject|1|||
27534445|NCT01134731|80150685|FG000|Overall Study|Lost to Follow-up|5|||
27534446|NCT01134731|80150686|FG001|Overall Study|Lost to Follow-up|4|||
27534447|NCT01134731|80150687|FG002|Overall Study|Lost to Follow-up|3|||
27534448|NCT02507973|80150688|FG000|Overall Study|Adverse Event|1|||
27534449|NCT02448810|80150694|FG000|Overall Study|Adverse Event|0|||
27534450|NCT02448810|80150695|FG001|Overall Study|Adverse Event|0|||
27534451|NCT02448810|80150696|FG002|Overall Study|Adverse Event|1|||
27630421|NCT02596035|80486779|FG001|Overall Study|study drug toxicity|3|||
27630422|NCT02596035|80486780|FG002|Overall Study|study drug toxicity|0|||
27630423|NCT02596035|80486778|FG000|Overall Study|AE unrelated to study drug|5|||
27534452|NCT02448810|80150697|FG003|Overall Study|Adverse Event|0|||
27534453|NCT02448810|80150698|FG004|Overall Study|Adverse Event|0|||
27630424|NCT02596035|80486779|FG001|Overall Study|AE unrelated to study drug|2|||
27630425|NCT02596035|80486780|FG002|Overall Study|AE unrelated to study drug|0|||
27914143|NCT02810418|81525748|FG001|Dose Expansion|Physician Decision|0|||
27914144|NCT02810418|81525749|FG002|Dose Expansion|Physician Decision|2|||
27534454|NCT02448810|80150699|FG005|Overall Study|Adverse Event|0|||
27534455|NCT02448810|80150700|FG006|Overall Study|Adverse Event|0|||
27534456|NCT02448810|80150701|FG007|Overall Study|Adverse Event|0|||
27534457|NCT02448810|80150694|FG000|Overall Study|Withdrawal by Subject|0|||
27534458|NCT02448810|80150695|FG001|Overall Study|Withdrawal by Subject|0|||
27534459|NCT02448810|80150696|FG002|Overall Study|Withdrawal by Subject|1|||
27534460|NCT02448810|80150697|FG003|Overall Study|Withdrawal by Subject|0|||
27737983|NCT04375878|80868536|FG002|Extension Phase|Withdrawal by Subject|0|||
27737984|NCT04375878|80868537|FG003|Extension Phase|Withdrawal by Subject|0|||
27737985|NCT04375878|80868538|FG004|Extension Phase|Withdrawal by Subject|1|||
27737986|NCT04375878|80868539|FG005|Extension Phase|Withdrawal by Subject|0|||
27737987|NCT01919307|80868541|FG000|Overall Study|Withdrawal by Subject|9|||
27737988|NCT00391976|80871065|FG000|Overall Study|Adverse Event|0|||
27737989|NCT00391976|80871066|FG001|Overall Study|Adverse Event|0|||
27737990|NCT00391976|80871067|FG002|Overall Study|Adverse Event|1|||
27737991|NCT00391976|80871065|FG000|Overall Study|Withdrawal of consent|0|||
27737992|NCT00391976|80871066|FG001|Overall Study|Withdrawal of consent|1|||
27737993|NCT00391976|80871067|FG002|Overall Study|Withdrawal of consent|1|||
27914145|NCT02810418|81525750|FG003|Dose Expansion|Physician Decision|0|||
27914146|NCT02810418|81525751|FG004|Dose Expansion|Physician Decision|0|||
27914147|NCT02810418|81525752|FG005|Dose Expansion|Physician Decision|0|||
27914148|NCT02810418|81525753|FG006|Dose Expansion|Physician Decision|0|||
27914149|NCT02810418|81525747|FG000|Arm B Dose Escalation|Adverse Event|0|||
27914150|NCT02810418|81525748|FG001|Arm B Dose Escalation|Adverse Event|0|||
27914151|NCT02810418|81525749|FG002|Arm B Dose Escalation|Adverse Event|0|||
27914152|NCT02810418|81525750|FG003|Arm B Dose Escalation|Adverse Event|0|||
27914153|NCT02810418|81525751|FG004|Arm B Dose Escalation|Adverse Event|1|||
27914154|NCT02810418|81525752|FG005|Arm B Dose Escalation|Adverse Event|2|||
27630426|NCT02596035|80486778|FG000|Overall Study|participant request to discontinue study treatment|2|||
27630427|NCT02596035|80486779|FG001|Overall Study|participant request to discontinue study treatment|0|||
27630428|NCT02596035|80486780|FG002|Overall Study|participant request to discontinue study treatment|0|||
27737994|NCT00391976|80871065|FG000|Overall Study|Lost to Follow-up|1|||
27914155|NCT02810418|81525753|FG006|Arm B Dose Escalation|Adverse Event|0|||
27914156|NCT03139552|81525754|FG000|Overall Study|unable to attend tasting due to schedule|3|||
27914157|NCT02239640|81525758|FG000|Overall Study|Withdrawal by Subject|3|||
27534461|NCT02448810|80150698|FG004|Overall Study|Withdrawal by Subject|3|||
27534462|NCT02448810|80150699|FG005|Overall Study|Withdrawal by Subject|5|||
27534463|NCT02448810|80150700|FG006|Overall Study|Withdrawal by Subject|0|||
27534464|NCT02448810|80150701|FG007|Overall Study|Withdrawal by Subject|2|||
27534465|NCT02448810|80150694|FG000|Overall Study|Other (study terminated by sponsor)|0|||
27534466|NCT02448810|80150695|FG001|Overall Study|Other (study terminated by sponsor)|0|||
27534467|NCT02448810|80150696|FG002|Overall Study|Other (study terminated by sponsor)|0|||
27534468|NCT02448810|80150697|FG003|Overall Study|Other (study terminated by sponsor)|0|||
27534469|NCT02448810|80150698|FG004|Overall Study|Other (study terminated by sponsor)|4|||
27534470|NCT02448810|80150699|FG005|Overall Study|Other (study terminated by sponsor)|2|||
27534471|NCT02448810|80150700|FG006|Overall Study|Other (study terminated by sponsor)|2|||
27534472|NCT02448810|80150701|FG007|Overall Study|Other (study terminated by sponsor)|1|||
27534473|NCT02448810|80150694|FG000|Overall Study|Death|1|||
27534474|NCT02448810|80150695|FG001|Overall Study|Death|0|||
27534475|NCT02448810|80150696|FG002|Overall Study|Death|1|||
27534476|NCT02448810|80150697|FG003|Overall Study|Death|0|||
27534477|NCT02448810|80150698|FG004|Overall Study|Death|1|||
27534478|NCT02448810|80150699|FG005|Overall Study|Death|0|||
27534479|NCT02448810|80150700|FG006|Overall Study|Death|0|||
27534480|NCT02448810|80150701|FG007|Overall Study|Death|0|||
27534481|NCT02448810|80150694|FG000|Overall Study|Other (Progressive disease)|2|||
27534482|NCT02448810|80150695|FG001|Overall Study|Other (Progressive disease)|2|||
27534483|NCT02448810|80150696|FG002|Overall Study|Other (Progressive disease)|0|||
27534484|NCT02448810|80150697|FG003|Overall Study|Other (Progressive disease)|3|||
27534485|NCT02448810|80150698|FG004|Overall Study|Other (Progressive disease)|23|||
27534486|NCT02448810|80150699|FG005|Overall Study|Other (Progressive disease)|9|||
27534487|NCT02448810|80150700|FG006|Overall Study|Other (Progressive disease)|14|||
27534488|NCT02448810|80150701|FG007|Overall Study|Other (Progressive disease)|5|||
27534489|NCT02448810|80150694|FG000|Overall Study|Lost to Follow-up|0|||
27534490|NCT02448810|80150695|FG001|Overall Study|Lost to Follow-up|1|||
27534491|NCT02448810|80150696|FG002|Overall Study|Lost to Follow-up|0|||
27534492|NCT02448810|80150697|FG003|Overall Study|Lost to Follow-up|0|||
27534493|NCT02448810|80150698|FG004|Overall Study|Lost to Follow-up|0|||
27534494|NCT02448810|80150699|FG005|Overall Study|Lost to Follow-up|0|||
27534495|NCT02448810|80150700|FG006|Overall Study|Lost to Follow-up|0|||
27534496|NCT02448810|80150701|FG007|Overall Study|Lost to Follow-up|0|||
27534497|NCT02448810|80150694|FG000|Overall Study|Other (unspecified)|0|||
27737995|NCT00391976|80871066|FG001|Overall Study|Lost to Follow-up|2|||
27737996|NCT00391976|80871067|FG002|Overall Study|Lost to Follow-up|0|||
27737997|NCT00391976|80871065|FG000|Overall Study|Inappropriate enrollment|1|||
27737998|NCT00391976|80871066|FG001|Overall Study|Inappropriate enrollment|1|||
27534498|NCT02448810|80150695|FG001|Overall Study|Other (unspecified)|0|||
27737999|NCT00391976|80871067|FG002|Overall Study|Inappropriate enrollment|0|||
27738000|NCT00391976|80871065|FG000|Overall Study|Protocol deviation/violation|4|||
27914158|NCT02239640|81525758|FG000|Overall Study|Lost to Follow-up|72|||
27534499|NCT02448810|80150696|FG002|Overall Study|Other (unspecified)|0|||
27914159|NCT02239640|81525758|FG000|Overall Study|Death|142|||
27534500|NCT02448810|80150697|FG003|Overall Study|Other (unspecified)|0|||
27534501|NCT02448810|80150698|FG004|Overall Study|Other (unspecified)|0|||
27738001|NCT00391976|80871066|FG001|Overall Study|Protocol deviation/violation|2|||
27738002|NCT00391976|80871067|FG002|Overall Study|Protocol deviation/violation|1|||
27738003|NCT00391976|80871065|FG000|Overall Study|Recurrence/no eradication of infection|21|||
27738004|NCT00391976|80871066|FG001|Overall Study|Recurrence/no eradication of infection|19|||
27738005|NCT00391976|80871067|FG002|Overall Study|Recurrence/no eradication of infection|0|||
27738006|NCT00391976|80871065|FG000|Overall Study|Unable to classify|0|||
27738007|NCT00391976|80871066|FG001|Overall Study|Unable to classify|0|||
27738008|NCT00391976|80871067|FG002|Overall Study|Unable to classify|1|||
27738009|NCT00391976|80871065|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
27738010|NCT00391976|80871066|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
27738011|NCT00391976|80871067|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
27738012|NCT01676116|80871068|FG000|Overall Study|Withdrawal criteria|2|||
27738013|NCT01676116|80871069|FG001|Overall Study|Withdrawal criteria|14|||
27738014|NCT01676116|80871068|FG000|Overall Study|Adverse Event|1|||
27738015|NCT01676116|80871069|FG001|Overall Study|Adverse Event|2|||
27738016|NCT01676116|80871068|FG000|Overall Study|Unclassified|4|||
27738017|NCT01676116|80871069|FG001|Overall Study|Unclassified|10|||
27738018|NCT01676116|80871068|FG000|Overall Study|Protocol Violation|9|||
27738019|NCT01676116|80871069|FG001|Overall Study|Protocol Violation|3|||
27738020|NCT00465569|80871073|FG000|Overall Study|persistent eczema during dose escalation|1|||
27738021|NCT00465569|80871074|FG001|Overall Study|persistent eczema during dose escalation|0|||
27738022|NCT01444391|80871079|FG000|Overall Study|Death|1|||
27738023|NCT01259466|80871080|FG000|Overall Study|Withdrawal by Subject|1|||
27738024|NCT01259466|80871081|FG001|Overall Study|Withdrawal by Subject|9|||
27738025|NCT02799381|80871082|FG000|Overall Study|Withdrew consent|3|||
27738026|NCT02799381|80871083|FG001|Overall Study|Withdrew consent|2|||
27738027|NCT02799381|80871082|FG000|Overall Study|Adverse Event|0|||
27738028|NCT02799381|80871083|FG001|Overall Study|Adverse Event|1|||
27738029|NCT02799381|80871082|FG000|Overall Study|Participant did not take any study drug|1|||
27738030|NCT02799381|80871083|FG001|Overall Study|Participant did not take any study drug|0|||
27738031|NCT00174941|80871093|FG000|Overall Study|Adverse Event|1|||
27738032|NCT00174941|80871094|FG001|Overall Study|Adverse Event|10|||
27738033|NCT00174941|80871095|FG002|Overall Study|Adverse Event|2|||
27738034|NCT00174941|80871096|FG003|Overall Study|Adverse Event|13|||
27738035|NCT00174941|80871093|FG000|Overall Study|Protocol Violation|0|||
27738036|NCT00174941|80871094|FG001|Overall Study|Protocol Violation|1|||
27738037|NCT00174941|80871095|FG002|Overall Study|Protocol Violation|0|||
27738038|NCT00174941|80871096|FG003|Overall Study|Protocol Violation|1|||
27738039|NCT00174941|80871093|FG000|Overall Study|Lost to Follow-up|0|||
27738040|NCT00174941|80871094|FG001|Overall Study|Lost to Follow-up|3|||
27738041|NCT00174941|80871095|FG002|Overall Study|Lost to Follow-up|2|||
27914160|NCT01096160|81525759|FG000|Overall Study|Adverse Event|0|||
27914161|NCT01096160|81525760|FG001|Overall Study|Adverse Event|0|||
27914162|NCT01096160|81525761|FG002|Overall Study|Adverse Event|1|||
27914163|NCT01096160|81525762|FG003|Overall Study|Adverse Event|0|||
27914164|NCT01096160|81525763|FG004|Overall Study|Adverse Event|0|||
27914165|NCT01096160|81525764|FG005|Overall Study|Adverse Event|0|||
27914166|NCT01096160|81525765|FG006|Overall Study|Adverse Event|0|||
27914167|NCT01096160|81525766|FG007|Overall Study|Adverse Event|0|||
27914168|NCT01096160|81525767|FG008|Overall Study|Adverse Event|0|||
27914169|NCT01096160|81525768|FG009|Overall Study|Adverse Event|1|||
27914170|NCT01096160|81525759|FG000|Overall Study|Met stopping criteria per protocol|0|||
27914171|NCT01096160|81525760|FG001|Overall Study|Met stopping criteria per protocol|0|||
27914172|NCT01096160|81525761|FG002|Overall Study|Met stopping criteria per protocol|0|||
27914173|NCT01096160|81525762|FG003|Overall Study|Met stopping criteria per protocol|0|||
27914174|NCT01096160|81525763|FG004|Overall Study|Met stopping criteria per protocol|1|||
27914175|NCT01096160|81525764|FG005|Overall Study|Met stopping criteria per protocol|0|||
27914176|NCT01096160|81525765|FG006|Overall Study|Met stopping criteria per protocol|2|||
27914177|NCT01096160|81525766|FG007|Overall Study|Met stopping criteria per protocol|0|||
27914178|NCT01096160|81525767|FG008|Overall Study|Met stopping criteria per protocol|2|||
27914179|NCT01096160|81525768|FG009|Overall Study|Met stopping criteria per protocol|0|||
27914180|NCT02346708|81525770|FG000|Overall Study|Adverse Event|2|||
27914181|NCT02346708|81525771|FG001|Overall Study|Adverse Event|0|||
27914182|NCT02346708|81525770|FG000|Overall Study|Protocol Violation|0|||
27914183|NCT02346708|81525771|FG001|Overall Study|Protocol Violation|1|||
27738042|NCT00174941|80871096|FG003|Overall Study|Lost to Follow-up|5|||
27914184|NCT03506438|81525772|FG000|Overall Study|Lost to Follow-up|8|||
27914185|NCT03506438|81525773|FG001|Overall Study|Lost to Follow-up|7|||
27914186|NCT03506438|81525774|FG002|Overall Study|Lost to Follow-up|8|||
27914187|NCT03506438|81525775|FG003|Overall Study|Lost to Follow-up|7|||
27738043|NCT00174941|80871093|FG000|Overall Study|Personal Reason(s)|0|||
27738044|NCT00174941|80871094|FG001|Overall Study|Personal Reason(s)|14|||
27738045|NCT00174941|80871095|FG002|Overall Study|Personal Reason(s)|8|||
27738046|NCT00174941|80871096|FG003|Overall Study|Personal Reason(s)|22|||
27914188|NCT03506438|81525776|FG004|Overall Study|Lost to Follow-up|0|||
27914189|NCT03506438|81525777|FG005|Overall Study|Lost to Follow-up|0|||
27914190|NCT01691378|81525778|FG000|Overall Study|Withdrawal by Subject|2|||
27534502|NCT02448810|80150699|FG005|Overall Study|Other (unspecified)|0|||
27534503|NCT02448810|80150700|FG006|Overall Study|Other (unspecified)|2|||
27534504|NCT02448810|80150701|FG007|Overall Study|Other (unspecified)|0|||
27534505|NCT00976677|80150702|FG000|Overall Study|Adverse Event|1|||
27534506|NCT00976677|80150703|FG001|Overall Study|Adverse Event|0|||
27534507|NCT00976677|80150702|FG000|Overall Study|Withdrawal by Subject|0|||
27534508|NCT00976677|80150703|FG001|Overall Study|Withdrawal by Subject|2|||
27534509|NCT00976677|80150702|FG000|Overall Study|Disease progression|1|||
27534510|NCT00976677|80150703|FG001|Overall Study|Disease progression|1|||
27534511|NCT00976677|80150702|FG000|Overall Study|Trial unblinded|2|||
27534512|NCT00976677|80150703|FG001|Overall Study|Trial unblinded|2|||
27630429|NCT02596035|80486778|FG000|Overall Study|participant withdrew consent|2|||
27630430|NCT02596035|80486779|FG001|Overall Study|participant withdrew consent|2|||
27630431|NCT02596035|80486780|FG002|Overall Study|participant withdrew consent|0|||
27630432|NCT02596035|80486778|FG000|Overall Study|Poor/Non Comlpiance|0|||
27630433|NCT02596035|80486779|FG001|Overall Study|Poor/Non Comlpiance|1|||
27630434|NCT02596035|80486780|FG002|Overall Study|Poor/Non Comlpiance|0|||
27630435|NCT02596035|80486778|FG000|Overall Study|participant no longer meets study criteria|1|||
27630436|NCT02596035|80486779|FG001|Overall Study|participant no longer meets study criteria|0|||
27630437|NCT02596035|80486780|FG002|Overall Study|participant no longer meets study criteria|0|||
27630438|NCT02596035|80486778|FG000|Overall Study|other reasons|11|||
27630439|NCT02596035|80486779|FG001|Overall Study|other reasons|4|||
27630440|NCT02596035|80486780|FG002|Overall Study|other reasons|0|||
27630441|NCT00344019|80486781|FG000|Overall Study|did not meet final inclusion criteria|0|||
27630442|NCT00344019|80486782|FG001|Overall Study|did not meet final inclusion criteria|0|||
27630443|NCT00344019|80486783|FG002|Overall Study|did not meet final inclusion criteria|74|||
27630444|NCT00943605|80486784|FG000|Overall Study|Study termination|30|||
27630445|NCT00943605|80486785|FG001|Overall Study|Study termination|30|||
27630446|NCT00109967|80486789|FG000|Overall Study|Cancel Prior to Treatment|2|||
27630447|NCT00109967|80486790|FG001|Overall Study|Cancel Prior to Treatment|0|||
27630448|NCT00109967|80486789|FG000|Overall Study|Adverse Event|12|||
27630449|NCT00109967|80486790|FG001|Overall Study|Adverse Event|1|||
27630450|NCT00109967|80486789|FG000|Overall Study|Withdrawal by Subject|5|||
27630451|NCT00109967|80486790|FG001|Overall Study|Withdrawal by Subject|0|||
27630452|NCT00109967|80486789|FG000|Overall Study|Physician Decision|1|||
27630453|NCT00109967|80486790|FG001|Overall Study|Physician Decision|3|||
27630454|NCT00109967|80486789|FG000|Overall Study|Death|0|||
27630455|NCT00109967|80486790|FG001|Overall Study|Death|2|||
27630456|NCT00957229|80486791|FG000|Study Start|Adverse Event|0|||
27630457|NCT00957229|80486792|FG001|Study Start|Adverse Event|3|||
27630458|NCT00957229|80486791|FG000|Study Start|Disease Progression|1|||
27630459|NCT00957229|80486792|FG001|Study Start|Disease Progression|0|||
27630460|NCT00957229|80486791|FG000|Reallocated to or Continued Vismodegib|Death|1|||
27630461|NCT00957229|80486792|FG001|Reallocated to or Continued Vismodegib|Death|1|||
27630462|NCT00957229|80486791|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
27630463|NCT00957229|80486792|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
27630464|NCT00559949|80486796|FG000|Overall Study|Progressive Disease during cycle 1|1|||
27630465|NCT00559949|80486796|FG000|Overall Study|Adverse Event|1|||
27630466|NCT00559949|80486796|FG000|Overall Study|Withdrawal by Subject|4|||
27630467|NCT00559949|80486796|FG000|Overall Study|No disease evaluation per protocol|1|||
27630468|NCT02537522|80486797|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
27738047|NCT00174941|80871093|FG000|Overall Study|Gout Flare|0|||
27738048|NCT00174941|80871094|FG001|Overall Study|Gout Flare|4|||
27738049|NCT00174941|80871095|FG002|Overall Study|Gout Flare|4|||
27738050|NCT00174941|80871096|FG003|Overall Study|Gout Flare|8|||
27914191|NCT01691378|81525779|FG001|Overall Study|Withdrawal by Subject|0|||
27914192|NCT01691378|81525778|FG000|Overall Study|Lost to Follow-up|5|||
27914193|NCT01691378|81525779|FG001|Overall Study|Lost to Follow-up|2|||
27914194|NCT00369915|81525791|FG000|Overall Study|expected side effects|2|||
27914195|NCT00369915|81525792|FG001|Overall Study|expected side effects|1|||
27914196|NCT00369915|81525791|FG000|Overall Study|Withdrawal by Subject|4|||
27534513|NCT00976677|80150702|FG000|Overall Study|Unknown/Missing|1|||
27534514|NCT00976677|80150703|FG001|Overall Study|Unknown/Missing|0|||
27534515|NCT01146912|80153284|FG000|Overall Study|Already received influenza vaccination|817|||
27534516|NCT01146912|80153285|FG001|Overall Study|Already received influenza vaccination|822|||
27630469|NCT02537522|80486798|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
27534517|NCT01146912|80153286|FG002|Overall Study|Already received influenza vaccination|13|||
27534518|NCT01146912|80153287|FG003|Overall Study|Already received influenza vaccination|15|||
27630470|NCT02537522|80486799|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
27534519|NCT01146912|80153288|FG004|Overall Study|Already received influenza vaccination|41|||
27630471|NCT02537522|80486800|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
27630472|NCT02537522|80486797|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
27630473|NCT02537522|80486798|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
27738051|NCT00174941|80871093|FG000|Overall Study|Reason Not Specified|1|||
27738052|NCT00174941|80871094|FG001|Overall Study|Reason Not Specified|6|||
27630474|NCT02537522|80486799|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
27630475|NCT02537522|80486800|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
27630476|NCT02537522|80486797|FG000|Phase I - Contralateral|incorrect randomization|0|||
27630477|NCT02537522|80486798|FG001|Phase I - Contralateral|incorrect randomization|1|||
27630478|NCT02537522|80486799|FG002|Phase I - Contralateral|incorrect randomization|0|||
27630479|NCT02537522|80486800|FG003|Phase I - Contralateral|incorrect randomization|0|||
27630480|NCT02537522|80486797|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
27630481|NCT02537522|80486798|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
27630482|NCT02537522|80486799|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
27630483|NCT02537522|80486800|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
27630484|NCT02537522|80486797|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
27630485|NCT02537522|80486798|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
27630486|NCT02537522|80486799|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
27630487|NCT02537522|80486800|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
27630488|NCT01988233|80486801|FG000|Overall Study|Lost to Follow-up|64|||
27630489|NCT01988233|80486802|FG001|Overall Study|Lost to Follow-up|51|||
27630490|NCT00964366|80486803|FG000|Overall Study|Did not qualify at Day 1|1|||
27630491|NCT00964366|80486804|FG001|Overall Study|Did not qualify at Day 1|0|||
27630492|NCT00964366|80486803|FG000|Overall Study|Withdrawal by Subject|0|||
27630493|NCT00964366|80486804|FG001|Overall Study|Withdrawal by Subject|1|||
27630494|NCT04588480|80486807|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
27630495|NCT04588480|80486808|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
27630496|NCT04588480|80486809|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
27630497|NCT04588480|80486807|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
27630498|NCT04588480|80486808|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
27630499|NCT04588480|80486809|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
27630500|NCT00573833|80489989|FG000|Overall Study|Not Treated|2|||
27630501|NCT00395018|80489994|FG000|On-Treatment|Death|4|||
27630502|NCT00395018|80489994|FG000|On-Treatment|Other Reason|2|||
27630503|NCT00395018|80489994|FG000|On-Treatment|Poor/non-compliance|2|||
27630504|NCT00395018|80489994|FG000|On-Treatment|Subject no longer meets study criteria|2|||
27630505|NCT00395018|80489994|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
27630506|NCT00395018|80489994|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
27534520|NCT01146912|80153289|FG005|Overall Study|Already received influenza vaccination|61|||
27534521|NCT01146912|80153290|FG006|Overall Study|Already received influenza vaccination|56|||
27534522|NCT01146912|80153291|FG007|Overall Study|Already received influenza vaccination|0|||
27534523|NCT01146912|80153284|FG000|Overall Study|< 14 weeks gestational age|0|||
27534524|NCT01146912|80153285|FG001|Overall Study|< 14 weeks gestational age|0|||
27534525|NCT01146912|80153286|FG002|Overall Study|< 14 weeks gestational age|3|||
27534526|NCT01146912|80153287|FG003|Overall Study|< 14 weeks gestational age|2|||
27534527|NCT01146912|80153288|FG004|Overall Study|< 14 weeks gestational age|0|||
27738053|NCT00174941|80871095|FG002|Overall Study|Reason Not Specified|2|||
27738054|NCT00174941|80871096|FG003|Overall Study|Reason Not Specified|9|||
27738055|NCT03065530|80871097|FG000|Overall Study|Lack of Efficacy|1|||
27738056|NCT03065530|80871098|FG001|Overall Study|Lack of Efficacy|1|||
27738057|NCT03065530|80871099|FG002|Overall Study|Lack of Efficacy|0|||
27738058|NCT03065530|80871100|FG003|Overall Study|Lack of Efficacy|1|||
27738059|NCT03065530|80871097|FG000|Overall Study|Protocol Violation|1|||
27534528|NCT01146912|80153289|FG005|Overall Study|< 14 weeks gestational age|0|||
27534529|NCT01146912|80153290|FG006|Overall Study|< 14 weeks gestational age|0|||
27534530|NCT01146912|80153291|FG007|Overall Study|< 14 weeks gestational age|0|||
27534531|NCT01146912|80153284|FG000|Overall Study|Duplicate patient|0|||
27534532|NCT01146912|80153285|FG001|Overall Study|Duplicate patient|0|||
27534533|NCT01146912|80153286|FG002|Overall Study|Duplicate patient|1|||
27534534|NCT01146912|80153287|FG003|Overall Study|Duplicate patient|0|||
27534535|NCT01146912|80153288|FG004|Overall Study|Duplicate patient|0|||
27534536|NCT01146912|80153289|FG005|Overall Study|Duplicate patient|0|||
27534537|NCT01146912|80153290|FG006|Overall Study|Duplicate patient|0|||
27534538|NCT01146912|80153291|FG007|Overall Study|Duplicate patient|0|||
27534539|NCT00543543|80153292|FG000|Base Study|Adverse Event|1|||
27534540|NCT00543543|80153293|FG001|Base Study|Adverse Event|11|||
27534541|NCT00543543|80153294|FG002|Base Study|Adverse Event|0|||
27534542|NCT00543543|80153295|FG003|Base Study|Adverse Event|5|||
27534543|NCT00543543|80153292|FG000|Base Study|Lost to Follow-up|12|||
27534544|NCT00543543|80153293|FG001|Base Study|Lost to Follow-up|749|||
27738060|NCT03065530|80871098|FG001|Overall Study|Protocol Violation|0|||
27534545|NCT00543543|80153294|FG002|Base Study|Lost to Follow-up|9|||
27534546|NCT00543543|80153295|FG003|Base Study|Lost to Follow-up|701|||
27534547|NCT00543543|80153292|FG000|Base Study|Physician Decision|0|||
27534548|NCT00543543|80153293|FG001|Base Study|Physician Decision|4|||
27534549|NCT00543543|80153294|FG002|Base Study|Physician Decision|0|||
27534550|NCT00543543|80153295|FG003|Base Study|Physician Decision|7|||
27534551|NCT00543543|80153292|FG000|Base Study|Protocol Violation|0|||
27630507|NCT00395018|80489994|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
27630508|NCT00117988|80489995|FG000|Overall Study|Death|3|||
27630509|NCT00117988|80489995|FG000|Overall Study|Adverse Event|1|||
27630510|NCT00961636|80489996|FG000|Overall Study|Adverse Event|35|||
27630511|NCT00961636|80489997|FG001|Overall Study|Adverse Event|54|||
27630512|NCT00961636|80489998|FG002|Overall Study|Adverse Event|13|||
27630513|NCT00961636|80489996|FG000|Overall Study|Flushing Symptoms|29|||
27630514|NCT00961636|80489997|FG001|Overall Study|Flushing Symptoms|46|||
27630515|NCT00961636|80489998|FG002|Overall Study|Flushing Symptoms|3|||
27630516|NCT00961636|80489996|FG000|Overall Study|Lost to Follow-up|2|||
27630517|NCT00961636|80489997|FG001|Overall Study|Lost to Follow-up|3|||
27630518|NCT00961636|80489998|FG002|Overall Study|Lost to Follow-up|1|||
27630519|NCT00961636|80489996|FG000|Overall Study|Physician Decision|3|||
27630520|NCT00961636|80489997|FG001|Overall Study|Physician Decision|1|||
27630521|NCT00961636|80489998|FG002|Overall Study|Physician Decision|1|||
27630522|NCT00961636|80489996|FG000|Overall Study|Protocol Violation|9|||
27630523|NCT00961636|80489997|FG001|Overall Study|Protocol Violation|5|||
27630524|NCT00961636|80489998|FG002|Overall Study|Protocol Violation|1|||
27630525|NCT00961636|80489996|FG000|Overall Study|Withdrawal by Subject|29|||
27630526|NCT00961636|80489997|FG001|Overall Study|Withdrawal by Subject|22|||
27630527|NCT00961636|80489998|FG002|Overall Study|Withdrawal by Subject|13|||
27630528|NCT02482233|80489999|FG000|Overall Study|Lost to Follow-up|1|||
27630529|NCT02482233|80490000|FG001|Overall Study|Lost to Follow-up|1|||
27630530|NCT01831791|80490001|FG000|Overall Study|Withdrawal by Subject|10|||
27630531|NCT01651949|80490003|FG000|Overall Study|Unknown status|4|||
27630532|NCT01651949|80490004|FG001|Overall Study|Unknown status|4|||
27630533|NCT01651949|80490005|FG002|Overall Study|Unknown status|0|||
27630534|NCT01651949|80490003|FG000|Overall Study|Lost to Follow-up|30|||
27630535|NCT01651949|80490004|FG001|Overall Study|Lost to Follow-up|56|||
27630536|NCT01651949|80490005|FG002|Overall Study|Lost to Follow-up|20|||
27914197|NCT00369915|81525792|FG001|Overall Study|Withdrawal by Subject|1|||
27914198|NCT00369915|81525791|FG000|Overall Study|W/drawl by investigators|0|||
27914199|NCT00369915|81525792|FG001|Overall Study|W/drawl by investigators|1|||
27914200|NCT03082729|81525793|FG000|Overall Study|Lost to Follow-up|7|||
27534552|NCT00543543|80153293|FG001|Base Study|Protocol Violation|6|||
27534553|NCT00543543|80153294|FG002|Base Study|Protocol Violation|0|||
27534554|NCT00543543|80153295|FG003|Base Study|Protocol Violation|6|||
27534555|NCT00543543|80153292|FG000|Base Study|Withdrawal by Subject|7|||
27534556|NCT00543543|80153293|FG001|Base Study|Withdrawal by Subject|482|||
27534557|NCT00543543|80153294|FG002|Base Study|Withdrawal by Subject|5|||
27534558|NCT00543543|80153295|FG003|Base Study|Withdrawal by Subject|503|||
27534559|NCT00543543|80153292|FG000|Extension Study|Adverse Event|0|||
27534560|NCT00543543|80153293|FG001|Extension Study|Adverse Event|0|||
27534561|NCT00543543|80153294|FG002|Extension Study|Adverse Event|0|||
27534562|NCT00543543|80153295|FG003|Extension Study|Adverse Event|5|||
27534563|NCT00543543|80153292|FG000|Extension Study|Lost to Follow-up|0|||
27534564|NCT00543543|80153293|FG001|Extension Study|Lost to Follow-up|0|||
27534565|NCT00543543|80153294|FG002|Extension Study|Lost to Follow-up|0|||
27534566|NCT00543543|80153295|FG003|Extension Study|Lost to Follow-up|77|||
27534567|NCT00543543|80153292|FG000|Extension Study|Physician Decision|0|||
27534568|NCT00543543|80153293|FG001|Extension Study|Physician Decision|0|||
27630537|NCT01651949|80490003|FG000|Overall Study|Protocol Violation|0|||
27914201|NCT03082729|81525793|FG000|Overall Study|Physician Decision|2|||
27914202|NCT03082729|81525793|FG000|Overall Study|Withdrawal by Subject|1|||
27914203|NCT03082729|81525793|FG000|Overall Study|Lack of Efficacy|9|||
27914204|NCT03082729|81525793|FG000|Overall Study|Adverse Event|4|||
27914205|NCT03082729|81525793|FG000|Overall Study|Protocol Violation|6|||
27914206|NCT03082729|81525793|FG000|Overall Study|Fear of study procedure|1|||
27914207|NCT03082729|81525793|FG000|Overall Study|Scheduling conflict|1|||
27914208|NCT00922116|81525795|FG000|Overall Study|Adverse Event|4|||
27914209|NCT00922116|81525795|FG000|Overall Study|Death|1|||
27914210|NCT00922116|81525795|FG000|Overall Study|Lost to Follow-up|1|||
27914211|NCT00922116|81525795|FG000|Overall Study|Withdrawal by Subject|4|||
27914212|NCT00922116|81525795|FG000|Overall Study|Other|5|||
27914213|NCT04396626|81525797|FG000|Overall Study|Premature termination of study|975|||
27914214|NCT04378569|81525798|FG000|Overall Study|Adverse Event|0|||
27914215|NCT04378569|81525799|FG001|Overall Study|Adverse Event|0|||
27630538|NCT01651949|80490004|FG001|Overall Study|Protocol Violation|2|||
27914216|NCT04378569|81525800|FG002|Overall Study|Adverse Event|2|||
27914217|NCT04378569|81525801|FG003|Overall Study|Adverse Event|0|||
27914218|NCT04378569|81525802|FG004|Overall Study|Adverse Event|3|||
27738061|NCT03065530|80871099|FG002|Overall Study|Protocol Violation|1|||
27914219|NCT04378569|81525803|FG005|Overall Study|Adverse Event|3|||
27914220|NCT04378569|81525798|FG000|Overall Study|Lost to Follow-up|0|||
27534569|NCT00543543|80153294|FG002|Extension Study|Physician Decision|0|||
27630539|NCT01651949|80490005|FG002|Overall Study|Protocol Violation|1|||
27630540|NCT01651949|80490003|FG000|Overall Study|Physician Decision|0|||
27630541|NCT01651949|80490004|FG001|Overall Study|Physician Decision|2|||
27630542|NCT01651949|80490005|FG002|Overall Study|Physician Decision|0|||
27630543|NCT01651949|80490003|FG000|Overall Study|Adverse Event|0|||
27630544|NCT01651949|80490004|FG001|Overall Study|Adverse Event|2|||
27630545|NCT01651949|80490005|FG002|Overall Study|Adverse Event|1|||
27914221|NCT04378569|81525799|FG001|Overall Study|Lost to Follow-up|3|||
27914222|NCT04378569|81525800|FG002|Overall Study|Lost to Follow-up|1|||
27914223|NCT04378569|81525801|FG003|Overall Study|Lost to Follow-up|0|||
27914224|NCT04378569|81525802|FG004|Overall Study|Lost to Follow-up|1|||
27914225|NCT04378569|81525803|FG005|Overall Study|Lost to Follow-up|1|||
27914226|NCT04378569|81525798|FG000|Overall Study|Protocol Violation|0|||
27914227|NCT04378569|81525799|FG001|Overall Study|Protocol Violation|0|||
27914228|NCT04378569|81525800|FG002|Overall Study|Protocol Violation|0|||
27534570|NCT00543543|80153295|FG003|Extension Study|Physician Decision|7|||
27534571|NCT00543543|80153292|FG000|Extension Study|Pregnancy|0|||
27914229|NCT04378569|81525801|FG003|Overall Study|Protocol Violation|0|||
27914230|NCT04378569|81525802|FG004|Overall Study|Protocol Violation|0|||
27914231|NCT04378569|81525803|FG005|Overall Study|Protocol Violation|1|||
27914232|NCT04378569|81525798|FG000|Overall Study|Withdrawal by Subject|0|||
27914233|NCT04378569|81525799|FG001|Overall Study|Withdrawal by Subject|6|||
27914234|NCT04378569|81525800|FG002|Overall Study|Withdrawal by Subject|7|||
27914235|NCT04378569|81525801|FG003|Overall Study|Withdrawal by Subject|4|||
27914236|NCT04378569|81525802|FG004|Overall Study|Withdrawal by Subject|5|||
27914237|NCT04378569|81525803|FG005|Overall Study|Withdrawal by Subject|4|||
27914238|NCT04378569|81525798|FG000|Overall Study|Lack of response|0|||
27914239|NCT04378569|81525799|FG001|Overall Study|Lack of response|0|||
27914240|NCT04378569|81525800|FG002|Overall Study|Lack of response|1|||
27914241|NCT04378569|81525801|FG003|Overall Study|Lack of response|0|||
27914242|NCT04378569|81525802|FG004|Overall Study|Lack of response|1|||
27534572|NCT00543543|80153293|FG001|Extension Study|Pregnancy|0|||
27534573|NCT00543543|80153294|FG002|Extension Study|Pregnancy|0|||
27914243|NCT04378569|81525803|FG005|Overall Study|Lack of response|1|||
27914244|NCT01274351|81525804|FG000|Overall Study|Lost to Follow-up|1|||
27534574|NCT00543543|80153295|FG003|Extension Study|Pregnancy|6|||
27534575|NCT00543543|80153292|FG000|Extension Study|Protocol Violation|0|||
27534576|NCT00543543|80153293|FG001|Extension Study|Protocol Violation|0|||
27534577|NCT00543543|80153294|FG002|Extension Study|Protocol Violation|0|||
27534578|NCT00543543|80153295|FG003|Extension Study|Protocol Violation|11|||
27534579|NCT00543543|80153292|FG000|Extension Study|Withdrawal by Subject|0|||
27534580|NCT00543543|80153293|FG001|Extension Study|Withdrawal by Subject|0|||
27534581|NCT00543543|80153294|FG002|Extension Study|Withdrawal by Subject|0|||
27534582|NCT00543543|80153295|FG003|Extension Study|Withdrawal by Subject|120|||
27534583|NCT02428608|80153296|FG000|Overall Study|Pregnancy|2|||
27534584|NCT02428608|80153296|FG000|Overall Study|Lost to Follow-up|37|||
27534585|NCT02428608|80153296|FG000|Overall Study|Withdrawal by Subject|2|||
27534586|NCT02428608|80153296|FG000|Overall Study|scheduling conflicts|15|||
27534587|NCT02428608|80153296|FG000|Overall Study|moved away|10|||
27534588|NCT02428608|80153296|FG000|Overall Study|Death|1|||
27534589|NCT02428608|80153296|FG000|Overall Study|various|16|||
27534590|NCT03595774|80153299|FG000|Overall Study|Adverse Event|1|||
27914245|NCT01274351|81525804|FG000|Overall Study|patient not compliant with the protocol|1|||
27914246|NCT01274351|81525804|FG000|Overall Study|Pregnancy|1|||
27914247|NCT01274351|81525804|FG000|Overall Study|Death|2|||
27914248|NCT01274351|81525804|FG000|Overall Study|Withdrawal by Subject|3|||
27914249|NCT01274351|81525804|FG000|Overall Study|Adverse Event|8|||
27914250|NCT01274351|81525804|FG000|Overall Study|progression of disease|3|||
27914251|NCT01274351|81525804|FG000|Overall Study|hospitalization|1|||
27914252|NCT01261390|81525809|FG000|Overall Study|Significant Concurrent Illness|1|||
27914253|NCT01261390|81525810|FG001|Overall Study|Significant Concurrent Illness|0|||
27914254|NCT01261390|81525811|FG002|Overall Study|Significant Concurrent Illness|1|||
27914255|NCT01261390|81525812|FG003|Overall Study|Significant Concurrent Illness|0|||
27914256|NCT01261390|81525809|FG000|Overall Study|Dissatisfaction with Treatment|2|||
27914257|NCT01261390|81525810|FG001|Overall Study|Dissatisfaction with Treatment|1|||
27914258|NCT01261390|81525811|FG002|Overall Study|Dissatisfaction with Treatment|1|||
27914259|NCT01261390|81525812|FG003|Overall Study|Dissatisfaction with Treatment|2|||
27914260|NCT01261390|81525809|FG000|Overall Study|Relocation|0|||
27914261|NCT01261390|81525810|FG001|Overall Study|Relocation|1|||
27738062|NCT03065530|80871100|FG003|Overall Study|Protocol Violation|1|||
27738063|NCT03826914|80871101|FG000|Overall Study|Withdrawal by Subject|1|||
27914262|NCT01261390|81525811|FG002|Overall Study|Relocation|0|||
27534591|NCT03595774|80153300|FG001|Overall Study|Adverse Event|0|||
27534592|NCT03595774|80153301|FG002|Overall Study|Adverse Event|1|||
27534593|NCT03595774|80153302|FG003|Overall Study|Adverse Event|0|||
27534594|NCT03595774|80153299|FG000|Overall Study|screen failure|0|||
27914263|NCT01261390|81525812|FG003|Overall Study|Relocation|0|||
27914264|NCT01261390|81525809|FG000|Overall Study|Loss of Interest in the Study|3|||
27914265|NCT01261390|81525810|FG001|Overall Study|Loss of Interest in the Study|1|||
27914266|NCT01261390|81525811|FG002|Overall Study|Loss of Interest in the Study|0|||
27914267|NCT01261390|81525812|FG003|Overall Study|Loss of Interest in the Study|0|||
27914268|NCT01261390|81525809|FG000|Overall Study|Lost to Follow-up|1|||
27914269|NCT01261390|81525810|FG001|Overall Study|Lost to Follow-up|6|||
27914270|NCT01261390|81525811|FG002|Overall Study|Lost to Follow-up|5|||
27914271|NCT01261390|81525812|FG003|Overall Study|Lost to Follow-up|6|||
27914272|NCT01819727|81525813|FG000|Overall Study|Adverse Event|8|||
27914273|NCT01819727|81525814|FG001|Overall Study|Adverse Event|9|||
27914274|NCT01819727|81525813|FG000|Overall Study|Death|1|||
27914275|NCT01819727|81525814|FG001|Overall Study|Death|0|||
27914276|NCT01819727|81525813|FG000|Overall Study|Lost to Follow-up|1|||
27914277|NCT01819727|81525814|FG001|Overall Study|Lost to Follow-up|1|||
27914278|NCT01819727|81525813|FG000|Overall Study|Physician Decision|3|||
27914279|NCT01819727|81525814|FG001|Overall Study|Physician Decision|2|||
27914280|NCT01819727|81525813|FG000|Overall Study|Pregnancy|1|||
27914281|NCT01819727|81525814|FG001|Overall Study|Pregnancy|0|||
27914282|NCT01819727|81525813|FG000|Overall Study|Protocol Violation|0|||
27914283|NCT01819727|81525814|FG001|Overall Study|Protocol Violation|2|||
27914284|NCT01819727|81525813|FG000|Overall Study|Study Terminated by Sponsor|0|||
27914285|NCT01819727|81525814|FG001|Overall Study|Study Terminated by Sponsor|1|||
27914286|NCT01819727|81525813|FG000|Overall Study|Withdrawal by Subject|6|||
27914287|NCT01819727|81525814|FG001|Overall Study|Withdrawal by Subject|11|||
27738064|NCT03826914|80871102|FG001|Overall Study|Withdrawal by Subject|1|||
27738065|NCT03478683|80871113|FG000|Overall Study|Adverse Event|5|||
27738066|NCT03478683|80871114|FG001|Overall Study|Adverse Event|3|||
27738067|NCT03478683|80871113|FG000|Overall Study|Lost to Follow-up|0|||
27738068|NCT03478683|80871114|FG001|Overall Study|Lost to Follow-up|5|||
27738069|NCT03478683|80871113|FG000|Overall Study|Physician Decision|1|||
27738070|NCT03478683|80871114|FG001|Overall Study|Physician Decision|3|||
27738071|NCT03478683|80871113|FG000|Overall Study|Withdrawal by Subject|7|||
27738072|NCT03478683|80871114|FG001|Overall Study|Withdrawal by Subject|7|||
27738073|NCT00852930|80871115|FG000|Overall Study|Withdrawal by Subject|1|||
27738074|NCT00852930|80871116|FG001|Overall Study|Withdrawal by Subject|1|||
27738075|NCT00852930|80871117|FG002|Overall Study|Withdrawal by Subject|1|||
27738076|NCT00852930|80871115|FG000|Overall Study|Physician Decision|0|||
27738077|NCT00852930|80871116|FG001|Overall Study|Physician Decision|0|||
27738078|NCT00852930|80871117|FG002|Overall Study|Physician Decision|1|||
27738079|NCT02111369|80871120|FG000|Overall Study|Lost to Follow-up|2|||
27738080|NCT02111369|80871120|FG000|Overall Study|Withdrawal by Subject|1|||
27738081|NCT00206518|80871126|FG000|Overall Study|Lack of Efficacy|6|||
27738082|NCT00206518|80871127|FG001|Overall Study|Lack of Efficacy|4|||
27738083|NCT00206518|80871126|FG000|Overall Study|Adverse Event|2|||
27738084|NCT00206518|80871127|FG001|Overall Study|Adverse Event|1|||
27738085|NCT00206518|80871126|FG000|Overall Study|Physician Decision|1|||
27738086|NCT00206518|80871127|FG001|Overall Study|Physician Decision|0|||
27738087|NCT00206518|80871126|FG000|Overall Study|Protocol Violation|1|||
27738088|NCT00206518|80871127|FG001|Overall Study|Protocol Violation|1|||
27738089|NCT01480180|80871128|FG000|Main Phase|Withdrawal criteria|12|||
27738090|NCT01480180|80871129|FG001|Main Phase|Withdrawal criteria|1|||
27738091|NCT01480180|80871130|FG002|Main Phase|Withdrawal criteria|0|||
27738092|NCT01480180|80871131|FG003|Main Phase|Withdrawal criteria|0|||
27738093|NCT01480180|80871132|FG004|Main Phase|Withdrawal criteria|0|||
27914288|NCT01819727|81525813|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
27534595|NCT03595774|80153300|FG001|Overall Study|screen failure|1|||
27534596|NCT03595774|80153301|FG002|Overall Study|screen failure|0|||
27534597|NCT03595774|80153302|FG003|Overall Study|screen failure|1|||
27534598|NCT01823146|80153303|FG000|Overall Study|Withdrawal by Subject|0|||
27534599|NCT01823146|80153304|FG001|Overall Study|Withdrawal by Subject|1|||
27534600|NCT01823146|80153303|FG000|Overall Study|Lost to Follow-up|2|||
27534601|NCT01823146|80153304|FG001|Overall Study|Lost to Follow-up|1|||
27534602|NCT00958789|80153305|FG000|Overall Study|Death|5|||
27534603|NCT00958789|80153305|FG000|Overall Study|Lost to Follow-up|14|||
27534604|NCT00958789|80153305|FG000|Overall Study|Withdrawal by Subject|17|||
27534605|NCT00958789|80153305|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
27534606|NCT00958789|80153305|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
27534607|NCT00958789|80153305|FG000|Overall Study|Subject terminated|2|||
27738094|NCT01480180|80871133|FG005|Main Phase|Withdrawal criteria|0|||
27738095|NCT01480180|80871128|FG000|Main Phase|Lack of Efficacy|1|||
27738096|NCT01480180|80871129|FG001|Main Phase|Lack of Efficacy|0|||
27738097|NCT01480180|80871130|FG002|Main Phase|Lack of Efficacy|0|||
27738098|NCT01480180|80871131|FG003|Main Phase|Lack of Efficacy|0|||
27738099|NCT01480180|80871132|FG004|Main Phase|Lack of Efficacy|0|||
27738100|NCT01480180|80871133|FG005|Main Phase|Lack of Efficacy|0|||
27534608|NCT00958789|80153305|FG000|Overall Study|Revision|7|||
27534609|NCT00191906|80153306|FG000|Study Period II|Adverse Event|0|||
27738101|NCT01480180|80871128|FG000|Main Phase|Non-compliance|3|||
27738102|NCT01480180|80871129|FG001|Main Phase|Non-compliance|0|||
27738103|NCT01480180|80871130|FG002|Main Phase|Non-compliance|0|||
27738104|NCT01480180|80871131|FG003|Main Phase|Non-compliance|0|||
27738105|NCT01480180|80871132|FG004|Main Phase|Non-compliance|0|||
27738106|NCT01480180|80871133|FG005|Main Phase|Non-compliance|0|||
27534610|NCT00191906|80153307|FG001|Study Period II|Adverse Event|1|||
27738107|NCT01480180|80871128|FG000|Main Phase|Unclassified|3|||
27534611|NCT00191906|80153308|FG002|Study Period II|Adverse Event|0|||
27738108|NCT01480180|80871129|FG001|Main Phase|Unclassified|0|||
27914289|NCT01819727|81525814|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
27914290|NCT01819727|81525813|FG000|Overall Study|Quit due to lack of health benifits|0|||
27914291|NCT01819727|81525814|FG001|Overall Study|Quit due to lack of health benifits|1|||
27914292|NCT01324947|81525817|FG000|Overall Study|Adverse Event|7|||
27914293|NCT01324947|81525817|FG000|Overall Study|Death|10|||
27914294|NCT01324947|81525817|FG000|Overall Study|Other|3|||
27914295|NCT01324947|81525817|FG000|Overall Study|Progressive Disease|50|||
27914296|NCT01324947|81525817|FG000|Overall Study|Withdrawal by Subject|3|||
27914297|NCT01324947|81525817|FG000|Overall Study|1 discontinued before starting drug|1|||
27914298|NCT01663402|81525822|FG000|Overall Study|Randomized but not treated|19|||
27914299|NCT01663402|81525823|FG001|Overall Study|Randomized but not treated|11|||
27914300|NCT01663402|81525822|FG000|Overall Study|Adverse Event|347|||
27914301|NCT01663402|81525823|FG001|Overall Study|Adverse Event|362|||
27914302|NCT01663402|81525822|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
27914303|NCT01663402|81525823|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
27914304|NCT01663402|81525822|FG000|Overall Study|Poor compliance to protocol|529|||
27914305|NCT01663402|81525823|FG001|Overall Study|Poor compliance to protocol|454|||
27914306|NCT01663402|81525822|FG000|Overall Study|Physician Decision|77|||
27914307|NCT01663402|81525823|FG001|Overall Study|Physician Decision|62|||
27914308|NCT01663402|81525822|FG000|Overall Study|Site terminated by sponsor|1|||
27914309|NCT01663402|81525823|FG001|Overall Study|Site terminated by sponsor|3|||
27914310|NCT01663402|81525822|FG000|Overall Study|Participant moved|139|||
27914311|NCT01663402|81525823|FG001|Overall Study|Participant moved|104|||
27914312|NCT01663402|81525822|FG000|Overall Study|Withdrawal by Subject|118|||
27914313|NCT01663402|81525823|FG001|Overall Study|Withdrawal by Subject|91|||
27630546|NCT01651949|80490003|FG000|Overall Study|Screen failure|2|||
27630547|NCT01651949|80490004|FG001|Overall Study|Screen failure|2|||
27630548|NCT01651949|80490005|FG002|Overall Study|Screen failure|0|||
27630549|NCT01651949|80490003|FG000|Overall Study|Withdrawal by Subject|17|||
27630550|NCT01651949|80490004|FG001|Overall Study|Withdrawal by Subject|18|||
27630551|NCT01651949|80490005|FG002|Overall Study|Withdrawal by Subject|9|||
27630552|NCT00430300|80490008|FG000|Overall Study|Adverse Event|0|||
27630553|NCT00430300|80490009|FG001|Overall Study|Adverse Event|2|||
27630554|NCT00430300|80490010|FG002|Overall Study|Adverse Event|1|||
27630555|NCT00430300|80490011|FG003|Overall Study|Adverse Event|1|||
27630556|NCT00430300|80490008|FG000|Overall Study|Withdrawal by Subject|1|||
27630557|NCT00430300|80490009|FG001|Overall Study|Withdrawal by Subject|0|||
27630558|NCT00430300|80490010|FG002|Overall Study|Withdrawal by Subject|5|||
27630559|NCT00430300|80490011|FG003|Overall Study|Withdrawal by Subject|0|||
27630560|NCT00430300|80490008|FG000|Overall Study|Laboratory abnormality|1|||
27630561|NCT00430300|80490009|FG001|Overall Study|Laboratory abnormality|0|||
27630562|NCT00430300|80490010|FG002|Overall Study|Laboratory abnormality|0|||
27630563|NCT00430300|80490011|FG003|Overall Study|Laboratory abnormality|0|||
27630564|NCT00430300|80490008|FG000|Overall Study|Other|0|||
27630565|NCT00430300|80490009|FG001|Overall Study|Other|0|||
27630566|NCT00430300|80490010|FG002|Overall Study|Other|0|||
27630567|NCT00430300|80490011|FG003|Overall Study|Other|1|||
27630568|NCT00547118|80490020|FG000|Overall Study|Did not qualify prior to starting drug|1|||
27630569|NCT00547118|80490021|FG001|Overall Study|Did not qualify prior to starting drug|1|||
27630570|NCT00547118|80490020|FG000|Overall Study|Study suspended|7|||
27630571|NCT00547118|80490021|FG001|Overall Study|Study suspended|8|||
27630572|NCT03710564|80490023|FG000|Overall Study|Study Terminated by Sponsor|104|||
27630573|NCT03710564|80490024|FG001|Overall Study|Study Terminated by Sponsor|55|||
27630574|NCT03710564|80490023|FG000|Overall Study|Withdrawal by Subject|57|||
27630575|NCT03710564|80490024|FG001|Overall Study|Withdrawal by Subject|25|||
27630576|NCT03710564|80490023|FG000|Overall Study|Death|10|||
27630577|NCT03710564|80490024|FG001|Overall Study|Death|4|||
27630578|NCT03710564|80490023|FG000|Overall Study|Lost to Follow-up|5|||
27630579|NCT03710564|80490024|FG001|Overall Study|Lost to Follow-up|4|||
27630580|NCT03710564|80490023|FG000|Overall Study|Protocol Violation|3|||
27630581|NCT03710564|80490024|FG001|Overall Study|Protocol Violation|2|||
27630582|NCT03710564|80490023|FG000|Overall Study|Adverse Event|3|||
27630583|NCT03710564|80490024|FG001|Overall Study|Adverse Event|0|||
27630584|NCT03710564|80490023|FG000|Overall Study|Physician Decision|2|||
27914314|NCT01663402|81525822|FG000|Overall Study|Related to study drug administration|96|||
27914315|NCT01663402|81525823|FG001|Overall Study|Related to study drug administration|105|||
27914316|NCT01663402|81525822|FG000|Overall Study|Lost to Follow-up|17|||
27630585|NCT03710564|80490024|FG001|Overall Study|Physician Decision|3|||
27630586|NCT00814346|80490029|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
27630587|NCT00814346|80490030|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
27630588|NCT00814346|80490029|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
27630589|NCT00814346|80490030|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
27914317|NCT01663402|81525823|FG001|Overall Study|Lost to Follow-up|15|||
27630590|NCT00814346|80490029|FG000|Open Phase (17 Months)|Adverse Event|5|||
27630591|NCT00814346|80490030|FG001|Open Phase (17 Months)|Adverse Event|0|||
27630592|NCT00814346|80490029|FG000|Open Phase (17 Months)|Consent|2|||
27630593|NCT00814346|80490030|FG001|Open Phase (17 Months)|Consent|0|||
27630594|NCT00814346|80490029|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
27914318|NCT01663402|81525822|FG000|Overall Study|Other than specified above|172|||
27630595|NCT00814346|80490030|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
27630596|NCT00814346|80490029|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
27630597|NCT00814346|80490030|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
27630598|NCT00612586|80490031|FG000|Overall Study|Adverse Event|6|||
27630599|NCT00612586|80490032|FG001|Overall Study|Adverse Event|2|||
27630600|NCT00612586|80490031|FG000|Overall Study|Death|1|||
27630601|NCT00612586|80490032|FG001|Overall Study|Death|0|||
27630602|NCT00612586|80490031|FG000|Overall Study|Entry Criteria Not Met|0|||
27630603|NCT00612586|80490032|FG001|Overall Study|Entry Criteria Not Met|2|||
27630604|NCT00612586|80490031|FG000|Overall Study|Withdrawal by Subject|7|||
27630605|NCT00612586|80490032|FG001|Overall Study|Withdrawal by Subject|9|||
27630606|NCT00612586|80490031|FG000|Overall Study|Physician Decision|1|||
27630607|NCT00612586|80490032|FG001|Overall Study|Physician Decision|2|||
27630608|NCT00612586|80490031|FG000|Overall Study|Sponsor Decision|1|||
27630609|NCT00612586|80490032|FG001|Overall Study|Sponsor Decision|1|||
27630610|NCT00612586|80490031|FG000|Overall Study|Progressive Disease|26|||
27630611|NCT00612586|80490032|FG001|Overall Study|Progressive Disease|24|||
27630612|NCT00612586|80490031|FG000|Overall Study|Randomized and Not Treated|1|||
27630613|NCT00612586|80490032|FG001|Overall Study|Randomized and Not Treated|1|||
27630614|NCT02674750|80490033|FG000|Overall Study|Death|4|||
27630615|NCT02674750|80490034|FG001|Overall Study|Death|5|||
27630616|NCT02674750|80490035|FG002|Overall Study|Death|8|||
27630617|NCT02674750|80490033|FG000|Overall Study|Lost to Follow-up|0|||
27630618|NCT02674750|80490034|FG001|Overall Study|Lost to Follow-up|8|||
27630619|NCT02674750|80490035|FG002|Overall Study|Lost to Follow-up|0|||
27630620|NCT02674750|80490033|FG000|Overall Study|Lack of Efficacy|1|||
27630621|NCT02674750|80490034|FG001|Overall Study|Lack of Efficacy|17|||
27630622|NCT02674750|80490035|FG002|Overall Study|Lack of Efficacy|3|||
27630623|NCT02674750|80490033|FG000|Overall Study|Withdrawal by Subject|0|||
27630624|NCT02674750|80490034|FG001|Overall Study|Withdrawal by Subject|7|||
27630625|NCT02674750|80490035|FG002|Overall Study|Withdrawal by Subject|1|||
27630626|NCT02674750|80490033|FG000|Overall Study|Other|0|||
27630627|NCT02674750|80490034|FG001|Overall Study|Other|8|||
27630628|NCT02674750|80490035|FG002|Overall Study|Other|0|||
27630629|NCT00383188|80490036|FG000|Overall Study|Adverse Event|4|||
27630630|NCT00383188|80490037|FG001|Overall Study|Adverse Event|7|||
27630631|NCT00383188|80490038|FG002|Overall Study|Adverse Event|9|||
27630632|NCT00383188|80490039|FG003|Overall Study|Adverse Event|8|||
27630633|NCT00383188|80490040|FG004|Overall Study|Adverse Event|8|||
27630634|NCT00383188|80490036|FG000|Overall Study|Lack of Efficacy|9|||
27630635|NCT00383188|80490037|FG001|Overall Study|Lack of Efficacy|3|||
27630636|NCT00383188|80490038|FG002|Overall Study|Lack of Efficacy|3|||
27630637|NCT00383188|80490039|FG003|Overall Study|Lack of Efficacy|2|||
27630638|NCT00383188|80490040|FG004|Overall Study|Lack of Efficacy|6|||
27630639|NCT00383188|80490036|FG000|Overall Study|Other|3|||
27630640|NCT00383188|80490037|FG001|Overall Study|Other|1|||
27630641|NCT00383188|80490038|FG002|Overall Study|Other|0|||
27630642|NCT00383188|80490039|FG003|Overall Study|Other|2|||
27630643|NCT00383188|80490040|FG004|Overall Study|Other|6|||
27630644|NCT00383188|80490036|FG000|Overall Study|No longer willing to participate|1|||
27630645|NCT00383188|80490037|FG001|Overall Study|No longer willing to participate|0|||
27630646|NCT00383188|80490038|FG002|Overall Study|No longer willing to participate|1|||
27630647|NCT00383188|80490039|FG003|Overall Study|No longer willing to participate|0|||
27630648|NCT00383188|80490040|FG004|Overall Study|No longer willing to participate|2|||
27630649|NCT00383188|80490036|FG000|Overall Study|Lost to Follow-up|0|||
27630650|NCT00383188|80490037|FG001|Overall Study|Lost to Follow-up|0|||
27630651|NCT00383188|80490038|FG002|Overall Study|Lost to Follow-up|0|||
27630652|NCT00383188|80490039|FG003|Overall Study|Lost to Follow-up|0|||
27630653|NCT00383188|80490040|FG004|Overall Study|Lost to Follow-up|1|||
27630654|NCT01792830|80490041|FG000|Overall Study|Withdrawal by Subject|22|||
27630655|NCT01792830|80490042|FG001|Overall Study|Withdrawal by Subject|0|||
27630656|NCT01792830|80490043|FG002|Overall Study|Withdrawal by Subject|0|||
27630657|NCT01792830|80490044|FG003|Overall Study|Withdrawal by Subject|2|||
27738109|NCT01480180|80871130|FG002|Main Phase|Unclassified|0|||
27630658|NCT01792830|80490045|FG004|Overall Study|Withdrawal by Subject|1|||
27630659|NCT01792830|80490046|FG005|Overall Study|Withdrawal by Subject|1|||
27630660|NCT01792830|80490047|FG006|Overall Study|Withdrawal by Subject|1|||
27630661|NCT01792830|80490048|FG007|Overall Study|Withdrawal by Subject|1|||
27630662|NCT01792830|80490049|FG008|Overall Study|Withdrawal by Subject|7|||
27630663|NCT01792830|80490050|FG009|Overall Study|Withdrawal by Subject|0|||
27630664|NCT01792830|80490051|FG010|Overall Study|Withdrawal by Subject|2|||
27630665|NCT01792830|80490041|FG000|Overall Study|Death|3|||
27630666|NCT01792830|80490042|FG001|Overall Study|Death|0|||
27630667|NCT01792830|80490043|FG002|Overall Study|Death|0|||
27630668|NCT01792830|80490044|FG003|Overall Study|Death|1|||
27630669|NCT01792830|80490045|FG004|Overall Study|Death|0|||
27630670|NCT01792830|80490046|FG005|Overall Study|Death|0|||
27630671|NCT01792830|80490047|FG006|Overall Study|Death|1|||
27630672|NCT01792830|80490048|FG007|Overall Study|Death|0|||
27630673|NCT01792830|80490049|FG008|Overall Study|Death|1|||
27630674|NCT01792830|80490050|FG009|Overall Study|Death|0|||
27630675|NCT01792830|80490051|FG010|Overall Study|Death|1|||
27630676|NCT01792830|80490041|FG000|Overall Study|Adverse Event|0|||
27630677|NCT01792830|80490042|FG001|Overall Study|Adverse Event|0|||
27630678|NCT01792830|80490043|FG002|Overall Study|Adverse Event|0|||
27630679|NCT01792830|80490044|FG003|Overall Study|Adverse Event|0|||
27630680|NCT01792830|80490045|FG004|Overall Study|Adverse Event|0|||
27630681|NCT01792830|80490046|FG005|Overall Study|Adverse Event|0|||
27630682|NCT01792830|80490047|FG006|Overall Study|Adverse Event|0|||
27630683|NCT01792830|80490048|FG007|Overall Study|Adverse Event|0|||
27630684|NCT01792830|80490049|FG008|Overall Study|Adverse Event|1|||
27630685|NCT01792830|80490050|FG009|Overall Study|Adverse Event|0|||
27534612|NCT00191906|80153309|FG003|Study Period II|Adverse Event|0|||
27534613|NCT00191906|80153306|FG000|Study Period II|Withdrawal by Subject|0|||
27534614|NCT00191906|80153307|FG001|Study Period II|Withdrawal by Subject|3|||
27534615|NCT00191906|80153308|FG002|Study Period II|Withdrawal by Subject|0|||
27534616|NCT00191906|80153309|FG003|Study Period II|Withdrawal by Subject|0|||
27534617|NCT00191906|80153306|FG000|Study Period II|Parent/Caregiver Decision|0|||
27534618|NCT00191906|80153307|FG001|Study Period II|Parent/Caregiver Decision|1|||
27534619|NCT00191906|80153308|FG002|Study Period II|Parent/Caregiver Decision|0|||
27534620|NCT00191906|80153309|FG003|Study Period II|Parent/Caregiver Decision|0|||
27534621|NCT00191906|80153306|FG000|Study Period II|Entry Criteria Exclusion|0|||
27534622|NCT00191906|80153307|FG001|Study Period II|Entry Criteria Exclusion|0|||
27534623|NCT00191906|80153308|FG002|Study Period II|Entry Criteria Exclusion|1|||
27534624|NCT00191906|80153309|FG003|Study Period II|Entry Criteria Exclusion|0|||
27534625|NCT00191906|80153306|FG000|Study Period III|Adverse Event|1|||
27534626|NCT00191906|80153307|FG001|Study Period III|Adverse Event|0|||
27534627|NCT00191906|80153308|FG002|Study Period III|Adverse Event|0|||
27534628|NCT00191906|80153309|FG003|Study Period III|Adverse Event|0|||
27534629|NCT00191906|80153306|FG000|Study Period III|Lost to Follow-up|0|||
27534630|NCT00191906|80153307|FG001|Study Period III|Lost to Follow-up|1|||
27534631|NCT00191906|80153308|FG002|Study Period III|Lost to Follow-up|0|||
27534632|NCT00191906|80153309|FG003|Study Period III|Lost to Follow-up|0|||
27534633|NCT00191906|80153306|FG000|Study Period III|Parent/Caregiver Decision|1|||
27534634|NCT00191906|80153307|FG001|Study Period III|Parent/Caregiver Decision|0|||
27534635|NCT00191906|80153308|FG002|Study Period III|Parent/Caregiver Decision|0|||
27534636|NCT00191906|80153309|FG003|Study Period III|Parent/Caregiver Decision|0|||
27534637|NCT00191906|80153306|FG000|Study Period III|Lack of Efficacy|3|||
27534638|NCT00191906|80153307|FG001|Study Period III|Lack of Efficacy|3|||
27534639|NCT00191906|80153308|FG002|Study Period III|Lack of Efficacy|0|||
27534640|NCT00191906|80153309|FG003|Study Period III|Lack of Efficacy|0|||
27534641|NCT03570697|80153312|FG000|Overall Study|Lost to Follow-up|0|||
27534642|NCT03570697|80153313|FG001|Overall Study|Lost to Follow-up|1|||
27534643|NCT03570697|80153312|FG000|Overall Study|Death|2|||
27534644|NCT03570697|80153313|FG001|Overall Study|Death|0|||
27534645|NCT03570697|80153312|FG000|Overall Study|Withdrawal by Subject|4|||
27534646|NCT03570697|80153313|FG001|Overall Study|Withdrawal by Subject|2|||
27534647|NCT00467857|80153324|FG000|Overall Study|Adverse Event|1|||
27630686|NCT01792830|80490051|FG010|Overall Study|Adverse Event|0|||
27630687|NCT02131324|80490052|FG000|Overall Study|Withdrawal by Subject|1|||
27630688|NCT02131324|80490053|FG001|Overall Study|Withdrawal by Subject|2|||
27630689|NCT02131324|80490052|FG000|Overall Study|Lost to Follow-up|1|||
27630690|NCT02131324|80490053|FG001|Overall Study|Lost to Follow-up|1|||
27630691|NCT02148133|80490054|FG000|Overall Study|Investigator discretion|1|||
27630692|NCT02148133|80490054|FG000|Overall Study|Lack of Efficacy|1|||
27630693|NCT02148133|80490054|FG000|Overall Study|Protocol deviation|1|||
27630694|NCT02148133|80490054|FG000|Overall Study|Protocol-defined stopping criteria|2|||
27630695|NCT02994654|80490055|FG000|Overall Study|Lost to Follow-up|1|||
27630696|NCT00408928|80490056|FG000|Overall Study|Withdrawal by Subject|1|||
27630697|NCT00408928|80490056|FG000|Overall Study|Death|1|||
27630698|NCT00408928|80490056|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
27630699|NCT01390402|80490059|FG000|Overall Study|Death|1|||
27630700|NCT01390402|80490059|FG000|Overall Study|Disease Progression|4|||
27630701|NCT01591616|80490062|FG000|Overall Study|Withdrawal by Subject|1|||
27630702|NCT03278028|80490063|FG000|Overall Study|Lost to Follow-up|1|||
27630703|NCT03278028|80490064|FG001|Overall Study|Lost to Follow-up|0|||
27630704|NCT03278028|80490063|FG000|Overall Study|Withdrawal by Subject|3|||
27630705|NCT03278028|80490064|FG001|Overall Study|Withdrawal by Subject|1|||
27630706|NCT03278028|80490063|FG000|Overall Study|Pregnancy|0|||
27630707|NCT03278028|80490064|FG001|Overall Study|Pregnancy|1|||
27630708|NCT03181958|80490068|FG000|Overall Study|Lost to Follow-up|17|||
27534648|NCT00467857|80153325|FG001|Overall Study|Adverse Event|0|||
27534649|NCT00467857|80153324|FG000|Overall Study|Withdrew consent|2|||
27534650|NCT00467857|80153325|FG001|Overall Study|Withdrew consent|0|||
27534651|NCT00467857|80153324|FG000|Overall Study|Death|0|||
27534652|NCT00467857|80153325|FG001|Overall Study|Death|1|||
27534653|NCT00467857|80153324|FG000|Overall Study|Discharged from court service|0|||
27534654|NCT00467857|80153325|FG001|Overall Study|Discharged from court service|1|||
27630709|NCT03181958|80490069|FG001|Overall Study|Lost to Follow-up|21|||
27630710|NCT03181958|80490070|FG002|Overall Study|Lost to Follow-up|15|||
27630711|NCT01499134|80490071|FG000|Overall Study|Withdrawal by Subject|0|||
27630712|NCT01499134|80490072|FG001|Overall Study|Withdrawal by Subject|1|||
27630713|NCT01048788|80490073|FG000|Overall Study|Adverse Event|5|||
27630714|NCT01048788|80490074|FG001|Overall Study|Adverse Event|1|||
27630715|NCT01048788|80490075|FG002|Overall Study|Adverse Event|1|||
27630716|NCT01048788|80490073|FG000|Overall Study|Lack of Efficacy|0|||
27630717|NCT01048788|80490074|FG001|Overall Study|Lack of Efficacy|0|||
27630718|NCT01048788|80490075|FG002|Overall Study|Lack of Efficacy|1|||
27630719|NCT01048788|80490073|FG000|Overall Study|Withdrawal by Subject|0|||
27630720|NCT01048788|80490074|FG001|Overall Study|Withdrawal by Subject|1|||
27630721|NCT01048788|80490075|FG002|Overall Study|Withdrawal by Subject|0|||
27630722|NCT02248480|80490076|FG000|Overall Study|Lack of Efficacy|4|||
27630723|NCT02248480|80490077|FG001|Overall Study|Lack of Efficacy|6|||
27630724|NCT02248480|80490076|FG000|Overall Study|Adverse Event|11|||
27630725|NCT02248480|80490077|FG001|Overall Study|Adverse Event|2|||
27630726|NCT02248480|80490076|FG000|Overall Study|Withdrawal by Subject|2|||
27630727|NCT02248480|80490077|FG001|Overall Study|Withdrawal by Subject|4|||
27630728|NCT02248480|80490076|FG000|Overall Study|Entry Criteria Not Met|0|||
27630729|NCT02248480|80490077|FG001|Overall Study|Entry Criteria Not Met|1|||
27630730|NCT02248480|80490076|FG000|Overall Study|Other:Physician Decision|0|||
27630731|NCT02248480|80490077|FG001|Overall Study|Other:Physician Decision|1|||
27630732|NCT02049866|80490078|FG000|Overall Study|Withdrawal by Subject|1|||
27630733|NCT05179837|80490080|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
27630734|NCT05179837|80490080|FG000|Overall Study|Device malfunctioned|1|||
27630735|NCT05179837|80490080|FG000|Overall Study|Image quality too low|2|||
27630736|NCT01196988|80490084|FG000|Overall Study|Adverse Event|1|||
27738110|NCT01480180|80871131|FG003|Main Phase|Unclassified|0|||
27914319|NCT01663402|81525823|FG001|Overall Study|Other than specified above|147|||
27914320|NCT04249427|81525824|FG000|Overall Study|Adverse Event|3|||
27914321|NCT04249427|81525825|FG001|Overall Study|Adverse Event|1|||
27914322|NCT04249427|81525824|FG000|Overall Study|Lack of Efficacy|0|||
27914323|NCT04249427|81525825|FG001|Overall Study|Lack of Efficacy|1|||
27914324|NCT04249427|81525824|FG000|Overall Study|Withdrawal by Subject|1|||
27914325|NCT04249427|81525825|FG001|Overall Study|Withdrawal by Subject|2|||
27914326|NCT02762084|81525827|FG000|Overall Study|Withdrawal by Subject|1|||
27914327|NCT02762084|81525828|FG001|Overall Study|Withdrawal by Subject|0|||
27914328|NCT02762084|81525829|FG002|Overall Study|Withdrawal by Subject|0|||
27914329|NCT02762084|81525827|FG000|Overall Study|Adverse Event|0|||
27914330|NCT02762084|81525828|FG001|Overall Study|Adverse Event|0|||
27914331|NCT02762084|81525829|FG002|Overall Study|Adverse Event|1|||
27914332|NCT03092752|81525830|FG000|Overall Study|Aged <40 years|14209|||
27914333|NCT03092752|81525830|FG000|Overall Study|At least one claim with T2DM|61299|||
27914334|NCT03092752|81525830|FG000|Overall Study|Having no claim of study drugs|29282|||
27914335|NCT03092752|81525830|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
27914336|NCT03092752|81525830|FG000|Overall Study|<6 month history|245900|||
27914337|NCT02329847|81525831|FG000|Overall Study|Death|4|||
27914338|NCT02329847|81525832|FG001|Overall Study|Death|4|||
27914339|NCT02329847|81525833|FG002|Overall Study|Death|22|||
27914340|NCT02329847|81525834|FG003|Overall Study|Death|12|||
27914341|NCT02329847|81525835|FG004|Overall Study|Death|20|||
27914342|NCT02329847|81525836|FG005|Overall Study|Death|13|||
27914343|NCT02329847|81525831|FG000|Overall Study|Lost to Follow-up|0|||
27534655|NCT00467857|80153324|FG000|Overall Study|Emergency care required|0|||
27534656|NCT00467857|80153325|FG001|Overall Study|Emergency care required|1|||
27534657|NCT00467857|80153324|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
27534658|NCT00467857|80153325|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
27534659|NCT00467857|80153324|FG000|Overall Study|Discontinuation reason missing|0|||
27534660|NCT00467857|80153325|FG001|Overall Study|Discontinuation reason missing|3|||
27534661|NCT01187433|80153326|FG000|Overall Study|Protocol Violation|6|||
27534662|NCT01187433|80153327|FG001|Overall Study|Protocol Violation|2|||
27914344|NCT02329847|81525832|FG001|Overall Study|Lost to Follow-up|0|||
27914345|NCT02329847|81525833|FG002|Overall Study|Lost to Follow-up|2|||
27914346|NCT02329847|81525834|FG003|Overall Study|Lost to Follow-up|3|||
27914347|NCT02329847|81525835|FG004|Overall Study|Lost to Follow-up|0|||
27914348|NCT02329847|81525836|FG005|Overall Study|Lost to Follow-up|1|||
27914349|NCT02329847|81525831|FG000|Overall Study|Physician Decision|0|||
27534663|NCT01187433|80153326|FG000|Overall Study|Withdrawal by Subject|5|||
27534664|NCT01187433|80153327|FG001|Overall Study|Withdrawal by Subject|2|||
27534665|NCT00302107|80153328|FG000|Overall Study|Lost to Follow-up|6|||
27534666|NCT00302107|80153329|FG001|Overall Study|Lost to Follow-up|5|||
27534667|NCT00302107|80153328|FG000|Overall Study|Protocol Violation|1|||
27534668|NCT00302107|80153329|FG001|Overall Study|Protocol Violation|0|||
27534669|NCT00302107|80153328|FG000|Overall Study|Relocation|0|||
27914350|NCT02329847|81525832|FG001|Overall Study|Physician Decision|0|||
27914351|NCT02329847|81525833|FG002|Overall Study|Physician Decision|0|||
27914352|NCT02329847|81525834|FG003|Overall Study|Physician Decision|0|||
27914353|NCT02329847|81525835|FG004|Overall Study|Physician Decision|1|||
27914354|NCT02329847|81525836|FG005|Overall Study|Physician Decision|0|||
27914355|NCT02329847|81525831|FG000|Overall Study|Withdrawal by Subject|2|||
27914356|NCT02329847|81525832|FG001|Overall Study|Withdrawal by Subject|1|||
27914357|NCT02329847|81525833|FG002|Overall Study|Withdrawal by Subject|5|||
27914358|NCT02329847|81525834|FG003|Overall Study|Withdrawal by Subject|7|||
27914359|NCT02329847|81525835|FG004|Overall Study|Withdrawal by Subject|8|||
27914360|NCT02329847|81525836|FG005|Overall Study|Withdrawal by Subject|3|||
27914361|NCT02329847|81525831|FG000|Overall Study|Other|1|||
27914362|NCT02329847|81525832|FG001|Overall Study|Other|2|||
27914363|NCT02329847|81525833|FG002|Overall Study|Other|6|||
27914364|NCT02329847|81525834|FG003|Overall Study|Other|13|||
27914365|NCT02329847|81525835|FG004|Overall Study|Other|10|||
27914366|NCT02329847|81525836|FG005|Overall Study|Other|3|||
27914367|NCT00667563|81525844|FG000|Overall Study|Protocol Violation|24|||
27914368|NCT03327324|81525846|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914369|NCT03327324|81525847|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27914370|NCT03327324|81525848|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914371|NCT03327324|81525849|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27914372|NCT03327324|81525850|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914373|NCT03327324|81525851|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
27914374|NCT03327324|81525846|FG000|Baseline (Month 0-Month 3)|Refused|0|||
27914375|NCT03327324|81525847|FG001|Baseline (Month 0-Month 3)|Refused|0|||
27914376|NCT03327324|81525848|FG002|Baseline (Month 0-Month 3)|Refused|0|||
27914377|NCT03327324|81525849|FG003|Baseline (Month 0-Month 3)|Refused|0|||
27914378|NCT03327324|81525850|FG004|Baseline (Month 0-Month 3)|Refused|1|||
27914379|NCT03327324|81525851|FG005|Baseline (Month 0-Month 3)|Refused|0|||
27914380|NCT03327324|81525846|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27914381|NCT03327324|81525847|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
27914382|NCT03327324|81525848|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27534670|NCT00302107|80153329|FG001|Overall Study|Relocation|1|||
27534671|NCT00302107|80153328|FG000|Overall Study|Withdrawal by Subject|0|||
27534672|NCT00302107|80153329|FG001|Overall Study|Withdrawal by Subject|3|||
27534673|NCT00302107|80153328|FG000|Overall Study|Adverse Event|1|||
27534674|NCT00302107|80153329|FG001|Overall Study|Adverse Event|0|||
27534675|NCT05095454|80153330|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
27534676|NCT05095454|80153331|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
27534677|NCT00338104|80153332|FG000|Overall Study|Protocol Violation|2|||
27534678|NCT00338104|80153333|FG001|Overall Study|Protocol Violation|1|||
27534679|NCT00338104|80153334|FG002|Overall Study|Protocol Violation|3|||
27534680|NCT03468985|80153337|FG000|Overall Study|Adverse Event|0|||
27534681|NCT03468985|80153338|FG001|Overall Study|Adverse Event|2|||
27534682|NCT03468985|80153339|FG002|Overall Study|Adverse Event|0|||
27534683|NCT03468985|80153340|FG003|Overall Study|Adverse Event|0|||
27534684|NCT03468985|80153337|FG000|Overall Study|Withdrawal by Subject|0|||
27534685|NCT03468985|80153338|FG001|Overall Study|Withdrawal by Subject|0|||
27534686|NCT03468985|80153339|FG002|Overall Study|Withdrawal by Subject|0|||
27534687|NCT03468985|80153340|FG003|Overall Study|Withdrawal by Subject|1|||
27534688|NCT02919696|80153341|FG000|Overall Study|Adverse Event|1|||
27534689|NCT02919696|80153342|FG001|Overall Study|Adverse Event|2|||
27534690|NCT02919696|80153341|FG000|Overall Study|Withdrawal by Subject|2|||
27534691|NCT02919696|80153342|FG001|Overall Study|Withdrawal by Subject|1|||
27534692|NCT02919696|80153341|FG000|Overall Study|Sponsor Decision|1|||
27534693|NCT02919696|80153342|FG001|Overall Study|Sponsor Decision|1|||
27534694|NCT02919696|80153341|FG000|Overall Study|Never Treated|0|||
27534695|NCT02919696|80153342|FG001|Overall Study|Never Treated|1|||
27534696|NCT00445978|80153344|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
27534697|NCT00445978|80153344|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
27534698|NCT00445978|80153344|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
27534699|NCT00445978|80153344|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
27534700|NCT00445978|80153344|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
27534701|NCT00445978|80153344|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
27534702|NCT00445978|80153344|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
27914383|NCT03327324|81525849|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27534703|NCT00445978|80153344|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
27534704|NCT00445978|80153344|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
27534705|NCT00617851|80153345|FG000|Overall Study|Death|0|||
27534706|NCT00617851|80153346|FG001|Overall Study|Death|0|||
27534707|NCT00617851|80153347|FG002|Overall Study|Death|0|||
27738111|NCT01480180|80871132|FG004|Main Phase|Unclassified|0|||
27738112|NCT01480180|80871133|FG005|Main Phase|Unclassified|0|||
27534708|NCT00617851|80153348|FG003|Overall Study|Death|1|||
27534709|NCT00617851|80153345|FG000|Overall Study|Withdrawal by Subject|14|||
27534710|NCT00617851|80153346|FG001|Overall Study|Withdrawal by Subject|7|||
27534711|NCT00617851|80153347|FG002|Overall Study|Withdrawal by Subject|12|||
27534712|NCT00617851|80153348|FG003|Overall Study|Withdrawal by Subject|4|||
27534713|NCT00617851|80153345|FG000|Overall Study|Lost to Follow-up|27|||
27534714|NCT00617851|80153346|FG001|Overall Study|Lost to Follow-up|29|||
27534715|NCT00617851|80153347|FG002|Overall Study|Lost to Follow-up|31|||
27534716|NCT00617851|80153348|FG003|Overall Study|Lost to Follow-up|19|||
27534717|NCT00617851|80153345|FG000|Overall Study|Inappropriate Enrollment|5|||
27534718|NCT00617851|80153346|FG001|Overall Study|Inappropriate Enrollment|4|||
27534719|NCT00617851|80153347|FG002|Overall Study|Inappropriate Enrollment|1|||
27534720|NCT00617851|80153348|FG003|Overall Study|Inappropriate Enrollment|1|||
27534721|NCT00617851|80153345|FG000|Overall Study|Unable to classify|1|||
27534722|NCT00617851|80153346|FG001|Overall Study|Unable to classify|0|||
27534723|NCT00617851|80153347|FG002|Overall Study|Unable to classify|1|||
27534724|NCT00617851|80153348|FG003|Overall Study|Unable to classify|0|||
27534725|NCT01254630|80153359|FG000|Overall Study|Adverse Event|36|||
27534726|NCT01254630|80153360|FG001|Overall Study|Adverse Event|15|||
27534727|NCT01254630|80153361|FG002|Overall Study|Adverse Event|40|||
27534728|NCT01254630|80153362|FG003|Overall Study|Adverse Event|8|||
27534729|NCT01254630|80153359|FG000|Overall Study|Death|461|||
27534730|NCT01254630|80153360|FG001|Overall Study|Death|151|||
27534731|NCT01254630|80153361|FG002|Overall Study|Death|478|||
27534732|NCT01254630|80153362|FG003|Overall Study|Death|139|||
27534733|NCT01254630|80153359|FG000|Overall Study|Lost to Follow-up|80|||
27534734|NCT01254630|80153360|FG001|Overall Study|Lost to Follow-up|26|||
27534735|NCT01254630|80153361|FG002|Overall Study|Lost to Follow-up|89|||
27534736|NCT01254630|80153362|FG003|Overall Study|Lost to Follow-up|32|||
27534737|NCT01254630|80153359|FG000|Overall Study|Physician Decision|24|||
27534738|NCT01254630|80153360|FG001|Overall Study|Physician Decision|8|||
27534739|NCT01254630|80153361|FG002|Overall Study|Physician Decision|16|||
27534740|NCT01254630|80153362|FG003|Overall Study|Physician Decision|7|||
27534741|NCT01254630|80153359|FG000|Overall Study|Withdrawal by Subject|201|||
27534742|NCT01254630|80153360|FG001|Overall Study|Withdrawal by Subject|94|||
27534743|NCT01254630|80153361|FG002|Overall Study|Withdrawal by Subject|188|||
27534744|NCT01254630|80153362|FG003|Overall Study|Withdrawal by Subject|89|||
27534745|NCT01254630|80153359|FG000|Overall Study|Study terminated by sponsor|0|||
27534746|NCT01254630|80153360|FG001|Overall Study|Study terminated by sponsor|994|||
27534747|NCT01254630|80153361|FG002|Overall Study|Study terminated by sponsor|0|||
27534748|NCT01254630|80153362|FG003|Overall Study|Study terminated by sponsor|1010|||
27914384|NCT03327324|81525850|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27914385|NCT03327324|81525851|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
27914386|NCT03327324|81525846|FG000|Baseline (Month 0-Month 3)|Death|0|||
27914387|NCT03327324|81525847|FG001|Baseline (Month 0-Month 3)|Death|0|||
27914388|NCT03327324|81525848|FG002|Baseline (Month 0-Month 3)|Death|0|||
27914389|NCT03327324|81525849|FG003|Baseline (Month 0-Month 3)|Death|0|||
27914390|NCT03327324|81525850|FG004|Baseline (Month 0-Month 3)|Death|1|||
27914391|NCT03327324|81525851|FG005|Baseline (Month 0-Month 3)|Death|0|||
27914392|NCT03327324|81525846|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914393|NCT03327324|81525847|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914394|NCT03327324|81525848|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914395|NCT03327324|81525849|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27534749|NCT01254630|80153359|FG000|Overall Study|Status not recorded|0|||
27534750|NCT01254630|80153360|FG001|Overall Study|Status not recorded|0|||
27534751|NCT01254630|80153361|FG002|Overall Study|Status not recorded|1|||
27534752|NCT01254630|80153362|FG003|Overall Study|Status not recorded|0|||
27534753|NCT02020577|80153363|FG000|Overall Study|Progressive disease|3|||
27534754|NCT02020577|80153364|FG001|Overall Study|Progressive disease|38|||
27534755|NCT02020577|80153363|FG000|Overall Study|Other AE or clinical progression|0|||
27534756|NCT02020577|80153364|FG001|Overall Study|Other AE or clinical progression|15|||
27534757|NCT02020577|80153363|FG000|Overall Study|Withdrawal by Subject|0|||
27534758|NCT02020577|80153364|FG001|Overall Study|Withdrawal by Subject|1|||
27534759|NCT02020577|80153363|FG000|Overall Study|Other than stated above|0|||
27534760|NCT02020577|80153364|FG001|Overall Study|Other than stated above|1|||
27534761|NCT00423514|80153365|FG000|Overall Study|Ineligible|1|||
27534762|NCT00423514|80153366|FG001|Overall Study|Ineligible|0|||
27534763|NCT01193842|80153369|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27534764|NCT01193842|80153370|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
27534765|NCT01193842|80153371|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27534766|NCT01193842|80153372|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27534767|NCT01193842|80153373|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
27534768|NCT01193842|80153369|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
27534769|NCT01193842|80153370|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27534770|NCT01193842|80153371|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27630737|NCT01196988|80490085|FG001|Overall Study|Adverse Event|2|||
27534771|NCT01193842|80153372|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27534772|NCT01193842|80153373|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
27534773|NCT01193842|80153369|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27534774|NCT01193842|80153370|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27534775|NCT01193842|80153371|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
27534776|NCT01193842|80153372|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27534777|NCT01193842|80153373|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
27534778|NCT01193842|80153369|FG000|Phase II: Randomized Groups|Death|0|||
27534779|NCT01193842|80153370|FG001|Phase II: Randomized Groups|Death|0|||
27534780|NCT01193842|80153371|FG002|Phase II: Randomized Groups|Death|0|||
27534781|NCT01193842|80153372|FG003|Phase II: Randomized Groups|Death|1|||
27534782|NCT01193842|80153373|FG004|Phase II: Randomized Groups|Death|1|||
27534783|NCT01193842|80153369|FG000|Phase II: Randomized Groups|Adverse Event|0|||
27534784|NCT01193842|80153370|FG001|Phase II: Randomized Groups|Adverse Event|0|||
27534785|NCT01193842|80153371|FG002|Phase II: Randomized Groups|Adverse Event|0|||
27534786|NCT01193842|80153372|FG003|Phase II: Randomized Groups|Adverse Event|5|||
27534787|NCT01193842|80153373|FG004|Phase II: Randomized Groups|Adverse Event|3|||
27534788|NCT01193842|80153369|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
27534789|NCT01193842|80153370|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
27534790|NCT01193842|80153371|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
27534791|NCT01193842|80153372|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
27534792|NCT01193842|80153373|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
27738113|NCT01480180|80871128|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
27738114|NCT01480180|80871129|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
27738115|NCT01480180|80871130|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
27738116|NCT01480180|80871131|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
27534793|NCT01193842|80153369|FG000|Phase II: Randomized Groups|Ineligible|0|||
27534794|NCT01193842|80153370|FG001|Phase II: Randomized Groups|Ineligible|0|||
27534795|NCT01193842|80153371|FG002|Phase II: Randomized Groups|Ineligible|0|||
27534796|NCT01193842|80153372|FG003|Phase II: Randomized Groups|Ineligible|0|||
27534797|NCT01193842|80153373|FG004|Phase II: Randomized Groups|Ineligible|1|||
27534798|NCT01193842|80153369|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
27534799|NCT01193842|80153370|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
27630738|NCT01196988|80490086|FG002|Overall Study|Adverse Event|0|||
27630739|NCT01196988|80490087|FG003|Overall Study|Adverse Event|0|||
27630740|NCT01196988|80490084|FG000|Overall Study|Withdrawal by Subject|5|||
27630741|NCT01196988|80490085|FG001|Overall Study|Withdrawal by Subject|1|||
27630742|NCT01196988|80490086|FG002|Overall Study|Withdrawal by Subject|4|||
27630743|NCT01196988|80490087|FG003|Overall Study|Withdrawal by Subject|0|||
27630744|NCT01196988|80490084|FG000|Overall Study|Lost to Follow-up|16|||
27630745|NCT01196988|80490085|FG001|Overall Study|Lost to Follow-up|29|||
27630746|NCT01196988|80490086|FG002|Overall Study|Lost to Follow-up|21|||
27630747|NCT01196988|80490087|FG003|Overall Study|Lost to Follow-up|1|||
27630748|NCT01196988|80490084|FG000|Overall Study|Other|2|||
27630749|NCT01196988|80490085|FG001|Overall Study|Other|0|||
27630750|NCT01196988|80490086|FG002|Overall Study|Other|0|||
27630751|NCT01196988|80490087|FG003|Overall Study|Other|0|||
27630752|NCT00001575|80490088|FG000|Overall Study|Screening failures-Ph I portion|22|||
27630753|NCT00001575|80490088|FG000|Overall Study|Withdrawn/deaths|23|||
27630754|NCT02770248|80490089|FG000|Overall Study|Adverse Event|0|||
27630755|NCT02770248|80490090|FG001|Overall Study|Adverse Event|1|||
27630756|NCT02770248|80490089|FG000|Overall Study|Randomized in error, prior to treatment|0|||
27630757|NCT02770248|80490090|FG001|Overall Study|Randomized in error, prior to treatment|1|||
27630758|NCT01697319|80490095|FG000|Primary Phase|Withdrawal by Subject|1|||
27630759|NCT01697319|80490095|FG000|Extension Phase|Terminated by Sponsor|15|||
27630760|NCT00337818|80490096|FG000|Overall Study|Lost to Follow-up|289|||
27630761|NCT00337818|80490097|FG001|Overall Study|Lost to Follow-up|91|||
27630762|NCT00337818|80490098|FG002|Overall Study|Lost to Follow-up|107|||
27630763|NCT03386929|80490099|FG000|Overall Study|Death|0|||
27630764|NCT03386929|80490100|FG001|Overall Study|Death|0|||
27630765|NCT03386929|80490101|FG002|Overall Study|Death|1|||
27630766|NCT03386929|80490099|FG000|Overall Study|Withdrawal by Subject|0|||
27630767|NCT03386929|80490100|FG001|Overall Study|Withdrawal by Subject|1|||
27630768|NCT03386929|80490101|FG002|Overall Study|Withdrawal by Subject|0|||
27738117|NCT01480180|80871132|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
27738118|NCT01480180|80871133|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
27630769|NCT03386929|80490099|FG000|Overall Study|Physician Decision|0|||
27630770|NCT03386929|80490100|FG001|Overall Study|Physician Decision|0|||
27630771|NCT03386929|80490101|FG002|Overall Study|Physician Decision|1|||
27630772|NCT03386929|80490099|FG000|Overall Study|Progression|4|||
27630773|NCT03386929|80490100|FG001|Overall Study|Progression|4|||
27630774|NCT03386929|80490101|FG002|Overall Study|Progression|0|||
27630775|NCT03386929|80490099|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
27534800|NCT01193842|80153371|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
27738119|NCT01480180|80871128|FG000|Extension Phase, Part 1|Unclassified|0|||
27738120|NCT01480180|80871129|FG001|Extension Phase, Part 1|Unclassified|0|||
27738121|NCT01480180|80871130|FG002|Extension Phase, Part 1|Unclassified|1|||
27738122|NCT01480180|80871131|FG003|Extension Phase, Part 1|Unclassified|0|||
27738123|NCT01480180|80871132|FG004|Extension Phase, Part 1|Unclassified|0|||
27738124|NCT01480180|80871133|FG005|Extension Phase, Part 1|Unclassified|0|||
27738125|NCT01480180|80871128|FG000|Extension Phase, Part 1|Adverse Event|0|||
27738126|NCT01480180|80871129|FG001|Extension Phase, Part 1|Adverse Event|0|||
27738127|NCT01480180|80871130|FG002|Extension Phase, Part 1|Adverse Event|4|||
27738128|NCT01480180|80871131|FG003|Extension Phase, Part 1|Adverse Event|1|||
27738129|NCT01480180|80871132|FG004|Extension Phase, Part 1|Adverse Event|0|||
27738130|NCT01480180|80871133|FG005|Extension Phase, Part 1|Adverse Event|0|||
27738131|NCT01480180|80871128|FG000|Extension Phase, Part 1|Change of treatment|0|||
27738132|NCT01480180|80871129|FG001|Extension Phase, Part 1|Change of treatment|0|||
27738133|NCT01480180|80871130|FG002|Extension Phase, Part 1|Change of treatment|0|||
27738134|NCT01480180|80871131|FG003|Extension Phase, Part 1|Change of treatment|9|||
27738135|NCT01480180|80871132|FG004|Extension Phase, Part 1|Change of treatment|0|||
27738136|NCT01480180|80871133|FG005|Extension Phase, Part 1|Change of treatment|0|||
27738137|NCT01480180|80871128|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
27738138|NCT01480180|80871129|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
27738139|NCT01480180|80871130|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
27738140|NCT01480180|80871131|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
27738141|NCT01480180|80871132|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
27738142|NCT01480180|80871133|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
27738143|NCT01480180|80871128|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
27738144|NCT01480180|80871129|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
27738145|NCT01480180|80871130|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
27738146|NCT01480180|80871131|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
27738147|NCT01480180|80871132|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
27738148|NCT01480180|80871133|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
27738149|NCT01480180|80871128|FG000|Extension Phase, Part 2|Unclassified|0|||
27738150|NCT01480180|80871129|FG001|Extension Phase, Part 2|Unclassified|0|||
27738151|NCT01480180|80871130|FG002|Extension Phase, Part 2|Unclassified|3|||
27738152|NCT01480180|80871131|FG003|Extension Phase, Part 2|Unclassified|1|||
27738153|NCT01480180|80871132|FG004|Extension Phase, Part 2|Unclassified|1|||
27738154|NCT01480180|80871133|FG005|Extension Phase, Part 2|Unclassified|0|||
27738155|NCT03414359|80871134|FG000|Overall Study|Lack of Efficacy|1|||
27738156|NCT03414359|80871135|FG001|Overall Study|Lack of Efficacy|1|||
27738157|NCT03414359|80871134|FG000|Overall Study|Protocol Violation|0|||
27738158|NCT03414359|80871135|FG001|Overall Study|Protocol Violation|1|||
27738159|NCT02579603|80871136|FG000|Overall Study|Not treated|1|||
27738160|NCT02579603|80871137|FG001|Overall Study|Not treated|0|||
27738161|NCT02579603|80871136|FG000|Overall Study|Adverse Event|2|||
27738162|NCT02579603|80871137|FG001|Overall Study|Adverse Event|2|||
27738163|NCT02579603|80871136|FG000|Overall Study|Other than stated|1|||
27738164|NCT02579603|80871137|FG001|Overall Study|Other than stated|0|||
27738165|NCT00474253|80871138|FG000|Overall Study|Withdrew consent|2|||
27534801|NCT01193842|80153372|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
27534802|NCT01193842|80153373|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
27534803|NCT01642407|80153379|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
27534804|NCT01642407|80153379|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
27534805|NCT01642407|80153379|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
27738166|NCT00474253|80871139|FG001|Overall Study|Withdrew consent|0|||
27738167|NCT00474253|80871138|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
27534806|NCT04697056|80153383|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
27534807|NCT04697056|80153384|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
27534808|NCT00828854|80153385|FG000|Overall Study|Disease Progression|17|||
27534809|NCT00828854|80153385|FG000|Overall Study|Adverse Event|9|||
27534810|NCT00828854|80153385|FG000|Overall Study|Reason not Specified|1|||
27534811|NCT01033851|80153386|FG000|Overall Study|Withdrawal by Subject|3|||
27534812|NCT01033851|80153387|FG001|Overall Study|Withdrawal by Subject|7|||
27534813|NCT00447005|80153388|FG000|Overall Study|Adverse Event|1|||
27534814|NCT00447005|80153388|FG000|Overall Study|Lack of Efficacy|11|||
27738168|NCT00474253|80871139|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
27738169|NCT00474253|80871138|FG000|Overall Study|Lost to Follow-up|1|||
27738170|NCT00474253|80871139|FG001|Overall Study|Lost to Follow-up|0|||
27738171|NCT00474253|80871138|FG000|Overall Study|Discharged prior to study completion|0|||
27738172|NCT00474253|80871139|FG001|Overall Study|Discharged prior to study completion|1|||
27738173|NCT00308620|80871143|FG000|Overall Study|Death|1|||
27738174|NCT00308620|80871144|FG001|Overall Study|Death|1|||
27738175|NCT00308620|80871145|FG002|Overall Study|Death|0|||
27738176|NCT00308620|80871143|FG000|Overall Study|Lost to Follow-up|0|||
27738177|NCT00308620|80871144|FG001|Overall Study|Lost to Follow-up|0|||
27738178|NCT00308620|80871145|FG002|Overall Study|Lost to Follow-up|1|||
27738179|NCT00467649|80871146|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
27738180|NCT00467649|80871147|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
27738181|NCT00467649|80871148|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
27738182|NCT00467649|80871149|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
27738183|NCT00467649|80871150|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
27738184|NCT00467649|80871151|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
27738185|NCT00467649|80871146|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
27738186|NCT00467649|80871147|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
27738187|NCT00467649|80871148|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
27738188|NCT00467649|80871149|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
27738189|NCT00467649|80871150|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
27738190|NCT00467649|80871151|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
27738191|NCT00467649|80871146|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
27738192|NCT00467649|80871147|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
27738193|NCT00467649|80871148|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
27738194|NCT00467649|80871149|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
27738195|NCT00467649|80871150|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
27738196|NCT00467649|80871151|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
27738197|NCT00467649|80871146|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
27738198|NCT00467649|80871147|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
27738199|NCT00467649|80871148|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
27738200|NCT00467649|80871149|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
27738201|NCT00467649|80871150|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
27534815|NCT00331422|80153395|FG000|Overall Study|Did not receive entire study regimen|5|||
27534816|NCT00721123|80153396|FG000|Overall Study|Adverse Event|96|||
27534817|NCT00721123|80153396|FG000|Overall Study|Death|10|||
27534818|NCT00721123|80153396|FG000|Overall Study|Insufficient Therapeutic Response|21|||
27738202|NCT00467649|80871151|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
27738203|NCT00467649|80871146|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
27738204|NCT00467649|80871147|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
27738205|NCT00467649|80871148|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
27738206|NCT00467649|80871149|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
27738207|NCT00467649|80871150|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
27738208|NCT00467649|80871151|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
27738209|NCT00467649|80871146|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
27738210|NCT00467649|80871147|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
27738211|NCT00467649|80871148|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
27738212|NCT00467649|80871149|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
27738213|NCT00467649|80871150|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
27738214|NCT00467649|80871151|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
27738215|NCT00467649|80871146|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
27738216|NCT00467649|80871147|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
27738217|NCT00467649|80871148|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
27738218|NCT00467649|80871149|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
27738219|NCT00467649|80871150|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
27738220|NCT00467649|80871151|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
27738221|NCT00814710|80871153|FG000|Overall Study|Adverse Event|1|||
27738222|NCT00814710|80871154|FG001|Overall Study|Adverse Event|0|||
27738223|NCT00814710|80871153|FG000|Overall Study|Lost to Follow-up|7|||
27738224|NCT00814710|80871154|FG001|Overall Study|Lost to Follow-up|3|||
27738225|NCT00636818|80871157|FG000|Overall Study|Adverse Event|1|||
27738226|NCT00636818|80871157|FG000|Overall Study|Lost to Follow-up|2|||
27738227|NCT00636818|80871157|FG000|Overall Study|Entry Criteria Exclusion|3|||
27738228|NCT00636818|80871157|FG000|Overall Study|Protocol Violation|1|||
27738229|NCT00636818|80871157|FG000|Overall Study|Withdrawal by Subject|4|||
27738230|NCT00377962|80871158|FG000|Core Study: 0-12 Months|Adverse Event|18|||
27738231|NCT00377962|80871159|FG001|Core Study: 0-12 Months|Adverse Event|2|||
27738232|NCT00377962|80871158|FG000|Core Study: 0-12 Months|Death|3|||
27738233|NCT00377962|80871159|FG001|Core Study: 0-12 Months|Death|0|||
27534819|NCT00721123|80153396|FG000|Overall Study|Protocol Violation|1|||
27534820|NCT00721123|80153396|FG000|Overall Study|Refused Treatment|41|||
27534821|NCT00721123|80153396|FG000|Overall Study|Failure to Return|9|||
27534822|NCT00721123|80153396|FG000|Overall Study|Withdrawal by Subject|5|||
27534823|NCT02833350|80153401|FG000|Overall Study|Adverse Event|0|||
27534824|NCT02833350|80153402|FG001|Overall Study|Adverse Event|3|||
27738234|NCT00377962|80871158|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
27958649|NCT01791517|81680061|FG003|Phase II|Pre-Existing Ocular Issue|0|||
27534825|NCT02833350|80153403|FG002|Overall Study|Adverse Event|4|||
27534826|NCT02833350|80153404|FG003|Overall Study|Adverse Event|4|||
27534827|NCT02833350|80153405|FG004|Overall Study|Adverse Event|1|||
27534828|NCT02833350|80153406|FG005|Overall Study|Adverse Event|0|||
27534829|NCT02833350|80153407|FG006|Overall Study|Adverse Event|1|||
27534830|NCT02833350|80153401|FG000|Overall Study|Death|0|||
27534831|NCT02833350|80153402|FG001|Overall Study|Death|0|||
27534832|NCT02833350|80153403|FG002|Overall Study|Death|1|||
27534833|NCT02833350|80153404|FG003|Overall Study|Death|0|||
27534834|NCT02833350|80153405|FG004|Overall Study|Death|0|||
27534835|NCT02833350|80153406|FG005|Overall Study|Death|0|||
27534836|NCT02833350|80153407|FG006|Overall Study|Death|0|||
27534837|NCT02833350|80153401|FG000|Overall Study|Lack of Efficacy|0|||
27534838|NCT02833350|80153402|FG001|Overall Study|Lack of Efficacy|2|||
27534839|NCT02833350|80153403|FG002|Overall Study|Lack of Efficacy|1|||
27534840|NCT02833350|80153404|FG003|Overall Study|Lack of Efficacy|4|||
27534841|NCT02833350|80153405|FG004|Overall Study|Lack of Efficacy|0|||
27534842|NCT02833350|80153406|FG005|Overall Study|Lack of Efficacy|1|||
27534843|NCT02833350|80153407|FG006|Overall Study|Lack of Efficacy|1|||
27534844|NCT02833350|80153401|FG000|Overall Study|Lost to Follow-up|0|||
27630776|NCT03386929|80490100|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
27630777|NCT03386929|80490101|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
27630778|NCT03386929|80490099|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
27630779|NCT03386929|80490100|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
27738235|NCT00377962|80871159|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
27738236|NCT00377962|80871158|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
27534845|NCT02833350|80153402|FG001|Overall Study|Lost to Follow-up|1|||
27534846|NCT02833350|80153403|FG002|Overall Study|Lost to Follow-up|0|||
27534847|NCT02833350|80153404|FG003|Overall Study|Lost to Follow-up|0|||
27534848|NCT02833350|80153405|FG004|Overall Study|Lost to Follow-up|0|||
27534849|NCT02833350|80153406|FG005|Overall Study|Lost to Follow-up|0|||
27534850|NCT02833350|80153407|FG006|Overall Study|Lost to Follow-up|1|||
27534851|NCT02833350|80153401|FG000|Overall Study|Withdrawal by Subject|3|||
27534852|NCT02833350|80153402|FG001|Overall Study|Withdrawal by Subject|3|||
27534853|NCT02833350|80153403|FG002|Overall Study|Withdrawal by Subject|2|||
27534854|NCT02833350|80153404|FG003|Overall Study|Withdrawal by Subject|0|||
27534855|NCT02833350|80153405|FG004|Overall Study|Withdrawal by Subject|2|||
27534856|NCT02833350|80153406|FG005|Overall Study|Withdrawal by Subject|0|||
27534857|NCT02833350|80153407|FG006|Overall Study|Withdrawal by Subject|2|||
27534858|NCT02477839|80153408|FG000|Overall Study|Adverse Event|0|||
27534859|NCT02477839|80153409|FG001|Overall Study|Adverse Event|1|||
27534860|NCT02477839|80153408|FG000|Overall Study|Protocol Violation|0|||
27534861|NCT02477839|80153409|FG001|Overall Study|Protocol Violation|2|||
27534862|NCT02477839|80153408|FG000|Overall Study|Withdrawal by Subject|3|||
27534863|NCT02477839|80153409|FG001|Overall Study|Withdrawal by Subject|3|||
27534864|NCT02477839|80153408|FG000|Overall Study|Participant had PGS during V6|0|||
27534865|NCT02477839|80153409|FG001|Overall Study|Participant had PGS during V6|1|||
27534866|NCT02477839|80153408|FG000|Overall Study|Parents decided to stop medication|0|||
27534867|NCT02477839|80153409|FG001|Overall Study|Parents decided to stop medication|1|||
27534868|NCT02477839|80153408|FG000|Overall Study|Lack of tolerability|0|||
27534869|NCT02477839|80153409|FG001|Overall Study|Lack of tolerability|1|||
27534870|NCT02477839|80153408|FG000|Overall Study|Exclusion criterion|0|||
27534871|NCT02477839|80153409|FG001|Overall Study|Exclusion criterion|1|||
27534872|NCT01497275|80153410|FG000|Overall Study|Death|1|||
27534873|NCT01497275|80153410|FG000|Overall Study|Adverse Event|1|||
27534874|NCT03800173|80153427|FG000|Overall Study|Lost to Follow-up|0|||
27534875|NCT03800173|80153428|FG001|Overall Study|Lost to Follow-up|0|||
27534876|NCT03800173|80153429|FG002|Overall Study|Lost to Follow-up|0|||
27534877|NCT03800173|80153430|FG003|Overall Study|Lost to Follow-up|0|||
27534878|NCT03800173|80153431|FG004|Overall Study|Lost to Follow-up|1|||
27534879|NCT02436681|80153432|FG000|Overall Study|Lost to Follow-up|10|||
27534880|NCT02436681|80153432|FG000|Overall Study|Withdrawal by Subject|2|||
27534881|NCT02436681|80153432|FG000|Overall Study|Death|2|||
27534882|NCT03452228|80153437|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27534883|NCT03452228|80153438|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
27738237|NCT00377962|80871159|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
27738238|NCT00377962|80871158|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
27534884|NCT03452228|80153439|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
27534885|NCT03452228|80153437|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27534886|NCT03452228|80153438|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
27534887|NCT03452228|80153439|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
27534888|NCT03452228|80153437|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
27534889|NCT03452228|80153438|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
27534890|NCT03452228|80153439|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
27534891|NCT03452228|80153437|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27534892|NCT03452228|80153438|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27914396|NCT03327324|81525850|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914397|NCT03327324|81525851|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
27914398|NCT03327324|81525846|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914399|NCT03327324|81525847|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914400|NCT03327324|81525848|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27914401|NCT03327324|81525849|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914402|NCT03327324|81525850|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914403|NCT03327324|81525851|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914404|NCT03327324|81525846|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
27914405|NCT03327324|81525847|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
27914406|NCT03327324|81525848|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
27914407|NCT03327324|81525849|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
27914408|NCT03327324|81525850|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
27534893|NCT03452228|80153439|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
27630780|NCT03386929|80490101|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
27630781|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
27630782|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
27630783|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
27630784|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27630785|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27630786|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27630787|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27630788|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27630789|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
27738239|NCT00377962|80871159|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
27738240|NCT00377962|80871158|FG000|Extension Study: 12-24 Months|Death|1|||
27738241|NCT00377962|80871159|FG001|Extension Study: 12-24 Months|Death|1|||
27738242|NCT00377962|80871158|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
27738243|NCT00377962|80871159|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
27738244|NCT00377962|80871158|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
27738245|NCT00377962|80871159|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
27738246|NCT00377962|80871158|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
27738247|NCT00377962|80871159|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
27738248|NCT00231478|80871163|FG000|Overall Study|Protocol Violation|3|||
27738249|NCT00231478|80871164|FG001|Overall Study|Protocol Violation|2|||
27738250|NCT00231478|80871163|FG000|Overall Study|Refused Treatment|1|||
27738251|NCT00231478|80871164|FG001|Overall Study|Refused Treatment|1|||
27738252|NCT00231478|80871163|FG000|Overall Study|Withdrawal by Subject|1|||
27738253|NCT00231478|80871164|FG001|Overall Study|Withdrawal by Subject|0|||
27738254|NCT00231478|80871163|FG000|Overall Study|Adverse Event|0|||
27738255|NCT00231478|80871164|FG001|Overall Study|Adverse Event|1|||
27534894|NCT01419626|80153440|FG000|Overall Study|Protocol Violation|3|||
27534895|NCT01419626|80153441|FG001|Overall Study|Protocol Violation|2|||
27534896|NCT01419626|80153442|FG002|Overall Study|Protocol Violation|2|||
27534897|NCT01419626|80153440|FG000|Overall Study|Withdrawal by Subject|1|||
27534898|NCT01419626|80153441|FG001|Overall Study|Withdrawal by Subject|0|||
27534899|NCT01419626|80153442|FG002|Overall Study|Withdrawal by Subject|0|||
27534900|NCT01419626|80153440|FG000|Overall Study|Lost to Follow-up|0|||
27534901|NCT01419626|80153441|FG001|Overall Study|Lost to Follow-up|1|||
27534902|NCT01419626|80153442|FG002|Overall Study|Lost to Follow-up|1|||
27534903|NCT01466179|80153443|FG000|Overall Study|Ongoing in core study|2|||
27534904|NCT01466179|80153443|FG000|Overall Study|Physician Decision|46|||
27534905|NCT01466179|80153443|FG000|Overall Study|Progressive disease|43|||
27534906|NCT01466179|80153443|FG000|Overall Study|Adverse Event|32|||
27534907|NCT01466179|80153443|FG000|Overall Study|Disease relapse|23|||
27534908|NCT01466179|80153443|FG000|Overall Study|Lack of Efficacy|14|||
27534909|NCT01466179|80153443|FG000|Overall Study|Death|7|||
27534910|NCT01466179|80153443|FG000|Overall Study|Withdrawal by Subject|7|||
27534911|NCT01466179|80153443|FG000|Overall Study|Protocol Violation|2|||
27534912|NCT01466179|80153443|FG000|Overall Study|Other|3|||
27534913|NCT03841448|80153444|FG000|Double-blind Treatment (DBT) Period|Death|1|||
27534914|NCT03841448|80153445|FG001|Double-blind Treatment (DBT) Period|Death|1|||
27738256|NCT00231478|80871163|FG000|Overall Study|Administrative|3|||
27738257|NCT00231478|80871164|FG001|Overall Study|Administrative|2|||
27534915|NCT03841448|80153446|FG002|Double-blind Treatment (DBT) Period|Death|0|||
27534916|NCT03841448|80153447|FG003|Double-blind Treatment (DBT) Period|Death|0|||
27534917|NCT03841448|80153444|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
27630790|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
27630791|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
27630792|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
27630793|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27630794|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27630795|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27630796|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27630797|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27630798|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
27630799|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
27630800|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
27630801|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
27630802|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27630803|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27630804|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27630805|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27630806|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27630807|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
27630808|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
27914409|NCT03327324|81525851|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
27914410|NCT03327324|81525846|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
27914411|NCT03327324|81525847|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27914412|NCT03327324|81525848|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27914413|NCT03327324|81525849|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27914414|NCT03327324|81525850|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27534918|NCT03841448|80153445|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
27534919|NCT03841448|80153446|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
27534920|NCT03841448|80153447|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
27534921|NCT03841448|80153444|FG000|Open-Label Extension (OLE) Period|Death|0|||
27534922|NCT03841448|80153445|FG001|Open-Label Extension (OLE) Period|Death|0|||
27534923|NCT03841448|80153446|FG002|Open-Label Extension (OLE) Period|Death|0|||
27534924|NCT03841448|80153447|FG003|Open-Label Extension (OLE) Period|Death|1|||
27534925|NCT03841448|80153444|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
27534926|NCT03841448|80153445|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
27534927|NCT03841448|80153446|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
27534928|NCT03841448|80153447|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
27534929|NCT03841448|80153444|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
27534930|NCT03841448|80153445|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
27534931|NCT03841448|80153446|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
27534932|NCT03841448|80153447|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
27534933|NCT03841448|80153444|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
27534934|NCT03841448|80153445|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
27534935|NCT03841448|80153446|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
27534936|NCT03841448|80153447|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
27534937|NCT01297920|80153448|FG000|Overall Study|Adverse Event|42|||
27534938|NCT01297920|80153449|FG001|Overall Study|Adverse Event|10|||
27534939|NCT01297920|80153450|FG002|Overall Study|Adverse Event|38|||
27534940|NCT01297920|80153448|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
27914415|NCT03327324|81525851|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
27914416|NCT03327324|81525846|FG000|Intervention (Month 3-Month 6)|Death|1|||
27914417|NCT03327324|81525847|FG001|Intervention (Month 3-Month 6)|Death|0|||
27914418|NCT03327324|81525848|FG002|Intervention (Month 3-Month 6)|Death|1|||
27914419|NCT03327324|81525849|FG003|Intervention (Month 3-Month 6)|Death|1|||
27914420|NCT03327324|81525850|FG004|Intervention (Month 3-Month 6)|Death|1|||
27914421|NCT03327324|81525851|FG005|Intervention (Month 3-Month 6)|Death|0|||
27914422|NCT03327324|81525846|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914423|NCT03327324|81525847|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914424|NCT03327324|81525848|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914425|NCT03327324|81525849|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914426|NCT03327324|81525850|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27958650|NCT01791517|81680062|FG004|Phase II|Pre-Existing Ocular Issue|0|||
27534941|NCT01297920|80153449|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
27534942|NCT01297920|80153450|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
27534943|NCT01297920|80153448|FG000|Overall Study|Noncompliance|1|||
27630809|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630810|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
27630811|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630812|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630813|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630814|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630815|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630816|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
27630817|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27630818|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
27630819|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
27630820|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27630821|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27630822|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27630823|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27630824|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27630825|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
27630826|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630827|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27630828|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
27630829|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630830|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630831|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630832|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630833|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630834|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
27630835|NCT01212757|80490102|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
27630836|NCT01212757|80490103|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
27630837|NCT01212757|80490104|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630838|NCT01212757|80490105|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630839|NCT01212757|80490106|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630840|NCT01212757|80490107|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630841|NCT01212757|80490108|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630842|NCT01212757|80490109|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630843|NCT01212757|80490110|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
27630844|NCT01212757|80490102|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27630845|NCT01212757|80490103|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
27630846|NCT01212757|80490104|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
27630847|NCT01212757|80490105|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
27630848|NCT01212757|80490106|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27630849|NCT01212757|80490107|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
27630850|NCT01212757|80490108|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27630851|NCT01212757|80490109|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27630852|NCT01212757|80490110|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
27630853|NCT01212757|80490102|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27630854|NCT01212757|80490103|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
27630855|NCT01212757|80490104|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
27630856|NCT01212757|80490105|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
27630857|NCT01212757|80490106|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27630858|NCT01212757|80490107|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
27630859|NCT01212757|80490108|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27630860|NCT01212757|80490109|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27630861|NCT01212757|80490110|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
27738258|NCT00840463|80871166|FG000|Overall Study|Adverse Event|1|||
27738259|NCT00840463|80871167|FG001|Overall Study|Adverse Event|0|||
27738260|NCT05480514|80871168|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
27738261|NCT05480514|80871169|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
27738262|NCT05480514|80871168|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
27738263|NCT05480514|80871169|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
27738264|NCT05480514|80871168|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
27738265|NCT05480514|80871169|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
27738266|NCT05480514|80871168|FG000|Period 1|Covid-19 Related|1|||
27630862|NCT01212757|80490102|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27630863|NCT01212757|80490103|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27738267|NCT05480514|80871169|FG001|Period 1|Covid-19 Related|0|||
27738268|NCT05480514|80871168|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
27738269|NCT05480514|80871169|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
27738270|NCT01609933|80871170|FG000|Overall Study|Adverse Event|1|||
27738271|NCT01609933|80871170|FG000|Overall Study|Withdrawal by Subject|3|||
27738272|NCT00793585|80871171|FG000|Overall Study|Adverse Event|1|||
27738273|NCT00793585|80871172|FG001|Overall Study|Adverse Event|1|||
27738274|NCT00793585|80871171|FG000|Overall Study|Protocol Violation|1|||
27738275|NCT00793585|80871172|FG001|Overall Study|Protocol Violation|2|||
27738276|NCT03476239|80871173|FG000|Overall Study|Withdrawal by Subject|10|||
27738277|NCT03476239|80871173|FG000|Overall Study|Death|80|||
27738278|NCT03476239|80871173|FG000|Overall Study|Lost to Follow-up|8|||
27914427|NCT03327324|81525851|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
27914428|NCT03327324|81525846|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
27914429|NCT03327324|81525847|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914430|NCT03327324|81525848|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914431|NCT03327324|81525849|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914432|NCT03327324|81525850|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914433|NCT03327324|81525851|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
27914434|NCT03327324|81525846|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
27914435|NCT03327324|81525847|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
27914436|NCT03327324|81525848|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27914437|NCT03327324|81525849|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27914438|NCT03327324|81525850|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27914439|NCT03327324|81525851|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
27914440|NCT03327324|81525846|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
27914441|NCT03327324|81525847|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
27914442|NCT03327324|81525848|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
27914443|NCT03327324|81525849|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
27914444|NCT03327324|81525850|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
27914445|NCT03327324|81525851|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
27914446|NCT03327324|81525846|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914447|NCT03327324|81525847|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914448|NCT03327324|81525848|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914449|NCT03327324|81525849|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
27914450|NCT03327324|81525850|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
27914451|NCT03327324|81525851|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
27914452|NCT03327324|81525846|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
27914453|NCT03327324|81525847|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27914454|NCT03327324|81525848|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27914455|NCT03327324|81525849|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27914456|NCT03327324|81525850|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27914457|NCT03327324|81525851|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
27914458|NCT03327324|81525846|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
27914459|NCT03327324|81525847|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27914460|NCT03327324|81525848|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27534944|NCT01297920|80153449|FG001|Overall Study|Noncompliance|0|||
27534945|NCT01297920|80153450|FG002|Overall Study|Noncompliance|0|||
27534946|NCT01297920|80153448|FG000|Overall Study|Protocol Violation|1|||
27534947|NCT01297920|80153449|FG001|Overall Study|Protocol Violation|3|||
27534948|NCT01297920|80153450|FG002|Overall Study|Protocol Violation|0|||
27534949|NCT01297920|80153448|FG000|Overall Study|Inadequate Control of IOP|7|||
27534950|NCT01297920|80153449|FG001|Overall Study|Inadequate Control of IOP|9|||
27534951|NCT01297920|80153450|FG002|Overall Study|Inadequate Control of IOP|17|||
27534952|NCT01297920|80153448|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
27534953|NCT01297920|80153449|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
27534954|NCT01297920|80153450|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
27534955|NCT03666624|80153451|FG000|Overall Study|participant grieving over recent death of parent|1|||
27534956|NCT03666624|80153452|FG001|Overall Study|participant grieving over recent death of parent|0|||
27534957|NCT03021304|80153455|FG000|Overall Study|Lack of Efficacy|1|||
27738279|NCT01450137|80871174|FG000|Up to Week 12|Adverse Event|2|||
27738280|NCT01450137|80871175|FG001|Up to Week 12|Adverse Event|1|||
27738281|NCT01450137|80871174|FG000|Up to Week 12|Withdrawal by Subject|0|||
27630864|NCT01212757|80490104|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
27630865|NCT01212757|80490105|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27630866|NCT01212757|80490106|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27630867|NCT01212757|80490107|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27630868|NCT01212757|80490108|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27738282|NCT01450137|80871175|FG001|Up to Week 12|Withdrawal by Subject|2|||
27738283|NCT01450137|80871174|FG000|Week 12 to Study End|Death|0|||
27914461|NCT03327324|81525849|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27914462|NCT03327324|81525850|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27914463|NCT03327324|81525851|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
27914464|NCT02974868|81525852|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
27914465|NCT02974868|81525853|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
27914466|NCT02974868|81525854|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
27914467|NCT02974868|81525855|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
27914468|NCT02974868|81525852|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
27914469|NCT02974868|81525853|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
27914470|NCT02974868|81525854|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
27914471|NCT02974868|81525855|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
27914472|NCT02974868|81525852|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
27914473|NCT02974868|81525853|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
27914474|NCT02974868|81525854|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
27914475|NCT02974868|81525855|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
27914476|NCT02974868|81525852|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
27914477|NCT02974868|81525853|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
27914478|NCT02974868|81525854|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
27914479|NCT02974868|81525855|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
27914480|NCT01973218|81525856|FG000|Overall Study|Adverse Event|1|||
27914481|NCT01973218|81525857|FG001|Overall Study|Adverse Event|0|||
27914482|NCT01973218|81525856|FG000|Overall Study|Withdrawal by Subject|1|||
27914483|NCT01973218|81525857|FG001|Overall Study|Withdrawal by Subject|0|||
27914484|NCT02595502|81525858|FG000|Period 1|Adverse Event|0|||
27914485|NCT02595502|81525859|FG001|Period 1|Adverse Event|1|||
27914486|NCT02595502|81525858|FG000|Period 1|Withdrawal by Subject|1|||
27914487|NCT02595502|81525859|FG001|Period 1|Withdrawal by Subject|0|||
27914488|NCT02595502|81525858|FG000|Period 1|Lost to Follow-up|0|||
27914489|NCT02595502|81525859|FG001|Period 1|Lost to Follow-up|1|||
27914490|NCT02595502|81525858|FG000|Period 2|Adverse Event|1|||
27914491|NCT02595502|81525859|FG001|Period 2|Adverse Event|1|||
27914492|NCT02595502|81525858|FG000|Period 2|Received incorrect lens at Period 1|0|||
27914493|NCT02595502|81525859|FG001|Period 2|Received incorrect lens at Period 1|1|||
27914494|NCT02595502|81525858|FG000|Period 3|Protocol Violation|0|||
27914495|NCT02595502|81525859|FG001|Period 3|Protocol Violation|1|||
27914496|NCT02595502|81525858|FG000|Period 3|Lost to Follow-up|1|||
27914497|NCT02595502|81525859|FG001|Period 3|Lost to Follow-up|0|||
27914498|NCT02595502|81525858|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
27914499|NCT02595502|81525859|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
27914500|NCT00929994|81525860|FG000|Overall Study|Withdrawal by Subject|1|||
27914501|NCT00929994|81525860|FG000|Overall Study|medical issue unrelated to intervention|4|||
27534958|NCT00002651|80153456|FG000|Induction|Adverse Event|44|||
27534959|NCT00002651|80153457|FG001|Induction|Adverse Event|0|||
27534960|NCT00002651|80153458|FG002|Induction|Adverse Event|0|||
27534961|NCT00002651|80153456|FG000|Induction|Refusal unrelated to adverse event|50|||
27534962|NCT00002651|80153457|FG001|Induction|Refusal unrelated to adverse event|0|||
27534963|NCT00002651|80153458|FG002|Induction|Refusal unrelated to adverse event|0|||
27534964|NCT00002651|80153456|FG000|Induction|Progression/relapse|274|||
27534965|NCT00002651|80153457|FG001|Induction|Progression/relapse|0|||
27534966|NCT00002651|80153458|FG002|Induction|Progression/relapse|0|||
27534967|NCT00002651|80153456|FG000|Induction|Death|62|||
27534968|NCT00002651|80153457|FG001|Induction|Death|0|||
27534969|NCT00002651|80153458|FG002|Induction|Death|0|||
27534970|NCT00002651|80153456|FG000|Induction|Other|823|||
27534971|NCT00002651|80153457|FG001|Induction|Other|0|||
27534972|NCT00002651|80153458|FG002|Induction|Other|0|||
27534973|NCT00002651|80153456|FG000|Induction|not eligible|90|||
27534974|NCT00002651|80153457|FG001|Induction|not eligible|0|||
27534975|NCT00002651|80153458|FG002|Induction|not eligible|0|||
27534976|NCT00002651|80153456|FG000|Consolidation and Randomization|Adverse Event|0|||
27534977|NCT00002651|80153457|FG001|Consolidation and Randomization|Adverse Event|36|||
27914502|NCT00929994|81525860|FG000|Overall Study|employment|1|||
27914503|NCT00467519|81525861|FG000|Overall Study|Protocol Violation|8|||
27534978|NCT00002651|80153458|FG002|Consolidation and Randomization|Adverse Event|14|||
27534979|NCT00002651|80153456|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
27914504|NCT00467519|81525862|FG001|Overall Study|Protocol Violation|4|||
27534980|NCT00002651|80153457|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
27914505|NCT00467519|81525861|FG000|Overall Study|Lost to Follow-up|2|||
27914506|NCT00467519|81525862|FG001|Overall Study|Lost to Follow-up|9|||
27914507|NCT00467519|81525861|FG000|Overall Study|Withdrawal by Subject|4|||
27914508|NCT00467519|81525862|FG001|Overall Study|Withdrawal by Subject|10|||
27914509|NCT00974311|81525863|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
27914510|NCT00974311|81525864|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
27914511|NCT00974311|81525863|FG000|DB Phase (up to 24 Months)|Death|561|||
27914512|NCT00974311|81525864|FG001|DB Phase (up to 24 Months)|Death|298|||
27914513|NCT00974311|81525863|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
27914514|NCT00974311|81525864|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
27914515|NCT00974311|81525863|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
27914516|NCT00974311|81525864|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
27914517|NCT00974311|81525863|FG000|DB Phase (up to 24 Months)|Other|1|||
27914518|NCT00974311|81525864|FG001|DB Phase (up to 24 Months)|Other|0|||
27630869|NCT01212757|80490109|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27630870|NCT01212757|80490110|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
27630871|NCT01212757|80490102|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27630872|NCT01212757|80490103|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
27630873|NCT01212757|80490104|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
27630874|NCT01212757|80490105|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
27630875|NCT01212757|80490106|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
27630876|NCT01212757|80490107|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
27630877|NCT01212757|80490108|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27630878|NCT01212757|80490109|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27630879|NCT01212757|80490110|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
27630880|NCT01212757|80490102|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630881|NCT01212757|80490103|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
27630882|NCT01212757|80490104|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630883|NCT01212757|80490105|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630884|NCT01212757|80490106|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
27630885|NCT01212757|80490107|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630886|NCT01212757|80490108|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630887|NCT01212757|80490109|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630888|NCT01212757|80490110|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
27630889|NCT01212757|80490102|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27630890|NCT01212757|80490103|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
27630891|NCT01212757|80490104|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
27914519|NCT00974311|81525863|FG000|OLE Phase (up to 77 Months)|Death|14|||
27914520|NCT00974311|81525864|FG001|OLE Phase (up to 77 Months)|Death|21|||
27914521|NCT00974311|81525863|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
27914522|NCT00974311|81525864|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
27914523|NCT00974311|81525863|FG000|OLE Phase (up to 77 Months)|Other|15|||
27914524|NCT00974311|81525864|FG001|OLE Phase (up to 77 Months)|Other|2|||
27914525|NCT00974311|81525863|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
27914526|NCT00974311|81525864|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
27914527|NCT00627497|81525865|FG000|Overall Study|Lost to Follow-up|1|||
27914528|NCT00627497|81525866|FG001|Overall Study|Lost to Follow-up|1|||
27914529|NCT00627497|81525867|FG002|Overall Study|Lost to Follow-up|0|||
27914530|NCT00627497|81525868|FG003|Overall Study|Lost to Follow-up|0|||
27914531|NCT03188055|81525877|FG000|Overall Study|Unavailable for training|0|||
27914532|NCT03188055|81525878|FG001|Overall Study|Unavailable for training|0|||
27914533|NCT03188055|81525879|FG002|Overall Study|Unavailable for training|19|||
27914534|NCT03188055|81525880|FG003|Overall Study|Unavailable for training|0|||
27914535|NCT03188055|81525881|FG004|Overall Study|Unavailable for training|0|||
27914536|NCT03188055|81525882|FG005|Overall Study|Unavailable for training|0|||
27914537|NCT03188055|81525877|FG000|Overall Study|Lost to Follow-up|0|||
27914538|NCT03188055|81525878|FG001|Overall Study|Lost to Follow-up|18|||
27914539|NCT03188055|81525879|FG002|Overall Study|Lost to Follow-up|0|||
27914540|NCT03188055|81525880|FG003|Overall Study|Lost to Follow-up|11|||
27914541|NCT03188055|81525881|FG004|Overall Study|Lost to Follow-up|0|||
27914542|NCT03188055|81525882|FG005|Overall Study|Lost to Follow-up|0|||
27914543|NCT03188055|81525877|FG000|Overall Study|Withdrawal by Subject|0|||
27914544|NCT03188055|81525878|FG001|Overall Study|Withdrawal by Subject|1|||
27914545|NCT03188055|81525879|FG002|Overall Study|Withdrawal by Subject|0|||
27914546|NCT03188055|81525880|FG003|Overall Study|Withdrawal by Subject|1|||
27914547|NCT03188055|81525881|FG004|Overall Study|Withdrawal by Subject|0|||
27914548|NCT03188055|81525882|FG005|Overall Study|Withdrawal by Subject|0|||
27630892|NCT01212757|80490105|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27630893|NCT01212757|80490106|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27630894|NCT01212757|80490107|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27630895|NCT01212757|80490108|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27914549|NCT02619617|81525886|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
27914550|NCT02619617|81525887|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
27914551|NCT02619617|81525886|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
27914552|NCT02619617|81525887|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
27914553|NCT00492726|81525897|FG000|Overall Study|Adverse Event|10|||
27914554|NCT00492726|81525898|FG001|Overall Study|Adverse Event|6|||
27914555|NCT00492726|81525897|FG000|Overall Study|Death|7|||
27914556|NCT00492726|81525898|FG001|Overall Study|Death|2|||
27914557|NCT00492726|81525897|FG000|Overall Study|Lack of Efficacy|0|||
27914558|NCT00492726|81525898|FG001|Overall Study|Lack of Efficacy|2|||
27914559|NCT00492726|81525897|FG000|Overall Study|Lost to Follow-up|27|||
27914560|NCT00492726|81525898|FG001|Overall Study|Lost to Follow-up|19|||
27914561|NCT00492726|81525897|FG000|Overall Study|Physician Decision|0|||
27914562|NCT00492726|81525898|FG001|Overall Study|Physician Decision|1|||
27914563|NCT00492726|81525897|FG000|Overall Study|Withdrawal by Subject|6|||
27914564|NCT00492726|81525898|FG001|Overall Study|Withdrawal by Subject|3|||
27914565|NCT00492726|81525897|FG000|Overall Study|Non compliant with study medication|0|||
27914566|NCT00492726|81525898|FG001|Overall Study|Non compliant with study medication|3|||
27914567|NCT01296412|81525899|FG000|Overall Study|Adverse Event|8|||
27914568|NCT01296412|81525900|FG001|Overall Study|Adverse Event|29|||
27914569|NCT01296412|81525899|FG000|Overall Study|Lack of Efficacy|1|||
27914570|NCT01296412|81525900|FG001|Overall Study|Lack of Efficacy|0|||
27914571|NCT01296412|81525899|FG000|Overall Study|Lost to Follow-up|10|||
27534981|NCT00002651|80153458|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
27534982|NCT00002651|80153456|FG000|Consolidation and Randomization|Progression/relapse|0|||
27534983|NCT00002651|80153457|FG001|Consolidation and Randomization|Progression/relapse|295|||
27914572|NCT01296412|81525900|FG001|Overall Study|Lost to Follow-up|7|||
27914573|NCT01296412|81525899|FG000|Overall Study|Non-compliance with study drug|1|||
27914574|NCT01296412|81525900|FG001|Overall Study|Non-compliance with study drug|2|||
27914575|NCT01296412|81525899|FG000|Overall Study|Other reason not specified|20|||
27914576|NCT01296412|81525900|FG001|Overall Study|Other reason not specified|15|||
27914577|NCT01296412|81525899|FG000|Overall Study|Physician Decision|1|||
27914578|NCT01296412|81525900|FG001|Overall Study|Physician Decision|3|||
27914579|NCT01296412|81525899|FG000|Overall Study|Pregnancy|0|||
27914580|NCT01296412|81525900|FG001|Overall Study|Pregnancy|1|||
27914581|NCT01296412|81525899|FG000|Overall Study|Withdrawal by Subject|10|||
27914582|NCT01296412|81525900|FG001|Overall Study|Withdrawal by Subject|13|||
27914583|NCT00230048|81525901|FG000|Overall Study|Lost to Follow-up|13|||
27914584|NCT00230048|81525902|FG001|Overall Study|Lost to Follow-up|18|||
27914585|NCT01774591|81525903|FG000|Overall Study|Physician Decision|1|||
27914586|NCT01774591|81525904|FG001|Overall Study|Physician Decision|1|||
27914587|NCT01774591|81525903|FG000|Overall Study|Withdrawal by Subject|0|||
27914588|NCT01774591|81525904|FG001|Overall Study|Withdrawal by Subject|1|||
27914589|NCT01774591|81525903|FG000|Overall Study|Adverse Event|0|||
27914590|NCT01774591|81525904|FG001|Overall Study|Adverse Event|2|||
27914591|NCT03286218|81525906|FG000|Qualification Phase Period 1|Adverse Event|1|||
27914592|NCT03286218|81525907|FG001|Qualification Phase Period 1|Adverse Event|0|||
27914593|NCT03286218|81525908|FG002|Qualification Phase Period 1|Adverse Event|0|||
27914594|NCT03286218|81525909|FG003|Qualification Phase Period 1|Adverse Event|0|||
27914595|NCT03286218|81525910|FG004|Qualification Phase Period 1|Adverse Event|0|||
27914596|NCT03286218|81525911|FG005|Qualification Phase Period 1|Adverse Event|0|||
27534984|NCT00002651|80153458|FG002|Consolidation and Randomization|Progression/relapse|298|||
27534985|NCT00002651|80153456|FG000|Consolidation and Randomization|Death|0|||
27534986|NCT00002651|80153457|FG001|Consolidation and Randomization|Death|38|||
27534987|NCT00002651|80153458|FG002|Consolidation and Randomization|Death|48|||
27534988|NCT00002651|80153456|FG000|Consolidation and Randomization|Other|0|||
27534989|NCT00002651|80153457|FG001|Consolidation and Randomization|Other|314|||
27534990|NCT00002651|80153458|FG002|Consolidation and Randomization|Other|313|||
27534991|NCT00002651|80153456|FG000|Consolidation and Randomization|not eligible|0|||
27534992|NCT00002651|80153457|FG001|Consolidation and Randomization|not eligible|102|||
27534993|NCT00002651|80153458|FG002|Consolidation and Randomization|not eligible|112|||
27534994|NCT00810693|80153459|FG000|Treatment Period|Adverse Event|8|||
27534995|NCT00810693|80153460|FG001|Treatment Period|Adverse Event|1|||
27534996|NCT00810693|80153461|FG002|Treatment Period|Adverse Event|7|||
27534997|NCT00810693|80153459|FG000|Treatment Period|Death|0|||
27534998|NCT00810693|80153460|FG001|Treatment Period|Death|1|||
27914597|NCT03286218|81525912|FG006|Qualification Phase Period 1|Adverse Event|0|||
27914598|NCT03286218|81525913|FG007|Qualification Phase Period 1|Adverse Event|0|||
27914599|NCT03286218|81525914|FG008|Qualification Phase Period 1|Adverse Event|0|||
27914600|NCT03286218|81525915|FG009|Qualification Phase Period 1|Adverse Event|0|||
27914601|NCT03286218|81525916|FG010|Qualification Phase Period 1|Adverse Event|0|||
27914602|NCT03286218|81525917|FG011|Qualification Phase Period 1|Adverse Event|0|||
27914603|NCT03286218|81525906|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914604|NCT03286218|81525907|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
27914605|NCT03286218|81525908|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914606|NCT03286218|81525909|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
27534999|NCT00810693|80153461|FG002|Treatment Period|Death|2|||
27535000|NCT00810693|80153459|FG000|Treatment Period|Lack of Efficacy|0|||
27535001|NCT00810693|80153460|FG001|Treatment Period|Lack of Efficacy|0|||
27535002|NCT00810693|80153461|FG002|Treatment Period|Lack of Efficacy|1|||
27535003|NCT00810693|80153459|FG000|Treatment Period|Lost to Follow-up|1|||
27535004|NCT00810693|80153460|FG001|Treatment Period|Lost to Follow-up|0|||
27535005|NCT00810693|80153461|FG002|Treatment Period|Lost to Follow-up|0|||
27535006|NCT00810693|80153459|FG000|Treatment Period|Non-compliance|1|||
27535007|NCT00810693|80153460|FG001|Treatment Period|Non-compliance|0|||
27535008|NCT00810693|80153461|FG002|Treatment Period|Non-compliance|0|||
27535009|NCT00810693|80153459|FG000|Treatment Period|Protocol Violation|1|||
27535010|NCT00810693|80153460|FG001|Treatment Period|Protocol Violation|2|||
27535011|NCT00810693|80153461|FG002|Treatment Period|Protocol Violation|2|||
27535012|NCT00810693|80153459|FG000|Treatment Period|Withdrawal by Subject|6|||
27535013|NCT00810693|80153460|FG001|Treatment Period|Withdrawal by Subject|2|||
27535014|NCT00810693|80153461|FG002|Treatment Period|Withdrawal by Subject|3|||
27535015|NCT00810693|80153459|FG000|Treatment Period|Not treated|0|||
27535016|NCT00810693|80153460|FG001|Treatment Period|Not treated|1|||
27535017|NCT00810693|80153461|FG002|Treatment Period|Not treated|1|||
27535018|NCT00810693|80153459|FG000|Follow-up Period (FUP)|Adverse Event|3|||
27535019|NCT00810693|80153460|FG001|Follow-up Period (FUP)|Adverse Event|1|||
27535020|NCT00810693|80153461|FG002|Follow-up Period (FUP)|Adverse Event|1|||
27535021|NCT00810693|80153459|FG000|Follow-up Period (FUP)|Death|2|||
27535022|NCT00810693|80153460|FG001|Follow-up Period (FUP)|Death|0|||
27535023|NCT00810693|80153461|FG002|Follow-up Period (FUP)|Death|1|||
27535024|NCT00810693|80153459|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
27535025|NCT00810693|80153460|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
27535026|NCT00810693|80153461|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
27535027|NCT00810693|80153459|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
27535028|NCT00810693|80153460|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
27535029|NCT00810693|80153461|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
27535030|NCT00810693|80153459|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
27535031|NCT00810693|80153460|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
27535032|NCT00810693|80153461|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
27535033|NCT03954132|80153466|FG000|Overall Study|Adverse Event|2|||
27535034|NCT03954132|80153467|FG001|Overall Study|Adverse Event|0|||
27535035|NCT03954132|80153466|FG000|Overall Study|Patient's wish|5|||
27535036|NCT03954132|80153467|FG001|Overall Study|Patient's wish|0|||
27535037|NCT03954132|80153466|FG000|Overall Study|Lost to Follow-up|10|||
27535038|NCT03954132|80153467|FG001|Overall Study|Lost to Follow-up|0|||
27535039|NCT03954132|80153466|FG000|Overall Study|Screening failure|0|||
27535040|NCT03954132|80153467|FG001|Overall Study|Screening failure|1|||
27535041|NCT03954132|80153466|FG000|Overall Study|No registration after Visit 1|5|||
27535042|NCT03954132|80153467|FG001|Overall Study|No registration after Visit 1|2|||
27535043|NCT03954132|80153466|FG000|Overall Study|Other reason than listed|2|||
27535044|NCT03954132|80153467|FG001|Overall Study|Other reason than listed|2|||
27535045|NCT03954132|80153466|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
27535046|NCT03954132|80153467|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
27535047|NCT03954132|80153466|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
27535048|NCT03954132|80153467|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
27535049|NCT02003365|80153468|FG000|Overall Study|Lost to Follow-up|0|||
27535050|NCT02003365|80153469|FG001|Overall Study|Lost to Follow-up|0|||
27535051|NCT02003365|80153470|FG002|Overall Study|Lost to Follow-up|1|||
27535052|NCT01436396|80153471|FG000|Overall Study|Protocol Violation|7|||
27535053|NCT01436396|80153472|FG001|Overall Study|Protocol Violation|5|||
27535054|NCT01436396|80153471|FG000|Overall Study|Adverse Event|1|||
27535055|NCT01436396|80153472|FG001|Overall Study|Adverse Event|2|||
27535056|NCT01436396|80153471|FG000|Overall Study|Withdrawal by Subject|19|||
27535057|NCT01436396|80153472|FG001|Overall Study|Withdrawal by Subject|29|||
27535058|NCT01436396|80153471|FG000|Overall Study|Serious adverse event|2|||
27535059|NCT01436396|80153472|FG001|Overall Study|Serious adverse event|3|||
27535060|NCT01436396|80153471|FG000|Overall Study|Lost to Follow-up|3|||
27535061|NCT01436396|80153472|FG001|Overall Study|Lost to Follow-up|3|||
27535062|NCT02777333|80153474|FG000|Overall Study|Withdrawal by Subject|0|||
27535063|NCT02777333|80153475|FG001|Overall Study|Withdrawal by Subject|1|||
27535064|NCT02777333|80153474|FG000|Overall Study|Lost to Follow-up|0|||
27535065|NCT02777333|80153475|FG001|Overall Study|Lost to Follow-up|1|||
27535066|NCT03228420|80153480|FG000|Overall Study|Lost to Follow-up|5|||
27535067|NCT03228420|80153481|FG001|Overall Study|Lost to Follow-up|3|||
27535068|NCT03228420|80153480|FG000|Overall Study|Withdrawal by Subject|10|||
27535069|NCT03228420|80153481|FG001|Overall Study|Withdrawal by Subject|0|||
27535070|NCT03228420|80153480|FG000|Overall Study|Adverse Event|5|||
27535071|NCT03228420|80153481|FG001|Overall Study|Adverse Event|2|||
27535072|NCT01303861|80153482|FG000|Overall Study|Lost to Follow-up|34|||
27535073|NCT01303861|80153483|FG001|Overall Study|Lost to Follow-up|14|||
27738284|NCT01450137|80871175|FG001|Week 12 to Study End|Death|1|||
27738285|NCT01450137|80871174|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
27738286|NCT01450137|80871175|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
27738287|NCT01845077|80871176|FG000|Washout Period|Lost to Follow-up|0|||
27738288|NCT01845077|80871177|FG001|Washout Period|Lost to Follow-up|1|||
27738289|NCT01845077|80871178|FG002|Washout Period|Lost to Follow-up|0|||
27738290|NCT01845077|80871179|FG003|Washout Period|Lost to Follow-up|1|||
27738291|NCT01845077|80871180|FG004|Washout Period|Lost to Follow-up|0|||
27738292|NCT01845077|80871181|FG005|Washout Period|Lost to Follow-up|1|||
27738293|NCT01845077|80871176|FG000|Washout Period|Adverse Event|1|||
27738294|NCT01845077|80871177|FG001|Washout Period|Adverse Event|0|||
27738295|NCT01845077|80871178|FG002|Washout Period|Adverse Event|0|||
27738296|NCT01845077|80871179|FG003|Washout Period|Adverse Event|0|||
27738297|NCT01845077|80871180|FG004|Washout Period|Adverse Event|0|||
27738298|NCT01845077|80871181|FG005|Washout Period|Adverse Event|0|||
27738299|NCT01845077|80871176|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
27738300|NCT01845077|80871177|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
27738301|NCT01845077|80871178|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
27738302|NCT01845077|80871179|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
27738303|NCT01845077|80871180|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
27738304|NCT01845077|80871181|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
27738305|NCT01845077|80871176|FG000|Washout Period|Protocol Violation|0|||
27738306|NCT01845077|80871177|FG001|Washout Period|Protocol Violation|0|||
27738307|NCT01845077|80871178|FG002|Washout Period|Protocol Violation|0|||
27738308|NCT01845077|80871179|FG003|Washout Period|Protocol Violation|1|||
27738309|NCT01845077|80871180|FG004|Washout Period|Protocol Violation|1|||
27738310|NCT01845077|80871181|FG005|Washout Period|Protocol Violation|0|||
27738311|NCT00847561|80871182|FG000|Overall Study|Withdrawal by Subject|4|||
27738312|NCT00847561|80871183|FG001|Overall Study|Withdrawal by Subject|3|||
27738313|NCT00847561|80871182|FG000|Overall Study|Unable to schedule|9|||
27738314|NCT00847561|80871183|FG001|Overall Study|Unable to schedule|1|||
27738315|NCT03842709|80871184|FG000|Overall Study|Withdrawal by Subject|3|||
27738316|NCT03842709|80871185|FG001|Overall Study|Withdrawal by Subject|3|||
27738317|NCT03842709|80871184|FG000|Overall Study|Lost to Follow-up|1|||
27738318|NCT03842709|80871185|FG001|Overall Study|Lost to Follow-up|0|||
27738319|NCT01926886|80871188|FG000|Overall Study|Administrative/other|1|||
27738320|NCT01926886|80871189|FG001|Overall Study|Administrative/other|0|||
27738321|NCT01926886|80871188|FG000|Overall Study|Adverse event/intercurrent illness|4|||
27914607|NCT03286218|81525910|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914608|NCT03286218|81525911|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914609|NCT03286218|81525912|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914610|NCT03286218|81525913|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914611|NCT03286218|81525914|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914612|NCT03286218|81525915|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914613|NCT03286218|81525916|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914614|NCT03286218|81525917|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
27914615|NCT03286218|81525906|FG000|Qualification Phase Period 2|Adverse Event|0|||
27914616|NCT03286218|81525907|FG001|Qualification Phase Period 2|Adverse Event|1|||
27914617|NCT03286218|81525908|FG002|Qualification Phase Period 2|Adverse Event|0|||
27914618|NCT03286218|81525909|FG003|Qualification Phase Period 2|Adverse Event|0|||
27914619|NCT03286218|81525910|FG004|Qualification Phase Period 2|Adverse Event|0|||
27914620|NCT03286218|81525911|FG005|Qualification Phase Period 2|Adverse Event|0|||
27914621|NCT03286218|81525912|FG006|Qualification Phase Period 2|Adverse Event|0|||
27914622|NCT03286218|81525913|FG007|Qualification Phase Period 2|Adverse Event|0|||
27914623|NCT03286218|81525914|FG008|Qualification Phase Period 2|Adverse Event|0|||
27914624|NCT03286218|81525915|FG009|Qualification Phase Period 2|Adverse Event|0|||
27914625|NCT03286218|81525916|FG010|Qualification Phase Period 2|Adverse Event|0|||
27914626|NCT03286218|81525917|FG011|Qualification Phase Period 2|Adverse Event|0|||
27914627|NCT03286218|81525906|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
27914628|NCT03286218|81525907|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
27914629|NCT03286218|81525908|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914630|NCT03286218|81525909|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914631|NCT03286218|81525910|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914632|NCT03286218|81525911|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914633|NCT03286218|81525912|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914634|NCT03286218|81525913|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914635|NCT03286218|81525914|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914636|NCT03286218|81525915|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27738322|NCT01926886|80871189|FG001|Overall Study|Adverse event/intercurrent illness|0|||
27738323|NCT01926886|80871188|FG000|Overall Study|Disease progression/recurrence|4|||
27914637|NCT03286218|81525916|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914638|NCT03286218|81525917|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
27914639|NCT03286218|81525906|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
27914640|NCT03286218|81525907|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
27914641|NCT03286218|81525908|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
27914642|NCT03286218|81525909|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
27914643|NCT03286218|81525910|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
27914644|NCT03286218|81525911|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
27914645|NCT03286218|81525912|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
27914646|NCT03286218|81525913|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
27914647|NCT03286218|81525914|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
27914648|NCT03286218|81525915|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
27914649|NCT03286218|81525916|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
27914650|NCT03286218|81525917|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
27914651|NCT03286218|81525906|FG000|Qualification Phase Period 2|Protocol Violation|2|||
27914652|NCT03286218|81525907|FG001|Qualification Phase Period 2|Protocol Violation|0|||
27914653|NCT03286218|81525908|FG002|Qualification Phase Period 2|Protocol Violation|0|||
27535074|NCT01303861|80153484|FG002|Overall Study|Lost to Follow-up|27|||
27535075|NCT01303861|80153485|FG003|Overall Study|Lost to Follow-up|31|||
27535076|NCT01303861|80153482|FG000|Overall Study|Lack of Efficacy|3|||
27738324|NCT01926886|80871189|FG001|Overall Study|Disease progression/recurrence|0|||
27738325|NCT01926886|80871188|FG000|Overall Study|Withdrawal by Subject|15|||
27738326|NCT01926886|80871189|FG001|Overall Study|Withdrawal by Subject|0|||
27738327|NCT01926886|80871188|FG000|Overall Study|Failure to return|3|||
27738328|NCT01926886|80871189|FG001|Overall Study|Failure to return|0|||
27738329|NCT01926886|80871188|FG000|Overall Study|Recurrence of disease|1|||
27738330|NCT01926886|80871189|FG001|Overall Study|Recurrence of disease|0|||
27738331|NCT01926886|80871188|FG000|Overall Study|Progression of disease|2|||
27738332|NCT01926886|80871189|FG001|Overall Study|Progression of disease|0|||
27738333|NCT01926886|80871188|FG000|Overall Study|Death|1|||
27738334|NCT01926886|80871189|FG001|Overall Study|Death|0|||
27738335|NCT01926886|80871188|FG000|Overall Study|Did not cooperate|1|||
27738336|NCT01926886|80871189|FG001|Overall Study|Did not cooperate|0|||
27738337|NCT01750918|80871190|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
27738338|NCT01750918|80871191|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
27914654|NCT03286218|81525909|FG003|Qualification Phase Period 2|Protocol Violation|0|||
27914655|NCT03286218|81525910|FG004|Qualification Phase Period 2|Protocol Violation|0|||
27914656|NCT03286218|81525911|FG005|Qualification Phase Period 2|Protocol Violation|0|||
27914657|NCT03286218|81525912|FG006|Qualification Phase Period 2|Protocol Violation|0|||
27738339|NCT01750918|80871192|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
27738340|NCT01750918|80871193|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
27738341|NCT01750918|80871194|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
27738342|NCT01750918|80871195|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
27738343|NCT01750918|80871196|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
27738344|NCT01750918|80871197|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
27738345|NCT01750918|80871190|FG000|Overall Study|Lost to Follow-up|0|||
27738346|NCT01750918|80871191|FG001|Overall Study|Lost to Follow-up|0|||
27738347|NCT01750918|80871192|FG002|Overall Study|Lost to Follow-up|2|||
27738348|NCT01750918|80871193|FG003|Overall Study|Lost to Follow-up|2|||
27738349|NCT01750918|80871194|FG004|Overall Study|Lost to Follow-up|0|||
27738350|NCT01750918|80871195|FG005|Overall Study|Lost to Follow-up|0|||
27738351|NCT01750918|80871196|FG006|Overall Study|Lost to Follow-up|0|||
27738352|NCT01750918|80871197|FG007|Overall Study|Lost to Follow-up|1|||
27738353|NCT01750918|80871190|FG000|Overall Study|Withdrawal by Subject|0|||
27738354|NCT01750918|80871191|FG001|Overall Study|Withdrawal by Subject|0|||
27738355|NCT01750918|80871192|FG002|Overall Study|Withdrawal by Subject|1|||
27738356|NCT01750918|80871193|FG003|Overall Study|Withdrawal by Subject|2|||
27738357|NCT01750918|80871194|FG004|Overall Study|Withdrawal by Subject|1|||
27738358|NCT01750918|80871195|FG005|Overall Study|Withdrawal by Subject|1|||
27914658|NCT03286218|81525913|FG007|Qualification Phase Period 2|Protocol Violation|0|||
27914659|NCT03286218|81525914|FG008|Qualification Phase Period 2|Protocol Violation|0|||
27914660|NCT03286218|81525915|FG009|Qualification Phase Period 2|Protocol Violation|0|||
27535077|NCT01303861|80153483|FG001|Overall Study|Lack of Efficacy|2|||
27535078|NCT01303861|80153484|FG002|Overall Study|Lack of Efficacy|1|||
27535079|NCT01303861|80153485|FG003|Overall Study|Lack of Efficacy|0|||
27535080|NCT01303861|80153482|FG000|Overall Study|Withdrawal by Subject|16|||
27535081|NCT01303861|80153483|FG001|Overall Study|Withdrawal by Subject|8|||
27535082|NCT01303861|80153484|FG002|Overall Study|Withdrawal by Subject|8|||
27535083|NCT01303861|80153485|FG003|Overall Study|Withdrawal by Subject|23|||
27535084|NCT01303861|80153482|FG000|Overall Study|Adverse Event|4|||
27535085|NCT01303861|80153483|FG001|Overall Study|Adverse Event|1|||
27738359|NCT01750918|80871196|FG006|Overall Study|Withdrawal by Subject|2|||
27738360|NCT01750918|80871197|FG007|Overall Study|Withdrawal by Subject|2|||
27738361|NCT01584024|80871201|FG000|Overall Study|Lost to Follow-up|10|||
27738362|NCT01584024|80871201|FG000|Overall Study|Withdrawal by Subject|3|||
27738363|NCT01633060|80871211|FG000|Randomization Phase|Protocol deviation|1|||
27738364|NCT01633060|80871212|FG001|Randomization Phase|Protocol deviation|2|||
27738365|NCT01633060|80871211|FG000|Randomization Phase|Technical problem|0|||
27738366|NCT01633060|80871212|FG001|Randomization Phase|Technical problem|1|||
27738367|NCT01633060|80871211|FG000|Treatment Phase|Adverse Event|24|||
27738368|NCT01633060|80871212|FG001|Treatment Phase|Adverse Event|3|||
27738369|NCT01633060|80871211|FG000|Treatment Phase|Lost to Follow-up|1|||
27738370|NCT01633060|80871212|FG001|Treatment Phase|Lost to Follow-up|0|||
27738371|NCT01633060|80871211|FG000|Treatment Phase|Physician Decision|16|||
27738372|NCT01633060|80871212|FG001|Treatment Phase|Physician Decision|7|||
27738373|NCT01633060|80871211|FG000|Treatment Phase|Progressive Disease|210|||
27738374|NCT01633060|80871212|FG001|Treatment Phase|Progressive Disease|120|||
27738375|NCT01633060|80871211|FG000|Treatment Phase|Protocol Deviation|1|||
27738376|NCT01633060|80871212|FG001|Treatment Phase|Protocol Deviation|0|||
27738377|NCT01633060|80871211|FG000|Treatment Phase|Study Terminated by sponsor|7|||
27738378|NCT01633060|80871212|FG001|Treatment Phase|Study Terminated by sponsor|3|||
27738379|NCT01633060|80871211|FG000|Treatment Phase|Subject/guardian decision|25|||
27738380|NCT01633060|80871212|FG001|Treatment Phase|Subject/guardian decision|4|||
27738381|NCT01633060|80871211|FG000|Treatment Phase|Death|4|||
27738382|NCT01633060|80871212|FG001|Treatment Phase|Death|3|||
27738383|NCT01633060|80871211|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
27738384|NCT01633060|80871212|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
27738385|NCT01633060|80871211|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
27738386|NCT01633060|80871212|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
27738387|NCT01633060|80871211|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
27738388|NCT01633060|80871212|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
27738389|NCT01633060|80871211|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
27738390|NCT01633060|80871212|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
27738391|NCT01633060|80871211|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
27738392|NCT01633060|80871212|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
27738393|NCT01633060|80871211|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
27738394|NCT01633060|80871212|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
27738395|NCT05309083|80871216|FG000|Overall Study|Withdrawal by Subject|2|||
27738396|NCT02088034|80871220|FG000|Overall Study|Lost to Follow-up|1|||
27738397|NCT02088034|80871221|FG001|Overall Study|Lost to Follow-up|1|||
27738398|NCT02088034|80871222|FG002|Overall Study|Lost to Follow-up|0|||
27738399|NCT02088034|80871220|FG000|Overall Study|Pregnancy|2|||
27738400|NCT02088034|80871221|FG001|Overall Study|Pregnancy|1|||
27738401|NCT02088034|80871222|FG002|Overall Study|Pregnancy|2|||
27738402|NCT00224016|80871229|FG000|Titration Period|Withdrawal by Subject|0|||
27738403|NCT00224016|80871230|FG001|Titration Period|Withdrawal by Subject|1|||
27738404|NCT00224016|80871229|FG000|Titration Period|Lost to Follow-up|1|||
27738405|NCT00224016|80871230|FG001|Titration Period|Lost to Follow-up|0|||
27738406|NCT00224016|80871229|FG000|Maintenance Period|Withdrawal by Subject|2|||
27738407|NCT00224016|80871230|FG001|Maintenance Period|Withdrawal by Subject|0|||
27738408|NCT00224016|80871229|FG000|Maintenance Period|Lost to Follow-up|0|||
27738409|NCT00224016|80871230|FG001|Maintenance Period|Lost to Follow-up|1|||
27738410|NCT02519231|80871231|FG000|Overall Study|Lost to Follow-up|2|||
27738411|NCT02519231|80871232|FG001|Overall Study|Lost to Follow-up|5|||
27738412|NCT02519231|80871231|FG000|Overall Study|Withdrawal by Subject|0|||
27738413|NCT02519231|80871232|FG001|Overall Study|Withdrawal by Subject|1|||
27914661|NCT03286218|81525916|FG010|Qualification Phase Period 2|Protocol Violation|0|||
27630896|NCT01212757|80490109|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27738414|NCT00784758|80871233|FG000|Overall Study|Withdrawal by Subject|3|||
27738415|NCT00784758|80871234|FG001|Overall Study|Withdrawal by Subject|0|||
27738416|NCT00784758|80871233|FG000|Overall Study|Adverse Event|1|||
27535086|NCT01303861|80153484|FG002|Overall Study|Adverse Event|0|||
27535087|NCT01303861|80153485|FG003|Overall Study|Adverse Event|5|||
27535088|NCT01303861|80153482|FG000|Overall Study|Pregnancy|1|||
27535089|NCT01303861|80153483|FG001|Overall Study|Pregnancy|0|||
27630897|NCT01212757|80490110|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
27630898|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630899|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630900|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630901|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630902|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630903|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630904|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630905|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
27630906|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
27630907|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27630908|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
27630909|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
27630910|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27630911|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27630912|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27630913|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
27630914|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
27630915|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
27630916|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27630917|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
27630918|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
27630919|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27630920|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27630921|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27630922|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27630923|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
27630924|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
27630925|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27630926|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
27630927|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
27630928|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27630929|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27630930|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27914662|NCT03286218|81525917|FG011|Qualification Phase Period 2|Protocol Violation|0|||
27535090|NCT01303861|80153484|FG002|Overall Study|Pregnancy|0|||
27535091|NCT01303861|80153485|FG003|Overall Study|Pregnancy|0|||
27535092|NCT00702689|80153486|FG000|Overall Study|Withdrawal by Subject|4|||
27535093|NCT00702689|80153486|FG000|Overall Study|Recurrent malignancy|1|||
27535094|NCT00702689|80153486|FG000|Overall Study|Adverse Event|1|||
27535095|NCT02758171|80153487|FG000|Wash-out|Withdrawal by Subject|1|||
27535096|NCT02758171|80153488|FG001|Wash-out|Withdrawal by Subject|0|||
27535097|NCT02758171|80153487|FG000|Wash-out|Other reason|1|||
27535098|NCT02758171|80153488|FG001|Wash-out|Other reason|0|||
27535099|NCT03001882|80153494|FG000|Overall Study|Death|1|||
27535100|NCT03001882|80153495|FG001|Overall Study|Death|0|||
27535101|NCT03001882|80153496|FG002|Overall Study|Death|0|||
27535102|NCT03001882|80153497|FG003|Overall Study|Death|3|||
27535103|NCT03001882|80153494|FG000|Overall Study|Participant withdrew consent|0|||
27535104|NCT03001882|80153495|FG001|Overall Study|Participant withdrew consent|1|||
27535105|NCT03001882|80153496|FG002|Overall Study|Participant withdrew consent|0|||
27535106|NCT03001882|80153497|FG003|Overall Study|Participant withdrew consent|5|||
27535107|NCT03001882|80153494|FG000|Overall Study|Other reasons|1|||
27535108|NCT03001882|80153495|FG001|Overall Study|Other reasons|2|||
27535109|NCT03001882|80153496|FG002|Overall Study|Other reasons|0|||
27535110|NCT03001882|80153497|FG003|Overall Study|Other reasons|5|||
27535111|NCT03001882|80153494|FG000|Overall Study|Administrative reason by sponsor|0|||
27535112|NCT03001882|80153495|FG001|Overall Study|Administrative reason by sponsor|0|||
27535113|NCT03001882|80153496|FG002|Overall Study|Administrative reason by sponsor|0|||
27535114|NCT03001882|80153497|FG003|Overall Study|Administrative reason by sponsor|1|||
27535115|NCT03001882|80153494|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
27535116|NCT03001882|80153495|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
27535117|NCT03001882|80153496|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
27535118|NCT03001882|80153497|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
27630931|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
27630932|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
27630933|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
27630934|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27738417|NCT00784758|80871234|FG001|Overall Study|Adverse Event|0|||
27738418|NCT02452359|80871235|FG000|Overall Study|Adverse Event|1|||
27738419|NCT02452359|80871235|FG000|Overall Study|Lost to Follow-up|15|||
27738420|NCT02452359|80871235|FG000|Overall Study|Pregnancy|1|||
27738421|NCT02452359|80871235|FG000|Overall Study|Withdrawal by Subject|4|||
27738422|NCT02623361|80871236|FG000|Overall Study|Protocol Violation|0|||
27738423|NCT02623361|80871237|FG001|Overall Study|Protocol Violation|1|||
27738424|NCT02623361|80871236|FG000|Overall Study|Withdrawal by Subject|0|||
27738425|NCT02623361|80871237|FG001|Overall Study|Withdrawal by Subject|1|||
27738426|NCT02259231|80871238|FG000|Overall Study|Adverse Event|1|||
27738427|NCT02259231|80871239|FG001|Overall Study|Adverse Event|1|||
27738428|NCT02259231|80871240|FG002|Overall Study|Adverse Event|2|||
27738429|NCT02259231|80871241|FG003|Overall Study|Adverse Event|0|||
27738430|NCT02259231|80871242|FG004|Overall Study|Adverse Event|0|||
27738431|NCT02259231|80871243|FG005|Overall Study|Adverse Event|0|||
27914663|NCT03286218|81525906|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
27914664|NCT03286218|81525907|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
27535119|NCT03001882|80153494|FG000|Overall Study|Not reported|0|||
27535120|NCT03001882|80153495|FG001|Overall Study|Not reported|0|||
27535121|NCT03001882|80153496|FG002|Overall Study|Not reported|0|||
27535122|NCT03001882|80153497|FG003|Overall Study|Not reported|6|||
27535123|NCT03001882|80153494|FG000|Overall Study|Maximum clinical benefit|2|||
27535124|NCT03001882|80153495|FG001|Overall Study|Maximum clinical benefit|3|||
27535125|NCT03001882|80153496|FG002|Overall Study|Maximum clinical benefit|0|||
27535126|NCT03001882|80153497|FG003|Overall Study|Maximum clinical benefit|10|||
27535127|NCT03001882|80153494|FG000|Overall Study|AE unrelated to study drug|3|||
27535128|NCT03001882|80153495|FG001|Overall Study|AE unrelated to study drug|3|||
27535129|NCT03001882|80153496|FG002|Overall Study|AE unrelated to study drug|0|||
27630935|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630936|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
27630937|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630938|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630939|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630940|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630941|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630942|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
27630943|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27535130|NCT03001882|80153497|FG003|Overall Study|AE unrelated to study drug|11|||
27535131|NCT03001882|80153494|FG000|Overall Study|Study Drug Toxicity|8|||
27535132|NCT03001882|80153495|FG001|Overall Study|Study Drug Toxicity|5|||
27535133|NCT03001882|80153496|FG002|Overall Study|Study Drug Toxicity|0|||
27535134|NCT03001882|80153497|FG003|Overall Study|Study Drug Toxicity|37|||
27535135|NCT03001882|80153494|FG000|Overall Study|Disease progression|16|||
27535136|NCT03001882|80153495|FG001|Overall Study|Disease progression|14|||
27535137|NCT03001882|80153496|FG002|Overall Study|Disease progression|1|||
27535138|NCT03001882|80153497|FG003|Overall Study|Disease progression|90|||
27535139|NCT01578330|80153498|FG000|Overall Study|Adverse Event|2|||
27535140|NCT01578330|80153498|FG000|Overall Study|Protocol Violation|5|||
27535141|NCT03039192|80153499|FG000|Overall Study|Lost to Follow-up|4|||
27535142|NCT03039192|80153500|FG001|Overall Study|Lost to Follow-up|4|||
27535143|NCT03039192|80153499|FG000|Overall Study|Adverse event, serious fatal|0|||
27535144|NCT03039192|80153500|FG001|Overall Study|Adverse event, serious fatal|1|||
27535145|NCT03039192|80153499|FG000|Overall Study|Adverse event, non-fatal|0|||
27535146|NCT03039192|80153500|FG001|Overall Study|Adverse event, non-fatal|2|||
27630944|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
27630945|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
27738432|NCT02259231|80871244|FG006|Overall Study|Adverse Event|0|||
27738433|NCT02259231|80871238|FG000|Overall Study|Progressive Disease|4|||
27738434|NCT02259231|80871239|FG001|Overall Study|Progressive Disease|5|||
27630946|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27630947|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27630948|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27914665|NCT03286218|81525908|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914666|NCT03286218|81525909|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914667|NCT03286218|81525910|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914668|NCT03286218|81525911|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914669|NCT03286218|81525912|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914670|NCT03286218|81525913|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914671|NCT03286218|81525914|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914672|NCT03286218|81525915|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914673|NCT03286218|81525916|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914674|NCT03286218|81525917|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
27914675|NCT03286218|81525906|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914676|NCT03286218|81525907|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914677|NCT03286218|81525908|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
27914678|NCT03286218|81525909|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
27914679|NCT03286218|81525910|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914680|NCT03286218|81525911|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
27535147|NCT03039192|80153499|FG000|Overall Study|Withdrawal by Subject|6|||
27535148|NCT03039192|80153500|FG001|Overall Study|Withdrawal by Subject|9|||
27535149|NCT03039192|80153499|FG000|Overall Study|Discontinued from treatment phase|19|||
27535150|NCT03039192|80153500|FG001|Overall Study|Discontinued from treatment phase|12|||
27535151|NCT03039192|80153499|FG000|Overall Study|Other|3|||
27535152|NCT03039192|80153500|FG001|Overall Study|Other|2|||
27535153|NCT01092507|80153507|FG000|Overall Study|Withdrawal by Subject|2|||
27535154|NCT01092507|80153508|FG001|Overall Study|Withdrawal by Subject|0|||
27535155|NCT03626168|80153509|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27535156|NCT03626168|80153510|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27535157|NCT03626168|80153509|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
27535158|NCT03626168|80153510|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
27535159|NCT03626168|80153509|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
27535160|NCT03626168|80153510|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
27535161|NCT05021081|80153514|FG000|Phase 2|Subject enrolled in error|1|||
27535162|NCT05021081|80153515|FG001|Phase 2|Subject enrolled in error|1|||
27535163|NCT05021081|80153516|FG002|Phase 2|Subject enrolled in error|0|||
27535164|NCT04122534|80153517|FG000|Overall Study|Lost to Follow-up|4|||
27535165|NCT00422097|80153519|FG000|Dose Level 2|Still on treatment|0|||
27535166|NCT00422097|80153520|FG001|Dose Level 2|Still on treatment|1|||
27535167|NCT00422097|80153521|FG002|Dose Level 2|Still on treatment|0|||
27535168|NCT00422097|80153522|FG003|Dose Level 2|Still on treatment|0|||
27535169|NCT00422097|80153523|FG004|Dose Level 2|Still on treatment|0|||
27535170|NCT00422097|80153524|FG005|Dose Level 2|Still on treatment|0|||
27535171|NCT00422097|80153525|FG006|Dose Level 2|Still on treatment|0|||
27535172|NCT00422097|80153526|FG007|Dose Level 2|Still on treatment|0|||
27535173|NCT01601132|80153527|FG000|Overall Study|Patient withdrew consent|1|||
27535174|NCT01601132|80153527|FG000|Overall Study|Protocol deviation|1|||
27535175|NCT01346969|80153528|FG000|Overall Study|Withdrawal by Subject|0|||
27535176|NCT01346969|80153529|FG001|Overall Study|Withdrawal by Subject|0|||
27535177|NCT01346969|80153530|FG002|Overall Study|Withdrawal by Subject|1|||
27535178|NCT01346969|80153531|FG003|Overall Study|Withdrawal by Subject|0|||
27535179|NCT01346969|80153528|FG000|Overall Study|Lost to Follow-up|1|||
27535180|NCT01346969|80153529|FG001|Overall Study|Lost to Follow-up|0|||
27535181|NCT01346969|80153530|FG002|Overall Study|Lost to Follow-up|2|||
27535182|NCT01346969|80153531|FG003|Overall Study|Lost to Follow-up|0|||
27535183|NCT01346969|80153528|FG000|Overall Study|Physician Decision|0|||
27535184|NCT01346969|80153529|FG001|Overall Study|Physician Decision|0|||
27535185|NCT01346969|80153530|FG002|Overall Study|Physician Decision|0|||
27535186|NCT01346969|80153531|FG003|Overall Study|Physician Decision|1|||
27535187|NCT01346969|80153528|FG000|Overall Study|Randomized but not treated|1|||
27535188|NCT01346969|80153529|FG001|Overall Study|Randomized but not treated|0|||
27535189|NCT01346969|80153530|FG002|Overall Study|Randomized but not treated|0|||
27535190|NCT01346969|80153531|FG003|Overall Study|Randomized but not treated|0|||
27535191|NCT03257371|80153533|FG000|Overall Study|Lost to Follow-up|1|||
27535192|NCT01024231|80153536|FG000|Overall Study|Other Reasons|1|||
27535193|NCT01024231|80153537|FG001|Overall Study|Other Reasons|2|||
27535194|NCT01024231|80153538|FG002|Overall Study|Other Reasons|0|||
27535195|NCT01024231|80153539|FG003|Overall Study|Other Reasons|0|||
27535196|NCT01024231|80153540|FG004|Overall Study|Other Reasons|2|||
27535197|NCT01024231|80153541|FG005|Overall Study|Other Reasons|0|||
27535198|NCT01024231|80153542|FG006|Overall Study|Other Reasons|1|||
27535199|NCT01024231|80153536|FG000|Overall Study|Maximum Clinical Benefit|1|||
27535200|NCT01024231|80153537|FG001|Overall Study|Maximum Clinical Benefit|2|||
27630949|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27630950|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
27630951|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
27630952|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27630953|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
27630954|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
27630955|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27630956|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27630957|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27630958|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
27630959|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
27630960|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
27630961|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630962|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630963|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
27630964|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630965|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630966|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630967|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630968|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630969|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
27630970|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27630971|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
27630972|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27630973|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27630974|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27630975|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27630976|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
27630977|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27630978|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
27630979|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630980|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630981|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630982|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630983|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630984|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630985|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630986|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
27630987|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
27630988|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630989|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
27630990|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630991|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630992|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630993|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630994|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630995|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630996|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
27630997|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27630998|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27630999|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
27631000|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27631001|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27631002|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27631003|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27631004|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
27631005|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
27631006|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27631007|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
27631008|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27631009|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27631010|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27914681|NCT03286218|81525912|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914682|NCT03286218|81525913|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
27631011|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27631012|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27631013|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
27631014|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
27631015|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27631016|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
27631017|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
27631018|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27631019|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27631020|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27631021|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
27631022|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
27631023|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
27631024|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27631025|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
27631026|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
27631027|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27631028|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27631029|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27631030|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
27631031|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
27631032|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
27631033|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27631034|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
27631035|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
27631036|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27631037|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27631038|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27631039|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
27631040|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
27631041|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
27631042|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
27631043|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
27631044|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
27631045|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
27631046|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
27631047|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
27631048|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
27631049|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
27631050|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
27535201|NCT01024231|80153538|FG002|Overall Study|Maximum Clinical Benefit|0|||
27535202|NCT01024231|80153539|FG003|Overall Study|Maximum Clinical Benefit|1|||
27535203|NCT01024231|80153540|FG004|Overall Study|Maximum Clinical Benefit|1|||
27535204|NCT01024231|80153541|FG005|Overall Study|Maximum Clinical Benefit|0|||
27535205|NCT01024231|80153542|FG006|Overall Study|Maximum Clinical Benefit|0|||
27535206|NCT01024231|80153536|FG000|Overall Study|Disease Progression|3|||
27535207|NCT01024231|80153537|FG001|Overall Study|Disease Progression|1|||
27535208|NCT01024231|80153538|FG002|Overall Study|Disease Progression|3|||
27535209|NCT01024231|80153539|FG003|Overall Study|Disease Progression|0|||
27535210|NCT01024231|80153540|FG004|Overall Study|Disease Progression|4|||
27535211|NCT01024231|80153541|FG005|Overall Study|Disease Progression|11|||
27535212|NCT01024231|80153542|FG006|Overall Study|Disease Progression|6|||
27535213|NCT01024231|80153536|FG000|Overall Study|AE unrelated to Study Drug|0|||
27535214|NCT01024231|80153537|FG001|Overall Study|AE unrelated to Study Drug|1|||
27535215|NCT01024231|80153538|FG002|Overall Study|AE unrelated to Study Drug|0|||
27535216|NCT01024231|80153539|FG003|Overall Study|AE unrelated to Study Drug|0|||
27631051|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631052|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631053|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631054|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631055|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631056|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631057|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27631058|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
27631059|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
27535217|NCT01024231|80153540|FG004|Overall Study|AE unrelated to Study Drug|0|||
27631060|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27631061|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
27631062|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
27631063|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27631064|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27631065|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27914683|NCT03286218|81525914|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914684|NCT03286218|81525915|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914685|NCT03286218|81525916|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
27914686|NCT03286218|81525917|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
27914687|NCT03286218|81525906|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914688|NCT03286218|81525907|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914689|NCT03286218|81525908|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914690|NCT03286218|81525909|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914691|NCT03286218|81525910|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914692|NCT03286218|81525911|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914693|NCT03286218|81525912|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914694|NCT03286218|81525913|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914695|NCT03286218|81525914|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914696|NCT03286218|81525915|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914697|NCT03286218|81525916|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
27914698|NCT03286218|81525917|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
27914699|NCT01817075|81525918|FG000|Overall Study|Adverse Event|7|||
27914700|NCT01817075|81525919|FG001|Overall Study|Adverse Event|5|||
27914701|NCT01817075|81525918|FG000|Overall Study|Physician Decision|9|||
27914702|NCT01817075|81525919|FG001|Overall Study|Physician Decision|12|||
27914703|NCT01817075|81525918|FG000|Overall Study|Withdrawal by Subject|31|||
27914704|NCT01817075|81525919|FG001|Overall Study|Withdrawal by Subject|15|||
27914705|NCT01817075|81525918|FG000|Overall Study|Received Sorafenib after enrollment|0|||
27914706|NCT01817075|81525919|FG001|Overall Study|Received Sorafenib after enrollment|1|||
27914707|NCT01817075|81525918|FG000|Overall Study|Ineligible|0|||
27914708|NCT01817075|81525919|FG001|Overall Study|Ineligible|2|||
27914709|NCT01806168|81525920|FG000|Overall Study|Adverse Event|1|||
27914710|NCT01806168|81525921|FG001|Overall Study|Adverse Event|0|||
27914711|NCT01806168|81525922|FG002|Overall Study|Adverse Event|0|||
27914712|NCT01806168|81525920|FG000|Overall Study|Withdrawal by Subject|0|||
27914713|NCT01806168|81525921|FG001|Overall Study|Withdrawal by Subject|1|||
27914714|NCT01806168|81525922|FG002|Overall Study|Withdrawal by Subject|2|||
27914715|NCT01806168|81525920|FG000|Overall Study|Protocol Violation|0|||
27914716|NCT01806168|81525921|FG001|Overall Study|Protocol Violation|0|||
27914717|NCT01806168|81525922|FG002|Overall Study|Protocol Violation|1|||
27914718|NCT03410992|81525927|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914719|NCT03410992|81525928|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
27914720|NCT03410992|81525929|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914721|NCT03410992|81525930|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914722|NCT03410992|81525931|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914723|NCT03410992|81525932|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914724|NCT03410992|81525933|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914725|NCT03410992|81525934|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914726|NCT03410992|81525935|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914727|NCT03410992|81525936|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914728|NCT03410992|81525937|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
27914729|NCT03410992|81525927|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
27914730|NCT03410992|81525928|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
27914731|NCT03410992|81525929|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914732|NCT03410992|81525930|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914733|NCT03410992|81525931|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914734|NCT03410992|81525932|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914735|NCT03410992|81525933|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914736|NCT03410992|81525934|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914737|NCT03410992|81525935|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914738|NCT03410992|81525936|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914739|NCT03410992|81525937|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
27914740|NCT03410992|81525927|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
27914741|NCT03410992|81525928|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
27914742|NCT03410992|81525929|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914743|NCT03410992|81525930|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914744|NCT03410992|81525931|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914745|NCT03410992|81525932|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914746|NCT03410992|81525933|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914747|NCT03410992|81525934|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914748|NCT03410992|81525935|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27738435|NCT02259231|80871240|FG002|Overall Study|Progressive Disease|4|||
27914749|NCT03410992|81525936|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914750|NCT03410992|81525937|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
27914751|NCT03410992|81525927|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
27914752|NCT03410992|81525928|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914753|NCT03410992|81525929|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914754|NCT03410992|81525930|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914755|NCT03410992|81525931|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914756|NCT03410992|81525932|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914757|NCT03410992|81525933|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914758|NCT03410992|81525934|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914759|NCT03410992|81525935|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914760|NCT03410992|81525936|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914761|NCT03410992|81525937|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
27914762|NCT03410992|81525927|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
27914763|NCT03410992|81525928|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
27631066|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
27631067|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27631068|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
27631069|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27631070|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
27631071|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
27631072|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27631073|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27631074|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27631075|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27631076|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
27631077|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
27631078|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27631079|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
27631080|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
27631081|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27631082|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27631083|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27631084|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
27631085|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
27631086|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
27631087|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631088|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
27631089|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631090|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631091|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631092|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631093|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631094|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631095|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
27631096|NCT01212757|80490102|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631097|NCT01212757|80490103|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
27631098|NCT01212757|80490104|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
27631099|NCT01212757|80490105|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631100|NCT01212757|80490106|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631101|NCT01212757|80490107|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631102|NCT01212757|80490108|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631103|NCT01212757|80490109|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631104|NCT01212757|80490110|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
27631105|NCT02918071|80490111|FG000|Overall Study|Withdrawal by Subject|2|||
27631106|NCT02918071|80490111|FG000|Overall Study|Lost to Follow-up|1|||
27914764|NCT03410992|81525929|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914765|NCT03410992|81525930|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914766|NCT03410992|81525931|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914767|NCT03410992|81525932|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914768|NCT03410992|81525933|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914769|NCT03410992|81525934|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914770|NCT03410992|81525935|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914771|NCT03410992|81525936|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914772|NCT03410992|81525937|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
27914773|NCT03410992|81525927|FG000|Week 16 Assessment|Incorrect escapers|0|||
27914774|NCT03410992|81525928|FG001|Week 16 Assessment|Incorrect escapers|6|||
27631107|NCT01186848|80490112|FG000|Overall Study|Lost to Follow-up|4|||
27631108|NCT01186848|80490112|FG000|Overall Study|Withdrawal by Subject|2|||
27631109|NCT01186848|80490112|FG000|Overall Study|Adverse Event|2|||
27631110|NCT00909363|80490113|FG000|Overall Study|Withdrawal by Subject|1|||
27535218|NCT01024231|80153541|FG005|Overall Study|AE unrelated to Study Drug|0|||
27535219|NCT01024231|80153542|FG006|Overall Study|AE unrelated to Study Drug|0|||
27535220|NCT01024231|80153536|FG000|Overall Study|No longer meets criteria|0|||
27535221|NCT01024231|80153537|FG001|Overall Study|No longer meets criteria|0|||
27535222|NCT01024231|80153538|FG002|Overall Study|No longer meets criteria|0|||
27535223|NCT01024231|80153539|FG003|Overall Study|No longer meets criteria|0|||
27535224|NCT01024231|80153540|FG004|Overall Study|No longer meets criteria|1|||
27535225|NCT01024231|80153541|FG005|Overall Study|No longer meets criteria|0|||
27535226|NCT01024231|80153542|FG006|Overall Study|No longer meets criteria|1|||
27535227|NCT01024231|80153536|FG000|Overall Study|Study Drug Toxicity|1|||
27535228|NCT01024231|80153537|FG001|Overall Study|Study Drug Toxicity|6|||
27535229|NCT01024231|80153538|FG002|Overall Study|Study Drug Toxicity|6|||
27535230|NCT01024231|80153539|FG003|Overall Study|Study Drug Toxicity|4|||
27535231|NCT01024231|80153540|FG004|Overall Study|Study Drug Toxicity|2|||
27535232|NCT01024231|80153541|FG005|Overall Study|Study Drug Toxicity|0|||
27535233|NCT01024231|80153542|FG006|Overall Study|Study Drug Toxicity|7|||
27535234|NCT01024231|80153536|FG000|Overall Study|Death|6|||
27535235|NCT01024231|80153537|FG001|Overall Study|Death|2|||
27535236|NCT01024231|80153538|FG002|Overall Study|Death|1|||
27535237|NCT01024231|80153539|FG003|Overall Study|Death|0|||
27535238|NCT01024231|80153540|FG004|Overall Study|Death|4|||
27535239|NCT01024231|80153541|FG005|Overall Study|Death|3|||
27535240|NCT01024231|80153542|FG006|Overall Study|Death|5|||
27535241|NCT01024231|80153536|FG000|Overall Study|Lost to Follow-up|0|||
27535242|NCT01024231|80153537|FG001|Overall Study|Lost to Follow-up|0|||
27535243|NCT01024231|80153538|FG002|Overall Study|Lost to Follow-up|0|||
27535244|NCT01024231|80153539|FG003|Overall Study|Lost to Follow-up|0|||
27535245|NCT01024231|80153540|FG004|Overall Study|Lost to Follow-up|0|||
27535246|NCT01024231|80153541|FG005|Overall Study|Lost to Follow-up|0|||
27535247|NCT01024231|80153542|FG006|Overall Study|Lost to Follow-up|1|||
27535248|NCT01024231|80153536|FG000|Overall Study|Withdrew Consent|0|||
27535249|NCT01024231|80153537|FG001|Overall Study|Withdrew Consent|1|||
27535250|NCT01024231|80153538|FG002|Overall Study|Withdrew Consent|0|||
27535251|NCT01024231|80153539|FG003|Overall Study|Withdrew Consent|0|||
27535252|NCT01024231|80153540|FG004|Overall Study|Withdrew Consent|0|||
27535253|NCT01024231|80153541|FG005|Overall Study|Withdrew Consent|0|||
27535254|NCT01024231|80153542|FG006|Overall Study|Withdrew Consent|0|||
27535255|NCT01024231|80153536|FG000|Overall Study|Continuing on Treatment|0|||
27535256|NCT01024231|80153537|FG001|Overall Study|Continuing on Treatment|0|||
27535257|NCT01024231|80153538|FG002|Overall Study|Continuing on Treatment|0|||
27535258|NCT01024231|80153539|FG003|Overall Study|Continuing on Treatment|0|||
27535259|NCT01024231|80153540|FG004|Overall Study|Continuing on Treatment|3|||
27535260|NCT01024231|80153541|FG005|Overall Study|Continuing on Treatment|2|||
27535261|NCT01024231|80153542|FG006|Overall Study|Continuing on Treatment|0|||
27535262|NCT01069627|80153545|FG000|Overall Study|Disease progression|7|||
27535263|NCT01069627|80153545|FG000|Overall Study|Adverse Event|12|||
27535264|NCT01069627|80153545|FG000|Overall Study|Protocol Violation|1|||
27535265|NCT00195273|80153551|FG000|Overall Study|Adverse Event|9|||
27535266|NCT00195273|80153552|FG001|Overall Study|Adverse Event|9|||
27535267|NCT00195273|80153551|FG000|Overall Study|Protocol deviation|0|||
27535268|NCT00195273|80153552|FG001|Overall Study|Protocol deviation|1|||
27535269|NCT00195273|80153551|FG000|Overall Study|Lack of Efficacy|3|||
27535270|NCT00195273|80153552|FG001|Overall Study|Lack of Efficacy|1|||
27535271|NCT00195273|80153551|FG000|Overall Study|Procedural complications|9|||
27535272|NCT00195273|80153552|FG001|Overall Study|Procedural complications|3|||
27535273|NCT03875768|80153553|FG000|Overall Study|Lost to Follow-up|16|||
27535274|NCT03875768|80153554|FG001|Overall Study|Lost to Follow-up|13|||
27535275|NCT03875768|80153553|FG000|Overall Study|Withdrawal by Subject|10|||
27535276|NCT03875768|80153554|FG001|Overall Study|Withdrawal by Subject|21|||
27535277|NCT03875768|80153553|FG000|Overall Study|Did not complete assessment|21|||
27535278|NCT03875768|80153554|FG001|Overall Study|Did not complete assessment|12|||
27535279|NCT03875768|80153553|FG000|Overall Study|Became ineligible|1|||
27535280|NCT03875768|80153554|FG001|Overall Study|Became ineligible|0|||
27535281|NCT01050543|80153557|FG000|Overall Study|Withdrawal by Subject|0|||
27535282|NCT01050543|80153558|FG001|Overall Study|Withdrawal by Subject|2|||
27535283|NCT01050543|80153557|FG000|Overall Study|Protocol Violation|0|||
27535284|NCT01050543|80153558|FG001|Overall Study|Protocol Violation|1|||
27535285|NCT01050543|80153557|FG000|Overall Study|Administrative|4|||
27535286|NCT01050543|80153558|FG001|Overall Study|Administrative|1|||
27535287|NCT01397201|80153560|FG000|Overall Study|Not treated|0|||
27535288|NCT01397201|80153561|FG001|Overall Study|Not treated|0|||
27535289|NCT01397201|80153562|FG002|Overall Study|Not treated|1|||
27535290|NCT01397201|80153563|FG003|Overall Study|Not treated|0|||
27535291|NCT01397201|80153564|FG004|Overall Study|Not treated|0|||
27535292|NCT01397201|80153560|FG000|Overall Study|Not yet defined|3|||
27535293|NCT01397201|80153561|FG001|Overall Study|Not yet defined|6|||
27535294|NCT01397201|80153562|FG002|Overall Study|Not yet defined|5|||
27535295|NCT01397201|80153563|FG003|Overall Study|Not yet defined|5|||
27535296|NCT01397201|80153564|FG004|Overall Study|Not yet defined|4|||
27535297|NCT01397201|80153560|FG000|Overall Study|Adverse Event|2|||
27631111|NCT00909363|80490114|FG001|Overall Study|Withdrawal by Subject|0|||
27631112|NCT00909363|80490115|FG002|Overall Study|Withdrawal by Subject|0|||
27631113|NCT00909363|80490113|FG000|Overall Study|Lack of Efficacy|1|||
27631114|NCT00909363|80490114|FG001|Overall Study|Lack of Efficacy|0|||
27631115|NCT00909363|80490115|FG002|Overall Study|Lack of Efficacy|0|||
27631116|NCT02736799|80490120|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
27631117|NCT02736799|80490121|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
27631118|NCT02736799|80490122|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
27631119|NCT02736799|80490123|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
27631120|NCT00530842|80490124|FG000|Overall Study|Adverse Event|10|||
27631121|NCT00530842|80490125|FG001|Overall Study|Adverse Event|6|||
27631122|NCT00530842|80490124|FG000|Overall Study|Lack of Efficacy|2|||
27631123|NCT00530842|80490125|FG001|Overall Study|Lack of Efficacy|1|||
27631124|NCT00530842|80490124|FG000|Overall Study|Lost to Follow-up|0|||
27631125|NCT00530842|80490125|FG001|Overall Study|Lost to Follow-up|4|||
27631126|NCT00530842|80490124|FG000|Overall Study|Protocol Violation|3|||
27631127|NCT00530842|80490125|FG001|Overall Study|Protocol Violation|2|||
27631128|NCT00530842|80490124|FG000|Overall Study|Withdrawal by Subject|4|||
27631129|NCT00530842|80490125|FG001|Overall Study|Withdrawal by Subject|5|||
27631130|NCT00530842|80490124|FG000|Overall Study|Individual different reasons|4|||
27631131|NCT00530842|80490125|FG001|Overall Study|Individual different reasons|3|||
27631132|NCT00530842|80490124|FG000|Period 1|Adverse Event|7|||
27631133|NCT00530842|80490125|FG001|Period 1|Adverse Event|3|||
27914775|NCT03410992|81525929|FG002|Week 16 Assessment|Incorrect escapers|0|||
27914776|NCT03410992|81525930|FG003|Week 16 Assessment|Incorrect escapers|0|||
27631134|NCT00530842|80490124|FG000|Period 1|Lack of Efficacy|1|||
27631135|NCT00530842|80490125|FG001|Period 1|Lack of Efficacy|1|||
27631136|NCT00530842|80490124|FG000|Period 1|Protocol Violation|2|||
27631137|NCT00530842|80490125|FG001|Period 1|Protocol Violation|1|||
27631138|NCT00530842|80490124|FG000|Period 1|Withdrawal by Subject|2|||
27631139|NCT00530842|80490125|FG001|Period 1|Withdrawal by Subject|3|||
27631140|NCT00530842|80490124|FG000|Period 1|Individual different reasons|2|||
27631141|NCT00530842|80490125|FG001|Period 1|Individual different reasons|3|||
27631142|NCT00530842|80490124|FG000|Period 2|Adverse Event|3|||
27631143|NCT00530842|80490125|FG001|Period 2|Adverse Event|3|||
27631144|NCT00530842|80490124|FG000|Period 2|Lack of Efficacy|1|||
27631145|NCT00530842|80490125|FG001|Period 2|Lack of Efficacy|0|||
27914777|NCT03410992|81525931|FG004|Week 16 Assessment|Incorrect escapers|0|||
27914778|NCT03410992|81525932|FG005|Week 16 Assessment|Incorrect escapers|0|||
27535298|NCT01397201|80153561|FG001|Overall Study|Adverse Event|0|||
27535299|NCT01397201|80153562|FG002|Overall Study|Adverse Event|0|||
27535300|NCT01397201|80153563|FG003|Overall Study|Adverse Event|0|||
27535301|NCT01397201|80153564|FG004|Overall Study|Adverse Event|0|||
27535302|NCT03511664|80153568|FG000|Overall Study|Treatment ongoing|49|||
27535303|NCT03511664|80153569|FG001|Overall Study|Treatment ongoing|5|||
27535304|NCT03511664|80153568|FG000|Overall Study|Entered long-term follow-up|140|||
27535305|NCT03511664|80153569|FG001|Overall Study|Entered long-term follow-up|50|||
27535306|NCT03511664|80153568|FG000|Overall Study|Withdrawal by Subject|29|||
27535307|NCT03511664|80153569|FG001|Overall Study|Withdrawal by Subject|53|||
27535308|NCT03511664|80153568|FG000|Overall Study|Lost to Follow-up|4|||
27535309|NCT03511664|80153569|FG001|Overall Study|Lost to Follow-up|4|||
27535310|NCT03511664|80153568|FG000|Overall Study|Physician Decision|0|||
27535311|NCT03511664|80153569|FG001|Overall Study|Physician Decision|1|||
27535312|NCT04879225|80153570|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
27535313|NCT04879225|80153570|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
27535314|NCT00333801|80156589|FG000|Overall Study|Moved to another state|5|||
27535315|NCT00333801|80156590|FG001|Overall Study|Moved to another state|3|||
27535316|NCT00333801|80156589|FG000|Overall Study|Lost to Follow-up|2|||
27535317|NCT00333801|80156590|FG001|Overall Study|Lost to Follow-up|0|||
27535318|NCT00333801|80156589|FG000|Overall Study|Incarcerated|1|||
27535319|NCT00333801|80156590|FG001|Overall Study|Incarcerated|2|||
27535320|NCT00333801|80156589|FG000|Overall Study|Withdrawal by Subject|0|||
27535321|NCT00333801|80156590|FG001|Overall Study|Withdrawal by Subject|1|||
27631146|NCT00530842|80490124|FG000|Period 2|Lost to Follow-up|0|||
27631147|NCT00530842|80490125|FG001|Period 2|Lost to Follow-up|4|||
27631148|NCT00530842|80490124|FG000|Period 2|Protocol Violation|1|||
27631149|NCT00530842|80490125|FG001|Period 2|Protocol Violation|0|||
27631150|NCT00530842|80490124|FG000|Period 2|Withdrawal by Subject|1|||
27631151|NCT00530842|80490125|FG001|Period 2|Withdrawal by Subject|2|||
27631152|NCT00530842|80490124|FG000|Period 2|Individual different reasons|2|||
27631153|NCT00530842|80490125|FG001|Period 2|Individual different reasons|0|||
27631154|NCT02918968|80490127|FG000|1st Line AAT|Progressive disease|9|||
27535322|NCT00406718|80156591|FG000|Overall Study|Withdrawal by Subject|2|||
27535323|NCT00406718|80156592|FG001|Overall Study|Withdrawal by Subject|9|||
27535324|NCT00406718|80156593|FG002|Overall Study|Withdrawal by Subject|4|||
27535325|NCT00406718|80156591|FG000|Overall Study|Lost to Follow-up|2|||
27535326|NCT00406718|80156592|FG001|Overall Study|Lost to Follow-up|5|||
27535327|NCT00406718|80156593|FG002|Overall Study|Lost to Follow-up|4|||
27631155|NCT02918968|80490128|FG001|1st Line AAT|Progressive disease|4|||
27631156|NCT02918968|80490127|FG000|1st Line AAT|Adverse Event|12|||
27914779|NCT03410992|81525933|FG006|Week 16 Assessment|Incorrect escapers|0|||
27914780|NCT03410992|81525934|FG007|Week 16 Assessment|Incorrect escapers|0|||
27914781|NCT03410992|81525935|FG008|Week 16 Assessment|Incorrect escapers|0|||
27914782|NCT03410992|81525936|FG009|Week 16 Assessment|Incorrect escapers|0|||
27914783|NCT03410992|81525937|FG010|Week 16 Assessment|Incorrect escapers|0|||
27914784|NCT03410992|81525927|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914785|NCT03410992|81525928|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914786|NCT03410992|81525929|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914787|NCT03410992|81525930|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
27914788|NCT03410992|81525931|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
27914789|NCT03410992|81525932|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914790|NCT03410992|81525933|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914791|NCT03410992|81525934|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27631157|NCT02918968|80490128|FG001|1st Line AAT|Adverse Event|3|||
27631158|NCT02918968|80490127|FG000|1st Line AAT|Physician Decision|4|||
27631159|NCT02918968|80490128|FG001|1st Line AAT|Physician Decision|2|||
27914792|NCT03410992|81525935|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914793|NCT03410992|81525936|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914794|NCT03410992|81525937|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
27914795|NCT03410992|81525927|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914796|NCT03410992|81525928|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914797|NCT03410992|81525929|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914798|NCT03410992|81525930|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
27914799|NCT03410992|81525931|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
27914800|NCT03410992|81525932|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
27914801|NCT03410992|81525933|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914802|NCT03410992|81525934|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914803|NCT03410992|81525935|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914804|NCT03410992|81525936|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914805|NCT03410992|81525937|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
27914806|NCT03410992|81525927|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914807|NCT03410992|81525928|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914808|NCT03410992|81525929|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914809|NCT03410992|81525930|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914810|NCT03410992|81525931|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914811|NCT03410992|81525932|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
27914812|NCT03410992|81525933|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27631160|NCT02918968|80490127|FG000|1st Line AAT|Withdrawal by Subject|2|||
27631161|NCT02918968|80490128|FG001|1st Line AAT|Withdrawal by Subject|1|||
27631162|NCT02918968|80490127|FG000|1st Line AAT|Lost to Follow-up|0|||
27631163|NCT02918968|80490128|FG001|1st Line AAT|Lost to Follow-up|1|||
27631164|NCT02918968|80490127|FG000|1st Line AAT|Death|1|||
27631165|NCT02918968|80490128|FG001|1st Line AAT|Death|0|||
27631166|NCT02918968|80490127|FG000|1st Line AAT|Miscellaneous|1|||
27631167|NCT02918968|80490128|FG001|1st Line AAT|Miscellaneous|0|||
27631168|NCT02918968|80490127|FG000|2nd Line AAT|Progressive disease|21|||
27631169|NCT02918968|80490128|FG001|2nd Line AAT|Progressive disease|3|||
27631170|NCT02918968|80490127|FG000|2nd Line AAT|Adverse Event|2|||
27535328|NCT01229371|80156595|FG000|Overall Study|Withdrawal by Subject|0|||
27535329|NCT01229371|80156596|FG001|Overall Study|Withdrawal by Subject|1|||
27535330|NCT01229371|80156597|FG002|Overall Study|Withdrawal by Subject|0|||
27535331|NCT01229371|80156598|FG003|Overall Study|Withdrawal by Subject|0|||
27535332|NCT00723398|80156599|FG000|Overall Study|Withdrawal by Subject|2|||
27535333|NCT00723398|80156600|FG001|Overall Study|Withdrawal by Subject|6|||
27631171|NCT02918968|80490128|FG001|2nd Line AAT|Adverse Event|5|||
27631172|NCT02918968|80490127|FG000|2nd Line AAT|Physician Decision|0|||
27631173|NCT02918968|80490128|FG001|2nd Line AAT|Physician Decision|1|||
27631174|NCT02918968|80490127|FG000|2nd Line AAT|Withdrawal by Subject|2|||
27914813|NCT03410992|81525934|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914814|NCT03410992|81525935|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914815|NCT03410992|81525936|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914816|NCT03410992|81525937|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
27914817|NCT03410992|81525927|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914818|NCT03410992|81525928|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914819|NCT03410992|81525929|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914820|NCT03410992|81525930|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
27914821|NCT03410992|81525931|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
27914822|NCT03410992|81525932|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
27914823|NCT03410992|81525933|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914824|NCT03410992|81525934|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914825|NCT03410992|81525935|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914826|NCT03410992|81525936|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914827|NCT03410992|81525937|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
27914828|NCT03410992|81525927|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914829|NCT03410992|81525928|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914830|NCT03410992|81525929|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914831|NCT03410992|81525930|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914832|NCT03410992|81525931|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914833|NCT03410992|81525932|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914834|NCT03410992|81525933|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
27535334|NCT00723398|80156601|FG002|Overall Study|Withdrawal by Subject|4|||
27535335|NCT00723398|80156602|FG003|Overall Study|Withdrawal by Subject|4|||
27631175|NCT02918968|80490128|FG001|2nd Line AAT|Withdrawal by Subject|2|||
27631176|NCT02918968|80490127|FG000|2nd Line AAT|Death|0|||
27631177|NCT02918968|80490128|FG001|2nd Line AAT|Death|1|||
27631178|NCT00364286|80490131|FG000|Overall Study|Withdrawal by Subject|1|||
27631179|NCT00364286|80490131|FG000|Overall Study|Adverse Event|2|||
27631180|NCT01801930|80490132|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
27631181|NCT01801930|80490133|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
27631182|NCT01801930|80490134|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
27535336|NCT00723398|80156603|FG004|Overall Study|Withdrawal by Subject|4|||
27631183|NCT01801930|80490135|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
27631184|NCT01801930|80490132|FG000|Overall Study|DLT occurs|0|||
27631185|NCT01801930|80490133|FG001|Overall Study|DLT occurs|1|||
27631186|NCT01801930|80490134|FG002|Overall Study|DLT occurs|0|||
27631187|NCT01801930|80490135|FG003|Overall Study|DLT occurs|0|||
27631188|NCT01194258|80490136|FG000|Titration Period|Withdrawal by Subject|6|||
27631189|NCT01194258|80490137|FG001|Titration Period|Withdrawal by Subject|0|||
27631190|NCT01194258|80490138|FG002|Titration Period|Withdrawal by Subject|0|||
27631191|NCT01194258|80490139|FG003|Titration Period|Withdrawal by Subject|0|||
27631192|NCT01194258|80490140|FG004|Titration Period|Withdrawal by Subject|0|||
27631193|NCT01194258|80490136|FG000|Titration Period|Lost to Follow-up|2|||
27631194|NCT01194258|80490137|FG001|Titration Period|Lost to Follow-up|0|||
27631195|NCT01194258|80490138|FG002|Titration Period|Lost to Follow-up|0|||
27631196|NCT01194258|80490139|FG003|Titration Period|Lost to Follow-up|0|||
27631197|NCT01194258|80490140|FG004|Titration Period|Lost to Follow-up|0|||
27631198|NCT01194258|80490136|FG000|Titration Period|Titration failure|3|||
27631199|NCT01194258|80490137|FG001|Titration Period|Titration failure|0|||
27535337|NCT00723398|80156599|FG000|Overall Study|Protocol Violation|2|||
27535338|NCT00723398|80156600|FG001|Overall Study|Protocol Violation|1|||
27535339|NCT00723398|80156601|FG002|Overall Study|Protocol Violation|5|||
27535340|NCT00723398|80156602|FG003|Overall Study|Protocol Violation|0|||
27535341|NCT00723398|80156603|FG004|Overall Study|Protocol Violation|0|||
27535342|NCT00723398|80156599|FG000|Overall Study|Physician Decision|2|||
27535343|NCT00723398|80156600|FG001|Overall Study|Physician Decision|2|||
27535344|NCT00723398|80156601|FG002|Overall Study|Physician Decision|5|||
27535345|NCT00723398|80156602|FG003|Overall Study|Physician Decision|0|||
27535346|NCT00723398|80156603|FG004|Overall Study|Physician Decision|1|||
27535347|NCT00723398|80156599|FG000|Overall Study|Adverse Event|0|||
27631200|NCT01194258|80490138|FG002|Titration Period|Titration failure|0|||
27631201|NCT01194258|80490139|FG003|Titration Period|Titration failure|0|||
27535348|NCT00723398|80156600|FG001|Overall Study|Adverse Event|5|||
27535349|NCT00723398|80156601|FG002|Overall Study|Adverse Event|3|||
27535350|NCT00723398|80156602|FG003|Overall Study|Adverse Event|1|||
27535351|NCT00723398|80156603|FG004|Overall Study|Adverse Event|4|||
27631202|NCT01194258|80490140|FG004|Titration Period|Titration failure|0|||
27631203|NCT01194258|80490136|FG000|Period 1 (12 Weeks)|Death|0|||
27631204|NCT01194258|80490137|FG001|Period 1 (12 Weeks)|Death|0|||
27631205|NCT01194258|80490138|FG002|Period 1 (12 Weeks)|Death|0|||
27631206|NCT01194258|80490139|FG003|Period 1 (12 Weeks)|Death|0|||
27631207|NCT01194258|80490140|FG004|Period 1 (12 Weeks)|Death|1|||
27631208|NCT01194258|80490136|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27631209|NCT01194258|80490137|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27631210|NCT01194258|80490138|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27631211|NCT01194258|80490139|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
27535352|NCT00723398|80156599|FG000|Overall Study|Lost to Follow-up|0|||
27535353|NCT00723398|80156600|FG001|Overall Study|Lost to Follow-up|1|||
27535354|NCT00723398|80156601|FG002|Overall Study|Lost to Follow-up|0|||
27535355|NCT00723398|80156602|FG003|Overall Study|Lost to Follow-up|0|||
27535356|NCT00723398|80156603|FG004|Overall Study|Lost to Follow-up|0|||
27535357|NCT02437513|80156606|FG000|Overall Study|Withdrawal by Subject|2|||
27535358|NCT04308304|80156607|FG000|Overall Study|Withdrawal by Subject|4|||
27631212|NCT01194258|80490140|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
27631213|NCT01194258|80490136|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
27631214|NCT01194258|80490137|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
27631215|NCT01194258|80490138|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
27631216|NCT01194258|80490139|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
27631217|NCT01194258|80490140|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
27631218|NCT01194258|80490136|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27631219|NCT01194258|80490137|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27631220|NCT01194258|80490138|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
27631221|NCT01194258|80490139|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27631222|NCT01194258|80490140|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
27631223|NCT00957658|80490141|FG000|Overall Study|Death|1|||
27631224|NCT00957658|80490141|FG000|Overall Study|Lost to Follow-up|4|||
27631225|NCT00957658|80490141|FG000|Overall Study|Withdrawal by Subject|12|||
27631226|NCT00957658|80490141|FG000|Overall Study|Revision|1|||
27631227|NCT00957658|80490141|FG000|Overall Study|Incomplete 2 yr data|28|||
27631228|NCT00957658|80490141|FG000|Overall Study|Site termination|10|||
27631229|NCT00957658|80490141|FG000|Overall Study|unwilling/unable to return|2|||
27631230|NCT00957658|80490141|FG000|Overall Study|surgery cancelled|2|||
27535359|NCT04308304|80156608|FG001|Overall Study|Withdrawal by Subject|0|||
27535360|NCT04308304|80156607|FG000|Overall Study|Protocol Violation|1|||
27535361|NCT04308304|80156608|FG001|Overall Study|Protocol Violation|0|||
27535362|NCT03906461|80156612|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
27535363|NCT03906461|80156612|FG000|Completed 12-month Follow-up|Missed Visit|6|||
27535364|NCT01898208|80156614|FG000|Overall Study|Positive blood culture|17|||
27535365|NCT01898208|80156615|FG001|Overall Study|Positive blood culture|23|||
27535366|NCT01898208|80156616|FG002|Overall Study|Positive blood culture|15|||
27535367|NCT01898208|80156614|FG000|Overall Study|Death/comfort care within 24 hours|10|||
27535368|NCT01898208|80156615|FG001|Overall Study|Death/comfort care within 24 hours|9|||
27535369|NCT01898208|80156616|FG002|Overall Study|Death/comfort care within 24 hours|8|||
27535370|NCT01898208|80156614|FG000|Overall Study|Negative Gram Stain|6|||
27535371|NCT01898208|80156615|FG001|Overall Study|Negative Gram Stain|9|||
27535372|NCT01898208|80156616|FG002|Overall Study|Negative Gram Stain|6|||
27535373|NCT01898208|80156614|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
27535374|NCT01898208|80156615|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
27535375|NCT01898208|80156616|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
27535376|NCT01898208|80156614|FG000|Overall Study|System/Technical Error|1|||
27535377|NCT01898208|80156615|FG001|Overall Study|System/Technical Error|2|||
27535378|NCT01898208|80156616|FG002|Overall Study|System/Technical Error|3|||
27535379|NCT01898208|80156614|FG000|Overall Study|Lost to Follow-up|3|||
27535380|NCT01898208|80156615|FG001|Overall Study|Lost to Follow-up|1|||
27535381|NCT01898208|80156616|FG002|Overall Study|Lost to Follow-up|1|||
27535382|NCT00369122|80156617|FG000|Overall Study|Ineligible|10|||
27535383|NCT00369122|80156617|FG000|Overall Study|No protocol treatment|1|||
27535384|NCT03917459|80156618|FG000|Overall Study|Adverse Event|1|||
27535385|NCT03917459|80156619|FG001|Overall Study|Adverse Event|0|||
27535386|NCT03917459|80156618|FG000|Overall Study|Withdrawal by Subject|0|||
27535387|NCT03917459|80156619|FG001|Overall Study|Withdrawal by Subject|1|||
27535388|NCT02586064|80156622|FG000|Overall Study|Other Obligations|6|||
27535389|NCT02586064|80156623|FG001|Overall Study|Other Obligations|6|||
27535390|NCT02586064|80156622|FG000|Overall Study|Other|3|||
27535391|NCT02586064|80156623|FG001|Overall Study|Other|7|||
27535392|NCT02586064|80156622|FG000|Overall Study|Never Started|3|||
27535393|NCT02586064|80156623|FG001|Overall Study|Never Started|3|||
27535394|NCT02586064|80156622|FG000|Overall Study|Lost Interest|1|||
27535395|NCT02586064|80156623|FG001|Overall Study|Lost Interest|4|||
27535396|NCT02586064|80156622|FG000|Overall Study|Miscellaneous Life Issues|0|||
27535397|NCT02586064|80156623|FG001|Overall Study|Miscellaneous Life Issues|5|||
27535398|NCT02586064|80156622|FG000|Overall Study|Infrequent Attendance|2|||
27535399|NCT02586064|80156623|FG001|Overall Study|Infrequent Attendance|1|||
27535400|NCT02586064|80156622|FG000|Overall Study|Timed Out|2|||
27535401|NCT02586064|80156623|FG001|Overall Study|Timed Out|0|||
27631231|NCT00957658|80490141|FG000|Overall Study|Protocol Violation|5|||
27631232|NCT04107805|80490142|FG000|Overall Study|Adverse Event|0|||
27631233|NCT04107805|80490143|FG001|Overall Study|Adverse Event|0|||
27631234|NCT04107805|80490144|FG002|Overall Study|Adverse Event|0|||
27535402|NCT02586064|80156622|FG000|Overall Study|AUD relapse|0|||
27535403|NCT02586064|80156623|FG001|Overall Study|AUD relapse|2|||
27535404|NCT02586064|80156622|FG000|Overall Study|Legal Issue|1|||
27914835|NCT03410992|81525934|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
27914836|NCT03410992|81525935|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914837|NCT03410992|81525936|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914838|NCT03410992|81525937|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
27914839|NCT03410992|81525927|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914840|NCT03410992|81525928|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914841|NCT03410992|81525929|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914842|NCT03410992|81525930|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914843|NCT03410992|81525931|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914844|NCT03410992|81525932|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914845|NCT03410992|81525933|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914846|NCT03410992|81525934|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914847|NCT03410992|81525935|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
27914848|NCT03410992|81525936|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914849|NCT03410992|81525937|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
27914850|NCT00338741|81525941|FG000|Overall Study|Lost to Follow-up|2|||
27535405|NCT02586064|80156623|FG001|Overall Study|Legal Issue|0|||
27535406|NCT02298023|80156624|FG000|Overall Study|Withdrawal by Subject|1|||
27535407|NCT02298023|80156625|FG001|Overall Study|Withdrawal by Subject|0|||
27535408|NCT02298023|80156626|FG002|Overall Study|Withdrawal by Subject|0|||
27738436|NCT02259231|80871241|FG003|Overall Study|Progressive Disease|5|||
27738437|NCT02259231|80871242|FG004|Overall Study|Progressive Disease|4|||
27738438|NCT02259231|80871243|FG005|Overall Study|Progressive Disease|5|||
27738439|NCT02259231|80871244|FG006|Overall Study|Progressive Disease|4|||
27738440|NCT02259231|80871238|FG000|Overall Study|Sponsor termination of study|1|||
27738441|NCT02259231|80871239|FG001|Overall Study|Sponsor termination of study|0|||
27738442|NCT02259231|80871240|FG002|Overall Study|Sponsor termination of study|0|||
27738443|NCT02259231|80871241|FG003|Overall Study|Sponsor termination of study|1|||
27738444|NCT02259231|80871242|FG004|Overall Study|Sponsor termination of study|2|||
27738445|NCT02259231|80871243|FG005|Overall Study|Sponsor termination of study|1|||
27738446|NCT02259231|80871244|FG006|Overall Study|Sponsor termination of study|1|||
27738447|NCT00104104|80871245|FG000|Overall Study|Adverse Event|8|||
27738448|NCT00104104|80871246|FG001|Overall Study|Adverse Event|8|||
27738449|NCT00104104|80871245|FG000|Overall Study|Abnormal laboratory value(s)|20|||
27738450|NCT00104104|80871246|FG001|Overall Study|Abnormal laboratory value(s)|14|||
27738451|NCT00104104|80871245|FG000|Overall Study|Lack of Efficacy|0|||
27738452|NCT00104104|80871246|FG001|Overall Study|Lack of Efficacy|3|||
27738453|NCT00104104|80871245|FG000|Overall Study|Condition no longer requires study drug|7|||
27738454|NCT00104104|80871246|FG001|Overall Study|Condition no longer requires study drug|4|||
27738455|NCT00104104|80871245|FG000|Overall Study|Protocol Violation|5|||
27738456|NCT00104104|80871246|FG001|Overall Study|Protocol Violation|2|||
27738457|NCT00104104|80871245|FG000|Overall Study|Withdrawal by Subject|11|||
27738458|NCT00104104|80871246|FG001|Overall Study|Withdrawal by Subject|15|||
27738459|NCT00104104|80871245|FG000|Overall Study|Lost to Follow-up|3|||
27738460|NCT00104104|80871246|FG001|Overall Study|Lost to Follow-up|7|||
27738461|NCT00104104|80871245|FG000|Overall Study|Administrative problems|12|||
27738462|NCT00104104|80871246|FG001|Overall Study|Administrative problems|13|||
27738463|NCT00104104|80871245|FG000|Overall Study|Death|9|||
27914851|NCT00338741|81525942|FG001|Overall Study|Lost to Follow-up|0|||
27914852|NCT01316575|81525943|FG000|Overall Study|Withdrawal by Subject|2|||
27914853|NCT01316575|81525944|FG001|Overall Study|Withdrawal by Subject|0|||
27914854|NCT01316575|81525943|FG000|Overall Study|Required alternate treatment|0|||
27914855|NCT01316575|81525944|FG001|Overall Study|Required alternate treatment|1|||
27914856|NCT01630135|81525947|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
27914857|NCT01630135|81525948|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
27914858|NCT02667301|81525949|FG000|Overall Study|Adverse Event|1|||
27914859|NCT02667301|81525949|FG000|Overall Study|Lack of Efficacy|1|||
27738464|NCT00104104|80871246|FG001|Overall Study|Death|6|||
27738465|NCT01416181|80871251|FG000|Part 1|Other|10|||
27738466|NCT01416181|80871252|FG001|Part 1|Other|24|||
27738467|NCT01416181|80871251|FG000|Part 1|Death|0|||
27738468|NCT01416181|80871252|FG001|Part 1|Death|1|||
27914860|NCT03874013|81525950|FG000|Overall Study|Adverse Event|0|||
27535409|NCT01254292|80156628|FG000|Comparative Phase|Adverse Event|25|||
27535410|NCT01254292|80156629|FG001|Comparative Phase|Adverse Event|25|||
27738469|NCT01416181|80871251|FG000|Part 1|Investigator Decision|7|||
27738470|NCT01416181|80871252|FG001|Part 1|Investigator Decision|6|||
27738471|NCT01416181|80871251|FG000|Part 1|Withdrawal by Subject|74|||
27738472|NCT01416181|80871252|FG001|Part 1|Withdrawal by Subject|48|||
27914861|NCT03874013|81525951|FG001|Overall Study|Adverse Event|1|||
27914862|NCT00791999|81525952|FG000|Overall Study|Protocol planed withdrawal|14|||
27914863|NCT00791999|81525953|FG001|Overall Study|Protocol planed withdrawal|11|||
27535411|NCT01254292|80156628|FG000|Comparative Phase|Lost to Follow-up|3|||
27535412|NCT01254292|80156629|FG001|Comparative Phase|Lost to Follow-up|21|||
27535413|NCT01254292|80156628|FG000|Comparative Phase|Pregnancy|2|||
27535414|NCT01254292|80156629|FG001|Comparative Phase|Pregnancy|6|||
27738473|NCT01416181|80871251|FG000|Part 1|Lack of Efficacy|16|||
27738474|NCT01416181|80871252|FG001|Part 1|Lack of Efficacy|8|||
27738475|NCT01416181|80871251|FG000|Part 1|Lost to Follow-up|1|||
27738476|NCT01416181|80871252|FG001|Part 1|Lost to Follow-up|1|||
27738477|NCT01416181|80871251|FG000|Part 1|Adverse Event|15|||
27738478|NCT01416181|80871252|FG001|Part 1|Adverse Event|18|||
27738479|NCT01416181|80871251|FG000|Part 1|Ongoing in Follow-Up|14|||
27738480|NCT01416181|80871252|FG001|Part 1|Ongoing in Follow-Up|8|||
27738481|NCT01416181|80871251|FG000|Part 2|Adverse Event|11|||
27738482|NCT01416181|80871252|FG001|Part 2|Adverse Event|4|||
27738483|NCT01416181|80871251|FG000|Part 2|Other|234|||
27738484|NCT01416181|80871252|FG001|Part 2|Other|267|||
27738485|NCT01416181|80871251|FG000|Part 2|Investigator Decision|6|||
27738486|NCT01416181|80871252|FG001|Part 2|Investigator Decision|7|||
27738487|NCT01416181|80871251|FG000|Part 2|Withdrawal by Subject|14|||
27738488|NCT01416181|80871252|FG001|Part 2|Withdrawal by Subject|5|||
27738489|NCT01416181|80871251|FG000|Part 2|Lack of Efficacy|4|||
27738490|NCT01416181|80871252|FG001|Part 2|Lack of Efficacy|1|||
27738491|NCT01416181|80871251|FG000|Part 2|Lost to Follow-up|2|||
27738492|NCT01416181|80871252|FG001|Part 2|Lost to Follow-up|2|||
27914864|NCT00791999|81525954|FG002|Overall Study|Protocol planed withdrawal|11|||
27914865|NCT00791999|81525955|FG003|Overall Study|Protocol planed withdrawal|45|||
27914866|NCT00791999|81525952|FG000|Overall Study|Withdrawal by Subject|0|||
27914867|NCT00791999|81525953|FG001|Overall Study|Withdrawal by Subject|1|||
27914868|NCT00791999|81525954|FG002|Overall Study|Withdrawal by Subject|0|||
27914869|NCT00791999|81525955|FG003|Overall Study|Withdrawal by Subject|2|||
27914870|NCT00791999|81525952|FG000|Overall Study|Protocol Violation|3|||
27914871|NCT00791999|81525953|FG001|Overall Study|Protocol Violation|0|||
27914872|NCT00791999|81525954|FG002|Overall Study|Protocol Violation|1|||
27914873|NCT00791999|81525955|FG003|Overall Study|Protocol Violation|0|||
27914874|NCT00791999|81525952|FG000|Overall Study|Adverse Event|3|||
27914875|NCT00791999|81525953|FG001|Overall Study|Adverse Event|3|||
27914876|NCT00791999|81525954|FG002|Overall Study|Adverse Event|7|||
27914877|NCT00791999|81525955|FG003|Overall Study|Adverse Event|3|||
27914878|NCT00791999|81525952|FG000|Overall Study|Lack of Efficacy|0|||
27914879|NCT00791999|81525953|FG001|Overall Study|Lack of Efficacy|1|||
27914880|NCT00791999|81525954|FG002|Overall Study|Lack of Efficacy|0|||
27914881|NCT00791999|81525955|FG003|Overall Study|Lack of Efficacy|2|||
27914882|NCT00791999|81525952|FG000|Overall Study|Reason other than those above|1|||
27914883|NCT00791999|81525953|FG001|Overall Study|Reason other than those above|0|||
27914884|NCT00791999|81525954|FG002|Overall Study|Reason other than those above|1|||
27914885|NCT00791999|81525955|FG003|Overall Study|Reason other than those above|0|||
27914886|NCT00577317|81525958|FG000|Overall Study|Study Terminated|0|||
27914887|NCT00577317|81525959|FG001|Overall Study|Study Terminated|2|||
27914888|NCT00705757|81525964|FG000|Overall Study|Lack of Efficacy|5|||
27914889|NCT00705757|81525965|FG001|Overall Study|Lack of Efficacy|1|||
27914890|NCT00705757|81525966|FG002|Overall Study|Lack of Efficacy|3|||
27914891|NCT00705757|81525964|FG000|Overall Study|Lost to Follow-up|7|||
27914892|NCT00705757|81525965|FG001|Overall Study|Lost to Follow-up|6|||
27914893|NCT00705757|81525966|FG002|Overall Study|Lost to Follow-up|6|||
27914894|NCT00705757|81525964|FG000|Overall Study|Withdrawal by Subject|1|||
27914895|NCT00705757|81525965|FG001|Overall Study|Withdrawal by Subject|1|||
27914896|NCT00705757|81525966|FG002|Overall Study|Withdrawal by Subject|2|||
27914897|NCT00676403|81525970|FG000|Overall Study|Adverse Event|1|||
27914898|NCT00676403|81525971|FG001|Overall Study|Adverse Event|2|||
27914899|NCT00676403|81525972|FG002|Overall Study|Adverse Event|0|||
27914900|NCT00676403|81525973|FG003|Overall Study|Adverse Event|5|||
27914901|NCT00676403|81525974|FG004|Overall Study|Adverse Event|1|||
27914902|NCT00676403|81525975|FG005|Overall Study|Adverse Event|2|||
27914903|NCT00676403|81525970|FG000|Overall Study|Lost to Follow-up|0|||
27914904|NCT00676403|81525971|FG001|Overall Study|Lost to Follow-up|0|||
27914905|NCT00676403|81525972|FG002|Overall Study|Lost to Follow-up|0|||
27914906|NCT00676403|81525973|FG003|Overall Study|Lost to Follow-up|0|||
27535415|NCT01254292|80156628|FG000|Comparative Phase|Withdrawal by Subject|20|||
27914907|NCT00676403|81525974|FG004|Overall Study|Lost to Follow-up|0|||
27914908|NCT00676403|81525975|FG005|Overall Study|Lost to Follow-up|1|||
27535416|NCT01254292|80156629|FG001|Comparative Phase|Withdrawal by Subject|21|||
27535417|NCT01254292|80156628|FG000|Comparative Phase|Protocol Violation|1|||
27535418|NCT01254292|80156629|FG001|Comparative Phase|Protocol Violation|2|||
27738493|NCT02493751|80871260|FG000|Overall Study|Withdrawal by Subject|2|||
27914909|NCT00676403|81525970|FG000|Overall Study|Reason Unspecified|1|||
27914910|NCT00676403|81525971|FG001|Overall Study|Reason Unspecified|0|||
27914911|NCT00676403|81525972|FG002|Overall Study|Reason Unspecified|1|||
27914912|NCT00676403|81525973|FG003|Overall Study|Reason Unspecified|0|||
27738494|NCT02493751|80871261|FG001|Overall Study|Withdrawal by Subject|8|||
27738495|NCT02493751|80871260|FG000|Overall Study|Death|6|||
27914913|NCT00676403|81525974|FG004|Overall Study|Reason Unspecified|0|||
27914914|NCT00676403|81525975|FG005|Overall Study|Reason Unspecified|1|||
27535419|NCT01254292|80156628|FG000|Comparative Phase|Wish for pregnancy|4|||
27535420|NCT01254292|80156629|FG001|Comparative Phase|Wish for pregnancy|6|||
27535421|NCT01254292|80156628|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
27535422|NCT01254292|80156629|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
27535423|NCT01254292|80156628|FG000|LCS12 Extension Phase|Adverse Event|9|||
27535424|NCT01254292|80156629|FG001|LCS12 Extension Phase|Adverse Event|0|||
27535425|NCT01254292|80156628|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
27535426|NCT01254292|80156629|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
27535427|NCT01254292|80156628|FG000|LCS12 Extension Phase|Other unknown|4|||
27535428|NCT01254292|80156629|FG001|LCS12 Extension Phase|Other unknown|0|||
27535429|NCT01254292|80156628|FG000|LCS12 Extension Phase|Pregnancy|2|||
27535430|NCT01254292|80156629|FG001|LCS12 Extension Phase|Pregnancy|0|||
27535431|NCT01254292|80156628|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
27535432|NCT01254292|80156629|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
27738496|NCT02493751|80871261|FG001|Overall Study|Death|13|||
27738497|NCT02493751|80871260|FG000|Overall Study|Lost to Follow-up|2|||
27738498|NCT02493751|80871261|FG001|Overall Study|Lost to Follow-up|3|||
27738499|NCT02493751|80871260|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
27738500|NCT02493751|80871261|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
27738501|NCT01772134|80871262|FG000|Overall Study|Adverse Event|6|||
27738502|NCT01772134|80871263|FG001|Overall Study|Adverse Event|5|||
27738503|NCT01772134|80871264|FG002|Overall Study|Adverse Event|10|||
27738504|NCT01772134|80871262|FG000|Overall Study|Withdrew Consent|3|||
27738505|NCT01772134|80871263|FG001|Overall Study|Withdrew Consent|1|||
27535433|NCT02478372|80156630|FG000|Overall Study|Protocol Violation|12|||
27535434|NCT02478372|80156631|FG001|Overall Study|Protocol Violation|8|||
27631235|NCT04107805|80490145|FG003|Overall Study|Adverse Event|1|||
27738506|NCT01772134|80871264|FG002|Overall Study|Withdrew Consent|5|||
27738507|NCT01772134|80871262|FG000|Overall Study|Lost to Follow-up|2|||
27738508|NCT01772134|80871263|FG001|Overall Study|Lost to Follow-up|0|||
27738509|NCT01772134|80871264|FG002|Overall Study|Lost to Follow-up|0|||
27738510|NCT01772134|80871262|FG000|Overall Study|Protocol Deviation|4|||
27738511|NCT01772134|80871263|FG001|Overall Study|Protocol Deviation|3|||
27738512|NCT01772134|80871264|FG002|Overall Study|Protocol Deviation|3|||
27738513|NCT01772134|80871262|FG000|Overall Study|Lack of Efficacy|11|||
27738514|NCT01772134|80871263|FG001|Overall Study|Lack of Efficacy|5|||
27738515|NCT01772134|80871264|FG002|Overall Study|Lack of Efficacy|3|||
27914915|NCT00676403|81525970|FG000|Overall Study|Withdrawal by Subject|0|||
27631236|NCT04107805|80490146|FG004|Overall Study|Adverse Event|0|||
27914916|NCT00676403|81525971|FG001|Overall Study|Withdrawal by Subject|0|||
27535435|NCT02478372|80156630|FG000|Overall Study|Lost to Follow-up|1|||
27535436|NCT02478372|80156631|FG001|Overall Study|Lost to Follow-up|4|||
27914917|NCT00676403|81525972|FG002|Overall Study|Withdrawal by Subject|0|||
27914918|NCT00676403|81525973|FG003|Overall Study|Withdrawal by Subject|0|||
27914919|NCT00676403|81525974|FG004|Overall Study|Withdrawal by Subject|0|||
27914920|NCT00676403|81525975|FG005|Overall Study|Withdrawal by Subject|1|||
27914921|NCT01232790|81525976|FG000|Randomization|Withdrawal by Subject|2|||
27914922|NCT01232790|81525977|FG001|Randomization|Withdrawal by Subject|0|||
27914923|NCT01232790|81525976|FG000|Randomization|Protocol Violation|0|||
27914924|NCT01232790|81525977|FG001|Randomization|Protocol Violation|1|||
27914925|NCT01232790|81525976|FG000|Randomization|Physician Decision|0|||
27914926|NCT01232790|81525977|FG001|Randomization|Physician Decision|1|||
27914927|NCT01232790|81525976|FG000|Initial Assessment|Withdrawal by Subject|0|||
27914928|NCT01232790|81525977|FG001|Initial Assessment|Withdrawal by Subject|1|||
27914929|NCT01232790|81525976|FG000|First Crossover|Withdrawal by Subject|1|||
27914930|NCT01232790|81525977|FG001|First Crossover|Withdrawal by Subject|0|||
27914931|NCT01232790|81525976|FG000|Second Crossover|Withdrawal by Subject|1|||
27914932|NCT01232790|81525977|FG001|Second Crossover|Withdrawal by Subject|2|||
27914933|NCT01825200|81525980|FG000|Overall Study|Lost to Follow-up|5|||
27914934|NCT01825200|81525981|FG001|Overall Study|Lost to Follow-up|6|||
27914935|NCT01825200|81525980|FG000|Overall Study|Withdrawal by Subject|0|||
27914936|NCT01825200|81525981|FG001|Overall Study|Withdrawal by Subject|1|||
27914937|NCT00887484|81525984|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
27914938|NCT00887484|81525984|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
27914939|NCT00887484|81525984|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
27914940|NCT01896193|81525985|FG000|Overall Study|Lack of Efficacy|20|||
27914941|NCT01896193|81525986|FG001|Overall Study|Lack of Efficacy|11|||
27914942|NCT01896193|81525985|FG000|Overall Study|Protocol Violation|0|||
27914943|NCT01896193|81525986|FG001|Overall Study|Protocol Violation|1|||
27914944|NCT01896193|81525985|FG000|Overall Study|Withdrew Consent|1|||
27914945|NCT01896193|81525986|FG001|Overall Study|Withdrew Consent|0|||
27914946|NCT02277028|81525987|FG000|Overall Study|Lost to Follow-up|1|||
27914947|NCT02277028|81525988|FG001|Overall Study|Lost to Follow-up|0|||
27914948|NCT02277028|81525987|FG000|Overall Study|Withdrawal by Subject|0|||
27535437|NCT02478372|80156630|FG000|Overall Study|Death|0|||
27535438|NCT02478372|80156631|FG001|Overall Study|Death|2|||
27914949|NCT02277028|81525988|FG001|Overall Study|Withdrawal by Subject|1|||
27914950|NCT01841970|81525991|FG000|Overall Study|Withdrawal by Subject|1|||
27535439|NCT03343067|80156635|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
27535440|NCT03343067|80156636|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
27535441|NCT03343067|80156637|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
27535442|NCT01863953|80156638|FG000|Overall Study|Adverse Event|0|||
27914951|NCT01841970|81525991|FG000|Overall Study|Physician Decision|2|||
27914952|NCT01841970|81525991|FG000|Overall Study|Lost to Follow-up|8|||
27914953|NCT02982863|81525996|FG000|Overall Study|Not eligible patients|809|||
27914954|NCT02982863|81525997|FG001|Overall Study|Not eligible patients|4261|||
27914955|NCT02982863|81525998|FG002|Overall Study|Not eligible patients|1852|||
27914956|NCT02982863|81525999|FG003|Overall Study|Not eligible patients|1400|||
27914957|NCT02982863|81526000|FG004|Overall Study|Not eligible patients|492|||
27914958|NCT01716806|81526004|FG000|Overall Study|Patient withdrawal of consent|4|||
27914959|NCT01716806|81526005|FG001|Overall Study|Patient withdrawal of consent|2|||
27535443|NCT01863953|80156639|FG001|Overall Study|Adverse Event|0|||
27535444|NCT01863953|80156640|FG002|Overall Study|Adverse Event|1|||
27535445|NCT00451451|80156641|FG000|Overall Study|Adverse Event|11|||
27535446|NCT00451451|80156642|FG001|Overall Study|Adverse Event|21|||
27535447|NCT00451451|80156643|FG002|Overall Study|Adverse Event|26|||
27631237|NCT04107805|80490147|FG005|Overall Study|Adverse Event|1|||
27535448|NCT00451451|80156644|FG003|Overall Study|Adverse Event|10|||
27914960|NCT01716806|81526006|FG002|Overall Study|Patient withdrawal of consent|4|||
27914961|NCT01716806|81526007|FG003|Overall Study|Patient withdrawal of consent|3|||
27631238|NCT04107805|80490148|FG006|Overall Study|Adverse Event|0|||
27631239|NCT04107805|80490149|FG007|Overall Study|Adverse Event|0|||
27631240|NCT04107805|80490150|FG008|Overall Study|Adverse Event|1|||
27631241|NCT02072226|80490151|FG000|Overall Study|Lost to Follow-up|11|||
27631242|NCT02072226|80490152|FG001|Overall Study|Lost to Follow-up|7|||
27631243|NCT02072226|80490151|FG000|Overall Study|Patient Non-compliance|2|||
27631244|NCT02072226|80490152|FG001|Overall Study|Patient Non-compliance|3|||
27631245|NCT02072226|80490151|FG000|Overall Study|Death|1|||
27631246|NCT02072226|80490152|FG001|Overall Study|Death|0|||
27631247|NCT02072226|80490151|FG000|Overall Study|Patient Withdrawal of Consent|1|||
27631248|NCT02072226|80490152|FG001|Overall Study|Patient Withdrawal of Consent|0|||
27631249|NCT03993392|80490159|FG000|Overall Study|Withdrawal by Subject|3|||
27631250|NCT03993392|80490159|FG000|Overall Study|Lost to Follow-up|2|||
27631251|NCT03993392|80490159|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
27631252|NCT00762463|80490160|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
27631253|NCT00762463|80490161|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
27631254|NCT00762463|80490162|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
27631255|NCT00762463|80490163|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
27631256|NCT00762463|80490160|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
27631257|NCT00762463|80490161|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
27631258|NCT00762463|80490162|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
27631259|NCT00762463|80490163|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
27631260|NCT00762463|80490160|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
27631261|NCT00762463|80490161|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
27631262|NCT00762463|80490162|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
27631263|NCT00762463|80490163|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
27631264|NCT00762463|80490160|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
27535449|NCT00451451|80156641|FG000|Overall Study|Lost to Follow-up|11|||
27535450|NCT00451451|80156642|FG001|Overall Study|Lost to Follow-up|9|||
27535451|NCT00451451|80156643|FG002|Overall Study|Lost to Follow-up|8|||
27535452|NCT00451451|80156644|FG003|Overall Study|Lost to Follow-up|11|||
27535453|NCT00451451|80156641|FG000|Overall Study|Consent Withdrawn|14|||
27535454|NCT00451451|80156642|FG001|Overall Study|Consent Withdrawn|9|||
27535455|NCT00451451|80156643|FG002|Overall Study|Consent Withdrawn|17|||
27535456|NCT00451451|80156644|FG003|Overall Study|Consent Withdrawn|17|||
27535457|NCT00451451|80156641|FG000|Overall Study|Investigator Decision|6|||
27535458|NCT00451451|80156642|FG001|Overall Study|Investigator Decision|2|||
27535459|NCT00451451|80156643|FG002|Overall Study|Investigator Decision|1|||
27914962|NCT01716806|81526008|FG004|Overall Study|Patient withdrawal of consent|2|||
27914963|NCT01716806|81526009|FG005|Overall Study|Patient withdrawal of consent|0|||
27914964|NCT01716806|81526004|FG000|Overall Study|Lost to Follow-up|3|||
27535460|NCT00451451|80156644|FG003|Overall Study|Investigator Decision|2|||
27535461|NCT00451451|80156641|FG000|Overall Study|Subject Non-Compliance|8|||
27535462|NCT00451451|80156642|FG001|Overall Study|Subject Non-Compliance|4|||
27535463|NCT00451451|80156643|FG002|Overall Study|Subject Non-Compliance|3|||
27535464|NCT00451451|80156644|FG003|Overall Study|Subject Non-Compliance|3|||
27535465|NCT00451451|80156641|FG000|Overall Study|Death|1|||
27535466|NCT00451451|80156642|FG001|Overall Study|Death|0|||
27535467|NCT00451451|80156643|FG002|Overall Study|Death|0|||
27535468|NCT00451451|80156644|FG003|Overall Study|Death|1|||
27535469|NCT00451451|80156641|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
27535470|NCT00451451|80156642|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
27535471|NCT00451451|80156643|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
27535472|NCT00451451|80156644|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
27535473|NCT03387683|80156647|FG000|Overall Study|In receipt of disallowed medication|1|||
27535474|NCT03387683|80156648|FG001|Overall Study|In receipt of disallowed medication|0|||
27535475|NCT03387683|80156647|FG000|Overall Study|Did not receive treatment|1|||
27535476|NCT03387683|80156648|FG001|Overall Study|Did not receive treatment|0|||
27535477|NCT03555435|80156653|FG000|Overall Study|Lost to Follow-up|17|||
27535478|NCT03555435|80156654|FG001|Overall Study|Lost to Follow-up|19|||
27535479|NCT03555435|80156655|FG002|Overall Study|Lost to Follow-up|8|||
27914965|NCT01716806|81526005|FG001|Overall Study|Lost to Follow-up|3|||
27535480|NCT01669928|80156656|FG000|First Intervention|Withdrawal by Subject|3|||
27631265|NCT00762463|80490161|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
27631266|NCT00762463|80490162|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
27631267|NCT00762463|80490163|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
27631268|NCT00762463|80490160|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
27631269|NCT00762463|80490161|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
27631270|NCT00762463|80490162|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
27631271|NCT00762463|80490163|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
27631272|NCT00762463|80490160|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
27631273|NCT00762463|80490161|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
27631274|NCT00762463|80490162|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
27631275|NCT00762463|80490163|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
27631276|NCT00762463|80490160|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
27631277|NCT00762463|80490161|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
27631278|NCT00762463|80490162|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
27631279|NCT00762463|80490163|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
27631280|NCT00762463|80490160|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
27631281|NCT00762463|80490161|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
27631282|NCT00762463|80490162|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
27631283|NCT00762463|80490163|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
27631284|NCT04148937|80490164|FG000|Overall Study|Withdrawal by Subject|0|||
27631285|NCT04148937|80490165|FG001|Overall Study|Withdrawal by Subject|0|||
27631286|NCT04148937|80490166|FG002|Overall Study|Withdrawal by Subject|0|||
27631287|NCT04148937|80490167|FG003|Overall Study|Withdrawal by Subject|1|||
27631288|NCT04148937|80490168|FG004|Overall Study|Withdrawal by Subject|0|||
27631289|NCT04148937|80490169|FG005|Overall Study|Withdrawal by Subject|1|||
27631290|NCT04148937|80490170|FG006|Overall Study|Withdrawal by Subject|1|||
27631291|NCT04148937|80490171|FG007|Overall Study|Withdrawal by Subject|0|||
27631292|NCT04148937|80490164|FG000|Overall Study|Lost to Follow-up|0|||
27631293|NCT04148937|80490165|FG001|Overall Study|Lost to Follow-up|0|||
27631294|NCT04148937|80490166|FG002|Overall Study|Lost to Follow-up|1|||
27631295|NCT04148937|80490167|FG003|Overall Study|Lost to Follow-up|0|||
27631296|NCT04148937|80490168|FG004|Overall Study|Lost to Follow-up|0|||
27631297|NCT04148937|80490169|FG005|Overall Study|Lost to Follow-up|2|||
27631298|NCT04148937|80490170|FG006|Overall Study|Lost to Follow-up|0|||
27631299|NCT04148937|80490171|FG007|Overall Study|Lost to Follow-up|0|||
27631300|NCT01909778|80490172|FG000|Overall Study|failed screening|1|||
27631301|NCT01352507|80490181|FG000|Treatment Period 1|Adverse Event|3|||
27631302|NCT01352507|80490182|FG001|Treatment Period 1|Adverse Event|0|||
27631303|NCT01352507|80490181|FG000|Treatment Period 1|Lost to Follow-up|3|||
27631304|NCT01352507|80490182|FG001|Treatment Period 1|Lost to Follow-up|4|||
27631305|NCT01352507|80490181|FG000|Treatment Period 1|Withdrawal by Subject|7|||
27631306|NCT01352507|80490182|FG001|Treatment Period 1|Withdrawal by Subject|5|||
27631307|NCT01352507|80490181|FG000|Treatment Period 1|Physician Decision|1|||
27631308|NCT01352507|80490182|FG001|Treatment Period 1|Physician Decision|0|||
27631309|NCT01352507|80490181|FG000|Washout Period|Withdrawal by Subject|0|||
27631310|NCT01352507|80490182|FG001|Washout Period|Withdrawal by Subject|1|||
27631311|NCT01352507|80490181|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
27631312|NCT01352507|80490182|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
27631313|NCT01352507|80490181|FG000|Treatment Period 2|Withdrawal by Subject|4|||
27631314|NCT01352507|80490182|FG001|Treatment Period 2|Withdrawal by Subject|3|||
27631315|NCT01352507|80490181|FG000|Treatment Period 2|Lack of Efficacy|1|||
27631316|NCT01352507|80490182|FG001|Treatment Period 2|Lack of Efficacy|0|||
27631317|NCT02145182|80490183|FG000|Overall Study|Adverse Event|4|||
27631318|NCT02145182|80490184|FG001|Overall Study|Adverse Event|1|||
27631319|NCT02145182|80490183|FG000|Overall Study|Death|7|||
27631320|NCT02145182|80490184|FG001|Overall Study|Death|7|||
27631321|NCT02145182|80490183|FG000|Overall Study|Lost to Follow-up|2|||
27631322|NCT02145182|80490184|FG001|Overall Study|Lost to Follow-up|2|||
27631323|NCT02145182|80490183|FG000|Overall Study|Pre-transplant Withdrawal|0|||
27631324|NCT02145182|80490184|FG001|Overall Study|Pre-transplant Withdrawal|2|||
27631325|NCT02145182|80490183|FG000|Overall Study|Withdrawal by Subject|5|||
27631326|NCT02145182|80490184|FG001|Overall Study|Withdrawal by Subject|4|||
27631327|NCT01253226|80490186|FG000|Overall Study|Adverse Event|0|||
27631328|NCT01253226|80490187|FG001|Overall Study|Adverse Event|0|||
27631329|NCT01253226|80490188|FG002|Overall Study|Adverse Event|1|||
27631330|NCT01253226|80490189|FG003|Overall Study|Adverse Event|0|||
27631331|NCT01253226|80490190|FG004|Overall Study|Adverse Event|0|||
27631332|NCT01253226|80490186|FG000|Overall Study|Death|0|||
27631333|NCT01253226|80490187|FG001|Overall Study|Death|1|||
27631334|NCT01253226|80490188|FG002|Overall Study|Death|0|||
27631335|NCT01253226|80490189|FG003|Overall Study|Death|0|||
27631336|NCT01253226|80490190|FG004|Overall Study|Death|0|||
27631337|NCT01253226|80490186|FG000|Overall Study|Physician Decision|0|||
27631338|NCT01253226|80490187|FG001|Overall Study|Physician Decision|0|||
27631339|NCT01253226|80490188|FG002|Overall Study|Physician Decision|0|||
27631340|NCT01253226|80490189|FG003|Overall Study|Physician Decision|0|||
27631341|NCT01253226|80490190|FG004|Overall Study|Physician Decision|2|||
27631342|NCT01253226|80490186|FG000|Overall Study|Withdrawal by Subject|0|||
27631343|NCT01253226|80490187|FG001|Overall Study|Withdrawal by Subject|0|||
27631344|NCT01253226|80490188|FG002|Overall Study|Withdrawal by Subject|0|||
27631345|NCT01253226|80490189|FG003|Overall Study|Withdrawal by Subject|1|||
27631346|NCT01253226|80490190|FG004|Overall Study|Withdrawal by Subject|0|||
27631347|NCT01729819|80490191|FG000|Overall Study|Adverse Event|2|||
27631348|NCT01729819|80490192|FG001|Overall Study|Adverse Event|4|||
27631349|NCT01729819|80490191|FG000|Overall Study|Lack of Efficacy|1|||
27631350|NCT01729819|80490192|FG001|Overall Study|Lack of Efficacy|0|||
27631351|NCT01729819|80490191|FG000|Overall Study|Lost to Follow-up|2|||
27631352|NCT01729819|80490192|FG001|Overall Study|Lost to Follow-up|0|||
27631353|NCT01729819|80490191|FG000|Overall Study|Other reason|1|||
27631354|NCT01729819|80490192|FG001|Overall Study|Other reason|0|||
27631355|NCT01729819|80490191|FG000|Overall Study|Protocol Violation|0|||
27631356|NCT01729819|80490192|FG001|Overall Study|Protocol Violation|1|||
27631357|NCT01729819|80490191|FG000|Overall Study|Withdrawal by Subject|0|||
27631358|NCT01729819|80490192|FG001|Overall Study|Withdrawal by Subject|2|||
27631359|NCT04842604|80490195|FG000|Overall Study|Death|1|||
27631360|NCT04842604|80490196|FG001|Overall Study|Death|0|||
27631361|NCT04842604|80490195|FG000|Overall Study|Other|4|||
27631362|NCT04842604|80490196|FG001|Overall Study|Other|4|||
27631363|NCT04842604|80490195|FG000|Overall Study|Randomized but not treated|1|||
27631364|NCT04842604|80490196|FG001|Overall Study|Randomized but not treated|0|||
27631365|NCT03621761|80490200|FG000|Overall Study|Lost to Follow-up|1|||
27631366|NCT03621761|80490201|FG001|Overall Study|Lost to Follow-up|1|||
27914966|NCT01716806|81526006|FG002|Overall Study|Lost to Follow-up|0|||
27914967|NCT01716806|81526007|FG003|Overall Study|Lost to Follow-up|2|||
27914968|NCT01716806|81526008|FG004|Overall Study|Lost to Follow-up|1|||
27914969|NCT01716806|81526009|FG005|Overall Study|Lost to Follow-up|0|||
27914970|NCT01716806|81526004|FG000|Overall Study|Death|13|||
27914971|NCT01716806|81526005|FG001|Overall Study|Death|9|||
27914972|NCT01716806|81526006|FG002|Overall Study|Death|12|||
27914973|NCT01716806|81526007|FG003|Overall Study|Death|4|||
27914974|NCT01716806|81526008|FG004|Overall Study|Death|10|||
27914975|NCT01716806|81526009|FG005|Overall Study|Death|5|||
27914976|NCT01716806|81526004|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
27914977|NCT01716806|81526005|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
27914978|NCT01716806|81526006|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
27914979|NCT01716806|81526007|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
27535481|NCT01669928|80156657|FG001|First Intervention|Withdrawal by Subject|5|||
27535482|NCT03848065|80156658|FG000|Overall Study|Death|0|||
27535483|NCT03848065|80156659|FG001|Overall Study|Death|1|||
27535484|NCT03848065|80156660|FG002|Overall Study|Death|0|||
27535485|NCT03848065|80156658|FG000|Overall Study|Lost to Follow-up|0|||
27535486|NCT03848065|80156659|FG001|Overall Study|Lost to Follow-up|0|||
27535487|NCT03848065|80156660|FG002|Overall Study|Lost to Follow-up|1|||
27535488|NCT03848065|80156658|FG000|Overall Study|Physician Decision|0|||
27914980|NCT01716806|81526008|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
27914981|NCT01716806|81526009|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
27914982|NCT01716806|81526004|FG000|Overall Study|PI decision|0|||
27914983|NCT01716806|81526005|FG001|Overall Study|PI decision|0|||
27914984|NCT01716806|81526006|FG002|Overall Study|PI decision|0|||
27914985|NCT01716806|81526007|FG003|Overall Study|PI decision|0|||
27914986|NCT01716806|81526008|FG004|Overall Study|PI decision|1|||
27914987|NCT01716806|81526009|FG005|Overall Study|PI decision|0|||
27914988|NCT01716806|81526004|FG000|Overall Study|Change in performance status|1|||
27914989|NCT01716806|81526005|FG001|Overall Study|Change in performance status|0|||
27914990|NCT01716806|81526006|FG002|Overall Study|Change in performance status|0|||
27914991|NCT01716806|81526007|FG003|Overall Study|Change in performance status|0|||
27914992|NCT01716806|81526008|FG004|Overall Study|Change in performance status|0|||
27914993|NCT01716806|81526009|FG005|Overall Study|Change in performance status|0|||
27914994|NCT01716806|81526004|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
27535489|NCT03848065|80156659|FG001|Overall Study|Physician Decision|0|||
27914995|NCT01716806|81526005|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
27535490|NCT03848065|80156660|FG002|Overall Study|Physician Decision|1|||
27631367|NCT03621761|80490202|FG002|Overall Study|Lost to Follow-up|2|||
27631368|NCT03621761|80490200|FG000|Overall Study|Withdrawal by Subject|2|||
27631369|NCT03621761|80490201|FG001|Overall Study|Withdrawal by Subject|1|||
27631370|NCT03621761|80490202|FG002|Overall Study|Withdrawal by Subject|1|||
27631371|NCT03621761|80490200|FG000|Overall Study|Became Ineligible|0|||
27631372|NCT03621761|80490201|FG001|Overall Study|Became Ineligible|2|||
27631373|NCT03621761|80490202|FG002|Overall Study|Became Ineligible|0|||
27631374|NCT00954707|80490203|FG000|Overall Study|Death|34|||
27914996|NCT01716806|81526006|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
27914997|NCT01716806|81526007|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
27914998|NCT01716806|81526008|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
27914999|NCT01716806|81526009|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
27915000|NCT01716806|81526004|FG000|Overall Study|Sponsor direction|7|||
27915001|NCT01716806|81526005|FG001|Overall Study|Sponsor direction|8|||
27915002|NCT01716806|81526006|FG002|Overall Study|Sponsor direction|5|||
27915003|NCT01716806|81526007|FG003|Overall Study|Sponsor direction|12|||
27915004|NCT01716806|81526008|FG004|Overall Study|Sponsor direction|16|||
27915005|NCT01716806|81526009|FG005|Overall Study|Sponsor direction|1|||
27915006|NCT00165503|81529113|FG000|Overall Study|Death|1|||
27915007|NCT00165503|81529113|FG000|Overall Study|Lost to Follow-up|12|||
27915008|NCT00165503|81529113|FG000|Overall Study|Unresectable|3|||
27915009|NCT02781324|81529114|FG000|Overall Study|Withdrawal by Subject|1|||
27915010|NCT02781324|81529115|FG001|Overall Study|Withdrawal by Subject|0|||
27915011|NCT02781324|81529114|FG000|Overall Study|Physician Decision|1|||
27915012|NCT02781324|81529115|FG001|Overall Study|Physician Decision|2|||
27915013|NCT01789047|81529116|FG000|Overall Study|Adverse Event|3|||
27915014|NCT01789047|81529117|FG001|Overall Study|Adverse Event|2|||
27915015|NCT01789047|81529116|FG000|Overall Study|Withdrawal by Subject|1|||
27915016|NCT01789047|81529117|FG001|Overall Study|Withdrawal by Subject|2|||
27915017|NCT03160716|81529118|FG000|Overall Study|Lost to Follow-up|1|||
27915018|NCT00289276|81529119|FG000|Second Part of FAST Study (Expansion)|Death|0|||
27915019|NCT00289276|81529120|FG001|Second Part of FAST Study (Expansion)|Death|2|||
27915020|NCT00289276|81529119|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
27915021|NCT00289276|81529120|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
27915022|NCT00971867|81529121|FG000|Overall Study|Adverse Event|4|||
27915023|NCT00971867|81529121|FG000|Overall Study|Participant Withdrew Consent|1|||
27915024|NCT00971867|81529121|FG000|Overall Study|Disease Progression|6|||
27631375|NCT00954707|80490203|FG000|Overall Study|Withdrawal by Subject|100|||
27631376|NCT00954707|80490203|FG000|Overall Study|Lost to Follow-up|33|||
27631377|NCT01368406|80490204|FG000|Overall Study|Lost to Follow-up|8|||
27631378|NCT01368406|80490205|FG001|Overall Study|Lost to Follow-up|4|||
27631379|NCT01368406|80490204|FG000|Overall Study|Withdrawal by Subject|8|||
27631380|NCT01368406|80490205|FG001|Overall Study|Withdrawal by Subject|4|||
27631381|NCT01368406|80490204|FG000|Overall Study|relapse of the disease|3|||
27631382|NCT01368406|80490205|FG001|Overall Study|relapse of the disease|2|||
27631383|NCT01368406|80490204|FG000|Overall Study|started working|2|||
27631384|NCT01368406|80490205|FG001|Overall Study|started working|3|||
27631385|NCT00367055|80490206|FG000|Overall Study|Adverse Event|6|||
27915025|NCT01716663|81529122|FG000|Overall Study|Withdrawn prior to procedure|4|||
27915026|NCT01716663|81529122|FG000|Overall Study|Treated with non-study catheter|2|||
27915027|NCT01534273|81529123|FG000|Period 1|Physician Decision|0|||
27915028|NCT01534273|81529124|FG001|Period 1|Physician Decision|0|||
27915029|NCT01534273|81529125|FG002|Period 1|Physician Decision|0|||
27915030|NCT01534273|81529126|FG003|Period 1|Physician Decision|1|||
27915031|NCT01534273|81529127|FG004|Period 1|Physician Decision|0|||
27915032|NCT01534273|81529128|FG005|Period 1|Physician Decision|0|||
27915033|NCT01534273|81529129|FG006|Period 1|Physician Decision|0|||
27915034|NCT02175121|81529132|FG000|Overall Study|Lack of Efficacy|1|||
27915035|NCT02175121|81529133|FG001|Overall Study|Lack of Efficacy|0|||
27915036|NCT02175121|81529134|FG002|Overall Study|Lack of Efficacy|0|||
27915037|NCT02175121|81529135|FG003|Overall Study|Lack of Efficacy|0|||
27915038|NCT02175121|81529136|FG004|Overall Study|Lack of Efficacy|0|||
27915039|NCT02175121|81529132|FG000|Overall Study|Lost to Follow-up|0|||
27915040|NCT02175121|81529133|FG001|Overall Study|Lost to Follow-up|1|||
27915041|NCT02175121|81529134|FG002|Overall Study|Lost to Follow-up|0|||
27915042|NCT02175121|81529135|FG003|Overall Study|Lost to Follow-up|1|||
27915043|NCT02175121|81529136|FG004|Overall Study|Lost to Follow-up|0|||
27915044|NCT02175121|81529132|FG000|Overall Study|Personal emergency|0|||
27915045|NCT02175121|81529133|FG001|Overall Study|Personal emergency|0|||
27915046|NCT02175121|81529134|FG002|Overall Study|Personal emergency|0|||
27915047|NCT02175121|81529135|FG003|Overall Study|Personal emergency|0|||
27915048|NCT02175121|81529136|FG004|Overall Study|Personal emergency|1|||
27915049|NCT02175121|81529132|FG000|Overall Study|Schedule conflict|0|||
27915050|NCT02175121|81529133|FG001|Overall Study|Schedule conflict|0|||
27915051|NCT02175121|81529134|FG002|Overall Study|Schedule conflict|1|||
27915052|NCT02175121|81529135|FG003|Overall Study|Schedule conflict|0|||
27915053|NCT02175121|81529136|FG004|Overall Study|Schedule conflict|0|||
27915054|NCT02175121|81529132|FG000|Overall Study|Time issues|0|||
27915055|NCT02175121|81529133|FG001|Overall Study|Time issues|0|||
27915056|NCT02175121|81529134|FG002|Overall Study|Time issues|1|||
27631386|NCT00367055|80490207|FG001|Overall Study|Adverse Event|3|||
27631387|NCT00367055|80490206|FG000|Overall Study|Patient's Willing|3|||
27631388|NCT00367055|80490207|FG001|Overall Study|Patient's Willing|2|||
27631389|NCT00367055|80490206|FG000|Overall Study|Lack of Efficacy|1|||
27915057|NCT02175121|81529135|FG003|Overall Study|Time issues|0|||
27915058|NCT02175121|81529136|FG004|Overall Study|Time issues|0|||
27915059|NCT03131167|81529138|FG000|Overall Study|Other (Unspecified)|0|||
27631390|NCT00367055|80490207|FG001|Overall Study|Lack of Efficacy|2|||
27631391|NCT00367055|80490206|FG000|Overall Study|Lost to Follow-up|1|||
27631392|NCT00367055|80490207|FG001|Overall Study|Lost to Follow-up|1|||
27631393|NCT00367055|80490206|FG000|Overall Study|Protocol Violation|0|||
27631394|NCT00367055|80490207|FG001|Overall Study|Protocol Violation|1|||
27631395|NCT00367055|80490206|FG000|Overall Study|Stopping Criterion Met|0|||
27631396|NCT00367055|80490207|FG001|Overall Study|Stopping Criterion Met|1|||
27631397|NCT00367055|80490206|FG000|Overall Study|Participant Living too Far from Hospital|0|||
27631398|NCT00367055|80490207|FG001|Overall Study|Participant Living too Far from Hospital|1|||
27631399|NCT01405924|80490210|FG000|Overall Study|Protocol Violation|8|||
27631400|NCT01405924|80490210|FG000|Overall Study|Missing/Incomplete Data|2|||
27631401|NCT02299635|80490211|FG000|Overall Study|Adverse Event|2|||
27631402|NCT02299635|80490211|FG000|Overall Study|Death|1|||
27631403|NCT02299635|80490211|FG000|Overall Study|Global deterioration of health status|1|||
27631404|NCT02299635|80490211|FG000|Overall Study|Objective progression or relapse|10|||
27631405|NCT02299635|80490211|FG000|Overall Study|Withdrawal by Subject|2|||
27631406|NCT02299635|80490211|FG000|Overall Study|Other|3|||
27631407|NCT01152190|80490212|FG000|Overall Study|Adverse Event|2|||
27631408|NCT01152190|80490213|FG001|Overall Study|Adverse Event|4|||
27631409|NCT01152190|80490212|FG000|Overall Study|Death|1|||
27631410|NCT01152190|80490213|FG001|Overall Study|Death|0|||
27631411|NCT01152190|80490212|FG000|Overall Study|Protocol Violation|1|||
27631412|NCT01152190|80490213|FG001|Overall Study|Protocol Violation|1|||
27631413|NCT01152190|80490212|FG000|Overall Study|Withdrawal by Subject|1|||
27631414|NCT01152190|80490213|FG001|Overall Study|Withdrawal by Subject|3|||
27631415|NCT01689519|80490214|FG000|Intent to Treat|Death|157|||
27631416|NCT01689519|80490215|FG001|Intent to Treat|Death|167|||
27631417|NCT01689519|80490214|FG000|Intent to Treat|Lost to Follow-up|4|||
27631418|NCT01689519|80490215|FG001|Intent to Treat|Lost to Follow-up|8|||
27631419|NCT01689519|80490214|FG000|Intent to Treat|Other|2|||
27631420|NCT01689519|80490215|FG001|Intent to Treat|Other|4|||
27631421|NCT01689519|80490214|FG000|Intent to Treat|Physician Decision|4|||
27631422|NCT01689519|80490215|FG001|Intent to Treat|Physician Decision|1|||
27631423|NCT01689519|80490214|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
27631424|NCT01689519|80490215|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
27631425|NCT01689519|80490214|FG000|Intent to Treat|Withdrawal by Subject|21|||
27631426|NCT01689519|80490215|FG001|Intent to Treat|Withdrawal by Subject|20|||
27915060|NCT03131167|81529139|FG001|Overall Study|Other (Unspecified)|0|||
27915061|NCT03131167|81529140|FG002|Overall Study|Other (Unspecified)|0|||
27915062|NCT03131167|81529141|FG003|Overall Study|Other (Unspecified)|0|||
27915063|NCT03131167|81529142|FG004|Overall Study|Other (Unspecified)|0|||
27915064|NCT03131167|81529143|FG005|Overall Study|Other (Unspecified)|1|||
27915065|NCT03131167|81529144|FG006|Overall Study|Other (Unspecified)|0|||
27915066|NCT03131167|81529145|FG007|Overall Study|Other (Unspecified)|0|||
27915067|NCT03131167|81529146|FG008|Overall Study|Other (Unspecified)|0|||
27915068|NCT03131167|81529147|FG009|Overall Study|Other (Unspecified)|0|||
27915069|NCT03131167|81529148|FG010|Overall Study|Other (Unspecified)|0|||
27915070|NCT03131167|81529149|FG011|Overall Study|Other (Unspecified)|0|||
27915071|NCT03131167|81529150|FG012|Overall Study|Other (Unspecified)|0|||
27915072|NCT03299101|81529151|FG000|Overall Study|Lost to Follow-up|1|||
27535491|NCT01858376|80156666|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
27915073|NCT03299101|81529151|FG000|Overall Study|Withdrawal by Subject|5|||
27915074|NCT03299101|81529151|FG000|Overall Study|Surgery was changed|3|||
27535492|NCT00747461|80156669|FG000|Overall Study|study terminated by sponsor|5|||
27535493|NCT01612858|80156670|FG000|Overall Study|Withdrawal by Subject|5|||
27535494|NCT01612858|80156671|FG001|Overall Study|Withdrawal by Subject|1|||
27535495|NCT01025154|80156677|FG000|Overall Study|Lost to Follow-up|1|||
27535496|NCT01025154|80156677|FG000|Overall Study|Withdrawal by Subject|1|||
27535497|NCT02410551|80156678|FG000|Overall Study|Adverse Event|1|||
27535498|NCT02410551|80156678|FG000|Overall Study|Withdrawal by Subject|1|||
27535499|NCT02410551|80156678|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
27535500|NCT01268150|80156682|FG000|Treatment Phase|Progression of disease|18|||
27535501|NCT01268150|80156682|FG000|Treatment Phase|Adverse Event|3|||
27535502|NCT01268150|80156682|FG000|Treatment Phase|Withdrawal by Subject|3|||
27535503|NCT01268150|80156682|FG000|Treatment Phase|Other|4|||
27535504|NCT01268150|80156682|FG000|Extension Phase|Adverse Event|3|||
27535505|NCT01268150|80156682|FG000|Extension Phase|Disease progression|18|||
27535506|NCT01268150|80156682|FG000|Extension Phase|Other|6|||
27631427|NCT01689519|80490214|FG000|Safety Population|Death|158|||
27631428|NCT01689519|80490215|FG001|Safety Population|Death|165|||
27631429|NCT01689519|80490214|FG000|Safety Population|Lost to Follow-up|4|||
27631430|NCT01689519|80490215|FG001|Safety Population|Lost to Follow-up|8|||
27631431|NCT01689519|80490214|FG000|Safety Population|Other|2|||
27631432|NCT01689519|80490215|FG001|Safety Population|Other|4|||
27631433|NCT01689519|80490214|FG000|Safety Population|Physician Decision|4|||
27631434|NCT01689519|80490215|FG001|Safety Population|Physician Decision|1|||
27915075|NCT03299101|81529151|FG000|Overall Study|Not enough time to complete prehab|1|||
27915076|NCT03028142|81529152|FG000|Overall Study|Adverse Event|1|||
27915077|NCT03028142|81529153|FG001|Overall Study|Adverse Event|1|||
27915078|NCT03028142|81529154|FG002|Overall Study|Adverse Event|0|||
27915079|NCT03028142|81529155|FG003|Overall Study|Adverse Event|0|||
27915080|NCT03028142|81529156|FG004|Overall Study|Adverse Event|0|||
27915081|NCT03028142|81529157|FG005|Overall Study|Adverse Event|1|||
27915082|NCT03028142|81529152|FG000|Overall Study|Withdrawal by Subject|0|||
27915083|NCT03028142|81529153|FG001|Overall Study|Withdrawal by Subject|0|||
27915084|NCT03028142|81529154|FG002|Overall Study|Withdrawal by Subject|0|||
27915085|NCT03028142|81529155|FG003|Overall Study|Withdrawal by Subject|0|||
27915086|NCT03028142|81529156|FG004|Overall Study|Withdrawal by Subject|1|||
27915087|NCT03028142|81529157|FG005|Overall Study|Withdrawal by Subject|0|||
27915088|NCT02567188|81529158|FG000|Overall Study|Death|10|||
27915089|NCT02567188|81529158|FG000|Overall Study|Terminated Mircera Treatment|9|||
27915090|NCT02567188|81529158|FG000|Overall Study|Lost to Follow-up|5|||
27915091|NCT02567188|81529158|FG000|Overall Study|Adverse Event|1|||
27915092|NCT02567188|81529158|FG000|Overall Study|Withdrawal by Subject|1|||
27915093|NCT02567188|81529158|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
27915094|NCT02567188|81529158|FG000|Overall Study|Moved and Changed Clinic|1|||
27915095|NCT02567188|81529158|FG000|Overall Study|Started Hemodialysis|2|||
27915096|NCT02567188|81529158|FG000|Overall Study|Protocol Violation|5|||
27915097|NCT01939314|81529159|FG000|Overall Study|Withdrawal by Subject|3|||
27915098|NCT01939314|81529160|FG001|Overall Study|Withdrawal by Subject|1|||
27915099|NCT01939314|81529159|FG000|Overall Study|Protocol Violation|1|||
27915100|NCT01939314|81529160|FG001|Overall Study|Protocol Violation|0|||
27915101|NCT01939314|81529159|FG000|Overall Study|Pregnancy|0|||
27915102|NCT01939314|81529160|FG001|Overall Study|Pregnancy|1|||
27915103|NCT01939314|81529159|FG000|Overall Study|Lost to Follow-up|5|||
27915104|NCT01939314|81529160|FG001|Overall Study|Lost to Follow-up|6|||
27915105|NCT01151345|81529163|FG000|First Intervention Period|Protocol Violation|0|||
27915106|NCT01151345|81529164|FG001|First Intervention Period|Protocol Violation|1|||
27915107|NCT00281697|81529167|FG000|Overall Study|> 60 days since last dose of study drug|4|||
27915108|NCT00281697|81529168|FG001|Overall Study|> 60 days since last dose of study drug|4|||
27915109|NCT00281697|81529167|FG000|Overall Study|Adverse Event|54|||
27915110|NCT00281697|81529168|FG001|Overall Study|Adverse Event|15|||
27915111|NCT00281697|81529167|FG000|Overall Study|Death|8|||
27915112|NCT00281697|81529168|FG001|Overall Study|Death|3|||
27915113|NCT00281697|81529167|FG000|Overall Study|Disease progression|279|||
27915114|NCT00281697|81529168|FG001|Overall Study|Disease progression|149|||
27915115|NCT00281697|81529167|FG000|Overall Study|Other|5|||
27915116|NCT00281697|81529168|FG001|Overall Study|Other|6|||
27915117|NCT00281697|81529167|FG000|Overall Study|Physician's decision to withdraw|15|||
27915118|NCT00281697|81529168|FG001|Overall Study|Physician's decision to withdraw|12|||
27915119|NCT00281697|81529167|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
27915120|NCT00281697|81529168|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
27915121|NCT00281697|81529167|FG000|Overall Study|Did not receive study drug|3|||
27915122|NCT00281697|81529168|FG001|Overall Study|Did not receive study drug|2|||
27915123|NCT01573000|81529169|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
27915124|NCT01573000|81529170|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
27915125|NCT01573000|81529169|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
27915126|NCT01573000|81529170|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
27915127|NCT01573000|81529169|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
27915128|NCT01573000|81529170|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
27915129|NCT01573000|81529169|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
27915130|NCT01573000|81529170|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
27915131|NCT01573000|81529169|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
27915132|NCT01573000|81529170|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
27915133|NCT01573000|81529169|FG000|Crossover Phase|Lack of Efficacy|0|||
27915134|NCT01573000|81529170|FG001|Crossover Phase|Lack of Efficacy|13|||
27535507|NCT02213042|80156683|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
27535508|NCT02213042|80156684|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
27535509|NCT02213042|80156685|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
27535510|NCT02213042|80156683|FG000|Overall Study|Adverse Event|2|||
27535511|NCT02213042|80156684|FG001|Overall Study|Adverse Event|1|||
27535512|NCT02213042|80156685|FG002|Overall Study|Adverse Event|0|||
27535513|NCT02213042|80156683|FG000|Overall Study|Withdrawal by Subject|0|||
27535514|NCT02213042|80156684|FG001|Overall Study|Withdrawal by Subject|1|||
27535515|NCT02213042|80156685|FG002|Overall Study|Withdrawal by Subject|1|||
27535516|NCT02213042|80156683|FG000|Overall Study|Protocol Violation|1|||
27535517|NCT02213042|80156684|FG001|Overall Study|Protocol Violation|0|||
27535518|NCT02213042|80156685|FG002|Overall Study|Protocol Violation|0|||
27535519|NCT02213042|80156683|FG000|Overall Study|Investigator discretion|0|||
27535520|NCT02213042|80156684|FG001|Overall Study|Investigator discretion|0|||
27535521|NCT02213042|80156685|FG002|Overall Study|Investigator discretion|1|||
27535522|NCT00747812|80156686|FG000|Overall Study|Research Site Staff Relocation|5|||
27535523|NCT00747812|80156687|FG001|Overall Study|Research Site Staff Relocation|3|||
27915135|NCT01573000|81529169|FG000|Crossover Phase|Lost to Follow-up|0|||
27915136|NCT01573000|81529170|FG001|Crossover Phase|Lost to Follow-up|2|||
27915137|NCT01573000|81529169|FG000|Crossover Phase|Death|0|||
27915138|NCT01573000|81529170|FG001|Crossover Phase|Death|3|||
27915139|NCT01573000|81529169|FG000|Long-Term Follow-Up|Death|3|||
27915140|NCT01573000|81529170|FG001|Long-Term Follow-Up|Death|0|||
27915141|NCT01573000|81529169|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
27915142|NCT01573000|81529170|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
27915143|NCT02427841|81529171|FG000|Overall Study|Lack of Efficacy|5|||
27915144|NCT02427841|81529171|FG000|Overall Study|Physician Decision|2|||
27915145|NCT02427841|81529171|FG000|Overall Study|Withdrawal by Subject|1|||
27915146|NCT01598610|81529172|FG000|Overall Study|Adverse Event|1|||
27631435|NCT01689519|80490214|FG000|Safety Population|Study Terminated By Sponsor|60|||
27631436|NCT01689519|80490215|FG001|Safety Population|Study Terminated By Sponsor|47|||
27631437|NCT01689519|80490214|FG000|Safety Population|Withdrawal by Subject|20|||
27631438|NCT01689519|80490215|FG001|Safety Population|Withdrawal by Subject|20|||
27631439|NCT00424762|80490216|FG000|Overall Study|Withdrawal by Subject|18|||
27631440|NCT00424762|80490217|FG001|Overall Study|Withdrawal by Subject|19|||
27631441|NCT00424762|80490216|FG000|Overall Study|Lost to Follow-up|2|||
27631442|NCT00424762|80490217|FG001|Overall Study|Lost to Follow-up|3|||
27631443|NCT03439124|80490221|FG000|Overall Study|Adverse Event|2|||
27631444|NCT03439124|80490222|FG001|Overall Study|Adverse Event|0|||
27631445|NCT03439124|80490221|FG000|Overall Study|Lost to Follow-up|1|||
27631446|NCT03439124|80490222|FG001|Overall Study|Lost to Follow-up|0|||
27631447|NCT03439124|80490221|FG000|Overall Study|Other reasons|1|||
27631448|NCT03439124|80490222|FG001|Overall Study|Other reasons|0|||
27631449|NCT00487578|80490223|FG000|Overall Study|Adverse Event|1|||
27631450|NCT00487578|80490224|FG001|Overall Study|Adverse Event|2|||
27631451|NCT00487578|80490223|FG000|Overall Study|Lack of Efficacy|0|||
27631452|NCT00487578|80490224|FG001|Overall Study|Lack of Efficacy|1|||
27631453|NCT00487578|80490223|FG000|Overall Study|Lost to Follow-up|0|||
27631454|NCT00487578|80490224|FG001|Overall Study|Lost to Follow-up|1|||
27631455|NCT00606580|80490225|FG000|Overall Study|Lost to Follow-up|1|||
27631456|NCT00606580|80490226|FG001|Overall Study|Lost to Follow-up|1|||
27631457|NCT00606580|80490227|FG002|Overall Study|Lost to Follow-up|4|||
27631458|NCT00606580|80490225|FG000|Overall Study|Clinical failures|1|||
27631459|NCT00606580|80490226|FG001|Overall Study|Clinical failures|0|||
27631460|NCT00606580|80490227|FG002|Overall Study|Clinical failures|12|||
27631461|NCT00606580|80490225|FG000|Overall Study|Withdrawal by investigator|0|||
27631462|NCT00606580|80490226|FG001|Overall Study|Withdrawal by investigator|1|||
27631463|NCT00606580|80490227|FG002|Overall Study|Withdrawal by investigator|6|||
27631464|NCT00606580|80490225|FG000|Overall Study|Withdrawal by Subject|0|||
27631465|NCT00606580|80490226|FG001|Overall Study|Withdrawal by Subject|1|||
27631466|NCT00606580|80490227|FG002|Overall Study|Withdrawal by Subject|0|||
27631467|NCT01050569|80490228|FG000|Overall Study|Lost to Follow-up|20|||
27631468|NCT01050569|80490229|FG001|Overall Study|Lost to Follow-up|14|||
27631469|NCT01050569|80490230|FG002|Overall Study|Lost to Follow-up|16|||
27631470|NCT01050569|80490228|FG000|Overall Study|Withdrawal by Subject|9|||
27631471|NCT01050569|80490229|FG001|Overall Study|Withdrawal by Subject|3|||
27631472|NCT01050569|80490230|FG002|Overall Study|Withdrawal by Subject|11|||
27535524|NCT03082261|80156689|FG000|Overall Study|Death|4|||
27915147|NCT00128661|81529174|FG000|Overall Study|Adverse Event|14|||
27915148|NCT00128661|81529175|FG001|Overall Study|Adverse Event|11|||
27915149|NCT00128661|81529174|FG000|Overall Study|Lost to Follow-up|10|||
27631473|NCT01050569|80490228|FG000|Overall Study|Lack of Efficacy|5|||
27631474|NCT01050569|80490229|FG001|Overall Study|Lack of Efficacy|4|||
27631475|NCT01050569|80490230|FG002|Overall Study|Lack of Efficacy|3|||
27915150|NCT00128661|81529175|FG001|Overall Study|Lost to Follow-up|7|||
27915151|NCT00128661|81529174|FG000|Overall Study|Withdrawal by Subject|243|||
27631476|NCT01050569|80490228|FG000|Overall Study|Adverse Event|1|||
27631477|NCT01050569|80490229|FG001|Overall Study|Adverse Event|0|||
27631478|NCT01050569|80490230|FG002|Overall Study|Adverse Event|0|||
27631479|NCT01050569|80490228|FG000|Overall Study|Physician Decision|3|||
27915152|NCT00128661|81529175|FG001|Overall Study|Withdrawal by Subject|232|||
27915153|NCT00128661|81529174|FG000|Overall Study|Other|7|||
27915154|NCT00128661|81529175|FG001|Overall Study|Other|8|||
27915155|NCT02791269|81529176|FG000|Overall Study|Lost to Follow-up|0|||
27915156|NCT02791269|81529177|FG001|Overall Study|Lost to Follow-up|1|||
27915157|NCT01316224|81529178|FG000|Overall Study|Protocol Violation|3|||
27915158|NCT01316224|81529178|FG000|Overall Study|Adverse Event|3|||
27915159|NCT01316224|81529178|FG000|Overall Study|Lack of Efficacy|1|||
27915160|NCT01316224|81529178|FG000|Overall Study|Withdrawal by Subject|1|||
27535525|NCT03082261|80156689|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
27535526|NCT03082261|80156689|FG000|Overall Study|Insurance denial|1|||
27535527|NCT03082261|80156689|FG000|Overall Study|Peripheral lead added|1|||
27535528|NCT03082261|80156689|FG000|Overall Study|Withdrawal by Subject|40|||
27535529|NCT03082261|80156689|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
27535530|NCT03082261|80156689|FG000|Overall Study|Subject implanted with device other than study device|1|||
27535531|NCT03082261|80156689|FG000|Overall Study|Lost to Follow-up|14|||
27535532|NCT03082261|80156689|FG000|Overall Study|Subject moved to a different state|1|||
27535533|NCT03082261|80156689|FG000|Overall Study|Subject non-compliance|2|||
27535534|NCT03082261|80156689|FG000|Overall Study|Subject participation terminated by investigator|9|||
27535535|NCT03082261|80156689|FG000|Overall Study|Subject participation terminated by sponsor|4|||
27535536|NCT03082261|80156689|FG000|Overall Study|System explant|19|||
27535537|NCT03082261|80156689|FG000|Overall Study|Unable to place lead(s)|2|||
27535538|NCT03082261|80156689|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
27535539|NCT02360995|80156690|FG000|Overall Study|Lost to Follow-up|2|||
27535540|NCT02360995|80156691|FG001|Overall Study|Lost to Follow-up|0|||
27535541|NCT02360995|80156692|FG002|Overall Study|Lost to Follow-up|2|||
27535542|NCT02360995|80156690|FG000|Overall Study|Withdrawal by Subject|0|||
27535543|NCT02360995|80156691|FG001|Overall Study|Withdrawal by Subject|1|||
27535544|NCT02360995|80156692|FG002|Overall Study|Withdrawal by Subject|0|||
27535545|NCT00808483|80156693|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
27535546|NCT00808483|80156694|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
27535547|NCT00808483|80156693|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
27535548|NCT00808483|80156694|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
27535549|NCT00808483|80156693|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
27535550|NCT00808483|80156694|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
27915161|NCT01316224|81529178|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
27915162|NCT01316224|81529178|FG000|Overall Study|Other|1|||
27915163|NCT03225287|81529179|FG000|Overall Study|Adverse Event|0|||
27915164|NCT03225287|81529180|FG001|Overall Study|Adverse Event|0|||
27915165|NCT03225287|81529181|FG002|Overall Study|Adverse Event|1|||
27915166|NCT03225287|81529179|FG000|Overall Study|Protocol non-compliance|0|||
27915167|NCT03225287|81529180|FG001|Overall Study|Protocol non-compliance|0|||
27915168|NCT03225287|81529181|FG002|Overall Study|Protocol non-compliance|1|||
27915169|NCT03225287|81529179|FG000|Overall Study|Subject withdraws consent|3|||
27915170|NCT03225287|81529180|FG001|Overall Study|Subject withdraws consent|0|||
27915171|NCT03225287|81529181|FG002|Overall Study|Subject withdraws consent|0|||
27915172|NCT03225287|81529179|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
27915173|NCT03225287|81529180|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
27915174|NCT03225287|81529181|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
27915175|NCT03225287|81529179|FG000|Overall Study|Trial drug not effective|0|||
27915176|NCT03225287|81529180|FG001|Overall Study|Trial drug not effective|1|||
27915177|NCT03225287|81529181|FG002|Overall Study|Trial drug not effective|0|||
27915178|NCT03225287|81529179|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
27915179|NCT03225287|81529180|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
27915180|NCT03225287|81529181|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
27915181|NCT03225287|81529179|FG000|Overall Study|Stem cell transplantation|0|||
27915182|NCT03225287|81529180|FG001|Overall Study|Stem cell transplantation|1|||
27915183|NCT03225287|81529181|FG002|Overall Study|Stem cell transplantation|0|||
27915184|NCT00274742|81529182|FG000|Overall Study|Adverse Event|0|||
27915185|NCT00274742|81529183|FG001|Overall Study|Adverse Event|4|||
27915186|NCT00274742|81529184|FG002|Overall Study|Adverse Event|1|||
27915187|NCT00274742|81529185|FG003|Overall Study|Adverse Event|4|||
27915188|NCT00274742|81529186|FG004|Overall Study|Adverse Event|12|||
27915189|NCT00274742|81529187|FG005|Overall Study|Adverse Event|3|||
27915190|NCT00274742|81529182|FG000|Overall Study|Lost to Follow-up|0|||
27915191|NCT00274742|81529183|FG001|Overall Study|Lost to Follow-up|0|||
27915192|NCT00274742|81529184|FG002|Overall Study|Lost to Follow-up|0|||
27915193|NCT00274742|81529185|FG003|Overall Study|Lost to Follow-up|0|||
27535551|NCT01967173|80156695|FG000|Overall Study|Lost to Follow-up|5|||
27535552|NCT01967173|80156696|FG001|Overall Study|Lost to Follow-up|3|||
27915194|NCT00274742|81529186|FG004|Overall Study|Lost to Follow-up|1|||
27535553|NCT01967173|80156697|FG002|Overall Study|Lost to Follow-up|2|||
27915195|NCT00274742|81529187|FG005|Overall Study|Lost to Follow-up|0|||
27915196|NCT00274742|81529182|FG000|Overall Study|End of Study|0|||
27915197|NCT00274742|81529183|FG001|Overall Study|End of Study|0|||
27535554|NCT01967173|80156698|FG003|Overall Study|Lost to Follow-up|4|||
27535555|NCT01967173|80156699|FG004|Overall Study|Lost to Follow-up|8|||
27535556|NCT01967173|80156700|FG005|Overall Study|Lost to Follow-up|12|||
27535557|NCT01967173|80156701|FG006|Overall Study|Lost to Follow-up|6|||
27535558|NCT01967173|80156702|FG007|Overall Study|Lost to Follow-up|8|||
27535559|NCT01967173|80156695|FG000|Overall Study|Physician Decision|2|||
27631480|NCT01050569|80490229|FG001|Overall Study|Physician Decision|3|||
27915198|NCT00274742|81529184|FG002|Overall Study|End of Study|0|||
27915199|NCT00274742|81529185|FG003|Overall Study|End of Study|1|||
27915200|NCT00274742|81529186|FG004|Overall Study|End of Study|0|||
27915201|NCT00274742|81529187|FG005|Overall Study|End of Study|0|||
27915202|NCT00274742|81529182|FG000|Overall Study|Disease Progression|0|||
27915203|NCT00274742|81529183|FG001|Overall Study|Disease Progression|1|||
27915204|NCT00274742|81529184|FG002|Overall Study|Disease Progression|1|||
27915205|NCT00274742|81529185|FG003|Overall Study|Disease Progression|0|||
27915206|NCT00274742|81529186|FG004|Overall Study|Disease Progression|1|||
27915207|NCT00274742|81529187|FG005|Overall Study|Disease Progression|0|||
27915208|NCT00274742|81529182|FG000|Overall Study|Other|0|||
27535560|NCT01967173|80156696|FG001|Overall Study|Physician Decision|0|||
27535561|NCT01967173|80156697|FG002|Overall Study|Physician Decision|2|||
27535562|NCT01967173|80156698|FG003|Overall Study|Physician Decision|1|||
27535563|NCT01967173|80156699|FG004|Overall Study|Physician Decision|1|||
27535564|NCT01967173|80156700|FG005|Overall Study|Physician Decision|1|||
27631481|NCT01050569|80490230|FG002|Overall Study|Physician Decision|3|||
27631482|NCT02685033|80490233|FG000|Overall Study|Withdrawal of Consent|0|||
27631483|NCT02685033|80490234|FG001|Overall Study|Withdrawal of Consent|1|||
27631484|NCT02685033|80490233|FG000|Overall Study|Lost to Follow-up|2|||
27631485|NCT02685033|80490234|FG001|Overall Study|Lost to Follow-up|1|||
27631486|NCT02685033|80490233|FG000|Overall Study|Adverse Event|1|||
27631487|NCT02685033|80490234|FG001|Overall Study|Adverse Event|0|||
27631488|NCT01786564|80490235|FG000|Overall Study|Lost to Follow-up|47|||
27631489|NCT01786564|80490235|FG000|Overall Study|Ineligible|17|||
27631490|NCT01144182|80490242|FG000|Overall Study|Death|5|||
27631491|NCT01144182|80490243|FG001|Overall Study|Death|6|||
27631492|NCT01144182|80490242|FG000|Overall Study|Withdrawal by Subject|3|||
27631493|NCT01144182|80490243|FG001|Overall Study|Withdrawal by Subject|6|||
27631494|NCT01144182|80490242|FG000|Overall Study|Lost to Follow-up|9|||
27535565|NCT01967173|80156701|FG006|Overall Study|Physician Decision|1|||
27915209|NCT00274742|81529183|FG001|Overall Study|Other|3|||
27535566|NCT01967173|80156702|FG007|Overall Study|Physician Decision|0|||
27535567|NCT01967173|80156695|FG000|Overall Study|Lack of Efficacy|2|||
27535568|NCT01967173|80156696|FG001|Overall Study|Lack of Efficacy|0|||
27535569|NCT01967173|80156697|FG002|Overall Study|Lack of Efficacy|2|||
27535570|NCT01967173|80156698|FG003|Overall Study|Lack of Efficacy|2|||
27535571|NCT01967173|80156699|FG004|Overall Study|Lack of Efficacy|0|||
27535572|NCT01967173|80156700|FG005|Overall Study|Lack of Efficacy|1|||
27535573|NCT01967173|80156701|FG006|Overall Study|Lack of Efficacy|0|||
27535574|NCT01967173|80156702|FG007|Overall Study|Lack of Efficacy|2|||
27535575|NCT01967173|80156695|FG000|Overall Study|Pregnancy|0|||
27535576|NCT01967173|80156696|FG001|Overall Study|Pregnancy|0|||
27535577|NCT01967173|80156697|FG002|Overall Study|Pregnancy|0|||
27535578|NCT01967173|80156698|FG003|Overall Study|Pregnancy|0|||
27535579|NCT01967173|80156699|FG004|Overall Study|Pregnancy|0|||
27535580|NCT01967173|80156700|FG005|Overall Study|Pregnancy|0|||
27535581|NCT01967173|80156701|FG006|Overall Study|Pregnancy|1|||
27535582|NCT01967173|80156702|FG007|Overall Study|Pregnancy|1|||
27535583|NCT01967173|80156695|FG000|Overall Study|Adverse Event|0|||
27535584|NCT01967173|80156696|FG001|Overall Study|Adverse Event|0|||
27535585|NCT01967173|80156697|FG002|Overall Study|Adverse Event|0|||
27535586|NCT01967173|80156698|FG003|Overall Study|Adverse Event|0|||
27535587|NCT01967173|80156699|FG004|Overall Study|Adverse Event|0|||
27535588|NCT01967173|80156700|FG005|Overall Study|Adverse Event|0|||
27535589|NCT01967173|80156701|FG006|Overall Study|Adverse Event|0|||
27631495|NCT01144182|80490243|FG001|Overall Study|Lost to Follow-up|9|||
27631496|NCT03885596|80490244|FG000|Overall Study|Withdrawal by Subject|2|||
27631497|NCT03885596|80490245|FG001|Overall Study|Withdrawal by Subject|1|||
27631498|NCT03885596|80490246|FG002|Overall Study|Withdrawal by Subject|0|||
27631499|NCT03885596|80490247|FG003|Overall Study|Withdrawal by Subject|0|||
27631500|NCT03999554|80490252|FG000|Overall Study|Lost to Follow-up|4|||
27631501|NCT03999554|80490253|FG001|Overall Study|Lost to Follow-up|5|||
27915210|NCT00274742|81529184|FG002|Overall Study|Other|0|||
27915211|NCT00274742|81529185|FG003|Overall Study|Other|0|||
27915212|NCT00274742|81529186|FG004|Overall Study|Other|2|||
27535590|NCT01967173|80156702|FG007|Overall Study|Adverse Event|1|||
27535591|NCT01967173|80156695|FG000|Overall Study|Withdrawal by Subject|15|||
27535592|NCT01967173|80156696|FG001|Overall Study|Withdrawal by Subject|14|||
27535593|NCT01967173|80156697|FG002|Overall Study|Withdrawal by Subject|10|||
27535594|NCT01967173|80156698|FG003|Overall Study|Withdrawal by Subject|7|||
27535595|NCT01967173|80156699|FG004|Overall Study|Withdrawal by Subject|8|||
27535596|NCT01967173|80156700|FG005|Overall Study|Withdrawal by Subject|9|||
27535597|NCT01967173|80156701|FG006|Overall Study|Withdrawal by Subject|10|||
27535598|NCT01967173|80156702|FG007|Overall Study|Withdrawal by Subject|12|||
27535599|NCT00973674|80156703|FG000|Overall Study|Protocol Violation|2|||
27535600|NCT00973674|80156704|FG001|Overall Study|Protocol Violation|0|||
27535601|NCT01042678|80156705|FG000|Overall Study|Physician Decision|1|||
27535602|NCT01042678|80156706|FG001|Overall Study|Physician Decision|0|||
27535603|NCT01042678|80156707|FG002|Overall Study|Physician Decision|0|||
27535604|NCT01042678|80156708|FG003|Overall Study|Physician Decision|0|||
27535605|NCT01042678|80156709|FG004|Overall Study|Physician Decision|0|||
27631502|NCT03999554|80490254|FG002|Overall Study|Lost to Follow-up|4|||
27631503|NCT03999554|80490255|FG003|Overall Study|Lost to Follow-up|5|||
27631504|NCT03999554|80490256|FG004|Overall Study|Lost to Follow-up|8|||
27631505|NCT03999554|80490252|FG000|Overall Study|Protocol Violation|0|||
27631506|NCT03999554|80490253|FG001|Overall Study|Protocol Violation|0|||
27631507|NCT03999554|80490254|FG002|Overall Study|Protocol Violation|5|||
27631508|NCT03999554|80490255|FG003|Overall Study|Protocol Violation|0|||
27631509|NCT03999554|80490256|FG004|Overall Study|Protocol Violation|0|||
27631510|NCT03999554|80490252|FG000|Overall Study|Pregnancy|0|||
27631511|NCT03999554|80490253|FG001|Overall Study|Pregnancy|0|||
27631512|NCT03999554|80490254|FG002|Overall Study|Pregnancy|1|||
27631513|NCT03999554|80490255|FG003|Overall Study|Pregnancy|0|||
27631514|NCT03999554|80490256|FG004|Overall Study|Pregnancy|0|||
27631515|NCT03999554|80490252|FG000|Overall Study|Withdrawal by Subject|2|||
27631516|NCT03999554|80490253|FG001|Overall Study|Withdrawal by Subject|2|||
27631517|NCT03999554|80490254|FG002|Overall Study|Withdrawal by Subject|2|||
27631518|NCT03999554|80490255|FG003|Overall Study|Withdrawal by Subject|1|||
27631519|NCT03999554|80490256|FG004|Overall Study|Withdrawal by Subject|1|||
27631520|NCT03999554|80490252|FG000|Overall Study|failure to comply with protocol requirements|0|||
27631521|NCT03999554|80490253|FG001|Overall Study|failure to comply with protocol requirements|0|||
27631522|NCT03999554|80490254|FG002|Overall Study|failure to comply with protocol requirements|0|||
27631523|NCT03999554|80490255|FG003|Overall Study|failure to comply with protocol requirements|1|||
27631524|NCT03999554|80490256|FG004|Overall Study|failure to comply with protocol requirements|0|||
27631525|NCT00768651|80490262|FG000|Overall Study|Withdrawal by Subject|1|||
27631526|NCT00377455|80490263|FG000|Overall Study|Withdrawal by Subject|1|||
27631527|NCT04381494|80490264|FG000|Overall Study|Early termination of trial|19|||
27631528|NCT04381494|80490264|FG000|Overall Study|Investigator's discretion|1|||
27631529|NCT04381494|80490264|FG000|Overall Study|Withdrawal by Subject|9|||
27631530|NCT04381494|80490264|FG000|Overall Study|NSCLC disease progression|4|||
27535606|NCT01042678|80156710|FG005|Overall Study|Physician Decision|0|||
27535607|NCT04607980|80156711|FG000|Overall Study|Adverse Event|3|||
27535608|NCT04607980|80156712|FG001|Overall Study|Adverse Event|4|||
27535609|NCT04607980|80156711|FG000|Overall Study|Death|0|||
27535610|NCT04607980|80156712|FG001|Overall Study|Death|1|||
27535611|NCT04607980|80156711|FG000|Overall Study|Withdrawal by Subject|2|||
27535612|NCT04607980|80156712|FG001|Overall Study|Withdrawal by Subject|5|||
27535613|NCT04607980|80156711|FG000|Overall Study|Lost to Follow-up|4|||
27535614|NCT04607980|80156712|FG001|Overall Study|Lost to Follow-up|8|||
27535615|NCT04607980|80156711|FG000|Overall Study|Protocol Violation|0|||
27535616|NCT04607980|80156712|FG001|Overall Study|Protocol Violation|3|||
27535617|NCT04607980|80156711|FG000|Overall Study|Other|3|||
27535618|NCT04607980|80156712|FG001|Overall Study|Other|0|||
27535619|NCT02121522|80156716|FG000|Overall Study|Adverse Event|1|||
27535620|NCT04327674|80156717|FG000|Overall Study|Protocol Violation|19|||
27535621|NCT04087213|80156719|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
27535622|NCT04087213|80156719|FG000|In-Facility Introduction|Adverse Event|1|||
27535623|NCT04087213|80156719|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
27535624|NCT04087213|80156719|FG000|Assisted Evaluable Period|Personal reasons|3|||
27535625|NCT04087213|80156719|FG000|Transition Period B|Renal Transplantation|1|||
27535626|NCT00413244|80156720|FG000|Overall Study|Withdrawal by Subject|10|||
27535627|NCT00413244|80156721|FG001|Overall Study|Withdrawal by Subject|1|||
27535628|NCT03643575|80156722|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
27535629|NCT03643575|80156723|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
27535630|NCT03643575|80156724|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
27535631|NCT03643575|80156725|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
27535632|NCT03643575|80156726|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
27535633|NCT03643575|80156727|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
27535634|NCT03643575|80156722|FG000|Washout: 7 Days|Adverse Event|1|||
27535635|NCT03643575|80156723|FG001|Washout: 7 Days|Adverse Event|0|||
27535636|NCT03643575|80156724|FG002|Washout: 7 Days|Adverse Event|0|||
27535637|NCT03643575|80156725|FG003|Washout: 7 Days|Adverse Event|0|||
27535638|NCT03643575|80156726|FG004|Washout: 7 Days|Adverse Event|0|||
27535639|NCT03643575|80156727|FG005|Washout: 7 Days|Adverse Event|0|||
27535640|NCT03643575|80156722|FG000|Washout: 7 Days|Non compliance check in|0|||
27535641|NCT03643575|80156723|FG001|Washout: 7 Days|Non compliance check in|1|||
27535642|NCT03643575|80156724|FG002|Washout: 7 Days|Non compliance check in|0|||
27535643|NCT03643575|80156725|FG003|Washout: 7 Days|Non compliance check in|0|||
27535644|NCT03643575|80156726|FG004|Washout: 7 Days|Non compliance check in|0|||
27535645|NCT03643575|80156727|FG005|Washout: 7 Days|Non compliance check in|0|||
27535646|NCT03945266|80156728|FG000|Overall Study|Withdrawal by Subject|1|||
27535647|NCT03945266|80156729|FG001|Overall Study|Withdrawal by Subject|0|||
27535648|NCT03945266|80156728|FG000|Overall Study|Miscarriage|0|||
27535649|NCT03945266|80156729|FG001|Overall Study|Miscarriage|2|||
27535650|NCT03945266|80156728|FG000|Overall Study|Lost to Follow-up|1|||
27535651|NCT03945266|80156729|FG001|Overall Study|Lost to Follow-up|0|||
27535652|NCT02846545|80156732|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
27535653|NCT02846545|80156733|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
27535654|NCT02846545|80156732|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
27631531|NCT04381494|80490264|FG000|Overall Study|Device-Related Adverse Event|2|||
27631532|NCT00678795|80490265|FG000|Overall Study|Adverse Event|7|||
27631533|NCT00678795|80490266|FG001|Overall Study|Adverse Event|3|||
27631534|NCT00678795|80490265|FG000|Overall Study|Withdrawal by Subject|3|||
27631535|NCT00678795|80490266|FG001|Overall Study|Withdrawal by Subject|0|||
27631536|NCT00678795|80490265|FG000|Overall Study|Protocol Violation|0|||
27631537|NCT00678795|80490266|FG001|Overall Study|Protocol Violation|1|||
27631538|NCT00678795|80490265|FG000|Overall Study|Lost to Follow-up|0|||
27631539|NCT00678795|80490266|FG001|Overall Study|Lost to Follow-up|1|||
27631540|NCT00678795|80490265|FG000|Overall Study|Lack of Efficacy|1|||
27631541|NCT00678795|80490266|FG001|Overall Study|Lack of Efficacy|1|||
27631542|NCT02459899|80490269|FG000|Overall Study|Adverse Event|1|||
27631543|NCT02459899|80490270|FG001|Overall Study|Adverse Event|1|||
27631544|NCT02459899|80490271|FG002|Overall Study|Adverse Event|0|||
27631545|NCT02459899|80490272|FG003|Overall Study|Adverse Event|0|||
27631546|NCT02459899|80490269|FG000|Overall Study|Lost to Follow-up|1|||
27631547|NCT02459899|80490270|FG001|Overall Study|Lost to Follow-up|2|||
27631548|NCT02459899|80490271|FG002|Overall Study|Lost to Follow-up|0|||
27631549|NCT02459899|80490272|FG003|Overall Study|Lost to Follow-up|1|||
27631550|NCT02459899|80490269|FG000|Overall Study|Non-compliance with the treatment|0|||
27631551|NCT02459899|80490270|FG001|Overall Study|Non-compliance with the treatment|0|||
27631552|NCT02459899|80490271|FG002|Overall Study|Non-compliance with the treatment|0|||
27631553|NCT02459899|80490272|FG003|Overall Study|Non-compliance with the treatment|1|||
27631554|NCT02459899|80490269|FG000|Overall Study|Withdrawal by Subject|1|||
27631555|NCT02459899|80490270|FG001|Overall Study|Withdrawal by Subject|3|||
27631556|NCT02459899|80490271|FG002|Overall Study|Withdrawal by Subject|0|||
27631557|NCT02459899|80490272|FG003|Overall Study|Withdrawal by Subject|0|||
27631558|NCT05046132|80490273|FG000|Overall Study|Adverse Event|4|||
27631559|NCT05046132|80490274|FG001|Overall Study|Adverse Event|0|||
27631560|NCT05046132|80490275|FG002|Overall Study|Adverse Event|0|||
27631561|NCT05046132|80490273|FG000|Overall Study|Withdrawal by Subject|3|||
27631562|NCT05046132|80490274|FG001|Overall Study|Withdrawal by Subject|0|||
27631563|NCT05046132|80490275|FG002|Overall Study|Withdrawal by Subject|0|||
27631564|NCT05046132|80490273|FG000|Overall Study|Positive Covid19 Result.|0|||
27631565|NCT05046132|80490274|FG001|Overall Study|Positive Covid19 Result.|1|||
27631566|NCT05046132|80490275|FG002|Overall Study|Positive Covid19 Result.|0|||
27631567|NCT03441360|80490276|FG000|Overall Study|Radiological disease progression|5|||
27631568|NCT03441360|80490277|FG001|Overall Study|Radiological disease progression|6|||
27631569|NCT03441360|80490278|FG002|Overall Study|Radiological disease progression|4|||
27631570|NCT03441360|80490276|FG000|Overall Study|Clinical disease progression|2|||
27631571|NCT03441360|80490277|FG001|Overall Study|Clinical disease progression|2|||
27631572|NCT03441360|80490278|FG002|Overall Study|Clinical disease progression|0|||
27631573|NCT03441360|80490276|FG000|Overall Study|Adverse Event|1|||
27535655|NCT02846545|80156733|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
27535656|NCT02846545|80156732|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
27631574|NCT03441360|80490277|FG001|Overall Study|Adverse Event|0|||
27631575|NCT03441360|80490278|FG002|Overall Study|Adverse Event|1|||
27631576|NCT03939819|80490279|FG000|Overall Study|Death|2|||
27535657|NCT02846545|80156733|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
27535658|NCT02846545|80156732|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
27535659|NCT02846545|80156733|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
27535660|NCT02846545|80156732|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
27535661|NCT02846545|80156733|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
27535662|NCT02081183|80156734|FG000|Overall Study|Lost to Follow-up|0|||
27535663|NCT02081183|80156735|FG001|Overall Study|Lost to Follow-up|1|||
27535664|NCT02081183|80156734|FG000|Overall Study|Protocol Violation|1|||
27535665|NCT02081183|80156735|FG001|Overall Study|Protocol Violation|0|||
27535666|NCT02081183|80156734|FG000|Overall Study|Other|3|||
27535667|NCT02081183|80156735|FG001|Overall Study|Other|3|||
27535668|NCT00735254|80156736|FG000|Overall Study|Protocol Violation|1|||
27535669|NCT00735254|80156737|FG001|Overall Study|Protocol Violation|1|||
27535670|NCT00735254|80156738|FG002|Overall Study|Protocol Violation|1|||
27535671|NCT00735254|80156739|FG003|Overall Study|Protocol Violation|0|||
27535672|NCT02030938|80156744|FG000|Overall Study|Lost to Follow-up|4|||
27535673|NCT02030938|80156744|FG000|Overall Study|Withdrawal by Subject|1|||
27535674|NCT02572388|80156745|FG000|Overall Study|Withdrawal by Subject|1|||
27535675|NCT02572388|80156746|FG001|Overall Study|Withdrawal by Subject|1|||
27915213|NCT00274742|81529187|FG005|Overall Study|Other|0|||
27535676|NCT02572388|80156747|FG002|Overall Study|Withdrawal by Subject|2|||
27915214|NCT01157845|81529188|FG000|Overall Study|Lost to Follow-up|5|||
27915215|NCT01157845|81529188|FG000|Overall Study|Withdrawal by Subject|12|||
27915216|NCT01157845|81529188|FG000|Overall Study|Physician Decision|3|||
27915217|NCT01157845|81529188|FG000|Overall Study|Protocol Violation|13|||
27535677|NCT02572388|80156748|FG003|Overall Study|Withdrawal by Subject|2|||
27535678|NCT02186873|80156751|FG000|Overall Study|Adverse Event|1|||
27535679|NCT02186873|80156752|FG001|Overall Study|Adverse Event|3|||
27535680|NCT02186873|80156751|FG000|Overall Study|Lack of Efficacy|0|||
27535681|NCT02186873|80156752|FG001|Overall Study|Lack of Efficacy|1|||
27535682|NCT02186873|80156751|FG000|Overall Study|Lost to Follow-up|1|||
27738516|NCT01772134|80871262|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
27738517|NCT01772134|80871263|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
27738518|NCT01772134|80871264|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
27738519|NCT01772134|80871262|FG000|Overall Study|Randomized Study Medication Not Received|2|||
27738520|NCT01772134|80871263|FG001|Overall Study|Randomized Study Medication Not Received|0|||
27738521|NCT01772134|80871264|FG002|Overall Study|Randomized Study Medication Not Received|1|||
27738522|NCT01756157|80871268|FG000|First Intervention Period|Withdrawal by Subject|1|||
27738523|NCT01756157|80871269|FG001|First Intervention Period|Withdrawal by Subject|0|||
27738524|NCT01756157|80871268|FG000|First Intervention Period|Lost to Follow-up|0|||
27738525|NCT01756157|80871269|FG001|First Intervention Period|Lost to Follow-up|2|||
27738526|NCT02629393|80871275|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
27738527|NCT02629393|80871275|FG000|Overall Study|Physician Decision|1|||
27738528|NCT01748760|80871288|FG000|Overall Study|Withdrawal by Subject|1|||
27738529|NCT01748760|80871289|FG001|Overall Study|Withdrawal by Subject|1|||
27738530|NCT01748760|80871288|FG000|Overall Study|Lost to Follow-up|5|||
27738531|NCT01748760|80871289|FG001|Overall Study|Lost to Follow-up|1|||
27915218|NCT01157845|81529188|FG000|Overall Study|Study was ended|1|||
27915219|NCT01157845|81529188|FG000|Overall Study|Device malfunction|1|||
27915220|NCT02340000|81529191|FG000|Time Period 1|Withdrawal by Subject|6|||
27535683|NCT02186873|80156752|FG001|Overall Study|Lost to Follow-up|2|||
27738532|NCT02179398|80871300|FG000|Overall Study|Lack of obligatory data|3|||
27738533|NCT02179398|80871301|FG001|Overall Study|Lack of obligatory data|3|||
27535684|NCT02186873|80156751|FG000|Overall Study|Withdrawal by Subject|7|||
27535685|NCT02186873|80156752|FG001|Overall Study|Withdrawal by Subject|2|||
27738534|NCT02179398|80871300|FG000|Overall Study|Lost to Follow-up|0|||
27738535|NCT02179398|80871301|FG001|Overall Study|Lost to Follow-up|1|||
27738536|NCT00772967|80871302|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
27738537|NCT00772967|80871303|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
27738538|NCT00772967|80871304|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
27738539|NCT00772967|80871305|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
27738540|NCT00772967|80871306|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
27738541|NCT00772967|80871307|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
27915221|NCT02340000|81529192|FG001|Time Period 1|Withdrawal by Subject|8|||
27915222|NCT02340000|81529191|FG000|Time Period 1|Lost to Follow-up|6|||
27738542|NCT00772967|80871302|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
27738543|NCT00772967|80871303|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
27738544|NCT00772967|80871304|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
27738545|NCT00772967|80871305|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
27738546|NCT00772967|80871306|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
27915223|NCT02340000|81529192|FG001|Time Period 1|Lost to Follow-up|7|||
27535686|NCT01759511|80156753|FG000|Overall Study|Adverse Event|4|||
27535687|NCT01759511|80156753|FG000|Overall Study|Death|2|||
27915224|NCT02340000|81529191|FG000|Time Period 2|Withdrawal by Subject|9|||
27535688|NCT01759511|80156753|FG000|Overall Study|Lack of Efficacy|2|||
27535689|NCT01759511|80156753|FG000|Overall Study|Physician Decision|1|||
27535690|NCT01759511|80156753|FG000|Overall Study|Progressive Disease|5|||
27535691|NCT01759511|80156753|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
27535692|NCT01759511|80156753|FG000|Overall Study|Study Terminated by Sponsor|13|||
27535693|NCT01759511|80156753|FG000|Overall Study|Withdrawal by Subject|3|||
27535694|NCT01772160|80156754|FG000|Overall Study|Death|3|||
27535695|NCT01772160|80156754|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
27535696|NCT01772160|80156754|FG000|Overall Study|Consent withdrawal|3|||
27535697|NCT01772160|80156754|FG000|Overall Study|Migrated / moved from the study area|4|||
27535698|NCT01772160|80156754|FG000|Overall Study|Lost to Follow-up|30|||
27535699|NCT01772160|80156754|FG000|Overall Study|Other|5|||
27535700|NCT02639546|80156755|FG000|Overall Study|Death|2|||
27535701|NCT02639546|80156756|FG001|Overall Study|Death|2|||
27535702|NCT02639546|80156757|FG002|Overall Study|Death|1|||
27535703|NCT02639546|80156758|FG003|Overall Study|Death|2|||
27535704|NCT02639546|80156759|FG004|Overall Study|Death|2|||
27738547|NCT00772967|80871307|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
27738548|NCT00772967|80871302|FG000|Crossover Treatment 3|Adverse Event|0|||
27738549|NCT00772967|80871303|FG001|Crossover Treatment 3|Adverse Event|0|||
27738550|NCT00772967|80871304|FG002|Crossover Treatment 3|Adverse Event|0|||
27738551|NCT00772967|80871305|FG003|Crossover Treatment 3|Adverse Event|0|||
27738552|NCT00772967|80871306|FG004|Crossover Treatment 3|Adverse Event|1|||
27738553|NCT00772967|80871307|FG005|Crossover Treatment 3|Adverse Event|0|||
27738554|NCT00964795|80871312|FG000|Overall Study|Withdrawal by Subject|79|||
27738555|NCT00964795|80871312|FG000|Overall Study|Adverse Event|12|||
27738556|NCT00964795|80871312|FG000|Overall Study|Death|14|||
27535705|NCT02639546|80156760|FG005|Overall Study|Death|2|||
27535706|NCT02639546|80156761|FG006|Overall Study|Death|0|||
27535707|NCT02639546|80156762|FG007|Overall Study|Death|0|||
27535708|NCT02639546|80156755|FG000|Overall Study|Lost to Follow-up|0|||
27535709|NCT02639546|80156756|FG001|Overall Study|Lost to Follow-up|0|||
27535710|NCT02639546|80156757|FG002|Overall Study|Lost to Follow-up|1|||
27535711|NCT02639546|80156758|FG003|Overall Study|Lost to Follow-up|0|||
27535712|NCT02639546|80156759|FG004|Overall Study|Lost to Follow-up|1|||
27535713|NCT02639546|80156760|FG005|Overall Study|Lost to Follow-up|1|||
27535714|NCT02639546|80156761|FG006|Overall Study|Lost to Follow-up|0|||
27535715|NCT02639546|80156762|FG007|Overall Study|Lost to Follow-up|1|||
27535716|NCT02639546|80156755|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
27535717|NCT02639546|80156756|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
27535718|NCT02639546|80156757|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
27738557|NCT00964795|80871312|FG000|Overall Study|Lost to Follow-up|7|||
27738558|NCT00964795|80871312|FG000|Overall Study|Termination of Study by Sponsor|169|||
27738559|NCT00964795|80871312|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
27738560|NCT00964795|80871312|FG000|Overall Study|Other|23|||
27738561|NCT01325493|80871313|FG000|Overall Study|Protocol Violation|0|||
27738562|NCT01325493|80871314|FG001|Overall Study|Protocol Violation|1|||
27738563|NCT01325493|80871313|FG000|Overall Study|loss of neuromonitoring signals|0|||
27738564|NCT01325493|80871314|FG001|Overall Study|loss of neuromonitoring signals|2|||
27738565|NCT01325493|80871313|FG000|Overall Study|Allergy|1|||
27738566|NCT01325493|80871314|FG001|Overall Study|Allergy|0|||
27738567|NCT01457339|80871315|FG000|Period 3 (100 mg)|Adverse Event|0|||
27738568|NCT01457339|80871316|FG001|Period 3 (100 mg)|Adverse Event|1|||
27738569|NCT01457339|80871315|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
27738570|NCT01457339|80871316|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
27738571|NCT01457339|80871315|FG000|Period 6 (250 mg)|Family Emergency|1|||
27738572|NCT01457339|80871316|FG001|Period 6 (250 mg)|Family Emergency|0|||
27738573|NCT01457339|80871315|FG000|Period 6 (250 mg)|Personal appointment|0|||
27738574|NCT01457339|80871316|FG001|Period 6 (250 mg)|Personal appointment|1|||
27738575|NCT03019549|80873877|FG000|Washout|DId not meet genotype criteria|11|||
27738576|NCT03019549|80873877|FG000|Period 2|Adverse Event|2|||
27738577|NCT03019549|80873877|FG000|Period 2|Physician Decision|2|||
27535719|NCT02639546|80156758|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
27535720|NCT02639546|80156759|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
27535721|NCT02639546|80156760|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
27631577|NCT03939819|80490280|FG001|Overall Study|Death|0|||
27738578|NCT03019549|80873877|FG000|Period 2|Withdrawal by Subject|1|||
27535722|NCT02639546|80156761|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
27535723|NCT02639546|80156762|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
27535724|NCT02639546|80156755|FG000|Overall Study|Study Terminated By Sponsor|0|||
27535725|NCT02639546|80156756|FG001|Overall Study|Study Terminated By Sponsor|2|||
27535726|NCT02639546|80156757|FG002|Overall Study|Study Terminated By Sponsor|3|||
27738579|NCT02981472|80873885|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
27738580|NCT02981472|80873886|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
27738581|NCT02981472|80873885|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27738582|NCT02981472|80873886|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27535727|NCT02639546|80156758|FG003|Overall Study|Study Terminated By Sponsor|4|||
27631578|NCT01693614|80490281|FG000|Overall Study|Adverse Event|7|||
27915225|NCT02340000|81529192|FG001|Time Period 2|Withdrawal by Subject|7|||
27535728|NCT02639546|80156759|FG004|Overall Study|Study Terminated By Sponsor|4|||
27535729|NCT02639546|80156760|FG005|Overall Study|Study Terminated By Sponsor|3|||
27535730|NCT02639546|80156761|FG006|Overall Study|Study Terminated By Sponsor|3|||
27631579|NCT01693614|80490282|FG001|Overall Study|Adverse Event|11|||
27631580|NCT01693614|80490283|FG002|Overall Study|Adverse Event|5|||
27915226|NCT02340000|81529191|FG000|Time Period 2|Lost to Follow-up|10|||
27915227|NCT02340000|81529192|FG001|Time Period 2|Lost to Follow-up|8|||
27915228|NCT00072410|81529193|FG000|Overall Study|Progressive disease|0|||
27915229|NCT00072410|81529194|FG001|Overall Study|Progressive disease|3|||
27915230|NCT02230891|81529199|FG000|Baseline|Did not meet inclusion|0|||
27915231|NCT02230891|81529200|FG001|Baseline|Did not meet inclusion|1|||
27915232|NCT02230891|81529201|FG002|Baseline|Did not meet inclusion|1|||
27535731|NCT02639546|80156762|FG007|Overall Study|Study Terminated By Sponsor|9|||
27535732|NCT02639546|80156755|FG000|Overall Study|Withdrawal by Subject|2|||
27535733|NCT02639546|80156756|FG001|Overall Study|Withdrawal by Subject|2|||
27535734|NCT02639546|80156757|FG002|Overall Study|Withdrawal by Subject|1|||
27535735|NCT02639546|80156758|FG003|Overall Study|Withdrawal by Subject|0|||
27535736|NCT02639546|80156759|FG004|Overall Study|Withdrawal by Subject|0|||
27535737|NCT02639546|80156760|FG005|Overall Study|Withdrawal by Subject|1|||
27535738|NCT02639546|80156761|FG006|Overall Study|Withdrawal by Subject|2|||
27535739|NCT02639546|80156762|FG007|Overall Study|Withdrawal by Subject|1|||
27631581|NCT01693614|80490281|FG000|Overall Study|Disease progression|11|||
27631582|NCT01693614|80490282|FG001|Overall Study|Disease progression|8|||
27631583|NCT01693614|80490283|FG002|Overall Study|Disease progression|7|||
27631584|NCT01693614|80490281|FG000|Overall Study|Protocol Violation|5|||
27631585|NCT01693614|80490282|FG001|Overall Study|Protocol Violation|2|||
27631586|NCT01693614|80490283|FG002|Overall Study|Protocol Violation|1|||
27631587|NCT01693614|80490281|FG000|Overall Study|Death|1|||
27631588|NCT01693614|80490282|FG001|Overall Study|Death|0|||
27631589|NCT01693614|80490283|FG002|Overall Study|Death|0|||
27631590|NCT01693614|80490281|FG000|Overall Study|Physician Decision|1|||
27631591|NCT01693614|80490282|FG001|Overall Study|Physician Decision|1|||
27631592|NCT01693614|80490283|FG002|Overall Study|Physician Decision|4|||
27631593|NCT01693614|80490281|FG000|Overall Study|Withdrawal by subject/guardian|0|||
27631594|NCT01693614|80490282|FG001|Overall Study|Withdrawal by subject/guardian|0|||
27631595|NCT01693614|80490283|FG002|Overall Study|Withdrawal by subject/guardian|2|||
27631596|NCT01693614|80490281|FG000|Overall Study|Withdrawal by Subject|1|||
27631597|NCT01693614|80490282|FG001|Overall Study|Withdrawal by Subject|0|||
27631598|NCT01693614|80490283|FG002|Overall Study|Withdrawal by Subject|5|||
27631599|NCT02954848|80490290|FG000|Overall Study|Randomized but Not Treated|0|||
27631600|NCT02954848|80490291|FG001|Overall Study|Randomized but Not Treated|1|||
27631601|NCT02954848|80490290|FG000|Overall Study|Adverse Event|2|||
27631602|NCT02954848|80490291|FG001|Overall Study|Adverse Event|3|||
27631603|NCT02954848|80490290|FG000|Overall Study|Withdrawal by Participant|0|||
27631604|NCT02954848|80490291|FG001|Overall Study|Withdrawal by Participant|1|||
27631605|NCT03525119|80490292|FG000|Overall Study|Adverse Event|0|||
27631606|NCT03525119|80490293|FG001|Overall Study|Adverse Event|1|||
27631607|NCT03525119|80490294|FG002|Overall Study|Adverse Event|0|||
27631608|NCT03525119|80490292|FG000|Overall Study|Lost to Follow-up|32|||
27631609|NCT03525119|80490293|FG001|Overall Study|Lost to Follow-up|33|||
27631610|NCT03525119|80490294|FG002|Overall Study|Lost to Follow-up|37|||
27631611|NCT03525119|80490292|FG000|Overall Study|Withdrawal by Subject|5|||
27631612|NCT03525119|80490293|FG001|Overall Study|Withdrawal by Subject|4|||
27631613|NCT03525119|80490294|FG002|Overall Study|Withdrawal by Subject|2|||
27631614|NCT03525119|80490292|FG000|Overall Study|Reason not Specified|2|||
27631615|NCT03525119|80490293|FG001|Overall Study|Reason not Specified|1|||
27631616|NCT03525119|80490294|FG002|Overall Study|Reason not Specified|2|||
27631617|NCT03525119|80490292|FG000|Overall Study|Randomized but not Vaccinated|1|||
27631618|NCT03525119|80490293|FG001|Overall Study|Randomized but not Vaccinated|0|||
27631619|NCT03525119|80490294|FG002|Overall Study|Randomized but not Vaccinated|2|||
27631620|NCT05193318|80490296|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
27631621|NCT05193318|80490296|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
27631622|NCT00544440|80490298|FG000|Overall Study|Other|1|||
27915233|NCT02230891|81529199|FG000|2 Week|Withdrawal by Subject|2|||
27535740|NCT00304239|80156763|FG000|Overall Study|Protocol Deviations/Violations|15|||
27535741|NCT00304239|80156764|FG001|Overall Study|Protocol Deviations/Violations|0|||
27535742|NCT00304239|80156763|FG000|Overall Study|Adverse Event|2|||
27631623|NCT00544440|80490298|FG000|Overall Study|Adverse Event|1|||
27631624|NCT00544440|80490298|FG000|Overall Study|Withdrawal by Subject|2|||
27631625|NCT00544440|80490298|FG000|Overall Study|Subject Non-compliance|1|||
27535743|NCT00304239|80156764|FG001|Overall Study|Adverse Event|0|||
27535744|NCT03898960|80156765|FG000|Overall Study|Death|10|||
27535745|NCT00122109|80156766|FG000|Overall Study|Did not meet criteria|6|||
27535746|NCT00122109|80156767|FG001|Overall Study|Did not meet criteria|7|||
27535747|NCT00936611|80156768|FG000|Overall Study|Progressive Disease|3|||
27915234|NCT02230891|81529200|FG001|2 Week|Withdrawal by Subject|2|||
27915235|NCT02230891|81529201|FG002|2 Week|Withdrawal by Subject|0|||
27535748|NCT00936611|80156768|FG000|Overall Study|New Systemic Therapy|22|||
27535749|NCT00936611|80156768|FG000|Overall Study|Lost to Follow-up|1|||
27535750|NCT00936611|80156768|FG000|Overall Study|Withdrawal by Subject|2|||
27535751|NCT00936611|80156768|FG000|Overall Study|Still on Follow-up|1|||
27535752|NCT00936611|80156768|FG000|Overall Study|Still on Active Therapy|7|||
27535753|NCT00936611|80156768|FG000|Overall Study|Ineligible for Study Drug|3|||
27535754|NCT04810481|80156773|FG000|Overall Study|Disqualified data sets|10|||
27535755|NCT04810481|80156774|FG001|Overall Study|Disqualified data sets|28|||
27535756|NCT02155881|80156775|FG000|Overall Study|Withdrawal by Subject|0|||
27535757|NCT02155881|80156776|FG001|Overall Study|Withdrawal by Subject|2|||
27535758|NCT02155881|80156775|FG000|Overall Study|Inappropriately randomized|2|||
27535759|NCT02155881|80156776|FG001|Overall Study|Inappropriately randomized|2|||
27535760|NCT02282358|80156778|FG000|Overall Study|Nonevaluable|1|||
27535761|NCT00839852|80156779|FG000|Overall Study|Adverse Event|10|||
27535762|NCT00839852|80156779|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27535763|NCT00839852|80156779|FG000|Overall Study|Protocol Violation|9|||
27535764|NCT00839852|80156779|FG000|Overall Study|Withdrawal of Consent|16|||
27535765|NCT00839852|80156779|FG000|Overall Study|Lost to Follow-up|7|||
27535766|NCT00839852|80156779|FG000|Overall Study|Lack of Compliance While in Jail|1|||
27535767|NCT00839852|80156779|FG000|Overall Study|Pregnancy|1|||
27535768|NCT03417219|80156780|FG000|Overall Study|Lost to Follow-up|0|||
27535769|NCT03417219|80156781|FG001|Overall Study|Lost to Follow-up|3|||
27535770|NCT00932126|80156782|FG000|Overall Study|Adverse Event|0|||
27535771|NCT00932126|80156783|FG001|Overall Study|Adverse Event|0|||
27535772|NCT00932126|80156784|FG002|Overall Study|Adverse Event|0|||
27535773|NCT00932126|80156785|FG003|Overall Study|Adverse Event|0|||
27535774|NCT00932126|80156786|FG004|Overall Study|Adverse Event|0|||
27535775|NCT00932126|80156787|FG005|Overall Study|Adverse Event|0|||
27535776|NCT00932126|80156788|FG006|Overall Study|Adverse Event|1|||
27535777|NCT00932126|80156789|FG007|Overall Study|Adverse Event|2|||
27535778|NCT00932126|80156782|FG000|Overall Study|Protocol Violation|0|||
27535779|NCT00932126|80156783|FG001|Overall Study|Protocol Violation|0|||
27535780|NCT00932126|80156784|FG002|Overall Study|Protocol Violation|0|||
27535781|NCT00932126|80156785|FG003|Overall Study|Protocol Violation|0|||
27535782|NCT00932126|80156786|FG004|Overall Study|Protocol Violation|1|||
27915236|NCT02230891|81529199|FG000|2 Week|Consent withdrawn|1|||
27915237|NCT02230891|81529200|FG001|2 Week|Consent withdrawn|0|||
27915238|NCT02230891|81529201|FG002|2 Week|Consent withdrawn|0|||
27915239|NCT02230891|81529199|FG000|6 Month|Withdrawal by Subject|1|||
27915240|NCT02230891|81529200|FG001|6 Month|Withdrawal by Subject|1|||
27915241|NCT02230891|81529201|FG002|6 Month|Withdrawal by Subject|1|||
27915242|NCT02230891|81529199|FG000|6 Month|Physician Decision|0|||
27915243|NCT02230891|81529200|FG001|6 Month|Physician Decision|2|||
27915244|NCT02230891|81529201|FG002|6 Month|Physician Decision|0|||
27535783|NCT00932126|80156787|FG005|Overall Study|Protocol Violation|0|||
27535784|NCT00932126|80156788|FG006|Overall Study|Protocol Violation|0|||
27535785|NCT00932126|80156789|FG007|Overall Study|Protocol Violation|0|||
27535786|NCT00932126|80156782|FG000|Overall Study|Withdrawal by Subject|0|||
27915245|NCT02230891|81529199|FG000|12 Month|Death|1|||
27915246|NCT02230891|81529200|FG001|12 Month|Death|0|||
27915247|NCT02230891|81529201|FG002|12 Month|Death|0|||
27631626|NCT00544440|80490298|FG000|Overall Study|Progressive Disease|47|||
27631627|NCT00544440|80490298|FG000|Overall Study|Other|5|||
27535787|NCT00932126|80156783|FG001|Overall Study|Withdrawal by Subject|0|||
27535788|NCT00932126|80156784|FG002|Overall Study|Withdrawal by Subject|1|||
27535789|NCT00932126|80156785|FG003|Overall Study|Withdrawal by Subject|0|||
27535790|NCT00932126|80156786|FG004|Overall Study|Withdrawal by Subject|0|||
27535791|NCT00932126|80156787|FG005|Overall Study|Withdrawal by Subject|0|||
27535792|NCT00932126|80156788|FG006|Overall Study|Withdrawal by Subject|0|||
27535793|NCT00932126|80156789|FG007|Overall Study|Withdrawal by Subject|1|||
27535794|NCT00932126|80156782|FG000|Overall Study|Objective progression or relapse|3|||
27535795|NCT00932126|80156783|FG001|Overall Study|Objective progression or relapse|3|||
27535796|NCT00932126|80156784|FG002|Overall Study|Objective progression or relapse|2|||
27535797|NCT00932126|80156785|FG003|Overall Study|Objective progression or relapse|3|||
27535798|NCT00932126|80156786|FG004|Overall Study|Objective progression or relapse|3|||
27535799|NCT00932126|80156787|FG005|Overall Study|Objective progression or relapse|3|||
27535800|NCT00932126|80156788|FG006|Overall Study|Objective progression or relapse|3|||
27535801|NCT00932126|80156789|FG007|Overall Study|Objective progression or relapse|5|||
27535802|NCT00932126|80156782|FG000|Overall Study|Other|0|||
27535803|NCT00932126|80156783|FG001|Overall Study|Other|0|||
27535804|NCT00932126|80156784|FG002|Overall Study|Other|0|||
27535805|NCT00932126|80156785|FG003|Overall Study|Other|0|||
27535806|NCT00932126|80156786|FG004|Overall Study|Other|1|||
27535807|NCT00932126|80156787|FG005|Overall Study|Other|0|||
27535808|NCT00932126|80156788|FG006|Overall Study|Other|1|||
27535809|NCT00932126|80156789|FG007|Overall Study|Other|2|||
27535810|NCT00579098|80156793|FG000|Overall Study|Lost to Follow-up|2|||
27535811|NCT00579098|80156794|FG001|Overall Study|Lost to Follow-up|0|||
27535812|NCT00579098|80156793|FG000|Overall Study|Adverse Event|2|||
27535813|NCT00579098|80156794|FG001|Overall Study|Adverse Event|3|||
27535814|NCT00579098|80156793|FG000|Overall Study|Withdrawal by Subject|2|||
27535815|NCT00579098|80156794|FG001|Overall Study|Withdrawal by Subject|3|||
27535816|NCT00579098|80156793|FG000|Overall Study|AF returned after ablation|3|||
27535817|NCT00579098|80156794|FG001|Overall Study|AF returned after ablation|2|||
27535818|NCT01934972|80156799|FG000|Overall Study|Withdrawal by Subject|9|||
27535819|NCT01934972|80156800|FG001|Overall Study|Withdrawal by Subject|6|||
27535820|NCT02423109|80156802|FG000|Lens 1|Adverse Event|1|||
27535821|NCT02423109|80156803|FG001|Lens 1|Adverse Event|0|||
27535822|NCT01032174|80156804|FG000|Overall Study|Adverse Event|0|||
27535823|NCT01032174|80156805|FG001|Overall Study|Adverse Event|1|||
27535824|NCT03061097|80156806|FG000|Overall Study|Withdrawal by Subject|0|||
27535825|NCT03061097|80156807|FG001|Overall Study|Withdrawal by Subject|3|||
27535826|NCT03605212|80156808|FG000|Treatment Period|Adverse Event|1|||
27535827|NCT03605212|80156809|FG001|Treatment Period|Adverse Event|0|||
27535828|NCT03605212|80156810|FG002|Treatment Period|Adverse Event|0|||
27535829|NCT03605212|80156811|FG003|Treatment Period|Adverse Event|0|||
27535830|NCT03605212|80156812|FG004|Treatment Period|Adverse Event|0|||
27535831|NCT03605212|80156808|FG000|Treatment Period|Physician Decision|0|||
27535832|NCT03605212|80156809|FG001|Treatment Period|Physician Decision|0|||
27535833|NCT03605212|80156810|FG002|Treatment Period|Physician Decision|0|||
27535834|NCT03605212|80156811|FG003|Treatment Period|Physician Decision|0|||
27535835|NCT03605212|80156812|FG004|Treatment Period|Physician Decision|1|||
27535836|NCT04638660|80156813|FG000|Overall Study|Withdrawal by Subject|2|||
27535837|NCT04638660|80156814|FG001|Overall Study|Withdrawal by Subject|0|||
27535838|NCT04638660|80156813|FG000|Overall Study|Lost to Follow-up|1|||
27535839|NCT04638660|80156814|FG001|Overall Study|Lost to Follow-up|0|||
27535840|NCT02247531|80156819|FG000|Overall Study|Adverse Event|3|||
27535841|NCT02247531|80156820|FG001|Overall Study|Adverse Event|4|||
27535842|NCT02247531|80156821|FG002|Overall Study|Adverse Event|9|||
27535843|NCT02247531|80156819|FG000|Overall Study|Death|8|||
27535844|NCT02247531|80156820|FG001|Overall Study|Death|9|||
27535845|NCT02247531|80156821|FG002|Overall Study|Death|5|||
27631628|NCT00309452|80490299|FG000|Overall Study|Withdrawal by Subject|3|||
27535846|NCT02247531|80156819|FG000|Overall Study|Lost to Follow-up|1|||
27631629|NCT00309452|80490300|FG001|Overall Study|Withdrawal by Subject|0|||
27535847|NCT02247531|80156820|FG001|Overall Study|Lost to Follow-up|8|||
27535848|NCT02247531|80156821|FG002|Overall Study|Lost to Follow-up|3|||
27535849|NCT02247531|80156819|FG000|Overall Study|Non-compliance|2|||
27631630|NCT00762606|80490301|FG000|Overall Study|Lost to Follow-up|18|||
27631631|NCT00762606|80490302|FG001|Overall Study|Lost to Follow-up|13|||
27631632|NCT02517307|80490304|FG000|Overall Study|Withdrawal by Subject|1|||
27631633|NCT02517307|80490305|FG001|Overall Study|Withdrawal by Subject|0|||
27631634|NCT02517307|80490306|FG002|Overall Study|Withdrawal by Subject|1|||
27631635|NCT02517307|80490307|FG003|Overall Study|Withdrawal by Subject|0|||
27631636|NCT02517307|80490304|FG000|Overall Study|Protocol Violation|0|||
27631637|NCT02517307|80490305|FG001|Overall Study|Protocol Violation|0|||
27631638|NCT02517307|80490306|FG002|Overall Study|Protocol Violation|1|||
27631639|NCT02517307|80490307|FG003|Overall Study|Protocol Violation|1|||
27631640|NCT00003656|80490308|FG000|Overall Study|Adverse Event|0|||
27631641|NCT00003656|80490309|FG001|Overall Study|Adverse Event|1|||
27631642|NCT02026258|80493529|FG000|Randomized|Did not start treatment|2|||
27631643|NCT02026258|80493530|FG001|Randomized|Did not start treatment|1|||
27631644|NCT02026258|80493529|FG000|Randomized|Change in treatment plan|1|||
27631645|NCT02026258|80493530|FG001|Randomized|Change in treatment plan|0|||
27535850|NCT02247531|80156820|FG001|Overall Study|Non-compliance|2|||
27535851|NCT02247531|80156821|FG002|Overall Study|Non-compliance|0|||
27535852|NCT02247531|80156819|FG000|Overall Study|Withdrawal by Subject|26|||
27535853|NCT02247531|80156820|FG001|Overall Study|Withdrawal by Subject|31|||
27535854|NCT02247531|80156821|FG002|Overall Study|Withdrawal by Subject|25|||
27535855|NCT02247531|80156819|FG000|Overall Study|Study Terminated by Sponsor|64|||
27535856|NCT02247531|80156820|FG001|Overall Study|Study Terminated by Sponsor|66|||
27535857|NCT02247531|80156821|FG002|Overall Study|Study Terminated by Sponsor|62|||
27535858|NCT02247531|80156819|FG000|Overall Study|Physician Decision|0|||
27535859|NCT02247531|80156820|FG001|Overall Study|Physician Decision|2|||
27535860|NCT02247531|80156821|FG002|Overall Study|Physician Decision|2|||
27535861|NCT02247531|80156819|FG000|Overall Study|Unspecified Reason|2|||
27535862|NCT02247531|80156820|FG001|Overall Study|Unspecified Reason|3|||
27535863|NCT02247531|80156821|FG002|Overall Study|Unspecified Reason|4|||
27535864|NCT02846324|80156823|FG000|Overall Study|Other|1|||
27535865|NCT02846324|80156824|FG001|Overall Study|Other|0|||
27535866|NCT02846324|80156825|FG002|Overall Study|Other|0|||
27535867|NCT02846324|80156826|FG003|Overall Study|Other|0|||
27535868|NCT02846324|80156823|FG000|Overall Study|Withdrawal by Subject|1|||
27535869|NCT02846324|80156824|FG001|Overall Study|Withdrawal by Subject|0|||
27535870|NCT02846324|80156825|FG002|Overall Study|Withdrawal by Subject|4|||
27535871|NCT02846324|80156826|FG003|Overall Study|Withdrawal by Subject|0|||
27535872|NCT03308786|80156830|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
27535873|NCT00631696|80156831|FG000|Overall Study|Entered, not randomized to treatment|1|||
27535874|NCT00631696|80156832|FG001|Overall Study|Entered, not randomized to treatment|1|||
27535875|NCT00631696|80156831|FG000|Overall Study|Discontinued after database release date|1|||
27535876|NCT00631696|80156832|FG001|Overall Study|Discontinued after database release date|0|||
27535877|NCT00631696|80156831|FG000|Overall Study|Follow up after database release date|1|||
27535878|NCT00631696|80156832|FG001|Overall Study|Follow up after database release date|0|||
27535879|NCT00631696|80156831|FG000|Overall Study|Lost to Follow-up|7|||
27535880|NCT00631696|80156832|FG001|Overall Study|Lost to Follow-up|10|||
27535881|NCT00631696|80156831|FG000|Overall Study|Withdrawal by Subject|2|||
27535882|NCT00631696|80156832|FG001|Overall Study|Withdrawal by Subject|9|||
27535883|NCT00631696|80156831|FG000|Overall Study|Other|8|||
27535884|NCT00631696|80156832|FG001|Overall Study|Other|8|||
27535885|NCT00631696|80156831|FG000|Overall Study|Protocol Violation|9|||
27535886|NCT00631696|80156832|FG001|Overall Study|Protocol Violation|9|||
27535887|NCT00631696|80156831|FG000|Overall Study|Study terminated by sponsor|3|||
27535888|NCT00631696|80156832|FG001|Overall Study|Study terminated by sponsor|3|||
27535889|NCT00631696|80156831|FG000|Overall Study|Adverse Event|5|||
27535890|NCT00631696|80156832|FG001|Overall Study|Adverse Event|0|||
27535891|NCT01386008|80156833|FG000|Overall Study|exited w/o incident /study discontinued|17|||
27535892|NCT01386008|80156833|FG000|Overall Study|Adverse Event|3|||
27535893|NCT02128932|80156836|FG000|Overall Study|Withdrawal by Subject|11|||
27535894|NCT02128932|80156837|FG001|Overall Study|Withdrawal by Subject|7|||
27535895|NCT02128932|80156838|FG002|Overall Study|Withdrawal by Subject|8|||
27535896|NCT02128932|80156836|FG000|Overall Study|Death|2|||
27535897|NCT02128932|80156837|FG001|Overall Study|Death|0|||
27535898|NCT02128932|80156838|FG002|Overall Study|Death|2|||
27535899|NCT02128932|80156836|FG000|Overall Study|Lost to Follow-up|2|||
27535900|NCT02128932|80156837|FG001|Overall Study|Lost to Follow-up|1|||
27631646|NCT02026258|80493529|FG000|Randomized|Presence of periodontal disease|1|||
27631647|NCT02026258|80493530|FG001|Randomized|Presence of periodontal disease|1|||
27631648|NCT02026258|80493529|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
27535901|NCT02128932|80156838|FG002|Overall Study|Lost to Follow-up|1|||
27631649|NCT02026258|80493530|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
27631650|NCT02026258|80493529|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
27631651|NCT02026258|80493530|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
27631652|NCT01072357|80493533|FG000|Overall Study|Lost to Follow-up|0|||
27535902|NCT02128932|80156836|FG000|Overall Study|No reason for withdrawal|12|||
27535903|NCT02128932|80156837|FG001|Overall Study|No reason for withdrawal|11|||
27631653|NCT01072357|80493534|FG001|Overall Study|Lost to Follow-up|1|||
27631654|NCT02957539|80493535|FG000|Baseline to Week 16|Lost to Follow-up|8|||
27631655|NCT02957539|80493536|FG001|Baseline to Week 16|Lost to Follow-up|10|||
27915248|NCT02230891|81529199|FG000|12 Month|Lost to Follow-up|0|||
27915249|NCT02230891|81529200|FG001|12 Month|Lost to Follow-up|1|||
27915250|NCT02230891|81529201|FG002|12 Month|Lost to Follow-up|0|||
27915251|NCT02230891|81529199|FG000|12 Month|Withdrawal by Subject|0|||
27915252|NCT02230891|81529200|FG001|12 Month|Withdrawal by Subject|2|||
27915253|NCT02230891|81529201|FG002|12 Month|Withdrawal by Subject|0|||
27915254|NCT02230891|81529199|FG000|18 Month End of Study|Death|0|||
27915255|NCT02230891|81529200|FG001|18 Month End of Study|Death|0|||
27915256|NCT02230891|81529201|FG002|18 Month End of Study|Death|1|||
27915257|NCT02230891|81529199|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
27915258|NCT02230891|81529200|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
27915259|NCT02230891|81529201|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
27915260|NCT04155463|81529202|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
27915261|NCT04155463|81529203|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
27915262|NCT01222104|81529206|FG000|Overall Study|Lost to Follow-up|37|||
27915263|NCT01222104|81529206|FG000|Overall Study|Death|10|||
27915264|NCT03492437|81529207|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27535904|NCT02128932|80156838|FG002|Overall Study|No reason for withdrawal|7|||
27535905|NCT03633617|80156841|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
27535906|NCT03633617|80156842|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
27535907|NCT03633617|80156843|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535908|NCT03633617|80156844|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535909|NCT03633617|80156845|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535910|NCT03633617|80156846|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535911|NCT03633617|80156847|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535912|NCT03633617|80156848|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535913|NCT03633617|80156849|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535914|NCT03633617|80156850|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535915|NCT03633617|80156851|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
27535916|NCT03633617|80156841|FG000|Part A|Unconfirmed early termination visit|1|||
27535917|NCT03633617|80156842|FG001|Part A|Unconfirmed early termination visit|0|||
27535918|NCT03633617|80156843|FG002|Part A|Unconfirmed early termination visit|0|||
27535919|NCT03633617|80156844|FG003|Part A|Unconfirmed early termination visit|0|||
27535920|NCT03633617|80156845|FG004|Part A|Unconfirmed early termination visit|0|||
27535921|NCT03633617|80156846|FG005|Part A|Unconfirmed early termination visit|0|||
27535922|NCT03633617|80156847|FG006|Part A|Unconfirmed early termination visit|0|||
27535923|NCT03633617|80156848|FG007|Part A|Unconfirmed early termination visit|0|||
27535924|NCT03633617|80156849|FG008|Part A|Unconfirmed early termination visit|0|||
27535925|NCT03633617|80156850|FG009|Part A|Unconfirmed early termination visit|0|||
27535926|NCT03633617|80156851|FG010|Part A|Unconfirmed early termination visit|0|||
27535927|NCT03633617|80156841|FG000|Part A|Adverse Event|0|||
27535928|NCT03633617|80156842|FG001|Part A|Adverse Event|1|||
27535929|NCT03633617|80156843|FG002|Part A|Adverse Event|0|||
27535930|NCT03633617|80156844|FG003|Part A|Adverse Event|0|||
27535931|NCT03633617|80156845|FG004|Part A|Adverse Event|0|||
27535932|NCT03633617|80156846|FG005|Part A|Adverse Event|0|||
27535933|NCT03633617|80156847|FG006|Part A|Adverse Event|0|||
27535934|NCT03633617|80156848|FG007|Part A|Adverse Event|0|||
27535935|NCT03633617|80156849|FG008|Part A|Adverse Event|0|||
27535936|NCT03633617|80156850|FG009|Part A|Adverse Event|0|||
27535937|NCT03633617|80156851|FG010|Part A|Adverse Event|0|||
27535938|NCT03633617|80156841|FG000|Part A|Pregnancy|1|||
27535939|NCT03633617|80156842|FG001|Part A|Pregnancy|0|||
27535940|NCT03633617|80156843|FG002|Part A|Pregnancy|0|||
27535941|NCT03633617|80156844|FG003|Part A|Pregnancy|0|||
27535942|NCT03633617|80156845|FG004|Part A|Pregnancy|0|||
27535943|NCT03633617|80156846|FG005|Part A|Pregnancy|0|||
27535944|NCT03633617|80156847|FG006|Part A|Pregnancy|0|||
27535945|NCT03633617|80156848|FG007|Part A|Pregnancy|0|||
27535946|NCT03633617|80156849|FG008|Part A|Pregnancy|0|||
27535947|NCT03633617|80156850|FG009|Part A|Pregnancy|0|||
27535948|NCT03633617|80156851|FG010|Part A|Pregnancy|0|||
27535949|NCT03633617|80156841|FG000|Part A|Withdrawal by Subject|0|||
27535950|NCT03633617|80156842|FG001|Part A|Withdrawal by Subject|1|||
27535951|NCT03633617|80156843|FG002|Part A|Withdrawal by Subject|0|||
27535952|NCT03633617|80156844|FG003|Part A|Withdrawal by Subject|0|||
27535953|NCT03633617|80156845|FG004|Part A|Withdrawal by Subject|0|||
27535954|NCT03633617|80156846|FG005|Part A|Withdrawal by Subject|0|||
27535955|NCT03633617|80156847|FG006|Part A|Withdrawal by Subject|0|||
27535956|NCT03633617|80156848|FG007|Part A|Withdrawal by Subject|0|||
27535957|NCT03633617|80156849|FG008|Part A|Withdrawal by Subject|0|||
27535958|NCT03633617|80156850|FG009|Part A|Withdrawal by Subject|0|||
27915265|NCT03492437|81529208|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27535959|NCT03633617|80156851|FG010|Part A|Withdrawal by Subject|0|||
27535960|NCT03633617|80156841|FG000|Part B|Adverse Event|0|||
27535961|NCT03633617|80156842|FG001|Part B|Adverse Event|0|||
27535962|NCT03633617|80156843|FG002|Part B|Adverse Event|2|||
27915266|NCT00901342|81529209|FG000|Overall Study|Adverse Event|1|||
27915267|NCT00901342|81529209|FG000|Overall Study|Death|4|||
27915268|NCT00901342|81529209|FG000|Overall Study|Disease progression|1|||
27915269|NCT00901342|81529209|FG000|Overall Study|Withdrawal by Subject|9|||
27915270|NCT00823134|81529210|FG000|Overall Study|Invalid measurement|1|||
27915271|NCT02976519|81529213|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
27915272|NCT02976519|81529214|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
27915273|NCT02976519|81529215|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
27915274|NCT02976519|81529216|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
27915275|NCT02976519|81529217|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
27915276|NCT02976519|81529218|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
27915277|NCT02976519|81529219|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
27915278|NCT02976519|81529213|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
27915279|NCT02976519|81529214|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
27915280|NCT02976519|81529215|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
27915281|NCT02976519|81529216|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
27915282|NCT02976519|81529217|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
27915283|NCT02976519|81529218|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
27915284|NCT02976519|81529219|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
27915285|NCT02976519|81529213|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
27915286|NCT02976519|81529214|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
27535963|NCT03633617|80156844|FG003|Part B|Adverse Event|2|||
27631656|NCT02957539|80493537|FG002|Baseline to Week 16|Lost to Follow-up|16|||
27915287|NCT02976519|81529215|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
27915288|NCT02976519|81529216|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
27915289|NCT02976519|81529217|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
27915290|NCT02976519|81529218|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
27915291|NCT02976519|81529219|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
27915292|NCT02976519|81529213|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
27915293|NCT02976519|81529214|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
27915294|NCT02976519|81529215|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
27915295|NCT02976519|81529216|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
27915296|NCT02976519|81529217|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
27915297|NCT02976519|81529218|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
27915298|NCT02976519|81529219|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
27915299|NCT02976519|81529213|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
27915300|NCT02976519|81529214|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
27915301|NCT02976519|81529215|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
27915302|NCT02976519|81529216|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
27915303|NCT02976519|81529217|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
27915304|NCT02976519|81529218|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
27915305|NCT02976519|81529219|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
27915306|NCT03489343|81529220|FG000|Overall Study|Documented progressive disease|1|||
27915307|NCT03489343|81529221|FG001|Overall Study|Documented progressive disease|0|||
27915308|NCT03489343|81529222|FG002|Overall Study|Documented progressive disease|3|||
27915309|NCT03489343|81529223|FG003|Overall Study|Documented progressive disease|1|||
27915310|NCT03489343|81529224|FG004|Overall Study|Documented progressive disease|3|||
27915311|NCT03489343|81529225|FG005|Overall Study|Documented progressive disease|5|||
27915312|NCT03489343|81529226|FG006|Overall Study|Documented progressive disease|4|||
27915313|NCT03489343|81529220|FG000|Overall Study|Adverse Event|0|||
27915314|NCT03489343|81529221|FG001|Overall Study|Adverse Event|1|||
27915315|NCT03489343|81529222|FG002|Overall Study|Adverse Event|0|||
27915316|NCT03489343|81529223|FG003|Overall Study|Adverse Event|0|||
27915317|NCT03489343|81529224|FG004|Overall Study|Adverse Event|0|||
27915318|NCT03489343|81529225|FG005|Overall Study|Adverse Event|1|||
27915319|NCT03489343|81529226|FG006|Overall Study|Adverse Event|0|||
27915320|NCT03489343|81529220|FG000|Overall Study|Withdrawal by Subject|0|||
27915321|NCT03489343|81529221|FG001|Overall Study|Withdrawal by Subject|0|||
27915322|NCT03489343|81529222|FG002|Overall Study|Withdrawal by Subject|0|||
27915323|NCT03489343|81529223|FG003|Overall Study|Withdrawal by Subject|1|||
27915324|NCT03489343|81529224|FG004|Overall Study|Withdrawal by Subject|0|||
27915325|NCT03489343|81529225|FG005|Overall Study|Withdrawal by Subject|1|||
27915326|NCT03489343|81529226|FG006|Overall Study|Withdrawal by Subject|1|||
27915327|NCT03489343|81529220|FG000|Overall Study|Clinical progression|0|||
27915328|NCT03489343|81529221|FG001|Overall Study|Clinical progression|0|||
27915329|NCT03489343|81529222|FG002|Overall Study|Clinical progression|0|||
27915330|NCT03489343|81529223|FG003|Overall Study|Clinical progression|1|||
27915331|NCT03489343|81529224|FG004|Overall Study|Clinical progression|0|||
27915332|NCT03489343|81529225|FG005|Overall Study|Clinical progression|0|||
27915333|NCT03489343|81529226|FG006|Overall Study|Clinical progression|1|||
27915334|NCT02254772|81529227|FG000|Overall Study|Ineligible|1|||
27915335|NCT02254772|81529227|FG000|Overall Study|Withdrawal by Subject|1|||
27915336|NCT01348139|81529232|FG000|Period 1|Adverse Event|1|||
27915337|NCT01348139|81529233|FG001|Period 1|Adverse Event|0|||
27915338|NCT01348139|81529234|FG002|Period 1|Adverse Event|0|||
27915339|NCT01348139|81529235|FG003|Period 1|Adverse Event|0|||
27915340|NCT01348139|81529236|FG004|Period 1|Adverse Event|0|||
27915341|NCT01348139|81529237|FG005|Period 1|Adverse Event|0|||
27915342|NCT04069715|81529241|FG000|Overall Study|Lost to Follow-up|1|||
27915343|NCT04069715|81529242|FG001|Overall Study|Lost to Follow-up|1|||
27915344|NCT04069715|81529241|FG000|Overall Study|Physician Decision|1|||
27915345|NCT04069715|81529242|FG001|Overall Study|Physician Decision|1|||
27915346|NCT04069715|81529241|FG000|Overall Study|Withdrawal by Subject|3|||
27915347|NCT04069715|81529242|FG001|Overall Study|Withdrawal by Subject|3|||
27915348|NCT01095835|81529244|FG000|Overall Study|Adverse Event|8|||
27915349|NCT01095835|81529245|FG001|Overall Study|Adverse Event|6|||
27915350|NCT01095835|81529246|FG002|Overall Study|Adverse Event|6|||
27915351|NCT01095835|81529244|FG000|Overall Study|Lack of Efficacy|0|||
27915352|NCT01095835|81529245|FG001|Overall Study|Lack of Efficacy|1|||
27915353|NCT01095835|81529246|FG002|Overall Study|Lack of Efficacy|0|||
27915354|NCT01095835|81529244|FG000|Overall Study|Physician Decision|0|||
27915355|NCT01095835|81529245|FG001|Overall Study|Physician Decision|0|||
27915356|NCT01095835|81529246|FG002|Overall Study|Physician Decision|1|||
27535964|NCT03633617|80156845|FG004|Part B|Adverse Event|1|||
27915357|NCT01095835|81529244|FG000|Overall Study|Withdrawal by Subject|1|||
27915358|NCT01095835|81529245|FG001|Overall Study|Withdrawal by Subject|3|||
27915359|NCT01095835|81529246|FG002|Overall Study|Withdrawal by Subject|0|||
27915360|NCT01095835|81529244|FG000|Overall Study|Non study compliance|0|||
27738583|NCT02981472|80873885|FG000|Treatment Period|Adverse Event|6|||
27915361|NCT01095835|81529245|FG001|Overall Study|Non study compliance|0|||
27915362|NCT01095835|81529246|FG002|Overall Study|Non study compliance|1|||
27915363|NCT01095835|81529244|FG000|Overall Study|Protocol Violation|1|||
27915364|NCT01095835|81529245|FG001|Overall Study|Protocol Violation|2|||
27915365|NCT01095835|81529246|FG002|Overall Study|Protocol Violation|0|||
27915366|NCT01676701|81529247|FG000|Overall Study|Protocol Violation|1|||
27915367|NCT01676701|81529248|FG001|Overall Study|Protocol Violation|0|||
27915368|NCT01676701|81529247|FG000|Overall Study|Sponsor Decision|3|||
27915369|NCT01676701|81529248|FG001|Overall Study|Sponsor Decision|4|||
27915370|NCT02419807|81529249|FG000|Overall Study|Withdrawal by Subject|4|||
27915371|NCT02419807|81529249|FG000|Overall Study|Physician Decision|1|||
27915372|NCT02419807|81529249|FG000|Overall Study|Protocol Violation|5|||
27915373|NCT02486692|81529252|FG000|Overall Study|did not login for randomization|4|||
27915374|NCT02486692|81529253|FG001|Overall Study|did not login for randomization|7|||
27915375|NCT04771013|81529254|FG000|Overall Study|Withdrawal by Subject|2|||
27915376|NCT04771013|81529255|FG001|Overall Study|Withdrawal by Subject|0|||
27915377|NCT04771013|81529254|FG000|Overall Study|Death|0|||
27915378|NCT04771013|81529255|FG001|Overall Study|Death|5|||
27915379|NCT04771013|81529254|FG000|Overall Study|Referred to another hospital before day 20|0|||
27915380|NCT04771013|81529255|FG001|Overall Study|Referred to another hospital before day 20|1|||
27915381|NCT01048541|81529256|FG000|Overall Study|Withdrawal by Subject|1|||
27915382|NCT01048541|81529257|FG001|Overall Study|Withdrawal by Subject|0|||
27915383|NCT01026948|81529258|FG000|Overall Study|Physician Decision|8|||
27915384|NCT00249834|81529259|FG000|Overall Study|Ovarian stimulation failed|1|||
27915385|NCT00249834|81529260|FG001|Overall Study|Ovarian stimulation failed|0|||
27915386|NCT00249834|81529261|FG002|Overall Study|Ovarian stimulation failed|0|||
27915387|NCT00249834|81529262|FG003|Overall Study|Ovarian stimulation failed|0|||
27915388|NCT00249834|81529263|FG004|Overall Study|Ovarian stimulation failed|0|||
27915389|NCT00249834|81529264|FG005|Overall Study|Ovarian stimulation failed|0|||
27915390|NCT00249834|81529265|FG006|Overall Study|Ovarian stimulation failed|0|||
27915391|NCT00249834|81529266|FG007|Overall Study|Ovarian stimulation failed|0|||
27915392|NCT00249834|81529259|FG000|Overall Study|Failure of down-regulation|0|||
27915393|NCT00249834|81529260|FG001|Overall Study|Failure of down-regulation|0|||
27915394|NCT00249834|81529261|FG002|Overall Study|Failure of down-regulation|0|||
27915395|NCT00249834|81529262|FG003|Overall Study|Failure of down-regulation|0|||
27738584|NCT02981472|80873886|FG001|Treatment Period|Adverse Event|1|||
27738585|NCT02981472|80873885|FG000|Treatment Period|Participant withdrew consent|1|||
27738586|NCT02981472|80873886|FG001|Treatment Period|Participant withdrew consent|0|||
27915396|NCT00249834|81529263|FG004|Overall Study|Failure of down-regulation|0|||
27631657|NCT02957539|80493535|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
27631658|NCT02957539|80493536|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
27631659|NCT02957539|80493537|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
27631660|NCT02957539|80493535|FG000|Week 16 to 32|Withdrawal by Subject|3|||
27631661|NCT02957539|80493536|FG001|Week 16 to 32|Withdrawal by Subject|3|||
27631662|NCT02957539|80493537|FG002|Week 16 to 32|Withdrawal by Subject|1|||
27631663|NCT02957539|80493535|FG000|Week 16 to 32|Lost to Follow-up|8|||
27631664|NCT02957539|80493536|FG001|Week 16 to 32|Lost to Follow-up|7|||
27631665|NCT02957539|80493537|FG002|Week 16 to 32|Lost to Follow-up|5|||
27631666|NCT02957539|80493535|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
27631667|NCT02957539|80493536|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
27915397|NCT00249834|81529264|FG005|Overall Study|Failure of down-regulation|0|||
27915398|NCT00249834|81529265|FG006|Overall Study|Failure of down-regulation|1|||
27915399|NCT00249834|81529266|FG007|Overall Study|Failure of down-regulation|0|||
27915400|NCT00249834|81529259|FG000|Overall Study|Protocol Violation|0|||
27915401|NCT00249834|81529260|FG001|Overall Study|Protocol Violation|19|||
27915402|NCT00249834|81529261|FG002|Overall Study|Protocol Violation|14|||
27738587|NCT02981472|80873885|FG000|Treatment Period|Lost to Follow-up|0|||
27738588|NCT02981472|80873886|FG001|Treatment Period|Lost to Follow-up|1|||
27738589|NCT00638846|80873892|FG000|Overall Study|Adverse Event|0|||
27738590|NCT00638846|80873893|FG001|Overall Study|Adverse Event|1|||
27738591|NCT00638846|80873892|FG000|Overall Study|Lost to Follow-up|3|||
27738592|NCT00638846|80873893|FG001|Overall Study|Lost to Follow-up|2|||
27738593|NCT00638846|80873892|FG000|Overall Study|lens issue|1|||
27738594|NCT00638846|80873893|FG001|Overall Study|lens issue|3|||
27738595|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Adverse Event|12|||
27738596|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Adverse Event|3|||
27631668|NCT02957539|80493537|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
27631669|NCT02957539|80493535|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
27915403|NCT00249834|81529262|FG003|Overall Study|Protocol Violation|8|||
27915404|NCT00249834|81529263|FG004|Overall Study|Protocol Violation|5|||
27915405|NCT00249834|81529264|FG005|Overall Study|Protocol Violation|2|||
27631670|NCT02957539|80493536|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
27915406|NCT00249834|81529265|FG006|Overall Study|Protocol Violation|0|||
27915407|NCT00249834|81529266|FG007|Overall Study|Protocol Violation|0|||
27915408|NCT03101150|81529269|FG000|Overall Study|Lost to Follow-up|2|||
27631671|NCT02957539|80493537|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
27631672|NCT00732381|80493539|FG000|Overall Study|Adverse Event|1|||
27738597|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Adverse Event|4|||
27738598|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Adverse Event|2|||
27915409|NCT03101150|81529270|FG001|Overall Study|Lost to Follow-up|4|||
27738599|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
27915410|NCT03101150|81529269|FG000|Overall Study|Miscarriage|3|||
27535965|NCT03633617|80156846|FG005|Part B|Adverse Event|0|||
27535966|NCT03633617|80156847|FG006|Part B|Adverse Event|0|||
27535967|NCT03633617|80156848|FG007|Part B|Adverse Event|0|||
27535968|NCT03633617|80156849|FG008|Part B|Adverse Event|0|||
27915411|NCT03101150|81529270|FG001|Overall Study|Miscarriage|6|||
27915412|NCT01610037|81529273|FG000|All Patients|Adverse Event|27|||
27915413|NCT01610037|81529274|FG001|All Patients|Adverse Event|22|||
27915414|NCT01610037|81529275|FG002|All Patients|Adverse Event|26|||
27915415|NCT01610037|81529273|FG000|All Patients|Withdrawal by Subject|12|||
27915416|NCT01610037|81529274|FG001|All Patients|Withdrawal by Subject|10|||
27915417|NCT01610037|81529275|FG002|All Patients|Withdrawal by Subject|20|||
27915418|NCT01610037|81529273|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
27915419|NCT01610037|81529274|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
27915420|NCT01610037|81529275|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
27915421|NCT01610037|81529273|FG000|All Patients|Death|4|||
27915422|NCT01610037|81529274|FG001|All Patients|Death|2|||
27915423|NCT01610037|81529275|FG002|All Patients|Death|1|||
27915424|NCT01610037|81529273|FG000|All Patients|Protocol deviation|4|||
27915425|NCT01610037|81529274|FG001|All Patients|Protocol deviation|3|||
27915426|NCT01610037|81529275|FG002|All Patients|Protocol deviation|3|||
27915427|NCT01610037|81529273|FG000|All Patients|Abnormal laboratory value|1|||
27915428|NCT01610037|81529274|FG001|All Patients|Abnormal laboratory value|1|||
27915429|NCT01610037|81529275|FG002|All Patients|Abnormal laboratory value|0|||
27915430|NCT01610037|81529273|FG000|All Patients|Administrative problems|1|||
27915431|NCT01610037|81529274|FG001|All Patients|Administrative problems|4|||
27915432|NCT01610037|81529275|FG002|All Patients|Administrative problems|4|||
27915433|NCT01610037|81529273|FG000|All Patients|Lost to Follow-up|1|||
27915434|NCT01610037|81529274|FG001|All Patients|Lost to Follow-up|0|||
27915435|NCT01610037|81529275|FG002|All Patients|Lost to Follow-up|0|||
27915436|NCT01610037|81529273|FG000|All Patients|Abnormal test procedure result(s)|0|||
27915437|NCT01610037|81529274|FG001|All Patients|Abnormal test procedure result(s)|1|||
27915438|NCT01610037|81529275|FG002|All Patients|Abnormal test procedure result(s)|3|||
27535969|NCT03633617|80156850|FG009|Part B|Adverse Event|0|||
27535970|NCT03633617|80156851|FG010|Part B|Adverse Event|0|||
27535971|NCT03633617|80156841|FG000|Part B|Withdrawal by Subject|0|||
27535972|NCT03633617|80156842|FG001|Part B|Withdrawal by Subject|0|||
27535973|NCT03633617|80156843|FG002|Part B|Withdrawal by Subject|1|||
27535974|NCT03633617|80156844|FG003|Part B|Withdrawal by Subject|0|||
27535975|NCT03633617|80156845|FG004|Part B|Withdrawal by Subject|2|||
27535976|NCT03633617|80156846|FG005|Part B|Withdrawal by Subject|0|||
27535977|NCT03633617|80156847|FG006|Part B|Withdrawal by Subject|0|||
27535978|NCT03633617|80156848|FG007|Part B|Withdrawal by Subject|0|||
27535979|NCT03633617|80156849|FG008|Part B|Withdrawal by Subject|0|||
27535980|NCT03633617|80156850|FG009|Part B|Withdrawal by Subject|0|||
27535981|NCT03633617|80156851|FG010|Part B|Withdrawal by Subject|0|||
27535982|NCT03633617|80156841|FG000|Part B|Lost to Follow-up|0|||
27535983|NCT03633617|80156842|FG001|Part B|Lost to Follow-up|0|||
27535984|NCT03633617|80156843|FG002|Part B|Lost to Follow-up|0|||
27535985|NCT03633617|80156844|FG003|Part B|Lost to Follow-up|0|||
27535986|NCT03633617|80156845|FG004|Part B|Lost to Follow-up|1|||
27915439|NCT01610037|81529273|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
27535987|NCT03633617|80156846|FG005|Part B|Lost to Follow-up|0|||
27535988|NCT03633617|80156847|FG006|Part B|Lost to Follow-up|0|||
27535989|NCT03633617|80156848|FG007|Part B|Lost to Follow-up|0|||
27631673|NCT00732381|80493540|FG001|Overall Study|Adverse Event|0|||
27915440|NCT01610037|81529274|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
27535990|NCT03633617|80156849|FG008|Part B|Lost to Follow-up|0|||
27535991|NCT03633617|80156850|FG009|Part B|Lost to Follow-up|0|||
27915441|NCT01610037|81529275|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
27915442|NCT01610037|81529273|FG000|Treatment and Follow up Period|Death|10|||
27915443|NCT01610037|81529274|FG001|Treatment and Follow up Period|Death|5|||
27915444|NCT01610037|81529275|FG002|Treatment and Follow up Period|Death|4|||
27535992|NCT03633617|80156851|FG010|Part B|Lost to Follow-up|0|||
27535993|NCT03633617|80156841|FG000|Part B|Physician Decision|0|||
27535994|NCT03633617|80156842|FG001|Part B|Physician Decision|0|||
27631674|NCT00732381|80493539|FG000|Overall Study|Treatment Failure|1|||
27631675|NCT00732381|80493540|FG001|Overall Study|Treatment Failure|1|||
27631676|NCT03394027|80493543|FG000|Overall Study|Ineligible|3|||
27631677|NCT03394027|80493544|FG001|Overall Study|Ineligible|1|||
27915445|NCT01610037|81529273|FG000|Treatment and Follow up Period|Administrative problems|1|||
27915446|NCT01610037|81529274|FG001|Treatment and Follow up Period|Administrative problems|3|||
27915447|NCT01610037|81529275|FG002|Treatment and Follow up Period|Administrative problems|2|||
27915448|NCT01610037|81529273|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
27915449|NCT01610037|81529274|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
27535995|NCT03633617|80156843|FG002|Part B|Physician Decision|0|||
27535996|NCT03633617|80156844|FG003|Part B|Physician Decision|0|||
27535997|NCT03633617|80156845|FG004|Part B|Physician Decision|1|||
27535998|NCT03633617|80156846|FG005|Part B|Physician Decision|0|||
27535999|NCT03633617|80156847|FG006|Part B|Physician Decision|0|||
27536000|NCT03633617|80156848|FG007|Part B|Physician Decision|0|||
27536001|NCT03633617|80156849|FG008|Part B|Physician Decision|0|||
27536002|NCT03633617|80156850|FG009|Part B|Physician Decision|0|||
27915450|NCT01610037|81529275|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
27915451|NCT02185417|81529276|FG000|Overall Study|Death|448|||
27915452|NCT02185417|81529277|FG001|Overall Study|Death|446|||
27915453|NCT02185417|81529278|FG002|Overall Study|Death|0|||
27915454|NCT02185417|81529276|FG000|Overall Study|Withdrawal by Subject|7|||
27915455|NCT02185417|81529277|FG001|Overall Study|Withdrawal by Subject|12|||
27915456|NCT02185417|81529278|FG002|Overall Study|Withdrawal by Subject|0|||
27915457|NCT01239394|81529279|FG000|Overall Study|Adverse Event|1|||
27915458|NCT02144701|81529280|FG000|Overall Study|development of relapse, GVHD or death|9|||
27915459|NCT02144701|81529281|FG001|Overall Study|development of relapse, GVHD or death|3|||
27915460|NCT01765296|81529287|FG000|Overall Study|Protocol Violation|0|||
27915461|NCT01765296|81529288|FG001|Overall Study|Protocol Violation|5|||
27915462|NCT01765296|81529289|FG002|Overall Study|Protocol Violation|4|||
27915463|NCT01765296|81529287|FG000|Overall Study|Withdrawal by Subject|4|||
27915464|NCT01765296|81529288|FG001|Overall Study|Withdrawal by Subject|2|||
27915465|NCT01765296|81529289|FG002|Overall Study|Withdrawal by Subject|2|||
27915466|NCT01765296|81529287|FG000|Overall Study|Adverse Event|1|||
27915467|NCT01765296|81529288|FG001|Overall Study|Adverse Event|13|||
27915468|NCT01765296|81529289|FG002|Overall Study|Adverse Event|5|||
27915469|NCT01765296|81529287|FG000|Overall Study|Lack of Efficacy|0|||
27915470|NCT01765296|81529288|FG001|Overall Study|Lack of Efficacy|0|||
27915471|NCT01765296|81529289|FG002|Overall Study|Lack of Efficacy|2|||
27915472|NCT00808067|81529290|FG000|Overall Study|Major/minor bleed|30|||
27915473|NCT00808067|81529291|FG001|Overall Study|Major/minor bleed|44|||
27915474|NCT00808067|81529290|FG000|Overall Study|Outcome event - other|33|||
27536003|NCT03633617|80156851|FG010|Part B|Physician Decision|0|||
27536004|NCT03633617|80156841|FG000|Part B|COVID-19 Restrictions|0|||
27536005|NCT03633617|80156842|FG001|Part B|COVID-19 Restrictions|0|||
27536006|NCT03633617|80156843|FG002|Part B|COVID-19 Restrictions|1|||
27536007|NCT03633617|80156844|FG003|Part B|COVID-19 Restrictions|0|||
27536008|NCT03633617|80156845|FG004|Part B|COVID-19 Restrictions|0|||
27536009|NCT03633617|80156846|FG005|Part B|COVID-19 Restrictions|0|||
27536010|NCT03633617|80156847|FG006|Part B|COVID-19 Restrictions|0|||
27536011|NCT03633617|80156848|FG007|Part B|COVID-19 Restrictions|0|||
27536012|NCT03633617|80156849|FG008|Part B|COVID-19 Restrictions|0|||
27631678|NCT03394027|80493545|FG002|Overall Study|Ineligible|3|||
27631679|NCT03394027|80493543|FG000|Overall Study|Participant declined to participate before treatment started|0|||
27631680|NCT03394027|80493544|FG001|Overall Study|Participant declined to participate before treatment started|0|||
27631681|NCT03394027|80493545|FG002|Overall Study|Participant declined to participate before treatment started|1|||
27631682|NCT03008915|80493546|FG000|Treatment 1|Withdrawal by Subject|0|||
27631683|NCT03008915|80493547|FG001|Treatment 1|Withdrawal by Subject|1|||
27631684|NCT00686517|80493548|FG000|Treatment|Serious Adverse Event|1|||
27631685|NCT00686517|80493549|FG001|Treatment|Serious Adverse Event|2|||
27631686|NCT00686517|80493550|FG002|Treatment|Serious Adverse Event|1|||
27631687|NCT00686517|80493548|FG000|Treatment|Adverse Event|2|||
27631688|NCT00686517|80493549|FG001|Treatment|Adverse Event|0|||
27915475|NCT00808067|81529291|FG001|Overall Study|Outcome event - other|25|||
27536013|NCT03633617|80156850|FG009|Part B|COVID-19 Restrictions|0|||
27536014|NCT03633617|80156851|FG010|Part B|COVID-19 Restrictions|0|||
27536015|NCT03633617|80156841|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27631689|NCT00686517|80493550|FG002|Treatment|Adverse Event|0|||
27631690|NCT00686517|80493548|FG000|Treatment|Poor Protocol Compliance|1|||
27915476|NCT00808067|81529290|FG000|Overall Study|Adverse Event|111|||
27915477|NCT00808067|81529291|FG001|Overall Study|Adverse Event|121|||
27915478|NCT00808067|81529290|FG000|Overall Study|Hospitalization (not including surgery)|18|||
27915479|NCT00808067|81529291|FG001|Overall Study|Hospitalization (not including surgery)|17|||
27915480|NCT00808067|81529290|FG000|Overall Study|Hospitalization due to surgery|37|||
27915481|NCT00808067|81529291|FG001|Overall Study|Hospitalization due to surgery|40|||
27915482|NCT00808067|81529290|FG000|Overall Study|Reduced creatinine clearance|53|||
27536016|NCT03633617|80156842|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27631691|NCT00686517|80493549|FG001|Treatment|Poor Protocol Compliance|0|||
27631692|NCT00686517|80493550|FG002|Treatment|Poor Protocol Compliance|0|||
27631693|NCT00686517|80493548|FG000|Treatment|Protocol Violation|2|||
27631694|NCT00686517|80493549|FG001|Treatment|Protocol Violation|1|||
27631695|NCT00686517|80493550|FG002|Treatment|Protocol Violation|0|||
27631696|NCT02106442|80493551|FG000|Overall Study|Case Report Forms Uncollected|7|||
27631697|NCT02106442|80493551|FG000|Overall Study|Protocol Deviation|30|||
27631698|NCT00217672|80493552|FG000|Allocation|Ineligible|2|||
27631699|NCT00217672|80493553|FG001|Allocation|Ineligible|0|||
27631700|NCT00217672|80493552|FG000|Treatment|disease progression|33|||
27631701|NCT00217672|80493553|FG001|Treatment|disease progression|4|||
27631702|NCT00217672|80493552|FG000|Treatment|Adverse Event|18|||
27631703|NCT00217672|80493553|FG001|Treatment|Adverse Event|2|||
27915483|NCT00808067|81529291|FG001|Overall Study|Reduced creatinine clearance|55|||
27915484|NCT00808067|81529290|FG000|Overall Study|Elevated LFT results|7|||
27915485|NCT00808067|81529291|FG001|Overall Study|Elevated LFT results|3|||
27536017|NCT03633617|80156843|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
27536018|NCT03633617|80156844|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536019|NCT03633617|80156845|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536020|NCT03633617|80156846|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536021|NCT03633617|80156847|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536022|NCT03633617|80156848|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27631704|NCT00217672|80493552|FG000|Treatment|reqd treatment not permitted by protocol|6|||
27915486|NCT00808067|81529290|FG000|Overall Study|Patient refused to take study medication|65|||
27915487|NCT00808067|81529291|FG001|Overall Study|Patient refused to take study medication|76|||
27915488|NCT00808067|81529290|FG000|Overall Study|Missing|1|||
27915489|NCT00808067|81529291|FG001|Overall Study|Missing|0|||
27915490|NCT00808067|81529290|FG000|Overall Study|Death|1|||
27915491|NCT00808067|81529291|FG001|Overall Study|Death|1|||
27915492|NCT00808067|81529290|FG000|Overall Study|Procedure|6|||
27915493|NCT00808067|81529291|FG001|Overall Study|Procedure|7|||
27915494|NCT00808067|81529290|FG000|Overall Study|Withdrawal by Subject|21|||
27915495|NCT00808067|81529291|FG001|Overall Study|Withdrawal by Subject|25|||
27915496|NCT00808067|81529290|FG000|Overall Study|Site closed|4|||
27915497|NCT00808067|81529291|FG001|Overall Study|Site closed|3|||
27915498|NCT00808067|81529290|FG000|Overall Study|Physician Decision|47|||
27915499|NCT00808067|81529291|FG001|Overall Study|Physician Decision|38|||
27915500|NCT00808067|81529290|FG000|Overall Study|Protocol Violation|3|||
27915501|NCT00808067|81529291|FG001|Overall Study|Protocol Violation|11|||
27915502|NCT00808067|81529290|FG000|Overall Study|Patient elected|7|||
27915503|NCT00808067|81529291|FG001|Overall Study|Patient elected|9|||
27915504|NCT00808067|81529290|FG000|Overall Study|Site closed for cause|19|||
27915505|NCT00808067|81529291|FG001|Overall Study|Site closed for cause|19|||
27915506|NCT00808067|81529290|FG000|Overall Study|Other reason not defined above|5|||
27915507|NCT00808067|81529291|FG001|Overall Study|Other reason not defined above|5|||
27915508|NCT00808067|81529290|FG000|Overall Study|Excluded from analysis|13|||
27915509|NCT00808067|81529291|FG001|Overall Study|Excluded from analysis|19|||
27915510|NCT03016169|81529292|FG000|Overall Study|Lost to Follow-up|4|||
27915511|NCT03016169|81529292|FG000|Overall Study|Death|54|||
27915512|NCT03016169|81529292|FG000|Overall Study|Device Explant|11|||
27915513|NCT03016169|81529292|FG000|Overall Study|Withdrawal by Subject|19|||
27915514|NCT03016169|81529292|FG000|Overall Study|Other Reasons|1|||
27915515|NCT01656395|81529296|FG000|Overall Study|Adverse Event|1|||
27915516|NCT01656395|81529297|FG001|Overall Study|Adverse Event|14|||
27915517|NCT01656395|81529298|FG002|Overall Study|Adverse Event|5|||
27915518|NCT01656395|81529299|FG003|Overall Study|Adverse Event|4|||
27915519|NCT01656395|81529300|FG004|Overall Study|Adverse Event|5|||
27915520|NCT01656395|81529301|FG005|Overall Study|Adverse Event|7|||
27915521|NCT01656395|81529302|FG006|Overall Study|Adverse Event|0|||
27915522|NCT01656395|81529303|FG007|Overall Study|Adverse Event|0|||
27915523|NCT01656395|81529296|FG000|Overall Study|Lack of Efficacy|1|||
27631705|NCT00217672|80493553|FG001|Treatment|reqd treatment not permitted by protocol|0|||
27631706|NCT00217672|80493552|FG000|Treatment|Physician Decision|6|||
27631707|NCT00217672|80493553|FG001|Treatment|Physician Decision|0|||
27631708|NCT00217672|80493552|FG000|Treatment|insurance issues|1|||
27631709|NCT00217672|80493553|FG001|Treatment|insurance issues|1|||
27915524|NCT01656395|81529297|FG001|Overall Study|Lack of Efficacy|8|||
27915525|NCT01656395|81529298|FG002|Overall Study|Lack of Efficacy|6|||
27915526|NCT01656395|81529299|FG003|Overall Study|Lack of Efficacy|1|||
27915527|NCT01656395|81529300|FG004|Overall Study|Lack of Efficacy|1|||
27915528|NCT01656395|81529301|FG005|Overall Study|Lack of Efficacy|6|||
27915529|NCT01656395|81529302|FG006|Overall Study|Lack of Efficacy|0|||
27915530|NCT01656395|81529303|FG007|Overall Study|Lack of Efficacy|0|||
27915531|NCT01656395|81529296|FG000|Overall Study|Lost to Follow-up|1|||
27915532|NCT01656395|81529297|FG001|Overall Study|Lost to Follow-up|0|||
27915533|NCT01656395|81529298|FG002|Overall Study|Lost to Follow-up|0|||
27536023|NCT03633617|80156849|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536024|NCT03633617|80156850|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536025|NCT03633617|80156851|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
27536026|NCT03633617|80156841|FG000|Part C (& Follow-up)|Adverse Event|0|||
27536027|NCT03633617|80156842|FG001|Part C (& Follow-up)|Adverse Event|0|||
27536028|NCT03633617|80156843|FG002|Part C (& Follow-up)|Adverse Event|0|||
27536029|NCT03633617|80156844|FG003|Part C (& Follow-up)|Adverse Event|0|||
27536030|NCT03633617|80156845|FG004|Part C (& Follow-up)|Adverse Event|0|||
27536031|NCT03633617|80156846|FG005|Part C (& Follow-up)|Adverse Event|1|||
27536032|NCT03633617|80156847|FG006|Part C (& Follow-up)|Adverse Event|0|||
27536033|NCT03633617|80156848|FG007|Part C (& Follow-up)|Adverse Event|1|||
27536034|NCT03633617|80156849|FG008|Part C (& Follow-up)|Adverse Event|0|||
27536035|NCT03633617|80156850|FG009|Part C (& Follow-up)|Adverse Event|0|||
27536036|NCT03633617|80156851|FG010|Part C (& Follow-up)|Adverse Event|0|||
27536037|NCT03633617|80156841|FG000|Part C (& Follow-up)|Pregnancy|0|||
27536038|NCT03633617|80156842|FG001|Part C (& Follow-up)|Pregnancy|0|||
27536039|NCT03633617|80156843|FG002|Part C (& Follow-up)|Pregnancy|0|||
27536040|NCT03633617|80156844|FG003|Part C (& Follow-up)|Pregnancy|0|||
27915534|NCT01656395|81529299|FG003|Overall Study|Lost to Follow-up|0|||
27915535|NCT01656395|81529300|FG004|Overall Study|Lost to Follow-up|0|||
27536041|NCT03633617|80156845|FG004|Part C (& Follow-up)|Pregnancy|0|||
27536042|NCT03633617|80156846|FG005|Part C (& Follow-up)|Pregnancy|0|||
27915536|NCT01656395|81529301|FG005|Overall Study|Lost to Follow-up|0|||
27536043|NCT03633617|80156847|FG006|Part C (& Follow-up)|Pregnancy|0|||
27536044|NCT03633617|80156848|FG007|Part C (& Follow-up)|Pregnancy|0|||
27631710|NCT00217672|80493552|FG000|Treatment|Death|2|||
27631711|NCT00217672|80493553|FG001|Treatment|Death|0|||
27631712|NCT00217672|80493552|FG000|Treatment|secondary malignancy|1|||
27631713|NCT00217672|80493553|FG001|Treatment|secondary malignancy|0|||
27631714|NCT00217672|80493552|FG000|Follow-up|Withdrawal by Subject|4|||
27631715|NCT00217672|80493553|FG001|Follow-up|Withdrawal by Subject|0|||
27631716|NCT00217672|80493552|FG000|Follow-up|Lost to Follow-up|1|||
27631717|NCT00217672|80493553|FG001|Follow-up|Lost to Follow-up|0|||
27631718|NCT01897233|80493559|FG000|Part B (24 Weeks)|Adverse Event|1|||
27631719|NCT01897233|80493559|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
27631720|NCT01897233|80493559|FG000|Part B (24 Weeks)|Physician Decision|1|||
27631721|NCT02614560|80493560|FG000|Overall Study|Death|6|||
27631722|NCT02614560|80493561|FG001|Overall Study|Death|2|||
27631723|NCT00798096|80493564|FG000|Overall Study|Ongoing|2|||
27631724|NCT02232178|80493565|FG000|Overall Study|Lost to Follow-up|0|||
27631725|NCT02232178|80493566|FG001|Overall Study|Lost to Follow-up|1|||
27631726|NCT02232178|80493567|FG002|Overall Study|Lost to Follow-up|0|||
27631727|NCT02232178|80493565|FG000|Overall Study|ineligibility|0|||
27631728|NCT02232178|80493566|FG001|Overall Study|ineligibility|0|||
27631729|NCT02232178|80493567|FG002|Overall Study|ineligibility|1|||
27631730|NCT02232178|80493565|FG000|Overall Study|surgical complication|1|||
27631731|NCT02232178|80493566|FG001|Overall Study|surgical complication|0|||
27631732|NCT02232178|80493567|FG002|Overall Study|surgical complication|0|||
27631733|NCT01713530|80493571|FG000|Overall Study|Adverse Event|0|||
27536045|NCT03633617|80156849|FG008|Part C (& Follow-up)|Pregnancy|0|||
27915537|NCT01656395|81529302|FG006|Overall Study|Lost to Follow-up|0|||
27915538|NCT01656395|81529303|FG007|Overall Study|Lost to Follow-up|0|||
27915539|NCT01656395|81529296|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27915540|NCT01656395|81529297|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27915541|NCT01656395|81529298|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27915542|NCT01656395|81529299|FG003|Overall Study|Non-Compliance with Study Drug|0|||
27915543|NCT01656395|81529300|FG004|Overall Study|Non-Compliance with Study Drug|1|||
27915544|NCT01656395|81529301|FG005|Overall Study|Non-Compliance with Study Drug|1|||
27915545|NCT01656395|81529302|FG006|Overall Study|Non-Compliance with Study Drug|0|||
27915546|NCT01656395|81529303|FG007|Overall Study|Non-Compliance with Study Drug|0|||
27915547|NCT01656395|81529296|FG000|Overall Study|Other|0|||
27915548|NCT01656395|81529297|FG001|Overall Study|Other|0|||
27915549|NCT01656395|81529298|FG002|Overall Study|Other|1|||
27915550|NCT01656395|81529299|FG003|Overall Study|Other|0|||
27915551|NCT01656395|81529300|FG004|Overall Study|Other|0|||
27536046|NCT03633617|80156850|FG009|Part C (& Follow-up)|Pregnancy|1|||
27536047|NCT03633617|80156851|FG010|Part C (& Follow-up)|Pregnancy|0|||
27631734|NCT01713530|80493572|FG001|Overall Study|Adverse Event|5|||
27915552|NCT01656395|81529301|FG005|Overall Study|Other|1|||
27631735|NCT01713530|80493571|FG000|Overall Study|Withdrawal criteria|21|||
27915553|NCT01656395|81529302|FG006|Overall Study|Other|0|||
27536048|NCT03633617|80156841|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
27631736|NCT01713530|80493572|FG001|Overall Study|Withdrawal criteria|12|||
27631737|NCT01713530|80493571|FG000|Overall Study|Unclassified|4|||
27631738|NCT01713530|80493572|FG001|Overall Study|Unclassified|2|||
27631739|NCT00854906|80493573|FG000|Overall Study|One person had no ocular history|1|||
27631740|NCT00189202|80493577|FG000|Overall Study|Physician Decision|5|||
27915554|NCT01656395|81529303|FG007|Overall Study|Other|0|||
27536049|NCT03633617|80156842|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
27536050|NCT03633617|80156843|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
27536051|NCT03633617|80156844|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
27536052|NCT03633617|80156845|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
27536053|NCT03633617|80156846|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
27536054|NCT03633617|80156847|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
27536055|NCT03633617|80156848|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
27536056|NCT03633617|80156849|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
27536057|NCT03633617|80156850|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
27536058|NCT03633617|80156851|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
27536059|NCT03633617|80156841|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
27536060|NCT03633617|80156842|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
27536061|NCT03633617|80156843|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
27536062|NCT03633617|80156844|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
27536063|NCT03633617|80156845|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
27536064|NCT03633617|80156846|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
27536065|NCT03633617|80156847|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
27536066|NCT03633617|80156848|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
27536067|NCT03633617|80156849|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
27536068|NCT03633617|80156850|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
27536069|NCT03633617|80156851|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
27536070|NCT03633617|80156841|FG000|Part C (& Follow-up)|Physician Decision|0|||
27536071|NCT03633617|80156842|FG001|Part C (& Follow-up)|Physician Decision|0|||
27536072|NCT03633617|80156843|FG002|Part C (& Follow-up)|Physician Decision|0|||
27536073|NCT03633617|80156844|FG003|Part C (& Follow-up)|Physician Decision|0|||
27536074|NCT03633617|80156845|FG004|Part C (& Follow-up)|Physician Decision|0|||
27536075|NCT03633617|80156846|FG005|Part C (& Follow-up)|Physician Decision|0|||
27536076|NCT03633617|80156847|FG006|Part C (& Follow-up)|Physician Decision|0|||
27536077|NCT03633617|80156848|FG007|Part C (& Follow-up)|Physician Decision|1|||
27536078|NCT03633617|80156849|FG008|Part C (& Follow-up)|Physician Decision|0|||
27536079|NCT03633617|80156850|FG009|Part C (& Follow-up)|Physician Decision|0|||
27536080|NCT03633617|80156851|FG010|Part C (& Follow-up)|Physician Decision|1|||
27536081|NCT03633617|80156841|FG000|Part C (& Follow-up)|COVID-19 related|0|||
27536082|NCT03633617|80156842|FG001|Part C (& Follow-up)|COVID-19 related|0|||
27536083|NCT03633617|80156843|FG002|Part C (& Follow-up)|COVID-19 related|0|||
27536084|NCT03633617|80156844|FG003|Part C (& Follow-up)|COVID-19 related|0|||
27536085|NCT03633617|80156845|FG004|Part C (& Follow-up)|COVID-19 related|0|||
27536086|NCT03633617|80156846|FG005|Part C (& Follow-up)|COVID-19 related|1|||
27536087|NCT03633617|80156847|FG006|Part C (& Follow-up)|COVID-19 related|0|||
27536088|NCT03633617|80156848|FG007|Part C (& Follow-up)|COVID-19 related|0|||
27536089|NCT03633617|80156849|FG008|Part C (& Follow-up)|COVID-19 related|0|||
27536090|NCT03633617|80156850|FG009|Part C (& Follow-up)|COVID-19 related|0|||
27536091|NCT03633617|80156851|FG010|Part C (& Follow-up)|COVID-19 related|0|||
27536092|NCT03633617|80156841|FG000|Part C (& Follow-up)|Protocol Violation|0|||
27536093|NCT03633617|80156842|FG001|Part C (& Follow-up)|Protocol Violation|0|||
27536094|NCT03633617|80156843|FG002|Part C (& Follow-up)|Protocol Violation|0|||
27536095|NCT03633617|80156844|FG003|Part C (& Follow-up)|Protocol Violation|0|||
27536096|NCT03633617|80156845|FG004|Part C (& Follow-up)|Protocol Violation|0|||
27536097|NCT03633617|80156846|FG005|Part C (& Follow-up)|Protocol Violation|0|||
27536098|NCT03633617|80156847|FG006|Part C (& Follow-up)|Protocol Violation|0|||
27536099|NCT03633617|80156848|FG007|Part C (& Follow-up)|Protocol Violation|0|||
27536100|NCT03633617|80156849|FG008|Part C (& Follow-up)|Protocol Violation|0|||
27536101|NCT03633617|80156850|FG009|Part C (& Follow-up)|Protocol Violation|3|||
27536102|NCT03633617|80156851|FG010|Part C (& Follow-up)|Protocol Violation|1|||
27536103|NCT03633617|80156841|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
27536104|NCT03633617|80156842|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
27536105|NCT03633617|80156843|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
27536106|NCT03633617|80156844|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
27536107|NCT03633617|80156845|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
27536108|NCT03633617|80156846|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
27536109|NCT03633617|80156847|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
27536110|NCT03633617|80156848|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
27536111|NCT03633617|80156849|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
27536112|NCT03633617|80156850|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
27536113|NCT03633617|80156851|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
27536114|NCT04223973|80156859|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
27536115|NCT04223973|80156860|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
27536116|NCT04223973|80156859|FG000|Overall Study|Adverse Event|4|||
27536117|NCT04223973|80156860|FG001|Overall Study|Adverse Event|0|||
27536118|NCT04223973|80156859|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
27536119|NCT04223973|80156860|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
27536120|NCT04223973|80156859|FG000|Overall Study|Physician Decision|1|||
27536121|NCT04223973|80156860|FG001|Overall Study|Physician Decision|1|||
27536122|NCT04223973|80156859|FG000|Overall Study|Withdrawal by Subject|0|||
27536123|NCT04223973|80156860|FG001|Overall Study|Withdrawal by Subject|1|||
27536124|NCT03113916|80156865|FG000|Overall Study|Withdrawal by Subject|9|||
27536125|NCT03113916|80156866|FG001|Overall Study|Withdrawal by Subject|7|||
27536126|NCT03113916|80156865|FG000|Overall Study|Pregnancy|1|||
27536127|NCT03113916|80156866|FG001|Overall Study|Pregnancy|3|||
27536128|NCT03113916|80156865|FG000|Overall Study|Lost to Follow-up|1|||
27536129|NCT03113916|80156866|FG001|Overall Study|Lost to Follow-up|2|||
27536130|NCT03403374|80156870|FG000|Overall Study|Lost to Follow-up|1|||
27536131|NCT01973569|80156871|FG000|Overall Study|Adverse Event|9|||
27536132|NCT01973569|80156872|FG001|Overall Study|Adverse Event|2|||
27536133|NCT01973569|80156873|FG002|Overall Study|Adverse Event|4|||
27631741|NCT03192046|80493578|FG000|Overall Study|Withdrawal by Subject|1|||
27631742|NCT03192046|80493579|FG001|Overall Study|Withdrawal by Subject|1|||
27631743|NCT01981850|80493584|FG000|Main Phase Stage 1|Death|2|||
27536134|NCT01973569|80156871|FG000|Overall Study|Protocol Violation|2|||
27536135|NCT01973569|80156872|FG001|Overall Study|Protocol Violation|1|||
27536136|NCT01973569|80156873|FG002|Overall Study|Protocol Violation|3|||
27536137|NCT01973569|80156871|FG000|Overall Study|Withdrawal by Subject|7|||
27536138|NCT01973569|80156872|FG001|Overall Study|Withdrawal by Subject|5|||
27536139|NCT01973569|80156873|FG002|Overall Study|Withdrawal by Subject|2|||
27631744|NCT01981850|80493585|FG001|Main Phase Stage 1|Death|0|||
27631745|NCT01981850|80493586|FG002|Main Phase Stage 1|Death|0|||
27915555|NCT01656395|81529296|FG000|Overall Study|Physician Decision|2|||
27915556|NCT01656395|81529297|FG001|Overall Study|Physician Decision|3|||
27915557|NCT01656395|81529298|FG002|Overall Study|Physician Decision|3|||
27915558|NCT01656395|81529299|FG003|Overall Study|Physician Decision|2|||
27915559|NCT01656395|81529300|FG004|Overall Study|Physician Decision|3|||
27915560|NCT01656395|81529301|FG005|Overall Study|Physician Decision|3|||
27915561|NCT01656395|81529302|FG006|Overall Study|Physician Decision|0|||
27915562|NCT01656395|81529303|FG007|Overall Study|Physician Decision|0|||
27915563|NCT01656395|81529296|FG000|Overall Study|Pregnancy|0|||
27915564|NCT01656395|81529297|FG001|Overall Study|Pregnancy|0|||
27915565|NCT01656395|81529298|FG002|Overall Study|Pregnancy|1|||
27915566|NCT01656395|81529299|FG003|Overall Study|Pregnancy|0|||
27915567|NCT01656395|81529300|FG004|Overall Study|Pregnancy|0|||
27915568|NCT01656395|81529301|FG005|Overall Study|Pregnancy|0|||
27915569|NCT01656395|81529302|FG006|Overall Study|Pregnancy|0|||
27915570|NCT01656395|81529303|FG007|Overall Study|Pregnancy|0|||
27915571|NCT01656395|81529296|FG000|Overall Study|Progressive Disease|0|||
27915572|NCT01656395|81529297|FG001|Overall Study|Progressive Disease|0|||
27915573|NCT01656395|81529298|FG002|Overall Study|Progressive Disease|0|||
27915574|NCT01656395|81529299|FG003|Overall Study|Progressive Disease|0|||
27915575|NCT01656395|81529300|FG004|Overall Study|Progressive Disease|0|||
27915576|NCT01656395|81529301|FG005|Overall Study|Progressive Disease|1|||
27915577|NCT01656395|81529302|FG006|Overall Study|Progressive Disease|0|||
27915578|NCT01656395|81529303|FG007|Overall Study|Progressive Disease|0|||
27915579|NCT01656395|81529296|FG000|Overall Study|Protocol Violation|6|||
27915580|NCT01656395|81529297|FG001|Overall Study|Protocol Violation|6|||
27915581|NCT01656395|81529298|FG002|Overall Study|Protocol Violation|9|||
27915582|NCT01656395|81529299|FG003|Overall Study|Protocol Violation|2|||
27915583|NCT01656395|81529300|FG004|Overall Study|Protocol Violation|4|||
27915584|NCT01656395|81529301|FG005|Overall Study|Protocol Violation|10|||
27915585|NCT01656395|81529302|FG006|Overall Study|Protocol Violation|0|||
27915586|NCT01656395|81529303|FG007|Overall Study|Protocol Violation|0|||
27536140|NCT01973569|80156871|FG000|Overall Study|Invasive dental treatment|3|||
27536141|NCT01973569|80156872|FG001|Overall Study|Invasive dental treatment|5|||
27536142|NCT01973569|80156873|FG002|Overall Study|Invasive dental treatment|6|||
27536143|NCT01973569|80156871|FG000|Overall Study|Prohibited concomitant d|1|||
27536144|NCT01973569|80156872|FG001|Overall Study|Prohibited concomitant d|5|||
27536145|NCT01973569|80156873|FG002|Overall Study|Prohibited concomitant d|0|||
27536146|NCT01973569|80156871|FG000|Overall Study|Disease progression|0|||
27536147|NCT01973569|80156872|FG001|Overall Study|Disease progression|3|||
27536148|NCT01973569|80156873|FG002|Overall Study|Disease progression|0|||
27536149|NCT01973569|80156871|FG000|Overall Study|Other|1|||
27536150|NCT01973569|80156872|FG001|Overall Study|Other|1|||
27536151|NCT01973569|80156873|FG002|Overall Study|Other|0|||
27536152|NCT01973569|80156871|FG000|Overall Study|Did not receive study drug|6|||
27536153|NCT01973569|80156872|FG001|Overall Study|Did not receive study drug|3|||
27536154|NCT01973569|80156873|FG002|Overall Study|Did not receive study drug|3|||
27536155|NCT02405780|80156874|FG000|Period I|Adverse Event|8|||
27536156|NCT02405780|80156875|FG001|Period I|Adverse Event|0|||
27536157|NCT02405780|80156876|FG002|Period I|Adverse Event|3|||
27536158|NCT02405780|80156877|FG003|Period I|Adverse Event|7|||
27631746|NCT01981850|80493587|FG003|Main Phase Stage 1|Death|0|||
27915587|NCT01656395|81529296|FG000|Overall Study|Screen Failure|2|||
27915588|NCT01656395|81529297|FG001|Overall Study|Screen Failure|1|||
27915589|NCT01656395|81529298|FG002|Overall Study|Screen Failure|7|||
27536159|NCT02405780|80156874|FG000|Period I|Medical reasons|1|||
27536160|NCT02405780|80156875|FG001|Period I|Medical reasons|1|||
27536161|NCT02405780|80156876|FG002|Period I|Medical reasons|0|||
27536162|NCT02405780|80156877|FG003|Period I|Medical reasons|1|||
27536163|NCT02405780|80156874|FG000|Period I|Screening Failure|1|||
27738600|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
27738601|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
27738602|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
27738603|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
27738604|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
27738605|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
27738606|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
27738607|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
27738608|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
27738609|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
27738610|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
27738611|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
27738612|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
27738613|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
27738614|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
27738615|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
27738616|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
27738617|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
27915590|NCT01656395|81529299|FG003|Overall Study|Screen Failure|1|||
27915591|NCT01656395|81529300|FG004|Overall Study|Screen Failure|0|||
27915592|NCT01656395|81529301|FG005|Overall Study|Screen Failure|8|||
27915593|NCT01656395|81529302|FG006|Overall Study|Screen Failure|0|||
27915594|NCT01656395|81529303|FG007|Overall Study|Screen Failure|0|||
27915595|NCT01656395|81529296|FG000|Overall Study|Withdrawal by Subject|3|||
27915596|NCT01656395|81529297|FG001|Overall Study|Withdrawal by Subject|1|||
27915597|NCT01656395|81529298|FG002|Overall Study|Withdrawal by Subject|4|||
27915598|NCT01656395|81529299|FG003|Overall Study|Withdrawal by Subject|2|||
27915599|NCT01656395|81529300|FG004|Overall Study|Withdrawal by Subject|0|||
27915600|NCT01656395|81529301|FG005|Overall Study|Withdrawal by Subject|3|||
27915601|NCT01656395|81529302|FG006|Overall Study|Withdrawal by Subject|0|||
27915602|NCT01656395|81529303|FG007|Overall Study|Withdrawal by Subject|0|||
27915603|NCT01190813|81529304|FG000|Overall Study|Lost to Follow-up|1|||
27915604|NCT01190813|81529305|FG001|Overall Study|Lost to Follow-up|2|||
27915605|NCT01190813|81529304|FG000|Overall Study|Withdrawal by Subject|2|||
27915606|NCT01190813|81529305|FG001|Overall Study|Withdrawal by Subject|1|||
27915607|NCT01190813|81529304|FG000|Overall Study|Refused study treatment after randomized|1|||
27915608|NCT01190813|81529305|FG001|Overall Study|Refused study treatment after randomized|0|||
27915609|NCT01190813|81529304|FG000|Overall Study|Adverse Event|0|||
27915610|NCT01190813|81529305|FG001|Overall Study|Adverse Event|1|||
27915611|NCT00264147|81529306|FG000|Treatment I Period|Adverse Event|3|||
27915612|NCT00264147|81529307|FG001|Treatment I Period|Adverse Event|6|||
27915613|NCT00264147|81529308|FG002|Treatment I Period|Adverse Event|3|||
27915614|NCT00264147|81529309|FG003|Treatment I Period|Adverse Event|5|||
27915615|NCT00264147|81529310|FG004|Treatment I Period|Adverse Event|7|||
27915616|NCT00264147|81529311|FG005|Treatment I Period|Adverse Event|0|||
27915617|NCT00264147|81529306|FG000|Treatment I Period|Laboratory Adverse Event|0|||
27915618|NCT00264147|81529307|FG001|Treatment I Period|Laboratory Adverse Event|0|||
27915619|NCT00264147|81529308|FG002|Treatment I Period|Laboratory Adverse Event|0|||
27915620|NCT00264147|81529309|FG003|Treatment I Period|Laboratory Adverse Event|1|||
27915621|NCT00264147|81529310|FG004|Treatment I Period|Laboratory Adverse Event|0|||
27915622|NCT00264147|81529311|FG005|Treatment I Period|Laboratory Adverse Event|0|||
27915623|NCT00264147|81529306|FG000|Treatment I Period|Lack of Efficacy|6|||
27915624|NCT00264147|81529307|FG001|Treatment I Period|Lack of Efficacy|2|||
27915625|NCT00264147|81529308|FG002|Treatment I Period|Lack of Efficacy|8|||
27915626|NCT00264147|81529309|FG003|Treatment I Period|Lack of Efficacy|0|||
27915627|NCT00264147|81529310|FG004|Treatment I Period|Lack of Efficacy|1|||
27915628|NCT00264147|81529311|FG005|Treatment I Period|Lack of Efficacy|0|||
27915629|NCT00264147|81529306|FG000|Treatment I Period|Lost to Follow-up|1|||
27915630|NCT00264147|81529307|FG001|Treatment I Period|Lost to Follow-up|0|||
27915631|NCT00264147|81529308|FG002|Treatment I Period|Lost to Follow-up|0|||
27915632|NCT00264147|81529309|FG003|Treatment I Period|Lost to Follow-up|1|||
27915633|NCT00264147|81529310|FG004|Treatment I Period|Lost to Follow-up|1|||
27915634|NCT00264147|81529311|FG005|Treatment I Period|Lost to Follow-up|0|||
27915635|NCT00264147|81529306|FG000|Treatment I Period|Protocol Violation|2|||
27915636|NCT00264147|81529307|FG001|Treatment I Period|Protocol Violation|2|||
27536164|NCT02405780|80156875|FG001|Period I|Screening Failure|0|||
27738618|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
27738619|NCT02436239|80873894|FG000|Open-Lable Treatment Period|Other Reason|1|||
27738620|NCT02436239|80873895|FG001|Open-Lable Treatment Period|Other Reason|1|||
27738621|NCT02436239|80873896|FG002|Open-Lable Treatment Period|Other Reason|0|||
27738622|NCT02436239|80873897|FG003|Open-Lable Treatment Period|Other Reason|0|||
27738623|NCT02436239|80873894|FG000|Down-Taper Period|Withdrawal by Subject|4|||
27738624|NCT02436239|80873895|FG001|Down-Taper Period|Withdrawal by Subject|4|||
27738625|NCT02436239|80873896|FG002|Down-Taper Period|Withdrawal by Subject|1|||
27738626|NCT02436239|80873897|FG003|Down-Taper Period|Withdrawal by Subject|2|||
27738627|NCT03894540|80873904|FG000|Overall Study|Adverse Event|0|||
27738628|NCT03894540|80873905|FG001|Overall Study|Adverse Event|0|||
27738629|NCT03894540|80873906|FG002|Overall Study|Adverse Event|0|||
27738630|NCT03894540|80873907|FG003|Overall Study|Adverse Event|0|||
27738631|NCT03894540|80873908|FG004|Overall Study|Adverse Event|1|||
27915637|NCT00264147|81529308|FG002|Treatment I Period|Protocol Violation|0|||
27915638|NCT00264147|81529309|FG003|Treatment I Period|Protocol Violation|0|||
27738632|NCT03894540|80873909|FG005|Overall Study|Adverse Event|0|||
27738633|NCT03894540|80873904|FG000|Overall Study|Withdrawal by Subject|0|||
27738634|NCT03894540|80873905|FG001|Overall Study|Withdrawal by Subject|0|||
27738635|NCT03894540|80873906|FG002|Overall Study|Withdrawal by Subject|0|||
27738636|NCT03894540|80873907|FG003|Overall Study|Withdrawal by Subject|0|||
27738637|NCT03894540|80873908|FG004|Overall Study|Withdrawal by Subject|1|||
27738638|NCT03894540|80873909|FG005|Overall Study|Withdrawal by Subject|0|||
27738639|NCT03894540|80873904|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
27738640|NCT03894540|80873905|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
27738641|NCT03894540|80873906|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
27738642|NCT03894540|80873907|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
27738643|NCT03894540|80873908|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
27738644|NCT03894540|80873909|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
27738645|NCT03894540|80873904|FG000|Overall Study|Progressive Disease Clinical|1|||
27738646|NCT03894540|80873905|FG001|Overall Study|Progressive Disease Clinical|1|||
27738647|NCT03894540|80873906|FG002|Overall Study|Progressive Disease Clinical|0|||
27738648|NCT03894540|80873907|FG003|Overall Study|Progressive Disease Clinical|1|||
27738649|NCT03894540|80873908|FG004|Overall Study|Progressive Disease Clinical|5|||
27738650|NCT03894540|80873909|FG005|Overall Study|Progressive Disease Clinical|1|||
27738651|NCT03894540|80873904|FG000|Overall Study|Study termination by sponsor|0|||
27738652|NCT03894540|80873905|FG001|Overall Study|Study termination by sponsor|0|||
27738653|NCT03894540|80873906|FG002|Overall Study|Study termination by sponsor|0|||
27738654|NCT03894540|80873907|FG003|Overall Study|Study termination by sponsor|0|||
27738655|NCT03894540|80873908|FG004|Overall Study|Study termination by sponsor|2|||
27738656|NCT03894540|80873909|FG005|Overall Study|Study termination by sponsor|0|||
27738657|NCT03937986|80873911|FG000|Overall Study|COVID-19 Pandemic|1|||
27915639|NCT00264147|81529310|FG004|Treatment I Period|Protocol Violation|0|||
27915640|NCT00264147|81529311|FG005|Treatment I Period|Protocol Violation|0|||
27915641|NCT00264147|81529306|FG000|Treatment I Period|Withdrawal by Subject|2|||
27915642|NCT00264147|81529307|FG001|Treatment I Period|Withdrawal by Subject|0|||
27915643|NCT00264147|81529308|FG002|Treatment I Period|Withdrawal by Subject|0|||
27915644|NCT00264147|81529309|FG003|Treatment I Period|Withdrawal by Subject|2|||
27536165|NCT02405780|80156876|FG002|Period I|Screening Failure|1|||
27915645|NCT00264147|81529310|FG004|Treatment I Period|Withdrawal by Subject|2|||
27915646|NCT00264147|81529311|FG005|Treatment I Period|Withdrawal by Subject|0|||
27915647|NCT00264147|81529306|FG000|Treatment I Period|Patient out of town for an extended time|0|||
27915648|NCT00264147|81529307|FG001|Treatment I Period|Patient out of town for an extended time|1|||
27915649|NCT00264147|81529308|FG002|Treatment I Period|Patient out of town for an extended time|0|||
27915650|NCT00264147|81529309|FG003|Treatment I Period|Patient out of town for an extended time|0|||
27915651|NCT00264147|81529310|FG004|Treatment I Period|Patient out of town for an extended time|0|||
27915652|NCT00264147|81529311|FG005|Treatment I Period|Patient out of town for an extended time|0|||
27915653|NCT00264147|81529306|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
27915654|NCT00264147|81529307|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
27915655|NCT00264147|81529308|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
27915656|NCT00264147|81529309|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
27915657|NCT00264147|81529310|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
27915658|NCT00264147|81529311|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
27915659|NCT00264147|81529306|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
27915660|NCT00264147|81529307|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
27915661|NCT00264147|81529308|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
27915662|NCT00264147|81529309|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
27738658|NCT00670111|80873914|FG000|Enrollment to One Month|Testing Failure|0|||
27536166|NCT02405780|80156877|FG003|Period I|Screening Failure|0|||
27536167|NCT02405780|80156874|FG000|Period I|Withdrawal by Subject|9|||
27536168|NCT02405780|80156875|FG001|Period I|Withdrawal by Subject|1|||
27536169|NCT02405780|80156876|FG002|Period I|Withdrawal by Subject|3|||
27536170|NCT02405780|80156877|FG003|Period I|Withdrawal by Subject|4|||
27536171|NCT02405780|80156874|FG000|Period I|Non-compliance with study procedures|8|||
27536172|NCT02405780|80156875|FG001|Period I|Non-compliance with study procedures|6|||
27536173|NCT02405780|80156876|FG002|Period I|Non-compliance with study procedures|8|||
27536174|NCT02405780|80156877|FG003|Period I|Non-compliance with study procedures|11|||
27536175|NCT02405780|80156874|FG000|Period II|Adverse Event|3|||
27536176|NCT02405780|80156875|FG001|Period II|Adverse Event|5|||
27536177|NCT02405780|80156876|FG002|Period II|Adverse Event|4|||
27536178|NCT02405780|80156877|FG003|Period II|Adverse Event|11|||
27536179|NCT02405780|80156874|FG000|Period II|Medical reason|0|||
27536180|NCT02405780|80156875|FG001|Period II|Medical reason|1|||
27536181|NCT02405780|80156876|FG002|Period II|Medical reason|0|||
27536182|NCT02405780|80156877|FG003|Period II|Medical reason|0|||
27536183|NCT02405780|80156874|FG000|Period II|Pregnancy|0|||
27536184|NCT02405780|80156875|FG001|Period II|Pregnancy|0|||
27536185|NCT02405780|80156876|FG002|Period II|Pregnancy|1|||
27536186|NCT02405780|80156877|FG003|Period II|Pregnancy|0|||
27536187|NCT02405780|80156874|FG000|Period II|Withdrawal by Subject|7|||
27536188|NCT02405780|80156875|FG001|Period II|Withdrawal by Subject|4|||
27536189|NCT02405780|80156876|FG002|Period II|Withdrawal by Subject|0|||
27536190|NCT02405780|80156877|FG003|Period II|Withdrawal by Subject|3|||
27536191|NCT02405780|80156874|FG000|Period II|Non-compliance with study procedures|5|||
27536192|NCT02405780|80156875|FG001|Period II|Non-compliance with study procedures|2|||
27915663|NCT00264147|81529310|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
27915664|NCT00264147|81529311|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
27915665|NCT00264147|81529306|FG000|Treatment II Period|Adverse Event|0|||
27915666|NCT00264147|81529307|FG001|Treatment II Period|Adverse Event|0|||
27915667|NCT00264147|81529308|FG002|Treatment II Period|Adverse Event|0|||
27915668|NCT00264147|81529309|FG003|Treatment II Period|Adverse Event|0|||
27915669|NCT00264147|81529310|FG004|Treatment II Period|Adverse Event|9|||
27915670|NCT00264147|81529311|FG005|Treatment II Period|Adverse Event|9|||
27915671|NCT00264147|81529306|FG000|Treatment II Period|Laboratory Adverse Event|0|||
27915672|NCT00264147|81529307|FG001|Treatment II Period|Laboratory Adverse Event|0|||
27915673|NCT00264147|81529308|FG002|Treatment II Period|Laboratory Adverse Event|0|||
27915674|NCT00264147|81529309|FG003|Treatment II Period|Laboratory Adverse Event|0|||
27915675|NCT00264147|81529310|FG004|Treatment II Period|Laboratory Adverse Event|0|||
27915676|NCT00264147|81529311|FG005|Treatment II Period|Laboratory Adverse Event|1|||
27915677|NCT00264147|81529306|FG000|Treatment II Period|Lack of Efficacy|0|||
27915678|NCT00264147|81529307|FG001|Treatment II Period|Lack of Efficacy|0|||
27915679|NCT00264147|81529308|FG002|Treatment II Period|Lack of Efficacy|0|||
27915680|NCT00264147|81529309|FG003|Treatment II Period|Lack of Efficacy|0|||
27915681|NCT00264147|81529310|FG004|Treatment II Period|Lack of Efficacy|20|||
27915682|NCT00264147|81529311|FG005|Treatment II Period|Lack of Efficacy|19|||
27915683|NCT00264147|81529306|FG000|Treatment II Period|Lost to Follow-up|0|||
27915684|NCT00264147|81529307|FG001|Treatment II Period|Lost to Follow-up|0|||
27915685|NCT00264147|81529308|FG002|Treatment II Period|Lost to Follow-up|0|||
27915686|NCT00264147|81529309|FG003|Treatment II Period|Lost to Follow-up|0|||
27915687|NCT00264147|81529310|FG004|Treatment II Period|Lost to Follow-up|1|||
27915688|NCT00264147|81529311|FG005|Treatment II Period|Lost to Follow-up|1|||
27915689|NCT00264147|81529306|FG000|Treatment II Period|Withdrawal by Subject|0|||
27915690|NCT00264147|81529307|FG001|Treatment II Period|Withdrawal by Subject|0|||
27915691|NCT00264147|81529308|FG002|Treatment II Period|Withdrawal by Subject|0|||
27915692|NCT00264147|81529309|FG003|Treatment II Period|Withdrawal by Subject|0|||
27915693|NCT00264147|81529310|FG004|Treatment II Period|Withdrawal by Subject|3|||
27915694|NCT00264147|81529311|FG005|Treatment II Period|Withdrawal by Subject|2|||
27915695|NCT00264147|81529306|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
27915696|NCT00264147|81529307|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
27915697|NCT00264147|81529308|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
27915698|NCT00264147|81529309|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
27915699|NCT00264147|81529310|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
27915700|NCT00264147|81529311|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
27915701|NCT03191552|81529312|FG000|Overall Study|Lost to Follow-up|1|||
27915702|NCT03191552|81529313|FG001|Overall Study|Lost to Follow-up|0|||
27915703|NCT03191552|81529314|FG002|Overall Study|Lost to Follow-up|0|||
27915704|NCT03191552|81529312|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
27915705|NCT03191552|81529313|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
27915706|NCT03191552|81529314|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
27915707|NCT00419757|81529318|FG000|Overall Study|Adverse Event|1|||
27915708|NCT00419757|81529319|FG001|Overall Study|Adverse Event|4|||
27915709|NCT00419757|81529318|FG000|Overall Study|Lost to Follow-up|1|||
27915710|NCT00419757|81529319|FG001|Overall Study|Lost to Follow-up|4|||
27915711|NCT00419757|81529318|FG000|Overall Study|Withdrawal by Subject|7|||
27915712|NCT00419757|81529319|FG001|Overall Study|Withdrawal by Subject|1|||
27915713|NCT00419757|81529318|FG000|Overall Study|Protocol Violation|2|||
27536193|NCT02405780|80156876|FG002|Period II|Non-compliance with study procedures|7|||
27536194|NCT02405780|80156877|FG003|Period II|Non-compliance with study procedures|4|||
27738659|NCT00670111|80873915|FG001|Enrollment to One Month|Testing Failure|0|||
27738660|NCT00670111|80873916|FG002|Enrollment to One Month|Testing Failure|13|||
27536195|NCT00100178|80156878|FG000|Overall Study|Lost to Follow-up|0|||
27536196|NCT00100178|80156879|FG001|Overall Study|Lost to Follow-up|6|||
27536197|NCT00100178|80156880|FG002|Overall Study|Lost to Follow-up|5|||
27536198|NCT00100178|80156878|FG000|Overall Study|Adverse Event|2|||
27536199|NCT00100178|80156879|FG001|Overall Study|Adverse Event|2|||
27536200|NCT00100178|80156880|FG002|Overall Study|Adverse Event|1|||
27536201|NCT00100178|80156878|FG000|Overall Study|Withdrawal by Subject|1|||
27536202|NCT00100178|80156879|FG001|Overall Study|Withdrawal by Subject|1|||
27738661|NCT00670111|80873914|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
27915714|NCT00419757|81529319|FG001|Overall Study|Protocol Violation|3|||
27536203|NCT00100178|80156880|FG002|Overall Study|Withdrawal by Subject|1|||
27536204|NCT00100178|80156878|FG000|Overall Study|Physician Decision|6|||
27536205|NCT00100178|80156879|FG001|Overall Study|Physician Decision|1|||
27631747|NCT01981850|80493588|FG004|Main Phase Stage 1|Death|0|||
27631748|NCT01981850|80493589|FG005|Main Phase Stage 1|Death|0|||
27631749|NCT01981850|80493590|FG006|Main Phase Stage 1|Death|0|||
27631750|NCT01981850|80493591|FG007|Main Phase Stage 1|Death|0|||
27631751|NCT01981850|80493592|FG008|Main Phase Stage 1|Death|0|||
27631752|NCT01981850|80493593|FG009|Main Phase Stage 1|Death|0|||
27631753|NCT01981850|80493584|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
27631754|NCT01981850|80493585|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631755|NCT01981850|80493586|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631756|NCT01981850|80493587|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631757|NCT01981850|80493588|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631758|NCT01981850|80493589|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631759|NCT01981850|80493590|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631760|NCT01981850|80493591|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631761|NCT01981850|80493592|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631762|NCT01981850|80493593|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
27631763|NCT01981850|80493584|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
27631764|NCT01981850|80493585|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
27631765|NCT01981850|80493586|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
27631766|NCT01981850|80493587|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
27631767|NCT01981850|80493588|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
27631768|NCT01981850|80493589|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
27631769|NCT01981850|80493590|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
27631770|NCT01981850|80493591|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
27631771|NCT01981850|80493592|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
27631772|NCT01981850|80493593|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
27631773|NCT01981850|80493584|FG000|Main Phase Stage 1|Various reasons|0|||
27631774|NCT01981850|80493585|FG001|Main Phase Stage 1|Various reasons|0|||
27631775|NCT01981850|80493586|FG002|Main Phase Stage 1|Various reasons|2|||
27631776|NCT01981850|80493587|FG003|Main Phase Stage 1|Various reasons|0|||
27631777|NCT01981850|80493588|FG004|Main Phase Stage 1|Various reasons|0|||
27631778|NCT01981850|80493589|FG005|Main Phase Stage 1|Various reasons|0|||
27631779|NCT01981850|80493590|FG006|Main Phase Stage 1|Various reasons|0|||
27631780|NCT01981850|80493591|FG007|Main Phase Stage 1|Various reasons|0|||
27631781|NCT01981850|80493592|FG008|Main Phase Stage 1|Various reasons|0|||
27631782|NCT01981850|80493593|FG009|Main Phase Stage 1|Various reasons|0|||
27631783|NCT01981850|80493584|FG000|Main Phase Stage 2|Adverse Event|0|||
27631784|NCT01981850|80493585|FG001|Main Phase Stage 2|Adverse Event|0|||
27631785|NCT01981850|80493586|FG002|Main Phase Stage 2|Adverse Event|0|||
27631786|NCT01981850|80493587|FG003|Main Phase Stage 2|Adverse Event|0|||
27631787|NCT01981850|80493588|FG004|Main Phase Stage 2|Adverse Event|6|||
27631788|NCT01981850|80493589|FG005|Main Phase Stage 2|Adverse Event|5|||
27631789|NCT01981850|80493590|FG006|Main Phase Stage 2|Adverse Event|7|||
27631790|NCT01981850|80493591|FG007|Main Phase Stage 2|Adverse Event|0|||
27631791|NCT01981850|80493592|FG008|Main Phase Stage 2|Adverse Event|0|||
27631792|NCT01981850|80493593|FG009|Main Phase Stage 2|Adverse Event|0|||
27631793|NCT01981850|80493584|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27536206|NCT00100178|80156880|FG002|Overall Study|Physician Decision|3|||
27631794|NCT01981850|80493585|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27631795|NCT01981850|80493586|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27631796|NCT01981850|80493587|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27631797|NCT01981850|80493588|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
27631798|NCT01981850|80493589|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
27536207|NCT01903031|80159903|FG000|Overall Study|Not Able to Attend Clinic|1|||
27536208|NCT01903031|80159904|FG001|Overall Study|Not Able to Attend Clinic|1|||
27631799|NCT01981850|80493590|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
27536209|NCT01903031|80159905|FG002|Overall Study|Not Able to Attend Clinic|0|||
27631800|NCT01981850|80493591|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27631801|NCT01981850|80493592|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27631802|NCT01981850|80493593|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
27631803|NCT01981850|80493584|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
27631804|NCT01981850|80493585|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
27631805|NCT01981850|80493586|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
27631806|NCT01981850|80493587|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
27631807|NCT01981850|80493588|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
27631808|NCT01981850|80493589|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
27631809|NCT01981850|80493590|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
27631810|NCT01981850|80493591|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
27631811|NCT01981850|80493592|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
27631812|NCT01981850|80493593|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
27631813|NCT01981850|80493584|FG000|Main Phase Stage 2|Various reasons|0|||
27631814|NCT01981850|80493585|FG001|Main Phase Stage 2|Various reasons|0|||
27631815|NCT01981850|80493586|FG002|Main Phase Stage 2|Various reasons|0|||
27631816|NCT01981850|80493587|FG003|Main Phase Stage 2|Various reasons|0|||
27631817|NCT01981850|80493588|FG004|Main Phase Stage 2|Various reasons|2|||
27631818|NCT01981850|80493589|FG005|Main Phase Stage 2|Various reasons|0|||
27631819|NCT01981850|80493590|FG006|Main Phase Stage 2|Various reasons|1|||
27631820|NCT01981850|80493591|FG007|Main Phase Stage 2|Various reasons|0|||
27631821|NCT01981850|80493592|FG008|Main Phase Stage 2|Various reasons|0|||
27631822|NCT01981850|80493593|FG009|Main Phase Stage 2|Various reasons|0|||
27631823|NCT01981850|80493584|FG000|Main Phase Stage 2|Progressive Disease|0|||
27631824|NCT01981850|80493585|FG001|Main Phase Stage 2|Progressive Disease|0|||
27631825|NCT01981850|80493586|FG002|Main Phase Stage 2|Progressive Disease|0|||
27631826|NCT01981850|80493587|FG003|Main Phase Stage 2|Progressive Disease|0|||
27631827|NCT01981850|80493588|FG004|Main Phase Stage 2|Progressive Disease|0|||
27631828|NCT01981850|80493589|FG005|Main Phase Stage 2|Progressive Disease|6|||
27631829|NCT01981850|80493590|FG006|Main Phase Stage 2|Progressive Disease|6|||
27631830|NCT01981850|80493591|FG007|Main Phase Stage 2|Progressive Disease|0|||
27631831|NCT01981850|80493592|FG008|Main Phase Stage 2|Progressive Disease|0|||
27631832|NCT01981850|80493593|FG009|Main Phase Stage 2|Progressive Disease|0|||
27631833|NCT01981850|80493584|FG000|Open Label Extension (OLE)|Adverse Event|0|||
27631834|NCT01981850|80493585|FG001|Open Label Extension (OLE)|Adverse Event|0|||
27631835|NCT01981850|80493586|FG002|Open Label Extension (OLE)|Adverse Event|0|||
27631836|NCT01981850|80493587|FG003|Open Label Extension (OLE)|Adverse Event|0|||
27631837|NCT01981850|80493588|FG004|Open Label Extension (OLE)|Adverse Event|0|||
27631838|NCT01981850|80493589|FG005|Open Label Extension (OLE)|Adverse Event|0|||
27631839|NCT01981850|80493590|FG006|Open Label Extension (OLE)|Adverse Event|0|||
27631840|NCT01981850|80493591|FG007|Open Label Extension (OLE)|Adverse Event|2|||
27631841|NCT01981850|80493592|FG008|Open Label Extension (OLE)|Adverse Event|1|||
27631842|NCT01981850|80493593|FG009|Open Label Extension (OLE)|Adverse Event|8|||
27631843|NCT01981850|80493584|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631844|NCT01981850|80493585|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631845|NCT01981850|80493586|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631846|NCT01981850|80493587|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631847|NCT01981850|80493588|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631848|NCT01981850|80493589|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631849|NCT01981850|80493590|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
27631850|NCT01981850|80493591|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
27631851|NCT01981850|80493592|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
27631852|NCT01981850|80493593|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
27631853|NCT01981850|80493584|FG000|Open Label Extension (OLE)|Various reasons|0|||
27631854|NCT01981850|80493585|FG001|Open Label Extension (OLE)|Various reasons|0|||
27631855|NCT01981850|80493586|FG002|Open Label Extension (OLE)|Various reasons|0|||
27631856|NCT01981850|80493587|FG003|Open Label Extension (OLE)|Various reasons|0|||
27631857|NCT01981850|80493588|FG004|Open Label Extension (OLE)|Various reasons|0|||
27631858|NCT01981850|80493589|FG005|Open Label Extension (OLE)|Various reasons|0|||
27631859|NCT01981850|80493590|FG006|Open Label Extension (OLE)|Various reasons|0|||
27631860|NCT01981850|80493591|FG007|Open Label Extension (OLE)|Various reasons|3|||
27631861|NCT01981850|80493592|FG008|Open Label Extension (OLE)|Various reasons|1|||
27631862|NCT01981850|80493593|FG009|Open Label Extension (OLE)|Various reasons|3|||
27631863|NCT01981850|80493584|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
27631864|NCT01981850|80493585|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
27631865|NCT01981850|80493586|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
27738662|NCT00670111|80873915|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
27738663|NCT00670111|80873916|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
27631866|NCT01981850|80493587|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
27631867|NCT01981850|80493588|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
27631868|NCT01981850|80493589|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
27631869|NCT01981850|80493590|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
27631870|NCT01981850|80493591|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
27631871|NCT01981850|80493592|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
27631872|NCT01981850|80493593|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
27631873|NCT01981850|80493584|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631874|NCT01981850|80493585|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631875|NCT01981850|80493586|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631876|NCT01981850|80493587|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631877|NCT01981850|80493588|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631878|NCT01981850|80493589|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631879|NCT01981850|80493590|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631880|NCT01981850|80493591|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631881|NCT01981850|80493592|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
27631882|NCT01981850|80493593|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
27631883|NCT01981850|80493584|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631884|NCT01981850|80493585|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631885|NCT01981850|80493586|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631886|NCT01981850|80493587|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631887|NCT01981850|80493588|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631888|NCT01981850|80493589|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631889|NCT01981850|80493590|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631890|NCT01981850|80493591|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631891|NCT01981850|80493592|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
27631892|NCT01981850|80493593|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
27631893|NCT00811057|80493596|FG000|Overall Study|Protocol Violation|5|||
27631894|NCT00811057|80493597|FG001|Overall Study|Protocol Violation|10|||
27631895|NCT00811057|80493598|FG002|Overall Study|Protocol Violation|10|||
27631896|NCT00831415|80493599|FG000|Overall Study|Adverse Event|14|||
27631897|NCT00831415|80493599|FG000|Overall Study|Failed to return|3|||
27631898|NCT00831415|80493599|FG000|Overall Study|Physician Decision|6|||
27631899|NCT00831415|80493599|FG000|Overall Study|Lost to Follow-up|9|||
27631900|NCT00831415|80493599|FG000|Overall Study|Protocol Violation|3|||
27631901|NCT00831415|80493599|FG000|Overall Study|Withdrawal by Subject|35|||
27631902|NCT00831415|80493599|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
27631903|NCT00831415|80493599|FG000|Overall Study|Death|1|||
27631904|NCT02975934|80493604|FG000|Treatment Phase|Ongoing at data-analysis|33|||
27631905|NCT02975934|80493605|FG001|Treatment Phase|Ongoing at data-analysis|5|||
27631906|NCT02975934|80493604|FG000|Treatment Phase|Discontinued prior to study drug|0|||
27631907|NCT02975934|80493605|FG001|Treatment Phase|Discontinued prior to study drug|5|||
27631908|NCT02975934|80493604|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
27631909|NCT02975934|80493605|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
27631910|NCT00244855|80493606|FG000|Overall Study|Withdrawal by Subject|0|||
27631911|NCT00244855|80493607|FG001|Overall Study|Withdrawal by Subject|1|||
27631912|NCT00842257|80493615|FG000|Overall Study|Adverse Event|1|||
27631913|NCT00828672|80493620|FG000|Study Treatment|Lost to Follow-up|1|||
27631914|NCT00828672|80493621|FG001|Study Treatment|Lost to Follow-up|0|||
27631915|NCT00828672|80493620|FG000|Study Treatment|Adverse Event|0|||
27631916|NCT00828672|80493621|FG001|Study Treatment|Adverse Event|1|||
27631917|NCT00828672|80493620|FG000|Study Treatment|Complete response, no surgery|1|||
27631918|NCT00828672|80493621|FG001|Study Treatment|Complete response, no surgery|1|||
27631919|NCT00828672|80493620|FG000|Post-surgery (<30 Days)|No central review materials|0|||
27631920|NCT00828672|80493621|FG001|Post-surgery (<30 Days)|No central review materials|1|||
27631921|NCT00768664|80493622|FG000|Overall Study|Death|57|||
27631922|NCT00768664|80493622|FG000|Overall Study|Lost to Follow-up|2|||
27631923|NCT00768664|80493622|FG000|Overall Study|Other|9|||
27631924|NCT00768664|80493622|FG000|Overall Study|Participant refused|1|||
27631925|NCT05308004|80493623|FG000|Overall Study|Not seen by Palliative Care NP|0|||
27631926|NCT05308004|80493624|FG001|Overall Study|Not seen by Palliative Care NP|1|||
27738664|NCT00670111|80873914|FG000|Enrollment to One Month|Physician Decision|1|||
27738665|NCT00670111|80873915|FG001|Enrollment to One Month|Physician Decision|0|||
27738666|NCT00670111|80873916|FG002|Enrollment to One Month|Physician Decision|0|||
27738667|NCT02158533|80873917|FG000|Stage 1|Adverse Event|6|||
27738668|NCT02158533|80873918|FG001|Stage 1|Adverse Event|4|||
27738669|NCT02158533|80873919|FG002|Stage 1|Adverse Event|7|||
27738670|NCT02158533|80873920|FG003|Stage 1|Adverse Event|0|||
27738671|NCT02158533|80873921|FG004|Stage 1|Adverse Event|0|||
27738672|NCT02158533|80873922|FG005|Stage 1|Adverse Event|0|||
27738673|NCT02158533|80873917|FG000|Stage 1|Withdrawal by Subject|3|||
27738674|NCT02158533|80873918|FG001|Stage 1|Withdrawal by Subject|2|||
27738675|NCT02158533|80873919|FG002|Stage 1|Withdrawal by Subject|1|||
27631927|NCT00605033|80493633|FG000|Overall Study|Adverse Event|2|||
27631928|NCT00605033|80493634|FG001|Overall Study|Adverse Event|2|||
27631929|NCT00605033|80493633|FG000|Overall Study|Lost to Follow-up|1|||
27631930|NCT00605033|80493634|FG001|Overall Study|Lost to Follow-up|1|||
27631931|NCT00605033|80493633|FG000|Overall Study|Withdrawal by Subject|3|||
27631932|NCT00605033|80493634|FG001|Overall Study|Withdrawal by Subject|4|||
27631933|NCT00605033|80493633|FG000|Overall Study|Protocol Violation|1|||
27631934|NCT00605033|80493634|FG001|Overall Study|Protocol Violation|1|||
27631935|NCT01254019|80493635|FG000|Overall Study|Adverse Event|0|||
27738676|NCT02158533|80873920|FG003|Stage 1|Withdrawal by Subject|0|||
27915715|NCT00419757|81529318|FG000|Overall Study|Study specific discontinuation criteria|4|||
27915716|NCT00419757|81529319|FG001|Overall Study|Study specific discontinuation criteria|8|||
27915717|NCT00419757|81529318|FG000|Overall Study|Multiple reasons|3|||
27915718|NCT00419757|81529319|FG001|Overall Study|Multiple reasons|1|||
27915719|NCT01063855|81529322|FG000|Overall Study|Adverse Event|4|||
27915720|NCT01063855|81529323|FG001|Overall Study|Adverse Event|4|||
27915721|NCT01063855|81529322|FG000|Overall Study|Death|0|||
27536210|NCT01903031|80159903|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
27536211|NCT01903031|80159904|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
27536212|NCT01903031|80159905|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
27536213|NCT01903031|80159903|FG000|Overall Study|Adverse Event|0|||
27536214|NCT01903031|80159904|FG001|Overall Study|Adverse Event|1|||
27536215|NCT01903031|80159905|FG002|Overall Study|Adverse Event|0|||
27536216|NCT01903031|80159903|FG000|Overall Study|Withdrawal by Subject|0|||
27536217|NCT01903031|80159904|FG001|Overall Study|Withdrawal by Subject|1|||
27536218|NCT01903031|80159905|FG002|Overall Study|Withdrawal by Subject|1|||
27536219|NCT01903031|80159903|FG000|Overall Study|Protocol Violation|0|||
27536220|NCT01903031|80159904|FG001|Overall Study|Protocol Violation|0|||
27536221|NCT01903031|80159905|FG002|Overall Study|Protocol Violation|2|||
27536222|NCT01903031|80159903|FG000|Overall Study|Lost to Follow-up|0|||
27536223|NCT01903031|80159904|FG001|Overall Study|Lost to Follow-up|0|||
27536224|NCT01903031|80159905|FG002|Overall Study|Lost to Follow-up|1|||
27536225|NCT01903031|80159903|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
27536226|NCT01903031|80159904|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
27536227|NCT01903031|80159905|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
27536228|NCT03330288|80159906|FG000|Overall Study|Other reason|1|||
27536229|NCT03330288|80159907|FG001|Overall Study|Other reason|1|||
27536230|NCT03330288|80159906|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
27536231|NCT03330288|80159907|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
27536232|NCT03330288|80159906|FG000|Overall Study|Adverse Event|1|||
27536233|NCT03330288|80159907|FG001|Overall Study|Adverse Event|0|||
27536234|NCT03330288|80159906|FG000|Overall Study|Withdrawal by Subject|1|||
27536235|NCT03330288|80159907|FG001|Overall Study|Withdrawal by Subject|0|||
27536236|NCT03330288|80159906|FG000|Overall Study|Lost to Follow-up|26|||
27536237|NCT03330288|80159907|FG001|Overall Study|Lost to Follow-up|7|||
27536238|NCT03277690|80159908|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
27536239|NCT03277690|80159909|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
27536240|NCT03277690|80159908|FG000|Dose Titration and Maintenance|Physician Decision|1|||
27536241|NCT03277690|80159909|FG001|Dose Titration and Maintenance|Physician Decision|0|||
27536242|NCT03277690|80159908|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
27536243|NCT03277690|80159909|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
27536244|NCT03277690|80159908|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
27536245|NCT03277690|80159909|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
27536246|NCT03277690|80159908|FG000|Dose Titration and Maintenance|Adverse Event|15|||
27536247|NCT03277690|80159909|FG001|Dose Titration and Maintenance|Adverse Event|0|||
27536248|NCT03277690|80159908|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
27536249|NCT03277690|80159909|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
27536250|NCT03277690|80159908|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
27536251|NCT03277690|80159909|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
27536252|NCT03398200|80159910|FG000|Overall Study|Withdrawal by Subject|0|||
27536253|NCT03398200|80159911|FG001|Overall Study|Withdrawal by Subject|1|||
27536254|NCT01938573|80159912|FG000|Overall Study|Lack of Efficacy|1|||
27536255|NCT01938573|80159913|FG001|Overall Study|Lack of Efficacy|0|||
27536256|NCT01938573|80159912|FG000|Overall Study|Operation at other hospital|1|||
27536257|NCT01938573|80159913|FG001|Overall Study|Operation at other hospital|0|||
27536258|NCT00287365|80159925|FG000|Overall Study|sample not acquired|13|||
27536259|NCT02122458|80159927|FG000|Overall Study|Withdrawal by Subject|0|||
27536260|NCT02122458|80159928|FG001|Overall Study|Withdrawal by Subject|0|||
27536261|NCT02122458|80159929|FG002|Overall Study|Withdrawal by Subject|0|||
27536262|NCT02122458|80159930|FG003|Overall Study|Withdrawal by Subject|4|||
27536263|NCT02122458|80159931|FG004|Overall Study|Withdrawal by Subject|4|||
27536264|NCT02122458|80159932|FG005|Overall Study|Withdrawal by Subject|4|||
27536265|NCT02122458|80159933|FG006|Overall Study|Withdrawal by Subject|0|||
27536266|NCT02122458|80159927|FG000|Overall Study|Lost to Follow-up|1|||
27536267|NCT02122458|80159928|FG001|Overall Study|Lost to Follow-up|3|||
27536268|NCT02122458|80159929|FG002|Overall Study|Lost to Follow-up|0|||
27536269|NCT02122458|80159930|FG003|Overall Study|Lost to Follow-up|7|||
27536270|NCT02122458|80159931|FG004|Overall Study|Lost to Follow-up|5|||
27536271|NCT02122458|80159932|FG005|Overall Study|Lost to Follow-up|15|||
27536272|NCT02122458|80159933|FG006|Overall Study|Lost to Follow-up|1|||
27915722|NCT01063855|81529323|FG001|Overall Study|Death|1|||
27915723|NCT01063855|81529322|FG000|Overall Study|Lost to Follow-up|8|||
27536273|NCT02122458|80159927|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
27915724|NCT01063855|81529323|FG001|Overall Study|Lost to Follow-up|4|||
27915725|NCT01063855|81529322|FG000|Overall Study|Pregnancy|1|||
27915726|NCT01063855|81529323|FG001|Overall Study|Pregnancy|0|||
27915727|NCT01063855|81529322|FG000|Overall Study|Lack of Efficacy|0|||
27915728|NCT01063855|81529323|FG001|Overall Study|Lack of Efficacy|1|||
27915729|NCT01063855|81529322|FG000|Overall Study|Withdrawal by Subject|11|||
27915730|NCT01063855|81529323|FG001|Overall Study|Withdrawal by Subject|8|||
27915731|NCT01063855|81529322|FG000|Overall Study|Reason not specified|13|||
27915732|NCT01063855|81529323|FG001|Overall Study|Reason not specified|11|||
27915733|NCT01566604|81529330|FG000|Overall Study|Patient's inability to use the device|1|||
27915734|NCT01566604|81529331|FG001|Overall Study|Patient's inability to use the device|0|||
27915735|NCT01566604|81529330|FG000|Overall Study|Administrative problems|1|||
27915736|NCT01566604|81529331|FG001|Overall Study|Administrative problems|0|||
27915737|NCT01566604|81529330|FG000|Overall Study|Lack of Efficacy|1|||
27915738|NCT01566604|81529331|FG001|Overall Study|Lack of Efficacy|2|||
27915739|NCT01566604|81529330|FG000|Overall Study|Protocol deviation|2|||
27915740|NCT01566604|81529331|FG001|Overall Study|Protocol deviation|0|||
27915741|NCT01566604|81529330|FG000|Overall Study|Abnormal laboratory value|2|||
27915742|NCT01566604|81529331|FG001|Overall Study|Abnormal laboratory value|0|||
27915743|NCT01566604|81529330|FG000|Overall Study|Death|4|||
27915744|NCT01566604|81529331|FG001|Overall Study|Death|1|||
27915745|NCT01566604|81529330|FG000|Overall Study|Adverse Event|4|||
27915746|NCT01566604|81529331|FG001|Overall Study|Adverse Event|2|||
27915747|NCT01566604|81529330|FG000|Overall Study|Withdrawal by Subject|9|||
27915748|NCT01566604|81529331|FG001|Overall Study|Withdrawal by Subject|6|||
27536274|NCT02122458|80159928|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
27536275|NCT02122458|80159929|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
27536276|NCT02122458|80159930|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
27536277|NCT02122458|80159931|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
27536278|NCT02122458|80159932|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
27536279|NCT02122458|80159933|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
27536280|NCT02122458|80159927|FG000|Overall Study|Adverse Event|1|||
27536281|NCT02122458|80159928|FG001|Overall Study|Adverse Event|0|||
27536282|NCT02122458|80159929|FG002|Overall Study|Adverse Event|0|||
27536283|NCT02122458|80159930|FG003|Overall Study|Adverse Event|0|||
27536284|NCT02122458|80159931|FG004|Overall Study|Adverse Event|0|||
27536285|NCT02122458|80159932|FG005|Overall Study|Adverse Event|0|||
27536286|NCT02122458|80159933|FG006|Overall Study|Adverse Event|0|||
27536287|NCT02122458|80159927|FG000|Overall Study|Experimental Error|0|||
27536288|NCT02122458|80159928|FG001|Overall Study|Experimental Error|0|||
27536289|NCT02122458|80159929|FG002|Overall Study|Experimental Error|0|||
27536290|NCT02122458|80159930|FG003|Overall Study|Experimental Error|0|||
27536291|NCT02122458|80159931|FG004|Overall Study|Experimental Error|3|||
27536292|NCT02122458|80159932|FG005|Overall Study|Experimental Error|0|||
27536293|NCT02122458|80159933|FG006|Overall Study|Experimental Error|0|||
27536294|NCT02122458|80159927|FG000|Overall Study|Deployed or Moved|0|||
27536295|NCT02122458|80159928|FG001|Overall Study|Deployed or Moved|0|||
27536296|NCT02122458|80159929|FG002|Overall Study|Deployed or Moved|0|||
27536297|NCT02122458|80159930|FG003|Overall Study|Deployed or Moved|0|||
27536298|NCT02122458|80159931|FG004|Overall Study|Deployed or Moved|1|||
27536299|NCT02122458|80159932|FG005|Overall Study|Deployed or Moved|0|||
27536300|NCT02122458|80159933|FG006|Overall Study|Deployed or Moved|0|||
27536301|NCT02122458|80159927|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
27536302|NCT02122458|80159928|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
27536303|NCT02122458|80159929|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
27536304|NCT02122458|80159930|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
27536305|NCT02122458|80159931|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
27536306|NCT02122458|80159932|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
27536307|NCT02122458|80159933|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
27536308|NCT02122458|80159927|FG000|Overall Study|Noncompliance|0|||
27536309|NCT02122458|80159928|FG001|Overall Study|Noncompliance|1|||
27536310|NCT02122458|80159929|FG002|Overall Study|Noncompliance|0|||
27536311|NCT02122458|80159930|FG003|Overall Study|Noncompliance|0|||
27536312|NCT02122458|80159931|FG004|Overall Study|Noncompliance|0|||
27915749|NCT04210986|81529332|FG000|Overall Study|Lost to Follow-up|5|||
27915750|NCT04210986|81529333|FG001|Overall Study|Lost to Follow-up|2|||
27536313|NCT02122458|80159932|FG005|Overall Study|Noncompliance|0|||
27536314|NCT02122458|80159933|FG006|Overall Study|Noncompliance|0|||
27536315|NCT03212690|80159934|FG000|Overall Study|Protocol Violation|1|||
27536316|NCT00333840|80159935|FG000|First-line Treatment Period|Adverse Event|38|||
27536317|NCT00333840|80159936|FG001|First-line Treatment Period|Adverse Event|37|||
27536318|NCT00333840|80159937|FG002|First-line Treatment Period|Adverse Event|0|||
27915751|NCT04210986|81529332|FG000|Overall Study|Withdrawal by Subject|3|||
27915752|NCT04210986|81529333|FG001|Overall Study|Withdrawal by Subject|1|||
27915753|NCT04210986|81529332|FG000|Overall Study|Protocol Violation|1|||
27915754|NCT04210986|81529333|FG001|Overall Study|Protocol Violation|1|||
27915755|NCT04210986|81529332|FG000|Overall Study|Physician Decision|0|||
27915756|NCT04210986|81529333|FG001|Overall Study|Physician Decision|1|||
27915757|NCT00994110|81529336|FG000|Overall Study|Withdrawal by Subject|9|||
27915758|NCT00994110|81529337|FG001|Overall Study|Withdrawal by Subject|9|||
27915759|NCT00994110|81529336|FG000|Overall Study|Not Treated|4|||
27915760|NCT00994110|81529337|FG001|Overall Study|Not Treated|8|||
27915761|NCT00994110|81529336|FG000|Overall Study|Adverse Event|1|||
27915762|NCT00994110|81529337|FG001|Overall Study|Adverse Event|0|||
27915763|NCT00994110|81529336|FG000|Overall Study|Patient not resected|41|||
27915764|NCT00994110|81529337|FG001|Overall Study|Patient not resected|52|||
27915765|NCT00994110|81529336|FG000|Overall Study|Pt not eligible|10|||
27915766|NCT00994110|81529337|FG001|Overall Study|Pt not eligible|5|||
27915767|NCT00606307|81529338|FG000|Overall Study|Adverse Event|2|||
27915768|NCT00606307|81529338|FG000|Overall Study|Withdrawal by Subject|2|||
27915769|NCT00606307|81529338|FG000|Overall Study|Disease progression|6|||
27915770|NCT00606307|81529338|FG000|Overall Study|QTc prolongation|1|||
27915771|NCT01001910|81529340|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
27915772|NCT02100839|81529341|FG000|Multiple Ascending Dose|Adverse Event|2|||
27915773|NCT02100839|81529342|FG001|Multiple Ascending Dose|Adverse Event|0|||
27915774|NCT02100839|81529341|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
27915775|NCT02100839|81529342|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
27915776|NCT00141518|81529343|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
27915777|NCT00141518|81529344|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
27915778|NCT00141518|81529345|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
27915779|NCT00141518|81529343|FG000|Overall Study|Adverse Event|7|||
27915780|NCT00141518|81529344|FG001|Overall Study|Adverse Event|5|||
27915781|NCT00141518|81529345|FG002|Overall Study|Adverse Event|2|||
27915782|NCT00141518|81529343|FG000|Overall Study|Withdrawal by Subject|2|||
27915783|NCT00141518|81529344|FG001|Overall Study|Withdrawal by Subject|0|||
27915784|NCT00141518|81529345|FG002|Overall Study|Withdrawal by Subject|2|||
27915785|NCT00141518|81529343|FG000|Overall Study|Protocol Violation|1|||
27915786|NCT00141518|81529344|FG001|Overall Study|Protocol Violation|1|||
27915787|NCT00141518|81529345|FG002|Overall Study|Protocol Violation|2|||
27915788|NCT00141518|81529343|FG000|Overall Study|Lack of Efficacy|5|||
27915789|NCT00141518|81529344|FG001|Overall Study|Lack of Efficacy|0|||
27915790|NCT00141518|81529345|FG002|Overall Study|Lack of Efficacy|0|||
27915791|NCT03205150|81529346|FG000|Overall Study|Protocol deviation|1|||
27915792|NCT03205150|81529347|FG001|Overall Study|Protocol deviation|3|||
27915793|NCT03205150|81529348|FG002|Overall Study|Protocol deviation|0|||
27915794|NCT03205150|81529346|FG000|Overall Study|Patient/guardian decision|0|||
27915795|NCT03205150|81529347|FG001|Overall Study|Patient/guardian decision|3|||
27915796|NCT03205150|81529348|FG002|Overall Study|Patient/guardian decision|0|||
27915797|NCT03205150|81529346|FG000|Overall Study|Adverse Event|1|||
27915798|NCT03205150|81529347|FG001|Overall Study|Adverse Event|1|||
27915799|NCT03205150|81529348|FG002|Overall Study|Adverse Event|1|||
27915800|NCT03205150|81529346|FG000|Overall Study|Lost to Follow-up|0|||
27536319|NCT00333840|80159938|FG003|First-line Treatment Period|Adverse Event|0|||
27536320|NCT00333840|80159935|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
27536321|NCT00333840|80159936|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
27536322|NCT00333840|80159937|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
27536323|NCT00333840|80159938|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
27536324|NCT00333840|80159935|FG000|First-line Treatment Period|Abnormal procedure|2|||
27536325|NCT00333840|80159936|FG001|First-line Treatment Period|Abnormal procedure|0|||
27915801|NCT03205150|81529347|FG001|Overall Study|Lost to Follow-up|0|||
27915802|NCT03205150|81529348|FG002|Overall Study|Lost to Follow-up|1|||
27915803|NCT02438280|81529349|FG000|Overall Study|Physician Decision|1|||
27915804|NCT02438280|81529350|FG001|Overall Study|Physician Decision|0|||
27915805|NCT02260817|81529351|FG000|Overall Study|Lost to Follow-up|0|||
27915806|NCT02260817|81529352|FG001|Overall Study|Lost to Follow-up|14|||
27915807|NCT02260817|81529351|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
27536326|NCT00333840|80159937|FG002|First-line Treatment Period|Abnormal procedure|0|||
27536327|NCT00333840|80159938|FG003|First-line Treatment Period|Abnormal procedure|0|||
27536328|NCT00333840|80159935|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
27536329|NCT00333840|80159936|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
27536330|NCT00333840|80159937|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
27536331|NCT00333840|80159938|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
27915808|NCT02260817|81529352|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
27915809|NCT02260817|81529351|FG000|Overall Study|Observation, no biopsy|0|||
27915810|NCT02260817|81529352|FG001|Overall Study|Observation, no biopsy|1|||
27915811|NCT02260817|81529351|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
27915812|NCT02260817|81529352|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
27915813|NCT02260817|81529351|FG000|Overall Study|Protocol Violation|0|||
27915814|NCT02260817|81529352|FG001|Overall Study|Protocol Violation|14|||
27915815|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
27915816|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
27915817|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Adverse Event|57|||
27915818|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Adverse Event|49|||
27915819|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
27915820|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
27915821|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Site closure|3|||
27915822|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Site closure|2|||
27915823|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
27915824|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
27915825|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Physician Decision|48|||
27915826|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Physician Decision|38|||
27915827|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
27915828|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
27915829|NCT01705977|81529353|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
27915830|NCT01705977|81529354|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
27915831|NCT01705977|81529353|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
27915832|NCT01705977|81529354|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
27915833|NCT01705977|81529353|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
27915834|NCT01705977|81529354|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
27915835|NCT01705977|81529353|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
27915836|NCT01705977|81529354|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
27915837|NCT01705977|81529353|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
27915838|NCT01705977|81529354|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
27915839|NCT00964028|81529355|FG000|Overall Study|Withdrawal by Subject|0|||
27915840|NCT00964028|81529356|FG001|Overall Study|Withdrawal by Subject|1|||
27915841|NCT00095979|81529361|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
27915842|NCT02700048|81529362|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
27915843|NCT02700048|81529363|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
27915844|NCT04460326|81529367|FG000|Completed at Least 4 Meals|Early discharge|5|||
27915845|NCT04460326|81529368|FG001|Completed at Least 4 Meals|Early discharge|5|||
27915846|NCT04460326|81529367|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
27915847|NCT04460326|81529368|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
27915848|NCT04460326|81529367|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
27915849|NCT04460326|81529368|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
27915850|NCT04460326|81529367|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
27915851|NCT04460326|81529368|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
27915852|NCT04460326|81529367|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
27915853|NCT04460326|81529368|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
27915854|NCT04460326|81529367|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
27915855|NCT04460326|81529368|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
27915856|NCT01149655|81529376|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
27915857|NCT01149655|81529377|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
27915858|NCT01149655|81529378|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
27915859|NCT01149655|81529379|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
27915860|NCT01149655|81529376|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
27915861|NCT01149655|81529377|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
27915862|NCT01149655|81529378|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
27915863|NCT01149655|81529379|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
27915864|NCT01149655|81529376|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
27536332|NCT00333840|80159935|FG000|First-line Treatment Period|No longer required study drug|21|||
27536333|NCT00333840|80159936|FG001|First-line Treatment Period|No longer required study drug|8|||
27536334|NCT00333840|80159937|FG002|First-line Treatment Period|No longer required study drug|0|||
27536335|NCT00333840|80159938|FG003|First-line Treatment Period|No longer required study drug|0|||
27536336|NCT00333840|80159935|FG000|First-line Treatment Period|Protocol Violation|17|||
27536337|NCT00333840|80159936|FG001|First-line Treatment Period|Protocol Violation|17|||
27536338|NCT00333840|80159937|FG002|First-line Treatment Period|Protocol Violation|0|||
27536339|NCT00333840|80159938|FG003|First-line Treatment Period|Protocol Violation|0|||
27536340|NCT00333840|80159935|FG000|First-line Treatment Period|Subject withdrew consent|57|||
27536341|NCT00333840|80159936|FG001|First-line Treatment Period|Subject withdrew consent|77|||
27536342|NCT00333840|80159937|FG002|First-line Treatment Period|Subject withdrew consent|0|||
27536343|NCT00333840|80159938|FG003|First-line Treatment Period|Subject withdrew consent|0|||
27536344|NCT00333840|80159935|FG000|First-line Treatment Period|Lost to Follow-up|15|||
27631936|NCT01254019|80493636|FG001|Overall Study|Adverse Event|2|||
27631937|NCT01254019|80493635|FG000|Overall Study|Protocol Violation|1|||
27631938|NCT01254019|80493636|FG001|Overall Study|Protocol Violation|0|||
27631939|NCT01254019|80493635|FG000|Overall Study|Withdrawal by Subject|0|||
27631940|NCT01254019|80493636|FG001|Overall Study|Withdrawal by Subject|2|||
27738677|NCT02158533|80873921|FG004|Stage 1|Withdrawal by Subject|0|||
27738678|NCT02158533|80873922|FG005|Stage 1|Withdrawal by Subject|0|||
27738679|NCT02158533|80873917|FG000|Stage 1|Lack of Efficacy|1|||
27738680|NCT02158533|80873918|FG001|Stage 1|Lack of Efficacy|0|||
27738681|NCT02158533|80873919|FG002|Stage 1|Lack of Efficacy|0|||
27738682|NCT02158533|80873920|FG003|Stage 1|Lack of Efficacy|0|||
27738683|NCT02158533|80873921|FG004|Stage 1|Lack of Efficacy|0|||
27738684|NCT02158533|80873922|FG005|Stage 1|Lack of Efficacy|0|||
27738685|NCT02158533|80873917|FG000|Stage 1|Lost to Follow-up|3|||
27738686|NCT02158533|80873918|FG001|Stage 1|Lost to Follow-up|1|||
27738687|NCT02158533|80873919|FG002|Stage 1|Lost to Follow-up|0|||
27536345|NCT00333840|80159936|FG001|First-line Treatment Period|Lost to Follow-up|6|||
27536346|NCT00333840|80159937|FG002|First-line Treatment Period|Lost to Follow-up|0|||
27536347|NCT00333840|80159938|FG003|First-line Treatment Period|Lost to Follow-up|0|||
27536348|NCT00333840|80159935|FG000|First-line Treatment Period|Administrative problems|12|||
27536349|NCT00333840|80159936|FG001|First-line Treatment Period|Administrative problems|6|||
27536350|NCT00333840|80159937|FG002|First-line Treatment Period|Administrative problems|0|||
27738688|NCT02158533|80873920|FG003|Stage 1|Lost to Follow-up|0|||
27738689|NCT02158533|80873921|FG004|Stage 1|Lost to Follow-up|0|||
27738690|NCT02158533|80873922|FG005|Stage 1|Lost to Follow-up|0|||
27738691|NCT02158533|80873917|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
27738692|NCT02158533|80873918|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
27738693|NCT02158533|80873919|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
27738694|NCT02158533|80873920|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
27738695|NCT02158533|80873921|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
27738696|NCT02158533|80873922|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
27738697|NCT02158533|80873917|FG000|Stage 1|Non-compliance with study visits|1|||
27738698|NCT02158533|80873918|FG001|Stage 1|Non-compliance with study visits|0|||
27738699|NCT02158533|80873919|FG002|Stage 1|Non-compliance with study visits|0|||
27738700|NCT02158533|80873920|FG003|Stage 1|Non-compliance with study visits|0|||
27738701|NCT02158533|80873921|FG004|Stage 1|Non-compliance with study visits|0|||
27738702|NCT02158533|80873922|FG005|Stage 1|Non-compliance with study visits|0|||
27738703|NCT02158533|80873917|FG000|Stage 2|Adverse Event|0|||
27738704|NCT02158533|80873918|FG001|Stage 2|Adverse Event|0|||
27738705|NCT02158533|80873919|FG002|Stage 2|Adverse Event|0|||
27738706|NCT02158533|80873920|FG003|Stage 2|Adverse Event|0|||
27738707|NCT02158533|80873921|FG004|Stage 2|Adverse Event|0|||
27738708|NCT02158533|80873922|FG005|Stage 2|Adverse Event|1|||
27738709|NCT02158533|80873917|FG000|Stage 2|Lack of Efficacy|0|||
27738710|NCT02158533|80873918|FG001|Stage 2|Lack of Efficacy|0|||
27738711|NCT02158533|80873919|FG002|Stage 2|Lack of Efficacy|0|||
27738712|NCT02158533|80873920|FG003|Stage 2|Lack of Efficacy|0|||
27738713|NCT02158533|80873921|FG004|Stage 2|Lack of Efficacy|1|||
27738714|NCT02158533|80873922|FG005|Stage 2|Lack of Efficacy|0|||
27738715|NCT02158533|80873917|FG000|Stage 2|Lost to Follow-up|0|||
27738716|NCT02158533|80873918|FG001|Stage 2|Lost to Follow-up|0|||
27738717|NCT02158533|80873919|FG002|Stage 2|Lost to Follow-up|0|||
27738718|NCT02158533|80873920|FG003|Stage 2|Lost to Follow-up|1|||
27738719|NCT02158533|80873921|FG004|Stage 2|Lost to Follow-up|1|||
27738720|NCT02158533|80873922|FG005|Stage 2|Lost to Follow-up|2|||
27738721|NCT02158533|80873917|FG000|Stage 2|Withdrawal by Subject|0|||
27738722|NCT02158533|80873918|FG001|Stage 2|Withdrawal by Subject|0|||
27738723|NCT02158533|80873919|FG002|Stage 2|Withdrawal by Subject|0|||
27915865|NCT01149655|81529377|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27915866|NCT01149655|81529378|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27915867|NCT01149655|81529379|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
27915868|NCT01149655|81529376|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
27536351|NCT00333840|80159938|FG003|First-line Treatment Period|Administrative problems|0|||
27536352|NCT00333840|80159935|FG000|First-line Treatment Period|Death|19|||
27536353|NCT00333840|80159936|FG001|First-line Treatment Period|Death|2|||
27536354|NCT00333840|80159937|FG002|First-line Treatment Period|Death|0|||
27536355|NCT00333840|80159938|FG003|First-line Treatment Period|Death|0|||
27536356|NCT00333840|80159935|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
27536357|NCT00333840|80159936|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
27536358|NCT00333840|80159937|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
27536359|NCT00333840|80159938|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
27536360|NCT00333840|80159935|FG000|Second-line Treatment Period|Adverse Event|0|||
27536361|NCT00333840|80159936|FG001|Second-line Treatment Period|Adverse Event|0|||
27536362|NCT00333840|80159937|FG002|Second-line Treatment Period|Adverse Event|3|||
27536363|NCT00333840|80159938|FG003|Second-line Treatment Period|Adverse Event|34|||
27536364|NCT00333840|80159935|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
27536365|NCT00333840|80159936|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
27536366|NCT00333840|80159937|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
27738724|NCT02158533|80873920|FG003|Stage 2|Withdrawal by Subject|0|||
27738725|NCT02158533|80873921|FG004|Stage 2|Withdrawal by Subject|1|||
27738726|NCT02158533|80873922|FG005|Stage 2|Withdrawal by Subject|2|||
27738727|NCT02158533|80873917|FG000|Stage 2|Physician Decision|0|||
27738728|NCT02158533|80873918|FG001|Stage 2|Physician Decision|0|||
27738729|NCT02158533|80873919|FG002|Stage 2|Physician Decision|0|||
27631941|NCT00597519|80493637|FG000|Overall Study|Death|1|||
27631942|NCT02698891|80493640|FG000|Overall Study|Withdrawal by Subject|2|||
27631943|NCT02698891|80493640|FG000|Overall Study|deemed ineligible|1|||
27631944|NCT02698891|80493640|FG000|Overall Study|Adverse Event|9|||
27631945|NCT01959412|80493642|FG000|Overall Study|Protocol deviation|1|||
27631946|NCT01959412|80493643|FG001|Overall Study|Protocol deviation|1|||
27631947|NCT01959412|80493644|FG002|Overall Study|Protocol deviation|0|||
27631948|NCT01959412|80493645|FG003|Overall Study|Protocol deviation|1|||
27631949|NCT01959412|80493646|FG004|Overall Study|Protocol deviation|3|||
27631950|NCT01959412|80493647|FG005|Overall Study|Protocol deviation|0|||
27631951|NCT01959412|80493642|FG000|Overall Study|Adverse Event|0|||
27631952|NCT01959412|80493643|FG001|Overall Study|Adverse Event|0|||
27631953|NCT01959412|80493644|FG002|Overall Study|Adverse Event|0|||
27631954|NCT01959412|80493645|FG003|Overall Study|Adverse Event|1|||
27631955|NCT01959412|80493646|FG004|Overall Study|Adverse Event|0|||
27631956|NCT01959412|80493647|FG005|Overall Study|Adverse Event|0|||
27631957|NCT04033432|80493648|FG000|Overall Study|Progressive Disease|8|||
27631958|NCT04033432|80493648|FG000|Overall Study|Adverse Event|4|||
27631959|NCT04033432|80493648|FG000|Overall Study|Death|1|||
27631960|NCT01460290|80493649|FG000|Overall Study|Adverse Event|3|||
27631961|NCT01460290|80493649|FG000|Overall Study|Elevated liver function|1|||
27631962|NCT01490580|80493650|FG000|Overall Study|Parents withdrew consent|0|||
27631963|NCT01490580|80493651|FG001|Overall Study|Parents withdrew consent|2|||
27631964|NCT00305695|80493652|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
27631965|NCT00305695|80493653|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
27631966|NCT00305695|80493652|FG000|Overall Study|Did not have baseline scan|1|||
27631967|NCT00305695|80493653|FG001|Overall Study|Did not have baseline scan|1|||
27631968|NCT03743246|80493654|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
27631969|NCT03743246|80493655|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
27631970|NCT03743246|80493656|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
27631971|NCT03743246|80493657|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
27631972|NCT03743246|80493654|FG000|Pre-Treatment Period|Death|0|||
27631973|NCT03743246|80493655|FG001|Pre-Treatment Period|Death|1|||
27631974|NCT03743246|80493656|FG002|Pre-Treatment Period|Death|0|||
27631975|NCT03743246|80493657|FG003|Pre-Treatment Period|Death|1|||
27631976|NCT03743246|80493654|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
27631977|NCT03743246|80493655|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
27631978|NCT03743246|80493656|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
27631979|NCT03743246|80493657|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
27631980|NCT03743246|80493654|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
27631981|NCT03743246|80493655|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
27631982|NCT03743246|80493656|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
27631983|NCT03743246|80493657|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
27631984|NCT03743246|80493654|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
27631985|NCT03743246|80493655|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
27631986|NCT03743246|80493656|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
27631987|NCT03743246|80493657|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
27631988|NCT03743246|80493654|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
27631989|NCT03743246|80493655|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
27631990|NCT03743246|80493656|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
27631991|NCT03743246|80493657|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
27631992|NCT03743246|80493654|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
27631993|NCT03743246|80493655|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
27631994|NCT03743246|80493656|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
27631995|NCT03743246|80493657|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
27631996|NCT03743246|80493654|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
27631997|NCT03743246|80493655|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
27631998|NCT03743246|80493656|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
27631999|NCT03743246|80493657|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
27632000|NCT03743246|80493654|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
27632001|NCT03743246|80493655|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
27915869|NCT01149655|81529377|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
27632002|NCT03743246|80493656|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
27632003|NCT03743246|80493657|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
27632004|NCT02524288|80493662|FG000|Overall Study|Adverse Event|115|||
27632005|NCT02524288|80493662|FG000|Overall Study|Lost to Follow-up|216|||
27632006|NCT02524288|80493662|FG000|Overall Study|Non-Compliance With Protocol|32|||
27632007|NCT02524288|80493662|FG000|Overall Study|Non-Compliance With Study Drug|14|||
27632008|NCT02524288|80493662|FG000|Overall Study|Pregnancy Wish|6|||
27632009|NCT02524288|80493662|FG000|Overall Study|Protocol Violation|6|||
27632010|NCT02524288|80493662|FG000|Overall Study|Screen Failure|2|||
27632011|NCT02524288|80493662|FG000|Overall Study|Site Discontinued Study Participation|1|||
27632012|NCT02524288|80493662|FG000|Overall Study|Study Terminated By Sponsor|1417|||
27632013|NCT02524288|80493662|FG000|Overall Study|Subject Moved|32|||
27632014|NCT02524288|80493662|FG000|Overall Study|Withdrawal by Subject|76|||
27632015|NCT02524288|80493662|FG000|Overall Study|Pregnancy|22|||
27632016|NCT02524288|80493662|FG000|Overall Study|Physician Decision|2|||
27632017|NCT01835899|80493664|FG000|Overall Study|Adverse Event|0|||
27632018|NCT01835899|80493665|FG001|Overall Study|Adverse Event|0|||
27632019|NCT01835899|80493666|FG002|Overall Study|Adverse Event|1|||
27632020|NCT01835899|80493664|FG000|Overall Study|Other than stated above|0|||
27632021|NCT01835899|80493665|FG001|Overall Study|Other than stated above|1|||
27632022|NCT01835899|80493666|FG002|Overall Study|Other than stated above|0|||
27632023|NCT01768676|80493669|FG000|Overall Study|Adverse Event|3|||
27632024|NCT01768676|80493670|FG001|Overall Study|Adverse Event|3|||
27632025|NCT01768676|80493669|FG000|Overall Study|Lost to Follow-up|13|||
27632026|NCT01768676|80493670|FG001|Overall Study|Lost to Follow-up|16|||
27632027|NCT01768676|80493669|FG000|Overall Study|Protocol Violation|1|||
27632028|NCT01768676|80493670|FG001|Overall Study|Protocol Violation|1|||
27632029|NCT01768676|80493669|FG000|Overall Study|Physician Decision|4|||
27632030|NCT01768676|80493670|FG001|Overall Study|Physician Decision|1|||
27632031|NCT01768676|80493669|FG000|Overall Study|Withdrawal by Subject|3|||
27632032|NCT01768676|80493670|FG001|Overall Study|Withdrawal by Subject|10|||
27632033|NCT03265210|80493671|FG000|Overall Study|Withdrawal by Subject|7|||
27632034|NCT03265210|80493672|FG001|Overall Study|Withdrawal by Subject|9|||
27632035|NCT03265210|80493671|FG000|Overall Study|Lost to Follow-up|2|||
27632036|NCT03265210|80493672|FG001|Overall Study|Lost to Follow-up|0|||
27632037|NCT03265210|80493671|FG000|Overall Study|Physician Decision|2|||
27632038|NCT03265210|80493672|FG001|Overall Study|Physician Decision|0|||
27632039|NCT03265210|80493671|FG000|Overall Study|Adverse Event|1|||
27632040|NCT03265210|80493672|FG001|Overall Study|Adverse Event|0|||
27632041|NCT01196429|80493676|FG000|Overall Study|Ineligible - inadequate pathology|1|||
27632042|NCT01196429|80493677|FG001|Overall Study|Ineligible - inadequate pathology|0|||
27632043|NCT01196429|80493676|FG000|Overall Study|Ineligible - wrong cell type|1|||
27632044|NCT01196429|80493677|FG001|Overall Study|Ineligible - wrong cell type|0|||
27632045|NCT01196429|80493676|FG000|Overall Study|Refused - Never Treated|1|||
27632046|NCT01196429|80493677|FG001|Overall Study|Refused - Never Treated|0|||
27632047|NCT03068468|80493678|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
27632048|NCT03068468|80493679|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
27632049|NCT03068468|80493680|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
27632050|NCT03068468|80493681|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
27632051|NCT03068468|80493678|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
27632052|NCT03068468|80493679|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
27632053|NCT03068468|80493680|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
27632054|NCT03068468|80493681|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
27632055|NCT03068468|80493678|FG000|Placebo-Controlled Period|Adverse Event|16|||
27632056|NCT03068468|80493679|FG001|Placebo-Controlled Period|Adverse Event|21|||
27632057|NCT03068468|80493680|FG002|Placebo-Controlled Period|Adverse Event|0|||
27632058|NCT03068468|80493681|FG003|Placebo-Controlled Period|Adverse Event|0|||
27632059|NCT03068468|80493678|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
27632060|NCT03068468|80493679|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
27536367|NCT00333840|80159938|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
27536368|NCT00333840|80159935|FG000|Second-line Treatment Period|Abnormal procedure|0|||
27536369|NCT00333840|80159936|FG001|Second-line Treatment Period|Abnormal procedure|0|||
27536370|NCT00333840|80159937|FG002|Second-line Treatment Period|Abnormal procedure|0|||
27536371|NCT00333840|80159938|FG003|Second-line Treatment Period|Abnormal procedure|1|||
27536372|NCT00333840|80159935|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
27536373|NCT00333840|80159936|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
27536374|NCT00333840|80159937|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
27536375|NCT00333840|80159938|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
27536376|NCT00333840|80159935|FG000|Second-line Treatment Period|No longer required study drug|0|||
27536377|NCT00333840|80159936|FG001|Second-line Treatment Period|No longer required study drug|0|||
27536378|NCT00333840|80159937|FG002|Second-line Treatment Period|No longer required study drug|1|||
27536379|NCT00333840|80159938|FG003|Second-line Treatment Period|No longer required study drug|14|||
27536380|NCT00333840|80159935|FG000|Second-line Treatment Period|Protocol Violation|0|||
27536381|NCT00333840|80159936|FG001|Second-line Treatment Period|Protocol Violation|0|||
27632061|NCT03068468|80493680|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
27632062|NCT03068468|80493681|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
27632063|NCT03068468|80493678|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
27632064|NCT03068468|80493679|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
27632065|NCT03068468|80493680|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27632066|NCT03068468|80493681|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
27632067|NCT03068468|80493678|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
27632068|NCT03068468|80493679|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
27632069|NCT03068468|80493680|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
27738730|NCT02158533|80873920|FG003|Stage 2|Physician Decision|0|||
27738731|NCT02158533|80873921|FG004|Stage 2|Physician Decision|1|||
27738732|NCT02158533|80873922|FG005|Stage 2|Physician Decision|0|||
27738733|NCT02158533|80873917|FG000|Stage 2|Pregnancy|0|||
27738734|NCT02158533|80873918|FG001|Stage 2|Pregnancy|0|||
27738735|NCT02158533|80873919|FG002|Stage 2|Pregnancy|0|||
27738736|NCT02158533|80873920|FG003|Stage 2|Pregnancy|1|||
27738737|NCT02158533|80873921|FG004|Stage 2|Pregnancy|0|||
27738738|NCT02158533|80873922|FG005|Stage 2|Pregnancy|0|||
27738739|NCT02158533|80873917|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
27738740|NCT02158533|80873918|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
27738741|NCT02158533|80873919|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
27738742|NCT02158533|80873920|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
27738743|NCT02158533|80873921|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
27738744|NCT02158533|80873922|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
27738745|NCT02158533|80873917|FG000|Stage 2|Non-adherence with study visits|0|||
27536382|NCT00333840|80159937|FG002|Second-line Treatment Period|Protocol Violation|1|||
27536383|NCT00333840|80159938|FG003|Second-line Treatment Period|Protocol Violation|10|||
27536384|NCT00333840|80159935|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
27536385|NCT00333840|80159936|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
27536386|NCT00333840|80159937|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
27536387|NCT00333840|80159938|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
27536388|NCT00333840|80159935|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
27915870|NCT01149655|81529378|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
27915871|NCT01149655|81529379|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
27915872|NCT01149655|81529376|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
27536389|NCT00333840|80159936|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
27536390|NCT00333840|80159937|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
27536391|NCT00333840|80159938|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
27738746|NCT02158533|80873918|FG001|Stage 2|Non-adherence with study visits|0|||
27738747|NCT02158533|80873919|FG002|Stage 2|Non-adherence with study visits|0|||
27738748|NCT02158533|80873920|FG003|Stage 2|Non-adherence with study visits|0|||
27738749|NCT02158533|80873921|FG004|Stage 2|Non-adherence with study visits|0|||
27738750|NCT02158533|80873922|FG005|Stage 2|Non-adherence with study visits|1|||
27738751|NCT02273973|80873923|FG000|Overall Study|Adverse Event|4|||
27738752|NCT02273973|80873924|FG001|Overall Study|Adverse Event|0|||
27738753|NCT02273973|80873923|FG000|Overall Study|Withdrawal by Subject|2|||
27738754|NCT02273973|80873924|FG001|Overall Study|Withdrawal by Subject|3|||
27738755|NCT02273973|80873923|FG000|Overall Study|Death|1|||
27738756|NCT02273973|80873924|FG001|Overall Study|Death|0|||
27738757|NCT02273973|80873923|FG000|Overall Study|Non-compliance|1|||
27738758|NCT02273973|80873924|FG001|Overall Study|Non-compliance|0|||
27738759|NCT02273973|80873923|FG000|Overall Study|Protocol Violation|1|||
27738760|NCT02273973|80873924|FG001|Overall Study|Protocol Violation|0|||
27738761|NCT02273973|80873923|FG000|Overall Study|Progression of disease|0|||
27738762|NCT02273973|80873924|FG001|Overall Study|Progression of disease|2|||
27738763|NCT02273973|80873923|FG000|Overall Study|Lost to Follow-up|0|||
27738764|NCT02273973|80873924|FG001|Overall Study|Lost to Follow-up|1|||
27738765|NCT02273973|80873923|FG000|Overall Study|Physician Decision|0|||
27738766|NCT02273973|80873924|FG001|Overall Study|Physician Decision|1|||
27738767|NCT02273973|80873923|FG000|Overall Study|Reason not specified|0|||
27738768|NCT02273973|80873924|FG001|Overall Study|Reason not specified|1|||
27738769|NCT01450540|80873929|FG000|Overall Study|Withdrawal by Subject|19|||
27738770|NCT01450540|80873930|FG001|Overall Study|Withdrawal by Subject|13|||
27738771|NCT01450540|80873929|FG000|Overall Study|protocol deviation|3|||
27738772|NCT01450540|80873930|FG001|Overall Study|protocol deviation|23|||
27738773|NCT00095303|80873931|FG000|Main Study|Lost to Follow-up|91|||
27738774|NCT00095303|80873932|FG001|Main Study|Lost to Follow-up|87|||
27738775|NCT00095303|80873931|FG000|Follow Up Study|Lost to Follow-up|59|||
27738776|NCT00095303|80873932|FG001|Follow Up Study|Lost to Follow-up|58|||
27738777|NCT02902809|80873935|FG000|Overall Study|Discontinuation of asthma program|28|||
27738778|NCT01208181|80873936|FG000|Part 1|Withdrawal by Subject|11|||
27738779|NCT01208181|80873937|FG001|Part 1|Withdrawal by Subject|10|||
27738780|NCT01208181|80873938|FG002|Part 1|Withdrawal by Subject|0|||
27738781|NCT01208181|80873939|FG003|Part 1|Withdrawal by Subject|0|||
27738782|NCT01208181|80873940|FG004|Part 1|Withdrawal by Subject|0|||
27738783|NCT01208181|80873936|FG000|Part 1|Technical problem|5|||
27915873|NCT01149655|81529377|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27738784|NCT01208181|80873937|FG001|Part 1|Technical problem|0|||
27738785|NCT01208181|80873938|FG002|Part 1|Technical problem|0|||
27738786|NCT01208181|80873939|FG003|Part 1|Technical problem|0|||
27738787|NCT01208181|80873940|FG004|Part 1|Technical problem|0|||
27738788|NCT01208181|80873936|FG000|Part 1|Protocol Violation|10|||
27738789|NCT01208181|80873937|FG001|Part 1|Protocol Violation|5|||
27738790|NCT01208181|80873938|FG002|Part 1|Protocol Violation|0|||
27738791|NCT01208181|80873939|FG003|Part 1|Protocol Violation|0|||
27738792|NCT01208181|80873940|FG004|Part 1|Protocol Violation|0|||
27738793|NCT01208181|80873936|FG000|Part 1|Physician Decision|4|||
27738794|NCT01208181|80873937|FG001|Part 1|Physician Decision|0|||
27738795|NCT01208181|80873938|FG002|Part 1|Physician Decision|0|||
27738796|NCT01208181|80873939|FG003|Part 1|Physician Decision|0|||
27738797|NCT01208181|80873940|FG004|Part 1|Physician Decision|0|||
27738798|NCT01208181|80873936|FG000|Part 1|Non-compliance with study drug|1|||
27738799|NCT01208181|80873937|FG001|Part 1|Non-compliance with study drug|1|||
27738800|NCT01208181|80873938|FG002|Part 1|Non-compliance with study drug|0|||
27738801|NCT01208181|80873939|FG003|Part 1|Non-compliance with study drug|0|||
27738802|NCT01208181|80873940|FG004|Part 1|Non-compliance with study drug|0|||
27738803|NCT01208181|80873936|FG000|Part 1|Lost to Follow-up|5|||
27738804|NCT01208181|80873937|FG001|Part 1|Lost to Follow-up|3|||
27738805|NCT01208181|80873938|FG002|Part 1|Lost to Follow-up|0|||
27738806|NCT01208181|80873939|FG003|Part 1|Lost to Follow-up|0|||
27738807|NCT01208181|80873940|FG004|Part 1|Lost to Follow-up|1|||
27738808|NCT01208181|80873936|FG000|Part 1|Lack of Efficacy|37|||
27738809|NCT01208181|80873937|FG001|Part 1|Lack of Efficacy|12|||
27738810|NCT01208181|80873938|FG002|Part 1|Lack of Efficacy|0|||
27738811|NCT01208181|80873939|FG003|Part 1|Lack of Efficacy|0|||
27738812|NCT01208181|80873940|FG004|Part 1|Lack of Efficacy|17|||
27738813|NCT01208181|80873936|FG000|Part 1|Adverse Event|26|||
27738814|NCT01208181|80873937|FG001|Part 1|Adverse Event|24|||
27738815|NCT01208181|80873938|FG002|Part 1|Adverse Event|0|||
27738816|NCT01208181|80873939|FG003|Part 1|Adverse Event|0|||
27738817|NCT01208181|80873940|FG004|Part 1|Adverse Event|4|||
27738818|NCT01208181|80873936|FG000|Part 2|Adverse Event|0|||
27738819|NCT01208181|80873937|FG001|Part 2|Adverse Event|0|||
27738820|NCT01208181|80873938|FG002|Part 2|Adverse Event|6|||
27738821|NCT01208181|80873939|FG003|Part 2|Adverse Event|7|||
27915874|NCT01149655|81529378|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27915875|NCT01149655|81529379|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
27915876|NCT01149655|81529376|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
27915877|NCT01149655|81529377|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
27915878|NCT01149655|81529378|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
27536392|NCT00333840|80159935|FG000|Second-line Treatment Period|Administrative problems|0|||
27915879|NCT01149655|81529379|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
27915880|NCT01149655|81529376|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
27915881|NCT01149655|81529377|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
27915882|NCT01149655|81529378|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
27536393|NCT00333840|80159936|FG001|Second-line Treatment Period|Administrative problems|0|||
27536394|NCT00333840|80159937|FG002|Second-line Treatment Period|Administrative problems|0|||
27536395|NCT00333840|80159938|FG003|Second-line Treatment Period|Administrative problems|7|||
27536396|NCT00333840|80159935|FG000|Second-line Treatment Period|Death|0|||
27632070|NCT03068468|80493681|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
27738822|NCT01208181|80873940|FG004|Part 2|Adverse Event|0|||
27738823|NCT01208181|80873936|FG000|Part 2|Withdrawal by Subject|0|||
27738824|NCT01208181|80873937|FG001|Part 2|Withdrawal by Subject|0|||
27738825|NCT01208181|80873938|FG002|Part 2|Withdrawal by Subject|1|||
27738826|NCT01208181|80873939|FG003|Part 2|Withdrawal by Subject|1|||
27915883|NCT01149655|81529379|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
27915884|NCT01149655|81529376|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
27915885|NCT01149655|81529377|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
27915886|NCT01149655|81529378|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
27915887|NCT01149655|81529379|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
27915888|NCT01149655|81529376|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
27915889|NCT01149655|81529377|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
27915890|NCT01149655|81529378|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
27915891|NCT01149655|81529379|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
27915892|NCT01149655|81529376|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
27536397|NCT00333840|80159936|FG001|Second-line Treatment Period|Death|0|||
27536398|NCT00333840|80159937|FG002|Second-line Treatment Period|Death|0|||
27536399|NCT00333840|80159938|FG003|Second-line Treatment Period|Death|9|||
27536400|NCT01298531|80159939|FG000|Overall Study|Lack of Efficacy|0|||
27536401|NCT01298531|80159940|FG001|Overall Study|Lack of Efficacy|1|||
27536402|NCT01298531|80159939|FG000|Overall Study|Lost to Follow-up|2|||
27536403|NCT01298531|80159940|FG001|Overall Study|Lost to Follow-up|0|||
27536404|NCT01298531|80159939|FG000|Overall Study|Protocol Violation|1|||
27536405|NCT01298531|80159940|FG001|Overall Study|Protocol Violation|1|||
27632071|NCT03068468|80493678|FG000|Placebo-Controlled Period|Death|0|||
27632072|NCT03068468|80493679|FG001|Placebo-Controlled Period|Death|1|||
27738827|NCT01208181|80873940|FG004|Part 2|Withdrawal by Subject|0|||
27536406|NCT01298531|80159939|FG000|Overall Study|Adverse Event|4|||
27738828|NCT01208181|80873936|FG000|Part 2|Protocol Violation|0|||
27738829|NCT01208181|80873937|FG001|Part 2|Protocol Violation|0|||
27738830|NCT01208181|80873938|FG002|Part 2|Protocol Violation|1|||
27738831|NCT01208181|80873939|FG003|Part 2|Protocol Violation|0|||
27738832|NCT01208181|80873940|FG004|Part 2|Protocol Violation|0|||
27738833|NCT01208181|80873936|FG000|Part 2|Physician Decision|0|||
27738834|NCT01208181|80873937|FG001|Part 2|Physician Decision|0|||
27738835|NCT01208181|80873938|FG002|Part 2|Physician Decision|1|||
27738836|NCT01208181|80873939|FG003|Part 2|Physician Decision|2|||
27738837|NCT01208181|80873940|FG004|Part 2|Physician Decision|0|||
27738838|NCT01208181|80873936|FG000|Part 2|Non-compliance with study drug|0|||
27738839|NCT01208181|80873937|FG001|Part 2|Non-compliance with study drug|0|||
27738840|NCT01208181|80873938|FG002|Part 2|Non-compliance with study drug|1|||
27738841|NCT01208181|80873939|FG003|Part 2|Non-compliance with study drug|1|||
27738842|NCT01208181|80873940|FG004|Part 2|Non-compliance with study drug|0|||
27738843|NCT01208181|80873936|FG000|Part 2|Lost to Follow-up|0|||
27738844|NCT01208181|80873937|FG001|Part 2|Lost to Follow-up|0|||
27738845|NCT01208181|80873938|FG002|Part 2|Lost to Follow-up|1|||
27738846|NCT01208181|80873939|FG003|Part 2|Lost to Follow-up|2|||
27738847|NCT01208181|80873940|FG004|Part 2|Lost to Follow-up|0|||
27738848|NCT01208181|80873936|FG000|Part 2|Lack of Efficacy|0|||
27738849|NCT01208181|80873937|FG001|Part 2|Lack of Efficacy|0|||
27738850|NCT01208181|80873938|FG002|Part 2|Lack of Efficacy|5|||
27738851|NCT01208181|80873939|FG003|Part 2|Lack of Efficacy|7|||
27536407|NCT01298531|80159940|FG001|Overall Study|Adverse Event|3|||
27536408|NCT01298531|80159939|FG000|Overall Study|Does not meet entrance criteria|0|||
27536409|NCT01298531|80159940|FG001|Overall Study|Does not meet entrance criteria|1|||
27536410|NCT01298531|80159939|FG000|Overall Study|Other|2|||
27536411|NCT01298531|80159940|FG001|Overall Study|Other|1|||
27536412|NCT00331864|80159941|FG000|Overall Study|Adverse Event|30|||
27536413|NCT00331864|80159942|FG001|Overall Study|Adverse Event|1|||
27536414|NCT00331864|80159941|FG000|Overall Study|Lack of Efficacy|4|||
27536415|NCT00331864|80159942|FG001|Overall Study|Lack of Efficacy|0|||
27536416|NCT00331864|80159941|FG000|Overall Study|Protocol Violation|3|||
27536417|NCT00331864|80159942|FG001|Overall Study|Protocol Violation|0|||
27536418|NCT00331864|80159941|FG000|Overall Study|Withdrawal by Subject|10|||
27536419|NCT00331864|80159942|FG001|Overall Study|Withdrawal by Subject|0|||
27536420|NCT00331864|80159941|FG000|Overall Study|Lost to Follow-up|4|||
27536421|NCT00331864|80159942|FG001|Overall Study|Lost to Follow-up|3|||
27632073|NCT03068468|80493680|FG002|Placebo-Controlled Period|Death|0|||
27632074|NCT03068468|80493681|FG003|Placebo-Controlled Period|Death|0|||
27632075|NCT03068468|80493678|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
27632076|NCT03068468|80493679|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
27632077|NCT03068468|80493680|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
27632078|NCT03068468|80493681|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
27632079|NCT03068468|80493678|FG000|Open-Label Extension Period|Adverse Event|0|||
27632080|NCT03068468|80493679|FG001|Open-Label Extension Period|Adverse Event|0|||
27632081|NCT03068468|80493680|FG002|Open-Label Extension Period|Adverse Event|13|||
27632082|NCT03068468|80493681|FG003|Open-Label Extension Period|Adverse Event|17|||
27632083|NCT03068468|80493678|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
27632084|NCT03068468|80493679|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
27632085|NCT03068468|80493680|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
27632086|NCT03068468|80493681|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
27632087|NCT03068468|80493678|FG000|Open-Label Extension Period|Death|0|||
27632088|NCT03068468|80493679|FG001|Open-Label Extension Period|Death|0|||
27632089|NCT03068468|80493680|FG002|Open-Label Extension Period|Death|0|||
27632090|NCT03068468|80493681|FG003|Open-Label Extension Period|Death|1|||
27632091|NCT03068468|80493678|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
27632092|NCT03068468|80493679|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
27632093|NCT03068468|80493680|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
27632094|NCT03068468|80493681|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
27632095|NCT03068468|80493678|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
27632096|NCT03068468|80493679|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
27536422|NCT00331864|80159941|FG000|Overall Study|Administrative Problems|1|||
27632097|NCT03068468|80493680|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
27632098|NCT03068468|80493681|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
27632099|NCT03068468|80493678|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
27632100|NCT03068468|80493679|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
27632101|NCT03068468|80493680|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
27632102|NCT03068468|80493681|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
27738852|NCT01208181|80873940|FG004|Part 2|Lack of Efficacy|0|||
27738853|NCT00756002|80873941|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
27536423|NCT00331864|80159942|FG001|Overall Study|Administrative Problems|0|||
27536424|NCT00331864|80159941|FG000|Overall Study|Death|6|||
27632103|NCT03068468|80493678|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
27632104|NCT03068468|80493679|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
27632105|NCT03068468|80493680|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
27738854|NCT00756002|80873942|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
27738855|NCT00756002|80873941|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27738856|NCT00756002|80873942|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
27536425|NCT00331864|80159942|FG001|Overall Study|Death|0|||
27915893|NCT01149655|81529377|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
27536426|NCT02651467|80159943|FG000|Overall Study|Withdrawal by Subject|0|||
27536427|NCT02651467|80159944|FG001|Overall Study|Withdrawal by Subject|0|||
27536428|NCT02651467|80159945|FG002|Overall Study|Withdrawal by Subject|2|||
27536429|NCT02651467|80159943|FG000|Overall Study|Other (Not specified)|1|||
27536430|NCT02651467|80159944|FG001|Overall Study|Other (Not specified)|0|||
27536431|NCT02651467|80159945|FG002|Overall Study|Other (Not specified)|2|||
27536432|NCT01328431|80159946|FG000|Baseline|Protocol Violation|0|||
27536433|NCT01328431|80159947|FG001|Baseline|Protocol Violation|2|||
27536434|NCT01328431|80159946|FG000|1 Month (1M)|Lost to Follow-up|55|||
27536435|NCT01328431|80159947|FG001|1 Month (1M)|Lost to Follow-up|58|||
27536436|NCT01328431|80159946|FG000|3 Month (3M)|Death|2|||
27536437|NCT01328431|80159947|FG001|3 Month (3M)|Death|2|||
27536438|NCT01328431|80159946|FG000|3 Month (3M)|Lost to Follow-up|75|||
27536439|NCT01328431|80159947|FG001|3 Month (3M)|Lost to Follow-up|70|||
27536440|NCT01328431|80159946|FG000|12 Month (12M)|Death|2|||
27536441|NCT01328431|80159947|FG001|12 Month (12M)|Death|6|||
27536442|NCT01328431|80159946|FG000|12 Month (12M)|Lost to Follow-up|82|||
27536443|NCT01328431|80159947|FG001|12 Month (12M)|Lost to Follow-up|91|||
27536444|NCT02761733|80159948|FG000|Overall Study|Death|3|||
27536445|NCT02761733|80159949|FG001|Overall Study|Death|5|||
27536446|NCT02761733|80159950|FG002|Overall Study|Death|1|||
27536447|NCT02761733|80159951|FG003|Overall Study|Death|1|||
27536448|NCT02761733|80159948|FG000|Overall Study|Lost to Follow-up|6|||
27536449|NCT02761733|80159949|FG001|Overall Study|Lost to Follow-up|7|||
27536450|NCT02761733|80159950|FG002|Overall Study|Lost to Follow-up|0|||
27536451|NCT02761733|80159951|FG003|Overall Study|Lost to Follow-up|3|||
27536452|NCT02761733|80159948|FG000|Overall Study|Physician Decision|4|||
27536453|NCT02761733|80159949|FG001|Overall Study|Physician Decision|0|||
27536454|NCT02761733|80159950|FG002|Overall Study|Physician Decision|0|||
27536455|NCT02761733|80159951|FG003|Overall Study|Physician Decision|0|||
27536456|NCT02761733|80159948|FG000|Overall Study|Withdrawal by Subject|2|||
27536457|NCT02761733|80159949|FG001|Overall Study|Withdrawal by Subject|0|||
27536458|NCT02761733|80159950|FG002|Overall Study|Withdrawal by Subject|0|||
27536459|NCT02761733|80159951|FG003|Overall Study|Withdrawal by Subject|0|||
27536460|NCT02761733|80159948|FG000|Overall Study|Discharged from Study Site|10|||
27536461|NCT02761733|80159949|FG001|Overall Study|Discharged from Study Site|9|||
27536462|NCT02761733|80159950|FG002|Overall Study|Discharged from Study Site|25|||
27536463|NCT02761733|80159951|FG003|Overall Study|Discharged from Study Site|11|||
27536464|NCT02761733|80159948|FG000|Overall Study|Cognitive Impairment|5|||
27536465|NCT02761733|80159949|FG001|Overall Study|Cognitive Impairment|0|||
27536466|NCT02761733|80159950|FG002|Overall Study|Cognitive Impairment|1|||
27536467|NCT02761733|80159951|FG003|Overall Study|Cognitive Impairment|0|||
27536468|NCT00239590|80159954|FG000|Randomized|Lost to Follow-up|0|||
27536469|NCT00239590|80159955|FG001|Randomized|Lost to Follow-up|1|||
27536470|NCT00239590|80159954|FG000|Randomized|Withdrawal by Subject|0|||
27536471|NCT00239590|80159955|FG001|Randomized|Withdrawal by Subject|1|||
27536472|NCT00239590|80159954|FG000|Completed Study Protocol|Adverse Event|1|||
27536473|NCT00239590|80159955|FG001|Completed Study Protocol|Adverse Event|1|||
27536474|NCT00239590|80159954|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
27536475|NCT00239590|80159955|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
27536476|NCT02663908|80159956|FG000|Overall Study|Withdrawal by Subject|8|||
27536477|NCT02663908|80159957|FG001|Overall Study|Withdrawal by Subject|5|||
27536478|NCT02663908|80159956|FG000|Overall Study|Lost to Follow-up|1|||
27536479|NCT02663908|80159957|FG001|Overall Study|Lost to Follow-up|5|||
27536480|NCT02663908|80159956|FG000|Overall Study|Adverse Event|13|||
27536481|NCT02663908|80159957|FG001|Overall Study|Adverse Event|11|||
27536482|NCT02663908|80159956|FG000|Overall Study|Protocol Violation|1|||
27536483|NCT02663908|80159957|FG001|Overall Study|Protocol Violation|2|||
27536484|NCT02663908|80159956|FG000|Overall Study|Lack of therapeutic response|2|||
27536485|NCT02663908|80159957|FG001|Overall Study|Lack of therapeutic response|0|||
27536486|NCT02663908|80159956|FG000|Overall Study|COVID-19|1|||
27536487|NCT02663908|80159957|FG001|Overall Study|COVID-19|0|||
27536488|NCT02663908|80159956|FG000|Overall Study|Site closed|1|||
27536489|NCT02663908|80159957|FG001|Overall Study|Site closed|0|||
27536490|NCT02663908|80159956|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
27536491|NCT02663908|80159957|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
27536492|NCT02663908|80159956|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
27536493|NCT02663908|80159957|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
27536494|NCT02663908|80159956|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
27536495|NCT02663908|80159957|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
27536496|NCT02663908|80159956|FG000|Overall Study|Death|1|||
27536497|NCT02663908|80159957|FG001|Overall Study|Death|0|||
27536498|NCT02663908|80159956|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
27536499|NCT02663908|80159957|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
27536500|NCT02663908|80159956|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
27632106|NCT03068468|80493681|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
27632107|NCT03068468|80493678|FG000|Open-Label Extension Period|Reason not Specified|0|||
27632108|NCT03068468|80493679|FG001|Open-Label Extension Period|Reason not Specified|0|||
27632109|NCT03068468|80493680|FG002|Open-Label Extension Period|Reason not Specified|1|||
27632110|NCT03068468|80493681|FG003|Open-Label Extension Period|Reason not Specified|4|||
27632111|NCT04849416|80493682|FG000|Overall Study|Ongoing Treatment|12|||
27632112|NCT04849416|80493683|FG001|Overall Study|Ongoing Treatment|5|||
27632113|NCT04849416|80493684|FG002|Overall Study|Ongoing Treatment|3|||
27632114|NCT04849416|80493682|FG000|Overall Study|On Post-Treatment Follow-up|8|||
27632115|NCT04849416|80493683|FG001|Overall Study|On Post-Treatment Follow-up|9|||
27632116|NCT04849416|80493684|FG002|Overall Study|On Post-Treatment Follow-up|10|||
27632117|NCT04849416|80493682|FG000|Overall Study|Withdrawal by Subject|0|||
27632118|NCT04849416|80493683|FG001|Overall Study|Withdrawal by Subject|0|||
27632119|NCT04849416|80493684|FG002|Overall Study|Withdrawal by Subject|1|||
27632120|NCT04849416|80493682|FG000|Overall Study|Lost to Follow-up|1|||
27632121|NCT04849416|80493683|FG001|Overall Study|Lost to Follow-up|0|||
27632122|NCT04849416|80493684|FG002|Overall Study|Lost to Follow-up|0|||
27632123|NCT01595321|80493686|FG000|Overall Study|Adverse Event|1|||
27632124|NCT01595321|80493687|FG001|Overall Study|Adverse Event|1|||
27632125|NCT01595321|80493688|FG002|Overall Study|Adverse Event|1|||
27632126|NCT01595321|80493686|FG000|Overall Study|Lack of Efficacy|0|||
27632127|NCT01595321|80493687|FG001|Overall Study|Lack of Efficacy|0|||
27632128|NCT01595321|80493688|FG002|Overall Study|Lack of Efficacy|4|||
27632129|NCT00758602|80493689|FG000|Overall Study|Adverse Event|11|||
27632130|NCT00758602|80493690|FG001|Overall Study|Adverse Event|10|||
27632131|NCT00758602|80493689|FG000|Overall Study|Lost to Follow-up|4|||
27632132|NCT00758602|80493690|FG001|Overall Study|Lost to Follow-up|3|||
27632133|NCT00758602|80493689|FG000|Overall Study|Withdrawal by Subject|1|||
27632134|NCT00758602|80493690|FG001|Overall Study|Withdrawal by Subject|3|||
27632135|NCT00758602|80493689|FG000|Overall Study|Protocol Violation|0|||
27632136|NCT00758602|80493690|FG001|Overall Study|Protocol Violation|2|||
27632137|NCT00758602|80493689|FG000|Overall Study|Death|0|||
27632138|NCT00758602|80493690|FG001|Overall Study|Death|1|||
27632139|NCT00758602|80493689|FG000|Overall Study|Reason not specified|3|||
27632140|NCT00758602|80493690|FG001|Overall Study|Reason not specified|3|||
27632141|NCT00972504|80493691|FG000|Overall Study|Adverse Event|2|||
27632142|NCT00972504|80493691|FG000|Overall Study|Investigator discretion|1|||
27632143|NCT00708032|80493692|FG000|Overall Study|Adverse Event|0|||
27632144|NCT00708032|80493693|FG001|Overall Study|Adverse Event|2|||
27632145|NCT00708032|80493692|FG000|Overall Study|Lost to Follow-up|1|||
27632146|NCT00708032|80493693|FG001|Overall Study|Lost to Follow-up|2|||
27632147|NCT00708032|80493692|FG000|Overall Study|Pregnancy|0|||
27632148|NCT00708032|80493693|FG001|Overall Study|Pregnancy|1|||
27632149|NCT00708032|80493692|FG000|Overall Study|Poor vision|0|||
27632150|NCT00708032|80493693|FG001|Overall Study|Poor vision|6|||
27632151|NCT00708032|80493692|FG000|Overall Study|Visit out of range at month 12|4|||
27632152|NCT00708032|80493693|FG001|Overall Study|Visit out of range at month 12|1|||
27632153|NCT00708032|80493692|FG000|Overall Study|Did not meet protocol criteria|1|||
27632154|NCT00708032|80493693|FG001|Overall Study|Did not meet protocol criteria|2|||
27632155|NCT00708032|80493692|FG000|Overall Study|Protocol Violation|4|||
27632156|NCT00708032|80493693|FG001|Overall Study|Protocol Violation|1|||
27632157|NCT00708032|80493692|FG000|Overall Study|Withdrawal by Subject|0|||
27536501|NCT02663908|80159957|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
27536502|NCT00241358|80159968|FG000|Overall Study|Determined to be not ineligible|0|||
27536503|NCT00241358|80159969|FG001|Overall Study|Determined to be not ineligible|1|||
27536504|NCT00241358|80159970|FG002|Overall Study|Determined to be not ineligible|1|||
27536505|NCT04402060|80159971|FG000|Overall Study|Death|1|||
27536506|NCT04402060|80159972|FG001|Overall Study|Death|12|||
27536507|NCT04402060|80159973|FG002|Overall Study|Death|7|||
27536508|NCT04402060|80159971|FG000|Overall Study|Adverse Event|0|||
27536509|NCT04402060|80159972|FG001|Overall Study|Adverse Event|0|||
27632158|NCT00708032|80493693|FG001|Overall Study|Withdrawal by Subject|1|||
27632159|NCT03125382|80493694|FG000|Randomization|screening failure|1|||
27632160|NCT03125382|80493695|FG001|Randomization|screening failure|4|||
27632161|NCT03125382|80493696|FG002|Randomization|screening failure|2|||
27632162|NCT03125382|80493697|FG003|Randomization|screening failure|0|||
27632163|NCT03125382|80493694|FG000|Follow-up|Death|1|||
27632164|NCT03125382|80493695|FG001|Follow-up|Death|2|||
27632165|NCT03125382|80493696|FG002|Follow-up|Death|1|||
27632166|NCT03125382|80493697|FG003|Follow-up|Death|2|||
27632167|NCT03125382|80493694|FG000|Follow-up|Lost to Follow-up|1|||
27632168|NCT03125382|80493695|FG001|Follow-up|Lost to Follow-up|4|||
27632169|NCT03125382|80493696|FG002|Follow-up|Lost to Follow-up|3|||
27632170|NCT03125382|80493697|FG003|Follow-up|Lost to Follow-up|1|||
27536510|NCT04402060|80159973|FG002|Overall Study|Adverse Event|1|||
27536511|NCT04402060|80159971|FG000|Overall Study|Withdrawal by Subject|0|||
27632171|NCT02281318|80493698|FG000|Overall Study|Adverse Event|2|||
27632172|NCT02281318|80493699|FG001|Overall Study|Adverse Event|2|||
27632173|NCT02281318|80493698|FG000|Overall Study|Lack of Efficacy|2|||
27632174|NCT02281318|80493699|FG001|Overall Study|Lack of Efficacy|0|||
27632175|NCT02281318|80493698|FG000|Overall Study|Lost to Follow-up|2|||
27632176|NCT02281318|80493699|FG001|Overall Study|Lost to Follow-up|1|||
27632177|NCT02281318|80493698|FG000|Overall Study|Physician Decision|2|||
27632178|NCT02281318|80493699|FG001|Overall Study|Physician Decision|0|||
27632179|NCT02281318|80493698|FG000|Overall Study|Withdrawal by Subject|6|||
27632180|NCT02281318|80493699|FG001|Overall Study|Withdrawal by Subject|2|||
27632181|NCT04860258|80493700|FG000|Overall Study|Withdrawal by Subject|0|||
27632182|NCT04860258|80493701|FG001|Overall Study|Withdrawal by Subject|0|||
27632183|NCT04860258|80493702|FG002|Overall Study|Withdrawal by Subject|4|||
27632184|NCT04860258|80493703|FG003|Overall Study|Withdrawal by Subject|1|||
27632185|NCT04860258|80493704|FG004|Overall Study|Withdrawal by Subject|4|||
27632186|NCT04860258|80493705|FG005|Overall Study|Withdrawal by Subject|1|||
27632187|NCT04860258|80493706|FG006|Overall Study|Withdrawal by Subject|0|||
27632188|NCT01838200|80493712|FG000|Overall Study|Adverse Event|0|||
27632189|NCT01838200|80493713|FG001|Overall Study|Adverse Event|2|||
27632190|NCT01838200|80493712|FG000|Overall Study|Progressive disease|3|||
27632191|NCT01838200|80493713|FG001|Overall Study|Progressive disease|0|||
27632192|NCT04012853|80493718|FG000|Overall Study|Withdrawal by Subject|1|||
27632193|NCT04012853|80493719|FG001|Overall Study|Withdrawal by Subject|1|||
27632194|NCT04012853|80493718|FG000|Overall Study|Protocol Violation|1|||
27632195|NCT04012853|80493719|FG001|Overall Study|Protocol Violation|0|||
27632196|NCT04012853|80493718|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
27632197|NCT04012853|80493719|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
27632198|NCT03861767|80493722|FG000|Overall Study|Withdrawal by Subject|2|||
27536512|NCT04402060|80159972|FG001|Overall Study|Withdrawal by Subject|1|||
27536513|NCT04402060|80159973|FG002|Overall Study|Withdrawal by Subject|2|||
27632199|NCT03861767|80493723|FG001|Overall Study|Withdrawal by Subject|1|||
27632200|NCT03861767|80493724|FG002|Overall Study|Withdrawal by Subject|0|||
27632201|NCT03861767|80493725|FG003|Overall Study|Withdrawal by Subject|5|||
27632202|NCT03861767|80493726|FG004|Overall Study|Withdrawal by Subject|2|||
27632203|NCT03861767|80493727|FG005|Overall Study|Withdrawal by Subject|1|||
27632204|NCT03861767|80493728|FG006|Overall Study|Withdrawal by Subject|3|||
27632205|NCT03861767|80493729|FG007|Overall Study|Withdrawal by Subject|1|||
27632206|NCT03861767|80493730|FG008|Overall Study|Withdrawal by Subject|0|||
27632207|NCT03861767|80493731|FG009|Overall Study|Withdrawal by Subject|5|||
27632208|NCT03185819|80493737|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
27632209|NCT03185819|80493738|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
27632210|NCT03185819|80493739|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
27632211|NCT03185819|80493740|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
27632212|NCT03185819|80493737|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
27632213|NCT03185819|80493738|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
27632214|NCT03185819|80493739|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
27632215|NCT03185819|80493740|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
27632216|NCT03185819|80493737|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
27632217|NCT03185819|80493738|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
27632218|NCT03185819|80493739|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
27632219|NCT03185819|80493740|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
27632220|NCT03185819|80493737|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
27632221|NCT03185819|80493738|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
27632222|NCT03185819|80493739|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
27632223|NCT03185819|80493740|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
27632224|NCT03185819|80493737|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
27632225|NCT03185819|80493738|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
27632226|NCT03185819|80493739|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
27632227|NCT03185819|80493740|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
27536514|NCT04402060|80159971|FG000|Overall Study|Sponsor Request|0|||
27536515|NCT04402060|80159972|FG001|Overall Study|Sponsor Request|2|||
27536516|NCT04402060|80159973|FG002|Overall Study|Sponsor Request|0|||
27536517|NCT04402060|80159971|FG000|Overall Study|Physician Decision|0|||
27536518|NCT04402060|80159972|FG001|Overall Study|Physician Decision|0|||
27536519|NCT04402060|80159973|FG002|Overall Study|Physician Decision|1|||
27536520|NCT04402060|80159971|FG000|Overall Study|Other|0|||
27536521|NCT04402060|80159972|FG001|Overall Study|Other|1|||
27536522|NCT04402060|80159973|FG002|Overall Study|Other|0|||
27536523|NCT02264639|80159974|FG000|Overall Study|Death (after completing single-dose phase)|1|||
27536524|NCT02264639|80159975|FG001|Overall Study|Death (after completing single-dose phase)|0|||
27536525|NCT02264639|80159976|FG002|Overall Study|Death (after completing single-dose phase)|0|||
27536526|NCT02264639|80159977|FG003|Overall Study|Death (after completing single-dose phase)|0|||
27536527|NCT02264639|80159978|FG004|Overall Study|Death (after completing single-dose phase)|0|||
27536528|NCT02264639|80159974|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
27632228|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
27915894|NCT01149655|81529378|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
27915895|NCT01149655|81529379|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
27915896|NCT01149655|81529376|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
27536529|NCT02264639|80159975|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27536530|NCT02264639|80159976|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27536531|NCT02264639|80159977|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27536532|NCT02264639|80159978|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
27536533|NCT02264639|80159974|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27536534|NCT02264639|80159975|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27536535|NCT02264639|80159976|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
27536536|NCT02264639|80159977|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27536537|NCT02264639|80159978|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
27536538|NCT02264639|80159974|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27536539|NCT02264639|80159975|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27536540|NCT02264639|80159976|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27536541|NCT02264639|80159977|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
27536542|NCT02264639|80159978|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
27536543|NCT00354614|80159979|FG000|Overall Study|Lack of Efficacy|28|||
27536544|NCT01495975|80159980|FG000|Overall Study|Lost to Follow-up|1|||
27536545|NCT01495975|80159981|FG001|Overall Study|Lost to Follow-up|0|||
27536546|NCT00370071|80159982|FG000|Overall Study|Withdrawal by Subject|2|||
27536547|NCT03643159|80159983|FG000|Overall Study|Adverse Event|1|||
27536548|NCT03643159|80159983|FG000|Overall Study|Withdrawal by Subject|1|||
27536549|NCT02215096|80159984|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
27536550|NCT02215096|80159985|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
27536551|NCT02215096|80159986|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
27536552|NCT02215096|80159987|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
27536553|NCT02215096|80159988|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
27536554|NCT02215096|80159984|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27536555|NCT02215096|80159985|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27536556|NCT02215096|80159986|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27536557|NCT02215096|80159987|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
27536558|NCT02215096|80159988|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
27536559|NCT02215096|80159984|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27536560|NCT02215096|80159985|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27536561|NCT02215096|80159986|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27536562|NCT02215096|80159987|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
27536563|NCT02215096|80159988|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
27536564|NCT02215096|80159984|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
27536565|NCT02215096|80159985|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
27536566|NCT02215096|80159986|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
27536567|NCT02215096|80159987|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
27536568|NCT02215096|80159988|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
27536569|NCT02147184|80159989|FG000|Overall Study|Lost to Follow-up|28|||
27536570|NCT02147184|80159990|FG001|Overall Study|Lost to Follow-up|15|||
27536571|NCT02147184|80159989|FG000|Overall Study|Study Burden|11|||
27536572|NCT02147184|80159990|FG001|Overall Study|Study Burden|7|||
27536573|NCT02147184|80159989|FG000|Overall Study|Pregnancy|6|||
27536574|NCT02147184|80159990|FG001|Overall Study|Pregnancy|0|||
27536575|NCT02147184|80159989|FG000|Overall Study|Moved out of state|3|||
27536576|NCT02147184|80159990|FG001|Overall Study|Moved out of state|3|||
27536577|NCT02147184|80159989|FG000|Overall Study|Physician Decision|0|||
27536578|NCT02147184|80159990|FG001|Overall Study|Physician Decision|2|||
27632229|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
27632230|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
27632231|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
27632232|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
27915897|NCT01149655|81529377|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
27536579|NCT02147184|80159989|FG000|Overall Study|Other|1|||
27536580|NCT02147184|80159990|FG001|Overall Study|Other|0|||
27536581|NCT01680965|80159991|FG000|Overall Study|Death|0|||
27536582|NCT01680965|80159992|FG001|Overall Study|Death|0|||
27536583|NCT01680965|80159993|FG002|Overall Study|Death|0|||
27536584|NCT01680965|80159994|FG003|Overall Study|Death|6|||
27536585|NCT01361568|80160000|FG000|Overall Study|Adverse Event|0|||
27536586|NCT01361568|80160001|FG001|Overall Study|Adverse Event|0|||
27536587|NCT01361568|80160002|FG002|Overall Study|Adverse Event|0|||
27536588|NCT01361568|80160003|FG003|Overall Study|Adverse Event|0|||
27536589|NCT01361568|80160004|FG004|Overall Study|Adverse Event|1|||
27536590|NCT01361568|80160005|FG005|Overall Study|Adverse Event|0|||
27536591|NCT01361568|80160000|FG000|Overall Study|Physician Decision|0|||
27536592|NCT01361568|80160001|FG001|Overall Study|Physician Decision|0|||
27536593|NCT01361568|80160002|FG002|Overall Study|Physician Decision|0|||
27536594|NCT01361568|80160003|FG003|Overall Study|Physician Decision|0|||
27915898|NCT01149655|81529378|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
27915899|NCT01149655|81529379|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
27915900|NCT01149655|81529376|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
27915901|NCT01149655|81529377|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
27915902|NCT01149655|81529378|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
27915903|NCT01149655|81529379|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
27915904|NCT01149655|81529376|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
27915905|NCT01149655|81529377|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
27915906|NCT01149655|81529378|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
27915907|NCT01149655|81529379|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
27915908|NCT01149655|81529376|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
27915909|NCT01149655|81529377|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
27915910|NCT01149655|81529378|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
27915911|NCT01149655|81529379|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
27915912|NCT01149655|81529376|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
27915913|NCT01149655|81529377|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
27915914|NCT01149655|81529378|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
27915915|NCT01149655|81529379|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
27915916|NCT01149655|81529376|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
27915917|NCT01149655|81529377|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
27915918|NCT01149655|81529378|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
27915919|NCT01149655|81529379|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
27915920|NCT02337491|81529384|FG000|Overall Study|Death|1|||
27915921|NCT02337491|81529385|FG001|Overall Study|Death|1|||
27915922|NCT02337491|81529384|FG000|Overall Study|Adverse Event|0|||
27915923|NCT02337491|81529385|FG001|Overall Study|Adverse Event|1|||
27915924|NCT02337491|81529384|FG000|Overall Study|Withdrawal by Subject|3|||
27915925|NCT02337491|81529385|FG001|Overall Study|Withdrawal by Subject|0|||
27915926|NCT02337491|81529384|FG000|Overall Study|Progressive Disease|44|||
27915927|NCT02337491|81529385|FG001|Overall Study|Progressive Disease|28|||
27915928|NCT02337491|81529384|FG000|Overall Study|On Treatment|2|||
27915929|NCT02337491|81529385|FG001|Overall Study|On Treatment|0|||
27915930|NCT00471497|81529390|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
27915931|NCT00471497|81529391|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
27915932|NCT00471497|81529392|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
27915933|NCT00471497|81529390|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
27915934|NCT00471497|81529391|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
27915935|NCT00471497|81529392|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
27915936|NCT00471497|81529390|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
27915937|NCT00471497|81529391|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
27915938|NCT00471497|81529392|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
27915939|NCT00471497|81529390|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
27915940|NCT00471497|81529391|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
27915941|NCT00471497|81529392|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
27915942|NCT00471497|81529390|FG000|Core Treatment Phase|Lost to Follow-up|6|||
27915943|NCT00471497|81529391|FG001|Core Treatment Phase|Lost to Follow-up|6|||
27915944|NCT00471497|81529392|FG002|Core Treatment Phase|Lost to Follow-up|3|||
27915945|NCT00471497|81529390|FG000|Core Treatment Phase|Death|3|||
27915946|NCT00471497|81529391|FG001|Core Treatment Phase|Death|9|||
27915947|NCT00471497|81529392|FG002|Core Treatment Phase|Death|3|||
27915948|NCT00471497|81529390|FG000|Core Treatment Phase|Disease Progression|10|||
27915949|NCT00471497|81529391|FG001|Core Treatment Phase|Disease Progression|2|||
27915950|NCT00471497|81529392|FG002|Core Treatment Phase|Disease Progression|4|||
27915951|NCT00471497|81529390|FG000|Core Treatment Phase|Protocol Violation|6|||
27536595|NCT01361568|80160004|FG004|Overall Study|Physician Decision|0|||
27536596|NCT01361568|80160005|FG005|Overall Study|Physician Decision|1|||
27536597|NCT01361568|80160000|FG000|Overall Study|Withdrawal by Subject|2|||
27536598|NCT01361568|80160001|FG001|Overall Study|Withdrawal by Subject|1|||
27536599|NCT01361568|80160002|FG002|Overall Study|Withdrawal by Subject|0|||
27915952|NCT00471497|81529391|FG001|Core Treatment Phase|Protocol Violation|15|||
27915953|NCT00471497|81529392|FG002|Core Treatment Phase|Protocol Violation|11|||
27915954|NCT00471497|81529390|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
27915955|NCT00471497|81529391|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
27915956|NCT00471497|81529392|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
27536600|NCT01361568|80160003|FG003|Overall Study|Withdrawal by Subject|0|||
27536601|NCT01361568|80160004|FG004|Overall Study|Withdrawal by Subject|0|||
27536602|NCT01361568|80160005|FG005|Overall Study|Withdrawal by Subject|1|||
27536603|NCT02281773|80160006|FG000|Overall Study|Adverse Event|6|||
27536604|NCT02281773|80160007|FG001|Overall Study|Adverse Event|1|||
27536605|NCT02281773|80160008|FG002|Overall Study|Adverse Event|4|||
27536606|NCT02281773|80160009|FG003|Overall Study|Adverse Event|8|||
27536607|NCT02281773|80160010|FG004|Overall Study|Adverse Event|9|||
27536608|NCT02281773|80160006|FG000|Overall Study|Protocol Violation|1|||
27536609|NCT02281773|80160007|FG001|Overall Study|Protocol Violation|0|||
27536610|NCT02281773|80160008|FG002|Overall Study|Protocol Violation|0|||
27536611|NCT02281773|80160009|FG003|Overall Study|Protocol Violation|2|||
27536612|NCT02281773|80160010|FG004|Overall Study|Protocol Violation|2|||
27536613|NCT02281773|80160006|FG000|Overall Study|Lost to Follow-up|2|||
27536614|NCT02281773|80160007|FG001|Overall Study|Lost to Follow-up|2|||
27536615|NCT02281773|80160008|FG002|Overall Study|Lost to Follow-up|6|||
27536616|NCT02281773|80160009|FG003|Overall Study|Lost to Follow-up|2|||
27536617|NCT02281773|80160010|FG004|Overall Study|Lost to Follow-up|10|||
27536618|NCT02281773|80160006|FG000|Overall Study|Withdrawal by Subject|2|||
27536619|NCT02281773|80160007|FG001|Overall Study|Withdrawal by Subject|8|||
27536620|NCT02281773|80160008|FG002|Overall Study|Withdrawal by Subject|6|||
27536621|NCT02281773|80160009|FG003|Overall Study|Withdrawal by Subject|6|||
27536622|NCT02281773|80160010|FG004|Overall Study|Withdrawal by Subject|8|||
27536623|NCT02281773|80160006|FG000|Overall Study|Other Reason|0|||
27536624|NCT02281773|80160007|FG001|Overall Study|Other Reason|4|||
27536625|NCT02281773|80160008|FG002|Overall Study|Other Reason|2|||
27536626|NCT02281773|80160009|FG003|Overall Study|Other Reason|3|||
27536627|NCT02281773|80160010|FG004|Overall Study|Other Reason|1|||
27536628|NCT02345226|80160011|FG000|Double-Blind Phase|Adverse Event|5|||
27536629|NCT02345226|80160012|FG001|Double-Blind Phase|Adverse Event|6|||
27536630|NCT02345226|80160011|FG000|Double-Blind Phase|Death|3|||
27536631|NCT02345226|80160012|FG001|Double-Blind Phase|Death|0|||
27536632|NCT02345226|80160011|FG000|Double-Blind Phase|Pregnancy|0|||
27536633|NCT02345226|80160012|FG001|Double-Blind Phase|Pregnancy|1|||
27536634|NCT02345226|80160011|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27536635|NCT02345226|80160012|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27536636|NCT02345226|80160011|FG000|Double-Blind Phase|Investigator's Discretion|4|||
27536637|NCT02345226|80160012|FG001|Double-Blind Phase|Investigator's Discretion|3|||
27536638|NCT02345226|80160011|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27536639|NCT02345226|80160012|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
27536640|NCT02345226|80160011|FG000|Double-Blind Phase|Withdrew Consent|41|||
27536641|NCT02345226|80160012|FG001|Double-Blind Phase|Withdrew Consent|39|||
27536642|NCT02345226|80160011|FG000|Double-Blind Phase|Lost to Follow-up|12|||
27536643|NCT02345226|80160012|FG001|Double-Blind Phase|Lost to Follow-up|16|||
27536644|NCT02345226|80160011|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
27536645|NCT02345226|80160012|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
27536646|NCT02345226|80160011|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27536647|NCT02345226|80160012|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
27536648|NCT00810355|80160015|FG000|Overall Study|Lost to Follow-up|13|||
27536649|NCT00810355|80160016|FG001|Overall Study|Lost to Follow-up|17|||
27536650|NCT00810355|80160017|FG002|Overall Study|Lost to Follow-up|11|||
27536651|NCT00810355|80160015|FG000|Overall Study|Withdrawal by Subject|1|||
27536652|NCT00810355|80160016|FG001|Overall Study|Withdrawal by Subject|0|||
27536653|NCT00810355|80160017|FG002|Overall Study|Withdrawal by Subject|0|||
27536654|NCT00285818|80160018|FG000|Overall Study|Withdrawal by Subject|3|||
27536655|NCT00285818|80160019|FG001|Overall Study|Withdrawal by Subject|2|||
27536656|NCT00285818|80160018|FG000|Overall Study|Lost to Follow-up|1|||
27536657|NCT00285818|80160019|FG001|Overall Study|Lost to Follow-up|0|||
27536658|NCT00697788|80160025|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536659|NCT00697788|80160026|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
27632233|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
27632234|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
27632235|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
27632236|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
27536660|NCT00697788|80160027|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536661|NCT00697788|80160028|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536662|NCT00697788|80160029|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536663|NCT00697788|80160030|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536664|NCT00697788|80160031|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536665|NCT00697788|80160032|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
27536666|NCT00697788|80160025|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536667|NCT00697788|80160026|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536668|NCT00697788|80160027|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536669|NCT00697788|80160028|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536670|NCT00697788|80160029|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
27536671|NCT00697788|80160030|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536672|NCT00697788|80160031|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536673|NCT00697788|80160032|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
27536674|NCT02024555|80160035|FG000|Overall Study|Lost to Follow-up|1|||
27536675|NCT02024555|80160036|FG001|Overall Study|Lost to Follow-up|1|||
27536676|NCT02024555|80160035|FG000|Overall Study|Withdrawal by Subject|5|||
27536677|NCT02024555|80160036|FG001|Overall Study|Withdrawal by Subject|1|||
27536678|NCT00621959|80160037|FG000|Overall Study|Adverse Event|4|||
27632237|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
27632238|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
27536679|NCT00621959|80160038|FG001|Overall Study|Adverse Event|2|||
27536680|NCT00621959|80160037|FG000|Overall Study|Lack of Efficacy|1|||
27536681|NCT00621959|80160038|FG001|Overall Study|Lack of Efficacy|1|||
27536682|NCT00621959|80160037|FG000|Overall Study|Lost to Follow-up|0|||
27536683|NCT00621959|80160038|FG001|Overall Study|Lost to Follow-up|2|||
27536684|NCT00621959|80160037|FG000|Overall Study|Withdrawal by Subject|1|||
27536685|NCT00621959|80160038|FG001|Overall Study|Withdrawal by Subject|1|||
27536686|NCT00621959|80160037|FG000|Overall Study|Other|1|||
27536687|NCT00621959|80160038|FG001|Overall Study|Other|3|||
27536688|NCT00494299|80160039|FG000|Overall Study|Adverse Event|93|||
27536689|NCT00494299|80160040|FG001|Overall Study|Adverse Event|13|||
27536690|NCT00494299|80160039|FG000|Overall Study|Lost to Follow-up|1|||
27536691|NCT00494299|80160040|FG001|Overall Study|Lost to Follow-up|0|||
27536692|NCT00494299|80160039|FG000|Overall Study|Physician Decision|0|||
27536693|NCT00494299|80160040|FG001|Overall Study|Physician Decision|2|||
27536694|NCT00494299|80160039|FG000|Overall Study|Protocol Violation|1|||
27536695|NCT00494299|80160040|FG001|Overall Study|Protocol Violation|2|||
27536696|NCT00494299|80160039|FG000|Overall Study|Withdrawal by Subject|8|||
27536697|NCT00494299|80160040|FG001|Overall Study|Withdrawal by Subject|3|||
27536698|NCT00494299|80160039|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
27536699|NCT00494299|80160040|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
27536700|NCT00494299|80160039|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
27536701|NCT00494299|80160040|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
27536702|NCT00494299|80160039|FG000|Overall Study|Site Closed by Sponsor|6|||
27536703|NCT00494299|80160040|FG001|Overall Study|Site Closed by Sponsor|0|||
27536704|NCT00494299|80160039|FG000|Overall Study|Protocol Driven Decision Point|11|||
27536705|NCT00494299|80160040|FG001|Overall Study|Protocol Driven Decision Point|22|||
27536706|NCT02349542|80160046|FG000|Overall Study|Withdrawal by Subject|5|||
27536707|NCT03945214|80160059|FG000|Overall Study|Lost to Follow-up|3|||
27536708|NCT03945214|80160060|FG001|Overall Study|Lost to Follow-up|4|||
27536709|NCT03945214|80160061|FG002|Overall Study|Lost to Follow-up|7|||
27536710|NCT03945214|80160062|FG003|Overall Study|Lost to Follow-up|4|||
27536711|NCT02124161|80160063|FG000|Overall Study|Other unspecified|0|||
27536712|NCT02124161|80160064|FG001|Overall Study|Other unspecified|1|||
27536713|NCT02124161|80160063|FG000|Overall Study|Death|1|||
27536714|NCT02124161|80160064|FG001|Overall Study|Death|0|||
27536715|NCT02124161|80160063|FG000|Overall Study|Protocol Violation|2|||
27536716|NCT02124161|80160064|FG001|Overall Study|Protocol Violation|1|||
27536717|NCT02124161|80160063|FG000|Overall Study|Withdrawal by Subject|1|||
27632239|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
27738857|NCT00756002|80873941|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
27738858|NCT00756002|80873942|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
27915957|NCT00471497|81529390|FG000|Core Treatment Phase|Administrative problems|14|||
27915958|NCT00471497|81529391|FG001|Core Treatment Phase|Administrative problems|14|||
27915959|NCT00471497|81529392|FG002|Core Treatment Phase|Administrative problems|12|||
27915960|NCT00471497|81529390|FG000|Core Treatment Phase|Adverse Event|43|||
27915961|NCT00471497|81529391|FG001|Core Treatment Phase|Adverse Event|53|||
27915962|NCT00471497|81529392|FG002|Core Treatment Phase|Adverse Event|89|||
27915963|NCT00471497|81529390|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
27915964|NCT00471497|81529391|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
27915965|NCT00471497|81529392|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
27915966|NCT00471497|81529390|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
27915967|NCT00471497|81529391|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
27536718|NCT02124161|80160064|FG001|Overall Study|Withdrawal by Subject|2|||
27536719|NCT02124161|80160063|FG000|Overall Study|Adverse Event|2|||
27536720|NCT02124161|80160064|FG001|Overall Study|Adverse Event|0|||
27536721|NCT02124161|80160063|FG000|Overall Study|Does not meet entrance criteria|2|||
27536722|NCT02124161|80160064|FG001|Overall Study|Does not meet entrance criteria|3|||
27536723|NCT02124161|80160063|FG000|Overall Study|No longer meets eligibility criteria|5|||
27536724|NCT02124161|80160064|FG001|Overall Study|No longer meets eligibility criteria|4|||
27536725|NCT02124161|80160063|FG000|Overall Study|Lost to Follow-up|3|||
27536726|NCT02124161|80160064|FG001|Overall Study|Lost to Follow-up|4|||
27536727|NCT02905149|80160067|FG000|Overall Study|Lost to Follow-up|2|||
27536728|NCT02905149|80160068|FG001|Overall Study|Lost to Follow-up|0|||
27536729|NCT01013350|80160069|FG000|Overall Study|Lost to Follow-up|15|||
27738859|NCT00756002|80873941|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
27738860|NCT00756002|80873942|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
27738861|NCT00756002|80873941|FG000|Double-Blind Treatment Period|Other|2|||
27738862|NCT00756002|80873942|FG001|Double-Blind Treatment Period|Other|2|||
27738863|NCT01614457|80873943|FG000|Overall Study|Non-Compliance|1|||
27738864|NCT01614457|80873944|FG001|Overall Study|Non-Compliance|0|||
27738865|NCT01614457|80873943|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
27738866|NCT01614457|80873944|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
27738867|NCT01416610|80873945|FG000|Overall Study|Adverse Event|4|||
27738868|NCT01416610|80873945|FG000|Overall Study|Adverse Event -Patient decision|3|||
27738869|NCT01416610|80873945|FG000|Overall Study|Lack of Efficacy|4|||
27738870|NCT01416610|80873945|FG000|Overall Study|No reason given|5|||
27738871|NCT01416610|80873945|FG000|Overall Study|Withdrawal by Subject|13|||
27738872|NCT01416610|80873945|FG000|Overall Study|Lost to Follow-up|7|||
27738873|NCT01416610|80873945|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
27738874|NCT00907738|80873946|FG000|Overall Study|Adverse Event|2|||
27738875|NCT00907738|80873947|FG001|Overall Study|Adverse Event|0|||
27738876|NCT00907738|80873948|FG002|Overall Study|Adverse Event|1|||
27738877|NCT00907738|80873949|FG003|Overall Study|Adverse Event|0|||
27738878|NCT00907738|80873950|FG004|Overall Study|Adverse Event|0|||
27738879|NCT00907738|80873946|FG000|Overall Study|not specified or withdrew consent|3|||
27738880|NCT00907738|80873947|FG001|Overall Study|not specified or withdrew consent|0|||
27738881|NCT00907738|80873948|FG002|Overall Study|not specified or withdrew consent|0|||
27738882|NCT00907738|80873949|FG003|Overall Study|not specified or withdrew consent|0|||
27738883|NCT00907738|80873950|FG004|Overall Study|not specified or withdrew consent|0|||
27738884|NCT00907738|80873946|FG000|Overall Study|Disease progression|8|||
27738885|NCT00907738|80873947|FG001|Overall Study|Disease progression|1|||
27738886|NCT00907738|80873948|FG002|Overall Study|Disease progression|6|||
27738887|NCT00907738|80873949|FG003|Overall Study|Disease progression|4|||
27738888|NCT00907738|80873950|FG004|Overall Study|Disease progression|2|||
27738889|NCT02240628|80873951|FG000|Overall Study|Physician Decision|6|||
27738890|NCT02240628|80873952|FG001|Overall Study|Physician Decision|5|||
27738891|NCT00850499|80873954|FG000|Overall Study|Adverse Event|3|||
27738892|NCT00850499|80873955|FG001|Overall Study|Adverse Event|1|||
27738893|NCT00850499|80873954|FG000|Overall Study|Lack of Efficacy|0|||
27738894|NCT00850499|80873955|FG001|Overall Study|Lack of Efficacy|1|||
27738895|NCT02285010|80873956|FG000|Overall Study|not abdominal hysterectomy|2|||
27738896|NCT02285010|80873957|FG001|Overall Study|not abdominal hysterectomy|0|||
27738897|NCT02285010|80873956|FG000|Overall Study|Not spinal anesthesia|3|||
27738898|NCT02285010|80873957|FG001|Overall Study|Not spinal anesthesia|1|||
27738899|NCT03443024|80873961|FG000|Overall Study|Adverse Event|2|||
27738900|NCT03443024|80873962|FG001|Overall Study|Adverse Event|4|||
27738901|NCT03443024|80873963|FG002|Overall Study|Adverse Event|3|||
27738902|NCT03443024|80873964|FG003|Overall Study|Adverse Event|1|||
27738903|NCT03443024|80873961|FG000|Overall Study|Lost to Follow-up|9|||
27738904|NCT03443024|80873962|FG001|Overall Study|Lost to Follow-up|9|||
27738905|NCT03443024|80873963|FG002|Overall Study|Lost to Follow-up|7|||
27738906|NCT03443024|80873964|FG003|Overall Study|Lost to Follow-up|5|||
27738907|NCT03443024|80873961|FG000|Overall Study|Withdrawal by Subject|8|||
27738908|NCT03443024|80873962|FG001|Overall Study|Withdrawal by Subject|15|||
27738909|NCT03443024|80873963|FG002|Overall Study|Withdrawal by Subject|9|||
27738910|NCT03443024|80873964|FG003|Overall Study|Withdrawal by Subject|23|||
27738911|NCT03443024|80873961|FG000|Overall Study|Physician Decision|1|||
27738912|NCT03443024|80873962|FG001|Overall Study|Physician Decision|2|||
27738913|NCT03443024|80873963|FG002|Overall Study|Physician Decision|0|||
27738914|NCT03443024|80873964|FG003|Overall Study|Physician Decision|1|||
27738915|NCT03443024|80873961|FG000|Overall Study|Sponsor Decision|1|||
27738916|NCT03443024|80873962|FG001|Overall Study|Sponsor Decision|1|||
27738917|NCT03443024|80873963|FG002|Overall Study|Sponsor Decision|0|||
27738918|NCT03443024|80873964|FG003|Overall Study|Sponsor Decision|0|||
27738919|NCT03443024|80873961|FG000|Overall Study|Protocol Deviation|0|||
27738920|NCT03443024|80873962|FG001|Overall Study|Protocol Deviation|0|||
27738921|NCT03443024|80873963|FG002|Overall Study|Protocol Deviation|0|||
27738922|NCT03443024|80873964|FG003|Overall Study|Protocol Deviation|2|||
27738923|NCT02990338|80873968|FG000|Overall Study|Ongoing|30|||
27738924|NCT02990338|80873969|FG001|Overall Study|Ongoing|36|||
27738925|NCT01901328|80873970|FG000|Overall Study|Lost to Follow-up|1|||
27738926|NCT01901328|80873971|FG001|Overall Study|Lost to Follow-up|0|||
27738927|NCT01901328|80873970|FG000|Overall Study|Physician Decision|0|||
27738928|NCT01901328|80873971|FG001|Overall Study|Physician Decision|1|||
27738929|NCT01901328|80873970|FG000|Overall Study|Protocol Violation|1|||
27738930|NCT01901328|80873971|FG001|Overall Study|Protocol Violation|1|||
27738931|NCT01901328|80873970|FG000|Overall Study|Study Terminated by Sponsor|19|||
27738932|NCT01901328|80873971|FG001|Overall Study|Study Terminated by Sponsor|16|||
27738933|NCT01901328|80873970|FG000|Overall Study|Withdrawal by Subject|1|||
27738934|NCT01901328|80873971|FG001|Overall Study|Withdrawal by Subject|2|||
27738935|NCT01901328|80873970|FG000|Overall Study|Lack of Efficacy|0|||
27738936|NCT01901328|80873971|FG001|Overall Study|Lack of Efficacy|1|||
27738937|NCT02109029|80873972|FG000|Part B|Adverse Event|0|||
27536730|NCT01013350|80160070|FG001|Overall Study|Lost to Follow-up|95|||
27536731|NCT01013350|80160069|FG000|Overall Study|Adverse Event|0|||
27536732|NCT01013350|80160070|FG001|Overall Study|Adverse Event|1|||
27536733|NCT01013350|80160069|FG000|Overall Study|Physician Decision|4|||
27632240|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
27632241|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
27632242|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
27632243|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
27632244|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
27632245|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
27632246|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
27632247|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
27632248|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
27632249|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
27632250|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
27632251|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
27632252|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
27632253|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
27632254|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
27632255|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
27738938|NCT02109029|80873973|FG001|Part B|Adverse Event|0|||
27738939|NCT02109029|80873974|FG002|Part B|Adverse Event|0|||
27738940|NCT02109029|80873975|FG003|Part B|Adverse Event|0|||
27738941|NCT02109029|80873976|FG004|Part B|Adverse Event|1|||
27738942|NCT02109029|80873977|FG005|Part B|Adverse Event|1|||
27738943|NCT04272606|80873978|FG000|Overall Study|Protocol Violation|1|||
27738944|NCT04272606|80873979|FG001|Overall Study|Protocol Violation|1|||
27738945|NCT04272606|80873978|FG000|Overall Study|Physician Decision|0|||
27738946|NCT04272606|80873979|FG001|Overall Study|Physician Decision|1|||
27738947|NCT00090285|80873980|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
27738948|NCT00090285|80873981|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
27738949|NCT00090285|80873982|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
27738950|NCT00090285|80873983|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
27738951|NCT00090285|80873984|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
27738952|NCT00090285|80873985|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
27738953|NCT00090285|80873980|FG000|Base Study Vaccination Period|Adverse Event|2|||
27738954|NCT00090285|80873981|FG001|Base Study Vaccination Period|Adverse Event|4|||
27738955|NCT00090285|80873982|FG002|Base Study Vaccination Period|Adverse Event|0|||
27738956|NCT00090285|80873983|FG003|Base Study Vaccination Period|Adverse Event|0|||
27738957|NCT00090285|80873984|FG004|Base Study Vaccination Period|Adverse Event|0|||
27738958|NCT00090285|80873985|FG005|Base Study Vaccination Period|Adverse Event|0|||
27738959|NCT00090285|80873980|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
27738960|NCT00090285|80873981|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
27738961|NCT00090285|80873982|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
27738962|NCT00090285|80873983|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
27738963|NCT00090285|80873984|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
27738964|NCT00090285|80873985|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
27536734|NCT01013350|80160070|FG001|Overall Study|Physician Decision|20|||
27536735|NCT01013350|80160069|FG000|Overall Study|Withdrawal by Subject|15|||
27536736|NCT01013350|80160070|FG001|Overall Study|Withdrawal by Subject|38|||
27536737|NCT01013350|80160069|FG000|Overall Study|Death|3|||
27536738|NCT01013350|80160070|FG001|Overall Study|Death|5|||
27536739|NCT01013350|80160069|FG000|Overall Study|Participant entered interventional study|0|||
27536740|NCT01013350|80160070|FG001|Overall Study|Participant entered interventional study|8|||
27536741|NCT01013350|80160069|FG000|Overall Study|Other|1|||
27536742|NCT01013350|80160070|FG001|Overall Study|Other|25|||
27536743|NCT04587271|80160078|FG000|Overall Study|Lost to Follow-up|2|||
27536744|NCT04587271|80160079|FG001|Overall Study|Lost to Follow-up|2|||
27536745|NCT04587271|80160080|FG002|Overall Study|Lost to Follow-up|0|||
27536746|NCT04587271|80160081|FG003|Overall Study|Lost to Follow-up|2|||
27536747|NCT04587271|80160082|FG004|Overall Study|Lost to Follow-up|2|||
27536748|NCT04587271|80160083|FG005|Overall Study|Lost to Follow-up|0|||
27536749|NCT04587271|80160078|FG000|Overall Study|Caregiver brought child to visits|0|||
27536750|NCT04587271|80160079|FG001|Overall Study|Caregiver brought child to visits|0|||
27536751|NCT04587271|80160080|FG002|Overall Study|Caregiver brought child to visits|0|||
27536752|NCT04587271|80160081|FG003|Overall Study|Caregiver brought child to visits|1|||
27536753|NCT04587271|80160082|FG004|Overall Study|Caregiver brought child to visits|0|||
27536754|NCT04587271|80160083|FG005|Overall Study|Caregiver brought child to visits|0|||
27536755|NCT01254331|80160084|FG000|Initial Phase|Adverse Event|3|||
27915968|NCT00471497|81529392|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
27915969|NCT00471497|81529390|FG000|Extension Phase|Adverse Event|9|||
27915970|NCT00471497|81529391|FG001|Extension Phase|Adverse Event|5|||
27915971|NCT00471497|81529392|FG002|Extension Phase|Adverse Event|1|||
27915972|NCT00471497|81529390|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
27915973|NCT00471497|81529391|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
27915974|NCT00471497|81529392|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
27915975|NCT00471497|81529390|FG000|Extension Phase|Withdrawal by Subject|3|||
27915976|NCT00471497|81529391|FG001|Extension Phase|Withdrawal by Subject|1|||
27915977|NCT00471497|81529392|FG002|Extension Phase|Withdrawal by Subject|0|||
27915978|NCT00471497|81529390|FG000|Extension Phase|Lost to Follow-up|2|||
27915979|NCT00471497|81529391|FG001|Extension Phase|Lost to Follow-up|0|||
27915980|NCT00471497|81529392|FG002|Extension Phase|Lost to Follow-up|0|||
27915981|NCT00471497|81529390|FG000|Extension Phase|Death|1|||
27915982|NCT00471497|81529391|FG001|Extension Phase|Death|0|||
27536756|NCT01254331|80160084|FG000|Initial Phase|Withdrawal by Subject|1|||
27536757|NCT01254331|80160084|FG000|Initial Phase|Pregnancy|1|||
27536758|NCT01254331|80160084|FG000|Extension Phase|Lack of Efficacy|1|||
27536759|NCT01254331|80160084|FG000|Extension Phase|Lost to Follow-up|3|||
27536760|NCT04203498|80160088|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
27536761|NCT04203498|80160089|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
27536762|NCT04203498|80160088|FG000|Overall Study|Withdrawal of patient consent|7|||
27536763|NCT04203498|80160089|FG001|Overall Study|Withdrawal of patient consent|2|||
27536764|NCT04203498|80160088|FG000|Overall Study|Adverse Event|4|||
27536765|NCT04203498|80160089|FG001|Overall Study|Adverse Event|1|||
27536766|NCT04203498|80160088|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
27536767|NCT04203498|80160089|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
27536768|NCT04203498|80160088|FG000|Overall Study|Did not receive IMP|2|||
27536769|NCT04203498|80160089|FG001|Overall Study|Did not receive IMP|0|||
27536770|NCT04806503|80160090|FG000|Overall Study|Lost to Follow-up|0|||
27536771|NCT04806503|80160091|FG001|Overall Study|Lost to Follow-up|0|||
27536772|NCT04806503|80160092|FG002|Overall Study|Lost to Follow-up|1|||
27536773|NCT04806503|80160093|FG003|Overall Study|Lost to Follow-up|0|||
27536774|NCT04806503|80160094|FG004|Overall Study|Lost to Follow-up|0|||
27536775|NCT04806503|80160090|FG000|Overall Study|Withdrawal by Subject|1|||
27632256|NCT03185819|80493737|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
27632257|NCT03185819|80493738|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
27632258|NCT03185819|80493739|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
27632259|NCT03185819|80493740|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
27632260|NCT00878722|80493741|FG000|Overall Study|Progressive disease|3|||
27632261|NCT00878722|80493742|FG001|Overall Study|Progressive disease|3|||
27632262|NCT00878722|80493743|FG002|Overall Study|Progressive disease|3|||
27632263|NCT00878722|80493744|FG003|Overall Study|Progressive disease|7|||
27632264|NCT00878722|80493745|FG004|Overall Study|Progressive disease|7|||
27632265|NCT00878722|80493746|FG005|Overall Study|Progressive disease|1|||
27632266|NCT00878722|80493747|FG006|Overall Study|Progressive disease|4|||
27632267|NCT00878722|80493748|FG007|Overall Study|Progressive disease|3|||
27632268|NCT00878722|80493741|FG000|Overall Study|Death|0|||
27632269|NCT00878722|80493742|FG001|Overall Study|Death|0|||
27632270|NCT00878722|80493743|FG002|Overall Study|Death|0|||
27536776|NCT04806503|80160091|FG001|Overall Study|Withdrawal by Subject|0|||
27536777|NCT04806503|80160092|FG002|Overall Study|Withdrawal by Subject|1|||
27536778|NCT04806503|80160093|FG003|Overall Study|Withdrawal by Subject|1|||
27536779|NCT04806503|80160094|FG004|Overall Study|Withdrawal by Subject|1|||
27536780|NCT04806503|80160090|FG000|Overall Study|Adverse Event|1|||
27536781|NCT04806503|80160091|FG001|Overall Study|Adverse Event|1|||
27536782|NCT04806503|80160092|FG002|Overall Study|Adverse Event|0|||
27536783|NCT04806503|80160093|FG003|Overall Study|Adverse Event|1|||
27536784|NCT04806503|80160094|FG004|Overall Study|Adverse Event|0|||
27536785|NCT04154930|80160098|FG000|Overall Study|Withdrawal by Subject|15|||
27536786|NCT04154930|80160099|FG001|Overall Study|Withdrawal by Subject|6|||
27536787|NCT04154930|80160098|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
27536788|NCT04154930|80160099|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
27536789|NCT04154930|80160098|FG000|Overall Study|Lost to Follow-up|14|||
27536790|NCT04154930|80160099|FG001|Overall Study|Lost to Follow-up|6|||
27632271|NCT00878722|80493744|FG003|Overall Study|Death|1|||
27632272|NCT00878722|80493745|FG004|Overall Study|Death|0|||
27915983|NCT00471497|81529392|FG002|Extension Phase|Death|0|||
27915984|NCT00471497|81529390|FG000|Extension Phase|Disease progression|2|||
27915985|NCT00471497|81529391|FG001|Extension Phase|Disease progression|0|||
27915986|NCT00471497|81529392|FG002|Extension Phase|Disease progression|0|||
27915987|NCT00471497|81529390|FG000|Extension Phase|Protocol Violation|2|||
27915988|NCT00471497|81529391|FG001|Extension Phase|Protocol Violation|2|||
27915989|NCT00471497|81529392|FG002|Extension Phase|Protocol Violation|0|||
27915990|NCT03528551|81529393|FG000|Overall Study|Lost to Follow-up|0|||
27915991|NCT03528551|81529394|FG001|Overall Study|Lost to Follow-up|1|||
27536791|NCT04154930|80160098|FG000|Overall Study|Other|6|||
27632273|NCT00878722|80493746|FG005|Overall Study|Death|1|||
27632274|NCT00878722|80493747|FG006|Overall Study|Death|0|||
27632275|NCT00878722|80493748|FG007|Overall Study|Death|2|||
27632276|NCT00878722|80493741|FG000|Overall Study|Adverse Event|0|||
27632277|NCT00878722|80493742|FG001|Overall Study|Adverse Event|0|||
27632278|NCT00878722|80493743|FG002|Overall Study|Adverse Event|0|||
27632279|NCT00878722|80493744|FG003|Overall Study|Adverse Event|0|||
27632280|NCT00878722|80493745|FG004|Overall Study|Adverse Event|0|||
27915992|NCT03528551|81529395|FG002|Overall Study|Lost to Follow-up|0|||
27915993|NCT03528551|81529393|FG000|Overall Study|Transferred to other arm/group|2|||
27915994|NCT03528551|81529394|FG001|Overall Study|Transferred to other arm/group|3|||
27915995|NCT03528551|81529395|FG002|Overall Study|Transferred to other arm/group|0|||
27915996|NCT03528551|81529393|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27915997|NCT03528551|81529394|FG001|Overall Study|Withdrawal by parent/guardian|5|||
27915998|NCT03528551|81529395|FG002|Overall Study|Withdrawal by parent/guardian|0|||
27915999|NCT03528551|81529393|FG000|Overall Study|Protocol Violation|0|||
27916000|NCT03528551|81529394|FG001|Overall Study|Protocol Violation|3|||
27916001|NCT03528551|81529395|FG002|Overall Study|Protocol Violation|0|||
27916002|NCT03528551|81529393|FG000|Overall Study|Withdrawal by Subject|0|||
27916003|NCT03528551|81529394|FG001|Overall Study|Withdrawal by Subject|7|||
27916004|NCT03528551|81529395|FG002|Overall Study|Withdrawal by Subject|0|||
27916005|NCT03110354|81529396|FG000|Overall Study|Death|1|||
27916006|NCT03110354|81529397|FG001|Overall Study|Death|0|||
27916007|NCT03110354|81529398|FG002|Overall Study|Death|0|||
27536792|NCT04154930|80160099|FG001|Overall Study|Other|0|||
27536793|NCT02357979|80160100|FG000|Overall Study|Lost to Follow-up|5|||
27536794|NCT02357979|80160101|FG001|Overall Study|Lost to Follow-up|5|||
27536795|NCT00910273|80160102|FG000|Overall Study|Lack of Efficacy|6|||
27536796|NCT00910273|80160103|FG001|Overall Study|Lack of Efficacy|9|||
27536797|NCT00910273|80160102|FG000|Overall Study|Adverse Event|1|||
27536798|NCT00910273|80160103|FG001|Overall Study|Adverse Event|1|||
27536799|NCT00910273|80160102|FG000|Overall Study|Withdrawal by Subject|1|||
27536800|NCT00910273|80160103|FG001|Overall Study|Withdrawal by Subject|0|||
27536801|NCT00910273|80160102|FG000|Overall Study|Discontinuation of study by sponsor|8|||
27536802|NCT00910273|80160103|FG001|Overall Study|Discontinuation of study by sponsor|2|||
27536803|NCT00910273|80160102|FG000|Overall Study|Protocol Violation|1|||
27536804|NCT00910273|80160103|FG001|Overall Study|Protocol Violation|0|||
27536805|NCT00910273|80160102|FG000|Overall Study|Lost to Follow-up|1|||
27536806|NCT00910273|80160103|FG001|Overall Study|Lost to Follow-up|1|||
27536807|NCT03437512|80160104|FG000|Randomized|Withdrawal by Subject|0|||
27536808|NCT03437512|80160105|FG001|Randomized|Withdrawal by Subject|2|||
27536809|NCT03437512|80160104|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
27536810|NCT03437512|80160105|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
27536811|NCT00406354|80160108|FG000|All Randomized Patients|Protocol Violation|0|||
27536812|NCT00406354|80160109|FG001|All Randomized Patients|Protocol Violation|0|||
27536813|NCT00406354|80160110|FG002|All Randomized Patients|Protocol Violation|1|||
27536814|NCT00406354|80160108|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
27536815|NCT00406354|80160109|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
27536816|NCT00406354|80160110|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
27536817|NCT00406354|80160108|FG000|All Randomized and Treated Patients|Adverse Event|6|||
27536818|NCT00406354|80160109|FG001|All Randomized and Treated Patients|Adverse Event|2|||
27536819|NCT00406354|80160110|FG002|All Randomized and Treated Patients|Adverse Event|1|||
27536820|NCT00406354|80160108|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
27536821|NCT00406354|80160109|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
27536822|NCT00406354|80160110|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
27536823|NCT00406354|80160108|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
27536824|NCT00406354|80160109|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
27536825|NCT00406354|80160110|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
27632281|NCT00878722|80493746|FG005|Overall Study|Adverse Event|0|||
27632282|NCT00878722|80493747|FG006|Overall Study|Adverse Event|2|||
27632283|NCT00878722|80493748|FG007|Overall Study|Adverse Event|0|||
27632284|NCT00878722|80493741|FG000|Overall Study|Withdrawal by Subject|0|||
27916008|NCT03110354|81529399|FG003|Overall Study|Death|1|||
27916009|NCT03110354|81529400|FG004|Overall Study|Death|0|||
27916010|NCT03110354|81529396|FG000|Overall Study|Start of new therapy|0|||
27916011|NCT03110354|81529397|FG001|Overall Study|Start of new therapy|0|||
27916012|NCT03110354|81529398|FG002|Overall Study|Start of new therapy|0|||
27916013|NCT03110354|81529399|FG003|Overall Study|Start of new therapy|0|||
27916014|NCT03110354|81529400|FG004|Overall Study|Start of new therapy|1|||
27916015|NCT03110354|81529396|FG000|Overall Study|Failure to achieve response|2|||
27916016|NCT03110354|81529397|FG001|Overall Study|Failure to achieve response|3|||
27916017|NCT03110354|81529398|FG002|Overall Study|Failure to achieve response|0|||
27916018|NCT03110354|81529399|FG003|Overall Study|Failure to achieve response|2|||
27916019|NCT03110354|81529400|FG004|Overall Study|Failure to achieve response|1|||
27916020|NCT03110354|81529396|FG000|Overall Study|Progressive disease|1|||
27916021|NCT03110354|81529397|FG001|Overall Study|Progressive disease|1|||
27632285|NCT00878722|80493742|FG001|Overall Study|Withdrawal by Subject|0|||
27632286|NCT00878722|80493743|FG002|Overall Study|Withdrawal by Subject|0|||
27632287|NCT00878722|80493744|FG003|Overall Study|Withdrawal by Subject|0|||
27632288|NCT00878722|80493745|FG004|Overall Study|Withdrawal by Subject|0|||
27632289|NCT00878722|80493746|FG005|Overall Study|Withdrawal by Subject|0|||
27632290|NCT00878722|80493747|FG006|Overall Study|Withdrawal by Subject|0|||
27632291|NCT00878722|80493748|FG007|Overall Study|Withdrawal by Subject|2|||
27632292|NCT00878722|80493741|FG000|Overall Study|Relapse|0|||
27632293|NCT00878722|80493742|FG001|Overall Study|Relapse|0|||
27632294|NCT00878722|80493743|FG002|Overall Study|Relapse|0|||
27632295|NCT00878722|80493744|FG003|Overall Study|Relapse|1|||
27632296|NCT00878722|80493745|FG004|Overall Study|Relapse|0|||
27916022|NCT03110354|81529398|FG002|Overall Study|Progressive disease|3|||
27916023|NCT03110354|81529399|FG003|Overall Study|Progressive disease|4|||
27916024|NCT03110354|81529400|FG004|Overall Study|Progressive disease|2|||
27916025|NCT03110354|81529396|FG000|Overall Study|Adverse Event|0|||
27916026|NCT03110354|81529397|FG001|Overall Study|Adverse Event|0|||
27916027|NCT03110354|81529398|FG002|Overall Study|Adverse Event|0|||
27916028|NCT03110354|81529399|FG003|Overall Study|Adverse Event|2|||
27916029|NCT03110354|81529400|FG004|Overall Study|Adverse Event|2|||
27916030|NCT03110354|81529396|FG000|Overall Study|Other|0|||
27916031|NCT03110354|81529397|FG001|Overall Study|Other|0|||
27916032|NCT03110354|81529398|FG002|Overall Study|Other|0|||
27536826|NCT00406354|80160108|FG000|All Randomized and Treated Patients|Physician Decision|0|||
27536827|NCT00406354|80160109|FG001|All Randomized and Treated Patients|Physician Decision|0|||
27536828|NCT00406354|80160110|FG002|All Randomized and Treated Patients|Physician Decision|1|||
27536829|NCT04195906|80160111|FG000|Part 1|Adverse Event|3|||
27536830|NCT04195906|80160112|FG001|Part 1|Adverse Event|7|||
27536831|NCT04195906|80160111|FG000|Part 1|Withdrawal by Subject|0|||
27536832|NCT04195906|80160112|FG001|Part 1|Withdrawal by Subject|1|||
27536833|NCT04195906|80160111|FG000|Part 2|Adverse Event|1|||
27536834|NCT04195906|80160112|FG001|Part 2|Adverse Event|1|||
27536835|NCT04195906|80160111|FG000|Part 2|Withdrawal by Subject|0|||
27536836|NCT04195906|80160112|FG001|Part 2|Withdrawal by Subject|3|||
27536837|NCT04195906|80160111|FG000|Part 2|Other|1|||
27536838|NCT04195906|80160112|FG001|Part 2|Other|3|||
27536839|NCT01890746|80160113|FG000|Overall Study|Death|39|||
27632297|NCT00878722|80493746|FG005|Overall Study|Relapse|0|||
27632298|NCT00878722|80493747|FG006|Overall Study|Relapse|0|||
27738965|NCT00090285|80873980|FG000|Base Study Vaccination Period|Protocol Violation|2|||
27738966|NCT00090285|80873981|FG001|Base Study Vaccination Period|Protocol Violation|3|||
27916033|NCT03110354|81529399|FG003|Overall Study|Other|1|||
27916034|NCT03110354|81529400|FG004|Overall Study|Other|1|||
27916035|NCT01526785|81529401|FG000|Overall Study|Study Terminated by Sponsor|8|||
27916036|NCT01526785|81529401|FG000|Overall Study|Death|2|||
27916037|NCT01526785|81529401|FG000|Overall Study|Physician Decision|1|||
27916038|NCT01526785|81529401|FG000|Overall Study|Withdrawal by Subject|2|||
27916039|NCT02364388|81529402|FG000|Overall Study|Protocol Violation|1|||
27916040|NCT02364388|81529402|FG000|Overall Study|Technical Failure|3|||
27916041|NCT02364388|81529402|FG000|Overall Study|No OA/US data|2|||
27916042|NCT02364388|81529402|FG000|Overall Study|No Biopsy|2|||
27916043|NCT01159574|81529405|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
27916044|NCT01159574|81529405|FG000|Treatment Phase|Adverse Event|3|||
27916045|NCT01159574|81529405|FG000|Treatment Phase|Death|6|||
27916046|NCT01159574|81529405|FG000|Treatment Phase|Physician Decision|2|||
27916047|NCT01159574|81529405|FG000|Treatment Phase|Withdrawal by Subject|7|||
27916048|NCT01159574|81529405|FG000|Treatment Phase|still on treatment|2|||
27916049|NCT01159574|81529405|FG000|Follow Up Phase|Lost to Follow-up|2|||
27916050|NCT01159574|81529405|FG000|Follow Up Phase|still being followed for overall surviva|18|||
27916051|NCT00577772|81529407|FG000|Overall Study|Lost to Follow-up|0|||
27916052|NCT00577772|81529408|FG001|Overall Study|Lost to Follow-up|1|||
27916053|NCT02899065|81529409|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
27916054|NCT02899065|81529410|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
27916055|NCT02899065|81529409|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
27916056|NCT02899065|81529410|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
27916057|NCT02899065|81529409|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
27536840|NCT01890746|80160114|FG001|Overall Study|Death|30|||
27536841|NCT01890746|80160113|FG000|Overall Study|Adverse Event|1|||
27916058|NCT02899065|81529410|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
27916059|NCT00875563|81529411|FG000|Overall Study|Death|4|||
27536842|NCT01890746|80160114|FG001|Overall Study|Adverse Event|0|||
27536843|NCT01890746|80160113|FG000|Overall Study|Lost to Follow-up|4|||
27536844|NCT01890746|80160114|FG001|Overall Study|Lost to Follow-up|1|||
27738967|NCT00090285|80873982|FG002|Base Study Vaccination Period|Protocol Violation|0|||
27916060|NCT00875563|81529411|FG000|Overall Study|Withdrawal by Subject|7|||
27536845|NCT01890746|80160113|FG000|Overall Study|Physician Decision|3|||
27632299|NCT00878722|80493748|FG007|Overall Study|Relapse|0|||
27632300|NCT01069341|80493752|FG000|Overall Study|Lost to Follow-up|1|||
27916061|NCT00875563|81529411|FG000|Overall Study|No long-term (3-5 year) consent|6|||
27916062|NCT00875563|81529411|FG000|Overall Study|Still be eligible for follow-up|7|||
27916063|NCT00315445|81529412|FG000|Overall Study|Adverse Event|7|||
27916064|NCT00315445|81529413|FG001|Overall Study|Adverse Event|12|||
27916065|NCT00315445|81529414|FG002|Overall Study|Adverse Event|15|||
27536846|NCT01890746|80160114|FG001|Overall Study|Physician Decision|2|||
27916066|NCT00315445|81529412|FG000|Overall Study|Lack of Efficacy|16|||
27916067|NCT00315445|81529413|FG001|Overall Study|Lack of Efficacy|1|||
27916068|NCT00315445|81529414|FG002|Overall Study|Lack of Efficacy|7|||
27916069|NCT00315445|81529412|FG000|Overall Study|Lost to Follow-up|1|||
27536847|NCT01890746|80160113|FG000|Overall Study|Withdrawal by Subject|5|||
27536848|NCT01890746|80160114|FG001|Overall Study|Withdrawal by Subject|8|||
27536849|NCT03198078|80160115|FG000|Overall Study|Adverse Event|0|||
27536850|NCT03198078|80160116|FG001|Overall Study|Adverse Event|1|||
27536851|NCT03198078|80160117|FG002|Overall Study|Adverse Event|2|||
27536852|NCT03198078|80160115|FG000|Overall Study|Lack of Efficacy|0|||
27536853|NCT03198078|80160116|FG001|Overall Study|Lack of Efficacy|0|||
27536854|NCT03198078|80160117|FG002|Overall Study|Lack of Efficacy|3|||
27536855|NCT03198078|80160115|FG000|Overall Study|Lost to Follow-up|1|||
27536856|NCT03198078|80160116|FG001|Overall Study|Lost to Follow-up|0|||
27536857|NCT03198078|80160117|FG002|Overall Study|Lost to Follow-up|0|||
27536858|NCT03198078|80160115|FG000|Overall Study|Pregnancy|0|||
27536859|NCT03198078|80160116|FG001|Overall Study|Pregnancy|1|||
27536860|NCT03198078|80160117|FG002|Overall Study|Pregnancy|0|||
27536861|NCT03198078|80160115|FG000|Overall Study|Withdrawal by Subject|1|||
27536862|NCT03198078|80160116|FG001|Overall Study|Withdrawal by Subject|0|||
27536863|NCT03198078|80160117|FG002|Overall Study|Withdrawal by Subject|2|||
27536864|NCT03198078|80160115|FG000|Overall Study|Withdrawal by Caregiver|1|||
27536865|NCT03198078|80160116|FG001|Overall Study|Withdrawal by Caregiver|3|||
27536866|NCT03198078|80160117|FG002|Overall Study|Withdrawal by Caregiver|5|||
27536867|NCT05246397|80160118|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
27536868|NCT02716805|80160119|FG000|Overall Study|Progressive disease|2|||
27536869|NCT02716805|80160120|FG001|Overall Study|Progressive disease|0|||
27536870|NCT02716805|80160121|FG002|Overall Study|Progressive disease|0|||
27536871|NCT02716805|80160122|FG003|Overall Study|Progressive disease|0|||
27536872|NCT04032652|80160123|FG000|Overall Study|The study was terminated and the PI has|1|||
27536873|NCT04032652|80160124|FG001|Overall Study|The study was terminated and the PI has|1|||
27536874|NCT03080454|80160127|FG000|Baseline|Adverse Event|2|||
27536875|NCT03080454|80160127|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
27536876|NCT03080454|80160127|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
27536877|NCT03650556|80160137|FG000|Overall Study|Death|2|||
27536878|NCT03650556|80160137|FG000|Overall Study|Withdrawal by Subject|20|||
27536879|NCT03650556|80160137|FG000|Overall Study|Physician Decision|2|||
27536880|NCT03650556|80160137|FG000|Overall Study|Lost to Follow-up|8|||
27536881|NCT03650556|80160137|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
27536882|NCT03650556|80160137|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
27536883|NCT00107783|80160138|FG000|Overall Study|Adverse Event|0|||
27536884|NCT00107783|80160139|FG001|Overall Study|Adverse Event|2|||
27536885|NCT00107783|80160138|FG000|Overall Study|Death|0|||
27536886|NCT00107783|80160139|FG001|Overall Study|Death|1|||
27536887|NCT00107783|80160138|FG000|Overall Study|Withdrawal by Subject|2|||
27536888|NCT00107783|80160139|FG001|Overall Study|Withdrawal by Subject|0|||
27536889|NCT00107783|80160138|FG000|Overall Study|Second hip replacement|1|||
27536890|NCT00107783|80160139|FG001|Overall Study|Second hip replacement|1|||
27536891|NCT00566111|80160140|FG000|Overall Study|Adverse Event|0|||
27536892|NCT00566111|80160141|FG001|Overall Study|Adverse Event|2|||
27536893|NCT00113087|80160142|FG000|Overall Study|Death or Transplant|14|||
27536894|NCT00113087|80160143|FG001|Overall Study|Death or Transplant|16|||
27536895|NCT00113087|80160142|FG000|Overall Study|Family or MD withdrew subject|10|||
27536896|NCT00113087|80160143|FG001|Overall Study|Family or MD withdrew subject|5|||
27536897|NCT02104752|80160145|FG000|Overall Study|Withdrawal by Subject|1|||
27536898|NCT02104752|80160146|FG001|Overall Study|Withdrawal by Subject|0|||
27536899|NCT02104752|80160145|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
27536900|NCT02104752|80160146|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
27536901|NCT00408629|80160149|FG000|Overall Study|Adverse Event|13|||
27536902|NCT00408629|80160150|FG001|Overall Study|Adverse Event|27|||
27536903|NCT00408629|80160149|FG000|Overall Study|Withdrawal by Subject|8|||
27536904|NCT00408629|80160150|FG001|Overall Study|Withdrawal by Subject|4|||
27916070|NCT00315445|81529413|FG001|Overall Study|Lost to Follow-up|0|||
27916071|NCT00315445|81529414|FG002|Overall Study|Lost to Follow-up|1|||
27536905|NCT00408629|80160149|FG000|Overall Study|Lost to Follow-up|1|||
27536906|NCT00408629|80160150|FG001|Overall Study|Lost to Follow-up|1|||
27536907|NCT00408629|80160149|FG000|Overall Study|Lack of Efficacy|63|||
27536908|NCT00408629|80160150|FG001|Overall Study|Lack of Efficacy|73|||
27536909|NCT00408629|80160149|FG000|Overall Study|Protocol Violation|1|||
27536910|NCT00408629|80160150|FG001|Overall Study|Protocol Violation|5|||
27536911|NCT00408629|80160149|FG000|Overall Study|Miscellaneous|11|||
27536912|NCT00408629|80160150|FG001|Overall Study|Miscellaneous|15|||
27632301|NCT01134562|80493753|FG000|Overall Study|Adverse Event|0|||
27632302|NCT01134562|80493754|FG001|Overall Study|Adverse Event|1|||
27632303|NCT01134562|80493755|FG002|Overall Study|Adverse Event|0|||
27632304|NCT01134562|80493756|FG003|Overall Study|Adverse Event|0|||
27632305|NCT01134562|80493757|FG004|Overall Study|Adverse Event|0|||
27632306|NCT02299336|80493760|FG000|Overall Study|Withdrawal by Subject|11|||
27632307|NCT02299336|80493760|FG000|Overall Study|Adverse Event|1|||
27916072|NCT00315445|81529412|FG000|Overall Study|Protocol Violation|2|||
27916073|NCT00315445|81529413|FG001|Overall Study|Protocol Violation|0|||
27916074|NCT00315445|81529414|FG002|Overall Study|Protocol Violation|1|||
27916075|NCT00315445|81529412|FG000|Overall Study|Other|1|||
27916076|NCT00315445|81529413|FG001|Overall Study|Other|3|||
27916077|NCT00315445|81529414|FG002|Overall Study|Other|0|||
27916078|NCT01545388|81533048|FG000|Overall Study|Adverse Event|2|||
27916079|NCT01545388|81533049|FG001|Overall Study|Adverse Event|4|||
27916080|NCT01545388|81533050|FG002|Overall Study|Adverse Event|1|||
27916081|NCT01545388|81533048|FG000|Overall Study|Lack of Efficacy|3|||
27916082|NCT01545388|81533049|FG001|Overall Study|Lack of Efficacy|2|||
27916083|NCT01545388|81533050|FG002|Overall Study|Lack of Efficacy|5|||
27916084|NCT01545388|81533048|FG000|Overall Study|Participant moved or relocated|1|||
27916085|NCT01545388|81533049|FG001|Overall Study|Participant moved or relocated|0|||
27916086|NCT01545388|81533050|FG002|Overall Study|Participant moved or relocated|0|||
27916087|NCT01545388|81533048|FG000|Overall Study|Withdrawal by Subject|1|||
27916088|NCT01545388|81533049|FG001|Overall Study|Withdrawal by Subject|4|||
27916089|NCT01545388|81533050|FG002|Overall Study|Withdrawal by Subject|2|||
27916090|NCT01545388|81533048|FG000|Overall Study|Other|1|||
27916091|NCT01545388|81533049|FG001|Overall Study|Other|1|||
27916092|NCT01545388|81533050|FG002|Overall Study|Other|0|||
27916093|NCT00447772|81533051|FG000|Overall Study|Lack of Efficacy|3|||
27916094|NCT00447772|81533051|FG000|Overall Study|Insufficient compliance|6|||
27916095|NCT00447772|81533051|FG000|Overall Study|Discontinuation of drug therapy|1|||
27916096|NCT00447772|81533051|FG000|Overall Study|Lost to Follow-up|9|||
27916097|NCT00447772|81533051|FG000|Overall Study|Withdrawal by Subject|1|||
27916098|NCT00447772|81533051|FG000|Overall Study|Unable to attend all study visits|2|||
27916099|NCT00447772|81533051|FG000|Overall Study|Adverse Event|1|||
27916100|NCT00447772|81533051|FG000|Overall Study|Patient relocated|1|||
27916101|NCT00447772|81533051|FG000|Overall Study|Incomplete documentation at visit 1|1|||
27916102|NCT00447772|81533051|FG000|Overall Study|Chemotherapy for lung cancer|1|||
27536913|NCT04729621|80160151|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
27536914|NCT04729621|80160152|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
27536915|NCT04729621|80160153|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
27536916|NCT04729621|80160154|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
27536917|NCT04729621|80160155|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
27536918|NCT04729621|80160151|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
27536919|NCT04729621|80160152|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
27536920|NCT04729621|80160153|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
27536921|NCT04729621|80160154|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
27536922|NCT04729621|80160155|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
27536923|NCT04729621|80160151|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
27536924|NCT04729621|80160152|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
27536925|NCT04729621|80160153|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
27536926|NCT04729621|80160154|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
27536927|NCT04729621|80160155|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
27536928|NCT04729621|80160151|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
27536929|NCT04729621|80160152|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
27536930|NCT04729621|80160153|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
27536931|NCT04729621|80160154|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
27536932|NCT04729621|80160155|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
27536933|NCT04729621|80160151|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
27536934|NCT04729621|80160152|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
27536935|NCT04729621|80160153|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
27536936|NCT04729621|80160154|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
27536937|NCT04729621|80160155|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
27632308|NCT02299336|80493760|FG000|Overall Study|Death|1|||
27632309|NCT02299336|80493760|FG000|Overall Study|Lost to Follow-up|1|||
27632310|NCT02873754|80493764|FG000|Overall Study|Lost to Follow-up|5|||
27916103|NCT00447772|81533051|FG000|Overall Study|Premature re-injection required|1|||
27916104|NCT01447407|81533056|FG000|Overall Study|Withdrawal by Subject|2|||
27916105|NCT01447407|81533057|FG001|Overall Study|Withdrawal by Subject|0|||
27916106|NCT01447407|81533058|FG002|Overall Study|Withdrawal by Subject|0|||
27916107|NCT01447407|81533059|FG003|Overall Study|Withdrawal by Subject|1|||
27916108|NCT01447407|81533056|FG000|Overall Study|Physician Decision|0|||
27536938|NCT04729621|80160151|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
27536939|NCT04729621|80160152|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
27536940|NCT04729621|80160153|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
27536941|NCT04729621|80160154|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
27536942|NCT04729621|80160155|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
27536943|NCT01758523|80160156|FG000|Overall Study|Adverse Event|2|||
27536944|NCT01758523|80160157|FG001|Overall Study|Adverse Event|1|||
27536945|NCT01758523|80160156|FG000|Overall Study|Lack of Efficacy|4|||
27536946|NCT01758523|80160157|FG001|Overall Study|Lack of Efficacy|2|||
27536947|NCT01758523|80160156|FG000|Overall Study|Lost to Follow-up|3|||
27536948|NCT01758523|80160157|FG001|Overall Study|Lost to Follow-up|4|||
27536949|NCT01758523|80160156|FG000|Overall Study|Withdrawal by Subject|12|||
27536950|NCT01758523|80160157|FG001|Overall Study|Withdrawal by Subject|7|||
27536951|NCT03096483|80160158|FG000|Overall Study|Withdrawal by site|1|||
27536952|NCT02180165|80160164|FG000|Overall Study|Not Treated|0|||
27536953|NCT02180165|80160165|FG001|Overall Study|Not Treated|0|||
27536954|NCT02180165|80160166|FG002|Overall Study|Not Treated|1|||
27536955|NCT02180165|80160167|FG003|Overall Study|Not Treated|0|||
27536956|NCT02180165|80160164|FG000|Overall Study|Adverse Event|7|||
27536957|NCT02180165|80160165|FG001|Overall Study|Adverse Event|0|||
27536958|NCT02180165|80160166|FG002|Overall Study|Adverse Event|18|||
27536959|NCT02180165|80160167|FG003|Overall Study|Adverse Event|3|||
27536960|NCT02180165|80160164|FG000|Overall Study|Lack of Efficacy|0|||
27536961|NCT02180165|80160165|FG001|Overall Study|Lack of Efficacy|1|||
27536962|NCT02180165|80160166|FG002|Overall Study|Lack of Efficacy|3|||
27536963|NCT02180165|80160167|FG003|Overall Study|Lack of Efficacy|2|||
27536964|NCT02180165|80160164|FG000|Overall Study|Physician Decision|1|||
27536965|NCT02180165|80160165|FG001|Overall Study|Physician Decision|0|||
27536966|NCT02180165|80160166|FG002|Overall Study|Physician Decision|5|||
27536967|NCT02180165|80160167|FG003|Overall Study|Physician Decision|0|||
27536968|NCT02180165|80160164|FG000|Overall Study|Withdrawal by Subject|3|||
27536969|NCT02180165|80160165|FG001|Overall Study|Withdrawal by Subject|0|||
27536970|NCT02180165|80160166|FG002|Overall Study|Withdrawal by Subject|2|||
27536971|NCT02180165|80160167|FG003|Overall Study|Withdrawal by Subject|1|||
27536972|NCT00257608|80160168|FG000|Chemotherapy Phase|Adverse Event|138|||
27536973|NCT00257608|80160169|FG001|Chemotherapy Phase|Adverse Event|0|||
27536974|NCT00257608|80160170|FG002|Chemotherapy Phase|Adverse Event|0|||
27536975|NCT00257608|80160168|FG000|Chemotherapy Phase|Disease progression|139|||
27536976|NCT00257608|80160169|FG001|Chemotherapy Phase|Disease progression|0|||
27536977|NCT00257608|80160170|FG002|Chemotherapy Phase|Disease progression|0|||
27536978|NCT00257608|80160168|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
27536979|NCT00257608|80160169|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
27536980|NCT00257608|80160170|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
27536981|NCT00257608|80160168|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
27536982|NCT00257608|80160169|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
27536983|NCT00257608|80160170|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
27536984|NCT00257608|80160168|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
27536985|NCT00257608|80160169|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
27536986|NCT00257608|80160170|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
27536987|NCT00257608|80160168|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
27536988|NCT00257608|80160169|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
27536989|NCT00257608|80160170|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
27536990|NCT00257608|80160168|FG000|Chemotherapy Phase|Physician Decision|28|||
27536991|NCT00257608|80160169|FG001|Chemotherapy Phase|Physician Decision|0|||
27536992|NCT00257608|80160170|FG002|Chemotherapy Phase|Physician Decision|0|||
27536993|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Adverse Event|0|||
27536994|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Adverse Event|34|||
27536995|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Adverse Event|38|||
27536996|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Disease progression|0|||
27536997|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Disease progression|204|||
27536998|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Disease progression|168|||
27536999|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
27537000|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
27537001|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
27537002|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
27537003|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
27537004|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
27537005|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
27537006|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
27537007|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
27537008|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
27537009|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
27632311|NCT02873754|80493764|FG000|Overall Study|Couldn't complete study procedures|1|||
27632312|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
27632313|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
27916109|NCT01447407|81533057|FG001|Overall Study|Physician Decision|0|||
27916110|NCT01447407|81533058|FG002|Overall Study|Physician Decision|1|||
27916111|NCT01447407|81533059|FG003|Overall Study|Physician Decision|1|||
27916112|NCT00126594|81533060|FG000|Overall Study|Ineligible|2|||
27916113|NCT00126594|81533061|FG001|Overall Study|Ineligible|0|||
27916114|NCT00126594|81533060|FG000|Overall Study|Withdrawal by Subject|0|||
27916115|NCT00126594|81533061|FG001|Overall Study|Withdrawal by Subject|4|||
27916116|NCT00126594|81533060|FG000|Overall Study|Physician Decision|1|||
27916117|NCT00126594|81533061|FG001|Overall Study|Physician Decision|3|||
27916118|NCT00126594|81533060|FG000|Overall Study|Adverse Event|7|||
27916119|NCT00126594|81533061|FG001|Overall Study|Adverse Event|5|||
27916120|NCT00126594|81533060|FG000|Overall Study|Non-compliance|0|||
27916121|NCT00126594|81533061|FG001|Overall Study|Non-compliance|1|||
27916122|NCT00126594|81533060|FG000|Overall Study|Disease Progression|29|||
27916123|NCT00126594|81533061|FG001|Overall Study|Disease Progression|24|||
27916124|NCT01705080|81533064|FG000|Overall Study|Missed visit|10|||
27916125|NCT01705080|81533065|FG001|Overall Study|Missed visit|4|||
27916126|NCT01705080|81533066|FG002|Overall Study|Missed visit|1|||
27916127|NCT01705080|81533064|FG000|Overall Study|Death|4|||
27916128|NCT01705080|81533065|FG001|Overall Study|Death|4|||
27916129|NCT01705080|81533066|FG002|Overall Study|Death|6|||
27916130|NCT01705080|81533064|FG000|Overall Study|Withdrawal by Subject|61|||
27916131|NCT01705080|81533065|FG001|Overall Study|Withdrawal by Subject|44|||
27916132|NCT01705080|81533066|FG002|Overall Study|Withdrawal by Subject|9|||
27916133|NCT00885118|81533067|FG000|Overall Study|Adverse Event|1|||
27916134|NCT00885118|81533068|FG001|Overall Study|Adverse Event|0|||
27916135|NCT00885118|81533069|FG002|Overall Study|Adverse Event|0|||
27916136|NCT00885118|81533070|FG003|Overall Study|Adverse Event|0|||
27916137|NCT00885118|81533071|FG004|Overall Study|Adverse Event|0|||
27916138|NCT00885118|81533067|FG000|Overall Study|Withdrawal by Subject|0|||
27916139|NCT00885118|81533068|FG001|Overall Study|Withdrawal by Subject|0|||
27916140|NCT00885118|81533069|FG002|Overall Study|Withdrawal by Subject|0|||
27916141|NCT00885118|81533070|FG003|Overall Study|Withdrawal by Subject|0|||
27537010|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
27537011|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
27537012|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
27537013|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
27537014|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Physician Decision|0|||
27537015|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Physician Decision|8|||
27537016|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Physician Decision|11|||
27537017|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
27537018|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
27537019|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
27537020|NCT00257608|80160168|FG000|Post Chemotherapy Phase|Not treated|0|||
27537021|NCT00257608|80160169|FG001|Post Chemotherapy Phase|Not treated|4|||
27537022|NCT00257608|80160170|FG002|Post Chemotherapy Phase|Not treated|7|||
27537023|NCT00066729|80160171|FG000|Overall Study|Lost to Follow-up|1|||
27537024|NCT00066729|80160171|FG000|Overall Study|Disease progression|1|||
27537025|NCT00917501|80160172|FG000|Overall Study|Lost to Follow-up|4|||
27537026|NCT00917501|80160173|FG001|Overall Study|Lost to Follow-up|1|||
27537027|NCT00917501|80160172|FG000|Overall Study|Withdrawal by Subject|3|||
27537028|NCT00917501|80160173|FG001|Overall Study|Withdrawal by Subject|1|||
27537029|NCT00917501|80160172|FG000|Overall Study|Lack of Efficacy|1|||
27537030|NCT00917501|80160173|FG001|Overall Study|Lack of Efficacy|2|||
27537031|NCT00917501|80160172|FG000|Overall Study|trouble swollowing capsules|0|||
27537032|NCT00917501|80160173|FG001|Overall Study|trouble swollowing capsules|1|||
27537033|NCT00142935|80160174|FG000|Overall Study|Other reason|1|||
27537034|NCT00142935|80160175|FG001|Overall Study|Other reason|1|||
27537035|NCT00142935|80160176|FG002|Overall Study|Other reason|1|||
27537036|NCT00142935|80160174|FG000|Overall Study|Lost to Follow-up|2|||
27916142|NCT00885118|81533071|FG004|Overall Study|Withdrawal by Subject|1|||
27916143|NCT00885118|81533067|FG000|Overall Study|Other reason not defined above|0|||
27537037|NCT00142935|80160175|FG001|Overall Study|Lost to Follow-up|5|||
27916144|NCT00885118|81533068|FG001|Overall Study|Other reason not defined above|0|||
27916145|NCT00885118|81533069|FG002|Overall Study|Other reason not defined above|1|||
27916146|NCT00885118|81533070|FG003|Overall Study|Other reason not defined above|0|||
27537038|NCT00142935|80160176|FG002|Overall Study|Lost to Follow-up|5|||
27537039|NCT00142935|80160174|FG000|Overall Study|Death|0|||
27537040|NCT00142935|80160175|FG001|Overall Study|Death|2|||
27537041|NCT00142935|80160176|FG002|Overall Study|Death|1|||
27916147|NCT00885118|81533071|FG004|Overall Study|Other reason not defined above|0|||
27916148|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
27916149|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
27916150|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
27632314|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
27632315|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
27632316|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
27632317|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
27632318|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
27632319|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
27632320|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
27916151|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
27916152|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
27916153|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
27916154|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
27916155|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
27916156|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
27916157|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
27916158|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
27916159|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
27916160|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
27916161|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
27916162|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
27916163|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
27916164|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
27916165|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
27916166|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
27916167|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
27916168|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
27916169|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
27916170|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
27916171|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
27916172|NCT01198002|81533074|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
27916173|NCT01198002|81533075|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
27916174|NCT01198002|81533076|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
27916175|NCT01198002|81533074|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
27916176|NCT01198002|81533075|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
27916177|NCT01198002|81533076|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
27916178|NCT01198002|81533074|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
27916179|NCT01198002|81533075|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
27916180|NCT01198002|81533076|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
27537042|NCT02601027|80160177|FG000|Registration to Surgery|Withdrawal by Subject|20|||
27537043|NCT02601027|80160178|FG001|Registration to Surgery|Withdrawal by Subject|10|||
27537044|NCT00961649|80160179|FG000|Overall Study|Adverse Event|4|||
27537045|NCT00961649|80160180|FG001|Overall Study|Adverse Event|0|||
27537046|NCT00961649|80160181|FG002|Overall Study|Adverse Event|0|||
27537047|NCT00961649|80160182|FG003|Overall Study|Adverse Event|2|||
27537048|NCT00961649|80160179|FG000|Overall Study|Inadequate control of IOP|0|||
27632321|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
27632322|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
27632323|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
27632324|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
27632325|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
27632326|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
27632327|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
27632328|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
27632329|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
27632330|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
27632331|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
27632332|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
27632333|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
27632334|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
27632335|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
27632336|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
27632337|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
27632338|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
27916181|NCT01198002|81533074|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
27916182|NCT01198002|81533075|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
27916183|NCT01198002|81533076|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
27916184|NCT01198002|81533074|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
27916185|NCT01198002|81533075|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
27916186|NCT01198002|81533076|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
27537049|NCT00961649|80160180|FG001|Overall Study|Inadequate control of IOP|0|||
27738968|NCT00090285|80873983|FG003|Base Study Vaccination Period|Protocol Violation|0|||
27738969|NCT00090285|80873984|FG004|Base Study Vaccination Period|Protocol Violation|0|||
27738970|NCT00090285|80873985|FG005|Base Study Vaccination Period|Protocol Violation|0|||
27738971|NCT00090285|80873980|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
27738972|NCT00090285|80873981|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
27738973|NCT00090285|80873982|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
27738974|NCT00090285|80873983|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
27738975|NCT00090285|80873984|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
27738976|NCT00090285|80873985|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
27738977|NCT00090285|80873980|FG000|Base Study Vaccination Period|Uncooperative|2|||
27738978|NCT00090285|80873981|FG001|Base Study Vaccination Period|Uncooperative|2|||
27738979|NCT00090285|80873982|FG002|Base Study Vaccination Period|Uncooperative|0|||
27738980|NCT00090285|80873983|FG003|Base Study Vaccination Period|Uncooperative|0|||
27738981|NCT00090285|80873984|FG004|Base Study Vaccination Period|Uncooperative|0|||
27738982|NCT00090285|80873985|FG005|Base Study Vaccination Period|Uncooperative|0|||
27738983|NCT00090285|80873980|FG000|Base Study Vaccination Period|Moved|20|||
27738984|NCT00090285|80873981|FG001|Base Study Vaccination Period|Moved|21|||
27738985|NCT00090285|80873982|FG002|Base Study Vaccination Period|Moved|0|||
27738986|NCT00090285|80873983|FG003|Base Study Vaccination Period|Moved|0|||
27738987|NCT00090285|80873984|FG004|Base Study Vaccination Period|Moved|0|||
27738988|NCT00090285|80873985|FG005|Base Study Vaccination Period|Moved|0|||
27738989|NCT00090285|80873980|FG000|Base Study Vaccination Period|Site Terminated|1|||
27738990|NCT00090285|80873981|FG001|Base Study Vaccination Period|Site Terminated|0|||
27738991|NCT00090285|80873982|FG002|Base Study Vaccination Period|Site Terminated|0|||
27738992|NCT00090285|80873983|FG003|Base Study Vaccination Period|Site Terminated|0|||
27738993|NCT00090285|80873984|FG004|Base Study Vaccination Period|Site Terminated|0|||
27738994|NCT00090285|80873985|FG005|Base Study Vaccination Period|Site Terminated|0|||
27738995|NCT00090285|80873980|FG000|Base Study Vaccination Period|Other|2|||
27738996|NCT00090285|80873981|FG001|Base Study Vaccination Period|Other|2|||
27738997|NCT00090285|80873982|FG002|Base Study Vaccination Period|Other|0|||
27738998|NCT00090285|80873983|FG003|Base Study Vaccination Period|Other|0|||
27738999|NCT00090285|80873984|FG004|Base Study Vaccination Period|Other|0|||
27739000|NCT00090285|80873985|FG005|Base Study Vaccination Period|Other|0|||
27739001|NCT00090285|80873980|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
27739002|NCT00090285|80873981|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
27739003|NCT00090285|80873982|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
27739004|NCT00090285|80873983|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
27739005|NCT00090285|80873984|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
27739006|NCT00090285|80873985|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
27739007|NCT00090285|80873980|FG000|Base Study Vaccination Period|HIV positive|1|||
27739008|NCT00090285|80873981|FG001|Base Study Vaccination Period|HIV positive|1|||
27739009|NCT00090285|80873982|FG002|Base Study Vaccination Period|HIV positive|0|||
27739010|NCT00090285|80873983|FG003|Base Study Vaccination Period|HIV positive|0|||
27739011|NCT00090285|80873984|FG004|Base Study Vaccination Period|HIV positive|0|||
27739012|NCT00090285|80873985|FG005|Base Study Vaccination Period|HIV positive|0|||
27739013|NCT00090285|80873980|FG000|Base Study Follow-up Period|Adverse Event|3|||
27739014|NCT00090285|80873981|FG001|Base Study Follow-up Period|Adverse Event|10|||
27739015|NCT00090285|80873982|FG002|Base Study Follow-up Period|Adverse Event|0|||
27739016|NCT00090285|80873983|FG003|Base Study Follow-up Period|Adverse Event|0|||
27537050|NCT00961649|80160181|FG002|Overall Study|Inadequate control of IOP|0|||
27537051|NCT00961649|80160182|FG003|Overall Study|Inadequate control of IOP|1|||
27537052|NCT00961649|80160179|FG000|Overall Study|Patient has travel plans during holidays|0|||
27537053|NCT00961649|80160180|FG001|Overall Study|Patient has travel plans during holidays|0|||
27537054|NCT00961649|80160181|FG002|Overall Study|Patient has travel plans during holidays|1|||
27537055|NCT00961649|80160182|FG003|Overall Study|Patient has travel plans during holidays|0|||
27537056|NCT00961649|80160179|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
27537057|NCT00961649|80160180|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
27537058|NCT00961649|80160181|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
27537059|NCT00961649|80160182|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
27632339|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
27632340|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
27632341|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
27632342|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
27739017|NCT00090285|80873984|FG004|Base Study Follow-up Period|Adverse Event|0|||
27739018|NCT00090285|80873985|FG005|Base Study Follow-up Period|Adverse Event|0|||
27739019|NCT00090285|80873980|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
27739020|NCT00090285|80873981|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
27739021|NCT00090285|80873982|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
27739022|NCT00090285|80873983|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
27739023|NCT00090285|80873984|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
27739024|NCT00090285|80873985|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
27739025|NCT00090285|80873980|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
27739026|NCT00090285|80873981|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
27739027|NCT00090285|80873982|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
27739028|NCT00090285|80873983|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
27739029|NCT00090285|80873984|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
27739030|NCT00090285|80873985|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
27739031|NCT00090285|80873980|FG000|Base Study Follow-up Period|Moved|41|||
27739032|NCT00090285|80873981|FG001|Base Study Follow-up Period|Moved|36|||
27739033|NCT00090285|80873982|FG002|Base Study Follow-up Period|Moved|0|||
27739034|NCT00090285|80873983|FG003|Base Study Follow-up Period|Moved|0|||
27739035|NCT00090285|80873984|FG004|Base Study Follow-up Period|Moved|0|||
27739036|NCT00090285|80873985|FG005|Base Study Follow-up Period|Moved|0|||
27739037|NCT00090285|80873980|FG000|Base Study Follow-up Period|Other|2|||
27739038|NCT00090285|80873981|FG001|Base Study Follow-up Period|Other|0|||
27739039|NCT00090285|80873982|FG002|Base Study Follow-up Period|Other|0|||
27739040|NCT00090285|80873983|FG003|Base Study Follow-up Period|Other|0|||
27739041|NCT00090285|80873984|FG004|Base Study Follow-up Period|Other|0|||
27739042|NCT00090285|80873985|FG005|Base Study Follow-up Period|Other|0|||
27739043|NCT00090285|80873980|FG000|Base Study Follow-up Period|Protocol Violation|1|||
27739044|NCT00090285|80873981|FG001|Base Study Follow-up Period|Protocol Violation|0|||
27739045|NCT00090285|80873982|FG002|Base Study Follow-up Period|Protocol Violation|0|||
27739046|NCT00090285|80873983|FG003|Base Study Follow-up Period|Protocol Violation|0|||
27739047|NCT00090285|80873984|FG004|Base Study Follow-up Period|Protocol Violation|0|||
27739048|NCT00090285|80873985|FG005|Base Study Follow-up Period|Protocol Violation|0|||
27739049|NCT00090285|80873980|FG000|Base Study Follow-up Period|Uncooperative|3|||
27739050|NCT00090285|80873981|FG001|Base Study Follow-up Period|Uncooperative|4|||
27739051|NCT00090285|80873982|FG002|Base Study Follow-up Period|Uncooperative|0|||
27739052|NCT00090285|80873983|FG003|Base Study Follow-up Period|Uncooperative|0|||
27739053|NCT00090285|80873984|FG004|Base Study Follow-up Period|Uncooperative|0|||
27739054|NCT00090285|80873985|FG005|Base Study Follow-up Period|Uncooperative|0|||
27739055|NCT00090285|80873980|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
27739056|NCT00090285|80873981|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
27739057|NCT00090285|80873982|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
27739058|NCT00090285|80873983|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
27739059|NCT00090285|80873984|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
27739060|NCT00090285|80873985|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
27739061|NCT00090285|80873980|FG000|Extension 1|Adverse Event|0|||
27739062|NCT00090285|80873981|FG001|Extension 1|Adverse Event|0|||
27739063|NCT00090285|80873982|FG002|Extension 1|Adverse Event|2|||
27739064|NCT00090285|80873983|FG003|Extension 1|Adverse Event|0|||
27739065|NCT00090285|80873984|FG004|Extension 1|Adverse Event|0|||
27739066|NCT00090285|80873985|FG005|Extension 1|Adverse Event|0|||
27739067|NCT00090285|80873980|FG000|Extension 1|Lost to Follow-up|0|||
27739068|NCT00090285|80873981|FG001|Extension 1|Lost to Follow-up|0|||
27739069|NCT00090285|80873982|FG002|Extension 1|Lost to Follow-up|35|||
27739070|NCT00090285|80873983|FG003|Extension 1|Lost to Follow-up|0|||
27739071|NCT00090285|80873984|FG004|Extension 1|Lost to Follow-up|0|||
27739072|NCT00090285|80873985|FG005|Extension 1|Lost to Follow-up|0|||
27739073|NCT00090285|80873980|FG000|Extension 1|Withdrawal by Subject|0|||
27739074|NCT00090285|80873981|FG001|Extension 1|Withdrawal by Subject|0|||
27739075|NCT00090285|80873982|FG002|Extension 1|Withdrawal by Subject|13|||
27739076|NCT00090285|80873983|FG003|Extension 1|Withdrawal by Subject|1|||
27739077|NCT00090285|80873984|FG004|Extension 1|Withdrawal by Subject|0|||
27739078|NCT00090285|80873985|FG005|Extension 1|Withdrawal by Subject|0|||
27739079|NCT00090285|80873980|FG000|Extension 1|Other|0|||
27739080|NCT00090285|80873981|FG001|Extension 1|Other|0|||
27739081|NCT00090285|80873982|FG002|Extension 1|Other|4|||
27739082|NCT00090285|80873983|FG003|Extension 1|Other|0|||
27739083|NCT00090285|80873984|FG004|Extension 1|Other|0|||
27739084|NCT00090285|80873985|FG005|Extension 1|Other|0|||
27739085|NCT00090285|80873980|FG000|Extension 1|Moved|0|||
27739086|NCT00090285|80873981|FG001|Extension 1|Moved|0|||
27739087|NCT00090285|80873982|FG002|Extension 1|Moved|3|||
27739088|NCT00090285|80873983|FG003|Extension 1|Moved|0|||
27739089|NCT00090285|80873984|FG004|Extension 1|Moved|0|||
27916187|NCT01198002|81533074|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
27739090|NCT00090285|80873985|FG005|Extension 1|Moved|0|||
27739091|NCT00090285|80873980|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
27739092|NCT00090285|80873981|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
27739093|NCT00090285|80873982|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
27739094|NCT00090285|80873983|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
27739095|NCT00090285|80873984|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
27739096|NCT00090285|80873985|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
27739097|NCT00090285|80873980|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27739098|NCT00090285|80873981|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27739099|NCT00090285|80873982|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27739100|NCT00090285|80873983|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
27739101|NCT00090285|80873984|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
27739102|NCT00090285|80873985|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
27739103|NCT00090285|80873980|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27739104|NCT00090285|80873981|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27739105|NCT00090285|80873982|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27739106|NCT00090285|80873983|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
27739107|NCT00090285|80873984|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
27739108|NCT00090285|80873985|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
27739109|NCT00090285|80873980|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
27739110|NCT00090285|80873981|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
27739111|NCT00090285|80873982|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
27739112|NCT00090285|80873983|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
27739113|NCT00090285|80873984|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
27739114|NCT00090285|80873985|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
27739115|NCT01845025|80873989|FG000|Overall Study|Adverse Event|6|||
27739116|NCT01845025|80873990|FG001|Overall Study|Adverse Event|3|||
27739117|NCT01845025|80873989|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27739118|NCT01845025|80873990|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27739119|NCT01845025|80873989|FG000|Overall Study|Withdrawal by Subject|48|||
27739120|NCT01845025|80873990|FG001|Overall Study|Withdrawal by Subject|44|||
27739121|NCT01845025|80873989|FG000|Overall Study|Lost to Follow-up|13|||
27739122|NCT01845025|80873990|FG001|Overall Study|Lost to Follow-up|13|||
27739123|NCT01845025|80873989|FG000|Overall Study|Administrative problems|8|||
27739124|NCT01845025|80873990|FG001|Overall Study|Administrative problems|8|||
27739125|NCT01845025|80873989|FG000|Overall Study|Death|2|||
27739126|NCT01845025|80873990|FG001|Overall Study|Death|0|||
27739127|NCT01845025|80873989|FG000|Overall Study|Protocol deviation|3|||
27739128|NCT01845025|80873990|FG001|Overall Study|Protocol deviation|6|||
27739129|NCT01845025|80873989|FG000|Overall Study|Missing|1|||
27739130|NCT01845025|80873990|FG001|Overall Study|Missing|1|||
27739131|NCT02032875|80873991|FG000|Treatment Period|Adverse Event|1|||
27739132|NCT02032875|80873992|FG001|Treatment Period|Adverse Event|0|||
27739133|NCT02032875|80873991|FG000|Treatment Period|Liver transplant, No extension needed|0|||
27739134|NCT02032875|80873992|FG001|Treatment Period|Liver transplant, No extension needed|1|||
27739135|NCT02032875|80873991|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
27739136|NCT02032875|80873992|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
27739137|NCT02032875|80873991|FG000|Follow-up Period|Death|0|||
27739138|NCT02032875|80873992|FG001|Follow-up Period|Death|1|||
27739139|NCT02032875|80873991|FG000|Follow-up Period|Virologic Relapse|3|||
27739140|NCT02032875|80873992|FG001|Follow-up Period|Virologic Relapse|10|||
27739141|NCT03671369|80874001|FG000|Overall Study|Other|1|||
27739142|NCT03671369|80874001|FG000|Overall Study|Withdrawal by Subject|289|||
27739143|NCT03671369|80874001|FG000|Overall Study|Not willing to be vaccinated|1|||
27739144|NCT02489630|80874002|FG000|Overall Study|Oversedation|1|||
27739145|NCT02489630|80874003|FG001|Overall Study|Oversedation|1|||
27739146|NCT02489630|80874002|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
27739147|NCT02489630|80874003|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
27739148|NCT00553787|80874004|FG000|Overall Study|Adverse Event|34|||
27739149|NCT00553787|80874005|FG001|Overall Study|Adverse Event|21|||
27739150|NCT00553787|80874006|FG002|Overall Study|Adverse Event|67|||
27739151|NCT00553787|80874004|FG000|Overall Study|Lost to Follow-up|132|||
27739152|NCT00553787|80874005|FG001|Overall Study|Lost to Follow-up|44|||
27739153|NCT00553787|80874006|FG002|Overall Study|Lost to Follow-up|78|||
27632343|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
27632344|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
27632345|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27632346|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
27632347|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
27632348|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
27632349|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27632350|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27632351|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27632352|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27632353|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27739154|NCT00553787|80874004|FG000|Overall Study|Withdrawal by Subject|151|||
27632354|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27739155|NCT00553787|80874005|FG001|Overall Study|Withdrawal by Subject|40|||
27739156|NCT00553787|80874006|FG002|Overall Study|Withdrawal by Subject|83|||
27739157|NCT00553787|80874004|FG000|Overall Study|Lack of Efficacy|31|||
27739158|NCT00553787|80874005|FG001|Overall Study|Lack of Efficacy|1|||
27739159|NCT00553787|80874006|FG002|Overall Study|Lack of Efficacy|3|||
27739160|NCT00553787|80874004|FG000|Overall Study|Pregnancy|0|||
27739161|NCT00553787|80874005|FG001|Overall Study|Pregnancy|1|||
27739162|NCT00553787|80874006|FG002|Overall Study|Pregnancy|2|||
27739163|NCT00553787|80874004|FG000|Overall Study|non compliance|4|||
27537060|NCT00961649|80160179|FG000|Overall Study|Study terminated by sponsor|4|||
27537061|NCT00961649|80160180|FG001|Overall Study|Study terminated by sponsor|4|||
27537062|NCT00961649|80160181|FG002|Overall Study|Study terminated by sponsor|4|||
27537063|NCT00961649|80160182|FG003|Overall Study|Study terminated by sponsor|1|||
27537064|NCT01914757|80160192|FG000|Overall Study|Severe non-compliance to protocol|3|||
27537065|NCT01914757|80160193|FG001|Overall Study|Severe non-compliance to protocol|1|||
27537066|NCT01914757|80160194|FG002|Overall Study|Severe non-compliance to protocol|2|||
27537067|NCT01914757|80160192|FG000|Overall Study|Lost to Follow-up|5|||
27537068|NCT01914757|80160193|FG001|Overall Study|Lost to Follow-up|8|||
27537069|NCT01914757|80160194|FG002|Overall Study|Lost to Follow-up|6|||
27537070|NCT01914757|80160192|FG000|Overall Study|Withdrawal by Subject|15|||
27537071|NCT01914757|80160193|FG001|Overall Study|Withdrawal by Subject|27|||
27537072|NCT01914757|80160194|FG002|Overall Study|Withdrawal by Subject|19|||
27537073|NCT01914757|80160192|FG000|Overall Study|Death|2|||
27537074|NCT01914757|80160193|FG001|Overall Study|Death|2|||
27537075|NCT01914757|80160194|FG002|Overall Study|Death|1|||
27537076|NCT01914757|80160192|FG000|Overall Study|Adverse Event|4|||
27537077|NCT01914757|80160193|FG001|Overall Study|Adverse Event|3|||
27537078|NCT01914757|80160194|FG002|Overall Study|Adverse Event|4|||
27537079|NCT01914757|80160192|FG000|Overall Study|Study specific withdrawal criteria|0|||
27537080|NCT01914757|80160193|FG001|Overall Study|Study specific withdrawal criteria|1|||
27537081|NCT01914757|80160194|FG002|Overall Study|Study specific withdrawal criteria|0|||
27537082|NCT01914757|80160192|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
27537083|NCT01914757|80160193|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
27537084|NCT01914757|80160194|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
27537085|NCT01914757|80160192|FG000|Overall Study|Other reasons|5|||
27537086|NCT01914757|80160193|FG001|Overall Study|Other reasons|9|||
27537087|NCT01914757|80160194|FG002|Overall Study|Other reasons|4|||
27537088|NCT02840721|80160197|FG000|Treatment Period|Adverse Event|1|||
27537089|NCT02840721|80160197|FG000|Follow-Up|Lack of Efficacy|1|||
27537090|NCT02840721|80160197|FG000|Follow-Up|Withdrawal by Subject|4|||
27537091|NCT02840721|80160197|FG000|Follow-Up|Withdrawal of Consent|2|||
27537092|NCT00669396|80160199|FG000|Overall Study|Lost to Follow-up|10|||
27537093|NCT00669396|80160200|FG001|Overall Study|Lost to Follow-up|12|||
27537094|NCT00573937|80160201|FG000|Overall Study|Study Terminated|0|||
27537095|NCT00573937|80160202|FG001|Overall Study|Study Terminated|1|||
27537096|NCT00595465|80160203|FG000|Overall Study|Adverse Event|4|||
27537097|NCT00595465|80160204|FG001|Overall Study|Adverse Event|3|||
27537098|NCT00595465|80160205|FG002|Overall Study|Adverse Event|3|||
27537099|NCT00595465|80160203|FG000|Overall Study|Pregnancy|0|||
27537100|NCT00595465|80160204|FG001|Overall Study|Pregnancy|0|||
27537101|NCT00595465|80160205|FG002|Overall Study|Pregnancy|1|||
27537102|NCT00595465|80160203|FG000|Overall Study|Protocol Violation|2|||
27537103|NCT00595465|80160204|FG001|Overall Study|Protocol Violation|1|||
27537104|NCT00595465|80160205|FG002|Overall Study|Protocol Violation|0|||
27537105|NCT00595465|80160203|FG000|Overall Study|Lost to Follow-up|0|||
27537106|NCT00595465|80160204|FG001|Overall Study|Lost to Follow-up|0|||
27537107|NCT00595465|80160205|FG002|Overall Study|Lost to Follow-up|2|||
27537108|NCT00595465|80160203|FG000|Overall Study|administrative reason|0|||
27537109|NCT00595465|80160204|FG001|Overall Study|administrative reason|0|||
27537110|NCT00595465|80160205|FG002|Overall Study|administrative reason|1|||
27537111|NCT00395733|80160208|FG000|Period 2|Withdrawal by Subject|1|||
27537112|NCT00395733|80160209|FG001|Period 2|Withdrawal by Subject|2|||
27537113|NCT00395733|80160208|FG000|Period 2|Protocol Violation|0|||
27537114|NCT00395733|80160209|FG001|Period 2|Protocol Violation|1|||
27537115|NCT00395733|80160208|FG000|Period 2|Adverse Event|0|||
27537116|NCT00395733|80160209|FG001|Period 2|Adverse Event|2|||
27537117|NCT00395733|80160208|FG000|Period 2|Technical problems|1|||
27537118|NCT00395733|80160209|FG001|Period 2|Technical problems|0|||
27537119|NCT00864721|80160212|FG000|Overall Study|Patient request|11|||
27537120|NCT00864721|80160212|FG000|Overall Study|Hospitalized|1|||
27537121|NCT00864721|80160212|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
27537122|NCT00864721|80160212|FG000|Overall Study|Adverse Event|21|||
27537123|NCT01868503|80160213|FG000|Overall Study|Withdrawal by Subject|1|||
27537124|NCT01868503|80160213|FG000|Overall Study|Protocol Violation|1|||
27537125|NCT03855228|80160214|FG000|Overall Study|Adverse Event|2|||
27537126|NCT03855228|80160215|FG001|Overall Study|Adverse Event|4|||
27537127|NCT03855228|80160216|FG002|Overall Study|Adverse Event|4|||
27537128|NCT03855228|80160217|FG003|Overall Study|Adverse Event|8|||
27537129|NCT03855228|80160214|FG000|Overall Study|Treatment Failure|1|||
27537130|NCT03855228|80160215|FG001|Overall Study|Treatment Failure|2|||
27537131|NCT03855228|80160216|FG002|Overall Study|Treatment Failure|1|||
27537132|NCT03855228|80160217|FG003|Overall Study|Treatment Failure|8|||
27632355|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
27632356|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27537133|NCT03855228|80160214|FG000|Overall Study|Lost to Follow-up|0|||
27537134|NCT03855228|80160215|FG001|Overall Study|Lost to Follow-up|0|||
27537135|NCT03855228|80160216|FG002|Overall Study|Lost to Follow-up|0|||
27537136|NCT03855228|80160217|FG003|Overall Study|Lost to Follow-up|1|||
27632357|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632358|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27537137|NCT03855228|80160214|FG000|Overall Study|Protocol Violation|0|||
27537138|NCT03855228|80160215|FG001|Overall Study|Protocol Violation|1|||
27632359|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632360|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
27632361|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632362|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632363|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632364|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632365|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632366|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
27632367|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
27632368|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632369|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632370|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632371|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632372|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632373|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632374|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632375|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632376|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632377|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
27632378|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
27632379|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
27632380|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
27632381|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
27632382|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
27632383|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
27632384|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
27632385|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
27632386|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
27632387|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
27537139|NCT03855228|80160216|FG002|Overall Study|Protocol Violation|2|||
27537140|NCT03855228|80160217|FG003|Overall Study|Protocol Violation|1|||
27537141|NCT03855228|80160214|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
27537142|NCT03855228|80160215|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
27537143|NCT03855228|80160216|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
27537144|NCT03855228|80160217|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
27537145|NCT01206166|80163426|FG000|Overall Study|No evaluable data|2|||
27537146|NCT01206166|80163427|FG001|Overall Study|No evaluable data|3|||
27537147|NCT00216476|80163428|FG000|Overall Study|Withdrawal by Subject|59|||
27537148|NCT00216476|80163429|FG001|Overall Study|Withdrawal by Subject|72|||
27537149|NCT00216476|80163430|FG002|Overall Study|Withdrawal by Subject|9|||
27537150|NCT00216476|80163428|FG000|Overall Study|Lost to Follow-up|10|||
27537151|NCT00216476|80163429|FG001|Overall Study|Lost to Follow-up|9|||
27537152|NCT00216476|80163430|FG002|Overall Study|Lost to Follow-up|1|||
27537153|NCT00216476|80163428|FG000|Overall Study|Adverse Event|6|||
27537154|NCT00216476|80163429|FG001|Overall Study|Adverse Event|10|||
27537155|NCT00216476|80163430|FG002|Overall Study|Adverse Event|1|||
27537156|NCT00216476|80163428|FG000|Overall Study|Lack of Efficacy|4|||
27537157|NCT00216476|80163429|FG001|Overall Study|Lack of Efficacy|3|||
27537158|NCT00216476|80163430|FG002|Overall Study|Lack of Efficacy|0|||
27537159|NCT00216476|80163428|FG000|Overall Study|Death|2|||
27537160|NCT00216476|80163429|FG001|Overall Study|Death|0|||
27537161|NCT00216476|80163430|FG002|Overall Study|Death|0|||
27537162|NCT00216476|80163428|FG000|Overall Study|Pregnancy|0|||
27537163|NCT00216476|80163429|FG001|Overall Study|Pregnancy|1|||
27537164|NCT00216476|80163430|FG002|Overall Study|Pregnancy|1|||
27537165|NCT00216476|80163428|FG000|Overall Study|Other|0|||
27537166|NCT00216476|80163429|FG001|Overall Study|Other|0|||
27537167|NCT00216476|80163430|FG002|Overall Study|Other|1|||
27537168|NCT00216476|80163428|FG000|Overall Study|Refuses Injection|11|||
27537169|NCT00216476|80163429|FG001|Overall Study|Refuses Injection|0|||
27537170|NCT00216476|80163430|FG002|Overall Study|Refuses Injection|0|||
27537171|NCT00216476|80163428|FG000|Overall Study|No Further Need for Treatment|3|||
27537172|NCT00216476|80163429|FG001|Overall Study|No Further Need for Treatment|4|||
27537173|NCT00216476|80163430|FG002|Overall Study|No Further Need for Treatment|1|||
27537174|NCT00216476|80163428|FG000|Overall Study|Non-compliance|0|||
27537175|NCT00216476|80163429|FG001|Overall Study|Non-compliance|4|||
27537176|NCT00216476|80163430|FG002|Overall Study|Non-compliance|1|||
27537177|NCT00216476|80163428|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
27537178|NCT00216476|80163429|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
27632388|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
27537179|NCT00216476|80163430|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
27537180|NCT00216476|80163428|FG000|Overall Study|Administrative Reasons|1|||
27537181|NCT00216476|80163429|FG001|Overall Study|Administrative Reasons|1|||
27537182|NCT00216476|80163430|FG002|Overall Study|Administrative Reasons|0|||
27537183|NCT00216476|80163428|FG000|Overall Study|Protocol Deviation|5|||
27537184|NCT00216476|80163429|FG001|Overall Study|Protocol Deviation|1|||
27537185|NCT00216476|80163430|FG002|Overall Study|Protocol Deviation|0|||
27537186|NCT00216476|80163428|FG000|Overall Study|Patient Moved|2|||
27537187|NCT00216476|80163429|FG001|Overall Study|Patient Moved|2|||
27537188|NCT00216476|80163430|FG002|Overall Study|Patient Moved|0|||
27537189|NCT01484275|80163431|FG000|Overall Study|Study terminated by sponsor|28|||
27537190|NCT01484275|80163432|FG001|Overall Study|Study terminated by sponsor|32|||
27537191|NCT01484275|80163431|FG000|Overall Study|Other|10|||
27537192|NCT01484275|80163432|FG001|Overall Study|Other|0|||
27537193|NCT01484275|80163431|FG000|Overall Study|Death|3|||
27537194|NCT01484275|80163432|FG001|Overall Study|Death|4|||
27537195|NCT01484275|80163431|FG000|Overall Study|Withdrawal by Subject|1|||
27537196|NCT01484275|80163432|FG001|Overall Study|Withdrawal by Subject|5|||
27537197|NCT01484275|80163431|FG000|Overall Study|Lost to Follow-up|1|||
27537198|NCT01484275|80163432|FG001|Overall Study|Lost to Follow-up|1|||
27537199|NCT01031381|80163433|FG000|Overall Study|Physician Decision|3|||
27537200|NCT01031381|80163433|FG000|Overall Study|Withdrawal by Subject|6|||
27537201|NCT02106975|80163435|FG000|Overall Study|Death|25|||
27537202|NCT02106975|80163436|FG001|Overall Study|Death|39|||
27537203|NCT00590135|80163439|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
27537204|NCT01522248|80163440|FG000|Overall Study|Lost to Follow-up|1|||
27537205|NCT01522248|80163441|FG001|Overall Study|Lost to Follow-up|0|||
27537206|NCT02058693|80163442|FG000|Phase 1|Withdrawal by Subject|3|||
27537207|NCT02058693|80163443|FG001|Phase 1|Withdrawal by Subject|2|||
27537208|NCT02058693|80163442|FG000|Phase 1|Adverse Event|0|||
27537209|NCT02058693|80163443|FG001|Phase 1|Adverse Event|1|||
27537210|NCT02058693|80163442|FG000|Phase 1|Lack of Efficacy|1|||
27537211|NCT02058693|80163443|FG001|Phase 1|Lack of Efficacy|0|||
27537212|NCT02058693|80163442|FG000|Phase 1|Physician Decision|1|||
27537213|NCT02058693|80163443|FG001|Phase 1|Physician Decision|1|||
27537214|NCT02058693|80163442|FG000|Phase 2|Withdrawal by Subject|0|||
27537215|NCT02058693|80163443|FG001|Phase 2|Withdrawal by Subject|2|||
27537216|NCT01426438|80163444|FG000|Overall Study|Lost to Follow-up|1|||
27537217|NCT01426438|80163445|FG001|Overall Study|Lost to Follow-up|3|||
27537218|NCT01426438|80163444|FG000|Overall Study|Off study Treatment|9|||
27537219|NCT01426438|80163445|FG001|Overall Study|Off study Treatment|3|||
27537220|NCT01426438|80163444|FG000|Overall Study|Poor scan quality|3|||
27632389|NCT02914522|80493765|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632390|NCT02914522|80493766|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
27632391|NCT02914522|80493767|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632392|NCT02914522|80493768|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632393|NCT02914522|80493769|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
27632394|NCT02914522|80493770|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
27632395|NCT02914522|80493771|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632396|NCT02914522|80493772|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632397|NCT02914522|80493773|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632398|NCT02914522|80493774|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632399|NCT02914522|80493775|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
27632400|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
27632401|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
27632402|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
27632403|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
27632404|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
27632405|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
27632406|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
27632407|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
27537221|NCT01426438|80163445|FG001|Overall Study|Poor scan quality|2|||
27537222|NCT01426438|80163444|FG000|Overall Study|Missed Scan|2|||
27632408|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
27537223|NCT01426438|80163445|FG001|Overall Study|Missed Scan|2|||
27537224|NCT02764333|80163446|FG000|Overall Study|Ineligible|1|||
27537225|NCT00369824|80163447|FG000|Overall Study|Adverse Event|0|||
27537226|NCT00369824|80163448|FG001|Overall Study|Adverse Event|2|||
27537227|NCT00369824|80163449|FG002|Overall Study|Adverse Event|0|||
27537228|NCT00369824|80163450|FG003|Overall Study|Adverse Event|0|||
27537229|NCT00369824|80163451|FG004|Overall Study|Adverse Event|1|||
27537230|NCT00369824|80163452|FG005|Overall Study|Adverse Event|0|||
27537231|NCT00369824|80163447|FG000|Overall Study|Protocol Violation|0|||
27632409|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
27632410|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
27632411|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
27632412|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
27632413|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
27632414|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
27632415|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
27632416|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
27632417|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
27632418|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
27632419|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
27632420|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
27632421|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
27632422|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632423|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632424|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632425|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632426|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632427|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632428|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
27632429|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
27632430|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
27632431|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
27632432|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
27632433|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
27632434|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
27632435|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
27537232|NCT00369824|80163448|FG001|Overall Study|Protocol Violation|1|||
27537233|NCT00369824|80163449|FG002|Overall Study|Protocol Violation|0|||
27632436|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
27632437|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
27739164|NCT00553787|80874005|FG001|Overall Study|non compliance|0|||
27739165|NCT00553787|80874006|FG002|Overall Study|non compliance|11|||
27739166|NCT00553787|80874004|FG000|Overall Study|Requirement for restricted medication|8|||
27739167|NCT00553787|80874005|FG001|Overall Study|Requirement for restricted medication|7|||
27739168|NCT00553787|80874006|FG002|Overall Study|Requirement for restricted medication|5|||
27739169|NCT00553787|80874004|FG000|Overall Study|Other|18|||
27739170|NCT00553787|80874005|FG001|Overall Study|Other|10|||
27739171|NCT00553787|80874006|FG002|Overall Study|Other|13|||
27739172|NCT01282814|80874011|FG000|First Intervention|Emesis During Dosing Interval|0|||
27739173|NCT01282814|80874012|FG001|First Intervention|Emesis During Dosing Interval|3|||
27739174|NCT01282814|80874011|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
27739175|NCT01282814|80874012|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27739176|NCT03227861|80874013|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
27739177|NCT03227861|80874013|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
27739178|NCT03227861|80874013|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
27739179|NCT03227861|80874013|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
27739180|NCT03227861|80874013|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
27916188|NCT01198002|81533075|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
27916189|NCT01198002|81533076|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
27537234|NCT00369824|80163450|FG003|Overall Study|Protocol Violation|1|||
27537235|NCT00369824|80163451|FG004|Overall Study|Protocol Violation|1|||
27537236|NCT00369824|80163452|FG005|Overall Study|Protocol Violation|0|||
27537237|NCT00369824|80163447|FG000|Overall Study|Withdrawal by Subject|9|||
27537238|NCT00369824|80163448|FG001|Overall Study|Withdrawal by Subject|5|||
27537239|NCT00369824|80163449|FG002|Overall Study|Withdrawal by Subject|5|||
27537240|NCT00369824|80163450|FG003|Overall Study|Withdrawal by Subject|4|||
27537241|NCT00369824|80163451|FG004|Overall Study|Withdrawal by Subject|6|||
27537242|NCT00369824|80163452|FG005|Overall Study|Withdrawal by Subject|2|||
27537243|NCT00369824|80163447|FG000|Overall Study|Lost to Follow-up|6|||
27537244|NCT00369824|80163448|FG001|Overall Study|Lost to Follow-up|11|||
27537245|NCT00369824|80163449|FG002|Overall Study|Lost to Follow-up|7|||
27537246|NCT00369824|80163450|FG003|Overall Study|Lost to Follow-up|8|||
27537247|NCT00369824|80163451|FG004|Overall Study|Lost to Follow-up|9|||
27632438|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
27739181|NCT03227861|80874013|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
27916190|NCT01198002|81533074|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
27916191|NCT01198002|81533075|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
27537248|NCT00369824|80163452|FG005|Overall Study|Lost to Follow-up|6|||
27537249|NCT00369824|80163447|FG000|Overall Study|Other|0|||
27537250|NCT00369824|80163448|FG001|Overall Study|Other|0|||
27537251|NCT00369824|80163449|FG002|Overall Study|Other|0|||
27537252|NCT00369824|80163450|FG003|Overall Study|Other|2|||
27537253|NCT00369824|80163451|FG004|Overall Study|Other|1|||
27537254|NCT00369824|80163452|FG005|Overall Study|Other|3|||
27537255|NCT02935842|80163455|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
27537256|NCT02935842|80163456|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
27537257|NCT02935842|80163457|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
27537258|NCT02935842|80163458|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
27537259|NCT02935842|80163455|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
27537260|NCT02935842|80163456|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
27537261|NCT02935842|80163457|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
27537262|NCT02935842|80163458|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
27537263|NCT02935842|80163455|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
27537264|NCT02935842|80163456|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
27537265|NCT02935842|80163457|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
27537266|NCT02935842|80163458|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
27537267|NCT02935842|80163455|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
27537268|NCT02935842|80163456|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
27739182|NCT03227861|80874013|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
27739183|NCT03227861|80874013|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
27739184|NCT03227861|80874013|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
27739185|NCT03227861|80874013|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
27739186|NCT00440401|80874014|FG000|Overall Study|Adverse Event|2|||
27739187|NCT00440401|80874015|FG001|Overall Study|Adverse Event|1|||
27739188|NCT00440401|80874014|FG000|Overall Study|Other|2|||
27739189|NCT00440401|80874015|FG001|Overall Study|Other|5|||
27739190|NCT01158950|80874018|FG000|1st Intervention (1 Day)|Physician Decision|1|||
27739191|NCT01158950|80874019|FG001|1st Intervention (1 Day)|Physician Decision|2|||
27739192|NCT00542815|80874020|FG000|Overall Study|Adverse Event|19|||
27916192|NCT01198002|81533076|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
27537269|NCT02935842|80163457|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
27537270|NCT02935842|80163458|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
27537271|NCT02935842|80163455|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
27537272|NCT02935842|80163456|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
27537273|NCT02935842|80163457|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
27537274|NCT02935842|80163458|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
27537275|NCT03307785|80163459|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
27537276|NCT03307785|80163460|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
27537277|NCT03307785|80163461|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
27537278|NCT03307785|80163462|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
27537279|NCT03307785|80163463|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
27537280|NCT03307785|80163464|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
27537281|NCT03307785|80163465|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
27537282|NCT03307785|80163466|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
27537283|NCT03307785|80163467|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
27537284|NCT03307785|80163468|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
27537285|NCT03307785|80163469|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
27537286|NCT03307785|80163459|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
27537287|NCT03307785|80163460|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
27537288|NCT03307785|80163461|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537289|NCT03307785|80163462|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537290|NCT03307785|80163463|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537291|NCT03307785|80163464|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537292|NCT03307785|80163465|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537293|NCT03307785|80163466|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537294|NCT03307785|80163467|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537295|NCT03307785|80163468|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537296|NCT03307785|80163469|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
27537297|NCT03307785|80163459|FG000|Part A: Up to 28.5 Months|Death|4|||
27537298|NCT03307785|80163460|FG001|Part A: Up to 28.5 Months|Death|4|||
27739193|NCT00542815|80874021|FG001|Overall Study|Adverse Event|6|||
27916193|NCT03102762|81533079|FG000|Overall Study|Lost to Follow-up|1|||
27916194|NCT03102762|81533080|FG001|Overall Study|Lost to Follow-up|0|||
27537299|NCT03307785|80163461|FG002|Part A: Up to 28.5 Months|Death|0|||
27739194|NCT00542815|80874022|FG002|Overall Study|Adverse Event|9|||
27739195|NCT00542815|80874020|FG000|Overall Study|Death|10|||
27537300|NCT03307785|80163462|FG003|Part A: Up to 28.5 Months|Death|0|||
27537301|NCT03307785|80163463|FG004|Part A: Up to 28.5 Months|Death|0|||
27537302|NCT03307785|80163464|FG005|Part A: Up to 28.5 Months|Death|0|||
27537303|NCT03307785|80163465|FG006|Part A: Up to 28.5 Months|Death|0|||
27537304|NCT03307785|80163466|FG007|Part A: Up to 28.5 Months|Death|0|||
27916195|NCT02783170|81533081|FG000|Overall Study|Randomized but not Vaccinated|1|||
27916196|NCT02783170|81533082|FG001|Overall Study|Randomized but not Vaccinated|0|||
27916197|NCT03704064|81533083|FG000|Overall Study|Lost to Follow-up|8|||
27916198|NCT03704064|81533084|FG001|Overall Study|Lost to Follow-up|4|||
27916199|NCT03704064|81533083|FG000|Overall Study|Withdrawal by Subject|1|||
27916200|NCT03704064|81533084|FG001|Overall Study|Withdrawal by Subject|1|||
27916201|NCT03704064|81533083|FG000|Overall Study|No longer available for study visits|0|||
27916202|NCT03704064|81533084|FG001|Overall Study|No longer available for study visits|1|||
27916203|NCT03704064|81533083|FG000|Overall Study|Censoring event|1|||
27916204|NCT03704064|81533084|FG001|Overall Study|Censoring event|0|||
27916205|NCT00875810|81533085|FG000|Overall Study|Withdrawal by Subject|1|||
27916206|NCT00875810|81533085|FG000|Overall Study|Physician Decision|3|||
27916207|NCT00875810|81533085|FG000|Overall Study|Lost to Follow-up|39|||
27916208|NCT00875810|81533085|FG000|Overall Study|Patient enroled but not implanted|2|||
27916209|NCT00875810|81533085|FG000|Overall Study|Device explanted|1|||
27916210|NCT03322293|81533087|FG000|Overall Study|Lost to Follow-up|0|||
27916211|NCT03322293|81533088|FG001|Overall Study|Lost to Follow-up|0|||
27916212|NCT03322293|81533089|FG002|Overall Study|Lost to Follow-up|1|||
27916213|NCT01064479|81533090|FG000|Overall Study|Death|10|||
27916214|NCT01064479|81533091|FG001|Overall Study|Death|11|||
27916215|NCT01064479|81533090|FG000|Overall Study|Withdrawal by Subject|2|||
27916216|NCT01064479|81533091|FG001|Overall Study|Withdrawal by Subject|2|||
27916217|NCT01064479|81533090|FG000|Overall Study|Disease progression|1|||
27916218|NCT01064479|81533091|FG001|Overall Study|Disease progression|1|||
27916219|NCT01064479|81533090|FG000|Overall Study|Toxicity|1|||
27916220|NCT01064479|81533091|FG001|Overall Study|Toxicity|1|||
27916221|NCT01064479|81533090|FG000|Overall Study|Other|1|||
27537305|NCT03307785|80163467|FG008|Part A: Up to 28.5 Months|Death|0|||
27537306|NCT03307785|80163468|FG009|Part A: Up to 28.5 Months|Death|0|||
27537307|NCT03307785|80163469|FG010|Part A: Up to 28.5 Months|Death|0|||
27537308|NCT03307785|80163459|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
27537309|NCT03307785|80163460|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
27537310|NCT03307785|80163461|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
27537311|NCT03307785|80163462|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
27916222|NCT01064479|81533091|FG001|Overall Study|Other|2|||
27537312|NCT03307785|80163463|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
27537313|NCT03307785|80163464|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
27537314|NCT03307785|80163465|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
27537315|NCT03307785|80163466|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
27537316|NCT03307785|80163467|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
27537317|NCT03307785|80163468|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
27537318|NCT03307785|80163469|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
27537319|NCT03307785|80163459|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537320|NCT03307785|80163460|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537321|NCT03307785|80163461|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
27537322|NCT03307785|80163462|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537323|NCT03307785|80163463|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537324|NCT03307785|80163464|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537325|NCT03307785|80163465|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537326|NCT03307785|80163466|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537327|NCT03307785|80163467|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537328|NCT03307785|80163468|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537329|NCT03307785|80163469|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
27537330|NCT03307785|80163459|FG000|Part B: Up to Approx. 66 Months|Death|0|||
27537331|NCT03307785|80163460|FG001|Part B: Up to Approx. 66 Months|Death|0|||
27537332|NCT03307785|80163461|FG002|Part B: Up to Approx. 66 Months|Death|7|||
27537333|NCT03307785|80163462|FG003|Part B: Up to Approx. 66 Months|Death|0|||
27537334|NCT03307785|80163463|FG004|Part B: Up to Approx. 66 Months|Death|0|||
27537335|NCT03307785|80163464|FG005|Part B: Up to Approx. 66 Months|Death|0|||
27537336|NCT03307785|80163465|FG006|Part B: Up to Approx. 66 Months|Death|0|||
27537337|NCT03307785|80163466|FG007|Part B: Up to Approx. 66 Months|Death|0|||
27537338|NCT03307785|80163467|FG008|Part B: Up to Approx. 66 Months|Death|0|||
27916223|NCT01251952|81533098|FG000|Overall Study|Adverse Event|1|||
27916224|NCT00928434|81533101|FG000|Overall Study|Adverse Event|14|||
27537339|NCT03307785|80163468|FG009|Part B: Up to Approx. 66 Months|Death|0|||
27537340|NCT03307785|80163469|FG010|Part B: Up to Approx. 66 Months|Death|0|||
27537341|NCT03307785|80163459|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27916225|NCT00928434|81533102|FG001|Overall Study|Adverse Event|5|||
27916226|NCT00928434|81533103|FG002|Overall Study|Adverse Event|18|||
27916227|NCT00928434|81533101|FG000|Overall Study|Protocol Violation|5|||
27916228|NCT00928434|81533102|FG001|Overall Study|Protocol Violation|0|||
27537342|NCT03307785|80163460|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27916229|NCT00928434|81533103|FG002|Overall Study|Protocol Violation|8|||
27916230|NCT00928434|81533101|FG000|Overall Study|Physician Decision|2|||
27916231|NCT00928434|81533102|FG001|Overall Study|Physician Decision|0|||
27916232|NCT00928434|81533103|FG002|Overall Study|Physician Decision|3|||
27916233|NCT00928434|81533101|FG000|Overall Study|Lost to Follow-up|1|||
27916234|NCT00928434|81533102|FG001|Overall Study|Lost to Follow-up|0|||
27916235|NCT00928434|81533103|FG002|Overall Study|Lost to Follow-up|3|||
27916236|NCT00928434|81533101|FG000|Overall Study|Withdrawal by Subject|5|||
27916237|NCT00928434|81533102|FG001|Overall Study|Withdrawal by Subject|3|||
27739196|NCT00542815|80874021|FG001|Overall Study|Death|7|||
27739197|NCT00542815|80874022|FG002|Overall Study|Death|3|||
27739198|NCT00542815|80874020|FG000|Overall Study|Lack of Efficacy|9|||
27739199|NCT00542815|80874021|FG001|Overall Study|Lack of Efficacy|2|||
27739200|NCT00542815|80874022|FG002|Overall Study|Lack of Efficacy|0|||
27739201|NCT00542815|80874020|FG000|Overall Study|Physician Decision|2|||
27739202|NCT00542815|80874021|FG001|Overall Study|Physician Decision|1|||
27916238|NCT00928434|81533103|FG002|Overall Study|Withdrawal by Subject|2|||
27916239|NCT00928434|81533101|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
27537343|NCT03307785|80163461|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
27537344|NCT03307785|80163462|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537345|NCT03307785|80163463|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537346|NCT03307785|80163464|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537347|NCT03307785|80163465|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537348|NCT03307785|80163466|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27916240|NCT00928434|81533102|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
27916241|NCT00928434|81533103|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
27916242|NCT00928434|81533101|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
27916243|NCT00928434|81533102|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
27916244|NCT00928434|81533103|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
27916245|NCT00928434|81533101|FG000|Overall Study|Other (not meeting above criteria)|5|||
27916246|NCT00928434|81533102|FG001|Overall Study|Other (not meeting above criteria)|1|||
27916247|NCT00928434|81533103|FG002|Overall Study|Other (not meeting above criteria)|2|||
27916248|NCT04817332|81533113|FG000|Overall Study|Lost to Follow-up|3|||
27916249|NCT04817332|81533114|FG001|Overall Study|Lost to Follow-up|3|||
27916250|NCT04817332|81533113|FG000|Overall Study|Protocol Violation|2|||
27916251|NCT04817332|81533114|FG001|Overall Study|Protocol Violation|0|||
27916252|NCT04161391|81533115|FG000|Overall Study|Adverse Event|0|||
27916253|NCT04161391|81533116|FG001|Overall Study|Adverse Event|1|||
27916254|NCT04161391|81533117|FG002|Overall Study|Adverse Event|0|||
27916255|NCT04161391|81533118|FG003|Overall Study|Adverse Event|1|||
27916256|NCT04161391|81533119|FG004|Overall Study|Adverse Event|0|||
27916257|NCT04161391|81533120|FG005|Overall Study|Adverse Event|0|||
27916258|NCT04161391|81533121|FG006|Overall Study|Adverse Event|0|||
27916259|NCT04161391|81533122|FG007|Overall Study|Adverse Event|3|||
27916260|NCT04161391|81533123|FG008|Overall Study|Adverse Event|0|||
27916261|NCT04161391|81533115|FG000|Overall Study|Death|0|||
27916262|NCT04161391|81533116|FG001|Overall Study|Death|0|||
27916263|NCT04161391|81533117|FG002|Overall Study|Death|0|||
27916264|NCT04161391|81533118|FG003|Overall Study|Death|0|||
27916265|NCT04161391|81533119|FG004|Overall Study|Death|0|||
27916266|NCT04161391|81533120|FG005|Overall Study|Death|0|||
27916267|NCT04161391|81533121|FG006|Overall Study|Death|0|||
27916268|NCT04161391|81533122|FG007|Overall Study|Death|1|||
27916269|NCT04161391|81533123|FG008|Overall Study|Death|0|||
27916270|NCT04161391|81533115|FG000|Overall Study|Physician Decision|0|||
27916271|NCT04161391|81533116|FG001|Overall Study|Physician Decision|0|||
27537349|NCT03307785|80163467|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537350|NCT03307785|80163468|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537351|NCT03307785|80163469|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
27537352|NCT03307785|80163459|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537353|NCT03307785|80163460|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537354|NCT03307785|80163461|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
27537355|NCT03307785|80163462|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27916272|NCT04161391|81533117|FG002|Overall Study|Physician Decision|1|||
27916273|NCT04161391|81533118|FG003|Overall Study|Physician Decision|2|||
27916274|NCT04161391|81533119|FG004|Overall Study|Physician Decision|0|||
27916275|NCT04161391|81533120|FG005|Overall Study|Physician Decision|0|||
27916276|NCT04161391|81533121|FG006|Overall Study|Physician Decision|2|||
27916277|NCT04161391|81533122|FG007|Overall Study|Physician Decision|0|||
27739203|NCT00542815|80874022|FG002|Overall Study|Physician Decision|0|||
27739204|NCT00542815|80874020|FG000|Overall Study|Protocol Violation|1|||
27916278|NCT04161391|81533123|FG008|Overall Study|Physician Decision|0|||
27916279|NCT04161391|81533115|FG000|Overall Study|Progressive Disease|4|||
27916280|NCT04161391|81533116|FG001|Overall Study|Progressive Disease|3|||
27916281|NCT04161391|81533117|FG002|Overall Study|Progressive Disease|3|||
27916282|NCT04161391|81533118|FG003|Overall Study|Progressive Disease|5|||
27916283|NCT04161391|81533119|FG004|Overall Study|Progressive Disease|3|||
27916284|NCT04161391|81533120|FG005|Overall Study|Progressive Disease|3|||
27916285|NCT04161391|81533121|FG006|Overall Study|Progressive Disease|5|||
27537356|NCT03307785|80163463|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537357|NCT03307785|80163464|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537358|NCT03307785|80163465|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537359|NCT03307785|80163466|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537360|NCT03307785|80163467|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537361|NCT03307785|80163468|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537362|NCT03307785|80163469|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
27537363|NCT03307785|80163459|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537364|NCT03307785|80163460|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537365|NCT03307785|80163461|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
27537366|NCT03307785|80163462|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537367|NCT03307785|80163463|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537368|NCT03307785|80163464|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537369|NCT03307785|80163465|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537370|NCT03307785|80163466|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537371|NCT03307785|80163467|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537372|NCT03307785|80163468|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537373|NCT03307785|80163469|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
27537374|NCT03307785|80163459|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537375|NCT03307785|80163460|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537376|NCT03307785|80163461|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537377|NCT03307785|80163462|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
27537378|NCT03307785|80163463|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
27537379|NCT03307785|80163464|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537380|NCT03307785|80163465|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537381|NCT03307785|80163466|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537382|NCT03307785|80163467|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537383|NCT03307785|80163468|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537384|NCT03307785|80163469|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
27537385|NCT03307785|80163459|FG000|Part C: Up to Approx. 60 Months|Death|0|||
27537386|NCT03307785|80163460|FG001|Part C: Up to Approx. 60 Months|Death|0|||
27537387|NCT03307785|80163461|FG002|Part C: Up to Approx. 60 Months|Death|0|||
27537388|NCT03307785|80163462|FG003|Part C: Up to Approx. 60 Months|Death|2|||
27537389|NCT03307785|80163463|FG004|Part C: Up to Approx. 60 Months|Death|5|||
27537390|NCT03307785|80163464|FG005|Part C: Up to Approx. 60 Months|Death|0|||
27537391|NCT03307785|80163465|FG006|Part C: Up to Approx. 60 Months|Death|0|||
27537392|NCT03307785|80163466|FG007|Part C: Up to Approx. 60 Months|Death|0|||
27537393|NCT03307785|80163467|FG008|Part C: Up to Approx. 60 Months|Death|0|||
27537394|NCT03307785|80163468|FG009|Part C: Up to Approx. 60 Months|Death|0|||
27537395|NCT03307785|80163469|FG010|Part C: Up to Approx. 60 Months|Death|0|||
27537396|NCT03307785|80163459|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537397|NCT03307785|80163460|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27916286|NCT04161391|81533122|FG007|Overall Study|Progressive Disease|2|||
27916287|NCT04161391|81533123|FG008|Overall Study|Progressive Disease|2|||
27916288|NCT01093846|81533124|FG000|Overall Study|Adverse Event|0|||
27916289|NCT01093846|81533125|FG001|Overall Study|Adverse Event|0|||
27916290|NCT01093846|81533126|FG002|Overall Study|Adverse Event|1|||
27916291|NCT01093846|81533124|FG000|Overall Study|Lack of Efficacy|0|||
27916292|NCT01093846|81533125|FG001|Overall Study|Lack of Efficacy|0|||
27916293|NCT01093846|81533126|FG002|Overall Study|Lack of Efficacy|4|||
27916294|NCT01093846|81533124|FG000|Overall Study|Condition no longer required study drug|1|||
27916295|NCT01093846|81533125|FG001|Overall Study|Condition no longer required study drug|1|||
27916296|NCT01093846|81533126|FG002|Overall Study|Condition no longer required study drug|1|||
27916297|NCT01093846|81533124|FG000|Overall Study|Administrative Problems|18|||
27916298|NCT01093846|81533125|FG001|Overall Study|Administrative Problems|17|||
27916299|NCT01093846|81533126|FG002|Overall Study|Administrative Problems|15|||
27916300|NCT03342001|81533127|FG000|Overall Study|Adverse Event|1|||
27916301|NCT03342001|81533127|FG000|Overall Study|Lost to Follow-up|1|||
27916302|NCT05556148|81533128|FG000|Overall Study|Early Termination|29|||
27916303|NCT05556148|81533128|FG000|Overall Study|Baseline Tasks Expired|4|||
27916304|NCT05556148|81533128|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
27537398|NCT03307785|80163461|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537399|NCT03307785|80163462|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
27916305|NCT05556148|81533128|FG000|Overall Study|No Longer Wished to Participate|1|||
27916306|NCT05556148|81533128|FG000|Overall Study|Bacterial Conjunctivitis|1|||
27916307|NCT03217591|81533129|FG000|Overall Study|Adverse Event|1|||
27916308|NCT03217591|81533130|FG001|Overall Study|Adverse Event|2|||
27916309|NCT03217591|81533131|FG002|Overall Study|Adverse Event|6|||
27916310|NCT03217591|81533129|FG000|Overall Study|Withdrawal by Subject|0|||
27916311|NCT03217591|81533130|FG001|Overall Study|Withdrawal by Subject|1|||
27537400|NCT03307785|80163463|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537401|NCT03307785|80163464|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27632439|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
27632440|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
27632441|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
27632442|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
27632443|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
27632444|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
27632445|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
27632446|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
27632447|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
27632448|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
27632449|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
27632450|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
27632451|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
27632452|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
27632453|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
27632454|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
27632455|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632456|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632457|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632458|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27537402|NCT03307785|80163465|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537403|NCT03307785|80163466|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537404|NCT03307785|80163467|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27632459|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632460|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632461|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632462|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
27632463|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
27632464|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632465|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
27632466|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632467|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632468|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632469|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27916312|NCT03217591|81533131|FG002|Overall Study|Withdrawal by Subject|3|||
27916313|NCT03217591|81533129|FG000|Overall Study|Lost to Follow-up|1|||
27916314|NCT03217591|81533130|FG001|Overall Study|Lost to Follow-up|0|||
27916315|NCT03217591|81533131|FG002|Overall Study|Lost to Follow-up|0|||
27916316|NCT03217591|81533129|FG000|Overall Study|Protocol Violation|1|||
27916317|NCT03217591|81533130|FG001|Overall Study|Protocol Violation|0|||
27537405|NCT03307785|80163468|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537406|NCT03307785|80163469|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
27537407|NCT03307785|80163459|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537408|NCT03307785|80163460|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537409|NCT03307785|80163461|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537410|NCT03307785|80163462|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537411|NCT03307785|80163463|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
27537412|NCT03307785|80163464|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537413|NCT03307785|80163465|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537414|NCT03307785|80163466|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537415|NCT03307785|80163467|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537416|NCT03307785|80163468|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537417|NCT03307785|80163469|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
27537418|NCT03307785|80163459|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537419|NCT03307785|80163460|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537420|NCT03307785|80163461|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537421|NCT03307785|80163462|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537422|NCT03307785|80163463|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537423|NCT03307785|80163464|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
27537424|NCT03307785|80163465|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537425|NCT03307785|80163466|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537426|NCT03307785|80163467|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27632470|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632471|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27916318|NCT03217591|81533131|FG002|Overall Study|Protocol Violation|1|||
27916319|NCT03154086|81533132|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916320|NCT03154086|81533133|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916321|NCT03154086|81533134|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916322|NCT03154086|81533135|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
27916323|NCT03154086|81533136|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916324|NCT03154086|81533137|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916325|NCT03154086|81533138|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916326|NCT03154086|81533139|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916327|NCT03154086|81533140|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916328|NCT03154086|81533141|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916329|NCT03154086|81533142|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916330|NCT03154086|81533143|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916331|NCT03154086|81533144|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916332|NCT03154086|81533145|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27537427|NCT03307785|80163468|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537428|NCT03307785|80163469|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
27537429|NCT03307785|80163459|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
27537430|NCT03307785|80163460|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
27537431|NCT03307785|80163461|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
27537432|NCT03307785|80163462|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
27537433|NCT03307785|80163463|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
27916333|NCT03154086|81533146|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
27916334|NCT03154086|81533132|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916335|NCT03154086|81533133|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
27916336|NCT03154086|81533134|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916337|NCT03154086|81533135|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916338|NCT03154086|81533136|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916339|NCT03154086|81533137|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916340|NCT03154086|81533138|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916341|NCT03154086|81533139|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916342|NCT03154086|81533140|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916343|NCT03154086|81533141|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916344|NCT03154086|81533142|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916345|NCT03154086|81533143|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916346|NCT03154086|81533144|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916347|NCT03154086|81533145|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916348|NCT03154086|81533146|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
27916349|NCT03154086|81533132|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916350|NCT03154086|81533133|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916351|NCT03154086|81533134|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
27916352|NCT03154086|81533135|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916353|NCT03154086|81533136|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916354|NCT03154086|81533137|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916355|NCT03154086|81533138|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916356|NCT03154086|81533139|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916357|NCT03154086|81533140|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27632472|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632473|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632474|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
27632475|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
27632476|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
27632477|NCT02914522|80493765|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632478|NCT02914522|80493766|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632479|NCT02914522|80493767|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632480|NCT02914522|80493768|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632481|NCT02914522|80493769|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632482|NCT02914522|80493770|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27916358|NCT03154086|81533141|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916359|NCT03154086|81533142|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916360|NCT03154086|81533143|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916361|NCT03154086|81533144|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916362|NCT03154086|81533145|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916363|NCT03154086|81533146|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
27916364|NCT03154086|81533132|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
27916365|NCT03154086|81533133|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916366|NCT03154086|81533134|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916367|NCT03154086|81533135|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916368|NCT03154086|81533136|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916369|NCT03154086|81533137|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916370|NCT03154086|81533138|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916371|NCT03154086|81533139|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916372|NCT03154086|81533140|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916373|NCT03154086|81533141|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916374|NCT03154086|81533142|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916375|NCT03154086|81533143|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916376|NCT03154086|81533144|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916377|NCT03154086|81533145|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916378|NCT03154086|81533146|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
27916379|NCT03154086|81533132|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916380|NCT03154086|81533133|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916381|NCT03154086|81533134|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916382|NCT03154086|81533135|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916383|NCT03154086|81533136|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916384|NCT03154086|81533137|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916385|NCT03154086|81533138|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916386|NCT03154086|81533139|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916387|NCT03154086|81533140|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
27916388|NCT03154086|81533141|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916389|NCT03154086|81533142|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916390|NCT03154086|81533143|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916391|NCT03154086|81533144|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916392|NCT03154086|81533145|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916393|NCT03154086|81533146|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
27916394|NCT03154086|81533132|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916395|NCT03154086|81533133|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916396|NCT03154086|81533134|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916397|NCT03154086|81533135|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916398|NCT03154086|81533136|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916399|NCT03154086|81533137|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916400|NCT03154086|81533138|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916401|NCT03154086|81533139|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
27916402|NCT03154086|81533140|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916403|NCT03154086|81533141|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916404|NCT03154086|81533142|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916405|NCT03154086|81533143|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916406|NCT03154086|81533144|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916407|NCT03154086|81533145|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916408|NCT03154086|81533146|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
27916409|NCT03154086|81533132|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
27916410|NCT03154086|81533133|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
27916411|NCT03154086|81533134|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
27916412|NCT03154086|81533135|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
27916413|NCT03154086|81533136|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
27916414|NCT03154086|81533137|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
27916415|NCT03154086|81533138|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
27916416|NCT03154086|81533139|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
27916417|NCT03154086|81533140|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
27916418|NCT03154086|81533141|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
27916419|NCT03154086|81533142|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
27916420|NCT03154086|81533143|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
27916421|NCT03154086|81533144|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
27916422|NCT03154086|81533145|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
27916423|NCT03154086|81533146|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
27916424|NCT02446691|81533149|FG000|Overall Study|Withdrawal by Subject|2|||
27916425|NCT02446691|81533149|FG000|Overall Study|Lost to Follow-up|8|||
27916426|NCT02446691|81533149|FG000|Overall Study|Protocol Violation|1|||
27916427|NCT01783743|81533150|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
27916428|NCT01783743|81533151|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
27916429|NCT01783743|81533150|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
27916430|NCT01783743|81533151|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
27537434|NCT03307785|80163464|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
27916431|NCT01783743|81533150|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
27916432|NCT01783743|81533151|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
27916433|NCT01239797|81533152|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
27916434|NCT01239797|81533153|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
27916435|NCT01239797|81533152|FG000|Randomized Participants|Participant withdrew consent|1|||
27916436|NCT01239797|81533153|FG001|Randomized Participants|Participant withdrew consent|7|||
27916437|NCT01239797|81533152|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
27916438|NCT01239797|81533153|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
27916439|NCT01239797|81533152|FG000|Treated Participants|Disease progression|185|||
27916440|NCT01239797|81533153|FG001|Treated Participants|Disease progression|185|||
27537435|NCT03307785|80163465|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
27537436|NCT03307785|80163466|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
27537437|NCT03307785|80163467|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
27537438|NCT03307785|80163468|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
27537439|NCT03307785|80163469|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
27537440|NCT03307785|80163459|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537441|NCT03307785|80163460|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537442|NCT03307785|80163461|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537443|NCT03307785|80163462|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537444|NCT03307785|80163463|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537445|NCT03307785|80163464|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
27537446|NCT03307785|80163465|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537447|NCT03307785|80163466|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537448|NCT03307785|80163467|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537449|NCT03307785|80163468|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537450|NCT03307785|80163469|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
27537451|NCT03307785|80163459|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537452|NCT03307785|80163460|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537453|NCT03307785|80163461|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537454|NCT03307785|80163462|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537455|NCT03307785|80163463|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537456|NCT03307785|80163464|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
27537457|NCT03307785|80163465|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537458|NCT03307785|80163466|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537459|NCT03307785|80163467|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537460|NCT03307785|80163468|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537461|NCT03307785|80163469|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
27537462|NCT03307785|80163459|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537463|NCT03307785|80163460|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537464|NCT03307785|80163461|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537465|NCT03307785|80163462|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537466|NCT03307785|80163463|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537467|NCT03307785|80163464|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
27537468|NCT03307785|80163465|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537469|NCT03307785|80163466|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537470|NCT03307785|80163467|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537471|NCT03307785|80163468|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537472|NCT03307785|80163469|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
27537473|NCT03307785|80163459|FG000|Part E: Up to 4.4 Months|Death|0|||
27537474|NCT03307785|80163460|FG001|Part E: Up to 4.4 Months|Death|0|||
27537475|NCT03307785|80163461|FG002|Part E: Up to 4.4 Months|Death|0|||
27537476|NCT03307785|80163462|FG003|Part E: Up to 4.4 Months|Death|0|||
27537477|NCT03307785|80163463|FG004|Part E: Up to 4.4 Months|Death|0|||
27537478|NCT03307785|80163464|FG005|Part E: Up to 4.4 Months|Death|0|||
27537479|NCT03307785|80163465|FG006|Part E: Up to 4.4 Months|Death|1|||
27537480|NCT03307785|80163466|FG007|Part E: Up to 4.4 Months|Death|0|||
27537481|NCT03307785|80163467|FG008|Part E: Up to 4.4 Months|Death|0|||
27537482|NCT03307785|80163468|FG009|Part E: Up to 4.4 Months|Death|0|||
27537483|NCT03307785|80163469|FG010|Part E: Up to 4.4 Months|Death|0|||
27537484|NCT03307785|80163459|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
27537485|NCT03307785|80163460|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
27916441|NCT01239797|81533152|FG000|Treated Participants|Study drug toxicity|39|||
27916442|NCT01239797|81533153|FG001|Treated Participants|Study drug toxicity|45|||
27916443|NCT01239797|81533152|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
27916444|NCT01239797|81533153|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
27916445|NCT01239797|81533152|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
27916446|NCT01239797|81533153|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
27916447|NCT01239797|81533152|FG000|Treated Participants|Administrative reason by sponsor|13|||
27916448|NCT01239797|81533153|FG001|Treated Participants|Administrative reason by sponsor|4|||
27916449|NCT01239797|81533152|FG000|Treated Participants|Other reasons|14|||
27916450|NCT01239797|81533153|FG001|Treated Participants|Other reasons|14|||
27916451|NCT01239797|81533152|FG000|Treated Participants|Participant withdrew consent|6|||
27916452|NCT01239797|81533153|FG001|Treated Participants|Participant withdrew consent|11|||
27916453|NCT01239797|81533152|FG000|Treated Participants|Death|1|||
27739205|NCT00542815|80874021|FG001|Overall Study|Protocol Violation|1|||
27739206|NCT00542815|80874022|FG002|Overall Study|Protocol Violation|2|||
27739207|NCT00542815|80874020|FG000|Overall Study|Withdrawal by Subject|41|||
27739208|NCT00542815|80874021|FG001|Overall Study|Withdrawal by Subject|5|||
27739209|NCT00542815|80874022|FG002|Overall Study|Withdrawal by Subject|8|||
27916454|NCT01239797|81533153|FG001|Treated Participants|Death|1|||
27916455|NCT01239797|81533152|FG000|Treated Participants|Participant no longer meets study criteria|1|||
27739210|NCT00542815|80874020|FG000|Overall Study|Other reasons|24|||
27739211|NCT00542815|80874021|FG001|Overall Study|Other reasons|10|||
27739212|NCT00542815|80874022|FG002|Overall Study|Other reasons|10|||
27739213|NCT01887912|80874023|FG000|Overall Study|Serious adverse event|400|||
27739214|NCT01887912|80874024|FG001|Overall Study|Serious adverse event|198|||
27739215|NCT01887912|80874023|FG000|Overall Study|Other Adverse Event|34|||
27916456|NCT01239797|81533153|FG001|Treated Participants|Participant no longer meets study criteria|1|||
27916457|NCT01239797|81533152|FG000|Treated Participants|Poor/non-compliance|0|||
27916458|NCT01239797|81533153|FG001|Treated Participants|Poor/non-compliance|1|||
27916459|NCT00570401|81533154|FG000|Overall Study|Adverse Event|2|||
27916460|NCT05002972|81533155|FG000|Overall Study|Withdrawal by Subject|2|||
27916461|NCT01919164|81533156|FG000|Overall Study|Adverse Event|6|||
27916462|NCT01919164|81533157|FG001|Overall Study|Adverse Event|4|||
27916463|NCT01919164|81533158|FG002|Overall Study|Adverse Event|9|||
27916464|NCT01919164|81533159|FG003|Overall Study|Adverse Event|3|||
27916465|NCT01919164|81533160|FG004|Overall Study|Adverse Event|2|||
27916466|NCT01919164|81533156|FG000|Overall Study|Lost to Follow-up|2|||
27916467|NCT01919164|81533157|FG001|Overall Study|Lost to Follow-up|2|||
27916468|NCT01919164|81533158|FG002|Overall Study|Lost to Follow-up|2|||
27916469|NCT01919164|81533159|FG003|Overall Study|Lost to Follow-up|0|||
27916470|NCT01919164|81533160|FG004|Overall Study|Lost to Follow-up|4|||
27916471|NCT01919164|81533156|FG000|Overall Study|Death|1|||
27739216|NCT01887912|80874024|FG001|Overall Study|Other Adverse Event|15|||
27739217|NCT01887912|80874023|FG000|Overall Study|Protocol Violation|67|||
27739218|NCT01887912|80874024|FG001|Overall Study|Protocol Violation|37|||
27739219|NCT01887912|80874023|FG000|Overall Study|Lost to Follow-up|163|||
27739220|NCT01887912|80874024|FG001|Overall Study|Lost to Follow-up|74|||
27739221|NCT01887912|80874023|FG000|Overall Study|Withdrawal by Subject|606|||
27916472|NCT01919164|81533157|FG001|Overall Study|Death|0|||
27916473|NCT01919164|81533158|FG002|Overall Study|Death|0|||
27916474|NCT01919164|81533159|FG003|Overall Study|Death|0|||
27916475|NCT01919164|81533160|FG004|Overall Study|Death|0|||
27916476|NCT01919164|81533156|FG000|Overall Study|Protocol Violation|6|||
27916477|NCT01919164|81533157|FG001|Overall Study|Protocol Violation|0|||
27916478|NCT01919164|81533158|FG002|Overall Study|Protocol Violation|3|||
27916479|NCT01919164|81533159|FG003|Overall Study|Protocol Violation|2|||
27916480|NCT01919164|81533160|FG004|Overall Study|Protocol Violation|2|||
27537486|NCT03307785|80163461|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
27537487|NCT03307785|80163462|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
27537488|NCT03307785|80163463|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
27537489|NCT03307785|80163464|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
27537490|NCT03307785|80163465|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
27537491|NCT03307785|80163466|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
27537492|NCT03307785|80163467|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
27537493|NCT03307785|80163468|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
27537494|NCT03307785|80163469|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
27537495|NCT03307785|80163459|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
27537496|NCT03307785|80163460|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
27537497|NCT03307785|80163461|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
27537498|NCT03307785|80163462|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
27537499|NCT03307785|80163463|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
27537500|NCT03307785|80163464|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
27537501|NCT03307785|80163465|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
27537502|NCT03307785|80163466|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
27537503|NCT03307785|80163467|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
27537504|NCT03307785|80163468|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
27537505|NCT03307785|80163469|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
27739222|NCT01887912|80874024|FG001|Overall Study|Withdrawal by Subject|349|||
27916481|NCT01919164|81533156|FG000|Overall Study|Disease progression|2|||
27537506|NCT02486302|80163470|FG000|Overall Study|Discontinued prematurely|410|||
27537507|NCT02486302|80163470|FG000|Overall Study|Documentation not completed|255|||
27537508|NCT02486302|80163470|FG000|Overall Study|Excluded due to legal reasons|8|||
27537509|NCT02486302|80163470|FG000|Overall Study|Not treated|3|||
27537510|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
27537511|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
27537512|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
27537513|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
27537514|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
27537515|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
27537516|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Death|6|||
27632483|NCT02914522|80493771|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632484|NCT02914522|80493772|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632485|NCT02914522|80493773|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632486|NCT02914522|80493774|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
27632487|NCT02914522|80493775|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
27632488|NCT01456936|80493778|FG000|Overall Study|Other reason|41|||
27632489|NCT01456936|80493779|FG001|Overall Study|Other reason|30|||
27632490|NCT01456936|80493780|FG002|Overall Study|Other reason|36|||
27632491|NCT01456936|80493781|FG003|Overall Study|Other reason|33|||
27632492|NCT01456936|80493778|FG000|Overall Study|No longer meets eligibility criteria|4|||
27632493|NCT01456936|80493779|FG001|Overall Study|No longer meets eligibility criteria|8|||
27632494|NCT01456936|80493780|FG002|Overall Study|No longer meets eligibility criteria|6|||
27632495|NCT01456936|80493781|FG003|Overall Study|No longer meets eligibility criteria|5|||
27632496|NCT01456936|80493778|FG000|Overall Study|Protocol Violation|4|||
27632497|NCT01456936|80493779|FG001|Overall Study|Protocol Violation|2|||
27632498|NCT01456936|80493780|FG002|Overall Study|Protocol Violation|5|||
27632499|NCT01456936|80493781|FG003|Overall Study|Protocol Violation|5|||
27632500|NCT01456936|80493778|FG000|Overall Study|Pregnancy|1|||
27632501|NCT01456936|80493779|FG001|Overall Study|Pregnancy|0|||
27632502|NCT01456936|80493780|FG002|Overall Study|Pregnancy|0|||
27632503|NCT01456936|80493781|FG003|Overall Study|Pregnancy|1|||
27632504|NCT01456936|80493778|FG000|Overall Study|Insufficient clinical response|4|||
27632505|NCT01456936|80493779|FG001|Overall Study|Insufficient clinical response|4|||
27739223|NCT01887912|80874023|FG000|Overall Study|Other|122|||
27916482|NCT01919164|81533157|FG001|Overall Study|Disease progression|2|||
27916483|NCT01919164|81533158|FG002|Overall Study|Disease progression|1|||
27916484|NCT01919164|81533159|FG003|Overall Study|Disease progression|2|||
27916485|NCT01919164|81533160|FG004|Overall Study|Disease progression|1|||
27537517|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Death|0|||
27537518|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Death|0|||
27537519|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
27537520|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
27916486|NCT01919164|81533156|FG000|Overall Study|Withdrew consent|13|||
27916487|NCT01919164|81533157|FG001|Overall Study|Withdrew consent|13|||
27916488|NCT01919164|81533158|FG002|Overall Study|Withdrew consent|14|||
27916489|NCT01919164|81533159|FG003|Overall Study|Withdrew consent|14|||
27916490|NCT01919164|81533160|FG004|Overall Study|Withdrew consent|9|||
27537521|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
27537522|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
27537523|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
27537524|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
27537525|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
27537526|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
27537527|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
27537528|NCT01539083|80163471|FG000|Before Randomization (VCD Induction)|Other|5|||
27537529|NCT01539083|80163472|FG001|Before Randomization (VCD Induction)|Other|0|||
27537530|NCT01539083|80163473|FG002|Before Randomization (VCD Induction)|Other|0|||
27537531|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
27537532|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
27537533|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
27537534|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Other|0|||
27537535|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Other|1|||
27739224|NCT01887912|80874024|FG001|Overall Study|Other|58|||
27537536|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Other|1|||
27537537|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
27537538|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
27537539|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
27632506|NCT01456936|80493780|FG002|Overall Study|Insufficient clinical response|14|||
27632507|NCT01456936|80493781|FG003|Overall Study|Insufficient clinical response|13|||
27739225|NCT01508676|80874025|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
27916491|NCT01919164|81533156|FG000|Overall Study|Other Un-specified|13|||
27916492|NCT01919164|81533157|FG001|Overall Study|Other Un-specified|9|||
27916493|NCT01919164|81533158|FG002|Overall Study|Other Un-specified|8|||
27916494|NCT01919164|81533159|FG003|Overall Study|Other Un-specified|7|||
27916495|NCT01919164|81533160|FG004|Overall Study|Other Un-specified|15|||
27916496|NCT03718429|81533161|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
27916497|NCT03718429|81533162|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
27916498|NCT03718429|81533163|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
27916499|NCT03718429|81533164|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
27916500|NCT05117060|81533165|FG000|Overall Study|Adverse Event|3|||
27916501|NCT05117060|81533166|FG001|Overall Study|Adverse Event|5|||
27916502|NCT05117060|81533167|FG002|Overall Study|Adverse Event|6|||
27916503|NCT05117060|81533168|FG003|Overall Study|Adverse Event|1|||
27916504|NCT05117060|81533165|FG000|Overall Study|Lost to Follow-up|0|||
27916505|NCT05117060|81533166|FG001|Overall Study|Lost to Follow-up|0|||
27916506|NCT05117060|81533167|FG002|Overall Study|Lost to Follow-up|0|||
27916507|NCT05117060|81533168|FG003|Overall Study|Lost to Follow-up|1|||
27916508|NCT05117060|81533165|FG000|Overall Study|Lack of Efficacy|4|||
27916509|NCT05117060|81533166|FG001|Overall Study|Lack of Efficacy|5|||
27916510|NCT05117060|81533167|FG002|Overall Study|Lack of Efficacy|2|||
27916511|NCT05117060|81533168|FG003|Overall Study|Lack of Efficacy|6|||
27916512|NCT05117060|81533165|FG000|Overall Study|Withdrawal by Subject|8|||
27916513|NCT05117060|81533166|FG001|Overall Study|Withdrawal by Subject|5|||
27916514|NCT05117060|81533167|FG002|Overall Study|Withdrawal by Subject|5|||
27537540|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
27537541|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
27537542|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
27537543|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
27537544|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
27537545|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
27537546|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
27537547|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
27537548|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
27537549|NCT01539083|80163471|FG000|After Randomization (TP and VTP)|Death|0|||
27537550|NCT01539083|80163472|FG001|After Randomization (TP and VTP)|Death|6|||
27537551|NCT01539083|80163473|FG002|After Randomization (TP and VTP)|Death|11|||
27537552|NCT00734474|80163475|FG000|Overall Study|Entry Criteria Not Met|0|||
27537553|NCT00734474|80163476|FG001|Overall Study|Entry Criteria Not Met|0|||
27537554|NCT00734474|80163477|FG002|Overall Study|Entry Criteria Not Met|5|||
27537555|NCT00734474|80163478|FG003|Overall Study|Entry Criteria Not Met|0|||
27537556|NCT00734474|80163479|FG004|Overall Study|Entry Criteria Not Met|3|||
27537557|NCT00734474|80163480|FG005|Overall Study|Entry Criteria Not Met|1|||
27537558|NCT00734474|80163481|FG006|Overall Study|Entry Criteria Not Met|0|||
27537559|NCT00734474|80163482|FG007|Overall Study|Entry Criteria Not Met|1|||
27537560|NCT00734474|80163483|FG008|Overall Study|Entry Criteria Not Met|1|||
27537561|NCT00734474|80163475|FG000|Overall Study|Lost to Follow-up|1|||
27537562|NCT00734474|80163476|FG001|Overall Study|Lost to Follow-up|0|||
27537563|NCT00734474|80163477|FG002|Overall Study|Lost to Follow-up|13|||
27537564|NCT00734474|80163478|FG003|Overall Study|Lost to Follow-up|0|||
27537565|NCT00734474|80163479|FG004|Overall Study|Lost to Follow-up|11|||
27537566|NCT00734474|80163480|FG005|Overall Study|Lost to Follow-up|1|||
27537567|NCT00734474|80163481|FG006|Overall Study|Lost to Follow-up|0|||
27537568|NCT00734474|80163482|FG007|Overall Study|Lost to Follow-up|9|||
27537569|NCT00734474|80163483|FG008|Overall Study|Lost to Follow-up|4|||
27537570|NCT00734474|80163475|FG000|Overall Study|Withdrawal by Subject|2|||
27537571|NCT00734474|80163476|FG001|Overall Study|Withdrawal by Subject|1|||
27537572|NCT00734474|80163477|FG002|Overall Study|Withdrawal by Subject|18|||
27537573|NCT00734474|80163478|FG003|Overall Study|Withdrawal by Subject|0|||
27537574|NCT00734474|80163479|FG004|Overall Study|Withdrawal by Subject|24|||
27537575|NCT00734474|80163480|FG005|Overall Study|Withdrawal by Subject|2|||
27537576|NCT00734474|80163481|FG006|Overall Study|Withdrawal by Subject|0|||
27537577|NCT00734474|80163482|FG007|Overall Study|Withdrawal by Subject|36|||
27537578|NCT00734474|80163483|FG008|Overall Study|Withdrawal by Subject|21|||
27537579|NCT00734474|80163475|FG000|Overall Study|Physician Decision|0|||
27537580|NCT00734474|80163476|FG001|Overall Study|Physician Decision|0|||
27537581|NCT00734474|80163477|FG002|Overall Study|Physician Decision|4|||
27537582|NCT00734474|80163478|FG003|Overall Study|Physician Decision|1|||
27632508|NCT01456936|80493778|FG000|Overall Study|No longer willing to participate|195|||
27537583|NCT00734474|80163479|FG004|Overall Study|Physician Decision|11|||
27537584|NCT00734474|80163480|FG005|Overall Study|Physician Decision|0|||
27537585|NCT00734474|80163481|FG006|Overall Study|Physician Decision|0|||
27537586|NCT00734474|80163482|FG007|Overall Study|Physician Decision|9|||
27537587|NCT00734474|80163483|FG008|Overall Study|Physician Decision|9|||
27916515|NCT05117060|81533168|FG003|Overall Study|Withdrawal by Subject|6|||
27916516|NCT05117060|81533165|FG000|Overall Study|Other|2|||
27916517|NCT05117060|81533166|FG001|Overall Study|Other|1|||
27632509|NCT01456936|80493779|FG001|Overall Study|No longer willing to participate|218|||
27632510|NCT01456936|80493780|FG002|Overall Study|No longer willing to participate|224|||
27632511|NCT01456936|80493781|FG003|Overall Study|No longer willing to participate|248|||
27632512|NCT01456936|80493778|FG000|Overall Study|Lost to Follow-up|135|||
27632513|NCT01456936|80493779|FG001|Overall Study|Lost to Follow-up|126|||
27632514|NCT01456936|80493780|FG002|Overall Study|Lost to Follow-up|144|||
27632515|NCT01456936|80493781|FG003|Overall Study|Lost to Follow-up|127|||
27632516|NCT01456936|80493778|FG000|Overall Study|Medication error|0|||
27632517|NCT01456936|80493779|FG001|Overall Study|Medication error|1|||
27632518|NCT01456936|80493780|FG002|Overall Study|Medication error|0|||
27632519|NCT01456936|80493781|FG003|Overall Study|Medication error|1|||
27632520|NCT01456936|80493778|FG000|Overall Study|Adverse event (study drug)|25|||
27632521|NCT01456936|80493779|FG001|Overall Study|Adverse event (study drug)|21|||
27632522|NCT01456936|80493780|FG002|Overall Study|Adverse event (study drug)|26|||
27632523|NCT01456936|80493781|FG003|Overall Study|Adverse event (study drug)|17|||
27632524|NCT01456936|80493778|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
27632525|NCT01456936|80493779|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
27632526|NCT01456936|80493780|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
27632527|NCT01456936|80493781|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
27632528|NCT01456936|80493778|FG000|Overall Study|Death|0|||
27632529|NCT01456936|80493779|FG001|Overall Study|Death|3|||
27632530|NCT01456936|80493780|FG002|Overall Study|Death|1|||
27632531|NCT01456936|80493781|FG003|Overall Study|Death|3|||
27916518|NCT05117060|81533167|FG002|Overall Study|Other|3|||
27916519|NCT05117060|81533168|FG003|Overall Study|Other|1|||
27916520|NCT01781962|81533172|FG000|Overall Study|Other Miscellaneous Reasons|5|||
27916521|NCT01418339|81533173|FG000|Overall Study|Adverse Event|5|||
27916522|NCT01418339|81533174|FG001|Overall Study|Adverse Event|2|||
27916523|NCT01418339|81533173|FG000|Overall Study|Subject Withdrew Consent|1|||
27537588|NCT00734474|80163475|FG000|Overall Study|Adverse Event|4|||
27537589|NCT00734474|80163476|FG001|Overall Study|Adverse Event|4|||
27537590|NCT00734474|80163477|FG002|Overall Study|Adverse Event|63|||
27537591|NCT00734474|80163478|FG003|Overall Study|Adverse Event|1|||
27537592|NCT00734474|80163479|FG004|Overall Study|Adverse Event|64|||
27632532|NCT01456936|80493778|FG000|Overall Study|Randomized but not treated|21|||
27632533|NCT01456936|80493779|FG001|Overall Study|Randomized but not treated|28|||
27632534|NCT01456936|80493780|FG002|Overall Study|Randomized but not treated|16|||
27632535|NCT01456936|80493781|FG003|Overall Study|Randomized but not treated|21|||
27632536|NCT01802632|80493782|FG000|Overall Study|Death|28|||
27537593|NCT00734474|80163480|FG005|Overall Study|Adverse Event|0|||
27632537|NCT01802632|80493783|FG001|Overall Study|Death|1|||
27632538|NCT01802632|80493784|FG002|Overall Study|Death|38|||
27632539|NCT01802632|80493785|FG003|Overall Study|Death|0|||
27537594|NCT00734474|80163481|FG006|Overall Study|Adverse Event|1|||
27632540|NCT01802632|80493786|FG004|Overall Study|Death|2|||
27632541|NCT01802632|80493787|FG005|Overall Study|Death|0|||
27632542|NCT01802632|80493782|FG000|Overall Study|Withdrawal by Subject|4|||
27632543|NCT01802632|80493783|FG001|Overall Study|Withdrawal by Subject|2|||
27632544|NCT01802632|80493784|FG002|Overall Study|Withdrawal by Subject|7|||
27632545|NCT01802632|80493785|FG003|Overall Study|Withdrawal by Subject|3|||
27632546|NCT01802632|80493786|FG004|Overall Study|Withdrawal by Subject|0|||
27632547|NCT01802632|80493787|FG005|Overall Study|Withdrawal by Subject|1|||
27537595|NCT00734474|80163482|FG007|Overall Study|Adverse Event|65|||
27537596|NCT00734474|80163483|FG008|Overall Study|Adverse Event|39|||
27537597|NCT00734474|80163475|FG000|Overall Study|Protocol Violation|0|||
27537598|NCT00734474|80163476|FG001|Overall Study|Protocol Violation|0|||
27537599|NCT00734474|80163477|FG002|Overall Study|Protocol Violation|4|||
27537600|NCT00734474|80163478|FG003|Overall Study|Protocol Violation|0|||
27537601|NCT00734474|80163479|FG004|Overall Study|Protocol Violation|3|||
27537602|NCT00734474|80163480|FG005|Overall Study|Protocol Violation|0|||
27632548|NCT01802632|80493782|FG000|Overall Study|Objective Disease Progression|1|||
27632549|NCT01802632|80493783|FG001|Overall Study|Objective Disease Progression|12|||
27632550|NCT01802632|80493784|FG002|Overall Study|Objective Disease Progression|104|||
27632551|NCT01802632|80493785|FG003|Overall Study|Objective Disease Progression|6|||
27632552|NCT01802632|80493786|FG004|Overall Study|Objective Disease Progression|4|||
27632553|NCT01802632|80493787|FG005|Overall Study|Objective Disease Progression|4|||
27632554|NCT01802632|80493782|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
27632555|NCT01802632|80493783|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
27916524|NCT01418339|81533174|FG001|Overall Study|Subject Withdrew Consent|2|||
27537603|NCT00734474|80163481|FG006|Overall Study|Protocol Violation|0|||
27537604|NCT00734474|80163482|FG007|Overall Study|Protocol Violation|3|||
27537605|NCT00734474|80163483|FG008|Overall Study|Protocol Violation|1|||
27537606|NCT00734474|80163475|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
27537607|NCT00734474|80163476|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
27632556|NCT01802632|80493784|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
27632557|NCT01802632|80493785|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
27632558|NCT01802632|80493786|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
27632559|NCT01802632|80493787|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
27632560|NCT01802632|80493782|FG000|Overall Study|Other (not specified)|0|||
27632561|NCT01802632|80493783|FG001|Overall Study|Other (not specified)|0|||
27632562|NCT01802632|80493784|FG002|Overall Study|Other (not specified)|7|||
27632563|NCT01802632|80493785|FG003|Overall Study|Other (not specified)|1|||
27632564|NCT01802632|80493786|FG004|Overall Study|Other (not specified)|0|||
27537608|NCT00734474|80163477|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
27537609|NCT00734474|80163478|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
27537610|NCT00734474|80163479|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
27537611|NCT00734474|80163480|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
27537612|NCT00734474|80163481|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
27537613|NCT00734474|80163482|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
27537614|NCT00734474|80163483|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
27537615|NCT00734474|80163475|FG000|Overall Study|Sponsor Decision|0|||
27537616|NCT00734474|80163476|FG001|Overall Study|Sponsor Decision|0|||
27537617|NCT00734474|80163477|FG002|Overall Study|Sponsor Decision|0|||
27537618|NCT00734474|80163478|FG003|Overall Study|Sponsor Decision|0|||
27537619|NCT00734474|80163479|FG004|Overall Study|Sponsor Decision|2|||
27537620|NCT00734474|80163480|FG005|Overall Study|Sponsor Decision|0|||
27537621|NCT00734474|80163481|FG006|Overall Study|Sponsor Decision|0|||
27537622|NCT00734474|80163482|FG007|Overall Study|Sponsor Decision|0|||
27537623|NCT00734474|80163483|FG008|Overall Study|Sponsor Decision|0|||
27537624|NCT00734474|80163475|FG000|Overall Study|Death|0|||
27537625|NCT00734474|80163476|FG001|Overall Study|Death|0|||
27537626|NCT00734474|80163477|FG002|Overall Study|Death|1|||
27916525|NCT01418339|81533173|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
27916526|NCT01418339|81533174|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
27537627|NCT00734474|80163478|FG003|Overall Study|Death|0|||
27537628|NCT00734474|80163479|FG004|Overall Study|Death|0|||
27537629|NCT00734474|80163480|FG005|Overall Study|Death|0|||
27916527|NCT01365130|81533177|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
27916528|NCT01499810|81533178|FG000|Overall Study|Lost to Follow-up|10|||
27916529|NCT01499810|81533178|FG000|Overall Study|Protocol Violation|1|||
27916530|NCT01499810|81533178|FG000|Overall Study|Withdrawal by Subject|1|||
27537630|NCT00734474|80163481|FG006|Overall Study|Death|0|||
27537631|NCT00734474|80163482|FG007|Overall Study|Death|2|||
27537632|NCT00734474|80163483|FG008|Overall Study|Death|1|||
27632565|NCT01802632|80493787|FG005|Overall Study|Other (not specified)|1|||
27632566|NCT01943799|80493788|FG000|Overall Study|Lost to Follow-up|0|||
27632567|NCT01943799|80493789|FG001|Overall Study|Lost to Follow-up|1|||
27632568|NCT01943799|80493790|FG002|Overall Study|Lost to Follow-up|1|||
27632569|NCT01943799|80493791|FG003|Overall Study|Lost to Follow-up|0|||
27632570|NCT01943799|80493788|FG000|Overall Study|Protocol Violation|1|||
27632571|NCT01943799|80493789|FG001|Overall Study|Protocol Violation|0|||
27632572|NCT01943799|80493790|FG002|Overall Study|Protocol Violation|0|||
27632573|NCT01943799|80493791|FG003|Overall Study|Protocol Violation|0|||
27632574|NCT01943799|80493788|FG000|Overall Study|Withdrawal by Subject|4|||
27632575|NCT01943799|80493789|FG001|Overall Study|Withdrawal by Subject|2|||
27632576|NCT01943799|80493790|FG002|Overall Study|Withdrawal by Subject|1|||
27632577|NCT01943799|80493791|FG003|Overall Study|Withdrawal by Subject|0|||
27632578|NCT02274493|80493792|FG000|Overall Study|Withdrawal by Subject|1|||
27632579|NCT00494442|80493793|FG000|Overall Study|Death|1|||
27632580|NCT00494442|80493794|FG001|Overall Study|Death|1|||
27632581|NCT00494442|80493793|FG000|Overall Study|Lack of Efficacy|16|||
27632582|NCT00494442|80493794|FG001|Overall Study|Lack of Efficacy|10|||
27632583|NCT00494442|80493793|FG000|Overall Study|Adverse Event|0|||
27739226|NCT01508676|80874026|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
27916531|NCT02592447|81533179|FG000|Overall Study|Lost to Follow-up|1|||
27916532|NCT02592447|81533180|FG001|Overall Study|Lost to Follow-up|0|||
27537633|NCT00734474|80163475|FG000|Overall Study|Lack of Efficacy|0|||
27632584|NCT00494442|80493794|FG001|Overall Study|Adverse Event|2|||
27632585|NCT00494442|80493793|FG000|Overall Study|Physician Decision|0|||
27916533|NCT02592447|81533179|FG000|Overall Study|Ineligible after randomization|1|||
27537634|NCT00734474|80163476|FG001|Overall Study|Lack of Efficacy|0|||
27537635|NCT00734474|80163477|FG002|Overall Study|Lack of Efficacy|4|||
27537636|NCT00734474|80163478|FG003|Overall Study|Lack of Efficacy|0|||
27537637|NCT00734474|80163479|FG004|Overall Study|Lack of Efficacy|0|||
27537638|NCT00734474|80163480|FG005|Overall Study|Lack of Efficacy|0|||
27537639|NCT00734474|80163481|FG006|Overall Study|Lack of Efficacy|0|||
27537640|NCT00734474|80163482|FG007|Overall Study|Lack of Efficacy|4|||
27537641|NCT00734474|80163483|FG008|Overall Study|Lack of Efficacy|6|||
27537642|NCT01453725|80163484|FG000|Overall Study|Adverse Event|3|||
27537643|NCT01453725|80163485|FG001|Overall Study|Adverse Event|3|||
27537644|NCT01453725|80163484|FG000|Overall Study|Lost to Follow-up|4|||
27632586|NCT00494442|80493794|FG001|Overall Study|Physician Decision|1|||
27632587|NCT00494442|80493793|FG000|Overall Study|Non-compliance|0|||
27632588|NCT00494442|80493794|FG001|Overall Study|Non-compliance|1|||
27632589|NCT00494442|80493793|FG000|Overall Study|Intercurrent illness|0|||
27632590|NCT00494442|80493794|FG001|Overall Study|Intercurrent illness|1|||
27632591|NCT01289119|80493799|FG000|Overall Study|Adverse Event|2|||
27632592|NCT01289119|80493800|FG001|Overall Study|Adverse Event|1|||
27632593|NCT01289119|80493801|FG002|Overall Study|Adverse Event|0|||
27632594|NCT01289119|80493802|FG003|Overall Study|Adverse Event|2|||
27632595|NCT01289119|80493803|FG004|Overall Study|Adverse Event|1|||
27632596|NCT01289119|80493804|FG005|Overall Study|Adverse Event|0|||
27537645|NCT01453725|80163485|FG001|Overall Study|Lost to Follow-up|0|||
27537646|NCT01453725|80163484|FG000|Overall Study|Non-compliance With Protocol|1|||
27537647|NCT01453725|80163485|FG001|Overall Study|Non-compliance With Protocol|2|||
27537648|NCT01453725|80163484|FG000|Overall Study|Protocol Violation|1|||
27537649|NCT01453725|80163485|FG001|Overall Study|Protocol Violation|0|||
27537650|NCT01453725|80163484|FG000|Overall Study|Withdrawal by Subject|2|||
27537651|NCT01453725|80163485|FG001|Overall Study|Withdrawal by Subject|3|||
27537652|NCT01453725|80163484|FG000|Overall Study|Pregnancy Wish|0|||
27537653|NCT01453725|80163485|FG001|Overall Study|Pregnancy Wish|2|||
27537654|NCT01453725|80163484|FG000|Overall Study|Pregnancy|1|||
27632597|NCT01289119|80493799|FG000|Overall Study|Major Protocol Deviation|2|||
27632598|NCT01289119|80493800|FG001|Overall Study|Major Protocol Deviation|1|||
27632599|NCT01289119|80493801|FG002|Overall Study|Major Protocol Deviation|3|||
27632600|NCT01289119|80493802|FG003|Overall Study|Major Protocol Deviation|0|||
27632601|NCT01289119|80493803|FG004|Overall Study|Major Protocol Deviation|2|||
27632602|NCT01289119|80493804|FG005|Overall Study|Major Protocol Deviation|1|||
27537655|NCT01453725|80163485|FG001|Overall Study|Pregnancy|0|||
27537656|NCT01453725|80163484|FG000|Overall Study|Physician Decision|1|||
27632603|NCT01289119|80493799|FG000|Overall Study|Lost to Follow-up|0|||
27632604|NCT01289119|80493800|FG001|Overall Study|Lost to Follow-up|3|||
27632605|NCT01289119|80493801|FG002|Overall Study|Lost to Follow-up|0|||
27632606|NCT01289119|80493802|FG003|Overall Study|Lost to Follow-up|0|||
27537657|NCT01453725|80163485|FG001|Overall Study|Physician Decision|1|||
27632607|NCT01289119|80493803|FG004|Overall Study|Lost to Follow-up|0|||
27632608|NCT01289119|80493804|FG005|Overall Study|Lost to Follow-up|1|||
27632609|NCT01289119|80493799|FG000|Overall Study|Withdrawal by Subject|4|||
27916534|NCT02592447|81533180|FG001|Overall Study|Ineligible after randomization|0|||
27916535|NCT02592447|81533179|FG000|Overall Study|Withdrawal by Subject|0|||
27916536|NCT02592447|81533180|FG001|Overall Study|Withdrawal by Subject|1|||
27916537|NCT01077323|81533183|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
27916538|NCT01077323|81533184|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
27916539|NCT01077323|81533185|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
27916540|NCT01077323|81533183|FG000|Overall Study|Dispensing of drug in baseline period|0|||
27916541|NCT01077323|81533184|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
27916542|NCT01077323|81533185|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
27916543|NCT01077323|81533183|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
27916544|NCT01077323|81533184|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
27916545|NCT01077323|81533185|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
27916546|NCT05133323|81533186|FG000|Overall Study|Lack of Efficacy|0|||
27916547|NCT05133323|81533187|FG001|Overall Study|Lack of Efficacy|0|||
27916548|NCT05133323|81533188|FG002|Overall Study|Lack of Efficacy|1|||
27916549|NCT05133323|81533186|FG000|Overall Study|Withdrawal by Subject|2|||
27916550|NCT05133323|81533187|FG001|Overall Study|Withdrawal by Subject|1|||
27916551|NCT05133323|81533188|FG002|Overall Study|Withdrawal by Subject|0|||
27916552|NCT01190891|81533189|FG000|Overall Study|Protocol Violation|1|||
27916553|NCT01190891|81533190|FG001|Overall Study|Protocol Violation|0|||
27916554|NCT01190891|81533189|FG000|Overall Study|Withdrawal by Subject|5|||
27916555|NCT01190891|81533190|FG001|Overall Study|Withdrawal by Subject|0|||
27916556|NCT02498678|81533191|FG000|Overall Study|interference from the surgical team|0|||
27916557|NCT02498678|81533192|FG001|Overall Study|interference from the surgical team|2|||
27916558|NCT00452439|81533197|FG000|Overall Study|Lost to Follow-up|1|||
27916559|NCT00452439|81533198|FG001|Overall Study|Lost to Follow-up|1|||
27916560|NCT00452439|81533197|FG000|Overall Study|Refused Treatment|4|||
27916561|NCT00452439|81533198|FG001|Overall Study|Refused Treatment|3|||
27916562|NCT00452439|81533197|FG000|Overall Study|Death|3|||
27537658|NCT02906332|80163496|FG000|Overall Study|Withdrawal by Subject|1|||
27537659|NCT01560403|80163506|FG000|Overall Study|Lost to Follow-up|0|||
27632610|NCT01289119|80493800|FG001|Overall Study|Withdrawal by Subject|2|||
27632611|NCT01289119|80493801|FG002|Overall Study|Withdrawal by Subject|4|||
27632612|NCT01289119|80493802|FG003|Overall Study|Withdrawal by Subject|3|||
27632613|NCT01289119|80493803|FG004|Overall Study|Withdrawal by Subject|1|||
27632614|NCT01289119|80493804|FG005|Overall Study|Withdrawal by Subject|1|||
27632615|NCT01289119|80493799|FG000|Overall Study|Pregnancy|0|||
27632616|NCT01289119|80493800|FG001|Overall Study|Pregnancy|1|||
27537660|NCT01560403|80163507|FG001|Overall Study|Lost to Follow-up|1|||
27537661|NCT01611155|80163516|FG000|Overall Study|Adverse Event|1|||
27632617|NCT01289119|80493801|FG002|Overall Study|Pregnancy|0|||
27916563|NCT00452439|81533198|FG001|Overall Study|Death|1|||
27916564|NCT00452439|81533197|FG000|Overall Study|Bone Marrow Transplant|0|||
27632618|NCT01289119|80493802|FG003|Overall Study|Pregnancy|0|||
27632619|NCT01289119|80493803|FG004|Overall Study|Pregnancy|0|||
27916565|NCT00452439|81533198|FG001|Overall Study|Bone Marrow Transplant|1|||
27916566|NCT00452439|81533197|FG000|Overall Study|Too Ill to Continue|0|||
27916567|NCT00452439|81533198|FG001|Overall Study|Too Ill to Continue|1|||
27916568|NCT00452439|81533197|FG000|Overall Study|Failed to achieve complete response|2|||
27916569|NCT00452439|81533198|FG001|Overall Study|Failed to achieve complete response|0|||
27916570|NCT00452439|81533197|FG000|Overall Study|Relapse|3|||
27916571|NCT00452439|81533198|FG001|Overall Study|Relapse|0|||
27916572|NCT00452439|81533197|FG000|Overall Study|Fracture|1|||
27739227|NCT01508676|80874025|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
27739228|NCT01508676|80874026|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
27739229|NCT01508676|80874025|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
27739230|NCT01508676|80874026|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
27739231|NCT01508676|80874025|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
27739232|NCT01508676|80874026|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
27739233|NCT01508676|80874025|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
27739234|NCT01508676|80874026|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
27739235|NCT02515669|80874028|FG000|228 Week Open-Label Phase|Other|0|||
27739236|NCT02515669|80874029|FG001|228 Week Open-Label Phase|Other|0|||
27739237|NCT02515669|80874030|FG002|228 Week Open-Label Phase|Other|1|||
27739238|NCT02515669|80874031|FG003|228 Week Open-Label Phase|Other|4|||
27739239|NCT02515669|80874028|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
27739240|NCT02515669|80874029|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
27739241|NCT02515669|80874030|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
27739242|NCT02515669|80874031|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
27739243|NCT02515669|80874028|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
27739244|NCT02515669|80874029|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
27739245|NCT02515669|80874030|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
27739246|NCT02515669|80874031|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
27739247|NCT02515669|80874028|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
27739248|NCT02515669|80874029|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
27739249|NCT02515669|80874030|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
27739250|NCT02515669|80874031|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
27739251|NCT02515669|80874028|FG000|228 Week Open-Label Phase|Missing|0|||
27739252|NCT02515669|80874029|FG001|228 Week Open-Label Phase|Missing|2|||
27739253|NCT02515669|80874030|FG002|228 Week Open-Label Phase|Missing|2|||
27739254|NCT02515669|80874031|FG003|228 Week Open-Label Phase|Missing|2|||
27916573|NCT00452439|81533198|FG001|Overall Study|Fracture|0|||
27916574|NCT01051921|81533199|FG000|Overall Study|Physician Decision|9|||
27916575|NCT01051921|81533199|FG000|Overall Study|Adverse Event|8|||
27916576|NCT01051921|81533199|FG000|Overall Study|Withdrawal by Subject|7|||
27916577|NCT01051921|81533199|FG000|Overall Study|Lost to Follow-up|4|||
27916578|NCT01051921|81533199|FG000|Overall Study|virological failure|1|||
27537662|NCT01611155|80163517|FG001|Overall Study|Adverse Event|1|||
27537663|NCT01611155|80163516|FG000|Overall Study|Refused further treatment|6|||
27537664|NCT01611155|80163517|FG001|Overall Study|Refused further treatment|4|||
27537665|NCT01611155|80163516|FG000|Overall Study|Disease progression|1|||
27537666|NCT01611155|80163517|FG001|Overall Study|Disease progression|0|||
27537667|NCT01611155|80163516|FG000|Overall Study|Withdrawal by Subject|1|||
27537668|NCT01611155|80163517|FG001|Overall Study|Withdrawal by Subject|0|||
27537669|NCT01611155|80163516|FG000|Overall Study|Alternative treatment|0|||
27537670|NCT01611155|80163517|FG001|Overall Study|Alternative treatment|1|||
27537671|NCT01611155|80163516|FG000|Overall Study|Ineligible patient|0|||
27537672|NCT01611155|80163517|FG001|Overall Study|Ineligible patient|1|||
27537673|NCT00810108|80163524|FG000|Overall Study|Withdrawal by Subject|1|||
27537674|NCT00810108|80163525|FG001|Overall Study|Withdrawal by Subject|0|||
27537675|NCT03386474|80163527|FG000|Overall Study|Death|1|||
27537676|NCT03386474|80163528|FG001|Overall Study|Death|0|||
27537677|NCT03386474|80163527|FG000|Overall Study|Adverse Event|0|||
27537678|NCT03386474|80163528|FG001|Overall Study|Adverse Event|1|||
27916579|NCT01051921|81533199|FG000|Overall Study|patient moved|1|||
27916580|NCT00113295|81533202|FG000|Overall Study|Adverse Event|4|||
27916581|NCT00113295|81533203|FG001|Overall Study|Adverse Event|1|||
27916582|NCT00113295|81533202|FG000|Overall Study|Unrelated Medical Illness|1|||
27916583|NCT00113295|81533203|FG001|Overall Study|Unrelated Medical Illness|0|||
27916584|NCT00614874|81533204|FG000|Overall Study|Protocol Violation|1|||
27916585|NCT00614874|81533204|FG000|Overall Study|Withdrawal by Subject|1|||
27916586|NCT00960193|81533209|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
27537679|NCT01160211|80163531|FG000|Overall Study|ongoing|90|||
27537680|NCT01160211|80163532|FG001|Overall Study|ongoing|75|||
27537681|NCT01160211|80163533|FG002|Overall Study|ongoing|79|||
27537682|NCT01160211|80163531|FG000|Overall Study|Withdrawal by Subject|3|||
27537683|NCT01160211|80163532|FG001|Overall Study|Withdrawal by Subject|5|||
27537684|NCT01160211|80163533|FG002|Overall Study|Withdrawal by Subject|3|||
27739255|NCT04919564|80874032|FG000|Overall Study|Lost to Follow-up|1|||
27739256|NCT04919564|80874033|FG001|Overall Study|Lost to Follow-up|0|||
27739257|NCT04919564|80874032|FG000|Overall Study|Physician Decision|1|||
27739258|NCT04919564|80874033|FG001|Overall Study|Physician Decision|1|||
27739259|NCT00947154|80874036|FG000|Overall Study|Lost to Follow-up|1|||
27739260|NCT01919411|80874042|FG000|Overall Study|Lost to Follow-up|2|||
27739261|NCT01919411|80874043|FG001|Overall Study|Lost to Follow-up|4|||
27739262|NCT01919411|80874042|FG000|Overall Study|Physician Decision|1|||
27739263|NCT01919411|80874043|FG001|Overall Study|Physician Decision|0|||
27739264|NCT01919411|80874042|FG000|Overall Study|Protocol Violation|2|||
27739265|NCT01919411|80874043|FG001|Overall Study|Protocol Violation|1|||
27739266|NCT02124798|80874044|FG000|Overall Study|Adverse Event|3|||
27739267|NCT02124798|80874044|FG000|Overall Study|Lost to Follow-up|1|||
27739268|NCT01491945|80874045|FG000|Overall Study|Death|30|||
27739269|NCT01491945|80874045|FG000|Overall Study|Withdrwan/LTF|16|||
27739270|NCT01491945|80874045|FG000|Overall Study|Conversion|4|||
27739271|NCT01491945|80874045|FG000|Overall Study|Missed Visit|1|||
27739272|NCT00376688|80874047|FG000|Overall Study|Adverse Event|3|||
27739273|NCT00376688|80874047|FG000|Overall Study|Death|1|||
27739274|NCT01024244|80874048|FG000|Overall Study|Adverse Event|1|||
27739275|NCT01024244|80874049|FG001|Overall Study|Adverse Event|2|||
27739276|NCT01024244|80874050|FG002|Overall Study|Adverse Event|0|||
27739277|NCT01024244|80874051|FG003|Overall Study|Adverse Event|1|||
27739278|NCT01024244|80874052|FG004|Overall Study|Adverse Event|2|||
27739279|NCT01024244|80874048|FG000|Overall Study|Entry Criteria Not Met|0|||
27739280|NCT01024244|80874049|FG001|Overall Study|Entry Criteria Not Met|1|||
27739281|NCT01024244|80874050|FG002|Overall Study|Entry Criteria Not Met|0|||
27739282|NCT01024244|80874051|FG003|Overall Study|Entry Criteria Not Met|0|||
27739283|NCT01024244|80874052|FG004|Overall Study|Entry Criteria Not Met|0|||
27739284|NCT01024244|80874048|FG000|Overall Study|Lack of Efficacy|1|||
27739285|NCT01024244|80874049|FG001|Overall Study|Lack of Efficacy|0|||
27739286|NCT01024244|80874050|FG002|Overall Study|Lack of Efficacy|0|||
27739287|NCT01024244|80874051|FG003|Overall Study|Lack of Efficacy|0|||
27739288|NCT01024244|80874052|FG004|Overall Study|Lack of Efficacy|0|||
27739289|NCT01024244|80874048|FG000|Overall Study|Protocol Violation|1|||
27739290|NCT01024244|80874049|FG001|Overall Study|Protocol Violation|0|||
27739291|NCT01024244|80874050|FG002|Overall Study|Protocol Violation|0|||
27739292|NCT01024244|80874051|FG003|Overall Study|Protocol Violation|0|||
27739293|NCT01024244|80874052|FG004|Overall Study|Protocol Violation|2|||
27739294|NCT01024244|80874048|FG000|Overall Study|Sponsor Decision|14|||
27739295|NCT01024244|80874049|FG001|Overall Study|Sponsor Decision|7|||
27739296|NCT01024244|80874050|FG002|Overall Study|Sponsor Decision|14|||
27739297|NCT01024244|80874051|FG003|Overall Study|Sponsor Decision|12|||
27739298|NCT01024244|80874052|FG004|Overall Study|Sponsor Decision|10|||
27739299|NCT01024244|80874048|FG000|Overall Study|Withdrawal by Subject|0|||
27739300|NCT01024244|80874049|FG001|Overall Study|Withdrawal by Subject|1|||
27739301|NCT01024244|80874050|FG002|Overall Study|Withdrawal by Subject|0|||
27739302|NCT01024244|80874051|FG003|Overall Study|Withdrawal by Subject|0|||
27739303|NCT01024244|80874052|FG004|Overall Study|Withdrawal by Subject|0|||
27739304|NCT00447421|80874053|FG000|Overall Study|Lack of Efficacy|1|||
27916587|NCT00269152|81533212|FG000|Overall Study|Adverse Event|9|||
27916588|NCT00269152|81533213|FG001|Overall Study|Adverse Event|3|||
27916589|NCT00269152|81533212|FG000|Overall Study|Withdrawal by Subject|7|||
27916590|NCT00269152|81533213|FG001|Overall Study|Withdrawal by Subject|3|||
27916591|NCT00269152|81533212|FG000|Overall Study|Physician Decision|2|||
27916592|NCT00269152|81533213|FG001|Overall Study|Physician Decision|3|||
27916593|NCT00269152|81533212|FG000|Overall Study|Protocol Violation|0|||
27916594|NCT00269152|81533213|FG001|Overall Study|Protocol Violation|1|||
27916595|NCT00871234|81533216|FG000|Overall Study|Adverse Event|2|||
27916596|NCT00871234|81533216|FG000|Overall Study|Lost to Follow-up|3|||
27916597|NCT05222880|81533217|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
27916598|NCT05222880|81533217|FG000|Overall Study|Withdrew Consent during Study|1|||
27916599|NCT05222880|81533217|FG000|Overall Study|COVID-19 Related|1|||
27916600|NCT02532374|81533221|FG000|Overall Study|Withdrawal by Subject|1|||
27916601|NCT02532374|81533221|FG000|Overall Study|Physician Decision|1|||
27916602|NCT01462630|81533222|FG000|Overall Study|Did not initiate therapy|3|||
27916603|NCT01462630|81533222|FG000|Overall Study|Death|1|||
27916604|NCT01462630|81533222|FG000|Overall Study|Protocol Violation|2|||
27916605|NCT01462630|81533222|FG000|Overall Study|Adverse Event|1|||
27916606|NCT02914834|81533226|FG000|Overall Study|Study halted due to COVID|1|||
27739305|NCT00447421|80874053|FG000|Overall Study|Adverse Event|3|||
27739306|NCT00447421|80874053|FG000|Overall Study|Sponsor Decision|2|||
27739307|NCT04430348|80874054|FG000|Overall Study|Death|3|||
27739308|NCT04430348|80874055|FG001|Overall Study|Death|2|||
27739309|NCT04430348|80874056|FG002|Overall Study|Death|2|||
27739310|NCT04430348|80874057|FG003|Overall Study|Death|2|||
27739311|NCT04430348|80874058|FG004|Overall Study|Death|2|||
27739312|NCT04430348|80874059|FG005|Overall Study|Death|3|||
27739313|NCT04430348|80874054|FG000|Overall Study|Lost to Follow-up|0|||
27739314|NCT04430348|80874055|FG001|Overall Study|Lost to Follow-up|0|||
27739315|NCT04430348|80874056|FG002|Overall Study|Lost to Follow-up|0|||
27739316|NCT04430348|80874057|FG003|Overall Study|Lost to Follow-up|1|||
27916607|NCT02914834|81533227|FG001|Overall Study|Study halted due to COVID|1|||
27916608|NCT02914834|81533226|FG000|Overall Study|1 subject withdrew|0|||
27916609|NCT02914834|81533227|FG001|Overall Study|1 subject withdrew|1|||
27916610|NCT01228591|81533228|FG000|Baseline|Lack of Efficacy|1|||
27916611|NCT01228591|81533229|FG001|Baseline|Lack of Efficacy|2|||
27916612|NCT02723188|81533232|FG000|Overall Study|Withdrawal by Subject|1|||
27537685|NCT01160211|80163531|FG000|Overall Study|Physician Decision|2|||
27537686|NCT01160211|80163532|FG001|Overall Study|Physician Decision|0|||
27537687|NCT01160211|80163533|FG002|Overall Study|Physician Decision|0|||
27916613|NCT02723188|81533233|FG001|Overall Study|Withdrawal by Subject|0|||
27916614|NCT02723188|81533234|FG002|Overall Study|Withdrawal by Subject|0|||
27916615|NCT04350827|81533236|FG000|Overall Study|Lost to Follow-up|1|||
27916616|NCT04350827|81533237|FG001|Overall Study|Lost to Follow-up|2|||
27916617|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
27916618|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
27916619|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
27916620|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
27916621|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
27916622|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
27916623|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
27916624|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27916625|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27916626|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
27916627|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
27916628|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
27916629|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
27916630|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
27916631|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
27916632|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
27916633|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
27916634|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27916635|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27916636|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
27916637|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
27916638|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
27916639|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27916640|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27916641|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
27916642|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
27916643|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
27916644|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
27916645|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
27916646|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
27916647|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
27537688|NCT01160211|80163531|FG000|Overall Study|Lost to Follow-up|4|||
27537689|NCT01160211|80163532|FG001|Overall Study|Lost to Follow-up|7|||
27537690|NCT01160211|80163533|FG002|Overall Study|Lost to Follow-up|5|||
27537691|NCT00354744|80163535|FG000|Overall Study|Adverse Event|2|||
27537692|NCT00354744|80163535|FG000|Overall Study|Death|2|||
27537693|NCT00354744|80163535|FG000|Overall Study|Lack of Efficacy|11|||
27537694|NCT00354744|80163535|FG000|Overall Study|Lost to Follow-up|2|||
27537695|NCT00354744|80163535|FG000|Overall Study|Physician Decision|11|||
27537696|NCT00354744|80163535|FG000|Overall Study|Withdrawal by Subject|14|||
27537697|NCT02187744|80163536|FG000|Study|Participant refused further follow-up|1|||
27537698|NCT02187744|80163537|FG001|Study|Participant refused further follow-up|0|||
27537699|NCT02187744|80163536|FG000|Study|Other|2|||
27537700|NCT02187744|80163537|FG001|Study|Other|1|||
27537701|NCT02187744|80163536|FG000|Study|Lost to Follow-up|0|||
27537702|NCT02187744|80163537|FG001|Study|Lost to Follow-up|2|||
27537703|NCT02187744|80163536|FG000|Study|Related adverse event, not serious|0|||
27632620|NCT01289119|80493804|FG005|Overall Study|Pregnancy|0|||
27916648|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
27916649|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
27916650|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
27916651|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
27537704|NCT02187744|80163537|FG001|Study|Related adverse event, not serious|2|||
27537705|NCT02187744|80163536|FG000|Study|Death|1|||
27537706|NCT02187744|80163537|FG001|Study|Death|0|||
27537707|NCT02187744|80163536|FG000|Study|Related adverse event, serious non-fatal|0|||
27537708|NCT02187744|80163537|FG001|Study|Related adverse event, serious non-fatal|1|||
27537709|NCT02187744|80163536|FG000|Treatment|Death|1|||
27537710|NCT02187744|80163537|FG001|Treatment|Death|0|||
27632621|NCT01289119|80493799|FG000|Overall Study|Lack of Efficacy|0|||
27632622|NCT01289119|80493800|FG001|Overall Study|Lack of Efficacy|1|||
27632623|NCT01289119|80493801|FG002|Overall Study|Lack of Efficacy|1|||
27632624|NCT01289119|80493802|FG003|Overall Study|Lack of Efficacy|1|||
27916652|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
27916653|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
27916654|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
27916655|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
27916656|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
27916657|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
27916658|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27916659|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27916660|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27916661|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
27632625|NCT01289119|80493803|FG004|Overall Study|Lack of Efficacy|1|||
27632626|NCT01289119|80493804|FG005|Overall Study|Lack of Efficacy|1|||
27632627|NCT01289119|80493799|FG000|Overall Study|Other|1|||
27632628|NCT01289119|80493800|FG001|Overall Study|Other|0|||
27632629|NCT01289119|80493801|FG002|Overall Study|Other|1|||
27632630|NCT01289119|80493802|FG003|Overall Study|Other|0|||
27632631|NCT01289119|80493803|FG004|Overall Study|Other|0|||
27632632|NCT01289119|80493804|FG005|Overall Study|Other|0|||
27632633|NCT00457691|80493807|FG000|Overall Study|Adverse Event|4|||
27632634|NCT00457691|80493808|FG001|Overall Study|Adverse Event|1|||
27632635|NCT00457691|80493807|FG000|Overall Study|Death|163|||
27632636|NCT00457691|80493808|FG001|Overall Study|Death|148|||
27632637|NCT00457691|80493807|FG000|Overall Study|Protocol Violation|1|||
27632638|NCT00457691|80493808|FG001|Overall Study|Protocol Violation|3|||
27632639|NCT00457691|80493807|FG000|Overall Study|Lost to Follow-up|23|||
27632640|NCT00457691|80493808|FG001|Overall Study|Lost to Follow-up|14|||
27632641|NCT00457691|80493807|FG000|Overall Study|Study terminated by Sponsor|1|||
27632642|NCT00457691|80493808|FG001|Overall Study|Study terminated by Sponsor|1|||
27632643|NCT00457691|80493807|FG000|Overall Study|Subject refused (reason other than AE)|14|||
27632644|NCT00457691|80493808|FG001|Overall Study|Subject refused (reason other than AE)|19|||
27739317|NCT04430348|80874058|FG004|Overall Study|Lost to Follow-up|0|||
27916662|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
27916663|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
27916664|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
27916665|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
27916666|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
27916667|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
27916668|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
27916669|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
27916670|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
27916671|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
27916672|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
27916673|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27916674|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27916675|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27916676|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
27916677|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
27916678|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27916679|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27739318|NCT04430348|80874059|FG005|Overall Study|Lost to Follow-up|0|||
27916680|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27916681|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
27916682|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27916683|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
27916684|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27916685|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27632645|NCT00457691|80493807|FG000|Overall Study|Disease progression, study terminated|180|||
27632646|NCT00457691|80493808|FG001|Overall Study|Disease progression, study terminated|196|||
27632647|NCT01956669|80493809|FG000|Overall Study|Disease Progression|12|||
27632648|NCT01956669|80493810|FG001|Overall Study|Disease Progression|7|||
27632649|NCT01956669|80493811|FG002|Overall Study|Disease Progression|7|||
27632650|NCT01956669|80493812|FG003|Overall Study|Disease Progression|8|||
27632651|NCT01956669|80493813|FG004|Overall Study|Disease Progression|4|||
27632652|NCT01956669|80493814|FG005|Overall Study|Disease Progression|3|||
27632653|NCT01956669|80493815|FG006|Overall Study|Disease Progression|5|||
27916686|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
27916687|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
27916688|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
27916689|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
27537711|NCT02187744|80163536|FG000|Treatment|Related adverse event, serious non-fatal|0|||
27537712|NCT02187744|80163537|FG001|Treatment|Related adverse event, serious non-fatal|1|||
27537713|NCT02187744|80163536|FG000|Treatment|Related adverse event, not serious|0|||
27537714|NCT02187744|80163537|FG001|Treatment|Related adverse event, not serious|2|||
27537715|NCT02187744|80163536|FG000|Treatment|Lost to Follow-up|0|||
27537716|NCT02187744|80163537|FG001|Treatment|Lost to Follow-up|1|||
27537717|NCT02187744|80163536|FG000|Treatment|Other|2|||
27537718|NCT02187744|80163537|FG001|Treatment|Other|0|||
27916690|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
27916691|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
27916692|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27916693|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
27916694|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27916695|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27916696|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
27916697|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
27916698|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27916699|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27916700|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27916701|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
27916702|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27916703|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
27916704|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27916705|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27916706|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
27916707|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
27916708|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27916709|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27916710|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27916711|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
27916712|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27916713|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
27916714|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27916715|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27916716|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
27916717|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
27916718|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27916719|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27916720|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27916721|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
27916722|NCT02717195|81533238|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
27916723|NCT02717195|81533239|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27916724|NCT02717195|81533240|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27916725|NCT02717195|81533241|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27916726|NCT02717195|81533242|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
27916727|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
27916728|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
27916729|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
27916730|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
27916731|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
27916732|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
27916733|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
27916734|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
27916735|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
27916736|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
27537719|NCT02187744|80163536|FG000|Treatment|Participant refused continued treatment|1|||
27537720|NCT02187744|80163537|FG001|Treatment|Participant refused continued treatment|1|||
27537721|NCT00968864|80163538|FG000|Overall Study|Protocol exception/ not evaluable|1|||
27632654|NCT01956669|80493809|FG000|Overall Study|Adverse Event|0|||
27632655|NCT01956669|80493810|FG001|Overall Study|Adverse Event|2|||
27916737|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
27916738|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
27916739|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
27916740|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
27916741|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
27916742|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
27916743|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
27916744|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
27916745|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
27916746|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
27916747|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27916748|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
27916749|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
27916750|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
27916751|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
27916752|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
27916753|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
27916754|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
27916755|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
27916756|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
27916757|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27916758|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27916759|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
27916760|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27916761|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
27916762|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
27916763|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
27916764|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
27916765|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
27916766|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
27916767|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
27916768|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
27916769|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
27916770|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
27916771|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
27916772|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27916773|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27916774|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27916775|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
27916776|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
27916777|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
27916778|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
27916779|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
27916780|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
27916781|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
27916782|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27916783|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27916784|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27916785|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
27916786|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
27916787|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27916788|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27916789|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
27916790|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27916791|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
27916792|NCT02717195|81533238|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
27916793|NCT02717195|81533239|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
27916794|NCT02717195|81533240|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
27916795|NCT02717195|81533241|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
27916796|NCT02717195|81533242|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
27916797|NCT02175225|81533251|FG000|Overall Study|Withdrawal by Subject|1|||
27916798|NCT02175225|81533252|FG001|Overall Study|Withdrawal by Subject|2|||
27916799|NCT02175225|81533251|FG000|Overall Study|Lost to Follow-up|6|||
27537722|NCT02229383|80163539|FG000|Overall Study|Adverse Event|7|||
27916800|NCT02175225|81533252|FG001|Overall Study|Lost to Follow-up|7|||
27916801|NCT02175225|81533251|FG000|Overall Study|Study drug not administered|1|||
27916802|NCT02175225|81533252|FG001|Overall Study|Study drug not administered|2|||
27916803|NCT03933449|81533253|FG000|Overall Study|Adverse Event|6|||
27916804|NCT03933449|81533254|FG001|Overall Study|Adverse Event|4|||
27916805|NCT03933449|81533253|FG000|Overall Study|Death|55|||
27916806|NCT03933449|81533254|FG001|Overall Study|Death|57|||
27916807|NCT03933449|81533253|FG000|Overall Study|Sponsor Decision|1|||
27916808|NCT03933449|81533254|FG001|Overall Study|Sponsor Decision|0|||
27916809|NCT00102596|81533255|FG000|Part A|Screen failures|6|||
27916810|NCT00102596|81533256|FG001|Part A|Screen failures|0|||
27916811|NCT00102596|81533255|FG000|Part A|Adverse Event|1|||
27916812|NCT00102596|81533256|FG001|Part A|Adverse Event|0|||
27916813|NCT00789321|81533259|FG000|Overall Study|Adverse Event|0|||
27916814|NCT00789321|81533260|FG001|Overall Study|Adverse Event|1|||
27916815|NCT02869789|81533263|FG000|Overall Study|Disease progression|184|||
27916816|NCT02869789|81533264|FG001|Overall Study|Disease progression|109|||
27916817|NCT02869789|81533265|FG002|Overall Study|Disease progression|260|||
27916818|NCT02869789|81533266|FG003|Overall Study|Disease progression|19|||
27916819|NCT02869789|81533263|FG000|Overall Study|Study drug toxicity|90|||
27916820|NCT02869789|81533264|FG001|Overall Study|Study drug toxicity|32|||
27916821|NCT02869789|81533265|FG002|Overall Study|Study drug toxicity|55|||
27916822|NCT02869789|81533266|FG003|Overall Study|Study drug toxicity|14|||
27916823|NCT02869789|81533263|FG000|Overall Study|Death|7|||
27916824|NCT02869789|81533264|FG001|Overall Study|Death|3|||
27916825|NCT02869789|81533265|FG002|Overall Study|Death|5|||
27916826|NCT02869789|81533266|FG003|Overall Study|Death|1|||
27916827|NCT02869789|81533263|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
27916828|NCT02869789|81533264|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
27916829|NCT02869789|81533265|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
27916830|NCT02869789|81533266|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
27916831|NCT02869789|81533263|FG000|Overall Study|Participant request to discontinue study treatment|10|||
27916832|NCT02869789|81533264|FG001|Overall Study|Participant request to discontinue study treatment|5|||
27916833|NCT02869789|81533265|FG002|Overall Study|Participant request to discontinue study treatment|5|||
27916834|NCT02869789|81533266|FG003|Overall Study|Participant request to discontinue study treatment|3|||
27916835|NCT02869789|81533263|FG000|Overall Study|Withdrawal by Subject|5|||
27916836|NCT02869789|81533264|FG001|Overall Study|Withdrawal by Subject|2|||
27916837|NCT02869789|81533265|FG002|Overall Study|Withdrawal by Subject|7|||
27916838|NCT02869789|81533266|FG003|Overall Study|Withdrawal by Subject|2|||
27916839|NCT02869789|81533263|FG000|Overall Study|Lost to Follow-up|0|||
27916840|NCT02869789|81533264|FG001|Overall Study|Lost to Follow-up|0|||
27916841|NCT02869789|81533265|FG002|Overall Study|Lost to Follow-up|2|||
27916842|NCT02869789|81533266|FG003|Overall Study|Lost to Follow-up|0|||
27916843|NCT02869789|81533263|FG000|Overall Study|Maximum clinical benefit|5|||
27916844|NCT02869789|81533264|FG001|Overall Study|Maximum clinical benefit|2|||
27916845|NCT02869789|81533265|FG002|Overall Study|Maximum clinical benefit|1|||
27916846|NCT02869789|81533266|FG003|Overall Study|Maximum clinical benefit|0|||
27916847|NCT02869789|81533263|FG000|Overall Study|Poor/Non-compliance|0|||
27916848|NCT02869789|81533264|FG001|Overall Study|Poor/Non-compliance|2|||
27916849|NCT02869789|81533265|FG002|Overall Study|Poor/Non-compliance|1|||
27916850|NCT02869789|81533266|FG003|Overall Study|Poor/Non-compliance|0|||
27916851|NCT02869789|81533263|FG000|Overall Study|Participant no longer meets study criteria|0|||
27916852|NCT02869789|81533264|FG001|Overall Study|Participant no longer meets study criteria|1|||
27916853|NCT02869789|81533265|FG002|Overall Study|Participant no longer meets study criteria|1|||
27916854|NCT02869789|81533266|FG003|Overall Study|Participant no longer meets study criteria|0|||
27916855|NCT02869789|81533263|FG000|Overall Study|Administrative reason by sponsor|0|||
27916856|NCT02869789|81533264|FG001|Overall Study|Administrative reason by sponsor|0|||
27537723|NCT02229383|80163540|FG001|Overall Study|Adverse Event|4|||
27537724|NCT02229383|80163539|FG000|Overall Study|Death|0|||
27537725|NCT02229383|80163540|FG001|Overall Study|Death|1|||
27537726|NCT02229383|80163539|FG000|Overall Study|Lost to Follow-up|5|||
27537727|NCT02229383|80163540|FG001|Overall Study|Lost to Follow-up|3|||
27537728|NCT02229383|80163539|FG000|Overall Study|Withdrawal by Subject|4|||
27537729|NCT02229383|80163540|FG001|Overall Study|Withdrawal by Subject|6|||
27537730|NCT02229383|80163539|FG000|Overall Study|Did not receive treatment|1|||
27537731|NCT02229383|80163540|FG001|Overall Study|Did not receive treatment|0|||
27537732|NCT02229383|80163539|FG000|Overall Study|Other|3|||
27916857|NCT02869789|81533265|FG002|Overall Study|Administrative reason by sponsor|1|||
27537733|NCT02229383|80163540|FG001|Overall Study|Other|8|||
27537734|NCT00866788|80163541|FG000|Overall Study|Adverse Event|0|||
27916858|NCT02869789|81533266|FG003|Overall Study|Administrative reason by sponsor|0|||
27916859|NCT02869789|81533263|FG000|Overall Study|Other reasons|4|||
27916860|NCT02869789|81533264|FG001|Overall Study|Other reasons|8|||
27916861|NCT02869789|81533265|FG002|Overall Study|Other reasons|6|||
27916862|NCT02869789|81533266|FG003|Overall Study|Other reasons|0|||
27537735|NCT00866788|80163542|FG001|Overall Study|Adverse Event|2|||
27537736|NCT00866788|80163543|FG002|Overall Study|Adverse Event|0|||
27916863|NCT03163446|81533267|FG000|Overall Study|Unable to return for Day 180 visit|2|||
27916864|NCT03163446|81533268|FG001|Overall Study|Unable to return for Day 180 visit|0|||
27916865|NCT03163446|81533267|FG000|Overall Study|Withdrawal by Subject|2|||
27916866|NCT03163446|81533268|FG001|Overall Study|Withdrawal by Subject|6|||
27916867|NCT03163446|81533267|FG000|Overall Study|Death|16|||
27916868|NCT03163446|81533268|FG001|Overall Study|Death|5|||
27916869|NCT03163446|81533267|FG000|Overall Study|Lost to Follow-up|6|||
27916870|NCT03163446|81533268|FG001|Overall Study|Lost to Follow-up|5|||
27916871|NCT03163446|81533267|FG000|Overall Study|Physician Decision|1|||
27916872|NCT03163446|81533268|FG001|Overall Study|Physician Decision|1|||
27916873|NCT03163446|81533267|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
27916874|NCT03163446|81533268|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
27916875|NCT01494818|81533269|FG000|Overall Study|Relocation|1|||
27916876|NCT01494818|81533270|FG001|Overall Study|Relocation|2|||
27916877|NCT01494818|81533269|FG000|Overall Study|Lost to Follow-up|1|||
27916878|NCT01494818|81533270|FG001|Overall Study|Lost to Follow-up|0|||
27916879|NCT00739648|81533271|FG000|Overall Study|Adverse Event|3|||
27916880|NCT00739648|81533272|FG001|Overall Study|Adverse Event|15|||
27916881|NCT00739648|81533271|FG000|Overall Study|Withdrawal by Subject|13|||
27916882|NCT00739648|81533272|FG001|Overall Study|Withdrawal by Subject|25|||
27916883|NCT00739648|81533271|FG000|Overall Study|Lost to Follow-up|4|||
27916884|NCT00739648|81533272|FG001|Overall Study|Lost to Follow-up|7|||
27916885|NCT00739648|81533271|FG000|Overall Study|Death|2|||
27916886|NCT00739648|81533272|FG001|Overall Study|Death|0|||
27916887|NCT00739648|81533271|FG000|Overall Study|Do not know|4|||
27916888|NCT00739648|81533272|FG001|Overall Study|Do not know|6|||
27916889|NCT00072384|81533275|FG000|Overall Study|Physician Decision|1|||
27916890|NCT00072384|81533275|FG000|Overall Study|Ineligible|8|||
27916891|NCT03234036|81533276|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
27916892|NCT03234036|81533277|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
27916893|NCT03234036|81533278|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
27916894|NCT03234036|81533279|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
27916895|NCT02062437|81533280|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
27916896|NCT02062437|81533280|FG000|Overall Study|Patient not available for the 2y visit|18|||
27916897|NCT02062437|81533280|FG000|Overall Study|Death|2|||
27916898|NCT02062437|81533280|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
27916899|NCT03934216|81533281|FG000|Overall Study|Other Reasons|5|||
27916900|NCT03934216|81533282|FG001|Overall Study|Other Reasons|5|||
27916901|NCT03934216|81533281|FG000|Overall Study|Adverse Event|22|||
27916902|NCT03934216|81533282|FG001|Overall Study|Adverse Event|11|||
27916903|NCT03934216|81533281|FG000|Overall Study|Lack of Efficacy|8|||
27916904|NCT03934216|81533282|FG001|Overall Study|Lack of Efficacy|7|||
27916905|NCT03934216|81533281|FG000|Overall Study|Lost to Follow-up|2|||
27916906|NCT03934216|81533282|FG001|Overall Study|Lost to Follow-up|0|||
27916907|NCT03934216|81533281|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27537737|NCT00866788|80163544|FG003|Overall Study|Adverse Event|1|||
27537738|NCT00866788|80163541|FG000|Overall Study|Lost to Follow-up|1|||
27537739|NCT00866788|80163542|FG001|Overall Study|Lost to Follow-up|1|||
27537740|NCT00866788|80163543|FG002|Overall Study|Lost to Follow-up|0|||
27537741|NCT00866788|80163544|FG003|Overall Study|Lost to Follow-up|2|||
27537742|NCT00866788|80163541|FG000|Overall Study|Withdrawal by Subject|2|||
27537743|NCT00866788|80163542|FG001|Overall Study|Withdrawal by Subject|1|||
27537744|NCT00866788|80163543|FG002|Overall Study|Withdrawal by Subject|0|||
27537745|NCT00866788|80163544|FG003|Overall Study|Withdrawal by Subject|1|||
27537746|NCT00866788|80163541|FG000|Overall Study|Pregnancy|0|||
27537747|NCT00866788|80163542|FG001|Overall Study|Pregnancy|1|||
27537748|NCT00866788|80163543|FG002|Overall Study|Pregnancy|0|||
27537749|NCT00866788|80163544|FG003|Overall Study|Pregnancy|0|||
27537750|NCT00866788|80163541|FG000|Overall Study|Disease progression|3|||
27537751|NCT00866788|80163542|FG001|Overall Study|Disease progression|1|||
27537752|NCT00866788|80163543|FG002|Overall Study|Disease progression|1|||
27537753|NCT00866788|80163544|FG003|Overall Study|Disease progression|0|||
27537754|NCT00866788|80163541|FG000|Overall Study|Physician Decision|0|||
27537755|NCT00866788|80163542|FG001|Overall Study|Physician Decision|0|||
27537756|NCT00866788|80163543|FG002|Overall Study|Physician Decision|1|||
27537757|NCT00866788|80163544|FG003|Overall Study|Physician Decision|1|||
27537758|NCT02083081|80163545|FG000|Overall Study|Lost to Follow-up|31|||
27537759|NCT02083081|80163546|FG001|Overall Study|Lost to Follow-up|9|||
27537760|NCT01846104|80163547|FG000|Overall Study|Withdrawal by Subject|1|||
27916908|NCT03934216|81533282|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27916909|NCT03934216|81533281|FG000|Overall Study|Pregnancy|1|||
27537761|NCT01893203|80163548|FG000|Overall Study|Withdrawal by Subject|1|||
27537762|NCT00246753|80163549|FG000|Overall Study|Withdrawal by Subject|2|||
27537763|NCT00246753|80163549|FG000|Overall Study|Physician Decision|2|||
27537764|NCT00246753|80163549|FG000|Overall Study|Adverse Event|2|||
27537765|NCT00246753|80163549|FG000|Overall Study|Unacceptable toxicity|2|||
27537766|NCT00474760|80163552|FG000|Overall Study|Death|0|||
27537767|NCT00474760|80163553|FG001|Overall Study|Death|0|||
27916910|NCT03934216|81533282|FG001|Overall Study|Pregnancy|0|||
27916911|NCT03934216|81533281|FG000|Overall Study|Withdrawal by Subject|18|||
27916912|NCT03934216|81533282|FG001|Overall Study|Withdrawal by Subject|6|||
27916913|NCT03934216|81533281|FG000|Overall Study|Randomized but not treated|1|||
27916914|NCT03934216|81533282|FG001|Overall Study|Randomized but not treated|1|||
27916915|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Death|20|||
27916916|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Death|26|||
27916917|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
27916918|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
27916919|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
27916920|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
27916921|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
27916922|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
27916923|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
27916924|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
27916925|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
27916926|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
27916927|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
27916928|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
27916929|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
27916930|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
27916931|NCT00643201|81533283|FG000|Randomized, Completed 6 Months of Study|Other|107|||
27916932|NCT00643201|81533284|FG001|Randomized, Completed 6 Months of Study|Other|107|||
27916933|NCT00643201|81533283|FG000|Completed Study Follow Up|Death|28|||
27916934|NCT00643201|81533284|FG001|Completed Study Follow Up|Death|34|||
27916935|NCT00643201|81533283|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
27916936|NCT00643201|81533284|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
27916937|NCT00643201|81533283|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
27916938|NCT00643201|81533284|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
27916939|NCT00643201|81533283|FG000|Completed Study Follow Up|non-specified|1|||
27916940|NCT00643201|81533284|FG001|Completed Study Follow Up|non-specified|0|||
27916941|NCT00327340|81533285|FG000|Overall Study|Withdrawal by Subject|1|||
27916942|NCT00327340|81533286|FG001|Overall Study|Withdrawal by Subject|5|||
27916943|NCT00327340|81533285|FG000|Overall Study|Physician Decision|1|||
27916944|NCT00327340|81533286|FG001|Overall Study|Physician Decision|1|||
27537768|NCT00474760|80163554|FG002|Overall Study|Death|0|||
27537769|NCT00474760|80163555|FG003|Overall Study|Death|0|||
27537770|NCT00474760|80163556|FG004|Overall Study|Death|2|||
27537771|NCT00474760|80163557|FG005|Overall Study|Death|0|||
27537772|NCT00474760|80163558|FG006|Overall Study|Death|0|||
27537773|NCT00474760|80163552|FG000|Overall Study|Adverse Event|0|||
27537774|NCT00474760|80163553|FG001|Overall Study|Adverse Event|0|||
27537775|NCT00474760|80163554|FG002|Overall Study|Adverse Event|0|||
27537776|NCT00474760|80163555|FG003|Overall Study|Adverse Event|0|||
27537777|NCT00474760|80163556|FG004|Overall Study|Adverse Event|1|||
27537778|NCT00474760|80163557|FG005|Overall Study|Adverse Event|7|||
27537779|NCT00474760|80163558|FG006|Overall Study|Adverse Event|0|||
27537780|NCT00474760|80163552|FG000|Overall Study|Laboratory abnormality|0|||
27537781|NCT00474760|80163553|FG001|Overall Study|Laboratory abnormality|0|||
27537782|NCT00474760|80163554|FG002|Overall Study|Laboratory abnormality|0|||
27537783|NCT00474760|80163555|FG003|Overall Study|Laboratory abnormality|0|||
27537784|NCT00474760|80163556|FG004|Overall Study|Laboratory abnormality|0|||
27537785|NCT00474760|80163557|FG005|Overall Study|Laboratory abnormality|1|||
27537786|NCT00474760|80163558|FG006|Overall Study|Laboratory abnormality|0|||
27537787|NCT00474760|80163552|FG000|Overall Study|Withdrawal by Subject|0|||
27537788|NCT00474760|80163553|FG001|Overall Study|Withdrawal by Subject|0|||
27537789|NCT00474760|80163554|FG002|Overall Study|Withdrawal by Subject|0|||
27537790|NCT00474760|80163555|FG003|Overall Study|Withdrawal by Subject|1|||
27537791|NCT00474760|80163556|FG004|Overall Study|Withdrawal by Subject|0|||
27537792|NCT00474760|80163557|FG005|Overall Study|Withdrawal by Subject|1|||
27537793|NCT00474760|80163558|FG006|Overall Study|Withdrawal by Subject|1|||
27632656|NCT01956669|80493811|FG002|Overall Study|Adverse Event|2|||
27632657|NCT01956669|80493812|FG003|Overall Study|Adverse Event|1|||
27632658|NCT01956669|80493813|FG004|Overall Study|Adverse Event|0|||
27632659|NCT01956669|80493814|FG005|Overall Study|Adverse Event|0|||
27632660|NCT01956669|80493815|FG006|Overall Study|Adverse Event|0|||
27632661|NCT01956669|80493809|FG000|Overall Study|Physician Decision|0|||
27632662|NCT01956669|80493810|FG001|Overall Study|Physician Decision|2|||
27916945|NCT00327340|81533285|FG000|Overall Study|Disease Progression|10|||
27537794|NCT00474760|80163552|FG000|Overall Study|Other|0|||
27537795|NCT00474760|80163553|FG001|Overall Study|Other|1|||
27537796|NCT00474760|80163554|FG002|Overall Study|Other|0|||
27632663|NCT01956669|80493811|FG002|Overall Study|Physician Decision|0|||
27916946|NCT00327340|81533286|FG001|Overall Study|Disease Progression|19|||
27916947|NCT00327340|81533285|FG000|Overall Study|Symptomatic Disease|0|||
27632664|NCT01956669|80493812|FG003|Overall Study|Physician Decision|0|||
27632665|NCT01956669|80493813|FG004|Overall Study|Physician Decision|0|||
27632666|NCT01956669|80493814|FG005|Overall Study|Physician Decision|1|||
27632667|NCT01956669|80493815|FG006|Overall Study|Physician Decision|0|||
27632668|NCT01956669|80493809|FG000|Overall Study|Withdrawal by Subject|0|||
27632669|NCT01956669|80493810|FG001|Overall Study|Withdrawal by Subject|0|||
27632670|NCT01956669|80493811|FG002|Overall Study|Withdrawal by Subject|1|||
27632671|NCT01956669|80493812|FG003|Overall Study|Withdrawal by Subject|1|||
27632672|NCT01956669|80493813|FG004|Overall Study|Withdrawal by Subject|0|||
27632673|NCT01956669|80493814|FG005|Overall Study|Withdrawal by Subject|0|||
27632674|NCT01956669|80493815|FG006|Overall Study|Withdrawal by Subject|1|||
27632675|NCT00546871|80493816|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
27632676|NCT00546871|80493817|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
27632677|NCT00546871|80493816|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
27632678|NCT00546871|80493817|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
27632679|NCT00546871|80493816|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
27632680|NCT00546871|80493817|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
27632681|NCT00546871|80493816|FG000|Study Extension Period|Protocol Violation|1|||
27632682|NCT00546871|80493817|FG001|Study Extension Period|Protocol Violation|0|||
27632683|NCT00546871|80493816|FG000|Study Extension Period|Withdrawal by Subject|0|||
27916948|NCT00327340|81533286|FG001|Overall Study|Symptomatic Disease|2|||
27916949|NCT00327340|81533285|FG000|Overall Study|Adverse Event|3|||
27916950|NCT00327340|81533286|FG001|Overall Study|Adverse Event|3|||
27916951|NCT02121795|81533287|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
27916952|NCT02121795|81533288|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
27916953|NCT02121795|81533287|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
27916954|NCT02121795|81533288|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
27916955|NCT02121795|81533287|FG000|Double-Blind Phase|Lost to Follow-up|7|||
27916956|NCT02121795|81533288|FG001|Double-Blind Phase|Lost to Follow-up|4|||
27916957|NCT02121795|81533287|FG000|Double-Blind Phase|Physician Decision|2|||
27916958|NCT02121795|81533288|FG001|Double-Blind Phase|Physician Decision|5|||
27916959|NCT02121795|81533287|FG000|Double-Blind Phase|Adverse Event|5|||
27916960|NCT02121795|81533288|FG001|Double-Blind Phase|Adverse Event|0|||
27916961|NCT02121795|81533287|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
27537797|NCT00474760|80163555|FG003|Overall Study|Other|0|||
27537798|NCT00474760|80163556|FG004|Overall Study|Other|1|||
27537799|NCT00474760|80163557|FG005|Overall Study|Other|0|||
27537800|NCT00474760|80163558|FG006|Overall Study|Other|0|||
27537801|NCT00474760|80163552|FG000|Overall Study|Progressive disease|3|||
27537802|NCT00474760|80163553|FG001|Overall Study|Progressive disease|2|||
27537803|NCT00474760|80163554|FG002|Overall Study|Progressive disease|3|||
27537804|NCT00474760|80163555|FG003|Overall Study|Progressive disease|2|||
27537805|NCT00474760|80163556|FG004|Overall Study|Progressive disease|8|||
27537806|NCT00474760|80163557|FG005|Overall Study|Progressive disease|20|||
27537807|NCT00474760|80163558|FG006|Overall Study|Progressive disease|7|||
27537808|NCT00474760|80163552|FG000|Overall Study|Terminated by sponsor|0|||
27537809|NCT00474760|80163553|FG001|Overall Study|Terminated by sponsor|0|||
27537810|NCT00474760|80163554|FG002|Overall Study|Terminated by sponsor|0|||
27537811|NCT00474760|80163555|FG003|Overall Study|Terminated by sponsor|0|||
27537812|NCT00474760|80163556|FG004|Overall Study|Terminated by sponsor|0|||
27537813|NCT00474760|80163557|FG005|Overall Study|Terminated by sponsor|0|||
27537814|NCT00474760|80163558|FG006|Overall Study|Terminated by sponsor|2|||
27537815|NCT01558739|80163559|FG000|Overall Study|Adverse Event|7|||
27537816|NCT01558739|80163559|FG000|Overall Study|Withdrawal by Subject|2|||
27537817|NCT01558739|80163559|FG000|Overall Study|Death|3|||
27537818|NCT01558739|80163559|FG000|Overall Study|Disease Progression|4|||
27537819|NCT01558739|80163559|FG000|Overall Study|Protocol Violation|1|||
27537820|NCT02628938|80163560|FG000|Overall Study|Did not attend the follow up recall|2|||
27537821|NCT02628938|80163561|FG001|Overall Study|Did not attend the follow up recall|2|||
27537822|NCT02628938|80163562|FG002|Overall Study|Did not attend the follow up recall|1|||
27537823|NCT02628938|80163560|FG000|Overall Study|Failure to comply with the instructions|3|||
27537824|NCT02628938|80163561|FG001|Overall Study|Failure to comply with the instructions|0|||
27537825|NCT02628938|80163562|FG002|Overall Study|Failure to comply with the instructions|3|||
27537826|NCT01313312|80163565|FG000|Overall Study|Adverse Event|5|||
27632684|NCT00546871|80493817|FG001|Study Extension Period|Withdrawal by Subject|1|||
27632685|NCT03058991|80493822|FG000|Overall Study|Lost to Follow-up|17|||
27632686|NCT03058991|80493823|FG001|Overall Study|Lost to Follow-up|12|||
27632687|NCT03058991|80493824|FG002|Overall Study|Lost to Follow-up|12|||
27632688|NCT03058991|80493822|FG000|Overall Study|Withdrawal by Subject|1|||
27632689|NCT03058991|80493823|FG001|Overall Study|Withdrawal by Subject|0|||
27632690|NCT03058991|80493824|FG002|Overall Study|Withdrawal by Subject|0|||
27632691|NCT02955069|80497451|FG000|Overall Study|Adverse Event|7|||
27916962|NCT02121795|81533288|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27632692|NCT02955069|80497452|FG001|Overall Study|Adverse Event|2|||
27916963|NCT02121795|81533287|FG000|Double-Blind Phase|Protocol Violation|0|||
27916964|NCT02121795|81533288|FG001|Double-Blind Phase|Protocol Violation|3|||
27537827|NCT01313312|80163565|FG000|Overall Study|Withdrawal by Subject|18|||
27537828|NCT01313312|80163565|FG000|Overall Study|Lack of Efficacy|3|||
27537829|NCT01313312|80163565|FG000|Overall Study|Investigator Decision|1|||
27916965|NCT02121795|81533287|FG000|Double-Blind Phase|Death|1|||
27916966|NCT02121795|81533288|FG001|Double-Blind Phase|Death|1|||
27916967|NCT02121795|81533287|FG000|Open-Label Phase|Physician Decision|8|||
27916968|NCT02121795|81533288|FG001|Open-Label Phase|Physician Decision|8|||
27916969|NCT02121795|81533287|FG000|Open-Label Phase|Withdrawal by Subject|3|||
27916970|NCT02121795|81533288|FG001|Open-Label Phase|Withdrawal by Subject|2|||
27916971|NCT02121795|81533287|FG000|Open-Label Phase|Lost to Follow-up|1|||
27916972|NCT02121795|81533288|FG001|Open-Label Phase|Lost to Follow-up|0|||
27916973|NCT00643760|81533289|FG000|Overall Study|Adverse Event|11|||
27916974|NCT00643760|81533290|FG001|Overall Study|Adverse Event|5|||
27916975|NCT00643760|81533291|FG002|Overall Study|Adverse Event|12|||
27916976|NCT00643760|81533292|FG003|Overall Study|Adverse Event|21|||
27916977|NCT00643760|81533293|FG004|Overall Study|Adverse Event|6|||
27916978|NCT00643760|81533289|FG000|Overall Study|Lack of Efficacy|3|||
27916979|NCT00643760|81533290|FG001|Overall Study|Lack of Efficacy|1|||
27916980|NCT00643760|81533291|FG002|Overall Study|Lack of Efficacy|0|||
27916981|NCT00643760|81533292|FG003|Overall Study|Lack of Efficacy|4|||
27916982|NCT00643760|81533293|FG004|Overall Study|Lack of Efficacy|3|||
27916983|NCT00643760|81533289|FG000|Overall Study|Protocol Violation|7|||
27916984|NCT00643760|81533290|FG001|Overall Study|Protocol Violation|6|||
27916985|NCT00643760|81533291|FG002|Overall Study|Protocol Violation|4|||
27916986|NCT00643760|81533292|FG003|Overall Study|Protocol Violation|4|||
27916987|NCT00643760|81533293|FG004|Overall Study|Protocol Violation|6|||
27916988|NCT00643760|81533289|FG000|Overall Study|Lost to Follow-up|6|||
27916989|NCT00643760|81533290|FG001|Overall Study|Lost to Follow-up|2|||
27916990|NCT00643760|81533291|FG002|Overall Study|Lost to Follow-up|1|||
27916991|NCT00643760|81533292|FG003|Overall Study|Lost to Follow-up|3|||
27916992|NCT00643760|81533293|FG004|Overall Study|Lost to Follow-up|3|||
27916993|NCT00643760|81533289|FG000|Overall Study|Investigator Discretion|0|||
27916994|NCT00643760|81533290|FG001|Overall Study|Investigator Discretion|0|||
27916995|NCT00643760|81533291|FG002|Overall Study|Investigator Discretion|0|||
27916996|NCT00643760|81533292|FG003|Overall Study|Investigator Discretion|2|||
27916997|NCT00643760|81533293|FG004|Overall Study|Investigator Discretion|0|||
27916998|NCT00643760|81533289|FG000|Overall Study|Withdrawal by Subject|3|||
27916999|NCT00643760|81533290|FG001|Overall Study|Withdrawal by Subject|1|||
27917000|NCT00643760|81533291|FG002|Overall Study|Withdrawal by Subject|2|||
27917001|NCT00643760|81533292|FG003|Overall Study|Withdrawal by Subject|4|||
27917002|NCT00643760|81533293|FG004|Overall Study|Withdrawal by Subject|1|||
27917003|NCT00661089|81533294|FG000|Overall Study|1 subject withdrawal|0|||
27917004|NCT00661089|81533295|FG001|Overall Study|1 subject withdrawal|1|||
27917005|NCT00661089|81533294|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
27917006|NCT00661089|81533295|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
27917007|NCT02224625|81533298|FG000|Irritation|Adverse Event|6|||
27917008|NCT02224625|81533298|FG000|Sensitization|Adverse Event|55|||
27917009|NCT01307787|81533299|FG000|Overall Study|Withdrawal by Subject|2|||
27917010|NCT01307787|81533300|FG001|Overall Study|Withdrawal by Subject|0|||
27917011|NCT01714544|81533301|FG000|Overall Study|Lost to Follow-up|1|||
27917012|NCT01714544|81533301|FG000|Overall Study|Physician Decision|1|||
27917013|NCT01714544|81533301|FG000|Overall Study|Withdrawal by Subject|1|||
27917014|NCT01775670|81533302|FG000|Overall Study|Lost to Follow-up|1|||
27917015|NCT01775670|81533303|FG001|Overall Study|Lost to Follow-up|1|||
27917016|NCT02048722|81533304|FG000|2 Cycles of Treatment|Adverse Event|2|||
27917017|NCT02048722|81533304|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
27537830|NCT01313312|80163565|FG000|Overall Study|Observational Phase|1|||
27537831|NCT01313312|80163565|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
27537832|NCT01313312|80163565|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
27537833|NCT01058655|80163570|FG000|Overall Study|Withdrawal by Subject|1|||
27537834|NCT01058655|80163571|FG001|Overall Study|Withdrawal by Subject|0|||
27537835|NCT01058655|80163572|FG002|Overall Study|Withdrawal by Subject|3|||
27537836|NCT01058655|80163573|FG003|Overall Study|Withdrawal by Subject|4|||
27537837|NCT01058655|80163570|FG000|Overall Study|Prolonged Treatment Delay|0|||
27537838|NCT01058655|80163571|FG001|Overall Study|Prolonged Treatment Delay|0|||
27537839|NCT01058655|80163572|FG002|Overall Study|Prolonged Treatment Delay|0|||
27537840|NCT01058655|80163573|FG003|Overall Study|Prolonged Treatment Delay|2|||
27537841|NCT01058655|80163570|FG000|Overall Study|Symptomatic Deterioration|0|||
27537842|NCT01058655|80163571|FG001|Overall Study|Symptomatic Deterioration|0|||
27537843|NCT01058655|80163572|FG002|Overall Study|Symptomatic Deterioration|0|||
27917018|NCT02048722|81533304|FG000|2 Cycles of Treatment|Progressive Disease|2|||
27537844|NCT01058655|80163573|FG003|Overall Study|Symptomatic Deterioration|1|||
27537845|NCT01058655|80163570|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
27917019|NCT02048722|81533304|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
27917020|NCT02048722|81533304|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
27917021|NCT02048722|81533304|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
27917022|NCT01128296|81533305|FG000|Overall Study|Physician Decision|0|||
27917023|NCT01128296|81533306|FG001|Overall Study|Physician Decision|0|||
27917024|NCT01128296|81533307|FG002|Overall Study|Physician Decision|0|||
27917025|NCT01128296|81533308|FG003|Overall Study|Physician Decision|0|||
27917026|NCT01128296|81533309|FG004|Overall Study|Physician Decision|0|||
27917027|NCT01128296|81533310|FG005|Overall Study|Physician Decision|3|||
27917028|NCT01128296|81533305|FG000|Overall Study|Withdrawal by Subject|0|||
27917029|NCT01128296|81533306|FG001|Overall Study|Withdrawal by Subject|0|||
27917030|NCT01128296|81533307|FG002|Overall Study|Withdrawal by Subject|0|||
27917031|NCT01128296|81533308|FG003|Overall Study|Withdrawal by Subject|0|||
27917032|NCT01128296|81533309|FG004|Overall Study|Withdrawal by Subject|0|||
27917033|NCT01128296|81533310|FG005|Overall Study|Withdrawal by Subject|2|||
27917034|NCT03804268|81533312|FG000|Overall Study|Adverse Event|2|||
27917035|NCT03804268|81533313|FG001|Overall Study|Adverse Event|2|||
27917036|NCT03804268|81533312|FG000|Overall Study|Withdrawal by Subject|2|||
27917037|NCT03804268|81533313|FG001|Overall Study|Withdrawal by Subject|0|||
27917038|NCT03804268|81533312|FG000|Overall Study|Lost to Follow-up|1|||
27917039|NCT03804268|81533313|FG001|Overall Study|Lost to Follow-up|0|||
27917040|NCT03804268|81533312|FG000|Overall Study|Physician Decision|2|||
27917041|NCT03804268|81533313|FG001|Overall Study|Physician Decision|0|||
27917042|NCT01089127|81533314|FG000|Overall Study|Adverse Event|5|||
27917043|NCT01089127|81533315|FG001|Overall Study|Adverse Event|1|||
27917044|NCT01089127|81533316|FG002|Overall Study|Adverse Event|1|||
27917045|NCT01089127|81533317|FG003|Overall Study|Adverse Event|0|||
27917046|NCT01089127|81533318|FG004|Overall Study|Adverse Event|0|||
27917047|NCT01089127|81533319|FG005|Overall Study|Adverse Event|1|||
27917048|NCT01089127|81533314|FG000|Overall Study|Subject withdrew consent|0|||
27917049|NCT01089127|81533315|FG001|Overall Study|Subject withdrew consent|1|||
27917050|NCT01089127|81533316|FG002|Overall Study|Subject withdrew consent|1|||
27917051|NCT01089127|81533317|FG003|Overall Study|Subject withdrew consent|1|||
27917052|NCT01089127|81533318|FG004|Overall Study|Subject withdrew consent|0|||
27917053|NCT01089127|81533319|FG005|Overall Study|Subject withdrew consent|2|||
27917054|NCT01089127|81533314|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27917055|NCT01089127|81533315|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27917056|NCT01089127|81533316|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27917057|NCT01089127|81533317|FG003|Overall Study|Abnormal test procedure result(s)|0|||
27917058|NCT01089127|81533318|FG004|Overall Study|Abnormal test procedure result(s)|0|||
27537846|NCT01058655|80163571|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
27537847|NCT01058655|80163572|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
27537848|NCT01058655|80163573|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
27537849|NCT01058655|80163570|FG000|Overall Study|Death|0|||
27537850|NCT01058655|80163571|FG001|Overall Study|Death|1|||
27537851|NCT01058655|80163572|FG002|Overall Study|Death|1|||
27537852|NCT01058655|80163573|FG003|Overall Study|Death|0|||
27537853|NCT01058655|80163570|FG000|Overall Study|Disease Progression|1|||
27537854|NCT01058655|80163571|FG001|Overall Study|Disease Progression|2|||
27537855|NCT01058655|80163572|FG002|Overall Study|Disease Progression|4|||
27537856|NCT01058655|80163573|FG003|Overall Study|Disease Progression|24|||
27537857|NCT01058655|80163570|FG000|Overall Study|Other|0|||
27537858|NCT01058655|80163571|FG001|Overall Study|Other|0|||
27537859|NCT01058655|80163572|FG002|Overall Study|Other|0|||
27537860|NCT01058655|80163573|FG003|Overall Study|Other|4|||
27537861|NCT05447897|80163574|FG000|Overall Study|Did not participate in survey|2|||
27537862|NCT02476201|80163580|FG000|Overall Study|Unable to program MPP|9|||
27537863|NCT02476201|80163580|FG000|Overall Study|Study echo not performed|5|||
27537864|NCT02476201|80163580|FG000|Overall Study|Adverse Event|4|||
27537865|NCT02476201|80163580|FG000|Overall Study|Death|2|||
27537866|NCT02476201|80163580|FG000|Overall Study|Lost to Follow-up|2|||
27537867|NCT02476201|80163580|FG000|Overall Study|MPP programmed to OFF|2|||
27537868|NCT02476201|80163580|FG000|Overall Study|Withdrawal by Subject|1|||
27537869|NCT02476201|80163580|FG000|Overall Study|Unsuccessful implant|1|||
27537870|NCT01332331|80163581|FG000|Overall Study|Lost to Follow-up|0|||
27537871|NCT01332331|80163582|FG001|Overall Study|Lost to Follow-up|1|||
27537872|NCT01332331|80163581|FG000|Overall Study|Adverse Event|1|||
27537873|NCT01332331|80163582|FG001|Overall Study|Adverse Event|1|||
27537874|NCT01332331|80163581|FG000|Overall Study|Physician Decision|1|||
27537875|NCT01332331|80163582|FG001|Overall Study|Physician Decision|0|||
27537876|NCT01952145|80163584|FG000|Overall Study|Protocol Violation|2|||
27537877|NCT01952145|80163585|FG001|Overall Study|Protocol Violation|1|||
27537878|NCT01952145|80163584|FG000|Overall Study|Death|0|||
27537879|NCT01952145|80163585|FG001|Overall Study|Death|1|||
27537880|NCT01952145|80163584|FG000|Overall Study|Adverse Event|9|||
27537881|NCT01952145|80163585|FG001|Overall Study|Adverse Event|0|||
27537882|NCT01952145|80163584|FG000|Overall Study|Withdrawal Criteria|16|||
27917059|NCT01089127|81533319|FG005|Overall Study|Abnormal test procedure result(s)|0|||
27537883|NCT01952145|80163585|FG001|Overall Study|Withdrawal Criteria|11|||
27537884|NCT01952145|80163584|FG000|Overall Study|Unclassified|1|||
27537885|NCT01952145|80163585|FG001|Overall Study|Unclassified|1|||
27632693|NCT02955069|80497451|FG000|Overall Study|Death|7|||
27917060|NCT01089127|81533314|FG000|Overall Study|Lost to Follow-up|1|||
27632694|NCT02955069|80497452|FG001|Overall Study|Death|3|||
27632695|NCT02955069|80497451|FG000|Overall Study|Physician Decision|10|||
27632696|NCT02955069|80497452|FG001|Overall Study|Physician Decision|2|||
27632697|NCT02955069|80497451|FG000|Overall Study|Progressive disease|64|||
27632698|NCT02955069|80497452|FG001|Overall Study|Progressive disease|13|||
27632699|NCT02955069|80497451|FG000|Overall Study|Study terminated by sponsor|4|||
27632700|NCT02955069|80497452|FG001|Overall Study|Study terminated by sponsor|0|||
27632701|NCT02955069|80497451|FG000|Overall Study|Subject/Guardian decision|3|||
27632702|NCT02955069|80497452|FG001|Overall Study|Subject/Guardian decision|1|||
27632703|NCT04340362|80497455|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
27632704|NCT00794118|80497456|FG000|Overall Study|Lost to Follow-up|16|||
27632705|NCT00794118|80497456|FG000|Overall Study|Withdrawal by Subject|9|||
27632706|NCT00794118|80497456|FG000|Overall Study|Changed hospital center|2|||
27632707|NCT02507752|80497458|FG000|Overall Study|Adverse Event|1|||
27632708|NCT02507752|80497458|FG000|Overall Study|Protocol Violation|6|||
27632709|NCT02507752|80497458|FG000|Overall Study|Lost to Follow-up|7|||
27632710|NCT02507752|80497458|FG000|Overall Study|Infusion reaction at first infusion|1|||
27632711|NCT02507752|80497458|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
27632712|NCT02507752|80497458|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
27537886|NCT04622306|80163604|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
27537887|NCT04622306|80163605|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
27632713|NCT02371746|80497459|FG000|Overall Study|Consent withdrawn|0|||
27632714|NCT02371746|80497460|FG001|Overall Study|Consent withdrawn|0|||
27632715|NCT02371746|80497461|FG002|Overall Study|Consent withdrawn|0|||
27632716|NCT02371746|80497462|FG003|Overall Study|Consent withdrawn|0|||
27632717|NCT02371746|80497463|FG004|Overall Study|Consent withdrawn|0|||
27632718|NCT02371746|80497464|FG005|Overall Study|Consent withdrawn|0|||
27632719|NCT02371746|80497465|FG006|Overall Study|Consent withdrawn|1|||
27632720|NCT02020616|80497466|FG000|Overall Study|Adverse Event|0|||
27632721|NCT02020616|80497467|FG001|Overall Study|Adverse Event|0|||
27632722|NCT02020616|80497468|FG002|Overall Study|Adverse Event|0|||
27632723|NCT02020616|80497469|FG003|Overall Study|Adverse Event|0|||
27632724|NCT02020616|80497470|FG004|Overall Study|Adverse Event|0|||
27632725|NCT02020616|80497471|FG005|Overall Study|Adverse Event|1|||
27632726|NCT02020616|80497472|FG006|Overall Study|Adverse Event|1|||
27537888|NCT04622306|80163606|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
27537889|NCT04622306|80163607|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
27537890|NCT04622306|80163608|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
27537891|NCT04622306|80163609|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
27537892|NCT04622306|80163604|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27537893|NCT04622306|80163605|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27537894|NCT04622306|80163606|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
27537895|NCT04622306|80163607|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
27537896|NCT04622306|80163608|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27537897|NCT04622306|80163609|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
27537898|NCT00004635|80163613|FG000|Period One|refused|2|||
27537899|NCT00004635|80163614|FG001|Period One|refused|1|||
27537900|NCT00004635|80163613|FG000|Period One|Withdrawal by Subject|1|||
27537901|NCT00004635|80163614|FG001|Period One|Withdrawal by Subject|1|||
27537902|NCT00004635|80163613|FG000|Period One|Protocol Violation|1|||
27537903|NCT00004635|80163614|FG001|Period One|Protocol Violation|0|||
27537904|NCT00004635|80163613|FG000|Period One|PSA did not go <5 ng/mL|1|||
27537905|NCT00004635|80163614|FG001|Period One|PSA did not go <5 ng/mL|0|||
27537906|NCT00004635|80163613|FG000|Period One|second malignancy|1|||
27537907|NCT00004635|80163614|FG001|Period One|second malignancy|0|||
27537908|NCT00004635|80163613|FG000|Period One|progressed|0|||
27537909|NCT00004635|80163614|FG001|Period One|progressed|2|||
27537910|NCT00004635|80163613|FG000|Period One|health problem|0|||
27537911|NCT00004635|80163614|FG001|Period One|health problem|1|||
27537912|NCT00004635|80163613|FG000|Period One|discrepancy in data entry|0|||
27537913|NCT00004635|80163614|FG001|Period One|discrepancy in data entry|1|||
27537914|NCT00004635|80163613|FG000|Period Two|progression|2|||
27537915|NCT00004635|80163614|FG001|Period Two|progression|3|||
27537916|NCT00004635|80163613|FG000|Period Two|Adverse Event|1|||
27537917|NCT00004635|80163614|FG001|Period Two|Adverse Event|0|||
27632727|NCT02020616|80497466|FG000|Overall Study|Physician Decision|0|||
27632728|NCT02020616|80497467|FG001|Overall Study|Physician Decision|0|||
27632729|NCT02020616|80497468|FG002|Overall Study|Physician Decision|0|||
27632730|NCT02020616|80497469|FG003|Overall Study|Physician Decision|0|||
27632731|NCT02020616|80497470|FG004|Overall Study|Physician Decision|0|||
27632732|NCT02020616|80497471|FG005|Overall Study|Physician Decision|1|||
27632733|NCT02020616|80497472|FG006|Overall Study|Physician Decision|2|||
27537918|NCT00004635|80163613|FG000|Period Two|refused|0|||
27537919|NCT00004635|80163614|FG001|Period Two|refused|2|||
27632734|NCT02020616|80497466|FG000|Overall Study|Withdrawal by Subject|0|||
27632735|NCT02020616|80497467|FG001|Overall Study|Withdrawal by Subject|0|||
27632736|NCT02020616|80497468|FG002|Overall Study|Withdrawal by Subject|1|||
27632737|NCT02020616|80497469|FG003|Overall Study|Withdrawal by Subject|0|||
27632738|NCT02020616|80497470|FG004|Overall Study|Withdrawal by Subject|0|||
27632739|NCT02020616|80497471|FG005|Overall Study|Withdrawal by Subject|1|||
27632740|NCT02020616|80497472|FG006|Overall Study|Withdrawal by Subject|1|||
27632741|NCT02020616|80497466|FG000|Overall Study|Lost to Follow-up|0|||
27739319|NCT04430348|80874054|FG000|Overall Study|Adverse Event|0|||
27739320|NCT04430348|80874055|FG001|Overall Study|Adverse Event|0|||
27739321|NCT04430348|80874056|FG002|Overall Study|Adverse Event|0|||
27537920|NCT00004635|80163613|FG000|Period Two|health problem|1|||
27537921|NCT00004635|80163614|FG001|Period Two|health problem|1|||
27739322|NCT04430348|80874057|FG003|Overall Study|Adverse Event|0|||
27739323|NCT04430348|80874058|FG004|Overall Study|Adverse Event|0|||
27739324|NCT04430348|80874059|FG005|Overall Study|Adverse Event|1|||
27739325|NCT04430348|80874054|FG000|Overall Study|Withdrawal by Subject|0|||
27739326|NCT04430348|80874055|FG001|Overall Study|Withdrawal by Subject|1|||
27739327|NCT04430348|80874056|FG002|Overall Study|Withdrawal by Subject|0|||
27537922|NCT00004635|80163613|FG000|Period Two|travel issues|0|||
27537923|NCT00004635|80163614|FG001|Period Two|travel issues|1|||
27537924|NCT00004635|80163613|FG000|Period Two|secondary malignancy|1|||
27537925|NCT00004635|80163614|FG001|Period Two|secondary malignancy|1|||
27537926|NCT00004635|80163613|FG000|Period Two|Lost to Follow-up|1|||
27537927|NCT00004635|80163614|FG001|Period Two|Lost to Follow-up|0|||
27537928|NCT00004635|80163613|FG000|Period Two|discrepancy in data entry|0|||
27537929|NCT00004635|80163614|FG001|Period Two|discrepancy in data entry|1|||
27537930|NCT00788073|80163617|FG000|STX209 Then Placebo|Adverse Event|1|||
27537931|NCT00788073|80163618|FG001|STX209 Then Placebo|Adverse Event|0|||
27537932|NCT00788073|80163617|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
27537933|NCT00788073|80163618|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
27537934|NCT00788073|80163617|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
27537935|NCT00788073|80163618|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
27537936|NCT00788073|80163617|FG000|STX209 Then Placebo|unable to return due to travel|0|||
27632742|NCT02020616|80497467|FG001|Overall Study|Lost to Follow-up|1|||
27739328|NCT04430348|80874057|FG003|Overall Study|Withdrawal by Subject|0|||
27739329|NCT04430348|80874058|FG004|Overall Study|Withdrawal by Subject|0|||
27739330|NCT04430348|80874059|FG005|Overall Study|Withdrawal by Subject|1|||
27739331|NCT04430348|80874054|FG000|Overall Study|Study Terminated by Sponsor|0|||
27739332|NCT04430348|80874055|FG001|Overall Study|Study Terminated by Sponsor|0|||
27739333|NCT04430348|80874056|FG002|Overall Study|Study Terminated by Sponsor|2|||
27739334|NCT04430348|80874057|FG003|Overall Study|Study Terminated by Sponsor|0|||
27739335|NCT04430348|80874058|FG004|Overall Study|Study Terminated by Sponsor|1|||
27739336|NCT04430348|80874059|FG005|Overall Study|Study Terminated by Sponsor|1|||
27739337|NCT00858832|80874063|FG000|Overall Study|became ineligible: delivered vaginally|1|||
27739338|NCT00858832|80874064|FG001|Overall Study|became ineligible: delivered vaginally|0|||
27739339|NCT00858832|80874063|FG000|Overall Study|Adverse Event|0|||
27739340|NCT00858832|80874064|FG001|Overall Study|Adverse Event|1|||
27739341|NCT00871858|80874065|FG000|Overall Study|Protocol Violation|3|||
27739342|NCT00871858|80874066|FG001|Overall Study|Protocol Violation|4|||
27739343|NCT00871858|80874065|FG000|Overall Study|Adverse Event|1|||
27739344|NCT00871858|80874066|FG001|Overall Study|Adverse Event|1|||
27739345|NCT00871858|80874065|FG000|Overall Study|Withdrawal by Subject|1|||
27739346|NCT00871858|80874066|FG001|Overall Study|Withdrawal by Subject|1|||
27739347|NCT00871858|80874065|FG000|Overall Study|Lost to Follow-up|0|||
27739348|NCT00871858|80874066|FG001|Overall Study|Lost to Follow-up|1|||
27739349|NCT01821963|80874067|FG000|Overall Study|Adverse Event|1|||
27739350|NCT01088412|80874068|FG000|Overall Study|Adverse Event|38|||
27739351|NCT01088412|80874069|FG001|Overall Study|Adverse Event|0|||
27739352|NCT01088412|80874070|FG002|Overall Study|Adverse Event|0|||
27739353|NCT01088412|80874068|FG000|Overall Study|Death|42|||
27739354|NCT01088412|80874069|FG001|Overall Study|Death|6|||
27739355|NCT01088412|80874070|FG002|Overall Study|Death|0|||
27739356|NCT01088412|80874068|FG000|Overall Study|Other Reason per Case Report Form|2089|||
27739357|NCT01088412|80874069|FG001|Overall Study|Other Reason per Case Report Form|103|||
27537937|NCT00788073|80163618|FG001|STX209 Then Placebo|unable to return due to travel|1|||
27537938|NCT00788073|80163617|FG000|Placebo Then STX209|Adverse Event|2|||
27537939|NCT00788073|80163618|FG001|Placebo Then STX209|Adverse Event|0|||
27537940|NCT00788073|80163617|FG000|Placebo Then STX209|Protocol Violation|0|||
27739358|NCT01088412|80874070|FG002|Overall Study|Other Reason per Case Report Form|9|||
27739359|NCT01088412|80874068|FG000|Overall Study|Withdrawal by Subject|1761|||
27739360|NCT01088412|80874069|FG001|Overall Study|Withdrawal by Subject|25|||
27739361|NCT01088412|80874070|FG002|Overall Study|Withdrawal by Subject|1|||
27537941|NCT00788073|80163618|FG001|Placebo Then STX209|Protocol Violation|1|||
27537942|NCT02949700|80163619|FG000|Phase I|Withdrawal by Subject|1|||
27537943|NCT02949700|80163620|FG001|Phase I|Withdrawal by Subject|1|||
27537944|NCT02949700|80163621|FG002|Phase I|Withdrawal by Subject|0|||
27632743|NCT02020616|80497468|FG002|Overall Study|Lost to Follow-up|0|||
27739362|NCT01088412|80874068|FG000|Overall Study|Received Another GH Product|79|||
27739363|NCT01088412|80874069|FG001|Overall Study|Received Another GH Product|0|||
27632744|NCT02020616|80497469|FG003|Overall Study|Lost to Follow-up|1|||
27632745|NCT02020616|80497470|FG004|Overall Study|Lost to Follow-up|1|||
27632746|NCT02020616|80497471|FG005|Overall Study|Lost to Follow-up|1|||
27632747|NCT02020616|80497472|FG006|Overall Study|Lost to Follow-up|0|||
27632748|NCT02020616|80497466|FG000|Overall Study|Early Termination Criteria Met|0|||
27632749|NCT02020616|80497467|FG001|Overall Study|Early Termination Criteria Met|0|||
27632750|NCT02020616|80497468|FG002|Overall Study|Early Termination Criteria Met|1|||
27632751|NCT02020616|80497469|FG003|Overall Study|Early Termination Criteria Met|0|||
27632752|NCT02020616|80497470|FG004|Overall Study|Early Termination Criteria Met|0|||
27632753|NCT02020616|80497471|FG005|Overall Study|Early Termination Criteria Met|1|||
27632754|NCT02020616|80497472|FG006|Overall Study|Early Termination Criteria Met|0|||
27632755|NCT02020616|80497466|FG000|Overall Study|Randomized in Error|0|||
27632756|NCT02020616|80497467|FG001|Overall Study|Randomized in Error|0|||
27632757|NCT02020616|80497468|FG002|Overall Study|Randomized in Error|0|||
27632758|NCT02020616|80497469|FG003|Overall Study|Randomized in Error|1|||
27632759|NCT02020616|80497470|FG004|Overall Study|Randomized in Error|0|||
27632760|NCT02020616|80497471|FG005|Overall Study|Randomized in Error|0|||
27537945|NCT02949700|80163622|FG003|Phase I|Withdrawal by Subject|0|||
27537946|NCT02949700|80163619|FG000|Phase I|Protocol Violation|1|||
27537947|NCT02949700|80163620|FG001|Phase I|Protocol Violation|0|||
27537948|NCT02949700|80163621|FG002|Phase I|Protocol Violation|0|||
27537949|NCT02949700|80163622|FG003|Phase I|Protocol Violation|0|||
27537950|NCT02949700|80163619|FG000|Phase II|Withdrawal by Subject|0|||
27537951|NCT02949700|80163620|FG001|Phase II|Withdrawal by Subject|0|||
27537952|NCT02949700|80163621|FG002|Phase II|Withdrawal by Subject|0|||
27537953|NCT02949700|80163622|FG003|Phase II|Withdrawal by Subject|2|||
27537954|NCT02949700|80163619|FG000|Phase II|Protocol Violation|0|||
27537955|NCT02949700|80163620|FG001|Phase II|Protocol Violation|0|||
27537956|NCT02949700|80163621|FG002|Phase II|Protocol Violation|1|||
27537957|NCT02949700|80163622|FG003|Phase II|Protocol Violation|3|||
27537958|NCT01811225|80163623|FG000|Treatment Period 1|Adverse Event|2|||
27537959|NCT01811225|80163624|FG001|Treatment Period 1|Adverse Event|3|||
27632761|NCT02020616|80497472|FG006|Overall Study|Randomized in Error|0|||
27632762|NCT02020616|80497466|FG000|Overall Study|Lack of Efficacy|0|||
27632763|NCT02020616|80497467|FG001|Overall Study|Lack of Efficacy|0|||
27632764|NCT02020616|80497468|FG002|Overall Study|Lack of Efficacy|0|||
27632765|NCT02020616|80497469|FG003|Overall Study|Lack of Efficacy|0|||
27632766|NCT02020616|80497470|FG004|Overall Study|Lack of Efficacy|1|||
27632767|NCT02020616|80497471|FG005|Overall Study|Lack of Efficacy|0|||
27632768|NCT02020616|80497472|FG006|Overall Study|Lack of Efficacy|0|||
27917061|NCT01089127|81533315|FG001|Overall Study|Lost to Follow-up|1|||
27537960|NCT01811225|80163623|FG000|Treatment Period 1|Lost to Follow-up|12|||
27537961|NCT01811225|80163624|FG001|Treatment Period 1|Lost to Follow-up|8|||
27537962|NCT01811225|80163623|FG000|Treatment Period 1|transporation|1|||
27537963|NCT01811225|80163624|FG001|Treatment Period 1|transporation|0|||
27537964|NCT01811225|80163623|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
27537965|NCT01811225|80163624|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
27537966|NCT01811225|80163623|FG000|Treatment Period 2|Lost to Follow-up|1|||
27537967|NCT01811225|80163624|FG001|Treatment Period 2|Lost to Follow-up|2|||
27537968|NCT01811225|80163623|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
27537969|NCT01811225|80163624|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
27537970|NCT00913380|80163626|FG000|Clinical Outcomes|Lost to Follow-up|6|||
27537971|NCT00913380|80163627|FG001|Clinical Outcomes|Lost to Follow-up|6|||
27537972|NCT03576495|80163628|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
27537973|NCT03576495|80163629|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
27537974|NCT03608254|80163630|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
27537975|NCT03608254|80163630|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
27537976|NCT01719783|80163631|FG000|Dose 2|Physician Decision|1|||
27917062|NCT01089127|81533316|FG002|Overall Study|Lost to Follow-up|0|||
27917063|NCT01089127|81533317|FG003|Overall Study|Lost to Follow-up|0|||
27537977|NCT01719783|80163632|FG001|Dose 2|Physician Decision|0|||
27537978|NCT00891462|80163633|FG000|Overall Study|Withdrawal by Subject|9|||
27537979|NCT00891462|80163634|FG001|Overall Study|Withdrawal by Subject|6|||
27632769|NCT01490086|80497473|FG000|Overall Study|Consent withdrawn|4|||
27632770|NCT01490086|80497474|FG001|Overall Study|Consent withdrawn|4|||
27632771|NCT01490086|80497475|FG002|Overall Study|Consent withdrawn|3|||
27632772|NCT01490086|80497476|FG003|Overall Study|Consent withdrawn|0|||
27632773|NCT01490086|80497477|FG004|Overall Study|Consent withdrawn|1|||
27632774|NCT01490086|80497473|FG000|Overall Study|Non-compliance|0|||
27537980|NCT00891462|80163635|FG002|Overall Study|Withdrawal by Subject|7|||
27537981|NCT00891462|80163633|FG000|Overall Study|Adverse Event|7|||
27537982|NCT00891462|80163634|FG001|Overall Study|Adverse Event|8|||
27537983|NCT00891462|80163635|FG002|Overall Study|Adverse Event|7|||
27632775|NCT01490086|80497474|FG001|Overall Study|Non-compliance|1|||
27632776|NCT01490086|80497475|FG002|Overall Study|Non-compliance|0|||
27632777|NCT01490086|80497476|FG003|Overall Study|Non-compliance|0|||
27632778|NCT01490086|80497477|FG004|Overall Study|Non-compliance|0|||
27917064|NCT01089127|81533318|FG004|Overall Study|Lost to Follow-up|1|||
27917065|NCT01089127|81533319|FG005|Overall Study|Lost to Follow-up|0|||
27537984|NCT00891462|80163633|FG000|Overall Study|Lack of Efficacy|10|||
27537985|NCT00891462|80163634|FG001|Overall Study|Lack of Efficacy|5|||
27537986|NCT00891462|80163635|FG002|Overall Study|Lack of Efficacy|1|||
27537987|NCT00891462|80163633|FG000|Overall Study|COPD exacerbation|7|||
27537988|NCT00891462|80163634|FG001|Overall Study|COPD exacerbation|4|||
27537989|NCT00891462|80163635|FG002|Overall Study|COPD exacerbation|1|||
27537990|NCT00891462|80163633|FG000|Overall Study|Other Reason|2|||
27537991|NCT00891462|80163634|FG001|Overall Study|Other Reason|5|||
27537992|NCT00891462|80163635|FG002|Overall Study|Other Reason|3|||
27537993|NCT00891462|80163633|FG000|Overall Study|Protocol Violation|2|||
27537994|NCT00891462|80163634|FG001|Overall Study|Protocol Violation|1|||
27537995|NCT00891462|80163635|FG002|Overall Study|Protocol Violation|3|||
27537996|NCT00891462|80163633|FG000|Overall Study|Inclusion/exclusion criteria|0|||
27537997|NCT00891462|80163634|FG001|Overall Study|Inclusion/exclusion criteria|2|||
27537998|NCT00891462|80163635|FG002|Overall Study|Inclusion/exclusion criteria|2|||
27537999|NCT00891462|80163633|FG000|Overall Study|Lost to Follow-up|0|||
27538000|NCT00891462|80163634|FG001|Overall Study|Lost to Follow-up|2|||
27538001|NCT00891462|80163635|FG002|Overall Study|Lost to Follow-up|0|||
27538002|NCT02925117|80163636|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
27538003|NCT02925117|80163637|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
27538004|NCT02925117|80163638|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
27538005|NCT02925117|80163639|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
27538006|NCT02925117|80163640|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538007|NCT02925117|80163641|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538008|NCT02925117|80163642|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538009|NCT02925117|80163643|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538010|NCT02925117|80163644|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538011|NCT02925117|80163645|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538012|NCT02925117|80163646|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27538013|NCT02925117|80163647|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
27632779|NCT01490086|80497473|FG000|Overall Study|Abnormal laboratory findings|1|||
27538014|NCT02925117|80163636|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
27538015|NCT02925117|80163637|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
27538016|NCT02925117|80163638|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
27538017|NCT02925117|80163639|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538018|NCT02925117|80163640|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538019|NCT02925117|80163641|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538020|NCT02925117|80163642|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538021|NCT02925117|80163643|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538022|NCT02925117|80163644|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538023|NCT02925117|80163645|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538024|NCT02925117|80163646|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538025|NCT02925117|80163647|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
27538026|NCT02925117|80163636|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
27538027|NCT02925117|80163637|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
27538028|NCT02925117|80163638|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538029|NCT02925117|80163639|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538030|NCT02925117|80163640|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538031|NCT02925117|80163641|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27632780|NCT01490086|80497474|FG001|Overall Study|Abnormal laboratory findings|0|||
27632781|NCT01490086|80497475|FG002|Overall Study|Abnormal laboratory findings|0|||
27632782|NCT01490086|80497476|FG003|Overall Study|Abnormal laboratory findings|0|||
27632783|NCT01490086|80497477|FG004|Overall Study|Abnormal laboratory findings|0|||
27632784|NCT01490086|80497473|FG000|Overall Study|Lost to Follow-up|0|||
27632785|NCT01490086|80497474|FG001|Overall Study|Lost to Follow-up|0|||
27632786|NCT01490086|80497475|FG002|Overall Study|Lost to Follow-up|0|||
27632787|NCT01490086|80497476|FG003|Overall Study|Lost to Follow-up|0|||
27632788|NCT01490086|80497477|FG004|Overall Study|Lost to Follow-up|1|||
27632789|NCT01490086|80497473|FG000|Overall Study|Physician Decision|3|||
27917066|NCT01089127|81533314|FG000|Overall Study|Protocol deviation|0|||
27538032|NCT02925117|80163642|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538033|NCT02925117|80163643|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538034|NCT02925117|80163644|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538035|NCT02925117|80163645|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27917067|NCT01089127|81533315|FG001|Overall Study|Protocol deviation|1|||
27917068|NCT01089127|81533316|FG002|Overall Study|Protocol deviation|0|||
27632790|NCT01490086|80497474|FG001|Overall Study|Physician Decision|4|||
27917069|NCT01089127|81533317|FG003|Overall Study|Protocol deviation|0|||
27538036|NCT02925117|80163646|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27632791|NCT01490086|80497475|FG002|Overall Study|Physician Decision|2|||
27538037|NCT02925117|80163647|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
27538038|NCT02925117|80163636|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
27538039|NCT02925117|80163637|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
27538040|NCT02925117|80163638|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
27739364|NCT01088412|80874070|FG002|Overall Study|Received Another GH Product|0|||
27632792|NCT01490086|80497476|FG003|Overall Study|Physician Decision|3|||
27632793|NCT01490086|80497477|FG004|Overall Study|Physician Decision|1|||
27632794|NCT01490086|80497473|FG000|Overall Study|Adverse Event|0|||
27632795|NCT01490086|80497474|FG001|Overall Study|Adverse Event|0|||
27632796|NCT01490086|80497475|FG002|Overall Study|Adverse Event|1|||
27632797|NCT01490086|80497476|FG003|Overall Study|Adverse Event|2|||
27632798|NCT01490086|80497477|FG004|Overall Study|Adverse Event|0|||
27632799|NCT01490086|80497473|FG000|Overall Study|Lack of Efficacy|0|||
27632800|NCT01490086|80497474|FG001|Overall Study|Lack of Efficacy|3|||
27632801|NCT01490086|80497475|FG002|Overall Study|Lack of Efficacy|1|||
27632802|NCT01490086|80497476|FG003|Overall Study|Lack of Efficacy|0|||
27632803|NCT01490086|80497477|FG004|Overall Study|Lack of Efficacy|8|||
27632804|NCT01490086|80497473|FG000|Overall Study|Worsening of symptoms|0|||
27632805|NCT01490086|80497474|FG001|Overall Study|Worsening of symptoms|1|||
27739365|NCT01088412|80874068|FG000|Overall Study|Participant Moved|601|||
27739366|NCT01088412|80874069|FG001|Overall Study|Participant Moved|21|||
27739367|NCT01088412|80874070|FG002|Overall Study|Participant Moved|2|||
27739368|NCT01088412|80874068|FG000|Overall Study|Physician Decision|1041|||
27739369|NCT01088412|80874069|FG001|Overall Study|Physician Decision|8|||
27739370|NCT01088412|80874070|FG002|Overall Study|Physician Decision|4|||
27739371|NCT01088412|80874068|FG000|Overall Study|Sponsor Decision|4467|||
27739372|NCT01088412|80874069|FG001|Overall Study|Sponsor Decision|79|||
27739373|NCT01088412|80874070|FG002|Overall Study|Sponsor Decision|23|||
27739374|NCT01088412|80874068|FG000|Overall Study|Third Party Required to Change Brand|487|||
27739375|NCT01088412|80874069|FG001|Overall Study|Third Party Required to Change Brand|0|||
27739376|NCT01088412|80874070|FG002|Overall Study|Third Party Required to Change Brand|0|||
27739377|NCT01088412|80874068|FG000|Overall Study|Lost to Follow-up|3052|||
27739378|NCT01088412|80874069|FG001|Overall Study|Lost to Follow-up|130|||
27739379|NCT01088412|80874070|FG002|Overall Study|Lost to Follow-up|11|||
27917070|NCT01089127|81533318|FG004|Overall Study|Protocol deviation|1|||
27917071|NCT01089127|81533319|FG005|Overall Study|Protocol deviation|0|||
27739380|NCT01088412|80874068|FG000|Overall Study|Study Summary Not Completed|4360|||
27739381|NCT01088412|80874069|FG001|Overall Study|Study Summary Not Completed|64|||
27739382|NCT01088412|80874070|FG002|Overall Study|Study Summary Not Completed|22|||
27739383|NCT04723537|80874077|FG000|Overall Study|Withdrawal by Subject|3|||
27739384|NCT04723537|80874078|FG001|Overall Study|Withdrawal by Subject|0|||
27739385|NCT04723537|80874079|FG002|Overall Study|Withdrawal by Subject|0|||
27739386|NCT04723537|80874077|FG000|Overall Study|Physician Decision|0|||
27739387|NCT04723537|80874078|FG001|Overall Study|Physician Decision|0|||
27739388|NCT04723537|80874079|FG002|Overall Study|Physician Decision|1|||
27739389|NCT04723537|80874077|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
27739390|NCT04723537|80874078|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
27739391|NCT04723537|80874079|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
27739392|NCT03167619|80874080|FG000|Overall Study|Death|11|||
27739393|NCT03167619|80874081|FG001|Overall Study|Death|8|||
27739394|NCT03167619|80874080|FG000|Overall Study|Withdrawal by Subject|1|||
27739395|NCT03167619|80874081|FG001|Overall Study|Withdrawal by Subject|2|||
27917072|NCT04805671|81533320|FG000|Overall Study|Death|2|||
27917073|NCT04805671|81533321|FG001|Overall Study|Death|7|||
27917074|NCT04805671|81533320|FG000|Overall Study|Lost to Follow-up|1|||
27917075|NCT04805671|81533321|FG001|Overall Study|Lost to Follow-up|0|||
27917076|NCT04805671|81533320|FG000|Overall Study|Withdrawal by Subject|9|||
27917077|NCT04805671|81533321|FG001|Overall Study|Withdrawal by Subject|7|||
27538041|NCT02925117|80163639|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
27538042|NCT02925117|80163640|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
27538043|NCT02925117|80163641|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
27538044|NCT02925117|80163642|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
27538045|NCT02925117|80163643|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
27538046|NCT02925117|80163644|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
27538047|NCT02925117|80163645|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
27538048|NCT02925117|80163646|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
27538049|NCT02925117|80163647|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
27739396|NCT03167619|80874080|FG000|Overall Study|Physician Decision|0|||
27739397|NCT03167619|80874081|FG001|Overall Study|Physician Decision|1|||
27917078|NCT04805671|81533320|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
27917079|NCT04805671|81533321|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
27917080|NCT01065818|81533327|FG000|Overall Study|Withdrawal by Subject|1|||
27917081|NCT01065818|81533327|FG000|Overall Study|Not a candidate for surgery|1|||
27538050|NCT02925117|80163636|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538051|NCT02925117|80163637|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27632806|NCT01490086|80497475|FG002|Overall Study|Worsening of symptoms|0|||
27632807|NCT01490086|80497476|FG003|Overall Study|Worsening of symptoms|1|||
27917082|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
27538052|NCT02925117|80163638|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27632808|NCT01490086|80497477|FG004|Overall Study|Worsening of symptoms|0|||
27538053|NCT02925117|80163639|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538054|NCT02925117|80163640|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538055|NCT02925117|80163641|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
27538056|NCT02925117|80163642|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538057|NCT02925117|80163643|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538058|NCT02925117|80163644|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538059|NCT02925117|80163645|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
27538060|NCT02925117|80163646|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
27538061|NCT02925117|80163647|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
27538062|NCT02925117|80163636|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
27538063|NCT02925117|80163637|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
27538064|NCT02925117|80163638|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
27538065|NCT02925117|80163639|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
27538066|NCT02925117|80163640|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
27538067|NCT02925117|80163641|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
27538068|NCT02925117|80163642|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
27538069|NCT02925117|80163643|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
27538070|NCT02925117|80163644|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
27538071|NCT02925117|80163645|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
27538072|NCT02925117|80163646|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
27538073|NCT02925117|80163647|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
27538074|NCT02925117|80163636|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
27538075|NCT02925117|80163637|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
27538076|NCT02925117|80163638|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
27538077|NCT02925117|80163639|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
27538078|NCT02925117|80163640|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
27538079|NCT02925117|80163641|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
27538080|NCT02925117|80163642|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
27538081|NCT02925117|80163643|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
27538082|NCT02925117|80163644|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
27538083|NCT02925117|80163645|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
27538084|NCT02925117|80163646|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
27538085|NCT02925117|80163647|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
27538086|NCT02925117|80163636|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
27538087|NCT02925117|80163637|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
27538088|NCT02925117|80163638|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
27538089|NCT02925117|80163639|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
27538090|NCT02925117|80163640|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
27538091|NCT02925117|80163641|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
27538092|NCT02925117|80163642|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
27538093|NCT02925117|80163643|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
27632809|NCT01490086|80497473|FG000|Overall Study|Subject uncontrollable and abusive|0|||
27632810|NCT01490086|80497474|FG001|Overall Study|Subject uncontrollable and abusive|1|||
27632811|NCT01490086|80497475|FG002|Overall Study|Subject uncontrollable and abusive|0|||
27632812|NCT01490086|80497476|FG003|Overall Study|Subject uncontrollable and abusive|0|||
27632813|NCT01490086|80497477|FG004|Overall Study|Subject uncontrollable and abusive|0|||
27632814|NCT01490086|80497473|FG000|Overall Study|Subject left hospital|0|||
27632815|NCT01490086|80497474|FG001|Overall Study|Subject left hospital|1|||
27632816|NCT01490086|80497475|FG002|Overall Study|Subject left hospital|0|||
27632817|NCT01490086|80497476|FG003|Overall Study|Subject left hospital|1|||
27632818|NCT01490086|80497477|FG004|Overall Study|Subject left hospital|0|||
27632819|NCT02001623|80497478|FG000|Overall Study|Disease Progression|2|||
27632820|NCT02001623|80497479|FG001|Overall Study|Disease Progression|2|||
27632821|NCT02001623|80497480|FG002|Overall Study|Disease Progression|3|||
27632822|NCT02001623|80497481|FG003|Overall Study|Disease Progression|2|||
27632823|NCT02001623|80497482|FG004|Overall Study|Disease Progression|3|||
27632824|NCT02001623|80497483|FG005|Overall Study|Disease Progression|2|||
27632825|NCT02001623|80497484|FG006|Overall Study|Disease Progression|3|||
27632826|NCT02001623|80497485|FG007|Overall Study|Disease Progression|3|||
27632827|NCT02001623|80497486|FG008|Overall Study|Disease Progression|7|||
27632828|NCT02001623|80497487|FG009|Overall Study|Disease Progression|40|||
27632829|NCT02001623|80497488|FG010|Overall Study|Disease Progression|5|||
27632830|NCT02001623|80497489|FG011|Overall Study|Disease Progression|9|||
27632831|NCT02001623|80497490|FG012|Overall Study|Disease Progression|9|||
27632832|NCT02001623|80497491|FG013|Overall Study|Disease Progression|20|||
27538094|NCT02925117|80163644|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
27538095|NCT02925117|80163645|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
27538096|NCT02925117|80163646|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
27538097|NCT02925117|80163647|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
27538098|NCT03758443|80163648|FG000|Induction Period|Adverse Event|2|||
27538099|NCT03758443|80163649|FG001|Induction Period|Adverse Event|4|||
27632833|NCT02001623|80497492|FG014|Overall Study|Disease Progression|9|||
27632834|NCT02001623|80497478|FG000|Overall Study|Physician Decision|0|||
27632835|NCT02001623|80497479|FG001|Overall Study|Physician Decision|0|||
27632836|NCT02001623|80497480|FG002|Overall Study|Physician Decision|0|||
27538100|NCT03758443|80163650|FG002|Induction Period|Adverse Event|2|||
27538101|NCT03758443|80163651|FG003|Induction Period|Adverse Event|3|||
27538102|NCT03758443|80163648|FG000|Induction Period|Physician Decision|1|||
27538103|NCT03758443|80163649|FG001|Induction Period|Physician Decision|1|||
27538104|NCT03758443|80163650|FG002|Induction Period|Physician Decision|3|||
27538105|NCT03758443|80163651|FG003|Induction Period|Physician Decision|0|||
27538106|NCT03758443|80163648|FG000|Induction Period|Protocol Violation|0|||
27632837|NCT02001623|80497481|FG003|Overall Study|Physician Decision|0|||
27632838|NCT02001623|80497482|FG004|Overall Study|Physician Decision|0|||
27632839|NCT02001623|80497483|FG005|Overall Study|Physician Decision|0|||
27632840|NCT02001623|80497484|FG006|Overall Study|Physician Decision|0|||
27632841|NCT02001623|80497485|FG007|Overall Study|Physician Decision|0|||
27632842|NCT02001623|80497486|FG008|Overall Study|Physician Decision|3|||
27538107|NCT03758443|80163649|FG001|Induction Period|Protocol Violation|0|||
27538108|NCT03758443|80163650|FG002|Induction Period|Protocol Violation|0|||
27538109|NCT03758443|80163651|FG003|Induction Period|Protocol Violation|1|||
27538110|NCT03758443|80163648|FG000|Induction Period|Withdrawal by Subject|3|||
27538111|NCT03758443|80163649|FG001|Induction Period|Withdrawal by Subject|2|||
27538112|NCT03758443|80163650|FG002|Induction Period|Withdrawal by Subject|2|||
27538113|NCT03758443|80163651|FG003|Induction Period|Withdrawal by Subject|4|||
27538114|NCT03758443|80163648|FG000|Extended Induction Period|Adverse Event|1|||
27538115|NCT03758443|80163649|FG001|Extended Induction Period|Adverse Event|1|||
27538116|NCT03758443|80163650|FG002|Extended Induction Period|Adverse Event|0|||
27538117|NCT03758443|80163651|FG003|Extended Induction Period|Adverse Event|1|||
27538118|NCT03758443|80163648|FG000|Extended Induction Period|Lost to Follow-up|1|||
27538119|NCT03758443|80163649|FG001|Extended Induction Period|Lost to Follow-up|0|||
27538120|NCT03758443|80163650|FG002|Extended Induction Period|Lost to Follow-up|0|||
27538121|NCT03758443|80163651|FG003|Extended Induction Period|Lost to Follow-up|0|||
27632843|NCT02001623|80497487|FG009|Overall Study|Physician Decision|2|||
27632844|NCT02001623|80497488|FG010|Overall Study|Physician Decision|3|||
27632845|NCT02001623|80497489|FG011|Overall Study|Physician Decision|3|||
27632846|NCT02001623|80497490|FG012|Overall Study|Physician Decision|1|||
27632847|NCT02001623|80497491|FG013|Overall Study|Physician Decision|2|||
27632848|NCT02001623|80497492|FG014|Overall Study|Physician Decision|1|||
27632849|NCT02001623|80497478|FG000|Overall Study|Death|0|||
27632850|NCT02001623|80497479|FG001|Overall Study|Death|1|||
27632851|NCT02001623|80497480|FG002|Overall Study|Death|0|||
27632852|NCT02001623|80497481|FG003|Overall Study|Death|0|||
27632853|NCT02001623|80497482|FG004|Overall Study|Death|0|||
27632854|NCT02001623|80497483|FG005|Overall Study|Death|0|||
27632855|NCT02001623|80497484|FG006|Overall Study|Death|0|||
27632856|NCT02001623|80497485|FG007|Overall Study|Death|0|||
27632857|NCT02001623|80497486|FG008|Overall Study|Death|0|||
27632858|NCT02001623|80497487|FG009|Overall Study|Death|0|||
27632859|NCT02001623|80497488|FG010|Overall Study|Death|0|||
27632860|NCT02001623|80497489|FG011|Overall Study|Death|0|||
27632861|NCT02001623|80497490|FG012|Overall Study|Death|0|||
27632862|NCT02001623|80497491|FG013|Overall Study|Death|0|||
27632863|NCT02001623|80497492|FG014|Overall Study|Death|0|||
27632864|NCT02001623|80497478|FG000|Overall Study|Adverse Event|0|||
27632865|NCT02001623|80497479|FG001|Overall Study|Adverse Event|0|||
27632866|NCT02001623|80497480|FG002|Overall Study|Adverse Event|0|||
27632867|NCT02001623|80497481|FG003|Overall Study|Adverse Event|0|||
27632868|NCT02001623|80497482|FG004|Overall Study|Adverse Event|0|||
27632869|NCT02001623|80497483|FG005|Overall Study|Adverse Event|1|||
27632870|NCT02001623|80497484|FG006|Overall Study|Adverse Event|0|||
27632871|NCT02001623|80497485|FG007|Overall Study|Adverse Event|3|||
27632872|NCT02001623|80497486|FG008|Overall Study|Adverse Event|4|||
27632873|NCT02001623|80497487|FG009|Overall Study|Adverse Event|6|||
27632874|NCT02001623|80497488|FG010|Overall Study|Adverse Event|4|||
27632875|NCT02001623|80497489|FG011|Overall Study|Adverse Event|0|||
27632876|NCT02001623|80497490|FG012|Overall Study|Adverse Event|3|||
27632877|NCT02001623|80497491|FG013|Overall Study|Adverse Event|5|||
27739398|NCT05421754|80874084|FG000|Overall Study|Technical issue with sensor|1|||
27917083|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27917084|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27538122|NCT03758443|80163648|FG000|Extended Induction Period|Physician Decision|2|||
27538123|NCT03758443|80163649|FG001|Extended Induction Period|Physician Decision|1|||
27632878|NCT02001623|80497492|FG014|Overall Study|Adverse Event|6|||
27632879|NCT02001623|80497478|FG000|Overall Study|Other - Miscellaneous|0|||
27632880|NCT02001623|80497479|FG001|Overall Study|Other - Miscellaneous|0|||
27632881|NCT02001623|80497480|FG002|Overall Study|Other - Miscellaneous|0|||
27739399|NCT00393458|80874085|FG000|Overall Study|Adverse Event|35|||
27739400|NCT00393458|80874086|FG001|Overall Study|Adverse Event|24|||
27538124|NCT03758443|80163650|FG002|Extended Induction Period|Physician Decision|2|||
27538125|NCT03758443|80163651|FG003|Extended Induction Period|Physician Decision|2|||
27538126|NCT03758443|80163648|FG000|Extended Induction Period|Protocol Violation|0|||
27632882|NCT02001623|80497481|FG003|Overall Study|Other - Miscellaneous|0|||
27632883|NCT02001623|80497482|FG004|Overall Study|Other - Miscellaneous|0|||
27632884|NCT02001623|80497483|FG005|Overall Study|Other - Miscellaneous|0|||
27632885|NCT02001623|80497484|FG006|Overall Study|Other - Miscellaneous|0|||
27632886|NCT02001623|80497485|FG007|Overall Study|Other - Miscellaneous|0|||
27632887|NCT02001623|80497486|FG008|Overall Study|Other - Miscellaneous|0|||
27632888|NCT02001623|80497487|FG009|Overall Study|Other - Miscellaneous|1|||
27632889|NCT02001623|80497488|FG010|Overall Study|Other - Miscellaneous|0|||
27632890|NCT02001623|80497489|FG011|Overall Study|Other - Miscellaneous|0|||
27632891|NCT02001623|80497490|FG012|Overall Study|Other - Miscellaneous|0|||
27632892|NCT02001623|80497491|FG013|Overall Study|Other - Miscellaneous|1|||
27632893|NCT02001623|80497492|FG014|Overall Study|Other - Miscellaneous|0|||
27538127|NCT03758443|80163649|FG001|Extended Induction Period|Protocol Violation|0|||
27538128|NCT03758443|80163650|FG002|Extended Induction Period|Protocol Violation|0|||
27538129|NCT03758443|80163651|FG003|Extended Induction Period|Protocol Violation|1|||
27538130|NCT03758443|80163648|FG000|Extended Induction Period|Withdrawal by Subject|8|||
27538131|NCT03758443|80163649|FG001|Extended Induction Period|Withdrawal by Subject|1|||
27538132|NCT03758443|80163650|FG002|Extended Induction Period|Withdrawal by Subject|7|||
27538133|NCT03758443|80163651|FG003|Extended Induction Period|Withdrawal by Subject|3|||
27538134|NCT03758443|80163648|FG000|Extended Induction Period|Miscellaneous|1|||
27538135|NCT03758443|80163649|FG001|Extended Induction Period|Miscellaneous|0|||
27538136|NCT03758443|80163650|FG002|Extended Induction Period|Miscellaneous|0|||
27538137|NCT03758443|80163651|FG003|Extended Induction Period|Miscellaneous|0|||
27538138|NCT03758443|80163648|FG000|Maintenance Period|Adverse Event|1|||
27538139|NCT03758443|80163649|FG001|Maintenance Period|Adverse Event|2|||
27538140|NCT03758443|80163650|FG002|Maintenance Period|Adverse Event|0|||
27538141|NCT03758443|80163651|FG003|Maintenance Period|Adverse Event|0|||
27538142|NCT03758443|80163648|FG000|Maintenance Period|Lost to Follow-up|0|||
27538143|NCT03758443|80163649|FG001|Maintenance Period|Lost to Follow-up|0|||
27538144|NCT03758443|80163650|FG002|Maintenance Period|Lost to Follow-up|0|||
27538145|NCT03758443|80163651|FG003|Maintenance Period|Lost to Follow-up|1|||
27538146|NCT03758443|80163648|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
27538147|NCT03758443|80163649|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
27538148|NCT03758443|80163650|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
27538149|NCT03758443|80163651|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
27632894|NCT02001623|80497478|FG000|Overall Study|Withdrawal by Subject|1|||
27739401|NCT00393458|80874087|FG002|Overall Study|Adverse Event|40|||
27917085|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27917086|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27917087|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27917088|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
27917089|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
27917090|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27917091|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27917092|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27917093|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27917094|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27917095|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
27917096|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27917097|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
27917098|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27917099|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27917100|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27917101|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27917102|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
27917103|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27917104|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27917105|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
27917106|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27917107|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27917108|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27917109|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
27917110|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27917111|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27917112|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
27538150|NCT03758443|80163648|FG000|Maintenance Period|Protocol Violation|0|||
27632895|NCT02001623|80497479|FG001|Overall Study|Withdrawal by Subject|0|||
27632896|NCT02001623|80497480|FG002|Overall Study|Withdrawal by Subject|0|||
27632897|NCT02001623|80497481|FG003|Overall Study|Withdrawal by Subject|0|||
27632898|NCT02001623|80497482|FG004|Overall Study|Withdrawal by Subject|0|||
27538151|NCT03758443|80163649|FG001|Maintenance Period|Protocol Violation|1|||
27538152|NCT03758443|80163650|FG002|Maintenance Period|Protocol Violation|0|||
27538153|NCT03758443|80163651|FG003|Maintenance Period|Protocol Violation|0|||
27538154|NCT03758443|80163648|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
27538155|NCT03758443|80163649|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
27538156|NCT03758443|80163650|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
27538157|NCT03758443|80163651|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
27538158|NCT03758443|80163648|FG000|Maintenance Period|Withdrawal by Subject|1|||
27538159|NCT03758443|80163649|FG001|Maintenance Period|Withdrawal by Subject|0|||
27538160|NCT03758443|80163650|FG002|Maintenance Period|Withdrawal by Subject|1|||
27538161|NCT03758443|80163651|FG003|Maintenance Period|Withdrawal by Subject|1|||
27538162|NCT03758443|80163648|FG000|Maintenance Period|Miscellaneous|0|||
27538163|NCT03758443|80163649|FG001|Maintenance Period|Miscellaneous|0|||
27538164|NCT03758443|80163650|FG002|Maintenance Period|Miscellaneous|1|||
27538165|NCT03758443|80163651|FG003|Maintenance Period|Miscellaneous|0|||
27538166|NCT02959983|80163654|FG000|Overall Study|Protocol Violation|0|||
27538167|NCT02959983|80163655|FG001|Overall Study|Protocol Violation|1|||
27538168|NCT02959983|80163654|FG000|Overall Study|Lack of Efficacy|0|||
27538169|NCT02959983|80163655|FG001|Overall Study|Lack of Efficacy|1|||
27538170|NCT02959983|80163654|FG000|Overall Study|Lost to Follow-up|12|||
27538171|NCT02959983|80163655|FG001|Overall Study|Lost to Follow-up|9|||
27538172|NCT02959983|80163654|FG000|Overall Study|Other|1|||
27538173|NCT02959983|80163655|FG001|Overall Study|Other|1|||
27538174|NCT02959983|80163654|FG000|Overall Study|Physician Decision|1|||
27538175|NCT02959983|80163655|FG001|Overall Study|Physician Decision|0|||
27538176|NCT02959983|80163654|FG000|Overall Study|Adverse Event|5|||
27538177|NCT02959983|80163655|FG001|Overall Study|Adverse Event|1|||
27538178|NCT02959983|80163654|FG000|Overall Study|Withdrawal by Subject|7|||
27538179|NCT02959983|80163655|FG001|Overall Study|Withdrawal by Subject|12|||
27538180|NCT03822182|80163656|FG000|Overall Study|Protocol Violation|0|||
27538181|NCT03822182|80163657|FG001|Overall Study|Protocol Violation|1|||
27538182|NCT03822182|80163658|FG002|Overall Study|Protocol Violation|1|||
27538183|NCT04295772|80163663|FG000|Overall Study|Protocol Violation|1|||
27538184|NCT04295772|80163664|FG001|Overall Study|Protocol Violation|0|||
27538185|NCT04295772|80163663|FG000|Overall Study|Ongoing for safety monitoring|14|||
27538186|NCT04295772|80163664|FG001|Overall Study|Ongoing for safety monitoring|1|||
27538187|NCT04295772|80163663|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
27538188|NCT04295772|80163664|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
27538189|NCT03846804|80163665|FG000|Overall Study|Refused blood draw|1|||
27538190|NCT03846804|80163665|FG000|Overall Study|Protocol Violation|1|||
27538191|NCT00657358|80163669|FG000|Overall Study|Lack of Efficacy|6|||
27538192|NCT00785928|80163672|FG000|Treatment Phase|Adverse Event|1|||
27538193|NCT00785928|80163673|FG001|Treatment Phase|Adverse Event|1|||
27538194|NCT00785928|80163674|FG002|Treatment Phase|Adverse Event|2|||
27538195|NCT00785928|80163675|FG003|Treatment Phase|Adverse Event|0|||
27538196|NCT00785928|80163676|FG004|Treatment Phase|Adverse Event|0|||
27538197|NCT00785928|80163677|FG005|Treatment Phase|Adverse Event|0|||
27538198|NCT00785928|80163678|FG006|Treatment Phase|Adverse Event|2|||
27538199|NCT00785928|80163672|FG000|Treatment Phase|Inadequate Response|0|||
27538200|NCT00785928|80163673|FG001|Treatment Phase|Inadequate Response|1|||
27538201|NCT00785928|80163674|FG002|Treatment Phase|Inadequate Response|0|||
27538202|NCT00785928|80163675|FG003|Treatment Phase|Inadequate Response|0|||
27538203|NCT00785928|80163676|FG004|Treatment Phase|Inadequate Response|0|||
27538204|NCT00785928|80163677|FG005|Treatment Phase|Inadequate Response|0|||
27538205|NCT00785928|80163678|FG006|Treatment Phase|Inadequate Response|0|||
27538206|NCT00785928|80163672|FG000|Treatment Phase|Lack of Efficacy|0|||
27538207|NCT00785928|80163673|FG001|Treatment Phase|Lack of Efficacy|1|||
27538208|NCT00785928|80163674|FG002|Treatment Phase|Lack of Efficacy|1|||
27538209|NCT00785928|80163675|FG003|Treatment Phase|Lack of Efficacy|0|||
27538210|NCT00785928|80163676|FG004|Treatment Phase|Lack of Efficacy|0|||
27538211|NCT00785928|80163677|FG005|Treatment Phase|Lack of Efficacy|0|||
27538212|NCT00785928|80163678|FG006|Treatment Phase|Lack of Efficacy|0|||
27538213|NCT00785928|80163672|FG000|Treatment Phase|Physician Decision|0|||
27538214|NCT00785928|80163673|FG001|Treatment Phase|Physician Decision|0|||
27538215|NCT00785928|80163674|FG002|Treatment Phase|Physician Decision|0|||
27538216|NCT00785928|80163675|FG003|Treatment Phase|Physician Decision|0|||
27538217|NCT00785928|80163676|FG004|Treatment Phase|Physician Decision|1|||
27538218|NCT00785928|80163677|FG005|Treatment Phase|Physician Decision|0|||
27917113|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27538219|NCT00785928|80163678|FG006|Treatment Phase|Physician Decision|0|||
27538220|NCT00785928|80163672|FG000|Treatment Phase|Sponsor Decision|1|||
27538221|NCT00785928|80163673|FG001|Treatment Phase|Sponsor Decision|0|||
27538222|NCT00785928|80163674|FG002|Treatment Phase|Sponsor Decision|0|||
27538223|NCT00785928|80163675|FG003|Treatment Phase|Sponsor Decision|0|||
27538224|NCT00785928|80163676|FG004|Treatment Phase|Sponsor Decision|0|||
27538225|NCT00785928|80163677|FG005|Treatment Phase|Sponsor Decision|0|||
27538226|NCT00785928|80163678|FG006|Treatment Phase|Sponsor Decision|1|||
27538227|NCT00785928|80163672|FG000|Treatment Phase|Withdrawal by Subject|1|||
27917114|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27917115|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27917116|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
27917117|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27917118|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27917119|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
27917120|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27917121|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27917122|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27917123|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
27917124|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27917125|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27917126|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27917127|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
27917128|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27917129|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27917130|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
27917131|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27917132|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27917133|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27917134|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
27917135|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27917136|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27917137|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
27917138|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27917139|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27917140|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27917141|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27917142|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
27917143|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27917144|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
27917145|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27917146|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27917147|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27917148|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27917149|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
27917150|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27917151|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
27917152|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27917153|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27917154|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27917155|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27917156|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
27917157|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27917158|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
27917159|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27917160|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27917161|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27538228|NCT00785928|80163673|FG001|Treatment Phase|Withdrawal by Subject|2|||
27739402|NCT00393458|80874088|FG003|Overall Study|Adverse Event|35|||
27917162|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27917163|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
27917164|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27917165|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
27917166|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27917167|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27917168|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27917169|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27917170|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27538229|NCT00785928|80163674|FG002|Treatment Phase|Withdrawal by Subject|0|||
27538230|NCT00785928|80163675|FG003|Treatment Phase|Withdrawal by Subject|0|||
27538231|NCT00785928|80163676|FG004|Treatment Phase|Withdrawal by Subject|1|||
27538232|NCT00785928|80163677|FG005|Treatment Phase|Withdrawal by Subject|0|||
27538233|NCT00785928|80163678|FG006|Treatment Phase|Withdrawal by Subject|0|||
27538234|NCT03208127|80163679|FG000|Overall Study|Death|1|||
27538235|NCT02436304|80163682|FG000|Overall Study|Lost to Follow-up|0|||
27632899|NCT02001623|80497483|FG005|Overall Study|Withdrawal by Subject|0|||
27632900|NCT02001623|80497484|FG006|Overall Study|Withdrawal by Subject|0|||
27632901|NCT02001623|80497485|FG007|Overall Study|Withdrawal by Subject|0|||
27632902|NCT02001623|80497486|FG008|Overall Study|Withdrawal by Subject|1|||
27632903|NCT02001623|80497487|FG009|Overall Study|Withdrawal by Subject|3|||
27632904|NCT02001623|80497488|FG010|Overall Study|Withdrawal by Subject|2|||
27632905|NCT02001623|80497489|FG011|Overall Study|Withdrawal by Subject|2|||
27632906|NCT02001623|80497490|FG012|Overall Study|Withdrawal by Subject|1|||
27632907|NCT02001623|80497491|FG013|Overall Study|Withdrawal by Subject|5|||
27632908|NCT02001623|80497492|FG014|Overall Study|Withdrawal by Subject|2|||
27632909|NCT02001623|80497478|FG000|Overall Study|Lost to Follow-up|0|||
27632910|NCT02001623|80497479|FG001|Overall Study|Lost to Follow-up|0|||
27632911|NCT02001623|80497480|FG002|Overall Study|Lost to Follow-up|0|||
27632912|NCT02001623|80497481|FG003|Overall Study|Lost to Follow-up|0|||
27632913|NCT02001623|80497482|FG004|Overall Study|Lost to Follow-up|0|||
27632914|NCT02001623|80497483|FG005|Overall Study|Lost to Follow-up|0|||
27632915|NCT02001623|80497484|FG006|Overall Study|Lost to Follow-up|0|||
27632916|NCT02001623|80497485|FG007|Overall Study|Lost to Follow-up|0|||
27632917|NCT02001623|80497486|FG008|Overall Study|Lost to Follow-up|0|||
27632918|NCT02001623|80497487|FG009|Overall Study|Lost to Follow-up|1|||
27632919|NCT02001623|80497488|FG010|Overall Study|Lost to Follow-up|0|||
27632920|NCT02001623|80497489|FG011|Overall Study|Lost to Follow-up|0|||
27632921|NCT02001623|80497490|FG012|Overall Study|Lost to Follow-up|0|||
27632922|NCT02001623|80497491|FG013|Overall Study|Lost to Follow-up|0|||
27632923|NCT02001623|80497492|FG014|Overall Study|Lost to Follow-up|0|||
27632924|NCT02001623|80497478|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
27632925|NCT02001623|80497479|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
27632926|NCT02001623|80497480|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
27632927|NCT02001623|80497481|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
27632928|NCT02001623|80497482|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
27632929|NCT02001623|80497483|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
27632930|NCT02001623|80497484|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
27632931|NCT02001623|80497485|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
27632932|NCT02001623|80497486|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
27632933|NCT02001623|80497487|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
27632934|NCT02001623|80497488|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
27632935|NCT02001623|80497489|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
27632936|NCT02001623|80497490|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
27632937|NCT02001623|80497491|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
27632938|NCT02001623|80497492|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
27632939|NCT02001623|80497478|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
27632940|NCT02001623|80497479|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
27632941|NCT02001623|80497480|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
27632942|NCT02001623|80497481|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
27632943|NCT02001623|80497482|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
27917171|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
27917172|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
27917173|NCT01791595|81533332|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27917174|NCT01791595|81533333|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27917175|NCT01791595|81533334|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27917176|NCT01791595|81533335|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27917177|NCT01791595|81533336|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27917178|NCT01791595|81533337|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
27917179|NCT01791595|81533338|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
27917180|NCT01791595|81533332|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27917181|NCT01791595|81533333|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27917182|NCT01791595|81533334|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27917183|NCT01791595|81533335|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27917184|NCT01791595|81533336|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27917185|NCT01791595|81533337|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
27917186|NCT01791595|81533338|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
27917187|NCT01791595|81533332|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27917188|NCT01791595|81533333|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27632944|NCT02001623|80497483|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
27632945|NCT02001623|80497484|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
27632946|NCT02001623|80497485|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
27632947|NCT02001623|80497486|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
27632948|NCT02001623|80497487|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
27632949|NCT02001623|80497488|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
27632950|NCT02001623|80497489|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
27632951|NCT02001623|80497490|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
27632952|NCT02001623|80497491|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
27917189|NCT01791595|81533334|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27917190|NCT01791595|81533335|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27917191|NCT01791595|81533336|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27917192|NCT01791595|81533337|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
27917193|NCT01791595|81533338|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
27917194|NCT01791595|81533332|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27917195|NCT01791595|81533333|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27917196|NCT01791595|81533334|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27917197|NCT01791595|81533335|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27917198|NCT01791595|81533336|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27917199|NCT01791595|81533337|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
27917200|NCT01791595|81533338|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
27917201|NCT01791595|81533332|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27917202|NCT01791595|81533333|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27917203|NCT01791595|81533334|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27917204|NCT01791595|81533335|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27917205|NCT01791595|81533336|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27917206|NCT01791595|81533337|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
27917207|NCT01791595|81533338|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
27917208|NCT02692586|81533339|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
27917209|NCT02692586|81533339|FG000|Overall Study|Received adjunctive thrombolytics|2|||
27917210|NCT00617357|81533340|FG000|Overall Study|Lost to Follow-up|7|||
27917211|NCT00617357|81533340|FG000|Overall Study|Death|5|||
27917212|NCT00617357|81533340|FG000|Overall Study|insurance concerns|2|||
27917213|NCT00617357|81533340|FG000|Overall Study|Withdrawal by Subject|1|||
27917214|NCT00617357|81533340|FG000|Overall Study|Physician Decision|1|||
27917215|NCT00838097|81533343|FG000|Overall Study|Ineligibility determined|6|||
27917216|NCT00838097|81533343|FG000|Overall Study|Adverse Event|2|||
27917217|NCT00838097|81533343|FG000|Overall Study|Withdrawal by Subject|3|||
27917218|NCT00838097|81533343|FG000|Overall Study|Requirement for alternative therapy|2|||
27917219|NCT00838097|81533343|FG000|Overall Study|Physician Decision|4|||
27917220|NCT00838097|81533343|FG000|Overall Study|Lost to Follow-up|11|||
27739403|NCT00393458|80874085|FG000|Overall Study|Subject withdrew consent|27|||
27917221|NCT00838097|81533343|FG000|Overall Study|Death|6|||
27917222|NCT00838097|81533343|FG000|Overall Study|Protocol-specified criteria|142|||
27917223|NCT01079780|81533344|FG000|Overall Study|Disease progression|43|||
27917224|NCT01079780|81533345|FG001|Overall Study|Disease progression|7|||
27917225|NCT01079780|81533346|FG002|Overall Study|Disease progression|31|||
27917226|NCT01079780|81533344|FG000|Overall Study|Adverse Event|13|||
27538236|NCT02436304|80163683|FG001|Overall Study|Lost to Follow-up|1|||
27538237|NCT02436304|80163684|FG002|Overall Study|Lost to Follow-up|0|||
27538238|NCT02436304|80163682|FG000|Overall Study|Withdrawal by Subject|0|||
27538239|NCT02436304|80163683|FG001|Overall Study|Withdrawal by Subject|1|||
27538240|NCT02436304|80163684|FG002|Overall Study|Withdrawal by Subject|0|||
27538241|NCT02436304|80163682|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
27538242|NCT02436304|80163683|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
27538243|NCT02436304|80163684|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
27538244|NCT02019277|80163693|FG000|Overall Study|Withdrawal by Subject|3|||
27538245|NCT02019277|80163693|FG000|Overall Study|Death|7|||
27538246|NCT02019277|80163693|FG000|Overall Study|Did no Cooperate|1|||
27538247|NCT02019277|80163693|FG000|Overall Study|Adverse Event|1|||
27538248|NCT01649804|80163694|FG000|Overall Study|Administrative/Other|8|||
27538249|NCT00676338|80163695|FG000|Overall Study|Adverse Event|6|||
27538250|NCT00676338|80163696|FG001|Overall Study|Adverse Event|6|||
27538251|NCT00676338|80163697|FG002|Overall Study|Adverse Event|5|||
27538252|NCT00676338|80163698|FG003|Overall Study|Adverse Event|1|||
27538253|NCT00676338|80163695|FG000|Overall Study|Lost to Follow-up|4|||
27538254|NCT00676338|80163696|FG001|Overall Study|Lost to Follow-up|1|||
27538255|NCT00676338|80163697|FG002|Overall Study|Lost to Follow-up|3|||
27538256|NCT00676338|80163698|FG003|Overall Study|Lost to Follow-up|4|||
27538257|NCT00676338|80163695|FG000|Overall Study|Physician Decision|3|||
27538258|NCT00676338|80163696|FG001|Overall Study|Physician Decision|3|||
27538259|NCT00676338|80163697|FG002|Overall Study|Physician Decision|2|||
27538260|NCT00676338|80163698|FG003|Overall Study|Physician Decision|3|||
27538261|NCT00676338|80163695|FG000|Overall Study|Protocol Violation|5|||
27538262|NCT00676338|80163696|FG001|Overall Study|Protocol Violation|9|||
27538263|NCT00676338|80163697|FG002|Overall Study|Protocol Violation|2|||
27538264|NCT00676338|80163698|FG003|Overall Study|Protocol Violation|5|||
27538265|NCT00676338|80163695|FG000|Overall Study|Withdrawal by Subject|17|||
27538266|NCT00676338|80163696|FG001|Overall Study|Withdrawal by Subject|9|||
27538267|NCT00676338|80163697|FG002|Overall Study|Withdrawal by Subject|12|||
27538268|NCT00676338|80163698|FG003|Overall Study|Withdrawal by Subject|6|||
27538269|NCT00676338|80163695|FG000|Overall Study|Entry Criteria Not Met|0|||
27632953|NCT02001623|80497492|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
27632954|NCT00746330|80497494|FG000|Period 1|Abnormal test procedure result|0|||
27632955|NCT00746330|80497495|FG001|Period 1|Abnormal test procedure result|0|||
27632956|NCT00746330|80497496|FG002|Period 1|Abnormal test procedure result|1|||
27632957|NCT00746330|80497497|FG003|Period 1|Abnormal test procedure result|0|||
27632958|NCT02261467|80497508|FG000|Overall Study|Enrolled in Error|1|||
27632959|NCT02261467|80497509|FG001|Overall Study|Enrolled in Error|0|||
27632960|NCT02261467|80497508|FG000|Overall Study|Protocol Violation|0|||
27632961|NCT02261467|80497509|FG001|Overall Study|Protocol Violation|1|||
27632962|NCT02261467|80497508|FG000|Overall Study|Personal Reasons|17|||
27632963|NCT02261467|80497509|FG001|Overall Study|Personal Reasons|22|||
27632964|NCT02261467|80497508|FG000|Overall Study|Lost to Follow-up|2|||
27632965|NCT02261467|80497509|FG001|Overall Study|Lost to Follow-up|13|||
27632966|NCT02261467|80497508|FG000|Overall Study|Adverse Event|1|||
27632967|NCT02261467|80497509|FG001|Overall Study|Adverse Event|1|||
27632968|NCT00843193|80497510|FG000|Overall Study|Adverse Event|2|||
27632969|NCT00843193|80497511|FG001|Overall Study|Adverse Event|4|||
27632970|NCT00843193|80497510|FG000|Overall Study|Lack of Efficacy|1|||
27632971|NCT00843193|80497511|FG001|Overall Study|Lack of Efficacy|1|||
27632972|NCT00843193|80497510|FG000|Overall Study|Protocol Violation|1|||
27632973|NCT00843193|80497511|FG001|Overall Study|Protocol Violation|2|||
27632974|NCT00843193|80497510|FG000|Overall Study|Lost to Follow-up|1|||
27632975|NCT00843193|80497511|FG001|Overall Study|Lost to Follow-up|0|||
27632976|NCT00843193|80497510|FG000|Overall Study|Physician Decision|0|||
27632977|NCT00843193|80497511|FG001|Overall Study|Physician Decision|1|||
27632978|NCT00843193|80497510|FG000|Overall Study|Withdrawal by Subject|3|||
27632979|NCT00843193|80497511|FG001|Overall Study|Withdrawal by Subject|3|||
27632980|NCT03959241|80497513|FG000|Overall Study|Withdrawal by Subject|7|||
27632981|NCT03959241|80497514|FG001|Overall Study|Withdrawal by Subject|8|||
27632982|NCT03959241|80497513|FG000|Overall Study|Lost to Follow-up|1|||
27632983|NCT03959241|80497514|FG001|Overall Study|Lost to Follow-up|0|||
27632984|NCT03959241|80497513|FG000|Overall Study|Move to Hospice Care|1|||
27632985|NCT03959241|80497514|FG001|Overall Study|Move to Hospice Care|0|||
27632986|NCT03959241|80497513|FG000|Overall Study|Screen Failure|1|||
27632987|NCT03959241|80497514|FG001|Overall Study|Screen Failure|0|||
27632988|NCT03959241|80497513|FG000|Overall Study|Disease Relapse|0|||
27632989|NCT03959241|80497514|FG001|Overall Study|Disease Relapse|1|||
27632990|NCT03959241|80497513|FG000|Overall Study|Off Study|1|||
27632991|NCT03959241|80497514|FG001|Overall Study|Off Study|0|||
27632992|NCT03257813|80497516|FG000|Overall Study|Protocol Violation|6|||
27632993|NCT03257813|80497517|FG001|Overall Study|Protocol Violation|3|||
27632994|NCT02698241|80497523|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
27632995|NCT02698241|80497523|FG000|Overall Study|Screening not met|7|||
27632996|NCT02698241|80497523|FG000|Overall Study|Withdrawal by Subject|7|||
27632997|NCT02698241|80497523|FG000|Overall Study|Physician Decision|2|||
27632998|NCT02698241|80497523|FG000|Overall Study|Subject underwent system modification|2|||
27538270|NCT00676338|80163696|FG001|Overall Study|Entry Criteria Not Met|2|||
27538271|NCT00676338|80163697|FG002|Overall Study|Entry Criteria Not Met|1|||
27538272|NCT00676338|80163698|FG003|Overall Study|Entry Criteria Not Met|1|||
27538273|NCT00676338|80163695|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
27538274|NCT00676338|80163696|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
27538275|NCT00676338|80163697|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
27538276|NCT00676338|80163698|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
27538277|NCT00347360|80163699|FG000|Overall Study|Adverse Event|1|||
27538278|NCT00347360|80163700|FG001|Overall Study|Adverse Event|2|||
27538279|NCT00347360|80163701|FG002|Overall Study|Adverse Event|0|||
27538280|NCT00347360|80163702|FG003|Overall Study|Adverse Event|4|||
27538281|NCT00347360|80163703|FG004|Overall Study|Adverse Event|1|||
27538282|NCT00347360|80163704|FG005|Overall Study|Adverse Event|2|||
27538283|NCT00347360|80163705|FG006|Overall Study|Adverse Event|2|||
27538284|NCT00347360|80163706|FG007|Overall Study|Adverse Event|0|||
27632999|NCT02698241|80497523|FG000|Overall Study|Lost to Follow-up|3|||
27633000|NCT02698241|80497523|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
27633001|NCT02698241|80497523|FG000|Overall Study|geographic and licensing issue|1|||
27633002|NCT02698241|80497523|FG000|Overall Study|Death|2|||
27538285|NCT00347360|80163707|FG008|Overall Study|Adverse Event|2|||
27538286|NCT00347360|80163708|FG009|Overall Study|Adverse Event|3|||
27633003|NCT05136443|80497528|FG000|Overall Study|Lost to Follow-up|2|||
27917227|NCT01079780|81533345|FG001|Overall Study|Adverse Event|5|||
27917228|NCT01079780|81533346|FG002|Overall Study|Adverse Event|7|||
27538287|NCT00347360|80163709|FG010|Overall Study|Adverse Event|3|||
27538288|NCT00347360|80163710|FG011|Overall Study|Adverse Event|1|||
27633004|NCT05136443|80497528|FG000|Overall Study|Adverse Event|2|||
27633005|NCT01212991|80497529|FG000|Double-blind|Lost to Follow-up|8|||
27633006|NCT01212991|80497530|FG001|Double-blind|Lost to Follow-up|4|||
27633007|NCT01212991|80497531|FG002|Double-blind|Lost to Follow-up|0|||
27633008|NCT01212991|80497529|FG000|Double-blind|Death|699|||
27633009|NCT01212991|80497530|FG001|Double-blind|Death|550|||
27633010|NCT01212991|80497531|FG002|Double-blind|Death|0|||
27538289|NCT00347360|80163711|FG012|Overall Study|Adverse Event|3|||
27633011|NCT01212991|80497529|FG000|Double-blind|Withdrawal by Subject|16|||
27633012|NCT01212991|80497530|FG001|Double-blind|Withdrawal by Subject|19|||
27633013|NCT01212991|80497531|FG002|Double-blind|Withdrawal by Subject|0|||
27633014|NCT01212991|80497529|FG000|Double-blind|Other|7|||
27633015|NCT01212991|80497530|FG001|Double-blind|Other|0|||
27633016|NCT01212991|80497531|FG002|Double-blind|Other|0|||
27633017|NCT01212991|80497529|FG000|Double-blind|Sponsor decision|142|||
27633018|NCT01212991|80497530|FG001|Double-blind|Sponsor decision|38|||
27633019|NCT01212991|80497531|FG002|Double-blind|Sponsor decision|0|||
27633020|NCT01212991|80497529|FG000|Open-label|Death|0|||
27633021|NCT01212991|80497530|FG001|Open-label|Death|0|||
27633022|NCT01212991|80497531|FG002|Open-label|Death|166|||
27633023|NCT01212991|80497529|FG000|Open-label|Lost to Follow-up|0|||
27633024|NCT01212991|80497530|FG001|Open-label|Lost to Follow-up|0|||
27633025|NCT01212991|80497531|FG002|Open-label|Lost to Follow-up|5|||
27633026|NCT01212991|80497529|FG000|Open-label|Withdrawal by Subject|0|||
27633027|NCT01212991|80497530|FG001|Open-label|Withdrawal by Subject|0|||
27633028|NCT01212991|80497531|FG002|Open-label|Withdrawal by Subject|7|||
27633029|NCT01212991|80497529|FG000|Open-label|Sponsor decision|0|||
27633030|NCT01212991|80497530|FG001|Open-label|Sponsor decision|0|||
27917229|NCT01079780|81533344|FG000|Overall Study|Death|2|||
27917230|NCT01079780|81533345|FG001|Overall Study|Death|0|||
27917231|NCT01079780|81533346|FG002|Overall Study|Death|2|||
27917232|NCT01079780|81533344|FG000|Overall Study|Withdrawal by Subject|6|||
27917233|NCT01079780|81533345|FG001|Overall Study|Withdrawal by Subject|4|||
27917234|NCT01079780|81533346|FG002|Overall Study|Withdrawal by Subject|4|||
27917235|NCT01079780|81533344|FG000|Overall Study|Alternative therapy|2|||
27917236|NCT01079780|81533345|FG001|Overall Study|Alternative therapy|0|||
27917237|NCT01079780|81533346|FG002|Overall Study|Alternative therapy|2|||
27917238|NCT01079780|81533344|FG000|Overall Study|Physician Decision|1|||
27917239|NCT01079780|81533345|FG001|Overall Study|Physician Decision|0|||
27917240|NCT01079780|81533346|FG002|Overall Study|Physician Decision|1|||
27917241|NCT01079780|81533344|FG000|Overall Study|Error made in lesion measurement|1|||
27917242|NCT01079780|81533345|FG001|Overall Study|Error made in lesion measurement|0|||
27917243|NCT01079780|81533346|FG002|Overall Study|Error made in lesion measurement|0|||
27917244|NCT01079780|81533344|FG000|Overall Study|Patient had surgery|1|||
27917245|NCT01079780|81533345|FG001|Overall Study|Patient had surgery|0|||
27917246|NCT01079780|81533346|FG002|Overall Study|Patient had surgery|0|||
27917247|NCT01079780|81533344|FG000|Overall Study|Treatment cycle delay|0|||
27538290|NCT00347360|80163712|FG013|Overall Study|Adverse Event|2|||
27538291|NCT00347360|80163713|FG014|Overall Study|Adverse Event|2|||
27538292|NCT00347360|80163699|FG000|Overall Study|Lost to Follow-up|0|||
27538293|NCT00347360|80163700|FG001|Overall Study|Lost to Follow-up|0|||
27538294|NCT00347360|80163701|FG002|Overall Study|Lost to Follow-up|0|||
27538295|NCT00347360|80163702|FG003|Overall Study|Lost to Follow-up|2|||
27538296|NCT00347360|80163703|FG004|Overall Study|Lost to Follow-up|1|||
27538297|NCT00347360|80163704|FG005|Overall Study|Lost to Follow-up|1|||
27538298|NCT00347360|80163705|FG006|Overall Study|Lost to Follow-up|0|||
27538299|NCT00347360|80163706|FG007|Overall Study|Lost to Follow-up|1|||
27538300|NCT00347360|80163707|FG008|Overall Study|Lost to Follow-up|1|||
27538301|NCT00347360|80163708|FG009|Overall Study|Lost to Follow-up|2|||
27538302|NCT00347360|80163709|FG010|Overall Study|Lost to Follow-up|0|||
27538303|NCT00347360|80163710|FG011|Overall Study|Lost to Follow-up|0|||
27538304|NCT00347360|80163711|FG012|Overall Study|Lost to Follow-up|1|||
27538305|NCT00347360|80163712|FG013|Overall Study|Lost to Follow-up|0|||
27538306|NCT00347360|80163713|FG014|Overall Study|Lost to Follow-up|0|||
27538307|NCT00347360|80163699|FG000|Overall Study|Protocol Violation|2|||
27538308|NCT00347360|80163700|FG001|Overall Study|Protocol Violation|3|||
27538309|NCT00347360|80163701|FG002|Overall Study|Protocol Violation|1|||
27633031|NCT01212991|80497531|FG002|Open-label|Sponsor decision|53|||
27633032|NCT01212991|80497529|FG000|Open-label|Other|0|||
27633033|NCT01212991|80497530|FG001|Open-label|Other|0|||
27633034|NCT01212991|80497531|FG002|Open-label|Other|3|||
27917248|NCT01079780|81533345|FG001|Overall Study|Treatment cycle delay|0|||
27917249|NCT01079780|81533346|FG002|Overall Study|Treatment cycle delay|1|||
27538310|NCT00347360|80163702|FG003|Overall Study|Protocol Violation|2|||
27538311|NCT00347360|80163703|FG004|Overall Study|Protocol Violation|1|||
27538312|NCT00347360|80163704|FG005|Overall Study|Protocol Violation|2|||
27917250|NCT01079780|81533344|FG000|Overall Study|Never started treatment|1|||
27917251|NCT01079780|81533345|FG001|Overall Study|Never started treatment|0|||
27917252|NCT01079780|81533346|FG002|Overall Study|Never started treatment|2|||
27917253|NCT00969228|81533347|FG000|Overall Study|Adverse Event|1|||
27538313|NCT00347360|80163705|FG006|Overall Study|Protocol Violation|0|||
27538314|NCT00347360|80163706|FG007|Overall Study|Protocol Violation|0|||
27917254|NCT00969228|81533348|FG001|Overall Study|Adverse Event|0|||
27917255|NCT00969228|81533347|FG000|Overall Study|Withdrawal by Subject|4|||
27538315|NCT00347360|80163707|FG008|Overall Study|Protocol Violation|1|||
27538316|NCT00347360|80163708|FG009|Overall Study|Protocol Violation|2|||
27633035|NCT02937831|80497532|FG000|Overall Study|Protocol Violation|4|||
27633036|NCT00970307|80497535|FG000|Overall Study|Serious Adverse Event|1|||
27633037|NCT00970307|80497536|FG001|Overall Study|Serious Adverse Event|0|||
27633038|NCT00970307|80497537|FG002|Overall Study|Serious Adverse Event|0|||
27633039|NCT00970307|80497535|FG000|Overall Study|Withdrawal by Subject|2|||
27633040|NCT00970307|80497536|FG001|Overall Study|Withdrawal by Subject|3|||
27633041|NCT00970307|80497537|FG002|Overall Study|Withdrawal by Subject|2|||
27633042|NCT01353963|80497538|FG000|Overall Study|Adverse Event|2|||
27633043|NCT00517933|80497541|FG000|Period 1|Death|2|||
27633044|NCT00517933|80497542|FG001|Period 1|Death|1|||
27633045|NCT00517933|80497541|FG000|Period 1|Adverse Event|4|||
27633046|NCT00517933|80497542|FG001|Period 1|Adverse Event|4|||
27633047|NCT00517933|80497541|FG000|Period 1|Lost to Follow-up|2|||
27633048|NCT00517933|80497542|FG001|Period 1|Lost to Follow-up|0|||
27633049|NCT00517933|80497541|FG000|Period 1|Underwent lung transplant|0|||
27633050|NCT00517933|80497542|FG001|Period 1|Underwent lung transplant|1|||
27633051|NCT00517933|80497541|FG000|Period 2|Death|2|||
27633052|NCT00517933|80497542|FG001|Period 2|Death|4|||
27633053|NCT00517933|80497541|FG000|Period 2|Adverse Event|2|||
27633054|NCT00517933|80497542|FG001|Period 2|Adverse Event|4|||
27633055|NCT00517933|80497541|FG000|Period 2|Physician Decision|1|||
27633056|NCT00517933|80497542|FG001|Period 2|Physician Decision|0|||
27633057|NCT00517933|80497541|FG000|Period 2|Withdrawal by Subject|1|||
27633058|NCT00517933|80497542|FG001|Period 2|Withdrawal by Subject|3|||
27633059|NCT00517933|80497541|FG000|Period 2|Underwent lung transplant|0|||
27633060|NCT00517933|80497542|FG001|Period 2|Underwent lung transplant|2|||
27633061|NCT01510912|80497553|FG000|Overall Study|Adverse Event|99|||
27633062|NCT01510912|80497553|FG000|Overall Study|Lack of Efficacy|12|||
27633063|NCT01510912|80497553|FG000|Overall Study|Non-compliance with trial drug|23|||
27633064|NCT01510912|80497553|FG000|Overall Study|Withdrawal by Subject|49|||
27633065|NCT01510912|80497553|FG000|Overall Study|Physician Decision|1|||
27633066|NCT01510912|80497553|FG000|Overall Study|Protocol Violation|27|||
27633067|NCT01510912|80497553|FG000|Overall Study|Lost to Follow-up|26|||
27633068|NCT01510912|80497553|FG000|Overall Study|Other, including joint replacement|5|||
27633069|NCT00880048|80497556|FG000|Overall Study|Adverse Event|2|||
27633070|NCT00880048|80497557|FG001|Overall Study|Adverse Event|3|||
27633071|NCT00880048|80497558|FG002|Overall Study|Adverse Event|5|||
27633072|NCT00880048|80497556|FG000|Overall Study|Lack of Efficacy|1|||
27633073|NCT00880048|80497557|FG001|Overall Study|Lack of Efficacy|2|||
27633074|NCT00880048|80497558|FG002|Overall Study|Lack of Efficacy|2|||
27633075|NCT00880048|80497556|FG000|Overall Study|Protocol Violation|4|||
27633076|NCT00880048|80497557|FG001|Overall Study|Protocol Violation|6|||
27633077|NCT00880048|80497558|FG002|Overall Study|Protocol Violation|5|||
27633078|NCT00880048|80497556|FG000|Overall Study|Lost to Follow-up|6|||
27633079|NCT00880048|80497557|FG001|Overall Study|Lost to Follow-up|6|||
27633080|NCT00880048|80497558|FG002|Overall Study|Lost to Follow-up|5|||
27633081|NCT00880048|80497556|FG000|Overall Study|Physician Decision|1|||
27633082|NCT00880048|80497557|FG001|Overall Study|Physician Decision|1|||
27633083|NCT00880048|80497558|FG002|Overall Study|Physician Decision|7|||
27633084|NCT00880048|80497556|FG000|Overall Study|Withdrawal by Subject|5|||
27633085|NCT00880048|80497557|FG001|Overall Study|Withdrawal by Subject|8|||
27633086|NCT00880048|80497558|FG002|Overall Study|Withdrawal by Subject|5|||
27633087|NCT00880048|80497556|FG000|Overall Study|Study closed/terminated|9|||
27633088|NCT00880048|80497557|FG001|Overall Study|Study closed/terminated|7|||
27633089|NCT00880048|80497558|FG002|Overall Study|Study closed/terminated|6|||
27633090|NCT00102063|80497561|FG000|Overall Study|Lack of Efficacy|5|||
27633091|NCT00102063|80497562|FG001|Overall Study|Lack of Efficacy|1|||
27633092|NCT00102063|80497563|FG002|Overall Study|Lack of Efficacy|1|||
27917256|NCT00969228|81533348|FG001|Overall Study|Withdrawal by Subject|0|||
27538317|NCT00347360|80163709|FG010|Overall Study|Protocol Violation|0|||
27538318|NCT00347360|80163710|FG011|Overall Study|Protocol Violation|0|||
27538319|NCT00347360|80163711|FG012|Overall Study|Protocol Violation|0|||
27538320|NCT00347360|80163712|FG013|Overall Study|Protocol Violation|1|||
27538321|NCT00347360|80163713|FG014|Overall Study|Protocol Violation|0|||
27917257|NCT00969228|81533347|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
27917258|NCT00969228|81533348|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
27917259|NCT01619852|81533349|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
27917260|NCT01619852|81533350|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
27917261|NCT01619852|81533349|FG000|3 Month Follow up|Lost to Follow-up|31|||
27917262|NCT01619852|81533350|FG001|3 Month Follow up|Lost to Follow-up|34|||
27917263|NCT01278342|81533351|FG000|Overall Study|Physician Decision|0|||
27917264|NCT01278342|81533352|FG001|Overall Study|Physician Decision|1|||
27633093|NCT00102063|80497561|FG000|Overall Study|Adverse Event|7|||
27917265|NCT01278342|81533353|FG002|Overall Study|Physician Decision|0|||
27538322|NCT00347360|80163699|FG000|Overall Study|Withdrawal by Subject|0|||
27633094|NCT00102063|80497562|FG001|Overall Study|Adverse Event|4|||
27633095|NCT00102063|80497563|FG002|Overall Study|Adverse Event|2|||
27633096|NCT00102063|80497561|FG000|Overall Study|Withdrawal by Subject|4|||
27633097|NCT00102063|80497562|FG001|Overall Study|Withdrawal by Subject|12|||
27633098|NCT00102063|80497563|FG002|Overall Study|Withdrawal by Subject|5|||
27917266|NCT01278342|81533351|FG000|Overall Study|Lost to Follow-up|1|||
27633099|NCT00102063|80497561|FG000|Overall Study|Lost to Follow-up|0|||
27917267|NCT01278342|81533352|FG001|Overall Study|Lost to Follow-up|0|||
27917268|NCT01278342|81533353|FG002|Overall Study|Lost to Follow-up|0|||
27917269|NCT01278342|81533351|FG000|Overall Study|Administrative problems|2|||
27917270|NCT01278342|81533352|FG001|Overall Study|Administrative problems|0|||
27917271|NCT01278342|81533353|FG002|Overall Study|Administrative problems|0|||
27917272|NCT01278342|81533351|FG000|Overall Study|Other|1|||
27917273|NCT01278342|81533352|FG001|Overall Study|Other|0|||
27917274|NCT01278342|81533353|FG002|Overall Study|Other|0|||
27917275|NCT03498521|81533354|FG000|Overall Study|Death|191|||
27917276|NCT03498521|81533355|FG001|Overall Study|Death|64|||
27917277|NCT03498521|81533356|FG002|Overall Study|Death|72|||
27917278|NCT03498521|81533354|FG000|Overall Study|Exclusion criteria|1|||
27917279|NCT03498521|81533355|FG001|Overall Study|Exclusion criteria|0|||
27917280|NCT03498521|81533356|FG002|Overall Study|Exclusion criteria|0|||
27917281|NCT03498521|81533354|FG000|Overall Study|Lost to Follow-up|3|||
27917282|NCT03498521|81533355|FG001|Overall Study|Lost to Follow-up|3|||
27917283|NCT03498521|81533356|FG002|Overall Study|Lost to Follow-up|3|||
27917284|NCT03498521|81533354|FG000|Overall Study|No profile due to technical failure|1|||
27917285|NCT03498521|81533355|FG001|Overall Study|No profile due to technical failure|0|||
27917286|NCT03498521|81533356|FG002|Overall Study|No profile due to technical failure|0|||
27917287|NCT03498521|81533354|FG000|Overall Study|Physician Decision|0|||
27917288|NCT03498521|81533355|FG001|Overall Study|Physician Decision|1|||
27917289|NCT03498521|81533356|FG002|Overall Study|Physician Decision|0|||
27917290|NCT03498521|81533354|FG000|Overall Study|Withdrawal by Subject|9|||
27917291|NCT03498521|81533355|FG001|Overall Study|Withdrawal by Subject|6|||
27917292|NCT03498521|81533356|FG002|Overall Study|Withdrawal by Subject|2|||
27917293|NCT03498521|81533354|FG000|Overall Study|Study ongoing|121|||
27917294|NCT03498521|81533355|FG001|Overall Study|Study ongoing|36|||
27917295|NCT03498521|81533356|FG002|Overall Study|Study ongoing|15|||
27917296|NCT03200548|81533357|FG000|Overall Study|Withdrawal by Subject|5|||
27917297|NCT03200548|81533358|FG001|Overall Study|Withdrawal by Subject|11|||
27917298|NCT03200548|81533359|FG002|Overall Study|Withdrawal by Subject|7|||
27917299|NCT03200548|81533360|FG003|Overall Study|Withdrawal by Subject|6|||
27917300|NCT01396083|81533365|FG000|Overall Study|Adverse Event|2|||
27917301|NCT01396083|81533366|FG001|Overall Study|Adverse Event|28|||
27917302|NCT01396083|81533365|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27917303|NCT01396083|81533366|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
27917304|NCT01396083|81533365|FG000|Overall Study|Consent withdrawn|4|||
27917305|NCT01396083|81533366|FG001|Overall Study|Consent withdrawn|5|||
27917306|NCT01396083|81533365|FG000|Overall Study|Protocol deviation(s)|0|||
27917307|NCT01396083|81533366|FG001|Overall Study|Protocol deviation(s)|1|||
27917308|NCT01396083|81533365|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27917309|NCT01396083|81533366|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27917310|NCT01396083|81533365|FG000|Overall Study|Administrative problems|1|||
27633100|NCT00102063|80497562|FG001|Overall Study|Lost to Follow-up|0|||
27633101|NCT00102063|80497563|FG002|Overall Study|Lost to Follow-up|1|||
27633102|NCT00102063|80497561|FG000|Overall Study|Protocol Violation|0|||
27633103|NCT00102063|80497562|FG001|Overall Study|Protocol Violation|1|||
27633104|NCT00102063|80497563|FG002|Overall Study|Protocol Violation|1|||
27633105|NCT04246762|80497567|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
27633106|NCT01140048|80497568|FG000|Overall Study|Physician Decision|1|||
27633107|NCT01140048|80497568|FG000|Overall Study|Withdrawal by Subject|13|||
27633108|NCT01140048|80497568|FG000|Overall Study|Lost to Follow-up|31|||
27917311|NCT01396083|81533366|FG001|Overall Study|Administrative problems|0|||
27917312|NCT01396083|81533365|FG000|Overall Study|Lost to Follow-up|1|||
27917313|NCT01396083|81533366|FG001|Overall Study|Lost to Follow-up|0|||
27917314|NCT02457195|81533370|FG000|Overall Study|Adverse Event|3|||
27538323|NCT00347360|80163700|FG001|Overall Study|Withdrawal by Subject|1|||
27538324|NCT00347360|80163701|FG002|Overall Study|Withdrawal by Subject|2|||
27538325|NCT00347360|80163702|FG003|Overall Study|Withdrawal by Subject|4|||
27538326|NCT00347360|80163703|FG004|Overall Study|Withdrawal by Subject|1|||
27538327|NCT00347360|80163704|FG005|Overall Study|Withdrawal by Subject|2|||
27538328|NCT00347360|80163705|FG006|Overall Study|Withdrawal by Subject|1|||
27538329|NCT00347360|80163706|FG007|Overall Study|Withdrawal by Subject|1|||
27538330|NCT00347360|80163707|FG008|Overall Study|Withdrawal by Subject|1|||
27917315|NCT02457195|81533370|FG000|Overall Study|Protocol Violation|2|||
27917316|NCT02457195|81533370|FG000|Overall Study|Withdrawal by Subject|4|||
27538331|NCT00347360|80163708|FG009|Overall Study|Withdrawal by Subject|1|||
27538332|NCT00347360|80163709|FG010|Overall Study|Withdrawal by Subject|0|||
27538333|NCT00347360|80163710|FG011|Overall Study|Withdrawal by Subject|3|||
27633109|NCT01585558|80497569|FG000|Overall Study|Withdrawal by Subject|4|||
27917317|NCT03902613|81533376|FG000|Overall Study|Physician Decision|1|||
27917318|NCT03044314|81533377|FG000|Overall Study|Physician Decision|2|||
27917319|NCT03044314|81533377|FG000|Overall Study|Withdrawal by Subject|1|||
27917320|NCT03044314|81533377|FG000|Overall Study|Connector tubing not available|1|||
27917321|NCT01165307|81533378|FG000|Overall Study|Lost to Follow-up|11|||
27917322|NCT01165307|81533379|FG001|Overall Study|Lost to Follow-up|3|||
27633110|NCT01585558|80497570|FG001|Overall Study|Withdrawal by Subject|5|||
27633111|NCT01585558|80497571|FG002|Overall Study|Withdrawal by Subject|8|||
27633112|NCT01585558|80497569|FG000|Overall Study|Lost to Follow-up|2|||
27633113|NCT01585558|80497570|FG001|Overall Study|Lost to Follow-up|0|||
27633114|NCT01585558|80497571|FG002|Overall Study|Lost to Follow-up|3|||
27633115|NCT01585558|80497569|FG000|Overall Study|Adverse Event|3|||
27633116|NCT01585558|80497570|FG001|Overall Study|Adverse Event|4|||
27633117|NCT01585558|80497571|FG002|Overall Study|Adverse Event|1|||
27633118|NCT01585558|80497569|FG000|Overall Study|Protocol Violation|4|||
27633119|NCT01585558|80497570|FG001|Overall Study|Protocol Violation|3|||
27633120|NCT01585558|80497571|FG002|Overall Study|Protocol Violation|2|||
27633121|NCT01585558|80497569|FG000|Overall Study|Lack of Efficacy|0|||
27633122|NCT01585558|80497570|FG001|Overall Study|Lack of Efficacy|0|||
27633123|NCT01585558|80497571|FG002|Overall Study|Lack of Efficacy|1|||
27633124|NCT00436644|80497573|FG000|Overall Study|Adverse Event|2|||
27633125|NCT00436644|80497573|FG000|Overall Study|Death|1|||
27633126|NCT02202499|80497576|FG000|Overall Study|Cancer diagnosis|0|||
27633127|NCT02202499|80497577|FG001|Overall Study|Cancer diagnosis|0|||
27633128|NCT02202499|80497578|FG002|Overall Study|Cancer diagnosis|1|||
27633129|NCT02202499|80497576|FG000|Overall Study|Moved from area|0|||
27633130|NCT02202499|80497577|FG001|Overall Study|Moved from area|0|||
27633131|NCT02202499|80497578|FG002|Overall Study|Moved from area|1|||
27633132|NCT02202499|80497576|FG000|Overall Study|Declined before randomization|1|||
27633133|NCT02202499|80497577|FG001|Overall Study|Declined before randomization|0|||
27633134|NCT02202499|80497578|FG002|Overall Study|Declined before randomization|0|||
27633135|NCT02202499|80497576|FG000|Overall Study|Auto accident|1|||
27633136|NCT02202499|80497577|FG001|Overall Study|Auto accident|0|||
27538334|NCT00347360|80163711|FG012|Overall Study|Withdrawal by Subject|4|||
27538335|NCT00347360|80163712|FG013|Overall Study|Withdrawal by Subject|2|||
27538336|NCT00347360|80163713|FG014|Overall Study|Withdrawal by Subject|1|||
27538337|NCT00347360|80163699|FG000|Overall Study|Lack of Efficacy|1|||
27633137|NCT02202499|80497578|FG002|Overall Study|Auto accident|0|||
27633138|NCT02057692|80497579|FG000|Overall Study|Adverse Event|1|||
27633139|NCT02057692|80497580|FG001|Overall Study|Adverse Event|0|||
27633140|NCT02057692|80497581|FG002|Overall Study|Adverse Event|0|||
27633141|NCT02057692|80497582|FG003|Overall Study|Adverse Event|0|||
27633142|NCT02057692|80497579|FG000|Overall Study|Lost to Follow-up|0|||
27633143|NCT02057692|80497580|FG001|Overall Study|Lost to Follow-up|0|||
27633144|NCT02057692|80497581|FG002|Overall Study|Lost to Follow-up|0|||
27633145|NCT02057692|80497582|FG003|Overall Study|Lost to Follow-up|1|||
27633146|NCT00845832|80497590|FG000|Treatment Period|Adverse Event|0|||
27633147|NCT00845832|80497591|FG001|Treatment Period|Adverse Event|2|||
27633148|NCT00845832|80497592|FG002|Treatment Period|Adverse Event|0|||
27633149|NCT00845832|80497590|FG000|Treatment Period|Protocol Violation|1|||
27633150|NCT00845832|80497591|FG001|Treatment Period|Protocol Violation|1|||
27633151|NCT00845832|80497592|FG002|Treatment Period|Protocol Violation|0|||
27633152|NCT00845832|80497590|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
27633153|NCT00845832|80497591|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
27633154|NCT00845832|80497592|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
27633155|NCT00845832|80497590|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
27633156|NCT00845832|80497591|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
27633157|NCT00845832|80497592|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
27633158|NCT01393119|80497593|FG000|Overall Study|Adverse Event|1|||
27633159|NCT01393119|80497594|FG001|Overall Study|Adverse Event|1|||
27633160|NCT01393119|80497595|FG002|Overall Study|Adverse Event|0|||
27538338|NCT00347360|80163700|FG001|Overall Study|Lack of Efficacy|1|||
27538339|NCT00347360|80163701|FG002|Overall Study|Lack of Efficacy|3|||
27538340|NCT00347360|80163702|FG003|Overall Study|Lack of Efficacy|1|||
27538341|NCT00347360|80163703|FG004|Overall Study|Lack of Efficacy|0|||
27538342|NCT00347360|80163704|FG005|Overall Study|Lack of Efficacy|1|||
27538343|NCT00347360|80163705|FG006|Overall Study|Lack of Efficacy|0|||
27633161|NCT01393119|80497596|FG003|Overall Study|Adverse Event|1|||
27633162|NCT01393119|80497593|FG000|Overall Study|Withdrawal by Subject|0|||
27538344|NCT00347360|80163706|FG007|Overall Study|Lack of Efficacy|1|||
27538345|NCT00347360|80163707|FG008|Overall Study|Lack of Efficacy|1|||
27633163|NCT01393119|80497594|FG001|Overall Study|Withdrawal by Subject|1|||
27633164|NCT01393119|80497595|FG002|Overall Study|Withdrawal by Subject|1|||
27633165|NCT01393119|80497596|FG003|Overall Study|Withdrawal by Subject|0|||
27633166|NCT01393119|80497593|FG000|Overall Study|Lack of Efficacy|1|||
27633167|NCT01393119|80497594|FG001|Overall Study|Lack of Efficacy|0|||
27633168|NCT01393119|80497595|FG002|Overall Study|Lack of Efficacy|2|||
27538346|NCT00347360|80163708|FG009|Overall Study|Lack of Efficacy|0|||
27538347|NCT00347360|80163709|FG010|Overall Study|Lack of Efficacy|0|||
27538348|NCT00347360|80163710|FG011|Overall Study|Lack of Efficacy|0|||
27633169|NCT01393119|80497596|FG003|Overall Study|Lack of Efficacy|1|||
27633170|NCT01393119|80497593|FG000|Overall Study|Protocol Violation|0|||
27633171|NCT01393119|80497594|FG001|Overall Study|Protocol Violation|0|||
27633172|NCT01393119|80497595|FG002|Overall Study|Protocol Violation|1|||
27633173|NCT01393119|80497596|FG003|Overall Study|Protocol Violation|0|||
27633174|NCT01393119|80497593|FG000|Overall Study|Death|0|||
27633175|NCT01393119|80497594|FG001|Overall Study|Death|0|||
27917323|NCT01165307|81533378|FG000|Overall Study|Withdrawal by Subject|2|||
27917324|NCT01165307|81533379|FG001|Overall Study|Withdrawal by Subject|0|||
27917325|NCT01165307|81533378|FG000|Overall Study|Subject not available for contact|1|||
27917326|NCT01165307|81533379|FG001|Overall Study|Subject not available for contact|0|||
27917327|NCT00232557|81533382|FG000|Overall Study|Lost to Follow-up|3|||
27917328|NCT00232557|81533383|FG001|Overall Study|Lost to Follow-up|5|||
27917329|NCT01265498|81533384|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
27739404|NCT00393458|80874086|FG001|Overall Study|Subject withdrew consent|40|||
27739405|NCT00393458|80874087|FG002|Overall Study|Subject withdrew consent|33|||
27739406|NCT00393458|80874088|FG003|Overall Study|Subject withdrew consent|50|||
27739407|NCT00393458|80874085|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
27739408|NCT00393458|80874086|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
27739409|NCT00393458|80874087|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
27739410|NCT00393458|80874088|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
27739411|NCT00393458|80874085|FG000|Overall Study|Protocol deviation|11|||
27739412|NCT00393458|80874086|FG001|Overall Study|Protocol deviation|11|||
27739413|NCT00393458|80874087|FG002|Overall Study|Protocol deviation|11|||
27739414|NCT00393458|80874088|FG003|Overall Study|Protocol deviation|10|||
27739415|NCT00393458|80874085|FG000|Overall Study|Administrative problems|7|||
27739416|NCT00393458|80874086|FG001|Overall Study|Administrative problems|8|||
27739417|NCT00393458|80874087|FG002|Overall Study|Administrative problems|5|||
27739418|NCT00393458|80874088|FG003|Overall Study|Administrative problems|2|||
27739419|NCT00393458|80874085|FG000|Overall Study|Lost to Follow-up|5|||
27739420|NCT00393458|80874086|FG001|Overall Study|Lost to Follow-up|6|||
27739421|NCT00393458|80874087|FG002|Overall Study|Lost to Follow-up|5|||
27739422|NCT00393458|80874088|FG003|Overall Study|Lost to Follow-up|3|||
27739423|NCT00393458|80874085|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27739424|NCT00393458|80874086|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27739425|NCT00393458|80874087|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27739426|NCT00393458|80874088|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27739427|NCT00393458|80874085|FG000|Overall Study|Death|1|||
27739428|NCT00393458|80874086|FG001|Overall Study|Death|1|||
27739429|NCT00393458|80874087|FG002|Overall Study|Death|5|||
27739430|NCT00393458|80874088|FG003|Overall Study|Death|5|||
27739431|NCT00393458|80874085|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27739432|NCT00393458|80874086|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27917330|NCT01265498|81533385|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
27917331|NCT00297648|81536394|FG000|Overall Study|Adverse Event|13|||
27633176|NCT01393119|80497595|FG002|Overall Study|Death|0|||
27633177|NCT01393119|80497596|FG003|Overall Study|Death|1|||
27633178|NCT01393119|80497593|FG000|Overall Study|Randomized but Not treated|1|||
27633179|NCT01393119|80497594|FG001|Overall Study|Randomized but Not treated|0|||
27633180|NCT01393119|80497595|FG002|Overall Study|Randomized but Not treated|1|||
27633181|NCT01393119|80497596|FG003|Overall Study|Randomized but Not treated|1|||
27633182|NCT01393119|80497593|FG000|Overall Study|Sponsor Termination of Study|11|||
27633183|NCT01393119|80497594|FG001|Overall Study|Sponsor Termination of Study|12|||
27633184|NCT01393119|80497595|FG002|Overall Study|Sponsor Termination of Study|9|||
27633185|NCT01393119|80497596|FG003|Overall Study|Sponsor Termination of Study|12|||
27633186|NCT04581824|80497597|FG000|Overall Study|Ongoing|75|||
27633187|NCT04581824|80497598|FG001|Overall Study|Ongoing|69|||
27633188|NCT04581824|80497597|FG000|Overall Study|Withdrawal by Subject|3|||
27633189|NCT04581824|80497598|FG001|Overall Study|Withdrawal by Subject|5|||
27917332|NCT00297648|81536394|FG000|Overall Study|Lack of Efficacy|18|||
27917333|NCT00297648|81536394|FG000|Overall Study|Lost to Follow-up|1|||
27917334|NCT00297648|81536394|FG000|Overall Study|Withdrawal by Subject|3|||
27917335|NCT00297648|81536394|FG000|Overall Study|Other: Incompliance|1|||
27917336|NCT01305564|81536395|FG000|Overall Study|Death|21|||
27917337|NCT01305564|81536395|FG000|Overall Study|Lost to Follow-up|12|||
27917338|NCT01305564|81536395|FG000|Overall Study|Withdrawal by Subject|1|||
27917339|NCT01305564|81536395|FG000|Overall Study|Physician Decision|3|||
27917340|NCT04085601|81536399|FG000|Overall Study|Lost to Follow-up|1|||
27917341|NCT04085601|81536400|FG001|Overall Study|Lost to Follow-up|0|||
27917342|NCT04085601|81536399|FG000|Overall Study|Death|1|||
27917343|NCT04085601|81536400|FG001|Overall Study|Death|1|||
27633190|NCT04581824|80497597|FG000|Overall Study|Lost to Follow-up|1|||
27633191|NCT04581824|80497598|FG001|Overall Study|Lost to Follow-up|0|||
27633192|NCT04379713|80497599|FG000|Overall Study|Adverse Event|2|||
27633193|NCT04379713|80497600|FG001|Overall Study|Adverse Event|0|||
27633194|NCT04379713|80497599|FG000|Overall Study|Physician Decision|2|||
27739433|NCT00393458|80874087|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27739434|NCT00393458|80874088|FG003|Overall Study|Abnormal test procedure result(s)|2|||
27917344|NCT04644029|81536401|FG000|Overall Study|Death|1|||
27917345|NCT04644029|81536402|FG001|Overall Study|Death|0|||
27633195|NCT04379713|80497600|FG001|Overall Study|Physician Decision|1|||
27633196|NCT04379713|80497599|FG000|Overall Study|Protocol Violation|11|||
27633197|NCT04379713|80497600|FG001|Overall Study|Protocol Violation|6|||
27917346|NCT04644029|81536401|FG000|Overall Study|Physician Decision|1|||
27917347|NCT04644029|81536402|FG001|Overall Study|Physician Decision|2|||
27917348|NCT04644029|81536401|FG000|Overall Study|Withdrawal by Subject|21|||
27917349|NCT04644029|81536402|FG001|Overall Study|Withdrawal by Subject|19|||
27917350|NCT04644029|81536401|FG000|Overall Study|Lost to Follow-up|31|||
27917351|NCT04644029|81536402|FG001|Overall Study|Lost to Follow-up|34|||
27917352|NCT04644029|81536401|FG000|Overall Study|Study Terminated by Sponsor|305|||
27917353|NCT04644029|81536402|FG001|Overall Study|Study Terminated by Sponsor|301|||
27917354|NCT04644029|81536401|FG000|Overall Study|Status Not Recorded|3|||
27917355|NCT04644029|81536402|FG001|Overall Study|Status Not Recorded|8|||
27917356|NCT04644029|81536401|FG000|Overall Study|Randomized in Error|2|||
27633198|NCT04379713|80497599|FG000|Overall Study|No longer met eligibility criteria|14|||
27633199|NCT04379713|80497600|FG001|Overall Study|No longer met eligibility criteria|11|||
27633200|NCT04379713|80497599|FG000|Overall Study|Withdrawal by parent/guardian|36|||
27633201|NCT04379713|80497600|FG001|Overall Study|Withdrawal by parent/guardian|15|||
27633202|NCT04379713|80497599|FG000|Overall Study|Lost to Follow-up|31|||
27633203|NCT04379713|80497600|FG001|Overall Study|Lost to Follow-up|21|||
27633204|NCT04347954|80497601|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
27633205|NCT04347954|80497602|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
27633206|NCT04347954|80497603|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
27633207|NCT04347954|80497601|FG000|Overall Study|Lost to Follow-up|0|||
27633208|NCT04347954|80497602|FG001|Overall Study|Lost to Follow-up|1|||
27633209|NCT04347954|80497603|FG002|Overall Study|Lost to Follow-up|0|||
27633210|NCT01070888|80497604|FG000|First Intervention (14 Days)|Adverse Event|0|||
27633211|NCT01070888|80497605|FG001|First Intervention (14 Days)|Adverse Event|1|||
27633212|NCT01070888|80497604|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
27633213|NCT01070888|80497605|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
27633214|NCT01070888|80497604|FG000|Washout (14 Days)|Physician Decision|1|||
27633215|NCT01070888|80497605|FG001|Washout (14 Days)|Physician Decision|0|||
27917357|NCT04644029|81536402|FG001|Overall Study|Randomized in Error|1|||
27917358|NCT04644029|81536401|FG000|Overall Study|Other|0|||
27917359|NCT04644029|81536402|FG001|Overall Study|Other|1|||
27538349|NCT00347360|80163711|FG012|Overall Study|Lack of Efficacy|0|||
27538350|NCT00347360|80163712|FG013|Overall Study|Lack of Efficacy|0|||
27633216|NCT01290224|80497606|FG000|Overall Study|Adverse Event|1|||
27633217|NCT01290224|80497606|FG000|Overall Study|Refused Further Treatment|4|||
27633218|NCT04580303|80497619|FG000|Overall Study|Adverse Event|0|||
27633219|NCT04580303|80497620|FG001|Overall Study|Adverse Event|1|||
27538351|NCT00347360|80163713|FG014|Overall Study|Lack of Efficacy|0|||
27538352|NCT00347360|80163699|FG000|Overall Study|Reason not listed/blank|1|||
27538353|NCT00347360|80163700|FG001|Overall Study|Reason not listed/blank|0|||
27538354|NCT00347360|80163701|FG002|Overall Study|Reason not listed/blank|0|||
27538355|NCT00347360|80163702|FG003|Overall Study|Reason not listed/blank|0|||
27538356|NCT00347360|80163703|FG004|Overall Study|Reason not listed/blank|0|||
27538357|NCT00347360|80163704|FG005|Overall Study|Reason not listed/blank|0|||
27633220|NCT04580303|80497621|FG002|Overall Study|Adverse Event|0|||
27633221|NCT04580303|80497622|FG003|Overall Study|Adverse Event|0|||
27633222|NCT04580303|80497619|FG000|Overall Study|Withdrawal by Subject|0|||
27633223|NCT04580303|80497620|FG001|Overall Study|Withdrawal by Subject|0|||
27633224|NCT04580303|80497621|FG002|Overall Study|Withdrawal by Subject|1|||
27633225|NCT04580303|80497622|FG003|Overall Study|Withdrawal by Subject|0|||
27633226|NCT02950558|80497634|FG000|Overall Study|Lost to Follow-up|2|||
27633227|NCT02950558|80497635|FG001|Overall Study|Lost to Follow-up|0|||
27538358|NCT00347360|80163705|FG006|Overall Study|Reason not listed/blank|1|||
27538359|NCT00347360|80163706|FG007|Overall Study|Reason not listed/blank|0|||
27633228|NCT02031471|80497636|FG000|24 Week Treatment Period|Adverse Event|6|||
27633229|NCT02031471|80497636|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
27633230|NCT02031471|80497636|FG000|24 Week Treatment Period|Protocol Violation|1|||
27633231|NCT02031471|80497636|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
27633232|NCT02031471|80497636|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
27633233|NCT02031471|80497636|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
27633234|NCT02031471|80497636|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
27633235|NCT00739102|80497641|FG000|Overall Study|Death|5|||
27538360|NCT00347360|80163707|FG008|Overall Study|Reason not listed/blank|0|||
27538361|NCT00347360|80163708|FG009|Overall Study|Reason not listed/blank|0|||
27538362|NCT00347360|80163709|FG010|Overall Study|Reason not listed/blank|0|||
27538363|NCT00347360|80163710|FG011|Overall Study|Reason not listed/blank|0|||
27538364|NCT00347360|80163711|FG012|Overall Study|Reason not listed/blank|0|||
27538365|NCT00347360|80163712|FG013|Overall Study|Reason not listed/blank|1|||
27633236|NCT00739102|80497641|FG000|Overall Study|Withdrawal by Subject|10|||
27633237|NCT01241292|80497642|FG000|Overall Study|Administrative Reason by Sponsor|1|||
27739435|NCT00393458|80874085|FG000|Overall Study|Subject no longer requires study drug|0|||
27917360|NCT01325350|81536403|FG000|Overall Study|Adverse Event|3|||
27917361|NCT01325350|81536404|FG001|Overall Study|Adverse Event|3|||
27917362|NCT01325350|81536405|FG002|Overall Study|Adverse Event|3|||
27633238|NCT01241292|80497643|FG001|Overall Study|Administrative Reason by Sponsor|0|||
27633239|NCT01241292|80497642|FG000|Overall Study|Disease Progression|2|||
27633240|NCT01241292|80497643|FG001|Overall Study|Disease Progression|0|||
27633241|NCT01241292|80497642|FG000|Overall Study|Study Drug Toxicity|0|||
27633242|NCT01241292|80497643|FG001|Overall Study|Study Drug Toxicity|1|||
27633243|NCT01241292|80497642|FG000|Overall Study|Participant Discontinued Treatment|0|||
27633244|NCT01241292|80497643|FG001|Overall Study|Participant Discontinued Treatment|2|||
27633245|NCT03920215|80497646|FG000|Overall Study|Lost to Follow-up|1|||
27633246|NCT03920215|80497647|FG001|Overall Study|Lost to Follow-up|2|||
27633247|NCT03920215|80497648|FG002|Overall Study|Lost to Follow-up|0|||
27633248|NCT03920215|80497649|FG003|Overall Study|Lost to Follow-up|0|||
27633249|NCT03920215|80497646|FG000|Overall Study|Death|0|||
27633250|NCT03920215|80497647|FG001|Overall Study|Death|0|||
27633251|NCT03920215|80497648|FG002|Overall Study|Death|0|||
27633252|NCT03920215|80497649|FG003|Overall Study|Death|1|||
27633253|NCT01194154|80497653|FG000|Overall Study|Adverse Event|12|||
27633254|NCT01194154|80497654|FG001|Overall Study|Adverse Event|7|||
27633255|NCT01194154|80497653|FG000|Overall Study|Lost to Follow-up|2|||
27633256|NCT01194154|80497654|FG001|Overall Study|Lost to Follow-up|3|||
27633257|NCT01194154|80497653|FG000|Overall Study|Protocol Violation|0|||
27633258|NCT01194154|80497654|FG001|Overall Study|Protocol Violation|1|||
27633259|NCT01194154|80497653|FG000|Overall Study|Withdrawal by Subject|5|||
27633260|NCT01194154|80497654|FG001|Overall Study|Withdrawal by Subject|6|||
27633261|NCT01194154|80497653|FG000|Overall Study|Blood pressure increase|5|||
27633262|NCT01194154|80497654|FG001|Overall Study|Blood pressure increase|3|||
27633263|NCT01194154|80497653|FG000|Overall Study|Hemoglobin decrease|0|||
27633264|NCT01194154|80497654|FG001|Overall Study|Hemoglobin decrease|1|||
27633265|NCT01194154|80497653|FG000|Overall Study|Hemoglobin increase|12|||
27633266|NCT01194154|80497654|FG001|Overall Study|Hemoglobin increase|3|||
27633267|NCT01194154|80497653|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
27633268|NCT01194154|80497654|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
27633269|NCT01194154|80497653|FG000|Overall Study|Treatment with prohibited medication|4|||
27633270|NCT01194154|80497654|FG001|Overall Study|Treatment with prohibited medication|5|||
27633271|NCT01194154|80497653|FG000|Overall Study|Other|4|||
27633272|NCT01194154|80497654|FG001|Overall Study|Other|0|||
27633273|NCT01194154|80497653|FG000|Overall Study|Did not receive study medication|2|||
27917363|NCT01325350|81536406|FG003|Overall Study|Adverse Event|1|||
27917364|NCT01325350|81536407|FG004|Overall Study|Adverse Event|2|||
27538366|NCT00347360|80163713|FG014|Overall Study|Reason not listed/blank|0|||
27538367|NCT00347360|80163699|FG000|Overall Study|Per sponsors instruction|0|||
27538368|NCT00347360|80163700|FG001|Overall Study|Per sponsors instruction|1|||
27538369|NCT00347360|80163701|FG002|Overall Study|Per sponsors instruction|0|||
27538370|NCT00347360|80163702|FG003|Overall Study|Per sponsors instruction|0|||
27538371|NCT00347360|80163703|FG004|Overall Study|Per sponsors instruction|0|||
27538372|NCT00347360|80163704|FG005|Overall Study|Per sponsors instruction|0|||
27917365|NCT01325350|81536403|FG000|Overall Study|Pregnancy|0|||
27917366|NCT01325350|81536404|FG001|Overall Study|Pregnancy|0|||
27917367|NCT01325350|81536405|FG002|Overall Study|Pregnancy|1|||
27917368|NCT01325350|81536406|FG003|Overall Study|Pregnancy|0|||
27917369|NCT01325350|81536407|FG004|Overall Study|Pregnancy|1|||
27917370|NCT01325350|81536403|FG000|Overall Study|Lost to Follow-up|1|||
27538373|NCT00347360|80163705|FG006|Overall Study|Per sponsors instruction|0|||
27538374|NCT00347360|80163706|FG007|Overall Study|Per sponsors instruction|0|||
27538375|NCT00347360|80163707|FG008|Overall Study|Per sponsors instruction|0|||
27538376|NCT00347360|80163708|FG009|Overall Study|Per sponsors instruction|0|||
27538377|NCT00347360|80163709|FG010|Overall Study|Per sponsors instruction|0|||
27917371|NCT01325350|81536404|FG001|Overall Study|Lost to Follow-up|0|||
27917372|NCT01325350|81536405|FG002|Overall Study|Lost to Follow-up|5|||
27917373|NCT01325350|81536406|FG003|Overall Study|Lost to Follow-up|1|||
27538378|NCT00347360|80163710|FG011|Overall Study|Per sponsors instruction|0|||
27538379|NCT00347360|80163711|FG012|Overall Study|Per sponsors instruction|0|||
27538380|NCT00347360|80163712|FG013|Overall Study|Per sponsors instruction|0|||
27538381|NCT00347360|80163713|FG014|Overall Study|Per sponsors instruction|0|||
27538382|NCT00347360|80163699|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
27633274|NCT01194154|80497654|FG001|Overall Study|Did not receive study medication|4|||
27633275|NCT05257798|80497655|FG000|Follow-up Phase|Lost to Follow-up|1|||
27633276|NCT05257798|80497656|FG001|Follow-up Phase|Lost to Follow-up|0|||
27633277|NCT00346151|80497657|FG000|Overall Study|Withdrawal by Subject|3|||
27633278|NCT01183780|80497662|FG000|Overall Study|Withdrawal by Subject|25|||
27917374|NCT01325350|81536407|FG004|Overall Study|Lost to Follow-up|5|||
27917375|NCT01325350|81536403|FG000|Overall Study|Personal Reasons|2|||
27917376|NCT01325350|81536404|FG001|Overall Study|Personal Reasons|1|||
27917377|NCT01325350|81536405|FG002|Overall Study|Personal Reasons|6|||
27633279|NCT01183780|80497663|FG001|Overall Study|Withdrawal by Subject|14|||
27633280|NCT01183780|80497662|FG000|Overall Study|Lost to Follow-up|6|||
27633281|NCT01183780|80497663|FG001|Overall Study|Lost to Follow-up|11|||
27633282|NCT00157014|80497667|FG000|Overall Study|Death|4|||
27917378|NCT01325350|81536406|FG003|Overall Study|Personal Reasons|5|||
27633283|NCT00157014|80497668|FG001|Overall Study|Death|2|||
27633284|NCT00157014|80497669|FG002|Overall Study|Death|1|||
27633285|NCT00157014|80497670|FG003|Overall Study|Death|1|||
27633286|NCT00157014|80497667|FG000|Overall Study|Physician Decision|0|||
27633287|NCT00157014|80497668|FG001|Overall Study|Physician Decision|1|||
27633288|NCT00157014|80497669|FG002|Overall Study|Physician Decision|0|||
27633289|NCT00157014|80497670|FG003|Overall Study|Physician Decision|0|||
27633290|NCT00157014|80497667|FG000|Overall Study|Medications withdrawn on family request|0|||
27633291|NCT00157014|80497668|FG001|Overall Study|Medications withdrawn on family request|1|||
27633292|NCT00157014|80497669|FG002|Overall Study|Medications withdrawn on family request|0|||
27633293|NCT00157014|80497670|FG003|Overall Study|Medications withdrawn on family request|0|||
27633294|NCT00157014|80497667|FG000|Overall Study|Patient withdrawn by investigator|1|||
27633295|NCT00157014|80497668|FG001|Overall Study|Patient withdrawn by investigator|0|||
27633296|NCT00157014|80497669|FG002|Overall Study|Patient withdrawn by investigator|0|||
27633297|NCT00157014|80497670|FG003|Overall Study|Patient withdrawn by investigator|0|||
27538383|NCT00347360|80163700|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
27538384|NCT00347360|80163701|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
27538385|NCT00347360|80163702|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
27538386|NCT00347360|80163703|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
27538387|NCT00347360|80163704|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
27538388|NCT00347360|80163705|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
27538389|NCT00347360|80163706|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
27538390|NCT00347360|80163707|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
27538391|NCT00347360|80163708|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
27538392|NCT00347360|80163709|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
27538393|NCT00347360|80163710|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
27538394|NCT00347360|80163711|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
27633298|NCT00157014|80497667|FG000|Overall Study|Patient unable to return in nursing home|1|||
27633299|NCT00157014|80497668|FG001|Overall Study|Patient unable to return in nursing home|0|||
27633300|NCT00157014|80497669|FG002|Overall Study|Patient unable to return in nursing home|0|||
27633301|NCT00157014|80497670|FG003|Overall Study|Patient unable to return in nursing home|0|||
27633302|NCT00157014|80497667|FG000|Overall Study|Patient would not receive transplant|0|||
27633303|NCT00157014|80497668|FG001|Overall Study|Patient would not receive transplant|1|||
27633304|NCT00157014|80497669|FG002|Overall Study|Patient would not receive transplant|0|||
27633305|NCT00157014|80497670|FG003|Overall Study|Patient would not receive transplant|0|||
27538395|NCT00347360|80163712|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
27538396|NCT00347360|80163713|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
27538397|NCT00347360|80163699|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
27538398|NCT00347360|80163700|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
27538399|NCT00347360|80163701|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
27538400|NCT00347360|80163702|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
27917379|NCT01325350|81536407|FG004|Overall Study|Personal Reasons|3|||
27917380|NCT01325350|81536403|FG000|Overall Study|Protocol Violation|0|||
27538401|NCT00347360|80163703|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
27633306|NCT00157014|80497667|FG000|Overall Study|Withdrawal by Subject|1|||
27633307|NCT00157014|80497668|FG001|Overall Study|Withdrawal by Subject|0|||
27633308|NCT00157014|80497669|FG002|Overall Study|Withdrawal by Subject|0|||
27633309|NCT00157014|80497670|FG003|Overall Study|Withdrawal by Subject|0|||
27633310|NCT04480827|80497671|FG000|Overall Study|Adverse Event|0|||
27538402|NCT00347360|80163704|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
27538403|NCT00347360|80163705|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
27538404|NCT00347360|80163706|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
27538405|NCT00347360|80163707|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
27538406|NCT00347360|80163708|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
27538407|NCT00347360|80163709|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
27538408|NCT00347360|80163710|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
27538409|NCT00347360|80163711|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
27538410|NCT00347360|80163712|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
27538411|NCT00347360|80163713|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
27538412|NCT00347360|80163699|FG000|Overall Study|Abnormal lab values|0|||
27538413|NCT00347360|80163700|FG001|Overall Study|Abnormal lab values|0|||
27538414|NCT00347360|80163701|FG002|Overall Study|Abnormal lab values|0|||
27633311|NCT04480827|80497672|FG001|Overall Study|Adverse Event|0|||
27633312|NCT04480827|80497673|FG002|Overall Study|Adverse Event|0|||
27633313|NCT04480827|80497674|FG003|Overall Study|Adverse Event|0|||
27633314|NCT04480827|80497675|FG004|Overall Study|Adverse Event|0|||
27739436|NCT00393458|80874086|FG001|Overall Study|Subject no longer requires study drug|1|||
27917381|NCT01325350|81536404|FG001|Overall Study|Protocol Violation|0|||
27917382|NCT01325350|81536405|FG002|Overall Study|Protocol Violation|0|||
27917383|NCT01325350|81536406|FG003|Overall Study|Protocol Violation|1|||
27538415|NCT00347360|80163702|FG003|Overall Study|Abnormal lab values|0|||
27538416|NCT00347360|80163703|FG004|Overall Study|Abnormal lab values|0|||
27538417|NCT00347360|80163704|FG005|Overall Study|Abnormal lab values|0|||
27538418|NCT00347360|80163705|FG006|Overall Study|Abnormal lab values|1|||
27538419|NCT00347360|80163706|FG007|Overall Study|Abnormal lab values|0|||
27538420|NCT00347360|80163707|FG008|Overall Study|Abnormal lab values|0|||
27538421|NCT00347360|80163708|FG009|Overall Study|Abnormal lab values|0|||
27538422|NCT00347360|80163709|FG010|Overall Study|Abnormal lab values|0|||
27538423|NCT00347360|80163710|FG011|Overall Study|Abnormal lab values|0|||
27538424|NCT00347360|80163711|FG012|Overall Study|Abnormal lab values|0|||
27538425|NCT00347360|80163712|FG013|Overall Study|Abnormal lab values|0|||
27538426|NCT00347360|80163713|FG014|Overall Study|Abnormal lab values|0|||
27538427|NCT00347360|80163699|FG000|Overall Study|PI recommended early withdrawal|0|||
27538428|NCT00347360|80163700|FG001|Overall Study|PI recommended early withdrawal|0|||
27538429|NCT00347360|80163701|FG002|Overall Study|PI recommended early withdrawal|0|||
27538430|NCT00347360|80163702|FG003|Overall Study|PI recommended early withdrawal|0|||
27538431|NCT00347360|80163703|FG004|Overall Study|PI recommended early withdrawal|0|||
27538432|NCT00347360|80163704|FG005|Overall Study|PI recommended early withdrawal|0|||
27633315|NCT04480827|80497676|FG005|Overall Study|Adverse Event|1|||
27633316|NCT04480827|80497677|FG006|Overall Study|Adverse Event|0|||
27633317|NCT00711958|80497680|FG000|Overall Study|Withdrawal by Subject|6|||
27633318|NCT00711958|80497681|FG001|Overall Study|Withdrawal by Subject|8|||
27633319|NCT00711958|80497680|FG000|Overall Study|Lack of Efficacy|3|||
27633320|NCT00711958|80497681|FG001|Overall Study|Lack of Efficacy|1|||
27633321|NCT00711958|80497680|FG000|Overall Study|Clinical deterioration|1|||
27633322|NCT00711958|80497681|FG001|Overall Study|Clinical deterioration|0|||
27538433|NCT00347360|80163705|FG006|Overall Study|PI recommended early withdrawal|0|||
27538434|NCT00347360|80163706|FG007|Overall Study|PI recommended early withdrawal|0|||
27538435|NCT00347360|80163707|FG008|Overall Study|PI recommended early withdrawal|0|||
27538436|NCT00347360|80163708|FG009|Overall Study|PI recommended early withdrawal|1|||
27538437|NCT00347360|80163709|FG010|Overall Study|PI recommended early withdrawal|0|||
27538438|NCT00347360|80163710|FG011|Overall Study|PI recommended early withdrawal|0|||
27538439|NCT00347360|80163711|FG012|Overall Study|PI recommended early withdrawal|0|||
27538440|NCT00347360|80163712|FG013|Overall Study|PI recommended early withdrawal|0|||
27633323|NCT00711958|80497680|FG000|Overall Study|Adverse Event|9|||
27633324|NCT00711958|80497681|FG001|Overall Study|Adverse Event|7|||
27633325|NCT00711958|80497680|FG000|Overall Study|Protocol Violation|1|||
27633326|NCT00711958|80497681|FG001|Overall Study|Protocol Violation|0|||
27633327|NCT00711958|80497680|FG000|Overall Study|Lost to Follow-up|2|||
27633328|NCT00711958|80497681|FG001|Overall Study|Lost to Follow-up|2|||
27633329|NCT00711958|80497680|FG000|Overall Study|Death|10|||
27633330|NCT00711958|80497681|FG001|Overall Study|Death|5|||
27633331|NCT00711958|80497680|FG000|Overall Study|Progression of disease|1|||
27633332|NCT00711958|80497681|FG001|Overall Study|Progression of disease|0|||
27633333|NCT03823911|80497682|FG000|Overall Study|Lost to Follow-up|1|||
27633334|NCT03823911|80497683|FG001|Overall Study|Lost to Follow-up|5|||
27633335|NCT03823911|80497684|FG002|Overall Study|Lost to Follow-up|2|||
27633336|NCT03823911|80497682|FG000|Overall Study|Did not meet eligibility criteria|13|||
27633337|NCT03823911|80497683|FG001|Overall Study|Did not meet eligibility criteria|7|||
27633338|NCT03823911|80497684|FG002|Overall Study|Did not meet eligibility criteria|4|||
27633339|NCT03823911|80497682|FG000|Overall Study|Death|0|||
27633340|NCT03823911|80497683|FG001|Overall Study|Death|1|||
27633341|NCT03823911|80497684|FG002|Overall Study|Death|0|||
27633342|NCT00688519|80497685|FG000|Overall Study|Adverse Event|2|||
27633343|NCT00688519|80497686|FG001|Overall Study|Adverse Event|3|||
27633344|NCT00688519|80497685|FG000|Overall Study|Lost to Follow-up|3|||
27633345|NCT00688519|80497686|FG001|Overall Study|Lost to Follow-up|3|||
27633346|NCT00688519|80497685|FG000|Overall Study|Lack of Efficacy|3|||
27633347|NCT00688519|80497686|FG001|Overall Study|Lack of Efficacy|1|||
27538441|NCT00347360|80163713|FG014|Overall Study|PI recommended early withdrawal|0|||
27538442|NCT00347360|80163699|FG000|Overall Study|Did not meet criteria before ABPM|0|||
27538443|NCT00347360|80163700|FG001|Overall Study|Did not meet criteria before ABPM|0|||
27633348|NCT00688519|80497685|FG000|Overall Study|Withdrawal by Subject|7|||
27633349|NCT00688519|80497686|FG001|Overall Study|Withdrawal by Subject|6|||
27633350|NCT00688519|80497685|FG000|Overall Study|Prohibited medication|1|||
27633351|NCT00688519|80497686|FG001|Overall Study|Prohibited medication|0|||
27633352|NCT00688519|80497685|FG000|Overall Study|Non-compliance|0|||
27633353|NCT00688519|80497686|FG001|Overall Study|Non-compliance|1|||
27538444|NCT00347360|80163701|FG002|Overall Study|Did not meet criteria before ABPM|0|||
27538445|NCT00347360|80163702|FG003|Overall Study|Did not meet criteria before ABPM|0|||
27538446|NCT00347360|80163703|FG004|Overall Study|Did not meet criteria before ABPM|0|||
27538447|NCT00347360|80163704|FG005|Overall Study|Did not meet criteria before ABPM|0|||
27633354|NCT00688519|80497685|FG000|Overall Study|Subject moved out of state|1|||
27633355|NCT00688519|80497686|FG001|Overall Study|Subject moved out of state|0|||
27633356|NCT00688519|80497685|FG000|Overall Study|Investigator decision|1|||
27633357|NCT00688519|80497686|FG001|Overall Study|Investigator decision|0|||
27633358|NCT00688519|80497685|FG000|Overall Study|Subject moved out of area|1|||
27538448|NCT00347360|80163705|FG006|Overall Study|Did not meet criteria before ABPM|0|||
27538449|NCT00347360|80163706|FG007|Overall Study|Did not meet criteria before ABPM|0|||
27538450|NCT00347360|80163707|FG008|Overall Study|Did not meet criteria before ABPM|0|||
27538451|NCT00347360|80163708|FG009|Overall Study|Did not meet criteria before ABPM|0|||
27538452|NCT00347360|80163709|FG010|Overall Study|Did not meet criteria before ABPM|1|||
27538453|NCT00347360|80163710|FG011|Overall Study|Did not meet criteria before ABPM|0|||
27538454|NCT00347360|80163711|FG012|Overall Study|Did not meet criteria before ABPM|0|||
27633359|NCT00688519|80497686|FG001|Overall Study|Subject moved out of area|0|||
27633360|NCT00688519|80497685|FG000|Overall Study|Pregnancy|0|||
27633361|NCT00688519|80497686|FG001|Overall Study|Pregnancy|1|||
27633362|NCT02314117|80497689|FG000|Overall Study|Lost to Follow-up|9|||
27633363|NCT02314117|80497690|FG001|Overall Study|Lost to Follow-up|14|||
27633364|NCT02314117|80497689|FG000|Overall Study|Withdrawal by Subject|3|||
27633365|NCT02314117|80497690|FG001|Overall Study|Withdrawal by Subject|2|||
27633366|NCT01930045|80497691|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27633367|NCT01930045|80497692|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27633368|NCT01930045|80497693|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27633369|NCT01930045|80497694|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27633370|NCT01930045|80497695|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
27633371|NCT01930045|80497696|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
27633372|NCT01930045|80497691|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
27633373|NCT01930045|80497692|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
27633374|NCT01930045|80497693|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
27633375|NCT01930045|80497694|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
27633376|NCT01930045|80497695|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
27633377|NCT01930045|80497696|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
27633378|NCT02000817|80497700|FG000|Overall Study|Withdrawal by Subject|2|||
27633379|NCT02000817|80497701|FG001|Overall Study|Withdrawal by Subject|0|||
27633380|NCT02000817|80497702|FG002|Overall Study|Withdrawal by Subject|0|||
27633381|NCT02000817|80497703|FG003|Overall Study|Withdrawal by Subject|0|||
27633382|NCT02000817|80497700|FG000|Overall Study|Adverse Event|0|||
27633383|NCT02000817|80497701|FG001|Overall Study|Adverse Event|1|||
27633384|NCT02000817|80497702|FG002|Overall Study|Adverse Event|0|||
27633385|NCT02000817|80497703|FG003|Overall Study|Adverse Event|0|||
27633386|NCT02000817|80497700|FG000|Overall Study|Lost to Follow-up|0|||
27633387|NCT02000817|80497701|FG001|Overall Study|Lost to Follow-up|0|||
27633388|NCT02000817|80497702|FG002|Overall Study|Lost to Follow-up|1|||
27633389|NCT02000817|80497703|FG003|Overall Study|Lost to Follow-up|0|||
27633390|NCT01810263|80497710|FG000|Overall Study|Lost to Follow-up|8|||
27633391|NCT01810263|80497711|FG001|Overall Study|Lost to Follow-up|7|||
27633392|NCT03418324|80497714|FG000|Overall Study|Death|0|||
27633393|NCT03418324|80497715|FG001|Overall Study|Death|1|||
27633394|NCT03418324|80497714|FG000|Overall Study|Physician Decision|1|||
27633395|NCT03418324|80497715|FG001|Overall Study|Physician Decision|1|||
27633396|NCT02263508|80497716|FG000|Overall Study|Withdrawal by Subject|1|||
27633397|NCT02263508|80497717|FG001|Overall Study|Withdrawal by Subject|23|||
27633398|NCT02263508|80497718|FG002|Overall Study|Withdrawal by Subject|17|||
27633399|NCT02263508|80497716|FG000|Overall Study|Sponsor Decision|12|||
27633400|NCT02263508|80497717|FG001|Overall Study|Sponsor Decision|165|||
27633401|NCT02263508|80497718|FG002|Overall Study|Sponsor Decision|182|||
27633402|NCT02263508|80497716|FG000|Overall Study|Lost to Follow-up|2|||
27633403|NCT02263508|80497717|FG001|Overall Study|Lost to Follow-up|7|||
27633404|NCT02263508|80497718|FG002|Overall Study|Lost to Follow-up|7|||
27633405|NCT02263508|80497716|FG000|Overall Study|Death|6|||
27633406|NCT02263508|80497717|FG001|Overall Study|Death|151|||
27633407|NCT02263508|80497718|FG002|Overall Study|Death|140|||
27633408|NCT01370694|80497726|FG000|Overall Study|Switched to rituximab|4|||
27633409|NCT01370694|80497726|FG000|Overall Study|Progressive disease|2|||
27633410|NCT01233050|80497727|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
27633411|NCT01233050|80497728|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
27739437|NCT00393458|80874087|FG002|Overall Study|Subject no longer requires study drug|0|||
27739438|NCT00393458|80874088|FG003|Overall Study|Subject no longer requires study drug|0|||
27917384|NCT01325350|81536407|FG004|Overall Study|Protocol Violation|0|||
27917385|NCT01325350|81536403|FG000|Overall Study|Withdrawal by Subject|0|||
27633412|NCT02613364|80497729|FG000|Overall Study|Other|19|||
27633413|NCT02613364|80497730|FG001|Overall Study|Other|29|||
27633414|NCT02613364|80497731|FG002|Overall Study|Other|17|||
27633415|NCT02613364|80497729|FG000|Overall Study|Too time consuming|21|||
27633416|NCT02613364|80497730|FG001|Overall Study|Too time consuming|26|||
27633417|NCT02613364|80497731|FG002|Overall Study|Too time consuming|26|||
27538455|NCT00347360|80163712|FG013|Overall Study|Did not meet criteria before ABPM|0|||
27633418|NCT02613364|80497729|FG000|Overall Study|Withdrawal by Subject|13|||
27917386|NCT01325350|81536404|FG001|Overall Study|Withdrawal by Subject|0|||
27633419|NCT02613364|80497730|FG001|Overall Study|Withdrawal by Subject|18|||
27633420|NCT02613364|80497731|FG002|Overall Study|Withdrawal by Subject|17|||
27633421|NCT02613364|80497729|FG000|Overall Study|Medical|12|||
27633422|NCT02613364|80497730|FG001|Overall Study|Medical|13|||
27739439|NCT00283712|80874089|FG000|Overall Study|Death|0|||
27739440|NCT00283712|80874090|FG001|Overall Study|Death|1|||
27739441|NCT01824602|80874091|FG000|Overall Study|Withdrawal by Subject|0|||
27739442|NCT01824602|80874092|FG001|Overall Study|Withdrawal by Subject|0|||
27739443|NCT01824602|80874093|FG002|Overall Study|Withdrawal by Subject|1|||
27739444|NCT01824602|80874094|FG003|Overall Study|Withdrawal by Subject|2|||
27739445|NCT01824602|80874091|FG000|Overall Study|Patient non-compliance|0|||
27739446|NCT01824602|80874092|FG001|Overall Study|Patient non-compliance|0|||
27739447|NCT01824602|80874093|FG002|Overall Study|Patient non-compliance|1|||
27739448|NCT01824602|80874094|FG003|Overall Study|Patient non-compliance|0|||
27739449|NCT01824602|80874091|FG000|Overall Study|Adverse Event|1|||
27739450|NCT01824602|80874092|FG001|Overall Study|Adverse Event|0|||
27739451|NCT01824602|80874093|FG002|Overall Study|Adverse Event|2|||
27739452|NCT01824602|80874094|FG003|Overall Study|Adverse Event|2|||
27739453|NCT01824602|80874091|FG000|Overall Study|Treatment failure|0|||
27739454|NCT01824602|80874092|FG001|Overall Study|Treatment failure|0|||
27739455|NCT01824602|80874093|FG002|Overall Study|Treatment failure|0|||
27739456|NCT01824602|80874094|FG003|Overall Study|Treatment failure|1|||
27739457|NCT00506389|80874095|FG000|In-treatment Period|Other|3|||
27739458|NCT00506389|80874096|FG001|In-treatment Period|Other|3|||
27739459|NCT00506389|80874097|FG002|In-treatment Period|Other|4|||
27739460|NCT00506389|80874095|FG000|In-treatment Period|Lost to Follow-up|0|||
27739461|NCT00506389|80874096|FG001|In-treatment Period|Lost to Follow-up|0|||
27739462|NCT00506389|80874097|FG002|In-treatment Period|Lost to Follow-up|1|||
27739463|NCT00506389|80874095|FG000|In-treatment Period|Lack of compliance|1|||
27739464|NCT00506389|80874096|FG001|In-treatment Period|Lack of compliance|0|||
27739465|NCT00506389|80874097|FG002|In-treatment Period|Lack of compliance|0|||
27739466|NCT00506389|80874095|FG000|In-treatment Period|Reasons not related to trial|4|||
27739467|NCT00506389|80874096|FG001|In-treatment Period|Reasons not related to trial|1|||
27739468|NCT00506389|80874097|FG002|In-treatment Period|Reasons not related to trial|0|||
27739469|NCT00506389|80874095|FG000|In-treatment Period|Withdrawal by Subject|3|||
27739470|NCT00506389|80874096|FG001|In-treatment Period|Withdrawal by Subject|3|||
27739471|NCT00506389|80874097|FG002|In-treatment Period|Withdrawal by Subject|4|||
27739472|NCT00506389|80874095|FG000|In-treatment Period|Lack of Efficacy|0|||
27739473|NCT00506389|80874096|FG001|In-treatment Period|Lack of Efficacy|2|||
27739474|NCT00506389|80874097|FG002|In-treatment Period|Lack of Efficacy|0|||
27917387|NCT01325350|81536405|FG002|Overall Study|Withdrawal by Subject|1|||
27917388|NCT01325350|81536406|FG003|Overall Study|Withdrawal by Subject|1|||
27917389|NCT01325350|81536407|FG004|Overall Study|Withdrawal by Subject|0|||
27917390|NCT01325350|81536403|FG000|Overall Study|Did Not Receive Treatment|0|||
27917391|NCT01325350|81536404|FG001|Overall Study|Did Not Receive Treatment|1|||
27917392|NCT01325350|81536405|FG002|Overall Study|Did Not Receive Treatment|1|||
27917393|NCT01325350|81536406|FG003|Overall Study|Did Not Receive Treatment|0|||
27917394|NCT01325350|81536407|FG004|Overall Study|Did Not Receive Treatment|1|||
27917395|NCT01181167|81536418|FG000|Overall Study|Adverse Event|11|||
27917396|NCT01181167|81536419|FG001|Overall Study|Adverse Event|21|||
27917397|NCT01181167|81536418|FG000|Overall Study|Lost to Follow-up|1|||
27917398|NCT01181167|81536419|FG001|Overall Study|Lost to Follow-up|0|||
27917399|NCT01181167|81536418|FG000|Overall Study|Physician Decision|2|||
27917400|NCT01181167|81536419|FG001|Overall Study|Physician Decision|3|||
27917401|NCT01181167|81536418|FG000|Overall Study|Protocol Violation|3|||
27917402|NCT01181167|81536419|FG001|Overall Study|Protocol Violation|0|||
27917403|NCT01181167|81536418|FG000|Overall Study|Withdrawal by Subject|6|||
27917404|NCT01181167|81536419|FG001|Overall Study|Withdrawal by Subject|8|||
27917405|NCT00010257|81536420|FG000|Overall Study|Withdrawal by Subject|1|||
27917406|NCT00010257|81536421|FG001|Overall Study|Withdrawal by Subject|0|||
27917407|NCT00716456|81536424|FG000|Overall Study|Adverse Event|0|||
27917408|NCT00716456|81536425|FG001|Overall Study|Adverse Event|2|||
27917409|NCT00716456|81536426|FG002|Overall Study|Adverse Event|0|||
27917410|NCT00483652|81536427|FG000|Double-blind Treatment Period|Protocol Violation|2|||
27917411|NCT00483652|81536428|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27917412|NCT00483652|81536427|FG000|Double-blind Treatment Period|Adverse Event|3|||
27917413|NCT00483652|81536428|FG001|Double-blind Treatment Period|Adverse Event|4|||
27917414|NCT00483652|81536427|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
27739475|NCT00506389|80874095|FG000|In-treatment Period|Adverse Event|11|||
27917415|NCT00483652|81536428|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
27633423|NCT02613364|80497731|FG002|Overall Study|Medical|9|||
27739476|NCT00506389|80874096|FG001|In-treatment Period|Adverse Event|5|||
27739477|NCT00506389|80874097|FG002|In-treatment Period|Adverse Event|2|||
27739478|NCT00506389|80874095|FG000|In-treatment Period|Randomized but not treated|4|||
27739479|NCT00506389|80874096|FG001|In-treatment Period|Randomized but not treated|1|||
27739480|NCT00506389|80874097|FG002|In-treatment Period|Randomized but not treated|1|||
27739481|NCT00949650|80874099|FG000|Overall Study|Progressive disease|188|||
27917416|NCT00483652|81536427|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
27917417|NCT00483652|81536428|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
27739482|NCT00949650|80874100|FG001|Overall Study|Progressive disease|19|||
27917418|NCT01791985|81536448|FG000|Overall Study|Adverse Event|7|||
27917419|NCT01791985|81536448|FG000|Overall Study|Withdrawal by Subject|1|||
27917420|NCT03118934|81536449|FG000|Overall Study|Adverse Event|0|||
27917421|NCT03118934|81536450|FG001|Overall Study|Adverse Event|0|||
27633424|NCT02613364|80497729|FG000|Overall Study|Disliked Study Procedure|1|||
27633425|NCT02613364|80497730|FG001|Overall Study|Disliked Study Procedure|1|||
27633426|NCT02613364|80497731|FG002|Overall Study|Disliked Study Procedure|4|||
27633427|NCT02613364|80497729|FG000|Overall Study|Disliked Intervention|0|||
27633428|NCT02613364|80497730|FG001|Overall Study|Disliked Intervention|3|||
27633429|NCT02613364|80497731|FG002|Overall Study|Disliked Intervention|3|||
27633430|NCT01596504|80497732|FG000|Overall Study|Participant's Private Reason|0|||
27633431|NCT01596504|80497733|FG001|Overall Study|Participant's Private Reason|1|||
27633432|NCT01596504|80497734|FG002|Overall Study|Participant's Private Reason|0|||
27633433|NCT01596504|80497732|FG000|Overall Study|Adverse Event|1|||
27633434|NCT01596504|80497733|FG001|Overall Study|Adverse Event|2|||
27633435|NCT01596504|80497734|FG002|Overall Study|Adverse Event|1|||
27633436|NCT01596504|80497732|FG000|Overall Study|Withdrawal by Subject|1|||
27633437|NCT01596504|80497733|FG001|Overall Study|Withdrawal by Subject|0|||
27633438|NCT01596504|80497734|FG002|Overall Study|Withdrawal by Subject|0|||
27633439|NCT00940992|80497736|FG000|Overall Study|Adverse Event|2|||
27633440|NCT00940992|80497737|FG001|Overall Study|Adverse Event|0|||
27633441|NCT00940992|80497738|FG002|Overall Study|Adverse Event|1|||
27633442|NCT00940992|80497736|FG000|Overall Study|subject request|2|||
27633443|NCT00940992|80497737|FG001|Overall Study|subject request|1|||
27633444|NCT00940992|80497738|FG002|Overall Study|subject request|0|||
27633445|NCT00940992|80497736|FG000|Overall Study|Lost to Follow-up|0|||
27633446|NCT00940992|80497737|FG001|Overall Study|Lost to Follow-up|1|||
27633447|NCT00940992|80497738|FG002|Overall Study|Lost to Follow-up|1|||
27633448|NCT02551055|80497739|FG000|Overall Study|Death|2|||
27633449|NCT02551055|80497740|FG001|Overall Study|Death|4|||
27633450|NCT02551055|80497741|FG002|Overall Study|Death|2|||
27739483|NCT00949650|80874099|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
27739484|NCT00949650|80874100|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
27739485|NCT00949650|80874099|FG000|Overall Study|Other Adverse Event (AE)|28|||
27739486|NCT00949650|80874100|FG001|Overall Study|Other Adverse Event (AE)|17|||
27739487|NCT00949650|80874099|FG000|Overall Study|Protocol Violation|1|||
27739488|NCT00949650|80874100|FG001|Overall Study|Protocol Violation|4|||
27739489|NCT00949650|80874099|FG000|Overall Study|Refusal to continue medication|7|||
27739490|NCT00949650|80874100|FG001|Overall Study|Refusal to continue medication|11|||
27739491|NCT00949650|80874099|FG000|Overall Study|Not treated|1|||
27739492|NCT00949650|80874100|FG001|Overall Study|Not treated|4|||
27739493|NCT00949650|80874099|FG000|Overall Study|Other not specified above|5|||
27739494|NCT00949650|80874100|FG001|Overall Study|Other not specified above|0|||
27739495|NCT01121406|80874101|FG000|Overall Study|Progressive disease RECIST|44|||
27739496|NCT01121406|80874102|FG001|Overall Study|Progressive disease RECIST|28|||
27739497|NCT01121406|80874101|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
27739498|NCT01121406|80874102|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
27739499|NCT01121406|80874101|FG000|Overall Study|Other AE|3|||
27739500|NCT01121406|80874102|FG001|Overall Study|Other AE|10|||
27739501|NCT01121406|80874101|FG000|Overall Study|Non-compliant with protocol|0|||
27739502|NCT01121406|80874102|FG001|Overall Study|Non-compliant with protocol|2|||
27739503|NCT01121406|80874101|FG000|Overall Study|Lost to Follow-up|0|||
27917422|NCT03118934|81536451|FG002|Overall Study|Adverse Event|0|||
27917423|NCT03118934|81536452|FG003|Overall Study|Adverse Event|0|||
27917424|NCT03118934|81536453|FG004|Overall Study|Adverse Event|0|||
27917425|NCT03118934|81536454|FG005|Overall Study|Adverse Event|1|||
27917426|NCT03118934|81536449|FG000|Overall Study|Physician Decision|0|||
27917427|NCT03118934|81536450|FG001|Overall Study|Physician Decision|0|||
27917428|NCT03118934|81536451|FG002|Overall Study|Physician Decision|0|||
27917429|NCT03118934|81536452|FG003|Overall Study|Physician Decision|0|||
27917430|NCT03118934|81536453|FG004|Overall Study|Physician Decision|0|||
27917431|NCT03118934|81536454|FG005|Overall Study|Physician Decision|1|||
27917432|NCT03118934|81536449|FG000|Overall Study|Discontinued prior to exposure|0|||
27917433|NCT03118934|81536450|FG001|Overall Study|Discontinued prior to exposure|1|||
27917434|NCT03118934|81536451|FG002|Overall Study|Discontinued prior to exposure|1|||
27917435|NCT03118934|81536452|FG003|Overall Study|Discontinued prior to exposure|1|||
27917436|NCT03118934|81536453|FG004|Overall Study|Discontinued prior to exposure|2|||
27917437|NCT03118934|81536454|FG005|Overall Study|Discontinued prior to exposure|0|||
27739504|NCT01121406|80874102|FG001|Overall Study|Lost to Follow-up|1|||
27739505|NCT01121406|80874101|FG000|Overall Study|Refused continuation of study med.|1|||
27739506|NCT01121406|80874102|FG001|Overall Study|Refused continuation of study med.|2|||
27739507|NCT01121406|80874101|FG000|Overall Study|Reason other than specified above|2|||
27739508|NCT01121406|80874102|FG001|Overall Study|Reason other than specified above|6|||
27917438|NCT01286129|81536468|FG000|Overall Study|Withdrawal by Subject|4|||
27917439|NCT01286129|81536469|FG001|Overall Study|Withdrawal by Subject|1|||
27917440|NCT01286129|81536468|FG000|Overall Study|Could not comply with study requirements|4|||
27633451|NCT02551055|80497742|FG003|Overall Study|Death|2|||
27739509|NCT01121406|80874101|FG000|Overall Study|Not treated|1|||
27739510|NCT01121406|80874102|FG001|Overall Study|Not treated|0|||
27739511|NCT02786537|80874107|FG000|As Randomized|Adverse Event|0|||
27739512|NCT02786537|80874108|FG001|As Randomized|Adverse Event|11|||
27739513|NCT02786537|80874109|FG002|As Randomized|Adverse Event|0|||
27739514|NCT02786537|80874110|FG003|As Randomized|Adverse Event|4|||
27739515|NCT02786537|80874111|FG004|As Randomized|Adverse Event|6|||
27739516|NCT02786537|80874112|FG005|As Randomized|Adverse Event|2|||
27739517|NCT02786537|80874107|FG000|As Randomized|Lack of Efficacy|0|||
27739518|NCT02786537|80874108|FG001|As Randomized|Lack of Efficacy|0|||
27739519|NCT02786537|80874109|FG002|As Randomized|Lack of Efficacy|0|||
27739520|NCT02786537|80874110|FG003|As Randomized|Lack of Efficacy|1|||
27739521|NCT02786537|80874111|FG004|As Randomized|Lack of Efficacy|0|||
27739522|NCT02786537|80874112|FG005|As Randomized|Lack of Efficacy|0|||
27739523|NCT02786537|80874107|FG000|As Randomized|Withdrawal by Subject|1|||
27739524|NCT02786537|80874108|FG001|As Randomized|Withdrawal by Subject|2|||
27739525|NCT02786537|80874109|FG002|As Randomized|Withdrawal by Subject|0|||
27739526|NCT02786537|80874110|FG003|As Randomized|Withdrawal by Subject|1|||
27739527|NCT02786537|80874111|FG004|As Randomized|Withdrawal by Subject|1|||
27739528|NCT02786537|80874112|FG005|As Randomized|Withdrawal by Subject|0|||
27739529|NCT02786537|80874107|FG000|As Randomized|Death|0|||
27739530|NCT02786537|80874108|FG001|As Randomized|Death|2|||
27739531|NCT02786537|80874109|FG002|As Randomized|Death|0|||
27739532|NCT02786537|80874110|FG003|As Randomized|Death|3|||
27739533|NCT02786537|80874111|FG004|As Randomized|Death|1|||
27739534|NCT02786537|80874112|FG005|As Randomized|Death|0|||
27739535|NCT02786537|80874107|FG000|As Randomized|Non-compliance with study drug|1|||
27739536|NCT02786537|80874108|FG001|As Randomized|Non-compliance with study drug|11|||
27739537|NCT02786537|80874109|FG002|As Randomized|Non-compliance with study drug|0|||
27739538|NCT02786537|80874110|FG003|As Randomized|Non-compliance with study drug|1|||
27739539|NCT02786537|80874111|FG004|As Randomized|Non-compliance with study drug|0|||
27739540|NCT02786537|80874112|FG005|As Randomized|Non-compliance with study drug|1|||
27739541|NCT02786537|80874107|FG000|As Randomized|Lost to treatment follow-up|4|||
27739542|NCT02786537|80874108|FG001|As Randomized|Lost to treatment follow-up|32|||
27739543|NCT02786537|80874109|FG002|As Randomized|Lost to treatment follow-up|0|||
27739544|NCT02786537|80874110|FG003|As Randomized|Lost to treatment follow-up|24|||
27739545|NCT02786537|80874111|FG004|As Randomized|Lost to treatment follow-up|4|||
27739546|NCT02786537|80874112|FG005|As Randomized|Lost to treatment follow-up|4|||
27739547|NCT02786537|80874107|FG000|As Randomized|Incarceration|0|||
27739548|NCT02786537|80874108|FG001|As Randomized|Incarceration|1|||
27739549|NCT02786537|80874109|FG002|As Randomized|Incarceration|0|||
27739550|NCT02786537|80874110|FG003|As Randomized|Incarceration|0|||
27739551|NCT02786537|80874111|FG004|As Randomized|Incarceration|0|||
27739552|NCT02786537|80874112|FG005|As Randomized|Incarceration|0|||
27917441|NCT01286129|81536469|FG001|Overall Study|Could not comply with study requirements|4|||
27538456|NCT00347360|80163713|FG014|Overall Study|Did not meet criteria before ABPM|0|||
27538457|NCT00347360|80163699|FG000|Overall Study|Randomized in error|0|||
27538458|NCT00347360|80163700|FG001|Overall Study|Randomized in error|0|||
27538459|NCT00347360|80163701|FG002|Overall Study|Randomized in error|0|||
27538460|NCT00347360|80163702|FG003|Overall Study|Randomized in error|0|||
27538461|NCT00347360|80163703|FG004|Overall Study|Randomized in error|0|||
27538462|NCT00347360|80163704|FG005|Overall Study|Randomized in error|0|||
27538463|NCT00347360|80163705|FG006|Overall Study|Randomized in error|0|||
27538464|NCT00347360|80163706|FG007|Overall Study|Randomized in error|0|||
27538465|NCT00347360|80163707|FG008|Overall Study|Randomized in error|0|||
27538466|NCT00347360|80163708|FG009|Overall Study|Randomized in error|0|||
27538467|NCT00347360|80163709|FG010|Overall Study|Randomized in error|0|||
27538468|NCT00347360|80163710|FG011|Overall Study|Randomized in error|1|||
27538469|NCT00347360|80163711|FG012|Overall Study|Randomized in error|0|||
27538470|NCT00347360|80163712|FG013|Overall Study|Randomized in error|0|||
27538471|NCT00347360|80163713|FG014|Overall Study|Randomized in error|0|||
27538472|NCT00347360|80163699|FG000|Overall Study|Failed inclusion criteria #4|0|||
27538473|NCT00347360|80163700|FG001|Overall Study|Failed inclusion criteria #4|0|||
27739553|NCT02786537|80874107|FG000|As Randomized|Opiate Dependency Relapse|0|||
27739554|NCT02786537|80874108|FG001|As Randomized|Opiate Dependency Relapse|1|||
27739555|NCT02786537|80874109|FG002|As Randomized|Opiate Dependency Relapse|0|||
27739556|NCT02786537|80874110|FG003|As Randomized|Opiate Dependency Relapse|0|||
27739557|NCT02786537|80874111|FG004|As Randomized|Opiate Dependency Relapse|0|||
27739558|NCT02786537|80874112|FG005|As Randomized|Opiate Dependency Relapse|0|||
27739559|NCT02786537|80874107|FG000|As Randomized|HCV drugs stolen from pt|0|||
27739560|NCT02786537|80874108|FG001|As Randomized|HCV drugs stolen from pt|1|||
27538474|NCT00347360|80163701|FG002|Overall Study|Failed inclusion criteria #4|0|||
27633452|NCT02551055|80497743|FG004|Overall Study|Death|2|||
27739561|NCT02786537|80874109|FG002|As Randomized|HCV drugs stolen from pt|0|||
27739562|NCT02786537|80874110|FG003|As Randomized|HCV drugs stolen from pt|0|||
27739563|NCT02786537|80874111|FG004|As Randomized|HCV drugs stolen from pt|0|||
27739564|NCT02786537|80874112|FG005|As Randomized|HCV drugs stolen from pt|0|||
27739565|NCT02786537|80874107|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
27538475|NCT00347360|80163702|FG003|Overall Study|Failed inclusion criteria #4|0|||
27538476|NCT00347360|80163703|FG004|Overall Study|Failed inclusion criteria #4|0|||
27538477|NCT00347360|80163704|FG005|Overall Study|Failed inclusion criteria #4|0|||
27538478|NCT00347360|80163705|FG006|Overall Study|Failed inclusion criteria #4|0|||
27538479|NCT00347360|80163706|FG007|Overall Study|Failed inclusion criteria #4|0|||
27538480|NCT00347360|80163707|FG008|Overall Study|Failed inclusion criteria #4|0|||
27538481|NCT00347360|80163708|FG009|Overall Study|Failed inclusion criteria #4|0|||
27538482|NCT00347360|80163709|FG010|Overall Study|Failed inclusion criteria #4|0|||
27538483|NCT00347360|80163710|FG011|Overall Study|Failed inclusion criteria #4|1|||
27538484|NCT00347360|80163711|FG012|Overall Study|Failed inclusion criteria #4|0|||
27538485|NCT00347360|80163712|FG013|Overall Study|Failed inclusion criteria #4|0|||
27538486|NCT00347360|80163713|FG014|Overall Study|Failed inclusion criteria #4|0|||
27538487|NCT00347360|80163699|FG000|Overall Study|Prolonged duration between visits|0|||
27538488|NCT00347360|80163700|FG001|Overall Study|Prolonged duration between visits|0|||
27538489|NCT00347360|80163701|FG002|Overall Study|Prolonged duration between visits|0|||
27538490|NCT00347360|80163702|FG003|Overall Study|Prolonged duration between visits|0|||
27538491|NCT00347360|80163703|FG004|Overall Study|Prolonged duration between visits|0|||
27538492|NCT00347360|80163704|FG005|Overall Study|Prolonged duration between visits|0|||
27538493|NCT00347360|80163705|FG006|Overall Study|Prolonged duration between visits|0|||
27538494|NCT00347360|80163706|FG007|Overall Study|Prolonged duration between visits|0|||
27538495|NCT00347360|80163707|FG008|Overall Study|Prolonged duration between visits|0|||
27538496|NCT00347360|80163708|FG009|Overall Study|Prolonged duration between visits|0|||
27538497|NCT00347360|80163709|FG010|Overall Study|Prolonged duration between visits|0|||
27538498|NCT00347360|80163710|FG011|Overall Study|Prolonged duration between visits|0|||
27538499|NCT00347360|80163711|FG012|Overall Study|Prolonged duration between visits|1|||
27538500|NCT00347360|80163712|FG013|Overall Study|Prolonged duration between visits|0|||
27538501|NCT00347360|80163713|FG014|Overall Study|Prolonged duration between visits|0|||
27538502|NCT00347360|80163699|FG000|Overall Study|Subject left town, ran out of study drug|0|||
27538503|NCT00347360|80163700|FG001|Overall Study|Subject left town, ran out of study drug|0|||
27538504|NCT00347360|80163701|FG002|Overall Study|Subject left town, ran out of study drug|0|||
27538505|NCT00347360|80163702|FG003|Overall Study|Subject left town, ran out of study drug|0|||
27538506|NCT00347360|80163703|FG004|Overall Study|Subject left town, ran out of study drug|0|||
27538507|NCT00347360|80163704|FG005|Overall Study|Subject left town, ran out of study drug|0|||
27538508|NCT00347360|80163705|FG006|Overall Study|Subject left town, ran out of study drug|0|||
27538509|NCT00347360|80163706|FG007|Overall Study|Subject left town, ran out of study drug|0|||
27538510|NCT00347360|80163707|FG008|Overall Study|Subject left town, ran out of study drug|0|||
27538511|NCT00347360|80163708|FG009|Overall Study|Subject left town, ran out of study drug|0|||
27538512|NCT00347360|80163709|FG010|Overall Study|Subject left town, ran out of study drug|0|||
27538513|NCT00347360|80163710|FG011|Overall Study|Subject left town, ran out of study drug|0|||
27538514|NCT00347360|80163711|FG012|Overall Study|Subject left town, ran out of study drug|0|||
27538515|NCT00347360|80163712|FG013|Overall Study|Subject left town, ran out of study drug|1|||
27538516|NCT00347360|80163713|FG014|Overall Study|Subject left town, ran out of study drug|0|||
27633453|NCT02551055|80497744|FG005|Overall Study|Death|1|||
27633454|NCT02551055|80497745|FG006|Overall Study|Death|2|||
27633455|NCT02551055|80497746|FG007|Overall Study|Death|0|||
27633456|NCT02551055|80497739|FG000|Overall Study|Study Terminated by Sponsor|1|||
27633457|NCT02551055|80497740|FG001|Overall Study|Study Terminated by Sponsor|1|||
27633458|NCT02551055|80497741|FG002|Overall Study|Study Terminated by Sponsor|0|||
27633459|NCT02551055|80497742|FG003|Overall Study|Study Terminated by Sponsor|2|||
27633460|NCT02551055|80497743|FG004|Overall Study|Study Terminated by Sponsor|2|||
27633461|NCT02551055|80497744|FG005|Overall Study|Study Terminated by Sponsor|0|||
27633462|NCT02551055|80497745|FG006|Overall Study|Study Terminated by Sponsor|0|||
27633463|NCT02551055|80497746|FG007|Overall Study|Study Terminated by Sponsor|0|||
27633464|NCT02551055|80497739|FG000|Overall Study|Withdrawal by Subject|1|||
27633465|NCT02551055|80497740|FG001|Overall Study|Withdrawal by Subject|1|||
27633466|NCT02551055|80497741|FG002|Overall Study|Withdrawal by Subject|0|||
27633467|NCT02551055|80497742|FG003|Overall Study|Withdrawal by Subject|1|||
27633468|NCT02551055|80497743|FG004|Overall Study|Withdrawal by Subject|2|||
27633469|NCT02551055|80497744|FG005|Overall Study|Withdrawal by Subject|0|||
27633470|NCT02551055|80497745|FG006|Overall Study|Withdrawal by Subject|0|||
27633471|NCT02551055|80497746|FG007|Overall Study|Withdrawal by Subject|0|||
27633472|NCT02551055|80497739|FG000|Overall Study|Reason not specified|0|||
27633473|NCT02551055|80497740|FG001|Overall Study|Reason not specified|0|||
27633474|NCT02551055|80497741|FG002|Overall Study|Reason not specified|0|||
27633475|NCT02551055|80497742|FG003|Overall Study|Reason not specified|0|||
27633476|NCT02551055|80497743|FG004|Overall Study|Reason not specified|1|||
27633477|NCT02551055|80497744|FG005|Overall Study|Reason not specified|0|||
27633478|NCT02551055|80497745|FG006|Overall Study|Reason not specified|1|||
27633479|NCT02551055|80497746|FG007|Overall Study|Reason not specified|0|||
27633480|NCT01391130|80497747|FG000|Overall Study|Withdrawal by Subject|3|||
27633481|NCT01391130|80497748|FG001|Overall Study|Withdrawal by Subject|2|||
27538517|NCT00347360|80163699|FG000|Overall Study|Subject refuse to sign updated consent|0|||
27538518|NCT00347360|80163700|FG001|Overall Study|Subject refuse to sign updated consent|0|||
27538519|NCT00347360|80163701|FG002|Overall Study|Subject refuse to sign updated consent|0|||
27538520|NCT00347360|80163702|FG003|Overall Study|Subject refuse to sign updated consent|0|||
27538521|NCT00347360|80163703|FG004|Overall Study|Subject refuse to sign updated consent|0|||
27538522|NCT00347360|80163704|FG005|Overall Study|Subject refuse to sign updated consent|0|||
27538523|NCT00347360|80163705|FG006|Overall Study|Subject refuse to sign updated consent|0|||
27538524|NCT00347360|80163706|FG007|Overall Study|Subject refuse to sign updated consent|0|||
27538525|NCT00347360|80163707|FG008|Overall Study|Subject refuse to sign updated consent|0|||
27538526|NCT00347360|80163708|FG009|Overall Study|Subject refuse to sign updated consent|0|||
27538527|NCT00347360|80163709|FG010|Overall Study|Subject refuse to sign updated consent|0|||
27538528|NCT00347360|80163710|FG011|Overall Study|Subject refuse to sign updated consent|0|||
27538529|NCT00347360|80163711|FG012|Overall Study|Subject refuse to sign updated consent|0|||
27538530|NCT00347360|80163712|FG013|Overall Study|Subject refuse to sign updated consent|0|||
27538531|NCT00347360|80163713|FG014|Overall Study|Subject refuse to sign updated consent|1|||
27538532|NCT00347360|80163699|FG000|Overall Study|Visits conflicted with new job|0|||
27917442|NCT00671788|81536470|FG000|Overall Study|Adverse Event|8|||
27917443|NCT00671788|81536470|FG000|Overall Study|Refused further treatment|3|||
27917444|NCT00671788|81536470|FG000|Overall Study|Ineligible|1|||
27917445|NCT00671788|81536470|FG000|Overall Study|MD Decision|1|||
27917446|NCT00671788|81536470|FG000|Overall Study|Other|1|||
27917447|NCT00735709|81536471|FG000|Overall Study|Adverse Event|2|||
27917448|NCT00735709|81536472|FG001|Overall Study|Adverse Event|3|||
27917449|NCT00735709|81536473|FG002|Overall Study|Adverse Event|1|||
27917450|NCT00735709|81536474|FG003|Overall Study|Adverse Event|5|||
27917451|NCT00735709|81536471|FG000|Overall Study|Lack of Efficacy|8|||
27917452|NCT00735709|81536472|FG001|Overall Study|Lack of Efficacy|4|||
27917453|NCT00735709|81536473|FG002|Overall Study|Lack of Efficacy|2|||
27917454|NCT00735709|81536474|FG003|Overall Study|Lack of Efficacy|3|||
27538533|NCT00347360|80163700|FG001|Overall Study|Visits conflicted with new job|0|||
27538534|NCT00347360|80163701|FG002|Overall Study|Visits conflicted with new job|0|||
27633482|NCT01391130|80497747|FG000|Overall Study|Physician Decision|2|||
27633483|NCT01391130|80497748|FG001|Overall Study|Physician Decision|3|||
27739566|NCT02786537|80874108|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
27739567|NCT02786537|80874109|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
27739568|NCT02786537|80874110|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
27739569|NCT02786537|80874111|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
27739570|NCT02786537|80874112|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
27739571|NCT02786537|80874107|FG000|As Randomized|Subject lost insurance|0|||
27739572|NCT02786537|80874108|FG001|As Randomized|Subject lost insurance|0|||
27739573|NCT02786537|80874109|FG002|As Randomized|Subject lost insurance|0|||
27739574|NCT02786537|80874110|FG003|As Randomized|Subject lost insurance|1|||
27739575|NCT02786537|80874111|FG004|As Randomized|Subject lost insurance|0|||
27739576|NCT02786537|80874112|FG005|As Randomized|Subject lost insurance|0|||
27739577|NCT02786537|80874107|FG000|As Treated|Adverse Event|0|||
27739578|NCT02786537|80874108|FG001|As Treated|Adverse Event|11|||
27739579|NCT02786537|80874109|FG002|As Treated|Adverse Event|0|||
27739580|NCT02786537|80874110|FG003|As Treated|Adverse Event|4|||
27739581|NCT02786537|80874111|FG004|As Treated|Adverse Event|6|||
27739582|NCT02786537|80874112|FG005|As Treated|Adverse Event|2|||
27739583|NCT02786537|80874107|FG000|As Treated|Death|0|||
27739584|NCT02786537|80874108|FG001|As Treated|Death|2|||
27739585|NCT02786537|80874109|FG002|As Treated|Death|0|||
27739586|NCT02786537|80874110|FG003|As Treated|Death|3|||
27739587|NCT02786537|80874111|FG004|As Treated|Death|1|||
27739588|NCT02786537|80874112|FG005|As Treated|Death|0|||
27739589|NCT02786537|80874107|FG000|As Treated|Lack of Efficacy|0|||
27739590|NCT02786537|80874108|FG001|As Treated|Lack of Efficacy|0|||
27739591|NCT02786537|80874109|FG002|As Treated|Lack of Efficacy|0|||
27739592|NCT02786537|80874110|FG003|As Treated|Lack of Efficacy|1|||
27739593|NCT02786537|80874111|FG004|As Treated|Lack of Efficacy|0|||
27538535|NCT00347360|80163702|FG003|Overall Study|Visits conflicted with new job|0|||
27739594|NCT02786537|80874112|FG005|As Treated|Lack of Efficacy|0|||
27739595|NCT02786537|80874107|FG000|As Treated|Lost to Follow-up|4|||
27739596|NCT02786537|80874108|FG001|As Treated|Lost to Follow-up|32|||
27739597|NCT02786537|80874109|FG002|As Treated|Lost to Follow-up|0|||
27739598|NCT02786537|80874110|FG003|As Treated|Lost to Follow-up|25|||
27739599|NCT02786537|80874111|FG004|As Treated|Lost to Follow-up|4|||
27739600|NCT02786537|80874112|FG005|As Treated|Lost to Follow-up|4|||
27917455|NCT00735709|81536471|FG000|Overall Study|Noncompliance|0|||
27917456|NCT00735709|81536472|FG001|Overall Study|Noncompliance|0|||
27917457|NCT00735709|81536473|FG002|Overall Study|Noncompliance|1|||
27538536|NCT00347360|80163703|FG004|Overall Study|Visits conflicted with new job|0|||
27538537|NCT00347360|80163704|FG005|Overall Study|Visits conflicted with new job|0|||
27739601|NCT02786537|80874107|FG000|As Treated|Non-compliance with study drug|1|||
27917458|NCT00735709|81536474|FG003|Overall Study|Noncompliance|0|||
27739602|NCT02786537|80874108|FG001|As Treated|Non-compliance with study drug|11|||
27739603|NCT02786537|80874109|FG002|As Treated|Non-compliance with study drug|0|||
27739604|NCT02786537|80874110|FG003|As Treated|Non-compliance with study drug|1|||
27538538|NCT00347360|80163705|FG006|Overall Study|Visits conflicted with new job|1|||
27538539|NCT00347360|80163706|FG007|Overall Study|Visits conflicted with new job|0|||
27538540|NCT00347360|80163707|FG008|Overall Study|Visits conflicted with new job|0|||
27538541|NCT00347360|80163708|FG009|Overall Study|Visits conflicted with new job|0|||
27538542|NCT00347360|80163709|FG010|Overall Study|Visits conflicted with new job|0|||
27538543|NCT00347360|80163710|FG011|Overall Study|Visits conflicted with new job|0|||
27538544|NCT00347360|80163711|FG012|Overall Study|Visits conflicted with new job|0|||
27538545|NCT00347360|80163712|FG013|Overall Study|Visits conflicted with new job|0|||
27538546|NCT00347360|80163713|FG014|Overall Study|Visits conflicted with new job|0|||
27538547|NCT03546062|80163714|FG000|Overall Study|Adverse Event|6|||
27538548|NCT03546062|80163715|FG001|Overall Study|Adverse Event|5|||
27538549|NCT03546062|80163716|FG002|Overall Study|Adverse Event|8|||
27538550|NCT02095223|80163717|FG000|Overall Study|Withdrawal by Subject|1|||
27538551|NCT02095223|80163718|FG001|Overall Study|Withdrawal by Subject|0|||
27538552|NCT01739309|80163719|FG000|Overall Study|Adverse Event|1|||
27538553|NCT01739309|80163719|FG000|Overall Study|Withdrawal by Subject|1|||
27739605|NCT02786537|80874111|FG004|As Treated|Non-compliance with study drug|0|||
27739606|NCT02786537|80874112|FG005|As Treated|Non-compliance with study drug|1|||
27739607|NCT02786537|80874107|FG000|As Treated|Lost insurance|0|||
27739608|NCT02786537|80874108|FG001|As Treated|Lost insurance|0|||
27739609|NCT02786537|80874109|FG002|As Treated|Lost insurance|0|||
27739610|NCT02786537|80874110|FG003|As Treated|Lost insurance|1|||
27739611|NCT02786537|80874111|FG004|As Treated|Lost insurance|0|||
27739612|NCT02786537|80874112|FG005|As Treated|Lost insurance|0|||
27739613|NCT02786537|80874107|FG000|As Treated|Withdrawal by Subject|1|||
27739614|NCT02786537|80874108|FG001|As Treated|Withdrawal by Subject|2|||
27739615|NCT02786537|80874109|FG002|As Treated|Withdrawal by Subject|0|||
27739616|NCT02786537|80874110|FG003|As Treated|Withdrawal by Subject|0|||
27739617|NCT02786537|80874111|FG004|As Treated|Withdrawal by Subject|1|||
27739618|NCT02786537|80874112|FG005|As Treated|Withdrawal by Subject|0|||
27739619|NCT02786537|80874107|FG000|As Treated|Incarceration|0|||
27739620|NCT02786537|80874108|FG001|As Treated|Incarceration|1|||
27739621|NCT02786537|80874109|FG002|As Treated|Incarceration|0|||
27739622|NCT02786537|80874110|FG003|As Treated|Incarceration|0|||
27739623|NCT02786537|80874111|FG004|As Treated|Incarceration|0|||
27739624|NCT02786537|80874112|FG005|As Treated|Incarceration|0|||
27739625|NCT02786537|80874107|FG000|As Treated|Opiate dependency relapse|0|||
27739626|NCT02786537|80874108|FG001|As Treated|Opiate dependency relapse|1|||
27739627|NCT02786537|80874109|FG002|As Treated|Opiate dependency relapse|0|||
27739628|NCT02786537|80874110|FG003|As Treated|Opiate dependency relapse|0|||
27739629|NCT02786537|80874111|FG004|As Treated|Opiate dependency relapse|0|||
27739630|NCT02786537|80874112|FG005|As Treated|Opiate dependency relapse|0|||
27739631|NCT02786537|80874107|FG000|As Treated|Drugs stolen from patient|0|||
27739632|NCT02786537|80874108|FG001|As Treated|Drugs stolen from patient|1|||
27739633|NCT02786537|80874109|FG002|As Treated|Drugs stolen from patient|0|||
27739634|NCT02786537|80874110|FG003|As Treated|Drugs stolen from patient|0|||
27739635|NCT02786537|80874111|FG004|As Treated|Drugs stolen from patient|0|||
27739636|NCT02786537|80874112|FG005|As Treated|Drugs stolen from patient|0|||
27739637|NCT02786537|80874107|FG000|As Treated|Advised to stop tx after loss of meds|0|||
27739638|NCT02786537|80874108|FG001|As Treated|Advised to stop tx after loss of meds|1|||
27739639|NCT02786537|80874109|FG002|As Treated|Advised to stop tx after loss of meds|0|||
27739640|NCT02786537|80874110|FG003|As Treated|Advised to stop tx after loss of meds|0|||
27739641|NCT02786537|80874111|FG004|As Treated|Advised to stop tx after loss of meds|0|||
27739642|NCT02786537|80874112|FG005|As Treated|Advised to stop tx after loss of meds|0|||
27739643|NCT01570491|80874113|FG000|Overall Study|Lost to Follow-up|3|||
27538554|NCT01788046|80163720|FG000|Overall Study|Withdrawal by Subject|12|||
27538555|NCT01788046|80163721|FG001|Overall Study|Withdrawal by Subject|12|||
27538556|NCT01788046|80163720|FG000|Overall Study|Lost to Follow-up|12|||
27739644|NCT01570491|80874114|FG001|Overall Study|Lost to Follow-up|1|||
27739645|NCT01570491|80874113|FG000|Overall Study|treatment: not given or discontinued|2|||
27739646|NCT01570491|80874114|FG001|Overall Study|treatment: not given or discontinued|0|||
27739647|NCT00618956|80874115|FG000|Overall Study|Adverse Event|10|||
27739648|NCT00618956|80874116|FG001|Overall Study|Adverse Event|34|||
27917459|NCT00735709|81536471|FG000|Overall Study|Protocol deviations|1|||
27538557|NCT01788046|80163721|FG001|Overall Study|Lost to Follow-up|19|||
27739649|NCT00618956|80874115|FG000|Overall Study|Lack of Efficacy|2|||
27739650|NCT00618956|80874116|FG001|Overall Study|Lack of Efficacy|1|||
27538558|NCT01788046|80163720|FG000|Overall Study|Death|7|||
27538559|NCT01788046|80163721|FG001|Overall Study|Death|5|||
27538560|NCT01788046|80163720|FG000|Overall Study|Protocol Specified Criteria|25|||
27538561|NCT01788046|80163721|FG001|Overall Study|Protocol Specified Criteria|1|||
27538562|NCT03953820|80163722|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
27538563|NCT03953820|80163723|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
27739651|NCT00618956|80874115|FG000|Overall Study|Withdrawal by Subject|5|||
27739652|NCT00618956|80874116|FG001|Overall Study|Withdrawal by Subject|7|||
27739653|NCT00618956|80874115|FG000|Overall Study|Lost to Follow-up|4|||
27739654|NCT00618956|80874116|FG001|Overall Study|Lost to Follow-up|5|||
27739655|NCT00618956|80874115|FG000|Overall Study|Protocol Violation|2|||
27739656|NCT00618956|80874116|FG001|Overall Study|Protocol Violation|2|||
27739657|NCT00618956|80874115|FG000|Overall Study|did not meet criteria, non-compliance|2|||
27739658|NCT00618956|80874116|FG001|Overall Study|did not meet criteria, non-compliance|1|||
27739659|NCT01634243|80874119|FG000|Overall Study|Adverse Event|5|||
27739660|NCT01634243|80874120|FG001|Overall Study|Adverse Event|5|||
27739661|NCT01634243|80874119|FG000|Overall Study|Lack of Efficacy|1|||
27739662|NCT01634243|80874120|FG001|Overall Study|Lack of Efficacy|0|||
27739663|NCT02723630|80874126|FG000|Intervention Period 1|Adverse Event|1|||
27739664|NCT02723630|80874127|FG001|Intervention Period 1|Adverse Event|0|||
27739665|NCT02723630|80874128|FG002|Intervention Period 1|Adverse Event|0|||
27739666|NCT02723630|80874129|FG003|Intervention Period 1|Adverse Event|0|||
27739667|NCT02723630|80874130|FG004|Intervention Period 1|Adverse Event|0|||
27739668|NCT02723630|80874131|FG005|Intervention Period 1|Adverse Event|0|||
27739669|NCT02723630|80874126|FG000|Intervention Period 3|consumption of restricted item|0|||
27739670|NCT02723630|80874127|FG001|Intervention Period 3|consumption of restricted item|1|||
27739671|NCT02723630|80874128|FG002|Intervention Period 3|consumption of restricted item|0|||
27739672|NCT02723630|80874129|FG003|Intervention Period 3|consumption of restricted item|0|||
27739673|NCT02723630|80874130|FG004|Intervention Period 3|consumption of restricted item|0|||
27739674|NCT02723630|80874131|FG005|Intervention Period 3|consumption of restricted item|0|||
27739675|NCT00753922|80874132|FG000|Overall Study|Lost to Follow-up|155|||
27739676|NCT00753922|80874133|FG001|Overall Study|Lost to Follow-up|24|||
27739677|NCT00753922|80874134|FG002|Overall Study|Lost to Follow-up|28|||
27739678|NCT00753922|80874135|FG003|Overall Study|Lost to Follow-up|5|||
27739679|NCT00753922|80874132|FG000|Overall Study|Withdrawal by Subject|9|||
27739680|NCT00753922|80874133|FG001|Overall Study|Withdrawal by Subject|11|||
27739681|NCT00753922|80874134|FG002|Overall Study|Withdrawal by Subject|4|||
27739682|NCT00753922|80874135|FG003|Overall Study|Withdrawal by Subject|2|||
27739683|NCT00753922|80874132|FG000|Overall Study|Patient Non-compliance|55|||
27739684|NCT00753922|80874133|FG001|Overall Study|Patient Non-compliance|22|||
27739685|NCT00753922|80874134|FG002|Overall Study|Patient Non-compliance|14|||
27739686|NCT00753922|80874135|FG003|Overall Study|Patient Non-compliance|11|||
27739687|NCT00753922|80874132|FG000|Overall Study|Patients Not Completing Visit|11|||
27739688|NCT00753922|80874133|FG001|Overall Study|Patients Not Completing Visit|0|||
27739689|NCT00753922|80874134|FG002|Overall Study|Patients Not Completing Visit|1|||
27739690|NCT00753922|80874135|FG003|Overall Study|Patients Not Completing Visit|0|||
27739691|NCT00753922|80874132|FG000|Overall Study|Death|2|||
27739692|NCT00753922|80874133|FG001|Overall Study|Death|23|||
27739693|NCT00753922|80874134|FG002|Overall Study|Death|2|||
27739694|NCT00753922|80874135|FG003|Overall Study|Death|1|||
27739695|NCT00753922|80874132|FG000|Overall Study|Discontinuation Due to Explantation|14|||
27739696|NCT00753922|80874133|FG001|Overall Study|Discontinuation Due to Explantation|14|||
27739697|NCT00753922|80874134|FG002|Overall Study|Discontinuation Due to Explantation|14|||
27739698|NCT00753922|80874135|FG003|Overall Study|Discontinuation Due to Explantation|4|||
27739699|NCT02873221|80874136|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
27739700|NCT02873221|80874137|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
27739701|NCT02873221|80874138|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
27739702|NCT02873221|80874136|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
27739703|NCT02873221|80874137|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
27538564|NCT03953820|80163724|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
27538565|NCT03953820|80163722|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
27538566|NCT03953820|80163723|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
27538567|NCT03953820|80163724|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
27739704|NCT02873221|80874138|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
27739705|NCT02873221|80874136|FG000|Treatment Period|Protocol Violation|2|||
27739706|NCT02873221|80874137|FG001|Treatment Period|Protocol Violation|5|||
27739707|NCT02873221|80874138|FG002|Treatment Period|Protocol Violation|8|||
27917460|NCT00735709|81536472|FG001|Overall Study|Protocol deviations|2|||
27917461|NCT00735709|81536473|FG002|Overall Study|Protocol deviations|1|||
27538568|NCT00423722|80163727|FG000|Overall Study|Death|4|||
27739708|NCT02873221|80874136|FG000|Treatment Period|Pregnancy|4|||
27917462|NCT00735709|81536474|FG003|Overall Study|Protocol deviations|1|||
27538569|NCT00423722|80163728|FG001|Overall Study|Death|4|||
27739709|NCT02873221|80874137|FG001|Treatment Period|Pregnancy|6|||
27739710|NCT02873221|80874138|FG002|Treatment Period|Pregnancy|3|||
27739711|NCT02873221|80874136|FG000|Treatment Period|Lack of Qualifying Event|0|||
27739712|NCT02873221|80874137|FG001|Treatment Period|Lack of Qualifying Event|3|||
27739713|NCT02873221|80874138|FG002|Treatment Period|Lack of Qualifying Event|1|||
27739714|NCT02873221|80874136|FG000|Treatment Period|Withdrawal of Consent|52|||
27739715|NCT02873221|80874137|FG001|Treatment Period|Withdrawal of Consent|51|||
27538570|NCT00423722|80163727|FG000|Overall Study|Declined to participate|2|||
27739716|NCT02873221|80874138|FG002|Treatment Period|Withdrawal of Consent|41|||
27739717|NCT02873221|80874136|FG000|Treatment Period|Lack of Efficacy|0|||
27739718|NCT02873221|80874137|FG001|Treatment Period|Lack of Efficacy|17|||
27739719|NCT02873221|80874138|FG002|Treatment Period|Lack of Efficacy|12|||
27739720|NCT02873221|80874136|FG000|Treatment Period|Adverse Event|4|||
27739721|NCT02873221|80874137|FG001|Treatment Period|Adverse Event|9|||
27739722|NCT02873221|80874138|FG002|Treatment Period|Adverse Event|11|||
27739723|NCT02873221|80874136|FG000|Treatment Period|Lost to Follow-up|26|||
27739724|NCT02873221|80874137|FG001|Treatment Period|Lost to Follow-up|30|||
27739725|NCT02873221|80874138|FG002|Treatment Period|Lost to Follow-up|26|||
27739726|NCT02873221|80874136|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
27739727|NCT02873221|80874137|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
27739728|NCT02873221|80874138|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
27739729|NCT02873221|80874136|FG000|Safety Follow-up Period|Protocol Violation|0|||
27739730|NCT02873221|80874137|FG001|Safety Follow-up Period|Protocol Violation|0|||
27739731|NCT02873221|80874138|FG002|Safety Follow-up Period|Protocol Violation|1|||
27739732|NCT02873221|80874136|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
27739733|NCT02873221|80874137|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
27739734|NCT02873221|80874138|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
27739735|NCT02873221|80874136|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
27739736|NCT02873221|80874137|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
27739737|NCT02873221|80874138|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
27739738|NCT03607682|80874139|FG000|Overall Study|Withdrawal by Subject|1|||
27739739|NCT03607682|80874139|FG000|Overall Study|Disease progression|1|||
27739740|NCT01362322|80874142|FG000|Overall Study|Withdrawal by Subject|3|||
27739741|NCT01362322|80874143|FG001|Overall Study|Withdrawal by Subject|1|||
27739742|NCT01362322|80874142|FG000|Overall Study|Lost to Follow-up|2|||
27739743|NCT01362322|80874143|FG001|Overall Study|Lost to Follow-up|6|||
27739744|NCT03228186|80874147|FG000|Overall Study|Patient never started treatment|1|||
27739745|NCT02053246|80877293|FG000|Overall Study|Withdrawal by Subject|3|||
27739746|NCT02053246|80877293|FG000|Overall Study|Physician Decision|1|||
27739747|NCT00064701|80877295|FG000|One Year Post-transplant|Did not receive study drug|7|||
27739748|NCT00064701|80877296|FG001|One Year Post-transplant|Did not receive study drug|12|||
27917463|NCT00735709|81536471|FG000|Overall Study|Voluntary Withdrawal|1|||
27917464|NCT00735709|81536472|FG001|Overall Study|Voluntary Withdrawal|3|||
27917465|NCT00735709|81536473|FG002|Overall Study|Voluntary Withdrawal|5|||
27917466|NCT00735709|81536474|FG003|Overall Study|Voluntary Withdrawal|7|||
27917467|NCT00735709|81536471|FG000|Overall Study|Lost to Follow-up|0|||
27917468|NCT00735709|81536472|FG001|Overall Study|Lost to Follow-up|1|||
27917469|NCT00735709|81536473|FG002|Overall Study|Lost to Follow-up|1|||
27917470|NCT00735709|81536474|FG003|Overall Study|Lost to Follow-up|1|||
27917471|NCT00735709|81536471|FG000|Overall Study|Excluded medication|1|||
27917472|NCT00735709|81536472|FG001|Overall Study|Excluded medication|0|||
27917473|NCT00735709|81536473|FG002|Overall Study|Excluded medication|0|||
27917474|NCT00735709|81536474|FG003|Overall Study|Excluded medication|1|||
27917475|NCT01776554|81536475|FG000|Overall Study|Adverse Event|1|||
27917476|NCT01776554|81536476|FG001|Overall Study|Adverse Event|0|||
27917477|NCT01776554|81536475|FG000|Overall Study|Withdrawal by Subject|3|||
27917478|NCT01776554|81536476|FG001|Overall Study|Withdrawal by Subject|8|||
27917479|NCT01776554|81536475|FG000|Overall Study|Lost to Follow-up|6|||
27917480|NCT01776554|81536476|FG001|Overall Study|Lost to Follow-up|9|||
27917481|NCT01776554|81536475|FG000|Overall Study|Administrative Reason|2|||
27917482|NCT01776554|81536476|FG001|Overall Study|Administrative Reason|5|||
27917483|NCT01776554|81536475|FG000|Overall Study|Protocol Violation|1|||
27917484|NCT01776554|81536476|FG001|Overall Study|Protocol Violation|0|||
27917485|NCT01776554|81536475|FG000|Overall Study|Unclassified|4|||
27917486|NCT01776554|81536476|FG001|Overall Study|Unclassified|1|||
27917487|NCT00749398|81536486|FG000|Overall Study|Lack of Efficacy|7|||
27917488|NCT00749398|81536486|FG000|Overall Study|Adverse Event|4|||
27917489|NCT00749398|81536486|FG000|Overall Study|Serious adverse event|11|||
27917490|NCT00749398|81536486|FG000|Overall Study|Withdrawal by Subject|17|||
27917491|NCT00749398|81536486|FG000|Overall Study|Lost to Follow-up|11|||
27917492|NCT00749398|81536486|FG000|Overall Study|Reason not specified|2|||
27917493|NCT00749398|81536486|FG000|Overall Study|Unknown reason|1|||
27917494|NCT00617279|81536487|FG000|Overall Study|Study terminated by Sponsor|10|||
27917495|NCT00617279|81536488|FG001|Overall Study|Study terminated by Sponsor|15|||
27917496|NCT00617279|81536487|FG000|Overall Study|Graft abandonment|2|||
27917497|NCT00617279|81536488|FG001|Overall Study|Graft abandonment|0|||
27917498|NCT00617279|81536487|FG000|Overall Study|Lost to Follow-up|1|||
27739749|NCT00064701|80877297|FG002|One Year Post-transplant|Did not receive study drug|11|||
27739750|NCT00064701|80877295|FG000|One Year Post-transplant|Adverse Event|23|||
27739751|NCT00064701|80877296|FG001|One Year Post-transplant|Adverse Event|19|||
27739752|NCT00064701|80877297|FG002|One Year Post-transplant|Adverse Event|37|||
27739753|NCT00064701|80877295|FG000|One Year Post-transplant|Rejection|0|||
27917499|NCT00617279|81536488|FG001|Overall Study|Lost to Follow-up|0|||
27917500|NCT00617279|81536487|FG000|Overall Study|Death|1|||
27917501|NCT00617279|81536488|FG001|Overall Study|Death|2|||
27538571|NCT00423722|80163728|FG001|Overall Study|Declined to participate|3|||
27538572|NCT00423722|80163727|FG000|Overall Study|Unable to complete questionnaires|4|||
27538573|NCT00423722|80163728|FG001|Overall Study|Unable to complete questionnaires|4|||
27538574|NCT00423722|80163727|FG000|Overall Study|Withdrawal by Subject|4|||
27538575|NCT00423722|80163728|FG001|Overall Study|Withdrawal by Subject|2|||
27633484|NCT01391130|80497747|FG000|Overall Study|Did not Receive Drug|1|||
27633485|NCT01391130|80497748|FG001|Overall Study|Did not Receive Drug|1|||
27633486|NCT00754936|80497749|FG000|Overall Study|Lost to Follow-up|3|||
27633487|NCT00754936|80497749|FG000|Overall Study|Physician Decision|1|||
27917502|NCT02515630|81536489|FG000|Overall Study|Withdrawal by Subject|5|||
27917503|NCT02515630|81536489|FG000|Overall Study|Adverse Event|4|||
27917504|NCT02515630|81536489|FG000|Overall Study|Physician Decision|4|||
27917505|NCT02515630|81536489|FG000|Overall Study|Death|2|||
27917506|NCT02515630|81536489|FG000|Overall Study|Disease Progression|1|||
27917507|NCT02456727|81536490|FG000|Overall Study|Lost to Follow-up|63|||
27633488|NCT00754936|80497749|FG000|Overall Study|Withdrawal by Subject|2|||
27633489|NCT00754936|80497749|FG000|Overall Study|Side Effects|3|||
27633490|NCT00754936|80497749|FG000|Overall Study|Inter-current medical events|3|||
27633491|NCT03808883|80497750|FG000|Overall Study|Withdrawal by Subject|2|||
27633492|NCT03808883|80497751|FG001|Overall Study|Withdrawal by Subject|0|||
27633493|NCT03808883|80497750|FG000|Overall Study|Did not complete pre test or post test survey|4|||
27633494|NCT03808883|80497751|FG001|Overall Study|Did not complete pre test or post test survey|3|||
27633495|NCT00486330|80497752|FG000|Overall Study|Adverse Event|2|||
27633496|NCT02104765|80497753|FG000|Overall Study|Lost to Follow-up|0|||
27633497|NCT02104765|80497754|FG001|Overall Study|Lost to Follow-up|0|||
27633498|NCT02104765|80497755|FG002|Overall Study|Lost to Follow-up|1|||
27633499|NCT02104765|80497756|FG003|Overall Study|Lost to Follow-up|0|||
27739754|NCT00064701|80877296|FG001|One Year Post-transplant|Rejection|1|||
27739755|NCT00064701|80877297|FG002|One Year Post-transplant|Rejection|16|||
27739756|NCT00064701|80877295|FG000|One Year Post-transplant|Non-compliance|4|||
27739757|NCT00064701|80877296|FG001|One Year Post-transplant|Non-compliance|2|||
27739758|NCT00064701|80877297|FG002|One Year Post-transplant|Non-compliance|5|||
27739759|NCT00064701|80877295|FG000|One Year Post-transplant|Graft Failure|3|||
27739760|NCT00064701|80877296|FG001|One Year Post-transplant|Graft Failure|2|||
27739761|NCT00064701|80877297|FG002|One Year Post-transplant|Graft Failure|1|||
27739762|NCT00064701|80877295|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
27917508|NCT02456727|81536491|FG001|Overall Study|Lost to Follow-up|65|||
27917509|NCT02456727|81536490|FG000|Overall Study|Death|2|||
27917510|NCT02456727|81536491|FG001|Overall Study|Death|1|||
27917511|NCT02456727|81536490|FG000|Overall Study|Withdrawal by Subject|1|||
27917512|NCT02456727|81536491|FG001|Overall Study|Withdrawal by Subject|10|||
27917513|NCT02456727|81536490|FG000|Overall Study|Never Initiated Treatment|43|||
27917514|NCT02456727|81536491|FG001|Overall Study|Never Initiated Treatment|30|||
27917515|NCT01619865|81536492|FG000|Overall Study|Adverse Event|1|||
27917516|NCT01619865|81536492|FG000|Overall Study|Death|2|||
27917517|NCT01619865|81536492|FG000|Overall Study|subject not able to comply|1|||
27917518|NCT01883895|81536495|FG000|Overall Study|Lost to Follow-up|2|||
27917519|NCT00511810|81536496|FG000|Overall Study|Lost to Follow-up|1|||
27917520|NCT00511810|81536497|FG001|Overall Study|Lost to Follow-up|2|||
27917521|NCT00511810|81536496|FG000|Overall Study|Lack of Efficacy|0|||
27538576|NCT00181155|80163731|FG000|Overall Study|Physician Decision|1|||
27538577|NCT00181155|80163732|FG001|Overall Study|Physician Decision|0|||
27538578|NCT00181155|80163731|FG000|Overall Study|Withdrawal by Subject|1|||
27538579|NCT00181155|80163732|FG001|Overall Study|Withdrawal by Subject|0|||
27538580|NCT01871142|80163739|FG000|Overall Study|Adverse Event|1|||
27538581|NCT00165984|80163744|FG000|Overall Study|Death|15|||
27538582|NCT00137631|80166900|FG000|Overall Study|Lost to Follow-up|37|||
27538583|NCT00137631|80166901|FG001|Overall Study|Lost to Follow-up|41|||
27538584|NCT04218695|80166902|FG000|Overall Study|Adverse Event|1|||
27538585|NCT04218695|80166903|FG001|Overall Study|Adverse Event|0|||
27538586|NCT02171065|80166906|FG000|Overall Study|Withdrawal by Subject|1|||
27538587|NCT02171065|80166907|FG001|Overall Study|Withdrawal by Subject|0|||
27633500|NCT02104765|80497757|FG004|Overall Study|Lost to Follow-up|0|||
27739763|NCT00064701|80877296|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
27917522|NCT00511810|81536497|FG001|Overall Study|Lack of Efficacy|2|||
27917523|NCT00511810|81536496|FG000|Overall Study|Refused second scn|0|||
27538588|NCT02171065|80166908|FG002|Overall Study|Withdrawal by Subject|0|||
27538589|NCT02171065|80166906|FG000|Overall Study|Lost to Follow-up|0|||
27633501|NCT02104765|80497758|FG005|Overall Study|Lost to Follow-up|0|||
27633502|NCT02104765|80497759|FG006|Overall Study|Lost to Follow-up|0|||
27633503|NCT02104765|80497753|FG000|Overall Study|Withdrawal by Subject|0|||
27633504|NCT02104765|80497754|FG001|Overall Study|Withdrawal by Subject|0|||
27917524|NCT00511810|81536497|FG001|Overall Study|Refused second scn|1|||
27917525|NCT02287038|81536500|FG000|Overall Study|Stopped attending appointments|3|||
27538590|NCT02171065|80166907|FG001|Overall Study|Lost to Follow-up|0|||
27538591|NCT02171065|80166908|FG002|Overall Study|Lost to Follow-up|1|||
27538592|NCT01193530|80166909|FG000|Overall Study|Withdrawal by Subject|2|||
27538593|NCT01193530|80166910|FG001|Overall Study|Withdrawal by Subject|2|||
27538594|NCT01193530|80166909|FG000|Overall Study|Began Contraindicated Therapy|1|||
27538595|NCT01193530|80166910|FG001|Overall Study|Began Contraindicated Therapy|0|||
27538596|NCT01193530|80166909|FG000|Overall Study|Lost Light Box|0|||
27538597|NCT01193530|80166910|FG001|Overall Study|Lost Light Box|1|||
27538598|NCT01193530|80166909|FG000|Overall Study|Returned home - out of state|0|||
27538599|NCT01193530|80166910|FG001|Overall Study|Returned home - out of state|1|||
27538600|NCT01193530|80166909|FG000|Overall Study|Non-Compliance|0|||
27633505|NCT02104765|80497755|FG002|Overall Study|Withdrawal by Subject|0|||
27633506|NCT02104765|80497756|FG003|Overall Study|Withdrawal by Subject|1|||
27633507|NCT02104765|80497757|FG004|Overall Study|Withdrawal by Subject|1|||
27633508|NCT02104765|80497758|FG005|Overall Study|Withdrawal by Subject|0|||
27633509|NCT02104765|80497759|FG006|Overall Study|Withdrawal by Subject|1|||
27633510|NCT02194933|80497760|FG000|Overall Study|Lost to Follow-up|1|||
27633511|NCT02194933|80497761|FG001|Overall Study|Lost to Follow-up|2|||
27633512|NCT02194933|80497760|FG000|Overall Study|Participant met withdrawal criteria|1|||
27633513|NCT02194933|80497761|FG001|Overall Study|Participant met withdrawal criteria|3|||
27633514|NCT02194933|80497760|FG000|Overall Study|Withdrawal by Subject|0|||
27633515|NCT02194933|80497761|FG001|Overall Study|Withdrawal by Subject|2|||
27633516|NCT02194933|80497760|FG000|Overall Study|Lack of Efficacy|1|||
27633517|NCT02194933|80497761|FG001|Overall Study|Lack of Efficacy|2|||
27633518|NCT04439799|80497762|FG000|Overall Study|Lost to Follow-up|6|||
27633519|NCT04439799|80497763|FG001|Overall Study|Lost to Follow-up|6|||
27633520|NCT04439799|80497762|FG000|Overall Study|Withdrawal by Subject|2|||
27633521|NCT04439799|80497763|FG001|Overall Study|Withdrawal by Subject|6|||
27633522|NCT04439799|80497762|FG000|Overall Study|Adverse Event|2|||
27633523|NCT04439799|80497763|FG001|Overall Study|Adverse Event|5|||
27633524|NCT00726999|80497764|FG000|Overall Study|Physician Decision|0|||
27633525|NCT00726999|80497765|FG001|Overall Study|Physician Decision|1|||
27633526|NCT00726999|80497764|FG000|Overall Study|Withdrawal by Subject|2|||
27633527|NCT00726999|80497765|FG001|Overall Study|Withdrawal by Subject|0|||
27633528|NCT00726999|80497764|FG000|Overall Study|Protocol Violation|1|||
27633529|NCT00726999|80497765|FG001|Overall Study|Protocol Violation|0|||
27633530|NCT05274217|80497766|FG000|Overall Study|Study terminated.|11|||
27633531|NCT05274217|80497767|FG001|Overall Study|Study terminated.|0|||
27633532|NCT03478956|80497768|FG000|Overall Study|Adverse Event|1|||
27633533|NCT03478956|80497769|FG001|Overall Study|Adverse Event|0|||
27633534|NCT03478956|80497768|FG000|Overall Study|Withdrawal by Subject|0|||
27917526|NCT02287038|81536501|FG001|Overall Study|Stopped attending appointments|2|||
27917527|NCT02287038|81536500|FG000|Overall Study|Anxiety after starting medication|0|||
27917528|NCT02287038|81536501|FG001|Overall Study|Anxiety after starting medication|1|||
27917529|NCT02287038|81536500|FG000|Overall Study|Nausea after starting medication|1|||
27917530|NCT02287038|81536501|FG001|Overall Study|Nausea after starting medication|0|||
27917531|NCT02287038|81536500|FG000|Overall Study|Abnormal ECG after starting medication|1|||
27917532|NCT02287038|81536501|FG001|Overall Study|Abnormal ECG after starting medication|0|||
27917533|NCT02662569|81536504|FG000|Overall Study|Withdrawal by Subject|6|||
27917534|NCT02662569|81536505|FG001|Overall Study|Withdrawal by Subject|1|||
27917535|NCT02662569|81536506|FG002|Overall Study|Withdrawal by Subject|6|||
27917536|NCT02662569|81536507|FG003|Overall Study|Withdrawal by Subject|4|||
27917537|NCT02662569|81536504|FG000|Overall Study|Lost to Follow-up|1|||
27917538|NCT02662569|81536505|FG001|Overall Study|Lost to Follow-up|0|||
27917539|NCT02662569|81536506|FG002|Overall Study|Lost to Follow-up|0|||
27917540|NCT02662569|81536507|FG003|Overall Study|Lost to Follow-up|0|||
27917541|NCT02557295|81536512|FG000|Overall Study|Withdrawal by Subject|9|||
27917542|NCT02557295|81536513|FG001|Overall Study|Withdrawal by Subject|2|||
27917543|NCT02557295|81536514|FG002|Overall Study|Withdrawal by Subject|4|||
27917544|NCT02557295|81536515|FG003|Overall Study|Withdrawal by Subject|0|||
27917545|NCT02557295|81536516|FG004|Overall Study|Withdrawal by Subject|0|||
27917546|NCT02557295|81536517|FG005|Overall Study|Withdrawal by Subject|0|||
27917547|NCT02557295|81536518|FG006|Overall Study|Withdrawal by Subject|15|||
27917548|NCT02557295|81536519|FG007|Overall Study|Withdrawal by Subject|1|||
27917549|NCT02557295|81536520|FG008|Overall Study|Withdrawal by Subject|3|||
27917550|NCT02557295|81536512|FG000|Overall Study|Disease Progression|0|||
27917551|NCT02557295|81536513|FG001|Overall Study|Disease Progression|0|||
27633535|NCT03478956|80497769|FG001|Overall Study|Withdrawal by Subject|1|||
27633536|NCT03478956|80497768|FG000|Overall Study|Ongoing in the Study|11|||
27633537|NCT03478956|80497769|FG001|Overall Study|Ongoing in the Study|11|||
27633538|NCT00855465|80497770|FG000|Treatment Period|Adverse Event|4|||
27917552|NCT02557295|81536514|FG002|Overall Study|Disease Progression|0|||
27633539|NCT00855465|80497771|FG001|Treatment Period|Adverse Event|2|||
27633540|NCT00855465|80497770|FG000|Treatment Period|Death|2|||
27633541|NCT00855465|80497771|FG001|Treatment Period|Death|2|||
27917553|NCT02557295|81536515|FG003|Overall Study|Disease Progression|0|||
27633542|NCT00855465|80497770|FG000|Treatment Period|Lack of Efficacy|2|||
27538601|NCT01193530|80166910|FG001|Overall Study|Non-Compliance|1|||
27538602|NCT00066365|80166911|FG000|Overall Study|Adverse Event|1|||
27917554|NCT02557295|81536516|FG004|Overall Study|Disease Progression|0|||
27538603|NCT00066365|80166912|FG001|Overall Study|Adverse Event|0|||
27917555|NCT02557295|81536517|FG005|Overall Study|Disease Progression|0|||
27917556|NCT02557295|81536518|FG006|Overall Study|Disease Progression|1|||
27917557|NCT02557295|81536519|FG007|Overall Study|Disease Progression|0|||
27917558|NCT02557295|81536520|FG008|Overall Study|Disease Progression|0|||
27538604|NCT00066365|80166911|FG000|Overall Study|Lack of Efficacy|15|||
27538605|NCT00066365|80166912|FG001|Overall Study|Lack of Efficacy|12|||
27633543|NCT00855465|80497771|FG001|Treatment Period|Lack of Efficacy|1|||
27633544|NCT00855465|80497770|FG000|Treatment Period|Non-compliance|1|||
27538606|NCT00066365|80166911|FG000|Overall Study|Physician Decision|1|||
27538607|NCT00066365|80166912|FG001|Overall Study|Physician Decision|0|||
27538608|NCT00066365|80166911|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
27538609|NCT00066365|80166912|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
27538610|NCT00066365|80166911|FG000|Overall Study|Ineligible|4|||
27538611|NCT00066365|80166912|FG001|Overall Study|Ineligible|2|||
27538612|NCT00892047|80166913|FG000|Overall Study|Adverse Event|2|||
27538613|NCT00892047|80166914|FG001|Overall Study|Adverse Event|2|||
27538614|NCT00892047|80166913|FG000|Overall Study|subject burden|2|||
27538615|NCT00892047|80166914|FG001|Overall Study|subject burden|3|||
27538616|NCT00892047|80166913|FG000|Overall Study|Lack of Efficacy|0|||
27538617|NCT00892047|80166914|FG001|Overall Study|Lack of Efficacy|2|||
27538618|NCT03113071|80166919|FG000|Overall Study|Withdrawal by Subject|1|||
27538619|NCT03113071|80166920|FG001|Overall Study|Withdrawal by Subject|0|||
27538620|NCT00397215|80166921|FG000|Month 0 (Day 0)|Adverse Event|0|||
27538621|NCT00397215|80166922|FG001|Month 0 (Day 0)|Adverse Event|1|||
27538622|NCT00397215|80166923|FG002|Month 0 (Day 0)|Adverse Event|0|||
27538623|NCT00397215|80166924|FG003|Month 0 (Day 0)|Adverse Event|0|||
27538624|NCT00397215|80166921|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
27538625|NCT00397215|80166922|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
27538626|NCT00397215|80166923|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
27538627|NCT00397215|80166924|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
27538628|NCT00397215|80166921|FG000|Month 0 (Day 0)|Other|4|||
27538629|NCT00397215|80166922|FG001|Month 0 (Day 0)|Other|1|||
27538630|NCT00397215|80166923|FG002|Month 0 (Day 0)|Other|3|||
27538631|NCT00397215|80166924|FG003|Month 0 (Day 0)|Other|3|||
27538632|NCT00397215|80166921|FG000|Month 6 (Day 180)|Adverse Event|0|||
27538633|NCT00397215|80166922|FG001|Month 6 (Day 180)|Adverse Event|3|||
27538634|NCT00397215|80166923|FG002|Month 6 (Day 180)|Adverse Event|2|||
27538635|NCT00397215|80166924|FG003|Month 6 (Day 180)|Adverse Event|0|||
27538636|NCT00397215|80166921|FG000|Month 6 (Day 180)|Other|2|||
27538637|NCT00397215|80166922|FG001|Month 6 (Day 180)|Other|0|||
27538638|NCT00397215|80166923|FG002|Month 6 (Day 180)|Other|3|||
27538639|NCT00397215|80166924|FG003|Month 6 (Day 180)|Other|0|||
27538640|NCT00085709|80166925|FG000|Overall Study|Adverse Event|8|||
27538641|NCT00085709|80166926|FG001|Overall Study|Adverse Event|0|||
27633545|NCT00855465|80497771|FG001|Treatment Period|Non-compliance|0|||
27633546|NCT00855465|80497770|FG000|Treatment Period|Protocol Violation|2|||
27633547|NCT00855465|80497771|FG001|Treatment Period|Protocol Violation|0|||
27633548|NCT00855465|80497770|FG000|Treatment Period|Withdrawal by Subject|2|||
27633549|NCT00855465|80497771|FG001|Treatment Period|Withdrawal by Subject|0|||
27633550|NCT00855465|80497770|FG000|Treatment Period|Not treated|1|||
27633551|NCT00855465|80497771|FG001|Treatment Period|Not treated|0|||
27633552|NCT00855465|80497770|FG000|Follow-up Period (FUP)|Adverse Event|0|||
27633553|NCT00855465|80497771|FG001|Follow-up Period (FUP)|Adverse Event|1|||
27633554|NCT00855465|80497770|FG000|Follow-up Period (FUP)|Death|0|||
27633555|NCT00855465|80497771|FG001|Follow-up Period (FUP)|Death|1|||
27633556|NCT00855465|80497770|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
27633557|NCT00855465|80497771|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
27633558|NCT00855465|80497770|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
27633559|NCT00855465|80497771|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
27633560|NCT00855465|80497770|FG000|Follow-up Period (FUP)|Missing|1|||
27538642|NCT00085709|80166925|FG000|Overall Study|Death|8|||
27538643|NCT00085709|80166926|FG001|Overall Study|Death|2|||
27538644|NCT00085709|80166925|FG000|Overall Study|Refusal unrelated to adverse events|1|||
27538645|NCT00085709|80166926|FG001|Overall Study|Refusal unrelated to adverse events|2|||
27538646|NCT00085709|80166925|FG000|Overall Study|Progression|3|||
27633561|NCT00855465|80497771|FG001|Follow-up Period (FUP)|Missing|0|||
27633562|NCT01597258|80497775|FG000|Overall Study|No Drug Administration|1|||
27633563|NCT04678830|80497776|FG000|Overall Study|Lack of Efficacy|2|||
27917559|NCT02557295|81536512|FG000|Overall Study|Lack of Efficacy|24|||
27633564|NCT04678830|80497777|FG001|Overall Study|Lack of Efficacy|0|||
27538647|NCT00085709|80166926|FG001|Overall Study|Progression|4|||
27633565|NCT04678830|80497776|FG000|Overall Study|Withdrawal by Subject|0|||
27538648|NCT00085709|80166925|FG000|Overall Study|Not protocol specified|12|||
27538649|NCT00085709|80166926|FG001|Overall Study|Not protocol specified|22|||
27538650|NCT00085709|80166925|FG000|Overall Study|Not eligible|19|||
27538651|NCT00085709|80166926|FG001|Overall Study|Not eligible|19|||
27538652|NCT00085709|80166925|FG000|Overall Study|Withdrawal by Subject|2|||
27538653|NCT00085709|80166926|FG001|Overall Study|Withdrawal by Subject|1|||
27538654|NCT01145625|80166927|FG000|Overall Study|Lost to Follow-up|8|||
27538655|NCT01145625|80166928|FG001|Overall Study|Lost to Follow-up|9|||
27538656|NCT01145625|80166927|FG000|Overall Study|Adverse Event|6|||
27538657|NCT01145625|80166928|FG001|Overall Study|Adverse Event|4|||
27538658|NCT01145625|80166927|FG000|Overall Study|Protocol Violation|3|||
27633566|NCT04678830|80497777|FG001|Overall Study|Withdrawal by Subject|1|||
27633567|NCT00442117|80497782|FG000|Overall Study|Adverse Event|3|||
27633568|NCT00442117|80497783|FG001|Overall Study|Adverse Event|2|||
27633569|NCT00442117|80497782|FG000|Overall Study|Lack of Efficacy|2|||
27633570|NCT00442117|80497783|FG001|Overall Study|Lack of Efficacy|6|||
27633571|NCT00442117|80497782|FG000|Overall Study|Lost to Follow-up|1|||
27633572|NCT00442117|80497783|FG001|Overall Study|Lost to Follow-up|2|||
27633573|NCT00442117|80497782|FG000|Overall Study|Withdrawal by Subject|2|||
27633574|NCT00442117|80497783|FG001|Overall Study|Withdrawal by Subject|2|||
27917560|NCT02557295|81536513|FG001|Overall Study|Lack of Efficacy|1|||
27917561|NCT02557295|81536514|FG002|Overall Study|Lack of Efficacy|3|||
27917562|NCT02557295|81536515|FG003|Overall Study|Lack of Efficacy|0|||
27917563|NCT02557295|81536516|FG004|Overall Study|Lack of Efficacy|0|||
27917564|NCT02557295|81536517|FG005|Overall Study|Lack of Efficacy|0|||
27917565|NCT02557295|81536518|FG006|Overall Study|Lack of Efficacy|12|||
27917566|NCT02557295|81536519|FG007|Overall Study|Lack of Efficacy|1|||
27917567|NCT02557295|81536520|FG008|Overall Study|Lack of Efficacy|0|||
27917568|NCT02557295|81536512|FG000|Overall Study|Adverse Event|16|||
27917569|NCT02557295|81536513|FG001|Overall Study|Adverse Event|2|||
27917570|NCT02557295|81536514|FG002|Overall Study|Adverse Event|3|||
27917571|NCT02557295|81536515|FG003|Overall Study|Adverse Event|0|||
27538659|NCT01145625|80166928|FG001|Overall Study|Protocol Violation|1|||
27538660|NCT01145625|80166927|FG000|Overall Study|Withdrawal by Subject|7|||
27538661|NCT01145625|80166928|FG001|Overall Study|Withdrawal by Subject|16|||
27538662|NCT01145625|80166927|FG000|Overall Study|Pregnancy|0|||
27538663|NCT01145625|80166928|FG001|Overall Study|Pregnancy|1|||
27538664|NCT01890473|80166932|FG000|Overall Study|Lost to Follow-up|1|||
27538665|NCT01890473|80166933|FG001|Overall Study|Lost to Follow-up|0|||
27538666|NCT01890473|80166932|FG000|Overall Study|Poor/non-compliance|1|||
27538667|NCT01890473|80166933|FG001|Overall Study|Poor/non-compliance|0|||
27538668|NCT05085730|80166938|FG000|Overall Study|Withdrawal by Subject|4|||
27538669|NCT05085730|80166938|FG000|Overall Study|Physician Decision|1|||
27538670|NCT01696071|80166939|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
27538671|NCT01696071|80166940|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
27538672|NCT00691301|80166941|FG000|Overall Study|Adverse Event|10|||
27538673|NCT00691301|80166941|FG000|Overall Study|Death|2|||
27538674|NCT00691301|80166941|FG000|Overall Study|Lack of Efficacy|32|||
27538675|NCT00691301|80166941|FG000|Overall Study|Withdrawal by Subject|4|||
27538676|NCT00691301|80166941|FG000|Overall Study|Concurrent illness|2|||
27538677|NCT00691301|80166941|FG000|Overall Study|other reason|3|||
27538678|NCT00691301|80166941|FG000|Overall Study|Did not initiate study treatment|1|||
27538679|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
27538680|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
27538681|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
27538682|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
27538683|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
27538684|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
27538685|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
27538686|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
27538687|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
27538688|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
27538689|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
27538690|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
27538691|NCT00044083|80166942|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
27538692|NCT00044083|80166943|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
27538693|NCT00044083|80166942|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
27538694|NCT00044083|80166943|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
27538695|NCT00044083|80166942|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
27538696|NCT00044083|80166943|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
27538697|NCT00044083|80166942|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
27538698|NCT00044083|80166943|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
27538699|NCT00781274|80166944|FG000|Overall Study|Withdrawal by Subject|2|||
27917572|NCT02557295|81536516|FG004|Overall Study|Adverse Event|0|||
27917573|NCT02557295|81536517|FG005|Overall Study|Adverse Event|0|||
27538700|NCT03344796|80166945|FG000|Overall Study|Lost to Follow-up|0|||
27538701|NCT03344796|80166946|FG001|Overall Study|Lost to Follow-up|0|||
27538702|NCT03344796|80166947|FG002|Overall Study|Lost to Follow-up|0|||
27633575|NCT00442117|80497782|FG000|Overall Study|Major Deviation|25|||
27633576|NCT00442117|80497783|FG001|Overall Study|Major Deviation|20|||
27633577|NCT00442117|80497782|FG000|Overall Study|Non compliance with protocol|3|||
27917574|NCT02557295|81536518|FG006|Overall Study|Adverse Event|2|||
27917575|NCT02557295|81536519|FG007|Overall Study|Adverse Event|1|||
27538703|NCT03344796|80166948|FG003|Overall Study|Lost to Follow-up|0|||
27538704|NCT03344796|80166949|FG004|Overall Study|Lost to Follow-up|0|||
27538705|NCT03344796|80166950|FG005|Overall Study|Lost to Follow-up|2|||
27538706|NCT04545385|80166951|FG000|Overall Study|Withdrawal by Subject|2|||
27538707|NCT04545385|80166952|FG001|Overall Study|Withdrawal by Subject|0|||
27538708|NCT04545385|80166951|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
27633578|NCT00442117|80497783|FG001|Overall Study|Non compliance with protocol|5|||
27917576|NCT02557295|81536520|FG008|Overall Study|Adverse Event|1|||
27917577|NCT02557295|81536512|FG000|Overall Study|Lost to Follow-up|4|||
27917578|NCT02557295|81536513|FG001|Overall Study|Lost to Follow-up|0|||
27917579|NCT02557295|81536514|FG002|Overall Study|Lost to Follow-up|0|||
27917580|NCT02557295|81536515|FG003|Overall Study|Lost to Follow-up|0|||
27917581|NCT02557295|81536516|FG004|Overall Study|Lost to Follow-up|0|||
27917582|NCT02557295|81536517|FG005|Overall Study|Lost to Follow-up|0|||
27917583|NCT02557295|81536518|FG006|Overall Study|Lost to Follow-up|9|||
27917584|NCT02557295|81536519|FG007|Overall Study|Lost to Follow-up|0|||
27917585|NCT02557295|81536520|FG008|Overall Study|Lost to Follow-up|0|||
27917586|NCT02557295|81536512|FG000|Overall Study|Study Close|54|||
27917587|NCT02557295|81536513|FG001|Overall Study|Study Close|3|||
27917588|NCT02557295|81536514|FG002|Overall Study|Study Close|5|||
27917589|NCT02557295|81536515|FG003|Overall Study|Study Close|3|||
27917590|NCT02557295|81536516|FG004|Overall Study|Study Close|0|||
27917591|NCT02557295|81536517|FG005|Overall Study|Study Close|0|||
27917592|NCT02557295|81536518|FG006|Overall Study|Study Close|37|||
27917593|NCT02557295|81536519|FG007|Overall Study|Study Close|3|||
27917594|NCT02557295|81536520|FG008|Overall Study|Study Close|19|||
27917595|NCT02557295|81536512|FG000|Overall Study|except for study close|4|||
27917596|NCT02557295|81536513|FG001|Overall Study|except for study close|0|||
27917597|NCT02557295|81536514|FG002|Overall Study|except for study close|0|||
27917598|NCT02557295|81536515|FG003|Overall Study|except for study close|0|||
27538709|NCT04545385|80166952|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
27538710|NCT04545385|80166951|FG000|Overall Study|Study termination|10|||
27538711|NCT04545385|80166952|FG001|Overall Study|Study termination|10|||
27538712|NCT04545385|80166951|FG000|Overall Study|Sponsor decision|2|||
27538713|NCT04545385|80166952|FG001|Overall Study|Sponsor decision|2|||
27538714|NCT04545385|80166951|FG000|Overall Study|Other than specified|1|||
27538715|NCT04545385|80166952|FG001|Overall Study|Other than specified|0|||
27538716|NCT01390649|80166959|FG000|Overall Study|Physician Decision|1|||
27538717|NCT00516074|80166961|FG000|Overall Study|Adverse Event|0|||
27538718|NCT00516074|80166962|FG001|Overall Study|Adverse Event|1|||
27538719|NCT00516074|80166961|FG000|Overall Study|Subject Decision|4|||
27538720|NCT00516074|80166962|FG001|Overall Study|Subject Decision|2|||
27538721|NCT00516074|80166961|FG000|Overall Study|Loss of Glucose Control|2|||
27538722|NCT00516074|80166962|FG001|Overall Study|Loss of Glucose Control|0|||
27633579|NCT00442117|80497782|FG000|Overall Study|Met Withdrawal Criteria|2|||
27633580|NCT00442117|80497783|FG001|Overall Study|Met Withdrawal Criteria|1|||
27917599|NCT02557295|81536516|FG004|Overall Study|except for study close|0|||
27917600|NCT02557295|81536517|FG005|Overall Study|except for study close|0|||
27917601|NCT02557295|81536518|FG006|Overall Study|except for study close|5|||
27917602|NCT02557295|81536519|FG007|Overall Study|except for study close|1|||
27917603|NCT02557295|81536520|FG008|Overall Study|except for study close|0|||
27917604|NCT02154139|81536523|FG000|Overall Study|Injection not administered|2|||
27917605|NCT02154139|81536523|FG000|Overall Study|Other|2|||
27917606|NCT02154139|81536523|FG000|Overall Study|Investigator transferred|3|||
27917607|NCT03234465|81536528|FG000|Overall Study|Adverse Event|4|||
27917608|NCT03234465|81536529|FG001|Overall Study|Adverse Event|2|||
27917609|NCT03234465|81536528|FG000|Overall Study|Death|0|||
27917610|NCT03234465|81536529|FG001|Overall Study|Death|1|||
27917611|NCT03234465|81536528|FG000|Overall Study|Lost to Follow-up|1|||
27917612|NCT03234465|81536529|FG001|Overall Study|Lost to Follow-up|1|||
27917613|NCT03234465|81536528|FG000|Overall Study|Withdrawal by Subject|12|||
27917614|NCT03234465|81536529|FG001|Overall Study|Withdrawal by Subject|27|||
27917615|NCT03234465|81536528|FG000|Overall Study|Symptomatic deterioration|0|||
27917616|NCT03234465|81536529|FG001|Overall Study|Symptomatic deterioration|1|||
27917617|NCT03234465|81536528|FG000|Overall Study|Non-compliance|2|||
27917618|NCT03234465|81536529|FG001|Overall Study|Non-compliance|0|||
27917619|NCT03234465|81536528|FG000|Overall Study|Other|14|||
27917620|NCT03234465|81536529|FG001|Overall Study|Other|8|||
27917621|NCT00073918|81536530|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
27917622|NCT00073918|81536530|FG000|Overall Study|Rapid disease progression|2|||
27917623|NCT00073918|81536530|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
27917624|NCT00528424|81536532|FG000|Overall Study|Lost to Follow-up|13|||
27917625|NCT00528424|81536532|FG000|Overall Study|Withdrew consent|2|||
27538723|NCT00074984|80166963|FG000|Overall Study|Death|1|||
27538724|NCT00074984|80166964|FG001|Overall Study|Death|2|||
27538725|NCT00074984|80166963|FG000|Overall Study|Withdrawal by Subject|2|||
27633581|NCT00101010|80500216|FG000|Overall Study|Physician Decision|1|||
27917626|NCT00528424|81536532|FG000|Overall Study|Administrative reason|2|||
27917627|NCT00528424|81536532|FG000|Overall Study|Other|12|||
27917628|NCT02100124|81536533|FG000|Overall Study|Lost to Follow-up|5|||
27633582|NCT02027558|80500217|FG000|Overall Study|Death|0|||
27633583|NCT02027558|80500218|FG001|Overall Study|Death|1|||
27633584|NCT02027558|80500217|FG000|Overall Study|Withdrawal by Subject|2|||
27538726|NCT00074984|80166964|FG001|Overall Study|Withdrawal by Subject|3|||
27633585|NCT02027558|80500218|FG001|Overall Study|Withdrawal by Subject|0|||
27633586|NCT02027558|80500217|FG000|Overall Study|Lost to Follow-up|4|||
27633587|NCT02027558|80500218|FG001|Overall Study|Lost to Follow-up|1|||
27538727|NCT00074984|80166963|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
27538728|NCT00074984|80166964|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
27538729|NCT02038881|80166965|FG000|Overall Study|Withdrawal by Subject|0|||
27538730|NCT02038881|80166966|FG001|Overall Study|Withdrawal by Subject|0|||
27538731|NCT02038881|80166967|FG002|Overall Study|Withdrawal by Subject|1|||
27538732|NCT02038881|80166965|FG000|Overall Study|Lost to Follow-up|2|||
27538733|NCT02038881|80166966|FG001|Overall Study|Lost to Follow-up|0|||
27538734|NCT02038881|80166967|FG002|Overall Study|Lost to Follow-up|0|||
27538735|NCT02038881|80166965|FG000|Overall Study|incarcerated|1|||
27538736|NCT02038881|80166966|FG001|Overall Study|incarcerated|0|||
27538737|NCT02038881|80166967|FG002|Overall Study|incarcerated|0|||
27538738|NCT03896165|80166968|FG000|Overall Study|Withdrawal by Subject|2|||
27538739|NCT05047770|80166971|FG000|Overall Study|Withdrawal by Subject|15|||
27538740|NCT05047770|80166972|FG001|Overall Study|Withdrawal by Subject|10|||
27538741|NCT05047770|80166973|FG002|Overall Study|Withdrawal by Subject|6|||
27538742|NCT05047770|80166974|FG003|Overall Study|Withdrawal by Subject|12|||
27538743|NCT05047770|80166971|FG000|Overall Study|Lost to Follow-up|7|||
27538744|NCT05047770|80166972|FG001|Overall Study|Lost to Follow-up|5|||
27538745|NCT05047770|80166973|FG002|Overall Study|Lost to Follow-up|12|||
27538746|NCT05047770|80166974|FG003|Overall Study|Lost to Follow-up|13|||
27633588|NCT02027558|80500217|FG000|Overall Study|Refused assessment|3|||
27633589|NCT02027558|80500218|FG001|Overall Study|Refused assessment|0|||
27917629|NCT02100124|81536534|FG001|Overall Study|Lost to Follow-up|11|||
27633590|NCT00057837|80500223|FG000|Overall Study|Progression/relapse|12|||
27633591|NCT00057837|80500224|FG001|Overall Study|Progression/relapse|14|||
27633592|NCT00057837|80500223|FG000|Overall Study|Adverse Event|2|||
27633593|NCT00057837|80500224|FG001|Overall Study|Adverse Event|12|||
27633594|NCT00057837|80500223|FG000|Overall Study|Death|5|||
27633595|NCT00057837|80500224|FG001|Overall Study|Death|4|||
27917630|NCT02100124|81536535|FG002|Overall Study|Lost to Follow-up|3|||
27917631|NCT02100124|81536533|FG000|Overall Study|Withdrawal by Subject|1|||
27917632|NCT02100124|81536534|FG001|Overall Study|Withdrawal by Subject|0|||
27917633|NCT02100124|81536535|FG002|Overall Study|Withdrawal by Subject|0|||
27917634|NCT03638128|81536536|FG000|Overall Study|Withdrawal by Subject|1|||
27917635|NCT03638128|81536537|FG001|Overall Study|Withdrawal by Subject|7|||
27917636|NCT03638128|81536538|FG002|Overall Study|Withdrawal by Subject|6|||
27917637|NCT03638128|81536536|FG000|Overall Study|Sponsor Decision|15|||
27917638|NCT03638128|81536537|FG001|Overall Study|Sponsor Decision|12|||
27917639|NCT03638128|81536538|FG002|Overall Study|Sponsor Decision|19|||
27917640|NCT03638128|81536536|FG000|Overall Study|Lost to Follow-up|0|||
27917641|NCT03638128|81536537|FG001|Overall Study|Lost to Follow-up|0|||
27917642|NCT03638128|81536538|FG002|Overall Study|Lost to Follow-up|1|||
27917643|NCT03575702|81536539|FG000|Overall Study|Withdrawal by Subject|1|||
27917644|NCT03575702|81536540|FG001|Overall Study|Withdrawal by Subject|1|||
27917645|NCT03575702|81536539|FG000|Overall Study|Lost to Follow-up|1|||
27917646|NCT03575702|81536540|FG001|Overall Study|Lost to Follow-up|2|||
27917647|NCT03575702|81536539|FG000|Overall Study|Protocol Violation|0|||
27917648|NCT03575702|81536540|FG001|Overall Study|Protocol Violation|1|||
27917649|NCT03575702|81536539|FG000|Overall Study|Patient non compliance|4|||
27917650|NCT03575702|81536540|FG001|Overall Study|Patient non compliance|0|||
27917651|NCT02063672|81536541|FG000|Overall Study|Ongoing Follow-up|27|||
27917652|NCT02063672|81536542|FG001|Overall Study|Ongoing Follow-up|14|||
27917653|NCT02063672|81536541|FG000|Overall Study|Death|5|||
27538747|NCT05047770|80166971|FG000|Overall Study|Other|1|||
27538748|NCT05047770|80166972|FG001|Overall Study|Other|0|||
27538749|NCT05047770|80166973|FG002|Overall Study|Other|1|||
27538750|NCT05047770|80166974|FG003|Overall Study|Other|0|||
27538751|NCT03948581|80166975|FG000|Overall Study|Lost to Follow-up|0|||
27917654|NCT02063672|81536542|FG001|Overall Study|Death|3|||
27917655|NCT02063672|81536541|FG000|Overall Study|Lost to Follow-up|1|||
27917656|NCT02063672|81536542|FG001|Overall Study|Lost to Follow-up|3|||
27917657|NCT02063672|81536541|FG000|Overall Study|Withdrawal by Subject|2|||
27538752|NCT03948581|80166976|FG001|Overall Study|Lost to Follow-up|1|||
27633596|NCT00057837|80500223|FG000|Overall Study|Withdrawal by Subject|5|||
27633597|NCT00057837|80500224|FG001|Overall Study|Withdrawal by Subject|3|||
27917658|NCT02063672|81536542|FG001|Overall Study|Withdrawal by Subject|2|||
27917659|NCT00161213|81536543|FG000|Overall Study|Withdrawal by Subject|1|||
27917660|NCT00161213|81536543|FG000|Overall Study|Evaluable for toxicity but not response|1|||
27917661|NCT01001429|81536544|FG000|Overall Study|surgery cancelled|0|||
27538753|NCT01790932|80166977|FG000|Overall Study|Disease Progression|41|||
27538754|NCT01790932|80166977|FG000|Overall Study|Adverse Event|7|||
27633598|NCT00057837|80500223|FG000|Overall Study|Alternative therapy|0|||
27538755|NCT01790932|80166977|FG000|Overall Study|Physician Decision|1|||
27538756|NCT01790932|80166977|FG000|Overall Study|Withdrawal by Subject|1|||
27538757|NCT04553679|80166978|FG000|Overall Study|Withdrawal by Subject|2|||
27538758|NCT04553679|80166979|FG001|Overall Study|Withdrawal by Subject|0|||
27538759|NCT04553679|80166978|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
27538760|NCT04553679|80166979|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
27538761|NCT00875979|80166980|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
27538762|NCT00875979|80166981|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
27633599|NCT00057837|80500224|FG001|Overall Study|Alternative therapy|1|||
27633600|NCT00057837|80500223|FG000|Overall Study|Other complicating disease|2|||
27633601|NCT00057837|80500224|FG001|Overall Study|Other complicating disease|1|||
27633602|NCT00057837|80500223|FG000|Overall Study|Physician Decision|1|||
27633603|NCT00057837|80500224|FG001|Overall Study|Physician Decision|0|||
27633604|NCT00057837|80500223|FG000|Overall Study|Ineligible|3|||
27633605|NCT00057837|80500224|FG001|Overall Study|Ineligible|3|||
27633606|NCT00057837|80500223|FG000|Overall Study|Never started treatment|1|||
27633607|NCT00057837|80500224|FG001|Overall Study|Never started treatment|1|||
27633608|NCT01692730|80500225|FG000|Overall Study|Lost to Follow-up|225|||
27633609|NCT01692730|80500226|FG001|Overall Study|Lost to Follow-up|227|||
27633610|NCT01901276|80500227|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
27633611|NCT01901276|80500228|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
27633612|NCT01576484|80500229|FG000|Overall Study|Adverse Event|1|||
27633613|NCT01576484|80500230|FG001|Overall Study|Adverse Event|1|||
27633614|NCT01576484|80500229|FG000|Overall Study|Protocol Violation|0|||
27633615|NCT01576484|80500230|FG001|Overall Study|Protocol Violation|2|||
27633616|NCT01576484|80500229|FG000|Overall Study|Sponsor Decision|2|||
27633617|NCT01576484|80500230|FG001|Overall Study|Sponsor Decision|8|||
27633618|NCT01576484|80500229|FG000|Overall Study|Withdrawal by Subject|0|||
27633619|NCT01576484|80500230|FG001|Overall Study|Withdrawal by Subject|3|||
27633620|NCT01576484|80500229|FG000|Overall Study|Other|2|||
27633621|NCT01576484|80500230|FG001|Overall Study|Other|5|||
27633622|NCT04504916|80500231|FG000|Overall Study|Study terminated|7|||
27633623|NCT04504916|80500232|FG001|Overall Study|Study terminated|8|||
27633624|NCT04504916|80500231|FG000|Overall Study|Death|54|||
27633625|NCT04504916|80500232|FG001|Overall Study|Death|18|||
27633626|NCT04504916|80500231|FG000|Overall Study|Lost to Follow-up|1|||
27633627|NCT04504916|80500232|FG001|Overall Study|Lost to Follow-up|1|||
27633628|NCT04504916|80500231|FG000|Overall Study|Withdrawal by Subject|8|||
27633629|NCT04504916|80500232|FG001|Overall Study|Withdrawal by Subject|4|||
27633630|NCT04504916|80500231|FG000|Overall Study|Did not agree to follow-up|0|||
27633631|NCT04504916|80500232|FG001|Overall Study|Did not agree to follow-up|1|||
27633632|NCT00486759|80500235|FG000|Treatment|Adverse event/intercurrent illness|86|||
27633633|NCT00486759|80500236|FG001|Treatment|Adverse event/intercurrent illness|39|||
27633634|NCT00486759|80500235|FG000|Treatment|Insufficient therapeutic response|37|||
27633635|NCT00486759|80500236|FG001|Treatment|Insufficient therapeutic response|39|||
27633636|NCT00486759|80500235|FG000|Treatment|Death|17|||
27633637|NCT00486759|80500236|FG001|Treatment|Death|10|||
27633638|NCT00486759|80500235|FG000|Treatment|Withdrew consent|15|||
27633639|NCT00486759|80500236|FG001|Treatment|Withdrew consent|12|||
27633640|NCT00486759|80500235|FG000|Treatment|Administrative/reason not specified|17|||
27633641|NCT00486759|80500236|FG001|Treatment|Administrative/reason not specified|21|||
27633642|NCT00486759|80500235|FG000|Treatment|Refused treatment|10|||
27633643|NCT00486759|80500236|FG001|Treatment|Refused treatment|7|||
27633644|NCT00486759|80500235|FG000|Treatment|Violation of selection criteria at entry|3|||
27633645|NCT00486759|80500236|FG001|Treatment|Violation of selection criteria at entry|3|||
27633646|NCT00486759|80500235|FG000|Treatment|Other protocol violation|1|||
27633647|NCT00486759|80500236|FG001|Treatment|Other protocol violation|5|||
27633648|NCT00486759|80500235|FG000|Treatment|Failure to return|1|||
27633649|NCT00486759|80500236|FG001|Treatment|Failure to return|1|||
27633650|NCT00486759|80500235|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
27633651|NCT00486759|80500236|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
27633652|NCT00486759|80500235|FG000|Safety Follow-up|Death|40|||
27633653|NCT00486759|80500236|FG001|Safety Follow-up|Death|29|||
27917662|NCT01001429|81536545|FG001|Overall Study|surgery cancelled|1|||
27538763|NCT00875979|80166980|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
27538764|NCT00875979|80166981|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
27633654|NCT00486759|80500235|FG000|Safety Follow-up|Withdrew consent|32|||
27633655|NCT00486759|80500236|FG001|Safety Follow-up|Withdrew consent|23|||
27633656|NCT00486759|80500235|FG000|Safety Follow-up|Failure to return|9|||
27633657|NCT00486759|80500236|FG001|Safety Follow-up|Failure to return|6|||
27633658|NCT00486759|80500235|FG000|Safety Follow-up|Administrative/not specified|8|||
27633659|NCT00486759|80500236|FG001|Safety Follow-up|Administrative/not specified|6|||
27633660|NCT00486759|80500235|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
27633661|NCT00486759|80500236|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
27633662|NCT00486759|80500235|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
27739764|NCT00064701|80877297|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
27739765|NCT00064701|80877295|FG000|One Year Post-transplant|Lost to Follow-up|1|||
27739766|NCT00064701|80877296|FG001|One Year Post-transplant|Lost to Follow-up|0|||
27917663|NCT03713684|81536551|FG000|Overall Study|Adverse Event|1|||
27917664|NCT03713684|81536552|FG001|Overall Study|Adverse Event|3|||
27917665|NCT03713684|81536553|FG002|Overall Study|Adverse Event|1|||
27917666|NCT03713684|81536554|FG003|Overall Study|Adverse Event|0|||
27739767|NCT00064701|80877297|FG002|One Year Post-transplant|Lost to Follow-up|0|||
27739768|NCT00064701|80877295|FG000|One Year Post-transplant|Converted to rapamycin|1|||
27739769|NCT00064701|80877296|FG001|One Year Post-transplant|Converted to rapamycin|0|||
27739770|NCT00064701|80877297|FG002|One Year Post-transplant|Converted to rapamycin|0|||
27739771|NCT00064701|80877295|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
27739772|NCT00064701|80877296|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
27739773|NCT00064701|80877297|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
27739774|NCT00064701|80877295|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
27739775|NCT00064701|80877296|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
27739776|NCT00064701|80877297|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
27739777|NCT00064701|80877295|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
27739778|NCT00064701|80877296|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
27739779|NCT00064701|80877297|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
27739780|NCT00064701|80877295|FG000|One Year Post-transplant|Poor absorption|0|||
27739781|NCT00064701|80877296|FG001|One Year Post-transplant|Poor absorption|1|||
27739782|NCT00064701|80877297|FG002|One Year Post-transplant|Poor absorption|0|||
27739783|NCT00064701|80877295|FG000|One Year Post-transplant|Pancreas transplant|0|||
27739784|NCT00064701|80877296|FG001|One Year Post-transplant|Pancreas transplant|0|||
27739785|NCT00064701|80877297|FG002|One Year Post-transplant|Pancreas transplant|1|||
27739786|NCT00064701|80877295|FG000|Clinical Continuation Phase|Adverse Event|12|||
27739787|NCT00064701|80877296|FG001|Clinical Continuation Phase|Adverse Event|21|||
27739788|NCT00064701|80877297|FG002|Clinical Continuation Phase|Adverse Event|14|||
27739789|NCT00064701|80877295|FG000|Clinical Continuation Phase|Non-compliance|8|||
27739790|NCT00064701|80877296|FG001|Clinical Continuation Phase|Non-compliance|6|||
27739791|NCT00064701|80877297|FG002|Clinical Continuation Phase|Non-compliance|7|||
27739792|NCT00064701|80877295|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
27739793|NCT00064701|80877296|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
27739794|NCT00064701|80877297|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
27739795|NCT00064701|80877295|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
27739796|NCT00064701|80877296|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
27739797|NCT00064701|80877297|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
27739798|NCT00064701|80877295|FG000|Clinical Continuation Phase|Graft Failure|5|||
27739799|NCT00064701|80877296|FG001|Clinical Continuation Phase|Graft Failure|5|||
27739800|NCT00064701|80877297|FG002|Clinical Continuation Phase|Graft Failure|2|||
27739801|NCT00064701|80877295|FG000|Clinical Continuation Phase|Rejection|1|||
27739802|NCT00064701|80877296|FG001|Clinical Continuation Phase|Rejection|2|||
27739803|NCT00064701|80877297|FG002|Clinical Continuation Phase|Rejection|2|||
27739804|NCT00064701|80877295|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
27739805|NCT00064701|80877296|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
27739806|NCT00064701|80877297|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
27739807|NCT00064701|80877295|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
27739808|NCT00064701|80877296|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
27739809|NCT00064701|80877297|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
27739810|NCT00064701|80877295|FG000|Clinical Continuation Phase|Physician Decision|1|||
27739811|NCT00064701|80877296|FG001|Clinical Continuation Phase|Physician Decision|3|||
27739812|NCT00064701|80877297|FG002|Clinical Continuation Phase|Physician Decision|0|||
27739813|NCT00064701|80877295|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
27739814|NCT00064701|80877296|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
27739815|NCT00064701|80877297|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
27739816|NCT00064701|80877295|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
27917667|NCT03713684|81536551|FG000|Overall Study|Poor compliance to protocol|2|||
27917668|NCT03713684|81536552|FG001|Overall Study|Poor compliance to protocol|1|||
27633663|NCT00486759|80500236|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
27739817|NCT00064701|80877296|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
27739818|NCT00064701|80877297|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
27739819|NCT00064701|80877295|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
27739820|NCT00064701|80877296|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
27739821|NCT00064701|80877297|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
27739822|NCT00064701|80877295|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
27739823|NCT00064701|80877296|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
27917669|NCT03713684|81536553|FG002|Overall Study|Poor compliance to protocol|0|||
27917670|NCT03713684|81536554|FG003|Overall Study|Poor compliance to protocol|1|||
27739824|NCT00064701|80877297|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
27739825|NCT00064701|80877295|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
27739826|NCT00064701|80877296|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
27917671|NCT03713684|81536551|FG000|Overall Study|Withdrawal by Subject|14|||
27917672|NCT03713684|81536552|FG001|Overall Study|Withdrawal by Subject|6|||
27917673|NCT03713684|81536553|FG002|Overall Study|Withdrawal by Subject|14|||
27917674|NCT03713684|81536554|FG003|Overall Study|Withdrawal by Subject|16|||
27739827|NCT00064701|80877297|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
27739828|NCT00064701|80877295|FG000|Clinical Continuation Phase|Patient opted out|0|||
27739829|NCT00064701|80877296|FG001|Clinical Continuation Phase|Patient opted out|0|||
27739830|NCT00064701|80877297|FG002|Clinical Continuation Phase|Patient opted out|1|||
27917675|NCT03713684|81536551|FG000|Overall Study|Other than specified|69|||
27917676|NCT03713684|81536552|FG001|Overall Study|Other than specified|77|||
27917677|NCT03713684|81536553|FG002|Overall Study|Other than specified|73|||
27917678|NCT03713684|81536554|FG003|Overall Study|Other than specified|70|||
27917679|NCT02460289|81536555|FG000|Overall Study|Adverse Event|1|||
27917680|NCT02460289|81536555|FG000|Overall Study|Withdrawal by Subject|8|||
27917681|NCT02460289|81536555|FG000|Overall Study|Lost to Follow-up|1|||
27917682|NCT04609514|81536556|FG000|Overall Study|Lost to Follow-up|5|||
27739831|NCT02424539|80877298|FG000|Overall Study|Adverse Event|0|||
27739832|NCT02424539|80877299|FG001|Overall Study|Adverse Event|0|||
27739833|NCT02424539|80877300|FG002|Overall Study|Adverse Event|1|||
27739834|NCT02424539|80877298|FG000|Overall Study|Physician Decision|0|||
27739835|NCT02424539|80877299|FG001|Overall Study|Physician Decision|0|||
27739836|NCT02424539|80877300|FG002|Overall Study|Physician Decision|1|||
27739837|NCT02424539|80877298|FG000|Overall Study|Withdrawal by Subject|3|||
27739838|NCT02424539|80877299|FG001|Overall Study|Withdrawal by Subject|1|||
27739839|NCT02424539|80877300|FG002|Overall Study|Withdrawal by Subject|0|||
27739840|NCT02424539|80877298|FG000|Overall Study|Other: Reached stopping criteria|11|||
27739841|NCT02424539|80877299|FG001|Overall Study|Other: Reached stopping criteria|7|||
27739842|NCT02424539|80877300|FG002|Overall Study|Other: Reached stopping criteria|6|||
27739843|NCT01164501|80877302|FG000|Overall Study|Not treated|2|||
27739844|NCT01164501|80877303|FG001|Overall Study|Not treated|0|||
27917683|NCT04609514|81536557|FG001|Overall Study|Lost to Follow-up|4|||
27917684|NCT04609514|81536556|FG000|Overall Study|Withdrawal by PI|0|||
27917685|NCT04609514|81536557|FG001|Overall Study|Withdrawal by PI|2|||
27917686|NCT03428100|81536559|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
27917687|NCT03428100|81536560|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917688|NCT03428100|81536561|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
27739845|NCT01164501|80877304|FG002|Overall Study|Not treated|1|||
27739846|NCT01164501|80877302|FG000|Overall Study|Adverse Event|18|||
27917689|NCT03428100|81536562|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
27538765|NCT00875979|80166980|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
27538766|NCT00875979|80166981|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
27538767|NCT00875979|80166980|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
27538768|NCT00875979|80166981|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
27538769|NCT00875979|80166980|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
27538770|NCT00875979|80166981|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
27538771|NCT00875979|80166980|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
27538772|NCT00875979|80166981|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
27538773|NCT00875979|80166980|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
27538774|NCT00875979|80166981|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
27538775|NCT00875979|80166980|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
27538776|NCT00875979|80166981|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
27538777|NCT00875979|80166980|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
27538778|NCT00875979|80166981|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
27538779|NCT00851630|80166982|FG000|Overall Study|Death|2|||
27538780|NCT00851630|80166983|FG001|Overall Study|Death|1|||
27538781|NCT00851630|80166982|FG000|Overall Study|Clinical failure|0|||
27538782|NCT00851630|80166983|FG001|Overall Study|Clinical failure|1|||
27538783|NCT01950169|80166984|FG000|Overall Study|Withdrawal by Subject|2|||
27538784|NCT01950169|80166985|FG001|Overall Study|Withdrawal by Subject|8|||
27538785|NCT01950169|80166986|FG002|Overall Study|Withdrawal by Subject|1|||
27538786|NCT01950169|80166984|FG000|Overall Study|Death|1|||
27739847|NCT01164501|80877303|FG001|Overall Study|Adverse Event|4|||
27739848|NCT01164501|80877304|FG002|Overall Study|Adverse Event|21|||
27739849|NCT01164501|80877302|FG000|Overall Study|Lack of Efficacy|0|||
27917690|NCT03428100|81536563|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917691|NCT03428100|81536564|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917692|NCT03428100|81536565|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917693|NCT03428100|81536566|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917694|NCT03428100|81536567|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27633664|NCT00367991|80500239|FG000|Overall Study|Withdrawal by Subject|1|||
27633665|NCT00367991|80500240|FG001|Overall Study|Withdrawal by Subject|1|||
27633666|NCT00367991|80500239|FG000|Overall Study|Adverse Event|1|||
27633667|NCT00367991|80500240|FG001|Overall Study|Adverse Event|1|||
27633668|NCT00753012|80500242|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
27633669|NCT00753012|80500243|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
27633670|NCT00753012|80500242|FG000|Overall Study|Adverse Event|2|||
27633671|NCT00753012|80500243|FG001|Overall Study|Adverse Event|0|||
27633672|NCT00753012|80500242|FG000|Overall Study|Withdrawal by Subject|0|||
27633673|NCT00753012|80500243|FG001|Overall Study|Withdrawal by Subject|1|||
27633674|NCT00753012|80500242|FG000|Overall Study|Lost to Follow-up|4|||
27633675|NCT00753012|80500243|FG001|Overall Study|Lost to Follow-up|0|||
27633676|NCT00753012|80500242|FG000|Overall Study|Confounded endpoint data|1|||
27633677|NCT00753012|80500243|FG001|Overall Study|Confounded endpoint data|0|||
27633678|NCT02013830|80500244|FG000|Overall Study|Adverse Event|3|||
27633679|NCT02013830|80500244|FG000|Overall Study|Death|1|||
27633680|NCT02013830|80500244|FG000|Overall Study|Insufficient therapeutic response|25|||
27633681|NCT02013830|80500244|FG000|Overall Study|Refused treatment|1|||
27633682|NCT01883492|80500247|FG000|Overall Study|Lost to Follow-up|3|||
27633683|NCT01883492|80500248|FG001|Overall Study|Lost to Follow-up|4|||
27633684|NCT01883492|80500247|FG000|Overall Study|Surgery on contra-lateral hip|0|||
27917695|NCT03428100|81536568|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917696|NCT03428100|81536569|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917697|NCT03428100|81536570|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917698|NCT03428100|81536571|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917699|NCT03428100|81536572|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27538787|NCT01950169|80166985|FG001|Overall Study|Death|0|||
27538788|NCT01950169|80166986|FG002|Overall Study|Death|0|||
27538789|NCT02404220|80166987|FG000|Overall Study|Adverse Event|0|||
27538790|NCT02404220|80166988|FG001|Overall Study|Adverse Event|0|||
27538791|NCT02404220|80166989|FG002|Overall Study|Adverse Event|1|||
27538792|NCT02404220|80166990|FG003|Overall Study|Adverse Event|0|||
27538793|NCT02404220|80166987|FG000|Overall Study|Death|5|||
27538794|NCT02404220|80166988|FG001|Overall Study|Death|5|||
27538795|NCT02404220|80166989|FG002|Overall Study|Death|3|||
27538796|NCT02404220|80166990|FG003|Overall Study|Death|8|||
27538797|NCT02404220|80166987|FG000|Overall Study|Progressive Disease|0|||
27538798|NCT02404220|80166988|FG001|Overall Study|Progressive Disease|0|||
27538799|NCT02404220|80166989|FG002|Overall Study|Progressive Disease|1|||
27538800|NCT02404220|80166990|FG003|Overall Study|Progressive Disease|1|||
27538801|NCT02404220|80166987|FG000|Overall Study|Study Terminated by Sponsor|0|||
27538802|NCT02404220|80166988|FG001|Overall Study|Study Terminated by Sponsor|0|||
27538803|NCT02404220|80166989|FG002|Overall Study|Study Terminated by Sponsor|2|||
27538804|NCT02404220|80166990|FG003|Overall Study|Study Terminated by Sponsor|1|||
27538805|NCT02404220|80166987|FG000|Overall Study|Withdrawal by Subject|0|||
27538806|NCT02404220|80166988|FG001|Overall Study|Withdrawal by Subject|1|||
27538807|NCT02404220|80166989|FG002|Overall Study|Withdrawal by Subject|0|||
27538808|NCT02404220|80166990|FG003|Overall Study|Withdrawal by Subject|0|||
27538809|NCT02404220|80166987|FG000|Overall Study|Enrolled but Never Treated|0|||
27538810|NCT02404220|80166988|FG001|Overall Study|Enrolled but Never Treated|2|||
27538811|NCT02404220|80166989|FG002|Overall Study|Enrolled but Never Treated|0|||
27538812|NCT02404220|80166990|FG003|Overall Study|Enrolled but Never Treated|0|||
27538813|NCT04447794|80166993|FG000|Overall Study|Lost to Follow-up|2|||
27538814|NCT04447794|80166994|FG001|Overall Study|Lost to Follow-up|3|||
27538815|NCT04447794|80166995|FG002|Overall Study|Lost to Follow-up|8|||
27538816|NCT04447794|80166993|FG000|Overall Study|Withdrawal by Subject|1|||
27538817|NCT04447794|80166994|FG001|Overall Study|Withdrawal by Subject|1|||
27538818|NCT04447794|80166995|FG002|Overall Study|Withdrawal by Subject|0|||
27538819|NCT02564796|80166996|FG000|Overall Study|Physician Decision|2|||
27538820|NCT02564796|80166997|FG001|Overall Study|Physician Decision|2|||
27538821|NCT00108433|80166998|FG000|Overall Study|Lack of Efficacy|1|||
27538822|NCT00108433|80166999|FG001|Overall Study|Lack of Efficacy|2|||
27538823|NCT00108433|80166998|FG000|Overall Study|Death|3|||
27633685|NCT01883492|80500248|FG001|Overall Study|Surgery on contra-lateral hip|1|||
27917700|NCT03428100|81536573|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27538824|NCT00108433|80166999|FG001|Overall Study|Death|0|||
27538825|NCT00108433|80166998|FG000|Overall Study|Adverse Event|3|||
27538826|NCT00108433|80166999|FG001|Overall Study|Adverse Event|1|||
27538827|NCT00108433|80166998|FG000|Overall Study|Other|14|||
27538828|NCT00108433|80166999|FG001|Overall Study|Other|14|||
27538829|NCT01548287|80167001|FG000|Screening|No reason provided|0|||
27538830|NCT01548287|80167002|FG001|Screening|No reason provided|0|||
27538831|NCT01548287|80167003|FG002|Screening|No reason provided|0|||
27538832|NCT01548287|80167004|FG003|Screening|No reason provided|0|||
27633686|NCT01883492|80500247|FG000|Overall Study|Poor X-ray quality|7|||
27633687|NCT01883492|80500248|FG001|Overall Study|Poor X-ray quality|4|||
27633688|NCT01883492|80500247|FG000|Overall Study|Withdrawal by Subject|1|||
27633689|NCT01883492|80500248|FG001|Overall Study|Withdrawal by Subject|0|||
27633690|NCT01883492|80500247|FG000|Overall Study|inappropriate implant used|1|||
27633691|NCT01883492|80500248|FG001|Overall Study|inappropriate implant used|1|||
27633692|NCT01883492|80500247|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
27633693|NCT01883492|80500248|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
27633694|NCT00419094|80500251|FG000|Overall Study|Adverse Event|3|||
27633695|NCT00419094|80500252|FG001|Overall Study|Adverse Event|7|||
27633696|NCT00419094|80500251|FG000|Overall Study|Lack of Efficacy|1|||
27917701|NCT03428100|81536574|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917702|NCT03428100|81536575|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917703|NCT03428100|81536576|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917704|NCT03428100|81536577|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
27917705|NCT03428100|81536559|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
27917706|NCT03428100|81536560|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
27917707|NCT03428100|81536561|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
27917708|NCT03428100|81536562|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
27538833|NCT01548287|80167005|FG004|Screening|No reason provided|9|||
27538834|NCT01548287|80167001|FG000|Screening|Did not meet eligibility criteria|0|||
27538835|NCT01548287|80167002|FG001|Screening|Did not meet eligibility criteria|0|||
27633697|NCT00419094|80500252|FG001|Overall Study|Lack of Efficacy|0|||
27633698|NCT00419094|80500251|FG000|Overall Study|Lost to Follow-up|0|||
27538836|NCT01548287|80167003|FG002|Screening|Did not meet eligibility criteria|0|||
27538837|NCT01548287|80167004|FG003|Screening|Did not meet eligibility criteria|0|||
27538838|NCT01548287|80167005|FG004|Screening|Did not meet eligibility criteria|74|||
27538839|NCT01548287|80167001|FG000|Randomized Period|Did not meet inclusion criteria|0|||
27538840|NCT01548287|80167002|FG001|Randomized Period|Did not meet inclusion criteria|0|||
27538841|NCT01548287|80167003|FG002|Randomized Period|Did not meet inclusion criteria|2|||
27538842|NCT01548287|80167004|FG003|Randomized Period|Did not meet inclusion criteria|0|||
27917709|NCT03428100|81536563|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917710|NCT03428100|81536564|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917711|NCT03428100|81536565|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917712|NCT03428100|81536566|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917713|NCT03428100|81536567|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917714|NCT03428100|81536568|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917715|NCT03428100|81536569|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917716|NCT03428100|81536570|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917717|NCT03428100|81536571|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917718|NCT03428100|81536572|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917719|NCT03428100|81536573|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917720|NCT03428100|81536574|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917721|NCT03428100|81536575|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27538843|NCT01548287|80167005|FG004|Randomized Period|Did not meet inclusion criteria|0|||
27538844|NCT01548287|80167001|FG000|Randomized Period|Adverse Event|0|||
27538845|NCT01548287|80167002|FG001|Randomized Period|Adverse Event|2|||
27538846|NCT01548287|80167003|FG002|Randomized Period|Adverse Event|5|||
27538847|NCT01548287|80167004|FG003|Randomized Period|Adverse Event|0|||
27538848|NCT01548287|80167005|FG004|Randomized Period|Adverse Event|0|||
27633699|NCT00419094|80500252|FG001|Overall Study|Lost to Follow-up|2|||
27538849|NCT02008318|80167009|FG000|Overall Study|Adverse Event|4|||
27538850|NCT02008318|80167010|FG001|Overall Study|Adverse Event|0|||
27538851|NCT02008318|80167009|FG000|Overall Study|Physician Decision|2|||
27633700|NCT00419094|80500251|FG000|Overall Study|Protocol Violation|1|||
27633701|NCT00419094|80500252|FG001|Overall Study|Protocol Violation|14|||
27633702|NCT00419094|80500251|FG000|Overall Study|Withdrawal of consent|1|||
27538852|NCT02008318|80167010|FG001|Overall Study|Physician Decision|0|||
27538853|NCT02008318|80167009|FG000|Overall Study|Progressive Disease|2|||
27538854|NCT02008318|80167010|FG001|Overall Study|Progressive Disease|0|||
27538855|NCT02008318|80167009|FG000|Overall Study|Protocol Violation|1|||
27538856|NCT02008318|80167010|FG001|Overall Study|Protocol Violation|1|||
27633703|NCT00419094|80500252|FG001|Overall Study|Withdrawal of consent|5|||
27633704|NCT00419094|80500251|FG000|Overall Study|Other: Error determining exit criteria|1|||
27633705|NCT00419094|80500252|FG001|Overall Study|Other: Error determining exit criteria|0|||
27633706|NCT00419094|80500251|FG000|Overall Study|Other: Patient non-compliant|0|||
27633707|NCT00419094|80500252|FG001|Overall Study|Other: Patient non-compliant|1|||
27633708|NCT00419094|80500251|FG000|Overall Study|Other: No contact for extended period|0|||
27633709|NCT00419094|80500252|FG001|Overall Study|Other: No contact for extended period|1|||
27633710|NCT02393716|80500255|FG000|Overall Study|Death|29|||
27633711|NCT02393716|80500255|FG000|Overall Study|Withdrawal by Subject|8|||
27917722|NCT03428100|81536576|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27917723|NCT03428100|81536577|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
27538857|NCT02008318|80167009|FG000|Overall Study|Withdrawal by Subject|3|||
27538858|NCT02008318|80167010|FG001|Overall Study|Withdrawal by Subject|0|||
27917724|NCT03428100|81536559|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917725|NCT03428100|81536560|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
27917726|NCT03428100|81536561|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
27917727|NCT03428100|81536562|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917728|NCT03428100|81536563|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27538859|NCT00660673|80167012|FG000|Overall Study|Adverse Event|84|||
27538860|NCT00660673|80167012|FG000|Overall Study|Lack of Efficacy|7|||
27538861|NCT00660673|80167012|FG000|Overall Study|Withdrawal by Subject|22|||
27538862|NCT00660673|80167012|FG000|Overall Study|Administrative|2|||
27538863|NCT00660673|80167012|FG000|Overall Study|Protocol Violation|2|||
27538864|NCT00398411|80167013|FG000|Overall Study|Death|0|||
27538865|NCT00398411|80167014|FG001|Overall Study|Death|1|||
27538866|NCT04289623|80167019|FG000|Wave 1 Emails|Email was not delivered|268|||
27538867|NCT04289623|80167020|FG001|Wave 1 Emails|Email was not delivered|257|||
27538868|NCT04289623|80167021|FG002|Wave 1 Emails|Email was not delivered|0|||
27538869|NCT04289623|80167022|FG003|Wave 1 Emails|Email was not delivered|0|||
27538870|NCT04289623|80167023|FG004|Wave 1 Emails|Email was not delivered|0|||
27538871|NCT04289623|80167024|FG005|Wave 1 Emails|Email was not delivered|0|||
27538872|NCT01235689|80167025|FG000|Overall Study|Adverse Event|12|||
27538873|NCT01235689|80167026|FG001|Overall Study|Adverse Event|16|||
27538874|NCT01235689|80167025|FG000|Overall Study|Lack of Efficacy|12|||
27538875|NCT01235689|80167026|FG001|Overall Study|Lack of Efficacy|5|||
27538876|NCT01235689|80167025|FG000|Overall Study|Withdrawal by Subject|3|||
27538877|NCT01235689|80167026|FG001|Overall Study|Withdrawal by Subject|4|||
27538878|NCT01235689|80167025|FG000|Overall Study|Lost to Follow-up|1|||
27538879|NCT01235689|80167026|FG001|Overall Study|Lost to Follow-up|2|||
27538880|NCT01235689|80167025|FG000|Overall Study|Miscellaneous|1|||
27538881|NCT01235689|80167026|FG001|Overall Study|Miscellaneous|5|||
27538882|NCT01897714|80167028|FG000|Phase I (Dose Escalation)|Disease progression|3|||
27538883|NCT01897714|80167029|FG001|Phase I (Dose Escalation)|Disease progression|5|||
27538884|NCT01897714|80167030|FG002|Phase I (Dose Escalation)|Disease progression|1|||
27739850|NCT01164501|80877303|FG001|Overall Study|Lack of Efficacy|0|||
27739851|NCT01164501|80877304|FG002|Overall Study|Lack of Efficacy|1|||
27739852|NCT01164501|80877302|FG000|Overall Study|Non compliant with protocol|1|||
27739853|NCT01164501|80877303|FG001|Overall Study|Non compliant with protocol|1|||
27739854|NCT01164501|80877304|FG002|Overall Study|Non compliant with protocol|4|||
27739855|NCT01164501|80877302|FG000|Overall Study|Lost to Follow-up|3|||
27739856|NCT01164501|80877303|FG001|Overall Study|Lost to Follow-up|0|||
27739857|NCT01164501|80877304|FG002|Overall Study|Lost to Follow-up|3|||
27739858|NCT01164501|80877302|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
27739859|NCT01164501|80877303|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
27739860|NCT01164501|80877304|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
27739861|NCT01164501|80877302|FG000|Overall Study|Other reason not defined above|9|||
27739862|NCT01164501|80877303|FG001|Overall Study|Other reason not defined above|1|||
27739863|NCT01164501|80877304|FG002|Overall Study|Other reason not defined above|4|||
27739864|NCT02522377|80877305|FG000|Overall Study|Withdrawal by Subject|1|||
27739865|NCT02522377|80877306|FG001|Overall Study|Withdrawal by Subject|0|||
27739866|NCT02522377|80877305|FG000|Overall Study|Remission Achieved|3|||
27917729|NCT03428100|81536564|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917730|NCT03428100|81536565|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917731|NCT03428100|81536566|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917732|NCT03428100|81536567|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917733|NCT03428100|81536568|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917734|NCT03428100|81536569|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917735|NCT03428100|81536570|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917736|NCT03428100|81536571|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917737|NCT03428100|81536572|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917738|NCT03428100|81536573|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917739|NCT03428100|81536574|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917740|NCT03428100|81536575|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917741|NCT03428100|81536576|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27538885|NCT01897714|80167031|FG003|Phase I (Dose Escalation)|Disease progression|3|||
27538886|NCT01897714|80167032|FG004|Phase I (Dose Escalation)|Disease progression|0|||
27538887|NCT01897714|80167033|FG005|Phase I (Dose Escalation)|Disease progression|0|||
27739867|NCT02522377|80877306|FG001|Overall Study|Remission Achieved|0|||
27739868|NCT01887210|80877307|FG000|Overall Study|Withdrawal by Subject|1|||
27739869|NCT01887210|80877308|FG001|Overall Study|Withdrawal by Subject|3|||
27538888|NCT01897714|80167028|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
27538889|NCT01897714|80167029|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
27538890|NCT01897714|80167030|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
27739870|NCT01887210|80877307|FG000|Overall Study|Lost to Follow-up|0|||
27917742|NCT03428100|81536577|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
27917743|NCT03428100|81536559|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
27917744|NCT03428100|81536560|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917745|NCT03428100|81536561|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917746|NCT03428100|81536562|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917747|NCT03428100|81536563|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917748|NCT03428100|81536564|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917749|NCT03428100|81536565|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917750|NCT03428100|81536566|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917751|NCT03428100|81536567|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917752|NCT03428100|81536568|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917753|NCT03428100|81536569|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917754|NCT03428100|81536570|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917755|NCT03428100|81536571|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917756|NCT03428100|81536572|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917757|NCT03428100|81536573|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917758|NCT03428100|81536574|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917759|NCT03428100|81536575|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917760|NCT03428100|81536576|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917761|NCT03428100|81536577|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
27917762|NCT03428100|81536559|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917763|NCT03428100|81536560|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
27917764|NCT03428100|81536561|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917765|NCT03428100|81536562|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917766|NCT03428100|81536563|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917767|NCT03428100|81536564|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917768|NCT03428100|81536565|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917769|NCT03428100|81536566|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917770|NCT03428100|81536567|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917771|NCT03428100|81536568|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917772|NCT03428100|81536569|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917773|NCT03428100|81536570|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917774|NCT03428100|81536571|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917775|NCT03428100|81536572|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917776|NCT03428100|81536573|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917777|NCT03428100|81536574|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917778|NCT03428100|81536575|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917779|NCT03428100|81536576|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27538891|NCT01897714|80167031|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
27917780|NCT03428100|81536577|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
27917781|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917782|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917783|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917784|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917785|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917786|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
27917787|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
27917788|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
27917789|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
27917790|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917791|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
27917792|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917793|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
27917794|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
27917795|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
27917796|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
27917797|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
27917798|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27538892|NCT01897714|80167032|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
27538893|NCT01897714|80167033|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
27538894|NCT01897714|80167028|FG000|Phase I (Dose Escalation)|Other|0|||
27538895|NCT01897714|80167029|FG001|Phase I (Dose Escalation)|Other|1|||
27538896|NCT01897714|80167030|FG002|Phase I (Dose Escalation)|Other|0|||
27538897|NCT01897714|80167031|FG003|Phase I (Dose Escalation)|Other|0|||
27538898|NCT01897714|80167032|FG004|Phase I (Dose Escalation)|Other|0|||
27538899|NCT01897714|80167033|FG005|Phase I (Dose Escalation)|Other|0|||
27538900|NCT01897714|80167028|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
27538901|NCT01897714|80167029|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
27538902|NCT01897714|80167030|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
27538903|NCT01897714|80167031|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
27538904|NCT01897714|80167032|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
27633712|NCT02393716|80500255|FG000|Overall Study|Device Explanted|8|||
27538905|NCT01897714|80167033|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
27538906|NCT01897714|80167028|FG000|Phase II (MTD)|Lost to Follow-up|0|||
27538907|NCT01897714|80167029|FG001|Phase II (MTD)|Lost to Follow-up|0|||
27538908|NCT01897714|80167030|FG002|Phase II (MTD)|Lost to Follow-up|0|||
27538909|NCT01897714|80167031|FG003|Phase II (MTD)|Lost to Follow-up|0|||
27538910|NCT01897714|80167032|FG004|Phase II (MTD)|Lost to Follow-up|1|||
27538911|NCT01897714|80167033|FG005|Phase II (MTD)|Lost to Follow-up|0|||
27538912|NCT01897714|80167028|FG000|Phase II (MTD)|Death|0|||
27538913|NCT01897714|80167029|FG001|Phase II (MTD)|Death|0|||
27538914|NCT01897714|80167030|FG002|Phase II (MTD)|Death|0|||
27538915|NCT01897714|80167031|FG003|Phase II (MTD)|Death|0|||
27538916|NCT01897714|80167032|FG004|Phase II (MTD)|Death|25|||
27538917|NCT01897714|80167033|FG005|Phase II (MTD)|Death|10|||
27538918|NCT01897714|80167028|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
27538919|NCT01897714|80167029|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
27538920|NCT01897714|80167030|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
27538921|NCT01897714|80167031|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
27538922|NCT01897714|80167032|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
27538923|NCT01897714|80167033|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
27538924|NCT01897714|80167028|FG000|Phase II (MTD)|Other|0|||
27917799|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
27917800|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
27633713|NCT02393716|80500255|FG000|Overall Study|Missed visit|16|||
27633714|NCT05001945|80500256|FG000|Overall Study|Adverse Event|0|||
27633715|NCT05001945|80500257|FG001|Overall Study|Adverse Event|0|||
27538925|NCT01897714|80167029|FG001|Phase II (MTD)|Other|0|||
27538926|NCT01897714|80167030|FG002|Phase II (MTD)|Other|0|||
27538927|NCT01897714|80167031|FG003|Phase II (MTD)|Other|0|||
27538928|NCT01897714|80167032|FG004|Phase II (MTD)|Other|3|||
27538929|NCT01897714|80167033|FG005|Phase II (MTD)|Other|0|||
27538930|NCT00289016|80167034|FG000|Overall Study|Disease Progression|29|||
27538931|NCT00289016|80167034|FG000|Overall Study|Death|2|||
27538932|NCT00289016|80167034|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
27538933|NCT00289016|80167034|FG000|Overall Study|Withdrawal by Subject|2|||
27538934|NCT00289016|80167034|FG000|Overall Study|Adverse Event|1|||
27538935|NCT00289016|80167034|FG000|Overall Study|Other|1|||
27538936|NCT02202837|80167035|FG000|Overall Study|Enbrel treatment discontinued|36|||
27538937|NCT02202837|80167036|FG001|Overall Study|Enbrel treatment discontinued|4|||
27917801|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
27917802|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
27917803|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
27917804|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
27917805|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
27917806|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
27917807|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
27917808|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
27917809|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
27917810|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
27917811|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
27917812|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
27917813|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
27917814|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
27917815|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
27917816|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
27917817|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
27917818|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
27538938|NCT02202837|80167035|FG000|Overall Study|Other|10|||
27538939|NCT02202837|80167036|FG001|Overall Study|Other|0|||
27538940|NCT02202837|80167035|FG000|Overall Study|Lost to Follow-up|7|||
27538941|NCT02202837|80167036|FG001|Overall Study|Lost to Follow-up|1|||
27538942|NCT00075218|80167037|FG000|Double-Blind Treatment|Adverse Event|23|||
27538943|NCT00075218|80167038|FG001|Double-Blind Treatment|Adverse Event|4|||
27538944|NCT00075218|80167039|FG002|Double-Blind Treatment|Adverse Event|0|||
27538945|NCT00075218|80167037|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
27538946|NCT00075218|80167038|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
27538947|NCT00075218|80167039|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
27538948|NCT00075218|80167037|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
27633716|NCT05001945|80500258|FG002|Overall Study|Adverse Event|0|||
27633717|NCT05001945|80500259|FG003|Overall Study|Adverse Event|1|||
27633718|NCT05001945|80500260|FG004|Overall Study|Adverse Event|0|||
27633719|NCT05001945|80500261|FG005|Overall Study|Adverse Event|0|||
27633720|NCT05001945|80500262|FG006|Overall Study|Adverse Event|0|||
27633721|NCT05001945|80500263|FG007|Overall Study|Adverse Event|0|||
27633722|NCT05001945|80500256|FG000|Overall Study|Lost to Follow-up|0|||
27633723|NCT05001945|80500257|FG001|Overall Study|Lost to Follow-up|1|||
27633724|NCT05001945|80500258|FG002|Overall Study|Lost to Follow-up|1|||
27633725|NCT05001945|80500259|FG003|Overall Study|Lost to Follow-up|2|||
27633726|NCT05001945|80500260|FG004|Overall Study|Lost to Follow-up|0|||
27633727|NCT05001945|80500261|FG005|Overall Study|Lost to Follow-up|1|||
27633728|NCT05001945|80500262|FG006|Overall Study|Lost to Follow-up|0|||
27633729|NCT05001945|80500263|FG007|Overall Study|Lost to Follow-up|0|||
27633730|NCT05001945|80500256|FG000|Overall Study|Protocol Violation|1|||
27633731|NCT05001945|80500257|FG001|Overall Study|Protocol Violation|0|||
27633732|NCT05001945|80500258|FG002|Overall Study|Protocol Violation|1|||
27633733|NCT05001945|80500259|FG003|Overall Study|Protocol Violation|1|||
27633734|NCT05001945|80500260|FG004|Overall Study|Protocol Violation|0|||
27633735|NCT05001945|80500261|FG005|Overall Study|Protocol Violation|1|||
27633736|NCT05001945|80500262|FG006|Overall Study|Protocol Violation|0|||
27633737|NCT05001945|80500263|FG007|Overall Study|Protocol Violation|0|||
27633738|NCT05001945|80500256|FG000|Overall Study|Withdrawal by Subject|0|||
27633739|NCT05001945|80500257|FG001|Overall Study|Withdrawal by Subject|0|||
27633740|NCT05001945|80500258|FG002|Overall Study|Withdrawal by Subject|0|||
27633741|NCT05001945|80500259|FG003|Overall Study|Withdrawal by Subject|1|||
27633742|NCT05001945|80500260|FG004|Overall Study|Withdrawal by Subject|1|||
27633743|NCT05001945|80500261|FG005|Overall Study|Withdrawal by Subject|1|||
27538949|NCT00075218|80167038|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
27538950|NCT00075218|80167039|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
27538951|NCT00075218|80167037|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
27538952|NCT00075218|80167038|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
27538953|NCT00075218|80167039|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
27538954|NCT00075218|80167037|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
27538955|NCT00075218|80167038|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
27538956|NCT00075218|80167039|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
27538957|NCT00075218|80167037|FG000|Double-Blind Treatment|No study medication taken|2|||
27538958|NCT00075218|80167038|FG001|Double-Blind Treatment|No study medication taken|0|||
27538959|NCT00075218|80167039|FG002|Double-Blind Treatment|No study medication taken|0|||
27538960|NCT00075218|80167037|FG000|Open-Label Treatment|Lack of Efficacy|0|||
27538961|NCT00075218|80167038|FG001|Open-Label Treatment|Lack of Efficacy|0|||
27538962|NCT00075218|80167039|FG002|Open-Label Treatment|Lack of Efficacy|174|||
27538963|NCT00075218|80167037|FG000|Open-Label Treatment|Adverse Event|0|||
27538964|NCT00075218|80167038|FG001|Open-Label Treatment|Adverse Event|0|||
27538965|NCT00075218|80167039|FG002|Open-Label Treatment|Adverse Event|51|||
27538966|NCT00075218|80167037|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
27538967|NCT00075218|80167038|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
27538968|NCT00075218|80167039|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
27538969|NCT00075218|80167037|FG000|Open-Label Treatment|Decision of Sponsor|0|||
27538970|NCT00075218|80167038|FG001|Open-Label Treatment|Decision of Sponsor|0|||
27538971|NCT00075218|80167039|FG002|Open-Label Treatment|Decision of Sponsor|8|||
27538972|NCT00075218|80167037|FG000|Open-Label Treatment|Protocol Violation|0|||
27538973|NCT00075218|80167038|FG001|Open-Label Treatment|Protocol Violation|0|||
27538974|NCT00075218|80167039|FG002|Open-Label Treatment|Protocol Violation|1|||
27538975|NCT00075218|80167037|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
27538976|NCT00075218|80167038|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
27538977|NCT00075218|80167039|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
27538978|NCT02609828|80167042|FG000|Overall Study|Adverse Event|8|||
27538979|NCT02609828|80167043|FG001|Overall Study|Adverse Event|1|||
27538980|NCT02609828|80167044|FG002|Overall Study|Adverse Event|0|||
27538981|NCT02609828|80167045|FG003|Overall Study|Adverse Event|6|||
27538982|NCT02609828|80167042|FG000|Overall Study|Death|15|||
27538983|NCT02609828|80167043|FG001|Overall Study|Death|1|||
27538984|NCT02609828|80167044|FG002|Overall Study|Death|1|||
27633744|NCT05001945|80500262|FG006|Overall Study|Withdrawal by Subject|0|||
27633745|NCT05001945|80500263|FG007|Overall Study|Withdrawal by Subject|1|||
27538985|NCT02609828|80167045|FG003|Overall Study|Death|19|||
27538986|NCT02609828|80167042|FG000|Overall Study|Insufficient clinical response|2|||
27538987|NCT02609828|80167043|FG001|Overall Study|Insufficient clinical response|1|||
27538988|NCT02609828|80167044|FG002|Overall Study|Insufficient clinical response|0|||
27538989|NCT02609828|80167045|FG003|Overall Study|Insufficient clinical response|0|||
27538990|NCT02609828|80167042|FG000|Overall Study|Lost to Follow-up|0|||
27538991|NCT02609828|80167043|FG001|Overall Study|Lost to Follow-up|0|||
27633746|NCT05001945|80500256|FG000|Overall Study|Not specified by Investigator|0|||
27633747|NCT05001945|80500257|FG001|Overall Study|Not specified by Investigator|3|||
27633748|NCT05001945|80500258|FG002|Overall Study|Not specified by Investigator|0|||
27917819|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
27917820|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
27917821|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
27917822|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
27917823|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
27917824|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
27917825|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
27917826|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
27917827|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
27917828|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
27917829|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
27917830|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
27917831|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
27917832|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
27917833|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
27917834|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
27917835|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
27917836|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
27917837|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
27917838|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917839|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917840|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917841|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917842|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917843|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917844|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917845|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
27917846|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917847|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917848|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917849|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
27917850|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
27917851|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917852|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
27917853|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917854|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917855|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
27917856|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
27917857|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
27917858|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
27917859|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
27917860|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
27917861|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
27917862|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
27917863|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
27917864|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
27917865|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
27917866|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
27917867|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
27917868|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
27917869|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
27917870|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
27917871|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
27917872|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
27917873|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
27917874|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
27917875|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
27917876|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917877|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917878|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917879|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917880|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917881|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917882|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
27917883|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917884|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27538992|NCT02609828|80167044|FG002|Overall Study|Lost to Follow-up|0|||
27538993|NCT02609828|80167045|FG003|Overall Study|Lost to Follow-up|1|||
27538994|NCT02609828|80167042|FG000|Overall Study|Protocol Violation|2|||
27538995|NCT02609828|80167043|FG001|Overall Study|Protocol Violation|0|||
27538996|NCT02609828|80167044|FG002|Overall Study|Protocol Violation|0|||
27538997|NCT02609828|80167045|FG003|Overall Study|Protocol Violation|1|||
27538998|NCT02609828|80167042|FG000|Overall Study|Withdrawal by Subject|12|||
27538999|NCT02609828|80167043|FG001|Overall Study|Withdrawal by Subject|1|||
27539000|NCT02609828|80167044|FG002|Overall Study|Withdrawal by Subject|0|||
27917885|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917886|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917887|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917888|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917889|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917890|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917891|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917892|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917893|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
27917894|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
27539001|NCT02609828|80167045|FG003|Overall Study|Withdrawal by Subject|10|||
27539002|NCT02609828|80167042|FG000|Overall Study|Other|3|||
27539003|NCT02609828|80167043|FG001|Overall Study|Other|0|||
27539004|NCT02609828|80167044|FG002|Overall Study|Other|0|||
27539005|NCT02609828|80167045|FG003|Overall Study|Other|6|||
27539006|NCT02609828|80167042|FG000|Overall Study|Randomized but not treated|1|||
27539007|NCT02609828|80167043|FG001|Overall Study|Randomized but not treated|0|||
27539008|NCT02609828|80167044|FG002|Overall Study|Randomized but not treated|0|||
27539009|NCT02609828|80167045|FG003|Overall Study|Randomized but not treated|0|||
27539010|NCT02202980|80167046|FG000|Overall Study|Lack of Efficacy|1|||
27539011|NCT02202980|80167047|FG001|Overall Study|Lack of Efficacy|0|||
27539012|NCT02202980|80167048|FG002|Overall Study|Lack of Efficacy|7|||
27539013|NCT02202980|80167049|FG003|Overall Study|Lack of Efficacy|0|||
27539014|NCT02202980|80167050|FG004|Overall Study|Lack of Efficacy|3|||
27539015|NCT02202980|80167051|FG005|Overall Study|Lack of Efficacy|1|||
27539016|NCT02202980|80167052|FG006|Overall Study|Lack of Efficacy|11|||
27539017|NCT02202980|80167053|FG007|Overall Study|Lack of Efficacy|2|||
27539018|NCT02202980|80167054|FG008|Overall Study|Lack of Efficacy|2|||
27539019|NCT02202980|80167055|FG009|Overall Study|Lack of Efficacy|0|||
27539020|NCT02202980|80167056|FG010|Overall Study|Lack of Efficacy|0|||
27539021|NCT02202980|80167057|FG011|Overall Study|Lack of Efficacy|3|||
27539022|NCT02202980|80167058|FG012|Overall Study|Lack of Efficacy|10|||
27539023|NCT02202980|80167059|FG013|Overall Study|Lack of Efficacy|0|||
27539024|NCT02202980|80167046|FG000|Overall Study|Protocol Violation|0|||
27539025|NCT02202980|80167047|FG001|Overall Study|Protocol Violation|0|||
27539026|NCT02202980|80167048|FG002|Overall Study|Protocol Violation|0|||
27539027|NCT02202980|80167049|FG003|Overall Study|Protocol Violation|3|||
27539028|NCT02202980|80167050|FG004|Overall Study|Protocol Violation|3|||
27539029|NCT02202980|80167051|FG005|Overall Study|Protocol Violation|0|||
27539030|NCT02202980|80167052|FG006|Overall Study|Protocol Violation|0|||
27539031|NCT02202980|80167053|FG007|Overall Study|Protocol Violation|0|||
27539032|NCT02202980|80167054|FG008|Overall Study|Protocol Violation|0|||
27539033|NCT02202980|80167055|FG009|Overall Study|Protocol Violation|0|||
27539034|NCT02202980|80167056|FG010|Overall Study|Protocol Violation|0|||
27539035|NCT02202980|80167057|FG011|Overall Study|Protocol Violation|0|||
27539036|NCT02202980|80167058|FG012|Overall Study|Protocol Violation|0|||
27539037|NCT02202980|80167059|FG013|Overall Study|Protocol Violation|0|||
27539038|NCT02202980|80167046|FG000|Overall Study|Lost to Follow-up|0|||
27539039|NCT02202980|80167047|FG001|Overall Study|Lost to Follow-up|1|||
27539040|NCT02202980|80167048|FG002|Overall Study|Lost to Follow-up|1|||
27539041|NCT02202980|80167049|FG003|Overall Study|Lost to Follow-up|1|||
27539042|NCT02202980|80167050|FG004|Overall Study|Lost to Follow-up|0|||
27739871|NCT01887210|80877308|FG001|Overall Study|Lost to Follow-up|1|||
27739872|NCT05370157|80877314|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
27739873|NCT05370157|80877315|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
27539043|NCT02202980|80167051|FG005|Overall Study|Lost to Follow-up|0|||
27539044|NCT02202980|80167052|FG006|Overall Study|Lost to Follow-up|0|||
27539045|NCT02202980|80167053|FG007|Overall Study|Lost to Follow-up|1|||
27539046|NCT02202980|80167054|FG008|Overall Study|Lost to Follow-up|1|||
27539047|NCT02202980|80167055|FG009|Overall Study|Lost to Follow-up|0|||
27539048|NCT02202980|80167056|FG010|Overall Study|Lost to Follow-up|0|||
27539049|NCT02202980|80167057|FG011|Overall Study|Lost to Follow-up|0|||
27539050|NCT02202980|80167058|FG012|Overall Study|Lost to Follow-up|1|||
27539051|NCT02202980|80167059|FG013|Overall Study|Lost to Follow-up|0|||
27539052|NCT02202980|80167046|FG000|Overall Study|Withdrew Consent|0|||
27539053|NCT02202980|80167047|FG001|Overall Study|Withdrew Consent|1|||
27539054|NCT02202980|80167048|FG002|Overall Study|Withdrew Consent|2|||
27539055|NCT02202980|80167049|FG003|Overall Study|Withdrew Consent|0|||
27633749|NCT05001945|80500259|FG003|Overall Study|Not specified by Investigator|0|||
27633750|NCT05001945|80500260|FG004|Overall Study|Not specified by Investigator|1|||
27633751|NCT05001945|80500261|FG005|Overall Study|Not specified by Investigator|0|||
27633752|NCT05001945|80500262|FG006|Overall Study|Not specified by Investigator|0|||
27633753|NCT05001945|80500263|FG007|Overall Study|Not specified by Investigator|0|||
27633754|NCT03720210|80500264|FG000|Overall Study|Lost to Follow-up|1|||
27633755|NCT01251354|80500265|FG000|Overall Study|Adverse Event|1|||
27633756|NCT01251354|80500265|FG000|Overall Study|Investigator's Decision|1|||
27633757|NCT01251354|80500265|FG000|Overall Study|Disease Progression|4|||
27633758|NCT02814643|80500266|FG000|Overall Study|Lost to Follow-up|0|||
27633759|NCT02814643|80500267|FG001|Overall Study|Lost to Follow-up|1|||
27633760|NCT02814643|80500266|FG000|Overall Study|Withdrawal by Subject|1|||
27633761|NCT02814643|80500267|FG001|Overall Study|Withdrawal by Subject|2|||
27633762|NCT01063517|80500270|FG000|Overall Study|Consent withdrawal|1|||
27633763|NCT01063517|80500271|FG001|Overall Study|Consent withdrawal|0|||
27633764|NCT01063517|80500270|FG000|Overall Study|Study reached data cut-off|19|||
27633765|NCT01063517|80500271|FG001|Overall Study|Study reached data cut-off|7|||
27633766|NCT01063517|80500270|FG000|Overall Study|Lost to Follow-up|4|||
27633767|NCT01063517|80500271|FG001|Overall Study|Lost to Follow-up|3|||
27633768|NCT01063517|80500270|FG000|Overall Study|Withdrawal by Subject|1|||
27633769|NCT01063517|80500271|FG001|Overall Study|Withdrawal by Subject|2|||
27633770|NCT01063517|80500270|FG000|Overall Study|Death|33|||
27633771|NCT01063517|80500271|FG001|Overall Study|Death|48|||
27539056|NCT02202980|80167050|FG004|Overall Study|Withdrew Consent|0|||
27539057|NCT02202980|80167051|FG005|Overall Study|Withdrew Consent|0|||
27633772|NCT02739035|80500274|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
27633773|NCT02739035|80500275|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
27633774|NCT02739035|80500274|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
27633775|NCT02739035|80500275|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
27633776|NCT02739035|80500274|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
27739874|NCT05370157|80877314|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
27739875|NCT05370157|80877315|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
27739876|NCT04655586|80877320|FG000|Overall Study|Physician Decision|1|||
27739877|NCT04655586|80877321|FG001|Overall Study|Physician Decision|3|||
27739878|NCT04655586|80877322|FG002|Overall Study|Physician Decision|4|||
27917895|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
27917896|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
27539058|NCT02202980|80167052|FG006|Overall Study|Withdrew Consent|0|||
27539059|NCT02202980|80167053|FG007|Overall Study|Withdrew Consent|0|||
27539060|NCT02202980|80167054|FG008|Overall Study|Withdrew Consent|1|||
27539061|NCT02202980|80167055|FG009|Overall Study|Withdrew Consent|0|||
27539062|NCT02202980|80167056|FG010|Overall Study|Withdrew Consent|0|||
27539063|NCT02202980|80167057|FG011|Overall Study|Withdrew Consent|0|||
27539064|NCT02202980|80167058|FG012|Overall Study|Withdrew Consent|0|||
27539065|NCT02202980|80167059|FG013|Overall Study|Withdrew Consent|0|||
27539066|NCT01705730|80167062|FG000|Overall Study|Lack of Efficacy|1|||
27539067|NCT01705730|80167062|FG000|Overall Study|Adverse Event|3|||
27539068|NCT01705730|80167062|FG000|Overall Study|Lost to Follow-up|1|||
27539069|NCT01705730|80167062|FG000|Overall Study|Reason not Specified|4|||
27539070|NCT01824875|80167067|FG000|Overall Study|Disease progression|22|||
27539071|NCT01824875|80167068|FG001|Overall Study|Disease progression|15|||
27539072|NCT01824875|80167067|FG000|Overall Study|Withdrawal by Subject|5|||
27539073|NCT01824875|80167068|FG001|Overall Study|Withdrawal by Subject|4|||
27539074|NCT01824875|80167067|FG000|Overall Study|Adverse Event|4|||
27539075|NCT01824875|80167068|FG001|Overall Study|Adverse Event|10|||
27539076|NCT01824875|80167067|FG000|Overall Study|Alternative therapy|3|||
27539077|NCT01824875|80167068|FG001|Overall Study|Alternative therapy|0|||
27539078|NCT01824875|80167067|FG000|Overall Study|Complicating disease|1|||
27539079|NCT01824875|80167068|FG001|Overall Study|Complicating disease|0|||
27539080|NCT01824875|80167067|FG000|Overall Study|Physician Decision|0|||
27539081|NCT01824875|80167068|FG001|Overall Study|Physician Decision|1|||
27539082|NCT01824875|80167067|FG000|Overall Study|Non-compliance|1|||
27539083|NCT01824875|80167068|FG001|Overall Study|Non-compliance|1|||
27539084|NCT01824875|80167067|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
27539085|NCT01824875|80167068|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
27539086|NCT01824875|80167067|FG000|Overall Study|Administrative issues|0|||
27633777|NCT02739035|80500275|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
27633778|NCT02739035|80500274|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
27633779|NCT02739035|80500275|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
27633780|NCT02082158|80500276|FG000|Overall Study|Withdrawal by Subject|0|||
27633781|NCT02082158|80500277|FG001|Overall Study|Withdrawal by Subject|0|||
27539087|NCT01824875|80167068|FG001|Overall Study|Administrative issues|2|||
27539088|NCT01824875|80167067|FG000|Overall Study|Ineligible or never started treatment|9|||
27539089|NCT01824875|80167068|FG001|Overall Study|Ineligible or never started treatment|5|||
27539090|NCT01824875|80167067|FG000|Overall Study|Other|0|||
27539091|NCT01824875|80167068|FG001|Overall Study|Other|2|||
27539092|NCT01706146|80167076|FG000|Overall Study|Withdrawal by Subject|1|||
27633782|NCT02082158|80500278|FG002|Overall Study|Withdrawal by Subject|0|||
27633783|NCT02082158|80500279|FG003|Overall Study|Withdrawal by Subject|0|||
27633784|NCT02082158|80500280|FG004|Overall Study|Withdrawal by Subject|1|||
27633785|NCT02082158|80500281|FG005|Overall Study|Withdrawal by Subject|0|||
27633786|NCT02082158|80500276|FG000|Overall Study|Failed Fit-testing|8|||
27633787|NCT02082158|80500277|FG001|Overall Study|Failed Fit-testing|8|||
27633788|NCT02082158|80500278|FG002|Overall Study|Failed Fit-testing|14|||
27633789|NCT02082158|80500279|FG003|Overall Study|Failed Fit-testing|4|||
27633790|NCT02082158|80500280|FG004|Overall Study|Failed Fit-testing|3|||
27633791|NCT02082158|80500281|FG005|Overall Study|Failed Fit-testing|7|||
27633792|NCT02534350|80500282|FG000|Overall Study|Randomized But Not Treated|1|||
27633793|NCT02534350|80500283|FG001|Overall Study|Randomized But Not Treated|0|||
27633794|NCT02534350|80500282|FG000|Overall Study|Protocol Violation|1|||
27633795|NCT02534350|80500283|FG001|Overall Study|Protocol Violation|0|||
27633796|NCT02534350|80500282|FG000|Overall Study|Withdrew Consent|2|||
27633797|NCT02534350|80500283|FG001|Overall Study|Withdrew Consent|0|||
27633798|NCT03895034|80500284|FG000|Overall Study|Lost to Follow-up|2|||
27633799|NCT00509769|80500285|FG000|Overall Study|Progressive disease|77|||
27633800|NCT00509769|80500285|FG000|Overall Study|Adverse Event|4|||
27739879|NCT04655586|80877320|FG000|Overall Study|Withdrawal by Subject|1|||
27539093|NCT01706146|80167076|FG000|Overall Study|Adverse Event|3|||
27539094|NCT01706146|80167076|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
27539095|NCT00799383|80167077|FG000|Overall Study|Protocol Violation|1|||
27539096|NCT00799383|80167078|FG001|Overall Study|Protocol Violation|1|||
27539097|NCT00799383|80167077|FG000|Overall Study|Adverse Event|0|||
27539098|NCT00799383|80167078|FG001|Overall Study|Adverse Event|1|||
27539099|NCT00799383|80167077|FG000|Overall Study|Lost to Follow-up|1|||
27539100|NCT00799383|80167078|FG001|Overall Study|Lost to Follow-up|2|||
27539101|NCT00799383|80167077|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
27539102|NCT00799383|80167078|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
27539103|NCT00799383|80167077|FG000|Overall Study|Withdrawal by Subject|0|||
27539104|NCT00799383|80167078|FG001|Overall Study|Withdrawal by Subject|1|||
27539105|NCT01414608|80167079|FG000|Overall Study|Ineligible|5|||
27539106|NCT01414608|80167080|FG001|Overall Study|Ineligible|2|||
27539107|NCT02877134|80167081|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539108|NCT02877134|80167082|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
27539109|NCT02877134|80167083|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539110|NCT02877134|80167084|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
27739880|NCT04655586|80877321|FG001|Overall Study|Withdrawal by Subject|3|||
27539111|NCT02877134|80167085|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539112|NCT02877134|80167086|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
27539113|NCT02877134|80167087|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
27739881|NCT04655586|80877322|FG002|Overall Study|Withdrawal by Subject|1|||
27739882|NCT01981187|80877327|FG000|Overall Study|Participant/guardian decision|2|||
27739883|NCT01981187|80877327|FG000|Overall Study|Physician Decision|1|||
27739884|NCT01981187|80877327|FG000|Overall Study|Disease progression|2|||
27739885|NCT01981187|80877327|FG000|Overall Study|Adverse Event|7|||
27739886|NCT00069121|80877328|FG000|Overall Study|Death|286|||
27739887|NCT00069121|80877329|FG001|Overall Study|Death|242|||
27739888|NCT00069121|80877328|FG000|Overall Study|Withdrawal by Subject|18|||
27917897|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
27917898|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
27917899|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
27917900|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
27917901|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
27917902|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
27917903|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
27539114|NCT02877134|80167088|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
27917904|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
27539115|NCT02877134|80167089|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539116|NCT02877134|80167090|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539117|NCT02877134|80167091|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539118|NCT02877134|80167092|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
27539119|NCT02877134|80167081|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27739889|NCT00069121|80877329|FG001|Overall Study|Withdrawal by Subject|20|||
27539120|NCT02877134|80167082|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
27539121|NCT02877134|80167083|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27633801|NCT00509769|80500285|FG000|Overall Study|Patient's decision|1|||
27633802|NCT00509769|80500285|FG000|Overall Study|Physician Decision|8|||
27633803|NCT00509769|80500285|FG000|Overall Study|Use of prohibited therapies during study|1|||
27739890|NCT00069121|80877328|FG000|Overall Study|Lost to Follow-up|63|||
27917905|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
27917906|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
27917907|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
27917908|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
27917909|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
27917910|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
27917911|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
27917912|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
27917913|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
27917914|NCT03428100|81536559|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917915|NCT03428100|81536560|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917916|NCT03428100|81536561|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917917|NCT03428100|81536562|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917918|NCT03428100|81536563|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
27917919|NCT03428100|81536564|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917920|NCT03428100|81536565|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
27917921|NCT03428100|81536566|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
27539122|NCT02877134|80167084|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
27739891|NCT00069121|80877329|FG001|Overall Study|Lost to Follow-up|63|||
27739892|NCT02024464|80877330|FG000|Overall Study|Discontinued|5|||
27739893|NCT02024464|80877331|FG001|Overall Study|Discontinued|4|||
27739894|NCT02024464|80877330|FG000|Overall Study|Missed Visits|1|||
27739895|NCT02024464|80877331|FG001|Overall Study|Missed Visits|0|||
27739896|NCT02024464|80877330|FG000|Overall Study|Lost to Follow-up|4|||
27739897|NCT02024464|80877331|FG001|Overall Study|Lost to Follow-up|7|||
27739898|NCT04538950|80877334|FG000|Overall Study|Pulmonary Issues|2|||
27739899|NCT04538950|80877334|FG000|Overall Study|illness|2|||
27539123|NCT02877134|80167085|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27739900|NCT01287117|80877335|FG000|Overall Study|Adverse Event|2|||
27739901|NCT01287117|80877336|FG001|Overall Study|Adverse Event|1|||
27739902|NCT01287117|80877337|FG002|Overall Study|Adverse Event|1|||
27739903|NCT01287117|80877338|FG003|Overall Study|Adverse Event|1|||
27739904|NCT01287117|80877335|FG000|Overall Study|Lost to Follow-up|1|||
27739905|NCT01287117|80877336|FG001|Overall Study|Lost to Follow-up|1|||
27739906|NCT01287117|80877337|FG002|Overall Study|Lost to Follow-up|0|||
27739907|NCT01287117|80877338|FG003|Overall Study|Lost to Follow-up|0|||
27739908|NCT01287117|80877335|FG000|Overall Study|Physician Decision|0|||
27739909|NCT01287117|80877336|FG001|Overall Study|Physician Decision|1|||
27739910|NCT01287117|80877337|FG002|Overall Study|Physician Decision|1|||
27739911|NCT01287117|80877338|FG003|Overall Study|Physician Decision|1|||
27739912|NCT01287117|80877335|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
27739913|NCT01287117|80877336|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
27739914|NCT01287117|80877337|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
27739915|NCT01287117|80877338|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
27739916|NCT01287117|80877335|FG000|Overall Study|Disease Progression|10|||
27739917|NCT01287117|80877336|FG001|Overall Study|Disease Progression|5|||
27739918|NCT01287117|80877337|FG002|Overall Study|Disease Progression|6|||
27739919|NCT01287117|80877338|FG003|Overall Study|Disease Progression|5|||
27739920|NCT00546351|80877345|FG000|Overall Study|Adverse Event|76|||
27739921|NCT00546351|80877345|FG000|Overall Study|Lack of Efficacy|15|||
27739922|NCT00546351|80877345|FG000|Overall Study|Withdrawal by Subject|109|||
27739923|NCT00546351|80877345|FG000|Overall Study|Lost to Follow-up|9|||
27739924|NCT00546351|80877345|FG000|Overall Study|Protocol Deviation|1|||
27739925|NCT00546351|80877345|FG000|Overall Study|Unsatisfactory compliance|9|||
27739926|NCT00546351|80877345|FG000|Overall Study|Other reasons for premature termination|17|||
27739927|NCT01524289|80877346|FG000|Overall Study|Lost to Follow-up|0|||
27739928|NCT01524289|80877347|FG001|Overall Study|Lost to Follow-up|1|||
27739929|NCT01524289|80877346|FG000|Overall Study|Physician Decision|1|||
27739930|NCT01524289|80877347|FG001|Overall Study|Physician Decision|0|||
27739931|NCT01524289|80877346|FG000|Overall Study|Protocol Violation|5|||
27739932|NCT01524289|80877347|FG001|Overall Study|Protocol Violation|1|||
27739933|NCT01524289|80877346|FG000|Overall Study|Withdrawal by Subject|11|||
27739934|NCT01524289|80877347|FG001|Overall Study|Withdrawal by Subject|7|||
27739935|NCT01524289|80877346|FG000|Overall Study|Adverse Event|12|||
27539124|NCT02877134|80167086|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27539125|NCT02877134|80167087|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
27633804|NCT03546907|80500286|FG000|Overall Study|Lack of Efficacy|1|||
27739936|NCT01524289|80877347|FG001|Overall Study|Adverse Event|5|||
27739937|NCT01524289|80877346|FG000|Overall Study|Did not take study medication|1|||
27739938|NCT01524289|80877347|FG001|Overall Study|Did not take study medication|0|||
27739939|NCT03952650|80877348|FG000|Overall Study|TRAVEL|0|||
27739940|NCT03952650|80877349|FG001|Overall Study|TRAVEL|4|||
27739941|NCT03952650|80877350|FG002|Overall Study|TRAVEL|0|||
27739942|NCT03952650|80877351|FG003|Overall Study|TRAVEL|4|||
27739943|NCT03952650|80877352|FG004|Overall Study|TRAVEL|0|||
27739944|NCT03952650|80877353|FG005|Overall Study|TRAVEL|3|||
27739945|NCT03952650|80877354|FG006|Overall Study|TRAVEL|2|||
27739946|NCT03952650|80877348|FG000|Overall Study|Withdrawal by Subject|0|||
27739947|NCT03952650|80877349|FG001|Overall Study|Withdrawal by Subject|2|||
27739948|NCT03952650|80877350|FG002|Overall Study|Withdrawal by Subject|0|||
27739949|NCT03952650|80877351|FG003|Overall Study|Withdrawal by Subject|3|||
27739950|NCT03952650|80877352|FG004|Overall Study|Withdrawal by Subject|0|||
27739951|NCT03952650|80877353|FG005|Overall Study|Withdrawal by Subject|1|||
27739952|NCT03952650|80877354|FG006|Overall Study|Withdrawal by Subject|1|||
27739953|NCT03952650|80877348|FG000|Overall Study|Lost to Follow-up|0|||
27739954|NCT03952650|80877349|FG001|Overall Study|Lost to Follow-up|1|||
27739955|NCT03952650|80877350|FG002|Overall Study|Lost to Follow-up|0|||
27739956|NCT03952650|80877351|FG003|Overall Study|Lost to Follow-up|0|||
27739957|NCT03952650|80877352|FG004|Overall Study|Lost to Follow-up|0|||
27739958|NCT03952650|80877353|FG005|Overall Study|Lost to Follow-up|1|||
27739959|NCT03952650|80877354|FG006|Overall Study|Lost to Follow-up|1|||
27739960|NCT03952650|80877348|FG000|Overall Study|Received wrong vaccine and travelled|0|||
27739961|NCT03952650|80877349|FG001|Overall Study|Received wrong vaccine and travelled|0|||
27739962|NCT03952650|80877350|FG002|Overall Study|Received wrong vaccine and travelled|0|||
27739963|NCT03952650|80877351|FG003|Overall Study|Received wrong vaccine and travelled|0|||
27739964|NCT03952650|80877352|FG004|Overall Study|Received wrong vaccine and travelled|0|||
27739965|NCT03952650|80877353|FG005|Overall Study|Received wrong vaccine and travelled|1|||
27739966|NCT03952650|80877354|FG006|Overall Study|Received wrong vaccine and travelled|0|||
27739967|NCT03952650|80877348|FG000|Overall Study|Unable to make study visit|0|||
27739968|NCT03952650|80877349|FG001|Overall Study|Unable to make study visit|0|||
27739969|NCT03952650|80877350|FG002|Overall Study|Unable to make study visit|0|||
27739970|NCT03952650|80877351|FG003|Overall Study|Unable to make study visit|0|||
27739971|NCT03952650|80877352|FG004|Overall Study|Unable to make study visit|0|||
27739972|NCT03952650|80877353|FG005|Overall Study|Unable to make study visit|1|||
27739973|NCT03952650|80877354|FG006|Overall Study|Unable to make study visit|0|||
27739974|NCT00922935|80877355|FG000|Overall Study|Protocol Violation|0|||
27739975|NCT00922935|80877356|FG001|Overall Study|Protocol Violation|3|||
27739976|NCT00922935|80877357|FG002|Overall Study|Protocol Violation|0|||
27739977|NCT00922935|80877355|FG000|Overall Study|Physician Decision|1|||
27739978|NCT00922935|80877356|FG001|Overall Study|Physician Decision|1|||
27739979|NCT00922935|80877357|FG002|Overall Study|Physician Decision|0|||
27739980|NCT00922935|80877355|FG000|Overall Study|Lost to Follow-up|0|||
27739981|NCT00922935|80877356|FG001|Overall Study|Lost to Follow-up|1|||
27739982|NCT00922935|80877357|FG002|Overall Study|Lost to Follow-up|0|||
27739983|NCT02128490|80877358|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
27739984|NCT02128490|80877359|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27739985|NCT02128490|80877360|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27739986|NCT02128490|80877361|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27739987|NCT02128490|80877362|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
27739988|NCT02128490|80877358|FG000|Overall Study|Major Protocol Deviation|1|||
27739989|NCT02128490|80877359|FG001|Overall Study|Major Protocol Deviation|2|||
27739990|NCT02128490|80877360|FG002|Overall Study|Major Protocol Deviation|0|||
27739991|NCT02128490|80877361|FG003|Overall Study|Major Protocol Deviation|2|||
27739992|NCT02128490|80877362|FG004|Overall Study|Major Protocol Deviation|2|||
27739993|NCT02128490|80877358|FG000|Overall Study|Lost to Follow-up|0|||
27739994|NCT02128490|80877359|FG001|Overall Study|Lost to Follow-up|0|||
27739995|NCT02128490|80877360|FG002|Overall Study|Lost to Follow-up|1|||
27739996|NCT02128490|80877361|FG003|Overall Study|Lost to Follow-up|1|||
27739997|NCT02128490|80877362|FG004|Overall Study|Lost to Follow-up|1|||
27739998|NCT02128490|80877358|FG000|Overall Study|Voluntary Withdrawal|3|||
27739999|NCT02128490|80877359|FG001|Overall Study|Voluntary Withdrawal|3|||
27740000|NCT02128490|80877360|FG002|Overall Study|Voluntary Withdrawal|1|||
27740001|NCT02128490|80877361|FG003|Overall Study|Voluntary Withdrawal|1|||
27740002|NCT02128490|80877362|FG004|Overall Study|Voluntary Withdrawal|2|||
27539126|NCT02877134|80167088|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27539127|NCT02877134|80167089|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27740003|NCT02128490|80877358|FG000|Overall Study|Lack of Efficacy|0|||
27740004|NCT02128490|80877359|FG001|Overall Study|Lack of Efficacy|1|||
27740005|NCT02128490|80877360|FG002|Overall Study|Lack of Efficacy|0|||
27740006|NCT02128490|80877361|FG003|Overall Study|Lack of Efficacy|0|||
27740007|NCT02128490|80877362|FG004|Overall Study|Lack of Efficacy|0|||
27539128|NCT02877134|80167090|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27740008|NCT02128490|80877358|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27740009|NCT02128490|80877359|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27740010|NCT02128490|80877360|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27740011|NCT02128490|80877361|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
27740012|NCT02128490|80877362|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
27740013|NCT02128490|80877358|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27740014|NCT02128490|80877359|FG001|Overall Study|Other Miscellaneous Reasons|0|||
27740015|NCT02128490|80877360|FG002|Overall Study|Other Miscellaneous Reasons|2|||
27740016|NCT02128490|80877361|FG003|Overall Study|Other Miscellaneous Reasons|1|||
27740017|NCT02128490|80877362|FG004|Overall Study|Other Miscellaneous Reasons|1|||
27740018|NCT04329949|80877363|FG000|Overall Study|Death|36|||
27740019|NCT04329949|80877363|FG000|Overall Study|Withdrawal by Subject|4|||
27740020|NCT04329949|80877363|FG000|Overall Study|Termination of study by sponsor|3|||
27740021|NCT00149214|80877364|FG000|Overall Study|Adverse Event|12|||
27740022|NCT00149214|80877365|FG001|Overall Study|Adverse Event|9|||
27740023|NCT00149214|80877364|FG000|Overall Study|Withdrawal by Subject|4|||
27740024|NCT00149214|80877365|FG001|Overall Study|Withdrawal by Subject|1|||
27740025|NCT00149214|80877364|FG000|Overall Study|Physician Decision|3|||
27740026|NCT00149214|80877365|FG001|Overall Study|Physician Decision|3|||
27740027|NCT00149214|80877364|FG000|Overall Study|Sponsor Decision|0|||
27740028|NCT00149214|80877365|FG001|Overall Study|Sponsor Decision|1|||
27740029|NCT00149214|80877364|FG000|Overall Study|Progressive Disease|7|||
27740030|NCT00149214|80877365|FG001|Overall Study|Progressive Disease|3|||
27740031|NCT03952130|80877371|FG000|Overall Study|Adverse Event|0|||
27740032|NCT03952130|80877372|FG001|Overall Study|Adverse Event|1|||
27740033|NCT03952130|80877371|FG000|Overall Study|Lost to Follow-up|1|||
27740034|NCT03952130|80877372|FG001|Overall Study|Lost to Follow-up|0|||
27740035|NCT03952130|80877371|FG000|Overall Study|Withdrawal by Subject|1|||
27740036|NCT03952130|80877372|FG001|Overall Study|Withdrawal by Subject|5|||
27740037|NCT04332419|80877373|FG000|Overall Study|Withdrawal by Subject|1|||
27740038|NCT00824421|80877374|FG000|Overall Study|Adverse Event|6|||
27740039|NCT00824421|80877375|FG001|Overall Study|Adverse Event|6|||
27740040|NCT00824421|80877376|FG002|Overall Study|Adverse Event|6|||
27740041|NCT00824421|80877374|FG000|Overall Study|Death|0|||
27740042|NCT00824421|80877375|FG001|Overall Study|Death|1|||
27740043|NCT00824421|80877376|FG002|Overall Study|Death|0|||
27740044|NCT00824421|80877374|FG000|Overall Study|Lack of Efficacy|5|||
27740045|NCT00824421|80877375|FG001|Overall Study|Lack of Efficacy|7|||
27740046|NCT00824421|80877376|FG002|Overall Study|Lack of Efficacy|4|||
27740047|NCT00824421|80877374|FG000|Overall Study|Lost to Follow-up|2|||
27740048|NCT00824421|80877375|FG001|Overall Study|Lost to Follow-up|3|||
27740049|NCT00824421|80877376|FG002|Overall Study|Lost to Follow-up|0|||
27740050|NCT00824421|80877374|FG000|Overall Study|Pregnancy|1|||
27740051|NCT00824421|80877375|FG001|Overall Study|Pregnancy|0|||
27740052|NCT00824421|80877376|FG002|Overall Study|Pregnancy|1|||
27740053|NCT00824421|80877374|FG000|Overall Study|Withdrawal by Subject|2|||
27740054|NCT00824421|80877375|FG001|Overall Study|Withdrawal by Subject|3|||
27740055|NCT00824421|80877376|FG002|Overall Study|Withdrawal by Subject|3|||
27740056|NCT00824421|80877374|FG000|Overall Study|Randomized but not Treated|1|||
27539129|NCT02877134|80167091|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27539130|NCT02877134|80167092|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
27539131|NCT02877134|80167081|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
27539132|NCT02877134|80167082|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
27539133|NCT02877134|80167083|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
27539134|NCT02877134|80167084|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
27539135|NCT02877134|80167085|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
27539136|NCT02877134|80167086|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
27539137|NCT02877134|80167087|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
27539138|NCT02877134|80167088|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
27539139|NCT02877134|80167089|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
27539140|NCT02877134|80167090|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
27539141|NCT02877134|80167091|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
27539142|NCT02877134|80167092|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
27539143|NCT02877134|80167081|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
27539144|NCT02877134|80167082|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
27539145|NCT02877134|80167083|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
27539146|NCT02877134|80167084|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
27539147|NCT02877134|80167085|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
27740057|NCT00824421|80877375|FG001|Overall Study|Randomized but not Treated|1|||
27740058|NCT00824421|80877376|FG002|Overall Study|Randomized but not Treated|0|||
27539148|NCT02877134|80167086|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
27740059|NCT00824421|80877374|FG000|Overall Study|Other|0|||
27740060|NCT00824421|80877375|FG001|Overall Study|Other|1|||
27740061|NCT00824421|80877376|FG002|Overall Study|Other|0|||
27740062|NCT03750838|80877377|FG000|Overall Study|Lost to Follow-up|10|||
27740063|NCT03750838|80877378|FG001|Overall Study|Lost to Follow-up|6|||
27740064|NCT00783289|80877380|FG000|Overall Study|Protocol Violation|0|||
27740065|NCT00783289|80877381|FG001|Overall Study|Protocol Violation|1|||
27740066|NCT00783289|80877382|FG002|Overall Study|Protocol Violation|0|||
27740067|NCT00783289|80877383|FG003|Overall Study|Protocol Violation|0|||
27740068|NCT00650585|80877384|FG000|Overall Study|Lost to Follow-up|505|||
27539149|NCT02877134|80167087|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
27539150|NCT02877134|80167088|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
27539151|NCT02877134|80167089|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
27539152|NCT02877134|80167090|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
27539153|NCT02877134|80167091|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
27539154|NCT02877134|80167092|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
27539155|NCT02877134|80167081|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539156|NCT02877134|80167082|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539157|NCT02877134|80167083|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539158|NCT02877134|80167084|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539159|NCT02877134|80167085|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539160|NCT02877134|80167086|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539161|NCT02877134|80167087|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539162|NCT02877134|80167088|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539163|NCT02877134|80167089|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
27539164|NCT02877134|80167090|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539165|NCT02877134|80167091|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539166|NCT02877134|80167092|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
27539167|NCT02877134|80167081|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539168|NCT02877134|80167082|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539169|NCT02877134|80167083|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539170|NCT02877134|80167084|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539171|NCT02877134|80167085|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539172|NCT02877134|80167086|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539173|NCT02877134|80167087|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
27539174|NCT02877134|80167088|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
27539175|NCT02877134|80167089|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
27539176|NCT02877134|80167090|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
27539177|NCT02877134|80167091|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
27539178|NCT02877134|80167092|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
27539179|NCT02877134|80167081|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539180|NCT02877134|80167082|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539181|NCT02877134|80167083|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539182|NCT02877134|80167084|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539183|NCT02877134|80167085|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539184|NCT02877134|80167086|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539185|NCT02877134|80167087|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539186|NCT02877134|80167088|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
27539187|NCT02877134|80167089|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
27539188|NCT02877134|80167090|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
27539189|NCT02877134|80167091|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539190|NCT02877134|80167092|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
27539191|NCT02877134|80167081|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
27539192|NCT02877134|80167082|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
27539193|NCT02877134|80167083|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
27539194|NCT02877134|80167084|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
27539195|NCT02877134|80167085|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
27539196|NCT02877134|80167086|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
27539197|NCT02877134|80167087|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
27539198|NCT02877134|80167088|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
27539199|NCT02877134|80167089|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
27917922|NCT03428100|81536567|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917923|NCT03428100|81536568|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
27917924|NCT03428100|81536569|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
27917925|NCT03428100|81536570|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
27917926|NCT03428100|81536571|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
27917927|NCT03428100|81536572|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
27917928|NCT03428100|81536573|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
27539200|NCT02877134|80167090|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
27539201|NCT02877134|80167091|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
27539202|NCT02877134|80167092|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
27740069|NCT00650585|80877385|FG001|Overall Study|Lost to Follow-up|482|||
27740070|NCT00650585|80877384|FG000|Overall Study|No parental consent|935|||
27539203|NCT01816074|80167099|FG000|Phase 1|Time commitment issues|0|||
27740071|NCT00650585|80877385|FG001|Overall Study|No parental consent|866|||
27740072|NCT00650585|80877384|FG000|Overall Study|Excluded/ruled ineligible|357|||
27539204|NCT01816074|80167100|FG001|Phase 1|Time commitment issues|0|||
27917929|NCT03428100|81536574|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917930|NCT03428100|81536575|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
27917931|NCT03428100|81536576|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
27917932|NCT03428100|81536577|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
27917933|NCT00863707|81536578|FG000|Overall Study|Randomized, but drug not received|4|||
27917934|NCT00863707|81536579|FG001|Overall Study|Randomized, but drug not received|3|||
27917935|NCT02074514|81536580|FG000|Overall Study|Lack of Efficacy|3|||
27917936|NCT02074514|81536581|FG001|Overall Study|Lack of Efficacy|2|||
27917937|NCT02074514|81536580|FG000|Overall Study|Lost to Follow-up|0|||
27917938|NCT02074514|81536581|FG001|Overall Study|Lost to Follow-up|1|||
27917939|NCT02074514|81536580|FG000|Overall Study|Withdrew Consent|0|||
27917940|NCT02074514|81536581|FG001|Overall Study|Withdrew Consent|1|||
27917941|NCT00468585|81536582|FG000|Overall Study|Patient not treated|1|||
27917942|NCT00468585|81536583|FG001|Overall Study|Patient not treated|0|||
27917943|NCT00468585|81536584|FG002|Overall Study|Patient not treated|1|||
27917944|NCT00468585|81536585|FG003|Overall Study|Patient not treated|0|||
27917945|NCT00468585|81536582|FG000|Overall Study|Patient found to be ineligible|0|||
27539205|NCT01816074|80167101|FG002|Phase 1|Time commitment issues|1|||
27539206|NCT01816074|80167102|FG003|Phase 1|Time commitment issues|0|||
27539207|NCT01816074|80167099|FG000|Phase 2|Time commitment Issues|0|||
27539208|NCT01816074|80167100|FG001|Phase 2|Time commitment Issues|2|||
27539209|NCT01816074|80167101|FG002|Phase 2|Time commitment Issues|0|||
27539210|NCT01816074|80167102|FG003|Phase 2|Time commitment Issues|0|||
27539211|NCT01816074|80167099|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
27539212|NCT01816074|80167100|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
27539213|NCT01816074|80167101|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
27539214|NCT01816074|80167102|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
27539215|NCT01816074|80167099|FG000|Phase 2|Physician Decision|0|||
27539216|NCT01816074|80167100|FG001|Phase 2|Physician Decision|0|||
27539217|NCT01816074|80167101|FG002|Phase 2|Physician Decision|0|||
27539218|NCT01816074|80167102|FG003|Phase 2|Physician Decision|1|||
27539219|NCT01816074|80167099|FG000|Phase 2|Withdrawal by Subject|1|||
27539220|NCT01816074|80167100|FG001|Phase 2|Withdrawal by Subject|0|||
27539221|NCT01816074|80167101|FG002|Phase 2|Withdrawal by Subject|0|||
27539222|NCT01816074|80167102|FG003|Phase 2|Withdrawal by Subject|0|||
27539223|NCT00722800|80167104|FG000|Overall Study|Withdrawal by Subject|1|||
27539224|NCT00722800|80167105|FG001|Overall Study|Withdrawal by Subject|0|||
27539225|NCT00722800|80167104|FG000|Overall Study|Physician Decision|1|||
27539226|NCT00722800|80167105|FG001|Overall Study|Physician Decision|0|||
27539227|NCT03068455|80167106|FG000|Pre-treatment Period|Disease progression|0|||
27539228|NCT03068455|80167107|FG001|Pre-treatment Period|Disease progression|1|||
27539229|NCT03068455|80167106|FG000|Pre-treatment Period|Participant withdrew consent|1|||
27539230|NCT03068455|80167107|FG001|Pre-treatment Period|Participant withdrew consent|1|||
27539231|NCT03068455|80167106|FG000|Pre-treatment Period|Poor/non-compliance|0|||
27539232|NCT03068455|80167107|FG001|Pre-treatment Period|Poor/non-compliance|1|||
27539233|NCT03068455|80167106|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
27539234|NCT03068455|80167107|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
27539235|NCT03068455|80167106|FG000|Pre-treatment Period|Not reported|2|||
27539236|NCT03068455|80167107|FG001|Pre-treatment Period|Not reported|1|||
27539237|NCT03068455|80167106|FG000|Treatment Period|Disease progression|166|||
27539238|NCT03068455|80167107|FG001|Treatment Period|Disease progression|208|||
27539239|NCT03068455|80167106|FG000|Treatment Period|Study drug toxicity|317|||
27539240|NCT03068455|80167107|FG001|Treatment Period|Study drug toxicity|104|||
27539241|NCT03068455|80167106|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
27539242|NCT03068455|80167107|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
27539243|NCT03068455|80167106|FG000|Treatment Period|Participant request to stop therapy|33|||
27539244|NCT03068455|80167107|FG001|Treatment Period|Participant request to stop therapy|20|||
27539245|NCT03068455|80167106|FG000|Treatment Period|Participant withdrew consent|5|||
27539246|NCT03068455|80167107|FG001|Treatment Period|Participant withdrew consent|10|||
27539247|NCT03068455|80167106|FG000|Treatment Period|Poor/non-compliance|3|||
27539248|NCT03068455|80167107|FG001|Treatment Period|Poor/non-compliance|0|||
27539249|NCT03068455|80167106|FG000|Treatment Period|Participant no longer meets study criteria|1|||
27539250|NCT03068455|80167107|FG001|Treatment Period|Participant no longer meets study criteria|3|||
27917946|NCT00468585|81536583|FG001|Overall Study|Patient found to be ineligible|0|||
27539251|NCT03068455|80167106|FG000|Treatment Period|Other reasons|12|||
27539252|NCT03068455|80167107|FG001|Treatment Period|Other reasons|4|||
27539253|NCT02598960|80167108|FG000|Treatment Period|Disease Progression|4|||
27539254|NCT02598960|80167109|FG001|Treatment Period|Disease Progression|4|||
27917947|NCT00468585|81536584|FG002|Overall Study|Patient found to be ineligible|1|||
27917948|NCT00468585|81536585|FG003|Overall Study|Patient found to be ineligible|0|||
27539255|NCT02598960|80167110|FG002|Treatment Period|Disease Progression|4|||
27917949|NCT00468585|81536582|FG000|Overall Study|Adverse Event|0|||
27917950|NCT00468585|81536583|FG001|Overall Study|Adverse Event|0|||
27539256|NCT02598960|80167111|FG003|Treatment Period|Disease Progression|6|||
27633805|NCT03546907|80500287|FG001|Overall Study|Lack of Efficacy|1|||
27633806|NCT03546907|80500286|FG000|Overall Study|Withdrawal by Subject|8|||
27633807|NCT03546907|80500287|FG001|Overall Study|Withdrawal by Subject|9|||
27633808|NCT03546907|80500286|FG000|Overall Study|Adverse events (AEs)|7|||
27633809|NCT03546907|80500287|FG001|Overall Study|Adverse events (AEs)|10|||
27633810|NCT03546907|80500286|FG000|Overall Study|Other-unspecified|1|||
27633811|NCT03546907|80500287|FG001|Overall Study|Other-unspecified|1|||
27633812|NCT00723450|80500288|FG000|Open-Label Phase|Adverse Event|26|||
27633813|NCT00723450|80500289|FG001|Open-Label Phase|Adverse Event|0|||
27633814|NCT00723450|80500290|FG002|Open-Label Phase|Adverse Event|0|||
27633815|NCT00723450|80500288|FG000|Open-Label Phase|Lack of Efficacy|18|||
27633816|NCT00723450|80500289|FG001|Open-Label Phase|Lack of Efficacy|0|||
27633817|NCT00723450|80500290|FG002|Open-Label Phase|Lack of Efficacy|0|||
27633818|NCT00723450|80500288|FG000|Open-Label Phase|Protocol Violation|35|||
27633819|NCT00723450|80500289|FG001|Open-Label Phase|Protocol Violation|0|||
27633820|NCT00723450|80500290|FG002|Open-Label Phase|Protocol Violation|0|||
27633821|NCT00723450|80500288|FG000|Open-Label Phase|Lost to Follow-up|7|||
27633822|NCT00723450|80500289|FG001|Open-Label Phase|Lost to Follow-up|0|||
27633823|NCT00723450|80500290|FG002|Open-Label Phase|Lost to Follow-up|0|||
27633824|NCT00723450|80500288|FG000|Open-Label Phase|Physician Decision|2|||
27633825|NCT00723450|80500289|FG001|Open-Label Phase|Physician Decision|0|||
27633826|NCT00723450|80500290|FG002|Open-Label Phase|Physician Decision|0|||
27633827|NCT00723450|80500288|FG000|Open-Label Phase|Withdrawal by Subject|37|||
27633828|NCT00723450|80500289|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27633829|NCT00723450|80500290|FG002|Open-Label Phase|Withdrawal by Subject|0|||
27633830|NCT00723450|80500288|FG000|Randomized Phase|Adverse Event|0|||
27633831|NCT00723450|80500289|FG001|Randomized Phase|Adverse Event|26|||
27633832|NCT00723450|80500290|FG002|Randomized Phase|Adverse Event|17|||
27633833|NCT00723450|80500288|FG000|Randomized Phase|Lack of Efficacy|0|||
27633834|NCT00723450|80500289|FG001|Randomized Phase|Lack of Efficacy|11|||
27633835|NCT00723450|80500290|FG002|Randomized Phase|Lack of Efficacy|11|||
27633836|NCT00723450|80500288|FG000|Randomized Phase|Protocol Violation|0|||
27633837|NCT00723450|80500289|FG001|Randomized Phase|Protocol Violation|9|||
27633838|NCT00723450|80500290|FG002|Randomized Phase|Protocol Violation|13|||
27633839|NCT00723450|80500288|FG000|Randomized Phase|Lost to Follow-up|0|||
27633840|NCT00723450|80500289|FG001|Randomized Phase|Lost to Follow-up|2|||
27633841|NCT00723450|80500290|FG002|Randomized Phase|Lost to Follow-up|3|||
27633842|NCT00723450|80500288|FG000|Randomized Phase|Physician Decision|0|||
27917951|NCT00468585|81536584|FG002|Overall Study|Adverse Event|1|||
27917952|NCT00468585|81536585|FG003|Overall Study|Adverse Event|0|||
27917953|NCT00468585|81536582|FG000|Overall Study|Withdrawal by Subject|0|||
27917954|NCT00468585|81536583|FG001|Overall Study|Withdrawal by Subject|0|||
27917955|NCT00468585|81536584|FG002|Overall Study|Withdrawal by Subject|2|||
27917956|NCT00468585|81536585|FG003|Overall Study|Withdrawal by Subject|1|||
27917957|NCT00243919|81536588|FG000|Overall Study|Death|3|||
27917958|NCT00243919|81536589|FG001|Overall Study|Death|4|||
27917959|NCT00243919|81536590|FG002|Overall Study|Death|6|||
27917960|NCT00243919|81536588|FG000|Overall Study|Withdrawal by Subject|6|||
27539257|NCT02598960|80167112|FG004|Treatment Period|Disease Progression|8|||
27539258|NCT02598960|80167113|FG005|Treatment Period|Disease Progression|2|||
27539259|NCT02598960|80167114|FG006|Treatment Period|Disease Progression|2|||
27539260|NCT02598960|80167115|FG007|Treatment Period|Disease Progression|3|||
27539261|NCT02598960|80167116|FG008|Treatment Period|Disease Progression|7|||
27539262|NCT02598960|80167117|FG009|Treatment Period|Disease Progression|9|||
27539263|NCT02598960|80167118|FG010|Treatment Period|Disease Progression|7|||
27539264|NCT02598960|80167119|FG011|Treatment Period|Disease Progression|143|||
27539265|NCT02598960|80167120|FG012|Treatment Period|Disease Progression|23|||
27539266|NCT02598960|80167108|FG000|Treatment Period|Study drug toxicity|0|||
27539267|NCT02598960|80167109|FG001|Treatment Period|Study drug toxicity|0|||
27539268|NCT02598960|80167110|FG002|Treatment Period|Study drug toxicity|0|||
27539269|NCT02598960|80167111|FG003|Treatment Period|Study drug toxicity|0|||
27539270|NCT02598960|80167112|FG004|Treatment Period|Study drug toxicity|0|||
27539271|NCT02598960|80167113|FG005|Treatment Period|Study drug toxicity|0|||
27539272|NCT02598960|80167114|FG006|Treatment Period|Study drug toxicity|0|||
27633843|NCT00723450|80500289|FG001|Randomized Phase|Physician Decision|3|||
27633844|NCT00723450|80500290|FG002|Randomized Phase|Physician Decision|1|||
27633845|NCT00723450|80500288|FG000|Randomized Phase|Withdrawal by Subject|0|||
27633846|NCT00723450|80500289|FG001|Randomized Phase|Withdrawal by Subject|14|||
27633847|NCT00723450|80500290|FG002|Randomized Phase|Withdrawal by Subject|22|||
27539273|NCT02598960|80167115|FG007|Treatment Period|Study drug toxicity|0|||
27539274|NCT02598960|80167116|FG008|Treatment Period|Study drug toxicity|0|||
27633848|NCT04493242|80500291|FG000|Overall Study|Death|10|||
27633849|NCT04493242|80500292|FG001|Overall Study|Death|14|||
27633850|NCT04493242|80500293|FG002|Overall Study|Death|16|||
27633851|NCT04493242|80500291|FG000|Overall Study|Lost to Follow-up|1|||
27633852|NCT04493242|80500292|FG001|Overall Study|Lost to Follow-up|1|||
27917961|NCT00243919|81536589|FG001|Overall Study|Withdrawal by Subject|6|||
27633853|NCT04493242|80500293|FG002|Overall Study|Lost to Follow-up|0|||
27740073|NCT00650585|80877385|FG001|Overall Study|Excluded/ruled ineligible|129|||
27740074|NCT02403206|80877386|FG000|Overall Study|Lost to Follow-up|4|||
27740075|NCT02403206|80877387|FG001|Overall Study|Lost to Follow-up|3|||
27740076|NCT02403206|80877386|FG000|Overall Study|Physician Decision|2|||
27539275|NCT02598960|80167117|FG009|Treatment Period|Study drug toxicity|1|||
27539276|NCT02598960|80167118|FG010|Treatment Period|Study drug toxicity|0|||
27539277|NCT02598960|80167119|FG011|Treatment Period|Study drug toxicity|3|||
27539278|NCT02598960|80167120|FG012|Treatment Period|Study drug toxicity|0|||
27539279|NCT02598960|80167108|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
27539280|NCT02598960|80167109|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
27539281|NCT02598960|80167110|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
27539282|NCT02598960|80167111|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
27539283|NCT02598960|80167112|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
27539284|NCT02598960|80167113|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
27539285|NCT02598960|80167114|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
27539286|NCT02598960|80167115|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
27539287|NCT02598960|80167116|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
27539288|NCT02598960|80167117|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
27539289|NCT02598960|80167118|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
27539290|NCT02598960|80167119|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
27539291|NCT02598960|80167120|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
27539292|NCT02598960|80167108|FG000|Treatment Period|participant request to discontinue|0|||
27539293|NCT02598960|80167109|FG001|Treatment Period|participant request to discontinue|1|||
27539294|NCT02598960|80167110|FG002|Treatment Period|participant request to discontinue|0|||
27539295|NCT02598960|80167111|FG003|Treatment Period|participant request to discontinue|0|||
27539296|NCT02598960|80167112|FG004|Treatment Period|participant request to discontinue|1|||
27539297|NCT02598960|80167113|FG005|Treatment Period|participant request to discontinue|0|||
27539298|NCT02598960|80167114|FG006|Treatment Period|participant request to discontinue|0|||
27539299|NCT02598960|80167115|FG007|Treatment Period|participant request to discontinue|0|||
27539300|NCT02598960|80167116|FG008|Treatment Period|participant request to discontinue|0|||
27539301|NCT02598960|80167117|FG009|Treatment Period|participant request to discontinue|0|||
27539302|NCT02598960|80167118|FG010|Treatment Period|participant request to discontinue|1|||
27539303|NCT02598960|80167119|FG011|Treatment Period|participant request to discontinue|4|||
27539304|NCT02598960|80167120|FG012|Treatment Period|participant request to discontinue|0|||
27539305|NCT02598960|80167108|FG000|Treatment Period|participant withdrew consent|0|||
27539306|NCT02598960|80167109|FG001|Treatment Period|participant withdrew consent|0|||
27539307|NCT02598960|80167110|FG002|Treatment Period|participant withdrew consent|0|||
27539308|NCT02598960|80167111|FG003|Treatment Period|participant withdrew consent|0|||
27539309|NCT02598960|80167112|FG004|Treatment Period|participant withdrew consent|0|||
27539310|NCT02598960|80167113|FG005|Treatment Period|participant withdrew consent|0|||
27539311|NCT02598960|80167114|FG006|Treatment Period|participant withdrew consent|0|||
27539312|NCT02598960|80167115|FG007|Treatment Period|participant withdrew consent|0|||
27539313|NCT02598960|80167116|FG008|Treatment Period|participant withdrew consent|0|||
27539314|NCT02598960|80167117|FG009|Treatment Period|participant withdrew consent|0|||
27539315|NCT02598960|80167118|FG010|Treatment Period|participant withdrew consent|0|||
27539316|NCT02598960|80167119|FG011|Treatment Period|participant withdrew consent|3|||
27539317|NCT02598960|80167120|FG012|Treatment Period|participant withdrew consent|0|||
27539318|NCT02598960|80167108|FG000|Treatment Period|No longer meets study criteria|0|||
27539319|NCT02598960|80167109|FG001|Treatment Period|No longer meets study criteria|0|||
27539320|NCT02598960|80167110|FG002|Treatment Period|No longer meets study criteria|0|||
27539321|NCT02598960|80167111|FG003|Treatment Period|No longer meets study criteria|0|||
27539322|NCT02598960|80167112|FG004|Treatment Period|No longer meets study criteria|0|||
27539323|NCT02598960|80167113|FG005|Treatment Period|No longer meets study criteria|0|||
27539324|NCT02598960|80167114|FG006|Treatment Period|No longer meets study criteria|0|||
27539325|NCT02598960|80167115|FG007|Treatment Period|No longer meets study criteria|0|||
27539326|NCT02598960|80167116|FG008|Treatment Period|No longer meets study criteria|0|||
27539327|NCT02598960|80167117|FG009|Treatment Period|No longer meets study criteria|0|||
27539328|NCT02598960|80167118|FG010|Treatment Period|No longer meets study criteria|0|||
27539329|NCT02598960|80167119|FG011|Treatment Period|No longer meets study criteria|1|||
27539330|NCT02598960|80167120|FG012|Treatment Period|No longer meets study criteria|0|||
27539331|NCT02598960|80167108|FG000|Treatment Period|Other Reasons|0|||
27539332|NCT02598960|80167109|FG001|Treatment Period|Other Reasons|0|||
27539333|NCT02598960|80167110|FG002|Treatment Period|Other Reasons|0|||
27539334|NCT02598960|80167111|FG003|Treatment Period|Other Reasons|0|||
27539335|NCT02598960|80167112|FG004|Treatment Period|Other Reasons|0|||
27539336|NCT02598960|80167113|FG005|Treatment Period|Other Reasons|0|||
27539337|NCT02598960|80167114|FG006|Treatment Period|Other Reasons|0|||
27539338|NCT02598960|80167115|FG007|Treatment Period|Other Reasons|0|||
27740077|NCT02403206|80877387|FG001|Overall Study|Physician Decision|0|||
27633854|NCT04493242|80500291|FG000|Overall Study|Withdrawal by Subject|1|||
27633855|NCT04493242|80500292|FG001|Overall Study|Withdrawal by Subject|0|||
27633856|NCT04493242|80500293|FG002|Overall Study|Withdrawal by Subject|0|||
27633857|NCT04493242|80500291|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
27633858|NCT04493242|80500292|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
27633859|NCT04493242|80500293|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
27633860|NCT04493242|80500291|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
27633861|NCT04493242|80500292|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
27633862|NCT04493242|80500293|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
27633863|NCT01091454|80500294|FG000|Overall Study|Ineligible|1|||
27633864|NCT03070483|80500297|FG000|Overall Study|Lost to Follow-up|2|||
27633865|NCT01849055|80500298|FG000|Overall Study|Withdrawal by Subject|0|||
27633866|NCT01849055|80500299|FG001|Overall Study|Withdrawal by Subject|0|||
27633867|NCT01849055|80500300|FG002|Overall Study|Withdrawal by Subject|1|||
27633868|NCT01849055|80500301|FG003|Overall Study|Withdrawal by Subject|0|||
27633869|NCT01849055|80500302|FG004|Overall Study|Withdrawal by Subject|0|||
27633870|NCT01849055|80500303|FG005|Overall Study|Withdrawal by Subject|0|||
27633871|NCT02631148|80500304|FG000|Overall Study|8 were ineligible|8|||
27633872|NCT02631148|80500305|FG001|Overall Study|8 were ineligible|0|||
27633873|NCT02631148|80500304|FG000|Overall Study|Withdrawal by Subject|1|||
27633874|NCT02631148|80500305|FG001|Overall Study|Withdrawal by Subject|0|||
27633875|NCT02631148|80500304|FG000|Overall Study|PAH not available to study participant|1|||
27633876|NCT02631148|80500305|FG001|Overall Study|PAH not available to study participant|0|||
27633877|NCT01131494|80500306|FG000|Overall Study|Withdrawal by Subject|2|||
27633878|NCT03299816|80500307|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
27633879|NCT03299816|80500308|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
27633880|NCT03299816|80500307|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
27633881|NCT03299816|80500308|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
27633882|NCT03299816|80500307|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
27633883|NCT03299816|80500308|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
27633884|NCT00246012|80500309|FG000|Overall Study|Adverse Event|0|||
27633885|NCT00246012|80500310|FG001|Overall Study|Adverse Event|0|||
27633886|NCT00246012|80500311|FG002|Overall Study|Adverse Event|0|||
27633887|NCT00246012|80500312|FG003|Overall Study|Adverse Event|0|||
27633888|NCT00246012|80500313|FG004|Overall Study|Adverse Event|0|||
27633889|NCT00246012|80500314|FG005|Overall Study|Adverse Event|1|||
27633890|NCT00246012|80500315|FG006|Overall Study|Adverse Event|0|||
27633891|NCT00246012|80500316|FG007|Overall Study|Adverse Event|0|||
27633892|NCT00246012|80500317|FG008|Overall Study|Adverse Event|2|||
27633893|NCT00246012|80500309|FG000|Overall Study|Withdrawal by Subject|0|||
27633894|NCT00246012|80500310|FG001|Overall Study|Withdrawal by Subject|0|||
27633895|NCT00246012|80500311|FG002|Overall Study|Withdrawal by Subject|0|||
27633896|NCT00246012|80500312|FG003|Overall Study|Withdrawal by Subject|0|||
27917962|NCT00243919|81536590|FG002|Overall Study|Withdrawal by Subject|2|||
27917963|NCT00243919|81536588|FG000|Overall Study|Lost to Follow-up|6|||
27917964|NCT00243919|81536589|FG001|Overall Study|Lost to Follow-up|7|||
27917965|NCT00243919|81536590|FG002|Overall Study|Lost to Follow-up|3|||
27917966|NCT00243919|81536588|FG000|Overall Study|Administrative Error|1|||
27917967|NCT00243919|81536589|FG001|Overall Study|Administrative Error|0|||
27917968|NCT00243919|81536590|FG002|Overall Study|Administrative Error|0|||
27539339|NCT02598960|80167116|FG008|Treatment Period|Other Reasons|0|||
27539340|NCT02598960|80167117|FG009|Treatment Period|Other Reasons|0|||
27539341|NCT02598960|80167118|FG010|Treatment Period|Other Reasons|0|||
27539342|NCT02598960|80167119|FG011|Treatment Period|Other Reasons|0|||
27539343|NCT02598960|80167120|FG012|Treatment Period|Other Reasons|1|||
27539344|NCT02598960|80167108|FG000|Participants Entering Follow Up Period|Death|1|||
27539345|NCT02598960|80167109|FG001|Participants Entering Follow Up Period|Death|0|||
27539346|NCT02598960|80167110|FG002|Participants Entering Follow Up Period|Death|0|||
27539347|NCT02598960|80167111|FG003|Participants Entering Follow Up Period|Death|0|||
27539348|NCT02598960|80167112|FG004|Participants Entering Follow Up Period|Death|0|||
27539349|NCT02598960|80167113|FG005|Participants Entering Follow Up Period|Death|0|||
27539350|NCT02598960|80167114|FG006|Participants Entering Follow Up Period|Death|0|||
27539351|NCT02598960|80167115|FG007|Participants Entering Follow Up Period|Death|0|||
27539352|NCT02598960|80167116|FG008|Participants Entering Follow Up Period|Death|0|||
27539353|NCT02598960|80167117|FG009|Participants Entering Follow Up Period|Death|1|||
27539354|NCT02598960|80167118|FG010|Participants Entering Follow Up Period|Death|0|||
27633897|NCT00246012|80500313|FG004|Overall Study|Withdrawal by Subject|0|||
27633898|NCT00246012|80500314|FG005|Overall Study|Withdrawal by Subject|1|||
27633899|NCT00246012|80500315|FG006|Overall Study|Withdrawal by Subject|0|||
27633900|NCT00246012|80500316|FG007|Overall Study|Withdrawal by Subject|0|||
27633901|NCT00246012|80500317|FG008|Overall Study|Withdrawal by Subject|0|||
27633902|NCT00246012|80500309|FG000|Overall Study|Disease progression|3|||
27917969|NCT00243919|81536588|FG000|Overall Study|Physician Decision|1|||
27633903|NCT00246012|80500310|FG001|Overall Study|Disease progression|1|||
27633904|NCT00246012|80500311|FG002|Overall Study|Disease progression|2|||
27633905|NCT00246012|80500312|FG003|Overall Study|Disease progression|3|||
27633906|NCT00246012|80500313|FG004|Overall Study|Disease progression|3|||
27633907|NCT00246012|80500314|FG005|Overall Study|Disease progression|25|||
27633908|NCT00246012|80500315|FG006|Overall Study|Disease progression|30|||
27633909|NCT00246012|80500316|FG007|Overall Study|Disease progression|27|||
27633910|NCT00246012|80500317|FG008|Overall Study|Disease progression|26|||
27633911|NCT00246012|80500309|FG000|Overall Study|Other|0|||
27633912|NCT00246012|80500310|FG001|Overall Study|Other|0|||
27633913|NCT00246012|80500311|FG002|Overall Study|Other|0|||
27633914|NCT00246012|80500312|FG003|Overall Study|Other|0|||
27633915|NCT00246012|80500313|FG004|Overall Study|Other|0|||
27633916|NCT00246012|80500314|FG005|Overall Study|Other|0|||
27633917|NCT00246012|80500315|FG006|Overall Study|Other|0|||
27633918|NCT00246012|80500316|FG007|Overall Study|Other|1|||
27633919|NCT00246012|80500317|FG008|Overall Study|Other|0|||
27633920|NCT00246012|80500309|FG000|Overall Study|Randomly assigned but not treated|0|||
27633921|NCT00246012|80500310|FG001|Overall Study|Randomly assigned but not treated|0|||
27633922|NCT00246012|80500311|FG002|Overall Study|Randomly assigned but not treated|0|||
27633923|NCT00246012|80500312|FG003|Overall Study|Randomly assigned but not treated|0|||
27633924|NCT00246012|80500313|FG004|Overall Study|Randomly assigned but not treated|0|||
27633925|NCT00246012|80500314|FG005|Overall Study|Randomly assigned but not treated|1|||
27633926|NCT00246012|80500315|FG006|Overall Study|Randomly assigned but not treated|1|||
27633927|NCT00246012|80500316|FG007|Overall Study|Randomly assigned but not treated|0|||
27633928|NCT00246012|80500317|FG008|Overall Study|Randomly assigned but not treated|0|||
27633929|NCT02045836|80500320|FG000|Overall Study|Adverse Event|4|||
27633930|NCT02045836|80500321|FG001|Overall Study|Adverse Event|4|||
27740078|NCT02403206|80877386|FG000|Overall Study|Withdrawal by Subject|3|||
27633931|NCT02045836|80500320|FG000|Overall Study|Withdrawal by Subject|1|||
27633932|NCT02045836|80500321|FG001|Overall Study|Withdrawal by Subject|1|||
27633933|NCT02045836|80500320|FG000|Overall Study|Lost to Follow-up|4|||
27633934|NCT02045836|80500321|FG001|Overall Study|Lost to Follow-up|7|||
27633935|NCT02045836|80500320|FG000|Overall Study|Migrated from study area|0|||
27633936|NCT02045836|80500321|FG001|Overall Study|Migrated from study area|2|||
27633937|NCT02715258|80500322|FG000|Overall Study|Withdrawal by Subject|6|||
27633938|NCT02715258|80500323|FG001|Overall Study|Withdrawal by Subject|1|||
27633939|NCT02715258|80500322|FG000|Overall Study|Lost to Follow-up|7|||
27633940|NCT02715258|80500323|FG001|Overall Study|Lost to Follow-up|1|||
27633941|NCT02715258|80500322|FG000|Overall Study|Terminated by Sponsor|0|||
27633942|NCT02715258|80500323|FG001|Overall Study|Terminated by Sponsor|1|||
27633943|NCT02715258|80500322|FG000|Overall Study|Death|0|||
27633944|NCT02715258|80500323|FG001|Overall Study|Death|1|||
27633945|NCT02715258|80500322|FG000|Overall Study|Subject non-compliant|1|||
27633946|NCT02715258|80500323|FG001|Overall Study|Subject non-compliant|1|||
27633947|NCT02715258|80500322|FG000|Overall Study|GCP violation|2|||
27633948|NCT02715258|80500323|FG001|Overall Study|GCP violation|1|||
27633949|NCT02754479|80500327|FG000|Overall Study|Lost to Follow-up|1|||
27633950|NCT00319436|80500329|FG000|Overall Study|Withdrawal by Subject|6|||
27633951|NCT00319436|80500330|FG001|Overall Study|Withdrawal by Subject|7|||
27633952|NCT02041104|80500331|FG000|Overall Study|Lost to Follow-up|1|||
27633953|NCT02041104|80500332|FG001|Overall Study|Lost to Follow-up|4|||
27740079|NCT02403206|80877387|FG001|Overall Study|Withdrawal by Subject|3|||
27740080|NCT02403206|80877386|FG000|Overall Study|Reason not given|2|||
27740081|NCT02403206|80877387|FG001|Overall Study|Reason not given|4|||
27740082|NCT00414440|80877388|FG000|Core Period|Withdrawal by Subject|70|||
27740083|NCT00414440|80877389|FG001|Core Period|Withdrawal by Subject|32|||
27740084|NCT00414440|80877388|FG000|Extension Period|Lost to Follow-up|44|||
27740085|NCT00414440|80877389|FG001|Extension Period|Lost to Follow-up|52|||
27740086|NCT00414440|80877388|FG000|Extension Period|Did not consent to continue follow up|61|||
27740087|NCT00414440|80877389|FG001|Extension Period|Did not consent to continue follow up|54|||
27740088|NCT00414440|80877388|FG000|Extension Period|Other|1|||
27740089|NCT00414440|80877389|FG001|Extension Period|Other|1|||
27740090|NCT00414440|80877388|FG000|Extension Period|Administrative|16|||
27740091|NCT00414440|80877389|FG001|Extension Period|Administrative|16|||
27740092|NCT00414440|80877388|FG000|Extension Period|Death|1|||
27917970|NCT00243919|81536589|FG001|Overall Study|Physician Decision|1|||
27917971|NCT00243919|81536590|FG002|Overall Study|Physician Decision|0|||
27917972|NCT01401322|81536591|FG000|Overall Study|Withdrawal by Subject|1|||
27917973|NCT01401322|81536591|FG000|Overall Study|Physician Decision|1|||
27633954|NCT02041104|80500331|FG000|Overall Study|discomfort during OGTT|0|||
27633955|NCT02041104|80500332|FG001|Overall Study|discomfort during OGTT|3|||
27633956|NCT03201562|80500336|FG000|Overall Study|Physician Decision|0|||
27633957|NCT03201562|80500337|FG001|Overall Study|Physician Decision|0|||
27633958|NCT03201562|80500338|FG002|Overall Study|Physician Decision|1|||
27633959|NCT03201562|80500336|FG000|Overall Study|Adverse Event|0|||
27633960|NCT03201562|80500337|FG001|Overall Study|Adverse Event|0|||
27633961|NCT03201562|80500338|FG002|Overall Study|Adverse Event|1|||
27740093|NCT00414440|80877389|FG001|Extension Period|Death|2|||
27633962|NCT03201562|80500336|FG000|Overall Study|Lost to Follow-up|0|||
27633963|NCT03201562|80500337|FG001|Overall Study|Lost to Follow-up|1|||
27633964|NCT03201562|80500338|FG002|Overall Study|Lost to Follow-up|2|||
27633965|NCT01321606|80500339|FG000|Overall Study|Lost to Follow-up|0|||
27633966|NCT01321606|80500340|FG001|Overall Study|Lost to Follow-up|0|||
27633967|NCT01321606|80500341|FG002|Overall Study|Lost to Follow-up|0|||
27633968|NCT01321606|80500342|FG003|Overall Study|Lost to Follow-up|1|||
27633969|NCT03837028|80500345|FG000|Overall Study|Lost to Follow-up|4|||
27633970|NCT03837028|80500346|FG001|Overall Study|Lost to Follow-up|0|||
27633971|NCT03837028|80500347|FG002|Overall Study|Lost to Follow-up|2|||
27633972|NCT03837028|80500348|FG003|Overall Study|Lost to Follow-up|0|||
27633973|NCT03837028|80500345|FG000|Overall Study|Withdrawal by Subject|12|||
27633974|NCT03837028|80500346|FG001|Overall Study|Withdrawal by Subject|11|||
27633975|NCT03837028|80500347|FG002|Overall Study|Withdrawal by Subject|11|||
27633976|NCT03837028|80500348|FG003|Overall Study|Withdrawal by Subject|7|||
27633977|NCT00558363|80500349|FG000|Overall Study|Physician Decision|18|||
27633978|NCT00558363|80500350|FG001|Overall Study|Physician Decision|4|||
27633979|NCT00558363|80500349|FG000|Overall Study|Withdrawal by Subject|11|||
27633980|NCT00558363|80500350|FG001|Overall Study|Withdrawal by Subject|4|||
27633981|NCT00558363|80500349|FG000|Overall Study|Adverse Event|5|||
27633982|NCT00558363|80500350|FG001|Overall Study|Adverse Event|5|||
27633983|NCT00558363|80500349|FG000|Overall Study|Lack of Efficacy|2|||
27633984|NCT00558363|80500350|FG001|Overall Study|Lack of Efficacy|2|||
27633985|NCT00558363|80500349|FG000|Overall Study|Protocol Violation|2|||
27633986|NCT00558363|80500350|FG001|Overall Study|Protocol Violation|1|||
27633987|NCT00558363|80500349|FG000|Overall Study|Lost to Follow-up|0|||
27633988|NCT00558363|80500350|FG001|Overall Study|Lost to Follow-up|1|||
27633989|NCT00558363|80500349|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
27633990|NCT00558363|80500350|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
27633991|NCT00558363|80500349|FG000|Overall Study|Randomized in Error|1|||
27633992|NCT00558363|80500350|FG001|Overall Study|Randomized in Error|2|||
27633993|NCT00558363|80500349|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
27633994|NCT00558363|80500350|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
27633995|NCT04567888|80500353|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
27740094|NCT00414440|80877388|FG000|Extension Period|Withdrawal by Subject|9|||
27740095|NCT00414440|80877389|FG001|Extension Period|Withdrawal by Subject|7|||
27740096|NCT00414440|80877388|FG000|Extension Period|Not included in follow up period|18|||
27740097|NCT00414440|80877389|FG001|Extension Period|Not included in follow up period|8|||
27740098|NCT03497689|80877390|FG000|Overall Study|Adverse Event|2|||
27740099|NCT03497689|80877390|FG000|Overall Study|Death|1|||
27740100|NCT03497689|80877390|FG000|Overall Study|Physician Decision|1|||
27740101|NCT03497689|80877390|FG000|Overall Study|Withdrawal by Subject|1|||
27740102|NCT03497689|80877390|FG000|Overall Study|Protocol Violation|2|||
27740103|NCT00942708|80877395|FG000|Overall Study|Withdrawal by Subject|1|||
27740104|NCT01645930|80877398|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
27740105|NCT01645930|80877398|FG000|Overall Study|Progressive Disease|12|||
27740106|NCT01645930|80877398|FG000|Overall Study|Adverse Event|4|||
27740107|NCT01645930|80877398|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
27740108|NCT01645930|80877398|FG000|Overall Study|Withdrawal by Participant|2|||
27740109|NCT01645930|80877398|FG000|Overall Study|Reason not Defined|1|||
27740110|NCT02345161|80877399|FG000|Overall Study|Withdrawal by Subject|25|||
27740111|NCT02345161|80877400|FG001|Overall Study|Withdrawal by Subject|33|||
27740112|NCT02345161|80877399|FG000|Overall Study|Adverse Event|16|||
27740113|NCT02345161|80877400|FG001|Overall Study|Adverse Event|19|||
27740114|NCT02345161|80877399|FG000|Overall Study|Physician Decision|4|||
27917974|NCT00830765|81536592|FG000|Overall Study|Protocol Violation|3|||
27917975|NCT00830765|81536593|FG001|Overall Study|Protocol Violation|2|||
27917976|NCT00368251|81536594|FG000|Overall Study|SAE, non-fatal|1|||
27917977|NCT00368251|81536595|FG001|Overall Study|SAE, non-fatal|0|||
27917978|NCT00368251|81536596|FG002|Overall Study|SAE, non-fatal|0|||
27917979|NCT00368251|81536594|FG000|Overall Study|AE, non-serious non-fatal|0|||
27917980|NCT00368251|81536595|FG001|Overall Study|AE, non-serious non-fatal|0|||
27917981|NCT00368251|81536596|FG002|Overall Study|AE, non-serious non-fatal|1|||
27917982|NCT01100502|81536597|FG000|Overall Study|Withdrawal by Subject|18|||
27917983|NCT01100502|81536598|FG001|Overall Study|Withdrawal by Subject|25|||
27633996|NCT04567888|80500354|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
27633997|NCT04567888|80500353|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
27633998|NCT04567888|80500354|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
27633999|NCT04567888|80500353|FG000|Overall Study|Reported Unusual Birth Year|2|||
27634000|NCT04567888|80500354|FG001|Overall Study|Reported Unusual Birth Year|3|||
27634001|NCT04567888|80500353|FG000|Overall Study|Duplicate Responses|0|||
27634002|NCT04567888|80500354|FG001|Overall Study|Duplicate Responses|1|||
27634003|NCT00158054|80500355|FG000|Overall Study|Refused to continue|3|||
27917984|NCT01100502|81536597|FG000|Overall Study|Lost to Follow-up|13|||
27634004|NCT00158054|80500356|FG001|Overall Study|Refused to continue|0|||
27634005|NCT00158054|80500355|FG000|Overall Study|Unavailable for follow up|7|||
27917985|NCT01100502|81536598|FG001|Overall Study|Lost to Follow-up|28|||
27539355|NCT02598960|80167119|FG011|Participants Entering Follow Up Period|Death|11|||
27539356|NCT02598960|80167120|FG012|Participants Entering Follow Up Period|Death|2|||
27539357|NCT02598960|80167108|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539358|NCT02598960|80167109|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
27740115|NCT02345161|80877400|FG001|Overall Study|Physician Decision|4|||
27917986|NCT01100502|81536597|FG000|Overall Study|Site request to end participation in study|0|||
27917987|NCT01100502|81536598|FG001|Overall Study|Site request to end participation in study|1|||
27917988|NCT01100502|81536597|FG000|Overall Study|Death|45|||
27917989|NCT01100502|81536598|FG001|Overall Study|Death|40|||
27917990|NCT02801331|81536599|FG000|Overall Study|Transferred to another hospital|8|||
27917991|NCT02801331|81536600|FG001|Overall Study|Transferred to another hospital|7|||
27917992|NCT02801331|81536599|FG000|Overall Study|Withdrawal by Subject|0|||
27917993|NCT02801331|81536600|FG001|Overall Study|Withdrawal by Subject|4|||
27917994|NCT02801331|81536599|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
27917995|NCT02801331|81536600|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
27917996|NCT01614470|81536603|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
27917997|NCT01614470|81536604|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27917998|NCT01614470|81536605|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27917999|NCT01614470|81536603|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
27918000|NCT01614470|81536604|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
27539359|NCT02598960|80167110|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
27740116|NCT02345161|80877399|FG000|Overall Study|Lost to Follow-up|0|||
27918001|NCT01614470|81536605|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
27918002|NCT02849587|81536606|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
27918003|NCT02849587|81536607|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
27918004|NCT02849587|81536608|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
27918005|NCT02849587|81536606|FG000|Overall Study|Withdrawal by Subject|0|||
27918006|NCT02849587|81536607|FG001|Overall Study|Withdrawal by Subject|1|||
27918007|NCT02849587|81536608|FG002|Overall Study|Withdrawal by Subject|0|||
27918008|NCT00726609|81536609|FG000|Overall Study|Adverse Event|10|||
27918009|NCT00726609|81536609|FG000|Overall Study|Withdrawal by Subject|2|||
27918010|NCT00726609|81536609|FG000|Overall Study|Lack of Efficacy|25|||
27918011|NCT00726609|81536609|FG000|Overall Study|Other|16|||
27918012|NCT00726609|81536609|FG000|Overall Study|Missing|42|||
27918013|NCT00726609|81536609|FG000|Overall Study|Other|3|||
27918014|NCT02736617|81536610|FG000|Treatment|Adverse Event|1|||
27918015|NCT02736617|81536610|FG000|Treatment|Lack of Efficacy|1|||
27918016|NCT02736617|81536610|FG000|Treatment|Withdrawal by Subject|1|||
27918017|NCT02736617|81536610|FG000|Maintenance|Lack of Efficacy|4|||
27918018|NCT02736617|81536610|FG000|Maintenance|Physician Decision|1|||
27918019|NCT02806713|81536611|FG000|Overall Study|Urethral injury during procedure|1|||
27918020|NCT02806713|81536612|FG001|Overall Study|Urethral injury during procedure|0|||
27918021|NCT02806713|81536611|FG000|Overall Study|cancelled surgery|1|||
27918022|NCT02806713|81536612|FG001|Overall Study|cancelled surgery|2|||
27918023|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
27918024|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27918025|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27918026|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27918027|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
27918028|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
27740117|NCT02345161|80877400|FG001|Overall Study|Lost to Follow-up|1|||
27740118|NCT01507246|80877405|FG000|Overall Study|Required different surgical procedures|2|||
27740119|NCT01507246|80877406|FG001|Overall Study|Required different surgical procedures|1|||
27740120|NCT01174784|80877407|FG000|Overall Study|Screen fails|4|||
27740121|NCT00971321|80877408|FG000|Up to Month 7|Withdrawal by Subject|1|||
27740122|NCT00971321|80877409|FG001|Up to Month 7|Withdrawal by Subject|0|||
27740123|NCT00971321|80877408|FG000|Up to Month 7|Migrated/moved from study area|3|||
27740124|NCT00971321|80877409|FG001|Up to Month 7|Migrated/moved from study area|2|||
27740125|NCT00971321|80877408|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
27740126|NCT00971321|80877409|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
27740127|NCT00971321|80877408|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
27740128|NCT00971321|80877409|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
27740129|NCT00971321|80877408|FG000|Up to Month 11-12|Lost to Follow-up|1|||
27740130|NCT00971321|80877409|FG001|Up to Month 11-12|Lost to Follow-up|0|||
27740131|NCT03067311|80877410|FG000|Overall Study|Lost to Follow-up|1|||
27740132|NCT03067311|80877411|FG001|Overall Study|Lost to Follow-up|1|||
27740133|NCT03067311|80877410|FG000|Overall Study|Moved away|1|||
27740134|NCT03067311|80877411|FG001|Overall Study|Moved away|1|||
27740135|NCT00500071|80877415|FG000|Screening and Washout Phase|Protocol Violation|1|||
27918029|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27918030|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27918031|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27634006|NCT00158054|80500356|FG001|Overall Study|Unavailable for follow up|3|||
27634007|NCT00585533|80500357|FG000|Overall Study|objective or symptomatic progression|9|||
27634008|NCT03615924|80500358|FG000|Overall Study|Withdrawal by Subject|2|||
27634009|NCT03615924|80500359|FG001|Overall Study|Withdrawal by Subject|5|||
27634010|NCT03615924|80500358|FG000|Overall Study|Death|3|||
27634011|NCT03615924|80500359|FG001|Overall Study|Death|1|||
27634012|NCT03615924|80500358|FG000|Overall Study|Lost to Follow-up|1|||
27634013|NCT03615924|80500359|FG001|Overall Study|Lost to Follow-up|0|||
27634014|NCT03615924|80500358|FG000|Overall Study|Randomized in error|1|||
27634015|NCT03615924|80500359|FG001|Overall Study|Randomized in error|0|||
27634016|NCT03615924|80500358|FG000|Overall Study|Study termination by Sponsor|94|||
27634017|NCT03615924|80500359|FG001|Overall Study|Study termination by Sponsor|86|||
27634018|NCT04128319|80500360|FG000|Overall Study|Death|3|||
27634019|NCT00361283|80500367|FG000|Overall Study|Lost to Follow-up|27|||
27634020|NCT03923491|80500368|FG000|Overall Study|Lost to Follow-up|5|||
27634021|NCT03923491|80500369|FG001|Overall Study|Lost to Follow-up|8|||
27634022|NCT03923491|80500368|FG000|Overall Study|Withdrawal by Subject|4|||
27634023|NCT03923491|80500369|FG001|Overall Study|Withdrawal by Subject|6|||
27634024|NCT00922207|80500373|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
27634025|NCT00922207|80500374|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
27634026|NCT00922207|80500375|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
27634027|NCT00922207|80500373|FG000|Overall Study|Insufficient Therapeutic Response|0|||
27634028|NCT00922207|80500374|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27634029|NCT00922207|80500375|FG002|Overall Study|Insufficient Therapeutic Response|1|||
27634030|NCT00922207|80500373|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
27634031|NCT00922207|80500374|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27634032|NCT00922207|80500375|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
27634033|NCT00922207|80500373|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
27634034|NCT00922207|80500374|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27634035|NCT00922207|80500375|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27634036|NCT00922207|80500373|FG000|Overall Study|Withdrew Consent|2|||
27634037|NCT00922207|80500374|FG001|Overall Study|Withdrew Consent|5|||
27634038|NCT00922207|80500375|FG002|Overall Study|Withdrew Consent|2|||
27634039|NCT00922207|80500373|FG000|Overall Study|Abnormality of Laboratory Test|0|||
27634040|NCT00922207|80500374|FG001|Overall Study|Abnormality of Laboratory Test|1|||
27740136|NCT00500071|80877415|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
27740137|NCT00500071|80877415|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
27740138|NCT00500071|80877415|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
27740139|NCT00500071|80877415|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
27740140|NCT00500071|80877415|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
27740141|NCT00500071|80877415|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
27740142|NCT00377299|80877416|FG000|Overall Study|Lost to Follow-up|14|||
27918032|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
27918033|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
27918034|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27918035|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27918036|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27918037|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
27918038|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
27918039|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27918040|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27918041|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27918042|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
27918043|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
27918044|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27918045|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27918046|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27918047|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
27918048|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
27918049|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27918050|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27918051|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27918052|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
27634041|NCT00922207|80500375|FG002|Overall Study|Abnormality of Laboratory Test|1|||
27634042|NCT01157182|80500388|FG000|Washout of 28 Days|Adverse Event|2|||
27634043|NCT01157182|80500389|FG001|Washout of 28 Days|Adverse Event|0|||
27634044|NCT01546155|80500390|FG000|Overall Study|could not tolerate long scan duration|3|||
27634045|NCT00545077|80500393|FG000|Overall Study|Treatment not received|5|||
27634046|NCT00545077|80500394|FG001|Overall Study|Treatment not received|1|||
27634047|NCT00545077|80500393|FG000|Overall Study|Disease Progression|131|||
27634048|NCT00545077|80500394|FG001|Overall Study|Disease Progression|98|||
27634049|NCT00545077|80500393|FG000|Overall Study|Withdrawal by Subject|3|||
27740143|NCT00377299|80877417|FG001|Overall Study|Lost to Follow-up|19|||
27740144|NCT00377299|80877416|FG000|Overall Study|Adverse Event|0|||
27740145|NCT00377299|80877417|FG001|Overall Study|Adverse Event|1|||
27740146|NCT00377299|80877416|FG000|Overall Study|Withdrawal by Subject|5|||
27740147|NCT00377299|80877417|FG001|Overall Study|Withdrawal by Subject|4|||
27740148|NCT00201851|80877418|FG000|Overall Study|Lost to Follow-up|2|||
27740149|NCT00201851|80877419|FG001|Overall Study|Lost to Follow-up|1|||
27740150|NCT00201851|80877420|FG002|Overall Study|Lost to Follow-up|0|||
27740151|NCT00201851|80877418|FG000|Overall Study|Ineligible post enrollment|6|||
27740152|NCT00201851|80877419|FG001|Overall Study|Ineligible post enrollment|1|||
27740153|NCT00201851|80877420|FG002|Overall Study|Ineligible post enrollment|1|||
27740154|NCT00853905|80877421|FG000|Overall Study|Lost to Follow-up|1|||
27740155|NCT00853905|80877422|FG001|Overall Study|Lost to Follow-up|3|||
27740156|NCT00853905|80877421|FG000|Overall Study|Withdrawal by Subject|0|||
27740157|NCT00853905|80877422|FG001|Overall Study|Withdrawal by Subject|1|||
27740158|NCT00853905|80877421|FG000|Overall Study|never had surgery|1|||
27740159|NCT00853905|80877422|FG001|Overall Study|never had surgery|0|||
27740160|NCT03518840|80877423|FG000|Overall Study|Lost to Follow-up|6|||
27740161|NCT01165229|80877424|FG000|Overall Study|Serious Adverse Event|456|||
27740162|NCT01165229|80877425|FG001|Overall Study|Serious Adverse Event|487|||
27740163|NCT01165229|80877424|FG000|Overall Study|Non-Serious Adverse Event|47|||
27740164|NCT01165229|80877425|FG001|Overall Study|Non-Serious Adverse Event|15|||
27740165|NCT01165229|80877424|FG000|Overall Study|Protocol Violation|6|||
27740166|NCT01165229|80877425|FG001|Overall Study|Protocol Violation|8|||
27740167|NCT01165229|80877424|FG000|Overall Study|Withdrawal by Subject|387|||
27740168|NCT01165229|80877425|FG001|Overall Study|Withdrawal by Subject|396|||
27740169|NCT01165229|80877424|FG000|Overall Study|Migrated/moved from study area|51|||
27740170|NCT01165229|80877425|FG001|Overall Study|Migrated/moved from study area|46|||
27740171|NCT01165229|80877424|FG000|Overall Study|Lost to Follow-up|123|||
27740172|NCT01165229|80877425|FG001|Overall Study|Lost to Follow-up|133|||
27740173|NCT01165229|80877424|FG000|Overall Study|Suspected HZ Episode|2|||
27740174|NCT01165229|80877425|FG001|Overall Study|Suspected HZ Episode|2|||
27740175|NCT01165229|80877424|FG000|Overall Study|No reason from the subject|108|||
27918053|NCT01111565|81536613|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
27918054|NCT01111565|81536614|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27918055|NCT01111565|81536615|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27918056|NCT01111565|81536616|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27918057|NCT01111565|81536617|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
27918058|NCT01111565|81536613|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27918059|NCT01111565|81536614|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27918060|NCT01111565|81536615|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27918061|NCT01111565|81536616|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
27918062|NCT01111565|81536617|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27918063|NCT01111565|81536613|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27918064|NCT01111565|81536614|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27918065|NCT01111565|81536615|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
27918066|NCT01111565|81536616|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27918067|NCT01111565|81536617|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27918068|NCT01111565|81536613|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
27918069|NCT01111565|81536614|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
27918070|NCT01111565|81536615|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
27918071|NCT01111565|81536616|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
27918072|NCT01111565|81536617|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
27918073|NCT01111565|81536613|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27918074|NCT01111565|81536614|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27918075|NCT01111565|81536615|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27918076|NCT01111565|81536616|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
27918077|NCT01111565|81536617|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
27918078|NCT01111565|81536613|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27918079|NCT01111565|81536614|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27918080|NCT01111565|81536615|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27918081|NCT01111565|81536616|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
27918082|NCT01111565|81536617|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
27918083|NCT01924533|81536618|FG000|Overall Study|Death|181|||
27740176|NCT01165229|80877425|FG001|Overall Study|No reason from the subject|102|||
27740177|NCT01165229|80877424|FG000|Overall Study|Unknown completion status|0|||
27740178|NCT01165229|80877425|FG001|Overall Study|Unknown completion status|1|||
27740179|NCT02190591|80877426|FG000|Overall Study|Withdrawal by Subject|1|||
27740180|NCT02190591|80877427|FG001|Overall Study|Withdrawal by Subject|8|||
27740181|NCT02190591|80877426|FG000|Overall Study|Protocol Violation|1|||
27918084|NCT01924533|81536619|FG001|Overall Study|Death|200|||
27918085|NCT01924533|81536618|FG000|Overall Study|Lost to Follow-up|0|||
27918086|NCT01924533|81536619|FG001|Overall Study|Lost to Follow-up|1|||
27918087|NCT01924533|81536618|FG000|Overall Study|Withdrawal by Subject|7|||
27918088|NCT01924533|81536619|FG001|Overall Study|Withdrawal by Subject|3|||
27918089|NCT01924533|81536618|FG000|Overall Study|Other Eligibility criteria|1|||
27918090|NCT01924533|81536619|FG001|Overall Study|Other Eligibility criteria|1|||
27918091|NCT03644017|81536620|FG000|Overall Study|Access Abandonment|5|||
27918092|NCT03644017|81536620|FG000|Overall Study|Kidney Transplant|2|||
27918093|NCT01309386|81536621|FG000|Overall Study|Other|2|||
27918094|NCT01309386|81536622|FG001|Overall Study|Other|0|||
27918095|NCT01309386|81536621|FG000|Overall Study|Withdrawal by Subject|2|||
27918096|NCT01309386|81536622|FG001|Overall Study|Withdrawal by Subject|0|||
27918097|NCT01309386|81536621|FG000|Overall Study|Progressive disease|9|||
27918098|NCT01309386|81536622|FG001|Overall Study|Progressive disease|11|||
27918099|NCT01309386|81536621|FG000|Overall Study|Physician Decision|1|||
27918100|NCT01309386|81536622|FG001|Overall Study|Physician Decision|1|||
27918101|NCT01309386|81536621|FG000|Overall Study|Lack of Efficacy|3|||
27918102|NCT01309386|81536622|FG001|Overall Study|Lack of Efficacy|1|||
27918103|NCT01309386|81536621|FG000|Overall Study|Adverse Event|5|||
27918104|NCT01309386|81536622|FG001|Overall Study|Adverse Event|8|||
27918105|NCT02668640|81536625|FG000|Overall Study|Lost to Follow-up|13|||
27918106|NCT02668640|81536625|FG000|Overall Study|Other, not specified|1|||
27918107|NCT00111761|81536626|FG000|Part 1|Physician Decision|0|||
27918108|NCT00111761|81536627|FG001|Part 1|Physician Decision|1|||
27918109|NCT00111761|81536626|FG000|Part 1|Death|0|||
27918110|NCT00111761|81536627|FG001|Part 1|Death|2|||
27918111|NCT00111761|81536626|FG000|Part 1|Other|0|||
27918112|NCT00111761|81536627|FG001|Part 1|Other|1|||
27918113|NCT00111761|81536626|FG000|Part 1|Withdrawal by Subject|0|||
27918114|NCT00111761|81536627|FG001|Part 1|Withdrawal by Subject|1|||
27918115|NCT00111761|81536626|FG000|Part 2|Adverse Event|1|||
27918116|NCT00111761|81536627|FG001|Part 2|Adverse Event|0|||
27918117|NCT00111761|81536626|FG000|Part 2|Physician Decision|1|||
27918118|NCT00111761|81536627|FG001|Part 2|Physician Decision|0|||
27918119|NCT00111761|81536626|FG000|Part 2|Death|1|||
27918120|NCT00111761|81536627|FG001|Part 2|Death|0|||
27918121|NCT00111761|81536626|FG000|Part 2|Disease progression|3|||
27918122|NCT00111761|81536627|FG001|Part 2|Disease progression|0|||
27918123|NCT00111761|81536626|FG000|Part 2|Protocol-specified criteria|1|||
27918124|NCT00111761|81536627|FG001|Part 2|Protocol-specified criteria|0|||
27918125|NCT00111761|81536626|FG000|Part 2|Other|1|||
27918126|NCT00111761|81536627|FG001|Part 2|Other|0|||
27918127|NCT02187783|81536632|FG000|Overall Study|Adverse Event|8|||
27918128|NCT02187783|81536632|FG000|Overall Study|Death|3|||
27918129|NCT02187783|81536632|FG000|Overall Study|Progressive disease|80|||
27918130|NCT02187783|81536632|FG000|Overall Study|Protocol Violation|3|||
27918131|NCT02187783|81536632|FG000|Overall Study|Physician Decision|2|||
27918132|NCT02187783|81536632|FG000|Overall Study|Withdrawal by Subject|9|||
27918133|NCT02187783|81536632|FG000|Overall Study|Study terminated by sponsor|1|||
27918134|NCT02812186|81536637|FG000|Period 1|Post randomization screen failure|5|||
27918135|NCT02812186|81536638|FG001|Period 1|Post randomization screen failure|9|||
27918136|NCT02812186|81536637|FG000|Period 1|nonevaluable data sets|6|||
27918137|NCT02812186|81536638|FG001|Period 1|nonevaluable data sets|6|||
27918138|NCT02666222|81536639|FG000|Overall Study|Death|2|||
27918139|NCT03368664|81536640|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
27918140|NCT03368664|81536640|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
27918141|NCT03368664|81536640|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
27918142|NCT03368664|81536640|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
27918143|NCT00983372|81536642|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
27918144|NCT00983372|81536642|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
27918145|NCT00983372|81536642|FG000|Diltiazem ER Alone|Adverse Event|1|||
27918146|NCT02792504|81536643|FG000|Overall Study|Lost to Follow-up|24|||
27918147|NCT02792504|81536643|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
27918148|NCT02027025|81536646|FG000|Overall Study|Adverse Event|0|||
27918149|NCT02027025|81536647|FG001|Overall Study|Adverse Event|1|||
27918150|NCT02027025|81536648|FG002|Overall Study|Adverse Event|1|||
27918151|NCT02027025|81536646|FG000|Overall Study|Protocol Violation|1|||
27918152|NCT02027025|81536647|FG001|Overall Study|Protocol Violation|0|||
27918153|NCT02027025|81536648|FG002|Overall Study|Protocol Violation|0|||
27918154|NCT02027025|81536646|FG000|Overall Study|Lost to Follow-up|0|||
27918155|NCT02027025|81536647|FG001|Overall Study|Lost to Follow-up|2|||
27918156|NCT02027025|81536648|FG002|Overall Study|Lost to Follow-up|0|||
27918157|NCT02027025|81536646|FG000|Overall Study|Withdrawal by Subject|0|||
27918158|NCT02027025|81536647|FG001|Overall Study|Withdrawal by Subject|1|||
27918159|NCT02027025|81536648|FG002|Overall Study|Withdrawal by Subject|0|||
27918160|NCT02027025|81536646|FG000|Overall Study|Sponsor's decision|0|||
27918161|NCT02027025|81536647|FG001|Overall Study|Sponsor's decision|1|||
27918162|NCT02027025|81536648|FG002|Overall Study|Sponsor's decision|0|||
27918163|NCT01294423|81536651|FG000|Overall Study|Adverse Event|1|||
27740182|NCT02190591|80877427|FG001|Overall Study|Protocol Violation|0|||
27740183|NCT02190591|80877426|FG000|Overall Study|did not use peanut ball as instructed|0|||
27740184|NCT02190591|80877427|FG001|Overall Study|did not use peanut ball as instructed|2|||
27740185|NCT02190591|80877426|FG000|Overall Study|face presentation so she was ineligible|0|||
27740186|NCT02190591|80877427|FG001|Overall Study|face presentation so she was ineligible|1|||
27740187|NCT00793104|80877428|FG000|Overall Study|Lost to Follow-up|1|||
27740188|NCT00072189|80877429|FG000|Overall Study|Withdrawal by Subject|1|||
27740189|NCT01415440|80877437|FG000|Overall Study|Lost to Follow-up|0|||
27740190|NCT01415440|80877438|FG001|Overall Study|Lost to Follow-up|1|||
27740191|NCT01415440|80877439|FG002|Overall Study|Lost to Follow-up|2|||
27740192|NCT01415440|80877437|FG000|Overall Study|Physician Decision|3|||
27918164|NCT01294423|81536652|FG001|Overall Study|Adverse Event|2|||
27918165|NCT01294423|81536653|FG002|Overall Study|Adverse Event|3|||
27918166|NCT01294423|81536651|FG000|Overall Study|Withdrawal by Subject|1|||
27918167|NCT01294423|81536652|FG001|Overall Study|Withdrawal by Subject|2|||
27918168|NCT01294423|81536653|FG002|Overall Study|Withdrawal by Subject|2|||
27918169|NCT01294423|81536651|FG000|Overall Study|subject no longer meets study criteria|2|||
27918170|NCT01294423|81536652|FG001|Overall Study|subject no longer meets study criteria|5|||
27918171|NCT01294423|81536653|FG002|Overall Study|subject no longer meets study criteria|2|||
27918172|NCT01294423|81536651|FG000|Overall Study|poor/non-compliance|1|||
27918173|NCT01294423|81536652|FG001|Overall Study|poor/non-compliance|0|||
27918174|NCT01294423|81536653|FG002|Overall Study|poor/non-compliance|1|||
27918175|NCT00731822|81536661|FG000|Overall Study|Adverse Event|2|||
27918176|NCT00731822|81536662|FG001|Overall Study|Adverse Event|1|||
27918177|NCT00731822|81536661|FG000|Overall Study|Protocol Violation|1|||
27918178|NCT00731822|81536662|FG001|Overall Study|Protocol Violation|0|||
27918179|NCT00731822|81536661|FG000|Overall Study|Lost to Follow-up|1|||
27918180|NCT00731822|81536662|FG001|Overall Study|Lost to Follow-up|0|||
27918181|NCT02033759|81536663|FG000|Overall Study|Withdrawal by Subject|2|||
27918182|NCT02033759|81536664|FG001|Overall Study|Withdrawal by Subject|1|||
27918183|NCT02033759|81536663|FG000|Overall Study|Protocol Violation|1|||
27918184|NCT02033759|81536664|FG001|Overall Study|Protocol Violation|1|||
27918185|NCT01719380|81536665|FG000|Overall Study|Adverse Event|0|||
27918186|NCT01719380|81536666|FG001|Overall Study|Adverse Event|0|||
27918187|NCT01719380|81536667|FG002|Overall Study|Adverse Event|1|||
27918188|NCT01719380|81536668|FG003|Overall Study|Adverse Event|2|||
27918189|NCT01719380|81536669|FG004|Overall Study|Adverse Event|0|||
27918190|NCT01719380|81536670|FG005|Overall Study|Adverse Event|1|||
27918191|NCT01719380|81536671|FG006|Overall Study|Adverse Event|0|||
27918192|NCT01719380|81536672|FG007|Overall Study|Adverse Event|1|||
27918193|NCT01719380|81536673|FG008|Overall Study|Adverse Event|4|||
27918194|NCT01719380|81536674|FG009|Overall Study|Adverse Event|3|||
27918195|NCT01719380|81536665|FG000|Overall Study|Death|0|||
27918196|NCT01719380|81536666|FG001|Overall Study|Death|1|||
27918197|NCT01719380|81536667|FG002|Overall Study|Death|0|||
27740193|NCT01415440|80877438|FG001|Overall Study|Physician Decision|0|||
27918198|NCT01719380|81536668|FG003|Overall Study|Death|0|||
27918199|NCT01719380|81536669|FG004|Overall Study|Death|0|||
27918200|NCT01719380|81536670|FG005|Overall Study|Death|0|||
27918201|NCT01719380|81536671|FG006|Overall Study|Death|0|||
27918202|NCT01719380|81536672|FG007|Overall Study|Death|0|||
27918203|NCT01719380|81536673|FG008|Overall Study|Death|3|||
27918204|NCT01719380|81536674|FG009|Overall Study|Death|3|||
27918205|NCT01719380|81536665|FG000|Overall Study|Participant/Guardian Decision|0|||
27918206|NCT01719380|81536666|FG001|Overall Study|Participant/Guardian Decision|0|||
27918207|NCT01719380|81536667|FG002|Overall Study|Participant/Guardian Decision|1|||
27918208|NCT01719380|81536668|FG003|Overall Study|Participant/Guardian Decision|0|||
27918209|NCT01719380|81536669|FG004|Overall Study|Participant/Guardian Decision|0|||
27918210|NCT01719380|81536670|FG005|Overall Study|Participant/Guardian Decision|0|||
27918211|NCT01719380|81536671|FG006|Overall Study|Participant/Guardian Decision|0|||
27918212|NCT01719380|81536672|FG007|Overall Study|Participant/Guardian Decision|0|||
27918213|NCT01719380|81536673|FG008|Overall Study|Participant/Guardian Decision|2|||
27918214|NCT01719380|81536674|FG009|Overall Study|Participant/Guardian Decision|2|||
27918215|NCT01719380|81536665|FG000|Overall Study|Physician Decision|0|||
27918216|NCT01719380|81536666|FG001|Overall Study|Physician Decision|0|||
27740194|NCT01415440|80877439|FG002|Overall Study|Physician Decision|0|||
27740195|NCT01415440|80877437|FG000|Overall Study|Withdrawal by Subject|1|||
27740196|NCT01415440|80877438|FG001|Overall Study|Withdrawal by Subject|0|||
27918217|NCT01719380|81536667|FG002|Overall Study|Physician Decision|2|||
27918218|NCT01719380|81536668|FG003|Overall Study|Physician Decision|0|||
27918219|NCT01719380|81536669|FG004|Overall Study|Physician Decision|0|||
27918220|NCT01719380|81536670|FG005|Overall Study|Physician Decision|0|||
27918221|NCT01719380|81536671|FG006|Overall Study|Physician Decision|0|||
27918222|NCT01719380|81536672|FG007|Overall Study|Physician Decision|0|||
27918223|NCT01719380|81536673|FG008|Overall Study|Physician Decision|1|||
27740197|NCT01415440|80877439|FG002|Overall Study|Withdrawal by Subject|0|||
27918224|NCT01719380|81536674|FG009|Overall Study|Physician Decision|1|||
27918225|NCT01719380|81536665|FG000|Overall Study|Lack of Efficacy|2|||
27918226|NCT01719380|81536666|FG001|Overall Study|Lack of Efficacy|6|||
27918227|NCT01719380|81536667|FG002|Overall Study|Lack of Efficacy|5|||
27918228|NCT01719380|81536668|FG003|Overall Study|Lack of Efficacy|6|||
27539360|NCT02598960|80167111|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539361|NCT02598960|80167112|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539362|NCT02598960|80167113|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539363|NCT02598960|80167114|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539364|NCT02598960|80167115|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539365|NCT02598960|80167116|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539366|NCT02598960|80167117|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539367|NCT02598960|80167118|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539368|NCT02598960|80167119|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
27539369|NCT02598960|80167120|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
27539370|NCT02598960|80167108|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
27539371|NCT02598960|80167109|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
27539372|NCT02598960|80167110|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
27539373|NCT02598960|80167111|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
27539374|NCT02598960|80167112|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
27539375|NCT02598960|80167113|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
27539376|NCT02598960|80167114|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
27539377|NCT02598960|80167115|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
27634050|NCT00545077|80500394|FG001|Overall Study|Withdrawal by Subject|14|||
27634051|NCT00545077|80500393|FG000|Overall Study|Physician Decision|6|||
27634052|NCT00545077|80500394|FG001|Overall Study|Physician Decision|3|||
27918229|NCT01719380|81536669|FG004|Overall Study|Lack of Efficacy|3|||
27918230|NCT01719380|81536670|FG005|Overall Study|Lack of Efficacy|7|||
27918231|NCT01719380|81536671|FG006|Overall Study|Lack of Efficacy|10|||
27634053|NCT00545077|80500393|FG000|Overall Study|Lost to Follow-up|2|||
27634054|NCT00545077|80500394|FG001|Overall Study|Lost to Follow-up|0|||
27634055|NCT00545077|80500393|FG000|Overall Study|Protocol Violation|1|||
27634056|NCT00545077|80500394|FG001|Overall Study|Protocol Violation|0|||
27634057|NCT00545077|80500393|FG000|Overall Study|Adverse Event|0|||
27634058|NCT00545077|80500394|FG001|Overall Study|Adverse Event|31|||
27634059|NCT00545077|80500393|FG000|Overall Study|Death|0|||
27634060|NCT00545077|80500394|FG001|Overall Study|Death|8|||
27634061|NCT04353037|80500398|FG000|Overall Study|Lost to Follow-up|0|||
27634062|NCT04353037|80500399|FG001|Overall Study|Lost to Follow-up|1|||
27634063|NCT04353037|80500400|FG002|Overall Study|Lost to Follow-up|2|||
27634064|NCT04353037|80500401|FG003|Overall Study|Lost to Follow-up|3|||
27918232|NCT01719380|81536672|FG007|Overall Study|Lack of Efficacy|6|||
27918233|NCT01719380|81536673|FG008|Overall Study|Lack of Efficacy|39|||
27918234|NCT01719380|81536674|FG009|Overall Study|Lack of Efficacy|42|||
27918235|NCT01719380|81536665|FG000|Overall Study|Progressive Disease|0|||
27918236|NCT01719380|81536666|FG001|Overall Study|Progressive Disease|0|||
27634065|NCT04353037|80500398|FG000|Overall Study|Withdrawal by Subject|0|||
27918237|NCT01719380|81536667|FG002|Overall Study|Progressive Disease|0|||
27918238|NCT01719380|81536668|FG003|Overall Study|Progressive Disease|0|||
27918239|NCT01719380|81536669|FG004|Overall Study|Progressive Disease|0|||
27918240|NCT01719380|81536670|FG005|Overall Study|Progressive Disease|0|||
27918241|NCT01719380|81536671|FG006|Overall Study|Progressive Disease|0|||
27918242|NCT01719380|81536672|FG007|Overall Study|Progressive Disease|0|||
27918243|NCT01719380|81536673|FG008|Overall Study|Progressive Disease|1|||
27918244|NCT01719380|81536674|FG009|Overall Study|Progressive Disease|0|||
27918245|NCT01692119|81536675|FG000|Overall Study|Protocol Violation|3|||
27918246|NCT01692119|81536676|FG001|Overall Study|Protocol Violation|1|||
27918247|NCT01692119|81536675|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
27918248|NCT01692119|81536676|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
27918249|NCT02089347|81536677|FG000|Overall Study|Protocol Violation|1|||
27918250|NCT02089347|81536678|FG001|Overall Study|Protocol Violation|0|||
27918251|NCT00848497|81536679|FG000|Overall Study|Screen failure|2|||
27918252|NCT00848497|81536680|FG001|Overall Study|Screen failure|0|||
27918253|NCT00848497|81536679|FG000|Overall Study|Withdrawal by Subject|0|||
27918254|NCT00848497|81536680|FG001|Overall Study|Withdrawal by Subject|1|||
27918255|NCT00449163|81536683|FG000|Overall Study|Physician Decision|3|||
27918256|NCT00104052|81536685|FG000|Overall Study|Adverse Event|1|||
27918257|NCT00104052|81536685|FG000|Overall Study|Lack of Efficacy|26|||
27918258|NCT00104052|81536685|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
27634066|NCT04353037|80500399|FG001|Overall Study|Withdrawal by Subject|2|||
27918259|NCT04494646|81536686|FG000|Overall Study|Adverse Event|0|||
27918260|NCT04494646|81536687|FG001|Overall Study|Adverse Event|1|||
27740198|NCT01380093|80877441|FG000|Naloxone Challenge Phase|Screen failures|21|||
27740199|NCT01380093|80877442|FG001|Naloxone Challenge Phase|Screen failures|0|||
27918261|NCT04494646|81536686|FG000|Overall Study|Withdrawal by Subject|0|||
27918262|NCT04494646|81536687|FG001|Overall Study|Withdrawal by Subject|1|||
27634067|NCT04353037|80500400|FG002|Overall Study|Withdrawal by Subject|3|||
27634068|NCT04353037|80500401|FG003|Overall Study|Withdrawal by Subject|5|||
27634069|NCT04353037|80500398|FG000|Overall Study|Adverse Event|0|||
27634070|NCT04353037|80500399|FG001|Overall Study|Adverse Event|0|||
27634071|NCT04353037|80500400|FG002|Overall Study|Adverse Event|2|||
27634072|NCT04353037|80500401|FG003|Overall Study|Adverse Event|0|||
27634073|NCT04353037|80500398|FG000|Overall Study|Exposure Change|0|||
27634074|NCT04353037|80500399|FG001|Overall Study|Exposure Change|0|||
27634075|NCT04353037|80500400|FG002|Overall Study|Exposure Change|0|||
27634076|NCT04353037|80500401|FG003|Overall Study|Exposure Change|2|||
27634077|NCT01025843|80500402|FG000|Washout 4|Withdrawal by Subject|0|||
27634078|NCT01025843|80500403|FG001|Washout 4|Withdrawal by Subject|0|||
27634079|NCT01025843|80500404|FG002|Washout 4|Withdrawal by Subject|1|||
27634080|NCT01025843|80500405|FG003|Washout 4|Withdrawal by Subject|1|||
27634081|NCT01025843|80500406|FG004|Washout 4|Withdrawal by Subject|0|||
27634082|NCT01025843|80500407|FG005|Washout 4|Withdrawal by Subject|0|||
27634083|NCT01025843|80500408|FG006|Washout 4|Withdrawal by Subject|0|||
27634084|NCT01025843|80500409|FG007|Washout 4|Withdrawal by Subject|0|||
27634085|NCT01025843|80500410|FG008|Washout 4|Withdrawal by Subject|0|||
27634086|NCT01025843|80500411|FG009|Washout 4|Withdrawal by Subject|0|||
27634087|NCT00868192|80500413|FG000|Overall Study|Ineligible|4|||
27634088|NCT00414648|80500414|FG000|Overall Study|Adverse Event|5|||
27634089|NCT00414648|80500415|FG001|Overall Study|Adverse Event|5|||
27634090|NCT00414648|80500414|FG000|Overall Study|Death|0|||
27634091|NCT00414648|80500415|FG001|Overall Study|Death|1|||
27634092|NCT00414648|80500414|FG000|Overall Study|Lack of Efficacy|0|||
27634093|NCT00414648|80500415|FG001|Overall Study|Lack of Efficacy|2|||
27634094|NCT00414648|80500414|FG000|Overall Study|Withdrawal by Subject|0|||
27634095|NCT00414648|80500415|FG001|Overall Study|Withdrawal by Subject|1|||
27634096|NCT04424641|80500416|FG000|Overall Study|Death|1|||
27634097|NCT04424641|80500417|FG001|Overall Study|Death|2|||
27634098|NCT04424641|80500418|FG002|Overall Study|Death|3|||
27634099|NCT04424641|80500419|FG003|Overall Study|Death|0|||
27634100|NCT04424641|80500420|FG004|Overall Study|Death|3|||
27634101|NCT04424641|80500421|FG005|Overall Study|Death|0|||
27634102|NCT04424641|80500422|FG006|Overall Study|Death|1|||
27634103|NCT04424641|80500423|FG007|Overall Study|Death|2|||
27634104|NCT04424641|80500416|FG000|Overall Study|Sponsor decision|0|||
27634105|NCT04424641|80500417|FG001|Overall Study|Sponsor decision|2|||
27634106|NCT04424641|80500418|FG002|Overall Study|Sponsor decision|3|||
27634107|NCT04424641|80500419|FG003|Overall Study|Sponsor decision|7|||
27634108|NCT04424641|80500420|FG004|Overall Study|Sponsor decision|2|||
27634109|NCT04424641|80500421|FG005|Overall Study|Sponsor decision|2|||
27634110|NCT04424641|80500422|FG006|Overall Study|Sponsor decision|3|||
27634111|NCT04424641|80500423|FG007|Overall Study|Sponsor decision|4|||
27634112|NCT04424641|80500416|FG000|Overall Study|Withdrawal by Subject|0|||
27634113|NCT04424641|80500417|FG001|Overall Study|Withdrawal by Subject|0|||
27634114|NCT04424641|80500418|FG002|Overall Study|Withdrawal by Subject|0|||
27634115|NCT04424641|80500419|FG003|Overall Study|Withdrawal by Subject|0|||
27634116|NCT04424641|80500420|FG004|Overall Study|Withdrawal by Subject|1|||
27634117|NCT04424641|80500421|FG005|Overall Study|Withdrawal by Subject|0|||
27634118|NCT04424641|80500422|FG006|Overall Study|Withdrawal by Subject|0|||
27634119|NCT04424641|80500423|FG007|Overall Study|Withdrawal by Subject|0|||
27634120|NCT04424641|80500416|FG000|Overall Study|Other|0|||
27634121|NCT04424641|80500417|FG001|Overall Study|Other|0|||
27634122|NCT04424641|80500418|FG002|Overall Study|Other|1|||
27634123|NCT04424641|80500419|FG003|Overall Study|Other|0|||
27634124|NCT04424641|80500420|FG004|Overall Study|Other|0|||
27634125|NCT04424641|80500421|FG005|Overall Study|Other|0|||
27634126|NCT04424641|80500422|FG006|Overall Study|Other|0|||
27634127|NCT04424641|80500423|FG007|Overall Study|Other|0|||
27634128|NCT01121549|80500427|FG000|Overall Study|Adverse Event|10|||
27634129|NCT01121549|80500427|FG000|Overall Study|Lack of Efficacy|11|||
27634130|NCT01121549|80500427|FG000|Overall Study|Lost to Follow-up|12|||
27634131|NCT01121549|80500427|FG000|Overall Study|Did not meet entrance criteria|9|||
27740200|NCT01380093|80877443|FG002|Naloxone Challenge Phase|Screen failures|0|||
27740201|NCT01380093|80877444|FG003|Naloxone Challenge Phase|Screen failures|0|||
27634132|NCT01121549|80500427|FG000|Overall Study|Study terminated by sponsor|197|||
27634133|NCT01121549|80500427|FG000|Overall Study|Pregnancy|1|||
27740202|NCT01380093|80877445|FG004|Naloxone Challenge Phase|Screen failures|0|||
27634134|NCT01121549|80500427|FG000|Overall Study|Protocol Violation|33|||
27634135|NCT01121549|80500427|FG000|Overall Study|Withdrawal by Subject|16|||
27634136|NCT01121549|80500427|FG000|Overall Study|Other|58|||
27634137|NCT02808338|80500437|FG000|Screening|Screen Failure|10|||
27634138|NCT02808338|80500437|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
27634139|NCT02808338|80500437|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
27634140|NCT05149313|80500438|FG000|Overall Study|Adverse Event|2|||
27634141|NCT05149313|80500439|FG001|Overall Study|Adverse Event|2|||
27634142|NCT05149313|80500438|FG000|Overall Study|Lost to Follow-up|2|||
27634143|NCT05149313|80500439|FG001|Overall Study|Lost to Follow-up|3|||
27634144|NCT05149313|80500438|FG000|Overall Study|Pregnancy|1|||
27634145|NCT05149313|80500439|FG001|Overall Study|Pregnancy|0|||
27634146|NCT05149313|80500438|FG000|Overall Study|Withdrawal by Subject|2|||
27634147|NCT05149313|80500439|FG001|Overall Study|Withdrawal by Subject|5|||
27634148|NCT05149313|80500438|FG000|Overall Study|Physician Decision|1|||
27634149|NCT05149313|80500439|FG001|Overall Study|Physician Decision|0|||
27634150|NCT05149313|80500438|FG000|Overall Study|Other|0|||
27634151|NCT05149313|80500439|FG001|Overall Study|Other|1|||
27634152|NCT02621424|80500440|FG000|Overall Study|Withdrawal by Subject|1|||
27634153|NCT02621424|80500441|FG001|Overall Study|Withdrawal by Subject|2|||
27634154|NCT01350804|80500442|FG000|Core Study|Withdrawal by Subject|11|||
27634155|NCT01350804|80500443|FG001|Core Study|Withdrawal by Subject|17|||
27634156|NCT01350804|80500444|FG002|Core Study|Withdrawal by Subject|16|||
27634157|NCT01350804|80500445|FG003|Core Study|Withdrawal by Subject|7|||
27634158|NCT01350804|80500442|FG000|Core Study|Study terminated by Sponsor|0|||
27634159|NCT01350804|80500443|FG001|Core Study|Study terminated by Sponsor|0|||
27634160|NCT01350804|80500444|FG002|Core Study|Study terminated by Sponsor|0|||
27634161|NCT01350804|80500445|FG003|Core Study|Study terminated by Sponsor|2|||
27634162|NCT01350804|80500442|FG000|Core Study|Protocol deviation|1|||
27634163|NCT01350804|80500443|FG001|Core Study|Protocol deviation|0|||
27634164|NCT01350804|80500444|FG002|Core Study|Protocol deviation|1|||
27634165|NCT01350804|80500445|FG003|Core Study|Protocol deviation|0|||
27634166|NCT01350804|80500442|FG000|Core Study|Physician Decision|1|||
27634167|NCT01350804|80500443|FG001|Core Study|Physician Decision|0|||
27634168|NCT01350804|80500444|FG002|Core Study|Physician Decision|1|||
27634169|NCT01350804|80500445|FG003|Core Study|Physician Decision|3|||
27634170|NCT01350804|80500442|FG000|Core Study|Lost to Follow-up|3|||
27634171|NCT01350804|80500443|FG001|Core Study|Lost to Follow-up|0|||
27634172|NCT01350804|80500444|FG002|Core Study|Lost to Follow-up|2|||
27634173|NCT01350804|80500445|FG003|Core Study|Lost to Follow-up|1|||
27634174|NCT01350804|80500442|FG000|Core Study|Lack of Efficacy|16|||
27634175|NCT01350804|80500443|FG001|Core Study|Lack of Efficacy|19|||
27634176|NCT01350804|80500444|FG002|Core Study|Lack of Efficacy|18|||
27634177|NCT01350804|80500445|FG003|Core Study|Lack of Efficacy|5|||
27634178|NCT01350804|80500442|FG000|Core Study|Death|1|||
27634179|NCT01350804|80500443|FG001|Core Study|Death|1|||
27634180|NCT01350804|80500444|FG002|Core Study|Death|1|||
27634181|NCT01350804|80500445|FG003|Core Study|Death|0|||
27634182|NCT01350804|80500442|FG000|Core Study|Adverse Event|8|||
27634183|NCT01350804|80500443|FG001|Core Study|Adverse Event|10|||
27634184|NCT01350804|80500444|FG002|Core Study|Adverse Event|8|||
27634185|NCT01350804|80500445|FG003|Core Study|Adverse Event|8|||
27634186|NCT01350804|80500442|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
27634187|NCT01350804|80500443|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
27634188|NCT01350804|80500444|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
27634189|NCT01350804|80500445|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
27634190|NCT01350804|80500442|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
27634191|NCT01350804|80500443|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
27634192|NCT01350804|80500444|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
27634193|NCT01350804|80500445|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
27634194|NCT01350804|80500442|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
27634195|NCT01350804|80500443|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
27634196|NCT01350804|80500444|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
27634197|NCT01350804|80500445|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
27634198|NCT01350804|80500442|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
27634199|NCT01350804|80500443|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
27634200|NCT01350804|80500444|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
27634201|NCT01350804|80500445|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
27634202|NCT01350804|80500442|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
27634203|NCT01350804|80500443|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
27634204|NCT01350804|80500444|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
27634205|NCT01350804|80500445|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
27634206|NCT01350804|80500442|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
27634207|NCT01350804|80500443|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
27634208|NCT01350804|80500444|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
27634209|NCT01350804|80500445|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
27634210|NCT03646123|80500446|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
27634211|NCT03646123|80500447|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
27634212|NCT03646123|80500448|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
27634213|NCT03646123|80500446|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
27634214|NCT03646123|80500447|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
27634215|NCT03646123|80500448|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
27634216|NCT03646123|80500446|FG000|Overall Study|Non-compliance to study protocol|1|||
27634217|NCT03646123|80500447|FG001|Overall Study|Non-compliance to study protocol|0|||
27634218|NCT03646123|80500448|FG002|Overall Study|Non-compliance to study protocol|0|||
27634219|NCT03646123|80500446|FG000|Overall Study|Ineligible due to progression during screening|0|||
27634220|NCT03646123|80500447|FG001|Overall Study|Ineligible due to progression during screening|0|||
27634221|NCT03646123|80500448|FG002|Overall Study|Ineligible due to progression during screening|1|||
27634222|NCT03646123|80500446|FG000|Overall Study|Withdrawal by Subject|2|||
27634223|NCT03646123|80500447|FG001|Overall Study|Withdrawal by Subject|1|||
27634224|NCT03646123|80500448|FG002|Overall Study|Withdrawal by Subject|3|||
27634225|NCT03646123|80500446|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
27634226|NCT03646123|80500447|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
27634227|NCT03646123|80500448|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
27634228|NCT03646123|80500446|FG000|Overall Study|Death|2|||
27634229|NCT03646123|80500447|FG001|Overall Study|Death|1|||
27634230|NCT03646123|80500448|FG002|Overall Study|Death|1|||
27634231|NCT03646123|80500446|FG000|Overall Study|Lost to Follow-up|4|||
27634232|NCT03646123|80500447|FG001|Overall Study|Lost to Follow-up|7|||
27634233|NCT03646123|80500448|FG002|Overall Study|Lost to Follow-up|6|||
27634234|NCT03646123|80500446|FG000|Overall Study|Participants in long term follow-up|0|||
27634235|NCT03646123|80500447|FG001|Overall Study|Participants in long term follow-up|48|||
27634236|NCT03646123|80500448|FG002|Overall Study|Participants in long term follow-up|144|||
27634237|NCT00790790|80500455|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
27634238|NCT00790790|80500456|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
27634239|NCT00790790|80500457|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
27634240|NCT00790790|80500455|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
27634241|NCT00790790|80500456|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
27634242|NCT00790790|80500457|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
27634243|NCT00790790|80500455|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
27634244|NCT00790790|80500456|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
27634245|NCT00790790|80500457|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
27634246|NCT00790790|80500455|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
27634247|NCT00790790|80500456|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
27634248|NCT00790790|80500457|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
27634249|NCT00790790|80500455|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
27634250|NCT00790790|80500456|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
27634251|NCT00790790|80500457|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
27634252|NCT01281813|80500458|FG000|Overall Study|Adverse Event|0|||
27634253|NCT01281813|80500459|FG001|Overall Study|Adverse Event|0|||
27634254|NCT01281813|80500460|FG002|Overall Study|Adverse Event|10|||
27634255|NCT01281813|80500458|FG000|Overall Study|Lost to Follow-up|0|||
27634256|NCT01281813|80500459|FG001|Overall Study|Lost to Follow-up|0|||
27634257|NCT01281813|80500460|FG002|Overall Study|Lost to Follow-up|31|||
27634258|NCT01281813|80500458|FG000|Overall Study|Withdrawal by Subject|0|||
27634259|NCT01281813|80500459|FG001|Overall Study|Withdrawal by Subject|0|||
27634260|NCT01281813|80500460|FG002|Overall Study|Withdrawal by Subject|13|||
27634261|NCT01281813|80500458|FG000|Overall Study|Subject Non-Compliant|0|||
27634262|NCT01281813|80500459|FG001|Overall Study|Subject Non-Compliant|0|||
27634263|NCT01281813|80500460|FG002|Overall Study|Subject Non-Compliant|6|||
27634264|NCT01281813|80500458|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
27634265|NCT01281813|80500459|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
27634266|NCT01281813|80500460|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
27634267|NCT01281813|80500458|FG000|Overall Study|Sponsor's Decision|4|||
27634268|NCT01281813|80500459|FG001|Overall Study|Sponsor's Decision|3|||
27634269|NCT01281813|80500460|FG002|Overall Study|Sponsor's Decision|7|||
27634270|NCT01281813|80500458|FG000|Overall Study|Switched to Commercially Available Medication|0|||
27634271|NCT01281813|80500459|FG001|Overall Study|Switched to Commercially Available Medication|0|||
27634272|NCT01281813|80500460|FG002|Overall Study|Switched to Commercially Available Medication|26|||
27634273|NCT01281813|80500458|FG000|Overall Study|Other|0|||
27634274|NCT01281813|80500459|FG001|Overall Study|Other|1|||
27634275|NCT01281813|80500460|FG002|Overall Study|Other|39|||
27634276|NCT00736853|80500461|FG000|Open-Label Period|Physician Decision|2|||
27634277|NCT00736853|80500462|FG001|Open-Label Period|Physician Decision|0|||
27634278|NCT00736853|80500463|FG002|Open-Label Period|Physician Decision|0|||
27634279|NCT00736853|80500461|FG000|Open-Label Period|Adverse Event|31|||
27634280|NCT00736853|80500462|FG001|Open-Label Period|Adverse Event|0|||
27634281|NCT00736853|80500463|FG002|Open-Label Period|Adverse Event|0|||
27634282|NCT00736853|80500461|FG000|Open-Label Period|Withdrawal by Subject|16|||
27634283|NCT00736853|80500462|FG001|Open-Label Period|Withdrawal by Subject|0|||
27634284|NCT00736853|80500463|FG002|Open-Label Period|Withdrawal by Subject|0|||
27634285|NCT00736853|80500461|FG000|Open-Label Period|Started but not treated|42|||
27634286|NCT00736853|80500462|FG001|Open-Label Period|Started but not treated|0|||
27634287|NCT00736853|80500463|FG002|Open-Label Period|Started but not treated|0|||
27634288|NCT00736853|80500461|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
27634289|NCT00736853|80500462|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
27918263|NCT00735007|81536689|FG000|Overall Study|Adverse Event|4|||
27918264|NCT00735007|81536689|FG000|Overall Study|Protocol Violation|1|||
27918265|NCT03769649|81536698|FG000|Overall Study|Lost to Follow-up|4|||
27918266|NCT01746862|81536699|FG000|Overall Study|Withdrawal by Subject|1|||
27918267|NCT01746862|81536700|FG001|Overall Study|Withdrawal by Subject|1|||
27918268|NCT01746862|81536699|FG000|Overall Study|Protocol Violation|1|||
27918269|NCT01746862|81536700|FG001|Overall Study|Protocol Violation|0|||
27918270|NCT01746862|81536699|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
27918271|NCT01746862|81536700|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
27918272|NCT01746862|81536699|FG000|Overall Study|Entered puberty during the study|1|||
27918273|NCT01746862|81536700|FG001|Overall Study|Entered puberty during the study|0|||
27918274|NCT01926028|81536701|FG000|Overall Study|Lost to Follow-up|7|||
27918275|NCT01926028|81536702|FG001|Overall Study|Lost to Follow-up|6|||
27918276|NCT01926028|81536703|FG002|Overall Study|Lost to Follow-up|0|||
27918277|NCT01926028|81536701|FG000|Overall Study|Physician Decision|1|||
27918278|NCT01926028|81536702|FG001|Overall Study|Physician Decision|5|||
27918279|NCT01926028|81536703|FG002|Overall Study|Physician Decision|0|||
27918280|NCT01926028|81536701|FG000|Overall Study|Withdrawal by Subject|9|||
27918281|NCT01926028|81536702|FG001|Overall Study|Withdrawal by Subject|9|||
27918282|NCT01926028|81536703|FG002|Overall Study|Withdrawal by Subject|2|||
27918283|NCT01926028|81536701|FG000|Overall Study|Non compliance or other reasons|4|||
27918284|NCT01926028|81536702|FG001|Overall Study|Non compliance or other reasons|2|||
27918285|NCT01926028|81536703|FG002|Overall Study|Non compliance or other reasons|0|||
27918286|NCT02900352|81536704|FG000|Overall Study|Lost to Follow-up|28|||
27918287|NCT02900352|81536705|FG001|Overall Study|Lost to Follow-up|17|||
27918288|NCT00666237|81539629|FG000|Overall Study|Death|5|||
27918289|NCT00666237|81539630|FG001|Overall Study|Death|5|||
27918290|NCT00666237|81539629|FG000|Overall Study|Lost to Follow-up|29|||
27918291|NCT00666237|81539630|FG001|Overall Study|Lost to Follow-up|25|||
27918292|NCT03074695|81539631|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
27918293|NCT03074695|81539632|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
27918294|NCT03074695|81539631|FG000|Overall Study|Research staff not available|1|||
27918295|NCT03074695|81539632|FG001|Overall Study|Research staff not available|2|||
27918296|NCT03074695|81539631|FG000|Overall Study|Did not receive neuraxial block|2|||
27918297|NCT03074695|81539632|FG001|Overall Study|Did not receive neuraxial block|2|||
27918298|NCT01386606|81539634|FG000|Overall Study|Adverse Event|0|||
27918299|NCT01386606|81539635|FG001|Overall Study|Adverse Event|1|||
27539378|NCT02598960|80167116|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
27539379|NCT02598960|80167117|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
27539380|NCT02598960|80167118|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
27539381|NCT02598960|80167119|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
27539382|NCT02598960|80167120|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
27539383|NCT02598960|80167108|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539384|NCT02598960|80167109|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539385|NCT02598960|80167110|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539386|NCT02598960|80167111|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539387|NCT02598960|80167112|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539388|NCT02598960|80167113|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539389|NCT02598960|80167114|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539390|NCT02598960|80167115|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539391|NCT02598960|80167116|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539392|NCT02598960|80167117|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539393|NCT02598960|80167118|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539394|NCT02598960|80167119|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
27539395|NCT02598960|80167120|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
27539396|NCT02598960|80167108|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
27539397|NCT02598960|80167109|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
27539398|NCT02598960|80167110|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
27539399|NCT02598960|80167111|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
27539400|NCT02598960|80167112|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
27539401|NCT02598960|80167113|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
27539402|NCT02598960|80167114|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
27539403|NCT02598960|80167115|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
27539404|NCT02598960|80167116|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
27634290|NCT00736853|80500463|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
27918300|NCT01386606|81539636|FG002|Overall Study|Adverse Event|0|||
27918301|NCT01386606|81539637|FG003|Overall Study|Adverse Event|0|||
27918302|NCT01386606|81539634|FG000|Overall Study|Withdrawal by Subject|0|||
27918303|NCT01386606|81539635|FG001|Overall Study|Withdrawal by Subject|1|||
27918304|NCT01386606|81539636|FG002|Overall Study|Withdrawal by Subject|1|||
27918305|NCT01386606|81539637|FG003|Overall Study|Withdrawal by Subject|0|||
27634291|NCT00736853|80500461|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
27634292|NCT00736853|80500462|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
27539405|NCT02598960|80167117|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
27539406|NCT02598960|80167118|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
27539407|NCT02598960|80167119|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
27539408|NCT02598960|80167120|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
27539409|NCT03342963|80167121|FG000|Overall Study|Adverse Event|1|||
27539410|NCT03342963|80167122|FG001|Overall Study|Adverse Event|2|||
27539411|NCT03342963|80167123|FG002|Overall Study|Adverse Event|0|||
27539412|NCT03342963|80167124|FG003|Overall Study|Adverse Event|0|||
27539413|NCT03342963|80167121|FG000|Overall Study|Withdrawal by Subject|1|||
27539414|NCT03342963|80167122|FG001|Overall Study|Withdrawal by Subject|0|||
27539415|NCT03342963|80167123|FG002|Overall Study|Withdrawal by Subject|0|||
27539416|NCT03342963|80167124|FG003|Overall Study|Withdrawal by Subject|0|||
27539417|NCT03606512|80167125|FG000|Overall Study|Lost to Follow-up|0|||
27740203|NCT01380093|80877446|FG005|Naloxone Challenge Phase|Screen failures|0|||
27539418|NCT03606512|80167126|FG001|Overall Study|Lost to Follow-up|1|||
27634293|NCT00736853|80500463|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
27634294|NCT00736853|80500461|FG000|Double-Blind Period|Lack of Efficacy|0|||
27634295|NCT00736853|80500462|FG001|Double-Blind Period|Lack of Efficacy|19|||
27634296|NCT00736853|80500463|FG002|Double-Blind Period|Lack of Efficacy|42|||
27634297|NCT00736853|80500461|FG000|Double-Blind Period|Adverse Event|0|||
27634298|NCT00736853|80500462|FG001|Double-Blind Period|Adverse Event|3|||
27634299|NCT00736853|80500463|FG002|Double-Blind Period|Adverse Event|2|||
27634300|NCT00736853|80500461|FG000|Double-Blind Period|Withdrawal by Subject|0|||
27634301|NCT00736853|80500462|FG001|Double-Blind Period|Withdrawal by Subject|1|||
27634302|NCT00736853|80500463|FG002|Double-Blind Period|Withdrawal by Subject|4|||
27634303|NCT00736853|80500461|FG000|Double-Blind Period|Ineligible to participate the study|0|||
27634304|NCT00736853|80500462|FG001|Double-Blind Period|Ineligible to participate the study|1|||
27634305|NCT00736853|80500463|FG002|Double-Blind Period|Ineligible to participate the study|0|||
27634306|NCT00756730|80503107|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
27634307|NCT00756730|80503108|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
27634308|NCT00756730|80503107|FG000|Overall Study|persistent low-level viremmia|0|||
27634309|NCT00756730|80503108|FG001|Overall Study|persistent low-level viremmia|1|||
27634310|NCT03512756|80503109|FG000|Part 1|Death|23|||
27634311|NCT03512756|80503110|FG001|Part 1|Death|18|||
27634312|NCT03512756|80503111|FG002|Part 1|Death|0|||
27634313|NCT03512756|80503112|FG003|Part 1|Death|0|||
27634314|NCT03512756|80503109|FG000|Part 1|Lost to Follow-up|0|||
27634315|NCT03512756|80503110|FG001|Part 1|Lost to Follow-up|3|||
27634316|NCT03512756|80503111|FG002|Part 1|Lost to Follow-up|0|||
27740204|NCT01380093|80877447|FG006|Naloxone Challenge Phase|Screen failures|0|||
27740205|NCT01380093|80877448|FG007|Naloxone Challenge Phase|Screen failures|0|||
27539419|NCT03606512|80167125|FG000|Overall Study|'moved from study area|0|||
27539420|NCT03606512|80167126|FG001|Overall Study|'moved from study area|1|||
27539421|NCT01786148|80167129|FG000|Overall Study|Lost to Follow-up|21|||
27539422|NCT01786148|80167130|FG001|Overall Study|Lost to Follow-up|13|||
27539423|NCT01786148|80167129|FG000|Overall Study|Death|0|||
27539424|NCT01786148|80167130|FG001|Overall Study|Death|1|||
27539425|NCT01786148|80167129|FG000|Overall Study|Withdrawal by Subject|0|||
27539426|NCT01786148|80167130|FG001|Overall Study|Withdrawal by Subject|7|||
27539427|NCT01786148|80167129|FG000|Overall Study|Incarceration|1|||
27539428|NCT01786148|80167130|FG001|Overall Study|Incarceration|1|||
27539429|NCT02699593|80167131|FG000|Period 1|Unsatisfactory Visual Response|0|||
27539430|NCT02699593|80167132|FG001|Period 1|Unsatisfactory Visual Response|1|||
27539431|NCT02699593|80167131|FG000|Period 1|Torn Contact Len|4|||
27539432|NCT02699593|80167132|FG001|Period 1|Torn Contact Len|3|||
27539433|NCT02699593|80167131|FG000|Period 1|Protocol Violation|0|||
27539434|NCT02699593|80167132|FG001|Period 1|Protocol Violation|1|||
27539435|NCT02699593|80167131|FG000|Period 1|Withdrawal by Subject|0|||
27539436|NCT02699593|80167132|FG001|Period 1|Withdrawal by Subject|1|||
27539437|NCT02699593|80167131|FG000|Period 1|Adverse Event|1|||
27539438|NCT02699593|80167132|FG001|Period 1|Adverse Event|1|||
27539439|NCT02699593|80167131|FG000|Period 2|Adverse Event|1|||
27539440|NCT02699593|80167132|FG001|Period 2|Adverse Event|1|||
27539441|NCT02699593|80167131|FG000|Period 2|Lost Contact Lens|0|||
27539442|NCT02699593|80167132|FG001|Period 2|Lost Contact Lens|1|||
27634317|NCT03512756|80503112|FG003|Part 1|Lost to Follow-up|0|||
27634318|NCT03512756|80503109|FG000|Part 1|Physician Decision|0|||
27740206|NCT01380093|80877449|FG008|Naloxone Challenge Phase|Screen failures|0|||
27740207|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27539443|NCT02699593|80167131|FG000|Period 2|Torn Contact Lens|1|||
27539444|NCT02699593|80167132|FG001|Period 2|Torn Contact Lens|0|||
27539445|NCT02339285|80167133|FG000|Overall Study|Withdrawal by Subject|0|||
27634319|NCT03512756|80503110|FG001|Part 1|Physician Decision|1|||
27634320|NCT03512756|80503111|FG002|Part 1|Physician Decision|0|||
27634321|NCT03512756|80503112|FG003|Part 1|Physician Decision|0|||
27634322|NCT03512756|80503109|FG000|Part 1|Withdrawal by Subject|2|||
27634323|NCT03512756|80503110|FG001|Part 1|Withdrawal by Subject|2|||
27634324|NCT03512756|80503111|FG002|Part 1|Withdrawal by Subject|0|||
27634325|NCT03512756|80503112|FG003|Part 1|Withdrawal by Subject|0|||
27634326|NCT03512756|80503109|FG000|Part 2|Death|0|||
27539446|NCT02339285|80167134|FG001|Overall Study|Withdrawal by Subject|1|||
27539447|NCT02339285|80167135|FG002|Overall Study|Withdrawal by Subject|1|||
27539448|NCT02339285|80167133|FG000|Overall Study|Lost to Follow-up|1|||
27539449|NCT02339285|80167134|FG001|Overall Study|Lost to Follow-up|1|||
27539450|NCT02339285|80167135|FG002|Overall Study|Lost to Follow-up|1|||
27539451|NCT02339285|80167133|FG000|Overall Study|Protocol Deviation|0|||
27539452|NCT02339285|80167134|FG001|Overall Study|Protocol Deviation|1|||
27539453|NCT02339285|80167135|FG002|Overall Study|Protocol Deviation|0|||
27539454|NCT02083965|80167136|FG000|Treatment Period|Other|1|||
27539455|NCT02083965|80167137|FG001|Treatment Period|Other|0|||
27539456|NCT00705289|80167138|FG000|Overall Study|Subject or treating physician's choice|131|||
27539457|NCT00761631|80167139|FG000|Overall Study|Parent/legal guardian request|8|||
27539458|NCT00761631|80167140|FG001|Overall Study|Parent/legal guardian request|3|||
27539459|NCT00761631|80167141|FG002|Overall Study|Parent/legal guardian request|8|||
27539460|NCT00761631|80167142|FG003|Overall Study|Parent/legal guardian request|0|||
27539461|NCT00761631|80167143|FG004|Overall Study|Parent/legal guardian request|5|||
27539462|NCT00761631|80167144|FG005|Overall Study|Parent/legal guardian request|0|||
27539463|NCT00761631|80167139|FG000|Overall Study|Lost to Follow-up|2|||
27539464|NCT00761631|80167140|FG001|Overall Study|Lost to Follow-up|4|||
27539465|NCT00761631|80167141|FG002|Overall Study|Lost to Follow-up|7|||
27539466|NCT00761631|80167142|FG003|Overall Study|Lost to Follow-up|1|||
27539467|NCT00761631|80167143|FG004|Overall Study|Lost to Follow-up|6|||
27539468|NCT00761631|80167144|FG005|Overall Study|Lost to Follow-up|1|||
27539469|NCT00761631|80167139|FG000|Overall Study|Protocol Violation|2|||
27539470|NCT00761631|80167140|FG001|Overall Study|Protocol Violation|0|||
27539471|NCT00761631|80167141|FG002|Overall Study|Protocol Violation|0|||
27539472|NCT00761631|80167142|FG003|Overall Study|Protocol Violation|1|||
27539473|NCT00761631|80167143|FG004|Overall Study|Protocol Violation|5|||
27539474|NCT00761631|80167144|FG005|Overall Study|Protocol Violation|1|||
27539475|NCT00761631|80167139|FG000|Overall Study|Randomized, not treated|1|||
27539476|NCT00761631|80167140|FG001|Overall Study|Randomized, not treated|0|||
27539477|NCT00761631|80167141|FG002|Overall Study|Randomized, not treated|0|||
27539478|NCT00761631|80167142|FG003|Overall Study|Randomized, not treated|0|||
27539479|NCT00761631|80167143|FG004|Overall Study|Randomized, not treated|0|||
27539480|NCT00761631|80167144|FG005|Overall Study|Randomized, not treated|0|||
27539481|NCT00761631|80167139|FG000|Overall Study|Failed to return|1|||
27539482|NCT00761631|80167140|FG001|Overall Study|Failed to return|0|||
27539483|NCT00761631|80167141|FG002|Overall Study|Failed to return|1|||
27539484|NCT00761631|80167142|FG003|Overall Study|Failed to return|1|||
27539485|NCT00761631|80167143|FG004|Overall Study|Failed to return|5|||
27539486|NCT00761631|80167144|FG005|Overall Study|Failed to return|2|||
27539487|NCT00761631|80167139|FG000|Overall Study|Physician Decision|1|||
27539488|NCT00761631|80167140|FG001|Overall Study|Physician Decision|0|||
27539489|NCT00761631|80167141|FG002|Overall Study|Physician Decision|0|||
27539490|NCT00761631|80167142|FG003|Overall Study|Physician Decision|0|||
27539491|NCT00761631|80167143|FG004|Overall Study|Physician Decision|0|||
27539492|NCT00761631|80167144|FG005|Overall Study|Physician Decision|0|||
27539493|NCT00761631|80167139|FG000|Overall Study|Other|0|||
27539494|NCT00761631|80167140|FG001|Overall Study|Other|0|||
27539495|NCT00761631|80167141|FG002|Overall Study|Other|0|||
27539496|NCT00761631|80167142|FG003|Overall Study|Other|0|||
27539497|NCT00761631|80167143|FG004|Overall Study|Other|1|||
27539498|NCT00761631|80167144|FG005|Overall Study|Other|1|||
27539499|NCT01752985|80167146|FG000|Treatment Period|Subject request to discontinue treatment|1|||
27539500|NCT01752985|80167147|FG001|Treatment Period|Subject request to discontinue treatment|0|||
27539501|NCT01752985|80167148|FG002|Treatment Period|Subject request to discontinue treatment|1|||
27539502|NCT01752985|80167146|FG000|Treatment Period|Subject no longer meets study criteria|0|||
27539503|NCT01752985|80167147|FG001|Treatment Period|Subject no longer meets study criteria|1|||
27634327|NCT03512756|80503110|FG001|Part 2|Death|0|||
27740208|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
27539504|NCT01752985|80167148|FG002|Treatment Period|Subject no longer meets study criteria|1|||
27539505|NCT01752985|80167146|FG000|Treatment Period|Adverse Event|2|||
27539506|NCT01752985|80167147|FG001|Treatment Period|Adverse Event|1|||
27539507|NCT01752985|80167148|FG002|Treatment Period|Adverse Event|2|||
27539508|NCT01752985|80167146|FG000|Treatment Period|Withdrawal by Subject|1|||
27539509|NCT01752985|80167147|FG001|Treatment Period|Withdrawal by Subject|1|||
27740209|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27539510|NCT01752985|80167148|FG002|Treatment Period|Withdrawal by Subject|0|||
27539511|NCT01752985|80167146|FG000|Treatment Period|Lost to Follow-up|0|||
27634328|NCT03512756|80503111|FG002|Part 2|Death|32|||
27634329|NCT03512756|80503112|FG003|Part 2|Death|21|||
27918306|NCT01386606|81539634|FG000|Overall Study|Protocol Violation|1|||
27918307|NCT01386606|81539635|FG001|Overall Study|Protocol Violation|0|||
27918308|NCT01386606|81539636|FG002|Overall Study|Protocol Violation|1|||
27918309|NCT01386606|81539637|FG003|Overall Study|Protocol Violation|1|||
27918310|NCT01386606|81539634|FG000|Overall Study|Lost to Follow-up|2|||
27918311|NCT01386606|81539635|FG001|Overall Study|Lost to Follow-up|0|||
27918312|NCT01386606|81539636|FG002|Overall Study|Lost to Follow-up|0|||
27918313|NCT01386606|81539637|FG003|Overall Study|Lost to Follow-up|0|||
27918314|NCT01386606|81539634|FG000|Overall Study|Subject incarcerated|0|||
27918315|NCT01386606|81539635|FG001|Overall Study|Subject incarcerated|1|||
27539512|NCT01752985|80167147|FG001|Treatment Period|Lost to Follow-up|0|||
27539513|NCT01752985|80167148|FG002|Treatment Period|Lost to Follow-up|1|||
27539514|NCT02248701|80167149|FG000|Overall Study|Withdrawal by Subject|2|||
27539515|NCT02248701|80167150|FG001|Overall Study|Withdrawal by Subject|1|||
27539516|NCT02248701|80167149|FG000|Overall Study|Physician Decision|0|||
27539517|NCT02248701|80167150|FG001|Overall Study|Physician Decision|1|||
27539518|NCT02248701|80167149|FG000|Overall Study|Adverse Event|1|||
27539519|NCT02248701|80167150|FG001|Overall Study|Adverse Event|0|||
27539520|NCT02248701|80167149|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
27539521|NCT02248701|80167150|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
27539522|NCT01030536|80167151|FG000|Overall Study|Withdrawal by Subject|0|||
27539523|NCT01030536|80167152|FG001|Overall Study|Withdrawal by Subject|0|||
27539524|NCT01030536|80167153|FG002|Overall Study|Withdrawal by Subject|1|||
27539525|NCT01030536|80167154|FG003|Overall Study|Withdrawal by Subject|0|||
27539526|NCT01030536|80167155|FG004|Overall Study|Withdrawal by Subject|0|||
27539527|NCT01030536|80167151|FG000|Overall Study|undefined|1|||
27539528|NCT01030536|80167152|FG001|Overall Study|undefined|0|||
27539529|NCT01030536|80167153|FG002|Overall Study|undefined|1|||
27539530|NCT01030536|80167154|FG003|Overall Study|undefined|1|||
27539531|NCT01030536|80167155|FG004|Overall Study|undefined|0|||
27634330|NCT03512756|80503109|FG000|Part 2|Lost to Follow-up|0|||
27634331|NCT03512756|80503110|FG001|Part 2|Lost to Follow-up|0|||
27634332|NCT03512756|80503111|FG002|Part 2|Lost to Follow-up|1|||
27634333|NCT03512756|80503112|FG003|Part 2|Lost to Follow-up|0|||
27634334|NCT03512756|80503109|FG000|Part 2|Physician Decision|0|||
27634335|NCT03512756|80503110|FG001|Part 2|Physician Decision|0|||
27634336|NCT03512756|80503111|FG002|Part 2|Physician Decision|2|||
27634337|NCT03512756|80503112|FG003|Part 2|Physician Decision|4|||
27634338|NCT03512756|80503109|FG000|Part 2|Study Terminated by Sponsor|0|||
27634339|NCT03512756|80503110|FG001|Part 2|Study Terminated by Sponsor|0|||
27634340|NCT03512756|80503111|FG002|Part 2|Study Terminated by Sponsor|2|||
27634341|NCT03512756|80503112|FG003|Part 2|Study Terminated by Sponsor|6|||
27634342|NCT03512756|80503109|FG000|Part 2|Protocol Violation|0|||
27634343|NCT03512756|80503110|FG001|Part 2|Protocol Violation|0|||
27634344|NCT03512756|80503111|FG002|Part 2|Protocol Violation|1|||
27634345|NCT03512756|80503112|FG003|Part 2|Protocol Violation|0|||
27634346|NCT03512756|80503109|FG000|Part 2|Withdrawal by Subject|0|||
27634347|NCT03512756|80503110|FG001|Part 2|Withdrawal by Subject|0|||
27634348|NCT03512756|80503111|FG002|Part 2|Withdrawal by Subject|3|||
27634349|NCT03512756|80503112|FG003|Part 2|Withdrawal by Subject|9|||
27634350|NCT05686421|80503115|FG000|Overall Study|Screen failure|22|||
27634351|NCT05686421|80503116|FG001|Overall Study|Screen failure|0|||
27634352|NCT05686421|80503117|FG002|Overall Study|Screen failure|0|||
27634353|NCT05686421|80503118|FG003|Overall Study|Screen failure|0|||
27634354|NCT01259102|80503125|FG000|Overall Study|Adverse Event|1|||
27634355|NCT01259102|80503126|FG001|Overall Study|Adverse Event|0|||
27634356|NCT01259102|80503127|FG002|Overall Study|Adverse Event|1|||
27634357|NCT01259102|80503128|FG003|Overall Study|Adverse Event|1|||
27634358|NCT01259102|80503129|FG004|Overall Study|Adverse Event|0|||
27634359|NCT01259102|80503125|FG000|Overall Study|Other|0|||
27634360|NCT01259102|80503126|FG001|Overall Study|Other|0|||
27634361|NCT01259102|80503127|FG002|Overall Study|Other|1|||
27634362|NCT01259102|80503128|FG003|Overall Study|Other|1|||
27634363|NCT01259102|80503129|FG004|Overall Study|Other|1|||
27634364|NCT00813904|80503130|FG000|Overall Study|Death|1|||
27634365|NCT00834834|80503131|FG000|Overall Study|Withdrawal by Subject|4|||
27634366|NCT00834834|80503132|FG001|Overall Study|Withdrawal by Subject|3|||
27634367|NCT02425111|80503133|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
27634368|NCT02425111|80503133|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
27634369|NCT02425111|80503133|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
27634370|NCT02425111|80503133|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
27918316|NCT01386606|81539636|FG002|Overall Study|Subject incarcerated|0|||
27634371|NCT02425111|80503133|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
27634372|NCT02425111|80503133|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
27634373|NCT00258895|80503142|FG000|Overall Study|Lost to Follow-up|3|||
27918317|NCT01386606|81539637|FG003|Overall Study|Subject incarcerated|0|||
27634374|NCT00258895|80503143|FG001|Overall Study|Lost to Follow-up|1|||
27634375|NCT00258895|80503142|FG000|Overall Study|Protocol Violation|6|||
27634376|NCT00258895|80503143|FG001|Overall Study|Protocol Violation|2|||
27634377|NCT00258895|80503142|FG000|Overall Study|Withdrawal by Subject|1|||
27634378|NCT00258895|80503143|FG001|Overall Study|Withdrawal by Subject|0|||
27634379|NCT03380390|80503144|FG000|Overall Study|Adverse Event|3|||
27634380|NCT00172185|80503145|FG000|Overall Study|Adverse Event|0|||
27634381|NCT00172185|80503146|FG001|Overall Study|Adverse Event|1|||
27634382|NCT00172185|80503147|FG002|Overall Study|Adverse Event|3|||
27634383|NCT00172185|80503148|FG003|Overall Study|Adverse Event|4|||
27634384|NCT00172185|80503145|FG000|Overall Study|Physician Decision|0|||
27634385|NCT00172185|80503146|FG001|Overall Study|Physician Decision|0|||
27634386|NCT00172185|80503147|FG002|Overall Study|Physician Decision|1|||
27634387|NCT00172185|80503148|FG003|Overall Study|Physician Decision|0|||
27634388|NCT00172185|80503145|FG000|Overall Study|SPONSOR Decision|0|||
27634389|NCT00172185|80503146|FG001|Overall Study|SPONSOR Decision|1|||
27634390|NCT00172185|80503147|FG002|Overall Study|SPONSOR Decision|0|||
27634391|NCT00172185|80503148|FG003|Overall Study|SPONSOR Decision|0|||
27634392|NCT00172185|80503145|FG000|Overall Study|Withdrawal by Subject|0|||
27634393|NCT00172185|80503146|FG001|Overall Study|Withdrawal by Subject|0|||
27634394|NCT00172185|80503147|FG002|Overall Study|Withdrawal by Subject|1|||
27634395|NCT00172185|80503148|FG003|Overall Study|Withdrawal by Subject|0|||
27634396|NCT00801983|80503149|FG000|Period 1|Lost to Follow-up|2|||
27634397|NCT00801983|80503150|FG001|Period 1|Lost to Follow-up|0|||
27634398|NCT00801983|80503149|FG000|Period 1|Withdrawal by Subject|2|||
27634399|NCT00801983|80503150|FG001|Period 1|Withdrawal by Subject|8|||
27634400|NCT00801983|80503149|FG000|Period 2|Withdrawal by Subject|2|||
27634401|NCT00801983|80503150|FG001|Period 2|Withdrawal by Subject|1|||
27634402|NCT04740164|80503152|FG000|Overall Study|Lack of Efficacy|4|||
27634403|NCT04740164|80503153|FG001|Overall Study|Lack of Efficacy|0|||
27634404|NCT04740164|80503152|FG000|Overall Study|Physician Decision|3|||
27634405|NCT04740164|80503153|FG001|Overall Study|Physician Decision|3|||
27634406|NCT02670525|80503160|FG000|Overall Study|Death|94|||
27634407|NCT02670525|80503161|FG001|Overall Study|Death|14|||
27634408|NCT02670525|80503160|FG000|Overall Study|Lost to Follow-up|4|||
27634409|NCT02670525|80503161|FG001|Overall Study|Lost to Follow-up|1|||
27918318|NCT01386606|81539634|FG000|Overall Study|Unable to draw PK|1|||
27918319|NCT01386606|81539635|FG001|Overall Study|Unable to draw PK|0|||
27918320|NCT01386606|81539636|FG002|Overall Study|Unable to draw PK|0|||
27918321|NCT01386606|81539637|FG003|Overall Study|Unable to draw PK|0|||
27918322|NCT01386606|81539634|FG000|Overall Study|T levels too high|0|||
27918323|NCT01386606|81539635|FG001|Overall Study|T levels too high|1|||
27918324|NCT01386606|81539636|FG002|Overall Study|T levels too high|1|||
27918325|NCT01386606|81539637|FG003|Overall Study|T levels too high|0|||
27918326|NCT03191799|81539638|FG000|Overall Study|Withdrawal by Subject|4|||
27918327|NCT03191799|81539638|FG000|Overall Study|Physician Decision|2|||
27539532|NCT01030536|80167151|FG000|Overall Study|Adverse Event|0|||
27539533|NCT01030536|80167152|FG001|Overall Study|Adverse Event|3|||
27539534|NCT01030536|80167153|FG002|Overall Study|Adverse Event|1|||
27539535|NCT01030536|80167154|FG003|Overall Study|Adverse Event|0|||
27539536|NCT01030536|80167155|FG004|Overall Study|Adverse Event|1|||
27539537|NCT01030536|80167151|FG000|Overall Study|Progressive disease|6|||
27539538|NCT01030536|80167152|FG001|Overall Study|Progressive disease|2|||
27539539|NCT01030536|80167153|FG002|Overall Study|Progressive disease|3|||
27539540|NCT01030536|80167154|FG003|Overall Study|Progressive disease|2|||
27539541|NCT01030536|80167155|FG004|Overall Study|Progressive disease|0|||
27539542|NCT01030536|80167151|FG000|Overall Study|Death|0|||
27539543|NCT01030536|80167152|FG001|Overall Study|Death|1|||
27539544|NCT01030536|80167153|FG002|Overall Study|Death|0|||
27539545|NCT01030536|80167154|FG003|Overall Study|Death|0|||
27539546|NCT01030536|80167155|FG004|Overall Study|Death|0|||
27539547|NCT02762578|80167156|FG000|Overall Study|Adverse Event|1|||
27539548|NCT02762578|80167157|FG001|Overall Study|Adverse Event|6|||
27539549|NCT02762578|80167156|FG000|Overall Study|Protocol Violation|4|||
27539550|NCT02762578|80167157|FG001|Overall Study|Protocol Violation|2|||
27539551|NCT02762578|80167156|FG000|Overall Study|Withdrawal by Subject|4|||
27539552|NCT02762578|80167157|FG001|Overall Study|Withdrawal by Subject|2|||
27539553|NCT02762578|80167156|FG000|Overall Study|Unclassified|6|||
27634410|NCT02670525|80503160|FG000|Overall Study|Subject withdrew consent|1|||
27918328|NCT03191799|81539638|FG000|Overall Study|Lost to Follow-up|1|||
27918329|NCT03191799|81539638|FG000|Overall Study|Death|2|||
27634411|NCT02670525|80503161|FG001|Overall Study|Subject withdrew consent|0|||
27634412|NCT02670525|80503160|FG000|Overall Study|Unknown, data entry delayed|123|||
27634413|NCT02670525|80503161|FG001|Overall Study|Unknown, data entry delayed|78|||
27634414|NCT01063036|80503167|FG000|Participants Treated With Study Drug|Adverse Event|1|||
27634415|NCT01063036|80503167|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
27634416|NCT01063036|80503167|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
27634417|NCT01063036|80503167|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
27918330|NCT03669588|81539639|FG000|Overall Study|Adverse Event|1|||
27918331|NCT03669588|81539640|FG001|Overall Study|Adverse Event|0|||
27539554|NCT02762578|80167157|FG001|Overall Study|Unclassified|0|||
27539555|NCT02002091|80167168|FG000|Screening|Lost to Follow-up|10|||
27539556|NCT02002091|80167169|FG001|Screening|Lost to Follow-up|12|||
27740210|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27740211|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27740212|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27740213|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27740214|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27740215|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
27740216|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740217|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
27740218|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
27740219|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740220|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740221|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740222|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740223|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740224|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
27740225|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740226|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
27740227|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740228|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740229|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740230|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740231|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740232|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740233|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
27740234|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740235|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
27740236|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
27740237|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740238|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740239|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740240|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740241|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740242|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
27740243|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740244|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
27740245|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
27740246|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740247|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740248|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740249|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740250|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740251|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
27740252|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740253|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740254|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
27740255|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740256|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740257|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740258|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740259|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740260|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
27740261|NCT01380093|80877441|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740262|NCT01380093|80877442|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740263|NCT01380093|80877443|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
27740264|NCT01380093|80877444|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740265|NCT01380093|80877445|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740266|NCT01380093|80877446|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740267|NCT01380093|80877447|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740268|NCT01380093|80877448|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740269|NCT01380093|80877449|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
27740270|NCT01380093|80877441|FG000|Treatment Phase: Second Intervention|Other|0|||
27740271|NCT01380093|80877442|FG001|Treatment Phase: Second Intervention|Other|0|||
27740272|NCT01380093|80877443|FG002|Treatment Phase: Second Intervention|Other|0|||
27740273|NCT01380093|80877444|FG003|Treatment Phase: Second Intervention|Other|1|||
27740274|NCT01380093|80877445|FG004|Treatment Phase: Second Intervention|Other|0|||
27539557|NCT02002091|80167168|FG000|Screening|Death|3|||
27740275|NCT01380093|80877446|FG005|Treatment Phase: Second Intervention|Other|0|||
27740276|NCT01380093|80877447|FG006|Treatment Phase: Second Intervention|Other|0|||
27740277|NCT01380093|80877448|FG007|Treatment Phase: Second Intervention|Other|0|||
27740278|NCT01380093|80877449|FG008|Treatment Phase: Second Intervention|Other|0|||
27740279|NCT01380093|80877441|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
27740280|NCT01380093|80877442|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
27740281|NCT01380093|80877443|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
27740282|NCT01380093|80877444|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
27740283|NCT01380093|80877445|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
27740284|NCT01380093|80877446|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
27740285|NCT01380093|80877447|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
27740286|NCT01380093|80877448|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
27740287|NCT01380093|80877449|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
27740288|NCT01380093|80877441|FG000|Treatment Phase: Third Intervention|Other|0|||
27740289|NCT01380093|80877442|FG001|Treatment Phase: Third Intervention|Other|0|||
27740290|NCT01380093|80877443|FG002|Treatment Phase: Third Intervention|Other|0|||
27740291|NCT01380093|80877444|FG003|Treatment Phase: Third Intervention|Other|0|||
27740292|NCT01380093|80877445|FG004|Treatment Phase: Third Intervention|Other|0|||
27740293|NCT01380093|80877446|FG005|Treatment Phase: Third Intervention|Other|0|||
27740294|NCT01380093|80877447|FG006|Treatment Phase: Third Intervention|Other|0|||
27740295|NCT01380093|80877448|FG007|Treatment Phase: Third Intervention|Other|0|||
27740296|NCT01380093|80877449|FG008|Treatment Phase: Third Intervention|Other|1|||
27740297|NCT02559505|80877450|FG000|Overall Study|Lost to Follow-up|23|||
27740298|NCT02559505|80877451|FG001|Overall Study|Lost to Follow-up|20|||
27740299|NCT02559505|80877450|FG000|Overall Study|Withdrawal by Subject|4|||
27740300|NCT02559505|80877451|FG001|Overall Study|Withdrawal by Subject|2|||
27740301|NCT03825042|80877456|FG000|Overall Study|Adverse Event|1|||
27740302|NCT03825042|80877457|FG001|Overall Study|Adverse Event|0|||
27740303|NCT03825042|80877456|FG000|Overall Study|Withdrawal by Subject|1|||
27740304|NCT03825042|80877457|FG001|Overall Study|Withdrawal by Subject|0|||
27740305|NCT01318902|80877458|FG000|Overall Study|Symptomatic Deterioration|0|||
27740306|NCT01318902|80877459|FG001|Overall Study|Symptomatic Deterioration|1|||
27740307|NCT01318902|80877460|FG002|Overall Study|Symptomatic Deterioration|1|||
27740308|NCT01318902|80877461|FG003|Overall Study|Symptomatic Deterioration|2|||
27740309|NCT01318902|80877458|FG000|Overall Study|Withdrawal by Patient|0|||
27740310|NCT01318902|80877459|FG001|Overall Study|Withdrawal by Patient|1|||
27740311|NCT01318902|80877460|FG002|Overall Study|Withdrawal by Patient|0|||
27740312|NCT01318902|80877461|FG003|Overall Study|Withdrawal by Patient|3|||
27740313|NCT01318902|80877458|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
27740314|NCT01318902|80877459|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
27740315|NCT01318902|80877460|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27740316|NCT01318902|80877461|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
27740317|NCT01318902|80877458|FG000|Overall Study|Adverse Event|0|||
27740318|NCT01318902|80877459|FG001|Overall Study|Adverse Event|1|||
27740319|NCT01318902|80877460|FG002|Overall Study|Adverse Event|0|||
27740320|NCT01318902|80877461|FG003|Overall Study|Adverse Event|0|||
27740321|NCT01318902|80877458|FG000|Overall Study|Terminated by Sponsor|0|||
27740322|NCT01318902|80877459|FG001|Overall Study|Terminated by Sponsor|0|||
27740323|NCT01318902|80877460|FG002|Overall Study|Terminated by Sponsor|1|||
27740324|NCT01318902|80877461|FG003|Overall Study|Terminated by Sponsor|0|||
27740325|NCT03088605|80877471|FG000|Overall Study|Withdrawal by Subject|1|||
27740326|NCT03088605|80877472|FG001|Overall Study|Withdrawal by Subject|0|||
27740327|NCT02243176|80877473|FG000|Overall Study|Other reason|1|||
27740328|NCT02243176|80877474|FG001|Overall Study|Other reason|2|||
27740329|NCT02243176|80877473|FG000|Overall Study|protocol specified withdrawal critera|1|||
27740330|NCT02243176|80877474|FG001|Overall Study|protocol specified withdrawal critera|3|||
27740331|NCT02243176|80877473|FG000|Overall Study|Protocol Violation|2|||
27740332|NCT02243176|80877474|FG001|Overall Study|Protocol Violation|1|||
27740333|NCT02243176|80877473|FG000|Overall Study|Withdrawal by Subject|8|||
27740334|NCT02243176|80877474|FG001|Overall Study|Withdrawal by Subject|7|||
27740335|NCT02243176|80877473|FG000|Overall Study|Adverse Event|2|||
27740336|NCT02243176|80877474|FG001|Overall Study|Adverse Event|2|||
27740337|NCT02795156|80877475|FG000|Overall Study|Progressive Disease|22|||
27740338|NCT02795156|80877476|FG001|Overall Study|Progressive Disease|7|||
27740339|NCT02795156|80877477|FG002|Overall Study|Progressive Disease|34|||
27918332|NCT03669588|81539639|FG000|Overall Study|Physician Decision|0|||
27740340|NCT02795156|80877478|FG003|Overall Study|Progressive Disease|7|||
27740341|NCT02795156|80877475|FG000|Overall Study|Adverse Event|13|||
27740342|NCT02795156|80877476|FG001|Overall Study|Adverse Event|2|||
27740343|NCT02795156|80877477|FG002|Overall Study|Adverse Event|3|||
27740344|NCT02795156|80877478|FG003|Overall Study|Adverse Event|2|||
27740345|NCT02795156|80877475|FG000|Overall Study|Death|1|||
27740346|NCT02795156|80877476|FG001|Overall Study|Death|1|||
27740347|NCT02795156|80877477|FG002|Overall Study|Death|1|||
27740348|NCT02795156|80877478|FG003|Overall Study|Death|0|||
27740349|NCT02795156|80877475|FG000|Overall Study|Physician Decision|1|||
27740350|NCT02795156|80877476|FG001|Overall Study|Physician Decision|0|||
27740351|NCT02795156|80877477|FG002|Overall Study|Physician Decision|1|||
27740352|NCT02795156|80877478|FG003|Overall Study|Physician Decision|0|||
27740353|NCT02795156|80877475|FG000|Overall Study|Withdrawal by Subject|2|||
27740354|NCT02795156|80877476|FG001|Overall Study|Withdrawal by Subject|0|||
27740355|NCT02795156|80877477|FG002|Overall Study|Withdrawal by Subject|3|||
27740356|NCT02795156|80877478|FG003|Overall Study|Withdrawal by Subject|0|||
27740357|NCT03941548|80877482|FG000|Overall Study|Adverse Event|0|||
27740358|NCT03941548|80877483|FG001|Overall Study|Adverse Event|1|||
27740359|NCT03941548|80877482|FG000|Overall Study|Lost to Follow-up|0|||
27740360|NCT03941548|80877483|FG001|Overall Study|Lost to Follow-up|1|||
27740361|NCT03941548|80877482|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
27740362|NCT03941548|80877483|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
27740363|NCT00707577|80877484|FG000|Overall Study|Withdrawal by Subject|3|||
27740364|NCT00707577|80877485|FG001|Overall Study|Withdrawal by Subject|2|||
27740365|NCT00707577|80877484|FG000|Overall Study|Lost to Follow-up|34|||
27740366|NCT00707577|80877485|FG001|Overall Study|Lost to Follow-up|25|||
27740367|NCT00707577|80877484|FG000|Overall Study|Left employment|13|||
27740368|NCT00707577|80877485|FG001|Overall Study|Left employment|10|||
27740369|NCT00707577|80877484|FG000|Overall Study|Pregnancy|4|||
27740370|NCT00707577|80877485|FG001|Overall Study|Pregnancy|1|||
27740371|NCT00091793|80877490|FG000|Overall Study|Adverse Event|1|||
27740372|NCT00091793|80877491|FG001|Overall Study|Adverse Event|2|||
27740373|NCT00091793|80877490|FG000|Overall Study|Withdrawal by Subject|10|||
27740374|NCT00091793|80877491|FG001|Overall Study|Withdrawal by Subject|15|||
27740375|NCT00091793|80877490|FG000|Overall Study|Ineligibility determined|2|||
27740376|NCT00091793|80877491|FG001|Overall Study|Ineligibility determined|0|||
27740377|NCT00091793|80877490|FG000|Overall Study|Lost to Follow-up|7|||
27539558|NCT02002091|80167169|FG001|Screening|Death|2|||
27539559|NCT01622231|80167171|FG000|Overall Study|Physician Decision|1|||
27539560|NCT01622231|80167171|FG000|Overall Study|Withdrawal by Subject|1|||
27539561|NCT00983437|80167172|FG000|Overall Study|Adverse Event|9|||
27539562|NCT00983437|80167172|FG000|Overall Study|Lack of Efficacy|1|||
27539563|NCT00983437|80167172|FG000|Overall Study|Withdrawal by Subject|8|||
27539564|NCT00983437|80167172|FG000|Overall Study|Noncompliance to Study Procedures|1|||
27539565|NCT00983437|80167172|FG000|Overall Study|Lost to Follow-up|2|||
27539566|NCT00983437|80167172|FG000|Overall Study|Other Reason|26|||
27539567|NCT00293033|80167173|FG000|Open-label Titration Period|Adverse Event|10|||
27539568|NCT00293033|80167173|FG000|Open-label Titration Period|Death|3|||
27539569|NCT00293033|80167173|FG000|Open-label Titration Period|Lack of Efficacy|5|||
27539570|NCT00293033|80167173|FG000|Open-label Titration Period|Protocol Violation|2|||
27539571|NCT00293033|80167173|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
27539572|NCT00293033|80167173|FG000|Open-label Titration Period|Noncompliance and other|27|||
27539573|NCT00293033|80167173|FG000|Double-blind Treatment Period|Adverse Event|3|||
27539574|NCT00293033|80167173|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
27539575|NCT00293033|80167173|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
27918333|NCT03669588|81539640|FG001|Overall Study|Physician Decision|1|||
27918334|NCT03669588|81539639|FG000|Overall Study|Protocol Violation|1|||
27740378|NCT00091793|80877491|FG001|Overall Study|Lost to Follow-up|5|||
27740379|NCT00091793|80877490|FG000|Overall Study|Noncompliance|2|||
27740380|NCT00091793|80877491|FG001|Overall Study|Noncompliance|0|||
27740381|NCT00091793|80877490|FG000|Overall Study|Other|2|||
27740382|NCT00091793|80877491|FG001|Overall Study|Other|0|||
27740383|NCT04101422|80877492|FG000|Overall Study|Ineligible|1|||
27740384|NCT04101422|80877493|FG001|Overall Study|Ineligible|0|||
27740385|NCT04101422|80877494|FG002|Overall Study|Ineligible|9|||
27918335|NCT03669588|81539640|FG001|Overall Study|Protocol Violation|0|||
27539576|NCT00293033|80167173|FG000|Double-blind Treatment Period|Noncompliance|4|||
27539577|NCT02243696|80167178|FG000|Overall Study|Death|282|||
27539578|NCT02243696|80167178|FG000|Overall Study|Withdrawal by Subject|79|||
27539579|NCT02243696|80167178|FG000|Overall Study|Lost to Follow-up|57|||
27634418|NCT01063036|80503167|FG000|Participants Treated With Study Drug|Pregnancy|1|||
27634419|NCT01063036|80503167|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
27740386|NCT04101422|80877495|FG003|Overall Study|Ineligible|0|||
27740387|NCT04101422|80877492|FG000|Overall Study|Withdrawal by Subject|0|||
27740388|NCT04101422|80877493|FG001|Overall Study|Withdrawal by Subject|0|||
27740389|NCT04101422|80877494|FG002|Overall Study|Withdrawal by Subject|1|||
27918336|NCT03669588|81539639|FG000|Overall Study|Sponsor Decision|1|||
27539580|NCT02243696|80167178|FG000|Overall Study|Subject No Longer has Study System|42|||
27539581|NCT02243696|80167178|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
27539582|NCT02243696|80167178|FG000|Overall Study|Study Terminated for EP PASSION|961|||
27740390|NCT04101422|80877495|FG003|Overall Study|Withdrawal by Subject|0|||
27740391|NCT04101422|80877492|FG000|Overall Study|Not attending to the stimuli|0|||
27740392|NCT04101422|80877493|FG001|Overall Study|Not attending to the stimuli|0|||
27740393|NCT04101422|80877494|FG002|Overall Study|Not attending to the stimuli|4|||
27918337|NCT03669588|81539640|FG001|Overall Study|Sponsor Decision|1|||
27740394|NCT04101422|80877495|FG003|Overall Study|Not attending to the stimuli|0|||
27740395|NCT04101422|80877492|FG000|Overall Study|Did not download app|0|||
27740396|NCT04101422|80877493|FG001|Overall Study|Did not download app|0|||
27740397|NCT04101422|80877494|FG002|Overall Study|Did not download app|0|||
27740398|NCT04101422|80877495|FG003|Overall Study|Did not download app|17|||
27740399|NCT04101422|80877492|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
27740400|NCT04101422|80877493|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
27740401|NCT04101422|80877494|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
27740402|NCT04101422|80877495|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
27539583|NCT03641339|80167181|FG000|Overall Study|Physician Decision|1|||
27539584|NCT03641339|80167182|FG001|Overall Study|Physician Decision|0|||
27539585|NCT03641339|80167183|FG002|Overall Study|Physician Decision|0|||
27539586|NCT03641339|80167184|FG003|Overall Study|Physician Decision|0|||
27539587|NCT03641339|80167185|FG004|Overall Study|Physician Decision|0|||
27539588|NCT03641339|80167186|FG005|Overall Study|Physician Decision|0|||
27539589|NCT03641339|80167181|FG000|Overall Study|Withdrawal by Subject|0|||
27539590|NCT03641339|80167182|FG001|Overall Study|Withdrawal by Subject|2|||
27539591|NCT03641339|80167183|FG002|Overall Study|Withdrawal by Subject|0|||
27634420|NCT01063036|80503167|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
27634421|NCT01063036|80503167|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
27634422|NCT03691428|80503168|FG000|Overall Study|Withdrawal by Subject|6|||
27634423|NCT03691428|80503169|FG001|Overall Study|Withdrawal by Subject|8|||
27634424|NCT03781336|80503170|FG000|Overall Study|Withdrawal by Subject|2|||
27634425|NCT03781336|80503171|FG001|Overall Study|Withdrawal by Subject|2|||
27634426|NCT02448446|80503172|FG000|Overall Study|Withdrawal by Subject|1|||
27634427|NCT02448446|80503173|FG001|Overall Study|Withdrawal by Subject|0|||
27634428|NCT01039688|80503174|FG000|Overall Study|Adverse Event|38|||
27634429|NCT01039688|80503175|FG001|Overall Study|Adverse Event|39|||
27634430|NCT01039688|80503176|FG002|Overall Study|Adverse Event|24|||
27634431|NCT01039688|80503174|FG000|Overall Study|Lack of Efficacy|20|||
27634432|NCT01039688|80503175|FG001|Overall Study|Lack of Efficacy|11|||
27634433|NCT01039688|80503176|FG002|Overall Study|Lack of Efficacy|26|||
27634434|NCT01039688|80503174|FG000|Overall Study|Lost to Follow-up|11|||
27634435|NCT01039688|80503175|FG001|Overall Study|Lost to Follow-up|9|||
27634436|NCT01039688|80503176|FG002|Overall Study|Lost to Follow-up|5|||
27634437|NCT01039688|80503174|FG000|Overall Study|Other|13|||
27634438|NCT01039688|80503175|FG001|Overall Study|Other|25|||
27634439|NCT01039688|80503176|FG002|Overall Study|Other|12|||
27634440|NCT01039688|80503174|FG000|Overall Study|Withdrawal by Subject|23|||
27634441|NCT01039688|80503175|FG001|Overall Study|Withdrawal by Subject|27|||
27634442|NCT01039688|80503176|FG002|Overall Study|Withdrawal by Subject|13|||
27634443|NCT01039688|80503174|FG000|Overall Study|Death|2|||
27634444|NCT01039688|80503175|FG001|Overall Study|Death|0|||
27634445|NCT01039688|80503176|FG002|Overall Study|Death|0|||
27634446|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
27634447|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
27634448|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
27634449|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
27634450|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
27634451|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
27634452|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
27634453|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
27634454|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
27634455|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
27634456|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
27634457|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
27634458|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
27634459|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
27634460|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
27634461|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634462|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634463|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
27634464|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27539592|NCT03641339|80167184|FG003|Overall Study|Withdrawal by Subject|2|||
27539593|NCT03641339|80167185|FG004|Overall Study|Withdrawal by Subject|0|||
27634465|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27918338|NCT03669588|81539639|FG000|Overall Study|Withdrawal by Subject|1|||
27539594|NCT03641339|80167186|FG005|Overall Study|Withdrawal by Subject|1|||
27634466|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634467|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634468|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634469|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634470|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27740403|NCT00642616|80877502|FG000|Overall Study|Adverse Event|2|||
27740404|NCT00642616|80877503|FG001|Overall Study|Adverse Event|0|||
27740405|NCT00642616|80877504|FG002|Overall Study|Adverse Event|1|||
27740406|NCT00642616|80877505|FG003|Overall Study|Adverse Event|0|||
27740407|NCT00642616|80877502|FG000|Overall Study|Study Terminated by Sponsor|7|||
27740408|NCT00642616|80877503|FG001|Overall Study|Study Terminated by Sponsor|6|||
27740409|NCT00642616|80877504|FG002|Overall Study|Study Terminated by Sponsor|4|||
27740410|NCT00642616|80877505|FG003|Overall Study|Study Terminated by Sponsor|5|||
27740411|NCT00642616|80877502|FG000|Overall Study|Withdrawal by Subject|0|||
27740412|NCT00642616|80877503|FG001|Overall Study|Withdrawal by Subject|1|||
27740413|NCT00642616|80877504|FG002|Overall Study|Withdrawal by Subject|1|||
27740414|NCT00642616|80877505|FG003|Overall Study|Withdrawal by Subject|1|||
27740415|NCT00642616|80877502|FG000|Overall Study|Protocol Violation|0|||
27740416|NCT00642616|80877503|FG001|Overall Study|Protocol Violation|0|||
27740417|NCT00642616|80877504|FG002|Overall Study|Protocol Violation|2|||
27740418|NCT00642616|80877505|FG003|Overall Study|Protocol Violation|0|||
27740419|NCT00642616|80877502|FG000|Overall Study|Physician Decision|0|||
27740420|NCT00642616|80877503|FG001|Overall Study|Physician Decision|0|||
27740421|NCT00642616|80877504|FG002|Overall Study|Physician Decision|1|||
27740422|NCT00642616|80877505|FG003|Overall Study|Physician Decision|1|||
27740423|NCT00872898|80877506|FG000|Part Two - Double Blind|Adverse Event|4|||
27740424|NCT00872898|80877507|FG001|Part Two - Double Blind|Adverse Event|3|||
27740425|NCT00872898|80877506|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
27740426|NCT00872898|80877507|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
27740427|NCT00872898|80877506|FG000|Part Two - Double Blind|Protocol Violation|1|||
27740428|NCT00872898|80877507|FG001|Part Two - Double Blind|Protocol Violation|0|||
27740429|NCT00872898|80877506|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
27539595|NCT00199875|80167189|FG000|Overall Study|Withdrawal by Subject|0|||
27539596|NCT00199875|80167190|FG001|Overall Study|Withdrawal by Subject|0|||
27539597|NCT00199875|80167191|FG002|Overall Study|Withdrawal by Subject|0|||
27539598|NCT00199875|80167192|FG003|Overall Study|Withdrawal by Subject|0|||
27539599|NCT00199875|80167193|FG004|Overall Study|Withdrawal by Subject|1|||
27539600|NCT01449539|80171552|FG000|Overall Study|Withdrawal by Subject|3|||
27539601|NCT01449539|80171552|FG000|Overall Study|Toxicity not study related|1|||
27539602|NCT00722423|80171553|FG000|Overall Study|Protocol Violation|0|||
27539603|NCT00722423|80171554|FG001|Overall Study|Protocol Violation|1|||
27539604|NCT02191137|80171555|FG000|Treatment|Death|4|||
27539605|NCT02191137|80171555|FG000|Treatment|Withdrawal by Subject|3|||
27539606|NCT02191137|80171555|FG000|Treatment|Adverse Event|2|||
27539607|NCT02191137|80171555|FG000|Treatment|Other|1|||
27539608|NCT02191137|80171555|FG000|Follow-up|Lost to Follow-up|2|||
27539609|NCT02191137|80171555|FG000|Follow-up|Ongoing/unknown|2|||
27539610|NCT02191137|80171555|FG000|Follow-up|Adverse Event|1|||
27539611|NCT00850343|80171557|FG000|Overall Study|Withdrawal by Subject|11|||
27539612|NCT00850343|80171558|FG001|Overall Study|Withdrawal by Subject|0|||
27539613|NCT00850343|80171559|FG002|Overall Study|Withdrawal by Subject|3|||
27539614|NCT00850343|80171560|FG003|Overall Study|Withdrawal by Subject|2|||
27539615|NCT00850343|80171557|FG000|Overall Study|Adverse Event|15|||
27539616|NCT00850343|80171558|FG001|Overall Study|Adverse Event|2|||
27539617|NCT00850343|80171559|FG002|Overall Study|Adverse Event|6|||
27539618|NCT00850343|80171560|FG003|Overall Study|Adverse Event|6|||
27539619|NCT00850343|80171557|FG000|Overall Study|Pregnancy|0|||
27539620|NCT00850343|80171558|FG001|Overall Study|Pregnancy|0|||
27539621|NCT00850343|80171559|FG002|Overall Study|Pregnancy|0|||
27539622|NCT00850343|80171560|FG003|Overall Study|Pregnancy|1|||
27539623|NCT00850343|80171557|FG000|Overall Study|Lack of Efficacy|17|||
27539624|NCT00850343|80171558|FG001|Overall Study|Lack of Efficacy|0|||
27539625|NCT00850343|80171559|FG002|Overall Study|Lack of Efficacy|3|||
27539626|NCT00850343|80171560|FG003|Overall Study|Lack of Efficacy|2|||
27539627|NCT00850343|80171557|FG000|Overall Study|Non-compliance with Study Procedures|1|||
27539628|NCT00850343|80171558|FG001|Overall Study|Non-compliance with Study Procedures|0|||
27539629|NCT00850343|80171559|FG002|Overall Study|Non-compliance with Study Procedures|1|||
27539630|NCT00850343|80171560|FG003|Overall Study|Non-compliance with Study Procedures|1|||
27539631|NCT00850343|80171557|FG000|Overall Study|Physician Decision|2|||
27539632|NCT00850343|80171558|FG001|Overall Study|Physician Decision|1|||
27539633|NCT00850343|80171559|FG002|Overall Study|Physician Decision|1|||
27539634|NCT00850343|80171560|FG003|Overall Study|Physician Decision|1|||
27539635|NCT00094172|80171563|FG000|Overall Study|Adverse Event|0|||
27539636|NCT00094172|80171564|FG001|Overall Study|Adverse Event|1|||
27539637|NCT00094172|80171563|FG000|Overall Study|Lost to Follow-up|2|||
27539638|NCT00094172|80171564|FG001|Overall Study|Lost to Follow-up|0|||
27539639|NCT00094172|80171563|FG000|Overall Study|Protocol Violation|0|||
27539640|NCT00094172|80171564|FG001|Overall Study|Protocol Violation|1|||
27539641|NCT00094172|80171563|FG000|Overall Study|Withdrawal by Subject|10|||
27539642|NCT00094172|80171564|FG001|Overall Study|Withdrawal by Subject|5|||
27539643|NCT00094172|80171563|FG000|Overall Study|Primary endpoint met.|1|||
27539644|NCT00094172|80171564|FG001|Overall Study|Primary endpoint met.|0|||
27539645|NCT00094172|80171563|FG000|Overall Study|Started other MS therapy due to disease|1|||
27539646|NCT00094172|80171564|FG001|Overall Study|Started other MS therapy due to disease|0|||
27539647|NCT02158975|80171566|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
27539648|NCT02693119|80171569|FG000|Open-Label Period|Withdrawal by Subject|0|||
27539649|NCT02693119|80171570|FG001|Open-Label Period|Withdrawal by Subject|1|||
27539650|NCT02110238|80171572|FG000|12 Week Pivotal Phase|Adverse Event|3|||
27539651|NCT02110238|80171573|FG001|12 Week Pivotal Phase|Adverse Event|0|||
27539652|NCT02110238|80171572|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
27539653|NCT02110238|80171573|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
27539654|NCT02110238|80171572|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
27539655|NCT02110238|80171573|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
27740430|NCT00872898|80877507|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
27740431|NCT00872898|80877506|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
27740432|NCT00872898|80877507|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
27740433|NCT00872898|80877506|FG000|Part Two - Double Blind|Other reasons|2|||
27740434|NCT00872898|80877507|FG001|Part Two - Double Blind|Other reasons|0|||
27539656|NCT02110238|80171572|FG000|12 Week Pivotal Phase|Physician Decision|0|||
27740435|NCT01520922|80877509|FG000|Treatment Phase|Physician Decision|2|||
27740436|NCT01520922|80877510|FG001|Treatment Phase|Physician Decision|1|||
27740437|NCT01520922|80877509|FG000|Treatment Phase|Progression|0|||
27918339|NCT03669588|81539640|FG001|Overall Study|Withdrawal by Subject|4|||
27918340|NCT03669588|81539639|FG000|Overall Study|Rescue Therapy Needed|0|||
27918341|NCT03669588|81539640|FG001|Overall Study|Rescue Therapy Needed|1|||
27918342|NCT02823470|81539641|FG000|Overall Study|Adverse Event|1|||
27918343|NCT02823470|81539642|FG001|Overall Study|Adverse Event|0|||
27918344|NCT02823470|81539641|FG000|Overall Study|Study terminated by sponsor|8|||
27918345|NCT02823470|81539642|FG001|Overall Study|Study terminated by sponsor|15|||
27918346|NCT01107925|81539643|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
27918347|NCT01107925|81539644|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27918348|NCT01107925|81539645|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27918349|NCT01107925|81539646|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27918350|NCT01107925|81539647|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
27918351|NCT01107925|81539648|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
27918352|NCT01107925|81539643|FG000|Period 2|Withdrawal by Subject|0|||
27918353|NCT01107925|81539644|FG001|Period 2|Withdrawal by Subject|1|||
27918354|NCT01107925|81539645|FG002|Period 2|Withdrawal by Subject|0|||
27918355|NCT01107925|81539646|FG003|Period 2|Withdrawal by Subject|0|||
27918356|NCT01107925|81539647|FG004|Period 2|Withdrawal by Subject|0|||
27918357|NCT01107925|81539648|FG005|Period 2|Withdrawal by Subject|1|||
27918358|NCT03558516|81539650|FG000|Overall Study|Protocol Violation|2|||
27918359|NCT03558516|81539651|FG001|Overall Study|Protocol Violation|2|||
27918360|NCT00379834|81539652|FG000|Overall Study|Time constraints|2|||
27918361|NCT01022203|81539654|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
27918362|NCT01022203|81539655|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
27918363|NCT01022203|81539654|FG000|Post Treatment Assessment|Physician Decision|2|||
27918364|NCT01022203|81539655|FG001|Post Treatment Assessment|Physician Decision|0|||
27918365|NCT01022203|81539654|FG000|Post Treatment Assessment|Adverse Event|0|||
27740438|NCT01520922|80877510|FG001|Treatment Phase|Progression|2|||
27740439|NCT01520922|80877509|FG000|Treatment Phase|Adverse Event|3|||
27740440|NCT01520922|80877510|FG001|Treatment Phase|Adverse Event|5|||
27740441|NCT01520922|80877509|FG000|Follow up|Lost to Follow-up|0|||
27740442|NCT01520922|80877510|FG001|Follow up|Lost to Follow-up|1|||
27740443|NCT01520922|80877509|FG000|Survival Follow-up|Withdrawal by Subject|1|||
27740444|NCT01520922|80877510|FG001|Survival Follow-up|Withdrawal by Subject|0|||
27740445|NCT03429556|80877516|FG000|Overall Study|Lost to Follow-up|0|||
27740446|NCT03429556|80877517|FG001|Overall Study|Lost to Follow-up|1|||
27740447|NCT03429556|80877518|FG002|Overall Study|Lost to Follow-up|0|||
27918366|NCT01022203|81539655|FG001|Post Treatment Assessment|Adverse Event|2|||
27918367|NCT01022203|81539654|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
27918368|NCT01022203|81539655|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
27539657|NCT02110238|80171573|FG001|12 Week Pivotal Phase|Physician Decision|2|||
27539658|NCT02110238|80171572|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
27539659|NCT02110238|80171573|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
27539660|NCT02110238|80171572|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
27539661|NCT02110238|80171573|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
27539662|NCT02110238|80171572|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
27539663|NCT02110238|80171573|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
27539664|NCT02110238|80171572|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
27539665|NCT02110238|80171573|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
27539666|NCT02110238|80171572|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
27539667|NCT02110238|80171573|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
27740448|NCT03429556|80877519|FG003|Overall Study|Lost to Follow-up|0|||
27740449|NCT01040832|80877520|FG000|Overall Study|Adverse Event|4|||
27740450|NCT01040832|80877521|FG001|Overall Study|Adverse Event|5|||
27918369|NCT00496769|81539656|FG000|Double Blind|>=1 reason assigned per patient|558|||
27918370|NCT00496769|81539657|FG001|Double Blind|>=1 reason assigned per patient|649|||
27918371|NCT00496769|81539658|FG002|Double Blind|>=1 reason assigned per patient|0|||
27918372|NCT00496769|81539656|FG000|Open Label|>=1 reason assigned per patient|0|||
27918373|NCT00496769|81539657|FG001|Open Label|>=1 reason assigned per patient|0|||
27918374|NCT00496769|81539658|FG002|Open Label|>=1 reason assigned per patient|1011|||
27918375|NCT05081388|81539664|FG000|Overall Study|Adverse Event|1|||
27918376|NCT05081388|81539665|FG001|Overall Study|Adverse Event|0|||
27539668|NCT02110238|80171572|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
27539669|NCT02110238|80171573|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
27539670|NCT02110238|80171572|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
27539671|NCT02110238|80171573|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
27539672|NCT00622284|80171574|FG000|Overall Study|Lack of Efficacy|45|||
27539673|NCT00622284|80171575|FG001|Overall Study|Lack of Efficacy|15|||
27539674|NCT00622284|80171574|FG000|Overall Study|Adverse Event|61|||
27539675|NCT00622284|80171575|FG001|Overall Study|Adverse Event|90|||
27539676|NCT00622284|80171574|FG000|Overall Study|Protocol Violation|12|||
27740451|NCT01040832|80877520|FG000|Overall Study|Death|4|||
27740452|NCT01040832|80877521|FG001|Overall Study|Death|6|||
27740453|NCT01040832|80877520|FG000|Overall Study|Withdrawal by Subject|2|||
27740454|NCT01040832|80877521|FG001|Overall Study|Withdrawal by Subject|3|||
27740455|NCT01040832|80877520|FG000|Overall Study|Progressive disease|32|||
27740456|NCT01040832|80877521|FG001|Overall Study|Progressive disease|17|||
27740457|NCT01040832|80877520|FG000|Overall Study|Symptomatic deterioration|2|||
27740458|NCT01040832|80877521|FG001|Overall Study|Symptomatic deterioration|5|||
27740459|NCT01040832|80877520|FG000|Overall Study|Other|2|||
27740460|NCT01040832|80877521|FG001|Overall Study|Other|1|||
27740461|NCT00893789|80877524|FG000|Overall Study|Withdrawal by Subject|3|||
27740462|NCT00893789|80877525|FG001|Overall Study|Withdrawal by Subject|1|||
27740463|NCT00893789|80877526|FG002|Overall Study|Withdrawal by Subject|3|||
27740464|NCT00893789|80877527|FG003|Overall Study|Withdrawal by Subject|1|||
27740465|NCT00893789|80877524|FG000|Overall Study|Noncompliance With Study Drug|1|||
27740466|NCT00893789|80877525|FG001|Overall Study|Noncompliance With Study Drug|0|||
27740467|NCT00893789|80877526|FG002|Overall Study|Noncompliance With Study Drug|1|||
27918377|NCT05081388|81539666|FG002|Overall Study|Adverse Event|0|||
27918378|NCT05081388|81539667|FG003|Overall Study|Adverse Event|0|||
27918379|NCT05081388|81539668|FG004|Overall Study|Adverse Event|0|||
27918380|NCT05081388|81539664|FG000|Overall Study|Lost to Follow-up|0|||
27918381|NCT05081388|81539665|FG001|Overall Study|Lost to Follow-up|1|||
27918382|NCT05081388|81539666|FG002|Overall Study|Lost to Follow-up|0|||
27918383|NCT05081388|81539667|FG003|Overall Study|Lost to Follow-up|0|||
27918384|NCT05081388|81539668|FG004|Overall Study|Lost to Follow-up|0|||
27918385|NCT05081388|81539664|FG000|Overall Study|Subject decision|0|||
27918386|NCT05081388|81539665|FG001|Overall Study|Subject decision|0|||
27918387|NCT05081388|81539666|FG002|Overall Study|Subject decision|0|||
27918388|NCT05081388|81539667|FG003|Overall Study|Subject decision|1|||
27918389|NCT05081388|81539668|FG004|Overall Study|Subject decision|0|||
27918390|NCT00297167|81539671|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
27918391|NCT00297167|81539672|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
27918392|NCT00297167|81539673|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
27918393|NCT00297167|81539671|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
27918394|NCT00297167|81539672|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
27918395|NCT00297167|81539673|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
27918396|NCT01814007|81539674|FG000|Overall Study|Withdrawal by Subject|1|||
27918397|NCT00116688|81539677|FG000|Overall Study|Protocol deviation|1|||
27918398|NCT00116688|81539678|FG001|Overall Study|Protocol deviation|0|||
27918399|NCT00116688|81539677|FG000|Overall Study|Noncompliance|3|||
27918400|NCT00116688|81539678|FG001|Overall Study|Noncompliance|1|||
27918401|NCT00116688|81539677|FG000|Overall Study|Adverse Event|11|||
27918402|NCT00116688|81539678|FG001|Overall Study|Adverse Event|0|||
27918403|NCT00116688|81539677|FG000|Overall Study|Withdrawal by Subject|26|||
27740468|NCT00893789|80877527|FG003|Overall Study|Noncompliance With Study Drug|2|||
27740469|NCT00893789|80877524|FG000|Overall Study|Noncompliance With Study Procedures|1|||
27918404|NCT00116688|81539678|FG001|Overall Study|Withdrawal by Subject|2|||
27918405|NCT00116688|81539677|FG000|Overall Study|Requirement for alternative therapy|11|||
27918406|NCT00116688|81539678|FG001|Overall Study|Requirement for alternative therapy|1|||
27918407|NCT00116688|81539677|FG000|Overall Study|Physician Decision|7|||
27918408|NCT00116688|81539678|FG001|Overall Study|Physician Decision|0|||
27918409|NCT00116688|81539677|FG000|Overall Study|Lost to Follow-up|3|||
27918410|NCT00116688|81539678|FG001|Overall Study|Lost to Follow-up|0|||
27918411|NCT00116688|81539677|FG000|Overall Study|Death|15|||
27918412|NCT00116688|81539678|FG001|Overall Study|Death|0|||
27918413|NCT00116688|81539677|FG000|Overall Study|Protocol-specified criteria|3|||
27918414|NCT00116688|81539678|FG001|Overall Study|Protocol-specified criteria|0|||
27539677|NCT00622284|80171575|FG001|Overall Study|Protocol Violation|5|||
27539678|NCT00622284|80171574|FG000|Overall Study|Lost to Follow-up|11|||
27740470|NCT00893789|80877525|FG001|Overall Study|Noncompliance With Study Procedures|0|||
27740471|NCT00893789|80877526|FG002|Overall Study|Noncompliance With Study Procedures|0|||
27740472|NCT00893789|80877527|FG003|Overall Study|Noncompliance With Study Procedures|0|||
27740473|NCT00893789|80877524|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
27740474|NCT00893789|80877525|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
27740475|NCT00893789|80877526|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
27740476|NCT00893789|80877527|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
27740477|NCT00893789|80877524|FG000|Overall Study|Adverse Event|0|||
27740478|NCT00893789|80877525|FG001|Overall Study|Adverse Event|2|||
27740479|NCT00893789|80877526|FG002|Overall Study|Adverse Event|1|||
27740480|NCT00893789|80877527|FG003|Overall Study|Adverse Event|5|||
27740481|NCT00893789|80877524|FG000|Overall Study|Protocol Violation|0|||
27740482|NCT00893789|80877525|FG001|Overall Study|Protocol Violation|1|||
27740483|NCT00893789|80877526|FG002|Overall Study|Protocol Violation|1|||
27740484|NCT00893789|80877527|FG003|Overall Study|Protocol Violation|4|||
27740485|NCT00893789|80877524|FG000|Overall Study|Lost to Follow-up|0|||
27740486|NCT00893789|80877525|FG001|Overall Study|Lost to Follow-up|0|||
27740487|NCT00893789|80877526|FG002|Overall Study|Lost to Follow-up|0|||
27740488|NCT00893789|80877527|FG003|Overall Study|Lost to Follow-up|1|||
27740489|NCT04090164|80877532|FG000|Overall Study|incomplete data on file|245|||
27740490|NCT04090164|80877533|FG001|Overall Study|incomplete data on file|0|||
27740491|NCT03114969|80877534|FG000|Overall Study|Lost to Follow-up|0|||
27740492|NCT03114969|80877535|FG001|Overall Study|Lost to Follow-up|0|||
27740493|NCT03114969|80877536|FG002|Overall Study|Lost to Follow-up|3|||
27740494|NCT03114969|80877537|FG003|Overall Study|Lost to Follow-up|2|||
27740495|NCT03114969|80877538|FG004|Overall Study|Lost to Follow-up|0|||
27740496|NCT03114969|80877539|FG005|Overall Study|Lost to Follow-up|0|||
27740497|NCT03114969|80877540|FG006|Overall Study|Lost to Follow-up|0|||
27740498|NCT03114969|80877541|FG007|Overall Study|Lost to Follow-up|0|||
27740499|NCT03114969|80877542|FG008|Overall Study|Lost to Follow-up|0|||
27740500|NCT03114969|80877534|FG000|Overall Study|Adverse Event|0|||
27740501|NCT03114969|80877535|FG001|Overall Study|Adverse Event|0|||
27740502|NCT03114969|80877536|FG002|Overall Study|Adverse Event|1|||
27740503|NCT03114969|80877537|FG003|Overall Study|Adverse Event|0|||
27740504|NCT03114969|80877538|FG004|Overall Study|Adverse Event|0|||
27740505|NCT03114969|80877539|FG005|Overall Study|Adverse Event|1|||
27740506|NCT03114969|80877540|FG006|Overall Study|Adverse Event|1|||
27740507|NCT03114969|80877541|FG007|Overall Study|Adverse Event|0|||
27740508|NCT03114969|80877542|FG008|Overall Study|Adverse Event|2|||
27740509|NCT00482001|80877543|FG000|Overall Study|Protocol Violation|1|||
27740510|NCT00482001|80877544|FG001|Overall Study|Protocol Violation|1|||
27740511|NCT00196937|80877550|FG000|Overall Study|Serious Adverse Event|1|||
27740512|NCT00196937|80877551|FG001|Overall Study|Serious Adverse Event|0|||
27740513|NCT00196937|80877552|FG002|Overall Study|Serious Adverse Event|0|||
27740514|NCT00196937|80877550|FG000|Overall Study|Non-serious adverse event|1|||
27740515|NCT00196937|80877551|FG001|Overall Study|Non-serious adverse event|1|||
27740516|NCT00196937|80877552|FG002|Overall Study|Non-serious adverse event|1|||
27740517|NCT00196937|80877550|FG000|Overall Study|Withdrawal by Subject|0|||
27740518|NCT00196937|80877551|FG001|Overall Study|Withdrawal by Subject|0|||
27740519|NCT00196937|80877552|FG002|Overall Study|Withdrawal by Subject|2|||
27740520|NCT00196937|80877550|FG000|Overall Study|Lost to Follow-up|4|||
27740521|NCT00196937|80877551|FG001|Overall Study|Lost to Follow-up|3|||
27539679|NCT00622284|80171575|FG001|Overall Study|Lost to Follow-up|13|||
27539680|NCT00622284|80171574|FG000|Overall Study|Withdrawal by Subject|27|||
27539681|NCT00622284|80171575|FG001|Overall Study|Withdrawal by Subject|24|||
27539682|NCT00622284|80171574|FG000|Overall Study|Other reason (not specified)|33|||
27539683|NCT00622284|80171575|FG001|Overall Study|Other reason (not specified)|24|||
27539684|NCT00457301|80171576|FG000|Overall Study|Withdrawal by Subject|3|||
27740522|NCT00196937|80877552|FG002|Overall Study|Lost to Follow-up|3|||
27740523|NCT00196937|80877550|FG000|Overall Study|Other|3|||
27740524|NCT00196937|80877551|FG001|Overall Study|Other|1|||
27740525|NCT00196937|80877552|FG002|Overall Study|Other|1|||
27740526|NCT04407507|80877553|FG000|Overall Study|Withdrawal by Subject|0|||
27740527|NCT04407507|80877554|FG001|Overall Study|Withdrawal by Subject|1|||
27740528|NCT02388776|80877558|FG000|Overall Study|Death|1|||
27740529|NCT02388776|80877558|FG000|Overall Study|Lost to Follow-up|1|||
27740530|NCT01821677|80877561|FG000|Overall Study|Adverse Event|4|||
27740531|NCT01821677|80877562|FG001|Overall Study|Adverse Event|6|||
27740532|NCT01821677|80877563|FG002|Overall Study|Adverse Event|5|||
27740533|NCT01821677|80877561|FG000|Overall Study|Physician Decision|1|||
27740534|NCT01821677|80877562|FG001|Overall Study|Physician Decision|4|||
27740535|NCT01821677|80877563|FG002|Overall Study|Physician Decision|1|||
27918415|NCT00116688|81539677|FG000|Overall Study|Pregnancy|1|||
27539685|NCT00457301|80171577|FG001|Overall Study|Withdrawal by Subject|3|||
27539686|NCT00457301|80171576|FG000|Overall Study|Censored out of the study|15|||
27740536|NCT01821677|80877561|FG000|Overall Study|Non-compliance|0|||
27740537|NCT01821677|80877562|FG001|Overall Study|Non-compliance|1|||
27740538|NCT01821677|80877563|FG002|Overall Study|Non-compliance|2|||
27740539|NCT01821677|80877561|FG000|Overall Study|Lost to Follow-up|2|||
27918416|NCT00116688|81539678|FG001|Overall Study|Pregnancy|0|||
27539687|NCT00457301|80171577|FG001|Overall Study|Censored out of the study|14|||
27539688|NCT00457301|80171576|FG000|Overall Study|Death|5|||
27539689|NCT00457301|80171577|FG001|Overall Study|Death|7|||
27539690|NCT01447433|80171578|FG000|Overall Study|Lost to Follow-up|0|||
27740540|NCT01821677|80877562|FG001|Overall Study|Lost to Follow-up|1|||
27740541|NCT01821677|80877563|FG002|Overall Study|Lost to Follow-up|3|||
27740542|NCT01821677|80877561|FG000|Overall Study|Protocol Violation|0|||
27740543|NCT01821677|80877562|FG001|Overall Study|Protocol Violation|0|||
27539691|NCT01447433|80171579|FG001|Overall Study|Lost to Follow-up|2|||
27539692|NCT01447433|80171578|FG000|Overall Study|Withdrawal by Subject|3|||
27539693|NCT01447433|80171579|FG001|Overall Study|Withdrawal by Subject|3|||
27918417|NCT00116688|81539677|FG000|Overall Study|Other|11|||
27918418|NCT00116688|81539678|FG001|Overall Study|Other|0|||
27918419|NCT03608826|81539679|FG000|Overall Study|Death|3|||
27918420|NCT03608826|81539679|FG000|Overall Study|Heart Transplant|3|||
27918421|NCT03608826|81539679|FG000|Overall Study|Physician Decision|4|||
27918422|NCT02163395|81539680|FG000|Overall Study|Withdrawal by Subject|1|||
27918423|NCT02163395|81539680|FG000|Overall Study|Lost to Follow-up|3|||
27918424|NCT02163395|81539680|FG000|Overall Study|Adverse Event|1|||
27918425|NCT03150082|81539681|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
27918426|NCT03150082|81539682|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
27918427|NCT03316586|81539683|FG000|Overall Study|Adverse Event|2|||
27918428|NCT03316586|81539683|FG000|Overall Study|Physician Decision|3|||
27918429|NCT03316586|81539683|FG000|Overall Study|Lack of Efficacy|10|||
27918430|NCT03316586|81539683|FG000|Overall Study|still on treatment|1|||
27539694|NCT01447433|80171578|FG000|Overall Study|Protocol Violation|1|||
27539695|NCT01447433|80171579|FG001|Overall Study|Protocol Violation|1|||
27539696|NCT00450255|80171580|FG000|Overall Study|Prior RFA ablation of liver|1|||
27539697|NCT01409434|80171581|FG000|Overall Study|Protocol Violation|4|||
27539698|NCT00508755|80171582|FG000|Overall Study|Withdrawal by Subject|1|||
27539699|NCT00736944|80171583|FG000|Induction|Death|1|||
27539700|NCT00736944|80171583|FG000|Definitive Treatment|Physician Decision|1|||
27539701|NCT00492531|80171588|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
27539702|NCT00492531|80171589|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
27539703|NCT04478266|80171590|FG000|Overall Study|Adverse Event|20|||
27539704|NCT04478266|80171591|FG001|Overall Study|Adverse Event|21|||
27539705|NCT04478266|80171590|FG000|Overall Study|Progressive disease|146|||
27634471|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
27634472|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
27634473|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
27634474|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
27634475|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
27634476|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
27634477|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
27634478|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
27634479|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
27634480|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
27634481|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
27634482|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
27634483|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
27634484|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
27634485|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634486|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
27634487|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
27740544|NCT01821677|80877563|FG002|Overall Study|Protocol Violation|2|||
27740545|NCT01821677|80877561|FG000|Overall Study|Withdrawal by Subject|7|||
27740546|NCT01821677|80877562|FG001|Overall Study|Withdrawal by Subject|3|||
27740547|NCT01821677|80877563|FG002|Overall Study|Withdrawal by Subject|2|||
27740548|NCT01821677|80877561|FG000|Overall Study|Other|9|||
27740549|NCT01821677|80877562|FG001|Overall Study|Other|0|||
27740550|NCT01821677|80877563|FG002|Overall Study|Other|0|||
27740551|NCT01426386|80877564|FG000|Overall Study|Adverse Event|0|||
27740552|NCT01426386|80877565|FG001|Overall Study|Adverse Event|1|||
27918431|NCT03316586|81539683|FG000|Overall Study|Patient needed radiation therapy|1|||
27918432|NCT03316586|81539683|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
27918433|NCT03903172|81539684|FG000|Overall Study|screen fail|4|||
27539706|NCT04478266|80171591|FG001|Overall Study|Progressive disease|168|||
27539707|NCT04478266|80171590|FG000|Overall Study|Poor compliance to protocol|1|||
27539708|NCT04478266|80171591|FG001|Overall Study|Poor compliance to protocol|0|||
27539709|NCT04478266|80171590|FG000|Overall Study|Withdrawal by Subject|19|||
27740553|NCT01426386|80877566|FG002|Overall Study|Adverse Event|0|||
27740554|NCT01426386|80877567|FG003|Overall Study|Adverse Event|0|||
27740555|NCT01426386|80877568|FG004|Overall Study|Adverse Event|0|||
27740556|NCT01426386|80877569|FG005|Overall Study|Adverse Event|0|||
27539710|NCT04478266|80171591|FG001|Overall Study|Withdrawal by Subject|16|||
27740557|NCT01426386|80877564|FG000|Overall Study|Did not attend scheduled visit|1|||
27634488|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634489|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
27634490|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634491|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634492|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634493|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634494|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634495|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634496|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634497|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
27634498|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
27634499|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
27634500|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
27634501|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
27634502|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
27634503|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634504|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634505|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634506|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
27634507|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634508|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634509|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634510|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
27634511|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
27634512|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634513|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634514|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634515|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634516|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
27634517|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
27634518|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
27634519|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634520|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634521|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634522|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634523|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
27634524|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
27634525|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
27634526|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
27634527|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
27634528|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
27634529|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
27634530|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
27634531|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
27634532|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
27634533|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
27634534|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
27634535|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
27634536|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
27918434|NCT03903172|81539685|FG001|Overall Study|screen fail|1|||
27918435|NCT01285518|81539688|FG000|Overall Study|Lost to Follow-up|0|||
27634537|NCT04707313|80503180|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27740558|NCT01426386|80877565|FG001|Overall Study|Did not attend scheduled visit|4|||
27740559|NCT01426386|80877566|FG002|Overall Study|Did not attend scheduled visit|0|||
27740560|NCT01426386|80877567|FG003|Overall Study|Did not attend scheduled visit|0|||
27740561|NCT01426386|80877568|FG004|Overall Study|Did not attend scheduled visit|2|||
27740562|NCT01426386|80877569|FG005|Overall Study|Did not attend scheduled visit|1|||
27740563|NCT01426386|80877564|FG000|Overall Study|Poor response|2|||
27740564|NCT01426386|80877565|FG001|Overall Study|Poor response|1|||
27740565|NCT01426386|80877566|FG002|Overall Study|Poor response|2|||
27740566|NCT01426386|80877567|FG003|Overall Study|Poor response|0|||
27740567|NCT01426386|80877568|FG004|Overall Study|Poor response|1|||
27740568|NCT01426386|80877569|FG005|Overall Study|Poor response|0|||
27740569|NCT01426386|80877564|FG000|Overall Study|Personal reasons|0|||
27740570|NCT01426386|80877565|FG001|Overall Study|Personal reasons|0|||
27918436|NCT01285518|81539689|FG001|Overall Study|Lost to Follow-up|0|||
27740571|NCT01426386|80877566|FG002|Overall Study|Personal reasons|0|||
27918437|NCT01285518|81539690|FG002|Overall Study|Lost to Follow-up|0|||
27918438|NCT01285518|81539691|FG003|Overall Study|Lost to Follow-up|0|||
27918439|NCT01285518|81539692|FG004|Overall Study|Lost to Follow-up|0|||
27918440|NCT01285518|81539693|FG005|Overall Study|Lost to Follow-up|1|||
27918441|NCT01285518|81539694|FG006|Overall Study|Lost to Follow-up|0|||
27918442|NCT01285518|81539695|FG007|Overall Study|Lost to Follow-up|0|||
27918443|NCT02087774|81539696|FG000|Overall Study|Were absent day of data collection|8|||
27539711|NCT04478266|80171590|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
27539712|NCT04478266|80171591|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
27539713|NCT04478266|80171590|FG000|Overall Study|Study terminated by sponsor|33|||
27539714|NCT04478266|80171591|FG001|Overall Study|Study terminated by sponsor|35|||
27539715|NCT04478266|80171590|FG000|Overall Study|Other: unspecified|5|||
27539716|NCT04478266|80171591|FG001|Overall Study|Other: unspecified|7|||
27539717|NCT04478266|80171590|FG000|Overall Study|Randomized but not treated|1|||
27539718|NCT04478266|80171591|FG001|Overall Study|Randomized but not treated|1|||
27539719|NCT03750955|80171593|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
27539720|NCT03750955|80171594|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
27539721|NCT03750955|80171593|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
27539722|NCT03750955|80171594|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
27539723|NCT02369016|80171597|FG000|Overall Study|AE associated with clinical disease progression|2|||
27539724|NCT02369016|80171598|FG001|Overall Study|AE associated with clinical disease progression|1|||
27539725|NCT02369016|80171597|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
27539726|NCT02369016|80171598|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
27539727|NCT02369016|80171597|FG000|Overall Study|Progressive disease - clinical progression|1|||
27539728|NCT02369016|80171598|FG001|Overall Study|Progressive disease - clinical progression|4|||
27539729|NCT02369016|80171597|FG000|Overall Study|withdrawal by patient|4|||
27539730|NCT02369016|80171598|FG001|Overall Study|withdrawal by patient|0|||
27539731|NCT02369016|80171597|FG000|Overall Study|Progressive disease - radiological progression|6|||
27539732|NCT02369016|80171598|FG001|Overall Study|Progressive disease - radiological progression|2|||
27539733|NCT01387789|80171599|FG000|Overall Study|Adverse Event|5|||
27539734|NCT01387789|80171599|FG000|Overall Study|Lack of Efficacy|2|||
27539735|NCT01387789|80171599|FG000|Overall Study|Lost to Follow-up|1|||
27539736|NCT00586625|80171600|FG000|Overall Study|Adverse Event|6|||
27539737|NCT00586625|80171601|FG001|Overall Study|Adverse Event|6|||
27539738|NCT00586625|80171600|FG000|Overall Study|Protocol Violation|3|||
27539739|NCT00586625|80171601|FG001|Overall Study|Protocol Violation|0|||
27539740|NCT00586625|80171600|FG000|Overall Study|Withdrawal by Subject|32|||
27539741|NCT00586625|80171601|FG001|Overall Study|Withdrawal by Subject|10|||
27539742|NCT00586625|80171600|FG000|Overall Study|Subject non-compliance|0|||
27539743|NCT00586625|80171601|FG001|Overall Study|Subject non-compliance|1|||
27539744|NCT00586625|80171600|FG000|Overall Study|Subject unable to return for visit|2|||
27539745|NCT00586625|80171601|FG001|Overall Study|Subject unable to return for visit|0|||
27539746|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
27539747|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
27539748|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
27539749|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
27539750|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
27539751|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
27539752|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
27539753|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
27539754|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
27539755|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
27539756|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
27539757|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
27539758|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
27539759|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
27539760|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
27539761|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
27539762|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
27539763|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
27740572|NCT01426386|80877567|FG003|Overall Study|Personal reasons|0|||
27918444|NCT02087774|81539697|FG001|Overall Study|Were absent day of data collection|20|||
27918445|NCT03321721|81539698|FG000|Overall Study|Lost to Follow-up|4|||
27539764|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
27539765|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
27539766|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
27539767|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
27539768|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
27539769|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
27918446|NCT03321721|81539699|FG001|Overall Study|Lost to Follow-up|8|||
27918447|NCT03321721|81539700|FG002|Overall Study|Lost to Follow-up|11|||
27918448|NCT01618968|81539701|FG000|Overall Study|Adverse Event|1|||
27918449|NCT01618968|81539702|FG001|Overall Study|Adverse Event|0|||
27918450|NCT01618968|81539703|FG002|Overall Study|Adverse Event|0|||
27918451|NCT01618968|81539704|FG003|Overall Study|Adverse Event|0|||
27918452|NCT01618968|81539701|FG000|Overall Study|Death|0|||
27918453|NCT01618968|81539702|FG001|Overall Study|Death|0|||
27918454|NCT01618968|81539703|FG002|Overall Study|Death|0|||
27918455|NCT01618968|81539704|FG003|Overall Study|Death|1|||
27918456|NCT01965327|81539707|FG000|Overall Study|Physician Decision|2|||
27918457|NCT00828711|81539708|FG000|Overall Study|Lost to Follow-up|1|||
27918458|NCT00828711|81539709|FG001|Overall Study|Lost to Follow-up|0|||
27918459|NCT00828711|81539710|FG002|Overall Study|Lost to Follow-up|0|||
27918460|NCT03964207|81539711|FG000|First Treatment|Withdrawal by Subject|1|||
27918461|NCT03964207|81539712|FG001|First Treatment|Withdrawal by Subject|2|||
27918462|NCT03964207|81539711|FG000|First Treatment|Protocol Violation|1|||
27918463|NCT03964207|81539712|FG001|First Treatment|Protocol Violation|0|||
27918464|NCT03964207|81539711|FG000|First Treatment|Lost to Follow-up|1|||
27918465|NCT03964207|81539712|FG001|First Treatment|Lost to Follow-up|0|||
27918466|NCT03964207|81539711|FG000|Second Treatment|Lost to Follow-up|0|||
27918467|NCT03964207|81539712|FG001|Second Treatment|Lost to Follow-up|1|||
27918468|NCT03964207|81539711|FG000|Second Treatment|Adverse Event|1|||
27918469|NCT03964207|81539712|FG001|Second Treatment|Adverse Event|2|||
27918470|NCT01178294|81539713|FG000|Overall Study|Adverse Event|4|||
27918471|NCT01178294|81539713|FG000|Overall Study|Lost to Follow-up|2|||
27918472|NCT01178294|81539713|FG000|Overall Study|Lack of Efficacy|1|||
27918473|NCT01178294|81539713|FG000|Overall Study|Death|1|||
27918474|NCT01178294|81539713|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
27918475|NCT01178294|81539713|FG000|Overall Study|Subject status is terminal|1|||
27918476|NCT01178294|81539713|FG000|Overall Study|Completion status could not be verified|1|||
27918477|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
27918478|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
27918479|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918480|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918481|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918482|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918483|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918484|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918485|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918486|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
27918487|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
27918488|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
27539770|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Death|2|||
27539771|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Death|1|||
27539772|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Death|0|||
27539773|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Death|0|||
27539774|NCT02607930|80171608|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
27539775|NCT02607930|80171609|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
27539776|NCT02607930|80171610|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
27539777|NCT02607930|80171611|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
27539778|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
27539779|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
27539780|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
27539781|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
27539782|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
27539783|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
27539784|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
27539785|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
27539786|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
27539787|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
27539788|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
27539789|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
27539790|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
27539791|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
27539792|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
27539793|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
27539794|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
27539795|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
27539796|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
27539797|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
27539798|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
27539799|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
27539800|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
27634538|NCT04707313|80503181|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634539|NCT04707313|80503182|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
27634540|NCT04707313|80503183|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634541|NCT04707313|80503184|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634542|NCT04707313|80503185|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634543|NCT04707313|80503186|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634544|NCT04707313|80503187|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
27634545|NCT04707313|80503188|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634546|NCT04707313|80503189|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634547|NCT04707313|80503190|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634548|NCT04707313|80503191|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634549|NCT04707313|80503192|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
27634550|NCT04707313|80503180|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634551|NCT04707313|80503181|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634552|NCT04707313|80503182|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634553|NCT04707313|80503183|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634554|NCT04707313|80503184|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634555|NCT04707313|80503185|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634556|NCT04707313|80503186|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634557|NCT04707313|80503187|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634558|NCT04707313|80503188|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634559|NCT04707313|80503189|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
27634560|NCT04707313|80503190|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
27634561|NCT04707313|80503191|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
27634562|NCT04707313|80503192|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
27634563|NCT04707313|80503180|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634564|NCT04707313|80503181|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634565|NCT04707313|80503182|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634566|NCT04707313|80503183|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634567|NCT04707313|80503184|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634568|NCT04707313|80503185|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634569|NCT04707313|80503186|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634570|NCT04707313|80503187|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634571|NCT04707313|80503188|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634572|NCT04707313|80503189|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
27634573|NCT04707313|80503190|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
27634574|NCT04707313|80503191|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
27634575|NCT04707313|80503192|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
27634576|NCT04707313|80503180|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634577|NCT04707313|80503181|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634578|NCT04707313|80503182|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634579|NCT04707313|80503183|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634580|NCT04707313|80503184|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634581|NCT04707313|80503185|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634582|NCT04707313|80503186|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634583|NCT04707313|80503187|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634584|NCT04707313|80503188|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
27634585|NCT04707313|80503189|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
27634586|NCT04707313|80503190|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
27634587|NCT04707313|80503191|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
27634588|NCT04707313|80503192|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
27634589|NCT04707313|80503180|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634590|NCT04707313|80503181|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634591|NCT04707313|80503182|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634592|NCT04707313|80503183|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634593|NCT04707313|80503184|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634594|NCT04707313|80503185|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634595|NCT04707313|80503186|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634596|NCT04707313|80503187|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634597|NCT04707313|80503188|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634598|NCT04707313|80503189|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634599|NCT04707313|80503190|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
27634600|NCT04707313|80503191|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
27634601|NCT04707313|80503192|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
27634602|NCT04707313|80503180|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634603|NCT04707313|80503181|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634604|NCT04707313|80503182|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634605|NCT04707313|80503183|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634606|NCT04707313|80503184|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634607|NCT04707313|80503185|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634608|NCT04707313|80503186|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634609|NCT04707313|80503187|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634610|NCT04707313|80503188|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634611|NCT04707313|80503189|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
27634612|NCT04707313|80503190|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
27634613|NCT04707313|80503191|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634614|NCT04707313|80503192|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
27634615|NCT04707313|80503180|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634616|NCT04707313|80503181|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634617|NCT04707313|80503182|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634618|NCT04707313|80503183|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634619|NCT04707313|80503184|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634620|NCT04707313|80503185|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634621|NCT04707313|80503186|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634622|NCT04707313|80503187|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634623|NCT04707313|80503188|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
27634624|NCT04707313|80503189|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
27634625|NCT04707313|80503190|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
27634626|NCT04707313|80503191|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
27634627|NCT04707313|80503192|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
27634628|NCT02553460|80503193|FG000|Overall Study|Death|3|||
27634629|NCT02553460|80503193|FG000|Overall Study|Withdrawal by Subject|1|||
27634630|NCT02553460|80503193|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
27634631|NCT02553460|80503193|FG000|Overall Study|Relapse or Transplant|14|||
27634632|NCT02553460|80503193|FG000|Overall Study|No response to treatment|2|||
27634633|NCT02553460|80503193|FG000|Overall Study|Still on therapy|7|||
27634634|NCT02553460|80503193|FG000|Overall Study|CAR T cells|1|||
27634635|NCT00468910|80503197|FG000|Overall Study|Lost to Follow-up|2|||
27634636|NCT00468910|80503198|FG001|Overall Study|Lost to Follow-up|1|||
27634637|NCT00468910|80503197|FG000|Overall Study|Withdrawal by Subject|2|||
27634638|NCT00468910|80503198|FG001|Overall Study|Withdrawal by Subject|1|||
27634639|NCT00468910|80503197|FG000|Overall Study|Medical Contraindication|0|||
27634640|NCT00468910|80503198|FG001|Overall Study|Medical Contraindication|1|||
27634641|NCT04266795|80503199|FG000|Overall Study|Adverse Event|10|||
27634642|NCT04266795|80503200|FG001|Overall Study|Adverse Event|19|||
27634643|NCT04266795|80503199|FG000|Overall Study|Death|7|||
27634644|NCT04266795|80503200|FG001|Overall Study|Death|8|||
27634645|NCT04266795|80503199|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
27634646|NCT04266795|80503200|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
27634647|NCT04266795|80503199|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
27634648|NCT04266795|80503200|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27634649|NCT04266795|80503199|FG000|Overall Study|Progressive Disease|12|||
27634650|NCT04266795|80503200|FG001|Overall Study|Progressive Disease|9|||
27634651|NCT04266795|80503199|FG000|Overall Study|Withdrawal by Patient|5|||
27634652|NCT04266795|80503200|FG001|Overall Study|Withdrawal by Patient|6|||
27634653|NCT04266795|80503199|FG000|Overall Study|Disease Relapse|3|||
27634654|NCT04266795|80503200|FG001|Overall Study|Disease Relapse|6|||
27634655|NCT04266795|80503199|FG000|Overall Study|Reason not Specified|12|||
27634656|NCT04266795|80503200|FG001|Overall Study|Reason not Specified|10|||
27634657|NCT04266795|80503199|FG000|Overall Study|Participants Ongoing on Treatment|25|||
27634658|NCT04266795|80503200|FG001|Overall Study|Participants Ongoing on Treatment|23|||
27634659|NCT00079183|80503201|FG000|Overall Study|Withdrawal by Subject|4|||
27634660|NCT00079183|80503201|FG000|Overall Study|Study medication non-compliance|2|||
27634661|NCT00079183|80503201|FG000|Overall Study|Specimen collection non-compliance|1|||
27634662|NCT02969863|80503202|FG000|Overall Study|Physician Decision|1|||
27634663|NCT02969863|80503203|FG001|Overall Study|Physician Decision|0|||
27634664|NCT02969863|80503204|FG002|Overall Study|Physician Decision|0|||
27634665|NCT02969863|80503205|FG003|Overall Study|Physician Decision|0|||
27634666|NCT02969863|80503206|FG004|Overall Study|Physician Decision|0|||
27634667|NCT02969863|80503207|FG005|Overall Study|Physician Decision|0|||
27634668|NCT00716144|80503211|FG000|Overall Study|Withdrawal by Subject|4|||
27634669|NCT00716144|80503212|FG001|Overall Study|Withdrawal by Subject|2|||
27634670|NCT00716144|80503213|FG002|Overall Study|Withdrawal by Subject|6|||
27634671|NCT00716144|80503214|FG003|Overall Study|Withdrawal by Subject|6|||
27634672|NCT00716144|80503211|FG000|Overall Study|Lost to Follow-up|2|||
27634673|NCT00716144|80503212|FG001|Overall Study|Lost to Follow-up|2|||
27740573|NCT01426386|80877568|FG004|Overall Study|Personal reasons|1|||
27740574|NCT01426386|80877569|FG005|Overall Study|Personal reasons|0|||
27634674|NCT00716144|80503213|FG002|Overall Study|Lost to Follow-up|1|||
27634675|NCT00716144|80503214|FG003|Overall Study|Lost to Follow-up|2|||
27634676|NCT00716144|80503211|FG000|Overall Study|Adverse Event|0|||
27634677|NCT00716144|80503212|FG001|Overall Study|Adverse Event|0|||
27634678|NCT00716144|80503213|FG002|Overall Study|Adverse Event|0|||
27634679|NCT00716144|80503214|FG003|Overall Study|Adverse Event|2|||
27634680|NCT00716144|80503211|FG000|Overall Study|Non-compliance|1|||
27634681|NCT00716144|80503212|FG001|Overall Study|Non-compliance|0|||
27634682|NCT00716144|80503213|FG002|Overall Study|Non-compliance|0|||
27634683|NCT00716144|80503214|FG003|Overall Study|Non-compliance|0|||
27634684|NCT00716144|80503211|FG000|Overall Study|Protocol Violation|2|||
27634685|NCT00716144|80503212|FG001|Overall Study|Protocol Violation|0|||
27634686|NCT00716144|80503213|FG002|Overall Study|Protocol Violation|1|||
27634687|NCT00716144|80503214|FG003|Overall Study|Protocol Violation|0|||
27634688|NCT00716144|80503211|FG000|Overall Study|Physician Decision|0|||
27740575|NCT00479466|80877570|FG000|Overall Study|Adverse Event|5|||
27740576|NCT00479466|80877571|FG001|Overall Study|Adverse Event|1|||
27740577|NCT00479466|80877572|FG002|Overall Study|Adverse Event|0|||
27740578|NCT00479466|80877573|FG003|Overall Study|Adverse Event|1|||
27740579|NCT00479466|80877574|FG004|Overall Study|Adverse Event|2|||
27740580|NCT00479466|80877575|FG005|Overall Study|Adverse Event|0|||
27740581|NCT00479466|80877570|FG000|Overall Study|Hyperglycemia|0|||
27740582|NCT00479466|80877571|FG001|Overall Study|Hyperglycemia|0|||
27740583|NCT00479466|80877572|FG002|Overall Study|Hyperglycemia|0|||
27740584|NCT00479466|80877573|FG003|Overall Study|Hyperglycemia|0|||
27740585|NCT00479466|80877574|FG004|Overall Study|Hyperglycemia|0|||
27740586|NCT00479466|80877575|FG005|Overall Study|Hyperglycemia|1|||
27740587|NCT00479466|80877570|FG000|Overall Study|Lack of Efficacy|2|||
27740588|NCT00479466|80877571|FG001|Overall Study|Lack of Efficacy|0|||
27740589|NCT00479466|80877572|FG002|Overall Study|Lack of Efficacy|1|||
27740590|NCT00479466|80877573|FG003|Overall Study|Lack of Efficacy|0|||
27740591|NCT00479466|80877574|FG004|Overall Study|Lack of Efficacy|0|||
27740592|NCT00479466|80877575|FG005|Overall Study|Lack of Efficacy|0|||
27740593|NCT00479466|80877570|FG000|Overall Study|Lost to Follow-up|0|||
27740594|NCT00479466|80877571|FG001|Overall Study|Lost to Follow-up|1|||
27740595|NCT00479466|80877572|FG002|Overall Study|Lost to Follow-up|1|||
27740596|NCT00479466|80877573|FG003|Overall Study|Lost to Follow-up|0|||
27740597|NCT00479466|80877574|FG004|Overall Study|Lost to Follow-up|2|||
27740598|NCT00479466|80877575|FG005|Overall Study|Lost to Follow-up|2|||
27740599|NCT00479466|80877570|FG000|Overall Study|Physician Decision|2|||
27740600|NCT00479466|80877571|FG001|Overall Study|Physician Decision|1|||
27740601|NCT00479466|80877572|FG002|Overall Study|Physician Decision|1|||
27740602|NCT00479466|80877573|FG003|Overall Study|Physician Decision|0|||
27918489|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27918490|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27918491|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27634689|NCT00716144|80503212|FG001|Overall Study|Physician Decision|1|||
27740603|NCT00479466|80877574|FG004|Overall Study|Physician Decision|0|||
27740604|NCT00479466|80877575|FG005|Overall Study|Physician Decision|0|||
27740605|NCT00479466|80877570|FG000|Overall Study|Pregnancy|0|||
27740606|NCT00479466|80877571|FG001|Overall Study|Pregnancy|0|||
27740607|NCT00479466|80877572|FG002|Overall Study|Pregnancy|0|||
27740608|NCT00479466|80877573|FG003|Overall Study|Pregnancy|0|||
27918492|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27740609|NCT00479466|80877574|FG004|Overall Study|Pregnancy|1|||
27740610|NCT00479466|80877575|FG005|Overall Study|Pregnancy|0|||
27918493|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27918494|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27918495|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27918496|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
27918497|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
27918498|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918499|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918500|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918501|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918502|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918503|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918504|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918505|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918506|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
27918507|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
27918508|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
27918509|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27918510|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27740611|NCT00479466|80877570|FG000|Overall Study|Protocol Violation|1|||
27740612|NCT00479466|80877571|FG001|Overall Study|Protocol Violation|0|||
27634690|NCT00716144|80503213|FG002|Overall Study|Physician Decision|2|||
27740613|NCT00479466|80877572|FG002|Overall Study|Protocol Violation|0|||
27740614|NCT00479466|80877573|FG003|Overall Study|Protocol Violation|0|||
27740615|NCT00479466|80877574|FG004|Overall Study|Protocol Violation|0|||
27634691|NCT00716144|80503214|FG003|Overall Study|Physician Decision|2|||
27634692|NCT00716144|80503211|FG000|Overall Study|Intercurrent illness|0|||
27634693|NCT00716144|80503212|FG001|Overall Study|Intercurrent illness|0|||
27634694|NCT00716144|80503213|FG002|Overall Study|Intercurrent illness|1|||
27634695|NCT00716144|80503214|FG003|Overall Study|Intercurrent illness|0|||
27634696|NCT00716144|80503211|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
27634697|NCT00716144|80503212|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
27634698|NCT00716144|80503213|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
27634699|NCT00716144|80503214|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
27634700|NCT00716144|80503211|FG000|Overall Study|Adverse event: left foot pain|0|||
27634701|NCT00716144|80503212|FG001|Overall Study|Adverse event: left foot pain|1|||
27634702|NCT00716144|80503213|FG002|Overall Study|Adverse event: left foot pain|0|||
27634703|NCT00716144|80503214|FG003|Overall Study|Adverse event: left foot pain|0|||
27634704|NCT00716144|80503211|FG000|Overall Study|Clinical Depression|0|||
27634705|NCT00716144|80503212|FG001|Overall Study|Clinical Depression|1|||
27634706|NCT00716144|80503213|FG002|Overall Study|Clinical Depression|0|||
27634707|NCT00716144|80503214|FG003|Overall Study|Clinical Depression|0|||
27634708|NCT02878330|80503215|FG000|Overall Study|Death|3|||
27634709|NCT02878330|80503216|FG001|Overall Study|Death|2|||
27634710|NCT02878330|80503215|FG000|Overall Study|Lost to Follow-up|11|||
27634711|NCT02878330|80503216|FG001|Overall Study|Lost to Follow-up|26|||
27634712|NCT02878330|80503215|FG000|Overall Study|Withdrawal by Subject|11|||
27634713|NCT02878330|80503216|FG001|Overall Study|Withdrawal by Subject|21|||
27634714|NCT02878330|80503215|FG000|Overall Study|Other|4|||
27634715|NCT02878330|80503216|FG001|Overall Study|Other|7|||
27634716|NCT00420316|80503217|FG000|Overall Study|Withdrawal by Subject|0|||
27634717|NCT00420316|80503218|FG001|Overall Study|Withdrawal by Subject|1|||
27634718|NCT00420316|80503217|FG000|Overall Study|Lost to Follow-up|12|||
27634719|NCT00420316|80503218|FG001|Overall Study|Lost to Follow-up|8|||
27634720|NCT01787760|80503220|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
27634721|NCT01787760|80503221|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
27634722|NCT01787760|80503222|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
27634723|NCT01787760|80503220|FG000|Overall Study|Decompensated on left exotropia|0|||
27634724|NCT01787760|80503221|FG001|Overall Study|Decompensated on left exotropia|0|||
27634725|NCT01787760|80503222|FG002|Overall Study|Decompensated on left exotropia|1|||
27634726|NCT01787760|80503220|FG000|Overall Study|Dryness|0|||
27634727|NCT01787760|80503221|FG001|Overall Study|Dryness|1|||
27634728|NCT01787760|80503222|FG002|Overall Study|Dryness|0|||
27634729|NCT01787760|80503220|FG000|Overall Study|Relocation|1|||
27634730|NCT01787760|80503221|FG001|Overall Study|Relocation|1|||
27634731|NCT01787760|80503222|FG002|Overall Study|Relocation|0|||
27634732|NCT01787760|80503220|FG000|Overall Study|Lens discomfort|3|||
27634733|NCT01787760|80503221|FG001|Overall Study|Lens discomfort|0|||
27634734|NCT01787760|80503222|FG002|Overall Study|Lens discomfort|0|||
27740616|NCT00479466|80877575|FG005|Overall Study|Protocol Violation|0|||
27740617|NCT00479466|80877570|FG000|Overall Study|Withdrawal by Subject|3|||
27740618|NCT00479466|80877571|FG001|Overall Study|Withdrawal by Subject|5|||
27740619|NCT00479466|80877572|FG002|Overall Study|Withdrawal by Subject|0|||
27740620|NCT00479466|80877573|FG003|Overall Study|Withdrawal by Subject|2|||
27740621|NCT00479466|80877574|FG004|Overall Study|Withdrawal by Subject|3|||
27740622|NCT00479466|80877575|FG005|Overall Study|Withdrawal by Subject|1|||
27740623|NCT01787591|80877576|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
27740624|NCT01787591|80877577|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
27740625|NCT01787591|80877578|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
27740626|NCT01787591|80877579|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
27740627|NCT01873950|80877581|FG000|Period 5|Withdrawal by Subject|0|||
27740628|NCT01873950|80877582|FG001|Period 5|Withdrawal by Subject|0|||
27740629|NCT01873950|80877583|FG002|Period 5|Withdrawal by Subject|0|||
27740630|NCT01873950|80877584|FG003|Period 5|Withdrawal by Subject|1|||
27740631|NCT01873950|80877585|FG004|Period 5|Withdrawal by Subject|0|||
27740632|NCT00881205|80877586|FG000|Overall Study|Adverse Event|8|||
27918511|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27918512|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27918513|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27634735|NCT01787760|80503220|FG000|Overall Study|Lens handling difficulty|1|||
27740633|NCT00881205|80877587|FG001|Overall Study|Adverse Event|3|||
27740634|NCT00881205|80877586|FG000|Overall Study|Withdrawal by Subject|1|||
27740635|NCT00881205|80877587|FG001|Overall Study|Withdrawal by Subject|2|||
27740636|NCT00881205|80877586|FG000|Overall Study|Lost to Follow-up|0|||
27740637|NCT00881205|80877587|FG001|Overall Study|Lost to Follow-up|1|||
27634736|NCT01787760|80503221|FG001|Overall Study|Lens handling difficulty|2|||
27634737|NCT01787760|80503222|FG002|Overall Study|Lens handling difficulty|0|||
27634738|NCT01787760|80503220|FG000|Overall Study|Protocol Violation|6|||
27634739|NCT01787760|80503221|FG001|Overall Study|Protocol Violation|0|||
27634740|NCT01787760|80503222|FG002|Overall Study|Protocol Violation|1|||
27634741|NCT01787760|80503220|FG000|Overall Study|Withdrawal by Subject|5|||
27740638|NCT00881205|80877586|FG000|Overall Study|Administrative problems|1|||
27740639|NCT00881205|80877587|FG001|Overall Study|Administrative problems|1|||
27918514|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27918515|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27634742|NCT01787760|80503221|FG001|Overall Study|Withdrawal by Subject|1|||
27634743|NCT01787760|80503222|FG002|Overall Study|Withdrawal by Subject|2|||
27634744|NCT01787760|80503220|FG000|Overall Study|Lost to Follow-up|1|||
27634745|NCT01787760|80503221|FG001|Overall Study|Lost to Follow-up|0|||
27634746|NCT01787760|80503222|FG002|Overall Study|Lost to Follow-up|1|||
27634747|NCT01787760|80503220|FG000|Overall Study|Stroke|1|||
27634748|NCT01787760|80503221|FG001|Overall Study|Stroke|0|||
27634749|NCT01787760|80503222|FG002|Overall Study|Stroke|0|||
27634750|NCT01787760|80503220|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
27634751|NCT01787760|80503221|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
27634752|NCT01787760|80503222|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
27634753|NCT01787760|80503220|FG000|Overall Study|Unsatisfactory physiological response|2|||
27634754|NCT01787760|80503221|FG001|Overall Study|Unsatisfactory physiological response|4|||
27634755|NCT01787760|80503222|FG002|Overall Study|Unsatisfactory physiological response|0|||
27634756|NCT01787760|80503220|FG000|Overall Study|Unsatisfactory visual response|1|||
27634757|NCT01787760|80503221|FG001|Overall Study|Unsatisfactory visual response|1|||
27634758|NCT01787760|80503222|FG002|Overall Study|Unsatisfactory visual response|0|||
27634759|NCT01787760|80503220|FG000|Overall Study|Near vision blur|1|||
27634760|NCT01787760|80503221|FG001|Overall Study|Near vision blur|0|||
27634761|NCT01787760|80503222|FG002|Overall Study|Near vision blur|0|||
27918516|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
27918517|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
27918518|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
27918519|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918520|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918521|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918522|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918523|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918524|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918525|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918526|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
27918527|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
27918528|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
27918529|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918530|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918531|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918532|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918533|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918534|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918535|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918536|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
27918537|NCT01232283|81539714|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
27918538|NCT01232283|81539715|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
27918539|NCT01232283|81539716|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27918540|NCT01232283|81539717|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27918541|NCT01232283|81539718|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27539801|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
27539802|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
27539803|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
27539804|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
27539805|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
27539806|NCT02607930|80171608|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
27539807|NCT02607930|80171609|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
27539808|NCT02607930|80171610|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
27539809|NCT02607930|80171611|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
27539810|NCT00850070|80171614|FG000|Overall Study|Lack of Efficacy|1|||
27539811|NCT00850070|80171615|FG001|Overall Study|Lack of Efficacy|1|||
27539812|NCT00850070|80171614|FG000|Overall Study|Adverse Event|2|||
27634762|NCT05609032|80503223|FG000|Overall Study|Lost to Follow-up|3|||
27634763|NCT05609032|80503224|FG001|Overall Study|Lost to Follow-up|1|||
27918542|NCT01232283|81539719|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27539813|NCT00850070|80171615|FG001|Overall Study|Adverse Event|0|||
27539814|NCT00809354|80171624|FG000|Overall Study|Adverse Event|32|||
27539815|NCT00809354|80171625|FG001|Overall Study|Adverse Event|45|||
27539816|NCT00809354|80171626|FG002|Overall Study|Adverse Event|37|||
27634764|NCT05609032|80503223|FG000|Overall Study|Withdrawal by Subject|1|||
27918543|NCT01232283|81539720|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27918544|NCT01232283|81539721|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27918545|NCT01232283|81539722|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27918546|NCT01232283|81539723|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
27918547|NCT01232283|81539714|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27634765|NCT05609032|80503224|FG001|Overall Study|Withdrawal by Subject|0|||
27918548|NCT01232283|81539715|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27918549|NCT01232283|81539716|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
27918550|NCT01232283|81539717|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
27918551|NCT01232283|81539718|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27918552|NCT01232283|81539719|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27918553|NCT01232283|81539720|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27918554|NCT01232283|81539721|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27634766|NCT00630786|80503227|FG000|Overall Study|Physician Decision|0|||
27634767|NCT00630786|80503228|FG001|Overall Study|Physician Decision|0|||
27634768|NCT00630786|80503229|FG002|Overall Study|Physician Decision|1|||
27634769|NCT00630786|80503227|FG000|Overall Study|Withdrawal by Subject|0|||
27634770|NCT00630786|80503228|FG001|Overall Study|Withdrawal by Subject|1|||
27634771|NCT00630786|80503229|FG002|Overall Study|Withdrawal by Subject|1|||
27634772|NCT00630786|80503227|FG000|Overall Study|Lost to Follow-up|0|||
27634773|NCT00630786|80503228|FG001|Overall Study|Lost to Follow-up|1|||
27634774|NCT00630786|80503229|FG002|Overall Study|Lost to Follow-up|0|||
27634775|NCT00630786|80503227|FG000|Overall Study|Other|1|||
27634776|NCT00630786|80503228|FG001|Overall Study|Other|0|||
27634777|NCT00630786|80503229|FG002|Overall Study|Other|0|||
27634778|NCT01075217|80503230|FG000|Overall Study|Adverse Event|1|||
27634779|NCT01075217|80503231|FG001|Overall Study|Adverse Event|1|||
27634780|NCT01075217|80503230|FG000|Overall Study|Physician Decision|1|||
27634781|NCT01075217|80503231|FG001|Overall Study|Physician Decision|0|||
27634782|NCT01924767|80503232|FG000|Overall Study|Adverse Event|1|||
27634783|NCT01924767|80503233|FG001|Overall Study|Adverse Event|0|||
27634784|NCT01924767|80503234|FG002|Overall Study|Adverse Event|1|||
27634785|NCT01924767|80503235|FG003|Overall Study|Adverse Event|0|||
27634786|NCT01924767|80503236|FG004|Overall Study|Adverse Event|0|||
27634787|NCT01685606|80503237|FG000|Overall Study|Withdrawal by Subject|1|||
27634788|NCT03804918|80503238|FG000|Overall Study|Participant did not use the app|1|||
27634789|NCT01560416|80503241|FG000|Randomized Phase|Crossover Participants|7|||
27634790|NCT01560416|80503242|FG001|Randomized Phase|Crossover Participants|0|||
27634791|NCT00666276|80503247|FG000|Overall Study|Protocol Violation|34|||
27634792|NCT01111526|80503251|FG000|Overall Study|GVHD Disease Progression|0|||
27634793|NCT01111526|80503252|FG001|Overall Study|GVHD Disease Progression|1|||
27634794|NCT01111526|80503253|FG002|Overall Study|GVHD Disease Progression|2|||
27634795|NCT04222959|80503254|FG000|Overall Study|Lost to Follow-up|76|||
27634796|NCT04222959|80503255|FG001|Overall Study|Lost to Follow-up|28|||
27634797|NCT00943735|80503256|FG000|Overall Study|Adverse Event|12|||
27634798|NCT00943735|80503256|FG000|Overall Study|Withdrawal by Subject|8|||
27634799|NCT00943735|80503256|FG000|Overall Study|Death|1|||
27634800|NCT00943735|80503256|FG000|Overall Study|Other|8|||
27634801|NCT00943735|80503256|FG000|Overall Study|Other|3|||
27634802|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
27634803|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
27634804|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
27634805|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
27634806|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
27634807|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
27634808|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
27634809|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
27634810|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
27634811|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
27634812|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
27634813|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
27634814|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Death|7|||
27634815|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Death|4|||
27634816|NCT00410124|80503261|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
27918555|NCT01232283|81539722|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27634817|NCT00410124|80503262|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
27918556|NCT01232283|81539723|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
27918557|NCT01232283|81539714|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27634818|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
27634819|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
27634820|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
27634821|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
27634822|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
27918558|NCT01232283|81539715|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918559|NCT01232283|81539716|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
27918560|NCT01232283|81539717|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
27918561|NCT01232283|81539718|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918562|NCT01232283|81539719|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918563|NCT01232283|81539720|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918564|NCT01232283|81539721|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918565|NCT01232283|81539722|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918566|NCT01232283|81539723|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
27918567|NCT01232283|81539714|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918568|NCT01232283|81539715|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918569|NCT01232283|81539716|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
27918570|NCT01232283|81539717|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918571|NCT01232283|81539718|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918572|NCT01232283|81539719|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918573|NCT01232283|81539720|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918574|NCT01232283|81539721|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918575|NCT01232283|81539722|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918576|NCT01232283|81539723|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
27918577|NCT01232283|81539714|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918578|NCT01232283|81539715|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918579|NCT01232283|81539716|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
27918580|NCT01232283|81539717|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
27918581|NCT01232283|81539718|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918582|NCT01232283|81539719|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918583|NCT01232283|81539720|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918584|NCT01232283|81539721|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918585|NCT01232283|81539722|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918586|NCT01232283|81539723|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
27918587|NCT01232283|81539714|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918588|NCT01232283|81539715|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918589|NCT01232283|81539716|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
27918590|NCT01232283|81539717|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
27918591|NCT01232283|81539718|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918592|NCT01232283|81539719|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918593|NCT01232283|81539720|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918594|NCT01232283|81539721|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918595|NCT01232283|81539722|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918596|NCT01232283|81539723|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
27918597|NCT01232283|81539714|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
27918598|NCT01232283|81539715|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
27918599|NCT01232283|81539716|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
27918600|NCT01232283|81539717|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
27918601|NCT01232283|81539718|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
27918602|NCT01232283|81539719|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
27918603|NCT01232283|81539720|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
27918604|NCT01232283|81539721|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
27539817|NCT00809354|80171627|FG003|Overall Study|Adverse Event|53|||
27539818|NCT00809354|80171628|FG004|Overall Study|Adverse Event|26|||
27539819|NCT00809354|80171629|FG005|Overall Study|Adverse Event|33|||
27539820|NCT00809354|80171630|FG006|Overall Study|Adverse Event|44|||
27539821|NCT00809354|80171631|FG007|Overall Study|Adverse Event|40|||
27539822|NCT00809354|80171632|FG008|Overall Study|Adverse Event|46|||
27539823|NCT00809354|80171633|FG009|Overall Study|Adverse Event|26|||
27539824|NCT00809354|80171624|FG000|Overall Study|Lack of Efficacy|23|||
27539825|NCT00809354|80171625|FG001|Overall Study|Lack of Efficacy|23|||
27539826|NCT00809354|80171626|FG002|Overall Study|Lack of Efficacy|22|||
27539827|NCT00809354|80171627|FG003|Overall Study|Lack of Efficacy|15|||
27539828|NCT00809354|80171628|FG004|Overall Study|Lack of Efficacy|40|||
27539829|NCT00809354|80171629|FG005|Overall Study|Lack of Efficacy|19|||
27539830|NCT00809354|80171630|FG006|Overall Study|Lack of Efficacy|21|||
27539831|NCT00809354|80171631|FG007|Overall Study|Lack of Efficacy|15|||
27539832|NCT00809354|80171632|FG008|Overall Study|Lack of Efficacy|18|||
27539833|NCT00809354|80171633|FG009|Overall Study|Lack of Efficacy|38|||
27539834|NCT00809354|80171624|FG000|Overall Study|Lost to Follow-up|10|||
27539835|NCT00809354|80171625|FG001|Overall Study|Lost to Follow-up|11|||
27539836|NCT00809354|80171626|FG002|Overall Study|Lost to Follow-up|8|||
27539837|NCT00809354|80171627|FG003|Overall Study|Lost to Follow-up|13|||
27539838|NCT00809354|80171628|FG004|Overall Study|Lost to Follow-up|6|||
27539839|NCT00809354|80171629|FG005|Overall Study|Lost to Follow-up|2|||
27539840|NCT00809354|80171630|FG006|Overall Study|Lost to Follow-up|0|||
27539841|NCT00809354|80171631|FG007|Overall Study|Lost to Follow-up|5|||
27634823|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
27634824|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
27634825|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
27634826|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
27634827|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
27634828|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
27634829|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
27634830|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
27634831|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
27634832|NCT00410124|80503261|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
27634833|NCT00410124|80503262|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
27634834|NCT01199705|80503265|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
27634835|NCT02888080|80503271|FG000|Overall Study|Subject / Guardian decision|1|||
27634836|NCT02888080|80503272|FG001|Overall Study|Subject / Guardian decision|3|||
27634837|NCT02888080|80503271|FG000|Overall Study|New Therapy for study indication|1|||
27634838|NCT02888080|80503272|FG001|Overall Study|New Therapy for study indication|0|||
27634839|NCT02888080|80503271|FG000|Overall Study|Lack of Efficacy|0|||
27634840|NCT02888080|80503272|FG001|Overall Study|Lack of Efficacy|1|||
27634841|NCT02888080|80503271|FG000|Overall Study|Adverse Event|0|||
27634842|NCT02888080|80503272|FG001|Overall Study|Adverse Event|1|||
27634843|NCT00082810|80503273|FG000|Overall Study|Adverse Event|3|||
27634844|NCT00082810|80503273|FG000|Overall Study|Progressive disease|24|||
27634845|NCT00082810|80503273|FG000|Overall Study|Withdrawal by Subject|4|||
27634846|NCT00588666|80503278|FG000|Overall Study|Adverse Event|4|||
27634847|NCT06136897|80503279|FG000|Overall Study|Ineligible|3|||
27634848|NCT06136897|80503279|FG000|Overall Study|Mutation status not confirmed|7|||
27634849|NCT06136897|80503279|FG000|Overall Study|Adverse Event|2|||
27634850|NCT06136897|80503279|FG000|Overall Study|Death|1|||
27634851|NCT06136897|80503279|FG000|Overall Study|Disease progression|18|||
27539842|NCT00809354|80171632|FG008|Overall Study|Lost to Follow-up|4|||
27539843|NCT00809354|80171633|FG009|Overall Study|Lost to Follow-up|0|||
27539844|NCT00809354|80171624|FG000|Overall Study|Protocol Violation|7|||
27539845|NCT00809354|80171625|FG001|Overall Study|Protocol Violation|14|||
27539846|NCT00809354|80171626|FG002|Overall Study|Protocol Violation|14|||
27539847|NCT00809354|80171627|FG003|Overall Study|Protocol Violation|12|||
27539848|NCT00809354|80171628|FG004|Overall Study|Protocol Violation|14|||
27539849|NCT00809354|80171629|FG005|Overall Study|Protocol Violation|6|||
27539850|NCT00809354|80171630|FG006|Overall Study|Protocol Violation|4|||
27539851|NCT00809354|80171631|FG007|Overall Study|Protocol Violation|6|||
27539852|NCT00809354|80171632|FG008|Overall Study|Protocol Violation|9|||
27539853|NCT00809354|80171633|FG009|Overall Study|Protocol Violation|3|||
27539854|NCT00809354|80171624|FG000|Overall Study|Withdrawal by Subject|32|||
27539855|NCT00809354|80171625|FG001|Overall Study|Withdrawal by Subject|27|||
27539856|NCT00809354|80171626|FG002|Overall Study|Withdrawal by Subject|31|||
27539857|NCT00809354|80171627|FG003|Overall Study|Withdrawal by Subject|33|||
27539858|NCT00809354|80171628|FG004|Overall Study|Withdrawal by Subject|34|||
27539859|NCT00809354|80171629|FG005|Overall Study|Withdrawal by Subject|29|||
27539860|NCT00809354|80171630|FG006|Overall Study|Withdrawal by Subject|27|||
27539861|NCT00809354|80171631|FG007|Overall Study|Withdrawal by Subject|19|||
27539862|NCT00809354|80171632|FG008|Overall Study|Withdrawal by Subject|18|||
27539863|NCT00809354|80171633|FG009|Overall Study|Withdrawal by Subject|20|||
27539864|NCT00809354|80171624|FG000|Overall Study|Other|10|||
27539865|NCT00809354|80171625|FG001|Overall Study|Other|2|||
27539866|NCT00809354|80171626|FG002|Overall Study|Other|7|||
27539867|NCT00809354|80171627|FG003|Overall Study|Other|10|||
27539868|NCT00809354|80171628|FG004|Overall Study|Other|5|||
27539869|NCT00809354|80171629|FG005|Overall Study|Other|3|||
27539870|NCT00809354|80171630|FG006|Overall Study|Other|2|||
27539871|NCT00809354|80171631|FG007|Overall Study|Other|3|||
27539872|NCT00809354|80171632|FG008|Overall Study|Other|4|||
27539873|NCT00809354|80171633|FG009|Overall Study|Other|3|||
27539874|NCT00809354|80171624|FG000|Overall Study|Study terminated by sponsor|138|||
27539875|NCT00809354|80171625|FG001|Overall Study|Study terminated by sponsor|134|||
27539876|NCT00809354|80171626|FG002|Overall Study|Study terminated by sponsor|129|||
27539877|NCT00809354|80171627|FG003|Overall Study|Study terminated by sponsor|120|||
27634852|NCT06136897|80503279|FG000|Overall Study|Other complicating disease|1|||
27634853|NCT06136897|80503279|FG000|Overall Study|Withdrawal by Subject|1|||
27634854|NCT06136897|80503279|FG000|Overall Study|Still on treatment|1|||
27634855|NCT06136897|80503279|FG000|Overall Study|Lost to Follow-up|1|||
27539878|NCT00809354|80171628|FG004|Overall Study|Study terminated by sponsor|126|||
27539879|NCT00809354|80171629|FG005|Overall Study|Study terminated by sponsor|133|||
27539880|NCT00809354|80171630|FG006|Overall Study|Study terminated by sponsor|124|||
27634856|NCT04661150|80503285|FG000|Overall Study|Ongoing in study|19|||
27634857|NCT04661150|80503286|FG001|Overall Study|Ongoing in study|20|||
27634858|NCT04661150|80503285|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
27539881|NCT00809354|80171631|FG007|Overall Study|Study terminated by sponsor|148|||
27634859|NCT04661150|80503286|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
27634860|NCT04661150|80503285|FG000|Overall Study|Death|2|||
27634861|NCT04661150|80503286|FG001|Overall Study|Death|0|||
27634862|NCT00658996|80503287|FG000|First Intervention|Positive slit lamp finding|1|||
27634863|NCT00658996|80503288|FG001|First Intervention|Positive slit lamp finding|0|||
27634864|NCT00658996|80503287|FG000|First Intervention|Lack of lenses|0|||
27634865|NCT00658996|80503288|FG001|First Intervention|Lack of lenses|1|||
27634866|NCT00658996|80503287|FG000|Crossover Period|Physician Decision|1|||
27634867|NCT00658996|80503288|FG001|Crossover Period|Physician Decision|0|||
27634868|NCT00658996|80503287|FG000|Crossover Period|Ineligible|1|||
27634869|NCT00658996|80503288|FG001|Crossover Period|Ineligible|1|||
27634870|NCT00658996|80503287|FG000|Second Intervention|Developed a stye on upper lid|1|||
27634871|NCT00658996|80503288|FG001|Second Intervention|Developed a stye on upper lid|0|||
27634872|NCT00658996|80503287|FG000|Second Intervention|Positive slit lamp finding|0|||
27634873|NCT00658996|80503288|FG001|Second Intervention|Positive slit lamp finding|1|||
27634874|NCT00959946|80503291|FG000|Overall Study|Adverse Event|0|||
27634875|NCT00959946|80503292|FG001|Overall Study|Adverse Event|0|||
27634876|NCT00959946|80503293|FG002|Overall Study|Adverse Event|2|||
27634877|NCT00959946|80503294|FG003|Overall Study|Adverse Event|1|||
27634878|NCT00959946|80503295|FG004|Overall Study|Adverse Event|0|||
27634879|NCT00959946|80503296|FG005|Overall Study|Adverse Event|1|||
27634880|NCT00959946|80503297|FG006|Overall Study|Adverse Event|0|||
27634881|NCT00959946|80503298|FG007|Overall Study|Adverse Event|0|||
27634882|NCT00959946|80503291|FG000|Overall Study|Death|0|||
27634883|NCT00959946|80503292|FG001|Overall Study|Death|0|||
27918605|NCT01232283|81539722|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
27918606|NCT01232283|81539723|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
27918607|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27918608|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27918609|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27539882|NCT00809354|80171632|FG008|Overall Study|Study terminated by sponsor|127|||
27539883|NCT00809354|80171633|FG009|Overall Study|Study terminated by sponsor|135|||
27539884|NCT00809354|80171624|FG000|Overall Study|Withdrawn due to pregnancy|0|||
27539885|NCT00809354|80171625|FG001|Overall Study|Withdrawn due to pregnancy|1|||
27539886|NCT00809354|80171626|FG002|Overall Study|Withdrawn due to pregnancy|0|||
27539887|NCT00809354|80171627|FG003|Overall Study|Withdrawn due to pregnancy|0|||
27539888|NCT00809354|80171628|FG004|Overall Study|Withdrawn due to pregnancy|0|||
27539889|NCT00809354|80171629|FG005|Overall Study|Withdrawn due to pregnancy|0|||
27539890|NCT00809354|80171630|FG006|Overall Study|Withdrawn due to pregnancy|0|||
27539891|NCT00809354|80171631|FG007|Overall Study|Withdrawn due to pregnancy|0|||
27539892|NCT00809354|80171632|FG008|Overall Study|Withdrawn due to pregnancy|0|||
27539893|NCT00809354|80171633|FG009|Overall Study|Withdrawn due to pregnancy|0|||
27539894|NCT00809354|80171624|FG000|Overall Study|Randomized but not Treated|3|||
27539895|NCT00809354|80171625|FG001|Overall Study|Randomized but not Treated|1|||
27539896|NCT00809354|80171626|FG002|Overall Study|Randomized but not Treated|6|||
27539897|NCT00809354|80171627|FG003|Overall Study|Randomized but not Treated|0|||
27539898|NCT00809354|80171628|FG004|Overall Study|Randomized but not Treated|5|||
27539899|NCT00809354|80171629|FG005|Overall Study|Randomized but not Treated|0|||
27539900|NCT00809354|80171630|FG006|Overall Study|Randomized but not Treated|1|||
27539901|NCT00809354|80171631|FG007|Overall Study|Randomized but not Treated|1|||
27539902|NCT00809354|80171632|FG008|Overall Study|Randomized but not Treated|2|||
27539903|NCT00809354|80171633|FG009|Overall Study|Randomized but not Treated|1|||
27539904|NCT00809354|80171624|FG000|Overall Study|Death|0|||
27539905|NCT00809354|80171625|FG001|Overall Study|Death|0|||
27539906|NCT00809354|80171626|FG002|Overall Study|Death|0|||
27539907|NCT00809354|80171627|FG003|Overall Study|Death|0|||
27539908|NCT00809354|80171628|FG004|Overall Study|Death|0|||
27539909|NCT00809354|80171629|FG005|Overall Study|Death|0|||
27539910|NCT00809354|80171630|FG006|Overall Study|Death|0|||
27539911|NCT00809354|80171631|FG007|Overall Study|Death|1|||
27539912|NCT00809354|80171632|FG008|Overall Study|Death|0|||
27539913|NCT00809354|80171633|FG009|Overall Study|Death|0|||
27539914|NCT02465515|80171634|FG000|Overall Study|Investigator site closed|4|||
27539915|NCT02465515|80171635|FG001|Overall Study|Investigator site closed|5|||
27539916|NCT02465515|80171634|FG000|Overall Study|Withdrawal by Subject|74|||
27539917|NCT02465515|80171635|FG001|Overall Study|Withdrawal by Subject|43|||
27634884|NCT00959946|80503293|FG002|Overall Study|Death|0|||
27634885|NCT00959946|80503294|FG003|Overall Study|Death|0|||
27539918|NCT02465515|80171634|FG000|Overall Study|Physician Decision|8|||
27634886|NCT00959946|80503295|FG004|Overall Study|Death|0|||
27634887|NCT00959946|80503296|FG005|Overall Study|Death|1|||
27634888|NCT00959946|80503297|FG006|Overall Study|Death|0|||
27539919|NCT02465515|80171635|FG001|Overall Study|Physician Decision|12|||
27634889|NCT00959946|80503298|FG007|Overall Study|Death|0|||
27634890|NCT00959946|80503291|FG000|Overall Study|Disease Progression|2|||
27634891|NCT00959946|80503292|FG001|Overall Study|Disease Progression|4|||
27634892|NCT00959946|80503293|FG002|Overall Study|Disease Progression|2|||
27539920|NCT02465515|80171634|FG000|Overall Study|Lost to Follow-up|68|||
27539921|NCT02465515|80171635|FG001|Overall Study|Lost to Follow-up|51|||
27539922|NCT00091442|80171636|FG000|Overall Study|Progressive Disease|220|||
27539923|NCT00091442|80171637|FG001|Overall Study|Progressive Disease|189|||
27539924|NCT00091442|80171636|FG000|Overall Study|Physician Decision|61|||
27539925|NCT00091442|80171637|FG001|Overall Study|Physician Decision|58|||
27539926|NCT00091442|80171636|FG000|Overall Study|Withdrawal by Subject|38|||
27539927|NCT00091442|80171637|FG001|Overall Study|Withdrawal by Subject|46|||
27539928|NCT00091442|80171636|FG000|Overall Study|Adverse Event|29|||
27539929|NCT00091442|80171637|FG001|Overall Study|Adverse Event|48|||
27539930|NCT00091442|80171636|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
27539931|NCT00091442|80171637|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
27634893|NCT00959946|80503294|FG003|Overall Study|Disease Progression|4|||
27634894|NCT00959946|80503295|FG004|Overall Study|Disease Progression|4|||
27634895|NCT00959946|80503296|FG005|Overall Study|Disease Progression|6|||
27634896|NCT00959946|80503297|FG006|Overall Study|Disease Progression|2|||
27634897|NCT00959946|80503298|FG007|Overall Study|Disease Progression|2|||
27634898|NCT00959946|80503291|FG000|Overall Study|Withdrawal by Subject|0|||
27634899|NCT00959946|80503292|FG001|Overall Study|Withdrawal by Subject|0|||
27634900|NCT00959946|80503293|FG002|Overall Study|Withdrawal by Subject|0|||
27634901|NCT00959946|80503294|FG003|Overall Study|Withdrawal by Subject|0|||
27634902|NCT00959946|80503295|FG004|Overall Study|Withdrawal by Subject|0|||
27634903|NCT00959946|80503296|FG005|Overall Study|Withdrawal by Subject|1|||
27634904|NCT00959946|80503297|FG006|Overall Study|Withdrawal by Subject|0|||
27634905|NCT00959946|80503298|FG007|Overall Study|Withdrawal by Subject|0|||
27740640|NCT00881205|80877586|FG000|Overall Study|Condition no longer requires drug|1|||
27740641|NCT00881205|80877587|FG001|Overall Study|Condition no longer requires drug|0|||
27740642|NCT02082184|80880688|FG000|Overall Study|Adverse Event|1|||
27740643|NCT02082184|80880689|FG001|Overall Study|Adverse Event|0|||
27740644|NCT02082184|80880688|FG000|Overall Study|Medical diagnosis|1|||
27740645|NCT02082184|80880689|FG001|Overall Study|Medical diagnosis|2|||
27740646|NCT02082184|80880688|FG000|Overall Study|Device associated symptoms|5|||
27740647|NCT02082184|80880689|FG001|Overall Study|Device associated symptoms|0|||
27740648|NCT02082184|80880688|FG000|Overall Study|Withdrawal by Subject|3|||
27740649|NCT02082184|80880689|FG001|Overall Study|Withdrawal by Subject|2|||
27740650|NCT02082184|80880688|FG000|Overall Study|Protocol Violation|0|||
27740651|NCT02082184|80880689|FG001|Overall Study|Protocol Violation|6|||
27740652|NCT02082184|80880688|FG000|Overall Study|Lost to Follow-up|0|||
27740653|NCT02082184|80880689|FG001|Overall Study|Lost to Follow-up|2|||
27740654|NCT02082184|80880688|FG000|Overall Study|Subject non-compliance|0|||
27740655|NCT02082184|80880689|FG001|Overall Study|Subject non-compliance|1|||
27740656|NCT04651777|80880692|FG000|Overall Study|Adverse Event|1|||
27740657|NCT04651777|80880692|FG000|Overall Study|Withdrawal by Subject|2|||
27740658|NCT00637728|80880697|FG000|Double-blind Phase|Adverse Event|1|||
27740659|NCT00637728|80880698|FG001|Double-blind Phase|Adverse Event|0|||
27740660|NCT00637728|80880699|FG002|Double-blind Phase|Adverse Event|0|||
27740661|NCT00637728|80880697|FG000|Double-blind Phase|Non-compliance|2|||
27740662|NCT00637728|80880698|FG001|Double-blind Phase|Non-compliance|0|||
27740663|NCT00637728|80880699|FG002|Double-blind Phase|Non-compliance|0|||
27740664|NCT00637728|80880697|FG000|Double-blind Phase|Study Discontinued|1|||
27740665|NCT00637728|80880698|FG001|Double-blind Phase|Study Discontinued|1|||
27740666|NCT00637728|80880699|FG002|Double-blind Phase|Study Discontinued|0|||
27740667|NCT02725177|80880700|FG000|Overall Study|Physician Decision|4|||
27740668|NCT02725177|80880700|FG000|Overall Study|Adverse Event|1|||
27740669|NCT02385123|80880705|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
27740670|NCT00501852|80880710|FG000|Overall Study|Adverse Event|3|||
27740671|NCT00501852|80880710|FG000|Overall Study|Withdrawal by Subject|2|||
27740672|NCT01707147|80880717|FG000|Overall Study|Administered Trajenta prior to contract|5|||
27740673|NCT01707147|80880717|FG000|Overall Study|Patients who have not taken Trajenta|1|||
27539932|NCT00091442|80171636|FG000|Overall Study|Death|9|||
27634906|NCT00918957|80503299|FG000|Overall Study|Adverse Event|2|||
27634907|NCT00918957|80503300|FG001|Overall Study|Adverse Event|0|||
27634908|NCT00918957|80503299|FG000|Overall Study|Withdrawal by Subject|1|||
27740674|NCT01707147|80880717|FG000|Overall Study|Follow-up failure|17|||
27740675|NCT01707147|80880717|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
27740676|NCT00550238|80880720|FG000|Overall Study|Adverse Event|88|||
27740677|NCT00550238|80880720|FG000|Overall Study|Death|34|||
27740678|NCT00550238|80880720|FG000|Overall Study|Disease progression|46|||
27740679|NCT00550238|80880720|FG000|Overall Study|Withdrawal by Subject|167|||
27539933|NCT00091442|80171637|FG001|Overall Study|Death|7|||
27740680|NCT00550238|80880720|FG000|Overall Study|Physician Decision|31|||
27740681|NCT00550238|80880720|FG000|Overall Study|Patient noncompliance|25|||
27740682|NCT00550238|80880720|FG000|Overall Study|Lost to Follow-up|13|||
27539934|NCT00091442|80171636|FG000|Overall Study|Lost to Follow-up|1|||
27634909|NCT00918957|80503300|FG001|Overall Study|Withdrawal by Subject|0|||
27634910|NCT02613871|80503303|FG000|Overall Study|Death|2|||
27634911|NCT02613871|80503303|FG000|Overall Study|Withdrew Consent|1|||
27634912|NCT00346333|80503304|FG000|Overall Study|Death|1|||
27740683|NCT00550238|80880720|FG000|Overall Study|Sponsor decision|55|||
27740684|NCT04419506|80880721|FG000|Overall Study|Adverse Event|0|||
27740685|NCT04419506|80880722|FG001|Overall Study|Adverse Event|10|||
27740686|NCT04419506|80880723|FG002|Overall Study|Adverse Event|0|||
27740687|NCT04419506|80880724|FG003|Overall Study|Adverse Event|3|||
27740688|NCT04419506|80880721|FG000|Overall Study|Withdrawal by Subject|0|||
27740689|NCT04419506|80880722|FG001|Overall Study|Withdrawal by Subject|0|||
27740690|NCT04419506|80880723|FG002|Overall Study|Withdrawal by Subject|0|||
27740691|NCT04419506|80880724|FG003|Overall Study|Withdrawal by Subject|1|||
27740692|NCT04419506|80880721|FG000|Overall Study|poor-compliance|0|||
27740693|NCT04419506|80880722|FG001|Overall Study|poor-compliance|0|||
27740694|NCT04419506|80880723|FG002|Overall Study|poor-compliance|0|||
27740695|NCT04419506|80880724|FG003|Overall Study|poor-compliance|1|||
27740696|NCT03705494|80880725|FG000|Overall Study|Lost to Follow-up|2|||
27740697|NCT03705494|80880726|FG001|Overall Study|Lost to Follow-up|1|||
27740698|NCT03705494|80880725|FG000|Overall Study|Withdrawal by Subject|5|||
27740699|NCT03705494|80880726|FG001|Overall Study|Withdrawal by Subject|2|||
27740700|NCT04814823|80880727|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
27740701|NCT00875420|80880728|FG000|Overall Study|Adverse Event|0|||
27740702|NCT00875420|80880729|FG001|Overall Study|Adverse Event|1|||
27740703|NCT00875420|80880730|FG002|Overall Study|Adverse Event|1|||
27740704|NCT00875420|80880731|FG003|Overall Study|Adverse Event|0|||
27740705|NCT00875420|80880732|FG004|Overall Study|Adverse Event|0|||
27740706|NCT00875420|80880728|FG000|Overall Study|Inability to complete study procedures|1|||
27740707|NCT00875420|80880729|FG001|Overall Study|Inability to complete study procedures|0|||
27740708|NCT00875420|80880730|FG002|Overall Study|Inability to complete study procedures|1|||
27740709|NCT00875420|80880731|FG003|Overall Study|Inability to complete study procedures|1|||
27740710|NCT00875420|80880732|FG004|Overall Study|Inability to complete study procedures|1|||
27740711|NCT00875420|80880728|FG000|Overall Study|Lost to Follow-up|1|||
27740712|NCT00875420|80880729|FG001|Overall Study|Lost to Follow-up|0|||
27740713|NCT00875420|80880730|FG002|Overall Study|Lost to Follow-up|0|||
27740714|NCT00875420|80880731|FG003|Overall Study|Lost to Follow-up|0|||
27740715|NCT00875420|80880732|FG004|Overall Study|Lost to Follow-up|0|||
27539935|NCT00091442|80171637|FG001|Overall Study|Lost to Follow-up|3|||
27539936|NCT00091442|80171636|FG000|Overall Study|Other|2|||
27740716|NCT00875420|80880728|FG000|Overall Study|Personal reason|0|||
27740717|NCT00875420|80880729|FG001|Overall Study|Personal reason|0|||
27740718|NCT00875420|80880730|FG002|Overall Study|Personal reason|0|||
27740719|NCT00875420|80880731|FG003|Overall Study|Personal reason|0|||
27740720|NCT00875420|80880732|FG004|Overall Study|Personal reason|1|||
27740721|NCT00875420|80880728|FG000|Overall Study|Prohibited medication|0|||
27740722|NCT00875420|80880729|FG001|Overall Study|Prohibited medication|0|||
27740723|NCT00875420|80880730|FG002|Overall Study|Prohibited medication|0|||
27740724|NCT00875420|80880731|FG003|Overall Study|Prohibited medication|1|||
27740725|NCT00875420|80880732|FG004|Overall Study|Prohibited medication|0|||
27740726|NCT00875420|80880728|FG000|Overall Study|Sponsor decision|0|||
27740727|NCT00875420|80880729|FG001|Overall Study|Sponsor decision|1|||
27740728|NCT00875420|80880730|FG002|Overall Study|Sponsor decision|0|||
27740729|NCT00875420|80880731|FG003|Overall Study|Sponsor decision|0|||
27740730|NCT00875420|80880732|FG004|Overall Study|Sponsor decision|0|||
27740731|NCT00875420|80880728|FG000|Overall Study|Withdrawal by Subject|0|||
27740732|NCT00875420|80880729|FG001|Overall Study|Withdrawal by Subject|0|||
27740733|NCT00875420|80880730|FG002|Overall Study|Withdrawal by Subject|1|||
27740734|NCT00875420|80880731|FG003|Overall Study|Withdrawal by Subject|0|||
27740735|NCT00875420|80880732|FG004|Overall Study|Withdrawal by Subject|0|||
27740736|NCT00035815|80880735|FG000|Overall Study|Withdrawal by Subject|17|||
27740737|NCT00035815|80880736|FG001|Overall Study|Withdrawal by Subject|11|||
27740738|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
27740739|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
27539937|NCT00091442|80171637|FG001|Overall Study|Other|6|||
27539938|NCT01453361|80171641|FG000|Overall Study|Disease Progression|6|||
27539939|NCT01453361|80171641|FG000|Overall Study|Screen-Failures|10|||
27539940|NCT03095612|80171642|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
27539941|NCT03095612|80171643|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
27740740|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Death|0|||
27740741|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Death|4|||
27740742|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
27740743|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
27740744|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
27740745|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
27740746|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
27740747|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
27740748|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
27740749|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
27740750|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
27740751|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
27740752|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Other|4|||
27740753|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Other|3|||
27740754|NCT03517722|80880739|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
27740755|NCT03517722|80880740|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
27740756|NCT03517722|80880739|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
27740757|NCT03517722|80880740|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
27740758|NCT03517722|80880739|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
27740759|NCT03517722|80880740|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
27740760|NCT03517722|80880739|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
27740761|NCT03517722|80880740|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
27740762|NCT03517722|80880739|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
27740763|NCT03517722|80880740|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
27740764|NCT01716169|80880743|FG000|Overall Study|Adverse Event|1|||
27740765|NCT01716169|80880743|FG000|Overall Study|Lost to Follow-up|1|||
27740766|NCT01716169|80880743|FG000|Overall Study|Withdrawal by Subject|1|||
27740767|NCT01716169|80880743|FG000|Overall Study|inconsistent dressing application|1|||
27740768|NCT00404768|80880744|FG000|Part A and B|Withdrawn due to labor progression|1|||
27740769|NCT00404768|80880745|FG001|Part A and B|Withdrawn due to labor progression|0|||
27740770|NCT00404768|80880746|FG002|Part A and B|Withdrawn due to labor progression|0|||
27740771|NCT00404768|80880747|FG003|Part A and B|Withdrawn due to labor progression|0|||
27740772|NCT00404768|80880744|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
27740773|NCT00404768|80880745|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
27740774|NCT00404768|80880746|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
27740775|NCT00404768|80880747|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
27740776|NCT00404768|80880744|FG000|Part C|Adverse Event|0|||
27740777|NCT00404768|80880745|FG001|Part C|Adverse Event|0|||
27740778|NCT00404768|80880746|FG002|Part C|Adverse Event|0|||
27740779|NCT00404768|80880747|FG003|Part C|Adverse Event|3|||
27740780|NCT00404768|80880744|FG000|Part C|Lost to Follow-up|0|||
27740781|NCT00404768|80880745|FG001|Part C|Lost to Follow-up|0|||
27740782|NCT00404768|80880746|FG002|Part C|Lost to Follow-up|3|||
27740783|NCT00404768|80880747|FG003|Part C|Lost to Follow-up|1|||
27740784|NCT00404768|80880744|FG000|Part C|Withdrawal by Subject|0|||
27740785|NCT00404768|80880745|FG001|Part C|Withdrawal by Subject|0|||
27740786|NCT00404768|80880746|FG002|Part C|Withdrawal by Subject|2|||
27740787|NCT00404768|80880747|FG003|Part C|Withdrawal by Subject|1|||
27740788|NCT00404768|80880744|FG000|Part C|Early withdrawal from study medication|0|||
27740789|NCT00404768|80880745|FG001|Part C|Early withdrawal from study medication|0|||
27740790|NCT00404768|80880746|FG002|Part C|Early withdrawal from study medication|1|||
27740791|NCT00404768|80880747|FG003|Part C|Early withdrawal from study medication|0|||
27740792|NCT00404768|80880744|FG000|Part C|Participant did not respond to therapy|0|||
27740793|NCT00404768|80880745|FG001|Part C|Participant did not respond to therapy|0|||
27740794|NCT00404768|80880746|FG002|Part C|Participant did not respond to therapy|1|||
27740795|NCT00404768|80880747|FG003|Part C|Participant did not respond to therapy|1|||
27740796|NCT00404768|80880744|FG000|Part C|Physician withdrew the study medication|0|||
27740797|NCT00404768|80880745|FG001|Part C|Physician withdrew the study medication|0|||
27740798|NCT00404768|80880746|FG002|Part C|Physician withdrew the study medication|1|||
27740799|NCT00404768|80880747|FG003|Part C|Physician withdrew the study medication|0|||
27740800|NCT00404768|80880744|FG000|Part C|Participant delivered baby|0|||
27740801|NCT00404768|80880745|FG001|Part C|Participant delivered baby|0|||
27539942|NCT03095612|80171644|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
27539943|NCT03095612|80171645|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
27539944|NCT03095612|80171646|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
27539945|NCT03095612|80171647|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
27539946|NCT03095612|80171648|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
27539947|NCT00560105|80171649|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
27539948|NCT00560105|80171650|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
27539949|NCT01817530|80171651|FG000|Overall Study|Exclusionary Medication Received|0|||
27539950|NCT01817530|80171652|FG001|Overall Study|Exclusionary Medication Received|0|||
27539951|NCT01817530|80171653|FG002|Overall Study|Exclusionary Medication Received|0|||
27539952|NCT01817530|80171654|FG003|Overall Study|Exclusionary Medication Received|0|||
27539953|NCT01817530|80171655|FG004|Overall Study|Exclusionary Medication Received|1|||
27539954|NCT01817530|80171656|FG005|Overall Study|Exclusionary Medication Received|0|||
27539955|NCT01817530|80171657|FG006|Overall Study|Exclusionary Medication Received|0|||
27539956|NCT01817530|80171658|FG007|Overall Study|Exclusionary Medication Received|0|||
27539957|NCT01817530|80171651|FG000|Overall Study|Adverse Event|6|||
27740802|NCT00404768|80880746|FG002|Part C|Participant delivered baby|0|||
27740803|NCT00404768|80880747|FG003|Part C|Participant delivered baby|1|||
27740804|NCT00404768|80880744|FG000|Part C|Unsatisfactory uterine response to IP|0|||
27539958|NCT01817530|80171652|FG001|Overall Study|Adverse Event|3|||
27539959|NCT01817530|80171653|FG002|Overall Study|Adverse Event|2|||
27539960|NCT01817530|80171654|FG003|Overall Study|Adverse Event|5|||
27539961|NCT01817530|80171655|FG004|Overall Study|Adverse Event|0|||
27539962|NCT01817530|80171656|FG005|Overall Study|Adverse Event|10|||
27539963|NCT01817530|80171657|FG006|Overall Study|Adverse Event|5|||
27539964|NCT01817530|80171658|FG007|Overall Study|Adverse Event|8|||
27539965|NCT01817530|80171651|FG000|Overall Study|Subject Noncompliant|3|||
27539966|NCT01817530|80171652|FG001|Overall Study|Subject Noncompliant|1|||
27539967|NCT01817530|80171653|FG002|Overall Study|Subject Noncompliant|0|||
27539968|NCT01817530|80171654|FG003|Overall Study|Subject Noncompliant|4|||
27539969|NCT01817530|80171655|FG004|Overall Study|Subject Noncompliant|0|||
27539970|NCT01817530|80171656|FG005|Overall Study|Subject Noncompliant|1|||
27539971|NCT01817530|80171657|FG006|Overall Study|Subject Noncompliant|1|||
27539972|NCT01817530|80171658|FG007|Overall Study|Subject Noncompliant|1|||
27539973|NCT01817530|80171651|FG000|Overall Study|Lack of Efficacy|1|||
27539974|NCT01817530|80171652|FG001|Overall Study|Lack of Efficacy|0|||
27539975|NCT01817530|80171653|FG002|Overall Study|Lack of Efficacy|0|||
27539976|NCT01817530|80171654|FG003|Overall Study|Lack of Efficacy|0|||
27539977|NCT01817530|80171655|FG004|Overall Study|Lack of Efficacy|0|||
27539978|NCT01817530|80171656|FG005|Overall Study|Lack of Efficacy|1|||
27539979|NCT01817530|80171657|FG006|Overall Study|Lack of Efficacy|0|||
27539980|NCT01817530|80171658|FG007|Overall Study|Lack of Efficacy|1|||
27539981|NCT01817530|80171651|FG000|Overall Study|Pregnancy|0|||
27539982|NCT01817530|80171652|FG001|Overall Study|Pregnancy|0|||
27539983|NCT01817530|80171653|FG002|Overall Study|Pregnancy|0|||
27539984|NCT01817530|80171654|FG003|Overall Study|Pregnancy|0|||
27539985|NCT01817530|80171655|FG004|Overall Study|Pregnancy|0|||
27539986|NCT01817530|80171656|FG005|Overall Study|Pregnancy|1|||
27539987|NCT01817530|80171657|FG006|Overall Study|Pregnancy|0|||
27539988|NCT01817530|80171658|FG007|Overall Study|Pregnancy|0|||
27539989|NCT01817530|80171651|FG000|Overall Study|Other|0|||
27539990|NCT01817530|80171652|FG001|Overall Study|Other|1|||
27539991|NCT01817530|80171653|FG002|Overall Study|Other|0|||
27539992|NCT01817530|80171654|FG003|Overall Study|Other|0|||
27539993|NCT01817530|80171655|FG004|Overall Study|Other|1|||
27539994|NCT01817530|80171656|FG005|Overall Study|Other|0|||
27539995|NCT01817530|80171657|FG006|Overall Study|Other|5|||
27539996|NCT01817530|80171658|FG007|Overall Study|Other|0|||
27539997|NCT01817530|80171651|FG000|Overall Study|Surgery or Invasive Intervention|1|||
27539998|NCT01817530|80171652|FG001|Overall Study|Surgery or Invasive Intervention|0|||
27539999|NCT01817530|80171653|FG002|Overall Study|Surgery or Invasive Intervention|0|||
27540000|NCT01817530|80171654|FG003|Overall Study|Surgery or Invasive Intervention|0|||
27540001|NCT01817530|80171655|FG004|Overall Study|Surgery or Invasive Intervention|1|||
27540002|NCT01817530|80171656|FG005|Overall Study|Surgery or Invasive Intervention|1|||
27540003|NCT01817530|80171657|FG006|Overall Study|Surgery or Invasive Intervention|1|||
27540004|NCT01817530|80171658|FG007|Overall Study|Surgery or Invasive Intervention|0|||
27540005|NCT01817530|80171651|FG000|Overall Study|Consent Withdrawn by Subject|3|||
27540006|NCT01817530|80171652|FG001|Overall Study|Consent Withdrawn by Subject|4|||
27540007|NCT01817530|80171653|FG002|Overall Study|Consent Withdrawn by Subject|7|||
27540008|NCT01817530|80171654|FG003|Overall Study|Consent Withdrawn by Subject|3|||
27540009|NCT01817530|80171655|FG004|Overall Study|Consent Withdrawn by Subject|5|||
27540010|NCT01817530|80171656|FG005|Overall Study|Consent Withdrawn by Subject|3|||
27918610|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27918611|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
27918612|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
27918613|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27918614|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
27918615|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27918616|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
27918617|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27918618|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27918619|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27540011|NCT01817530|80171657|FG006|Overall Study|Consent Withdrawn by Subject|3|||
27540012|NCT01817530|80171658|FG007|Overall Study|Consent Withdrawn by Subject|10|||
27540013|NCT01817530|80171651|FG000|Overall Study|Lost to Follow-up|1|||
27540014|NCT01817530|80171652|FG001|Overall Study|Lost to Follow-up|4|||
27540015|NCT01817530|80171653|FG002|Overall Study|Lost to Follow-up|2|||
27540016|NCT01817530|80171654|FG003|Overall Study|Lost to Follow-up|1|||
27540017|NCT01817530|80171655|FG004|Overall Study|Lost to Follow-up|3|||
27540018|NCT01817530|80171656|FG005|Overall Study|Lost to Follow-up|2|||
27918620|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27540019|NCT01817530|80171657|FG006|Overall Study|Lost to Follow-up|8|||
27540020|NCT01817530|80171658|FG007|Overall Study|Lost to Follow-up|4|||
27540021|NCT01128842|80171659|FG000|Overall Study|Adverse Event|1|||
27540022|NCT01128842|80171659|FG000|Overall Study|Disease Progression|6|||
27634913|NCT00346333|80503305|FG001|Overall Study|Death|0|||
27634914|NCT00346333|80503304|FG000|Overall Study|unwilling or unable to continue|4|||
27634915|NCT00346333|80503305|FG001|Overall Study|unwilling or unable to continue|8|||
27540023|NCT03685123|80171660|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
27540024|NCT03685123|80171661|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
27540025|NCT03685123|80171662|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
27540026|NCT03685123|80171660|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
27540027|NCT03685123|80171661|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
27540028|NCT03685123|80171662|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
27540029|NCT03685123|80171660|FG000|Weight Loss Phase|Lost to Follow-up|1|||
27540030|NCT03685123|80171661|FG001|Weight Loss Phase|Lost to Follow-up|0|||
27540031|NCT03685123|80171662|FG002|Weight Loss Phase|Lost to Follow-up|0|||
27540032|NCT03685123|80171660|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
27540033|NCT03685123|80171661|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
27634916|NCT02999477|80503310|FG000|Overall Study|found ineligible after first dose|0|||
27634917|NCT02999477|80503311|FG001|Overall Study|found ineligible after first dose|1|||
27634918|NCT02999477|80503310|FG000|Overall Study|Withdrawal by Subject|1|||
27634919|NCT02999477|80503311|FG001|Overall Study|Withdrawal by Subject|1|||
27634920|NCT01373346|80503314|FG000|Overall Study|Death|1|||
27634921|NCT02488980|80503315|FG000|Overall Study|Protocol Violation|2|||
27634922|NCT02488980|80503316|FG001|Overall Study|Protocol Violation|2|||
27634923|NCT02488980|80503317|FG002|Overall Study|Protocol Violation|2|||
27634924|NCT02705586|80503321|FG000|Overall Study|Health Issues|2|||
27634925|NCT02705586|80503321|FG000|Overall Study|Transportation Difficulties|5|||
27634926|NCT02705586|80503321|FG000|Overall Study|Vacation/Planned Absence|1|||
27634927|NCT03737240|80503322|FG000|Overall Study|Lost to Follow-up|16|||
27634928|NCT03737240|80503323|FG001|Overall Study|Lost to Follow-up|15|||
27634929|NCT01161498|80503324|FG000|Overall Study|Disease Progression|0|||
27634930|NCT01161498|80503325|FG001|Overall Study|Disease Progression|1|||
27634931|NCT02879695|80503326|FG000|Overall Study|Did not start study treatment|2|||
27634932|NCT02879695|80503327|FG001|Overall Study|Did not start study treatment|0|||
27634933|NCT02879695|80503328|FG002|Overall Study|Did not start study treatment|3|||
27634934|NCT02879695|80503329|FG003|Overall Study|Did not start study treatment|0|||
27634935|NCT04594759|80503330|FG000|Overall Study|Lost to Follow-up|3|||
27634936|NCT02139046|80503335|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27634937|NCT02139046|80503336|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
27634938|NCT02139046|80503337|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
27634939|NCT02139046|80503338|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
27634940|NCT02139046|80503339|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
27634941|NCT02139046|80503335|FG000|Overall Study|Major Protocol Deviation|9|||
27634942|NCT02139046|80503336|FG001|Overall Study|Major Protocol Deviation|10|||
27634943|NCT02139046|80503337|FG002|Overall Study|Major Protocol Deviation|16|||
27634944|NCT02139046|80503338|FG003|Overall Study|Major Protocol Deviation|12|||
27634945|NCT02139046|80503339|FG004|Overall Study|Major Protocol Deviation|6|||
27634946|NCT02139046|80503335|FG000|Overall Study|Lost to Follow-up|13|||
27634947|NCT02139046|80503336|FG001|Overall Study|Lost to Follow-up|16|||
27634948|NCT02139046|80503337|FG002|Overall Study|Lost to Follow-up|16|||
27634949|NCT02139046|80503338|FG003|Overall Study|Lost to Follow-up|18|||
27634950|NCT02139046|80503339|FG004|Overall Study|Lost to Follow-up|13|||
27634951|NCT02139046|80503335|FG000|Overall Study|Voluntary Withdrawal|20|||
27634952|NCT02139046|80503336|FG001|Overall Study|Voluntary Withdrawal|8|||
27634953|NCT02139046|80503337|FG002|Overall Study|Voluntary Withdrawal|10|||
27634954|NCT02139046|80503338|FG003|Overall Study|Voluntary Withdrawal|15|||
27634955|NCT02139046|80503339|FG004|Overall Study|Voluntary Withdrawal|16|||
27634956|NCT02139046|80503335|FG000|Overall Study|Lack of Efficacy|0|||
27634957|NCT02139046|80503336|FG001|Overall Study|Lack of Efficacy|1|||
27634958|NCT02139046|80503337|FG002|Overall Study|Lack of Efficacy|2|||
27634959|NCT02139046|80503338|FG003|Overall Study|Lack of Efficacy|1|||
27634960|NCT02139046|80503339|FG004|Overall Study|Lack of Efficacy|2|||
27634961|NCT02139046|80503335|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
27918621|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
27540034|NCT03685123|80171662|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
27634962|NCT02139046|80503336|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
27634963|NCT02139046|80503337|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
27918622|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27634964|NCT02139046|80503338|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
27634965|NCT02139046|80503339|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
27634966|NCT02139046|80503335|FG000|Overall Study|Other Miscellaneous Reasons|10|||
27634967|NCT02139046|80503336|FG001|Overall Study|Other Miscellaneous Reasons|9|||
27634968|NCT02139046|80503337|FG002|Overall Study|Other Miscellaneous Reasons|4|||
27634969|NCT02139046|80503338|FG003|Overall Study|Other Miscellaneous Reasons|9|||
27634970|NCT02139046|80503339|FG004|Overall Study|Other Miscellaneous Reasons|12|||
27634971|NCT00949975|80503340|FG000|Overall Study|Voluntary discontinuation|6|||
27634972|NCT00949975|80503341|FG001|Overall Study|Voluntary discontinuation|5|||
27540035|NCT03685123|80171660|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
27540036|NCT03685123|80171661|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
27540037|NCT03685123|80171662|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
27540038|NCT03685123|80171660|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
27540039|NCT03685123|80171661|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
27540040|NCT03685123|80171662|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
27540041|NCT01797731|80171668|FG000|Overall Study|Didn't have proper radiographs required|3|||
27540042|NCT01797731|80171669|FG001|Overall Study|Didn't have proper radiographs required|3|||
27540043|NCT00491764|80171680|FG000|Overall Study|Adverse Event|1|||
27540044|NCT00491764|80171681|FG001|Overall Study|Adverse Event|2|||
27540045|NCT00491764|80171682|FG002|Overall Study|Adverse Event|4|||
27540046|NCT00491764|80171683|FG003|Overall Study|Adverse Event|4|||
27540047|NCT00491764|80171684|FG004|Overall Study|Adverse Event|0|||
27540048|NCT00491764|80171685|FG005|Overall Study|Adverse Event|1|||
27540049|NCT00491764|80171680|FG000|Overall Study|Lost to Follow-up|0|||
27540050|NCT00491764|80171681|FG001|Overall Study|Lost to Follow-up|1|||
27540051|NCT00491764|80171682|FG002|Overall Study|Lost to Follow-up|0|||
27540052|NCT00491764|80171683|FG003|Overall Study|Lost to Follow-up|1|||
27540053|NCT00491764|80171684|FG004|Overall Study|Lost to Follow-up|0|||
27634973|NCT00949975|80503342|FG002|Overall Study|Voluntary discontinuation|3|||
27634974|NCT00949975|80503343|FG003|Overall Study|Voluntary discontinuation|6|||
27634975|NCT00949975|80503340|FG000|Overall Study|Adverse Event|11|||
27634976|NCT00949975|80503341|FG001|Overall Study|Adverse Event|11|||
27634977|NCT00949975|80503342|FG002|Overall Study|Adverse Event|10|||
27634978|NCT00949975|80503343|FG003|Overall Study|Adverse Event|10|||
27634979|NCT00949975|80503340|FG000|Overall Study|Safety reason|0|||
27918623|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
27918624|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
27918625|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27918626|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
27634980|NCT00949975|80503341|FG001|Overall Study|Safety reason|1|||
27918627|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27918628|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27918629|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27918630|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27918631|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
27634981|NCT00949975|80503342|FG002|Overall Study|Safety reason|0|||
27634982|NCT00949975|80503343|FG003|Overall Study|Safety reason|0|||
27634983|NCT00949975|80503340|FG000|Overall Study|Study-specific criteria|0|||
27634984|NCT00949975|80503341|FG001|Overall Study|Study-specific criteria|1|||
27634985|NCT00949975|80503342|FG002|Overall Study|Study-specific criteria|1|||
27634986|NCT00949975|80503343|FG003|Overall Study|Study-specific criteria|0|||
27634987|NCT00949975|80503340|FG000|Overall Study|Incorrect enrolment|5|||
27634988|NCT00949975|80503341|FG001|Overall Study|Incorrect enrolment|10|||
27634989|NCT00949975|80503342|FG002|Overall Study|Incorrect enrolment|4|||
27634990|NCT00949975|80503343|FG003|Overall Study|Incorrect enrolment|7|||
27634991|NCT00949975|80503340|FG000|Overall Study|Severe non-compliance|3|||
27634992|NCT00949975|80503341|FG001|Overall Study|Severe non-compliance|1|||
27634993|NCT00949975|80503342|FG002|Overall Study|Severe non-compliance|0|||
27634994|NCT00949975|80503343|FG003|Overall Study|Severe non-compliance|2|||
27634995|NCT00949975|80503340|FG000|Overall Study|Lost to Follow-up|1|||
27634996|NCT00949975|80503341|FG001|Overall Study|Lost to Follow-up|0|||
27634997|NCT00949975|80503342|FG002|Overall Study|Lost to Follow-up|1|||
27634998|NCT00949975|80503343|FG003|Overall Study|Lost to Follow-up|3|||
27634999|NCT00949975|80503340|FG000|Overall Study|Other|1|||
27635000|NCT00949975|80503341|FG001|Overall Study|Other|0|||
27635001|NCT00949975|80503342|FG002|Overall Study|Other|0|||
27635002|NCT00949975|80503343|FG003|Overall Study|Other|0|||
27635003|NCT01692938|80503347|FG000|Overall Study|Protocol Deviation|1|||
27635004|NCT01692938|80503348|FG001|Overall Study|Protocol Deviation|1|||
27635005|NCT01692938|80503347|FG000|Overall Study|Study completed prior to site completion|3|||
27635006|NCT01692938|80503348|FG001|Overall Study|Study completed prior to site completion|3|||
27740805|NCT00404768|80880745|FG001|Part C|Unsatisfactory uterine response to IP|0|||
27540054|NCT00491764|80171685|FG005|Overall Study|Lost to Follow-up|3|||
27540055|NCT00491764|80171680|FG000|Overall Study|Withdrawal by Subject|2|||
27540056|NCT00491764|80171681|FG001|Overall Study|Withdrawal by Subject|3|||
27635007|NCT00617201|80503353|FG000|Overall Study|Lost to Follow-up|9|||
27635008|NCT00617201|80503354|FG001|Overall Study|Lost to Follow-up|13|||
27635009|NCT02139943|80503356|FG000|Overall Study|Adverse Event|0|||
27635010|NCT02139943|80503357|FG001|Overall Study|Adverse Event|1|||
27740806|NCT00404768|80880746|FG002|Part C|Unsatisfactory uterine response to IP|0|||
27540057|NCT00491764|80171682|FG002|Overall Study|Withdrawal by Subject|1|||
27540058|NCT00491764|80171683|FG003|Overall Study|Withdrawal by Subject|2|||
27635011|NCT02139943|80503358|FG002|Overall Study|Adverse Event|2|||
27635012|NCT02139943|80503356|FG000|Overall Study|Lost to Follow-up|3|||
27918632|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
27918633|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
27918634|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
27918635|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27918636|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
27918637|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918638|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918639|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918640|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918641|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
27918642|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918643|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918644|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918645|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918646|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
27918647|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918648|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918649|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918650|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918651|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
27918652|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918653|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
27918654|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
27918655|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918656|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
27918657|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918658|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918659|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918660|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918661|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918662|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918663|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918664|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
27918665|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918666|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
27918667|NCT01232283|81539714|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918668|NCT01232283|81539715|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918669|NCT01232283|81539716|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27540059|NCT00491764|80171684|FG004|Overall Study|Withdrawal by Subject|2|||
27540060|NCT00491764|80171685|FG005|Overall Study|Withdrawal by Subject|4|||
27540061|NCT00491764|80171680|FG000|Overall Study|Non Compliance with the Protocol|1|||
27540062|NCT00491764|80171681|FG001|Overall Study|Non Compliance with the Protocol|0|||
27540063|NCT00491764|80171682|FG002|Overall Study|Non Compliance with the Protocol|0|||
27540064|NCT00491764|80171683|FG003|Overall Study|Non Compliance with the Protocol|0|||
27540065|NCT00491764|80171684|FG004|Overall Study|Non Compliance with the Protocol|0|||
27540066|NCT00491764|80171685|FG005|Overall Study|Non Compliance with the Protocol|0|||
27540067|NCT00491764|80171680|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
27540068|NCT00491764|80171681|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
27540069|NCT00491764|80171682|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
27540070|NCT00491764|80171683|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
27540071|NCT00491764|80171684|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
27540072|NCT00491764|80171685|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
27540073|NCT00491764|80171680|FG000|Overall Study|Administrative|1|||
27540074|NCT00491764|80171681|FG001|Overall Study|Administrative|0|||
27540075|NCT00491764|80171682|FG002|Overall Study|Administrative|2|||
27540076|NCT00491764|80171683|FG003|Overall Study|Administrative|1|||
27540077|NCT00491764|80171684|FG004|Overall Study|Administrative|0|||
27918670|NCT01232283|81539717|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918671|NCT01232283|81539718|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918672|NCT01232283|81539719|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
27918673|NCT01232283|81539720|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918674|NCT01232283|81539721|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918675|NCT01232283|81539722|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27918676|NCT01232283|81539723|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
27540078|NCT00491764|80171685|FG005|Overall Study|Administrative|0|||
27540079|NCT05306977|80171686|FG000|Overall Study|Withdrawal by Subject|1|||
27540080|NCT00799422|80171687|FG000|First Week of Wear|Lost to Follow-up|0|||
27918677|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27635013|NCT02139943|80503357|FG001|Overall Study|Lost to Follow-up|2|||
27635014|NCT02139943|80503358|FG002|Overall Study|Lost to Follow-up|2|||
27635015|NCT02139943|80503356|FG000|Overall Study|Withdrawal by Subject|4|||
27635016|NCT02139943|80503357|FG001|Overall Study|Withdrawal by Subject|3|||
27635017|NCT02139943|80503358|FG002|Overall Study|Withdrawal by Subject|0|||
27635018|NCT02139943|80503356|FG000|Overall Study|Other|0|||
27635019|NCT02139943|80503357|FG001|Overall Study|Other|0|||
27635020|NCT02139943|80503358|FG002|Overall Study|Other|1|||
27635021|NCT02139943|80503356|FG000|Overall Study|Participant wishes to discontinue|2|||
27635022|NCT02139943|80503357|FG001|Overall Study|Participant wishes to discontinue|0|||
27635023|NCT02139943|80503358|FG002|Overall Study|Participant wishes to discontinue|0|||
27635024|NCT02139943|80503356|FG000|Overall Study|Participant in Poor Compliance|1|||
27635025|NCT02139943|80503357|FG001|Overall Study|Participant in Poor Compliance|0|||
27635026|NCT02139943|80503358|FG002|Overall Study|Participant in Poor Compliance|1|||
27635027|NCT02139943|80503356|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
27635028|NCT02139943|80503357|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
27635029|NCT02139943|80503358|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
27635030|NCT00835380|80503361|FG000|Overall Study|Withdrawal by Subject|2|||
27635031|NCT01081145|80505807|FG000|Open-Label Phase|Lack of Efficacy|56|||
27635032|NCT01081145|80505808|FG001|Open-Label Phase|Lack of Efficacy|0|||
27635033|NCT01081145|80505807|FG000|Open-Label Phase|Response criteria not met|46|||
27635034|NCT01081145|80505808|FG001|Open-Label Phase|Response criteria not met|0|||
27635035|NCT01081145|80505807|FG000|Open-Label Phase|Adverse Event|42|||
27635036|NCT01081145|80505808|FG001|Open-Label Phase|Adverse Event|0|||
27635037|NCT01081145|80505807|FG000|Open-Label Phase|Withdrawal by Subject|41|||
27635038|NCT01081145|80505808|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27635039|NCT01081145|80505807|FG000|Open-Label Phase|Other|12|||
27635040|NCT01081145|80505808|FG001|Open-Label Phase|Other|0|||
27635041|NCT01081145|80505807|FG000|Open-Label Phase|Lost to Follow-up|11|||
27635042|NCT01081145|80505808|FG001|Open-Label Phase|Lost to Follow-up|0|||
27635043|NCT01081145|80505807|FG000|Open-Label Phase|Protocol Violation|4|||
27635044|NCT01081145|80505808|FG001|Open-Label Phase|Protocol Violation|0|||
27635045|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
27635046|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
27918678|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918679|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918680|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918681|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918682|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918683|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918684|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
27918685|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
27918686|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
27918687|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918688|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918689|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918690|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918691|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918692|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918693|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918694|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
27918695|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
27918696|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
27918697|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918698|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918699|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918700|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918701|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918702|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918703|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918704|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
27918705|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
27918706|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
27918707|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918708|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918709|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918710|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918711|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918712|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918713|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918714|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
27918715|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
27918716|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
27918717|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918718|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27635047|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
27635048|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
27635049|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
27635050|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
27635051|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
27635052|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
27635053|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
27635054|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
27635055|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
27635056|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
27635057|NCT01081145|80505807|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
27635058|NCT01081145|80505808|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
27740807|NCT00404768|80880747|FG003|Part C|Unsatisfactory uterine response to IP|1|||
27740808|NCT00404768|80880744|FG000|Part C|Active labor|0|||
27740809|NCT00404768|80880745|FG001|Part C|Active labor|0|||
27740810|NCT00404768|80880746|FG002|Part C|Active labor|0|||
27740811|NCT00404768|80880747|FG003|Part C|Active labor|1|||
27740812|NCT00404768|80880744|FG000|Part C|Lack of Efficacy|0|||
27740813|NCT00404768|80880745|FG001|Part C|Lack of Efficacy|0|||
27740814|NCT00404768|80880746|FG002|Part C|Lack of Efficacy|0|||
27740815|NCT00404768|80880747|FG003|Part C|Lack of Efficacy|2|||
27740816|NCT00404768|80880744|FG000|Part C|Treatment failure|0|||
27740817|NCT00404768|80880745|FG001|Part C|Treatment failure|0|||
27740818|NCT00404768|80880746|FG002|Part C|Treatment failure|0|||
27740819|NCT00404768|80880747|FG003|Part C|Treatment failure|1|||
27740820|NCT00404768|80880744|FG000|Part C|Investigator discretion|0|||
27740821|NCT00404768|80880745|FG001|Part C|Investigator discretion|0|||
27740822|NCT00404768|80880746|FG002|Part C|Investigator discretion|0|||
27740823|NCT00404768|80880747|FG003|Part C|Investigator discretion|1|||
27740824|NCT00404768|80880744|FG000|Part C|Researcher suspended study medication|0|||
27740825|NCT00404768|80880745|FG001|Part C|Researcher suspended study medication|0|||
27740826|NCT00404768|80880746|FG002|Part C|Researcher suspended study medication|0|||
27740827|NCT00404768|80880747|FG003|Part C|Researcher suspended study medication|1|||
27740828|NCT01522651|80880751|FG000|Overall Study|Adverse Event|3|||
27740829|NCT01522651|80880752|FG001|Overall Study|Adverse Event|4|||
27740830|NCT01522651|80880753|FG002|Overall Study|Adverse Event|4|||
27740831|NCT01522651|80880754|FG003|Overall Study|Adverse Event|5|||
27918719|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918720|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918721|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918722|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918723|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918724|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
27918725|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
27918726|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
27918727|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918728|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918729|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918730|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918731|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918732|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918733|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918734|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918735|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
27918736|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
27918737|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918738|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918739|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918740|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27635059|NCT00703911|80505817|FG000|Overall Study|Death|1|||
27635060|NCT00703911|80505817|FG000|Overall Study|Physician Decision|6|||
27740832|NCT01522651|80880755|FG004|Overall Study|Adverse Event|4|||
27740833|NCT01522651|80880751|FG000|Overall Study|Cardioversion|1|||
27740834|NCT01522651|80880752|FG001|Overall Study|Cardioversion|0|||
27635061|NCT00703911|80505817|FG000|Overall Study|Lost to Follow-up|1|||
27635062|NCT00703911|80505817|FG000|Overall Study|Withdrawal by Subject|2|||
27635063|NCT05190419|80505818|FG000|Overall Study|Lack of Efficacy|8|||
27635064|NCT05190419|80505819|FG001|Overall Study|Lack of Efficacy|0|||
27635065|NCT05190419|80505820|FG002|Overall Study|Lack of Efficacy|1|||
27635066|NCT05190419|80505821|FG003|Overall Study|Lack of Efficacy|0|||
27635067|NCT05190419|80505818|FG000|Overall Study|Withdrawal by Subject|7|||
27635068|NCT05190419|80505819|FG001|Overall Study|Withdrawal by Subject|1|||
27635069|NCT05190419|80505820|FG002|Overall Study|Withdrawal by Subject|2|||
27635070|NCT05190419|80505821|FG003|Overall Study|Withdrawal by Subject|2|||
27635071|NCT05190419|80505818|FG000|Overall Study|Adverse Event|2|||
27635072|NCT05190419|80505819|FG001|Overall Study|Adverse Event|10|||
27635073|NCT05190419|80505820|FG002|Overall Study|Adverse Event|11|||
27635074|NCT05190419|80505821|FG003|Overall Study|Adverse Event|21|||
27635075|NCT05190419|80505818|FG000|Overall Study|Lost to Follow-up|1|||
27635076|NCT05190419|80505819|FG001|Overall Study|Lost to Follow-up|2|||
27635077|NCT05190419|80505820|FG002|Overall Study|Lost to Follow-up|3|||
27635078|NCT05190419|80505821|FG003|Overall Study|Lost to Follow-up|1|||
27635079|NCT05190419|80505818|FG000|Overall Study|Other|1|||
27635080|NCT05190419|80505819|FG001|Overall Study|Other|1|||
27635081|NCT05190419|80505820|FG002|Overall Study|Other|0|||
27635082|NCT05190419|80505821|FG003|Overall Study|Other|3|||
27635083|NCT00178399|80505822|FG000|Overall Study|Physician Decision|4|||
27635084|NCT00178399|80505822|FG000|Overall Study|Withdrawal by Subject|8|||
27635085|NCT00178399|80505822|FG000|Overall Study|Lost to Follow-up|1|||
27635086|NCT04200365|80505824|FG000|Overall Study|Adverse Event|2|||
27635087|NCT04200365|80505824|FG000|Overall Study|Progressive Disease|4|||
27635088|NCT04200365|80505824|FG000|Overall Study|Lack of Efficacy|1|||
27635089|NCT04200365|80505824|FG000|Overall Study|Study Closure|4|||
27635090|NCT00470704|80505827|FG000|Overall Study|Withdrawal by Subject|4|||
27635091|NCT00470704|80505828|FG001|Overall Study|Withdrawal by Subject|3|||
27635092|NCT00470704|80505827|FG000|Overall Study|Relapse/Progression|37|||
27635093|NCT00470704|80505828|FG001|Overall Study|Relapse/Progression|42|||
27635094|NCT00470704|80505827|FG000|Overall Study|toxicity|0|||
27635095|NCT00470704|80505828|FG001|Overall Study|toxicity|1|||
27918741|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918742|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918743|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918744|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918745|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
27918746|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
27918747|NCT01232283|81539714|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918748|NCT01232283|81539715|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918749|NCT01232283|81539716|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918750|NCT01232283|81539717|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918751|NCT01232283|81539718|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918752|NCT01232283|81539719|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918753|NCT01232283|81539720|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918754|NCT01232283|81539721|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
27918755|NCT01232283|81539722|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
27918756|NCT01232283|81539723|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
27918757|NCT01100853|81539724|FG000|Overall Study|Lost to Follow-up|11|||
27918758|NCT01100853|81539725|FG001|Overall Study|Lost to Follow-up|6|||
27918759|NCT01100853|81539724|FG000|Overall Study|Received <4 study injections|10|||
27918760|NCT01100853|81539725|FG001|Overall Study|Received <4 study injections|13|||
27918761|NCT01100853|81539724|FG000|Overall Study|Withdrawal by Subject|6|||
27918762|NCT01100853|81539725|FG001|Overall Study|Withdrawal by Subject|4|||
27918763|NCT03410823|81539726|FG000|Overall Study|Death|1|||
27918764|NCT03410823|81539726|FG000|Overall Study|Withdrawal by Subject|2|||
27918765|NCT03410823|81539726|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
27918766|NCT01118052|81539731|FG000|Overall Study|Never treated|2|||
27918767|NCT00785356|81539732|FG000|Overall Study|Study prematurely terminated|8|||
27918768|NCT01053741|81539733|FG000|2nd Study Intervention|Physician Decision|0|||
27635096|NCT00457743|80505829|FG000|Overall Study|Adverse Event|0|||
27635097|NCT00457743|80505830|FG001|Overall Study|Adverse Event|4|||
27635098|NCT00457743|80505831|FG002|Overall Study|Adverse Event|0|||
27918769|NCT01053741|81539734|FG001|2nd Study Intervention|Physician Decision|1|||
27918770|NCT04006145|81539741|FG000|Overall Study|Lost to Follow-up|0|||
27918771|NCT04006145|81539742|FG001|Overall Study|Lost to Follow-up|1|||
27918772|NCT04006145|81539741|FG000|Overall Study|Other|1|||
27635099|NCT00457743|80505829|FG000|Overall Study|Lack of Efficacy|3|||
27635100|NCT00457743|80505830|FG001|Overall Study|Lack of Efficacy|23|||
27635101|NCT00457743|80505831|FG002|Overall Study|Lack of Efficacy|3|||
27635102|NCT01430611|80505833|FG000|Overall Study|Adverse Event|0|||
27635103|NCT01430611|80505834|FG001|Overall Study|Adverse Event|1|||
27635104|NCT01430611|80505833|FG000|Overall Study|Protocol Violation|1|||
27635105|NCT01430611|80505834|FG001|Overall Study|Protocol Violation|0|||
27635106|NCT01430611|80505833|FG000|Overall Study|Lost to Follow-up|1|||
27635107|NCT01430611|80505834|FG001|Overall Study|Lost to Follow-up|0|||
27635108|NCT01430611|80505833|FG000|Overall Study|Withdrawal by Subject|15|||
27635109|NCT01430611|80505834|FG001|Overall Study|Withdrawal by Subject|14|||
27635110|NCT05283395|80505839|FG000|Overall Study|Adverse Event|4|||
27635111|NCT05283395|80505840|FG001|Overall Study|Adverse Event|4|||
27635112|NCT05283395|80505841|FG002|Overall Study|Adverse Event|0|||
27635113|NCT05283395|80505839|FG000|Overall Study|Patient Lost to Follow-Up|0|||
27635114|NCT05283395|80505840|FG001|Overall Study|Patient Lost to Follow-Up|0|||
27635115|NCT05283395|80505841|FG002|Overall Study|Patient Lost to Follow-Up|1|||
27635116|NCT05283395|80505839|FG000|Overall Study|Patient Withdrawal|2|||
27635117|NCT05283395|80505840|FG001|Overall Study|Patient Withdrawal|4|||
27635118|NCT05283395|80505841|FG002|Overall Study|Patient Withdrawal|2|||
27635119|NCT05283395|80505839|FG000|Overall Study|Investigator Decision|1|||
27635120|NCT05283395|80505840|FG001|Overall Study|Investigator Decision|0|||
27635121|NCT05283395|80505841|FG002|Overall Study|Investigator Decision|1|||
27635122|NCT05283395|80505839|FG000|Overall Study|Enrolled in error|0|||
27635123|NCT05283395|80505840|FG001|Overall Study|Enrolled in error|0|||
27635124|NCT05283395|80505841|FG002|Overall Study|Enrolled in error|1|||
27635125|NCT00951379|80505842|FG000|Overall Study|Adverse Event|4|||
27635126|NCT00951379|80505843|FG001|Overall Study|Adverse Event|1|||
27635127|NCT00951379|80505842|FG000|Overall Study|Withdrawal by Subject|1|||
27635128|NCT00951379|80505843|FG001|Overall Study|Withdrawal by Subject|0|||
27635129|NCT00951379|80505842|FG000|Overall Study|Noncompliance|1|||
27635130|NCT00951379|80505843|FG001|Overall Study|Noncompliance|0|||
27635131|NCT00951379|80505842|FG000|Overall Study|Disease Progression|0|||
27635132|NCT00951379|80505843|FG001|Overall Study|Disease Progression|1|||
27635133|NCT02341625|80505844|FG000|Overall Study|Disease Progression|2|||
27635134|NCT02341625|80505845|FG001|Overall Study|Disease Progression|2|||
27635135|NCT02341625|80505846|FG002|Overall Study|Disease Progression|3|||
27635136|NCT02341625|80505847|FG003|Overall Study|Disease Progression|6|||
27635137|NCT02341625|80505848|FG004|Overall Study|Disease Progression|7|||
27635138|NCT02341625|80505849|FG005|Overall Study|Disease Progression|7|||
27635139|NCT02341625|80505850|FG006|Overall Study|Disease Progression|28|||
27635140|NCT02341625|80505851|FG007|Overall Study|Disease Progression|5|||
27635141|NCT02341625|80505852|FG008|Overall Study|Disease Progression|4|||
27635142|NCT02341625|80505853|FG009|Overall Study|Disease Progression|19|||
27635143|NCT02341625|80505844|FG000|Overall Study|Study Drug Toxicity|0|||
27635144|NCT02341625|80505845|FG001|Overall Study|Study Drug Toxicity|0|||
27635145|NCT02341625|80505846|FG002|Overall Study|Study Drug Toxicity|0|||
27635146|NCT02341625|80505847|FG003|Overall Study|Study Drug Toxicity|1|||
27635147|NCT02341625|80505848|FG004|Overall Study|Study Drug Toxicity|0|||
27635148|NCT02341625|80505849|FG005|Overall Study|Study Drug Toxicity|3|||
27635149|NCT02341625|80505850|FG006|Overall Study|Study Drug Toxicity|10|||
27635150|NCT02341625|80505851|FG007|Overall Study|Study Drug Toxicity|0|||
27635151|NCT02341625|80505852|FG008|Overall Study|Study Drug Toxicity|0|||
27635152|NCT02341625|80505853|FG009|Overall Study|Study Drug Toxicity|3|||
27635153|NCT02341625|80505844|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635154|NCT02341625|80505845|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635155|NCT02341625|80505846|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635156|NCT02341625|80505847|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635157|NCT02341625|80505848|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635158|NCT02341625|80505849|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635159|NCT02341625|80505850|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27635160|NCT02341625|80505851|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
27635161|NCT02341625|80505852|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27635162|NCT02341625|80505853|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27918773|NCT04006145|81539742|FG001|Overall Study|Other|2|||
27918774|NCT03006562|81539745|FG000|Overall Study|Lost to Follow-up|0|||
27918775|NCT03006562|81539746|FG001|Overall Study|Lost to Follow-up|1|||
27918776|NCT03555149|81539748|FG000|Overall Study|Death|18|||
27918777|NCT03555149|81539749|FG001|Overall Study|Death|15|||
27635163|NCT02341625|80505844|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635164|NCT02341625|80505845|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635165|NCT02341625|80505846|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635166|NCT02341625|80505847|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27918778|NCT03555149|81539750|FG002|Overall Study|Death|15|||
27740835|NCT01522651|80880753|FG002|Overall Study|Cardioversion|0|||
27740836|NCT01522651|80880754|FG003|Overall Study|Cardioversion|0|||
27635167|NCT02341625|80505848|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635168|NCT02341625|80505849|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635169|NCT02341625|80505850|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
27635170|NCT02341625|80505851|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
27740837|NCT01522651|80880755|FG004|Overall Study|Cardioversion|0|||
27918779|NCT03555149|81539751|FG003|Overall Study|Death|4|||
27635171|NCT02341625|80505852|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635172|NCT02341625|80505853|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
27635173|NCT02341625|80505844|FG000|Overall Study|Participant Withdrew Consent|0|||
27635174|NCT02341625|80505845|FG001|Overall Study|Participant Withdrew Consent|0|||
27635175|NCT02341625|80505846|FG002|Overall Study|Participant Withdrew Consent|0|||
27635176|NCT02341625|80505847|FG003|Overall Study|Participant Withdrew Consent|1|||
27635177|NCT02341625|80505848|FG004|Overall Study|Participant Withdrew Consent|0|||
27635178|NCT02341625|80505849|FG005|Overall Study|Participant Withdrew Consent|0|||
27635179|NCT02341625|80505850|FG006|Overall Study|Participant Withdrew Consent|0|||
27635180|NCT02341625|80505851|FG007|Overall Study|Participant Withdrew Consent|0|||
27635181|NCT02341625|80505852|FG008|Overall Study|Participant Withdrew Consent|0|||
27635182|NCT02341625|80505853|FG009|Overall Study|Participant Withdrew Consent|0|||
27635183|NCT02341625|80505844|FG000|Overall Study|Completed Treatment as per Protocol|0|||
27918780|NCT03555149|81539752|FG004|Overall Study|Death|4|||
27635184|NCT02341625|80505845|FG001|Overall Study|Completed Treatment as per Protocol|0|||
27635185|NCT02341625|80505846|FG002|Overall Study|Completed Treatment as per Protocol|0|||
27635186|NCT02341625|80505847|FG003|Overall Study|Completed Treatment as per Protocol|0|||
27635187|NCT02341625|80505848|FG004|Overall Study|Completed Treatment as per Protocol|0|||
27918781|NCT03555149|81539753|FG005|Overall Study|Death|11|||
27918782|NCT03555149|81539754|FG006|Overall Study|Death|12|||
27918783|NCT03555149|81539755|FG007|Overall Study|Death|1|||
27918784|NCT03555149|81539748|FG000|Overall Study|Lost to Follow-up|1|||
27918785|NCT03555149|81539749|FG001|Overall Study|Lost to Follow-up|0|||
27918786|NCT03555149|81539750|FG002|Overall Study|Lost to Follow-up|0|||
27918787|NCT03555149|81539751|FG003|Overall Study|Lost to Follow-up|0|||
27918788|NCT03555149|81539752|FG004|Overall Study|Lost to Follow-up|0|||
27918789|NCT03555149|81539753|FG005|Overall Study|Lost to Follow-up|1|||
27918790|NCT03555149|81539754|FG006|Overall Study|Lost to Follow-up|0|||
27918791|NCT03555149|81539755|FG007|Overall Study|Lost to Follow-up|0|||
27918792|NCT03555149|81539748|FG000|Overall Study|Physician Decision|1|||
27918793|NCT03555149|81539749|FG001|Overall Study|Physician Decision|0|||
27918794|NCT03555149|81539750|FG002|Overall Study|Physician Decision|0|||
27918795|NCT03555149|81539751|FG003|Overall Study|Physician Decision|0|||
27918796|NCT03555149|81539752|FG004|Overall Study|Physician Decision|0|||
27918797|NCT03555149|81539753|FG005|Overall Study|Physician Decision|0|||
27918798|NCT03555149|81539754|FG006|Overall Study|Physician Decision|0|||
27918799|NCT03555149|81539755|FG007|Overall Study|Physician Decision|0|||
27918800|NCT03555149|81539748|FG000|Overall Study|Study Terminated By Sponsor|1|||
27918801|NCT03555149|81539749|FG001|Overall Study|Study Terminated By Sponsor|0|||
27918802|NCT03555149|81539750|FG002|Overall Study|Study Terminated By Sponsor|0|||
27918803|NCT03555149|81539751|FG003|Overall Study|Study Terminated By Sponsor|0|||
27918804|NCT03555149|81539752|FG004|Overall Study|Study Terminated By Sponsor|0|||
27918805|NCT03555149|81539753|FG005|Overall Study|Study Terminated By Sponsor|2|||
27918806|NCT03555149|81539754|FG006|Overall Study|Study Terminated By Sponsor|3|||
27918807|NCT03555149|81539755|FG007|Overall Study|Study Terminated By Sponsor|1|||
27918808|NCT03555149|81539748|FG000|Overall Study|Withdrawal by Subject|3|||
27918809|NCT03555149|81539749|FG001|Overall Study|Withdrawal by Subject|0|||
27918810|NCT03555149|81539750|FG002|Overall Study|Withdrawal by Subject|0|||
27918811|NCT03555149|81539751|FG003|Overall Study|Withdrawal by Subject|2|||
27918812|NCT03555149|81539752|FG004|Overall Study|Withdrawal by Subject|0|||
27918813|NCT03555149|81539753|FG005|Overall Study|Withdrawal by Subject|1|||
27918814|NCT03555149|81539754|FG006|Overall Study|Withdrawal by Subject|0|||
27918815|NCT03555149|81539755|FG007|Overall Study|Withdrawal by Subject|0|||
27635188|NCT02341625|80505849|FG005|Overall Study|Completed Treatment as per Protocol|0|||
27740838|NCT01522651|80880751|FG000|Overall Study|Device Malfunction|0|||
27918816|NCT00192114|81539756|FG000|Overall Study|Objective Tumor Progression|19|||
27918817|NCT00192114|81539756|FG000|Overall Study|Adverse Event|2|||
27918818|NCT00192114|81539756|FG000|Overall Study|Clinical Progression|2|||
27918819|NCT00192114|81539756|FG000|Overall Study|Death|1|||
27918820|NCT04356937|81539759|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
27918821|NCT04356937|81539760|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
27918822|NCT02404545|81539762|FG000|Overall Study|Sponsor Termination|6|||
27918823|NCT02404545|81539763|FG001|Overall Study|Sponsor Termination|6|||
27918824|NCT02051296|81539775|FG000|Overall Study|Lost to Follow-up|1|||
27918825|NCT02051296|81539776|FG001|Overall Study|Lost to Follow-up|2|||
27918826|NCT02051296|81539775|FG000|Overall Study|withdraw prior to treatment|7|||
27918827|NCT02051296|81539776|FG001|Overall Study|withdraw prior to treatment|7|||
27918828|NCT02247466|81539777|FG000|Overall Study|Procedure changed to open surgery|0|||
27918829|NCT02247466|81539778|FG001|Overall Study|Procedure changed to open surgery|3|||
27918830|NCT00909844|81539783|FG000|Overall Study|Adverse Event|1|||
27918831|NCT00909844|81539783|FG000|Overall Study|Withdrawal by Subject|1|||
27918832|NCT00909844|81539783|FG000|Overall Study|Lost to Follow-up|2|||
27918833|NCT03713281|81539784|FG000|Overall Study|Lens handling difficuluties|2|||
27740839|NCT01522651|80880752|FG001|Overall Study|Device Malfunction|1|||
27918834|NCT03713281|81539784|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
27918835|NCT02121210|81539792|FG000|Overall Study|Adverse Event|5|||
27918836|NCT02121210|81539793|FG001|Overall Study|Adverse Event|7|||
27918837|NCT02121210|81539792|FG000|Overall Study|Lack of Efficacy|2|||
27918838|NCT02121210|81539793|FG001|Overall Study|Lack of Efficacy|0|||
27918839|NCT02121210|81539792|FG000|Overall Study|Other than specified above|0|||
27918840|NCT02121210|81539793|FG001|Overall Study|Other than specified above|2|||
27918841|NCT00746551|81539794|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
27918842|NCT00746551|81539795|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
27918843|NCT00746551|81539794|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
27918844|NCT00746551|81539795|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
27918845|NCT00746551|81539794|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
27918846|NCT00746551|81539795|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
27918847|NCT03435055|81539796|FG000|Screening|Physician Decision|2|||
27918848|NCT03435055|81539796|FG000|Received Intervention|Did not complete nitrous administration|3|||
27918849|NCT00720499|81539797|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
27918850|NCT00720499|81539798|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
27918851|NCT00720499|81539797|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
27918852|NCT00720499|81539798|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
27918853|NCT00720499|81539797|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
27918854|NCT00720499|81539798|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
27918855|NCT00521365|81539800|FG000|Overall Study|Adverse Event|3|||
27918856|NCT00521365|81539800|FG000|Overall Study|Lost to Follow-up|6|||
27918857|NCT00521365|81539800|FG000|Overall Study|Protocol deviation|2|||
27918858|NCT00521365|81539800|FG000|Overall Study|Drug compliance|3|||
27918859|NCT00521365|81539800|FG000|Overall Study|Usage of not allowed drugs|6|||
27918860|NCT01774981|81539801|FG000|Overall Study|Adverse Event|0|||
27918861|NCT01774981|81539802|FG001|Overall Study|Adverse Event|0|||
27918862|NCT01774981|81539803|FG002|Overall Study|Adverse Event|0|||
27918863|NCT01774981|81539804|FG003|Overall Study|Adverse Event|0|||
27918864|NCT01774981|81539805|FG004|Overall Study|Adverse Event|0|||
27918865|NCT01774981|81539806|FG005|Overall Study|Adverse Event|1|||
27918866|NCT01774981|81539807|FG006|Overall Study|Adverse Event|0|||
27918867|NCT01774981|81539808|FG007|Overall Study|Adverse Event|0|||
27918868|NCT01774981|81539801|FG000|Overall Study|Withdrawal by Subject|0|||
27918869|NCT01774981|81539802|FG001|Overall Study|Withdrawal by Subject|0|||
27635189|NCT02341625|80505850|FG006|Overall Study|Completed Treatment as per Protocol|0|||
27635190|NCT02341625|80505851|FG007|Overall Study|Completed Treatment as per Protocol|0|||
27635191|NCT02341625|80505852|FG008|Overall Study|Completed Treatment as per Protocol|0|||
27635192|NCT02341625|80505853|FG009|Overall Study|Completed Treatment as per Protocol|1|||
27635193|NCT02341625|80505844|FG000|Overall Study|Other Reasons|0|||
27635194|NCT02341625|80505845|FG001|Overall Study|Other Reasons|0|||
27635195|NCT02341625|80505846|FG002|Overall Study|Other Reasons|0|||
27635196|NCT02341625|80505847|FG003|Overall Study|Other Reasons|0|||
27635197|NCT02341625|80505848|FG004|Overall Study|Other Reasons|1|||
27635198|NCT02341625|80505849|FG005|Overall Study|Other Reasons|0|||
27635199|NCT02341625|80505850|FG006|Overall Study|Other Reasons|5|||
27635200|NCT02341625|80505851|FG007|Overall Study|Other Reasons|0|||
27635201|NCT02341625|80505852|FG008|Overall Study|Other Reasons|0|||
27635202|NCT02341625|80505853|FG009|Overall Study|Other Reasons|2|||
27635203|NCT02341625|80505844|FG000|Overall Study|Not Reported|0|||
27635204|NCT02341625|80505845|FG001|Overall Study|Not Reported|0|||
27635205|NCT02341625|80505846|FG002|Overall Study|Not Reported|0|||
27635206|NCT02341625|80505847|FG003|Overall Study|Not Reported|0|||
27635207|NCT02341625|80505848|FG004|Overall Study|Not Reported|0|||
27635208|NCT02341625|80505849|FG005|Overall Study|Not Reported|0|||
27635209|NCT02341625|80505850|FG006|Overall Study|Not Reported|0|||
27635210|NCT02341625|80505851|FG007|Overall Study|Not Reported|0|||
27635211|NCT02341625|80505852|FG008|Overall Study|Not Reported|0|||
27635212|NCT02341625|80505853|FG009|Overall Study|Not Reported|3|||
27635213|NCT01135511|80505855|FG000|Overall Study|Adverse Event|0|||
27635214|NCT01135511|80505856|FG001|Overall Study|Adverse Event|1|||
27635215|NCT01135511|80505857|FG002|Overall Study|Adverse Event|2|||
27635216|NCT01135511|80505858|FG003|Overall Study|Adverse Event|0|||
27635217|NCT01135511|80505859|FG004|Overall Study|Adverse Event|0|||
27635218|NCT01135511|80505860|FG005|Overall Study|Adverse Event|1|||
27635219|NCT01135511|80505861|FG006|Overall Study|Adverse Event|0|||
27635220|NCT01135511|80505862|FG007|Overall Study|Adverse Event|1|||
27635221|NCT01135511|80505863|FG008|Overall Study|Adverse Event|0|||
27635222|NCT01135511|80505855|FG000|Overall Study|Lack of Efficacy|0|||
27918870|NCT01774981|81539803|FG002|Overall Study|Withdrawal by Subject|0|||
27918871|NCT01774981|81539804|FG003|Overall Study|Withdrawal by Subject|0|||
27918872|NCT01774981|81539805|FG004|Overall Study|Withdrawal by Subject|0|||
27635223|NCT01135511|80505856|FG001|Overall Study|Lack of Efficacy|1|||
27635224|NCT01135511|80505857|FG002|Overall Study|Lack of Efficacy|1|||
27918873|NCT01774981|81539806|FG005|Overall Study|Withdrawal by Subject|0|||
27635225|NCT01135511|80505858|FG003|Overall Study|Lack of Efficacy|2|||
27635226|NCT01135511|80505859|FG004|Overall Study|Lack of Efficacy|0|||
27635227|NCT01135511|80505860|FG005|Overall Study|Lack of Efficacy|0|||
27635228|NCT01135511|80505861|FG006|Overall Study|Lack of Efficacy|0|||
27635229|NCT01135511|80505862|FG007|Overall Study|Lack of Efficacy|0|||
27635230|NCT01135511|80505863|FG008|Overall Study|Lack of Efficacy|0|||
27635231|NCT01135511|80505855|FG000|Overall Study|Protocol Violation|0|||
27635232|NCT01135511|80505856|FG001|Overall Study|Protocol Violation|0|||
27635233|NCT01135511|80505857|FG002|Overall Study|Protocol Violation|3|||
27635234|NCT01135511|80505858|FG003|Overall Study|Protocol Violation|0|||
27635235|NCT01135511|80505859|FG004|Overall Study|Protocol Violation|0|||
27635236|NCT01135511|80505860|FG005|Overall Study|Protocol Violation|0|||
27635237|NCT01135511|80505861|FG006|Overall Study|Protocol Violation|0|||
27635238|NCT01135511|80505862|FG007|Overall Study|Protocol Violation|0|||
27635239|NCT01135511|80505863|FG008|Overall Study|Protocol Violation|0|||
27918874|NCT01774981|81539807|FG006|Overall Study|Withdrawal by Subject|0|||
27918875|NCT01774981|81539808|FG007|Overall Study|Withdrawal by Subject|1|||
27918876|NCT01774981|81539801|FG000|Overall Study|Death|0|||
27918877|NCT01774981|81539802|FG001|Overall Study|Death|0|||
27540081|NCT00799422|80171688|FG001|First Week of Wear|Lost to Follow-up|0|||
27540082|NCT00799422|80171689|FG002|First Week of Wear|Lost to Follow-up|1|||
27540083|NCT00799422|80171690|FG003|First Week of Wear|Lost to Follow-up|0|||
27540084|NCT00799422|80171691|FG004|First Week of Wear|Lost to Follow-up|0|||
27540085|NCT00799422|80171692|FG005|First Week of Wear|Lost to Follow-up|0|||
27540086|NCT00799422|80171687|FG000|First Week of Wear|Adverse Event|0|||
27540087|NCT00799422|80171688|FG001|First Week of Wear|Adverse Event|0|||
27540088|NCT00799422|80171689|FG002|First Week of Wear|Adverse Event|0|||
27540089|NCT00799422|80171690|FG003|First Week of Wear|Adverse Event|1|||
27540090|NCT00799422|80171691|FG004|First Week of Wear|Adverse Event|0|||
27540091|NCT00799422|80171692|FG005|First Week of Wear|Adverse Event|0|||
27540092|NCT00389597|80171697|FG000|Overall Study|Lost to Follow-up|8|||
27540093|NCT00389597|80171698|FG001|Overall Study|Lost to Follow-up|6|||
27540094|NCT00389597|80171699|FG002|Overall Study|Lost to Follow-up|4|||
27540095|NCT00389597|80171700|FG003|Overall Study|Lost to Follow-up|6|||
27540096|NCT00191269|80171703|FG000|Overall Study|Protocol Violation|0|||
27540097|NCT00191269|80171704|FG001|Overall Study|Protocol Violation|2|||
27540098|NCT00191269|80171703|FG000|Overall Study|Adverse Event|1|||
27540099|NCT00191269|80171704|FG001|Overall Study|Adverse Event|4|||
27540100|NCT00191269|80171703|FG000|Overall Study|Progression of Disease|4|||
27540101|NCT00191269|80171704|FG001|Overall Study|Progression of Disease|42|||
27540102|NCT00191269|80171703|FG000|Overall Study|Lack of Efficacy|1|||
27540103|NCT00191269|80171704|FG001|Overall Study|Lack of Efficacy|5|||
27540104|NCT00191269|80171703|FG000|Overall Study|Withdrawal by Subject|0|||
27540105|NCT00191269|80171704|FG001|Overall Study|Withdrawal by Subject|1|||
27540106|NCT00191269|80171703|FG000|Overall Study|Pathologic Aggrevation|0|||
27540107|NCT00191269|80171704|FG001|Overall Study|Pathologic Aggrevation|1|||
27540108|NCT00191269|80171703|FG000|Overall Study|Physician Decision|0|||
27540109|NCT00191269|80171704|FG001|Overall Study|Physician Decision|3|||
27540110|NCT00660699|80171713|FG000|Overall Study|Withdrawal by Subject|2|||
27540111|NCT01980940|80171714|FG000|Overall Study|Protocol Violation|0|||
27540112|NCT01980940|80171715|FG001|Overall Study|Protocol Violation|0|||
27540113|NCT01980940|80171716|FG002|Overall Study|Protocol Violation|0|||
27540114|NCT01980940|80171717|FG003|Overall Study|Protocol Violation|0|||
27540115|NCT01980940|80171718|FG004|Overall Study|Protocol Violation|0|||
27540116|NCT01980940|80171719|FG005|Overall Study|Protocol Violation|2|||
27540117|NCT01980940|80171720|FG006|Overall Study|Protocol Violation|0|||
27540118|NCT01980940|80171721|FG007|Overall Study|Protocol Violation|0|||
27540119|NCT00573183|80171722|FG000|Overall Study|Lost to Follow-up|52|||
27540120|NCT00573183|80171723|FG001|Overall Study|Lost to Follow-up|50|||
27635240|NCT01135511|80505855|FG000|Overall Study|Pregnancy|0|||
27635241|NCT01135511|80505856|FG001|Overall Study|Pregnancy|0|||
27635242|NCT01135511|80505857|FG002|Overall Study|Pregnancy|0|||
27635243|NCT01135511|80505858|FG003|Overall Study|Pregnancy|1|||
27918878|NCT01774981|81539803|FG002|Overall Study|Death|0|||
27918879|NCT01774981|81539804|FG003|Overall Study|Death|0|||
27918880|NCT01774981|81539805|FG004|Overall Study|Death|1|||
27918881|NCT01774981|81539806|FG005|Overall Study|Death|0|||
27540121|NCT00573183|80171722|FG000|Overall Study|Withdrawal by Subject|8|||
27540122|NCT00573183|80171723|FG001|Overall Study|Withdrawal by Subject|2|||
27540123|NCT00573183|80171722|FG000|Overall Study|Death|0|||
27540124|NCT00573183|80171723|FG001|Overall Study|Death|1|||
27540125|NCT00573183|80171722|FG000|Overall Study|Adverse Event|2|||
27540126|NCT00573183|80171723|FG001|Overall Study|Adverse Event|0|||
27540127|NCT00573183|80171722|FG000|Overall Study|Incarceration|5|||
27540128|NCT00573183|80171723|FG001|Overall Study|Incarceration|8|||
27540129|NCT00573183|80171722|FG000|Overall Study|Other|5|||
27540130|NCT00573183|80171723|FG001|Overall Study|Other|2|||
27540131|NCT02004522|80171728|FG000|Overall Study|Adverse Event|55|||
27540132|NCT02004522|80171729|FG001|Overall Study|Adverse Event|6|||
27540133|NCT02004522|80171728|FG000|Overall Study|Withdrawal by Subject|13|||
27635244|NCT01135511|80505859|FG004|Overall Study|Pregnancy|0|||
27635245|NCT01135511|80505860|FG005|Overall Study|Pregnancy|0|||
27918882|NCT01774981|81539807|FG006|Overall Study|Death|0|||
27918883|NCT01774981|81539808|FG007|Overall Study|Death|0|||
27918884|NCT00975416|81539813|FG000|Overall Study|early discharge from tx|3|||
27918885|NCT00975416|81539814|FG001|Overall Study|early discharge from tx|5|||
27918886|NCT02999789|81539818|FG000|Overall Study|Withdrawal by Subject|0|||
27918887|NCT02999789|81539819|FG001|Overall Study|Withdrawal by Subject|1|||
27918888|NCT02999789|81539818|FG000|Overall Study|Became ineligible|1|||
27635246|NCT01135511|80505861|FG006|Overall Study|Pregnancy|0|||
27635247|NCT01135511|80505862|FG007|Overall Study|Pregnancy|0|||
27635248|NCT01135511|80505863|FG008|Overall Study|Pregnancy|0|||
27635249|NCT01135511|80505855|FG000|Overall Study|could not visit the clinic|0|||
27635250|NCT01135511|80505856|FG001|Overall Study|could not visit the clinic|1|||
27635251|NCT01135511|80505857|FG002|Overall Study|could not visit the clinic|2|||
27635252|NCT01135511|80505858|FG003|Overall Study|could not visit the clinic|0|||
27635253|NCT01135511|80505859|FG004|Overall Study|could not visit the clinic|0|||
27635254|NCT01135511|80505860|FG005|Overall Study|could not visit the clinic|0|||
27635255|NCT01135511|80505861|FG006|Overall Study|could not visit the clinic|0|||
27635256|NCT01135511|80505862|FG007|Overall Study|could not visit the clinic|0|||
27635257|NCT01135511|80505863|FG008|Overall Study|could not visit the clinic|0|||
27635258|NCT01135511|80505855|FG000|Overall Study|noncompliance with study drug taken|0|||
27635259|NCT01135511|80505856|FG001|Overall Study|noncompliance with study drug taken|0|||
27635260|NCT01135511|80505857|FG002|Overall Study|noncompliance with study drug taken|0|||
27635261|NCT01135511|80505858|FG003|Overall Study|noncompliance with study drug taken|0|||
27635262|NCT01135511|80505859|FG004|Overall Study|noncompliance with study drug taken|1|||
27635263|NCT01135511|80505860|FG005|Overall Study|noncompliance with study drug taken|0|||
27635264|NCT01135511|80505861|FG006|Overall Study|noncompliance with study drug taken|0|||
27635265|NCT01135511|80505862|FG007|Overall Study|noncompliance with study drug taken|0|||
27635266|NCT01135511|80505863|FG008|Overall Study|noncompliance with study drug taken|0|||
27635267|NCT01135511|80505855|FG000|Overall Study|Withdrawal by Subject|0|||
27635268|NCT01135511|80505856|FG001|Overall Study|Withdrawal by Subject|0|||
27635269|NCT01135511|80505857|FG002|Overall Study|Withdrawal by Subject|0|||
27635270|NCT01135511|80505858|FG003|Overall Study|Withdrawal by Subject|0|||
27635271|NCT01135511|80505859|FG004|Overall Study|Withdrawal by Subject|0|||
27635272|NCT01135511|80505860|FG005|Overall Study|Withdrawal by Subject|0|||
27635273|NCT01135511|80505861|FG006|Overall Study|Withdrawal by Subject|1|||
27635274|NCT01135511|80505862|FG007|Overall Study|Withdrawal by Subject|0|||
27635275|NCT01135511|80505863|FG008|Overall Study|Withdrawal by Subject|1|||
27635276|NCT00114244|80505864|FG000|Overall Study|Adverse Event|2|||
27635277|NCT00114244|80505865|FG001|Overall Study|Adverse Event|5|||
27635278|NCT00114244|80505864|FG000|Overall Study|Withdrawal by Subject|0|||
27635279|NCT00114244|80505865|FG001|Overall Study|Withdrawal by Subject|2|||
27635280|NCT01064817|80505866|FG000|Study Completion|Physician Decision|1|||
27635281|NCT01064817|80505867|FG001|Study Completion|Physician Decision|0|||
27635282|NCT01064817|80505866|FG000|Study Completion|Withdrawal by Subject|1|||
27635283|NCT01064817|80505867|FG001|Study Completion|Withdrawal by Subject|0|||
27635284|NCT02960659|80505868|FG000|Overall Study|Withdrawal by Subject|1|||
27635285|NCT02960659|80505869|FG001|Overall Study|Withdrawal by Subject|0|||
27635286|NCT02960659|80505868|FG000|Overall Study|Poor compliance|0|||
27635287|NCT02960659|80505869|FG001|Overall Study|Poor compliance|1|||
27635288|NCT00206375|80505870|FG000|Overall Study|Lost to Follow-up|1|||
27635289|NCT00206375|80505871|FG001|Overall Study|Lost to Follow-up|0|||
27635290|NCT00206375|80505872|FG002|Overall Study|Lost to Follow-up|0|||
27635291|NCT00206375|80505870|FG000|Overall Study|Withdrawal by Subject|2|||
27635292|NCT00206375|80505871|FG001|Overall Study|Withdrawal by Subject|1|||
27635293|NCT00206375|80505872|FG002|Overall Study|Withdrawal by Subject|3|||
27635294|NCT00206375|80505870|FG000|Overall Study|Study terminated due to lack of funds|0|||
27635295|NCT00206375|80505871|FG001|Overall Study|Study terminated due to lack of funds|1|||
27635296|NCT00206375|80505872|FG002|Overall Study|Study terminated due to lack of funds|1|||
27635297|NCT00463788|80505876|FG000|Overall Study|Progressive Disease|86|||
27635298|NCT00463788|80505877|FG001|Overall Study|Progressive Disease|42|||
27635299|NCT00463788|80505876|FG000|Overall Study|Adverse Event|6|||
27635300|NCT00463788|80505877|FG001|Overall Study|Adverse Event|2|||
27918889|NCT02999789|81539819|FG001|Overall Study|Became ineligible|2|||
27918890|NCT03426345|81539820|FG000|Overall Study|Adverse Event|4|||
27635301|NCT00463788|80505876|FG000|Overall Study|Withdrawal by Subject|6|||
27635302|NCT00463788|80505877|FG001|Overall Study|Withdrawal by Subject|2|||
27635303|NCT00463788|80505876|FG000|Overall Study|Death|4|||
27635304|NCT00463788|80505877|FG001|Overall Study|Death|3|||
27635305|NCT00463788|80505876|FG000|Overall Study|Symptomatic Deterioration|2|||
27918891|NCT03426345|81539821|FG001|Overall Study|Adverse Event|4|||
27635306|NCT00463788|80505877|FG001|Overall Study|Symptomatic Deterioration|3|||
27635307|NCT00463788|80505876|FG000|Overall Study|Lost to Follow-up|1|||
27635308|NCT00463788|80505877|FG001|Overall Study|Lost to Follow-up|0|||
27635309|NCT00463788|80505876|FG000|Overall Study|Protocol Violation|0|||
27635310|NCT00463788|80505877|FG001|Overall Study|Protocol Violation|1|||
27635311|NCT00463788|80505876|FG000|Overall Study|Other|3|||
27918892|NCT03426345|81539820|FG000|Overall Study|Lack of Efficacy|1|||
27918893|NCT03426345|81539821|FG001|Overall Study|Lack of Efficacy|0|||
27740840|NCT01522651|80880753|FG002|Overall Study|Device Malfunction|0|||
27740841|NCT01522651|80880754|FG003|Overall Study|Device Malfunction|0|||
27740842|NCT01522651|80880755|FG004|Overall Study|Device Malfunction|0|||
27740843|NCT01522651|80880751|FG000|Overall Study|Investigator's Discretion|0|||
27918894|NCT03426345|81539820|FG000|Overall Study|Withdrawal by Subject|5|||
27918895|NCT03426345|81539821|FG001|Overall Study|Withdrawal by Subject|6|||
27918896|NCT03426345|81539820|FG000|Overall Study|Lost to Follow-up|3|||
27918897|NCT03426345|81539821|FG001|Overall Study|Lost to Follow-up|1|||
27918898|NCT03426345|81539820|FG000|Overall Study|Protocol Deviation|3|||
27918899|NCT03426345|81539821|FG001|Overall Study|Protocol Deviation|4|||
27918900|NCT03426345|81539820|FG000|Overall Study|Reason Not Specified|1|||
27918901|NCT03426345|81539821|FG001|Overall Study|Reason Not Specified|2|||
27918902|NCT03426345|81539820|FG000|Overall Study|Missing Completion Status|1|||
27918903|NCT03426345|81539821|FG001|Overall Study|Missing Completion Status|0|||
27918904|NCT01811732|81539824|FG000|Overall Study|Lost to Follow-up|24|||
27918905|NCT01811732|81539825|FG001|Overall Study|Lost to Follow-up|30|||
27918906|NCT01811732|81539824|FG000|Overall Study|Withdrawal by Subject|16|||
27918907|NCT01811732|81539825|FG001|Overall Study|Withdrawal by Subject|10|||
27918908|NCT01811732|81539824|FG000|Overall Study|Adverse Event|3|||
27918909|NCT01811732|81539825|FG001|Overall Study|Adverse Event|9|||
27918910|NCT01811732|81539824|FG000|Overall Study|Lack of Efficacy|3|||
27918911|NCT01811732|81539825|FG001|Overall Study|Lack of Efficacy|1|||
27918912|NCT01811732|81539824|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
27540134|NCT02004522|80171729|FG001|Overall Study|Withdrawal by Subject|7|||
27540135|NCT02004522|80171728|FG000|Overall Study|Death|12|||
27540136|NCT02004522|80171729|FG001|Overall Study|Death|3|||
27540137|NCT02004522|80171728|FG000|Overall Study|Physician Decision|3|||
27540138|NCT02004522|80171729|FG001|Overall Study|Physician Decision|4|||
27540139|NCT02004522|80171728|FG000|Overall Study|Protocol Violation|1|||
27540140|NCT02004522|80171729|FG001|Overall Study|Protocol Violation|0|||
27540141|NCT02004522|80171728|FG000|Overall Study|Other is reason listed by PI|4|||
27540142|NCT02004522|80171729|FG001|Overall Study|Other is reason listed by PI|1|||
27540143|NCT02004522|80171728|FG000|Overall Study|Never Dosed|2|||
27540144|NCT02004522|80171729|FG001|Overall Study|Never Dosed|4|||
27540145|NCT02004522|80171728|FG000|Overall Study|Disease Progression|35|||
27540146|NCT02004522|80171729|FG001|Overall Study|Disease Progression|31|||
27540147|NCT02004522|80171728|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
27540148|NCT02004522|80171729|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
27540149|NCT03320057|80171730|FG000|Overall Study|Lost to Follow-up|4|||
27540150|NCT03320057|80171731|FG001|Overall Study|Lost to Follow-up|17|||
27540151|NCT03320057|80171730|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
27540152|NCT03320057|80171731|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
27540153|NCT04528732|80171732|FG000|Overall Study|Death|1|||
27540154|NCT04528732|80171733|FG001|Overall Study|Death|0|||
27540155|NCT04528732|80171734|FG002|Overall Study|Death|1|||
27540156|NCT04528732|80171732|FG000|Overall Study|Lost to Follow-up|0|||
27540157|NCT04528732|80171733|FG001|Overall Study|Lost to Follow-up|1|||
27540158|NCT04528732|80171734|FG002|Overall Study|Lost to Follow-up|2|||
27540159|NCT01330030|80171735|FG000|Overall Study|Lost to Follow-up|16|||
27540160|NCT01330030|80171736|FG001|Overall Study|Lost to Follow-up|17|||
27540161|NCT00319501|80171737|FG000|Double-blind Period|Withdrawal by Subject|0|||
27740844|NCT01522651|80880752|FG001|Overall Study|Investigator's Discretion|1|||
27740845|NCT01522651|80880753|FG002|Overall Study|Investigator's Discretion|0|||
27740846|NCT01522651|80880754|FG003|Overall Study|Investigator's Discretion|0|||
27740847|NCT01522651|80880755|FG004|Overall Study|Investigator's Discretion|0|||
27740848|NCT01522651|80880751|FG000|Overall Study|Protocol Violation|3|||
27740849|NCT01522651|80880752|FG001|Overall Study|Protocol Violation|0|||
27740850|NCT01522651|80880753|FG002|Overall Study|Protocol Violation|0|||
27740851|NCT01522651|80880754|FG003|Overall Study|Protocol Violation|0|||
27740852|NCT01522651|80880755|FG004|Overall Study|Protocol Violation|0|||
27740853|NCT01522651|80880751|FG000|Overall Study|Reason Not Specified|0|||
27740854|NCT01522651|80880752|FG001|Overall Study|Reason Not Specified|0|||
27918913|NCT01811732|81539825|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
27918914|NCT01811732|81539824|FG000|Overall Study|Physician Decision|2|||
27918915|NCT01811732|81539825|FG001|Overall Study|Physician Decision|0|||
27918916|NCT01811732|81539824|FG000|Overall Study|Death|1|||
27918917|NCT01811732|81539825|FG001|Overall Study|Death|1|||
27918918|NCT01811732|81539824|FG000|Overall Study|Insufficient venous access|0|||
27540162|NCT00319501|80171738|FG001|Double-blind Period|Withdrawal by Subject|3|||
27540163|NCT00319501|80171737|FG000|Double-blind Period|Sponsor Request|1|||
27540164|NCT00319501|80171738|FG001|Double-blind Period|Sponsor Request|0|||
27540165|NCT00319501|80171737|FG000|Double-blind Period|Did not receive treatment|42|||
27540166|NCT00319501|80171738|FG001|Double-blind Period|Did not receive treatment|29|||
27635312|NCT00463788|80505877|FG001|Overall Study|Other|0|||
27918919|NCT01811732|81539825|FG001|Overall Study|Insufficient venous access|1|||
27918920|NCT01811732|81539824|FG000|Overall Study|Protocol Violation|0|||
27540167|NCT00319501|80171737|FG000|Open-label Period|Adverse Event|5|||
27540168|NCT00319501|80171738|FG001|Open-label Period|Adverse Event|0|||
27918921|NCT01811732|81539825|FG001|Overall Study|Protocol Violation|1|||
27918922|NCT01811732|81539824|FG000|Overall Study|Subject incarcerated|1|||
27918923|NCT01811732|81539825|FG001|Overall Study|Subject incarcerated|2|||
27918924|NCT01811732|81539824|FG000|Overall Study|Admitted to another facility|1|||
27918925|NCT01811732|81539825|FG001|Overall Study|Admitted to another facility|0|||
27918926|NCT01811732|81539824|FG000|Overall Study|Correct study drug not available on site|1|||
27918927|NCT01811732|81539825|FG001|Overall Study|Correct study drug not available on site|0|||
27918928|NCT02008526|81539826|FG000|Overall Study|Death|0|||
27918929|NCT02008526|81539827|FG001|Overall Study|Death|2|||
27918930|NCT02008526|81539828|FG002|Overall Study|Death|1|||
27918931|NCT02008526|81539826|FG000|Overall Study|Withdrawal by Subject|3|||
27918932|NCT02008526|81539827|FG001|Overall Study|Withdrawal by Subject|3|||
27918933|NCT02008526|81539828|FG002|Overall Study|Withdrawal by Subject|2|||
27918934|NCT02008526|81539826|FG000|Overall Study|Lost to Follow-up|5|||
27918935|NCT02008526|81539827|FG001|Overall Study|Lost to Follow-up|9|||
27918936|NCT02008526|81539828|FG002|Overall Study|Lost to Follow-up|6|||
27918937|NCT02351934|81539829|FG000|Allocation|POD weight<pre-op weight|3|||
27918938|NCT02351934|81539830|FG001|Allocation|POD weight<pre-op weight|0|||
27918939|NCT02351934|81539829|FG000|Allocation|Hypotension preventing administration|2|||
27918940|NCT02351934|81539830|FG001|Allocation|Hypotension preventing administration|0|||
27918941|NCT02351934|81539829|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
27918942|NCT02351934|81539830|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
27918943|NCT02351934|81539829|FG000|Follow-Up|POD weight<pre-op weight|3|||
27918944|NCT02351934|81539830|FG001|Follow-Up|POD weight<pre-op weight|0|||
27918945|NCT02351934|81539829|FG000|Follow-Up|Acute Kidney Injury|1|||
27918946|NCT02351934|81539830|FG001|Follow-Up|Acute Kidney Injury|0|||
27918947|NCT02351934|81539829|FG000|Follow-Up|Early dismissal|3|||
27918948|NCT02351934|81539830|FG001|Follow-Up|Early dismissal|0|||
27918949|NCT02351934|81539829|FG000|Follow-Up|Hypotension|3|||
27918950|NCT02351934|81539830|FG001|Follow-Up|Hypotension|0|||
27918951|NCT02351934|81539829|FG000|Follow-Up|No documentation|2|||
27918952|NCT02351934|81539830|FG001|Follow-Up|No documentation|0|||
27918953|NCT02351934|81539829|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
27918954|NCT02351934|81539830|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
27918955|NCT02351934|81539829|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
27918956|NCT02351934|81539830|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
27918957|NCT01715831|81539831|FG000|Overall Study|Adverse Event|1|||
27918958|NCT03533751|81539838|FG000|Overall Study|Withdrawal by Subject|12|||
27918959|NCT03533751|81539839|FG001|Overall Study|Withdrawal by Subject|6|||
27918960|NCT03533751|81539840|FG002|Overall Study|Withdrawal by Subject|11|||
27918961|NCT03533751|81539841|FG003|Overall Study|Withdrawal by Subject|9|||
27918962|NCT03533751|81539842|FG004|Overall Study|Withdrawal by Subject|10|||
27918963|NCT03533751|81539838|FG000|Overall Study|Adverse Event|4|||
27918964|NCT03533751|81539839|FG001|Overall Study|Adverse Event|7|||
27918965|NCT03533751|81539840|FG002|Overall Study|Adverse Event|2|||
27918966|NCT03533751|81539841|FG003|Overall Study|Adverse Event|4|||
27918967|NCT03533751|81539842|FG004|Overall Study|Adverse Event|5|||
27918968|NCT03533751|81539838|FG000|Overall Study|Physician Decision|0|||
27918969|NCT03533751|81539839|FG001|Overall Study|Physician Decision|2|||
27918970|NCT03533751|81539840|FG002|Overall Study|Physician Decision|1|||
27918971|NCT03533751|81539841|FG003|Overall Study|Physician Decision|2|||
27918972|NCT03533751|81539842|FG004|Overall Study|Physician Decision|1|||
27918973|NCT03533751|81539838|FG000|Overall Study|Sponsor Decision|0|||
27918974|NCT03533751|81539839|FG001|Overall Study|Sponsor Decision|0|||
27918975|NCT03533751|81539840|FG002|Overall Study|Sponsor Decision|1|||
27918976|NCT03533751|81539841|FG003|Overall Study|Sponsor Decision|1|||
27918977|NCT03533751|81539842|FG004|Overall Study|Sponsor Decision|0|||
27918978|NCT03533751|81539838|FG000|Overall Study|Lost to Follow-up|3|||
27918979|NCT03533751|81539839|FG001|Overall Study|Lost to Follow-up|7|||
27918980|NCT03533751|81539840|FG002|Overall Study|Lost to Follow-up|6|||
27918981|NCT03533751|81539841|FG003|Overall Study|Lost to Follow-up|4|||
27918982|NCT03533751|81539842|FG004|Overall Study|Lost to Follow-up|3|||
27918983|NCT03533751|81539838|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
27918984|NCT03533751|81539839|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
27918985|NCT03533751|81539840|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
27918986|NCT03533751|81539841|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
27918987|NCT03533751|81539842|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
27918988|NCT03533751|81539838|FG000|Overall Study|Other|0|||
27918989|NCT03533751|81539839|FG001|Overall Study|Other|2|||
27918990|NCT03533751|81539840|FG002|Overall Study|Other|1|||
27918991|NCT03533751|81539841|FG003|Overall Study|Other|0|||
27918992|NCT03533751|81539842|FG004|Overall Study|Other|3|||
27635313|NCT00463788|80505876|FG000|Overall Study|Randomized but not treated|1|||
27635314|NCT00463788|80505877|FG001|Overall Study|Randomized but not treated|1|||
27918993|NCT00492297|81539843|FG000|Treatment|Death|2|||
27918994|NCT00492297|81539843|FG000|Treatment|Study terminated by sponsor|3|||
27918995|NCT00492297|81539843|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
27918996|NCT00492297|81539843|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
27540169|NCT00319501|80171737|FG000|Open-label Period|Protocol Violation|6|||
27540170|NCT00319501|80171738|FG001|Open-label Period|Protocol Violation|0|||
27540171|NCT00319501|80171737|FG000|Open-label Period|Withdrawal by Subject|38|||
27540172|NCT00319501|80171738|FG001|Open-label Period|Withdrawal by Subject|0|||
27540173|NCT00319501|80171737|FG000|Open-label Period|Principal Investigator decision|6|||
27540174|NCT00319501|80171738|FG001|Open-label Period|Principal Investigator decision|0|||
27540175|NCT00319501|80171737|FG000|Open-label Period|Sponsor request|12|||
27540176|NCT00319501|80171738|FG001|Open-label Period|Sponsor request|0|||
27540177|NCT00319501|80171737|FG000|Open-label Period|Lost to Follow-up|5|||
27540178|NCT00319501|80171738|FG001|Open-label Period|Lost to Follow-up|0|||
27540179|NCT00319501|80171737|FG000|Open-label Period|Did not receive treatment|33|||
27540180|NCT00319501|80171738|FG001|Open-label Period|Did not receive treatment|0|||
27540181|NCT00319501|80171737|FG000|Open-label Period|Other|11|||
27540182|NCT00319501|80171738|FG001|Open-label Period|Other|0|||
27540183|NCT00319501|80171737|FG000|Open-label Extension Period|Adverse Event|2|||
27540184|NCT00319501|80171738|FG001|Open-label Extension Period|Adverse Event|0|||
27540185|NCT00319501|80171737|FG000|Open-label Extension Period|Did not receive treatment|18|||
27540186|NCT00319501|80171738|FG001|Open-label Extension Period|Did not receive treatment|0|||
27540187|NCT00319501|80171737|FG000|Open-label Extension Period|Other|1|||
27635315|NCT01117480|80505878|FG000|Overall Study|Protocol Violation|8|||
27635316|NCT01117480|80505878|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
27635317|NCT01199575|80505879|FG000|Overall Study|Withdrawal by Subject|5|||
27635318|NCT00997386|80505880|FG000|Overall Study|Death|7|||
27635319|NCT01147341|80505881|FG000|Double Blind Period|Lack of Efficacy|1|||
27635320|NCT01147341|80505882|FG001|Double Blind Period|Lack of Efficacy|1|||
27635321|NCT01147341|80505881|FG000|Double Blind Period|Withdrawal by Subject|0|||
27635322|NCT01147341|80505882|FG001|Double Blind Period|Withdrawal by Subject|1|||
27635323|NCT01147341|80505881|FG000|Open Label Period|Lack of Efficacy|3|||
27635324|NCT01147341|80505882|FG001|Open Label Period|Lack of Efficacy|0|||
27635325|NCT01147341|80505881|FG000|Open Label Period|Subject moved|1|||
27635326|NCT01147341|80505882|FG001|Open Label Period|Subject moved|0|||
27635327|NCT05510245|80505883|FG000|Overall Study|Withdrawal by Subject|1|||
27635328|NCT05510245|80505884|FG001|Overall Study|Withdrawal by Subject|0|||
27635329|NCT05510245|80505885|FG002|Overall Study|Withdrawal by Subject|0|||
27635330|NCT02751580|80505886|FG000|Overall Study|Lost to Follow-up|4|||
27635331|NCT02751580|80505886|FG000|Overall Study|Death|2|||
27635332|NCT04535544|80505887|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
27635333|NCT04535544|80505888|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
27635334|NCT04535544|80505889|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
27635335|NCT04535544|80505890|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
27635336|NCT04535544|80505887|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
27635337|NCT04535544|80505888|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
27635338|NCT04535544|80505889|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
27635339|NCT04535544|80505890|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
27635340|NCT04535544|80505887|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
27635341|NCT04535544|80505888|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
27635342|NCT04535544|80505889|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
27635343|NCT04535544|80505890|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
27635344|NCT04535544|80505887|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
27635345|NCT04535544|80505888|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
27540188|NCT00319501|80171738|FG001|Open-label Extension Period|Other|0|||
27635346|NCT04535544|80505889|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
27635347|NCT04535544|80505890|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
27635348|NCT04535544|80505887|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
27635349|NCT04535544|80505888|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
27635350|NCT04535544|80505889|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
27635351|NCT04535544|80505890|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
27635352|NCT04535544|80505887|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
27635353|NCT04535544|80505888|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
27540189|NCT00319501|80171737|FG000|Open-label Extension Period|Principal investigator decision|2|||
27540190|NCT00319501|80171738|FG001|Open-label Extension Period|Principal investigator decision|0|||
27540191|NCT00319501|80171737|FG000|Open-label Extension Period|Sponsor request|26|||
27540192|NCT00319501|80171738|FG001|Open-label Extension Period|Sponsor request|0|||
27540193|NCT00319501|80171737|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
27540194|NCT00319501|80171738|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
27540195|NCT04515394|80171739|FG000|Overall Study|Participant did not receive treatment|1|||
27540196|NCT00150709|80171740|FG000|Overall Study|Protocol Violation|7|||
27540197|NCT00150709|80171741|FG001|Overall Study|Protocol Violation|8|||
27540198|NCT00150709|80171742|FG002|Overall Study|Protocol Violation|3|||
27540199|NCT00150709|80171743|FG003|Overall Study|Protocol Violation|1|||
27540200|NCT00150709|80171740|FG000|Overall Study|Adverse Event|8|||
27540201|NCT00150709|80171741|FG001|Overall Study|Adverse Event|2|||
27540202|NCT00150709|80171742|FG002|Overall Study|Adverse Event|2|||
27540203|NCT00150709|80171743|FG003|Overall Study|Adverse Event|3|||
27540204|NCT00150709|80171740|FG000|Overall Study|Lack of Efficacy|6|||
27540205|NCT00150709|80171741|FG001|Overall Study|Lack of Efficacy|11|||
27540206|NCT00150709|80171742|FG002|Overall Study|Lack of Efficacy|9|||
27540207|NCT00150709|80171743|FG003|Overall Study|Lack of Efficacy|0|||
27540208|NCT00150709|80171740|FG000|Overall Study|Withdrawal by Subject|7|||
27540209|NCT00150709|80171741|FG001|Overall Study|Withdrawal by Subject|10|||
27540210|NCT00150709|80171742|FG002|Overall Study|Withdrawal by Subject|5|||
27540211|NCT00150709|80171743|FG003|Overall Study|Withdrawal by Subject|0|||
27540212|NCT00150709|80171740|FG000|Overall Study|Lost to Follow-up|3|||
27540213|NCT00150709|80171741|FG001|Overall Study|Lost to Follow-up|2|||
27540214|NCT00150709|80171742|FG002|Overall Study|Lost to Follow-up|0|||
27540215|NCT00150709|80171743|FG003|Overall Study|Lost to Follow-up|0|||
27540216|NCT00150709|80171740|FG000|Overall Study|Sponsor decision|0|||
27540217|NCT00150709|80171741|FG001|Overall Study|Sponsor decision|0|||
27540218|NCT00150709|80171742|FG002|Overall Study|Sponsor decision|0|||
27540219|NCT00150709|80171743|FG003|Overall Study|Sponsor decision|1|||
27540220|NCT00150709|80171740|FG000|Overall Study|Site/Investigator discontinued the study|5|||
27540221|NCT00150709|80171741|FG001|Overall Study|Site/Investigator discontinued the study|5|||
27540222|NCT00150709|80171742|FG002|Overall Study|Site/Investigator discontinued the study|2|||
27635354|NCT04535544|80505889|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
27635355|NCT04535544|80505890|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
27635356|NCT04535544|80505887|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
27635357|NCT04535544|80505888|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
27635358|NCT04535544|80505889|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
27635359|NCT04535544|80505890|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
27635360|NCT04535544|80505887|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
27635361|NCT04535544|80505888|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
27635362|NCT04535544|80505889|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
27635363|NCT04535544|80505890|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
27635364|NCT05641311|80505895|FG000|Dosing Period 1|Adverse Event|1|||
27635365|NCT05641311|80505896|FG001|Dosing Period 1|Adverse Event|0|||
27635366|NCT03227757|80505898|FG000|Overall Study|Death|25|||
27635367|NCT03227757|80505898|FG000|Overall Study|Withdrawal|10|||
27635368|NCT03227757|80505898|FG000|Overall Study|Missed visits|1|||
27635369|NCT03227757|80505898|FG000|Overall Study|Lost to Follow-up|2|||
27635370|NCT00665444|80505899|FG000|Overall Study|Physician Decision|1|||
27635371|NCT00665444|80505899|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
27635372|NCT02471755|80505900|FG000|Overall Study|Withdrawal by Subject|1|||
27635373|NCT02471755|80505901|FG001|Overall Study|Withdrawal by Subject|0|||
27635374|NCT02471755|80505900|FG000|Overall Study|Lost to Follow-up|0|||
27635375|NCT02471755|80505901|FG001|Overall Study|Lost to Follow-up|1|||
27635376|NCT00446550|80505906|FG000|Overall Study|Adverse Event|1|||
27635377|NCT00446550|80505907|FG001|Overall Study|Adverse Event|0|||
27635378|NCT04054635|80505908|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
27635379|NCT04054635|80505909|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
27635380|NCT04054635|80505910|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
27635381|NCT04054635|80505908|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
27635382|NCT04054635|80505909|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
27635383|NCT04054635|80505910|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
27635384|NCT03024606|80505912|FG000|Overall Study|Withdrawal by Subject|9|||
27635385|NCT03024606|80505913|FG001|Overall Study|Withdrawal by Subject|10|||
27635386|NCT02320123|80505914|FG000|Overall Study|Lost to Follow-up|4|||
27635387|NCT02320123|80505915|FG001|Overall Study|Lost to Follow-up|6|||
27635388|NCT02320123|80505914|FG000|Overall Study|Death|6|||
27635389|NCT02320123|80505915|FG001|Overall Study|Death|5|||
27635390|NCT01239316|80505916|FG000|Overall Study|Progression/Relapse|11|||
27635391|NCT01239316|80505916|FG000|Overall Study|Adverse Event|1|||
27635392|NCT00988637|80505917|FG000|Overall Study|Lost to Follow-up|2|||
27635393|NCT00988637|80505918|FG001|Overall Study|Lost to Follow-up|1|||
27635394|NCT00988637|80505917|FG000|Overall Study|Withdrawal by Subject|1|||
27540223|NCT00150709|80171743|FG003|Overall Study|Site/Investigator discontinued the study|0|||
27635395|NCT00988637|80505918|FG001|Overall Study|Withdrawal by Subject|1|||
27540224|NCT00150709|80171740|FG000|Overall Study|Decision of parent(s)|1|||
27540225|NCT00150709|80171741|FG001|Overall Study|Decision of parent(s)|2|||
27540226|NCT00150709|80171742|FG002|Overall Study|Decision of parent(s)|0|||
27540227|NCT00150709|80171743|FG003|Overall Study|Decision of parent(s)|0|||
27540228|NCT00150709|80171740|FG000|Overall Study|Decision of parent(s) and investigator|3|||
27635396|NCT00988637|80505917|FG000|Overall Study|non-compliance with study drug|0|||
27635397|NCT00988637|80505918|FG001|Overall Study|non-compliance with study drug|1|||
27635398|NCT01832480|80505919|FG000|Overall Study|Lost to Follow-up|33|||
27635399|NCT01832480|80505920|FG001|Overall Study|Lost to Follow-up|30|||
27635400|NCT01832480|80505919|FG000|Overall Study|Withdrawal by Subject|0|||
27635401|NCT01832480|80505920|FG001|Overall Study|Withdrawal by Subject|2|||
27635402|NCT01832480|80505919|FG000|Overall Study|post randomization ineligible|8|||
27918997|NCT00492297|81539843|FG000|Survival Only Follow-up|Death|46|||
27918998|NCT00492297|81539843|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
27918999|NCT00492297|81539843|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
27919000|NCT01041859|81539846|FG000|Open-Label Titration|Adverse Event|69|||
27919001|NCT01041859|81539847|FG001|Open-Label Titration|Adverse Event|0|||
27919002|NCT01041859|81539848|FG002|Open-Label Titration|Adverse Event|0|||
27919003|NCT01041859|81539846|FG000|Open-Label Titration|Lack of Efficacy|3|||
27919004|NCT01041859|81539847|FG001|Open-Label Titration|Lack of Efficacy|0|||
27919005|NCT01041859|81539848|FG002|Open-Label Titration|Lack of Efficacy|0|||
27919006|NCT01041859|81539846|FG000|Open-Label Titration|Lost to Follow-up|1|||
27919007|NCT01041859|81539847|FG001|Open-Label Titration|Lost to Follow-up|0|||
27919008|NCT01041859|81539848|FG002|Open-Label Titration|Lost to Follow-up|0|||
27919009|NCT01041859|81539846|FG000|Open-Label Titration|Physician Decision|1|||
27919010|NCT01041859|81539847|FG001|Open-Label Titration|Physician Decision|0|||
27919011|NCT01041859|81539848|FG002|Open-Label Titration|Physician Decision|0|||
27919012|NCT01041859|81539846|FG000|Open-Label Titration|Protocol Violation|1|||
27919013|NCT01041859|81539847|FG001|Open-Label Titration|Protocol Violation|0|||
27919014|NCT01041859|81539848|FG002|Open-Label Titration|Protocol Violation|0|||
27919015|NCT01041859|81539846|FG000|Open-Label Titration|Other|7|||
27919016|NCT01041859|81539847|FG001|Open-Label Titration|Other|0|||
27919017|NCT01041859|81539848|FG002|Open-Label Titration|Other|0|||
27919018|NCT01041859|81539846|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
27919019|NCT01041859|81539847|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
27919020|NCT01041859|81539848|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
27919021|NCT01041859|81539846|FG000|Open-Label Titration|Withdrawal by Subject|11|||
27919022|NCT01041859|81539847|FG001|Open-Label Titration|Withdrawal by Subject|0|||
27919023|NCT01041859|81539848|FG002|Open-Label Titration|Withdrawal by Subject|0|||
27919024|NCT01041859|81539846|FG000|Double-Blind Maintenance|Adverse Event|0|||
27919025|NCT01041859|81539847|FG001|Double-Blind Maintenance|Adverse Event|23|||
27919026|NCT01041859|81539848|FG002|Double-Blind Maintenance|Adverse Event|13|||
27919027|NCT01041859|81539846|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
27919028|NCT01041859|81539847|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
27919029|NCT01041859|81539848|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
27919030|NCT01041859|81539846|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
27919031|NCT01041859|81539847|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
27919032|NCT01041859|81539848|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
27919033|NCT01041859|81539846|FG000|Double-Blind Maintenance|Physician Decision|0|||
27919034|NCT01041859|81539847|FG001|Double-Blind Maintenance|Physician Decision|2|||
27919035|NCT01041859|81539848|FG002|Double-Blind Maintenance|Physician Decision|1|||
27919036|NCT01041859|81539846|FG000|Double-Blind Maintenance|Protocol Violation|0|||
27919037|NCT01041859|81539847|FG001|Double-Blind Maintenance|Protocol Violation|1|||
27919038|NCT01041859|81539848|FG002|Double-Blind Maintenance|Protocol Violation|3|||
27919039|NCT01041859|81539846|FG000|Double-Blind Maintenance|Other|0|||
27919040|NCT01041859|81539847|FG001|Double-Blind Maintenance|Other|6|||
27919041|NCT01041859|81539848|FG002|Double-Blind Maintenance|Other|2|||
27919042|NCT01041859|81539846|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
27919043|NCT01041859|81539847|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
27919044|NCT01041859|81539848|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
27919045|NCT01041859|81539846|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
27919046|NCT01041859|81539847|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
27919047|NCT01041859|81539848|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
27919048|NCT01245101|81539849|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
27919049|NCT01245101|81539850|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
27919050|NCT01245101|81539849|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
27919051|NCT01245101|81539850|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
27919052|NCT01245101|81539849|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
27919053|NCT01245101|81539850|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
27919054|NCT03368807|81539851|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
27919055|NCT03368807|81539851|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
27919056|NCT03368807|81539851|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
27919057|NCT03368807|81539851|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
27919058|NCT01576575|81539856|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
27919059|NCT01576575|81539856|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
27919060|NCT01576575|81539856|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
27919061|NCT02314728|81539857|FG000|Overall Study|Protocol Violation|1|||
27919062|NCT02314728|81539858|FG001|Overall Study|Protocol Violation|0|||
27919063|NCT02314728|81539857|FG000|Overall Study|Lost to Follow-up|0|||
27919064|NCT02314728|81539858|FG001|Overall Study|Lost to Follow-up|1|||
27919065|NCT03248037|81539859|FG000|Overall Study|Withdrawal by Subject|6|||
27919066|NCT03248037|81539860|FG001|Overall Study|Withdrawal by Subject|9|||
27919067|NCT03248037|81539859|FG000|Overall Study|Adverse Event|15|||
27919068|NCT03248037|81539860|FG001|Overall Study|Adverse Event|0|||
27919069|NCT01123655|81539861|FG000|Overall Study|Medication for RA had to be changed|1|||
27635403|NCT01832480|80505920|FG001|Overall Study|post randomization ineligible|10|||
27635404|NCT02692417|80505927|FG000|Overall Study|Withdrawal by Subject|5|||
27635405|NCT02692417|80505928|FG001|Overall Study|Withdrawal by Subject|1|||
27635406|NCT02692417|80505927|FG000|Overall Study|Adverse Event|1|||
27635407|NCT02692417|80505928|FG001|Overall Study|Adverse Event|0|||
27635408|NCT00293293|80505929|FG000|Overall Study|Withdrawal by Subject|1|||
27635409|NCT00293293|80505930|FG001|Overall Study|Withdrawal by Subject|1|||
27635410|NCT00293293|80505929|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
27635411|NCT00293293|80505930|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
27635412|NCT00293293|80505929|FG000|Overall Study|Patient discontinued chemotherapy|0|||
27635413|NCT00293293|80505930|FG001|Overall Study|Patient discontinued chemotherapy|1|||
27635414|NCT01184508|80505931|FG000|Overall Study|Adverse Event|4|||
27635415|NCT01184508|80505932|FG001|Overall Study|Adverse Event|6|||
27635416|NCT01184508|80505931|FG000|Overall Study|Lack of Efficacy|1|||
27635417|NCT01184508|80505932|FG001|Overall Study|Lack of Efficacy|1|||
27635418|NCT01184508|80505931|FG000|Overall Study|Lost to Follow-up|1|||
27635419|NCT01184508|80505932|FG001|Overall Study|Lost to Follow-up|1|||
27635420|NCT01184508|80505931|FG000|Overall Study|Physician Decision|1|||
27635421|NCT01184508|80505932|FG001|Overall Study|Physician Decision|0|||
27635422|NCT01184508|80505931|FG000|Overall Study|Protocol Violation|3|||
27635423|NCT01184508|80505932|FG001|Overall Study|Protocol Violation|1|||
27635424|NCT01184508|80505931|FG000|Overall Study|Sponsor Decision|5|||
27635425|NCT01184508|80505932|FG001|Overall Study|Sponsor Decision|2|||
27635426|NCT01184508|80505931|FG000|Overall Study|Withdrawal by Subject|1|||
27635427|NCT01184508|80505932|FG001|Overall Study|Withdrawal by Subject|3|||
27635428|NCT01184508|80505931|FG000|Overall Study|Randomized, Not Treated|0|||
27635429|NCT01184508|80505932|FG001|Overall Study|Randomized, Not Treated|1|||
27635430|NCT00364013|80505934|FG000|Overall Study|Ineligibility determined|4|||
27635431|NCT00364013|80505935|FG001|Overall Study|Ineligibility determined|2|||
27635432|NCT00364013|80505934|FG000|Overall Study|Adverse Event|4|||
27635433|NCT00364013|80505935|FG001|Overall Study|Adverse Event|3|||
27635434|NCT00364013|80505934|FG000|Overall Study|Withdrawal by Subject|13|||
27635435|NCT00364013|80505935|FG001|Overall Study|Withdrawal by Subject|18|||
27635436|NCT00364013|80505934|FG000|Overall Study|Physician Decision|3|||
27635437|NCT00364013|80505935|FG001|Overall Study|Physician Decision|3|||
27635438|NCT00364013|80505934|FG000|Overall Study|Lost to Follow-up|10|||
27635439|NCT00364013|80505935|FG001|Overall Study|Lost to Follow-up|3|||
27635440|NCT00364013|80505934|FG000|Overall Study|Protocol-specified criteria|6|||
27635441|NCT00364013|80505935|FG001|Overall Study|Protocol-specified criteria|6|||
27635442|NCT00364013|80505934|FG000|Overall Study|Other|41|||
27635443|NCT00364013|80505935|FG001|Overall Study|Other|47|||
27635444|NCT00364013|80505934|FG000|Overall Study|Ongoing|20|||
27635445|NCT00364013|80505935|FG001|Overall Study|Ongoing|13|||
27635446|NCT03863834|80505939|FG000|Overall Study|Lost to Follow-up|3|||
27635447|NCT04009577|80505941|FG000|Core Study|Adverse Event|1|||
27635448|NCT04009577|80505942|FG001|Core Study|Adverse Event|0|||
27635449|NCT04009577|80505943|FG002|Core Study|Adverse Event|2|||
27635450|NCT04009577|80505944|FG003|Core Study|Adverse Event|4|||
27635451|NCT04009577|80505941|FG000|Core Study|Withdrawal by Subject|0|||
27635452|NCT04009577|80505942|FG001|Core Study|Withdrawal by Subject|0|||
27635453|NCT04009577|80505943|FG002|Core Study|Withdrawal by Subject|2|||
27635454|NCT04009577|80505944|FG003|Core Study|Withdrawal by Subject|0|||
27635455|NCT04009577|80505941|FG000|Core Study|Other|0|||
27635456|NCT04009577|80505942|FG001|Core Study|Other|0|||
27635457|NCT04009577|80505943|FG002|Core Study|Other|0|||
27635458|NCT04009577|80505944|FG003|Core Study|Other|1|||
27635459|NCT04009577|80505941|FG000|Extension Phase|Adverse Event|0|||
27635460|NCT04009577|80505942|FG001|Extension Phase|Adverse Event|0|||
27635461|NCT04009577|80505943|FG002|Extension Phase|Adverse Event|0|||
27635462|NCT04009577|80505944|FG003|Extension Phase|Adverse Event|1|||
27635463|NCT04009577|80505941|FG000|Extension Phase|Inadequate therapeutic effect|0|||
27635464|NCT04009577|80505942|FG001|Extension Phase|Inadequate therapeutic effect|0|||
27635465|NCT04009577|80505943|FG002|Extension Phase|Inadequate therapeutic effect|1|||
27635466|NCT04009577|80505944|FG003|Extension Phase|Inadequate therapeutic effect|0|||
27635467|NCT04009577|80505941|FG000|Extension Phase|Withdrawal by Subject|0|||
27635468|NCT04009577|80505942|FG001|Extension Phase|Withdrawal by Subject|0|||
27635469|NCT04009577|80505943|FG002|Extension Phase|Withdrawal by Subject|1|||
27635470|NCT04009577|80505944|FG003|Extension Phase|Withdrawal by Subject|0|||
27635471|NCT04009577|80505941|FG000|Extension Phase|Not Treated|0|||
27635472|NCT04009577|80505942|FG001|Extension Phase|Not Treated|0|||
27635473|NCT04009577|80505943|FG002|Extension Phase|Not Treated|2|||
27635474|NCT04009577|80505944|FG003|Extension Phase|Not Treated|0|||
27635475|NCT00396084|80505945|FG000|Overall Study|Adverse Event|0|||
27635476|NCT00396084|80505946|FG001|Overall Study|Adverse Event|0|||
27635477|NCT00396084|80505947|FG002|Overall Study|Adverse Event|0|||
27635478|NCT00396084|80505948|FG003|Overall Study|Adverse Event|0|||
27635479|NCT00396084|80505949|FG004|Overall Study|Adverse Event|1|||
27635480|NCT00396084|80505950|FG005|Overall Study|Adverse Event|2|||
27635481|NCT00396084|80505945|FG000|Overall Study|Withdrawal by Subject|0|||
27540229|NCT00150709|80171741|FG001|Overall Study|Decision of parent(s) and investigator|0|||
27540230|NCT00150709|80171742|FG002|Overall Study|Decision of parent(s) and investigator|0|||
27540231|NCT00150709|80171743|FG003|Overall Study|Decision of parent(s) and investigator|0|||
27540232|NCT00150709|80171740|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
27540233|NCT00150709|80171741|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
27540234|NCT00150709|80171742|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
27540235|NCT00150709|80171743|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
27540236|NCT00150709|80171740|FG000|Overall Study|Investigator decision|1|||
27540237|NCT00150709|80171741|FG001|Overall Study|Investigator decision|0|||
27540238|NCT00150709|80171742|FG002|Overall Study|Investigator decision|0|||
27540239|NCT00150709|80171743|FG003|Overall Study|Investigator decision|1|||
27540240|NCT00150709|80171740|FG000|Overall Study|Subject relocated|2|||
27540241|NCT00150709|80171741|FG001|Overall Study|Subject relocated|2|||
27540242|NCT00150709|80171742|FG002|Overall Study|Subject relocated|1|||
27540243|NCT00150709|80171743|FG003|Overall Study|Subject relocated|0|||
27540244|NCT00150709|80171740|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
27540245|NCT00150709|80171741|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
27540246|NCT00150709|80171742|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
27540247|NCT00150709|80171743|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
27540248|NCT00150709|80171740|FG000|Overall Study|Convenience|0|||
27540249|NCT00150709|80171741|FG001|Overall Study|Convenience|1|||
27540250|NCT00150709|80171742|FG002|Overall Study|Convenience|0|||
27540251|NCT00150709|80171743|FG003|Overall Study|Convenience|0|||
27540252|NCT00150709|80171740|FG000|Overall Study|Subject entered new drug study|0|||
27540253|NCT00150709|80171741|FG001|Overall Study|Subject entered new drug study|1|||
27540254|NCT00150709|80171742|FG002|Overall Study|Subject entered new drug study|0|||
27540255|NCT00150709|80171743|FG003|Overall Study|Subject entered new drug study|0|||
27540256|NCT00150709|80171740|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
27540257|NCT00150709|80171741|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
27540258|NCT00150709|80171742|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
27540259|NCT00150709|80171743|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
27540260|NCT00150709|80171740|FG000|Overall Study|Lack of ease of swallowing|0|||
27540261|NCT00150709|80171741|FG001|Overall Study|Lack of ease of swallowing|1|||
27540262|NCT00150709|80171742|FG002|Overall Study|Lack of ease of swallowing|0|||
27540263|NCT00150709|80171743|FG003|Overall Study|Lack of ease of swallowing|0|||
27540264|NCT01500031|80171744|FG000|Overall Study|Death|1|||
27540265|NCT01500031|80171744|FG000|Overall Study|Withdrawal by Subject|4|||
27540266|NCT01604408|80171745|FG000|Treatment Period 1|Protocol Violation|0|||
27540267|NCT01604408|80171746|FG001|Treatment Period 1|Protocol Violation|1|||
27540268|NCT01604408|80171745|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27540269|NCT01604408|80171746|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27540270|NCT01604408|80171745|FG000|Treatment Period 2|Protocol Violation|1|||
27540271|NCT01604408|80171746|FG001|Treatment Period 2|Protocol Violation|0|||
27540272|NCT01604408|80171745|FG000|Treatment Period 2|Adverse Event|0|||
27540273|NCT01604408|80171746|FG001|Treatment Period 2|Adverse Event|1|||
27540274|NCT01604408|80171745|FG000|Treatment Period 3|Protocol Violation|1|||
27540275|NCT01604408|80171746|FG001|Treatment Period 3|Protocol Violation|1|||
27540276|NCT01604408|80171745|FG000|Treatment Period 3|Adverse Event|0|||
27540277|NCT01604408|80171746|FG001|Treatment Period 3|Adverse Event|3|||
27540278|NCT01604408|80171745|FG000|Treatment Period 3|Withdrawal by Subject|3|||
27540279|NCT01604408|80171746|FG001|Treatment Period 3|Withdrawal by Subject|1|||
27540280|NCT01604408|80171745|FG000|Treatment Period 3|Sponsor Decision|1|||
27540281|NCT01604408|80171746|FG001|Treatment Period 3|Sponsor Decision|0|||
27540282|NCT01604408|80171745|FG000|Treatment Period 4|Death|1|||
27540283|NCT01604408|80171746|FG001|Treatment Period 4|Death|0|||
27540284|NCT01604408|80171745|FG000|Treatment Period 4|Withdrawal by Subject|2|||
27540285|NCT01604408|80171746|FG001|Treatment Period 4|Withdrawal by Subject|1|||
27540286|NCT01604408|80171745|FG000|Treatment Period 4|Adverse Event|0|||
27540287|NCT01604408|80171746|FG001|Treatment Period 4|Adverse Event|1|||
27540288|NCT01604408|80171745|FG000|Treatment Period 5|Adverse Event|4|||
27540289|NCT01604408|80171746|FG001|Treatment Period 5|Adverse Event|0|||
27540290|NCT01604408|80171745|FG000|Treatment Period 6|Lost to Follow-up|0|||
27540291|NCT01604408|80171746|FG001|Treatment Period 6|Lost to Follow-up|1|||
27540292|NCT01604408|80171745|FG000|Treatment Period 6|Adverse Event|2|||
27919070|NCT01123655|81539862|FG001|Overall Study|Medication for RA had to be changed|0|||
27635482|NCT00396084|80505946|FG001|Overall Study|Withdrawal by Subject|0|||
27919071|NCT01123655|81539863|FG002|Overall Study|Medication for RA had to be changed|0|||
27919072|NCT01123655|81539861|FG000|Overall Study|new illness|0|||
27540293|NCT01604408|80171746|FG001|Treatment Period 6|Adverse Event|0|||
27540294|NCT01604408|80171745|FG000|Treatment Period 6|Sponsor decision|0|||
27540295|NCT01604408|80171746|FG001|Treatment Period 6|Sponsor decision|1|||
27540296|NCT01604408|80171745|FG000|Observation Period|Adverse Event|1|||
27540297|NCT01604408|80171746|FG001|Observation Period|Adverse Event|1|||
27540298|NCT01604408|80171745|FG000|Observation Period|Withdrawal by Subject|0|||
27635483|NCT00396084|80505947|FG002|Overall Study|Withdrawal by Subject|0|||
27635484|NCT00396084|80505948|FG003|Overall Study|Withdrawal by Subject|1|||
27635485|NCT00396084|80505949|FG004|Overall Study|Withdrawal by Subject|0|||
27635486|NCT00396084|80505950|FG005|Overall Study|Withdrawal by Subject|0|||
27635487|NCT02694978|80505957|FG000|Overall Study|Adverse Event|10|||
27635488|NCT02694978|80505958|FG001|Overall Study|Adverse Event|9|||
27635489|NCT02694978|80505957|FG000|Overall Study|Withdrawal by Subject|22|||
27635490|NCT02694978|80505958|FG001|Overall Study|Withdrawal by Subject|19|||
27635491|NCT02694978|80505957|FG000|Overall Study|Lost to Follow-up|14|||
27635492|NCT02694978|80505958|FG001|Overall Study|Lost to Follow-up|17|||
27635493|NCT02694978|80505957|FG000|Overall Study|Death|4|||
27635494|NCT02694978|80505958|FG001|Overall Study|Death|1|||
27635495|NCT02694978|80505957|FG000|Overall Study|Other-Decision of Participant|6|||
27635496|NCT02694978|80505958|FG001|Overall Study|Other-Decision of Participant|1|||
27635497|NCT02694978|80505957|FG000|Overall Study|Other-Investigator's decision|1|||
27635498|NCT02694978|80505958|FG001|Overall Study|Other-Investigator's decision|0|||
27635499|NCT02694978|80505957|FG000|Overall Study|Other-Unable to be reached|0|||
27635500|NCT02694978|80505958|FG001|Overall Study|Other-Unable to be reached|1|||
27635501|NCT02694978|80505957|FG000|Overall Study|Other-Protocol noncompliant|2|||
27635502|NCT02694978|80505958|FG001|Overall Study|Other-Protocol noncompliant|1|||
27635503|NCT02694978|80505957|FG000|Overall Study|Other-Personal reasons|3|||
27635504|NCT02694978|80505958|FG001|Overall Study|Other-Personal reasons|3|||
27635505|NCT02694978|80505957|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
27635506|NCT02694978|80505958|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
27635507|NCT00891930|80505959|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
27635508|NCT00891930|80505959|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
27635509|NCT00891930|80505959|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
27635510|NCT00891930|80505959|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
27635511|NCT00891930|80505959|FG000|Part 2 Panitumumab + AMG479|Death|30|||
27635512|NCT02441036|80505960|FG000|Overall Study|No tissue resected|0|||
27635513|NCT02441036|80505961|FG001|Overall Study|No tissue resected|1|||
27635514|NCT02441036|80505962|FG002|Overall Study|No tissue resected|0|||
27635515|NCT02441036|80505963|FG003|Overall Study|No tissue resected|1|||
27635516|NCT02441036|80505964|FG004|Overall Study|No tissue resected|0|||
27635517|NCT02570711|80505965|FG000|Overall Study|Death|1|||
27635518|NCT02570711|80505966|FG001|Overall Study|Death|0|||
27635519|NCT02570711|80505965|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
27635520|NCT02570711|80505966|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
27635521|NCT01087762|80505967|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
27635522|NCT01087762|80505968|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
27919073|NCT01123655|81539862|FG001|Overall Study|new illness|1|||
27919074|NCT01123655|81539863|FG002|Overall Study|new illness|0|||
27919075|NCT01123655|81539861|FG000|Overall Study|began prohibitive drug|0|||
27919076|NCT01123655|81539862|FG001|Overall Study|began prohibitive drug|0|||
27919077|NCT01123655|81539863|FG002|Overall Study|began prohibitive drug|1|||
27919078|NCT04584788|81539864|FG000|Overall Study|Physician Decision|8|||
27919079|NCT04584788|81539864|FG000|Overall Study|Withdrawal by Subject|1|||
27919080|NCT04584788|81539864|FG000|Overall Study|Adverse Event|3|||
27919081|NCT03106077|81539865|FG000|Overall Study|Screen Failure|94|||
27919082|NCT03106077|81539866|FG001|Overall Study|Screen Failure|0|||
27919083|NCT01405560|81539867|FG000|Overall Study|Physician Decision|1|||
27919084|NCT01408706|81539873|FG000|Overall Study|Physician Decision|1|||
27919085|NCT01408706|81539874|FG001|Overall Study|Physician Decision|0|||
27540299|NCT01604408|80171746|FG001|Observation Period|Withdrawal by Subject|2|||
27540300|NCT00533897|80171747|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
27540301|NCT00533897|80171748|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
27540302|NCT00533897|80171749|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
27540303|NCT00533897|80171750|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
27540304|NCT00533897|80171751|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
27540305|NCT00533897|80171752|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
27635523|NCT01087762|80505969|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
27635524|NCT01087762|80505970|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
27635525|NCT01087762|80505971|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
27635526|NCT01087762|80505967|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
27635527|NCT01087762|80505968|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
27635528|NCT01087762|80505969|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
27919086|NCT00764790|81539875|FG000|Overall Study|Protocol Violation|0|||
27540306|NCT00533897|80171753|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
27540307|NCT00533897|80171754|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
27919087|NCT00764790|81539876|FG001|Overall Study|Protocol Violation|0|||
27919088|NCT00764790|81539877|FG002|Overall Study|Protocol Violation|1|||
27635529|NCT01087762|80505970|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
27635530|NCT01087762|80505971|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
27635531|NCT01087762|80505967|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
27635532|NCT01087762|80505968|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
27919089|NCT00764790|81539875|FG000|Overall Study|Withdrawal by Subject|10|||
27540308|NCT00533897|80171747|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
27540309|NCT00533897|80171748|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540310|NCT00533897|80171749|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540311|NCT00533897|80171750|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540312|NCT00533897|80171751|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540313|NCT00533897|80171752|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540314|NCT00533897|80171753|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540315|NCT00533897|80171754|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
27540316|NCT00533897|80171747|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
27540317|NCT00533897|80171748|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540318|NCT00533897|80171749|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540319|NCT00533897|80171750|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540320|NCT00533897|80171751|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540321|NCT00533897|80171752|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540322|NCT00533897|80171753|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540323|NCT00533897|80171754|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
27540324|NCT00533897|80171747|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
27540325|NCT00533897|80171748|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540326|NCT00533897|80171749|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540327|NCT00533897|80171750|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540328|NCT00533897|80171751|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540329|NCT00533897|80171752|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540330|NCT00533897|80171753|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540331|NCT00533897|80171754|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
27540332|NCT00533897|80171747|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
27540333|NCT00533897|80171748|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540334|NCT00533897|80171749|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540335|NCT00533897|80171750|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540336|NCT00533897|80171751|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540337|NCT00533897|80171752|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540338|NCT00533897|80171753|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540339|NCT00533897|80171754|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
27540340|NCT00533897|80171747|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
27540341|NCT00533897|80171748|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540342|NCT00533897|80171749|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540343|NCT00533897|80171750|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540344|NCT00533897|80171751|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540345|NCT00533897|80171752|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540346|NCT00533897|80171753|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540347|NCT00533897|80171754|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
27540348|NCT00533897|80171747|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
27540349|NCT00533897|80171748|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
27540350|NCT00533897|80171749|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
27540351|NCT00533897|80171750|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
27540352|NCT00533897|80171751|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
27540353|NCT00533897|80171752|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
27540354|NCT00533897|80171753|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
27540355|NCT00533897|80171754|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
27540356|NCT00533897|80171747|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540357|NCT00533897|80171748|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540358|NCT00533897|80171749|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
27540359|NCT00533897|80171750|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540360|NCT00533897|80171751|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540361|NCT00533897|80171752|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540362|NCT00533897|80171753|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540363|NCT00533897|80171754|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
27540364|NCT00533897|80171747|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540365|NCT00533897|80171748|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540366|NCT00533897|80171749|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540367|NCT00533897|80171750|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540368|NCT00533897|80171751|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540369|NCT00533897|80171752|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
27540370|NCT00533897|80171753|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540371|NCT00533897|80171754|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
27540372|NCT00533897|80171747|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27540373|NCT00533897|80171748|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27635533|NCT01087762|80505969|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
27635534|NCT01087762|80505970|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
27635535|NCT01087762|80505971|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
27635536|NCT01087762|80505967|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
27635537|NCT01087762|80505968|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
27635538|NCT01087762|80505969|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
27635539|NCT01087762|80505970|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
27635540|NCT01087762|80505971|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
27635541|NCT01087762|80505967|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
27635542|NCT01087762|80505968|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
27635543|NCT01087762|80505969|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
27635544|NCT01087762|80505970|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
27635545|NCT01087762|80505971|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
27635546|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
27635547|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
27635548|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
27919090|NCT00764790|81539876|FG001|Overall Study|Withdrawal by Subject|12|||
27919091|NCT00764790|81539877|FG002|Overall Study|Withdrawal by Subject|6|||
27919092|NCT00764790|81539875|FG000|Overall Study|Lost to Follow-up|28|||
27919093|NCT00764790|81539876|FG001|Overall Study|Lost to Follow-up|29|||
27919094|NCT00764790|81539877|FG002|Overall Study|Lost to Follow-up|23|||
27919095|NCT01884597|81539880|FG000|Overall Study|Adverse Event|0|||
27919096|NCT01884597|81539881|FG001|Overall Study|Adverse Event|0|||
27919097|NCT01884597|81539882|FG002|Overall Study|Adverse Event|1|||
27919098|NCT01884597|81539880|FG000|Overall Study|Lack of Efficacy|1|||
27919099|NCT01884597|81539881|FG001|Overall Study|Lack of Efficacy|0|||
27919100|NCT01884597|81539882|FG002|Overall Study|Lack of Efficacy|0|||
27635549|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
27635550|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
27635551|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
27635552|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
27635553|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
27635554|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
27635555|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
27635556|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
27635557|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
27635558|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
27635559|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
27635560|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
27635561|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
27635562|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
27635563|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
27635564|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
27635565|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
27635566|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
27635567|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
27635568|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
27635569|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
27635570|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
27635571|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
27635572|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
27635573|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
27635574|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
27635575|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
27635576|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
27635577|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
27635578|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
27635579|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
27635580|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
27635581|NCT01087762|80505967|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
27635582|NCT01087762|80505968|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
27635583|NCT01087762|80505969|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
27635584|NCT01087762|80505970|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
27635585|NCT01087762|80505971|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
27635586|NCT02547922|80505972|FG000|Overall Study|Withdrawal by Subject|9|||
27635587|NCT02547922|80505973|FG001|Overall Study|Withdrawal by Subject|6|||
27919101|NCT01884597|81539880|FG000|Overall Study|Death|0|||
27919102|NCT01884597|81539881|FG001|Overall Study|Death|1|||
27919103|NCT01884597|81539882|FG002|Overall Study|Death|0|||
27635588|NCT02547922|80505974|FG002|Overall Study|Withdrawal by Subject|10|||
27635589|NCT02547922|80505972|FG000|Overall Study|Adverse Event|3|||
27635590|NCT02547922|80505973|FG001|Overall Study|Adverse Event|1|||
27635591|NCT02547922|80505974|FG002|Overall Study|Adverse Event|2|||
27635592|NCT02547922|80505972|FG000|Overall Study|Lost to Follow-up|1|||
27635593|NCT02547922|80505973|FG001|Overall Study|Lost to Follow-up|0|||
27635594|NCT02547922|80505974|FG002|Overall Study|Lost to Follow-up|0|||
27635595|NCT02547922|80505972|FG000|Overall Study|Lack of Efficacy|5|||
27635596|NCT02547922|80505973|FG001|Overall Study|Lack of Efficacy|7|||
27635597|NCT02547922|80505974|FG002|Overall Study|Lack of Efficacy|4|||
27635598|NCT02547922|80505972|FG000|Overall Study|Death|1|||
27635599|NCT02547922|80505973|FG001|Overall Study|Death|0|||
27919104|NCT01200329|81539883|FG000|Overall Study|Lack of financial coverage|2|||
27919105|NCT01200329|81539883|FG000|Overall Study|Progressive disease|1|||
27919106|NCT02771275|81539884|FG000|Overall Study|Reoperation|3|||
27919107|NCT02771275|81539884|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
27919108|NCT03054428|81539885|FG000|Overall Study|Physician Decision|0|||
27919109|NCT03054428|81539886|FG001|Overall Study|Physician Decision|1|||
27919110|NCT03054428|81539887|FG002|Overall Study|Physician Decision|1|||
27919111|NCT03054428|81539885|FG000|Overall Study|Lack of Efficacy|3|||
27919112|NCT03054428|81539886|FG001|Overall Study|Lack of Efficacy|1|||
27919113|NCT03054428|81539887|FG002|Overall Study|Lack of Efficacy|0|||
27919114|NCT03054428|81539885|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
27919115|NCT03054428|81539886|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
27919116|NCT03054428|81539887|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
27919117|NCT03054428|81539885|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
27919118|NCT03054428|81539886|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
27919119|NCT03054428|81539887|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
27919120|NCT03054428|81539885|FG000|Overall Study|Transitioned to OLE study|76|||
27919121|NCT03054428|81539886|FG001|Overall Study|Transitioned to OLE study|76|||
27919122|NCT03054428|81539887|FG002|Overall Study|Transitioned to OLE study|73|||
27919123|NCT03054428|81539885|FG000|Overall Study|Withdrawal by Subject|3|||
27919124|NCT03054428|81539886|FG001|Overall Study|Withdrawal by Subject|2|||
27919125|NCT03054428|81539887|FG002|Overall Study|Withdrawal by Subject|3|||
27919126|NCT03054428|81539885|FG000|Overall Study|Lost to Follow-up|0|||
27919127|NCT03054428|81539886|FG001|Overall Study|Lost to Follow-up|0|||
27919128|NCT03054428|81539887|FG002|Overall Study|Lost to Follow-up|1|||
27919129|NCT01604785|81539888|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
27919130|NCT01604785|81539889|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
27919131|NCT00313846|81539899|FG000|Overall Study|Withdrawal by Subject|2|||
27919132|NCT00313846|81539900|FG001|Overall Study|Withdrawal by Subject|0|||
27919133|NCT00313846|81539899|FG000|Overall Study|Adverse Event|1|||
27540374|NCT00533897|80171749|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27540375|NCT00533897|80171750|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27540376|NCT00533897|80171751|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27540377|NCT00533897|80171752|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
27540378|NCT00533897|80171753|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27540379|NCT00533897|80171754|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
27540380|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
27540381|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
27540382|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
27540383|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
27540384|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
27540385|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
27540386|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
27540387|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
27540388|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Death|0|||
27540389|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Death|0|||
27540390|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Death|0|||
27540391|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Death|0|||
27540392|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Death|0|||
27540393|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Death|0|||
27540394|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Death|1|||
27540395|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Death|3|||
27540396|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
27540397|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
27540398|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
27540399|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
27635600|NCT02547922|80505974|FG002|Overall Study|Death|0|||
27635601|NCT02547922|80505972|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
27919134|NCT00313846|81539900|FG001|Overall Study|Adverse Event|8|||
27919135|NCT00313846|81539899|FG000|Overall Study|Administrative|2|||
27919136|NCT00313846|81539900|FG001|Overall Study|Administrative|3|||
27635602|NCT02547922|80505973|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
27635603|NCT02547922|80505974|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
27635604|NCT02547922|80505972|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
27635605|NCT02547922|80505973|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
27635606|NCT02547922|80505974|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
27635607|NCT02547922|80505972|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
27635608|NCT02547922|80505973|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
27635609|NCT02547922|80505974|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
27635610|NCT02547922|80505972|FG000|Overall Study|Physician Decision|2|||
27635611|NCT02547922|80505973|FG001|Overall Study|Physician Decision|1|||
27635612|NCT02547922|80505974|FG002|Overall Study|Physician Decision|2|||
27635613|NCT02547922|80505972|FG000|Overall Study|Patients did not receive IP|1|||
27635614|NCT02547922|80505973|FG001|Overall Study|Patients did not receive IP|1|||
27635615|NCT02547922|80505974|FG002|Overall Study|Patients did not receive IP|0|||
27635616|NCT00356265|80505975|FG000|Overall Study|Withdrawal by Subject|0|||
27635617|NCT00356265|80505976|FG001|Overall Study|Withdrawal by Subject|0|||
27635618|NCT00356265|80505977|FG002|Overall Study|Withdrawal by Subject|1|||
27635619|NCT03102710|80505986|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
27635620|NCT03102710|80505987|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
27635621|NCT03102710|80505988|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
27635622|NCT03102710|80505986|FG000|Overall Study|Technical issues during final MRI scan|0|||
27635623|NCT03102710|80505987|FG001|Overall Study|Technical issues during final MRI scan|1|||
27635624|NCT03102710|80505988|FG002|Overall Study|Technical issues during final MRI scan|0|||
27635625|NCT03102710|80505986|FG000|Overall Study|Nausea during MRI scan|0|||
27635626|NCT03102710|80505987|FG001|Overall Study|Nausea during MRI scan|1|||
27635627|NCT03102710|80505988|FG002|Overall Study|Nausea during MRI scan|0|||
27635628|NCT03102710|80505986|FG000|Overall Study|Subject unable to attend final session|0|||
27635629|NCT03102710|80505987|FG001|Overall Study|Subject unable to attend final session|1|||
27635630|NCT03102710|80505988|FG002|Overall Study|Subject unable to attend final session|0|||
27635631|NCT01190007|80505993|FG000|Overall Study|Withdrawal by Subject|4|||
27635632|NCT01190007|80505993|FG000|Overall Study|Adverse Event|8|||
27635633|NCT01190007|80505993|FG000|Overall Study|Difficulty of visit for complications|1|||
27635634|NCT01190007|80505993|FG000|Overall Study|Participant was arrested|1|||
27635635|NCT02412748|80505997|FG000|Overall Study|Lost to Follow-up|38|||
27635636|NCT02412748|80505998|FG001|Overall Study|Lost to Follow-up|39|||
27635637|NCT00004124|80506001|FG000|Overall Study|Received no protocol therapy|12|||
27635638|NCT00004124|80506002|FG001|Overall Study|Received no protocol therapy|20|||
27635639|NCT00028769|80506003|FG000|Overall Study|Adverse Event|2|||
27635640|NCT00028769|80506003|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
27635641|NCT00028769|80506003|FG000|Overall Study|Progression or Death|31|||
27635642|NCT00028769|80506003|FG000|Overall Study|Other - Not Protocol Specified|1|||
27635643|NCT00028769|80506003|FG000|Overall Study|Ineligible|5|||
27635644|NCT00028769|80506003|FG000|Overall Study|Not Analyzable|1|||
27635645|NCT00628862|80506004|FG000|Overall Study|Adverse Event|6|||
27635646|NCT00628862|80506005|FG001|Overall Study|Adverse Event|8|||
27635647|NCT00628862|80506006|FG002|Overall Study|Adverse Event|10|||
27635648|NCT00628862|80506004|FG000|Overall Study|Withdrawal by Subject|4|||
27635649|NCT00628862|80506005|FG001|Overall Study|Withdrawal by Subject|6|||
27635650|NCT00628862|80506006|FG002|Overall Study|Withdrawal by Subject|11|||
27635651|NCT00628862|80506004|FG000|Overall Study|Lost to Follow-up|0|||
27635652|NCT00628862|80506005|FG001|Overall Study|Lost to Follow-up|2|||
27919137|NCT04919317|81539901|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
27540400|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
27540401|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
27540402|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
27540403|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
27540404|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540405|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540406|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540407|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540408|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540409|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540410|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
27540411|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
27540412|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Adverse Event|0|||
27635653|NCT00628862|80506006|FG002|Overall Study|Lost to Follow-up|1|||
27635654|NCT00628862|80506004|FG000|Overall Study|Protocol Violation|1|||
27635655|NCT00628862|80506005|FG001|Overall Study|Protocol Violation|0|||
27635656|NCT00628862|80506006|FG002|Overall Study|Protocol Violation|0|||
27635657|NCT00628862|80506004|FG000|Overall Study|COPD Exacerbation|0|||
27635658|NCT00628862|80506005|FG001|Overall Study|COPD Exacerbation|1|||
27540413|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Adverse Event|0|||
27540414|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Adverse Event|0|||
27635659|NCT00628862|80506006|FG002|Overall Study|COPD Exacerbation|0|||
27635660|NCT01505881|80506007|FG000|Overall Study|Adverse Event|0|||
27635661|NCT01505881|80506008|FG001|Overall Study|Adverse Event|1|||
27635662|NCT01505881|80506007|FG000|Overall Study|Lost to Follow-up|2|||
27635663|NCT01505881|80506008|FG001|Overall Study|Lost to Follow-up|0|||
27635664|NCT01505881|80506007|FG000|Overall Study|Withdrawal by Subject|2|||
27635665|NCT01505881|80506008|FG001|Overall Study|Withdrawal by Subject|0|||
27635666|NCT04722003|80506014|FG000|Overall Study|Lost to Follow-up|2|||
27635667|NCT04722003|80506015|FG001|Overall Study|Lost to Follow-up|0|||
27635668|NCT04722003|80506014|FG000|Overall Study|Physician Decision|1|||
27635669|NCT04722003|80506015|FG001|Overall Study|Physician Decision|0|||
27635670|NCT00494780|80506016|FG000|Overall Study|Adverse Event|1|||
27635671|NCT00494780|80506017|FG001|Overall Study|Adverse Event|0|||
27635672|NCT00494780|80506016|FG000|Overall Study|Withdrew before Dosed|0|||
27635673|NCT00494780|80506017|FG001|Overall Study|Withdrew before Dosed|1|||
27635674|NCT00494780|80506016|FG000|Overall Study|Progression of Study Disease|7|||
27635675|NCT00494780|80506017|FG001|Overall Study|Progression of Study Disease|8|||
27635676|NCT00494780|80506016|FG000|Overall Study|New Treatment|2|||
27635677|NCT00494780|80506017|FG001|Overall Study|New Treatment|2|||
27635678|NCT00494780|80506016|FG000|Overall Study|Non-compliance|1|||
27635679|NCT00494780|80506017|FG001|Overall Study|Non-compliance|0|||
27635680|NCT00494780|80506016|FG000|Overall Study|Residual Tumour Mass|0|||
27635681|NCT00494780|80506017|FG001|Overall Study|Residual Tumour Mass|1|||
27635682|NCT00494780|80506016|FG000|Overall Study|Insurance Issues|0|||
27635683|NCT00494780|80506017|FG001|Overall Study|Insurance Issues|1|||
27635684|NCT05790408|80506020|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
27635685|NCT00223795|80506028|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
27635686|NCT00223795|80506029|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
27635687|NCT00223795|80506028|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
27635688|NCT00223795|80506029|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
27635689|NCT01266265|80506033|FG000|Overall Study|Death|95|||
27635690|NCT01266265|80506034|FG001|Overall Study|Death|73|||
27635691|NCT01266265|80506033|FG000|Overall Study|Lost to Follow-up|23|||
27635692|NCT01266265|80506034|FG001|Overall Study|Lost to Follow-up|28|||
27635693|NCT01266265|80506033|FG000|Overall Study|Withdrawal by Subject|13|||
27635694|NCT01266265|80506034|FG001|Overall Study|Withdrawal by Subject|11|||
27919138|NCT04919317|81539902|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
27919139|NCT04919317|81539901|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
27919140|NCT04919317|81539902|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
27540415|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Adverse Event|0|||
27540416|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Adverse Event|0|||
27540417|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Adverse Event|0|||
27540418|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Adverse Event|2|||
27540419|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Adverse Event|5|||
27540420|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Pregnancy|0|||
27540421|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Pregnancy|0|||
27540422|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Pregnancy|0|||
27540423|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Pregnancy|0|||
27540424|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Pregnancy|0|||
27540425|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Pregnancy|0|||
27540426|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Pregnancy|0|||
27540427|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Pregnancy|2|||
27540428|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
27540429|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
27919141|NCT01443858|81539903|FG000|Overall Study|Withdrawal by Subject|9|||
27919142|NCT01443858|81539904|FG001|Overall Study|Withdrawal by Subject|8|||
27919143|NCT01443858|81539905|FG002|Overall Study|Withdrawal by Subject|5|||
27919144|NCT01443858|81539903|FG000|Overall Study|Lack of Efficacy|1|||
27540430|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
27540431|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
27635695|NCT01266265|80506033|FG000|Overall Study|Respiratory-related adverse event|2|||
27635696|NCT01266265|80506034|FG001|Overall Study|Respiratory-related adverse event|1|||
27635697|NCT01266265|80506033|FG000|Overall Study|Transferred care to another provider|22|||
27635698|NCT01266265|80506034|FG001|Overall Study|Transferred care to another provider|28|||
27635699|NCT01266265|80506033|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
27635700|NCT01266265|80506034|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
27635701|NCT01266265|80506033|FG000|Overall Study|Enrolled in another clinical study|15|||
27635702|NCT01266265|80506034|FG001|Overall Study|Enrolled in another clinical study|26|||
27635703|NCT01266265|80506033|FG000|Overall Study|Non-compliance|8|||
27919145|NCT01443858|81539904|FG001|Overall Study|Lack of Efficacy|0|||
27635704|NCT01266265|80506034|FG001|Overall Study|Non-compliance|5|||
27635705|NCT01266265|80506033|FG000|Overall Study|Lung transplant|6|||
27635706|NCT01266265|80506034|FG001|Overall Study|Lung transplant|5|||
27635707|NCT01266265|80506033|FG000|Overall Study|Site closed early|4|||
27919146|NCT01443858|81539905|FG002|Overall Study|Lack of Efficacy|0|||
27540432|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
27540433|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
27540434|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
27540435|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
27540436|NCT00533897|80171747|FG000|Long Term Extension (LTE)|Other|0|||
27540437|NCT00533897|80171748|FG001|Long Term Extension (LTE)|Other|0|||
27540438|NCT00533897|80171749|FG002|Long Term Extension (LTE)|Other|0|||
27540439|NCT00533897|80171750|FG003|Long Term Extension (LTE)|Other|0|||
27540440|NCT00533897|80171751|FG004|Long Term Extension (LTE)|Other|0|||
27540441|NCT00533897|80171752|FG005|Long Term Extension (LTE)|Other|0|||
27540442|NCT00533897|80171753|FG006|Long Term Extension (LTE)|Other|1|||
27540443|NCT00533897|80171754|FG007|Long Term Extension (LTE)|Other|6|||
27540444|NCT02336373|80171755|FG000|Overall Study|Protocol closed early|4|||
27540445|NCT02336373|80171755|FG000|Overall Study|Physician Decision|14|||
27540446|NCT00306189|80171756|FG000|Overall Study|Physician Decision|0|||
27540447|NCT00306189|80171757|FG001|Overall Study|Physician Decision|0|||
27540448|NCT00306189|80171758|FG002|Overall Study|Physician Decision|0|||
27540449|NCT00306189|80171759|FG003|Overall Study|Physician Decision|1|||
27540450|NCT00306189|80171756|FG000|Overall Study|Adverse Event|3|||
27540451|NCT00306189|80171757|FG001|Overall Study|Adverse Event|3|||
27540452|NCT00306189|80171758|FG002|Overall Study|Adverse Event|2|||
27540453|NCT00306189|80171759|FG003|Overall Study|Adverse Event|2|||
27540454|NCT00306189|80171756|FG000|Overall Study|Withdrawal by Subject|4|||
27540455|NCT00306189|80171757|FG001|Overall Study|Withdrawal by Subject|2|||
27540456|NCT00306189|80171758|FG002|Overall Study|Withdrawal by Subject|8|||
27540457|NCT00306189|80171759|FG003|Overall Study|Withdrawal by Subject|1|||
27540458|NCT00306189|80171756|FG000|Overall Study|Ineligibility determined|1|||
27540459|NCT00306189|80171757|FG001|Overall Study|Ineligibility determined|1|||
27540460|NCT00306189|80171758|FG002|Overall Study|Ineligibility determined|1|||
27540461|NCT00306189|80171759|FG003|Overall Study|Ineligibility determined|1|||
27540462|NCT00306189|80171756|FG000|Overall Study|Other|1|||
27540463|NCT00306189|80171757|FG001|Overall Study|Other|0|||
27540464|NCT00306189|80171758|FG002|Overall Study|Other|0|||
27540465|NCT00306189|80171759|FG003|Overall Study|Other|0|||
27540466|NCT00806351|80171763|FG000|Overall Study|Death|5|||
27540467|NCT00806351|80171764|FG001|Overall Study|Death|4|||
27540468|NCT03519178|80171765|FG000|PF-06873600 Treatment|Adverse Event|0|||
27540469|NCT03519178|80171766|FG001|PF-06873600 Treatment|Adverse Event|0|||
27540470|NCT03519178|80171767|FG002|PF-06873600 Treatment|Adverse Event|0|||
27540471|NCT03519178|80171768|FG003|PF-06873600 Treatment|Adverse Event|0|||
27540472|NCT03519178|80171769|FG004|PF-06873600 Treatment|Adverse Event|0|||
27540473|NCT03519178|80171770|FG005|PF-06873600 Treatment|Adverse Event|0|||
27540474|NCT03519178|80171771|FG006|PF-06873600 Treatment|Adverse Event|0|||
27540475|NCT03519178|80171772|FG007|PF-06873600 Treatment|Adverse Event|2|||
27540476|NCT03519178|80171773|FG008|PF-06873600 Treatment|Adverse Event|1|||
27540477|NCT03519178|80171774|FG009|PF-06873600 Treatment|Adverse Event|0|||
27540478|NCT03519178|80171775|FG010|PF-06873600 Treatment|Adverse Event|0|||
27540479|NCT03519178|80171776|FG011|PF-06873600 Treatment|Adverse Event|0|||
27540480|NCT03519178|80171777|FG012|PF-06873600 Treatment|Adverse Event|1|||
27540481|NCT03519178|80171778|FG013|PF-06873600 Treatment|Adverse Event|3|||
27540482|NCT03519178|80171779|FG014|PF-06873600 Treatment|Adverse Event|2|||
27540483|NCT03519178|80171765|FG000|PF-06873600 Treatment|Death|0|||
27540484|NCT03519178|80171766|FG001|PF-06873600 Treatment|Death|0|||
27540485|NCT03519178|80171767|FG002|PF-06873600 Treatment|Death|0|||
27540486|NCT03519178|80171768|FG003|PF-06873600 Treatment|Death|0|||
27540487|NCT03519178|80171769|FG004|PF-06873600 Treatment|Death|0|||
27540488|NCT03519178|80171770|FG005|PF-06873600 Treatment|Death|0|||
27540489|NCT03519178|80171771|FG006|PF-06873600 Treatment|Death|0|||
27540490|NCT03519178|80171772|FG007|PF-06873600 Treatment|Death|0|||
27540491|NCT03519178|80171773|FG008|PF-06873600 Treatment|Death|1|||
27540492|NCT03519178|80171774|FG009|PF-06873600 Treatment|Death|1|||
27540493|NCT03519178|80171775|FG010|PF-06873600 Treatment|Death|0|||
27540494|NCT03519178|80171776|FG011|PF-06873600 Treatment|Death|0|||
27540495|NCT03519178|80171777|FG012|PF-06873600 Treatment|Death|0|||
27540496|NCT03519178|80171778|FG013|PF-06873600 Treatment|Death|0|||
27919147|NCT01443858|81539903|FG000|Overall Study|Lost to Follow-up|5|||
27540497|NCT03519178|80171779|FG014|PF-06873600 Treatment|Death|1|||
27540498|NCT03519178|80171765|FG000|PF-06873600 Treatment|Physician Decision|0|||
27919148|NCT01443858|81539904|FG001|Overall Study|Lost to Follow-up|5|||
27919149|NCT01443858|81539905|FG002|Overall Study|Lost to Follow-up|2|||
27919150|NCT01241279|81539906|FG000|Overall Study|Lost to Follow-up|0|||
27540499|NCT03519178|80171766|FG001|PF-06873600 Treatment|Physician Decision|0|||
27540500|NCT03519178|80171767|FG002|PF-06873600 Treatment|Physician Decision|0|||
27540501|NCT03519178|80171768|FG003|PF-06873600 Treatment|Physician Decision|0|||
27540502|NCT03519178|80171769|FG004|PF-06873600 Treatment|Physician Decision|0|||
27540503|NCT03519178|80171770|FG005|PF-06873600 Treatment|Physician Decision|0|||
27540504|NCT03519178|80171771|FG006|PF-06873600 Treatment|Physician Decision|0|||
27540505|NCT03519178|80171772|FG007|PF-06873600 Treatment|Physician Decision|1|||
27919151|NCT01241279|81539907|FG001|Overall Study|Lost to Follow-up|1|||
27919152|NCT01855958|81539908|FG000|Overall Study|Withdrawal by Subject|1|||
27919153|NCT01855958|81539909|FG001|Overall Study|Withdrawal by Subject|0|||
27919154|NCT00372424|81539912|FG000|Overall Study|Adverse Event|2|||
27919155|NCT00372424|81539912|FG000|Overall Study|Withdrawal by Subject|1|||
27919156|NCT00372424|81539912|FG000|Overall Study|Death|1|||
27919157|NCT00372424|81539912|FG000|Overall Study|Objective Progression or Relapse|14|||
27919158|NCT00372424|81539912|FG000|Overall Study|Other|7|||
27919159|NCT00372424|81539912|FG000|Overall Study|Enrolled, Not Treated|1|||
27919160|NCT01204671|81539913|FG000|Overall Study|Adverse Event|4|||
27919161|NCT01204671|81539914|FG001|Overall Study|Adverse Event|3|||
27919162|NCT01204671|81539915|FG002|Overall Study|Adverse Event|3|||
27540506|NCT03519178|80171773|FG008|PF-06873600 Treatment|Physician Decision|0|||
27540507|NCT03519178|80171774|FG009|PF-06873600 Treatment|Physician Decision|0|||
27919163|NCT01204671|81539916|FG003|Overall Study|Adverse Event|3|||
27919164|NCT01204671|81539917|FG004|Overall Study|Adverse Event|1|||
27919165|NCT01204671|81539913|FG000|Overall Study|Withdrawal by Subject|2|||
27919166|NCT01204671|81539914|FG001|Overall Study|Withdrawal by Subject|3|||
27919167|NCT01204671|81539915|FG002|Overall Study|Withdrawal by Subject|4|||
27919168|NCT01204671|81539916|FG003|Overall Study|Withdrawal by Subject|5|||
27919169|NCT01204671|81539917|FG004|Overall Study|Withdrawal by Subject|3|||
27919170|NCT01204671|81539913|FG000|Overall Study|Lost to Follow-up|7|||
27919171|NCT01204671|81539914|FG001|Overall Study|Lost to Follow-up|8|||
27919172|NCT01204671|81539915|FG002|Overall Study|Lost to Follow-up|6|||
27919173|NCT01204671|81539916|FG003|Overall Study|Lost to Follow-up|4|||
27919174|NCT01204671|81539917|FG004|Overall Study|Lost to Follow-up|0|||
27919175|NCT01204671|81539913|FG000|Overall Study|Unknown Completion Status|1|||
27919176|NCT01204671|81539914|FG001|Overall Study|Unknown Completion Status|1|||
27919177|NCT01204671|81539915|FG002|Overall Study|Unknown Completion Status|0|||
27919178|NCT01204671|81539916|FG003|Overall Study|Unknown Completion Status|0|||
27919179|NCT01204671|81539917|FG004|Overall Study|Unknown Completion Status|0|||
27919180|NCT01204671|81539913|FG000|Overall Study|Physician Decision|0|||
27919181|NCT01204671|81539914|FG001|Overall Study|Physician Decision|0|||
27919182|NCT01204671|81539915|FG002|Overall Study|Physician Decision|0|||
27919183|NCT01204671|81539916|FG003|Overall Study|Physician Decision|1|||
27919184|NCT01204671|81539917|FG004|Overall Study|Physician Decision|0|||
27919185|NCT03257436|81543468|FG000|Overall Study|Withdrawal by Subject|76|||
27540508|NCT03519178|80171775|FG010|PF-06873600 Treatment|Physician Decision|1|||
27540509|NCT03519178|80171776|FG011|PF-06873600 Treatment|Physician Decision|0|||
27540510|NCT03519178|80171777|FG012|PF-06873600 Treatment|Physician Decision|0|||
27540511|NCT03519178|80171778|FG013|PF-06873600 Treatment|Physician Decision|4|||
27540512|NCT03519178|80171779|FG014|PF-06873600 Treatment|Physician Decision|1|||
27540513|NCT03519178|80171765|FG000|PF-06873600 Treatment|Progressive disease|1|||
27540514|NCT03519178|80171766|FG001|PF-06873600 Treatment|Progressive disease|1|||
27540515|NCT03519178|80171767|FG002|PF-06873600 Treatment|Progressive disease|1|||
27540516|NCT03519178|80171768|FG003|PF-06873600 Treatment|Progressive disease|1|||
27540517|NCT03519178|80171769|FG004|PF-06873600 Treatment|Progressive disease|6|||
27540518|NCT03519178|80171770|FG005|PF-06873600 Treatment|Progressive disease|7|||
27540519|NCT03519178|80171771|FG006|PF-06873600 Treatment|Progressive disease|3|||
27540520|NCT03519178|80171772|FG007|PF-06873600 Treatment|Progressive disease|7|||
27540521|NCT03519178|80171773|FG008|PF-06873600 Treatment|Progressive disease|3|||
27540522|NCT03519178|80171774|FG009|PF-06873600 Treatment|Progressive disease|5|||
27540523|NCT03519178|80171775|FG010|PF-06873600 Treatment|Progressive disease|4|||
27540524|NCT03519178|80171776|FG011|PF-06873600 Treatment|Progressive disease|3|||
27540525|NCT03519178|80171777|FG012|PF-06873600 Treatment|Progressive disease|4|||
27540526|NCT03519178|80171778|FG013|PF-06873600 Treatment|Progressive disease|28|||
27540527|NCT03519178|80171779|FG014|PF-06873600 Treatment|Progressive disease|7|||
27540528|NCT03519178|80171765|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
27540529|NCT03519178|80171766|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
27540530|NCT03519178|80171767|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
27540531|NCT03519178|80171768|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
27540532|NCT03519178|80171769|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
27919186|NCT03257436|81543468|FG000|Overall Study|Death|19|||
27919187|NCT01433159|81543469|FG000|Overall Study|Adverse Event|1|||
27919188|NCT01433159|81543470|FG001|Overall Study|Adverse Event|0|||
27919189|NCT01433159|81543469|FG000|Overall Study|Physician Decision|1|||
27919190|NCT01433159|81543470|FG001|Overall Study|Physician Decision|0|||
27919191|NCT01433159|81543469|FG000|Overall Study|Protocol Violation|0|||
27919192|NCT01433159|81543470|FG001|Overall Study|Protocol Violation|1|||
27540533|NCT03519178|80171770|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
27919193|NCT00086190|81543471|FG000|Overall Study|Adverse Event|6|||
27540534|NCT03519178|80171771|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
27540535|NCT03519178|80171772|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
27540536|NCT03519178|80171773|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
27540537|NCT03519178|80171774|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
27540538|NCT03519178|80171775|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
27919194|NCT00086190|81543472|FG001|Overall Study|Adverse Event|2|||
27919195|NCT00086190|81543473|FG002|Overall Study|Adverse Event|2|||
27919196|NCT00086190|81543471|FG000|Overall Study|Withdrawal by Subject|0|||
27919197|NCT00086190|81543472|FG001|Overall Study|Withdrawal by Subject|2|||
27919198|NCT00086190|81543473|FG002|Overall Study|Withdrawal by Subject|2|||
27919199|NCT00086190|81543471|FG000|Overall Study|Protocol Violation|1|||
27919200|NCT00086190|81543472|FG001|Overall Study|Protocol Violation|0|||
27919201|NCT00086190|81543473|FG002|Overall Study|Protocol Violation|0|||
27919202|NCT00086190|81543471|FG000|Overall Study|Moved|1|||
27919203|NCT00086190|81543472|FG001|Overall Study|Moved|0|||
27919204|NCT00086190|81543473|FG002|Overall Study|Moved|0|||
27919205|NCT00086190|81543471|FG000|Overall Study|Worsening depression|0|||
27919206|NCT00086190|81543472|FG001|Overall Study|Worsening depression|0|||
27919207|NCT00086190|81543473|FG002|Overall Study|Worsening depression|2|||
27919208|NCT00296244|81543475|FG000|Overall Study|Underwent retransplant|0|||
27919209|NCT00296244|81543476|FG001|Overall Study|Underwent retransplant|1|||
27919210|NCT02481050|81543477|FG000|Overall Study|Adverse Event|1|||
27919211|NCT02481050|81543477|FG000|Overall Study|Disease Progression|47|||
27919212|NCT02481050|81543477|FG000|Overall Study|Withdrawal by Subject|7|||
27919213|NCT02481050|81543477|FG000|Overall Study|Other|3|||
27919214|NCT03122171|81543478|FG000|Overall Study|Withdrawal by Subject|1|||
27919215|NCT00001566|81543479|FG000|Overall Study|patients' choice to discontinue protocol|3|||
27919216|NCT00001566|81543479|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
27919217|NCT00001566|81543479|FG000|Overall Study|Death|13|||
27919218|NCT00001566|81543479|FG000|Overall Study|Lost to Follow-up|1|||
27919219|NCT00001566|81543479|FG000|Overall Study|unable to complete initial apheresis|1|||
27919220|NCT00728494|81543480|FG000|Overall Study|Adverse Event|7|||
27919221|NCT00728494|81543481|FG001|Overall Study|Adverse Event|0|||
27919222|NCT00728494|81543480|FG000|Overall Study|Withdrawal by Subject|0|||
27919223|NCT00728494|81543481|FG001|Overall Study|Withdrawal by Subject|2|||
27919224|NCT00728494|81543480|FG000|Overall Study|Lack of Efficacy|2|||
27919225|NCT00728494|81543481|FG001|Overall Study|Lack of Efficacy|4|||
27919226|NCT00728494|81543480|FG000|Overall Study|No data available|0|||
27919227|NCT00728494|81543481|FG001|Overall Study|No data available|1|||
27919228|NCT00087178|81543482|FG000|Overall Study|No follow up data|5|||
27919229|NCT00087178|81543483|FG001|Overall Study|No follow up data|15|||
27919230|NCT00087178|81543482|FG000|Overall Study|No clinical assessment|1|||
27919231|NCT00087178|81543483|FG001|Overall Study|No clinical assessment|2|||
27919232|NCT00087178|81543482|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
27919233|NCT00087178|81543483|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
27919234|NCT00113607|81543484|FG000|Overall Study|Adverse Event|40|||
27919235|NCT00113607|81543485|FG001|Overall Study|Adverse Event|71|||
27919236|NCT00113607|81543484|FG000|Overall Study|Death|8|||
27919237|NCT00113607|81543485|FG001|Overall Study|Death|8|||
27919238|NCT00113607|81543484|FG000|Overall Study|Withdrawal by Subject|50|||
27919239|NCT00113607|81543485|FG001|Overall Study|Withdrawal by Subject|58|||
27919240|NCT00113607|81543484|FG000|Overall Study|Lost to Follow-up|0|||
27919241|NCT00113607|81543485|FG001|Overall Study|Lost to Follow-up|2|||
27919242|NCT00113607|81543484|FG000|Overall Study|Disease Progression|180|||
27919243|NCT00113607|81543485|FG001|Overall Study|Disease Progression|142|||
27919244|NCT00113607|81543484|FG000|Overall Study|Complete Response (Confirmed)|14|||
27919245|NCT00113607|81543485|FG001|Overall Study|Complete Response (Confirmed)|24|||
27919246|NCT00113607|81543484|FG000|Overall Study|Other|43|||
27919247|NCT00113607|81543485|FG001|Overall Study|Other|32|||
27919248|NCT01317940|81543488|FG000|Overall Study|Death|1|||
27919249|NCT01317940|81543489|FG001|Overall Study|Death|0|||
27919250|NCT01317940|81543490|FG002|Overall Study|Death|1|||
27919251|NCT01317940|81543491|FG003|Overall Study|Death|0|||
27919252|NCT01317940|81543492|FG004|Overall Study|Death|0|||
27919253|NCT01317940|81543493|FG005|Overall Study|Death|0|||
27919254|NCT01317940|81543488|FG000|Overall Study|Lost to Follow-up|0|||
27919255|NCT01317940|81543489|FG001|Overall Study|Lost to Follow-up|0|||
27919256|NCT01317940|81543490|FG002|Overall Study|Lost to Follow-up|1|||
27540539|NCT03519178|80171776|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
27540540|NCT03519178|80171777|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
27919257|NCT01317940|81543491|FG003|Overall Study|Lost to Follow-up|1|||
27919258|NCT01317940|81543492|FG004|Overall Study|Lost to Follow-up|1|||
27919259|NCT01317940|81543493|FG005|Overall Study|Lost to Follow-up|0|||
27919260|NCT01317940|81543488|FG000|Overall Study|Change in therapy plan|0|||
27919261|NCT01317940|81543489|FG001|Overall Study|Change in therapy plan|0|||
27919262|NCT01317940|81543490|FG002|Overall Study|Change in therapy plan|3|||
27919263|NCT01317940|81543491|FG003|Overall Study|Change in therapy plan|0|||
27919264|NCT01317940|81543492|FG004|Overall Study|Change in therapy plan|0|||
27919265|NCT01317940|81543493|FG005|Overall Study|Change in therapy plan|0|||
27919266|NCT00879658|81543494|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27919267|NCT00879658|81543495|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27919268|NCT00879658|81543496|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27919269|NCT00879658|81543497|FG003|Overall Study|Abnormal laboratory value(s)|1|||
27919270|NCT00879658|81543498|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27540541|NCT03519178|80171778|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
27540542|NCT03519178|80171779|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
27540543|NCT03519178|80171765|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
27540544|NCT03519178|80171766|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
27540545|NCT03519178|80171767|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
27919271|NCT00879658|81543499|FG005|Overall Study|Abnormal laboratory value(s)|0|||
27919272|NCT00879658|81543500|FG006|Overall Study|Abnormal laboratory value(s)|0|||
27919273|NCT00879658|81543494|FG000|Overall Study|Administrative problems|2|||
27919274|NCT00879658|81543495|FG001|Overall Study|Administrative problems|1|||
27919275|NCT00879658|81543496|FG002|Overall Study|Administrative problems|0|||
27919276|NCT00879658|81543497|FG003|Overall Study|Administrative problems|1|||
27919277|NCT00879658|81543498|FG004|Overall Study|Administrative problems|0|||
27919278|NCT00879658|81543499|FG005|Overall Study|Administrative problems|0|||
27919279|NCT00879658|81543500|FG006|Overall Study|Administrative problems|0|||
27919280|NCT00879658|81543494|FG000|Overall Study|Adverse Event|6|||
27919281|NCT00879658|81543495|FG001|Overall Study|Adverse Event|4|||
27919282|NCT00879658|81543496|FG002|Overall Study|Adverse Event|3|||
27919283|NCT00879658|81543497|FG003|Overall Study|Adverse Event|1|||
27919284|NCT00879658|81543498|FG004|Overall Study|Adverse Event|2|||
27919285|NCT00879658|81543499|FG005|Overall Study|Adverse Event|0|||
27919286|NCT00879658|81543500|FG006|Overall Study|Adverse Event|0|||
27919287|NCT00879658|81543494|FG000|Overall Study|Protocol Violation|1|||
27919288|NCT00879658|81543495|FG001|Overall Study|Protocol Violation|0|||
27919289|NCT00879658|81543496|FG002|Overall Study|Protocol Violation|0|||
27919290|NCT00879658|81543497|FG003|Overall Study|Protocol Violation|0|||
27540546|NCT03519178|80171768|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
27540547|NCT03519178|80171769|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
27540548|NCT03519178|80171770|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
27540549|NCT03519178|80171771|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
27540550|NCT03519178|80171772|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
27540551|NCT03519178|80171773|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
27540552|NCT03519178|80171774|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
27540553|NCT03519178|80171775|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
27540554|NCT03519178|80171776|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
27540555|NCT03519178|80171777|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
27540556|NCT03519178|80171778|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
27540557|NCT03519178|80171779|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
27540558|NCT03519178|80171765|FG000|PF-06873600 Treatment|Refused further treatment|0|||
27540559|NCT03519178|80171766|FG001|PF-06873600 Treatment|Refused further treatment|1|||
27540560|NCT03519178|80171767|FG002|PF-06873600 Treatment|Refused further treatment|0|||
27540561|NCT03519178|80171768|FG003|PF-06873600 Treatment|Refused further treatment|0|||
27540562|NCT03519178|80171769|FG004|PF-06873600 Treatment|Refused further treatment|1|||
27740855|NCT01522651|80880753|FG002|Overall Study|Reason Not Specified|0|||
27919291|NCT00879658|81543498|FG004|Overall Study|Protocol Violation|0|||
27919292|NCT00879658|81543499|FG005|Overall Study|Protocol Violation|0|||
27919293|NCT00879658|81543500|FG006|Overall Study|Protocol Violation|0|||
27919294|NCT00879658|81543494|FG000|Overall Study|Withdrawal by Subject|3|||
27919295|NCT00879658|81543495|FG001|Overall Study|Withdrawal by Subject|0|||
27919296|NCT00879658|81543496|FG002|Overall Study|Withdrawal by Subject|2|||
27919297|NCT00879658|81543497|FG003|Overall Study|Withdrawal by Subject|0|||
27919298|NCT00879658|81543498|FG004|Overall Study|Withdrawal by Subject|0|||
27919299|NCT00879658|81543499|FG005|Overall Study|Withdrawal by Subject|1|||
27919300|NCT00879658|81543500|FG006|Overall Study|Withdrawal by Subject|0|||
27919301|NCT00879658|81543494|FG000|Overall Study|Lack of Efficacy|0|||
27919302|NCT00879658|81543495|FG001|Overall Study|Lack of Efficacy|0|||
27919303|NCT00879658|81543496|FG002|Overall Study|Lack of Efficacy|2|||
27919304|NCT00879658|81543497|FG003|Overall Study|Lack of Efficacy|0|||
27919305|NCT00879658|81543498|FG004|Overall Study|Lack of Efficacy|0|||
27919306|NCT00879658|81543499|FG005|Overall Study|Lack of Efficacy|0|||
27919307|NCT00879658|81543500|FG006|Overall Study|Lack of Efficacy|0|||
27919308|NCT00879658|81543494|FG000|Overall Study|misrandomized (never received study med)|0|||
27919309|NCT00879658|81543495|FG001|Overall Study|misrandomized (never received study med)|0|||
27919310|NCT00879658|81543496|FG002|Overall Study|misrandomized (never received study med)|0|||
27919311|NCT00879658|81543497|FG003|Overall Study|misrandomized (never received study med)|1|||
27919312|NCT00879658|81543498|FG004|Overall Study|misrandomized (never received study med)|0|||
27919313|NCT00879658|81543499|FG005|Overall Study|misrandomized (never received study med)|0|||
27919314|NCT00879658|81543500|FG006|Overall Study|misrandomized (never received study med)|0|||
27919315|NCT00977197|81543501|FG000|Overall Study|Withdrawal by Subject|3|||
27919316|NCT00977197|81543502|FG001|Overall Study|Withdrawal by Subject|4|||
27919317|NCT00977197|81543501|FG000|Overall Study|Adverse Event|3|||
27919318|NCT00977197|81543502|FG001|Overall Study|Adverse Event|1|||
27919319|NCT00977197|81543501|FG000|Overall Study|Lack of Efficacy|1|||
27919320|NCT00977197|81543502|FG001|Overall Study|Lack of Efficacy|0|||
27919321|NCT00977197|81543501|FG000|Overall Study|Lost to Follow-up|1|||
27919322|NCT00977197|81543502|FG001|Overall Study|Lost to Follow-up|3|||
27919323|NCT00977197|81543501|FG000|Overall Study|Nonadherence|1|||
27919324|NCT00977197|81543502|FG001|Overall Study|Nonadherence|1|||
27919325|NCT03087058|81543503|FG000|Overall Study|Withdrawal by Subject|2|||
27919326|NCT03087058|81543504|FG001|Overall Study|Withdrawal by Subject|0|||
27919327|NCT03087058|81543505|FG002|Overall Study|Withdrawal by Subject|0|||
27919328|NCT03439137|81543506|FG000|Overall Study|Adverse Event|16|||
27919329|NCT03439137|81543507|FG001|Overall Study|Adverse Event|12|||
27919330|NCT03439137|81543506|FG000|Overall Study|Physician Decision|0|||
27919331|NCT03439137|81543507|FG001|Overall Study|Physician Decision|5|||
27919332|NCT03439137|81543506|FG000|Overall Study|Withdrawal by Subject|14|||
27919333|NCT03439137|81543507|FG001|Overall Study|Withdrawal by Subject|4|||
27919334|NCT03439137|81543506|FG000|Overall Study|Conducting rescue therapy|2|||
27919335|NCT03439137|81543507|FG001|Overall Study|Conducting rescue therapy|1|||
27919336|NCT03439137|81543506|FG000|Overall Study|Difficult to control Hb|10|||
27919337|NCT03439137|81543507|FG001|Overall Study|Difficult to control Hb|2|||
27919338|NCT03439137|81543506|FG000|Overall Study|Initiation of a renal transplant|0|||
27919339|NCT03439137|81543507|FG001|Overall Study|Initiation of a renal transplant|2|||
27919340|NCT02984982|81543510|FG000|Overall Study|Adverse Event|2|||
27919341|NCT02984982|81543511|FG001|Overall Study|Adverse Event|5|||
27919342|NCT02984982|81543510|FG000|Overall Study|Poor Compliance to Protocol|4|||
27919343|NCT02984982|81543511|FG001|Overall Study|Poor Compliance to Protocol|4|||
27919344|NCT02984982|81543510|FG000|Overall Study|Withdrawal by Subject|2|||
27919345|NCT02984982|81543511|FG001|Overall Study|Withdrawal by Subject|0|||
27919346|NCT02984982|81543510|FG000|Overall Study|Randomized but not treated|0|||
27919347|NCT02984982|81543511|FG001|Overall Study|Randomized but not treated|1|||
27919348|NCT00830128|81543512|FG000|Overall Study|Adverse Event|5|||
27919349|NCT00830128|81543512|FG000|Overall Study|Lack of Efficacy|7|||
27919350|NCT00830128|81543512|FG000|Overall Study|Protocol Violation|1|||
27919351|NCT00830128|81543512|FG000|Overall Study|Withdrawal by Subject|2|||
27919352|NCT00830128|81543512|FG000|Overall Study|Family obligation|1|||
27919353|NCT00830128|81543512|FG000|Overall Study|Relocation|1|||
27919354|NCT00830128|81543512|FG000|Overall Study|Work obligation|1|||
27919355|NCT00830128|81543512|FG000|Overall Study|Operating a vehicle|1|||
27919356|NCT01483118|81543513|FG000|Overall Study|Lost to Follow-up|12|||
27919357|NCT01483118|81543514|FG001|Overall Study|Lost to Follow-up|16|||
27919358|NCT03353792|81543515|FG000|Overall Study|Lost to Follow-up|1|||
27919359|NCT03353792|81543516|FG001|Overall Study|Lost to Follow-up|0|||
27919360|NCT03353792|81543515|FG000|Overall Study|Participant Unable to Manage Device|1|||
27919361|NCT03353792|81543516|FG001|Overall Study|Participant Unable to Manage Device|0|||
27919362|NCT01274533|81543521|FG000|Overall Study|Withdrawal by Subject|1|||
27919363|NCT01274533|81543521|FG000|Overall Study|Non-compliance|1|||
27919364|NCT01274533|81543521|FG000|Overall Study|Disease progression|2|||
27919365|NCT02737722|81543522|FG000|Overall Study|Physician Decision|0|||
27919366|NCT02737722|81543523|FG001|Overall Study|Physician Decision|0|||
27919367|NCT02737722|81543524|FG002|Overall Study|Physician Decision|1|||
27919368|NCT02737722|81543525|FG003|Overall Study|Physician Decision|0|||
27919369|NCT02308046|81543526|FG000|Overall Study|Negative yeast culture at Baseline|32|||
27919370|NCT02308046|81543527|FG001|Overall Study|Negative yeast culture at Baseline|33|||
27919371|NCT02308046|81543526|FG000|Overall Study|Positive for STD at Baseline|1|||
27919372|NCT02308046|81543527|FG001|Overall Study|Positive for STD at Baseline|2|||
27540563|NCT03519178|80171770|FG005|PF-06873600 Treatment|Refused further treatment|0|||
27540564|NCT03519178|80171771|FG006|PF-06873600 Treatment|Refused further treatment|0|||
27540565|NCT03519178|80171772|FG007|PF-06873600 Treatment|Refused further treatment|0|||
27540566|NCT03519178|80171773|FG008|PF-06873600 Treatment|Refused further treatment|0|||
27540567|NCT03519178|80171774|FG009|PF-06873600 Treatment|Refused further treatment|0|||
27540568|NCT03519178|80171775|FG010|PF-06873600 Treatment|Refused further treatment|0|||
27540569|NCT03519178|80171776|FG011|PF-06873600 Treatment|Refused further treatment|0|||
27540570|NCT03519178|80171777|FG012|PF-06873600 Treatment|Refused further treatment|0|||
27540571|NCT03519178|80171778|FG013|PF-06873600 Treatment|Refused further treatment|0|||
27540572|NCT03519178|80171779|FG014|PF-06873600 Treatment|Refused further treatment|1|||
27540573|NCT03519178|80171765|FG000|PF-06873600 Treatment|Other|0|||
27540574|NCT03519178|80171766|FG001|PF-06873600 Treatment|Other|0|||
27540575|NCT03519178|80171767|FG002|PF-06873600 Treatment|Other|0|||
27919373|NCT02308046|81543526|FG000|Overall Study|Lost to Follow-up|1|||
27919374|NCT02308046|81543527|FG001|Overall Study|Lost to Follow-up|3|||
27919375|NCT01928771|81543530|FG000|Overall Study|Adverse Event|6|||
27919376|NCT01928771|81543531|FG001|Overall Study|Adverse Event|5|||
27919377|NCT01928771|81543532|FG002|Overall Study|Adverse Event|1|||
27919378|NCT01928771|81543530|FG000|Overall Study|Death|2|||
27919379|NCT01928771|81543531|FG001|Overall Study|Death|2|||
27919380|NCT01928771|81543532|FG002|Overall Study|Death|2|||
27919381|NCT01928771|81543530|FG000|Overall Study|Lost to Follow-up|5|||
27919382|NCT01928771|81543531|FG001|Overall Study|Lost to Follow-up|6|||
27919383|NCT01928771|81543532|FG002|Overall Study|Lost to Follow-up|3|||
27919384|NCT01928771|81543530|FG000|Overall Study|Withdrawal by Subject|20|||
27919385|NCT01928771|81543531|FG001|Overall Study|Withdrawal by Subject|15|||
27919386|NCT01928771|81543532|FG002|Overall Study|Withdrawal by Subject|17|||
27919387|NCT01928771|81543530|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
27919388|NCT01928771|81543531|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
27919389|NCT01928771|81543532|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
27919390|NCT01928771|81543530|FG000|Overall Study|Other Reasons|9|||
27919391|NCT01928771|81543531|FG001|Overall Study|Other Reasons|9|||
27919392|NCT01928771|81543532|FG002|Overall Study|Other Reasons|14|||
27919393|NCT01928771|81543530|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
27919394|NCT01928771|81543531|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
27919395|NCT01928771|81543532|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
27919396|NCT03642990|81543533|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
27919397|NCT03642990|81543533|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
27919398|NCT01004614|81543534|FG000|Washout|Withdrawal by Subject|0|||
27919399|NCT01004614|81543535|FG001|Washout|Withdrawal by Subject|1|||
27919400|NCT01004614|81543536|FG002|Washout|Withdrawal by Subject|0|||
27919401|NCT01004614|81543537|FG003|Washout|Withdrawal by Subject|0|||
27919402|NCT02785939|81543540|FG000|Overall Study|Progression|25|||
27919403|NCT02785939|81543541|FG001|Overall Study|Progression|8|||
27919404|NCT02785939|81543540|FG000|Overall Study|Adverse Event|3|||
27919405|NCT02785939|81543541|FG001|Overall Study|Adverse Event|1|||
27919406|NCT02785939|81543540|FG000|Overall Study|Death|1|||
27919407|NCT02785939|81543541|FG001|Overall Study|Death|0|||
27919408|NCT02785939|81543540|FG000|Overall Study|Refusal|1|||
27919409|NCT02785939|81543541|FG001|Overall Study|Refusal|0|||
27919410|NCT02785939|81543540|FG000|Overall Study|Deteriorating health|1|||
27919411|NCT02785939|81543541|FG001|Overall Study|Deteriorating health|0|||
27919412|NCT02785939|81543540|FG000|Overall Study|Not protocol specified|0|||
27919413|NCT02785939|81543541|FG001|Overall Study|Not protocol specified|1|||
27919414|NCT04076917|81543545|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
27919415|NCT04076917|81543545|FG000|Overall Study|Study closure|13|||
27919416|NCT04076917|81543545|FG000|Overall Study|Physician Decision|3|||
27919417|NCT04076917|81543545|FG000|Overall Study|Death|1|||
27919418|NCT04076917|81543545|FG000|Overall Study|Lost to Follow-up|1|||
27919419|NCT04076917|81543545|FG000|Overall Study|Withdrawal by Subject|1|||
27919420|NCT04076917|81543545|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
27919421|NCT02592824|81543547|FG000|Overall Study|Protocol Violation|5|||
27919422|NCT02592824|81543548|FG001|Overall Study|Protocol Violation|3|||
27919423|NCT02592824|81543547|FG000|Overall Study|Lost to Follow-up|2|||
27919424|NCT02592824|81543548|FG001|Overall Study|Lost to Follow-up|1|||
27919425|NCT00641056|81543549|FG000|Overall Study|Adverse Event|12|||
27919426|NCT00641056|81543550|FG001|Overall Study|Adverse Event|2|||
27919427|NCT00641056|81543549|FG000|Overall Study|Lost to Follow-up|2|||
27919428|NCT00641056|81543550|FG001|Overall Study|Lost to Follow-up|1|||
27919429|NCT00641056|81543549|FG000|Overall Study|Physician Decision|3|||
27919430|NCT00641056|81543550|FG001|Overall Study|Physician Decision|1|||
27919431|NCT00641056|81543549|FG000|Overall Study|Protocol Violation|2|||
27919432|NCT00641056|81543550|FG001|Overall Study|Protocol Violation|0|||
27919433|NCT00641056|81543549|FG000|Overall Study|Entry Criteria Not Met|3|||
27919434|NCT00641056|81543550|FG001|Overall Study|Entry Criteria Not Met|0|||
27919435|NCT00641056|81543549|FG000|Overall Study|Subject Decision|6|||
27919436|NCT00641056|81543550|FG001|Overall Study|Subject Decision|19|||
27919437|NCT00641056|81543549|FG000|Overall Study|Sponsor Decision|1|||
27919438|NCT00641056|81543550|FG001|Overall Study|Sponsor Decision|2|||
27919439|NCT02563899|81543551|FG000|Overall Study|Protocol Violation|1|||
27919440|NCT02563899|81543552|FG001|Overall Study|Protocol Violation|0|||
27919441|NCT02563899|81543553|FG002|Overall Study|Protocol Violation|0|||
27919442|NCT02563899|81543554|FG003|Overall Study|Protocol Violation|0|||
27919443|NCT02563899|81543551|FG000|Overall Study|Withdrawal by Subject|0|||
27919444|NCT02563899|81543552|FG001|Overall Study|Withdrawal by Subject|0|||
27919445|NCT02563899|81543553|FG002|Overall Study|Withdrawal by Subject|1|||
27919446|NCT02563899|81543554|FG003|Overall Study|Withdrawal by Subject|0|||
27919447|NCT01268267|81543555|FG000|Overall Study|Protocol Violation|1|||
27919448|NCT02378662|81543562|FG000|Overall Study|Early Discontinuation|2|||
27919449|NCT02378662|81543563|FG001|Overall Study|Early Discontinuation|0|||
27919450|NCT01287936|81543578|FG000|Overall Study|Lost to Follow-up|0|||
27919451|NCT01287936|81543579|FG001|Overall Study|Lost to Follow-up|1|||
27919452|NCT01287936|81543580|FG002|Overall Study|Lost to Follow-up|1|||
27919453|NCT01075048|81543581|FG000|Overall Study|Death|4|||
27919454|NCT01075048|81543582|FG001|Overall Study|Death|17|||
27919455|NCT01075048|81543583|FG002|Overall Study|Death|12|||
27919456|NCT01075048|81543581|FG000|Overall Study|Start of other or new therapy|4|||
27919457|NCT01075048|81543582|FG001|Overall Study|Start of other or new therapy|36|||
27919458|NCT01075048|81543583|FG002|Overall Study|Start of other or new therapy|46|||
27919459|NCT01075048|81543581|FG000|Overall Study|Withdrawal by Subject|1|||
27919460|NCT01075048|81543582|FG001|Overall Study|Withdrawal by Subject|6|||
27919461|NCT01075048|81543583|FG002|Overall Study|Withdrawal by Subject|3|||
27635708|NCT01266265|80506034|FG001|Overall Study|Site closed early|3|||
27635709|NCT01266265|80506033|FG000|Overall Study|Clinical worsening|1|||
27635710|NCT01266265|80506034|FG001|Overall Study|Clinical worsening|1|||
27635711|NCT03183518|80506035|FG000|Overall Study|Other (Not specified)|2|||
27635712|NCT03183518|80506035|FG000|Overall Study|Other (Withdrawal of consent)|1|||
27635713|NCT00414544|80506036|FG000|Overall Study|Lost to Follow-up|14|||
27635714|NCT03247543|80506037|FG000|Overall Study|Adverse Event|3|||
27635715|NCT03247543|80506038|FG001|Overall Study|Adverse Event|6|||
27635716|NCT03247543|80506039|FG002|Overall Study|Adverse Event|4|||
27635717|NCT03247543|80506037|FG000|Overall Study|Lost to Follow-up|10|||
27635718|NCT03247543|80506038|FG001|Overall Study|Lost to Follow-up|7|||
27635719|NCT03247543|80506039|FG002|Overall Study|Lost to Follow-up|8|||
27635720|NCT03247543|80506037|FG000|Overall Study|Consent withdrawn by caregiver|2|||
27635721|NCT03247543|80506038|FG001|Overall Study|Consent withdrawn by caregiver|2|||
27635722|NCT03247543|80506039|FG002|Overall Study|Consent withdrawn by caregiver|9|||
27635723|NCT03247543|80506037|FG000|Overall Study|Withdrawal by Subject|0|||
27635724|NCT03247543|80506038|FG001|Overall Study|Withdrawal by Subject|0|||
27635725|NCT03247543|80506039|FG002|Overall Study|Withdrawal by Subject|1|||
27635726|NCT03247543|80506037|FG000|Overall Study|Failure to Follow study procedures|1|||
27635727|NCT03247543|80506038|FG001|Overall Study|Failure to Follow study procedures|3|||
27635728|NCT03247543|80506039|FG002|Overall Study|Failure to Follow study procedures|1|||
27635729|NCT03247543|80506037|FG000|Overall Study|Lack of Efficacy|1|||
27635730|NCT03247543|80506038|FG001|Overall Study|Lack of Efficacy|0|||
27635731|NCT03247543|80506039|FG002|Overall Study|Lack of Efficacy|0|||
27919462|NCT01075048|81543581|FG000|Overall Study|Lost to Follow-up|0|||
27919463|NCT01075048|81543582|FG001|Overall Study|Lost to Follow-up|1|||
27919464|NCT01075048|81543583|FG002|Overall Study|Lost to Follow-up|1|||
27919465|NCT00721799|81543584|FG000|Overall Study|Withdrawal by Subject|7|||
27919466|NCT00721799|81543584|FG000|Overall Study|withdraw by subject after scan 1|1|||
27919467|NCT01064414|81543585|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
27919468|NCT01064414|81543586|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
27919469|NCT01064414|81543587|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
27919470|NCT01064414|81543585|FG000|Core Period: Baseline to Week 26|Death|0|||
27919471|NCT01064414|81543586|FG001|Core Period: Baseline to Week 26|Death|1|||
27919472|NCT01064414|81543587|FG002|Core Period: Baseline to Week 26|Death|0|||
27919473|NCT01064414|81543585|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
27919474|NCT01064414|81543586|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
27919475|NCT01064414|81543587|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
27919476|NCT01064414|81543585|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
27919477|NCT01064414|81543586|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
27919478|NCT01064414|81543587|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
27919479|NCT01064414|81543585|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27919480|NCT01064414|81543586|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
27919481|NCT01064414|81543587|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
27919482|NCT01064414|81543585|FG000|Core Period: Baseline to Week 26|Other|4|||
27919483|NCT01064414|81543586|FG001|Core Period: Baseline to Week 26|Other|7|||
27919484|NCT01064414|81543587|FG002|Core Period: Baseline to Week 26|Other|2|||
27919485|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
27919486|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
27919487|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
27919488|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Death|0|||
27919489|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Death|1|||
27919490|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Death|0|||
27540576|NCT03519178|80171768|FG003|PF-06873600 Treatment|Other|0|||
27540577|NCT03519178|80171769|FG004|PF-06873600 Treatment|Other|0|||
27540578|NCT03519178|80171770|FG005|PF-06873600 Treatment|Other|0|||
27540579|NCT03519178|80171771|FG006|PF-06873600 Treatment|Other|0|||
27540580|NCT03519178|80171772|FG007|PF-06873600 Treatment|Other|0|||
27540581|NCT03519178|80171773|FG008|PF-06873600 Treatment|Other|1|||
27540582|NCT03519178|80171774|FG009|PF-06873600 Treatment|Other|0|||
27635732|NCT03247543|80506037|FG000|Overall Study|Non-compliance with study visits|0|||
27635733|NCT03247543|80506038|FG001|Overall Study|Non-compliance with study visits|1|||
27635734|NCT03247543|80506039|FG002|Overall Study|Non-compliance with study visits|0|||
27919491|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
27919492|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27919493|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
27540583|NCT03519178|80171775|FG010|PF-06873600 Treatment|Other|0|||
27635735|NCT05355116|80506044|FG000|Overall Study|Withdrawal by Subject|2|||
27635736|NCT00976937|80506049|FG000|Overall Study|Adverse Event|4|||
27635737|NCT00976937|80506050|FG001|Overall Study|Adverse Event|5|||
27635738|NCT00976937|80506049|FG000|Overall Study|Lost to Follow-up|2|||
27540584|NCT03519178|80171776|FG011|PF-06873600 Treatment|Other|0|||
27540585|NCT03519178|80171777|FG012|PF-06873600 Treatment|Other|0|||
27919494|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
27919495|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27919496|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
27919497|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27919498|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
27919499|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
27919500|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
27919501|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
27919502|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
27919503|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27919504|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27919505|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
27919506|NCT01064414|81543585|FG000|Extension Period: Week 26 to Week 52|Other|5|||
27919507|NCT01064414|81543586|FG001|Extension Period: Week 26 to Week 52|Other|2|||
27919508|NCT01064414|81543587|FG002|Extension Period: Week 26 to Week 52|Other|1|||
27540586|NCT03519178|80171778|FG013|PF-06873600 Treatment|Other|1|||
27540587|NCT03519178|80171779|FG014|PF-06873600 Treatment|Other|3|||
27540588|NCT03519178|80171765|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
27540589|NCT03519178|80171766|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
27540590|NCT03519178|80171767|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
27540591|NCT03519178|80171768|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
27540592|NCT03519178|80171769|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
27540593|NCT03519178|80171770|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
27540594|NCT03519178|80171771|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
27540595|NCT03519178|80171772|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
27540596|NCT03519178|80171773|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
27540597|NCT03519178|80171774|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
27540598|NCT03519178|80171775|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
27540599|NCT03519178|80171776|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
27540600|NCT03519178|80171777|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
27540601|NCT03519178|80171778|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
27540602|NCT03519178|80171779|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
27540603|NCT03519178|80171765|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540604|NCT03519178|80171766|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540605|NCT03519178|80171767|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540606|NCT03519178|80171768|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540607|NCT03519178|80171769|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540608|NCT03519178|80171770|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540609|NCT03519178|80171771|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540610|NCT03519178|80171772|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540611|NCT03519178|80171773|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540612|NCT03519178|80171774|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540613|NCT03519178|80171775|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540614|NCT03519178|80171776|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540615|NCT03519178|80171777|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
27540616|NCT03519178|80171778|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
27540617|NCT03519178|80171779|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
27540618|NCT03519178|80171765|FG000|PF-06873600 Treatment|Ongoing|0|||
27540619|NCT03519178|80171766|FG001|PF-06873600 Treatment|Ongoing|0|||
27540620|NCT03519178|80171767|FG002|PF-06873600 Treatment|Ongoing|0|||
27540621|NCT03519178|80171768|FG003|PF-06873600 Treatment|Ongoing|0|||
27540622|NCT03519178|80171769|FG004|PF-06873600 Treatment|Ongoing|0|||
27540623|NCT03519178|80171770|FG005|PF-06873600 Treatment|Ongoing|0|||
27540624|NCT03519178|80171771|FG006|PF-06873600 Treatment|Ongoing|0|||
27540625|NCT03519178|80171772|FG007|PF-06873600 Treatment|Ongoing|0|||
27540626|NCT03519178|80171773|FG008|PF-06873600 Treatment|Ongoing|0|||
27540627|NCT03519178|80171774|FG009|PF-06873600 Treatment|Ongoing|0|||
27540628|NCT03519178|80171775|FG010|PF-06873600 Treatment|Ongoing|0|||
27540629|NCT03519178|80171776|FG011|PF-06873600 Treatment|Ongoing|0|||
27540630|NCT03519178|80171777|FG012|PF-06873600 Treatment|Ongoing|0|||
27540631|NCT03519178|80171778|FG013|PF-06873600 Treatment|Ongoing|1|||
27540632|NCT03519178|80171779|FG014|PF-06873600 Treatment|Ongoing|6|||
27540633|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540634|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540635|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540636|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540637|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540638|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540639|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540640|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540641|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27919509|NCT03885908|81543588|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
27919510|NCT03885908|81543589|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
27919511|NCT03885908|81543588|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
27919512|NCT03885908|81543589|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
27919513|NCT03885908|81543588|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
27919514|NCT03885908|81543589|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
27919515|NCT03885908|81543588|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
27919516|NCT03885908|81543589|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
27919517|NCT00619827|81543590|FG000|Overall Study|Adverse Event|1|||
27919518|NCT00619827|81543591|FG001|Overall Study|Adverse Event|2|||
27919519|NCT00619827|81543590|FG000|Overall Study|Withdrawal by Subject|2|||
27919520|NCT00619827|81543591|FG001|Overall Study|Withdrawal by Subject|2|||
27919521|NCT03573297|81543595|FG000|Open Label Treatment Period|Adverse Event|67|||
27919522|NCT03573297|81543596|FG001|Open Label Treatment Period|Adverse Event|0|||
27919523|NCT03573297|81543597|FG002|Open Label Treatment Period|Adverse Event|0|||
27919524|NCT03573297|81543598|FG003|Open Label Treatment Period|Adverse Event|0|||
27919525|NCT03573297|81543595|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
27919526|NCT03573297|81543596|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
27919527|NCT03573297|81543597|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
27919528|NCT03573297|81543598|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
27919529|NCT03573297|81543595|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
27919530|NCT03573297|81543596|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
27919531|NCT03573297|81543597|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
27919532|NCT03573297|81543598|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
27919533|NCT03573297|81543595|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
27919534|NCT03573297|81543596|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
27919535|NCT03573297|81543597|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
27919536|NCT03573297|81543598|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
27919537|NCT03573297|81543595|FG000|Open Label Treatment Period|Pregnancy|1|||
27919538|NCT03573297|81543596|FG001|Open Label Treatment Period|Pregnancy|0|||
27919539|NCT03573297|81543597|FG002|Open Label Treatment Period|Pregnancy|0|||
27919540|NCT03573297|81543598|FG003|Open Label Treatment Period|Pregnancy|0|||
27919541|NCT03573297|81543595|FG000|Open Label Treatment Period|Protocol Violation|17|||
27919542|NCT03573297|81543596|FG001|Open Label Treatment Period|Protocol Violation|0|||
27919543|NCT03573297|81543597|FG002|Open Label Treatment Period|Protocol Violation|0|||
27919544|NCT03573297|81543598|FG003|Open Label Treatment Period|Protocol Violation|0|||
27919545|NCT03573297|81543595|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
27919546|NCT03573297|81543596|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
27919547|NCT03573297|81543597|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
27919548|NCT03573297|81543598|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
27919549|NCT03573297|81543595|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
27919550|NCT03573297|81543596|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
27919551|NCT03573297|81543597|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
27919552|NCT03573297|81543598|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
27540642|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540643|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540644|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540645|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540646|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
27540647|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
27540648|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Death|0|||
27540649|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Death|0|||
27540650|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Death|0|||
27540651|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Death|0|||
27540652|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Death|0|||
27540653|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Death|0|||
27540654|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Death|0|||
27540655|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Death|0|||
27540656|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Death|0|||
27540657|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Death|1|||
27540658|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Death|0|||
27919553|NCT03573297|81543595|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
27919554|NCT03573297|81543596|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
27919555|NCT03573297|81543597|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
27919556|NCT03573297|81543598|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
27540659|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Death|0|||
27635739|NCT00976937|80506050|FG001|Overall Study|Lost to Follow-up|1|||
27635740|NCT00976937|80506049|FG000|Overall Study|Withdrawal by Subject|5|||
27635741|NCT00976937|80506050|FG001|Overall Study|Withdrawal by Subject|3|||
27635742|NCT00976937|80506049|FG000|Overall Study|Poor compliance to protocol|3|||
27635743|NCT00976937|80506050|FG001|Overall Study|Poor compliance to protocol|0|||
27635744|NCT00976937|80506049|FG000|Overall Study|Personal and Familial Reason|2|||
27635745|NCT00976937|80506050|FG001|Overall Study|Personal and Familial Reason|2|||
27635746|NCT01104415|80506053|FG000|Core Phase|Consent withdrawn by subjects|1|||
27635747|NCT01104415|80506054|FG001|Core Phase|Consent withdrawn by subjects|0|||
27635748|NCT01104415|80506053|FG000|Extension Period|Progressive disease|0|||
27635749|NCT01104415|80506054|FG001|Extension Period|Progressive disease|4|||
27635750|NCT01104415|80506053|FG000|Extension Period|Death|0|||
27635751|NCT01104415|80506054|FG001|Extension Period|Death|1|||
27635752|NCT01104415|80506053|FG000|Extension Period|Physician Decision|0|||
27635753|NCT01104415|80506054|FG001|Extension Period|Physician Decision|1|||
27635754|NCT01104415|80506053|FG000|Extension Period|Transition to Study LX1606.302|0|||
27635755|NCT01104415|80506054|FG001|Extension Period|Transition to Study LX1606.302|4|||
27635756|NCT01104415|80506053|FG000|Extension Period|Heart surgery/feeling miserable|0|||
27635757|NCT01104415|80506054|FG001|Extension Period|Heart surgery/feeling miserable|1|||
27635758|NCT03233633|80506055|FG000|Overall Study|Adverse Event|2|||
27635759|NCT03233633|80506055|FG000|Overall Study|Less Than 3 Days of Data|6|||
27635760|NCT00869258|80506059|FG000|Overall Study|Physician Decision|1|||
27540660|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Death|0|||
27540661|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Death|0|||
27540662|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Death|1|||
27540663|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540664|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540665|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540666|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540667|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540668|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540669|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540670|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540671|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540672|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540673|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540674|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540675|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540676|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
27540677|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
27540678|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540679|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540680|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540681|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540682|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540683|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540684|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540685|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540686|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540687|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540688|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540689|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540690|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
27540691|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
27540692|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
27540693|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540694|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540695|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540696|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540697|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540698|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540699|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540700|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540701|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540702|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
27540703|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540704|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27635761|NCT01697969|80509585|FG000|Overall Study|Did not meet inc/exc criteria|3|||
27540705|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
27540706|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
27540707|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
27540708|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27919557|NCT03573297|81543595|FG000|Open Label Treatment Period|Other, Not Specified|7|||
27919558|NCT03573297|81543596|FG001|Open Label Treatment Period|Other, Not Specified|0|||
27919559|NCT03573297|81543597|FG002|Open Label Treatment Period|Other, Not Specified|0|||
27919560|NCT03573297|81543598|FG003|Open Label Treatment Period|Other, Not Specified|0|||
27919561|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
27919562|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
27919563|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
27919564|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
27919565|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27919566|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27919567|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Adverse Event|5|||
27919568|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Adverse Event|1|||
27919569|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
27919570|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
27919571|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
27919572|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
27919573|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27919574|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
27919575|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
27919576|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
27919577|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27919578|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
27919579|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
27919580|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
27919581|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27919582|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
27919583|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
27919584|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
27919585|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
27919586|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
27540709|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540710|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540711|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540712|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540713|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540714|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540715|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540716|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540717|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540718|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540719|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540720|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
27540721|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
27540722|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
27540723|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540724|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540725|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540726|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540727|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540728|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540729|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540730|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540731|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540732|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
27540733|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540734|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540735|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
27540736|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
27540737|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
27635762|NCT02731755|80509586|FG000|First Intervention|Withdrawal by Subject|0|||
27540738|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540739|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540740|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540741|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540742|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540743|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540744|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540745|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540746|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540747|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
27540748|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540749|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540750|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540751|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
27540752|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
27540753|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540754|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27919587|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
27919588|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
27919589|NCT03573297|81543595|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
27919590|NCT03573297|81543596|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
27919591|NCT03573297|81543597|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
27919592|NCT03573297|81543598|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
27919593|NCT02814526|81543603|FG000|Overall Study|Adverse Event|4|||
27919594|NCT02814526|81543604|FG001|Overall Study|Adverse Event|3|||
27919595|NCT02814526|81543603|FG000|Overall Study|Death|1|||
27919596|NCT02814526|81543604|FG001|Overall Study|Death|1|||
27919597|NCT02814526|81543603|FG000|Overall Study|Lost to Follow-up|3|||
27540755|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540756|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540757|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540758|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540759|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540760|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540761|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540762|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540763|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540764|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540765|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540766|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
27540767|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
27540768|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Other|0|||
27540769|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Other|0|||
27540770|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Other|0|||
27540771|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Other|0|||
27540772|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Other|0|||
27540773|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Other|0|||
27540774|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Other|0|||
27540775|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Other|0|||
27540776|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Other|0|||
27540777|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Other|0|||
27540778|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Other|0|||
27540779|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Other|0|||
27540780|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Other|0|||
27540781|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Other|1|||
27540782|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Other|3|||
27540783|NCT03519178|80171765|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540784|NCT03519178|80171766|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540785|NCT03519178|80171767|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540786|NCT03519178|80171768|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540787|NCT03519178|80171769|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540788|NCT03519178|80171770|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
27919598|NCT02814526|81543604|FG001|Overall Study|Lost to Follow-up|4|||
27919599|NCT02814526|81543603|FG000|Overall Study|non site physician decision|1|||
27919600|NCT02814526|81543604|FG001|Overall Study|non site physician decision|0|||
27919601|NCT02814526|81543603|FG000|Overall Study|participant noncompliance|1|||
27919602|NCT02814526|81543604|FG001|Overall Study|participant noncompliance|1|||
27919603|NCT02814526|81543603|FG000|Overall Study|Withdrawal by Subject|20|||
27919604|NCT02814526|81543604|FG001|Overall Study|Withdrawal by Subject|14|||
27919605|NCT02814526|81543603|FG000|Overall Study|safety risk|2|||
27919606|NCT02814526|81543604|FG001|Overall Study|safety risk|1|||
27919607|NCT02814526|81543603|FG000|Overall Study|early termination-study terminated|1|||
27919608|NCT02814526|81543604|FG001|Overall Study|early termination-study terminated|2|||
27919609|NCT02814526|81543603|FG000|Overall Study|Other|0|||
27919610|NCT02814526|81543604|FG001|Overall Study|Other|4|||
27919611|NCT03506477|81543607|FG000|Overall Study|Withdrawal by Subject|1|||
27919612|NCT03506477|81543608|FG001|Overall Study|Withdrawal by Subject|0|||
27919613|NCT01802385|81543609|FG000|Overall Study|Death|106|||
27919614|NCT01802385|81543610|FG001|Overall Study|Death|120|||
27919615|NCT01302899|81543611|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
27919616|NCT01302899|81543612|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
27919617|NCT01302899|81543611|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
27919618|NCT01302899|81543612|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
27919619|NCT02611882|81543615|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
27919620|NCT02611882|81543616|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
27919621|NCT02611882|81543617|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
27919622|NCT00909870|81543618|FG000|Overall Study|Adverse Event|13|||
27919623|NCT00909870|81543619|FG001|Overall Study|Adverse Event|7|||
27919624|NCT00909870|81543618|FG000|Overall Study|Protocol Violation|1|||
27919625|NCT00909870|81543619|FG001|Overall Study|Protocol Violation|2|||
27919626|NCT00909870|81543618|FG000|Overall Study|Withdrawal by Subject|5|||
27919627|NCT00909870|81543619|FG001|Overall Study|Withdrawal by Subject|8|||
27919628|NCT00909870|81543618|FG000|Overall Study|Lost to Follow-up|3|||
27919629|NCT00909870|81543619|FG001|Overall Study|Lost to Follow-up|3|||
27919630|NCT00909870|81543618|FG000|Overall Study|Physician Decision|0|||
27919631|NCT00909870|81543619|FG001|Overall Study|Physician Decision|2|||
27919632|NCT00909870|81543618|FG000|Overall Study|Other|1|||
27919633|NCT00909870|81543619|FG001|Overall Study|Other|5|||
27919634|NCT01867008|81543620|FG000|Overall Study|Withdrawal by Subject|1|||
27919635|NCT01387269|81543622|FG000|Overall Study|Death|38|||
27919636|NCT01387269|81543623|FG001|Overall Study|Death|20|||
27919637|NCT01387269|81543622|FG000|Overall Study|Other|8|||
27919638|NCT01387269|81543623|FG001|Overall Study|Other|7|||
27919639|NCT01387269|81543622|FG000|Overall Study|Unrelated AE|12|||
27919640|NCT01387269|81543623|FG001|Overall Study|Unrelated AE|3|||
27919641|NCT01387269|81543622|FG000|Overall Study|Withdrawal by patient|32|||
27919642|NCT01387269|81543623|FG001|Overall Study|Withdrawal by patient|10|||
27919643|NCT01387269|81543622|FG000|Overall Study|Study drug-related AE|1|||
27540789|NCT03519178|80171771|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540790|NCT03519178|80171772|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540791|NCT03519178|80171773|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
27740856|NCT01522651|80880754|FG003|Overall Study|Reason Not Specified|1|||
27740857|NCT01522651|80880755|FG004|Overall Study|Reason Not Specified|0|||
27740858|NCT01522651|80880751|FG000|Overall Study|Participant Non-Compliance|1|||
27740859|NCT01522651|80880752|FG001|Overall Study|Participant Non-Compliance|0|||
27740860|NCT01522651|80880753|FG002|Overall Study|Participant Non-Compliance|0|||
27740861|NCT01522651|80880754|FG003|Overall Study|Participant Non-Compliance|0|||
27740862|NCT01522651|80880755|FG004|Overall Study|Participant Non-Compliance|0|||
27740863|NCT01522651|80880751|FG000|Overall Study|Withdrew Consent|1|||
27740864|NCT01522651|80880752|FG001|Overall Study|Withdrew Consent|1|||
27740865|NCT01522651|80880753|FG002|Overall Study|Withdrew Consent|0|||
27740866|NCT01522651|80880754|FG003|Overall Study|Withdrew Consent|1|||
27740867|NCT01522651|80880755|FG004|Overall Study|Withdrew Consent|1|||
27740868|NCT01522651|80880751|FG000|Overall Study|Randomized but Never Treated|0|||
27740869|NCT01522651|80880752|FG001|Overall Study|Randomized but Never Treated|1|||
27740870|NCT01522651|80880753|FG002|Overall Study|Randomized but Never Treated|0|||
27740871|NCT01522651|80880754|FG003|Overall Study|Randomized but Never Treated|1|||
27740872|NCT01522651|80880755|FG004|Overall Study|Randomized but Never Treated|1|||
27919644|NCT01387269|81543623|FG001|Overall Study|Study drug-related AE|0|||
27919645|NCT01387269|81543622|FG000|Overall Study|Lost to Follow-up|1|||
27540792|NCT03519178|80171774|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540793|NCT03519178|80171775|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
27919646|NCT01387269|81543623|FG001|Overall Study|Lost to Follow-up|0|||
27540794|NCT03519178|80171776|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
27540795|NCT03519178|80171777|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
27740873|NCT03976401|80880756|FG000|Overall Study|Adverse Event|2|||
27919647|NCT02000921|81543625|FG000|Overall Study|Withdrawal by Subject|3|||
27919648|NCT02000921|81543626|FG001|Overall Study|Withdrawal by Subject|10|||
27919649|NCT02000921|81543627|FG002|Overall Study|Withdrawal by Subject|5|||
27919650|NCT02000921|81543625|FG000|Overall Study|Lost to Follow-up|2|||
27540796|NCT03519178|80171778|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
27540797|NCT03519178|80171779|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
27540798|NCT03519178|80171765|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
27540799|NCT03519178|80171766|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
27540800|NCT03519178|80171767|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
27540801|NCT03519178|80171768|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
27540802|NCT03519178|80171769|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
27540803|NCT03519178|80171770|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
27540804|NCT03519178|80171771|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
27540805|NCT03519178|80171772|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
27540806|NCT03519178|80171773|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
27540807|NCT03519178|80171774|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
27540808|NCT03519178|80171775|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
27540809|NCT03519178|80171776|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
27540810|NCT03519178|80171777|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
27540811|NCT03519178|80171778|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
27540812|NCT03519178|80171779|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
27540813|NCT03519178|80171765|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
27540814|NCT03519178|80171766|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
27540815|NCT03519178|80171767|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
27540816|NCT03519178|80171768|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
27540817|NCT03519178|80171769|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
27540818|NCT03519178|80171770|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
27540819|NCT03519178|80171771|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
27540820|NCT03519178|80171772|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
27540821|NCT03519178|80171773|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
27540822|NCT03519178|80171774|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
27540823|NCT03519178|80171775|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
27540824|NCT03519178|80171776|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
27540825|NCT03519178|80171777|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
27540826|NCT03519178|80171778|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
27540827|NCT03519178|80171779|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
27540828|NCT03519178|80171765|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540829|NCT03519178|80171766|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540830|NCT03519178|80171767|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540831|NCT03519178|80171768|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540832|NCT03519178|80171769|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540833|NCT03519178|80171770|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27635763|NCT02731755|80509587|FG001|First Intervention|Withdrawal by Subject|2|||
27635764|NCT00065260|80509589|FG000|Overall Study|Death|0|||
27635765|NCT00065260|80509590|FG001|Overall Study|Death|1|||
27635766|NCT02496702|80509591|FG000|Overall Study|Lost to Follow-up|8|||
27635767|NCT02496702|80509592|FG001|Overall Study|Lost to Follow-up|6|||
27635768|NCT02496702|80509591|FG000|Overall Study|Only partially tested|0|||
27635769|NCT02496702|80509592|FG001|Overall Study|Only partially tested|2|||
27635770|NCT04833855|80509593|FG000|Overall Study|Decision by sponsor|0|||
27635771|NCT04833855|80509594|FG001|Overall Study|Decision by sponsor|1|||
27635772|NCT04833855|80509595|FG002|Overall Study|Decision by sponsor|0|||
27635773|NCT04833855|80509596|FG003|Overall Study|Decision by sponsor|0|||
27635774|NCT04833855|80509593|FG000|Overall Study|Withdrawal by Subject|4|||
27635775|NCT04833855|80509594|FG001|Overall Study|Withdrawal by Subject|1|||
27635776|NCT04833855|80509595|FG002|Overall Study|Withdrawal by Subject|3|||
27635777|NCT04833855|80509596|FG003|Overall Study|Withdrawal by Subject|1|||
27635778|NCT04833855|80509593|FG000|Overall Study|Lost to Follow-up|1|||
27635779|NCT04833855|80509594|FG001|Overall Study|Lost to Follow-up|0|||
27635780|NCT04833855|80509595|FG002|Overall Study|Lost to Follow-up|2|||
27635781|NCT04833855|80509596|FG003|Overall Study|Lost to Follow-up|2|||
27635782|NCT04833855|80509593|FG000|Overall Study|Protocol specified criteria|0|||
27635783|NCT04833855|80509594|FG001|Overall Study|Protocol specified criteria|0|||
27635784|NCT04833855|80509595|FG002|Overall Study|Protocol specified criteria|2|||
27635785|NCT04833855|80509596|FG003|Overall Study|Protocol specified criteria|1|||
27635786|NCT02918279|80509599|FG000|Overall Study|Lost to Follow-up|3|||
27635787|NCT02918279|80509600|FG001|Overall Study|Lost to Follow-up|6|||
27635788|NCT02918279|80509599|FG000|Overall Study|Withdrawal by Subject|5|||
27635789|NCT02918279|80509600|FG001|Overall Study|Withdrawal by Subject|15|||
27635790|NCT02918279|80509599|FG000|Overall Study|Withdrawal by parent/guardian|2|||
27740874|NCT03976401|80880757|FG001|Overall Study|Adverse Event|0|||
27740875|NCT03976401|80880758|FG002|Overall Study|Adverse Event|4|||
27740876|NCT03976401|80880759|FG003|Overall Study|Adverse Event|1|||
27740877|NCT03976401|80880760|FG004|Overall Study|Adverse Event|1|||
27635791|NCT02918279|80509600|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27635792|NCT02918279|80509599|FG000|Overall Study|Other|3|||
27635793|NCT02918279|80509600|FG001|Overall Study|Other|1|||
27635794|NCT03981822|80509601|FG000|Overall Study|Lost to Follow-up|0|||
27635795|NCT03981822|80509602|FG001|Overall Study|Lost to Follow-up|1|||
27635796|NCT03981822|80509603|FG002|Overall Study|Lost to Follow-up|1|||
27635797|NCT03981822|80509604|FG003|Overall Study|Lost to Follow-up|0|||
27635798|NCT03981822|80509605|FG004|Overall Study|Lost to Follow-up|6|||
27635799|NCT03981822|80509606|FG005|Overall Study|Lost to Follow-up|4|||
27635800|NCT03981822|80509607|FG006|Overall Study|Lost to Follow-up|4|||
27635801|NCT03981822|80509608|FG007|Overall Study|Lost to Follow-up|2|||
27635802|NCT03981822|80509601|FG000|Overall Study|Withdrawal by Subject|0|||
27635803|NCT03981822|80509602|FG001|Overall Study|Withdrawal by Subject|1|||
27635804|NCT03981822|80509603|FG002|Overall Study|Withdrawal by Subject|0|||
27635805|NCT03981822|80509604|FG003|Overall Study|Withdrawal by Subject|0|||
27635806|NCT03981822|80509605|FG004|Overall Study|Withdrawal by Subject|0|||
27635807|NCT03981822|80509606|FG005|Overall Study|Withdrawal by Subject|1|||
27635808|NCT03981822|80509607|FG006|Overall Study|Withdrawal by Subject|0|||
27635809|NCT03981822|80509608|FG007|Overall Study|Withdrawal by Subject|2|||
27635810|NCT03981822|80509601|FG000|Overall Study|COVID-19 Related|0|||
27635811|NCT03981822|80509602|FG001|Overall Study|COVID-19 Related|0|||
27635812|NCT03981822|80509603|FG002|Overall Study|COVID-19 Related|0|||
27635813|NCT03981822|80509604|FG003|Overall Study|COVID-19 Related|0|||
27635814|NCT03981822|80509605|FG004|Overall Study|COVID-19 Related|2|||
27635815|NCT03981822|80509606|FG005|Overall Study|COVID-19 Related|1|||
27635816|NCT03981822|80509607|FG006|Overall Study|COVID-19 Related|2|||
27635817|NCT03981822|80509608|FG007|Overall Study|COVID-19 Related|1|||
27635818|NCT02957136|80509609|FG000|Overall Study|Withdrawal by Subject|2|||
27635819|NCT02957136|80509610|FG001|Overall Study|Withdrawal by Subject|1|||
27635820|NCT00159783|80509613|FG000|Overall Study|Adverse Event|5|||
27635821|NCT00159783|80509614|FG001|Overall Study|Adverse Event|7|||
27635822|NCT00159783|80509615|FG002|Overall Study|Adverse Event|9|||
27635823|NCT00159783|80509613|FG000|Overall Study|Lack of Efficacy|1|||
27635824|NCT00159783|80509614|FG001|Overall Study|Lack of Efficacy|2|||
27635825|NCT00159783|80509615|FG002|Overall Study|Lack of Efficacy|3|||
27635826|NCT00159783|80509613|FG000|Overall Study|Withdrawal by Subject|7|||
27635827|NCT00159783|80509614|FG001|Overall Study|Withdrawal by Subject|11|||
27635828|NCT00159783|80509615|FG002|Overall Study|Withdrawal by Subject|12|||
27635829|NCT00159783|80509613|FG000|Overall Study|Lost to Follow-up|6|||
27635830|NCT00159783|80509614|FG001|Overall Study|Lost to Follow-up|5|||
27635831|NCT00159783|80509615|FG002|Overall Study|Lost to Follow-up|11|||
27635832|NCT00159783|80509613|FG000|Overall Study|Other|0|||
27635833|NCT00159783|80509614|FG001|Overall Study|Other|2|||
27635834|NCT00159783|80509615|FG002|Overall Study|Other|4|||
27635835|NCT01171625|80509616|FG000|Overall Study|On-Protocol|67|||
27635836|NCT01171625|80509616|FG000|Overall Study|Death|38|||
27635837|NCT01171625|80509616|FG000|Overall Study|Withdrawal by Subject|31|||
27635838|NCT01171625|80509616|FG000|Overall Study|Explanted|10|||
27635839|NCT01171625|80509616|FG000|Overall Study|Lost to Follow-up|5|||
27635840|NCT01171625|80509616|FG000|Overall Study|Patient received valve-in-valve|3|||
27635841|NCT01171625|80509616|FG000|Overall Study|Other|1|||
27635842|NCT01171625|80509616|FG000|Overall Study|Consented but did not receive device|25|||
27635843|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
27740878|NCT03976401|80880761|FG005|Overall Study|Adverse Event|0|||
27919651|NCT02000921|81543626|FG001|Overall Study|Lost to Follow-up|4|||
27740879|NCT03976401|80880756|FG000|Overall Study|Withdrawal by Subject|0|||
27740880|NCT03976401|80880757|FG001|Overall Study|Withdrawal by Subject|1|||
27740881|NCT03976401|80880758|FG002|Overall Study|Withdrawal by Subject|0|||
27740882|NCT03976401|80880759|FG003|Overall Study|Withdrawal by Subject|0|||
27740883|NCT03976401|80880760|FG004|Overall Study|Withdrawal by Subject|0|||
27740884|NCT03976401|80880761|FG005|Overall Study|Withdrawal by Subject|1|||
27740885|NCT03976401|80880756|FG000|Overall Study|Physician Decision|0|||
27740886|NCT03976401|80880757|FG001|Overall Study|Physician Decision|0|||
27635844|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
27635845|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
27635846|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
27635847|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
27635848|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
27635849|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
27635850|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
27635851|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
27635852|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
27635853|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
27635854|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
27635855|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
27740887|NCT03976401|80880758|FG002|Overall Study|Physician Decision|1|||
27635856|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
27635857|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
27635858|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
27635859|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
27635860|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
27635861|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
27635862|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
27635863|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
27635864|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
27635865|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
27635866|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
27635867|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
27635868|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
27635869|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
27635870|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
27635871|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
27635872|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
27635873|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
27635874|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
27635875|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
27919652|NCT02000921|81543627|FG002|Overall Study|Lost to Follow-up|5|||
27919653|NCT02000921|81543625|FG000|Overall Study|Physician Decision|0|||
27919654|NCT02000921|81543626|FG001|Overall Study|Physician Decision|2|||
27919655|NCT02000921|81543627|FG002|Overall Study|Physician Decision|0|||
27919656|NCT01710020|81543631|FG000|Period 1|Protocol Violation|1|||
27919657|NCT01172873|81543639|FG000|Overall Study|Withdrawal by Subject|3|||
27919658|NCT01172873|81543640|FG001|Overall Study|Withdrawal by Subject|2|||
27919659|NCT02119299|81543653|FG000|Overall Study|Withdrawal by Subject|7|||
27919660|NCT02119299|81543653|FG000|Overall Study|Lack of Efficacy|1|||
27919661|NCT02119299|81543653|FG000|Overall Study|Pregnancy|1|||
27740888|NCT03976401|80880759|FG003|Overall Study|Physician Decision|0|||
27540834|NCT03519178|80171771|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27635876|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
27540835|NCT03519178|80171772|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540836|NCT03519178|80171773|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540837|NCT03519178|80171774|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540838|NCT03519178|80171775|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
27540839|NCT03519178|80171776|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540840|NCT03519178|80171777|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540841|NCT03519178|80171778|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540842|NCT03519178|80171779|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
27540843|NCT03519178|80171765|FG000|Follow-Up|Death|0|||
27540844|NCT03519178|80171766|FG001|Follow-Up|Death|0|||
27540845|NCT03519178|80171767|FG002|Follow-Up|Death|1|||
27540846|NCT03519178|80171768|FG003|Follow-Up|Death|0|||
27540847|NCT03519178|80171769|FG004|Follow-Up|Death|0|||
27540848|NCT03519178|80171770|FG005|Follow-Up|Death|0|||
27540849|NCT03519178|80171771|FG006|Follow-Up|Death|0|||
27540850|NCT03519178|80171772|FG007|Follow-Up|Death|0|||
27540851|NCT03519178|80171773|FG008|Follow-Up|Death|3|||
27540852|NCT03519178|80171774|FG009|Follow-Up|Death|1|||
27540853|NCT03519178|80171775|FG010|Follow-Up|Death|0|||
27540854|NCT03519178|80171776|FG011|Follow-Up|Death|0|||
27540855|NCT03519178|80171777|FG012|Follow-Up|Death|2|||
27540856|NCT03519178|80171778|FG013|Follow-Up|Death|0|||
27540857|NCT03519178|80171779|FG014|Follow-Up|Death|0|||
27540858|NCT03519178|80171765|FG000|Follow-Up|Lost to Follow-up|0|||
27540859|NCT03519178|80171766|FG001|Follow-Up|Lost to Follow-up|0|||
27540860|NCT03519178|80171767|FG002|Follow-Up|Lost to Follow-up|0|||
27540861|NCT03519178|80171768|FG003|Follow-Up|Lost to Follow-up|0|||
27540862|NCT03519178|80171769|FG004|Follow-Up|Lost to Follow-up|0|||
27540863|NCT03519178|80171770|FG005|Follow-Up|Lost to Follow-up|3|||
27540864|NCT03519178|80171771|FG006|Follow-Up|Lost to Follow-up|1|||
27740889|NCT03976401|80880760|FG004|Overall Study|Physician Decision|0|||
27540865|NCT03519178|80171772|FG007|Follow-Up|Lost to Follow-up|4|||
27540866|NCT03519178|80171773|FG008|Follow-Up|Lost to Follow-up|1|||
27540867|NCT03519178|80171774|FG009|Follow-Up|Lost to Follow-up|0|||
27540868|NCT03519178|80171775|FG010|Follow-Up|Lost to Follow-up|0|||
27540869|NCT03519178|80171776|FG011|Follow-Up|Lost to Follow-up|0|||
27540870|NCT03519178|80171777|FG012|Follow-Up|Lost to Follow-up|0|||
27919662|NCT03652818|81543658|FG000|Overall Study|Adverse Event|1|||
27919663|NCT03652818|81543659|FG001|Overall Study|Adverse Event|0|||
27919664|NCT03652818|81543660|FG002|Overall Study|Adverse Event|0|||
27540871|NCT03519178|80171778|FG013|Follow-Up|Lost to Follow-up|0|||
27919665|NCT03652818|81543661|FG003|Overall Study|Adverse Event|0|||
27919666|NCT03652818|81543662|FG004|Overall Study|Adverse Event|0|||
27919667|NCT03652818|81543658|FG000|Overall Study|Physician Decision|1|||
27919668|NCT03652818|81543659|FG001|Overall Study|Physician Decision|0|||
27919669|NCT03652818|81543660|FG002|Overall Study|Physician Decision|0|||
27919670|NCT03652818|81543661|FG003|Overall Study|Physician Decision|0|||
27919671|NCT03652818|81543662|FG004|Overall Study|Physician Decision|0|||
27919672|NCT03652818|81543658|FG000|Overall Study|Lost to Follow-up|0|||
27919673|NCT03652818|81543659|FG001|Overall Study|Lost to Follow-up|1|||
27919674|NCT03652818|81543660|FG002|Overall Study|Lost to Follow-up|2|||
27919675|NCT03652818|81543661|FG003|Overall Study|Lost to Follow-up|1|||
27919676|NCT03652818|81543662|FG004|Overall Study|Lost to Follow-up|1|||
27919677|NCT01317641|81543665|FG000|Overall Study|Not treated|0|||
27919678|NCT01317641|81543666|FG001|Overall Study|Not treated|0|||
27919679|NCT01317641|81543667|FG002|Overall Study|Not treated|0|||
27919680|NCT01317641|81543668|FG003|Overall Study|Not treated|0|||
27919681|NCT01317641|81543669|FG004|Overall Study|Not treated|0|||
27919682|NCT01317641|81543670|FG005|Overall Study|Not treated|0|||
27919683|NCT01317641|81543671|FG006|Overall Study|Not treated|0|||
27919684|NCT01317641|81543672|FG007|Overall Study|Not treated|1|||
27919685|NCT01317641|81543673|FG008|Overall Study|Not treated|1|||
27919686|NCT01317641|81543665|FG000|Overall Study|Adverse Event|0|||
27919687|NCT01317641|81543666|FG001|Overall Study|Adverse Event|1|||
27919688|NCT01317641|81543667|FG002|Overall Study|Adverse Event|0|||
27919689|NCT01317641|81543668|FG003|Overall Study|Adverse Event|1|||
27919690|NCT01317641|81543669|FG004|Overall Study|Adverse Event|0|||
27919691|NCT01317641|81543670|FG005|Overall Study|Adverse Event|0|||
27919692|NCT01317641|81543671|FG006|Overall Study|Adverse Event|2|||
27919693|NCT01317641|81543672|FG007|Overall Study|Adverse Event|1|||
27919694|NCT01317641|81543673|FG008|Overall Study|Adverse Event|0|||
27919695|NCT01317641|81543665|FG000|Overall Study|Protocol Violation|1|||
27919696|NCT01317641|81543666|FG001|Overall Study|Protocol Violation|0|||
27919697|NCT01317641|81543667|FG002|Overall Study|Protocol Violation|0|||
27919698|NCT01317641|81543668|FG003|Overall Study|Protocol Violation|0|||
27919699|NCT01317641|81543669|FG004|Overall Study|Protocol Violation|0|||
27919700|NCT01317641|81543670|FG005|Overall Study|Protocol Violation|0|||
27919701|NCT01317641|81543671|FG006|Overall Study|Protocol Violation|0|||
27919702|NCT01317641|81543672|FG007|Overall Study|Protocol Violation|0|||
27919703|NCT01317641|81543673|FG008|Overall Study|Protocol Violation|0|||
27919704|NCT01317641|81543665|FG000|Overall Study|Disease progression|0|||
27919705|NCT01317641|81543666|FG001|Overall Study|Disease progression|0|||
27919706|NCT01317641|81543667|FG002|Overall Study|Disease progression|0|||
27919707|NCT01317641|81543668|FG003|Overall Study|Disease progression|0|||
27919708|NCT01317641|81543669|FG004|Overall Study|Disease progression|0|||
27919709|NCT01317641|81543670|FG005|Overall Study|Disease progression|0|||
27919710|NCT01317641|81543671|FG006|Overall Study|Disease progression|0|||
27919711|NCT01317641|81543672|FG007|Overall Study|Disease progression|3|||
27919712|NCT01317641|81543673|FG008|Overall Study|Disease progression|4|||
27919713|NCT01317641|81543665|FG000|Overall Study|Withdrawal by Subject|0|||
27919714|NCT01317641|81543666|FG001|Overall Study|Withdrawal by Subject|0|||
27919715|NCT01317641|81543667|FG002|Overall Study|Withdrawal by Subject|0|||
27919716|NCT01317641|81543668|FG003|Overall Study|Withdrawal by Subject|0|||
27919717|NCT01317641|81543669|FG004|Overall Study|Withdrawal by Subject|0|||
27919718|NCT01317641|81543670|FG005|Overall Study|Withdrawal by Subject|0|||
27919719|NCT01317641|81543671|FG006|Overall Study|Withdrawal by Subject|1|||
27919720|NCT01317641|81543672|FG007|Overall Study|Withdrawal by Subject|0|||
27919721|NCT01317641|81543673|FG008|Overall Study|Withdrawal by Subject|0|||
27919722|NCT01677741|81543674|FG000|Overall Study|Death|0|||
27919723|NCT01677741|81543675|FG001|Overall Study|Death|0|||
27919724|NCT01677741|81543676|FG002|Overall Study|Death|0|||
27919725|NCT01677741|81543677|FG003|Overall Study|Death|1|||
27919726|NCT01677741|81543678|FG004|Overall Study|Death|0|||
27919727|NCT01677741|81543679|FG005|Overall Study|Death|1|||
27919728|NCT01677741|81543680|FG006|Overall Study|Death|0|||
27919729|NCT01677741|81543681|FG007|Overall Study|Death|0|||
27919730|NCT01677741|81543674|FG000|Overall Study|Withdrawal by Subject|2|||
27919731|NCT01677741|81543675|FG001|Overall Study|Withdrawal by Subject|7|||
27919732|NCT01677741|81543676|FG002|Overall Study|Withdrawal by Subject|5|||
27919733|NCT01677741|81543677|FG003|Overall Study|Withdrawal by Subject|4|||
27919734|NCT01677741|81543678|FG004|Overall Study|Withdrawal by Subject|11|||
27919735|NCT01677741|81543679|FG005|Overall Study|Withdrawal by Subject|20|||
27919736|NCT01677741|81543680|FG006|Overall Study|Withdrawal by Subject|4|||
27919737|NCT01677741|81543681|FG007|Overall Study|Withdrawal by Subject|2|||
27919738|NCT01677741|81543674|FG000|Overall Study|Enrolled in a rollover study|0|||
27919739|NCT01677741|81543675|FG001|Overall Study|Enrolled in a rollover study|3|||
27919740|NCT01677741|81543676|FG002|Overall Study|Enrolled in a rollover study|2|||
27919741|NCT01677741|81543677|FG003|Overall Study|Enrolled in a rollover study|1|||
27919742|NCT01677741|81543678|FG004|Overall Study|Enrolled in a rollover study|6|||
27919743|NCT01677741|81543679|FG005|Overall Study|Enrolled in a rollover study|6|||
27919744|NCT01677741|81543680|FG006|Overall Study|Enrolled in a rollover study|7|||
27919745|NCT01677741|81543681|FG007|Overall Study|Enrolled in a rollover study|0|||
27919746|NCT01677741|81543674|FG000|Overall Study|Progressive disease|1|||
27919747|NCT01677741|81543675|FG001|Overall Study|Progressive disease|0|||
27919748|NCT01677741|81543676|FG002|Overall Study|Progressive disease|1|||
27919749|NCT01677741|81543677|FG003|Overall Study|Progressive disease|0|||
27919750|NCT01677741|81543678|FG004|Overall Study|Progressive disease|0|||
27919751|NCT01677741|81543679|FG005|Overall Study|Progressive disease|1|||
27919752|NCT01677741|81543680|FG006|Overall Study|Progressive disease|0|||
27919753|NCT01677741|81543681|FG007|Overall Study|Progressive disease|0|||
27919754|NCT00706004|81543682|FG000|Overall Study|Did not meet eligibility criteria|2|||
27919755|NCT01914393|81543686|FG000|Overall Study|Protocol Violation|11|||
27919756|NCT01914393|81543687|FG001|Overall Study|Protocol Violation|3|||
27919757|NCT01914393|81543688|FG002|Overall Study|Protocol Violation|19|||
27919758|NCT01914393|81543686|FG000|Overall Study|Lack of Efficacy|11|||
27919759|NCT01914393|81543687|FG001|Overall Study|Lack of Efficacy|16|||
27919760|NCT01914393|81543688|FG002|Overall Study|Lack of Efficacy|5|||
27919761|NCT01914393|81543686|FG000|Overall Study|no reason given|14|||
27635877|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
27635878|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
27635879|NCT03593213|80509619|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
27635880|NCT03593213|80509620|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
27635881|NCT03593213|80509621|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
27635882|NCT03593213|80509622|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
27635883|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
27635884|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
27635885|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
27635886|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
27635887|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
27635888|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
27635889|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
27635890|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
27635891|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
27635892|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
27635893|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
27635894|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
27635895|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
27635896|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
27635897|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
27635898|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
27635899|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
27635900|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
27635901|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
27635902|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
27635903|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
27635904|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
27635905|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
27635906|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
27635907|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
27635908|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
27635909|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
27635910|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
27635911|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
27740890|NCT03976401|80880761|FG005|Overall Study|Physician Decision|0|||
27919762|NCT01914393|81543687|FG001|Overall Study|no reason given|8|||
27919763|NCT01914393|81543688|FG002|Overall Study|no reason given|16|||
27919764|NCT01914393|81543686|FG000|Overall Study|Adverse Event|29|||
27919765|NCT01914393|81543687|FG001|Overall Study|Adverse Event|18|||
27919766|NCT01914393|81543688|FG002|Overall Study|Adverse Event|31|||
27919767|NCT01914393|81543686|FG000|Overall Study|Withdrawal by Subject|38|||
27919768|NCT01914393|81543687|FG001|Overall Study|Withdrawal by Subject|20|||
27919769|NCT01914393|81543688|FG002|Overall Study|Withdrawal by Subject|47|||
27919770|NCT01914393|81543686|FG000|Overall Study|Lost to Follow-up|12|||
27919771|NCT01914393|81543687|FG001|Overall Study|Lost to Follow-up|6|||
27919772|NCT01914393|81543688|FG002|Overall Study|Lost to Follow-up|19|||
27919773|NCT01914393|81543686|FG000|Overall Study|subject never dosed|0|||
27919774|NCT01914393|81543687|FG001|Overall Study|subject never dosed|0|||
27919775|NCT01914393|81543688|FG002|Overall Study|subject never dosed|1|||
27919776|NCT00499122|81543689|FG000|Overall Study|Withdrawal by Subject|2|||
27540872|NCT03519178|80171779|FG014|Follow-Up|Lost to Follow-up|0|||
27540873|NCT03519178|80171765|FG000|Follow-Up|Withdrawal by Subject|1|||
27540874|NCT03519178|80171766|FG001|Follow-Up|Withdrawal by Subject|2|||
27540875|NCT03519178|80171767|FG002|Follow-Up|Withdrawal by Subject|2|||
27540876|NCT03519178|80171768|FG003|Follow-Up|Withdrawal by Subject|3|||
27540877|NCT03519178|80171769|FG004|Follow-Up|Withdrawal by Subject|5|||
27540878|NCT03519178|80171770|FG005|Follow-Up|Withdrawal by Subject|1|||
27540879|NCT03519178|80171771|FG006|Follow-Up|Withdrawal by Subject|2|||
27540880|NCT03519178|80171772|FG007|Follow-Up|Withdrawal by Subject|6|||
27540881|NCT03519178|80171773|FG008|Follow-Up|Withdrawal by Subject|5|||
27540882|NCT03519178|80171774|FG009|Follow-Up|Withdrawal by Subject|2|||
27540883|NCT03519178|80171775|FG010|Follow-Up|Withdrawal by Subject|3|||
27540884|NCT03519178|80171776|FG011|Follow-Up|Withdrawal by Subject|5|||
27540885|NCT03519178|80171777|FG012|Follow-Up|Withdrawal by Subject|2|||
27540886|NCT03519178|80171778|FG013|Follow-Up|Withdrawal by Subject|0|||
27540887|NCT03519178|80171779|FG014|Follow-Up|Withdrawal by Subject|0|||
27540888|NCT03519178|80171765|FG000|Follow-Up|Other|0|||
27540889|NCT03519178|80171766|FG001|Follow-Up|Other|0|||
27540890|NCT03519178|80171767|FG002|Follow-Up|Other|0|||
27540891|NCT03519178|80171768|FG003|Follow-Up|Other|0|||
27540892|NCT03519178|80171769|FG004|Follow-Up|Other|0|||
27540893|NCT03519178|80171770|FG005|Follow-Up|Other|0|||
27540894|NCT03519178|80171771|FG006|Follow-Up|Other|0|||
27540895|NCT03519178|80171772|FG007|Follow-Up|Other|1|||
27540896|NCT03519178|80171773|FG008|Follow-Up|Other|0|||
27540897|NCT03519178|80171774|FG009|Follow-Up|Other|0|||
27540898|NCT03519178|80171775|FG010|Follow-Up|Other|0|||
27540899|NCT03519178|80171776|FG011|Follow-Up|Other|0|||
27540900|NCT03519178|80171777|FG012|Follow-Up|Other|0|||
27540901|NCT03519178|80171778|FG013|Follow-Up|Other|0|||
27540902|NCT03519178|80171779|FG014|Follow-Up|Other|0|||
27540903|NCT03519178|80171765|FG000|Long-term Follow-up|Death|0|||
27540904|NCT03519178|80171766|FG001|Long-term Follow-up|Death|0|||
27540905|NCT03519178|80171767|FG002|Long-term Follow-up|Death|0|||
27540906|NCT03519178|80171768|FG003|Long-term Follow-up|Death|0|||
27540907|NCT03519178|80171769|FG004|Long-term Follow-up|Death|0|||
27540908|NCT03519178|80171770|FG005|Long-term Follow-up|Death|0|||
27540909|NCT03519178|80171771|FG006|Long-term Follow-up|Death|0|||
27540910|NCT03519178|80171772|FG007|Long-term Follow-up|Death|0|||
27540911|NCT03519178|80171773|FG008|Long-term Follow-up|Death|0|||
27540912|NCT03519178|80171774|FG009|Long-term Follow-up|Death|0|||
27540913|NCT03519178|80171775|FG010|Long-term Follow-up|Death|0|||
27540914|NCT03519178|80171776|FG011|Long-term Follow-up|Death|0|||
27540915|NCT03519178|80171777|FG012|Long-term Follow-up|Death|0|||
27540916|NCT03519178|80171778|FG013|Long-term Follow-up|Death|4|||
27540917|NCT03519178|80171779|FG014|Long-term Follow-up|Death|4|||
27540918|NCT03519178|80171765|FG000|Long-term Follow-up|Lost to Follow-up|0|||
27540919|NCT03519178|80171766|FG001|Long-term Follow-up|Lost to Follow-up|0|||
27540920|NCT03519178|80171767|FG002|Long-term Follow-up|Lost to Follow-up|0|||
27540921|NCT03519178|80171768|FG003|Long-term Follow-up|Lost to Follow-up|0|||
27540922|NCT03519178|80171769|FG004|Long-term Follow-up|Lost to Follow-up|0|||
27540923|NCT03519178|80171770|FG005|Long-term Follow-up|Lost to Follow-up|0|||
27540924|NCT03519178|80171771|FG006|Long-term Follow-up|Lost to Follow-up|0|||
27540925|NCT03519178|80171772|FG007|Long-term Follow-up|Lost to Follow-up|0|||
27540926|NCT03519178|80171773|FG008|Long-term Follow-up|Lost to Follow-up|0|||
27540927|NCT03519178|80171774|FG009|Long-term Follow-up|Lost to Follow-up|0|||
27540928|NCT03519178|80171775|FG010|Long-term Follow-up|Lost to Follow-up|0|||
27540929|NCT03519178|80171776|FG011|Long-term Follow-up|Lost to Follow-up|0|||
27540930|NCT03519178|80171777|FG012|Long-term Follow-up|Lost to Follow-up|0|||
27540931|NCT03519178|80171778|FG013|Long-term Follow-up|Lost to Follow-up|1|||
27540932|NCT03519178|80171779|FG014|Long-term Follow-up|Lost to Follow-up|1|||
27540933|NCT03519178|80171765|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
27540934|NCT03519178|80171766|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
27540935|NCT03519178|80171767|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
27540936|NCT03519178|80171768|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
27540937|NCT03519178|80171769|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
27540938|NCT03519178|80171770|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
27540939|NCT03519178|80171771|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
27540940|NCT03519178|80171772|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
27540941|NCT03519178|80171773|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
27540942|NCT03519178|80171774|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
27540943|NCT03519178|80171775|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
27540944|NCT03519178|80171776|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
27540945|NCT03519178|80171777|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
27540946|NCT03519178|80171778|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
27540947|NCT03519178|80171779|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
27540948|NCT03519178|80171765|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
27540949|NCT03519178|80171766|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
27540950|NCT03519178|80171767|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
27540951|NCT03519178|80171768|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
27540952|NCT03519178|80171769|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
27540953|NCT03519178|80171770|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
27540954|NCT03519178|80171771|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
27540955|NCT03519178|80171772|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
27540956|NCT03519178|80171773|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
27540957|NCT03519178|80171774|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
27540958|NCT03519178|80171775|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
27540959|NCT03519178|80171776|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
27540960|NCT03519178|80171777|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
27540961|NCT03519178|80171778|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
27540962|NCT03519178|80171779|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
27540963|NCT03519178|80171765|FG000|Long-term Follow-up|Other|0|||
27540964|NCT03519178|80171766|FG001|Long-term Follow-up|Other|0|||
27540965|NCT03519178|80171767|FG002|Long-term Follow-up|Other|0|||
27540966|NCT03519178|80171768|FG003|Long-term Follow-up|Other|0|||
27540967|NCT03519178|80171769|FG004|Long-term Follow-up|Other|0|||
27540968|NCT03519178|80171770|FG005|Long-term Follow-up|Other|0|||
27540969|NCT03519178|80171771|FG006|Long-term Follow-up|Other|0|||
27540970|NCT03519178|80171772|FG007|Long-term Follow-up|Other|0|||
27540971|NCT03519178|80171773|FG008|Long-term Follow-up|Other|0|||
27540972|NCT03519178|80171774|FG009|Long-term Follow-up|Other|0|||
27540973|NCT03519178|80171775|FG010|Long-term Follow-up|Other|0|||
27540974|NCT03519178|80171776|FG011|Long-term Follow-up|Other|0|||
27540975|NCT03519178|80171777|FG012|Long-term Follow-up|Other|0|||
27540976|NCT03519178|80171778|FG013|Long-term Follow-up|Other|0|||
27540977|NCT03519178|80171779|FG014|Long-term Follow-up|Other|1|||
27540978|NCT03519178|80171765|FG000|Long-term Follow-up|Ongoing|0|||
27540979|NCT03519178|80171766|FG001|Long-term Follow-up|Ongoing|0|||
27540980|NCT03519178|80171767|FG002|Long-term Follow-up|Ongoing|0|||
27540981|NCT03519178|80171768|FG003|Long-term Follow-up|Ongoing|0|||
27540982|NCT03519178|80171769|FG004|Long-term Follow-up|Ongoing|0|||
27540983|NCT03519178|80171770|FG005|Long-term Follow-up|Ongoing|0|||
27540984|NCT03519178|80171771|FG006|Long-term Follow-up|Ongoing|0|||
27540985|NCT03519178|80171772|FG007|Long-term Follow-up|Ongoing|0|||
27540986|NCT03519178|80171773|FG008|Long-term Follow-up|Ongoing|0|||
27540987|NCT03519178|80171774|FG009|Long-term Follow-up|Ongoing|0|||
27540988|NCT03519178|80171775|FG010|Long-term Follow-up|Ongoing|0|||
27540989|NCT03519178|80171776|FG011|Long-term Follow-up|Ongoing|0|||
27540990|NCT03519178|80171777|FG012|Long-term Follow-up|Ongoing|0|||
27540991|NCT03519178|80171778|FG013|Long-term Follow-up|Ongoing|1|||
27540992|NCT03519178|80171779|FG014|Long-term Follow-up|Ongoing|0|||
27540993|NCT00400764|80171790|FG000|Phase Ib|Adverse Event|1|||
27540994|NCT00400764|80171791|FG001|Phase Ib|Adverse Event|0|||
27540995|NCT00400764|80171792|FG002|Phase Ib|Adverse Event|0|||
27540996|NCT00400764|80171793|FG003|Phase Ib|Adverse Event|0|||
27540997|NCT00400764|80171794|FG004|Phase Ib|Adverse Event|0|||
27540998|NCT00400764|80171790|FG000|Phase Ib|Death|1|||
27540999|NCT00400764|80171791|FG001|Phase Ib|Death|0|||
27541000|NCT00400764|80171792|FG002|Phase Ib|Death|0|||
27541001|NCT00400764|80171793|FG003|Phase Ib|Death|0|||
27541002|NCT00400764|80171794|FG004|Phase Ib|Death|0|||
27541003|NCT00400764|80171790|FG000|Phase Ib|Disease Progression|4|||
27541004|NCT00400764|80171791|FG001|Phase Ib|Disease Progression|4|||
27541005|NCT00400764|80171792|FG002|Phase Ib|Disease Progression|0|||
27541006|NCT00400764|80171793|FG003|Phase Ib|Disease Progression|0|||
27541007|NCT00400764|80171794|FG004|Phase Ib|Disease Progression|0|||
27541008|NCT00400764|80171790|FG000|Phase II|Death|0|||
27541009|NCT00400764|80171791|FG001|Phase II|Death|0|||
27541010|NCT00400764|80171792|FG002|Phase II|Death|1|||
27541011|NCT00400764|80171793|FG003|Phase II|Death|2|||
27541012|NCT00400764|80171794|FG004|Phase II|Death|0|||
27541013|NCT00400764|80171790|FG000|Phase II|Lost to Follow-up|0|||
27541014|NCT00400764|80171791|FG001|Phase II|Lost to Follow-up|0|||
27541015|NCT00400764|80171792|FG002|Phase II|Lost to Follow-up|1|||
27541016|NCT00400764|80171793|FG003|Phase II|Lost to Follow-up|0|||
27541017|NCT00400764|80171794|FG004|Phase II|Lost to Follow-up|0|||
27740891|NCT03976401|80880756|FG000|Overall Study|Lost to Follow-up|1|||
27740892|NCT03976401|80880757|FG001|Overall Study|Lost to Follow-up|2|||
27740893|NCT03976401|80880758|FG002|Overall Study|Lost to Follow-up|0|||
27541018|NCT00400764|80171790|FG000|Phase II|Physician Decision|0|||
27541019|NCT00400764|80171791|FG001|Phase II|Physician Decision|0|||
27541020|NCT00400764|80171792|FG002|Phase II|Physician Decision|1|||
27541021|NCT00400764|80171793|FG003|Phase II|Physician Decision|1|||
27541022|NCT00400764|80171794|FG004|Phase II|Physician Decision|0|||
27740894|NCT03976401|80880759|FG003|Overall Study|Lost to Follow-up|0|||
27541023|NCT00400764|80171790|FG000|Phase II|Sponsor's decision to terminate|0|||
27541024|NCT00400764|80171791|FG001|Phase II|Sponsor's decision to terminate|0|||
27541025|NCT00400764|80171792|FG002|Phase II|Sponsor's decision to terminate|18|||
27541026|NCT00400764|80171793|FG003|Phase II|Sponsor's decision to terminate|22|||
27541027|NCT00400764|80171794|FG004|Phase II|Sponsor's decision to terminate|11|||
27541028|NCT00400764|80171790|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
27541029|NCT00400764|80171791|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
27541030|NCT00400764|80171792|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
27541031|NCT00400764|80171793|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
27635912|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
27635913|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
27635914|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
27635915|NCT03593213|80509619|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
27635916|NCT03593213|80509620|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
27635917|NCT03593213|80509621|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
27635918|NCT03593213|80509622|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
27635919|NCT02477670|80509623|FG000|Stage 1|Adverse Event|2|||
27635920|NCT02477670|80509624|FG001|Stage 1|Adverse Event|7|||
27635921|NCT02477670|80509625|FG002|Stage 1|Adverse Event|0|||
27635922|NCT02477670|80509626|FG003|Stage 1|Adverse Event|0|||
27635923|NCT02477670|80509627|FG004|Stage 1|Adverse Event|0|||
27635924|NCT02477670|80509628|FG005|Stage 1|Adverse Event|0|||
27635925|NCT02477670|80509629|FG006|Stage 1|Adverse Event|0|||
27635926|NCT02477670|80509623|FG000|Stage 1|Lost to Follow-up|0|||
27635927|NCT02477670|80509624|FG001|Stage 1|Lost to Follow-up|2|||
27919777|NCT01863771|81543690|FG000|Induction Phase|Adverse Event|9|||
27919778|NCT01863771|81543691|FG001|Induction Phase|Adverse Event|0|||
27919779|NCT01863771|81543692|FG002|Induction Phase|Adverse Event|0|||
27919780|NCT01863771|81543693|FG003|Induction Phase|Adverse Event|0|||
27919781|NCT01863771|81543690|FG000|Induction Phase|Lack of Efficacy|10|||
27919782|NCT01863771|81543691|FG001|Induction Phase|Lack of Efficacy|0|||
27919783|NCT01863771|81543692|FG002|Induction Phase|Lack of Efficacy|0|||
27919784|NCT01863771|81543693|FG003|Induction Phase|Lack of Efficacy|0|||
27919785|NCT01863771|81543690|FG000|Induction Phase|Withdrawal by Subject|2|||
27919786|NCT01863771|81543691|FG001|Induction Phase|Withdrawal by Subject|0|||
27919787|NCT01863771|81543692|FG002|Induction Phase|Withdrawal by Subject|0|||
27919788|NCT01863771|81543693|FG003|Induction Phase|Withdrawal by Subject|0|||
27919789|NCT01863771|81543690|FG000|Maintenance Phase|Adverse Event|0|||
27919790|NCT01863771|81543691|FG001|Maintenance Phase|Adverse Event|0|||
27919791|NCT01863771|81543692|FG002|Maintenance Phase|Adverse Event|1|||
27919792|NCT01863771|81543693|FG003|Maintenance Phase|Adverse Event|1|||
27919793|NCT01863771|81543690|FG000|Maintenance Phase|Lack of Efficacy|0|||
27919794|NCT01863771|81543691|FG001|Maintenance Phase|Lack of Efficacy|3|||
27919795|NCT01863771|81543692|FG002|Maintenance Phase|Lack of Efficacy|7|||
27919796|NCT01863771|81543693|FG003|Maintenance Phase|Lack of Efficacy|38|||
27919797|NCT01863771|81543690|FG000|Maintenance Phase|Physician Decision|0|||
27919798|NCT01863771|81543691|FG001|Maintenance Phase|Physician Decision|0|||
27919799|NCT01863771|81543692|FG002|Maintenance Phase|Physician Decision|2|||
27919800|NCT01863771|81543693|FG003|Maintenance Phase|Physician Decision|1|||
27919801|NCT01863771|81543690|FG000|Maintenance Phase|Pregnancy|0|||
27919802|NCT01863771|81543691|FG001|Maintenance Phase|Pregnancy|1|||
27919803|NCT01863771|81543692|FG002|Maintenance Phase|Pregnancy|0|||
27919804|NCT01863771|81543693|FG003|Maintenance Phase|Pregnancy|0|||
27919805|NCT01863771|81543690|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27919806|NCT01863771|81543691|FG001|Maintenance Phase|Withdrawal by Subject|1|||
27919807|NCT01863771|81543692|FG002|Maintenance Phase|Withdrawal by Subject|2|||
27919808|NCT01863771|81543693|FG003|Maintenance Phase|Withdrawal by Subject|3|||
27919809|NCT02765035|81543698|FG000|First Intervention (90 Days)|Adverse Event|1|||
27919810|NCT02765035|81543699|FG001|First Intervention (90 Days)|Adverse Event|1|||
27919811|NCT02765035|81543698|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
27919812|NCT02765035|81543699|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
27635928|NCT02477670|80509625|FG002|Stage 1|Lost to Follow-up|0|||
27635929|NCT02477670|80509626|FG003|Stage 1|Lost to Follow-up|0|||
27635930|NCT02477670|80509627|FG004|Stage 1|Lost to Follow-up|0|||
27635931|NCT02477670|80509628|FG005|Stage 1|Lost to Follow-up|0|||
27919813|NCT00288912|81543705|FG000|Overall Study|Developed exclusion criterion|4|||
27635932|NCT02477670|80509629|FG006|Stage 1|Lost to Follow-up|0|||
27635933|NCT02477670|80509623|FG000|Stage 1|Withdrawal by Subject|1|||
27635934|NCT02477670|80509624|FG001|Stage 1|Withdrawal by Subject|2|||
27635935|NCT02477670|80509625|FG002|Stage 1|Withdrawal by Subject|0|||
27635936|NCT02477670|80509626|FG003|Stage 1|Withdrawal by Subject|0|||
27635937|NCT02477670|80509627|FG004|Stage 1|Withdrawal by Subject|0|||
27635938|NCT02477670|80509628|FG005|Stage 1|Withdrawal by Subject|0|||
27635939|NCT02477670|80509629|FG006|Stage 1|Withdrawal by Subject|0|||
27919814|NCT00288912|81543706|FG001|Overall Study|Developed exclusion criterion|6|||
27635940|NCT02477670|80509623|FG000|Stage 1|Non-compliance with Study Drug|1|||
27635941|NCT02477670|80509624|FG001|Stage 1|Non-compliance with Study Drug|2|||
27635942|NCT02477670|80509625|FG002|Stage 1|Non-compliance with Study Drug|0|||
27919815|NCT00288912|81543707|FG002|Overall Study|Developed exclusion criterion|7|||
27919816|NCT00288912|81543705|FG000|Overall Study|Lost to Follow-up|9|||
27635943|NCT02477670|80509626|FG003|Stage 1|Non-compliance with Study Drug|0|||
27635944|NCT02477670|80509627|FG004|Stage 1|Non-compliance with Study Drug|0|||
27635945|NCT02477670|80509628|FG005|Stage 1|Non-compliance with Study Drug|0|||
27740895|NCT03976401|80880760|FG004|Overall Study|Lost to Follow-up|0|||
27919817|NCT00288912|81543706|FG001|Overall Study|Lost to Follow-up|6|||
27919818|NCT00288912|81543707|FG002|Overall Study|Lost to Follow-up|9|||
27635946|NCT02477670|80509629|FG006|Stage 1|Non-compliance with Study Drug|0|||
27635947|NCT02477670|80509623|FG000|Stage 2|Adverse Event|0|||
27635948|NCT02477670|80509624|FG001|Stage 2|Adverse Event|0|||
27635949|NCT02477670|80509625|FG002|Stage 2|Adverse Event|1|||
27635950|NCT02477670|80509626|FG003|Stage 2|Adverse Event|0|||
27635951|NCT02477670|80509627|FG004|Stage 2|Adverse Event|0|||
27635952|NCT02477670|80509628|FG005|Stage 2|Adverse Event|0|||
27919819|NCT00288912|81543705|FG000|Overall Study|Withdrawal by Subject|4|||
27919820|NCT00288912|81543706|FG001|Overall Study|Withdrawal by Subject|5|||
27919821|NCT00288912|81543707|FG002|Overall Study|Withdrawal by Subject|12|||
27919822|NCT02966834|81543708|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
27919823|NCT02966834|81543709|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
27541032|NCT00400764|80171794|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
27541033|NCT00400764|80171790|FG000|Phase II|Withdrawal by Subject|0|||
27541034|NCT00400764|80171791|FG001|Phase II|Withdrawal by Subject|0|||
27541035|NCT00400764|80171792|FG002|Phase II|Withdrawal by Subject|1|||
27541036|NCT00400764|80171793|FG003|Phase II|Withdrawal by Subject|1|||
27541037|NCT00400764|80171794|FG004|Phase II|Withdrawal by Subject|0|||
27541038|NCT01233258|80171795|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
27541039|NCT01233258|80171796|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
27541040|NCT01233258|80171797|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
27635953|NCT02477670|80509629|FG006|Stage 2|Adverse Event|0|||
27635954|NCT02477670|80509623|FG000|Stage 2|Antipsychotic Medication Changed|0|||
27635955|NCT02477670|80509624|FG001|Stage 2|Antipsychotic Medication Changed|0|||
27635956|NCT02477670|80509625|FG002|Stage 2|Antipsychotic Medication Changed|1|||
27635957|NCT02477670|80509626|FG003|Stage 2|Antipsychotic Medication Changed|0|||
27635958|NCT02477670|80509627|FG004|Stage 2|Antipsychotic Medication Changed|0|||
27635959|NCT02477670|80509628|FG005|Stage 2|Antipsychotic Medication Changed|0|||
27635960|NCT02477670|80509629|FG006|Stage 2|Antipsychotic Medication Changed|0|||
27635961|NCT02477670|80509623|FG000|Stage 2|Withdrawal by Subject|0|||
27635962|NCT02477670|80509624|FG001|Stage 2|Withdrawal by Subject|0|||
27635963|NCT02477670|80509625|FG002|Stage 2|Withdrawal by Subject|0|||
27635964|NCT02477670|80509626|FG003|Stage 2|Withdrawal by Subject|1|||
27635965|NCT02477670|80509627|FG004|Stage 2|Withdrawal by Subject|0|||
27635966|NCT02477670|80509628|FG005|Stage 2|Withdrawal by Subject|0|||
27635967|NCT02477670|80509629|FG006|Stage 2|Withdrawal by Subject|0|||
27635968|NCT01185782|80509630|FG000|Overall Study|Adverse Event|0|||
27635969|NCT01185782|80509631|FG001|Overall Study|Adverse Event|1|||
27635970|NCT01185782|80509630|FG000|Overall Study|Protocol Violation|1|||
27635971|NCT01185782|80509631|FG001|Overall Study|Protocol Violation|0|||
27635972|NCT01185782|80509630|FG000|Overall Study|Poor Response to Treatment|3|||
27635973|NCT01185782|80509631|FG001|Overall Study|Poor Response to Treatment|1|||
27635974|NCT01185782|80509630|FG000|Overall Study|Other|2|||
27635975|NCT01185782|80509631|FG001|Overall Study|Other|5|||
27635976|NCT01185782|80509630|FG000|Overall Study|Randomized but not treated|0|||
27635977|NCT01185782|80509631|FG001|Overall Study|Randomized but not treated|4|||
27635978|NCT04464421|80509634|FG000|Overall Study|Lost to Follow-up|2|||
27635979|NCT04464421|80509635|FG001|Overall Study|Lost to Follow-up|2|||
27635980|NCT02512965|80509644|FG000|Overall Study|Withdrawal by Subject|0|||
27635981|NCT02512965|80509645|FG001|Overall Study|Withdrawal by Subject|4|||
27635982|NCT02423291|80509648|FG000|Overall Study|Lack of Efficacy|14|||
27635983|NCT02423291|80509648|FG000|Overall Study|Adverse Event|1|||
27635984|NCT00841035|80509649|FG000|Phase 1 Overall Study|Physician Decision|13|||
27635985|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
27635986|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
27635987|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
27635988|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
27635989|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
27635990|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
27635991|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
27635992|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
27635993|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
27635994|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
27635995|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
27635996|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
27919824|NCT02966834|81543710|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
27919825|NCT02966834|81543711|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
27541041|NCT01233258|80171798|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
27541042|NCT01233258|80171799|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
27541043|NCT01233258|80171800|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
27541044|NCT01233258|80171795|FG000|First Intervention (6 Months)|Protocol Violation|0|||
27635997|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
27635998|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
27635999|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
27541045|NCT01233258|80171796|FG001|First Intervention (6 Months)|Protocol Violation|0|||
27919826|NCT02966834|81543712|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
27919827|NCT02966834|81543713|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
27919828|NCT02966834|81543708|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
27919829|NCT02966834|81543709|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27919830|NCT02966834|81543710|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27919831|NCT02966834|81543711|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27919832|NCT02966834|81543712|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27541046|NCT01233258|80171797|FG002|First Intervention (6 Months)|Protocol Violation|1|||
27541047|NCT01233258|80171798|FG003|First Intervention (6 Months)|Protocol Violation|0|||
27541048|NCT01233258|80171799|FG004|First Intervention (6 Months)|Protocol Violation|0|||
27541049|NCT01233258|80171800|FG005|First Intervention (6 Months)|Protocol Violation|0|||
27541050|NCT01233258|80171795|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
27541051|NCT01233258|80171796|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
27541052|NCT01233258|80171797|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
27541053|NCT01233258|80171798|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
27541054|NCT01233258|80171799|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
27541055|NCT01233258|80171800|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
27541056|NCT03719586|80171801|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
27541057|NCT03719586|80171802|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
27541058|NCT03719586|80171803|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
27541059|NCT03719586|80171804|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
27541060|NCT05213481|80171808|FG000|Overall Study|Adverse Event|3|||
27541061|NCT05213481|80171808|FG000|Overall Study|Lost to Follow-up|1|||
27541062|NCT00434954|80171813|FG000|Overall Study|Adverse Event|17|||
27541063|NCT00434954|80171814|FG001|Overall Study|Adverse Event|2|||
27541064|NCT00434954|80171813|FG000|Overall Study|Entry criteria not met|14|||
27740896|NCT03976401|80880761|FG005|Overall Study|Lost to Follow-up|0|||
27740897|NCT03976401|80880756|FG000|Overall Study|Protocol Violation|0|||
27919833|NCT02966834|81543713|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27919834|NCT02966834|81543708|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
27919835|NCT02966834|81543709|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
27919836|NCT02966834|81543710|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
27919837|NCT02966834|81543711|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
27919838|NCT02966834|81543712|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
27919839|NCT02966834|81543713|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
27919840|NCT02966834|81543708|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
27919841|NCT02966834|81543709|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
27919842|NCT02966834|81543710|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
27919843|NCT02966834|81543711|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
27919844|NCT02966834|81543712|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
27919845|NCT02966834|81543713|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
27919846|NCT02966834|81543708|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27919847|NCT02966834|81543709|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27919848|NCT02966834|81543710|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27919849|NCT02966834|81543711|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
27919850|NCT02966834|81543712|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27919851|NCT02966834|81543713|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
27919852|NCT02966834|81543708|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
27919853|NCT02966834|81543709|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
27919854|NCT02966834|81543710|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
27919855|NCT02966834|81543711|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
27919856|NCT02966834|81543712|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
27919857|NCT02966834|81543713|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
27919858|NCT01255163|81543714|FG000|Overall Study|Withdrawal by Subject|1|||
27919859|NCT01255163|81543715|FG001|Overall Study|Withdrawal by Subject|0|||
27919860|NCT01255163|81543714|FG000|Overall Study|Lost to Follow-up|2|||
27919861|NCT01255163|81543715|FG001|Overall Study|Lost to Follow-up|0|||
27919862|NCT01255163|81543714|FG000|Overall Study|Adverse Event|0|||
27919863|NCT01255163|81543715|FG001|Overall Study|Adverse Event|2|||
27919864|NCT01255163|81543714|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
27919865|NCT01255163|81543715|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
27919866|NCT03167242|81543716|FG000|Overall Study|Patient/Guardian Decision|0|||
27919867|NCT03167242|81543717|FG001|Overall Study|Patient/Guardian Decision|1|||
27740898|NCT03976401|80880757|FG001|Overall Study|Protocol Violation|1|||
27740899|NCT03976401|80880758|FG002|Overall Study|Protocol Violation|0|||
27636000|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
27636001|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
27636002|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
27636003|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
27636004|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
27636005|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
27636006|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
27636007|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
27636008|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
27636009|NCT01061151|80509650|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
27636010|NCT01061151|80509651|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
27636011|NCT01061151|80509652|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
27636012|NCT01061151|80509653|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
27636013|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
27636014|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
27636015|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
27636016|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
27636017|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
27636018|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
27636019|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
27636020|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
27636021|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
27636022|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
27636023|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
27636024|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
27636025|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
27636026|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
27919868|NCT03167242|81543718|FG002|Overall Study|Patient/Guardian Decision|2|||
27636027|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
27636028|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
27636029|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
27919869|NCT03167242|81543719|FG003|Overall Study|Patient/Guardian Decision|1|||
27919870|NCT03167242|81543720|FG004|Overall Study|Patient/Guardian Decision|1|||
27919871|NCT03167242|81543721|FG005|Overall Study|Patient/Guardian Decision|1|||
27919872|NCT03167242|81543722|FG006|Overall Study|Patient/Guardian Decision|0|||
27919873|NCT03167242|81543723|FG007|Overall Study|Patient/Guardian Decision|0|||
27919874|NCT03167242|81543724|FG008|Overall Study|Patient/Guardian Decision|0|||
27919875|NCT03167242|81543725|FG009|Overall Study|Patient/Guardian Decision|0|||
27919876|NCT03167242|81543726|FG010|Overall Study|Patient/Guardian Decision|1|||
27919877|NCT03167242|81543727|FG011|Overall Study|Patient/Guardian Decision|0|||
27919878|NCT03167242|81543716|FG000|Overall Study|Lost to Follow-up|0|||
27919879|NCT03167242|81543717|FG001|Overall Study|Lost to Follow-up|0|||
27919880|NCT03167242|81543718|FG002|Overall Study|Lost to Follow-up|1|||
27919881|NCT03167242|81543719|FG003|Overall Study|Lost to Follow-up|0|||
27919882|NCT03167242|81543720|FG004|Overall Study|Lost to Follow-up|0|||
27919883|NCT03167242|81543721|FG005|Overall Study|Lost to Follow-up|1|||
27919884|NCT03167242|81543722|FG006|Overall Study|Lost to Follow-up|2|||
27919885|NCT03167242|81543723|FG007|Overall Study|Lost to Follow-up|1|||
27919886|NCT03167242|81543724|FG008|Overall Study|Lost to Follow-up|0|||
27919887|NCT03167242|81543725|FG009|Overall Study|Lost to Follow-up|0|||
27919888|NCT03167242|81543726|FG010|Overall Study|Lost to Follow-up|1|||
27919889|NCT03167242|81543727|FG011|Overall Study|Lost to Follow-up|1|||
27919890|NCT03167242|81543716|FG000|Overall Study|Reason not provided|0|||
27919891|NCT03167242|81543717|FG001|Overall Study|Reason not provided|0|||
27919892|NCT03167242|81543718|FG002|Overall Study|Reason not provided|0|||
27919893|NCT03167242|81543719|FG003|Overall Study|Reason not provided|0|||
27919894|NCT03167242|81543720|FG004|Overall Study|Reason not provided|0|||
27919895|NCT03167242|81543721|FG005|Overall Study|Reason not provided|0|||
27919896|NCT03167242|81543722|FG006|Overall Study|Reason not provided|0|||
27919897|NCT03167242|81543723|FG007|Overall Study|Reason not provided|0|||
27919898|NCT03167242|81543724|FG008|Overall Study|Reason not provided|1|||
27919899|NCT03167242|81543725|FG009|Overall Study|Reason not provided|0|||
27919900|NCT03167242|81543726|FG010|Overall Study|Reason not provided|0|||
27919901|NCT03167242|81543727|FG011|Overall Study|Reason not provided|0|||
27919902|NCT02683109|81543728|FG000|Overall Study|Adverse Event|1|||
27919903|NCT02683109|81543729|FG001|Overall Study|Adverse Event|0|||
27919904|NCT01674725|81543731|FG000|Overall Study|Adverse Event|1|||
27636030|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
27919905|NCT01674725|81543732|FG001|Overall Study|Adverse Event|0|||
27919906|NCT01674725|81543731|FG000|Overall Study|Did not receive study drug|1|||
27919907|NCT01674725|81543732|FG001|Overall Study|Did not receive study drug|0|||
27919908|NCT01674725|81543731|FG000|Overall Study|Withdrawal by Subject|1|||
27919909|NCT01674725|81543732|FG001|Overall Study|Withdrawal by Subject|0|||
27919910|NCT01674725|81543731|FG000|Overall Study|Lost to Follow-up|0|||
27919911|NCT01674725|81543732|FG001|Overall Study|Lost to Follow-up|1|||
27919912|NCT01723072|81543734|FG000|Overall Study|Withdrawal by Subject|7|||
27919913|NCT01723072|81543735|FG001|Overall Study|Withdrawal by Subject|13|||
27740900|NCT03976401|80880759|FG003|Overall Study|Protocol Violation|0|||
27740901|NCT03976401|80880760|FG004|Overall Study|Protocol Violation|0|||
27919914|NCT01723072|81543734|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
27919915|NCT01723072|81543735|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
27919916|NCT01723072|81543734|FG000|Overall Study|Other|4|||
27919917|NCT01723072|81543735|FG001|Overall Study|Other|3|||
27919918|NCT01035138|81543737|FG000|Overall Study|Adverse Event|4|||
27919919|NCT01035138|81543738|FG001|Overall Study|Adverse Event|0|||
27919920|NCT01035138|81543739|FG002|Overall Study|Adverse Event|2|||
27919921|NCT01035138|81543737|FG000|Overall Study|Caregiver Decision|2|||
27919922|NCT01035138|81543738|FG001|Overall Study|Caregiver Decision|0|||
27919923|NCT01035138|81543739|FG002|Overall Study|Caregiver Decision|1|||
27740902|NCT03976401|80880761|FG005|Overall Study|Protocol Violation|0|||
27740903|NCT03976401|80880756|FG000|Overall Study|Withdrew Consent|0|||
27740904|NCT03976401|80880757|FG001|Overall Study|Withdrew Consent|0|||
27740905|NCT03976401|80880758|FG002|Overall Study|Withdrew Consent|0|||
27740906|NCT03976401|80880759|FG003|Overall Study|Withdrew Consent|1|||
27740907|NCT03976401|80880760|FG004|Overall Study|Withdrew Consent|0|||
27740908|NCT03976401|80880761|FG005|Overall Study|Withdrew Consent|0|||
27740909|NCT00673673|80880762|FG000|Overall Study|Progressive disease|27|||
27740910|NCT00673673|80880762|FG000|Overall Study|Adverse Event|4|||
27740911|NCT00673673|80880762|FG000|Overall Study|Withdrawal by Subject|3|||
27740912|NCT00673673|80880762|FG000|Overall Study|Investigators' discretion|2|||
27740913|NCT00443560|80880763|FG000|Overall Study|No intrathecal dose|58|||
27740914|NCT00443560|80880764|FG001|Overall Study|No intrathecal dose|26|||
27740915|NCT00443560|80880763|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
27740916|NCT00443560|80880764|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
27740917|NCT01736683|80880768|FG000|Overall Study|Disease Relapse|0|||
27636031|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
27636032|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
27636033|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
27636034|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
27636035|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
27636036|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
27636037|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
27636038|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
27636039|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
27636040|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
27636041|NCT01061151|80509650|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
27636042|NCT01061151|80509651|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
27636043|NCT01061151|80509652|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
27636044|NCT01061151|80509653|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
27636045|NCT00507689|80509654|FG000|Pre-Randomization Period|Adverse Event|1|||
27636046|NCT00507689|80509655|FG001|Pre-Randomization Period|Adverse Event|0|||
27636047|NCT00507689|80509654|FG000|Pre-Randomization Period|Physician Decision|1|||
27636048|NCT00507689|80509655|FG001|Pre-Randomization Period|Physician Decision|0|||
27636049|NCT00507689|80509654|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
27636050|NCT00507689|80509655|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
27636051|NCT00507689|80509654|FG000|Randomized Period|Adverse Event|1|||
27636052|NCT00507689|80509655|FG001|Randomized Period|Adverse Event|1|||
27636053|NCT00507689|80509654|FG000|Randomized Period|Withdrawal by Subject|0|||
27636054|NCT00507689|80509655|FG001|Randomized Period|Withdrawal by Subject|1|||
27636055|NCT00869323|80509656|FG000|Maintenance Therapy|concurrent illness|1|||
27636056|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
27740918|NCT01736683|80880769|FG001|Overall Study|Disease Relapse|0|||
27740919|NCT01736683|80880770|FG002|Overall Study|Disease Relapse|2|||
27740920|NCT01736683|80880771|FG003|Overall Study|Disease Relapse|1|||
27919924|NCT01035138|81543737|FG000|Overall Study|Withdrawal by Subject|1|||
27541065|NCT00434954|80171814|FG001|Overall Study|Entry criteria not met|16|||
27541066|NCT00434954|80171813|FG000|Overall Study|Lost to Follow-up|0|||
27541067|NCT00434954|80171814|FG001|Overall Study|Lost to Follow-up|1|||
27740921|NCT01736683|80880772|FG004|Overall Study|Disease Relapse|0|||
27541068|NCT00434954|80171813|FG000|Overall Study|Physician Decision|6|||
27541069|NCT00434954|80171814|FG001|Overall Study|Physician Decision|3|||
27740922|NCT01736683|80880768|FG000|Overall Study|Adverse Event|0|||
27919925|NCT01035138|81543738|FG001|Overall Study|Withdrawal by Subject|0|||
27919926|NCT01035138|81543739|FG002|Overall Study|Withdrawal by Subject|0|||
27636057|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
27919927|NCT01035138|81543737|FG000|Overall Study|Physician Decision|0|||
27919928|NCT01035138|81543738|FG001|Overall Study|Physician Decision|0|||
27919929|NCT01035138|81543739|FG002|Overall Study|Physician Decision|1|||
27919930|NCT01035138|81543737|FG000|Overall Study|Sponsor Decision|66|||
27919931|NCT01035138|81543738|FG001|Overall Study|Sponsor Decision|60|||
27919932|NCT01035138|81543739|FG002|Overall Study|Sponsor Decision|42|||
27919933|NCT01035138|81543737|FG000|Overall Study|Lost to Follow-up|0|||
27919934|NCT01035138|81543738|FG001|Overall Study|Lost to Follow-up|0|||
27919935|NCT01035138|81543739|FG002|Overall Study|Lost to Follow-up|1|||
27919936|NCT02659943|81543757|FG000|Overall Study|Switched to alternative treatment|1|||
27919937|NCT02659943|81543758|FG001|Overall Study|Switched to alternative treatment|1|||
27919938|NCT02659943|81543759|FG002|Overall Study|Switched to alternative treatment|0|||
27919939|NCT02659943|81543760|FG003|Overall Study|Switched to alternative treatment|2|||
27919940|NCT02659943|81543761|FG004|Overall Study|Switched to alternative treatment|1|||
27919941|NCT02659943|81543762|FG005|Overall Study|Switched to alternative treatment|0|||
27919942|NCT02659943|81543763|FG006|Overall Study|Switched to alternative treatment|1|||
27919943|NCT02659943|81543757|FG000|Overall Study|Disease progression on study|0|||
27919944|NCT02659943|81543758|FG001|Overall Study|Disease progression on study|1|||
27919945|NCT02659943|81543759|FG002|Overall Study|Disease progression on study|1|||
27919946|NCT02659943|81543760|FG003|Overall Study|Disease progression on study|1|||
27919947|NCT02659943|81543761|FG004|Overall Study|Disease progression on study|1|||
27919948|NCT02659943|81543762|FG005|Overall Study|Disease progression on study|4|||
27919949|NCT02659943|81543763|FG006|Overall Study|Disease progression on study|0|||
27919950|NCT02659943|81543757|FG000|Overall Study|Patient's condition per principal investigator|0|||
27919951|NCT02659943|81543758|FG001|Overall Study|Patient's condition per principal investigator|0|||
27919952|NCT02659943|81543759|FG002|Overall Study|Patient's condition per principal investigator|0|||
27919953|NCT02659943|81543760|FG003|Overall Study|Patient's condition per principal investigator|0|||
27919954|NCT02659943|81543761|FG004|Overall Study|Patient's condition per principal investigator|0|||
27919955|NCT02659943|81543762|FG005|Overall Study|Patient's condition per principal investigator|1|||
27919956|NCT02659943|81543763|FG006|Overall Study|Patient's condition per principal investigator|0|||
27919957|NCT02659943|81543757|FG000|Overall Study|Ineligible|0|||
27919958|NCT02659943|81543758|FG001|Overall Study|Ineligible|0|||
27919959|NCT02659943|81543759|FG002|Overall Study|Ineligible|0|||
27919960|NCT02659943|81543760|FG003|Overall Study|Ineligible|0|||
27919961|NCT02659943|81543761|FG004|Overall Study|Ineligible|0|||
27919962|NCT02659943|81543762|FG005|Overall Study|Ineligible|0|||
27919963|NCT02659943|81543763|FG006|Overall Study|Ineligible|1|||
27919964|NCT02659943|81543757|FG000|Overall Study|No longer meets eligibility|0|||
27919965|NCT02659943|81543758|FG001|Overall Study|No longer meets eligibility|0|||
27919966|NCT02659943|81543759|FG002|Overall Study|No longer meets eligibility|0|||
27919967|NCT02659943|81543760|FG003|Overall Study|No longer meets eligibility|0|||
27919968|NCT02659943|81543761|FG004|Overall Study|No longer meets eligibility|0|||
27919969|NCT02659943|81543762|FG005|Overall Study|No longer meets eligibility|0|||
27919970|NCT02659943|81543763|FG006|Overall Study|No longer meets eligibility|1|||
27919971|NCT02659943|81543757|FG000|Overall Study|No treatment, per protocol|0|||
27919972|NCT02659943|81543758|FG001|Overall Study|No treatment, per protocol|0|||
27919973|NCT02659943|81543759|FG002|Overall Study|No treatment, per protocol|0|||
27919974|NCT02659943|81543760|FG003|Overall Study|No treatment, per protocol|0|||
27919975|NCT02659943|81543761|FG004|Overall Study|No treatment, per protocol|0|||
27919976|NCT02659943|81543762|FG005|Overall Study|No treatment, per protocol|0|||
27919977|NCT02659943|81543763|FG006|Overall Study|No treatment, per protocol|3|||
27919978|NCT00843492|81543766|FG000|Overall Study|Adverse Event|0|||
27919979|NCT00843492|81543767|FG001|Overall Study|Adverse Event|3|||
27919980|NCT00843492|81543766|FG000|Overall Study|Lost to Follow-up|4|||
27919981|NCT00843492|81543767|FG001|Overall Study|Lost to Follow-up|4|||
27919982|NCT00843492|81543766|FG000|Overall Study|Withdrawal by Subject|0|||
27919983|NCT00843492|81543767|FG001|Overall Study|Withdrawal by Subject|4|||
27919984|NCT00843492|81543766|FG000|Overall Study|Immobilization Stopped|1|||
27919985|NCT00843492|81543767|FG001|Overall Study|Immobilization Stopped|0|||
27919986|NCT00843492|81543766|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
27919987|NCT00843492|81543767|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
27919988|NCT00843492|81543766|FG000|Overall Study|Orthopedic Surgery|0|||
27919989|NCT00843492|81543767|FG001|Overall Study|Orthopedic Surgery|2|||
27919990|NCT00843492|81543766|FG000|Overall Study|Visit Not Performed|1|||
27919991|NCT00843492|81543767|FG001|Overall Study|Visit Not Performed|0|||
27919992|NCT00843492|81543766|FG000|Overall Study|Deep-vein Thrombosis|1|||
27919993|NCT00843492|81543767|FG001|Overall Study|Deep-vein Thrombosis|0|||
27919994|NCT02452047|81543769|FG000|Overall Study|Adverse Event|0|||
27919995|NCT02452047|81543770|FG001|Overall Study|Adverse Event|1|||
27541070|NCT00434954|80171813|FG000|Overall Study|Protocol Violation|36|||
27740923|NCT01736683|80880769|FG001|Overall Study|Adverse Event|2|||
27919996|NCT02452047|81543771|FG002|Overall Study|Adverse Event|1|||
27541071|NCT00434954|80171814|FG001|Overall Study|Protocol Violation|27|||
27740924|NCT01736683|80880770|FG002|Overall Study|Adverse Event|2|||
27919997|NCT02452047|81543769|FG000|Overall Study|Death|1|||
27919998|NCT02452047|81543770|FG001|Overall Study|Death|3|||
27919999|NCT02452047|81543771|FG002|Overall Study|Death|1|||
27920000|NCT02452047|81543769|FG000|Overall Study|Physician Decision|1|||
27920001|NCT02452047|81543770|FG001|Overall Study|Physician Decision|0|||
27920002|NCT02452047|81543771|FG002|Overall Study|Physician Decision|0|||
27920003|NCT02452047|81543769|FG000|Overall Study|Lost to Follow-up|1|||
27920004|NCT02452047|81543770|FG001|Overall Study|Lost to Follow-up|1|||
27920005|NCT02452047|81543771|FG002|Overall Study|Lost to Follow-up|0|||
27920006|NCT02452047|81543769|FG000|Overall Study|Withdrawal by Subject|1|||
27920007|NCT02452047|81543770|FG001|Overall Study|Withdrawal by Subject|0|||
27920008|NCT02452047|81543771|FG002|Overall Study|Withdrawal by Subject|0|||
27920009|NCT00336544|81543772|FG000|Overall Study|Lack of Efficacy|8|||
27920010|NCT00336544|81543773|FG001|Overall Study|Lack of Efficacy|5|||
27920011|NCT00336544|81543772|FG000|Overall Study|Adverse Event|4|||
27920012|NCT00336544|81543773|FG001|Overall Study|Adverse Event|9|||
27920013|NCT00336544|81543772|FG000|Overall Study|Withdrawal by Subject|4|||
27920014|NCT00336544|81543773|FG001|Overall Study|Withdrawal by Subject|3|||
27920015|NCT00336544|81543772|FG000|Overall Study|Other|3|||
27920016|NCT00336544|81543773|FG001|Overall Study|Other|5|||
27920017|NCT04456686|81543774|FG000|Overall Study|Adverse Event|2|||
27920018|NCT04456686|81543775|FG001|Overall Study|Adverse Event|1|||
27636058|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
27636059|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
27636060|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
27636061|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
27636062|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
27636063|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
27636064|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
27636065|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
27636066|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
27636067|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
27636068|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
27636069|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
27636070|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
27636071|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
27636072|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
27636073|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
27636074|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
27636075|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
27636076|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
27636077|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
27636078|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
27636079|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
27636080|NCT00311363|80509658|FG000|24-Week Single-Blind Treatment Period|Death|1|||
27636081|NCT00311363|80509659|FG001|24-Week Single-Blind Treatment Period|Death|0|||
27636082|NCT00311363|80509660|FG002|24-Week Single-Blind Treatment Period|Death|0|||
27636083|NCT00311363|80509658|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
27636084|NCT00311363|80509659|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
27636085|NCT00311363|80509660|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
27636086|NCT00311363|80509658|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
27636087|NCT00311363|80509659|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
27636088|NCT00311363|80509660|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
27636089|NCT00311363|80509658|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
27636090|NCT00311363|80509659|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
27636091|NCT00311363|80509660|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
27636092|NCT00311363|80509658|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
27636093|NCT00311363|80509659|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
27636094|NCT00311363|80509660|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
27636095|NCT00311363|80509658|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
27636096|NCT00311363|80509659|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
27636097|NCT00311363|80509660|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
27636098|NCT00311363|80509658|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
27636099|NCT00311363|80509659|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
27636100|NCT00311363|80509660|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
27636101|NCT02192606|80509665|FG000|Overall Study|surgery type was changed|1|||
27636102|NCT02192606|80509666|FG001|Overall Study|surgery type was changed|1|||
27740925|NCT01736683|80880771|FG003|Overall Study|Adverse Event|3|||
27740926|NCT01736683|80880772|FG004|Overall Study|Adverse Event|2|||
27920019|NCT04456686|81543774|FG000|Overall Study|Lack of Efficacy|3|||
27920020|NCT04456686|81543775|FG001|Overall Study|Lack of Efficacy|1|||
27920021|NCT04456686|81543774|FG000|Overall Study|Withdrew consent|3|||
27636103|NCT02192606|80509665|FG000|Overall Study|Physician Decision|1|||
27636104|NCT02192606|80509666|FG001|Overall Study|Physician Decision|2|||
27636105|NCT02192606|80509665|FG000|Overall Study|3D equipment rep unable to join|0|||
27636106|NCT02192606|80509666|FG001|Overall Study|3D equipment rep unable to join|1|||
27636107|NCT03830866|80509670|FG000|Overall Study|Death|90|||
27636108|NCT03830866|80509671|FG001|Overall Study|Death|111|||
27636109|NCT03830866|80509670|FG000|Overall Study|Lost to Follow-up|7|||
27636110|NCT03830866|80509671|FG001|Overall Study|Lost to Follow-up|7|||
27636111|NCT03830866|80509670|FG000|Overall Study|Withdrawal by Subject|19|||
27636112|NCT03830866|80509671|FG001|Overall Study|Withdrawal by Subject|16|||
27636113|NCT03830866|80509670|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
27636114|NCT03830866|80509671|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
27636115|NCT03830866|80509670|FG000|Overall Study|Other|1|||
27636116|NCT03830866|80509671|FG001|Overall Study|Other|1|||
27636117|NCT03520413|80509672|FG000|Overall Study|Lost to Follow-up|1|||
27636118|NCT03520413|80509673|FG001|Overall Study|Lost to Follow-up|1|||
27636119|NCT03520413|80509672|FG000|Overall Study|Withdrawal by Subject|1|||
27636120|NCT03520413|80509673|FG001|Overall Study|Withdrawal by Subject|2|||
27636121|NCT03520413|80509672|FG000|Overall Study|Death|0|||
27636122|NCT03520413|80509673|FG001|Overall Study|Death|1|||
27636123|NCT03520413|80509672|FG000|Overall Study|Physician Decision|3|||
27636124|NCT03520413|80509673|FG001|Overall Study|Physician Decision|3|||
27636125|NCT03520413|80509672|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
27636126|NCT03520413|80509673|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
27636127|NCT00638963|80509674|FG000|Overall Study|Withdrawal by Subject|1|||
27636128|NCT00638963|80509675|FG001|Overall Study|Withdrawal by Subject|0|||
27636129|NCT03062358|80509676|FG000|Overall Study|Death|220|||
27636130|NCT03062358|80509677|FG001|Overall Study|Death|127|||
27636131|NCT03062358|80509676|FG000|Overall Study|Withdrawal by Subject|2|||
27636132|NCT03062358|80509677|FG001|Overall Study|Withdrawal by Subject|1|||
27636133|NCT03062358|80509676|FG000|Overall Study|Ongoing in Trial|78|||
27636134|NCT03062358|80509677|FG001|Overall Study|Ongoing in Trial|25|||
27636135|NCT02880241|80509678|FG000|Overall Study|Lack of Efficacy|1|||
27636136|NCT02880241|80509679|FG001|Overall Study|Lack of Efficacy|0|||
27636137|NCT02880241|80509680|FG002|Overall Study|Lack of Efficacy|0|||
27636138|NCT02880241|80509681|FG003|Overall Study|Lack of Efficacy|0|||
27636139|NCT02880241|80509682|FG004|Overall Study|Lack of Efficacy|0|||
27636140|NCT02880241|80509683|FG005|Overall Study|Lack of Efficacy|0|||
27636141|NCT00661778|80509689|FG000|Overall Study|Disease Progression|23|||
27636142|NCT00661778|80509689|FG000|Overall Study|Adverse Event|18|||
27636143|NCT00661778|80509689|FG000|Overall Study|Reason not Specified|6|||
27636144|NCT00661778|80509689|FG000|Overall Study|Protocol Violation|2|||
27636145|NCT00661778|80509689|FG000|Overall Study|Withdrawal of Consent|1|||
27636146|NCT00980330|80509692|FG000|Overall Study|Adverse Event|0|||
27636147|NCT00980330|80509693|FG001|Overall Study|Adverse Event|0|||
27636148|NCT00980330|80509694|FG002|Overall Study|Adverse Event|0|||
27636149|NCT00980330|80509695|FG003|Overall Study|Adverse Event|1|||
27636150|NCT00980330|80509696|FG004|Overall Study|Adverse Event|0|||
27636151|NCT00980330|80509697|FG005|Overall Study|Adverse Event|0|||
27636152|NCT00980330|80509698|FG006|Overall Study|Adverse Event|0|||
27636153|NCT00980330|80509692|FG000|Overall Study|Lost to Follow-up|1|||
27636154|NCT00980330|80509693|FG001|Overall Study|Lost to Follow-up|1|||
27636155|NCT00980330|80509694|FG002|Overall Study|Lost to Follow-up|4|||
27636156|NCT00980330|80509695|FG003|Overall Study|Lost to Follow-up|2|||
27636157|NCT00980330|80509696|FG004|Overall Study|Lost to Follow-up|1|||
27636158|NCT00980330|80509697|FG005|Overall Study|Lost to Follow-up|1|||
27636159|NCT00980330|80509698|FG006|Overall Study|Lost to Follow-up|2|||
27636160|NCT00980330|80509692|FG000|Overall Study|Withdrawal by Subject|2|||
27636161|NCT00980330|80509693|FG001|Overall Study|Withdrawal by Subject|4|||
27636162|NCT00980330|80509694|FG002|Overall Study|Withdrawal by Subject|4|||
27636163|NCT00980330|80509695|FG003|Overall Study|Withdrawal by Subject|1|||
27636164|NCT00980330|80509696|FG004|Overall Study|Withdrawal by Subject|3|||
27636165|NCT00980330|80509697|FG005|Overall Study|Withdrawal by Subject|2|||
27636166|NCT00980330|80509698|FG006|Overall Study|Withdrawal by Subject|5|||
27636167|NCT00980330|80509692|FG000|Overall Study|(not specified)|2|||
27920022|NCT04456686|81543775|FG001|Overall Study|Withdrew consent|1|||
27636168|NCT00980330|80509693|FG001|Overall Study|(not specified)|0|||
27636169|NCT00980330|80509694|FG002|Overall Study|(not specified)|0|||
27636170|NCT00980330|80509695|FG003|Overall Study|(not specified)|1|||
27636171|NCT00980330|80509696|FG004|Overall Study|(not specified)|1|||
27636172|NCT00980330|80509697|FG005|Overall Study|(not specified)|1|||
27636173|NCT00980330|80509698|FG006|Overall Study|(not specified)|0|||
27636174|NCT04305405|80509699|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27636175|NCT04305405|80509700|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27636176|NCT01538719|80509701|FG000|Overall Study|Lost to Follow-up|2|||
27636177|NCT01538719|80509702|FG001|Overall Study|Lost to Follow-up|0|||
27636178|NCT01041417|80509703|FG000|Overall Study|Adverse Event|5|||
27636179|NCT01041417|80509704|FG001|Overall Study|Adverse Event|2|||
27920023|NCT04456686|81543774|FG000|Overall Study|Physician Decision|2|||
27920024|NCT04456686|81543775|FG001|Overall Study|Physician Decision|2|||
27920025|NCT04456686|81543774|FG000|Overall Study|Withdrawal by Subject|5|||
27920026|NCT04456686|81543775|FG001|Overall Study|Withdrawal by Subject|1|||
27920027|NCT04456686|81543774|FG000|Overall Study|Protocol Violation|0|||
27920028|NCT04456686|81543775|FG001|Overall Study|Protocol Violation|1|||
27920029|NCT00094445|81543778|FG000|Overall Study|Withdrawal by Subject|3|||
27920030|NCT00094445|81543778|FG000|Overall Study|Lost to Follow-up|1|||
27920031|NCT00094445|81543778|FG000|Overall Study|Progressive Disease|2|||
27920032|NCT00869960|81543779|FG000|Overall Study|Lost to Follow-up|2|||
27920033|NCT00266708|81543780|FG000|Overall Study|No renal function|1|||
27920034|NCT00266708|81543781|FG001|Overall Study|No renal function|1|||
27920035|NCT00266708|81543780|FG000|Overall Study|Refused biopsy|3|||
27920036|NCT00266708|81543781|FG001|Overall Study|Refused biopsy|6|||
27920037|NCT00266708|81543780|FG000|Overall Study|Asthma|0|||
27920038|NCT00266708|81543781|FG001|Overall Study|Asthma|2|||
27920039|NCT01787552|81543782|FG000|Overall Study|Withdrawal by Subject|2|||
27920040|NCT01787552|81543783|FG001|Overall Study|Withdrawal by Subject|0|||
27920041|NCT01787552|81543784|FG002|Overall Study|Withdrawal by Subject|0|||
27541072|NCT00434954|80171813|FG000|Overall Study|Sponsor decision|1|||
27541073|NCT00434954|80171814|FG001|Overall Study|Sponsor decision|0|||
27541074|NCT00434954|80171813|FG000|Overall Study|Subject decision|8|||
27541075|NCT00434954|80171814|FG001|Overall Study|Subject decision|22|||
27541076|NCT02728596|80171821|FG000|Overall Study|Refusal unrelated to adverse event|3|||
27541077|NCT02728596|80171822|FG001|Overall Study|Refusal unrelated to adverse event|6|||
27541078|NCT02728596|80171823|FG002|Overall Study|Refusal unrelated to adverse event|7|||
27541079|NCT02728596|80171824|FG003|Overall Study|Refusal unrelated to adverse event|7|||
27636180|NCT01041417|80509703|FG000|Overall Study|Lost to Follow-up|1|||
27636181|NCT01041417|80509704|FG001|Overall Study|Lost to Follow-up|1|||
27636182|NCT01041417|80509703|FG000|Overall Study|Death|1|||
27636183|NCT01041417|80509704|FG001|Overall Study|Death|0|||
27636184|NCT02815566|80509705|FG000|Overall Study|Adverse Event|1|||
27636185|NCT02815566|80509706|FG001|Overall Study|Adverse Event|1|||
27636186|NCT02815566|80509705|FG000|Overall Study|Withdrawal by Subject|1|||
27636187|NCT02815566|80509706|FG001|Overall Study|Withdrawal by Subject|0|||
27636188|NCT02815566|80509705|FG000|Overall Study|Lost to Follow-up|0|||
27541080|NCT02728596|80171821|FG000|Overall Study|Death|44|||
27541081|NCT02728596|80171822|FG001|Overall Study|Death|42|||
27541082|NCT02728596|80171823|FG002|Overall Study|Death|123|||
27541083|NCT02728596|80171824|FG003|Overall Study|Death|68|||
27541084|NCT00843856|80171825|FG000|Overall Study|Lost to Follow-up|1|||
27541085|NCT00843856|80171826|FG001|Overall Study|Lost to Follow-up|2|||
27541086|NCT04057365|80171828|FG000|Overall Study|Withdrawal by Subject|2|||
27541087|NCT04057365|80171829|FG001|Overall Study|Withdrawal by Subject|0|||
27541088|NCT00644228|80171830|FG000|Randomization & Eligibility|Ineligible|31|||
27541089|NCT00644228|80171831|FG001|Randomization & Eligibility|Ineligible|21|||
27541090|NCT00644228|80171830|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
27541091|NCT00644228|80171831|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
27541092|NCT00644228|80171830|FG000|Randomization & Eligibility|Invalid Consent|0|||
27541093|NCT00644228|80171831|FG001|Randomization & Eligibility|Invalid Consent|1|||
27541094|NCT00644228|80171830|FG000|Induction Therapy|Adverse Event|22|||
27541095|NCT00644228|80171831|FG001|Induction Therapy|Adverse Event|55|||
27541096|NCT00644228|80171830|FG000|Induction Therapy|Withdrawal by Subject|10|||
27541097|NCT00644228|80171831|FG001|Induction Therapy|Withdrawal by Subject|3|||
27541098|NCT00644228|80171830|FG000|Induction Therapy|Progression/Relapse|24|||
27541099|NCT00644228|80171831|FG001|Induction Therapy|Progression/Relapse|12|||
27541100|NCT00644228|80171830|FG000|Induction Therapy|Death|3|||
27541101|NCT00644228|80171831|FG001|Induction Therapy|Death|7|||
27541102|NCT00644228|80171830|FG000|Induction Therapy|Not Protocol-Specified|24|||
27541103|NCT00644228|80171831|FG001|Induction Therapy|Not Protocol-Specified|28|||
27920042|NCT01787552|81543785|FG003|Overall Study|Withdrawal by Subject|4|||
27920043|NCT01787552|81543782|FG000|Overall Study|Physician Decision|2|||
27541104|NCT00644228|80171830|FG000|Maintenance|Adverse Event|27|||
27541105|NCT00644228|80171831|FG001|Maintenance|Adverse Event|31|||
27541106|NCT00644228|80171830|FG000|Maintenance|Withdrawal by Subject|6|||
27541107|NCT00644228|80171831|FG001|Maintenance|Withdrawal by Subject|4|||
27541108|NCT00644228|80171830|FG000|Maintenance|Progression/Relapse|67|||
27541109|NCT00644228|80171831|FG001|Maintenance|Progression/Relapse|42|||
27541110|NCT00644228|80171830|FG000|Maintenance|Death|3|||
27541111|NCT00644228|80171831|FG001|Maintenance|Death|3|||
27541112|NCT00644228|80171830|FG000|Maintenance|Not Protocol-Specified|14|||
27541113|NCT00644228|80171831|FG001|Maintenance|Not Protocol-Specified|15|||
27541114|NCT00644228|80171830|FG000|Maintenance|On Treatment|26|||
27636189|NCT02815566|80509706|FG001|Overall Study|Lost to Follow-up|1|||
27636190|NCT00390299|80509709|FG000|Overall Study|Cancellation|1|||
27920044|NCT01787552|81543783|FG001|Overall Study|Physician Decision|2|||
27920045|NCT01787552|81543784|FG002|Overall Study|Physician Decision|1|||
27920046|NCT01787552|81543785|FG003|Overall Study|Physician Decision|2|||
27541115|NCT00644228|80171831|FG001|Maintenance|On Treatment|40|||
27541116|NCT00385762|80171832|FG000|Overall Study|Adverse Event|1|||
27541117|NCT00385762|80171832|FG000|Overall Study|Lost to Follow-up|1|||
27541118|NCT03583697|80171833|FG000|Overall Study|Withdrawal by Subject|0|||
27541119|NCT03583697|80171834|FG001|Overall Study|Withdrawal by Subject|0|||
27541120|NCT03583697|80171835|FG002|Overall Study|Withdrawal by Subject|1|||
27541121|NCT03583697|80171833|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
27541122|NCT03583697|80171834|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
27541123|NCT03583697|80171835|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
27541124|NCT02059408|80171837|FG000|Overall Study|Did not get tested|0|||
27541125|NCT02059408|80171838|FG001|Overall Study|Did not get tested|330|||
27541126|NCT02059408|80171839|FG002|Overall Study|Did not get tested|358|||
27541127|NCT00392015|80171840|FG000|Overall Study|Lost to Follow-up|2|||
27541128|NCT00392015|80171841|FG001|Overall Study|Lost to Follow-up|0|||
27541129|NCT00392015|80171842|FG002|Overall Study|Lost to Follow-up|2|||
27541130|NCT00392015|80171843|FG003|Overall Study|Lost to Follow-up|1|||
27541131|NCT00392015|80171844|FG004|Overall Study|Lost to Follow-up|1|||
27541132|NCT00392015|80171845|FG005|Overall Study|Lost to Follow-up|0|||
27541133|NCT00392015|80171840|FG000|Overall Study|Withdrawal by Subject|0|||
27541134|NCT00392015|80171841|FG001|Overall Study|Withdrawal by Subject|0|||
27541135|NCT00392015|80171842|FG002|Overall Study|Withdrawal by Subject|2|||
27541136|NCT00392015|80171843|FG003|Overall Study|Withdrawal by Subject|0|||
27541137|NCT00392015|80171844|FG004|Overall Study|Withdrawal by Subject|0|||
27541138|NCT00392015|80171845|FG005|Overall Study|Withdrawal by Subject|0|||
27541139|NCT00392015|80171840|FG000|Overall Study|Adverse Event|0|||
27541140|NCT00392015|80171841|FG001|Overall Study|Adverse Event|0|||
27541141|NCT00392015|80171842|FG002|Overall Study|Adverse Event|0|||
27541142|NCT00392015|80171843|FG003|Overall Study|Adverse Event|0|||
27541143|NCT00392015|80171844|FG004|Overall Study|Adverse Event|1|||
27541144|NCT00392015|80171845|FG005|Overall Study|Adverse Event|0|||
27541145|NCT00392015|80171840|FG000|Overall Study|Previous trial recipient|0|||
27541146|NCT00392015|80171841|FG001|Overall Study|Previous trial recipient|0|||
27541147|NCT00392015|80171842|FG002|Overall Study|Previous trial recipient|0|||
27541148|NCT00392015|80171843|FG003|Overall Study|Previous trial recipient|0|||
27541149|NCT00392015|80171844|FG004|Overall Study|Previous trial recipient|1|||
27541150|NCT00392015|80171845|FG005|Overall Study|Previous trial recipient|0|||
27541151|NCT01443078|80171846|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
27541152|NCT01443078|80171846|FG000|Overall Study|Withdrawal by Subject|1|||
27541153|NCT01443078|80171846|FG000|Overall Study|Patient had brain mets|1|||
27541154|NCT00668707|80171850|FG000|Overall Study|Cancer Recurrence|58|||
27541155|NCT00668707|80171851|FG001|Overall Study|Cancer Recurrence|58|||
27541156|NCT00668707|80171850|FG000|Overall Study|Withdrawal by Subject|117|||
27541157|NCT00668707|80171851|FG001|Overall Study|Withdrawal by Subject|100|||
27541158|NCT00668707|80171850|FG000|Overall Study|Lost to Follow-up|3|||
27541159|NCT00668707|80171851|FG001|Overall Study|Lost to Follow-up|6|||
27541160|NCT00668707|80171850|FG000|Overall Study|Protocol Violation|10|||
27541161|NCT00668707|80171851|FG001|Overall Study|Protocol Violation|12|||
27541162|NCT00668707|80171850|FG000|Overall Study|Death|11|||
27541163|NCT00668707|80171851|FG001|Overall Study|Death|4|||
27541164|NCT01393301|80171852|FG000|Overall Study|Lost to Follow-up|5|||
27541165|NCT01393301|80171853|FG001|Overall Study|Lost to Follow-up|3|||
27541166|NCT01393301|80171852|FG000|Overall Study|Withdrawal by Subject|2|||
27541167|NCT01393301|80171853|FG001|Overall Study|Withdrawal by Subject|0|||
27541168|NCT01393301|80171852|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
27541169|NCT01393301|80171853|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
27541170|NCT00615108|80171855|FG000|Overall Study|Adverse Event|122|||
27541171|NCT00615108|80171855|FG000|Overall Study|Other|370|||
27541172|NCT00615108|80171855|FG000|Overall Study|Lost to Follow-up|15|||
27541173|NCT00762229|80171860|FG000|Overall Study|Lost to Follow-up|1|||
27541174|NCT00762229|80171861|FG001|Overall Study|Lost to Follow-up|1|||
27541175|NCT00762229|80171860|FG000|Overall Study|did not recveive intervention|0|||
27541176|NCT00762229|80171861|FG001|Overall Study|did not recveive intervention|1|||
27541177|NCT01602120|80171862|FG000|Overall Study|Adverse Event|3|||
27541178|NCT01602120|80171863|FG001|Overall Study|Adverse Event|6|||
27541179|NCT01602120|80171864|FG002|Overall Study|Adverse Event|0|||
27541180|NCT01602120|80171865|FG003|Overall Study|Adverse Event|2|||
27541181|NCT01602120|80171862|FG000|Overall Study|Death|0|||
27541182|NCT01602120|80171863|FG001|Overall Study|Death|4|||
27541183|NCT01602120|80171864|FG002|Overall Study|Death|0|||
27541184|NCT01602120|80171865|FG003|Overall Study|Death|0|||
27541185|NCT01602120|80171862|FG000|Overall Study|Lost to Follow-up|0|||
27541186|NCT01602120|80171863|FG001|Overall Study|Lost to Follow-up|1|||
27541187|NCT01602120|80171864|FG002|Overall Study|Lost to Follow-up|0|||
27541188|NCT01602120|80171865|FG003|Overall Study|Lost to Follow-up|1|||
27541189|NCT01602120|80171862|FG000|Overall Study|Protocol Violation|1|||
27541190|NCT01602120|80171863|FG001|Overall Study|Protocol Violation|1|||
27541191|NCT01602120|80171864|FG002|Overall Study|Protocol Violation|0|||
27541192|NCT01602120|80171865|FG003|Overall Study|Protocol Violation|0|||
27541193|NCT01602120|80171862|FG000|Overall Study|Non-compliance|0|||
27920047|NCT01787552|81543782|FG000|Overall Study|Death|0|||
27920048|NCT01787552|81543783|FG001|Overall Study|Death|0|||
27920049|NCT01787552|81543784|FG002|Overall Study|Death|0|||
27920050|NCT01787552|81543785|FG003|Overall Study|Death|1|||
27920051|NCT01787552|81543782|FG000|Overall Study|Adverse Event|2|||
27920052|NCT01787552|81543783|FG001|Overall Study|Adverse Event|5|||
27920053|NCT01787552|81543784|FG002|Overall Study|Adverse Event|2|||
27920054|NCT01787552|81543785|FG003|Overall Study|Adverse Event|16|||
27920055|NCT01787552|81543782|FG000|Overall Study|Study terminated by Sponsor|0|||
27920056|NCT01787552|81543783|FG001|Overall Study|Study terminated by Sponsor|0|||
27920057|NCT01787552|81543784|FG002|Overall Study|Study terminated by Sponsor|1|||
27920058|NCT01787552|81543785|FG003|Overall Study|Study terminated by Sponsor|3|||
27920059|NCT01787552|81543782|FG000|Overall Study|Progressive Disease|2|||
27920060|NCT01787552|81543783|FG001|Overall Study|Progressive Disease|2|||
27920061|NCT01787552|81543784|FG002|Overall Study|Progressive Disease|1|||
27920062|NCT01787552|81543785|FG003|Overall Study|Progressive Disease|1|||
27920063|NCT00794664|81543786|FG000|Treatment Period|Withdrawal by Subject|0|||
27920064|NCT00794664|81543787|FG001|Treatment Period|Withdrawal by Subject|2|||
27920065|NCT00794664|81543786|FG000|Treatment Period|Protocol non-compliance|0|||
27920066|NCT00794664|81543787|FG001|Treatment Period|Protocol non-compliance|1|||
27920067|NCT00794664|81543786|FG000|Treatment Period|Other|0|||
27920068|NCT00794664|81543787|FG001|Treatment Period|Other|1|||
27920069|NCT00794664|81543786|FG000|Treatment Period|Adverse Event|1|||
27920070|NCT00794664|81543787|FG001|Treatment Period|Adverse Event|8|||
27920071|NCT00794664|81543786|FG000|Follow-up Period|Other|1|||
27920072|NCT00794664|81543787|FG001|Follow-up Period|Other|2|||
27920073|NCT00794664|81543786|FG000|Follow-up Period|Withdrawal by Subject|0|||
27920074|NCT00794664|81543787|FG001|Follow-up Period|Withdrawal by Subject|2|||
27920075|NCT00794664|81543786|FG000|Follow-up Period|Protocol non-compliance|0|||
27920076|NCT00794664|81543787|FG001|Follow-up Period|Protocol non-compliance|1|||
27920077|NCT01529606|81543788|FG000|Overall Study|Lost to Follow-up|21|||
27920078|NCT01529606|81543789|FG001|Overall Study|Lost to Follow-up|18|||
27920079|NCT03074500|81543790|FG000|Overall Study|Lost to Follow-up|1|||
27920080|NCT03074500|81543791|FG001|Overall Study|Lost to Follow-up|0|||
27920081|NCT03074500|81543792|FG002|Overall Study|Lost to Follow-up|0|||
27920082|NCT03074500|81543790|FG000|Overall Study|Lack of Efficacy|0|||
27920083|NCT03074500|81543791|FG001|Overall Study|Lack of Efficacy|1|||
27920084|NCT03074500|81543792|FG002|Overall Study|Lack of Efficacy|0|||
27920085|NCT03074500|81543790|FG000|Overall Study|Adverse Event|0|||
27920086|NCT03074500|81543791|FG001|Overall Study|Adverse Event|0|||
27920087|NCT03074500|81543792|FG002|Overall Study|Adverse Event|1|||
27920088|NCT00402831|81543793|FG000|Overall Study|Lost to Follow-up|1|||
27920089|NCT00402831|81543794|FG001|Overall Study|Lost to Follow-up|2|||
27920090|NCT00402831|81543793|FG000|Overall Study|Non-compliance with protocol|0|||
27920091|NCT00402831|81543794|FG001|Overall Study|Non-compliance with protocol|1|||
27920092|NCT00827567|81543795|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
27920093|NCT03080935|81543796|FG000|Overall Study|Death|34|||
27920094|NCT03080935|81543797|FG001|Overall Study|Death|50|||
27920095|NCT03080935|81543796|FG000|Overall Study|Lost to Follow-up|5|||
27920096|NCT03080935|81543797|FG001|Overall Study|Lost to Follow-up|4|||
27920097|NCT03080935|81543796|FG000|Overall Study|Withdrawal by Subject|11|||
27920098|NCT03080935|81543797|FG001|Overall Study|Withdrawal by Subject|15|||
27920099|NCT01114724|81543798|FG000|Overall Study|Death|8|||
27920100|NCT01114724|81543798|FG000|Overall Study|Lost to Follow-up|1|||
27920101|NCT01114724|81543798|FG000|Overall Study|Withdrawal by Subject|1|||
27920102|NCT01147822|81543801|FG000|Overall Study|Death|66|||
27920103|NCT01147822|81543802|FG001|Overall Study|Death|59|||
27920104|NCT01147822|81543801|FG000|Overall Study|Protocol Violation|0|||
27920105|NCT01147822|81543802|FG001|Overall Study|Protocol Violation|1|||
27920106|NCT01147822|81543801|FG000|Overall Study|Lost to Follow-up|3|||
27920107|NCT01147822|81543802|FG001|Overall Study|Lost to Follow-up|2|||
27920108|NCT01147822|81543801|FG000|Overall Study|Physician Decision|0|||
27920109|NCT01147822|81543802|FG001|Overall Study|Physician Decision|2|||
27920110|NCT01147822|81543801|FG000|Overall Study|Withdrawal by Subject|8|||
27920111|NCT01147822|81543802|FG001|Overall Study|Withdrawal by Subject|13|||
27920112|NCT01147822|81543801|FG000|Overall Study|Not Completed/Ongoing|111|||
27541194|NCT01602120|80171863|FG001|Overall Study|Non-compliance|3|||
27920113|NCT01147822|81543802|FG001|Overall Study|Not Completed/Ongoing|102|||
27920114|NCT01020123|81543803|FG000|Main Period|Withdrawal by Subject|6|||
27920115|NCT01020123|81543804|FG001|Main Period|Withdrawal by Subject|5|||
27920116|NCT01020123|81543805|FG002|Main Period|Withdrawal by Subject|3|||
27920117|NCT01020123|81543806|FG003|Main Period|Withdrawal by Subject|1|||
27920118|NCT01020123|81543807|FG004|Main Period|Withdrawal by Subject|6|||
27920119|NCT01020123|81543808|FG005|Main Period|Withdrawal by Subject|3|||
27920120|NCT01020123|81543809|FG006|Main Period|Withdrawal by Subject|2|||
27920121|NCT01020123|81543803|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
27920122|NCT01020123|81543804|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
27920123|NCT01020123|81543805|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
27920124|NCT01020123|81543806|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
27541195|NCT01602120|80171864|FG002|Overall Study|Non-compliance|0|||
27541196|NCT01602120|80171865|FG003|Overall Study|Non-compliance|1|||
27541197|NCT01602120|80171862|FG000|Overall Study|Withdrawal by Subject|8|||
27541198|NCT01602120|80171863|FG001|Overall Study|Withdrawal by Subject|17|||
27541199|NCT01602120|80171864|FG002|Overall Study|Withdrawal by Subject|0|||
27541200|NCT01602120|80171865|FG003|Overall Study|Withdrawal by Subject|3|||
27541201|NCT01602120|80171862|FG000|Overall Study|Study Terminated by Sponsor|12|||
27541202|NCT01602120|80171863|FG001|Overall Study|Study Terminated by Sponsor|24|||
27541203|NCT01602120|80171864|FG002|Overall Study|Study Terminated by Sponsor|17|||
27541204|NCT01602120|80171865|FG003|Overall Study|Study Terminated by Sponsor|44|||
27920125|NCT01020123|81543807|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
27920126|NCT01020123|81543808|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
27920127|NCT01020123|81543809|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
27920128|NCT01020123|81543803|FG000|Main Period|Adverse Event|5|||
27920129|NCT01020123|81543804|FG001|Main Period|Adverse Event|2|||
27920130|NCT01020123|81543805|FG002|Main Period|Adverse Event|2|||
27920131|NCT01020123|81543806|FG003|Main Period|Adverse Event|1|||
27920132|NCT01020123|81543807|FG004|Main Period|Adverse Event|1|||
27920133|NCT01020123|81543808|FG005|Main Period|Adverse Event|2|||
27920134|NCT01020123|81543809|FG006|Main Period|Adverse Event|1|||
27920135|NCT01020123|81543803|FG000|Main Period|Protocol Violation|4|||
27920136|NCT01020123|81543804|FG001|Main Period|Protocol Violation|4|||
27920137|NCT01020123|81543805|FG002|Main Period|Protocol Violation|2|||
27920138|NCT01020123|81543806|FG003|Main Period|Protocol Violation|5|||
27920139|NCT01020123|81543807|FG004|Main Period|Protocol Violation|2|||
27920140|NCT01020123|81543808|FG005|Main Period|Protocol Violation|3|||
27920141|NCT01020123|81543809|FG006|Main Period|Protocol Violation|2|||
27920142|NCT01020123|81543803|FG000|Main Period|Lost to Follow-up|0|||
27920143|NCT01020123|81543804|FG001|Main Period|Lost to Follow-up|2|||
27920144|NCT01020123|81543805|FG002|Main Period|Lost to Follow-up|0|||
27920145|NCT01020123|81543806|FG003|Main Period|Lost to Follow-up|0|||
27920146|NCT01020123|81543807|FG004|Main Period|Lost to Follow-up|0|||
27636191|NCT00390299|80509710|FG001|Overall Study|Cancellation|0|||
27636192|NCT00390299|80509711|FG002|Overall Study|Cancellation|0|||
27636193|NCT00390299|80509712|FG003|Overall Study|Cancellation|0|||
27636194|NCT00390299|80509713|FG004|Overall Study|Cancellation|0|||
27636195|NCT03997916|80509714|FG000|Overall Study|Protocol Violation|35|||
27636196|NCT03020745|80509715|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636197|NCT03020745|80509716|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636198|NCT03020745|80509717|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636199|NCT03020745|80509718|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636200|NCT03020745|80509719|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636201|NCT03020745|80509720|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636202|NCT03020745|80509721|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636203|NCT03020745|80509722|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636204|NCT03020745|80509723|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
27636205|NCT03020745|80509724|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
27636206|NCT03020745|80509715|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27636207|NCT03020745|80509716|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27636208|NCT03020745|80509717|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27636209|NCT03020745|80509718|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27740927|NCT01736683|80880768|FG000|Overall Study|Withdrawal by Subject|0|||
27920147|NCT01020123|81543808|FG005|Main Period|Lost to Follow-up|0|||
27920148|NCT01020123|81543809|FG006|Main Period|Lost to Follow-up|0|||
27920149|NCT01020123|81543803|FG000|Main Period|Unclasified|2|||
27920150|NCT01020123|81543804|FG001|Main Period|Unclasified|0|||
27920151|NCT01020123|81543805|FG002|Main Period|Unclasified|1|||
27920152|NCT01020123|81543806|FG003|Main Period|Unclasified|0|||
27920153|NCT01020123|81543807|FG004|Main Period|Unclasified|1|||
27920154|NCT01020123|81543808|FG005|Main Period|Unclasified|3|||
27920155|NCT01020123|81543809|FG006|Main Period|Unclasified|6|||
27920156|NCT01020123|81543803|FG000|Extention Period|Withdrawal by Subject|2|||
27920157|NCT01020123|81543804|FG001|Extention Period|Withdrawal by Subject|1|||
27541205|NCT01602120|80171862|FG000|Overall Study|Physician Decision|2|||
27636210|NCT03020745|80509719|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27920158|NCT01020123|81543805|FG002|Extention Period|Withdrawal by Subject|1|||
27920159|NCT01020123|81543806|FG003|Extention Period|Withdrawal by Subject|0|||
27920160|NCT01020123|81543807|FG004|Extention Period|Withdrawal by Subject|0|||
27541206|NCT01602120|80171863|FG001|Overall Study|Physician Decision|3|||
27636211|NCT03020745|80509720|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27636212|NCT03020745|80509721|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27920161|NCT01020123|81543808|FG005|Extention Period|Withdrawal by Subject|0|||
27920162|NCT01020123|81543809|FG006|Extention Period|Withdrawal by Subject|0|||
27920163|NCT01020123|81543803|FG000|Extention Period|Adverse Event|0|||
27920164|NCT01020123|81543804|FG001|Extention Period|Adverse Event|0|||
27920165|NCT01020123|81543805|FG002|Extention Period|Adverse Event|0|||
27920166|NCT01020123|81543806|FG003|Extention Period|Adverse Event|1|||
27920167|NCT01020123|81543807|FG004|Extention Period|Adverse Event|0|||
27920168|NCT01020123|81543808|FG005|Extention Period|Adverse Event|0|||
27636213|NCT03020745|80509722|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
27636214|NCT03020745|80509723|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27636215|NCT03020745|80509724|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
27636216|NCT03020745|80509715|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636217|NCT03020745|80509716|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636218|NCT03020745|80509717|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636219|NCT03020745|80509718|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636220|NCT03020745|80509719|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636221|NCT03020745|80509720|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
27636222|NCT03020745|80509721|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636223|NCT03020745|80509722|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636224|NCT03020745|80509723|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
27636225|NCT03020745|80509724|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
27636226|NCT03020745|80509715|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636227|NCT03020745|80509716|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636228|NCT03020745|80509717|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636229|NCT03020745|80509718|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636230|NCT03020745|80509719|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636231|NCT03020745|80509720|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636232|NCT03020745|80509721|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636233|NCT03020745|80509722|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636234|NCT03020745|80509723|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
27636235|NCT03020745|80509724|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
27636236|NCT00516386|80509729|FG000|Overall Study|not interested in the study|4|||
27636237|NCT00516386|80509729|FG000|Overall Study|Lost to Follow-up|2|||
27636238|NCT02158091|80509733|FG000|Overall Study|DLT|2|||
27636239|NCT02158091|80509734|FG001|Overall Study|DLT|1|||
27636240|NCT02158091|80509735|FG002|Overall Study|DLT|0|||
27636241|NCT04358549|80509737|FG000|Overall Study|Adverse Event|0|||
27636242|NCT04358549|80509738|FG001|Overall Study|Adverse Event|1|||
27636243|NCT04358549|80509737|FG000|Overall Study|Death|1|||
27636244|NCT04358549|80509738|FG001|Overall Study|Death|0|||
27636245|NCT04358549|80509737|FG000|Overall Study|Lost to Follow-up|2|||
27541207|NCT01602120|80171864|FG002|Overall Study|Physician Decision|0|||
27541208|NCT01602120|80171865|FG003|Overall Study|Physician Decision|0|||
27541209|NCT01602120|80171862|FG000|Overall Study|Unspecified Reason|3|||
27541210|NCT01602120|80171863|FG001|Overall Study|Unspecified Reason|1|||
27541211|NCT01602120|80171864|FG002|Overall Study|Unspecified Reason|0|||
27541212|NCT01602120|80171865|FG003|Overall Study|Unspecified Reason|2|||
27541213|NCT01034631|80171866|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
27541214|NCT01034631|80171867|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
27541215|NCT01034631|80171868|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
27541216|NCT01034631|80171866|FG000|Phase II|Not Evaluable per protocol|0|||
27541217|NCT01034631|80171867|FG001|Phase II|Not Evaluable per protocol|0|||
27541218|NCT01034631|80171868|FG002|Phase II|Not Evaluable per protocol|2|||
27541219|NCT01034631|80171866|FG000|Phase II|Determined Ineligible per protocol|0|||
27541220|NCT01034631|80171867|FG001|Phase II|Determined Ineligible per protocol|1|||
27541221|NCT01034631|80171868|FG002|Phase II|Determined Ineligible per protocol|0|||
27541222|NCT03780543|80171869|FG000|Overall Study|Adverse Event|1|||
27541223|NCT03780543|80171870|FG001|Overall Study|Adverse Event|0|||
27541224|NCT03780543|80171871|FG002|Overall Study|Adverse Event|2|||
27541225|NCT03780543|80171869|FG000|Overall Study|Lost to Follow-up|2|||
27541226|NCT03780543|80171870|FG001|Overall Study|Lost to Follow-up|0|||
27541227|NCT03780543|80171871|FG002|Overall Study|Lost to Follow-up|1|||
27541228|NCT03780543|80171869|FG000|Overall Study|Study terminated by Sponsor|8|||
27541229|NCT03780543|80171870|FG001|Overall Study|Study terminated by Sponsor|7|||
27541230|NCT03780543|80171871|FG002|Overall Study|Study terminated by Sponsor|13|||
27541231|NCT03780543|80171869|FG000|Overall Study|Withdrawal by Subject|1|||
27541232|NCT03780543|80171870|FG001|Overall Study|Withdrawal by Subject|8|||
27541233|NCT03780543|80171871|FG002|Overall Study|Withdrawal by Subject|1|||
27541234|NCT03780543|80171869|FG000|Overall Study|Noncompliance with study drug|1|||
27636246|NCT04358549|80509738|FG001|Overall Study|Lost to Follow-up|1|||
27636247|NCT04358549|80509737|FG000|Overall Study|Withdrawal by Subject|6|||
27636248|NCT04358549|80509738|FG001|Overall Study|Withdrawal by Subject|6|||
27541235|NCT03780543|80171870|FG001|Overall Study|Noncompliance with study drug|0|||
27541236|NCT03780543|80171871|FG002|Overall Study|Noncompliance with study drug|0|||
27541237|NCT02980783|80171872|FG000|Overall Study|Lost to Follow-up|1|||
27636249|NCT04358549|80509737|FG000|Overall Study|Start remdesivir|1|||
27636250|NCT04358549|80509738|FG001|Overall Study|Start remdesivir|0|||
27636251|NCT02798835|80509740|FG000|Overall Study|Protocol Violation|0|||
27636252|NCT02798835|80509741|FG001|Overall Study|Protocol Violation|0|||
27541238|NCT00369707|80171876|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
27541239|NCT00369707|80171876|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
27636253|NCT02798835|80509742|FG002|Overall Study|Protocol Violation|3|||
27920169|NCT01020123|81543809|FG006|Extention Period|Adverse Event|0|||
27920170|NCT01020123|81543803|FG000|Extention Period|Protocol Violation|1|||
27920171|NCT01020123|81543804|FG001|Extention Period|Protocol Violation|1|||
27920172|NCT01020123|81543805|FG002|Extention Period|Protocol Violation|1|||
27920173|NCT01020123|81543806|FG003|Extention Period|Protocol Violation|0|||
27920174|NCT01020123|81543807|FG004|Extention Period|Protocol Violation|0|||
27636254|NCT00510887|80509743|FG000|Overall Study|Lost to Follow-up|1|||
27636255|NCT02059980|80509747|FG000|Overall Study|Lost to Follow-up|2|||
27920175|NCT01020123|81543808|FG005|Extention Period|Protocol Violation|0|||
27920176|NCT01020123|81543809|FG006|Extention Period|Protocol Violation|1|||
27920177|NCT01020123|81543803|FG000|Extention Period|Lost to Follow-up|0|||
27920178|NCT01020123|81543804|FG001|Extention Period|Lost to Follow-up|0|||
27920179|NCT01020123|81543805|FG002|Extention Period|Lost to Follow-up|0|||
27920180|NCT01020123|81543806|FG003|Extention Period|Lost to Follow-up|0|||
27920181|NCT01020123|81543807|FG004|Extention Period|Lost to Follow-up|0|||
27920182|NCT01020123|81543808|FG005|Extention Period|Lost to Follow-up|2|||
27920183|NCT01020123|81543809|FG006|Extention Period|Lost to Follow-up|0|||
27920184|NCT00830219|81543810|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
27920185|NCT00830219|81543811|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
27920186|NCT02737358|81543812|FG000|Overall Study|Withdrawal by Subject|7|||
27920187|NCT02737358|81543813|FG001|Overall Study|Withdrawal by Subject|12|||
27920188|NCT02737358|81543812|FG000|Overall Study|Lost to Follow-up|2|||
27920189|NCT02737358|81543813|FG001|Overall Study|Lost to Follow-up|3|||
27920190|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
27920191|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
27920192|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
27920193|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
27920194|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
27920195|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
27920196|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
27920197|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
27920198|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
27920199|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
27920200|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
27920201|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
27920202|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
27920203|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
27920204|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
27920205|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
27920206|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
27920207|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
27920208|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
27920209|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
27920210|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
27920211|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
27920212|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
27920213|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
27920214|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
27920215|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
27920216|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
27920217|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
27920218|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
27541240|NCT00369707|80171876|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
27541241|NCT00369707|80171876|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
27541242|NCT00369707|80171876|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
27541243|NCT00369707|80171876|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
27541244|NCT00369707|80171876|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
27541245|NCT00369707|80171876|FG000|Follow up for 2 Years After Treatment|Death|1|||
27541246|NCT00369707|80171876|FG000|Follow up for 2 Years After Treatment|Other|2|||
27541247|NCT05350410|80171879|FG000|Overall Study|Withdrawal by Subject|1|||
27541248|NCT00825682|80171886|FG000|Overall Study|personal reasons/ inconvenience|13|||
27541249|NCT00825682|80171887|FG001|Overall Study|personal reasons/ inconvenience|5|||
27541250|NCT00282412|80171888|FG000|Overall Study|Death|2|||
27541251|NCT01488370|80171889|FG000|Overall Study|Protocol Violation|0|||
27541252|NCT01488370|80171890|FG001|Overall Study|Protocol Violation|1|||
27920219|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
27920220|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
27541253|NCT01488370|80171891|FG002|Overall Study|Protocol Violation|1|||
27636256|NCT02059980|80509748|FG001|Overall Study|Lost to Follow-up|1|||
27920221|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
27920222|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
27920223|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
27920224|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
27920225|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
27920226|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
27920227|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
27920228|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
27920229|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
27920230|NCT02709746|81543815|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
27920231|NCT02709746|81543816|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
27920232|NCT02709746|81543817|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
27920233|NCT02709746|81543818|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
27920234|NCT02709746|81543819|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
27920235|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
27920236|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
27920237|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
27920238|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
27920239|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
27920240|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
27920241|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
27920242|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
27920243|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
27920244|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
27920245|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
27920246|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
27920247|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
27541254|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
27541255|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
27541256|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
27541257|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
27541258|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
27541259|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
27541260|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
27541261|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
27541262|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
27541263|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
27541264|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
27541265|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
27541266|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
27541267|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
27541268|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
27541269|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
27541270|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
27541271|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
27541272|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
27541273|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
27541274|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
27541275|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
27541276|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
27541277|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
27541278|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
27541279|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
27541280|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
27541281|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
27541282|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
27541283|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
27541284|NCT00313300|80171892|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
27541285|NCT00313300|80171893|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
27541286|NCT00313300|80171894|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
27541287|NCT00313300|80171895|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
27541288|NCT00313300|80171896|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
27541289|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
27541290|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
27636257|NCT02988817|80509750|FG000|Overall Study|Withdrawal by Subject|1|||
27636258|NCT02988817|80509751|FG001|Overall Study|Withdrawal by Subject|0|||
27636259|NCT02988817|80509752|FG002|Overall Study|Withdrawal by Subject|0|||
27636260|NCT02988817|80509753|FG003|Overall Study|Withdrawal by Subject|1|||
27636261|NCT02988817|80509754|FG004|Overall Study|Withdrawal by Subject|3|||
27636262|NCT02988817|80509755|FG005|Overall Study|Withdrawal by Subject|1|||
27636263|NCT02988817|80509756|FG006|Overall Study|Withdrawal by Subject|2|||
27636264|NCT02988817|80509757|FG007|Overall Study|Withdrawal by Subject|1|||
27636265|NCT02988817|80509758|FG008|Overall Study|Withdrawal by Subject|1|||
27636266|NCT02988817|80509759|FG009|Overall Study|Withdrawal by Subject|1|||
27636267|NCT02988817|80509760|FG010|Overall Study|Withdrawal by Subject|1|||
27636268|NCT02988817|80509761|FG011|Overall Study|Withdrawal by Subject|12|||
27636269|NCT02988817|80509762|FG012|Overall Study|Withdrawal by Subject|6|||
27636270|NCT02988817|80509763|FG013|Overall Study|Withdrawal by Subject|6|||
27636271|NCT02988817|80509764|FG014|Overall Study|Withdrawal by Subject|4|||
27636272|NCT02988817|80509765|FG015|Overall Study|Withdrawal by Subject|5|||
27636273|NCT02988817|80509766|FG016|Overall Study|Withdrawal by Subject|4|||
27636274|NCT02988817|80509767|FG017|Overall Study|Withdrawal by Subject|11|||
27636275|NCT02988817|80509768|FG018|Overall Study|Withdrawal by Subject|4|||
27636276|NCT02988817|80509769|FG019|Overall Study|Withdrawal by Subject|2|||
27636277|NCT02988817|80509750|FG000|Overall Study|Death|0|||
27636278|NCT02988817|80509751|FG001|Overall Study|Death|1|||
27636279|NCT02988817|80509752|FG002|Overall Study|Death|3|||
27636280|NCT02988817|80509753|FG003|Overall Study|Death|1|||
27636281|NCT02988817|80509754|FG004|Overall Study|Death|6|||
27636282|NCT02988817|80509755|FG005|Overall Study|Death|10|||
27636283|NCT02988817|80509756|FG006|Overall Study|Death|1|||
27636284|NCT02988817|80509757|FG007|Overall Study|Death|2|||
27636285|NCT02988817|80509758|FG008|Overall Study|Death|1|||
27636286|NCT02988817|80509759|FG009|Overall Study|Death|5|||
27636287|NCT02988817|80509760|FG010|Overall Study|Death|1|||
27636288|NCT02988817|80509761|FG011|Overall Study|Death|8|||
27636289|NCT02988817|80509762|FG012|Overall Study|Death|9|||
27636290|NCT02988817|80509763|FG013|Overall Study|Death|17|||
27636291|NCT02988817|80509764|FG014|Overall Study|Death|18|||
27636292|NCT02988817|80509765|FG015|Overall Study|Death|30|||
27636293|NCT02988817|80509766|FG016|Overall Study|Death|17|||
27636294|NCT02988817|80509767|FG017|Overall Study|Death|38|||
27636295|NCT02988817|80509768|FG018|Overall Study|Death|14|||
27636296|NCT02988817|80509769|FG019|Overall Study|Death|16|||
27636297|NCT02988817|80509750|FG000|Overall Study|Other|0|||
27636298|NCT02988817|80509751|FG001|Overall Study|Other|0|||
27636299|NCT02988817|80509752|FG002|Overall Study|Other|0|||
27636300|NCT02988817|80509753|FG003|Overall Study|Other|1|||
27636301|NCT02988817|80509754|FG004|Overall Study|Other|1|||
27636302|NCT02988817|80509755|FG005|Overall Study|Other|0|||
27636303|NCT02988817|80509756|FG006|Overall Study|Other|0|||
27636304|NCT02988817|80509757|FG007|Overall Study|Other|0|||
27636305|NCT02988817|80509758|FG008|Overall Study|Other|0|||
27636306|NCT02988817|80509759|FG009|Overall Study|Other|0|||
27636307|NCT02988817|80509760|FG010|Overall Study|Other|0|||
27636308|NCT02988817|80509761|FG011|Overall Study|Other|0|||
27636309|NCT02988817|80509762|FG012|Overall Study|Other|0|||
27636310|NCT02988817|80509763|FG013|Overall Study|Other|0|||
27636311|NCT02988817|80509764|FG014|Overall Study|Other|0|||
27636312|NCT02988817|80509765|FG015|Overall Study|Other|1|||
27636313|NCT02988817|80509766|FG016|Overall Study|Other|0|||
27636314|NCT02988817|80509767|FG017|Overall Study|Other|0|||
27636315|NCT02988817|80509768|FG018|Overall Study|Other|0|||
27636316|NCT02988817|80509769|FG019|Overall Study|Other|0|||
27636317|NCT02988817|80509750|FG000|Overall Study|Lost to Follow-up|0|||
27636318|NCT02988817|80509751|FG001|Overall Study|Lost to Follow-up|0|||
27636319|NCT02988817|80509752|FG002|Overall Study|Lost to Follow-up|0|||
27636320|NCT02988817|80509753|FG003|Overall Study|Lost to Follow-up|0|||
27636321|NCT02988817|80509754|FG004|Overall Study|Lost to Follow-up|0|||
27920248|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
27636322|NCT02988817|80509755|FG005|Overall Study|Lost to Follow-up|0|||
27636323|NCT02988817|80509756|FG006|Overall Study|Lost to Follow-up|0|||
27636324|NCT02988817|80509757|FG007|Overall Study|Lost to Follow-up|0|||
27636325|NCT02988817|80509758|FG008|Overall Study|Lost to Follow-up|1|||
27636326|NCT02988817|80509759|FG009|Overall Study|Lost to Follow-up|0|||
27636327|NCT02988817|80509760|FG010|Overall Study|Lost to Follow-up|1|||
27636328|NCT02988817|80509761|FG011|Overall Study|Lost to Follow-up|1|||
27636329|NCT02988817|80509762|FG012|Overall Study|Lost to Follow-up|0|||
27636330|NCT02988817|80509763|FG013|Overall Study|Lost to Follow-up|0|||
27636331|NCT02988817|80509764|FG014|Overall Study|Lost to Follow-up|1|||
27636332|NCT02988817|80509765|FG015|Overall Study|Lost to Follow-up|1|||
27636333|NCT02988817|80509766|FG016|Overall Study|Lost to Follow-up|2|||
27636334|NCT02988817|80509767|FG017|Overall Study|Lost to Follow-up|3|||
27636335|NCT02988817|80509768|FG018|Overall Study|Lost to Follow-up|0|||
27636336|NCT02988817|80509769|FG019|Overall Study|Lost to Follow-up|0|||
27636337|NCT02988817|80509750|FG000|Overall Study|Sponsor decision|0|||
27920249|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
27920250|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
27920251|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
27920252|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
27920253|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
27920254|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
27920255|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
27920256|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
27920257|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
27920258|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
27920259|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
27920260|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
27920261|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
27920262|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
27920263|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
27920264|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
27920265|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
27920266|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
27920267|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
27920268|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
27920269|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
27920270|NCT02709746|81543815|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
27920271|NCT02709746|81543816|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
27920272|NCT02709746|81543817|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
27920273|NCT02709746|81543818|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
27920274|NCT02709746|81543819|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
27920275|NCT01420536|81543820|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
27920276|NCT01420536|81543821|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
27920277|NCT01701245|81543822|FG000|Overall Study|Protocol Violation|1|||
27920278|NCT01701245|81543823|FG001|Overall Study|Protocol Violation|3|||
27920279|NCT01701245|81543822|FG000|Overall Study|Did not complete the open label period|11|||
27920280|NCT01701245|81543823|FG001|Overall Study|Did not complete the open label period|12|||
27541291|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
27541292|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
27541293|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
27541294|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
27541295|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
27541296|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
27541297|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
27541298|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
27541299|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
27541300|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
27541301|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
27541302|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
27541303|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
27541304|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
27541305|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
27541306|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
27541307|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
27541308|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
27541309|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
27541310|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
27541311|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
27541312|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
27541313|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
27541314|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
27541315|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
27541316|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
27541317|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
27541318|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
27541319|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
27541320|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
27541321|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
27541322|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
27541323|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
27541324|NCT00313300|80171892|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
27920281|NCT00551369|81543824|FG000|Overall Study|Protocol Violation|5|||
27920282|NCT00551369|81543824|FG000|Overall Study|Withdrawal by Subject|1|||
27920283|NCT00551369|81543824|FG000|Overall Study|Not treated per protocol and re|1|||
27920284|NCT05379920|81546822|FG000|Overall Study|Lost to Follow-up|0|||
27920285|NCT05379920|81546823|FG001|Overall Study|Lost to Follow-up|5|||
27920286|NCT05379920|81546824|FG002|Overall Study|Lost to Follow-up|0|||
27920287|NCT05379920|81546825|FG003|Overall Study|Lost to Follow-up|0|||
27920288|NCT03630393|81546826|FG000|Overall Study|Death|1|||
27920289|NCT03630393|81546827|FG001|Overall Study|Death|0|||
27920290|NCT03103503|81546828|FG000|Overall Study|Death|64|||
27920291|NCT03103503|81546828|FG000|Overall Study|Physician Decision|57|||
27920292|NCT03103503|81546828|FG000|Overall Study|Withdrawal by Subject|10|||
27920293|NCT03103503|81546828|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
27920294|NCT03103503|81546828|FG000|Overall Study|Lost to Follow-up|3|||
27920295|NCT03103503|81546828|FG000|Overall Study|Study Closure|757|||
27920296|NCT01103323|81546834|FG000|Without/Before Drug Switch|Adverse Event|50|||
27920297|NCT01103323|81546835|FG001|Without/Before Drug Switch|Adverse Event|7|||
27920298|NCT01103323|81546834|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
27920299|NCT01103323|81546835|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
27920300|NCT01103323|81546834|FG000|Without/Before Drug Switch|Protocol Violation|2|||
27920301|NCT01103323|81546835|FG001|Without/Before Drug Switch|Protocol Violation|0|||
27920302|NCT01103323|81546834|FG000|Without/Before Drug Switch|Physician Decision|2|||
27920303|NCT01103323|81546835|FG001|Without/Before Drug Switch|Physician Decision|0|||
27920304|NCT01103323|81546834|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
27920305|NCT01103323|81546835|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
27920306|NCT01103323|81546834|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
27920307|NCT01103323|81546835|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
27920308|NCT01103323|81546834|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
27920309|NCT01103323|81546835|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
27920310|NCT03886272|81546836|FG000|Period 1|Withdrawal by Subject|0|||
27920311|NCT03886272|81546837|FG001|Period 1|Withdrawal by Subject|0|||
27920312|NCT03886272|81546838|FG002|Period 1|Withdrawal by Subject|0|||
27920313|NCT03886272|81546839|FG003|Period 1|Withdrawal by Subject|0|||
27920314|NCT03886272|81546840|FG004|Period 1|Withdrawal by Subject|0|||
27920315|NCT03886272|81546841|FG005|Period 1|Withdrawal by Subject|1|||
27920316|NCT03886272|81546842|FG006|Period 1|Withdrawal by Subject|0|||
27920317|NCT01586195|81546843|FG000|Overall Study|Death|11|||
27920318|NCT01586195|81546843|FG000|Overall Study|Withdrawal of Consent|5|||
27920319|NCT01586195|81546843|FG000|Overall Study|Started new anti-melanoma therapy|1|||
27920320|NCT01586195|81546843|FG000|Overall Study|Reason not specified|9|||
27920321|NCT01900444|81546844|FG000|Overall Study|Protocol Violation|2|||
27920322|NCT01900444|81546844|FG000|Overall Study|Lost to Follow-up|1|||
27920323|NCT00427908|81546852|FG000|Primary Phase|Lost to Follow-up|4|||
27920324|NCT00427908|81546853|FG001|Primary Phase|Lost to Follow-up|0|||
27920325|NCT00427908|81546854|FG002|Primary Phase|Lost to Follow-up|2|||
27920326|NCT00427908|81546855|FG003|Primary Phase|Lost to Follow-up|0|||
27920327|NCT00427908|81546852|FG000|Primary Phase|Withdrawal by Subject|1|||
27920328|NCT00427908|81546853|FG001|Primary Phase|Withdrawal by Subject|2|||
27920329|NCT00427908|81546854|FG002|Primary Phase|Withdrawal by Subject|1|||
27920330|NCT00427908|81546855|FG003|Primary Phase|Withdrawal by Subject|0|||
27920331|NCT00427908|81546852|FG000|Primary Phase|Adverse Event|0|||
27920332|NCT00427908|81546853|FG001|Primary Phase|Adverse Event|1|||
27920333|NCT00427908|81546854|FG002|Primary Phase|Adverse Event|0|||
27920334|NCT00427908|81546855|FG003|Primary Phase|Adverse Event|0|||
27920335|NCT02696616|81546856|FG000|Overall Study|Adverse Event|0|||
27920336|NCT02696616|81546857|FG001|Overall Study|Adverse Event|1|||
27920337|NCT02696616|81546858|FG002|Overall Study|Adverse Event|0|||
27920338|NCT02696616|81546859|FG003|Overall Study|Adverse Event|0|||
27920339|NCT02696616|81546860|FG004|Overall Study|Adverse Event|0|||
27920340|NCT02696616|81546861|FG005|Overall Study|Adverse Event|0|||
27920341|NCT02696616|81546862|FG006|Overall Study|Adverse Event|0|||
27920342|NCT01981616|81546863|FG000|Overall Study|Adverse Event|0|||
27920343|NCT01981616|81546864|FG001|Overall Study|Adverse Event|1|||
27920344|NCT01981616|81546863|FG000|Overall Study|Protocol Violation|1|||
27920345|NCT01981616|81546864|FG001|Overall Study|Protocol Violation|0|||
27920346|NCT02870868|81546867|FG000|Overall Study|Withdrawal by Subject|2|||
27920347|NCT02870868|81546868|FG001|Overall Study|Withdrawal by Subject|1|||
27920348|NCT01670292|81546874|FG000|Overall Study|Lost to Follow-up|14|||
27920349|NCT01832766|81546875|FG000|Washout|Lost to Follow-up|0|||
27920350|NCT01832766|81546876|FG001|Washout|Lost to Follow-up|1|||
27920351|NCT01718483|81546885|FG000|Overall Study|Withdrawal by Subject|14|||
27920352|NCT01718483|81546886|FG001|Overall Study|Withdrawal by Subject|12|||
27920353|NCT01718483|81546885|FG000|Overall Study|Adverse Event|5|||
27920354|NCT01718483|81546886|FG001|Overall Study|Adverse Event|12|||
27920355|NCT01718483|81546885|FG000|Overall Study|Lost to Follow-up|8|||
27920356|NCT01718483|81546886|FG001|Overall Study|Lost to Follow-up|3|||
27920357|NCT01718483|81546885|FG000|Overall Study|Protocol Violation|4|||
27920358|NCT01718483|81546886|FG001|Overall Study|Protocol Violation|2|||
27636338|NCT02988817|80509751|FG001|Overall Study|Sponsor decision|0|||
27636339|NCT02988817|80509752|FG002|Overall Study|Sponsor decision|0|||
27636340|NCT02988817|80509753|FG003|Overall Study|Sponsor decision|0|||
27636341|NCT02988817|80509754|FG004|Overall Study|Sponsor decision|0|||
27636342|NCT02988817|80509755|FG005|Overall Study|Sponsor decision|0|||
27541325|NCT00313300|80171893|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
27541326|NCT00313300|80171894|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
27541327|NCT00313300|80171895|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
27541328|NCT00313300|80171896|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
27541329|NCT00313300|80171892|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
27541330|NCT00313300|80171893|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
27541331|NCT00313300|80171894|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
27541332|NCT00313300|80171895|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
27541333|NCT00313300|80171896|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
27541334|NCT00313300|80171892|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
27541335|NCT00313300|80171893|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
27541336|NCT00313300|80171894|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
27541337|NCT00313300|80171895|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
27541338|NCT00313300|80171896|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
27541339|NCT00313300|80171892|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
27541340|NCT00313300|80171893|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
27541341|NCT00313300|80171894|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
27541342|NCT00313300|80171895|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
27920359|NCT01718483|81546885|FG000|Overall Study|Other|1|||
27920360|NCT01718483|81546886|FG001|Overall Study|Other|4|||
27920361|NCT01718483|81546885|FG000|Overall Study|Pregnancy|1|||
27541343|NCT00313300|80171896|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
27541344|NCT00313300|80171892|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
27541345|NCT00313300|80171893|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
27541346|NCT00313300|80171894|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
27541347|NCT00313300|80171895|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
27636343|NCT02988817|80509756|FG006|Overall Study|Sponsor decision|0|||
27636344|NCT02988817|80509757|FG007|Overall Study|Sponsor decision|0|||
27636345|NCT02988817|80509758|FG008|Overall Study|Sponsor decision|0|||
27636346|NCT02988817|80509759|FG009|Overall Study|Sponsor decision|0|||
27636347|NCT02988817|80509760|FG010|Overall Study|Sponsor decision|0|||
27636348|NCT02988817|80509761|FG011|Overall Study|Sponsor decision|1|||
27636349|NCT02988817|80509762|FG012|Overall Study|Sponsor decision|1|||
27636350|NCT02988817|80509763|FG013|Overall Study|Sponsor decision|2|||
27636351|NCT02988817|80509764|FG014|Overall Study|Sponsor decision|2|||
27636352|NCT02988817|80509765|FG015|Overall Study|Sponsor decision|6|||
27636353|NCT02988817|80509766|FG016|Overall Study|Sponsor decision|2|||
27636354|NCT02988817|80509767|FG017|Overall Study|Sponsor decision|3|||
27636355|NCT02988817|80509768|FG018|Overall Study|Sponsor decision|2|||
27636356|NCT02988817|80509769|FG019|Overall Study|Sponsor decision|7|||
27636357|NCT02988817|80509750|FG000|Overall Study|Physician Decision|0|||
27920362|NCT01718483|81546886|FG001|Overall Study|Pregnancy|1|||
27920363|NCT01718483|81546885|FG000|Overall Study|Lack of Efficacy|1|||
27920364|NCT01718483|81546886|FG001|Overall Study|Lack of Efficacy|0|||
27920365|NCT00744939|81546887|FG000|Overall Study|Withdrawal by Subject|9|||
27920366|NCT00744939|81546887|FG000|Overall Study|Protocol Violation|13|||
27920367|NCT00744939|81546887|FG000|Overall Study|Death|24|||
27920368|NCT00744939|81546887|FG000|Overall Study|distance|4|||
27920369|NCT00744939|81546887|FG000|Overall Study|Lost to Follow-up|12|||
27920370|NCT00744939|81546887|FG000|Overall Study|Medical history exclusionary|1|||
27920371|NCT00744939|81546887|FG000|Overall Study|Did not receive Magnevist|7|||
27920372|NCT00744939|81546887|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
27920373|NCT00744939|81546887|FG000|Overall Study|coma|1|||
27920374|NCT00744939|81546887|FG000|Overall Study|incorrect race|1|||
27920375|NCT00472420|81546888|FG000|Induction Treatment Period|Physician Decision|9|||
27920376|NCT00472420|81546888|FG000|Induction Treatment Period|Adverse Event|3|||
27920377|NCT00472420|81546888|FG000|Induction Treatment Period|Non-compliance|1|||
27920378|NCT00472420|81546888|FG000|Induction Treatment Period|Death|3|||
27920379|NCT00472420|81546888|FG000|Follow-up Period|Death|5|||
27920380|NCT00472420|81546888|FG000|Follow-up Period|Physician Decision|9|||
27920381|NCT00472420|81546888|FG000|Follow-up Period|Lost to Follow-up|2|||
27920382|NCT00472420|81546888|FG000|Follow-up Period|Protocol Violation|1|||
27920383|NCT01764841|81546896|FG000|Overall Study|Logistical Difficulties|0|||
27920384|NCT01764841|81546897|FG001|Overall Study|Logistical Difficulties|1|||
27920385|NCT01764841|81546898|FG002|Overall Study|Logistical Difficulties|0|||
27541348|NCT00313300|80171896|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
27541349|NCT00313300|80171892|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
27636358|NCT02988817|80509751|FG001|Overall Study|Physician Decision|0|||
27636359|NCT02988817|80509752|FG002|Overall Study|Physician Decision|0|||
27920386|NCT01764841|81546899|FG003|Overall Study|Logistical Difficulties|0|||
27920387|NCT01764841|81546896|FG000|Overall Study|Death|3|||
27920388|NCT01764841|81546897|FG001|Overall Study|Death|0|||
27920389|NCT01764841|81546898|FG002|Overall Study|Death|1|||
27920390|NCT01764841|81546899|FG003|Overall Study|Death|4|||
27920391|NCT01764841|81546896|FG000|Overall Study|No Follow Up|1|||
27920392|NCT01764841|81546897|FG001|Overall Study|No Follow Up|0|||
27920393|NCT01764841|81546898|FG002|Overall Study|No Follow Up|1|||
27920394|NCT01764841|81546899|FG003|Overall Study|No Follow Up|0|||
27920395|NCT01764841|81546896|FG000|Overall Study|Protocol Violation|0|||
27920396|NCT01764841|81546897|FG001|Overall Study|Protocol Violation|1|||
27920397|NCT01764841|81546898|FG002|Overall Study|Protocol Violation|0|||
27920398|NCT01764841|81546899|FG003|Overall Study|Protocol Violation|0|||
27920399|NCT01764841|81546896|FG000|Overall Study|Withdrawal by Subject|16|||
27920400|NCT01764841|81546897|FG001|Overall Study|Withdrawal by Subject|24|||
27920401|NCT01764841|81546898|FG002|Overall Study|Withdrawal by Subject|11|||
27920402|NCT01764841|81546899|FG003|Overall Study|Withdrawal by Subject|15|||
27920403|NCT01764841|81546896|FG000|Overall Study|Lost to Follow-up|3|||
27920404|NCT01764841|81546897|FG001|Overall Study|Lost to Follow-up|0|||
27920405|NCT01764841|81546898|FG002|Overall Study|Lost to Follow-up|1|||
27920406|NCT01764841|81546899|FG003|Overall Study|Lost to Follow-up|0|||
27920407|NCT00473655|81546900|FG000|Overall Study|Lost to Follow-up|9|||
27920408|NCT00473655|81546901|FG001|Overall Study|Lost to Follow-up|5|||
27920409|NCT00473655|81546902|FG002|Overall Study|Lost to Follow-up|8|||
27920410|NCT00386334|81546903|FG000|Double Blind Period|Adverse Event|9|||
27920411|NCT00386334|81546904|FG001|Double Blind Period|Adverse Event|14|||
27920412|NCT00386334|81546903|FG000|Double Blind Period|Protocol Violation|1|||
27920413|NCT00386334|81546904|FG001|Double Blind Period|Protocol Violation|1|||
27920414|NCT00386334|81546903|FG000|Double Blind Period|Withdrawal by Subject|9|||
27920415|NCT00386334|81546904|FG001|Double Blind Period|Withdrawal by Subject|13|||
27920416|NCT00386334|81546903|FG000|Double Blind Period|Lack of Efficacy|20|||
27920417|NCT00386334|81546904|FG001|Double Blind Period|Lack of Efficacy|11|||
27920418|NCT00386334|81546903|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
27920419|NCT00386334|81546904|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
27920420|NCT00386334|81546903|FG000|Double Blind Period|Other|3|||
27920421|NCT00386334|81546904|FG001|Double Blind Period|Other|3|||
27920422|NCT00386334|81546903|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
27920423|NCT00386334|81546904|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
27920424|NCT03409744|81546905|FG000|Overall Study|Death|2|||
27920425|NCT03409744|81546905|FG000|Overall Study|Physician Decision|5|||
27920426|NCT03409744|81546905|FG000|Overall Study|Pregnancy|1|||
27920427|NCT03409744|81546905|FG000|Overall Study|Lost to Follow-up|1|||
27920428|NCT03409744|81546905|FG000|Overall Study|Protocol Violation|1|||
27920429|NCT03641508|81546906|FG000|First Injection|Lost to Follow-up|2|||
27920430|NCT03641508|81546907|FG001|First Injection|Lost to Follow-up|0|||
27920431|NCT00385840|81546908|FG000|Overall Study|Adverse Event|1|||
27920432|NCT00385840|81546909|FG001|Overall Study|Adverse Event|1|||
27920433|NCT00385840|81546908|FG000|Overall Study|Lost to Follow-up|3|||
27920434|NCT00385840|81546909|FG001|Overall Study|Lost to Follow-up|13|||
27920435|NCT00062166|81546910|FG000|Overall Study|Withdrawal by Subject|6|||
27920436|NCT02997163|81546913|FG000|Overall Study|Adverse Event|1|||
27920437|NCT02997163|81546914|FG001|Overall Study|Adverse Event|0|||
27920438|NCT02997163|81546915|FG002|Overall Study|Adverse Event|0|||
27920439|NCT02997163|81546916|FG003|Overall Study|Adverse Event|1|||
27920440|NCT00183430|81546917|FG000|Overall Study|Adverse Event|1|||
27920441|NCT00183430|81546918|FG001|Overall Study|Adverse Event|0|||
27920442|NCT00183430|81546917|FG000|Overall Study|Lost to Follow-up|3|||
27920443|NCT00183430|81546918|FG001|Overall Study|Lost to Follow-up|0|||
27920444|NCT00183430|81546917|FG000|Overall Study|did not meet inclusion criteria|1|||
27920445|NCT00183430|81546918|FG001|Overall Study|did not meet inclusion criteria|0|||
27920446|NCT00183430|81546917|FG000|Overall Study|Withdrawal by Subject|1|||
27920447|NCT00183430|81546918|FG001|Overall Study|Withdrawal by Subject|0|||
27920448|NCT03427411|81546919|FG000|Overall Study|Screen failure - platelets too low|0|||
27920449|NCT03427411|81546920|FG001|Overall Study|Screen failure - platelets too low|1|||
27920450|NCT04275336|81546921|FG000|Overall Study|First venipuncture failed|4|||
27920451|NCT04275336|81546922|FG001|Overall Study|First venipuncture failed|6|||
27920452|NCT04275336|81546923|FG002|Overall Study|First venipuncture failed|5|||
27920453|NCT04275336|81546921|FG000|Overall Study|Unscheduled venipuncture|9|||
27920454|NCT04275336|81546922|FG001|Overall Study|Unscheduled venipuncture|13|||
27920455|NCT04275336|81546923|FG002|Overall Study|Unscheduled venipuncture|7|||
27920456|NCT04275336|81546921|FG000|Overall Study|Failed specimen of saliva|4|||
27920457|NCT04275336|81546922|FG001|Overall Study|Failed specimen of saliva|3|||
27920458|NCT04275336|81546923|FG002|Overall Study|Failed specimen of saliva|4|||
27920459|NCT01324102|81546924|FG000|Overall Study|illness|1|||
27920460|NCT01324102|81546925|FG001|Overall Study|illness|6|||
27920461|NCT01631214|81546927|FG000|Overall Study|Withdrawal by Subject|276|||
27920462|NCT01631214|81546928|FG001|Overall Study|Withdrawal by Subject|290|||
27920463|NCT01631214|81546927|FG000|Overall Study|Death|113|||
27920464|NCT01631214|81546928|FG001|Overall Study|Death|106|||
27920465|NCT01631214|81546927|FG000|Overall Study|Lost to Follow-up|54|||
27920466|NCT01631214|81546928|FG001|Overall Study|Lost to Follow-up|40|||
27920467|NCT01631214|81546927|FG000|Overall Study|Adverse Event|45|||
27920468|NCT01631214|81546928|FG001|Overall Study|Adverse Event|45|||
27920469|NCT01631214|81546927|FG000|Overall Study|Other|22|||
27920470|NCT01631214|81546928|FG001|Overall Study|Other|19|||
27541350|NCT00313300|80171893|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
27541351|NCT00313300|80171894|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
27920471|NCT01631214|81546927|FG000|Overall Study|Noncompliance|16|||
27920472|NCT01631214|81546928|FG001|Overall Study|Noncompliance|15|||
27920473|NCT01631214|81546927|FG000|Overall Study|Requirement for Alternative Therapy|8|||
27920474|NCT01631214|81546928|FG001|Overall Study|Requirement for Alternative Therapy|3|||
27920475|NCT01631214|81546927|FG000|Overall Study|Protocol Deviation|4|||
27920476|NCT01631214|81546928|FG001|Overall Study|Protocol Deviation|3|||
27920477|NCT01631214|81546927|FG000|Overall Study|Ineligibility determined|5|||
27920478|NCT01631214|81546928|FG001|Overall Study|Ineligibility determined|2|||
27920479|NCT01631214|81546927|FG000|Overall Study|Administrative Decision|1|||
27920480|NCT01631214|81546928|FG001|Overall Study|Administrative Decision|0|||
27920481|NCT03722576|81546931|FG000|Overall Study|Withdrawal by Subject|3|||
27920482|NCT03722576|81546931|FG000|Overall Study|Adverse Event|2|||
27920483|NCT03722576|81546931|FG000|Overall Study|Physician Decision|1|||
27920484|NCT03722576|81546931|FG000|Overall Study|Lost to Follow-up|1|||
27920485|NCT02579629|81546933|FG000|Overall Study|Withdrawal by Subject|0|||
27541352|NCT00313300|80171895|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
27541353|NCT00313300|80171896|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
27541354|NCT00313300|80171892|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
27541355|NCT00313300|80171893|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
27636360|NCT02988817|80509753|FG003|Overall Study|Physician Decision|0|||
27636361|NCT02988817|80509754|FG004|Overall Study|Physician Decision|0|||
27920486|NCT02579629|81546934|FG001|Overall Study|Withdrawal by Subject|1|||
27920487|NCT02579629|81546935|FG002|Overall Study|Withdrawal by Subject|0|||
27920488|NCT02579629|81546933|FG000|Overall Study|Screen Failure|2|||
27920489|NCT02579629|81546934|FG001|Overall Study|Screen Failure|0|||
27920490|NCT02579629|81546935|FG002|Overall Study|Screen Failure|2|||
27920491|NCT00748241|81546939|FG000|Overall Study|Implant failure|1|||
27920492|NCT00748241|81546939|FG000|Overall Study|Lost to Follow-up|5|||
27920493|NCT00748241|81546939|FG000|Overall Study|Death|2|||
27920494|NCT02204917|81546944|FG000|Overall Study|Protocol Violation|1|||
27920495|NCT03712280|81546945|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
27920496|NCT03712280|81546946|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
27920497|NCT03712280|81546947|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
27920498|NCT03712280|81546948|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
27920499|NCT03712280|81546945|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
27920500|NCT03712280|81546946|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
27920501|NCT03712280|81546947|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
27920502|NCT03712280|81546948|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
27920503|NCT03712280|81546945|FG000|Overall Study|Adverse Event|0|||
27920504|NCT03712280|81546946|FG001|Overall Study|Adverse Event|0|||
27920505|NCT03712280|81546947|FG002|Overall Study|Adverse Event|1|||
27920506|NCT03712280|81546948|FG003|Overall Study|Adverse Event|0|||
27920507|NCT01930539|81546952|FG000|Overall Study|Withdrawal by Subject|2|||
27920508|NCT01930539|81546953|FG001|Overall Study|Withdrawal by Subject|2|||
27920509|NCT00856180|81546968|FG000|Overall Study|Adverse Event|4|||
27920510|NCT00856180|81546968|FG000|Overall Study|Progressive Disease|16|||
27920511|NCT01603277|81546969|FG000|Overall Study|Adverse Event|1|||
27920512|NCT01603277|81546970|FG001|Overall Study|Adverse Event|2|||
27920513|NCT01603277|81546969|FG000|Overall Study|Physician Decision|0|||
27920514|NCT01603277|81546970|FG001|Overall Study|Physician Decision|1|||
27541356|NCT00313300|80171894|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
27541357|NCT00313300|80171895|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
27636362|NCT02988817|80509755|FG005|Overall Study|Physician Decision|0|||
27636363|NCT02988817|80509756|FG006|Overall Study|Physician Decision|0|||
27636364|NCT02988817|80509757|FG007|Overall Study|Physician Decision|0|||
27920515|NCT01603277|81546969|FG000|Overall Study|Protocol Violation|6|||
27920516|NCT01603277|81546970|FG001|Overall Study|Protocol Violation|10|||
27920517|NCT01603277|81546969|FG000|Overall Study|Withdrawal by Subject|5|||
27920518|NCT01603277|81546970|FG001|Overall Study|Withdrawal by Subject|4|||
27920519|NCT01603277|81546969|FG000|Overall Study|Non-Compliance|2|||
27920520|NCT01603277|81546970|FG001|Overall Study|Non-Compliance|1|||
27920521|NCT01155570|81546971|FG000|Overall Study|Adverse Event|39|||
27920522|NCT01155570|81546971|FG000|Overall Study|Lack of Efficacy|46|||
27920523|NCT01155570|81546971|FG000|Overall Study|Participant's Economic Reasons|17|||
27920524|NCT01155570|81546971|FG000|Overall Study|No Hospital Visits|7|||
27920525|NCT01155570|81546971|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
27920526|NCT01155570|81546971|FG000|Overall Study|Adverse Event + Other Reasons|7|||
27541358|NCT00313300|80171896|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
27541359|NCT01972568|80171897|FG000|Overall Study|Other events|3|||
27541360|NCT01972568|80171898|FG001|Overall Study|Other events|0|||
27541361|NCT01972568|80171899|FG002|Overall Study|Other events|0|||
27541362|NCT01972568|80171897|FG000|Overall Study|Lack of Efficacy|0|||
27541363|NCT01972568|80171898|FG001|Overall Study|Lack of Efficacy|1|||
27541364|NCT01972568|80171899|FG002|Overall Study|Lack of Efficacy|2|||
27541365|NCT01972568|80171897|FG000|Overall Study|Protocol Violation|1|||
27541366|NCT01972568|80171898|FG001|Overall Study|Protocol Violation|2|||
27541367|NCT01972568|80171899|FG002|Overall Study|Protocol Violation|2|||
27541368|NCT01972568|80171897|FG000|Overall Study|Withdrawal by Subject|6|||
27541369|NCT01972568|80171898|FG001|Overall Study|Withdrawal by Subject|3|||
27920527|NCT01155570|81546971|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
27920528|NCT01155570|81546971|FG000|Overall Study|Other Reasons|23|||
27541370|NCT01972568|80171899|FG002|Overall Study|Withdrawal by Subject|7|||
27541371|NCT01972568|80171897|FG000|Overall Study|Lost to Follow-up|1|||
27541372|NCT01972568|80171898|FG001|Overall Study|Lost to Follow-up|0|||
27920529|NCT00427934|81546974|FG000|Overall Study|Adverse Event|1|||
27920530|NCT00427934|81546975|FG001|Overall Study|Adverse Event|0|||
27920531|NCT00427934|81546976|FG002|Overall Study|Adverse Event|5|||
27920532|NCT00427934|81546977|FG003|Overall Study|Adverse Event|4|||
27920533|NCT00427934|81546974|FG000|Overall Study|Lack of Efficacy|0|||
27920534|NCT00427934|81546975|FG001|Overall Study|Lack of Efficacy|0|||
27541373|NCT01972568|80171899|FG002|Overall Study|Lost to Follow-up|0|||
27541374|NCT01972568|80171897|FG000|Overall Study|Adverse Event|5|||
27541375|NCT01972568|80171898|FG001|Overall Study|Adverse Event|6|||
27541376|NCT01972568|80171899|FG002|Overall Study|Adverse Event|5|||
27541377|NCT00003487|80171900|FG000|Overall Study|Not evaluable|2|||
27541378|NCT00446251|80171901|FG000|Overall Study|On-study Transplants|2|||
27541379|NCT00446251|80171901|FG000|Overall Study|Rituximab Infusion Reaction|2|||
27541380|NCT00446251|80171901|FG000|Overall Study|Lost to Follow-up|1|||
27541381|NCT00231842|80171903|FG000|Overall Study|Withdrawal by Subject|3|||
27541382|NCT00231842|80171903|FG000|Overall Study|Did not complete the last 3 cycle|8|||
27541383|NCT01083485|80171904|FG000|Overall Study|Adverse Event|0|||
27541384|NCT01083485|80171905|FG001|Overall Study|Adverse Event|1|||
27541385|NCT01083485|80171904|FG000|Overall Study|Protocol Violation|1|||
27541386|NCT01083485|80171905|FG001|Overall Study|Protocol Violation|0|||
27541387|NCT01083485|80171904|FG000|Overall Study|Withdrawal by Subject|5|||
27541388|NCT01083485|80171905|FG001|Overall Study|Withdrawal by Subject|2|||
27541389|NCT01083485|80171904|FG000|Overall Study|Other|1|||
27541390|NCT01083485|80171905|FG001|Overall Study|Other|0|||
27541391|NCT00412542|80171906|FG000|Overall Study|Withdrawal by Subject|0|||
27541392|NCT00412542|80171907|FG001|Overall Study|Withdrawal by Subject|2|||
27541393|NCT00412542|80171906|FG000|Overall Study|Not Eligible|0|||
27541394|NCT00412542|80171907|FG001|Overall Study|Not Eligible|1|||
27541395|NCT01201785|80171911|FG000|Overall Study|Lost to Follow-up|16|||
27541396|NCT00428792|80171914|FG000|Overall Study|Lack of Efficacy|1|||
27541397|NCT00428792|80171915|FG001|Overall Study|Lack of Efficacy|3|||
27541398|NCT00428792|80171914|FG000|Overall Study|Lost to Follow-up|0|||
27541399|NCT00428792|80171915|FG001|Overall Study|Lost to Follow-up|1|||
27541400|NCT00633750|80171916|FG000|Overall Study|Adverse Event|2|||
27541401|NCT00633750|80171916|FG000|Overall Study|Withdrawal by Subject|3|||
27541402|NCT00142298|80171917|FG000|Overall Study|Adverse Event|10|||
27920535|NCT00427934|81546976|FG002|Overall Study|Lack of Efficacy|5|||
27920536|NCT00427934|81546977|FG003|Overall Study|Lack of Efficacy|2|||
27920537|NCT00427934|81546974|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
27920538|NCT00427934|81546975|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
27920539|NCT00427934|81546976|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
27920540|NCT00427934|81546977|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
27541403|NCT00142298|80171918|FG001|Overall Study|Adverse Event|10|||
27541404|NCT00142298|80171919|FG002|Overall Study|Adverse Event|1|||
27541405|NCT00142298|80171920|FG003|Overall Study|Adverse Event|5|||
27636365|NCT02988817|80509758|FG008|Overall Study|Physician Decision|0|||
27636366|NCT02988817|80509759|FG009|Overall Study|Physician Decision|0|||
27541406|NCT00142298|80171921|FG004|Overall Study|Adverse Event|2|||
27541407|NCT00142298|80171922|FG005|Overall Study|Adverse Event|2|||
27541408|NCT00142298|80171923|FG006|Overall Study|Adverse Event|0|||
27541409|NCT00142298|80171924|FG007|Overall Study|Adverse Event|0|||
27541410|NCT00142298|80171925|FG008|Overall Study|Adverse Event|0|||
27920541|NCT00427934|81546974|FG000|Overall Study|Other|0|||
27920542|NCT00427934|81546975|FG001|Overall Study|Other|0|||
27920543|NCT00427934|81546976|FG002|Overall Study|Other|11|||
27541411|NCT00142298|80171926|FG009|Overall Study|Adverse Event|0|||
27541412|NCT00142298|80171917|FG000|Overall Study|Clinical disease progression|1|||
27541413|NCT00142298|80171918|FG001|Overall Study|Clinical disease progression|0|||
27541414|NCT00142298|80171919|FG002|Overall Study|Clinical disease progression|0|||
27541415|NCT00142298|80171920|FG003|Overall Study|Clinical disease progression|0|||
27636367|NCT02988817|80509760|FG010|Overall Study|Physician Decision|0|||
27541416|NCT00142298|80171921|FG004|Overall Study|Clinical disease progression|0|||
27541417|NCT00142298|80171922|FG005|Overall Study|Clinical disease progression|0|||
27541418|NCT00142298|80171923|FG006|Overall Study|Clinical disease progression|0|||
27541419|NCT00142298|80171924|FG007|Overall Study|Clinical disease progression|0|||
27541420|NCT00142298|80171925|FG008|Overall Study|Clinical disease progression|0|||
27920544|NCT00427934|81546977|FG003|Overall Study|Other|5|||
27920545|NCT00427934|81546974|FG000|Overall Study|Withdrawal by Subject|0|||
27920546|NCT00427934|81546975|FG001|Overall Study|Withdrawal by Subject|0|||
27920547|NCT00427934|81546976|FG002|Overall Study|Withdrawal by Subject|1|||
27920548|NCT00427934|81546977|FG003|Overall Study|Withdrawal by Subject|3|||
27920549|NCT03585270|81546989|FG000|Overall Study|Withdrawal by Subject|2|||
27541421|NCT00142298|80171926|FG009|Overall Study|Clinical disease progression|0|||
27541422|NCT00142298|80171917|FG000|Overall Study|Death|1|||
27541423|NCT00142298|80171918|FG001|Overall Study|Death|1|||
27541424|NCT00142298|80171919|FG002|Overall Study|Death|1|||
27541425|NCT00142298|80171920|FG003|Overall Study|Death|0|||
27541426|NCT00142298|80171921|FG004|Overall Study|Death|0|||
27541427|NCT00142298|80171922|FG005|Overall Study|Death|6|||
27541428|NCT00142298|80171923|FG006|Overall Study|Death|0|||
27541429|NCT00142298|80171924|FG007|Overall Study|Death|0|||
27541430|NCT00142298|80171925|FG008|Overall Study|Death|0|||
27541431|NCT00142298|80171926|FG009|Overall Study|Death|0|||
27541432|NCT00142298|80171917|FG000|Overall Study|Lack of Efficacy|44|||
27541433|NCT00142298|80171918|FG001|Overall Study|Lack of Efficacy|62|||
27541434|NCT00142298|80171919|FG002|Overall Study|Lack of Efficacy|9|||
27541435|NCT00142298|80171920|FG003|Overall Study|Lack of Efficacy|12|||
27541436|NCT00142298|80171921|FG004|Overall Study|Lack of Efficacy|1|||
27541437|NCT00142298|80171922|FG005|Overall Study|Lack of Efficacy|0|||
27541438|NCT00142298|80171923|FG006|Overall Study|Lack of Efficacy|0|||
27541439|NCT00142298|80171924|FG007|Overall Study|Lack of Efficacy|1|||
27541440|NCT00142298|80171925|FG008|Overall Study|Lack of Efficacy|0|||
27541441|NCT00142298|80171926|FG009|Overall Study|Lack of Efficacy|0|||
27541442|NCT00142298|80171917|FG000|Overall Study|Non-compliance|15|||
27541443|NCT00142298|80171918|FG001|Overall Study|Non-compliance|13|||
27541444|NCT00142298|80171919|FG002|Overall Study|Non-compliance|0|||
27541445|NCT00142298|80171920|FG003|Overall Study|Non-compliance|6|||
27920550|NCT03585270|81546990|FG001|Overall Study|Withdrawal by Subject|6|||
27920551|NCT03585270|81546989|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
27920552|NCT03585270|81546990|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
27920553|NCT03585270|81546989|FG000|Overall Study|Adverse Event|5|||
27920554|NCT03585270|81546990|FG001|Overall Study|Adverse Event|2|||
27541446|NCT00142298|80171921|FG004|Overall Study|Non-compliance|1|||
27541447|NCT00142298|80171922|FG005|Overall Study|Non-compliance|0|||
27541448|NCT00142298|80171923|FG006|Overall Study|Non-compliance|0|||
27541449|NCT00142298|80171924|FG007|Overall Study|Non-compliance|3|||
27541450|NCT00142298|80171925|FG008|Overall Study|Non-compliance|3|||
27541451|NCT00142298|80171926|FG009|Overall Study|Non-compliance|0|||
27541452|NCT00142298|80171917|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
27541453|NCT00142298|80171918|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
27541454|NCT00142298|80171919|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
27541455|NCT00142298|80171920|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
27541456|NCT00142298|80171921|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
27541457|NCT00142298|80171922|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
27541458|NCT00142298|80171923|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
27541459|NCT00142298|80171924|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
27541460|NCT00142298|80171925|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
27541461|NCT00142298|80171926|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
27541462|NCT00142298|80171917|FG000|Overall Study|Pregnancy|4|||
27541463|NCT00142298|80171918|FG001|Overall Study|Pregnancy|4|||
27541464|NCT00142298|80171919|FG002|Overall Study|Pregnancy|2|||
27541465|NCT00142298|80171920|FG003|Overall Study|Pregnancy|3|||
27541466|NCT00142298|80171921|FG004|Overall Study|Pregnancy|0|||
27541467|NCT00142298|80171922|FG005|Overall Study|Pregnancy|0|||
27541468|NCT00142298|80171923|FG006|Overall Study|Pregnancy|0|||
27541469|NCT00142298|80171924|FG007|Overall Study|Pregnancy|0|||
27541470|NCT00142298|80171925|FG008|Overall Study|Pregnancy|1|||
27541471|NCT00142298|80171926|FG009|Overall Study|Pregnancy|0|||
27541472|NCT00142298|80171917|FG000|Overall Study|Virologic breakthrough|19|||
27541473|NCT00142298|80171918|FG001|Overall Study|Virologic breakthrough|23|||
27541474|NCT00142298|80171919|FG002|Overall Study|Virologic breakthrough|9|||
27541475|NCT00142298|80171920|FG003|Overall Study|Virologic breakthrough|7|||
27740928|NCT01736683|80880769|FG001|Overall Study|Withdrawal by Subject|0|||
27920555|NCT03585270|81546989|FG000|Overall Study|Lost to Follow-up|1|||
27541476|NCT00142298|80171921|FG004|Overall Study|Virologic breakthrough|2|||
27541477|NCT00142298|80171922|FG005|Overall Study|Virologic breakthrough|3|||
27541478|NCT00142298|80171923|FG006|Overall Study|Virologic breakthrough|3|||
27541479|NCT00142298|80171924|FG007|Overall Study|Virologic breakthrough|0|||
27541480|NCT00142298|80171925|FG008|Overall Study|Virologic breakthrough|0|||
27920556|NCT03585270|81546990|FG001|Overall Study|Lost to Follow-up|4|||
27920557|NCT03585270|81546989|FG000|Overall Study|Death|5|||
27920558|NCT03585270|81546990|FG001|Overall Study|Death|3|||
27920559|NCT03585270|81546989|FG000|Overall Study|Other reasons|2|||
27920560|NCT03585270|81546990|FG001|Overall Study|Other reasons|2|||
27920561|NCT01850641|81546991|FG000|Overall Study|Physician Decision|1|||
27920562|NCT01850641|81546991|FG000|Overall Study|Decrease in serum phosphorus|1|||
27920563|NCT01850641|81546991|FG000|Overall Study|Decrease in serum calcium|2|||
27920564|NCT01850641|81546991|FG000|Overall Study|Increase in serum ferritin|1|||
27920565|NCT01673386|81546992|FG000|Overall Study|Study terminated by sponsor|16|||
27920566|NCT01673386|81546993|FG001|Overall Study|Study terminated by sponsor|22|||
27920567|NCT01673386|81546992|FG000|Overall Study|Adverse Event|5|||
27920568|NCT01673386|81546993|FG001|Overall Study|Adverse Event|2|||
27920569|NCT01673386|81546992|FG000|Overall Study|Progressive disease|4|||
27920570|NCT01673386|81546993|FG001|Overall Study|Progressive disease|1|||
27541481|NCT00142298|80171926|FG009|Overall Study|Virologic breakthrough|0|||
27541482|NCT00142298|80171917|FG000|Overall Study|Other- not specified|0|||
27541483|NCT00142298|80171918|FG001|Overall Study|Other- not specified|3|||
27541484|NCT00142298|80171919|FG002|Overall Study|Other- not specified|0|||
27541485|NCT00142298|80171920|FG003|Overall Study|Other- not specified|1|||
27636368|NCT02988817|80509761|FG011|Overall Study|Physician Decision|0|||
27636369|NCT02988817|80509762|FG012|Overall Study|Physician Decision|0|||
27636370|NCT02988817|80509763|FG013|Overall Study|Physician Decision|0|||
27636371|NCT02988817|80509764|FG014|Overall Study|Physician Decision|0|||
27636372|NCT02988817|80509765|FG015|Overall Study|Physician Decision|1|||
27636373|NCT02988817|80509766|FG016|Overall Study|Physician Decision|0|||
27636374|NCT02988817|80509767|FG017|Overall Study|Physician Decision|0|||
27636375|NCT02988817|80509768|FG018|Overall Study|Physician Decision|1|||
27636376|NCT02988817|80509769|FG019|Overall Study|Physician Decision|1|||
27636377|NCT01400776|80509770|FG000|Overall Study|Adverse Event|7|||
27920571|NCT01673386|81546992|FG000|Overall Study|Withdrawal by Subject|0|||
27920572|NCT01673386|81546993|FG001|Overall Study|Withdrawal by Subject|2|||
27920573|NCT00368108|81546994|FG000|Overall Study|Adverse Event|38|||
27920574|NCT00368108|81546995|FG001|Overall Study|Adverse Event|26|||
27541486|NCT00142298|80171921|FG004|Overall Study|Other- not specified|0|||
27541487|NCT00142298|80171922|FG005|Overall Study|Other- not specified|0|||
27541488|NCT00142298|80171923|FG006|Overall Study|Other- not specified|0|||
27541489|NCT00142298|80171924|FG007|Overall Study|Other- not specified|0|||
27541490|NCT00142298|80171925|FG008|Overall Study|Other- not specified|0|||
27541491|NCT00142298|80171926|FG009|Overall Study|Other- not specified|0|||
27541492|NCT00142298|80171917|FG000|Overall Study|Lost to Follow-up|0|||
27541493|NCT00142298|80171918|FG001|Overall Study|Lost to Follow-up|0|||
27541494|NCT00142298|80171919|FG002|Overall Study|Lost to Follow-up|0|||
27541495|NCT00142298|80171920|FG003|Overall Study|Lost to Follow-up|0|||
27541496|NCT00142298|80171921|FG004|Overall Study|Lost to Follow-up|0|||
27920575|NCT00368108|81546996|FG002|Overall Study|Adverse Event|44|||
27920576|NCT00368108|81546994|FG000|Overall Study|Abnormal Laboratory Value|0|||
27920577|NCT00368108|81546995|FG001|Overall Study|Abnormal Laboratory Value|0|||
27920578|NCT00368108|81546996|FG002|Overall Study|Abnormal Laboratory Value|3|||
27920579|NCT00368108|81546994|FG000|Overall Study|Protocol Violation|5|||
27920580|NCT00368108|81546995|FG001|Overall Study|Protocol Violation|9|||
27920581|NCT00368108|81546996|FG002|Overall Study|Protocol Violation|9|||
27920582|NCT00368108|81546994|FG000|Overall Study|Withdrawal by Subject|9|||
27920583|NCT00368108|81546995|FG001|Overall Study|Withdrawal by Subject|3|||
27920584|NCT00368108|81546996|FG002|Overall Study|Withdrawal by Subject|5|||
27920585|NCT00368108|81546994|FG000|Overall Study|Lack of Efficacy|7|||
27920586|NCT00368108|81546995|FG001|Overall Study|Lack of Efficacy|8|||
27920587|NCT00368108|81546996|FG002|Overall Study|Lack of Efficacy|5|||
27920588|NCT00368108|81546994|FG000|Overall Study|Physician Decision|2|||
27920589|NCT00368108|81546995|FG001|Overall Study|Physician Decision|0|||
27920590|NCT00368108|81546996|FG002|Overall Study|Physician Decision|1|||
27541497|NCT00142298|80171922|FG005|Overall Study|Lost to Follow-up|0|||
27541498|NCT00142298|80171923|FG006|Overall Study|Lost to Follow-up|2|||
27541499|NCT00142298|80171924|FG007|Overall Study|Lost to Follow-up|0|||
27541500|NCT00142298|80171925|FG008|Overall Study|Lost to Follow-up|0|||
27541501|NCT00142298|80171926|FG009|Overall Study|Lost to Follow-up|0|||
27541502|NCT00142298|80171917|FG000|Overall Study|Treatment Failure|0|||
27541503|NCT00142298|80171918|FG001|Overall Study|Treatment Failure|0|||
27920591|NCT00368108|81546994|FG000|Overall Study|Other|3|||
27920592|NCT00368108|81546995|FG001|Overall Study|Other|7|||
27541504|NCT00142298|80171919|FG002|Overall Study|Treatment Failure|0|||
27541505|NCT00142298|80171920|FG003|Overall Study|Treatment Failure|0|||
27541506|NCT00142298|80171921|FG004|Overall Study|Treatment Failure|0|||
27920593|NCT00368108|81546996|FG002|Overall Study|Other|1|||
27920594|NCT01712178|81546999|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
27636378|NCT01400776|80509771|FG001|Overall Study|Adverse Event|2|||
27636379|NCT01400776|80509772|FG002|Overall Study|Adverse Event|9|||
27636380|NCT01400776|80509773|FG003|Overall Study|Adverse Event|2|||
27920595|NCT01712178|81547000|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
27541507|NCT00142298|80171922|FG005|Overall Study|Treatment Failure|2|||
27541508|NCT00142298|80171923|FG006|Overall Study|Treatment Failure|2|||
27541509|NCT00142298|80171924|FG007|Overall Study|Treatment Failure|0|||
27541510|NCT00142298|80171925|FG008|Overall Study|Treatment Failure|0|||
27541511|NCT00142298|80171926|FG009|Overall Study|Treatment Failure|0|||
27541512|NCT00939640|80171929|FG000|Overall Study|Physician Decision|1|||
27541513|NCT02899299|80171932|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
27541514|NCT02899299|80171933|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
27541515|NCT02899299|80171932|FG000|Pre-treatment|Participant withdrew consent|1|||
27541516|NCT02899299|80171933|FG001|Pre-treatment|Participant withdrew consent|11|||
27541517|NCT02899299|80171932|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
27541518|NCT02899299|80171933|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
27541519|NCT02899299|80171932|FG000|Pre-treatment|Not reported|0|||
27541520|NCT02899299|80171933|FG001|Pre-treatment|Not reported|1|||
27541521|NCT02899299|80171932|FG000|Treatment|Disease Progression|182|||
27541522|NCT02899299|80171933|FG001|Treatment|Disease Progression|43|||
27541523|NCT02899299|80171932|FG000|Treatment|Study Drug Toxicity|60|||
27541524|NCT02899299|80171933|FG001|Treatment|Study Drug Toxicity|24|||
27541525|NCT02899299|80171932|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
27541526|NCT02899299|80171933|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
27541527|NCT02899299|80171932|FG000|Treatment|Participant request to discontinue Study treatment|4|||
27541528|NCT02899299|80171933|FG001|Treatment|Participant request to discontinue Study treatment|10|||
27541529|NCT02899299|80171932|FG000|Treatment|Participant withdrew consent|6|||
27541530|NCT02899299|80171933|FG001|Treatment|Participant withdrew consent|3|||
27541531|NCT02899299|80171932|FG000|Treatment|Lost to Follow-up|0|||
27541532|NCT02899299|80171933|FG001|Treatment|Lost to Follow-up|2|||
27541533|NCT02899299|80171932|FG000|Treatment|Maximum Clinical Benefit|11|||
27541534|NCT02899299|80171933|FG001|Treatment|Maximum Clinical Benefit|2|||
27541535|NCT02899299|80171932|FG000|Treatment|Poor/Non-compliance|1|||
27541536|NCT02899299|80171933|FG001|Treatment|Poor/Non-compliance|0|||
27541537|NCT02899299|80171932|FG000|Treatment|Participant no longer meets Study criteria|4|||
27541538|NCT02899299|80171933|FG001|Treatment|Participant no longer meets Study criteria|0|||
27541539|NCT02899299|80171932|FG000|Treatment|Administrative reason by Sponsor|2|||
27541540|NCT02899299|80171933|FG001|Treatment|Administrative reason by Sponsor|0|||
27541541|NCT02899299|80171932|FG000|Treatment|Other reasons|12|||
27541542|NCT02899299|80171933|FG001|Treatment|Other reasons|2|||
27541543|NCT02899299|80171932|FG000|Treatment|Not reported|7|||
27541544|NCT02899299|80171933|FG001|Treatment|Not reported|0|||
27541545|NCT03758066|80171934|FG000|Overall Study|Lost to Follow-up|14|||
27541546|NCT03087643|80175642|FG000|Overall Study|Withdrawal by Subject|2|||
27541547|NCT03087643|80175643|FG001|Overall Study|Withdrawal by Subject|4|||
27541548|NCT03087643|80175642|FG000|Overall Study|Death|2|||
27541549|NCT03087643|80175643|FG001|Overall Study|Death|2|||
27541550|NCT01787331|80175644|FG000|Overall Study|Physician Decision|1|||
27541551|NCT01787331|80175644|FG000|Overall Study|Withdrawal by Subject|1|||
27541552|NCT00570765|80175645|FG000|DB Phase|Withdrawal by Subject|1|||
27541553|NCT00570765|80175646|FG001|DB Phase|Withdrawal by Subject|0|||
27541554|NCT00570765|80175647|FG002|DB Phase|Withdrawal by Subject|0|||
27541555|NCT00570765|80175648|FG003|DB Phase|Withdrawal by Subject|0|||
27541556|NCT00570765|80175645|FG000|DB Phase|Protocol Violation|0|||
27541557|NCT00570765|80175646|FG001|DB Phase|Protocol Violation|1|||
27541558|NCT00570765|80175647|FG002|DB Phase|Protocol Violation|0|||
27541559|NCT00570765|80175648|FG003|DB Phase|Protocol Violation|0|||
27541560|NCT00570765|80175645|FG000|DB Phase|Adverse Event|3|||
27541561|NCT00570765|80175646|FG001|DB Phase|Adverse Event|6|||
27541562|NCT00570765|80175647|FG002|DB Phase|Adverse Event|0|||
27541563|NCT00570765|80175648|FG003|DB Phase|Adverse Event|0|||
27541564|NCT00570765|80175645|FG000|DB Phase|Did Not Receive Study Drug|0|||
27541565|NCT00570765|80175646|FG001|DB Phase|Did Not Receive Study Drug|0|||
27541566|NCT00570765|80175647|FG002|DB Phase|Did Not Receive Study Drug|1|||
27541567|NCT00570765|80175648|FG003|DB Phase|Did Not Receive Study Drug|0|||
27541568|NCT00570765|80175645|FG000|LTSE Phase|Withdrawal by Subject|0|||
27541569|NCT00570765|80175646|FG001|LTSE Phase|Withdrawal by Subject|0|||
27541570|NCT00570765|80175647|FG002|LTSE Phase|Withdrawal by Subject|0|||
27541571|NCT00570765|80175648|FG003|LTSE Phase|Withdrawal by Subject|1|||
27541572|NCT00570765|80175645|FG000|LTSE Phase|Adverse Event|0|||
27541573|NCT00570765|80175646|FG001|LTSE Phase|Adverse Event|0|||
27920596|NCT01712178|81546999|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
27920597|NCT01712178|81547000|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
27541574|NCT00570765|80175647|FG002|LTSE Phase|Adverse Event|0|||
27541575|NCT00570765|80175648|FG003|LTSE Phase|Adverse Event|7|||
27541576|NCT00570765|80175645|FG000|LTSE Phase|Physician Decision|0|||
27541577|NCT00570765|80175646|FG001|LTSE Phase|Physician Decision|0|||
27541578|NCT00570765|80175647|FG002|LTSE Phase|Physician Decision|0|||
27541579|NCT00570765|80175648|FG003|LTSE Phase|Physician Decision|4|||
27541580|NCT00717093|80175649|FG000|Overall Study|Adverse Event|19|||
27541581|NCT00717093|80175650|FG001|Overall Study|Adverse Event|9|||
27541582|NCT00717093|80175649|FG000|Overall Study|Lack of Efficacy|3|||
27541583|NCT00717093|80175650|FG001|Overall Study|Lack of Efficacy|13|||
27541584|NCT00717093|80175649|FG000|Overall Study|Lost to Follow-up|9|||
27541585|NCT00717093|80175650|FG001|Overall Study|Lost to Follow-up|6|||
27541586|NCT00717093|80175649|FG000|Overall Study|Withdrawal by Subject|12|||
27541587|NCT00717093|80175650|FG001|Overall Study|Withdrawal by Subject|19|||
27541588|NCT00717093|80175649|FG000|Overall Study|Other|0|||
27541589|NCT00717093|80175650|FG001|Overall Study|Other|1|||
27541590|NCT00717093|80175649|FG000|Overall Study|Randomized but not treated|1|||
27541591|NCT00717093|80175650|FG001|Overall Study|Randomized but not treated|0|||
27541592|NCT01218113|80175651|FG000|Overall Study|Withdrawal by Subject|1|||
27541593|NCT01218113|80175652|FG001|Overall Study|Withdrawal by Subject|0|||
27541594|NCT01218113|80175653|FG002|Overall Study|Withdrawal by Subject|1|||
27541595|NCT01218113|80175651|FG000|Overall Study|Lost to Follow-up|4|||
27541596|NCT01218113|80175652|FG001|Overall Study|Lost to Follow-up|1|||
27541597|NCT01218113|80175653|FG002|Overall Study|Lost to Follow-up|4|||
27541598|NCT01218113|80175651|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
27541599|NCT01218113|80175652|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
27541600|NCT01218113|80175653|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
27541601|NCT03334539|80175655|FG000|Overall Study|Adverse Event|3|||
27541602|NCT03334539|80175656|FG001|Overall Study|Adverse Event|5|||
27541603|NCT03334539|80175657|FG002|Overall Study|Adverse Event|0|||
27541604|NCT03334539|80175655|FG000|Overall Study|Withdrawal by Subject|0|||
27541605|NCT03334539|80175656|FG001|Overall Study|Withdrawal by Subject|1|||
27541606|NCT03334539|80175657|FG002|Overall Study|Withdrawal by Subject|1|||
27541607|NCT03334539|80175655|FG000|Overall Study|Administrative Reasons|1|||
27541608|NCT03334539|80175656|FG001|Overall Study|Administrative Reasons|0|||
27541609|NCT03334539|80175657|FG002|Overall Study|Administrative Reasons|0|||
27541610|NCT03334539|80175655|FG000|Overall Study|Hypertension Not Controlled|0|||
27541611|NCT03334539|80175656|FG001|Overall Study|Hypertension Not Controlled|1|||
27541612|NCT03334539|80175657|FG002|Overall Study|Hypertension Not Controlled|0|||
27541613|NCT01539538|80175658|FG000|Overall Study|Adverse Event|13|||
27541614|NCT01539538|80175659|FG001|Overall Study|Adverse Event|18|||
27541615|NCT01539538|80175658|FG000|Overall Study|Lack of Efficacy|13|||
27541616|NCT01539538|80175659|FG001|Overall Study|Lack of Efficacy|16|||
27541617|NCT01539538|80175658|FG000|Overall Study|Withdrawal by Subject|2|||
27541618|NCT01539538|80175659|FG001|Overall Study|Withdrawal by Subject|3|||
27541619|NCT01539538|80175658|FG000|Overall Study|PCA no longer required or PCA problem|3|||
27541620|NCT01539538|80175659|FG001|Overall Study|PCA no longer required or PCA problem|7|||
27541621|NCT01090492|80175660|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27541622|NCT01090492|80175661|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27541623|NCT01090492|80175662|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27541624|NCT01090492|80175663|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
27541625|NCT01090492|80175664|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
27541626|NCT01090492|80175665|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
27541627|NCT01090492|80175666|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
27541628|NCT01090492|80175667|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
27541629|NCT01090492|80175660|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27541630|NCT01090492|80175661|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
27541631|NCT01090492|80175662|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27541632|NCT01090492|80175663|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27541633|NCT01090492|80175664|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27541634|NCT01090492|80175665|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27541635|NCT01090492|80175666|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
27541636|NCT01090492|80175667|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
27541637|NCT01090492|80175660|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541638|NCT01090492|80175661|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541639|NCT01090492|80175662|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
27541640|NCT01090492|80175663|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541641|NCT01090492|80175664|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541642|NCT01090492|80175665|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541643|NCT01090492|80175666|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541644|NCT01090492|80175667|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541645|NCT01090492|80175660|FG000|First Intervention Period (4 Weeks)|Other|0|||
27541646|NCT01090492|80175661|FG001|First Intervention Period (4 Weeks)|Other|0|||
27541647|NCT01090492|80175662|FG002|First Intervention Period (4 Weeks)|Other|1|||
27541648|NCT01090492|80175663|FG003|First Intervention Period (4 Weeks)|Other|1|||
27541649|NCT01090492|80175664|FG004|First Intervention Period (4 Weeks)|Other|2|||
27541650|NCT01090492|80175665|FG005|First Intervention Period (4 Weeks)|Other|0|||
27541651|NCT01090492|80175666|FG006|First Intervention Period (4 Weeks)|Other|0|||
27920598|NCT01712178|81546999|FG000|Overall Study|Lost to Follow-up|0|||
27541652|NCT01090492|80175667|FG007|First Intervention Period (4 Weeks)|Other|0|||
27541653|NCT01090492|80175660|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541654|NCT01090492|80175661|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541655|NCT01090492|80175662|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541656|NCT01090492|80175663|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541657|NCT01090492|80175664|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
27541658|NCT01090492|80175665|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541659|NCT01090492|80175666|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541660|NCT01090492|80175667|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
27541661|NCT01090492|80175660|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
27541662|NCT01090492|80175661|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
27541663|NCT01090492|80175662|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
27541664|NCT01090492|80175663|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
27541665|NCT01090492|80175664|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
27541666|NCT01090492|80175665|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
27541667|NCT01090492|80175666|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
27541668|NCT01090492|80175667|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
27541669|NCT01090492|80175660|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27541670|NCT01090492|80175661|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27541671|NCT01090492|80175662|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27541672|NCT01090492|80175663|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27541673|NCT01090492|80175664|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27541674|NCT01090492|80175665|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
27541675|NCT01090492|80175666|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27541676|NCT01090492|80175667|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
27636381|NCT01400776|80509770|FG000|Overall Study|Lost to Follow-up|1|||
27636382|NCT01400776|80509771|FG001|Overall Study|Lost to Follow-up|0|||
27636383|NCT01400776|80509772|FG002|Overall Study|Lost to Follow-up|4|||
27636384|NCT01400776|80509773|FG003|Overall Study|Lost to Follow-up|1|||
27636385|NCT01400776|80509770|FG000|Overall Study|Withdrew Consent|4|||
27636386|NCT01400776|80509771|FG001|Overall Study|Withdrew Consent|2|||
27636387|NCT01400776|80509772|FG002|Overall Study|Withdrew Consent|6|||
27636388|NCT01400776|80509773|FG003|Overall Study|Withdrew Consent|1|||
27636389|NCT01400776|80509770|FG000|Overall Study|Protocol Deviation|6|||
27636390|NCT01400776|80509771|FG001|Overall Study|Protocol Deviation|1|||
27636391|NCT01400776|80509772|FG002|Overall Study|Protocol Deviation|5|||
27636392|NCT01400776|80509773|FG003|Overall Study|Protocol Deviation|2|||
27636393|NCT01400776|80509770|FG000|Overall Study|Reason not Specified|3|||
27636394|NCT01400776|80509771|FG001|Overall Study|Reason not Specified|0|||
27636395|NCT01400776|80509772|FG002|Overall Study|Reason not Specified|4|||
27636396|NCT01400776|80509773|FG003|Overall Study|Reason not Specified|3|||
27636397|NCT01066923|80509775|FG000|Overall Study|Withdrawal by Subject|3|||
27636398|NCT01066923|80509776|FG001|Overall Study|Withdrawal by Subject|3|||
27636399|NCT01066923|80509777|FG002|Overall Study|Withdrawal by Subject|8|||
27636400|NCT01066923|80509778|FG003|Overall Study|Withdrawal by Subject|8|||
27636401|NCT00539292|80509780|FG000|Overall Study|Physician Decision|1|||
27636402|NCT00539292|80509781|FG001|Overall Study|Physician Decision|0|||
27636403|NCT03621696|80509789|FG000|Overall Study|Not eligible|0|||
27636404|NCT03621696|80509790|FG001|Overall Study|Not eligible|0|||
27636405|NCT03621696|80509791|FG002|Overall Study|Not eligible|0|||
27636406|NCT03621696|80509792|FG003|Overall Study|Not eligible|5|||
27636407|NCT03621696|80509789|FG000|Overall Study|Withdrawal by Subject|1|||
27636408|NCT03621696|80509790|FG001|Overall Study|Withdrawal by Subject|1|||
27636409|NCT03621696|80509791|FG002|Overall Study|Withdrawal by Subject|1|||
27636410|NCT03621696|80509792|FG003|Overall Study|Withdrawal by Subject|0|||
27920599|NCT01712178|81547000|FG001|Overall Study|Lost to Follow-up|1|||
27920600|NCT00846365|81547005|FG000|Overall Study|Adverse Event|20|||
27920601|NCT00846365|81547006|FG001|Overall Study|Adverse Event|30|||
27920602|NCT00846365|81547007|FG002|Overall Study|Adverse Event|11|||
27920603|NCT00846365|81547005|FG000|Overall Study|Protocol Violation|5|||
27920604|NCT00846365|81547006|FG001|Overall Study|Protocol Violation|4|||
27920605|NCT00846365|81547007|FG002|Overall Study|Protocol Violation|0|||
27920606|NCT00846365|81547005|FG000|Overall Study|Lost to Follow-up|8|||
27920607|NCT00846365|81547006|FG001|Overall Study|Lost to Follow-up|2|||
27636411|NCT03621696|80509789|FG000|Overall Study|Physician Decision|0|||
27636412|NCT03621696|80509790|FG001|Overall Study|Physician Decision|0|||
27636413|NCT03621696|80509791|FG002|Overall Study|Physician Decision|1|||
27636414|NCT03621696|80509792|FG003|Overall Study|Physician Decision|0|||
27636415|NCT01561989|80509793|FG000|Overall Study|accural target not met.|5|||
27636416|NCT01561989|80509794|FG001|Overall Study|accural target not met.|6|||
27636417|NCT02549170|80509795|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
27636418|NCT02549170|80509796|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
27636419|NCT02549170|80509797|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
27920608|NCT00846365|81547007|FG002|Overall Study|Lost to Follow-up|5|||
27920609|NCT00846365|81547005|FG000|Overall Study|Withdrawal by Subject|11|||
27920610|NCT00846365|81547006|FG001|Overall Study|Withdrawal by Subject|11|||
27920611|NCT00846365|81547007|FG002|Overall Study|Withdrawal by Subject|9|||
27920612|NCT00846365|81547005|FG000|Overall Study|Pregnancy|1|||
27920613|NCT00846365|81547006|FG001|Overall Study|Pregnancy|0|||
27920614|NCT00846365|81547007|FG002|Overall Study|Pregnancy|0|||
27920615|NCT00846365|81547005|FG000|Overall Study|Lack of Efficacy|1|||
27920616|NCT00846365|81547006|FG001|Overall Study|Lack of Efficacy|1|||
27920617|NCT00846365|81547007|FG002|Overall Study|Lack of Efficacy|2|||
27920618|NCT00846365|81547005|FG000|Overall Study|Other|9|||
27920619|NCT00846365|81547006|FG001|Overall Study|Other|1|||
27920620|NCT00846365|81547007|FG002|Overall Study|Other|6|||
27541677|NCT01090492|80175660|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541678|NCT01090492|80175661|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
27541679|NCT01090492|80175662|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541680|NCT01090492|80175663|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541681|NCT01090492|80175664|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541682|NCT01090492|80175665|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541683|NCT01090492|80175666|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541684|NCT01090492|80175667|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
27541685|NCT01090492|80175660|FG000|Second Intervention Period (4 Weeks)|Other|0|||
27541686|NCT01090492|80175661|FG001|Second Intervention Period (4 Weeks)|Other|1|||
27541687|NCT01090492|80175662|FG002|Second Intervention Period (4 Weeks)|Other|1|||
27541688|NCT01090492|80175663|FG003|Second Intervention Period (4 Weeks)|Other|0|||
27541689|NCT01090492|80175664|FG004|Second Intervention Period (4 Weeks)|Other|0|||
27541690|NCT01090492|80175665|FG005|Second Intervention Period (4 Weeks)|Other|0|||
27541691|NCT01090492|80175666|FG006|Second Intervention Period (4 Weeks)|Other|0|||
27541692|NCT01090492|80175667|FG007|Second Intervention Period (4 Weeks)|Other|0|||
27636420|NCT02549170|80509798|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
27636421|NCT02549170|80509799|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
27636422|NCT02549170|80509795|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
27636423|NCT02549170|80509796|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
27636424|NCT02549170|80509797|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
27636425|NCT02549170|80509798|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
27636426|NCT02549170|80509799|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
27636427|NCT02549170|80509795|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
27636428|NCT02549170|80509796|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
27636429|NCT02549170|80509797|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
27920621|NCT04556760|81547010|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
27920622|NCT04556760|81547011|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
27920623|NCT04556760|81547012|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
27920624|NCT04556760|81547013|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
27920625|NCT04556760|81547014|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
27920626|NCT04556760|81547015|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
27920627|NCT04556760|81547010|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
27920628|NCT04556760|81547011|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
27920629|NCT04556760|81547012|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
27920630|NCT04556760|81547013|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
27920631|NCT04556760|81547014|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
27920632|NCT04556760|81547015|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
27920633|NCT01186770|81547020|FG000|Overall Study|Ineligibility|0|||
27920634|NCT01186770|81547021|FG001|Overall Study|Ineligibility|0|||
27920635|NCT01186770|81547022|FG002|Overall Study|Ineligibility|2|||
27920636|NCT01186770|81547023|FG003|Overall Study|Ineligibility|0|||
27920637|NCT01186770|81547020|FG000|Overall Study|Protocol Violation|7|||
27920638|NCT01186770|81547021|FG001|Overall Study|Protocol Violation|9|||
27920639|NCT01186770|81547022|FG002|Overall Study|Protocol Violation|12|||
27920640|NCT01186770|81547023|FG003|Overall Study|Protocol Violation|14|||
27920641|NCT01186770|81547020|FG000|Overall Study|Adverse Event|2|||
27920642|NCT01186770|81547021|FG001|Overall Study|Adverse Event|9|||
27920643|NCT01186770|81547022|FG002|Overall Study|Adverse Event|7|||
27636430|NCT02549170|80509798|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
27740929|NCT01736683|80880770|FG002|Overall Study|Withdrawal by Subject|3|||
27920644|NCT01186770|81547023|FG003|Overall Study|Adverse Event|9|||
27920645|NCT01186770|81547020|FG000|Overall Study|Withdrawal by Subject|15|||
27920646|NCT01186770|81547021|FG001|Overall Study|Withdrawal by Subject|13|||
27920647|NCT01186770|81547022|FG002|Overall Study|Withdrawal by Subject|11|||
27920648|NCT01186770|81547023|FG003|Overall Study|Withdrawal by Subject|17|||
27920649|NCT01186770|81547020|FG000|Overall Study|Lost to Follow-up|10|||
27920650|NCT01186770|81547021|FG001|Overall Study|Lost to Follow-up|6|||
27920651|NCT01186770|81547022|FG002|Overall Study|Lost to Follow-up|14|||
27920652|NCT01186770|81547023|FG003|Overall Study|Lost to Follow-up|9|||
27920653|NCT01186770|81547020|FG000|Overall Study|Insufficient response to treatment|7|||
27920654|NCT01186770|81547021|FG001|Overall Study|Insufficient response to treatment|8|||
27920655|NCT01186770|81547022|FG002|Overall Study|Insufficient response to treatment|5|||
27541693|NCT01090492|80175660|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
27541694|NCT01090492|80175661|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
27541695|NCT01090492|80175662|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27541696|NCT01090492|80175663|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
27541697|NCT01090492|80175664|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27541698|NCT01090492|80175665|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27541699|NCT01090492|80175666|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
27541700|NCT01090492|80175667|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
27541701|NCT01090492|80175660|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541702|NCT01090492|80175661|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541703|NCT01090492|80175662|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541704|NCT01090492|80175663|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541705|NCT01090492|80175664|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541706|NCT01090492|80175665|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541707|NCT01090492|80175666|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
27541708|NCT01090492|80175667|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
27541709|NCT01681472|80175668|FG000|Overall Study|Adverse Event|0|||
27541710|NCT01681472|80175669|FG001|Overall Study|Adverse Event|1|||
27541711|NCT01681472|80175670|FG002|Overall Study|Adverse Event|0|||
27541712|NCT01681472|80175671|FG003|Overall Study|Adverse Event|0|||
27541713|NCT01889238|80175672|FG000|Overall Study|Treatment ongoing|9|||
27541714|NCT00675948|80175673|FG000|Overall Study|Adverse Event|23|||
27541715|NCT00675948|80175674|FG001|Overall Study|Adverse Event|1|||
27541716|NCT00675948|80175673|FG000|Overall Study|Lack of Efficacy|3|||
27541717|NCT00675948|80175674|FG001|Overall Study|Lack of Efficacy|0|||
27541718|NCT00675948|80175673|FG000|Overall Study|Withdrawal by Subject|7|||
27541719|NCT00675948|80175674|FG001|Overall Study|Withdrawal by Subject|0|||
27541720|NCT00675948|80175673|FG000|Overall Study|Lost to Follow-up|2|||
27541721|NCT00675948|80175674|FG001|Overall Study|Lost to Follow-up|0|||
27541722|NCT00675948|80175673|FG000|Overall Study|Protocol Violation|1|||
27541723|NCT00675948|80175674|FG001|Overall Study|Protocol Violation|0|||
27541724|NCT00675948|80175673|FG000|Overall Study|Pain under control|1|||
27541725|NCT00675948|80175674|FG001|Overall Study|Pain under control|0|||
27541726|NCT00675948|80175673|FG000|Overall Study|Sponsor decision|0|||
27541727|NCT00675948|80175674|FG001|Overall Study|Sponsor decision|1|||
27541728|NCT00675948|80175673|FG000|Overall Study|Patient died|1|||
27541729|NCT00675948|80175674|FG001|Overall Study|Patient died|0|||
27541730|NCT00675948|80175673|FG000|Overall Study|Patient unable to comply with diaries|1|||
27541731|NCT00675948|80175674|FG001|Overall Study|Patient unable to comply with diaries|0|||
27541732|NCT00675948|80175673|FG000|Overall Study|Patient feels unable to take medication|0|||
27541733|NCT00675948|80175674|FG001|Overall Study|Patient feels unable to take medication|1|||
27541734|NCT00437983|80175675|FG000|Overall Study|Adverse Event|6|||
27541735|NCT00437983|80175676|FG001|Overall Study|Adverse Event|6|||
27541736|NCT00437983|80175675|FG000|Overall Study|Protocol Violation|2|||
27541737|NCT00437983|80175676|FG001|Overall Study|Protocol Violation|1|||
27541738|NCT00437983|80175675|FG000|Overall Study|Withdrawal by Subject|5|||
27541739|NCT00437983|80175676|FG001|Overall Study|Withdrawal by Subject|6|||
27541740|NCT00531934|80175678|FG000|Overall Study|Adverse Event|4|||
27541741|NCT00531934|80175679|FG001|Overall Study|Adverse Event|8|||
27541742|NCT00531934|80175678|FG000|Overall Study|Progression|52|||
27541743|NCT00531934|80175679|FG001|Overall Study|Progression|42|||
27541744|NCT00531934|80175678|FG000|Overall Study|Death|7|||
27541745|NCT00531934|80175679|FG001|Overall Study|Death|10|||
27541746|NCT00531934|80175678|FG000|Overall Study|Withdrawal by Subject|1|||
27541747|NCT00531934|80175679|FG001|Overall Study|Withdrawal by Subject|1|||
27541748|NCT00531934|80175678|FG000|Overall Study|Other|2|||
27541749|NCT00531934|80175679|FG001|Overall Study|Other|2|||
27541750|NCT01313858|80175680|FG000|Overall Study|Premature Treatment Termination|251|||
27541751|NCT01313858|80175681|FG001|Overall Study|Premature Treatment Termination|219|||
27541752|NCT01313858|80175682|FG002|Overall Study|Premature Treatment Termination|191|||
27541753|NCT01313858|80175680|FG000|Overall Study|Lost to Follow-up|35|||
27636431|NCT02549170|80509799|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
27740930|NCT01736683|80880771|FG003|Overall Study|Withdrawal by Subject|1|||
27740931|NCT01736683|80880772|FG004|Overall Study|Withdrawal by Subject|1|||
27740932|NCT01736683|80880768|FG000|Overall Study|Lack of Therapeutic Effect|7|||
27920656|NCT01186770|81547023|FG003|Overall Study|Insufficient response to treatment|7|||
27541754|NCT01313858|80175681|FG001|Overall Study|Lost to Follow-up|51|||
27541755|NCT01313858|80175682|FG002|Overall Study|Lost to Follow-up|47|||
27541756|NCT01849783|80175683|FG000|Overall Study|Adverse Event|5|||
27541757|NCT01849783|80175683|FG000|Overall Study|Death|2|||
27541758|NCT01849783|80175683|FG000|Overall Study|Physician Decision|1|||
27541759|NCT01849783|80175683|FG000|Overall Study|Withdrawal by Subject|1|||
27541760|NCT01849783|80175683|FG000|Overall Study|Unable to comply|2|||
27541761|NCT01849783|80175683|FG000|Overall Study|Disease progression|11|||
27541762|NCT02302807|80175684|FG000|Overall Study|Withdrawal by Subject|28|||
27541763|NCT02302807|80175685|FG001|Overall Study|Withdrawal by Subject|11|||
27541764|NCT02302807|80175684|FG000|Overall Study|Lost to Follow-up|4|||
27541765|NCT02302807|80175685|FG001|Overall Study|Lost to Follow-up|6|||
27541766|NCT02302807|80175684|FG000|Overall Study|Death|397|||
27541767|NCT02302807|80175685|FG001|Overall Study|Death|385|||
27541768|NCT02302807|80175684|FG000|Overall Study|Study Terminated By Sponsor|35|||
27541769|NCT02302807|80175685|FG001|Overall Study|Study Terminated By Sponsor|64|||
27541770|NCT02302807|80175684|FG000|Overall Study|Physician Decision|0|||
27541771|NCT02302807|80175685|FG001|Overall Study|Physician Decision|1|||
27541772|NCT00724932|80175688|FG000|Overall Study|Lost to Follow-up|1|||
27541773|NCT00724932|80175689|FG001|Overall Study|Lost to Follow-up|0|||
27541774|NCT00724932|80175688|FG000|Overall Study|Not treated|4|||
27541775|NCT00724932|80175689|FG001|Overall Study|Not treated|3|||
27541776|NCT01387932|80175690|FG000|Randomized and Treated|Physician Decision|3|||
27541777|NCT01387932|80175691|FG001|Randomized and Treated|Physician Decision|2|||
27541778|NCT01387932|80175690|FG000|Randomized and Treated|Withdrawal by Subject|4|||
27541779|NCT01387932|80175691|FG001|Randomized and Treated|Withdrawal by Subject|2|||
27541780|NCT01387932|80175690|FG000|Survival Follow-up|Liver Transplant|24|||
27541781|NCT01387932|80175691|FG001|Survival Follow-up|Liver Transplant|28|||
27636432|NCT04048135|80509805|FG000|Overall Study|Withdrawal by Subject|1|||
27636433|NCT04048135|80509806|FG001|Overall Study|Withdrawal by Subject|1|||
27636434|NCT04048135|80509807|FG002|Overall Study|Withdrawal by Subject|1|||
27636435|NCT04048135|80509808|FG003|Overall Study|Withdrawal by Subject|2|||
27636436|NCT04048135|80509809|FG004|Overall Study|Withdrawal by Subject|0|||
27636437|NCT04048135|80509810|FG005|Overall Study|Withdrawal by Subject|0|||
27636438|NCT04048135|80509811|FG006|Overall Study|Withdrawal by Subject|1|||
27636439|NCT04048135|80509812|FG007|Overall Study|Withdrawal by Subject|1|||
27636440|NCT04048135|80509805|FG000|Overall Study|Adverse Event|0|||
27636441|NCT04048135|80509806|FG001|Overall Study|Adverse Event|0|||
27636442|NCT04048135|80509807|FG002|Overall Study|Adverse Event|0|||
27636443|NCT04048135|80509808|FG003|Overall Study|Adverse Event|1|||
27636444|NCT04048135|80509809|FG004|Overall Study|Adverse Event|1|||
27636445|NCT04048135|80509810|FG005|Overall Study|Adverse Event|0|||
27636446|NCT04048135|80509811|FG006|Overall Study|Adverse Event|0|||
27636447|NCT04048135|80509812|FG007|Overall Study|Adverse Event|0|||
27636448|NCT04048135|80509805|FG000|Overall Study|Protocol Violation|0|||
27636449|NCT04048135|80509806|FG001|Overall Study|Protocol Violation|0|||
27636450|NCT04048135|80509807|FG002|Overall Study|Protocol Violation|0|||
27636451|NCT04048135|80509808|FG003|Overall Study|Protocol Violation|0|||
27636452|NCT04048135|80509809|FG004|Overall Study|Protocol Violation|0|||
27636453|NCT04048135|80509810|FG005|Overall Study|Protocol Violation|1|||
27636454|NCT04048135|80509811|FG006|Overall Study|Protocol Violation|0|||
27636455|NCT04048135|80509812|FG007|Overall Study|Protocol Violation|0|||
27636456|NCT01068743|80509813|FG000|Period 3|Adverse Event|0|||
27636457|NCT01068743|80509814|FG001|Period 3|Adverse Event|1|||
27636458|NCT01068743|80509815|FG002|Period 3|Adverse Event|0|||
27636459|NCT01068743|80509816|FG003|Period 3|Adverse Event|0|||
27636460|NCT03557008|80509817|FG000|Overall Study|Withdrawal by Subject|2|||
27636461|NCT03557008|80509818|FG001|Overall Study|Withdrawal by Subject|2|||
27636462|NCT03557008|80509817|FG000|Overall Study|Early termination from study|3|||
27636463|NCT03557008|80509818|FG001|Overall Study|Early termination from study|1|||
27636464|NCT01867216|80509827|FG000|Overall Study|Withdrawal by Subject|2|||
27636465|NCT01867216|80509828|FG001|Overall Study|Withdrawal by Subject|0|||
27541782|NCT01387932|80175690|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
27541783|NCT01387932|80175691|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
27541784|NCT01387932|80175690|FG000|Survival Follow-up|Withdrawal by Subject|2|||
27541785|NCT01387932|80175691|FG001|Survival Follow-up|Withdrawal by Subject|4|||
27541786|NCT01387932|80175690|FG000|Survival Follow-up|Lost to Follow-up|6|||
27541787|NCT01387932|80175691|FG001|Survival Follow-up|Lost to Follow-up|5|||
27636466|NCT01867216|80509829|FG002|Overall Study|Withdrawal by Subject|0|||
27636467|NCT01867216|80509830|FG003|Overall Study|Withdrawal by Subject|0|||
27636468|NCT01867216|80509831|FG004|Overall Study|Withdrawal by Subject|1|||
27636469|NCT01867216|80509832|FG005|Overall Study|Withdrawal by Subject|0|||
27636470|NCT01867216|80509833|FG006|Overall Study|Withdrawal by Subject|1|||
27636471|NCT01867216|80509827|FG000|Overall Study|Physician Decision|1|||
27636472|NCT01867216|80509828|FG001|Overall Study|Physician Decision|0|||
27636473|NCT01867216|80509829|FG002|Overall Study|Physician Decision|0|||
27541788|NCT00915278|80175692|FG000|Overall Study|Death|1|||
27541789|NCT00915278|80175693|FG001|Overall Study|Death|0|||
27541790|NCT00915278|80175694|FG002|Overall Study|Death|0|||
27636474|NCT01867216|80509830|FG003|Overall Study|Physician Decision|0|||
27541791|NCT00915278|80175695|FG003|Overall Study|Death|0|||
27541792|NCT00915278|80175696|FG004|Overall Study|Death|0|||
27541793|NCT00915278|80175697|FG005|Overall Study|Death|0|||
27541794|NCT00915278|80175692|FG000|Overall Study|Lost to Follow-up|0|||
27541795|NCT00915278|80175693|FG001|Overall Study|Lost to Follow-up|1|||
27541796|NCT00915278|80175694|FG002|Overall Study|Lost to Follow-up|0|||
27541797|NCT00915278|80175695|FG003|Overall Study|Lost to Follow-up|0|||
27541798|NCT00915278|80175696|FG004|Overall Study|Lost to Follow-up|0|||
27541799|NCT00915278|80175697|FG005|Overall Study|Lost to Follow-up|0|||
27541800|NCT00915278|80175692|FG000|Overall Study|Withdrawal by Subject|0|||
27541801|NCT00915278|80175693|FG001|Overall Study|Withdrawal by Subject|1|||
27541802|NCT00915278|80175694|FG002|Overall Study|Withdrawal by Subject|0|||
27541803|NCT00915278|80175695|FG003|Overall Study|Withdrawal by Subject|0|||
27541804|NCT00915278|80175696|FG004|Overall Study|Withdrawal by Subject|1|||
27541805|NCT00915278|80175697|FG005|Overall Study|Withdrawal by Subject|4|||
27541806|NCT00915278|80175692|FG000|Overall Study|Adverse Event|4|||
27541807|NCT00915278|80175693|FG001|Overall Study|Adverse Event|1|||
27541808|NCT00915278|80175694|FG002|Overall Study|Adverse Event|0|||
27541809|NCT00915278|80175695|FG003|Overall Study|Adverse Event|0|||
27541810|NCT00915278|80175696|FG004|Overall Study|Adverse Event|0|||
27541811|NCT00915278|80175697|FG005|Overall Study|Adverse Event|0|||
27541812|NCT00915278|80175692|FG000|Overall Study|Progressive disease/clinical progression|0|||
27541813|NCT00915278|80175693|FG001|Overall Study|Progressive disease/clinical progression|0|||
27541814|NCT00915278|80175694|FG002|Overall Study|Progressive disease/clinical progression|0|||
27541815|NCT00915278|80175695|FG003|Overall Study|Progressive disease/clinical progression|3|||
27541816|NCT00915278|80175696|FG004|Overall Study|Progressive disease/clinical progression|1|||
27541817|NCT00915278|80175697|FG005|Overall Study|Progressive disease/clinical progression|2|||
27541818|NCT00915278|80175692|FG000|Overall Study|Infusion related AEs|0|||
27541819|NCT00915278|80175693|FG001|Overall Study|Infusion related AEs|0|||
27541820|NCT00915278|80175694|FG002|Overall Study|Infusion related AEs|0|||
27541821|NCT00915278|80175695|FG003|Overall Study|Infusion related AEs|0|||
27541822|NCT00915278|80175696|FG004|Overall Study|Infusion related AEs|0|||
27541823|NCT00915278|80175697|FG005|Overall Study|Infusion related AEs|2|||
27541824|NCT00915278|80175692|FG000|Overall Study|Admission to hospice|0|||
27541825|NCT00915278|80175693|FG001|Overall Study|Admission to hospice|0|||
27541826|NCT00915278|80175694|FG002|Overall Study|Admission to hospice|1|||
27541827|NCT00915278|80175695|FG003|Overall Study|Admission to hospice|0|||
27541828|NCT00915278|80175696|FG004|Overall Study|Admission to hospice|0|||
27541829|NCT00915278|80175697|FG005|Overall Study|Admission to hospice|0|||
27541830|NCT00334958|80175700|FG000|Overall Study|Medication Noncompliance|0|||
27541831|NCT00334958|80175701|FG001|Overall Study|Medication Noncompliance|3|||
27541832|NCT00334958|80175700|FG000|Overall Study|Protocol Violation|2|||
27541833|NCT00334958|80175701|FG001|Overall Study|Protocol Violation|2|||
27541834|NCT00334958|80175700|FG000|Overall Study|Request of the investigator or sponsor|0|||
27541835|NCT00334958|80175701|FG001|Overall Study|Request of the investigator or sponsor|1|||
27541836|NCT00334958|80175700|FG000|Overall Study|Withdrawal by Subject|7|||
27541837|NCT00334958|80175701|FG001|Overall Study|Withdrawal by Subject|4|||
27920657|NCT01186770|81547020|FG000|Overall Study|Other than specified|0|||
27920658|NCT01186770|81547021|FG001|Overall Study|Other than specified|1|||
27920659|NCT01186770|81547022|FG002|Overall Study|Other than specified|1|||
27920660|NCT01186770|81547023|FG003|Overall Study|Other than specified|2|||
27920661|NCT03817528|81547024|FG000|Overall Study|Withdrawal by Subject|1|||
27920662|NCT03817528|81547024|FG000|Overall Study|Adverse Event|2|||
27920663|NCT01922934|81547025|FG000|Eligible Patients|Death|0|||
27920664|NCT01922934|81547026|FG001|Eligible Patients|Death|7|||
27920665|NCT01922934|81547025|FG000|Eligible Patients|Physician Decision|17|||
27920666|NCT01922934|81547026|FG001|Eligible Patients|Physician Decision|0|||
27920667|NCT01922934|81547025|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
27920668|NCT01922934|81547026|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
27920669|NCT01922934|81547025|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
27920670|NCT01922934|81547026|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
27920671|NCT01922934|81547025|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
27920672|NCT01922934|81547026|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
27920673|NCT01922934|81547025|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
27541838|NCT00334958|80175700|FG000|Overall Study|Adverse Event|27|||
27920674|NCT01922934|81547026|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
27920675|NCT00171249|81547027|FG000|Overall Study|Withdrawal by Subject|2|||
27920676|NCT00171249|81547028|FG001|Overall Study|Withdrawal by Subject|0|||
27920677|NCT00171249|81547029|FG002|Overall Study|Withdrawal by Subject|0|||
27541839|NCT00334958|80175701|FG001|Overall Study|Adverse Event|12|||
27541840|NCT00334958|80175700|FG000|Overall Study|Other|1|||
27541841|NCT00334958|80175701|FG001|Overall Study|Other|2|||
27541842|NCT02015754|80175703|FG000|Overall Study|Disease progression|5|||
27541843|NCT02015754|80175703|FG000|Overall Study|Change in treatment modality|5|||
27541844|NCT02015754|80175703|FG000|Overall Study|Lost to Follow-up|1|||
27636475|NCT01867216|80509831|FG004|Overall Study|Physician Decision|0|||
27636476|NCT01867216|80509832|FG005|Overall Study|Physician Decision|0|||
27636477|NCT01867216|80509833|FG006|Overall Study|Physician Decision|0|||
27636478|NCT01867216|80509827|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
27636479|NCT01867216|80509828|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27636480|NCT01867216|80509829|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27636481|NCT01867216|80509830|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27541845|NCT00518687|80175704|FG000|Overall Study|Adverse Event|201|||
27541846|NCT00518687|80175705|FG001|Overall Study|Adverse Event|177|||
27541847|NCT00518687|80175704|FG000|Overall Study|Lost to Follow-up|144|||
27541848|NCT00518687|80175705|FG001|Overall Study|Lost to Follow-up|155|||
27541849|NCT00518687|80175704|FG000|Overall Study|Physician Decision|42|||
27541850|NCT00518687|80175705|FG001|Overall Study|Physician Decision|48|||
27541851|NCT00518687|80175704|FG000|Overall Study|Progressive disease|2|||
27541852|NCT00518687|80175705|FG001|Overall Study|Progressive disease|2|||
27541853|NCT00518687|80175704|FG000|Overall Study|Protocol Violation|8|||
27541854|NCT00518687|80175705|FG001|Overall Study|Protocol Violation|10|||
27541855|NCT00518687|80175704|FG000|Overall Study|Study terminated by sponsor|930|||
27541856|NCT00518687|80175705|FG001|Overall Study|Study terminated by sponsor|918|||
27541857|NCT00518687|80175704|FG000|Overall Study|Withdrawal by Subject|110|||
27541858|NCT00518687|80175705|FG001|Overall Study|Withdrawal by Subject|110|||
27541859|NCT00005044|80175706|FG000|Overall Study|Protocol Violation|37|||
27541860|NCT00005044|80175707|FG001|Overall Study|Protocol Violation|46|||
27541861|NCT00005044|80175706|FG000|Overall Study|Withdrawal by Subject|1|||
27541862|NCT00005044|80175707|FG001|Overall Study|Withdrawal by Subject|5|||
27541863|NCT00005044|80175706|FG000|Overall Study|No protocol treatment|0|||
27541864|NCT00005044|80175707|FG001|Overall Study|No protocol treatment|1|||
27541865|NCT00365508|80175708|FG000|Overall Study|Lost to Follow-up|139|||
27541866|NCT00365508|80175709|FG001|Overall Study|Lost to Follow-up|154|||
27541867|NCT01397890|80175713|FG000|Overall Study|Withdrawal by Subject|7|||
27541868|NCT01397890|80175714|FG001|Overall Study|Withdrawal by Subject|11|||
27541869|NCT01397890|80175713|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
27541870|NCT01397890|80175714|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
27541871|NCT01397890|80175713|FG000|Overall Study|Death|2|||
27541872|NCT01397890|80175714|FG001|Overall Study|Death|3|||
27541873|NCT01397890|80175713|FG000|Overall Study|Lost to Follow-up|1|||
27541874|NCT01397890|80175714|FG001|Overall Study|Lost to Follow-up|4|||
27541875|NCT01397890|80175713|FG000|Overall Study|Condition under Investigation Worsened|1|||
27541876|NCT01397890|80175714|FG001|Overall Study|Condition under Investigation Worsened|3|||
27541877|NCT01397890|80175713|FG000|Overall Study|Adverse Event|1|||
27541878|NCT01397890|80175714|FG001|Overall Study|Adverse Event|2|||
27541879|NCT01397890|80175713|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
27541880|NCT01397890|80175714|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
27541881|NCT01397890|80175713|FG000|Overall Study|Others|2|||
27541882|NCT01397890|80175714|FG001|Overall Study|Others|1|||
27541883|NCT05399641|80175715|FG000|Overall Study|Adverse Event|0|||
27541884|NCT05399641|80175716|FG001|Overall Study|Adverse Event|1|||
27541885|NCT05399641|80175717|FG002|Overall Study|Adverse Event|1|||
27541886|NCT05399641|80175715|FG000|Overall Study|Lost to Follow-up|1|||
27541887|NCT05399641|80175716|FG001|Overall Study|Lost to Follow-up|2|||
27541888|NCT05399641|80175717|FG002|Overall Study|Lost to Follow-up|2|||
27541889|NCT05399641|80175715|FG000|Overall Study|Physician Decision|1|||
27541890|NCT05399641|80175716|FG001|Overall Study|Physician Decision|3|||
27541891|NCT05399641|80175717|FG002|Overall Study|Physician Decision|3|||
27541892|NCT05399641|80175715|FG000|Overall Study|Withdrawal by Subject|4|||
27541893|NCT05399641|80175716|FG001|Overall Study|Withdrawal by Subject|11|||
27541894|NCT05399641|80175717|FG002|Overall Study|Withdrawal by Subject|7|||
27541895|NCT05399641|80175715|FG000|Overall Study|Reason not defined|3|||
27541896|NCT05399641|80175716|FG001|Overall Study|Reason not defined|5|||
27541897|NCT05399641|80175717|FG002|Overall Study|Reason not defined|6|||
27541898|NCT02021773|80175720|FG000|Overall Study|Adverse Event|1|||
27541899|NCT02021773|80175721|FG001|Overall Study|Adverse Event|4|||
27541900|NCT02021773|80175722|FG002|Overall Study|Adverse Event|3|||
27541901|NCT02021773|80175720|FG000|Overall Study|Lack of Efficacy|2|||
27541902|NCT02021773|80175721|FG001|Overall Study|Lack of Efficacy|2|||
27541903|NCT02021773|80175722|FG002|Overall Study|Lack of Efficacy|2|||
27541904|NCT02021773|80175720|FG000|Overall Study|Protocol Violation|2|||
27541905|NCT02021773|80175721|FG001|Overall Study|Protocol Violation|3|||
27541906|NCT02021773|80175722|FG002|Overall Study|Protocol Violation|1|||
27541907|NCT02021773|80175720|FG000|Overall Study|Withdrawal by Subject|3|||
27740933|NCT01736683|80880769|FG001|Overall Study|Lack of Therapeutic Effect|4|||
27541908|NCT02021773|80175721|FG001|Overall Study|Withdrawal by Subject|4|||
27541909|NCT02021773|80175722|FG002|Overall Study|Withdrawal by Subject|5|||
27636482|NCT01867216|80509831|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27740934|NCT01736683|80880770|FG002|Overall Study|Lack of Therapeutic Effect|13|||
27541910|NCT02021773|80175720|FG000|Overall Study|Lost to Follow-up|1|||
27541911|NCT02021773|80175721|FG001|Overall Study|Lost to Follow-up|3|||
27636483|NCT01867216|80509832|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27636484|NCT01867216|80509833|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
27636485|NCT00094575|80509835|FG000|Overall Study|Death|146|||
27636486|NCT00094575|80509836|FG001|Overall Study|Death|146|||
27636487|NCT02983617|80509837|FG000|Overall Study|Adverse Event|0|||
27636488|NCT02983617|80509838|FG001|Overall Study|Adverse Event|7|||
27636489|NCT02983617|80509837|FG000|Overall Study|Death|0|||
27636490|NCT02983617|80509838|FG001|Overall Study|Death|1|||
27636491|NCT02983617|80509837|FG000|Overall Study|Investigator's Discretion|0|||
27636492|NCT02983617|80509838|FG001|Overall Study|Investigator's Discretion|1|||
27636493|NCT02299375|80509839|FG000|Overall Study|Adverse Event, serious fatal|1|||
27636494|NCT02299375|80509840|FG001|Overall Study|Adverse Event, serious fatal|3|||
27636495|NCT02299375|80509839|FG000|Overall Study|Adverse Event, non-fatal|8|||
27636496|NCT02299375|80509840|FG001|Overall Study|Adverse Event, non-fatal|9|||
27636497|NCT02299375|80509839|FG000|Overall Study|Lack of Efficacy|1|||
27636498|NCT02299375|80509840|FG001|Overall Study|Lack of Efficacy|3|||
27636499|NCT02299375|80509839|FG000|Overall Study|Protocol Violation|1|||
27636500|NCT02299375|80509840|FG001|Overall Study|Protocol Violation|3|||
27636501|NCT02299375|80509839|FG000|Overall Study|Other: Met stopping criteria|1|||
27636502|NCT02299375|80509840|FG001|Overall Study|Other: Met stopping criteria|0|||
27636503|NCT02299375|80509839|FG000|Overall Study|Other: Study closed/terminated|66|||
27636504|NCT02299375|80509840|FG001|Overall Study|Other: Study closed/terminated|55|||
27636505|NCT02299375|80509839|FG000|Overall Study|Lost to Follow-up|0|||
27636506|NCT02299375|80509840|FG001|Overall Study|Lost to Follow-up|2|||
27636507|NCT02299375|80509839|FG000|Overall Study|Physician Decision|1|||
27636508|NCT02299375|80509840|FG001|Overall Study|Physician Decision|1|||
27636509|NCT02299375|80509839|FG000|Overall Study|Withdrawal by Subject|1|||
27636510|NCT02299375|80509840|FG001|Overall Study|Withdrawal by Subject|4|||
27636511|NCT00444600|80509845|FG000|Overall Study|Death|7|||
27636512|NCT00444600|80509846|FG001|Overall Study|Death|5|||
27636513|NCT00444600|80509847|FG002|Overall Study|Death|3|||
27636514|NCT00444600|80509848|FG003|Overall Study|Death|2|||
27636515|NCT00444600|80509845|FG000|Overall Study|Dropped|11|||
27636516|NCT00444600|80509846|FG001|Overall Study|Dropped|11|||
27636517|NCT00444600|80509847|FG002|Overall Study|Dropped|7|||
27636518|NCT00444600|80509848|FG003|Overall Study|Dropped|7|||
27636519|NCT00444600|80509845|FG000|Overall Study|Missed visit|1|||
27636520|NCT00444600|80509846|FG001|Overall Study|Missed visit|0|||
27636521|NCT00444600|80509847|FG002|Overall Study|Missed visit|0|||
27636522|NCT00444600|80509848|FG003|Overall Study|Missed visit|1|||
27636523|NCT00393848|80509857|FG000|Overall Study|Surgical schedule|0|||
27636524|NCT00393848|80509858|FG001|Overall Study|Surgical schedule|0|||
27636525|NCT00393848|80509859|FG002|Overall Study|Surgical schedule|0|||
27636526|NCT00393848|80509860|FG003|Overall Study|Surgical schedule|1|||
27636527|NCT00393848|80509857|FG000|Overall Study|Personal reasons|0|||
27636528|NCT00393848|80509858|FG001|Overall Study|Personal reasons|0|||
27636529|NCT00393848|80509859|FG002|Overall Study|Personal reasons|2|||
27636530|NCT00393848|80509860|FG003|Overall Study|Personal reasons|0|||
27636531|NCT00636207|80509865|FG000|Overall Study|Adverse Event|1|||
27636532|NCT00636207|80509866|FG001|Overall Study|Adverse Event|0|||
27636533|NCT00636207|80509867|FG002|Overall Study|Adverse Event|0|||
27636534|NCT00636207|80509868|FG003|Overall Study|Adverse Event|0|||
27636535|NCT00636207|80509869|FG004|Overall Study|Adverse Event|0|||
27636536|NCT00636207|80509870|FG005|Overall Study|Adverse Event|0|||
27636537|NCT00636207|80509871|FG006|Overall Study|Adverse Event|0|||
27636538|NCT00636207|80509865|FG000|Overall Study|Withdrawal by Subject|0|||
27636539|NCT00636207|80509866|FG001|Overall Study|Withdrawal by Subject|1|||
27636540|NCT00636207|80509867|FG002|Overall Study|Withdrawal by Subject|0|||
27636541|NCT00636207|80509868|FG003|Overall Study|Withdrawal by Subject|0|||
27636542|NCT00636207|80509869|FG004|Overall Study|Withdrawal by Subject|1|||
27636543|NCT00636207|80509870|FG005|Overall Study|Withdrawal by Subject|0|||
27636544|NCT00636207|80509871|FG006|Overall Study|Withdrawal by Subject|0|||
27636545|NCT01415349|80509874|FG000|Treatment Period 1|Adverse Event|0|||
27636546|NCT01415349|80509875|FG001|Treatment Period 1|Adverse Event|1|||
27740935|NCT01736683|80880771|FG003|Overall Study|Lack of Therapeutic Effect|20|||
27541912|NCT02021773|80175722|FG002|Overall Study|Lost to Follow-up|0|||
27541913|NCT02021773|80175720|FG000|Overall Study|Reason not specified|3|||
27541914|NCT02021773|80175721|FG001|Overall Study|Reason not specified|0|||
27541915|NCT02021773|80175722|FG002|Overall Study|Reason not specified|0|||
27541916|NCT03988088|80175723|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
27541917|NCT03988088|80175724|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
27541918|NCT03988088|80175725|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
27541919|NCT03988088|80175726|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
27541920|NCT03988088|80175723|FG000|Open-Label Addendum|Lost to Follow-up|0|||
27541921|NCT03988088|80175724|FG001|Open-Label Addendum|Lost to Follow-up|0|||
27541922|NCT03988088|80175725|FG002|Open-Label Addendum|Lost to Follow-up|1|||
27541923|NCT03988088|80175726|FG003|Open-Label Addendum|Lost to Follow-up|0|||
27636547|NCT01415349|80509874|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27920678|NCT00171249|81547030|FG003|Overall Study|Withdrawal by Subject|6|||
27920679|NCT00171249|81547031|FG004|Overall Study|Withdrawal by Subject|0|||
27920680|NCT00171249|81547032|FG005|Overall Study|Withdrawal by Subject|0|||
27920681|NCT00171249|81547033|FG006|Overall Study|Withdrawal by Subject|0|||
27920682|NCT00171249|81547027|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
27920683|NCT00171249|81547028|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27920684|NCT00171249|81547029|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
27920685|NCT00171249|81547030|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
27920686|NCT00171249|81547031|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
27920687|NCT00171249|81547032|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
27920688|NCT00171249|81547033|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
27920689|NCT00171249|81547027|FG000|Overall Study|Death|7|||
27920690|NCT00171249|81547028|FG001|Overall Study|Death|1|||
27920691|NCT00171249|81547029|FG002|Overall Study|Death|0|||
27920692|NCT00171249|81547030|FG003|Overall Study|Death|4|||
27920693|NCT00171249|81547031|FG004|Overall Study|Death|0|||
27920694|NCT00171249|81547032|FG005|Overall Study|Death|3|||
27920695|NCT00171249|81547033|FG006|Overall Study|Death|1|||
27920696|NCT00171249|81547027|FG000|Overall Study|Other|10|||
27920697|NCT00171249|81547028|FG001|Overall Study|Other|0|||
27920698|NCT00171249|81547029|FG002|Overall Study|Other|0|||
27920699|NCT00171249|81547030|FG003|Overall Study|Other|43|||
27920700|NCT00171249|81547031|FG004|Overall Study|Other|0|||
27920701|NCT00171249|81547032|FG005|Overall Study|Other|2|||
27920702|NCT00171249|81547033|FG006|Overall Study|Other|0|||
27920703|NCT00171249|81547027|FG000|Overall Study|No Longer Requires Study Drug|4|||
27920704|NCT00171249|81547028|FG001|Overall Study|No Longer Requires Study Drug|0|||
27920705|NCT00171249|81547029|FG002|Overall Study|No Longer Requires Study Drug|0|||
27920706|NCT00171249|81547030|FG003|Overall Study|No Longer Requires Study Drug|3|||
27920707|NCT00171249|81547031|FG004|Overall Study|No Longer Requires Study Drug|0|||
27920708|NCT00171249|81547032|FG005|Overall Study|No Longer Requires Study Drug|5|||
27920709|NCT00171249|81547033|FG006|Overall Study|No Longer Requires Study Drug|0|||
27920710|NCT00171249|81547027|FG000|Overall Study|Administrative Problems|1|||
27920711|NCT00171249|81547028|FG001|Overall Study|Administrative Problems|0|||
27541924|NCT01976338|80175728|FG000|Overall Study|Physician Decision|0|||
27541925|NCT01976338|80175729|FG001|Overall Study|Physician Decision|1|||
27541926|NCT01976338|80175728|FG000|Overall Study|Lost to Follow-up|3|||
27541927|NCT01976338|80175729|FG001|Overall Study|Lost to Follow-up|0|||
27541928|NCT01976338|80175728|FG000|Overall Study|Withdrawal by Subject|5|||
27541929|NCT01976338|80175729|FG001|Overall Study|Withdrawal by Subject|2|||
27541930|NCT01976338|80175728|FG000|Overall Study|Adverse Event|5|||
27541931|NCT01976338|80175729|FG001|Overall Study|Adverse Event|1|||
27541932|NCT03307967|80175734|FG000|Overall Study|Lost to Follow-up|4|||
27541933|NCT00751933|80175735|FG000|Overall Study|Withdrawal by Subject|0|||
27541934|NCT00751933|80175736|FG001|Overall Study|Withdrawal by Subject|1|||
27541935|NCT00751933|80175737|FG002|Overall Study|Withdrawal by Subject|0|||
27541936|NCT00751933|80175738|FG003|Overall Study|Withdrawal by Subject|0|||
27541937|NCT00751933|80175735|FG000|Overall Study|Physician Decision|0|||
27541938|NCT00751933|80175736|FG001|Overall Study|Physician Decision|0|||
27541939|NCT00751933|80175737|FG002|Overall Study|Physician Decision|1|||
27541940|NCT00751933|80175738|FG003|Overall Study|Physician Decision|1|||
27541941|NCT00621582|80175739|FG000|Overall Study|Adverse Event|7|||
27541942|NCT00621582|80175739|FG000|Overall Study|Protocol Violation|57|||
27541943|NCT00621582|80175739|FG000|Overall Study|Lost to Follow-up|24|||
27541944|NCT00621582|80175739|FG000|Overall Study|issues not identified by investigators|18|||
27541945|NCT05439941|80175740|FG000|Overall Study|Lack of Efficacy|8|||
27541946|NCT05439941|80175741|FG001|Overall Study|Lack of Efficacy|5|||
27541947|NCT05439941|80175742|FG002|Overall Study|Lack of Efficacy|3|||
27541948|NCT05439941|80175740|FG000|Overall Study|Treatment Failure|0|||
27541949|NCT05439941|80175741|FG001|Overall Study|Treatment Failure|1|||
27541950|NCT05439941|80175742|FG002|Overall Study|Treatment Failure|0|||
27541951|NCT05439941|80175740|FG000|Overall Study|Adverse Event|1|||
27920712|NCT00171249|81547029|FG002|Overall Study|Administrative Problems|0|||
27920713|NCT00171249|81547030|FG003|Overall Study|Administrative Problems|2|||
27920714|NCT00171249|81547031|FG004|Overall Study|Administrative Problems|0|||
27920715|NCT00171249|81547032|FG005|Overall Study|Administrative Problems|0|||
27920716|NCT00171249|81547033|FG006|Overall Study|Administrative Problems|0|||
27541952|NCT05439941|80175741|FG001|Overall Study|Adverse Event|3|||
27541953|NCT05439941|80175742|FG002|Overall Study|Adverse Event|0|||
27541954|NCT05439941|80175740|FG000|Overall Study|Adverse Event - Parent Study|1|||
27541955|NCT05439941|80175741|FG001|Overall Study|Adverse Event - Parent Study|0|||
27541956|NCT05439941|80175742|FG002|Overall Study|Adverse Event - Parent Study|0|||
27920717|NCT00171249|81547027|FG000|Overall Study|Adverse Event|3|||
27541957|NCT05439941|80175740|FG000|Overall Study|Pregnancy|1|||
27541958|NCT05439941|80175741|FG001|Overall Study|Pregnancy|0|||
27541959|NCT05439941|80175742|FG002|Overall Study|Pregnancy|0|||
27920718|NCT00171249|81547028|FG001|Overall Study|Adverse Event|1|||
27920719|NCT00171249|81547029|FG002|Overall Study|Adverse Event|0|||
27920720|NCT00171249|81547030|FG003|Overall Study|Adverse Event|15|||
27920721|NCT00171249|81547031|FG004|Overall Study|Adverse Event|0|||
27920722|NCT00171249|81547032|FG005|Overall Study|Adverse Event|2|||
27920723|NCT00171249|81547033|FG006|Overall Study|Adverse Event|0|||
27920724|NCT00171249|81547027|FG000|Overall Study|Lost to Follow-up|5|||
27920725|NCT00171249|81547028|FG001|Overall Study|Lost to Follow-up|0|||
27920726|NCT00171249|81547029|FG002|Overall Study|Lost to Follow-up|0|||
27920727|NCT00171249|81547030|FG003|Overall Study|Lost to Follow-up|9|||
27920728|NCT00171249|81547031|FG004|Overall Study|Lost to Follow-up|0|||
27920729|NCT00171249|81547032|FG005|Overall Study|Lost to Follow-up|0|||
27920730|NCT00171249|81547033|FG006|Overall Study|Lost to Follow-up|0|||
27920731|NCT00888654|81547043|FG000|Overall Study|Problems swallowing oral meds.|1|||
27920732|NCT00888654|81547043|FG000|Overall Study|Not enough oral meds before surgery|3|||
27920733|NCT00888654|81547043|FG000|Overall Study|Surgery aborted|2|||
27920734|NCT00888654|81547043|FG000|Overall Study|Withdrawal by Subject|1|||
27920735|NCT00888654|81547043|FG000|Overall Study|Inelig. due to contraindication of med|1|||
27920736|NCT00888654|81547043|FG000|Overall Study|Change in surg date|1|||
27920737|NCT00888654|81547043|FG000|Overall Study|Stopped meds due to headaches|1|||
27920738|NCT01811238|81547045|FG000|Overall Study|Withdrawal by Subject|42|||
27920739|NCT01811238|81547045|FG000|Overall Study|Adverse Event|25|||
27920740|NCT01811238|81547045|FG000|Overall Study|Protocol Violation|4|||
27541960|NCT05439941|80175740|FG000|Overall Study|Withdrawal by Subject|9|||
27541961|NCT05439941|80175741|FG001|Overall Study|Withdrawal by Subject|6|||
27541962|NCT05439941|80175742|FG002|Overall Study|Withdrawal by Subject|10|||
27541963|NCT05439941|80175740|FG000|Overall Study|Non-Compliance|1|||
27920741|NCT01811238|81547045|FG000|Overall Study|Lack of Efficacy|4|||
27920742|NCT01811238|81547045|FG000|Overall Study|subject refused study medication|6|||
27920743|NCT03499795|81547047|FG000|Overall Study|Adverse Event|1|||
27920744|NCT03499795|81547047|FG000|Overall Study|Lost to Follow-up|1|||
27920745|NCT02732639|81547053|FG000|Overall Study|Lost to Follow-up|1|||
27541964|NCT05439941|80175741|FG001|Overall Study|Non-Compliance|1|||
27541965|NCT05439941|80175742|FG002|Overall Study|Non-Compliance|1|||
27541966|NCT05439941|80175740|FG000|Overall Study|Lost to Follow-up|2|||
27636548|NCT01415349|80509875|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27636549|NCT00668863|80512479|FG000|Overall Study|Objective Progression or Relapse|42|||
27920746|NCT00896493|81547054|FG000|Overall Study|Early disease relapse|3|||
27920747|NCT02513550|81547058|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
27541967|NCT05439941|80175741|FG001|Overall Study|Lost to Follow-up|2|||
27541968|NCT05439941|80175742|FG002|Overall Study|Lost to Follow-up|0|||
27541969|NCT05439941|80175740|FG000|Overall Study|Physician Decision|1|||
27541970|NCT05439941|80175741|FG001|Overall Study|Physician Decision|0|||
27541971|NCT05439941|80175742|FG002|Overall Study|Physician Decision|0|||
27541972|NCT05439941|80175740|FG000|Overall Study|Trial Termination by Sponsor|78|||
27541973|NCT05439941|80175741|FG001|Overall Study|Trial Termination by Sponsor|83|||
27541974|NCT05439941|80175742|FG002|Overall Study|Trial Termination by Sponsor|65|||
27541975|NCT05439941|80175740|FG000|Overall Study|Other than Reasons Listed|2|||
27541976|NCT05439941|80175741|FG001|Overall Study|Other than Reasons Listed|1|||
27541977|NCT05439941|80175742|FG002|Overall Study|Other than Reasons Listed|0|||
27541978|NCT04674644|80175743|FG000|Overall Study|with missing data|37|||
27541979|NCT00968201|80175746|FG000|Base Study - (Period II)|Adverse Event|8|||
27541980|NCT00968201|80175747|FG001|Base Study - (Period II)|Adverse Event|0|||
27541981|NCT00968201|80175748|FG002|Base Study - (Period II)|Adverse Event|16|||
27541982|NCT00968201|80175746|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
27541983|NCT00968201|80175747|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
27541984|NCT00968201|80175748|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
27541985|NCT00968201|80175746|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
27541986|NCT00968201|80175747|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
27541987|NCT00968201|80175748|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
27541988|NCT00968201|80175746|FG000|Base Study - (Period II)|Protocol Violation|12|||
27541989|NCT00968201|80175747|FG001|Base Study - (Period II)|Protocol Violation|0|||
27541990|NCT00968201|80175748|FG002|Base Study - (Period II)|Protocol Violation|12|||
27541991|NCT00968201|80175746|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
27541992|NCT00968201|80175747|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
27541993|NCT00968201|80175748|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
27541994|NCT00968201|80175746|FG000|Base Study - (Period II)|Site Error|0|||
27636550|NCT00668863|80512479|FG000|Overall Study|Adverse Event|13|||
27920748|NCT02513550|81547059|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
27541995|NCT00968201|80175747|FG001|Base Study - (Period II)|Site Error|0|||
27541996|NCT00968201|80175748|FG002|Base Study - (Period II)|Site Error|1|||
27541997|NCT00968201|80175746|FG000|Extension Study - (Period III)|Adverse Event|0|||
27541998|NCT00968201|80175747|FG001|Extension Study - (Period III)|Adverse Event|5|||
27920749|NCT02513550|81547060|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
27920750|NCT02513550|81547061|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
27920751|NCT02513550|81547062|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27920752|NCT02513550|81547063|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
27636551|NCT00668863|80512479|FG000|Overall Study|Study Terminated by Sponsor|8|||
27636552|NCT00668863|80512479|FG000|Overall Study|Global Deterioration of Health Status|4|||
27636553|NCT00668863|80512479|FG000|Overall Study|Withdrawal by Subject|1|||
27636554|NCT00668863|80512479|FG000|Overall Study|Surgery|1|||
27636555|NCT00668863|80512479|FG000|Overall Study|Subject's work scheduling problem|1|||
27636556|NCT00668863|80512479|FG000|Overall Study|Physician Decision|1|||
27636557|NCT00529659|80512480|FG000|Overall Study|Adverse Event|8|||
27636558|NCT00529659|80512481|FG001|Overall Study|Adverse Event|7|||
27636559|NCT00529659|80512480|FG000|Overall Study|Lost to Follow-up|0|||
27636560|NCT00529659|80512481|FG001|Overall Study|Lost to Follow-up|2|||
27636561|NCT00529659|80512480|FG000|Overall Study|Physician Decision|0|||
27636562|NCT00529659|80512481|FG001|Overall Study|Physician Decision|2|||
27636563|NCT00529659|80512480|FG000|Overall Study|Protocol Violation|2|||
27636564|NCT00529659|80512481|FG001|Overall Study|Protocol Violation|6|||
27636565|NCT00529659|80512480|FG000|Overall Study|Withdrawal by Subject|1|||
27636566|NCT00529659|80512481|FG001|Overall Study|Withdrawal by Subject|6|||
27636567|NCT03712930|80512482|FG000|Overall Study|Death|7|||
27636568|NCT03712930|80512482|FG000|Overall Study|Physician Decision|1|||
27636569|NCT03712930|80512482|FG000|Overall Study|Study Terminated by Sponsor|3|||
27636570|NCT03712930|80512482|FG000|Overall Study|Progressive Disease|2|||
27636571|NCT00970359|80512483|FG000|Overall Study|Not Treated|4|||
27541999|NCT00968201|80175748|FG002|Extension Study - (Period III)|Adverse Event|22|||
27542000|NCT00968201|80175746|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
27542001|NCT00968201|80175747|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
27542002|NCT00968201|80175748|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
27542003|NCT00968201|80175746|FG000|Extension Study - (Period III)|Protocol Violation|0|||
27542004|NCT00968201|80175747|FG001|Extension Study - (Period III)|Protocol Violation|17|||
27542005|NCT00968201|80175748|FG002|Extension Study - (Period III)|Protocol Violation|14|||
27542006|NCT00968201|80175746|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
27542007|NCT00968201|80175747|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
27542008|NCT00968201|80175748|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
27542009|NCT00968201|80175746|FG000|Extension Study - (Period III)|Patient Relocated|0|||
27542010|NCT00968201|80175747|FG001|Extension Study - (Period III)|Patient Relocated|1|||
27542011|NCT00968201|80175748|FG002|Extension Study - (Period III)|Patient Relocated|1|||
27542012|NCT00968201|80175746|FG000|Extension Study - (Period III)|Noncompliance|0|||
27542013|NCT00968201|80175747|FG001|Extension Study - (Period III)|Noncompliance|0|||
27542014|NCT00968201|80175748|FG002|Extension Study - (Period III)|Noncompliance|3|||
27542015|NCT00968201|80175746|FG000|Extension Study - (Period III)|Other|0|||
27542016|NCT00968201|80175747|FG001|Extension Study - (Period III)|Other|0|||
27542017|NCT00968201|80175748|FG002|Extension Study - (Period III)|Other|2|||
27542018|NCT00968201|80175746|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
27542019|NCT00968201|80175747|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
27542020|NCT00968201|80175748|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
27542021|NCT03385564|80175749|FG000|Overall Study|Adverse Event|0|||
27542022|NCT03385564|80175750|FG001|Overall Study|Adverse Event|0|||
27542023|NCT03385564|80175751|FG002|Overall Study|Adverse Event|3|||
27542024|NCT03385564|80175752|FG003|Overall Study|Adverse Event|3|||
27542025|NCT03385564|80175749|FG000|Overall Study|Other than listed|0|||
27542026|NCT03385564|80175750|FG001|Overall Study|Other than listed|0|||
27542027|NCT03385564|80175751|FG002|Overall Study|Other than listed|0|||
27542028|NCT03385564|80175752|FG003|Overall Study|Other than listed|5|||
27542029|NCT03385564|80175749|FG000|Overall Study|Withdrawal by Subject|0|||
27542030|NCT03385564|80175750|FG001|Overall Study|Withdrawal by Subject|1|||
27542031|NCT03385564|80175751|FG002|Overall Study|Withdrawal by Subject|1|||
27542032|NCT03385564|80175752|FG003|Overall Study|Withdrawal by Subject|0|||
27542033|NCT03385564|80175749|FG000|Overall Study|Lack of Efficacy|0|||
27542034|NCT03385564|80175750|FG001|Overall Study|Lack of Efficacy|0|||
27542035|NCT03385564|80175751|FG002|Overall Study|Lack of Efficacy|0|||
27542036|NCT03385564|80175752|FG003|Overall Study|Lack of Efficacy|1|||
27542037|NCT03385564|80175749|FG000|Overall Study|Death|0|||
27542038|NCT03385564|80175750|FG001|Overall Study|Death|0|||
27542039|NCT03385564|80175751|FG002|Overall Study|Death|1|||
27636572|NCT03811574|80512489|FG000|Overall Study|Withdrawal by Subject|2|||
27920753|NCT02513550|81547058|FG000|Double Blind Treatment Period|Adverse Event|5|||
27542040|NCT03385564|80175752|FG003|Overall Study|Death|0|||
27542041|NCT01788228|80175758|FG000|Overall Study|Migrated/moved from study area|1|||
27542042|NCT01788228|80175759|FG001|Overall Study|Migrated/moved from study area|0|||
27542043|NCT00868608|80175760|FG000|Overall Study|Withdrawal by Subject|3|||
27920754|NCT02513550|81547059|FG001|Double Blind Treatment Period|Adverse Event|13|||
27636573|NCT03811574|80512490|FG001|Overall Study|Withdrawal by Subject|4|||
27636574|NCT03811574|80512491|FG002|Overall Study|Withdrawal by Subject|0|||
27636575|NCT00393484|80512492|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
27542044|NCT00868608|80175761|FG001|Overall Study|Withdrawal by Subject|1|||
27542045|NCT00868608|80175762|FG002|Overall Study|Withdrawal by Subject|0|||
27542046|NCT00868608|80175760|FG000|Overall Study|Lost to Follow-up|3|||
27636576|NCT00393484|80512493|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
27636577|NCT00393484|80512492|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
27636578|NCT00393484|80512493|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
27636579|NCT00393484|80512492|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
27636580|NCT00393484|80512493|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
27636581|NCT00393484|80512492|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
27636582|NCT00393484|80512493|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
27636583|NCT00393484|80512492|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
27636584|NCT00393484|80512493|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
27636585|NCT00393484|80512492|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
27636586|NCT00393484|80512493|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
27636587|NCT00393484|80512492|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
27636588|NCT00393484|80512493|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
27636589|NCT00393484|80512492|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
27542047|NCT00868608|80175761|FG001|Overall Study|Lost to Follow-up|0|||
27542048|NCT00868608|80175762|FG002|Overall Study|Lost to Follow-up|1|||
27542049|NCT00868608|80175760|FG000|Overall Study|Death|16|||
27542050|NCT00868608|80175761|FG001|Overall Study|Death|2|||
27542051|NCT00868608|80175762|FG002|Overall Study|Death|4|||
27542052|NCT00868608|80175760|FG000|Overall Study|Other - Unspecified|1|||
27542053|NCT00868608|80175761|FG001|Overall Study|Other - Unspecified|0|||
27542054|NCT00868608|80175762|FG002|Overall Study|Other - Unspecified|0|||
27542055|NCT01543958|80175763|FG000|Overall Study|Loss to follow-up|3|||
27542056|NCT01543958|80175763|FG000|Overall Study|ART initiation|1|||
27542057|NCT02296320|80175764|FG000|Overall Study|Withdrawal by Subject|4|||
27542058|NCT02296320|80175765|FG001|Overall Study|Withdrawal by Subject|0|||
27542059|NCT02296320|80175766|FG002|Overall Study|Withdrawal by Subject|2|||
27542060|NCT02296320|80175764|FG000|Overall Study|Death|24|||
27542061|NCT02296320|80175765|FG001|Overall Study|Death|3|||
27542062|NCT02296320|80175766|FG002|Overall Study|Death|27|||
27542063|NCT02296320|80175764|FG000|Overall Study|Lost to Follow-up|5|||
27542064|NCT02296320|80175765|FG001|Overall Study|Lost to Follow-up|2|||
27542065|NCT02296320|80175766|FG002|Overall Study|Lost to Follow-up|7|||
27542066|NCT02296320|80175764|FG000|Overall Study|Not treated|2|||
27542067|NCT02296320|80175765|FG001|Overall Study|Not treated|0|||
27542068|NCT02296320|80175766|FG002|Overall Study|Not treated|0|||
27542069|NCT02296320|80175764|FG000|Overall Study|Not - specified|0|||
27542070|NCT02296320|80175765|FG001|Overall Study|Not - specified|0|||
27542071|NCT02296320|80175766|FG002|Overall Study|Not - specified|1|||
27542072|NCT04203797|80175767|FG000|Overall Study|Adverse Event|1|||
27542073|NCT04203797|80175768|FG001|Overall Study|Adverse Event|0|||
27542074|NCT04203797|80175767|FG000|Overall Study|Did not complete End of Study follow-up|1|||
27542075|NCT04203797|80175768|FG001|Overall Study|Did not complete End of Study follow-up|0|||
27542076|NCT01020981|80175769|FG000|Overall Study|Did not return mailed survey|74|||
27636590|NCT00393484|80512493|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
27636591|NCT00393484|80512492|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
27636592|NCT00393484|80512493|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
27636593|NCT00393484|80512492|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
27636594|NCT00393484|80512493|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
27636595|NCT05382104|80512494|FG000|Period 2 (2 Days)|Adverse Event|0|||
27636596|NCT05382104|80512495|FG001|Period 2 (2 Days)|Adverse Event|1|||
27636597|NCT05382104|80512496|FG002|Period 2 (2 Days)|Adverse Event|0|||
27636598|NCT05382104|80512497|FG003|Period 2 (2 Days)|Adverse Event|0|||
27636599|NCT05382104|80512498|FG004|Period 2 (2 Days)|Adverse Event|0|||
27636600|NCT05382104|80512499|FG005|Period 2 (2 Days)|Adverse Event|0|||
27636601|NCT02807493|80512500|FG000|Overall Study|Adverse Event|5|||
27636602|NCT02807493|80512501|FG001|Overall Study|Adverse Event|2|||
27636603|NCT02807493|80512500|FG000|Overall Study|Lost to Follow-up|6|||
27636604|NCT02807493|80512501|FG001|Overall Study|Lost to Follow-up|0|||
27636605|NCT02807493|80512500|FG000|Overall Study|Physician Decision|4|||
27636606|NCT02807493|80512501|FG001|Overall Study|Physician Decision|1|||
27636607|NCT02807493|80512500|FG000|Overall Study|Protocol Violation|7|||
27542077|NCT01020981|80175770|FG001|Overall Study|Did not return mailed survey|58|||
27542078|NCT01020981|80175769|FG000|Overall Study|Survey returned undeliverable|8|||
27636608|NCT02807493|80512501|FG001|Overall Study|Protocol Violation|0|||
27636609|NCT02807493|80512500|FG000|Overall Study|Withdrawal by Subject|17|||
27636610|NCT02807493|80512501|FG001|Overall Study|Withdrawal by Subject|10|||
27636611|NCT02807493|80512500|FG000|Overall Study|Other withdrawal|17|||
27636612|NCT02807493|80512501|FG001|Overall Study|Other withdrawal|0|||
27636613|NCT02807493|80512500|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
27636614|NCT02807493|80512501|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
27542079|NCT01020981|80175770|FG001|Overall Study|Survey returned undeliverable|32|||
27542080|NCT01020981|80175769|FG000|Overall Study|Participant declined to complete survey|2|||
27542081|NCT01020981|80175770|FG001|Overall Study|Participant declined to complete survey|0|||
27542082|NCT03724032|80175771|FG000|Overall Study|Physician Decision|1|||
27920755|NCT02513550|81547060|FG002|Double Blind Treatment Period|Adverse Event|17|||
27920756|NCT02513550|81547061|FG003|Double Blind Treatment Period|Adverse Event|0|||
27920757|NCT02513550|81547062|FG004|Double Blind Treatment Period|Adverse Event|1|||
27920758|NCT02513550|81547063|FG005|Double Blind Treatment Period|Adverse Event|0|||
27920759|NCT02513550|81547058|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
27920760|NCT02513550|81547059|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
27920761|NCT02513550|81547060|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
27920762|NCT02513550|81547061|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
27920763|NCT02513550|81547062|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
27920764|NCT02513550|81547063|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
27920765|NCT02513550|81547058|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
27920766|NCT02513550|81547059|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
27920767|NCT02513550|81547060|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
27920768|NCT02513550|81547061|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
27920769|NCT02513550|81547062|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
27920770|NCT02513550|81547063|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
27920771|NCT02513550|81547058|FG000|Double Blind Treatment Period|Protocol Violation|1|||
27920772|NCT02513550|81547059|FG001|Double Blind Treatment Period|Protocol Violation|1|||
27920773|NCT02513550|81547060|FG002|Double Blind Treatment Period|Protocol Violation|4|||
27920774|NCT02513550|81547061|FG003|Double Blind Treatment Period|Protocol Violation|0|||
27920775|NCT02513550|81547062|FG004|Double Blind Treatment Period|Protocol Violation|0|||
27920776|NCT02513550|81547063|FG005|Double Blind Treatment Period|Protocol Violation|0|||
27920777|NCT02513550|81547058|FG000|Double Blind Treatment Period|Physician Decision|2|||
27920778|NCT02513550|81547059|FG001|Double Blind Treatment Period|Physician Decision|0|||
27920779|NCT02513550|81547060|FG002|Double Blind Treatment Period|Physician Decision|4|||
27920780|NCT02513550|81547061|FG003|Double Blind Treatment Period|Physician Decision|0|||
27920781|NCT02513550|81547062|FG004|Double Blind Treatment Period|Physician Decision|0|||
27920782|NCT02513550|81547063|FG005|Double Blind Treatment Period|Physician Decision|0|||
27920783|NCT02513550|81547058|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
27920784|NCT02513550|81547059|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
27542083|NCT03724032|80175772|FG001|Overall Study|Physician Decision|0|||
27542084|NCT03724032|80175773|FG002|Overall Study|Physician Decision|0|||
27542085|NCT03724032|80175771|FG000|Overall Study|Protocol Violation|2|||
27542086|NCT03724032|80175772|FG001|Overall Study|Protocol Violation|2|||
27542087|NCT03724032|80175773|FG002|Overall Study|Protocol Violation|1|||
27542088|NCT00478231|80175774|FG000|Overall Study|Death|7|||
27542089|NCT00478231|80175774|FG000|Overall Study|Lack of Efficacy|47|||
27542090|NCT00478231|80175774|FG000|Overall Study|Lost to Follow-up|7|||
27542091|NCT00478231|80175774|FG000|Overall Study|Withdrawal by Subject|6|||
27542092|NCT00478231|80175774|FG000|Overall Study|Other|9|||
27542093|NCT00478231|80175774|FG000|Overall Study|Adverse Event|5|||
27542094|NCT00478231|80175774|FG000|Overall Study|Randomized, not treated|3|||
27542095|NCT00178633|80175784|FG000|Overall Study|Lost to Follow-up|6|||
27542096|NCT03469934|80175785|FG000|Overall Study|Withdrawal by Subject|0|||
27542097|NCT03469934|80175786|FG001|Overall Study|Withdrawal by Subject|1|||
27542098|NCT02422303|80175787|FG000|Overall Study|Lost to Follow-up|1|||
27542099|NCT02422303|80175788|FG001|Overall Study|Lost to Follow-up|1|||
27542100|NCT03607487|80175789|FG000|Overall Study|Withdrawal by Subject|2|||
27542101|NCT03607487|80175790|FG001|Overall Study|Withdrawal by Subject|0|||
27542102|NCT03607487|80175791|FG002|Overall Study|Withdrawal by Subject|0|||
27542103|NCT03607487|80175792|FG003|Overall Study|Withdrawal by Subject|1|||
27542104|NCT05248867|80175794|FG000|Double-blind Period|Lost to Follow-up|0|||
27542105|NCT05248867|80175795|FG001|Double-blind Period|Lost to Follow-up|3|||
27542106|NCT05248867|80175796|FG002|Double-blind Period|Lost to Follow-up|0|||
27542107|NCT05248867|80175797|FG003|Double-blind Period|Lost to Follow-up|0|||
27542108|NCT05248867|80175798|FG004|Double-blind Period|Lost to Follow-up|0|||
27542109|NCT05248867|80175799|FG005|Double-blind Period|Lost to Follow-up|0|||
27542110|NCT05248867|80175794|FG000|Double-blind Period|Withdrawal by Subject|5|||
27542111|NCT05248867|80175795|FG001|Double-blind Period|Withdrawal by Subject|14|||
27542112|NCT05248867|80175796|FG002|Double-blind Period|Withdrawal by Subject|0|||
27542113|NCT05248867|80175797|FG003|Double-blind Period|Withdrawal by Subject|0|||
27542114|NCT05248867|80175798|FG004|Double-blind Period|Withdrawal by Subject|0|||
27542115|NCT05248867|80175799|FG005|Double-blind Period|Withdrawal by Subject|0|||
27542116|NCT05248867|80175794|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
27636615|NCT03050814|80512505|FG000|Overall Study|Screen failures|0|||
27636616|NCT03050814|80512506|FG001|Overall Study|Screen failures|0|||
27542117|NCT05248867|80175795|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
27542118|NCT05248867|80175796|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
27636617|NCT03050814|80512507|FG002|Overall Study|Screen failures|4|||
27636618|NCT01124734|80512508|FG000|Overall Study|Disease progression|13|||
27920785|NCT02513550|81547060|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
27542119|NCT05248867|80175797|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
27542120|NCT05248867|80175798|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
27636619|NCT01124734|80512508|FG000|Overall Study|Adverse Event|1|||
27636620|NCT01124734|80512508|FG000|Overall Study|Withdrawal by Subject|1|||
27636621|NCT01124734|80512508|FG000|Overall Study|Elected for alternative treatment|2|||
27636622|NCT01563354|80512509|FG000|Core Phase|Adverse Event|5|||
27542121|NCT05248867|80175799|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
27542122|NCT05248867|80175794|FG000|Double-blind Period|Other, not specified|3|||
27542123|NCT05248867|80175795|FG001|Double-blind Period|Other, not specified|8|||
27542124|NCT05248867|80175796|FG002|Double-blind Period|Other, not specified|0|||
27542125|NCT05248867|80175797|FG003|Double-blind Period|Other, not specified|0|||
27542126|NCT05248867|80175798|FG004|Double-blind Period|Other, not specified|0|||
27542127|NCT05248867|80175799|FG005|Double-blind Period|Other, not specified|0|||
27542128|NCT05248867|80175794|FG000|Open-label Period|Withdrawal by Subject|0|||
27542129|NCT05248867|80175795|FG001|Open-label Period|Withdrawal by Subject|0|||
27542130|NCT05248867|80175796|FG002|Open-label Period|Withdrawal by Subject|3|||
27542131|NCT05248867|80175797|FG003|Open-label Period|Withdrawal by Subject|1|||
27542132|NCT05248867|80175798|FG004|Open-label Period|Withdrawal by Subject|7|||
27542133|NCT05248867|80175799|FG005|Open-label Period|Withdrawal by Subject|9|||
27542134|NCT05248867|80175794|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
27636623|NCT01563354|80512510|FG001|Core Phase|Adverse Event|15|||
27636624|NCT01563354|80512511|FG002|Core Phase|Adverse Event|13|||
27636625|NCT01563354|80512509|FG000|Core Phase|Withdrawal by Subject|1|||
27636626|NCT01563354|80512510|FG001|Core Phase|Withdrawal by Subject|0|||
27636627|NCT01563354|80512511|FG002|Core Phase|Withdrawal by Subject|3|||
27636628|NCT01563354|80512509|FG000|Core Phase|Lost to Follow-up|1|||
27636629|NCT01563354|80512510|FG001|Core Phase|Lost to Follow-up|0|||
27636630|NCT01563354|80512511|FG002|Core Phase|Lost to Follow-up|0|||
27636631|NCT01563354|80512509|FG000|Core Phase|Death|1|||
27636632|NCT01563354|80512510|FG001|Core Phase|Death|5|||
27636633|NCT01563354|80512511|FG002|Core Phase|Death|2|||
27636634|NCT01563354|80512509|FG000|Core Phase|Diseasse progression|18|||
27636635|NCT01563354|80512510|FG001|Core Phase|Diseasse progression|7|||
27636636|NCT01563354|80512511|FG002|Core Phase|Diseasse progression|8|||
27542135|NCT05248867|80175795|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
27542136|NCT05248867|80175796|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
27542137|NCT05248867|80175797|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
27542138|NCT05248867|80175798|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
27542139|NCT05248867|80175799|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
27542140|NCT05248867|80175794|FG000|Open-label Period|Lost to Follow-up|0|||
27542141|NCT05248867|80175795|FG001|Open-label Period|Lost to Follow-up|0|||
27542142|NCT05248867|80175796|FG002|Open-label Period|Lost to Follow-up|0|||
27542143|NCT05248867|80175797|FG003|Open-label Period|Lost to Follow-up|0|||
27542144|NCT05248867|80175798|FG004|Open-label Period|Lost to Follow-up|5|||
27542145|NCT05248867|80175799|FG005|Open-label Period|Lost to Follow-up|2|||
27542146|NCT05248867|80175794|FG000|Open-label Period|COVID-19 Infection|0|||
27542147|NCT05248867|80175795|FG001|Open-label Period|COVID-19 Infection|0|||
27542148|NCT05248867|80175796|FG002|Open-label Period|COVID-19 Infection|0|||
27542149|NCT05248867|80175797|FG003|Open-label Period|COVID-19 Infection|0|||
27542150|NCT05248867|80175798|FG004|Open-label Period|COVID-19 Infection|1|||
27542151|NCT05248867|80175799|FG005|Open-label Period|COVID-19 Infection|0|||
27542152|NCT05248867|80175794|FG000|Open-label Period|Other, not specified|0|||
27542153|NCT05248867|80175795|FG001|Open-label Period|Other, not specified|0|||
27542154|NCT05248867|80175796|FG002|Open-label Period|Other, not specified|0|||
27542155|NCT05248867|80175797|FG003|Open-label Period|Other, not specified|0|||
27542156|NCT05248867|80175798|FG004|Open-label Period|Other, not specified|4|||
27542157|NCT05248867|80175799|FG005|Open-label Period|Other, not specified|0|||
27542158|NCT01696695|80175803|FG000|Overall Study|Disease progression|373|||
27542159|NCT01696695|80175803|FG000|Overall Study|Death|29|||
27542160|NCT01696695|80175803|FG000|Overall Study|Adverse Event|74|||
27542161|NCT01696695|80175803|FG000|Overall Study|Withdrawal by Subject|92|||
27542162|NCT01696695|80175803|FG000|Overall Study|Lost to Follow-up|48|||
27542163|NCT01696695|80175803|FG000|Overall Study|Other|74|||
27636637|NCT01563354|80512509|FG000|Core Phase|Protocol deviation|2|||
27636638|NCT01563354|80512510|FG001|Core Phase|Protocol deviation|0|||
27740936|NCT01736683|80880772|FG004|Overall Study|Lack of Therapeutic Effect|1|||
27740937|NCT01736683|80880768|FG000|Overall Study|Progressive Disease|0|||
27740938|NCT01736683|80880769|FG001|Overall Study|Progressive Disease|0|||
27740939|NCT01736683|80880770|FG002|Overall Study|Progressive Disease|0|||
27542164|NCT01696695|80175803|FG000|Overall Study|Major Protocol Violation|192|||
27636639|NCT01563354|80512511|FG002|Core Phase|Protocol deviation|0|||
27636640|NCT01563354|80512509|FG000|Core Phase|PI decision - did not enter extension|0|||
27636641|NCT01563354|80512510|FG001|Core Phase|PI decision - did not enter extension|1|||
27542165|NCT00259610|80175804|FG000|Overall Study|Withdrawal by Subject|33|||
27542166|NCT00259610|80175805|FG001|Overall Study|Withdrawal by Subject|25|||
27542167|NCT00259610|80175806|FG002|Overall Study|Withdrawal by Subject|29|||
27542168|NCT00259610|80175807|FG003|Overall Study|Withdrawal by Subject|19|||
27636642|NCT01563354|80512511|FG002|Core Phase|PI decision - did not enter extension|0|||
27542169|NCT00259610|80175804|FG000|Overall Study|Lost to Follow-up|19|||
27542170|NCT00259610|80175805|FG001|Overall Study|Lost to Follow-up|8|||
27542171|NCT00259610|80175806|FG002|Overall Study|Lost to Follow-up|18|||
27542172|NCT00259610|80175807|FG003|Overall Study|Lost to Follow-up|15|||
27542173|NCT00259610|80175804|FG000|Overall Study|Physician Decision|6|||
27542174|NCT00259610|80175805|FG001|Overall Study|Physician Decision|4|||
27542175|NCT00259610|80175806|FG002|Overall Study|Physician Decision|7|||
27542176|NCT00259610|80175807|FG003|Overall Study|Physician Decision|2|||
27542177|NCT00259610|80175804|FG000|Overall Study|Death|1|||
27542178|NCT00259610|80175805|FG001|Overall Study|Death|1|||
27542179|NCT00259610|80175806|FG002|Overall Study|Death|2|||
27636643|NCT01563354|80512509|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
27636644|NCT01563354|80512510|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
27636645|NCT01563354|80512511|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
27636646|NCT01563354|80512509|FG000|Extension Phase|Adverse Event|0|||
27636647|NCT01563354|80512510|FG001|Extension Phase|Adverse Event|3|||
27636648|NCT01563354|80512511|FG002|Extension Phase|Adverse Event|2|||
27542180|NCT00259610|80175807|FG003|Overall Study|Death|0|||
27542181|NCT00259610|80175804|FG000|Overall Study|non medical reason|6|||
27542182|NCT00259610|80175805|FG001|Overall Study|non medical reason|2|||
27542183|NCT00259610|80175806|FG002|Overall Study|non medical reason|10|||
27542184|NCT00259610|80175807|FG003|Overall Study|non medical reason|3|||
27542185|NCT00259610|80175804|FG000|Overall Study|Adverse Event|3|||
27542186|NCT00259610|80175805|FG001|Overall Study|Adverse Event|4|||
27542187|NCT00259610|80175806|FG002|Overall Study|Adverse Event|5|||
27542188|NCT00259610|80175807|FG003|Overall Study|Adverse Event|2|||
27542189|NCT00259610|80175804|FG000|Overall Study|Serious Adverse Event|8|||
27542190|NCT00259610|80175805|FG001|Overall Study|Serious Adverse Event|2|||
27542191|NCT00259610|80175806|FG002|Overall Study|Serious Adverse Event|2|||
27542192|NCT00259610|80175807|FG003|Overall Study|Serious Adverse Event|2|||
27542193|NCT00087607|80175808|FG000|Overall Study|Adverse Event|14|||
27542194|NCT00087607|80175809|FG001|Overall Study|Adverse Event|24|||
27542195|NCT00087607|80175808|FG000|Overall Study|Death|0|||
27542196|NCT00087607|80175809|FG001|Overall Study|Death|1|||
27542197|NCT00087607|80175808|FG000|Overall Study|Insufficient Therapeutic Response|53|||
27542198|NCT00087607|80175809|FG001|Overall Study|Insufficient Therapeutic Response|42|||
27542199|NCT00087607|80175808|FG000|Overall Study|Failure to return|21|||
27542200|NCT00087607|80175809|FG001|Overall Study|Failure to return|17|||
27542201|NCT00087607|80175808|FG000|Overall Study|Withdrew Consent|12|||
27542202|NCT00087607|80175809|FG001|Overall Study|Withdrew Consent|16|||
27542203|NCT00087607|80175808|FG000|Overall Study|Administrative|12|||
27542204|NCT00087607|80175809|FG001|Overall Study|Administrative|12|||
27542205|NCT00087607|80175808|FG000|Overall Study|Refused Treatment|5|||
27542206|NCT00087607|80175809|FG001|Overall Study|Refused Treatment|7|||
27542207|NCT00087607|80175808|FG000|Overall Study|Other Protocol Violation|5|||
27542208|NCT00087607|80175809|FG001|Overall Study|Other Protocol Violation|2|||
27542209|NCT00087607|80175808|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
27636649|NCT01563354|80512509|FG000|Extension Phase|Withdrawal by Subject|0|||
27636650|NCT01563354|80512510|FG001|Extension Phase|Withdrawal by Subject|1|||
27636651|NCT01563354|80512511|FG002|Extension Phase|Withdrawal by Subject|0|||
27636652|NCT01563354|80512509|FG000|Extension Phase|Administration problems|3|||
27636653|NCT01563354|80512510|FG001|Extension Phase|Administration problems|2|||
27636654|NCT01563354|80512511|FG002|Extension Phase|Administration problems|3|||
27636655|NCT01563354|80512509|FG000|Extension Phase|Disease progression|9|||
27636656|NCT01563354|80512510|FG001|Extension Phase|Disease progression|8|||
27636657|NCT01563354|80512511|FG002|Extension Phase|Disease progression|10|||
27636658|NCT01331824|80512514|FG000|Overall Study|Adverse Event|2|||
27636659|NCT01331824|80512514|FG000|Overall Study|Death|1|||
27636660|NCT01331824|80512514|FG000|Overall Study|Disease Progression|9|||
27636661|NCT01331824|80512514|FG000|Overall Study|Withdrawal by Subject|1|||
27636662|NCT03383146|80512515|FG000|Overall Study|Screen Failure|1|||
27542210|NCT00087607|80175809|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
27542211|NCT01180985|80175810|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
27636663|NCT03383146|80512516|FG001|Overall Study|Screen Failure|0|||
27636664|NCT03383146|80512515|FG000|Overall Study|Adverse Event|6|||
27636665|NCT03383146|80512516|FG001|Overall Study|Adverse Event|18|||
27542212|NCT01180985|80175811|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
27542213|NCT00371826|80175812|FG000|Core Phase (12 Months)|Adverse Event|15|||
27542214|NCT00371826|80175813|FG001|Core Phase (12 Months)|Adverse Event|4|||
27542215|NCT00371826|80175814|FG002|Core Phase (12 Months)|Adverse Event|9|||
27542216|NCT00371826|80175812|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
27542217|NCT00371826|80175813|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
27542218|NCT00371826|80175814|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
27542219|NCT00371826|80175812|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
27542220|NCT00371826|80175813|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
27542221|NCT00371826|80175814|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
27542222|NCT00371826|80175812|FG000|Core Phase (12 Months)|Protocol Violation|1|||
27542223|NCT00371826|80175813|FG001|Core Phase (12 Months)|Protocol Violation|0|||
27542224|NCT00371826|80175814|FG002|Core Phase (12 Months)|Protocol Violation|1|||
27542225|NCT00371826|80175812|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
27542226|NCT00371826|80175813|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
27542227|NCT00371826|80175814|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
27542228|NCT00371826|80175812|FG000|Core Phase (12 Months)|Administrative problems|1|||
27542229|NCT00371826|80175813|FG001|Core Phase (12 Months)|Administrative problems|0|||
27542230|NCT00371826|80175814|FG002|Core Phase (12 Months)|Administrative problems|8|||
27542231|NCT00371826|80175812|FG000|Core Phase (12 Months)|Graft Loss|0|||
27542232|NCT00371826|80175813|FG001|Core Phase (12 Months)|Graft Loss|1|||
27542233|NCT00371826|80175814|FG002|Core Phase (12 Months)|Graft Loss|0|||
27542234|NCT00371826|80175812|FG000|Extension Phase (24 Months)|Adverse Event|4|||
27542235|NCT00371826|80175813|FG001|Extension Phase (24 Months)|Adverse Event|5|||
27542236|NCT00371826|80175814|FG002|Extension Phase (24 Months)|Adverse Event|0|||
27542237|NCT00371826|80175812|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
27636666|NCT03383146|80512515|FG000|Overall Study|Lack of Efficacy|0|||
27636667|NCT03383146|80512516|FG001|Overall Study|Lack of Efficacy|3|||
27636668|NCT03383146|80512515|FG000|Overall Study|Withdrawal by Subject|20|||
27636669|NCT03383146|80512516|FG001|Overall Study|Withdrawal by Subject|36|||
27636670|NCT03383146|80512515|FG000|Overall Study|Lost to Follow-up|5|||
27636671|NCT03383146|80512516|FG001|Overall Study|Lost to Follow-up|15|||
27636672|NCT03383146|80512515|FG000|Overall Study|Death|0|||
27636673|NCT03383146|80512516|FG001|Overall Study|Death|2|||
27636674|NCT03383146|80512515|FG000|Overall Study|Physician Decision|0|||
27636675|NCT03383146|80512516|FG001|Overall Study|Physician Decision|1|||
27636676|NCT03383146|80512515|FG000|Overall Study|Protocol Deviation|1|||
27636677|NCT03383146|80512516|FG001|Overall Study|Protocol Deviation|8|||
27636678|NCT03383146|80512515|FG000|Overall Study|Study Terminated by the Sponsor|48|||
27636679|NCT03383146|80512516|FG001|Overall Study|Study Terminated by the Sponsor|95|||
27636680|NCT03383146|80512515|FG000|Overall Study|Reason not Specified|4|||
27636681|NCT03383146|80512516|FG001|Overall Study|Reason not Specified|6|||
27636682|NCT01443845|80512517|FG000|Overall Study|Protocol Violation|43|||
27636683|NCT01443845|80512518|FG001|Overall Study|Protocol Violation|45|||
27636684|NCT01443845|80512517|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
27636685|NCT01443845|80512518|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
27636686|NCT01443845|80512517|FG000|Overall Study|Deterioration in pulmonary function|1|||
27636687|NCT01443845|80512518|FG001|Overall Study|Deterioration in pulmonary function|4|||
27636688|NCT01443845|80512517|FG000|Overall Study|Lack of Efficacy|10|||
27636689|NCT01443845|80512518|FG001|Overall Study|Lack of Efficacy|5|||
27636690|NCT01443845|80512517|FG000|Overall Study|Adverse Event|64|||
27636691|NCT01443845|80512518|FG001|Overall Study|Adverse Event|138|||
27636692|NCT01443845|80512517|FG000|Overall Study|Withdrawal by Subject|63|||
27636693|NCT01443845|80512518|FG001|Overall Study|Withdrawal by Subject|67|||
27636694|NCT01443845|80512517|FG000|Overall Study|Military Conflict - Site Terminated|20|||
27636695|NCT01443845|80512518|FG001|Overall Study|Military Conflict - Site Terminated|21|||
27636696|NCT01443845|80512517|FG000|Overall Study|Lost to Follow-up|9|||
27636697|NCT01443845|80512518|FG001|Overall Study|Lost to Follow-up|13|||
27636698|NCT00704184|80512519|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
27636699|NCT00704184|80512520|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
27636700|NCT00704184|80512521|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
27636701|NCT00704184|80512522|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
27636702|NCT00704184|80512523|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
27636703|NCT00704184|80512519|FG000|Open-Label Treatment|Adverse Event|0|||
27636704|NCT00704184|80512520|FG001|Open-Label Treatment|Adverse Event|0|||
27636705|NCT00704184|80512521|FG002|Open-Label Treatment|Adverse Event|2|||
27636706|NCT00704184|80512522|FG003|Open-Label Treatment|Adverse Event|0|||
27636707|NCT00704184|80512523|FG004|Open-Label Treatment|Adverse Event|1|||
27636708|NCT00704184|80512519|FG000|Open-Label Treatment|Lack of Efficacy|0|||
27636709|NCT00704184|80512520|FG001|Open-Label Treatment|Lack of Efficacy|2|||
27636710|NCT00704184|80512521|FG002|Open-Label Treatment|Lack of Efficacy|2|||
27636711|NCT00704184|80512522|FG003|Open-Label Treatment|Lack of Efficacy|2|||
27740940|NCT01736683|80880771|FG003|Overall Study|Progressive Disease|1|||
27740941|NCT01736683|80880772|FG004|Overall Study|Progressive Disease|0|||
27542238|NCT00371826|80175813|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
27542239|NCT00371826|80175814|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
27636712|NCT00704184|80512523|FG004|Open-Label Treatment|Lack of Efficacy|1|||
27636713|NCT00704184|80512519|FG000|Open-Label Treatment|Physician Decision|0|||
27636714|NCT00704184|80512520|FG001|Open-Label Treatment|Physician Decision|0|||
27636715|NCT00704184|80512521|FG002|Open-Label Treatment|Physician Decision|0|||
27636716|NCT00704184|80512522|FG003|Open-Label Treatment|Physician Decision|0|||
27636717|NCT00704184|80512523|FG004|Open-Label Treatment|Physician Decision|1|||
27542240|NCT00371826|80175812|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
27636718|NCT00704184|80512519|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
27740942|NCT01736683|80880768|FG000|Overall Study|Other|0|||
27542241|NCT00371826|80175813|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
27542242|NCT00371826|80175814|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
27542243|NCT00371826|80175812|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
27542244|NCT00371826|80175813|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
27542245|NCT00371826|80175814|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
27542246|NCT00371826|80175812|FG000|Extension Phase (24 Months)|Administrative problems|0|||
27542247|NCT00371826|80175813|FG001|Extension Phase (24 Months)|Administrative problems|0|||
27542248|NCT00371826|80175814|FG002|Extension Phase (24 Months)|Administrative problems|2|||
27542249|NCT01217801|80175815|FG000|Period 1|Protocol Violation|1|||
27542250|NCT01217801|80175816|FG001|Period 1|Protocol Violation|1|||
27542251|NCT01217801|80175815|FG000|Period 1|Withdrawal by Subject|0|||
27542252|NCT01217801|80175816|FG001|Period 1|Withdrawal by Subject|1|||
27542253|NCT01921387|80175818|FG000|Overall Study|Adverse Event|1|||
27542254|NCT01065597|80175833|FG000|Overall Study|Adverse Event|1|||
27542255|NCT04696055|80175834|FG000|Overall Study|Adverse Event|10|||
27542256|NCT04696055|80175835|FG001|Overall Study|Adverse Event|0|||
27542257|NCT04696055|80175834|FG000|Overall Study|Death|2|||
27542258|NCT04696055|80175835|FG001|Overall Study|Death|1|||
27542259|NCT04696055|80175834|FG000|Overall Study|Other|4|||
27542260|NCT04696055|80175835|FG001|Overall Study|Other|0|||
27542261|NCT04696055|80175834|FG000|Overall Study|Physician Decision|1|||
27542262|NCT04696055|80175835|FG001|Overall Study|Physician Decision|0|||
27542263|NCT04696055|80175834|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
27542264|NCT04696055|80175835|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
27542265|NCT04696055|80175834|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
27542266|NCT04696055|80175835|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
27542267|NCT04696055|80175834|FG000|Overall Study|Subject Decision|1|||
27542268|NCT04696055|80175835|FG001|Overall Study|Subject Decision|2|||
27542269|NCT04696055|80175834|FG000|Overall Study|Ongoing with study treatment|13|||
27542270|NCT04696055|80175835|FG001|Overall Study|Ongoing with study treatment|10|||
27542271|NCT00674362|80175836|FG000|Double Blind|Adverse Event|6|||
27542272|NCT00674362|80175837|FG001|Double Blind|Adverse Event|6|||
27542273|NCT00674362|80175836|FG000|Double Blind|Lack of Efficacy|2|||
27542274|NCT00674362|80175837|FG001|Double Blind|Lack of Efficacy|6|||
27542275|NCT00674362|80175836|FG000|Double Blind|Loss of efficacy|0|||
27542276|NCT00674362|80175837|FG001|Double Blind|Loss of efficacy|1|||
27636719|NCT00704184|80512520|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
27636720|NCT00704184|80512521|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
27636721|NCT00704184|80512522|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
27636722|NCT00704184|80512523|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
27636723|NCT00835770|80512524|FG000|Overall Study|MS Relapse|17|||
27636724|NCT00835770|80512525|FG001|Overall Study|MS Relapse|23|||
27636725|NCT00835770|80512524|FG000|Overall Study|MS Progression|14|||
27636726|NCT00835770|80512525|FG001|Overall Study|MS Progression|9|||
27636727|NCT00835770|80512524|FG000|Overall Study|Adverse Event|113|||
27636728|NCT00835770|80512525|FG001|Overall Study|Adverse Event|124|||
27636729|NCT00835770|80512524|FG000|Overall Study|Lost to Follow-up|22|||
27636730|NCT00835770|80512525|FG001|Overall Study|Lost to Follow-up|19|||
27636731|NCT00835770|80512524|FG000|Overall Study|Consent Withdrawn|144|||
27636732|NCT00835770|80512525|FG001|Overall Study|Consent Withdrawn|156|||
27636733|NCT00835770|80512524|FG000|Overall Study|Investigator Decision|42|||
27636734|NCT00835770|80512525|FG001|Overall Study|Investigator Decision|42|||
27636735|NCT00835770|80512524|FG000|Overall Study|Participant Non-Compliance|11|||
27636736|NCT00835770|80512525|FG001|Overall Study|Participant Non-Compliance|9|||
27636737|NCT00835770|80512524|FG000|Overall Study|Death|4|||
27542277|NCT00674362|80175836|FG000|Double Blind|Withdrawal by Subject|4|||
27542278|NCT00674362|80175837|FG001|Double Blind|Withdrawal by Subject|3|||
27542279|NCT00674362|80175836|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
27542280|NCT00674362|80175837|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
27542281|NCT00674362|80175836|FG000|Double Blind|Other: Surgery|0|||
27542282|NCT00674362|80175837|FG001|Double Blind|Other: Surgery|1|||
27542283|NCT00674362|80175836|FG000|Open Label|Adverse Event|1|||
27542284|NCT00674362|80175837|FG001|Open Label|Adverse Event|0|||
27542285|NCT00674362|80175836|FG000|Open Label|Other: Subject moved to extension study|1|||
27636738|NCT00835770|80512525|FG001|Overall Study|Death|6|||
27636739|NCT00835770|80512524|FG000|Overall Study|Other|115|||
27636740|NCT00835770|80512525|FG001|Overall Study|Other|104|||
27636741|NCT00835770|80512524|FG000|Overall Study|Other|2|||
27636742|NCT00835770|80512525|FG001|Overall Study|Other|1|||
27636743|NCT01580293|80512526|FG000|Part A_Main Trial|Adverse Event|0|||
27542286|NCT00674362|80175837|FG001|Open Label|Other: Subject moved to extension study|0|||
27542287|NCT04502433|80175838|FG000|Overall Study|Death|2|||
27542288|NCT04502433|80175839|FG001|Overall Study|Death|4|||
27542289|NCT04502433|80175838|FG000|Overall Study|Lost to Follow-up|1|||
27542290|NCT04502433|80175839|FG001|Overall Study|Lost to Follow-up|0|||
27542291|NCT04502433|80175838|FG000|Overall Study|Physician Decision|0|||
27636744|NCT01580293|80512527|FG001|Part A_Main Trial|Adverse Event|2|||
27542292|NCT04502433|80175839|FG001|Overall Study|Physician Decision|1|||
27542293|NCT03689530|80175840|FG000|Overall Study|Withdrawal by Subject|53|||
27542294|NCT03689530|80175841|FG001|Overall Study|Withdrawal by Subject|16|||
27542295|NCT00679432|80175842|FG000|Overall Study|Adverse Event|5|||
27542296|NCT00679432|80175843|FG001|Overall Study|Adverse Event|6|||
27920786|NCT02513550|81547061|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
27920787|NCT02513550|81547062|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
27542297|NCT00679432|80175844|FG002|Overall Study|Adverse Event|10|||
27542298|NCT00679432|80175845|FG003|Overall Study|Adverse Event|7|||
27542299|NCT00679432|80175842|FG000|Overall Study|Protocol Violation|1|||
27542300|NCT00679432|80175843|FG001|Overall Study|Protocol Violation|1|||
27542301|NCT00679432|80175844|FG002|Overall Study|Protocol Violation|2|||
27542302|NCT00679432|80175845|FG003|Overall Study|Protocol Violation|1|||
27542303|NCT00679432|80175842|FG000|Overall Study|Withdrawal by Subject|8|||
27542304|NCT00679432|80175843|FG001|Overall Study|Withdrawal by Subject|11|||
27542305|NCT00679432|80175844|FG002|Overall Study|Withdrawal by Subject|10|||
27636745|NCT01580293|80512528|FG002|Part A_Main Trial|Adverse Event|0|||
27920788|NCT02513550|81547063|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
27636746|NCT01580293|80512526|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
27636747|NCT01580293|80512527|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
27636748|NCT01580293|80512528|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
27636749|NCT01580293|80512526|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
27636750|NCT01580293|80512527|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
27636751|NCT01580293|80512528|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
27920789|NCT02513550|81547058|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27636752|NCT01580293|80512526|FG000|Part A_Extension|Adverse Event|0|||
27636753|NCT01580293|80512527|FG001|Part A_Extension|Adverse Event|2|||
27636754|NCT01580293|80512528|FG002|Part A_Extension|Adverse Event|0|||
27636755|NCT01580293|80512526|FG000|Part A_Extension|Withdrawal by Subject|0|||
27636756|NCT01580293|80512527|FG001|Part A_Extension|Withdrawal by Subject|3|||
27636757|NCT01580293|80512528|FG002|Part A_Extension|Withdrawal by Subject|0|||
27636758|NCT01580293|80512526|FG000|Part A_Extension|Lost to Follow-up|0|||
27636759|NCT01580293|80512527|FG001|Part A_Extension|Lost to Follow-up|1|||
27636760|NCT01580293|80512528|FG002|Part A_Extension|Lost to Follow-up|0|||
27636761|NCT01580293|80512526|FG000|Part A_Extension|Other Reason|0|||
27636762|NCT01580293|80512527|FG001|Part A_Extension|Other Reason|1|||
27636763|NCT01580293|80512528|FG002|Part A_Extension|Other Reason|0|||
27636764|NCT01580293|80512526|FG000|Part A_Extension|Completed Japan only|0|||
27636765|NCT01580293|80512527|FG001|Part A_Extension|Completed Japan only|5|||
27636766|NCT01580293|80512528|FG002|Part A_Extension|Completed Japan only|0|||
27636767|NCT01580293|80512526|FG000|Part B|Withdrawal by Subject|0|||
27636768|NCT01580293|80512527|FG001|Part B|Withdrawal by Subject|0|||
27636769|NCT01580293|80512528|FG002|Part B|Withdrawal by Subject|1|||
27636770|NCT01580293|80512526|FG000|Part B|Other reason|0|||
27636771|NCT01580293|80512527|FG001|Part B|Other reason|0|||
27636772|NCT01580293|80512528|FG002|Part B|Other reason|1|||
27920790|NCT02513550|81547059|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27920791|NCT02513550|81547060|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
27920792|NCT02513550|81547061|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27920793|NCT02513550|81547062|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27920794|NCT02513550|81547063|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
27920795|NCT02513550|81547058|FG000|Double Blind Treatment Period|Due to personal business|2|||
27920796|NCT02513550|81547059|FG001|Double Blind Treatment Period|Due to personal business|0|||
27920797|NCT02513550|81547060|FG002|Double Blind Treatment Period|Due to personal business|1|||
27920798|NCT02513550|81547061|FG003|Double Blind Treatment Period|Due to personal business|0|||
27920799|NCT02513550|81547062|FG004|Double Blind Treatment Period|Due to personal business|0|||
27920800|NCT02513550|81547063|FG005|Double Blind Treatment Period|Due to personal business|0|||
27920801|NCT02513550|81547058|FG000|Double Blind Treatment Period|Death|1|||
27920802|NCT02513550|81547059|FG001|Double Blind Treatment Period|Death|0|||
27542306|NCT00679432|80175845|FG003|Overall Study|Withdrawal by Subject|9|||
27542307|NCT00679432|80175842|FG000|Overall Study|Lost to Follow-up|1|||
27542308|NCT00679432|80175843|FG001|Overall Study|Lost to Follow-up|5|||
27542309|NCT00679432|80175844|FG002|Overall Study|Lost to Follow-up|4|||
27542310|NCT00679432|80175845|FG003|Overall Study|Lost to Follow-up|2|||
27636773|NCT00566527|80512531|FG000|Overall Study|Reason not provided|3|||
27636774|NCT00566527|80512532|FG001|Overall Study|Reason not provided|11|||
27636775|NCT00566527|80512533|FG002|Overall Study|Reason not provided|10|||
27636776|NCT00566527|80512531|FG000|Overall Study|Adverse Event|2|||
27636777|NCT00566527|80512532|FG001|Overall Study|Adverse Event|0|||
27920803|NCT02513550|81547060|FG002|Double Blind Treatment Period|Death|2|||
27542311|NCT00679432|80175842|FG000|Overall Study|Physician Decision|3|||
27542312|NCT00679432|80175843|FG001|Overall Study|Physician Decision|2|||
27542313|NCT00679432|80175844|FG002|Overall Study|Physician Decision|2|||
27542314|NCT00679432|80175845|FG003|Overall Study|Physician Decision|2|||
27636778|NCT00566527|80512533|FG002|Overall Study|Adverse Event|1|||
27920804|NCT02513550|81547061|FG003|Double Blind Treatment Period|Death|0|||
27920805|NCT02513550|81547062|FG004|Double Blind Treatment Period|Death|0|||
27920806|NCT02513550|81547063|FG005|Double Blind Treatment Period|Death|0|||
27920807|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
27920808|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
27920809|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
27920810|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27920811|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27920812|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
27920813|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
27920814|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
27920815|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
27920816|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
27920817|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
27920818|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
27920819|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
27920820|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
27920821|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
27920822|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27920823|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27920824|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
27920825|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
27920826|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
27920827|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
27920828|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
27920829|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
27920830|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
27920831|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
27920832|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
27920833|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
27920834|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
27920835|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
27920836|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
27920837|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Death|0|||
27920838|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Death|0|||
27920839|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Death|1|||
27920840|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Death|0|||
27920841|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Death|0|||
27920842|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Death|0|||
27920843|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
27920844|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
27920845|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
27920846|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
27920847|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
27920848|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
27920849|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27920850|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27920851|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
27542315|NCT00679432|80175842|FG000|Overall Study|Sponsor decision|1|||
27542316|NCT00679432|80175843|FG001|Overall Study|Sponsor decision|0|||
27542317|NCT00679432|80175844|FG002|Overall Study|Sponsor decision|0|||
27542318|NCT00679432|80175845|FG003|Overall Study|Sponsor decision|0|||
27542319|NCT00679432|80175842|FG000|Overall Study|Lack of Efficacy|13|||
27542320|NCT00679432|80175843|FG001|Overall Study|Lack of Efficacy|9|||
27542321|NCT00679432|80175844|FG002|Overall Study|Lack of Efficacy|14|||
27542322|NCT00679432|80175845|FG003|Overall Study|Lack of Efficacy|8|||
27542323|NCT00679432|80175842|FG000|Overall Study|Infectious colitis, normal histology|5|||
27542324|NCT00679432|80175843|FG001|Overall Study|Infectious colitis, normal histology|4|||
27542325|NCT00679432|80175844|FG002|Overall Study|Infectious colitis, normal histology|8|||
27542326|NCT00679432|80175845|FG003|Overall Study|Infectious colitis, normal histology|3|||
27542327|NCT00679432|80175842|FG000|Overall Study|Randomization error, return to prior Rx|0|||
27542328|NCT00679432|80175843|FG001|Overall Study|Randomization error, return to prior Rx|0|||
27542329|NCT00679432|80175844|FG002|Overall Study|Randomization error, return to prior Rx|3|||
27920852|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27920853|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27542330|NCT00679432|80175845|FG003|Overall Study|Randomization error, return to prior Rx|0|||
27542331|NCT00036270|80175846|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
27636779|NCT00566527|80512531|FG000|Overall Study|Physician Decision|3|||
27636780|NCT00566527|80512532|FG001|Overall Study|Physician Decision|8|||
27636781|NCT00566527|80512533|FG002|Overall Study|Physician Decision|20|||
27636782|NCT00566527|80512531|FG000|Overall Study|Lost to Follow-up|3|||
27636783|NCT00566527|80512532|FG001|Overall Study|Lost to Follow-up|4|||
27636784|NCT00566527|80512533|FG002|Overall Study|Lost to Follow-up|4|||
27636785|NCT00566527|80512531|FG000|Overall Study|Withdrawal by Subject|6|||
27636786|NCT00566527|80512532|FG001|Overall Study|Withdrawal by Subject|43|||
27636787|NCT00566527|80512533|FG002|Overall Study|Withdrawal by Subject|43|||
27636788|NCT04057196|80512536|FG000|Overall Study|Withdrawal by Subject|3|||
27636789|NCT04057196|80512536|FG000|Overall Study|Death|3|||
27920854|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
27636790|NCT01968226|80512537|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
27636791|NCT00639002|80512541|FG000|Overall Study|Death|1|||
27636792|NCT00639002|80512541|FG000|Overall Study|Adverse Event|1|||
27636793|NCT00639002|80512541|FG000|Overall Study|Protocol Violation|1|||
27636794|NCT00639002|80512541|FG000|Overall Study|Disease progression|3|||
27636795|NCT00639002|80512541|FG000|Overall Study|Physician Decision|6|||
27636796|NCT00639002|80512541|FG000|Overall Study|Lack of Efficacy|1|||
27636797|NCT00177216|80512542|FG000|Overall Study|Withdrawal by Subject|6|||
27636798|NCT00177216|80512543|FG001|Overall Study|Withdrawal by Subject|3|||
27636799|NCT00177216|80512544|FG002|Overall Study|Withdrawal by Subject|1|||
27636800|NCT03069313|80512545|FG000|Overall Study|Adverse Event|5|||
27636801|NCT01458210|80512546|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
27636802|NCT01458210|80512546|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
27636803|NCT01458210|80512546|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
27636804|NCT01458210|80512546|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
27636805|NCT00482729|80512554|FG000|Overall Study|Adverse Event|29|||
27636806|NCT00482729|80512555|FG001|Overall Study|Adverse Event|33|||
27636807|NCT00482729|80512554|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
27636808|NCT00482729|80512555|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
27636809|NCT00482729|80512554|FG000|Overall Study|Hyperglycemia Criteria|7|||
27636810|NCT00482729|80512555|FG001|Overall Study|Hyperglycemia Criteria|5|||
27636811|NCT00482729|80512554|FG000|Overall Study|Lack of Efficacy|4|||
27636812|NCT00482729|80512555|FG001|Overall Study|Lack of Efficacy|16|||
27636813|NCT00482729|80512554|FG000|Overall Study|Lost to Follow-up|86|||
27636814|NCT00482729|80512555|FG001|Overall Study|Lost to Follow-up|66|||
27636815|NCT00482729|80512554|FG000|Overall Study|Physician Decision|10|||
27636816|NCT00482729|80512555|FG001|Overall Study|Physician Decision|7|||
27636817|NCT00482729|80512554|FG000|Overall Study|Pregnancy|4|||
27636818|NCT00482729|80512555|FG001|Overall Study|Pregnancy|2|||
27636819|NCT00482729|80512554|FG000|Overall Study|Protocol Violation|10|||
27636820|NCT00482729|80512555|FG001|Overall Study|Protocol Violation|18|||
27636821|NCT00482729|80512554|FG000|Overall Study|Withdrawal by Subject|67|||
27636822|NCT00482729|80512555|FG001|Overall Study|Withdrawal by Subject|69|||
27636823|NCT01395758|80512556|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
27636824|NCT01395758|80512557|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27636825|NCT01395758|80512558|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
27636826|NCT00716859|80512563|FG000|Overall Study|Adverse Event|4|||
27920855|NCT02513550|81547058|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
27920856|NCT02513550|81547059|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
27920857|NCT02513550|81547060|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
27920858|NCT02513550|81547061|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
27920859|NCT02513550|81547062|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
27920860|NCT02513550|81547063|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
27920861|NCT02701634|81547064|FG000|Overall Study|Adverse Event|2|||
27920862|NCT02701634|81547065|FG001|Overall Study|Adverse Event|3|||
27920863|NCT02701634|81547064|FG000|Overall Study|Death|1|||
27920864|NCT02701634|81547065|FG001|Overall Study|Death|0|||
27920865|NCT02701634|81547064|FG000|Overall Study|Investigator's Discretion|7|||
27920866|NCT02701634|81547065|FG001|Overall Study|Investigator's Discretion|4|||
27920867|NCT02701634|81547064|FG000|Overall Study|Study terminated by Sponsor|15|||
27920868|NCT02701634|81547065|FG001|Overall Study|Study terminated by Sponsor|17|||
27636827|NCT00716859|80512564|FG001|Overall Study|Adverse Event|1|||
27636828|NCT00716859|80512563|FG000|Overall Study|Lack of Efficacy|3|||
27636829|NCT00716859|80512564|FG001|Overall Study|Lack of Efficacy|0|||
27636830|NCT00716859|80512563|FG000|Overall Study|Withdrawal by Subject|1|||
27636831|NCT00716859|80512564|FG001|Overall Study|Withdrawal by Subject|3|||
27636832|NCT00716859|80512563|FG000|Overall Study|Not treated|1|||
27636833|NCT00716859|80512564|FG001|Overall Study|Not treated|1|||
27920869|NCT02701634|81547064|FG000|Overall Study|Withdrew Consent|6|||
27920870|NCT02701634|81547065|FG001|Overall Study|Withdrew Consent|7|||
27920871|NCT02701634|81547064|FG000|Overall Study|Randomized but not treated|1|||
27636834|NCT00150176|80512566|FG000|Overall Study|Adverse Event|16|||
27636835|NCT00150176|80512567|FG001|Overall Study|Adverse Event|53|||
27920872|NCT02701634|81547065|FG001|Overall Study|Randomized but not treated|0|||
27920873|NCT02273167|81547084|FG000|Overall Study|Adverse Event|1|||
27636836|NCT00150176|80512566|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
27636837|NCT00150176|80512567|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
27636838|NCT00150176|80512566|FG000|Overall Study|Withdrawal by Subject|19|||
27636839|NCT00150176|80512567|FG001|Overall Study|Withdrawal by Subject|12|||
27636840|NCT00150176|80512566|FG000|Overall Study|Lost to Follow-up|3|||
27636841|NCT00150176|80512567|FG001|Overall Study|Lost to Follow-up|3|||
27636842|NCT00150176|80512566|FG000|Overall Study|OTHER|11|||
27636843|NCT00150176|80512567|FG001|Overall Study|OTHER|13|||
27636844|NCT00979992|80512568|FG000|Overall Study|Ineligible - inadequate pathology|1|||
27636845|NCT00979992|80512568|FG000|Overall Study|Ineligible - wrong cell type|2|||
27636846|NCT00979992|80512568|FG000|Overall Study|Refused - Never Treated|2|||
27636847|NCT00520546|80512569|FG000|Overall Study|Withdrawal by Subject|1|||
27636848|NCT00520546|80512569|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
27636849|NCT02506257|80512571|FG000|Overall Study|Adverse Event|0|||
27636850|NCT02506257|80512572|FG001|Overall Study|Adverse Event|2|||
27636851|NCT02506257|80512573|FG002|Overall Study|Adverse Event|3|||
27636852|NCT02506257|80512574|FG003|Overall Study|Adverse Event|0|||
27636853|NCT02506257|80512571|FG000|Overall Study|Protocol Violation|0|||
27636854|NCT02506257|80512572|FG001|Overall Study|Protocol Violation|0|||
27636855|NCT02506257|80512573|FG002|Overall Study|Protocol Violation|1|||
27636856|NCT02506257|80512574|FG003|Overall Study|Protocol Violation|0|||
27636857|NCT02810080|80512575|FG000|Overall Study|Adverse Event|3|||
27636858|NCT02810080|80512576|FG001|Overall Study|Adverse Event|0|||
27740943|NCT01736683|80880769|FG001|Overall Study|Other|0|||
27740944|NCT01736683|80880770|FG002|Overall Study|Other|1|||
27740945|NCT01736683|80880771|FG003|Overall Study|Other|9|||
27740946|NCT01736683|80880772|FG004|Overall Study|Other|1|||
27740947|NCT01326962|80880776|FG000|Overall Study|Adverse Event|1|||
27740948|NCT01326962|80880776|FG000|Overall Study|Withdrawal by Subject|1|||
27740949|NCT01326962|80880776|FG000|Overall Study|Lost to Follow-up|3|||
27740950|NCT01326962|80880776|FG000|Overall Study|Other|2|||
27740951|NCT01849848|80880777|FG000|Overall Study|Physician Decision|1|||
27740952|NCT01849848|80880777|FG000|Overall Study|Progression of the primary disease|3|||
27740953|NCT02961764|80880778|FG000|Overall Study|Protocol Violation|0|||
27740954|NCT02961764|80880779|FG001|Overall Study|Protocol Violation|1|||
27740955|NCT02961764|80880778|FG000|Overall Study|Death|2|||
27740956|NCT02961764|80880779|FG001|Overall Study|Death|0|||
27740957|NCT02961764|80880778|FG000|Overall Study|Lost to Follow-up|35|||
27740958|NCT02961764|80880779|FG001|Overall Study|Lost to Follow-up|24|||
27740959|NCT02961764|80880778|FG000|Overall Study|Withdrawal by Subject|2|||
27740960|NCT02961764|80880779|FG001|Overall Study|Withdrawal by Subject|0|||
27740961|NCT02400346|80880782|FG000|Overall Study|Adverse Event|24|||
27740962|NCT02400346|80880782|FG000|Overall Study|Lack of Efficacy|9|||
27740963|NCT02400346|80880782|FG000|Overall Study|Non-compliance with IMP|1|||
27740964|NCT02400346|80880782|FG000|Overall Study|Withdrawal by Subject|7|||
27740965|NCT02400346|80880782|FG000|Overall Study|Administrative or other reason(s)|2|||
27740966|NCT02400346|80880782|FG000|Overall Study|Lost to Follow-up|1|||
27740967|NCT01499576|80880783|FG000|Overall Study|Physician Decision|12|||
27740968|NCT01499576|80880783|FG000|Overall Study|Withdrawal by Subject|9|||
27740969|NCT00144300|80880786|FG000|Overall Study|Adverse Event|18|||
27740970|NCT00144300|80880787|FG001|Overall Study|Adverse Event|16|||
27740971|NCT00144300|80880786|FG000|Overall Study|Protocol Violation|1|||
27740972|NCT00144300|80880787|FG001|Overall Study|Protocol Violation|3|||
27740973|NCT00144300|80880786|FG000|Overall Study|Lost to Follow-up|3|||
27740974|NCT00144300|80880787|FG001|Overall Study|Lost to Follow-up|0|||
27740975|NCT00144300|80880786|FG000|Overall Study|Withdrawal by Subject|6|||
27740976|NCT00144300|80880787|FG001|Overall Study|Withdrawal by Subject|6|||
27740977|NCT00144300|80880786|FG000|Overall Study|Other reason (not specified)|1|||
27740978|NCT00144300|80880787|FG001|Overall Study|Other reason (not specified)|3|||
27740979|NCT03241173|80880789|FG000|Overall Study|Death|3|||
27740980|NCT03241173|80880790|FG001|Overall Study|Death|2|||
27740981|NCT03241173|80880791|FG002|Overall Study|Death|4|||
27740982|NCT03241173|80880792|FG003|Overall Study|Death|4|||
27740983|NCT03241173|80880793|FG004|Overall Study|Death|2|||
27740984|NCT03241173|80880794|FG005|Overall Study|Death|2|||
27740985|NCT03241173|80880795|FG006|Overall Study|Death|3|||
27740986|NCT03241173|80880796|FG007|Overall Study|Death|1|||
27740987|NCT03241173|80880797|FG008|Overall Study|Death|0|||
27740988|NCT03241173|80880798|FG009|Overall Study|Death|5|||
27740989|NCT03241173|80880799|FG010|Overall Study|Death|4|||
27740990|NCT03241173|80880800|FG011|Overall Study|Death|3|||
27740991|NCT03241173|80880801|FG012|Overall Study|Death|0|||
27740992|NCT03241173|80880802|FG013|Overall Study|Death|0|||
27740993|NCT03241173|80880803|FG014|Overall Study|Death|0|||
27740994|NCT03241173|80880789|FG000|Overall Study|Withdrawal by Subject|0|||
27740995|NCT03241173|80880790|FG001|Overall Study|Withdrawal by Subject|0|||
27636859|NCT02810080|80512575|FG000|Overall Study|Death|0|||
27740996|NCT03241173|80880791|FG002|Overall Study|Withdrawal by Subject|1|||
27740997|NCT03241173|80880792|FG003|Overall Study|Withdrawal by Subject|0|||
27740998|NCT03241173|80880793|FG004|Overall Study|Withdrawal by Subject|0|||
27636860|NCT02810080|80512576|FG001|Overall Study|Death|2|||
27636861|NCT02810080|80512575|FG000|Overall Study|Physician Decision|4|||
27636862|NCT02810080|80512576|FG001|Overall Study|Physician Decision|0|||
27636863|NCT02810080|80512575|FG000|Overall Study|Withdrawal by Subject|0|||
27636864|NCT02810080|80512576|FG001|Overall Study|Withdrawal by Subject|2|||
27636865|NCT00743444|80512577|FG000|First Intervention|Catheter placement problems|0|||
27636866|NCT00743444|80512578|FG001|First Intervention|Catheter placement problems|1|||
27636867|NCT00743444|80512577|FG000|Washout Period|Adverse Event|0|||
27636868|NCT00743444|80512578|FG001|Washout Period|Adverse Event|1|||
27636869|NCT01925339|80512584|FG000|Overall Study|Adverse Event|2|||
27636870|NCT01925339|80512585|FG001|Overall Study|Adverse Event|0|||
27636871|NCT01202955|80512586|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
27636872|NCT01202955|80512587|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
27636873|NCT04218266|80512588|FG000|Overall Study|Death|1|||
27636874|NCT04218266|80512589|FG001|Overall Study|Death|2|||
27636875|NCT04218266|80512590|FG002|Overall Study|Death|3|||
27636876|NCT04218266|80512588|FG000|Overall Study|Adverse Event|13|||
27636877|NCT04218266|80512589|FG001|Overall Study|Adverse Event|14|||
27636878|NCT04218266|80512590|FG002|Overall Study|Adverse Event|11|||
27636879|NCT04218266|80512588|FG000|Overall Study|Other|7|||
27636880|NCT04218266|80512589|FG001|Overall Study|Other|5|||
27636881|NCT04218266|80512590|FG002|Overall Study|Other|14|||
27636882|NCT04218266|80512588|FG000|Overall Study|Physician Decision|1|||
27636883|NCT04218266|80512589|FG001|Overall Study|Physician Decision|3|||
27636884|NCT04218266|80512590|FG002|Overall Study|Physician Decision|2|||
27636885|NCT04218266|80512588|FG000|Overall Study|Non-compliance with study drug|0|||
27636886|NCT04218266|80512589|FG001|Overall Study|Non-compliance with study drug|0|||
27636887|NCT04218266|80512590|FG002|Overall Study|Non-compliance with study drug|1|||
27636888|NCT04218266|80512588|FG000|Overall Study|Withdrawal by Subject|1|||
27636889|NCT04218266|80512589|FG001|Overall Study|Withdrawal by Subject|3|||
27636890|NCT04218266|80512590|FG002|Overall Study|Withdrawal by Subject|1|||
27636891|NCT04218266|80512588|FG000|Overall Study|Study drug never administered|2|||
27636892|NCT04218266|80512589|FG001|Overall Study|Study drug never administered|0|||
27636893|NCT04218266|80512590|FG002|Overall Study|Study drug never administered|0|||
27636894|NCT02529995|80512591|FG000|Part A|Ongoing Study at Data Cut-off|14|||
27636895|NCT02529995|80512592|FG001|Part A|Ongoing Study at Data Cut-off|16|||
27636896|NCT02529995|80512591|FG000|Part A|Discontinued Study|1|||
27636897|NCT02529995|80512592|FG001|Part A|Discontinued Study|0|||
27636898|NCT02529995|80512591|FG000|Part B|Ongoing Study at Data Cut-off|0|||
27636899|NCT02529995|80512592|FG001|Part B|Ongoing Study at Data Cut-off|7|||
27636900|NCT02529995|80512591|FG000|Part B|Discontinued Study|6|||
27636901|NCT02529995|80512592|FG001|Part B|Discontinued Study|5|||
27636902|NCT01595061|80512595|FG000|Overall Study|Never Treated|3|||
27636903|NCT01595061|80512595|FG000|Overall Study|Inadequate Pathology|1|||
27636904|NCT01198275|80512596|FG000|Overall Study|Adverse Event|2|||
27636905|NCT01198275|80512597|FG001|Overall Study|Adverse Event|3|||
27636906|NCT01198275|80512596|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
27920874|NCT02273167|81547085|FG001|Overall Study|Adverse Event|0|||
27920875|NCT02273167|81547086|FG002|Overall Study|Adverse Event|0|||
27542332|NCT00036270|80175847|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
27542333|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
27542334|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
27542335|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
27542336|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
27542337|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
27542338|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
27542339|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Other|277|||
27542340|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Other|288|||
27542341|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
27542342|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
27542343|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
27542344|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
27636907|NCT01198275|80512597|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
27636908|NCT00933400|80512598|FG000|Overall Study|Withdrawal by Subject|21|||
27636909|NCT00933400|80512599|FG001|Overall Study|Withdrawal by Subject|1|||
27636910|NCT00807144|80512600|FG000|Overall Study|Lost to Follow-up|0|||
27636911|NCT00807144|80512601|FG001|Overall Study|Lost to Follow-up|1|||
27636912|NCT01764464|80512602|FG000|First Intervention|Withdrawal by Subject|1|||
27636913|NCT01764464|80512603|FG001|First Intervention|Withdrawal by Subject|0|||
27542345|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
27542346|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
27542347|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
27636914|NCT01764464|80512602|FG000|First Intervention|Lost to Follow-up|1|||
27636915|NCT01764464|80512603|FG001|First Intervention|Lost to Follow-up|0|||
27636916|NCT01764464|80512602|FG000|First Intervention|Adverse Event|0|||
27920876|NCT02273167|81547084|FG000|Overall Study|Protocol Violation|3|||
27636917|NCT01764464|80512603|FG001|First Intervention|Adverse Event|2|||
27636918|NCT01764464|80512602|FG000|First Intervention|did not receive study drug|0|||
27636919|NCT01764464|80512603|FG001|First Intervention|did not receive study drug|1|||
27636920|NCT01764464|80512602|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
27636921|NCT01764464|80512603|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
27636922|NCT00712335|80512606|FG000|Overall Study|Withdrawal by Subject|0|||
27636923|NCT00712335|80512607|FG001|Overall Study|Withdrawal by Subject|7|||
27636924|NCT00712335|80512608|FG002|Overall Study|Withdrawal by Subject|2|||
27636925|NCT00712335|80512609|FG003|Overall Study|Withdrawal by Subject|3|||
27636926|NCT00712335|80512610|FG004|Overall Study|Withdrawal by Subject|0|||
27636927|NCT00712335|80512606|FG000|Overall Study|Lost to Follow-up|2|||
27636928|NCT00712335|80512607|FG001|Overall Study|Lost to Follow-up|5|||
27636929|NCT00712335|80512608|FG002|Overall Study|Lost to Follow-up|0|||
27636930|NCT00712335|80512609|FG003|Overall Study|Lost to Follow-up|1|||
27636931|NCT00712335|80512610|FG004|Overall Study|Lost to Follow-up|0|||
27636932|NCT00712335|80512606|FG000|Overall Study|Protocol Violation|1|||
27636933|NCT00712335|80512607|FG001|Overall Study|Protocol Violation|2|||
27636934|NCT00712335|80512608|FG002|Overall Study|Protocol Violation|1|||
27636935|NCT00712335|80512609|FG003|Overall Study|Protocol Violation|0|||
27636936|NCT00712335|80512610|FG004|Overall Study|Protocol Violation|0|||
27636937|NCT00712335|80512606|FG000|Overall Study|Lack of Efficacy|0|||
27636938|NCT00712335|80512607|FG001|Overall Study|Lack of Efficacy|0|||
27636939|NCT00712335|80512608|FG002|Overall Study|Lack of Efficacy|1|||
27636940|NCT00712335|80512609|FG003|Overall Study|Lack of Efficacy|1|||
27636941|NCT00712335|80512610|FG004|Overall Study|Lack of Efficacy|0|||
27636942|NCT00712335|80512606|FG000|Overall Study|Other Reason|0|||
27636943|NCT00712335|80512607|FG001|Overall Study|Other Reason|3|||
27636944|NCT00712335|80512608|FG002|Overall Study|Other Reason|1|||
27636945|NCT00712335|80512609|FG003|Overall Study|Other Reason|0|||
27636946|NCT00712335|80512610|FG004|Overall Study|Other Reason|0|||
27636947|NCT02296424|80512611|FG000|Part 1|New therapy for study indication|0|||
27636948|NCT02296424|80512612|FG001|Part 1|New therapy for study indication|1|||
27636949|NCT02296424|80512613|FG002|Part 1|New therapy for study indication|0|||
27636950|NCT02296424|80512614|FG003|Part 1|New therapy for study indication|0|||
27636951|NCT02296424|80512611|FG000|Part 1|Protocol Violation|0|||
27920877|NCT02273167|81547085|FG001|Overall Study|Protocol Violation|1|||
27920878|NCT02273167|81547086|FG002|Overall Study|Protocol Violation|1|||
27920879|NCT02273167|81547084|FG000|Overall Study|Lost to Follow-up|0|||
27920880|NCT02273167|81547085|FG001|Overall Study|Lost to Follow-up|1|||
27920881|NCT02273167|81547086|FG002|Overall Study|Lost to Follow-up|1|||
27920882|NCT02273167|81547084|FG000|Overall Study|Withdrawal by Subject|10|||
27920883|NCT02273167|81547085|FG001|Overall Study|Withdrawal by Subject|12|||
27920884|NCT02273167|81547086|FG002|Overall Study|Withdrawal by Subject|11|||
27920885|NCT02273167|81547084|FG000|Overall Study|Various|10|||
27920886|NCT02273167|81547085|FG001|Overall Study|Various|9|||
27920887|NCT02273167|81547086|FG002|Overall Study|Various|8|||
27920888|NCT03627832|81547088|FG000|Overall Study|Withdrawal by Subject|10|||
27920889|NCT03627832|81547089|FG001|Overall Study|Withdrawal by Subject|1|||
27920890|NCT02078817|81547090|FG000|Overall Study|Withdrawal by Subject|1|||
27920891|NCT01290718|81547091|FG000|Overall Study|Early termination of the study|4|||
27920892|NCT02111083|81550507|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
27920893|NCT02111083|81550508|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
27920894|NCT00408499|81550509|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
27920895|NCT00408499|81550510|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
27920896|NCT00408499|81550511|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
27920897|NCT00408499|81550512|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
27920898|NCT00408499|81550513|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
27920899|NCT00408499|81550509|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
27920900|NCT00408499|81550510|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
27920901|NCT00408499|81550511|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
27920902|NCT00408499|81550512|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
27920903|NCT00408499|81550513|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
27920904|NCT00408499|81550509|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
27920905|NCT00408499|81550510|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
27920906|NCT00408499|81550511|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
27636952|NCT02296424|80512612|FG001|Part 1|Protocol Violation|1|||
27920907|NCT00408499|81550512|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
27920908|NCT00408499|81550513|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
27920909|NCT00408499|81550509|FG000|Phase II- MTD Expansion|Adverse Event|0|||
27636953|NCT02296424|80512613|FG002|Part 1|Protocol Violation|0|||
27636954|NCT02296424|80512614|FG003|Part 1|Protocol Violation|0|||
27636955|NCT02296424|80512611|FG000|Part 1|Withdrawal by Subject|0|||
27636956|NCT02296424|80512612|FG001|Part 1|Withdrawal by Subject|2|||
27636957|NCT02296424|80512613|FG002|Part 1|Withdrawal by Subject|0|||
27636958|NCT02296424|80512614|FG003|Part 1|Withdrawal by Subject|0|||
27636959|NCT02296424|80512611|FG000|Part 1|Study terminated by sponsor|0|||
27920910|NCT00408499|81550510|FG001|Phase II- MTD Expansion|Adverse Event|0|||
27542348|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
27542349|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
27542350|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
27542351|NCT00036270|80175846|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
27542352|NCT00036270|80175847|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
27542353|NCT00316719|80175848|FG000|Overall Study|Adverse Event|0|||
27542354|NCT00316719|80175849|FG001|Overall Study|Adverse Event|6|||
27542355|NCT00316719|80175848|FG000|Overall Study|Consent withdrawn|2|||
27542356|NCT00316719|80175849|FG001|Overall Study|Consent withdrawn|0|||
27542357|NCT00293215|80175850|FG000|Overall Study|Progressive disease|3|||
27542358|NCT00293215|80175851|FG001|Overall Study|Progressive disease|1|||
27542359|NCT00293215|80175850|FG000|Overall Study|Adverse Event|2|||
27542360|NCT00293215|80175851|FG001|Overall Study|Adverse Event|2|||
27542361|NCT00880542|80175852|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
27542362|NCT00880542|80175852|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
27542363|NCT00880542|80175852|FG000|REP: Surgical Resection|progressive disease|1|||
27542364|NCT01441180|80175853|FG000|Overall Study|Lost to Follow-up|1|||
27542365|NCT01441180|80175854|FG001|Overall Study|Lost to Follow-up|1|||
27542366|NCT01441180|80175855|FG002|Overall Study|Lost to Follow-up|1|||
27542367|NCT01441180|80175853|FG000|Overall Study|Discontinued|0|||
27920911|NCT00408499|81550511|FG002|Phase II- MTD Expansion|Adverse Event|0|||
27920912|NCT00408499|81550512|FG003|Phase II- MTD Expansion|Adverse Event|0|||
27542368|NCT01441180|80175854|FG001|Overall Study|Discontinued|0|||
27542369|NCT01441180|80175855|FG002|Overall Study|Discontinued|2|||
27542370|NCT00404235|80175858|FG000|Overall Study|Withdrawal by Subject|1|||
27542371|NCT00404235|80175859|FG001|Overall Study|Withdrawal by Subject|2|||
27542372|NCT00894166|80175860|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
27542373|NCT00894166|80175861|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
27542374|NCT00894166|80175862|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
27542375|NCT00894166|80175863|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
27542376|NCT00894166|80175864|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
27542377|NCT00894166|80175865|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
27542378|NCT00894166|80175866|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
27542379|NCT00894166|80175867|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
27542380|NCT00894166|80175860|FG000|Overall Study|Death|0|||
27542381|NCT00894166|80175861|FG001|Overall Study|Death|0|||
27542382|NCT00894166|80175862|FG002|Overall Study|Death|0|||
27542383|NCT00894166|80175863|FG003|Overall Study|Death|1|||
27542384|NCT00894166|80175864|FG004|Overall Study|Death|0|||
27542385|NCT00894166|80175865|FG005|Overall Study|Death|0|||
27542386|NCT00894166|80175866|FG006|Overall Study|Death|0|||
27542387|NCT00894166|80175867|FG007|Overall Study|Death|0|||
27542388|NCT00003473|80175868|FG000|Overall Study|Three patients were not evaluable.|3|||
27542389|NCT00242216|80175870|FG000|Overall Study|Lost to Follow-up|12|||
27542390|NCT00242216|80175871|FG001|Overall Study|Lost to Follow-up|17|||
27542391|NCT00242216|80175870|FG000|Overall Study|Death|4|||
27542392|NCT00242216|80175871|FG001|Overall Study|Death|2|||
27542393|NCT00242216|80175870|FG000|Overall Study|Lack of Efficacy|1|||
27542394|NCT00242216|80175871|FG001|Overall Study|Lack of Efficacy|2|||
27542395|NCT00242216|80175870|FG000|Overall Study|no medicaiton dispensed|1|||
27542396|NCT00242216|80175871|FG001|Overall Study|no medicaiton dispensed|1|||
27542397|NCT01466153|80175875|FG000|Overall Study|Disease Progression|2|||
27542398|NCT01466153|80175876|FG001|Overall Study|Disease Progression|2|||
27542399|NCT01466153|80175877|FG002|Overall Study|Disease Progression|0|||
27542400|NCT01466153|80175875|FG000|Overall Study|Adverse Event|14|||
27542401|NCT01466153|80175876|FG001|Overall Study|Adverse Event|13|||
27542402|NCT01466153|80175877|FG002|Overall Study|Adverse Event|17|||
27542403|NCT01466153|80175875|FG000|Overall Study|Withdrawal of Consent|2|||
27542404|NCT01466153|80175876|FG001|Overall Study|Withdrawal of Consent|0|||
27542405|NCT01466153|80175877|FG002|Overall Study|Withdrawal of Consent|0|||
27542406|NCT01466153|80175875|FG000|Overall Study|Investigator Discretion|3|||
27542407|NCT01466153|80175876|FG001|Overall Study|Investigator Discretion|2|||
27542408|NCT01466153|80175877|FG002|Overall Study|Investigator Discretion|2|||
27542409|NCT01466153|80175875|FG000|Overall Study|Randomized-Not Treated|2|||
27542410|NCT01466153|80175876|FG001|Overall Study|Randomized-Not Treated|3|||
27542411|NCT01466153|80175877|FG002|Overall Study|Randomized-Not Treated|4|||
27542412|NCT01466153|80175875|FG000|Overall Study|Other-Unspecified|6|||
27542413|NCT01466153|80175876|FG001|Overall Study|Other-Unspecified|4|||
27542414|NCT01466153|80175877|FG002|Overall Study|Other-Unspecified|2|||
27542415|NCT01686828|80175878|FG000|Overall Study|Physician Decision|1|||
27542416|NCT01686828|80175879|FG001|Overall Study|Physician Decision|0|||
27542417|NCT01686828|80175880|FG002|Overall Study|Physician Decision|0|||
27542418|NCT01686828|80175881|FG003|Overall Study|Physician Decision|0|||
27542419|NCT01686828|80175878|FG000|Overall Study|New Job|0|||
27542420|NCT01686828|80175879|FG001|Overall Study|New Job|1|||
27542421|NCT01686828|80175880|FG002|Overall Study|New Job|0|||
27542422|NCT01686828|80175881|FG003|Overall Study|New Job|0|||
27542423|NCT01686828|80175878|FG000|Overall Study|Weight Loss|0|||
27542424|NCT01686828|80175879|FG001|Overall Study|Weight Loss|0|||
27920913|NCT00408499|81550513|FG004|Phase II- MTD Expansion|Adverse Event|9|||
27920914|NCT00408499|81550509|FG000|Phase II- MTD Expansion|Death|0|||
27920915|NCT00408499|81550510|FG001|Phase II- MTD Expansion|Death|0|||
27920916|NCT00408499|81550511|FG002|Phase II- MTD Expansion|Death|0|||
27920917|NCT00408499|81550512|FG003|Phase II- MTD Expansion|Death|0|||
27920918|NCT00408499|81550513|FG004|Phase II- MTD Expansion|Death|2|||
27920919|NCT00408499|81550509|FG000|Phase II- MTD Expansion|Physician Decision|0|||
27920920|NCT00408499|81550510|FG001|Phase II- MTD Expansion|Physician Decision|0|||
27920921|NCT00408499|81550511|FG002|Phase II- MTD Expansion|Physician Decision|0|||
27920922|NCT00408499|81550512|FG003|Phase II- MTD Expansion|Physician Decision|0|||
27920923|NCT00408499|81550513|FG004|Phase II- MTD Expansion|Physician Decision|1|||
27920924|NCT00408499|81550509|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
27920925|NCT00408499|81550510|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
27920926|NCT00408499|81550511|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
27920927|NCT00408499|81550512|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
27920928|NCT00408499|81550513|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
27920929|NCT00408499|81550509|FG000|Phase II- MTD Expansion|treatment delay|0|||
27920930|NCT00408499|81550510|FG001|Phase II- MTD Expansion|treatment delay|0|||
27920931|NCT00408499|81550511|FG002|Phase II- MTD Expansion|treatment delay|0|||
27542425|NCT01686828|80175880|FG002|Overall Study|Weight Loss|1|||
27542426|NCT01686828|80175881|FG003|Overall Study|Weight Loss|0|||
27542427|NCT00001880|80175882|FG000|Overall Study|Death|14|||
27542428|NCT02538029|80175883|FG000|Overall Study|unable to complete cognitive assessments|1|||
27542429|NCT02538029|80175884|FG001|Overall Study|unable to complete cognitive assessments|0|||
27542430|NCT02538029|80175885|FG002|Overall Study|unable to complete cognitive assessments|1|||
27542431|NCT00934089|80175888|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
27542432|NCT00934089|80175889|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
27542433|NCT00934089|80175888|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
27542434|NCT00934089|80175889|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
27542435|NCT03338010|80175890|FG000|Overall Study|Withdrawal by Subject|14|||
27542436|NCT03338010|80175891|FG001|Overall Study|Withdrawal by Subject|8|||
27542437|NCT03338010|80175890|FG000|Overall Study|Lost to Follow-up|4|||
27542438|NCT03338010|80175891|FG001|Overall Study|Lost to Follow-up|2|||
27542439|NCT03338010|80175890|FG000|Overall Study|Adverse Event|3|||
27542440|NCT03338010|80175891|FG001|Overall Study|Adverse Event|2|||
27542441|NCT03338010|80175890|FG000|Overall Study|Physician Decision|2|||
27542442|NCT03338010|80175891|FG001|Overall Study|Physician Decision|2|||
27542443|NCT03338010|80175890|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27542444|NCT03338010|80175891|FG001|Overall Study|Non-Compliance with Study Drug|3|||
27542445|NCT03338010|80175890|FG000|Overall Study|Protocol Violation|0|||
27542446|NCT03338010|80175891|FG001|Overall Study|Protocol Violation|1|||
27542447|NCT01365052|80175892|FG000|Overall Study|Adverse Event|4|||
27542448|NCT01365052|80175893|FG001|Overall Study|Adverse Event|4|||
27542449|NCT02349061|80175894|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
27542450|NCT02349061|80175895|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
27542451|NCT02349061|80175896|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
27542452|NCT02349061|80175894|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
27542453|NCT02349061|80175895|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
27542454|NCT02349061|80175896|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
27542455|NCT02349061|80175894|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
27542456|NCT02349061|80175895|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
27542457|NCT02349061|80175896|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
27542458|NCT02349061|80175894|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
27542459|NCT02349061|80175895|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
27542460|NCT02349061|80175896|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
27542461|NCT02349061|80175894|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
27542462|NCT02349061|80175895|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
27542463|NCT02349061|80175896|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
27542464|NCT02349061|80175894|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
27542465|NCT02349061|80175895|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
27542466|NCT02349061|80175896|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
27542467|NCT02349061|80175894|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
27636960|NCT02296424|80512612|FG001|Part 1|Study terminated by sponsor|1|||
27920932|NCT00408499|81550512|FG003|Phase II- MTD Expansion|treatment delay|0|||
27920933|NCT00408499|81550513|FG004|Phase II- MTD Expansion|treatment delay|3|||
27920934|NCT02127658|81550514|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
27542468|NCT02349061|80175895|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
27542469|NCT02349061|80175896|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
27542470|NCT02349061|80175894|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
27636961|NCT02296424|80512613|FG002|Part 1|Study terminated by sponsor|0|||
27920935|NCT02127658|81550515|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
27920936|NCT02127658|81550514|FG000|Overall Study|Withdrawal by Subject|0|||
27636962|NCT02296424|80512614|FG003|Part 1|Study terminated by sponsor|0|||
27636963|NCT02296424|80512611|FG000|Part 1|Adverse Event|2|||
27636964|NCT02296424|80512612|FG001|Part 1|Adverse Event|11|||
27636965|NCT02296424|80512613|FG002|Part 1|Adverse Event|0|||
27636966|NCT02296424|80512614|FG003|Part 1|Adverse Event|0|||
27636967|NCT02296424|80512611|FG000|Part 1|Lack of Efficacy|5|||
27636968|NCT02296424|80512612|FG001|Part 1|Lack of Efficacy|17|||
27636969|NCT02296424|80512613|FG002|Part 1|Lack of Efficacy|0|||
27636970|NCT02296424|80512614|FG003|Part 1|Lack of Efficacy|0|||
27636971|NCT02296424|80512611|FG000|Part 1|16 directly started part II|16|||
27636972|NCT02296424|80512612|FG001|Part 1|16 directly started part II|0|||
27636973|NCT02296424|80512613|FG002|Part 1|16 directly started part II|0|||
27636974|NCT02296424|80512614|FG003|Part 1|16 directly started part II|0|||
27636975|NCT02296424|80512611|FG000|Part 2|Lack of Efficacy|0|||
27636976|NCT02296424|80512612|FG001|Part 2|Lack of Efficacy|0|||
27636977|NCT02296424|80512613|FG002|Part 2|Lack of Efficacy|1|||
27636978|NCT02296424|80512614|FG003|Part 2|Lack of Efficacy|0|||
27636979|NCT02296424|80512611|FG000|Part 2|Adverse Event|0|||
27636980|NCT02296424|80512612|FG001|Part 2|Adverse Event|0|||
27636981|NCT02296424|80512613|FG002|Part 2|Adverse Event|1|||
27636982|NCT02296424|80512614|FG003|Part 2|Adverse Event|0|||
27636983|NCT02296424|80512611|FG000|Part 2|Lost to Follow-up|0|||
27636984|NCT02296424|80512612|FG001|Part 2|Lost to Follow-up|0|||
27636985|NCT02296424|80512613|FG002|Part 2|Lost to Follow-up|1|||
27636986|NCT02296424|80512614|FG003|Part 2|Lost to Follow-up|0|||
27636987|NCT01118377|80512615|FG000|Overall Study|Did Not Receive Study Medication|1|||
27636988|NCT01118377|80512615|FG000|Overall Study|Death|38|||
27636989|NCT01118377|80512615|FG000|Overall Study|Failure to Return|3|||
27636990|NCT02706717|80512621|FG000|Overall Study|Withdrawal by Subject|1|||
27636991|NCT02706717|80512622|FG001|Overall Study|Withdrawal by Subject|8|||
27636992|NCT02706717|80512621|FG000|Overall Study|Lost to Follow-up|0|||
27636993|NCT02706717|80512622|FG001|Overall Study|Lost to Follow-up|1|||
27636994|NCT02706717|80512621|FG000|Overall Study|Physician Decision|0|||
27636995|NCT02706717|80512622|FG001|Overall Study|Physician Decision|1|||
27636996|NCT02706717|80512621|FG000|Overall Study|Death|0|||
27636997|NCT02706717|80512622|FG001|Overall Study|Death|1|||
27542471|NCT02349061|80175895|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
27542472|NCT02349061|80175896|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
27542473|NCT02349061|80175894|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
27542474|NCT02349061|80175895|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
27542475|NCT02349061|80175896|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
27542476|NCT02349061|80175894|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
27542477|NCT02349061|80175895|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
27542478|NCT02349061|80175896|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
27542479|NCT02349061|80175894|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
27542480|NCT02349061|80175895|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
27542481|NCT02349061|80175896|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
27542482|NCT02349061|80175894|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
27542483|NCT02349061|80175895|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
27542484|NCT02349061|80175896|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
27636998|NCT02525796|80512624|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
27636999|NCT02525796|80512625|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
27637000|NCT02525796|80512626|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
27637001|NCT02525796|80512624|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
27637002|NCT02525796|80512625|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
27637003|NCT02525796|80512626|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
27637004|NCT02525796|80512624|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
27637005|NCT02525796|80512625|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
27920937|NCT02127658|81550515|FG001|Overall Study|Withdrawal by Subject|2|||
27920938|NCT02127658|81550514|FG000|Overall Study|Physician Decision|0|||
27542485|NCT02349061|80175894|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
27542486|NCT02349061|80175895|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
27542487|NCT02349061|80175896|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
27542488|NCT03000569|80175897|FG000|Overall Study|Withdrawal by Subject|1|||
27637006|NCT02525796|80512626|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
27637007|NCT02525796|80512624|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
27920939|NCT02127658|81550515|FG001|Overall Study|Physician Decision|1|||
27637008|NCT02525796|80512625|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
27637009|NCT02525796|80512626|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
27637010|NCT02525796|80512624|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
27637011|NCT02525796|80512625|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
27637012|NCT02525796|80512626|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
27637013|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
27637014|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27542489|NCT03000569|80175898|FG001|Overall Study|Withdrawal by Subject|0|||
27920940|NCT04239924|81550516|FG000|Overall Study|Lost to Follow-up|2|||
27920941|NCT03834350|81550517|FG000|Overall Study|Withdrawal by Subject|1|||
27920942|NCT01192178|81550519|FG000|Overall Study|Withdrawal by Subject|6|||
27920943|NCT01192178|81550520|FG001|Overall Study|Withdrawal by Subject|10|||
27920944|NCT01192178|81550519|FG000|Overall Study|Protocol Violation|10|||
27920945|NCT01192178|81550520|FG001|Overall Study|Protocol Violation|3|||
27542490|NCT03840174|80175899|FG000|Overall Study|Withdrawal by Subject|1|||
27542491|NCT03840174|80175900|FG001|Overall Study|Withdrawal by Subject|0|||
27542492|NCT03840174|80175901|FG002|Overall Study|Withdrawal by Subject|0|||
27542493|NCT03840174|80175902|FG003|Overall Study|Withdrawal by Subject|0|||
27542494|NCT03128411|80175903|FG000|Treatment Phase|Adverse Event|21|||
27542495|NCT03128411|80175903|FG000|Treatment Phase|Physician Decision|1|||
27542496|NCT03128411|80175903|FG000|Treatment Phase|Other|2|||
27542497|NCT03128411|80175903|FG000|Long Term Follow-up Phase|Death|2|||
27542498|NCT03817879|80175904|FG000|Overall Study|Drop out|5|||
27542499|NCT03817879|80175905|FG001|Overall Study|Drop out|12|||
27542500|NCT03817879|80175904|FG000|Overall Study|Withdrawal by Subject|0|||
27542501|NCT03817879|80175905|FG001|Overall Study|Withdrawal by Subject|1|||
27542502|NCT03478930|80175914|FG000|Overall Study|Adverse Event|0|||
27542503|NCT03478930|80175915|FG001|Overall Study|Adverse Event|1|||
27542504|NCT03478930|80175914|FG000|Overall Study|Lack of Efficacy|3|||
27542505|NCT03478930|80175915|FG001|Overall Study|Lack of Efficacy|3|||
27542506|NCT03478930|80175914|FG000|Overall Study|Withdrawal by Subject|6|||
27542507|NCT03478930|80175915|FG001|Overall Study|Withdrawal by Subject|5|||
27920946|NCT01192178|81550519|FG000|Overall Study|Physician Decision|2|||
27920947|NCT01192178|81550520|FG001|Overall Study|Physician Decision|4|||
27920948|NCT01192178|81550519|FG000|Overall Study|Lost to Follow-up|3|||
27920949|NCT01192178|81550520|FG001|Overall Study|Lost to Follow-up|3|||
27920950|NCT01192178|81550519|FG000|Overall Study|Adverse Event|2|||
27920951|NCT01192178|81550520|FG001|Overall Study|Adverse Event|1|||
27920952|NCT01192178|81550519|FG000|Overall Study|Lack of Efficacy|1|||
27920953|NCT01192178|81550520|FG001|Overall Study|Lack of Efficacy|2|||
27920954|NCT01162343|81550521|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
27920955|NCT01162343|81550521|FG000|Overall Study|Refused psychiatrist assessment|12|||
27920956|NCT00630916|81550522|FG000|Overall Study|Death|110|||
27920957|NCT00630916|81550522|FG000|Overall Study|Explant|8|||
27920958|NCT00630916|81550522|FG000|Overall Study|Lost to Follow-up|5|||
27920959|NCT00630916|81550522|FG000|Overall Study|Withdrawal by Subject|30|||
27920960|NCT00630916|81550522|FG000|Overall Study|Protocol Violation|7|||
27920961|NCT00630916|81550522|FG000|Overall Study|Physician Decision|47|||
27920962|NCT00630916|81550522|FG000|Overall Study|Lack of Efficacy|3|||
27920963|NCT02631941|81550523|FG000|Overall Study|Physician Decision|0|||
27920964|NCT02631941|81550524|FG001|Overall Study|Physician Decision|1|||
27920965|NCT02631941|81550525|FG002|Overall Study|Physician Decision|0|||
27920966|NCT02631941|81550526|FG003|Overall Study|Physician Decision|0|||
27920967|NCT02631941|81550527|FG004|Overall Study|Physician Decision|0|||
27920968|NCT02631941|81550528|FG005|Overall Study|Physician Decision|0|||
27920969|NCT02631941|81550529|FG006|Overall Study|Physician Decision|0|||
27920970|NCT02631941|81550530|FG007|Overall Study|Physician Decision|0|||
27920971|NCT02631941|81550531|FG008|Overall Study|Physician Decision|0|||
27920972|NCT02631941|81550532|FG009|Overall Study|Physician Decision|0|||
27920973|NCT02631941|81550523|FG000|Overall Study|Adverse Event|0|||
27920974|NCT02631941|81550524|FG001|Overall Study|Adverse Event|1|||
27920975|NCT02631941|81550525|FG002|Overall Study|Adverse Event|0|||
27920976|NCT02631941|81550526|FG003|Overall Study|Adverse Event|0|||
27920977|NCT02631941|81550527|FG004|Overall Study|Adverse Event|0|||
27920978|NCT02631941|81550528|FG005|Overall Study|Adverse Event|0|||
27920979|NCT02631941|81550529|FG006|Overall Study|Adverse Event|0|||
27920980|NCT02631941|81550530|FG007|Overall Study|Adverse Event|0|||
27920981|NCT02631941|81550531|FG008|Overall Study|Adverse Event|0|||
27542508|NCT01945281|80175916|FG000|Overall Study|Adverse Event|1|||
27542509|NCT01945281|80175917|FG001|Overall Study|Adverse Event|0|||
27542510|NCT01945281|80175916|FG000|Overall Study|Death|3|||
27542511|NCT01945281|80175917|FG001|Overall Study|Death|3|||
27740999|NCT03241173|80880794|FG005|Overall Study|Withdrawal by Subject|1|||
27920982|NCT02631941|81550532|FG009|Overall Study|Adverse Event|0|||
27920983|NCT02631941|81550523|FG000|Overall Study|Withdrawal by Subject|0|||
27920984|NCT02631941|81550524|FG001|Overall Study|Withdrawal by Subject|0|||
27542512|NCT01945281|80175916|FG000|Overall Study|Physician Decision|1|||
27542513|NCT01945281|80175917|FG001|Overall Study|Physician Decision|1|||
27920985|NCT02631941|81550525|FG002|Overall Study|Withdrawal by Subject|0|||
27920986|NCT02631941|81550526|FG003|Overall Study|Withdrawal by Subject|0|||
27920987|NCT02631941|81550527|FG004|Overall Study|Withdrawal by Subject|1|||
27920988|NCT02631941|81550528|FG005|Overall Study|Withdrawal by Subject|0|||
27920989|NCT02631941|81550529|FG006|Overall Study|Withdrawal by Subject|0|||
27920990|NCT02631941|81550530|FG007|Overall Study|Withdrawal by Subject|1|||
27920991|NCT02631941|81550531|FG008|Overall Study|Withdrawal by Subject|0|||
27920992|NCT02631941|81550532|FG009|Overall Study|Withdrawal by Subject|0|||
27920993|NCT02631941|81550523|FG000|Overall Study|Lost to Follow-up|0|||
27920994|NCT02631941|81550524|FG001|Overall Study|Lost to Follow-up|0|||
27920995|NCT02631941|81550525|FG002|Overall Study|Lost to Follow-up|0|||
27920996|NCT02631941|81550526|FG003|Overall Study|Lost to Follow-up|0|||
27920997|NCT02631941|81550527|FG004|Overall Study|Lost to Follow-up|0|||
27920998|NCT02631941|81550528|FG005|Overall Study|Lost to Follow-up|0|||
27920999|NCT02631941|81550529|FG006|Overall Study|Lost to Follow-up|0|||
27921000|NCT02631941|81550530|FG007|Overall Study|Lost to Follow-up|0|||
27921001|NCT02631941|81550531|FG008|Overall Study|Lost to Follow-up|1|||
27921002|NCT02631941|81550532|FG009|Overall Study|Lost to Follow-up|0|||
27921003|NCT02643693|81550533|FG000|Overall Study|Physician Decision|0|||
27921004|NCT02643693|81550534|FG001|Overall Study|Physician Decision|1|||
27921005|NCT02643693|81550535|FG002|Overall Study|Physician Decision|0|||
27921006|NCT02643693|81550536|FG003|Overall Study|Physician Decision|0|||
27921007|NCT02643693|81550537|FG004|Overall Study|Physician Decision|0|||
27921008|NCT02643693|81550538|FG005|Overall Study|Physician Decision|0|||
27921009|NCT02643693|81550533|FG000|Overall Study|Withdrawal by Subject|0|||
27921010|NCT02643693|81550534|FG001|Overall Study|Withdrawal by Subject|1|||
27921011|NCT02643693|81550535|FG002|Overall Study|Withdrawal by Subject|0|||
27921012|NCT02643693|81550536|FG003|Overall Study|Withdrawal by Subject|0|||
27921013|NCT02643693|81550537|FG004|Overall Study|Withdrawal by Subject|0|||
27921014|NCT02643693|81550538|FG005|Overall Study|Withdrawal by Subject|0|||
27921015|NCT02643693|81550533|FG000|Overall Study|Protocol Adherence Issues|2|||
27921016|NCT02643693|81550534|FG001|Overall Study|Protocol Adherence Issues|0|||
27921017|NCT02643693|81550535|FG002|Overall Study|Protocol Adherence Issues|1|||
27921018|NCT02643693|81550536|FG003|Overall Study|Protocol Adherence Issues|0|||
27921019|NCT02643693|81550537|FG004|Overall Study|Protocol Adherence Issues|0|||
27921020|NCT02643693|81550538|FG005|Overall Study|Protocol Adherence Issues|1|||
27921021|NCT03470922|81550542|FG000|Overall Study|Death|107|||
27921022|NCT03470922|81550543|FG001|Overall Study|Death|118|||
27921023|NCT03470922|81550542|FG000|Overall Study|Lost to Follow-up|5|||
27921024|NCT03470922|81550543|FG001|Overall Study|Lost to Follow-up|5|||
27921025|NCT03470922|81550542|FG000|Overall Study|Participant Withdrew Consent|4|||
27921026|NCT03470922|81550543|FG001|Overall Study|Participant Withdrew Consent|9|||
27921027|NCT03470922|81550542|FG000|Overall Study|Other reasons|1|||
27921028|NCT03470922|81550543|FG001|Overall Study|Other reasons|0|||
27921029|NCT03470922|81550542|FG000|Overall Study|Not reported|1|||
27921030|NCT03470922|81550543|FG001|Overall Study|Not reported|0|||
27921031|NCT00611806|81550545|FG000|Overall Study|Withdrawal by Subject|8|||
27921032|NCT00611806|81550546|FG001|Overall Study|Withdrawal by Subject|2|||
27921033|NCT00611806|81550545|FG000|Overall Study|Adverse Event|2|||
27921034|NCT00611806|81550546|FG001|Overall Study|Adverse Event|1|||
27921035|NCT00611806|81550545|FG000|Overall Study|Lost to Follow-up|6|||
27921036|NCT00611806|81550546|FG001|Overall Study|Lost to Follow-up|0|||
27921037|NCT00703534|81550554|FG000|Overall Study|Adverse Event|14|||
27921038|NCT00703534|81550555|FG001|Overall Study|Adverse Event|3|||
27921039|NCT00703534|81550554|FG000|Overall Study|Withdrawal by Subject|8|||
27921040|NCT00703534|81550555|FG001|Overall Study|Withdrawal by Subject|7|||
27921041|NCT00703534|81550554|FG000|Overall Study|Incorrect Enrollment|6|||
27921042|NCT00703534|81550555|FG001|Overall Study|Incorrect Enrollment|6|||
27921043|NCT00703534|81550554|FG000|Overall Study|Lost to Follow-up|1|||
27921044|NCT00703534|81550555|FG001|Overall Study|Lost to Follow-up|4|||
27921045|NCT00703534|81550554|FG000|Overall Study|Severe Non Compliance|1|||
27921046|NCT00703534|81550555|FG001|Overall Study|Severe Non Compliance|5|||
27921047|NCT01101178|81550556|FG000|Period 1|Withdrawal by Subject|1|||
27921048|NCT01101178|81550557|FG001|Period 1|Withdrawal by Subject|2|||
27921049|NCT01101178|81550556|FG000|Period 1|Positive drug screen|1|||
27921050|NCT01101178|81550557|FG001|Period 1|Positive drug screen|1|||
27921051|NCT01101178|81550556|FG000|Period 1|Adverse Event|2|||
27921052|NCT01101178|81550557|FG001|Period 1|Adverse Event|1|||
27921053|NCT01101178|81550556|FG000|Period 2|Withdrawal by Subject|0|||
27921054|NCT01101178|81550557|FG001|Period 2|Withdrawal by Subject|1|||
27921055|NCT03363906|81550563|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
27542514|NCT01945281|80175916|FG000|Overall Study|Technical Problems|1|||
27921056|NCT03363906|81550564|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
27921057|NCT03363906|81550563|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
27921058|NCT03363906|81550564|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
27921059|NCT03363906|81550563|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
27921060|NCT03363906|81550564|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
27921061|NCT03363906|81550563|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
27921062|NCT03363906|81550564|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
27921063|NCT04539275|81550569|FG000|Overall Study|Death|2|||
27921064|NCT04539275|81550570|FG001|Overall Study|Death|4|||
27542515|NCT01945281|80175917|FG001|Overall Study|Technical Problems|0|||
27921065|NCT04539275|81550569|FG000|Overall Study|Lost to Follow-up|1|||
27921066|NCT04539275|81550570|FG001|Overall Study|Lost to Follow-up|1|||
27921067|NCT04539275|81550569|FG000|Overall Study|Withdrawal by Subject|3|||
27921068|NCT04539275|81550570|FG001|Overall Study|Withdrawal by Subject|0|||
27921069|NCT03040726|81550571|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
27921070|NCT03040726|81550572|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
27921071|NCT03040726|81550571|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
27921072|NCT03040726|81550572|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
27921073|NCT03040726|81550571|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
27921074|NCT03040726|81550572|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
27921075|NCT03040726|81550571|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
27921076|NCT03040726|81550572|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
27921077|NCT03040726|81550571|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
27921078|NCT03040726|81550572|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
27921079|NCT02988661|81550573|FG000|Overall Study|Death|2|||
27921080|NCT02988661|81550574|FG001|Overall Study|Death|18|||
27921081|NCT02988661|81550573|FG000|Overall Study|Lost to Follow-up|0|||
27921082|NCT02988661|81550574|FG001|Overall Study|Lost to Follow-up|33|||
27921083|NCT02988661|81550573|FG000|Overall Study|Withdrawal by Subject|0|||
27921084|NCT02988661|81550574|FG001|Overall Study|Withdrawal by Subject|6|||
27921085|NCT02988661|81550573|FG000|Overall Study|Unable to complete the 18-month survey|1|||
27921086|NCT02988661|81550574|FG001|Overall Study|Unable to complete the 18-month survey|27|||
27921087|NCT00301834|81550575|FG000|Overall Study|Death|1|||
27921088|NCT02495389|81550576|FG000|Overall Study|Withdrawal by Subject|40|||
27921089|NCT02153918|81550581|FG000|Overall Study|Refused further treatment|1|||
27921090|NCT00239720|81550582|FG000|Overall Study|Adverse Event|1|||
27921091|NCT00239720|81550583|FG001|Overall Study|Adverse Event|0|||
27921092|NCT00239720|81550582|FG000|Overall Study|Lost to Follow-up|0|||
27921093|NCT00239720|81550583|FG001|Overall Study|Lost to Follow-up|1|||
27921094|NCT03863353|81550584|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
27921095|NCT03863353|81550585|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
27921096|NCT03538041|81550593|FG000|12-Week Treatment Period|Adverse Event|1|||
27921097|NCT03538041|81550594|FG001|12-Week Treatment Period|Adverse Event|1|||
27921098|NCT03538041|81550593|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
27921099|NCT03538041|81550594|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
27921100|NCT03538041|81550593|FG000|Treatment Extension Period|Adverse Event|4|||
27921101|NCT03538041|81550594|FG001|Treatment Extension Period|Adverse Event|0|||
27921102|NCT03538041|81550593|FG000|Treatment Extension Period|Physician Decision|1|||
27921103|NCT03538041|81550594|FG001|Treatment Extension Period|Physician Decision|0|||
27921104|NCT03538041|81550593|FG000|Treatment Extension Period|Lack of Efficacy|1|||
27921105|NCT03538041|81550594|FG001|Treatment Extension Period|Lack of Efficacy|3|||
27921106|NCT03538041|81550593|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
27921107|NCT03538041|81550594|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
27921108|NCT03805841|81550601|FG000|Overall Study|Clinical Progression|2|||
27921109|NCT03805841|81550602|FG001|Overall Study|Clinical Progression|0|||
27921110|NCT03805841|81550603|FG002|Overall Study|Clinical Progression|0|||
27921111|NCT03805841|81550601|FG000|Overall Study|Death|0|||
27921112|NCT03805841|81550602|FG001|Overall Study|Death|3|||
27921113|NCT03805841|81550603|FG002|Overall Study|Death|1|||
27921114|NCT03805841|81550601|FG000|Overall Study|Lost to Follow-up|0|||
27921115|NCT03805841|81550602|FG001|Overall Study|Lost to Follow-up|0|||
27921116|NCT03805841|81550603|FG002|Overall Study|Lost to Follow-up|1|||
27921117|NCT03805841|81550601|FG000|Overall Study|Withdrawal by Subject|2|||
27921118|NCT03805841|81550602|FG001|Overall Study|Withdrawal by Subject|3|||
27921119|NCT03805841|81550603|FG002|Overall Study|Withdrawal by Subject|0|||
27921120|NCT03805841|81550601|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
27921121|NCT03805841|81550602|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
27921122|NCT03805841|81550603|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
27921123|NCT03034967|81550607|FG000|Overall Study|Withdrawal by Subject|9|||
27921124|NCT03034967|81550608|FG001|Overall Study|Withdrawal by Subject|2|||
27921125|NCT03034967|81550609|FG002|Overall Study|Withdrawal by Subject|6|||
27921126|NCT03034967|81550610|FG003|Overall Study|Withdrawal by Subject|6|||
27921127|NCT03034967|81550611|FG004|Overall Study|Withdrawal by Subject|9|||
27921128|NCT03034967|81550612|FG005|Overall Study|Withdrawal by Subject|2|||
27921129|NCT03034967|81550607|FG000|Overall Study|Physician Decision|1|||
27921130|NCT03034967|81550608|FG001|Overall Study|Physician Decision|0|||
27921131|NCT03034967|81550609|FG002|Overall Study|Physician Decision|1|||
27921132|NCT03034967|81550610|FG003|Overall Study|Physician Decision|1|||
27921133|NCT03034967|81550611|FG004|Overall Study|Physician Decision|1|||
27921134|NCT03034967|81550612|FG005|Overall Study|Physician Decision|0|||
27921135|NCT03034967|81550607|FG000|Overall Study|Lost to Follow-up|0|||
27921136|NCT03034967|81550608|FG001|Overall Study|Lost to Follow-up|0|||
27921137|NCT03034967|81550609|FG002|Overall Study|Lost to Follow-up|0|||
27542516|NCT03137537|80175919|FG000|Overall Study|Adverse Event|0|||
27921138|NCT03034967|81550610|FG003|Overall Study|Lost to Follow-up|1|||
27921139|NCT03034967|81550611|FG004|Overall Study|Lost to Follow-up|0|||
27921140|NCT03034967|81550612|FG005|Overall Study|Lost to Follow-up|2|||
27921141|NCT03034967|81550607|FG000|Overall Study|Liver function test abnormality|0|||
27921142|NCT03034967|81550608|FG001|Overall Study|Liver function test abnormality|0|||
27921143|NCT03034967|81550609|FG002|Overall Study|Liver function test abnormality|1|||
27921144|NCT03034967|81550610|FG003|Overall Study|Liver function test abnormality|0|||
27921145|NCT03034967|81550611|FG004|Overall Study|Liver function test abnormality|0|||
27921146|NCT03034967|81550612|FG005|Overall Study|Liver function test abnormality|0|||
27921147|NCT03034967|81550607|FG000|Overall Study|Protocol Violation|1|||
27921148|NCT03034967|81550608|FG001|Overall Study|Protocol Violation|0|||
27921149|NCT03034967|81550609|FG002|Overall Study|Protocol Violation|0|||
27921150|NCT03034967|81550610|FG003|Overall Study|Protocol Violation|0|||
27921151|NCT03034967|81550611|FG004|Overall Study|Protocol Violation|0|||
27921152|NCT03034967|81550612|FG005|Overall Study|Protocol Violation|2|||
27921153|NCT03034967|81550607|FG000|Overall Study|Lack of Efficacy|0|||
27921154|NCT03034967|81550608|FG001|Overall Study|Lack of Efficacy|1|||
27921155|NCT03034967|81550609|FG002|Overall Study|Lack of Efficacy|2|||
27921156|NCT03034967|81550610|FG003|Overall Study|Lack of Efficacy|1|||
27921157|NCT03034967|81550611|FG004|Overall Study|Lack of Efficacy|1|||
27921158|NCT03034967|81550612|FG005|Overall Study|Lack of Efficacy|0|||
27921159|NCT03034967|81550607|FG000|Overall Study|Adverse Event, non-fatal|3|||
27921160|NCT03034967|81550608|FG001|Overall Study|Adverse Event, non-fatal|1|||
27921161|NCT03034967|81550609|FG002|Overall Study|Adverse Event, non-fatal|2|||
27921162|NCT03034967|81550610|FG003|Overall Study|Adverse Event, non-fatal|0|||
27921163|NCT03034967|81550611|FG004|Overall Study|Adverse Event, non-fatal|2|||
27921164|NCT03034967|81550612|FG005|Overall Study|Adverse Event, non-fatal|8|||
27921165|NCT03034967|81550607|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
27921166|NCT03034967|81550608|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
27921167|NCT03034967|81550609|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
27921168|NCT03034967|81550610|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
27921169|NCT03034967|81550611|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
27921170|NCT03034967|81550612|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
27921171|NCT01369433|81550613|FG000|Overall Study|Adverse Event|31|||
27921172|NCT01369433|81550614|FG001|Overall Study|Adverse Event|1|||
27921173|NCT01369433|81550613|FG000|Overall Study|Required significant surgical procedure|1|||
27921174|NCT01369433|81550614|FG001|Overall Study|Required significant surgical procedure|0|||
27921175|NCT01369433|81550613|FG000|Overall Study|Non-compliance|1|||
27921176|NCT01369433|81550614|FG001|Overall Study|Non-compliance|0|||
27921177|NCT01369433|81550613|FG000|Overall Study|Withdrawal by Subject|5|||
27921178|NCT01369433|81550614|FG001|Overall Study|Withdrawal by Subject|2|||
27921179|NCT01369433|81550613|FG000|Overall Study|Study terminated by Sponsor|67|||
27921180|NCT01369433|81550614|FG001|Overall Study|Study terminated by Sponsor|0|||
27921181|NCT01369433|81550613|FG000|Overall Study|Lost to Follow-up|1|||
27921182|NCT01369433|81550614|FG001|Overall Study|Lost to Follow-up|0|||
27921183|NCT01369433|81550613|FG000|Overall Study|Death|5|||
27921184|NCT01369433|81550614|FG001|Overall Study|Death|0|||
27921185|NCT01369433|81550613|FG000|Overall Study|Investigator discretion|6|||
27921186|NCT01369433|81550614|FG001|Overall Study|Investigator discretion|1|||
27921187|NCT01369433|81550613|FG000|Overall Study|Progressive Disease|92|||
27921188|NCT01369433|81550614|FG001|Overall Study|Progressive Disease|12|||
27921189|NCT01033136|81550615|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
27921190|NCT01033136|81550616|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
27921191|NCT02340949|81550617|FG000|Overall Study|Adverse Event|4|||
27921192|NCT02340949|81550618|FG001|Overall Study|Adverse Event|2|||
27921193|NCT02340949|81550617|FG000|Overall Study|Withdrawal by Subject|2|||
27921194|NCT02340949|81550618|FG001|Overall Study|Withdrawal by Subject|0|||
27921195|NCT02340949|81550617|FG000|Overall Study|Progression disease|6|||
27921196|NCT02340949|81550618|FG001|Overall Study|Progression disease|2|||
27921197|NCT02340949|81550617|FG000|Overall Study|Death|3|||
27921198|NCT02340949|81550618|FG001|Overall Study|Death|0|||
27921199|NCT02340949|81550617|FG000|Overall Study|Physician Decision|1|||
27921200|NCT02340949|81550618|FG001|Overall Study|Physician Decision|0|||
27921201|NCT01977846|81550624|FG000|Total Study - Prospective|Death|0|||
27921202|NCT01977846|81550625|FG001|Total Study - Prospective|Death|1|||
27921203|NCT01977846|81550624|FG000|Total Study - Prospective|Lost to Follow-up|0|||
27921204|NCT01977846|81550625|FG001|Total Study - Prospective|Lost to Follow-up|8|||
27921205|NCT01977846|81550624|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
27921206|NCT01977846|81550625|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
27921207|NCT01977846|81550624|FG000|Total Study - Prospective|Not available at time of visit|0|||
27921208|NCT01977846|81550625|FG001|Total Study - Prospective|Not available at time of visit|5|||
27921209|NCT01977846|81550624|FG000|Total Study - Prospective|No show|0|||
27921210|NCT01977846|81550625|FG001|Total Study - Prospective|No show|1|||
27921211|NCT01977846|81550624|FG000|Total Study - Prospective|Protocol Violation|0|||
27921212|NCT01977846|81550625|FG001|Total Study - Prospective|Protocol Violation|1|||
27921213|NCT03502798|81550626|FG000|Overall Study|equipment failure|0|||
27921214|NCT03502798|81550627|FG001|Overall Study|equipment failure|7|||
27921215|NCT03353220|81550628|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
27921216|NCT03353220|81550629|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
27921217|NCT00853762|81550633|FG000|Overall Study|Premature Termination|16|||
27921218|NCT00853762|81550634|FG001|Overall Study|Premature Termination|15|||
27921219|NCT00853762|81550635|FG002|Overall Study|Premature Termination|14|||
27921220|NCT00853762|81550636|FG003|Overall Study|Premature Termination|21|||
27921221|NCT00853762|81550633|FG000|Overall Study|Protocol Violation|0|||
27921222|NCT00853762|81550634|FG001|Overall Study|Protocol Violation|0|||
27921223|NCT00853762|81550635|FG002|Overall Study|Protocol Violation|0|||
27921224|NCT00853762|81550636|FG003|Overall Study|Protocol Violation|1|||
27921225|NCT00853762|81550633|FG000|Overall Study|Withdrawal by Subject|0|||
27921226|NCT00853762|81550634|FG001|Overall Study|Withdrawal by Subject|0|||
27921227|NCT00853762|81550635|FG002|Overall Study|Withdrawal by Subject|1|||
27921228|NCT00853762|81550636|FG003|Overall Study|Withdrawal by Subject|0|||
27921229|NCT00853762|81550633|FG000|Overall Study|Other|0|||
27921230|NCT00853762|81550634|FG001|Overall Study|Other|2|||
27921231|NCT00853762|81550635|FG002|Overall Study|Other|0|||
27921232|NCT00853762|81550636|FG003|Overall Study|Other|0|||
27921233|NCT00853762|81550633|FG000|Overall Study|Randomised but not Treated|0|||
27921234|NCT00853762|81550634|FG001|Overall Study|Randomised but not Treated|2|||
27921235|NCT00853762|81550635|FG002|Overall Study|Randomised but not Treated|2|||
27921236|NCT00853762|81550636|FG003|Overall Study|Randomised but not Treated|0|||
27921237|NCT02765165|81550639|FG000|Treatment Period|Progressive disease|3|||
27921238|NCT02765165|81550640|FG001|Treatment Period|Progressive disease|2|||
27542517|NCT03137537|80175920|FG001|Overall Study|Adverse Event|1|||
27542518|NCT04094883|80175921|FG000|Overall Study|Withdrawal by Subject|1|||
27542519|NCT02747875|80175922|FG000|Overall Study|Physician Decision|1|||
27542520|NCT02747875|80175923|FG001|Overall Study|Physician Decision|0|||
27542521|NCT02747875|80175922|FG000|Overall Study|Adverse Event|0|||
27542522|NCT02747875|80175923|FG001|Overall Study|Adverse Event|1|||
27542523|NCT04523220|80178609|FG000|Main Treatment Period|Physician Decision|1|||
27542524|NCT04523220|80178610|FG001|Main Treatment Period|Physician Decision|1|||
27542525|NCT04523220|80178611|FG002|Main Treatment Period|Physician Decision|0|||
27542526|NCT04523220|80178609|FG000|Main Treatment Period|Other|5|||
27637015|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27637016|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27921239|NCT02765165|81550641|FG002|Treatment Period|Progressive disease|3|||
27921240|NCT02765165|81550642|FG003|Treatment Period|Progressive disease|3|||
27921241|NCT02765165|81550643|FG004|Treatment Period|Progressive disease|4|||
27921242|NCT02765165|81550644|FG005|Treatment Period|Progressive disease|2|||
27921243|NCT02765165|81550645|FG006|Treatment Period|Progressive disease|2|||
27921244|NCT02765165|81550639|FG000|Treatment Period|Physician Decision|0|||
27921245|NCT02765165|81550640|FG001|Treatment Period|Physician Decision|1|||
27542527|NCT04523220|80178610|FG001|Main Treatment Period|Other|2|||
27637017|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
27637018|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
27637019|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27637020|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27637021|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27637022|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
27637023|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
27637024|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27637025|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27637026|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27637027|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
27637028|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
27637029|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27637030|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27637031|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27921246|NCT02765165|81550641|FG002|Treatment Period|Physician Decision|0|||
27542528|NCT04523220|80178611|FG002|Main Treatment Period|Other|4|||
27637032|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
27637033|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
27921247|NCT02765165|81550642|FG003|Treatment Period|Physician Decision|0|||
27921248|NCT02765165|81550643|FG004|Treatment Period|Physician Decision|0|||
27921249|NCT02765165|81550644|FG005|Treatment Period|Physician Decision|0|||
27921250|NCT02765165|81550645|FG006|Treatment Period|Physician Decision|0|||
27542529|NCT04523220|80178609|FG000|Main Treatment Period|Subject Decision|5|||
27542530|NCT04523220|80178610|FG001|Main Treatment Period|Subject Decision|7|||
27542531|NCT04523220|80178611|FG002|Main Treatment Period|Subject Decision|3|||
27542532|NCT04523220|80178609|FG000|Main Treatment Period|Death|5|||
27637034|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27921251|NCT02765165|81550639|FG000|Treatment Period|Adverse Event|0|||
27921252|NCT02765165|81550640|FG001|Treatment Period|Adverse Event|1|||
27921253|NCT02765165|81550641|FG002|Treatment Period|Adverse Event|0|||
27921254|NCT02765165|81550642|FG003|Treatment Period|Adverse Event|0|||
27921255|NCT02765165|81550643|FG004|Treatment Period|Adverse Event|0|||
27921256|NCT02765165|81550644|FG005|Treatment Period|Adverse Event|0|||
27921257|NCT02765165|81550645|FG006|Treatment Period|Adverse Event|0|||
27921258|NCT02765165|81550639|FG000|Treatment Period|Withdrawal by Subject|0|||
27921259|NCT02765165|81550640|FG001|Treatment Period|Withdrawal by Subject|0|||
27921260|NCT02765165|81550641|FG002|Treatment Period|Withdrawal by Subject|0|||
27921261|NCT02765165|81550642|FG003|Treatment Period|Withdrawal by Subject|0|||
27921262|NCT02765165|81550643|FG004|Treatment Period|Withdrawal by Subject|2|||
27921263|NCT02765165|81550644|FG005|Treatment Period|Withdrawal by Subject|0|||
27921264|NCT02765165|81550645|FG006|Treatment Period|Withdrawal by Subject|0|||
27921265|NCT02765165|81550639|FG000|Treatment Period|Study terminated|0|||
27921266|NCT02765165|81550640|FG001|Treatment Period|Study terminated|0|||
27921267|NCT02765165|81550641|FG002|Treatment Period|Study terminated|0|||
27921268|NCT02765165|81550642|FG003|Treatment Period|Study terminated|0|||
27921269|NCT02765165|81550643|FG004|Treatment Period|Study terminated|0|||
27921270|NCT02765165|81550644|FG005|Treatment Period|Study terminated|1|||
27921271|NCT02765165|81550645|FG006|Treatment Period|Study terminated|2|||
27921272|NCT02765165|81550639|FG000|Post-treatment Follow-up|Death|1|||
27921273|NCT02765165|81550640|FG001|Post-treatment Follow-up|Death|2|||
27921274|NCT02765165|81550641|FG002|Post-treatment Follow-up|Death|1|||
27921275|NCT02765165|81550642|FG003|Post-treatment Follow-up|Death|1|||
27921276|NCT02765165|81550643|FG004|Post-treatment Follow-up|Death|1|||
27921277|NCT02765165|81550644|FG005|Post-treatment Follow-up|Death|1|||
27921278|NCT02765165|81550645|FG006|Post-treatment Follow-up|Death|0|||
27921279|NCT02765165|81550639|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
27542533|NCT04523220|80178610|FG001|Main Treatment Period|Death|11|||
27542534|NCT04523220|80178611|FG002|Main Treatment Period|Death|4|||
27542535|NCT04523220|80178609|FG000|Main Treatment Period|Adverse Event|11|||
27542536|NCT04523220|80178610|FG001|Main Treatment Period|Adverse Event|9|||
27542537|NCT04523220|80178611|FG002|Main Treatment Period|Adverse Event|9|||
27542538|NCT04523220|80178609|FG000|Main Treatment Period|Withdrawal by Subject|3|||
27542539|NCT04523220|80178610|FG001|Main Treatment Period|Withdrawal by Subject|3|||
27542540|NCT04523220|80178611|FG002|Main Treatment Period|Withdrawal by Subject|4|||
27542541|NCT04523220|80178609|FG000|Main Treatment Period|Study drug never adminstered|10|||
27542542|NCT04523220|80178610|FG001|Main Treatment Period|Study drug never adminstered|3|||
27542543|NCT04523220|80178611|FG002|Main Treatment Period|Study drug never adminstered|5|||
27542544|NCT04523220|80178609|FG000|Extension Treatment Period|Physician Decision|1|||
27542545|NCT04523220|80178610|FG001|Extension Treatment Period|Physician Decision|0|||
27542546|NCT04523220|80178611|FG002|Extension Treatment Period|Physician Decision|3|||
27542547|NCT04523220|80178609|FG000|Extension Treatment Period|Other|2|||
27542548|NCT04523220|80178610|FG001|Extension Treatment Period|Other|6|||
27542549|NCT04523220|80178611|FG002|Extension Treatment Period|Other|6|||
27542550|NCT04523220|80178609|FG000|Extension Treatment Period|Subject Decision|5|||
27542551|NCT04523220|80178610|FG001|Extension Treatment Period|Subject Decision|2|||
27542552|NCT04523220|80178611|FG002|Extension Treatment Period|Subject Decision|4|||
27542553|NCT04523220|80178609|FG000|Extension Treatment Period|Death|6|||
27542554|NCT04523220|80178610|FG001|Extension Treatment Period|Death|4|||
27542555|NCT04523220|80178611|FG002|Extension Treatment Period|Death|7|||
27542556|NCT04523220|80178609|FG000|Extension Treatment Period|Adverse Event|6|||
27542557|NCT04523220|80178610|FG001|Extension Treatment Period|Adverse Event|7|||
27542558|NCT04523220|80178611|FG002|Extension Treatment Period|Adverse Event|9|||
27542559|NCT04523220|80178609|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
27542560|NCT04523220|80178610|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
27542561|NCT04523220|80178611|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
27542562|NCT04523220|80178609|FG000|Extension Treatment Period|Study drug never administered|0|||
27542563|NCT04523220|80178610|FG001|Extension Treatment Period|Study drug never administered|1|||
27542564|NCT04523220|80178611|FG002|Extension Treatment Period|Study drug never administered|0|||
27542565|NCT02657369|80178618|FG000|Overall Study|Death|27|||
27542566|NCT02657369|80178618|FG000|Overall Study|Study terminated by sponsor|7|||
27542567|NCT01300650|80178623|FG000|Overall Study|Adverse Event|1|||
27542568|NCT00845858|80178624|FG000|Overall Study|Withdrawal by Subject|5|||
27542569|NCT00845858|80178625|FG001|Overall Study|Withdrawal by Subject|1|||
27542570|NCT00845858|80178626|FG002|Overall Study|Withdrawal by Subject|1|||
27542571|NCT00845858|80178624|FG000|Overall Study|Adverse Event|3|||
27542572|NCT00845858|80178625|FG001|Overall Study|Adverse Event|8|||
27542573|NCT00845858|80178626|FG002|Overall Study|Adverse Event|4|||
27542574|NCT00845858|80178624|FG000|Overall Study|Protocol Violation|0|||
27542575|NCT00845858|80178625|FG001|Overall Study|Protocol Violation|0|||
27921280|NCT02765165|81550640|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
27921281|NCT02765165|81550641|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
27921282|NCT02765165|81550642|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
27921283|NCT02765165|81550643|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
27921284|NCT02765165|81550644|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
27921285|NCT02765165|81550645|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
27921286|NCT02765165|81550639|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
27921287|NCT02765165|81550640|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
27921288|NCT02765165|81550641|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
27921289|NCT02765165|81550642|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
27921290|NCT02765165|81550643|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
27921291|NCT02765165|81550644|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
27921292|NCT02765165|81550645|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
27921293|NCT02765165|81550639|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27542576|NCT00845858|80178626|FG002|Overall Study|Protocol Violation|1|||
27921294|NCT02765165|81550640|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27921295|NCT02765165|81550641|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
27921296|NCT02765165|81550642|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
27921297|NCT02765165|81550643|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27637035|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27637036|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27637037|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
27637038|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
27637039|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27637040|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27637041|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27637042|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
27637043|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
27637044|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27637045|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27637046|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27637047|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
27637048|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
27637049|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27542577|NCT00845858|80178624|FG000|Overall Study|not eligible|0|||
27542578|NCT00845858|80178625|FG001|Overall Study|not eligible|3|||
27542579|NCT00845858|80178626|FG002|Overall Study|not eligible|2|||
27542580|NCT00566995|80178627|FG000|Overall Study|Toxicity|4|||
27542581|NCT00566995|80178627|FG000|Overall Study|Withdrew consent|3|||
27542582|NCT01364649|80178630|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
27542583|NCT01364649|80178631|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
27637050|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27637051|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27637052|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
27637053|NCT02709655|80512627|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
27637054|NCT02709655|80512628|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27637055|NCT02709655|80512629|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27637056|NCT02709655|80512630|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27637057|NCT02709655|80512631|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
27637058|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
27637059|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
27637060|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
27637061|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
27637062|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
27637063|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
27637064|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
27637065|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
27637066|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
27637067|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
27637068|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
27637069|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
27637070|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
27637071|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
27637072|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
27637073|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27637074|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
27921298|NCT02765165|81550644|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27921299|NCT02765165|81550645|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
27921300|NCT02765165|81550639|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
27921301|NCT02765165|81550640|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
27542584|NCT01364649|80178630|FG000|Overall Study|Lack of Efficacy|6|||
27637075|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27637076|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27542585|NCT01364649|80178631|FG001|Overall Study|Lack of Efficacy|0|||
27542586|NCT01364649|80178630|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
27542587|NCT01364649|80178631|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
27542588|NCT01364649|80178630|FG000|Overall Study|Protocol Deviations|4|||
27542589|NCT01364649|80178631|FG001|Overall Study|Protocol Deviations|8|||
27542590|NCT01364649|80178630|FG000|Overall Study|Withdrawal of Consent|9|||
27542591|NCT01364649|80178631|FG001|Overall Study|Withdrawal of Consent|7|||
27542592|NCT01364649|80178630|FG000|Overall Study|Lost to Follow-up|12|||
27542593|NCT01364649|80178631|FG001|Overall Study|Lost to Follow-up|13|||
27542594|NCT01364649|80178630|FG000|Overall Study|Other|4|||
27542595|NCT01364649|80178631|FG001|Overall Study|Other|1|||
27542596|NCT03478657|80178634|FG000|Overall Study|Withdrawal by Subject|0|||
27542597|NCT03478657|80178635|FG001|Overall Study|Withdrawal by Subject|1|||
27542598|NCT00191139|80178636|FG000|Overall Study|Adverse Event|2|||
27542599|NCT00191139|80178637|FG001|Overall Study|Adverse Event|6|||
27542600|NCT00191139|80178636|FG000|Overall Study|Death|2|||
27542601|NCT00191139|80178637|FG001|Overall Study|Death|0|||
27542602|NCT00191139|80178636|FG000|Overall Study|Withdrawal by Subject|0|||
27542603|NCT00191139|80178637|FG001|Overall Study|Withdrawal by Subject|3|||
27542604|NCT00191139|80178636|FG000|Overall Study|Disease Progression|0|||
27542605|NCT00191139|80178637|FG001|Overall Study|Disease Progression|1|||
27542606|NCT00191139|80178636|FG000|Overall Study|Other|1|||
27542607|NCT00191139|80178637|FG001|Overall Study|Other|2|||
27542608|NCT01773733|80178640|FG000|Overall Study|Adverse Event|3286|||
27542609|NCT01773733|80178641|FG001|Overall Study|Adverse Event|540|||
27542610|NCT01773733|80178640|FG000|Overall Study|Pregnancy|28|||
27542611|NCT01773733|80178641|FG001|Overall Study|Pregnancy|0|||
27542612|NCT01773733|80178640|FG000|Overall Study|Other different categories of not compl|55415|||
27542613|NCT01773733|80178641|FG001|Overall Study|Other different categories of not compl|7781|||
27542614|NCT01064310|80178642|FG000|Period 1|Adverse Event|7|||
27542615|NCT01064310|80178643|FG001|Period 1|Adverse Event|10|||
27542616|NCT01064310|80178644|FG002|Period 1|Adverse Event|0|||
27542617|NCT01064310|80178642|FG000|Period 1|Physician Decision|1|||
27542618|NCT01064310|80178643|FG001|Period 1|Physician Decision|0|||
27542619|NCT01064310|80178644|FG002|Period 1|Physician Decision|0|||
27542620|NCT01064310|80178642|FG000|Period 1|Withdrawal by Subject|2|||
27542621|NCT01064310|80178643|FG001|Period 1|Withdrawal by Subject|2|||
27542622|NCT01064310|80178644|FG002|Period 1|Withdrawal by Subject|0|||
27542623|NCT01064310|80178642|FG000|Period 1|Lack of Efficacy|3|||
27542624|NCT01064310|80178643|FG001|Period 1|Lack of Efficacy|5|||
27542625|NCT01064310|80178644|FG002|Period 1|Lack of Efficacy|0|||
27542626|NCT01064310|80178642|FG000|Period 1|Entered Open-label Period|1|||
27542627|NCT01064310|80178643|FG001|Period 1|Entered Open-label Period|1|||
27542628|NCT01064310|80178644|FG002|Period 1|Entered Open-label Period|0|||
27542629|NCT01064310|80178642|FG000|Period 2|Adverse Event|2|||
27542630|NCT01064310|80178643|FG001|Period 2|Adverse Event|1|||
27542631|NCT01064310|80178644|FG002|Period 2|Adverse Event|0|||
27542632|NCT01064310|80178642|FG000|Period 2|Physician Decision|0|||
27542633|NCT01064310|80178643|FG001|Period 2|Physician Decision|1|||
27542634|NCT01064310|80178644|FG002|Period 2|Physician Decision|0|||
27542635|NCT01064310|80178642|FG000|Period 2|Entered Open-label Period|1|||
27542636|NCT01064310|80178643|FG001|Period 2|Entered Open-label Period|0|||
27542637|NCT01064310|80178644|FG002|Period 2|Entered Open-label Period|0|||
27542638|NCT01064310|80178642|FG000|Period 2|Lack of Efficacy|1|||
27542639|NCT01064310|80178643|FG001|Period 2|Lack of Efficacy|4|||
27542640|NCT01064310|80178644|FG002|Period 2|Lack of Efficacy|0|||
27542641|NCT01064310|80178642|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
27542642|NCT01064310|80178643|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
27542643|NCT01064310|80178644|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
27542644|NCT01064310|80178642|FG000|Open Label Pazopinib|Adverse Event|0|||
27542645|NCT01064310|80178643|FG001|Open Label Pazopinib|Adverse Event|0|||
27637077|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
27637078|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
27542646|NCT01064310|80178644|FG002|Open Label Pazopinib|Adverse Event|12|||
27542647|NCT01064310|80178642|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
27542648|NCT01064310|80178643|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
27542649|NCT01064310|80178644|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
27542650|NCT01064310|80178642|FG000|Open Label Pazopinib|Physician Decision|0|||
27542651|NCT01064310|80178643|FG001|Open Label Pazopinib|Physician Decision|0|||
27542652|NCT01064310|80178644|FG002|Open Label Pazopinib|Physician Decision|20|||
27542653|NCT00622401|80178645|FG000|Overall Study|Disease progression prior to treatment|3|||
27542654|NCT00622401|80178646|FG001|Overall Study|Disease progression prior to treatment|2|||
27542655|NCT00622401|80178647|FG002|Overall Study|Disease progression prior to treatment|0|||
27542656|NCT00289133|80178648|FG000|Overall Study|Non-study device implanted|12|||
27542657|NCT00289133|80178649|FG001|Overall Study|Non-study device implanted|0|||
27542658|NCT00289133|80178648|FG000|Overall Study|Protocol Violation|32|||
27637079|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
27637080|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
27637081|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
27637082|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
27637083|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
27637084|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
27637085|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
27637086|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
27637087|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
27637088|NCT02709655|80512627|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
27637089|NCT02709655|80512628|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
27637090|NCT02709655|80512629|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
27637091|NCT02709655|80512630|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
27637092|NCT02709655|80512631|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
27637093|NCT05132478|80512634|FG000|Overall Study|did not complete survey after consent|1|||
27637094|NCT05132478|80512635|FG001|Overall Study|did not complete survey after consent|1|||
27637095|NCT05132478|80512634|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
27637096|NCT05132478|80512635|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
27637097|NCT01662336|80512636|FG000|Overall Study|Adverse Event|1|||
27637098|NCT01662336|80512636|FG000|Overall Study|No longer on LPV/r|30|||
27637099|NCT01662336|80512636|FG000|Overall Study|Other|29|||
27637100|NCT01662336|80512636|FG000|Overall Study|Withdrawal by Subject|6|||
27637101|NCT00360698|80512640|FG000|Run-In|Physician Decision|0|||
27637102|NCT00360698|80512641|FG001|Run-In|Physician Decision|1|||
27637103|NCT00360698|80512640|FG000|Run-In|Withdrawal by Subject|0|||
27637104|NCT00360698|80512641|FG001|Run-In|Withdrawal by Subject|2|||
27637105|NCT00360698|80512640|FG000|Run-In|Non compliance with treatment procedure|0|||
27637106|NCT00360698|80512641|FG001|Run-In|Non compliance with treatment procedure|1|||
27637107|NCT00360698|80512640|FG000|Run-In|Sponsor request|0|||
27637108|NCT00360698|80512641|FG001|Run-In|Sponsor request|2|||
27637109|NCT00360698|80512640|FG000|Run-In|Patient did not meet inclusion criteria|0|||
27637110|NCT00360698|80512641|FG001|Run-In|Patient did not meet inclusion criteria|1|||
27637111|NCT00360698|80512640|FG000|Run-In|Patient personal reasons|0|||
27637112|NCT00360698|80512641|FG001|Run-In|Patient personal reasons|2|||
27637113|NCT00360698|80512640|FG000|Run-In|Need of insulin with meals|0|||
27637114|NCT00360698|80512641|FG001|Run-In|Need of insulin with meals|1|||
27637115|NCT00360698|80512640|FG000|Treatment Period|Non compliance with treatment procedure|1|||
27637116|NCT00360698|80512641|FG001|Treatment Period|Non compliance with treatment procedure|0|||
27637117|NCT00360698|80512640|FG000|Treatment Period|Early termination by error|0|||
27637118|NCT00360698|80512641|FG001|Treatment Period|Early termination by error|1|||
27637119|NCT03460756|80512650|FG000|Overall Study|Adverse Event|0|||
27637120|NCT03460756|80512651|FG001|Overall Study|Adverse Event|0|||
27637121|NCT03460756|80512652|FG002|Overall Study|Adverse Event|0|||
27637122|NCT03460756|80512653|FG003|Overall Study|Adverse Event|1|||
27637123|NCT03460756|80512650|FG000|Overall Study|Lack of Efficacy|0|||
27637124|NCT03460756|80512651|FG001|Overall Study|Lack of Efficacy|0|||
27637125|NCT03460756|80512652|FG002|Overall Study|Lack of Efficacy|0|||
27637126|NCT03460756|80512653|FG003|Overall Study|Lack of Efficacy|2|||
27637127|NCT03460756|80512650|FG000|Overall Study|Lost to Follow-up|0|||
27637128|NCT03460756|80512651|FG001|Overall Study|Lost to Follow-up|1|||
27637129|NCT03460756|80512652|FG002|Overall Study|Lost to Follow-up|2|||
27637130|NCT03460756|80512653|FG003|Overall Study|Lost to Follow-up|1|||
27637131|NCT03460756|80512650|FG000|Overall Study|Pregnancy|0|||
27637132|NCT03460756|80512651|FG001|Overall Study|Pregnancy|0|||
27637133|NCT03460756|80512652|FG002|Overall Study|Pregnancy|0|||
27637134|NCT03460756|80512653|FG003|Overall Study|Pregnancy|1|||
27637135|NCT03460756|80512650|FG000|Overall Study|Protocol Violation|0|||
27637136|NCT03460756|80512651|FG001|Overall Study|Protocol Violation|0|||
27637137|NCT03460756|80512652|FG002|Overall Study|Protocol Violation|0|||
27637138|NCT03460756|80512653|FG003|Overall Study|Protocol Violation|1|||
27637139|NCT03460756|80512650|FG000|Overall Study|Withdrawal by Subject|0|||
27637140|NCT03460756|80512651|FG001|Overall Study|Withdrawal by Subject|4|||
27637141|NCT03460756|80512652|FG002|Overall Study|Withdrawal by Subject|7|||
27637142|NCT03460756|80512653|FG003|Overall Study|Withdrawal by Subject|3|||
27637143|NCT04199728|80512657|FG000|Overall Study|Adverse Event|1|||
27637144|NCT04199728|80512658|FG001|Overall Study|Adverse Event|0|||
27637145|NCT04199728|80512657|FG000|Overall Study|Withdrawal by Subject|8|||
27637146|NCT04199728|80512658|FG001|Overall Study|Withdrawal by Subject|3|||
27637147|NCT04199728|80512657|FG000|Overall Study|Screen fail after consent|0|||
27637148|NCT04199728|80512658|FG001|Overall Study|Screen fail after consent|1|||
27637149|NCT04199728|80512657|FG000|Overall Study|Early withdraw criteria met|0|||
27637150|NCT04199728|80512658|FG001|Overall Study|Early withdraw criteria met|1|||
27637151|NCT04199728|80512657|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
27637152|NCT04199728|80512658|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
27637153|NCT02685488|80512659|FG000|Overall Study|Withdrawal by Subject|0|||
27637154|NCT02685488|80512660|FG001|Overall Study|Withdrawal by Subject|1|||
27637155|NCT01713946|80512663|FG000|Overall Study|Death|0|||
27637156|NCT01713946|80512664|FG001|Overall Study|Death|2|||
27637157|NCT01713946|80512665|FG002|Overall Study|Death|2|||
27637158|NCT01713946|80512663|FG000|Overall Study|Adverse Event|19|||
27637159|NCT01713946|80512664|FG001|Overall Study|Adverse Event|14|||
27637160|NCT01713946|80512665|FG002|Overall Study|Adverse Event|13|||
27637161|NCT01713946|80512663|FG000|Overall Study|Withdrawal by Subject|12|||
27637162|NCT01713946|80512664|FG001|Overall Study|Withdrawal by Subject|12|||
27637163|NCT01713946|80512665|FG002|Overall Study|Withdrawal by Subject|8|||
27637164|NCT01713946|80512663|FG000|Overall Study|Lack of Efficacy|8|||
27637165|NCT01713946|80512664|FG001|Overall Study|Lack of Efficacy|8|||
27637166|NCT01713946|80512665|FG002|Overall Study|Lack of Efficacy|14|||
27637167|NCT01713946|80512663|FG000|Overall Study|Protocol Violation|2|||
27637168|NCT01713946|80512664|FG001|Overall Study|Protocol Violation|4|||
27637169|NCT01713946|80512665|FG002|Overall Study|Protocol Violation|1|||
27637170|NCT01713946|80512663|FG000|Overall Study|Lost to Follow-up|0|||
27637171|NCT01713946|80512664|FG001|Overall Study|Lost to Follow-up|0|||
27637172|NCT01713946|80512665|FG002|Overall Study|Lost to Follow-up|1|||
27637173|NCT01713946|80512663|FG000|Overall Study|Administrative problems|1|||
27637174|NCT01713946|80512664|FG001|Overall Study|Administrative problems|0|||
27637175|NCT01713946|80512665|FG002|Overall Study|Administrative problems|0|||
27637176|NCT01713946|80512663|FG000|Overall Study|Did not continue in Ext|0|||
27637177|NCT01713946|80512664|FG001|Overall Study|Did not continue in Ext|3|||
27637178|NCT01713946|80512665|FG002|Overall Study|Did not continue in Ext|0|||
27637179|NCT01713946|80512663|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
27637180|NCT01713946|80512664|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
27637181|NCT01713946|80512665|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
27637182|NCT01713946|80512663|FG000|Overall Study|Patients never switched to everolimus|0|||
27637183|NCT01713946|80512664|FG001|Overall Study|Patients never switched to everolimus|0|||
27637184|NCT01713946|80512665|FG002|Overall Study|Patients never switched to everolimus|5|||
27637185|NCT02383472|80512666|FG000|Overall Study|Withdrawal by Subject|1|||
27637186|NCT02383472|80512667|FG001|Overall Study|Withdrawal by Subject|1|||
27637187|NCT00373529|80512670|FG000|Overall Study|Physician Decision|19|||
27637188|NCT00373529|80512670|FG000|Overall Study|Withdrawal by Subject|7|||
27637189|NCT00373529|80512670|FG000|Overall Study|Adverse Event|7|||
27637190|NCT00373529|80512670|FG000|Overall Study|Treatment failure|36|||
27637191|NCT00373529|80512670|FG000|Overall Study|Disease recurrence|10|||
27637192|NCT00373529|80512670|FG000|Overall Study|Death|16|||
27637193|NCT00373529|80512670|FG000|Overall Study|Need for treatment prohibited by study|1|||
27637194|NCT00373529|80512670|FG000|Overall Study|Other|8|||
27637195|NCT00373529|80512670|FG000|Overall Study|Failed independent confirmation of AML|3|||
27637196|NCT00373529|80512670|FG000|Overall Study|Consent violation|1|||
27637197|NCT00439569|80512673|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
27542659|NCT00289133|80178649|FG001|Overall Study|Protocol Violation|38|||
27542660|NCT00289133|80178648|FG000|Overall Study|Withdrawal by Subject|9|||
27542661|NCT00289133|80178649|FG001|Overall Study|Withdrawal by Subject|10|||
27542662|NCT00289133|80178648|FG000|Overall Study|Death|5|||
27542663|NCT00289133|80178649|FG001|Overall Study|Death|10|||
27542664|NCT00289133|80178648|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
27542665|NCT00289133|80178649|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
27542666|NCT00289133|80178648|FG000|Overall Study|Physician Decision|41|||
27542667|NCT00289133|80178649|FG001|Overall Study|Physician Decision|45|||
27542668|NCT00289133|80178648|FG000|Overall Study|Revision|8|||
27542669|NCT00289133|80178649|FG001|Overall Study|Revision|6|||
27542670|NCT00289133|80178648|FG000|Overall Study|Lost to Follow-up|92|||
27542671|NCT00289133|80178649|FG001|Overall Study|Lost to Follow-up|115|||
27542672|NCT02021331|80178650|FG000|Overall Study|Adverse Event|0|||
27542673|NCT02021331|80178651|FG001|Overall Study|Adverse Event|2|||
27542674|NCT01146665|80178656|FG000|Overall Study|Withdrawal by Subject|10|||
27542675|NCT01146665|80178657|FG001|Overall Study|Withdrawal by Subject|16|||
27637198|NCT00439569|80512673|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
27637199|NCT00439569|80512673|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
27637200|NCT02594735|80512675|FG000|Overall Study|Adverse Event|1|||
27637201|NCT03074331|80512676|FG000|Overall Study|Enrolled but Not Treated|1|||
27637202|NCT03074331|80512676|FG000|Overall Study|Lost to Follow-up|5|||
27921302|NCT02765165|81550641|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
27542676|NCT00696800|80178658|FG000|Overall Study|Adverse Event|16|||
27542677|NCT00696800|80178659|FG001|Overall Study|Adverse Event|3|||
27542678|NCT00696800|80178658|FG000|Overall Study|Insufficient compliance with medication|2|||
27637203|NCT03074331|80512676|FG000|Overall Study|Withdrew Consent|1|||
27637204|NCT00357097|80512677|FG000|Overall Study|Did not meet inclusion criteria|5|||
27637205|NCT00357097|80512678|FG001|Overall Study|Did not meet inclusion criteria|3|||
27637206|NCT00357097|80512677|FG000|Overall Study|Adverse Event|34|||
27637207|NCT00357097|80512678|FG001|Overall Study|Adverse Event|6|||
27637208|NCT00357097|80512677|FG000|Overall Study|Withdrawal by Subject|8|||
27637209|NCT00357097|80512678|FG001|Overall Study|Withdrawal by Subject|7|||
27542679|NCT00696800|80178659|FG001|Overall Study|Insufficient compliance with medication|1|||
27542680|NCT00696800|80178658|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
27542681|NCT00696800|80178659|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
27542682|NCT00696800|80178658|FG000|Overall Study|Insufficient ovarian response|4|||
27542683|NCT00696800|80178659|FG001|Overall Study|Insufficient ovarian response|1|||
27542684|NCT00696800|80178658|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
27542685|NCT00696800|80178659|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
27542686|NCT00696800|80178658|FG000|Overall Study|Too high ovarian response|6|||
27542687|NCT00696800|80178659|FG001|Overall Study|Too high ovarian response|1|||
27542688|NCT00696800|80178658|FG000|Overall Study|No/too few/bad quality oocytes|4|||
27542689|NCT00696800|80178659|FG001|Overall Study|No/too few/bad quality oocytes|3|||
27637210|NCT00357097|80512677|FG000|Overall Study|Non-compliance|1|||
27637211|NCT00357097|80512678|FG001|Overall Study|Non-compliance|2|||
27637212|NCT00357097|80512677|FG000|Overall Study|Lack of Efficacy|2|||
27637213|NCT00357097|80512678|FG001|Overall Study|Lack of Efficacy|8|||
27637214|NCT00357097|80512677|FG000|Overall Study|Met Exclusion Criteria|3|||
27637215|NCT00357097|80512678|FG001|Overall Study|Met Exclusion Criteria|1|||
27637216|NCT00357097|80512677|FG000|Overall Study|Other|1|||
27637217|NCT00357097|80512678|FG001|Overall Study|Other|1|||
27637218|NCT00357097|80512677|FG000|Overall Study|Increase of RLS Symptoms|0|||
27637219|NCT00357097|80512678|FG001|Overall Study|Increase of RLS Symptoms|1|||
27637220|NCT00465816|80512698|FG000|Overall Study|Lost to Follow-up|0|||
27637221|NCT00465816|80512699|FG001|Overall Study|Lost to Follow-up|0|||
27637222|NCT00465816|80512700|FG002|Overall Study|Lost to Follow-up|2|||
27637223|NCT03988023|80512705|FG000|Overall Study|Non-compliance|3|||
27637224|NCT03988023|80512706|FG001|Overall Study|Non-compliance|0|||
27637225|NCT03988023|80512705|FG000|Overall Study|Withdrawal by Subject|39|||
27637226|NCT03988023|80512706|FG001|Overall Study|Withdrawal by Subject|37|||
27637227|NCT03988023|80512705|FG000|Overall Study|Adverse Event|0|||
27637228|NCT03988023|80512706|FG001|Overall Study|Adverse Event|2|||
27637229|NCT03988023|80512705|FG000|Overall Study|Physician Decision|0|||
27637230|NCT03988023|80512706|FG001|Overall Study|Physician Decision|1|||
27637231|NCT03988023|80512705|FG000|Overall Study|Lost to Follow-up|5|||
27637232|NCT03988023|80512706|FG001|Overall Study|Lost to Follow-up|8|||
27637233|NCT03988023|80512705|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
27637234|NCT03988023|80512706|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
27637235|NCT03988023|80512705|FG000|Overall Study|Lack of Efficacy|3|||
27637236|NCT03988023|80512706|FG001|Overall Study|Lack of Efficacy|1|||
27637237|NCT03988023|80512705|FG000|Overall Study|COVID-19 pandemic|225|||
27637238|NCT03988023|80512706|FG001|Overall Study|COVID-19 pandemic|227|||
27637239|NCT02794480|80512709|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
27637240|NCT02794480|80512710|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
27637241|NCT02794480|80512711|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
27637242|NCT02794480|80512712|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
27637243|NCT02794480|80512709|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
27637244|NCT02794480|80512710|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
27921303|NCT02765165|81550642|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
27921304|NCT02765165|81550643|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
27921305|NCT02765165|81550644|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
27921306|NCT02765165|81550645|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
27921307|NCT02765165|81550639|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27921308|NCT02765165|81550640|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27921309|NCT02765165|81550641|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27921310|NCT02765165|81550642|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
27921311|NCT02765165|81550643|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
27921312|NCT02765165|81550644|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
27921313|NCT02765165|81550645|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
27921314|NCT03292016|81550648|FG000|Second Washout|Adverse Event|0|||
27921315|NCT03292016|81550649|FG001|Second Washout|Adverse Event|1|||
27921316|NCT03292016|81550650|FG002|Second Washout|Adverse Event|0|||
27921317|NCT03292016|81550651|FG003|Second Washout|Adverse Event|0|||
27921318|NCT03292016|81550652|FG004|Second Washout|Adverse Event|0|||
27921319|NCT03292016|81550653|FG005|Second Washout|Adverse Event|0|||
27921320|NCT00296517|81550654|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
27921321|NCT00296517|81550655|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
27637245|NCT02794480|80512711|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
27637246|NCT02794480|80512712|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
27921322|NCT00296517|81550654|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
27542690|NCT00696800|80178658|FG000|Overall Study|No/abnormal fertilization|11|||
27637247|NCT02794480|80512709|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27637248|NCT02794480|80512710|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27637249|NCT02794480|80512711|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
27637250|NCT02794480|80512712|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
27921323|NCT00296517|81550655|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
27921324|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
27921325|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
27921326|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
27921327|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
27921328|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
27921329|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
27921330|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
27921331|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
27921332|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
27921333|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
27921334|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
27921335|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
27921336|NCT00296517|81550654|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
27921337|NCT00296517|81550655|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
27921338|NCT02858401|81550664|FG000|Overall Study|Withdrew Consent|0|||
27921339|NCT02858401|81550665|FG001|Overall Study|Withdrew Consent|0|||
27921340|NCT02858401|81550666|FG002|Overall Study|Withdrew Consent|0|||
27921341|NCT02858401|81550667|FG003|Overall Study|Withdrew Consent|0|||
27921342|NCT02858401|81550668|FG004|Overall Study|Withdrew Consent|0|||
27921343|NCT02858401|81550669|FG005|Overall Study|Withdrew Consent|1|||
27921344|NCT02858401|81550670|FG006|Overall Study|Withdrew Consent|0|||
27921345|NCT02858401|81550664|FG000|Overall Study|Lost to Follow-up|0|||
27921346|NCT02858401|81550665|FG001|Overall Study|Lost to Follow-up|1|||
27921347|NCT02858401|81550666|FG002|Overall Study|Lost to Follow-up|0|||
27921348|NCT02858401|81550667|FG003|Overall Study|Lost to Follow-up|0|||
27921349|NCT02858401|81550668|FG004|Overall Study|Lost to Follow-up|0|||
27921350|NCT02858401|81550669|FG005|Overall Study|Lost to Follow-up|0|||
27921351|NCT02858401|81550670|FG006|Overall Study|Lost to Follow-up|0|||
27921352|NCT00321763|81550672|FG000|Overall Study|Adverse Event|1|||
27921353|NCT00321763|81550673|FG001|Overall Study|Adverse Event|1|||
27921354|NCT00321763|81550674|FG002|Overall Study|Adverse Event|0|||
27921355|NCT00321763|81550675|FG003|Overall Study|Adverse Event|1|||
27921356|NCT00321763|81550672|FG000|Overall Study|Withdrawal by Subject|2|||
27921357|NCT00321763|81550673|FG001|Overall Study|Withdrawal by Subject|0|||
27921358|NCT00321763|81550674|FG002|Overall Study|Withdrawal by Subject|1|||
27921359|NCT00321763|81550675|FG003|Overall Study|Withdrawal by Subject|0|||
27921360|NCT00321763|81550672|FG000|Overall Study|Lost to Follow-up|3|||
27921361|NCT00321763|81550673|FG001|Overall Study|Lost to Follow-up|1|||
27921362|NCT00321763|81550674|FG002|Overall Study|Lost to Follow-up|5|||
27921363|NCT00321763|81550675|FG003|Overall Study|Lost to Follow-up|4|||
27921364|NCT00486044|81550676|FG000|Overall Study|Withdrawal by Subject|2|||
27921365|NCT00486044|81550677|FG001|Overall Study|Withdrawal by Subject|1|||
27542691|NCT00696800|80178659|FG001|Overall Study|No/abnormal fertilization|13|||
27542692|NCT00696800|80178658|FG000|Overall Study|No/too few/bad quality embryos|24|||
27542693|NCT00696800|80178659|FG001|Overall Study|No/too few/bad quality embryos|18|||
27542694|NCT00696800|80178658|FG000|Overall Study|Other Reasons|5|||
27542695|NCT00696800|80178659|FG001|Overall Study|Other Reasons|3|||
27542696|NCT00696800|80178658|FG000|Overall Study|Not treated|1|||
27542697|NCT00696800|80178659|FG001|Overall Study|Not treated|2|||
27542698|NCT00911547|80178660|FG000|Overall Study|Adverse Event|8|||
27542699|NCT00911547|80178661|FG001|Overall Study|Adverse Event|27|||
27542700|NCT00911547|80178662|FG002|Overall Study|Adverse Event|11|||
27542701|NCT00911547|80178663|FG003|Overall Study|Adverse Event|6|||
27542702|NCT00911547|80178660|FG000|Overall Study|Lost to Follow-up|0|||
27542703|NCT00911547|80178661|FG001|Overall Study|Lost to Follow-up|0|||
27542704|NCT00911547|80178662|FG002|Overall Study|Lost to Follow-up|2|||
27542705|NCT00911547|80178663|FG003|Overall Study|Lost to Follow-up|1|||
27921366|NCT00486044|81550676|FG000|Overall Study|Adverse Event|0|||
27921367|NCT00486044|81550677|FG001|Overall Study|Adverse Event|1|||
27921368|NCT00486044|81550676|FG000|Overall Study|Lost to Follow-up|0|||
27921369|NCT00486044|81550677|FG001|Overall Study|Lost to Follow-up|1|||
27542706|NCT00911547|80178660|FG000|Overall Study|Protocol Violation|0|||
27542707|NCT00911547|80178661|FG001|Overall Study|Protocol Violation|5|||
27921370|NCT03176771|81550678|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
27921371|NCT03176771|81550679|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
27921372|NCT03176771|81550680|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
27921373|NCT03176771|81550681|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
27921374|NCT03176771|81550682|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
27921375|NCT03176771|81550678|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
27921376|NCT03176771|81550679|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
27921377|NCT03176771|81550680|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
27921378|NCT03176771|81550681|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
27542708|NCT00911547|80178662|FG002|Overall Study|Protocol Violation|5|||
27542709|NCT00911547|80178663|FG003|Overall Study|Protocol Violation|1|||
27542710|NCT00911547|80178660|FG000|Overall Study|Withdrawal by Subject|3|||
27921379|NCT03176771|81550682|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
27921380|NCT03176771|81550678|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
27542711|NCT00911547|80178661|FG001|Overall Study|Withdrawal by Subject|10|||
27542712|NCT00911547|80178662|FG002|Overall Study|Withdrawal by Subject|4|||
27542713|NCT00911547|80178663|FG003|Overall Study|Withdrawal by Subject|8|||
27542714|NCT00496470|80178666|FG000|Overall Study|Adverse Event|8|||
27542715|NCT00496470|80178667|FG001|Overall Study|Adverse Event|10|||
27542716|NCT00496470|80178666|FG000|Overall Study|Withdrawal by Subject|5|||
27542717|NCT00496470|80178667|FG001|Overall Study|Withdrawal by Subject|12|||
27542718|NCT00496470|80178666|FG000|Overall Study|Incorrectly enrolled|13|||
27542719|NCT00496470|80178667|FG001|Overall Study|Incorrectly enrolled|5|||
27542720|NCT00496470|80178666|FG000|Overall Study|Other reason|0|||
27542721|NCT00496470|80178667|FG001|Overall Study|Other reason|2|||
27542722|NCT01201850|80178673|FG000|Overall Study|Tumor progression|4|||
27542723|NCT02850965|80178676|FG000|Overall Study|Other than listed|3|||
27542724|NCT02850965|80178677|FG001|Overall Study|Other than listed|4|||
27542725|NCT02850965|80178676|FG000|Overall Study|Protocol Violation|0|||
27542726|NCT02850965|80178677|FG001|Overall Study|Protocol Violation|2|||
27542727|NCT02850965|80178676|FG000|Overall Study|Lost to Follow-up|5|||
27542728|NCT02850965|80178677|FG001|Overall Study|Lost to Follow-up|3|||
27542729|NCT02850965|80178676|FG000|Overall Study|Lack of Efficacy|4|||
27542730|NCT02850965|80178677|FG001|Overall Study|Lack of Efficacy|8|||
27542731|NCT02850965|80178676|FG000|Overall Study|Adverse Event|3|||
27542732|NCT02850965|80178677|FG001|Overall Study|Adverse Event|2|||
27542733|NCT02850965|80178676|FG000|Overall Study|Withdrawal by Subject|3|||
27542734|NCT02850965|80178677|FG001|Overall Study|Withdrawal by Subject|4|||
27542735|NCT02850965|80178676|FG000|Overall Study|Physician Decision|0|||
27542736|NCT02850965|80178677|FG001|Overall Study|Physician Decision|1|||
27542737|NCT02850965|80178676|FG000|Overall Study|Randomized but not treated|0|||
27542738|NCT02850965|80178677|FG001|Overall Study|Randomized but not treated|1|||
27542739|NCT02378961|80178681|FG000|Overall Study|Lack of Efficacy|4|||
27542740|NCT02378961|80178682|FG001|Overall Study|Lack of Efficacy|2|||
27542741|NCT02378961|80178683|FG002|Overall Study|Lack of Efficacy|0|||
27542742|NCT02378961|80178684|FG003|Overall Study|Lack of Efficacy|1|||
27542743|NCT02378961|80178681|FG000|Overall Study|Death|0|||
27542744|NCT02378961|80178682|FG001|Overall Study|Death|0|||
27542745|NCT02378961|80178683|FG002|Overall Study|Death|1|||
27542746|NCT02378961|80178684|FG003|Overall Study|Death|0|||
27542747|NCT02571075|80178692|FG000|Overall Study|Lost to Follow-up|20|||
27542748|NCT02571075|80178693|FG001|Overall Study|Lost to Follow-up|24|||
27542749|NCT01876420|80178702|FG000|Overall Study|Missed 30 day visit|1|||
27542750|NCT01854658|80178703|FG000|Overall Study|Protocol Violation|6|||
27542751|NCT01854658|80178704|FG001|Overall Study|Protocol Violation|2|||
27542752|NCT01854658|80178705|FG002|Overall Study|Protocol Violation|2|||
27542753|NCT01854658|80178706|FG003|Overall Study|Protocol Violation|1|||
27542754|NCT01854658|80178703|FG000|Overall Study|Physician Decision|7|||
27542755|NCT01854658|80178704|FG001|Overall Study|Physician Decision|5|||
27542756|NCT01854658|80178705|FG002|Overall Study|Physician Decision|2|||
27542757|NCT01854658|80178706|FG003|Overall Study|Physician Decision|4|||
27542758|NCT01854658|80178703|FG000|Overall Study|Lost to Follow-up|8|||
27542759|NCT01854658|80178704|FG001|Overall Study|Lost to Follow-up|9|||
27542760|NCT01854658|80178705|FG002|Overall Study|Lost to Follow-up|8|||
27542761|NCT01854658|80178706|FG003|Overall Study|Lost to Follow-up|4|||
27542762|NCT01854658|80178703|FG000|Overall Study|Withdrawal by Subject|28|||
27542763|NCT01854658|80178704|FG001|Overall Study|Withdrawal by Subject|21|||
27542764|NCT01854658|80178705|FG002|Overall Study|Withdrawal by Subject|29|||
27542765|NCT01854658|80178706|FG003|Overall Study|Withdrawal by Subject|15|||
27542766|NCT01854658|80178703|FG000|Overall Study|Protocol-specified criteria|15|||
27542767|NCT01854658|80178704|FG001|Overall Study|Protocol-specified criteria|15|||
27542768|NCT01854658|80178705|FG002|Overall Study|Protocol-specified criteria|10|||
27542769|NCT01854658|80178706|FG003|Overall Study|Protocol-specified criteria|7|||
27542770|NCT01854658|80178703|FG000|Overall Study|Lack of Efficacy|3|||
27542771|NCT01854658|80178704|FG001|Overall Study|Lack of Efficacy|8|||
27542772|NCT01854658|80178705|FG002|Overall Study|Lack of Efficacy|4|||
27542773|NCT01854658|80178706|FG003|Overall Study|Lack of Efficacy|7|||
27542774|NCT01854658|80178703|FG000|Overall Study|Adverse Event|21|||
27542775|NCT01854658|80178704|FG001|Overall Study|Adverse Event|14|||
27542776|NCT01854658|80178705|FG002|Overall Study|Adverse Event|23|||
27542777|NCT01854658|80178706|FG003|Overall Study|Adverse Event|19|||
27542778|NCT01854658|80178703|FG000|Overall Study|Administrative reasons|5|||
27542779|NCT01854658|80178704|FG001|Overall Study|Administrative reasons|1|||
27542780|NCT01854658|80178705|FG002|Overall Study|Administrative reasons|2|||
27542781|NCT01854658|80178706|FG003|Overall Study|Administrative reasons|2|||
27542782|NCT00945893|80178707|FG000|Overall Study|Lost to Follow-up|2|||
27542783|NCT00945893|80178708|FG001|Overall Study|Lost to Follow-up|8|||
27542784|NCT00945893|80178707|FG000|Overall Study|Withdrawal of consent|1|||
27542785|NCT00945893|80178708|FG001|Overall Study|Withdrawal of consent|2|||
27542786|NCT03673046|80178709|FG000|Overall Study|Adverse Event|1|||
27542787|NCT03673046|80178710|FG001|Overall Study|Adverse Event|1|||
27921381|NCT03176771|81550679|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
27921382|NCT03176771|81550680|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
27921383|NCT03176771|81550681|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
27921384|NCT03176771|81550682|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
27921385|NCT03176771|81550678|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
27921386|NCT03176771|81550679|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
27921387|NCT03176771|81550680|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
27637251|NCT02794480|80512709|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27637252|NCT02794480|80512710|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
27637253|NCT02794480|80512711|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27637254|NCT02794480|80512712|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27637255|NCT02794480|80512709|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
27637256|NCT02794480|80512710|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27637257|NCT02794480|80512711|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
27637258|NCT02794480|80512712|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
27637259|NCT02738840|80512714|FG000|Overall Study|MRI Scan not Performed|5|||
27637260|NCT02738840|80512714|FG000|Overall Study|Lost to Follow-up|1|||
27637261|NCT02738840|80512714|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
27637262|NCT02738840|80512714|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
27637263|NCT00857649|80512715|FG000|Overall Study|Adverse Event|15|||
27637264|NCT00857649|80512716|FG001|Overall Study|Adverse Event|10|||
27637265|NCT00857649|80512715|FG000|Overall Study|Non-compliance|1|||
27542788|NCT03673046|80178709|FG000|Overall Study|Withdrawal by Subject|8|||
27542789|NCT03673046|80178710|FG001|Overall Study|Withdrawal by Subject|2|||
27542790|NCT03228433|80178719|FG000|Overall Study|Lost to Follow-up|1|||
27542791|NCT03228433|80178720|FG001|Overall Study|Lost to Follow-up|0|||
27637266|NCT00857649|80512716|FG001|Overall Study|Non-compliance|1|||
27637267|NCT00857649|80512715|FG000|Overall Study|Protocol Violation|2|||
27637268|NCT00857649|80512716|FG001|Overall Study|Protocol Violation|2|||
27542792|NCT03228433|80178721|FG002|Overall Study|Lost to Follow-up|0|||
27542793|NCT03228433|80178722|FG003|Overall Study|Lost to Follow-up|0|||
27637269|NCT00857649|80512715|FG000|Overall Study|Withdrawal of Consent|10|||
27637270|NCT00857649|80512716|FG001|Overall Study|Withdrawal of Consent|7|||
27637271|NCT00857649|80512715|FG000|Overall Study|Nursing Home Placement|2|||
27637272|NCT00857649|80512716|FG001|Overall Study|Nursing Home Placement|9|||
27637273|NCT00857649|80512715|FG000|Overall Study|Other Reasons|1|||
27637274|NCT00857649|80512716|FG001|Overall Study|Other Reasons|3|||
27637275|NCT00542789|80512726|FG000|Overall Study|Adverse Event|18|||
27637276|NCT00542789|80512727|FG001|Overall Study|Adverse Event|17|||
27637277|NCT00542789|80512726|FG000|Overall Study|Withdrawal by Subject|7|||
27637278|NCT00542789|80512727|FG001|Overall Study|Withdrawal by Subject|3|||
27637279|NCT00542789|80512726|FG000|Overall Study|Protocol Violation|8|||
27921388|NCT03176771|81550681|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
27921389|NCT03176771|81550682|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
27921390|NCT03176771|81550678|FG000|Double-Blind Extension Period|Adverse Event|0|||
27542794|NCT03228433|80178723|FG004|Overall Study|Lost to Follow-up|0|||
27542795|NCT03228433|80178724|FG005|Overall Study|Lost to Follow-up|0|||
27542796|NCT03228433|80178719|FG000|Overall Study|Positive alcohol test|0|||
27542797|NCT03228433|80178720|FG001|Overall Study|Positive alcohol test|0|||
27542798|NCT03228433|80178721|FG002|Overall Study|Positive alcohol test|0|||
27542799|NCT03228433|80178722|FG003|Overall Study|Positive alcohol test|1|||
27542800|NCT03228433|80178723|FG004|Overall Study|Positive alcohol test|0|||
27542801|NCT03228433|80178724|FG005|Overall Study|Positive alcohol test|0|||
27542802|NCT00816595|80178727|FG000|Overall Study|Withdrawal by Subject|2|||
27542803|NCT00816595|80178728|FG001|Overall Study|Withdrawal by Subject|0|||
27542804|NCT04377620|80178729|FG000|Overall Study|Death|42|||
27542805|NCT04377620|80178730|FG001|Overall Study|Death|48|||
27637280|NCT00542789|80512727|FG001|Overall Study|Protocol Violation|1|||
27637281|NCT00542789|80512726|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
27637282|NCT00542789|80512727|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
27637283|NCT00493649|80515752|FG000|Overall Study|Adverse Event|44|||
27637284|NCT00493649|80515752|FG000|Overall Study|Patient Request|21|||
27637285|NCT00493649|80515752|FG000|Overall Study|Investigator Request|2|||
27637286|NCT00493649|80515752|FG000|Overall Study|Disease Progression|1|||
27637287|NCT00493649|80515752|FG000|Overall Study|Lost to Follow-up|1|||
27637288|NCT00493649|80515752|FG000|Overall Study|Other|13|||
27637289|NCT00508924|80515755|FG000|Overall Study|Protocol Violation|0|||
27741000|NCT03241173|80880795|FG006|Overall Study|Withdrawal by Subject|0|||
27637290|NCT00508924|80515756|FG001|Overall Study|Protocol Violation|0|||
27542806|NCT04377620|80178731|FG002|Overall Study|Death|36|||
27542807|NCT04377620|80178729|FG000|Overall Study|Withdrawal by Subject|0|||
27542808|NCT04377620|80178730|FG001|Overall Study|Withdrawal by Subject|2|||
27637291|NCT00508924|80515757|FG002|Overall Study|Protocol Violation|1|||
27637292|NCT00508924|80515758|FG003|Overall Study|Protocol Violation|1|||
27637293|NCT00610649|80515763|FG000|Overall Study|Adverse Event|1|||
27637294|NCT00610649|80515764|FG001|Overall Study|Adverse Event|0|||
27637295|NCT00610649|80515765|FG002|Overall Study|Adverse Event|0|||
27637296|NCT00610649|80515766|FG003|Overall Study|Adverse Event|0|||
27637297|NCT00610649|80515767|FG004|Overall Study|Adverse Event|0|||
27637298|NCT00610649|80515768|FG005|Overall Study|Adverse Event|0|||
27637299|NCT00610649|80515769|FG006|Overall Study|Adverse Event|0|||
27637300|NCT00610649|80515770|FG007|Overall Study|Adverse Event|0|||
27637301|NCT00610649|80515771|FG008|Overall Study|Adverse Event|0|||
27637302|NCT00610649|80515772|FG009|Overall Study|Adverse Event|0|||
27637303|NCT00610649|80515773|FG010|Overall Study|Adverse Event|1|||
27637304|NCT00610649|80515763|FG000|Overall Study|Family Emergency|0|||
27637305|NCT00610649|80515764|FG001|Overall Study|Family Emergency|1|||
27637306|NCT00610649|80515765|FG002|Overall Study|Family Emergency|0|||
27741001|NCT03241173|80880796|FG007|Overall Study|Withdrawal by Subject|0|||
27741002|NCT03241173|80880797|FG008|Overall Study|Withdrawal by Subject|0|||
27921391|NCT03176771|81550679|FG001|Double-Blind Extension Period|Adverse Event|0|||
27921392|NCT03176771|81550680|FG002|Double-Blind Extension Period|Adverse Event|0|||
27921393|NCT03176771|81550681|FG003|Double-Blind Extension Period|Adverse Event|15|||
27921394|NCT03176771|81550682|FG004|Double-Blind Extension Period|Adverse Event|18|||
27921395|NCT03176771|81550678|FG000|Double-Blind Extension Period|Death|0|||
27921396|NCT03176771|81550679|FG001|Double-Blind Extension Period|Death|0|||
27921397|NCT03176771|81550680|FG002|Double-Blind Extension Period|Death|0|||
27921398|NCT03176771|81550681|FG003|Double-Blind Extension Period|Death|3|||
27921399|NCT03176771|81550682|FG004|Double-Blind Extension Period|Death|4|||
27921400|NCT03176771|81550678|FG000|Double-Blind Extension Period|Physician Decision|0|||
27921401|NCT03176771|81550679|FG001|Double-Blind Extension Period|Physician Decision|0|||
27921402|NCT03176771|81550680|FG002|Double-Blind Extension Period|Physician Decision|0|||
27637307|NCT00610649|80515766|FG003|Overall Study|Family Emergency|0|||
27921403|NCT03176771|81550681|FG003|Double-Blind Extension Period|Physician Decision|3|||
27921404|NCT03176771|81550682|FG004|Double-Blind Extension Period|Physician Decision|1|||
27921405|NCT03176771|81550678|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
27921406|NCT03176771|81550679|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
27921407|NCT03176771|81550680|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
27921408|NCT03176771|81550681|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
27921409|NCT03176771|81550682|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
27921410|NCT02897349|81550685|FG000|Overall Study|Lost to Follow-up|2|||
27921411|NCT02897349|81550686|FG001|Overall Study|Lost to Follow-up|2|||
27921412|NCT02897349|81550685|FG000|Overall Study|Adverse Event|3|||
27921413|NCT02897349|81550686|FG001|Overall Study|Adverse Event|3|||
27921414|NCT02897349|81550685|FG000|Overall Study|Other than listed above|0|||
27921415|NCT02897349|81550686|FG001|Overall Study|Other than listed above|1|||
27921416|NCT02295644|81550687|FG000|Overall Study|Did not meet inclusion criterion|0|||
27921417|NCT02295644|81550688|FG001|Overall Study|Did not meet inclusion criterion|0|||
27921418|NCT02295644|81550689|FG002|Overall Study|Did not meet inclusion criterion|1|||
27921419|NCT02295644|81550690|FG003|Overall Study|Did not meet inclusion criterion|2|||
27921420|NCT00323063|81550691|FG000|Overall Study|Adverse Event|1|||
27921421|NCT00323063|81550692|FG001|Overall Study|Adverse Event|0|||
27921422|NCT00323063|81550691|FG000|Overall Study|brain mets discovered prior to treatment|1|||
27921423|NCT00323063|81550692|FG001|Overall Study|brain mets discovered prior to treatment|0|||
27921424|NCT00262119|81550695|FG000|Overall Study|Lost to Follow-up|38|||
27921425|NCT00262119|81550696|FG001|Overall Study|Lost to Follow-up|51|||
27921426|NCT00262119|81550697|FG002|Overall Study|Lost to Follow-up|42|||
27921427|NCT00262119|81550695|FG000|Overall Study|Death|20|||
27921428|NCT00262119|81550696|FG001|Overall Study|Death|19|||
27921429|NCT00262119|81550697|FG002|Overall Study|Death|16|||
27921430|NCT02674516|81550702|FG000|Overall Study|Lost to Follow-up|3|||
27921431|NCT02674516|81550703|FG001|Overall Study|Lost to Follow-up|0|||
27921432|NCT02674516|81550702|FG000|Overall Study|Protocol Violation|0|||
27921433|NCT02674516|81550703|FG001|Overall Study|Protocol Violation|4|||
27637308|NCT00610649|80515767|FG004|Overall Study|Family Emergency|0|||
27637309|NCT00610649|80515768|FG005|Overall Study|Family Emergency|0|||
27637310|NCT00610649|80515769|FG006|Overall Study|Family Emergency|0|||
27637311|NCT00610649|80515770|FG007|Overall Study|Family Emergency|0|||
27741003|NCT03241173|80880798|FG009|Overall Study|Withdrawal by Subject|0|||
27741004|NCT03241173|80880799|FG010|Overall Study|Withdrawal by Subject|0|||
27921434|NCT02674516|81550702|FG000|Overall Study|Knowledge of study hypothesis|1|||
27921435|NCT02674516|81550703|FG001|Overall Study|Knowledge of study hypothesis|0|||
27921436|NCT00997334|81550704|FG000|Overall Study|still on therapy|12|||
27921437|NCT00997334|81550704|FG000|Overall Study|Adverse Event|3|||
27637312|NCT00610649|80515771|FG008|Overall Study|Family Emergency|0|||
27637313|NCT00610649|80515772|FG009|Overall Study|Family Emergency|0|||
27921438|NCT00997334|81550704|FG000|Overall Study|Patient non-compliance|1|||
27921439|NCT00997334|81550704|FG000|Overall Study|Withdrawal by Subject|3|||
27921440|NCT00997334|81550704|FG000|Overall Study|Death|2|||
27921441|NCT00997334|81550704|FG000|Overall Study|Urgent Palliative Care|2|||
27921442|NCT00997334|81550704|FG000|Overall Study|No lesion amenable|1|||
27921443|NCT00997334|81550704|FG000|Overall Study|Ineligible|1|||
27921444|NCT02410629|81550707|FG000|Overall Study|Family cannot commit to the study|2|||
27921445|NCT02410629|81550708|FG001|Overall Study|Family cannot commit to the study|1|||
27921446|NCT02410629|81550707|FG000|Overall Study|Subject returned to work|1|||
27921447|NCT02410629|81550708|FG001|Overall Study|Subject returned to work|0|||
27921448|NCT02410629|81550707|FG000|Overall Study|Subject moved back to home country|0|||
27921449|NCT02410629|81550708|FG001|Overall Study|Subject moved back to home country|1|||
27921450|NCT02410629|81550707|FG000|Overall Study|Subject underwent heart surgery|0|||
27921451|NCT02410629|81550708|FG001|Overall Study|Subject underwent heart surgery|1|||
27921452|NCT01799889|81550709|FG000|Overall Study|Adverse Event|4|||
27921453|NCT01799889|81550710|FG001|Overall Study|Adverse Event|4|||
27921454|NCT01799889|81550711|FG002|Overall Study|Adverse Event|5|||
27921455|NCT01799889|81550712|FG003|Overall Study|Adverse Event|1|||
27921456|NCT01799889|81550713|FG004|Overall Study|Adverse Event|11|||
27921457|NCT01799889|81550714|FG005|Overall Study|Adverse Event|1|||
27921458|NCT01799889|81550715|FG006|Overall Study|Adverse Event|5|||
27921459|NCT01799889|81550716|FG007|Overall Study|Adverse Event|2|||
27921460|NCT01799889|81550717|FG008|Overall Study|Adverse Event|3|||
27921461|NCT01799889|81550718|FG009|Overall Study|Adverse Event|1|||
27921462|NCT01799889|81550719|FG010|Overall Study|Adverse Event|1|||
27921463|NCT01799889|81550720|FG011|Overall Study|Adverse Event|0|||
27921464|NCT01799889|81550709|FG000|Overall Study|Death|1|||
27921465|NCT01799889|81550710|FG001|Overall Study|Death|0|||
27921466|NCT01799889|81550711|FG002|Overall Study|Death|5|||
27921467|NCT01799889|81550712|FG003|Overall Study|Death|3|||
27921468|NCT01799889|81550713|FG004|Overall Study|Death|1|||
27921469|NCT01799889|81550714|FG005|Overall Study|Death|0|||
27921470|NCT01799889|81550715|FG006|Overall Study|Death|0|||
27921471|NCT01799889|81550716|FG007|Overall Study|Death|0|||
27921472|NCT01799889|81550717|FG008|Overall Study|Death|1|||
27921473|NCT01799889|81550718|FG009|Overall Study|Death|0|||
27921474|NCT01799889|81550719|FG010|Overall Study|Death|1|||
27921475|NCT01799889|81550720|FG011|Overall Study|Death|0|||
27921476|NCT01799889|81550709|FG000|Overall Study|Lack of Efficacy|1|||
27921477|NCT01799889|81550710|FG001|Overall Study|Lack of Efficacy|1|||
27921478|NCT01799889|81550711|FG002|Overall Study|Lack of Efficacy|0|||
27921479|NCT01799889|81550712|FG003|Overall Study|Lack of Efficacy|1|||
27921480|NCT01799889|81550713|FG004|Overall Study|Lack of Efficacy|2|||
27921481|NCT01799889|81550714|FG005|Overall Study|Lack of Efficacy|2|||
27921482|NCT01799889|81550715|FG006|Overall Study|Lack of Efficacy|0|||
27921483|NCT01799889|81550716|FG007|Overall Study|Lack of Efficacy|0|||
27921484|NCT01799889|81550717|FG008|Overall Study|Lack of Efficacy|2|||
27921485|NCT01799889|81550718|FG009|Overall Study|Lack of Efficacy|0|||
27921486|NCT01799889|81550719|FG010|Overall Study|Lack of Efficacy|1|||
27921487|NCT01799889|81550720|FG011|Overall Study|Lack of Efficacy|0|||
27921488|NCT01799889|81550709|FG000|Overall Study|Lost to Follow-up|0|||
27921489|NCT01799889|81550710|FG001|Overall Study|Lost to Follow-up|1|||
27921490|NCT01799889|81550711|FG002|Overall Study|Lost to Follow-up|0|||
27921491|NCT01799889|81550712|FG003|Overall Study|Lost to Follow-up|0|||
27921492|NCT01799889|81550713|FG004|Overall Study|Lost to Follow-up|0|||
27921493|NCT01799889|81550714|FG005|Overall Study|Lost to Follow-up|0|||
27921494|NCT01799889|81550715|FG006|Overall Study|Lost to Follow-up|0|||
27921495|NCT01799889|81550716|FG007|Overall Study|Lost to Follow-up|0|||
27921496|NCT01799889|81550717|FG008|Overall Study|Lost to Follow-up|0|||
27921497|NCT01799889|81550718|FG009|Overall Study|Lost to Follow-up|0|||
27921498|NCT01799889|81550719|FG010|Overall Study|Lost to Follow-up|0|||
27921499|NCT01799889|81550720|FG011|Overall Study|Lost to Follow-up|0|||
27921500|NCT01799889|81550709|FG000|Overall Study|Physician Decision|3|||
27921501|NCT01799889|81550710|FG001|Overall Study|Physician Decision|2|||
27921502|NCT01799889|81550711|FG002|Overall Study|Physician Decision|4|||
27921503|NCT01799889|81550712|FG003|Overall Study|Physician Decision|4|||
27921504|NCT01799889|81550713|FG004|Overall Study|Physician Decision|5|||
27921505|NCT01799889|81550714|FG005|Overall Study|Physician Decision|5|||
27921506|NCT01799889|81550715|FG006|Overall Study|Physician Decision|5|||
27921507|NCT01799889|81550716|FG007|Overall Study|Physician Decision|2|||
27921508|NCT01799889|81550717|FG008|Overall Study|Physician Decision|6|||
27921509|NCT01799889|81550718|FG009|Overall Study|Physician Decision|0|||
27921510|NCT01799889|81550719|FG010|Overall Study|Physician Decision|0|||
27921511|NCT01799889|81550720|FG011|Overall Study|Physician Decision|1|||
27921512|NCT01799889|81550709|FG000|Overall Study|Progressive Disease|30|||
27921513|NCT01799889|81550710|FG001|Overall Study|Progressive Disease|26|||
27921514|NCT01799889|81550711|FG002|Overall Study|Progressive Disease|25|||
27921515|NCT01799889|81550712|FG003|Overall Study|Progressive Disease|30|||
27921516|NCT01799889|81550713|FG004|Overall Study|Progressive Disease|23|||
27921517|NCT01799889|81550714|FG005|Overall Study|Progressive Disease|9|||
27921518|NCT01799889|81550715|FG006|Overall Study|Progressive Disease|8|||
27921519|NCT01799889|81550716|FG007|Overall Study|Progressive Disease|13|||
27921520|NCT01799889|81550717|FG008|Overall Study|Progressive Disease|18|||
27921521|NCT01799889|81550718|FG009|Overall Study|Progressive Disease|5|||
27921522|NCT01799889|81550719|FG010|Overall Study|Progressive Disease|3|||
27921523|NCT01799889|81550720|FG011|Overall Study|Progressive Disease|1|||
27921524|NCT01799889|81550709|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
27921525|NCT01799889|81550710|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
27921526|NCT01799889|81550711|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
27921527|NCT01799889|81550712|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
27921528|NCT01799889|81550713|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
27921529|NCT01799889|81550714|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
27921530|NCT01799889|81550715|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
27921531|NCT01799889|81550716|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
27921532|NCT01799889|81550717|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
27921533|NCT01799889|81550718|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
27921534|NCT01799889|81550719|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
27921535|NCT01799889|81550720|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
27921536|NCT01799889|81550709|FG000|Overall Study|Study Terminated By Sponsor|1|||
27921537|NCT01799889|81550710|FG001|Overall Study|Study Terminated By Sponsor|0|||
27921538|NCT01799889|81550711|FG002|Overall Study|Study Terminated By Sponsor|0|||
27921539|NCT01799889|81550712|FG003|Overall Study|Study Terminated By Sponsor|0|||
27921540|NCT01799889|81550713|FG004|Overall Study|Study Terminated By Sponsor|2|||
27921541|NCT01799889|81550714|FG005|Overall Study|Study Terminated By Sponsor|1|||
27921542|NCT01799889|81550715|FG006|Overall Study|Study Terminated By Sponsor|0|||
27921543|NCT01799889|81550716|FG007|Overall Study|Study Terminated By Sponsor|2|||
27921544|NCT01799889|81550717|FG008|Overall Study|Study Terminated By Sponsor|1|||
27921545|NCT01799889|81550718|FG009|Overall Study|Study Terminated By Sponsor|1|||
27921546|NCT01799889|81550719|FG010|Overall Study|Study Terminated By Sponsor|0|||
27921547|NCT01799889|81550720|FG011|Overall Study|Study Terminated By Sponsor|0|||
27921548|NCT01799889|81550709|FG000|Overall Study|Withdrawal by Subject|1|||
27921549|NCT01799889|81550710|FG001|Overall Study|Withdrawal by Subject|6|||
27921550|NCT01799889|81550711|FG002|Overall Study|Withdrawal by Subject|4|||
27921551|NCT01799889|81550712|FG003|Overall Study|Withdrawal by Subject|0|||
27921552|NCT01799889|81550713|FG004|Overall Study|Withdrawal by Subject|5|||
27921553|NCT01799889|81550714|FG005|Overall Study|Withdrawal by Subject|1|||
27921554|NCT01799889|81550715|FG006|Overall Study|Withdrawal by Subject|3|||
27921555|NCT01799889|81550716|FG007|Overall Study|Withdrawal by Subject|1|||
27921556|NCT01799889|81550717|FG008|Overall Study|Withdrawal by Subject|2|||
27921557|NCT01799889|81550718|FG009|Overall Study|Withdrawal by Subject|1|||
27921558|NCT01799889|81550719|FG010|Overall Study|Withdrawal by Subject|1|||
27921559|NCT01799889|81550720|FG011|Overall Study|Withdrawal by Subject|1|||
27921560|NCT01799889|81550709|FG000|Overall Study|Non-Compliance With Study Drug|0|||
27921561|NCT01799889|81550710|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27921562|NCT01799889|81550711|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27921563|NCT01799889|81550712|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27921564|NCT01799889|81550713|FG004|Overall Study|Non-Compliance With Study Drug|0|||
27921565|NCT01799889|81550714|FG005|Overall Study|Non-Compliance With Study Drug|1|||
27921566|NCT01799889|81550715|FG006|Overall Study|Non-Compliance With Study Drug|0|||
27921567|NCT01799889|81550716|FG007|Overall Study|Non-Compliance With Study Drug|0|||
27921568|NCT01799889|81550717|FG008|Overall Study|Non-Compliance With Study Drug|0|||
27921569|NCT01799889|81550718|FG009|Overall Study|Non-Compliance With Study Drug|0|||
27921570|NCT01799889|81550719|FG010|Overall Study|Non-Compliance With Study Drug|0|||
27921571|NCT01799889|81550720|FG011|Overall Study|Non-Compliance With Study Drug|0|||
27542809|NCT04377620|80178731|FG002|Overall Study|Withdrawal by Subject|0|||
27542810|NCT04390191|80178732|FG000|Overall Study|Withdrawal by Subject|1|||
27542811|NCT04390191|80178733|FG001|Overall Study|Withdrawal by Subject|0|||
27542812|NCT01197560|80178738|FG000|Overall Study|Adverse Event|6|||
27542813|NCT01197560|80178739|FG001|Overall Study|Adverse Event|8|||
27542814|NCT01197560|80178738|FG000|Overall Study|Death|3|||
27542815|NCT01197560|80178739|FG001|Overall Study|Death|5|||
27542816|NCT01197560|80178738|FG000|Overall Study|Withdrawal by Subject|1|||
27542817|NCT01197560|80178739|FG001|Overall Study|Withdrawal by Subject|1|||
27542818|NCT01197560|80178738|FG000|Overall Study|Disease progression|40|||
27542819|NCT01197560|80178739|FG001|Overall Study|Disease progression|35|||
27542820|NCT01197560|80178738|FG000|Overall Study|Miscellaneous|4|||
27542821|NCT01197560|80178739|FG001|Overall Study|Miscellaneous|3|||
27921572|NCT01721798|81550721|FG000|Overall Study|Death|0|||
27921573|NCT01721798|81550722|FG001|Overall Study|Death|0|||
27921574|NCT01721798|81550723|FG002|Overall Study|Death|1|||
27921575|NCT01721798|81550724|FG003|Overall Study|Death|1|||
27921576|NCT01721798|81550721|FG000|Overall Study|Lost to Follow-up|2|||
27921577|NCT01721798|81550722|FG001|Overall Study|Lost to Follow-up|2|||
27921578|NCT01721798|81550723|FG002|Overall Study|Lost to Follow-up|9|||
27921579|NCT01721798|81550724|FG003|Overall Study|Lost to Follow-up|9|||
27921580|NCT01721798|81550721|FG000|Overall Study|Pregnancy|0|||
27921581|NCT01721798|81550722|FG001|Overall Study|Pregnancy|0|||
27921582|NCT01721798|81550723|FG002|Overall Study|Pregnancy|1|||
27542822|NCT01197560|80178738|FG000|Overall Study|Missing|0|||
27542823|NCT01197560|80178739|FG001|Overall Study|Missing|1|||
27542824|NCT04066023|80178740|FG000|Overall Study|Adverse Event|0|||
27542825|NCT04066023|80178741|FG001|Overall Study|Adverse Event|0|||
27542826|NCT04066023|80178742|FG002|Overall Study|Adverse Event|1|||
27542827|NCT04066023|80178740|FG000|Overall Study|Sponsor decision|3|||
27542828|NCT04066023|80178741|FG001|Overall Study|Sponsor decision|6|||
27542829|NCT04066023|80178742|FG002|Overall Study|Sponsor decision|2|||
27542830|NCT04066023|80178740|FG000|Overall Study|Physician Decision|0|||
27542831|NCT04066023|80178741|FG001|Overall Study|Physician Decision|0|||
27542832|NCT04066023|80178742|FG002|Overall Study|Physician Decision|1|||
27542833|NCT04066023|80178740|FG000|Overall Study|Lost to Follow-up|0|||
27921583|NCT01721798|81550724|FG003|Overall Study|Pregnancy|1|||
27921584|NCT01721798|81550721|FG000|Overall Study|Withdrawal by Subject|1|||
27921585|NCT01721798|81550722|FG001|Overall Study|Withdrawal by Subject|0|||
27921586|NCT01721798|81550723|FG002|Overall Study|Withdrawal by Subject|2|||
27921587|NCT01721798|81550724|FG003|Overall Study|Withdrawal by Subject|1|||
27921588|NCT01721798|81550721|FG000|Overall Study|Not eligible for 24 month visit|1|||
27921589|NCT01721798|81550722|FG001|Overall Study|Not eligible for 24 month visit|0|||
27921590|NCT01721798|81550723|FG002|Overall Study|Not eligible for 24 month visit|8|||
27921591|NCT01721798|81550724|FG003|Overall Study|Not eligible for 24 month visit|7|||
27921592|NCT00003537|81550725|FG000|Overall Study|Not evalauable|1|||
27921593|NCT01704261|81550726|FG000|Overall Study|Withdrawal by Subject|12|||
27921594|NCT01704261|81550727|FG001|Overall Study|Withdrawal by Subject|15|||
27921595|NCT01704261|81550726|FG000|Overall Study|Lost to Follow-up|1|||
27921596|NCT01704261|81550727|FG001|Overall Study|Lost to Follow-up|0|||
27921597|NCT00717886|81550728|FG000|Overall Study|Withdrawal by Subject|3|||
27921598|NCT00717886|81550728|FG000|Overall Study|Treatment Failure|1|||
27921599|NCT00834041|81550740|FG000|Overall Study|Withdrawal by Subject|1|||
27921600|NCT00834041|81550741|FG001|Overall Study|Withdrawal by Subject|0|||
27921601|NCT00834041|81550740|FG000|Overall Study|Lost to Follow-up|0|||
27921602|NCT00834041|81550741|FG001|Overall Study|Lost to Follow-up|1|||
27921603|NCT00505921|81550744|FG000|Overall Study|Ineligible|1|||
27921604|NCT00505921|81550744|FG000|Overall Study|Failed to Mobilize|8|||
27921605|NCT03307174|81550745|FG000|Overall Study|Unplanned ICU Administrion|5|||
27921606|NCT03307174|81550746|FG001|Overall Study|Unplanned ICU Administrion|3|||
27921607|NCT03307174|81550745|FG000|Overall Study|Aborted Surgery|1|||
27921608|NCT03307174|81550746|FG001|Overall Study|Aborted Surgery|2|||
27921609|NCT03307174|81550745|FG000|Overall Study|Hypotension|6|||
27921610|NCT03307174|81550746|FG001|Overall Study|Hypotension|0|||
27921611|NCT03307174|81550745|FG000|Overall Study|Nonfunctional epidural|1|||
27921612|NCT03307174|81550746|FG001|Overall Study|Nonfunctional epidural|1|||
27921613|NCT03307174|81550745|FG000|Overall Study|Planned epidural removal|1|||
27921614|NCT03307174|81550746|FG001|Overall Study|Planned epidural removal|0|||
27921615|NCT03307174|81550745|FG000|Overall Study|Intrathecal catheter placement|0|||
27921616|NCT03307174|81550746|FG001|Overall Study|Intrathecal catheter placement|1|||
27921617|NCT01225549|81550749|FG000|Period 4 - Washout|Disallowed medication|0|||
27921618|NCT01225549|81550750|FG001|Period 4 - Washout|Disallowed medication|1|||
27921619|NCT01225549|81550751|FG002|Period 4 - Washout|Disallowed medication|0|||
27921620|NCT01225549|81550752|FG003|Period 4 - Washout|Disallowed medication|0|||
27921621|NCT01225549|81550753|FG004|Period 4 - Washout|Disallowed medication|0|||
27921622|NCT01225549|81550754|FG005|Period 4 - Washout|Disallowed medication|0|||
27921623|NCT01225549|81550755|FG006|Period 4 - Washout|Disallowed medication|0|||
27921624|NCT01225549|81550756|FG007|Period 4 - Washout|Disallowed medication|0|||
27921625|NCT01225549|81550757|FG008|Period 4 - Washout|Disallowed medication|0|||
27921626|NCT01225549|81550758|FG009|Period 4 - Washout|Disallowed medication|0|||
27921627|NCT01225549|81550749|FG000|Period 6 - Washout|Disallowed medication|0|||
27921628|NCT01225549|81550750|FG001|Period 6 - Washout|Disallowed medication|0|||
27921629|NCT01225549|81550751|FG002|Period 6 - Washout|Disallowed medication|0|||
27921630|NCT01225549|81550752|FG003|Period 6 - Washout|Disallowed medication|1|||
27921631|NCT01225549|81550753|FG004|Period 6 - Washout|Disallowed medication|0|||
27921632|NCT01225549|81550754|FG005|Period 6 - Washout|Disallowed medication|0|||
27921633|NCT01225549|81550755|FG006|Period 6 - Washout|Disallowed medication|0|||
27542834|NCT04066023|80178741|FG001|Overall Study|Lost to Follow-up|1|||
27741005|NCT03241173|80880800|FG011|Overall Study|Withdrawal by Subject|0|||
27921634|NCT01225549|81550756|FG007|Period 6 - Washout|Disallowed medication|0|||
27921635|NCT01225549|81550757|FG008|Period 6 - Washout|Disallowed medication|0|||
27921636|NCT01225549|81550758|FG009|Period 6 - Washout|Disallowed medication|0|||
27921637|NCT03256578|81550763|FG000|Overall Study|Excluded Post Randomization|66|||
27921638|NCT03256578|81550764|FG001|Overall Study|Excluded Post Randomization|56|||
27921639|NCT02147626|81550767|FG000|Overall Study|Lost to Follow-up|4|||
27921640|NCT02147626|81550768|FG001|Overall Study|Lost to Follow-up|4|||
27921641|NCT02147626|81550767|FG000|Overall Study|Pregnancy|1|||
27921642|NCT02147626|81550768|FG001|Overall Study|Pregnancy|2|||
27921643|NCT02147626|81550767|FG000|Overall Study|Withdrawal by Subject|0|||
27542835|NCT04066023|80178742|FG002|Overall Study|Lost to Follow-up|1|||
27542836|NCT04066023|80178740|FG000|Overall Study|Noncompliance|0|||
27542837|NCT04066023|80178741|FG001|Overall Study|Noncompliance|1|||
27542838|NCT04066023|80178742|FG002|Overall Study|Noncompliance|1|||
27921644|NCT02147626|81550768|FG001|Overall Study|Withdrawal by Subject|1|||
27921645|NCT01411852|81550774|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
27921646|NCT01411852|81550775|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
27921647|NCT01411852|81550774|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
27921648|NCT01411852|81550775|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
27921649|NCT01411852|81550774|FG000|Prehospital Intervention Phase|Found to be under age|0|||
27921650|NCT01411852|81550775|FG001|Prehospital Intervention Phase|Found to be under age|1|||
27921651|NCT01411852|81550774|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
27921652|NCT01411852|81550775|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
27921653|NCT01411852|81550774|FG000|Hospital Intervention Phase|Severe head injury|5|||
27921654|NCT01411852|81550775|FG001|Hospital Intervention Phase|Severe head injury|4|||
27921655|NCT01411852|81550774|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
27921656|NCT01411852|81550775|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
27921657|NCT01411852|81550774|FG000|Hospital Intervention Phase|Miscommunication error|1|||
27921658|NCT01411852|81550775|FG001|Hospital Intervention Phase|Miscommunication error|2|||
27921659|NCT01411852|81550774|FG000|Hospital Intervention Phase|CPR administered|3|||
27921660|NCT01411852|81550775|FG001|Hospital Intervention Phase|CPR administered|1|||
27921661|NCT01411852|81550774|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
27921662|NCT01411852|81550775|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
27921663|NCT01411852|81550774|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
27921664|NCT01411852|81550775|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
27921665|NCT01411852|81550774|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
27921666|NCT01411852|81550775|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
27921667|NCT01411852|81550774|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
27921668|NCT01411852|81550775|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
27921669|NCT01411852|81550774|FG000|Hospital Intervention Phase|Other ineligible|2|||
27921670|NCT01411852|81550775|FG001|Hospital Intervention Phase|Other ineligible|2|||
27921671|NCT01411852|81550774|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
27921672|NCT01411852|81550775|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
27921673|NCT01411852|81550774|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
27921674|NCT01411852|81550775|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
27921675|NCT01411852|81550774|FG000|Hospital Intervention Phase|Vascular access failed|1|||
27921676|NCT01411852|81550775|FG001|Hospital Intervention Phase|Vascular access failed|0|||
27921677|NCT01474486|81550780|FG000|Overall Study|Death|2|||
27921678|NCT01474486|81550780|FG000|Overall Study|Withdrawal by Subject|4|||
27921679|NCT01474486|81550780|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
27921680|NCT02466399|81550786|FG000|Overall Study|Adverse Event|1|||
27921681|NCT02466399|81550787|FG001|Overall Study|Adverse Event|0|||
27921682|NCT02466399|81550786|FG000|Overall Study|Early exit due to family emergency|1|||
27921683|NCT02466399|81550787|FG001|Overall Study|Early exit due to family emergency|0|||
27921684|NCT01699750|81550788|FG000|Overall Study|Withdrew Consent|0|||
27921685|NCT01699750|81550789|FG001|Overall Study|Withdrew Consent|1|||
27921686|NCT01699750|81550788|FG000|Overall Study|Other|0|||
27921687|NCT01699750|81550789|FG001|Overall Study|Other|2|||
27921688|NCT00855218|81550790|FG000|Overall Study|Adverse Event|43|||
27542839|NCT01546883|80178743|FG000|Overall Study|Withdrawal by Subject|3|||
27542840|NCT01546883|80178743|FG000|Overall Study|Adverse Event|4|||
27921689|NCT00855218|81550791|FG001|Overall Study|Adverse Event|27|||
27921690|NCT00855218|81550790|FG000|Overall Study|Withdrawal by Subject|10|||
27921691|NCT00855218|81550791|FG001|Overall Study|Withdrawal by Subject|6|||
27921692|NCT00855218|81550790|FG000|Overall Study|Physician Decision|18|||
27921693|NCT00855218|81550791|FG001|Overall Study|Physician Decision|11|||
27921694|NCT00855218|81550790|FG000|Overall Study|Lost to Follow-up|0|||
27921695|NCT00855218|81550791|FG001|Overall Study|Lost to Follow-up|1|||
27921696|NCT00855218|81550790|FG000|Overall Study|Protocol Violation|5|||
27921697|NCT00855218|81550791|FG001|Overall Study|Protocol Violation|9|||
27921698|NCT00855218|81550790|FG000|Overall Study|non-compliant with study drug|3|||
27921699|NCT00855218|81550791|FG001|Overall Study|non-compliant with study drug|1|||
27921700|NCT00855218|81550790|FG000|Overall Study|patient convenience|2|||
27921701|NCT00855218|81550791|FG001|Overall Study|patient convenience|0|||
27542841|NCT01546883|80178743|FG000|Overall Study|Lost to Follow-up|2|||
27741006|NCT03241173|80880801|FG012|Overall Study|Withdrawal by Subject|0|||
27921702|NCT00855218|81550790|FG000|Overall Study|technical problems|2|||
27921703|NCT00855218|81550791|FG001|Overall Study|technical problems|1|||
27921704|NCT00855218|81550790|FG000|Overall Study|Still treated with study medication|0|||
27921705|NCT00855218|81550791|FG001|Overall Study|Still treated with study medication|1|||
27921706|NCT00855218|81550790|FG000|Overall Study|Untreatable disease progression|54|||
27921707|NCT00855218|81550791|FG001|Overall Study|Untreatable disease progression|67|||
27741007|NCT03241173|80880802|FG013|Overall Study|Withdrawal by Subject|0|||
27921708|NCT00855218|81550790|FG000|Overall Study|Second malignancy|0|||
27542842|NCT01546883|80178743|FG000|Overall Study|early closure of study|2|||
27921709|NCT00855218|81550791|FG001|Overall Study|Second malignancy|1|||
27921710|NCT00855218|81550790|FG000|Overall Study|Progression measurement proven|7|||
27921711|NCT00855218|81550791|FG001|Overall Study|Progression measurement proven|15|||
27921712|NCT00855218|81550790|FG000|Overall Study|Clinical endpoint reached|10|||
27921713|NCT00855218|81550791|FG001|Overall Study|Clinical endpoint reached|13|||
27921714|NCT00921024|81550793|FG000|Overall Study|Lost to Follow-up|2|||
27921715|NCT00921024|81550794|FG001|Overall Study|Lost to Follow-up|0|||
27921716|NCT00921024|81550793|FG000|Overall Study|Received concomittant therapy|2|||
27921717|NCT00921024|81550794|FG001|Overall Study|Received concomittant therapy|0|||
27921718|NCT00921024|81550793|FG000|Overall Study|Withdrawal by Subject|0|||
27921719|NCT00921024|81550794|FG001|Overall Study|Withdrawal by Subject|3|||
27921720|NCT01901185|81550795|FG000|Overall Study|Withdrawal by Subject|2|||
27921721|NCT02669849|81550806|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
27921722|NCT02669849|81550807|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
27921723|NCT02669849|81550808|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
27921724|NCT02669849|81550806|FG000|Overall Study|Lost to Follow-up|1|||
27921725|NCT02669849|81550807|FG001|Overall Study|Lost to Follow-up|0|||
27921726|NCT02669849|81550808|FG002|Overall Study|Lost to Follow-up|3|||
27921727|NCT02669849|81550806|FG000|Overall Study|Death|1|||
27921728|NCT02669849|81550807|FG001|Overall Study|Death|1|||
27542843|NCT01546883|80178743|FG000|Overall Study|other unrelated illness|1|||
27542844|NCT00957580|80178745|FG000|Overall Study|Ongoing at data cut-off|0|||
27542845|NCT00957580|80178746|FG001|Overall Study|Ongoing at data cut-off|1|||
27542846|NCT00957580|80178747|FG002|Overall Study|Ongoing at data cut-off|0|||
27542847|NCT00957580|80178745|FG000|Overall Study|Enrolled but not treated|0|||
27542848|NCT00957580|80178746|FG001|Overall Study|Enrolled but not treated|1|||
27921729|NCT02669849|81550808|FG002|Overall Study|Death|2|||
27921730|NCT02669849|81550806|FG000|Overall Study|Study terminated by sponsor|16|||
27921731|NCT02669849|81550807|FG001|Overall Study|Study terminated by sponsor|1|||
27921732|NCT02669849|81550808|FG002|Overall Study|Study terminated by sponsor|14|||
27921733|NCT02669849|81550806|FG000|Overall Study|Other|0|||
27921734|NCT02669849|81550807|FG001|Overall Study|Other|0|||
27921735|NCT02669849|81550808|FG002|Overall Study|Other|2|||
27921736|NCT00686972|81550809|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
27921737|NCT00284856|81550810|FG000|Overall Study|Adverse Event|3|||
27921738|NCT00284856|81550811|FG001|Overall Study|Adverse Event|3|||
27921739|NCT00284856|81550812|FG002|Overall Study|Adverse Event|3|||
27921740|NCT00284856|81550810|FG000|Overall Study|Lack of Efficacy|2|||
27921741|NCT00284856|81550811|FG001|Overall Study|Lack of Efficacy|1|||
27921742|NCT00284856|81550812|FG002|Overall Study|Lack of Efficacy|8|||
27921743|NCT00284856|81550810|FG000|Overall Study|Lost to Follow-up|25|||
27921744|NCT00284856|81550811|FG001|Overall Study|Lost to Follow-up|21|||
27921745|NCT00284856|81550812|FG002|Overall Study|Lost to Follow-up|22|||
27921746|NCT00284856|81550810|FG000|Overall Study|Protocol Violation|5|||
27921747|NCT00284856|81550811|FG001|Overall Study|Protocol Violation|4|||
27921748|NCT00284856|81550812|FG002|Overall Study|Protocol Violation|5|||
27921749|NCT00284856|81550810|FG000|Overall Study|Withdrawal by Subject|12|||
27921750|NCT00284856|81550811|FG001|Overall Study|Withdrawal by Subject|16|||
27921751|NCT00284856|81550812|FG002|Overall Study|Withdrawal by Subject|18|||
27921752|NCT00284856|81550810|FG000|Overall Study|Other|4|||
27542849|NCT00957580|80178747|FG002|Overall Study|Enrolled but not treated|0|||
27542850|NCT00702923|80178748|FG000|Overall Study|Adverse Event|1|||
27542851|NCT02925923|80178749|FG000|Overall Study|blood samples hemolyzed|0|||
27542852|NCT02925923|80178750|FG001|Overall Study|blood samples hemolyzed|2|||
27542853|NCT00493025|80178757|FG000|Overall Study|Physician Decision|19|||
27542854|NCT00453063|80178758|FG000|Overall Study|Adverse Event|1|||
27542855|NCT00453063|80178759|FG001|Overall Study|Adverse Event|2|||
27542856|NCT00453063|80178758|FG000|Overall Study|Withdrawal by Subject|1|||
27542857|NCT00453063|80178759|FG001|Overall Study|Withdrawal by Subject|1|||
27542858|NCT00453063|80178758|FG000|Overall Study|Protocol Violation|1|||
27542859|NCT00453063|80178759|FG001|Overall Study|Protocol Violation|0|||
27741008|NCT03241173|80880803|FG014|Overall Study|Withdrawal by Subject|0|||
27921753|NCT00284856|81550811|FG001|Overall Study|Other|5|||
27921754|NCT00284856|81550812|FG002|Overall Study|Other|4|||
27921755|NCT01240746|81550813|FG000|Overall Study|Adverse Event|2|||
27921756|NCT01240746|81550814|FG001|Overall Study|Adverse Event|0|||
27921757|NCT01240746|81550815|FG002|Overall Study|Adverse Event|10|||
27921758|NCT01240746|81550813|FG000|Overall Study|Lost to Follow-up|23|||
27921759|NCT01240746|81550814|FG001|Overall Study|Lost to Follow-up|20|||
27921760|NCT01240746|81550815|FG002|Overall Study|Lost to Follow-up|102|||
27921761|NCT01240746|81550813|FG000|Overall Study|Protocol Violation|24|||
27921762|NCT01240746|81550814|FG001|Overall Study|Protocol Violation|15|||
27542860|NCT02572401|80178761|FG000|Overall Study|Lost to Follow-up|5|||
27542861|NCT02572401|80178762|FG001|Overall Study|Lost to Follow-up|8|||
27542862|NCT02572401|80178763|FG002|Overall Study|Lost to Follow-up|9|||
27542863|NCT02572401|80178764|FG003|Overall Study|Lost to Follow-up|9|||
27542864|NCT02572401|80178761|FG000|Overall Study|Death|0|||
27921763|NCT01240746|81550815|FG002|Overall Study|Protocol Violation|72|||
27921764|NCT01240746|81550813|FG000|Overall Study|Withdrawal by Subject|10|||
27921765|NCT01240746|81550814|FG001|Overall Study|Withdrawal by Subject|13|||
27921766|NCT01240746|81550815|FG002|Overall Study|Withdrawal by Subject|59|||
27921767|NCT01294046|81550828|FG000|Overall Study|Infection and surgical explant|1|||
27921768|NCT01294046|81550828|FG000|Overall Study|Eligibility criteria expanded|1|||
27637314|NCT00610649|80515773|FG010|Overall Study|Family Emergency|0|||
27637315|NCT00610649|80515763|FG000|Overall Study|Withdrawal by Subject|0|||
27637316|NCT00610649|80515764|FG001|Overall Study|Withdrawal by Subject|0|||
27637317|NCT00610649|80515765|FG002|Overall Study|Withdrawal by Subject|0|||
27637318|NCT00610649|80515766|FG003|Overall Study|Withdrawal by Subject|0|||
27921769|NCT01294046|81550828|FG000|Overall Study|Stimulation response inadqequate|1|||
27921770|NCT00644059|81550829|FG000|Overall Study|Lost to Follow-up|37|||
27542865|NCT02572401|80178762|FG001|Overall Study|Death|0|||
27542866|NCT02572401|80178763|FG002|Overall Study|Death|0|||
27542867|NCT02572401|80178764|FG003|Overall Study|Death|1|||
27542868|NCT01926015|80178765|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27542869|NCT01926015|80178766|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27542870|NCT01926015|80178765|FG000|Overall Study|Randomized not treated|2|||
27542871|NCT01926015|80178766|FG001|Overall Study|Randomized not treated|0|||
27542872|NCT01253408|80178769|FG000|Overall Study|Adverse Event|0|||
27542873|NCT01253408|80178770|FG001|Overall Study|Adverse Event|1|||
27542874|NCT01253408|80178771|FG002|Overall Study|Adverse Event|0|||
27637319|NCT00610649|80515767|FG004|Overall Study|Withdrawal by Subject|0|||
27637320|NCT00610649|80515768|FG005|Overall Study|Withdrawal by Subject|0|||
27637321|NCT00610649|80515769|FG006|Overall Study|Withdrawal by Subject|0|||
27637322|NCT00610649|80515770|FG007|Overall Study|Withdrawal by Subject|0|||
27637323|NCT00610649|80515771|FG008|Overall Study|Withdrawal by Subject|0|||
27637324|NCT00610649|80515772|FG009|Overall Study|Withdrawal by Subject|1|||
27637325|NCT00610649|80515773|FG010|Overall Study|Withdrawal by Subject|0|||
27637326|NCT04732338|80515774|FG000|Overall Study|Lost to Follow-up|3|||
27637327|NCT04732338|80515775|FG001|Overall Study|Lost to Follow-up|3|||
27637328|NCT04149002|80515782|FG000|Overall Study|Lost to Follow-up|1|||
27637329|NCT04149002|80515783|FG001|Overall Study|Lost to Follow-up|0|||
27637330|NCT04149002|80515782|FG000|Overall Study|Withdrawal by Subject|1|||
27637331|NCT04149002|80515783|FG001|Overall Study|Withdrawal by Subject|0|||
27637332|NCT04035668|80515784|FG000|Overall Study|Adverse Event|3|||
27637333|NCT04035668|80515785|FG001|Overall Study|Adverse Event|4|||
27637334|NCT04035668|80515786|FG002|Overall Study|Adverse Event|2|||
27637335|NCT04035668|80515784|FG000|Overall Study|Lost to Follow-up|0|||
27637336|NCT04035668|80515785|FG001|Overall Study|Lost to Follow-up|1|||
27637337|NCT04035668|80515786|FG002|Overall Study|Lost to Follow-up|0|||
27637338|NCT04035668|80515784|FG000|Overall Study|Physician Decision|2|||
27637339|NCT04035668|80515785|FG001|Overall Study|Physician Decision|1|||
27637340|NCT04035668|80515786|FG002|Overall Study|Physician Decision|1|||
27637341|NCT04035668|80515784|FG000|Overall Study|Subject Decision|2|||
27637342|NCT04035668|80515785|FG001|Overall Study|Subject Decision|2|||
27637343|NCT04035668|80515786|FG002|Overall Study|Subject Decision|0|||
27637344|NCT01198028|80515787|FG000|Overall Study|Adverse Event|5|||
27637345|NCT01198028|80515787|FG000|Overall Study|Death|3|||
27637346|NCT01198028|80515787|FG000|Overall Study|Physician Decision|2|||
27921771|NCT00644059|81550830|FG001|Overall Study|Lost to Follow-up|34|||
27921772|NCT00644059|81550831|FG002|Overall Study|Lost to Follow-up|16|||
27921773|NCT00644059|81550829|FG000|Overall Study|Withdrawal by Subject|52|||
27921774|NCT00644059|81550830|FG001|Overall Study|Withdrawal by Subject|60|||
27921775|NCT00644059|81550831|FG002|Overall Study|Withdrawal by Subject|30|||
27921776|NCT00644059|81550829|FG000|Overall Study|Adverse Event|8|||
27921777|NCT00644059|81550830|FG001|Overall Study|Adverse Event|5|||
27921778|NCT00644059|81550831|FG002|Overall Study|Adverse Event|1|||
27921779|NCT00644059|81550829|FG000|Overall Study|Inappropriate Enrollment|1|||
27921780|NCT00644059|81550830|FG001|Overall Study|Inappropriate Enrollment|3|||
27921781|NCT00644059|81550831|FG002|Overall Study|Inappropriate Enrollment|0|||
27921782|NCT00644059|81550829|FG000|Overall Study|Protocol Deviation/violation|20|||
27921783|NCT00644059|81550830|FG001|Overall Study|Protocol Deviation/violation|19|||
27921784|NCT00644059|81550831|FG002|Overall Study|Protocol Deviation/violation|15|||
27921785|NCT00644059|81550829|FG000|Overall Study|Unable to classify|6|||
27921786|NCT00644059|81550830|FG001|Overall Study|Unable to classify|2|||
27921787|NCT00644059|81550831|FG002|Overall Study|Unable to classify|3|||
27921788|NCT02160626|81550833|FG000|Overall Study|Adverse Event|1|||
27921789|NCT02160626|81550834|FG001|Overall Study|Adverse Event|0|||
27921790|NCT02160626|81550835|FG002|Overall Study|Adverse Event|0|||
27921791|NCT02160626|81550833|FG000|Overall Study|Schedule not conducive to study visits|0|||
27921792|NCT02160626|81550834|FG001|Overall Study|Schedule not conducive to study visits|0|||
27542875|NCT01534962|80178772|FG000|Overall Study|Randomized but did not start treatment|2|||
27542876|NCT01534962|80178773|FG001|Overall Study|Randomized but did not start treatment|0|||
27637347|NCT01227278|80515797|FG000|Overall Study|Withdrawal by Subject|4|||
27637348|NCT01227278|80515798|FG001|Overall Study|Withdrawal by Subject|4|||
27921793|NCT02160626|81550835|FG002|Overall Study|Schedule not conducive to study visits|1|||
27921794|NCT02160626|81550833|FG000|Overall Study|Withdrawal by Subject|0|||
27921795|NCT02160626|81550834|FG001|Overall Study|Withdrawal by Subject|1|||
27921796|NCT02160626|81550835|FG002|Overall Study|Withdrawal by Subject|0|||
27921797|NCT01249131|81550838|FG000|Washout Period of 10 Days|Adverse Event|0|||
27921798|NCT01249131|81550839|FG001|Washout Period of 10 Days|Adverse Event|0|||
27754921|NCT02065622|80929631|FG001|Maintenance Study|Subject Non-Compliance|0|||
27921799|NCT01249131|81550840|FG002|Washout Period of 10 Days|Adverse Event|0|||
27921800|NCT01249131|81550841|FG003|Washout Period of 10 Days|Adverse Event|0|||
27921801|NCT01249131|81550842|FG004|Washout Period of 10 Days|Adverse Event|1|||
27921802|NCT01249131|81550843|FG005|Washout Period of 10 Days|Adverse Event|0|||
27921803|NCT00947544|81550846|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
27921804|NCT00947544|81550847|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
27921805|NCT02472353|81550854|FG000|Overall Study|Lost to Follow-up|1|||
27921806|NCT02472353|81550855|FG001|Overall Study|Lost to Follow-up|1|||
27921807|NCT02472353|81550854|FG000|Overall Study|Withdrawal by Subject|2|||
27921808|NCT02472353|81550855|FG001|Overall Study|Withdrawal by Subject|1|||
27921809|NCT02472353|81550854|FG000|Overall Study|Study Termination|1|||
27921810|NCT02472353|81550855|FG001|Overall Study|Study Termination|4|||
27921811|NCT01326871|81550856|FG000|Overall Study|Major surgery|0|||
27921812|NCT01326871|81550857|FG001|Overall Study|Major surgery|1|||
27921813|NCT01326871|81550858|FG002|Overall Study|Major surgery|0|||
27921814|NCT01326871|81550856|FG000|Overall Study|SAE and death|0|||
27921815|NCT01326871|81550857|FG001|Overall Study|SAE and death|2|||
27921816|NCT01326871|81550858|FG002|Overall Study|SAE and death|0|||
27921817|NCT01326871|81550856|FG000|Overall Study|Physician decision and decreased performance status|0|||
27921818|NCT01326871|81550857|FG001|Overall Study|Physician decision and decreased performance status|1|||
27921819|NCT01326871|81550858|FG002|Overall Study|Physician decision and decreased performance status|0|||
27921820|NCT01326871|81550856|FG000|Overall Study|Disease progression|0|||
27921821|NCT01326871|81550857|FG001|Overall Study|Disease progression|11|||
27921822|NCT01326871|81550858|FG002|Overall Study|Disease progression|5|||
27921823|NCT01326871|81550856|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
27921824|NCT01326871|81550857|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
27921825|NCT01326871|81550858|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
27921826|NCT01326871|81550856|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
27921827|NCT01326871|81550857|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
27921828|NCT01326871|81550858|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
27921829|NCT01326871|81550856|FG000|Overall Study|Withdrawal by Subject|0|||
27921830|NCT01326871|81550857|FG001|Overall Study|Withdrawal by Subject|1|||
27921831|NCT01326871|81550858|FG002|Overall Study|Withdrawal by Subject|0|||
27921832|NCT01326871|81550856|FG000|Overall Study|DLT|0|||
27921833|NCT01326871|81550857|FG001|Overall Study|DLT|2|||
27921834|NCT01326871|81550858|FG002|Overall Study|DLT|0|||
27921835|NCT01326871|81550856|FG000|Overall Study|SAE, disease progression and subject decision|0|||
27921836|NCT01326871|81550857|FG001|Overall Study|SAE, disease progression and subject decision|1|||
27921837|NCT01326871|81550858|FG002|Overall Study|SAE, disease progression and subject decision|0|||
27921838|NCT01326871|81550856|FG000|Overall Study|Death|0|||
27921839|NCT01326871|81550857|FG001|Overall Study|Death|1|||
27921840|NCT01326871|81550858|FG002|Overall Study|Death|0|||
27921841|NCT01326871|81550856|FG000|Overall Study|Other|0|||
27921842|NCT01326871|81550857|FG001|Overall Study|Other|3|||
27921843|NCT01326871|81550858|FG002|Overall Study|Other|0|||
27921844|NCT01326871|81550856|FG000|Overall Study|SAE and disease progression|0|||
27921845|NCT01326871|81550857|FG001|Overall Study|SAE and disease progression|0|||
27921846|NCT01326871|81550858|FG002|Overall Study|SAE and disease progression|1|||
27921847|NCT01326871|81550856|FG000|Overall Study|SAE and physician decision|0|||
27921848|NCT01326871|81550857|FG001|Overall Study|SAE and physician decision|0|||
27921849|NCT01326871|81550858|FG002|Overall Study|SAE and physician decision|1|||
27921850|NCT01326871|81550856|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
27921851|NCT01326871|81550857|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
27921852|NCT01326871|81550858|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
27921853|NCT01326871|81550856|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
27921854|NCT01326871|81550857|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
27542877|NCT01534962|80178774|FG002|Overall Study|Randomized but did not start treatment|0|||
27542878|NCT01534962|80178775|FG003|Overall Study|Randomized but did not start treatment|1|||
27542879|NCT01534962|80178772|FG000|Overall Study|Discontinued at AF recurrence|35|||
27542880|NCT01534962|80178773|FG001|Overall Study|Discontinued at AF recurrence|26|||
27542881|NCT01534962|80178774|FG002|Overall Study|Discontinued at AF recurrence|24|||
27542882|NCT01534962|80178775|FG003|Overall Study|Discontinued at AF recurrence|31|||
27542883|NCT00709761|80178786|FG000|Overall Study|Withdrawal by Subject|8|||
27542884|NCT00709761|80178786|FG000|Overall Study|study closed/terminated|17|||
27921855|NCT01326871|81550858|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
27921856|NCT01326871|81550856|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
27921857|NCT01326871|81550857|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
27921858|NCT01326871|81550858|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
27921859|NCT01326871|81550856|FG000|Overall Study|Physician Decision|0|||
27921860|NCT01326871|81550857|FG001|Overall Study|Physician Decision|0|||
27921861|NCT01326871|81550858|FG002|Overall Study|Physician Decision|1|||
27921862|NCT01326871|81550856|FG000|Overall Study|SAE|0|||
27921863|NCT01326871|81550857|FG001|Overall Study|SAE|0|||
27542885|NCT00709761|80178786|FG000|Overall Study|Lost to Follow-up|2|||
27542886|NCT04930965|80178787|FG000|Overall Study|Lost to Follow-up|7|||
27542887|NCT04930965|80178788|FG001|Overall Study|Lost to Follow-up|5|||
27542888|NCT01708161|80178789|FG000|Overall Study|Adverse Event|1|||
27542889|NCT01708161|80178790|FG001|Overall Study|Adverse Event|3|||
27542890|NCT01708161|80178791|FG002|Overall Study|Adverse Event|4|||
27542891|NCT01708161|80178792|FG003|Overall Study|Adverse Event|2|||
27542892|NCT01708161|80178793|FG004|Overall Study|Adverse Event|3|||
27542893|NCT01708161|80178794|FG005|Overall Study|Adverse Event|0|||
27542894|NCT01708161|80178789|FG000|Overall Study|Death|0|||
27542895|NCT01708161|80178790|FG001|Overall Study|Death|0|||
27542896|NCT01708161|80178791|FG002|Overall Study|Death|0|||
27542897|NCT01708161|80178792|FG003|Overall Study|Death|1|||
27542898|NCT01708161|80178793|FG004|Overall Study|Death|0|||
27542899|NCT01708161|80178794|FG005|Overall Study|Death|1|||
27542900|NCT01708161|80178789|FG000|Overall Study|Withdrawal by Subject|0|||
27542901|NCT01708161|80178790|FG001|Overall Study|Withdrawal by Subject|1|||
27542902|NCT01708161|80178791|FG002|Overall Study|Withdrawal by Subject|1|||
27542903|NCT01708161|80178792|FG003|Overall Study|Withdrawal by Subject|0|||
27542904|NCT01708161|80178793|FG004|Overall Study|Withdrawal by Subject|0|||
27542905|NCT01708161|80178794|FG005|Overall Study|Withdrawal by Subject|0|||
27921864|NCT01326871|81550858|FG002|Overall Study|SAE|1|||
27921865|NCT01326871|81550856|FG000|Overall Study|Disease progression and death|0|||
27921866|NCT01326871|81550857|FG001|Overall Study|Disease progression and death|0|||
27921867|NCT01326871|81550858|FG002|Overall Study|Disease progression and death|1|||
27921868|NCT01326871|81550856|FG000|Overall Study|Subject decision|0|||
27921869|NCT01326871|81550857|FG001|Overall Study|Subject decision|0|||
27921870|NCT01326871|81550858|FG002|Overall Study|Subject decision|1|||
27921871|NCT01663623|81550859|FG000|Overall Study|Adverse Event|3|||
27921872|NCT01663623|81550860|FG001|Overall Study|Adverse Event|7|||
27921873|NCT01663623|81550859|FG000|Overall Study|Lack of Efficacy|5|||
27921874|NCT01663623|81550860|FG001|Overall Study|Lack of Efficacy|6|||
27921875|NCT01663623|81550859|FG000|Overall Study|Protocol Violation|0|||
27921876|NCT01663623|81550860|FG001|Overall Study|Protocol Violation|1|||
27921877|NCT01663623|81550859|FG000|Overall Study|Other-Study closed/terminated|1|||
27921878|NCT01663623|81550860|FG001|Overall Study|Other-Study closed/terminated|1|||
27921879|NCT01663623|81550859|FG000|Overall Study|Physician Decision|1|||
27921880|NCT01663623|81550860|FG001|Overall Study|Physician Decision|4|||
27921881|NCT01663623|81550859|FG000|Overall Study|Withdrawal by Subject|2|||
27921882|NCT01663623|81550860|FG001|Overall Study|Withdrawal by Subject|1|||
27921883|NCT02382939|81550861|FG000|Overall Study|Adverse Event|1|||
27921884|NCT02382939|81550862|FG001|Overall Study|Adverse Event|1|||
27921885|NCT02382939|81550861|FG000|Overall Study|Withdrawal by Subject|2|||
27921886|NCT02382939|81550862|FG001|Overall Study|Withdrawal by Subject|2|||
27921887|NCT03587636|81553748|FG000|Overall Study|Lost to Follow-up|2|||
27921888|NCT03587636|81553749|FG001|Overall Study|Lost to Follow-up|5|||
27921889|NCT04219189|81553750|FG000|Overall Study|Withdrawal by Subject|1|||
27921890|NCT04219189|81553751|FG001|Overall Study|Withdrawal by Subject|2|||
27921891|NCT04219189|81553750|FG000|Overall Study|Protocol Violation|0|||
27921892|NCT04219189|81553751|FG001|Overall Study|Protocol Violation|1|||
27542906|NCT01708161|80178789|FG000|Overall Study|Administrative problems|0|||
27921893|NCT04219189|81553750|FG000|Overall Study|Lost to Follow-up|0|||
27921894|NCT04219189|81553751|FG001|Overall Study|Lost to Follow-up|1|||
27921895|NCT04219189|81553750|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
27921896|NCT04219189|81553751|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
27921897|NCT01652690|81553752|FG000|Overall Study|Withdrawal by Subject|16|||
27921898|NCT01652690|81553753|FG001|Overall Study|Withdrawal by Subject|4|||
27921899|NCT01652690|81553752|FG000|Overall Study|Other|8|||
27921900|NCT01652690|81553753|FG001|Overall Study|Other|9|||
27921901|NCT01652690|81553752|FG000|Overall Study|Lost to Follow-up|6|||
27921902|NCT01652690|81553753|FG001|Overall Study|Lost to Follow-up|6|||
27542907|NCT01708161|80178790|FG001|Overall Study|Administrative problems|1|||
27542908|NCT01708161|80178791|FG002|Overall Study|Administrative problems|0|||
27542909|NCT01708161|80178792|FG003|Overall Study|Administrative problems|0|||
27542910|NCT01708161|80178793|FG004|Overall Study|Administrative problems|0|||
27542911|NCT01708161|80178794|FG005|Overall Study|Administrative problems|0|||
27542912|NCT01708161|80178789|FG000|Overall Study|Disease progression|3|||
27542913|NCT01708161|80178790|FG001|Overall Study|Disease progression|5|||
27921903|NCT01652690|81553752|FG000|Overall Study|Death|5|||
27921904|NCT01652690|81553753|FG001|Overall Study|Death|2|||
27921905|NCT01094288|81553754|FG000|Overall Study|Adverse Event|0|||
27921906|NCT01094288|81553755|FG001|Overall Study|Adverse Event|3|||
27921907|NCT01094288|81553756|FG002|Overall Study|Adverse Event|1|||
27921908|NCT01094288|81553757|FG003|Overall Study|Adverse Event|1|||
27921909|NCT01094288|81553758|FG004|Overall Study|Adverse Event|0|||
27921910|NCT01094288|81553759|FG005|Overall Study|Adverse Event|0|||
27921911|NCT01094288|81553760|FG006|Overall Study|Adverse Event|0|||
27921912|NCT01094288|81553761|FG007|Overall Study|Adverse Event|0|||
27921913|NCT01094288|81553754|FG000|Overall Study|Withdrawal by Subject|0|||
27921914|NCT01094288|81553755|FG001|Overall Study|Withdrawal by Subject|1|||
27921915|NCT01094288|81553756|FG002|Overall Study|Withdrawal by Subject|2|||
27921916|NCT01094288|81553757|FG003|Overall Study|Withdrawal by Subject|0|||
27921917|NCT01094288|81553758|FG004|Overall Study|Withdrawal by Subject|0|||
27921918|NCT01094288|81553759|FG005|Overall Study|Withdrawal by Subject|0|||
27921919|NCT01094288|81553760|FG006|Overall Study|Withdrawal by Subject|0|||
27921920|NCT01094288|81553761|FG007|Overall Study|Withdrawal by Subject|2|||
27921921|NCT01094288|81553754|FG000|Overall Study|Initiation of Alternative Therapy|0|||
27637349|NCT01227278|80515797|FG000|Overall Study|Death|0|||
27637350|NCT01227278|80515798|FG001|Overall Study|Death|2|||
27637351|NCT01227278|80515797|FG000|Overall Study|Other|1|||
27637352|NCT01227278|80515798|FG001|Overall Study|Other|2|||
27637353|NCT03703336|80515799|FG000|Overall Study|Parent withdrew consent|29|||
27637354|NCT03703336|80515800|FG001|Overall Study|Parent withdrew consent|8|||
27637355|NCT03703336|80515799|FG000|Overall Study|Migration|3|||
27921922|NCT01094288|81553755|FG001|Overall Study|Initiation of Alternative Therapy|0|||
27921923|NCT01094288|81553756|FG002|Overall Study|Initiation of Alternative Therapy|1|||
27542914|NCT01708161|80178791|FG002|Overall Study|Disease progression|5|||
27542915|NCT01708161|80178792|FG003|Overall Study|Disease progression|13|||
27921924|NCT01094288|81553757|FG003|Overall Study|Initiation of Alternative Therapy|0|||
27921925|NCT01094288|81553758|FG004|Overall Study|Initiation of Alternative Therapy|0|||
27921926|NCT01094288|81553759|FG005|Overall Study|Initiation of Alternative Therapy|0|||
27921927|NCT01094288|81553760|FG006|Overall Study|Initiation of Alternative Therapy|0|||
27921928|NCT01094288|81553761|FG007|Overall Study|Initiation of Alternative Therapy|0|||
27921929|NCT01094288|81553754|FG000|Overall Study|Reason not Specified|2|||
27921930|NCT01094288|81553755|FG001|Overall Study|Reason not Specified|3|||
27921931|NCT01094288|81553756|FG002|Overall Study|Reason not Specified|0|||
27921932|NCT01094288|81553757|FG003|Overall Study|Reason not Specified|1|||
27921933|NCT01094288|81553758|FG004|Overall Study|Reason not Specified|0|||
27921934|NCT01094288|81553759|FG005|Overall Study|Reason not Specified|0|||
27921935|NCT01094288|81553760|FG006|Overall Study|Reason not Specified|0|||
27921936|NCT01094288|81553761|FG007|Overall Study|Reason not Specified|0|||
27921937|NCT01094288|81553754|FG000|Overall Study|Ongoing Participants|0|||
27921938|NCT01094288|81553755|FG001|Overall Study|Ongoing Participants|3|||
27921939|NCT01094288|81553756|FG002|Overall Study|Ongoing Participants|0|||
27921940|NCT01094288|81553757|FG003|Overall Study|Ongoing Participants|0|||
27921941|NCT01094288|81553758|FG004|Overall Study|Ongoing Participants|0|||
27921942|NCT01094288|81553759|FG005|Overall Study|Ongoing Participants|0|||
27921943|NCT01094288|81553760|FG006|Overall Study|Ongoing Participants|0|||
27921944|NCT01094288|81553761|FG007|Overall Study|Ongoing Participants|0|||
27921945|NCT05412134|81553765|FG000|Overall Study|Lost to Follow-up|2|||
27921946|NCT05412134|81553766|FG001|Overall Study|Lost to Follow-up|0|||
27921947|NCT00106002|81553767|FG000|Overall Study|Did not take any study drug|1|||
27921948|NCT00106002|81553767|FG000|Overall Study|Ineligible after Registration|1|||
27921949|NCT01685437|81553769|FG000|Overall Study|Withdrawal by Subject|22|||
27921950|NCT01685437|81553769|FG000|Overall Study|Lost to Follow-up|3|||
27921951|NCT01685437|81553769|FG000|Overall Study|Adverse Event|1|||
27921952|NCT01685437|81553769|FG000|Overall Study|Protocol Violation|4|||
27921953|NCT01685437|81553769|FG000|Overall Study|Unable to make visits due to work|1|||
27921954|NCT00314145|81553770|FG000|Overall Study|Withdrawal by Subject|8|||
27921955|NCT00314145|81553771|FG001|Overall Study|Withdrawal by Subject|10|||
27921956|NCT00314145|81553770|FG000|Overall Study|Lost to Follow-up|5|||
27921957|NCT00314145|81553771|FG001|Overall Study|Lost to Follow-up|12|||
27921958|NCT00314145|81553770|FG000|Overall Study|Physician Decision|3|||
27542916|NCT01708161|80178793|FG004|Overall Study|Disease progression|3|||
27542917|NCT01708161|80178794|FG005|Overall Study|Disease progression|0|||
27542918|NCT00415168|80178795|FG000|Overall Study|Death|26|||
27542919|NCT00415168|80178795|FG000|Overall Study|Lost to Follow-up|3|||
27637356|NCT03703336|80515800|FG001|Overall Study|Migration|3|||
27637357|NCT03703336|80515799|FG000|Overall Study|Protocol Violation|3|||
27637358|NCT03703336|80515800|FG001|Overall Study|Protocol Violation|1|||
27921959|NCT00314145|81553771|FG001|Overall Study|Physician Decision|4|||
27921960|NCT00314145|81553770|FG000|Overall Study|Adverse Event|0|||
27921961|NCT00314145|81553771|FG001|Overall Study|Adverse Event|3|||
27921962|NCT00314145|81553770|FG000|Overall Study|Protocol Violation|3|||
27542920|NCT00415168|80178795|FG000|Overall Study|Physician Decision|13|||
27542921|NCT00415168|80178795|FG000|Overall Study|Sponsor Decision|4|||
27921963|NCT00314145|81553771|FG001|Overall Study|Protocol Violation|0|||
27921964|NCT00314145|81553770|FG000|Overall Study|Sponsor Decision|2|||
27921965|NCT00314145|81553771|FG001|Overall Study|Sponsor Decision|0|||
27921966|NCT01277861|81553772|FG000|Overall Study|Physician Decision|2|||
27921967|NCT01277861|81553773|FG001|Overall Study|Physician Decision|2|||
27921968|NCT02164916|81553774|FG000|Overall Study|Adverse Event|3|||
27921969|NCT02164916|81553775|FG001|Overall Study|Adverse Event|8|||
27921970|NCT02164916|81553774|FG000|Overall Study|Death|1|||
27921971|NCT02164916|81553775|FG001|Overall Study|Death|1|||
27921972|NCT02164916|81553774|FG000|Overall Study|Refusal unrelated to adverse event|3|||
27921973|NCT02164916|81553775|FG001|Overall Study|Refusal unrelated to adverse event|7|||
27921974|NCT02164916|81553774|FG000|Overall Study|Progression|37|||
27921975|NCT02164916|81553775|FG001|Overall Study|Progression|26|||
27921976|NCT02164916|81553774|FG000|Overall Study|Not protocol specified|5|||
27921977|NCT02164916|81553775|FG001|Overall Study|Not protocol specified|1|||
27921978|NCT02164916|81553774|FG000|Overall Study|Reason under review|1|||
27921979|NCT02164916|81553775|FG001|Overall Study|Reason under review|6|||
27921980|NCT02164916|81553774|FG000|Overall Study|Not eligible|2|||
27921981|NCT02164916|81553775|FG001|Overall Study|Not eligible|5|||
27921982|NCT03980223|81553778|FG000|Overall Study|Lost to Follow-up|3|||
27921983|NCT03980223|81553779|FG001|Overall Study|Lost to Follow-up|7|||
27921984|NCT03980223|81553780|FG002|Overall Study|Lost to Follow-up|10|||
27921985|NCT03980223|81553781|FG003|Overall Study|Lost to Follow-up|8|||
27921986|NCT03980223|81553778|FG000|Overall Study|Withdrawal by Subject|0|||
27921987|NCT03980223|81553779|FG001|Overall Study|Withdrawal by Subject|0|||
27921988|NCT03980223|81553780|FG002|Overall Study|Withdrawal by Subject|1|||
27921989|NCT03980223|81553781|FG003|Overall Study|Withdrawal by Subject|2|||
27921990|NCT03980223|81553778|FG000|Overall Study|Physician Decision|0|||
27921991|NCT03980223|81553779|FG001|Overall Study|Physician Decision|0|||
27921992|NCT03980223|81553780|FG002|Overall Study|Physician Decision|1|||
27921993|NCT03980223|81553781|FG003|Overall Study|Physician Decision|0|||
27921994|NCT03980223|81553778|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
27921995|NCT03980223|81553779|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
27921996|NCT03980223|81553780|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
27921997|NCT03980223|81553781|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
27921998|NCT00529035|81553782|FG000|Overall Study|Withdrawal by Subject|1|||
27921999|NCT01145482|81553783|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
27922000|NCT01145482|81553784|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
27922001|NCT03504917|81553787|FG000|Blinded Treatment Period|Protocol Violation|1|||
27922002|NCT03504917|81553788|FG001|Blinded Treatment Period|Protocol Violation|0|||
27922003|NCT03504917|81553787|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
27922004|NCT03504917|81553788|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
27922005|NCT03504917|81553787|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
27922006|NCT03504917|81553788|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
27922007|NCT03504917|81553787|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
27922008|NCT03504917|81553788|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
27922009|NCT03504917|81553787|FG000|Blinded Treatment Period|Adverse Event|4|||
27922010|NCT03504917|81553788|FG001|Blinded Treatment Period|Adverse Event|4|||
27922011|NCT03504917|81553787|FG000|Blinded Treatment Period|Physician Decision|1|||
27922012|NCT03504917|81553788|FG001|Blinded Treatment Period|Physician Decision|0|||
27922013|NCT03504917|81553787|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
27922014|NCT03504917|81553788|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
27922015|NCT03504917|81553787|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
27922016|NCT03504917|81553788|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
27922017|NCT03504917|81553787|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
27922018|NCT03504917|81553788|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
27922019|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
27922020|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
27922021|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
27922022|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
27922023|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
27922024|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
27922025|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
27922026|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
27922027|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
27922028|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
27922029|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
27922030|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
27922031|NCT03504917|81553787|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
27542922|NCT00415168|80178795|FG000|Overall Study|Withdrawal by Subject|6|||
27542923|NCT01218243|80178797|FG000|Overall Study|Lack of Efficacy|1|||
27542924|NCT01218243|80178798|FG001|Overall Study|Lack of Efficacy|1|||
27542925|NCT01218243|80178797|FG000|Overall Study|Lost to Follow-up|3|||
27542926|NCT01218243|80178798|FG001|Overall Study|Lost to Follow-up|3|||
27542927|NCT01218243|80178797|FG000|Overall Study|Protocol Violation|5|||
27542928|NCT01218243|80178798|FG001|Overall Study|Protocol Violation|10|||
27542929|NCT02130297|80178802|FG000|Overall Study|Lost to Follow-up|4|||
27542930|NCT00115739|80178804|FG000|Overall Study|Lost to Follow-up|3|||
27542931|NCT04401423|80178805|FG000|Overall Study|Withdrawal by Subject|3|||
27542932|NCT04401423|80178806|FG001|Overall Study|Withdrawal by Subject|1|||
27542933|NCT04401423|80178805|FG000|Overall Study|Physician Decision|2|||
27542934|NCT04401423|80178806|FG001|Overall Study|Physician Decision|1|||
27542935|NCT01930123|80178809|FG000|Overall Study|Adverse Event|1|||
27542936|NCT01930123|80178810|FG001|Overall Study|Adverse Event|0|||
27542937|NCT01930123|80178809|FG000|Overall Study|Physician Decision|21|||
27542938|NCT01930123|80178810|FG001|Overall Study|Physician Decision|8|||
27637359|NCT03703336|80515799|FG000|Overall Study|Physician Decision|2|||
27637360|NCT03703336|80515800|FG001|Overall Study|Physician Decision|0|||
27637361|NCT03703336|80515799|FG000|Overall Study|Adverse Event|0|||
27542939|NCT01930123|80178809|FG000|Overall Study|Withdrawal by Subject|1|||
27542940|NCT01930123|80178810|FG001|Overall Study|Withdrawal by Subject|0|||
27637362|NCT03703336|80515800|FG001|Overall Study|Adverse Event|2|||
27637363|NCT03703336|80515799|FG000|Overall Study|Lost to Follow-up|1|||
27637364|NCT03703336|80515800|FG001|Overall Study|Lost to Follow-up|0|||
27637365|NCT00391846|80515803|FG000|Overall Study|Adverse Event|4|||
27637366|NCT00391846|80515804|FG001|Overall Study|Adverse Event|1|||
27637367|NCT00391846|80515803|FG000|Overall Study|Did not meet the required elig. crit|2|||
27637368|NCT00391846|80515804|FG001|Overall Study|Did not meet the required elig. crit|2|||
27637369|NCT00391846|80515803|FG000|Overall Study|Withdrawal by Subject|2|||
27637370|NCT00391846|80515804|FG001|Overall Study|Withdrawal by Subject|3|||
27637371|NCT00391846|80515803|FG000|Overall Study|Developed study specific DC criteria|0|||
27637372|NCT00391846|80515804|FG001|Overall Study|Developed study specific DC criteria|1|||
27637373|NCT01759771|80515805|FG000|Overall Study|Withdrawal by Subject|1|||
27637374|NCT01759771|80515806|FG001|Overall Study|Withdrawal by Subject|1|||
27637375|NCT01102231|80515807|FG000|Overall Study|Protocol Violation|3|||
27637376|NCT01102231|80515807|FG000|Overall Study|Lack of Efficacy|2|||
27637377|NCT01102231|80515807|FG000|Overall Study|Death|2|||
27637378|NCT01102231|80515807|FG000|Overall Study|Adverse Event|3|||
27637379|NCT01102231|80515807|FG000|Overall Study|Withdrawal by Subject|1|||
27637380|NCT01102231|80515807|FG000|Overall Study|Did not received the treatment|4|||
27922032|NCT03504917|81553788|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
27922033|NCT00761319|81553799|FG000|Overall Study|Protocol Violation|21|||
27922034|NCT00761319|81553800|FG001|Overall Study|Protocol Violation|14|||
27922035|NCT00761319|81553799|FG000|Overall Study|Adverse Event|11|||
27922036|NCT00761319|81553800|FG001|Overall Study|Adverse Event|7|||
27922037|NCT00761319|81553799|FG000|Overall Study|Withdrawal by Subject|8|||
27922038|NCT00761319|81553800|FG001|Overall Study|Withdrawal by Subject|7|||
27542941|NCT00986830|80178811|FG000|Overall Study|Death|1|||
27542942|NCT00986830|80178811|FG000|Overall Study|Lost to Follow-up|1|||
27542943|NCT00986830|80178811|FG000|Overall Study|Lack of Efficacy|1|||
27542944|NCT00986830|80178811|FG000|Overall Study|Unable to access sinus with device|5|||
27542945|NCT01896050|80178812|FG000|Overall Study|Adverse Event|37|||
27542946|NCT01896050|80178813|FG001|Overall Study|Adverse Event|2|||
27542947|NCT01896050|80178812|FG000|Overall Study|Death|1|||
27542948|NCT01896050|80178813|FG001|Overall Study|Death|0|||
27542949|NCT00762385|80178816|FG000|First Intervention|Lens Issue|1|||
27542950|NCT00762385|80178817|FG001|First Intervention|Lens Issue|1|||
27542951|NCT00762385|80178816|FG000|First Intervention|Lost to Follow-up|0|||
27637381|NCT01070069|80515808|FG000|Overall Study|Death|1|||
27637382|NCT01070069|80515809|FG001|Overall Study|Death|0|||
27637383|NCT01070069|80515810|FG002|Overall Study|Death|2|||
27637384|NCT01070069|80515811|FG003|Overall Study|Death|0|||
27542952|NCT00762385|80178817|FG001|First Intervention|Lost to Follow-up|2|||
27542953|NCT00762385|80178816|FG000|First Intervention|Ineligible|1|||
27637385|NCT01070069|80515812|FG004|Overall Study|Death|1|||
27637386|NCT01070069|80515808|FG000|Overall Study|Withdrawal by Subject|1|||
27637387|NCT01070069|80515809|FG001|Overall Study|Withdrawal by Subject|1|||
27637388|NCT01070069|80515810|FG002|Overall Study|Withdrawal by Subject|4|||
27637389|NCT01070069|80515811|FG003|Overall Study|Withdrawal by Subject|0|||
27922039|NCT00761319|81553799|FG000|Overall Study|Noncompliance|4|||
27542954|NCT00762385|80178817|FG001|First Intervention|Ineligible|0|||
27542955|NCT00762385|80178816|FG000|First Intervention|Protocol Violation|0|||
27542956|NCT00762385|80178817|FG001|First Intervention|Protocol Violation|1|||
27542957|NCT00762385|80178816|FG000|Second Intervention|Protocol Violation|3|||
27542958|NCT00762385|80178817|FG001|Second Intervention|Protocol Violation|3|||
27542959|NCT00040365|80178823|FG000|Overall Study|Death|1|||
27542960|NCT00040365|80178823|FG000|Overall Study|Progressive disease|7|||
27542961|NCT00040365|80178823|FG000|Overall Study|Lost to Follow-up|3|||
27637390|NCT01070069|80515812|FG004|Overall Study|Withdrawal by Subject|0|||
27637391|NCT01070069|80515808|FG000|Overall Study|Lost to Follow-up|4|||
27637392|NCT01070069|80515809|FG001|Overall Study|Lost to Follow-up|1|||
27637393|NCT01070069|80515810|FG002|Overall Study|Lost to Follow-up|0|||
27637394|NCT01070069|80515811|FG003|Overall Study|Lost to Follow-up|0|||
27637395|NCT01070069|80515812|FG004|Overall Study|Lost to Follow-up|3|||
27637396|NCT00106080|80515813|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
27637397|NCT00106080|80515814|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
27637398|NCT01616459|80515821|FG000|Overall Study|Adverse Event|1|||
27637399|NCT01616459|80515822|FG001|Overall Study|Adverse Event|1|||
27637400|NCT01616459|80515823|FG002|Overall Study|Adverse Event|2|||
27637401|NCT01616459|80515824|FG003|Overall Study|Adverse Event|0|||
27637402|NCT01616459|80515821|FG000|Overall Study|Lost to Follow-up|1|||
27637403|NCT01616459|80515822|FG001|Overall Study|Lost to Follow-up|11|||
27637404|NCT01616459|80515823|FG002|Overall Study|Lost to Follow-up|3|||
27637405|NCT01616459|80515824|FG003|Overall Study|Lost to Follow-up|2|||
27637406|NCT01616459|80515821|FG000|Overall Study|Protocol Violation|0|||
27637407|NCT01616459|80515822|FG001|Overall Study|Protocol Violation|0|||
27637408|NCT01616459|80515823|FG002|Overall Study|Protocol Violation|0|||
27637409|NCT01616459|80515824|FG003|Overall Study|Protocol Violation|2|||
27637410|NCT01616459|80515821|FG000|Overall Study|Withdrawal by Subject|2|||
27637411|NCT01616459|80515822|FG001|Overall Study|Withdrawal by Subject|4|||
27637412|NCT01616459|80515823|FG002|Overall Study|Withdrawal by Subject|4|||
27637413|NCT01616459|80515824|FG003|Overall Study|Withdrawal by Subject|4|||
27637414|NCT01616459|80515821|FG000|Overall Study|Other reason|0|||
27637415|NCT01616459|80515822|FG001|Overall Study|Other reason|1|||
27637416|NCT01616459|80515823|FG002|Overall Study|Other reason|1|||
27637417|NCT01616459|80515824|FG003|Overall Study|Other reason|0|||
27637418|NCT00480077|80515826|FG000|Overall Study|Death|19|||
27637419|NCT00480077|80515827|FG001|Overall Study|Death|15|||
27637420|NCT00480077|80515826|FG000|Overall Study|early exit|12|||
27637421|NCT00480077|80515827|FG001|Overall Study|early exit|11|||
27637422|NCT01610297|80515828|FG000|Overall Study|Lost to Follow-up|1|||
27637423|NCT02759016|80515830|FG000|Overall Study|Not treated with BI 836826|1|||
27637424|NCT02759016|80515831|FG001|Overall Study|Not treated with BI 836826|0|||
27637425|NCT02759016|80515830|FG000|Overall Study|Progressive disease|1|||
27637426|NCT02759016|80515831|FG001|Overall Study|Progressive disease|0|||
27637427|NCT02759016|80515830|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
27637428|NCT02759016|80515831|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
27637429|NCT02759016|80515830|FG000|Overall Study|Other not defined above|2|||
27637430|NCT02759016|80515831|FG001|Overall Study|Other not defined above|1|||
27637431|NCT02015520|80515832|FG000|Overall Study|Lack of Efficacy|1|||
27637432|NCT02015520|80515833|FG001|Overall Study|Lack of Efficacy|0|||
27637433|NCT02015520|80515834|FG002|Overall Study|Lack of Efficacy|3|||
27637434|NCT02015520|80515835|FG003|Overall Study|Lack of Efficacy|2|||
27542962|NCT01999868|80178824|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
27542963|NCT01999868|80178825|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
27542964|NCT01999868|80178826|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
27542965|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
27542966|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
27542967|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
27542968|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
27542969|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
27542970|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
27542971|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
27542972|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
27542973|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
27542974|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
27542975|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
27542976|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
27542977|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
27542978|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
27542979|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
27637435|NCT02015520|80515832|FG000|Overall Study|Adverse Event|0|||
27637436|NCT02015520|80515833|FG001|Overall Study|Adverse Event|0|||
27637437|NCT02015520|80515834|FG002|Overall Study|Adverse Event|0|||
27637438|NCT02015520|80515835|FG003|Overall Study|Adverse Event|1|||
27637439|NCT02015520|80515832|FG000|Overall Study|Withdrawal by Subject|2|||
27637440|NCT02015520|80515833|FG001|Overall Study|Withdrawal by Subject|2|||
27637441|NCT02015520|80515834|FG002|Overall Study|Withdrawal by Subject|1|||
27922040|NCT00761319|81553800|FG001|Overall Study|Noncompliance|3|||
27637442|NCT02015520|80515835|FG003|Overall Study|Withdrawal by Subject|0|||
27637443|NCT02015520|80515832|FG000|Overall Study|Death|1|||
27637444|NCT02015520|80515833|FG001|Overall Study|Death|0|||
27637445|NCT02015520|80515834|FG002|Overall Study|Death|0|||
27637446|NCT02015520|80515835|FG003|Overall Study|Death|0|||
27637447|NCT02015520|80515832|FG000|Overall Study|Lost to Follow-up|0|||
27637448|NCT02015520|80515833|FG001|Overall Study|Lost to Follow-up|0|||
27637449|NCT02015520|80515834|FG002|Overall Study|Lost to Follow-up|1|||
27637450|NCT02015520|80515835|FG003|Overall Study|Lost to Follow-up|0|||
27637451|NCT02015520|80515832|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
27637452|NCT02015520|80515833|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
27637453|NCT02015520|80515834|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
27637454|NCT02015520|80515835|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
27637455|NCT02015520|80515832|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
27637456|NCT02015520|80515833|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
27637457|NCT02015520|80515834|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
27637458|NCT02015520|80515835|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
27637459|NCT04056611|80515836|FG000|Overall Study|Physician Decision|1|||
27637460|NCT01599104|80515837|FG000|Overall Study|Withdrawal by Subject|1|||
27637461|NCT01599104|80515838|FG001|Overall Study|Withdrawal by Subject|1|||
27637462|NCT01599104|80515839|FG002|Overall Study|Withdrawal by Subject|2|||
27637463|NCT01599104|80515837|FG000|Overall Study|Technical Problems|1|||
27637464|NCT01599104|80515838|FG001|Overall Study|Technical Problems|0|||
27637465|NCT01599104|80515839|FG002|Overall Study|Technical Problems|0|||
27637466|NCT01599104|80515837|FG000|Overall Study|Physician Decision|3|||
27637467|NCT01599104|80515838|FG001|Overall Study|Physician Decision|2|||
27637468|NCT01599104|80515839|FG002|Overall Study|Physician Decision|2|||
27637469|NCT01599104|80515837|FG000|Overall Study|Non-compliance with study treatment|0|||
27637470|NCT01599104|80515838|FG001|Overall Study|Non-compliance with study treatment|1|||
27637471|NCT01599104|80515839|FG002|Overall Study|Non-compliance with study treatment|0|||
27637472|NCT01599104|80515837|FG000|Overall Study|Lack of Efficacy|4|||
27637473|NCT01599104|80515838|FG001|Overall Study|Lack of Efficacy|4|||
27637474|NCT01599104|80515839|FG002|Overall Study|Lack of Efficacy|10|||
27637475|NCT01599104|80515837|FG000|Overall Study|Adverse Event|7|||
27637476|NCT01599104|80515838|FG001|Overall Study|Adverse Event|6|||
27637477|NCT01599104|80515839|FG002|Overall Study|Adverse Event|12|||
27637478|NCT00529516|80515840|FG000|Overall Study|Adverse Event|2|||
27637479|NCT00529516|80515841|FG001|Overall Study|Adverse Event|1|||
27637480|NCT00529516|80515842|FG002|Overall Study|Adverse Event|0|||
27637481|NCT00529516|80515840|FG000|Overall Study|Withdrawal by Subject|1|||
27637482|NCT00529516|80515841|FG001|Overall Study|Withdrawal by Subject|1|||
27637483|NCT00529516|80515842|FG002|Overall Study|Withdrawal by Subject|0|||
27637484|NCT00529516|80515840|FG000|Overall Study|Lost to Follow-up|0|||
27637485|NCT00529516|80515841|FG001|Overall Study|Lost to Follow-up|0|||
27637486|NCT00529516|80515842|FG002|Overall Study|Lost to Follow-up|1|||
27637487|NCT02200770|80515843|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
27637488|NCT02200770|80515844|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
27637489|NCT02200770|80515843|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
27637490|NCT02200770|80515844|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
27637491|NCT02200770|80515843|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
27637492|NCT02200770|80515844|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
27637493|NCT02200770|80515843|FG000|Randomized-controlled Period (RCP)|Other|1|||
27637494|NCT02200770|80515844|FG001|Randomized-controlled Period (RCP)|Other|2|||
27637495|NCT02200770|80515843|FG000|Open-label Period (OLP)|Adverse Event|1|||
27637496|NCT02200770|80515844|FG001|Open-label Period (OLP)|Adverse Event|2|||
27637497|NCT02200770|80515843|FG000|Open-label Period (OLP)|Death|1|||
27637498|NCT02200770|80515844|FG001|Open-label Period (OLP)|Death|2|||
27637499|NCT02200770|80515843|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
27637500|NCT02200770|80515844|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
27637501|NCT02200770|80515843|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
27637502|NCT02200770|80515844|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
27637503|NCT02200770|80515843|FG000|Open-label Period (OLP)|Other|6|||
27637504|NCT02200770|80515844|FG001|Open-label Period (OLP)|Other|15|||
27637505|NCT03452189|80515846|FG000|First Intervention (3 Months)|Adverse Event|1|||
27637506|NCT03452189|80515847|FG001|First Intervention (3 Months)|Adverse Event|0|||
27637507|NCT03452189|80515846|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
27637508|NCT03452189|80515847|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
27637509|NCT01369498|80515848|FG000|Overall Study|Lack of Efficacy|9|||
27637510|NCT01369498|80515849|FG001|Overall Study|Lack of Efficacy|9|||
27922041|NCT00761319|81553799|FG000|Overall Study|Lost to Follow-up|1|||
27922042|NCT00761319|81553800|FG001|Overall Study|Lost to Follow-up|1|||
27637511|NCT01369498|80515850|FG002|Overall Study|Lack of Efficacy|1|||
27637512|NCT01369498|80515851|FG003|Overall Study|Lack of Efficacy|3|||
27637513|NCT01369498|80515848|FG000|Overall Study|Adverse Event|1|||
27637514|NCT01369498|80515849|FG001|Overall Study|Adverse Event|2|||
27922043|NCT00761319|81553799|FG000|Overall Study|Nonspecified|2|||
27637515|NCT01369498|80515850|FG002|Overall Study|Adverse Event|0|||
27637516|NCT01369498|80515851|FG003|Overall Study|Adverse Event|1|||
27922044|NCT00761319|81553800|FG001|Overall Study|Nonspecified|2|||
27637517|NCT01369498|80515848|FG000|Overall Study|Withdrawal of Consent|0|||
27637518|NCT01369498|80515849|FG001|Overall Study|Withdrawal of Consent|1|||
27637519|NCT01369498|80515850|FG002|Overall Study|Withdrawal of Consent|1|||
27922045|NCT00761319|81553799|FG000|Overall Study|Missing|1|||
27922046|NCT00761319|81553800|FG001|Overall Study|Missing|0|||
27922047|NCT03183908|81553801|FG000|Overall Study|Missing Symptom Diary Data|0|||
27922048|NCT03183908|81553802|FG001|Overall Study|Missing Symptom Diary Data|2|||
27542980|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
27542981|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
27542982|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
27542983|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
27542984|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
27542985|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
27542986|NCT01999868|80178824|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
27542987|NCT01999868|80178825|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
27542988|NCT01999868|80178826|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
27542989|NCT01999868|80178824|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
27542990|NCT01999868|80178825|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
27542991|NCT01999868|80178826|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
27542992|NCT01999868|80178824|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
27542993|NCT01999868|80178825|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
27542994|NCT01999868|80178826|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
27542995|NCT01999868|80178824|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
27542996|NCT01999868|80178825|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
27542997|NCT01999868|80178826|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
27542998|NCT01999868|80178824|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
27542999|NCT01999868|80178825|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
27543000|NCT01999868|80178826|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
27543001|NCT01999868|80178824|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
27543002|NCT01999868|80178825|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
27543003|NCT01999868|80178826|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
27543004|NCT01999868|80178824|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
27543005|NCT01999868|80178825|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
27543006|NCT01999868|80178826|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
27543007|NCT03386448|80178829|FG000|Overall Study|Adverse Event|0|||
27543008|NCT03386448|80178830|FG001|Overall Study|Adverse Event|2|||
27543009|NCT01402011|80178834|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
27543010|NCT01402011|80178835|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
27543011|NCT01402011|80178836|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
27543012|NCT01402011|80178834|FG000|Active Treatment Period|Withdrawal by Subject|1|||
27543013|NCT01402011|80178835|FG001|Active Treatment Period|Withdrawal by Subject|3|||
27543014|NCT01402011|80178836|FG002|Active Treatment Period|Withdrawal by Subject|0|||
27543015|NCT01402011|80178834|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
27543016|NCT01402011|80178835|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
27543017|NCT01402011|80178836|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
27543018|NCT01999114|80178837|FG000|Overall Study|Adverse Event|8|||
27543019|NCT01999114|80178838|FG001|Overall Study|Adverse Event|7|||
27543020|NCT01999114|80178839|FG002|Overall Study|Adverse Event|2|||
27543021|NCT01999114|80178840|FG003|Overall Study|Adverse Event|2|||
27543022|NCT01999114|80178841|FG004|Overall Study|Adverse Event|1|||
27543023|NCT01999114|80178837|FG000|Overall Study|Withdrawal by Subject|0|||
27543024|NCT01999114|80178838|FG001|Overall Study|Withdrawal by Subject|0|||
27543025|NCT01999114|80178839|FG002|Overall Study|Withdrawal by Subject|1|||
27543026|NCT01999114|80178840|FG003|Overall Study|Withdrawal by Subject|0|||
27543027|NCT01999114|80178841|FG004|Overall Study|Withdrawal by Subject|1|||
27543028|NCT01999114|80178837|FG000|Overall Study|Lost to Follow-up|0|||
27543029|NCT01999114|80178838|FG001|Overall Study|Lost to Follow-up|0|||
27543030|NCT01999114|80178839|FG002|Overall Study|Lost to Follow-up|1|||
27543031|NCT01999114|80178840|FG003|Overall Study|Lost to Follow-up|0|||
27543032|NCT01999114|80178841|FG004|Overall Study|Lost to Follow-up|0|||
27543033|NCT01999114|80178837|FG000|Overall Study|Administrative|0|||
27543034|NCT01999114|80178838|FG001|Overall Study|Administrative|0|||
27637520|NCT01369498|80515851|FG003|Overall Study|Withdrawal of Consent|1|||
27637521|NCT01369498|80515848|FG000|Overall Study|Death|0|||
27741009|NCT03241173|80880789|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
27741010|NCT03241173|80880790|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
27922049|NCT03238417|81553803|FG000|Overall|non-response|955|||
27543035|NCT01999114|80178839|FG002|Overall Study|Administrative|1|||
27543036|NCT01999114|80178840|FG003|Overall Study|Administrative|1|||
27637522|NCT01369498|80515849|FG001|Overall Study|Death|0|||
27637523|NCT01369498|80515850|FG002|Overall Study|Death|1|||
27637524|NCT01369498|80515851|FG003|Overall Study|Death|0|||
27637525|NCT01369498|80515848|FG000|Overall Study|Investigator's Discretion|1|||
27637526|NCT01369498|80515849|FG001|Overall Study|Investigator's Discretion|0|||
27637527|NCT01369498|80515850|FG002|Overall Study|Investigator's Discretion|1|||
27637528|NCT01369498|80515851|FG003|Overall Study|Investigator's Discretion|3|||
27637529|NCT01369498|80515848|FG000|Overall Study|Unknown Reason|1|||
27637530|NCT01369498|80515849|FG001|Overall Study|Unknown Reason|0|||
27637531|NCT01369498|80515850|FG002|Overall Study|Unknown Reason|11|||
27637532|NCT01369498|80515851|FG003|Overall Study|Unknown Reason|6|||
27637533|NCT01369498|80515848|FG000|Overall Study|Disease Progression|0|||
27637534|NCT01369498|80515849|FG001|Overall Study|Disease Progression|0|||
27637535|NCT01369498|80515850|FG002|Overall Study|Disease Progression|0|||
27637536|NCT01369498|80515851|FG003|Overall Study|Disease Progression|1|||
27637537|NCT01376089|80515852|FG000|Overall Study|Patient received no contrast media|3|||
27637538|NCT01376089|80515853|FG001|Overall Study|Patient received no contrast media|4|||
27637539|NCT02178098|80515854|FG000|Overall Study|Withdrawal by Subject|0|||
27637540|NCT02178098|80515855|FG001|Overall Study|Withdrawal by Subject|6|||
27637541|NCT02178098|80515854|FG000|Overall Study|Adverse Event|1|||
27637542|NCT02178098|80515855|FG001|Overall Study|Adverse Event|2|||
27637543|NCT02178098|80515854|FG000|Overall Study|Protocol Violation|1|||
27637544|NCT02178098|80515855|FG001|Overall Study|Protocol Violation|1|||
27637545|NCT02178098|80515854|FG000|Overall Study|Lost to Follow-up|0|||
27637546|NCT02178098|80515855|FG001|Overall Study|Lost to Follow-up|1|||
27637547|NCT02178098|80515854|FG000|Overall Study|Sponsor Request|1|||
27637548|NCT02178098|80515855|FG001|Overall Study|Sponsor Request|0|||
27637549|NCT02178098|80515854|FG000|Overall Study|Other|2|||
27637550|NCT02178098|80515855|FG001|Overall Study|Other|2|||
27637551|NCT04723394|80515856|FG000|Overall Study|Adverse Event|0|||
27637552|NCT04723394|80515857|FG001|Overall Study|Adverse Event|3|||
27637553|NCT04723394|80515856|FG000|Overall Study|Death|8|||
27637554|NCT04723394|80515857|FG001|Overall Study|Death|8|||
27637555|NCT04723394|80515856|FG000|Overall Study|Lost to Follow-up|20|||
27637556|NCT04723394|80515857|FG001|Overall Study|Lost to Follow-up|17|||
27637557|NCT04723394|80515856|FG000|Overall Study|Physician Decision|1|||
27637558|NCT04723394|80515857|FG001|Overall Study|Physician Decision|0|||
27637559|NCT04723394|80515856|FG000|Overall Study|Withdrawal by Subject|20|||
27637560|NCT04723394|80515857|FG001|Overall Study|Withdrawal by Subject|34|||
27637561|NCT04723394|80515856|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
27637562|NCT04723394|80515857|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
27637563|NCT00433199|80515858|FG000|Double-Blind Period|Adverse Event|0|||
27637564|NCT00433199|80515859|FG001|Double-Blind Period|Adverse Event|25|||
27637565|NCT00433199|80515858|FG000|Double-Blind Period|Lack of Efficacy|0|||
27637566|NCT00433199|80515859|FG001|Double-Blind Period|Lack of Efficacy|2|||
27637567|NCT00433199|80515858|FG000|Double-Blind Period|Lost to Follow-up|2|||
27637568|NCT00433199|80515859|FG001|Double-Blind Period|Lost to Follow-up|5|||
27637569|NCT00433199|80515858|FG000|Double-Blind Period|Withdrawal by Subject|8|||
27543037|NCT01999114|80178841|FG004|Overall Study|Administrative|2|||
27543038|NCT03334630|80178850|FG000|Overall Study|Withdrawal by Subject|7|||
27543039|NCT03334630|80178851|FG001|Overall Study|Withdrawal by Subject|7|||
27543040|NCT03334630|80178850|FG000|Overall Study|Lost to Follow-up|3|||
27543041|NCT03334630|80178851|FG001|Overall Study|Lost to Follow-up|1|||
27543042|NCT03334630|80178850|FG000|Overall Study|Adverse Event|0|||
27543043|NCT03334630|80178851|FG001|Overall Study|Adverse Event|1|||
27543044|NCT03334630|80178850|FG000|Overall Study|Physician Decision|1|||
27543045|NCT03334630|80178851|FG001|Overall Study|Physician Decision|1|||
27543046|NCT03334630|80178850|FG000|Overall Study|Enrollment closed|2|||
27637570|NCT00433199|80515859|FG001|Double-Blind Period|Withdrawal by Subject|19|||
27637571|NCT00433199|80515858|FG000|Double-Blind Period|Protocol Violation|1|||
27637572|NCT00433199|80515859|FG001|Double-Blind Period|Protocol Violation|10|||
27637573|NCT00433199|80515858|FG000|Double-Blind Period|Administrative|1|||
27637574|NCT00433199|80515859|FG001|Double-Blind Period|Administrative|5|||
27637575|NCT00433199|80515858|FG000|Open-Label Period|Adverse Event|0|||
27922050|NCT03238417|81553804|FG001|Overall|non-response|1920|||
27922051|NCT03238417|81553803|FG000|Overall|partial completion|48|||
27543047|NCT03334630|80178851|FG001|Overall Study|Enrollment closed|1|||
27543048|NCT03334630|80178850|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
27637576|NCT00433199|80515859|FG001|Open-Label Period|Adverse Event|19|||
27637577|NCT00433199|80515858|FG000|Open-Label Period|Lack of Efficacy|0|||
27637578|NCT00433199|80515859|FG001|Open-Label Period|Lack of Efficacy|2|||
27637579|NCT00433199|80515858|FG000|Open-Label Period|Lost to Follow-up|0|||
27637580|NCT00433199|80515859|FG001|Open-Label Period|Lost to Follow-up|3|||
27637581|NCT00433199|80515858|FG000|Open-Label Period|Withdrawal by Subject|0|||
27543049|NCT03334630|80178851|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
27543050|NCT03334630|80178850|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
27543051|NCT03334630|80178851|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
27543052|NCT01578187|80178864|FG000|Usability Phase|Withdrawal by Subject|1|||
27543053|NCT00401531|80178865|FG000|Overall Study|Adverse Event|2|||
27543054|NCT00401531|80178866|FG001|Overall Study|Adverse Event|0|||
27543055|NCT00401531|80178865|FG000|Overall Study|Protocol Violation|3|||
27543056|NCT00401531|80178866|FG001|Overall Study|Protocol Violation|7|||
27543057|NCT00401531|80178865|FG000|Overall Study|Lost to Follow-up|1|||
27543058|NCT00401531|80178866|FG001|Overall Study|Lost to Follow-up|1|||
27543059|NCT00401531|80178865|FG000|Overall Study|Withdrawal by Subject|3|||
27543060|NCT00401531|80178866|FG001|Overall Study|Withdrawal by Subject|2|||
27543061|NCT01786668|80178869|FG000|Overall Study|Adverse Event|0|||
27543062|NCT01786668|80178870|FG001|Overall Study|Adverse Event|1|||
27543063|NCT01786668|80178871|FG002|Overall Study|Adverse Event|1|||
27543064|NCT01786668|80178872|FG003|Overall Study|Adverse Event|2|||
27543065|NCT01786668|80178869|FG000|Overall Study|Withdrawal by Subject|0|||
27543066|NCT01786668|80178870|FG001|Overall Study|Withdrawal by Subject|0|||
27543067|NCT01786668|80178871|FG002|Overall Study|Withdrawal by Subject|3|||
27543068|NCT01786668|80178872|FG003|Overall Study|Withdrawal by Subject|1|||
27543069|NCT01786668|80178869|FG000|Overall Study|Pregnancy|0|||
27543070|NCT01786668|80178870|FG001|Overall Study|Pregnancy|0|||
27543071|NCT01786668|80178871|FG002|Overall Study|Pregnancy|0|||
27543072|NCT01786668|80178872|FG003|Overall Study|Pregnancy|1|||
27543073|NCT01786668|80178869|FG000|Overall Study|Lost to Follow-up|1|||
27543074|NCT01786668|80178870|FG001|Overall Study|Lost to Follow-up|0|||
27543075|NCT01786668|80178871|FG002|Overall Study|Lost to Follow-up|1|||
27543076|NCT01786668|80178872|FG003|Overall Study|Lost to Follow-up|0|||
27543077|NCT01744197|80182059|FG000|Overall Study|Received 1 patch|2|||
27543078|NCT01744197|80182060|FG001|Overall Study|Received 1 patch|1|||
27543079|NCT01744197|80182059|FG000|Overall Study|No patch received|2|||
27543080|NCT01744197|80182060|FG001|Overall Study|No patch received|2|||
27543081|NCT04431453|80182063|FG000|Overall Study|Withdrew Consent|0|||
27543082|NCT04431453|80182064|FG001|Overall Study|Withdrew Consent|1|||
27543083|NCT04431453|80182065|FG002|Overall Study|Withdrew Consent|0|||
27543084|NCT04431453|80182066|FG003|Overall Study|Withdrew Consent|2|||
27543085|NCT04431453|80182067|FG004|Overall Study|Withdrew Consent|0|||
27543086|NCT04431453|80182068|FG005|Overall Study|Withdrew Consent|0|||
27543087|NCT04431453|80182069|FG006|Overall Study|Withdrew Consent|0|||
27543088|NCT04431453|80182070|FG007|Overall Study|Withdrew Consent|0|||
27543089|NCT04431453|80182063|FG000|Overall Study|Death|1|||
27543090|NCT04431453|80182064|FG001|Overall Study|Death|0|||
27543091|NCT04431453|80182065|FG002|Overall Study|Death|0|||
27543092|NCT04431453|80182066|FG003|Overall Study|Death|0|||
27543093|NCT04431453|80182067|FG004|Overall Study|Death|0|||
27543094|NCT04431453|80182068|FG005|Overall Study|Death|0|||
27543095|NCT04431453|80182069|FG006|Overall Study|Death|0|||
27543096|NCT04431453|80182070|FG007|Overall Study|Death|1|||
27543097|NCT04431453|80182063|FG000|Overall Study|Lost to Follow-up|0|||
27543098|NCT04431453|80182064|FG001|Overall Study|Lost to Follow-up|0|||
27543099|NCT04431453|80182065|FG002|Overall Study|Lost to Follow-up|1|||
27543100|NCT04431453|80182066|FG003|Overall Study|Lost to Follow-up|1|||
27543101|NCT04431453|80182067|FG004|Overall Study|Lost to Follow-up|0|||
27543102|NCT04431453|80182068|FG005|Overall Study|Lost to Follow-up|0|||
27543103|NCT04431453|80182069|FG006|Overall Study|Lost to Follow-up|0|||
27543104|NCT04431453|80182070|FG007|Overall Study|Lost to Follow-up|0|||
27543105|NCT04431453|80182063|FG000|Overall Study|Enrolled but Never Treated|0|||
27543106|NCT04431453|80182064|FG001|Overall Study|Enrolled but Never Treated|0|||
27543107|NCT04431453|80182065|FG002|Overall Study|Enrolled but Never Treated|0|||
27543108|NCT04431453|80182066|FG003|Overall Study|Enrolled but Never Treated|0|||
27543109|NCT04431453|80182067|FG004|Overall Study|Enrolled but Never Treated|1|||
27543110|NCT04431453|80182068|FG005|Overall Study|Enrolled but Never Treated|0|||
27543111|NCT04431453|80182069|FG006|Overall Study|Enrolled but Never Treated|0|||
27543112|NCT04431453|80182070|FG007|Overall Study|Enrolled but Never Treated|0|||
27543113|NCT02400333|80182079|FG000|Overall Study|Withdrawal by Subject|0|||
27543114|NCT02400333|80182080|FG001|Overall Study|Withdrawal by Subject|1|||
27543115|NCT02400333|80182081|FG002|Overall Study|Withdrawal by Subject|0|||
27543116|NCT02400333|80182082|FG003|Overall Study|Withdrawal by Subject|1|||
27543117|NCT02400333|80182079|FG000|Overall Study|Protocol Violation|1|||
27543118|NCT02400333|80182080|FG001|Overall Study|Protocol Violation|0|||
27543119|NCT02400333|80182081|FG002|Overall Study|Protocol Violation|2|||
27543120|NCT02400333|80182082|FG003|Overall Study|Protocol Violation|1|||
27543121|NCT01999179|80182083|FG000|Overall Study|Adverse Event|1|||
27543122|NCT01999179|80182083|FG000|Overall Study|Lost to Follow-up|1|||
27543123|NCT01999179|80182083|FG000|Overall Study|Change in Therapy|3|||
27543124|NCT01999179|80182083|FG000|Overall Study|New catheter|2|||
27543125|NCT01513343|80182086|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
27543126|NCT01513343|80182087|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
27543127|NCT01513343|80182086|FG000|Post Data Collection|Dropped/withdrew from study|7|||
27543128|NCT01513343|80182087|FG001|Post Data Collection|Dropped/withdrew from study|1|||
27922052|NCT03238417|81553804|FG001|Overall|partial completion|68|||
27922053|NCT03238417|81553803|FG000|Baseline|Partial completion|17|||
27922054|NCT03238417|81553804|FG001|Baseline|Partial completion|48|||
27922055|NCT03238417|81553803|FG000|Baseline|non-response|372|||
27922056|NCT03238417|81553804|FG001|Baseline|non-response|669|||
27922057|NCT03238417|81553803|FG000|12-month|non-response|296|||
27922058|NCT03238417|81553804|FG001|12-month|non-response|669|||
27922059|NCT03238417|81553803|FG000|12-month|partial completion|23|||
27922060|NCT03238417|81553804|FG001|12-month|partial completion|37|||
27922061|NCT03238417|81553803|FG000|24-month|non-response|287|||
27922062|NCT03238417|81553804|FG001|24-month|non-response|594|||
27922063|NCT03238417|81553803|FG000|24-month|partial completion|8|||
27922064|NCT03238417|81553804|FG001|24-month|partial completion|31|||
27922065|NCT01299909|81553806|FG000|Overall Study|Lost to Follow-up|22|||
27922066|NCT01299909|81553807|FG001|Overall Study|Lost to Follow-up|18|||
27922067|NCT01299909|81553808|FG002|Overall Study|Lost to Follow-up|17|||
27922068|NCT03093181|81553813|FG000|Overall Study|Withdrawal by Subject|2|||
27543129|NCT01513343|80182086|FG000|Post Data Collection|Lost to Follow-up|10|||
27922069|NCT03093181|81553814|FG001|Overall Study|Withdrawal by Subject|1|||
27922070|NCT03093181|81553815|FG002|Overall Study|Withdrawal by Subject|2|||
27922071|NCT03093181|81553813|FG000|Overall Study|Other (Not specified)|1|||
27922072|NCT03093181|81553814|FG001|Overall Study|Other (Not specified)|0|||
27922073|NCT03093181|81553815|FG002|Overall Study|Other (Not specified)|0|||
27922074|NCT03093181|81553813|FG000|Overall Study|Adverse Event|0|||
27922075|NCT03093181|81553814|FG001|Overall Study|Adverse Event|1|||
27922076|NCT03093181|81553815|FG002|Overall Study|Adverse Event|0|||
27922077|NCT03093181|81553813|FG000|Overall Study|Other (Protocol violation)|0|||
27922078|NCT03093181|81553814|FG001|Overall Study|Other (Protocol violation)|0|||
27922079|NCT03093181|81553815|FG002|Overall Study|Other (Protocol violation)|1|||
27922080|NCT01384877|81553818|FG000|Treatment 2|Lost to Follow-up|2|||
27922081|NCT01384877|81553819|FG001|Treatment 2|Lost to Follow-up|2|||
27922082|NCT00741611|81553820|FG000|Overall Study|Death|0|||
27922083|NCT00741611|81553821|FG001|Overall Study|Death|0|||
27922084|NCT00741611|81553822|FG002|Overall Study|Death|1|||
27922085|NCT00741611|81553820|FG000|Overall Study|Withdrawal by Subject|0|||
27922086|NCT00741611|81553821|FG001|Overall Study|Withdrawal by Subject|2|||
27922087|NCT00741611|81553822|FG002|Overall Study|Withdrawal by Subject|2|||
27922088|NCT03055936|81553823|FG000|Overall Study|Adverse Event|0|||
27922089|NCT03055936|81553824|FG001|Overall Study|Adverse Event|1|||
27543130|NCT01513343|80182087|FG001|Post Data Collection|Lost to Follow-up|23|||
27543131|NCT01513343|80182086|FG000|6-month Follow-up|Lost to Follow-up|28|||
27543132|NCT01513343|80182087|FG001|6-month Follow-up|Lost to Follow-up|17|||
27543133|NCT01513343|80182086|FG000|12-month Follow-up|Lost to Follow-up|10|||
27543134|NCT01513343|80182087|FG001|12-month Follow-up|Lost to Follow-up|3|||
27543135|NCT01552694|80182091|FG000|Overall Study|Lost to Follow-up|0|||
27543136|NCT01552694|80182092|FG001|Overall Study|Lost to Follow-up|1|||
27543137|NCT01552694|80182091|FG000|Overall Study|Protocol Violation|0|||
27543138|NCT01552694|80182092|FG001|Overall Study|Protocol Violation|1|||
27543139|NCT00378378|80182095|FG000|Overall Study|Withdrawal by Subject|0|||
27543140|NCT00378378|80182096|FG001|Overall Study|Withdrawal by Subject|1|||
27543141|NCT00378378|80182097|FG002|Overall Study|Withdrawal by Subject|0|||
27543142|NCT00378378|80182095|FG000|Overall Study|Treatment Failure|0|||
27543143|NCT00378378|80182096|FG001|Overall Study|Treatment Failure|0|||
27543144|NCT00378378|80182097|FG002|Overall Study|Treatment Failure|1|||
27543145|NCT00378378|80182095|FG000|Overall Study|Non-compliance with protocol|0|||
27543146|NCT00378378|80182096|FG001|Overall Study|Non-compliance with protocol|0|||
27543147|NCT00378378|80182097|FG002|Overall Study|Non-compliance with protocol|1|||
27543148|NCT01397162|80182098|FG000|Overall Study|Adverse Event|4|||
27543149|NCT01397162|80182099|FG001|Overall Study|Adverse Event|0|||
27543150|NCT01397162|80182100|FG002|Overall Study|Adverse Event|0|||
27543151|NCT01397162|80182101|FG003|Overall Study|Adverse Event|0|||
27543152|NCT01397162|80182102|FG004|Overall Study|Adverse Event|0|||
27922090|NCT03055936|81553825|FG002|Overall Study|Adverse Event|1|||
27922091|NCT03055936|81553826|FG003|Overall Study|Adverse Event|1|||
27543153|NCT01397162|80182098|FG000|Overall Study|Not yet defined|3|||
27922092|NCT03055936|81553823|FG000|Overall Study|Personal reason|2|||
27543154|NCT01397162|80182099|FG001|Overall Study|Not yet defined|4|||
27543155|NCT01397162|80182100|FG002|Overall Study|Not yet defined|3|||
27543156|NCT01397162|80182101|FG003|Overall Study|Not yet defined|5|||
27543157|NCT01397162|80182102|FG004|Overall Study|Not yet defined|3|||
27922093|NCT03055936|81553824|FG001|Overall Study|Personal reason|0|||
27922094|NCT03055936|81553825|FG002|Overall Study|Personal reason|1|||
27922095|NCT03055936|81553826|FG003|Overall Study|Personal reason|0|||
27922096|NCT02471339|81553827|FG000|Overall Study|Did not provide follow-up data|2|||
27922097|NCT02471339|81553828|FG001|Overall Study|Did not provide follow-up data|0|||
27922098|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
27543158|NCT01768286|80182104|FG000|Overall Study|Randomized But Not Treated|0|||
27922099|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
27922100|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
27543159|NCT01768286|80182105|FG001|Overall Study|Randomized But Not Treated|0|||
27543160|NCT01768286|80182106|FG002|Overall Study|Randomized But Not Treated|1|||
27543161|NCT01768286|80182107|FG003|Overall Study|Randomized But Not Treated|0|||
27543162|NCT01768286|80182104|FG000|Overall Study|Lack of Efficacy|7|||
27543163|NCT01768286|80182105|FG001|Overall Study|Lack of Efficacy|4|||
27543164|NCT01768286|80182106|FG002|Overall Study|Lack of Efficacy|0|||
27922101|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
27922102|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
27922103|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
27922104|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
27922105|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
27922106|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
27922107|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
27922108|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
27922109|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
27922110|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
27922111|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
27922112|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
27922113|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
27922114|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
27922115|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
27922116|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
27922117|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
27922118|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
27922119|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
27922120|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
27922121|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
27922122|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
27922123|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
27922124|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
27543165|NCT01768286|80182107|FG003|Overall Study|Lack of Efficacy|1|||
27543166|NCT01768286|80182104|FG000|Overall Study|Withdrew Consent|0|||
27543167|NCT01768286|80182105|FG001|Overall Study|Withdrew Consent|0|||
27543168|NCT01768286|80182106|FG002|Overall Study|Withdrew Consent|1|||
27543169|NCT01768286|80182107|FG003|Overall Study|Withdrew Consent|0|||
27543170|NCT04138810|80182108|FG000|Overall Study|Withdrawal by Subject|0|||
27543171|NCT04138810|80182109|FG001|Overall Study|Withdrawal by Subject|1|||
27543172|NCT04138810|80182108|FG000|Overall Study|Subject cancelled surgery|1|||
27543173|NCT04138810|80182109|FG001|Overall Study|Subject cancelled surgery|0|||
27543174|NCT03345914|80182112|FG000|Overall Study|Transition to another study at week 16|80|||
27543175|NCT03345914|80182113|FG001|Overall Study|Transition to another study at week 16|86|||
27543176|NCT03345914|80182114|FG002|Overall Study|Transition to another study at week 16|78|||
27543177|NCT03345914|80182112|FG000|Overall Study|Transition to OLE during follow-up|37|||
27922125|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
27922126|NCT01668797|81553833|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
27922127|NCT01668797|81553834|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
27543178|NCT03345914|80182113|FG001|Overall Study|Transition to OLE during follow-up|33|||
27543179|NCT03345914|80182114|FG002|Overall Study|Transition to OLE during follow-up|39|||
27543180|NCT03345914|80182112|FG000|Overall Study|Physician Decision|0|||
27543181|NCT03345914|80182113|FG001|Overall Study|Physician Decision|1|||
27543182|NCT03345914|80182114|FG002|Overall Study|Physician Decision|1|||
27543183|NCT03345914|80182112|FG000|Overall Study|Withdrawal by Subject|5|||
27543184|NCT03345914|80182113|FG001|Overall Study|Withdrawal by Subject|1|||
27543185|NCT03345914|80182114|FG002|Overall Study|Withdrawal by Subject|2|||
27543186|NCT03345914|80182112|FG000|Overall Study|Other|1|||
27543187|NCT03345914|80182113|FG001|Overall Study|Other|1|||
27543188|NCT03345914|80182114|FG002|Overall Study|Other|1|||
27543189|NCT03345914|80182112|FG000|Overall Study|Ongoing|0|||
27543190|NCT03345914|80182113|FG001|Overall Study|Ongoing|0|||
27543191|NCT03345914|80182114|FG002|Overall Study|Ongoing|1|||
27543192|NCT02527161|80182115|FG000|Overall Study|Failed MRI|52|||
27543193|NCT02527161|80182115|FG000|Overall Study|Withdrawal by Subject|19|||
27543194|NCT02527161|80182115|FG000|Overall Study|Delay in or unfit for surgery|16|||
27543195|NCT02527161|80182115|FG000|Overall Study|MRI contraindication|6|||
27543196|NCT02527161|80182115|FG000|Overall Study|Consent violation|4|||
27543197|NCT02527161|80182115|FG000|Overall Study|Only Recruited to Part A|27|||
27543198|NCT02527161|80182115|FG000|Overall Study|Physician Decision|1|||
27922128|NCT01668797|81553835|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
27922129|NCT01668797|81553836|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
27543199|NCT02527161|80182115|FG000|Overall Study|Adverse Event|1|||
27543200|NCT02527161|80182115|FG000|Overall Study|Lost to Follow-up|6|||
27543201|NCT00443261|80182116|FG000|Overall Study|Death|1|||
27543202|NCT01091974|80182119|FG000|Overall Study|Did not start intervention|3|||
27543203|NCT01091974|80182120|FG001|Overall Study|Did not start intervention|1|||
27543204|NCT01091974|80182121|FG002|Overall Study|Did not start intervention|3|||
27543205|NCT01091974|80182122|FG003|Overall Study|Did not start intervention|1|||
27543206|NCT01091974|80182119|FG000|Overall Study|resumed sleep medication|0|||
27543207|NCT01091974|80182120|FG001|Overall Study|resumed sleep medication|0|||
27543208|NCT01091974|80182121|FG002|Overall Study|resumed sleep medication|1|||
27543209|NCT01091974|80182122|FG003|Overall Study|resumed sleep medication|2|||
27543210|NCT01091974|80182119|FG000|Overall Study|Withdrawal by Subject|1|||
27543211|NCT01091974|80182120|FG001|Overall Study|Withdrawal by Subject|3|||
27543212|NCT01091974|80182121|FG002|Overall Study|Withdrawal by Subject|2|||
27543213|NCT01091974|80182122|FG003|Overall Study|Withdrawal by Subject|2|||
27543214|NCT01091974|80182119|FG000|Overall Study|side-effects|1|||
27543215|NCT01091974|80182120|FG001|Overall Study|side-effects|1|||
27543216|NCT01091974|80182121|FG002|Overall Study|side-effects|0|||
27543217|NCT01091974|80182122|FG003|Overall Study|side-effects|2|||
27543218|NCT00926328|80182123|FG000|Overall Study|Lost to Follow-up|12|||
27543219|NCT00926328|80182124|FG001|Overall Study|Lost to Follow-up|14|||
27543220|NCT01133522|80182125|FG000|Overall Study|Withdrawal by Subject|0|||
27543221|NCT01133522|80182126|FG001|Overall Study|Withdrawal by Subject|1|||
27543222|NCT01133522|80182127|FG002|Overall Study|Withdrawal by Subject|0|||
27543223|NCT01133522|80182128|FG003|Overall Study|Withdrawal by Subject|1|||
27637582|NCT00433199|80515859|FG001|Open-Label Period|Withdrawal by Subject|7|||
27637583|NCT00433199|80515858|FG000|Open-Label Period|Protocol Violation|0|||
27637584|NCT00433199|80515859|FG001|Open-Label Period|Protocol Violation|2|||
27637585|NCT00433199|80515858|FG000|Open-Label Period|Administrative|0|||
27637586|NCT00433199|80515859|FG001|Open-Label Period|Administrative|1|||
27637587|NCT04425629|80515862|FG000|Overall Study|Adverse Event|0|||
27637588|NCT04425629|80515863|FG001|Overall Study|Adverse Event|0|||
27637589|NCT04425629|80515864|FG002|Overall Study|Adverse Event|0|||
27637590|NCT04425629|80515865|FG003|Overall Study|Adverse Event|0|||
27637591|NCT04425629|80515866|FG004|Overall Study|Adverse Event|1|||
27637592|NCT04425629|80515867|FG005|Overall Study|Adverse Event|0|||
27637593|NCT04425629|80515868|FG006|Overall Study|Adverse Event|0|||
27637594|NCT04425629|80515869|FG007|Overall Study|Adverse Event|0|||
27637595|NCT04425629|80515870|FG008|Overall Study|Adverse Event|0|||
27637596|NCT04425629|80515871|FG009|Overall Study|Adverse Event|3|||
27637597|NCT04425629|80515872|FG010|Overall Study|Adverse Event|2|||
27637598|NCT04425629|80515873|FG011|Overall Study|Adverse Event|1|||
27637599|NCT04425629|80515874|FG012|Overall Study|Adverse Event|1|||
27637600|NCT04425629|80515875|FG013|Overall Study|Adverse Event|0|||
27543224|NCT01133522|80182129|FG004|Overall Study|Withdrawal by Subject|0|||
27637601|NCT04425629|80515876|FG014|Overall Study|Adverse Event|0|||
27637602|NCT04425629|80515877|FG015|Overall Study|Adverse Event|0|||
27922130|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
27922131|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
27637603|NCT04425629|80515878|FG016|Overall Study|Adverse Event|0|||
27637604|NCT04425629|80515879|FG017|Overall Study|Adverse Event|0|||
27637605|NCT04425629|80515880|FG018|Overall Study|Adverse Event|0|||
27637606|NCT04425629|80515862|FG000|Overall Study|Lost to Follow-up|1|||
27637607|NCT04425629|80515863|FG001|Overall Study|Lost to Follow-up|3|||
27637608|NCT04425629|80515864|FG002|Overall Study|Lost to Follow-up|1|||
27637609|NCT04425629|80515865|FG003|Overall Study|Lost to Follow-up|7|||
27922132|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
27922133|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
27922134|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
27922135|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
27922136|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
27922137|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
27922138|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
27922139|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
27922140|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
27922141|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
27543225|NCT01133522|80182130|FG005|Overall Study|Withdrawal by Subject|0|||
27543226|NCT01133522|80182131|FG006|Overall Study|Withdrawal by Subject|0|||
27543227|NCT01133522|80182132|FG007|Overall Study|Withdrawal by Subject|0|||
27543228|NCT01133522|80182133|FG008|Overall Study|Withdrawal by Subject|0|||
27543229|NCT01133522|80182134|FG009|Overall Study|Withdrawal by Subject|0|||
27543230|NCT01133522|80182125|FG000|Overall Study|Physician Decision|0|||
27637610|NCT04425629|80515866|FG004|Overall Study|Lost to Follow-up|1|||
27637611|NCT04425629|80515867|FG005|Overall Study|Lost to Follow-up|2|||
27637612|NCT04425629|80515868|FG006|Overall Study|Lost to Follow-up|1|||
27637613|NCT04425629|80515869|FG007|Overall Study|Lost to Follow-up|0|||
27637614|NCT04425629|80515870|FG008|Overall Study|Lost to Follow-up|1|||
27922142|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
27543231|NCT01133522|80182126|FG001|Overall Study|Physician Decision|0|||
27637615|NCT04425629|80515871|FG009|Overall Study|Lost to Follow-up|64|||
27922143|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
27922144|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
27922145|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
27922146|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
27922147|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
27922148|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
27922149|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
27922150|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
27922151|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
27922152|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
27922153|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
27922154|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
27922155|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
27922156|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
27922157|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
27922158|NCT01668797|81553833|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
27922159|NCT01668797|81553834|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
27922160|NCT01668797|81553835|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
27922161|NCT01668797|81553836|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
27922162|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
27922163|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
27922164|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
27922165|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
27922166|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
27922167|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
27922168|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
27922169|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
27922170|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
27922171|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
27922172|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
27922173|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
27922174|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
27922175|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
27922176|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
27922177|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
27922178|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
27922179|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
27922180|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
27922181|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
27922182|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
27922183|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
27922184|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
27922185|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
27922186|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
27922187|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
27922188|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
27922189|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
27543232|NCT01133522|80182127|FG002|Overall Study|Physician Decision|0|||
27543233|NCT01133522|80182128|FG003|Overall Study|Physician Decision|0|||
27543234|NCT01133522|80182129|FG004|Overall Study|Physician Decision|1|||
27543235|NCT01133522|80182130|FG005|Overall Study|Physician Decision|0|||
27543236|NCT01133522|80182131|FG006|Overall Study|Physician Decision|0|||
27543237|NCT01133522|80182132|FG007|Overall Study|Physician Decision|0|||
27543238|NCT01133522|80182133|FG008|Overall Study|Physician Decision|0|||
27543239|NCT01133522|80182134|FG009|Overall Study|Physician Decision|0|||
27543240|NCT01651039|80182144|FG000|Overall Study|Non-evaluables|5|||
27543241|NCT01651039|80182144|FG000|Overall Study|Physician Decision|2|||
27543242|NCT01651039|80182144|FG000|Overall Study|Withdrawal by Subject|1|||
27543243|NCT01651039|80182144|FG000|Overall Study|Progressive Disease|22|||
27543244|NCT01348165|80182147|FG000|Overall Study|Adverse Event|0|||
27543245|NCT01348165|80182148|FG001|Overall Study|Adverse Event|0|||
27543246|NCT01348165|80182149|FG002|Overall Study|Adverse Event|0|||
27637616|NCT04425629|80515872|FG010|Overall Study|Lost to Follow-up|70|||
27637617|NCT04425629|80515873|FG011|Overall Study|Lost to Follow-up|98|||
27543247|NCT01348165|80182150|FG003|Overall Study|Adverse Event|0|||
27637618|NCT04425629|80515874|FG012|Overall Study|Lost to Follow-up|30|||
27543248|NCT01348165|80182151|FG004|Overall Study|Adverse Event|0|||
27543249|NCT01348165|80182152|FG005|Overall Study|Adverse Event|0|||
27543250|NCT01348165|80182153|FG006|Overall Study|Adverse Event|1|||
27543251|NCT00129272|80182159|FG000|Overall Study|Lost to Follow-up|12|||
27543252|NCT00129272|80182160|FG001|Overall Study|Lost to Follow-up|11|||
27543253|NCT00129272|80182159|FG000|Overall Study|Withdrawal by Subject|5|||
27543254|NCT00129272|80182160|FG001|Overall Study|Withdrawal by Subject|11|||
27543255|NCT01189604|80182161|FG000|Overall Study|Impossible to visit|0|||
27543256|NCT01189604|80182162|FG001|Overall Study|Impossible to visit|0|||
27543257|NCT01189604|80182163|FG002|Overall Study|Impossible to visit|0|||
27543258|NCT01189604|80182164|FG003|Overall Study|Impossible to visit|0|||
27543259|NCT01189604|80182165|FG004|Overall Study|Impossible to visit|0|||
27543260|NCT01189604|80182166|FG005|Overall Study|Impossible to visit|1|||
27543261|NCT01189604|80182167|FG006|Overall Study|Impossible to visit|0|||
27543262|NCT01189604|80182161|FG000|Overall Study|Adverse Event|0|||
27543263|NCT01189604|80182162|FG001|Overall Study|Adverse Event|1|||
27543264|NCT01189604|80182163|FG002|Overall Study|Adverse Event|0|||
27543265|NCT01189604|80182164|FG003|Overall Study|Adverse Event|0|||
27543266|NCT01189604|80182165|FG004|Overall Study|Adverse Event|2|||
27543267|NCT01189604|80182166|FG005|Overall Study|Adverse Event|0|||
27637619|NCT04425629|80515875|FG013|Overall Study|Lost to Follow-up|0|||
27637620|NCT04425629|80515876|FG014|Overall Study|Lost to Follow-up|5|||
27637621|NCT04425629|80515877|FG015|Overall Study|Lost to Follow-up|4|||
27922190|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
27922191|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
27637622|NCT04425629|80515878|FG016|Overall Study|Lost to Follow-up|0|||
27637623|NCT04425629|80515879|FG017|Overall Study|Lost to Follow-up|3|||
27637624|NCT04425629|80515880|FG018|Overall Study|Lost to Follow-up|1|||
27637625|NCT04425629|80515862|FG000|Overall Study|Subject Decision|0|||
27637626|NCT04425629|80515863|FG001|Overall Study|Subject Decision|2|||
27637627|NCT04425629|80515864|FG002|Overall Study|Subject Decision|1|||
27637628|NCT04425629|80515865|FG003|Overall Study|Subject Decision|3|||
27637629|NCT04425629|80515866|FG004|Overall Study|Subject Decision|6|||
27637630|NCT04425629|80515867|FG005|Overall Study|Subject Decision|6|||
27922192|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
27922193|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
27922194|NCT01668797|81553833|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
27922195|NCT01668797|81553834|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
27922196|NCT01668797|81553835|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
27922197|NCT01668797|81553836|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
27922198|NCT00984867|81553837|FG000|Overall Study|Adverse Event|3|||
27922199|NCT00984867|81553838|FG001|Overall Study|Adverse Event|7|||
27922200|NCT00984867|81553837|FG000|Overall Study|Death|1|||
27922201|NCT00984867|81553838|FG001|Overall Study|Death|0|||
27922202|NCT00984867|81553837|FG000|Overall Study|Withdrawal by Subject|13|||
27922203|NCT00984867|81553838|FG001|Overall Study|Withdrawal by Subject|4|||
27922204|NCT00984867|81553837|FG000|Overall Study|Lost to Follow-up|3|||
27922205|NCT00984867|81553838|FG001|Overall Study|Lost to Follow-up|4|||
27922206|NCT00984867|81553837|FG000|Overall Study|Poor/non-compliance|0|||
27922207|NCT00984867|81553838|FG001|Overall Study|Poor/non-compliance|1|||
27922208|NCT00984867|81553837|FG000|Overall Study|Subject no longer meets study criteria|1|||
27922209|NCT00984867|81553838|FG001|Overall Study|Subject no longer meets study criteria|1|||
27922210|NCT00984867|81553837|FG000|Overall Study|site closing|1|||
27922211|NCT00984867|81553838|FG001|Overall Study|site closing|0|||
27922212|NCT00984867|81553837|FG000|Overall Study|lack of efficacy and subject compliance|1|||
27922213|NCT00984867|81553838|FG001|Overall Study|lack of efficacy and subject compliance|0|||
27922214|NCT01525589|81553839|FG000|Overall Study|Non-treatment-related AE|1|||
27922215|NCT01525589|81553840|FG001|Overall Study|Non-treatment-related AE|0|||
27922216|NCT01525589|81553841|FG002|Overall Study|Non-treatment-related AE|0|||
27922217|NCT01525589|81553839|FG000|Overall Study|Progressive disease|48|||
27922218|NCT01525589|81553840|FG001|Overall Study|Progressive disease|15|||
27922219|NCT01525589|81553841|FG002|Overall Study|Progressive disease|29|||
27922220|NCT01525589|81553839|FG000|Overall Study|Never treated|2|||
27922221|NCT01525589|81553840|FG001|Overall Study|Never treated|0|||
27922222|NCT01525589|81553841|FG002|Overall Study|Never treated|0|||
27922223|NCT01525589|81553839|FG000|Overall Study|Physician Decision|4|||
27543268|NCT01189604|80182167|FG006|Overall Study|Adverse Event|1|||
27543269|NCT01189604|80182161|FG000|Overall Study|Withdrawal by Subject|1|||
27543270|NCT01189604|80182162|FG001|Overall Study|Withdrawal by Subject|0|||
27922224|NCT01525589|81553840|FG001|Overall Study|Physician Decision|2|||
27543271|NCT01189604|80182163|FG002|Overall Study|Withdrawal by Subject|0|||
27637631|NCT04425629|80515868|FG006|Overall Study|Subject Decision|3|||
27637632|NCT04425629|80515869|FG007|Overall Study|Subject Decision|3|||
27637633|NCT04425629|80515870|FG008|Overall Study|Subject Decision|1|||
27543272|NCT01189604|80182164|FG003|Overall Study|Withdrawal by Subject|0|||
27741011|NCT03241173|80880791|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
27741012|NCT03241173|80880792|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
27741013|NCT03241173|80880793|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
27922225|NCT01525589|81553841|FG002|Overall Study|Physician Decision|2|||
27922226|NCT01525589|81553839|FG000|Overall Study|Death|0|||
27922227|NCT01525589|81553840|FG001|Overall Study|Death|0|||
27922228|NCT01525589|81553841|FG002|Overall Study|Death|2|||
27922229|NCT01525589|81553839|FG000|Overall Study|Treatment-related AE|1|||
27922230|NCT01525589|81553840|FG001|Overall Study|Treatment-related AE|1|||
27922231|NCT01525589|81553841|FG002|Overall Study|Treatment-related AE|2|||
27922232|NCT01525589|81553839|FG000|Overall Study|Other reasons|0|||
27922233|NCT01525589|81553840|FG001|Overall Study|Other reasons|1|||
27922234|NCT01525589|81553841|FG002|Overall Study|Other reasons|0|||
27922235|NCT01525589|81553839|FG000|Overall Study|Withdrawal by Subject|0|||
27922236|NCT01525589|81553840|FG001|Overall Study|Withdrawal by Subject|1|||
27922237|NCT01525589|81553841|FG002|Overall Study|Withdrawal by Subject|0|||
27922238|NCT00634504|81553842|FG000|Overall Study|Protocol Violation|1|||
27922239|NCT00634504|81553843|FG001|Overall Study|Protocol Violation|0|||
27543273|NCT01189604|80182165|FG004|Overall Study|Withdrawal by Subject|0|||
27543274|NCT01189604|80182166|FG005|Overall Study|Withdrawal by Subject|0|||
27543275|NCT01189604|80182167|FG006|Overall Study|Withdrawal by Subject|0|||
27543276|NCT02570074|80182168|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
27543277|NCT02570074|80182169|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
27543278|NCT03741062|80182170|FG000|Overall Study|Protocol Violation|1|||
27543279|NCT03741062|80182171|FG001|Overall Study|Protocol Violation|0|||
27543280|NCT00530946|80182172|FG000|Overall Study|Adverse Event|1|||
27543281|NCT00530946|80182173|FG001|Overall Study|Adverse Event|2|||
27543282|NCT00530946|80182174|FG002|Overall Study|Adverse Event|1|||
27543283|NCT00530946|80182175|FG003|Overall Study|Adverse Event|1|||
27543284|NCT00530946|80182172|FG000|Overall Study|Protocol Violation|0|||
27543285|NCT00530946|80182173|FG001|Overall Study|Protocol Violation|0|||
27543286|NCT00530946|80182174|FG002|Overall Study|Protocol Violation|0|||
27543287|NCT00530946|80182175|FG003|Overall Study|Protocol Violation|1|||
27543288|NCT00530946|80182172|FG000|Overall Study|Noncompliance|1|||
27543289|NCT00530946|80182173|FG001|Overall Study|Noncompliance|0|||
27543290|NCT00530946|80182174|FG002|Overall Study|Noncompliance|0|||
27543291|NCT00530946|80182175|FG003|Overall Study|Noncompliance|0|||
27543292|NCT03166735|80182176|FG000|Overall Study|Not Treated|1|||
27543293|NCT03166735|80182177|FG001|Overall Study|Not Treated|0|||
27543294|NCT03166735|80182178|FG002|Overall Study|Not Treated|0|||
27543295|NCT03166735|80182179|FG003|Overall Study|Not Treated|0|||
27543296|NCT03166735|80182180|FG004|Overall Study|Not Treated|0|||
27543297|NCT03166735|80182176|FG000|Overall Study|follow-up not completed as planned|0|||
27543298|NCT03166735|80182177|FG001|Overall Study|follow-up not completed as planned|1|||
27543299|NCT03166735|80182178|FG002|Overall Study|follow-up not completed as planned|1|||
27543300|NCT03166735|80182179|FG003|Overall Study|follow-up not completed as planned|0|||
27922240|NCT00325416|81553846|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
27922241|NCT00325416|81553847|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
27922242|NCT00325416|81553846|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
27922243|NCT00325416|81553847|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
27922244|NCT00325416|81553846|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
27922245|NCT00325416|81553847|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
27922246|NCT00325416|81553846|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
27922247|NCT00325416|81553847|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
27922248|NCT00325416|81553846|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
27922249|NCT00325416|81553847|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
27922250|NCT00325416|81553846|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
27922251|NCT00325416|81553847|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
27922252|NCT00374868|81553850|FG000|Overall Study|Adverse Event|12|||
27922253|NCT00374868|81553850|FG000|Overall Study|Progressive Disease|7|||
27922254|NCT00374868|81553850|FG000|Overall Study|Physician Decision|13|||
27922255|NCT00374868|81553850|FG000|Overall Study|Lost to Follow-up|1|||
27922256|NCT00374868|81553850|FG000|Overall Study|Death|2|||
27543301|NCT03166735|80182180|FG004|Overall Study|follow-up not completed as planned|1|||
27543302|NCT03166735|80182176|FG000|Overall Study|Withdrawal by Subject|0|||
27543303|NCT03166735|80182177|FG001|Overall Study|Withdrawal by Subject|0|||
27543304|NCT03166735|80182178|FG002|Overall Study|Withdrawal by Subject|1|||
27543305|NCT03166735|80182179|FG003|Overall Study|Withdrawal by Subject|1|||
27637634|NCT04425629|80515871|FG009|Overall Study|Subject Decision|70|||
27637635|NCT04425629|80515872|FG010|Overall Study|Subject Decision|95|||
27922257|NCT00374868|81553850|FG000|Overall Study|Other - Not Specified|1|||
27922258|NCT04635839|81553851|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
27922259|NCT04635839|81553852|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
27922260|NCT00656617|81553853|FG000|Overall Study|Adverse Event|1|||
27637636|NCT04425629|80515873|FG011|Overall Study|Subject Decision|124|||
27637637|NCT04425629|80515874|FG012|Overall Study|Subject Decision|25|||
27637638|NCT04425629|80515875|FG013|Overall Study|Subject Decision|0|||
27637639|NCT04425629|80515876|FG014|Overall Study|Subject Decision|1|||
27637640|NCT04425629|80515877|FG015|Overall Study|Subject Decision|4|||
27637641|NCT04425629|80515878|FG016|Overall Study|Subject Decision|1|||
27637642|NCT04425629|80515879|FG017|Overall Study|Subject Decision|0|||
27637643|NCT04425629|80515880|FG018|Overall Study|Subject Decision|2|||
27922261|NCT00656617|81553853|FG000|Overall Study|Death|2|||
27637644|NCT04425629|80515862|FG000|Overall Study|Death|0|||
27637645|NCT04425629|80515863|FG001|Overall Study|Death|0|||
27637646|NCT04425629|80515864|FG002|Overall Study|Death|0|||
27637647|NCT04425629|80515865|FG003|Overall Study|Death|0|||
27637648|NCT04425629|80515866|FG004|Overall Study|Death|0|||
27637649|NCT04425629|80515867|FG005|Overall Study|Death|0|||
27637650|NCT04425629|80515868|FG006|Overall Study|Death|0|||
27637651|NCT04425629|80515869|FG007|Overall Study|Death|0|||
27637652|NCT04425629|80515870|FG008|Overall Study|Death|0|||
27637653|NCT04425629|80515871|FG009|Overall Study|Death|11|||
27637654|NCT04425629|80515872|FG010|Overall Study|Death|2|||
27637655|NCT04425629|80515873|FG011|Overall Study|Death|4|||
27637656|NCT04425629|80515874|FG012|Overall Study|Death|0|||
27637657|NCT04425629|80515875|FG013|Overall Study|Death|0|||
27637658|NCT04425629|80515876|FG014|Overall Study|Death|0|||
27637659|NCT04425629|80515877|FG015|Overall Study|Death|0|||
27637660|NCT04425629|80515878|FG016|Overall Study|Death|0|||
27637661|NCT04425629|80515879|FG017|Overall Study|Death|0|||
27637662|NCT04425629|80515880|FG018|Overall Study|Death|0|||
27637663|NCT04425629|80515862|FG000|Overall Study|Sponsor Request|0|||
27637664|NCT04425629|80515863|FG001|Overall Study|Sponsor Request|0|||
27637665|NCT04425629|80515864|FG002|Overall Study|Sponsor Request|0|||
27637666|NCT04425629|80515865|FG003|Overall Study|Sponsor Request|2|||
27637667|NCT04425629|80515866|FG004|Overall Study|Sponsor Request|2|||
27637668|NCT04425629|80515867|FG005|Overall Study|Sponsor Request|2|||
27637669|NCT04425629|80515868|FG006|Overall Study|Sponsor Request|1|||
27637670|NCT04425629|80515869|FG007|Overall Study|Sponsor Request|0|||
27637671|NCT04425629|80515870|FG008|Overall Study|Sponsor Request|0|||
27637672|NCT04425629|80515871|FG009|Overall Study|Sponsor Request|9|||
27637673|NCT04425629|80515872|FG010|Overall Study|Sponsor Request|9|||
27637674|NCT04425629|80515873|FG011|Overall Study|Sponsor Request|10|||
27637675|NCT04425629|80515874|FG012|Overall Study|Sponsor Request|8|||
27637676|NCT04425629|80515875|FG013|Overall Study|Sponsor Request|0|||
27637677|NCT04425629|80515876|FG014|Overall Study|Sponsor Request|0|||
27637678|NCT04425629|80515877|FG015|Overall Study|Sponsor Request|1|||
27637679|NCT04425629|80515878|FG016|Overall Study|Sponsor Request|0|||
27637680|NCT04425629|80515879|FG017|Overall Study|Sponsor Request|0|||
27637681|NCT04425629|80515880|FG018|Overall Study|Sponsor Request|0|||
27637682|NCT04425629|80515862|FG000|Overall Study|Physician Decision|0|||
27922262|NCT00656617|81553853|FG000|Overall Study|Insurance Issues|2|||
27922263|NCT00656617|81553853|FG000|Overall Study|Move to different clinical trial|2|||
27922264|NCT00407511|81553859|FG000|Overall Study|Adverse Event|9|||
27922265|NCT00407511|81553859|FG000|Overall Study|Lost to Follow-up|4|||
27922266|NCT00407511|81553859|FG000|Overall Study|Other|5|||
27922267|NCT00407511|81553859|FG000|Overall Study|Withdrawal by Subject|4|||
27922268|NCT02497469|81553860|FG000|Overall Study|Randomized but not Treated|0|||
27922269|NCT02497469|81553861|FG001|Overall Study|Randomized but not Treated|2|||
27922270|NCT02497469|81553860|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
27922271|NCT02497469|81553861|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
27922272|NCT02497469|81553860|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
27922273|NCT02497469|81553861|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
27922274|NCT02497469|81553860|FG000|Overall Study|Significant Protocol Deviation|4|||
27922275|NCT02497469|81553861|FG001|Overall Study|Significant Protocol Deviation|5|||
27922276|NCT02497469|81553860|FG000|Overall Study|Lost to Follow-up|14|||
27922277|NCT02497469|81553861|FG001|Overall Study|Lost to Follow-up|4|||
27922278|NCT02497469|81553860|FG000|Overall Study|Voluntary Withdrawal|39|||
27637683|NCT04425629|80515863|FG001|Overall Study|Physician Decision|0|||
27637684|NCT04425629|80515864|FG002|Overall Study|Physician Decision|0|||
27637685|NCT04425629|80515865|FG003|Overall Study|Physician Decision|0|||
27637686|NCT04425629|80515866|FG004|Overall Study|Physician Decision|0|||
27637687|NCT04425629|80515867|FG005|Overall Study|Physician Decision|0|||
27637688|NCT04425629|80515868|FG006|Overall Study|Physician Decision|0|||
27637689|NCT04425629|80515869|FG007|Overall Study|Physician Decision|0|||
27637690|NCT04425629|80515870|FG008|Overall Study|Physician Decision|0|||
27637691|NCT04425629|80515871|FG009|Overall Study|Physician Decision|4|||
27637692|NCT04425629|80515872|FG010|Overall Study|Physician Decision|3|||
27637693|NCT04425629|80515873|FG011|Overall Study|Physician Decision|5|||
27637694|NCT04425629|80515874|FG012|Overall Study|Physician Decision|1|||
27637695|NCT04425629|80515875|FG013|Overall Study|Physician Decision|0|||
27637696|NCT04425629|80515876|FG014|Overall Study|Physician Decision|0|||
27637697|NCT04425629|80515877|FG015|Overall Study|Physician Decision|1|||
27922279|NCT02497469|81553861|FG001|Overall Study|Voluntary Withdrawal|41|||
27922280|NCT02497469|81553860|FG000|Overall Study|Pregnancy|1|||
27922281|NCT02497469|81553861|FG001|Overall Study|Pregnancy|1|||
27637698|NCT04425629|80515878|FG016|Overall Study|Physician Decision|0|||
27637699|NCT04425629|80515879|FG017|Overall Study|Physician Decision|0|||
27637700|NCT04425629|80515880|FG018|Overall Study|Physician Decision|0|||
27637701|NCT04425629|80515862|FG000|Overall Study|Lack of Efficacy|0|||
27637702|NCT04425629|80515863|FG001|Overall Study|Lack of Efficacy|0|||
27637703|NCT04425629|80515864|FG002|Overall Study|Lack of Efficacy|0|||
27637704|NCT04425629|80515865|FG003|Overall Study|Lack of Efficacy|0|||
27637705|NCT04425629|80515866|FG004|Overall Study|Lack of Efficacy|0|||
27637706|NCT04425629|80515867|FG005|Overall Study|Lack of Efficacy|0|||
27637707|NCT04425629|80515868|FG006|Overall Study|Lack of Efficacy|0|||
27637708|NCT04425629|80515869|FG007|Overall Study|Lack of Efficacy|0|||
27637709|NCT04425629|80515870|FG008|Overall Study|Lack of Efficacy|0|||
27637710|NCT04425629|80515871|FG009|Overall Study|Lack of Efficacy|0|||
27637711|NCT04425629|80515872|FG010|Overall Study|Lack of Efficacy|1|||
27637712|NCT04425629|80515873|FG011|Overall Study|Lack of Efficacy|0|||
27637713|NCT04425629|80515874|FG012|Overall Study|Lack of Efficacy|0|||
27637714|NCT04425629|80515875|FG013|Overall Study|Lack of Efficacy|0|||
27637715|NCT04425629|80515876|FG014|Overall Study|Lack of Efficacy|0|||
27741014|NCT03241173|80880794|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
27741015|NCT03241173|80880795|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
27741016|NCT03241173|80880796|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
27741017|NCT03241173|80880797|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
27741018|NCT03241173|80880798|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
27741019|NCT03241173|80880799|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
27741020|NCT03241173|80880800|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
27741021|NCT03241173|80880801|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
27741022|NCT03241173|80880802|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
27741023|NCT03241173|80880803|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
27741024|NCT03241173|80880789|FG000|Overall Study|Lost to Follow-up|0|||
27741025|NCT03241173|80880790|FG001|Overall Study|Lost to Follow-up|0|||
27741026|NCT03241173|80880791|FG002|Overall Study|Lost to Follow-up|0|||
27741027|NCT03241173|80880792|FG003|Overall Study|Lost to Follow-up|0|||
27741028|NCT03241173|80880793|FG004|Overall Study|Lost to Follow-up|1|||
27741029|NCT03241173|80880794|FG005|Overall Study|Lost to Follow-up|0|||
27741030|NCT03241173|80880795|FG006|Overall Study|Lost to Follow-up|0|||
27741031|NCT03241173|80880796|FG007|Overall Study|Lost to Follow-up|0|||
27741032|NCT03241173|80880797|FG008|Overall Study|Lost to Follow-up|0|||
27741033|NCT03241173|80880798|FG009|Overall Study|Lost to Follow-up|1|||
27741034|NCT03241173|80880799|FG010|Overall Study|Lost to Follow-up|0|||
27741035|NCT03241173|80880800|FG011|Overall Study|Lost to Follow-up|0|||
27741036|NCT03241173|80880801|FG012|Overall Study|Lost to Follow-up|0|||
27741037|NCT03241173|80880802|FG013|Overall Study|Lost to Follow-up|0|||
27741038|NCT03241173|80880803|FG014|Overall Study|Lost to Follow-up|0|||
27741039|NCT03575468|80880804|FG000|Overall Study|Withdrawal by Subject|3|||
27741040|NCT03575468|80880805|FG001|Overall Study|Withdrawal by Subject|0|||
27741041|NCT03575468|80880804|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
27741042|NCT03575468|80880805|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
27741043|NCT03575468|80880804|FG000|Overall Study|Lost to Follow-up|13|||
27741044|NCT03575468|80880805|FG001|Overall Study|Lost to Follow-up|17|||
27741045|NCT02263365|80880806|FG000|Overall Study|Physician Decision|22|||
27741046|NCT02263365|80880807|FG001|Overall Study|Physician Decision|18|||
27741047|NCT00117338|80880808|FG000|Overall Study|Adverse Event|0|||
27741048|NCT00117338|80880809|FG001|Overall Study|Adverse Event|1|||
27741049|NCT00117338|80880808|FG000|Overall Study|Protocol Violation|3|||
27741050|NCT00117338|80880809|FG001|Overall Study|Protocol Violation|2|||
27741051|NCT00117338|80880808|FG000|Overall Study|Withdrawal by Subject|1|||
27741052|NCT00117338|80880809|FG001|Overall Study|Withdrawal by Subject|0|||
27741053|NCT00117338|80880808|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
27741054|NCT00117338|80880809|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
27741055|NCT00117338|80880808|FG000|Overall Study|Lack of Efficacy|0|||
27741056|NCT00117338|80880809|FG001|Overall Study|Lack of Efficacy|1|||
27741057|NCT00510692|80880810|FG000|Overall Study|Adverse Event|1|||
27741058|NCT00510692|80880811|FG001|Overall Study|Adverse Event|3|||
27741059|NCT00510692|80880810|FG000|Overall Study|Withdrawal by Subject|1|||
27741060|NCT00510692|80880811|FG001|Overall Study|Withdrawal by Subject|0|||
27922282|NCT02497469|81553860|FG000|Overall Study|Lack of Efficacy|86|||
27741061|NCT02369510|80880813|FG000|Overall Study|Spilled Medication|1|||
27922283|NCT02497469|81553861|FG001|Overall Study|Lack of Efficacy|40|||
27637716|NCT04425629|80515877|FG015|Overall Study|Lack of Efficacy|0|||
27637717|NCT04425629|80515878|FG016|Overall Study|Lack of Efficacy|0|||
27637718|NCT04425629|80515879|FG017|Overall Study|Lack of Efficacy|0|||
27637719|NCT04425629|80515880|FG018|Overall Study|Lack of Efficacy|0|||
27637720|NCT02528188|80515883|FG000|Overall Study|Adverse Event|23|||
27637721|NCT02528188|80515884|FG001|Overall Study|Adverse Event|22|||
27543306|NCT03166735|80182180|FG004|Overall Study|Withdrawal by Subject|2|||
27543307|NCT03166735|80182176|FG000|Overall Study|Lost to Follow-up|0|||
27543308|NCT03166735|80182177|FG001|Overall Study|Lost to Follow-up|2|||
27543309|NCT03166735|80182178|FG002|Overall Study|Lost to Follow-up|1|||
27543310|NCT03166735|80182179|FG003|Overall Study|Lost to Follow-up|0|||
27543311|NCT03166735|80182180|FG004|Overall Study|Lost to Follow-up|1|||
27543312|NCT02993757|80182181|FG000|Overall Study|Non compliance with the protocol|155|||
27543313|NCT02993757|80182182|FG001|Overall Study|Non compliance with the protocol|170|||
27543314|NCT02993757|80182181|FG000|Overall Study|Lost to Follow-up|1|||
27543315|NCT02993757|80182182|FG001|Overall Study|Lost to Follow-up|0|||
27543316|NCT02993757|80182181|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
27543317|NCT02993757|80182182|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
27543318|NCT00672646|80182183|FG000|Overall Study|Lost to Follow-up|0|||
27543319|NCT00672646|80182184|FG001|Overall Study|Lost to Follow-up|1|||
27543320|NCT00672646|80182185|FG002|Overall Study|Lost to Follow-up|2|||
27543321|NCT00672646|80182183|FG000|Overall Study|Withdrawal by Subject|0|||
27543322|NCT00672646|80182184|FG001|Overall Study|Withdrawal by Subject|0|||
27543323|NCT00672646|80182185|FG002|Overall Study|Withdrawal by Subject|1|||
27543324|NCT02763462|80182186|FG000|Overall Study|Protocol Violation|6|||
27543325|NCT00639678|80182189|FG000|Overall Study|Withdrawal by Subject|3|||
27543326|NCT00639678|80182190|FG001|Overall Study|Withdrawal by Subject|0|||
27543327|NCT00639678|80182191|FG002|Overall Study|Withdrawal by Subject|4|||
27543328|NCT00639678|80182192|FG003|Overall Study|Withdrawal by Subject|0|||
27543329|NCT00639678|80182189|FG000|Overall Study|Lost to Follow-up|1|||
27543330|NCT00639678|80182190|FG001|Overall Study|Lost to Follow-up|0|||
27543331|NCT00639678|80182191|FG002|Overall Study|Lost to Follow-up|6|||
27543332|NCT00639678|80182192|FG003|Overall Study|Lost to Follow-up|0|||
27543333|NCT00639678|80182189|FG000|Overall Study|Adverse Event|0|||
27543334|NCT00639678|80182190|FG001|Overall Study|Adverse Event|1|||
27543335|NCT00639678|80182191|FG002|Overall Study|Adverse Event|0|||
27543336|NCT00639678|80182192|FG003|Overall Study|Adverse Event|0|||
27543337|NCT00639678|80182189|FG000|Overall Study|Lack of Compliance|0|||
27543338|NCT00639678|80182190|FG001|Overall Study|Lack of Compliance|0|||
27543339|NCT00639678|80182191|FG002|Overall Study|Lack of Compliance|1|||
27543340|NCT00639678|80182192|FG003|Overall Study|Lack of Compliance|0|||
27543341|NCT03173313|80182193|FG000|Overall Study|Lost to Follow-up|2|||
27543342|NCT03173313|80182194|FG001|Overall Study|Lost to Follow-up|3|||
27543343|NCT03173313|80182193|FG000|Overall Study|Withdrawal by Subject|0|||
27543344|NCT03173313|80182194|FG001|Overall Study|Withdrawal by Subject|1|||
27543345|NCT03173313|80182193|FG000|Overall Study|Death|5|||
27543346|NCT03173313|80182194|FG001|Overall Study|Death|0|||
27543347|NCT03173313|80182193|FG000|Overall Study|Physician Decision|1|||
27543348|NCT03173313|80182194|FG001|Overall Study|Physician Decision|0|||
27543349|NCT03173313|80182193|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
27543350|NCT03173313|80182194|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
27543351|NCT03173313|80182193|FG000|Overall Study|Bone Fracture|1|||
27543352|NCT03173313|80182194|FG001|Overall Study|Bone Fracture|0|||
27543353|NCT02151110|80182195|FG000|Overall Study|Withdrawal by Subject|0|||
27543354|NCT02151110|80182196|FG001|Overall Study|Withdrawal by Subject|0|||
27543355|NCT02151110|80182197|FG002|Overall Study|Withdrawal by Subject|0|||
27543356|NCT02151110|80182198|FG003|Overall Study|Withdrawal by Subject|0|||
27543357|NCT02151110|80182199|FG004|Overall Study|Withdrawal by Subject|0|||
27543358|NCT02151110|80182200|FG005|Overall Study|Withdrawal by Subject|0|||
27543359|NCT02151110|80182201|FG006|Overall Study|Withdrawal by Subject|0|||
27543360|NCT02151110|80182202|FG007|Overall Study|Withdrawal by Subject|1|||
27543361|NCT02151110|80182195|FG000|Overall Study|Lost to Follow-up|0|||
27543362|NCT02151110|80182196|FG001|Overall Study|Lost to Follow-up|0|||
27543363|NCT02151110|80182197|FG002|Overall Study|Lost to Follow-up|0|||
27543364|NCT02151110|80182198|FG003|Overall Study|Lost to Follow-up|0|||
27543365|NCT02151110|80182199|FG004|Overall Study|Lost to Follow-up|0|||
27543366|NCT02151110|80182200|FG005|Overall Study|Lost to Follow-up|0|||
27543367|NCT02151110|80182201|FG006|Overall Study|Lost to Follow-up|0|||
27741062|NCT02369510|80880814|FG001|Overall Study|Spilled Medication|2|||
27741063|NCT02369510|80880815|FG002|Overall Study|Spilled Medication|1|||
27741064|NCT02369510|80880813|FG000|Overall Study|Epidural Activation|1|||
27543368|NCT02151110|80182202|FG007|Overall Study|Lost to Follow-up|2|||
27543369|NCT00726986|80182203|FG000|Induction Phase|Adverse Event|4|||
27543370|NCT00726986|80182203|FG000|Induction Phase|Withdrawal by Subject|2|||
27543371|NCT00726986|80182203|FG000|Induction Phase|Death|2|||
27543372|NCT00726986|80182203|FG000|Induction Phase|Lack of Efficacy|5|||
27543373|NCT00726986|80182203|FG000|Induction Phase|Secondary Disease|2|||
27543374|NCT00726986|80182203|FG000|Maintenance Phase|Adverse Event|1|||
27543375|NCT00726986|80182203|FG000|Maintenance Phase|Lack of Efficacy|2|||
27543376|NCT02985957|80182204|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27543377|NCT02985957|80182205|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27543378|NCT02985957|80182206|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27741065|NCT02369510|80880814|FG001|Overall Study|Epidural Activation|1|||
27637722|NCT02528188|80515885|FG002|Overall Study|Adverse Event|8|||
27637723|NCT02528188|80515883|FG000|Overall Study|Protocol Violation|4|||
27637724|NCT02528188|80515884|FG001|Overall Study|Protocol Violation|6|||
27637725|NCT02528188|80515885|FG002|Overall Study|Protocol Violation|4|||
27637726|NCT02528188|80515883|FG000|Overall Study|Lack of Efficacy|19|||
27637727|NCT02528188|80515884|FG001|Overall Study|Lack of Efficacy|21|||
27637728|NCT02528188|80515885|FG002|Overall Study|Lack of Efficacy|22|||
27637729|NCT02528188|80515883|FG000|Overall Study|Withdrawal by Subject|97|||
27637730|NCT02528188|80515884|FG001|Overall Study|Withdrawal by Subject|104|||
27637731|NCT02528188|80515885|FG002|Overall Study|Withdrawal by Subject|100|||
27637732|NCT02528188|80515883|FG000|Overall Study|Lost to Follow-up|25|||
27637733|NCT02528188|80515884|FG001|Overall Study|Lost to Follow-up|21|||
27637734|NCT02528188|80515885|FG002|Overall Study|Lost to Follow-up|31|||
27637735|NCT02528188|80515883|FG000|Overall Study|Death|4|||
27637736|NCT02528188|80515884|FG001|Overall Study|Death|4|||
27637737|NCT02528188|80515885|FG002|Overall Study|Death|0|||
27543379|NCT02985957|80182207|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27543380|NCT02985957|80182208|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
27543381|NCT02985957|80182209|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27543382|NCT02985957|80182210|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
27543383|NCT02985957|80182204|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
27543384|NCT02985957|80182205|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27543385|NCT02985957|80182206|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
27543386|NCT02985957|80182207|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
27543387|NCT02985957|80182208|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
27543388|NCT02985957|80182209|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
27543389|NCT02985957|80182210|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
27543390|NCT02985957|80182204|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27543391|NCT02985957|80182205|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27543392|NCT02985957|80182206|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27543393|NCT02985957|80182207|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27543394|NCT02985957|80182208|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27543395|NCT02985957|80182209|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
27543396|NCT02985957|80182210|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
27543397|NCT02985957|80182204|FG000|Treatment Period|Death|0|||
27543398|NCT02985957|80182205|FG001|Treatment Period|Death|0|||
27543399|NCT02985957|80182206|FG002|Treatment Period|Death|0|||
27543400|NCT02985957|80182207|FG003|Treatment Period|Death|0|||
27543401|NCT02985957|80182208|FG004|Treatment Period|Death|1|||
27543402|NCT02985957|80182209|FG005|Treatment Period|Death|0|||
27543403|NCT02985957|80182210|FG006|Treatment Period|Death|0|||
27543404|NCT02985957|80182204|FG000|Treatment Period|Participant withdrew consent|0|||
27543405|NCT02985957|80182205|FG001|Treatment Period|Participant withdrew consent|0|||
27543406|NCT02985957|80182206|FG002|Treatment Period|Participant withdrew consent|0|||
27543407|NCT02985957|80182207|FG003|Treatment Period|Participant withdrew consent|1|||
27543408|NCT02985957|80182208|FG004|Treatment Period|Participant withdrew consent|3|||
27543409|NCT02985957|80182209|FG005|Treatment Period|Participant withdrew consent|0|||
27543410|NCT02985957|80182210|FG006|Treatment Period|Participant withdrew consent|1|||
27543411|NCT02985957|80182204|FG000|Treatment Period|Lost to Follow-up|0|||
27543412|NCT02985957|80182205|FG001|Treatment Period|Lost to Follow-up|0|||
27543413|NCT02985957|80182206|FG002|Treatment Period|Lost to Follow-up|0|||
27543414|NCT02985957|80182207|FG003|Treatment Period|Lost to Follow-up|0|||
27543415|NCT02985957|80182208|FG004|Treatment Period|Lost to Follow-up|1|||
27543416|NCT02985957|80182209|FG005|Treatment Period|Lost to Follow-up|0|||
27543417|NCT02985957|80182210|FG006|Treatment Period|Lost to Follow-up|0|||
27543418|NCT02985957|80182204|FG000|Treatment Period|Other reasons|0|||
27543419|NCT02985957|80182205|FG001|Treatment Period|Other reasons|0|||
27543420|NCT02985957|80182206|FG002|Treatment Period|Other reasons|1|||
27543421|NCT02985957|80182207|FG003|Treatment Period|Other reasons|3|||
27543422|NCT02985957|80182208|FG004|Treatment Period|Other reasons|6|||
27543423|NCT02985957|80182209|FG005|Treatment Period|Other reasons|0|||
27637738|NCT02528188|80515883|FG000|Overall Study|Other|89|||
27637739|NCT02528188|80515884|FG001|Overall Study|Other|91|||
27543424|NCT02985957|80182210|FG006|Treatment Period|Other reasons|1|||
27543425|NCT02985957|80182204|FG000|Treatment Period|Not reported|0|||
27543426|NCT02985957|80182205|FG001|Treatment Period|Not reported|1|||
27543427|NCT02985957|80182206|FG002|Treatment Period|Not reported|2|||
27543428|NCT02985957|80182207|FG003|Treatment Period|Not reported|5|||
27543429|NCT02985957|80182208|FG004|Treatment Period|Not reported|0|||
27543430|NCT02985957|80182209|FG005|Treatment Period|Not reported|0|||
27543431|NCT02985957|80182210|FG006|Treatment Period|Not reported|0|||
27543432|NCT02985957|80182204|FG000|Treatment Period|Maximum clinical benefit|0|||
27543433|NCT02985957|80182205|FG001|Treatment Period|Maximum clinical benefit|0|||
27637740|NCT02528188|80515885|FG002|Overall Study|Other|74|||
27637741|NCT02528188|80515883|FG000|Overall Study|Randomized but not treated|6|||
27637742|NCT02528188|80515884|FG001|Overall Study|Randomized but not treated|7|||
27922284|NCT02497469|81553860|FG000|Overall Study|Reason not Specified|6|||
27922285|NCT02497469|81553861|FG001|Overall Study|Reason not Specified|6|||
27922286|NCT03444584|81553862|FG000|Overall Study|Withdrawal by Subject|0|||
27922287|NCT03444584|81553863|FG001|Overall Study|Withdrawal by Subject|1|||
27922288|NCT03444584|81553862|FG000|Overall Study|Other|0|||
27922289|NCT03444584|81553863|FG001|Overall Study|Other|1|||
27922290|NCT03810183|81553864|FG000|Overall Study|Study terminated by Sponsor|2|||
27922291|NCT03810183|81553865|FG001|Overall Study|Study terminated by Sponsor|1|||
27922292|NCT01026493|81553866|FG000|Overall Study|Protocol Violation|0|||
27922293|NCT01026493|81553867|FG001|Overall Study|Protocol Violation|1|||
27922294|NCT01026493|81553868|FG002|Overall Study|Protocol Violation|0|||
27922295|NCT01026493|81553869|FG003|Overall Study|Protocol Violation|0|||
27922296|NCT01026493|81553870|FG004|Overall Study|Protocol Violation|2|||
27922297|NCT01026493|81553871|FG005|Overall Study|Protocol Violation|3|||
27922298|NCT01026493|81553872|FG006|Overall Study|Protocol Violation|4|||
27922299|NCT01026493|81553873|FG007|Overall Study|Protocol Violation|1|||
27922300|NCT00964782|81553876|FG000|Overall Study|Lost to Follow-up|1|||
27922301|NCT00964782|81553877|FG001|Overall Study|Lost to Follow-up|0|||
27922302|NCT00465179|81553878|FG000|Overall Study|Adverse Event|4|||
27922303|NCT00465179|81553878|FG000|Overall Study|Withdrawal by Subject|2|||
27922304|NCT00465179|81553878|FG000|Overall Study|Progression of Disease|47|||
27922305|NCT01868646|81553879|FG000|Overall Study|Do not meet inclusion criteria|3|||
27922306|NCT01868646|81553880|FG001|Overall Study|Do not meet inclusion criteria|5|||
27922307|NCT00626639|81553883|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
27922308|NCT00626639|81553884|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
27922309|NCT01548404|81553895|FG000|Overall Study|Adverse Event|3|||
27922310|NCT01548404|81553896|FG001|Overall Study|Adverse Event|1|||
27543434|NCT02985957|80182206|FG002|Treatment Period|Maximum clinical benefit|1|||
27922311|NCT01548404|81553895|FG000|Overall Study|Physician Decision|2|||
27922312|NCT01548404|81553896|FG001|Overall Study|Physician Decision|1|||
27543435|NCT02985957|80182207|FG003|Treatment Period|Maximum clinical benefit|1|||
27543436|NCT02985957|80182208|FG004|Treatment Period|Maximum clinical benefit|0|||
27922313|NCT01548404|81553895|FG000|Overall Study|Inadequate response to study treatment|23|||
27922314|NCT01548404|81553896|FG001|Overall Study|Inadequate response to study treatment|7|||
27922315|NCT01548404|81553895|FG000|Overall Study|Lost to Follow-up|2|||
27922316|NCT01548404|81553896|FG001|Overall Study|Lost to Follow-up|0|||
27922317|NCT01548404|81553895|FG000|Overall Study|Withdrawal by Subject|0|||
27922318|NCT01548404|81553896|FG001|Overall Study|Withdrawal by Subject|3|||
27922319|NCT01548404|81553895|FG000|Overall Study|Other than specified above|0|||
27922320|NCT01548404|81553896|FG001|Overall Study|Other than specified above|2|||
27922321|NCT00142415|81553897|FG000|Overall Study|Physician Decision|0|||
27922322|NCT00142415|81553898|FG001|Overall Study|Physician Decision|0|||
27922323|NCT00142415|81553899|FG002|Overall Study|Physician Decision|0|||
27922324|NCT00142415|81553900|FG003|Overall Study|Physician Decision|0|||
27922325|NCT00142415|81553901|FG004|Overall Study|Physician Decision|1|||
27543437|NCT02985957|80182209|FG005|Treatment Period|Maximum clinical benefit|0|||
27543438|NCT02985957|80182210|FG006|Treatment Period|Maximum clinical benefit|2|||
27543439|NCT02985957|80182204|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
27543440|NCT02985957|80182205|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
27543441|NCT02985957|80182206|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
27543442|NCT02985957|80182207|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
27543443|NCT02985957|80182208|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
27543444|NCT02985957|80182209|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
27543445|NCT02985957|80182210|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
27543446|NCT02985957|80182204|FG000|Treatment Period|Study drug toxicity|1|||
27543447|NCT02985957|80182205|FG001|Treatment Period|Study drug toxicity|23|||
27543448|NCT02985957|80182206|FG002|Treatment Period|Study drug toxicity|20|||
27543449|NCT02985957|80182207|FG003|Treatment Period|Study drug toxicity|11|||
27543450|NCT02985957|80182208|FG004|Treatment Period|Study drug toxicity|19|||
27543451|NCT02985957|80182209|FG005|Treatment Period|Study drug toxicity|3|||
27543452|NCT02985957|80182210|FG006|Treatment Period|Study drug toxicity|5|||
27543453|NCT02985957|80182204|FG000|Treatment Period|Disease progression|0|||
27741066|NCT02369510|80880815|FG002|Overall Study|Epidural Activation|5|||
27543454|NCT02985957|80182205|FG001|Treatment Period|Disease progression|16|||
27543455|NCT02985957|80182206|FG002|Treatment Period|Disease progression|20|||
27543456|NCT02985957|80182207|FG003|Treatment Period|Disease progression|39|||
27741067|NCT00519532|80880816|FG000|Overall Study|Adverse Event|11|||
27922326|NCT00142415|81553902|FG005|Overall Study|Physician Decision|2|||
27922327|NCT00719901|81553906|FG000|Overall Study|Adverse Event|5|||
27922328|NCT00719901|81553906|FG000|Overall Study|Withdrawal by Subject|1|||
27922329|NCT00719901|81553906|FG000|Overall Study|Alternate Treatment|1|||
27922330|NCT00719901|81553906|FG000|Overall Study|Disease Progression|3|||
27922331|NCT00719901|81553906|FG000|Overall Study|Availability of Study Drug|1|||
27922332|NCT02774889|81553908|FG000|Overall Study|Lost to Follow-up|2|||
27922333|NCT02774889|81553909|FG001|Overall Study|Lost to Follow-up|1|||
27922334|NCT02020941|81553910|FG000|Overall Study|Adverse Event|1|||
27922335|NCT02020941|81553910|FG000|Overall Study|Physician Decision|2|||
27922336|NCT02020941|81553910|FG000|Overall Study|Withdrawal by Subject|1|||
27922337|NCT02020941|81553910|FG000|Overall Study|Disease Progression|4|||
27922338|NCT00537277|81553915|FG000|Overall Study|Adverse Event|1|||
27922339|NCT00537277|81553915|FG000|Overall Study|Lack of Efficacy|2|||
27922340|NCT00537277|81553915|FG000|Overall Study|Lost to Follow-up|12|||
27922341|NCT00537277|81553915|FG000|Overall Study|Protocol Violation|11|||
27922342|NCT00537277|81553915|FG000|Overall Study|Unclassified|4|||
27922343|NCT00537277|81553915|FG000|Overall Study|Inability to tolerate trial medication|4|||
27922344|NCT00537277|81553915|FG000|Overall Study|Non-compliance with trial procedures|15|||
27922345|NCT02394756|81553924|FG000|Period 1|Lens Discomfort|0|||
27922346|NCT02394756|81553925|FG001|Period 1|Lens Discomfort|0|||
27922347|NCT02394756|81553926|FG002|Period 1|Lens Discomfort|0|||
27922348|NCT02394756|81553927|FG003|Period 1|Lens Discomfort|0|||
27922349|NCT02394756|81553928|FG004|Period 1|Lens Discomfort|0|||
27922350|NCT02394756|81553929|FG005|Period 1|Lens Discomfort|1|||
27922351|NCT02394756|81553924|FG000|Period 1|Withdrawal by Subject|0|||
27922352|NCT02394756|81553925|FG001|Period 1|Withdrawal by Subject|1|||
27922353|NCT02394756|81553926|FG002|Period 1|Withdrawal by Subject|1|||
27922354|NCT02394756|81553927|FG003|Period 1|Withdrawal by Subject|1|||
27543457|NCT02985957|80182208|FG004|Treatment Period|Disease progression|29|||
27543458|NCT02985957|80182209|FG005|Treatment Period|Disease progression|11|||
27922355|NCT02394756|81553928|FG004|Period 1|Withdrawal by Subject|0|||
27922356|NCT02394756|81553929|FG005|Period 1|Withdrawal by Subject|0|||
27922357|NCT02394756|81553924|FG000|Period 2|Unsatisfactory Visual Response|0|||
27922358|NCT02394756|81553925|FG001|Period 2|Unsatisfactory Visual Response|0|||
27922359|NCT02394756|81553926|FG002|Period 2|Unsatisfactory Visual Response|0|||
27922360|NCT02394756|81553927|FG003|Period 2|Unsatisfactory Visual Response|0|||
27922361|NCT02394756|81553928|FG004|Period 2|Unsatisfactory Visual Response|1|||
27922362|NCT02394756|81553929|FG005|Period 2|Unsatisfactory Visual Response|0|||
27922363|NCT02371616|81553930|FG000|Overall Study|Protocol Violation|2|||
27922364|NCT02371616|81553931|FG001|Overall Study|Protocol Violation|1|||
27922365|NCT02371616|81553930|FG000|Overall Study|Adverse Event|0|||
27922366|NCT02371616|81553931|FG001|Overall Study|Adverse Event|1|||
27922367|NCT02371616|81553930|FG000|Overall Study|Withdrawal of Consent|1|||
27922368|NCT02371616|81553931|FG001|Overall Study|Withdrawal of Consent|0|||
27922369|NCT02371616|81553930|FG000|Overall Study|Other (Not specified)|1|||
27922370|NCT02371616|81553931|FG001|Overall Study|Other (Not specified)|5|||
27922371|NCT02426684|81553940|FG000|Overall Study|Physician Decision|1|||
27922372|NCT00819039|81553943|FG000|Overall Study|Physician Decision|1|||
27922373|NCT00819039|81553944|FG001|Overall Study|Physician Decision|0|||
27922374|NCT00819039|81553945|FG002|Overall Study|Physician Decision|1|||
27922375|NCT00819039|81553943|FG000|Overall Study|Protocol Violation|1|||
27922376|NCT00819039|81553944|FG001|Overall Study|Protocol Violation|0|||
27922377|NCT00819039|81553945|FG002|Overall Study|Protocol Violation|0|||
27922378|NCT03311555|81553946|FG000|Overall Study|Adverse Event|1|||
27922379|NCT02391337|81553953|FG000|6 Months Follow-up|Death|5|||
27922380|NCT02391337|81553954|FG001|6 Months Follow-up|Death|4|||
27922381|NCT02391337|81553953|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
27922382|NCT02391337|81553954|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
27922383|NCT02391337|81553953|FG000|12 Months Follow-up|Death|2|||
27922384|NCT02391337|81553954|FG001|12 Months Follow-up|Death|0|||
27922385|NCT02391337|81553953|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
27922386|NCT02391337|81553954|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
27922387|NCT02391337|81553953|FG000|12 Months Follow-up|Lost to Follow-up|0|||
27922388|NCT02391337|81553954|FG001|12 Months Follow-up|Lost to Follow-up|2|||
27922389|NCT02133508|81553963|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
27922390|NCT02133508|81553963|FG000|Overall Study|Death|12|||
27922391|NCT02133508|81553963|FG000|Overall Study|Lost to Follow-up|2|||
27922392|NCT02251275|81553964|FG000|Overall Study|Adverse Event|23|||
27543459|NCT02985957|80182210|FG006|Treatment Period|Disease progression|28|||
27543460|NCT02985957|80182204|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
27922393|NCT02251275|81553965|FG001|Overall Study|Adverse Event|60|||
27922394|NCT02251275|81553966|FG002|Overall Study|Adverse Event|28|||
27922395|NCT02251275|81553967|FG003|Overall Study|Adverse Event|0|||
27543461|NCT02985957|80182205|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
27922396|NCT02251275|81553968|FG004|Overall Study|Adverse Event|0|||
27922397|NCT02251275|81553964|FG000|Overall Study|Lost to Follow-up|5|||
27922398|NCT02251275|81553965|FG001|Overall Study|Lost to Follow-up|6|||
27922399|NCT02251275|81553966|FG002|Overall Study|Lost to Follow-up|4|||
27922400|NCT02251275|81553967|FG003|Overall Study|Lost to Follow-up|0|||
27922401|NCT02251275|81553968|FG004|Overall Study|Lost to Follow-up|0|||
27922402|NCT02251275|81553964|FG000|Overall Study|Physician Decision|19|||
27922403|NCT02251275|81553965|FG001|Overall Study|Physician Decision|30|||
27922404|NCT02251275|81553966|FG002|Overall Study|Physician Decision|26|||
27922405|NCT02251275|81553967|FG003|Overall Study|Physician Decision|0|||
27922406|NCT02251275|81553968|FG004|Overall Study|Physician Decision|1|||
27922407|NCT02251275|81553964|FG000|Overall Study|Protocol Deviation|0|||
27922408|NCT02251275|81553965|FG001|Overall Study|Protocol Deviation|0|||
27922409|NCT02251275|81553966|FG002|Overall Study|Protocol Deviation|1|||
27922410|NCT02251275|81553967|FG003|Overall Study|Protocol Deviation|0|||
27922411|NCT02251275|81553968|FG004|Overall Study|Protocol Deviation|0|||
27922412|NCT02251275|81553964|FG000|Overall Study|Withdrawal by Subject|25|||
27922413|NCT02251275|81553965|FG001|Overall Study|Withdrawal by Subject|51|||
27922414|NCT02251275|81553966|FG002|Overall Study|Withdrawal by Subject|35|||
27922415|NCT02251275|81553967|FG003|Overall Study|Withdrawal by Subject|1|||
27922416|NCT02251275|81553968|FG004|Overall Study|Withdrawal by Subject|0|||
27922417|NCT01548599|81553969|FG000|Overall Study|Lost to Follow-up|0|||
27922418|NCT01548599|81553970|FG001|Overall Study|Lost to Follow-up|1|||
27922419|NCT01548599|81553969|FG000|Overall Study|Withdrawal by Subject|4|||
27922420|NCT01548599|81553970|FG001|Overall Study|Withdrawal by Subject|0|||
27922421|NCT01548599|81553969|FG000|Overall Study|Death|2|||
27922422|NCT01548599|81553970|FG001|Overall Study|Death|1|||
27922423|NCT02029417|81553971|FG000|Overall Study|Death|1|||
27922424|NCT02029417|81553971|FG000|Overall Study|Adverse Event|1|||
27922425|NCT00473083|81553975|FG000|Overall Study|Adverse Event|1|||
27922426|NCT00473083|81553976|FG001|Overall Study|Adverse Event|0|||
27922427|NCT00473083|81553977|FG002|Overall Study|Adverse Event|0|||
27922428|NCT01654276|81553981|FG000|Overall Study|Lack of Efficacy|1|||
27922429|NCT01654276|81553981|FG000|Overall Study|Lost to Follow-up|4|||
27922430|NCT01654276|81553981|FG000|Overall Study|Withdrawal by Subject|1|||
27922431|NCT01030900|81553982|FG000|Overall Study|Not treated due to congestive heart failure|1|||
27922432|NCT01030900|81553982|FG000|Overall Study|Not treated due to rapid disease|1|||
27922433|NCT01933594|81553983|FG000|Overall Study|Lost to Follow-up|1|||
27922434|NCT01933594|81553984|FG001|Overall Study|Lost to Follow-up|0|||
27922435|NCT01933594|81553985|FG002|Overall Study|Lost to Follow-up|0|||
27922436|NCT01933594|81553986|FG003|Overall Study|Lost to Follow-up|0|||
27922437|NCT01933594|81553987|FG004|Overall Study|Lost to Follow-up|1|||
27922438|NCT01933594|81553988|FG005|Overall Study|Lost to Follow-up|0|||
27922439|NCT01933594|81553983|FG000|Overall Study|Ineligible for subsequent study step|0|||
27922440|NCT01933594|81553984|FG001|Overall Study|Ineligible for subsequent study step|0|||
27922441|NCT01933594|81553985|FG002|Overall Study|Ineligible for subsequent study step|0|||
27922442|NCT01933594|81553986|FG003|Overall Study|Ineligible for subsequent study step|0|||
27922443|NCT01933594|81553987|FG004|Overall Study|Ineligible for subsequent study step|1|||
27922444|NCT01933594|81553988|FG005|Overall Study|Ineligible for subsequent study step|0|||
27922445|NCT01316614|81553989|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
27922446|NCT01316614|81553989|FG000|Overall Study|Cytology slides not available for review|4|||
27922447|NCT01316614|81553989|FG000|Overall Study|Cystic lesion|5|||
27922448|NCT01316614|81553989|FG000|Overall Study|Inadequate number of passes|2|||
27922449|NCT01316614|81553989|FG000|Overall Study|Medically unstable|1|||
27922450|NCT01130272|81553993|FG000|Overall Study|Adverse Event|2|||
27922451|NCT01130272|81553994|FG001|Overall Study|Adverse Event|5|||
27922452|NCT01130272|81553995|FG002|Overall Study|Adverse Event|6|||
27922453|NCT01130272|81553996|FG003|Overall Study|Adverse Event|22|||
27922454|NCT01130272|81553997|FG004|Overall Study|Adverse Event|7|||
27922455|NCT01130272|81553993|FG000|Overall Study|IVRS-confirmed constipation|0|||
27922456|NCT01130272|81553994|FG001|Overall Study|IVRS-confirmed constipation|1|||
27922457|NCT01130272|81553995|FG002|Overall Study|IVRS-confirmed constipation|1|||
27922458|NCT01130272|81553996|FG003|Overall Study|IVRS-confirmed constipation|2|||
27922459|NCT01130272|81553997|FG004|Overall Study|IVRS-confirmed constipation|0|||
27922460|NCT01130272|81553993|FG000|Overall Study|Rescue medications due to diarrhea|3|||
27922461|NCT01130272|81553994|FG001|Overall Study|Rescue medications due to diarrhea|5|||
27922462|NCT01130272|81553995|FG002|Overall Study|Rescue medications due to diarrhea|8|||
27922463|NCT01130272|81553996|FG003|Overall Study|Rescue medications due to diarrhea|8|||
27922464|NCT01130272|81553997|FG004|Overall Study|Rescue medications due to diarrhea|6|||
27922465|NCT01130272|81553993|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
27922466|NCT01130272|81553994|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
27922467|NCT01130272|81553995|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
27922468|NCT01130272|81553996|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
27922469|NCT01130272|81553997|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
27922470|NCT01130272|81553993|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27922471|NCT01130272|81553994|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27922472|NCT01130272|81553995|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27922473|NCT01130272|81553996|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
27922474|NCT01130272|81553997|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
27922475|NCT01130272|81553993|FG000|Overall Study|Protocol Violation|0|||
27922476|NCT01130272|81553994|FG001|Overall Study|Protocol Violation|0|||
27922477|NCT01130272|81553995|FG002|Overall Study|Protocol Violation|3|||
27922478|NCT01130272|81553996|FG003|Overall Study|Protocol Violation|5|||
27922479|NCT01130272|81553997|FG004|Overall Study|Protocol Violation|5|||
27922480|NCT01130272|81553993|FG000|Overall Study|Lost to Follow-up|4|||
27922481|NCT01130272|81553994|FG001|Overall Study|Lost to Follow-up|3|||
27922482|NCT01130272|81553995|FG002|Overall Study|Lost to Follow-up|4|||
27922483|NCT01130272|81553996|FG003|Overall Study|Lost to Follow-up|7|||
27922484|NCT01130272|81553997|FG004|Overall Study|Lost to Follow-up|6|||
27922485|NCT01130272|81553993|FG000|Overall Study|Withdrawal by Subject|4|||
27922486|NCT01130272|81553994|FG001|Overall Study|Withdrawal by Subject|11|||
27922487|NCT01130272|81553995|FG002|Overall Study|Withdrawal by Subject|10|||
27922488|NCT01130272|81553996|FG003|Overall Study|Withdrawal by Subject|9|||
27922489|NCT01130272|81553997|FG004|Overall Study|Withdrawal by Subject|8|||
27922490|NCT01130272|81553993|FG000|Overall Study|Physician Decision|1|||
27922491|NCT01130272|81553994|FG001|Overall Study|Physician Decision|1|||
27922492|NCT01130272|81553995|FG002|Overall Study|Physician Decision|0|||
27922493|NCT01130272|81553996|FG003|Overall Study|Physician Decision|1|||
27922494|NCT01130272|81553997|FG004|Overall Study|Physician Decision|2|||
27922495|NCT01130272|81553993|FG000|Overall Study|Sponsor decision|6|||
27922496|NCT01130272|81553994|FG001|Overall Study|Sponsor decision|15|||
27922497|NCT01130272|81553995|FG002|Overall Study|Sponsor decision|16|||
27922498|NCT01130272|81553996|FG003|Overall Study|Sponsor decision|13|||
27922499|NCT01130272|81553997|FG004|Overall Study|Sponsor decision|16|||
27922500|NCT01130272|81553993|FG000|Overall Study|Study arm discontinued|38|||
27922501|NCT01130272|81553994|FG001|Overall Study|Study arm discontinued|0|||
27543462|NCT02985957|80182206|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
27543463|NCT02985957|80182207|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
27543464|NCT02985957|80182208|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
27543465|NCT02985957|80182209|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
27543466|NCT02985957|80182210|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
27543467|NCT02985957|80182204|FG000|Treatment Period|Poor/Non-Compliance|0|||
27922502|NCT01130272|81553995|FG002|Overall Study|Study arm discontinued|0|||
27922503|NCT01130272|81553996|FG003|Overall Study|Study arm discontinued|0|||
27922504|NCT01130272|81553997|FG004|Overall Study|Study arm discontinued|0|||
27922505|NCT04018066|81554000|FG000|Overall Study|participants started taking medications during the study period|3|||
27922506|NCT04018066|81554000|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
27922507|NCT02834975|81554001|FG000|Overall Study|Physician Decision|2|||
27922508|NCT02834975|81554001|FG000|Overall Study|Adverse Event|1|||
27922509|NCT02834975|81554001|FG000|Overall Study|Withdrawal by Subject|1|||
27922510|NCT02834975|81554001|FG000|Overall Study|Lack of Efficacy|1|||
27922511|NCT03427892|81554002|FG000|Overall Study|Lost to Follow-up|2|||
27922512|NCT01963611|81554005|FG000|Overall Study|Adverse Event|1|||
27922513|NCT01963611|81554006|FG001|Overall Study|Adverse Event|1|||
27922514|NCT01963611|81554007|FG002|Overall Study|Adverse Event|3|||
27922515|NCT01963611|81554008|FG003|Overall Study|Adverse Event|4|||
27922516|NCT01963611|81554009|FG004|Overall Study|Adverse Event|3|||
27922517|NCT01963611|81554005|FG000|Overall Study|Protocol Violation|0|||
27922518|NCT01963611|81554006|FG001|Overall Study|Protocol Violation|0|||
27922519|NCT01963611|81554007|FG002|Overall Study|Protocol Violation|0|||
27922520|NCT01963611|81554008|FG003|Overall Study|Protocol Violation|1|||
27922521|NCT01963611|81554009|FG004|Overall Study|Protocol Violation|0|||
27922522|NCT01963611|81554005|FG000|Overall Study|Lack of Efficacy|0|||
27922523|NCT01963611|81554006|FG001|Overall Study|Lack of Efficacy|0|||
27922524|NCT01963611|81554007|FG002|Overall Study|Lack of Efficacy|0|||
27922525|NCT01963611|81554008|FG003|Overall Study|Lack of Efficacy|1|||
27922526|NCT01963611|81554009|FG004|Overall Study|Lack of Efficacy|0|||
27922527|NCT01963611|81554005|FG000|Overall Study|Withdrawal by Subject|3|||
27922528|NCT01963611|81554006|FG001|Overall Study|Withdrawal by Subject|2|||
27922529|NCT01963611|81554007|FG002|Overall Study|Withdrawal by Subject|1|||
27922530|NCT01963611|81554008|FG003|Overall Study|Withdrawal by Subject|1|||
27543468|NCT02985957|80182205|FG001|Treatment Period|Poor/Non-Compliance|0|||
27543469|NCT02985957|80182206|FG002|Treatment Period|Poor/Non-Compliance|0|||
27543470|NCT02985957|80182207|FG003|Treatment Period|Poor/Non-Compliance|0|||
27543471|NCT02985957|80182208|FG004|Treatment Period|Poor/Non-Compliance|1|||
27543472|NCT02985957|80182209|FG005|Treatment Period|Poor/Non-Compliance|1|||
27543473|NCT02985957|80182210|FG006|Treatment Period|Poor/Non-Compliance|0|||
27543474|NCT02985957|80182204|FG000|Treatment Period|Continuing in Treatment Period|0|||
27543475|NCT02985957|80182205|FG001|Treatment Period|Continuing in Treatment Period|1|||
27543476|NCT02985957|80182206|FG002|Treatment Period|Continuing in Treatment Period|0|||
27543477|NCT02985957|80182207|FG003|Treatment Period|Continuing in Treatment Period|4|||
27543478|NCT02985957|80182208|FG004|Treatment Period|Continuing in Treatment Period|4|||
27543479|NCT02985957|80182209|FG005|Treatment Period|Continuing in Treatment Period|0|||
27922531|NCT01963611|81554009|FG004|Overall Study|Withdrawal by Subject|3|||
27922532|NCT01963611|81554005|FG000|Overall Study|Other|47|||
27922533|NCT01963611|81554006|FG001|Overall Study|Other|46|||
27922534|NCT01963611|81554007|FG002|Overall Study|Other|48|||
27922535|NCT01963611|81554008|FG003|Overall Study|Other|45|||
27922536|NCT01963611|81554009|FG004|Overall Study|Other|45|||
27922537|NCT03451071|81554013|FG000|First Vaccine|Withdrawal by Subject|1|||
27922538|NCT03451071|81554013|FG000|Second Vaccine|Lost to Follow-up|19|||
27922539|NCT03451071|81554013|FG000|Third Vaccine|Lost to Follow-up|22|||
27922540|NCT03451071|81554013|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
27922541|NCT05259917|81554014|FG000|Overall Study|Protocol Violation|0|||
27922542|NCT05259917|81554015|FG001|Overall Study|Protocol Violation|0|||
27922543|NCT05259917|81554016|FG002|Overall Study|Protocol Violation|1|||
27922544|NCT05259917|81554017|FG003|Overall Study|Protocol Violation|0|||
27922545|NCT05259917|81554018|FG004|Overall Study|Protocol Violation|0|||
27922546|NCT05259917|81554019|FG005|Overall Study|Protocol Violation|0|||
27922547|NCT05259917|81554014|FG000|Overall Study|Lost to Follow-up|0|||
27922548|NCT05259917|81554015|FG001|Overall Study|Lost to Follow-up|0|||
27922549|NCT05259917|81554016|FG002|Overall Study|Lost to Follow-up|1|||
27922550|NCT05259917|81554017|FG003|Overall Study|Lost to Follow-up|0|||
27922551|NCT05259917|81554018|FG004|Overall Study|Lost to Follow-up|0|||
27922552|NCT05259917|81554019|FG005|Overall Study|Lost to Follow-up|1|||
27922553|NCT05259917|81554014|FG000|Overall Study|Physician Decision|0|||
27922554|NCT05259917|81554015|FG001|Overall Study|Physician Decision|1|||
27922555|NCT05259917|81554016|FG002|Overall Study|Physician Decision|0|||
27922556|NCT05259917|81554017|FG003|Overall Study|Physician Decision|0|||
27922557|NCT05259917|81554018|FG004|Overall Study|Physician Decision|0|||
27922558|NCT05259917|81554019|FG005|Overall Study|Physician Decision|0|||
27922559|NCT05259917|81554014|FG000|Overall Study|Withdrawal by Subject|0|||
27922560|NCT05259917|81554015|FG001|Overall Study|Withdrawal by Subject|1|||
27922561|NCT05259917|81554016|FG002|Overall Study|Withdrawal by Subject|0|||
27922562|NCT05259917|81554017|FG003|Overall Study|Withdrawal by Subject|0|||
27922563|NCT05259917|81554018|FG004|Overall Study|Withdrawal by Subject|1|||
27922564|NCT05259917|81554019|FG005|Overall Study|Withdrawal by Subject|1|||
27922565|NCT05259917|81554014|FG000|Overall Study|Trial Termination by Sponsor|7|||
27922566|NCT05259917|81554015|FG001|Overall Study|Trial Termination by Sponsor|2|||
27922567|NCT05259917|81554016|FG002|Overall Study|Trial Termination by Sponsor|3|||
27922568|NCT05259917|81554017|FG003|Overall Study|Trial Termination by Sponsor|5|||
27922569|NCT05259917|81554018|FG004|Overall Study|Trial Termination by Sponsor|11|||
27922570|NCT05259917|81554019|FG005|Overall Study|Trial Termination by Sponsor|4|||
27922571|NCT05259917|81554014|FG000|Overall Study|Other|1|||
27922572|NCT05259917|81554015|FG001|Overall Study|Other|0|||
27922573|NCT05259917|81554016|FG002|Overall Study|Other|2|||
27922574|NCT05259917|81554017|FG003|Overall Study|Other|0|||
27922575|NCT05259917|81554018|FG004|Overall Study|Other|0|||
27922576|NCT05259917|81554019|FG005|Overall Study|Other|0|||
27922577|NCT02783911|81554023|FG000|Overall Study|Lost to Follow-up|3|||
27922578|NCT02783911|81554024|FG001|Overall Study|Lost to Follow-up|32|||
27922579|NCT03620162|81554025|FG000|Overall Study|Physician Decision|4|||
27922580|NCT03620162|81554026|FG001|Overall Study|Physician Decision|0|||
27922581|NCT03620162|81554027|FG002|Overall Study|Physician Decision|1|||
27922582|NCT03620162|81554028|FG003|Overall Study|Physician Decision|0|||
27922583|NCT03620162|81554029|FG004|Overall Study|Physician Decision|2|||
27922584|NCT03620162|81554025|FG000|Overall Study|Lost to Follow-up|2|||
27922585|NCT03620162|81554026|FG001|Overall Study|Lost to Follow-up|6|||
27922586|NCT03620162|81554027|FG002|Overall Study|Lost to Follow-up|7|||
27922587|NCT03620162|81554028|FG003|Overall Study|Lost to Follow-up|3|||
27922588|NCT03620162|81554029|FG004|Overall Study|Lost to Follow-up|2|||
27922589|NCT03620162|81554025|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
27922590|NCT03620162|81554026|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
27922591|NCT03620162|81554027|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
27922592|NCT03620162|81554028|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
27922593|NCT03620162|81554029|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
27922594|NCT01218308|81554030|FG000|Overall Study|Adverse Event|1|||
27922595|NCT01218308|81554031|FG001|Overall Study|Adverse Event|2|||
27922596|NCT01218308|81554030|FG000|Overall Study|Protocol Violation|0|||
27922597|NCT01218308|81554031|FG001|Overall Study|Protocol Violation|2|||
27922598|NCT01218308|81554030|FG000|Overall Study|Withdrawal by Subject|61|||
27922599|NCT01218308|81554031|FG001|Overall Study|Withdrawal by Subject|64|||
27922600|NCT01218308|81554030|FG000|Overall Study|Lost to Follow-up|27|||
27922601|NCT01218308|81554031|FG001|Overall Study|Lost to Follow-up|31|||
27922602|NCT01218308|81554030|FG000|Overall Study|Other|14|||
27543480|NCT02985957|80182210|FG006|Treatment Period|Continuing in Treatment Period|0|||
27543481|NCT03302234|80182212|FG000|Overall Study|Death|191|||
27741068|NCT00519532|80880816|FG000|Overall Study|Withdrawal by Subject|5|||
27922603|NCT01218308|81554031|FG001|Overall Study|Other|21|||
27922604|NCT01299584|81554033|FG000|Overall Study|Protocol Violation|9|||
27922605|NCT02265510|81554038|FG000|Overall Study|Withdrawal by Subject|1|||
27922606|NCT02265510|81554039|FG001|Overall Study|Withdrawal by Subject|1|||
27543482|NCT03302234|80182213|FG001|Overall Study|Death|192|||
27922607|NCT02265510|81554040|FG002|Overall Study|Withdrawal by Subject|2|||
27922608|NCT02265510|81554041|FG003|Overall Study|Withdrawal by Subject|1|||
27922609|NCT02265510|81554042|FG004|Overall Study|Withdrawal by Subject|0|||
27922610|NCT02265510|81554043|FG005|Overall Study|Withdrawal by Subject|2|||
27543483|NCT03302234|80182212|FG000|Overall Study|Withdrawal by Subject|2|||
27922611|NCT02265510|81554044|FG006|Overall Study|Withdrawal by Subject|0|||
27922612|NCT02265510|81554045|FG007|Overall Study|Withdrawal by Subject|2|||
27922613|NCT02265510|81554046|FG008|Overall Study|Withdrawal by Subject|0|||
27922614|NCT02265510|81554047|FG009|Overall Study|Withdrawal by Subject|0|||
27922615|NCT02265510|81554048|FG010|Overall Study|Withdrawal by Subject|0|||
27922616|NCT02265510|81554049|FG011|Overall Study|Withdrawal by Subject|0|||
27922617|NCT02265510|81554050|FG012|Overall Study|Withdrawal by Subject|1|||
27922618|NCT02265510|81554051|FG013|Overall Study|Withdrawal by Subject|0|||
27922619|NCT02265510|81554038|FG000|Overall Study|Disease Progression|0|||
27922620|NCT02265510|81554039|FG001|Overall Study|Disease Progression|1|||
27922621|NCT02265510|81554040|FG002|Overall Study|Disease Progression|2|||
27922622|NCT02265510|81554041|FG003|Overall Study|Disease Progression|1|||
27922623|NCT02265510|81554042|FG004|Overall Study|Disease Progression|1|||
27922624|NCT02265510|81554043|FG005|Overall Study|Disease Progression|0|||
27922625|NCT02265510|81554044|FG006|Overall Study|Disease Progression|0|||
27922626|NCT02265510|81554045|FG007|Overall Study|Disease Progression|0|||
27922627|NCT02265510|81554046|FG008|Overall Study|Disease Progression|0|||
27922628|NCT02265510|81554047|FG009|Overall Study|Disease Progression|0|||
27922629|NCT02265510|81554048|FG010|Overall Study|Disease Progression|0|||
27922630|NCT02265510|81554049|FG011|Overall Study|Disease Progression|0|||
27922631|NCT02265510|81554050|FG012|Overall Study|Disease Progression|0|||
27922632|NCT02265510|81554051|FG013|Overall Study|Disease Progression|0|||
27922633|NCT02265510|81554038|FG000|Overall Study|Death|2|||
27922634|NCT02265510|81554039|FG001|Overall Study|Death|0|||
27922635|NCT02265510|81554040|FG002|Overall Study|Death|2|||
27922636|NCT02265510|81554041|FG003|Overall Study|Death|2|||
27922637|NCT02265510|81554042|FG004|Overall Study|Death|1|||
27922638|NCT02265510|81554043|FG005|Overall Study|Death|3|||
27922639|NCT02265510|81554044|FG006|Overall Study|Death|2|||
27922640|NCT02265510|81554045|FG007|Overall Study|Death|1|||
27922641|NCT02265510|81554046|FG008|Overall Study|Death|3|||
27922642|NCT02265510|81554047|FG009|Overall Study|Death|3|||
27922643|NCT02265510|81554048|FG010|Overall Study|Death|4|||
27922644|NCT02265510|81554049|FG011|Overall Study|Death|12|||
27922645|NCT02265510|81554050|FG012|Overall Study|Death|7|||
27543484|NCT03302234|80182213|FG001|Overall Study|Withdrawal by Subject|2|||
27543485|NCT03302234|80182212|FG000|Overall Study|Sponsor Decision|90|||
27543486|NCT03302234|80182213|FG001|Overall Study|Sponsor Decision|89|||
27543487|NCT03302234|80182212|FG000|Overall Study|Laryngeal carcinoma|0|||
27543488|NCT03302234|80182213|FG001|Overall Study|Laryngeal carcinoma|1|||
27543489|NCT03302234|80182212|FG000|Overall Study|Not Reported|1|||
27543490|NCT03302234|80182213|FG001|Overall Study|Not Reported|0|||
27543491|NCT02217878|80182214|FG000|Overall Study|required morphine due to chest pain|1|||
27543492|NCT02217878|80182215|FG001|Overall Study|required morphine due to chest pain|2|||
27543493|NCT02217878|80182214|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
27543494|NCT02217878|80182215|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
27543495|NCT05209360|80182216|FG000|Overall Study|Withdrawal by Subject|0|||
27543496|NCT05209360|80182217|FG001|Overall Study|Withdrawal by Subject|0|||
27543497|NCT05209360|80182218|FG002|Overall Study|Withdrawal by Subject|1|||
27543498|NCT05209360|80182219|FG003|Overall Study|Withdrawal by Subject|0|||
27922646|NCT02265510|81554051|FG013|Overall Study|Death|6|||
27922647|NCT02265510|81554038|FG000|Overall Study|Lost to Follow-up|0|||
27922648|NCT02265510|81554039|FG001|Overall Study|Lost to Follow-up|0|||
27922649|NCT02265510|81554040|FG002|Overall Study|Lost to Follow-up|0|||
27922650|NCT02265510|81554041|FG003|Overall Study|Lost to Follow-up|0|||
27922651|NCT02265510|81554042|FG004|Overall Study|Lost to Follow-up|1|||
27922652|NCT02265510|81554043|FG005|Overall Study|Lost to Follow-up|0|||
27922653|NCT02265510|81554044|FG006|Overall Study|Lost to Follow-up|0|||
27922654|NCT02265510|81554045|FG007|Overall Study|Lost to Follow-up|0|||
27922655|NCT02265510|81554046|FG008|Overall Study|Lost to Follow-up|0|||
27922656|NCT02265510|81554047|FG009|Overall Study|Lost to Follow-up|2|||
27922657|NCT02265510|81554048|FG010|Overall Study|Lost to Follow-up|0|||
27922658|NCT02265510|81554049|FG011|Overall Study|Lost to Follow-up|0|||
27543499|NCT05209360|80182220|FG004|Overall Study|Withdrawal by Subject|0|||
27543500|NCT05209360|80182221|FG005|Overall Study|Withdrawal by Subject|0|||
27543501|NCT01487200|80182222|FG000|Overall Study|Withdrawal by Subject|0|||
27543502|NCT01487200|80182223|FG001|Overall Study|Withdrawal by Subject|1|||
27543503|NCT01487200|80182224|FG002|Overall Study|Withdrawal by Subject|0|||
27543504|NCT01487200|80182225|FG003|Overall Study|Withdrawal by Subject|0|||
27922659|NCT02265510|81554050|FG012|Overall Study|Lost to Follow-up|0|||
27922660|NCT02265510|81554051|FG013|Overall Study|Lost to Follow-up|2|||
27922661|NCT02265510|81554038|FG000|Overall Study|Other|0|||
27922662|NCT02265510|81554039|FG001|Overall Study|Other|1|||
27922663|NCT02265510|81554040|FG002|Overall Study|Other|0|||
27922664|NCT02265510|81554041|FG003|Overall Study|Other|0|||
27922665|NCT02265510|81554042|FG004|Overall Study|Other|0|||
27922666|NCT02265510|81554043|FG005|Overall Study|Other|0|||
27543505|NCT02083783|80182229|FG000|Overall Study|Withdrawal by Subject|1|||
27543506|NCT02083783|80182230|FG001|Overall Study|Withdrawal by Subject|0|||
27543507|NCT00134082|80182231|FG000|Overall Study|Adverse Event|2|||
27543508|NCT00134082|80182231|FG000|Overall Study|Death|1|||
27922667|NCT02265510|81554044|FG006|Overall Study|Other|0|||
27922668|NCT02265510|81554045|FG007|Overall Study|Other|0|||
27922669|NCT02265510|81554046|FG008|Overall Study|Other|0|||
27922670|NCT02265510|81554047|FG009|Overall Study|Other|0|||
27922671|NCT02265510|81554048|FG010|Overall Study|Other|0|||
27922672|NCT02265510|81554049|FG011|Overall Study|Other|0|||
27922673|NCT02265510|81554050|FG012|Overall Study|Other|0|||
27922674|NCT02265510|81554051|FG013|Overall Study|Other|0|||
27543509|NCT00847379|80182232|FG000|Overall Study|Study terminated by Sponsor|59|||
27543510|NCT00847379|80182233|FG001|Overall Study|Study terminated by Sponsor|57|||
27543511|NCT00847379|80182234|FG002|Overall Study|Study terminated by Sponsor|57|||
27543512|NCT01970397|80182236|FG000|Overall Study|Adverse Event|0|||
27543513|NCT01970397|80182237|FG001|Overall Study|Adverse Event|1|||
27543514|NCT01970397|80182236|FG000|Overall Study|Lost to Follow-up|0|||
27543515|NCT01970397|80182237|FG001|Overall Study|Lost to Follow-up|1|||
27543516|NCT01970397|80182236|FG000|Overall Study|Personal Reasons|1|||
27543517|NCT01970397|80182237|FG001|Overall Study|Personal Reasons|2|||
27543518|NCT01970397|80182236|FG000|Overall Study|Protocol Violation|1|||
27543519|NCT01970397|80182237|FG001|Overall Study|Protocol Violation|1|||
27543520|NCT02915016|80182243|FG000|Overall Study|Lost to Follow-up|4|||
27922675|NCT02265510|81554038|FG000|Overall Study|Study Terminated by Sponsor|0|||
27922676|NCT02265510|81554039|FG001|Overall Study|Study Terminated by Sponsor|0|||
27922677|NCT02265510|81554040|FG002|Overall Study|Study Terminated by Sponsor|0|||
27922678|NCT02265510|81554041|FG003|Overall Study|Study Terminated by Sponsor|0|||
27922679|NCT02265510|81554042|FG004|Overall Study|Study Terminated by Sponsor|0|||
27922680|NCT02265510|81554043|FG005|Overall Study|Study Terminated by Sponsor|1|||
27922681|NCT02265510|81554044|FG006|Overall Study|Study Terminated by Sponsor|1|||
27922682|NCT02265510|81554045|FG007|Overall Study|Study Terminated by Sponsor|1|||
27922683|NCT02265510|81554046|FG008|Overall Study|Study Terminated by Sponsor|1|||
27922684|NCT02265510|81554047|FG009|Overall Study|Study Terminated by Sponsor|2|||
27922685|NCT02265510|81554048|FG010|Overall Study|Study Terminated by Sponsor|1|||
27922686|NCT02265510|81554049|FG011|Overall Study|Study Terminated by Sponsor|4|||
27922687|NCT02265510|81554050|FG012|Overall Study|Study Terminated by Sponsor|1|||
27922688|NCT02265510|81554051|FG013|Overall Study|Study Terminated by Sponsor|2|||
27922689|NCT03334175|81554055|FG000|Overall Study|Lost to Follow-up|0|||
27922690|NCT03334175|81554056|FG001|Overall Study|Lost to Follow-up|1|||
27922691|NCT01122173|81554057|FG000|Overall Study|Lost to Follow-up|3|||
27922692|NCT01122173|81554057|FG000|Overall Study|Withdrawal by Subject|3|||
27922693|NCT01122173|81554057|FG000|Overall Study|Left study for other reasons|3|||
27922694|NCT00069264|81554058|FG000|Overall Study|Adverse Event|3|||
27922695|NCT00069264|81554058|FG000|Overall Study|Progressive Disease|23|||
27922696|NCT00069264|81554058|FG000|Overall Study|Withdrawal by Subject|3|||
27922697|NCT00069264|81554058|FG000|Overall Study|Discon Therapy|3|||
27922698|NCT02783066|81554059|FG000|Overall Study|Withdrawal by Subject|13|||
27922699|NCT01142336|81554060|FG000|Overall Study|Adverse Event|1|||
27922700|NCT01142336|81554061|FG001|Overall Study|Adverse Event|1|||
27922701|NCT01142336|81554060|FG000|Overall Study|Lost to Follow-up|0|||
27922702|NCT01142336|81554061|FG001|Overall Study|Lost to Follow-up|1|||
27922703|NCT00997893|81556846|FG000|Overall Study|Adverse Event|1|||
27922704|NCT00997893|81556847|FG001|Overall Study|Adverse Event|0|||
27922705|NCT00997893|81556848|FG002|Overall Study|Adverse Event|0|||
27922706|NCT00997893|81556846|FG000|Overall Study|Unable to meet study timelines|1|||
27922707|NCT00997893|81556847|FG001|Overall Study|Unable to meet study timelines|0|||
27922708|NCT00997893|81556848|FG002|Overall Study|Unable to meet study timelines|0|||
27922709|NCT00997893|81556846|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
27922710|NCT00997893|81556847|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
27922711|NCT00997893|81556848|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
27922712|NCT00891813|81556849|FG000|Overall Study|Adverse Event|3|||
27922713|NCT00891813|81556849|FG000|Overall Study|Withdrawal by Subject|1|||
27922714|NCT00891813|81556849|FG000|Overall Study|Patient Noncompliance|6|||
27543521|NCT02915016|80182244|FG001|Overall Study|Lost to Follow-up|2|||
27543522|NCT02915016|80182245|FG002|Overall Study|Lost to Follow-up|5|||
27543523|NCT02915016|80182246|FG003|Overall Study|Lost to Follow-up|3|||
27543524|NCT02915016|80182247|FG004|Overall Study|Lost to Follow-up|5|||
27543525|NCT02915016|80182248|FG005|Overall Study|Lost to Follow-up|2|||
27543526|NCT02915016|80182249|FG006|Overall Study|Lost to Follow-up|8|||
27543527|NCT02915016|80182250|FG007|Overall Study|Lost to Follow-up|2|||
27543528|NCT02915016|80182243|FG000|Overall Study|Physician Decision|0|||
27922715|NCT00891813|81556849|FG000|Overall Study|Protocol Violation|2|||
27922716|NCT00572832|81556850|FG000|Overall Study|Lost to Follow-up|0|||
27922717|NCT00572832|81556851|FG001|Overall Study|Lost to Follow-up|11|||
27922718|NCT00572832|81556850|FG000|Overall Study|Pregnancy|0|||
27922719|NCT00572832|81556851|FG001|Overall Study|Pregnancy|1|||
27922720|NCT01218802|81556852|FG000|Overall Study|Lost to Follow-up|5|||
27922721|NCT01218802|81556853|FG001|Overall Study|Lost to Follow-up|6|||
27922722|NCT01218802|81556852|FG000|Overall Study|Withdrawal by Subject|3|||
27543529|NCT02915016|80182244|FG001|Overall Study|Physician Decision|0|||
27543530|NCT02915016|80182245|FG002|Overall Study|Physician Decision|1|||
27543531|NCT02915016|80182246|FG003|Overall Study|Physician Decision|0|||
27543532|NCT02915016|80182247|FG004|Overall Study|Physician Decision|0|||
27543533|NCT02915016|80182248|FG005|Overall Study|Physician Decision|1|||
27543534|NCT02915016|80182249|FG006|Overall Study|Physician Decision|2|||
27543535|NCT02915016|80182250|FG007|Overall Study|Physician Decision|0|||
27922723|NCT01218802|81556853|FG001|Overall Study|Withdrawal by Subject|10|||
27922724|NCT01218802|81556852|FG000|Overall Study|Adverse Event|0|||
27922725|NCT01218802|81556853|FG001|Overall Study|Adverse Event|2|||
27922726|NCT01218802|81556852|FG000|Overall Study|Incarcerated|2|||
27922727|NCT01218802|81556853|FG001|Overall Study|Incarcerated|0|||
27922728|NCT01829347|81556854|FG000|VTI-210|Death|5|||
27922729|NCT01829347|81556855|FG001|VTI-210|Death|3|||
27922730|NCT01829347|81556854|FG000|VTI-210|Withdrawal by Subject|1|||
27922731|NCT01829347|81556855|FG001|VTI-210|Withdrawal by Subject|0|||
27922732|NCT01829347|81556854|FG000|VTI-210E|Death|2|||
27922733|NCT01829347|81556855|FG001|VTI-210E|Death|1|||
27922734|NCT01829347|81556854|FG000|VTI-210E|Study terminated prematurely|1|||
27922735|NCT01829347|81556855|FG001|VTI-210E|Study terminated prematurely|5|||
27922736|NCT03440320|81556869|FG000|Overall Study|Withdrawal by Subject|0|||
27922737|NCT03440320|81556870|FG001|Overall Study|Withdrawal by Subject|1|||
27922738|NCT02873689|81556871|FG000|Overall Study|Lack of Efficacy|1|||
27922739|NCT02873689|81556872|FG001|Overall Study|Lack of Efficacy|0|||
27922740|NCT02873689|81556871|FG000|Overall Study|Withdrawal by Subject|2|||
27922741|NCT02873689|81556872|FG001|Overall Study|Withdrawal by Subject|2|||
27922742|NCT02873689|81556871|FG000|Overall Study|Protocol Violation|1|||
27922743|NCT02873689|81556872|FG001|Overall Study|Protocol Violation|0|||
27922744|NCT02873689|81556871|FG000|Overall Study|Adverse Event|2|||
27922745|NCT02873689|81556872|FG001|Overall Study|Adverse Event|2|||
27922746|NCT02873689|81556871|FG000|Overall Study|Randomized but not Treated|1|||
27922747|NCT02873689|81556872|FG001|Overall Study|Randomized but not Treated|1|||
27922748|NCT01140906|81556873|FG000|Overall Study|Adverse Event|7|||
27922749|NCT01140906|81556874|FG001|Overall Study|Adverse Event|10|||
27922750|NCT01140906|81556875|FG002|Overall Study|Adverse Event|17|||
27922751|NCT01140906|81556876|FG003|Overall Study|Adverse Event|7|||
27922752|NCT01140906|81556873|FG000|Overall Study|Lack of Efficacy|6|||
27922753|NCT01140906|81556874|FG001|Overall Study|Lack of Efficacy|8|||
27922754|NCT01140906|81556875|FG002|Overall Study|Lack of Efficacy|2|||
27922755|NCT01140906|81556876|FG003|Overall Study|Lack of Efficacy|1|||
27922756|NCT01140906|81556873|FG000|Overall Study|Non-compliance|0|||
27922757|NCT01140906|81556874|FG001|Overall Study|Non-compliance|1|||
27922758|NCT01140906|81556875|FG002|Overall Study|Non-compliance|0|||
27922759|NCT01140906|81556876|FG003|Overall Study|Non-compliance|1|||
27922760|NCT01140906|81556873|FG000|Overall Study|Protocol Violation|5|||
27922761|NCT01140906|81556874|FG001|Overall Study|Protocol Violation|3|||
27922762|NCT01140906|81556875|FG002|Overall Study|Protocol Violation|2|||
27922763|NCT01140906|81556876|FG003|Overall Study|Protocol Violation|1|||
27922764|NCT01140906|81556873|FG000|Overall Study|Withdrawal of consent|6|||
27922765|NCT01140906|81556874|FG001|Overall Study|Withdrawal of consent|6|||
27922766|NCT01140906|81556875|FG002|Overall Study|Withdrawal of consent|2|||
27922767|NCT01140906|81556876|FG003|Overall Study|Withdrawal of consent|2|||
27922768|NCT01140906|81556873|FG000|Overall Study|Lost to Follow-up|1|||
27922769|NCT01140906|81556874|FG001|Overall Study|Lost to Follow-up|1|||
27543536|NCT02915016|80182243|FG000|Overall Study|Withdrawal by Subject|2|||
27543537|NCT02915016|80182244|FG001|Overall Study|Withdrawal by Subject|0|||
27543538|NCT02915016|80182245|FG002|Overall Study|Withdrawal by Subject|1|||
27543539|NCT02915016|80182246|FG003|Overall Study|Withdrawal by Subject|0|||
27543540|NCT02915016|80182247|FG004|Overall Study|Withdrawal by Subject|1|||
27543541|NCT02915016|80182248|FG005|Overall Study|Withdrawal by Subject|3|||
27543542|NCT02915016|80182249|FG006|Overall Study|Withdrawal by Subject|1|||
27543543|NCT02915016|80182250|FG007|Overall Study|Withdrawal by Subject|1|||
27543544|NCT02915016|80182243|FG000|Overall Study|Elected not to continue|0|||
27543545|NCT02915016|80182244|FG001|Overall Study|Elected not to continue|0|||
27543546|NCT02915016|80182245|FG002|Overall Study|Elected not to continue|0|||
27543547|NCT02915016|80182246|FG003|Overall Study|Elected not to continue|1|||
27543548|NCT02915016|80182247|FG004|Overall Study|Elected not to continue|0|||
27543549|NCT02915016|80182248|FG005|Overall Study|Elected not to continue|0|||
27741069|NCT00519532|80880816|FG000|Overall Study|Lost to Follow-up|2|||
27922770|NCT01140906|81556875|FG002|Overall Study|Lost to Follow-up|0|||
27922771|NCT01140906|81556876|FG003|Overall Study|Lost to Follow-up|2|||
27922772|NCT01140906|81556873|FG000|Overall Study|Administrative or other reason|0|||
27922773|NCT01140906|81556874|FG001|Overall Study|Administrative or other reason|5|||
27922774|NCT01140906|81556875|FG002|Overall Study|Administrative or other reason|3|||
27922775|NCT01140906|81556876|FG003|Overall Study|Administrative or other reason|2|||
27922776|NCT01294514|81556883|FG000|Overall Study|Excluded due to Arrhythmia|1|||
27922777|NCT00375752|81556884|FG000|Overall Study|Lack of Efficacy|4|||
27922778|NCT00375752|81556885|FG001|Overall Study|Lack of Efficacy|4|||
27922779|NCT00375752|81556884|FG000|Overall Study|Adverse Event|1|||
27543550|NCT02915016|80182249|FG006|Overall Study|Elected not to continue|1|||
27543551|NCT02915016|80182250|FG007|Overall Study|Elected not to continue|0|||
27543552|NCT02915016|80182243|FG000|Overall Study|HIV infection|1|||
27543553|NCT02915016|80182244|FG001|Overall Study|HIV infection|1|||
27922780|NCT00375752|81556885|FG001|Overall Study|Adverse Event|6|||
27922781|NCT00375752|81556884|FG000|Overall Study|Withdrawal by Subject|6|||
27922782|NCT00375752|81556885|FG001|Overall Study|Withdrawal by Subject|1|||
27543554|NCT02915016|80182245|FG002|Overall Study|HIV infection|1|||
27543555|NCT02915016|80182246|FG003|Overall Study|HIV infection|0|||
27543556|NCT02915016|80182247|FG004|Overall Study|HIV infection|1|||
27543557|NCT02915016|80182248|FG005|Overall Study|HIV infection|0|||
27543558|NCT02915016|80182249|FG006|Overall Study|HIV infection|0|||
27543559|NCT02915016|80182250|FG007|Overall Study|HIV infection|0|||
27922783|NCT00375752|81556884|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
27922784|NCT00375752|81556885|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
27922785|NCT00375752|81556884|FG000|Overall Study|Protocol Violation|0|||
27922786|NCT00375752|81556885|FG001|Overall Study|Protocol Violation|2|||
27922787|NCT00375752|81556884|FG000|Overall Study|Administrative Problems|0|||
27922788|NCT00375752|81556885|FG001|Overall Study|Administrative Problems|1|||
27922789|NCT01648764|81556888|FG000|Overall Study|Progressive Disease|0|||
27922790|NCT01648764|81556889|FG001|Overall Study|Progressive Disease|1|||
27922791|NCT01648764|81556890|FG002|Overall Study|Progressive Disease|0|||
27922792|NCT01648764|81556891|FG003|Overall Study|Progressive Disease|0|||
27543560|NCT02915016|80182243|FG000|Overall Study|Participant unable to adhere|0|||
27543561|NCT02915016|80182244|FG001|Overall Study|Participant unable to adhere|0|||
27543562|NCT02915016|80182245|FG002|Overall Study|Participant unable to adhere|0|||
27543563|NCT02915016|80182246|FG003|Overall Study|Participant unable to adhere|0|||
27543564|NCT02915016|80182247|FG004|Overall Study|Participant unable to adhere|0|||
27543565|NCT02915016|80182248|FG005|Overall Study|Participant unable to adhere|0|||
27543566|NCT02915016|80182249|FG006|Overall Study|Participant unable to adhere|0|||
27543567|NCT02915016|80182250|FG007|Overall Study|Participant unable to adhere|1|||
27543568|NCT00667875|80182255|FG000|Overall Study|Adverse Event|0|||
27543569|NCT00667875|80182256|FG001|Overall Study|Adverse Event|2|||
27543570|NCT00667875|80182257|FG002|Overall Study|Adverse Event|6|||
27543571|NCT00667875|80182255|FG000|Overall Study|Withdrawal by Subject|10|||
27543572|NCT00667875|80182256|FG001|Overall Study|Withdrawal by Subject|9|||
27543573|NCT00667875|80182257|FG002|Overall Study|Withdrawal by Subject|7|||
27543574|NCT02030041|80182258|FG000|Overall Study|Withdrawal by Subject|2|||
27543575|NCT02030041|80182259|FG001|Overall Study|Withdrawal by Subject|2|||
27543576|NCT02030041|80182260|FG002|Overall Study|Withdrawal by Subject|1|||
27637743|NCT02528188|80515885|FG002|Overall Study|Randomized but not treated|12|||
27637744|NCT00186186|80515893|FG000|Overall Study|Lack of Efficacy|3|||
27637745|NCT00186186|80515893|FG000|Overall Study|Withdrawal by Subject|3|||
27637746|NCT00186186|80515893|FG000|Overall Study|Not reported as to reason|2|||
27637747|NCT01677936|80515895|FG000|Overall Study|Lost to Follow-up|4|||
27637748|NCT01677936|80515896|FG001|Overall Study|Lost to Follow-up|1|||
27637749|NCT01677936|80515895|FG000|Overall Study|Protocol Violation|3|||
27637750|NCT01677936|80515896|FG001|Overall Study|Protocol Violation|0|||
27637751|NCT01677936|80515895|FG000|Overall Study|Adverse Event|1|||
27637752|NCT01677936|80515896|FG001|Overall Study|Adverse Event|0|||
27637753|NCT01677936|80515895|FG000|Overall Study|Lost to Follow-up|1|||
27637754|NCT01677936|80515896|FG001|Overall Study|Lost to Follow-up|0|||
27637755|NCT01677936|80515895|FG000|Overall Study|Protocol Violation|0|||
27637756|NCT01677936|80515896|FG001|Overall Study|Protocol Violation|4|||
27637757|NCT04218110|80515897|FG000|Overall Study|Withdrawal by Subject|0|||
27637758|NCT04218110|80515898|FG001|Overall Study|Withdrawal by Subject|0|||
27741070|NCT02795767|80880821|FG000|Overall Study|Received Commercial Emicizumab|1|||
27741071|NCT02795767|80880822|FG001|Overall Study|Received Commercial Emicizumab|0|||
27741072|NCT02795767|80880823|FG002|Overall Study|Received Commercial Emicizumab|0|||
27741073|NCT03000452|80880824|FG000|Treatment Period|Death|1|||
27741074|NCT03000452|80880824|FG000|Treatment Period|Progressive Disease (PD)|14|||
27741075|NCT03000452|80880824|FG000|Treatment Period|Physician Decision|1|||
27741076|NCT03000452|80880824|FG000|Treatment Period|Miscellaneous|2|||
27741077|NCT03000452|80880824|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
27741078|NCT03000452|80880824|FG000|Follow-Up Period|Death|3|||
27741079|NCT03000452|80880824|FG000|Follow-Up Period|Withdrawal by Subject|3|||
27741080|NCT01507545|80880827|FG000|Overall Study|Withdrawal by Subject|6|||
27741081|NCT01507545|80880828|FG001|Overall Study|Withdrawal by Subject|2|||
27741082|NCT01507545|80880827|FG000|Overall Study|Lost to Follow-up|1|||
27741083|NCT01507545|80880828|FG001|Overall Study|Lost to Follow-up|0|||
27922793|NCT01648764|81556892|FG004|Overall Study|Progressive Disease|0|||
27741084|NCT01507545|80880827|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
27741085|NCT01507545|80880828|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
27543577|NCT01727297|80182261|FG000|Overall Study|Death|13|||
27741086|NCT01507545|80880827|FG000|Overall Study|Progressive disease|60|||
27543578|NCT01727297|80182262|FG001|Overall Study|Death|0|||
27543579|NCT01727297|80182261|FG000|Overall Study|Protocol Violation|1|||
27543580|NCT01727297|80182262|FG001|Overall Study|Protocol Violation|10|||
27543581|NCT01727297|80182261|FG000|Overall Study|Adverse Event|3|||
27543582|NCT01727297|80182262|FG001|Overall Study|Adverse Event|1|||
27637759|NCT04218110|80515899|FG002|Overall Study|Withdrawal by Subject|0|||
27637760|NCT04218110|80515900|FG003|Overall Study|Withdrawal by Subject|1|||
27637761|NCT01546753|80515901|FG000|Overall Study|anxiety|1|||
27637762|NCT01546753|80515902|FG001|Overall Study|anxiety|1|||
27543583|NCT01727297|80182261|FG000|Overall Study|Lost to Follow-up|11|||
27543584|NCT01727297|80182262|FG001|Overall Study|Lost to Follow-up|0|||
27543585|NCT01727297|80182261|FG000|Overall Study|Withdrawal by Subject|26|||
27543586|NCT01727297|80182262|FG001|Overall Study|Withdrawal by Subject|27|||
27543587|NCT01727297|80182261|FG000|Overall Study|Physician Decision|19|||
27543588|NCT01727297|80182262|FG001|Overall Study|Physician Decision|5|||
27543589|NCT01727297|80182261|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
27543590|NCT01727297|80182262|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
27543591|NCT01392443|80182265|FG000|Overall Study|Disease progression|30|||
27543592|NCT01392443|80182265|FG000|Overall Study|Adverse Event|24|||
27543593|NCT01392443|80182265|FG000|Overall Study|Death|7|||
27543594|NCT01392443|80182265|FG000|Overall Study|Withdrawal by Subject|5|||
27543595|NCT01392443|80182265|FG000|Overall Study|Lost to Follow-up|1|||
27543596|NCT01392443|80182265|FG000|Overall Study|Protocol Violation|1|||
27543597|NCT04752475|80182266|FG000|Overall Study|Withdrawal by Subject|1|||
27543598|NCT04752475|80182267|FG001|Overall Study|Withdrawal by Subject|1|||
27543599|NCT02969369|80182271|FG000|Study|Adverse Event|1|||
27543600|NCT02969369|80182272|FG001|Study|Adverse Event|6|||
27543601|NCT02969369|80182271|FG000|Study|Lack of Efficacy|0|||
27543602|NCT02969369|80182272|FG001|Study|Lack of Efficacy|1|||
27543603|NCT02969369|80182271|FG000|Study|Lost to Follow-up|0|||
27543604|NCT02969369|80182272|FG001|Study|Lost to Follow-up|1|||
27543605|NCT02969369|80182271|FG000|Study|Withdrawal by Subject|3|||
27543606|NCT02969369|80182272|FG001|Study|Withdrawal by Subject|5|||
27543607|NCT02969369|80182271|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
27543608|NCT02969369|80182272|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
27543609|NCT02969369|80182271|FG000|Double-blind Period|Adverse Event|1|||
27543610|NCT02969369|80182272|FG001|Double-blind Period|Adverse Event|5|||
27543611|NCT02969369|80182271|FG000|Double-blind Period|Lost to Follow-up|0|||
27543612|NCT02969369|80182272|FG001|Double-blind Period|Lost to Follow-up|1|||
27543613|NCT02969369|80182271|FG000|Double-blind Period|Withdrawal by Subject|2|||
27543614|NCT02969369|80182272|FG001|Double-blind Period|Withdrawal by Subject|3|||
27543615|NCT02969369|80182271|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
27543616|NCT02969369|80182272|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
27543617|NCT02969369|80182271|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
27543618|NCT02969369|80182272|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
27543619|NCT02969369|80182271|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
27543620|NCT02969369|80182272|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
27543621|NCT02969369|80182271|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
27543622|NCT02969369|80182272|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
27543623|NCT00190671|80182273|FG000|Overall Study|Satisfactory Response|4|||
27543624|NCT00190671|80182274|FG001|Overall Study|Satisfactory Response|7|||
27543625|NCT00190671|80182273|FG000|Overall Study|Lack of Efficacy|19|||
27543626|NCT00190671|80182274|FG001|Overall Study|Lack of Efficacy|24|||
27543627|NCT00190671|80182273|FG000|Overall Study|Death from Study Disease|1|||
27543628|NCT00190671|80182274|FG001|Overall Study|Death from Study Disease|1|||
27543629|NCT00190671|80182273|FG000|Overall Study|Adverse Event|3|||
27543630|NCT00190671|80182274|FG001|Overall Study|Adverse Event|2|||
27543631|NCT00190671|80182273|FG000|Overall Study|Clinical Relapse|0|||
27543632|NCT00190671|80182274|FG001|Overall Study|Clinical Relapse|1|||
27543633|NCT00190671|80182273|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
27543634|NCT00190671|80182274|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
27543635|NCT00190671|80182273|FG000|Overall Study|Death from Other Causes|0|||
27543636|NCT00190671|80182274|FG001|Overall Study|Death from Other Causes|2|||
27543637|NCT00190671|80182273|FG000|Overall Study|Protocol Violation|0|||
27543638|NCT00190671|80182274|FG001|Overall Study|Protocol Violation|1|||
27543639|NCT00190671|80182273|FG000|Overall Study|Withdrawal by Subject|0|||
27543640|NCT00190671|80182274|FG001|Overall Study|Withdrawal by Subject|2|||
27543641|NCT00282984|80182276|FG000|Overall Study|Death|2|||
27543642|NCT00282984|80182277|FG001|Overall Study|Death|5|||
27543643|NCT00282984|80182276|FG000|Overall Study|Adverse Event|8|||
27543644|NCT00282984|80182277|FG001|Overall Study|Adverse Event|5|||
27543645|NCT00282984|80182276|FG000|Overall Study|Lack of Efficacy|0|||
27543646|NCT00282984|80182277|FG001|Overall Study|Lack of Efficacy|2|||
27543647|NCT00282984|80182276|FG000|Overall Study|Lost to Follow-up|14|||
27543648|NCT00282984|80182277|FG001|Overall Study|Lost to Follow-up|10|||
27543649|NCT00282984|80182276|FG000|Overall Study|Withdrawal by Participant|22|||
27543650|NCT00282984|80182277|FG001|Overall Study|Withdrawal by Participant|34|||
27543651|NCT00282984|80182276|FG000|Overall Study|Participant stopped study medication|2|||
27543652|NCT00282984|80182277|FG001|Overall Study|Participant stopped study medication|2|||
27543653|NCT00282984|80182276|FG000|Overall Study|Participant only allowed phone follow-up|0|||
27543654|NCT00282984|80182277|FG001|Overall Study|Participant only allowed phone follow-up|1|||
27543655|NCT00282984|80182276|FG000|Overall Study|Participant used antipsychosis meds|0|||
27543656|NCT00282984|80182277|FG001|Overall Study|Participant used antipsychosis meds|1|||
27543657|NCT00282984|80182276|FG000|Overall Study|lack of motivation|1|||
27543658|NCT00282984|80182277|FG001|Overall Study|lack of motivation|0|||
27637763|NCT01546753|80515901|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
27637764|NCT01546753|80515902|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
27637765|NCT03740009|80515903|FG000|Overall Study|Physician Decision|9|||
27637766|NCT03740009|80515903|FG000|Overall Study|Lost to Follow-up|1|||
27637767|NCT01318382|80515909|FG000|Overall Study|Physician Decision|2|||
27637768|NCT01318382|80515909|FG000|Overall Study|Device Malfunction|10|||
27637769|NCT01318382|80515909|FG000|Overall Study|Protocol Violation|1|||
27637770|NCT04867902|80515910|FG000|Overall Study|Lost to Follow-up|1|||
27637771|NCT04867902|80515910|FG000|Overall Study|Withdrawal by Subject|2|||
27637772|NCT04867902|80515910|FG000|Overall Study|Protocol Violation|1|||
27637773|NCT01278394|80515911|FG000|Overall Study|Lost to Follow-up|1|||
27637774|NCT00807937|80515912|FG000|Overall Study|Adverse Event|12|||
27637775|NCT00807937|80515913|FG001|Overall Study|Adverse Event|12|||
27637776|NCT00807937|80515914|FG002|Overall Study|Adverse Event|5|||
27637777|NCT00807937|80515915|FG003|Overall Study|Adverse Event|4|||
27637778|NCT00807937|80515912|FG000|Overall Study|Protocol Violation|4|||
27637779|NCT00807937|80515913|FG001|Overall Study|Protocol Violation|5|||
27637780|NCT00807937|80515914|FG002|Overall Study|Protocol Violation|3|||
27637781|NCT00807937|80515915|FG003|Overall Study|Protocol Violation|3|||
27637782|NCT00807937|80515912|FG000|Overall Study|Withdrawal by Subject|5|||
27637783|NCT00807937|80515913|FG001|Overall Study|Withdrawal by Subject|4|||
27637784|NCT00807937|80515914|FG002|Overall Study|Withdrawal by Subject|1|||
27637785|NCT00807937|80515915|FG003|Overall Study|Withdrawal by Subject|4|||
27637786|NCT00807937|80515912|FG000|Overall Study|Lost to Follow-up|4|||
27637787|NCT00807937|80515913|FG001|Overall Study|Lost to Follow-up|0|||
27637788|NCT00807937|80515914|FG002|Overall Study|Lost to Follow-up|2|||
27637789|NCT00807937|80515915|FG003|Overall Study|Lost to Follow-up|1|||
27637790|NCT00807937|80515912|FG000|Overall Study|Lack of Efficacy|0|||
27637791|NCT00807937|80515913|FG001|Overall Study|Lack of Efficacy|0|||
27637792|NCT00807937|80515914|FG002|Overall Study|Lack of Efficacy|1|||
27637793|NCT00807937|80515915|FG003|Overall Study|Lack of Efficacy|2|||
27637794|NCT00807937|80515912|FG000|Overall Study|Intake of prohibited medicine|0|||
27637795|NCT00807937|80515913|FG001|Overall Study|Intake of prohibited medicine|0|||
27637796|NCT00807937|80515914|FG002|Overall Study|Intake of prohibited medicine|2|||
27637797|NCT00807937|80515915|FG003|Overall Study|Intake of prohibited medicine|0|||
27637798|NCT00807937|80515912|FG000|Overall Study|All other reasons (not provided)|2|||
27637799|NCT00807937|80515913|FG001|Overall Study|All other reasons (not provided)|4|||
27637800|NCT00807937|80515914|FG002|Overall Study|All other reasons (not provided)|0|||
27637801|NCT00807937|80515915|FG003|Overall Study|All other reasons (not provided)|1|||
27637802|NCT03051165|80515916|FG000|Overall Study|Withdrawal by Subject|1|||
27637803|NCT03051165|80515916|FG000|Overall Study|Early termination of study|12|||
27637804|NCT02769858|80515917|FG000|Overall Study|Withdrawal by Subject|2|||
27637805|NCT00818454|80515919|FG000|Treatment Period 1|Adverse Event|0|||
27637806|NCT00818454|80515920|FG001|Treatment Period 1|Adverse Event|1|||
27637807|NCT00818454|80515921|FG002|Treatment Period 1|Adverse Event|0|||
27637808|NCT00818454|80515922|FG003|Treatment Period 1|Adverse Event|0|||
27922794|NCT01648764|81556893|FG005|Overall Study|Progressive Disease|1|||
27922795|NCT01648764|81556894|FG006|Overall Study|Progressive Disease|1|||
27922796|NCT01648764|81556895|FG007|Overall Study|Progressive Disease|0|||
27922797|NCT01648764|81556896|FG008|Overall Study|Progressive Disease|0|||
27543659|NCT00282984|80182276|FG000|Overall Study|in prison|0|||
27543660|NCT00282984|80182277|FG001|Overall Study|in prison|1|||
27543661|NCT00282984|80182276|FG000|Overall Study|Protocol Violation|2|||
27543662|NCT00282984|80182277|FG001|Overall Study|Protocol Violation|0|||
27543663|NCT00345839|80182284|FG000|Overall Study|Withdrawal by Subject|91|||
27543664|NCT00345839|80182285|FG001|Overall Study|Withdrawal by Subject|98|||
27543665|NCT00345839|80182284|FG000|Overall Study|Lost to Follow-up|58|||
27543666|NCT00345839|80182285|FG001|Overall Study|Lost to Follow-up|61|||
27543667|NCT01269463|80182292|FG000|First Intervention|Withdrawal by Subject|1|||
27637809|NCT00818454|80515919|FG000|Treatment Period 1|Other|3|||
27637810|NCT00818454|80515920|FG001|Treatment Period 1|Other|0|||
27922798|NCT01648764|81556897|FG009|Overall Study|Progressive Disease|2|||
27922799|NCT01648764|81556898|FG010|Overall Study|Progressive Disease|0|||
27922800|NCT01648764|81556899|FG011|Overall Study|Progressive Disease|1|||
27922801|NCT01648764|81556900|FG012|Overall Study|Progressive Disease|2|||
27922802|NCT01648764|81556901|FG013|Overall Study|Progressive Disease|1|||
27922803|NCT01648764|81556888|FG000|Overall Study|Adverse Event|0|||
27922804|NCT01648764|81556889|FG001|Overall Study|Adverse Event|0|||
27637811|NCT00818454|80515921|FG002|Treatment Period 1|Other|0|||
27637812|NCT00818454|80515922|FG003|Treatment Period 1|Other|0|||
27637813|NCT00818454|80515919|FG000|Washout Period of 1 Week|Adverse Event|1|||
27637814|NCT00818454|80515920|FG001|Washout Period of 1 Week|Adverse Event|1|||
27637815|NCT00818454|80515921|FG002|Washout Period of 1 Week|Adverse Event|0|||
27543668|NCT01269463|80182293|FG001|First Intervention|Withdrawal by Subject|0|||
27543669|NCT01269463|80182292|FG000|First Intervention|Adverse Event|1|||
27543670|NCT01269463|80182293|FG001|First Intervention|Adverse Event|0|||
27637816|NCT00818454|80515922|FG003|Washout Period of 1 Week|Adverse Event|0|||
27637817|NCT00818454|80515919|FG000|Washout Period of 1 Week|Protocol Violation|2|||
27922805|NCT01648764|81556890|FG002|Overall Study|Adverse Event|0|||
27543671|NCT01269463|80182292|FG000|First Intervention|Lack of Efficacy|0|||
27922806|NCT01648764|81556891|FG003|Overall Study|Adverse Event|0|||
27922807|NCT01648764|81556892|FG004|Overall Study|Adverse Event|0|||
27922808|NCT01648764|81556893|FG005|Overall Study|Adverse Event|1|||
27922809|NCT01648764|81556894|FG006|Overall Study|Adverse Event|0|||
27922810|NCT01648764|81556895|FG007|Overall Study|Adverse Event|0|||
27922811|NCT01648764|81556896|FG008|Overall Study|Adverse Event|0|||
27922812|NCT01648764|81556897|FG009|Overall Study|Adverse Event|1|||
27922813|NCT01648764|81556898|FG010|Overall Study|Adverse Event|0|||
27922814|NCT01648764|81556899|FG011|Overall Study|Adverse Event|3|||
27922815|NCT01648764|81556900|FG012|Overall Study|Adverse Event|1|||
27922816|NCT01648764|81556901|FG013|Overall Study|Adverse Event|1|||
27922817|NCT01648764|81556888|FG000|Overall Study|Death|0|||
27922818|NCT01648764|81556889|FG001|Overall Study|Death|0|||
27922819|NCT01648764|81556890|FG002|Overall Study|Death|0|||
27922820|NCT01648764|81556891|FG003|Overall Study|Death|0|||
27922821|NCT01648764|81556892|FG004|Overall Study|Death|0|||
27922822|NCT01648764|81556893|FG005|Overall Study|Death|0|||
27922823|NCT01648764|81556894|FG006|Overall Study|Death|1|||
27922824|NCT01648764|81556895|FG007|Overall Study|Death|0|||
27922825|NCT01648764|81556896|FG008|Overall Study|Death|0|||
27922826|NCT01648764|81556897|FG009|Overall Study|Death|0|||
27922827|NCT01648764|81556898|FG010|Overall Study|Death|0|||
27922828|NCT01648764|81556899|FG011|Overall Study|Death|0|||
27922829|NCT01648764|81556900|FG012|Overall Study|Death|0|||
27922830|NCT01648764|81556901|FG013|Overall Study|Death|1|||
27922831|NCT01648764|81556888|FG000|Overall Study|Withdrawal by Subject|0|||
27922832|NCT01648764|81556889|FG001|Overall Study|Withdrawal by Subject|0|||
27922833|NCT01648764|81556890|FG002|Overall Study|Withdrawal by Subject|0|||
27922834|NCT01648764|81556891|FG003|Overall Study|Withdrawal by Subject|0|||
27922835|NCT01648764|81556892|FG004|Overall Study|Withdrawal by Subject|0|||
27922836|NCT01648764|81556893|FG005|Overall Study|Withdrawal by Subject|0|||
27922837|NCT01648764|81556894|FG006|Overall Study|Withdrawal by Subject|2|||
27922838|NCT01648764|81556895|FG007|Overall Study|Withdrawal by Subject|0|||
27922839|NCT01648764|81556896|FG008|Overall Study|Withdrawal by Subject|0|||
27922840|NCT01648764|81556897|FG009|Overall Study|Withdrawal by Subject|0|||
27922841|NCT01648764|81556898|FG010|Overall Study|Withdrawal by Subject|0|||
27922842|NCT01648764|81556899|FG011|Overall Study|Withdrawal by Subject|0|||
27922843|NCT01648764|81556900|FG012|Overall Study|Withdrawal by Subject|1|||
27922844|NCT01648764|81556901|FG013|Overall Study|Withdrawal by Subject|0|||
27922845|NCT01648764|81556888|FG000|Overall Study|Investigator Decision|0|||
27922846|NCT01648764|81556889|FG001|Overall Study|Investigator Decision|0|||
27922847|NCT01648764|81556890|FG002|Overall Study|Investigator Decision|0|||
27922848|NCT01648764|81556891|FG003|Overall Study|Investigator Decision|0|||
27922849|NCT01648764|81556892|FG004|Overall Study|Investigator Decision|0|||
27922850|NCT01648764|81556893|FG005|Overall Study|Investigator Decision|0|||
27922851|NCT01648764|81556894|FG006|Overall Study|Investigator Decision|1|||
27922852|NCT01648764|81556895|FG007|Overall Study|Investigator Decision|0|||
27922853|NCT01648764|81556896|FG008|Overall Study|Investigator Decision|0|||
27922854|NCT01648764|81556897|FG009|Overall Study|Investigator Decision|0|||
27922855|NCT01648764|81556898|FG010|Overall Study|Investigator Decision|0|||
27922856|NCT01648764|81556899|FG011|Overall Study|Investigator Decision|1|||
27922857|NCT01648764|81556900|FG012|Overall Study|Investigator Decision|0|||
27922858|NCT01648764|81556901|FG013|Overall Study|Investigator Decision|0|||
27922859|NCT02014272|81556904|FG000|Intervention Period 1|Withdrawal by Subject|1|||
27922860|NCT02014272|81556905|FG001|Intervention Period 1|Withdrawal by Subject|0|||
27922861|NCT02014272|81556904|FG000|Intervention Period 1|Adverse Event|0|||
27922862|NCT02014272|81556905|FG001|Intervention Period 1|Adverse Event|1|||
27922863|NCT00961064|81556908|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
27922864|NCT00961064|81556908|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
27922865|NCT00961064|81556908|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
27922866|NCT00961064|81556908|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
27922867|NCT00961064|81556908|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
27922868|NCT00961064|81556908|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
27922869|NCT00961064|81556908|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
27922870|NCT00961064|81556908|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
27543672|NCT01269463|80182293|FG001|First Intervention|Lack of Efficacy|1|||
27543673|NCT01269463|80182292|FG000|First Intervention|Physician Decision|0|||
27543674|NCT01269463|80182293|FG001|First Intervention|Physician Decision|1|||
27922871|NCT01516216|81556911|FG000|Overall Study|Adverse Event|2|||
27922872|NCT01516216|81556912|FG001|Overall Study|Adverse Event|4|||
27922873|NCT01516216|81556911|FG000|Overall Study|Disease Progression|38|||
27543675|NCT00814164|80182295|FG000|Overall Study|Progression|7|||
27922874|NCT01516216|81556912|FG001|Overall Study|Disease Progression|34|||
27922875|NCT01516216|81556911|FG000|Overall Study|Withdrawal by Subject|9|||
27922876|NCT01516216|81556912|FG001|Overall Study|Withdrawal by Subject|11|||
27922877|NCT01516216|81556911|FG000|Overall Study|Potentially Curative Resection|6|||
27922878|NCT01516216|81556912|FG001|Overall Study|Potentially Curative Resection|12|||
27922879|NCT01516216|81556911|FG000|Overall Study|Nonadherence|2|||
27922880|NCT01516216|81556912|FG001|Overall Study|Nonadherence|3|||
27922881|NCT01516216|81556911|FG000|Overall Study|Physician Decision|6|||
27922882|NCT01516216|81556912|FG001|Overall Study|Physician Decision|3|||
27922883|NCT01516216|81556911|FG000|Overall Study|Prolonged Treatment Delay|5|||
27922884|NCT01516216|81556912|FG001|Overall Study|Prolonged Treatment Delay|1|||
27922885|NCT01516216|81556911|FG000|Overall Study|Intercurrent Illness|1|||
27922886|NCT01516216|81556912|FG001|Overall Study|Intercurrent Illness|0|||
27922887|NCT01516216|81556911|FG000|Overall Study|Death|1|||
27922888|NCT01516216|81556912|FG001|Overall Study|Death|1|||
27922889|NCT01259245|81556914|FG000|Overall Study|Withdrawal by Subject|27|||
27543676|NCT00814164|80182295|FG000|Overall Study|not stated|7|||
27543677|NCT00814164|80182295|FG000|Overall Study|Death|5|||
27543678|NCT03230097|80182300|FG000|Overall Study|Adverse Event|2|||
27543679|NCT03230097|80182301|FG001|Overall Study|Adverse Event|1|||
27543680|NCT03230097|80182300|FG000|Overall Study|non-compliance|0|||
27543681|NCT03230097|80182301|FG001|Overall Study|non-compliance|1|||
27543682|NCT03230097|80182300|FG000|Overall Study|Lost to Follow-up|2|||
27543683|NCT03230097|80182301|FG001|Overall Study|Lost to Follow-up|4|||
27543684|NCT03230097|80182300|FG000|Overall Study|Withdrawal by Subject|7|||
27543685|NCT03230097|80182301|FG001|Overall Study|Withdrawal by Subject|3|||
27543686|NCT03230097|80182300|FG000|Overall Study|Trial termination|4|||
27543687|NCT03230097|80182301|FG001|Overall Study|Trial termination|5|||
27543688|NCT03230097|80182300|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
27543689|NCT03230097|80182301|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
27543690|NCT03230097|80182300|FG000|Overall Study|outcome event|0|||
27543691|NCT03230097|80182301|FG001|Overall Study|outcome event|1|||
27543692|NCT03298867|80182305|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
27543693|NCT03298867|80182306|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
27543694|NCT03298867|80182305|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
27543695|NCT03298867|80182306|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
27543696|NCT03298867|80182305|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
27543697|NCT03298867|80182306|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
27543698|NCT03298867|80182305|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
27543699|NCT03298867|80182306|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
27543700|NCT03298867|80182305|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
27543701|NCT03298867|80182306|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
27543702|NCT03298867|80182305|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
27543703|NCT03298867|80182306|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
27543704|NCT03298867|80182305|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
27543705|NCT03298867|80182306|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
27543706|NCT03298867|80182305|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
27543707|NCT03298867|80182306|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
27543708|NCT03298867|80182305|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
27543709|NCT03298867|80182306|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
27543710|NCT00221403|80182311|FG000|Overall Study|Protocol Violation|1|||
27543711|NCT00221403|80182312|FG001|Overall Study|Protocol Violation|0|||
27543712|NCT00221403|80182313|FG002|Overall Study|Protocol Violation|0|||
27543713|NCT00221403|80182311|FG000|Overall Study|Physician Decision|1|||
27543714|NCT00221403|80182312|FG001|Overall Study|Physician Decision|0|||
27543715|NCT00221403|80182313|FG002|Overall Study|Physician Decision|0|||
27543716|NCT00221403|80182311|FG000|Overall Study|Withdrawal by Subject|0|||
27543717|NCT00221403|80182312|FG001|Overall Study|Withdrawal by Subject|3|||
27543718|NCT00221403|80182313|FG002|Overall Study|Withdrawal by Subject|0|||
27543719|NCT00221403|80182311|FG000|Overall Study|Lack of Efficacy|0|||
27543720|NCT00221403|80182312|FG001|Overall Study|Lack of Efficacy|1|||
27543721|NCT00221403|80182313|FG002|Overall Study|Lack of Efficacy|0|||
27543722|NCT00221403|80182311|FG000|Overall Study|Adverse Event|0|||
27543723|NCT00221403|80182312|FG001|Overall Study|Adverse Event|1|||
27543724|NCT00221403|80182313|FG002|Overall Study|Adverse Event|0|||
27543725|NCT02339584|80182317|FG000|Overall Study|Adverse Event|11|||
27543726|NCT02339584|80182318|FG001|Overall Study|Adverse Event|7|||
27543727|NCT02339584|80182317|FG000|Overall Study|Lack of Efficacy|0|||
27543728|NCT02339584|80182318|FG001|Overall Study|Lack of Efficacy|1|||
27543729|NCT02339584|80182317|FG000|Overall Study|Physician Decision|1|||
27922890|NCT01259245|81556915|FG001|Overall Study|Withdrawal by Subject|24|||
27922891|NCT01259245|81556914|FG000|Overall Study|Death|1|||
27922892|NCT01259245|81556915|FG001|Overall Study|Death|2|||
27637818|NCT00818454|80515920|FG001|Washout Period of 1 Week|Protocol Violation|0|||
27637819|NCT00818454|80515921|FG002|Washout Period of 1 Week|Protocol Violation|0|||
27922893|NCT00797563|81556923|FG000|Overall Study|Adverse Event|1|||
27922894|NCT00720759|81556924|FG000|Overall Study|Lost to Follow-up|0|||
27922895|NCT00720759|81556925|FG001|Overall Study|Lost to Follow-up|1|||
27637820|NCT00818454|80515922|FG003|Washout Period of 1 Week|Protocol Violation|0|||
27637821|NCT00818454|80515919|FG000|Washout Period of 1 Week|Other|1|||
27637822|NCT00818454|80515920|FG001|Washout Period of 1 Week|Other|2|||
27637823|NCT00818454|80515921|FG002|Washout Period of 1 Week|Other|0|||
27637824|NCT00818454|80515922|FG003|Washout Period of 1 Week|Other|0|||
27637825|NCT00818454|80515919|FG000|Treatment Period 2|Other|2|||
27637826|NCT00818454|80515920|FG001|Treatment Period 2|Other|1|||
27637827|NCT00818454|80515921|FG002|Treatment Period 2|Other|0|||
27637828|NCT00818454|80515922|FG003|Treatment Period 2|Other|0|||
27637829|NCT00818454|80515919|FG000|Treatment Period 3|Adverse Event|0|||
27637830|NCT00818454|80515920|FG001|Treatment Period 3|Adverse Event|0|||
27637831|NCT00818454|80515921|FG002|Treatment Period 3|Adverse Event|0|||
27543730|NCT02339584|80182318|FG001|Overall Study|Physician Decision|2|||
27543731|NCT02339584|80182317|FG000|Overall Study|Protocol Violation|1|||
27543732|NCT02339584|80182318|FG001|Overall Study|Protocol Violation|1|||
27543733|NCT02339584|80182317|FG000|Overall Study|Withdrawal by Subject|2|||
27543734|NCT02339584|80182318|FG001|Overall Study|Withdrawal by Subject|4|||
27543735|NCT03600818|80182319|FG000|Overall Study|Adverse Event|4|||
27543736|NCT03600818|80182320|FG001|Overall Study|Adverse Event|7|||
27543737|NCT03600818|80182319|FG000|Overall Study|Lack of Efficacy|9|||
27543738|NCT03600818|80182320|FG001|Overall Study|Lack of Efficacy|4|||
27543739|NCT03600818|80182319|FG000|Overall Study|Withdrawal by Subject|4|||
27543740|NCT03600818|80182320|FG001|Overall Study|Withdrawal by Subject|3|||
27543741|NCT03600818|80182319|FG000|Overall Study|Other-unspecified|5|||
27543742|NCT03600818|80182320|FG001|Overall Study|Other-unspecified|3|||
27543743|NCT03600818|80182319|FG000|Overall Study|Randomized and not treated|0|||
27543744|NCT03600818|80182320|FG001|Overall Study|Randomized and not treated|1|||
27543745|NCT02099708|80182321|FG000|Overall Study|Data Not Available|30|||
27543746|NCT02099708|80182321|FG000|Overall Study|Lost to Follow-up|141|||
27543747|NCT02099708|80182321|FG000|Overall Study|Other|29|||
27543748|NCT01281865|80182322|FG000|Overall Study|Adverse Event|1|||
27543749|NCT01281865|80182323|FG001|Overall Study|Adverse Event|1|||
27543750|NCT01281865|80182322|FG000|Overall Study|Withdrawal by Subject|1|||
27543751|NCT01281865|80182323|FG001|Overall Study|Withdrawal by Subject|0|||
27543752|NCT01281865|80182322|FG000|Overall Study|Lack of Efficacy|1|||
27543753|NCT01281865|80182323|FG001|Overall Study|Lack of Efficacy|0|||
27543754|NCT00114530|80182324|FG000|Overall Study|Death|3|||
27543755|NCT00114530|80182325|FG001|Overall Study|Death|11|||
27543756|NCT00114530|80182324|FG000|Overall Study|Lost to Follow-up|1|||
27543757|NCT00114530|80182325|FG001|Overall Study|Lost to Follow-up|1|||
27543758|NCT00114530|80182324|FG000|Overall Study|Physician Decision|1|||
27543759|NCT00114530|80182325|FG001|Overall Study|Physician Decision|1|||
27543760|NCT00114530|80182324|FG000|Overall Study|Withdrawal by Subject|2|||
27543761|NCT00114530|80182325|FG001|Overall Study|Withdrawal by Subject|6|||
27543762|NCT00114530|80182324|FG000|Overall Study|Breast Cancer|1|||
27543763|NCT00114530|80182325|FG001|Overall Study|Breast Cancer|0|||
27543764|NCT00114530|80182324|FG000|Overall Study|Subject decision after endpoint failure|0|||
27543765|NCT00114530|80182325|FG001|Overall Study|Subject decision after endpoint failure|1|||
27543766|NCT00114530|80182324|FG000|Overall Study|Ineligible|1|||
27543767|NCT00114530|80182325|FG001|Overall Study|Ineligible|0|||
27543768|NCT02695329|80182326|FG000|Overall Study|Adverse Event|1|||
27543769|NCT02695329|80182327|FG001|Overall Study|Adverse Event|0|||
27543770|NCT02695329|80182326|FG000|Overall Study|Poor X-ray quality for measurement|4|||
27543771|NCT02695329|80182327|FG001|Overall Study|Poor X-ray quality for measurement|5|||
27543772|NCT02610725|80182328|FG000|Overall Study|Lost to Follow-up|197|||
27543773|NCT02610725|80182328|FG000|Overall Study|self-reported contraindication|9|||
27543774|NCT01781975|80182331|FG000|Overall Study|Death|1|||
27543775|NCT01781975|80182332|FG001|Overall Study|Death|0|||
27543776|NCT01781975|80182331|FG000|Overall Study|Withdrawal by Subject|1|||
27543777|NCT01781975|80182332|FG001|Overall Study|Withdrawal by Subject|1|||
27543778|NCT00261807|80182333|FG000|Overall Study|Lost to Follow-up|2|||
27543779|NCT00261807|80182333|FG000|Overall Study|Adverse Event|2|||
27543780|NCT00261807|80182333|FG000|Overall Study|Death|1|||
27543781|NCT00261807|80182333|FG000|Overall Study|Protocol Violation|2|||
27543782|NCT02742441|80182334|FG000|Overall Study|Lost to Follow-up|4|||
27543783|NCT02742441|80182335|FG001|Overall Study|Lost to Follow-up|4|||
27543784|NCT02742441|80182334|FG000|Overall Study|Withdrawal by Subject|2|||
27543785|NCT02742441|80182335|FG001|Overall Study|Withdrawal by Subject|2|||
27543786|NCT02742441|80182334|FG000|Overall Study|Adverse Event|0|||
27543787|NCT02742441|80182335|FG001|Overall Study|Adverse Event|2|||
27543788|NCT02166905|80182338|FG000|Overall Study|Withdrawal by Subject|1|||
27543789|NCT02166905|80182339|FG001|Overall Study|Withdrawal by Subject|0|||
27637832|NCT00818454|80515922|FG003|Treatment Period 3|Adverse Event|1|||
27543790|NCT02166905|80182340|FG002|Overall Study|Withdrawal by Subject|0|||
27543791|NCT02166905|80182341|FG003|Overall Study|Withdrawal by Subject|0|||
27543792|NCT00538291|80182342|FG000|Overall Study|Adverse Event|2|||
27543793|NCT00538291|80182342|FG000|Overall Study|Withdrawal by Subject|1|||
27637833|NCT04484935|80515923|FG000|Overall Study|Other|0|||
27637834|NCT04484935|80515924|FG001|Overall Study|Other|1|||
27637835|NCT04484935|80515923|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27922896|NCT00720759|81556926|FG002|Overall Study|Lost to Follow-up|1|||
27922897|NCT00720759|81556927|FG003|Overall Study|Lost to Follow-up|0|||
27922898|NCT00207740|81556930|FG000|Overall Study|Adverse Event|4|||
27922899|NCT00207740|81556931|FG001|Overall Study|Adverse Event|14|||
27922900|NCT00207740|81556932|FG002|Overall Study|Adverse Event|14|||
27922901|NCT00207740|81556933|FG003|Overall Study|Adverse Event|11|||
27922902|NCT00207740|81556930|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27922903|NCT00207740|81556931|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27922904|NCT00207740|81556932|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
27922905|NCT00207740|81556933|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
27922906|NCT00207740|81556930|FG000|Overall Study|Lost to Follow-up|0|||
27922907|NCT00207740|81556931|FG001|Overall Study|Lost to Follow-up|2|||
27922908|NCT00207740|81556932|FG002|Overall Study|Lost to Follow-up|1|||
27922909|NCT00207740|81556933|FG003|Overall Study|Lost to Follow-up|1|||
27922910|NCT00207740|81556930|FG000|Overall Study|Death|0|||
27922911|NCT00207740|81556931|FG001|Overall Study|Death|0|||
27922912|NCT00207740|81556932|FG002|Overall Study|Death|0|||
27922913|NCT00207740|81556933|FG003|Overall Study|Death|1|||
27922914|NCT00207740|81556930|FG000|Overall Study|Sponsor Directive|22|||
27922915|NCT00207740|81556931|FG001|Overall Study|Sponsor Directive|15|||
27922916|NCT00207740|81556932|FG002|Overall Study|Sponsor Directive|16|||
27922917|NCT00207740|81556933|FG003|Overall Study|Sponsor Directive|21|||
27922918|NCT00207740|81556930|FG000|Overall Study|Other|2|||
27922919|NCT00207740|81556931|FG001|Overall Study|Other|10|||
27922920|NCT00207740|81556932|FG002|Overall Study|Other|7|||
27922921|NCT00207740|81556933|FG003|Overall Study|Other|5|||
27922922|NCT00091819|81556934|FG000|Overall Study|Adverse Event|1|||
27922923|NCT00091819|81556935|FG001|Overall Study|Adverse Event|1|||
27922924|NCT00091819|81556934|FG000|Overall Study|Death|4|||
27922925|NCT00091819|81556935|FG001|Overall Study|Death|5|||
27922926|NCT00091819|81556934|FG000|Overall Study|Lost to Follow-up|26|||
27922927|NCT00091819|81556935|FG001|Overall Study|Lost to Follow-up|23|||
27922928|NCT00091819|81556934|FG000|Overall Study|Withdrawal by Subject|5|||
27922929|NCT00091819|81556935|FG001|Overall Study|Withdrawal by Subject|8|||
27922930|NCT00091819|81556934|FG000|Overall Study|Protocol Violation|1|||
27922931|NCT00091819|81556935|FG001|Overall Study|Protocol Violation|2|||
27922932|NCT00091819|81556934|FG000|Overall Study|Other|2|||
27922933|NCT00091819|81556935|FG001|Overall Study|Other|3|||
27543794|NCT00705484|80182343|FG000|Overall Study|Adverse Event|28|||
27543795|NCT00705484|80182344|FG001|Overall Study|Adverse Event|27|||
27543796|NCT00705484|80182343|FG000|Overall Study|Lost to Follow-up|169|||
27543797|NCT00705484|80182344|FG001|Overall Study|Lost to Follow-up|250|||
27543798|NCT00705484|80182343|FG000|Overall Study|Withdrawal by Subject|96|||
27543799|NCT00705484|80182344|FG001|Overall Study|Withdrawal by Subject|72|||
27543800|NCT00705484|80182343|FG000|Overall Study|Administrative|89|||
27543801|NCT00705484|80182344|FG001|Overall Study|Administrative|59|||
27543802|NCT01273597|80182347|FG000|Overall Study|Adverse Event|5|||
27543803|NCT01273597|80182347|FG000|Overall Study|Underwent Kidney Transplantation|2|||
27543804|NCT01273597|80182347|FG000|Overall Study|Reason Not Reported|1|||
27543805|NCT02582983|80182348|FG000|Overall Study|Death|3|||
27543806|NCT02582983|80182348|FG000|Overall Study|Withdrawal by Subject|2|||
27543807|NCT02582983|80182348|FG000|Overall Study|Adverse Event|1|||
27543808|NCT01256008|80182349|FG000|Overall Study|Lost to Follow-up|6|||
27543809|NCT01256008|80182350|FG001|Overall Study|Lost to Follow-up|4|||
27543810|NCT01256008|80182351|FG002|Overall Study|Lost to Follow-up|11|||
27543811|NCT01256008|80182349|FG000|Overall Study|Withdrawal by Subject|2|||
27543812|NCT01256008|80182350|FG001|Overall Study|Withdrawal by Subject|3|||
27543813|NCT01256008|80182351|FG002|Overall Study|Withdrawal by Subject|10|||
27543814|NCT01637272|80182355|FG000|Overall Study|Adverse Event|6|||
27543815|NCT01637272|80182355|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
27922934|NCT00091819|81556934|FG000|Overall Study|Never received study treatment|3|||
27922935|NCT00091819|81556935|FG001|Overall Study|Never received study treatment|4|||
27922936|NCT00141817|81556936|FG000|Overall Study|Protocol Violation|0|||
27922937|NCT00141817|81556937|FG001|Overall Study|Protocol Violation|0|||
27922938|NCT00141817|81556938|FG002|Overall Study|Protocol Violation|1|||
27543816|NCT01637272|80182355|FG000|Overall Study|Withdrawal by Subject|3|||
27543817|NCT01637272|80182355|FG000|Overall Study|Lost to Follow-up|2|||
27543818|NCT01637272|80182355|FG000|Overall Study|completed core, did not enter ext. phase|4|||
27922939|NCT00141817|81556939|FG003|Overall Study|Protocol Violation|0|||
27922940|NCT00141817|81556936|FG000|Overall Study|Parent request|1|||
27922941|NCT00141817|81556937|FG001|Overall Study|Parent request|0|||
27922942|NCT00141817|81556938|FG002|Overall Study|Parent request|0|||
27922943|NCT00141817|81556939|FG003|Overall Study|Parent request|0|||
27922944|NCT01027949|81556940|FG000|Overall Study|Death|174|||
27922945|NCT01027949|81556940|FG000|Overall Study|Progressive Disease|163|||
27543819|NCT01637272|80182355|FG000|Overall Study|Administrative problems|1|||
27543820|NCT01637272|80182355|FG000|Overall Study|Protocol Violation|2|||
27543821|NCT03372096|80182356|FG000|Overall Study|Study Closed|8|||
27922946|NCT01027949|81556940|FG000|Overall Study|Adverse Event|172|||
27922947|NCT01027949|81556940|FG000|Overall Study|Withdrawal by Subject|113|||
27543822|NCT02605824|80185631|FG000|Overall Study|Physician Decision|1|||
27543823|NCT02605824|80185632|FG001|Overall Study|Physician Decision|0|||
27543824|NCT00753415|80185633|FG000|Part A|Disease progression|1|||
27543825|NCT00753415|80185634|FG001|Part A|Disease progression|0|||
27543826|NCT00753415|80185635|FG002|Part A|Disease progression|1|||
27922948|NCT01027949|81556940|FG000|Overall Study|Lost to Follow-up|17|||
27922949|NCT01027949|81556940|FG000|Overall Study|Protocol Violation|13|||
27922950|NCT01027949|81556940|FG000|Overall Study|PI Decision|8|||
27922951|NCT01027949|81556940|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
27922952|NCT01027949|81556940|FG000|Overall Study|Non-compliance with Study Procedures|7|||
27922953|NCT01027949|81556940|FG000|Overall Study|Lung Transplant|5|||
27922954|NCT01027949|81556940|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
27922955|NCT01027949|81556940|FG000|Overall Study|Use of Excluded Medication|2|||
27922956|NCT01027949|81556940|FG000|Overall Study|Patient Self-discontinuation|1|||
27922957|NCT01027949|81556940|FG000|Overall Study|Pregnancy|1|||
27922958|NCT01027949|81556940|FG000|Overall Study|Surgery|1|||
27922959|NCT01553851|81556941|FG000|Overall Study|Adverse Event|2|||
27922960|NCT01553851|81556941|FG000|Overall Study|constipation|1|||
27922961|NCT03257267|81556942|FG000|Overall Study|Adverse Event|17|||
27922962|NCT03257267|81556943|FG001|Overall Study|Adverse Event|7|||
27922963|NCT03257267|81556942|FG000|Overall Study|Death|96|||
27543827|NCT00753415|80185636|FG003|Part A|Disease progression|2|||
27543828|NCT00753415|80185637|FG004|Part A|Disease progression|0|||
27543829|NCT00753415|80185638|FG005|Part A|Disease progression|0|||
27543830|NCT00753415|80185639|FG006|Part A|Disease progression|0|||
27543831|NCT00753415|80185640|FG007|Part A|Disease progression|0|||
27543832|NCT00753415|80185641|FG008|Part A|Disease progression|0|||
27543833|NCT00753415|80185642|FG009|Part A|Disease progression|0|||
27543834|NCT00753415|80185633|FG000|Part A|Withdrawal by Subject|0|||
27543835|NCT00753415|80185634|FG001|Part A|Withdrawal by Subject|0|||
27543836|NCT00753415|80185635|FG002|Part A|Withdrawal by Subject|1|||
27543837|NCT00753415|80185636|FG003|Part A|Withdrawal by Subject|0|||
27543838|NCT00753415|80185637|FG004|Part A|Withdrawal by Subject|0|||
27543839|NCT00753415|80185638|FG005|Part A|Withdrawal by Subject|0|||
27543840|NCT00753415|80185639|FG006|Part A|Withdrawal by Subject|0|||
27543841|NCT00753415|80185640|FG007|Part A|Withdrawal by Subject|0|||
27543842|NCT00753415|80185641|FG008|Part A|Withdrawal by Subject|0|||
27543843|NCT00753415|80185642|FG009|Part A|Withdrawal by Subject|0|||
27543844|NCT00753415|80185633|FG000|Part B|Lost to Follow-up|0|||
27543845|NCT00753415|80185634|FG001|Part B|Lost to Follow-up|0|||
27543846|NCT00753415|80185635|FG002|Part B|Lost to Follow-up|0|||
27543847|NCT00753415|80185636|FG003|Part B|Lost to Follow-up|0|||
27543848|NCT00753415|80185637|FG004|Part B|Lost to Follow-up|0|||
27543849|NCT00753415|80185638|FG005|Part B|Lost to Follow-up|0|||
27543850|NCT00753415|80185639|FG006|Part B|Lost to Follow-up|0|||
27543851|NCT00753415|80185640|FG007|Part B|Lost to Follow-up|1|||
27543852|NCT00753415|80185641|FG008|Part B|Lost to Follow-up|1|||
27543853|NCT00753415|80185642|FG009|Part B|Lost to Follow-up|0|||
27543854|NCT00753415|80185633|FG000|Part B|Disease progression|0|||
27543855|NCT00753415|80185634|FG001|Part B|Disease progression|0|||
27543856|NCT00753415|80185635|FG002|Part B|Disease progression|0|||
27543857|NCT00753415|80185636|FG003|Part B|Disease progression|0|||
27543858|NCT00753415|80185637|FG004|Part B|Disease progression|0|||
27543859|NCT00753415|80185638|FG005|Part B|Disease progression|0|||
27543860|NCT00753415|80185639|FG006|Part B|Disease progression|0|||
27543861|NCT00753415|80185640|FG007|Part B|Disease progression|0|||
27543862|NCT00753415|80185641|FG008|Part B|Disease progression|2|||
27543863|NCT00753415|80185642|FG009|Part B|Disease progression|1|||
27543864|NCT02571777|80185643|FG000|Overall Study|Subject/guardian decision|34|||
27543865|NCT02571777|80185644|FG001|Overall Study|Subject/guardian decision|26|||
27543866|NCT02571777|80185645|FG002|Overall Study|Subject/guardian decision|26|||
27543867|NCT02571777|80185646|FG003|Overall Study|Subject/guardian decision|25|||
27543868|NCT02571777|80185647|FG004|Overall Study|Subject/guardian decision|27|||
27922964|NCT03257267|81556943|FG001|Overall Study|Death|98|||
27922965|NCT03257267|81556942|FG000|Overall Study|Lost to Follow-up|2|||
27922966|NCT03257267|81556943|FG001|Overall Study|Lost to Follow-up|2|||
27922967|NCT03257267|81556942|FG000|Overall Study|Non-compliance with Study Drug|0|||
27922968|NCT03257267|81556943|FG001|Overall Study|Non-compliance with Study Drug|2|||
27543869|NCT02571777|80185643|FG000|Overall Study|Protocol Deviation|2|||
27543870|NCT02571777|80185644|FG001|Overall Study|Protocol Deviation|3|||
27543871|NCT02571777|80185645|FG002|Overall Study|Protocol Deviation|4|||
27543872|NCT02571777|80185646|FG003|Overall Study|Protocol Deviation|8|||
27543873|NCT02571777|80185647|FG004|Overall Study|Protocol Deviation|4|||
27543874|NCT02571777|80185643|FG000|Overall Study|Death|1|||
27543875|NCT02571777|80185644|FG001|Overall Study|Death|1|||
27922969|NCT03257267|81556942|FG000|Overall Study|Participant Decision|35|||
27922970|NCT03257267|81556943|FG001|Overall Study|Participant Decision|43|||
27922971|NCT03257267|81556942|FG000|Overall Study|Sponsor Decision|1|||
27543876|NCT02571777|80185645|FG002|Overall Study|Death|4|||
27543877|NCT02571777|80185646|FG003|Overall Study|Death|0|||
27543878|NCT02571777|80185647|FG004|Overall Study|Death|0|||
27637836|NCT04484935|80515924|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27637837|NCT04484935|80515923|FG000|Overall Study|Lost to Follow-up|1|||
27637838|NCT04484935|80515924|FG001|Overall Study|Lost to Follow-up|0|||
27637839|NCT04484935|80515923|FG000|Overall Study|Death|2|||
27637840|NCT04484935|80515924|FG001|Overall Study|Death|1|||
27637841|NCT01875250|80515925|FG000|Overall Study|Adverse Event|2|||
27637842|NCT01875250|80515926|FG001|Overall Study|Adverse Event|0|||
27637843|NCT01359592|80515930|FG000|Initial Registration|Adverse Event|1|||
27637844|NCT01359592|80515931|FG001|Initial Registration|Adverse Event|0|||
27637845|NCT01359592|80515932|FG002|Initial Registration|Adverse Event|0|||
27637846|NCT01359592|80515933|FG003|Initial Registration|Adverse Event|0|||
27922972|NCT03257267|81556943|FG001|Overall Study|Sponsor Decision|0|||
27922973|NCT03257267|81556942|FG000|Overall Study|Physician Decision|1|||
27922974|NCT03257267|81556943|FG001|Overall Study|Physician Decision|3|||
27922975|NCT03257267|81556942|FG000|Overall Study|Disease Progression|109|||
27922976|NCT03257267|81556943|FG001|Overall Study|Disease Progression|121|||
27922977|NCT03257267|81556942|FG000|Overall Study|Withdrawal by Subject|8|||
27922978|NCT03257267|81556943|FG001|Overall Study|Withdrawal by Subject|26|||
27922979|NCT03257267|81556942|FG000|Overall Study|Other|0|||
27922980|NCT03257267|81556943|FG001|Overall Study|Other|2|||
27922981|NCT02696798|81556944|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
27922982|NCT02696798|81556945|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
27922983|NCT02696798|81556946|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
27922984|NCT02696798|81556944|FG000|Blinded Treatment Dosing Period|Death|0|||
27922985|NCT02696798|81556945|FG001|Blinded Treatment Dosing Period|Death|0|||
27922986|NCT02696798|81556946|FG002|Blinded Treatment Dosing Period|Death|1|||
27922987|NCT02696798|81556944|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
27922988|NCT02696798|81556945|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
27922989|NCT02696798|81556946|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
27922990|NCT02696798|81556944|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
27922991|NCT02696798|81556945|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
27922992|NCT02696798|81556946|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
27922993|NCT02696798|81556944|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
27922994|NCT02696798|81556945|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
27922995|NCT02696798|81556946|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
27922996|NCT02696798|81556944|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
27543879|NCT02571777|80185643|FG000|Overall Study|Lost to Follow-up|1|||
27543880|NCT02571777|80185644|FG001|Overall Study|Lost to Follow-up|1|||
27543881|NCT02571777|80185645|FG002|Overall Study|Lost to Follow-up|2|||
27543882|NCT02571777|80185646|FG003|Overall Study|Lost to Follow-up|0|||
27543883|NCT02571777|80185647|FG004|Overall Study|Lost to Follow-up|1|||
27543884|NCT02571777|80185643|FG000|Overall Study|Physician Decision|1|||
27543885|NCT02571777|80185644|FG001|Overall Study|Physician Decision|7|||
27543886|NCT02571777|80185645|FG002|Overall Study|Physician Decision|5|||
27543887|NCT02571777|80185646|FG003|Overall Study|Physician Decision|2|||
27543888|NCT02571777|80185647|FG004|Overall Study|Physician Decision|4|||
27543889|NCT02571777|80185643|FG000|Overall Study|Pregnancy|0|||
27543890|NCT02571777|80185644|FG001|Overall Study|Pregnancy|0|||
27543891|NCT02571777|80185645|FG002|Overall Study|Pregnancy|0|||
27543892|NCT02571777|80185646|FG003|Overall Study|Pregnancy|2|||
27543893|NCT02571777|80185647|FG004|Overall Study|Pregnancy|0|||
27543894|NCT03288129|80185651|FG000|Overall Study|Adverse Event|10|||
27543895|NCT03288129|80185651|FG000|Overall Study|Lost to Follow-up|3|||
27543896|NCT03288129|80185651|FG000|Overall Study|Withdrawal by Subject|3|||
27543897|NCT03288129|80185651|FG000|Overall Study|Withdrawal of consent/assent|1|||
27543898|NCT03288129|80185651|FG000|Overall Study|Other|5|||
27543899|NCT03733470|80185652|FG000|Overall Study|PI Decision|1|||
27543900|NCT03733470|80185653|FG001|Overall Study|PI Decision|1|||
27543901|NCT00923156|80185654|FG000|Overall Study|Adverse Event|0|||
27543902|NCT00923156|80185655|FG001|Overall Study|Adverse Event|2|||
27543903|NCT00923156|80185656|FG002|Overall Study|Adverse Event|1|||
27637847|NCT01359592|80515930|FG000|Initial Registration|Death|1|||
27637848|NCT01359592|80515931|FG001|Initial Registration|Death|0|||
27637849|NCT01359592|80515932|FG002|Initial Registration|Death|0|||
27922997|NCT02696798|81556945|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
27922998|NCT02696798|81556946|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
27922999|NCT02696798|81556944|FG000|Extended Treatment Period|Adverse Event|1|||
27923000|NCT02696798|81556945|FG001|Extended Treatment Period|Adverse Event|4|||
27923001|NCT02696798|81556946|FG002|Extended Treatment Period|Adverse Event|5|||
27543904|NCT00923156|80185654|FG000|Overall Study|Abnormal laboratory values|0|||
27543905|NCT00923156|80185655|FG001|Overall Study|Abnormal laboratory values|0|||
27543906|NCT00923156|80185656|FG002|Overall Study|Abnormal laboratory values|1|||
27637850|NCT01359592|80515933|FG003|Initial Registration|Death|0|||
27543907|NCT00923156|80185654|FG000|Overall Study|Withdrawal by Subject|0|||
27543908|NCT00923156|80185655|FG001|Overall Study|Withdrawal by Subject|1|||
27543909|NCT00923156|80185656|FG002|Overall Study|Withdrawal by Subject|0|||
27637851|NCT01359592|80515930|FG000|Initial Registration|Other reason not protocol specified|1|||
27637852|NCT01359592|80515931|FG001|Initial Registration|Other reason not protocol specified|0|||
27637853|NCT01359592|80515932|FG002|Initial Registration|Other reason not protocol specified|0|||
27637854|NCT01359592|80515933|FG003|Initial Registration|Other reason not protocol specified|0|||
27637855|NCT01359592|80515930|FG000|Initial Registration|Ineligible|26|||
27637856|NCT01359592|80515931|FG001|Initial Registration|Ineligible|0|||
27637857|NCT01359592|80515932|FG002|Initial Registration|Ineligible|0|||
27637858|NCT01359592|80515933|FG003|Initial Registration|Ineligible|0|||
27637859|NCT01359592|80515930|FG000|PET-Directed Therapy|Adverse Event|0|||
27637860|NCT01359592|80515931|FG001|PET-Directed Therapy|Adverse Event|0|||
27637861|NCT01359592|80515932|FG002|PET-Directed Therapy|Adverse Event|1|||
27637862|NCT01359592|80515933|FG003|PET-Directed Therapy|Adverse Event|0|||
27637863|NCT01359592|80515930|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
27637864|NCT01359592|80515931|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
27637865|NCT01359592|80515932|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
27637866|NCT01359592|80515933|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
27637867|NCT01359592|80515930|FG000|PET-Directed Therapy|Ineligible|0|||
27637868|NCT01359592|80515931|FG001|PET-Directed Therapy|Ineligible|0|||
27637869|NCT01359592|80515932|FG002|PET-Directed Therapy|Ineligible|24|||
27637870|NCT01359592|80515933|FG003|PET-Directed Therapy|Ineligible|0|||
27637871|NCT03990649|80515934|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
27637872|NCT03990649|80515935|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
27637873|NCT03990649|80515936|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
27637874|NCT03990649|80515934|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
27637875|NCT03990649|80515935|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
27637876|NCT03990649|80515936|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
27637877|NCT03990649|80515934|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
27637878|NCT03990649|80515935|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
27637879|NCT03990649|80515936|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
27637880|NCT03990649|80515934|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
27637881|NCT03990649|80515935|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
27637882|NCT03990649|80515936|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
27637883|NCT03990649|80515934|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
27637884|NCT03990649|80515935|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
27637885|NCT03990649|80515936|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
27637886|NCT03990649|80515934|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
27637887|NCT03990649|80515935|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
27637888|NCT03990649|80515936|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
27637889|NCT03990649|80515934|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
27637890|NCT03990649|80515935|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
27637891|NCT03990649|80515936|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
27637892|NCT01179334|80515945|FG000|Treatment Period|Adverse Event|1|||
27637893|NCT01179334|80515946|FG001|Treatment Period|Adverse Event|0|||
27741087|NCT01507545|80880828|FG001|Overall Study|Progressive disease|27|||
27741088|NCT01507545|80880827|FG000|Overall Study|Other|6|||
27741089|NCT01507545|80880828|FG001|Overall Study|Other|4|||
27741090|NCT00542828|80880840|FG000|Overall Study|Physician Decision|1|||
27741091|NCT00542828|80880840|FG000|Overall Study|Need for Prohibited Treatment|3|||
27741092|NCT00542828|80880840|FG000|Overall Study|Study Prematurely Discontinued|7|||
27543910|NCT00923156|80185654|FG000|Overall Study|Death|0|||
27543911|NCT00923156|80185655|FG001|Overall Study|Death|1|||
27543912|NCT00923156|80185656|FG002|Overall Study|Death|0|||
27543913|NCT00923156|80185654|FG000|Overall Study|Lack of Efficacy|0|||
27543914|NCT00923156|80185655|FG001|Overall Study|Lack of Efficacy|0|||
27543915|NCT00923156|80185656|FG002|Overall Study|Lack of Efficacy|1|||
27543916|NCT02784431|80185657|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
27543917|NCT02784431|80185657|FG000|Overall Study|Early Study Termination|19|||
27543918|NCT02619175|80185661|FG000|Overall Study|Withdrawal by Subject|1|||
27543919|NCT02619175|80185662|FG001|Overall Study|Withdrawal by Subject|0|||
27543920|NCT02619175|80185661|FG000|Overall Study|foot pain|1|||
27543921|NCT02619175|80185662|FG001|Overall Study|foot pain|0|||
27543922|NCT00824720|80185663|FG000|Overall Study|failed plug insertion|3|||
27543923|NCT00824720|80185664|FG001|Overall Study|failed plug insertion|1|||
27543924|NCT00824720|80185665|FG002|Overall Study|failed plug insertion|0|||
27543925|NCT00824720|80185663|FG000|Overall Study|Protocol Violation|0|||
27543926|NCT00824720|80185664|FG001|Overall Study|Protocol Violation|0|||
27543927|NCT00824720|80185665|FG002|Overall Study|Protocol Violation|1|||
27543928|NCT02200211|80185669|FG000|Overall Study|Lost to Follow-up|7|||
27543929|NCT02200211|80185670|FG001|Overall Study|Lost to Follow-up|7|||
27543930|NCT02200211|80185671|FG002|Overall Study|Lost to Follow-up|1|||
27543931|NCT02200211|80185672|FG003|Overall Study|Lost to Follow-up|2|||
27543932|NCT02200211|80185669|FG000|Overall Study|Withdrawal by Subject|1|||
27543933|NCT02200211|80185670|FG001|Overall Study|Withdrawal by Subject|0|||
27923002|NCT02696798|81556944|FG000|Extended Treatment Period|Lack of Efficacy|7|||
27923003|NCT02696798|81556945|FG001|Extended Treatment Period|Lack of Efficacy|2|||
27923004|NCT02696798|81556946|FG002|Extended Treatment Period|Lack of Efficacy|2|||
27923005|NCT02696798|81556944|FG000|Extended Treatment Period|Lost to Follow-up|1|||
27923006|NCT02696798|81556945|FG001|Extended Treatment Period|Lost to Follow-up|0|||
27923007|NCT02696798|81556946|FG002|Extended Treatment Period|Lost to Follow-up|0|||
27923008|NCT02696798|81556944|FG000|Extended Treatment Period|Physician Decision|0|||
27923009|NCT02696798|81556945|FG001|Extended Treatment Period|Physician Decision|1|||
27923010|NCT02696798|81556946|FG002|Extended Treatment Period|Physician Decision|0|||
27543934|NCT02200211|80185671|FG002|Overall Study|Withdrawal by Subject|0|||
27543935|NCT02200211|80185672|FG003|Overall Study|Withdrawal by Subject|0|||
27543936|NCT02412618|80185673|FG000|Overall Study|Withdrawal by Subject|1|||
27543937|NCT02412618|80185674|FG001|Overall Study|Withdrawal by Subject|1|||
27543938|NCT02412618|80185673|FG000|Overall Study|Expulsion|1|||
27543939|NCT02412618|80185674|FG001|Overall Study|Expulsion|1|||
27543940|NCT00133952|80185675|FG000|Overall Study|Adverse Event|1|||
27543941|NCT00133952|80185676|FG001|Overall Study|Adverse Event|2|||
27543942|NCT00133952|80185675|FG000|Overall Study|Death|3|||
27543943|NCT00133952|80185676|FG001|Overall Study|Death|2|||
27543944|NCT00133952|80185675|FG000|Overall Study|Lost to Follow-up|9|||
27543945|NCT00133952|80185676|FG001|Overall Study|Lost to Follow-up|14|||
27543946|NCT00133952|80185675|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
27543947|NCT00133952|80185676|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
27543948|NCT00133952|80185675|FG000|Overall Study|Protocol Violation|1|||
27543949|NCT00133952|80185676|FG001|Overall Study|Protocol Violation|1|||
27543950|NCT00133952|80185675|FG000|Overall Study|Withdrawal by Subject|20|||
27543951|NCT00133952|80185676|FG001|Overall Study|Withdrawal by Subject|4|||
27543952|NCT00133952|80185675|FG000|Overall Study|Physician Decision|4|||
27543953|NCT00133952|80185676|FG001|Overall Study|Physician Decision|3|||
27543954|NCT00133952|80185675|FG000|Overall Study|Sponsor Decision|0|||
27543955|NCT00133952|80185676|FG001|Overall Study|Sponsor Decision|1|||
27543956|NCT00256750|80185677|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
27543957|NCT00256750|80185678|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
27543958|NCT00256750|80185679|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
27543959|NCT00256750|80185677|FG000|Transplanted Pre-Treatment|Other|2|||
27543960|NCT00256750|80185678|FG001|Transplanted Pre-Treatment|Other|0|||
27543961|NCT00256750|80185679|FG002|Transplanted Pre-Treatment|Other|0|||
27543962|NCT00256750|80185677|FG000|Transplanted Pre-Treatment|Death|1|||
27543963|NCT00256750|80185678|FG001|Transplanted Pre-Treatment|Death|0|||
27543964|NCT00256750|80185679|FG002|Transplanted Pre-Treatment|Death|0|||
27543965|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
27543966|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
27543967|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
27543968|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Death|3|||
27543969|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Death|2|||
27543970|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Death|4|||
27543971|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
27543972|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
27543973|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
27637894|NCT01179334|80515945|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
27637895|NCT01179334|80515946|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
27637896|NCT01179334|80515945|FG000|Long-term Extension (LTE) Period|Death|3|||
27637897|NCT01179334|80515946|FG001|Long-term Extension (LTE) Period|Death|0|||
27637898|NCT01179334|80515945|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
27637899|NCT01179334|80515946|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
27637900|NCT01803555|80515947|FG000|Overall Study|Adverse Event|3|||
27637901|NCT01803555|80515948|FG001|Overall Study|Adverse Event|2|||
27637902|NCT01803555|80515947|FG000|Overall Study|Withdrawal by Subject|3|||
27637903|NCT01803555|80515948|FG001|Overall Study|Withdrawal by Subject|3|||
27637904|NCT01803555|80515947|FG000|Overall Study|Non-compliance|1|||
27637905|NCT01803555|80515948|FG001|Overall Study|Non-compliance|1|||
27637906|NCT01803555|80515947|FG000|Overall Study|Protocol Violation|3|||
27923011|NCT02696798|81556944|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
27923012|NCT02696798|81556945|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
27923013|NCT02696798|81556946|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
27923014|NCT02696798|81556944|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
27543974|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
27543975|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
27543976|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
27637907|NCT01803555|80515948|FG001|Overall Study|Protocol Violation|5|||
27637908|NCT01803555|80515947|FG000|Overall Study|Lost to Follow-up|0|||
27543977|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Other|5|||
27543978|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Other|4|||
27543979|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Other|2|||
27637909|NCT01803555|80515948|FG001|Overall Study|Lost to Follow-up|2|||
27637910|NCT01803555|80515947|FG000|Overall Study|Other than specified|3|||
27637911|NCT01803555|80515948|FG001|Overall Study|Other than specified|5|||
27637912|NCT02577835|80515949|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
27637913|NCT00332241|80515950|FG000|Overall Study|Lack of Efficacy|6|||
27637914|NCT00332241|80515951|FG001|Overall Study|Lack of Efficacy|1|||
27637915|NCT00332241|80515950|FG000|Overall Study|Adverse Event|3|||
27637916|NCT00332241|80515951|FG001|Overall Study|Adverse Event|5|||
27637917|NCT00332241|80515950|FG000|Overall Study|Withdrawal by Subject|2|||
27637918|NCT00332241|80515951|FG001|Overall Study|Withdrawal by Subject|1|||
27637919|NCT00332241|80515950|FG000|Overall Study|Lost to Follow-up|4|||
27637920|NCT00332241|80515951|FG001|Overall Study|Lost to Follow-up|1|||
27637921|NCT00738699|80515953|FG000|Overall Study|Withdrawal by Subject|5|||
27637922|NCT00738699|80515954|FG001|Overall Study|Withdrawal by Subject|0|||
27637923|NCT00738699|80515953|FG000|Overall Study|Lost to Follow-up|1|||
27637924|NCT00738699|80515954|FG001|Overall Study|Lost to Follow-up|0|||
27637925|NCT00738699|80515953|FG000|Overall Study|Death|144|||
27637926|NCT00738699|80515954|FG001|Overall Study|Death|68|||
27637927|NCT00738699|80515953|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
27637928|NCT00738699|80515954|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
27637929|NCT00738699|80515953|FG000|Overall Study|Other|2|||
27637930|NCT00738699|80515954|FG001|Overall Study|Other|0|||
27637931|NCT02238483|80515955|FG000|Overall Study|Withdrawal by Subject|2|||
27637932|NCT02238483|80515956|FG001|Overall Study|Withdrawal by Subject|7|||
27637933|NCT02238483|80515955|FG000|Overall Study|Lost to Follow-up|1|||
27637934|NCT02238483|80515956|FG001|Overall Study|Lost to Follow-up|1|||
27637935|NCT02238483|80515955|FG000|Overall Study|Protocol Violation|1|||
27923015|NCT02696798|81556945|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
27923016|NCT02696798|81556946|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
27923017|NCT02696798|81556944|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
27923018|NCT02696798|81556945|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
27923019|NCT02696798|81556946|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
27923020|NCT02696798|81556944|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
27543980|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
27543981|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
27543982|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
27543983|NCT00256750|80185677|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
27543984|NCT00256750|80185678|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
27543985|NCT00256750|80185679|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
27543986|NCT00256750|80185677|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
27543987|NCT00256750|80185678|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
27543988|NCT00256750|80185679|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
27543989|NCT00256750|80185677|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
27543990|NCT00256750|80185678|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
27543991|NCT00256750|80185679|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
27543992|NCT00256750|80185677|FG000|Post-Transplant Treated (24 Months)|Death|3|||
27543993|NCT00256750|80185678|FG001|Post-Transplant Treated (24 Months)|Death|0|||
27543994|NCT00256750|80185679|FG002|Post-Transplant Treated (24 Months)|Death|0|||
27543995|NCT00256750|80185677|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
27543996|NCT00256750|80185678|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
27543997|NCT00256750|80185679|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
27543998|NCT00256750|80185677|FG000|Post-Transplant Treated (24 Months)|Other|2|||
27543999|NCT00256750|80185678|FG001|Post-Transplant Treated (24 Months)|Other|0|||
27544000|NCT00256750|80185679|FG002|Post-Transplant Treated (24 Months)|Other|1|||
27544001|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
27544002|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
27544003|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
27544004|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
27544005|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
27637936|NCT02238483|80515956|FG001|Overall Study|Protocol Violation|2|||
27637937|NCT02238483|80515955|FG000|Overall Study|Death|1|||
27637938|NCT02238483|80515956|FG001|Overall Study|Death|0|||
27637939|NCT02238483|80515955|FG000|Overall Study|Adverse Event|7|||
27637940|NCT02238483|80515956|FG001|Overall Study|Adverse Event|3|||
27544006|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
27544007|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Death|0|||
27544008|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Death|2|||
27637941|NCT02238483|80515955|FG000|Overall Study|Withdrawn due to physician decision|1|||
27637942|NCT02238483|80515956|FG001|Overall Study|Withdrawn due to physician decision|0|||
27637943|NCT02238483|80515955|FG000|Overall Study|Completion status not recorded|1|||
27637944|NCT02238483|80515956|FG001|Overall Study|Completion status not recorded|1|||
27741093|NCT00542828|80880840|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
27923021|NCT02696798|81556945|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
27923022|NCT02696798|81556946|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
27923023|NCT02696798|81556944|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
27923024|NCT02696798|81556945|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
27923025|NCT02696798|81556946|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
27923026|NCT02696798|81556944|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
27923027|NCT02696798|81556945|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
27923028|NCT02696798|81556946|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
27923029|NCT02696798|81556944|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
27923030|NCT02696798|81556945|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
27923031|NCT02696798|81556946|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
27923032|NCT04745351|81556949|FG000|Overall Study|Death|51|||
27923033|NCT04745351|81556950|FG001|Overall Study|Death|25|||
27923034|NCT04745351|81556949|FG000|Overall Study|Lost to Follow-up|9|||
27923035|NCT04745351|81556950|FG001|Overall Study|Lost to Follow-up|3|||
27923036|NCT04745351|81556949|FG000|Overall Study|Randomized but Never Treated|3|||
27923037|NCT04745351|81556950|FG001|Overall Study|Randomized but Never Treated|3|||
27923038|NCT04745351|81556949|FG000|Overall Study|Adverse Event|4|||
27923039|NCT04745351|81556950|FG001|Overall Study|Adverse Event|0|||
27923040|NCT04745351|81556949|FG000|Overall Study|Withdrew Consent|1|||
27544009|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Death|1|||
27544010|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
27544011|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
27544012|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
27637945|NCT02238483|80515955|FG000|Overall Study|Illness in family member|1|||
27637946|NCT02238483|80515956|FG001|Overall Study|Illness in family member|0|||
27637947|NCT01170962|80515957|FG000|Treatment Period|Lack of Efficacy|96|||
27637948|NCT01170962|80515958|FG001|Treatment Period|Lack of Efficacy|91|||
27637949|NCT01170962|80515959|FG002|Treatment Period|Lack of Efficacy|7|||
27637950|NCT01170962|80515957|FG000|Treatment Period|Adverse Event|11|||
27637951|NCT01170962|80515958|FG001|Treatment Period|Adverse Event|12|||
27741094|NCT01618656|80880843|FG000|Overall Study|Withdrawal by Subject|7|||
27544013|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
27544014|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
27544015|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
27544016|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
27741095|NCT01618656|80880844|FG001|Overall Study|Withdrawal by Subject|3|||
27741096|NCT01618656|80880843|FG000|Overall Study|Physician Decision|1|||
27544017|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
27544018|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
27544019|NCT00256750|80185677|FG000|Post-Transplant Treated (36 Months)|Other|0|||
27544020|NCT00256750|80185678|FG001|Post-Transplant Treated (36 Months)|Other|1|||
27544021|NCT00256750|80185679|FG002|Post-Transplant Treated (36 Months)|Other|1|||
27544022|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
27544023|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
27544024|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
27544025|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
27544026|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
27544027|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
27544028|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
27741097|NCT01618656|80880844|FG001|Overall Study|Physician Decision|1|||
27741098|NCT01486238|80880847|FG000|Overall Study|Death|0|||
27741099|NCT01486238|80880848|FG001|Overall Study|Death|2|||
27741100|NCT01486238|80880847|FG000|Overall Study|Withdrawal by Subject|2|||
27741101|NCT01486238|80880848|FG001|Overall Study|Withdrawal by Subject|1|||
27741102|NCT01486238|80880847|FG000|Overall Study|Lost to Follow-up|0|||
27741103|NCT01486238|80880848|FG001|Overall Study|Lost to Follow-up|3|||
27741104|NCT03694522|80880849|FG000|Overall Study|Withdrawal by Subject|8|||
27741105|NCT03694522|80880850|FG001|Overall Study|Withdrawal by Subject|10|||
27741106|NCT03694522|80880849|FG000|Overall Study|Physician Decision|53|||
27741107|NCT03694522|80880850|FG001|Overall Study|Physician Decision|54|||
27741108|NCT03694522|80880849|FG000|Overall Study|Other|1|||
27544029|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
27544030|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
27637952|NCT01170962|80515959|FG002|Treatment Period|Adverse Event|3|||
27741109|NCT03694522|80880850|FG001|Overall Study|Other|1|||
27741110|NCT03694522|80880849|FG000|Overall Study|Lost to Follow-up|0|||
27741111|NCT03694522|80880850|FG001|Overall Study|Lost to Follow-up|1|||
27741112|NCT01050062|80880851|FG000|Overall Study|Adverse Event|75|||
27923041|NCT04745351|81556950|FG001|Overall Study|Withdrew Consent|2|||
27923042|NCT04745351|81556949|FG000|Overall Study|Investigator's Discretion|2|||
27923043|NCT04745351|81556950|FG001|Overall Study|Investigator's Discretion|0|||
27741113|NCT01050062|80880852|FG001|Overall Study|Adverse Event|22|||
27923044|NCT04745351|81556949|FG000|Overall Study|Protocol Violation|1|||
27923045|NCT04745351|81556950|FG001|Overall Study|Protocol Violation|0|||
27923046|NCT01160614|81556951|FG000|Overall Study|Withdrawal by Subject|0|||
27923047|NCT01160614|81556952|FG001|Overall Study|Withdrawal by Subject|2|||
27923048|NCT00487188|81556953|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
27923049|NCT00487188|81556954|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
27923050|NCT00487188|81556955|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
27923051|NCT00487188|81556953|FG000|Induction Phase|Adverse Event|5|||
27923052|NCT00487188|81556954|FG001|Induction Phase|Adverse Event|0|||
27923053|NCT00487188|81556955|FG002|Induction Phase|Adverse Event|0|||
27923054|NCT00487188|81556953|FG000|Induction Phase|Lack of Efficacy|0|||
27923055|NCT00487188|81556954|FG001|Induction Phase|Lack of Efficacy|1|||
27923056|NCT00487188|81556955|FG002|Induction Phase|Lack of Efficacy|0|||
27923057|NCT00487188|81556953|FG000|Induction Phase|Protocol Violation|1|||
27923058|NCT00487188|81556954|FG001|Induction Phase|Protocol Violation|0|||
27923059|NCT00487188|81556955|FG002|Induction Phase|Protocol Violation|0|||
27923060|NCT00487188|81556953|FG000|Induction Phase|Refused Treatment|1|||
27923061|NCT00487188|81556954|FG001|Induction Phase|Refused Treatment|2|||
27923062|NCT00487188|81556955|FG002|Induction Phase|Refused Treatment|0|||
27923063|NCT00487188|81556953|FG000|Induction Phase|Lost to Follow-up|2|||
27923064|NCT00487188|81556954|FG001|Induction Phase|Lost to Follow-up|2|||
27923065|NCT00487188|81556955|FG002|Induction Phase|Lost to Follow-up|0|||
27923066|NCT00487188|81556953|FG000|Induction Phase|Administrative|0|||
27923067|NCT00487188|81556954|FG001|Induction Phase|Administrative|1|||
27923068|NCT00487188|81556955|FG002|Induction Phase|Administrative|0|||
27923069|NCT00487188|81556953|FG000|Maintenance Phase|Adverse Event|1|||
27923070|NCT00487188|81556954|FG001|Maintenance Phase|Adverse Event|0|||
27923071|NCT00487188|81556955|FG002|Maintenance Phase|Adverse Event|0|||
27923072|NCT00487188|81556953|FG000|Maintenance Phase|Death|1|||
27923073|NCT00487188|81556954|FG001|Maintenance Phase|Death|0|||
27923074|NCT00487188|81556955|FG002|Maintenance Phase|Death|0|||
27923075|NCT00487188|81556953|FG000|Maintenance Phase|Lost to Follow-up|1|||
27923076|NCT00487188|81556954|FG001|Maintenance Phase|Lost to Follow-up|0|||
27923077|NCT00487188|81556955|FG002|Maintenance Phase|Lost to Follow-up|0|||
27923078|NCT00487188|81556953|FG000|Maintenance Phase|Administrative|0|||
27923079|NCT00487188|81556954|FG001|Maintenance Phase|Administrative|0|||
27923080|NCT00487188|81556955|FG002|Maintenance Phase|Administrative|1|||
27923081|NCT02349386|81556960|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
27923082|NCT02349386|81556961|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
27923083|NCT02349386|81556962|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
27923084|NCT02349386|81556963|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
27923085|NCT02349386|81556960|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
27923086|NCT02349386|81556961|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
27923087|NCT02349386|81556962|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
27923088|NCT02349386|81556963|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
27923089|NCT02349386|81556960|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
27923090|NCT02349386|81556961|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
27923091|NCT02349386|81556962|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
27923092|NCT02349386|81556963|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
27923093|NCT02349386|81556960|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
27923094|NCT02349386|81556961|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
27923095|NCT02349386|81556962|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
27923096|NCT02349386|81556963|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
27923097|NCT02349386|81556960|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
27544031|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
27923098|NCT02349386|81556961|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
27544032|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
27544033|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
27544034|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
27544035|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
27544036|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
27741114|NCT01050062|80880851|FG000|Overall Study|Lost to Follow-up|83|||
27923099|NCT02349386|81556962|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
27923100|NCT02349386|81556963|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
27923101|NCT02349386|81556960|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
27923102|NCT02349386|81556961|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
27923103|NCT02349386|81556962|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
27923104|NCT02349386|81556963|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
27923105|NCT03415178|81556964|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
27544037|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
27923106|NCT03415178|81556965|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
27923107|NCT03415178|81556964|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
27923108|NCT03415178|81556965|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
27923109|NCT00737048|81556966|FG000|Overall Study|Physician Decision|0|||
27923110|NCT00737048|81556967|FG001|Overall Study|Physician Decision|0|||
27923111|NCT00737048|81556968|FG002|Overall Study|Physician Decision|1|||
27923112|NCT00737048|81556966|FG000|Overall Study|Adverse Event|0|||
27923113|NCT00737048|81556967|FG001|Overall Study|Adverse Event|1|||
27923114|NCT00737048|81556968|FG002|Overall Study|Adverse Event|0|||
27923115|NCT00737048|81556966|FG000|Overall Study|Worsening of the symptoms|3|||
27923116|NCT00737048|81556967|FG001|Overall Study|Worsening of the symptoms|5|||
27923117|NCT00737048|81556968|FG002|Overall Study|Worsening of the symptoms|3|||
27923118|NCT00903968|81556969|FG000|Overall Study|Adverse Event|0|||
27923119|NCT00903968|81556970|FG001|Overall Study|Adverse Event|0|||
27923120|NCT00903968|81556971|FG002|Overall Study|Adverse Event|0|||
27923121|NCT00903968|81556972|FG003|Overall Study|Adverse Event|0|||
27923122|NCT00903968|81556973|FG004|Overall Study|Adverse Event|0|||
27923123|NCT00903968|81556974|FG005|Overall Study|Adverse Event|0|||
27923124|NCT00903968|81556975|FG006|Overall Study|Adverse Event|1|||
27923125|NCT00903968|81556976|FG007|Overall Study|Adverse Event|8|||
27923126|NCT00903968|81556969|FG000|Overall Study|DLT|0|||
27923127|NCT00903968|81556970|FG001|Overall Study|DLT|0|||
27923128|NCT00903968|81556971|FG002|Overall Study|DLT|0|||
27923129|NCT00903968|81556972|FG003|Overall Study|DLT|0|||
27923130|NCT00903968|81556973|FG004|Overall Study|DLT|0|||
27923131|NCT00903968|81556974|FG005|Overall Study|DLT|0|||
27923132|NCT00903968|81556975|FG006|Overall Study|DLT|2|||
27923133|NCT00903968|81556976|FG007|Overall Study|DLT|0|||
27923134|NCT00903968|81556969|FG000|Overall Study|Withdrawal by Subject|1|||
27923135|NCT00903968|81556970|FG001|Overall Study|Withdrawal by Subject|0|||
27923136|NCT00903968|81556971|FG002|Overall Study|Withdrawal by Subject|1|||
27923137|NCT00903968|81556972|FG003|Overall Study|Withdrawal by Subject|0|||
27923138|NCT00903968|81556973|FG004|Overall Study|Withdrawal by Subject|1|||
27923139|NCT00903968|81556974|FG005|Overall Study|Withdrawal by Subject|1|||
27923140|NCT00903968|81556975|FG006|Overall Study|Withdrawal by Subject|0|||
27923141|NCT00903968|81556976|FG007|Overall Study|Withdrawal by Subject|4|||
27923142|NCT00903968|81556969|FG000|Overall Study|Non-Compliance|0|||
27923143|NCT00903968|81556970|FG001|Overall Study|Non-Compliance|0|||
27923144|NCT00903968|81556971|FG002|Overall Study|Non-Compliance|0|||
27923145|NCT00903968|81556972|FG003|Overall Study|Non-Compliance|0|||
27923146|NCT00903968|81556973|FG004|Overall Study|Non-Compliance|0|||
27923147|NCT00903968|81556974|FG005|Overall Study|Non-Compliance|1|||
27923148|NCT00903968|81556975|FG006|Overall Study|Non-Compliance|0|||
27923149|NCT00903968|81556976|FG007|Overall Study|Non-Compliance|0|||
27923150|NCT00903968|81556969|FG000|Overall Study|Physician Decision|0|||
27923151|NCT00903968|81556970|FG001|Overall Study|Physician Decision|0|||
27923152|NCT00903968|81556971|FG002|Overall Study|Physician Decision|0|||
27923153|NCT00903968|81556972|FG003|Overall Study|Physician Decision|0|||
27923154|NCT00903968|81556973|FG004|Overall Study|Physician Decision|0|||
27544038|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
27544039|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
27544040|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
27544041|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
27544042|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
27544043|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
27544044|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
27544045|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
27544046|NCT00256750|80185677|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
27544047|NCT00256750|80185678|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
27544048|NCT00256750|80185679|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
27544049|NCT04092582|80185680|FG000|Overall Study|Death|1|||
27544050|NCT04092582|80185681|FG001|Overall Study|Death|1|||
27544051|NCT04092582|80185680|FG000|Overall Study|Withdrawal by Subject|4|||
27923155|NCT00903968|81556974|FG005|Overall Study|Physician Decision|1|||
27923156|NCT00903968|81556975|FG006|Overall Study|Physician Decision|0|||
27923157|NCT00903968|81556976|FG007|Overall Study|Physician Decision|0|||
27923158|NCT00903968|81556969|FG000|Overall Study|Progressive Disease|2|||
27923159|NCT00903968|81556970|FG001|Overall Study|Progressive Disease|3|||
27923160|NCT00903968|81556971|FG002|Overall Study|Progressive Disease|2|||
27923161|NCT00903968|81556972|FG003|Overall Study|Progressive Disease|3|||
27923162|NCT00903968|81556973|FG004|Overall Study|Progressive Disease|3|||
27923163|NCT00903968|81556974|FG005|Overall Study|Progressive Disease|3|||
27923164|NCT00903968|81556975|FG006|Overall Study|Progressive Disease|0|||
27923165|NCT00903968|81556976|FG007|Overall Study|Progressive Disease|18|||
27923166|NCT00903968|81556969|FG000|Overall Study|Lack of Efficacy|0|||
27544052|NCT04092582|80185681|FG001|Overall Study|Withdrawal by Subject|1|||
27923167|NCT00903968|81556970|FG001|Overall Study|Lack of Efficacy|0|||
27923168|NCT00903968|81556971|FG002|Overall Study|Lack of Efficacy|0|||
27544053|NCT04092582|80185680|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
27544054|NCT04092582|80185681|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
27544055|NCT00826943|80185687|FG000|Overall Study|Withdrawal by Subject|0|||
27544056|NCT00826943|80185688|FG001|Overall Study|Withdrawal by Subject|0|||
27544057|NCT00826943|80185689|FG002|Overall Study|Withdrawal by Subject|0|||
27544058|NCT00826943|80185690|FG003|Overall Study|Withdrawal by Subject|0|||
27544059|NCT00826943|80185691|FG004|Overall Study|Withdrawal by Subject|1|||
27544060|NCT00826943|80185692|FG005|Overall Study|Withdrawal by Subject|0|||
27544061|NCT00833794|80185693|FG000|Open-label Phase|Adverse Event|225|||
27544062|NCT00833794|80185694|FG001|Open-label Phase|Adverse Event|0|||
27544063|NCT00833794|80185693|FG000|Open-label Phase|Lack of Efficacy|28|||
27544064|NCT00833794|80185694|FG001|Open-label Phase|Lack of Efficacy|0|||
27544065|NCT00833794|80185693|FG000|Open-label Phase|Withdrawal by Subject|48|||
27544066|NCT00833794|80185694|FG001|Open-label Phase|Withdrawal by Subject|0|||
27544067|NCT00833794|80185693|FG000|Open-label Phase|Physician Decision|20|||
27544068|NCT00833794|80185694|FG001|Open-label Phase|Physician Decision|0|||
27544069|NCT00833794|80185693|FG000|Open-label Phase|Administrative reason|1|||
27544070|NCT00833794|80185694|FG001|Open-label Phase|Administrative reason|0|||
27544071|NCT00833794|80185693|FG000|Open-label Phase|Protocol Violation|47|||
27544072|NCT00833794|80185694|FG001|Open-label Phase|Protocol Violation|0|||
27544073|NCT00833794|80185693|FG000|Open-label Phase|Did not complete wash-out period|12|||
27544074|NCT00833794|80185694|FG001|Open-label Phase|Did not complete wash-out period|0|||
27544075|NCT00833794|80185693|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
27544076|NCT00833794|80185694|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
27544077|NCT00833794|80185693|FG000|Double-blind Phase|Adverse Event|44|||
27544078|NCT00833794|80185694|FG001|Double-blind Phase|Adverse Event|11|||
27544079|NCT00833794|80185693|FG000|Double-blind Phase|Lack of Efficacy|34|||
27544080|NCT00833794|80185694|FG001|Double-blind Phase|Lack of Efficacy|22|||
27544081|NCT00833794|80185693|FG000|Double-blind Phase|Withdrawal by Subject|23|||
27637953|NCT01170962|80515957|FG000|Treatment Period|Withdrawal by Subject|2|||
27637954|NCT01170962|80515958|FG001|Treatment Period|Withdrawal by Subject|1|||
27637955|NCT01170962|80515959|FG002|Treatment Period|Withdrawal by Subject|0|||
27637956|NCT01170962|80515957|FG000|Treatment Period|Lost to Follow-up|1|||
27637957|NCT01170962|80515958|FG001|Treatment Period|Lost to Follow-up|1|||
27637958|NCT01170962|80515959|FG002|Treatment Period|Lost to Follow-up|1|||
27637959|NCT01170962|80515957|FG000|Treatment Period|Participant no longer meets criteria|0|||
27637960|NCT01170962|80515958|FG001|Treatment Period|Participant no longer meets criteria|1|||
27637961|NCT01170962|80515959|FG002|Treatment Period|Participant no longer meets criteria|0|||
27637962|NCT01170962|80515957|FG000|Treatment Period|Request to discontinue treatment|7|||
27637963|NCT01170962|80515958|FG001|Treatment Period|Request to discontinue treatment|3|||
27923169|NCT00903968|81556972|FG003|Overall Study|Lack of Efficacy|0|||
27923170|NCT00903968|81556973|FG004|Overall Study|Lack of Efficacy|0|||
27637964|NCT01170962|80515959|FG002|Treatment Period|Request to discontinue treatment|1|||
27637965|NCT01170962|80515957|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
27637966|NCT01170962|80515958|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
27637967|NCT01170962|80515959|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
27637968|NCT01170962|80515957|FG000|Follow up Period|Withdrawal by Subject|14|||
27637969|NCT01170962|80515958|FG001|Follow up Period|Withdrawal by Subject|10|||
27637970|NCT01170962|80515959|FG002|Follow up Period|Withdrawal by Subject|2|||
27637971|NCT01170962|80515957|FG000|Follow up Period|Lost to Follow-up|13|||
27544082|NCT00833794|80185694|FG001|Double-blind Phase|Withdrawal by Subject|6|||
27544083|NCT00833794|80185693|FG000|Double-blind Phase|Physician Decision|4|||
27544084|NCT00833794|80185694|FG001|Double-blind Phase|Physician Decision|7|||
27544085|NCT00833794|80185693|FG000|Double-blind Phase|Administrative reason|1|||
27544086|NCT00833794|80185694|FG001|Double-blind Phase|Administrative reason|3|||
27544087|NCT01546207|80185695|FG000|Overall Study|Death|1|||
27544088|NCT01203098|80185696|FG000|Overall Study|Adverse Event|3|||
27544089|NCT01203098|80185697|FG001|Overall Study|Adverse Event|1|||
27544090|NCT01203098|80185698|FG002|Overall Study|Adverse Event|7|||
27637972|NCT01170962|80515958|FG001|Follow up Period|Lost to Follow-up|8|||
27637973|NCT01170962|80515959|FG002|Follow up Period|Lost to Follow-up|1|||
27637974|NCT01170962|80515957|FG000|Follow up Period|Death|2|||
27637975|NCT01170962|80515958|FG001|Follow up Period|Death|2|||
27637976|NCT01170962|80515959|FG002|Follow up Period|Death|0|||
27923171|NCT00903968|81556974|FG005|Overall Study|Lack of Efficacy|0|||
27637977|NCT01170962|80515957|FG000|Follow up Period|Others|10|||
27637978|NCT01170962|80515958|FG001|Follow up Period|Others|7|||
27923172|NCT00903968|81556975|FG006|Overall Study|Lack of Efficacy|0|||
27923173|NCT00903968|81556976|FG007|Overall Study|Lack of Efficacy|3|||
27544091|NCT01203098|80185696|FG000|Overall Study|Lost to Follow-up|0|||
27544092|NCT01203098|80185697|FG001|Overall Study|Lost to Follow-up|0|||
27544093|NCT01203098|80185698|FG002|Overall Study|Lost to Follow-up|1|||
27544094|NCT01203098|80185696|FG000|Overall Study|Physician Decision|2|||
27544095|NCT01203098|80185697|FG001|Overall Study|Physician Decision|2|||
27637979|NCT01170962|80515959|FG002|Follow up Period|Others|3|||
27923174|NCT00350545|81556977|FG000|Overall Study|Withdrawal by Subject|2|||
27923175|NCT04465422|81556978|FG000|Overall Study|Lost to Follow-up|0|||
27923176|NCT04465422|81556979|FG001|Overall Study|Lost to Follow-up|2|||
27923177|NCT00753519|81556980|FG000|Overall Study|Withdrawal by Subject|0|||
27923178|NCT00753519|81556981|FG001|Overall Study|Withdrawal by Subject|2|||
27923179|NCT04889040|81556990|FG000|Overall Study|Withdrawal by Subject|3|||
27923180|NCT04889040|81556991|FG001|Overall Study|Withdrawal by Subject|3|||
27923181|NCT04889040|81556990|FG000|Overall Study|Lost to Follow-up|0|||
27923182|NCT04889040|81556991|FG001|Overall Study|Lost to Follow-up|1|||
27923183|NCT04889040|81556990|FG000|Overall Study|Adverse Event|2|||
27923184|NCT04889040|81556991|FG001|Overall Study|Adverse Event|1|||
27923185|NCT01582451|81556995|FG000|Overall Study|Adverse Event|1|||
27923186|NCT01582451|81556996|FG001|Overall Study|Adverse Event|3|||
27923187|NCT01582451|81556995|FG000|Overall Study|Death|3|||
27741115|NCT01050062|80880852|FG001|Overall Study|Lost to Follow-up|35|||
27923188|NCT01582451|81556996|FG001|Overall Study|Death|3|||
27923189|NCT01582451|81556995|FG000|Overall Study|Lost to Follow-up|0|||
27923190|NCT01582451|81556996|FG001|Overall Study|Lost to Follow-up|2|||
27923191|NCT01582451|81556995|FG000|Overall Study|Protocol Violation|11|||
27923192|NCT01582451|81556996|FG001|Overall Study|Protocol Violation|3|||
27923193|NCT01582451|81556995|FG000|Overall Study|Withdrawal by Subject|13|||
27923194|NCT01582451|81556996|FG001|Overall Study|Withdrawal by Subject|9|||
27923195|NCT01582451|81556995|FG000|Overall Study|Physician Decision|3|||
27923196|NCT01582451|81556996|FG001|Overall Study|Physician Decision|0|||
27923197|NCT01582451|81556995|FG000|Overall Study|Sponsor Decision|1|||
27923198|NCT01582451|81556996|FG001|Overall Study|Sponsor Decision|0|||
27923199|NCT04079790|81557001|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
27923200|NCT04079790|81557002|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
27923201|NCT04079790|81557003|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
27923202|NCT04079790|81557004|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
27923203|NCT04079790|81557001|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
27923204|NCT04079790|81557002|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
27923205|NCT04079790|81557003|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
27923206|NCT04079790|81557004|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
27923207|NCT04079790|81557001|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
27923208|NCT04079790|81557002|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
27923209|NCT04079790|81557003|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
27923210|NCT04079790|81557004|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
27923211|NCT01047319|81557005|FG000|Overall Study|Teva requested participant withdrawal|3|||
27923212|NCT01047319|81557006|FG001|Overall Study|Teva requested participant withdrawal|0|||
27923213|NCT01047319|81557007|FG002|Overall Study|Teva requested participant withdrawal|1|||
27923214|NCT01047319|81557005|FG000|Overall Study|Protocol Violation|3|||
27923215|NCT01047319|81557006|FG001|Overall Study|Protocol Violation|2|||
27923216|NCT01047319|81557007|FG002|Overall Study|Protocol Violation|4|||
27923217|NCT01047319|81557005|FG000|Overall Study|Lack of Efficacy|4|||
27923218|NCT01047319|81557006|FG001|Overall Study|Lack of Efficacy|3|||
27923219|NCT01047319|81557007|FG002|Overall Study|Lack of Efficacy|3|||
27923220|NCT01047319|81557005|FG000|Overall Study|Death|5|||
27923221|NCT01047319|81557006|FG001|Overall Study|Death|1|||
27923222|NCT01047319|81557007|FG002|Overall Study|Death|5|||
27923223|NCT01047319|81557005|FG000|Overall Study|Pregnancy|13|||
27923224|NCT01047319|81557006|FG001|Overall Study|Pregnancy|8|||
27923225|NCT01047319|81557007|FG002|Overall Study|Pregnancy|8|||
27923226|NCT01047319|81557005|FG000|Overall Study|Physician Decision|12|||
27923227|NCT01047319|81557006|FG001|Overall Study|Physician Decision|9|||
27923228|NCT01047319|81557007|FG002|Overall Study|Physician Decision|10|||
27923229|NCT01047319|81557005|FG000|Overall Study|Lost to Follow-up|14|||
27923230|NCT01047319|81557006|FG001|Overall Study|Lost to Follow-up|10|||
27923231|NCT01047319|81557007|FG002|Overall Study|Lost to Follow-up|10|||
27923232|NCT01047319|81557005|FG000|Overall Study|Adverse Event|16|||
27923233|NCT01047319|81557006|FG001|Overall Study|Adverse Event|27|||
27923234|NCT01047319|81557007|FG002|Overall Study|Adverse Event|21|||
27923235|NCT01047319|81557005|FG000|Overall Study|Withdrawal by Subject|77|||
27923236|NCT01047319|81557006|FG001|Overall Study|Withdrawal by Subject|75|||
27923237|NCT01047319|81557007|FG002|Overall Study|Withdrawal by Subject|87|||
27923238|NCT01047319|81557005|FG000|Overall Study|Study terminated by Sponsor|198|||
27923239|NCT01047319|81557006|FG001|Overall Study|Study terminated by Sponsor|215|||
27923240|NCT01047319|81557007|FG002|Overall Study|Study terminated by Sponsor|203|||
27923241|NCT02550795|81557008|FG000|Overall Study|Physician Decision|0|||
27923242|NCT02550795|81557009|FG001|Overall Study|Physician Decision|1|||
27923243|NCT02550795|81557010|FG002|Overall Study|Physician Decision|0|||
27923244|NCT03937778|81557012|FG000|Overall Study|Withdrawal by Subject|1|||
27923245|NCT03937778|81557012|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
27923246|NCT00726453|81557015|FG000|Primary Enrollment Group|Death|18|||
27923247|NCT00726453|81557016|FG001|Primary Enrollment Group|Death|0|||
27923248|NCT00726453|81557015|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
27923249|NCT00726453|81557016|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
27923250|NCT00726453|81557015|FG000|38 mm Length Group|Death|0|||
27923251|NCT00726453|81557016|FG001|38 mm Length Group|Death|3|||
27923252|NCT02337764|81557018|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
27923253|NCT02337764|81557018|FG000|Overall Study|Voluntary Withdrawal|12|||
27923254|NCT02337764|81557018|FG000|Overall Study|Lack of Efficacy|2|||
27923255|NCT03861039|81557019|FG000|Overall Study|Adverse Event|2|||
27923256|NCT03861039|81557020|FG001|Overall Study|Adverse Event|5|||
27923257|NCT03861039|81557021|FG002|Overall Study|Adverse Event|11|||
27923258|NCT03861039|81557019|FG000|Overall Study|Withdrawal by Subject|1|||
27923259|NCT03861039|81557020|FG001|Overall Study|Withdrawal by Subject|3|||
27923260|NCT03861039|81557021|FG002|Overall Study|Withdrawal by Subject|4|||
27923261|NCT00076570|81557024|FG000|Overall Study|Drug intolerance|8|||
27923262|NCT00076570|81557025|FG001|Overall Study|Drug intolerance|8|||
27923263|NCT00433836|81557033|FG000|Overall Study|Adverse Event|7|||
27923264|NCT00433836|81557034|FG001|Overall Study|Adverse Event|0|||
27923265|NCT00433836|81557033|FG000|Overall Study|Lost to Follow-up|3|||
27923266|NCT00433836|81557034|FG001|Overall Study|Lost to Follow-up|0|||
27923267|NCT00433836|81557033|FG000|Overall Study|Withdrawal by Subject|2|||
27923268|NCT00433836|81557034|FG001|Overall Study|Withdrawal by Subject|1|||
27923269|NCT00433836|81557033|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27923270|NCT00433836|81557034|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27923271|NCT00433836|81557033|FG000|Overall Study|Protocol Violation|0|||
27923272|NCT00433836|81557034|FG001|Overall Study|Protocol Violation|2|||
27923273|NCT00433836|81557033|FG000|Overall Study|Condition no longer requires study drug|0|||
27923274|NCT00433836|81557034|FG001|Overall Study|Condition no longer requires study drug|1|||
27923275|NCT00433836|81557033|FG000|Overall Study|Abnormal laboratory values|0|||
27923276|NCT00433836|81557034|FG001|Overall Study|Abnormal laboratory values|1|||
27923277|NCT00109343|81557037|FG000|Overall Study|Adverse Event|1|||
27923278|NCT00109343|81557038|FG001|Overall Study|Adverse Event|0|||
27923279|NCT00109343|81557039|FG002|Overall Study|Adverse Event|2|||
27923280|NCT00109343|81557037|FG000|Overall Study|Lack of Efficacy|1|||
27923281|NCT00109343|81557038|FG001|Overall Study|Lack of Efficacy|0|||
27923282|NCT00109343|81557039|FG002|Overall Study|Lack of Efficacy|0|||
27923283|NCT00109343|81557037|FG000|Overall Study|Lost to Follow-up|35|||
27923284|NCT00109343|81557038|FG001|Overall Study|Lost to Follow-up|20|||
27923285|NCT00109343|81557039|FG002|Overall Study|Lost to Follow-up|14|||
27923286|NCT00109343|81557037|FG000|Overall Study|Protocol Violation|1|||
27923287|NCT00109343|81557038|FG001|Overall Study|Protocol Violation|2|||
27923288|NCT00109343|81557039|FG002|Overall Study|Protocol Violation|2|||
27923289|NCT00109343|81557037|FG000|Overall Study|Withdrawal by Subject|15|||
27923290|NCT00109343|81557038|FG001|Overall Study|Withdrawal by Subject|11|||
27923291|NCT00109343|81557039|FG002|Overall Study|Withdrawal by Subject|10|||
27923292|NCT00109343|81557037|FG000|Overall Study|Subject Moved|6|||
27923293|NCT00109343|81557038|FG001|Overall Study|Subject Moved|2|||
27923294|NCT00109343|81557039|FG002|Overall Study|Subject Moved|1|||
27923295|NCT00109343|81557037|FG000|Overall Study|Other|5|||
27923296|NCT00109343|81557038|FG001|Overall Study|Other|2|||
27923297|NCT00109343|81557039|FG002|Overall Study|Other|1|||
27923298|NCT04040439|81557040|FG000|Overall Study|Invalid registration|11|||
27923299|NCT04040439|81557040|FG000|Overall Study|No IC* on publication of study results|2|||
27923300|NCT00490035|81557041|FG000|Overall Study|AE, non-serious non-fatal|3|||
27923301|NCT00490035|81557042|FG001|Overall Study|AE, non-serious non-fatal|4|||
27923302|NCT00490035|81557043|FG002|Overall Study|AE, non-serious non-fatal|4|||
27923303|NCT00490035|81557044|FG003|Overall Study|AE, non-serious non-fatal|5|||
27923304|NCT00490035|81557041|FG000|Overall Study|Lost to Follow-up|2|||
27923305|NCT00490035|81557042|FG001|Overall Study|Lost to Follow-up|0|||
27923306|NCT00490035|81557043|FG002|Overall Study|Lost to Follow-up|1|||
27923307|NCT00490035|81557044|FG003|Overall Study|Lost to Follow-up|0|||
27923308|NCT00490035|81557041|FG000|Overall Study|Withdrawal by Subject|2|||
27923309|NCT00490035|81557042|FG001|Overall Study|Withdrawal by Subject|1|||
27923310|NCT00490035|81557043|FG002|Overall Study|Withdrawal by Subject|1|||
27923311|NCT00490035|81557044|FG003|Overall Study|Withdrawal by Subject|0|||
27923312|NCT00490035|81557041|FG000|Overall Study|Other reason|0|||
27923313|NCT00490035|81557042|FG001|Overall Study|Other reason|1|||
27923314|NCT00490035|81557043|FG002|Overall Study|Other reason|3|||
27923315|NCT00490035|81557044|FG003|Overall Study|Other reason|1|||
27923316|NCT00490035|81557041|FG000|Overall Study|AE, serious fatal|1|||
27923317|NCT00490035|81557042|FG001|Overall Study|AE, serious fatal|0|||
27923318|NCT00490035|81557043|FG002|Overall Study|AE, serious fatal|0|||
27923319|NCT00490035|81557044|FG003|Overall Study|AE, serious fatal|0|||
27923320|NCT00490035|81557041|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
27923321|NCT00490035|81557042|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
27923322|NCT00490035|81557043|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
27923323|NCT00490035|81557044|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
27923324|NCT00490035|81557041|FG000|Overall Study|AE of unknown type|0|||
27923325|NCT00490035|81557042|FG001|Overall Study|AE of unknown type|0|||
27923326|NCT00490035|81557043|FG002|Overall Study|AE of unknown type|2|||
27923327|NCT00490035|81557044|FG003|Overall Study|AE of unknown type|0|||
27923328|NCT00695019|81557045|FG000|Overall Study|Withdrawal by Subject|8|||
27923329|NCT00695019|81557046|FG001|Overall Study|Withdrawal by Subject|6|||
27923330|NCT00695019|81557047|FG002|Overall Study|Withdrawal by Subject|4|||
27923331|NCT00695019|81557045|FG000|Overall Study|Protocol Violation|1|||
27923332|NCT00695019|81557046|FG001|Overall Study|Protocol Violation|3|||
27923333|NCT00695019|81557047|FG002|Overall Study|Protocol Violation|1|||
27923334|NCT00695019|81557045|FG000|Overall Study|Lack of Efficacy|0|||
27923335|NCT00695019|81557046|FG001|Overall Study|Lack of Efficacy|0|||
27923336|NCT00695019|81557047|FG002|Overall Study|Lack of Efficacy|1|||
27923337|NCT00695019|81557045|FG000|Overall Study|Various|4|||
27923338|NCT00695019|81557046|FG001|Overall Study|Various|5|||
27923339|NCT00695019|81557047|FG002|Overall Study|Various|4|||
27923340|NCT00959751|81557048|FG000|Overall Study|Lost to Follow-up|2|||
27923341|NCT00959751|81557049|FG001|Overall Study|Lost to Follow-up|3|||
27923342|NCT00959751|81557048|FG000|Overall Study|Consent Withdrawn|0|||
27923343|NCT00959751|81557049|FG001|Overall Study|Consent Withdrawn|1|||
27923344|NCT00959751|81557048|FG000|Overall Study|Non-compliance to Study Procedures|0|||
27923345|NCT00959751|81557049|FG001|Overall Study|Non-compliance to Study Procedures|1|||
27923346|NCT00959751|81557048|FG000|Overall Study|No migraine headache without aura|7|||
27923347|NCT00959751|81557049|FG001|Overall Study|No migraine headache without aura|7|||
27544096|NCT01203098|80185698|FG002|Overall Study|Physician Decision|0|||
27544097|NCT01203098|80185696|FG000|Overall Study|Withdrawal by Subject|1|||
27544098|NCT01203098|80185697|FG001|Overall Study|Withdrawal by Subject|1|||
27544099|NCT01203098|80185698|FG002|Overall Study|Withdrawal by Subject|3|||
27544100|NCT00980057|80185699|FG000|Overall Study|Death|13|||
27544101|NCT00980057|80185700|FG001|Overall Study|Death|3|||
27544102|NCT00980057|80185699|FG000|Overall Study|Adverse Event|0|||
27544103|NCT00980057|80185700|FG001|Overall Study|Adverse Event|1|||
27544104|NCT00980057|80185699|FG000|Overall Study|Physician Decision|4|||
27544105|NCT00980057|80185700|FG001|Overall Study|Physician Decision|0|||
27544106|NCT00980057|80185699|FG000|Overall Study|Lost to Follow-up|1|||
27544107|NCT00980057|80185700|FG001|Overall Study|Lost to Follow-up|0|||
27544108|NCT00980057|80185699|FG000|Overall Study|Withdrawal by Subject|1|||
27544109|NCT00980057|80185700|FG001|Overall Study|Withdrawal by Subject|1|||
27544110|NCT01858389|80185703|FG000|Overall Study|Death|1|||
27544111|NCT01858389|80185704|FG001|Overall Study|Death|3|||
27544112|NCT01858389|80185703|FG000|Overall Study|Study terminated by sponsor|0|||
27544113|NCT01858389|80185704|FG001|Overall Study|Study terminated by sponsor|2|||
27544114|NCT01858389|80185703|FG000|Overall Study|Withdrawal by Subject|0|||
27544115|NCT01858389|80185704|FG001|Overall Study|Withdrawal by Subject|1|||
27544116|NCT01858389|80185703|FG000|Overall Study|Progressive disease|10|||
27544117|NCT01858389|80185704|FG001|Overall Study|Progressive disease|11|||
27544118|NCT01858389|80185703|FG000|Overall Study|Other|2|||
27923348|NCT02690727|81557052|FG000|Overall Study|Adverse Event|2|||
27923349|NCT02690727|81557053|FG001|Overall Study|Adverse Event|2|||
27923350|NCT04400318|81557055|FG000|Overall Study|Adverse Event|1|||
27923351|NCT04400318|81557056|FG001|Overall Study|Adverse Event|0|||
27923352|NCT04400318|81557055|FG000|Overall Study|Withdrawal by Subject|1|||
27923353|NCT04400318|81557056|FG001|Overall Study|Withdrawal by Subject|1|||
27923354|NCT04400318|81557055|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
27923355|NCT04400318|81557056|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
27923356|NCT05001620|81557058|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
27923357|NCT05001620|81557059|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
27923358|NCT00423046|81557060|FG000|Overall Study|Other|340|||
27923359|NCT00423046|81557061|FG001|Overall Study|Other|345|||
27923360|NCT04796415|81557062|FG000|Overall Study|not interested|12|||
27923361|NCT04796415|81557062|FG000|Overall Study|health issue|8|||
27923362|NCT04796415|81557062|FG000|Overall Study|Other|4|||
27923363|NCT04796415|81557062|FG000|Overall Study|discharged from home health service|3|||
27923364|NCT04796415|81557062|FG000|Overall Study|re-hospitalization|2|||
27923365|NCT04796415|81557062|FG000|Overall Study|moving to nursing home|1|||
27923366|NCT04796415|81557062|FG000|Overall Study|lost contact|1|||
27923367|NCT00557466|81557065|FG000|Overall Study|Adverse Event|3|||
27923368|NCT00557466|81557066|FG001|Overall Study|Adverse Event|1|||
27544119|NCT01858389|80185704|FG001|Overall Study|Other|4|||
27923369|NCT00557466|81557067|FG002|Overall Study|Adverse Event|4|||
27923370|NCT00557466|81557068|FG003|Overall Study|Adverse Event|1|||
27923371|NCT00557466|81557069|FG004|Overall Study|Adverse Event|2|||
27923372|NCT00557466|81557070|FG005|Overall Study|Adverse Event|4|||
27923373|NCT00557466|81557065|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27923374|NCT00557466|81557066|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27923375|NCT00557466|81557067|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27923376|NCT00557466|81557068|FG003|Overall Study|Abnormal laboratory value(s)|0|||
27544120|NCT01858389|80185703|FG000|Overall Study|Adverse Event|3|||
27544121|NCT01858389|80185704|FG001|Overall Study|Adverse Event|1|||
27544122|NCT01858389|80185703|FG000|Overall Study|Did not receive treatment|0|||
27544123|NCT01858389|80185704|FG001|Overall Study|Did not receive treatment|3|||
27544124|NCT01325584|80185705|FG000|Overall Study|Death|1|||
27544125|NCT02100514|80185706|FG000|Treatment Period|Adverse Event|0|||
27544126|NCT02100514|80185707|FG001|Treatment Period|Adverse Event|5|||
27544127|NCT02100514|80185708|FG002|Treatment Period|Adverse Event|0|||
27544128|NCT02100514|80185709|FG003|Treatment Period|Adverse Event|0|||
27923377|NCT00557466|81557069|FG004|Overall Study|Abnormal laboratory value(s)|0|||
27923378|NCT00557466|81557070|FG005|Overall Study|Abnormal laboratory value(s)|0|||
27923379|NCT00557466|81557065|FG000|Overall Study|Protocol deviation|0|||
27923380|NCT00557466|81557066|FG001|Overall Study|Protocol deviation|1|||
27923381|NCT00557466|81557067|FG002|Overall Study|Protocol deviation|0|||
27923382|NCT00557466|81557068|FG003|Overall Study|Protocol deviation|2|||
27923383|NCT00557466|81557069|FG004|Overall Study|Protocol deviation|0|||
27923384|NCT00557466|81557070|FG005|Overall Study|Protocol deviation|0|||
27923385|NCT00557466|81557065|FG000|Overall Study|Subject withdrew consent|0|||
27923386|NCT00557466|81557066|FG001|Overall Study|Subject withdrew consent|0|||
27741116|NCT01050062|80880851|FG000|Overall Study|Lack of Efficacy|22|||
27741117|NCT01050062|80880852|FG001|Overall Study|Lack of Efficacy|35|||
27741118|NCT01050062|80880851|FG000|Overall Study|Physician Decision|74|||
27741119|NCT01050062|80880852|FG001|Overall Study|Physician Decision|9|||
27741120|NCT01050062|80880851|FG000|Overall Study|Others|17|||
27741121|NCT01050062|80880852|FG001|Overall Study|Others|11|||
27741122|NCT00685178|80880853|FG000|Overall Study|Adverse Event|1|||
27741123|NCT00685178|80880854|FG001|Overall Study|Adverse Event|5|||
27741124|NCT00685178|80880855|FG002|Overall Study|Adverse Event|2|||
27741125|NCT00685178|80880856|FG003|Overall Study|Adverse Event|4|||
27741126|NCT00685178|80880853|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
27741127|NCT00685178|80880854|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
27741128|NCT00685178|80880855|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
27741129|NCT00685178|80880856|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
27741130|NCT00685178|80880853|FG000|Overall Study|voluntary study discharge|4|||
27741131|NCT00685178|80880854|FG001|Overall Study|voluntary study discharge|5|||
27741132|NCT00685178|80880855|FG002|Overall Study|voluntary study discharge|1|||
27741133|NCT00685178|80880856|FG003|Overall Study|voluntary study discharge|1|||
27741134|NCT00685178|80880853|FG000|Overall Study|incarcerated|1|||
27544129|NCT02100514|80185710|FG004|Treatment Period|Adverse Event|0|||
27544130|NCT02100514|80185706|FG000|Treatment Period|Death|2|||
27544131|NCT02100514|80185707|FG001|Treatment Period|Death|2|||
27544132|NCT02100514|80185708|FG002|Treatment Period|Death|0|||
27544133|NCT02100514|80185709|FG003|Treatment Period|Death|0|||
27544134|NCT02100514|80185710|FG004|Treatment Period|Death|0|||
27544135|NCT02100514|80185706|FG000|Treatment Period|Lost to Follow-up|5|||
27544136|NCT02100514|80185707|FG001|Treatment Period|Lost to Follow-up|17|||
27741135|NCT00685178|80880854|FG001|Overall Study|incarcerated|3|||
27741136|NCT00685178|80880855|FG002|Overall Study|incarcerated|7|||
27741137|NCT00685178|80880856|FG003|Overall Study|incarcerated|0|||
27741138|NCT00685178|80880853|FG000|Overall Study|administrative (disciplinary) discharge|0|||
27741139|NCT00685178|80880854|FG001|Overall Study|administrative (disciplinary) discharge|1|||
27741140|NCT00685178|80880855|FG002|Overall Study|administrative (disciplinary) discharge|0|||
27741141|NCT00685178|80880856|FG003|Overall Study|administrative (disciplinary) discharge|2|||
27741142|NCT00685178|80880853|FG000|Overall Study|Pregnancy|0|||
27923387|NCT00557466|81557067|FG002|Overall Study|Subject withdrew consent|0|||
27923388|NCT00557466|81557068|FG003|Overall Study|Subject withdrew consent|0|||
27923389|NCT00557466|81557069|FG004|Overall Study|Subject withdrew consent|1|||
27923390|NCT00557466|81557070|FG005|Overall Study|Subject withdrew consent|2|||
27923391|NCT00557466|81557065|FG000|Overall Study|Administrative problems|0|||
27923392|NCT00557466|81557066|FG001|Overall Study|Administrative problems|1|||
27923393|NCT00557466|81557067|FG002|Overall Study|Administrative problems|1|||
27923394|NCT00557466|81557068|FG003|Overall Study|Administrative problems|0|||
27923395|NCT00557466|81557069|FG004|Overall Study|Administrative problems|0|||
27923396|NCT00557466|81557070|FG005|Overall Study|Administrative problems|0|||
27923397|NCT00557466|81557065|FG000|Overall Study|Abnormal test procedure results|0|||
27923398|NCT00557466|81557066|FG001|Overall Study|Abnormal test procedure results|0|||
27923399|NCT00557466|81557067|FG002|Overall Study|Abnormal test procedure results|1|||
27923400|NCT00557466|81557068|FG003|Overall Study|Abnormal test procedure results|0|||
27544137|NCT02100514|80185708|FG002|Treatment Period|Lost to Follow-up|0|||
27544138|NCT02100514|80185709|FG003|Treatment Period|Lost to Follow-up|0|||
27637980|NCT00089544|80515962|FG000|Overall Study|Ineligible|1|||
27741143|NCT00685178|80880854|FG001|Overall Study|Pregnancy|0|||
27923401|NCT00557466|81557069|FG004|Overall Study|Abnormal test procedure results|0|||
27544139|NCT02100514|80185710|FG004|Treatment Period|Lost to Follow-up|0|||
27544140|NCT02100514|80185706|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
27741144|NCT00685178|80880855|FG002|Overall Study|Pregnancy|0|||
27741145|NCT00685178|80880856|FG003|Overall Study|Pregnancy|1|||
27741146|NCT01171521|80880857|FG000|Overall Study|Lost to Follow-up|5|||
27741147|NCT01171521|80880857|FG000|Overall Study|screen failure|1|||
27923402|NCT00557466|81557070|FG005|Overall Study|Abnormal test procedure results|0|||
27544141|NCT02100514|80185707|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
27923403|NCT00557466|81557065|FG000|Overall Study|Lost to Follow-up|0|||
27923404|NCT00557466|81557066|FG001|Overall Study|Lost to Follow-up|0|||
27923405|NCT00557466|81557067|FG002|Overall Study|Lost to Follow-up|0|||
27923406|NCT00557466|81557068|FG003|Overall Study|Lost to Follow-up|1|||
27923407|NCT00557466|81557069|FG004|Overall Study|Lost to Follow-up|0|||
27923408|NCT00557466|81557070|FG005|Overall Study|Lost to Follow-up|0|||
27923409|NCT01655901|81557073|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27923410|NCT01655901|81557074|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27923411|NCT01655901|81557075|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27923412|NCT01655901|81557076|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
27923413|NCT01655901|81557077|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
27923414|NCT01655901|81557078|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
27923415|NCT00655889|81557079|FG000|Overall Study|Inadequate cell growth|1|||
27923416|NCT00655889|81557079|FG000|Overall Study|Protocol Violation|1|||
27923417|NCT01664091|81557080|FG000|Overall Study|Death|1|||
27923418|NCT01664091|81557080|FG000|Overall Study|Disease Progression|2|||
27923419|NCT01664091|81557080|FG000|Overall Study|Lost to Follow-up|2|||
27923420|NCT01664091|81557080|FG000|Overall Study|Withdrawal by Subject|1|||
27923421|NCT03091439|81557082|FG000|Overall Study|Study Terminated by the Sponsor|1|||
27923422|NCT03091439|81557083|FG001|Overall Study|Study Terminated by the Sponsor|0|||
27923423|NCT02832037|81557084|FG000|Overall Study|Administrative reasons|0|||
27923424|NCT02832037|81557085|FG001|Overall Study|Administrative reasons|0|||
27923425|NCT02832037|81557086|FG002|Overall Study|Administrative reasons|1|||
27923426|NCT02832037|81557087|FG003|Overall Study|Administrative reasons|0|||
27923427|NCT02832037|81557088|FG004|Overall Study|Administrative reasons|0|||
27923428|NCT02832037|81557084|FG000|Overall Study|Protocol Violation|3|||
27923429|NCT02832037|81557085|FG001|Overall Study|Protocol Violation|0|||
27923430|NCT02832037|81557086|FG002|Overall Study|Protocol Violation|4|||
27923431|NCT02832037|81557087|FG003|Overall Study|Protocol Violation|1|||
27923432|NCT02832037|81557088|FG004|Overall Study|Protocol Violation|2|||
27923433|NCT02832037|81557084|FG000|Overall Study|Lost to Follow-up|2|||
27923434|NCT02832037|81557085|FG001|Overall Study|Lost to Follow-up|0|||
27923435|NCT02832037|81557086|FG002|Overall Study|Lost to Follow-up|3|||
27923436|NCT02832037|81557087|FG003|Overall Study|Lost to Follow-up|0|||
27923437|NCT02832037|81557088|FG004|Overall Study|Lost to Follow-up|5|||
27923438|NCT02832037|81557084|FG000|Overall Study|Withdrawal by Subject|9|||
27923439|NCT02832037|81557085|FG001|Overall Study|Withdrawal by Subject|8|||
27923440|NCT02832037|81557086|FG002|Overall Study|Withdrawal by Subject|0|||
27923441|NCT02832037|81557087|FG003|Overall Study|Withdrawal by Subject|4|||
27923442|NCT02832037|81557088|FG004|Overall Study|Withdrawal by Subject|8|||
27923443|NCT02832037|81557084|FG000|Overall Study|Adverse Event|5|||
27923444|NCT02832037|81557085|FG001|Overall Study|Adverse Event|4|||
27923445|NCT02832037|81557086|FG002|Overall Study|Adverse Event|0|||
27923446|NCT02832037|81557087|FG003|Overall Study|Adverse Event|2|||
27923447|NCT02832037|81557088|FG004|Overall Study|Adverse Event|4|||
27923448|NCT00900562|81557089|FG000|Overall Study|Progressive disease|9|||
27923449|NCT00900562|81557090|FG001|Overall Study|Progressive disease|5|||
27923450|NCT00900562|81557089|FG000|Overall Study|Toxicity|1|||
27923451|NCT00900562|81557090|FG001|Overall Study|Toxicity|0|||
27923452|NCT00900562|81557089|FG000|Overall Study|Death|1|||
27923453|NCT00900562|81557090|FG001|Overall Study|Death|1|||
27923454|NCT00900562|81557089|FG000|Overall Study|Withdrawal by Subject|0|||
27923455|NCT00900562|81557090|FG001|Overall Study|Withdrawal by Subject|1|||
27923456|NCT00900562|81557089|FG000|Overall Study|Unrelated adverse event|1|||
27923457|NCT00900562|81557090|FG001|Overall Study|Unrelated adverse event|0|||
27923458|NCT01569022|81557097|FG000|First Intervention|Lost to Follow-up|2|||
27923459|NCT01569022|81557098|FG001|First Intervention|Lost to Follow-up|1|||
27923460|NCT01569022|81557097|FG000|Second Intervention|Lost to Follow-up|2|||
27923461|NCT01569022|81557098|FG001|Second Intervention|Lost to Follow-up|2|||
27923462|NCT01838876|81557099|FG000|Overall Study|Adverse Event|49|||
27923463|NCT01838876|81557099|FG000|Overall Study|Insufficient Therapeutic Response|10|||
27923464|NCT01838876|81557099|FG000|Overall Study|Protocol Violation|34|||
27923465|NCT01838876|81557099|FG000|Overall Study|Withdrawal of Consent|33|||
27923466|NCT01838876|81557099|FG000|Overall Study|Lost to Follow-up|21|||
27923467|NCT01838876|81557099|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
27923468|NCT01838876|81557099|FG000|Overall Study|Reason not Specified|7|||
27923469|NCT01838876|81557099|FG000|Overall Study|Did not meet eligibility criteria|78|||
27544142|NCT02100514|80185708|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
27544143|NCT02100514|80185709|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
27544144|NCT02100514|80185710|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
27923470|NCT02530385|81557100|FG000|Overall Study|Withdrawal by Subject|0|||
27923471|NCT02530385|81557101|FG001|Overall Study|Withdrawal by Subject|1|||
27923472|NCT03408899|81557102|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
27923473|NCT03839641|81557103|FG000|Overall Study|Withdrawal by Subject|1|||
27923474|NCT03839641|81557104|FG001|Overall Study|Withdrawal by Subject|1|||
27923475|NCT01206764|81557105|FG000|Overall Study|Adverse Event|20|||
27923476|NCT01206764|81557105|FG000|Overall Study|Abnormal laboratory value|2|||
27923477|NCT01206764|81557105|FG000|Overall Study|Abnormal test procedure result|1|||
27923478|NCT01206764|81557105|FG000|Overall Study|Patient withdrew consent|5|||
27923479|NCT01206764|81557105|FG000|Overall Study|Lost to Follow-up|6|||
27923480|NCT01206764|81557105|FG000|Overall Study|Death|11|||
27923481|NCT01206764|81557105|FG000|Overall Study|New cancer therapy|2|||
27923482|NCT01206764|81557105|FG000|Overall Study|Disease progression|88|||
27923483|NCT01206764|81557105|FG000|Overall Study|Protocol deviation|3|||
27923484|NCT01572792|81557111|FG000|Lead-in Study|Lost to Follow-up|5|||
27923485|NCT01572792|81557112|FG001|Lead-in Study|Lost to Follow-up|9|||
27923486|NCT01572792|81557113|FG002|Lead-in Study|Lost to Follow-up|4|||
27923487|NCT01572792|81557114|FG003|Lead-in Study|Lost to Follow-up|2|||
27923488|NCT01572792|81557115|FG004|Lead-in Study|Lost to Follow-up|4|||
27923489|NCT01572792|81557111|FG000|Lead-in Study|Withdrawal by Subject|22|||
27923490|NCT01572792|81557112|FG001|Lead-in Study|Withdrawal by Subject|11|||
27923491|NCT01572792|81557113|FG002|Lead-in Study|Withdrawal by Subject|12|||
27923492|NCT01572792|81557114|FG003|Lead-in Study|Withdrawal by Subject|24|||
27923493|NCT01572792|81557115|FG004|Lead-in Study|Withdrawal by Subject|11|||
27923494|NCT01572792|81557111|FG000|Lead-in Study|Protocol Violation|19|||
27923495|NCT01572792|81557112|FG001|Lead-in Study|Protocol Violation|10|||
27923496|NCT01572792|81557113|FG002|Lead-in Study|Protocol Violation|12|||
27923497|NCT01572792|81557114|FG003|Lead-in Study|Protocol Violation|13|||
27923498|NCT01572792|81557115|FG004|Lead-in Study|Protocol Violation|21|||
27923499|NCT01572792|81557111|FG000|Lead-in Study|Lack of Efficacy|20|||
27923500|NCT01572792|81557112|FG001|Lead-in Study|Lack of Efficacy|5|||
27923501|NCT01572792|81557113|FG002|Lead-in Study|Lack of Efficacy|4|||
27923502|NCT01572792|81557114|FG003|Lead-in Study|Lack of Efficacy|8|||
27923503|NCT01572792|81557115|FG004|Lead-in Study|Lack of Efficacy|10|||
27923504|NCT01572792|81557111|FG000|Lead-in Study|Adverse Event|21|||
27923505|NCT01572792|81557112|FG001|Lead-in Study|Adverse Event|21|||
27923506|NCT01572792|81557113|FG002|Lead-in Study|Adverse Event|22|||
27923507|NCT01572792|81557114|FG003|Lead-in Study|Adverse Event|16|||
27923508|NCT01572792|81557115|FG004|Lead-in Study|Adverse Event|14|||
27923509|NCT01572792|81557111|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
27923510|NCT01572792|81557112|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
27544145|NCT02100514|80185706|FG000|Treatment Period|Protocol Violation|1|||
27544146|NCT02100514|80185707|FG001|Treatment Period|Protocol Violation|1|||
27544147|NCT02100514|80185708|FG002|Treatment Period|Protocol Violation|0|||
27544148|NCT02100514|80185709|FG003|Treatment Period|Protocol Violation|0|||
27544149|NCT02100514|80185710|FG004|Treatment Period|Protocol Violation|0|||
27544150|NCT02100514|80185706|FG000|Treatment Period|Withdrawal by Subject|12|||
27544151|NCT02100514|80185707|FG001|Treatment Period|Withdrawal by Subject|37|||
27923511|NCT01572792|81557113|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
27923512|NCT01572792|81557114|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
27923513|NCT01572792|81557115|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
27544152|NCT02100514|80185708|FG002|Treatment Period|Withdrawal by Subject|0|||
27544153|NCT02100514|80185709|FG003|Treatment Period|Withdrawal by Subject|0|||
27544154|NCT02100514|80185710|FG004|Treatment Period|Withdrawal by Subject|0|||
27544155|NCT02100514|80185706|FG000|Treatment Period|Other|9|||
27544156|NCT02100514|80185707|FG001|Treatment Period|Other|11|||
27544157|NCT02100514|80185708|FG002|Treatment Period|Other|0|||
27544158|NCT02100514|80185709|FG003|Treatment Period|Other|0|||
27544159|NCT02100514|80185710|FG004|Treatment Period|Other|0|||
27544160|NCT02100514|80185706|FG000|Extension Period|Withdrew consent|0|||
27544161|NCT02100514|80185707|FG001|Extension Period|Withdrew consent|0|||
27923514|NCT01572792|81557111|FG000|Extension Study|Lost to Follow-up|6|||
27544162|NCT02100514|80185708|FG002|Extension Period|Withdrew consent|2|||
27544163|NCT02100514|80185709|FG003|Extension Period|Withdrew consent|0|||
27544164|NCT02100514|80185710|FG004|Extension Period|Withdrew consent|0|||
27544165|NCT00939770|80185714|FG000|Overall Study|Adverse Event|1|||
27544166|NCT00939770|80185715|FG001|Overall Study|Adverse Event|1|||
27544167|NCT00939770|80185716|FG002|Overall Study|Adverse Event|0|||
27544168|NCT00939770|80185717|FG003|Overall Study|Adverse Event|0|||
27544169|NCT00939770|80185718|FG004|Overall Study|Adverse Event|6|||
27923515|NCT01572792|81557112|FG001|Extension Study|Lost to Follow-up|2|||
27923516|NCT01572792|81557113|FG002|Extension Study|Lost to Follow-up|0|||
27923517|NCT01572792|81557114|FG003|Extension Study|Lost to Follow-up|3|||
27923518|NCT01572792|81557115|FG004|Extension Study|Lost to Follow-up|3|||
27923519|NCT01572792|81557111|FG000|Extension Study|Withdrawal by Subject|7|||
27923520|NCT01572792|81557112|FG001|Extension Study|Withdrawal by Subject|6|||
27923521|NCT01572792|81557113|FG002|Extension Study|Withdrawal by Subject|11|||
27923522|NCT01572792|81557114|FG003|Extension Study|Withdrawal by Subject|8|||
27923523|NCT01572792|81557115|FG004|Extension Study|Withdrawal by Subject|14|||
27923524|NCT01572792|81557111|FG000|Extension Study|Protocol Violation|0|||
27544170|NCT00939770|80185719|FG005|Overall Study|Adverse Event|2|||
27544171|NCT00939770|80185720|FG006|Overall Study|Adverse Event|1|||
27544172|NCT00939770|80185721|FG007|Overall Study|Adverse Event|1|||
27544173|NCT00939770|80185714|FG000|Overall Study|Lack of Efficacy|4|||
27544174|NCT00939770|80185715|FG001|Overall Study|Lack of Efficacy|6|||
27923525|NCT01572792|81557112|FG001|Extension Study|Protocol Violation|4|||
27923526|NCT01572792|81557113|FG002|Extension Study|Protocol Violation|3|||
27923527|NCT01572792|81557114|FG003|Extension Study|Protocol Violation|4|||
27923528|NCT01572792|81557115|FG004|Extension Study|Protocol Violation|3|||
27923529|NCT01572792|81557111|FG000|Extension Study|Lack of Efficacy|2|||
27923530|NCT01572792|81557112|FG001|Extension Study|Lack of Efficacy|3|||
27923531|NCT01572792|81557113|FG002|Extension Study|Lack of Efficacy|3|||
27923532|NCT01572792|81557114|FG003|Extension Study|Lack of Efficacy|2|||
27923533|NCT01572792|81557115|FG004|Extension Study|Lack of Efficacy|2|||
27923534|NCT01572792|81557111|FG000|Extension Study|Adverse Event|7|||
27923535|NCT01572792|81557112|FG001|Extension Study|Adverse Event|6|||
27923536|NCT01572792|81557113|FG002|Extension Study|Adverse Event|5|||
27923537|NCT01572792|81557114|FG003|Extension Study|Adverse Event|6|||
27923538|NCT01572792|81557115|FG004|Extension Study|Adverse Event|4|||
27923539|NCT01572792|81557111|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
27923540|NCT01572792|81557112|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
27923541|NCT01572792|81557113|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
27923542|NCT01572792|81557114|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
27923543|NCT01572792|81557115|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
27923544|NCT01925417|81557117|FG000|Overall Study|Withdrawal by Subject|2|||
27923545|NCT01925417|81557117|FG000|Overall Study|Death|1|||
27923546|NCT01408641|81557118|FG000|Overall Study|Physician Decision|1|||
27923547|NCT01408641|81557119|FG001|Overall Study|Physician Decision|0|||
27923548|NCT00701363|81557120|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
27923549|NCT00701363|81557121|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
27923550|NCT00701363|81557122|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
27923551|NCT00701363|81557123|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
27923552|NCT00701363|81557120|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
27923553|NCT00701363|81557121|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
27923554|NCT00701363|81557122|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
27923555|NCT00701363|81557123|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
27923556|NCT00701363|81557120|FG000|Treatment Phase 1|Adverse Event|7|||
27923557|NCT00701363|81557121|FG001|Treatment Phase 1|Adverse Event|0|||
27923558|NCT00701363|81557122|FG002|Treatment Phase 1|Adverse Event|0|||
27923559|NCT00701363|81557123|FG003|Treatment Phase 1|Adverse Event|0|||
27923560|NCT00701363|81557120|FG000|Treatment Phase 1|Protocol Violation|1|||
27923561|NCT00701363|81557121|FG001|Treatment Phase 1|Protocol Violation|0|||
27923562|NCT00701363|81557122|FG002|Treatment Phase 1|Protocol Violation|0|||
27923563|NCT00701363|81557123|FG003|Treatment Phase 1|Protocol Violation|0|||
27923564|NCT00701363|81557120|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
27923565|NCT00701363|81557121|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
27923566|NCT00701363|81557122|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
27923567|NCT00701363|81557123|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
27923568|NCT00701363|81557120|FG000|Treatment Phase 1|Lack of Efficacy|1|||
27923569|NCT00701363|81557121|FG001|Treatment Phase 1|Lack of Efficacy|0|||
27923570|NCT00701363|81557122|FG002|Treatment Phase 1|Lack of Efficacy|0|||
27923571|NCT00701363|81557123|FG003|Treatment Phase 1|Lack of Efficacy|0|||
27923572|NCT00701363|81557120|FG000|Treatment Phase 2|Adverse Event|0|||
27923573|NCT00701363|81557121|FG001|Treatment Phase 2|Adverse Event|0|||
27923574|NCT00701363|81557122|FG002|Treatment Phase 2|Adverse Event|1|||
27923575|NCT00701363|81557123|FG003|Treatment Phase 2|Adverse Event|0|||
27923576|NCT00701363|81557120|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
27923577|NCT00701363|81557121|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
27923578|NCT00701363|81557122|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
27923579|NCT00701363|81557123|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
27923580|NCT03329885|81557124|FG000|Overall Study|Sponsor discontinued the study early|0|||
27923581|NCT03329885|81557125|FG001|Overall Study|Sponsor discontinued the study early|0|||
27923582|NCT03329885|81557126|FG002|Overall Study|Sponsor discontinued the study early|0|||
27923583|NCT03329885|81557127|FG003|Overall Study|Sponsor discontinued the study early|0|||
27923584|NCT03329885|81557128|FG004|Overall Study|Sponsor discontinued the study early|0|||
27923585|NCT03329885|81557129|FG005|Overall Study|Sponsor discontinued the study early|0|||
27923586|NCT03329885|81557130|FG006|Overall Study|Sponsor discontinued the study early|1|||
27923587|NCT03329885|81557131|FG007|Overall Study|Sponsor discontinued the study early|1|||
27923588|NCT03329885|81557132|FG008|Overall Study|Sponsor discontinued the study early|0|||
27923589|NCT01125930|81560711|FG000|Overall Study|Adverse Event|0|||
27923590|NCT01125930|81560712|FG001|Overall Study|Adverse Event|1|||
27923591|NCT01125930|81560711|FG000|Overall Study|Withdrawal by Subject|1|||
27923592|NCT01125930|81560712|FG001|Overall Study|Withdrawal by Subject|6|||
27923593|NCT01125930|81560711|FG000|Overall Study|Protocol Violation|0|||
27923594|NCT01125930|81560712|FG001|Overall Study|Protocol Violation|1|||
27923595|NCT01125930|81560711|FG000|Overall Study|Lost to Follow-up|0|||
27923596|NCT01125930|81560712|FG001|Overall Study|Lost to Follow-up|2|||
27923597|NCT04181788|81560713|FG000|TREATMENT|Adverse Event|0|||
27923598|NCT04181788|81560714|FG001|TREATMENT|Adverse Event|2|||
27923599|NCT04181788|81560715|FG002|TREATMENT|Adverse Event|1|||
27923600|NCT04181788|81560716|FG003|TREATMENT|Adverse Event|0|||
27923601|NCT04181788|81560717|FG004|TREATMENT|Adverse Event|1|||
27923602|NCT04181788|81560718|FG005|TREATMENT|Adverse Event|3|||
27923603|NCT04181788|81560713|FG000|TREATMENT|Death|0|||
27923604|NCT04181788|81560714|FG001|TREATMENT|Death|0|||
27923605|NCT04181788|81560715|FG002|TREATMENT|Death|0|||
27923606|NCT04181788|81560716|FG003|TREATMENT|Death|0|||
27923607|NCT04181788|81560717|FG004|TREATMENT|Death|8|||
27923608|NCT04181788|81560718|FG005|TREATMENT|Death|8|||
27923609|NCT04181788|81560713|FG000|TREATMENT|Physician Decision|0|||
27923610|NCT04181788|81560714|FG001|TREATMENT|Physician Decision|0|||
27923611|NCT04181788|81560715|FG002|TREATMENT|Physician Decision|0|||
27923612|NCT04181788|81560716|FG003|TREATMENT|Physician Decision|0|||
27923613|NCT04181788|81560717|FG004|TREATMENT|Physician Decision|0|||
27923614|NCT04181788|81560718|FG005|TREATMENT|Physician Decision|1|||
27923615|NCT04181788|81560713|FG000|TREATMENT|Progressive disease|3|||
27923616|NCT04181788|81560714|FG001|TREATMENT|Progressive disease|3|||
27923617|NCT04181788|81560715|FG002|TREATMENT|Progressive disease|5|||
27923618|NCT04181788|81560716|FG003|TREATMENT|Progressive disease|7|||
27923619|NCT04181788|81560717|FG004|TREATMENT|Progressive disease|20|||
27923620|NCT04181788|81560718|FG005|TREATMENT|Progressive disease|38|||
27923621|NCT04181788|81560713|FG000|TREATMENT|Global deterioration of health status|0|||
27923622|NCT04181788|81560714|FG001|TREATMENT|Global deterioration of health status|2|||
27923623|NCT04181788|81560715|FG002|TREATMENT|Global deterioration of health status|0|||
27923624|NCT04181788|81560716|FG003|TREATMENT|Global deterioration of health status|0|||
27923625|NCT04181788|81560717|FG004|TREATMENT|Global deterioration of health status|2|||
27923626|NCT04181788|81560718|FG005|TREATMENT|Global deterioration of health status|8|||
27923627|NCT04181788|81560713|FG000|TREATMENT|Withdrawal by Subject|1|||
27923628|NCT04181788|81560714|FG001|TREATMENT|Withdrawal by Subject|2|||
27923629|NCT04181788|81560715|FG002|TREATMENT|Withdrawal by Subject|0|||
27923630|NCT04181788|81560716|FG003|TREATMENT|Withdrawal by Subject|0|||
27923631|NCT04181788|81560717|FG004|TREATMENT|Withdrawal by Subject|3|||
27923632|NCT04181788|81560718|FG005|TREATMENT|Withdrawal by Subject|5|||
27923633|NCT04181788|81560713|FG000|TREATMENT|Other unspecified|0|||
27923634|NCT04181788|81560714|FG001|TREATMENT|Other unspecified|0|||
27923635|NCT04181788|81560715|FG002|TREATMENT|Other unspecified|0|||
27923636|NCT04181788|81560716|FG003|TREATMENT|Other unspecified|0|||
27923637|NCT04181788|81560717|FG004|TREATMENT|Other unspecified|0|||
27923638|NCT04181788|81560718|FG005|TREATMENT|Other unspecified|2|||
27923639|NCT04181788|81560713|FG000|TREATMENT|Ongoing|0|||
27923640|NCT04181788|81560714|FG001|TREATMENT|Ongoing|3|||
27923641|NCT04181788|81560715|FG002|TREATMENT|Ongoing|0|||
27923642|NCT04181788|81560716|FG003|TREATMENT|Ongoing|5|||
27544175|NCT00939770|80185716|FG002|Overall Study|Lack of Efficacy|13|||
27544176|NCT00939770|80185717|FG003|Overall Study|Lack of Efficacy|9|||
27544177|NCT00939770|80185718|FG004|Overall Study|Lack of Efficacy|16|||
27544178|NCT00939770|80185719|FG005|Overall Study|Lack of Efficacy|8|||
27544179|NCT00939770|80185720|FG006|Overall Study|Lack of Efficacy|11|||
27544180|NCT00939770|80185721|FG007|Overall Study|Lack of Efficacy|1|||
27544181|NCT00939770|80185714|FG000|Overall Study|Lost to Follow-up|0|||
27923643|NCT04181788|81560717|FG004|TREATMENT|Ongoing|7|||
27923644|NCT04181788|81560718|FG005|TREATMENT|Ongoing|15|||
27923645|NCT04181788|81560713|FG000|FOLLOW-UP|Death|0|||
27923646|NCT04181788|81560714|FG001|FOLLOW-UP|Death|0|||
27923647|NCT04181788|81560715|FG002|FOLLOW-UP|Death|1|||
27923648|NCT04181788|81560716|FG003|FOLLOW-UP|Death|2|||
27923649|NCT04181788|81560717|FG004|FOLLOW-UP|Death|8|||
27923650|NCT04181788|81560718|FG005|FOLLOW-UP|Death|20|||
27923651|NCT04181788|81560713|FG000|FOLLOW-UP|Lost to Follow-up|0|||
27544182|NCT00939770|80185715|FG001|Overall Study|Lost to Follow-up|0|||
27544183|NCT00939770|80185716|FG002|Overall Study|Lost to Follow-up|0|||
27544184|NCT00939770|80185717|FG003|Overall Study|Lost to Follow-up|0|||
27544185|NCT00939770|80185718|FG004|Overall Study|Lost to Follow-up|1|||
27544186|NCT00939770|80185719|FG005|Overall Study|Lost to Follow-up|0|||
27923652|NCT04181788|81560714|FG001|FOLLOW-UP|Lost to Follow-up|0|||
27923653|NCT04181788|81560715|FG002|FOLLOW-UP|Lost to Follow-up|0|||
27923654|NCT04181788|81560716|FG003|FOLLOW-UP|Lost to Follow-up|0|||
27923655|NCT04181788|81560717|FG004|FOLLOW-UP|Lost to Follow-up|0|||
27923656|NCT04181788|81560718|FG005|FOLLOW-UP|Lost to Follow-up|2|||
27923657|NCT04181788|81560713|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
27923658|NCT04181788|81560714|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
27923659|NCT04181788|81560715|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
27923660|NCT04181788|81560716|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
27923661|NCT04181788|81560717|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
27923662|NCT04181788|81560718|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
27923663|NCT04181788|81560713|FG000|FOLLOW-UP|Other unspecified|0|||
27923664|NCT04181788|81560714|FG001|FOLLOW-UP|Other unspecified|1|||
27923665|NCT04181788|81560715|FG002|FOLLOW-UP|Other unspecified|0|||
27923666|NCT04181788|81560716|FG003|FOLLOW-UP|Other unspecified|0|||
27923667|NCT04181788|81560717|FG004|FOLLOW-UP|Other unspecified|0|||
27923668|NCT04181788|81560718|FG005|FOLLOW-UP|Other unspecified|3|||
27923669|NCT04181788|81560713|FG000|FOLLOW-UP|Ongoing|0|||
27923670|NCT04181788|81560714|FG001|FOLLOW-UP|Ongoing|0|||
27544187|NCT00939770|80185720|FG006|Overall Study|Lost to Follow-up|0|||
27544188|NCT00939770|80185721|FG007|Overall Study|Lost to Follow-up|0|||
27544189|NCT00939770|80185714|FG000|Overall Study|Physician Decision|0|||
27544190|NCT00939770|80185715|FG001|Overall Study|Physician Decision|0|||
27544191|NCT00939770|80185716|FG002|Overall Study|Physician Decision|2|||
27544192|NCT00939770|80185717|FG003|Overall Study|Physician Decision|0|||
27544193|NCT00939770|80185718|FG004|Overall Study|Physician Decision|7|||
27544194|NCT00939770|80185719|FG005|Overall Study|Physician Decision|1|||
27544195|NCT00939770|80185720|FG006|Overall Study|Physician Decision|0|||
27544196|NCT00939770|80185721|FG007|Overall Study|Physician Decision|6|||
27544197|NCT00939770|80185714|FG000|Overall Study|Protocol Violation|0|||
27544198|NCT00939770|80185715|FG001|Overall Study|Protocol Violation|0|||
27544199|NCT00939770|80185716|FG002|Overall Study|Protocol Violation|0|||
27544200|NCT00939770|80185717|FG003|Overall Study|Protocol Violation|0|||
27544201|NCT00939770|80185718|FG004|Overall Study|Protocol Violation|1|||
27544202|NCT00939770|80185719|FG005|Overall Study|Protocol Violation|0|||
27544203|NCT00939770|80185720|FG006|Overall Study|Protocol Violation|0|||
27544204|NCT00939770|80185721|FG007|Overall Study|Protocol Violation|0|||
27544205|NCT00939770|80185714|FG000|Overall Study|Withdrawal by Subject|0|||
27544206|NCT00939770|80185715|FG001|Overall Study|Withdrawal by Subject|1|||
27544207|NCT00939770|80185716|FG002|Overall Study|Withdrawal by Subject|5|||
27544208|NCT00939770|80185717|FG003|Overall Study|Withdrawal by Subject|2|||
27544209|NCT00939770|80185718|FG004|Overall Study|Withdrawal by Subject|6|||
27544210|NCT00939770|80185719|FG005|Overall Study|Withdrawal by Subject|0|||
27544211|NCT00939770|80185720|FG006|Overall Study|Withdrawal by Subject|2|||
27544212|NCT00939770|80185721|FG007|Overall Study|Withdrawal by Subject|2|||
27544213|NCT03322631|80185722|FG000|Overall Study|Withdrawal by Subject|0|||
27544214|NCT03322631|80185723|FG001|Overall Study|Withdrawal by Subject|1|||
27544215|NCT03322631|80185724|FG002|Overall Study|Withdrawal by Subject|0|||
27544216|NCT03322631|80185725|FG003|Overall Study|Withdrawal by Subject|0|||
27544217|NCT03322631|80185722|FG000|Overall Study|Adverse Event|0|||
27544218|NCT03322631|80185723|FG001|Overall Study|Adverse Event|0|||
27544219|NCT03322631|80185724|FG002|Overall Study|Adverse Event|1|||
27544220|NCT03322631|80185725|FG003|Overall Study|Adverse Event|0|||
27544221|NCT01606800|80185726|FG000|Overall Study|Adverse Event|3|||
27544222|NCT01606800|80185727|FG001|Overall Study|Adverse Event|1|||
27544223|NCT01606800|80185726|FG000|Overall Study|Participant withdrew consent|0|||
27923671|NCT04181788|81560715|FG002|FOLLOW-UP|Ongoing|1|||
27923672|NCT04181788|81560716|FG003|FOLLOW-UP|Ongoing|3|||
27923673|NCT04181788|81560717|FG004|FOLLOW-UP|Ongoing|2|||
27923674|NCT04181788|81560718|FG005|FOLLOW-UP|Ongoing|2|||
27923675|NCT03736967|81560722|FG000|Overall Study|Withdrawal by Subject|26|||
27923676|NCT03736967|81560723|FG001|Overall Study|Withdrawal by Subject|25|||
27923677|NCT03736967|81560724|FG002|Overall Study|Withdrawal by Subject|23|||
27923678|NCT03736967|81560725|FG003|Overall Study|Withdrawal by Subject|26|||
27923679|NCT03736967|81560722|FG000|Overall Study|Lost to Follow-up|3|||
27923680|NCT03736967|81560723|FG001|Overall Study|Lost to Follow-up|2|||
27544224|NCT01606800|80185727|FG001|Overall Study|Participant withdrew consent|1|||
27544225|NCT01606800|80185726|FG000|Overall Study|Missing completion status|2|||
27544226|NCT01606800|80185727|FG001|Overall Study|Missing completion status|0|||
27544227|NCT02362269|80185730|FG000|Overall Study|Moved|1|||
27544228|NCT02362269|80185731|FG001|Overall Study|Moved|0|||
27544229|NCT02362269|80185730|FG000|Overall Study|Lost to Follow-up|0|||
27544230|NCT02362269|80185731|FG001|Overall Study|Lost to Follow-up|6|||
27544231|NCT00300274|80185732|FG000|Overall Study|Withdrawal by Subject|12|||
27544232|NCT00300274|80185733|FG001|Overall Study|Withdrawal by Subject|3|||
27544233|NCT00300274|80185734|FG002|Overall Study|Withdrawal by Subject|14|||
27544234|NCT00300274|80185732|FG000|Overall Study|Lost to Follow-up|3|||
27544235|NCT00300274|80185733|FG001|Overall Study|Lost to Follow-up|4|||
27544236|NCT00300274|80185734|FG002|Overall Study|Lost to Follow-up|5|||
27544237|NCT00300274|80185732|FG000|Overall Study|Death|31|||
27544238|NCT00300274|80185733|FG001|Overall Study|Death|20|||
27544239|NCT00300274|80185734|FG002|Overall Study|Death|25|||
27544240|NCT00300274|80185732|FG000|Overall Study|Re-transplant|0|||
27544241|NCT00300274|80185733|FG001|Overall Study|Re-transplant|0|||
27544242|NCT00300274|80185734|FG002|Overall Study|Re-transplant|1|||
27544243|NCT02197520|80185735|FG000|Period 1|Withdrawal by Subject|1|||
27544244|NCT02197520|80185736|FG001|Period 1|Withdrawal by Subject|0|||
27544245|NCT02197520|80185735|FG000|Period 2|Adverse Event|0|||
27544246|NCT02197520|80185736|FG001|Period 2|Adverse Event|2|||
27544247|NCT02197520|80185735|FG000|Period 2|Withdrawal by Subject|1|||
27923681|NCT03736967|81560724|FG002|Overall Study|Lost to Follow-up|1|||
27923682|NCT03736967|81560725|FG003|Overall Study|Lost to Follow-up|1|||
27544248|NCT02197520|80185736|FG001|Period 2|Withdrawal by Subject|0|||
27544249|NCT03681405|80185737|FG000|Overall Study|Found to be ineligible after randomized|1|||
27544250|NCT03681405|80185738|FG001|Overall Study|Found to be ineligible after randomized|0|||
27544251|NCT01737697|80185739|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544252|NCT01737697|80185740|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
27544253|NCT01737697|80185741|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27923683|NCT03736967|81560722|FG000|Overall Study|Physician Decision|1|||
27923684|NCT03736967|81560723|FG001|Overall Study|Physician Decision|0|||
27923685|NCT03736967|81560724|FG002|Overall Study|Physician Decision|0|||
27923686|NCT03736967|81560725|FG003|Overall Study|Physician Decision|1|||
27923687|NCT03736967|81560722|FG000|Overall Study|Adverse Event|0|||
27923688|NCT03736967|81560723|FG001|Overall Study|Adverse Event|1|||
27923689|NCT03736967|81560724|FG002|Overall Study|Adverse Event|0|||
27923690|NCT03736967|81560725|FG003|Overall Study|Adverse Event|1|||
27923691|NCT03736967|81560722|FG000|Overall Study|Death|0|||
27923692|NCT03736967|81560723|FG001|Overall Study|Death|0|||
27923693|NCT03736967|81560724|FG002|Overall Study|Death|0|||
27923694|NCT03736967|81560725|FG003|Overall Study|Death|1|||
27923695|NCT03736967|81560722|FG000|Overall Study|Randomized but never treated|1|||
27923696|NCT03736967|81560723|FG001|Overall Study|Randomized but never treated|0|||
27923697|NCT03736967|81560724|FG002|Overall Study|Randomized but never treated|0|||
27923698|NCT03736967|81560725|FG003|Overall Study|Randomized but never treated|0|||
27923699|NCT00547339|81560726|FG000|Overall Study|Physician Decision|0|||
27741148|NCT02767570|80880858|FG000|Overall Study|Lost to Follow-up|3|||
27741149|NCT02767570|80880859|FG001|Overall Study|Lost to Follow-up|0|||
27741150|NCT02767570|80880858|FG000|Overall Study|COVID shutdown|2|||
27741151|NCT02767570|80880859|FG001|Overall Study|COVID shutdown|5|||
27741152|NCT02767570|80880858|FG000|Overall Study|Increased pain|2|||
27741153|NCT02767570|80880859|FG001|Overall Study|Increased pain|0|||
27741154|NCT02767570|80880858|FG000|Overall Study|Withdrawal by Subject|1|||
27741155|NCT02767570|80880859|FG001|Overall Study|Withdrawal by Subject|3|||
27741156|NCT02767570|80880858|FG000|Overall Study|Unrelated medical issue|1|||
27741157|NCT02767570|80880859|FG001|Overall Study|Unrelated medical issue|1|||
27741158|NCT02767570|80880858|FG000|Overall Study|Received intra-articular injection|0|||
27741159|NCT02767570|80880859|FG001|Overall Study|Received intra-articular injection|1|||
27741160|NCT01478347|80880860|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
27741161|NCT01478347|80880860|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
27741162|NCT01478347|80880860|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
27741163|NCT03103750|80880862|FG000|Overall Study|Adverse Event|1|||
27741164|NCT03103750|80880863|FG001|Overall Study|Adverse Event|0|||
27741165|NCT03103750|80880862|FG000|Overall Study|Lost to Follow-up|1|||
27741166|NCT03103750|80880863|FG001|Overall Study|Lost to Follow-up|0|||
27741167|NCT03103750|80880862|FG000|Overall Study|PET Equipment Related|2|||
27741168|NCT03103750|80880863|FG001|Overall Study|PET Equipment Related|2|||
27741169|NCT05590403|80880868|FG000|Overall Study|Lost to Follow-up|3|||
27741170|NCT05590403|80880869|FG001|Overall Study|Lost to Follow-up|0|||
27741171|NCT05590403|80880870|FG002|Overall Study|Lost to Follow-up|2|||
27741172|NCT05590403|80880871|FG003|Overall Study|Lost to Follow-up|0|||
27741173|NCT05590403|80880872|FG004|Overall Study|Lost to Follow-up|0|||
27741174|NCT05590403|80880868|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
27741175|NCT05590403|80880869|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
27741176|NCT05590403|80880870|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
27741177|NCT05590403|80880871|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
27741178|NCT05590403|80880872|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
27741179|NCT00003641|80880873|FG000|Overall Study|Withdrawal by Subject|0|||
27741180|NCT00003641|80880874|FG001|Overall Study|Withdrawal by Subject|100|||
27741181|NCT00003641|80880873|FG000|Overall Study|Adverse Event|0|||
27741182|NCT00003641|80880874|FG001|Overall Study|Adverse Event|38|||
27741183|NCT00003641|80880873|FG000|Overall Study|Disease progression|0|||
27741184|NCT00003641|80880874|FG001|Overall Study|Disease progression|2|||
27741185|NCT00003641|80880873|FG000|Overall Study|Unknown/missing|0|||
27741186|NCT00003641|80880874|FG001|Overall Study|Unknown/missing|22|||
27741187|NCT00003641|80880873|FG000|Overall Study|Should not receive interferon therapy|2|||
27741188|NCT00003641|80880874|FG001|Overall Study|Should not receive interferon therapy|0|||
27741189|NCT00003641|80880873|FG000|Overall Study|Never started interferon|567|||
27741190|NCT00003641|80880874|FG001|Overall Study|Never started interferon|12|||
27741191|NCT05253807|80880876|FG000|Overall Study|Death|1|||
27741192|NCT05253807|80880877|FG001|Overall Study|Death|4|||
27741193|NCT05253807|80880876|FG000|Overall Study|Withdrawal by Subject|1|||
27923700|NCT00547339|81560727|FG001|Overall Study|Physician Decision|0|||
27923701|NCT00547339|81560728|FG002|Overall Study|Physician Decision|1|||
27923702|NCT00547339|81560729|FG003|Overall Study|Physician Decision|0|||
27923703|NCT00975923|81560730|FG000|Overall Study|Withdrawal by Subject|0|||
27741194|NCT05253807|80880877|FG001|Overall Study|Withdrawal by Subject|0|||
27741195|NCT05253807|80880876|FG000|Overall Study|Study Terminated by Sponsor|1|||
27741196|NCT05253807|80880877|FG001|Overall Study|Study Terminated by Sponsor|1|||
27741197|NCT01903434|80880881|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
27741198|NCT01903434|80880882|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
27923704|NCT00975923|81560731|FG001|Overall Study|Withdrawal by Subject|1|||
27923705|NCT00251758|81560732|FG000|Overall Study|Adverse Event|7|||
27923706|NCT00251758|81560733|FG001|Overall Study|Adverse Event|9|||
27923707|NCT00251758|81560734|FG002|Overall Study|Adverse Event|11|||
27923708|NCT00251758|81560732|FG000|Overall Study|Lost to Follow-up|4|||
27923709|NCT00251758|81560733|FG001|Overall Study|Lost to Follow-up|2|||
27923710|NCT00251758|81560734|FG002|Overall Study|Lost to Follow-up|5|||
27923711|NCT00251758|81560732|FG000|Overall Study|Withdrawal by Subject|13|||
27923712|NCT00251758|81560733|FG001|Overall Study|Withdrawal by Subject|7|||
27923713|NCT00251758|81560734|FG002|Overall Study|Withdrawal by Subject|3|||
27923714|NCT00251758|81560732|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
27923715|NCT00251758|81560733|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
27923716|NCT00251758|81560734|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
27923717|NCT00251758|81560732|FG000|Overall Study|Lack of Efficacy|3|||
27923718|NCT00251758|81560733|FG001|Overall Study|Lack of Efficacy|0|||
27741199|NCT01903434|80880881|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
27544254|NCT01737697|80185742|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
27741200|NCT01903434|80880882|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
27544255|NCT01737697|80185743|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
27544256|NCT01737697|80185744|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27741201|NCT01009463|80880883|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
27741202|NCT01009463|80880884|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27741203|NCT01009463|80880885|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27741204|NCT01009463|80880886|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27741205|NCT01009463|80880887|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
27741206|NCT01009463|80880883|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
27741207|NCT01009463|80880884|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
27741208|NCT01009463|80880885|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
27923719|NCT00251758|81560734|FG002|Overall Study|Lack of Efficacy|0|||
27923720|NCT00251758|81560732|FG000|Overall Study|Noncompliant|0|||
27923721|NCT00251758|81560733|FG001|Overall Study|Noncompliant|2|||
27923722|NCT00251758|81560734|FG002|Overall Study|Noncompliant|2|||
27923723|NCT00251758|81560732|FG000|Overall Study|Pregnancy|0|||
27923724|NCT00251758|81560733|FG001|Overall Study|Pregnancy|1|||
27923725|NCT00251758|81560734|FG002|Overall Study|Pregnancy|0|||
27923726|NCT00251758|81560732|FG000|Overall Study|Per Subject Request|0|||
27923727|NCT00251758|81560733|FG001|Overall Study|Per Subject Request|0|||
27923728|NCT00251758|81560734|FG002|Overall Study|Per Subject Request|1|||
27923729|NCT00251758|81560732|FG000|Overall Study|Per Investigator Request|1|||
27923730|NCT00251758|81560733|FG001|Overall Study|Per Investigator Request|0|||
27923731|NCT00251758|81560734|FG002|Overall Study|Per Investigator Request|0|||
27923732|NCT02145390|81560735|FG000|Overall Study|Withdrawal by Subject|1|||
27923733|NCT02017717|81560738|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923734|NCT02017717|81560739|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923735|NCT02017717|81560740|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923736|NCT02017717|81560741|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
27923737|NCT02017717|81560742|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923738|NCT02017717|81560743|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923739|NCT02017717|81560744|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923740|NCT02017717|81560745|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923741|NCT02017717|81560746|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
27923742|NCT02017717|81560738|FG000|Before Treatment Period|Participant request to stop therapy|0|||
27923743|NCT02017717|81560739|FG001|Before Treatment Period|Participant request to stop therapy|0|||
27923744|NCT02017717|81560740|FG002|Before Treatment Period|Participant request to stop therapy|0|||
27923745|NCT02017717|81560741|FG003|Before Treatment Period|Participant request to stop therapy|0|||
27544257|NCT01737697|80185745|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544258|NCT01737697|80185746|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544259|NCT01737697|80185747|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544260|NCT01737697|80185748|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544261|NCT01737697|80185749|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544262|NCT01737697|80185750|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544263|NCT01737697|80185751|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544264|NCT01737697|80185752|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544265|NCT01737697|80185753|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
27544266|NCT01737697|80185739|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
27544267|NCT01737697|80185740|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
27544268|NCT01737697|80185741|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
27544269|NCT01737697|80185742|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544270|NCT01737697|80185743|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544271|NCT01737697|80185744|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544272|NCT01737697|80185745|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544273|NCT01737697|80185746|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544274|NCT01737697|80185747|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544275|NCT01737697|80185748|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544276|NCT01737697|80185749|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27741209|NCT01009463|80880886|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
27741210|NCT01009463|80880887|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
27741211|NCT01009463|80880883|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
27741212|NCT01009463|80880884|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27741213|NCT01009463|80880885|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27923746|NCT02017717|81560742|FG004|Before Treatment Period|Participant request to stop therapy|5|||
27923747|NCT02017717|81560743|FG005|Before Treatment Period|Participant request to stop therapy|0|||
27923748|NCT02017717|81560744|FG006|Before Treatment Period|Participant request to stop therapy|0|||
27923749|NCT02017717|81560745|FG007|Before Treatment Period|Participant request to stop therapy|0|||
27923750|NCT02017717|81560746|FG008|Before Treatment Period|Participant request to stop therapy|0|||
27923751|NCT02017717|81560738|FG000|Before Treatment Period|Participant withdrew consent|0|||
27544277|NCT01737697|80185750|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544278|NCT01737697|80185751|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27741214|NCT01009463|80880886|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27741215|NCT01009463|80880887|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
27741216|NCT01009463|80880883|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
27544279|NCT01737697|80185752|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27741217|NCT01009463|80880884|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
27741218|NCT01009463|80880885|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
27741219|NCT01009463|80880886|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
27741220|NCT01009463|80880887|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
27741221|NCT01009463|80880883|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
27741222|NCT01009463|80880884|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27741223|NCT01009463|80880885|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27741224|NCT01009463|80880886|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27741225|NCT01009463|80880887|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
27741226|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
27741227|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
27741228|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
27741229|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
27741230|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
27741231|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
27741232|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
27741233|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
27741234|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
27741235|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
27741236|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
27741237|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
27741238|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
27741239|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
27741240|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
27741241|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
27923752|NCT02017717|81560739|FG001|Before Treatment Period|Participant withdrew consent|0|||
27544280|NCT01737697|80185753|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
27544281|NCT01737697|80185739|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544282|NCT01737697|80185740|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544283|NCT01737697|80185741|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544284|NCT01737697|80185742|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
27544285|NCT01737697|80185743|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544286|NCT01737697|80185744|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544287|NCT01737697|80185745|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544288|NCT01737697|80185746|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544289|NCT01737697|80185747|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544290|NCT01737697|80185748|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544291|NCT01737697|80185749|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544292|NCT01737697|80185750|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544293|NCT01737697|80185751|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544294|NCT01737697|80185752|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544295|NCT01737697|80185753|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
27544296|NCT01737697|80185739|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544297|NCT01737697|80185740|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
27741242|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
27544298|NCT01737697|80185741|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544299|NCT01737697|80185742|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544300|NCT01737697|80185743|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544301|NCT01737697|80185744|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544302|NCT01737697|80185745|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544303|NCT01737697|80185746|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544304|NCT01737697|80185747|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544305|NCT01737697|80185748|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544306|NCT01737697|80185749|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544307|NCT01737697|80185750|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544308|NCT01737697|80185751|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544309|NCT01737697|80185752|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544310|NCT01737697|80185753|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
27544311|NCT01737697|80185739|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544312|NCT01737697|80185740|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544313|NCT01737697|80185741|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544314|NCT01737697|80185742|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544315|NCT01737697|80185743|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
27544316|NCT01737697|80185744|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544317|NCT01737697|80185745|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544318|NCT01737697|80185746|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544319|NCT01737697|80185747|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544320|NCT01737697|80185748|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544321|NCT01737697|80185749|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544322|NCT01737697|80185750|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544323|NCT01737697|80185751|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544324|NCT01737697|80185752|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544325|NCT01737697|80185753|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
27544326|NCT01737697|80185739|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544327|NCT01737697|80185740|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
27544328|NCT01737697|80185741|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
27544329|NCT01737697|80185742|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
27741243|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
27741244|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
27741245|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
27741246|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
27741247|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
27741248|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
27741249|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
27741250|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
27923753|NCT02017717|81560740|FG002|Before Treatment Period|Participant withdrew consent|0|||
27923754|NCT02017717|81560741|FG003|Before Treatment Period|Participant withdrew consent|0|||
27923755|NCT02017717|81560742|FG004|Before Treatment Period|Participant withdrew consent|11|||
27923756|NCT02017717|81560743|FG005|Before Treatment Period|Participant withdrew consent|0|||
27923757|NCT02017717|81560744|FG006|Before Treatment Period|Participant withdrew consent|0|||
27741251|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27741252|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
27741253|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27741254|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
27741255|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
27741256|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
27741257|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
27741258|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
27741259|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
27741260|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
27741261|NCT01009463|80880883|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
27741262|NCT01009463|80880884|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
27741263|NCT01009463|80880885|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
27741264|NCT01009463|80880886|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
27741265|NCT01009463|80880887|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
27741266|NCT03060577|80880888|FG000|Overall Study|Withdrawal by Subject|25|||
27741267|NCT03060577|80880889|FG001|Overall Study|Withdrawal by Subject|5|||
27741268|NCT03060577|80880888|FG000|Overall Study|Physician Decision|4|||
27741269|NCT03060577|80880889|FG001|Overall Study|Physician Decision|3|||
27923758|NCT02017717|81560745|FG007|Before Treatment Period|Participant withdrew consent|0|||
27923759|NCT02017717|81560746|FG008|Before Treatment Period|Participant withdrew consent|2|||
27544330|NCT01737697|80185743|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
27544331|NCT01737697|80185744|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544332|NCT01737697|80185745|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27637981|NCT00089544|80515963|FG001|Overall Study|Ineligible|0|||
27637982|NCT02708108|80515964|FG000|Overall Study|Death|1|||
27923760|NCT02017717|81560738|FG000|Before Treatment Period|Lost to Follow-up|0|||
27923761|NCT02017717|81560739|FG001|Before Treatment Period|Lost to Follow-up|0|||
27923762|NCT02017717|81560740|FG002|Before Treatment Period|Lost to Follow-up|0|||
27923763|NCT02017717|81560741|FG003|Before Treatment Period|Lost to Follow-up|0|||
27923764|NCT02017717|81560742|FG004|Before Treatment Period|Lost to Follow-up|1|||
27923765|NCT02017717|81560743|FG005|Before Treatment Period|Lost to Follow-up|0|||
27923766|NCT02017717|81560744|FG006|Before Treatment Period|Lost to Follow-up|0|||
27923767|NCT02017717|81560745|FG007|Before Treatment Period|Lost to Follow-up|0|||
27923768|NCT02017717|81560746|FG008|Before Treatment Period|Lost to Follow-up|0|||
27923769|NCT02017717|81560738|FG000|Before Treatment Period|Participant no longer met criteria|0|||
27923770|NCT02017717|81560739|FG001|Before Treatment Period|Participant no longer met criteria|0|||
27923771|NCT02017717|81560740|FG002|Before Treatment Period|Participant no longer met criteria|0|||
27923772|NCT02017717|81560741|FG003|Before Treatment Period|Participant no longer met criteria|1|||
27923773|NCT02017717|81560742|FG004|Before Treatment Period|Participant no longer met criteria|2|||
27544333|NCT01737697|80185746|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27923774|NCT02017717|81560743|FG005|Before Treatment Period|Participant no longer met criteria|0|||
27544334|NCT01737697|80185747|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544335|NCT01737697|80185748|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27923775|NCT02017717|81560744|FG006|Before Treatment Period|Participant no longer met criteria|0|||
27923776|NCT02017717|81560745|FG007|Before Treatment Period|Participant no longer met criteria|1|||
27923777|NCT02017717|81560746|FG008|Before Treatment Period|Participant no longer met criteria|0|||
27923778|NCT02017717|81560738|FG000|Before Treatment Period|other reason|0|||
27923779|NCT02017717|81560739|FG001|Before Treatment Period|other reason|0|||
27923780|NCT02017717|81560740|FG002|Before Treatment Period|other reason|0|||
27923781|NCT02017717|81560741|FG003|Before Treatment Period|other reason|0|||
27923782|NCT02017717|81560742|FG004|Before Treatment Period|other reason|1|||
27923783|NCT02017717|81560743|FG005|Before Treatment Period|other reason|0|||
27923784|NCT02017717|81560744|FG006|Before Treatment Period|other reason|0|||
27923785|NCT02017717|81560745|FG007|Before Treatment Period|other reason|0|||
27923786|NCT02017717|81560746|FG008|Before Treatment Period|other reason|0|||
27923787|NCT02017717|81560738|FG000|Treatment Period|Disease progression|7|||
27923788|NCT02017717|81560739|FG001|Treatment Period|Disease progression|9|||
27923789|NCT02017717|81560740|FG002|Treatment Period|Disease progression|12|||
27923790|NCT02017717|81560741|FG003|Treatment Period|Disease progression|165|||
27923791|NCT02017717|81560742|FG004|Treatment Period|Disease progression|134|||
27923792|NCT02017717|81560743|FG005|Treatment Period|Disease progression|20|||
27923793|NCT02017717|81560744|FG006|Treatment Period|Disease progression|26|||
27923794|NCT02017717|81560745|FG007|Treatment Period|Disease progression|17|||
27923795|NCT02017717|81560746|FG008|Treatment Period|Disease progression|22|||
27923796|NCT02017717|81560738|FG000|Treatment Period|Study drug toxicity|3|||
27923797|NCT02017717|81560739|FG001|Treatment Period|Study drug toxicity|0|||
27923798|NCT02017717|81560740|FG002|Treatment Period|Study drug toxicity|1|||
27923799|NCT02017717|81560741|FG003|Treatment Period|Study drug toxicity|7|||
27923800|NCT02017717|81560742|FG004|Treatment Period|Study drug toxicity|11|||
27923801|NCT02017717|81560743|FG005|Treatment Period|Study drug toxicity|4|||
27923802|NCT02017717|81560744|FG006|Treatment Period|Study drug toxicity|4|||
27544336|NCT01737697|80185749|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544337|NCT01737697|80185750|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544338|NCT01737697|80185751|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544339|NCT01737697|80185752|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544340|NCT01737697|80185753|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
27544341|NCT01737697|80185739|FG000|Subacute Phase|Adverse Event|0|||
27544342|NCT01737697|80185740|FG001|Subacute Phase|Adverse Event|0|||
27544343|NCT01737697|80185741|FG002|Subacute Phase|Adverse Event|0|||
27544344|NCT01737697|80185742|FG003|Subacute Phase|Adverse Event|0|||
27544345|NCT01737697|80185743|FG004|Subacute Phase|Adverse Event|0|||
27544346|NCT01737697|80185744|FG005|Subacute Phase|Adverse Event|1|||
27637983|NCT02708108|80515965|FG001|Overall Study|Death|2|||
27637984|NCT02708108|80515964|FG000|Overall Study|Regimen change|1|||
27637985|NCT02708108|80515965|FG001|Overall Study|Regimen change|0|||
27637986|NCT02708108|80515964|FG000|Overall Study|No MRD and no imaging available|0|||
27637987|NCT02708108|80515965|FG001|Overall Study|No MRD and no imaging available|1|||
27741270|NCT03060577|80880888|FG000|Overall Study|Lost to Follow-up|3|||
27741271|NCT03060577|80880889|FG001|Overall Study|Lost to Follow-up|0|||
27923803|NCT02017717|81560745|FG007|Treatment Period|Study drug toxicity|5|||
27544347|NCT01737697|80185745|FG006|Subacute Phase|Adverse Event|1|||
27544348|NCT01737697|80185746|FG007|Subacute Phase|Adverse Event|1|||
27544349|NCT01737697|80185747|FG008|Subacute Phase|Adverse Event|1|||
27544350|NCT01737697|80185748|FG009|Subacute Phase|Adverse Event|1|||
27741272|NCT03060577|80880888|FG000|Overall Study|Death|7|||
27741273|NCT03060577|80880889|FG001|Overall Study|Death|1|||
27923804|NCT02017717|81560746|FG008|Treatment Period|Study drug toxicity|3|||
27923805|NCT02017717|81560738|FG000|Treatment Period|Death|0|||
27923806|NCT02017717|81560739|FG001|Treatment Period|Death|0|||
27637988|NCT00174382|80515966|FG000|Overall Study|Death|2|||
27637989|NCT00174382|80515966|FG000|Overall Study|Adverse Event|19|||
27637990|NCT00174382|80515966|FG000|Overall Study|Withdrawal by Subject|6|||
27637991|NCT00174382|80515966|FG000|Overall Study|Protocol Violation|3|||
27637992|NCT00174382|80515966|FG000|Overall Study|Arrived early for last visit in error|1|||
27637993|NCT00174382|80515966|FG000|Overall Study|Subject felt pill not effective enough|1|||
27637994|NCT00174382|80515966|FG000|Overall Study|Lost to Follow-up|1|||
27741274|NCT03060577|80880888|FG000|Overall Study|Adverse Event|9|||
27637995|NCT01000480|80515967|FG000|Induction Phase|Adverse Event|2|||
27637996|NCT01000480|80515967|FG000|Induction Phase|Lost to Follow-up|1|||
27637997|NCT01000480|80515967|FG000|Induction Phase|Physician Decision|1|||
27637998|NCT01000480|80515967|FG000|Induction Phase|Entry Criteria Not Met|3|||
27637999|NCT01000480|80515967|FG000|Concurrent Therapy Phase|Adverse Event|4|||
27638000|NCT01000480|80515967|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
27638001|NCT01000480|80515967|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
27638002|NCT01000480|80515967|FG000|Concurrent Therapy Phase|Physician Decision|1|||
27638003|NCT00761605|80515969|FG000|Overall Study|Adverse Event|26|||
27638004|NCT00761605|80515969|FG000|Overall Study|Death|2|||
27638005|NCT00761605|80515969|FG000|Overall Study|Lack of Efficacy|26|||
27638006|NCT00761605|80515969|FG000|Overall Study|Lost to Follow-up|29|||
27638007|NCT00761605|80515969|FG000|Overall Study|Withdrawal by Subject|37|||
27638008|NCT00761605|80515969|FG000|Overall Study|Other|21|||
27638009|NCT02115139|80515972|FG000|Overall Study|Protocol Violation|1|||
27638010|NCT02115139|80515972|FG000|Overall Study|treatment discontinuation|6|||
27638011|NCT01426269|80515973|FG000|Period 1: 12 Weeks|Adverse Event|5|||
27638012|NCT01426269|80515974|FG001|Period 1: 12 Weeks|Adverse Event|0|||
27638013|NCT01426269|80515975|FG002|Period 1: 12 Weeks|Adverse Event|0|||
27638014|NCT01426269|80515973|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
27638015|NCT01426269|80515974|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
27638016|NCT01426269|80515975|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
27638017|NCT01426269|80515973|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
27638018|NCT01426269|80515974|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
27638019|NCT01426269|80515975|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
27638020|NCT01426269|80515973|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
27638021|NCT01426269|80515974|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
27638022|NCT01426269|80515975|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
27638023|NCT01426269|80515973|FG000|Period 1: 12 Weeks|Pregnancy|1|||
27638024|NCT01426269|80515974|FG001|Period 1: 12 Weeks|Pregnancy|0|||
27638025|NCT01426269|80515975|FG002|Period 1: 12 Weeks|Pregnancy|0|||
27638026|NCT01426269|80515973|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
27638027|NCT01426269|80515974|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
27741275|NCT03060577|80880889|FG001|Overall Study|Adverse Event|1|||
27741276|NCT03060577|80880888|FG000|Overall Study|Inclusion/Exclusion|1|||
27741277|NCT03060577|80880889|FG001|Overall Study|Inclusion/Exclusion|0|||
27741278|NCT03060577|80880888|FG000|Overall Study|Other|8|||
27741279|NCT03060577|80880889|FG001|Overall Study|Other|2|||
27741280|NCT02714205|80880893|FG000|Overall Study|Cannot tolerate medication|1|||
27741281|NCT02714205|80880894|FG001|Overall Study|Cannot tolerate medication|0|||
27741282|NCT02714205|80880893|FG000|Overall Study|Adverse Event|2|||
27638028|NCT01426269|80515975|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
27638029|NCT01426269|80515973|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
27638030|NCT01426269|80515974|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
27741283|NCT02714205|80880894|FG001|Overall Study|Adverse Event|0|||
27741284|NCT02714205|80880893|FG000|Overall Study|Too busy|1|||
27741285|NCT02714205|80880894|FG001|Overall Study|Too busy|0|||
27741286|NCT02714205|80880893|FG000|Overall Study|Incomplete outcome data|0|||
27741287|NCT02714205|80880894|FG001|Overall Study|Incomplete outcome data|1|||
27741288|NCT04601272|80880903|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
27741289|NCT04601272|80880904|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
27741290|NCT04601272|80880905|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
27741291|NCT04382651|80880906|FG000|Overall Study|Death|26|||
27741292|NCT04382651|80880907|FG001|Overall Study|Death|23|||
27741293|NCT04382651|80880906|FG000|Overall Study|Lost to Follow-up|3|||
27741294|NCT04382651|80880907|FG001|Overall Study|Lost to Follow-up|4|||
27638031|NCT01426269|80515975|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
27638032|NCT01426269|80515973|FG000|Period 2: 40 Weeks|Adverse Event|0|||
27741295|NCT04382651|80880906|FG000|Overall Study|Withdrawal by Subject|2|||
27638033|NCT01426269|80515974|FG001|Period 2: 40 Weeks|Adverse Event|1|||
27638034|NCT01426269|80515975|FG002|Period 2: 40 Weeks|Adverse Event|2|||
27638035|NCT01426269|80515973|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
27638036|NCT01426269|80515974|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
27741296|NCT04382651|80880907|FG001|Overall Study|Withdrawal by Subject|0|||
27741297|NCT04382651|80880906|FG000|Overall Study|Physician Decision|0|||
27741298|NCT04382651|80880907|FG001|Overall Study|Physician Decision|1|||
27741299|NCT02522481|80880911|FG000|Overall Study|discontinued|1|||
27923807|NCT02017717|81560740|FG002|Treatment Period|Death|1|||
27923808|NCT02017717|81560741|FG003|Treatment Period|Death|0|||
27923809|NCT02017717|81560742|FG004|Treatment Period|Death|0|||
27923810|NCT02017717|81560743|FG005|Treatment Period|Death|0|||
27923811|NCT02017717|81560744|FG006|Treatment Period|Death|0|||
27923812|NCT02017717|81560745|FG007|Treatment Period|Death|1|||
27923813|NCT02017717|81560746|FG008|Treatment Period|Death|0|||
27923814|NCT02017717|81560738|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
27923815|NCT02017717|81560739|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
27923816|NCT02017717|81560740|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
27923817|NCT02017717|81560741|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
27923818|NCT02017717|81560742|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
27923819|NCT02017717|81560743|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
27923820|NCT02017717|81560744|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
27923821|NCT02017717|81560745|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
27923822|NCT02017717|81560746|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
27923823|NCT02017717|81560738|FG000|Treatment Period|Participant request to stop therapy|0|||
27923824|NCT02017717|81560739|FG001|Treatment Period|Participant request to stop therapy|0|||
27923825|NCT02017717|81560740|FG002|Treatment Period|Participant request to stop therapy|3|||
27923826|NCT02017717|81560741|FG003|Treatment Period|Participant request to stop therapy|4|||
27923827|NCT02017717|81560742|FG004|Treatment Period|Participant request to stop therapy|7|||
27923828|NCT02017717|81560743|FG005|Treatment Period|Participant request to stop therapy|5|||
27923829|NCT02017717|81560744|FG006|Treatment Period|Participant request to stop therapy|0|||
27923830|NCT02017717|81560745|FG007|Treatment Period|Participant request to stop therapy|2|||
27923831|NCT02017717|81560746|FG008|Treatment Period|Participant request to stop therapy|1|||
27923832|NCT02017717|81560738|FG000|Treatment Period|Participant withdrew consent|0|||
27923833|NCT02017717|81560739|FG001|Treatment Period|Participant withdrew consent|0|||
27923834|NCT02017717|81560740|FG002|Treatment Period|Participant withdrew consent|1|||
27923835|NCT02017717|81560741|FG003|Treatment Period|Participant withdrew consent|1|||
27923836|NCT02017717|81560742|FG004|Treatment Period|Participant withdrew consent|4|||
27923837|NCT02017717|81560743|FG005|Treatment Period|Participant withdrew consent|0|||
27923838|NCT02017717|81560744|FG006|Treatment Period|Participant withdrew consent|0|||
27923839|NCT02017717|81560745|FG007|Treatment Period|Participant withdrew consent|2|||
27923840|NCT02017717|81560746|FG008|Treatment Period|Participant withdrew consent|0|||
27923841|NCT02017717|81560738|FG000|Treatment Period|Participant no longer met criteria|0|||
27923842|NCT02017717|81560739|FG001|Treatment Period|Participant no longer met criteria|0|||
27923843|NCT02017717|81560740|FG002|Treatment Period|Participant no longer met criteria|0|||
27923844|NCT02017717|81560741|FG003|Treatment Period|Participant no longer met criteria|0|||
27923845|NCT02017717|81560742|FG004|Treatment Period|Participant no longer met criteria|1|||
27923846|NCT02017717|81560743|FG005|Treatment Period|Participant no longer met criteria|0|||
27923847|NCT02017717|81560744|FG006|Treatment Period|Participant no longer met criteria|0|||
27923848|NCT02017717|81560745|FG007|Treatment Period|Participant no longer met criteria|0|||
27923849|NCT02017717|81560746|FG008|Treatment Period|Participant no longer met criteria|0|||
27923850|NCT02017717|81560738|FG000|Treatment Period|other reasons|0|||
27923851|NCT02017717|81560739|FG001|Treatment Period|other reasons|0|||
27923852|NCT02017717|81560740|FG002|Treatment Period|other reasons|0|||
27923853|NCT02017717|81560741|FG003|Treatment Period|other reasons|0|||
27923854|NCT02017717|81560742|FG004|Treatment Period|other reasons|1|||
27923855|NCT02017717|81560743|FG005|Treatment Period|other reasons|0|||
27923856|NCT02017717|81560744|FG006|Treatment Period|other reasons|0|||
27923857|NCT02017717|81560745|FG007|Treatment Period|other reasons|1|||
27923858|NCT02017717|81560746|FG008|Treatment Period|other reasons|1|||
27923859|NCT02017717|81560738|FG000|Treatment Period|Maximum clinical benefit|0|||
27923860|NCT02017717|81560739|FG001|Treatment Period|Maximum clinical benefit|0|||
27923861|NCT02017717|81560740|FG002|Treatment Period|Maximum clinical benefit|0|||
27923862|NCT02017717|81560741|FG003|Treatment Period|Maximum clinical benefit|0|||
27923863|NCT02017717|81560742|FG004|Treatment Period|Maximum clinical benefit|1|||
27923864|NCT02017717|81560743|FG005|Treatment Period|Maximum clinical benefit|0|||
27923865|NCT02017717|81560744|FG006|Treatment Period|Maximum clinical benefit|0|||
27923866|NCT02017717|81560745|FG007|Treatment Period|Maximum clinical benefit|0|||
27923867|NCT02017717|81560746|FG008|Treatment Period|Maximum clinical benefit|0|||
27923868|NCT04009837|81560747|FG000|Overall Study|Withdrawal by Subject|5|||
27923869|NCT04009837|81560748|FG001|Overall Study|Withdrawal by Subject|4|||
27923870|NCT04009837|81560747|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
27923871|NCT04009837|81560748|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
27923872|NCT01937299|81560749|FG000|Overall Study|Adverse Event|13|||
27923873|NCT01937299|81560750|FG001|Overall Study|Adverse Event|0|||
27923874|NCT01937299|81560749|FG000|Overall Study|Lack of Efficacy|0|||
27923875|NCT01937299|81560750|FG001|Overall Study|Lack of Efficacy|4|||
27923876|NCT01937299|81560749|FG000|Overall Study|Withdrawal by Subject|1|||
27923877|NCT01937299|81560750|FG001|Overall Study|Withdrawal by Subject|0|||
27923878|NCT00715208|81560751|FG000|Overall Study|Withdrawal by Subject|1|||
27923879|NCT00715208|81560752|FG001|Overall Study|Withdrawal by Subject|1|||
27923880|NCT00715208|81560751|FG000|Overall Study|Adverse Event|0|||
27923881|NCT00715208|81560752|FG001|Overall Study|Adverse Event|6|||
27923882|NCT00715208|81560751|FG000|Overall Study|Lack of Efficacy|0|||
27923883|NCT00715208|81560752|FG001|Overall Study|Lack of Efficacy|2|||
27923884|NCT02915835|81560754|FG000|Overall Study|Physician Decision|1|||
27923885|NCT02915835|81560755|FG001|Overall Study|Physician Decision|0|||
27923886|NCT02915835|81560754|FG000|Overall Study|Withdrawal by Subject|0|||
27923887|NCT02915835|81560755|FG001|Overall Study|Withdrawal by Subject|1|||
27923888|NCT01799941|81560756|FG000|Overall Study|Adverse Event|34|||
27923889|NCT01799941|81560756|FG000|Overall Study|Withdrawal by Subject|21|||
27923890|NCT01799941|81560756|FG000|Overall Study|Death|2|||
27923891|NCT01799941|81560756|FG000|Overall Study|Investigator Decision|4|||
27923892|NCT01799941|81560756|FG000|Overall Study|Lack of Efficacy|3|||
27923893|NCT01799941|81560756|FG000|Overall Study|Lost to Follow-up|17|||
27923894|NCT01799941|81560756|FG000|Overall Study|Other|15|||
27923895|NCT02566005|81560757|FG000|Overall Study|vaginal bleeding|0|||
27923896|NCT02566005|81560758|FG001|Overall Study|vaginal bleeding|1|||
27923897|NCT02566005|81560757|FG000|Overall Study|received foley|8|||
27923898|NCT02566005|81560758|FG001|Overall Study|received foley|0|||
27923899|NCT02566005|81560757|FG000|Overall Study|did not receive foley|0|||
27544351|NCT01737697|80185749|FG010|Subacute Phase|Adverse Event|4|||
27544352|NCT01737697|80185750|FG011|Subacute Phase|Adverse Event|1|||
27544353|NCT01737697|80185751|FG012|Subacute Phase|Adverse Event|1|||
27923900|NCT02566005|81560758|FG001|Overall Study|did not receive foley|1|||
27923901|NCT02566005|81560757|FG000|Overall Study|labor after randomization|0|||
27923902|NCT02566005|81560758|FG001|Overall Study|labor after randomization|4|||
27923903|NCT02152007|81560763|FG000|Overall Study|Withdrawal by Subject|1|||
27923904|NCT00390689|81560766|FG000|Overall Study|Adverse Event|2|||
27923905|NCT00390689|81560767|FG001|Overall Study|Adverse Event|5|||
27923906|NCT00390689|81560768|FG002|Overall Study|Adverse Event|2|||
27923907|NCT00390689|81560766|FG000|Overall Study|Lack of Efficacy|0|||
27923908|NCT00390689|81560767|FG001|Overall Study|Lack of Efficacy|0|||
27923909|NCT00390689|81560768|FG002|Overall Study|Lack of Efficacy|1|||
27923910|NCT00390689|81560766|FG000|Overall Study|Protocol Violation|1|||
27923911|NCT00390689|81560767|FG001|Overall Study|Protocol Violation|0|||
27923912|NCT00390689|81560768|FG002|Overall Study|Protocol Violation|0|||
27923913|NCT00390689|81560766|FG000|Overall Study|Investigator's judgement|2|||
27923914|NCT00390689|81560767|FG001|Overall Study|Investigator's judgement|0|||
27923915|NCT00390689|81560768|FG002|Overall Study|Investigator's judgement|0|||
27923916|NCT02313155|81560769|FG000|Overall Study|Lost to Follow-up|0|||
27923917|NCT02313155|81560770|FG001|Overall Study|Lost to Follow-up|1|||
27923918|NCT02990000|81560775|FG000|Overall Study|Failed to provide data beyond baseline|36|||
27923919|NCT02990000|81560776|FG001|Overall Study|Failed to provide data beyond baseline|34|||
27923920|NCT01461551|81560779|FG000|Overall Study|Physician Decision|2|||
27923921|NCT01461551|81560780|FG001|Overall Study|Physician Decision|1|||
27923922|NCT01461551|81560781|FG002|Overall Study|Physician Decision|2|||
27923923|NCT02722967|81560782|FG000|Overall Study|Adverse Event|1|||
27923924|NCT02722967|81560783|FG001|Overall Study|Adverse Event|0|||
27923925|NCT02722967|81560784|FG002|Overall Study|Adverse Event|0|||
27923926|NCT02722967|81560782|FG000|Overall Study|Lost to Follow-up|0|||
27923927|NCT02722967|81560783|FG001|Overall Study|Lost to Follow-up|1|||
27923928|NCT02722967|81560784|FG002|Overall Study|Lost to Follow-up|0|||
27923929|NCT02722967|81560782|FG000|Overall Study|Non-compliance with patch wearing|2|||
27923930|NCT02722967|81560783|FG001|Overall Study|Non-compliance with patch wearing|1|||
27923931|NCT02722967|81560784|FG002|Overall Study|Non-compliance with patch wearing|1|||
27923932|NCT02722967|81560782|FG000|Overall Study|Withdrawal by Subject|1|||
27923933|NCT02722967|81560783|FG001|Overall Study|Withdrawal by Subject|0|||
27923934|NCT02722967|81560784|FG002|Overall Study|Withdrawal by Subject|1|||
27923935|NCT02722967|81560782|FG000|Overall Study|Physician Decision|1|||
27923936|NCT02722967|81560783|FG001|Overall Study|Physician Decision|0|||
27923937|NCT02722967|81560784|FG002|Overall Study|Physician Decision|0|||
27923938|NCT02722967|81560782|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
27923939|NCT02722967|81560783|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
27923940|NCT02722967|81560784|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
27923941|NCT01649765|81560785|FG000|Overall Study|Adverse Event|5|||
27923942|NCT01649765|81560786|FG001|Overall Study|Adverse Event|3|||
27923943|NCT01649765|81560785|FG000|Overall Study|Lack of Efficacy|1|||
27544354|NCT01737697|80185752|FG013|Subacute Phase|Adverse Event|0|||
27544355|NCT01737697|80185753|FG014|Subacute Phase|Adverse Event|0|||
27923944|NCT01649765|81560786|FG001|Overall Study|Lack of Efficacy|1|||
27923945|NCT01649765|81560785|FG000|Overall Study|Physician Decision|0|||
27923946|NCT01649765|81560786|FG001|Overall Study|Physician Decision|3|||
27923947|NCT01649765|81560785|FG000|Overall Study|Protocol Violation|1|||
27923948|NCT01649765|81560786|FG001|Overall Study|Protocol Violation|0|||
27923949|NCT01649765|81560785|FG000|Overall Study|Withdrawal by Subject|2|||
27923950|NCT01649765|81560786|FG001|Overall Study|Withdrawal by Subject|1|||
27923951|NCT02324153|81560790|FG000|Overall Study|Withdrawal by Subject|4|||
27923952|NCT02324153|81560791|FG001|Overall Study|Withdrawal by Subject|1|||
27923953|NCT02324153|81560790|FG000|Overall Study|Surgery postponed after randomization|3|||
27923954|NCT02324153|81560791|FG001|Overall Study|Surgery postponed after randomization|0|||
27923955|NCT02324153|81560790|FG000|Overall Study|Developed delirium preoperatively|1|||
27923956|NCT02324153|81560791|FG001|Overall Study|Developed delirium preoperatively|0|||
27923957|NCT05172570|81560792|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
27923958|NCT05172570|81560793|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
27923959|NCT05172570|81560794|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
27923960|NCT05172570|81560792|FG000|Overall Study|PI Decision due to equipment shortages|0|||
27923961|NCT05172570|81560793|FG001|Overall Study|PI Decision due to equipment shortages|0|||
27923962|NCT05172570|81560794|FG002|Overall Study|PI Decision due to equipment shortages|1|||
27923963|NCT03479905|81560796|FG000|Overall Study|Other airway method used|4|||
27923964|NCT03479905|81560797|FG001|Overall Study|Other airway method used|5|||
27923965|NCT03479905|81560798|FG002|Overall Study|Other airway method used|5|||
27923966|NCT00671060|81560801|FG000|Overall Study|Protocol Violation|1|||
27923967|NCT00671060|81560802|FG001|Overall Study|Protocol Violation|0|||
27923968|NCT00671060|81560801|FG000|Overall Study|Physician Decision|0|||
27923969|NCT00671060|81560802|FG001|Overall Study|Physician Decision|1|||
27923970|NCT00630292|81560804|FG000|Overall Study|Withdrawal by Subject|1|||
27923971|NCT01248455|81560808|FG000|Overall Study|switched to alternate treatment|1|||
27923972|NCT03255187|81560809|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
27923973|NCT03255187|81560810|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
27923974|NCT03255187|81560809|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
27923975|NCT03255187|81560810|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
27923976|NCT00392223|81560811|FG000|Overall Study|Adverse Event|5|||
27923977|NCT00392223|81560812|FG001|Overall Study|Adverse Event|4|||
27923978|NCT00392223|81560811|FG000|Overall Study|Lost to Follow-up|1|||
27923979|NCT00392223|81560812|FG001|Overall Study|Lost to Follow-up|4|||
27923980|NCT00392223|81560811|FG000|Overall Study|Protocol Violation|0|||
27923981|NCT00392223|81560812|FG001|Overall Study|Protocol Violation|3|||
27923982|NCT00392223|81560811|FG000|Overall Study|Withdrawal by Subject|3|||
27923983|NCT00392223|81560812|FG001|Overall Study|Withdrawal by Subject|2|||
27923984|NCT01739335|81560813|FG000|Overall Study|Lost to Follow-up|7|||
27923985|NCT01739335|81560814|FG001|Overall Study|Lost to Follow-up|4|||
27923986|NCT01739335|81560813|FG000|Overall Study|Ineligible patient randomized|0|||
27923987|NCT01739335|81560814|FG001|Overall Study|Ineligible patient randomized|1|||
27923988|NCT01787838|81560815|FG000|Overall Study|refused|1413|||
27923989|NCT03188822|81560818|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
27923990|NCT03188822|81560818|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
27923991|NCT01715298|81560819|FG000|Overall Study|Lost to Follow-up|0|||
27638037|NCT01426269|80515975|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
27638038|NCT01426269|80515973|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
27638039|NCT01426269|80515974|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
27638040|NCT01426269|80515975|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
27638041|NCT01426269|80515973|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
27638042|NCT01426269|80515974|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
27638043|NCT01426269|80515975|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
27638044|NCT01426269|80515973|FG000|Period 2: 40 Weeks|Site closed|0|||
27638045|NCT01426269|80515974|FG001|Period 2: 40 Weeks|Site closed|6|||
27638046|NCT01426269|80515975|FG002|Period 2: 40 Weeks|Site closed|5|||
27638047|NCT01426269|80515973|FG000|Period 2: 40 Weeks|Relapsed|0|||
27638048|NCT01426269|80515974|FG001|Period 2: 40 Weeks|Relapsed|9|||
27638049|NCT01426269|80515975|FG002|Period 2: 40 Weeks|Relapsed|18|||
27741300|NCT02522481|80880911|FG000|Overall Study|Not dosed|2|||
27741301|NCT02586207|80880912|FG000|Overall Study|Physician Decision|1|||
27741302|NCT02586207|80880912|FG000|Overall Study|Withdrawal by Subject|1|||
27741303|NCT00465738|80880916|FG000|Overall Study|Lost to Follow-up|2|||
27741304|NCT00465738|80880917|FG001|Overall Study|Lost to Follow-up|0|||
27741305|NCT00465738|80880916|FG000|Overall Study|Adverse Event|0|||
27741306|NCT00465738|80880917|FG001|Overall Study|Adverse Event|1|||
27741307|NCT00465738|80880916|FG000|Overall Study|Withdrawal by Subject|2|||
27741308|NCT00465738|80880917|FG001|Overall Study|Withdrawal by Subject|0|||
27741309|NCT00465738|80880916|FG000|Overall Study|Other|2|||
27638050|NCT00632424|80515976|FG000|Overall Study|Disease Progression|17|||
27638051|NCT00632424|80515976|FG000|Overall Study|Study Drug Toxicity|1|||
27923992|NCT01715298|81560820|FG001|Overall Study|Lost to Follow-up|2|||
27638052|NCT02568683|80515981|FG000|Overall Study|Death|0|||
27638053|NCT02568683|80515982|FG001|Overall Study|Death|2|||
27638054|NCT02568683|80515981|FG000|Overall Study|Withdrew Consent|1|||
27638055|NCT02568683|80515982|FG001|Overall Study|Withdrew Consent|0|||
27638056|NCT02568683|80515981|FG000|Overall Study|Study Terminated By Sponsor|5|||
27741310|NCT00465738|80880917|FG001|Overall Study|Other|5|||
27741311|NCT05165394|80880923|FG000|Overall Study|Withdrawal by Subject|5|||
27741312|NCT05165394|80880924|FG001|Overall Study|Withdrawal by Subject|1|||
27923993|NCT01715298|81560819|FG000|Overall Study|Patient/guardian decision|7|||
27923994|NCT01715298|81560820|FG001|Overall Study|Patient/guardian decision|9|||
27923995|NCT00862992|81560821|FG000|Overall Study|Adverse Event|2|||
27923996|NCT00862992|81560822|FG001|Overall Study|Adverse Event|1|||
27638057|NCT02568683|80515982|FG001|Overall Study|Study Terminated By Sponsor|2|||
27638058|NCT01061671|80515985|FG000|Overall Study|Withdrawal by Subject|16|||
27638059|NCT01061671|80515986|FG001|Overall Study|Withdrawal by Subject|20|||
27638060|NCT01061671|80515985|FG000|Overall Study|Lost to Follow-up|3|||
27638061|NCT01061671|80515986|FG001|Overall Study|Lost to Follow-up|5|||
27544356|NCT01737697|80185739|FG000|Subacute Phase|Withdrawal by Subject|0|||
27638062|NCT01061671|80515985|FG000|Overall Study|Death|28|||
27638063|NCT01061671|80515986|FG001|Overall Study|Death|30|||
27638064|NCT02372253|80515987|FG000|Overall Study|Non Compliance|2|||
27638065|NCT02372253|80515988|FG001|Overall Study|Non Compliance|0|||
27638066|NCT01444417|80515990|FG000|Overall Study|Ineligibility Determined|0|||
27638067|NCT01444417|80515991|FG001|Overall Study|Ineligibility Determined|1|||
27638068|NCT01444417|80515990|FG000|Overall Study|Withdrawal by Subject|2|||
27741313|NCT05165394|80880923|FG000|Overall Study|Lost to Follow-up|1|||
27741314|NCT05165394|80880924|FG001|Overall Study|Lost to Follow-up|2|||
27741315|NCT05165394|80880923|FG000|Overall Study|Other Than Specified|0|||
27741316|NCT05165394|80880924|FG001|Overall Study|Other Than Specified|1|||
27741317|NCT01396525|80880925|FG000|Overall Study|Withdrawal by Subject|8|||
27544357|NCT01737697|80185740|FG001|Subacute Phase|Withdrawal by Subject|0|||
27544358|NCT01737697|80185741|FG002|Subacute Phase|Withdrawal by Subject|0|||
27544359|NCT01737697|80185742|FG003|Subacute Phase|Withdrawal by Subject|0|||
27544360|NCT01737697|80185743|FG004|Subacute Phase|Withdrawal by Subject|0|||
27544361|NCT01737697|80185744|FG005|Subacute Phase|Withdrawal by Subject|1|||
27544362|NCT01737697|80185745|FG006|Subacute Phase|Withdrawal by Subject|0|||
27544363|NCT01737697|80185746|FG007|Subacute Phase|Withdrawal by Subject|2|||
27544364|NCT01737697|80185747|FG008|Subacute Phase|Withdrawal by Subject|0|||
27544365|NCT01737697|80185748|FG009|Subacute Phase|Withdrawal by Subject|1|||
27544366|NCT01737697|80185749|FG010|Subacute Phase|Withdrawal by Subject|0|||
27544367|NCT01737697|80185750|FG011|Subacute Phase|Withdrawal by Subject|1|||
27923997|NCT00862992|81560823|FG002|Overall Study|Adverse Event|1|||
27923998|NCT00862992|81560821|FG000|Overall Study|Physician Decision|1|||
27923999|NCT00862992|81560822|FG001|Overall Study|Physician Decision|0|||
27924000|NCT00862992|81560823|FG002|Overall Study|Physician Decision|0|||
27544368|NCT01737697|80185751|FG012|Subacute Phase|Withdrawal by Subject|1|||
27544369|NCT01737697|80185752|FG013|Subacute Phase|Withdrawal by Subject|1|||
27544370|NCT01737697|80185753|FG014|Subacute Phase|Withdrawal by Subject|0|||
27544371|NCT01737697|80185739|FG000|Subacute Phase|Lost to Follow-up|0|||
27544372|NCT01737697|80185740|FG001|Subacute Phase|Lost to Follow-up|0|||
27544373|NCT01737697|80185741|FG002|Subacute Phase|Lost to Follow-up|0|||
27741318|NCT01396525|80880925|FG000|Overall Study|Death|14|||
27741319|NCT01396525|80880925|FG000|Overall Study|Lost to Follow-up|4|||
27741320|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Adverse Event|37|||
27924001|NCT00862992|81560821|FG000|Overall Study|Withdrawal by Subject|0|||
27924002|NCT00862992|81560822|FG001|Overall Study|Withdrawal by Subject|0|||
27741321|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Adverse Event|0|||
27741322|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Adverse Event|0|||
27741323|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Adverse Event|0|||
27924003|NCT00862992|81560823|FG002|Overall Study|Withdrawal by Subject|2|||
27924004|NCT00961415|81560824|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
27924005|NCT00961415|81560825|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
27924006|NCT00961415|81560826|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
27924007|NCT00961415|81560824|FG000|Induction Treatment Phase|Death|77|||
27924008|NCT00961415|81560825|FG001|Induction Treatment Phase|Death|0|||
27924009|NCT00961415|81560826|FG002|Induction Treatment Phase|Death|0|||
27924010|NCT00961415|81560824|FG000|Induction Treatment Phase|Protocol Violation|1|||
27924011|NCT00961415|81560825|FG001|Induction Treatment Phase|Protocol Violation|0|||
27924012|NCT00961415|81560826|FG002|Induction Treatment Phase|Protocol Violation|0|||
27924013|NCT00961415|81560824|FG000|Induction Treatment Phase|Physician Decision|2|||
27544374|NCT01737697|80185742|FG003|Subacute Phase|Lost to Follow-up|0|||
27924014|NCT00961415|81560825|FG001|Induction Treatment Phase|Physician Decision|0|||
27924015|NCT00961415|81560826|FG002|Induction Treatment Phase|Physician Decision|0|||
27924016|NCT00961415|81560824|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
27544375|NCT01737697|80185743|FG004|Subacute Phase|Lost to Follow-up|0|||
27544376|NCT01737697|80185744|FG005|Subacute Phase|Lost to Follow-up|0|||
27544377|NCT01737697|80185745|FG006|Subacute Phase|Lost to Follow-up|0|||
27544378|NCT01737697|80185746|FG007|Subacute Phase|Lost to Follow-up|0|||
27544379|NCT01737697|80185747|FG008|Subacute Phase|Lost to Follow-up|0|||
27638069|NCT01444417|80515991|FG001|Overall Study|Withdrawal by Subject|0|||
27638070|NCT02965846|80515992|FG000|Overall Study|Lost to Follow-up|1|||
27741324|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Death|2|||
27741325|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Death|0|||
27741326|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Death|0|||
27924017|NCT00961415|81560825|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
27544380|NCT01737697|80185748|FG009|Subacute Phase|Lost to Follow-up|0|||
27544381|NCT01737697|80185749|FG010|Subacute Phase|Lost to Follow-up|0|||
27544382|NCT01737697|80185750|FG011|Subacute Phase|Lost to Follow-up|0|||
27544383|NCT01737697|80185751|FG012|Subacute Phase|Lost to Follow-up|0|||
27544384|NCT01737697|80185752|FG013|Subacute Phase|Lost to Follow-up|0|||
27544385|NCT01737697|80185753|FG014|Subacute Phase|Lost to Follow-up|1|||
27544386|NCT01737697|80185739|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
27544387|NCT01737697|80185740|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
27544388|NCT01737697|80185741|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
27544389|NCT01737697|80185742|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
27544390|NCT01737697|80185743|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
27544391|NCT01737697|80185744|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
27544392|NCT01737697|80185745|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
27544393|NCT01737697|80185746|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
27544394|NCT01737697|80185747|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
27544395|NCT01737697|80185748|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
27544396|NCT01737697|80185749|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
27544397|NCT01737697|80185750|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
27544398|NCT01737697|80185751|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
27544399|NCT01737697|80185752|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
27544400|NCT01737697|80185753|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
27544401|NCT01737697|80185739|FG000|Subacute Phase|Protocol Violation|0|||
27544402|NCT01737697|80185740|FG001|Subacute Phase|Protocol Violation|0|||
27544403|NCT01737697|80185741|FG002|Subacute Phase|Protocol Violation|0|||
27544404|NCT01737697|80185742|FG003|Subacute Phase|Protocol Violation|0|||
27544405|NCT01737697|80185743|FG004|Subacute Phase|Protocol Violation|0|||
27544406|NCT01737697|80185744|FG005|Subacute Phase|Protocol Violation|1|||
27544407|NCT01737697|80185745|FG006|Subacute Phase|Protocol Violation|0|||
27544408|NCT01737697|80185746|FG007|Subacute Phase|Protocol Violation|0|||
27544409|NCT01737697|80185747|FG008|Subacute Phase|Protocol Violation|0|||
27544410|NCT01737697|80185748|FG009|Subacute Phase|Protocol Violation|0|||
27544411|NCT01737697|80185749|FG010|Subacute Phase|Protocol Violation|1|||
27544412|NCT01737697|80185750|FG011|Subacute Phase|Protocol Violation|0|||
27544413|NCT01737697|80185751|FG012|Subacute Phase|Protocol Violation|0|||
27544414|NCT01737697|80185752|FG013|Subacute Phase|Protocol Violation|0|||
27544415|NCT01737697|80185753|FG014|Subacute Phase|Protocol Violation|0|||
27544416|NCT01737697|80185739|FG000|Subacute Phase|Physician Decision|0|||
27544417|NCT01737697|80185740|FG001|Subacute Phase|Physician Decision|0|||
27544418|NCT01737697|80185741|FG002|Subacute Phase|Physician Decision|0|||
27544419|NCT01737697|80185742|FG003|Subacute Phase|Physician Decision|0|||
27544420|NCT01737697|80185743|FG004|Subacute Phase|Physician Decision|0|||
27544421|NCT01737697|80185744|FG005|Subacute Phase|Physician Decision|0|||
27544422|NCT01737697|80185745|FG006|Subacute Phase|Physician Decision|0|||
27544423|NCT01737697|80185746|FG007|Subacute Phase|Physician Decision|0|||
27544424|NCT01737697|80185747|FG008|Subacute Phase|Physician Decision|1|||
27924018|NCT00961415|81560826|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
27924019|NCT00961415|81560824|FG000|Induction Treatment Phase|Other Reason|5|||
27924020|NCT00961415|81560825|FG001|Induction Treatment Phase|Other Reason|0|||
27924021|NCT00961415|81560826|FG002|Induction Treatment Phase|Other Reason|0|||
27924022|NCT00961415|81560824|FG000|Maintenance Treatment Phase|Death|0|||
27924023|NCT00961415|81560825|FG001|Maintenance Treatment Phase|Death|42|||
27924024|NCT00961415|81560826|FG002|Maintenance Treatment Phase|Death|34|||
27924025|NCT00961415|81560824|FG000|Maintenance Treatment Phase|Investigators decision|0|||
27924026|NCT00961415|81560825|FG001|Maintenance Treatment Phase|Investigators decision|2|||
27924027|NCT00961415|81560826|FG002|Maintenance Treatment Phase|Investigators decision|0|||
27924028|NCT00961415|81560824|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
27924029|NCT00961415|81560825|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
27924030|NCT00961415|81560826|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
27924031|NCT00961415|81560824|FG000|Maintenance Treatment Phase|Other reason|0|||
27924032|NCT00961415|81560825|FG001|Maintenance Treatment Phase|Other reason|1|||
27924033|NCT00961415|81560826|FG002|Maintenance Treatment Phase|Other reason|3|||
27924034|NCT00922636|81560828|FG000|Overall Study|Adverse Event|3|||
27544425|NCT01737697|80185748|FG009|Subacute Phase|Physician Decision|0|||
27544426|NCT01737697|80185749|FG010|Subacute Phase|Physician Decision|0|||
27544427|NCT01737697|80185750|FG011|Subacute Phase|Physician Decision|0|||
27924035|NCT00922636|81560829|FG001|Overall Study|Adverse Event|3|||
27924036|NCT00922636|81560830|FG002|Overall Study|Adverse Event|2|||
27544428|NCT01737697|80185751|FG012|Subacute Phase|Physician Decision|0|||
27544429|NCT01737697|80185752|FG013|Subacute Phase|Physician Decision|0|||
27638071|NCT02965846|80515993|FG001|Overall Study|Lost to Follow-up|0|||
27924037|NCT00922636|81560831|FG003|Overall Study|Adverse Event|3|||
27544430|NCT01737697|80185753|FG014|Subacute Phase|Physician Decision|0|||
27544431|NCT01737697|80185739|FG000|Subacute Phase|Death|0|||
27544432|NCT01737697|80185740|FG001|Subacute Phase|Death|0|||
27544433|NCT01737697|80185741|FG002|Subacute Phase|Death|0|||
27544434|NCT01737697|80185742|FG003|Subacute Phase|Death|0|||
27544435|NCT01737697|80185743|FG004|Subacute Phase|Death|0|||
27544436|NCT01737697|80185744|FG005|Subacute Phase|Death|0|||
27924038|NCT00922636|81560832|FG004|Overall Study|Adverse Event|2|||
27924039|NCT00922636|81560828|FG000|Overall Study|Lack of Efficacy|1|||
27924040|NCT00922636|81560829|FG001|Overall Study|Lack of Efficacy|7|||
27924041|NCT00922636|81560830|FG002|Overall Study|Lack of Efficacy|3|||
27924042|NCT00922636|81560831|FG003|Overall Study|Lack of Efficacy|2|||
27924043|NCT00922636|81560832|FG004|Overall Study|Lack of Efficacy|4|||
27924044|NCT00922636|81560828|FG000|Overall Study|Sponsor Decision|0|||
27924045|NCT00922636|81560829|FG001|Overall Study|Sponsor Decision|0|||
27924046|NCT00922636|81560830|FG002|Overall Study|Sponsor Decision|2|||
27924047|NCT00922636|81560831|FG003|Overall Study|Sponsor Decision|0|||
27924048|NCT00922636|81560832|FG004|Overall Study|Sponsor Decision|0|||
27924049|NCT00922636|81560828|FG000|Overall Study|Withdrawal by Subject|0|||
27924050|NCT00922636|81560829|FG001|Overall Study|Withdrawal by Subject|0|||
27924051|NCT00922636|81560830|FG002|Overall Study|Withdrawal by Subject|5|||
27924052|NCT00922636|81560831|FG003|Overall Study|Withdrawal by Subject|2|||
27544437|NCT01737697|80185745|FG006|Subacute Phase|Death|0|||
27544438|NCT01737697|80185746|FG007|Subacute Phase|Death|0|||
27544439|NCT01737697|80185747|FG008|Subacute Phase|Death|0|||
27544440|NCT01737697|80185748|FG009|Subacute Phase|Death|0|||
27544441|NCT01737697|80185749|FG010|Subacute Phase|Death|1|||
27544442|NCT01737697|80185750|FG011|Subacute Phase|Death|0|||
27544443|NCT01737697|80185751|FG012|Subacute Phase|Death|0|||
27544444|NCT01737697|80185752|FG013|Subacute Phase|Death|0|||
27544445|NCT01737697|80185753|FG014|Subacute Phase|Death|0|||
27544446|NCT01683383|80185754|FG000|Overall Study|Infant was not transported|1|||
27544447|NCT01683383|80185755|FG001|Overall Study|Infant was not transported|0|||
27544448|NCT01866930|80185759|FG000|Treatment Period|Other|1|||
27544449|NCT01866930|80185760|FG001|Treatment Period|Other|0|||
27741327|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Death|0|||
27544450|NCT01866930|80185759|FG000|Treatment Period|Death|0|||
27741328|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
27741329|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
27741330|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
27741331|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
27741332|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
27741333|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
27741334|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
27741335|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
27741336|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
27741337|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
27741338|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
27741339|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
27741340|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
27741341|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
27741342|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
27741343|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
27741344|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Physician Decision|4|||
27741345|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Physician Decision|0|||
27544451|NCT01866930|80185760|FG001|Treatment Period|Death|2|||
27544452|NCT01866930|80185759|FG000|Treatment Period|Poor/non compliance|0|||
27544453|NCT01866930|80185760|FG001|Treatment Period|Poor/non compliance|2|||
27544454|NCT01866930|80185759|FG000|Treatment Period|No longer meets study criteria|0|||
27544455|NCT01866930|80185760|FG001|Treatment Period|No longer meets study criteria|1|||
27544456|NCT01866930|80185759|FG000|Treatment Period|Withdrawal by Subject|2|||
27544457|NCT01866930|80185760|FG001|Treatment Period|Withdrawal by Subject|8|||
27544458|NCT01866930|80185759|FG000|Treatment Period|Lack of Efficacy|1|||
27544459|NCT01866930|80185760|FG001|Treatment Period|Lack of Efficacy|9|||
27544460|NCT01866930|80185759|FG000|Treatment Period|Adverse Event|4|||
27544461|NCT01866930|80185760|FG001|Treatment Period|Adverse Event|12|||
27544462|NCT01866930|80185759|FG000|Treatment Period|Lost to Follow-up|1|||
27544463|NCT01866930|80185760|FG001|Treatment Period|Lost to Follow-up|1|||
27544464|NCT01866930|80185759|FG000|Follow-up Period|Lost to Follow-up|1|||
27544465|NCT01866930|80185760|FG001|Follow-up Period|Lost to Follow-up|1|||
27544466|NCT01866930|80185759|FG000|Follow-up Period|Other|1|||
27544467|NCT01866930|80185760|FG001|Follow-up Period|Other|5|||
27544468|NCT01866930|80185759|FG000|Follow-up Period|No longer required per protocol|1|||
27544469|NCT01866930|80185760|FG001|Follow-up Period|No longer required per protocol|0|||
27741346|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Physician Decision|0|||
27741347|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Physician Decision|0|||
27544470|NCT01866930|80185759|FG000|Follow-up Period|Withdrawal by Subject|3|||
27741348|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Pregnancy|1|||
27741349|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Pregnancy|0|||
27741350|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Pregnancy|0|||
27924053|NCT00922636|81560832|FG004|Overall Study|Withdrawal by Subject|4|||
27924054|NCT00922636|81560828|FG000|Overall Study|Protocol Violation|0|||
27924055|NCT00922636|81560829|FG001|Overall Study|Protocol Violation|0|||
27924056|NCT00922636|81560830|FG002|Overall Study|Protocol Violation|2|||
27544471|NCT01866930|80185760|FG001|Follow-up Period|Withdrawal by Subject|3|||
27544472|NCT00259649|80185761|FG000|Overall Study|Lost to Follow-up|7|||
27544473|NCT00259649|80185761|FG000|Overall Study|irregular menses|3|||
27544474|NCT01964430|80185766|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
27544475|NCT01964430|80185767|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
27544476|NCT01964430|80185766|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
27544477|NCT01964430|80185767|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
27544478|NCT01964430|80185766|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
27544479|NCT01964430|80185767|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
27544480|NCT01964430|80185766|FG000|Treatment Period|Adverse Event|71|||
27924057|NCT00922636|81560831|FG003|Overall Study|Protocol Violation|2|||
27924058|NCT00922636|81560832|FG004|Overall Study|Protocol Violation|0|||
27924059|NCT00922636|81560828|FG000|Overall Study|Entry Criteria Not Met|0|||
27924060|NCT00922636|81560829|FG001|Overall Study|Entry Criteria Not Met|0|||
27924061|NCT00922636|81560830|FG002|Overall Study|Entry Criteria Not Met|1|||
27924062|NCT00922636|81560831|FG003|Overall Study|Entry Criteria Not Met|1|||
27924063|NCT00922636|81560832|FG004|Overall Study|Entry Criteria Not Met|0|||
27924064|NCT00922636|81560828|FG000|Overall Study|Parent/Caregiver Decision|2|||
27924065|NCT00922636|81560829|FG001|Overall Study|Parent/Caregiver Decision|4|||
27924066|NCT00922636|81560830|FG002|Overall Study|Parent/Caregiver Decision|3|||
27924067|NCT00922636|81560831|FG003|Overall Study|Parent/Caregiver Decision|5|||
27924068|NCT00922636|81560832|FG004|Overall Study|Parent/Caregiver Decision|2|||
27924069|NCT00922636|81560828|FG000|Overall Study|Lost to Follow-up|1|||
27924070|NCT00922636|81560829|FG001|Overall Study|Lost to Follow-up|2|||
27924071|NCT00922636|81560830|FG002|Overall Study|Lost to Follow-up|2|||
27924072|NCT00922636|81560831|FG003|Overall Study|Lost to Follow-up|2|||
27544481|NCT01964430|80185767|FG001|Treatment Period|Adverse Event|37|||
27544482|NCT01964430|80185766|FG000|Treatment Period|Withdrawal by Subject|36|||
27924073|NCT00922636|81560832|FG004|Overall Study|Lost to Follow-up|4|||
27924074|NCT00700635|81560833|FG000|Overall Study|Adverse Event|1|||
27924075|NCT00700635|81560834|FG001|Overall Study|Adverse Event|0|||
27924076|NCT00700635|81560835|FG002|Overall Study|Adverse Event|0|||
27924077|NCT00700635|81560833|FG000|Overall Study|Lost to Follow-up|1|||
27924078|NCT00700635|81560834|FG001|Overall Study|Lost to Follow-up|3|||
27924079|NCT00700635|81560835|FG002|Overall Study|Lost to Follow-up|0|||
27924080|NCT00700635|81560833|FG000|Overall Study|Protocol Violation|2|||
27924081|NCT00700635|81560834|FG001|Overall Study|Protocol Violation|2|||
27924082|NCT00700635|81560835|FG002|Overall Study|Protocol Violation|0|||
27544483|NCT01964430|80185767|FG001|Treatment Period|Withdrawal by Subject|27|||
27544484|NCT01964430|80185766|FG000|Treatment Period|Death|1|||
27544485|NCT01964430|80185767|FG001|Treatment Period|Death|3|||
27544486|NCT01964430|80185766|FG000|Treatment Period|Protocol Deviation|0|||
27544487|NCT01964430|80185767|FG001|Treatment Period|Protocol Deviation|1|||
27544488|NCT01964430|80185766|FG000|Treatment Period|Physician Decision|5|||
27544489|NCT01964430|80185767|FG001|Treatment Period|Physician Decision|4|||
27544490|NCT01964430|80185766|FG000|Treatment Period|Disease Relapse|28|||
27544491|NCT01964430|80185767|FG001|Treatment Period|Disease Relapse|38|||
27544492|NCT01964430|80185766|FG000|Treatment Period|Other reasons|1|||
27544493|NCT01964430|80185767|FG001|Treatment Period|Other reasons|3|||
27544494|NCT01540838|80185768|FG000|Overall Study|Open nasogastric tube|9|||
27544495|NCT01540838|80185769|FG001|Overall Study|Open nasogastric tube|7|||
27544496|NCT01540838|80185768|FG000|Overall Study|Treatment doses missing|8|||
27544497|NCT01540838|80185769|FG001|Overall Study|Treatment doses missing|12|||
27544498|NCT01540838|80185768|FG000|Overall Study|Additional antibiotic treatment|1|||
27544499|NCT01540838|80185769|FG001|Overall Study|Additional antibiotic treatment|2|||
27544500|NCT01540838|80185768|FG000|Overall Study|Died before treatment initiation|1|||
27544501|NCT01540838|80185769|FG001|Overall Study|Died before treatment initiation|1|||
27544502|NCT01540838|80185768|FG000|Overall Study|Not BM. Other treatment|3|||
27544503|NCT01540838|80185769|FG001|Overall Study|Not BM. Other treatment|1|||
27638072|NCT02965846|80515994|FG002|Overall Study|Lost to Follow-up|0|||
27638073|NCT02965846|80515992|FG000|Overall Study|Withdrawal by Subject|0|||
27924083|NCT00700635|81560833|FG000|Overall Study|Withdrawal by Subject|7|||
27924084|NCT00700635|81560834|FG001|Overall Study|Withdrawal by Subject|3|||
27924085|NCT00700635|81560835|FG002|Overall Study|Withdrawal by Subject|1|||
27924086|NCT00143507|81560838|FG000|Overall Study|Death|572|||
27924087|NCT00143507|81560839|FG001|Overall Study|Death|547|||
27924088|NCT00143507|81560838|FG000|Overall Study|Withdrawal by Subject|114|||
27924089|NCT00143507|81560839|FG001|Overall Study|Withdrawal by Subject|102|||
27924090|NCT00143507|81560838|FG000|Overall Study|Lost to Follow-up|1|||
27924091|NCT00143507|81560839|FG001|Overall Study|Lost to Follow-up|0|||
27924092|NCT00143507|81560838|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
27544504|NCT05229406|80185772|FG000|Overall Study|Withdrawal by Subject|1|||
27544505|NCT05229406|80185773|FG001|Overall Study|Withdrawal by Subject|2|||
27544506|NCT01084083|80185784|FG000|Overall Study|Adverse Event|5|||
27544507|NCT01084083|80185784|FG000|Overall Study|Death|1|||
27638074|NCT02965846|80515993|FG001|Overall Study|Withdrawal by Subject|1|||
27924093|NCT00143507|81560839|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
27924094|NCT00607893|81560844|FG000|Overall Study|Lost to Follow-up|4|||
27924095|NCT00607893|81560845|FG001|Overall Study|Lost to Follow-up|0|||
27924096|NCT00607893|81560844|FG000|Overall Study|withdrew due to loss of interest|0|||
27924097|NCT00607893|81560845|FG001|Overall Study|withdrew due to loss of interest|1|||
27924098|NCT00607893|81560844|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
27924099|NCT00607893|81560845|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
27924100|NCT00607893|81560844|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
27924101|NCT00607893|81560845|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
27924102|NCT00607893|81560844|FG000|Overall Study|Declined to be treated|1|||
27924103|NCT00607893|81560845|FG001|Overall Study|Declined to be treated|0|||
27924104|NCT00607893|81560844|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
27924105|NCT00607893|81560845|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
27924106|NCT00549055|81560846|FG000|Overall Study|Adverse Event|4|||
27924107|NCT00549055|81560846|FG000|Overall Study|Lack of Efficacy|18|||
27924108|NCT00549055|81560846|FG000|Overall Study|Stabilization|5|||
27924109|NCT00549055|81560846|FG000|Overall Study|Progression to fibrosis|2|||
27924110|NCT00549055|81560846|FG000|Overall Study|Decrease of size|1|||
27924111|NCT00549055|81560846|FG000|Overall Study|Active choroidal neovascula increased|1|||
27924112|NCT00549055|81560846|FG000|Overall Study|Vitreous hemorrhage|1|||
27924113|NCT00549055|81560846|FG000|Overall Study|Growth choroidal neovascularisation|1|||
27924114|NCT00549055|81560846|FG000|Overall Study|Choroidal neovascularization|1|||
27924115|NCT00549055|81560846|FG000|Overall Study|Very low visual acuity (VA)|1|||
27924116|NCT00817063|81560847|FG000|Overall Study|Adverse Event|32|||
27924117|NCT00817063|81560848|FG001|Overall Study|Adverse Event|13|||
27924118|NCT00817063|81560847|FG000|Overall Study|Death|1|||
27924119|NCT00817063|81560848|FG001|Overall Study|Death|1|||
27924120|NCT00817063|81560847|FG000|Overall Study|Lack of Efficacy|33|||
27924121|NCT00817063|81560848|FG001|Overall Study|Lack of Efficacy|86|||
27924122|NCT00817063|81560847|FG000|Overall Study|Failure to Return|13|||
27924123|NCT00817063|81560848|FG001|Overall Study|Failure to Return|12|||
27924124|NCT00817063|81560847|FG000|Overall Study|Violation of Selection at Entry|7|||
27924125|NCT00817063|81560848|FG001|Overall Study|Violation of Selection at Entry|4|||
27924126|NCT00817063|81560847|FG000|Overall Study|Protocol Violation|3|||
27924127|NCT00817063|81560848|FG001|Overall Study|Protocol Violation|8|||
27924128|NCT00817063|81560847|FG000|Overall Study|Withdrawal by Subject|17|||
27924129|NCT00817063|81560848|FG001|Overall Study|Withdrawal by Subject|37|||
27924130|NCT00817063|81560847|FG000|Overall Study|Early Improvement|19|||
27924131|NCT00817063|81560848|FG001|Overall Study|Early Improvement|4|||
27924132|NCT00817063|81560847|FG000|Overall Study|Administrative|10|||
27924133|NCT00817063|81560848|FG001|Overall Study|Administrative|4|||
27924134|NCT00817063|81560847|FG000|Overall Study|Abnormality of Laboratory Test|2|||
27924135|NCT00817063|81560848|FG001|Overall Study|Abnormality of Laboratory Test|1|||
27924136|NCT01260948|81560849|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
27924137|NCT01260948|81560850|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
27924138|NCT01260948|81560849|FG000|Second Intervention|Emesis|0|||
27924139|NCT01260948|81560850|FG001|Second Intervention|Emesis|1|||
27924140|NCT01163617|81560851|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27924141|NCT01163617|81560852|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
27924142|NCT01163617|81560853|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27924143|NCT01163617|81560854|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27741351|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Pregnancy|0|||
27741352|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
27741353|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
27741354|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
27741355|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
27741356|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
27741357|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
27741358|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
27924144|NCT01163617|81560855|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27924145|NCT01163617|81560856|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27924146|NCT01163617|81560857|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27924147|NCT01163617|81560858|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
27924148|NCT01163617|81560851|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27924149|NCT01163617|81560852|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
27544508|NCT01084083|80185784|FG000|Overall Study|Withdrawal by Subject|2|||
27544509|NCT01084083|80185784|FG000|Overall Study|Complicating disease|1|||
27544510|NCT01084083|80185784|FG000|Overall Study|Other|2|||
27924150|NCT01163617|81560853|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27924151|NCT01163617|81560854|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27544511|NCT01084083|80185784|FG000|Overall Study|Never started assigned therapy|1|||
27741359|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
27741360|NCT01855789|80880928|FG000|1) Baseline up to Week 24|Other|4|||
27741361|NCT01855789|80880929|FG001|1) Baseline up to Week 24|Other|0|||
27741362|NCT01855789|80880930|FG002|1) Baseline up to Week 24|Other|0|||
27741363|NCT01855789|80880931|FG003|1) Baseline up to Week 24|Other|0|||
27741364|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
27741365|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
27741366|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
27741367|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
27741368|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
27741369|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
27741370|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
27741371|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
27741372|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
27741373|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
27741374|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
27741375|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
27741376|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
27741377|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
27741378|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
27741379|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
27741380|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
27741381|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
27741382|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
27741383|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
27741384|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
27741385|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
27741386|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
27741387|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
27741388|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
27741389|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
27741390|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
27741391|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
27741392|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
27741393|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
27741394|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
27741395|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
27741396|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
27741397|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
27741398|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
27924152|NCT01163617|81560855|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27924153|NCT01163617|81560856|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27924154|NCT01163617|81560857|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27924155|NCT01163617|81560858|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
27924156|NCT01163617|81560851|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27924157|NCT01163617|81560852|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27924158|NCT01163617|81560853|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
27924159|NCT01163617|81560854|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27544512|NCT02639065|80185785|FG000|Study Treatment|Disease Progression|13|||
27544513|NCT02639065|80185785|FG000|Study Treatment|Adverse Event|9|||
27544514|NCT02639065|80185785|FG000|Study Treatment|Withdrawal by Subject|1|||
27544515|NCT02639065|80185785|FG000|Follow up|Subject refused to follow up|1|||
27544516|NCT02639065|80185785|FG000|Follow up|Symptomatic Deterioration|2|||
27544517|NCT02639065|80185785|FG000|Follow up|Death|2|||
27544518|NCT02639065|80185785|FG000|Follow up|Study Terminated|1|||
27544519|NCT02639065|80185785|FG000|Follow up|Disease Progression|3|||
27544520|NCT01086033|80185786|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
27544521|NCT01086033|80185786|FG000|Overall Study|Lost to Follow-up|86|||
27544522|NCT01086033|80185786|FG000|Overall Study|Adverse Event|42|||
27741399|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
27741400|NCT01855789|80880928|FG000|2) Week 24 up to End of Study|Other|0|||
27741401|NCT01855789|80880929|FG001|2) Week 24 up to End of Study|Other|0|||
27741402|NCT01855789|80880930|FG002|2) Week 24 up to End of Study|Other|0|||
27544523|NCT01086033|80185786|FG000|Overall Study|Withdrawal by Subject|41|||
27741403|NCT01855789|80880931|FG003|2) Week 24 up to End of Study|Other|1|||
27544524|NCT01086033|80185786|FG000|Overall Study|Other|14|||
27544525|NCT01086033|80185786|FG000|Overall Study|Other|13|||
27544526|NCT01086033|80185786|FG000|Overall Study|AE and Withdrew Consent|5|||
27544527|NCT01086033|80185786|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
27741404|NCT02640612|80880932|FG000|Overall Study|Adverse Event|6|||
27544528|NCT01086033|80185786|FG000|Overall Study|Withdrew consent and Other Reason|4|||
27544529|NCT01086033|80185786|FG000|Overall Study|AE and Lack of Efficacy|4|||
27544530|NCT01086033|80185786|FG000|Overall Study|Death|1|||
27544531|NCT01086033|80185786|FG000|Overall Study|AE and Lost to Follow-up|1|||
27544532|NCT01086033|80185786|FG000|Overall Study|AE and Other Reason|1|||
27544533|NCT01086033|80185786|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
27544534|NCT01909674|80185787|FG000|Overall Study|Withdrawal by Subject|5|||
27544535|NCT01909674|80185788|FG001|Overall Study|Withdrawal by Subject|2|||
27544536|NCT02469298|80185789|FG000|Overall Study|Protocol Violation|0|||
27741405|NCT02640612|80880933|FG001|Overall Study|Adverse Event|7|||
27741406|NCT02640612|80880934|FG002|Overall Study|Adverse Event|2|||
27741407|NCT02640612|80880932|FG000|Overall Study|Death|1|||
27741408|NCT02640612|80880933|FG001|Overall Study|Death|0|||
27741409|NCT02640612|80880934|FG002|Overall Study|Death|0|||
27741410|NCT02640612|80880932|FG000|Overall Study|Withdrawal by Subject|10|||
27924160|NCT01163617|81560855|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27924161|NCT01163617|81560856|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27924162|NCT01163617|81560857|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27924163|NCT01163617|81560858|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
27924164|NCT05166876|81560859|FG000|Overall Study|Withdrawal by Subject|1|||
27924165|NCT05166876|81560860|FG001|Overall Study|Withdrawal by Subject|0|||
27924166|NCT05166876|81560861|FG002|Overall Study|Withdrawal by Subject|0|||
27924167|NCT01496456|81560869|FG000|Overall Study|Protocol Violation|1|||
27924168|NCT01496456|81560869|FG000|Overall Study|Lost to Follow-up|7|||
27924169|NCT03883386|81560870|FG000|First Assignment|Lost to Follow-up|1|||
27924170|NCT03883386|81560871|FG001|First Assignment|Lost to Follow-up|0|||
27924171|NCT03883386|81560870|FG000|First Assignment|Withdrawal by Subject|1|||
27544537|NCT02469298|80185790|FG001|Overall Study|Protocol Violation|1|||
27544538|NCT02469298|80185791|FG002|Overall Study|Protocol Violation|1|||
27638075|NCT02965846|80515994|FG002|Overall Study|Withdrawal by Subject|0|||
27741411|NCT02640612|80880933|FG001|Overall Study|Withdrawal by Subject|3|||
27741412|NCT02640612|80880934|FG002|Overall Study|Withdrawal by Subject|3|||
27741413|NCT02640612|80880932|FG000|Overall Study|Lost to Follow-up|4|||
27741414|NCT02640612|80880933|FG001|Overall Study|Lost to Follow-up|1|||
27741415|NCT02640612|80880934|FG002|Overall Study|Lost to Follow-up|1|||
27741416|NCT02640612|80880932|FG000|Overall Study|Protocol Violation|0|||
27741417|NCT02640612|80880933|FG001|Overall Study|Protocol Violation|2|||
27741418|NCT02640612|80880934|FG002|Overall Study|Protocol Violation|0|||
27741419|NCT02640612|80880932|FG000|Overall Study|Lack of Efficacy|1|||
27741420|NCT02640612|80880933|FG001|Overall Study|Lack of Efficacy|1|||
27741421|NCT02640612|80880934|FG002|Overall Study|Lack of Efficacy|0|||
27741422|NCT02234622|80880935|FG000|Overall Study|Withdrawal by Subject|16|||
27741423|NCT02234622|80880936|FG001|Overall Study|Withdrawal by Subject|22|||
27741424|NCT02234622|80880935|FG000|Overall Study|Lost to Follow-up|27|||
27741425|NCT02234622|80880936|FG001|Overall Study|Lost to Follow-up|14|||
27741426|NCT04075604|80880944|FG000|Overall Study|Adverse Event|0|||
27741427|NCT04075604|80880945|FG001|Overall Study|Adverse Event|0|||
27741428|NCT04075604|80880946|FG002|Overall Study|Adverse Event|3|||
27741429|NCT04075604|80880944|FG000|Overall Study|Participant request to discontinue study treatment|0|||
27741430|NCT04075604|80880945|FG001|Overall Study|Participant request to discontinue study treatment|0|||
27741431|NCT04075604|80880946|FG002|Overall Study|Participant request to discontinue study treatment|1|||
27741432|NCT04075604|80880944|FG000|Overall Study|Participant withdrew consent|0|||
27924172|NCT03883386|81560871|FG001|First Assignment|Withdrawal by Subject|1|||
27924173|NCT00300053|81560872|FG000|Overall Study|Patient/Caregiver Preference|2|||
27924174|NCT00300053|81560873|FG001|Overall Study|Patient/Caregiver Preference|2|||
27924175|NCT00300053|81560874|FG002|Overall Study|Patient/Caregiver Preference|3|||
27924176|NCT00300053|81560872|FG000|Overall Study|Death|0|||
27924177|NCT00300053|81560873|FG001|Overall Study|Death|0|||
27924178|NCT00300053|81560874|FG002|Overall Study|Death|3|||
27924179|NCT00300053|81560872|FG000|Overall Study|Lost to Follow-up|0|||
27924180|NCT00300053|81560873|FG001|Overall Study|Lost to Follow-up|1|||
27924181|NCT00300053|81560874|FG002|Overall Study|Lost to Follow-up|0|||
27924182|NCT03482024|81560875|FG000|Overall Study|Physician Decision|1|||
27924183|NCT03482024|81560876|FG001|Overall Study|Physician Decision|0|||
27924184|NCT03482024|81560877|FG002|Overall Study|Physician Decision|0|||
27924185|NCT03482024|81560878|FG003|Overall Study|Physician Decision|0|||
27924186|NCT03482024|81560879|FG004|Overall Study|Physician Decision|0|||
27924187|NCT04711005|81560880|FG000|Overall Study|Withdrawal by Subject|0|||
27741433|NCT04075604|80880945|FG001|Overall Study|Participant withdrew consent|0|||
27741434|NCT04075604|80880946|FG002|Overall Study|Participant withdrew consent|1|||
27741435|NCT04075604|80880944|FG000|Overall Study|Other reasons|1|||
27741436|NCT04075604|80880945|FG001|Overall Study|Other reasons|0|||
27741437|NCT04075604|80880946|FG002|Overall Study|Other reasons|0|||
27741438|NCT04075604|80880944|FG000|Overall Study|Disease progression|0|||
27741439|NCT04075604|80880945|FG001|Overall Study|Disease progression|1|||
27741440|NCT04075604|80880946|FG002|Overall Study|Disease progression|0|||
27741441|NCT04075604|80880944|FG000|Overall Study|Study drug toxicity|0|||
27741442|NCT04075604|80880945|FG001|Overall Study|Study drug toxicity|5|||
27741443|NCT04075604|80880946|FG002|Overall Study|Study drug toxicity|1|||
27741444|NCT02332915|80880947|FG000|Overall Study|Moved out of region|3|||
27741445|NCT02332915|80880948|FG001|Overall Study|Moved out of region|0|||
27741446|NCT02332915|80880947|FG000|Overall Study|Unrelated illness|1|||
27741447|NCT02332915|80880948|FG001|Overall Study|Unrelated illness|1|||
27741448|NCT02332915|80880947|FG000|Overall Study|Travel distance prohibitive|0|||
27741449|NCT02332915|80880948|FG001|Overall Study|Travel distance prohibitive|1|||
27741450|NCT02332915|80880947|FG000|Overall Study|did not meet inclusion criteria|2|||
27741451|NCT02332915|80880948|FG001|Overall Study|did not meet inclusion criteria|4|||
27924188|NCT04711005|81560881|FG001|Overall Study|Withdrawal by Subject|0|||
27924189|NCT04711005|81560882|FG002|Overall Study|Withdrawal by Subject|0|||
27924190|NCT04711005|81560883|FG003|Overall Study|Withdrawal by Subject|0|||
27924191|NCT04711005|81560884|FG004|Overall Study|Withdrawal by Subject|0|||
27638076|NCT02965846|80515992|FG000|Overall Study|Study Terminated By Sponsor|4|||
27638077|NCT02965846|80515993|FG001|Overall Study|Study Terminated By Sponsor|4|||
27638078|NCT02965846|80515994|FG002|Overall Study|Study Terminated By Sponsor|0|||
27638079|NCT02965846|80515992|FG000|Overall Study|Participants not randomized|0|||
27924192|NCT04711005|81560885|FG005|Overall Study|Withdrawal by Subject|0|||
27924193|NCT04711005|81560886|FG006|Overall Study|Withdrawal by Subject|0|||
27924194|NCT04711005|81560887|FG007|Overall Study|Withdrawal by Subject|1|||
27924195|NCT04711005|81560888|FG008|Overall Study|Withdrawal by Subject|0|||
27924196|NCT04711005|81560889|FG009|Overall Study|Withdrawal by Subject|0|||
27924197|NCT04711005|81560880|FG000|Overall Study|Physician Decision|0|||
27924198|NCT04711005|81560881|FG001|Overall Study|Physician Decision|0|||
27924199|NCT04711005|81560882|FG002|Overall Study|Physician Decision|0|||
27924200|NCT04711005|81560883|FG003|Overall Study|Physician Decision|0|||
27924201|NCT04711005|81560884|FG004|Overall Study|Physician Decision|0|||
27924202|NCT04711005|81560885|FG005|Overall Study|Physician Decision|0|||
27924203|NCT04711005|81560886|FG006|Overall Study|Physician Decision|0|||
27924204|NCT04711005|81560887|FG007|Overall Study|Physician Decision|2|||
27924205|NCT04711005|81560888|FG008|Overall Study|Physician Decision|1|||
27924206|NCT04711005|81560889|FG009|Overall Study|Physician Decision|0|||
27924207|NCT02469857|81560890|FG000|Overall Study|Death|24|||
27924208|NCT02469857|81560891|FG001|Overall Study|Death|29|||
27924209|NCT02469857|81560890|FG000|Overall Study|Discontinuation|1|||
27924210|NCT02469857|81560891|FG001|Overall Study|Discontinuation|3|||
27924211|NCT01860989|81560892|FG000|Overall Study|Unsatisfactory therapeutic|5|||
27924212|NCT04682301|81560893|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
27924213|NCT04682301|81560893|FG000|Overall Study|Death|2|||
27544539|NCT02469298|80185792|FG003|Overall Study|Protocol Violation|0|||
27544540|NCT02469298|80185789|FG000|Overall Study|Lost to Follow-up|1|||
27544541|NCT02469298|80185790|FG001|Overall Study|Lost to Follow-up|0|||
27544542|NCT02469298|80185791|FG002|Overall Study|Lost to Follow-up|1|||
27544543|NCT02469298|80185792|FG003|Overall Study|Lost to Follow-up|0|||
27544544|NCT02469298|80185789|FG000|Overall Study|Physician Decision|0|||
27544545|NCT02469298|80185790|FG001|Overall Study|Physician Decision|0|||
27544546|NCT02469298|80185791|FG002|Overall Study|Physician Decision|0|||
27544547|NCT02469298|80185792|FG003|Overall Study|Physician Decision|1|||
27544548|NCT02469298|80185789|FG000|Overall Study|Withdrawal by Subject|0|||
27544549|NCT02469298|80185790|FG001|Overall Study|Withdrawal by Subject|0|||
27544550|NCT02469298|80185791|FG002|Overall Study|Withdrawal by Subject|0|||
27544551|NCT02469298|80185792|FG003|Overall Study|Withdrawal by Subject|1|||
27544552|NCT00873912|80185793|FG000|Overall Study|Withdrawal by Subject|1|||
27544553|NCT00873912|80185794|FG001|Overall Study|Withdrawal by Subject|0|||
27544554|NCT00873912|80185793|FG000|Overall Study|Lost to Follow-up|2|||
27544555|NCT00873912|80185794|FG001|Overall Study|Lost to Follow-up|0|||
27544556|NCT03693300|80185796|FG000|Overall Study|Withdrawal by Subject|6|||
27544557|NCT03693300|80185797|FG001|Overall Study|Withdrawal by Subject|0|||
27544558|NCT03693300|80185796|FG000|Overall Study|Death|50|||
27638080|NCT02965846|80515993|FG001|Overall Study|Participants not randomized|0|||
27638081|NCT02965846|80515994|FG002|Overall Study|Participants not randomized|33|||
27638082|NCT00955825|80516001|FG000|Overall Study|Adverse Event|15|||
27741452|NCT04083222|80880949|FG000|Overall Study|Voluntary Withdrawal|0|||
27544559|NCT03693300|80185797|FG001|Overall Study|Death|2|||
27638083|NCT00955825|80516002|FG001|Overall Study|Adverse Event|2|||
27544560|NCT03693300|80185796|FG000|Overall Study|Lost to Follow-up|2|||
27544561|NCT03693300|80185797|FG001|Overall Study|Lost to Follow-up|0|||
27544562|NCT01702961|80185804|FG000|Overall Study|Additional treatment|3|||
27638084|NCT00955825|80516001|FG000|Overall Study|Withdrawal by Subject|4|||
27741453|NCT04083222|80880950|FG001|Overall Study|Voluntary Withdrawal|1|||
27741454|NCT04083222|80880949|FG000|Overall Study|Reason not Specified|0|||
27741455|NCT04083222|80880950|FG001|Overall Study|Reason not Specified|1|||
27741456|NCT00663858|80880951|FG000|Overall Study|Adverse Event|9|||
27924214|NCT00916578|81560894|FG000|Overall Study|Physician Decision|2|||
27924215|NCT00916578|81560894|FG000|Overall Study|Withdrawal by Subject|3|||
27924216|NCT00916578|81560894|FG000|Overall Study|Insurance Denial|2|||
27544563|NCT01702961|80185804|FG000|Overall Study|Progressive disease|5|||
27638085|NCT00955825|80516002|FG001|Overall Study|Withdrawal by Subject|6|||
27638086|NCT00955825|80516001|FG000|Overall Study|Any other reason not above-mentioned|7|||
27638087|NCT00955825|80516002|FG001|Overall Study|Any other reason not above-mentioned|9|||
27638088|NCT02214160|80516003|FG000|Overall Study|Withdrawal by Subject|1|||
27638089|NCT02214160|80516004|FG001|Overall Study|Withdrawal by Subject|0|||
27638090|NCT02214160|80516005|FG002|Overall Study|Withdrawal by Subject|6|||
27638091|NCT02214160|80516003|FG000|Overall Study|Death|2|||
27638092|NCT02214160|80516004|FG001|Overall Study|Death|2|||
27638093|NCT02214160|80516005|FG002|Overall Study|Death|1|||
27544564|NCT01702961|80185804|FG000|Overall Study|Relapse|20|||
27544565|NCT01702961|80185804|FG000|Overall Study|Death|6|||
27544566|NCT01702961|80185804|FG000|Overall Study|Lost to Follow-up|2|||
27544567|NCT01702961|80185804|FG000|Overall Study|Ongoing|11|||
27544568|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
27544569|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
27544570|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
27544571|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
27544572|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
27544573|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
27544574|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
27544575|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
27544576|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
27544577|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
27544578|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
27544579|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
27544580|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
27544581|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
27544582|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
27544583|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
27544584|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
27544585|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
27544586|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
27544587|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
27544588|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
27544589|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
27544590|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
27544591|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
27544592|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
27544593|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27544594|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27544595|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
27544596|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27544597|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
27544598|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
27544599|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27544600|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27544601|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27544602|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
27544603|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27544604|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
27544605|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27544606|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27544607|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
27544608|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
27544609|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
27544610|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
27544611|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
27544612|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
27544613|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27544614|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27544615|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
27544616|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27638094|NCT02214160|80516003|FG000|Overall Study|Subject Non-Compliance|0|||
27638095|NCT02214160|80516004|FG001|Overall Study|Subject Non-Compliance|3|||
27638096|NCT02214160|80516005|FG002|Overall Study|Subject Non-Compliance|1|||
27638097|NCT02214160|80516003|FG000|Overall Study|Adverse Event|0|||
27544617|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
27544618|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
27544619|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
27544620|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
27544621|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
27544622|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
27544623|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
27544624|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
27544625|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
27544626|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
27544627|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
27544628|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27544629|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27544630|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27544631|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
27544632|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
27544633|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27544634|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27544635|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
27544636|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27544637|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
27544638|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Change of location|0|||
27544639|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Change of location|0|||
27544640|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Change of location|0|||
27544641|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Change of location|1|||
27544642|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Change of location|0|||
27544643|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
27544644|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
27924217|NCT02948400|81560895|FG000|Overall Study|Withdrawal by Subject|17|||
27924218|NCT02948400|81560896|FG001|Overall Study|Withdrawal by Subject|10|||
27924219|NCT02948400|81560895|FG000|Overall Study|failed to attend appointments|47|||
27924220|NCT02948400|81560896|FG001|Overall Study|failed to attend appointments|34|||
27924221|NCT02948400|81560895|FG000|Overall Study|COVID-related closure|6|||
27924222|NCT02948400|81560896|FG001|Overall Study|COVID-related closure|2|||
27924223|NCT02948400|81560895|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
27924224|NCT02948400|81560896|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
27924225|NCT02948400|81560895|FG000|Overall Study|motion sickness in virtual reality|2|||
27924226|NCT02948400|81560896|FG001|Overall Study|motion sickness in virtual reality|0|||
27924227|NCT03738696|81560897|FG000|Overall Study|Withdrawal by Subject|0|||
27924228|NCT03738696|81560898|FG001|Overall Study|Withdrawal by Subject|1|||
27924229|NCT03738696|81560897|FG000|Overall Study|Lost to Follow-up|8|||
27924230|NCT03738696|81560898|FG001|Overall Study|Lost to Follow-up|14|||
27924231|NCT01349595|81560899|FG000|Overall Study|Lack of funding|2|||
27924232|NCT01349595|81560900|FG001|Overall Study|Lack of funding|2|||
27924233|NCT01118299|81560901|FG000|Overall Study|Death|7|||
27924234|NCT01118299|81560902|FG001|Overall Study|Death|5|||
27924235|NCT01118299|81560901|FG000|Overall Study|Withdrawal by Subject|8|||
27924236|NCT01118299|81560902|FG001|Overall Study|Withdrawal by Subject|8|||
27924237|NCT01118299|81560901|FG000|Overall Study|Lost to Follow-up|2|||
27924238|NCT01118299|81560902|FG001|Overall Study|Lost to Follow-up|1|||
27544645|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
27544646|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
27544647|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
27544648|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27544649|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27544650|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27544651|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
27544652|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
27544653|NCT00730405|80185805|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
27544654|NCT00730405|80185806|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27544655|NCT00730405|80185807|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27544656|NCT00730405|80185808|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27544657|NCT00730405|80185809|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
27544658|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
27544659|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
27544660|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
27924239|NCT01118299|81560901|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
27924240|NCT01118299|81560902|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
27924241|NCT00945243|81560903|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
27924242|NCT05630196|81560904|FG000|Overall Study|Adverse Event|2|||
27924243|NCT05630196|81560905|FG001|Overall Study|Adverse Event|1|||
27924244|NCT05630196|81560904|FG000|Overall Study|Lost to Follow-up|1|||
27924245|NCT05630196|81560905|FG001|Overall Study|Lost to Follow-up|1|||
27924246|NCT05630196|81560904|FG000|Overall Study|Protocol Violation|2|||
27924247|NCT05630196|81560905|FG001|Overall Study|Protocol Violation|3|||
27924248|NCT05630196|81560904|FG000|Overall Study|Physician Decision|1|||
27924249|NCT05630196|81560905|FG001|Overall Study|Physician Decision|0|||
27924250|NCT05630196|81560904|FG000|Overall Study|Withdrawal by Subject|3|||
27924251|NCT05630196|81560905|FG001|Overall Study|Withdrawal by Subject|4|||
27924252|NCT00833755|81560906|FG000|Overall Study|Physician Decision|4|||
27924253|NCT00833755|81560907|FG001|Overall Study|Physician Decision|4|||
27544661|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
27544662|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
27544663|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
27638098|NCT02214160|80516004|FG001|Overall Study|Adverse Event|1|||
27924254|NCT00833755|81560908|FG002|Overall Study|Physician Decision|2|||
27924255|NCT00833755|81560909|FG003|Overall Study|Physician Decision|6|||
27924256|NCT00833755|81560906|FG000|Overall Study|Subject had scheduling issues|0|||
27924257|NCT00833755|81560907|FG001|Overall Study|Subject had scheduling issues|1|||
27924258|NCT00833755|81560908|FG002|Overall Study|Subject had scheduling issues|0|||
27924259|NCT00833755|81560909|FG003|Overall Study|Subject had scheduling issues|0|||
27924260|NCT00937950|81560910|FG000|Overall Study|Withdrawal by Subject|23|||
27924261|NCT00937950|81560910|FG000|Overall Study|Migrated/moved from study area|27|||
27924262|NCT00937950|81560910|FG000|Overall Study|Lost to Follow-up|144|||
27924263|NCT00937950|81560910|FG000|Overall Study|Missing confirmed|4|||
27924264|NCT00937950|81560910|FG000|Overall Study|Other|18|||
27924265|NCT02034006|81560911|FG000|Overall Study|Withdrawal by Subject|7|||
27924266|NCT02034006|81560911|FG000|Overall Study|Lost to Follow-up|5|||
27924267|NCT02034006|81560911|FG000|Overall Study|Death|1|||
27924268|NCT02034006|81560911|FG000|Overall Study|Pregnancy|1|||
27924269|NCT01184872|81560912|FG000|Overall Study|Adverse Event|3|||
27924270|NCT01184872|81560913|FG001|Overall Study|Adverse Event|4|||
27924271|NCT01184872|81560912|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
27924272|NCT01184872|81560913|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27924273|NCT01184872|81560912|FG000|Overall Study|Withdrawal by Subject|2|||
27924274|NCT01184872|81560913|FG001|Overall Study|Withdrawal by Subject|0|||
27924275|NCT01184872|81560912|FG000|Overall Study|Lost to Follow-up|0|||
27924276|NCT01184872|81560913|FG001|Overall Study|Lost to Follow-up|1|||
27924277|NCT01184872|81560912|FG000|Overall Study|Administrative problems|1|||
27638099|NCT02214160|80516005|FG002|Overall Study|Adverse Event|1|||
27638100|NCT02214160|80516003|FG000|Overall Study|Sponsor Decision|0|||
27638101|NCT02214160|80516004|FG001|Overall Study|Sponsor Decision|2|||
27638102|NCT02214160|80516005|FG002|Overall Study|Sponsor Decision|0|||
27638103|NCT02214160|80516003|FG000|Overall Study|Protocol Violation|1|||
27638104|NCT02214160|80516004|FG001|Overall Study|Protocol Violation|0|||
27638105|NCT02214160|80516005|FG002|Overall Study|Protocol Violation|0|||
27638106|NCT02214160|80516003|FG000|Overall Study|Physician Decision|0|||
27638107|NCT02214160|80516004|FG001|Overall Study|Physician Decision|0|||
27638108|NCT02214160|80516005|FG002|Overall Study|Physician Decision|1|||
27544664|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
27544665|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
27544666|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
27638109|NCT02544152|80516008|FG000|Overall Study|Adverse Event|0|||
27638110|NCT02544152|80516009|FG001|Overall Study|Adverse Event|4|||
27924278|NCT01184872|81560913|FG001|Overall Study|Administrative problems|1|||
27924279|NCT01184872|81560912|FG000|Overall Study|Protocol deviation|1|||
27924280|NCT01184872|81560913|FG001|Overall Study|Protocol deviation|0|||
27924281|NCT02577029|81560914|FG000|Overall Study|Adverse Event|1|||
27544667|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
27544668|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
27544669|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
27544670|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
27544671|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
27544672|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
27544673|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Death|0|||
27544674|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Death|1|||
27638111|NCT02544152|80516008|FG000|Overall Study|Withdrawal by Subject|0|||
27924282|NCT02577029|81560915|FG001|Overall Study|Adverse Event|0|||
27924283|NCT02577029|81560916|FG002|Overall Study|Adverse Event|2|||
27924284|NCT02577029|81560917|FG003|Overall Study|Adverse Event|0|||
27638112|NCT02544152|80516009|FG001|Overall Study|Withdrawal by Subject|3|||
27924285|NCT02577029|81560918|FG004|Overall Study|Adverse Event|1|||
27544675|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Death|0|||
27924286|NCT02577029|81560919|FG005|Overall Study|Adverse Event|0|||
27924287|NCT02577029|81560920|FG006|Overall Study|Adverse Event|0|||
27544676|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Death|1|||
27544677|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Death|0|||
27544678|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Change of location|1|||
27544679|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Change of location|1|||
27544680|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Change of location|0|||
27544681|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Change of location|1|||
27544682|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Change of location|0|||
27544683|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
27544684|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
27544685|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
27544686|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
27544687|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
27544688|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27544689|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27544690|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
27544691|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27544692|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
27544693|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27544694|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27544695|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
27544696|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27544697|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
27544698|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27544699|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27544700|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27544701|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
27544702|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
27544703|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
27544704|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
27544705|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
27544706|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
27544707|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
27544708|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27544709|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27544710|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27544711|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
27544712|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
27544713|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
27544714|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
27544715|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
27544716|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
27544717|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
27544718|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
27544719|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
27544720|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
27544721|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
27544722|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
27544723|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
27544724|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
27544725|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
27544726|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
27544727|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
27544728|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
27544729|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
27544730|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
27544731|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
27544732|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
27544733|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Missing|0|||
27544734|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Missing|0|||
27638113|NCT02544152|80516008|FG000|Overall Study|Other|1|||
27638114|NCT02544152|80516009|FG001|Overall Study|Other|0|||
27638115|NCT04956575|80516018|FG000|Overall Study|Death|1|||
27638116|NCT04956575|80516019|FG001|Overall Study|Death|0|||
27638117|NCT04956575|80516020|FG002|Overall Study|Death|0|||
27638118|NCT04956575|80516021|FG003|Overall Study|Death|0|||
27544735|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Missing|2|||
27544736|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Missing|0|||
27544737|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Missing|0|||
27544738|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27544739|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27544740|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27544741|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
27544742|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
27544743|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27544744|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27544745|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
27544746|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27544747|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
27544748|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
27544749|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
27544750|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
27544751|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
27544752|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
27544753|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
27544754|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
27638119|NCT04956575|80516022|FG004|Overall Study|Death|0|||
27638120|NCT04956575|80516023|FG005|Overall Study|Death|0|||
27638121|NCT04956575|80516024|FG006|Overall Study|Death|0|||
27638122|NCT04956575|80516025|FG007|Overall Study|Death|1|||
27924288|NCT02577029|81560921|FG007|Overall Study|Adverse Event|0|||
27924289|NCT02577029|81560914|FG000|Overall Study|Withdrawal by Subject|0|||
27924290|NCT02577029|81560915|FG001|Overall Study|Withdrawal by Subject|0|||
27924291|NCT02577029|81560916|FG002|Overall Study|Withdrawal by Subject|0|||
27924292|NCT02577029|81560917|FG003|Overall Study|Withdrawal by Subject|0|||
27924293|NCT02577029|81560918|FG004|Overall Study|Withdrawal by Subject|0|||
27924294|NCT02577029|81560919|FG005|Overall Study|Withdrawal by Subject|1|||
27924295|NCT02577029|81560920|FG006|Overall Study|Withdrawal by Subject|0|||
27924296|NCT02577029|81560921|FG007|Overall Study|Withdrawal by Subject|0|||
27924297|NCT02577029|81560914|FG000|Overall Study|Sponsor Termination of the Study|9|||
27924298|NCT02577029|81560915|FG001|Overall Study|Sponsor Termination of the Study|2|||
27924299|NCT02577029|81560916|FG002|Overall Study|Sponsor Termination of the Study|5|||
27924300|NCT02577029|81560917|FG003|Overall Study|Sponsor Termination of the Study|12|||
27924301|NCT02577029|81560918|FG004|Overall Study|Sponsor Termination of the Study|10|||
27924302|NCT02577029|81560919|FG005|Overall Study|Sponsor Termination of the Study|12|||
27924303|NCT02577029|81560920|FG006|Overall Study|Sponsor Termination of the Study|12|||
27924304|NCT02577029|81560921|FG007|Overall Study|Sponsor Termination of the Study|12|||
27924305|NCT02349412|81560927|FG000|Overall Study|Withdrawal by Subject|7|||
27924306|NCT02349412|81560928|FG001|Overall Study|Withdrawal by Subject|7|||
27924307|NCT03098979|81560929|FG000|Overall Study|Adverse Event|1|||
27924308|NCT03098979|81560930|FG001|Overall Study|Adverse Event|0|||
27924309|NCT03098979|81560931|FG002|Overall Study|Adverse Event|1|||
27638123|NCT04956575|80516026|FG008|Overall Study|Death|0|||
27638124|NCT04956575|80516027|FG009|Overall Study|Death|1|||
27638125|NCT04956575|80516028|FG010|Overall Study|Death|0|||
27638126|NCT04956575|80516029|FG011|Overall Study|Death|0|||
27638127|NCT04956575|80516018|FG000|Overall Study|Lost to Follow-up|3|||
27638128|NCT04956575|80516019|FG001|Overall Study|Lost to Follow-up|4|||
27638129|NCT04956575|80516020|FG002|Overall Study|Lost to Follow-up|2|||
27638130|NCT04956575|80516021|FG003|Overall Study|Lost to Follow-up|3|||
27638131|NCT04956575|80516022|FG004|Overall Study|Lost to Follow-up|1|||
27638132|NCT04956575|80516023|FG005|Overall Study|Lost to Follow-up|10|||
27924310|NCT03098979|81560932|FG003|Overall Study|Adverse Event|4|||
27924311|NCT03098979|81560933|FG004|Overall Study|Adverse Event|6|||
27924312|NCT03098979|81560934|FG005|Overall Study|Adverse Event|1|||
27924313|NCT03098979|81560929|FG000|Overall Study|Withdrawal by Subject|2|||
27638133|NCT04956575|80516024|FG006|Overall Study|Lost to Follow-up|11|||
27638134|NCT04956575|80516025|FG007|Overall Study|Lost to Follow-up|7|||
27638135|NCT04956575|80516026|FG008|Overall Study|Lost to Follow-up|4|||
27924314|NCT03098979|81560930|FG001|Overall Study|Withdrawal by Subject|1|||
27924315|NCT03098979|81560931|FG002|Overall Study|Withdrawal by Subject|1|||
27638136|NCT04956575|80516027|FG009|Overall Study|Lost to Follow-up|2|||
27924316|NCT03098979|81560932|FG003|Overall Study|Withdrawal by Subject|1|||
27924317|NCT03098979|81560933|FG004|Overall Study|Withdrawal by Subject|2|||
27924318|NCT03098979|81560934|FG005|Overall Study|Withdrawal by Subject|1|||
27924319|NCT03098979|81560929|FG000|Overall Study|Death|1|||
27544755|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
27638137|NCT04956575|80516028|FG010|Overall Study|Lost to Follow-up|3|||
27638138|NCT04956575|80516029|FG011|Overall Study|Lost to Follow-up|8|||
27638139|NCT04956575|80516018|FG000|Overall Study|Withdrawal by Subject|1|||
27638140|NCT04956575|80516019|FG001|Overall Study|Withdrawal by Subject|2|||
27638141|NCT04956575|80516020|FG002|Overall Study|Withdrawal by Subject|1|||
27638142|NCT04956575|80516021|FG003|Overall Study|Withdrawal by Subject|4|||
27638143|NCT04956575|80516022|FG004|Overall Study|Withdrawal by Subject|2|||
27638144|NCT04956575|80516023|FG005|Overall Study|Withdrawal by Subject|8|||
27638145|NCT04956575|80516024|FG006|Overall Study|Withdrawal by Subject|5|||
27638146|NCT04956575|80516025|FG007|Overall Study|Withdrawal by Subject|1|||
27638147|NCT04956575|80516026|FG008|Overall Study|Withdrawal by Subject|1|||
27638148|NCT04956575|80516027|FG009|Overall Study|Withdrawal by Subject|0|||
27638149|NCT04956575|80516028|FG010|Overall Study|Withdrawal by Subject|3|||
27638150|NCT04956575|80516029|FG011|Overall Study|Withdrawal by Subject|1|||
27638151|NCT02531113|80516030|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
27638152|NCT02531113|80516030|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
27638153|NCT02531113|80516030|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
27638154|NCT02531113|80516030|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
27638155|NCT02531113|80516030|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
27638156|NCT02531113|80516030|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
27638157|NCT02531113|80516030|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
27638158|NCT02531113|80516030|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
27638159|NCT01109524|80516033|FG000|Overall Study|Disease Progression|29|||
27638160|NCT01109524|80516033|FG000|Overall Study|Study Drug toxicity|6|||
27638161|NCT01109524|80516033|FG000|Overall Study|Adverse Event|4|||
27638162|NCT01109524|80516033|FG000|Overall Study|Withdrawal by Subject|2|||
27638163|NCT01109524|80516033|FG000|Overall Study|Maximum clinical benefit|3|||
27638164|NCT01109524|80516033|FG000|Overall Study|Death|2|||
27638165|NCT01109524|80516033|FG000|Overall Study|No longer meets criteria|2|||
27638166|NCT01109524|80516033|FG000|Overall Study|Participant requested to end treatment|4|||
27638167|NCT01109524|80516033|FG000|Overall Study|Other|5|||
27638168|NCT01248936|80516038|FG000|Overall Study|Sponsor Decision|259|||
27638169|NCT01248936|80516038|FG000|Overall Study|Progression of Disease|50|||
27638170|NCT01248936|80516038|FG000|Overall Study|Death|26|||
27638171|NCT01248936|80516038|FG000|Overall Study|Withdrawal of Consent|20|||
27638172|NCT01248936|80516038|FG000|Overall Study|Adverse Event|8|||
27638173|NCT01248936|80516038|FG000|Overall Study|Lost to Follow-up|7|||
27638174|NCT01248936|80516038|FG000|Overall Study|Refused Treatment|1|||
27638175|NCT01248936|80516038|FG000|Overall Study|Other reason|3|||
27638176|NCT03403413|80516042|FG000|Overall Study|Lack of Efficacy|2|||
27638177|NCT00002842|80516044|FG000|Overall Study|ineligible for surgical resection|27|||
27638178|NCT01765543|80516048|FG000|Overall Study|Death|1|||
27638179|NCT01765543|80516048|FG000|Overall Study|Withdrawal by Subject|2|||
27638180|NCT03684044|80516053|FG000|Overall Study|Adverse Event|3|||
27638181|NCT03684044|80516054|FG001|Overall Study|Adverse Event|0|||
27638182|NCT03684044|80516053|FG000|Overall Study|Death|4|||
27638183|NCT03684044|80516054|FG001|Overall Study|Death|7|||
27638184|NCT03684044|80516053|FG000|Overall Study|Lost to Follow-up|3|||
27638185|NCT03684044|80516054|FG001|Overall Study|Lost to Follow-up|2|||
27638186|NCT03684044|80516053|FG000|Overall Study|Patient Not Available|0|||
27638187|NCT03684044|80516054|FG001|Overall Study|Patient Not Available|2|||
27638188|NCT03684044|80516053|FG000|Overall Study|Physician Decision|1|||
27638189|NCT03684044|80516054|FG001|Overall Study|Physician Decision|0|||
27638190|NCT03684044|80516053|FG000|Overall Study|Withdrawal by Subject|11|||
27638191|NCT03684044|80516054|FG001|Overall Study|Withdrawal by Subject|9|||
27638192|NCT00111813|80518707|FG000|Overall Study|Adverse Event|1|||
27638193|NCT00111813|80518708|FG001|Overall Study|Adverse Event|2|||
27638194|NCT00111813|80518709|FG002|Overall Study|Adverse Event|4|||
27638195|NCT00111813|80518710|FG003|Overall Study|Adverse Event|2|||
27638196|NCT00111813|80518711|FG004|Overall Study|Adverse Event|2|||
27638197|NCT00111813|80518712|FG005|Overall Study|Adverse Event|2|||
27638198|NCT00111813|80518707|FG000|Overall Study|Progressive disease|2|||
27638199|NCT00111813|80518708|FG001|Overall Study|Progressive disease|1|||
27638200|NCT00111813|80518709|FG002|Overall Study|Progressive disease|5|||
27638201|NCT00111813|80518710|FG003|Overall Study|Progressive disease|3|||
27638202|NCT00111813|80518711|FG004|Overall Study|Progressive disease|4|||
27638203|NCT00111813|80518712|FG005|Overall Study|Progressive disease|3|||
27638204|NCT00111813|80518707|FG000|Overall Study|Lack of Efficacy|0|||
27638205|NCT00111813|80518708|FG001|Overall Study|Lack of Efficacy|0|||
27638206|NCT00111813|80518709|FG002|Overall Study|Lack of Efficacy|0|||
27638207|NCT00111813|80518710|FG003|Overall Study|Lack of Efficacy|0|||
27638208|NCT00111813|80518711|FG004|Overall Study|Lack of Efficacy|0|||
27638209|NCT00111813|80518712|FG005|Overall Study|Lack of Efficacy|1|||
27638210|NCT00111813|80518707|FG000|Overall Study|Other|0|||
27638211|NCT00111813|80518708|FG001|Overall Study|Other|0|||
27638212|NCT00111813|80518709|FG002|Overall Study|Other|1|||
27638213|NCT00111813|80518710|FG003|Overall Study|Other|0|||
27638214|NCT00111813|80518711|FG004|Overall Study|Other|0|||
27638215|NCT00111813|80518712|FG005|Overall Study|Other|0|||
27741457|NCT00663858|80880952|FG001|Overall Study|Adverse Event|1|||
27638216|NCT00802464|80518714|FG000|Month 0 - Month 8|Adverse Event|0|||
27638217|NCT00802464|80518715|FG001|Month 0 - Month 8|Adverse Event|1|||
27638218|NCT00802464|80518716|FG002|Month 0 - Month 8|Adverse Event|1|||
27638219|NCT00802464|80518717|FG003|Month 0 - Month 8|Adverse Event|2|||
27544756|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
27544757|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
27638220|NCT00802464|80518714|FG000|Month 0 - Month 8|Protocol Violation|0|||
27638221|NCT00802464|80518715|FG001|Month 0 - Month 8|Protocol Violation|0|||
27638222|NCT00802464|80518716|FG002|Month 0 - Month 8|Protocol Violation|1|||
27638223|NCT00802464|80518717|FG003|Month 0 - Month 8|Protocol Violation|0|||
27638224|NCT00802464|80518714|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
27638225|NCT00802464|80518715|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
27638226|NCT00802464|80518716|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
27638227|NCT00802464|80518717|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
27638228|NCT00802464|80518714|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
27638229|NCT00802464|80518715|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
27638230|NCT00802464|80518716|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
27638231|NCT00802464|80518717|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
27638232|NCT00802464|80518714|FG000|Month 0 - Month 8|Other|0|||
27638233|NCT00802464|80518715|FG001|Month 0 - Month 8|Other|0|||
27638234|NCT00802464|80518716|FG002|Month 0 - Month 8|Other|1|||
27638235|NCT00802464|80518717|FG003|Month 0 - Month 8|Other|0|||
27638236|NCT00802464|80518714|FG000|Month 8 - Month 14|Adverse Event|0|||
27638237|NCT00802464|80518715|FG001|Month 8 - Month 14|Adverse Event|1|||
27544758|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27544759|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27544760|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27544761|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
27544762|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
27544763|NCT00730405|80185805|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
27544764|NCT00730405|80185806|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27544765|NCT00730405|80185807|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27544766|NCT00730405|80185808|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27544767|NCT00730405|80185809|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
27544768|NCT01496612|80185812|FG000|1st Intervention|Adverse Event|1|||
27544769|NCT01496612|80185813|FG001|1st Intervention|Adverse Event|0|||
27544770|NCT01496612|80185812|FG000|1st Intervention|Withdrawal by Subject|1|||
27544771|NCT01496612|80185813|FG001|1st Intervention|Withdrawal by Subject|0|||
27544772|NCT01370356|80185814|FG000|Overall Study|Death|1|||
27544773|NCT01370356|80185815|FG001|Overall Study|Death|0|||
27544774|NCT01370356|80185814|FG000|Overall Study|Lack of Efficacy|6|||
27544775|NCT01370356|80185815|FG001|Overall Study|Lack of Efficacy|28|||
27544776|NCT01370356|80185814|FG000|Overall Study|Lost to Follow-up|76|||
27544777|NCT01370356|80185815|FG001|Overall Study|Lost to Follow-up|81|||
27544778|NCT01370356|80185814|FG000|Overall Study|Withdrawal by Subject|54|||
27544779|NCT01370356|80185815|FG001|Overall Study|Withdrawal by Subject|59|||
27544780|NCT01370356|80185814|FG000|Overall Study|Reason not specified|39|||
27544781|NCT01370356|80185815|FG001|Overall Study|Reason not specified|43|||
27544782|NCT01370356|80185814|FG000|Overall Study|Protocol Violation|3|||
27544783|NCT01370356|80185815|FG001|Overall Study|Protocol Violation|3|||
27544784|NCT01370356|80185814|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
27544785|NCT01370356|80185815|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
27544786|NCT01370356|80185814|FG000|Overall Study|AE Not Related to Study Drug|1|||
27544787|NCT01370356|80185815|FG001|Overall Study|AE Not Related to Study Drug|4|||
27544788|NCT00395304|80185816|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27741458|NCT00663858|80880953|FG002|Overall Study|Adverse Event|6|||
27924320|NCT03098979|81560930|FG001|Overall Study|Death|0|||
27544789|NCT00395304|80185817|FG001|Treatment Period 1|Withdrawal by Subject|3|||
27544790|NCT00395304|80185818|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27544791|NCT00395304|80185819|FG003|Treatment Period 1|Withdrawal by Subject|2|||
27544792|NCT00395304|80185820|FG004|Treatment Period 1|Withdrawal by Subject|1|||
27544793|NCT00395304|80185821|FG005|Treatment Period 1|Withdrawal by Subject|1|||
27544794|NCT00395304|80185816|FG000|Treatment Period 1|Lost to Follow-up|1|||
27544795|NCT00395304|80185817|FG001|Treatment Period 1|Lost to Follow-up|0|||
27544796|NCT00395304|80185818|FG002|Treatment Period 1|Lost to Follow-up|0|||
27544797|NCT00395304|80185819|FG003|Treatment Period 1|Lost to Follow-up|1|||
27544798|NCT00395304|80185820|FG004|Treatment Period 1|Lost to Follow-up|0|||
27638238|NCT00802464|80518716|FG002|Month 8 - Month 14|Adverse Event|0|||
27638239|NCT00802464|80518717|FG003|Month 8 - Month 14|Adverse Event|0|||
27638240|NCT00802464|80518714|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
27638241|NCT00802464|80518715|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
27638242|NCT00802464|80518716|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
27544799|NCT00395304|80185821|FG005|Treatment Period 1|Lost to Follow-up|1|||
27544800|NCT00395304|80185816|FG000|Treatment Period 1|Physician Decision|0|||
27544801|NCT00395304|80185817|FG001|Treatment Period 1|Physician Decision|1|||
27924321|NCT03098979|81560931|FG002|Overall Study|Death|2|||
27638243|NCT00802464|80518717|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
27638244|NCT00802464|80518714|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
27638245|NCT00802464|80518715|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
27638246|NCT00802464|80518716|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
27638247|NCT00802464|80518717|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
27638248|NCT00686855|80518720|FG000|Overall Study|Lost to Follow-up|1|||
27638249|NCT00686855|80518721|FG001|Overall Study|Lost to Follow-up|0|||
27638250|NCT00686855|80518720|FG000|Overall Study|Progressive GVHD|0|||
27638251|NCT00686855|80518721|FG001|Overall Study|Progressive GVHD|1|||
27638252|NCT00609336|80518722|FG000|Overall Study|Protocol Violation|3|||
27638253|NCT00609336|80518722|FG000|Overall Study|Death|1|||
27638254|NCT00609336|80518722|FG000|Overall Study|LA or Met at Surgery|9|||
27638255|NCT02556138|80518723|FG000|Overall Study|Withdrawal by Subject|1|||
27638256|NCT02886286|80518724|FG000|Overall Study|pump motor stall|0|||
27638257|NCT02886286|80518725|FG001|Overall Study|pump motor stall|1|||
27638258|NCT01875848|80518726|FG000|Overall Study|Withdrawal by Subject|2|||
27638259|NCT01875848|80518727|FG001|Overall Study|Withdrawal by Subject|0|||
27638260|NCT03648762|80518728|FG000|Overall Study|Lost to Follow-up|1|||
27638261|NCT03648762|80518729|FG001|Overall Study|Lost to Follow-up|2|||
27638262|NCT03648762|80518730|FG002|Overall Study|Lost to Follow-up|0|||
27638263|NCT03648762|80518728|FG000|Overall Study|Withdrawal by Subject|5|||
27638264|NCT03648762|80518729|FG001|Overall Study|Withdrawal by Subject|2|||
27638265|NCT03648762|80518730|FG002|Overall Study|Withdrawal by Subject|1|||
27638266|NCT04530747|80518731|FG000|Overall Study|Withdrawal by Subject|1|||
27638267|NCT04530747|80518732|FG001|Overall Study|Withdrawal by Subject|0|||
27638268|NCT02271854|80518733|FG000|Overall Study|Withdrawal by Subject|2|||
27638269|NCT02271854|80518733|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
27638270|NCT02271854|80518733|FG000|Overall Study|Lost to Follow-up|1|||
27638271|NCT02539225|80518734|FG000|Part A|Adverse Event|13|||
27638272|NCT02539225|80518735|FG001|Part A|Adverse Event|4|||
27638273|NCT02539225|80518734|FG000|Part A|Withdrawal by Subject|2|||
27544802|NCT00395304|80185818|FG002|Treatment Period 1|Physician Decision|0|||
27544803|NCT00395304|80185819|FG003|Treatment Period 1|Physician Decision|0|||
27544804|NCT00395304|80185820|FG004|Treatment Period 1|Physician Decision|0|||
27544805|NCT00395304|80185821|FG005|Treatment Period 1|Physician Decision|0|||
27544806|NCT00395304|80185816|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27544807|NCT00395304|80185817|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27544808|NCT00395304|80185818|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27544809|NCT00395304|80185819|FG003|Treatment Period 2|Withdrawal by Subject|1|||
27544810|NCT00395304|80185820|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27544811|NCT00395304|80185821|FG005|Treatment Period 2|Withdrawal by Subject|2|||
27544812|NCT00395304|80185816|FG000|Treatment Period 2|Lost to Follow-up|0|||
27544813|NCT00395304|80185817|FG001|Treatment Period 2|Lost to Follow-up|3|||
27544814|NCT00395304|80185818|FG002|Treatment Period 2|Lost to Follow-up|0|||
27544815|NCT00395304|80185819|FG003|Treatment Period 2|Lost to Follow-up|0|||
27544816|NCT00395304|80185820|FG004|Treatment Period 2|Lost to Follow-up|0|||
27544817|NCT00395304|80185821|FG005|Treatment Period 2|Lost to Follow-up|0|||
27544818|NCT00395304|80185816|FG000|Treatment Period 2|Physician Decision|0|||
27544819|NCT00395304|80185817|FG001|Treatment Period 2|Physician Decision|0|||
27544820|NCT00395304|80185818|FG002|Treatment Period 2|Physician Decision|1|||
27544821|NCT00395304|80185819|FG003|Treatment Period 2|Physician Decision|0|||
27544822|NCT00395304|80185820|FG004|Treatment Period 2|Physician Decision|0|||
27544823|NCT00395304|80185821|FG005|Treatment Period 2|Physician Decision|0|||
27544824|NCT00395304|80185816|FG000|Treatment Period 2|Other|0|||
27544825|NCT00395304|80185817|FG001|Treatment Period 2|Other|1|||
27544826|NCT00395304|80185818|FG002|Treatment Period 2|Other|0|||
27544827|NCT00395304|80185819|FG003|Treatment Period 2|Other|0|||
27544828|NCT00395304|80185820|FG004|Treatment Period 2|Other|0|||
27544829|NCT00395304|80185821|FG005|Treatment Period 2|Other|0|||
27544830|NCT00395304|80185816|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27544831|NCT00395304|80185817|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27544832|NCT00395304|80185818|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27544833|NCT00395304|80185819|FG003|Treatment Period 3|Withdrawal by Subject|1|||
27638274|NCT02539225|80518735|FG001|Part A|Withdrawal by Subject|4|||
27544834|NCT00395304|80185820|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27544835|NCT00395304|80185821|FG005|Treatment Period 3|Withdrawal by Subject|1|||
27638275|NCT02539225|80518734|FG000|Part A|Physician Decision|4|||
27638276|NCT02539225|80518735|FG001|Part A|Physician Decision|7|||
27638277|NCT02539225|80518734|FG000|Part A|Did Not Receive study Drug|1|||
27924322|NCT03098979|81560932|FG003|Overall Study|Death|0|||
27544836|NCT00395304|80185816|FG000|Treatment Period 3|Lost to Follow-up|1|||
27544837|NCT00395304|80185817|FG001|Treatment Period 3|Lost to Follow-up|1|||
27544838|NCT00395304|80185818|FG002|Treatment Period 3|Lost to Follow-up|0|||
27544839|NCT00395304|80185819|FG003|Treatment Period 3|Lost to Follow-up|0|||
27638278|NCT02539225|80518735|FG001|Part A|Did Not Receive study Drug|1|||
27638279|NCT02539225|80518734|FG000|Pre Treatment for Part B|Progressive disease|1|||
27638280|NCT02539225|80518735|FG001|Pre Treatment for Part B|Progressive disease|1|||
27638281|NCT02539225|80518734|FG000|Pre Treatment for Part B|Adverse Event|1|||
27638282|NCT02539225|80518735|FG001|Pre Treatment for Part B|Adverse Event|1|||
27638283|NCT02539225|80518734|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
27638284|NCT02539225|80518735|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
27638285|NCT02539225|80518734|FG000|Pre Treatment for Part B|Physician Decision|2|||
27638286|NCT02539225|80518735|FG001|Pre Treatment for Part B|Physician Decision|0|||
27638287|NCT02539225|80518734|FG000|Part B|Adverse Event|4|||
27638288|NCT02539225|80518735|FG001|Part B|Adverse Event|4|||
27638289|NCT02539225|80518734|FG000|Part B|Withdrawal by Subject|0|||
27638290|NCT02539225|80518735|FG001|Part B|Withdrawal by Subject|3|||
27638291|NCT02539225|80518734|FG000|Part B|Physician Decision|0|||
27638292|NCT02539225|80518735|FG001|Part B|Physician Decision|9|||
27638293|NCT05082935|80518736|FG000|Overall Study|Lost to Follow-up|549|||
27638294|NCT05082935|80518737|FG001|Overall Study|Lost to Follow-up|631|||
27638295|NCT05082935|80518736|FG000|Overall Study|Withdrawal by Subject|27|||
27638296|NCT05082935|80518737|FG001|Overall Study|Withdrawal by Subject|58|||
27544840|NCT00395304|80185820|FG004|Treatment Period 3|Lost to Follow-up|0|||
27544841|NCT00395304|80185821|FG005|Treatment Period 3|Lost to Follow-up|0|||
27544842|NCT00395304|80185816|FG000|Treatment Period 3|Physician Decision|0|||
27544843|NCT00395304|80185817|FG001|Treatment Period 3|Physician Decision|1|||
27544844|NCT00395304|80185818|FG002|Treatment Period 3|Physician Decision|0|||
27544845|NCT00395304|80185819|FG003|Treatment Period 3|Physician Decision|0|||
27544846|NCT00395304|80185820|FG004|Treatment Period 3|Physician Decision|0|||
27544847|NCT00395304|80185821|FG005|Treatment Period 3|Physician Decision|0|||
27544848|NCT00395304|80185816|FG000|Treatment Period 3|Other|0|||
27544849|NCT00395304|80185817|FG001|Treatment Period 3|Other|0|||
27544850|NCT00395304|80185818|FG002|Treatment Period 3|Other|0|||
27544851|NCT00395304|80185819|FG003|Treatment Period 3|Other|1|||
27544852|NCT00395304|80185820|FG004|Treatment Period 3|Other|0|||
27544853|NCT00395304|80185821|FG005|Treatment Period 3|Other|0|||
27544854|NCT02854631|80185822|FG000|Overall Study|Adverse Event|1|||
27544855|NCT02854631|80185823|FG001|Overall Study|Adverse Event|2|||
27544856|NCT02854631|80185822|FG000|Overall Study|Withdrew Consent|3|||
27544857|NCT02854631|80185823|FG001|Overall Study|Withdrew Consent|2|||
27544858|NCT02854631|80185822|FG000|Overall Study|Investigator's Discretion|2|||
27544859|NCT02854631|80185823|FG001|Overall Study|Investigator's Discretion|0|||
27544860|NCT02854631|80185822|FG000|Overall Study|Death|12|||
27544861|NCT02854631|80185823|FG001|Overall Study|Death|8|||
27544862|NCT02854631|80185822|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
27544863|NCT02854631|80185823|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
27544864|NCT02854631|80185822|FG000|Overall Study|Protocol Violation|0|||
27544865|NCT02854631|80185823|FG001|Overall Study|Protocol Violation|1|||
27544866|NCT02854631|80185822|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
27544867|NCT02854631|80185823|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
27544868|NCT02854631|80185822|FG000|Overall Study|Lost to Follow-up|4|||
27544869|NCT02854631|80185823|FG001|Overall Study|Lost to Follow-up|2|||
27544870|NCT03408483|80185824|FG000|Overall Study|Physician Decision|3|||
27544871|NCT03408483|80185825|FG001|Overall Study|Physician Decision|3|||
27544872|NCT03408483|80185824|FG000|Overall Study|Lost to Follow-up|3|||
27544873|NCT03408483|80185825|FG001|Overall Study|Lost to Follow-up|0|||
27544874|NCT02591290|80185830|FG000|Overall Study|Withdrawal by Subject|2|||
27544875|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
27544876|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
27544877|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
27544878|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
27544879|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27544880|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27544881|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27544882|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27544883|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27544884|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27638297|NCT01236001|80518738|FG000|Overall Study|Adverse Event|5|||
27638298|NCT01236001|80518739|FG001|Overall Study|Adverse Event|14|||
27638299|NCT01236001|80518738|FG000|Overall Study|Lack of Efficacy|6|||
27741459|NCT00663858|80880951|FG000|Overall Study|Lack of Efficacy|5|||
27741460|NCT00663858|80880952|FG001|Overall Study|Lack of Efficacy|1|||
27544885|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
27544886|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
27544887|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
27544888|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
27638300|NCT01236001|80518739|FG001|Overall Study|Lack of Efficacy|6|||
27638301|NCT01236001|80518738|FG000|Overall Study|Lost to Follow-up|6|||
27638302|NCT01236001|80518739|FG001|Overall Study|Lost to Follow-up|1|||
27638303|NCT01236001|80518738|FG000|Overall Study|Incompliance|1|||
27638304|NCT01236001|80518739|FG001|Overall Study|Incompliance|0|||
27638305|NCT01236001|80518738|FG000|Overall Study|Planned Visit After End of Study|0|||
27638306|NCT01236001|80518739|FG001|Overall Study|Planned Visit After End of Study|1|||
27638307|NCT00761189|80518740|FG000|Overall Study|Adverse Event|42|||
27638308|NCT00761189|80518740|FG000|Overall Study|Lack of Efficacy|45|||
27638309|NCT00761189|80518740|FG000|Overall Study|Lost to Follow-up|36|||
27638310|NCT00761189|80518740|FG000|Overall Study|Withdrawal by Subject|49|||
27638311|NCT00761189|80518740|FG000|Overall Study|Other|13|||
27638312|NCT00925587|80518741|FG000|Overall Study|Protocol Specified Criteria|6|||
27638313|NCT00925587|80518742|FG001|Overall Study|Protocol Specified Criteria|6|||
27638314|NCT00925587|80518741|FG000|Overall Study|Physician Decision|4|||
27638315|NCT00925587|80518742|FG001|Overall Study|Physician Decision|1|||
27638316|NCT00925587|80518741|FG000|Overall Study|Protocol Violation|6|||
27638317|NCT00925587|80518742|FG001|Overall Study|Protocol Violation|4|||
27638318|NCT00925587|80518741|FG000|Overall Study|Withdrawal by Subject|9|||
27638319|NCT00925587|80518742|FG001|Overall Study|Withdrawal by Subject|6|||
27638320|NCT00925587|80518741|FG000|Overall Study|Death|5|||
27638321|NCT00925587|80518742|FG001|Overall Study|Death|5|||
27638322|NCT00925587|80518741|FG000|Overall Study|Adverse Event|6|||
27638323|NCT00925587|80518742|FG001|Overall Study|Adverse Event|2|||
27638324|NCT00925587|80518741|FG000|Overall Study|Lost to Follow-up|0|||
27638325|NCT00925587|80518742|FG001|Overall Study|Lost to Follow-up|1|||
27638326|NCT01062126|80518745|FG000|Overall Study|Death|209|||
27638327|NCT01062126|80518745|FG000|Overall Study|All Withdrawals|324|||
27544889|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
27638328|NCT01084707|80518748|FG000|Overall Study|Withdrawal by Subject|6|||
27638329|NCT03762668|80518749|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
27638330|NCT03762668|80518750|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
27638331|NCT00296036|80518751|FG000|Overall Study|Withdrawal by Subject|1|||
27638332|NCT00296036|80518752|FG001|Overall Study|Withdrawal by Subject|0|||
27638333|NCT00296036|80518753|FG002|Overall Study|Withdrawal by Subject|2|||
27638334|NCT00296036|80518754|FG003|Overall Study|Withdrawal by Subject|1|||
27638335|NCT00296036|80518755|FG004|Overall Study|Withdrawal by Subject|2|||
27638336|NCT00296036|80518756|FG005|Overall Study|Withdrawal by Subject|1|||
27638337|NCT00296036|80518751|FG000|Overall Study|Protocol Violation|0|||
27638338|NCT00296036|80518752|FG001|Overall Study|Protocol Violation|0|||
27638339|NCT00296036|80518753|FG002|Overall Study|Protocol Violation|0|||
27544890|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544891|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544892|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544893|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544894|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544895|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544896|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
27544897|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
27544898|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
27544899|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
27544900|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
27544901|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544902|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544903|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544904|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544905|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544906|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544907|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
27544908|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544909|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544910|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544911|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
27544912|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544913|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544914|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544915|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544916|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27638340|NCT00296036|80518754|FG003|Overall Study|Protocol Violation|0|||
27638341|NCT00296036|80518755|FG004|Overall Study|Protocol Violation|0|||
27638342|NCT00296036|80518756|FG005|Overall Study|Protocol Violation|3|||
27741461|NCT00663858|80880953|FG002|Overall Study|Lack of Efficacy|3|||
27638343|NCT00539734|80518757|FG000|Overall Study|Protocol Violation|1|||
27638344|NCT03036813|80518762|FG000|Overall Study|Adverse Event|6|||
27638345|NCT03036813|80518763|FG001|Overall Study|Adverse Event|11|||
27924323|NCT03098979|81560933|FG004|Overall Study|Death|1|||
27924324|NCT03098979|81560934|FG005|Overall Study|Death|0|||
27544917|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544918|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
27544919|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
27544920|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
27544921|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
27544922|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
27544923|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544924|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544925|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544926|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544927|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544928|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544929|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
27544930|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
27544931|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
27544932|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
27544933|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
27544934|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544935|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544936|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544937|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544938|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544939|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544940|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
27544941|NCT01847274|80185831|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
27544942|NCT01847274|80185832|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
27544943|NCT01847274|80185833|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
27544944|NCT01847274|80185834|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
27544945|NCT01847274|80185835|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27638346|NCT03036813|80518764|FG002|Overall Study|Adverse Event|6|||
27638347|NCT03036813|80518762|FG000|Overall Study|Withdrawal by Subject|12|||
27638348|NCT03036813|80518763|FG001|Overall Study|Withdrawal by Subject|6|||
27638349|NCT03036813|80518764|FG002|Overall Study|Withdrawal by Subject|10|||
27638350|NCT03036813|80518762|FG000|Overall Study|Lost to Follow-up|1|||
27638351|NCT03036813|80518763|FG001|Overall Study|Lost to Follow-up|1|||
27638352|NCT03036813|80518764|FG002|Overall Study|Lost to Follow-up|0|||
27638353|NCT03036813|80518762|FG000|Overall Study|Physician Decision|2|||
27638354|NCT03036813|80518763|FG001|Overall Study|Physician Decision|1|||
27638355|NCT03036813|80518764|FG002|Overall Study|Physician Decision|1|||
27638356|NCT03036813|80518762|FG000|Overall Study|Non-Compliance|1|||
27638357|NCT03036813|80518763|FG001|Overall Study|Non-Compliance|5|||
27638358|NCT03036813|80518764|FG002|Overall Study|Non-Compliance|3|||
27638359|NCT03036813|80518762|FG000|Overall Study|Pregnancy|0|||
27638360|NCT03036813|80518763|FG001|Overall Study|Pregnancy|0|||
27638361|NCT03036813|80518764|FG002|Overall Study|Pregnancy|1|||
27638362|NCT03036813|80518762|FG000|Overall Study|Other|0|||
27638363|NCT03036813|80518763|FG001|Overall Study|Other|3|||
27638364|NCT03036813|80518764|FG002|Overall Study|Other|5|||
27638365|NCT01771731|80518765|FG000|Overall Study|Physician Decision|1|||
27638366|NCT01771731|80518766|FG001|Overall Study|Physician Decision|0|||
27638367|NCT01771731|80518765|FG000|Overall Study|Protocol Violation|0|||
27638368|NCT01771731|80518766|FG001|Overall Study|Protocol Violation|1|||
27638369|NCT01771731|80518765|FG000|Overall Study|Adverse event: Pain Crisis|1|||
27638370|NCT01771731|80518766|FG001|Overall Study|Adverse event: Pain Crisis|1|||
27638371|NCT00589667|80518767|FG000|Overall Study|Adverse Event|2|||
27638372|NCT00589667|80518767|FG000|Overall Study|Withdrawal by Subject|1|||
27741462|NCT00663858|80880951|FG000|Overall Study|Withdrawal by Subject|7|||
27741463|NCT00663858|80880952|FG001|Overall Study|Withdrawal by Subject|3|||
27741464|NCT00663858|80880953|FG002|Overall Study|Withdrawal by Subject|3|||
27544946|NCT01847274|80185836|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27544947|NCT01847274|80185837|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27638373|NCT01747486|80518770|FG000|Stage 1|Physician Decision|3|||
27638374|NCT01747486|80518771|FG001|Stage 1|Physician Decision|0|||
27638375|NCT01747486|80518770|FG000|Stage 1|Withdrawal by Subject|4|||
27638376|NCT01747486|80518771|FG001|Stage 1|Withdrawal by Subject|3|||
27638377|NCT01747486|80518770|FG000|Stage 1|Disease progression|4|||
27638378|NCT01747486|80518771|FG001|Stage 1|Disease progression|9|||
27638379|NCT01747486|80518770|FG000|Stage 1|Death|1|||
27638380|NCT01747486|80518771|FG001|Stage 1|Death|1|||
27638381|NCT01747486|80518770|FG000|Stage 2|Physician Decision|2|||
27638382|NCT01747486|80518771|FG001|Stage 2|Physician Decision|0|||
27638383|NCT01747486|80518770|FG000|Stage 2|Withdrawal by Subject|1|||
27741465|NCT00663858|80880951|FG000|Overall Study|Protocol Violation|5|||
27924325|NCT03098979|81560929|FG000|Overall Study|Physician Decision|2|||
27924326|NCT03098979|81560930|FG001|Overall Study|Physician Decision|1|||
27924327|NCT03098979|81560931|FG002|Overall Study|Physician Decision|0|||
27924328|NCT03098979|81560932|FG003|Overall Study|Physician Decision|0|||
27924329|NCT03098979|81560933|FG004|Overall Study|Physician Decision|0|||
27924330|NCT03098979|81560934|FG005|Overall Study|Physician Decision|0|||
27924331|NCT03098979|81560929|FG000|Overall Study|Non-compliance|0|||
27924332|NCT03098979|81560930|FG001|Overall Study|Non-compliance|0|||
27924333|NCT03098979|81560931|FG002|Overall Study|Non-compliance|0|||
27924334|NCT03098979|81560932|FG003|Overall Study|Non-compliance|0|||
27924335|NCT03098979|81560933|FG004|Overall Study|Non-compliance|0|||
27924336|NCT03098979|81560934|FG005|Overall Study|Non-compliance|1|||
27924337|NCT03098979|81560929|FG000|Overall Study|Protocol Violation|0|||
27544948|NCT01847274|80185838|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27544949|NCT01847274|80185839|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27544950|NCT01847274|80185840|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27544951|NCT01847274|80185841|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
27544952|NCT01847274|80185831|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544953|NCT01847274|80185832|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27924338|NCT03098979|81560930|FG001|Overall Study|Protocol Violation|0|||
27924339|NCT03098979|81560931|FG002|Overall Study|Protocol Violation|0|||
27924340|NCT03098979|81560932|FG003|Overall Study|Protocol Violation|0|||
27924341|NCT03098979|81560933|FG004|Overall Study|Protocol Violation|0|||
27924342|NCT03098979|81560934|FG005|Overall Study|Protocol Violation|1|||
27924343|NCT00606008|81560938|FG000|Overall Study|Adverse Event|1|||
27924344|NCT00606008|81560938|FG000|Overall Study|Withdrawal by Subject|4|||
27924345|NCT03451045|81560939|FG000|Overall Study|Lack of Efficacy|3|||
27924346|NCT03451045|81560940|FG001|Overall Study|Lack of Efficacy|2|||
27924347|NCT03451045|81560941|FG002|Overall Study|Lack of Efficacy|2|||
27924348|NCT03451045|81560939|FG000|Overall Study|Physician Decision|1|||
27924349|NCT03451045|81560940|FG001|Overall Study|Physician Decision|1|||
27924350|NCT03451045|81560941|FG002|Overall Study|Physician Decision|1|||
27924351|NCT03451045|81560939|FG000|Overall Study|Withdrawal by Subject|4|||
27924352|NCT03451045|81560940|FG001|Overall Study|Withdrawal by Subject|0|||
27924353|NCT03451045|81560941|FG002|Overall Study|Withdrawal by Subject|5|||
27924354|NCT03451045|81560939|FG000|Overall Study|Pregnancy|0|||
27544954|NCT01847274|80185833|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544955|NCT01847274|80185834|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544956|NCT01847274|80185835|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544957|NCT01847274|80185836|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
27544958|NCT01847274|80185837|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544959|NCT01847274|80185838|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544960|NCT01847274|80185839|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544961|NCT01847274|80185840|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544962|NCT01847274|80185841|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
27544963|NCT01847274|80185831|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544964|NCT01847274|80185832|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544965|NCT01847274|80185833|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544966|NCT01847274|80185834|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544967|NCT01847274|80185835|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
27544968|NCT01847274|80185836|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544969|NCT01847274|80185837|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544970|NCT01847274|80185838|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544971|NCT01847274|80185839|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544972|NCT01847274|80185840|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544973|NCT01847274|80185841|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
27544974|NCT01847274|80185831|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544975|NCT01847274|80185832|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544976|NCT01847274|80185833|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544977|NCT01847274|80185834|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544978|NCT01847274|80185835|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544979|NCT01847274|80185836|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27638384|NCT01747486|80518771|FG001|Stage 2|Withdrawal by Subject|0|||
27638385|NCT01747486|80518770|FG000|Stage 2|New Cancer Therapy|3|||
27924355|NCT03451045|81560940|FG001|Overall Study|Pregnancy|0|||
27924356|NCT03451045|81560941|FG002|Overall Study|Pregnancy|2|||
27924357|NCT03451045|81560939|FG000|Overall Study|Adverse Event|7|||
27924358|NCT03451045|81560940|FG001|Overall Study|Adverse Event|1|||
27924359|NCT03451045|81560941|FG002|Overall Study|Adverse Event|3|||
27924360|NCT03451045|81560939|FG000|Overall Study|Non-compliance with study|2|||
27924361|NCT03451045|81560940|FG001|Overall Study|Non-compliance with study|0|||
27924362|NCT03451045|81560941|FG002|Overall Study|Non-compliance with study|1|||
27638386|NCT01747486|80518771|FG001|Stage 2|New Cancer Therapy|0|||
27638387|NCT01747486|80518770|FG000|Stage 2|Disease Progression|3|||
27638388|NCT01747486|80518771|FG001|Stage 2|Disease Progression|0|||
27638389|NCT01424670|80518772|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
27924363|NCT03451045|81560939|FG000|Overall Study|any other reason|10|||
27924364|NCT03451045|81560940|FG001|Overall Study|any other reason|2|||
27924365|NCT03451045|81560941|FG002|Overall Study|any other reason|13|||
27924366|NCT04113694|81560942|FG000|Overall Study|Adverse Event|2|||
27924367|NCT04113694|81560942|FG000|Overall Study|Lost to Follow-up|2|||
27924368|NCT04113694|81560942|FG000|Overall Study|Withdrawal by Subject|6|||
27924369|NCT04113694|81560942|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
27924370|NCT00423605|81560956|FG000|Overall Study|Adverse Event|129|||
27924371|NCT00423605|81560956|FG000|Overall Study|Withdrawal by Subject|36|||
27924372|NCT00423605|81560956|FG000|Overall Study|Lost to Follow-up|15|||
27924373|NCT00423605|81560956|FG000|Overall Study|Lack of Efficacy|38|||
27924374|NCT00423605|81560956|FG000|Overall Study|Sponsor Decision|3|||
27924375|NCT00423605|81560956|FG000|Overall Study|Physician Decision|8|||
27924376|NCT00423605|81560956|FG000|Overall Study|Protocol Violation|7|||
27924377|NCT00423605|81560956|FG000|Overall Study|Not one of the pre-specified options|5|||
27924378|NCT00712920|81560957|FG000|Overall Study|Adverse Event|3|||
27924379|NCT00712920|81560958|FG001|Overall Study|Adverse Event|4|||
27924380|NCT00712920|81560959|FG002|Overall Study|Adverse Event|7|||
27924381|NCT00712920|81560957|FG000|Overall Study|Withdrawal by Subject|4|||
27924382|NCT00712920|81560958|FG001|Overall Study|Withdrawal by Subject|2|||
27924383|NCT00712920|81560959|FG002|Overall Study|Withdrawal by Subject|1|||
27924384|NCT00712920|81560957|FG000|Overall Study|Lost to Follow-up|1|||
27924385|NCT00712920|81560958|FG001|Overall Study|Lost to Follow-up|4|||
27924386|NCT00712920|81560959|FG002|Overall Study|Lost to Follow-up|0|||
27924387|NCT00712920|81560957|FG000|Overall Study|Lack of Efficacy|1|||
27924388|NCT00712920|81560958|FG001|Overall Study|Lack of Efficacy|0|||
27924389|NCT00712920|81560959|FG002|Overall Study|Lack of Efficacy|1|||
27924390|NCT00712920|81560957|FG000|Overall Study|Other|5|||
27924391|NCT00712920|81560958|FG001|Overall Study|Other|7|||
27924392|NCT00712920|81560959|FG002|Overall Study|Other|3|||
27924393|NCT00712920|81560957|FG000|Overall Study|Non-compliance|3|||
27924394|NCT00712920|81560958|FG001|Overall Study|Non-compliance|0|||
27924395|NCT00712920|81560959|FG002|Overall Study|Non-compliance|0|||
27924396|NCT00754741|81560960|FG000|Overall Study|Died or disenrolled|57|||
27924397|NCT00754741|81560961|FG001|Overall Study|Died or disenrolled|69|||
27924398|NCT00754741|81560962|FG002|Overall Study|Died or disenrolled|54|||
27924399|NCT02357459|81560963|FG000|Overall Study|Adverse Event|0|||
27924400|NCT02357459|81560964|FG001|Overall Study|Adverse Event|1|||
27924401|NCT02357459|81560965|FG002|Overall Study|Adverse Event|1|||
27924402|NCT02357459|81560963|FG000|Overall Study|Withdrawal by Subject|5|||
27638390|NCT01424670|80518773|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
27638391|NCT01424670|80518772|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
27638392|NCT01424670|80518773|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
27638393|NCT01424670|80518772|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
27638394|NCT01424670|80518773|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
27638395|NCT01424670|80518772|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
27638396|NCT01424670|80518773|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
27638397|NCT01424670|80518772|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
27638398|NCT01424670|80518773|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
27638399|NCT01424670|80518772|FG000|Continuation Period|Adverse Event|13|||
27638400|NCT01424670|80518773|FG001|Continuation Period|Adverse Event|5|||
27638401|NCT01424670|80518772|FG000|Continuation Period|Lost to Follow-up|2|||
27638402|NCT01424670|80518773|FG001|Continuation Period|Lost to Follow-up|0|||
27638403|NCT01424670|80518772|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
27638404|NCT01424670|80518773|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
27638405|NCT01424670|80518772|FG000|Continuation Period|Physician Decision|5|||
27638406|NCT01424670|80518773|FG001|Continuation Period|Physician Decision|4|||
27638407|NCT01424670|80518772|FG000|Continuation Period|Withdrawal by Subject|13|||
27924403|NCT02357459|81560964|FG001|Overall Study|Withdrawal by Subject|3|||
27924404|NCT02357459|81560965|FG002|Overall Study|Withdrawal by Subject|3|||
27924405|NCT02357459|81560963|FG000|Overall Study|Physician Decision|0|||
27638408|NCT01424670|80518773|FG001|Continuation Period|Withdrawal by Subject|4|||
27638409|NCT01641198|80518774|FG000|After 12 Months of Function|Lost to Follow-up|3|||
27638410|NCT01641198|80518775|FG001|After 12 Months of Function|Lost to Follow-up|2|||
27924406|NCT02357459|81560964|FG001|Overall Study|Physician Decision|2|||
27924407|NCT02357459|81560965|FG002|Overall Study|Physician Decision|0|||
27924408|NCT02357459|81560963|FG000|Overall Study|Protocol Violation|1|||
27924409|NCT02357459|81560964|FG001|Overall Study|Protocol Violation|1|||
27924410|NCT02357459|81560965|FG002|Overall Study|Protocol Violation|0|||
27924411|NCT02357459|81560963|FG000|Overall Study|Lost to Follow-up|1|||
27924412|NCT02357459|81560964|FG001|Overall Study|Lost to Follow-up|3|||
27924413|NCT02357459|81560965|FG002|Overall Study|Lost to Follow-up|0|||
27924414|NCT02357459|81560963|FG000|Overall Study|Lack of Efficacy|7|||
27924415|NCT02357459|81560964|FG001|Overall Study|Lack of Efficacy|4|||
27924416|NCT02357459|81560965|FG002|Overall Study|Lack of Efficacy|4|||
27638411|NCT01641198|80518776|FG002|After 12 Months of Function|Lost to Follow-up|2|||
27638412|NCT01641198|80518774|FG000|After 12 Months of Function|Protocol Violation|1|||
27638413|NCT01641198|80518775|FG001|After 12 Months of Function|Protocol Violation|0|||
27638414|NCT01641198|80518776|FG002|After 12 Months of Function|Protocol Violation|0|||
27638415|NCT01641198|80518774|FG000|After 12 Months of Function|Adverse Event|0|||
27638416|NCT01641198|80518775|FG001|After 12 Months of Function|Adverse Event|1|||
27638417|NCT01641198|80518776|FG002|After 12 Months of Function|Adverse Event|0|||
27638418|NCT01641198|80518774|FG000|After 24 Months of Function|Lost to Follow-up|4|||
27638419|NCT01641198|80518775|FG001|After 24 Months of Function|Lost to Follow-up|9|||
27638420|NCT01641198|80518776|FG002|After 24 Months of Function|Lost to Follow-up|6|||
27638421|NCT01641198|80518774|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
27638422|NCT01641198|80518775|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
27638423|NCT01641198|80518776|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
27638424|NCT01641198|80518774|FG000|At 15-20 Years of Function|Death|1|||
27638425|NCT01641198|80518775|FG001|At 15-20 Years of Function|Death|0|||
27638426|NCT01641198|80518776|FG002|At 15-20 Years of Function|Death|1|||
27638427|NCT03482011|80518777|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
27638428|NCT03482011|80518778|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
27638429|NCT03482011|80518779|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
27638430|NCT03482011|80518780|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
27638431|NCT03482011|80518781|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
27638432|NCT03482011|80518782|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
27638433|NCT03482011|80518783|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
27638434|NCT03482011|80518784|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
27638435|NCT03482011|80518777|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
27638436|NCT03482011|80518778|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
27638437|NCT03482011|80518779|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27638438|NCT03482011|80518780|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27638439|NCT03482011|80518781|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27638440|NCT03482011|80518782|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27638441|NCT03482011|80518783|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27638442|NCT03482011|80518784|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
27638443|NCT03482011|80518777|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638444|NCT03482011|80518778|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
27638445|NCT03482011|80518779|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638446|NCT03482011|80518780|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638447|NCT03482011|80518781|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638448|NCT03482011|80518782|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638449|NCT03482011|80518783|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638450|NCT03482011|80518784|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
27638451|NCT03482011|80518777|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
27638452|NCT03482011|80518778|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
27638453|NCT03482011|80518779|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
27638454|NCT03482011|80518780|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
27638455|NCT03482011|80518781|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
27638456|NCT03482011|80518782|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
27638457|NCT03482011|80518783|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
27638458|NCT03482011|80518784|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
27638459|NCT03482011|80518777|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
27638460|NCT03482011|80518778|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
27638461|NCT03482011|80518779|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27638462|NCT03482011|80518780|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27638463|NCT03482011|80518781|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27638464|NCT03482011|80518782|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27638465|NCT03482011|80518783|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27638466|NCT03482011|80518784|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
27638467|NCT03482011|80518777|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
27638468|NCT03482011|80518778|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
27638469|NCT03482011|80518779|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
27638470|NCT03482011|80518780|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
27638471|NCT03482011|80518781|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
27638472|NCT03482011|80518782|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
27638473|NCT03482011|80518783|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
27638474|NCT03482011|80518784|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
27638475|NCT03482011|80518777|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
27638476|NCT03482011|80518778|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
27638477|NCT03482011|80518779|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
27924417|NCT02357459|81560963|FG000|Overall Study|Patient Relocated|2|||
27924418|NCT02357459|81560964|FG001|Overall Study|Patient Relocated|0|||
27924419|NCT02357459|81560965|FG002|Overall Study|Patient Relocated|0|||
27924420|NCT02357459|81560963|FG000|Overall Study|Instruction from PCP|1|||
27924421|NCT02357459|81560964|FG001|Overall Study|Instruction from PCP|0|||
27924422|NCT02357459|81560965|FG002|Overall Study|Instruction from PCP|0|||
27924423|NCT02357459|81560963|FG000|Overall Study|Incarceration|0|||
27924424|NCT02357459|81560964|FG001|Overall Study|Incarceration|0|||
27924425|NCT02357459|81560965|FG002|Overall Study|Incarceration|1|||
27924426|NCT02357459|81560963|FG000|Overall Study|Pre-planned Knee surgery|0|||
27924427|NCT02357459|81560964|FG001|Overall Study|Pre-planned Knee surgery|0|||
27924428|NCT02357459|81560965|FG002|Overall Study|Pre-planned Knee surgery|2|||
27924429|NCT02357459|81560963|FG000|Overall Study|Job Commitments|0|||
27924430|NCT02357459|81560964|FG001|Overall Study|Job Commitments|0|||
27924431|NCT02357459|81560965|FG002|Overall Study|Job Commitments|1|||
27924432|NCT01253161|81560968|FG000|Overall Study|Adverse Event|1|||
27924433|NCT02026141|81560969|FG000|Overall Study|Protocol Violation|0|||
27924434|NCT02026141|81560970|FG001|Overall Study|Protocol Violation|1|||
27924435|NCT00924898|81560971|FG000|Overall Study|Withdrawal by Subject|2|||
27924436|NCT02030600|81560975|FG000|Treatment Period 1|Adverse Event|5|||
27924437|NCT02030600|81560976|FG001|Treatment Period 1|Adverse Event|7|||
27638478|NCT03482011|80518780|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
27638479|NCT03482011|80518781|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
27638480|NCT03482011|80518782|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
27924438|NCT02030600|81560975|FG000|Treatment Period 1|Lack of Efficacy|0|||
27924439|NCT02030600|81560976|FG001|Treatment Period 1|Lack of Efficacy|1|||
27924440|NCT02030600|81560975|FG000|Treatment Period 1|Lost to Follow-up|11|||
27638481|NCT03482011|80518783|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
27638482|NCT03482011|80518784|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
27638483|NCT03482011|80518777|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27638484|NCT03482011|80518778|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27638485|NCT03482011|80518779|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27638486|NCT03482011|80518780|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27638487|NCT03482011|80518781|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
27638488|NCT03482011|80518782|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27638489|NCT03482011|80518783|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
27638490|NCT03482011|80518784|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
27638491|NCT03482011|80518777|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
27638492|NCT03482011|80518778|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
27638493|NCT03482011|80518779|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
27638494|NCT03482011|80518780|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
27924441|NCT02030600|81560976|FG001|Treatment Period 1|Lost to Follow-up|3|||
27924442|NCT02030600|81560975|FG000|Treatment Period 1|Protocol Violation|22|||
27924443|NCT02030600|81560976|FG001|Treatment Period 1|Protocol Violation|17|||
27924444|NCT02030600|81560975|FG000|Treatment Period 1|Withdrawal by Subject|13|||
27924445|NCT02030600|81560976|FG001|Treatment Period 1|Withdrawal by Subject|17|||
27924446|NCT02030600|81560975|FG000|Treatment Period 1|Casebook Unsigned|1|||
27924447|NCT02030600|81560976|FG001|Treatment Period 1|Casebook Unsigned|0|||
27924448|NCT02030600|81560975|FG000|Treatment Period 1|Unclassified|1|||
27924449|NCT02030600|81560976|FG001|Treatment Period 1|Unclassified|0|||
27924450|NCT02030600|81560975|FG000|Treatment Period 2|Adverse Event|4|||
27924451|NCT02030600|81560976|FG001|Treatment Period 2|Adverse Event|4|||
27924452|NCT02030600|81560975|FG000|Treatment Period 2|Lack of Efficacy|2|||
27924453|NCT02030600|81560976|FG001|Treatment Period 2|Lack of Efficacy|1|||
27924454|NCT02030600|81560975|FG000|Treatment Period 2|Lost to Follow-up|4|||
27924455|NCT02030600|81560976|FG001|Treatment Period 2|Lost to Follow-up|2|||
27924456|NCT02030600|81560975|FG000|Treatment Period 2|Protocol Violation|1|||
27924457|NCT02030600|81560976|FG001|Treatment Period 2|Protocol Violation|2|||
27638495|NCT03482011|80518781|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
27638496|NCT03482011|80518782|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
27638497|NCT03482011|80518783|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
27638498|NCT03482011|80518784|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
27638499|NCT03482011|80518777|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27638500|NCT03482011|80518778|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27638501|NCT03482011|80518779|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
27638502|NCT03482011|80518780|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
27638503|NCT03482011|80518781|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
27924458|NCT02030600|81560975|FG000|Treatment Period 2|Withdrawal by Subject|13|||
27924459|NCT02030600|81560976|FG001|Treatment Period 2|Withdrawal by Subject|9|||
27924460|NCT02030600|81560975|FG000|Treatment Period 2|Unclassified|1|||
27924461|NCT02030600|81560976|FG001|Treatment Period 2|Unclassified|0|||
27924462|NCT03312738|81560977|FG000|Overall Study|Progressive disease|58|||
27924463|NCT03312738|81560978|FG001|Overall Study|Progressive disease|67|||
27924464|NCT03312738|81560977|FG000|Overall Study|Patient/guardian decision|13|||
27924465|NCT03312738|81560978|FG001|Overall Study|Patient/guardian decision|5|||
27924466|NCT03312738|81560977|FG000|Overall Study|Adverse Event|5|||
27924467|NCT03312738|81560978|FG001|Overall Study|Adverse Event|3|||
27924468|NCT03312738|81560977|FG000|Overall Study|Protocol deviation|2|||
27924469|NCT03312738|81560978|FG001|Overall Study|Protocol deviation|0|||
27544980|NCT01847274|80185837|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
27544981|NCT01847274|80185838|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544982|NCT01847274|80185839|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544983|NCT01847274|80185840|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544984|NCT01847274|80185841|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
27544985|NCT01847274|80185831|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544986|NCT01847274|80185832|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544987|NCT01847274|80185833|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27638504|NCT03482011|80518782|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
27924470|NCT03312738|81560977|FG000|Overall Study|Technical problems|0|||
27924471|NCT03312738|81560978|FG001|Overall Study|Technical problems|1|||
27544988|NCT01847274|80185834|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544989|NCT01847274|80185835|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544990|NCT01847274|80185836|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544991|NCT01847274|80185837|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
27544992|NCT01847274|80185838|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27638505|NCT03482011|80518783|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
27924472|NCT03312738|81560977|FG000|Overall Study|Physician Decision|2|||
27924473|NCT03312738|81560978|FG001|Overall Study|Physician Decision|3|||
27924474|NCT00750269|81560981|FG000|Overall Study|Protocol Violation|0|||
27924475|NCT00750269|81560982|FG001|Overall Study|Protocol Violation|1|||
27924476|NCT00750269|81560983|FG002|Overall Study|Protocol Violation|1|||
27924477|NCT00750269|81560984|FG003|Overall Study|Protocol Violation|2|||
27924478|NCT00750269|81560985|FG004|Overall Study|Protocol Violation|4|||
27924479|NCT00750269|81560981|FG000|Overall Study|Withdrawal by Subject|0|||
27924480|NCT00750269|81560982|FG001|Overall Study|Withdrawal by Subject|0|||
27924481|NCT00750269|81560983|FG002|Overall Study|Withdrawal by Subject|2|||
27924482|NCT00750269|81560984|FG003|Overall Study|Withdrawal by Subject|2|||
27924483|NCT00750269|81560985|FG004|Overall Study|Withdrawal by Subject|2|||
27924484|NCT00750269|81560981|FG000|Overall Study|Physician Decision|0|||
27924485|NCT00750269|81560982|FG001|Overall Study|Physician Decision|0|||
27924486|NCT00750269|81560983|FG002|Overall Study|Physician Decision|0|||
27924487|NCT00750269|81560984|FG003|Overall Study|Physician Decision|0|||
27924488|NCT00750269|81560985|FG004|Overall Study|Physician Decision|2|||
27924489|NCT00750269|81560981|FG000|Overall Study|Patient too large for positioning|0|||
27924490|NCT00750269|81560982|FG001|Overall Study|Patient too large for positioning|0|||
27924491|NCT00750269|81560983|FG002|Overall Study|Patient too large for positioning|1|||
27924492|NCT00750269|81560984|FG003|Overall Study|Patient too large for positioning|0|||
27924493|NCT00750269|81560985|FG004|Overall Study|Patient too large for positioning|0|||
27924494|NCT00750269|81560981|FG000|Overall Study|Site error|0|||
27924495|NCT00750269|81560982|FG001|Overall Study|Site error|0|||
27924496|NCT00750269|81560983|FG002|Overall Study|Site error|0|||
27924497|NCT00750269|81560984|FG003|Overall Study|Site error|1|||
27924498|NCT00750269|81560985|FG004|Overall Study|Site error|0|||
27924499|NCT00750269|81560981|FG000|Overall Study|SBRT plan could not be drawn|0|||
27924500|NCT00750269|81560982|FG001|Overall Study|SBRT plan could not be drawn|0|||
27924501|NCT00750269|81560983|FG002|Overall Study|SBRT plan could not be drawn|0|||
27924502|NCT00750269|81560984|FG003|Overall Study|SBRT plan could not be drawn|0|||
27924503|NCT00750269|81560985|FG004|Overall Study|SBRT plan could not be drawn|1|||
27924504|NCT00750269|81560981|FG000|Overall Study|Fiducials could not be placed|0|||
27924505|NCT00750269|81560982|FG001|Overall Study|Fiducials could not be placed|0|||
27924506|NCT00750269|81560983|FG002|Overall Study|Fiducials could not be placed|0|||
27924507|NCT00750269|81560984|FG003|Overall Study|Fiducials could not be placed|0|||
27924508|NCT00750269|81560985|FG004|Overall Study|Fiducials could not be placed|1|||
27924509|NCT04748718|81561001|FG000|Overall Study|Lost to Follow-up|50|||
27924510|NCT03329989|81561002|FG000|Overall Study|Withdrawal by Subject|9|||
27924511|NCT03329989|81561002|FG000|Overall Study|Lost to Follow-up|8|||
27924512|NCT03329989|81561002|FG000|Overall Study|Adverse Event|5|||
27924513|NCT03329989|81561002|FG000|Overall Study|Protocol Violation|1|||
27924514|NCT02369653|81561003|FG000|Overall Study|Lost to Follow-up|0|||
27924515|NCT02369653|81561004|FG001|Overall Study|Lost to Follow-up|1|||
27924516|NCT02369653|81561003|FG000|Overall Study|Administrative reason by sponsor|0|||
27924517|NCT02369653|81561004|FG001|Overall Study|Administrative reason by sponsor|1|||
27924518|NCT02369653|81561003|FG000|Overall Study|Death|1|||
27924519|NCT02369653|81561004|FG001|Overall Study|Death|2|||
27544993|NCT01847274|80185839|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544994|NCT01847274|80185840|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27924520|NCT02369653|81561003|FG000|Overall Study|Participant withdrew consent|13|||
27924521|NCT02369653|81561004|FG001|Overall Study|Participant withdrew consent|3|||
27924522|NCT03250273|81561007|FG000|Overall Study|Disease Progression|2|||
27924523|NCT03250273|81561008|FG001|Overall Study|Disease Progression|11|||
27924524|NCT03250273|81561007|FG000|Overall Study|Death|0|||
27638506|NCT03482011|80518784|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
27638507|NCT03482011|80518777|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27638508|NCT03482011|80518778|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27638509|NCT03482011|80518779|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27638510|NCT03482011|80518780|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
27638511|NCT03482011|80518781|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
27638512|NCT03482011|80518782|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
27638513|NCT03482011|80518783|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
27638514|NCT03482011|80518784|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
27638515|NCT03482011|80518777|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
27638516|NCT03482011|80518778|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
27638517|NCT03482011|80518779|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
27638518|NCT03482011|80518780|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
27638519|NCT03482011|80518781|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
27638520|NCT03482011|80518782|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
27544995|NCT01847274|80185841|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
27544996|NCT01847274|80185831|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27544997|NCT01847274|80185832|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27544998|NCT01847274|80185833|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27544999|NCT01847274|80185834|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27545000|NCT01847274|80185835|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27545001|NCT01847274|80185836|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27638521|NCT03482011|80518783|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
27924525|NCT03250273|81561008|FG001|Overall Study|Death|1|||
27638522|NCT03482011|80518784|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
27638523|NCT03482011|80518777|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
27638524|NCT03482011|80518778|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
27638525|NCT03482011|80518779|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
27638526|NCT03482011|80518780|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
27638527|NCT03482011|80518781|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
27638528|NCT03482011|80518782|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
27638529|NCT03482011|80518783|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
27638530|NCT03482011|80518784|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
27638531|NCT03482011|80518777|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638532|NCT03482011|80518778|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638533|NCT03482011|80518779|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638534|NCT03482011|80518780|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638535|NCT03482011|80518781|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638536|NCT03482011|80518782|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638537|NCT03482011|80518783|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
27638538|NCT03482011|80518784|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
27638539|NCT03482011|80518777|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638540|NCT03482011|80518778|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638541|NCT03482011|80518779|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638542|NCT03482011|80518780|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638543|NCT03482011|80518781|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638544|NCT03482011|80518782|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638545|NCT03482011|80518783|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
27638546|NCT03482011|80518784|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
27638547|NCT00785512|80518785|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
27638548|NCT00785512|80518786|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
27638549|NCT00785512|80518785|FG000|Overall Study|Adverse Event|0|||
27638550|NCT00785512|80518786|FG001|Overall Study|Adverse Event|0|||
27638551|NCT00785512|80518785|FG000|Overall Study|Lack of Efficacy|0|||
27638552|NCT00785512|80518786|FG001|Overall Study|Lack of Efficacy|2|||
27638553|NCT00785512|80518785|FG000|Overall Study|Withdrawal by Subject|0|||
27638554|NCT00785512|80518786|FG001|Overall Study|Withdrawal by Subject|1|||
27638555|NCT00785512|80518785|FG000|Overall Study|Lost to Follow-up|3|||
27638556|NCT00785512|80518786|FG001|Overall Study|Lost to Follow-up|0|||
27638557|NCT00785512|80518785|FG000|Overall Study|Precedure Refused|0|||
27638558|NCT00785512|80518786|FG001|Overall Study|Precedure Refused|0|||
27638559|NCT00785512|80518785|FG000|Overall Study|IVRS Programing Error|0|||
27638560|NCT00785512|80518786|FG001|Overall Study|IVRS Programing Error|0|||
27638561|NCT00785512|80518785|FG000|Overall Study|Physician Decision|0|||
27638562|NCT00785512|80518786|FG001|Overall Study|Physician Decision|0|||
27638563|NCT00785512|80518785|FG000|Overall Study|Lack of compliance|0|||
27638564|NCT00785512|80518786|FG001|Overall Study|Lack of compliance|1|||
27545002|NCT01847274|80185837|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
27545003|NCT01847274|80185838|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27638565|NCT02079844|80518787|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
27638566|NCT02079844|80518788|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
27638567|NCT02079844|80518789|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
27924526|NCT01240382|81561009|FG000|Overall Study|Adverse Event|2|||
27924527|NCT01240382|81561010|FG001|Overall Study|Adverse Event|1|||
27924528|NCT01240382|81561009|FG000|Overall Study|Lack of Efficacy|0|||
27545004|NCT01847274|80185839|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27545005|NCT01847274|80185840|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27545006|NCT01847274|80185841|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
27545007|NCT01847274|80185831|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27545008|NCT01847274|80185832|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27545009|NCT01847274|80185833|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27924529|NCT01240382|81561010|FG001|Overall Study|Lack of Efficacy|2|||
27924530|NCT01240382|81561009|FG000|Overall Study|Fear of adverse events|0|||
27924531|NCT01240382|81561010|FG001|Overall Study|Fear of adverse events|1|||
27924532|NCT00424008|81561013|FG000|Overall Study|Adverse Event|8|||
27924533|NCT00424008|81561014|FG001|Overall Study|Adverse Event|6|||
27924534|NCT00424008|81561013|FG000|Overall Study|Lack of Efficacy|40|||
27924535|NCT00424008|81561014|FG001|Overall Study|Lack of Efficacy|34|||
27924536|NCT00424008|81561013|FG000|Overall Study|Lost to Follow-up|1|||
27924537|NCT00424008|81561014|FG001|Overall Study|Lost to Follow-up|2|||
27924538|NCT00424008|81561013|FG000|Overall Study|Withdrawal by Subject|5|||
27924539|NCT00424008|81561014|FG001|Overall Study|Withdrawal by Subject|8|||
27924540|NCT00424008|81561013|FG000|Overall Study|Noncompliance with protocol|13|||
27924541|NCT00424008|81561014|FG001|Overall Study|Noncompliance with protocol|7|||
27924542|NCT00424008|81561013|FG000|Overall Study|Did not meet protocol eligibility|16|||
27924543|NCT00424008|81561014|FG001|Overall Study|Did not meet protocol eligibility|21|||
27924544|NCT00424008|81561013|FG000|Overall Study|Administrative|266|||
27924545|NCT00424008|81561014|FG001|Overall Study|Administrative|257|||
27924546|NCT01697579|81561015|FG000|Base Study-Cycle 1|Adverse Event|1|||
27924547|NCT01697579|81561016|FG001|Base Study-Cycle 1|Adverse Event|0|||
27924548|NCT01697579|81561017|FG002|Base Study-Cycle 1|Adverse Event|0|||
27924549|NCT01697579|81561018|FG003|Base Study-Cycle 1|Adverse Event|0|||
27924550|NCT01697579|81561019|FG004|Base Study-Cycle 1|Adverse Event|0|||
27924551|NCT01697579|81561020|FG005|Base Study-Cycle 1|Adverse Event|0|||
27924552|NCT01697579|81561021|FG006|Base Study-Cycle 1|Adverse Event|0|||
27924553|NCT01697579|81561015|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
27924554|NCT01697579|81561016|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27924555|NCT01697579|81561017|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27924556|NCT01697579|81561018|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27545010|NCT01847274|80185834|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27545011|NCT01847274|80185835|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27545012|NCT01847274|80185836|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27545013|NCT01847274|80185837|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
27545014|NCT01847274|80185838|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
27545015|NCT01847274|80185839|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
27545016|NCT01847274|80185840|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
27545017|NCT01847274|80185841|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
27545018|NCT01847274|80185831|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545019|NCT01847274|80185832|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545020|NCT01847274|80185833|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545021|NCT01847274|80185834|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545022|NCT01847274|80185835|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545023|NCT01847274|80185836|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545024|NCT01847274|80185837|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545025|NCT01847274|80185838|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
27545026|NCT01847274|80185839|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545027|NCT01847274|80185840|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
27545028|NCT01847274|80185841|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
27545029|NCT01847274|80185831|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545030|NCT01847274|80185832|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545031|NCT01847274|80185833|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545032|NCT01847274|80185834|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27924557|NCT01697579|81561019|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27924558|NCT01697579|81561020|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27924559|NCT01697579|81561021|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
27924560|NCT01697579|81561015|FG000|Base Study-Cycle 1|Protocol Violation|0|||
27924561|NCT01697579|81561016|FG001|Base Study-Cycle 1|Protocol Violation|0|||
27924562|NCT01697579|81561017|FG002|Base Study-Cycle 1|Protocol Violation|0|||
27924563|NCT01697579|81561018|FG003|Base Study-Cycle 1|Protocol Violation|0|||
27924564|NCT01697579|81561019|FG004|Base Study-Cycle 1|Protocol Violation|3|||
27924565|NCT01697579|81561020|FG005|Base Study-Cycle 1|Protocol Violation|0|||
27924566|NCT01697579|81561021|FG006|Base Study-Cycle 1|Protocol Violation|0|||
27924567|NCT01697579|81561015|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27924568|NCT01697579|81561016|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
27924569|NCT01697579|81561017|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27924570|NCT01697579|81561018|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27924571|NCT01697579|81561019|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27924572|NCT01697579|81561020|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27924573|NCT01697579|81561021|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
27638568|NCT02079844|80518787|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
27638569|NCT02079844|80518788|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
27638570|NCT02079844|80518789|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
27638571|NCT03482635|80518793|FG000|Overall Study|Lack of Efficacy|0|||
27638572|NCT03482635|80518794|FG001|Overall Study|Lack of Efficacy|0|||
27638573|NCT03482635|80518795|FG002|Overall Study|Lack of Efficacy|1|||
27638574|NCT03482635|80518796|FG003|Overall Study|Lack of Efficacy|3|||
27638575|NCT03482635|80518793|FG000|Overall Study|Adverse Event|2|||
27638576|NCT03482635|80518794|FG001|Overall Study|Adverse Event|2|||
27638577|NCT03482635|80518795|FG002|Overall Study|Adverse Event|0|||
27638578|NCT03482635|80518796|FG003|Overall Study|Adverse Event|3|||
27638579|NCT03482635|80518793|FG000|Overall Study|Withdrawal by Subject|2|||
27924574|NCT01697579|81561015|FG000|Base Study-Cycle 1|Technical Problems|0|||
27924575|NCT01697579|81561016|FG001|Base Study-Cycle 1|Technical Problems|0|||
27924576|NCT01697579|81561017|FG002|Base Study-Cycle 1|Technical Problems|1|||
27924577|NCT01697579|81561018|FG003|Base Study-Cycle 1|Technical Problems|1|||
27545033|NCT01847274|80185835|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545034|NCT01847274|80185836|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545035|NCT01847274|80185837|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545036|NCT01847274|80185838|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
27545037|NCT01847274|80185839|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
27545038|NCT01847274|80185840|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
27545039|NCT01847274|80185841|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
27638580|NCT03482635|80518794|FG001|Overall Study|Withdrawal by Subject|1|||
27741466|NCT00663858|80880952|FG001|Overall Study|Protocol Violation|3|||
27924578|NCT01697579|81561019|FG004|Base Study-Cycle 1|Technical Problems|0|||
27924579|NCT01697579|81561020|FG005|Base Study-Cycle 1|Technical Problems|0|||
27924580|NCT01697579|81561021|FG006|Base Study-Cycle 1|Technical Problems|0|||
27924581|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Death|0|||
27924582|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Death|0|||
27924583|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Death|0|||
27924584|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Death|0|||
27924585|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Death|0|||
27924586|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Death|0|||
27924587|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Death|2|||
27924588|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27924589|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27924590|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27924591|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27924592|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27924593|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
27924594|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
27924595|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
27924596|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
27924597|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
27924598|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
27924599|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
27924600|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
27924601|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
27924602|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27924603|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27545040|NCT01847274|80185831|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27638581|NCT03482635|80518795|FG002|Overall Study|Withdrawal by Subject|0|||
27638582|NCT03482635|80518796|FG003|Overall Study|Withdrawal by Subject|1|||
27638583|NCT03482635|80518793|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
27638584|NCT03482635|80518794|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
27638585|NCT03482635|80518795|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
27638586|NCT03482635|80518796|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
27638587|NCT03482635|80518793|FG000|Overall Study|Not treated|0|||
27638588|NCT03482635|80518794|FG001|Overall Study|Not treated|0|||
27741467|NCT00663858|80880953|FG002|Overall Study|Protocol Violation|4|||
27741468|NCT00663858|80880951|FG000|Overall Study|Other|8|||
27545041|NCT01847274|80185832|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545042|NCT01847274|80185833|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545043|NCT01847274|80185834|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545044|NCT01847274|80185835|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545045|NCT01847274|80185836|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545046|NCT01847274|80185837|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545047|NCT01847274|80185838|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545048|NCT01847274|80185839|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545049|NCT01847274|80185840|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
27545050|NCT01847274|80185841|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
27545051|NCT04545060|80185842|FG000|Overall Study|Adverse Event|0|||
27545052|NCT04545060|80185843|FG001|Overall Study|Adverse Event|1|||
27545053|NCT04545060|80185842|FG000|Overall Study|Death|0|||
27545054|NCT04545060|80185843|FG001|Overall Study|Death|5|||
27545055|NCT04545060|80185842|FG000|Overall Study|Lost to Follow-up|10|||
27545056|NCT04545060|80185843|FG001|Overall Study|Lost to Follow-up|13|||
27545057|NCT04545060|80185842|FG000|Overall Study|Physician Decision|3|||
27545058|NCT04545060|80185843|FG001|Overall Study|Physician Decision|0|||
27545059|NCT04545060|80185842|FG000|Overall Study|Withdrawal by Subject|17|||
27545060|NCT04545060|80185843|FG001|Overall Study|Withdrawal by Subject|22|||
27545061|NCT01427972|80185846|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545062|NCT01427972|80185847|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27741469|NCT00663858|80880952|FG001|Overall Study|Other|2|||
27924604|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27924605|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27924606|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27924607|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
27924608|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
27924609|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27924610|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27924611|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27924612|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27924613|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
27924614|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
27924615|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
27924616|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27924617|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27924618|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27924619|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27924620|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27924621|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
27924622|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
27924623|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27924624|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27924625|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27924626|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27924627|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
27924628|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
27924629|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
27924630|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27924631|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27924632|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27924633|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27924634|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
27924635|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
27924636|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
27924637|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27924638|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27924639|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27924640|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27924641|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27924642|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
27741470|NCT00663858|80880953|FG002|Overall Study|Other|4|||
27545063|NCT01427972|80185848|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545064|NCT01427972|80185849|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545065|NCT01427972|80185850|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545066|NCT01427972|80185851|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545067|NCT01427972|80185852|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545068|NCT01427972|80185853|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
27545069|NCT01427972|80185854|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545070|NCT01427972|80185855|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545071|NCT01427972|80185856|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545072|NCT01427972|80185857|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
27545073|NCT01427972|80185846|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545074|NCT01427972|80185847|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545075|NCT01427972|80185848|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545076|NCT01427972|80185849|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545077|NCT01427972|80185850|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545078|NCT01427972|80185851|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
27638589|NCT03482635|80518795|FG002|Overall Study|Not treated|0|||
27638590|NCT03482635|80518796|FG003|Overall Study|Not treated|1|||
27638591|NCT00262301|80518797|FG000|Double-blind Phase|Lost to Follow-up|1|||
27638592|NCT00262301|80518798|FG001|Double-blind Phase|Lost to Follow-up|0|||
27638593|NCT00262301|80518799|FG002|Double-blind Phase|Lost to Follow-up|0|||
27638594|NCT00262301|80518797|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
27638595|NCT00262301|80518798|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
27638596|NCT00262301|80518799|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
27638597|NCT00001277|80518800|FG000|Overall Study|Adverse Event|0|||
27638598|NCT00001277|80518801|FG001|Overall Study|Adverse Event|0|||
27638599|NCT00001277|80518802|FG002|Overall Study|Adverse Event|1|||
27638600|NCT00001277|80518800|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
27638601|NCT00001277|80518801|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
27741471|NCT02908477|80880954|FG000|Overall Study|Withdrawal by Subject|8|||
27741472|NCT02908477|80880955|FG001|Overall Study|Withdrawal by Subject|28|||
27741473|NCT00955110|80880959|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
27741474|NCT00955110|80880959|FG000|Treatment Phase|Adverse Event|2|||
27741475|NCT00955110|80880959|FG000|Treatment Phase|Administrative reasons|2|||
27741476|NCT00955110|80880959|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
27924643|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
27924644|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
27924645|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
27924646|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
27924647|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
27924648|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
27924649|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
27924650|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
27924651|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
27924652|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
27924653|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
27924654|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
27924655|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
27924656|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
27924657|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
27924658|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27924659|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27924660|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27924661|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27924662|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
27924663|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
27924664|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
27924665|NCT01697579|81561015|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27924666|NCT01697579|81561016|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27924667|NCT01697579|81561017|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27924668|NCT01697579|81561018|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27924669|NCT01697579|81561019|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27545079|NCT01427972|80185852|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545080|NCT01427972|80185853|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545081|NCT01427972|80185854|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545082|NCT01427972|80185855|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545083|NCT01427972|80185856|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545084|NCT01427972|80185857|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
27545085|NCT01427972|80185846|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27638602|NCT00001277|80518802|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
27638603|NCT00068601|80518803|FG000|Overall Study|Ineligible|11|||
27638604|NCT00068601|80518804|FG001|Overall Study|Ineligible|13|||
27638605|NCT00068601|80518803|FG000|Overall Study|Not evaluable: withdrew consent|5|||
27741477|NCT00955110|80880959|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
27741478|NCT00519623|80880968|FG000|Overall Study|Adverse Event|1|||
27741479|NCT02224846|80880969|FG000|Period 1 (Month 3)|Adverse Event|2|||
27741480|NCT02224846|80880970|FG001|Period 1 (Month 3)|Adverse Event|1|||
27741481|NCT02224846|80880969|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
27741482|NCT02224846|80880970|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
27741483|NCT02224846|80880969|FG000|Period 1 (Month 3)|Protocol Violation|4|||
27741484|NCT02224846|80880970|FG001|Period 1 (Month 3)|Protocol Violation|8|||
27741485|NCT02224846|80880969|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
27545086|NCT01427972|80185847|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
27545087|NCT01427972|80185848|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545088|NCT01427972|80185849|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545089|NCT01427972|80185850|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545090|NCT01427972|80185851|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545091|NCT01427972|80185852|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545092|NCT01427972|80185853|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545093|NCT01427972|80185854|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545094|NCT01427972|80185855|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545095|NCT01427972|80185856|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545096|NCT01427972|80185857|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
27545097|NCT00458211|80185858|FG000|Overall Study|Lack of Efficacy|12|||
27545098|NCT00458211|80185858|FG000|Overall Study|Withdrawal by Subject|2|||
27545099|NCT00458211|80185858|FG000|Overall Study|Protocol Violation|2|||
27545100|NCT03602482|80185859|FG000|Overall Study|Withdrawal by Subject|6|||
27545101|NCT03602482|80185860|FG001|Overall Study|Withdrawal by Subject|7|||
27545102|NCT03602482|80185861|FG002|Overall Study|Withdrawal by Subject|0|||
27545103|NCT03602482|80185862|FG003|Overall Study|Withdrawal by Subject|0|||
27545104|NCT02587234|80185863|FG000|Overall Study|Withdrawal by Subject|1|||
27545105|NCT02587234|80185864|FG001|Overall Study|Withdrawal by Subject|1|||
27545106|NCT02587234|80185863|FG000|Overall Study|Lost to Follow-up|0|||
27545107|NCT02587234|80185864|FG001|Overall Study|Lost to Follow-up|2|||
27545108|NCT00555971|80185865|FG000|Overall Study|Adverse Event|1|||
27545109|NCT00555971|80185866|FG001|Overall Study|Adverse Event|1|||
27545110|NCT01405456|80185867|FG000|Overall Study|Lost to Follow-up|2|||
27545111|NCT01405456|80185868|FG001|Overall Study|Lost to Follow-up|1|||
27545112|NCT01405456|80185867|FG000|Overall Study|Physician Decision|1|||
27545113|NCT01405456|80185868|FG001|Overall Study|Physician Decision|0|||
27545114|NCT01350492|80185869|FG000|Intervention|Lost to Follow-up|2|||
27545115|NCT01350492|80185870|FG001|Intervention|Lost to Follow-up|5|||
27545116|NCT01350492|80185869|FG000|Intervention|Withdrawal by Subject|3|||
27545117|NCT01350492|80185870|FG001|Intervention|Withdrawal by Subject|1|||
27545118|NCT01350492|80185869|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
27545119|NCT01350492|80185870|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
27545120|NCT01350492|80185869|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
27545121|NCT01350492|80185870|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
27545122|NCT03725852|80185871|FG000|Overall Study|Death|1|||
27545123|NCT03725852|80185872|FG001|Overall Study|Death|0|||
27545124|NCT03725852|80185871|FG000|Overall Study|Withdrawal by Subject|1|||
27545125|NCT03725852|80185872|FG001|Overall Study|Withdrawal by Subject|0|||
27545126|NCT03725852|80185871|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
27545127|NCT03725852|80185872|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
27545128|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
27638606|NCT00068601|80518804|FG001|Overall Study|Not evaluable: withdrew consent|4|||
27638607|NCT00068601|80518803|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
27638608|NCT00068601|80518804|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
27638609|NCT00068601|80518803|FG000|Overall Study|Death|11|||
27638610|NCT00068601|80518804|FG001|Overall Study|Death|3|||
27638611|NCT00068601|80518803|FG000|Overall Study|Lost to Follow-up|3|||
27638612|NCT00068601|80518804|FG001|Overall Study|Lost to Follow-up|2|||
27638613|NCT00068601|80518803|FG000|Overall Study|Missing primary outcome data|30|||
27638614|NCT00068601|80518804|FG001|Overall Study|Missing primary outcome data|34|||
27638615|NCT03844269|80518808|FG000|Overall Study|Withdrawal pre-intervention|1|||
27638616|NCT03844269|80518808|FG000|Overall Study|Did not complete the intervention|2|||
27638617|NCT00826280|80518809|FG000|Overall Study|Randomized but drug not received|1|||
27638618|NCT00826280|80518810|FG001|Overall Study|Randomized but drug not received|0|||
27638619|NCT00826280|80518811|FG002|Overall Study|Randomized but drug not received|1|||
27638620|NCT00826280|80518809|FG000|Overall Study|Adverse Event|1|||
27638621|NCT00826280|80518810|FG001|Overall Study|Adverse Event|3|||
27638622|NCT00826280|80518811|FG002|Overall Study|Adverse Event|0|||
27638623|NCT00826280|80518809|FG000|Overall Study|Lost to Follow-up|0|||
27741486|NCT02224846|80880970|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
27741487|NCT02224846|80880969|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
27924670|NCT01697579|81561020|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
27741488|NCT02224846|80880970|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
27638624|NCT00826280|80518810|FG001|Overall Study|Lost to Follow-up|1|||
27638625|NCT00826280|80518811|FG002|Overall Study|Lost to Follow-up|0|||
27638626|NCT00826280|80518809|FG000|Overall Study|Sponsor discontinued subject or study|1|||
27638627|NCT00826280|80518810|FG001|Overall Study|Sponsor discontinued subject or study|0|||
27638628|NCT00826280|80518811|FG002|Overall Study|Sponsor discontinued subject or study|0|||
27638629|NCT00826280|80518809|FG000|Overall Study|Reversible ischemic defect not present|43|||
27638630|NCT00826280|80518810|FG001|Overall Study|Reversible ischemic defect not present|40|||
27638631|NCT00826280|80518811|FG002|Overall Study|Reversible ischemic defect not present|44|||
27638632|NCT00826280|80518809|FG000|Overall Study|Interpretation Failure|1|||
27638633|NCT00826280|80518810|FG001|Overall Study|Interpretation Failure|0|||
27638634|NCT00826280|80518811|FG002|Overall Study|Interpretation Failure|0|||
27638635|NCT00826280|80518809|FG000|Overall Study|Machine Failure|1|||
27638636|NCT00826280|80518810|FG001|Overall Study|Machine Failure|1|||
27638637|NCT00826280|80518811|FG002|Overall Study|Machine Failure|0|||
27638638|NCT00826280|80518809|FG000|Overall Study|One or more non-interpretable scan|0|||
27638639|NCT00826280|80518810|FG001|Overall Study|One or more non-interpretable scan|1|||
27924671|NCT01697579|81561021|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
27924672|NCT02364557|81561024|FG000|Overall Study|Protocol Violation|3|||
27545129|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
27638640|NCT00826280|80518811|FG002|Overall Study|One or more non-interpretable scan|1|||
27638641|NCT02272816|80518812|FG000|Overall Study|Adverse Event|1|||
27638642|NCT03544515|80518816|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
27638643|NCT03544515|80518817|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
27545130|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27545131|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27545132|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27545133|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
27545134|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
27545135|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
27545136|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27545137|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27638644|NCT03544515|80518816|FG000|Overall Study|Lost to Follow-up|2|||
27638645|NCT03544515|80518817|FG001|Overall Study|Lost to Follow-up|0|||
27638646|NCT04252586|80518818|FG000|Overall Study|Withdrawal by parent/guardian|3|||
27638647|NCT04252586|80518818|FG000|Overall Study|Adverse Event|1|||
27638648|NCT04252586|80518818|FG000|Overall Study|Death|2|||
27638649|NCT04252586|80518818|FG000|Overall Study|Study terminated by sponsor|4|||
27924673|NCT02364557|81561025|FG001|Overall Study|Protocol Violation|1|||
27924674|NCT01458587|81561026|FG000|Overall Study|Withdrawal by Subject|1|||
27924675|NCT01458587|81561027|FG001|Overall Study|Withdrawal by Subject|0|||
27924676|NCT00883181|81564711|FG000|Overall Study|Hematological Adverse Event|26|||
27924677|NCT00883181|81564711|FG000|Overall Study|Non-hematological Adverse Event|55|||
27924678|NCT00883181|81564711|FG000|Overall Study|Disease Progression|94|||
27924679|NCT00883181|81564711|FG000|Overall Study|Administrative Reason|24|||
27924680|NCT00883181|81564711|FG000|Overall Study|Withdrawal by Subject|4|||
27924681|NCT00883181|81564711|FG000|Overall Study|Death|31|||
27924682|NCT00883181|81564711|FG000|Overall Study|Other|38|||
27924683|NCT00883181|81564711|FG000|Overall Study|Protocol Deviation|3|||
27924684|NCT00883181|81564711|FG000|Overall Study|Noncompliance|3|||
27924685|NCT03370302|81564715|FG000|Dose Escalation Phase|Other|0|||
27924686|NCT03370302|81564716|FG001|Dose Escalation Phase|Other|1|||
27924687|NCT03370302|81564717|FG002|Dose Escalation Phase|Other|1|||
27924688|NCT03370302|81564718|FG003|Dose Escalation Phase|Other|0|||
27924689|NCT03370302|81564719|FG004|Dose Escalation Phase|Other|0|||
27545138|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27545139|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
27545140|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
27545141|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
27545142|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27545143|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27545144|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27545145|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
27545146|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
27924690|NCT03370302|81564720|FG005|Dose Escalation Phase|Other|0|||
27545147|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
27545148|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27545149|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27638650|NCT04252586|80518818|FG000|Overall Study|Sponsor request|10|||
27924691|NCT03370302|81564715|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27924692|NCT03370302|81564716|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
27924693|NCT03370302|81564717|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
27545150|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27545151|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
27545152|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
27545153|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
27545154|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27545155|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27545156|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27545157|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
27924694|NCT03370302|81564718|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27924695|NCT03370302|81564719|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
27545158|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27545159|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
27545160|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27545161|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27545162|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27545163|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
27545164|NCT00843024|80185874|FG000|Single-blind Placebo Run-In Phase|Other|0|||
27545165|NCT00843024|80185875|FG001|Single-blind Placebo Run-In Phase|Other|1|||
27545166|NCT00843024|80185876|FG002|Single-blind Placebo Run-In Phase|Other|0|||
27545167|NCT00843024|80185877|FG003|Single-blind Placebo Run-In Phase|Other|0|||
27545168|NCT00843024|80185878|FG004|Single-blind Placebo Run-In Phase|Other|0|||
27545169|NCT00843024|80185879|FG005|Single-blind Placebo Run-In Phase|Other|0|||
27545170|NCT00843024|80185874|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
27545171|NCT00843024|80185875|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
27545172|NCT00843024|80185876|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
27545173|NCT00843024|80185877|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
27545174|NCT00843024|80185878|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
27545175|NCT00843024|80185879|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
27545176|NCT00843024|80185874|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
27545177|NCT00843024|80185875|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
27545178|NCT00843024|80185876|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
27545179|NCT00843024|80185877|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
27545180|NCT00843024|80185878|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
27545181|NCT00843024|80185879|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
27545182|NCT00843024|80185874|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27545183|NCT00843024|80185875|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27545184|NCT00843024|80185876|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27545185|NCT00843024|80185877|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
27545186|NCT00843024|80185878|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
27545187|NCT00843024|80185879|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
27545188|NCT00843024|80185874|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
27545189|NCT00843024|80185875|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
27545190|NCT00843024|80185876|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
27545191|NCT00843024|80185877|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
27545192|NCT00843024|80185878|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
27545193|NCT00843024|80185879|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
27545194|NCT00843024|80185874|FG000|Double-blind Treatment Phase|Physician Decision|0|||
27545195|NCT00843024|80185875|FG001|Double-blind Treatment Phase|Physician Decision|0|||
27545196|NCT00843024|80185876|FG002|Double-blind Treatment Phase|Physician Decision|0|||
27545197|NCT00843024|80185877|FG003|Double-blind Treatment Phase|Physician Decision|3|||
27545198|NCT00843024|80185878|FG004|Double-blind Treatment Phase|Physician Decision|1|||
27545199|NCT00843024|80185879|FG005|Double-blind Treatment Phase|Physician Decision|1|||
27545200|NCT00843024|80185874|FG000|Double-blind Treatment Phase|Adverse Event|0|||
27545201|NCT00843024|80185875|FG001|Double-blind Treatment Phase|Adverse Event|0|||
27545202|NCT00843024|80185876|FG002|Double-blind Treatment Phase|Adverse Event|0|||
27545203|NCT00843024|80185877|FG003|Double-blind Treatment Phase|Adverse Event|0|||
27545204|NCT00843024|80185878|FG004|Double-blind Treatment Phase|Adverse Event|1|||
27545205|NCT00843024|80185879|FG005|Double-blind Treatment Phase|Adverse Event|1|||
27545206|NCT00843024|80185874|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
27545207|NCT00843024|80185875|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
27545208|NCT00843024|80185876|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
27545209|NCT00843024|80185877|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
27545210|NCT00843024|80185878|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
27545211|NCT00843024|80185879|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
27638651|NCT04252586|80518818|FG000|Overall Study|Did not complete treatment period|1|||
27545212|NCT03978832|80185884|FG000|Overall Study|Adverse Event|1|||
27545213|NCT03978832|80185884|FG000|Overall Study|Lost to Follow-up|1|||
27638652|NCT00529100|80518828|FG000|Overall Study|Adverse Event|0|||
27924696|NCT03370302|81564720|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
27638653|NCT00529100|80518829|FG001|Overall Study|Adverse Event|5|||
27638654|NCT00529100|80518828|FG000|Overall Study|Protocol Violation|0|||
27638655|NCT00529100|80518829|FG001|Overall Study|Protocol Violation|1|||
27638656|NCT00529100|80518828|FG000|Overall Study|Progressive Disease|0|||
27638657|NCT00529100|80518829|FG001|Overall Study|Progressive Disease|1|||
27638658|NCT00529100|80518828|FG000|Overall Study|Withdrawal by Subject|0|||
27638659|NCT00529100|80518829|FG001|Overall Study|Withdrawal by Subject|1|||
27638660|NCT00529100|80518828|FG000|Overall Study|Participant Ineligibility|0|||
27638661|NCT00529100|80518829|FG001|Overall Study|Participant Ineligibility|1|||
27741489|NCT02224846|80880969|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
27741490|NCT02224846|80880970|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
27741491|NCT02224846|80880969|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
27741492|NCT02224846|80880970|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
27741493|NCT02224846|80880969|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
27741494|NCT02224846|80880970|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
27741495|NCT02224846|80880969|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
27741496|NCT02224846|80880970|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
27741497|NCT02224846|80880969|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
27741498|NCT02224846|80880970|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
27741499|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
27741500|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
27741501|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
27741502|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
27741503|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
27741504|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
27741505|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
27741506|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
27741507|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
27741508|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
27741509|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
27741510|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
27741511|NCT02224846|80880969|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
27741512|NCT02224846|80880970|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
27741513|NCT00545818|80880971|FG000|Overall Study|Protocol Violation|1|||
27741514|NCT00545818|80880972|FG001|Overall Study|Protocol Violation|0|||
27741515|NCT00545818|80880971|FG000|Overall Study|Adverse Event|1|||
27741516|NCT00545818|80880972|FG001|Overall Study|Adverse Event|1|||
27741517|NCT00545818|80880971|FG000|Overall Study|Lost to Follow-up|1|||
27741518|NCT00545818|80880972|FG001|Overall Study|Lost to Follow-up|6|||
27741519|NCT01330381|80880974|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
27741520|NCT01330381|80880975|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
27741521|NCT01330381|80880976|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
27741522|NCT01330381|80880974|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
27741523|NCT01330381|80880975|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
27741524|NCT01330381|80880976|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
27741525|NCT01330381|80880974|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
27741526|NCT01330381|80880975|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
27741527|NCT01330381|80880976|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
27741528|NCT01330381|80880974|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
27741529|NCT01330381|80880975|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
27741530|NCT01330381|80880976|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
27741531|NCT01330381|80880974|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
27741532|NCT01330381|80880975|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
27741533|NCT01330381|80880976|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
27741534|NCT01330381|80880974|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
27741535|NCT01330381|80880975|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
27741536|NCT01330381|80880976|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
27924697|NCT03370302|81564715|FG000|Dose Escalation Phase|Adverse Event|1|||
27924698|NCT03370302|81564716|FG001|Dose Escalation Phase|Adverse Event|0|||
27638662|NCT03565315|80518833|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
27638663|NCT03565315|80518834|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
27638664|NCT03565315|80518835|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
27741537|NCT01330381|80880974|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
27638665|NCT03565315|80518836|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
27741538|NCT01330381|80880975|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
27741539|NCT01330381|80880976|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
27741540|NCT01330381|80880974|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
27741541|NCT01330381|80880975|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
27924699|NCT03370302|81564717|FG002|Dose Escalation Phase|Adverse Event|2|||
27741542|NCT01330381|80880976|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
27741543|NCT01330381|80880974|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
27741544|NCT01330381|80880975|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
27741545|NCT01330381|80880976|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
27741546|NCT01330381|80880974|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
27741547|NCT01330381|80880975|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
27741548|NCT01330381|80880976|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
27741549|NCT02441803|80880977|FG000|Overall Study|Physician Decision|0|||
27741550|NCT02441803|80880978|FG001|Overall Study|Physician Decision|2|||
27741551|NCT02441803|80880979|FG002|Overall Study|Physician Decision|2|||
27741552|NCT01589094|80880980|FG000|Overall Study|Did not receive treatment|2|||
27741553|NCT01713348|80880984|FG000|Overall Study|Withdrawal by Subject|3|||
27741554|NCT01713348|80880985|FG001|Overall Study|Withdrawal by Subject|2|||
27741555|NCT01713348|80880986|FG002|Overall Study|Withdrawal by Subject|2|||
27741556|NCT01713348|80880987|FG003|Overall Study|Withdrawal by Subject|0|||
27741557|NCT01713348|80880984|FG000|Overall Study|Lost to Follow-up|1|||
27741558|NCT01713348|80880985|FG001|Overall Study|Lost to Follow-up|0|||
27741559|NCT01713348|80880986|FG002|Overall Study|Lost to Follow-up|0|||
27741560|NCT01713348|80880987|FG003|Overall Study|Lost to Follow-up|0|||
27741561|NCT03598777|80880989|FG000|Overall Study|Study Terminated by Sponsor|3|||
27741562|NCT03598777|80880990|FG001|Overall Study|Study Terminated by Sponsor|0|||
27741563|NCT03598777|80880991|FG002|Overall Study|Study Terminated by Sponsor|0|||
27741564|NCT03598777|80880992|FG003|Overall Study|Study Terminated by Sponsor|0|||
27741565|NCT03598777|80880993|FG004|Overall Study|Study Terminated by Sponsor|15|||
27741566|NCT03598777|80880989|FG000|Overall Study|Withdrawal by Subject|1|||
27741567|NCT03598777|80880990|FG001|Overall Study|Withdrawal by Subject|1|||
27741568|NCT03598777|80880991|FG002|Overall Study|Withdrawal by Subject|0|||
27741569|NCT03598777|80880992|FG003|Overall Study|Withdrawal by Subject|0|||
27924700|NCT03370302|81564718|FG003|Dose Escalation Phase|Adverse Event|0|||
27741570|NCT03598777|80880993|FG004|Overall Study|Withdrawal by Subject|0|||
27741571|NCT03598777|80880989|FG000|Overall Study|Adverse Event|1|||
27741572|NCT03598777|80880990|FG001|Overall Study|Adverse Event|0|||
27924701|NCT03370302|81564719|FG004|Dose Escalation Phase|Adverse Event|0|||
27924702|NCT03370302|81564720|FG005|Dose Escalation Phase|Adverse Event|0|||
27924703|NCT03370302|81564715|FG000|Dose Escalation Phase|Progressive Disease|2|||
27924704|NCT03370302|81564716|FG001|Dose Escalation Phase|Progressive Disease|4|||
27924705|NCT03370302|81564717|FG002|Dose Escalation Phase|Progressive Disease|2|||
27924706|NCT03370302|81564718|FG003|Dose Escalation Phase|Progressive Disease|0|||
27924707|NCT03370302|81564719|FG004|Dose Escalation Phase|Progressive Disease|3|||
27924708|NCT03370302|81564720|FG005|Dose Escalation Phase|Progressive Disease|1|||
27924709|NCT03370302|81564715|FG000|Dose Expansion Phase|Progressive Disease|0|||
27924710|NCT03370302|81564716|FG001|Dose Expansion Phase|Progressive Disease|0|||
27741573|NCT03598777|80880991|FG002|Overall Study|Adverse Event|0|||
27741574|NCT03598777|80880992|FG003|Overall Study|Adverse Event|0|||
27741575|NCT03598777|80880993|FG004|Overall Study|Adverse Event|0|||
27741576|NCT03598777|80880989|FG000|Overall Study|Lost to Follow-up|1|||
27924711|NCT03370302|81564717|FG002|Dose Expansion Phase|Progressive Disease|0|||
27924712|NCT03370302|81564718|FG003|Dose Expansion Phase|Progressive Disease|6|||
27924713|NCT03370302|81564719|FG004|Dose Expansion Phase|Progressive Disease|0|||
27924714|NCT03370302|81564720|FG005|Dose Expansion Phase|Progressive Disease|0|||
27924715|NCT00706797|81564722|FG000|Overall Study|Lack of Efficacy|3|||
27924716|NCT00706797|81564723|FG001|Overall Study|Lack of Efficacy|0|||
27924717|NCT00706797|81564722|FG000|Overall Study|Adverse Event|0|||
27924718|NCT00706797|81564723|FG001|Overall Study|Adverse Event|3|||
27924719|NCT00706797|81564722|FG000|Overall Study|Withdrawal by Subject|8|||
27741577|NCT03598777|80880990|FG001|Overall Study|Lost to Follow-up|0|||
27741578|NCT03598777|80880991|FG002|Overall Study|Lost to Follow-up|0|||
27741579|NCT03598777|80880992|FG003|Overall Study|Lost to Follow-up|0|||
27741580|NCT03598777|80880993|FG004|Overall Study|Lost to Follow-up|0|||
27741581|NCT05372315|80880995|FG000|Overall Study|Withdrawal by Subject|1|||
27741582|NCT05372315|80880996|FG001|Overall Study|Withdrawal by Subject|0|||
27741583|NCT04024228|80880997|FG000|Overall Study|Adverse Event|1|||
27741584|NCT04024228|80880998|FG001|Overall Study|Adverse Event|0|||
27741585|NCT04024228|80880997|FG000|Overall Study|Protocol Deviation|0|||
27741586|NCT04024228|80880998|FG001|Overall Study|Protocol Deviation|2|||
27924720|NCT00706797|81564723|FG001|Overall Study|Withdrawal by Subject|1|||
27924721|NCT00706797|81564722|FG000|Overall Study|Death|1|||
27924722|NCT00706797|81564723|FG001|Overall Study|Death|0|||
27924723|NCT00706797|81564722|FG000|Overall Study|Discontinuation of study by sponsor|52|||
27924724|NCT00706797|81564723|FG001|Overall Study|Discontinuation of study by sponsor|63|||
27924725|NCT00706797|81564722|FG000|Overall Study|Protocol Violation|3|||
27924726|NCT00706797|81564723|FG001|Overall Study|Protocol Violation|2|||
27741587|NCT04024228|80880997|FG000|Overall Study|Withdrawal by Subject|3|||
27741588|NCT04024228|80880998|FG001|Overall Study|Withdrawal by Subject|4|||
27741589|NCT02903511|80884024|FG000|Overall Study|Withdrawal by Subject|1|||
27741590|NCT02903511|80884025|FG001|Overall Study|Withdrawal by Subject|0|||
27924727|NCT00706797|81564722|FG000|Overall Study|Lost to Follow-up|1|||
27924728|NCT00706797|81564723|FG001|Overall Study|Lost to Follow-up|2|||
27924729|NCT00706797|81564722|FG000|Overall Study|Other|1|||
27924730|NCT00706797|81564723|FG001|Overall Study|Other|0|||
27924731|NCT02101294|81564724|FG000|Overall Study|Withdrawal by Subject|5|||
27924732|NCT02101294|81564724|FG000|Overall Study|Lost to Follow-up|6|||
27924733|NCT03157089|81564727|FG000|Overall Study|Treated only with pembrolizumab|1|||
27638666|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
27638667|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
27924734|NCT03157089|81564728|FG001|Overall Study|Treated only with pembrolizumab|0|||
27924735|NCT03157089|81564727|FG000|Overall Study|Adverse Event|5|||
27924736|NCT03157089|81564728|FG001|Overall Study|Adverse Event|4|||
27924737|NCT03157089|81564727|FG000|Overall Study|Progressive disease|6|||
27924738|NCT03157089|81564728|FG001|Overall Study|Progressive disease|8|||
27924739|NCT01706328|81564730|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
27924740|NCT01706328|81564731|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27924741|NCT01706328|81564732|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
27924742|NCT01706328|81564730|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
27924743|NCT01706328|81564731|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27924744|NCT01706328|81564732|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27924745|NCT01706328|81564730|FG000|2-week Run-in Period|Physician Decision|4|||
27924746|NCT01706328|81564731|FG001|2-week Run-in Period|Physician Decision|0|||
27924747|NCT01706328|81564732|FG002|2-week Run-in Period|Physician Decision|0|||
27924748|NCT01706328|81564730|FG000|2-week Run-in Period|Adverse Event|4|||
27924749|NCT01706328|81564731|FG001|2-week Run-in Period|Adverse Event|0|||
27924750|NCT01706328|81564732|FG002|2-week Run-in Period|Adverse Event|0|||
27924751|NCT01706328|81564730|FG000|2-week Run-in Period|Lost to Follow-up|2|||
27924752|NCT01706328|81564731|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27924753|NCT01706328|81564732|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27924754|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
27924755|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
27924756|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
27924757|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
27924758|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
27924759|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
27924760|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
27924761|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
27924762|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
27924763|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
27924764|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
27924765|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
27924766|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
27924767|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
27924768|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
27924769|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
27924770|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
27924771|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
27924772|NCT01706328|81564730|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27924773|NCT01706328|81564731|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
27924774|NCT01706328|81564732|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
27924775|NCT01348269|81564740|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
27924776|NCT01348269|81564741|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
27924777|NCT01348269|81564740|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
27924778|NCT01348269|81564741|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
27924779|NCT01348269|81564740|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
27924780|NCT01348269|81564741|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
27924781|NCT03473197|81564742|FG000|Overall Study|Adverse Event|4|||
27924782|NCT03473197|81564742|FG000|Overall Study|Lost to Follow-up|1|||
27924783|NCT03473197|81564742|FG000|Overall Study|Withdrawal by Subject|5|||
27924784|NCT01541748|81564743|FG000|Overall Study|Lost to Follow-up|17|||
27924785|NCT01541748|81564743|FG000|Overall Study|Moved out of state|1|||
27924786|NCT01541748|81564743|FG000|Overall Study|Withdrawal by Subject|7|||
27924787|NCT01541748|81564743|FG000|Overall Study|Screen failure|5|||
27924788|NCT01541748|81564743|FG000|Overall Study|Did not receive study device|1|||
27924789|NCT04124965|81564745|FG000|Overall Study|Adverse event, non-fatal|3|||
27924790|NCT04124965|81564746|FG001|Overall Study|Adverse event, non-fatal|1|||
27638668|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
27638669|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
27924791|NCT04124965|81564745|FG000|Overall Study|Withdrawal by Subject|1|||
27924792|NCT04124965|81564746|FG001|Overall Study|Withdrawal by Subject|1|||
27741591|NCT02903511|80884024|FG000|Overall Study|Lost to Follow-up|3|||
27741592|NCT02903511|80884025|FG001|Overall Study|Lost to Follow-up|2|||
27741593|NCT00621023|80884026|FG000|Overall Study|Death|5|||
27741594|NCT00621023|80884026|FG000|Overall Study|Follow up discontinued|1|||
27741595|NCT01853228|80884032|FG000|Phase 1|Lack of Efficacy|8|||
27741596|NCT01853228|80884033|FG001|Phase 1|Lack of Efficacy|0|||
27741597|NCT01853228|80884032|FG000|Phase 1|Other|1|||
27741598|NCT01853228|80884033|FG001|Phase 1|Other|0|||
27741599|NCT01853228|80884032|FG000|Phase 2|Physician Decision|0|||
27741600|NCT01853228|80884033|FG001|Phase 2|Physician Decision|1|||
27741601|NCT01853228|80884032|FG000|Phase 2|Proceed To Transplant|0|||
27741602|NCT01853228|80884033|FG001|Phase 2|Proceed To Transplant|3|||
27741603|NCT01853228|80884032|FG000|Phase 2|Lack of Efficacy|0|||
27741604|NCT01853228|80884033|FG001|Phase 2|Lack of Efficacy|4|||
27741605|NCT02873715|80884034|FG000|Overall Study|Lost to Follow-up|84|||
27741606|NCT02873715|80884035|FG001|Overall Study|Lost to Follow-up|94|||
27741607|NCT02873715|80884034|FG000|Overall Study|Withdrawal by Subject|7|||
27741608|NCT02873715|80884035|FG001|Overall Study|Withdrawal by Subject|26|||
27741609|NCT02021812|80884042|FG000|Overall Study|Death|8|||
27741610|NCT02021812|80884042|FG000|Overall Study|Withdrawal by Subject|3|||
27741611|NCT02021812|80884042|FG000|Overall Study|Lost to Follow-up|2|||
27741612|NCT02021812|80884042|FG000|Overall Study|Refuse to return, COVD 19|2|||
27741613|NCT02492711|80884045|FG000|Overall Study|Adverse Event|9|||
27741614|NCT02492711|80884046|FG001|Overall Study|Adverse Event|9|||
27741615|NCT02492711|80884047|FG002|Overall Study|Adverse Event|2|||
27741616|NCT02492711|80884045|FG000|Overall Study|Death|3|||
27741617|NCT02492711|80884046|FG001|Overall Study|Death|3|||
27741618|NCT02492711|80884047|FG002|Overall Study|Death|0|||
27741619|NCT02492711|80884045|FG000|Overall Study|Withdrawal by Subject|10|||
27741620|NCT02492711|80884046|FG001|Overall Study|Withdrawal by Subject|16|||
27741621|NCT02492711|80884047|FG002|Overall Study|Withdrawal by Subject|5|||
27741622|NCT02492711|80884045|FG000|Overall Study|Physician Decision|10|||
27741623|NCT02492711|80884046|FG001|Overall Study|Physician Decision|6|||
27741624|NCT02492711|80884047|FG002|Overall Study|Physician Decision|4|||
27741625|NCT02492711|80884045|FG000|Overall Study|Lost to Follow-up|0|||
27741626|NCT02492711|80884046|FG001|Overall Study|Lost to Follow-up|0|||
27741627|NCT02492711|80884047|FG002|Overall Study|Lost to Follow-up|1|||
27741628|NCT02492711|80884045|FG000|Overall Study|study treatment delay|2|||
27741629|NCT02492711|80884046|FG001|Overall Study|study treatment delay|1|||
27741630|NCT02492711|80884047|FG002|Overall Study|study treatment delay|0|||
27741631|NCT02492711|80884045|FG000|Overall Study|change in chemotherapy|0|||
27741632|NCT02492711|80884046|FG001|Overall Study|change in chemotherapy|1|||
27741633|NCT02492711|80884047|FG002|Overall Study|change in chemotherapy|0|||
27741634|NCT02492711|80884045|FG000|Overall Study|never treated|2|||
27741635|NCT02492711|80884046|FG001|Overall Study|never treated|4|||
27741636|NCT02492711|80884047|FG002|Overall Study|never treated|0|||
27741637|NCT02492711|80884045|FG000|Overall Study|Other|0|||
27741638|NCT02492711|80884046|FG001|Overall Study|Other|0|||
27741639|NCT02492711|80884047|FG002|Overall Study|Other|1|||
27741640|NCT01041573|80884048|FG000|Overall Study|Withdrawal by Subject|2|||
27741641|NCT01041573|80884049|FG001|Overall Study|Withdrawal by Subject|5|||
27741642|NCT01041573|80884050|FG002|Overall Study|Withdrawal by Subject|2|||
27741643|NCT01041573|80884051|FG003|Overall Study|Withdrawal by Subject|0|||
27741644|NCT01041573|80884048|FG000|Overall Study|Death|1|||
27741645|NCT01041573|80884049|FG001|Overall Study|Death|0|||
27741646|NCT01041573|80884050|FG002|Overall Study|Death|0|||
27741647|NCT01041573|80884051|FG003|Overall Study|Death|0|||
27741648|NCT01041573|80884048|FG000|Overall Study|Lost to Follow-up|0|||
27741649|NCT01041573|80884049|FG001|Overall Study|Lost to Follow-up|1|||
27741650|NCT01041573|80884050|FG002|Overall Study|Lost to Follow-up|2|||
27741651|NCT01041573|80884051|FG003|Overall Study|Lost to Follow-up|1|||
27638670|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
27741652|NCT01041573|80884048|FG000|Overall Study|Adverse Event|0|||
27741653|NCT01041573|80884049|FG001|Overall Study|Adverse Event|2|||
27741654|NCT01041573|80884050|FG002|Overall Study|Adverse Event|0|||
27741655|NCT01041573|80884051|FG003|Overall Study|Adverse Event|0|||
27741656|NCT01041573|80884048|FG000|Overall Study|relocation|1|||
27741657|NCT01041573|80884049|FG001|Overall Study|relocation|4|||
27741658|NCT01041573|80884050|FG002|Overall Study|relocation|3|||
27741659|NCT01041573|80884051|FG003|Overall Study|relocation|1|||
27741660|NCT01041573|80884048|FG000|Overall Study|further blood extraction|0|||
27741661|NCT01041573|80884049|FG001|Overall Study|further blood extraction|1|||
27741662|NCT01041573|80884050|FG002|Overall Study|further blood extraction|0|||
27741663|NCT01041573|80884051|FG003|Overall Study|further blood extraction|0|||
27741664|NCT01041573|80884048|FG000|Overall Study|positive to anti-HCV|1|||
27741665|NCT01041573|80884049|FG001|Overall Study|positive to anti-HCV|0|||
27741666|NCT01041573|80884050|FG002|Overall Study|positive to anti-HCV|0|||
27741667|NCT01041573|80884051|FG003|Overall Study|positive to anti-HCV|0|||
27741668|NCT03280550|80884057|FG000|Overall Study|Withdrawal by Subject|2|||
27741669|NCT03280550|80884058|FG001|Overall Study|Withdrawal by Subject|2|||
27741670|NCT03280550|80884057|FG000|Overall Study|Physician Decision|0|||
27741671|NCT03280550|80884058|FG001|Overall Study|Physician Decision|1|||
27741672|NCT02859415|80884064|FG000|Overall Study|Physician Decision|1|||
27741673|NCT02859415|80884065|FG001|Overall Study|Physician Decision|0|||
27741674|NCT02859415|80884064|FG000|Overall Study|Off treatment due to cardiac event|0|||
27741675|NCT02859415|80884065|FG001|Overall Study|Off treatment due to cardiac event|1|||
27741676|NCT02413255|80884069|FG000|Overall Study|Voluntary Withdrawal|0|||
27741677|NCT02413255|80884070|FG001|Overall Study|Voluntary Withdrawal|0|||
27741678|NCT02413255|80884071|FG002|Overall Study|Voluntary Withdrawal|0|||
27741679|NCT02413255|80884072|FG003|Overall Study|Voluntary Withdrawal|0|||
27741680|NCT02413255|80884073|FG004|Overall Study|Voluntary Withdrawal|0|||
27741681|NCT02413255|80884074|FG005|Overall Study|Voluntary Withdrawal|0|||
27545214|NCT03978832|80185884|FG000|Overall Study|Withdrawal by Subject|6|||
27545215|NCT03978832|80185884|FG000|Overall Study|Physician Decision|2|||
27545216|NCT03978832|80185884|FG000|Overall Study|did not pass screening criteria|44|||
27545217|NCT04786990|80185885|FG000|Overall Study|Withdrawal by Subject|1|||
27545218|NCT04786990|80185885|FG000|Overall Study|Adverse Event|1|||
27545219|NCT04786990|80185885|FG000|Overall Study|Lost to Follow-up|1|||
27545220|NCT04786990|80185885|FG000|Overall Study|Noncompliance|1|||
27545221|NCT04786990|80185885|FG000|Overall Study|Unable to complete site visits|1|||
27545222|NCT04786990|80185885|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
27545223|NCT00481078|80185890|FG000|Overall Study|Progression of disease|11|||
27638671|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
27638672|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
27638673|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
27638674|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
27638675|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
27638676|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
27638677|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
27638678|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
27638679|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
27638680|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
27638681|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
27638682|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
27638683|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
27638684|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
27638685|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
27638686|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
27638687|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
27638688|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
27638689|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
27638690|NCT03338816|80518843|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
27638691|NCT03338816|80518844|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
27638692|NCT03338816|80518845|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
27638693|NCT03338816|80518846|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
27638694|NCT02092116|80518847|FG000|Overall Study|Withdrawal by Subject|0|||
27638695|NCT02092116|80518848|FG001|Overall Study|Withdrawal by Subject|3|||
27638696|NCT02092116|80518847|FG000|Overall Study|Adverse Event|0|||
27638697|NCT02092116|80518848|FG001|Overall Study|Adverse Event|1|||
27638698|NCT01759264|80518849|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
27638699|NCT01759264|80518849|FG000|Overall Study|Adverse Event|1|||
27638700|NCT01759264|80518849|FG000|Overall Study|Other|2|||
27638701|NCT01759264|80518849|FG000|Overall Study|Lost to Follow-up|2|||
27638702|NCT01759264|80518849|FG000|Overall Study|Withdrawal by Subject|3|||
27638703|NCT01759264|80518849|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
27638704|NCT01136876|80518852|FG000|Overall Study|Lost to Follow-up|0|||
27638705|NCT01136876|80518853|FG001|Overall Study|Lost to Follow-up|1|||
27638706|NCT01136876|80518852|FG000|Overall Study|Physician Decision|3|||
27638707|NCT01136876|80518853|FG001|Overall Study|Physician Decision|5|||
27638708|NCT01136876|80518852|FG000|Overall Study|Missing NGAL measurement|2|||
27638709|NCT01136876|80518853|FG001|Overall Study|Missing NGAL measurement|5|||
27638710|NCT00522951|80518854|FG000|Period 1|body motion|0|||
27638711|NCT00522951|80518855|FG001|Period 1|body motion|1|||
27638712|NCT00522951|80518854|FG000|Washout Period|Adverse Event|0|||
27638713|NCT00522951|80518855|FG001|Washout Period|Adverse Event|1|||
27638714|NCT00522951|80518854|FG000|Washout Period|Death|0|||
27638715|NCT00522951|80518855|FG001|Washout Period|Death|1|||
27638716|NCT00522951|80518854|FG000|Period 2|Withdrawal by Subject|1|||
27638717|NCT00522951|80518855|FG001|Period 2|Withdrawal by Subject|0|||
27741682|NCT02413255|80884075|FG006|Overall Study|Voluntary Withdrawal|0|||
27924793|NCT04124965|81564745|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
27545224|NCT00481078|80185891|FG001|Overall Study|Progression of disease|11|||
27545225|NCT00481078|80185890|FG000|Overall Study|Adverse Event|15|||
27924794|NCT04124965|81564746|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
27924795|NCT04124965|81564745|FG000|Overall Study|Pregnancy|1|||
27924796|NCT04124965|81564746|FG001|Overall Study|Pregnancy|0|||
27924797|NCT04124965|81564745|FG000|Overall Study|Sponsor and participant decision|0|||
27924798|NCT04124965|81564746|FG001|Overall Study|Sponsor and participant decision|1|||
27924799|NCT04124965|81564745|FG000|Overall Study|Personal surgery|0|||
27924800|NCT04124965|81564746|FG001|Overall Study|Personal surgery|1|||
27924801|NCT04124965|81564745|FG000|Overall Study|Physician Decision|0|||
27924802|NCT04124965|81564746|FG001|Overall Study|Physician Decision|1|||
27924803|NCT00116142|81564747|FG000|Overall Study|Adverse Event|8|||
27924804|NCT00116142|81564748|FG001|Overall Study|Adverse Event|7|||
27924805|NCT00116142|81564747|FG000|Overall Study|Protocol Violation|2|||
27924806|NCT00116142|81564748|FG001|Overall Study|Protocol Violation|1|||
27924807|NCT00116142|81564747|FG000|Overall Study|Withdrawal by Subject|5|||
27924808|NCT00116142|81564748|FG001|Overall Study|Withdrawal by Subject|5|||
27924809|NCT00116142|81564747|FG000|Overall Study|Physician Decision|3|||
27638718|NCT00522951|80518854|FG000|Period 2|residual contrast medium|1|||
27638719|NCT00522951|80518855|FG001|Period 2|residual contrast medium|1|||
27638720|NCT00535145|80518858|FG000|Phase I|Adverse Event|3|||
27638721|NCT00535145|80518858|FG000|Phase I|Lost to Follow-up|7|||
27638722|NCT00535145|80518858|FG000|Phase I|Withdrawal by Subject|6|||
27924810|NCT00116142|81564748|FG001|Overall Study|Physician Decision|1|||
27924811|NCT00116142|81564747|FG000|Overall Study|Delayed Radiation Therapy|1|||
27924812|NCT00116142|81564748|FG001|Overall Study|Delayed Radiation Therapy|0|||
27924813|NCT00116142|81564747|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
27924814|NCT00116142|81564748|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
27924815|NCT00116142|81564747|FG000|Overall Study|Patient stopped due to depression|0|||
27924816|NCT00116142|81564748|FG001|Overall Study|Patient stopped due to depression|1|||
27545226|NCT00481078|80185891|FG001|Overall Study|Adverse Event|3|||
27545227|NCT00481078|80185890|FG000|Overall Study|Death|5|||
27545228|NCT00481078|80185891|FG001|Overall Study|Death|3|||
27545229|NCT00481078|80185890|FG000|Overall Study|Intercurrent illness|1|||
27545230|NCT00481078|80185891|FG001|Overall Study|Intercurrent illness|0|||
27545231|NCT00481078|80185890|FG000|Overall Study|Withdrawal by Subject|7|||
27545232|NCT00481078|80185891|FG001|Overall Study|Withdrawal by Subject|1|||
27545233|NCT00481078|80185890|FG000|Overall Study|Information not available|1|||
27545234|NCT00481078|80185891|FG001|Overall Study|Information not available|0|||
27545235|NCT00481078|80185890|FG000|Overall Study|Received other treatment|2|||
27545236|NCT00481078|80185891|FG001|Overall Study|Received other treatment|1|||
27924817|NCT00116142|81564747|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
27924818|NCT00116142|81564748|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
27924819|NCT00116142|81564747|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
27545237|NCT00481078|80185890|FG000|Overall Study|Brain metastasis|0|||
27545238|NCT00481078|80185891|FG001|Overall Study|Brain metastasis|1|||
27545239|NCT02192359|80185895|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
27545240|NCT02192359|80185896|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
27545241|NCT02192359|80185897|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
27545242|NCT02192359|80185898|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
27638723|NCT00535145|80518858|FG000|Phase I|(eligibility)|8|||
27638724|NCT00535145|80518858|FG000|Phase I|(protocol violation)|1|||
27638725|NCT00535145|80518858|FG000|Phase I|(PI decision)|1|||
27638726|NCT00535145|80518858|FG000|Phase I|(diagnosis)|3|||
27638727|NCT00535145|80518858|FG000|Phase II|Adverse Event|2|||
27638728|NCT00535145|80518858|FG000|Phase II|Lack of Efficacy|1|||
27638729|NCT00535145|80518858|FG000|Phase II|Lost to Follow-up|5|||
27638730|NCT00535145|80518858|FG000|Phase II|Withdrawal by Subject|5|||
27638731|NCT00535145|80518858|FG000|Phase II|Subject non-compliance|2|||
27638732|NCT03527160|80518859|FG000|Overall Study|No urine collected|13|||
27638733|NCT03527160|80518859|FG000|Overall Study|No clinical serum creatinine collected|6|||
27638734|NCT03527160|80518859|FG000|Overall Study|Did not meet inclusion|2|||
27638735|NCT03473340|80518860|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
27638736|NCT03473340|80518861|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
27741683|NCT02413255|80884076|FG007|Overall Study|Voluntary Withdrawal|0|||
27741684|NCT02413255|80884077|FG008|Overall Study|Voluntary Withdrawal|0|||
27924820|NCT00116142|81564748|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
27545243|NCT02192359|80185895|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
27638737|NCT03473340|80518860|FG000|Overall Study|Withdrawal by Subject|1|||
27638738|NCT03473340|80518861|FG001|Overall Study|Withdrawal by Subject|0|||
27638739|NCT03473340|80518860|FG000|Overall Study|Lost to Follow-up|1|||
27638740|NCT03473340|80518861|FG001|Overall Study|Lost to Follow-up|2|||
27924821|NCT00116142|81564747|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
27638741|NCT01976312|80518862|FG000|Overall Study|Pregnancy|0|||
27638742|NCT01976312|80518863|FG001|Overall Study|Pregnancy|1|||
27924822|NCT00116142|81564748|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
27924823|NCT04919161|81564749|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
27924824|NCT04919161|81564750|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
27924825|NCT04919161|81564749|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
27924826|NCT04919161|81564750|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
27924827|NCT04919161|81564749|FG000|Overall Study|Acute ankle sprain after session 1|0|||
27638743|NCT01976312|80518862|FG000|Overall Study|Lost to Follow-up|2|||
27638744|NCT01976312|80518863|FG001|Overall Study|Lost to Follow-up|0|||
27638745|NCT01976312|80518862|FG000|Overall Study|Withdrawal by Subject|7|||
27638746|NCT01976312|80518863|FG001|Overall Study|Withdrawal by Subject|2|||
27638747|NCT01976312|80518862|FG000|Overall Study|Adverse Event|6|||
27638748|NCT01976312|80518863|FG001|Overall Study|Adverse Event|6|||
27638749|NCT01976312|80518862|FG000|Overall Study|Protocol Violation|2|||
27638750|NCT01976312|80518863|FG001|Overall Study|Protocol Violation|0|||
27638751|NCT00941655|80518865|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
27638752|NCT00941655|80518866|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
27638753|NCT00941655|80518865|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
27638754|NCT00941655|80518866|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
27638755|NCT00941655|80518865|FG000|Overall Study|progressed while on chemo|0|||
27638756|NCT00941655|80518866|FG001|Overall Study|progressed while on chemo|2|||
27638757|NCT00941655|80518865|FG000|Overall Study|refused further treatment|0|||
27638758|NCT00941655|80518866|FG001|Overall Study|refused further treatment|1|||
27638759|NCT00941655|80518865|FG000|Overall Study|withdrew consent|0|||
27638760|NCT00941655|80518866|FG001|Overall Study|withdrew consent|1|||
27638761|NCT00941655|80518865|FG000|Overall Study|non-compliant|0|||
27638762|NCT00941655|80518866|FG001|Overall Study|non-compliant|1|||
27638763|NCT02318134|80518867|FG000|Overall Study|Withdrawal by Subject|2|||
27638764|NCT02318134|80518868|FG001|Overall Study|Withdrawal by Subject|1|||
27638765|NCT01565148|80518872|FG000|Overall Study|Withdrawal by Subject|1|||
27638766|NCT01565148|80518873|FG001|Overall Study|Withdrawal by Subject|1|||
27638767|NCT01565148|80518874|FG002|Overall Study|Withdrawal by Subject|1|||
27638768|NCT01565148|80518875|FG003|Overall Study|Withdrawal by Subject|2|||
27638769|NCT01565148|80518872|FG000|Overall Study|Lost to Follow-up|4|||
27638770|NCT01565148|80518873|FG001|Overall Study|Lost to Follow-up|4|||
27638771|NCT01565148|80518874|FG002|Overall Study|Lost to Follow-up|0|||
27638772|NCT01565148|80518875|FG003|Overall Study|Lost to Follow-up|3|||
27638773|NCT01565148|80518872|FG000|Overall Study|Rescue Therapy|8|||
27638774|NCT01565148|80518873|FG001|Overall Study|Rescue Therapy|5|||
27638775|NCT01565148|80518874|FG002|Overall Study|Rescue Therapy|5|||
27638776|NCT01565148|80518875|FG003|Overall Study|Rescue Therapy|8|||
27638777|NCT01565148|80518872|FG000|Overall Study|Death|0|||
27638778|NCT01565148|80518873|FG001|Overall Study|Death|0|||
27638779|NCT01565148|80518874|FG002|Overall Study|Death|1|||
27638780|NCT01565148|80518875|FG003|Overall Study|Death|0|||
27638781|NCT01565148|80518872|FG000|Overall Study|Physician Decision|2|||
27638782|NCT01565148|80518873|FG001|Overall Study|Physician Decision|5|||
27638783|NCT01565148|80518874|FG002|Overall Study|Physician Decision|0|||
27638784|NCT01565148|80518875|FG003|Overall Study|Physician Decision|0|||
27638785|NCT01493778|80518876|FG000|Overall Study|Withdrawal by Subject|8|||
27638786|NCT01736215|80518878|FG000|Overall Study|Early termination of erythropoietin use|1|||
27638787|NCT01736215|80518878|FG000|Overall Study|Adverse Event|4|||
27638788|NCT01736215|80518878|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
27638789|NCT01736215|80518878|FG000|Overall Study|Insufficient data to perform analysis|8|||
27638790|NCT01499199|80518879|FG000|Overall Study|Adverse Event|1|||
27638791|NCT01499199|80518879|FG000|Overall Study|Lack of Efficacy|1|||
27638792|NCT00925899|80518886|FG000|Part 1|Death|1|||
27638793|NCT00925899|80518887|FG001|Part 1|Death|2|||
27638794|NCT00925899|80518886|FG000|Part 1|Withdrawal by Subject|10|||
27638795|NCT00925899|80518887|FG001|Part 1|Withdrawal by Subject|9|||
27638796|NCT02974634|80518889|FG000|Overall Study|Advanced disease|12|||
27638797|NCT02974634|80518890|FG001|Overall Study|Advanced disease|3|||
27638798|NCT02974634|80518889|FG000|Overall Study|Noncompliance|3|||
27924828|NCT04919161|81564750|FG001|Overall Study|Acute ankle sprain after session 1|1|||
27924829|NCT03407482|81564751|FG000|Overall Study|Adverse Event|12|||
27924830|NCT03407482|81564751|FG000|Overall Study|Disease Relapse|1|||
27638799|NCT02974634|80518890|FG001|Overall Study|Noncompliance|7|||
27638800|NCT02974634|80518889|FG000|Overall Study|intervention technology related issues|5|||
27638801|NCT02974634|80518890|FG001|Overall Study|intervention technology related issues|0|||
27638802|NCT02974634|80518889|FG000|Overall Study|Death|8|||
27638803|NCT02974634|80518890|FG001|Overall Study|Death|11|||
27638804|NCT01551355|80518891|FG000|Overall Study|Lost to Follow-up|51|||
27638805|NCT01551355|80518892|FG001|Overall Study|Lost to Follow-up|49|||
27638806|NCT01551355|80518893|FG002|Overall Study|Lost to Follow-up|34|||
27638807|NCT01551355|80518894|FG003|Overall Study|Lost to Follow-up|24|||
27638808|NCT01551355|80518895|FG004|Overall Study|Lost to Follow-up|9|||
27638809|NCT01551355|80518896|FG005|Overall Study|Lost to Follow-up|6|||
27638810|NCT04788641|80518897|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
27638811|NCT04788641|80518898|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
27638812|NCT04788641|80518899|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
27638813|NCT04788641|80518900|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
27638814|NCT04788641|80518897|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
27638815|NCT04788641|80518898|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
27638816|NCT04788641|80518899|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
27638817|NCT04788641|80518900|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
27638818|NCT04788641|80518897|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
27638819|NCT04788641|80518898|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
27638820|NCT04788641|80518899|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
27638821|NCT04788641|80518900|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
27638822|NCT02242487|80518901|FG000|Overall Study|Adverse Event|13|||
27638823|NCT02242487|80518902|FG001|Overall Study|Adverse Event|15|||
27638824|NCT02242487|80518901|FG000|Overall Study|Lack of Efficacy|4|||
27638825|NCT02242487|80518902|FG001|Overall Study|Lack of Efficacy|6|||
27638826|NCT02242487|80518901|FG000|Overall Study|Protocol Violation|2|||
27638827|NCT02242487|80518902|FG001|Overall Study|Protocol Violation|0|||
27741685|NCT02413255|80884078|FG009|Overall Study|Voluntary Withdrawal|0|||
27741686|NCT02413255|80884079|FG010|Overall Study|Voluntary Withdrawal|0|||
27741687|NCT02413255|80884080|FG011|Overall Study|Voluntary Withdrawal|0|||
27741688|NCT02413255|80884081|FG012|Overall Study|Voluntary Withdrawal|0|||
27741689|NCT02413255|80884082|FG013|Overall Study|Voluntary Withdrawal|0|||
27741690|NCT02413255|80884083|FG014|Overall Study|Voluntary Withdrawal|1|||
27741691|NCT02413255|80884084|FG015|Overall Study|Voluntary Withdrawal|0|||
27741692|NCT02413255|80884085|FG016|Overall Study|Voluntary Withdrawal|0|||
27741693|NCT01200511|80884087|FG000|Overall Study|Lost to Follow-up|3|||
27741694|NCT01200511|80884087|FG000|Overall Study|Withdrawal by Subject|1|||
27741695|NCT01200511|80884087|FG000|Overall Study|Adverse Event|1|||
27741696|NCT00686205|80884088|FG000|Overall Study|Protocol Violation|127|||
27741697|NCT00686205|80884089|FG001|Overall Study|Protocol Violation|0|||
27741698|NCT00686205|80884088|FG000|Overall Study|Withdrawal by Subject|2|||
27741699|NCT00686205|80884089|FG001|Overall Study|Withdrawal by Subject|0|||
27741700|NCT00686205|80884088|FG000|Overall Study|Specimen handling procedure altered|5878|||
27741701|NCT00686205|80884089|FG001|Overall Study|Specimen handling procedure altered|0|||
27741702|NCT00686205|80884088|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
27741703|NCT00686205|80884089|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
27741704|NCT02089737|80884090|FG000|Overall Study|Survey form not completed|5|||
27741705|NCT02089737|80884090|FG000|Overall Study|Not treated|1|||
27741706|NCT00231062|80884091|FG000|Overall Study|Physician Decision|6|||
27741707|NCT00969618|80884096|FG000|Overall Study|Adverse Event|29|||
27741708|NCT00969618|80884096|FG000|Overall Study|Entry Criteria Not Met|3|||
27741709|NCT00969618|80884096|FG000|Overall Study|Lack of Efficacy|2|||
27741710|NCT00969618|80884096|FG000|Overall Study|Lost to Follow-up|7|||
27741711|NCT00969618|80884096|FG000|Overall Study|Physician Decision|1|||
27741712|NCT00969618|80884096|FG000|Overall Study|Protocol Violation|9|||
27741713|NCT00969618|80884096|FG000|Overall Study|Withdrawal by Subject|27|||
27741714|NCT03133481|80884101|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
27741715|NCT03133481|80884102|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
27924831|NCT03407482|81564751|FG000|Overall Study|Lost to Follow-up|1|||
27545244|NCT02192359|80185896|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
27545245|NCT02192359|80185897|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
27545246|NCT02192359|80185898|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
27545247|NCT02192359|80185895|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
27545248|NCT02192359|80185896|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
27545249|NCT02192359|80185897|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
27545250|NCT02192359|80185898|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
27545251|NCT01471171|80185899|FG000|Treatment Period 1|Adverse Event|4|||
27545252|NCT01471171|80185900|FG001|Treatment Period 1|Adverse Event|1|||
27545253|NCT01471171|80185899|FG000|Treatment Period 2|Adverse Event|1|||
27545254|NCT01471171|80185900|FG001|Treatment Period 2|Adverse Event|0|||
27545255|NCT01434667|80185901|FG000|Overall Study|Lost to Follow-up|5|||
27545256|NCT01434667|80185902|FG001|Overall Study|Lost to Follow-up|10|||
27545257|NCT00299104|80185903|FG000|Treatment Period|Adverse Event|14|||
27545258|NCT00299104|80185904|FG001|Treatment Period|Adverse Event|9|||
27545259|NCT00299104|80185905|FG002|Treatment Period|Adverse Event|7|||
27545260|NCT00299104|80185903|FG000|Treatment Period|Death|1|||
27545261|NCT00299104|80185904|FG001|Treatment Period|Death|1|||
27741716|NCT01269125|80884104|FG000|Overall Study|Adverse Event|3|||
27741717|NCT01269125|80884105|FG001|Overall Study|Adverse Event|5|||
27741718|NCT01269125|80884106|FG002|Overall Study|Adverse Event|0|||
27741719|NCT01269125|80884104|FG000|Overall Study|Lost to Follow-up|4|||
27638828|NCT02242487|80518901|FG000|Overall Study|Lost to Follow-up|2|||
27638829|NCT02242487|80518902|FG001|Overall Study|Lost to Follow-up|1|||
27638830|NCT02242487|80518901|FG000|Overall Study|Other - Miscellaneous|4|||
27638831|NCT02242487|80518902|FG001|Overall Study|Other - Miscellaneous|6|||
27638832|NCT02242487|80518901|FG000|Overall Study|Withdrawal by Subject|37|||
27638833|NCT02242487|80518902|FG001|Overall Study|Withdrawal by Subject|19|||
27638834|NCT01264679|80518903|FG000|Overall Study|Participation in Another Clinical Trial|1|||
27638835|NCT01264679|80518903|FG000|Overall Study|Physician Decision|1|||
27638836|NCT01264679|80518903|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
27638837|NCT01264679|80518903|FG000|Overall Study|Withdrawal by Subject|1|||
27638838|NCT03454529|80518907|FG000|Overall Study|Did not receive treatment|6|||
27638839|NCT03454529|80518907|FG000|Overall Study|Received < 80% doses|1|||
27638840|NCT01337635|80518909|FG000|Overall Study|Lost to Follow-up|0|||
27638841|NCT01337635|80518910|FG001|Overall Study|Lost to Follow-up|1|||
27638842|NCT01943916|80518911|FG000|Overall Study|Technically invalid images|10|||
27638843|NCT01943916|80518911|FG000|Overall Study|Enrollment Failure|23|||
27638844|NCT01943916|80518911|FG000|Overall Study|Pilot Phase exclusion|100|||
27638845|NCT01943916|80518911|FG000|Overall Study|Quality Assurance Reader Fail|130|||
27638846|NCT01943916|80518911|FG000|Overall Study|Technical Failure|39|||
27638847|NCT01943916|80518911|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
27638848|NCT01943916|80518911|FG000|Overall Study|No Truth Panel Review|38|||
27638849|NCT01943916|80518911|FG000|Overall Study|Protocol Deviation|1|||
27741720|NCT01269125|80884105|FG001|Overall Study|Lost to Follow-up|0|||
27741721|NCT01269125|80884106|FG002|Overall Study|Lost to Follow-up|0|||
27741722|NCT00667277|80884110|FG000|Overall Study|Withdrawal by Subject|2|||
27741723|NCT02031146|80884111|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
27638850|NCT01044303|80518915|FG000|Overall Study|Lost to Follow-up|2|||
27638851|NCT00411216|80518916|FG000|Overall Study|Ten participants were entered into the c|0|||
27638852|NCT00411216|80518917|FG001|Overall Study|Ten participants were entered into the c|2|||
27638853|NCT03950622|80518919|FG000|Overall Study|Withdrawal by Subject|1|||
27924832|NCT03407482|81564751|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27638854|NCT03950622|80518920|FG001|Overall Study|Withdrawal by Subject|0|||
27638855|NCT03950622|80518919|FG000|Overall Study|Protocol Deviation|0|||
27638856|NCT03950622|80518920|FG001|Overall Study|Protocol Deviation|1|||
27924833|NCT03407482|81564751|FG000|Overall Study|Pregnancy|2|||
27924834|NCT03407482|81564751|FG000|Overall Study|Protocol Violation|1|||
27924835|NCT03407482|81564751|FG000|Overall Study|Study Terminated By Sponsor|106|||
27924836|NCT03407482|81564751|FG000|Overall Study|Withdrawal by Subject|6|||
27924837|NCT03407482|81564751|FG000|Overall Study|Data Entry Error|1|||
27924838|NCT03915067|81564752|FG000|Overall Study|Adverse Event|0|||
27924839|NCT03915067|81564753|FG001|Overall Study|Adverse Event|0|||
27924840|NCT03915067|81564754|FG002|Overall Study|Adverse Event|1|||
27638857|NCT03950622|80518919|FG000|Overall Study|Physician Decision|1|||
27924841|NCT03915067|81564752|FG000|Overall Study|Withdrawal by Subject|4|||
27924842|NCT03915067|81564753|FG001|Overall Study|Withdrawal by Subject|3|||
27924843|NCT03915067|81564754|FG002|Overall Study|Withdrawal by Subject|0|||
27924844|NCT03915067|81564752|FG000|Overall Study|Lost to Follow-up|3|||
27924845|NCT03915067|81564753|FG001|Overall Study|Lost to Follow-up|2|||
27924846|NCT03915067|81564754|FG002|Overall Study|Lost to Follow-up|0|||
27924847|NCT03915067|81564752|FG000|Overall Study|Protocol Deviation|0|||
27924848|NCT03915067|81564753|FG001|Overall Study|Protocol Deviation|0|||
27924849|NCT03915067|81564754|FG002|Overall Study|Protocol Deviation|1|||
27924850|NCT03915067|81564752|FG000|Overall Study|Covid-19 Related Issues|2|||
27924851|NCT03915067|81564753|FG001|Overall Study|Covid-19 Related Issues|4|||
27638858|NCT03950622|80518920|FG001|Overall Study|Physician Decision|0|||
27638859|NCT03950622|80518919|FG000|Overall Study|Lost to Follow-up|5|||
27638860|NCT03950622|80518920|FG001|Overall Study|Lost to Follow-up|5|||
27638861|NCT03950622|80518919|FG000|Overall Study|Death|1|||
27638862|NCT03950622|80518920|FG001|Overall Study|Death|1|||
27741724|NCT02031146|80884112|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
27741725|NCT02031146|80884113|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
27741726|NCT02031146|80884114|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
27741727|NCT02031146|80884115|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
27741728|NCT02031146|80884116|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
27741729|NCT02031146|80884117|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
27741730|NCT00728416|80884118|FG000|Overall Study|Adverse Event|1|||
27741731|NCT00728416|80884119|FG001|Overall Study|Adverse Event|1|||
27638863|NCT00309907|80518923|FG000|Overall Study|Death|4|||
27741732|NCT00728416|80884118|FG000|Overall Study|Treatment Failure|0|||
27741733|NCT00728416|80884119|FG001|Overall Study|Treatment Failure|1|||
27924852|NCT03915067|81564754|FG002|Overall Study|Covid-19 Related Issues|4|||
27924853|NCT03915067|81564752|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
27924854|NCT03915067|81564753|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
27638864|NCT00309907|80518923|FG000|Overall Study|Physician Decision|1|||
27638865|NCT00309907|80518923|FG000|Overall Study|Ineligible|11|||
27924855|NCT03915067|81564754|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
27924856|NCT00970944|81564755|FG000|Overall Study|Death|1|||
27924857|NCT00970944|81564756|FG001|Overall Study|Death|0|||
27924858|NCT00970944|81564755|FG000|Overall Study|Physician Decision|0|||
27924859|NCT00970944|81564756|FG001|Overall Study|Physician Decision|2|||
27924860|NCT00658528|81564758|FG000|Overall Study|Adverse Event|5|||
27924861|NCT00658528|81564759|FG001|Overall Study|Adverse Event|7|||
27924862|NCT00658528|81564758|FG000|Overall Study|Lost to Follow-up|14|||
27924863|NCT00658528|81564759|FG001|Overall Study|Lost to Follow-up|22|||
27924864|NCT00658528|81564758|FG000|Overall Study|Withdrawal by Subject|8|||
27924865|NCT00658528|81564759|FG001|Overall Study|Withdrawal by Subject|6|||
27924866|NCT00658528|81564758|FG000|Overall Study|Withdrawal of consent|5|||
27924867|NCT00658528|81564759|FG001|Overall Study|Withdrawal of consent|6|||
27924868|NCT00658528|81564758|FG000|Overall Study|Other|8|||
27924869|NCT00658528|81564759|FG001|Overall Study|Other|4|||
27924870|NCT02362451|81564760|FG000|Overall Study|Withdrawal by Subject|0|||
27924871|NCT02362451|81564761|FG001|Overall Study|Withdrawal by Subject|1|||
27924872|NCT02362451|81564760|FG000|Overall Study|Lack of Efficacy|2|||
27924873|NCT02362451|81564761|FG001|Overall Study|Lack of Efficacy|0|||
27924874|NCT02362451|81564760|FG000|Overall Study|Progression|1|||
27924875|NCT02362451|81564761|FG001|Overall Study|Progression|0|||
27545262|NCT00299104|80185905|FG002|Treatment Period|Death|1|||
27545263|NCT00299104|80185903|FG000|Treatment Period|Insufficient therapeutic response|34|||
27545264|NCT00299104|80185904|FG001|Treatment Period|Insufficient therapeutic response|13|||
27545265|NCT00299104|80185905|FG002|Treatment Period|Insufficient therapeutic response|8|||
27924876|NCT02362451|81564760|FG000|Overall Study|Participant chose other therapy.|1|||
27924877|NCT02362451|81564761|FG001|Overall Study|Participant chose other therapy.|0|||
27924878|NCT00390013|81564762|FG000|Phase 1|tired|0|||
27924879|NCT00390013|81564763|FG001|Phase 1|tired|0|||
27545266|NCT00299104|80185903|FG000|Treatment Period|Failure to return|9|||
27545267|NCT00299104|80185904|FG001|Treatment Period|Failure to return|8|||
27545268|NCT00299104|80185905|FG002|Treatment Period|Failure to return|8|||
27545269|NCT00299104|80185903|FG000|Treatment Period|Violation of selection criteria|1|||
27741734|NCT00728416|80884118|FG000|Overall Study|Withdrawal by Subject|1|||
27741735|NCT00728416|80884119|FG001|Overall Study|Withdrawal by Subject|0|||
27741736|NCT04334148|80884122|FG000|Overall Study|positive nasal swab at baseline|0|||
27741737|NCT04334148|80884123|FG001|Overall Study|positive nasal swab at baseline|1|||
27741738|NCT04770155|80884126|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741739|NCT04770155|80884127|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741740|NCT04770155|80884128|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741741|NCT04770155|80884129|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741742|NCT04770155|80884130|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741743|NCT04770155|80884131|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741744|NCT04770155|80884132|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741745|NCT04770155|80884133|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
27741746|NCT02675517|80884134|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
27741747|NCT02675517|80884134|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
27741748|NCT01927562|80884142|FG000|Overall Study|Lost to Follow-up|30|||
27741749|NCT01927562|80884142|FG000|Overall Study|Withdrawal by Subject|3|||
27741750|NCT01927562|80884142|FG000|Overall Study|Physician Decision|5|||
27741751|NCT03242759|80884143|FG000|Overall Study|Adverse Event|5|||
27741752|NCT03242759|80884144|FG001|Overall Study|Adverse Event|1|||
27741753|NCT03242759|80884143|FG000|Overall Study|Withdrawal by Subject|4|||
27741754|NCT03242759|80884144|FG001|Overall Study|Withdrawal by Subject|3|||
27741755|NCT03242759|80884143|FG000|Overall Study|Lost to Follow-up|3|||
27741756|NCT03242759|80884144|FG001|Overall Study|Lost to Follow-up|1|||
27741757|NCT03242759|80884143|FG000|Overall Study|Administrative problems|1|||
27741758|NCT03242759|80884144|FG001|Overall Study|Administrative problems|1|||
27741759|NCT03242759|80884143|FG000|Overall Study|Death|22|||
27741760|NCT03242759|80884144|FG001|Overall Study|Death|0|||
27741761|NCT03242759|80884143|FG000|Overall Study|Change visit schedule|0|||
27741762|NCT03242759|80884144|FG001|Overall Study|Change visit schedule|1|||
27924880|NCT00390013|81564764|FG002|Phase 1|tired|0|||
27924881|NCT00390013|81564765|FG003|Phase 1|tired|1|||
27924882|NCT00390013|81564762|FG000|Phase 2 First Treatment|tired|1|||
27545270|NCT00299104|80185904|FG001|Treatment Period|Violation of selection criteria|2|||
27545271|NCT00299104|80185905|FG002|Treatment Period|Violation of selection criteria|0|||
27924883|NCT00390013|81564763|FG001|Phase 2 First Treatment|tired|0|||
27924884|NCT00390013|81564764|FG002|Phase 2 First Treatment|tired|0|||
27924885|NCT00390013|81564765|FG003|Phase 2 First Treatment|tired|0|||
27924886|NCT00390013|81564762|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
27924887|NCT00390013|81564763|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
27741763|NCT04021862|80884153|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
27741764|NCT04021862|80884154|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
27741765|NCT04021862|80884155|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
27741766|NCT04021862|80884156|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
27741767|NCT04021862|80884157|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
27741768|NCT04021862|80884158|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
27741769|NCT04021862|80884153|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
27741770|NCT04021862|80884154|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
27741771|NCT04021862|80884155|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
27741772|NCT04021862|80884156|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
27741773|NCT04021862|80884157|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
27741774|NCT04021862|80884158|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
27741775|NCT04021862|80884153|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
27741776|NCT04021862|80884154|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
27741777|NCT04021862|80884155|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
27741778|NCT04021862|80884156|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
27741779|NCT04021862|80884157|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
27741780|NCT04021862|80884158|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
27741781|NCT04021862|80884153|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
27741782|NCT04021862|80884154|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
27741783|NCT04021862|80884155|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
27741784|NCT04021862|80884156|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
27741785|NCT04021862|80884157|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
27741786|NCT04021862|80884158|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
27741787|NCT04021862|80884153|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
27741788|NCT04021862|80884154|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
27741789|NCT04021862|80884155|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
27741790|NCT04021862|80884156|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
27741791|NCT04021862|80884157|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
27741792|NCT04021862|80884158|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
27741793|NCT02613572|80884161|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
27741794|NCT02613572|80884162|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
27741795|NCT02613572|80884163|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
27741796|NCT02613572|80884161|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
27741797|NCT02613572|80884162|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
27741798|NCT02613572|80884163|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
27741799|NCT01183858|80884167|FG000|Overall Study|Death not related to Progressive Disease|5|||
27741800|NCT01183858|80884168|FG001|Overall Study|Death not related to Progressive Disease|6|||
27741801|NCT01183858|80884167|FG000|Overall Study|Adverse Event|14|||
27741802|NCT01183858|80884168|FG001|Overall Study|Adverse Event|11|||
27741803|NCT01183858|80884167|FG000|Overall Study|Investigator's Decision|0|||
27741804|NCT01183858|80884168|FG001|Overall Study|Investigator's Decision|3|||
27741805|NCT01183858|80884167|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27741806|NCT01183858|80884168|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27741807|NCT01183858|80884167|FG000|Overall Study|Refused Treatment|1|||
27741808|NCT01183858|80884168|FG001|Overall Study|Refused Treatment|4|||
27741809|NCT01183858|80884167|FG000|Overall Study|Withdrew Consent|4|||
27741810|NCT01183858|80884168|FG001|Overall Study|Withdrew Consent|4|||
27741811|NCT01183858|80884167|FG000|Overall Study|Discontinued Smoking|3|||
27741812|NCT01183858|80884168|FG001|Overall Study|Discontinued Smoking|1|||
27741813|NCT01183858|80884167|FG000|Overall Study|Protocol Violation|1|||
27741814|NCT01183858|80884168|FG001|Overall Study|Protocol Violation|0|||
27741815|NCT01183858|80884167|FG000|Overall Study|Administrative/Other|6|||
27741816|NCT01183858|80884168|FG001|Overall Study|Administrative/Other|6|||
27741817|NCT01183858|80884167|FG000|Overall Study|Progressive Disease|112|||
27741818|NCT01183858|80884168|FG001|Overall Study|Progressive Disease|115|||
27741819|NCT01183858|80884167|FG000|Overall Study|Death related to Progressive Disease|4|||
27741820|NCT01183858|80884168|FG001|Overall Study|Death related to Progressive Disease|5|||
27741821|NCT01183858|80884167|FG000|Overall Study|Lost to Follow-up|1|||
27741822|NCT01183858|80884168|FG001|Overall Study|Lost to Follow-up|1|||
27741823|NCT01663740|80884173|FG000|Overall Study|Lost to Follow-up|1|||
27741824|NCT01663740|80884174|FG001|Overall Study|Lost to Follow-up|4|||
27741825|NCT01663740|80884173|FG000|Overall Study|Other|9|||
27741826|NCT01663740|80884174|FG001|Overall Study|Other|2|||
27741827|NCT01663740|80884173|FG000|Overall Study|Inclusion/Exclusion not met|1|||
27741828|NCT01663740|80884174|FG001|Overall Study|Inclusion/Exclusion not met|0|||
27741829|NCT01663740|80884173|FG000|Overall Study|Death|0|||
27741830|NCT01663740|80884174|FG001|Overall Study|Death|1|||
27741831|NCT01663740|80884173|FG000|Overall Study|Withdrawal by Subject|2|||
27741832|NCT01663740|80884174|FG001|Overall Study|Withdrawal by Subject|1|||
27741833|NCT01663740|80884173|FG000|Overall Study|No end of study status|3|||
27741834|NCT01663740|80884174|FG001|Overall Study|No end of study status|0|||
27741835|NCT03461289|80884175|FG000|Overall Study|Death|1|||
27741836|NCT01089725|80884176|FG000|Overall Study|Adverse Event|1|||
27741837|NCT01089725|80884177|FG001|Overall Study|Adverse Event|1|||
27741838|NCT01089725|80884178|FG002|Overall Study|Adverse Event|0|||
27741839|NCT01089725|80884179|FG003|Overall Study|Adverse Event|0|||
27741840|NCT01089725|80884180|FG004|Overall Study|Adverse Event|2|||
27741841|NCT01089725|80884176|FG000|Overall Study|Lack of Efficacy|4|||
27741842|NCT01089725|80884177|FG001|Overall Study|Lack of Efficacy|3|||
27741843|NCT01089725|80884178|FG002|Overall Study|Lack of Efficacy|1|||
27741844|NCT01089725|80884179|FG003|Overall Study|Lack of Efficacy|0|||
27741845|NCT01089725|80884180|FG004|Overall Study|Lack of Efficacy|4|||
27741846|NCT01089725|80884176|FG000|Overall Study|Lost to Follow-up|2|||
27741847|NCT01089725|80884177|FG001|Overall Study|Lost to Follow-up|2|||
27741848|NCT01089725|80884178|FG002|Overall Study|Lost to Follow-up|0|||
27741849|NCT01089725|80884179|FG003|Overall Study|Lost to Follow-up|3|||
27741850|NCT01089725|80884180|FG004|Overall Study|Lost to Follow-up|0|||
27741851|NCT01089725|80884176|FG000|Overall Study|Protocol Violation|0|||
27741852|NCT01089725|80884177|FG001|Overall Study|Protocol Violation|0|||
27741853|NCT01089725|80884178|FG002|Overall Study|Protocol Violation|1|||
27741854|NCT01089725|80884179|FG003|Overall Study|Protocol Violation|1|||
27741855|NCT01089725|80884180|FG004|Overall Study|Protocol Violation|0|||
27741856|NCT01089725|80884176|FG000|Overall Study|Withdrawal by Subject|5|||
27741857|NCT01089725|80884177|FG001|Overall Study|Withdrawal by Subject|5|||
27741858|NCT01089725|80884178|FG002|Overall Study|Withdrawal by Subject|4|||
27741859|NCT01089725|80884179|FG003|Overall Study|Withdrawal by Subject|5|||
27741860|NCT01089725|80884180|FG004|Overall Study|Withdrawal by Subject|4|||
27741861|NCT01089725|80884176|FG000|Overall Study|Study Terminated by Sponsor|51|||
27741862|NCT01089725|80884177|FG001|Overall Study|Study Terminated by Sponsor|56|||
27741863|NCT01089725|80884178|FG002|Overall Study|Study Terminated by Sponsor|53|||
27741864|NCT01089725|80884179|FG003|Overall Study|Study Terminated by Sponsor|68|||
27741865|NCT01089725|80884180|FG004|Overall Study|Study Terminated by Sponsor|68|||
27741866|NCT01089725|80884176|FG000|Overall Study|Randomized, but not treated|0|||
27741867|NCT01089725|80884177|FG001|Overall Study|Randomized, but not treated|1|||
27741868|NCT01089725|80884178|FG002|Overall Study|Randomized, but not treated|2|||
27741869|NCT01089725|80884179|FG003|Overall Study|Randomized, but not treated|1|||
27741870|NCT01089725|80884180|FG004|Overall Study|Randomized, but not treated|2|||
27741871|NCT01089725|80884176|FG000|Overall Study|Other|3|||
27741872|NCT01089725|80884177|FG001|Overall Study|Other|0|||
27741873|NCT01089725|80884178|FG002|Overall Study|Other|0|||
27741874|NCT01089725|80884179|FG003|Overall Study|Other|1|||
27741875|NCT01089725|80884180|FG004|Overall Study|Other|0|||
27741876|NCT00652093|80884181|FG000|Overall Study|Withdrawal by Subject|0|||
27741877|NCT00652093|80884182|FG001|Overall Study|Withdrawal by Subject|0|||
27741878|NCT00652093|80884183|FG002|Overall Study|Withdrawal by Subject|1|||
27741879|NCT00652093|80884184|FG003|Overall Study|Withdrawal by Subject|0|||
27741880|NCT00652093|80884185|FG004|Overall Study|Withdrawal by Subject|1|||
27741881|NCT00652093|80884186|FG005|Overall Study|Withdrawal by Subject|0|||
27924888|NCT00390013|81564764|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
27924889|NCT00390013|81564765|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
27924890|NCT02921789|81564766|FG000|Overall Study|Adverse Event|0|||
27924891|NCT02921789|81564767|FG001|Overall Study|Adverse Event|1|||
27924892|NCT02921789|81564766|FG000|Overall Study|Lost to Follow-up|1|||
27924893|NCT02921789|81564767|FG001|Overall Study|Lost to Follow-up|0|||
27924894|NCT02921789|81564766|FG000|Overall Study|Protocol Deviation|2|||
27924895|NCT02921789|81564767|FG001|Overall Study|Protocol Deviation|0|||
27924896|NCT02921789|81564766|FG000|Overall Study|Withdrawal by Subject|2|||
27924897|NCT02921789|81564767|FG001|Overall Study|Withdrawal by Subject|1|||
27924898|NCT02921789|81564766|FG000|Overall Study|Miscellaneous|3|||
27924899|NCT02921789|81564767|FG001|Overall Study|Miscellaneous|2|||
27924900|NCT02583269|81564770|FG000|Overall Study|Patient hospitalized prior to start|1|||
27924901|NCT02583269|81564771|FG001|Overall Study|Patient hospitalized prior to start|0|||
27924902|NCT02583269|81564772|FG002|Overall Study|Patient hospitalized prior to start|0|||
27924903|NCT02583269|81564773|FG003|Overall Study|Patient hospitalized prior to start|0|||
27924904|NCT02583269|81564774|FG004|Overall Study|Patient hospitalized prior to start|0|||
27924905|NCT02318940|81564775|FG000|Overall Study|lost the record|1|||
27924906|NCT02318940|81564776|FG001|Overall Study|lost the record|0|||
27924907|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
27924908|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
27924909|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
27924910|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
27741882|NCT00652093|80884181|FG000|Overall Study|Physician Decision|0|||
27741883|NCT00652093|80884182|FG001|Overall Study|Physician Decision|0|||
27924911|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
27924912|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
27924913|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
27924914|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
27741884|NCT00652093|80884183|FG002|Overall Study|Physician Decision|0|||
27741885|NCT00652093|80884184|FG003|Overall Study|Physician Decision|0|||
27741886|NCT00652093|80884185|FG004|Overall Study|Physician Decision|1|||
27741887|NCT00652093|80884186|FG005|Overall Study|Physician Decision|0|||
27741888|NCT00537745|80884187|FG000|Overall Study|Did not meet eligibility criteria|2|||
27741889|NCT00537745|80884187|FG000|Overall Study|Withdrawal by Subject|2|||
27741890|NCT00537745|80884187|FG000|Overall Study|Subject unable to provide Interlock info|1|||
27741891|NCT01645280|80884188|FG000|Overall Study|Death|0|||
27741892|NCT01645280|80884189|FG001|Overall Study|Death|1|||
27741893|NCT01645280|80884190|FG002|Overall Study|Death|0|||
27741894|NCT01645280|80884191|FG003|Overall Study|Death|0|||
27741895|NCT01645280|80884192|FG004|Overall Study|Death|0|||
27741896|NCT01645280|80884188|FG000|Overall Study|Withdrawal by Subject|4|||
27741897|NCT01645280|80884189|FG001|Overall Study|Withdrawal by Subject|0|||
27741898|NCT01645280|80884190|FG002|Overall Study|Withdrawal by Subject|2|||
27741899|NCT01645280|80884191|FG003|Overall Study|Withdrawal by Subject|4|||
27741900|NCT01645280|80884192|FG004|Overall Study|Withdrawal by Subject|5|||
27741901|NCT01645280|80884188|FG000|Overall Study|Lost to Follow-up|0|||
27741902|NCT01645280|80884189|FG001|Overall Study|Lost to Follow-up|0|||
27741903|NCT01645280|80884190|FG002|Overall Study|Lost to Follow-up|0|||
27741904|NCT01645280|80884191|FG003|Overall Study|Lost to Follow-up|2|||
27741905|NCT01645280|80884192|FG004|Overall Study|Lost to Follow-up|1|||
27741906|NCT01645280|80884188|FG000|Overall Study|Other|1|||
27741907|NCT01645280|80884189|FG001|Overall Study|Other|1|||
27741908|NCT01645280|80884190|FG002|Overall Study|Other|2|||
27741909|NCT01645280|80884191|FG003|Overall Study|Other|0|||
27741910|NCT01645280|80884192|FG004|Overall Study|Other|0|||
27741911|NCT01645280|80884188|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
27741912|NCT01645280|80884189|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
27924915|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
27924916|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
27545272|NCT00299104|80185903|FG000|Treatment Period|Protocol Violation|1|||
27545273|NCT00299104|80185904|FG001|Treatment Period|Protocol Violation|1|||
27545274|NCT00299104|80185905|FG002|Treatment Period|Protocol Violation|0|||
27545275|NCT00299104|80185903|FG000|Treatment Period|Refused treatment|9|||
27545276|NCT00299104|80185904|FG001|Treatment Period|Refused treatment|2|||
27924917|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
27924918|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
27924919|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
27924920|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
27924921|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
27924922|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
27924923|NCT00410163|81564777|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
27924924|NCT00410163|81564778|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
27924925|NCT00410163|81564777|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
27924926|NCT00410163|81564778|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
27924927|NCT00410163|81564777|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
27924928|NCT00410163|81564778|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
27924929|NCT00410163|81564777|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
27924930|NCT00410163|81564778|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
27924931|NCT00410163|81564777|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
27924932|NCT00410163|81564778|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
27924933|NCT00410163|81564777|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
27924934|NCT00410163|81564778|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
27924935|NCT01991314|81564779|FG000|Overall Study|Adverse Event|5|||
27924936|NCT01991314|81564780|FG001|Overall Study|Adverse Event|1|||
27924937|NCT01991314|81564779|FG000|Overall Study|Lost to Follow-up|6|||
27545277|NCT00299104|80185905|FG002|Treatment Period|Refused treatment|2|||
27545278|NCT00299104|80185903|FG000|Treatment Period|Withdrew consent|14|||
27545279|NCT00299104|80185904|FG001|Treatment Period|Withdrew consent|19|||
27545280|NCT00299104|80185905|FG002|Treatment Period|Withdrew consent|9|||
27545281|NCT00299104|80185903|FG000|Treatment Period|Administrative reasons|106|||
27741913|NCT01645280|80884190|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
27741914|NCT01645280|80884191|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
27741915|NCT01645280|80884192|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
27741916|NCT02760602|80884195|FG000|Overall Study|Withdrawal by Subject|1|||
27741917|NCT02760602|80884196|FG001|Overall Study|Withdrawal by Subject|0|||
27741918|NCT02760602|80884195|FG000|Overall Study|Terminated by sponsor|12|||
27741919|NCT02760602|80884196|FG001|Overall Study|Terminated by sponsor|13|||
27741920|NCT00492921|80884197|FG000|Overall Study|Death|1|||
27545282|NCT00299104|80185904|FG001|Treatment Period|Administrative reasons|120|||
27741921|NCT00492921|80884198|FG001|Overall Study|Death|0|||
27924938|NCT01991314|81564780|FG001|Overall Study|Lost to Follow-up|10|||
27924939|NCT03530696|81564781|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
27924940|NCT03530696|81564782|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
27924941|NCT01056536|81564784|FG000|Overall Study|Lost to Follow-up|202|||
27924942|NCT01056536|81564785|FG001|Overall Study|Lost to Follow-up|116|||
27924943|NCT01056536|81564786|FG002|Overall Study|Lost to Follow-up|248|||
27924944|NCT02246777|81564787|FG000|Overall Study|Adverse Event|2|||
27741922|NCT00492921|80884199|FG002|Overall Study|Death|1|||
27741923|NCT01348919|80884200|FG000|Overall Study|Adverse Event|3|||
27741924|NCT01348919|80884201|FG001|Overall Study|Adverse Event|1|||
27741925|NCT01348919|80884202|FG002|Overall Study|Adverse Event|0|||
27741926|NCT01348919|80884200|FG000|Overall Study|Withdrawal by Subject|0|||
27741927|NCT01348919|80884201|FG001|Overall Study|Withdrawal by Subject|1|||
27741928|NCT01348919|80884202|FG002|Overall Study|Withdrawal by Subject|0|||
27741929|NCT01348919|80884200|FG000|Overall Study|Disease progression|0|||
27741930|NCT01348919|80884201|FG001|Overall Study|Disease progression|1|||
27741931|NCT01348919|80884202|FG002|Overall Study|Disease progression|1|||
27924945|NCT02246777|81564787|FG000|Overall Study|Change of residence|1|||
27924946|NCT00903201|81564788|FG000|Overall Study|Adverse Event|1|||
27924947|NCT00903201|81564789|FG001|Overall Study|Adverse Event|4|||
27924948|NCT00903201|81564790|FG002|Overall Study|Adverse Event|0|||
27924949|NCT00903201|81564788|FG000|Overall Study|Protocol Violation|2|||
27924950|NCT00903201|81564789|FG001|Overall Study|Protocol Violation|1|||
27924951|NCT00903201|81564790|FG002|Overall Study|Protocol Violation|0|||
27924952|NCT00903201|81564788|FG000|Overall Study|Lost to Follow-up|0|||
27924953|NCT00903201|81564789|FG001|Overall Study|Lost to Follow-up|1|||
27741932|NCT01899144|80884203|FG000|Treatment Period 2|Other|1|||
27924954|NCT00903201|81564790|FG002|Overall Study|Lost to Follow-up|0|||
27924955|NCT00903201|81564788|FG000|Overall Study|Physician Decision|1|||
27924956|NCT00903201|81564789|FG001|Overall Study|Physician Decision|0|||
27924957|NCT00903201|81564790|FG002|Overall Study|Physician Decision|1|||
27924958|NCT00903201|81564788|FG000|Overall Study|Withdrawal by Subject|1|||
27924959|NCT00903201|81564789|FG001|Overall Study|Withdrawal by Subject|0|||
27924960|NCT00903201|81564790|FG002|Overall Study|Withdrawal by Subject|1|||
27924961|NCT00998946|81564794|FG000|Overall Study|Lost to Follow-up|1|||
27924962|NCT00998946|81564794|FG000|Overall Study|Withdrawal by Subject|1|||
27924963|NCT00998946|81564794|FG000|Overall Study|Death|2|||
27924964|NCT00998946|81564794|FG000|Overall Study|Reason Unspecified|3|||
27924965|NCT00998946|81564794|FG000|Overall Study|Enrolled but not Dosed|2|||
27924966|NCT00769561|81564797|FG000|Overall Study|Withdrawal by Subject|2|||
27924967|NCT00769561|81564798|FG001|Overall Study|Withdrawal by Subject|2|||
27924968|NCT00769561|81564797|FG000|Overall Study|Lost to Follow-up|1|||
27924969|NCT00769561|81564798|FG001|Overall Study|Lost to Follow-up|3|||
27924970|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
27924971|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
27924972|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
27545283|NCT00299104|80185905|FG002|Treatment Period|Administrative reasons|137|||
27545284|NCT00299104|80185903|FG000|Safety Follow-Up (SFU) Period|Death|3|||
27545285|NCT00299104|80185904|FG001|Safety Follow-Up (SFU) Period|Death|2|||
27545286|NCT00299104|80185905|FG002|Safety Follow-Up (SFU) Period|Death|1|||
27545287|NCT00299104|80185903|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
27741933|NCT01899144|80884203|FG000|Treatment Period 3|Other|2|||
27741934|NCT01899144|80884203|FG000|Treatment Period 5|Other|1|||
27741935|NCT02517515|80884204|FG000|Overall Study|Adverse Event|0|||
27741936|NCT02517515|80884205|FG001|Overall Study|Adverse Event|1|||
27741937|NCT02517515|80884204|FG000|Overall Study|Withdrew Consent|0|||
27741938|NCT02517515|80884205|FG001|Overall Study|Withdrew Consent|1|||
27741939|NCT02517515|80884204|FG000|Overall Study|Lost to Follow-up|1|||
27741940|NCT02517515|80884205|FG001|Overall Study|Lost to Follow-up|0|||
27545288|NCT00299104|80185904|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
27545289|NCT00299104|80185905|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
27545290|NCT00299104|80185903|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
27545291|NCT00299104|80185904|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
27545292|NCT00299104|80185905|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
27741941|NCT02517515|80884204|FG000|Overall Study|Other|1|||
27741942|NCT02517515|80884205|FG001|Overall Study|Other|0|||
27741943|NCT03634072|80884206|FG000|Overall Study|Early termination of overall study|1|||
27741944|NCT03634072|80884207|FG001|Overall Study|Early termination of overall study|0|||
27924973|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Death|1|||
27924974|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Death|0|||
27924975|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Death|0|||
27924976|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
27741945|NCT01342640|80884209|FG000|Overall Study|Adverse Event|3|||
27924977|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
27741946|NCT01342640|80884209|FG000|Overall Study|Protocol Violation|16|||
27741947|NCT01342640|80884209|FG000|Overall Study|Lost to Follow-up|21|||
27741948|NCT01342640|80884209|FG000|Overall Study|Other|1|||
27638866|NCT00309907|80518923|FG000|Overall Study|Major infectious event|4|||
27638867|NCT03169244|80518925|FG000|Overall Study|Lost to Follow-up|1|||
27638868|NCT03169244|80518926|FG001|Overall Study|Lost to Follow-up|2|||
27638869|NCT03169244|80518925|FG000|Overall Study|Adverse Event|1|||
27638870|NCT03169244|80518926|FG001|Overall Study|Adverse Event|0|||
27638871|NCT03169244|80518925|FG000|Overall Study|Withdrawal by Subject|2|||
27638872|NCT03169244|80518926|FG001|Overall Study|Withdrawal by Subject|2|||
27638873|NCT03169244|80518925|FG000|Overall Study|Physician Decision|1|||
27638874|NCT03169244|80518926|FG001|Overall Study|Physician Decision|0|||
27638875|NCT03887650|80518927|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
27638876|NCT03887650|80518928|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
27638877|NCT03887650|80518927|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
27638878|NCT03887650|80518928|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
27638879|NCT03887650|80518927|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
27638880|NCT03887650|80518928|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
27638881|NCT02538107|80518929|FG000|Overall Study|Did not receive any Mircera dose|11|||
27638882|NCT02538107|80518929|FG000|Overall Study|Missing|5|||
27638883|NCT02538107|80518929|FG000|Overall Study|Necessity of dialysis|20|||
27741949|NCT01541254|80884210|FG000|Overall Study|Withdrawal by Subject|1|||
27741950|NCT01541254|80884210|FG000|Overall Study|excluded - metal allergy|1|||
27741951|NCT01541254|80884210|FG000|Overall Study|enrolled after study closed|1|||
27741952|NCT01541254|80884210|FG000|Overall Study|GI bleed prior to procedure|1|||
27741953|NCT01541254|80884210|FG000|Overall Study|stent not required|1|||
27741954|NCT01541254|80884210|FG000|Overall Study|alternate stent used|1|||
27741955|NCT00564629|80884211|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
27741956|NCT00564629|80884212|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
27741957|NCT00375934|80884213|FG000|Overall Study|Adverse Event|1|||
27741958|NCT00375934|80884214|FG001|Overall Study|Adverse Event|1|||
27741959|NCT00375934|80884213|FG000|Overall Study|Withdrawal by Subject|2|||
27741960|NCT00375934|80884214|FG001|Overall Study|Withdrawal by Subject|2|||
27741961|NCT00375934|80884213|FG000|Overall Study|Lack of Efficacy|0|||
27741962|NCT00375934|80884214|FG001|Overall Study|Lack of Efficacy|2|||
27924978|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
27638884|NCT02538107|80518929|FG000|Overall Study|Administration of other ESA|11|||
27638885|NCT02538107|80518929|FG000|Overall Study|No further treatment necessary|18|||
27638886|NCT02538107|80518929|FG000|Overall Study|Withdrawal by Subject|17|||
27638887|NCT02538107|80518929|FG000|Overall Study|Death|4|||
27638888|NCT02538107|80518929|FG000|Overall Study|Administrative reason|5|||
27638889|NCT02538107|80518929|FG000|Overall Study|Adverse Event|4|||
27638890|NCT02538107|80518929|FG000|Overall Study|Surgery|1|||
27638891|NCT02538107|80518929|FG000|Overall Study|Other|7|||
27638892|NCT02538107|80518929|FG000|Overall Study|Not recorded|7|||
27638893|NCT01149369|80518932|FG000|Overall Study|Adverse Event|6|||
27638894|NCT01149369|80518933|FG001|Overall Study|Adverse Event|3|||
27638895|NCT02928224|80518938|FG000|Overall Study|Lost to Follow-up|1|||
27638896|NCT02928224|80518939|FG001|Overall Study|Lost to Follow-up|1|||
27924979|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
27924980|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
27638897|NCT02928224|80518940|FG002|Overall Study|Lost to Follow-up|3|||
27638898|NCT02928224|80518941|FG003|Overall Study|Lost to Follow-up|0|||
27638899|NCT02928224|80518938|FG000|Overall Study|Death|30|||
27638900|NCT02928224|80518939|FG001|Overall Study|Death|209|||
27638901|NCT02928224|80518940|FG002|Overall Study|Death|193|||
27638902|NCT02928224|80518941|FG003|Overall Study|Death|198|||
27638903|NCT02928224|80518938|FG000|Overall Study|Withdrawal by Subject|0|||
27638904|NCT02928224|80518939|FG001|Overall Study|Withdrawal by Subject|3|||
27638905|NCT02928224|80518940|FG002|Overall Study|Withdrawal by Subject|7|||
27638906|NCT02928224|80518941|FG003|Overall Study|Withdrawal by Subject|20|||
27638907|NCT02928224|80518938|FG000|Overall Study|Study participation terminated by sponsor|3|||
27638908|NCT02928224|80518939|FG001|Overall Study|Study participation terminated by sponsor|8|||
27638909|NCT02928224|80518940|FG002|Overall Study|Study participation terminated by sponsor|12|||
27638910|NCT02928224|80518941|FG003|Overall Study|Study participation terminated by sponsor|3|||
27741963|NCT00375934|80884213|FG000|Overall Study|Physician Decision|0|||
27924981|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
27924982|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
27638911|NCT02928224|80518938|FG000|Overall Study|Other|3|||
27638912|NCT02928224|80518939|FG001|Overall Study|Other|3|||
27638913|NCT02928224|80518940|FG002|Overall Study|Other|5|||
27741964|NCT00375934|80884214|FG001|Overall Study|Physician Decision|1|||
27638914|NCT02928224|80518941|FG003|Overall Study|Other|0|||
27638915|NCT01636687|80518942|FG000|Induction Period|Withdrawal by Subject|1|||
27638916|NCT01636687|80518943|FG001|Induction Period|Withdrawal by Subject|0|||
27638917|NCT01636687|80518944|FG002|Induction Period|Withdrawal by Subject|0|||
27741965|NCT00641147|80884215|FG000|Completed 4 Months.|Physician Decision|1|||
27741966|NCT00641147|80884216|FG001|Completed 4 Months.|Physician Decision|0|||
27741967|NCT00641147|80884215|FG000|Completed 4 Months.|Adverse Event|1|||
27741968|NCT00641147|80884216|FG001|Completed 4 Months.|Adverse Event|0|||
27638918|NCT01636687|80518945|FG003|Induction Period|Withdrawal by Subject|0|||
27638919|NCT01636687|80518946|FG004|Induction Period|Withdrawal by Subject|0|||
27638920|NCT01636687|80518942|FG000|Induction Period|Adverse Event|1|||
27638921|NCT01636687|80518943|FG001|Induction Period|Adverse Event|0|||
27638922|NCT01636687|80518944|FG002|Induction Period|Adverse Event|0|||
27638923|NCT01636687|80518945|FG003|Induction Period|Adverse Event|0|||
27638924|NCT01636687|80518946|FG004|Induction Period|Adverse Event|1|||
27638925|NCT01636687|80518942|FG000|Induction Period|Lack of Efficacy|0|||
27638926|NCT01636687|80518943|FG001|Induction Period|Lack of Efficacy|0|||
27638927|NCT01636687|80518944|FG002|Induction Period|Lack of Efficacy|0|||
27638928|NCT01636687|80518945|FG003|Induction Period|Lack of Efficacy|0|||
27638929|NCT01636687|80518946|FG004|Induction Period|Lack of Efficacy|1|||
27638930|NCT01636687|80518942|FG000|Induction Period|Physician Decision|1|||
27638931|NCT01636687|80518943|FG001|Induction Period|Physician Decision|0|||
27638932|NCT01636687|80518944|FG002|Induction Period|Physician Decision|0|||
27638933|NCT01636687|80518945|FG003|Induction Period|Physician Decision|0|||
27638934|NCT01636687|80518946|FG004|Induction Period|Physician Decision|0|||
27638935|NCT01636687|80518942|FG000|Maintenance Period|Withdrawal by Subject|2|||
27638936|NCT01636687|80518943|FG001|Maintenance Period|Withdrawal by Subject|0|||
27638937|NCT01636687|80518944|FG002|Maintenance Period|Withdrawal by Subject|2|||
27638938|NCT01636687|80518945|FG003|Maintenance Period|Withdrawal by Subject|0|||
27638939|NCT01636687|80518946|FG004|Maintenance Period|Withdrawal by Subject|0|||
27638940|NCT01636687|80518942|FG000|Maintenance Period|Adverse Event|1|||
27638941|NCT01636687|80518943|FG001|Maintenance Period|Adverse Event|0|||
27638942|NCT01636687|80518944|FG002|Maintenance Period|Adverse Event|0|||
27638943|NCT01636687|80518945|FG003|Maintenance Period|Adverse Event|0|||
27638944|NCT01636687|80518946|FG004|Maintenance Period|Adverse Event|0|||
27638945|NCT01636687|80518942|FG000|Maintenance Period|Lack of Efficacy|4|||
27638946|NCT01636687|80518943|FG001|Maintenance Period|Lack of Efficacy|1|||
27638947|NCT01636687|80518944|FG002|Maintenance Period|Lack of Efficacy|0|||
27638948|NCT01636687|80518945|FG003|Maintenance Period|Lack of Efficacy|0|||
27638949|NCT01636687|80518946|FG004|Maintenance Period|Lack of Efficacy|0|||
27638950|NCT01636687|80518942|FG000|Maintenance Period|Lost to Follow-up|1|||
27638951|NCT01636687|80518943|FG001|Maintenance Period|Lost to Follow-up|1|||
27638952|NCT01636687|80518944|FG002|Maintenance Period|Lost to Follow-up|0|||
27638953|NCT01636687|80518945|FG003|Maintenance Period|Lost to Follow-up|0|||
27638954|NCT01636687|80518946|FG004|Maintenance Period|Lost to Follow-up|1|||
27638955|NCT01636687|80518942|FG000|Maintenance Period|Physician Decision|0|||
27638956|NCT01636687|80518943|FG001|Maintenance Period|Physician Decision|0|||
27638957|NCT01636687|80518944|FG002|Maintenance Period|Physician Decision|0|||
27638958|NCT01636687|80518945|FG003|Maintenance Period|Physician Decision|0|||
27638959|NCT01636687|80518946|FG004|Maintenance Period|Physician Decision|1|||
27638960|NCT01636687|80518942|FG000|Extension Period|technical problems|0|||
27638961|NCT01636687|80518943|FG001|Extension Period|technical problems|1|||
27638962|NCT01636687|80518944|FG002|Extension Period|technical problems|2|||
27741969|NCT00641147|80884215|FG000|Completed 8 Months.|Physician Decision|2|||
27545293|NCT00299104|80185903|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
27545294|NCT00299104|80185904|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
27545295|NCT00299104|80185905|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
27545296|NCT00299104|80185903|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
27545297|NCT00299104|80185904|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
27545298|NCT00299104|80185905|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
27545299|NCT00299104|80185903|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
27545300|NCT00299104|80185904|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
27545301|NCT00299104|80185905|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
27545302|NCT00299104|80185903|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
27545303|NCT00299104|80185904|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
27545304|NCT00299104|80185905|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
27545305|NCT00299104|80185903|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
27545306|NCT00299104|80185904|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
27545307|NCT00299104|80185905|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
27545308|NCT03338998|80185908|FG000|Treatment Period|Withdrawal by Subject|1|||
27545309|NCT03338998|80185909|FG001|Treatment Period|Withdrawal by Subject|1|||
27545310|NCT03338998|80185908|FG000|Treatment Period|Adverse Event|0|||
27545311|NCT03338998|80185909|FG001|Treatment Period|Adverse Event|2|||
27545312|NCT03338998|80185908|FG000|Treatment Period|Protocol deviation|1|||
27545313|NCT03338998|80185909|FG001|Treatment Period|Protocol deviation|0|||
27545314|NCT03338998|80185908|FG000|Treatment Period|Physician Decision|2|||
27545315|NCT03338998|80185909|FG001|Treatment Period|Physician Decision|0|||
27545316|NCT03338998|80185908|FG000|Treatment Period|Subject failed swallow test|4|||
27545317|NCT03338998|80185909|FG001|Treatment Period|Subject failed swallow test|0|||
27545318|NCT03338998|80185908|FG000|Safety Follow-Up Period|Adverse Event|0|||
27638963|NCT01636687|80518945|FG003|Extension Period|technical problems|1|||
27638964|NCT01636687|80518946|FG004|Extension Period|technical problems|0|||
27924983|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
27924984|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
27924985|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
27924986|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
27924987|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
27924988|NCT05073315|81564799|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
27924989|NCT05073315|81564800|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
27924990|NCT05073315|81564801|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
27924991|NCT05073315|81564799|FG000|Period 2|Adverse Event|0|||
27924992|NCT05073315|81564800|FG001|Period 2|Adverse Event|3|||
27924993|NCT05073315|81564801|FG002|Period 2|Adverse Event|6|||
27924994|NCT05073315|81564799|FG000|Period 2|Lost to Follow-up|0|||
27924995|NCT05073315|81564800|FG001|Period 2|Lost to Follow-up|5|||
27924996|NCT05073315|81564801|FG002|Period 2|Lost to Follow-up|5|||
27924997|NCT05073315|81564799|FG000|Period 2|Withdrawal by Subject|0|||
27924998|NCT05073315|81564800|FG001|Period 2|Withdrawal by Subject|4|||
27924999|NCT05073315|81564801|FG002|Period 2|Withdrawal by Subject|9|||
27925000|NCT05073315|81564799|FG000|Period 2|Protocol Violation|0|||
27925001|NCT05073315|81564800|FG001|Period 2|Protocol Violation|0|||
27925002|NCT05073315|81564801|FG002|Period 2|Protocol Violation|1|||
27925003|NCT00134719|81564802|FG000|Primary Vaccination Phase|Adverse Event|4|||
27925004|NCT00134719|81564803|FG001|Primary Vaccination Phase|Adverse Event|0|||
27925005|NCT00134719|81564804|FG002|Primary Vaccination Phase|Adverse Event|0|||
27925006|NCT00134719|81564802|FG000|Primary Vaccination Phase|Protocol Violation|1|||
27925007|NCT00134719|81564803|FG001|Primary Vaccination Phase|Protocol Violation|0|||
27925008|NCT00134719|81564804|FG002|Primary Vaccination Phase|Protocol Violation|0|||
27925009|NCT00134719|81564802|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
27925010|NCT00134719|81564803|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
27925011|NCT00134719|81564804|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
27925012|NCT00134719|81564802|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
27925013|NCT00134719|81564803|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
27925014|NCT00134719|81564804|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
27925015|NCT00134719|81564802|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
27925016|NCT00134719|81564803|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
27925017|NCT00134719|81564804|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
27925018|NCT00134719|81564802|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
27925019|NCT00134719|81564803|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
27925020|NCT00134719|81564804|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
27925021|NCT03010501|81564806|FG000|Study Week 1|Withdrawal by Subject|2|||
27925022|NCT03010501|81564807|FG001|Study Week 1|Withdrawal by Subject|1|||
27925023|NCT03010501|81564808|FG002|Study Week 1|Withdrawal by Subject|0|||
27925024|NCT03010501|81564809|FG003|Study Week 1|Withdrawal by Subject|2|||
27925025|NCT03010501|81564810|FG004|Study Week 1|Withdrawal by Subject|0|||
27925026|NCT03010501|81564811|FG005|Study Week 1|Withdrawal by Subject|0|||
27925027|NCT03010501|81564806|FG000|Study Week 3|Withdrawal by Subject|0|||
27925028|NCT03010501|81564807|FG001|Study Week 3|Withdrawal by Subject|0|||
27545319|NCT03338998|80185909|FG001|Safety Follow-Up Period|Adverse Event|1|||
27545320|NCT03338998|80185908|FG000|Safety Follow-Up Period|Protocol deviation|1|||
27545321|NCT03338998|80185909|FG001|Safety Follow-Up Period|Protocol deviation|0|||
27545322|NCT03338998|80185908|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
27545323|NCT03338998|80185909|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
27545324|NCT02439138|80185910|FG000|Overall Study|Adverse Event|1|||
27545325|NCT02439138|80185910|FG000|Overall Study|PI decision to terminate the study|2|||
27545326|NCT04502693|80185911|FG000|Overall Study|Adverse Event|7|||
27545327|NCT04502693|80185912|FG001|Overall Study|Adverse Event|6|||
27545328|NCT04502693|80185913|FG002|Overall Study|Adverse Event|11|||
27545329|NCT04502693|80185914|FG003|Overall Study|Adverse Event|1|||
27545330|NCT04502693|80185911|FG000|Overall Study|Lost to Follow-up|32|||
27545331|NCT04502693|80185912|FG001|Overall Study|Lost to Follow-up|36|||
27545332|NCT04502693|80185913|FG002|Overall Study|Lost to Follow-up|69|||
27545333|NCT04502693|80185914|FG003|Overall Study|Lost to Follow-up|4|||
27545334|NCT04502693|80185911|FG000|Overall Study|Protocol Violation|8|||
27545335|NCT04502693|80185912|FG001|Overall Study|Protocol Violation|8|||
27925029|NCT03010501|81564808|FG002|Study Week 3|Withdrawal by Subject|0|||
27925030|NCT03010501|81564809|FG003|Study Week 3|Withdrawal by Subject|1|||
27925031|NCT03010501|81564810|FG004|Study Week 3|Withdrawal by Subject|0|||
27925032|NCT03010501|81564811|FG005|Study Week 3|Withdrawal by Subject|0|||
27545336|NCT04502693|80185913|FG002|Overall Study|Protocol Violation|16|||
27545337|NCT04502693|80185914|FG003|Overall Study|Protocol Violation|1|||
27925033|NCT02335944|81564814|FG000|Treatment Phase|Progressive Disease|2|||
27925034|NCT02335944|81564815|FG001|Treatment Phase|Progressive Disease|5|||
27925035|NCT02335944|81564816|FG002|Treatment Phase|Progressive Disease|2|||
27545338|NCT04502693|80185911|FG000|Overall Study|Withdrawal by Subject|46|||
27545339|NCT04502693|80185912|FG001|Overall Study|Withdrawal by Subject|38|||
27741970|NCT00641147|80884216|FG001|Completed 8 Months.|Physician Decision|1|||
27741971|NCT00641147|80884215|FG000|Completed 8 Months.|non compliance|1|||
27741972|NCT00641147|80884216|FG001|Completed 8 Months.|non compliance|0|||
27741973|NCT00641147|80884215|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
27925036|NCT02335944|81564817|FG003|Treatment Phase|Progressive Disease|11|||
27925037|NCT02335944|81564818|FG004|Treatment Phase|Progressive Disease|4|||
27925038|NCT02335944|81564819|FG005|Treatment Phase|Progressive Disease|25|||
27925039|NCT02335944|81564820|FG006|Treatment Phase|Progressive Disease|2|||
27925040|NCT02335944|81564821|FG007|Treatment Phase|Progressive Disease|30|||
27925041|NCT02335944|81564822|FG008|Treatment Phase|Progressive Disease|27|||
27925042|NCT02335944|81564823|FG009|Treatment Phase|Progressive Disease|0|||
27925043|NCT02335944|81564814|FG000|Treatment Phase|Adverse Event|2|||
27545340|NCT04502693|80185913|FG002|Overall Study|Withdrawal by Subject|54|||
27545341|NCT04502693|80185914|FG003|Overall Study|Withdrawal by Subject|7|||
27545342|NCT04502693|80185911|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
27545343|NCT04502693|80185912|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
27545344|NCT04502693|80185913|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
27545345|NCT04502693|80185914|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
27545346|NCT04502693|80185911|FG000|Overall Study|Other|1|||
27545347|NCT04502693|80185912|FG001|Overall Study|Other|0|||
27545348|NCT04502693|80185913|FG002|Overall Study|Other|1|||
27545349|NCT04502693|80185914|FG003|Overall Study|Other|1|||
27545350|NCT00289783|80185915|FG000|Primary Phase|Adverse Event|10|||
27545351|NCT00289783|80185916|FG001|Primary Phase|Adverse Event|1|||
27545352|NCT00289783|80185915|FG000|Primary Phase|Protocol Violation|27|||
27545353|NCT00289783|80185916|FG001|Primary Phase|Protocol Violation|6|||
27545354|NCT00289783|80185915|FG000|Primary Phase|Withdrawal by Subject|93|||
27545355|NCT00289783|80185916|FG001|Primary Phase|Withdrawal by Subject|40|||
27545356|NCT00289783|80185915|FG000|Primary Phase|Lost to Follow-up|60|||
27545357|NCT00289783|80185916|FG001|Primary Phase|Lost to Follow-up|14|||
27545358|NCT00289783|80185915|FG000|Primary Phase|Migration from the study area|26|||
27545359|NCT00289783|80185916|FG001|Primary Phase|Migration from the study area|10|||
27545360|NCT00289783|80185915|FG000|Primary Phase|Other|32|||
27545361|NCT00289783|80185916|FG001|Primary Phase|Other|12|||
27545362|NCT00289783|80185915|FG000|Fourth Dose Phase|Adverse Event|1|||
27545363|NCT00289783|80185916|FG001|Fourth Dose Phase|Adverse Event|0|||
27545364|NCT00289783|80185915|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
27545365|NCT00289783|80185916|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
27545366|NCT00289783|80185915|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
27545367|NCT00289783|80185916|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
27545368|NCT00289783|80185915|FG000|Fourth Dose Phase|Migration from the study area|1|||
27545369|NCT00289783|80185916|FG001|Fourth Dose Phase|Migration from the study area|1|||
27545370|NCT00289783|80185915|FG000|Fourth Dose Phase|Other|22|||
27545371|NCT00289783|80185916|FG001|Fourth Dose Phase|Other|10|||
27545372|NCT03727230|80185917|FG000|Overall Study|Lost to Follow-up|12|||
27545373|NCT00717197|80185920|FG000|Overall Study|Unable to purchase study drug|5|||
27545374|NCT00717197|80185920|FG000|Overall Study|Tumor Progression|1|||
27545375|NCT00717197|80185920|FG000|Overall Study|Physician Decision|1|||
27545376|NCT04749615|80185923|FG000|Overall Study|Lost to Follow-up|6|||
27545377|NCT04749615|80185924|FG001|Overall Study|Lost to Follow-up|10|||
27545378|NCT02197130|80185925|FG000|Overall Study|Adverse Event|13|||
27545379|NCT02197130|80185926|FG001|Overall Study|Adverse Event|4|||
27545380|NCT02197130|80185927|FG002|Overall Study|Adverse Event|23|||
27545381|NCT02197130|80185925|FG000|Overall Study|Death|0|||
27545382|NCT02197130|80185926|FG001|Overall Study|Death|1|||
27545383|NCT02197130|80185927|FG002|Overall Study|Death|0|||
27545384|NCT02197130|80185925|FG000|Overall Study|Lost to Follow-up|2|||
27545385|NCT02197130|80185926|FG001|Overall Study|Lost to Follow-up|0|||
27545386|NCT02197130|80185927|FG002|Overall Study|Lost to Follow-up|1|||
27741974|NCT00641147|80884216|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
27741975|NCT00641147|80884215|FG000|Completed 12 Months.|Physician Decision|1|||
27741976|NCT00641147|80884216|FG001|Completed 12 Months.|Physician Decision|1|||
27741977|NCT00641147|80884215|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
27741978|NCT00641147|80884216|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
27741979|NCT00641147|80884215|FG000|Completed 16 Months.|Physician Decision|1|||
27741980|NCT00641147|80884216|FG001|Completed 16 Months.|Physician Decision|0|||
27741981|NCT00641147|80884215|FG000|Completed 16 Months.|Lost to Follow-up|1|||
27741982|NCT00641147|80884216|FG001|Completed 16 Months.|Lost to Follow-up|0|||
27741983|NCT04430582|80884222|FG000|Overall Study|Found to meet exclusionary criteria|1|||
27545387|NCT02197130|80185925|FG000|Overall Study|Does not meet entrance criteria|0|||
27545388|NCT02197130|80185926|FG001|Overall Study|Does not meet entrance criteria|0|||
27545389|NCT02197130|80185927|FG002|Overall Study|Does not meet entrance criteria|1|||
27545390|NCT02197130|80185925|FG000|Overall Study|Withdrawal by Subject|0|||
27545391|NCT02197130|80185926|FG001|Overall Study|Withdrawal by Subject|3|||
27545392|NCT02197130|80185927|FG002|Overall Study|Withdrawal by Subject|4|||
27545393|NCT02197130|80185925|FG000|Overall Study|Other|1|||
27545394|NCT02197130|80185926|FG001|Overall Study|Other|0|||
27638965|NCT01636687|80518942|FG000|Extension Period|Adverse Event|4|||
27638966|NCT01636687|80518943|FG001|Extension Period|Adverse Event|3|||
27638967|NCT01636687|80518944|FG002|Extension Period|Adverse Event|2|||
27638968|NCT01636687|80518945|FG003|Extension Period|Adverse Event|1|||
27638969|NCT01636687|80518946|FG004|Extension Period|Adverse Event|0|||
27638970|NCT01636687|80518942|FG000|Extension Period|Lack of Efficacy|7|||
27638971|NCT01636687|80518943|FG001|Extension Period|Lack of Efficacy|0|||
27638972|NCT01636687|80518944|FG002|Extension Period|Lack of Efficacy|2|||
27638973|NCT01636687|80518945|FG003|Extension Period|Lack of Efficacy|1|||
27638974|NCT01636687|80518946|FG004|Extension Period|Lack of Efficacy|0|||
27638975|NCT01636687|80518942|FG000|Extension Period|Lost to Follow-up|1|||
27638976|NCT01636687|80518943|FG001|Extension Period|Lost to Follow-up|0|||
27638977|NCT01636687|80518944|FG002|Extension Period|Lost to Follow-up|1|||
27638978|NCT01636687|80518945|FG003|Extension Period|Lost to Follow-up|0|||
27638979|NCT01636687|80518946|FG004|Extension Period|Lost to Follow-up|0|||
27638980|NCT01636687|80518942|FG000|Extension Period|Physician Decision|1|||
27638981|NCT01636687|80518943|FG001|Extension Period|Physician Decision|0|||
27638982|NCT01636687|80518944|FG002|Extension Period|Physician Decision|0|||
27638983|NCT01636687|80518945|FG003|Extension Period|Physician Decision|1|||
27638984|NCT01636687|80518946|FG004|Extension Period|Physician Decision|0|||
27638985|NCT01636687|80518942|FG000|Extension Period|study terminated by sponsor|33|||
27638986|NCT01636687|80518943|FG001|Extension Period|study terminated by sponsor|50|||
27638987|NCT01636687|80518944|FG002|Extension Period|study terminated by sponsor|17|||
27638988|NCT01636687|80518945|FG003|Extension Period|study terminated by sponsor|23|||
27638989|NCT01636687|80518946|FG004|Extension Period|study terminated by sponsor|0|||
27638990|NCT01636687|80518942|FG000|Extension Period|Withdrawal by Subject|1|||
27638991|NCT01636687|80518943|FG001|Extension Period|Withdrawal by Subject|0|||
27638992|NCT01636687|80518944|FG002|Extension Period|Withdrawal by Subject|1|||
27638993|NCT01636687|80518945|FG003|Extension Period|Withdrawal by Subject|1|||
27638994|NCT01636687|80518946|FG004|Extension Period|Withdrawal by Subject|0|||
27638995|NCT01636687|80518942|FG000|Follow-up Period|Withdrawal by Subject|1|||
27925044|NCT02335944|81564815|FG001|Treatment Phase|Adverse Event|0|||
27925045|NCT02335944|81564816|FG002|Treatment Phase|Adverse Event|0|||
27925046|NCT02335944|81564817|FG003|Treatment Phase|Adverse Event|2|||
27925047|NCT02335944|81564818|FG004|Treatment Phase|Adverse Event|1|||
27925048|NCT02335944|81564819|FG005|Treatment Phase|Adverse Event|15|||
27925049|NCT02335944|81564820|FG006|Treatment Phase|Adverse Event|0|||
27925050|NCT02335944|81564821|FG007|Treatment Phase|Adverse Event|5|||
27925051|NCT02335944|81564822|FG008|Treatment Phase|Adverse Event|7|||
27925052|NCT02335944|81564823|FG009|Treatment Phase|Adverse Event|0|||
27925053|NCT02335944|81564814|FG000|Treatment Phase|Physician Decision|0|||
27925054|NCT02335944|81564815|FG001|Treatment Phase|Physician Decision|0|||
27925055|NCT02335944|81564816|FG002|Treatment Phase|Physician Decision|0|||
27925056|NCT02335944|81564817|FG003|Treatment Phase|Physician Decision|1|||
27925057|NCT02335944|81564818|FG004|Treatment Phase|Physician Decision|0|||
27925058|NCT02335944|81564819|FG005|Treatment Phase|Physician Decision|6|||
27925059|NCT02335944|81564820|FG006|Treatment Phase|Physician Decision|1|||
27925060|NCT02335944|81564821|FG007|Treatment Phase|Physician Decision|2|||
27925061|NCT02335944|81564822|FG008|Treatment Phase|Physician Decision|1|||
27545395|NCT02197130|80185927|FG002|Overall Study|Other|3|||
27545396|NCT00283400|80185928|FG000|Overall Study|Withdrawal by Subject|1|||
27545397|NCT00283400|80185929|FG001|Overall Study|Withdrawal by Subject|1|||
27545398|NCT00283400|80185930|FG002|Overall Study|Withdrawal by Subject|0|||
27545399|NCT00283400|80185931|FG003|Overall Study|Withdrawal by Subject|0|||
27545400|NCT00283400|80185928|FG000|Overall Study|Death|1|||
27545401|NCT00283400|80185929|FG001|Overall Study|Death|0|||
27545402|NCT00283400|80185930|FG002|Overall Study|Death|1|||
27545403|NCT00283400|80185931|FG003|Overall Study|Death|0|||
27545404|NCT04974697|80185932|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
27545405|NCT04974697|80185932|FG000|Overall Study|Lens discomfort|1|||
27545406|NCT00844896|80185935|FG000|Overall Study|Lost to Follow-up|12|||
27925062|NCT02335944|81564823|FG009|Treatment Phase|Physician Decision|0|||
27925063|NCT02335944|81564814|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
27925064|NCT02335944|81564815|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
27638996|NCT01636687|80518943|FG001|Follow-up Period|Withdrawal by Subject|0|||
27638997|NCT01636687|80518944|FG002|Follow-up Period|Withdrawal by Subject|0|||
27638998|NCT01636687|80518945|FG003|Follow-up Period|Withdrawal by Subject|0|||
27925065|NCT02335944|81564816|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
27925066|NCT02335944|81564817|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
27925067|NCT02335944|81564818|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
27545407|NCT00844896|80185936|FG001|Overall Study|Lost to Follow-up|16|||
27545408|NCT00844896|80185935|FG000|Overall Study|Parents did not have time to complete|0|||
27638999|NCT01636687|80518946|FG004|Follow-up Period|Withdrawal by Subject|1|||
27639000|NCT04210180|80518949|FG000|Overall Study|Withdrawal by Subject|2|||
27639001|NCT02396316|80518950|FG000|Overall Study|Physician Decision|1|||
27639002|NCT02396316|80518951|FG001|Overall Study|Physician Decision|0|||
27925068|NCT02335944|81564819|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
27925069|NCT02335944|81564820|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
27925070|NCT02335944|81564821|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
27925071|NCT02335944|81564822|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
27925072|NCT02335944|81564823|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
27925073|NCT02335944|81564814|FG000|Treatment Phase|Subject/Guardian Decision|0|||
27925074|NCT02335944|81564815|FG001|Treatment Phase|Subject/Guardian Decision|0|||
27925075|NCT02335944|81564816|FG002|Treatment Phase|Subject/Guardian Decision|1|||
27545409|NCT00844896|80185936|FG001|Overall Study|Parents did not have time to complete|1|||
27545410|NCT03616600|80185938|FG000|Overall Study|Withdrawal by Subject|1|||
27545411|NCT03616600|80185939|FG001|Overall Study|Withdrawal by Subject|0|||
27545412|NCT01962896|80185940|FG000|Overall Study|Lack of Efficacy|4|||
27545413|NCT01866293|80185941|FG000|Overall Study|Adverse Event|2|||
27545414|NCT00619177|80185948|FG000|Overall Study|Adverse Event|18|||
27545415|NCT00619177|80185948|FG000|Overall Study|Lost to Follow-up|2|||
27741984|NCT04430582|80884223|FG001|Overall Study|Found to meet exclusionary criteria|0|||
27925076|NCT02335944|81564817|FG003|Treatment Phase|Subject/Guardian Decision|0|||
27925077|NCT02335944|81564818|FG004|Treatment Phase|Subject/Guardian Decision|0|||
27925078|NCT02335944|81564819|FG005|Treatment Phase|Subject/Guardian Decision|1|||
27925079|NCT02335944|81564820|FG006|Treatment Phase|Subject/Guardian Decision|0|||
27925080|NCT02335944|81564821|FG007|Treatment Phase|Subject/Guardian Decision|4|||
27925081|NCT02335944|81564822|FG008|Treatment Phase|Subject/Guardian Decision|0|||
27925082|NCT02335944|81564823|FG009|Treatment Phase|Subject/Guardian Decision|0|||
27925083|NCT02335944|81564814|FG000|Post-treatment Follow-up|Progressive Disease|0|||
27925084|NCT02335944|81564815|FG001|Post-treatment Follow-up|Progressive Disease|0|||
27925085|NCT02335944|81564816|FG002|Post-treatment Follow-up|Progressive Disease|0|||
27925086|NCT02335944|81564817|FG003|Post-treatment Follow-up|Progressive Disease|1|||
27925087|NCT02335944|81564818|FG004|Post-treatment Follow-up|Progressive Disease|0|||
27925088|NCT02335944|81564819|FG005|Post-treatment Follow-up|Progressive Disease|9|||
27925089|NCT02335944|81564820|FG006|Post-treatment Follow-up|Progressive Disease|0|||
27925090|NCT02335944|81564821|FG007|Post-treatment Follow-up|Progressive Disease|2|||
27925091|NCT02335944|81564822|FG008|Post-treatment Follow-up|Progressive Disease|3|||
27925092|NCT02335944|81564823|FG009|Post-treatment Follow-up|Progressive Disease|0|||
27925093|NCT02335944|81564814|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925094|NCT02335944|81564815|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925095|NCT02335944|81564816|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925096|NCT02335944|81564817|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925097|NCT02335944|81564818|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925098|NCT02335944|81564819|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
27925099|NCT02335944|81564820|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925100|NCT02335944|81564821|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925101|NCT02335944|81564822|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925102|NCT02335944|81564823|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
27925103|NCT02335944|81564814|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925104|NCT02335944|81564815|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925105|NCT02335944|81564816|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925106|NCT02335944|81564817|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925107|NCT02335944|81564818|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925108|NCT02335944|81564819|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925109|NCT02335944|81564820|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925110|NCT02335944|81564821|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
27925111|NCT02335944|81564822|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925112|NCT02335944|81564823|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
27925113|NCT02335944|81564814|FG000|Post-treatment Follow-up|Adverse Event|0|||
27925114|NCT02335944|81564815|FG001|Post-treatment Follow-up|Adverse Event|0|||
27925115|NCT02335944|81564816|FG002|Post-treatment Follow-up|Adverse Event|0|||
27925116|NCT02335944|81564817|FG003|Post-treatment Follow-up|Adverse Event|0|||
27925117|NCT02335944|81564818|FG004|Post-treatment Follow-up|Adverse Event|0|||
27925118|NCT02335944|81564819|FG005|Post-treatment Follow-up|Adverse Event|1|||
27925119|NCT02335944|81564820|FG006|Post-treatment Follow-up|Adverse Event|0|||
27925120|NCT02335944|81564821|FG007|Post-treatment Follow-up|Adverse Event|0|||
27925121|NCT02335944|81564822|FG008|Post-treatment Follow-up|Adverse Event|0|||
27925122|NCT02335944|81564823|FG009|Post-treatment Follow-up|Adverse Event|0|||
27925123|NCT02335944|81564814|FG000|Post-treatment Follow-up|Death|0|||
27925124|NCT02335944|81564815|FG001|Post-treatment Follow-up|Death|0|||
27925125|NCT02335944|81564816|FG002|Post-treatment Follow-up|Death|0|||
27925126|NCT02335944|81564817|FG003|Post-treatment Follow-up|Death|1|||
27925127|NCT02335944|81564818|FG004|Post-treatment Follow-up|Death|0|||
27925128|NCT02335944|81564819|FG005|Post-treatment Follow-up|Death|1|||
27545416|NCT00619177|80185948|FG000|Overall Study|Lack of Efficacy|1|||
27545417|NCT00619177|80185948|FG000|Overall Study|Missing termination information|481|||
27545418|NCT00619177|80185948|FG000|Overall Study|Not specified reasons|6|||
27639003|NCT02396316|80518950|FG000|Overall Study|Progressive disease|6|||
27639004|NCT02396316|80518951|FG001|Overall Study|Progressive disease|3|||
27639005|NCT02396316|80518950|FG000|Overall Study|Protocol Violation|0|||
27639006|NCT02396316|80518951|FG001|Overall Study|Protocol Violation|1|||
27639007|NCT02396316|80518950|FG000|Overall Study|Treatment unblinded|0|||
27639008|NCT02396316|80518951|FG001|Overall Study|Treatment unblinded|1|||
27639009|NCT00901901|80522023|FG000|Treatment Period|Adverse Event|120|||
27639010|NCT00901901|80522024|FG001|Treatment Period|Adverse Event|128|||
27639011|NCT00901901|80522023|FG000|Treatment Period|Withdrawal by Subject|26|||
27639012|NCT00901901|80522024|FG001|Treatment Period|Withdrawal by Subject|24|||
27639013|NCT00901901|80522023|FG000|Treatment Period|Physician Decision|2|||
27639014|NCT00901901|80522024|FG001|Treatment Period|Physician Decision|2|||
27639015|NCT00901901|80522023|FG000|Treatment Period|Lost to Follow-up|3|||
27639016|NCT00901901|80522024|FG001|Treatment Period|Lost to Follow-up|5|||
27639017|NCT00901901|80522023|FG000|Treatment Period|Noncompliance with study medication|4|||
27639018|NCT00901901|80522024|FG001|Treatment Period|Noncompliance with study medication|1|||
27741985|NCT04430582|80884222|FG000|Overall Study|Withdrawal by Subject|0|||
27741986|NCT04430582|80884223|FG001|Overall Study|Withdrawal by Subject|1|||
27925129|NCT02335944|81564820|FG006|Post-treatment Follow-up|Death|0|||
27925130|NCT02335944|81564821|FG007|Post-treatment Follow-up|Death|0|||
27925131|NCT02335944|81564822|FG008|Post-treatment Follow-up|Death|0|||
27925132|NCT02335944|81564823|FG009|Post-treatment Follow-up|Death|0|||
27925133|NCT02335944|81564814|FG000|Post-treatment Follow-up|Physician Decision|1|||
27925134|NCT02335944|81564815|FG001|Post-treatment Follow-up|Physician Decision|0|||
27925135|NCT02335944|81564816|FG002|Post-treatment Follow-up|Physician Decision|0|||
27925136|NCT02335944|81564817|FG003|Post-treatment Follow-up|Physician Decision|0|||
27925137|NCT02335944|81564818|FG004|Post-treatment Follow-up|Physician Decision|0|||
27925138|NCT02335944|81564819|FG005|Post-treatment Follow-up|Physician Decision|0|||
27925139|NCT02335944|81564820|FG006|Post-treatment Follow-up|Physician Decision|0|||
27925140|NCT02335944|81564821|FG007|Post-treatment Follow-up|Physician Decision|1|||
27925141|NCT02335944|81564822|FG008|Post-treatment Follow-up|Physician Decision|0|||
27925142|NCT02335944|81564823|FG009|Post-treatment Follow-up|Physician Decision|0|||
27925143|NCT02188160|81564824|FG000|Overall Study|Adverse Event|1|||
27545419|NCT01626456|80189408|FG000|Overall Study|Withdrawal by Subject|21|||
27545420|NCT01626456|80189409|FG001|Overall Study|Withdrawal by Subject|46|||
27545421|NCT01626456|80189408|FG000|Overall Study|Adverse Event|2|||
27545422|NCT01626456|80189409|FG001|Overall Study|Adverse Event|27|||
27545423|NCT01626456|80189408|FG000|Overall Study|Lost to Follow-up|2|||
27545424|NCT01626456|80189409|FG001|Overall Study|Lost to Follow-up|27|||
27545425|NCT01626456|80189408|FG000|Overall Study|Lack of Efficacy|6|||
27545426|NCT01626456|80189409|FG001|Overall Study|Lack of Efficacy|7|||
27545427|NCT01626456|80189408|FG000|Overall Study|Physician Decision|1|||
27545428|NCT01626456|80189409|FG001|Overall Study|Physician Decision|4|||
27545429|NCT01626456|80189408|FG000|Overall Study|Protocol Violation|1|||
27545430|NCT01626456|80189409|FG001|Overall Study|Protocol Violation|1|||
27545431|NCT01626456|80189408|FG000|Overall Study|Site Closure|2|||
27545432|NCT01626456|80189409|FG001|Overall Study|Site Closure|3|||
27545433|NCT01626456|80189408|FG000|Overall Study|Incarceration|0|||
27545434|NCT01626456|80189409|FG001|Overall Study|Incarceration|2|||
27545435|NCT00602797|80189410|FG000|Overall Study|Adverse Event|1|||
27545436|NCT01169493|80189411|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
27545437|NCT01169493|80189412|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
27545438|NCT01169493|80189413|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
27545439|NCT01169493|80189414|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
27545440|NCT01169493|80189415|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
27545441|NCT01169493|80189416|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
27545442|NCT01169493|80189411|FG000|Period 3 (6 Months)|Adverse Event|0|||
27545443|NCT01169493|80189412|FG001|Period 3 (6 Months)|Adverse Event|1|||
27545444|NCT01169493|80189413|FG002|Period 3 (6 Months)|Adverse Event|0|||
27545445|NCT01169493|80189414|FG003|Period 3 (6 Months)|Adverse Event|0|||
27545446|NCT01169493|80189415|FG004|Period 3 (6 Months)|Adverse Event|0|||
27545447|NCT01169493|80189416|FG005|Period 3 (6 Months)|Adverse Event|0|||
27545448|NCT01169493|80189411|FG000|Period 3 (6 Months)|Physician Decision|0|||
27545449|NCT01169493|80189412|FG001|Period 3 (6 Months)|Physician Decision|1|||
27545450|NCT01169493|80189413|FG002|Period 3 (6 Months)|Physician Decision|1|||
27545451|NCT01169493|80189414|FG003|Period 3 (6 Months)|Physician Decision|0|||
27545452|NCT01169493|80189415|FG004|Period 3 (6 Months)|Physician Decision|0|||
27545453|NCT01169493|80189416|FG005|Period 3 (6 Months)|Physician Decision|0|||
27545454|NCT00518284|80189419|FG000|Overall Study|Adverse Event|0|||
27545455|NCT00518284|80189420|FG001|Overall Study|Adverse Event|1|||
27545456|NCT00518284|80189421|FG002|Overall Study|Adverse Event|0|||
27545457|NCT00518284|80189422|FG003|Overall Study|Adverse Event|0|||
27639019|NCT00901901|80522023|FG000|Treatment Period|Missing|1|||
27925144|NCT02188160|81564825|FG001|Overall Study|Adverse Event|0|||
27925145|NCT02188160|81564824|FG000|Overall Study|Use of an excluded medication|0|||
27925146|NCT02188160|81564825|FG001|Overall Study|Use of an excluded medication|1|||
27925147|NCT00851591|81564826|FG000|Overall Study|Withdrawal by Subject|2|||
27545458|NCT00518284|80189419|FG000|Overall Study|Study Termination|0|||
27545459|NCT00518284|80189420|FG001|Overall Study|Study Termination|2|||
27545460|NCT00518284|80189421|FG002|Overall Study|Study Termination|1|||
27545461|NCT00518284|80189422|FG003|Overall Study|Study Termination|2|||
27639020|NCT00901901|80522024|FG001|Treatment Period|Missing|0|||
27639021|NCT00901901|80522023|FG000|Treatment Period|Never treated|0|||
27925148|NCT00851591|81564827|FG001|Overall Study|Withdrawal by Subject|0|||
27545462|NCT00205881|80189423|FG000|Overall Study|Withdrawal by Subject|16|||
27545463|NCT02516163|80189424|FG000|Overall Study|Withdrawal by Subject|1|||
27639022|NCT00901901|80522024|FG001|Treatment Period|Never treated|3|||
27639023|NCT00901901|80522023|FG000|Treatment Period|Protocol driven decision point|0|||
27639024|NCT00901901|80522024|FG001|Treatment Period|Protocol driven decision point|2|||
27639025|NCT00901901|80522023|FG000|Treatment Period|Study terminated by sponsor|2|||
27639026|NCT00901901|80522024|FG001|Treatment Period|Study terminated by sponsor|0|||
27639027|NCT00901901|80522023|FG000|Treatment Period|Protocol Violation|5|||
27639028|NCT00901901|80522024|FG001|Treatment Period|Protocol Violation|9|||
27639029|NCT00901901|80522023|FG000|Treatment Period|Switch to commercial drug|1|||
27639030|NCT00901901|80522024|FG001|Treatment Period|Switch to commercial drug|1|||
27639031|NCT00901901|80522023|FG000|Treatment Period|Transfer to treatment continuation study|5|||
27639032|NCT00901901|80522024|FG001|Treatment Period|Transfer to treatment continuation study|2|||
27639033|NCT00901901|80522023|FG000|Follow-up Period|Death|181|||
27639034|NCT00901901|80522024|FG001|Follow-up Period|Death|208|||
27639035|NCT00901901|80522023|FG000|Follow-up Period|Protocol driven decision point|47|||
27639036|NCT00901901|80522024|FG001|Follow-up Period|Protocol driven decision point|36|||
27639037|NCT00901901|80522023|FG000|Follow-up Period|Withdrawal by Subject|6|||
27639038|NCT00901901|80522024|FG001|Follow-up Period|Withdrawal by Subject|9|||
27925149|NCT01189266|81564830|FG000|Overall Study|Adverse Event|1|||
27545464|NCT02516163|80189424|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
27545465|NCT02516163|80189424|FG000|Overall Study|Unfit/delay in surgery|3|||
27545466|NCT02516163|80189424|FG000|Overall Study|Use of incorrect measurement technique|5|||
27545467|NCT02516163|80189424|FG000|Overall Study|Data not recorded|2|||
27545468|NCT02516163|80189424|FG000|Overall Study|MRI contraindication exclusion|6|||
27545469|NCT00851747|80189431|FG000|Overall Study|Physician Decision|6|||
27545470|NCT00851747|80189432|FG001|Overall Study|Physician Decision|6|||
27545471|NCT00851747|80189433|FG002|Overall Study|Physician Decision|6|||
27545472|NCT00838578|80189434|FG000|Overall Study|Protocol Violation|2|||
27545473|NCT01306942|80189435|FG000|Phase I|Adverse Event|2|||
27545474|NCT01306942|80189436|FG001|Phase I|Adverse Event|2|||
27545475|NCT01306942|80189437|FG002|Phase I|Adverse Event|0|||
27545476|NCT01306942|80189438|FG003|Phase I|Adverse Event|0|||
27545477|NCT01306942|80189435|FG000|Phase I|Physician Decision|3|||
27545478|NCT01306942|80189436|FG001|Phase I|Physician Decision|1|||
27545479|NCT01306942|80189437|FG002|Phase I|Physician Decision|0|||
27545480|NCT01306942|80189438|FG003|Phase I|Physician Decision|0|||
27545481|NCT01306942|80189435|FG000|Phase II|Adverse Event|0|||
27545482|NCT01306942|80189436|FG001|Phase II|Adverse Event|0|||
27545483|NCT01306942|80189437|FG002|Phase II|Adverse Event|0|||
27545484|NCT01306942|80189438|FG003|Phase II|Adverse Event|6|||
27545485|NCT01306942|80189435|FG000|Phase II|Physician Decision|2|||
27545486|NCT01306942|80189436|FG001|Phase II|Physician Decision|0|||
27545487|NCT01306942|80189437|FG002|Phase II|Physician Decision|0|||
27545488|NCT01306942|80189438|FG003|Phase II|Physician Decision|5|||
27545489|NCT01306942|80189435|FG000|Phase II|Withdrawal by Subject|0|||
27545490|NCT01306942|80189436|FG001|Phase II|Withdrawal by Subject|0|||
27545491|NCT01306942|80189437|FG002|Phase II|Withdrawal by Subject|0|||
27545492|NCT01306942|80189438|FG003|Phase II|Withdrawal by Subject|2|||
27545493|NCT01306942|80189435|FG000|Phase II|Death|0|||
27545494|NCT01306942|80189436|FG001|Phase II|Death|0|||
27545495|NCT01306942|80189437|FG002|Phase II|Death|0|||
27545496|NCT01306942|80189438|FG003|Phase II|Death|1|||
27545497|NCT01306942|80189435|FG000|Phase II|Not finished treatment|0|||
27545498|NCT01306942|80189436|FG001|Phase II|Not finished treatment|0|||
27545499|NCT01306942|80189437|FG002|Phase II|Not finished treatment|0|||
27545500|NCT01306942|80189438|FG003|Phase II|Not finished treatment|1|||
27545501|NCT01306942|80189435|FG000|Phase II|Protocol Violation|0|||
27545502|NCT01306942|80189436|FG001|Phase II|Protocol Violation|0|||
27545503|NCT01306942|80189437|FG002|Phase II|Protocol Violation|0|||
27545504|NCT01306942|80189438|FG003|Phase II|Protocol Violation|1|||
27545505|NCT01416272|80189439|FG000|Overall Study|Unacceptable distance visual acuity|2|||
27545506|NCT01416272|80189439|FG000|Overall Study|Lost to Follow-up|1|||
27545507|NCT01416272|80189439|FG000|Overall Study|Study related complaints|1|||
27545508|NCT02256631|80189440|FG000|Overall Study|Lost to Follow-up|1|||
27545509|NCT02256631|80189441|FG001|Overall Study|Lost to Follow-up|1|||
27545510|NCT02256631|80189442|FG002|Overall Study|Lost to Follow-up|0|||
27545511|NCT02256631|80189443|FG003|Overall Study|Lost to Follow-up|2|||
27545512|NCT02256631|80189444|FG004|Overall Study|Lost to Follow-up|0|||
27639039|NCT00901901|80522023|FG000|Follow-up Period|Lost to Follow-up|12|||
27639040|NCT00901901|80522024|FG001|Follow-up Period|Lost to Follow-up|8|||
27639041|NCT00901901|80522023|FG000|Follow-up Period|Missing|94|||
27741987|NCT04786210|80884228|FG000|Overall Study|Lost to Follow-up|2|||
27741988|NCT04786210|80884228|FG000|Overall Study|Withdrawal by Subject|4|||
27741989|NCT01300286|80884229|FG000|Overall Study|did not get dosed|1|||
27741990|NCT02955186|80884230|FG000|Overall Study|Withdrawal by Subject|6|||
27741991|NCT02955186|80884231|FG001|Overall Study|Withdrawal by Subject|2|||
27545513|NCT02256631|80189445|FG005|Overall Study|Lost to Follow-up|4|||
27639042|NCT00901901|80522024|FG001|Follow-up Period|Missing|80|||
27639043|NCT00840177|80522028|FG000|Overall Study|Adverse Event|5|||
27639044|NCT00840177|80522029|FG001|Overall Study|Adverse Event|1|||
27639045|NCT00840177|80522030|FG002|Overall Study|Adverse Event|1|||
27639046|NCT00840177|80522028|FG000|Overall Study|Refusal unrelated to adverse events|1|||
27639047|NCT00840177|80522029|FG001|Overall Study|Refusal unrelated to adverse events|0|||
27639048|NCT00840177|80522030|FG002|Overall Study|Refusal unrelated to adverse events|1|||
27639049|NCT00840177|80522028|FG000|Overall Study|Progression/relapse|2|||
27639050|NCT00840177|80522029|FG001|Overall Study|Progression/relapse|0|||
27639051|NCT00840177|80522030|FG002|Overall Study|Progression/relapse|0|||
27639052|NCT00840177|80522028|FG000|Overall Study|Death|4|||
27741992|NCT02955186|80884230|FG000|Overall Study|Protocol Violation|1|||
27545514|NCT02256631|80189446|FG006|Overall Study|Lost to Follow-up|1|||
27545515|NCT02256631|80189440|FG000|Overall Study|Withdrawal by Subject|0|||
27545516|NCT02256631|80189441|FG001|Overall Study|Withdrawal by Subject|0|||
27545517|NCT02256631|80189442|FG002|Overall Study|Withdrawal by Subject|0|||
27545518|NCT02256631|80189443|FG003|Overall Study|Withdrawal by Subject|1|||
27545519|NCT02256631|80189444|FG004|Overall Study|Withdrawal by Subject|1|||
27545520|NCT02256631|80189445|FG005|Overall Study|Withdrawal by Subject|0|||
27545521|NCT02256631|80189446|FG006|Overall Study|Withdrawal by Subject|1|||
27545522|NCT02256631|80189440|FG000|Overall Study|Unable to get to clinic|0|||
27545523|NCT02256631|80189441|FG001|Overall Study|Unable to get to clinic|2|||
27545524|NCT02256631|80189442|FG002|Overall Study|Unable to get to clinic|0|||
27545525|NCT02256631|80189443|FG003|Overall Study|Unable to get to clinic|1|||
27545526|NCT02256631|80189444|FG004|Overall Study|Unable to get to clinic|0|||
27545527|NCT02256631|80189445|FG005|Overall Study|Unable to get to clinic|1|||
27545528|NCT02256631|80189446|FG006|Overall Study|Unable to get to clinic|2|||
27545529|NCT00126191|80189447|FG000|Overall Study|Physician Decision|0|||
27545530|NCT00126191|80189448|FG001|Overall Study|Physician Decision|1|||
27545531|NCT00126191|80189447|FG000|Overall Study|Death|0|||
27545532|NCT00126191|80189448|FG001|Overall Study|Death|1|||
27545533|NCT00042289|80189449|FG000|Overall Study|Lost to Follow-up|3|||
27545534|NCT00042289|80189450|FG001|Overall Study|Lost to Follow-up|0|||
27545535|NCT00042289|80189451|FG002|Overall Study|Lost to Follow-up|0|||
27545536|NCT00042289|80189452|FG003|Overall Study|Lost to Follow-up|1|||
27545537|NCT00042289|80189453|FG004|Overall Study|Lost to Follow-up|3|||
27545538|NCT00042289|80189454|FG005|Overall Study|Lost to Follow-up|3|||
27545539|NCT00042289|80189455|FG006|Overall Study|Lost to Follow-up|6|||
27545540|NCT00042289|80189456|FG007|Overall Study|Lost to Follow-up|1|||
27545541|NCT00042289|80189457|FG008|Overall Study|Lost to Follow-up|1|||
27545542|NCT00042289|80189458|FG009|Overall Study|Lost to Follow-up|0|||
27545543|NCT00042289|80189459|FG010|Overall Study|Lost to Follow-up|0|||
27545544|NCT00042289|80189460|FG011|Overall Study|Lost to Follow-up|0|||
27545545|NCT00042289|80189461|FG012|Overall Study|Lost to Follow-up|0|||
27545546|NCT00042289|80189462|FG013|Overall Study|Lost to Follow-up|0|||
27545547|NCT00042289|80189463|FG014|Overall Study|Lost to Follow-up|0|||
27545548|NCT00042289|80189464|FG015|Overall Study|Lost to Follow-up|1|||
27545549|NCT00042289|80189465|FG016|Overall Study|Lost to Follow-up|1|||
27545550|NCT00042289|80189466|FG017|Overall Study|Lost to Follow-up|0|||
27545551|NCT00042289|80189467|FG018|Overall Study|Lost to Follow-up|3|||
27545552|NCT00042289|80189468|FG019|Overall Study|Lost to Follow-up|2|||
27545553|NCT00042289|80189469|FG020|Overall Study|Lost to Follow-up|0|||
27545554|NCT00042289|80189470|FG021|Overall Study|Lost to Follow-up|0|||
27545555|NCT00042289|80189471|FG022|Overall Study|Lost to Follow-up|0|||
27545556|NCT00042289|80189472|FG023|Overall Study|Lost to Follow-up|0|||
27545557|NCT00042289|80189473|FG024|Overall Study|Lost to Follow-up|0|||
27545558|NCT00042289|80189474|FG025|Overall Study|Lost to Follow-up|0|||
27545559|NCT00042289|80189475|FG026|Overall Study|Lost to Follow-up|2|||
27545560|NCT00042289|80189476|FG027|Overall Study|Lost to Follow-up|2|||
27545561|NCT00042289|80189477|FG028|Overall Study|Lost to Follow-up|2|||
27545562|NCT00042289|80189478|FG029|Overall Study|Lost to Follow-up|0|||
27545563|NCT00042289|80189479|FG030|Overall Study|Lost to Follow-up|0|||
27545564|NCT00042289|80189480|FG031|Overall Study|Lost to Follow-up|2|||
27545565|NCT00042289|80189481|FG032|Overall Study|Lost to Follow-up|1|||
27545566|NCT00042289|80189482|FG033|Overall Study|Lost to Follow-up|1|||
27545567|NCT00042289|80189483|FG034|Overall Study|Lost to Follow-up|1|||
27639053|NCT00840177|80522029|FG001|Overall Study|Death|5|||
27639054|NCT00840177|80522030|FG002|Overall Study|Death|5|||
27545568|NCT00042289|80189484|FG035|Overall Study|Lost to Follow-up|2|||
27545569|NCT00042289|80189485|FG036|Overall Study|Lost to Follow-up|1|||
27545570|NCT00042289|80189486|FG037|Overall Study|Lost to Follow-up|1|||
27545571|NCT00042289|80189487|FG038|Overall Study|Lost to Follow-up|0|||
27545572|NCT00042289|80189488|FG039|Overall Study|Lost to Follow-up|5|||
27741993|NCT02955186|80884231|FG001|Overall Study|Protocol Violation|0|||
27925150|NCT01189266|81564831|FG001|Overall Study|Adverse Event|0|||
27925151|NCT01189266|81564832|FG002|Overall Study|Adverse Event|5|||
27925152|NCT01189266|81564830|FG000|Overall Study|Death|0|||
27925153|NCT01189266|81564831|FG001|Overall Study|Death|0|||
27925154|NCT01189266|81564832|FG002|Overall Study|Death|5|||
27925155|NCT01189266|81564830|FG000|Overall Study|Lack of Efficacy|4|||
27925156|NCT01189266|81564831|FG001|Overall Study|Lack of Efficacy|5|||
27925157|NCT01189266|81564832|FG002|Overall Study|Lack of Efficacy|44|||
27925158|NCT01189266|81564830|FG000|Overall Study|Physician Decision|0|||
27925159|NCT01189266|81564831|FG001|Overall Study|Physician Decision|0|||
27925160|NCT01189266|81564832|FG002|Overall Study|Physician Decision|1|||
27925161|NCT01189266|81564830|FG000|Overall Study|Protocol Violation|0|||
27925162|NCT01189266|81564831|FG001|Overall Study|Protocol Violation|1|||
27925163|NCT01189266|81564832|FG002|Overall Study|Protocol Violation|1|||
27925164|NCT01189266|81564830|FG000|Overall Study|Withdrawal by Subject|0|||
27925165|NCT01189266|81564831|FG001|Overall Study|Withdrawal by Subject|0|||
27925166|NCT01189266|81564832|FG002|Overall Study|Withdrawal by Subject|1|||
27925167|NCT01189266|81564830|FG000|Overall Study|Patient refuses further therapy|1|||
27925168|NCT01189266|81564831|FG001|Overall Study|Patient refuses further therapy|0|||
27545573|NCT00042289|80189489|FG040|Overall Study|Lost to Follow-up|0|||
27545574|NCT00042289|80189490|FG041|Overall Study|Lost to Follow-up|2|||
27545575|NCT00042289|80189491|FG042|Overall Study|Lost to Follow-up|2|||
27545576|NCT00042289|80189492|FG043|Overall Study|Lost to Follow-up|0|||
27545577|NCT00042289|80189493|FG044|Overall Study|Lost to Follow-up|0|||
27545578|NCT00042289|80189494|FG045|Overall Study|Lost to Follow-up|1|||
27925169|NCT01189266|81564832|FG002|Overall Study|Patient refuses further therapy|7|||
27925170|NCT01189266|81564830|FG000|Overall Study|No treatment|0|||
27925171|NCT01189266|81564831|FG001|Overall Study|No treatment|0|||
27925172|NCT01189266|81564832|FG002|Overall Study|No treatment|1|||
27925173|NCT02555878|81564840|FG000|Overall Study|Lost to Follow-up|2|||
27545579|NCT00042289|80189495|FG046|Overall Study|Lost to Follow-up|0|||
27545580|NCT00042289|80189449|FG000|Overall Study|Other reason|0|||
27545581|NCT00042289|80189450|FG001|Overall Study|Other reason|0|||
27545582|NCT00042289|80189451|FG002|Overall Study|Other reason|0|||
27545583|NCT00042289|80189452|FG003|Overall Study|Other reason|2|||
27545584|NCT00042289|80189453|FG004|Overall Study|Other reason|0|||
27545585|NCT00042289|80189454|FG005|Overall Study|Other reason|0|||
27545586|NCT00042289|80189455|FG006|Overall Study|Other reason|0|||
27545587|NCT00042289|80189456|FG007|Overall Study|Other reason|0|||
27545588|NCT00042289|80189457|FG008|Overall Study|Other reason|0|||
27545589|NCT00042289|80189458|FG009|Overall Study|Other reason|0|||
27545590|NCT00042289|80189459|FG010|Overall Study|Other reason|0|||
27545591|NCT00042289|80189460|FG011|Overall Study|Other reason|0|||
27545592|NCT00042289|80189461|FG012|Overall Study|Other reason|0|||
27545593|NCT00042289|80189462|FG013|Overall Study|Other reason|0|||
27545594|NCT00042289|80189463|FG014|Overall Study|Other reason|0|||
27545595|NCT00042289|80189464|FG015|Overall Study|Other reason|0|||
27545596|NCT00042289|80189465|FG016|Overall Study|Other reason|0|||
27545597|NCT00042289|80189466|FG017|Overall Study|Other reason|0|||
27545598|NCT00042289|80189467|FG018|Overall Study|Other reason|1|||
27545599|NCT00042289|80189468|FG019|Overall Study|Other reason|0|||
27545600|NCT00042289|80189469|FG020|Overall Study|Other reason|0|||
27545601|NCT00042289|80189470|FG021|Overall Study|Other reason|0|||
27545602|NCT00042289|80189471|FG022|Overall Study|Other reason|0|||
27545603|NCT00042289|80189472|FG023|Overall Study|Other reason|1|||
27545604|NCT00042289|80189473|FG024|Overall Study|Other reason|0|||
27545605|NCT00042289|80189474|FG025|Overall Study|Other reason|0|||
27545606|NCT00042289|80189475|FG026|Overall Study|Other reason|1|||
27545607|NCT00042289|80189476|FG027|Overall Study|Other reason|0|||
27545608|NCT00042289|80189477|FG028|Overall Study|Other reason|3|||
27545609|NCT00042289|80189478|FG029|Overall Study|Other reason|0|||
27545610|NCT00042289|80189479|FG030|Overall Study|Other reason|0|||
27545611|NCT00042289|80189480|FG031|Overall Study|Other reason|1|||
27545612|NCT00042289|80189481|FG032|Overall Study|Other reason|0|||
27545613|NCT00042289|80189482|FG033|Overall Study|Other reason|1|||
27545614|NCT00042289|80189483|FG034|Overall Study|Other reason|0|||
27545615|NCT00042289|80189484|FG035|Overall Study|Other reason|2|||
27545616|NCT00042289|80189485|FG036|Overall Study|Other reason|0|||
27545617|NCT00042289|80189486|FG037|Overall Study|Other reason|0|||
27545618|NCT00042289|80189487|FG038|Overall Study|Other reason|0|||
27545619|NCT00042289|80189488|FG039|Overall Study|Other reason|0|||
27545620|NCT00042289|80189489|FG040|Overall Study|Other reason|0|||
27545621|NCT00042289|80189490|FG041|Overall Study|Other reason|0|||
27545622|NCT00042289|80189491|FG042|Overall Study|Other reason|0|||
27545623|NCT00042289|80189492|FG043|Overall Study|Other reason|1|||
27925174|NCT02555878|81564841|FG001|Overall Study|Lost to Follow-up|3|||
27925175|NCT02555878|81564840|FG000|Overall Study|Withdrawal by Subject|48|||
27925176|NCT02555878|81564841|FG001|Overall Study|Withdrawal by Subject|48|||
27925177|NCT02555878|81564840|FG000|Overall Study|Adverse Event|12|||
27925178|NCT02555878|81564841|FG001|Overall Study|Adverse Event|8|||
27925179|NCT02555878|81564840|FG000|Overall Study|Death|74|||
27639055|NCT00840177|80522028|FG000|Overall Study|not protocol specified|6|||
27639056|NCT00840177|80522029|FG001|Overall Study|not protocol specified|3|||
27639057|NCT00840177|80522030|FG002|Overall Study|not protocol specified|0|||
27925180|NCT02555878|81564841|FG001|Overall Study|Death|59|||
27925181|NCT02555878|81564840|FG000|Overall Study|Protocol Violation|1|||
27639058|NCT00840177|80522028|FG000|Overall Study|Ineligible|0|||
27639059|NCT00840177|80522029|FG001|Overall Study|Ineligible|0|||
27925182|NCT02555878|81564841|FG001|Overall Study|Protocol Violation|2|||
27925183|NCT02555878|81564840|FG000|Overall Study|Physician Decision|12|||
27925184|NCT02555878|81564841|FG001|Overall Study|Physician Decision|13|||
27925185|NCT02555878|81564840|FG000|Overall Study|Other|17|||
27925186|NCT02555878|81564841|FG001|Overall Study|Other|17|||
27925187|NCT00671749|81564842|FG000|Overall Study|Adverse Event|2|||
27925188|NCT00671749|81564842|FG000|Overall Study|Withdrawal by Subject|4|||
27925189|NCT00671749|81564842|FG000|Overall Study|Protocol Violation|1|||
27925190|NCT00671749|81564842|FG000|Overall Study|Lost to Follow-up|1|||
27925191|NCT00317369|81564843|FG000|Overall Study|Adverse Event|2|||
27925192|NCT00317369|81564844|FG001|Overall Study|Adverse Event|1|||
27925193|NCT00317369|81564845|FG002|Overall Study|Adverse Event|0|||
27925194|NCT00317369|81564843|FG000|Overall Study|Lack of Efficacy|0|||
27925195|NCT00317369|81564844|FG001|Overall Study|Lack of Efficacy|1|||
27925196|NCT00317369|81564845|FG002|Overall Study|Lack of Efficacy|1|||
27925197|NCT00317369|81564843|FG000|Overall Study|Withdrawal by Subject|0|||
27925198|NCT00317369|81564844|FG001|Overall Study|Withdrawal by Subject|0|||
27925199|NCT00317369|81564845|FG002|Overall Study|Withdrawal by Subject|1|||
27925200|NCT03101020|81564846|FG000|Overall Study|Lack of time to participate|1|||
27925201|NCT03101020|81564847|FG001|Overall Study|Lack of time to participate|0|||
27925202|NCT03101020|81564846|FG000|Overall Study|Ran over by a car|0|||
27925203|NCT03101020|81564847|FG001|Overall Study|Ran over by a car|1|||
27925204|NCT03101020|81564846|FG000|Overall Study|Withdrawal by Subject|0|||
27925205|NCT03101020|81564847|FG001|Overall Study|Withdrawal by Subject|2|||
27925206|NCT02059239|81564848|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
27925207|NCT02059239|81564849|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
27925208|NCT02059239|81564848|FG000|Overall Study|Physician Decision|1|||
27925209|NCT02059239|81564849|FG001|Overall Study|Physician Decision|0|||
27925210|NCT01603602|81564851|FG000|Overall Study|Adverse Event|1|||
27925211|NCT01603602|81564852|FG001|Overall Study|Adverse Event|0|||
27925212|NCT01603602|81564853|FG002|Overall Study|Adverse Event|0|||
27925213|NCT01603602|81564851|FG000|Overall Study|Personal Reasons|1|||
27925214|NCT01603602|81564852|FG001|Overall Study|Personal Reasons|0|||
27925215|NCT01603602|81564853|FG002|Overall Study|Personal Reasons|1|||
27925216|NCT04739709|81564859|FG000|Overall Study|Physician Decision|1|||
27925217|NCT04739709|81564860|FG001|Overall Study|Physician Decision|0|||
27925218|NCT03416179|81564863|FG000|Overall Study|Death|90|||
27925219|NCT03416179|81564864|FG001|Overall Study|Death|87|||
27925220|NCT03416179|81564865|FG002|Overall Study|Death|117|||
27925221|NCT03416179|81564866|FG003|Overall Study|Death|113|||
27925222|NCT03416179|81564863|FG000|Overall Study|Withdrawal by Subject|15|||
27925223|NCT03416179|81564864|FG001|Overall Study|Withdrawal by Subject|20|||
27545624|NCT00042289|80189493|FG044|Overall Study|Other reason|0|||
27545625|NCT00042289|80189494|FG045|Overall Study|Other reason|0|||
27545626|NCT00042289|80189495|FG046|Overall Study|Other reason|0|||
27545627|NCT00042289|80189449|FG000|Overall Study|Severe debilitation, unable to continue|0|||
27545628|NCT00042289|80189450|FG001|Overall Study|Severe debilitation, unable to continue|0|||
27545629|NCT00042289|80189451|FG002|Overall Study|Severe debilitation, unable to continue|0|||
27545630|NCT00042289|80189452|FG003|Overall Study|Severe debilitation, unable to continue|0|||
27545631|NCT00042289|80189453|FG004|Overall Study|Severe debilitation, unable to continue|0|||
27639060|NCT00840177|80522030|FG002|Overall Study|Ineligible|3|||
27639061|NCT00840177|80522028|FG000|Overall Study|Did not start treatment|0|||
27639062|NCT00840177|80522029|FG001|Overall Study|Did not start treatment|0|||
27639063|NCT00840177|80522030|FG002|Overall Study|Did not start treatment|1|||
27639064|NCT02566902|80522031|FG000|Overall Study|Protocol Violation|2|||
27639065|NCT02566902|80522032|FG001|Overall Study|Protocol Violation|1|||
27639066|NCT02932579|80522034|FG000|Overall Study|Withdrawal by Subject|4|||
27925224|NCT03416179|81564865|FG002|Overall Study|Withdrawal by Subject|6|||
27925225|NCT03416179|81564866|FG003|Overall Study|Withdrawal by Subject|9|||
27925226|NCT03416179|81564863|FG000|Overall Study|Lost to Follow-up|1|||
27925227|NCT03416179|81564864|FG001|Overall Study|Lost to Follow-up|1|||
27925228|NCT03416179|81564865|FG002|Overall Study|Lost to Follow-up|0|||
27639067|NCT02932579|80522035|FG001|Overall Study|Withdrawal by Subject|1|||
27639068|NCT01571596|80522036|FG000|Overall Study|Adverse Event|2|||
27639069|NCT01571596|80522037|FG001|Overall Study|Adverse Event|0|||
27925229|NCT03416179|81564866|FG003|Overall Study|Lost to Follow-up|3|||
27925230|NCT03416179|81564863|FG000|Overall Study|Study participation terminated by Sponsor|93|||
27925231|NCT03416179|81564864|FG001|Overall Study|Study participation terminated by Sponsor|91|||
27925232|NCT03416179|81564865|FG002|Overall Study|Study participation terminated by Sponsor|26|||
27925233|NCT03416179|81564866|FG003|Overall Study|Study participation terminated by Sponsor|31|||
27925234|NCT03416179|81564863|FG000|Overall Study|Other|2|||
27925235|NCT03416179|81564864|FG001|Overall Study|Other|3|||
27925236|NCT03416179|81564865|FG002|Overall Study|Other|1|||
27925237|NCT03416179|81564866|FG003|Overall Study|Other|0|||
27925238|NCT02058095|81564869|FG000|Overall Study|Adverse Event|1|||
27925239|NCT02058095|81564870|FG001|Overall Study|Adverse Event|0|||
27925240|NCT02787304|81564871|FG000|Overall Study|Adverse Event|9|||
27925241|NCT02787304|81564872|FG001|Overall Study|Adverse Event|3|||
27925242|NCT02787304|81564873|FG002|Overall Study|Adverse Event|8|||
27925243|NCT02787304|81564874|FG003|Overall Study|Adverse Event|1|||
27925244|NCT02787304|81564871|FG000|Overall Study|Withdrawal by Subject|1|||
27925245|NCT02787304|81564872|FG001|Overall Study|Withdrawal by Subject|4|||
27925246|NCT02787304|81564873|FG002|Overall Study|Withdrawal by Subject|0|||
27925247|NCT02787304|81564874|FG003|Overall Study|Withdrawal by Subject|0|||
27925248|NCT02787304|81564871|FG000|Overall Study|Lost to Follow-up|1|||
27925249|NCT02787304|81564872|FG001|Overall Study|Lost to Follow-up|0|||
27925250|NCT02787304|81564873|FG002|Overall Study|Lost to Follow-up|0|||
27925251|NCT02787304|81564874|FG003|Overall Study|Lost to Follow-up|1|||
27925252|NCT02787304|81564871|FG000|Overall Study|Noncompliance with study drug|0|||
27925253|NCT02787304|81564872|FG001|Overall Study|Noncompliance with study drug|0|||
27925254|NCT02787304|81564873|FG002|Overall Study|Noncompliance with study drug|1|||
27925255|NCT02787304|81564874|FG003|Overall Study|Noncompliance with study drug|0|||
27925256|NCT02787304|81564871|FG000|Overall Study|Physician Decision|0|||
27925257|NCT02787304|81564872|FG001|Overall Study|Physician Decision|0|||
27925258|NCT02787304|81564873|FG002|Overall Study|Physician Decision|1|||
27925259|NCT02787304|81564874|FG003|Overall Study|Physician Decision|0|||
27925260|NCT02787304|81564871|FG000|Overall Study|Study terminated by sponsor|25|||
27925261|NCT02787304|81564872|FG001|Overall Study|Study terminated by sponsor|31|||
27925262|NCT02787304|81564873|FG002|Overall Study|Study terminated by sponsor|31|||
27925263|NCT02787304|81564874|FG003|Overall Study|Study terminated by sponsor|32|||
27925264|NCT02572167|81564875|FG000|Overall Study|Withdrawal by Subject|0|||
27925265|NCT02572167|81564876|FG001|Overall Study|Withdrawal by Subject|3|||
27925266|NCT02572167|81564877|FG002|Overall Study|Withdrawal by Subject|0|||
27925267|NCT02572167|81564875|FG000|Overall Study|Lost to Follow-up|2|||
27925268|NCT02572167|81564876|FG001|Overall Study|Lost to Follow-up|5|||
27925269|NCT02572167|81564877|FG002|Overall Study|Lost to Follow-up|3|||
27925270|NCT02572167|81564875|FG000|Overall Study|Death|0|||
27925271|NCT02572167|81564876|FG001|Overall Study|Death|8|||
27925272|NCT02572167|81564877|FG002|Overall Study|Death|3|||
27925273|NCT02572167|81564875|FG000|Overall Study|Did not meet inclusion criteria|0|||
27925274|NCT02572167|81564876|FG001|Overall Study|Did not meet inclusion criteria|0|||
27925275|NCT02572167|81564877|FG002|Overall Study|Did not meet inclusion criteria|1|||
27925276|NCT02572167|81564875|FG000|Overall Study|Study closure by Sponsor|4|||
27925277|NCT02572167|81564876|FG001|Overall Study|Study closure by Sponsor|40|||
27925278|NCT02572167|81564877|FG002|Overall Study|Study closure by Sponsor|24|||
27925279|NCT03617588|81564878|FG000|Overall Study|Withdrawal by Subject|1|||
27925280|NCT03617588|81564879|FG001|Overall Study|Withdrawal by Subject|0|||
27925281|NCT02515227|81564880|FG000|Overall Study|Adverse Event|0|||
27925282|NCT02515227|81564881|FG001|Overall Study|Adverse Event|2|||
27925283|NCT02515227|81564880|FG000|Overall Study|Progressive disease|2|||
27925284|NCT02515227|81564881|FG001|Overall Study|Progressive disease|9|||
27925285|NCT00420745|81564885|FG000|Overall Study|Adverse Event|2|||
27925286|NCT00420745|81564886|FG001|Overall Study|Adverse Event|2|||
27925287|NCT00420745|81564885|FG000|Overall Study|Lost to Follow-up|10|||
27925288|NCT00420745|81564886|FG001|Overall Study|Lost to Follow-up|2|||
27925289|NCT00420745|81564885|FG000|Overall Study|Protocol Violation|1|||
27925290|NCT00420745|81564886|FG001|Overall Study|Protocol Violation|0|||
27925291|NCT00420745|81564885|FG000|Overall Study|Physician Decision|1|||
27925292|NCT00420745|81564886|FG001|Overall Study|Physician Decision|1|||
27925293|NCT00420745|81564885|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
27925294|NCT00420745|81564886|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
27925295|NCT00420745|81564885|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
27925296|NCT00420745|81564886|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
27925297|NCT02475369|81564887|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
27925298|NCT02475369|81564888|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
27925299|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
27925300|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
27925301|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
27925302|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
27925303|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
27925304|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
27925305|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
27925306|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
27925307|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
27925308|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
27925309|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
27639070|NCT01571596|80522038|FG002|Overall Study|Adverse Event|0|||
27639071|NCT01571596|80522036|FG000|Overall Study|Study Terminated by the Sponsor|0|||
27639072|NCT01571596|80522037|FG001|Overall Study|Study Terminated by the Sponsor|1|||
27639073|NCT01571596|80522038|FG002|Overall Study|Study Terminated by the Sponsor|1|||
27639074|NCT01424397|80522039|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639075|NCT01424397|80522040|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639076|NCT01424397|80522041|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
27639077|NCT01424397|80522042|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639078|NCT01424397|80522043|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639079|NCT01424397|80522044|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639080|NCT01424397|80522045|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639081|NCT01424397|80522046|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639082|NCT01424397|80522047|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
27925310|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
27925311|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
27925312|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
27925313|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
27925314|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
27925315|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
27925316|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
27925317|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
27925318|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
27925319|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
27925320|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
27925321|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
27925322|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
27925323|NCT01715285|81564889|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
27925324|NCT01715285|81564890|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
27925325|NCT01715285|81564891|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
27925326|NCT01715285|81564889|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
27925327|NCT01715285|81564890|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
27925328|NCT01715285|81564891|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
27925329|NCT01715285|81564889|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
27925330|NCT01715285|81564890|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
27925331|NCT01715285|81564891|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
27925332|NCT01715285|81564889|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
27925333|NCT01715285|81564890|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
27925334|NCT01715285|81564891|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
27925335|NCT01715285|81564889|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
27925336|NCT01715285|81564890|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
27925337|NCT01715285|81564891|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
27925338|NCT01715285|81564889|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
27925339|NCT01715285|81564890|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
27925340|NCT01715285|81564891|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
27925341|NCT00324155|81564895|FG000|Enrolled and Randomized|No longer met study criteria|3|||
27925342|NCT00324155|81564896|FG001|Enrolled and Randomized|No longer met study criteria|0|||
27545632|NCT00042289|80189454|FG005|Overall Study|Severe debilitation, unable to continue|0|||
27545633|NCT00042289|80189455|FG006|Overall Study|Severe debilitation, unable to continue|0|||
27545634|NCT00042289|80189456|FG007|Overall Study|Severe debilitation, unable to continue|0|||
27545635|NCT00042289|80189457|FG008|Overall Study|Severe debilitation, unable to continue|0|||
27545636|NCT00042289|80189458|FG009|Overall Study|Severe debilitation, unable to continue|0|||
27545637|NCT00042289|80189459|FG010|Overall Study|Severe debilitation, unable to continue|0|||
27545638|NCT00042289|80189460|FG011|Overall Study|Severe debilitation, unable to continue|0|||
27545639|NCT00042289|80189461|FG012|Overall Study|Severe debilitation, unable to continue|0|||
27545640|NCT00042289|80189462|FG013|Overall Study|Severe debilitation, unable to continue|0|||
27545641|NCT00042289|80189463|FG014|Overall Study|Severe debilitation, unable to continue|0|||
27545642|NCT00042289|80189464|FG015|Overall Study|Severe debilitation, unable to continue|0|||
27545643|NCT00042289|80189465|FG016|Overall Study|Severe debilitation, unable to continue|0|||
27545644|NCT00042289|80189466|FG017|Overall Study|Severe debilitation, unable to continue|0|||
27545645|NCT00042289|80189467|FG018|Overall Study|Severe debilitation, unable to continue|0|||
27545646|NCT00042289|80189468|FG019|Overall Study|Severe debilitation, unable to continue|0|||
27545647|NCT00042289|80189469|FG020|Overall Study|Severe debilitation, unable to continue|0|||
27545648|NCT00042289|80189470|FG021|Overall Study|Severe debilitation, unable to continue|1|||
27639083|NCT01424397|80522048|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639084|NCT01424397|80522049|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639085|NCT01424397|80522050|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
27639086|NCT03714815|80522051|FG000|Overall Study|Physician Decision|2|||
27925343|NCT00324155|81564895|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
27925344|NCT00324155|81564896|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
27639087|NCT03714815|80522051|FG000|Overall Study|Withdrawal by Subject|2|||
27639088|NCT03714815|80522051|FG000|Overall Study|Death|11|||
27639089|NCT01985334|80522053|FG000|Overall Study|Administrative problems|1|||
27639090|NCT01985334|80522054|FG001|Overall Study|Administrative problems|1|||
27639091|NCT01985334|80522055|FG002|Overall Study|Administrative problems|0|||
27639092|NCT01985334|80522056|FG003|Overall Study|Administrative problems|2|||
27639093|NCT01985334|80522057|FG004|Overall Study|Administrative problems|0|||
27639094|NCT01985334|80522058|FG005|Overall Study|Administrative problems|1|||
27639095|NCT01985334|80522059|FG006|Overall Study|Administrative problems|1|||
27639096|NCT01985334|80522060|FG007|Overall Study|Administrative problems|3|||
27639097|NCT01985334|80522053|FG000|Overall Study|Death|1|||
27639098|NCT01985334|80522054|FG001|Overall Study|Death|0|||
27639099|NCT01985334|80522055|FG002|Overall Study|Death|0|||
27639100|NCT01985334|80522056|FG003|Overall Study|Death|3|||
27639101|NCT01985334|80522057|FG004|Overall Study|Death|0|||
27639102|NCT01985334|80522058|FG005|Overall Study|Death|0|||
27639103|NCT01985334|80522059|FG006|Overall Study|Death|1|||
27639104|NCT01985334|80522060|FG007|Overall Study|Death|2|||
27639105|NCT01985334|80522053|FG000|Overall Study|Worsening of disease|0|||
27639106|NCT01985334|80522054|FG001|Overall Study|Worsening of disease|0|||
27639107|NCT01985334|80522055|FG002|Overall Study|Worsening of disease|0|||
27639108|NCT01985334|80522056|FG003|Overall Study|Worsening of disease|1|||
27639109|NCT01985334|80522057|FG004|Overall Study|Worsening of disease|0|||
27639110|NCT01985334|80522058|FG005|Overall Study|Worsening of disease|3|||
27639111|NCT01985334|80522059|FG006|Overall Study|Worsening of disease|0|||
27639112|NCT01985334|80522060|FG007|Overall Study|Worsening of disease|1|||
27639113|NCT01985334|80522053|FG000|Overall Study|Other|2|||
27639114|NCT01985334|80522054|FG001|Overall Study|Other|9|||
27639115|NCT01985334|80522055|FG002|Overall Study|Other|7|||
27639116|NCT01985334|80522056|FG003|Overall Study|Other|17|||
27639117|NCT01985334|80522057|FG004|Overall Study|Other|4|||
27639118|NCT01985334|80522058|FG005|Overall Study|Other|8|||
27639119|NCT01985334|80522059|FG006|Overall Study|Other|4|||
27639120|NCT01985334|80522060|FG007|Overall Study|Other|7|||
27639121|NCT01985334|80522053|FG000|Overall Study|Protocol deviation|6|||
27639122|NCT01985334|80522054|FG001|Overall Study|Protocol deviation|31|||
27639123|NCT01985334|80522055|FG002|Overall Study|Protocol deviation|25|||
27639124|NCT01985334|80522056|FG003|Overall Study|Protocol deviation|84|||
27639125|NCT01985334|80522057|FG004|Overall Study|Protocol deviation|17|||
27639126|NCT01985334|80522058|FG005|Overall Study|Protocol deviation|47|||
27639127|NCT01985334|80522059|FG006|Overall Study|Protocol deviation|15|||
27639128|NCT01985334|80522060|FG007|Overall Study|Protocol deviation|42|||
27639129|NCT01985334|80522053|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
27639130|NCT01985334|80522054|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
27639131|NCT01985334|80522055|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
27639132|NCT01985334|80522056|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
27741994|NCT00945191|80884232|FG000|Overall Study|Did not achieve a complete response|18|||
27925345|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
27925346|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
27925347|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
27925348|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
27925349|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Death|8|||
27925350|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Death|15|||
27925351|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
27925352|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
27925353|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
27925354|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
27925355|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
27925356|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
27925357|NCT00324155|81564895|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
27925358|NCT00324155|81564896|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
27925359|NCT00324155|81564895|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
27925360|NCT00324155|81564896|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
27925361|NCT00324155|81564895|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
27925362|NCT00324155|81564896|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
27639133|NCT01985334|80522057|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
27639134|NCT01985334|80522058|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
27639135|NCT01985334|80522059|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
27639136|NCT01985334|80522060|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
27639137|NCT01985334|80522053|FG000|Overall Study|Subject withdrawal of consent|3|||
27639138|NCT01985334|80522054|FG001|Overall Study|Subject withdrawal of consent|6|||
27639139|NCT01985334|80522055|FG002|Overall Study|Subject withdrawal of consent|2|||
27639140|NCT01985334|80522056|FG003|Overall Study|Subject withdrawal of consent|28|||
27925363|NCT00324155|81564895|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
27925364|NCT00324155|81564896|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
27925365|NCT00324155|81564895|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
27925366|NCT00324155|81564896|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
27925367|NCT00324155|81564895|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
27925368|NCT00324155|81564896|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
27925369|NCT00324155|81564895|FG000|Follow-up Phase|On-going participants still on drug|11|||
27925370|NCT00324155|81564896|FG001|Follow-up Phase|On-going participants still on drug|6|||
27925371|NCT00479232|81564897|FG000|Overall Study|Adverse Event|0|||
27925372|NCT00479232|81564898|FG001|Overall Study|Adverse Event|0|||
27925373|NCT00479232|81564899|FG002|Overall Study|Adverse Event|5|||
27925374|NCT00479232|81564900|FG003|Overall Study|Adverse Event|0|||
27925375|NCT00479232|81564901|FG004|Overall Study|Adverse Event|0|||
27925376|NCT00479232|81564902|FG005|Overall Study|Adverse Event|10|||
27925377|NCT00479232|81564897|FG000|Overall Study|Deviation from Protocol|0|||
27925378|NCT00479232|81564898|FG001|Overall Study|Deviation from Protocol|0|||
27925379|NCT00479232|81564899|FG002|Overall Study|Deviation from Protocol|1|||
27925380|NCT00479232|81564900|FG003|Overall Study|Deviation from Protocol|0|||
27925381|NCT00479232|81564901|FG004|Overall Study|Deviation from Protocol|0|||
27925382|NCT00479232|81564902|FG005|Overall Study|Deviation from Protocol|0|||
27925383|NCT00479232|81564897|FG000|Overall Study|Lack of Efficacy|0|||
27925384|NCT00479232|81564898|FG001|Overall Study|Lack of Efficacy|0|||
27925385|NCT00479232|81564899|FG002|Overall Study|Lack of Efficacy|2|||
27925386|NCT00479232|81564900|FG003|Overall Study|Lack of Efficacy|0|||
27925387|NCT00479232|81564901|FG004|Overall Study|Lack of Efficacy|0|||
27925388|NCT00479232|81564902|FG005|Overall Study|Lack of Efficacy|4|||
27925389|NCT00479232|81564897|FG000|Overall Study|Physician Decision|0|||
27925390|NCT00479232|81564898|FG001|Overall Study|Physician Decision|0|||
27925391|NCT00479232|81564899|FG002|Overall Study|Physician Decision|2|||
27925392|NCT00479232|81564900|FG003|Overall Study|Physician Decision|0|||
27925393|NCT00479232|81564901|FG004|Overall Study|Physician Decision|0|||
27925394|NCT00479232|81564902|FG005|Overall Study|Physician Decision|1|||
27925395|NCT00479232|81564897|FG000|Overall Study|Progressive Disease|3|||
27925396|NCT00479232|81564898|FG001|Overall Study|Progressive Disease|1|||
27925397|NCT00479232|81564899|FG002|Overall Study|Progressive Disease|12|||
27925398|NCT00479232|81564900|FG003|Overall Study|Progressive Disease|3|||
27925399|NCT00479232|81564901|FG004|Overall Study|Progressive Disease|3|||
27925400|NCT00479232|81564902|FG005|Overall Study|Progressive Disease|12|||
27925401|NCT00479232|81564897|FG000|Overall Study|Withdrew Consent|0|||
27925402|NCT00479232|81564898|FG001|Overall Study|Withdrew Consent|2|||
27925403|NCT00479232|81564899|FG002|Overall Study|Withdrew Consent|6|||
27925404|NCT00479232|81564900|FG003|Overall Study|Withdrew Consent|0|||
27925405|NCT00479232|81564901|FG004|Overall Study|Withdrew Consent|1|||
27925406|NCT00479232|81564902|FG005|Overall Study|Withdrew Consent|3|||
27925407|NCT00294658|81564905|FG000|Overall Study|Death|0|||
27925408|NCT00294658|81564906|FG001|Overall Study|Death|1|||
27925409|NCT00294658|81564905|FG000|Overall Study|Lost to Follow-up|4|||
27925410|NCT00294658|81564906|FG001|Overall Study|Lost to Follow-up|0|||
27925411|NCT00294658|81564905|FG000|Overall Study|Physician Decision|1|||
27925412|NCT00294658|81564906|FG001|Overall Study|Physician Decision|2|||
27925413|NCT00294658|81564905|FG000|Overall Study|Pregnancy|0|||
27925414|NCT00294658|81564906|FG001|Overall Study|Pregnancy|1|||
27925415|NCT00294658|81564905|FG000|Overall Study|Withdrawal by Subject|0|||
27545649|NCT00042289|80189471|FG022|Overall Study|Severe debilitation, unable to continue|0|||
27545650|NCT00042289|80189472|FG023|Overall Study|Severe debilitation, unable to continue|1|||
27545651|NCT00042289|80189473|FG024|Overall Study|Severe debilitation, unable to continue|0|||
27545652|NCT00042289|80189474|FG025|Overall Study|Severe debilitation, unable to continue|0|||
27545653|NCT00042289|80189475|FG026|Overall Study|Severe debilitation, unable to continue|0|||
27545654|NCT00042289|80189476|FG027|Overall Study|Severe debilitation, unable to continue|1|||
27545655|NCT00042289|80189477|FG028|Overall Study|Severe debilitation, unable to continue|0|||
27545656|NCT00042289|80189478|FG029|Overall Study|Severe debilitation, unable to continue|0|||
27545657|NCT00042289|80189479|FG030|Overall Study|Severe debilitation, unable to continue|0|||
27925416|NCT00294658|81564906|FG001|Overall Study|Withdrawal by Subject|4|||
27925417|NCT00294658|81564905|FG000|Overall Study|Found to have invasive thymoma|1|||
27925418|NCT00294658|81564906|FG001|Overall Study|Found to have invasive thymoma|0|||
27925419|NCT00294658|81564905|FG000|Overall Study|Patient and family were not satisfied|0|||
27925420|NCT00294658|81564906|FG001|Overall Study|Patient and family were not satisfied|1|||
27925421|NCT02811159|81564907|FG000|Treatment Course 1|Lost to Follow-up|1|||
27925422|NCT00071981|81564908|FG000|Overall Study|Lack of Efficacy|37|||
27925423|NCT00071981|81564909|FG001|Overall Study|Lack of Efficacy|29|||
27925424|NCT00071981|81564910|FG002|Overall Study|Lack of Efficacy|30|||
27925425|NCT00071981|81564911|FG003|Overall Study|Lack of Efficacy|43|||
27925426|NCT00071981|81564908|FG000|Overall Study|Adverse Event|4|||
27925427|NCT00071981|81564909|FG001|Overall Study|Adverse Event|4|||
27925428|NCT00071981|81564910|FG002|Overall Study|Adverse Event|3|||
27925429|NCT00071981|81564911|FG003|Overall Study|Adverse Event|1|||
27925430|NCT00071981|81564908|FG000|Overall Study|Death|0|||
27925431|NCT00071981|81564909|FG001|Overall Study|Death|0|||
27925432|NCT00071981|81564910|FG002|Overall Study|Death|1|||
27925433|NCT00071981|81564911|FG003|Overall Study|Death|1|||
27925434|NCT00071981|81564908|FG000|Overall Study|Withdrawal by Subject|3|||
27925435|NCT00071981|81564909|FG001|Overall Study|Withdrawal by Subject|1|||
27925436|NCT00071981|81564910|FG002|Overall Study|Withdrawal by Subject|0|||
27925437|NCT00071981|81564911|FG003|Overall Study|Withdrawal by Subject|0|||
27925438|NCT00071981|81564908|FG000|Overall Study|No protocol therapy|2|||
27925439|NCT00071981|81564909|FG001|Overall Study|No protocol therapy|5|||
27925440|NCT00071981|81564910|FG002|Overall Study|No protocol therapy|1|||
27925441|NCT00071981|81564911|FG003|Overall Study|No protocol therapy|0|||
27925442|NCT00071981|81564908|FG000|Overall Study|others (not specified in the study)|0|||
27925443|NCT00071981|81564909|FG001|Overall Study|others (not specified in the study)|2|||
27925444|NCT00071981|81564910|FG002|Overall Study|others (not specified in the study)|2|||
27925445|NCT00071981|81564911|FG003|Overall Study|others (not specified in the study)|0|||
27925446|NCT02802228|81564912|FG000|Overall Study|Withdrawal by Subject|2|||
27925447|NCT02802228|81564913|FG001|Overall Study|Withdrawal by Subject|0|||
27925448|NCT02802228|81564912|FG000|Overall Study|Lost to Follow-up|1|||
27925449|NCT02802228|81564913|FG001|Overall Study|Lost to Follow-up|0|||
27925450|NCT02802228|81564912|FG000|Overall Study|Adverse Event|1|||
27925451|NCT02802228|81564913|FG001|Overall Study|Adverse Event|0|||
27925452|NCT02802228|81564912|FG000|Overall Study|Physician Decision|1|||
27925453|NCT02802228|81564913|FG001|Overall Study|Physician Decision|0|||
27925454|NCT00548327|81564916|FG000|Overall Study|Adverse Event|0|||
27925455|NCT00548327|81564917|FG001|Overall Study|Adverse Event|1|||
27925456|NCT02207608|81564918|FG000|Overall Study|Adverse Event|1|||
27925457|NCT02207608|81564919|FG001|Overall Study|Adverse Event|0|||
27925458|NCT00329108|81564922|FG000|Overall Study|Adverse Event|2|||
27925459|NCT00329108|81564923|FG001|Overall Study|Adverse Event|2|||
27545658|NCT00042289|80189480|FG031|Overall Study|Severe debilitation, unable to continue|1|||
27545659|NCT00042289|80189481|FG032|Overall Study|Severe debilitation, unable to continue|1|||
27545660|NCT00042289|80189482|FG033|Overall Study|Severe debilitation, unable to continue|0|||
27545661|NCT00042289|80189483|FG034|Overall Study|Severe debilitation, unable to continue|0|||
27545662|NCT00042289|80189484|FG035|Overall Study|Severe debilitation, unable to continue|0|||
27545663|NCT00042289|80189485|FG036|Overall Study|Severe debilitation, unable to continue|0|||
27545664|NCT00042289|80189486|FG037|Overall Study|Severe debilitation, unable to continue|0|||
27545665|NCT00042289|80189487|FG038|Overall Study|Severe debilitation, unable to continue|0|||
27545666|NCT00042289|80189488|FG039|Overall Study|Severe debilitation, unable to continue|0|||
27639141|NCT01985334|80522057|FG004|Overall Study|Subject withdrawal of consent|4|||
27639142|NCT01985334|80522058|FG005|Overall Study|Subject withdrawal of consent|19|||
27639143|NCT01985334|80522059|FG006|Overall Study|Subject withdrawal of consent|0|||
27639144|NCT01985334|80522060|FG007|Overall Study|Subject withdrawal of consent|20|||
27639145|NCT01985334|80522053|FG000|Overall Study|Adverse Event|0|||
27639146|NCT01985334|80522054|FG001|Overall Study|Adverse Event|8|||
27639147|NCT01985334|80522055|FG002|Overall Study|Adverse Event|2|||
27639148|NCT01985334|80522056|FG003|Overall Study|Adverse Event|26|||
27639149|NCT01985334|80522057|FG004|Overall Study|Adverse Event|3|||
27639150|NCT01985334|80522058|FG005|Overall Study|Adverse Event|18|||
27639151|NCT01985334|80522059|FG006|Overall Study|Adverse Event|3|||
27639152|NCT01985334|80522060|FG007|Overall Study|Adverse Event|15|||
27639153|NCT01985334|80522053|FG000|Overall Study|Other|4|||
27639154|NCT01985334|80522054|FG001|Overall Study|Other|2|||
27639155|NCT01985334|80522055|FG002|Overall Study|Other|3|||
27639156|NCT01985334|80522056|FG003|Overall Study|Other|10|||
27639157|NCT01985334|80522057|FG004|Overall Study|Other|1|||
27639158|NCT01985334|80522058|FG005|Overall Study|Other|6|||
27639159|NCT01985334|80522059|FG006|Overall Study|Other|2|||
27639160|NCT01985334|80522060|FG007|Overall Study|Other|2|||
27925460|NCT00329108|81564922|FG000|Overall Study|Lack of Efficacy|3|||
27925461|NCT00329108|81564923|FG001|Overall Study|Lack of Efficacy|3|||
27925462|NCT00329108|81564922|FG000|Overall Study|Withdrawal by Subject|0|||
27925463|NCT00329108|81564923|FG001|Overall Study|Withdrawal by Subject|2|||
27925464|NCT00329108|81564922|FG000|Overall Study|symptomatic deterioration|1|||
27925465|NCT00329108|81564923|FG001|Overall Study|symptomatic deterioration|1|||
27925466|NCT00329108|81564922|FG000|Overall Study|Subject no longer willing to participate|2|||
27925467|NCT00329108|81564923|FG001|Overall Study|Subject no longer willing to participate|2|||
27545667|NCT00042289|80189489|FG040|Overall Study|Severe debilitation, unable to continue|0|||
27639161|NCT01985334|80522053|FG000|Overall Study|Medication non-compliance|0|||
27639162|NCT01985334|80522054|FG001|Overall Study|Medication non-compliance|4|||
27639163|NCT01985334|80522055|FG002|Overall Study|Medication non-compliance|1|||
27639164|NCT01985334|80522056|FG003|Overall Study|Medication non-compliance|6|||
27925468|NCT00329108|81564922|FG000|Overall Study|study terminated by sponsor|1|||
27639165|NCT01985334|80522057|FG004|Overall Study|Medication non-compliance|2|||
27639166|NCT01985334|80522058|FG005|Overall Study|Medication non-compliance|3|||
27925469|NCT00329108|81564923|FG001|Overall Study|study terminated by sponsor|0|||
27925470|NCT00329108|81564922|FG000|Overall Study|withdrew patient after SAE resolved|1|||
27925471|NCT00329108|81564923|FG001|Overall Study|withdrew patient after SAE resolved|0|||
27925472|NCT00329108|81564922|FG000|Overall Study|Protocol Violation|0|||
27925473|NCT00329108|81564923|FG001|Overall Study|Protocol Violation|2|||
27925474|NCT01373164|81564924|FG000|Overall Study|Lost to Follow-up|0|||
27925475|NCT01373164|81564925|FG001|Overall Study|Lost to Follow-up|0|||
27925476|NCT01373164|81564926|FG002|Overall Study|Lost to Follow-up|1|||
27925477|NCT01373164|81564927|FG003|Overall Study|Lost to Follow-up|2|||
27925478|NCT01373164|81564928|FG004|Overall Study|Lost to Follow-up|0|||
27925479|NCT01373164|81564924|FG000|Overall Study|Withdrawal by Subject|0|||
27925480|NCT01373164|81564925|FG001|Overall Study|Withdrawal by Subject|1|||
27925481|NCT01373164|81564926|FG002|Overall Study|Withdrawal by Subject|0|||
27925482|NCT01373164|81564927|FG003|Overall Study|Withdrawal by Subject|10|||
27925483|NCT01373164|81564928|FG004|Overall Study|Withdrawal by Subject|2|||
27925484|NCT02911116|81564929|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27925485|NCT02911116|81564930|FG001|Overall Study|Insufficient Therapeutic Response|0|||
27925486|NCT02911116|81564929|FG000|Overall Study|Lost to Follow-up|0|||
27925487|NCT02911116|81564930|FG001|Overall Study|Lost to Follow-up|1|||
27925488|NCT00929669|81564931|FG000|Overall Study|elevated glucose levels|1|||
27925489|NCT03738215|81564932|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
27545668|NCT00042289|80189490|FG041|Overall Study|Severe debilitation, unable to continue|0|||
27925490|NCT03738215|81564933|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
27545669|NCT00042289|80189491|FG042|Overall Study|Severe debilitation, unable to continue|0|||
27545670|NCT00042289|80189492|FG043|Overall Study|Severe debilitation, unable to continue|0|||
27545671|NCT00042289|80189493|FG044|Overall Study|Severe debilitation, unable to continue|0|||
27545672|NCT00042289|80189494|FG045|Overall Study|Severe debilitation, unable to continue|0|||
27545673|NCT00042289|80189495|FG046|Overall Study|Severe debilitation, unable to continue|0|||
27545674|NCT00042289|80189449|FG000|Overall Study|Site closed|0|||
27545675|NCT00042289|80189450|FG001|Overall Study|Site closed|0|||
27545676|NCT00042289|80189451|FG002|Overall Study|Site closed|0|||
27545677|NCT00042289|80189452|FG003|Overall Study|Site closed|0|||
27545678|NCT00042289|80189453|FG004|Overall Study|Site closed|0|||
27545679|NCT00042289|80189454|FG005|Overall Study|Site closed|0|||
27545680|NCT00042289|80189455|FG006|Overall Study|Site closed|0|||
27545681|NCT00042289|80189456|FG007|Overall Study|Site closed|0|||
27545682|NCT00042289|80189457|FG008|Overall Study|Site closed|0|||
27545683|NCT00042289|80189458|FG009|Overall Study|Site closed|0|||
27545684|NCT00042289|80189459|FG010|Overall Study|Site closed|0|||
27545685|NCT00042289|80189460|FG011|Overall Study|Site closed|0|||
27545686|NCT00042289|80189461|FG012|Overall Study|Site closed|0|||
27545687|NCT00042289|80189462|FG013|Overall Study|Site closed|0|||
27545688|NCT00042289|80189463|FG014|Overall Study|Site closed|0|||
27545689|NCT00042289|80189464|FG015|Overall Study|Site closed|0|||
27545690|NCT00042289|80189465|FG016|Overall Study|Site closed|0|||
27545691|NCT00042289|80189466|FG017|Overall Study|Site closed|0|||
27545692|NCT00042289|80189467|FG018|Overall Study|Site closed|0|||
27545693|NCT00042289|80189468|FG019|Overall Study|Site closed|0|||
27545694|NCT00042289|80189469|FG020|Overall Study|Site closed|0|||
27545695|NCT00042289|80189470|FG021|Overall Study|Site closed|0|||
27545696|NCT00042289|80189471|FG022|Overall Study|Site closed|0|||
27545697|NCT00042289|80189472|FG023|Overall Study|Site closed|0|||
27545698|NCT00042289|80189473|FG024|Overall Study|Site closed|0|||
27545699|NCT00042289|80189474|FG025|Overall Study|Site closed|0|||
27545700|NCT00042289|80189475|FG026|Overall Study|Site closed|0|||
27545701|NCT00042289|80189476|FG027|Overall Study|Site closed|0|||
27545702|NCT00042289|80189477|FG028|Overall Study|Site closed|0|||
27545703|NCT00042289|80189478|FG029|Overall Study|Site closed|0|||
27545704|NCT00042289|80189479|FG030|Overall Study|Site closed|0|||
27545705|NCT00042289|80189480|FG031|Overall Study|Site closed|3|||
27545706|NCT00042289|80189481|FG032|Overall Study|Site closed|0|||
27545707|NCT00042289|80189482|FG033|Overall Study|Site closed|0|||
27545708|NCT00042289|80189483|FG034|Overall Study|Site closed|0|||
27545709|NCT00042289|80189484|FG035|Overall Study|Site closed|0|||
27545710|NCT00042289|80189485|FG036|Overall Study|Site closed|1|||
27545711|NCT00042289|80189486|FG037|Overall Study|Site closed|0|||
27545712|NCT00042289|80189487|FG038|Overall Study|Site closed|0|||
27545713|NCT00042289|80189488|FG039|Overall Study|Site closed|0|||
27925491|NCT03738215|81564934|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
27545714|NCT00042289|80189489|FG040|Overall Study|Site closed|0|||
27545715|NCT00042289|80189490|FG041|Overall Study|Site closed|0|||
27545716|NCT00042289|80189491|FG042|Overall Study|Site closed|1|||
27545717|NCT00042289|80189492|FG043|Overall Study|Site closed|0|||
27545718|NCT00042289|80189493|FG044|Overall Study|Site closed|0|||
27545719|NCT00042289|80189494|FG045|Overall Study|Site closed|0|||
27545720|NCT00042289|80189495|FG046|Overall Study|Site closed|0|||
27545721|NCT00042289|80189449|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
27545722|NCT00042289|80189450|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
27545723|NCT00042289|80189451|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
27925492|NCT03738215|81564932|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
27639167|NCT01985334|80522059|FG006|Overall Study|Medication non-compliance|1|||
27639168|NCT01985334|80522060|FG007|Overall Study|Medication non-compliance|3|||
27639169|NCT01985334|80522053|FG000|Overall Study|Use of prohibited treatment|1|||
27639170|NCT01985334|80522054|FG001|Overall Study|Use of prohibited treatment|4|||
27639171|NCT01985334|80522055|FG002|Overall Study|Use of prohibited treatment|1|||
27639172|NCT01985334|80522056|FG003|Overall Study|Use of prohibited treatment|2|||
27925493|NCT03738215|81564933|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
27925494|NCT03738215|81564934|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
27925495|NCT03738215|81564932|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
27925496|NCT03738215|81564933|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
27925497|NCT03738215|81564934|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
27925498|NCT03738215|81564932|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
27925499|NCT03738215|81564933|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
27925500|NCT03738215|81564934|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
27925501|NCT03738215|81564932|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
27925502|NCT03738215|81564933|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
27925503|NCT03738215|81564934|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
27925504|NCT03738215|81564932|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
27925505|NCT03738215|81564933|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
27925506|NCT03738215|81564934|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
27925507|NCT03738215|81564932|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
27925508|NCT03738215|81564933|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
27925509|NCT03738215|81564934|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
27925510|NCT03738215|81564932|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
27925511|NCT03738215|81564933|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
27925512|NCT03738215|81564934|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
27925513|NCT03738215|81564932|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
27639173|NCT01985334|80522057|FG004|Overall Study|Use of prohibited treatment|1|||
27639174|NCT01985334|80522058|FG005|Overall Study|Use of prohibited treatment|6|||
27639175|NCT01985334|80522059|FG006|Overall Study|Use of prohibited treatment|2|||
27639176|NCT01985334|80522060|FG007|Overall Study|Use of prohibited treatment|0|||
27639177|NCT01985334|80522053|FG000|Overall Study|Investigator decision|0|||
27639178|NCT01985334|80522054|FG001|Overall Study|Investigator decision|3|||
27639179|NCT01985334|80522055|FG002|Overall Study|Investigator decision|0|||
27639180|NCT01985334|80522056|FG003|Overall Study|Investigator decision|7|||
27639181|NCT01985334|80522057|FG004|Overall Study|Investigator decision|1|||
27925514|NCT03738215|81564933|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
27925515|NCT03738215|81564934|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
27925516|NCT03738215|81564932|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
27925517|NCT03738215|81564933|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
27925518|NCT03738215|81564934|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
27925519|NCT04900272|81564938|FG000|Overall Study|Lost to Follow-up|2|||
27925520|NCT04900272|81564938|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
27925521|NCT04900272|81564938|FG000|Overall Study|Withdrawal by Subject|1|||
27925522|NCT00593814|81564940|FG000|Overall Study|Death|7|||
27925523|NCT00593814|81564941|FG001|Overall Study|Death|0|||
27925524|NCT00593814|81564940|FG000|Overall Study|Withdrawal by Subject|7|||
27925525|NCT00593814|81564941|FG001|Overall Study|Withdrawal by Subject|0|||
27925526|NCT00593814|81564940|FG000|Overall Study|Lost to Follow-up|7|||
27925527|NCT00593814|81564941|FG001|Overall Study|Lost to Follow-up|0|||
27925528|NCT00593814|81564940|FG000|Overall Study|Physician Decision|3|||
27925529|NCT00593814|81564941|FG001|Overall Study|Physician Decision|0|||
27925530|NCT00596635|81564945|FG000|Overall Study|Lost to Follow-up|0|||
27925531|NCT00596635|81564946|FG001|Overall Study|Lost to Follow-up|2|||
27925532|NCT00596635|81564947|FG002|Overall Study|Lost to Follow-up|0|||
27925533|NCT00596635|81564945|FG000|Overall Study|Treatment for symptomatic UTI|4|||
27925534|NCT00596635|81564946|FG001|Overall Study|Treatment for symptomatic UTI|6|||
27925535|NCT00596635|81564947|FG002|Overall Study|Treatment for symptomatic UTI|3|||
27925536|NCT00596635|81564945|FG000|Overall Study|Hip fracture|2|||
27925537|NCT00596635|81564946|FG001|Overall Study|Hip fracture|3|||
27639182|NCT01985334|80522058|FG005|Overall Study|Investigator decision|1|||
27925538|NCT00596635|81564947|FG002|Overall Study|Hip fracture|3|||
27925539|NCT00596635|81564945|FG000|Overall Study|Could not provide urine specimen|1|||
27925540|NCT00596635|81564946|FG001|Overall Study|Could not provide urine specimen|2|||
27925541|NCT00596635|81564947|FG002|Overall Study|Could not provide urine specimen|2|||
27925542|NCT00112957|81564949|FG000|Overall Study|Progressive disease|18|||
27925543|NCT00112957|81564949|FG000|Overall Study|Physician Decision|1|||
27925544|NCT01117870|81564951|FG000|Overall Study|Inability to place needle|1|||
27639183|NCT01985334|80522059|FG006|Overall Study|Investigator decision|0|||
27639184|NCT01985334|80522060|FG007|Overall Study|Investigator decision|4|||
27639185|NCT01985334|80522053|FG000|Overall Study|Lost to Follow-up|0|||
27925545|NCT01117870|81564952|FG001|Overall Study|Inability to place needle|0|||
27925546|NCT01192815|81564953|FG000|Overall Study|Withdrawal by Subject|1|||
27925547|NCT01192815|81564953|FG000|Overall Study|Lack of Efficacy|1|||
27925548|NCT01529268|81564962|FG000|Overall Study|Lost to Follow-up|9|||
27925549|NCT01529268|81564963|FG001|Overall Study|Lost to Follow-up|3|||
27925550|NCT01529268|81564962|FG000|Overall Study|Moved|3|||
27925551|NCT01529268|81564963|FG001|Overall Study|Moved|0|||
27925552|NCT03636256|81564970|FG000|Overall Study|Lost to Follow-up|3|||
27925553|NCT03636256|81564971|FG001|Overall Study|Lost to Follow-up|0|||
27925554|NCT03636256|81564972|FG002|Overall Study|Lost to Follow-up|2|||
27925555|NCT03636256|81564973|FG003|Overall Study|Lost to Follow-up|1|||
27925556|NCT03636256|81564974|FG004|Overall Study|Lost to Follow-up|0|||
27545724|NCT00042289|80189452|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
27545725|NCT00042289|80189453|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
27545726|NCT00042289|80189454|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
27545727|NCT00042289|80189455|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
27545728|NCT00042289|80189456|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
27925557|NCT03636256|81564975|FG005|Overall Study|Lost to Follow-up|4|||
27925558|NCT03636256|81564976|FG006|Overall Study|Lost to Follow-up|2|||
27925559|NCT03636256|81564977|FG007|Overall Study|Lost to Follow-up|0|||
27925560|NCT03636256|81564978|FG008|Overall Study|Lost to Follow-up|4|||
27925561|NCT03636256|81564970|FG000|Overall Study|Withdrawal by Subject|0|||
27925562|NCT03636256|81564971|FG001|Overall Study|Withdrawal by Subject|0|||
27925563|NCT03636256|81564972|FG002|Overall Study|Withdrawal by Subject|0|||
27925564|NCT03636256|81564973|FG003|Overall Study|Withdrawal by Subject|0|||
27925565|NCT03636256|81564974|FG004|Overall Study|Withdrawal by Subject|0|||
27925566|NCT03636256|81564975|FG005|Overall Study|Withdrawal by Subject|0|||
27925567|NCT03636256|81564976|FG006|Overall Study|Withdrawal by Subject|0|||
27925568|NCT03636256|81564977|FG007|Overall Study|Withdrawal by Subject|0|||
27925569|NCT03636256|81564978|FG008|Overall Study|Withdrawal by Subject|1|||
27925570|NCT00724945|81564979|FG000|Period 1|non-compliance|1|||
27925571|NCT00724945|81564980|FG001|Period 1|non-compliance|0|||
27925572|NCT00724945|81564979|FG000|Period 1|Adverse Event|1|||
27925573|NCT00724945|81564980|FG001|Period 1|Adverse Event|1|||
27925574|NCT00724945|81564979|FG000|Period 1|Lost to Follow-up|1|||
27925575|NCT00724945|81564980|FG001|Period 1|Lost to Follow-up|0|||
27925576|NCT00724945|81564979|FG000|Period 2|lens comfort issue|3|||
27925577|NCT00724945|81564980|FG001|Period 2|lens comfort issue|0|||
27925578|NCT00724945|81564979|FG000|Period 2|lens physiology issue|1|||
27925579|NCT00724945|81564980|FG001|Period 2|lens physiology issue|0|||
27925580|NCT00941928|81564988|FG000|Overall Study|Withdrawal by Subject|1|||
27925581|NCT00941928|81564988|FG000|Overall Study|Disease Progression|1|||
27925582|NCT03530293|81564989|FG000|Pre-randomization|Adverse Event|12|||
27925583|NCT03530293|81564990|FG001|Pre-randomization|Adverse Event|0|||
27925584|NCT03530293|81564991|FG002|Pre-randomization|Adverse Event|0|||
27925585|NCT03530293|81564989|FG000|Pre-randomization|Protocol Violation|2|||
27545729|NCT00042289|80189457|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
27545730|NCT00042289|80189458|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
27545731|NCT00042289|80189459|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
27545732|NCT00042289|80189460|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
27545733|NCT00042289|80189461|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
27545734|NCT00042289|80189462|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
27545735|NCT00042289|80189463|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
27545736|NCT00042289|80189464|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
27545737|NCT00042289|80189465|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
27545738|NCT00042289|80189466|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
27545739|NCT00042289|80189467|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
27545740|NCT00042289|80189468|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
27545741|NCT00042289|80189469|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
27545742|NCT00042289|80189470|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
27545743|NCT00042289|80189471|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
27545744|NCT00042289|80189472|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
27545745|NCT00042289|80189473|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
27545746|NCT00042289|80189474|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
27545747|NCT00042289|80189475|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
27639186|NCT01985334|80522054|FG001|Overall Study|Lost to Follow-up|2|||
27741995|NCT00945191|80884232|FG000|Overall Study|Participant relocated to another state|1|||
27925586|NCT03530293|81564990|FG001|Pre-randomization|Protocol Violation|0|||
27925587|NCT03530293|81564991|FG002|Pre-randomization|Protocol Violation|0|||
27925588|NCT03530293|81564989|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
27925589|NCT03530293|81564990|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
27925590|NCT03530293|81564991|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
27545748|NCT00042289|80189476|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
27545749|NCT00042289|80189477|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
27545750|NCT00042289|80189478|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
27545751|NCT00042289|80189479|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
27545752|NCT00042289|80189480|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
27545753|NCT00042289|80189481|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
27545754|NCT00042289|80189482|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
27545755|NCT00042289|80189483|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
27545756|NCT00042289|80189484|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
27545757|NCT00042289|80189485|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
27545758|NCT00042289|80189486|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
27925591|NCT03530293|81564989|FG000|Pre-randomization|Withdrawal by Subject|5|||
27925592|NCT03530293|81564990|FG001|Pre-randomization|Withdrawal by Subject|0|||
27925593|NCT03530293|81564991|FG002|Pre-randomization|Withdrawal by Subject|0|||
27925594|NCT03530293|81564989|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
27925595|NCT03530293|81564990|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
27925596|NCT03530293|81564991|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
27925597|NCT03530293|81564989|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
27925598|NCT03530293|81564990|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
27925599|NCT03530293|81564991|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
27925600|NCT03530293|81564989|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
27925601|NCT03530293|81564990|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
27925602|NCT03530293|81564991|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
27925603|NCT03530293|81564989|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
27925604|NCT03530293|81564990|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
27925605|NCT03530293|81564991|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
27925606|NCT03530293|81564989|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
27925607|NCT03530293|81564990|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
27925608|NCT03530293|81564991|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
27925609|NCT00639509|81564992|FG000|Overall Study|Death|1|||
27925610|NCT00484159|81564993|FG000|Overall Study|Lost to Follow-up|1|||
27925611|NCT00484159|81564994|FG001|Overall Study|Lost to Follow-up|1|||
27545759|NCT00042289|80189487|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
27545760|NCT00042289|80189488|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
27545761|NCT00042289|80189489|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
27545762|NCT00042289|80189490|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
27545763|NCT00042289|80189491|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
27639187|NCT01985334|80522055|FG002|Overall Study|Lost to Follow-up|0|||
27639188|NCT01985334|80522056|FG003|Overall Study|Lost to Follow-up|3|||
27925612|NCT00484159|81564995|FG002|Overall Study|Lost to Follow-up|0|||
27925613|NCT02472405|81564997|FG000|Overall Study|Lost to Follow-up|9|||
27925614|NCT02472405|81564997|FG000|Overall Study|Adverse Event|1|||
27925615|NCT04459338|81565000|FG000|Overall Study|Loss of IV during study|1|||
27925616|NCT04459338|81565001|FG001|Overall Study|Loss of IV during study|0|||
27925617|NCT01126424|81565006|FG000|Overall Study|Adverse Event|0|||
27925618|NCT01126424|81565007|FG001|Overall Study|Adverse Event|0|||
27925619|NCT01126424|81565008|FG002|Overall Study|Adverse Event|0|||
27925620|NCT01126424|81565009|FG003|Overall Study|Adverse Event|0|||
27925621|NCT01126424|81565010|FG004|Overall Study|Adverse Event|1|||
27545764|NCT00042289|80189492|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
27639189|NCT01985334|80522057|FG004|Overall Study|Lost to Follow-up|1|||
27639190|NCT01985334|80522058|FG005|Overall Study|Lost to Follow-up|4|||
27639191|NCT01985334|80522059|FG006|Overall Study|Lost to Follow-up|0|||
27639192|NCT01985334|80522060|FG007|Overall Study|Lost to Follow-up|3|||
27639193|NCT00516321|80522061|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
27639194|NCT00516321|80522062|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
27639195|NCT00516321|80522063|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
27639196|NCT00516321|80522061|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
27639197|NCT00516321|80522062|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
27639198|NCT00516321|80522063|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
27639199|NCT00516321|80522061|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
27639200|NCT00516321|80522062|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
27639201|NCT00516321|80522063|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
27639202|NCT00516321|80522061|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
27639203|NCT00516321|80522062|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
27639204|NCT00516321|80522063|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
27741996|NCT00945191|80884232|FG000|Overall Study|Disease progression|3|||
27925622|NCT01126424|81565011|FG005|Overall Study|Adverse Event|0|||
27925623|NCT01126424|81565006|FG000|Overall Study|Withdrawal by Subject|0|||
27925624|NCT01126424|81565007|FG001|Overall Study|Withdrawal by Subject|0|||
27925625|NCT01126424|81565008|FG002|Overall Study|Withdrawal by Subject|1|||
27925626|NCT01126424|81565009|FG003|Overall Study|Withdrawal by Subject|3|||
27925627|NCT01126424|81565010|FG004|Overall Study|Withdrawal by Subject|1|||
27925628|NCT01126424|81565011|FG005|Overall Study|Withdrawal by Subject|0|||
27925629|NCT03704688|81565012|FG000|Overall Study|Adverse Event|0|||
27925630|NCT03704688|81565013|FG001|Overall Study|Adverse Event|0|||
27925631|NCT03704688|81565014|FG002|Overall Study|Adverse Event|0|||
27925632|NCT03704688|81565015|FG003|Overall Study|Adverse Event|4|||
27545765|NCT00042289|80189493|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
27545766|NCT00042289|80189494|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
27545767|NCT00042289|80189495|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
27545768|NCT00042289|80189449|FG000|Overall Study|Protocol Violation|0|||
27545769|NCT00042289|80189450|FG001|Overall Study|Protocol Violation|0|||
27545770|NCT00042289|80189451|FG002|Overall Study|Protocol Violation|0|||
27545771|NCT00042289|80189452|FG003|Overall Study|Protocol Violation|0|||
27545772|NCT00042289|80189453|FG004|Overall Study|Protocol Violation|0|||
27545773|NCT00042289|80189454|FG005|Overall Study|Protocol Violation|1|||
27545774|NCT00042289|80189455|FG006|Overall Study|Protocol Violation|0|||
27545775|NCT00042289|80189456|FG007|Overall Study|Protocol Violation|1|||
27545776|NCT00042289|80189457|FG008|Overall Study|Protocol Violation|0|||
27545777|NCT00042289|80189458|FG009|Overall Study|Protocol Violation|0|||
27545778|NCT00042289|80189459|FG010|Overall Study|Protocol Violation|0|||
27545779|NCT00042289|80189460|FG011|Overall Study|Protocol Violation|0|||
27545780|NCT00042289|80189461|FG012|Overall Study|Protocol Violation|0|||
27545781|NCT00042289|80189462|FG013|Overall Study|Protocol Violation|0|||
27545782|NCT00042289|80189463|FG014|Overall Study|Protocol Violation|0|||
27545783|NCT00042289|80189464|FG015|Overall Study|Protocol Violation|0|||
27545784|NCT00042289|80189465|FG016|Overall Study|Protocol Violation|0|||
27545785|NCT00042289|80189466|FG017|Overall Study|Protocol Violation|0|||
27545786|NCT00042289|80189467|FG018|Overall Study|Protocol Violation|0|||
27545787|NCT00042289|80189468|FG019|Overall Study|Protocol Violation|0|||
27545788|NCT00042289|80189469|FG020|Overall Study|Protocol Violation|0|||
27545789|NCT00042289|80189470|FG021|Overall Study|Protocol Violation|0|||
27545790|NCT00042289|80189471|FG022|Overall Study|Protocol Violation|0|||
27545791|NCT00042289|80189472|FG023|Overall Study|Protocol Violation|1|||
27545792|NCT00042289|80189473|FG024|Overall Study|Protocol Violation|1|||
27545793|NCT00042289|80189474|FG025|Overall Study|Protocol Violation|0|||
27545794|NCT00042289|80189475|FG026|Overall Study|Protocol Violation|2|||
27545795|NCT00042289|80189476|FG027|Overall Study|Protocol Violation|0|||
27545796|NCT00042289|80189477|FG028|Overall Study|Protocol Violation|0|||
27545797|NCT00042289|80189478|FG029|Overall Study|Protocol Violation|0|||
27545798|NCT00042289|80189479|FG030|Overall Study|Protocol Violation|1|||
27545799|NCT00042289|80189480|FG031|Overall Study|Protocol Violation|0|||
27545800|NCT00042289|80189481|FG032|Overall Study|Protocol Violation|0|||
27545801|NCT00042289|80189482|FG033|Overall Study|Protocol Violation|0|||
27545802|NCT00042289|80189483|FG034|Overall Study|Protocol Violation|0|||
27545803|NCT00042289|80189484|FG035|Overall Study|Protocol Violation|0|||
27545804|NCT00042289|80189485|FG036|Overall Study|Protocol Violation|0|||
27545805|NCT00042289|80189486|FG037|Overall Study|Protocol Violation|0|||
27545806|NCT00042289|80189487|FG038|Overall Study|Protocol Violation|0|||
27545807|NCT00042289|80189488|FG039|Overall Study|Protocol Violation|0|||
27545808|NCT00042289|80189489|FG040|Overall Study|Protocol Violation|0|||
27545809|NCT00042289|80189490|FG041|Overall Study|Protocol Violation|1|||
27545810|NCT00042289|80189491|FG042|Overall Study|Protocol Violation|1|||
27545811|NCT00042289|80189492|FG043|Overall Study|Protocol Violation|1|||
27545812|NCT00042289|80189493|FG044|Overall Study|Protocol Violation|0|||
27925633|NCT03704688|81565016|FG004|Overall Study|Adverse Event|1|||
27925634|NCT03704688|81565017|FG005|Overall Study|Adverse Event|0|||
27545813|NCT00042289|80189494|FG045|Overall Study|Protocol Violation|0|||
27545814|NCT00042289|80189495|FG046|Overall Study|Protocol Violation|0|||
27545815|NCT00042289|80189449|FG000|Overall Study|Withdrawal by Subject|4|||
27545816|NCT00042289|80189450|FG001|Overall Study|Withdrawal by Subject|1|||
27545817|NCT00042289|80189451|FG002|Overall Study|Withdrawal by Subject|0|||
27545818|NCT00042289|80189452|FG003|Overall Study|Withdrawal by Subject|2|||
27545819|NCT00042289|80189453|FG004|Overall Study|Withdrawal by Subject|0|||
27545820|NCT00042289|80189454|FG005|Overall Study|Withdrawal by Subject|2|||
27545821|NCT00042289|80189455|FG006|Overall Study|Withdrawal by Subject|0|||
27545822|NCT00042289|80189456|FG007|Overall Study|Withdrawal by Subject|0|||
27545823|NCT00042289|80189457|FG008|Overall Study|Withdrawal by Subject|0|||
27545824|NCT00042289|80189458|FG009|Overall Study|Withdrawal by Subject|1|||
27545825|NCT00042289|80189459|FG010|Overall Study|Withdrawal by Subject|0|||
27545826|NCT00042289|80189460|FG011|Overall Study|Withdrawal by Subject|0|||
27545827|NCT00042289|80189461|FG012|Overall Study|Withdrawal by Subject|2|||
27545828|NCT00042289|80189462|FG013|Overall Study|Withdrawal by Subject|0|||
27925635|NCT03704688|81565012|FG000|Overall Study|Disease Progression|0|||
27925636|NCT03704688|81565013|FG001|Overall Study|Disease Progression|0|||
27925637|NCT03704688|81565014|FG002|Overall Study|Disease Progression|0|||
27741997|NCT00945191|80884232|FG000|Overall Study|Serious adverse event or adverse event|1|||
27741998|NCT00945191|80884232|FG000|Overall Study|Investigator's discretion|1|||
27741999|NCT03270085|80884236|FG000|Overall Study|Withdrawal by Subject|1|||
27742000|NCT03270085|80884237|FG001|Overall Study|Withdrawal by Subject|0|||
27742001|NCT00306891|80884238|FG000|Part A|Withdrawal by Subject|1|||
27742002|NCT00306891|80884239|FG001|Part A|Withdrawal by Subject|1|||
27742003|NCT00306891|80884240|FG002|Part A|Withdrawal by Subject|0|||
27742004|NCT00306891|80884241|FG003|Part A|Withdrawal by Subject|0|||
27742005|NCT00306891|80884238|FG000|Part A|Condition under investigation worsened|2|||
27742006|NCT00306891|80884239|FG001|Part A|Condition under investigation worsened|2|||
27742007|NCT00306891|80884240|FG002|Part A|Condition under investigation worsened|0|||
27742008|NCT00306891|80884241|FG003|Part A|Condition under investigation worsened|0|||
27742009|NCT00306891|80884238|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
27742010|NCT00306891|80884239|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
27742011|NCT00306891|80884240|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
27742012|NCT00306891|80884241|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
27742013|NCT00306891|80884238|FG000|Part A|Partial bowel obstruction|1|||
27742014|NCT00306891|80884239|FG001|Part A|Partial bowel obstruction|0|||
27742015|NCT00306891|80884240|FG002|Part A|Partial bowel obstruction|0|||
27742016|NCT00306891|80884241|FG003|Part A|Partial bowel obstruction|0|||
27742017|NCT00306891|80884238|FG000|Part A|Reaccumul. of ascites following drainage|0|||
27742018|NCT00306891|80884239|FG001|Part A|Reaccumul. of ascites following drainage|1|||
27742019|NCT00306891|80884240|FG002|Part A|Reaccumul. of ascites following drainage|0|||
27742020|NCT00306891|80884241|FG003|Part A|Reaccumul. of ascites following drainage|0|||
27742021|NCT00306891|80884238|FG000|Part A|Suspicion of second malignancy|0|||
27742022|NCT00306891|80884239|FG001|Part A|Suspicion of second malignancy|1|||
27742023|NCT00306891|80884240|FG002|Part A|Suspicion of second malignancy|0|||
27742024|NCT00306891|80884241|FG003|Part A|Suspicion of second malignancy|0|||
27742025|NCT00306891|80884238|FG000|Part A|QTC interval outwith elig. criteria|1|||
27742026|NCT00306891|80884239|FG001|Part A|QTC interval outwith elig. criteria|0|||
27742027|NCT00306891|80884240|FG002|Part A|QTC interval outwith elig. criteria|0|||
27742028|NCT00306891|80884241|FG003|Part A|QTC interval outwith elig. criteria|0|||
27742029|NCT00306891|80884238|FG000|Part B|Death|0|||
27742030|NCT00306891|80884239|FG001|Part B|Death|0|||
27742031|NCT00306891|80884240|FG002|Part B|Death|1|||
27742032|NCT00306891|80884241|FG003|Part B|Death|2|||
27742033|NCT00306891|80884238|FG000|Part B|Adverse Event|0|||
27742034|NCT00306891|80884239|FG001|Part B|Adverse Event|0|||
27742035|NCT00306891|80884240|FG002|Part B|Adverse Event|5|||
27742036|NCT00306891|80884241|FG003|Part B|Adverse Event|5|||
27742037|NCT00306891|80884238|FG000|Part B|Withdrawal by Subject|0|||
27742038|NCT00306891|80884239|FG001|Part B|Withdrawal by Subject|0|||
27742039|NCT00306891|80884240|FG002|Part B|Withdrawal by Subject|3|||
27742040|NCT00306891|80884241|FG003|Part B|Withdrawal by Subject|1|||
27742041|NCT00306891|80884238|FG000|Part B|Condition under investigation worsened|0|||
27742042|NCT00306891|80884239|FG001|Part B|Condition under investigation worsened|0|||
27742043|NCT00306891|80884240|FG002|Part B|Condition under investigation worsened|2|||
27742044|NCT00306891|80884241|FG003|Part B|Condition under investigation worsened|8|||
27742045|NCT00306891|80884238|FG000|Part B|Development of study specific disc crit.|0|||
27742046|NCT00306891|80884239|FG001|Part B|Development of study specific disc crit.|0|||
27742047|NCT00306891|80884240|FG002|Part B|Development of study specific disc crit.|0|||
27742048|NCT00306891|80884241|FG003|Part B|Development of study specific disc crit.|1|||
27742049|NCT01632878|80884246|FG000|Screening|Physician Decision|268|||
27742050|NCT01632878|80884246|FG000|Treatment|Lost to Follow-up|41|||
27742051|NCT01632878|80884246|FG000|Treatment|Withdrawal by Subject|36|||
27742052|NCT01632878|80884246|FG000|Treatment|Physician Decision|34|||
27742053|NCT01632878|80884246|FG000|Treatment|missing information|4|||
27742054|NCT01632878|80884246|FG000|Treatment|no information on study completion|43|||
27742055|NCT01359982|80884252|FG000|Overall Study|Adverse Event|2|||
27742056|NCT01359982|80884253|FG001|Overall Study|Adverse Event|0|||
27742057|NCT01359982|80884254|FG002|Overall Study|Adverse Event|0|||
27742058|NCT01359982|80884255|FG003|Overall Study|Adverse Event|1|||
27742059|NCT01359982|80884256|FG004|Overall Study|Adverse Event|0|||
27742060|NCT01359982|80884257|FG005|Overall Study|Adverse Event|0|||
27742061|NCT01359982|80884252|FG000|Overall Study|Death|1|||
27742062|NCT01359982|80884253|FG001|Overall Study|Death|0|||
27742063|NCT01359982|80884254|FG002|Overall Study|Death|0|||
27742064|NCT01359982|80884255|FG003|Overall Study|Death|0|||
27742065|NCT01359982|80884256|FG004|Overall Study|Death|0|||
27742066|NCT01359982|80884257|FG005|Overall Study|Death|0|||
27742067|NCT00839098|80884265|FG000|Overall Study|Withdrawal by Subject|2|||
27742068|NCT00839098|80884266|FG001|Overall Study|Withdrawal by Subject|1|||
27742069|NCT00839098|80884267|FG002|Overall Study|Withdrawal by Subject|7|||
27742070|NCT03366844|80884268|FG000|Overall Study|Physician Decision|1|||
27742071|NCT03366844|80884268|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
27742072|NCT01172288|80884285|FG000|Overall Study|Adverse Event|1|||
27742073|NCT01172288|80884286|FG001|Overall Study|Adverse Event|0|||
27639205|NCT00516321|80522061|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
27639206|NCT00516321|80522062|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
27639207|NCT00516321|80522063|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
27639208|NCT00516321|80522061|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
27639209|NCT00516321|80522062|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
27639210|NCT00516321|80522063|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
27639211|NCT00516321|80522061|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
27639212|NCT00516321|80522062|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
27639213|NCT00516321|80522063|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
27545829|NCT00042289|80189463|FG014|Overall Study|Withdrawal by Subject|0|||
27545830|NCT00042289|80189464|FG015|Overall Study|Withdrawal by Subject|0|||
27545831|NCT00042289|80189465|FG016|Overall Study|Withdrawal by Subject|0|||
27545832|NCT00042289|80189466|FG017|Overall Study|Withdrawal by Subject|0|||
27545833|NCT00042289|80189467|FG018|Overall Study|Withdrawal by Subject|0|||
27545834|NCT00042289|80189468|FG019|Overall Study|Withdrawal by Subject|0|||
27545835|NCT00042289|80189469|FG020|Overall Study|Withdrawal by Subject|0|||
27545836|NCT00042289|80189470|FG021|Overall Study|Withdrawal by Subject|1|||
27545837|NCT00042289|80189471|FG022|Overall Study|Withdrawal by Subject|1|||
27545838|NCT00042289|80189472|FG023|Overall Study|Withdrawal by Subject|1|||
27545839|NCT00042289|80189473|FG024|Overall Study|Withdrawal by Subject|0|||
27545840|NCT00042289|80189474|FG025|Overall Study|Withdrawal by Subject|0|||
27545841|NCT00042289|80189475|FG026|Overall Study|Withdrawal by Subject|1|||
27545842|NCT00042289|80189476|FG027|Overall Study|Withdrawal by Subject|0|||
27925638|NCT03704688|81565015|FG003|Overall Study|Disease Progression|3|||
27925639|NCT03704688|81565016|FG004|Overall Study|Disease Progression|1|||
27925640|NCT03704688|81565017|FG005|Overall Study|Disease Progression|0|||
27925641|NCT03704688|81565012|FG000|Overall Study|Death|0|||
27925642|NCT03704688|81565013|FG001|Overall Study|Death|0|||
27925643|NCT03704688|81565014|FG002|Overall Study|Death|0|||
27925644|NCT03704688|81565015|FG003|Overall Study|Death|0|||
27925645|NCT03704688|81565016|FG004|Overall Study|Death|3|||
27925646|NCT03704688|81565017|FG005|Overall Study|Death|0|||
27925647|NCT02969018|81565036|FG000|Overall Study|Adverse Event|2|||
27925648|NCT02969018|81565037|FG001|Overall Study|Adverse Event|4|||
27925649|NCT02969018|81565038|FG002|Overall Study|Adverse Event|1|||
27925650|NCT02969018|81565039|FG003|Overall Study|Adverse Event|2|||
27925651|NCT02969018|81565040|FG004|Overall Study|Adverse Event|0|||
27925652|NCT02969018|81565041|FG005|Overall Study|Adverse Event|1|||
27925653|NCT02969018|81565042|FG006|Overall Study|Adverse Event|2|||
27925654|NCT02969018|81565043|FG007|Overall Study|Adverse Event|0|||
27925655|NCT02969018|81565036|FG000|Overall Study|Lack of Efficacy|0|||
27925656|NCT02969018|81565037|FG001|Overall Study|Lack of Efficacy|1|||
27925657|NCT02969018|81565038|FG002|Overall Study|Lack of Efficacy|0|||
27925658|NCT02969018|81565039|FG003|Overall Study|Lack of Efficacy|0|||
27925659|NCT02969018|81565040|FG004|Overall Study|Lack of Efficacy|1|||
27925660|NCT02969018|81565041|FG005|Overall Study|Lack of Efficacy|1|||
27925661|NCT02969018|81565042|FG006|Overall Study|Lack of Efficacy|1|||
27925662|NCT02969018|81565043|FG007|Overall Study|Lack of Efficacy|1|||
27925663|NCT02969018|81565036|FG000|Overall Study|Lost to Follow-up|1|||
27925664|NCT02969018|81565037|FG001|Overall Study|Lost to Follow-up|2|||
27639214|NCT00516321|80522061|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
27639215|NCT00516321|80522062|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
27639216|NCT00516321|80522063|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
27925665|NCT02969018|81565038|FG002|Overall Study|Lost to Follow-up|2|||
27925666|NCT02969018|81565039|FG003|Overall Study|Lost to Follow-up|0|||
27925667|NCT02969018|81565040|FG004|Overall Study|Lost to Follow-up|1|||
27545843|NCT00042289|80189477|FG028|Overall Study|Withdrawal by Subject|2|||
27545844|NCT00042289|80189478|FG029|Overall Study|Withdrawal by Subject|0|||
27545845|NCT00042289|80189479|FG030|Overall Study|Withdrawal by Subject|0|||
27545846|NCT00042289|80189480|FG031|Overall Study|Withdrawal by Subject|1|||
27545847|NCT00042289|80189481|FG032|Overall Study|Withdrawal by Subject|2|||
27545848|NCT00042289|80189482|FG033|Overall Study|Withdrawal by Subject|1|||
27545849|NCT00042289|80189483|FG034|Overall Study|Withdrawal by Subject|0|||
27545850|NCT00042289|80189484|FG035|Overall Study|Withdrawal by Subject|0|||
27545851|NCT00042289|80189485|FG036|Overall Study|Withdrawal by Subject|0|||
27639217|NCT00516321|80522061|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
27545852|NCT00042289|80189486|FG037|Overall Study|Withdrawal by Subject|1|||
27545853|NCT00042289|80189487|FG038|Overall Study|Withdrawal by Subject|0|||
27925668|NCT02969018|81565041|FG005|Overall Study|Lost to Follow-up|1|||
27925669|NCT02969018|81565042|FG006|Overall Study|Lost to Follow-up|0|||
27925670|NCT02969018|81565043|FG007|Overall Study|Lost to Follow-up|1|||
27925671|NCT02969018|81565036|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27925672|NCT02969018|81565037|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27925673|NCT02969018|81565038|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
27925674|NCT02969018|81565039|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
27545854|NCT00042289|80189488|FG039|Overall Study|Withdrawal by Subject|0|||
27545855|NCT00042289|80189489|FG040|Overall Study|Withdrawal by Subject|0|||
27545856|NCT00042289|80189490|FG041|Overall Study|Withdrawal by Subject|0|||
27545857|NCT00042289|80189491|FG042|Overall Study|Withdrawal by Subject|1|||
27545858|NCT00042289|80189492|FG043|Overall Study|Withdrawal by Subject|0|||
27545859|NCT00042289|80189493|FG044|Overall Study|Withdrawal by Subject|0|||
27545860|NCT00042289|80189494|FG045|Overall Study|Withdrawal by Subject|0|||
27545861|NCT00042289|80189495|FG046|Overall Study|Withdrawal by Subject|0|||
27545862|NCT01687998|80189496|FG000|Overall Study|Withdrawal by Subject|49|||
27545863|NCT01687998|80189497|FG001|Overall Study|Withdrawal by Subject|51|||
27545864|NCT01687998|80189496|FG000|Overall Study|Known to be Alive at Study End|54|||
27545865|NCT01687998|80189497|FG001|Overall Study|Known to be Alive at Study End|62|||
27545866|NCT01687998|80189496|FG000|Overall Study|Lost to Follow-up|9|||
27545867|NCT01687998|80189497|FG001|Overall Study|Lost to Follow-up|7|||
27545868|NCT02756013|80189500|FG000|Overall Study|Adverse Event|1|||
27545869|NCT02756013|80189500|FG000|Overall Study|Hypersensitivity|1|||
27639218|NCT00516321|80522062|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
27639219|NCT00516321|80522063|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
27639220|NCT00516321|80522061|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
27639221|NCT00516321|80522062|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
27639222|NCT00516321|80522063|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
27639223|NCT00516321|80522061|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
27639224|NCT00516321|80522062|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
27639225|NCT00516321|80522063|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
27639226|NCT00632203|80522070|FG000|Overall Study|Did not start study treatment|1|||
27925675|NCT02969018|81565040|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
27925676|NCT02969018|81565041|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27925677|NCT02969018|81565042|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
27925678|NCT02969018|81565043|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
27925679|NCT02969018|81565036|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27925680|NCT02969018|81565037|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27925681|NCT02969018|81565038|FG002|Overall Study|Non-Compliance With Study Drug|0|||
27925682|NCT02969018|81565039|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27925683|NCT02969018|81565040|FG004|Overall Study|Non-Compliance With Study Drug|0|||
27925684|NCT02969018|81565041|FG005|Overall Study|Non-Compliance With Study Drug|0|||
27925685|NCT02969018|81565042|FG006|Overall Study|Non-Compliance With Study Drug|0|||
27925686|NCT02969018|81565043|FG007|Overall Study|Non-Compliance With Study Drug|0|||
27925687|NCT02969018|81565036|FG000|Overall Study|Other|0|||
27925688|NCT02969018|81565037|FG001|Overall Study|Other|0|||
27925689|NCT02969018|81565038|FG002|Overall Study|Other|0|||
27925690|NCT02969018|81565039|FG003|Overall Study|Other|1|||
27925691|NCT02969018|81565040|FG004|Overall Study|Other|0|||
27925692|NCT02969018|81565041|FG005|Overall Study|Other|0|||
27925693|NCT02969018|81565042|FG006|Overall Study|Other|0|||
27925694|NCT02969018|81565043|FG007|Overall Study|Other|2|||
27925695|NCT02969018|81565036|FG000|Overall Study|Pregnancy|0|||
27925696|NCT02969018|81565037|FG001|Overall Study|Pregnancy|0|||
27925697|NCT02969018|81565038|FG002|Overall Study|Pregnancy|0|||
27925698|NCT02969018|81565039|FG003|Overall Study|Pregnancy|0|||
27925699|NCT02969018|81565040|FG004|Overall Study|Pregnancy|0|||
27925700|NCT02969018|81565041|FG005|Overall Study|Pregnancy|1|||
27925701|NCT02969018|81565042|FG006|Overall Study|Pregnancy|0|||
27925702|NCT02969018|81565043|FG007|Overall Study|Pregnancy|0|||
27639227|NCT00632203|80522071|FG001|Overall Study|Did not start study treatment|0|||
27742074|NCT01172288|80884285|FG000|Overall Study|Protocol Violation|0|||
27742075|NCT01172288|80884286|FG001|Overall Study|Protocol Violation|1|||
27742076|NCT02269319|80884287|FG000|Overall Study|Lost to Follow-up|4|||
27742077|NCT02269319|80884288|FG001|Overall Study|Lost to Follow-up|3|||
27742078|NCT02269319|80884287|FG000|Overall Study|Adverse Event|0|||
27742079|NCT02269319|80884288|FG001|Overall Study|Adverse Event|1|||
27742080|NCT02269319|80884287|FG000|Overall Study|Instructions not followed|1|||
27742081|NCT02269319|80884288|FG001|Overall Study|Instructions not followed|0|||
27742082|NCT04530825|80884289|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
27545870|NCT00743483|80189504|FG000|Baseline Period|Physician Decision|1|||
27545871|NCT00743483|80189504|FG000|Treatment Period|Adverse Event|1|||
27639228|NCT02574455|80522072|FG000|Overall Study|Death|197|||
27639229|NCT02574455|80522073|FG001|Overall Study|Death|210|||
27639230|NCT02574455|80522072|FG000|Overall Study|Withdrawal of Consent|11|||
27742083|NCT04530825|80884290|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
27742084|NCT04530825|80884291|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
27925703|NCT02969018|81565036|FG000|Overall Study|Protocol Violation|0|||
27925704|NCT02969018|81565037|FG001|Overall Study|Protocol Violation|0|||
27925705|NCT02969018|81565038|FG002|Overall Study|Protocol Violation|1|||
27925706|NCT02969018|81565039|FG003|Overall Study|Protocol Violation|1|||
27925707|NCT02969018|81565040|FG004|Overall Study|Protocol Violation|0|||
27925708|NCT02969018|81565041|FG005|Overall Study|Protocol Violation|0|||
27925709|NCT02969018|81565042|FG006|Overall Study|Protocol Violation|0|||
27925710|NCT02969018|81565043|FG007|Overall Study|Protocol Violation|0|||
27925711|NCT02969018|81565036|FG000|Overall Study|Withdrawal by Subject|0|||
27925712|NCT02969018|81565037|FG001|Overall Study|Withdrawal by Subject|1|||
27925713|NCT02969018|81565038|FG002|Overall Study|Withdrawal by Subject|2|||
27925714|NCT02969018|81565039|FG003|Overall Study|Withdrawal by Subject|1|||
27925715|NCT02969018|81565040|FG004|Overall Study|Withdrawal by Subject|0|||
27925716|NCT02969018|81565041|FG005|Overall Study|Withdrawal by Subject|4|||
27925717|NCT02969018|81565042|FG006|Overall Study|Withdrawal by Subject|4|||
27925718|NCT02969018|81565043|FG007|Overall Study|Withdrawal by Subject|3|||
27925719|NCT01631188|81565046|FG000|Overall Study|Physician Decision|75|||
27545872|NCT02499783|80189505|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
27639231|NCT02574455|80522073|FG001|Overall Study|Withdrawal of Consent|28|||
27639232|NCT02574455|80522072|FG000|Overall Study|Lost to Follow-up|4|||
27639233|NCT02574455|80522073|FG001|Overall Study|Lost to Follow-up|4|||
27639234|NCT02574455|80522072|FG000|Overall Study|Sponsor's Decision|55|||
27639235|NCT02574455|80522073|FG001|Overall Study|Sponsor's Decision|20|||
27639236|NCT02267824|80522074|FG000|Overall Study|Pregnancy|1|||
27639237|NCT02267824|80522075|FG001|Overall Study|Pregnancy|1|||
27639238|NCT02267824|80522074|FG000|Overall Study|Lost to Follow-up|4|||
27639239|NCT02267824|80522075|FG001|Overall Study|Lost to Follow-up|0|||
27639240|NCT02267824|80522074|FG000|Overall Study|Protocol Violation|3|||
27639241|NCT02267824|80522075|FG001|Overall Study|Protocol Violation|0|||
27639242|NCT02267824|80522074|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
27639243|NCT02267824|80522075|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
27639244|NCT00595413|80522076|FG000|Overall Study|Adverse Event|0|||
27639245|NCT00595413|80522077|FG001|Overall Study|Adverse Event|2|||
27639246|NCT00595413|80522078|FG002|Overall Study|Adverse Event|1|||
27639247|NCT00595413|80522079|FG003|Overall Study|Adverse Event|1|||
27639248|NCT00595413|80522076|FG000|Overall Study|Lost to Follow-up|2|||
27639249|NCT00595413|80522077|FG001|Overall Study|Lost to Follow-up|2|||
27639250|NCT00595413|80522078|FG002|Overall Study|Lost to Follow-up|1|||
27639251|NCT00595413|80522079|FG003|Overall Study|Lost to Follow-up|3|||
27639252|NCT00595413|80522076|FG000|Overall Study|Death|0|||
27639253|NCT00595413|80522077|FG001|Overall Study|Death|0|||
27545873|NCT02499783|80189506|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
27545874|NCT02499783|80189507|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
27545875|NCT02499783|80189505|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
27639254|NCT00595413|80522078|FG002|Overall Study|Death|1|||
27639255|NCT00595413|80522079|FG003|Overall Study|Death|0|||
27639256|NCT00595413|80522076|FG000|Overall Study|Other|5|||
27639257|NCT00595413|80522077|FG001|Overall Study|Other|1|||
27639258|NCT00595413|80522078|FG002|Overall Study|Other|5|||
27639259|NCT00595413|80522079|FG003|Overall Study|Other|0|||
27639260|NCT03175172|80522082|FG000|Overall Study|Death|3|||
27639261|NCT03175172|80522082|FG000|Overall Study|Withdrawal by Subject|3|||
27639262|NCT03175172|80522082|FG000|Overall Study|Lost to Follow-up|1|||
27639263|NCT03175172|80522082|FG000|Overall Study|Study Terminated by Sponsor|3|||
27639264|NCT02275611|80522084|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
27639265|NCT02275611|80522085|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
27639266|NCT02275611|80522086|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
27639267|NCT02275611|80522087|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
27639268|NCT00683696|80522088|FG000|Overall Study|Withdrawn due to study closure|337|||
27639269|NCT00683696|80522089|FG001|Overall Study|Withdrawn due to study closure|338|||
27925720|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
27925721|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
27925722|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Death|1|||
27545876|NCT02499783|80189506|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
27545877|NCT02499783|80189507|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
27545878|NCT02499783|80189505|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
27545879|NCT02499783|80189506|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
27545880|NCT02499783|80189507|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
27545881|NCT02499783|80189505|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
27639270|NCT00683696|80522088|FG000|Overall Study|Withdrawn prior to study closure|13|||
27639271|NCT00683696|80522089|FG001|Overall Study|Withdrawn prior to study closure|28|||
27639272|NCT00683696|80522088|FG000|Overall Study|Lost to Follow-up|5|||
27545882|NCT02499783|80189506|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
27545883|NCT02499783|80189507|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
27545884|NCT02499783|80189505|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
27639273|NCT00683696|80522089|FG001|Overall Study|Lost to Follow-up|6|||
27639274|NCT00683696|80522088|FG000|Overall Study|Vital status follow-up only|3|||
27639275|NCT00683696|80522089|FG001|Overall Study|Vital status follow-up only|3|||
27639276|NCT00683696|80522088|FG000|Overall Study|Death|46|||
27639277|NCT00683696|80522089|FG001|Overall Study|Death|30|||
27925723|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Death|3|||
27925724|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
27925725|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
27925726|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
27925727|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
27925728|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
27925729|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
27925730|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
27925731|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
27925732|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
27925733|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
27925734|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
27925735|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
27925736|NCT00362232|81565052|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
27925737|NCT00362232|81565053|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
27925738|NCT00362232|81565052|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
27925739|NCT00362232|81565053|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
27925740|NCT00362232|81565052|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
27925741|NCT00362232|81565053|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
27925742|NCT00362232|81565052|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
27925743|NCT00362232|81565053|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
27925744|NCT00362232|81565052|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
27925745|NCT00362232|81565053|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
27925746|NCT03069989|81565058|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
27545885|NCT02499783|80189506|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
27545886|NCT02499783|80189507|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
27925747|NCT03069989|81565059|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
27925748|NCT02115386|81565060|FG000|Overall Study|Protocol Violation|1|||
27639278|NCT01144468|80522090|FG000|Overall Study|Lost to Follow-up|4|||
27639279|NCT01144468|80522091|FG001|Overall Study|Lost to Follow-up|7|||
27545887|NCT02499783|80189505|FG000|DB Period: Weeks 0-8|Other|1|||
27545888|NCT02499783|80189506|FG001|DB Period: Weeks 0-8|Other|1|||
27545889|NCT02499783|80189507|FG002|DB Period: Weeks 0-8|Other|0|||
27545890|NCT02499783|80189505|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
27545891|NCT02499783|80189506|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
27545892|NCT02499783|80189507|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
27545893|NCT02499783|80189505|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
27545894|NCT02499783|80189506|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
27545895|NCT02499783|80189507|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
27545896|NCT02499783|80189505|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
27545897|NCT02499783|80189506|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
27545898|NCT02499783|80189507|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
27545899|NCT02499783|80189505|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
27545900|NCT02499783|80189506|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
27545901|NCT02499783|80189507|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
27545902|NCT00361569|80189508|FG000|Overall Study|Protocol Violation|3|||
27545903|NCT00361569|80189509|FG001|Overall Study|Protocol Violation|2|||
27639280|NCT01144468|80522090|FG000|Overall Study|Adverse Event|3|||
27639281|NCT01144468|80522091|FG001|Overall Study|Adverse Event|2|||
27639282|NCT01144468|80522090|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
27639283|NCT01144468|80522091|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
27639284|NCT00812461|80522103|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
27639285|NCT00812461|80522104|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
27639286|NCT00812461|80522103|FG000|All Treated Patients|Adverse Event|8|||
27742085|NCT04530825|80884292|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
27742086|NCT04530825|80884289|FG000|Overall Study|Did not complete follow-up|3|||
27925749|NCT02115386|81565060|FG000|Overall Study|Administrative - trial was terminated|6|||
27925750|NCT00262925|81565061|FG000|Overall Study|Lack of Efficacy|3|||
27925751|NCT00262925|81565061|FG000|Overall Study|Adverse Event|4|||
27545904|NCT00361569|80189510|FG002|Overall Study|Protocol Violation|4|||
27639287|NCT00812461|80522104|FG001|All Treated Patients|Adverse Event|15|||
27639288|NCT00812461|80522103|FG000|All Treated Patients|Lack of Efficacy|13|||
27925752|NCT00262925|81565061|FG000|Overall Study|Death|2|||
27925753|NCT00262925|81565061|FG000|Overall Study|alternative therapy|1|||
27545905|NCT00361569|80189511|FG003|Overall Study|Protocol Violation|2|||
27545906|NCT00361569|80189508|FG000|Overall Study|Withdrawal by Subject|2|||
27545907|NCT00361569|80189509|FG001|Overall Study|Withdrawal by Subject|1|||
27545908|NCT00361569|80189510|FG002|Overall Study|Withdrawal by Subject|9|||
27545909|NCT00361569|80189511|FG003|Overall Study|Withdrawal by Subject|14|||
27639289|NCT00812461|80522104|FG001|All Treated Patients|Lack of Efficacy|7|||
27639290|NCT00812461|80522103|FG000|All Treated Patients|Non-compliance|6|||
27925754|NCT00262925|81565061|FG000|Overall Study|Other|1|||
27925755|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
27925756|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
27925757|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
27925758|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
27925759|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
27925760|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
27925761|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
27925762|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
27925763|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
27925764|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
27925765|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
27925766|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
27925767|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
27925768|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
27925769|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
27925770|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
27925771|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
27925772|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
27925773|NCT01069939|81565063|FG000|Randomised and Included in the Analyses|Removal|1|||
27925774|NCT01069939|81565064|FG001|Randomised and Included in the Analyses|Removal|0|||
27925775|NCT01452347|81565072|FG000|Overall Study|Adverse Event|2|||
27925776|NCT01452347|81565073|FG001|Overall Study|Adverse Event|1|||
27925777|NCT01452347|81565072|FG000|Overall Study|Non compliance protocol|2|||
27925778|NCT01452347|81565073|FG001|Overall Study|Non compliance protocol|0|||
27925779|NCT01452347|81565072|FG000|Overall Study|Lost to Follow-up|2|||
27925780|NCT01452347|81565073|FG001|Overall Study|Lost to Follow-up|0|||
27925781|NCT01452347|81565072|FG000|Overall Study|Withdrawal by Subject|3|||
27925782|NCT01452347|81565073|FG001|Overall Study|Withdrawal by Subject|3|||
27925783|NCT01452347|81565072|FG000|Overall Study|Not treated|6|||
27925784|NCT01452347|81565073|FG001|Overall Study|Not treated|3|||
27925785|NCT01452347|81565072|FG000|Overall Study|Other reason not defined above|2|||
27925786|NCT01452347|81565073|FG001|Overall Study|Other reason not defined above|0|||
27925787|NCT02225587|81565074|FG000|Overall Study|Adverse Event|5|||
27639291|NCT00812461|80522104|FG001|All Treated Patients|Non-compliance|9|||
27639292|NCT00812461|80522103|FG000|All Treated Patients|Protocol Violation|36|||
27639293|NCT00812461|80522104|FG001|All Treated Patients|Protocol Violation|27|||
27639294|NCT00812461|80522103|FG000|All Treated Patients|Withdrawal by Subject|45|||
27639295|NCT00812461|80522104|FG001|All Treated Patients|Withdrawal by Subject|54|||
27925788|NCT02225587|81565075|FG001|Overall Study|Adverse Event|5|||
27925789|NCT02225587|81565074|FG000|Overall Study|Lost to Follow-up|5|||
27639296|NCT00812461|80522103|FG000|All Treated Patients|Lost to Follow-up|11|||
27639297|NCT00812461|80522104|FG001|All Treated Patients|Lost to Follow-up|14|||
27639298|NCT00812461|80522103|FG000|All Treated Patients|Other Reason|13|||
27639299|NCT00812461|80522104|FG001|All Treated Patients|Other Reason|21|||
27639300|NCT01308567|80522105|FG000|Overall Study|Lost to Follow-up|2|||
27639301|NCT01308567|80522106|FG001|Overall Study|Lost to Follow-up|4|||
27639302|NCT01308567|80522107|FG002|Overall Study|Lost to Follow-up|4|||
27639303|NCT01414738|80522110|FG000|Overall Study|Death|26|||
27639304|NCT01414738|80522110|FG000|Overall Study|Refused testing|5|||
27639305|NCT01414738|80522110|FG000|Overall Study|Lost to Follow-up|2|||
27639306|NCT01414738|80522110|FG000|Overall Study|Refused, disease progression|8|||
27639307|NCT01414738|80522110|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
27639308|NCT02224924|80522113|FG000|Overall Study|Withdrawal by Subject|7|||
27639309|NCT02224924|80522114|FG001|Overall Study|Withdrawal by Subject|6|||
27639310|NCT02224924|80522113|FG000|Overall Study|Biopsy cancelled|20|||
27639311|NCT02224924|80522114|FG001|Overall Study|Biopsy cancelled|14|||
27639312|NCT02224924|80522113|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
27639313|NCT02224924|80522114|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
27925790|NCT02225587|81565075|FG001|Overall Study|Lost to Follow-up|5|||
27925791|NCT02225587|81565074|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27925792|NCT02225587|81565075|FG001|Overall Study|Non-Compliance With Study Drug|0|||
27545910|NCT00361569|80189508|FG000|Overall Study|Adverse Event|3|||
27639314|NCT02224924|80522113|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
27639315|NCT02224924|80522114|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
27639316|NCT03262935|80522119|FG000|Overall Study|Withdrawal by Subject|6|||
27639317|NCT03262935|80522120|FG001|Overall Study|Withdrawal by Subject|7|||
27639318|NCT03262935|80522119|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
27639319|NCT03262935|80522120|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
27639320|NCT03262935|80522119|FG000|Overall Study|Death|181|||
27639321|NCT03262935|80522120|FG001|Overall Study|Death|94|||
27639322|NCT03262935|80522119|FG000|Overall Study|Lost to Follow-up|9|||
27639323|NCT03262935|80522120|FG001|Overall Study|Lost to Follow-up|4|||
27639324|NCT03262935|80522119|FG000|Overall Study|Other reason|5|||
27639325|NCT03262935|80522120|FG001|Overall Study|Other reason|0|||
27639326|NCT02121002|80522130|FG000|Overall Study|Physician Decision|2|||
27639327|NCT02121002|80522131|FG001|Overall Study|Physician Decision|0|||
27639328|NCT02121002|80522132|FG002|Overall Study|Physician Decision|0|||
27639329|NCT02121002|80522130|FG000|Overall Study|Withdrawal by Subject|3|||
27639330|NCT02121002|80522131|FG001|Overall Study|Withdrawal by Subject|1|||
27639331|NCT02121002|80522132|FG002|Overall Study|Withdrawal by Subject|4|||
27639332|NCT02121002|80522130|FG000|Overall Study|Protocol Violation|1|||
27639333|NCT02121002|80522131|FG001|Overall Study|Protocol Violation|2|||
27639334|NCT02121002|80522132|FG002|Overall Study|Protocol Violation|4|||
27639335|NCT02121002|80522130|FG000|Overall Study|Concomitant therapy|0|||
27639336|NCT02121002|80522131|FG001|Overall Study|Concomitant therapy|1|||
27639337|NCT02121002|80522132|FG002|Overall Study|Concomitant therapy|1|||
27639338|NCT02121002|80522130|FG000|Overall Study|Others|1|||
27639339|NCT02121002|80522131|FG001|Overall Study|Others|0|||
27639340|NCT02121002|80522132|FG002|Overall Study|Others|1|||
27639341|NCT01063972|80522133|FG000|Overall Study|Death|12|||
27639342|NCT01063972|80522134|FG001|Overall Study|Death|11|||
27639343|NCT01063972|80522133|FG000|Overall Study|Incarcerated|2|||
27639344|NCT01063972|80522134|FG001|Overall Study|Incarcerated|1|||
27639345|NCT01460446|80522135|FG000|Overall Study|Non-compliance|2|||
27639346|NCT01460446|80522136|FG001|Overall Study|Non-compliance|9|||
27639347|NCT01460446|80522135|FG000|Overall Study|Consent Withdrawn|0|||
27639348|NCT01460446|80522136|FG001|Overall Study|Consent Withdrawn|4|||
27639349|NCT01460446|80522135|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
27639350|NCT01460446|80522136|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
27639351|NCT01460446|80522135|FG000|Overall Study|Surgery/Illness|1|||
27639352|NCT01460446|80522136|FG001|Overall Study|Surgery/Illness|1|||
27639353|NCT01460446|80522135|FG000|Overall Study|Pregnancy|1|||
27639354|NCT01460446|80522136|FG001|Overall Study|Pregnancy|0|||
27639355|NCT01460446|80522135|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
27639356|NCT01460446|80522136|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
27639357|NCT02015546|80522140|FG000|Overall Study|Withdrawal by Subject|1|||
27639358|NCT02015546|80522141|FG001|Overall Study|Withdrawal by Subject|1|||
27639359|NCT02015546|80522142|FG002|Overall Study|Withdrawal by Subject|1|||
27639360|NCT02015546|80522140|FG000|Overall Study|Screem Failure|2|||
27639361|NCT02015546|80522141|FG001|Overall Study|Screem Failure|1|||
27639362|NCT02015546|80522142|FG002|Overall Study|Screem Failure|3|||
27639363|NCT00423098|80522148|FG000|Overall Study|Adverse Event|1|||
27639364|NCT00423098|80522149|FG001|Overall Study|Adverse Event|2|||
27639365|NCT00423098|80522148|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27639366|NCT00423098|80522149|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27639367|NCT00423098|80522148|FG000|Overall Study|Administrative problems|0|||
27639368|NCT00423098|80522149|FG001|Overall Study|Administrative problems|1|||
27639369|NCT00423098|80522148|FG000|Overall Study|Death|2|||
27639370|NCT00423098|80522149|FG001|Overall Study|Death|0|||
27639371|NCT04820686|80522150|FG000|Overall Study|Withdrawal by Subject|5|||
27639372|NCT04820686|80522151|FG001|Overall Study|Withdrawal by Subject|2|||
27639373|NCT04820686|80522152|FG002|Overall Study|Withdrawal by Subject|3|||
27639374|NCT04820686|80522150|FG000|Overall Study|Study Termination|25|||
27639375|NCT04820686|80522151|FG001|Overall Study|Study Termination|13|||
27639376|NCT04820686|80522152|FG002|Overall Study|Study Termination|14|||
27639377|NCT04820686|80522150|FG000|Overall Study|Adverse Event|0|||
27639378|NCT04820686|80522151|FG001|Overall Study|Adverse Event|1|||
27639379|NCT04820686|80522152|FG002|Overall Study|Adverse Event|0|||
27639380|NCT02724956|80522153|FG000|Overall Study|Physician Decision|1|||
27639381|NCT02724956|80522154|FG001|Overall Study|Physician Decision|0|||
27639382|NCT02724956|80522153|FG000|Overall Study|Lack of Efficacy|0|||
27639383|NCT02724956|80522154|FG001|Overall Study|Lack of Efficacy|1|||
27639384|NCT02724956|80522153|FG000|Overall Study|Withdrawal by Subject|0|||
27639385|NCT02724956|80522154|FG001|Overall Study|Withdrawal by Subject|1|||
27639386|NCT01266122|80522159|FG000|Overall Study|Lost to Follow-up|6|||
27639387|NCT01266122|80522160|FG001|Overall Study|Lost to Follow-up|6|||
27742087|NCT04530825|80884290|FG001|Overall Study|Did not complete follow-up|0|||
27639388|NCT02477605|80522171|FG000|Overall Study|Discontinued prior to treatment|1|||
27639389|NCT02477605|80522172|FG001|Overall Study|Discontinued prior to treatment|0|||
27639390|NCT02477605|80522171|FG000|Overall Study|Lost to Follow-up|0|||
27639391|NCT02477605|80522172|FG001|Overall Study|Lost to Follow-up|2|||
27639392|NCT02477605|80522171|FG000|Overall Study|Withdrawal by Subject|0|||
27639393|NCT02477605|80522172|FG001|Overall Study|Withdrawal by Subject|1|||
27639394|NCT02477605|80522171|FG000|Overall Study|Administered gas during surgery|0|||
27639395|NCT02477605|80522172|FG001|Overall Study|Administered gas during surgery|1|||
27639396|NCT03988842|80522173|FG000|Overall Study|Death|1|||
27639397|NCT00440011|80522174|FG000|Overall Study|Adverse Event|2|||
27639398|NCT00440011|80522175|FG001|Overall Study|Adverse Event|0|||
27639399|NCT00440011|80522174|FG000|Overall Study|Lost to Follow-up|0|||
27639400|NCT00440011|80522175|FG001|Overall Study|Lost to Follow-up|2|||
27639401|NCT00440011|80522174|FG000|Overall Study|Protocol Violation|1|||
27639402|NCT00440011|80522175|FG001|Overall Study|Protocol Violation|1|||
27639403|NCT00440011|80522174|FG000|Overall Study|Withdrawal by Subject|1|||
27742088|NCT04530825|80884291|FG002|Overall Study|Did not complete follow-up|0|||
27925793|NCT02225587|81565074|FG000|Overall Study|Physician Decision|2|||
27925794|NCT02225587|81565075|FG001|Overall Study|Physician Decision|0|||
27639404|NCT00440011|80522175|FG001|Overall Study|Withdrawal by Subject|0|||
27639405|NCT02466516|80522176|FG000|Overall Study|Adverse Event|1|||
27639406|NCT02466516|80522177|FG001|Overall Study|Adverse Event|1|||
27925795|NCT02225587|81565074|FG000|Overall Study|Protocol Violation|1|||
27925796|NCT02225587|81565075|FG001|Overall Study|Protocol Violation|0|||
27925797|NCT02225587|81565074|FG000|Overall Study|Participant Moved|1|||
27639407|NCT02466516|80522178|FG002|Overall Study|Adverse Event|0|||
27639408|NCT02466516|80522179|FG003|Overall Study|Adverse Event|0|||
27639409|NCT02466516|80522180|FG004|Overall Study|Adverse Event|0|||
27639410|NCT02466516|80522176|FG000|Overall Study|Withdrew Consent|1|||
27639411|NCT02466516|80522177|FG001|Overall Study|Withdrew Consent|0|||
27639412|NCT02466516|80522178|FG002|Overall Study|Withdrew Consent|0|||
27639413|NCT02466516|80522179|FG003|Overall Study|Withdrew Consent|0|||
27639414|NCT02466516|80522180|FG004|Overall Study|Withdrew Consent|0|||
27639415|NCT02466516|80522176|FG000|Overall Study|Lost to Follow-up|2|||
27639416|NCT02466516|80522177|FG001|Overall Study|Lost to Follow-up|0|||
27639417|NCT02466516|80522178|FG002|Overall Study|Lost to Follow-up|1|||
27639418|NCT02466516|80522179|FG003|Overall Study|Lost to Follow-up|0|||
27639419|NCT02466516|80522180|FG004|Overall Study|Lost to Follow-up|0|||
27639420|NCT03101930|80522181|FG000|Overall Study|Withdrawal by Subject|2|||
27639421|NCT03101930|80522182|FG001|Overall Study|Withdrawal by Subject|1|||
27639422|NCT03101930|80522183|FG002|Overall Study|Withdrawal by Subject|2|||
27639423|NCT01303445|80522189|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
27639424|NCT01303445|80522190|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
27639425|NCT01303445|80522189|FG000|Second Intervention (7 Days)|Adverse Event|0|||
27639426|NCT01303445|80522190|FG001|Second Intervention (7 Days)|Adverse Event|2|||
27639427|NCT01303445|80522189|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
27639428|NCT01303445|80522190|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
27639429|NCT01303445|80522189|FG000|Washout (14 Days)|Protocol Violation|1|||
27639430|NCT01303445|80522190|FG001|Washout (14 Days)|Protocol Violation|0|||
27639431|NCT01303445|80522189|FG000|Washout (14 Days)|Lost to Follow-up|0|||
27639432|NCT01303445|80522190|FG001|Washout (14 Days)|Lost to Follow-up|2|||
27639433|NCT01303445|80522189|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
27639434|NCT01303445|80522190|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
27639435|NCT01303445|80522189|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
27639436|NCT01303445|80522190|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
27639437|NCT01837966|80522191|FG000|Overall Study|Withdrawal by Subject|2|||
27639438|NCT01837966|80522192|FG001|Overall Study|Withdrawal by Subject|1|||
27639439|NCT03194958|80522193|FG000|Overall Study|Death|0|||
27639440|NCT03194958|80522194|FG001|Overall Study|Death|1|||
27639441|NCT03194958|80522195|FG002|Overall Study|Death|1|||
27639442|NCT03194958|80522196|FG003|Overall Study|Death|1|||
27639443|NCT03194958|80522193|FG000|Overall Study|Withdrawal by Subject|24|||
27925798|NCT02225587|81565075|FG001|Overall Study|Participant Moved|0|||
27925799|NCT02225587|81565074|FG000|Overall Study|Withdrawal by Subject|13|||
27925800|NCT02225587|81565075|FG001|Overall Study|Withdrawal by Subject|28|||
27925801|NCT00676143|81565076|FG000|Overall Study|Adverse Event|34|||
27925802|NCT00676143|81565077|FG001|Overall Study|Adverse Event|60|||
27925803|NCT00676143|81565076|FG000|Overall Study|Death|4|||
27925804|NCT00676143|81565077|FG001|Overall Study|Death|4|||
27925805|NCT00676143|81565076|FG000|Overall Study|Lack of Efficacy|0|||
27925806|NCT00676143|81565077|FG001|Overall Study|Lack of Efficacy|6|||
27925807|NCT00676143|81565076|FG000|Overall Study|Lost to Follow-up|0|||
27925808|NCT00676143|81565077|FG001|Overall Study|Lost to Follow-up|13|||
27925809|NCT00676143|81565076|FG000|Overall Study|Physician Decision|5|||
27925810|NCT00676143|81565077|FG001|Overall Study|Physician Decision|8|||
27925811|NCT00676143|81565076|FG000|Overall Study|Protocol Violation|4|||
27925812|NCT00676143|81565077|FG001|Overall Study|Protocol Violation|8|||
27925813|NCT00676143|81565076|FG000|Overall Study|Withdrawal by Subject|24|||
27639444|NCT03194958|80522194|FG001|Overall Study|Withdrawal by Subject|27|||
27639445|NCT03194958|80522195|FG002|Overall Study|Withdrawal by Subject|7|||
27639446|NCT03194958|80522196|FG003|Overall Study|Withdrawal by Subject|22|||
27639447|NCT03194958|80522193|FG000|Overall Study|Lost to Follow-up|168|||
27639448|NCT03194958|80522194|FG001|Overall Study|Lost to Follow-up|196|||
27639449|NCT03194958|80522195|FG002|Overall Study|Lost to Follow-up|174|||
27639450|NCT03194958|80522196|FG003|Overall Study|Lost to Follow-up|186|||
27639451|NCT01307267|80522197|FG000|Overall Study|Death|4|||
27639452|NCT01307267|80522198|FG001|Overall Study|Death|3|||
27639453|NCT01307267|80522199|FG002|Overall Study|Death|5|||
27639454|NCT01307267|80522200|FG003|Overall Study|Death|3|||
27639455|NCT01307267|80522201|FG004|Overall Study|Death|1|||
27639456|NCT01307267|80522202|FG005|Overall Study|Death|26|||
27925814|NCT00676143|81565077|FG001|Overall Study|Withdrawal by Subject|42|||
27925815|NCT00676143|81565076|FG000|Overall Study|Discontinuation of study by sponsor|65|||
27925816|NCT00676143|81565077|FG001|Overall Study|Discontinuation of study by sponsor|88|||
27925817|NCT00676143|81565076|FG000|Overall Study|Failed to return|2|||
27639457|NCT01307267|80522203|FG006|Overall Study|Death|2|||
27639458|NCT01307267|80522204|FG007|Overall Study|Death|2|||
27639459|NCT01307267|80522205|FG008|Overall Study|Death|21|||
27639460|NCT01307267|80522206|FG009|Overall Study|Death|2|||
27639461|NCT01307267|80522207|FG010|Overall Study|Death|3|||
27639462|NCT01307267|80522208|FG011|Overall Study|Death|9|||
27639463|NCT01307267|80522209|FG012|Overall Study|Death|0|||
27639464|NCT01307267|80522210|FG013|Overall Study|Death|0|||
27639465|NCT01307267|80522211|FG014|Overall Study|Death|0|||
27639466|NCT01307267|80522212|FG015|Overall Study|Death|0|||
27639467|NCT01307267|80522213|FG016|Overall Study|Death|1|||
27639468|NCT01307267|80522214|FG017|Overall Study|Death|1|||
27639469|NCT01307267|80522215|FG018|Overall Study|Death|2|||
27639470|NCT01307267|80522216|FG019|Overall Study|Death|8|||
27639471|NCT01307267|80522217|FG020|Overall Study|Death|1|||
27639472|NCT01307267|80522218|FG021|Overall Study|Death|2|||
27639473|NCT01307267|80522219|FG022|Overall Study|Death|2|||
27639474|NCT01307267|80522197|FG000|Overall Study|Lost to Follow-up|0|||
27639475|NCT01307267|80522198|FG001|Overall Study|Lost to Follow-up|0|||
27639476|NCT01307267|80522199|FG002|Overall Study|Lost to Follow-up|0|||
27639477|NCT01307267|80522200|FG003|Overall Study|Lost to Follow-up|0|||
27639478|NCT01307267|80522201|FG004|Overall Study|Lost to Follow-up|0|||
27639479|NCT01307267|80522202|FG005|Overall Study|Lost to Follow-up|7|||
27639480|NCT01307267|80522203|FG006|Overall Study|Lost to Follow-up|0|||
27639481|NCT01307267|80522204|FG007|Overall Study|Lost to Follow-up|0|||
27639482|NCT01307267|80522205|FG008|Overall Study|Lost to Follow-up|1|||
27639483|NCT01307267|80522206|FG009|Overall Study|Lost to Follow-up|2|||
27639484|NCT01307267|80522207|FG010|Overall Study|Lost to Follow-up|1|||
27639485|NCT01307267|80522208|FG011|Overall Study|Lost to Follow-up|0|||
27925818|NCT00676143|81565077|FG001|Overall Study|Failed to return|1|||
27545911|NCT00361569|80189509|FG001|Overall Study|Adverse Event|5|||
27545912|NCT00361569|80189510|FG002|Overall Study|Adverse Event|2|||
27545913|NCT00361569|80189511|FG003|Overall Study|Adverse Event|2|||
27545914|NCT00361569|80189508|FG000|Overall Study|Lost to Follow-up|2|||
27545915|NCT00361569|80189509|FG001|Overall Study|Lost to Follow-up|3|||
27545916|NCT00361569|80189510|FG002|Overall Study|Lost to Follow-up|3|||
27925819|NCT00676143|81565076|FG000|Overall Study|Loss of caregiver|5|||
27925820|NCT00676143|81565077|FG001|Overall Study|Loss of caregiver|3|||
27925821|NCT00676143|81565076|FG000|Overall Study|Other|11|||
27925822|NCT00676143|81565077|FG001|Overall Study|Other|20|||
27925823|NCT00676143|81565076|FG000|Overall Study|Participant participation unknown|1|||
27925824|NCT00676143|81565077|FG001|Overall Study|Participant participation unknown|4|||
27925825|NCT00676143|81565076|FG000|Overall Study|Vasogenic edema recurrence|1|||
27925826|NCT00676143|81565077|FG001|Overall Study|Vasogenic edema recurrence|3|||
27925827|NCT01513590|81565082|FG000|Overall Study|Adverse Event|2|||
27925828|NCT01513590|81565083|FG001|Overall Study|Adverse Event|3|||
27925829|NCT01513590|81565082|FG000|Overall Study|Withdrawal Criteria|3|||
27925830|NCT01513590|81565083|FG001|Overall Study|Withdrawal Criteria|0|||
27925831|NCT01513590|81565082|FG000|Overall Study|Unclassified|5|||
27925832|NCT01513590|81565083|FG001|Overall Study|Unclassified|10|||
27925833|NCT00127803|81565084|FG000|Overall Study|Adverse Event|2|||
27545917|NCT00361569|80189511|FG003|Overall Study|Lost to Follow-up|2|||
27545918|NCT00361569|80189508|FG000|Overall Study|Not specified by investigator|2|||
27545919|NCT00361569|80189509|FG001|Overall Study|Not specified by investigator|0|||
27545920|NCT00361569|80189510|FG002|Overall Study|Not specified by investigator|0|||
27545921|NCT00361569|80189511|FG003|Overall Study|Not specified by investigator|1|||
27545922|NCT02794883|80189512|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
27545923|NCT02794883|80189513|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
27545924|NCT02794883|80189514|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
27545925|NCT02794883|80189512|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
27545926|NCT02794883|80189513|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
27545927|NCT02794883|80189514|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
27545928|NCT02794883|80189512|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
27545929|NCT02794883|80189513|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
27545930|NCT02794883|80189514|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
27545931|NCT02794883|80189512|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
27545932|NCT02794883|80189513|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
27545933|NCT02794883|80189514|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
27639486|NCT01307267|80522209|FG012|Overall Study|Lost to Follow-up|0|||
27639487|NCT01307267|80522210|FG013|Overall Study|Lost to Follow-up|0|||
27639488|NCT01307267|80522211|FG014|Overall Study|Lost to Follow-up|0|||
27639489|NCT01307267|80522212|FG015|Overall Study|Lost to Follow-up|0|||
27639490|NCT01307267|80522213|FG016|Overall Study|Lost to Follow-up|0|||
27639491|NCT01307267|80522214|FG017|Overall Study|Lost to Follow-up|0|||
27639492|NCT01307267|80522215|FG018|Overall Study|Lost to Follow-up|0|||
27639493|NCT01307267|80522216|FG019|Overall Study|Lost to Follow-up|2|||
27639494|NCT01307267|80522217|FG020|Overall Study|Lost to Follow-up|0|||
27639495|NCT01307267|80522218|FG021|Overall Study|Lost to Follow-up|0|||
27639496|NCT01307267|80522219|FG022|Overall Study|Lost to Follow-up|0|||
27545934|NCT02794883|80189512|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
27545935|NCT02794883|80189513|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
27545936|NCT02794883|80189514|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
27545937|NCT02794883|80189512|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
27545938|NCT02794883|80189513|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
27545939|NCT02794883|80189514|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
27545940|NCT02794883|80189512|FG000|Follow-up Period (up to 2 Years)|Death|12|||
27545941|NCT02794883|80189513|FG001|Follow-up Period (up to 2 Years)|Death|10|||
27545942|NCT02794883|80189514|FG002|Follow-up Period (up to 2 Years)|Death|10|||
27545943|NCT02059395|80189519|FG000|Overall Study|Lost to Follow-up|2|||
27545944|NCT02059395|80189520|FG001|Overall Study|Lost to Follow-up|4|||
27545945|NCT00873015|80189521|FG000|Overall Study|Withdrawal by Subject|0|||
27545946|NCT00873015|80189522|FG001|Overall Study|Withdrawal by Subject|1|||
27545947|NCT00873015|80189523|FG002|Overall Study|Withdrawal by Subject|0|||
27639497|NCT01307267|80522197|FG000|Overall Study|Withdrawal by Subject|0|||
27639498|NCT01307267|80522198|FG001|Overall Study|Withdrawal by Subject|0|||
27639499|NCT01307267|80522199|FG002|Overall Study|Withdrawal by Subject|0|||
27639500|NCT01307267|80522200|FG003|Overall Study|Withdrawal by Subject|0|||
27639501|NCT01307267|80522201|FG004|Overall Study|Withdrawal by Subject|0|||
27639502|NCT01307267|80522202|FG005|Overall Study|Withdrawal by Subject|1|||
27639503|NCT01307267|80522203|FG006|Overall Study|Withdrawal by Subject|0|||
27639504|NCT01307267|80522204|FG007|Overall Study|Withdrawal by Subject|1|||
27639505|NCT01307267|80522205|FG008|Overall Study|Withdrawal by Subject|5|||
27639506|NCT01307267|80522206|FG009|Overall Study|Withdrawal by Subject|1|||
27639507|NCT01307267|80522207|FG010|Overall Study|Withdrawal by Subject|1|||
27639508|NCT01307267|80522208|FG011|Overall Study|Withdrawal by Subject|1|||
27639509|NCT01307267|80522209|FG012|Overall Study|Withdrawal by Subject|0|||
27639510|NCT01307267|80522210|FG013|Overall Study|Withdrawal by Subject|0|||
27639511|NCT01307267|80522211|FG014|Overall Study|Withdrawal by Subject|0|||
27639512|NCT01307267|80522212|FG015|Overall Study|Withdrawal by Subject|0|||
27639513|NCT01307267|80522213|FG016|Overall Study|Withdrawal by Subject|0|||
27639514|NCT01307267|80522214|FG017|Overall Study|Withdrawal by Subject|0|||
27639515|NCT01307267|80522215|FG018|Overall Study|Withdrawal by Subject|0|||
27639516|NCT01307267|80522216|FG019|Overall Study|Withdrawal by Subject|3|||
27639517|NCT01307267|80522217|FG020|Overall Study|Withdrawal by Subject|0|||
27639518|NCT01307267|80522218|FG021|Overall Study|Withdrawal by Subject|0|||
27639519|NCT01307267|80522219|FG022|Overall Study|Withdrawal by Subject|0|||
27639520|NCT01307267|80522197|FG000|Overall Study|Other|0|||
27639521|NCT01307267|80522198|FG001|Overall Study|Other|0|||
27639522|NCT01307267|80522199|FG002|Overall Study|Other|0|||
27639523|NCT01307267|80522200|FG003|Overall Study|Other|0|||
27639524|NCT01307267|80522201|FG004|Overall Study|Other|0|||
27639525|NCT01307267|80522202|FG005|Overall Study|Other|7|||
27639526|NCT01307267|80522203|FG006|Overall Study|Other|0|||
27639527|NCT01307267|80522204|FG007|Overall Study|Other|1|||
27639528|NCT01307267|80522205|FG008|Overall Study|Other|3|||
27639529|NCT01307267|80522206|FG009|Overall Study|Other|0|||
27639530|NCT01307267|80522207|FG010|Overall Study|Other|1|||
27639531|NCT01307267|80522208|FG011|Overall Study|Other|1|||
27639532|NCT01307267|80522209|FG012|Overall Study|Other|1|||
27639533|NCT01307267|80522210|FG013|Overall Study|Other|0|||
27639534|NCT01307267|80522211|FG014|Overall Study|Other|2|||
27639535|NCT01307267|80522212|FG015|Overall Study|Other|1|||
27639536|NCT01307267|80522213|FG016|Overall Study|Other|0|||
27639537|NCT01307267|80522214|FG017|Overall Study|Other|0|||
27639538|NCT01307267|80522215|FG018|Overall Study|Other|0|||
27639539|NCT01307267|80522216|FG019|Overall Study|Other|19|||
27639540|NCT01307267|80522217|FG020|Overall Study|Other|2|||
27639541|NCT01307267|80522218|FG021|Overall Study|Other|3|||
27639542|NCT01307267|80522219|FG022|Overall Study|Other|2|||
27545948|NCT00873015|80189524|FG003|Overall Study|Withdrawal by Subject|0|||
27545949|NCT00713323|80189525|FG000|Overall Study|Adverse Event|75|||
27545950|NCT00713323|80189525|FG000|Overall Study|Withdrawal by Subject|15|||
27545951|NCT00713323|80189525|FG000|Overall Study|Lost to Follow-up|11|||
27639543|NCT05368831|80522220|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
27639544|NCT03345901|80522224|FG000|Overall Study|The study was terminated|18|||
27639545|NCT04600752|80522226|FG000|Overall Study|Physician Decision|0|||
27545952|NCT00713323|80189525|FG000|Overall Study|Lack of Efficacy|36|||
27545953|NCT00713323|80189525|FG000|Overall Study|Low creatine clearance at screening|1|||
27545954|NCT00713323|80189525|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
27639546|NCT04600752|80522227|FG001|Overall Study|Physician Decision|0|||
27639547|NCT04600752|80522228|FG002|Overall Study|Physician Decision|1|||
27639548|NCT04600752|80522226|FG000|Overall Study|Adverse Event|0|||
27639549|NCT04600752|80522227|FG001|Overall Study|Adverse Event|1|||
27639550|NCT04600752|80522228|FG002|Overall Study|Adverse Event|0|||
27639551|NCT04600752|80522226|FG000|Overall Study|Withdrawal by Subject|2|||
27639552|NCT04600752|80522227|FG001|Overall Study|Withdrawal by Subject|1|||
27639553|NCT04600752|80522228|FG002|Overall Study|Withdrawal by Subject|0|||
27639554|NCT04600752|80522226|FG000|Overall Study|Lack of Efficacy|1|||
27639555|NCT04600752|80522227|FG001|Overall Study|Lack of Efficacy|0|||
27639556|NCT04600752|80522228|FG002|Overall Study|Lack of Efficacy|0|||
27639557|NCT03086369|80522229|FG000|Overall Study|Lost to Follow-up|1|||
27639558|NCT03086369|80522230|FG001|Overall Study|Lost to Follow-up|0|||
27639559|NCT03086369|80522231|FG002|Overall Study|Lost to Follow-up|0|||
27639560|NCT03086369|80522232|FG003|Overall Study|Lost to Follow-up|2|||
27639561|NCT03086369|80522233|FG004|Overall Study|Lost to Follow-up|1|||
27639562|NCT03086369|80522229|FG000|Overall Study|Physician Decision|0|||
27639563|NCT03086369|80522230|FG001|Overall Study|Physician Decision|0|||
27639564|NCT03086369|80522231|FG002|Overall Study|Physician Decision|0|||
27639565|NCT03086369|80522232|FG003|Overall Study|Physician Decision|1|||
27639566|NCT03086369|80522233|FG004|Overall Study|Physician Decision|2|||
27639567|NCT03086369|80522229|FG000|Overall Study|Withdrawal by Subject|0|||
27639568|NCT03086369|80522230|FG001|Overall Study|Withdrawal by Subject|0|||
27639569|NCT03086369|80522231|FG002|Overall Study|Withdrawal by Subject|0|||
27639570|NCT03086369|80522232|FG003|Overall Study|Withdrawal by Subject|5|||
27639571|NCT03086369|80522233|FG004|Overall Study|Withdrawal by Subject|3|||
27639572|NCT03086369|80522229|FG000|Overall Study|Progressive Disease|0|||
27639573|NCT03086369|80522230|FG001|Overall Study|Progressive Disease|0|||
27639574|NCT03086369|80522231|FG002|Overall Study|Progressive Disease|0|||
27639575|NCT03086369|80522232|FG003|Overall Study|Progressive Disease|1|||
27639576|NCT03086369|80522233|FG004|Overall Study|Progressive Disease|1|||
27639577|NCT00978042|80522234|FG000|Initial Treatment Period|Treated in Error|0|||
27639578|NCT00978042|80522235|FG001|Initial Treatment Period|Treated in Error|3|||
27639579|NCT00978042|80522234|FG000|Initial Treatment Period|Ineligibility|1|||
27639580|NCT00978042|80522235|FG001|Initial Treatment Period|Ineligibility|0|||
27639581|NCT00978042|80522234|FG000|Initial Treatment Period|Lost to Follow-up|21|||
27639582|NCT00978042|80522235|FG001|Initial Treatment Period|Lost to Follow-up|3|||
27639583|NCT00978042|80522234|FG000|Initial Treatment Period|Adverse Event|2|||
27639584|NCT00978042|80522235|FG001|Initial Treatment Period|Adverse Event|0|||
27639585|NCT00978042|80522234|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
27639586|NCT00978042|80522235|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
27639587|NCT00978042|80522234|FG000|Initial Treatment Period|Consent withdrawn|22|||
27639588|NCT00978042|80522235|FG001|Initial Treatment Period|Consent withdrawn|9|||
27639589|NCT00978042|80522234|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
27639590|NCT00978042|80522235|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
27639591|NCT03593876|80522240|FG000|Overall Study|Withdrawal by Subject|1|||
27639592|NCT03593876|80522240|FG000|Overall Study|Discharged home before intervention completion|2|||
27639593|NCT01811706|80522248|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
27639594|NCT01811706|80522249|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
27639595|NCT04056624|80522251|FG000|Overall Study|Withdrawal by Subject|0|||
27639596|NCT04056624|80522252|FG001|Overall Study|Withdrawal by Subject|0|||
27639597|NCT04056624|80522253|FG002|Overall Study|Withdrawal by Subject|1|||
27639598|NCT04056624|80522251|FG000|Overall Study|Protocol Violation|1|||
27639599|NCT04056624|80522252|FG001|Overall Study|Protocol Violation|2|||
27639600|NCT04056624|80522253|FG002|Overall Study|Protocol Violation|0|||
27545955|NCT00713323|80189525|FG000|Overall Study|Surgery cured allodynic pain|1|||
27545956|NCT00713323|80189525|FG000|Overall Study|Pain free|1|||
27545957|NCT00713323|80189525|FG000|Overall Study|Non-compliance|1|||
27545958|NCT00713323|80189525|FG000|Overall Study|Pain resolved|1|||
27545959|NCT00713323|80189525|FG000|Overall Study|Subject travelling to USA|1|||
27545960|NCT00713323|80189525|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
27545961|NCT00713323|80189525|FG000|Overall Study|Treatment that may interact with Sativex|1|||
27545962|NCT02871297|80189526|FG000|Overall Study|Adverse Event|34|||
27545963|NCT02871297|80189526|FG000|Overall Study|Lack of Efficacy|10|||
27545964|NCT02871297|80189526|FG000|Overall Study|Non-compliance with study drug|15|||
27545965|NCT02871297|80189526|FG000|Overall Study|Protocol Violation|3|||
27545966|NCT02871297|80189526|FG000|Overall Study|Withdrawal by Subject|20|||
27545967|NCT02871297|80189526|FG000|Overall Study|Lost to Follow-up|13|||
27545968|NCT02871297|80189526|FG000|Overall Study|Rolled over to 13546A|2|||
27639601|NCT01823536|80522254|FG000|Overall Study|Lost to Follow-up|1|||
27639602|NCT01823536|80522255|FG001|Overall Study|Lost to Follow-up|0|||
27639603|NCT01823536|80522256|FG002|Overall Study|Lost to Follow-up|0|||
27639604|NCT01823536|80522257|FG003|Overall Study|Lost to Follow-up|1|||
27639605|NCT01823536|80522258|FG004|Overall Study|Lost to Follow-up|1|||
27639606|NCT01823536|80522259|FG005|Overall Study|Lost to Follow-up|0|||
27545969|NCT02871297|80189526|FG000|Overall Study|Other than specified|39|||
27545970|NCT01446289|80189527|FG000|Overall Study|Withdrawal by Subject|1|||
27545971|NCT01446289|80189528|FG001|Overall Study|Withdrawal by Subject|0|||
27639607|NCT01823536|80522254|FG000|Overall Study|Protocol Violation|0|||
27639608|NCT01823536|80522255|FG001|Overall Study|Protocol Violation|1|||
27639609|NCT01823536|80522256|FG002|Overall Study|Protocol Violation|0|||
27639610|NCT01823536|80522257|FG003|Overall Study|Protocol Violation|0|||
27639611|NCT01823536|80522258|FG004|Overall Study|Protocol Violation|0|||
27639612|NCT01823536|80522259|FG005|Overall Study|Protocol Violation|0|||
27639613|NCT01823536|80522254|FG000|Overall Study|Withdrawal by Subject|1|||
27925834|NCT00127803|81565085|FG001|Overall Study|Adverse Event|0|||
27639614|NCT01823536|80522255|FG001|Overall Study|Withdrawal by Subject|1|||
27925835|NCT00127803|81565086|FG002|Overall Study|Adverse Event|0|||
27925836|NCT00127803|81565087|FG003|Overall Study|Adverse Event|0|||
27925837|NCT00127803|81565084|FG000|Overall Study|Withdrawal by Subject|1|||
27925838|NCT00127803|81565085|FG001|Overall Study|Withdrawal by Subject|0|||
27925839|NCT00127803|81565086|FG002|Overall Study|Withdrawal by Subject|0|||
27925840|NCT00127803|81565087|FG003|Overall Study|Withdrawal by Subject|0|||
27925841|NCT00127803|81565084|FG000|Overall Study|Lost to Follow-up|0|||
27925842|NCT00127803|81565085|FG001|Overall Study|Lost to Follow-up|0|||
27925843|NCT00127803|81565086|FG002|Overall Study|Lost to Follow-up|0|||
27925844|NCT00127803|81565087|FG003|Overall Study|Lost to Follow-up|1|||
27925845|NCT00426270|81567887|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
27925846|NCT00426270|81567887|FG000|Overall Study|Adverse Event|5|||
27925847|NCT02934178|81567888|FG000|Received Vaccination 2|Death|0|||
27925848|NCT02934178|81567889|FG001|Received Vaccination 2|Death|1|||
27925849|NCT02934178|81567888|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
27925850|NCT02934178|81567889|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
27925851|NCT01018979|81567893|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
27925852|NCT01018979|81567894|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
27925853|NCT01018979|81567893|FG000|Overall Study|Not received at least one dose|0|||
27925854|NCT01018979|81567894|FG001|Overall Study|Not received at least one dose|1|||
27925855|NCT02714153|81567901|FG000|Overall Study|Death|1|||
27925856|NCT02691572|81567904|FG000|Overall Study|Withdrawal by Subject|1|||
27925857|NCT02691572|81567905|FG001|Overall Study|Withdrawal by Subject|0|||
27925858|NCT02691572|81567904|FG000|Overall Study|Protocol Violation|0|||
27925859|NCT02691572|81567905|FG001|Overall Study|Protocol Violation|1|||
27925860|NCT01179399|81567907|FG000|Overall Study|Adverse Event|1|||
27925861|NCT01179399|81567907|FG000|Overall Study|Lack of Efficacy|30|||
27925862|NCT01179399|81567907|FG000|Overall Study|Withdrawal by Subject|1|||
27925863|NCT01847209|81567908|FG000|Overall Study|Withdrawal by Subject|1|||
27925864|NCT01847209|81567908|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
27925865|NCT00250588|81567909|FG000|Overall Study|Withdrawal by Subject|3|||
27925866|NCT00250588|81567910|FG001|Overall Study|Withdrawal by Subject|6|||
27925867|NCT00250588|81567911|FG002|Overall Study|Withdrawal by Subject|0|||
27925868|NCT00250588|81567909|FG000|Overall Study|Lost to Follow-up|6|||
27925869|NCT00250588|81567910|FG001|Overall Study|Lost to Follow-up|13|||
27925870|NCT00250588|81567911|FG002|Overall Study|Lost to Follow-up|13|||
27925871|NCT01551173|81567914|FG000|Overall Study|Withdrawal by Subject|11|||
27925872|NCT01551173|81567915|FG001|Overall Study|Withdrawal by Subject|16|||
27925873|NCT01551173|81567914|FG000|Overall Study|Adverse Event|7|||
27925874|NCT01551173|81567915|FG001|Overall Study|Adverse Event|6|||
27925875|NCT01551173|81567914|FG000|Overall Study|Lost to Follow-up|5|||
27925876|NCT01551173|81567915|FG001|Overall Study|Lost to Follow-up|7|||
27925877|NCT01551173|81567914|FG000|Overall Study|Other|5|||
27925878|NCT01551173|81567915|FG001|Overall Study|Other|3|||
27925879|NCT01389232|81567918|FG000|Overall Study|Had scaffold removed|15|||
27925880|NCT01389232|81567918|FG000|Overall Study|Personal reasons|2|||
27925881|NCT01389232|81567918|FG000|Overall Study|Adverse Event|1|||
27925882|NCT01389232|81567918|FG000|Overall Study|Death|1|||
27925883|NCT02326883|81567919|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
27925884|NCT02326883|81567920|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
27925885|NCT02326883|81567921|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
27925886|NCT02394275|81567922|FG000|Overall Study|Adverse Event|22|||
27639615|NCT01823536|80522256|FG002|Overall Study|Withdrawal by Subject|0|||
27639616|NCT01823536|80522257|FG003|Overall Study|Withdrawal by Subject|0|||
27639617|NCT01823536|80522258|FG004|Overall Study|Withdrawal by Subject|0|||
27639618|NCT01823536|80522259|FG005|Overall Study|Withdrawal by Subject|0|||
27639619|NCT01823536|80522254|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27925887|NCT02394275|81567922|FG000|Overall Study|Lost to Follow-up|7|||
27925888|NCT03462680|81567923|FG000|Overall Study|Withdrawal by Subject|3|||
27925889|NCT03462680|81567924|FG001|Overall Study|Withdrawal by Subject|5|||
27639620|NCT01823536|80522255|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27925890|NCT01695772|81567926|FG000|Overall Study|Withdrawal by Subject|18|||
27925891|NCT01695772|81567926|FG000|Overall Study|Progressive Disease|8|||
27925892|NCT01695772|81567926|FG000|Overall Study|Investigator Decision|5|||
27925893|NCT01695772|81567926|FG000|Overall Study|Lost to Follow-up|4|||
27925894|NCT01695772|81567926|FG000|Overall Study|Protocol Violation|2|||
27925895|NCT01695772|81567926|FG000|Overall Study|Unspecified Reason|1|||
27925896|NCT02107898|81567927|FG000|Overall Study|Adverse Event|4|||
27925897|NCT02107898|81567928|FG001|Overall Study|Adverse Event|7|||
27925898|NCT02107898|81567927|FG000|Overall Study|Poor compliance to protocol|0|||
27925899|NCT02107898|81567928|FG001|Overall Study|Poor compliance to protocol|1|||
27925900|NCT02107898|81567927|FG000|Overall Study|Participant moved|0|||
27925901|NCT02107898|81567928|FG001|Overall Study|Participant moved|2|||
27742089|NCT04530825|80884292|FG003|Overall Study|Did not complete follow-up|0|||
27742090|NCT00265941|80884293|FG000|Overall Study|Protocol Violation|22|||
27742091|NCT00265941|80884294|FG001|Overall Study|Protocol Violation|25|||
27925902|NCT02107898|81567927|FG000|Overall Study|Consent withdrawn by participant|2|||
27925903|NCT02107898|81567928|FG001|Overall Study|Consent withdrawn by participant|1|||
27925904|NCT02107898|81567927|FG000|Overall Study|Randomized but not treated|0|||
27925905|NCT02107898|81567928|FG001|Overall Study|Randomized but not treated|1|||
27925906|NCT01925794|81567938|FG000|180 Days|Death|2|||
27925907|NCT01925794|81567938|FG000|180 Days|Withdrawal by Subject|2|||
27925908|NCT01925794|81567938|FG000|270 Days|Death|2|||
27925909|NCT01925794|81567938|FG000|270 Days|Protocol Violation|3|||
27925910|NCT02114684|81567945|FG000|Overall Study|Death|6|||
27925911|NCT02114684|81567946|FG001|Overall Study|Death|4|||
27925912|NCT02114684|81567945|FG000|Overall Study|Lost to Follow-up|1|||
27925913|NCT02114684|81567946|FG001|Overall Study|Lost to Follow-up|2|||
27925914|NCT02114684|81567945|FG000|Overall Study|Withdrawal by Subject|1|||
27925915|NCT02114684|81567946|FG001|Overall Study|Withdrawal by Subject|2|||
27925916|NCT02114684|81567945|FG000|Overall Study|Relocation|3|||
27925917|NCT02114684|81567946|FG001|Overall Study|Relocation|1|||
27925918|NCT02114684|81567945|FG000|Overall Study|Rifampicin resistant on culture|0|||
27925919|NCT02114684|81567946|FG001|Overall Study|Rifampicin resistant on culture|1|||
27742092|NCT00265941|80884293|FG000|Overall Study|Lost to Follow-up|1|||
27742093|NCT00265941|80884294|FG001|Overall Study|Lost to Follow-up|1|||
27742094|NCT02973815|80884296|FG000|Post Intervention|Death|1|||
27925920|NCT02114684|81567945|FG000|Overall Study|Patient Incarcerated|1|||
27925921|NCT02114684|81567946|FG001|Overall Study|Patient Incarcerated|0|||
27925922|NCT00858988|81567952|FG000|Analysis|Lactulose unable to be detected in urine|2|||
27925923|NCT00858988|81567953|FG001|Analysis|Lactulose unable to be detected in urine|1|||
27925924|NCT03086343|81567957|FG000|Period 1|Adverse Event|7|||
27925925|NCT03086343|81567958|FG001|Period 1|Adverse Event|7|||
27925926|NCT03086343|81567959|FG002|Period 1|Adverse Event|0|||
27925927|NCT03086343|81567960|FG003|Period 1|Adverse Event|1|||
27925928|NCT03086343|81567957|FG000|Period 1|Withdrawal by Subject|6|||
27925929|NCT03086343|81567958|FG001|Period 1|Withdrawal by Subject|10|||
27925930|NCT03086343|81567959|FG002|Period 1|Withdrawal by Subject|0|||
27925931|NCT03086343|81567960|FG003|Period 1|Withdrawal by Subject|0|||
27925932|NCT03086343|81567957|FG000|Period 1|Lost to Follow-up|1|||
27925933|NCT03086343|81567958|FG001|Period 1|Lost to Follow-up|3|||
27925934|NCT03086343|81567959|FG002|Period 1|Lost to Follow-up|1|||
27545972|NCT01446289|80189529|FG002|Overall Study|Withdrawal by Subject|1|||
27545973|NCT01446289|80189530|FG003|Overall Study|Withdrawal by Subject|0|||
27545974|NCT00594659|80189536|FG000|Overall Study|Lost to Follow-up|13|||
27545975|NCT00594659|80189537|FG001|Overall Study|Lost to Follow-up|9|||
27545976|NCT00594659|80189538|FG002|Overall Study|Lost to Follow-up|7|||
27545977|NCT04213079|80189539|FG000|Overall Study|Lost to Follow-up|0|||
27545978|NCT04213079|80189540|FG001|Overall Study|Lost to Follow-up|2|||
27545979|NCT03310775|80189541|FG000|Overall Study|Lost to Follow-up|2|||
27545980|NCT03310775|80189542|FG001|Overall Study|Lost to Follow-up|3|||
27545981|NCT03310775|80189541|FG000|Overall Study|aggravation of depression|0|||
27545982|NCT03310775|80189542|FG001|Overall Study|aggravation of depression|1|||
27545983|NCT03797014|80189547|FG000|Overall Study|Withdrawal by Subject|1|||
27545984|NCT03797014|80189547|FG000|Overall Study|Lost to Follow-up|1|||
27545985|NCT03797014|80189547|FG000|Overall Study|Protocol Violation|1|||
27545986|NCT01405742|80189558|FG000|Overall Study|Lost to Follow-up|1|||
27545987|NCT01405742|80189559|FG001|Overall Study|Lost to Follow-up|0|||
27545988|NCT01010061|80189560|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
27545989|NCT01010061|80189561|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
27545990|NCT01010061|80189560|FG000|Overall Study|Disease Progression|2|||
27545991|NCT01010061|80189561|FG001|Overall Study|Disease Progression|8|||
27639621|NCT01823536|80522256|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
27639622|NCT01823536|80522257|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27925935|NCT03086343|81567960|FG003|Period 1|Lost to Follow-up|0|||
27545992|NCT01010061|80189560|FG000|Overall Study|Withdrew Consent|5|||
27545993|NCT01010061|80189561|FG001|Overall Study|Withdrew Consent|1|||
27545994|NCT01010061|80189560|FG000|Overall Study|Death|3|||
27545995|NCT01010061|80189561|FG001|Overall Study|Death|6|||
27545996|NCT01010061|80189560|FG000|Overall Study|Administrative/Other|0|||
27639623|NCT01823536|80522258|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27742095|NCT02973815|80884297|FG001|Post Intervention|Death|0|||
27742096|NCT02973815|80884296|FG000|Post Intervention|Lost to Follow-up|7|||
27925936|NCT03086343|81567957|FG000|Period 1|Other, Not Specified|10|||
27925937|NCT03086343|81567958|FG001|Period 1|Other, Not Specified|12|||
27925938|NCT03086343|81567959|FG002|Period 1|Other, Not Specified|2|||
27925939|NCT03086343|81567960|FG003|Period 1|Other, Not Specified|1|||
27925940|NCT03086343|81567957|FG000|Period 1|Missing|1|||
27925941|NCT03086343|81567958|FG001|Period 1|Missing|0|||
27925942|NCT03086343|81567959|FG002|Period 1|Missing|0|||
27925943|NCT03086343|81567960|FG003|Period 1|Missing|0|||
27925944|NCT03086343|81567957|FG000|Period 2|Adverse Event|20|||
27925945|NCT03086343|81567958|FG001|Period 2|Adverse Event|11|||
27545997|NCT01010061|80189561|FG001|Overall Study|Administrative/Other|1|||
27545998|NCT01010061|80189560|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
27545999|NCT01010061|80189561|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
27546000|NCT01010061|80189560|FG000|Overall Study|Insufficient Therapeutic Response|1|||
27546001|NCT01010061|80189561|FG001|Overall Study|Insufficient Therapeutic Response|5|||
27546002|NCT01010061|80189560|FG000|Overall Study|Violation of Selection Criteria|0|||
27546003|NCT01010061|80189561|FG001|Overall Study|Violation of Selection Criteria|1|||
27546004|NCT01010061|80189560|FG000|Overall Study|Did Not Receive Treatment|2|||
27546005|NCT01010061|80189561|FG001|Overall Study|Did Not Receive Treatment|2|||
27546006|NCT02042183|80189563|FG000|Overall Study|Physician Decision|7|||
27546007|NCT02042183|80189564|FG001|Overall Study|Physician Decision|2|||
27546008|NCT02042183|80189563|FG000|Overall Study|Lack of Efficacy|4|||
27546009|NCT02042183|80189564|FG001|Overall Study|Lack of Efficacy|3|||
27546010|NCT02042183|80189563|FG000|Overall Study|Non-compliance with Study Drug|2|||
27546011|NCT02042183|80189564|FG001|Overall Study|Non-compliance with Study Drug|3|||
27546012|NCT02042183|80189563|FG000|Overall Study|Adverse Event|17|||
27546013|NCT02042183|80189564|FG001|Overall Study|Adverse Event|6|||
27639624|NCT01823536|80522259|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
27639625|NCT01823536|80522254|FG000|Overall Study|Met exclusion criterion No 6|0|||
27639626|NCT01823536|80522255|FG001|Overall Study|Met exclusion criterion No 6|0|||
27639627|NCT01823536|80522256|FG002|Overall Study|Met exclusion criterion No 6|0|||
27639628|NCT01823536|80522257|FG003|Overall Study|Met exclusion criterion No 6|1|||
27639629|NCT01823536|80522258|FG004|Overall Study|Met exclusion criterion No 6|0|||
27639630|NCT01823536|80522259|FG005|Overall Study|Met exclusion criterion No 6|0|||
27639631|NCT01823536|80522254|FG000|Overall Study|Subject moved out of the state|0|||
27639632|NCT01823536|80522255|FG001|Overall Study|Subject moved out of the state|0|||
27639633|NCT01823536|80522256|FG002|Overall Study|Subject moved out of the state|0|||
27639634|NCT01823536|80522257|FG003|Overall Study|Subject moved out of the state|0|||
27639635|NCT01823536|80522258|FG004|Overall Study|Subject moved out of the state|1|||
27639636|NCT01823536|80522259|FG005|Overall Study|Subject moved out of the state|0|||
27639637|NCT01017146|80522260|FG000|Overall Study|Adverse Event|11|||
27639638|NCT01017146|80522261|FG001|Overall Study|Adverse Event|1|||
27639639|NCT01017146|80522260|FG000|Overall Study|Lost to Follow-up|14|||
27639640|NCT01017146|80522261|FG001|Overall Study|Lost to Follow-up|14|||
27639641|NCT01017146|80522260|FG000|Overall Study|Noncompliance with Study Product|1|||
27639642|NCT01017146|80522261|FG001|Overall Study|Noncompliance with Study Product|1|||
27639643|NCT01017146|80522260|FG000|Overall Study|Withdrawal by Subject|32|||
27639644|NCT01017146|80522261|FG001|Overall Study|Withdrawal by Subject|16|||
27639645|NCT01017146|80522260|FG000|Overall Study|Relocation|0|||
27639646|NCT01017146|80522261|FG001|Overall Study|Relocation|4|||
27639647|NCT01017146|80522260|FG000|Overall Study|Pregnancy|2|||
27639648|NCT01017146|80522261|FG001|Overall Study|Pregnancy|1|||
27639649|NCT01017146|80522260|FG000|Overall Study|Protocol Violation|2|||
27639650|NCT01017146|80522261|FG001|Overall Study|Protocol Violation|0|||
27639651|NCT01017146|80522260|FG000|Overall Study|Took Excluded Medication|2|||
27639652|NCT01017146|80522261|FG001|Overall Study|Took Excluded Medication|0|||
27639653|NCT01017146|80522260|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
27639654|NCT01017146|80522261|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
27639655|NCT01017146|80522260|FG000|Overall Study|Change in Work Situation|1|||
27639656|NCT01017146|80522261|FG001|Overall Study|Change in Work Situation|0|||
27639657|NCT02748317|80522262|FG000|Overall Study|Withdrawal by Subject|14|||
27639658|NCT02748317|80522262|FG000|Overall Study|Lost to Follow-up|8|||
27639659|NCT02748317|80522262|FG000|Overall Study|Death|1|||
27639660|NCT02411084|80522263|FG000|Overall Study|Lack of Efficacy|6|||
27639661|NCT02411084|80522264|FG001|Overall Study|Lack of Efficacy|3|||
27639662|NCT02411084|80522263|FG000|Overall Study|Death|5|||
27639663|NCT02411084|80522264|FG001|Overall Study|Death|4|||
27639664|NCT02411084|80522263|FG000|Overall Study|Adverse Event|2|||
27639665|NCT02411084|80522264|FG001|Overall Study|Adverse Event|1|||
27639666|NCT02411084|80522263|FG000|Overall Study|Other reasons|0|||
27639667|NCT02411084|80522264|FG001|Overall Study|Other reasons|5|||
27925946|NCT03086343|81567959|FG002|Period 2|Adverse Event|1|||
27925947|NCT03086343|81567960|FG003|Period 2|Adverse Event|2|||
27639668|NCT00203411|80522270|FG000|Follow-up|Progressive Disease|4|||
27639669|NCT03292913|80522272|FG000|Overall Study|Death|9|||
27742097|NCT02973815|80884297|FG001|Post Intervention|Lost to Follow-up|24|||
27639670|NCT03292913|80522273|FG001|Overall Study|Death|3|||
27925948|NCT03086343|81567957|FG000|Period 2|Withdrawal by Subject|15|||
27639671|NCT03292913|80522272|FG000|Overall Study|Lost to Follow-up|49|||
27639672|NCT03292913|80522273|FG001|Overall Study|Lost to Follow-up|49|||
27639673|NCT03292913|80522272|FG000|Overall Study|Withdrawal by Subject|2|||
27639674|NCT03292913|80522273|FG001|Overall Study|Withdrawal by Subject|0|||
27546014|NCT02042183|80189563|FG000|Overall Study|Other|3|||
27546015|NCT02042183|80189564|FG001|Overall Study|Other|3|||
27546016|NCT02042183|80189563|FG000|Overall Study|Withdrawal by Subject|21|||
27546017|NCT02042183|80189564|FG001|Overall Study|Withdrawal by Subject|16|||
27925949|NCT03086343|81567958|FG001|Period 2|Withdrawal by Subject|25|||
27639675|NCT03292913|80522272|FG000|Overall Study|Clinic closed due to COVID|22|||
27639676|NCT03292913|80522273|FG001|Overall Study|Clinic closed due to COVID|36|||
27639677|NCT02742519|80522276|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
27639678|NCT02742519|80522277|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
27639679|NCT02742519|80522278|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
27639680|NCT02742519|80522276|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
27925950|NCT03086343|81567959|FG002|Period 2|Withdrawal by Subject|2|||
27925951|NCT03086343|81567960|FG003|Period 2|Withdrawal by Subject|2|||
27925952|NCT03086343|81567957|FG000|Period 2|Lost to Follow-up|6|||
27639681|NCT02742519|80522277|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
27639682|NCT02742519|80522278|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
27639683|NCT02742519|80522276|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
27639684|NCT02742519|80522277|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
27639685|NCT02742519|80522278|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
27639686|NCT02755116|80522279|FG000|Overall Study|surgery converted to open, pt admitted|3|||
27639687|NCT02755116|80522280|FG001|Overall Study|surgery converted to open, pt admitted|1|||
27639688|NCT00411151|80522281|FG000|Overall Study|Death|38|||
27639689|NCT00411151|80522281|FG000|Overall Study|Withdrawal by Subject|2|||
27639690|NCT00411151|80522281|FG000|Overall Study|Lost to Follow-up|2|||
27639691|NCT00411151|80522281|FG000|Overall Study|Protocol Violation|1|||
27639692|NCT00411151|80522281|FG000|Overall Study|Trial prematurely closed|4|||
27639693|NCT02584829|80522282|FG000|Overall Study|Physician Decision|1|||
27639694|NCT02584829|80522283|FG001|Overall Study|Physician Decision|0|||
27639695|NCT02584829|80522282|FG000|Overall Study|Withdrawal by Subject|0|||
27639696|NCT02584829|80522283|FG001|Overall Study|Withdrawal by Subject|1|||
27639697|NCT02584829|80522282|FG000|Overall Study|Progressive Disease|0|||
27639698|NCT02584829|80522283|FG001|Overall Study|Progressive Disease|3|||
27639699|NCT00088413|80522284|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
27639700|NCT00088413|80522285|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
27639701|NCT00088413|80522286|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
27639702|NCT00088413|80522287|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
27639703|NCT00088413|80522284|FG000|Overall Study|Adverse Events/Side Effects|0|||
27639704|NCT00088413|80522285|FG001|Overall Study|Adverse Events/Side Effects|1|||
27639705|NCT00088413|80522286|FG002|Overall Study|Adverse Events/Side Effects|1|||
27639706|NCT00088413|80522287|FG003|Overall Study|Adverse Events/Side Effects|0|||
27639707|NCT00088413|80522284|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
27639708|NCT00088413|80522285|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
27639709|NCT00088413|80522286|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
27639710|NCT00088413|80522287|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
27639711|NCT00088413|80522284|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
27639712|NCT00088413|80522285|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
27639713|NCT00088413|80522286|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
27742098|NCT02973815|80884296|FG000|Follow-up|Lost to Follow-up|2|||
27742099|NCT02973815|80884297|FG001|Follow-up|Lost to Follow-up|0|||
27742100|NCT01084252|80884300|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742101|NCT01084252|80884301|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742102|NCT01084252|80884302|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742103|NCT01084252|80884303|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742104|NCT01084252|80884304|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742105|NCT01084252|80884305|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742106|NCT01084252|80884306|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742107|NCT01084252|80884307|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742108|NCT01084252|80884308|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742109|NCT01084252|80884309|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742110|NCT01084252|80884310|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742111|NCT01084252|80884311|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27925953|NCT03086343|81567958|FG001|Period 2|Lost to Follow-up|11|||
27925954|NCT03086343|81567959|FG002|Period 2|Lost to Follow-up|1|||
27925955|NCT03086343|81567960|FG003|Period 2|Lost to Follow-up|0|||
27925956|NCT03086343|81567957|FG000|Period 2|COVID-19 Infection|5|||
27925957|NCT03086343|81567958|FG001|Period 2|COVID-19 Infection|0|||
27925958|NCT03086343|81567959|FG002|Period 2|COVID-19 Infection|0|||
27925959|NCT03086343|81567960|FG003|Period 2|COVID-19 Infection|0|||
27925960|NCT03086343|81567957|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
27925961|NCT03086343|81567958|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
27925962|NCT03086343|81567959|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
27925963|NCT03086343|81567960|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
27925964|NCT03086343|81567957|FG000|Period 2|Other, Not Specified|23|||
27925965|NCT03086343|81567958|FG001|Period 2|Other, Not Specified|22|||
27639714|NCT00088413|80522287|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
27639715|NCT00088413|80522284|FG000|Overall Study|Death|0|||
27742112|NCT01084252|80884312|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
27742113|NCT01084252|80884313|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
27742114|NCT00779038|80884314|FG000|Overall Study|Study Prematurely Terminated|13|||
27742115|NCT00312377|80884315|FG000|Overall Study|Death|403|||
27742116|NCT00312377|80884316|FG001|Overall Study|Death|418|||
27742117|NCT00312377|80884315|FG000|Overall Study|Withdrawal by Subject|23|||
27742118|NCT00312377|80884316|FG001|Overall Study|Withdrawal by Subject|30|||
27742119|NCT00312377|80884315|FG000|Overall Study|Lost to Follow-up|9|||
27742120|NCT00312377|80884316|FG001|Overall Study|Lost to Follow-up|12|||
27742121|NCT00312377|80884315|FG000|Overall Study|Non-compliance|0|||
27742122|NCT00312377|80884316|FG001|Overall Study|Non-compliance|2|||
27742123|NCT00312377|80884315|FG000|Overall Study|Randomised but never received treatment|6|||
27742124|NCT00312377|80884316|FG001|Overall Study|Randomised but never received treatment|6|||
27742125|NCT00312377|80884315|FG000|Overall Study|Discontinue treatment survival follow up|202|||
27742126|NCT00312377|80884316|FG001|Overall Study|Discontinue treatment survival follow up|200|||
27742127|NCT00312377|80884315|FG000|Overall Study|Site ended participation in study|1|||
27742128|NCT00312377|80884316|FG001|Overall Study|Site ended participation in study|0|||
27742129|NCT01720667|80884317|FG000|Overall Study|Adverse Event|1|||
27742130|NCT01720667|80884318|FG001|Overall Study|Adverse Event|1|||
27742131|NCT01720667|80884317|FG000|Overall Study|Withdrawal by Subject|3|||
27742132|NCT01720667|80884318|FG001|Overall Study|Withdrawal by Subject|0|||
27742133|NCT02614794|80884319|FG000|Overall Study|Death|258|||
27742134|NCT02614794|80884320|FG001|Overall Study|Death|151|||
27742135|NCT02614794|80884319|FG000|Overall Study|Study closure by Sponsor|119|||
27742136|NCT02614794|80884320|FG001|Overall Study|Study closure by Sponsor|45|||
27742137|NCT02614794|80884319|FG000|Overall Study|Withdrawal by Subject|24|||
27742138|NCT02614794|80884320|FG001|Overall Study|Withdrawal by Subject|5|||
27742139|NCT02614794|80884319|FG000|Overall Study|Lost to Follow-up|7|||
27546018|NCT02042183|80189563|FG000|Overall Study|Site Terminated by Sponsor|2|||
27546019|NCT02042183|80189564|FG001|Overall Study|Site Terminated by Sponsor|1|||
27546020|NCT02042183|80189563|FG000|Overall Study|Lost to Follow-up|9|||
27546021|NCT02042183|80189564|FG001|Overall Study|Lost to Follow-up|2|||
27546022|NCT03648983|80189565|FG000|Overall Study|Study was terminated due to PI departure|95|||
27546023|NCT01049308|80189568|FG000|Pill Counts|Withdrawal by Subject|83|||
27546024|NCT00211510|80189569|FG000|Overall Study|Physician Decision|3|||
27546025|NCT00211510|80189570|FG001|Overall Study|Physician Decision|1|||
27546026|NCT00211510|80189569|FG000|Overall Study|Withdrawal by Subject|3|||
27546027|NCT00211510|80189570|FG001|Overall Study|Withdrawal by Subject|1|||
27546028|NCT03868124|80189577|FG000|Overall Study|Withdrawal by Subject|4|||
27546029|NCT03868124|80189578|FG001|Overall Study|Withdrawal by Subject|0|||
27742140|NCT02614794|80884320|FG001|Overall Study|Lost to Follow-up|0|||
27742141|NCT02614794|80884319|FG000|Overall Study|Physician Decision|1|||
27742142|NCT02614794|80884320|FG001|Overall Study|Physician Decision|1|||
27742143|NCT02614794|80884319|FG000|Overall Study|Hospital closure|1|||
27742144|NCT02614794|80884320|FG001|Overall Study|Hospital closure|0|||
27742145|NCT04799782|80886822|FG000|Washout|Physician Decision|2|||
27742146|NCT04799782|80886823|FG001|Washout|Physician Decision|0|||
27742147|NCT04799782|80886822|FG000|Washout|Withdrawal by Subject|0|||
27742148|NCT04799782|80886823|FG001|Washout|Withdrawal by Subject|2|||
27742149|NCT04799782|80886822|FG000|Washout|Lost to Follow-up|0|||
27742150|NCT04799782|80886823|FG001|Washout|Lost to Follow-up|1|||
27742151|NCT00857246|80886824|FG000|Induction Regimen|Adverse Event|1|||
27742152|NCT00857246|80886824|FG000|Induction Regimen|disease-related complications|1|||
27742153|NCT00857246|80886824|FG000|Induction Regimen|Withdrawal by Subject|1|||
27742154|NCT00857246|80886824|FG000|Surgery (Curative)|disease progression|6|||
27742155|NCT00857246|80886824|FG000|ChemoRT|Withdrawal by Subject|1|||
27742156|NCT00857246|80886824|FG000|ChemoRT|Adverse Event|2|||
27742157|NCT03849560|80886825|FG000|Overall Study|Withdrawal by Subject|1|||
27742158|NCT03849560|80886826|FG001|Overall Study|Withdrawal by Subject|0|||
27742159|NCT03849560|80886827|FG002|Overall Study|Withdrawal by Subject|0|||
27742160|NCT01118143|80886830|FG000|Overall Study|Withdrawal by Subject|2|||
27742161|NCT01118143|80886831|FG001|Overall Study|Withdrawal by Subject|5|||
27742162|NCT01001494|80886832|FG000|Overall Study|Adverse Event|8|||
27742163|NCT01001494|80886833|FG001|Overall Study|Adverse Event|4|||
27742164|NCT01001494|80886834|FG002|Overall Study|Adverse Event|6|||
27742165|NCT01001494|80886832|FG000|Overall Study|Protocol Violation|0|||
27742166|NCT01001494|80886833|FG001|Overall Study|Protocol Violation|1|||
27742167|NCT01001494|80886834|FG002|Overall Study|Protocol Violation|1|||
27742168|NCT01001494|80886832|FG000|Overall Study|Lost to Follow-up|2|||
27742169|NCT01001494|80886833|FG001|Overall Study|Lost to Follow-up|0|||
27742170|NCT01001494|80886834|FG002|Overall Study|Lost to Follow-up|1|||
27742171|NCT01001494|80886832|FG000|Overall Study|Withdrawal by Subject|9|||
27742172|NCT01001494|80886833|FG001|Overall Study|Withdrawal by Subject|7|||
27742173|NCT01001494|80886834|FG002|Overall Study|Withdrawal by Subject|17|||
27546030|NCT03868124|80189579|FG002|Overall Study|Withdrawal by Subject|1|||
27546031|NCT03868124|80189577|FG000|Overall Study|Physician Decision|1|||
27546032|NCT03868124|80189578|FG001|Overall Study|Physician Decision|0|||
27546033|NCT03868124|80189579|FG002|Overall Study|Physician Decision|1|||
27546034|NCT03868124|80189577|FG000|Overall Study|Lost to Follow-up|1|||
27546035|NCT03868124|80189578|FG001|Overall Study|Lost to Follow-up|1|||
27546036|NCT03868124|80189579|FG002|Overall Study|Lost to Follow-up|2|||
27546037|NCT03868124|80189577|FG000|Overall Study|Death|1|||
27546038|NCT03868124|80189578|FG001|Overall Study|Death|1|||
27546039|NCT03868124|80189579|FG002|Overall Study|Death|2|||
27742174|NCT01001494|80886832|FG000|Overall Study|COPD exacerbation|3|||
27742175|NCT01001494|80886833|FG001|Overall Study|COPD exacerbation|4|||
27925966|NCT03086343|81567959|FG002|Period 2|Other, Not Specified|2|||
27925967|NCT03086343|81567960|FG003|Period 2|Other, Not Specified|4|||
27742176|NCT01001494|80886834|FG002|Overall Study|COPD exacerbation|5|||
27742177|NCT01001494|80886832|FG000|Overall Study|Lack of Efficacy|2|||
27742178|NCT01001494|80886833|FG001|Overall Study|Lack of Efficacy|0|||
27742179|NCT01001494|80886834|FG002|Overall Study|Lack of Efficacy|8|||
27742180|NCT01001494|80886832|FG000|Overall Study|Other|0|||
27742181|NCT01001494|80886833|FG001|Overall Study|Other|1|||
27742182|NCT01001494|80886834|FG002|Overall Study|Other|3|||
27742183|NCT03472534|80886835|FG000|Overall Study|Withdrawal by Subject|9|||
27742184|NCT03472534|80886835|FG000|Overall Study|Adverse Event|2|||
27742185|NCT00184054|80886836|FG000|Overall Study|Adverse Event|1|||
27742186|NCT04275310|80886837|FG000|Overall Study|Non-randomized due to running out of funding|4|||
27742187|NCT04275310|80886838|FG001|Overall Study|Non-randomized due to running out of funding|0|||
27742188|NCT01749735|80886843|FG000|Overall Study|Withdrawal by Subject|1|||
27742189|NCT01749735|80886844|FG001|Overall Study|Withdrawal by Subject|0|||
27742190|NCT00487279|80886845|FG000|Overall Study|Death|1|||
27742191|NCT00487279|80886846|FG001|Overall Study|Death|0|||
27742192|NCT00487279|80886845|FG000|Overall Study|Withdrawal by Subject|0|||
27742193|NCT00487279|80886846|FG001|Overall Study|Withdrawal by Subject|2|||
27742194|NCT00227877|80886847|FG000|Pre-visit Assessment|Technical difficulties|7|||
27742195|NCT00227877|80886848|FG001|Pre-visit Assessment|Technical difficulties|3|||
27742196|NCT00227877|80886849|FG002|Pre-visit Assessment|Technical difficulties|0|||
27742197|NCT00227877|80886850|FG003|Pre-visit Assessment|Technical difficulties|0|||
27742198|NCT00227877|80886847|FG000|Post-visit Checklist|Lost to Follow-up|24|||
27742199|NCT00227877|80886848|FG001|Post-visit Checklist|Lost to Follow-up|13|||
27742200|NCT00227877|80886849|FG002|Post-visit Checklist|Lost to Follow-up|1|||
27742201|NCT00227877|80886850|FG003|Post-visit Checklist|Lost to Follow-up|0|||
27742202|NCT00227877|80886847|FG000|3-months Follow-up|Completed late|135|||
27742203|NCT00227877|80886848|FG001|3-months Follow-up|Completed late|128|||
27742204|NCT00227877|80886849|FG002|3-months Follow-up|Completed late|34|||
27742205|NCT00227877|80886850|FG003|3-months Follow-up|Completed late|8|||
27742206|NCT00227877|80886847|FG000|3-months Follow-up|Lost to Follow-up|178|||
27742207|NCT00227877|80886848|FG001|3-months Follow-up|Lost to Follow-up|139|||
27742208|NCT00227877|80886849|FG002|3-months Follow-up|Lost to Follow-up|18|||
27742209|NCT00227877|80886850|FG003|3-months Follow-up|Lost to Follow-up|13|||
27742210|NCT00227877|80886847|FG000|12-months Follow-up|Completed late|78|||
27742211|NCT00227877|80886848|FG001|12-months Follow-up|Completed late|74|||
27742212|NCT00227877|80886849|FG002|12-months Follow-up|Completed late|1|||
27925968|NCT00689936|81567973|FG000|Active Treatment Phase|Adverse Event|68|||
27925969|NCT00689936|81567974|FG001|Active Treatment Phase|Adverse Event|71|||
27925970|NCT00689936|81567975|FG002|Active Treatment Phase|Adverse Event|76|||
27925971|NCT00689936|81567973|FG000|Active Treatment Phase|Disease Progression|273|||
27925972|NCT00689936|81567974|FG001|Active Treatment Phase|Disease Progression|362|||
27925973|NCT00689936|81567975|FG002|Active Treatment Phase|Disease Progression|339|||
27925974|NCT00689936|81567973|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
27925975|NCT00689936|81567974|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
27925976|NCT00689936|81567975|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
27925977|NCT00689936|81567973|FG000|Active Treatment Phase|Death|60|||
27925978|NCT00689936|81567974|FG001|Active Treatment Phase|Death|28|||
27925979|NCT00689936|81567975|FG002|Active Treatment Phase|Death|37|||
27925980|NCT00689936|81567973|FG000|Active Treatment Phase|Lost to Follow-up|0|||
27925981|NCT00689936|81567974|FG001|Active Treatment Phase|Lost to Follow-up|2|||
27546040|NCT03868124|80189577|FG000|Overall Study|Adverse Event|0|||
27742213|NCT00227877|80886850|FG003|12-months Follow-up|Completed late|0|||
27925982|NCT00689936|81567975|FG002|Active Treatment Phase|Lost to Follow-up|2|||
27546041|NCT03868124|80189578|FG001|Overall Study|Adverse Event|0|||
27546042|NCT03868124|80189579|FG002|Overall Study|Adverse Event|3|||
27546043|NCT03868124|80189577|FG000|Overall Study|Explanted|2|||
27546044|NCT03868124|80189578|FG001|Overall Study|Explanted|1|||
27742214|NCT00227877|80886847|FG000|12-months Follow-up|Lost to Follow-up|232|||
27546045|NCT03868124|80189579|FG002|Overall Study|Explanted|0|||
27742215|NCT00227877|80886848|FG001|12-months Follow-up|Lost to Follow-up|189|||
27742216|NCT00227877|80886849|FG002|12-months Follow-up|Lost to Follow-up|30|||
27742217|NCT00227877|80886850|FG003|12-months Follow-up|Lost to Follow-up|26|||
27742218|NCT04003155|80886852|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
27925983|NCT00689936|81567973|FG000|Active Treatment Phase|Protocol Violation|2|||
27925984|NCT00689936|81567974|FG001|Active Treatment Phase|Protocol Violation|2|||
27742219|NCT04003155|80886853|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
27742220|NCT04003155|80886854|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
27742221|NCT04003155|80886855|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
27742222|NCT04003155|80886856|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
27742223|NCT04003155|80886852|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
27742224|NCT04003155|80886853|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
27742225|NCT04003155|80886854|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
27742226|NCT04003155|80886855|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
27742227|NCT04003155|80886856|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
27742228|NCT04003155|80886852|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
27742229|NCT04003155|80886853|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
27742230|NCT04003155|80886854|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
27742231|NCT04003155|80886855|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
27742232|NCT04003155|80886856|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
27742233|NCT04003155|80886852|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
27742234|NCT04003155|80886853|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
27742235|NCT04003155|80886854|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
27925985|NCT00689936|81567975|FG002|Active Treatment Phase|Protocol Violation|4|||
27546046|NCT03868124|80189577|FG000|Overall Study|Ongoing in study|176|||
27742236|NCT04003155|80886855|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
27742237|NCT04003155|80886856|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
27742238|NCT04003155|80886852|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
27742239|NCT04003155|80886853|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
27742240|NCT04003155|80886854|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
27742241|NCT04003155|80886855|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
27742242|NCT04003155|80886856|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
27742243|NCT04003155|80886852|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
27742244|NCT04003155|80886853|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
27742245|NCT04003155|80886854|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
27742246|NCT04003155|80886855|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
27742247|NCT04003155|80886856|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
27742248|NCT04003155|80886852|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
27925986|NCT00689936|81567973|FG000|Active Treatment Phase|Study Close Out|64|||
27925987|NCT00689936|81567974|FG001|Active Treatment Phase|Study Close Out|26|||
27925988|NCT00689936|81567975|FG002|Active Treatment Phase|Study Close Out|21|||
27546047|NCT03868124|80189578|FG001|Overall Study|Ongoing in study|180|||
27546048|NCT03868124|80189579|FG002|Overall Study|Ongoing in study|183|||
27546049|NCT02430311|80189581|FG000|Part A|Adverse Event|0|||
27546050|NCT02430311|80189582|FG001|Part A|Adverse Event|1|||
27546051|NCT02430311|80189581|FG000|Part A|Withdrawal by Subject|1|||
27546052|NCT02430311|80189582|FG001|Part A|Withdrawal by Subject|0|||
27546053|NCT02430311|80189581|FG000|Part B|Meet study-specific withdrawal criteria|6|||
27546054|NCT02430311|80189582|FG001|Part B|Meet study-specific withdrawal criteria|6|||
27546055|NCT02430311|80189581|FG000|Part B|Withdrawal by Subject|2|||
27546056|NCT02430311|80189582|FG001|Part B|Withdrawal by Subject|2|||
27546057|NCT02430311|80189581|FG000|Part B|Adverse Event|1|||
27546058|NCT02430311|80189582|FG001|Part B|Adverse Event|0|||
27546059|NCT02430311|80189581|FG000|Part B|Death|1|||
27546060|NCT02430311|80189582|FG001|Part B|Death|0|||
27546061|NCT01318993|80189592|FG000|Overall Study|Adverse Event|53|||
27546062|NCT01318993|80189592|FG000|Overall Study|Lack of Efficacy|121|||
27546063|NCT01318993|80189592|FG000|Overall Study|Protocol Violation|3|||
27546064|NCT01318993|80189592|FG000|Overall Study|Protocol based stopping criteria|6|||
27546065|NCT01318993|80189592|FG000|Overall Study|Study closed or terminated|174|||
27546066|NCT01318993|80189592|FG000|Overall Study|Lost to Follow-up|4|||
27546067|NCT01318993|80189592|FG000|Overall Study|Physician Decision|13|||
27546068|NCT01318993|80189592|FG000|Overall Study|Withdrawal by Subject|24|||
27546069|NCT00629707|80189593|FG000|Overall Study|Withdrawal by Subject|0|||
27546070|NCT00629707|80189594|FG001|Overall Study|Withdrawal by Subject|1|||
27546071|NCT00629707|80189593|FG000|Overall Study|Physician Decision|0|||
27546072|NCT00629707|80189594|FG001|Overall Study|Physician Decision|1|||
27925989|NCT00689936|81567973|FG000|Active Treatment Phase|Miscellaneous|52|||
27546073|NCT02590003|80189597|FG000|Overall Study|Death|1|||
27742249|NCT04003155|80886853|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
27925990|NCT00689936|81567974|FG001|Active Treatment Phase|Miscellaneous|34|||
27925991|NCT00689936|81567975|FG002|Active Treatment Phase|Miscellaneous|47|||
27546074|NCT02590003|80189598|FG001|Overall Study|Death|2|||
27925992|NCT00689936|81567973|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
27546075|NCT02468674|80189601|FG000|Overall Study|Adverse Event|0|||
27546076|NCT02468674|80189602|FG001|Overall Study|Adverse Event|0|||
27546077|NCT02468674|80189603|FG002|Overall Study|Adverse Event|0|||
27546078|NCT02468674|80189604|FG003|Overall Study|Adverse Event|1|||
27546079|NCT02468674|80189605|FG004|Overall Study|Adverse Event|0|||
27546080|NCT02468674|80189606|FG005|Overall Study|Adverse Event|1|||
27742250|NCT04003155|80886854|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
27742251|NCT04003155|80886855|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
27742252|NCT04003155|80886856|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
27742253|NCT04003155|80886852|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
27742254|NCT04003155|80886853|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
27742255|NCT04003155|80886854|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
27742256|NCT04003155|80886855|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
27742257|NCT04003155|80886856|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
27742258|NCT04003155|80886852|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
27742259|NCT04003155|80886853|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
27742260|NCT04003155|80886854|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
27742261|NCT04003155|80886855|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
27742262|NCT04003155|80886856|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
27742263|NCT00573131|80886857|FG000|Overall Study|Withdrawal by Subject|10|||
27742264|NCT00573131|80886858|FG001|Overall Study|Withdrawal by Subject|8|||
27742265|NCT02746679|80886859|FG000|Overall Study|Lost to Follow-up|4|||
27742266|NCT02746679|80886860|FG001|Overall Study|Lost to Follow-up|6|||
27742267|NCT03494725|80886861|FG000|Overall Study|Withdrawal by Subject|0|||
27925993|NCT00689936|81567974|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
27925994|NCT00689936|81567975|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
27925995|NCT02747927|81567976|FG000|Overall Study|Adverse Event|5|||
27925996|NCT02747927|81567977|FG001|Overall Study|Adverse Event|14|||
27925997|NCT02747927|81567976|FG000|Overall Study|Lost to Follow-up|22|||
27925998|NCT02747927|81567977|FG001|Overall Study|Lost to Follow-up|43|||
27925999|NCT02747927|81567976|FG000|Overall Study|Pregnancy|34|||
27926000|NCT02747927|81567977|FG001|Overall Study|Pregnancy|66|||
27926001|NCT02747927|81567976|FG000|Overall Study|Protocol Violation|2|||
27926002|NCT02747927|81567977|FG001|Overall Study|Protocol Violation|4|||
27926003|NCT02747927|81567976|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
27926004|NCT02747927|81567977|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
27926005|NCT02747927|81567976|FG000|Overall Study|Reason not Specified|11|||
27926006|NCT02747927|81567977|FG001|Overall Study|Reason not Specified|27|||
27926007|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
27926008|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
27926009|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
27926010|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
27926011|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
27926012|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
27926013|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
27926014|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
27926015|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
27926016|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
27926017|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
27926018|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
27926019|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
27926020|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
27926021|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
27926022|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
27926023|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
27926024|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
27926025|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
27926026|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
27546081|NCT02468674|80189607|FG006|Overall Study|Adverse Event|0|||
27546082|NCT02468674|80189608|FG007|Overall Study|Adverse Event|0|||
27546083|NCT02468674|80189609|FG008|Overall Study|Adverse Event|0|||
27546084|NCT02468674|80189601|FG000|Overall Study|Lost to Follow-up|1|||
27546085|NCT02468674|80189602|FG001|Overall Study|Lost to Follow-up|0|||
27546086|NCT02468674|80189603|FG002|Overall Study|Lost to Follow-up|0|||
27546087|NCT02468674|80189604|FG003|Overall Study|Lost to Follow-up|0|||
27546088|NCT02468674|80189605|FG004|Overall Study|Lost to Follow-up|0|||
27546089|NCT02468674|80189606|FG005|Overall Study|Lost to Follow-up|0|||
27546090|NCT02468674|80189607|FG006|Overall Study|Lost to Follow-up|0|||
27546091|NCT02468674|80189608|FG007|Overall Study|Lost to Follow-up|1|||
27546092|NCT02468674|80189609|FG008|Overall Study|Lost to Follow-up|1|||
27546093|NCT02468674|80189601|FG000|Overall Study|Physician Decision|0|||
27742268|NCT03494725|80886862|FG001|Overall Study|Withdrawal by Subject|2|||
27742269|NCT03494725|80886861|FG000|Overall Study|Antibiotic use|1|||
27742270|NCT03494725|80886862|FG001|Overall Study|Antibiotic use|0|||
27926027|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
27926028|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
27926029|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
27926030|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
27926031|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
27926032|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
27926033|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
27926034|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
27926035|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
27926036|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
27926037|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
27926038|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
27926039|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
27926040|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
27926041|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
27926042|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
27926043|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
27926044|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
27926045|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
27926046|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
27926047|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
27926048|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
27926049|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
27926050|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
27926051|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
27926052|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
27926053|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
27926054|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
27926055|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
27546094|NCT02468674|80189602|FG001|Overall Study|Physician Decision|0|||
27546095|NCT02468674|80189603|FG002|Overall Study|Physician Decision|0|||
27546096|NCT02468674|80189604|FG003|Overall Study|Physician Decision|0|||
27546097|NCT02468674|80189605|FG004|Overall Study|Physician Decision|0|||
27926056|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
27926057|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
27926058|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
27926059|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
27926060|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
27926061|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
27926062|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
27926063|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
27926064|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
27926065|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
27926066|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
27926067|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
27926068|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
27926069|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
27546098|NCT02468674|80189606|FG005|Overall Study|Physician Decision|0|||
27546099|NCT02468674|80189607|FG006|Overall Study|Physician Decision|1|||
27546100|NCT02468674|80189608|FG007|Overall Study|Physician Decision|0|||
27546101|NCT02468674|80189609|FG008|Overall Study|Physician Decision|0|||
27546102|NCT02468674|80189601|FG000|Overall Study|Patient/Guardian Decision|0|||
27546103|NCT02468674|80189602|FG001|Overall Study|Patient/Guardian Decision|0|||
27546104|NCT02468674|80189603|FG002|Overall Study|Patient/Guardian Decision|0|||
27546105|NCT02468674|80189604|FG003|Overall Study|Patient/Guardian Decision|0|||
27546106|NCT02468674|80189605|FG004|Overall Study|Patient/Guardian Decision|1|||
27546107|NCT02468674|80189606|FG005|Overall Study|Patient/Guardian Decision|0|||
27926070|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
27926071|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
27926072|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
27926073|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
27926074|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
27926075|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
27546108|NCT02468674|80189607|FG006|Overall Study|Patient/Guardian Decision|0|||
27546109|NCT02468674|80189608|FG007|Overall Study|Patient/Guardian Decision|2|||
27639716|NCT00088413|80522285|FG001|Overall Study|Death|1|||
27639717|NCT00088413|80522286|FG002|Overall Study|Death|0|||
27742271|NCT00538733|80886863|FG000|Overall Study|Adverse Event|8|||
27742272|NCT00538733|80886863|FG000|Overall Study|Death|1|||
27742273|NCT00538733|80886863|FG000|Overall Study|declined to participate|2|||
27742274|NCT00538733|80886863|FG000|Overall Study|still on therapy|1|||
27742275|NCT05111249|80886865|FG000|Overall Study|Lost to Follow-up|0|||
27742276|NCT05111249|80886866|FG001|Overall Study|Lost to Follow-up|2|||
27742277|NCT05111249|80886865|FG000|Overall Study|Physician Decision|0|||
27742278|NCT05111249|80886866|FG001|Overall Study|Physician Decision|1|||
27742279|NCT05111249|80886865|FG000|Overall Study|Participant decision|1|||
27742280|NCT05111249|80886866|FG001|Overall Study|Participant decision|5|||
27742281|NCT02532543|80886867|FG000|Overall Study|Lost to Follow-up|0|||
27742282|NCT02532543|80886868|FG001|Overall Study|Lost to Follow-up|0|||
27926076|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
27926077|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
27926078|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
27926079|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
27926080|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
27926081|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
27926082|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
27926083|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
27926084|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
27926085|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
27926086|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
27926087|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
27926088|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
27926089|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
27926090|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
27926091|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
27926092|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
27926093|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
27926094|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
27926095|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
27926096|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
27926097|NCT00090103|81567978|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
27926098|NCT00090103|81567979|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
27926099|NCT00090103|81567980|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
27926100|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
27926101|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
27926102|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
27926103|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
27926104|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
27926105|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
27926106|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
27926107|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
27926108|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
27926109|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
27926110|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
27926111|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
27926112|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
27926113|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
27926114|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
27926115|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
27926116|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
27926117|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
27926118|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
27546110|NCT02468674|80189609|FG008|Overall Study|Patient/Guardian Decision|1|||
27546111|NCT02468674|80189601|FG000|Overall Study|Protocol Deviation|0|||
27546112|NCT02468674|80189602|FG001|Overall Study|Protocol Deviation|0|||
27546113|NCT02468674|80189603|FG002|Overall Study|Protocol Deviation|0|||
27546114|NCT02468674|80189604|FG003|Overall Study|Protocol Deviation|0|||
27742283|NCT02532543|80886869|FG002|Overall Study|Lost to Follow-up|1|||
27742284|NCT02532543|80886870|FG003|Overall Study|Lost to Follow-up|0|||
27742285|NCT02342171|80886871|FG000|Overall Study|Death|4|||
27742286|NCT02342171|80886872|FG001|Overall Study|Death|87|||
27742287|NCT02342171|80886871|FG000|Overall Study|Received favipiravir|10|||
27742288|NCT02342171|80886872|FG001|Overall Study|Received favipiravir|0|||
27742289|NCT02342171|80886871|FG000|Overall Study|Missing cycle treshold value|1|||
27742290|NCT02342171|80886872|FG001|Overall Study|Missing cycle treshold value|0|||
27926119|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
27926120|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
27926121|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
27926122|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
27926123|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
27926124|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
27926125|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
27926126|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
27926127|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
27926128|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
27926129|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
27926130|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
27926131|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
27926132|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
27926133|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
27926134|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
27926135|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
27926136|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
27926137|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
27926138|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
27926139|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
27926140|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
27926141|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
27926142|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
27926143|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
27926144|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
27926145|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
27926146|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
27926147|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
27926148|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Death|1|||
27926149|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Death|0|||
27926150|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Death|1|||
27926151|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
27926152|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
27926153|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
27926154|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
27926155|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
27926156|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
27742291|NCT02342171|80886871|FG000|Overall Study|Unknown outcome|0|||
27742292|NCT02342171|80886872|FG001|Overall Study|Unknown outcome|1|||
27926157|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
27926158|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
27926159|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
27926160|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
27926161|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
27926162|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
27926163|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
27926164|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
27926165|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
27926166|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
27926167|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
27926168|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
27926169|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
27926170|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
27926171|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
27926172|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Depression|0|||
27926173|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Depression|1|||
27926174|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Depression|0|||
27926175|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
27926176|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
27926177|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
27926178|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Jailed|0|||
27926179|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Jailed|1|||
27742293|NCT02342171|80886871|FG000|Overall Study|Missing age data|0|||
27742294|NCT02342171|80886872|FG001|Overall Study|Missing age data|1|||
27926180|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Jailed|0|||
27926181|NCT00090103|81567978|FG000|16-Week Safety Follow-up Period|Other|0|||
27926182|NCT00090103|81567979|FG001|16-Week Safety Follow-up Period|Other|1|||
27926183|NCT00090103|81567980|FG002|16-Week Safety Follow-up Period|Other|0|||
27926184|NCT01416571|81567981|FG000|Overall Study|Lost to Follow-up|2|||
27926185|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
27926186|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
27926187|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
27926188|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
27926189|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
27926190|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
27926191|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
27926192|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
27926193|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
27926194|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
27926195|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
27926196|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
27546115|NCT02468674|80189605|FG004|Overall Study|Protocol Deviation|0|||
27546116|NCT02468674|80189606|FG005|Overall Study|Protocol Deviation|0|||
27546117|NCT02468674|80189607|FG006|Overall Study|Protocol Deviation|0|||
27546118|NCT02468674|80189608|FG007|Overall Study|Protocol Deviation|1|||
27546119|NCT02468674|80189609|FG008|Overall Study|Protocol Deviation|1|||
27546120|NCT03943147|80189610|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
27546121|NCT03943147|80189611|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
27546122|NCT03943147|80189610|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
27546123|NCT03943147|80189611|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
27546124|NCT03943147|80189610|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
27546125|NCT03943147|80189611|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
27546126|NCT03943147|80189610|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
27546127|NCT03943147|80189611|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
27546128|NCT03943147|80189610|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
27546129|NCT03943147|80189611|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
27926197|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
27926198|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
27926199|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
27926200|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
27926201|NCT00849056|81567982|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
27546130|NCT03943147|80189610|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
27546131|NCT03943147|80189611|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
27546132|NCT00039130|80189612|FG000|Overall Study|Adverse Event|11|||
27546133|NCT00039130|80189612|FG000|Overall Study|Death|9|||
27546134|NCT00039130|80189612|FG000|Overall Study|Withdrawal by Subject|3|||
27546135|NCT00039130|80189612|FG000|Overall Study|Progression|2|||
27546136|NCT00039130|80189612|FG000|Overall Study|Subsequent treatment|2|||
27546137|NCT00039130|80189612|FG000|Overall Study|Physician Decision|3|||
27546138|NCT00006237|80189617|FG000|Overall Study|Adverse Event|39|||
27546139|NCT00006237|80189618|FG001|Overall Study|Adverse Event|29|||
27546140|NCT00006237|80189617|FG000|Overall Study|Death|1|||
27546141|NCT00006237|80189618|FG001|Overall Study|Death|0|||
27926202|NCT00849056|81567983|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
27926203|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
27926204|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
27546142|NCT00006237|80189617|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
27546143|NCT00006237|80189618|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
27546144|NCT00006237|80189617|FG000|Overall Study|Progression/relapse|54|||
27546145|NCT00006237|80189618|FG001|Overall Study|Progression/relapse|2|||
27546146|NCT00006237|80189617|FG000|Overall Study|Not eligible|9|||
27546147|NCT00006237|80189618|FG001|Overall Study|Not eligible|20|||
27546148|NCT00006237|80189617|FG000|Overall Study|Withdrawal by Subject|0|||
27546149|NCT00006237|80189618|FG001|Overall Study|Withdrawal by Subject|1|||
27546150|NCT00006237|80189617|FG000|Overall Study|Not protocol specified|14|||
27546151|NCT00006237|80189618|FG001|Overall Study|Not protocol specified|5|||
27926205|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
27926206|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
27926207|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
27926208|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
27926209|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
27546152|NCT04112784|80189627|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
27546153|NCT04112784|80189627|FG000|Overall Study|Screen Failures|4|||
27546154|NCT02195583|80189628|FG000|Overall Study|Lost to Follow-up|1|||
27546155|NCT02195583|80189628|FG000|Overall Study|Withdrawal by Subject|4|||
27546156|NCT02195583|80189628|FG000|Overall Study|Adverse Event|2|||
27926210|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
27926211|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
27926212|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
27926213|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
27926214|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
27926215|NCT00849056|81567982|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
27926216|NCT00849056|81567983|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
27926217|NCT01431976|81567985|FG000|Overall Study|Adverse Event|6|||
27926218|NCT01431976|81567985|FG000|Overall Study|Lack of Efficacy|2|||
27926219|NCT01431976|81567985|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
27926220|NCT01431976|81567985|FG000|Overall Study|Physician Decision|1|||
27926221|NCT01431976|81567985|FG000|Overall Study|Withdrawal by Subject|1|||
27926222|NCT00303186|81567987|FG000|Overall Study|Other|52|||
27926223|NCT00352118|81567990|FG000|Overall Study|Physician Decision|4|||
27926224|NCT03846479|81567991|FG000|Overall Study|Death|8|||
27926225|NCT03846479|81567991|FG000|Overall Study|Lost to Follow-up|1|||
27926226|NCT03979313|81567993|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
27926227|NCT03979313|81567994|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
27926228|NCT03979313|81567993|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
27926229|NCT03979313|81567994|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
27926230|NCT03979313|81567993|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
27926231|NCT03979313|81567994|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
27926232|NCT03979313|81567993|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
27926233|NCT03979313|81567994|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
27926234|NCT03979313|81567993|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
27926235|NCT03979313|81567994|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
27926236|NCT03979313|81567993|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
27926237|NCT03979313|81567994|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
27926238|NCT03979313|81567993|FG000|All Subjects|Any Other Reason|16|||
27926239|NCT03979313|81567994|FG001|All Subjects|Any Other Reason|23|||
27926240|NCT03979313|81567993|FG000|All Subjects|Covid-19|1|||
27926241|NCT03979313|81567994|FG001|All Subjects|Covid-19|3|||
27926242|NCT03979313|81567993|FG000|All Subjects|Withdrawal by Subject|35|||
27926243|NCT03979313|81567994|FG001|All Subjects|Withdrawal by Subject|44|||
27926244|NCT03979313|81567993|FG000|All Subjects|Death|0|||
27926245|NCT03979313|81567994|FG001|All Subjects|Death|5|||
27926246|NCT03979313|81567993|FG000|All Subjects|Lost to Follow-up|28|||
27926247|NCT03979313|81567994|FG001|All Subjects|Lost to Follow-up|61|||
27926248|NCT00157755|81567995|FG000|Overall Study|Death|2|||
27926249|NCT00157755|81567996|FG001|Overall Study|Death|3|||
27926250|NCT00157755|81567997|FG002|Overall Study|Death|3|||
27926251|NCT00157755|81567998|FG003|Overall Study|Death|2|||
27926252|NCT00157755|81567999|FG004|Overall Study|Death|0|||
27926253|NCT00157755|81568000|FG005|Overall Study|Death|0|||
27926254|NCT00157755|81567995|FG000|Overall Study|Lost to Follow-up|0|||
27926255|NCT00157755|81567996|FG001|Overall Study|Lost to Follow-up|0|||
27926256|NCT00157755|81567997|FG002|Overall Study|Lost to Follow-up|1|||
27926257|NCT00157755|81567998|FG003|Overall Study|Lost to Follow-up|0|||
27926258|NCT00157755|81567999|FG004|Overall Study|Lost to Follow-up|0|||
27926259|NCT00157755|81568000|FG005|Overall Study|Lost to Follow-up|0|||
27926260|NCT00157755|81567995|FG000|Overall Study|Withdrawal by Subject|0|||
27926261|NCT00157755|81567996|FG001|Overall Study|Withdrawal by Subject|0|||
27926262|NCT00157755|81567997|FG002|Overall Study|Withdrawal by Subject|1|||
27926263|NCT00157755|81567998|FG003|Overall Study|Withdrawal by Subject|1|||
27926264|NCT00157755|81567999|FG004|Overall Study|Withdrawal by Subject|1|||
27926265|NCT00157755|81568000|FG005|Overall Study|Withdrawal by Subject|2|||
27546157|NCT02195583|80189628|FG000|Overall Study|Other Reason|2|||
27926266|NCT00157755|81567995|FG000|Overall Study|Explant due to infection|0|||
27926267|NCT00157755|81567996|FG001|Overall Study|Explant due to infection|0|||
27926268|NCT00157755|81567997|FG002|Overall Study|Explant due to infection|1|||
27926269|NCT00157755|81567998|FG003|Overall Study|Explant due to infection|0|||
27926270|NCT00157755|81567999|FG004|Overall Study|Explant due to infection|0|||
27926271|NCT00157755|81568000|FG005|Overall Study|Explant due to infection|0|||
27926272|NCT00157755|81567995|FG000|Overall Study|Medical reason|0|||
27926273|NCT00157755|81567996|FG001|Overall Study|Medical reason|0|||
27926274|NCT00157755|81567997|FG002|Overall Study|Medical reason|1|||
27926275|NCT00157755|81567998|FG003|Overall Study|Medical reason|1|||
27926276|NCT00157755|81567999|FG004|Overall Study|Medical reason|0|||
27926277|NCT00157755|81568000|FG005|Overall Study|Medical reason|0|||
27926278|NCT00157755|81567995|FG000|Overall Study|Study site closure|0|||
27926279|NCT00157755|81567996|FG001|Overall Study|Study site closure|1|||
27926280|NCT00157755|81567997|FG002|Overall Study|Study site closure|0|||
27926281|NCT00157755|81567998|FG003|Overall Study|Study site closure|0|||
27926282|NCT00157755|81567999|FG004|Overall Study|Study site closure|0|||
27926283|NCT00157755|81568000|FG005|Overall Study|Study site closure|0|||
27926284|NCT00157755|81567995|FG000|Overall Study|Subject non-compliance|0|||
27926285|NCT00157755|81567996|FG001|Overall Study|Subject non-compliance|0|||
27926286|NCT00157755|81567997|FG002|Overall Study|Subject non-compliance|0|||
27926287|NCT00157755|81567998|FG003|Overall Study|Subject non-compliance|0|||
27926288|NCT00157755|81567999|FG004|Overall Study|Subject non-compliance|0|||
27926289|NCT00157755|81568000|FG005|Overall Study|Subject non-compliance|1|||
27926290|NCT00157755|81567995|FG000|Overall Study|Study completion|0|||
27926291|NCT00157755|81567996|FG001|Overall Study|Study completion|0|||
27926292|NCT00157755|81567997|FG002|Overall Study|Study completion|0|||
27926293|NCT00157755|81567998|FG003|Overall Study|Study completion|0|||
27926294|NCT00157755|81567999|FG004|Overall Study|Study completion|1|||
27926295|NCT00157755|81568000|FG005|Overall Study|Study completion|2|||
27546158|NCT02094677|80189629|FG000|Overall Study|Screening|3|||
27546159|NCT02094677|80189630|FG001|Overall Study|Screening|1|||
27926296|NCT01881425|81568001|FG000|Overall Study|Death|5|||
27926297|NCT01881425|81568002|FG001|Overall Study|Death|1|||
27926298|NCT01881425|81568001|FG000|Overall Study|Withdrawal by Subject|8|||
27926299|NCT01881425|81568002|FG001|Overall Study|Withdrawal by Subject|3|||
27926300|NCT01881425|81568001|FG000|Overall Study|Physician Decision|2|||
27926301|NCT01881425|81568002|FG001|Overall Study|Physician Decision|1|||
27926302|NCT01881425|81568001|FG000|Overall Study|Adverse Event|3|||
27926303|NCT01881425|81568002|FG001|Overall Study|Adverse Event|0|||
27926304|NCT01881425|81568001|FG000|Overall Study|General Anesthesia panic attack|0|||
27926305|NCT01881425|81568002|FG001|Overall Study|General Anesthesia panic attack|1|||
27926306|NCT01881425|81568001|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
27926307|NCT01881425|81568002|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
27926308|NCT01881425|81568001|FG000|Overall Study|Lost to Follow-up|7|||
27926309|NCT01881425|81568002|FG001|Overall Study|Lost to Follow-up|2|||
27546160|NCT03715530|80189631|FG000|Overall Study|Lost to Follow-up|3|||
27546161|NCT03715530|80189632|FG001|Overall Study|Lost to Follow-up|1|||
27546162|NCT03715530|80189633|FG002|Overall Study|Lost to Follow-up|2|||
27546163|NCT03706079|80189634|FG000|Predecessor Study|Death|0|||
27546164|NCT03706079|80189635|FG001|Predecessor Study|Death|2|||
27546165|NCT03706079|80189636|FG002|Predecessor Study|Death|0|||
27546166|NCT03706079|80189637|FG003|Predecessor Study|Death|1|||
27926310|NCT01240694|81568007|FG000|Overall Study|Adverse Event|9|||
27926311|NCT01240694|81568007|FG000|Overall Study|Lack of Efficacy|6|||
27546167|NCT03706079|80189638|FG004|Predecessor Study|Death|0|||
27546168|NCT03706079|80189639|FG005|Predecessor Study|Death|0|||
27546169|NCT03706079|80189634|FG000|Predecessor Study|Lost to Follow-up|5|||
27546170|NCT03706079|80189635|FG001|Predecessor Study|Lost to Follow-up|2|||
27546171|NCT03706079|80189636|FG002|Predecessor Study|Lost to Follow-up|0|||
27546172|NCT03706079|80189637|FG003|Predecessor Study|Lost to Follow-up|0|||
27546173|NCT03706079|80189638|FG004|Predecessor Study|Lost to Follow-up|1|||
27546174|NCT03706079|80189639|FG005|Predecessor Study|Lost to Follow-up|0|||
27546175|NCT03706079|80189634|FG000|Predecessor Study|Withdrawal by Subject|8|||
27546176|NCT03706079|80189635|FG001|Predecessor Study|Withdrawal by Subject|15|||
27546177|NCT03706079|80189636|FG002|Predecessor Study|Withdrawal by Subject|0|||
27546178|NCT03706079|80189637|FG003|Predecessor Study|Withdrawal by Subject|5|||
27546179|NCT03706079|80189638|FG004|Predecessor Study|Withdrawal by Subject|2|||
27546180|NCT03706079|80189639|FG005|Predecessor Study|Withdrawal by Subject|0|||
27546181|NCT03706079|80189634|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
27546182|NCT03706079|80189635|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
27546183|NCT03706079|80189636|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
27546184|NCT03706079|80189637|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
27546185|NCT03706079|80189638|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
27546186|NCT03706079|80189639|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
27546187|NCT03706079|80189634|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
27546188|NCT03706079|80189635|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
27546189|NCT03706079|80189636|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
27546190|NCT03706079|80189637|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
27546191|NCT03706079|80189638|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
27546192|NCT03706079|80189639|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
27546193|NCT03706079|80189634|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
27546194|NCT03706079|80189635|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
27546195|NCT03706079|80189636|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
27926312|NCT01240694|81568007|FG000|Overall Study|Withdrawal by Subject|6|||
27926313|NCT01240694|81568007|FG000|Overall Study|Protocol Violation|2|||
27926314|NCT01240694|81568007|FG000|Overall Study|Lost to Follow-up|2|||
27926315|NCT01240694|81568007|FG000|Overall Study|Other than specified|3|||
27926316|NCT01240694|81568007|FG000|Overall Study|Withdrawn due to early study termination|107|||
27926317|NCT01499511|81568009|FG000|Overall Study|Death|1|||
27926318|NCT01499511|81568010|FG001|Overall Study|Death|0|||
27546196|NCT03706079|80189637|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
27546197|NCT03706079|80189638|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
27546198|NCT03706079|80189639|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
27546199|NCT03706079|80189634|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
27546200|NCT03706079|80189635|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
27546201|NCT03706079|80189636|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
27546202|NCT03706079|80189637|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
27926319|NCT00434252|81568011|FG000|Overall Study|Lack of Efficacy|50|||
27926320|NCT00434252|81568012|FG001|Overall Study|Lack of Efficacy|100|||
27926321|NCT00434252|81568011|FG000|Overall Study|Adverse Event|6|||
27926322|NCT00434252|81568012|FG001|Overall Study|Adverse Event|13|||
27546203|NCT03706079|80189638|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
27546204|NCT03706079|80189639|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
27546205|NCT03706079|80189634|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
27546206|NCT03706079|80189635|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
27546207|NCT03706079|80189636|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
27546208|NCT03706079|80189637|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
27546209|NCT03706079|80189638|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
27742295|NCT02749721|80886877|FG000|Screening|Withdrawal by Subject|1|||
27742296|NCT02749721|80886877|FG000|Screening|Lost to Follow-up|2|||
27742297|NCT02749721|80886877|FG000|Screening|Protocol Violation|3|||
27742298|NCT02749721|80886877|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
27742299|NCT02749721|80886877|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
27546210|NCT03706079|80189639|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
27546211|NCT03706079|80189634|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
27546212|NCT03706079|80189635|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
27546213|NCT03706079|80189636|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
27546214|NCT03706079|80189637|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
27546215|NCT03706079|80189638|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
27546216|NCT03706079|80189639|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
27546217|NCT03706079|80189634|FG000|Long Term Extension (DESTINATION)|Death|8|||
27546218|NCT03706079|80189635|FG001|Long Term Extension (DESTINATION)|Death|2|||
27742300|NCT01952015|80886879|FG000|Induction|Protocol Violation|1|||
27742301|NCT01952015|80886879|FG000|Maintenance|Adverse Event|2|||
27742302|NCT01952015|80886879|FG000|Treatment Period 3|Physician Decision|9|||
27742303|NCT04952389|80886880|FG000|Overall Study|Withdrawal by Subject|8|||
27742304|NCT04952389|80886881|FG001|Overall Study|Withdrawal by Subject|4|||
27742305|NCT00336492|80886882|FG000|Overall Study|Adverse Event|4|||
27926323|NCT00434252|81568011|FG000|Overall Study|Death|1|||
27926324|NCT00434252|81568012|FG001|Overall Study|Death|2|||
27926325|NCT00434252|81568011|FG000|Overall Study|Lost to Follow-up|0|||
27926326|NCT00434252|81568012|FG001|Overall Study|Lost to Follow-up|1|||
27926327|NCT00434252|81568011|FG000|Overall Study|Physician Decision|4|||
27926328|NCT00434252|81568012|FG001|Overall Study|Physician Decision|8|||
27926329|NCT00434252|81568011|FG000|Overall Study|Withdrawal by Subject|3|||
27926330|NCT00434252|81568012|FG001|Overall Study|Withdrawal by Subject|7|||
27926331|NCT00316004|81568013|FG000|Overall Study|Subject was not given study fluid.|14|||
27926332|NCT00316004|81568014|FG001|Overall Study|Subject was not given study fluid.|14|||
27926333|NCT00316004|81568015|FG002|Overall Study|Subject was not given study fluid.|21|||
27926334|NCT03095287|81568016|FG000|Overall Study|Treatment Failure|1|||
27926335|NCT03095287|81568016|FG000|Overall Study|Adverse Event|1|||
27926336|NCT01125748|81568021|FG000|Overall Study|Adverse Event|0|||
27926337|NCT01125748|81568022|FG001|Overall Study|Adverse Event|2|||
27926338|NCT01125748|81568021|FG000|Overall Study|Lost to Follow-up|0|||
27926339|NCT01125748|81568022|FG001|Overall Study|Lost to Follow-up|1|||
27926340|NCT01125748|81568021|FG000|Overall Study|Physician Decision|8|||
27926341|NCT01125748|81568022|FG001|Overall Study|Physician Decision|7|||
27926342|NCT01125748|81568021|FG000|Overall Study|Patient Decision to Withdraw|2|||
27926343|NCT01125748|81568022|FG001|Overall Study|Patient Decision to Withdraw|4|||
27926344|NCT01177410|81568023|FG000|Overall Study|Adverse Event|0|||
27926345|NCT01177410|81568024|FG001|Overall Study|Adverse Event|2|||
27926346|NCT01177410|81568025|FG002|Overall Study|Adverse Event|2|||
27546219|NCT03706079|80189636|FG002|Long Term Extension (DESTINATION)|Death|2|||
27546220|NCT03706079|80189637|FG003|Long Term Extension (DESTINATION)|Death|1|||
27742306|NCT00336492|80886883|FG001|Overall Study|Adverse Event|3|||
27742307|NCT00336492|80886884|FG002|Overall Study|Adverse Event|6|||
27926347|NCT01177410|81568023|FG000|Overall Study|Withdrawal by Subject|1|||
27926348|NCT01177410|81568024|FG001|Overall Study|Withdrawal by Subject|4|||
27926349|NCT01177410|81568025|FG002|Overall Study|Withdrawal by Subject|3|||
27926350|NCT01177410|81568023|FG000|Overall Study|Lost to Follow-up|0|||
27926351|NCT01177410|81568024|FG001|Overall Study|Lost to Follow-up|1|||
27926352|NCT01177410|81568025|FG002|Overall Study|Lost to Follow-up|0|||
27926353|NCT04790201|81568026|FG000|Overall Study|Lost to Follow-up|0|||
27926354|NCT04790201|81568027|FG001|Overall Study|Lost to Follow-up|0|||
27926355|NCT04790201|81568028|FG002|Overall Study|Lost to Follow-up|2|||
27926356|NCT04790201|81568026|FG000|Overall Study|Death|0|||
27926357|NCT04790201|81568027|FG001|Overall Study|Death|1|||
27926358|NCT04790201|81568028|FG002|Overall Study|Death|0|||
27926359|NCT04790201|81568026|FG000|Overall Study|Protocol Violation|1|||
27926360|NCT04790201|81568027|FG001|Overall Study|Protocol Violation|0|||
27926361|NCT04790201|81568028|FG002|Overall Study|Protocol Violation|1|||
27926362|NCT01245751|81568029|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
27926363|NCT01245751|81568030|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
27926364|NCT01245751|81568031|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
27926365|NCT01245751|81568032|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
27926366|NCT01245751|81568029|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
27926367|NCT01245751|81568030|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
27926368|NCT01245751|81568031|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
27926369|NCT01245751|81568032|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
27926370|NCT01245751|81568029|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
27926371|NCT01245751|81568030|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
27926372|NCT01245751|81568031|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
27926373|NCT01245751|81568032|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
27926374|NCT03122106|81568035|FG000|Overall Study|Not enough tissue|1|||
27926375|NCT03122106|81568035|FG000|Overall Study|Disease progression during screening|2|||
27926376|NCT03122106|81568035|FG000|Overall Study|Poor RNA quality for vaccine|1|||
27546221|NCT03706079|80189638|FG004|Long Term Extension (DESTINATION)|Death|0|||
27546222|NCT03706079|80189639|FG005|Long Term Extension (DESTINATION)|Death|0|||
27546223|NCT00444912|80189640|FG000|Overall Study|Death|1|||
27639718|NCT00088413|80522287|FG003|Overall Study|Death|0|||
27639719|NCT00088413|80522284|FG000|Overall Study|Progressive disease|9|||
27639720|NCT00088413|80522285|FG001|Overall Study|Progressive disease|11|||
27639721|NCT00088413|80522286|FG002|Overall Study|Progressive disease|8|||
27639722|NCT00088413|80522287|FG003|Overall Study|Progressive disease|14|||
27639723|NCT00088413|80522284|FG000|Overall Study|Other|0|||
27639724|NCT00088413|80522285|FG001|Overall Study|Other|1|||
27639725|NCT00088413|80522286|FG002|Overall Study|Other|0|||
27639726|NCT00088413|80522287|FG003|Overall Study|Other|0|||
27639727|NCT00088413|80522284|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
27546224|NCT00444912|80189641|FG001|Overall Study|Death|2|||
27546225|NCT00444912|80189640|FG000|Overall Study|Lost to Follow-up|1|||
27546226|NCT00444912|80189641|FG001|Overall Study|Lost to Follow-up|0|||
27546227|NCT00444912|80189640|FG000|Overall Study|Participant Failed Mobilization|1|||
27546228|NCT00444912|80189641|FG001|Overall Study|Participant Failed Mobilization|0|||
27546229|NCT02975336|80189652|FG000|DBPC (52 Weeks)|Adverse Event|16|||
27546230|NCT02975336|80189653|FG001|DBPC (52 Weeks)|Adverse Event|17|||
27546231|NCT02975336|80189654|FG002|DBPC (52 Weeks)|Adverse Event|13|||
27546232|NCT02975336|80189655|FG003|DBPC (52 Weeks)|Adverse Event|18|||
27546233|NCT02975336|80189656|FG004|DBPC (52 Weeks)|Adverse Event|0|||
27546234|NCT02975336|80189657|FG005|DBPC (52 Weeks)|Adverse Event|0|||
27546235|NCT02975336|80189658|FG006|DBPC (52 Weeks)|Adverse Event|0|||
27546236|NCT02975336|80189659|FG007|DBPC (52 Weeks)|Adverse Event|0|||
27546237|NCT02975336|80189652|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
27546238|NCT02975336|80189653|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
27546239|NCT02975336|80189654|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
27546240|NCT02975336|80189655|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
27546241|NCT02975336|80189656|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
27546242|NCT02975336|80189657|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
27546243|NCT02975336|80189658|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
27546244|NCT02975336|80189659|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
27546245|NCT02975336|80189652|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
27546246|NCT02975336|80189653|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
27546247|NCT02975336|80189654|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
27546248|NCT02975336|80189655|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
27546249|NCT02975336|80189656|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
27546250|NCT02975336|80189657|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
27546251|NCT02975336|80189658|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
27546252|NCT02975336|80189659|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
27639728|NCT00088413|80522285|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
27639729|NCT00088413|80522286|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
27639730|NCT00088413|80522287|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
27639731|NCT02724592|80522288|FG000|Overall Study|Lost to Follow-up|4|||
27926377|NCT02836769|81568053|FG000|Overall Study|Lost to Follow-up|10|||
27546253|NCT02975336|80189652|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
27546254|NCT02975336|80189653|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
27546255|NCT02975336|80189654|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
27546256|NCT02975336|80189655|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
27639732|NCT02724592|80522289|FG001|Overall Study|Lost to Follow-up|1|||
27926378|NCT02836769|81568053|FG000|Overall Study|Medical withdrawal|2|||
27926379|NCT02836769|81568053|FG000|Overall Study|Withdrawal by Subject|3|||
27926380|NCT01288430|81568054|FG000|Part 1|Progressive disease|2|||
27742308|NCT00336492|80886882|FG000|Overall Study|Lack of Efficacy|6|||
27742309|NCT00336492|80886883|FG001|Overall Study|Lack of Efficacy|1|||
27742310|NCT00336492|80886884|FG002|Overall Study|Lack of Efficacy|4|||
27742311|NCT00336492|80886882|FG000|Overall Study|Other|5|||
27742312|NCT00336492|80886883|FG001|Overall Study|Other|0|||
27742313|NCT00336492|80886884|FG002|Overall Study|Other|1|||
27742314|NCT00530712|80886895|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
27742315|NCT00530712|80886895|FG000|30 Day Follow-up Visit|Missed Visit|5|||
27742316|NCT00530712|80886895|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
27742317|NCT00530712|80886895|FG000|6 Month Follow-up Visit|Missed Visit|3|||
27742318|NCT00530712|80886895|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
27742319|NCT00530712|80886895|FG000|6 Month Follow-up Visit|Death|2|||
27742320|NCT00530712|80886895|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
27742321|NCT00530712|80886895|FG000|12 Month Follow-up Visit|Missed Visit|3|||
27742322|NCT00530712|80886895|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
27742323|NCT00530712|80886895|FG000|12 Month Follow-up Visit|Death|9|||
27742324|NCT00933335|80886898|FG000|Overall Study|Lost to Follow-up|1|||
27742325|NCT00933335|80886899|FG001|Overall Study|Lost to Follow-up|3|||
27742326|NCT00933335|80886898|FG000|Overall Study|Withdrawal by Subject|0|||
27742327|NCT00933335|80886899|FG001|Overall Study|Withdrawal by Subject|1|||
27742328|NCT00933335|80886898|FG000|Overall Study|Progressive Disease|0|||
27742329|NCT00933335|80886899|FG001|Overall Study|Progressive Disease|11|||
27742330|NCT00933335|80886898|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
27742331|NCT00933335|80886899|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
27742332|NCT00933335|80886898|FG000|Overall Study|Co-morbid Illness|1|||
27742333|NCT00933335|80886899|FG001|Overall Study|Co-morbid Illness|0|||
27546257|NCT02975336|80189656|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
27546258|NCT02975336|80189657|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
27546259|NCT02975336|80189658|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
27546260|NCT02975336|80189659|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
27546261|NCT02975336|80189652|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
27546262|NCT02975336|80189653|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
27742334|NCT04542291|80886900|FG000|Overall Study|Adverse Event|1|||
27742335|NCT04542291|80886900|FG000|Overall Study|Physician Decision|2|||
27926381|NCT01288430|81568055|FG001|Part 1|Progressive disease|1|||
27926382|NCT01288430|81568056|FG002|Part 1|Progressive disease|1|||
27926383|NCT01288430|81568057|FG003|Part 1|Progressive disease|6|||
27926384|NCT01288430|81568058|FG004|Part 1|Progressive disease|2|||
27926385|NCT01288430|81568059|FG005|Part 1|Progressive disease|4|||
27926386|NCT01288430|81568060|FG006|Part 1|Progressive disease|2|||
27926387|NCT01288430|81568061|FG007|Part 1|Progressive disease|0|||
27926388|NCT01288430|81568062|FG008|Part 1|Progressive disease|0|||
27926389|NCT01288430|81568063|FG009|Part 1|Progressive disease|0|||
27926390|NCT01288430|81568054|FG000|Part 1|Clinical disease progression|0|||
27926391|NCT01288430|81568055|FG001|Part 1|Clinical disease progression|0|||
27926392|NCT01288430|81568056|FG002|Part 1|Clinical disease progression|1|||
27926393|NCT01288430|81568057|FG003|Part 1|Clinical disease progression|0|||
27546263|NCT02975336|80189654|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
27546264|NCT02975336|80189655|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
27546265|NCT02975336|80189656|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
27546266|NCT02975336|80189657|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
27546267|NCT02975336|80189658|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
27742336|NCT01753518|80886901|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
27926394|NCT01288430|81568058|FG004|Part 1|Clinical disease progression|0|||
27926395|NCT01288430|81568059|FG005|Part 1|Clinical disease progression|2|||
27926396|NCT01288430|81568060|FG006|Part 1|Clinical disease progression|2|||
27926397|NCT01288430|81568061|FG007|Part 1|Clinical disease progression|0|||
27926398|NCT01288430|81568062|FG008|Part 1|Clinical disease progression|0|||
27926399|NCT01288430|81568063|FG009|Part 1|Clinical disease progression|0|||
27926400|NCT01288430|81568054|FG000|Part 1|Death due to disease progression|0|||
27926401|NCT01288430|81568055|FG001|Part 1|Death due to disease progression|0|||
27926402|NCT01288430|81568056|FG002|Part 1|Death due to disease progression|0|||
27926403|NCT01288430|81568057|FG003|Part 1|Death due to disease progression|0|||
27926404|NCT01288430|81568058|FG004|Part 1|Death due to disease progression|1|||
27926405|NCT01288430|81568059|FG005|Part 1|Death due to disease progression|0|||
27546268|NCT02975336|80189659|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
27546269|NCT02975336|80189652|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
27639733|NCT00549848|80522290|FG000|Overall Study|Death|1|||
27639734|NCT00549848|80522291|FG001|Overall Study|Death|4|||
27742337|NCT01753518|80886902|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
27742338|NCT01753518|80886901|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
27742339|NCT01753518|80886902|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
27926406|NCT01288430|81568060|FG006|Part 1|Death due to disease progression|0|||
27926407|NCT01288430|81568061|FG007|Part 1|Death due to disease progression|0|||
27926408|NCT01288430|81568062|FG008|Part 1|Death due to disease progression|0|||
27926409|NCT01288430|81568063|FG009|Part 1|Death due to disease progression|0|||
27926410|NCT01288430|81568054|FG000|Part 1|Adverse Event|0|||
27546270|NCT02975336|80189653|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
27926411|NCT01288430|81568055|FG001|Part 1|Adverse Event|0|||
27926412|NCT01288430|81568056|FG002|Part 1|Adverse Event|3|||
27926413|NCT01288430|81568057|FG003|Part 1|Adverse Event|1|||
27926414|NCT01288430|81568058|FG004|Part 1|Adverse Event|0|||
27926415|NCT01288430|81568059|FG005|Part 1|Adverse Event|0|||
27926416|NCT01288430|81568060|FG006|Part 1|Adverse Event|2|||
27926417|NCT01288430|81568061|FG007|Part 1|Adverse Event|0|||
27926418|NCT01288430|81568062|FG008|Part 1|Adverse Event|0|||
27926419|NCT01288430|81568063|FG009|Part 1|Adverse Event|0|||
27926420|NCT01288430|81568054|FG000|Part 1|Other|0|||
27926421|NCT01288430|81568055|FG001|Part 1|Other|2|||
27926422|NCT01288430|81568056|FG002|Part 1|Other|0|||
27926423|NCT01288430|81568057|FG003|Part 1|Other|0|||
27926424|NCT01288430|81568058|FG004|Part 1|Other|0|||
27926425|NCT01288430|81568059|FG005|Part 1|Other|0|||
27926426|NCT01288430|81568060|FG006|Part 1|Other|1|||
27926427|NCT01288430|81568061|FG007|Part 1|Other|0|||
27926428|NCT01288430|81568062|FG008|Part 1|Other|0|||
27926429|NCT01288430|81568063|FG009|Part 1|Other|0|||
27926430|NCT01288430|81568054|FG000|Part 2|Progressive disease|0|||
27926431|NCT01288430|81568055|FG001|Part 2|Progressive disease|0|||
27926432|NCT01288430|81568056|FG002|Part 2|Progressive disease|0|||
27926433|NCT01288430|81568057|FG003|Part 2|Progressive disease|0|||
27926434|NCT01288430|81568058|FG004|Part 2|Progressive disease|0|||
27926435|NCT01288430|81568059|FG005|Part 2|Progressive disease|0|||
27926436|NCT01288430|81568060|FG006|Part 2|Progressive disease|0|||
27926437|NCT01288430|81568061|FG007|Part 2|Progressive disease|8|||
27926438|NCT01288430|81568062|FG008|Part 2|Progressive disease|7|||
27926439|NCT01288430|81568063|FG009|Part 2|Progressive disease|2|||
27926440|NCT01288430|81568054|FG000|Part 2|Clinical disease progression|0|||
27926441|NCT01288430|81568055|FG001|Part 2|Clinical disease progression|0|||
27926442|NCT01288430|81568056|FG002|Part 2|Clinical disease progression|0|||
27926443|NCT01288430|81568057|FG003|Part 2|Clinical disease progression|0|||
27926444|NCT01288430|81568058|FG004|Part 2|Clinical disease progression|0|||
27926445|NCT01288430|81568059|FG005|Part 2|Clinical disease progression|0|||
27926446|NCT01288430|81568060|FG006|Part 2|Clinical disease progression|0|||
27926447|NCT01288430|81568061|FG007|Part 2|Clinical disease progression|2|||
27926448|NCT01288430|81568062|FG008|Part 2|Clinical disease progression|0|||
27926449|NCT01288430|81568063|FG009|Part 2|Clinical disease progression|0|||
27926450|NCT01288430|81568054|FG000|Part 2|Withdrawal by Subject|0|||
27926451|NCT01288430|81568055|FG001|Part 2|Withdrawal by Subject|0|||
27926452|NCT01288430|81568056|FG002|Part 2|Withdrawal by Subject|0|||
27926453|NCT01288430|81568057|FG003|Part 2|Withdrawal by Subject|0|||
27926454|NCT01288430|81568058|FG004|Part 2|Withdrawal by Subject|0|||
27926455|NCT01288430|81568059|FG005|Part 2|Withdrawal by Subject|0|||
27546271|NCT02975336|80189654|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
27546272|NCT02975336|80189655|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
27546273|NCT02975336|80189656|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
27926456|NCT01288430|81568060|FG006|Part 2|Withdrawal by Subject|0|||
27926457|NCT01288430|81568061|FG007|Part 2|Withdrawal by Subject|1|||
27926458|NCT01288430|81568062|FG008|Part 2|Withdrawal by Subject|4|||
27926459|NCT01288430|81568063|FG009|Part 2|Withdrawal by Subject|0|||
27926460|NCT01288430|81568054|FG000|Part 2|Adverse Event|0|||
27926461|NCT01288430|81568055|FG001|Part 2|Adverse Event|0|||
27926462|NCT01288430|81568056|FG002|Part 2|Adverse Event|0|||
27926463|NCT01288430|81568057|FG003|Part 2|Adverse Event|0|||
27926464|NCT01288430|81568058|FG004|Part 2|Adverse Event|0|||
27926465|NCT01288430|81568059|FG005|Part 2|Adverse Event|0|||
27926466|NCT01288430|81568060|FG006|Part 2|Adverse Event|0|||
27926467|NCT01288430|81568061|FG007|Part 2|Adverse Event|1|||
27926468|NCT01288430|81568062|FG008|Part 2|Adverse Event|1|||
27926469|NCT01288430|81568063|FG009|Part 2|Adverse Event|0|||
27926470|NCT01288430|81568054|FG000|Part 2|Other|0|||
27926471|NCT01288430|81568055|FG001|Part 2|Other|0|||
27926472|NCT01288430|81568056|FG002|Part 2|Other|0|||
27926473|NCT01288430|81568057|FG003|Part 2|Other|0|||
27926474|NCT01288430|81568058|FG004|Part 2|Other|0|||
27926475|NCT01288430|81568059|FG005|Part 2|Other|0|||
27926476|NCT01288430|81568060|FG006|Part 2|Other|0|||
27926477|NCT01288430|81568061|FG007|Part 2|Other|0|||
27926478|NCT01288430|81568062|FG008|Part 2|Other|0|||
27926479|NCT01288430|81568063|FG009|Part 2|Other|1|||
27926480|NCT00640289|81568070|FG000|Overall Study|Death|3|||
27926481|NCT00640289|81568070|FG000|Overall Study|Withdrawal by Subject|1|||
27926482|NCT00640289|81568070|FG000|Overall Study|Lost to Follow-up|1|||
27926483|NCT00640289|81568070|FG000|Overall Study|Data collected under different amendment|2|||
27926484|NCT00640289|81568070|FG000|Overall Study|Transferred to another center|1|||
27926485|NCT00640289|81568070|FG000|Overall Study|Missing status|5|||
27926486|NCT00699751|81568071|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
27926487|NCT00699751|81568072|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
27926488|NCT00699751|81568071|FG000|Period 1: Without/Before Drug Switch|Death|28|||
27926489|NCT00699751|81568072|FG001|Period 1: Without/Before Drug Switch|Death|29|||
27546274|NCT02975336|80189657|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
27546275|NCT02975336|80189658|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
27546276|NCT02975336|80189659|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
27546277|NCT02975336|80189652|FG000|LTE (104 Weeks)|Adverse Event|0|||
27546278|NCT02975336|80189653|FG001|LTE (104 Weeks)|Adverse Event|0|||
27546279|NCT02975336|80189654|FG002|LTE (104 Weeks)|Adverse Event|0|||
27546280|NCT02975336|80189655|FG003|LTE (104 Weeks)|Adverse Event|0|||
27546281|NCT02975336|80189656|FG004|LTE (104 Weeks)|Adverse Event|7|||
27546282|NCT02975336|80189657|FG005|LTE (104 Weeks)|Adverse Event|4|||
27546283|NCT02975336|80189658|FG006|LTE (104 Weeks)|Adverse Event|2|||
27546284|NCT02975336|80189659|FG007|LTE (104 Weeks)|Adverse Event|0|||
27546285|NCT02975336|80189652|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
27546286|NCT02975336|80189653|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
27546287|NCT02975336|80189654|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
27546288|NCT02975336|80189655|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
27546289|NCT02975336|80189656|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
27546290|NCT02975336|80189657|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
27546291|NCT02975336|80189658|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
27546292|NCT02975336|80189659|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
27546293|NCT02975336|80189652|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
27546294|NCT02975336|80189653|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
27546295|NCT02975336|80189654|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
27546296|NCT02975336|80189655|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
27546297|NCT02975336|80189656|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
27546298|NCT02975336|80189657|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
27926490|NCT00699751|81568071|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
27926491|NCT00699751|81568072|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
27926492|NCT00699751|81568071|FG000|Period 1: Without/Before Drug Switch|Other|30|||
27926493|NCT00699751|81568072|FG001|Period 1: Without/Before Drug Switch|Other|20|||
27926494|NCT00699751|81568071|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
27926495|NCT00699751|81568072|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
27926496|NCT00699751|81568071|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
27926497|NCT00699751|81568072|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
27926498|NCT00699751|81568071|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
27926499|NCT00699751|81568072|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
27926500|NCT00699751|81568071|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
27926501|NCT00699751|81568072|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
27926502|NCT04969289|81568073|FG000|Overall Study|Lost to Follow-up|13|||
27926503|NCT04969289|81568074|FG001|Overall Study|Lost to Follow-up|9|||
27926504|NCT00845182|81568075|FG000|Overall Study|Lost to Follow-up|3|||
27926505|NCT00845182|81568076|FG001|Overall Study|Lost to Follow-up|3|||
27926506|NCT00845182|81568077|FG002|Overall Study|Lost to Follow-up|4|||
27926507|NCT00845182|81568075|FG000|Overall Study|Adverse Event|0|||
27926508|NCT00845182|81568076|FG001|Overall Study|Adverse Event|1|||
27926509|NCT00845182|81568077|FG002|Overall Study|Adverse Event|1|||
27926510|NCT00845182|81568075|FG000|Overall Study|Physician Decision|0|||
27926511|NCT00845182|81568076|FG001|Overall Study|Physician Decision|0|||
27926512|NCT00845182|81568077|FG002|Overall Study|Physician Decision|1|||
27926513|NCT04424901|81568078|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
27926514|NCT04424901|81568079|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
27926515|NCT00832975|81568080|FG000|Overall Study|Lost to Follow-up|7|||
27926516|NCT00832975|81568080|FG000|Overall Study|Protocol Violation|6|||
27926517|NCT00832975|81568080|FG000|Overall Study|Death|5|||
27926518|NCT00832975|81568080|FG000|Overall Study|Physician Decision|4|||
27926519|NCT00832975|81568080|FG000|Overall Study|Withdrawal by Subject|3|||
27926520|NCT00832975|81568080|FG000|Overall Study|Other reasons|14|||
27926521|NCT02908347|81568081|FG000|Overall Study|Adverse Event|0|||
27926522|NCT02908347|81568082|FG001|Overall Study|Adverse Event|1|||
27926523|NCT02908347|81568081|FG000|Overall Study|Lost to Follow-up|1|||
27926524|NCT02908347|81568082|FG001|Overall Study|Lost to Follow-up|0|||
27926525|NCT00724893|81568084|FG000|Overall Study|Adverse Event|76|||
27926526|NCT00724893|81568085|FG001|Overall Study|Adverse Event|142|||
27926527|NCT00724893|81568084|FG000|Overall Study|Withdrawal by Subject|0|||
27926528|NCT00724893|81568085|FG001|Overall Study|Withdrawal by Subject|1|||
27926529|NCT00724893|81568084|FG000|Overall Study|Lack of virologic response|94|||
27926530|NCT00724893|81568085|FG001|Overall Study|Lack of virologic response|202|||
27546299|NCT02975336|80189658|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
27546300|NCT02975336|80189659|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
27546301|NCT02975336|80189652|FG000|LTE (104 Weeks)|Other|0|||
27926531|NCT00724893|81568084|FG000|Overall Study|Reason not specified|193|||
27926532|NCT00724893|81568085|FG001|Overall Study|Reason not specified|7|||
27546302|NCT02975336|80189653|FG001|LTE (104 Weeks)|Other|0|||
27546303|NCT02975336|80189654|FG002|LTE (104 Weeks)|Other|0|||
27546304|NCT02975336|80189655|FG003|LTE (104 Weeks)|Other|0|||
27926533|NCT00724893|81568084|FG000|Overall Study|Patient choice|0|||
27926534|NCT00724893|81568085|FG001|Overall Study|Patient choice|26|||
27639735|NCT00549848|80522292|FG002|Overall Study|Death|13|||
27639736|NCT00549848|80522290|FG000|Overall Study|Physician Decision|0|||
27639737|NCT00549848|80522291|FG001|Overall Study|Physician Decision|0|||
27639738|NCT00549848|80522292|FG002|Overall Study|Physician Decision|4|||
27639739|NCT00549848|80522290|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
27639740|NCT00549848|80522291|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
27639741|NCT00549848|80522292|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
27639742|NCT00549848|80522290|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
27742340|NCT01753518|80886901|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
27742341|NCT01753518|80886902|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
27742342|NCT01753518|80886901|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
27742343|NCT01753518|80886902|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
27742344|NCT00891657|80886903|FG000|Overall Study|Withdrawal by Subject|1|||
27742345|NCT00891657|80886904|FG001|Overall Study|Withdrawal by Subject|1|||
27742346|NCT01056107|80886905|FG000|Overall Study|Withdrawal by Subject|0|||
27742347|NCT01056107|80886906|FG001|Overall Study|Withdrawal by Subject|1|||
27742348|NCT01056107|80886907|FG002|Overall Study|Withdrawal by Subject|3|||
27742349|NCT01056107|80886908|FG003|Overall Study|Withdrawal by Subject|0|||
27742350|NCT05635838|80886909|FG000|16-Week DBVC Period|Adverse Event|2|||
27742351|NCT05635838|80886910|FG001|16-Week DBVC Period|Adverse Event|0|||
27742352|NCT05635838|80886911|FG002|16-Week DBVC Period|Adverse Event|0|||
27742353|NCT05635838|80886912|FG003|16-Week DBVC Period|Adverse Event|0|||
27742354|NCT05635838|80886909|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
27742355|NCT05635838|80886910|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
27742356|NCT05635838|80886911|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
27742357|NCT05635838|80886912|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
27742358|NCT05635838|80886909|FG000|16-Week DBVC Period|Physician Decision|0|||
27742359|NCT05635838|80886910|FG001|16-Week DBVC Period|Physician Decision|1|||
27742360|NCT05635838|80886911|FG002|16-Week DBVC Period|Physician Decision|0|||
27742361|NCT05635838|80886912|FG003|16-Week DBVC Period|Physician Decision|0|||
27742362|NCT05635838|80886909|FG000|16-Week DBVC Period|Protocol Violation|1|||
27742363|NCT05635838|80886910|FG001|16-Week DBVC Period|Protocol Violation|0|||
27742364|NCT05635838|80886911|FG002|16-Week DBVC Period|Protocol Violation|0|||
27742365|NCT05635838|80886912|FG003|16-Week DBVC Period|Protocol Violation|0|||
27742366|NCT05635838|80886909|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
27742367|NCT05635838|80886910|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
27926535|NCT00724893|81568084|FG000|Overall Study|Geographic reasons|0|||
27926536|NCT00724893|81568085|FG001|Overall Study|Geographic reasons|11|||
27926537|NCT00724893|81568084|FG000|Overall Study|Incarceration|0|||
27926538|NCT00724893|81568085|FG001|Overall Study|Incarceration|9|||
27926539|NCT00724893|81568084|FG000|Overall Study|Substance abuse|0|||
27926540|NCT00724893|81568085|FG001|Overall Study|Substance abuse|3|||
27926541|NCT00724893|81568084|FG000|Overall Study|Financial reasons|0|||
27926542|NCT00724893|81568085|FG001|Overall Study|Financial reasons|2|||
27926543|NCT00724893|81568084|FG000|Overall Study|Assigned shorter treatment|0|||
27926544|NCT00724893|81568085|FG001|Overall Study|Assigned shorter treatment|2|||
27926545|NCT00724893|81568084|FG000|Overall Study|Lost to Follow-up|0|||
27926546|NCT00724893|81568085|FG001|Overall Study|Lost to Follow-up|52|||
27926547|NCT00724893|81568084|FG000|Overall Study|Unknown, missing data|1|||
27546305|NCT02975336|80189656|FG004|LTE (104 Weeks)|Other|55|||
27546306|NCT02975336|80189657|FG005|LTE (104 Weeks)|Other|63|||
27546307|NCT02975336|80189658|FG006|LTE (104 Weeks)|Other|76|||
27546308|NCT02975336|80189659|FG007|LTE (104 Weeks)|Other|72|||
27546309|NCT04444895|80189662|FG000|Overall Study|Adverse Event|2|||
27546310|NCT04444895|80189662|FG000|Overall Study|Lost to Follow-up|2|||
27546311|NCT04444895|80189662|FG000|Overall Study|Withdrawal by Subject|5|||
27546312|NCT04661839|80189667|FG000|Overall Study|Not Treated|0|||
27546313|NCT04661839|80189668|FG001|Overall Study|Not Treated|0|||
27546314|NCT04661839|80189669|FG002|Overall Study|Not Treated|1|||
27546315|NCT04661839|80189670|FG003|Overall Study|Not Treated|0|||
27546316|NCT04661839|80189667|FG000|Overall Study|Lost to Follow-up|1|||
27546317|NCT04661839|80189668|FG001|Overall Study|Lost to Follow-up|0|||
27546318|NCT04661839|80189669|FG002|Overall Study|Lost to Follow-up|0|||
27639743|NCT00549848|80522291|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
27926548|NCT00724893|81568085|FG001|Overall Study|Unknown, missing data|1|||
27926549|NCT03880565|81568086|FG000|Overall Study|Withdrawal by Subject|1|||
27546319|NCT04661839|80189670|FG003|Overall Study|Lost to Follow-up|1|||
27742368|NCT05635838|80886911|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
27742369|NCT05635838|80886912|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
27742370|NCT05635838|80886909|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
27742371|NCT05635838|80886910|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
27742372|NCT05635838|80886911|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
27546320|NCT01774968|80189671|FG000|Overall Study|Adverse Event|4|||
27742373|NCT05635838|80886912|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
27742374|NCT05635838|80886909|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
27546321|NCT01774968|80189672|FG001|Overall Study|Adverse Event|4|||
27546322|NCT01774968|80189671|FG000|Overall Study|Death|0|||
27639744|NCT00549848|80522292|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
27639745|NCT00549848|80522290|FG000|Overall Study|Participant/Family Withdraw|2|||
27639746|NCT00549848|80522291|FG001|Overall Study|Participant/Family Withdraw|3|||
27639747|NCT00549848|80522292|FG002|Overall Study|Participant/Family Withdraw|5|||
27639748|NCT00549848|80522290|FG000|Overall Study|Second Malignancy|1|||
27639749|NCT00549848|80522291|FG001|Overall Study|Second Malignancy|0|||
27639750|NCT00549848|80522292|FG002|Overall Study|Second Malignancy|0|||
27639751|NCT00549848|80522290|FG000|Overall Study|Transplant|3|||
27639752|NCT00549848|80522291|FG001|Overall Study|Transplant|3|||
27639753|NCT00549848|80522292|FG002|Overall Study|Transplant|18|||
27546323|NCT01774968|80189672|FG001|Overall Study|Death|1|||
27546324|NCT01774968|80189671|FG000|Overall Study|Lost to Follow-up|1|||
27926550|NCT03880565|81568087|FG001|Overall Study|Withdrawal by Subject|0|||
27926551|NCT00481676|81568088|FG000|Overall Study|Adverse Event|0|||
27926552|NCT00481676|81568089|FG001|Overall Study|Adverse Event|1|||
27926553|NCT00481676|81568088|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27926554|NCT00481676|81568089|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27926555|NCT00481676|81568088|FG000|Overall Study|Administrative problem|1|||
27926556|NCT00481676|81568089|FG001|Overall Study|Administrative problem|0|||
27926557|NCT01202591|81568090|FG000|Overall Study|Adverse Event|2|||
27926558|NCT01202591|81568091|FG001|Overall Study|Adverse Event|1|||
27926559|NCT01202591|81568092|FG002|Overall Study|Adverse Event|4|||
27639754|NCT00549848|80522290|FG000|Overall Study|Unacceptable Toxicity|1|||
27639755|NCT00549848|80522291|FG001|Overall Study|Unacceptable Toxicity|6|||
27639756|NCT00549848|80522292|FG002|Overall Study|Unacceptable Toxicity|6|||
27639757|NCT03260140|80522293|FG000|Overall Study|Death|4|||
27639758|NCT03260140|80522294|FG001|Overall Study|Death|1|||
27639759|NCT03260140|80522293|FG000|Overall Study|Withdrawal by Subject|1|||
27639760|NCT03260140|80522294|FG001|Overall Study|Withdrawal by Subject|4|||
27639761|NCT02423798|80522301|FG000|Overall Study|Withdrawal by Subject|3|||
27639762|NCT00726596|80522302|FG000|Overall Study|Adverse Event|2|||
27639763|NCT00726596|80522303|FG001|Overall Study|Adverse Event|1|||
27639764|NCT00726596|80522302|FG000|Overall Study|Withdrawal by Subject|3|||
27639765|NCT00726596|80522303|FG001|Overall Study|Withdrawal by Subject|3|||
27639766|NCT01127373|80522304|FG000|Overall Study|Not Treated|3|||
27639767|NCT01127373|80522304|FG000|Overall Study|Lost to Follow-up|7|||
27639768|NCT01127373|80522304|FG000|Overall Study|Withdrawal by Subject|1|||
27639769|NCT01127373|80522304|FG000|Overall Study|Disease progression|1|||
27639770|NCT01198145|80522305|FG000|Overall Study|Withdrawal by Subject|1|||
27639771|NCT01198145|80522306|FG001|Overall Study|Withdrawal by Subject|1|||
27926560|NCT01202591|81568093|FG003|Overall Study|Adverse Event|4|||
27926561|NCT01202591|81568094|FG004|Overall Study|Adverse Event|0|||
27926562|NCT01202591|81568095|FG005|Overall Study|Adverse Event|0|||
27546325|NCT01774968|80189672|FG001|Overall Study|Lost to Follow-up|3|||
27546326|NCT01774968|80189671|FG000|Overall Study|Physician Decision|5|||
27546327|NCT01774968|80189672|FG001|Overall Study|Physician Decision|1|||
27546328|NCT01774968|80189671|FG000|Overall Study|Protocol Violation|14|||
27546329|NCT01774968|80189672|FG001|Overall Study|Protocol Violation|13|||
27546330|NCT01774968|80189671|FG000|Overall Study|Sponsor Decision|0|||
27546331|NCT01774968|80189672|FG001|Overall Study|Sponsor Decision|2|||
27546332|NCT01774968|80189671|FG000|Overall Study|Withdrawal by Subject|6|||
27546333|NCT01774968|80189672|FG001|Overall Study|Withdrawal by Subject|11|||
27546334|NCT05074667|80189674|FG000|Overall Study|Death|1|||
27546335|NCT05074667|80189674|FG000|Overall Study|Withdrawal by Subject|4|||
27546336|NCT05074667|80189674|FG000|Overall Study|Lost to Follow-up|10|||
27546337|NCT00558558|80189677|FG000|Overall Study|Unable to swallow|1|||
27546338|NCT00558558|80189677|FG000|Overall Study|Withdrawal by Subject|1|||
27546339|NCT00558558|80189677|FG000|Overall Study|Lack of Efficacy|4|||
27546340|NCT02165215|80189680|FG000|Induction Phase|Adverse Event|1|||
27546341|NCT02165215|80189681|FG001|Induction Phase|Adverse Event|0|||
27546342|NCT02165215|80189682|FG002|Induction Phase|Adverse Event|0|||
27546343|NCT02165215|80189680|FG000|Induction Phase|Withdrawal by Subject|10|||
27639772|NCT00434304|80522307|FG000|Overall Study|Adverse Event|14|||
27639773|NCT00434304|80522307|FG000|Overall Study|Lack of Efficacy|2|||
27546344|NCT02165215|80189681|FG001|Induction Phase|Withdrawal by Subject|0|||
27546345|NCT02165215|80189682|FG002|Induction Phase|Withdrawal by Subject|0|||
27639774|NCT00434304|80522307|FG000|Overall Study|Withdrawal by Subject|4|||
27639775|NCT03451721|80522308|FG000|Overall Study|Death|1|||
27546346|NCT02165215|80189680|FG000|Induction Phase|Protocol Violation|1|||
27546347|NCT02165215|80189681|FG001|Induction Phase|Protocol Violation|0|||
27546348|NCT02165215|80189682|FG002|Induction Phase|Protocol Violation|0|||
27546349|NCT02165215|80189680|FG000|Induction Phase|Physician Decision|1|||
27639776|NCT00371787|80522309|FG000|Overall Study|Withdrawal by Subject|3|||
27639777|NCT00371787|80522310|FG001|Overall Study|Withdrawal by Subject|1|||
27639778|NCT01011946|80522311|FG000|Overall Study|Transferred to another hospital|2|||
27926563|NCT01202591|81568090|FG000|Overall Study|Other reason as per investigator|3|||
27926564|NCT01202591|81568091|FG001|Overall Study|Other reason as per investigator|4|||
27546350|NCT02165215|80189681|FG001|Induction Phase|Physician Decision|0|||
27639779|NCT01011946|80522311|FG000|Overall Study|No pathological lab value|1|||
27639780|NCT01420549|80522315|FG000|Overall Study|Adverse Event|1|||
27639781|NCT01420549|80522316|FG001|Overall Study|Adverse Event|1|||
27639782|NCT01420549|80522315|FG000|Overall Study|Lost to Follow-up|2|||
27639783|NCT01420549|80522316|FG001|Overall Study|Lost to Follow-up|2|||
27639784|NCT01420549|80522315|FG000|Overall Study|Protocol Violation|0|||
27639785|NCT01420549|80522316|FG001|Overall Study|Protocol Violation|1|||
27639786|NCT01420549|80522315|FG000|Overall Study|Non-adherence to medication|4|||
27639787|NCT01420549|80522316|FG001|Overall Study|Non-adherence to medication|1|||
27639788|NCT01613716|80522317|FG000|Overall Study|screen failures|3|||
27639789|NCT01613716|80522317|FG000|Overall Study|Lost to Follow-up|4|||
27639790|NCT03432858|80522322|FG000|Overall Study|Protocol Violation|2|||
27639791|NCT03432858|80522323|FG001|Overall Study|Protocol Violation|1|||
27639792|NCT03432858|80522324|FG002|Overall Study|Protocol Violation|9|||
27639793|NCT03432858|80522322|FG000|Overall Study|Withdrawal by Subject|0|||
27639794|NCT03432858|80522323|FG001|Overall Study|Withdrawal by Subject|1|||
27639795|NCT03432858|80522324|FG002|Overall Study|Withdrawal by Subject|1|||
27639796|NCT03432858|80522322|FG000|Overall Study|Procedure canceled/rescheduled|0|||
27639797|NCT03432858|80522323|FG001|Overall Study|Procedure canceled/rescheduled|9|||
27639798|NCT03432858|80522324|FG002|Overall Study|Procedure canceled/rescheduled|6|||
27639799|NCT03432858|80522322|FG000|Overall Study|Required postop mobilization with splinting|0|||
27639800|NCT03432858|80522323|FG001|Overall Study|Required postop mobilization with splinting|0|||
27639801|NCT03432858|80522324|FG002|Overall Study|Required postop mobilization with splinting|1|||
27639802|NCT01078116|80522325|FG000|Overall Study|Lost to Follow-up|17|||
27639803|NCT01078116|80522325|FG000|Overall Study|Adverse Event|5|||
27639804|NCT01078116|80522325|FG000|Overall Study|Withdrawal by Subject|8|||
27639805|NCT01078116|80522325|FG000|Overall Study|Lack of effectiveness|15|||
27742375|NCT05635838|80886910|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
27926565|NCT01202591|81568092|FG002|Overall Study|Other reason as per investigator|7|||
27546351|NCT02165215|80189682|FG002|Induction Phase|Physician Decision|0|||
27546352|NCT02165215|80189680|FG000|Induction Phase|Lack of Efficacy|2|||
27546353|NCT02165215|80189681|FG001|Induction Phase|Lack of Efficacy|0|||
27546354|NCT02165215|80189682|FG002|Induction Phase|Lack of Efficacy|0|||
27546355|NCT02165215|80189680|FG000|Induction Phase|Non-Compliance|2|||
27546356|NCT02165215|80189681|FG001|Induction Phase|Non-Compliance|0|||
27546357|NCT02165215|80189682|FG002|Induction Phase|Non-Compliance|0|||
27546358|NCT02165215|80189680|FG000|Induction Phase|Lost to Follow-up|6|||
27546359|NCT02165215|80189681|FG001|Induction Phase|Lost to Follow-up|0|||
27546360|NCT02165215|80189682|FG002|Induction Phase|Lost to Follow-up|0|||
27546361|NCT02165215|80189680|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27546362|NCT02165215|80189681|FG001|Maintenance Phase|Withdrawal by Subject|7|||
27546363|NCT02165215|80189682|FG002|Maintenance Phase|Withdrawal by Subject|3|||
27546364|NCT02165215|80189680|FG000|Maintenance Phase|Multiple reasons|0|||
27546365|NCT02165215|80189681|FG001|Maintenance Phase|Multiple reasons|2|||
27546366|NCT02165215|80189682|FG002|Maintenance Phase|Multiple reasons|1|||
27546367|NCT02165215|80189680|FG000|Maintenance Phase|Lost to Follow-up|0|||
27546368|NCT02165215|80189681|FG001|Maintenance Phase|Lost to Follow-up|2|||
27546369|NCT02165215|80189682|FG002|Maintenance Phase|Lost to Follow-up|0|||
27546370|NCT02165215|80189680|FG000|Maintenance Phase|Adverse Event|0|||
27546371|NCT02165215|80189681|FG001|Maintenance Phase|Adverse Event|1|||
27546372|NCT02165215|80189682|FG002|Maintenance Phase|Adverse Event|1|||
27546373|NCT01063868|80189684|FG000|Overall Study|Adverse Event|9|||
27546374|NCT01063868|80189685|FG001|Overall Study|Adverse Event|7|||
27546375|NCT01063868|80189684|FG000|Overall Study|Withdrawal by Subject|3|||
27546376|NCT01063868|80189685|FG001|Overall Study|Withdrawal by Subject|1|||
27546377|NCT01063868|80189684|FG000|Overall Study|Study Terminated By Sponsor|23|||
27546378|NCT01063868|80189685|FG001|Overall Study|Study Terminated By Sponsor|4|||
27546379|NCT00982137|80189686|FG000|Overall Study|Lost to Follow-up|0|||
27546380|NCT00982137|80189687|FG001|Overall Study|Lost to Follow-up|0|||
27546381|NCT00982137|80189688|FG002|Overall Study|Lost to Follow-up|0|||
27546382|NCT00982137|80189689|FG003|Overall Study|Lost to Follow-up|1|||
27546383|NCT00982137|80189686|FG000|Overall Study|Withdrawal by Subject|0|||
27546384|NCT00982137|80189687|FG001|Overall Study|Withdrawal by Subject|1|||
27546385|NCT00982137|80189688|FG002|Overall Study|Withdrawal by Subject|0|||
27546386|NCT00982137|80189689|FG003|Overall Study|Withdrawal by Subject|0|||
27546387|NCT02862171|80189692|FG000|Overall Study|Death|1|||
27639806|NCT01078116|80522325|FG000|Overall Study|Case report form not completed|3|||
27639807|NCT00277355|80522334|FG000|Overall Study|Withdrawal by Subject|3|||
27639808|NCT00277355|80522335|FG001|Overall Study|Withdrawal by Subject|3|||
27639809|NCT00277355|80522334|FG000|Overall Study|Lost to Follow-up|2|||
27639810|NCT00277355|80522335|FG001|Overall Study|Lost to Follow-up|2|||
27742376|NCT05635838|80886911|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
27546388|NCT02862171|80189692|FG000|Overall Study|Lost to Follow-up|13|||
27546389|NCT02862171|80189692|FG000|Overall Study|Withdrawal by Subject|57|||
27546390|NCT02862171|80189692|FG000|Overall Study|Non-compliance|4|||
27639811|NCT00277355|80522334|FG000|Overall Study|Adverse Event|5|||
27926566|NCT01202591|81568093|FG003|Overall Study|Other reason as per investigator|3|||
27546391|NCT02862171|80189692|FG000|Overall Study|HIV-1 seroconversion|18|||
27546392|NCT03572062|80189694|FG000|Overall Study|Adverse Event|0|||
27546393|NCT03572062|80189695|FG001|Overall Study|Adverse Event|0|||
27546394|NCT03572062|80189696|FG002|Overall Study|Adverse Event|0|||
27546395|NCT03572062|80189697|FG003|Overall Study|Adverse Event|0|||
27742377|NCT05635838|80886912|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
27742378|NCT05635838|80886909|FG000|16-Week OLE Period|Adverse Event|0|||
27742379|NCT05635838|80886910|FG001|16-Week OLE Period|Adverse Event|0|||
27742380|NCT05635838|80886911|FG002|16-Week OLE Period|Adverse Event|0|||
27742381|NCT05635838|80886912|FG003|16-Week OLE Period|Adverse Event|2|||
27742382|NCT05635838|80886909|FG000|16-Week OLE Period|Lost to Follow-up|0|||
27742383|NCT05635838|80886910|FG001|16-Week OLE Period|Lost to Follow-up|0|||
27742384|NCT05635838|80886911|FG002|16-Week OLE Period|Lost to Follow-up|1|||
27742385|NCT05635838|80886912|FG003|16-Week OLE Period|Lost to Follow-up|3|||
27742386|NCT05635838|80886909|FG000|16-Week OLE Period|Physician Decision|0|||
27742387|NCT05635838|80886910|FG001|16-Week OLE Period|Physician Decision|0|||
27742388|NCT05635838|80886911|FG002|16-Week OLE Period|Physician Decision|0|||
27742389|NCT05635838|80886912|FG003|16-Week OLE Period|Physician Decision|1|||
27742390|NCT05635838|80886909|FG000|16-Week OLE Period|Protocol Violation|0|||
27742391|NCT05635838|80886910|FG001|16-Week OLE Period|Protocol Violation|0|||
27742392|NCT05635838|80886911|FG002|16-Week OLE Period|Protocol Violation|1|||
27742393|NCT05635838|80886912|FG003|16-Week OLE Period|Protocol Violation|1|||
27742394|NCT05635838|80886909|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
27742395|NCT05635838|80886910|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
27742396|NCT05635838|80886911|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
27742397|NCT05635838|80886912|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
27742398|NCT05635838|80886909|FG000|16-Week OLE Period|Pregnancy|0|||
27742399|NCT05635838|80886910|FG001|16-Week OLE Period|Pregnancy|0|||
27742400|NCT05635838|80886911|FG002|16-Week OLE Period|Pregnancy|1|||
27742401|NCT05635838|80886912|FG003|16-Week OLE Period|Pregnancy|0|||
27742402|NCT02333331|80886916|FG000|Overall Study|Adverse Event|1|||
27742403|NCT02333331|80886917|FG001|Overall Study|Adverse Event|0|||
27742404|NCT02333331|80886918|FG002|Overall Study|Adverse Event|4|||
27742405|NCT02333331|80886919|FG003|Overall Study|Adverse Event|1|||
27742406|NCT02333331|80886916|FG000|Overall Study|Death|0|||
27742407|NCT02333331|80886917|FG001|Overall Study|Death|0|||
27742408|NCT02333331|80886918|FG002|Overall Study|Death|2|||
27742409|NCT02333331|80886919|FG003|Overall Study|Death|0|||
27742410|NCT02333331|80886916|FG000|Overall Study|Lost to Follow-up|0|||
27742411|NCT02333331|80886917|FG001|Overall Study|Lost to Follow-up|0|||
27742412|NCT02333331|80886918|FG002|Overall Study|Lost to Follow-up|1|||
27742413|NCT02333331|80886919|FG003|Overall Study|Lost to Follow-up|0|||
27742414|NCT02333331|80886916|FG000|Overall Study|Physician Decision|0|||
27742415|NCT02333331|80886917|FG001|Overall Study|Physician Decision|1|||
27742416|NCT02333331|80886918|FG002|Overall Study|Physician Decision|0|||
27742417|NCT02333331|80886919|FG003|Overall Study|Physician Decision|0|||
27742418|NCT02333331|80886916|FG000|Overall Study|Protocol Deviation|0|||
27742419|NCT02333331|80886917|FG001|Overall Study|Protocol Deviation|3|||
27742420|NCT02333331|80886918|FG002|Overall Study|Protocol Deviation|2|||
27546396|NCT03572062|80189698|FG004|Overall Study|Adverse Event|0|||
27546397|NCT03572062|80189699|FG005|Overall Study|Adverse Event|0|||
27546398|NCT03572062|80189700|FG006|Overall Study|Adverse Event|0|||
27546399|NCT03572062|80189701|FG007|Overall Study|Adverse Event|0|||
27546400|NCT03572062|80189702|FG008|Overall Study|Adverse Event|1|||
27546401|NCT03572062|80189703|FG009|Overall Study|Adverse Event|3|||
27546402|NCT03572062|80189694|FG000|Overall Study|Death|0|||
27546403|NCT03572062|80189695|FG001|Overall Study|Death|0|||
27546404|NCT03572062|80189696|FG002|Overall Study|Death|0|||
27546405|NCT03572062|80189697|FG003|Overall Study|Death|0|||
27546406|NCT03572062|80189698|FG004|Overall Study|Death|0|||
27546407|NCT03572062|80189699|FG005|Overall Study|Death|1|||
27546408|NCT03572062|80189700|FG006|Overall Study|Death|0|||
27546409|NCT03572062|80189701|FG007|Overall Study|Death|0|||
27546410|NCT03572062|80189702|FG008|Overall Study|Death|0|||
27546411|NCT03572062|80189703|FG009|Overall Study|Death|0|||
27546412|NCT03572062|80189694|FG000|Overall Study|Lost to Follow-up|0|||
27742421|NCT02333331|80886919|FG003|Overall Study|Protocol Deviation|1|||
27742422|NCT02333331|80886916|FG000|Overall Study|Patient/Guardian Decision|1|||
27742423|NCT02333331|80886917|FG001|Overall Study|Patient/Guardian Decision|2|||
27742424|NCT02333331|80886918|FG002|Overall Study|Patient/Guardian Decision|9|||
27742425|NCT02333331|80886919|FG003|Overall Study|Patient/Guardian Decision|1|||
27742426|NCT03334214|80886920|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
27742427|NCT03334214|80886921|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
27742428|NCT03334214|80886920|FG000|Overall Study|Withdrawal by Subject|0|||
27546413|NCT03572062|80189695|FG001|Overall Study|Lost to Follow-up|0|||
27742429|NCT03334214|80886921|FG001|Overall Study|Withdrawal by Subject|1|||
27546414|NCT03572062|80189696|FG002|Overall Study|Lost to Follow-up|0|||
27546415|NCT03572062|80189697|FG003|Overall Study|Lost to Follow-up|0|||
27742430|NCT03334214|80886920|FG000|Overall Study|Other|1|||
27742431|NCT03334214|80886921|FG001|Overall Study|Other|0|||
27546416|NCT03572062|80189698|FG004|Overall Study|Lost to Follow-up|0|||
27546417|NCT03572062|80189699|FG005|Overall Study|Lost to Follow-up|1|||
27546418|NCT03572062|80189700|FG006|Overall Study|Lost to Follow-up|1|||
27546419|NCT03572062|80189701|FG007|Overall Study|Lost to Follow-up|0|||
27546420|NCT03572062|80189702|FG008|Overall Study|Lost to Follow-up|0|||
27546421|NCT03572062|80189703|FG009|Overall Study|Lost to Follow-up|0|||
27546422|NCT03572062|80189694|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
27639812|NCT00277355|80522335|FG001|Overall Study|Adverse Event|0|||
27639813|NCT00277355|80522334|FG000|Overall Study|Death|3|||
27639814|NCT00277355|80522335|FG001|Overall Study|Death|0|||
27639815|NCT00277355|80522334|FG000|Overall Study|Physician Decision|1|||
27639816|NCT00277355|80522335|FG001|Overall Study|Physician Decision|0|||
27639817|NCT01599793|80522337|FG000|Overall Study|Adverse Event|2|||
27639818|NCT00774852|80522340|FG000|Overall Study|Adverse Event|9|||
27639819|NCT00774852|80522341|FG001|Overall Study|Adverse Event|6|||
27639820|NCT00774852|80522340|FG000|Overall Study|Death|2|||
27639821|NCT00774852|80522341|FG001|Overall Study|Death|1|||
27639822|NCT00774852|80522340|FG000|Overall Study|Lack of Efficacy|3|||
27639823|NCT00774852|80522341|FG001|Overall Study|Lack of Efficacy|7|||
27639824|NCT00774852|80522340|FG000|Overall Study|Lost to Follow-up|9|||
27639825|NCT00774852|80522341|FG001|Overall Study|Lost to Follow-up|5|||
27639826|NCT00774852|80522340|FG000|Overall Study|Physician Decision|2|||
27639827|NCT00774852|80522341|FG001|Overall Study|Physician Decision|6|||
27639828|NCT00774852|80522340|FG000|Overall Study|Pregnancy|1|||
27639829|NCT00774852|80522341|FG001|Overall Study|Pregnancy|2|||
27639830|NCT00774852|80522340|FG000|Overall Study|Withdrawal by Subject|2|||
27639831|NCT00774852|80522341|FG001|Overall Study|Withdrawal by Subject|2|||
27639832|NCT00774852|80522340|FG000|Overall Study|Non-responder|15|||
27639833|NCT00774852|80522341|FG001|Overall Study|Non-responder|11|||
27639834|NCT00774852|80522340|FG000|Overall Study|Subject non-compliance|0|||
27639835|NCT00774852|80522341|FG001|Overall Study|Subject non-compliance|1|||
27639836|NCT00774852|80522340|FG000|Overall Study|Protocol Violation|1|||
27639837|NCT00774852|80522341|FG001|Overall Study|Protocol Violation|0|||
27639838|NCT00774852|80522340|FG000|Overall Study|Subject received prohibited medication|1|||
27639839|NCT00774852|80522341|FG001|Overall Study|Subject received prohibited medication|0|||
27639840|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Death|186|||
27639841|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Death|222|||
27639842|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Death|0|||
27639843|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
27639844|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
27639845|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
27639846|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
27639847|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
27639848|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
27639849|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
27639850|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
27639851|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
27639852|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Adverse Event|83|||
27639853|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Adverse Event|100|||
27639854|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Adverse Event|0|||
27639855|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Other|70|||
27639856|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Other|75|||
27639857|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Other|0|||
27639858|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
27639859|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
27639860|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
27639861|NCT00232180|80522342|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
27639862|NCT00232180|80522343|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
27639863|NCT00232180|80522344|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
27639864|NCT00232180|80522342|FG000|Open Label Phase|Death|0|||
27639865|NCT00232180|80522343|FG001|Open Label Phase|Death|0|||
27639866|NCT00232180|80522344|FG002|Open Label Phase|Death|48|||
27639867|NCT00232180|80522342|FG000|Open Label Phase|Lost to Follow-up|0|||
27639868|NCT00232180|80522343|FG001|Open Label Phase|Lost to Follow-up|0|||
27639869|NCT00232180|80522344|FG002|Open Label Phase|Lost to Follow-up|5|||
27639870|NCT00232180|80522342|FG000|Open Label Phase|Protocol Violation|0|||
27742432|NCT02792777|80886922|FG000|Overall Study|Withdrawal by Subject|2|||
27639871|NCT00232180|80522343|FG001|Open Label Phase|Protocol Violation|0|||
27639872|NCT00232180|80522344|FG002|Open Label Phase|Protocol Violation|3|||
27639873|NCT00232180|80522342|FG000|Open Label Phase|Study terminated by sponsor|0|||
27639874|NCT00232180|80522343|FG001|Open Label Phase|Study terminated by sponsor|0|||
27639875|NCT00232180|80522344|FG002|Open Label Phase|Study terminated by sponsor|3|||
27639876|NCT00232180|80522342|FG000|Open Label Phase|Withdrawal by Subject|0|||
27742433|NCT02792777|80886923|FG001|Overall Study|Withdrawal by Subject|0|||
27546423|NCT03572062|80189695|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546424|NCT03572062|80189696|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
27639877|NCT00232180|80522343|FG001|Open Label Phase|Withdrawal by Subject|0|||
27639878|NCT00232180|80522344|FG002|Open Label Phase|Withdrawal by Subject|37|||
27639879|NCT00232180|80522342|FG000|Open Label Phase|Other|0|||
27639880|NCT00232180|80522343|FG001|Open Label Phase|Other|0|||
27639881|NCT00232180|80522344|FG002|Open Label Phase|Other|16|||
27639882|NCT00232180|80522342|FG000|Open Label Phase|Adverse Event|0|||
27639883|NCT00232180|80522343|FG001|Open Label Phase|Adverse Event|0|||
27639884|NCT00232180|80522344|FG002|Open Label Phase|Adverse Event|25|||
27639885|NCT00232180|80522342|FG000|Open Label Phase|Laboratory abnormality|0|||
27639886|NCT00232180|80522343|FG001|Open Label Phase|Laboratory abnormality|0|||
27639887|NCT00232180|80522344|FG002|Open Label Phase|Laboratory abnormality|10|||
27639888|NCT00232180|80522342|FG000|Open Label Phase|Randomized but not treated|0|||
27639889|NCT00232180|80522343|FG001|Open Label Phase|Randomized but not treated|0|||
27639890|NCT00232180|80522344|FG002|Open Label Phase|Randomized but not treated|1|||
27639891|NCT01049503|80525720|FG000|Overall Study|Lost to Follow-up|11|||
27639892|NCT01049503|80525721|FG001|Overall Study|Lost to Follow-up|12|||
27639893|NCT01049503|80525722|FG002|Overall Study|Lost to Follow-up|24|||
27639894|NCT01049503|80525723|FG003|Overall Study|Lost to Follow-up|26|||
27639895|NCT01049503|80525724|FG004|Overall Study|Lost to Follow-up|27|||
27639896|NCT01049503|80525725|FG005|Overall Study|Lost to Follow-up|8|||
27639897|NCT03892564|80525728|FG000|Overall Study|Withdrawal by Subject|2|||
27639898|NCT02252042|80525729|FG000|Overall Study|Adverse Event|9|||
27639899|NCT02252042|80525730|FG001|Overall Study|Adverse Event|6|||
27639900|NCT02252042|80525729|FG000|Overall Study|Death|209|||
27639901|NCT02252042|80525730|FG001|Overall Study|Death|217|||
27639902|NCT02252042|80525729|FG000|Overall Study|Physician Decision|0|||
27639903|NCT02252042|80525730|FG001|Overall Study|Physician Decision|2|||
27639904|NCT02252042|80525729|FG000|Overall Study|Transferred to Extension Study|7|||
27639905|NCT02252042|80525730|FG001|Overall Study|Transferred to Extension Study|1|||
27639906|NCT02252042|80525729|FG000|Overall Study|Did Not Continue on Extension Study|7|||
27639907|NCT02252042|80525730|FG001|Overall Study|Did Not Continue on Extension Study|2|||
27639908|NCT02252042|80525729|FG000|Overall Study|Withdrawal by Subject|15|||
27926567|NCT01202591|81568094|FG004|Overall Study|Other reason as per investigator|1|||
27926568|NCT01202591|81568095|FG005|Overall Study|Other reason as per investigator|3|||
27926569|NCT01202591|81568090|FG000|Overall Study|Withdrawal by Subject|0|||
27926570|NCT01202591|81568091|FG001|Overall Study|Withdrawal by Subject|0|||
27926571|NCT01202591|81568092|FG002|Overall Study|Withdrawal by Subject|0|||
27926572|NCT01202591|81568093|FG003|Overall Study|Withdrawal by Subject|0|||
27926573|NCT01202591|81568094|FG004|Overall Study|Withdrawal by Subject|2|||
27926574|NCT01202591|81568095|FG005|Overall Study|Withdrawal by Subject|1|||
27926575|NCT01202591|81568090|FG000|Overall Study|Objective Disease Progression|0|||
27926576|NCT01202591|81568091|FG001|Overall Study|Objective Disease Progression|0|||
27926577|NCT01202591|81568092|FG002|Overall Study|Objective Disease Progression|0|||
27926578|NCT01202591|81568093|FG003|Overall Study|Objective Disease Progression|0|||
27926579|NCT01202591|81568094|FG004|Overall Study|Objective Disease Progression|2|||
27926580|NCT01202591|81568095|FG005|Overall Study|Objective Disease Progression|0|||
27926581|NCT01147458|81568096|FG000|First Intervention|Study terminated by sponsor|8|||
27926582|NCT01147458|81568097|FG001|First Intervention|Study terminated by sponsor|8|||
27926583|NCT01147458|81568098|FG002|First Intervention|Study terminated by sponsor|7|||
27926584|NCT01147458|81568099|FG003|First Intervention|Study terminated by sponsor|8|||
27926585|NCT01147458|81568096|FG000|First Intervention|Protocol Violation|2|||
27926586|NCT01147458|81568097|FG001|First Intervention|Protocol Violation|3|||
27546425|NCT03572062|80189697|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546426|NCT03572062|80189698|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546427|NCT03572062|80189699|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546428|NCT03572062|80189700|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546429|NCT03572062|80189701|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546430|NCT03572062|80189702|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
27546431|NCT03572062|80189703|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
27546432|NCT03572062|80189694|FG000|Overall Study|Study Terminated By Sponsor|0|||
27546433|NCT03572062|80189695|FG001|Overall Study|Study Terminated By Sponsor|0|||
27546434|NCT03572062|80189696|FG002|Overall Study|Study Terminated By Sponsor|0|||
27546435|NCT03572062|80189697|FG003|Overall Study|Study Terminated By Sponsor|0|||
27639909|NCT02252042|80525730|FG001|Overall Study|Withdrawal by Subject|20|||
27639910|NCT03531840|80525733|FG000|Overall Study|Death on study|3|||
27639911|NCT03531840|80525734|FG001|Overall Study|Death on study|2|||
27639912|NCT03531840|80525735|FG002|Overall Study|Death on study|1|||
27639913|NCT03531840|80525736|FG003|Overall Study|Death on study|2|||
27639914|NCT03531840|80525733|FG000|Overall Study|Death during follow up|2|||
27639915|NCT03531840|80525734|FG001|Overall Study|Death during follow up|3|||
27639916|NCT03531840|80525735|FG002|Overall Study|Death during follow up|4|||
27926587|NCT01147458|81568098|FG002|First Intervention|Protocol Violation|2|||
27926588|NCT01147458|81568099|FG003|First Intervention|Protocol Violation|3|||
27926589|NCT01147458|81568096|FG000|First Intervention|Withdrawal by Subject|3|||
27926590|NCT01147458|81568097|FG001|First Intervention|Withdrawal by Subject|0|||
27546436|NCT03572062|80189698|FG004|Overall Study|Study Terminated By Sponsor|0|||
27546437|NCT03572062|80189699|FG005|Overall Study|Study Terminated By Sponsor|0|||
27546438|NCT03572062|80189700|FG006|Overall Study|Study Terminated By Sponsor|0|||
27546439|NCT03572062|80189701|FG007|Overall Study|Study Terminated By Sponsor|0|||
27546440|NCT03572062|80189702|FG008|Overall Study|Study Terminated By Sponsor|29|||
27546441|NCT03572062|80189703|FG009|Overall Study|Study Terminated By Sponsor|27|||
27546442|NCT03572062|80189694|FG000|Overall Study|Physician Decision|0|||
27546443|NCT03572062|80189695|FG001|Overall Study|Physician Decision|0|||
27546444|NCT03572062|80189696|FG002|Overall Study|Physician Decision|0|||
27546445|NCT03572062|80189697|FG003|Overall Study|Physician Decision|0|||
27546446|NCT03572062|80189698|FG004|Overall Study|Physician Decision|0|||
27546447|NCT03572062|80189699|FG005|Overall Study|Physician Decision|0|||
27546448|NCT03572062|80189700|FG006|Overall Study|Physician Decision|0|||
27546449|NCT03572062|80189701|FG007|Overall Study|Physician Decision|0|||
27546450|NCT03572062|80189702|FG008|Overall Study|Physician Decision|1|||
27546451|NCT03572062|80189703|FG009|Overall Study|Physician Decision|0|||
27546452|NCT03572062|80189694|FG000|Overall Study|Withdrawal by Subject|0|||
27546453|NCT03572062|80189695|FG001|Overall Study|Withdrawal by Subject|0|||
27546454|NCT03572062|80189696|FG002|Overall Study|Withdrawal by Subject|0|||
27546455|NCT03572062|80189697|FG003|Overall Study|Withdrawal by Subject|0|||
27546456|NCT03572062|80189698|FG004|Overall Study|Withdrawal by Subject|0|||
27546457|NCT03572062|80189699|FG005|Overall Study|Withdrawal by Subject|0|||
27639917|NCT03531840|80525736|FG003|Overall Study|Death during follow up|1|||
27639918|NCT03733119|80525742|FG000|Overall Study|Physician Decision|2|||
27639919|NCT03733119|80525743|FG001|Overall Study|Physician Decision|1|||
27639920|NCT03733119|80525742|FG000|Overall Study|ineligible to treat per protocol|0|||
27742434|NCT02792777|80886922|FG000|Overall Study|Recording malfunction|2|||
27742435|NCT02792777|80886923|FG001|Overall Study|Recording malfunction|0|||
27546458|NCT03572062|80189700|FG006|Overall Study|Withdrawal by Subject|0|||
27546459|NCT03572062|80189701|FG007|Overall Study|Withdrawal by Subject|0|||
27546460|NCT03572062|80189702|FG008|Overall Study|Withdrawal by Subject|0|||
27546461|NCT03572062|80189703|FG009|Overall Study|Withdrawal by Subject|1|||
27546462|NCT03572062|80189694|FG000|Overall Study|Randomized But Not Treated|0|||
27546463|NCT03572062|80189695|FG001|Overall Study|Randomized But Not Treated|0|||
27546464|NCT03572062|80189696|FG002|Overall Study|Randomized But Not Treated|0|||
27546465|NCT03572062|80189697|FG003|Overall Study|Randomized But Not Treated|0|||
27546466|NCT03572062|80189698|FG004|Overall Study|Randomized But Not Treated|1|||
27546467|NCT03572062|80189699|FG005|Overall Study|Randomized But Not Treated|2|||
27546468|NCT03572062|80189700|FG006|Overall Study|Randomized But Not Treated|0|||
27546469|NCT03572062|80189701|FG007|Overall Study|Randomized But Not Treated|1|||
27546470|NCT03572062|80189702|FG008|Overall Study|Randomized But Not Treated|0|||
27546471|NCT03572062|80189703|FG009|Overall Study|Randomized But Not Treated|0|||
27546472|NCT01619423|80189704|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
27546473|NCT01619423|80189705|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
27546474|NCT01619423|80189706|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
27546475|NCT01619423|80189707|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
27546476|NCT04706091|80189710|FG000|Treatment 2|Withdrawal by Subject|1|||
27546477|NCT04706091|80189711|FG001|Treatment 2|Withdrawal by Subject|0|||
27546478|NCT02289417|80189712|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
27546479|NCT02289417|80189713|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546480|NCT02289417|80189714|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
27546481|NCT02289417|80189715|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546482|NCT02289417|80189716|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546483|NCT02289417|80189717|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546484|NCT02289417|80189718|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546485|NCT02289417|80189719|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546486|NCT02289417|80189720|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
27546487|NCT02289417|80189712|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
27639921|NCT03733119|80525743|FG001|Overall Study|ineligible to treat per protocol|1|||
27742436|NCT02792777|80886922|FG000|Overall Study|Later determined to be ineligible|2|||
27742437|NCT02792777|80886923|FG001|Overall Study|Later determined to be ineligible|0|||
27546488|NCT02289417|80189713|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
27546489|NCT02289417|80189714|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
27546490|NCT02289417|80189715|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27546491|NCT02289417|80189716|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27546492|NCT02289417|80189717|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27546493|NCT02289417|80189718|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27546494|NCT02289417|80189719|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27546495|NCT02289417|80189720|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
27546496|NCT02289417|80189712|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546497|NCT02289417|80189713|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
27546498|NCT02289417|80189714|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27742438|NCT02792777|80886922|FG000|Overall Study|Participant interviewed twice|1|||
27546499|NCT02289417|80189715|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546500|NCT02289417|80189716|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546501|NCT02289417|80189717|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546502|NCT02289417|80189718|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546503|NCT02289417|80189719|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546504|NCT02289417|80189720|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
27546505|NCT02289417|80189712|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
27546506|NCT02289417|80189713|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27639922|NCT02616900|80525744|FG000|Overall Study|Lack of Efficacy|7|||
27639923|NCT02616900|80525744|FG000|Overall Study|Lost to Follow-up|2|||
27639924|NCT02616900|80525744|FG000|Overall Study|Protocol Violation|5|||
27639925|NCT02616900|80525744|FG000|Overall Study|Withdrawal by Subject|3|||
27639926|NCT02616900|80525744|FG000|Overall Study|Incomplete data|6|||
27639927|NCT02601820|80525745|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
27639928|NCT02601820|80525745|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
27639929|NCT02601820|80525745|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
27639930|NCT02601820|80525745|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
27639931|NCT02554786|80525746|FG000|Overall Study|Subject/guardian decision|29|||
27639932|NCT02554786|80525747|FG001|Overall Study|Subject/guardian decision|17|||
27639933|NCT02554786|80525748|FG002|Overall Study|Subject/guardian decision|18|||
27639934|NCT02554786|80525749|FG003|Overall Study|Subject/guardian decision|30|||
27639935|NCT02554786|80525750|FG004|Overall Study|Subject/guardian decision|20|||
27639936|NCT02554786|80525746|FG000|Overall Study|Lost to Follow-up|4|||
27639937|NCT02554786|80525747|FG001|Overall Study|Lost to Follow-up|3|||
27639938|NCT02554786|80525748|FG002|Overall Study|Lost to Follow-up|4|||
27639939|NCT02554786|80525749|FG003|Overall Study|Lost to Follow-up|2|||
27639940|NCT02554786|80525750|FG004|Overall Study|Lost to Follow-up|2|||
27639941|NCT02554786|80525746|FG000|Overall Study|Protocol deviation|1|||
27639942|NCT02554786|80525747|FG001|Overall Study|Protocol deviation|3|||
27926591|NCT01147458|81568098|FG002|First Intervention|Withdrawal by Subject|1|||
27926592|NCT01147458|81568099|FG003|First Intervention|Withdrawal by Subject|0|||
27926593|NCT01147458|81568096|FG000|First Intervention|Adverse Event|0|||
27926594|NCT01147458|81568097|FG001|First Intervention|Adverse Event|3|||
27926595|NCT01147458|81568098|FG002|First Intervention|Adverse Event|2|||
27926596|NCT01147458|81568099|FG003|First Intervention|Adverse Event|3|||
27546507|NCT02289417|80189714|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546508|NCT02289417|80189715|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546509|NCT02289417|80189716|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546510|NCT02289417|80189717|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546511|NCT02289417|80189718|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546512|NCT02289417|80189719|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546513|NCT02289417|80189720|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
27546514|NCT02289417|80189712|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27546515|NCT02289417|80189713|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
27546516|NCT02289417|80189714|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
27546517|NCT02289417|80189715|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
27546518|NCT02289417|80189716|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
27546519|NCT02289417|80189717|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
27546520|NCT02289417|80189718|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27546521|NCT02289417|80189719|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27926597|NCT01147458|81568096|FG000|First Intervention|Other|1|||
27926598|NCT01147458|81568097|FG001|First Intervention|Other|2|||
27926599|NCT01147458|81568098|FG002|First Intervention|Other|0|||
27926600|NCT01147458|81568099|FG003|First Intervention|Other|0|||
27926601|NCT01147458|81568096|FG000|Second Intervention|Study terminated by sponsor|7|||
27926602|NCT01147458|81568097|FG001|Second Intervention|Study terminated by sponsor|5|||
27926603|NCT01147458|81568098|FG002|Second Intervention|Study terminated by sponsor|5|||
27926604|NCT01147458|81568099|FG003|Second Intervention|Study terminated by sponsor|3|||
27926605|NCT01147458|81568096|FG000|Second Intervention|Protocol Violation|0|||
27926606|NCT01147458|81568097|FG001|Second Intervention|Protocol Violation|1|||
27926607|NCT01147458|81568098|FG002|Second Intervention|Protocol Violation|1|||
27926608|NCT01147458|81568099|FG003|Second Intervention|Protocol Violation|0|||
27926609|NCT01147458|81568096|FG000|Second Intervention|Withdrawal by Subject|0|||
27926610|NCT01147458|81568097|FG001|Second Intervention|Withdrawal by Subject|1|||
27546522|NCT02289417|80189720|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
27546523|NCT02289417|80189712|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27639943|NCT02554786|80525748|FG002|Overall Study|Protocol deviation|3|||
27639944|NCT02554786|80525749|FG003|Overall Study|Protocol deviation|4|||
27639945|NCT02554786|80525750|FG004|Overall Study|Protocol deviation|2|||
27926611|NCT01147458|81568098|FG002|Second Intervention|Withdrawal by Subject|0|||
27926612|NCT01147458|81568099|FG003|Second Intervention|Withdrawal by Subject|0|||
27926613|NCT01147458|81568096|FG000|Second Intervention|Adverse Event|2|||
27926614|NCT01147458|81568097|FG001|Second Intervention|Adverse Event|0|||
27926615|NCT01147458|81568098|FG002|Second Intervention|Adverse Event|1|||
27546524|NCT02289417|80189713|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546525|NCT02289417|80189714|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
27546526|NCT02289417|80189715|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546527|NCT02289417|80189716|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546528|NCT02289417|80189717|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546529|NCT02289417|80189718|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546530|NCT02289417|80189719|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546531|NCT02289417|80189720|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
27546532|NCT02289417|80189712|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27639946|NCT02554786|80525746|FG000|Overall Study|Technical problems|1|||
27639947|NCT02554786|80525747|FG001|Overall Study|Technical problems|1|||
27639948|NCT02554786|80525748|FG002|Overall Study|Technical problems|0|||
27639949|NCT02554786|80525749|FG003|Overall Study|Technical problems|2|||
27926616|NCT01147458|81568099|FG003|Second Intervention|Adverse Event|1|||
27926617|NCT01147458|81568096|FG000|Second Intervention|Other|0|||
27926618|NCT01147458|81568097|FG001|Second Intervention|Other|0|||
27926619|NCT01147458|81568098|FG002|Second Intervention|Other|1|||
27926620|NCT01147458|81568099|FG003|Second Intervention|Other|0|||
27926621|NCT01301092|81568104|FG000|Overall Study|Lost to Follow-up|0|||
27926622|NCT01301092|81568105|FG001|Overall Study|Lost to Follow-up|0|||
27926623|NCT01301092|81568106|FG002|Overall Study|Lost to Follow-up|1|||
27926624|NCT02593864|81568108|FG000|Overall Study|Withdrawal by Subject|3|||
27926625|NCT02593864|81568108|FG000|Overall Study|Lost to Follow-up|3|||
27926626|NCT00165698|81568109|FG000|Overall Study|Adverse Event|2|||
27926627|NCT00165698|81568110|FG001|Overall Study|Adverse Event|10|||
27926628|NCT00165698|81568109|FG000|Overall Study|Lost to Follow-up|2|||
27926629|NCT00165698|81568110|FG001|Overall Study|Lost to Follow-up|2|||
27926630|NCT00165698|81568109|FG000|Overall Study|Withdrawal by Subject|2|||
27926631|NCT00165698|81568110|FG001|Overall Study|Withdrawal by Subject|1|||
27926632|NCT00165698|81568109|FG000|Overall Study|Protocol Violation|1|||
27926633|NCT00165698|81568110|FG001|Overall Study|Protocol Violation|0|||
27926634|NCT00165698|81568109|FG000|Overall Study|Not Taken/Lost the medicine|1|||
27926635|NCT00165698|81568110|FG001|Overall Study|Not Taken/Lost the medicine|2|||
27926636|NCT01500083|81568111|FG000|Overall Study|Adverse Event|4|||
27926637|NCT01500083|81568112|FG001|Overall Study|Adverse Event|17|||
27926638|NCT01500083|81568111|FG000|Overall Study|Death|0|||
27926639|NCT01500083|81568112|FG001|Overall Study|Death|2|||
27926640|NCT01500083|81568111|FG000|Overall Study|Lost to Follow-up|1|||
27926641|NCT01500083|81568112|FG001|Overall Study|Lost to Follow-up|0|||
27926642|NCT01500083|81568111|FG000|Overall Study|Withdrawal of Consent|0|||
27926643|NCT01500083|81568112|FG001|Overall Study|Withdrawal of Consent|1|||
27926644|NCT01500083|81568111|FG000|Overall Study|Disease Progression|2|||
27926645|NCT01500083|81568112|FG001|Overall Study|Disease Progression|10|||
27926646|NCT01500083|81568111|FG000|Overall Study|Investigator Discretion|3|||
27926647|NCT01500083|81568112|FG001|Overall Study|Investigator Discretion|8|||
27926648|NCT01500083|81568111|FG000|Overall Study|Other Reasons|2|||
27926649|NCT01500083|81568112|FG001|Overall Study|Other Reasons|5|||
27926650|NCT01134042|81568113|FG000|Overall Study|Adverse Event|3|||
27926651|NCT01134042|81568114|FG001|Overall Study|Adverse Event|7|||
27926652|NCT01134042|81568115|FG002|Overall Study|Adverse Event|2|||
27926653|NCT01134042|81568113|FG000|Overall Study|Lack of Efficacy|21|||
27639950|NCT02554786|80525750|FG004|Overall Study|Technical problems|1|||
27639951|NCT02554786|80525746|FG000|Overall Study|Adverse Event|0|||
27639952|NCT02554786|80525747|FG001|Overall Study|Adverse Event|0|||
27639953|NCT02554786|80525748|FG002|Overall Study|Adverse Event|0|||
27639954|NCT02554786|80525749|FG003|Overall Study|Adverse Event|0|||
27639955|NCT02554786|80525750|FG004|Overall Study|Adverse Event|2|||
27639956|NCT02554786|80525746|FG000|Overall Study|Death|0|||
27639957|NCT02554786|80525747|FG001|Overall Study|Death|0|||
27639958|NCT02554786|80525748|FG002|Overall Study|Death|0|||
27639959|NCT02554786|80525749|FG003|Overall Study|Death|1|||
27639960|NCT02554786|80525750|FG004|Overall Study|Death|0|||
27639961|NCT02554786|80525746|FG000|Overall Study|Non-compliance with study treatment|0|||
27639962|NCT02554786|80525747|FG001|Overall Study|Non-compliance with study treatment|1|||
27639963|NCT02554786|80525748|FG002|Overall Study|Non-compliance with study treatment|1|||
27639964|NCT02554786|80525749|FG003|Overall Study|Non-compliance with study treatment|0|||
27639965|NCT02554786|80525750|FG004|Overall Study|Non-compliance with study treatment|1|||
27639966|NCT02554786|80525746|FG000|Overall Study|Physician Decision|0|||
27639967|NCT02554786|80525747|FG001|Overall Study|Physician Decision|1|||
27926654|NCT01134042|81568114|FG001|Overall Study|Lack of Efficacy|6|||
27926655|NCT01134042|81568115|FG002|Overall Study|Lack of Efficacy|18|||
27926656|NCT01134042|81568113|FG000|Overall Study|Protocol Violation|5|||
27926657|NCT01134042|81568114|FG001|Overall Study|Protocol Violation|3|||
27926658|NCT01134042|81568115|FG002|Overall Study|Protocol Violation|5|||
27926659|NCT01134042|81568113|FG000|Overall Study|Lost to Follow-up|2|||
27639968|NCT02554786|80525748|FG002|Overall Study|Physician Decision|4|||
27639969|NCT02554786|80525749|FG003|Overall Study|Physician Decision|1|||
27926660|NCT01134042|81568114|FG001|Overall Study|Lost to Follow-up|0|||
27926661|NCT01134042|81568115|FG002|Overall Study|Lost to Follow-up|1|||
27639970|NCT02554786|80525750|FG004|Overall Study|Physician Decision|1|||
27639971|NCT02554786|80525746|FG000|Overall Study|Pregnancy|0|||
27639972|NCT02554786|80525747|FG001|Overall Study|Pregnancy|0|||
27639973|NCT02554786|80525748|FG002|Overall Study|Pregnancy|0|||
27639974|NCT02554786|80525749|FG003|Overall Study|Pregnancy|1|||
27639975|NCT02554786|80525750|FG004|Overall Study|Pregnancy|1|||
27639976|NCT01510717|80525753|FG000|Overall Study|Adverse Event|1|||
27639977|NCT01510717|80525754|FG001|Overall Study|Adverse Event|2|||
27639978|NCT01510717|80525753|FG000|Overall Study|Death|1|||
27639979|NCT01510717|80525754|FG001|Overall Study|Death|0|||
27639980|NCT01510717|80525753|FG000|Overall Study|Lost to Follow-up|0|||
27639981|NCT01510717|80525754|FG001|Overall Study|Lost to Follow-up|1|||
27639982|NCT01510717|80525753|FG000|Overall Study|Withdrawal by Subject|0|||
27639983|NCT01510717|80525754|FG001|Overall Study|Withdrawal by Subject|2|||
27639984|NCT02622568|80525755|FG000|Overall Study|Lost to Follow-up|5|||
27639985|NCT02622568|80525756|FG001|Overall Study|Lost to Follow-up|5|||
27639986|NCT00585052|80525757|FG000|Overall Study|Withdrawal by Subject|1|||
27639987|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
27639988|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
27639989|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
27639990|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
27639991|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
27639992|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
27926662|NCT01134042|81568113|FG000|Overall Study|Physician Decision|4|||
27926663|NCT01134042|81568114|FG001|Overall Study|Physician Decision|8|||
27926664|NCT01134042|81568115|FG002|Overall Study|Physician Decision|1|||
27926665|NCT01134042|81568113|FG000|Overall Study|Withdrawal by Subject|13|||
27926666|NCT01134042|81568114|FG001|Overall Study|Withdrawal by Subject|4|||
27926667|NCT01134042|81568115|FG002|Overall Study|Withdrawal by Subject|7|||
27546533|NCT02289417|80189713|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
27546534|NCT02289417|80189714|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
27546535|NCT02289417|80189715|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
27546536|NCT02289417|80189716|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
27546537|NCT02289417|80189717|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
27546538|NCT02289417|80189718|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27546539|NCT02289417|80189719|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27546540|NCT02289417|80189720|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
27546541|NCT02289417|80189712|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27926668|NCT00005047|81568116|FG000|Overall Study|Withdrawal by Subject|12|||
27926669|NCT00005047|81568117|FG001|Overall Study|Withdrawal by Subject|0|||
27546542|NCT02289417|80189713|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27546543|NCT02289417|80189714|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
27546544|NCT02289417|80189715|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27546545|NCT02289417|80189716|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
27546546|NCT02289417|80189717|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
27546547|NCT02289417|80189718|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27546548|NCT02289417|80189719|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27546549|NCT02289417|80189720|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
27546550|NCT02289417|80189712|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546551|NCT02289417|80189713|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546552|NCT02289417|80189714|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546553|NCT02289417|80189715|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546554|NCT02289417|80189716|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546555|NCT02289417|80189717|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546556|NCT02289417|80189718|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
27546557|NCT02289417|80189719|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546558|NCT02289417|80189720|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
27546559|NCT02289417|80189712|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27546560|NCT02289417|80189713|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27546561|NCT02289417|80189714|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27639993|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
27639994|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
27639995|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
27639996|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
27546562|NCT02289417|80189715|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
27546563|NCT02289417|80189716|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27546564|NCT02289417|80189717|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27639997|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
27639998|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
27639999|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
27546565|NCT02289417|80189718|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
27546566|NCT02289417|80189719|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27546567|NCT02289417|80189720|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
27546568|NCT02289417|80189712|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
27546569|NCT02289417|80189713|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
27546570|NCT02289417|80189714|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
27546571|NCT02289417|80189715|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
27546572|NCT02289417|80189716|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
27546573|NCT02289417|80189717|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
27546574|NCT02289417|80189718|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
27546575|NCT02289417|80189719|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
27640000|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
27640001|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
27640002|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
27640003|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
27640004|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
27640005|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
27640006|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
27640007|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
27640008|NCT00304031|80525759|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
27546576|NCT02289417|80189720|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
27546577|NCT02289417|80189712|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27546578|NCT02289417|80189713|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27546579|NCT02289417|80189714|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27546580|NCT02289417|80189715|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27546581|NCT02289417|80189716|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27546582|NCT02289417|80189717|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27546583|NCT02289417|80189718|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
27640009|NCT00304031|80525760|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
27640010|NCT00304031|80525761|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
27640011|NCT00304031|80525759|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
27640012|NCT00304031|80525760|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
27640013|NCT00304031|80525761|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
27640014|NCT03475316|80525764|FG000|6 Month Intervention|Adverse Event|2|||
27640015|NCT03475316|80525765|FG001|6 Month Intervention|Adverse Event|1|||
27640016|NCT03475316|80525764|FG000|6 Month Intervention|Withdrawal by Subject|2|||
27640017|NCT03475316|80525765|FG001|6 Month Intervention|Withdrawal by Subject|0|||
27640018|NCT03475316|80525764|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
27640019|NCT03475316|80525765|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
27640020|NCT03475316|80525764|FG000|9 Months|Study stopped due to COVID pandemic|3|||
27640021|NCT03475316|80525765|FG001|9 Months|Study stopped due to COVID pandemic|4|||
27640022|NCT00421889|80525768|FG000|Overall Study|Adverse Event|1|||
27640023|NCT00421889|80525769|FG001|Overall Study|Adverse Event|0|||
27640024|NCT00421889|80525770|FG002|Overall Study|Adverse Event|1|||
27640025|NCT00421889|80525771|FG003|Overall Study|Adverse Event|1|||
27640026|NCT00421889|80525772|FG004|Overall Study|Adverse Event|1|||
27640027|NCT00421889|80525773|FG005|Overall Study|Adverse Event|4|||
27640028|NCT00421889|80525774|FG006|Overall Study|Adverse Event|1|||
27640029|NCT00421889|80525775|FG007|Overall Study|Adverse Event|0|||
27640030|NCT00421889|80525776|FG008|Overall Study|Adverse Event|2|||
27640031|NCT00421889|80525768|FG000|Overall Study|Withdrawal by Subject|1|||
27640032|NCT00421889|80525769|FG001|Overall Study|Withdrawal by Subject|3|||
27640033|NCT00421889|80525770|FG002|Overall Study|Withdrawal by Subject|0|||
27640034|NCT00421889|80525771|FG003|Overall Study|Withdrawal by Subject|0|||
27640035|NCT00421889|80525772|FG004|Overall Study|Withdrawal by Subject|2|||
27640036|NCT00421889|80525773|FG005|Overall Study|Withdrawal by Subject|0|||
27640037|NCT00421889|80525774|FG006|Overall Study|Withdrawal by Subject|0|||
27640038|NCT00421889|80525775|FG007|Overall Study|Withdrawal by Subject|0|||
27640039|NCT00421889|80525776|FG008|Overall Study|Withdrawal by Subject|0|||
27640040|NCT00421889|80525768|FG000|Overall Study|Death|0|||
27640041|NCT00421889|80525769|FG001|Overall Study|Death|0|||
27742439|NCT02792777|80886923|FG001|Overall Study|Participant interviewed twice|0|||
27742440|NCT00984659|80886924|FG000|2-week Run-in Period|Adverse Event|8|||
27640042|NCT00421889|80525770|FG002|Overall Study|Death|0|||
27546584|NCT02289417|80189719|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
27546585|NCT02289417|80189720|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
27546586|NCT02289417|80189712|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27546587|NCT02289417|80189713|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27640043|NCT00421889|80525771|FG003|Overall Study|Death|0|||
27640044|NCT00421889|80525772|FG004|Overall Study|Death|1|||
27640045|NCT00421889|80525773|FG005|Overall Study|Death|1|||
27742441|NCT00984659|80886925|FG001|2-week Run-in Period|Adverse Event|0|||
27926670|NCT00005047|81568118|FG002|Overall Study|Withdrawal by Subject|0|||
27926671|NCT00005047|81568119|FG003|Overall Study|Withdrawal by Subject|0|||
27926672|NCT00005047|81568116|FG000|Overall Study|Adverse Event|5|||
27926673|NCT00005047|81568117|FG001|Overall Study|Adverse Event|0|||
27926674|NCT00005047|81568118|FG002|Overall Study|Adverse Event|0|||
27926675|NCT00005047|81568119|FG003|Overall Study|Adverse Event|0|||
27926676|NCT00005047|81568116|FG000|Overall Study|Lost to Follow-up|1|||
27640046|NCT00421889|80525774|FG006|Overall Study|Death|0|||
27640047|NCT00421889|80525775|FG007|Overall Study|Death|0|||
27640048|NCT00421889|80525776|FG008|Overall Study|Death|0|||
27640049|NCT00421889|80525768|FG000|Overall Study|Progressive disease|3|||
27640050|NCT00421889|80525769|FG001|Overall Study|Progressive disease|2|||
27640051|NCT00421889|80525770|FG002|Overall Study|Progressive disease|2|||
27640052|NCT00421889|80525771|FG003|Overall Study|Progressive disease|3|||
27640053|NCT00421889|80525772|FG004|Overall Study|Progressive disease|2|||
27640054|NCT00421889|80525773|FG005|Overall Study|Progressive disease|21|||
27640055|NCT00421889|80525774|FG006|Overall Study|Progressive disease|3|||
27640056|NCT00421889|80525775|FG007|Overall Study|Progressive disease|1|||
27640057|NCT00421889|80525776|FG008|Overall Study|Progressive disease|5|||
27640058|NCT00421889|80525768|FG000|Overall Study|Patient/Investigator request|0|||
27640059|NCT00421889|80525769|FG001|Overall Study|Patient/Investigator request|0|||
27926677|NCT00005047|81568117|FG001|Overall Study|Lost to Follow-up|0|||
27546588|NCT02289417|80189714|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27546589|NCT02289417|80189715|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27546590|NCT02289417|80189716|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27546591|NCT02289417|80189717|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27546592|NCT02289417|80189718|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
27546593|NCT02289417|80189719|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
27546594|NCT02289417|80189720|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
27546595|NCT02289417|80189712|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546596|NCT02289417|80189713|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546597|NCT02289417|80189714|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546598|NCT02289417|80189715|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546599|NCT02289417|80189716|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546600|NCT02289417|80189717|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546601|NCT02289417|80189718|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546602|NCT02289417|80189719|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
27546603|NCT02289417|80189720|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
27546604|NCT01032837|80189721|FG000|Overall Study|Adverse event/internal illness|0|||
27546605|NCT01032837|80189722|FG001|Overall Study|Adverse event/internal illness|1|||
27546606|NCT01032837|80189723|FG002|Overall Study|Adverse event/internal illness|0|||
27546607|NCT01032837|80189724|FG003|Overall Study|Adverse event/internal illness|1|||
27546608|NCT01032837|80189721|FG000|Overall Study|Withdrew consent|0|||
27546609|NCT01032837|80189722|FG001|Overall Study|Withdrew consent|2|||
27546610|NCT01032837|80189723|FG002|Overall Study|Withdrew consent|0|||
27546611|NCT01032837|80189724|FG003|Overall Study|Withdrew consent|1|||
27546612|NCT01032837|80189721|FG000|Overall Study|Failed to return|0|||
27546613|NCT01032837|80189722|FG001|Overall Study|Failed to return|0|||
27546614|NCT01032837|80189723|FG002|Overall Study|Failed to return|1|||
27546615|NCT01032837|80189724|FG003|Overall Study|Failed to return|0|||
27546616|NCT01032837|80189721|FG000|Overall Study|Refused treatment|0|||
27546617|NCT01032837|80189722|FG001|Overall Study|Refused treatment|0|||
27546618|NCT01032837|80189723|FG002|Overall Study|Refused treatment|0|||
27546619|NCT01032837|80189724|FG003|Overall Study|Refused treatment|1|||
27546620|NCT02197247|80189731|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
27546621|NCT02197247|80189731|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
27546622|NCT02197247|80189731|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
27546623|NCT02197247|80189731|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
27640060|NCT00421889|80525770|FG002|Overall Study|Patient/Investigator request|0|||
27926678|NCT00005047|81568118|FG002|Overall Study|Lost to Follow-up|0|||
27926679|NCT00005047|81568119|FG003|Overall Study|Lost to Follow-up|0|||
27926680|NCT00005047|81568116|FG000|Overall Study|Lack of Efficacy|1|||
27546624|NCT02197247|80189731|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
27546625|NCT02197247|80189731|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
27546626|NCT02197247|80189731|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
27546627|NCT02197247|80189731|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
27546628|NCT01550289|80189732|FG000|Overall Study|Protocol Violation|1|||
27546629|NCT01550289|80189733|FG001|Overall Study|Protocol Violation|0|||
27546630|NCT01550289|80189732|FG000|Overall Study|Lost to Follow-up|1|||
27640061|NCT00421889|80525771|FG003|Overall Study|Patient/Investigator request|0|||
27640062|NCT00421889|80525772|FG004|Overall Study|Patient/Investigator request|0|||
27640063|NCT00421889|80525773|FG005|Overall Study|Patient/Investigator request|9|||
27640064|NCT00421889|80525774|FG006|Overall Study|Patient/Investigator request|0|||
27926681|NCT00005047|81568117|FG001|Overall Study|Lack of Efficacy|0|||
27926682|NCT00005047|81568118|FG002|Overall Study|Lack of Efficacy|0|||
27926683|NCT00005047|81568119|FG003|Overall Study|Lack of Efficacy|0|||
27926684|NCT00118287|81568120|FG000|Overall Study|Intracranial haemorrhage|1|||
27926685|NCT00118287|81568120|FG000|Overall Study|Muscle pain|1|||
27926686|NCT01179516|81568123|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
27926687|NCT01179516|81568124|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
27926688|NCT01179516|81568125|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
27926689|NCT01179516|81568123|FG000|Overall Study|Lack of Efficacy|4|||
27926690|NCT01179516|81568124|FG001|Overall Study|Lack of Efficacy|2|||
27926691|NCT01179516|81568125|FG002|Overall Study|Lack of Efficacy|0|||
27926692|NCT01179516|81568123|FG000|Overall Study|Noncompliance with Study Drug|2|||
27926693|NCT01179516|81568124|FG001|Overall Study|Noncompliance with Study Drug|0|||
27926694|NCT01179516|81568125|FG002|Overall Study|Noncompliance with Study Drug|1|||
27926695|NCT01179516|81568123|FG000|Overall Study|Protocol Deviations|4|||
27926696|NCT01179516|81568124|FG001|Overall Study|Protocol Deviations|3|||
27926697|NCT01179516|81568125|FG002|Overall Study|Protocol Deviations|3|||
27926698|NCT01179516|81568123|FG000|Overall Study|Withdrawal of Consent|2|||
27926699|NCT01179516|81568124|FG001|Overall Study|Withdrawal of Consent|6|||
27926700|NCT01179516|81568125|FG002|Overall Study|Withdrawal of Consent|10|||
27926701|NCT01179516|81568123|FG000|Overall Study|Lost to Follow-up|7|||
27926702|NCT01179516|81568124|FG001|Overall Study|Lost to Follow-up|7|||
27926703|NCT01179516|81568125|FG002|Overall Study|Lost to Follow-up|3|||
27926704|NCT01179516|81568123|FG000|Overall Study|Other|2|||
27926705|NCT01179516|81568124|FG001|Overall Study|Other|0|||
27926706|NCT01179516|81568125|FG002|Overall Study|Other|2|||
27926707|NCT01155141|81568129|FG000|Overall Study|Withdrawal by Subject|1|||
27926708|NCT01155141|81568129|FG000|Overall Study|Screen Failure|1|||
27926709|NCT02202616|81568130|FG000|Overall Study|Screen failed|24|||
27926710|NCT02202616|81568130|FG000|Overall Study|Adverse Event|32|||
27926711|NCT02202616|81568130|FG000|Overall Study|Protocol deviation|18|||
27926712|NCT02202616|81568130|FG000|Overall Study|Patient withdrew consent|12|||
27926713|NCT02202616|81568130|FG000|Overall Study|Lost to Follow-up|6|||
27926714|NCT02202616|81568130|FG000|Overall Study|Administrative problems|6|||
27926715|NCT02202616|81568130|FG000|Overall Study|Abnormal test procedure result|1|||
27926716|NCT02202616|81568130|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27926717|NCT00576758|81568131|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
27926718|NCT00576758|81568132|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
27926719|NCT00576758|81568131|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
27926720|NCT00576758|81568132|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
27926721|NCT00576758|81568131|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
27926722|NCT00576758|81568132|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
27926723|NCT00576758|81568131|FG000|Induction Treatment Period|Death|1|||
27926724|NCT00576758|81568132|FG001|Induction Treatment Period|Death|0|||
27926725|NCT00576758|81568131|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
27926726|NCT00576758|81568132|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
27926727|NCT00576758|81568131|FG000|Induction Treatment Period|Withdrew consent|1|||
27926728|NCT00576758|81568132|FG001|Induction Treatment Period|Withdrew consent|0|||
27926729|NCT00576758|81568131|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
27926730|NCT00576758|81568132|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
27926731|NCT00576758|81568131|FG000|Extension Treatment Period|Death|1|||
27926732|NCT00576758|81568132|FG001|Extension Treatment Period|Death|1|||
27926733|NCT00576758|81568131|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
27926734|NCT00576758|81568132|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
27926735|NCT00576758|81568131|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
27926736|NCT00576758|81568132|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
27926737|NCT00576758|81568131|FG000|Extension Treatment Period|Administrative/Other|3|||
27926738|NCT00576758|81568132|FG001|Extension Treatment Period|Administrative/Other|1|||
27926739|NCT00576758|81568131|FG000|Follow-up Period|Administrative/Other|6|||
27926740|NCT00576758|81568132|FG001|Follow-up Period|Administrative/Other|8|||
27926741|NCT00576758|81568131|FG000|Follow-up Period|Death|3|||
27926742|NCT00576758|81568132|FG001|Follow-up Period|Death|3|||
27926743|NCT00576758|81568131|FG000|Follow-up Period|Insufficient therapeutic response|16|||
27926744|NCT00576758|81568132|FG001|Follow-up Period|Insufficient therapeutic response|5|||
27926745|NCT00576758|81568131|FG000|Follow-up Period|Withdrew consent|2|||
27546631|NCT01550289|80189733|FG001|Overall Study|Lost to Follow-up|1|||
27546632|NCT01550289|80189732|FG000|Overall Study|Withdrawal by Subject|11|||
27546633|NCT01550289|80189733|FG001|Overall Study|Withdrawal by Subject|3|||
27546634|NCT02801396|80189737|FG000|Period 1|Withdrawal by Subject|0|||
27546635|NCT02801396|80189738|FG001|Period 1|Withdrawal by Subject|0|||
27926746|NCT00576758|81568132|FG001|Follow-up Period|Withdrew consent|1|||
27926747|NCT00720278|81568136|FG000|Overall Study|Adverse Event|5|||
27926748|NCT00720278|81568137|FG001|Overall Study|Adverse Event|3|||
27926749|NCT00720278|81568138|FG002|Overall Study|Adverse Event|4|||
27926750|NCT00720278|81568136|FG000|Overall Study|Withdrawal by Subject|0|||
27926751|NCT00720278|81568137|FG001|Overall Study|Withdrawal by Subject|1|||
27926752|NCT00720278|81568138|FG002|Overall Study|Withdrawal by Subject|0|||
27926753|NCT00720278|81568136|FG000|Overall Study|Lost to Follow-up|0|||
27926754|NCT00720278|81568137|FG001|Overall Study|Lost to Follow-up|0|||
27926755|NCT00720278|81568138|FG002|Overall Study|Lost to Follow-up|1|||
27926756|NCT00720278|81568136|FG000|Overall Study|Non-compliance|1|||
27926757|NCT00720278|81568137|FG001|Overall Study|Non-compliance|0|||
27926758|NCT00720278|81568138|FG002|Overall Study|Non-compliance|0|||
27926759|NCT00720278|81568136|FG000|Overall Study|eligibility criteria violation|1|||
27926760|NCT00720278|81568137|FG001|Overall Study|eligibility criteria violation|0|||
27926761|NCT00720278|81568138|FG002|Overall Study|eligibility criteria violation|1|||
27926762|NCT00770367|81568142|FG000|First Intervention|Withdrawal by Subject|0|||
27926763|NCT00770367|81568143|FG001|First Intervention|Withdrawal by Subject|2|||
27926764|NCT00770367|81568142|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
27926765|NCT00770367|81568143|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
27926766|NCT00770367|81568142|FG000|Second Intervention|Lost to Follow-up|2|||
27926767|NCT00770367|81568143|FG001|Second Intervention|Lost to Follow-up|0|||
27926768|NCT02453048|81568144|FG000|Overall Study|Only part of initial 6 mo. study|0|||
27926769|NCT02453048|81568145|FG001|Overall Study|Only part of initial 6 mo. study|0|||
27546636|NCT02801396|80189739|FG002|Period 1|Withdrawal by Subject|0|||
27546637|NCT02801396|80189740|FG003|Period 1|Withdrawal by Subject|0|||
27546638|NCT02801396|80189741|FG004|Period 1|Withdrawal by Subject|1|||
27546639|NCT02801396|80189742|FG005|Period 1|Withdrawal by Subject|0|||
27546640|NCT00880009|80189743|FG000|Overall Study|Study terminated by sponsor|14|||
27546641|NCT00880009|80189743|FG000|Overall Study|Withdrawal by Subject|1|||
27546642|NCT00880009|80189743|FG000|Overall Study|Protocol Violation|1|||
27546643|NCT02521870|80189744|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546644|NCT02521870|80189745|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
27546645|NCT02521870|80189746|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546646|NCT02521870|80189747|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546647|NCT02521870|80189748|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546648|NCT02521870|80189749|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546649|NCT02521870|80189750|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546650|NCT02521870|80189751|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546651|NCT02521870|80189752|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546652|NCT02521870|80189753|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546653|NCT02521870|80189754|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546654|NCT02521870|80189755|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
27546655|NCT02521870|80189744|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
27546656|NCT02521870|80189745|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
27546657|NCT02521870|80189746|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
27546658|NCT02521870|80189747|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
27546659|NCT02521870|80189748|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
27546660|NCT02521870|80189749|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
27546661|NCT02521870|80189750|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
27546662|NCT02521870|80189751|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
27546663|NCT02521870|80189752|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
27546664|NCT02521870|80189753|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
27546665|NCT02521870|80189754|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
27546666|NCT02521870|80189755|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
27546667|NCT02521870|80189744|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
27546668|NCT02521870|80189745|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
27546669|NCT02521870|80189746|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
27546670|NCT02521870|80189747|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
27546671|NCT02521870|80189748|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
27546672|NCT02521870|80189749|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
27546673|NCT02521870|80189750|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
27546674|NCT02521870|80189751|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
27546675|NCT02521870|80189752|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
27546676|NCT02521870|80189753|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
27546677|NCT02521870|80189754|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
27546678|NCT02521870|80189755|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
27546679|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
27546680|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
27742442|NCT00984659|80886926|FG002|2-week Run-in Period|Adverse Event|0|||
27546681|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
27546682|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
27546683|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
27742443|NCT00984659|80886927|FG003|2-week Run-in Period|Adverse Event|0|||
27742444|NCT00984659|80886924|FG000|2-week Run-in Period|Protocol Violation|5|||
27926770|NCT02453048|81568146|FG002|Overall Study|Only part of initial 6 mo. study|0|||
27926771|NCT02453048|81568147|FG003|Overall Study|Only part of initial 6 mo. study|0|||
27926772|NCT02453048|81568148|FG004|Overall Study|Only part of initial 6 mo. study|6|||
27926773|NCT02453048|81568144|FG000|Overall Study|Lost to Follow-up|0|||
27926774|NCT02453048|81568145|FG001|Overall Study|Lost to Follow-up|1|||
27926775|NCT02453048|81568146|FG002|Overall Study|Lost to Follow-up|2|||
27926776|NCT02453048|81568147|FG003|Overall Study|Lost to Follow-up|0|||
27926777|NCT02453048|81568148|FG004|Overall Study|Lost to Follow-up|0|||
27926778|NCT02875080|81568149|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
27926779|NCT02875080|81568150|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
27926780|NCT02875080|81568151|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
27926781|NCT00662259|81568152|FG000|Overall Study|Adverse Event|2|||
27926782|NCT00662259|81568153|FG001|Overall Study|Adverse Event|0|||
27926783|NCT00831844|81571004|FG000|Overall Study|Adverse Event|2|||
27926784|NCT00831844|81571005|FG001|Overall Study|Adverse Event|0|||
27926785|NCT00831844|81571006|FG002|Overall Study|Adverse Event|0|||
27926786|NCT00831844|81571007|FG003|Overall Study|Adverse Event|0|||
27926787|NCT00831844|81571008|FG004|Overall Study|Adverse Event|1|||
27926788|NCT00831844|81571009|FG005|Overall Study|Adverse Event|1|||
27926789|NCT00831844|81571010|FG006|Overall Study|Adverse Event|2|||
27926790|NCT00831844|81571011|FG007|Overall Study|Adverse Event|0|||
27926791|NCT00831844|81571012|FG008|Overall Study|Adverse Event|0|||
27926792|NCT00831844|81571013|FG009|Overall Study|Adverse Event|0|||
27926793|NCT00831844|81571004|FG000|Overall Study|Death|0|||
27926794|NCT00831844|81571005|FG001|Overall Study|Death|0|||
27926795|NCT00831844|81571006|FG002|Overall Study|Death|0|||
27926796|NCT00831844|81571007|FG003|Overall Study|Death|1|||
27926797|NCT00831844|81571008|FG004|Overall Study|Death|0|||
27926798|NCT00831844|81571009|FG005|Overall Study|Death|0|||
27926799|NCT00831844|81571010|FG006|Overall Study|Death|0|||
27926800|NCT00831844|81571011|FG007|Overall Study|Death|0|||
27926801|NCT00831844|81571012|FG008|Overall Study|Death|0|||
27926802|NCT00831844|81571013|FG009|Overall Study|Death|0|||
27926803|NCT00831844|81571004|FG000|Overall Study|Lack of Efficacy|8|||
27926804|NCT00831844|81571005|FG001|Overall Study|Lack of Efficacy|10|||
27926805|NCT00831844|81571006|FG002|Overall Study|Lack of Efficacy|15|||
27926806|NCT00831844|81571007|FG003|Overall Study|Lack of Efficacy|8|||
27926807|NCT00831844|81571008|FG004|Overall Study|Lack of Efficacy|11|||
27926808|NCT00831844|81571009|FG005|Overall Study|Lack of Efficacy|17|||
27926809|NCT00831844|81571010|FG006|Overall Study|Lack of Efficacy|8|||
27926810|NCT00831844|81571011|FG007|Overall Study|Lack of Efficacy|9|||
27926811|NCT00831844|81571012|FG008|Overall Study|Lack of Efficacy|7|||
27926812|NCT00831844|81571013|FG009|Overall Study|Lack of Efficacy|0|||
27926813|NCT00831844|81571004|FG000|Overall Study|Physician Decision|0|||
27926814|NCT00831844|81571005|FG001|Overall Study|Physician Decision|1|||
27926815|NCT00831844|81571006|FG002|Overall Study|Physician Decision|3|||
27926816|NCT00831844|81571007|FG003|Overall Study|Physician Decision|1|||
27926817|NCT00831844|81571008|FG004|Overall Study|Physician Decision|1|||
27926818|NCT00831844|81571009|FG005|Overall Study|Physician Decision|1|||
27926819|NCT00831844|81571010|FG006|Overall Study|Physician Decision|0|||
27926820|NCT00831844|81571011|FG007|Overall Study|Physician Decision|0|||
27926821|NCT00831844|81571012|FG008|Overall Study|Physician Decision|1|||
27926822|NCT00831844|81571013|FG009|Overall Study|Physician Decision|0|||
27926823|NCT00831844|81571004|FG000|Overall Study|Withdrawal by Subject|0|||
27926824|NCT00831844|81571005|FG001|Overall Study|Withdrawal by Subject|0|||
27926825|NCT00831844|81571006|FG002|Overall Study|Withdrawal by Subject|1|||
27926826|NCT00831844|81571007|FG003|Overall Study|Withdrawal by Subject|0|||
27926827|NCT00831844|81571008|FG004|Overall Study|Withdrawal by Subject|0|||
27926828|NCT00831844|81571009|FG005|Overall Study|Withdrawal by Subject|0|||
27926829|NCT00831844|81571010|FG006|Overall Study|Withdrawal by Subject|0|||
27926830|NCT00831844|81571011|FG007|Overall Study|Withdrawal by Subject|1|||
27926831|NCT00831844|81571012|FG008|Overall Study|Withdrawal by Subject|1|||
27926832|NCT00831844|81571013|FG009|Overall Study|Withdrawal by Subject|0|||
27926833|NCT00831844|81571004|FG000|Overall Study|Ineligible|0|||
27926834|NCT00831844|81571005|FG001|Overall Study|Ineligible|1|||
27926835|NCT00831844|81571006|FG002|Overall Study|Ineligible|1|||
27926836|NCT00831844|81571007|FG003|Overall Study|Ineligible|0|||
27926837|NCT00831844|81571008|FG004|Overall Study|Ineligible|1|||
27926838|NCT00831844|81571009|FG005|Overall Study|Ineligible|0|||
27926839|NCT00831844|81571010|FG006|Overall Study|Ineligible|0|||
27926840|NCT00831844|81571011|FG007|Overall Study|Ineligible|0|||
27926841|NCT00831844|81571012|FG008|Overall Study|Ineligible|0|||
27926842|NCT00831844|81571013|FG009|Overall Study|Ineligible|0|||
27926843|NCT05417113|81571014|FG000|Overall Study|Lost to Follow-up|2|||
27926844|NCT05417113|81571015|FG001|Overall Study|Lost to Follow-up|2|||
27926845|NCT02452190|81571016|FG000|Overall Study|Withdrawal by Sponsor|1|||
27926846|NCT02452190|81571017|FG001|Overall Study|Withdrawal by Sponsor|3|||
27926847|NCT02452190|81571016|FG000|Overall Study|Pregnancy|1|||
27926848|NCT02452190|81571017|FG001|Overall Study|Pregnancy|0|||
27926849|NCT02452190|81571016|FG000|Overall Study|Investigator's Decision|2|||
27926850|NCT02452190|81571017|FG001|Overall Study|Investigator's Decision|0|||
27926851|NCT02452190|81571016|FG000|Overall Study|Lack of Efficacy|3|||
27926852|NCT02452190|81571017|FG001|Overall Study|Lack of Efficacy|1|||
27926853|NCT02452190|81571016|FG000|Overall Study|Lost to Follow-up|4|||
27640065|NCT00421889|80525775|FG007|Overall Study|Patient/Investigator request|1|||
27640066|NCT00421889|80525776|FG008|Overall Study|Patient/Investigator request|3|||
27640067|NCT00421889|80525768|FG000|Overall Study|Lost to Follow-up|0|||
27926854|NCT02452190|81571017|FG001|Overall Study|Lost to Follow-up|3|||
27926855|NCT02452190|81571016|FG000|Overall Study|Adverse Event|2|||
27640068|NCT00421889|80525769|FG001|Overall Study|Lost to Follow-up|0|||
27640069|NCT00421889|80525770|FG002|Overall Study|Lost to Follow-up|0|||
27640070|NCT00421889|80525771|FG003|Overall Study|Lost to Follow-up|0|||
27640071|NCT00421889|80525772|FG004|Overall Study|Lost to Follow-up|0|||
27640072|NCT00421889|80525773|FG005|Overall Study|Lost to Follow-up|0|||
27640073|NCT00421889|80525774|FG006|Overall Study|Lost to Follow-up|0|||
27640074|NCT00421889|80525775|FG007|Overall Study|Lost to Follow-up|0|||
27640075|NCT00421889|80525776|FG008|Overall Study|Lost to Follow-up|1|||
27640076|NCT02814838|80525777|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
27640077|NCT02814838|80525778|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
27640078|NCT02814838|80525777|FG000|Overall Study|Consent withdrawal|1|||
27640079|NCT02814838|80525778|FG001|Overall Study|Consent withdrawal|1|||
27640080|NCT00424645|80525780|FG000|Overall Study|Death|1|||
27640081|NCT00424645|80525781|FG001|Overall Study|Death|0|||
27640082|NCT02797184|80525785|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
27640083|NCT02797184|80525786|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
27640084|NCT03447249|80525794|FG000|Overall Study|Adverse Event|1|||
27640085|NCT03447249|80525795|FG001|Overall Study|Adverse Event|0|||
27742445|NCT00984659|80886925|FG001|2-week Run-in Period|Protocol Violation|0|||
27742446|NCT00984659|80886926|FG002|2-week Run-in Period|Protocol Violation|0|||
27742447|NCT00984659|80886927|FG003|2-week Run-in Period|Protocol Violation|0|||
27742448|NCT00984659|80886924|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
27742449|NCT00984659|80886925|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
27742450|NCT00984659|80886926|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
27742451|NCT00984659|80886927|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
27742452|NCT00984659|80886924|FG000|2-week Run-in Period|Lost to Follow-up|3|||
27742453|NCT00984659|80886925|FG001|2-week Run-in Period|Lost to Follow-up|0|||
27742454|NCT00984659|80886926|FG002|2-week Run-in Period|Lost to Follow-up|0|||
27742455|NCT00984659|80886927|FG003|2-week Run-in Period|Lost to Follow-up|0|||
27742456|NCT00984659|80886924|FG000|2-week Run-in Period|Physician Decision|10|||
27742457|NCT00984659|80886925|FG001|2-week Run-in Period|Physician Decision|0|||
27742458|NCT00984659|80886926|FG002|2-week Run-in Period|Physician Decision|0|||
27742459|NCT00984659|80886927|FG003|2-week Run-in Period|Physician Decision|0|||
27742460|NCT00984659|80886924|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
27742461|NCT00984659|80886925|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
27742462|NCT00984659|80886926|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
27742463|NCT00984659|80886927|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
27742464|NCT00984659|80886924|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
27742465|NCT00984659|80886925|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27742466|NCT00984659|80886926|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27742467|NCT00984659|80886927|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
27742468|NCT00984659|80886924|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
27742469|NCT00984659|80886925|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
27742470|NCT00984659|80886926|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
27742471|NCT00984659|80886927|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
27742472|NCT00984659|80886924|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
27742473|NCT00984659|80886925|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
27742474|NCT00984659|80886926|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
27742475|NCT00984659|80886927|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
27926856|NCT02452190|81571017|FG001|Overall Study|Adverse Event|5|||
27926857|NCT02452190|81571016|FG000|Overall Study|Withdrawal by Subject|20|||
27640086|NCT03447249|80525794|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
27640087|NCT03447249|80525795|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
27640088|NCT03447249|80525794|FG000|Overall Study|Other|3|||
27640089|NCT03447249|80525795|FG001|Overall Study|Other|0|||
27640090|NCT03621735|80525796|FG000|Overall Study|Withdrawal by Subject|13|||
27640091|NCT03621735|80525797|FG001|Overall Study|Withdrawal by Subject|13|||
27640092|NCT01534494|80525801|FG000|Overall Study|Withdrawal by Subject|1|||
27640093|NCT02730871|80525802|FG000|Overall Study|Adverse Event|6|||
27742476|NCT00984659|80886924|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
27742477|NCT00984659|80886925|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
27742478|NCT00984659|80886926|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
27742479|NCT00984659|80886927|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
27926858|NCT02452190|81571017|FG001|Overall Study|Withdrawal by Subject|11|||
27742480|NCT00984659|80886924|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
27640094|NCT02730871|80525803|FG001|Overall Study|Adverse Event|0|||
27640095|NCT02204982|80525804|FG000|Overall Study|Patient ineligible-medical monitor|1|||
27926859|NCT02452190|81571016|FG000|Overall Study|Noncompliance with study drug|1|||
27926860|NCT02452190|81571017|FG001|Overall Study|Noncompliance with study drug|0|||
27926861|NCT02452190|81571016|FG000|Overall Study|Participant traveled abroad|1|||
27926862|NCT02452190|81571017|FG001|Overall Study|Participant traveled abroad|0|||
27926863|NCT02452190|81571016|FG000|Overall Study|Death|0|||
27926864|NCT02452190|81571017|FG001|Overall Study|Death|1|||
27926865|NCT02347787|81571018|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
27926866|NCT02347787|81571019|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
27926867|NCT02347787|81571018|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
27926868|NCT02347787|81571019|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
27926869|NCT02347787|81571018|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
27926870|NCT02347787|81571019|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
27926871|NCT02347787|81571018|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
27926872|NCT02347787|81571019|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
27926873|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
27926874|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
27926875|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
27926876|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
27926877|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
27926878|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
27926879|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
27926880|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
27926881|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
27926882|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
27926883|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Death|3|||
27926884|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Death|1|||
27926885|NCT01056276|81571025|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
27926886|NCT01056276|81571026|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
27926887|NCT01056276|81571025|FG000|Maintenance Therapy|Toxicity|0|||
27926888|NCT01056276|81571026|FG001|Maintenance Therapy|Toxicity|2|||
27926889|NCT01056276|81571025|FG000|Maintenance Therapy|Progressive Disease|0|||
27926890|NCT01056276|81571026|FG001|Maintenance Therapy|Progressive Disease|9|||
27926891|NCT01056276|81571025|FG000|Maintenance Therapy|Physician Decision|0|||
27926892|NCT01056276|81571026|FG001|Maintenance Therapy|Physician Decision|1|||
27926893|NCT01056276|81571025|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
27926894|NCT01056276|81571026|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
27926895|NCT01056276|81571025|FG000|Maintenance Therapy|Intercurrent Illness|0|||
27926896|NCT01056276|81571026|FG001|Maintenance Therapy|Intercurrent Illness|1|||
27926897|NCT01056276|81571025|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
27926898|NCT01056276|81571026|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
27926899|NCT00857389|81571027|FG000|Overall Study|Did not proceed to transplant|2|||
27926900|NCT02184156|81571028|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
27926901|NCT02184156|81571029|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
27926902|NCT02184156|81571028|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
27926903|NCT02184156|81571029|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
27926904|NCT04000724|81571033|FG000|Overall Study|Withdrawal by Subject|5|||
27926905|NCT04000724|81571034|FG001|Overall Study|Withdrawal by Subject|3|||
27926906|NCT04000724|81571035|FG002|Overall Study|Withdrawal by Subject|4|||
27926907|NCT04000724|81571033|FG000|Overall Study|Lost to Follow-up|11|||
27926908|NCT04000724|81571034|FG001|Overall Study|Lost to Follow-up|7|||
27926909|NCT04000724|81571035|FG002|Overall Study|Lost to Follow-up|13|||
27926910|NCT03881371|81571044|FG000|Overall Study|Adverse Event|8|||
27926911|NCT03881371|81571045|FG001|Overall Study|Adverse Event|9|||
27926912|NCT03881371|81571044|FG000|Overall Study|Death|1|||
27926913|NCT03881371|81571045|FG001|Overall Study|Death|0|||
27926914|NCT03881371|81571044|FG000|Overall Study|Lost to Follow-up|1|||
27926915|NCT03881371|81571045|FG001|Overall Study|Lost to Follow-up|0|||
27926916|NCT03881371|81571044|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27926917|NCT03881371|81571045|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27926918|NCT03881371|81571044|FG000|Overall Study|Physician Decision|3|||
27926919|NCT03881371|81571045|FG001|Overall Study|Physician Decision|3|||
27926920|NCT03881371|81571044|FG000|Overall Study|Withdrawal by Subject|2|||
27926921|NCT03881371|81571045|FG001|Overall Study|Withdrawal by Subject|10|||
27926922|NCT03881371|81571044|FG000|Overall Study|Discontinuation from Study|1|||
27926923|NCT03881371|81571045|FG001|Overall Study|Discontinuation from Study|0|||
27926924|NCT01047501|81571048|FG000|Overall Study|Adverse Event|7|||
27926925|NCT01047501|81571049|FG001|Overall Study|Adverse Event|8|||
27926926|NCT01047501|81571050|FG002|Overall Study|Adverse Event|5|||
27926927|NCT01047501|81571048|FG000|Overall Study|Withdrew Consent|6|||
27926928|NCT01047501|81571049|FG001|Overall Study|Withdrew Consent|2|||
27926929|NCT01047501|81571050|FG002|Overall Study|Withdrew Consent|4|||
27926930|NCT01047501|81571048|FG000|Overall Study|Lost to Follow-up|0|||
27926931|NCT01047501|81571049|FG001|Overall Study|Lost to Follow-up|1|||
27926932|NCT01047501|81571050|FG002|Overall Study|Lost to Follow-up|1|||
27926933|NCT01047501|81571048|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
27926934|NCT01047501|81571049|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
27926935|NCT01047501|81571050|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
27926936|NCT01047501|81571048|FG000|Overall Study|Death|1|||
27926937|NCT01047501|81571049|FG001|Overall Study|Death|0|||
27926938|NCT01047501|81571050|FG002|Overall Study|Death|0|||
27926939|NCT01047501|81571048|FG000|Overall Study|Other discontinuation|1|||
27926940|NCT01047501|81571049|FG001|Overall Study|Other discontinuation|0|||
27926941|NCT01047501|81571050|FG002|Overall Study|Other discontinuation|1|||
27926942|NCT01047501|81571048|FG000|Overall Study|Investigator judgement|0|||
27926943|NCT01047501|81571049|FG001|Overall Study|Investigator judgement|0|||
27926944|NCT01047501|81571050|FG002|Overall Study|Investigator judgement|1|||
27926945|NCT01405911|81571051|FG000|Overall Study|Pre-treatment lab AE|0|||
27926946|NCT01405911|81571052|FG001|Overall Study|Pre-treatment lab AE|1|||
27926947|NCT01405911|81571053|FG002|Overall Study|Pre-treatment lab AE|0|||
27926948|NCT01405911|81571051|FG000|Overall Study|Lost to Follow-up|0|||
27926949|NCT01405911|81571052|FG001|Overall Study|Lost to Follow-up|1|||
27926950|NCT01405911|81571053|FG002|Overall Study|Lost to Follow-up|0|||
27926951|NCT01405911|81571051|FG000|Overall Study|Protocol Violation|1|||
27926952|NCT01405911|81571052|FG001|Overall Study|Protocol Violation|0|||
27926953|NCT01405911|81571053|FG002|Overall Study|Protocol Violation|0|||
27926954|NCT01405911|81571051|FG000|Overall Study|Withdrawal by Subject|3|||
27926955|NCT01405911|81571052|FG001|Overall Study|Withdrawal by Subject|1|||
27926956|NCT01405911|81571053|FG002|Overall Study|Withdrawal by Subject|1|||
27926957|NCT02328105|81571054|FG000|Overall Study|Death|6|||
27546684|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
27546685|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
27546686|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
27546687|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
27546688|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
27546689|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
27546690|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
27546691|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
27546692|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
27546693|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
27926958|NCT02328105|81571054|FG000|Overall Study|Withdrawal by Subject|1|||
27926959|NCT02328105|81571054|FG000|Overall Study|Still On Study in Follow-Up|4|||
27926960|NCT02008370|81571055|FG000|Overall Study|Lost to Follow-up|7|||
27926961|NCT01991795|81571056|FG000|Overall Study|Lost to Follow-up|6|||
27926962|NCT01991795|81571057|FG001|Overall Study|Lost to Follow-up|4|||
27926963|NCT01991795|81571056|FG000|Overall Study|Withdrawal by Subject|117|||
27926964|NCT01991795|81571057|FG001|Overall Study|Withdrawal by Subject|94|||
27926965|NCT01991795|81571056|FG000|Overall Study|Site prematurely closed by sponsor|26|||
27926966|NCT01991795|81571057|FG001|Overall Study|Site prematurely closed by sponsor|25|||
27926967|NCT05399771|81571058|FG000|Overall Study|Physician Decision|3|||
27926968|NCT05399771|81571058|FG000|Overall Study|Adverse Event|1|||
27926969|NCT01750346|81571060|FG000|Overall Study|Adverse Event|1|||
27926970|NCT01750346|81571061|FG001|Overall Study|Adverse Event|0|||
27926971|NCT01750346|81571062|FG002|Overall Study|Adverse Event|0|||
27926972|NCT02916927|81571069|FG000|Overall Study|Discharged prior to study drug receipt|0|||
27926973|NCT02916927|81571070|FG001|Overall Study|Discharged prior to study drug receipt|2|||
27546694|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
27926974|NCT02916927|81571069|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
27926975|NCT02916927|81571070|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
27926976|NCT02916927|81571069|FG000|Overall Study|Withdrawal before first time point|1|||
27926977|NCT02916927|81571070|FG001|Overall Study|Withdrawal before first time point|0|||
27926978|NCT02278354|81571071|FG000|Overall Study|Lost to Follow-up|2|||
27926979|NCT02278354|81571072|FG001|Overall Study|Lost to Follow-up|2|||
27926980|NCT02278354|81571071|FG000|Overall Study|Withdrawal by Subject|0|||
27926981|NCT02278354|81571072|FG001|Overall Study|Withdrawal by Subject|1|||
27926982|NCT02278354|81571071|FG000|Overall Study|<10 professional fights|2|||
27926983|NCT02278354|81571072|FG001|Overall Study|<10 professional fights|0|||
27926984|NCT00147238|81571075|FG000|Overall Study|Inevaluable|8|||
27926985|NCT03261401|81571076|FG000|Overall Study|Withdrawal by Subject|0|||
27546695|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
27546696|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
27546697|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
27926986|NCT03261401|81571077|FG001|Overall Study|Withdrawal by Subject|0|||
27926987|NCT03261401|81571078|FG002|Overall Study|Withdrawal by Subject|0|||
27926988|NCT03261401|81571079|FG003|Overall Study|Withdrawal by Subject|0|||
27926989|NCT03261401|81571080|FG004|Overall Study|Withdrawal by Subject|0|||
27926990|NCT03261401|81571081|FG005|Overall Study|Withdrawal by Subject|1|||
27926991|NCT03261401|81571082|FG006|Overall Study|Withdrawal by Subject|0|||
27926992|NCT03261401|81571083|FG007|Overall Study|Withdrawal by Subject|0|||
27926993|NCT03261401|81571084|FG008|Overall Study|Withdrawal by Subject|0|||
27926994|NCT03261401|81571085|FG009|Overall Study|Withdrawal by Subject|0|||
27926995|NCT03261401|81571086|FG010|Overall Study|Withdrawal by Subject|0|||
27926996|NCT03261401|81571087|FG011|Overall Study|Withdrawal by Subject|0|||
27926997|NCT03261401|81571088|FG012|Overall Study|Withdrawal by Subject|0|||
27926998|NCT03261401|81571076|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
27926999|NCT03261401|81571077|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
27927000|NCT03261401|81571078|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
27927001|NCT03261401|81571079|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
27927002|NCT03261401|81571080|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
27927003|NCT03261401|81571081|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
27927004|NCT03261401|81571082|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
27927005|NCT03261401|81571083|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
27927006|NCT03261401|81571084|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
27927007|NCT03261401|81571085|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
27927008|NCT03261401|81571086|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
27927009|NCT03261401|81571087|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
27927010|NCT03261401|81571088|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
27927011|NCT00632359|81571089|FG000|Overall Study|Withdrawal by Subject|2|||
27927012|NCT02471183|81571091|FG000|Main Treatment Period|Adverse Event|1|||
27927013|NCT02471183|81571091|FG000|Main Treatment Period|Withdrawal by Subject|1|||
27927014|NCT02471183|81571091|FG000|Extended Treatment Period|Lack of Efficacy|1|||
27927015|NCT01039675|81571092|FG000|Overall Study|Adverse Event|0|||
27927016|NCT01039675|81571093|FG001|Overall Study|Adverse Event|2|||
27927017|NCT01039675|81571092|FG000|Overall Study|Lack of Efficacy|0|||
27927018|NCT01039675|81571093|FG001|Overall Study|Lack of Efficacy|2|||
27927019|NCT01039675|81571092|FG000|Overall Study|Withdrawal by Subject|0|||
27927020|NCT01039675|81571093|FG001|Overall Study|Withdrawal by Subject|1|||
27927021|NCT01039675|81571092|FG000|Overall Study|Lost to Follow-up|0|||
27927022|NCT01039675|81571093|FG001|Overall Study|Lost to Follow-up|1|||
27927023|NCT01039675|81571092|FG000|Overall Study|Physician Decision|0|||
27927024|NCT01039675|81571093|FG001|Overall Study|Physician Decision|1|||
27927025|NCT02194465|81571101|FG000|Overall Study|Adverse Event|6|||
27927026|NCT02194465|81571102|FG001|Overall Study|Adverse Event|1|||
27927027|NCT02194465|81571103|FG002|Overall Study|Adverse Event|4|||
27927028|NCT02194465|81571104|FG003|Overall Study|Adverse Event|4|||
27927029|NCT02194465|81571105|FG004|Overall Study|Adverse Event|4|||
27927030|NCT02194465|81571106|FG005|Overall Study|Adverse Event|2|||
27927031|NCT02194465|81571107|FG006|Overall Study|Adverse Event|0|||
27927032|NCT02194465|81571101|FG000|Overall Study|Lost to Follow-up|0|||
27927033|NCT02194465|81571102|FG001|Overall Study|Lost to Follow-up|0|||
27927034|NCT02194465|81571103|FG002|Overall Study|Lost to Follow-up|0|||
27927035|NCT02194465|81571104|FG003|Overall Study|Lost to Follow-up|1|||
27927036|NCT02194465|81571105|FG004|Overall Study|Lost to Follow-up|0|||
27927037|NCT02194465|81571106|FG005|Overall Study|Lost to Follow-up|1|||
27927038|NCT02194465|81571107|FG006|Overall Study|Lost to Follow-up|0|||
27927039|NCT02194465|81571101|FG000|Overall Study|Physician Decision|1|||
27927040|NCT02194465|81571102|FG001|Overall Study|Physician Decision|0|||
27927041|NCT02194465|81571103|FG002|Overall Study|Physician Decision|0|||
27927042|NCT02194465|81571104|FG003|Overall Study|Physician Decision|0|||
27927043|NCT02194465|81571105|FG004|Overall Study|Physician Decision|0|||
27927044|NCT02194465|81571106|FG005|Overall Study|Physician Decision|0|||
27927045|NCT02194465|81571107|FG006|Overall Study|Physician Decision|0|||
27927046|NCT02194465|81571101|FG000|Overall Study|Protocol Violation|1|||
27927047|NCT02194465|81571102|FG001|Overall Study|Protocol Violation|1|||
27927048|NCT02194465|81571103|FG002|Overall Study|Protocol Violation|2|||
27927049|NCT02194465|81571104|FG003|Overall Study|Protocol Violation|1|||
27927050|NCT02194465|81571105|FG004|Overall Study|Protocol Violation|1|||
27927051|NCT02194465|81571106|FG005|Overall Study|Protocol Violation|0|||
27927052|NCT02194465|81571107|FG006|Overall Study|Protocol Violation|0|||
27927053|NCT02194465|81571101|FG000|Overall Study|Withdrawal by Subject|1|||
27927054|NCT02194465|81571102|FG001|Overall Study|Withdrawal by Subject|3|||
27927055|NCT02194465|81571103|FG002|Overall Study|Withdrawal by Subject|1|||
27927056|NCT02194465|81571104|FG003|Overall Study|Withdrawal by Subject|2|||
27546698|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
27546699|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
27546700|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
27927057|NCT02194465|81571105|FG004|Overall Study|Withdrawal by Subject|2|||
27927058|NCT02194465|81571106|FG005|Overall Study|Withdrawal by Subject|1|||
27927059|NCT02194465|81571107|FG006|Overall Study|Withdrawal by Subject|2|||
27927060|NCT02194465|81571101|FG000|Overall Study|Discontinued follow-up period|0|||
27927061|NCT02194465|81571102|FG001|Overall Study|Discontinued follow-up period|2|||
27927062|NCT02194465|81571103|FG002|Overall Study|Discontinued follow-up period|1|||
27927063|NCT02194465|81571104|FG003|Overall Study|Discontinued follow-up period|0|||
27927064|NCT02194465|81571105|FG004|Overall Study|Discontinued follow-up period|2|||
27927065|NCT02194465|81571106|FG005|Overall Study|Discontinued follow-up period|0|||
27927066|NCT02194465|81571107|FG006|Overall Study|Discontinued follow-up period|0|||
27927067|NCT00963235|81571108|FG000|Overall Study|Withdrawal by Subject|22|||
27927068|NCT00963235|81571108|FG000|Overall Study|Lost to Follow-up|14|||
27927069|NCT00963235|81571108|FG000|Overall Study|Failed to return|9|||
27927070|NCT00963235|81571108|FG000|Overall Study|Protocol Violation|7|||
27927071|NCT00963235|81571108|FG000|Overall Study|Adverse Event|5|||
27927072|NCT00963235|81571108|FG000|Overall Study|Physician Decision|2|||
27927073|NCT00963235|81571108|FG000|Overall Study|Other|1|||
27927074|NCT01006629|81571113|FG000|Overall Study|Adverse Event|1|||
27927075|NCT01006629|81571113|FG000|Overall Study|Parent refused to continue participation|1|||
27927076|NCT01006629|81571113|FG000|Overall Study|Parent unable to perform site visit|4|||
27927077|NCT01983930|81571114|FG000|Overall Study|Withdrawal by Subject|9|||
27927078|NCT01983930|81571115|FG001|Overall Study|Withdrawal by Subject|8|||
27927079|NCT01983930|81571114|FG000|Overall Study|Adverse Event|0|||
27546701|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
27927080|NCT01983930|81571115|FG001|Overall Study|Adverse Event|1|||
27927081|NCT00729586|81571120|FG000|Overall Study|Ineligible|0|||
27927082|NCT00729586|81571121|FG001|Overall Study|Ineligible|1|||
27927083|NCT00729586|81571120|FG000|Overall Study|never treated|1|||
27927084|NCT00729586|81571121|FG001|Overall Study|never treated|0|||
27927085|NCT02780388|81571124|FG000|Overall Study|Lost to Follow-up|0|||
27927086|NCT02780388|81571125|FG001|Overall Study|Lost to Follow-up|1|||
27927087|NCT02780388|81571126|FG002|Overall Study|Lost to Follow-up|0|||
27927088|NCT02780388|81571127|FG003|Overall Study|Lost to Follow-up|0|||
27927089|NCT02780388|81571128|FG004|Overall Study|Lost to Follow-up|0|||
27927090|NCT02780388|81571124|FG000|Overall Study|Withdrawal by Subject|1|||
27927091|NCT02780388|81571125|FG001|Overall Study|Withdrawal by Subject|1|||
27927092|NCT02780388|81571126|FG002|Overall Study|Withdrawal by Subject|0|||
27927093|NCT02780388|81571127|FG003|Overall Study|Withdrawal by Subject|0|||
27927094|NCT02780388|81571128|FG004|Overall Study|Withdrawal by Subject|0|||
27927095|NCT00587457|81571134|FG000|Overall Study|Adverse Event|1|||
27927096|NCT00587457|81571135|FG001|Overall Study|Adverse Event|2|||
27927097|NCT00587457|81571136|FG002|Overall Study|Adverse Event|1|||
27927098|NCT00587457|81571134|FG000|Overall Study|Disease progression|2|||
27927099|NCT00587457|81571135|FG001|Overall Study|Disease progression|0|||
27927100|NCT00587457|81571136|FG002|Overall Study|Disease progression|2|||
27927101|NCT00587457|81571134|FG000|Overall Study|Initiation of alternative therapy|0|||
27927102|NCT00587457|81571135|FG001|Overall Study|Initiation of alternative therapy|1|||
27927103|NCT00587457|81571136|FG002|Overall Study|Initiation of alternative therapy|0|||
27927104|NCT00587457|81571134|FG000|Overall Study|Undefined|0|||
27927105|NCT00587457|81571135|FG001|Overall Study|Undefined|0|||
27927106|NCT00587457|81571136|FG002|Overall Study|Undefined|1|||
27927107|NCT00587457|81571134|FG000|Overall Study|Development of neutralizing Abs|0|||
27927108|NCT00587457|81571135|FG001|Overall Study|Development of neutralizing Abs|0|||
27927109|NCT00587457|81571136|FG002|Overall Study|Development of neutralizing Abs|1|||
27927110|NCT00768053|81571137|FG000|Overall Study|Adverse Event|10|||
27927111|NCT00768053|81571137|FG000|Overall Study|Lost to Follow-up|1|||
27927112|NCT02181738|81571139|FG000|Overall Study|Participant Withdrew Consent|2|||
27927113|NCT02181738|81571140|FG001|Overall Study|Participant Withdrew Consent|1|||
27927114|NCT02181738|81571141|FG002|Overall Study|Participant Withdrew Consent|1|||
27927115|NCT02181738|81571142|FG003|Overall Study|Participant Withdrew Consent|1|||
27927116|NCT02181738|81571139|FG000|Overall Study|Lost to Follow-up|1|||
27927117|NCT02181738|81571140|FG001|Overall Study|Lost to Follow-up|2|||
27927118|NCT02181738|81571141|FG002|Overall Study|Lost to Follow-up|1|||
27927119|NCT02181738|81571142|FG003|Overall Study|Lost to Follow-up|1|||
27927120|NCT02181738|81571139|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
27927121|NCT02181738|81571140|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
27927122|NCT02181738|81571141|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
27927123|NCT02181738|81571142|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
27927124|NCT02181738|81571139|FG000|Overall Study|Poor/Non-Compliance|1|||
27927125|NCT02181738|81571140|FG001|Overall Study|Poor/Non-Compliance|0|||
27927126|NCT02181738|81571141|FG002|Overall Study|Poor/Non-Compliance|2|||
27927127|NCT02181738|81571142|FG003|Overall Study|Poor/Non-Compliance|1|||
27927128|NCT02181738|81571139|FG000|Overall Study|Disease Progression|28|||
27927129|NCT02181738|81571140|FG001|Overall Study|Disease Progression|35|||
27927130|NCT02181738|81571141|FG002|Overall Study|Disease Progression|40|||
27546702|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
27546703|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
27927131|NCT02181738|81571142|FG003|Overall Study|Disease Progression|0|||
27927132|NCT02181738|81571139|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
27927133|NCT02181738|81571140|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
27927134|NCT02181738|81571141|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
27927135|NCT02181738|81571142|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
27927136|NCT02181738|81571139|FG000|Overall Study|Study Drug Toxicity|6|||
27927137|NCT02181738|81571140|FG001|Overall Study|Study Drug Toxicity|11|||
27927138|NCT02181738|81571141|FG002|Overall Study|Study Drug Toxicity|8|||
27927139|NCT02181738|81571142|FG003|Overall Study|Study Drug Toxicity|1|||
27927140|NCT02181738|81571139|FG000|Overall Study|Other Reasons|14|||
27927141|NCT02181738|81571140|FG001|Overall Study|Other Reasons|16|||
27927142|NCT02181738|81571141|FG002|Overall Study|Other Reasons|28|||
27640096|NCT02204982|80525805|FG001|Overall Study|Patient ineligible-medical monitor|0|||
27640097|NCT02204982|80525804|FG000|Overall Study|Withdrawal by Subject|1|||
27640098|NCT02204982|80525805|FG001|Overall Study|Withdrawal by Subject|0|||
27640099|NCT02204982|80525804|FG000|Overall Study|Adverse Event|1|||
27927143|NCT02181738|81571142|FG003|Overall Study|Other Reasons|0|||
27927144|NCT02181738|81571139|FG000|Overall Study|Maximum Clinical Benefit|3|||
27640100|NCT02204982|80525805|FG001|Overall Study|Adverse Event|0|||
27640101|NCT02204982|80525804|FG000|Overall Study|Adverse Event and Investigator decision|1|||
27640102|NCT02204982|80525805|FG001|Overall Study|Adverse Event and Investigator decision|0|||
27927145|NCT02181738|81571140|FG001|Overall Study|Maximum Clinical Benefit|0|||
27927146|NCT02181738|81571141|FG002|Overall Study|Maximum Clinical Benefit|1|||
27927147|NCT02181738|81571142|FG003|Overall Study|Maximum Clinical Benefit|0|||
27927148|NCT02181738|81571139|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27927149|NCT02181738|81571140|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
27927150|NCT02181738|81571141|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
27927151|NCT02181738|81571142|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
27927152|NCT02724644|81571143|FG000|Overall Study|Adverse Event|7|||
27927153|NCT02724644|81571144|FG001|Overall Study|Adverse Event|1|||
27927154|NCT02724644|81571143|FG000|Overall Study|Lost to Follow-up|6|||
27927155|NCT02724644|81571144|FG001|Overall Study|Lost to Follow-up|2|||
27927156|NCT02724644|81571143|FG000|Overall Study|Withdrawal by Subject|7|||
27927157|NCT02724644|81571144|FG001|Overall Study|Withdrawal by Subject|1|||
27927158|NCT02724644|81571143|FG000|Overall Study|Administrative|1|||
27927159|NCT02724644|81571144|FG001|Overall Study|Administrative|0|||
27927160|NCT00958074|81571145|FG000|Overall Study|Withdrawal by Subject|0|||
27927161|NCT00958074|81571146|FG001|Overall Study|Withdrawal by Subject|1|||
27927162|NCT01562444|81571147|FG000|Overall Study|Did not meet entry criteria|2|||
27927163|NCT01562444|81571148|FG001|Overall Study|Did not meet entry criteria|0|||
27927164|NCT01562444|81571149|FG002|Overall Study|Did not meet entry criteria|3|||
27927165|NCT01562444|81571147|FG000|Overall Study|Did not comply with blood draw schedule|1|||
27546704|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
27546705|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
27546706|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
27546707|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
27546708|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
27546709|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
27546710|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
27546711|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
27546712|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
27546713|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
27546714|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
27546715|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Death|0|||
27546716|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Death|0|||
27546717|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Death|0|||
27546718|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Death|0|||
27927166|NCT01562444|81571148|FG001|Overall Study|Did not comply with blood draw schedule|0|||
27927167|NCT01562444|81571149|FG002|Overall Study|Did not comply with blood draw schedule|1|||
27927168|NCT01562444|81571147|FG000|Overall Study|Unavailable serological results|0|||
27927169|NCT01562444|81571148|FG001|Overall Study|Unavailable serological results|2|||
27927170|NCT01562444|81571149|FG002|Overall Study|Unavailable serological results|2|||
27927171|NCT01562444|81571147|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
27927172|NCT01562444|81571148|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
27546719|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Death|1|||
27640103|NCT02204982|80525804|FG000|Overall Study|Physician Decision|0|||
27640104|NCT02204982|80525805|FG001|Overall Study|Physician Decision|2|||
27640105|NCT02204982|80525804|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
27640106|NCT02204982|80525805|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
27640107|NCT02204982|80525804|FG000|Overall Study|Termination of Study bySponsor|0|||
27927173|NCT01562444|81571149|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
27546720|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Death|1|||
27640108|NCT02204982|80525805|FG001|Overall Study|Termination of Study bySponsor|1|||
27640109|NCT01188655|80525806|FG000|Overall Study|Lack of Efficacy|1|||
27640110|NCT01188655|80525806|FG000|Overall Study|Lost to Follow-up|1|||
27640111|NCT01188655|80525806|FG000|Overall Study|Other|11|||
27927174|NCT01562444|81571147|FG000|Overall Study|Protocol forbidden medication|1|||
27927175|NCT01562444|81571148|FG001|Overall Study|Protocol forbidden medication|0|||
27927176|NCT01562444|81571149|FG002|Overall Study|Protocol forbidden medication|0|||
27640112|NCT00031694|80525807|FG000|Overall Study|Adverse Event|12|||
27640113|NCT00031694|80525807|FG000|Overall Study|Death|2|||
27927177|NCT01137786|81571159|FG000|Overall Study|Lost to Follow-up|0|||
27640114|NCT00031694|80525807|FG000|Overall Study|Withdrawal by Subject|5|||
27640115|NCT00632749|80525811|FG000|Overall Study|Progressive disease|3|||
27640116|NCT00632749|80525812|FG001|Overall Study|Progressive disease|2|||
27927178|NCT01137786|81571160|FG001|Overall Study|Lost to Follow-up|2|||
27546721|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Death|3|||
27640117|NCT00632749|80525813|FG002|Overall Study|Progressive disease|2|||
27640118|NCT00632749|80525814|FG003|Overall Study|Progressive disease|2|||
27640119|NCT00632749|80525815|FG004|Overall Study|Progressive disease|4|||
27640120|NCT00632749|80525816|FG005|Overall Study|Progressive disease|4|||
27640121|NCT00632749|80525817|FG006|Overall Study|Progressive disease|3|||
27640122|NCT00632749|80525818|FG007|Overall Study|Progressive disease|2|||
27640123|NCT00632749|80525819|FG008|Overall Study|Progressive disease|3|||
27640124|NCT00632749|80525820|FG009|Overall Study|Progressive disease|2|||
27640125|NCT00632749|80525821|FG010|Overall Study|Progressive disease|4|||
27640126|NCT00632749|80525822|FG011|Overall Study|Progressive disease|3|||
27640127|NCT00632749|80525823|FG012|Overall Study|Progressive disease|2|||
27640128|NCT00632749|80525824|FG013|Overall Study|Progressive disease|4|||
27640129|NCT00632749|80525811|FG000|Overall Study|Other Adverse event|1|||
27640130|NCT00632749|80525812|FG001|Overall Study|Other Adverse event|1|||
27546722|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Death|1|||
27546723|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Death|1|||
27546724|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Death|5|||
27546725|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Death|2|||
27546726|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Death|2|||
27546727|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Other|0|||
27546728|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Other|0|||
27546729|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Other|0|||
27546730|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Other|0|||
27546731|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Other|10|||
27640131|NCT00632749|80525813|FG002|Overall Study|Other Adverse event|1|||
27640132|NCT00632749|80525814|FG003|Overall Study|Other Adverse event|1|||
27640133|NCT00632749|80525815|FG004|Overall Study|Other Adverse event|2|||
27640134|NCT00632749|80525816|FG005|Overall Study|Other Adverse event|4|||
27640135|NCT00632749|80525817|FG006|Overall Study|Other Adverse event|1|||
27640136|NCT00632749|80525818|FG007|Overall Study|Other Adverse event|2|||
27640137|NCT00632749|80525819|FG008|Overall Study|Other Adverse event|2|||
27640138|NCT00632749|80525820|FG009|Overall Study|Other Adverse event|0|||
27640139|NCT00632749|80525821|FG010|Overall Study|Other Adverse event|1|||
27640140|NCT00632749|80525822|FG011|Overall Study|Other Adverse event|0|||
27640141|NCT00632749|80525823|FG012|Overall Study|Other Adverse event|1|||
27546732|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Other|3|||
27546733|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Other|2|||
27546734|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Other|0|||
27546735|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Other|10|||
27546736|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Other|5|||
27546737|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Other|1|||
27546738|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Other|7|||
27546739|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546740|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546741|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546742|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546743|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
27546744|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546745|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546746|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546747|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546748|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546749|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546750|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
27546751|NCT02521870|80189744|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546752|NCT02521870|80189745|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546753|NCT02521870|80189746|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546754|NCT02521870|80189747|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546755|NCT02521870|80189748|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
27640142|NCT00632749|80525824|FG013|Overall Study|Other Adverse event|0|||
27640143|NCT00632749|80525811|FG000|Overall Study|Refuse to continue medication|0|||
27640144|NCT00632749|80525812|FG001|Overall Study|Refuse to continue medication|0|||
27640145|NCT00632749|80525813|FG002|Overall Study|Refuse to continue medication|0|||
27640146|NCT00632749|80525814|FG003|Overall Study|Refuse to continue medication|1|||
27640147|NCT00632749|80525815|FG004|Overall Study|Refuse to continue medication|0|||
27546756|NCT02521870|80189749|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546757|NCT02521870|80189750|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546758|NCT02521870|80189751|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546759|NCT02521870|80189752|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546760|NCT02521870|80189753|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546761|NCT02521870|80189754|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27640148|NCT00632749|80525816|FG005|Overall Study|Refuse to continue medication|0|||
27640149|NCT00632749|80525817|FG006|Overall Study|Refuse to continue medication|0|||
27640150|NCT00632749|80525818|FG007|Overall Study|Refuse to continue medication|0|||
27640151|NCT00632749|80525819|FG008|Overall Study|Refuse to continue medication|0|||
27640152|NCT00632749|80525820|FG009|Overall Study|Refuse to continue medication|1|||
27640153|NCT00632749|80525821|FG010|Overall Study|Refuse to continue medication|0|||
27640154|NCT00632749|80525822|FG011|Overall Study|Refuse to continue medication|0|||
27640155|NCT00632749|80525823|FG012|Overall Study|Refuse to continue medication|0|||
27640156|NCT00632749|80525824|FG013|Overall Study|Refuse to continue medication|0|||
27640157|NCT00632749|80525811|FG000|Overall Study|Reason other than those specified above|0|||
27640158|NCT00632749|80525812|FG001|Overall Study|Reason other than those specified above|2|||
27640159|NCT00632749|80525813|FG002|Overall Study|Reason other than those specified above|0|||
27640160|NCT00632749|80525814|FG003|Overall Study|Reason other than those specified above|0|||
27640161|NCT00632749|80525815|FG004|Overall Study|Reason other than those specified above|1|||
27640162|NCT00632749|80525816|FG005|Overall Study|Reason other than those specified above|0|||
27640163|NCT00632749|80525817|FG006|Overall Study|Reason other than those specified above|1|||
27640164|NCT00632749|80525818|FG007|Overall Study|Reason other than those specified above|0|||
27640165|NCT00632749|80525819|FG008|Overall Study|Reason other than those specified above|0|||
27640166|NCT00632749|80525820|FG009|Overall Study|Reason other than those specified above|0|||
27640167|NCT00632749|80525821|FG010|Overall Study|Reason other than those specified above|2|||
27640168|NCT00632749|80525822|FG011|Overall Study|Reason other than those specified above|1|||
27640169|NCT00632749|80525823|FG012|Overall Study|Reason other than those specified above|0|||
27640170|NCT00632749|80525824|FG013|Overall Study|Reason other than those specified above|2|||
27640171|NCT00495677|80525825|FG000|Stage 1 (25 Days)|Adverse Event|0|||
27640172|NCT00495677|80525826|FG001|Stage 1 (25 Days)|Adverse Event|0|||
27640173|NCT00495677|80525827|FG002|Stage 1 (25 Days)|Adverse Event|1|||
27640174|NCT00495677|80525828|FG003|Stage 1 (25 Days)|Adverse Event|0|||
27640175|NCT00495677|80525829|FG004|Stage 1 (25 Days)|Adverse Event|0|||
27640176|NCT00495677|80525830|FG005|Stage 1 (25 Days)|Adverse Event|0|||
27640177|NCT00495677|80525831|FG006|Stage 1 (25 Days)|Adverse Event|0|||
27640178|NCT01040689|80525832|FG000|Overall Study|Adverse Event|0|||
27640179|NCT01040689|80525833|FG001|Overall Study|Adverse Event|0|||
27640180|NCT01040689|80525834|FG002|Overall Study|Adverse Event|2|||
27640181|NCT01040689|80525835|FG003|Overall Study|Adverse Event|4|||
27640182|NCT01040689|80525832|FG000|Overall Study|Lack of Efficacy|0|||
27640183|NCT01040689|80525833|FG001|Overall Study|Lack of Efficacy|0|||
27640184|NCT01040689|80525834|FG002|Overall Study|Lack of Efficacy|1|||
27640185|NCT01040689|80525835|FG003|Overall Study|Lack of Efficacy|0|||
27640186|NCT01040689|80525832|FG000|Overall Study|Lost to Follow-up|1|||
27640187|NCT01040689|80525833|FG001|Overall Study|Lost to Follow-up|0|||
27640188|NCT01040689|80525834|FG002|Overall Study|Lost to Follow-up|0|||
27640189|NCT01040689|80525835|FG003|Overall Study|Lost to Follow-up|0|||
27927179|NCT01137786|81571159|FG000|Overall Study|Withdrawal by Subject|1|||
27927180|NCT01137786|81571160|FG001|Overall Study|Withdrawal by Subject|1|||
27546762|NCT02521870|80189755|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
27546763|NCT01081678|80189756|FG000|Overall Study|Ineligibility Determined|0|||
27546764|NCT01081678|80189757|FG001|Overall Study|Ineligibility Determined|0|||
27546765|NCT01081678|80189758|FG002|Overall Study|Ineligibility Determined|1|||
27546766|NCT01081678|80189759|FG003|Overall Study|Ineligibility Determined|1|||
27546767|NCT01081678|80189756|FG000|Overall Study|Noncompliance|3|||
27546768|NCT01081678|80189757|FG001|Overall Study|Noncompliance|4|||
27546769|NCT01081678|80189758|FG002|Overall Study|Noncompliance|5|||
27546770|NCT01081678|80189759|FG003|Overall Study|Noncompliance|2|||
27546771|NCT01081678|80189756|FG000|Overall Study|Adverse Event|2|||
27546772|NCT01081678|80189757|FG001|Overall Study|Adverse Event|1|||
27546773|NCT01081678|80189758|FG002|Overall Study|Adverse Event|2|||
27546774|NCT01081678|80189759|FG003|Overall Study|Adverse Event|2|||
27546775|NCT01081678|80189756|FG000|Overall Study|Withdrawal by Subject|15|||
27546776|NCT01081678|80189757|FG001|Overall Study|Withdrawal by Subject|7|||
27546777|NCT01081678|80189758|FG002|Overall Study|Withdrawal by Subject|17|||
27546778|NCT01081678|80189759|FG003|Overall Study|Withdrawal by Subject|14|||
27546779|NCT01081678|80189756|FG000|Overall Study|Administrative Decision|1|||
27546780|NCT01081678|80189757|FG001|Overall Study|Administrative Decision|0|||
27546781|NCT01081678|80189758|FG002|Overall Study|Administrative Decision|0|||
27546782|NCT01081678|80189759|FG003|Overall Study|Administrative Decision|1|||
27546783|NCT01081678|80189756|FG000|Overall Study|Lost to Follow-up|4|||
27546784|NCT01081678|80189757|FG001|Overall Study|Lost to Follow-up|1|||
27546785|NCT01081678|80189758|FG002|Overall Study|Lost to Follow-up|4|||
27546786|NCT01081678|80189759|FG003|Overall Study|Lost to Follow-up|3|||
27546787|NCT01081678|80189756|FG000|Overall Study|Death|2|||
27546788|NCT01081678|80189757|FG001|Overall Study|Death|2|||
27546789|NCT01081678|80189758|FG002|Overall Study|Death|2|||
27546790|NCT01081678|80189759|FG003|Overall Study|Death|6|||
27546791|NCT01081678|80189756|FG000|Overall Study|Other|0|||
27546792|NCT01081678|80189757|FG001|Overall Study|Other|1|||
27640190|NCT01040689|80525832|FG000|Overall Study|Withdrawal by Subject|2|||
27640191|NCT01040689|80525833|FG001|Overall Study|Withdrawal by Subject|1|||
27640192|NCT01040689|80525834|FG002|Overall Study|Withdrawal by Subject|1|||
27640193|NCT01040689|80525835|FG003|Overall Study|Withdrawal by Subject|0|||
27927181|NCT02065557|81571163|FG000|Induction Period|Withdrawal by Subject|2|||
27546793|NCT01081678|80189758|FG002|Overall Study|Other|0|||
27546794|NCT01081678|80189759|FG003|Overall Study|Other|0|||
27546795|NCT03486223|80189761|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
27546796|NCT03486223|80189762|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
27546797|NCT03060629|80189763|FG000|Overall Study|Death|4|||
27546798|NCT03060629|80189764|FG001|Overall Study|Death|5|||
27546799|NCT03060629|80189763|FG000|Overall Study|Withdrawal by Subject|50|||
27546800|NCT03060629|80189764|FG001|Overall Study|Withdrawal by Subject|35|||
27546801|NCT03060629|80189763|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
27546802|NCT03060629|80189764|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
27546803|NCT03060629|80189763|FG000|Overall Study|Participant Relocate|15|||
27546804|NCT03060629|80189764|FG001|Overall Study|Participant Relocate|15|||
27546805|NCT03060629|80189763|FG000|Overall Study|Unable to Contact Participant|34|||
27546806|NCT03060629|80189764|FG001|Overall Study|Unable to Contact Participant|23|||
27546807|NCT03060629|80189763|FG000|Overall Study|Investigator Decision|7|||
27546808|NCT03060629|80189764|FG001|Overall Study|Investigator Decision|7|||
27546809|NCT03060629|80189763|FG000|Overall Study|Study Terminated by Sponsor|1100|||
27546810|NCT03060629|80189764|FG001|Overall Study|Study Terminated by Sponsor|1123|||
27546811|NCT03060629|80189763|FG000|Overall Study|Other|4|||
27546812|NCT03060629|80189764|FG001|Overall Study|Other|4|||
27546813|NCT00288054|80189768|FG000|Overall Study|Protocol Violation|2|||
27546814|NCT00288054|80189768|FG000|Overall Study|Lack of Efficacy|16|||
27546815|NCT00288054|80189768|FG000|Overall Study|Adverse Event|3|||
27546816|NCT00288054|80189768|FG000|Overall Study|Withdrawal by Subject|1|||
27546817|NCT00288054|80189768|FG000|Overall Study|Not protocol specified|2|||
27546818|NCT02795832|80189769|FG000|Overall Study|Adverse Event|0|||
27546819|NCT02795832|80189770|FG001|Overall Study|Adverse Event|0|||
27546820|NCT02795832|80189771|FG002|Overall Study|Adverse Event|0|||
27546821|NCT02795832|80189772|FG003|Overall Study|Adverse Event|0|||
27546822|NCT02795832|80189773|FG004|Overall Study|Adverse Event|0|||
27546823|NCT02795832|80189774|FG005|Overall Study|Adverse Event|3|||
27546824|NCT01425281|80189783|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
27546825|NCT01425281|80189784|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
27546826|NCT01425281|80189783|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
27546827|NCT01425281|80189784|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
27546828|NCT01425281|80189783|FG000|At 180-day Clinical Follow-up|Death|0|||
27546829|NCT01425281|80189784|FG001|At 180-day Clinical Follow-up|Death|1|||
27546830|NCT01425281|80189783|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
27546831|NCT01425281|80189784|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
27546832|NCT01425281|80189783|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
27546833|NCT01425281|80189784|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
27546834|NCT01425281|80189783|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
27546835|NCT01425281|80189784|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
27546836|NCT01425281|80189783|FG000|At 2-year Clinical Follow-up|Death|2|||
27546837|NCT01425281|80189784|FG001|At 2-year Clinical Follow-up|Death|0|||
27546838|NCT01425281|80189783|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
27546839|NCT01425281|80189784|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
27546840|NCT01425281|80189783|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
27546841|NCT01425281|80189784|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
27546842|NCT01425281|80189783|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
27546843|NCT01425281|80189784|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
27546844|NCT01425281|80189783|FG000|At 3-year Clinical Follow-up|Death|2|||
27546845|NCT01425281|80189784|FG001|At 3-year Clinical Follow-up|Death|3|||
27546846|NCT01425281|80189783|FG000|At 4-year Clinical Follow-up|Death|7|||
27546847|NCT01425281|80189784|FG001|At 4-year Clinical Follow-up|Death|3|||
27546848|NCT01425281|80189783|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
27546849|NCT01425281|80189784|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
27546850|NCT01425281|80189783|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
27546851|NCT01425281|80189784|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
27546852|NCT01425281|80189783|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
27546853|NCT01425281|80189784|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
27546854|NCT01425281|80189783|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
27546855|NCT01425281|80189784|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
27546856|NCT01425281|80189783|FG000|At 5-year Clinical Follow-up|Death|2|||
27546857|NCT01425281|80189784|FG001|At 5-year Clinical Follow-up|Death|0|||
27742481|NCT00984659|80886925|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
27546858|NCT01425281|80189783|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
27546859|NCT01425281|80189784|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
27546860|NCT01425281|80189783|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
27546861|NCT01425281|80189784|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
27546862|NCT01425281|80189783|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
27546863|NCT01425281|80189784|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
27546864|NCT03311724|80189785|FG000|Overall Study|Physician Decision|0|||
27546865|NCT03311724|80189786|FG001|Overall Study|Physician Decision|0|||
27546866|NCT03311724|80189787|FG002|Overall Study|Physician Decision|0|||
27546867|NCT03311724|80189788|FG003|Overall Study|Physician Decision|1|||
27546868|NCT03311724|80189785|FG000|Overall Study|Protocol Violation|1|||
27927182|NCT02065557|81571164|FG001|Induction Period|Withdrawal by Subject|1|||
27927183|NCT02065557|81571165|FG002|Induction Period|Withdrawal by Subject|0|||
27927184|NCT02065557|81571166|FG003|Induction Period|Withdrawal by Subject|0|||
27927185|NCT02065557|81571167|FG004|Induction Period|Withdrawal by Subject|0|||
27927186|NCT02065557|81571168|FG005|Induction Period|Withdrawal by Subject|0|||
27546869|NCT03311724|80189786|FG001|Overall Study|Protocol Violation|0|||
27546870|NCT03311724|80189787|FG002|Overall Study|Protocol Violation|1|||
27546871|NCT03311724|80189788|FG003|Overall Study|Protocol Violation|0|||
27546872|NCT03311724|80189785|FG000|Overall Study|Withdrawal by Subject|1|||
27546873|NCT03311724|80189786|FG001|Overall Study|Withdrawal by Subject|1|||
27546874|NCT03311724|80189787|FG002|Overall Study|Withdrawal by Subject|0|||
27546875|NCT03311724|80189788|FG003|Overall Study|Withdrawal by Subject|0|||
27546876|NCT03311724|80189785|FG000|Overall Study|Lost to Follow-up|1|||
27546877|NCT03311724|80189786|FG001|Overall Study|Lost to Follow-up|0|||
27546878|NCT03311724|80189787|FG002|Overall Study|Lost to Follow-up|0|||
27546879|NCT03311724|80189788|FG003|Overall Study|Lost to Follow-up|0|||
27546880|NCT03311724|80189785|FG000|Overall Study|Sponsor Decision|0|||
27546881|NCT03311724|80189786|FG001|Overall Study|Sponsor Decision|0|||
27546882|NCT03311724|80189787|FG002|Overall Study|Sponsor Decision|1|||
27546883|NCT03311724|80189788|FG003|Overall Study|Sponsor Decision|0|||
27546884|NCT00621153|80189790|FG000|Overall Study|Safety Reason|8|||
27546885|NCT00621153|80189791|FG001|Overall Study|Safety Reason|7|||
27546886|NCT00621153|80189790|FG000|Overall Study|Adverse Event|3|||
27546887|NCT00621153|80189791|FG001|Overall Study|Adverse Event|2|||
27546888|NCT00621153|80189790|FG000|Overall Study|Lost to Follow-up|5|||
27546889|NCT00621153|80189791|FG001|Overall Study|Lost to Follow-up|1|||
27546890|NCT00621153|80189790|FG000|Overall Study|Withdrawal by Subject|4|||
27546891|NCT00621153|80189791|FG001|Overall Study|Withdrawal by Subject|5|||
27546892|NCT01862874|80189795|FG000|Overall Study|Randomized not treated|1|||
27546893|NCT01862874|80189796|FG001|Overall Study|Randomized not treated|0|||
27546894|NCT01862874|80189795|FG000|Overall Study|Adverse Event|0|||
27546895|NCT01862874|80189796|FG001|Overall Study|Adverse Event|3|||
27546896|NCT01862874|80189795|FG000|Overall Study|Lost to Follow-up|26|||
27546897|NCT01862874|80189796|FG001|Overall Study|Lost to Follow-up|29|||
27546898|NCT01862874|80189795|FG000|Overall Study|Physician Decision|5|||
27546899|NCT01862874|80189796|FG001|Overall Study|Physician Decision|3|||
27546900|NCT01862874|80189795|FG000|Overall Study|Withdrawn by parent/guardian|1|||
27546901|NCT01862874|80189796|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27546902|NCT01862874|80189795|FG000|Overall Study|Withdrawal by Subject|46|||
27546903|NCT01862874|80189796|FG001|Overall Study|Withdrawal by Subject|40|||
27546904|NCT01862874|80189795|FG000|Overall Study|Death|0|||
27546905|NCT01862874|80189796|FG001|Overall Study|Death|1|||
27546906|NCT01626391|80189800|FG000|Overall Study|Physician Decision|1|||
27546907|NCT01626391|80189801|FG001|Overall Study|Physician Decision|0|||
27546908|NCT01626391|80189800|FG000|Overall Study|Withdrawal by Subject|1|||
27640194|NCT01040689|80525832|FG000|Overall Study|Other reasons not listed above|0|||
27640195|NCT01040689|80525833|FG001|Overall Study|Other reasons not listed above|1|||
27640196|NCT01040689|80525834|FG002|Overall Study|Other reasons not listed above|0|||
27640197|NCT01040689|80525835|FG003|Overall Study|Other reasons not listed above|0|||
27640198|NCT00823472|80525840|FG000|Overall Study|Physician Decision|24|||
27927187|NCT02065557|81571163|FG000|Induction Period|Lack of Efficacy|2|||
27927188|NCT02065557|81571164|FG001|Induction Period|Lack of Efficacy|1|||
27927189|NCT02065557|81571165|FG002|Induction Period|Lack of Efficacy|1|||
27927190|NCT02065557|81571166|FG003|Induction Period|Lack of Efficacy|0|||
27546909|NCT01626391|80189801|FG001|Overall Study|Withdrawal by Subject|0|||
27546910|NCT02864498|80192970|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
27546911|NCT02864498|80192971|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
27546912|NCT02864498|80192972|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
27546913|NCT02864498|80192970|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
27546914|NCT02864498|80192971|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
27546915|NCT02864498|80192972|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
27546916|NCT02864498|80192970|FG000|Overall Study|Investigator Discretion|0|||
27546917|NCT02864498|80192971|FG001|Overall Study|Investigator Discretion|2|||
27640199|NCT00823472|80525841|FG001|Overall Study|Physician Decision|28|||
27640200|NCT01037985|80525845|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
27546918|NCT02864498|80192972|FG002|Overall Study|Investigator Discretion|1|||
27546919|NCT02864498|80192970|FG000|Overall Study|Lost to Follow-up|8|||
27927191|NCT02065557|81571167|FG004|Induction Period|Lack of Efficacy|0|||
27927192|NCT02065557|81571168|FG005|Induction Period|Lack of Efficacy|0|||
27546920|NCT02864498|80192971|FG001|Overall Study|Lost to Follow-up|6|||
27546921|NCT02864498|80192972|FG002|Overall Study|Lost to Follow-up|3|||
27546922|NCT02864498|80192970|FG000|Overall Study|Lack of Efficacy|5|||
27546923|NCT02864498|80192971|FG001|Overall Study|Lack of Efficacy|3|||
27546924|NCT02864498|80192972|FG002|Overall Study|Lack of Efficacy|3|||
27546925|NCT02864498|80192970|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
27546926|NCT02864498|80192971|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
27546927|NCT02864498|80192972|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
27546928|NCT02864498|80192970|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
27546929|NCT02864498|80192971|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
27546930|NCT02864498|80192972|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
27546931|NCT02864498|80192970|FG000|Overall Study|Subject moved out of the country.|0|||
27546932|NCT02864498|80192971|FG001|Overall Study|Subject moved out of the country.|0|||
27546933|NCT02864498|80192972|FG002|Overall Study|Subject moved out of the country.|1|||
27546934|NCT00224042|80192973|FG000|Overall Study|Adverse Event|2|||
27546935|NCT00224042|80192974|FG001|Overall Study|Adverse Event|1|||
27546936|NCT00224042|80192973|FG000|Overall Study|Protocol Violation|0|||
27546937|NCT00224042|80192974|FG001|Overall Study|Protocol Violation|1|||
27546938|NCT00224042|80192973|FG000|Overall Study|Physician Decision|0|||
27546939|NCT00224042|80192974|FG001|Overall Study|Physician Decision|1|||
27546940|NCT00224042|80192973|FG000|Overall Study|Did not meet lab incusion criteria|2|||
27546941|NCT00224042|80192974|FG001|Overall Study|Did not meet lab incusion criteria|3|||
27546942|NCT00224042|80192973|FG000|Overall Study|Other|2|||
27546943|NCT00224042|80192974|FG001|Overall Study|Other|0|||
27546944|NCT00506662|80192978|FG000|Overall Study|Adverse Event|0|||
27546945|NCT00506662|80192979|FG001|Overall Study|Adverse Event|2|||
27546946|NCT00506662|80192978|FG000|Overall Study|Lack of Efficacy|1|||
27546947|NCT00506662|80192979|FG001|Overall Study|Lack of Efficacy|0|||
27546948|NCT00506662|80192978|FG000|Overall Study|Protocol Violation|2|||
27546949|NCT00506662|80192979|FG001|Overall Study|Protocol Violation|4|||
27546950|NCT00506662|80192978|FG000|Overall Study|Trial terminated|10|||
27546951|NCT00506662|80192979|FG001|Overall Study|Trial terminated|16|||
27546952|NCT00506662|80192978|FG000|Overall Study|Not recorded|4|||
27546953|NCT00506662|80192979|FG001|Overall Study|Not recorded|6|||
27546954|NCT02321800|80192980|FG000|Overall Study|Withdrawal by Subject|3|||
27546955|NCT02321800|80192981|FG001|Overall Study|Withdrawal by Subject|3|||
27546956|NCT02321800|80192980|FG000|Overall Study|Death|1|||
27546957|NCT02321800|80192981|FG001|Overall Study|Death|0|||
27546958|NCT02321800|80192980|FG000|Overall Study|Protocol Violation|1|||
27546959|NCT02321800|80192981|FG001|Overall Study|Protocol Violation|0|||
27546960|NCT02321800|80192980|FG000|Overall Study|Lost to Follow-up|10|||
27546961|NCT02321800|80192981|FG001|Overall Study|Lost to Follow-up|4|||
27546962|NCT02321800|80192980|FG000|Overall Study|Adverse Event|2|||
27546963|NCT02321800|80192981|FG001|Overall Study|Adverse Event|3|||
27546964|NCT02321800|80192980|FG000|Overall Study|Other, Miscellaneous|3|||
27546965|NCT02321800|80192981|FG001|Overall Study|Other, Miscellaneous|1|||
27546966|NCT01594281|80192982|FG000|Interventional Core Phase|Protocol Deviation|1|||
27546967|NCT01594281|80192983|FG001|Interventional Core Phase|Protocol Deviation|0|||
27546968|NCT01594281|80192984|FG002|Interventional Core Phase|Protocol Deviation|0|||
27546969|NCT01594281|80192982|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
27546970|NCT01594281|80192983|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
27546971|NCT01594281|80192984|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
27546972|NCT01594281|80192982|FG000|Interventional Core Phase|Death|1|||
27546973|NCT01594281|80192983|FG001|Interventional Core Phase|Death|1|||
27546974|NCT01594281|80192984|FG002|Interventional Core Phase|Death|2|||
27927193|NCT02065557|81571163|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
27927194|NCT02065557|81571164|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
27927195|NCT02065557|81571165|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
27927196|NCT02065557|81571166|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
27546975|NCT01594281|80192982|FG000|Interventional Core Phase|Lost to Follow-up|1|||
27546976|NCT01594281|80192983|FG001|Interventional Core Phase|Lost to Follow-up|4|||
27546977|NCT01594281|80192984|FG002|Interventional Core Phase|Lost to Follow-up|1|||
27546978|NCT01594281|80192982|FG000|Interventional Core Phase|Adverse Event|4|||
27546979|NCT01594281|80192983|FG001|Interventional Core Phase|Adverse Event|4|||
27546980|NCT01594281|80192984|FG002|Interventional Core Phase|Adverse Event|4|||
27546981|NCT01594281|80192982|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
27546982|NCT01594281|80192983|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
27546983|NCT01594281|80192984|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
27546984|NCT01594281|80192982|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
27546985|NCT01594281|80192983|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
27546986|NCT01594281|80192984|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
27546987|NCT01594281|80192982|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
27546988|NCT01594281|80192983|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
27546989|NCT01594281|80192984|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
27546990|NCT02615145|80192985|FG000|Overall Study|Did Not Start Treatment|0|||
27927197|NCT02065557|81571167|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
27927198|NCT02065557|81571168|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
27927199|NCT02065557|81571163|FG000|Induction Period|Non-Responder at Week 8|4|||
27927200|NCT02065557|81571164|FG001|Induction Period|Non-Responder at Week 8|4|||
27927201|NCT02065557|81571165|FG002|Induction Period|Non-Responder at Week 8|0|||
27927202|NCT02065557|81571166|FG003|Induction Period|Non-Responder at Week 8|0|||
27927203|NCT02065557|81571167|FG004|Induction Period|Non-Responder at Week 8|0|||
27927204|NCT02065557|81571168|FG005|Induction Period|Non-Responder at Week 8|0|||
27927205|NCT02065557|81571163|FG000|Induction Period|Adverse Event|1|||
27927206|NCT02065557|81571164|FG001|Induction Period|Adverse Event|1|||
27927207|NCT02065557|81571165|FG002|Induction Period|Adverse Event|0|||
27927208|NCT02065557|81571166|FG003|Induction Period|Adverse Event|0|||
27927209|NCT02065557|81571167|FG004|Induction Period|Adverse Event|0|||
27927210|NCT02065557|81571168|FG005|Induction Period|Adverse Event|0|||
27927211|NCT02065557|81571163|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27927212|NCT02065557|81571164|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27927213|NCT02065557|81571165|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27927214|NCT02065557|81571166|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
27927215|NCT02065557|81571167|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
27927216|NCT02065557|81571168|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
27927217|NCT02065557|81571163|FG000|Maintenance Period|Withdrawal by Subject|0|||
27927218|NCT02065557|81571164|FG001|Maintenance Period|Withdrawal by Subject|0|||
27927219|NCT02065557|81571165|FG002|Maintenance Period|Withdrawal by Subject|0|||
27546991|NCT02615145|80192986|FG001|Overall Study|Did Not Start Treatment|0|||
27546992|NCT02615145|80192987|FG002|Overall Study|Did Not Start Treatment|1|||
27546993|NCT02615145|80192988|FG003|Overall Study|Did Not Start Treatment|1|||
27927220|NCT02065557|81571166|FG003|Maintenance Period|Withdrawal by Subject|0|||
27927221|NCT02065557|81571167|FG004|Maintenance Period|Withdrawal by Subject|2|||
27927222|NCT02065557|81571168|FG005|Maintenance Period|Withdrawal by Subject|1|||
27927223|NCT02065557|81571163|FG000|Maintenance Period|Lack of Efficacy|0|||
27927224|NCT02065557|81571164|FG001|Maintenance Period|Lack of Efficacy|0|||
27927225|NCT02065557|81571165|FG002|Maintenance Period|Lack of Efficacy|0|||
27927226|NCT02065557|81571166|FG003|Maintenance Period|Lack of Efficacy|0|||
27927227|NCT02065557|81571167|FG004|Maintenance Period|Lack of Efficacy|5|||
27927228|NCT02065557|81571168|FG005|Maintenance Period|Lack of Efficacy|2|||
27927229|NCT02065557|81571163|FG000|Maintenance Period|Subject Non-Compliance|0|||
27927230|NCT02065557|81571164|FG001|Maintenance Period|Subject Non-Compliance|0|||
27927231|NCT02065557|81571165|FG002|Maintenance Period|Subject Non-Compliance|0|||
27927232|NCT02065557|81571166|FG003|Maintenance Period|Subject Non-Compliance|0|||
27927233|NCT02065557|81571167|FG004|Maintenance Period|Subject Non-Compliance|0|||
27927234|NCT02065557|81571168|FG005|Maintenance Period|Subject Non-Compliance|1|||
27927235|NCT02309359|81571169|FG000|Overall Study|Adverse Event|4|||
27927236|NCT02309359|81571170|FG001|Overall Study|Adverse Event|5|||
27927237|NCT02309359|81571171|FG002|Overall Study|Adverse Event|5|||
27927238|NCT02309359|81571172|FG003|Overall Study|Adverse Event|4|||
27927239|NCT02309359|81571173|FG004|Overall Study|Adverse Event|4|||
27927240|NCT02309359|81571169|FG000|Overall Study|Death|1|||
27927241|NCT02309359|81571170|FG001|Overall Study|Death|0|||
27927242|NCT02309359|81571171|FG002|Overall Study|Death|0|||
27927243|NCT02309359|81571172|FG003|Overall Study|Death|0|||
27927244|NCT02309359|81571173|FG004|Overall Study|Death|0|||
27927245|NCT02309359|81571169|FG000|Overall Study|Withdrawal by Subject|2|||
27927246|NCT02309359|81571170|FG001|Overall Study|Withdrawal by Subject|2|||
27927247|NCT02309359|81571171|FG002|Overall Study|Withdrawal by Subject|4|||
27927248|NCT02309359|81571172|FG003|Overall Study|Withdrawal by Subject|4|||
27927249|NCT02309359|81571173|FG004|Overall Study|Withdrawal by Subject|0|||
27927250|NCT02309359|81571169|FG000|Overall Study|Lack of Efficacy|3|||
27927251|NCT02309359|81571170|FG001|Overall Study|Lack of Efficacy|1|||
27927252|NCT02309359|81571171|FG002|Overall Study|Lack of Efficacy|0|||
27927253|NCT02309359|81571172|FG003|Overall Study|Lack of Efficacy|0|||
27546994|NCT02615145|80192985|FG000|Overall Study|Failure to Return|20|||
27927254|NCT02309359|81571173|FG004|Overall Study|Lack of Efficacy|3|||
27927255|NCT02309359|81571169|FG000|Overall Study|Lost to Follow-up|0|||
27927256|NCT02309359|81571170|FG001|Overall Study|Lost to Follow-up|0|||
27927257|NCT02309359|81571171|FG002|Overall Study|Lost to Follow-up|0|||
27927258|NCT02309359|81571172|FG003|Overall Study|Lost to Follow-up|1|||
27927259|NCT02309359|81571173|FG004|Overall Study|Lost to Follow-up|0|||
27927260|NCT02309359|81571169|FG000|Overall Study|Other|2|||
27927261|NCT02309359|81571170|FG001|Overall Study|Other|0|||
27927262|NCT02309359|81571171|FG002|Overall Study|Other|2|||
27927263|NCT02309359|81571172|FG003|Overall Study|Other|3|||
27927264|NCT02309359|81571173|FG004|Overall Study|Other|2|||
27927265|NCT02949934|81571174|FG000|Natural Drinking Period|Adverse Event|1|||
27927266|NCT02949934|81571175|FG001|Natural Drinking Period|Adverse Event|0|||
27927267|NCT02949934|81571176|FG002|Natural Drinking Period|Adverse Event|0|||
27927268|NCT02949934|81571177|FG003|Natural Drinking Period|Adverse Event|1|||
27927269|NCT02949934|81571178|FG004|Natural Drinking Period|Adverse Event|0|||
27546995|NCT02615145|80192986|FG001|Overall Study|Failure to Return|10|||
27546996|NCT02615145|80192987|FG002|Overall Study|Failure to Return|7|||
27546997|NCT02615145|80192988|FG003|Overall Study|Failure to Return|0|||
27546998|NCT02615145|80192985|FG000|Overall Study|Death|2|||
27546999|NCT02615145|80192986|FG001|Overall Study|Death|3|||
27547000|NCT02615145|80192987|FG002|Overall Study|Death|0|||
27547001|NCT02615145|80192988|FG003|Overall Study|Death|0|||
27547002|NCT02615145|80192985|FG000|Overall Study|Other, Not Specified|5|||
27547003|NCT02615145|80192986|FG001|Overall Study|Other, Not Specified|2|||
27547004|NCT02615145|80192987|FG002|Overall Study|Other, Not Specified|0|||
27547005|NCT02615145|80192988|FG003|Overall Study|Other, Not Specified|0|||
27547006|NCT03736447|80192993|FG000|Overall Study|Adverse Event|5|||
27547007|NCT03736447|80192994|FG001|Overall Study|Adverse Event|1|||
27547008|NCT03736447|80192993|FG000|Overall Study|Withdrawal by Subject|5|||
27547009|NCT03736447|80192994|FG001|Overall Study|Withdrawal by Subject|1|||
27547010|NCT03736447|80192993|FG000|Overall Study|Lost to Follow-up|1|||
27547011|NCT03736447|80192994|FG001|Overall Study|Lost to Follow-up|0|||
27547012|NCT03736447|80192993|FG000|Overall Study|Physician Decision|1|||
27547013|NCT03736447|80192994|FG001|Overall Study|Physician Decision|0|||
27547014|NCT03736447|80192993|FG000|Overall Study|Continued commitment to study treatment|3|||
27547015|NCT03736447|80192994|FG001|Overall Study|Continued commitment to study treatment|0|||
27547016|NCT03736447|80192993|FG000|Overall Study|Taste aversion to study product|0|||
27547017|NCT03736447|80192994|FG001|Overall Study|Taste aversion to study product|1|||
27547018|NCT01243892|80192995|FG000|Overall Study|Did not meet eligibility criteria|2|||
27547019|NCT01243892|80192996|FG001|Overall Study|Did not meet eligibility criteria|0|||
27547020|NCT01785069|80192999|FG000|Overall Study|Implanted with nonstudy device|1|||
27927270|NCT02949934|81571179|FG005|Natural Drinking Period|Adverse Event|0|||
27927271|NCT02949934|81571174|FG000|Natural Drinking Period|Lost to Follow-up|0|||
27927272|NCT02949934|81571175|FG001|Natural Drinking Period|Lost to Follow-up|0|||
27927273|NCT02949934|81571176|FG002|Natural Drinking Period|Lost to Follow-up|0|||
27927274|NCT02949934|81571177|FG003|Natural Drinking Period|Lost to Follow-up|0|||
27927275|NCT02949934|81571178|FG004|Natural Drinking Period|Lost to Follow-up|1|||
27927276|NCT02949934|81571179|FG005|Natural Drinking Period|Lost to Follow-up|0|||
27547021|NCT01785069|80193000|FG001|Overall Study|Implanted with nonstudy device|2|||
27640201|NCT01037985|80525846|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
27640202|NCT01037985|80525845|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
27640203|NCT01037985|80525846|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
27640204|NCT01037985|80525845|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
27640205|NCT01037985|80525846|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
27640206|NCT01037985|80525845|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
27640207|NCT01037985|80525846|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
27640208|NCT01953692|80525849|FG000|Overall Study|Adverse Event|5|||
27640209|NCT01953692|80525850|FG001|Overall Study|Adverse Event|2|||
27640210|NCT01953692|80525851|FG002|Overall Study|Adverse Event|4|||
27640211|NCT01953692|80525852|FG003|Overall Study|Adverse Event|2|||
27640212|NCT01953692|80525853|FG004|Overall Study|Adverse Event|1|||
27640213|NCT01953692|80525854|FG005|Overall Study|Adverse Event|2|||
27640214|NCT01953692|80525855|FG006|Overall Study|Adverse Event|0|||
27640215|NCT01953692|80525856|FG007|Overall Study|Adverse Event|0|||
27640216|NCT01953692|80525857|FG008|Overall Study|Adverse Event|0|||
27640217|NCT01953692|80525849|FG000|Overall Study|Clinical Progression|0|||
27640218|NCT01953692|80525850|FG001|Overall Study|Clinical Progression|15|||
27640219|NCT01953692|80525851|FG002|Overall Study|Clinical Progression|7|||
27640220|NCT01953692|80525852|FG003|Overall Study|Clinical Progression|5|||
27742482|NCT00984659|80886926|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
27742483|NCT00984659|80886927|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
27742484|NCT00984659|80886924|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
27742485|NCT00984659|80886925|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
27742486|NCT00984659|80886926|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
27927277|NCT02949934|81571174|FG000|Neuroimaging|Protocol Violation|2|||
27927278|NCT02949934|81571175|FG001|Neuroimaging|Protocol Violation|0|||
27927279|NCT02949934|81571176|FG002|Neuroimaging|Protocol Violation|0|||
27547022|NCT01785069|80193001|FG002|Overall Study|Implanted with nonstudy device|1|||
27547023|NCT01785069|80193002|FG003|Overall Study|Implanted with nonstudy device|0|||
27547024|NCT01785069|80192999|FG000|Overall Study|Death|0|||
27547025|NCT01785069|80193000|FG001|Overall Study|Death|0|||
27547026|NCT01785069|80193001|FG002|Overall Study|Death|2|||
27640221|NCT01953692|80525853|FG004|Overall Study|Clinical Progression|0|||
27640222|NCT01953692|80525854|FG005|Overall Study|Clinical Progression|7|||
27640223|NCT01953692|80525855|FG006|Overall Study|Clinical Progression|20|||
27547027|NCT01785069|80193002|FG003|Overall Study|Death|0|||
27547028|NCT01785069|80192999|FG000|Overall Study|Subject choice|2|||
27547029|NCT01785069|80193000|FG001|Overall Study|Subject choice|2|||
27547030|NCT01785069|80193001|FG002|Overall Study|Subject choice|0|||
27547031|NCT01785069|80193002|FG003|Overall Study|Subject choice|1|||
27927280|NCT02949934|81571177|FG003|Neuroimaging|Protocol Violation|0|||
27927281|NCT02949934|81571178|FG004|Neuroimaging|Protocol Violation|1|||
27927282|NCT02949934|81571179|FG005|Neuroimaging|Protocol Violation|0|||
27640224|NCT01953692|80525856|FG007|Overall Study|Clinical Progression|3|||
27640225|NCT01953692|80525857|FG008|Overall Study|Clinical Progression|3|||
27640226|NCT01953692|80525849|FG000|Overall Study|Death|5|||
27640227|NCT01953692|80525850|FG001|Overall Study|Death|0|||
27640228|NCT01953692|80525851|FG002|Overall Study|Death|2|||
27640229|NCT01953692|80525852|FG003|Overall Study|Death|2|||
27640230|NCT01953692|80525853|FG004|Overall Study|Death|1|||
27640231|NCT01953692|80525854|FG005|Overall Study|Death|3|||
27927283|NCT02949934|81571174|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
27927284|NCT02949934|81571175|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
27927285|NCT02949934|81571176|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
27927286|NCT02949934|81571177|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
27927287|NCT02949934|81571178|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
27927288|NCT02949934|81571179|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
27927289|NCT02949934|81571174|FG000|Neuroimaging|Not scanned|0|||
27927290|NCT02949934|81571175|FG001|Neuroimaging|Not scanned|0|||
27927291|NCT02949934|81571176|FG002|Neuroimaging|Not scanned|1|||
27927292|NCT02949934|81571177|FG003|Neuroimaging|Not scanned|0|||
27927293|NCT02949934|81571178|FG004|Neuroimaging|Not scanned|0|||
27927294|NCT02949934|81571179|FG005|Neuroimaging|Not scanned|2|||
27927295|NCT02949934|81571174|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
27927296|NCT02949934|81571175|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
27927297|NCT02949934|81571176|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
27927298|NCT02949934|81571177|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
27927299|NCT02949934|81571178|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
27927300|NCT02949934|81571179|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
27927301|NCT02949934|81571174|FG000|Bar Laboratory|Adverse Event|1|||
27927302|NCT02949934|81571175|FG001|Bar Laboratory|Adverse Event|0|||
27927303|NCT02949934|81571176|FG002|Bar Laboratory|Adverse Event|2|||
27547032|NCT01785069|80192999|FG000|Overall Study|Lost to Follow-up|1|||
27547033|NCT01785069|80193000|FG001|Overall Study|Lost to Follow-up|2|||
27547034|NCT01785069|80193001|FG002|Overall Study|Lost to Follow-up|4|||
27547035|NCT01785069|80193002|FG003|Overall Study|Lost to Follow-up|1|||
27547036|NCT01785069|80192999|FG000|Overall Study|Reason not Specified|1|||
27547037|NCT01785069|80193000|FG001|Overall Study|Reason not Specified|2|||
27547038|NCT01785069|80193001|FG002|Overall Study|Reason not Specified|1|||
27547039|NCT01785069|80193002|FG003|Overall Study|Reason not Specified|4|||
27547040|NCT01785069|80192999|FG000|Overall Study|Not evaluable|7|||
27547041|NCT01785069|80193000|FG001|Overall Study|Not evaluable|4|||
27547042|NCT01785069|80193001|FG002|Overall Study|Not evaluable|5|||
27547043|NCT01785069|80193002|FG003|Overall Study|Not evaluable|8|||
27547044|NCT00289991|80193003|FG000|Overall Study|Death|35|||
27640232|NCT01953692|80525855|FG006|Overall Study|Death|6|||
27640233|NCT01953692|80525856|FG007|Overall Study|Death|2|||
27640234|NCT01953692|80525857|FG008|Overall Study|Death|1|||
27640235|NCT01953692|80525849|FG000|Overall Study|Excluded Medication|1|||
27640236|NCT01953692|80525850|FG001|Overall Study|Excluded Medication|0|||
27640237|NCT01953692|80525851|FG002|Overall Study|Excluded Medication|0|||
27640238|NCT01953692|80525852|FG003|Overall Study|Excluded Medication|0|||
27640239|NCT01953692|80525853|FG004|Overall Study|Excluded Medication|0|||
27640240|NCT01953692|80525854|FG005|Overall Study|Excluded Medication|0|||
27640241|NCT01953692|80525855|FG006|Overall Study|Excluded Medication|0|||
27640242|NCT01953692|80525856|FG007|Overall Study|Excluded Medication|0|||
27927304|NCT02949934|81571177|FG003|Bar Laboratory|Adverse Event|0|||
27927305|NCT02949934|81571178|FG004|Bar Laboratory|Adverse Event|1|||
27547045|NCT00289991|80193004|FG001|Overall Study|Death|38|||
27547046|NCT00289991|80193003|FG000|Overall Study|Adverse Event|15|||
27547047|NCT00289991|80193004|FG001|Overall Study|Adverse Event|13|||
27547048|NCT00289991|80193003|FG000|Overall Study|Failure of prophylaxis|1|||
27927306|NCT02949934|81571179|FG005|Bar Laboratory|Adverse Event|0|||
27927307|NCT02949934|81571174|FG000|Bar Laboratory|Protocol Violation|0|||
27927308|NCT02949934|81571175|FG001|Bar Laboratory|Protocol Violation|0|||
27927309|NCT02949934|81571176|FG002|Bar Laboratory|Protocol Violation|0|||
27547049|NCT00289991|80193004|FG001|Overall Study|Failure of prophylaxis|1|||
27640243|NCT01953692|80525857|FG008|Overall Study|Excluded Medication|0|||
27640244|NCT01953692|80525849|FG000|Overall Study|Lost to Follow-up|1|||
27640245|NCT01953692|80525850|FG001|Overall Study|Lost to Follow-up|0|||
27640246|NCT01953692|80525851|FG002|Overall Study|Lost to Follow-up|3|||
27640247|NCT01953692|80525852|FG003|Overall Study|Lost to Follow-up|1|||
27640248|NCT01953692|80525853|FG004|Overall Study|Lost to Follow-up|0|||
27927310|NCT02949934|81571177|FG003|Bar Laboratory|Protocol Violation|1|||
27547050|NCT00289991|80193003|FG000|Overall Study|Fungal breakthrough infection|0|||
27547051|NCT00289991|80193004|FG001|Overall Study|Fungal breakthrough infection|1|||
27547052|NCT00289991|80193003|FG000|Overall Study|Lost to Follow-up|0|||
27547053|NCT00289991|80193004|FG001|Overall Study|Lost to Follow-up|1|||
27547054|NCT00289991|80193003|FG000|Overall Study|Withdrawal by Subject|2|||
27547055|NCT00289991|80193004|FG001|Overall Study|Withdrawal by Subject|12|||
27547056|NCT00289991|80193003|FG000|Overall Study|Other|5|||
27547057|NCT00289991|80193004|FG001|Overall Study|Other|14|||
27547058|NCT00370032|80193006|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
27547059|NCT00370032|80193007|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
27547060|NCT00370032|80193006|FG000|Washout Period|Withdrawal by Subject|0|||
27927311|NCT02949934|81571178|FG004|Bar Laboratory|Protocol Violation|0|||
27547061|NCT00370032|80193007|FG001|Washout Period|Withdrawal by Subject|1|||
27547062|NCT00370032|80193006|FG000|Washout Period|Lost to Follow-up|0|||
27547063|NCT00370032|80193007|FG001|Washout Period|Lost to Follow-up|1|||
27547064|NCT00370032|80193006|FG000|Washout Period|Adverse Event|1|||
27547065|NCT00370032|80193007|FG001|Washout Period|Adverse Event|0|||
27547066|NCT00370032|80193006|FG000|Follow-up Period|Withdrawal by Subject|1|||
27547067|NCT00370032|80193007|FG001|Follow-up Period|Withdrawal by Subject|0|||
27547068|NCT00680017|80193008|FG000|Overall Study|Adverse Event|13|||
27547069|NCT00680017|80193009|FG001|Overall Study|Adverse Event|7|||
27547070|NCT00680017|80193008|FG000|Overall Study|Withdrawal by Subject|2|||
27547071|NCT00680017|80193009|FG001|Overall Study|Withdrawal by Subject|5|||
27547072|NCT00680017|80193008|FG000|Overall Study|Lost to Follow-up|2|||
27547073|NCT00680017|80193009|FG001|Overall Study|Lost to Follow-up|0|||
27547074|NCT05228132|80193010|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
27547075|NCT05228132|80193010|FG000|Overall Study|Adverse Event|3|||
27547076|NCT05228132|80193010|FG000|Overall Study|Lost to Follow-up|1|||
27547077|NCT05228132|80193010|FG000|Overall Study|Arteriovenous-fistula mature|1|||
27547078|NCT02944968|80193012|FG000|Overall Study|Subject excluded before study procedure|1|||
27547079|NCT02944968|80193012|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
27547080|NCT01056653|80193018|FG000|Overall Study|Lost to Follow-up|0|||
27547081|NCT01056653|80193019|FG001|Overall Study|Lost to Follow-up|0|||
27927312|NCT02949934|81571179|FG005|Bar Laboratory|Protocol Violation|0|||
27927313|NCT01303419|81571182|FG000|Overall Study|Discontinuation of study|60|||
27927314|NCT01303419|81571182|FG000|Overall Study|Did not complete both imaging methods|5|||
27927315|NCT01303419|81571182|FG000|Overall Study|Did not meet all I/E after screening|31|||
27927316|NCT00580840|81571183|FG000|Run-in|Adverse Event|17|||
27927317|NCT00580840|81571184|FG001|Run-in|Adverse Event|0|||
27927318|NCT00580840|81571185|FG002|Run-in|Adverse Event|0|||
27927319|NCT00580840|81571186|FG003|Run-in|Adverse Event|0|||
27927320|NCT00580840|81571183|FG000|Run-in|Lack of Efficacy|93|||
27927321|NCT00580840|81571184|FG001|Run-in|Lack of Efficacy|0|||
27927322|NCT00580840|81571185|FG002|Run-in|Lack of Efficacy|0|||
27927323|NCT00580840|81571186|FG003|Run-in|Lack of Efficacy|0|||
27927324|NCT00580840|81571183|FG000|Run-in|Loss of Efficacy|1|||
27927325|NCT00580840|81571184|FG001|Run-in|Loss of Efficacy|0|||
27927326|NCT00580840|81571185|FG002|Run-in|Loss of Efficacy|0|||
27927327|NCT00580840|81571186|FG003|Run-in|Loss of Efficacy|0|||
27927328|NCT00580840|81571183|FG000|Run-in|Lost to Follow-up|4|||
27927329|NCT00580840|81571184|FG001|Run-in|Lost to Follow-up|0|||
27927330|NCT00580840|81571185|FG002|Run-in|Lost to Follow-up|0|||
27927331|NCT00580840|81571186|FG003|Run-in|Lost to Follow-up|0|||
27927332|NCT00580840|81571183|FG000|Run-in|Withdrawal by Subject|5|||
27927333|NCT00580840|81571184|FG001|Run-in|Withdrawal by Subject|0|||
27927334|NCT00580840|81571185|FG002|Run-in|Withdrawal by Subject|0|||
27927335|NCT00580840|81571186|FG003|Run-in|Withdrawal by Subject|0|||
27927336|NCT00580840|81571183|FG000|Run-in|Other: Per Sponsor Request|2|||
27927337|NCT00580840|81571184|FG001|Run-in|Other: Per Sponsor Request|0|||
27927338|NCT00580840|81571185|FG002|Run-in|Other: Per Sponsor Request|0|||
27927339|NCT00580840|81571186|FG003|Run-in|Other: Per Sponsor Request|0|||
27927340|NCT00580840|81571183|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
27927341|NCT00580840|81571184|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
27547082|NCT01056653|80193020|FG002|Overall Study|Lost to Follow-up|2|||
27547083|NCT00582166|80193021|FG000|Overall Study|Death|1|||
27547084|NCT00582166|80193021|FG000|Overall Study|Ineligible pathology|1|||
27547085|NCT04678661|80193022|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
27547086|NCT04678661|80193023|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
27547087|NCT04678661|80193022|FG000|Overall Study|Protocol Violation|2|||
27927342|NCT00580840|81571185|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
27927343|NCT00580840|81571186|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
27927344|NCT00580840|81571183|FG000|Run-in|Other: Exclusionary Lab Value|1|||
27927345|NCT00580840|81571184|FG001|Run-in|Other: Exclusionary Lab Value|0|||
27927346|NCT00580840|81571185|FG002|Run-in|Other: Exclusionary Lab Value|0|||
27927347|NCT00580840|81571186|FG003|Run-in|Other: Exclusionary Lab Value|0|||
27927348|NCT00580840|81571183|FG000|Double-Blind|Adverse Event|0|||
27927349|NCT00580840|81571184|FG001|Double-Blind|Adverse Event|3|||
27927350|NCT00580840|81571185|FG002|Double-Blind|Adverse Event|4|||
27927351|NCT00580840|81571186|FG003|Double-Blind|Adverse Event|1|||
27927352|NCT00580840|81571183|FG000|Double-Blind|Loss of Efficacy|0|||
27547088|NCT04678661|80193023|FG001|Overall Study|Protocol Violation|0|||
27547089|NCT04678661|80193022|FG000|Overall Study|Withdrawal by Subject|1|||
27547090|NCT04678661|80193023|FG001|Overall Study|Withdrawal by Subject|0|||
27547091|NCT04678661|80193022|FG000|Overall Study|Lost to Follow-up|2|||
27547092|NCT04678661|80193023|FG001|Overall Study|Lost to Follow-up|0|||
27547093|NCT04678661|80193022|FG000|Overall Study|Death|2|||
27547094|NCT04678661|80193023|FG001|Overall Study|Death|0|||
27547095|NCT00598832|80193025|FG000|Overall Study|Lack of Efficacy|3|||
27547096|NCT00598832|80193026|FG001|Overall Study|Lack of Efficacy|7|||
27547097|NCT00598832|80193025|FG000|Overall Study|Adverse Event|6|||
27547098|NCT00598832|80193026|FG001|Overall Study|Adverse Event|2|||
27927353|NCT00580840|81571184|FG001|Double-Blind|Loss of Efficacy|1|||
27927354|NCT00580840|81571185|FG002|Double-Blind|Loss of Efficacy|2|||
27927355|NCT00580840|81571186|FG003|Double-Blind|Loss of Efficacy|10|||
27927356|NCT00580840|81571183|FG000|Double-Blind|Lost to Follow-up|0|||
27927357|NCT00580840|81571184|FG001|Double-Blind|Lost to Follow-up|1|||
27927358|NCT00580840|81571185|FG002|Double-Blind|Lost to Follow-up|0|||
27927359|NCT00580840|81571186|FG003|Double-Blind|Lost to Follow-up|2|||
27927360|NCT00580840|81571183|FG000|Double-Blind|Withdrawal by Subject|0|||
27927361|NCT00580840|81571184|FG001|Double-Blind|Withdrawal by Subject|1|||
27927362|NCT00580840|81571185|FG002|Double-Blind|Withdrawal by Subject|2|||
27927363|NCT00580840|81571186|FG003|Double-Blind|Withdrawal by Subject|2|||
27927364|NCT00580840|81571183|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
27927365|NCT00580840|81571184|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
27927366|NCT00580840|81571185|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
27927367|NCT00580840|81571186|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
27927368|NCT00580840|81571183|FG000|Double-Blind|Other: Forbidden Medication|0|||
27927369|NCT00580840|81571184|FG001|Double-Blind|Other: Forbidden Medication|0|||
27927370|NCT00580840|81571185|FG002|Double-Blind|Other: Forbidden Medication|1|||
27927371|NCT00580840|81571186|FG003|Double-Blind|Other: Forbidden Medication|0|||
27927372|NCT00283959|81571189|FG000|Extension Period|Low Compliance|1|||
27927373|NCT02110693|81571190|FG000|Overall Study|Withdrawal by Subject|6|||
27927374|NCT02110693|81571191|FG001|Overall Study|Withdrawal by Subject|7|||
27927375|NCT02110693|81571190|FG000|Overall Study|skipped assessment|15|||
27927376|NCT02110693|81571191|FG001|Overall Study|skipped assessment|18|||
27927377|NCT02110693|81571190|FG000|Overall Study|technical difficulties|6|||
27927378|NCT02110693|81571191|FG001|Overall Study|technical difficulties|4|||
27927379|NCT02110693|81571190|FG000|Overall Study|Other|1|||
27927380|NCT02110693|81571191|FG001|Overall Study|Other|0|||
27927381|NCT03197129|81571192|FG000|Overall Study|did not answer the VPT: shyness|4|||
27927382|NCT03197129|81571193|FG001|Overall Study|did not answer the VPT: shyness|5|||
27927383|NCT00870727|81571194|FG000|Overall Study|Lost to Follow-up|0|||
27927384|NCT00870727|81571195|FG001|Overall Study|Lost to Follow-up|1|||
27927385|NCT00870727|81571194|FG000|Overall Study|Lack of Efficacy|1|||
27927386|NCT00870727|81571195|FG001|Overall Study|Lack of Efficacy|3|||
27927387|NCT00870727|81571194|FG000|Overall Study|Adverse Event|0|||
27927388|NCT00870727|81571195|FG001|Overall Study|Adverse Event|1|||
27927389|NCT01022580|81571196|FG000|Overall Study|Death|18|||
27927390|NCT01022580|81571197|FG001|Overall Study|Death|22|||
27927391|NCT01510756|81571199|FG000|Overall Study|Death|1|||
27927392|NCT01510756|81571199|FG000|Overall Study|Lack of Efficacy|2|||
27927393|NCT01510756|81571199|FG000|Overall Study|Physician Decision|1|||
27927394|NCT01341470|81571200|FG000|Overall Study|Sponsor decision|0|||
27927395|NCT01341470|81571201|FG001|Overall Study|Sponsor decision|0|||
27927396|NCT01341470|81571202|FG002|Overall Study|Sponsor decision|1|||
27927397|NCT01341470|81571203|FG003|Overall Study|Sponsor decision|1|||
27927398|NCT01341470|81571204|FG004|Overall Study|Sponsor decision|0|||
27927399|NCT01341470|81571205|FG005|Overall Study|Sponsor decision|1|||
27927400|NCT02239328|81571206|FG000|Overall Study|Benign disease noted at time of surgery|6|||
27927401|NCT02239328|81571206|FG000|Overall Study|Equipment or website malfunction|2|||
27927402|NCT03743194|81571207|FG000|Overall Study|Protocol Violation|7|||
27927403|NCT03743194|81571208|FG001|Overall Study|Protocol Violation|7|||
27927404|NCT03743194|81571207|FG000|Overall Study|Physician Decision|0|||
27547099|NCT00598832|80193025|FG000|Overall Study|Withdrawal by Subject|25|||
27547100|NCT00598832|80193026|FG001|Overall Study|Withdrawal by Subject|36|||
27927405|NCT03743194|81571208|FG001|Overall Study|Physician Decision|2|||
27927406|NCT03600350|81571214|FG000|Overall Study|Death|1|||
27927407|NCT03600350|81571214|FG000|Overall Study|On Follow Up|18|||
27927408|NCT02595749|81571215|FG000|Overall Study|Withdrawal by Subject|12|||
27927409|NCT02595749|81571216|FG001|Overall Study|Withdrawal by Subject|7|||
27927410|NCT01171534|81571218|FG000|Overall Study|Lost to Follow-up|0|||
27927411|NCT01171534|81571219|FG001|Overall Study|Lost to Follow-up|2|||
27547101|NCT00598832|80193025|FG000|Overall Study|Protocol Violation|0|||
27927412|NCT01171534|81571218|FG000|Overall Study|screen failure|0|||
27927413|NCT01171534|81571219|FG001|Overall Study|screen failure|1|||
27927414|NCT00089648|81571220|FG000|Overall Study|Adverse Event|7|||
27547102|NCT00598832|80193026|FG001|Overall Study|Protocol Violation|2|||
27547103|NCT00598832|80193025|FG000|Overall Study|Lost to Follow-up|24|||
27927415|NCT00089648|81571220|FG000|Overall Study|Withdrawal by Subject|1|||
27927416|NCT00089648|81571220|FG000|Overall Study|Lack of Efficacy|33|||
27927417|NCT00435942|81571225|FG000|Overall Study|Death|17|||
27927418|NCT00435942|81571226|FG001|Overall Study|Death|10|||
27927419|NCT00435942|81571225|FG000|Overall Study|Withdrawal by Subject|2|||
27927420|NCT00435942|81571226|FG001|Overall Study|Withdrawal by Subject|0|||
27927421|NCT00435942|81571225|FG000|Overall Study|Lost to Follow-up|0|||
27927422|NCT00435942|81571226|FG001|Overall Study|Lost to Follow-up|16|||
27927423|NCT00435942|81571225|FG000|Overall Study|Conversion to Open Repair|1|||
27927424|NCT00435942|81571226|FG001|Overall Study|Conversion to Open Repair|0|||
27927425|NCT00435942|81571225|FG000|Overall Study|Technical Failure|3|||
27927426|NCT00435942|81571226|FG001|Overall Study|Technical Failure|0|||
27927427|NCT00435942|81571225|FG000|Overall Study|Other|0|||
27927428|NCT00435942|81571226|FG001|Overall Study|Other|1|||
27927429|NCT00226655|81571227|FG000|Overall Study|Death|13|||
27927430|NCT00226655|81571227|FG000|Overall Study|Withdrawal by Subject|15|||
27927431|NCT00226655|81571227|FG000|Overall Study|Adverse Event|35|||
27927432|NCT00226655|81571227|FG000|Overall Study|Physician Decision|6|||
27927433|NCT00226655|81571227|FG000|Overall Study|Clinical deterioration|10|||
27927434|NCT01462942|81571232|FG000|Overall Study|Adverse Event|7|||
27927435|NCT01462942|81571233|FG001|Overall Study|Adverse Event|12|||
27927436|NCT01462942|81571234|FG002|Overall Study|Adverse Event|10|||
27927437|NCT01462942|81571235|FG003|Overall Study|Adverse Event|11|||
27927438|NCT01462942|81571236|FG004|Overall Study|Adverse Event|11|||
27927439|NCT01462942|81571232|FG000|Overall Study|Other, including COPD exacerbation|3|||
27927440|NCT01462942|81571233|FG001|Overall Study|Other, including COPD exacerbation|5|||
27927441|NCT01462942|81571234|FG002|Overall Study|Other, including COPD exacerbation|2|||
27927442|NCT01462942|81571235|FG003|Overall Study|Other, including COPD exacerbation|8|||
27927443|NCT01462942|81571236|FG004|Overall Study|Other, including COPD exacerbation|5|||
27927444|NCT01462942|81571232|FG000|Overall Study|Withdrawal by Subject|14|||
27927445|NCT01462942|81571233|FG001|Overall Study|Withdrawal by Subject|10|||
27927446|NCT01462942|81571234|FG002|Overall Study|Withdrawal by Subject|14|||
27927447|NCT01462942|81571235|FG003|Overall Study|Withdrawal by Subject|16|||
27927448|NCT01462942|81571236|FG004|Overall Study|Withdrawal by Subject|19|||
27927449|NCT01462942|81571232|FG000|Overall Study|Lack of Efficacy|6|||
27927450|NCT01462942|81571233|FG001|Overall Study|Lack of Efficacy|0|||
27927451|NCT01462942|81571234|FG002|Overall Study|Lack of Efficacy|4|||
27927452|NCT01462942|81571235|FG003|Overall Study|Lack of Efficacy|5|||
27927453|NCT01462942|81571236|FG004|Overall Study|Lack of Efficacy|3|||
27927454|NCT01462942|81571232|FG000|Overall Study|Lost to Follow-up|0|||
27927455|NCT01462942|81571233|FG001|Overall Study|Lost to Follow-up|1|||
27927456|NCT01462942|81571234|FG002|Overall Study|Lost to Follow-up|1|||
27927457|NCT01462942|81571235|FG003|Overall Study|Lost to Follow-up|1|||
27927458|NCT01462942|81571236|FG004|Overall Study|Lost to Follow-up|1|||
27927459|NCT01462942|81571232|FG000|Overall Study|Protocol Violation|4|||
27927460|NCT01462942|81571233|FG001|Overall Study|Protocol Violation|6|||
27927461|NCT01462942|81571234|FG002|Overall Study|Protocol Violation|9|||
27927462|NCT01462942|81571235|FG003|Overall Study|Protocol Violation|9|||
27927463|NCT01462942|81571236|FG004|Overall Study|Protocol Violation|6|||
27927464|NCT01712516|81571238|FG000|Overall Study|Technical problems|0|||
27547104|NCT00598832|80193026|FG001|Overall Study|Lost to Follow-up|29|||
27547105|NCT00598832|80193025|FG000|Overall Study|Pregnancy|2|||
27547106|NCT00598832|80193026|FG001|Overall Study|Pregnancy|2|||
27547107|NCT00598832|80193025|FG000|Overall Study|Physician Decision|1|||
27547108|NCT00598832|80193026|FG001|Overall Study|Physician Decision|4|||
27547109|NCT00598832|80193025|FG000|Overall Study|Non compliance|1|||
27547110|NCT00598832|80193026|FG001|Overall Study|Non compliance|0|||
27547111|NCT02853604|80193027|FG000|Overall Study|Withdrawal by Subject|12|||
27547112|NCT02853604|80193028|FG001|Overall Study|Withdrawal by Subject|35|||
27927465|NCT01712516|81571239|FG001|Overall Study|Technical problems|0|||
27927466|NCT01712516|81571240|FG002|Overall Study|Technical problems|0|||
27927467|NCT01712516|81571241|FG003|Overall Study|Technical problems|2|||
27547113|NCT02853604|80193027|FG000|Overall Study|Lost to Follow-up|4|||
27547114|NCT02853604|80193028|FG001|Overall Study|Lost to Follow-up|8|||
27547115|NCT02853604|80193027|FG000|Overall Study|Death|1|||
27547116|NCT02853604|80193028|FG001|Overall Study|Death|5|||
27927468|NCT01712516|81571238|FG000|Overall Study|Lost to Follow-up|0|||
27927469|NCT01712516|81571239|FG001|Overall Study|Lost to Follow-up|0|||
27927470|NCT01712516|81571240|FG002|Overall Study|Lost to Follow-up|2|||
27927471|NCT01712516|81571241|FG003|Overall Study|Lost to Follow-up|1|||
27927472|NCT01712516|81571238|FG000|Overall Study|Death|0|||
27927473|NCT01712516|81571239|FG001|Overall Study|Death|1|||
27547117|NCT02853604|80193027|FG000|Overall Study|Miscellaneous|11|||
27927474|NCT01712516|81571240|FG002|Overall Study|Death|0|||
27927475|NCT01712516|81571241|FG003|Overall Study|Death|0|||
27927476|NCT01712516|81571238|FG000|Overall Study|Protocol deviation|1|||
27927477|NCT01712516|81571239|FG001|Overall Study|Protocol deviation|0|||
27927478|NCT01712516|81571240|FG002|Overall Study|Protocol deviation|1|||
27927479|NCT01712516|81571241|FG003|Overall Study|Protocol deviation|0|||
27927480|NCT01712516|81571238|FG000|Overall Study|Physician Decision|2|||
27927481|NCT01712516|81571239|FG001|Overall Study|Physician Decision|0|||
27927482|NCT01712516|81571240|FG002|Overall Study|Physician Decision|0|||
27927483|NCT01712516|81571241|FG003|Overall Study|Physician Decision|1|||
27927484|NCT01712516|81571238|FG000|Overall Study|Withdrawal by Subject|3|||
27927485|NCT01712516|81571239|FG001|Overall Study|Withdrawal by Subject|9|||
27927486|NCT01712516|81571240|FG002|Overall Study|Withdrawal by Subject|3|||
27927487|NCT01712516|81571241|FG003|Overall Study|Withdrawal by Subject|9|||
27927488|NCT00485303|81571242|FG000|Overall Study|Adverse Event|5|||
27927489|NCT00485303|81571242|FG000|Overall Study|Progressive Disease|44|||
27927490|NCT00485303|81571242|FG000|Overall Study|Other|3|||
27927491|NCT00485303|81571242|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
27927492|NCT00485303|81571242|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
27927493|NCT02332707|81571246|FG000|Overall Study|Adverse Event|0|||
27927494|NCT02332707|81571247|FG001|Overall Study|Adverse Event|0|||
27927495|NCT02332707|81571248|FG002|Overall Study|Adverse Event|0|||
27927496|NCT02332707|81571249|FG003|Overall Study|Adverse Event|0|||
27927497|NCT02332707|81571250|FG004|Overall Study|Adverse Event|0|||
27927498|NCT02332707|81571251|FG005|Overall Study|Adverse Event|0|||
27927499|NCT02332707|81571252|FG006|Overall Study|Adverse Event|0|||
27927500|NCT02332707|81571253|FG007|Overall Study|Adverse Event|0|||
27927501|NCT02332707|81571254|FG008|Overall Study|Adverse Event|0|||
27927502|NCT02332707|81571255|FG009|Overall Study|Adverse Event|0|||
27927503|NCT02332707|81571256|FG010|Overall Study|Adverse Event|0|||
27927504|NCT02332707|81571257|FG011|Overall Study|Adverse Event|0|||
27927505|NCT02332707|81571258|FG012|Overall Study|Adverse Event|1|||
27927506|NCT02332707|81571259|FG013|Overall Study|Adverse Event|0|||
27927507|NCT02332707|81571260|FG014|Overall Study|Adverse Event|0|||
27927508|NCT02332707|81571261|FG015|Overall Study|Adverse Event|0|||
27927509|NCT02332707|81571262|FG016|Overall Study|Adverse Event|0|||
27927510|NCT02332707|81571263|FG017|Overall Study|Adverse Event|0|||
27927511|NCT02332707|81571246|FG000|Overall Study|Lost to Follow-up|0|||
27927512|NCT02332707|81571247|FG001|Overall Study|Lost to Follow-up|0|||
27927513|NCT02332707|81571248|FG002|Overall Study|Lost to Follow-up|0|||
27927514|NCT02332707|81571249|FG003|Overall Study|Lost to Follow-up|0|||
27927515|NCT02332707|81571250|FG004|Overall Study|Lost to Follow-up|0|||
27927516|NCT02332707|81571251|FG005|Overall Study|Lost to Follow-up|1|||
27927517|NCT02332707|81571252|FG006|Overall Study|Lost to Follow-up|0|||
27927518|NCT02332707|81571253|FG007|Overall Study|Lost to Follow-up|0|||
27927519|NCT02332707|81571254|FG008|Overall Study|Lost to Follow-up|0|||
27547118|NCT02853604|80193028|FG001|Overall Study|Miscellaneous|2|||
27547119|NCT02853604|80193027|FG000|Overall Study|Progressive Disease|0|||
27547120|NCT02853604|80193028|FG001|Overall Study|Progressive Disease|2|||
27547121|NCT00279305|80193029|FG000|Overall Study|Pregnancy|1|||
27547122|NCT00279305|80193030|FG001|Overall Study|Pregnancy|0|||
27547123|NCT00279305|80193029|FG000|Overall Study|Withdrawal by Subject|2|||
27547124|NCT00279305|80193030|FG001|Overall Study|Withdrawal by Subject|0|||
27547125|NCT00279305|80193029|FG000|Overall Study|Dificulting establishing IV|1|||
27547126|NCT00279305|80193030|FG001|Overall Study|Dificulting establishing IV|0|||
27547127|NCT00279305|80193029|FG000|Overall Study|FDA Safety Alert|4|||
27547128|NCT00279305|80193030|FG001|Overall Study|FDA Safety Alert|1|||
27547129|NCT00217620|80193031|FG000|Overall Study|Adverse Event|2|||
27547130|NCT00217620|80193031|FG000|Overall Study|Progression|31|||
27547131|NCT00217620|80193031|FG000|Overall Study|Not Protocol Specified|4|||
27547132|NCT00217620|80193031|FG000|Overall Study|Ineligible|13|||
27547133|NCT00217620|80193031|FG000|Overall Study|Never received treatment|1|||
27547134|NCT02578316|80193032|FG000|Extension Phase|Progression of disease|6|||
27547135|NCT00745823|80193033|FG000|Overall Study|Adverse Event|5|||
27547136|NCT00745823|80193034|FG001|Overall Study|Adverse Event|3|||
27640249|NCT01953692|80525854|FG005|Overall Study|Lost to Follow-up|1|||
27640250|NCT01953692|80525855|FG006|Overall Study|Lost to Follow-up|0|||
27927520|NCT02332707|81571255|FG009|Overall Study|Lost to Follow-up|0|||
27547137|NCT00745823|80193033|FG000|Overall Study|Lack of Efficacy|20|||
27547138|NCT00745823|80193034|FG001|Overall Study|Lack of Efficacy|6|||
27547139|NCT00745823|80193033|FG000|Overall Study|Lost to Follow-up|10|||
27640251|NCT01953692|80525856|FG007|Overall Study|Lost to Follow-up|0|||
27640252|NCT01953692|80525857|FG008|Overall Study|Lost to Follow-up|0|||
27927521|NCT02332707|81571256|FG010|Overall Study|Lost to Follow-up|2|||
27927522|NCT02332707|81571257|FG011|Overall Study|Lost to Follow-up|0|||
27927523|NCT02332707|81571258|FG012|Overall Study|Lost to Follow-up|3|||
27927524|NCT02332707|81571259|FG013|Overall Study|Lost to Follow-up|0|||
27927525|NCT02332707|81571260|FG014|Overall Study|Lost to Follow-up|0|||
27927526|NCT02332707|81571261|FG015|Overall Study|Lost to Follow-up|0|||
27927527|NCT02332707|81571262|FG016|Overall Study|Lost to Follow-up|0|||
27547140|NCT00745823|80193034|FG001|Overall Study|Lost to Follow-up|11|||
27547141|NCT00745823|80193033|FG000|Overall Study|Physician Decision|10|||
27927528|NCT02332707|81571263|FG017|Overall Study|Lost to Follow-up|0|||
27927529|NCT02332707|81571246|FG000|Overall Study|Physician Decision|0|||
27927530|NCT02332707|81571247|FG001|Overall Study|Physician Decision|0|||
27547142|NCT00745823|80193034|FG001|Overall Study|Physician Decision|5|||
27547143|NCT00745823|80193033|FG000|Overall Study|Pregnancy|0|||
27547144|NCT00745823|80193034|FG001|Overall Study|Pregnancy|4|||
27547145|NCT00745823|80193033|FG000|Overall Study|Withdrawal by Subject|14|||
27547146|NCT00745823|80193034|FG001|Overall Study|Withdrawal by Subject|8|||
27547147|NCT00745823|80193033|FG000|Overall Study|Study Terminated by Sponsor|326|||
27547148|NCT00745823|80193034|FG001|Overall Study|Study Terminated by Sponsor|349|||
27547149|NCT01061177|80193035|FG000|Overall Study|Adverse Event|117|||
27547150|NCT01061177|80193035|FG000|Overall Study|Withdrawal by Subject|27|||
27547151|NCT01061177|80193035|FG000|Overall Study|Disease progression|17|||
27547152|NCT01061177|80193035|FG000|Overall Study|Protocol Violation|11|||
27547153|NCT01061177|80193035|FG000|Overall Study|Lost to Follow-up|9|||
27547154|NCT01061177|80193035|FG000|Overall Study|New cancer therapy|9|||
27547155|NCT01061177|80193035|FG000|Overall Study|Abnormal laboratory values|6|||
27547156|NCT01061177|80193035|FG000|Overall Study|Abnormal test procedure results|4|||
27547157|NCT01061177|80193035|FG000|Overall Study|Administratie problems|4|||
27547158|NCT01061177|80193035|FG000|Overall Study|Death|4|||
27547159|NCT01896102|80193050|FG000|Overall Study|Death|1|||
27547160|NCT01896102|80193050|FG000|Overall Study|Participant to receive allogenic transplant|2|||
27547161|NCT01507298|80193051|FG000|Overall Study|Protocol Violation|0|||
27547162|NCT01507298|80193052|FG001|Overall Study|Protocol Violation|6|||
27547163|NCT00319553|80193053|FG000|Overall Study|Protocol Violation|1|||
27547164|NCT00319553|80193054|FG001|Overall Study|Protocol Violation|2|||
27547165|NCT00319553|80193053|FG000|Overall Study|Lost to Follow-up|2|||
27547166|NCT00319553|80193054|FG001|Overall Study|Lost to Follow-up|1|||
27547167|NCT00319553|80193053|FG000|Overall Study|Withdrawal by Subject|1|||
27547168|NCT00319553|80193054|FG001|Overall Study|Withdrawal by Subject|1|||
27547169|NCT01947582|80193055|FG000|Overall Study|Withdrawal by Subject|1|||
27547170|NCT01644565|80193057|FG000|Overall Study|Undisclosed Medical History|1|||
27547171|NCT01644565|80193058|FG001|Overall Study|Undisclosed Medical History|0|||
27547172|NCT01644565|80193059|FG002|Overall Study|Undisclosed Medical History|0|||
27547173|NCT01644565|80193060|FG003|Overall Study|Undisclosed Medical History|0|||
27547174|NCT01644565|80193061|FG004|Overall Study|Undisclosed Medical History|0|||
27547175|NCT01644565|80193062|FG005|Overall Study|Undisclosed Medical History|0|||
27547176|NCT01644565|80193063|FG006|Overall Study|Undisclosed Medical History|0|||
27547177|NCT01644565|80193064|FG007|Overall Study|Undisclosed Medical History|0|||
27547178|NCT01644565|80193065|FG008|Overall Study|Undisclosed Medical History|0|||
27547179|NCT01644565|80193057|FG000|Overall Study|Lost to Follow-up|0|||
27547180|NCT01644565|80193058|FG001|Overall Study|Lost to Follow-up|0|||
27547181|NCT01644565|80193059|FG002|Overall Study|Lost to Follow-up|0|||
27640253|NCT01953692|80525849|FG000|Overall Study|Physician Decision|11|||
27640254|NCT01953692|80525850|FG001|Overall Study|Physician Decision|4|||
27640255|NCT01953692|80525851|FG002|Overall Study|Physician Decision|2|||
27547182|NCT01644565|80193060|FG003|Overall Study|Lost to Follow-up|1|||
27547183|NCT01644565|80193061|FG004|Overall Study|Lost to Follow-up|0|||
27547184|NCT01644565|80193062|FG005|Overall Study|Lost to Follow-up|0|||
27547185|NCT01644565|80193063|FG006|Overall Study|Lost to Follow-up|0|||
27547186|NCT01644565|80193064|FG007|Overall Study|Lost to Follow-up|2|||
27547187|NCT01644565|80193065|FG008|Overall Study|Lost to Follow-up|0|||
27547188|NCT01644565|80193057|FG000|Overall Study|Family emergency|0|||
27547189|NCT01644565|80193058|FG001|Overall Study|Family emergency|0|||
27547190|NCT01644565|80193059|FG002|Overall Study|Family emergency|0|||
27547191|NCT01644565|80193060|FG003|Overall Study|Family emergency|0|||
27640256|NCT01953692|80525852|FG003|Overall Study|Physician Decision|2|||
27640257|NCT01953692|80525853|FG004|Overall Study|Physician Decision|1|||
27640258|NCT01953692|80525854|FG005|Overall Study|Physician Decision|2|||
27640259|NCT01953692|80525855|FG006|Overall Study|Physician Decision|4|||
27640260|NCT01953692|80525856|FG007|Overall Study|Physician Decision|1|||
27640261|NCT01953692|80525857|FG008|Overall Study|Physician Decision|0|||
27640262|NCT01953692|80525849|FG000|Overall Study|Protocol Violation|0|||
27640263|NCT01953692|80525850|FG001|Overall Study|Protocol Violation|2|||
27640264|NCT01953692|80525851|FG002|Overall Study|Protocol Violation|1|||
27640265|NCT01953692|80525852|FG003|Overall Study|Protocol Violation|0|||
27640266|NCT01953692|80525853|FG004|Overall Study|Protocol Violation|0|||
27927531|NCT02332707|81571248|FG002|Overall Study|Physician Decision|0|||
27547192|NCT01644565|80193061|FG004|Overall Study|Family emergency|1|||
27547193|NCT01644565|80193062|FG005|Overall Study|Family emergency|0|||
27547194|NCT01644565|80193063|FG006|Overall Study|Family emergency|0|||
27547195|NCT01644565|80193064|FG007|Overall Study|Family emergency|0|||
27547196|NCT01644565|80193065|FG008|Overall Study|Family emergency|0|||
27547197|NCT01644565|80193057|FG000|Overall Study|Relocation|0|||
27547198|NCT01644565|80193058|FG001|Overall Study|Relocation|0|||
27640267|NCT01953692|80525854|FG005|Overall Study|Protocol Violation|0|||
27640268|NCT01953692|80525855|FG006|Overall Study|Protocol Violation|0|||
27927532|NCT02332707|81571249|FG003|Overall Study|Physician Decision|1|||
27547199|NCT01644565|80193059|FG002|Overall Study|Relocation|0|||
27547200|NCT01644565|80193060|FG003|Overall Study|Relocation|0|||
27547201|NCT01644565|80193061|FG004|Overall Study|Relocation|0|||
27640269|NCT01953692|80525856|FG007|Overall Study|Protocol Violation|1|||
27640270|NCT01953692|80525857|FG008|Overall Study|Protocol Violation|0|||
27927533|NCT02332707|81571250|FG004|Overall Study|Physician Decision|0|||
27927534|NCT02332707|81571251|FG005|Overall Study|Physician Decision|0|||
27927535|NCT02332707|81571252|FG006|Overall Study|Physician Decision|0|||
27927536|NCT02332707|81571253|FG007|Overall Study|Physician Decision|0|||
27927537|NCT02332707|81571254|FG008|Overall Study|Physician Decision|0|||
27927538|NCT02332707|81571255|FG009|Overall Study|Physician Decision|0|||
27927539|NCT02332707|81571256|FG010|Overall Study|Physician Decision|0|||
27927540|NCT02332707|81571257|FG011|Overall Study|Physician Decision|0|||
27927541|NCT02332707|81571258|FG012|Overall Study|Physician Decision|1|||
27927542|NCT02332707|81571259|FG013|Overall Study|Physician Decision|0|||
27927543|NCT02332707|81571260|FG014|Overall Study|Physician Decision|0|||
27927544|NCT02332707|81571261|FG015|Overall Study|Physician Decision|0|||
27927545|NCT02332707|81571262|FG016|Overall Study|Physician Decision|0|||
27927546|NCT02332707|81571263|FG017|Overall Study|Physician Decision|0|||
27927547|NCT02332707|81571246|FG000|Overall Study|Withdrawal by Subject|0|||
27927548|NCT02332707|81571247|FG001|Overall Study|Withdrawal by Subject|0|||
27927549|NCT02332707|81571248|FG002|Overall Study|Withdrawal by Subject|1|||
27927550|NCT02332707|81571249|FG003|Overall Study|Withdrawal by Subject|0|||
27927551|NCT02332707|81571250|FG004|Overall Study|Withdrawal by Subject|0|||
27927552|NCT02332707|81571251|FG005|Overall Study|Withdrawal by Subject|0|||
27927553|NCT02332707|81571252|FG006|Overall Study|Withdrawal by Subject|0|||
27927554|NCT02332707|81571253|FG007|Overall Study|Withdrawal by Subject|0|||
27927555|NCT02332707|81571254|FG008|Overall Study|Withdrawal by Subject|0|||
27927556|NCT02332707|81571255|FG009|Overall Study|Withdrawal by Subject|3|||
27927557|NCT02332707|81571256|FG010|Overall Study|Withdrawal by Subject|0|||
27927558|NCT02332707|81571257|FG011|Overall Study|Withdrawal by Subject|0|||
27927559|NCT02332707|81571258|FG012|Overall Study|Withdrawal by Subject|0|||
27927560|NCT02332707|81571259|FG013|Overall Study|Withdrawal by Subject|0|||
27927561|NCT02332707|81571260|FG014|Overall Study|Withdrawal by Subject|0|||
27927562|NCT02332707|81571261|FG015|Overall Study|Withdrawal by Subject|0|||
27927563|NCT02332707|81571262|FG016|Overall Study|Withdrawal by Subject|0|||
27927564|NCT02332707|81571263|FG017|Overall Study|Withdrawal by Subject|0|||
27927565|NCT01682031|81571264|FG000|Overall Study|Withdrawal by Subject|0|||
27927566|NCT01682031|81571265|FG001|Overall Study|Withdrawal by Subject|1|||
27927567|NCT01682031|81571264|FG000|Overall Study|Adverse Event|0|||
27927568|NCT01682031|81571265|FG001|Overall Study|Adverse Event|2|||
27927569|NCT01682031|81571264|FG000|Overall Study|MRI results indicate increased nodul|0|||
27927570|NCT01682031|81571265|FG001|Overall Study|MRI results indicate increased nodul|1|||
27927571|NCT01682031|81571264|FG000|Overall Study|Patient could not swallow tablets|1|||
27927572|NCT01682031|81571265|FG001|Overall Study|Patient could not swallow tablets|0|||
27927573|NCT01682031|81571264|FG000|Overall Study|Patient stopped selenium on his own|0|||
27927574|NCT01682031|81571265|FG001|Overall Study|Patient stopped selenium on his own|1|||
27927575|NCT00083915|81571266|FG000|Overall Study|Death|6|||
27927576|NCT00083915|81571267|FG001|Overall Study|Death|3|||
27927577|NCT00083915|81571266|FG000|Overall Study|Physician Decision|11|||
27927578|NCT00083915|81571267|FG001|Overall Study|Physician Decision|6|||
27927579|NCT00083915|81571266|FG000|Overall Study|Withdrawal by Subject|8|||
27927580|NCT00083915|81571267|FG001|Overall Study|Withdrawal by Subject|3|||
27927581|NCT00083915|81571266|FG000|Overall Study|disease progression|18|||
27927582|NCT00083915|81571267|FG001|Overall Study|disease progression|23|||
27927583|NCT00083915|81571266|FG000|Overall Study|Failure to collect|3|||
27927584|NCT00083915|81571267|FG001|Overall Study|Failure to collect|0|||
27927585|NCT00083915|81571266|FG000|Overall Study|No response|3|||
27927586|NCT00083915|81571267|FG001|Overall Study|No response|1|||
27927587|NCT00083915|81571266|FG000|Overall Study|Insurance issues|1|||
27927588|NCT00083915|81571267|FG001|Overall Study|Insurance issues|1|||
27927589|NCT01143324|81574552|FG000|Overall Study|Lost to Follow-up|11|||
27927590|NCT01143324|81574552|FG000|Overall Study|Withdrawal by Subject|4|||
27927591|NCT01143324|81574552|FG000|Overall Study|Explant of the device|4|||
27927592|NCT00876395|81574555|FG000|Overall Study|Untreated|8|||
27927593|NCT00876395|81574556|FG001|Overall Study|Untreated|1|||
27927594|NCT00876395|81574555|FG000|Overall Study|Adverse Event|63|||
27927595|NCT00876395|81574556|FG001|Overall Study|Adverse Event|11|||
27927596|NCT00876395|81574555|FG000|Overall Study|Abnormal test procedure result(s)|1|||
27927597|NCT00876395|81574556|FG001|Overall Study|Abnormal test procedure result(s)|0|||
27927598|NCT00876395|81574555|FG000|Overall Study|Disease progression|259|||
27927599|NCT00876395|81574556|FG001|Overall Study|Disease progression|162|||
27742487|NCT00984659|80886927|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
27742488|NCT00866294|80886928|FG000|Overall Study|Adverse Event|12|||
27927600|NCT00876395|81574555|FG000|Overall Study|New cancer therapy|25|||
27927601|NCT00876395|81574556|FG001|Overall Study|New cancer therapy|7|||
27927602|NCT00876395|81574555|FG000|Overall Study|Protocol Violation|5|||
27927603|NCT00876395|81574556|FG001|Overall Study|Protocol Violation|2|||
27927604|NCT00876395|81574555|FG000|Overall Study|Withdrawal by Subject|66|||
27927605|NCT00876395|81574556|FG001|Overall Study|Withdrawal by Subject|33|||
27927606|NCT00876395|81574555|FG000|Overall Study|Lost to Follow-up|2|||
27927607|NCT00876395|81574556|FG001|Overall Study|Lost to Follow-up|0|||
27927608|NCT00876395|81574555|FG000|Overall Study|Administrative problems|39|||
27927609|NCT00876395|81574556|FG001|Overall Study|Administrative problems|23|||
27927610|NCT00876395|81574555|FG000|Overall Study|Death|12|||
27547202|NCT01644565|80193062|FG005|Overall Study|Relocation|0|||
27547203|NCT01644565|80193063|FG006|Overall Study|Relocation|0|||
27547204|NCT01644565|80193064|FG007|Overall Study|Relocation|0|||
27547205|NCT01644565|80193065|FG008|Overall Study|Relocation|1|||
27640271|NCT01953692|80525849|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27547206|NCT02725710|80193066|FG000|Overall Study|Lost to Follow-up|1|||
27547207|NCT02725710|80193067|FG001|Overall Study|Lost to Follow-up|0|||
27547208|NCT01929343|80193068|FG000|Overall Study|Physician Decision|0|||
27547209|NCT01929343|80193069|FG001|Overall Study|Physician Decision|2|||
27547210|NCT01929343|80193070|FG002|Overall Study|Physician Decision|0|||
27547211|NCT01929343|80193068|FG000|Overall Study|Withdrawal by Subject|1|||
27547212|NCT01929343|80193069|FG001|Overall Study|Withdrawal by Subject|0|||
27547213|NCT01929343|80193070|FG002|Overall Study|Withdrawal by Subject|0|||
27547214|NCT03039283|80193071|FG000|Overall Study|Protocol Violation|2|||
27547215|NCT01782222|80193076|FG000|Overall Study|Adverse Event|4|||
27547216|NCT01782222|80193077|FG001|Overall Study|Adverse Event|5|||
27547217|NCT01782222|80193078|FG002|Overall Study|Adverse Event|3|||
27640272|NCT01953692|80525850|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27547218|NCT01782222|80193076|FG000|Overall Study|Lack of Efficacy|2|||
27547219|NCT01782222|80193077|FG001|Overall Study|Lack of Efficacy|1|||
27547220|NCT01782222|80193078|FG002|Overall Study|Lack of Efficacy|0|||
27547221|NCT01782222|80193076|FG000|Overall Study|Protocol Violation|1|||
27547222|NCT01782222|80193077|FG001|Overall Study|Protocol Violation|0|||
27547223|NCT01782222|80193078|FG002|Overall Study|Protocol Violation|0|||
27547224|NCT01782222|80193076|FG000|Overall Study|Withdrawal by Subject|1|||
27547225|NCT01782222|80193077|FG001|Overall Study|Withdrawal by Subject|4|||
27547226|NCT01782222|80193078|FG002|Overall Study|Withdrawal by Subject|1|||
27547227|NCT01782222|80193076|FG000|Overall Study|Moved to other state|0|||
27547228|NCT01782222|80193077|FG001|Overall Study|Moved to other state|1|||
27547229|NCT01782222|80193078|FG002|Overall Study|Moved to other state|0|||
27547230|NCT00612040|80193090|FG000|Overall Study|Adverse Event|0|||
27547231|NCT00612040|80193091|FG001|Overall Study|Adverse Event|2|||
27547232|NCT00612040|80193092|FG002|Overall Study|Adverse Event|1|||
27547233|NCT00612040|80193090|FG000|Overall Study|Protocol Violation|1|||
27547234|NCT00612040|80193091|FG001|Overall Study|Protocol Violation|2|||
27547235|NCT00612040|80193092|FG002|Overall Study|Protocol Violation|1|||
27547236|NCT00612040|80193090|FG000|Overall Study|Lack of Efficacy|2|||
27547237|NCT00612040|80193091|FG001|Overall Study|Lack of Efficacy|1|||
27547238|NCT00612040|80193092|FG002|Overall Study|Lack of Efficacy|0|||
27547239|NCT00612040|80193090|FG000|Overall Study|Unclassified|2|||
27547240|NCT00612040|80193091|FG001|Overall Study|Unclassified|2|||
27547241|NCT00612040|80193092|FG002|Overall Study|Unclassified|5|||
27547242|NCT00329238|80193093|FG000|Overall Study|Adverse Event|147|||
27547243|NCT00329238|80193094|FG001|Overall Study|Adverse Event|129|||
27547244|NCT00329238|80193093|FG000|Overall Study|Protocol Violation|23|||
27640273|NCT01953692|80525851|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27640274|NCT01953692|80525852|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27640275|NCT01953692|80525853|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27640276|NCT01953692|80525854|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27547245|NCT00329238|80193094|FG001|Overall Study|Protocol Violation|34|||
27547246|NCT00329238|80193093|FG000|Overall Study|Lost to Follow-up|2|||
27547247|NCT00329238|80193094|FG001|Overall Study|Lost to Follow-up|6|||
27547248|NCT00329238|80193093|FG000|Overall Study|Withdrawal by Subject|64|||
27547249|NCT00329238|80193094|FG001|Overall Study|Withdrawal by Subject|58|||
27547250|NCT00329238|80193093|FG000|Overall Study|Other reason (not specified)|40|||
27547251|NCT00329238|80193094|FG001|Overall Study|Other reason (not specified)|54|||
27547252|NCT01897454|80193095|FG000|Overall Study|Withdrawal by Subject|1|||
27547253|NCT03845985|80193099|FG000|Overall Study|Lost to Follow-up|2|||
27547254|NCT03845985|80193100|FG001|Overall Study|Lost to Follow-up|1|||
27547255|NCT03845985|80193099|FG000|Overall Study|Physician Decision|1|||
27547256|NCT03845985|80193100|FG001|Overall Study|Physician Decision|0|||
27547257|NCT03845985|80193099|FG000|Overall Study|Withdrawal by Subject|4|||
27547258|NCT03845985|80193100|FG001|Overall Study|Withdrawal by Subject|1|||
27640277|NCT01953692|80525855|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27927611|NCT00876395|81574556|FG001|Overall Study|Death|0|||
27547259|NCT03919799|80193101|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
27547260|NCT03919799|80193102|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
27927612|NCT04470427|81574557|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
27547261|NCT03919799|80193103|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
27547262|NCT03919799|80193104|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
27547263|NCT03919799|80193105|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
27547264|NCT03919799|80193101|FG000|DB Period (28 Weeks)|Adverse Event|1|||
27547265|NCT03919799|80193102|FG001|DB Period (28 Weeks)|Adverse Event|1|||
27547266|NCT03919799|80193103|FG002|DB Period (28 Weeks)|Adverse Event|1|||
27547267|NCT03919799|80193104|FG003|DB Period (28 Weeks)|Adverse Event|0|||
27547268|NCT03919799|80193105|FG004|DB Period (28 Weeks)|Adverse Event|0|||
27547269|NCT03919799|80193101|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
27547270|NCT03919799|80193102|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
27547271|NCT03919799|80193103|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
27547272|NCT03919799|80193104|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
27547273|NCT03919799|80193105|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
27547274|NCT03919799|80193101|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
27547275|NCT03919799|80193102|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
27547276|NCT03919799|80193103|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
27547277|NCT03919799|80193104|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
27547278|NCT03919799|80193105|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
27547279|NCT03919799|80193101|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
27547280|NCT03919799|80193102|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
27547281|NCT03919799|80193103|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
27547282|NCT03919799|80193104|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
27547283|NCT03919799|80193105|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
27547284|NCT00996307|80193106|FG000|Overall Study|Adverse Event|0|||
27547285|NCT00996307|80193107|FG001|Overall Study|Adverse Event|1|||
27547286|NCT00996307|80193108|FG002|Overall Study|Adverse Event|0|||
27547287|NCT00996307|80193109|FG003|Overall Study|Adverse Event|0|||
27547288|NCT00996307|80193106|FG000|Overall Study|Withdrawal by Subject|3|||
27547289|NCT00996307|80193107|FG001|Overall Study|Withdrawal by Subject|2|||
27547290|NCT00996307|80193108|FG002|Overall Study|Withdrawal by Subject|5|||
27547291|NCT00996307|80193109|FG003|Overall Study|Withdrawal by Subject|5|||
27547292|NCT00996307|80193106|FG000|Overall Study|Lost to Follow-up|13|||
27547293|NCT00996307|80193107|FG001|Overall Study|Lost to Follow-up|13|||
27927613|NCT04470427|81574558|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
27927614|NCT04470427|81574559|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
27927615|NCT04470427|81574560|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
27927616|NCT04470427|81574561|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
27927617|NCT04470427|81574562|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
27927618|NCT04470427|81574557|FG000|Part B :Open-label|Other than specified|0|||
27927619|NCT04470427|81574558|FG001|Part B :Open-label|Other than specified|0|||
27927620|NCT04470427|81574559|FG002|Part B :Open-label|Other than specified|788|||
27927621|NCT04470427|81574560|FG003|Part B :Open-label|Other than specified|0|||
27927622|NCT04470427|81574561|FG004|Part B :Open-label|Other than specified|523|||
27927623|NCT04470427|81574562|FG005|Part B :Open-label|Other than specified|0|||
27927624|NCT04470427|81574557|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
27927625|NCT04470427|81574558|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
27927626|NCT04470427|81574559|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
27927627|NCT04470427|81574560|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
27927628|NCT04470427|81574561|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
27547294|NCT00996307|80193108|FG002|Overall Study|Lost to Follow-up|7|||
27547295|NCT00996307|80193109|FG003|Overall Study|Lost to Follow-up|15|||
27547296|NCT00996307|80193106|FG000|Overall Study|Administrative reason|0|||
27547297|NCT00996307|80193107|FG001|Overall Study|Administrative reason|1|||
27547298|NCT00996307|80193108|FG002|Overall Study|Administrative reason|0|||
27927629|NCT04470427|81574562|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
27927630|NCT04470427|81574557|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
27927631|NCT04470427|81574558|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
27927632|NCT04470427|81574559|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
27927633|NCT04470427|81574560|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
27927634|NCT04470427|81574561|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
27927635|NCT04470427|81574562|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
27927636|NCT04327271|81574563|FG000|Overall Study|Death|1|||
27927637|NCT04327271|81574564|FG001|Overall Study|Death|0|||
27927638|NCT04327271|81574563|FG000|Overall Study|Withdrawal by Subject|1|||
27927639|NCT04327271|81574564|FG001|Overall Study|Withdrawal by Subject|0|||
27927640|NCT04327271|81574563|FG000|Overall Study|randomization error (data capture)|4|||
27927641|NCT04327271|81574564|FG001|Overall Study|randomization error (data capture)|3|||
27927642|NCT00368550|81574568|FG000|Overall Study|Adverse Event|7|||
27927643|NCT00368550|81574569|FG001|Overall Study|Adverse Event|4|||
27927644|NCT00368550|81574568|FG000|Overall Study|Lack of Efficacy|4|||
27927645|NCT00368550|81574569|FG001|Overall Study|Lack of Efficacy|9|||
27927646|NCT00368550|81574568|FG000|Overall Study|Withdrawal by Subject|17|||
27927647|NCT00368550|81574569|FG001|Overall Study|Withdrawal by Subject|10|||
27927648|NCT01279200|81574570|FG000|Overall Study|Withdrawal by Subject|1|||
27927649|NCT01279200|81574571|FG001|Overall Study|Withdrawal by Subject|3|||
27547299|NCT00996307|80193109|FG003|Overall Study|Administrative reason|0|||
27547300|NCT00996307|80193106|FG000|Overall Study|Unable to classify|4|||
27547301|NCT00996307|80193107|FG001|Overall Study|Unable to classify|0|||
27547302|NCT00996307|80193108|FG002|Overall Study|Unable to classify|2|||
27547303|NCT00996307|80193109|FG003|Overall Study|Unable to classify|1|||
27742489|NCT00866294|80886929|FG001|Overall Study|Adverse Event|13|||
27927650|NCT01279200|81574570|FG000|Overall Study|Patient withdrawal due to high cost|0|||
27927651|NCT01279200|81574571|FG001|Overall Study|Patient withdrawal due to high cost|1|||
27927652|NCT01279200|81574570|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
27927653|NCT01279200|81574571|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
27927654|NCT01279200|81574570|FG000|Overall Study|ultrasound screening failure|0|||
27927655|NCT01279200|81574571|FG001|Overall Study|ultrasound screening failure|1|||
27927656|NCT01279200|81574570|FG000|Overall Study|Lost to Follow-up|0|||
27927657|NCT01279200|81574571|FG001|Overall Study|Lost to Follow-up|1|||
27927658|NCT01279200|81574570|FG000|Overall Study|Adverse Event|1|||
27927659|NCT01279200|81574571|FG001|Overall Study|Adverse Event|0|||
27927660|NCT01695746|81574572|FG000|Overall Study|Adverse Event|1|||
27927661|NCT01695746|81574572|FG000|Overall Study|Non-compliance by the participant|3|||
27927662|NCT01695746|81574572|FG000|Overall Study|Protocol Violation|5|||
27927663|NCT01695746|81574572|FG000|Overall Study|Participant not willing to participate|3|||
27927664|NCT01898078|81574587|FG000|Overall Study|Progressive Disease|1|||
27927665|NCT01898078|81574588|FG001|Overall Study|Progressive Disease|5|||
27927666|NCT01898078|81574587|FG000|Overall Study|Adverse Event|2|||
27927667|NCT01898078|81574588|FG001|Overall Study|Adverse Event|1|||
27927668|NCT01898078|81574587|FG000|Overall Study|Withdrawal by Subject|1|||
27927669|NCT01898078|81574588|FG001|Overall Study|Withdrawal by Subject|1|||
27927670|NCT01898078|81574587|FG000|Overall Study|Symptomatic Deterioration|2|||
27927671|NCT01898078|81574588|FG001|Overall Study|Symptomatic Deterioration|0|||
27927672|NCT01898078|81574587|FG000|Overall Study|Reason not Specified|0|||
27927673|NCT01898078|81574588|FG001|Overall Study|Reason not Specified|1|||
27927674|NCT03677401|81574592|FG000|Overall Study|Adverse Event|4|||
27927675|NCT03677401|81574593|FG001|Overall Study|Adverse Event|14|||
27927676|NCT03677401|81574592|FG000|Overall Study|Lack of Efficacy|3|||
27927677|NCT03677401|81574593|FG001|Overall Study|Lack of Efficacy|1|||
27927678|NCT03677401|81574592|FG000|Overall Study|Withdrawal by Subject|2|||
27927679|NCT03677401|81574593|FG001|Overall Study|Withdrawal by Subject|2|||
27927680|NCT03677401|81574592|FG000|Overall Study|Sponsor decision|0|||
27927681|NCT03677401|81574593|FG001|Overall Study|Sponsor decision|1|||
27927682|NCT03677401|81574592|FG000|Overall Study|Reason Unspecified|1|||
27927683|NCT03677401|81574593|FG001|Overall Study|Reason Unspecified|0|||
27927684|NCT02421510|81574594|FG000|Overall Study|Other|4|||
27927685|NCT02421510|81574595|FG001|Overall Study|Other|2|||
27927686|NCT02421510|81574596|FG002|Overall Study|Other|3|||
27927687|NCT02421510|81574594|FG000|Overall Study|Protocol Violation|1|||
27927688|NCT02421510|81574595|FG001|Overall Study|Protocol Violation|2|||
27927689|NCT02421510|81574596|FG002|Overall Study|Protocol Violation|0|||
27927690|NCT02421510|81574594|FG000|Overall Study|Death|1|||
27927691|NCT02421510|81574595|FG001|Overall Study|Death|0|||
27927692|NCT02421510|81574596|FG002|Overall Study|Death|0|||
27927693|NCT02421510|81574594|FG000|Overall Study|Noncompliance with study drug|1|||
27927694|NCT02421510|81574595|FG001|Overall Study|Noncompliance with study drug|0|||
27927695|NCT02421510|81574596|FG002|Overall Study|Noncompliance with study drug|0|||
27927696|NCT02421510|81574594|FG000|Overall Study|Physician Decision|1|||
27927697|NCT02421510|81574595|FG001|Overall Study|Physician Decision|1|||
27927698|NCT02421510|81574596|FG002|Overall Study|Physician Decision|3|||
27927699|NCT02421510|81574594|FG000|Overall Study|Adverse Event|9|||
27927700|NCT02421510|81574595|FG001|Overall Study|Adverse Event|10|||
27547304|NCT02478632|80193110|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
27547305|NCT02478632|80193111|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
27547306|NCT02478632|80193110|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
27547307|NCT02478632|80193111|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
27547308|NCT02478632|80193110|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
27547309|NCT02478632|80193111|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
27547310|NCT01749137|80193112|FG000|Overall Study|Adverse Event|4|||
27547311|NCT01749137|80193113|FG001|Overall Study|Adverse Event|4|||
27547312|NCT01749137|80193112|FG000|Overall Study|Lost to Follow-up|2|||
27547313|NCT01749137|80193113|FG001|Overall Study|Lost to Follow-up|3|||
27927701|NCT02421510|81574596|FG002|Overall Study|Adverse Event|18|||
27927702|NCT02421510|81574594|FG000|Overall Study|Pregnancy|1|||
27927703|NCT02421510|81574595|FG001|Overall Study|Pregnancy|1|||
27927704|NCT02421510|81574596|FG002|Overall Study|Pregnancy|0|||
27927705|NCT02421510|81574594|FG000|Overall Study|Withdrawal by Subject|14|||
27927706|NCT02421510|81574595|FG001|Overall Study|Withdrawal by Subject|18|||
27927707|NCT02421510|81574596|FG002|Overall Study|Withdrawal by Subject|12|||
27927708|NCT02421510|81574594|FG000|Overall Study|Lost to Follow-up|1|||
27927709|NCT02421510|81574595|FG001|Overall Study|Lost to Follow-up|1|||
27927710|NCT02421510|81574596|FG002|Overall Study|Lost to Follow-up|0|||
27927711|NCT01078545|81574604|FG000|Overall Study|Lost to Follow-up|13|||
27547314|NCT01749137|80193112|FG000|Overall Study|Physician Decision|1|||
27927712|NCT01078545|81574604|FG000|Overall Study|Physician Decision|6|||
27927713|NCT01078545|81574604|FG000|Overall Study|Withdrawal by Subject|3|||
27927714|NCT01078545|81574604|FG000|Overall Study|Death|3|||
27927715|NCT01078545|81574604|FG000|Overall Study|Participant moved to another physician|1|||
27927716|NCT03003468|81574607|FG000|Overall Study|Withdrawal by Subject|0|||
27927717|NCT03003468|81574608|FG001|Overall Study|Withdrawal by Subject|0|||
27927718|NCT03003468|81574609|FG002|Overall Study|Withdrawal by Subject|1|||
27927719|NCT03003468|81574607|FG000|Overall Study|No measurable lesions|0|||
27927720|NCT03003468|81574608|FG001|Overall Study|No measurable lesions|0|||
27927721|NCT03003468|81574609|FG002|Overall Study|No measurable lesions|1|||
27927722|NCT02178956|81574615|FG000|Overall Study|Lost to Follow-up|4|||
27927723|NCT02178956|81574616|FG001|Overall Study|Lost to Follow-up|4|||
27927724|NCT02178956|81574615|FG000|Overall Study|Sponsor terminated study|49|||
27927725|NCT02178956|81574616|FG001|Overall Study|Sponsor terminated study|58|||
27927726|NCT02178956|81574615|FG000|Overall Study|Withdrawal by Subject|15|||
27927727|NCT02178956|81574616|FG001|Overall Study|Withdrawal by Subject|11|||
27927728|NCT02178956|81574615|FG000|Overall Study|Various Reasons|3|||
27927729|NCT02178956|81574616|FG001|Overall Study|Various Reasons|5|||
27927730|NCT01995201|81574620|FG000|From Baseline Until Week 24|Adverse Event|4|||
27927731|NCT01995201|81574621|FG001|From Baseline Until Week 24|Adverse Event|15|||
27927732|NCT01995201|81574622|FG002|From Baseline Until Week 24|Adverse Event|0|||
27927733|NCT01995201|81574623|FG003|From Baseline Until Week 24|Adverse Event|0|||
27927734|NCT01995201|81574624|FG004|From Baseline Until Week 24|Adverse Event|0|||
27927735|NCT01995201|81574625|FG005|From Baseline Until Week 24|Adverse Event|0|||
27927736|NCT01995201|81574626|FG006|From Baseline Until Week 24|Adverse Event|0|||
27927737|NCT01995201|81574620|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27927738|NCT01995201|81574621|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
27927739|NCT01995201|81574622|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27927740|NCT01995201|81574623|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27927741|NCT01995201|81574624|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27927742|NCT01995201|81574625|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27927743|NCT01995201|81574626|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
27927744|NCT01995201|81574620|FG000|From Baseline Until Week 24|Death|0|||
27927745|NCT01995201|81574621|FG001|From Baseline Until Week 24|Death|1|||
27927746|NCT01995201|81574622|FG002|From Baseline Until Week 24|Death|0|||
27927747|NCT01995201|81574623|FG003|From Baseline Until Week 24|Death|0|||
27927748|NCT01995201|81574624|FG004|From Baseline Until Week 24|Death|0|||
27927749|NCT01995201|81574625|FG005|From Baseline Until Week 24|Death|0|||
27927750|NCT01995201|81574626|FG006|From Baseline Until Week 24|Death|0|||
27547315|NCT01749137|80193113|FG001|Overall Study|Physician Decision|0|||
27547316|NCT01749137|80193112|FG000|Overall Study|Withdrawal by Subject|8|||
27547317|NCT01749137|80193113|FG001|Overall Study|Withdrawal by Subject|4|||
27547318|NCT03167411|80193114|FG000|Overall Study|Adverse Event|0|||
27547319|NCT03167411|80193115|FG001|Overall Study|Adverse Event|1|||
27547320|NCT01756898|80193116|FG000|Overall Study|Adverse Event|7|||
27547321|NCT01756898|80193117|FG001|Overall Study|Adverse Event|1|||
27547322|NCT01756898|80193118|FG002|Overall Study|Adverse Event|0|||
27547323|NCT01756898|80193119|FG003|Overall Study|Adverse Event|0|||
27547324|NCT01756898|80193116|FG000|Overall Study|Lack of Efficacy|4|||
27547325|NCT01756898|80193117|FG001|Overall Study|Lack of Efficacy|7|||
27547326|NCT01756898|80193118|FG002|Overall Study|Lack of Efficacy|6|||
27547327|NCT01756898|80193119|FG003|Overall Study|Lack of Efficacy|6|||
27547328|NCT01756898|80193116|FG000|Overall Study|Lost to Follow-up|2|||
27547329|NCT01756898|80193117|FG001|Overall Study|Lost to Follow-up|4|||
27547330|NCT01756898|80193118|FG002|Overall Study|Lost to Follow-up|2|||
27547331|NCT01756898|80193119|FG003|Overall Study|Lost to Follow-up|3|||
27547332|NCT01756898|80193116|FG000|Overall Study|Protocol Violation|1|||
27927751|NCT01995201|81574620|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
27927752|NCT01995201|81574621|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
27927753|NCT01995201|81574622|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
27927754|NCT01995201|81574623|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
27927755|NCT01995201|81574624|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
27927756|NCT01995201|81574625|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
27927757|NCT01995201|81574626|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
27927758|NCT01995201|81574620|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
27927759|NCT01995201|81574621|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
27927760|NCT01995201|81574622|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
27927761|NCT01995201|81574623|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
27547333|NCT01756898|80193117|FG001|Overall Study|Protocol Violation|2|||
27547334|NCT01756898|80193118|FG002|Overall Study|Protocol Violation|2|||
27547335|NCT01756898|80193119|FG003|Overall Study|Protocol Violation|1|||
27547336|NCT01756898|80193116|FG000|Overall Study|Withdrew Consent|5|||
27547337|NCT01756898|80193117|FG001|Overall Study|Withdrew Consent|3|||
27927762|NCT01995201|81574624|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
27927763|NCT01995201|81574625|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
27927764|NCT01995201|81574626|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
27927765|NCT01995201|81574620|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
27547338|NCT01756898|80193118|FG002|Overall Study|Withdrew Consent|5|||
27547339|NCT01756898|80193119|FG003|Overall Study|Withdrew Consent|6|||
27547340|NCT01756898|80193116|FG000|Overall Study|Other|0|||
27547341|NCT01756898|80193117|FG001|Overall Study|Other|2|||
27547342|NCT01756898|80193118|FG002|Overall Study|Other|2|||
27547343|NCT01756898|80193119|FG003|Overall Study|Other|0|||
27547344|NCT00119106|80193120|FG000|Overall Study|HIV infected at baseline|179|||
27547345|NCT00119106|80193121|FG001|Overall Study|HIV infected at baseline|178|||
27547346|NCT00519831|80193123|FG000|Overall Study|Adverse Event|3|||
27547347|NCT01606007|80193126|FG000|Overall Study|Reason 'Other' in the protocol|0|||
27547348|NCT01606007|80193127|FG001|Overall Study|Reason 'Other' in the protocol|1|||
27547349|NCT01606007|80193128|FG002|Overall Study|Reason 'Other' in the protocol|1|||
27547350|NCT01606007|80193126|FG000|Overall Study|Pregnancy|0|||
27547351|NCT01606007|80193127|FG001|Overall Study|Pregnancy|1|||
27640278|NCT01953692|80525856|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
27640279|NCT01953692|80525857|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
27640280|NCT01953692|80525849|FG000|Overall Study|Withdrawal by Subject|4|||
27640281|NCT01953692|80525850|FG001|Overall Study|Withdrawal by Subject|2|||
27640282|NCT01953692|80525851|FG002|Overall Study|Withdrawal by Subject|1|||
27640283|NCT01953692|80525852|FG003|Overall Study|Withdrawal by Subject|2|||
27640284|NCT01953692|80525853|FG004|Overall Study|Withdrawal by Subject|0|||
27640285|NCT01953692|80525854|FG005|Overall Study|Withdrawal by Subject|3|||
27927766|NCT01995201|81574621|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
27927767|NCT01995201|81574622|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
27547352|NCT01606007|80193128|FG002|Overall Study|Pregnancy|1|||
27547353|NCT01606007|80193126|FG000|Overall Study|Withdrawal by Subject|8|||
27547354|NCT01606007|80193127|FG001|Overall Study|Withdrawal by Subject|6|||
27547355|NCT01606007|80193128|FG002|Overall Study|Withdrawal by Subject|1|||
27547356|NCT01606007|80193126|FG000|Overall Study|Adverse Event|0|||
27547357|NCT01606007|80193127|FG001|Overall Study|Adverse Event|1|||
27547358|NCT01606007|80193128|FG002|Overall Study|Adverse Event|1|||
27547359|NCT01606007|80193126|FG000|Overall Study|discontinue study treatment|0|||
27547360|NCT01606007|80193127|FG001|Overall Study|discontinue study treatment|2|||
27547361|NCT01606007|80193128|FG002|Overall Study|discontinue study treatment|1|||
27547362|NCT01606007|80193126|FG000|Overall Study|Lost to Follow-up|6|||
27547363|NCT01606007|80193127|FG001|Overall Study|Lost to Follow-up|8|||
27547364|NCT01606007|80193128|FG002|Overall Study|Lost to Follow-up|5|||
27547365|NCT01606007|80193126|FG000|Overall Study|Poor/Non-compliance|1|||
27547366|NCT01606007|80193127|FG001|Overall Study|Poor/Non-compliance|0|||
27547367|NCT01606007|80193128|FG002|Overall Study|Poor/Non-compliance|0|||
27547368|NCT00687323|80193133|FG000|Overall Study|Death|25|||
27547369|NCT00687323|80193133|FG000|Overall Study|Withdrawal by Subject|1|||
27547370|NCT00687323|80193133|FG000|Overall Study|Excluded from efficacy evaluations|6|||
27547371|NCT00687323|80193133|FG000|Overall Study|Screen failure|148|||
27547372|NCT00228384|80193134|FG000|Overall Study|Death|9|||
27547373|NCT00228384|80193135|FG001|Overall Study|Death|3|||
27547374|NCT00228384|80193134|FG000|Overall Study|Lost to Follow-up|6|||
27547375|NCT00228384|80193135|FG001|Overall Study|Lost to Follow-up|10|||
27547376|NCT00228384|80193134|FG000|Overall Study|Surgical Intervention (bypass)|5|||
27547377|NCT00228384|80193135|FG001|Overall Study|Surgical Intervention (bypass)|5|||
27547378|NCT00228384|80193134|FG000|Overall Study|Withdrawal by Subject|9|||
27547379|NCT00228384|80193135|FG001|Overall Study|Withdrawal by Subject|10|||
27547380|NCT00228384|80193134|FG000|Overall Study|Physician Decision|0|||
27547381|NCT00228384|80193135|FG001|Overall Study|Physician Decision|1|||
27547382|NCT03808545|80193139|FG000|Overall Study|Withdrawal by Subject|1|||
27547383|NCT03808545|80193140|FG001|Overall Study|Withdrawal by Subject|1|||
27547384|NCT01826604|80193141|FG000|Overall Study|Lost to Follow-up|8|||
27547385|NCT01826604|80193142|FG001|Overall Study|Lost to Follow-up|9|||
27547386|NCT04659161|80193147|FG000|Overall Study|Adverse Event|10|||
27547387|NCT04659161|80193148|FG001|Overall Study|Adverse Event|6|||
27547388|NCT04659161|80193147|FG000|Overall Study|Withdrawal by Subject|13|||
27547389|NCT04659161|80193148|FG001|Overall Study|Withdrawal by Subject|12|||
27547390|NCT04659161|80193147|FG000|Overall Study|Other|9|||
27547391|NCT04659161|80193148|FG001|Overall Study|Other|8|||
27547392|NCT01389817|80193153|FG000|Overall Study|Physician Decision|1|||
27547393|NCT01389817|80193154|FG001|Overall Study|Physician Decision|0|||
27547394|NCT01389817|80193153|FG000|Overall Study|Lost to Follow-up|1|||
27547395|NCT01389817|80193154|FG001|Overall Study|Lost to Follow-up|0|||
27547396|NCT01389817|80193153|FG000|Overall Study|Withdrawal by Subject|2|||
27547397|NCT01389817|80193154|FG001|Overall Study|Withdrawal by Subject|0|||
27547398|NCT04189081|80193158|FG000|Overall Study|Lost to Follow-up|1|||
27547399|NCT04189081|80193159|FG001|Overall Study|Lost to Follow-up|0|||
27547400|NCT04189081|80193160|FG002|Overall Study|Lost to Follow-up|0|||
27927768|NCT01995201|81574623|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
27547401|NCT04189081|80193158|FG000|Overall Study|Withdrawal by Subject|0|||
27640286|NCT01953692|80525855|FG006|Overall Study|Withdrawal by Subject|2|||
27640287|NCT01953692|80525856|FG007|Overall Study|Withdrawal by Subject|1|||
27640288|NCT01953692|80525857|FG008|Overall Study|Withdrawal by Subject|1|||
27640289|NCT04377308|80525858|FG000|Overall Study|Withdrawal by Subject|0|||
27547402|NCT04189081|80193159|FG001|Overall Study|Withdrawal by Subject|0|||
27547403|NCT04189081|80193160|FG002|Overall Study|Withdrawal by Subject|1|||
27547404|NCT01898806|80193167|FG000|Overall Study|Withdrawal by Subject|2|||
27547405|NCT01898806|80193167|FG000|Overall Study|Physician Decision|1|||
27547406|NCT01217814|80193168|FG000|Overall Study|Adverse Event|1|||
27547407|NCT01217814|80193169|FG001|Overall Study|Adverse Event|1|||
27547408|NCT01217814|80193170|FG002|Overall Study|Adverse Event|0|||
27547409|NCT01217814|80193168|FG000|Overall Study|Lack of Efficacy|0|||
27547410|NCT01217814|80193169|FG001|Overall Study|Lack of Efficacy|0|||
27547411|NCT01217814|80193170|FG002|Overall Study|Lack of Efficacy|1|||
27547412|NCT03305575|80193175|FG000|Overall Study|Physician Decision|1|||
27547413|NCT03305575|80193176|FG001|Overall Study|Physician Decision|0|||
27547414|NCT03003390|80193179|FG000|Overall Study|Physician Decision|2|||
27547415|NCT03003390|80193180|FG001|Overall Study|Physician Decision|0|||
27547416|NCT03003390|80193179|FG000|Overall Study|Parent refused intervention|2|||
27547417|NCT03003390|80193180|FG001|Overall Study|Parent refused intervention|0|||
27547418|NCT01051323|80193184|FG000|Overall Study|Discontinuation of treatment|103|||
27547419|NCT01051323|80193184|FG000|Overall Study|Transplantation|28|||
27547420|NCT01051323|80193184|FG000|Overall Study|Dialysis dependency|22|||
27547421|NCT01051323|80193184|FG000|Overall Study|Withdrawal by Subject|13|||
27547422|NCT01051323|80193184|FG000|Overall Study|Lost to Follow-up|31|||
27547423|NCT01051323|80193184|FG000|Overall Study|Death|129|||
27547424|NCT01051323|80193184|FG000|Overall Study|Hospitalization|28|||
27547425|NCT01051323|80193184|FG000|Overall Study|Other|148|||
27547426|NCT01051323|80193184|FG000|Overall Study|Missing|37|||
27547427|NCT02036294|80193202|FG000|Overall Study|Death|7|||
27547428|NCT02036294|80193203|FG001|Overall Study|Death|8|||
27547429|NCT02036294|80193202|FG000|Overall Study|Withdrawal by Subject|2|||
27547430|NCT02036294|80193203|FG001|Overall Study|Withdrawal by Subject|3|||
27547431|NCT00064337|80193205|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
27547432|NCT00064337|80193205|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
27547433|NCT00064337|80193205|FG000|PBSCC or Induction/PBSCC|Progression|3|||
27547434|NCT00064337|80193205|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
27547435|NCT00064337|80193205|FG000|PBSCC or Induction/PBSCC|Death|2|||
27547436|NCT00064337|80193205|FG000|Transplant|Adverse Event|9|||
27547437|NCT00064337|80193205|FG000|Transplant|Not protocol-specified|5|||
27547438|NCT00064337|80193205|FG000|Transplant|Death|3|||
27547439|NCT00064337|80193205|FG000|Transplant|Patient Refusal|2|||
27547440|NCT00064337|80193205|FG000|Transplant|Progression|2|||
27547441|NCT00064337|80193205|FG000|Maintenance|Adverse Event|3|||
27547442|NCT00064337|80193205|FG000|Maintenance|Progression|2|||
27547443|NCT00064337|80193205|FG000|Maintenance|On treatment at time of analysis|2|||
27547444|NCT00064337|80193205|FG000|Maintenance|Not protocol-specified|2|||
27547445|NCT00064337|80193205|FG000|Maintenance|Death|1|||
27547446|NCT03782792|80193206|FG000|Overall Study|Patient left the country|0|||
27547447|NCT03782792|80193207|FG001|Overall Study|Patient left the country|1|||
27547448|NCT03782792|80193206|FG000|Overall Study|Withdrawal by Subject|1|||
27547449|NCT03782792|80193207|FG001|Overall Study|Withdrawal by Subject|2|||
27547450|NCT01408485|80193208|FG000|Overall Study|Withdrawal by Subject|21|||
27547451|NCT05048784|80193209|FG000|Period 1|Adverse Event|3|||
27547452|NCT05048784|80193210|FG001|Period 1|Adverse Event|1|||
27547453|NCT05048784|80193211|FG002|Period 1|Adverse Event|0|||
27547454|NCT05048784|80193212|FG003|Period 1|Adverse Event|0|||
27547455|NCT05048784|80193209|FG000|Period 2|Lost to Follow-up|0|||
27547456|NCT05048784|80193210|FG001|Period 2|Lost to Follow-up|1|||
27547457|NCT05048784|80193211|FG002|Period 2|Lost to Follow-up|0|||
27547458|NCT05048784|80193212|FG003|Period 2|Lost to Follow-up|0|||
27547459|NCT01918774|80193213|FG000|Overall Study|Lost prior to first CBTw session|4|||
27547460|NCT01918774|80193213|FG000|Overall Study|Lost to Follow-up|1|||
27547461|NCT01382212|80193214|FG000|Overall Study|Kidney transplant|1|||
27547462|NCT01382212|80193214|FG000|Overall Study|Withdrew consent|1|||
27547463|NCT03547583|80193215|FG000|Overall Study|Adverse Event|16|||
27742490|NCT00866294|80886930|FG002|Overall Study|Adverse Event|9|||
27547464|NCT03547583|80193216|FG001|Overall Study|Adverse Event|11|||
27547465|NCT03547583|80193217|FG002|Overall Study|Adverse Event|10|||
27547466|NCT03547583|80193215|FG000|Overall Study|Death|11|||
27742491|NCT00866294|80886928|FG000|Overall Study|Lack of Efficacy|7|||
27742492|NCT00866294|80886929|FG001|Overall Study|Lack of Efficacy|1|||
27742493|NCT00866294|80886930|FG002|Overall Study|Lack of Efficacy|0|||
27547467|NCT03547583|80193216|FG001|Overall Study|Death|7|||
27547468|NCT03547583|80193217|FG002|Overall Study|Death|4|||
27927769|NCT01995201|81574624|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
27927770|NCT01995201|81574625|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
27547469|NCT03547583|80193215|FG000|Overall Study|Lost to Follow-up|1|||
27547470|NCT03547583|80193216|FG001|Overall Study|Lost to Follow-up|0|||
27547471|NCT03547583|80193217|FG002|Overall Study|Lost to Follow-up|0|||
27547472|NCT03547583|80193215|FG000|Overall Study|Non-compliance with study drug|0|||
27547473|NCT03547583|80193216|FG001|Overall Study|Non-compliance with study drug|0|||
27547474|NCT03547583|80193217|FG002|Overall Study|Non-compliance with study drug|1|||
27742494|NCT00866294|80886928|FG000|Overall Study|Protocol Violation|2|||
27547475|NCT03547583|80193215|FG000|Overall Study|Physician Decision|1|||
27547476|NCT03547583|80193216|FG001|Overall Study|Physician Decision|0|||
27547477|NCT03547583|80193217|FG002|Overall Study|Physician Decision|3|||
27547478|NCT03547583|80193215|FG000|Overall Study|Protocol Violation|2|||
27547479|NCT03547583|80193216|FG001|Overall Study|Protocol Violation|1|||
27547480|NCT03547583|80193217|FG002|Overall Study|Protocol Violation|1|||
27547481|NCT03547583|80193215|FG000|Overall Study|Withdrawal by Subject|12|||
27547482|NCT03547583|80193216|FG001|Overall Study|Withdrawal by Subject|19|||
27547483|NCT03547583|80193217|FG002|Overall Study|Withdrawal by Subject|10|||
27547484|NCT03547583|80193215|FG000|Overall Study|Other|2|||
27547485|NCT03547583|80193216|FG001|Overall Study|Other|2|||
27547486|NCT03547583|80193217|FG002|Overall Study|Other|3|||
27547487|NCT00885846|80193218|FG000|Overall Study|Withdrawal by Subject|2|||
27547488|NCT00885846|80193219|FG001|Overall Study|Withdrawal by Subject|5|||
27547489|NCT00885846|80193220|FG002|Overall Study|Withdrawal by Subject|2|||
27547490|NCT02555683|80193221|FG000|Overall Study|Physician Decision|1|||
27547491|NCT02555683|80193222|FG001|Overall Study|Physician Decision|0|||
27547492|NCT02555683|80193223|FG002|Overall Study|Physician Decision|2|||
27547493|NCT02555683|80193221|FG000|Overall Study|Lost to Follow-up|2|||
27547494|NCT02555683|80193222|FG001|Overall Study|Lost to Follow-up|1|||
27547495|NCT02555683|80193223|FG002|Overall Study|Lost to Follow-up|2|||
27547496|NCT02555683|80193221|FG000|Overall Study|Technical Problems|1|||
27547497|NCT02555683|80193222|FG001|Overall Study|Technical Problems|1|||
27547498|NCT02555683|80193223|FG002|Overall Study|Technical Problems|0|||
27547499|NCT02555683|80193221|FG000|Overall Study|Protocol deviation|0|||
27547500|NCT02555683|80193222|FG001|Overall Study|Protocol deviation|1|||
27547501|NCT02555683|80193223|FG002|Overall Study|Protocol deviation|0|||
27547502|NCT02555683|80193221|FG000|Overall Study|Lack of Efficacy|2|||
27547503|NCT02555683|80193222|FG001|Overall Study|Lack of Efficacy|0|||
27547504|NCT02555683|80193223|FG002|Overall Study|Lack of Efficacy|0|||
27547505|NCT02555683|80193221|FG000|Overall Study|Death|0|||
27927771|NCT01995201|81574626|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
27927772|NCT01995201|81574620|FG000|From Baseline Until Week 24|Physician Decision|0|||
27927773|NCT01995201|81574621|FG001|From Baseline Until Week 24|Physician Decision|2|||
27927774|NCT01995201|81574622|FG002|From Baseline Until Week 24|Physician Decision|0|||
27927775|NCT01995201|81574623|FG003|From Baseline Until Week 24|Physician Decision|0|||
27927776|NCT01995201|81574624|FG004|From Baseline Until Week 24|Physician Decision|0|||
27927777|NCT01995201|81574625|FG005|From Baseline Until Week 24|Physician Decision|0|||
27927778|NCT01995201|81574626|FG006|From Baseline Until Week 24|Physician Decision|0|||
27547506|NCT02555683|80193222|FG001|Overall Study|Death|1|||
27547507|NCT02555683|80193223|FG002|Overall Study|Death|2|||
27547508|NCT02555683|80193221|FG000|Overall Study|Adverse Event|1|||
27547509|NCT02555683|80193222|FG001|Overall Study|Adverse Event|0|||
27547510|NCT02555683|80193223|FG002|Overall Study|Adverse Event|1|||
27547511|NCT02555683|80193221|FG000|Overall Study|Subject/guardian decision|12|||
27547512|NCT02555683|80193222|FG001|Overall Study|Subject/guardian decision|12|||
27547513|NCT02555683|80193223|FG002|Overall Study|Subject/guardian decision|22|||
27547514|NCT02555683|80193221|FG000|Overall Study|Death post Treatment/safety period|0|||
27547515|NCT02555683|80193222|FG001|Overall Study|Death post Treatment/safety period|1|||
27547516|NCT02555683|80193223|FG002|Overall Study|Death post Treatment/safety period|0|||
27547517|NCT01666782|80193224|FG000|Overall Study|Received 2 doses of vaccine|0|||
27547518|NCT01666782|80193225|FG001|Overall Study|Received 2 doses of vaccine|1|||
27547519|NCT01666782|80193224|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
27547520|NCT01666782|80193225|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
27547521|NCT00640601|80193226|FG000|Overall Study|Adverse Event|43|||
27547522|NCT00640601|80193226|FG000|Overall Study|Withdrawal by Subject|20|||
27547523|NCT00640601|80193226|FG000|Overall Study|Protocol Violation|6|||
27547524|NCT00640601|80193226|FG000|Overall Study|Lack of Efficacy|16|||
27742495|NCT00866294|80886929|FG001|Overall Study|Protocol Violation|0|||
27742496|NCT00866294|80886930|FG002|Overall Study|Protocol Violation|0|||
27927779|NCT01995201|81574620|FG000|From Baseline Until Week 24|Protocol Violation|0|||
27927780|NCT01995201|81574621|FG001|From Baseline Until Week 24|Protocol Violation|9|||
27547525|NCT00640601|80193226|FG000|Overall Study|Lost to Follow-up|9|||
27547526|NCT00640601|80193226|FG000|Overall Study|Physician Decision|8|||
27547527|NCT00640601|80193226|FG000|Overall Study|treatment naive, combination therapy|10|||
27547528|NCT03200860|80193231|FG000|Overall Study|Withdrawal by Subject|1|||
27547529|NCT03200860|80193232|FG001|Overall Study|Withdrawal by Subject|0|||
27547530|NCT00541931|80193233|FG000|Overall Study|Adverse Event|1|||
27927781|NCT01995201|81574622|FG002|From Baseline Until Week 24|Protocol Violation|0|||
27927782|NCT01995201|81574623|FG003|From Baseline Until Week 24|Protocol Violation|0|||
27547531|NCT00541931|80193234|FG001|Overall Study|Adverse Event|0|||
27547532|NCT00541931|80193233|FG000|Overall Study|Lost to Follow-up|3|||
27547533|NCT00541931|80193234|FG001|Overall Study|Lost to Follow-up|3|||
27547534|NCT00541931|80193233|FG000|Overall Study|Withdrawal by Subject|1|||
27547535|NCT00541931|80193234|FG001|Overall Study|Withdrawal by Subject|0|||
27547536|NCT00541931|80193233|FG000|Overall Study|Transportation Issue|0|||
27742497|NCT00866294|80886928|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
27927783|NCT01995201|81574624|FG004|From Baseline Until Week 24|Protocol Violation|0|||
27927784|NCT01995201|81574625|FG005|From Baseline Until Week 24|Protocol Violation|0|||
27927785|NCT01995201|81574626|FG006|From Baseline Until Week 24|Protocol Violation|0|||
27927786|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Adverse Event|0|||
27927787|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Adverse Event|0|||
27927788|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Adverse Event|2|||
27927789|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Adverse Event|1|||
27927790|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Adverse Event|1|||
27927791|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Adverse Event|3|||
27547537|NCT00541931|80193234|FG001|Overall Study|Transportation Issue|1|||
27547538|NCT02955602|80193235|FG000|Overall Study|Adverse Event|0|||
27927792|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Adverse Event|1|||
27927793|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Death|0|||
27927794|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Death|0|||
27927795|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Death|0|||
27927796|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Death|0|||
27927797|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Death|0|||
27927798|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Death|2|||
27927799|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Death|0|||
27927800|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
27927801|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
27927802|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
27927803|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
27927804|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
27927805|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
27927806|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
27927807|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
27927808|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
27927809|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
27927810|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
27927811|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
27927812|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
27927813|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
27927814|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27927815|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27927816|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
27927817|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27927818|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
27927819|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27927820|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
27927821|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Physician Decision|0|||
27927822|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Physician Decision|0|||
27927823|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Physician Decision|0|||
27927824|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Physician Decision|0|||
27927825|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Physician Decision|1|||
27927826|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Physician Decision|0|||
27927827|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Physician Decision|0|||
27927828|NCT01995201|81574620|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
27927829|NCT01995201|81574621|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
27927830|NCT01995201|81574622|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
27927831|NCT01995201|81574623|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
27927832|NCT01995201|81574624|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
27927833|NCT01995201|81574625|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
27927834|NCT01995201|81574626|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
27927835|NCT01033071|81574631|FG000|Overall Study|Adverse Event|28|||
27927836|NCT01033071|81574632|FG001|Overall Study|Adverse Event|51|||
27927837|NCT01033071|81574633|FG002|Overall Study|Adverse Event|26|||
27927838|NCT01033071|81574631|FG000|Overall Study|Protocol Violation|0|||
27927839|NCT01033071|81574632|FG001|Overall Study|Protocol Violation|2|||
27547539|NCT02955602|80193236|FG001|Overall Study|Adverse Event|3|||
27547540|NCT02955602|80193237|FG002|Overall Study|Adverse Event|0|||
27927840|NCT01033071|81574633|FG002|Overall Study|Protocol Violation|1|||
27927841|NCT01033071|81574631|FG000|Overall Study|Lost to Follow-up|4|||
27927842|NCT01033071|81574632|FG001|Overall Study|Lost to Follow-up|5|||
27927843|NCT01033071|81574633|FG002|Overall Study|Lost to Follow-up|5|||
27927844|NCT01033071|81574631|FG000|Overall Study|Withdrawal by Subject|17|||
27927845|NCT01033071|81574632|FG001|Overall Study|Withdrawal by Subject|14|||
27927846|NCT01033071|81574633|FG002|Overall Study|Withdrawal by Subject|11|||
27927847|NCT01033071|81574631|FG000|Overall Study|Lack of Efficacy|0|||
27927848|NCT01033071|81574632|FG001|Overall Study|Lack of Efficacy|1|||
27927849|NCT01033071|81574633|FG002|Overall Study|Lack of Efficacy|1|||
27927850|NCT01033071|81574631|FG000|Overall Study|Other|6|||
27927851|NCT01033071|81574632|FG001|Overall Study|Other|4|||
27547541|NCT02955602|80193235|FG000|Overall Study|Withdrawal of informed consent|1|||
27927852|NCT01033071|81574633|FG002|Overall Study|Other|3|||
27927853|NCT04871113|81574634|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927854|NCT04871113|81574635|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927855|NCT04871113|81574636|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927856|NCT04871113|81574637|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927857|NCT04871113|81574638|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927858|NCT04871113|81574639|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
27927859|NCT04871113|81574640|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927860|NCT04871113|81574641|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927861|NCT04871113|81574642|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927862|NCT04871113|81574643|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
27927863|NCT04871113|81574634|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927864|NCT04871113|81574635|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927865|NCT04871113|81574636|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927866|NCT04871113|81574637|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927867|NCT04871113|81574638|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927868|NCT04871113|81574639|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927869|NCT04871113|81574640|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
27927870|NCT04871113|81574641|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
27927871|NCT04871113|81574642|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927872|NCT04871113|81574643|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
27927873|NCT01454284|81574644|FG000|Overall Study|Adverse Event|20|||
27927874|NCT01454284|81574645|FG001|Overall Study|Adverse Event|7|||
27927875|NCT01454284|81574644|FG000|Overall Study|Death|0|||
27927876|NCT01454284|81574645|FG001|Overall Study|Death|3|||
27927877|NCT01454284|81574644|FG000|Overall Study|Lost to Follow-up|13|||
27927878|NCT01454284|81574645|FG001|Overall Study|Lost to Follow-up|8|||
27640290|NCT04377308|80525859|FG001|Overall Study|Withdrawal by Subject|1|||
27640291|NCT00087139|80525861|FG000|Overall Study|Adverse Event|18|||
27640292|NCT00087139|80525862|FG001|Overall Study|Adverse Event|17|||
27640293|NCT00087139|80525863|FG002|Overall Study|Adverse Event|13|||
27640294|NCT00087139|80525861|FG000|Overall Study|Death|2|||
27640295|NCT00087139|80525862|FG001|Overall Study|Death|1|||
27547542|NCT02955602|80193236|FG001|Overall Study|Withdrawal of informed consent|3|||
27547543|NCT02955602|80193237|FG002|Overall Study|Withdrawal of informed consent|2|||
27547544|NCT02955602|80193235|FG000|Overall Study|Lost to Follow-up|0|||
27547545|NCT02955602|80193236|FG001|Overall Study|Lost to Follow-up|0|||
27547546|NCT02955602|80193237|FG002|Overall Study|Lost to Follow-up|1|||
27547547|NCT02955602|80193235|FG000|Overall Study|Other|0|||
27547548|NCT02955602|80193236|FG001|Overall Study|Other|1|||
27547549|NCT02955602|80193237|FG002|Overall Study|Other|3|||
27547550|NCT01977794|80193238|FG000|Overall Study|Adverse Event|2|||
27547551|NCT01977794|80193239|FG001|Overall Study|Adverse Event|2|||
27547552|NCT01977794|80193238|FG000|Overall Study|Lost to Follow-up|2|||
27547553|NCT01977794|80193239|FG001|Overall Study|Lost to Follow-up|1|||
27547554|NCT01977794|80193238|FG000|Overall Study|Protocol Violation|1|||
27547555|NCT01977794|80193239|FG001|Overall Study|Protocol Violation|0|||
27547556|NCT01977794|80193238|FG000|Overall Study|Death|1|||
27640296|NCT00087139|80525863|FG002|Overall Study|Death|0|||
27927879|NCT01454284|81574644|FG000|Overall Study|Protocol Violation|9|||
27927880|NCT01454284|81574645|FG001|Overall Study|Protocol Violation|6|||
27927881|NCT01454284|81574644|FG000|Overall Study|Withdrawal by Subject|58|||
27927882|NCT01454284|81574645|FG001|Overall Study|Withdrawal by Subject|36|||
27927883|NCT01454284|81574644|FG000|Overall Study|Physician Decision|16|||
27927884|NCT01454284|81574645|FG001|Overall Study|Physician Decision|11|||
27927885|NCT01454284|81574644|FG000|Overall Study|Sponsor Decision|0|||
27927886|NCT01454284|81574645|FG001|Overall Study|Sponsor Decision|2|||
27927887|NCT00782067|81574646|FG000|Overall Study|Adverse Event|35|||
27927888|NCT00782067|81574646|FG000|Overall Study|Subject withdrew consent|11|||
27927889|NCT00782067|81574646|FG000|Overall Study|Lost to Follow-up|2|||
27927890|NCT00782067|81574646|FG000|Overall Study|Administrative problems|14|||
27927891|NCT00782067|81574646|FG000|Overall Study|Death|9|||
27927892|NCT00782067|81574646|FG000|Overall Study|Disease progression|43|||
27547557|NCT01977794|80193239|FG001|Overall Study|Death|1|||
27547558|NCT01977794|80193238|FG000|Overall Study|Withdrew consent|2|||
27640297|NCT00087139|80525861|FG000|Overall Study|Withdrawal by Subject|3|||
27927893|NCT00782067|81574646|FG000|Overall Study|Protocol deviation|2|||
27927894|NCT03550209|81574647|FG000|Overall Study|Lost to Follow-up|1|||
27927895|NCT03550209|81574648|FG001|Overall Study|Lost to Follow-up|0|||
27927896|NCT03550209|81574649|FG002|Overall Study|Lost to Follow-up|1|||
27927897|NCT03550209|81574650|FG003|Overall Study|Lost to Follow-up|0|||
27640298|NCT00087139|80525862|FG001|Overall Study|Withdrawal by Subject|2|||
27547559|NCT01977794|80193239|FG001|Overall Study|Withdrew consent|1|||
27640299|NCT00087139|80525863|FG002|Overall Study|Withdrawal by Subject|2|||
27547560|NCT01977794|80193238|FG000|Overall Study|Other|0|||
27927898|NCT03550209|81574647|FG000|Overall Study|Withdrawal by Subject|0|||
27547561|NCT01977794|80193239|FG001|Overall Study|Other|1|||
27547562|NCT01496807|80193240|FG000|Overall Study|Progressive Disease|21|||
27547563|NCT01496807|80193240|FG000|Overall Study|Participant preference/toxicity|8|||
27547564|NCT01496807|80193240|FG000|Overall Study|Change in diagnosis|1|||
27547565|NCT02549937|80193242|FG000|Overall Study|Death|0|||
27547566|NCT02549937|80193243|FG001|Overall Study|Death|1|||
27547567|NCT02549937|80193244|FG002|Overall Study|Death|0|||
27547568|NCT02549937|80193245|FG003|Overall Study|Death|1|||
27547569|NCT02549937|80193246|FG004|Overall Study|Death|0|||
27547570|NCT02549937|80193247|FG005|Overall Study|Death|8|||
27547571|NCT02549937|80193248|FG006|Overall Study|Death|0|||
27547572|NCT02549937|80193249|FG007|Overall Study|Death|0|||
27547573|NCT02549937|80193250|FG008|Overall Study|Death|19|||
27547574|NCT02549937|80193242|FG000|Overall Study|No follow up required|3|||
27547575|NCT02549937|80193243|FG001|Overall Study|No follow up required|6|||
27547576|NCT02549937|80193244|FG002|Overall Study|No follow up required|3|||
27547577|NCT02549937|80193245|FG003|Overall Study|No follow up required|8|||
27547578|NCT02549937|80193246|FG004|Overall Study|No follow up required|12|||
27547579|NCT02549937|80193247|FG005|Overall Study|No follow up required|21|||
27547580|NCT02549937|80193248|FG006|Overall Study|No follow up required|9|||
27547581|NCT02549937|80193249|FG007|Overall Study|No follow up required|11|||
27547582|NCT02549937|80193250|FG008|Overall Study|No follow up required|0|||
27547583|NCT02549937|80193242|FG000|Overall Study|Other|0|||
27547584|NCT02549937|80193243|FG001|Overall Study|Other|0|||
27547585|NCT02549937|80193244|FG002|Overall Study|Other|0|||
27547586|NCT02549937|80193245|FG003|Overall Study|Other|0|||
27547587|NCT02549937|80193246|FG004|Overall Study|Other|1|||
27547588|NCT02549937|80193247|FG005|Overall Study|Other|0|||
27547589|NCT02549937|80193248|FG006|Overall Study|Other|3|||
27547590|NCT02549937|80193249|FG007|Overall Study|Other|2|||
27547591|NCT02549937|80193250|FG008|Overall Study|Other|3|||
27547592|NCT02549937|80193242|FG000|Overall Study|Lost to Follow-up|0|||
27547593|NCT02549937|80193243|FG001|Overall Study|Lost to Follow-up|0|||
27547594|NCT02549937|80193244|FG002|Overall Study|Lost to Follow-up|0|||
27547595|NCT02549937|80193245|FG003|Overall Study|Lost to Follow-up|0|||
27547596|NCT02549937|80193246|FG004|Overall Study|Lost to Follow-up|0|||
27547597|NCT02549937|80193247|FG005|Overall Study|Lost to Follow-up|0|||
27547598|NCT02549937|80193248|FG006|Overall Study|Lost to Follow-up|0|||
27640300|NCT00087139|80525861|FG000|Overall Study|Physician Decision|1|||
27927899|NCT03550209|81574648|FG001|Overall Study|Withdrawal by Subject|3|||
27927900|NCT03550209|81574649|FG002|Overall Study|Withdrawal by Subject|1|||
27927901|NCT03550209|81574650|FG003|Overall Study|Withdrawal by Subject|2|||
27927902|NCT03550209|81574647|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
27927903|NCT03550209|81574648|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
27927904|NCT03550209|81574649|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
27927905|NCT03550209|81574650|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
27927906|NCT02965833|81574651|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
27927907|NCT02965833|81574652|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
27927908|NCT02965833|81574651|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
27927909|NCT02965833|81574652|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
27927910|NCT02965833|81574651|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
27927911|NCT02965833|81574652|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
27927912|NCT02965833|81574651|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
27927913|NCT02965833|81574652|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
27927914|NCT02965833|81574651|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
27927915|NCT02965833|81574652|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
27927916|NCT01910441|81574654|FG000|Overall Study|Sponsor decision|0|||
27927917|NCT01910441|81574655|FG001|Overall Study|Sponsor decision|2|||
27927918|NCT01910441|81574654|FG000|Overall Study|Lost to Follow-up|6|||
27927919|NCT01910441|81574655|FG001|Overall Study|Lost to Follow-up|5|||
27927920|NCT01910441|81574654|FG000|Overall Study|Withdrawal by Subject|0|||
27927921|NCT01910441|81574655|FG001|Overall Study|Withdrawal by Subject|1|||
27927922|NCT01910441|81574654|FG000|Overall Study|Non-compliance|0|||
27547599|NCT02549937|80193249|FG007|Overall Study|Lost to Follow-up|0|||
27547600|NCT02549937|80193250|FG008|Overall Study|Lost to Follow-up|3|||
27547601|NCT02549937|80193242|FG000|Overall Study|Withdrawal by Subject|0|||
27547602|NCT02549937|80193243|FG001|Overall Study|Withdrawal by Subject|0|||
27547603|NCT02549937|80193244|FG002|Overall Study|Withdrawal by Subject|0|||
27547604|NCT02549937|80193245|FG003|Overall Study|Withdrawal by Subject|0|||
27547605|NCT02549937|80193246|FG004|Overall Study|Withdrawal by Subject|0|||
27927923|NCT01910441|81574655|FG001|Overall Study|Non-compliance|1|||
27927924|NCT01910441|81574654|FG000|Overall Study|Adverse Event|1|||
27927925|NCT01910441|81574655|FG001|Overall Study|Adverse Event|0|||
27547606|NCT02549937|80193247|FG005|Overall Study|Withdrawal by Subject|1|||
27547607|NCT02549937|80193248|FG006|Overall Study|Withdrawal by Subject|4|||
27547608|NCT02549937|80193249|FG007|Overall Study|Withdrawal by Subject|3|||
27640301|NCT00087139|80525862|FG001|Overall Study|Physician Decision|1|||
27640302|NCT00087139|80525863|FG002|Overall Study|Physician Decision|1|||
27547609|NCT02549937|80193250|FG008|Overall Study|Withdrawal by Subject|2|||
27547610|NCT02549937|80193242|FG000|Overall Study|Sponsor Decision|0|||
27547611|NCT02549937|80193243|FG001|Overall Study|Sponsor Decision|0|||
27547612|NCT02549937|80193244|FG002|Overall Study|Sponsor Decision|0|||
27547613|NCT02549937|80193245|FG003|Overall Study|Sponsor Decision|0|||
27547614|NCT02549937|80193246|FG004|Overall Study|Sponsor Decision|0|||
27547615|NCT02549937|80193247|FG005|Overall Study|Sponsor Decision|0|||
27547616|NCT02549937|80193248|FG006|Overall Study|Sponsor Decision|0|||
27547617|NCT02549937|80193249|FG007|Overall Study|Sponsor Decision|0|||
27547618|NCT02549937|80193250|FG008|Overall Study|Sponsor Decision|6|||
27547619|NCT00777608|80193251|FG000|Overall Study|Lost to Follow-up|1|||
27547620|NCT00777608|80193252|FG001|Overall Study|Lost to Follow-up|1|||
27547621|NCT00777608|80193251|FG000|Overall Study|Withdrawal by Subject|1|||
27547622|NCT00777608|80193252|FG001|Overall Study|Withdrawal by Subject|3|||
27547623|NCT00777608|80193251|FG000|Overall Study|Protocol Violation|1|||
27547624|NCT00777608|80193252|FG001|Overall Study|Protocol Violation|0|||
27547625|NCT00777608|80193251|FG000|Overall Study|Investigator Decision|1|||
27547626|NCT00777608|80193252|FG001|Overall Study|Investigator Decision|2|||
27547627|NCT00571948|80193253|FG000|Overall Study|Lost to Follow-up|2|||
27547628|NCT00571948|80193254|FG001|Overall Study|Lost to Follow-up|0|||
27547629|NCT00571948|80193253|FG000|Overall Study|Withdrawal by Subject|1|||
27547630|NCT00571948|80193254|FG001|Overall Study|Withdrawal by Subject|2|||
27547631|NCT00571948|80193253|FG000|Overall Study|Protocol Violation|3|||
27547632|NCT00571948|80193254|FG001|Overall Study|Protocol Violation|3|||
27547633|NCT00571948|80193253|FG000|Overall Study|infant refused study meal|3|||
27547634|NCT00571948|80193254|FG001|Overall Study|infant refused study meal|4|||
27547635|NCT00571948|80193253|FG000|Overall Study|Parent were afraid of blood colection|2|||
27547636|NCT00571948|80193254|FG001|Overall Study|Parent were afraid of blood colection|5|||
27547637|NCT00074152|80193259|FG000|Overall Study|Death|21|||
27547638|NCT00074152|80193260|FG001|Overall Study|Death|9|||
27547639|NCT00074152|80193259|FG000|Overall Study|Lack of Efficacy|34|||
27547640|NCT00074152|80193260|FG001|Overall Study|Lack of Efficacy|24|||
27547641|NCT05570500|80193261|FG000|Overall Study|Lost to Follow-up|7|||
27547642|NCT05570500|80193262|FG001|Overall Study|Lost to Follow-up|5|||
27547643|NCT00967668|80193263|FG000|Overall Study|Withdrawal by Subject|13|||
27547644|NCT00967668|80193264|FG001|Overall Study|Withdrawal by Subject|8|||
27547645|NCT00967668|80193265|FG002|Overall Study|Withdrawal by Subject|8|||
27547646|NCT00967668|80193263|FG000|Overall Study|Death|0|||
27547647|NCT00967668|80193264|FG001|Overall Study|Death|2|||
27547648|NCT00967668|80193265|FG002|Overall Study|Death|4|||
27547649|NCT00967668|80193263|FG000|Overall Study|Removed due to behavior|1|||
27547650|NCT00967668|80193264|FG001|Overall Study|Removed due to behavior|1|||
27547651|NCT00967668|80193265|FG002|Overall Study|Removed due to behavior|2|||
27547652|NCT00967668|80193263|FG000|Overall Study|Refused Year 2|11|||
27547653|NCT00967668|80193264|FG001|Overall Study|Refused Year 2|6|||
27547654|NCT00967668|80193265|FG002|Overall Study|Refused Year 2|4|||
27547655|NCT00967668|80193263|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
27547656|NCT00967668|80193264|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
27547657|NCT00967668|80193265|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
27547658|NCT00967668|80193263|FG000|Overall Study|Lost to Follow-up|15|||
27547659|NCT00967668|80193264|FG001|Overall Study|Lost to Follow-up|9|||
27547660|NCT00967668|80193265|FG002|Overall Study|Lost to Follow-up|16|||
27547661|NCT00967668|80193263|FG000|Overall Study|Refused 12-mo assessment|3|||
27547662|NCT00967668|80193264|FG001|Overall Study|Refused 12-mo assessment|1|||
27547663|NCT00967668|80193265|FG002|Overall Study|Refused 12-mo assessment|9|||
27547664|NCT00967668|80193263|FG000|Overall Study|Pregnancy|1|||
27547665|NCT00967668|80193264|FG001|Overall Study|Pregnancy|0|||
27640303|NCT00087139|80525861|FG000|Overall Study|Disease progression|9|||
27640304|NCT00087139|80525862|FG001|Overall Study|Disease progression|19|||
27640305|NCT00087139|80525863|FG002|Overall Study|Disease progression|12|||
27640306|NCT00087139|80525861|FG000|Overall Study|Ineligible|4|||
27547666|NCT00967668|80193265|FG002|Overall Study|Pregnancy|0|||
27547667|NCT00393029|80193268|FG000|Overall Study|Not treated|0|||
27547668|NCT00393029|80193269|FG001|Overall Study|Not treated|1|||
27547669|NCT03329573|80193270|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
27547670|NCT03329573|80193271|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
27547671|NCT03329573|80193272|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
27547672|NCT03329573|80193273|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
27547673|NCT03329573|80193270|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
27547674|NCT03329573|80193271|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
27640307|NCT00087139|80525862|FG001|Overall Study|Ineligible|7|||
27640308|NCT00087139|80525863|FG002|Overall Study|Ineligible|4|||
27640309|NCT00087139|80525861|FG000|Overall Study|Symptomatic deterioration|1|||
27547675|NCT03329573|80193272|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27547676|NCT03329573|80193273|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
27547677|NCT03329573|80193270|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
27927926|NCT01910441|81574654|FG000|Overall Study|Physician Decision|0|||
27927927|NCT01910441|81574655|FG001|Overall Study|Physician Decision|1|||
27927928|NCT01482221|81574656|FG000|Overall Study|Lack of Efficacy|1|||
27927929|NCT01482221|81574657|FG001|Overall Study|Lack of Efficacy|0|||
27927930|NCT01482221|81574658|FG002|Overall Study|Lack of Efficacy|1|||
27927931|NCT01482221|81574656|FG000|Overall Study|Lost to Follow-up|3|||
27927932|NCT01482221|81574657|FG001|Overall Study|Lost to Follow-up|2|||
27927933|NCT01482221|81574658|FG002|Overall Study|Lost to Follow-up|1|||
27547678|NCT03329573|80193271|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
27547679|NCT03329573|80193272|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
27547680|NCT03329573|80193273|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
27547681|NCT03329573|80193270|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
27547682|NCT03329573|80193271|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
27547683|NCT03329573|80193272|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
27547684|NCT03329573|80193273|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
27927934|NCT01482221|81574656|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
27927935|NCT01482221|81574657|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
27927936|NCT01482221|81574658|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
27927937|NCT01482221|81574656|FG000|Overall Study|Condition under Investigation Worsened|3|||
27927938|NCT01482221|81574657|FG001|Overall Study|Condition under Investigation Worsened|2|||
27927939|NCT01482221|81574658|FG002|Overall Study|Condition under Investigation Worsened|4|||
27927940|NCT01482221|81574656|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
27927941|NCT01482221|81574657|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
27927942|NCT01482221|81574658|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
27927943|NCT01482221|81574656|FG000|Overall Study|Adverse Event|1|||
27927944|NCT01482221|81574657|FG001|Overall Study|Adverse Event|7|||
27927945|NCT01482221|81574658|FG002|Overall Study|Adverse Event|3|||
27927946|NCT01482221|81574656|FG000|Overall Study|Withdrawal by Subject|10|||
27927947|NCT01482221|81574657|FG001|Overall Study|Withdrawal by Subject|7|||
27927948|NCT01482221|81574658|FG002|Overall Study|Withdrawal by Subject|12|||
27927949|NCT01482221|81574656|FG000|Overall Study|Incorrect randomization|0|||
27927950|NCT01482221|81574657|FG001|Overall Study|Incorrect randomization|1|||
27927951|NCT01482221|81574658|FG002|Overall Study|Incorrect randomization|0|||
27927952|NCT01482221|81574656|FG000|Overall Study|Physician Decision|0|||
27927953|NCT01482221|81574657|FG001|Overall Study|Physician Decision|1|||
27927954|NCT01482221|81574658|FG002|Overall Study|Physician Decision|0|||
27927955|NCT00303953|81574659|FG000|Overall Study|Ineligible|1|||
27927956|NCT00303953|81574659|FG000|Overall Study|Death|1|||
27927957|NCT00303953|81574659|FG000|Overall Study|Adverse Event|4|||
27927958|NCT00303953|81574659|FG000|Overall Study|Lack of Efficacy|12|||
27927959|NCT00303953|81574659|FG000|Overall Study|Physician Decision|1|||
27927960|NCT01913353|81574663|FG000|Overall Study|Adverse Event|2|||
27927961|NCT01913353|81574664|FG001|Overall Study|Adverse Event|0|||
27927962|NCT01913353|81574663|FG000|Overall Study|Physician Decision|0|||
27927963|NCT01913353|81574664|FG001|Overall Study|Physician Decision|2|||
27927964|NCT01913353|81574663|FG000|Overall Study|Withdrawal by Subject|20|||
27927965|NCT01913353|81574664|FG001|Overall Study|Withdrawal by Subject|6|||
27927966|NCT01913353|81574663|FG000|Overall Study|multiple reasons|10|||
27927967|NCT01913353|81574664|FG001|Overall Study|multiple reasons|7|||
27927968|NCT01245062|81574666|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
27927969|NCT01245062|81574667|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
27927970|NCT01245062|81574668|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
27927971|NCT01245062|81574666|FG000|Randomization and Crossover Phase|Physician Decision|2|||
27927972|NCT01245062|81574667|FG001|Randomization and Crossover Phase|Physician Decision|4|||
27927973|NCT01245062|81574668|FG002|Randomization and Crossover Phase|Physician Decision|0|||
27927974|NCT01245062|81574666|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
27927975|NCT01245062|81574667|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
27927976|NCT01245062|81574668|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
27927977|NCT01245062|81574666|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
27927978|NCT01245062|81574667|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
27927979|NCT01245062|81574668|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
27927980|NCT01245062|81574666|FG000|Cross-over Phase|Lost to Follow-up|0|||
27927981|NCT01245062|81574667|FG001|Cross-over Phase|Lost to Follow-up|0|||
27927982|NCT01245062|81574668|FG002|Cross-over Phase|Lost to Follow-up|1|||
27927983|NCT01245062|81574666|FG000|Cross-over Phase|Physician Decision|0|||
27927984|NCT01245062|81574667|FG001|Cross-over Phase|Physician Decision|0|||
27927985|NCT01245062|81574668|FG002|Cross-over Phase|Physician Decision|1|||
27927986|NCT01245062|81574666|FG000|Cross-over Phase|Withdrew Consent|0|||
27927987|NCT01245062|81574667|FG001|Cross-over Phase|Withdrew Consent|0|||
27927988|NCT01245062|81574668|FG002|Cross-over Phase|Withdrew Consent|4|||
27927989|NCT01245062|81574666|FG000|Cross-over Phase|Study closed/ terminated|0|||
27927990|NCT01245062|81574667|FG001|Cross-over Phase|Study closed/ terminated|0|||
27927991|NCT01245062|81574668|FG002|Cross-over Phase|Study closed/ terminated|11|||
27927992|NCT00177671|81574671|FG000|Overall Study|Withdrawal by Subject|5|||
27927993|NCT00177671|81574672|FG001|Overall Study|Withdrawal by Subject|6|||
27927994|NCT00177671|81574671|FG000|Overall Study|medical complications|2|||
27927995|NCT00177671|81574672|FG001|Overall Study|medical complications|0|||
27927996|NCT00177671|81574671|FG000|Overall Study|Adverse Event|6|||
27927997|NCT00177671|81574672|FG001|Overall Study|Adverse Event|0|||
27927998|NCT00177671|81574671|FG000|Overall Study|Physician Decision|12|||
27927999|NCT00177671|81574672|FG001|Overall Study|Physician Decision|8|||
27928000|NCT03801252|81574673|FG000|Overall Study|Protocol Violation|1|||
27928001|NCT03801252|81574674|FG001|Overall Study|Protocol Violation|2|||
27928002|NCT04591015|81574677|FG000|Overall Study|Death|6|||
27928003|NCT04591015|81574678|FG001|Overall Study|Death|4|||
27928004|NCT04591015|81574677|FG000|Overall Study|Withdrawal by Subject|6|||
27928005|NCT04591015|81574678|FG001|Overall Study|Withdrawal by Subject|3|||
27547685|NCT01317160|80193274|FG000|Overall Study|Incorrect inclusion|1|||
27547686|NCT01317160|80193275|FG001|Overall Study|Incorrect inclusion|1|||
27547687|NCT01317160|80193274|FG000|Overall Study|Lost to Follow-up|3|||
27547688|NCT01317160|80193275|FG001|Overall Study|Lost to Follow-up|3|||
27547689|NCT01317160|80193274|FG000|Overall Study|Withdrawal by Subject|0|||
27547690|NCT01317160|80193275|FG001|Overall Study|Withdrawal by Subject|2|||
27547691|NCT00520936|80193276|FG000|Overall Study|Physician Decision|0|||
27547692|NCT00520936|80193277|FG001|Overall Study|Physician Decision|2|||
27547693|NCT00520936|80193278|FG002|Overall Study|Physician Decision|1|||
27928006|NCT04591015|81574677|FG000|Overall Study|Lost to Follow-up|16|||
27928007|NCT04591015|81574678|FG001|Overall Study|Lost to Follow-up|11|||
27928008|NCT01033942|81574685|FG000|Overall Study|Withdrawal by Subject|1|||
27928009|NCT01033942|81574686|FG001|Overall Study|Withdrawal by Subject|1|||
27928010|NCT01033942|81574687|FG002|Overall Study|Withdrawal by Subject|1|||
27928011|NCT01033942|81574685|FG000|Overall Study|Lost to Follow-up|1|||
27928012|NCT01033942|81574686|FG001|Overall Study|Lost to Follow-up|0|||
27928013|NCT01033942|81574687|FG002|Overall Study|Lost to Follow-up|0|||
27928014|NCT01033942|81574685|FG000|Overall Study|Enrolled in Extension Study|0|||
27928015|NCT01033942|81574686|FG001|Overall Study|Enrolled in Extension Study|3|||
27928016|NCT01033942|81574687|FG002|Overall Study|Enrolled in Extension Study|0|||
27928017|NCT03807843|81574688|FG000|Overall Study|Lost to Follow-up|1|||
27928018|NCT03807843|81574689|FG001|Overall Study|Lost to Follow-up|0|||
27928019|NCT01104766|81574690|FG000|Overall Study|Did not meet inc/exc criteria|1|||
27928020|NCT01104766|81574691|FG001|Overall Study|Did not meet inc/exc criteria|0|||
27928021|NCT01104766|81574692|FG002|Overall Study|Did not meet inc/exc criteria|0|||
27928022|NCT01104766|81574693|FG003|Overall Study|Did not meet inc/exc criteria|0|||
27928023|NCT01104766|81574690|FG000|Overall Study|Adverse Event|17|||
27928024|NCT01104766|81574691|FG001|Overall Study|Adverse Event|15|||
27928025|NCT01104766|81574692|FG002|Overall Study|Adverse Event|20|||
27928026|NCT01104766|81574693|FG003|Overall Study|Adverse Event|14|||
27928027|NCT01104766|81574690|FG000|Overall Study|Lack of Efficacy|20|||
27928028|NCT01104766|81574691|FG001|Overall Study|Lack of Efficacy|15|||
27928029|NCT01104766|81574692|FG002|Overall Study|Lack of Efficacy|14|||
27928030|NCT01104766|81574693|FG003|Overall Study|Lack of Efficacy|8|||
27928031|NCT01104766|81574690|FG000|Overall Study|Protocol Violation|2|||
27928032|NCT01104766|81574691|FG001|Overall Study|Protocol Violation|0|||
27928033|NCT01104766|81574692|FG002|Overall Study|Protocol Violation|0|||
27928034|NCT01104766|81574693|FG003|Overall Study|Protocol Violation|0|||
27928035|NCT01104766|81574690|FG000|Overall Study|Withdrawal by Subject|17|||
27928036|NCT01104766|81574691|FG001|Overall Study|Withdrawal by Subject|19|||
27928037|NCT01104766|81574692|FG002|Overall Study|Withdrawal by Subject|25|||
27928038|NCT01104766|81574693|FG003|Overall Study|Withdrawal by Subject|15|||
27928039|NCT01104766|81574690|FG000|Overall Study|Lost to Follow-up|1|||
27928040|NCT01104766|81574691|FG001|Overall Study|Lost to Follow-up|2|||
27928041|NCT01104766|81574692|FG002|Overall Study|Lost to Follow-up|1|||
27928042|NCT01104766|81574693|FG003|Overall Study|Lost to Follow-up|1|||
27928043|NCT02842866|81574694|FG000|Overall Study|Serious Adverse Event|0|||
27928044|NCT02842866|81574695|FG001|Overall Study|Serious Adverse Event|1|||
27547694|NCT00520936|80193279|FG003|Overall Study|Physician Decision|0|||
27547695|NCT00520936|80193280|FG004|Overall Study|Physician Decision|0|||
27547696|NCT00520936|80193281|FG005|Overall Study|Physician Decision|0|||
27928045|NCT02842866|81574694|FG000|Overall Study|Protocol Violation|4|||
27928046|NCT02842866|81574695|FG001|Overall Study|Protocol Violation|2|||
27928047|NCT02842866|81574694|FG000|Overall Study|Lost to Follow-up|2|||
27928048|NCT02842866|81574695|FG001|Overall Study|Lost to Follow-up|0|||
27928049|NCT02842866|81574694|FG000|Overall Study|Withdrawal by Subject|1|||
27547697|NCT00520936|80193282|FG006|Overall Study|Physician Decision|0|||
27547698|NCT00520936|80193283|FG007|Overall Study|Physician Decision|0|||
27547699|NCT00520936|80193276|FG000|Overall Study|Withdrawal by Subject|0|||
27928050|NCT02842866|81574695|FG001|Overall Study|Withdrawal by Subject|0|||
27928051|NCT02774278|81574696|FG000|Overall Study|Lack of Efficacy|199|||
27928052|NCT02774278|81574696|FG000|Overall Study|Death|29|||
27928053|NCT02774278|81574696|FG000|Overall Study|Adverse event/intercurrent illness|16|||
27547700|NCT00520936|80193277|FG001|Overall Study|Withdrawal by Subject|0|||
27547701|NCT00520936|80193278|FG002|Overall Study|Withdrawal by Subject|0|||
27928054|NCT02774278|81574696|FG000|Overall Study|Refused treatment/did not cooperate|9|||
27928055|NCT02774278|81574696|FG000|Overall Study|Administrative reasons|6|||
27928056|NCT02774278|81574696|FG000|Overall Study|Withdrawal by Subject|3|||
27928057|NCT02774278|81574696|FG000|Overall Study|Protocol Violation|2|||
27928058|NCT01113749|81574697|FG000|Overall Study|Lost to Follow-up|1|||
27928059|NCT01113749|81574698|FG001|Overall Study|Lost to Follow-up|2|||
27928060|NCT00800540|81574699|FG000|Period One: 6 Weeks|Noncompliance|1|||
27928061|NCT00800540|81574700|FG001|Period One: 6 Weeks|Noncompliance|0|||
27928062|NCT00800540|81574699|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
27928063|NCT00800540|81574700|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
27928064|NCT00800540|81574699|FG000|Period 2: 6 Weeks|Adverse Event|0|||
27928065|NCT00800540|81574700|FG001|Period 2: 6 Weeks|Adverse Event|1|||
27928066|NCT03670628|81574701|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
27928067|NCT03670628|81574702|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
27928068|NCT03670628|81574701|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
27928069|NCT03670628|81574702|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
27928070|NCT02401230|81574704|FG000|Overall Study|Adverse Event|3|||
27928071|NCT02401230|81574705|FG001|Overall Study|Adverse Event|2|||
27928072|NCT02401230|81574706|FG002|Overall Study|Adverse Event|0|||
27928073|NCT02401230|81574704|FG000|Overall Study|Withdrawal by Subject|2|||
27928074|NCT02401230|81574705|FG001|Overall Study|Withdrawal by Subject|1|||
27928075|NCT02401230|81574706|FG002|Overall Study|Withdrawal by Subject|1|||
27928076|NCT02401230|81574704|FG000|Overall Study|Lost to Follow-up|1|||
27928077|NCT02401230|81574705|FG001|Overall Study|Lost to Follow-up|3|||
27928078|NCT02401230|81574706|FG002|Overall Study|Lost to Follow-up|3|||
27928079|NCT04766333|81574707|FG000|Overall Study|Lost to Follow-up|40|||
27928080|NCT04766333|81574708|FG001|Overall Study|Lost to Follow-up|826|||
27928081|NCT03941483|81574709|FG000|Overall Study|Miscellaneous|2|||
27928082|NCT03941483|81574710|FG001|Overall Study|Miscellaneous|3|||
27928083|NCT03941483|81574711|FG002|Overall Study|Miscellaneous|0|||
27928084|NCT03941483|81574709|FG000|Overall Study|Study Terminated by Sponsor|1|||
27928085|NCT03941483|81574710|FG001|Overall Study|Study Terminated by Sponsor|0|||
27928086|NCT03941483|81574711|FG002|Overall Study|Study Terminated by Sponsor|0|||
27928087|NCT03941483|81574709|FG000|Overall Study|Withdrawal by Subject|1|||
27928088|NCT03941483|81574710|FG001|Overall Study|Withdrawal by Subject|4|||
27547702|NCT00520936|80193279|FG003|Overall Study|Withdrawal by Subject|0|||
27547703|NCT00520936|80193280|FG004|Overall Study|Withdrawal by Subject|0|||
27547704|NCT00520936|80193281|FG005|Overall Study|Withdrawal by Subject|0|||
27547705|NCT00520936|80193282|FG006|Overall Study|Withdrawal by Subject|0|||
27547706|NCT00520936|80193283|FG007|Overall Study|Withdrawal by Subject|1|||
27547707|NCT00520936|80193276|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
27547708|NCT00520936|80193277|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
27547709|NCT00520936|80193278|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
27547710|NCT00520936|80193279|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
27547711|NCT00520936|80193280|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
27547712|NCT00520936|80193281|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
27547713|NCT00520936|80193282|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
27547714|NCT00520936|80193283|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
27547715|NCT00520936|80193276|FG000|Overall Study|Death|0|||
27928089|NCT03941483|81574711|FG002|Overall Study|Withdrawal by Subject|1|||
27928090|NCT03941483|81574709|FG000|Overall Study|Lost to Follow-up|2|||
27928091|NCT03941483|81574710|FG001|Overall Study|Lost to Follow-up|1|||
27928092|NCT03941483|81574711|FG002|Overall Study|Lost to Follow-up|8|||
27928093|NCT03941483|81574709|FG000|Overall Study|Death|3|||
27928094|NCT03941483|81574710|FG001|Overall Study|Death|2|||
27928095|NCT03941483|81574711|FG002|Overall Study|Death|6|||
27928096|NCT00765076|81574716|FG000|Overall Study|Adverse Event|1|||
27928097|NCT00765076|81574717|FG001|Overall Study|Adverse Event|0|||
27928098|NCT00765076|81574718|FG002|Overall Study|Adverse Event|0|||
27928099|NCT00765076|81574716|FG000|Overall Study|Withdrawal by Subject|0|||
27928100|NCT00765076|81574717|FG001|Overall Study|Withdrawal by Subject|0|||
27547716|NCT00520936|80193277|FG001|Overall Study|Death|0|||
27547717|NCT00520936|80193278|FG002|Overall Study|Death|0|||
27547718|NCT00520936|80193279|FG003|Overall Study|Death|0|||
27928101|NCT00765076|81574718|FG002|Overall Study|Withdrawal by Subject|1|||
27928102|NCT01980888|81574719|FG000|Overall Study|Study Terminated by Sponsor|116|||
27928103|NCT01980888|81574720|FG001|Overall Study|Study Terminated by Sponsor|122|||
27928104|NCT01980888|81574719|FG000|Overall Study|Withdrew Consent|17|||
27928105|NCT01980888|81574720|FG001|Overall Study|Withdrew Consent|6|||
27547719|NCT00520936|80193280|FG004|Overall Study|Death|0|||
27928106|NCT01980888|81574719|FG000|Overall Study|Investigator's Discretion|8|||
27928107|NCT01980888|81574720|FG001|Overall Study|Investigator's Discretion|3|||
27928108|NCT01980888|81574719|FG000|Overall Study|Non-Compliance with Study Drug|3|||
27928109|NCT01980888|81574720|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27928110|NCT01002105|81574721|FG000|Overall Study|Lost to Follow-up|10|||
27928111|NCT01002105|81574722|FG001|Overall Study|Lost to Follow-up|16|||
27928112|NCT01002105|81574721|FG000|Overall Study|non compliance|5|||
27928113|NCT01002105|81574722|FG001|Overall Study|non compliance|3|||
27928114|NCT01002105|81574721|FG000|Overall Study|condition worsened|4|||
27928115|NCT01002105|81574722|FG001|Overall Study|condition worsened|2|||
27928116|NCT01397747|81574723|FG000|Overall Study|Multitarget DNA test excluded|689|||
27928117|NCT01397747|81574723|FG000|Overall Study|Colonoscopy excluded|304|||
27928118|NCT01397747|81574723|FG000|Overall Study|FIT excluded|34|||
27928119|NCT01013753|81574724|FG000|Overall Study|Adverse Event|8|||
27928120|NCT01013753|81574724|FG000|Overall Study|Protocol Violation|3|||
27928121|NCT01013753|81574724|FG000|Overall Study|Lost to Follow-up|1|||
27928122|NCT01013753|81574724|FG000|Overall Study|Withdrawal by Subject|2|||
27928123|NCT01013753|81574724|FG000|Overall Study|Other|2|||
27928124|NCT00544882|81574725|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
27928125|NCT00544882|81574726|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
27928126|NCT00544882|81574727|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
27928127|NCT00544882|81574725|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
27928128|NCT00544882|81574726|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
27928129|NCT00544882|81574727|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
27928130|NCT00544882|81574725|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
27928131|NCT00544882|81574726|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
27928132|NCT00544882|81574727|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
27928133|NCT00544882|81574725|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
27928134|NCT00544882|81574726|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
27928135|NCT00544882|81574727|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
27928136|NCT00544882|81574725|FG000|Cycle 3: Follow-up|Noncompliance|0|||
27928137|NCT00544882|81574726|FG001|Cycle 3: Follow-up|Noncompliance|1|||
27928138|NCT00544882|81574727|FG002|Cycle 3: Follow-up|Noncompliance|0|||
27928139|NCT00544882|81574725|FG000|Cycle 3: Follow-up|Pregnancy|0|||
27928140|NCT00544882|81574726|FG001|Cycle 3: Follow-up|Pregnancy|1|||
27928141|NCT00544882|81574727|FG002|Cycle 3: Follow-up|Pregnancy|0|||
27928142|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
27928143|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
27928144|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
27928145|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
27928146|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
27928147|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27928148|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
27928149|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27928150|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27928151|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
27928152|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Death|0|||
27928153|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Death|0|||
27928154|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Death|1|||
27928155|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Death|0|||
27928156|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Death|0|||
27547720|NCT00520936|80193281|FG005|Overall Study|Death|0|||
27547721|NCT00520936|80193282|FG006|Overall Study|Death|1|||
27547722|NCT00520936|80193283|FG007|Overall Study|Death|0|||
27547723|NCT00520936|80193276|FG000|Overall Study|Protocol Violation|0|||
27928157|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
27928158|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
27928159|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
27547724|NCT00520936|80193277|FG001|Overall Study|Protocol Violation|1|||
27547725|NCT00520936|80193278|FG002|Overall Study|Protocol Violation|1|||
27547726|NCT00520936|80193279|FG003|Overall Study|Protocol Violation|0|||
27640310|NCT00087139|80525862|FG001|Overall Study|Symptomatic deterioration|1|||
27640311|NCT00087139|80525863|FG002|Overall Study|Symptomatic deterioration|3|||
27928160|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
27928161|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
27928162|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Other|2|||
27928163|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Other|1|||
27928164|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Other|0|||
27928165|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Other|0|||
27928166|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Other|0|||
27928167|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27928168|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27928169|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
27928170|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27547727|NCT00520936|80193280|FG004|Overall Study|Protocol Violation|1|||
27547728|NCT00520936|80193281|FG005|Overall Study|Protocol Violation|0|||
27640312|NCT00087139|80525861|FG000|Overall Study|Use of coumadin|1|||
27928171|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
27640313|NCT00087139|80525862|FG001|Overall Study|Use of coumadin|0|||
27640314|NCT00087139|80525863|FG002|Overall Study|Use of coumadin|0|||
27640315|NCT00087139|80525861|FG000|Overall Study|Response achieved|0|||
27640316|NCT00087139|80525862|FG001|Overall Study|Response achieved|1|||
27640317|NCT00087139|80525863|FG002|Overall Study|Response achieved|0|||
27640318|NCT00087139|80525861|FG000|Overall Study|Extradural disease|0|||
27640319|NCT00087139|80525862|FG001|Overall Study|Extradural disease|0|||
27640320|NCT00087139|80525863|FG002|Overall Study|Extradural disease|1|||
27640321|NCT00714714|80525875|FG000|Overall Study|Adverse Event|1|||
27640322|NCT04093752|80525876|FG000|Overall Study|Adverse Event|7|||
27640323|NCT04093752|80525877|FG001|Overall Study|Adverse Event|19|||
27547729|NCT00520936|80193282|FG006|Overall Study|Protocol Violation|1|||
27547730|NCT00520936|80193283|FG007|Overall Study|Protocol Violation|0|||
27547731|NCT02849678|80193290|FG000|Overall Study|Protocol Violation|3|||
27547732|NCT02849678|80193291|FG001|Overall Study|Protocol Violation|6|||
27547733|NCT02495168|80196936|FG000|Overall Study|Other than Specified|18|||
27547734|NCT02495168|80196937|FG001|Overall Study|Other than Specified|22|||
27547735|NCT02495168|80196938|FG002|Overall Study|Other than Specified|5|||
27547736|NCT02495168|80196936|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
27547737|NCT02495168|80196937|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
27547738|NCT02495168|80196938|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
27547739|NCT02495168|80196936|FG000|Overall Study|Physician Decision|1|||
27547740|NCT02495168|80196937|FG001|Overall Study|Physician Decision|1|||
27547741|NCT02495168|80196938|FG002|Overall Study|Physician Decision|0|||
27547742|NCT02495168|80196936|FG000|Overall Study|Lost to Follow-up|10|||
27547743|NCT02495168|80196937|FG001|Overall Study|Lost to Follow-up|6|||
27547744|NCT02495168|80196938|FG002|Overall Study|Lost to Follow-up|1|||
27547745|NCT02495168|80196936|FG000|Overall Study|Withdrawal by Subject|1|||
27547746|NCT02495168|80196937|FG001|Overall Study|Withdrawal by Subject|4|||
27547747|NCT02495168|80196938|FG002|Overall Study|Withdrawal by Subject|2|||
27547748|NCT02495168|80196936|FG000|Overall Study|Protocol Violation|0|||
27547749|NCT02495168|80196937|FG001|Overall Study|Protocol Violation|10|||
27547750|NCT02495168|80196938|FG002|Overall Study|Protocol Violation|1|||
27547751|NCT02495168|80196936|FG000|Overall Study|Adverse Event|4|||
27547752|NCT02495168|80196937|FG001|Overall Study|Adverse Event|8|||
27547753|NCT02495168|80196938|FG002|Overall Study|Adverse Event|3|||
27547754|NCT02495168|80196936|FG000|Overall Study|Lack of Efficacy|0|||
27547755|NCT02495168|80196937|FG001|Overall Study|Lack of Efficacy|0|||
27547756|NCT02495168|80196938|FG002|Overall Study|Lack of Efficacy|3|||
27640324|NCT04093752|80525878|FG002|Overall Study|Adverse Event|18|||
27640325|NCT04093752|80525879|FG003|Overall Study|Adverse Event|4|||
27640326|NCT04093752|80525876|FG000|Overall Study|Withdrawal by Subject|6|||
27640327|NCT04093752|80525877|FG001|Overall Study|Withdrawal by Subject|6|||
27640328|NCT04093752|80525878|FG002|Overall Study|Withdrawal by Subject|8|||
27640329|NCT04093752|80525879|FG003|Overall Study|Withdrawal by Subject|20|||
27640330|NCT04093752|80525876|FG000|Overall Study|Lost to Follow-up|2|||
27640331|NCT04093752|80525877|FG001|Overall Study|Lost to Follow-up|1|||
27640332|NCT04093752|80525878|FG002|Overall Study|Lost to Follow-up|1|||
27640333|NCT04093752|80525879|FG003|Overall Study|Lost to Follow-up|1|||
27640334|NCT04093752|80525876|FG000|Overall Study|Death|0|||
27640335|NCT04093752|80525877|FG001|Overall Study|Death|0|||
27640336|NCT04093752|80525878|FG002|Overall Study|Death|1|||
27640337|NCT04093752|80525879|FG003|Overall Study|Death|2|||
27640338|NCT04093752|80525876|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
27640339|NCT04093752|80525877|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
27640340|NCT04093752|80525878|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
27640341|NCT04093752|80525879|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
27640342|NCT04093752|80525876|FG000|Overall Study|Covid 19|0|||
27640343|NCT04093752|80525877|FG001|Overall Study|Covid 19|0|||
27640344|NCT04093752|80525878|FG002|Overall Study|Covid 19|0|||
27928172|NCT03317496|81574728|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
27928173|NCT03317496|81574729|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
27547757|NCT02496611|80196943|FG000|Overall Study|Lost to Follow-up|2|||
27640345|NCT04093752|80525879|FG003|Overall Study|Covid 19|1|||
27640346|NCT04093752|80525876|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
27640347|NCT04093752|80525877|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
27640348|NCT04093752|80525878|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
27640349|NCT04093752|80525879|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
27640350|NCT04093752|80525876|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
27640351|NCT04093752|80525877|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
27640352|NCT04093752|80525878|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
27640353|NCT04093752|80525879|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
27547758|NCT02496611|80196944|FG001|Overall Study|Lost to Follow-up|1|||
27547759|NCT02496611|80196943|FG000|Overall Study|Withdrawal by Subject|5|||
27547760|NCT02496611|80196944|FG001|Overall Study|Withdrawal by Subject|2|||
27547761|NCT01819831|80196950|FG000|Overall Study|Withdrawal by Subject|1|||
27547762|NCT03851705|80196951|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
27547763|NCT03851705|80196952|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
27547764|NCT03851705|80196953|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
27547765|NCT03851705|80196954|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
27640354|NCT04093752|80525876|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
27640355|NCT04093752|80525877|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
27640356|NCT04093752|80525878|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
27640357|NCT04093752|80525879|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
27640358|NCT03485950|80525880|FG000|Overall Study|Adverse Event|1|||
27640359|NCT03485950|80525881|FG001|Overall Study|Adverse Event|0|||
27640360|NCT03485950|80525880|FG000|Overall Study|Death|3|||
27640361|NCT03485950|80525881|FG001|Overall Study|Death|2|||
27640362|NCT03485950|80525880|FG000|Overall Study|Withdrawal by Subject|3|||
27640363|NCT03485950|80525881|FG001|Overall Study|Withdrawal by Subject|0|||
27547766|NCT03851705|80196951|FG000|Part 1: Double-Blind Period|Other reason|1|||
27547767|NCT03851705|80196952|FG001|Part 1: Double-Blind Period|Other reason|0|||
27547768|NCT03851705|80196953|FG002|Part 1: Double-Blind Period|Other reason|0|||
27547769|NCT03851705|80196954|FG003|Part 1: Double-Blind Period|Other reason|0|||
27547770|NCT03851705|80196951|FG000|Part 2: Open-Label Period|Other reason|0|||
27547771|NCT03851705|80196952|FG001|Part 2: Open-Label Period|Other reason|0|||
27547772|NCT03851705|80196953|FG002|Part 2: Open-Label Period|Other reason|0|||
27547773|NCT03851705|80196954|FG003|Part 2: Open-Label Period|Other reason|1|||
27547774|NCT03851705|80196951|FG000|Part 2: Open-Label Period|Death|0|||
27547775|NCT03851705|80196952|FG001|Part 2: Open-Label Period|Death|0|||
27547776|NCT03851705|80196953|FG002|Part 2: Open-Label Period|Death|3|||
27547777|NCT03851705|80196954|FG003|Part 2: Open-Label Period|Death|0|||
27547778|NCT03851705|80196951|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
27547779|NCT03851705|80196952|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
27547780|NCT03851705|80196953|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
27547781|NCT03851705|80196954|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
27547782|NCT01806298|80196955|FG000|Overall Study|Adverse Event|3|||
27547783|NCT01806298|80196955|FG000|Overall Study|Protocol Non-compliance|1|||
27547784|NCT01806298|80196955|FG000|Overall Study|Withdrawal by Subject|1|||
27547785|NCT01806298|80196955|FG000|Overall Study|Other|5|||
27547786|NCT01365910|80196956|FG000|Overall Study|Withdrawal by Subject|7|||
27547787|NCT01365910|80196956|FG000|Overall Study|disease progression|18|||
27547788|NCT01365910|80196956|FG000|Overall Study|Adverse Event|3|||
27547789|NCT01365910|80196956|FG000|Overall Study|other complicating disease|1|||
27547790|NCT01365910|80196956|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
27547791|NCT01594762|80196957|FG000|Overall Study|Withdrawal by Subject|1|||
27547792|NCT01594762|80196958|FG001|Overall Study|Withdrawal by Subject|0|||
27547793|NCT01594762|80196957|FG000|Overall Study|Lost to Follow-up|10|||
27547794|NCT01594762|80196958|FG001|Overall Study|Lost to Follow-up|10|||
27547795|NCT00601458|80196961|FG000|Overall Study|Dosing Error|1|||
27547796|NCT00601458|80196962|FG001|Overall Study|Dosing Error|0|||
27547797|NCT00601458|80196963|FG002|Overall Study|Dosing Error|0|||
27547798|NCT00601458|80196961|FG000|Overall Study|Incomplete Data|0|||
27547799|NCT00601458|80196962|FG001|Overall Study|Incomplete Data|2|||
27547800|NCT00601458|80196963|FG002|Overall Study|Incomplete Data|0|||
27547801|NCT00601458|80196961|FG000|Overall Study|Protocol Violation|3|||
27547802|NCT00601458|80196962|FG001|Overall Study|Protocol Violation|2|||
27547803|NCT00601458|80196963|FG002|Overall Study|Protocol Violation|1|||
27547804|NCT00601458|80196961|FG000|Overall Study|Early Termination|0|||
27547805|NCT00601458|80196962|FG001|Overall Study|Early Termination|1|||
27547806|NCT00601458|80196963|FG002|Overall Study|Early Termination|1|||
27547807|NCT04584645|80196966|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
27547808|NCT04584645|80196967|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
27547809|NCT01235351|80196968|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
27547810|NCT01235351|80196969|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
27547811|NCT01877265|80196972|FG000|Treatment Period 1|Sponsor Decision|0|||
27547812|NCT01877265|80196973|FG001|Treatment Period 1|Sponsor Decision|0|||
27547813|NCT01877265|80196974|FG002|Treatment Period 1|Sponsor Decision|1|||
27640364|NCT04110054|80525882|FG000|Overall Study|COVID-19 reason other than AE|0|||
27547814|NCT01877265|80196975|FG003|Treatment Period 1|Sponsor Decision|0|||
27547815|NCT01877265|80196976|FG004|Treatment Period 1|Sponsor Decision|0|||
27547816|NCT01877265|80196977|FG005|Treatment Period 1|Sponsor Decision|0|||
27640365|NCT04110054|80525883|FG001|Overall Study|COVID-19 reason other than AE|0|||
27547817|NCT01877265|80196972|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27547818|NCT01877265|80196973|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27547819|NCT01877265|80196974|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27640366|NCT04110054|80525884|FG002|Overall Study|COVID-19 reason other than AE|2|||
27640367|NCT04110054|80525885|FG003|Overall Study|COVID-19 reason other than AE|0|||
27547820|NCT01877265|80196975|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27547821|NCT01877265|80196976|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
27547822|NCT01877265|80196977|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
27547823|NCT01877265|80196972|FG000|Treatment Period 3|Lost to Follow-up|1|||
27547824|NCT01877265|80196973|FG001|Treatment Period 3|Lost to Follow-up|0|||
27547825|NCT01877265|80196974|FG002|Treatment Period 3|Lost to Follow-up|0|||
27742498|NCT00866294|80886929|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27547826|NCT01877265|80196975|FG003|Treatment Period 3|Lost to Follow-up|0|||
27547827|NCT01877265|80196976|FG004|Treatment Period 3|Lost to Follow-up|0|||
27547828|NCT01877265|80196977|FG005|Treatment Period 3|Lost to Follow-up|0|||
27547829|NCT02280304|80196979|FG000|Overall Study|Lost to Follow-up|7|||
27547830|NCT02280304|80196980|FG001|Overall Study|Lost to Follow-up|8|||
27547831|NCT03428360|80196981|FG000|Overall Study|Informed consent withdrawn|5|||
27547832|NCT03428360|80196981|FG000|Overall Study|Withdrawal by Subject|4|||
27547833|NCT03428360|80196981|FG000|Overall Study|Lost to Follow-up|5|||
27547834|NCT03428360|80196981|FG000|Overall Study|Physician Decision|2|||
27547835|NCT03428360|80196981|FG000|Overall Study|Informed consent withdrawn|5|||
27547836|NCT03428360|80196981|FG000|Overall Study|Study terminated by sponsor|10|||
27547837|NCT03428360|80196981|FG000|Overall Study|Non-compliant with study|1|||
27547838|NCT03428360|80196981|FG000|Overall Study|Non-compliant with study drug|3|||
27547839|NCT03428360|80196981|FG000|Overall Study|Death|3|||
27547840|NCT03428360|80196981|FG000|Overall Study|Adverse Event|1|||
27547841|NCT03428360|80196981|FG000|Overall Study|Not on antiepileptic drug|1|||
27547842|NCT01709513|80196982|FG000|Overall Study|Randomized but not treated|0|||
27547843|NCT01709513|80196983|FG001|Overall Study|Randomized but not treated|1|||
27547844|NCT01709513|80196984|FG002|Overall Study|Randomized but not treated|0|||
27547845|NCT01709513|80196982|FG000|Overall Study|Adverse Event|16|||
27547846|NCT01709513|80196983|FG001|Overall Study|Adverse Event|31|||
27547847|NCT01709513|80196984|FG002|Overall Study|Adverse Event|23|||
27547848|NCT01709513|80196982|FG000|Overall Study|Poor compliance to protocol|2|||
27547849|NCT01709513|80196983|FG001|Overall Study|Poor compliance to protocol|0|||
27547850|NCT01709513|80196984|FG002|Overall Study|Poor compliance to protocol|0|||
27547851|NCT01709513|80196982|FG000|Overall Study|Other|3|||
27547852|NCT01709513|80196983|FG001|Overall Study|Other|11|||
27547853|NCT01709513|80196984|FG002|Overall Study|Other|7|||
27547854|NCT01731990|80196985|FG000|Overall Study|Adverse Event|1|||
27547855|NCT01731990|80196986|FG001|Overall Study|Adverse Event|5|||
27547856|NCT01731990|80196985|FG000|Overall Study|Withdrawal by Subject|1|||
27547857|NCT01731990|80196986|FG001|Overall Study|Withdrawal by Subject|1|||
27547858|NCT01731990|80196985|FG000|Overall Study|Protocol deviation|1|||
27547859|NCT01731990|80196986|FG001|Overall Study|Protocol deviation|2|||
27547860|NCT01731990|80196985|FG000|Overall Study|Death|1|||
27547861|NCT01731990|80196986|FG001|Overall Study|Death|0|||
27547862|NCT00730132|80196987|FG000|Overall Study|Protocol Violation|154|||
27547863|NCT00730132|80196987|FG000|Overall Study|Death|1|||
27547864|NCT05201703|80196990|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
27547865|NCT05201703|80196991|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
27547866|NCT05201703|80196990|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
27547867|NCT05201703|80196991|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
27547868|NCT01558271|80196992|FG000|Overall Study|Adverse Event|6|||
27547869|NCT01558271|80196993|FG001|Overall Study|Adverse Event|3|||
27547870|NCT01558271|80196994|FG002|Overall Study|Adverse Event|4|||
27547871|NCT01558271|80196992|FG000|Overall Study|Lost to Follow-up|1|||
27547872|NCT01558271|80196993|FG001|Overall Study|Lost to Follow-up|0|||
27547873|NCT01558271|80196994|FG002|Overall Study|Lost to Follow-up|0|||
27547874|NCT01558271|80196992|FG000|Overall Study|Protocol Violation|1|||
27742499|NCT00866294|80886930|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
27742500|NCT00866294|80886928|FG000|Overall Study|Lost to Follow-up|1|||
27742501|NCT00866294|80886929|FG001|Overall Study|Lost to Follow-up|3|||
27742502|NCT00866294|80886930|FG002|Overall Study|Lost to Follow-up|0|||
27742503|NCT00866294|80886928|FG000|Overall Study|Physician Decision|6|||
27742504|NCT00866294|80886929|FG001|Overall Study|Physician Decision|2|||
27742505|NCT00866294|80886930|FG002|Overall Study|Physician Decision|1|||
27742506|NCT02732912|80886931|FG000|Overall Study|Discharged before night|2|||
27742507|NCT02732912|80886932|FG001|Overall Study|Discharged before night|6|||
27640368|NCT04110054|80525882|FG000|Overall Study|Withdrawal by Subject|0|||
27640369|NCT04110054|80525883|FG001|Overall Study|Withdrawal by Subject|3|||
27640370|NCT04110054|80525884|FG002|Overall Study|Withdrawal by Subject|2|||
27742508|NCT02732912|80886931|FG000|Overall Study|Incomplete completion of questionnaire|2|||
27547875|NCT01558271|80196993|FG001|Overall Study|Protocol Violation|0|||
27547876|NCT01558271|80196994|FG002|Overall Study|Protocol Violation|0|||
27547877|NCT01558271|80196992|FG000|Overall Study|Withdrawal by Subject|10|||
27547878|NCT01558271|80196993|FG001|Overall Study|Withdrawal by Subject|6|||
27742509|NCT02732912|80886932|FG001|Overall Study|Incomplete completion of questionnaire|3|||
27742510|NCT02732912|80886931|FG000|Overall Study|No outcome; discharged or refused|6|||
27547879|NCT01558271|80196994|FG002|Overall Study|Withdrawal by Subject|12|||
27547880|NCT01558271|80196992|FG000|Overall Study|Physician Decision|0|||
27547881|NCT01558271|80196993|FG001|Overall Study|Physician Decision|2|||
27547882|NCT01558271|80196994|FG002|Overall Study|Physician Decision|1|||
27547883|NCT00660309|80196995|FG000|Overall Study|Adverse Event|2|||
27928174|NCT03317496|81574730|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
27928175|NCT03317496|81574731|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
27928176|NCT03317496|81574732|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
27928177|NCT03317496|81574728|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
27547884|NCT00660309|80196996|FG001|Overall Study|Adverse Event|0|||
27547885|NCT00660309|80196995|FG000|Overall Study|Withdrawal by Subject|0|||
27547886|NCT00660309|80196996|FG001|Overall Study|Withdrawal by Subject|3|||
27547887|NCT02161731|80196997|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
27547888|NCT02161731|80196998|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
27547889|NCT02161731|80196997|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
27547890|NCT02161731|80196998|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
27547891|NCT00317356|80196999|FG000|Overall Study|Adverse Event|0|||
27547892|NCT00317356|80197000|FG001|Overall Study|Adverse Event|0|||
27547893|NCT00317356|80197001|FG002|Overall Study|Adverse Event|1|||
27547894|NCT00317356|80197002|FG003|Overall Study|Adverse Event|0|||
27547895|NCT00317356|80196999|FG000|Overall Study|Lack of Efficacy|1|||
27547896|NCT00317356|80197000|FG001|Overall Study|Lack of Efficacy|1|||
27547897|NCT00317356|80197001|FG002|Overall Study|Lack of Efficacy|0|||
27547898|NCT00317356|80197002|FG003|Overall Study|Lack of Efficacy|3|||
27547899|NCT00317356|80196999|FG000|Overall Study|Physician Decision|0|||
27547900|NCT00317356|80197000|FG001|Overall Study|Physician Decision|1|||
27547901|NCT00317356|80197001|FG002|Overall Study|Physician Decision|0|||
27547902|NCT00317356|80197002|FG003|Overall Study|Physician Decision|0|||
27547903|NCT00382252|80197005|FG000|Overall Study|Death|4|||
27547904|NCT00382252|80197005|FG000|Overall Study|Protocol Violation|8|||
27547905|NCT00382252|80197005|FG000|Overall Study|Not treated by RFA|1|||
27547906|NCT00827502|80197006|FG000|Overall Study|randomized but not treated|11|||
27547907|NCT00827502|80197006|FG000|Overall Study|Adverse Event|1|||
27547908|NCT00827502|80197006|FG000|Overall Study|Lost to Follow-up|4|||
27547909|NCT00827502|80197006|FG000|Overall Study|Withdrawal by Subject|5|||
27547910|NCT00297830|80197007|FG000|6 Month Visit|Death|1|||
27547911|NCT00297830|80197008|FG001|6 Month Visit|Death|0|||
27547912|NCT00297830|80197009|FG002|6 Month Visit|Death|2|||
27547913|NCT00297830|80197007|FG000|6 Month Visit|Withdrawal by Subject|2|||
27547914|NCT00297830|80197008|FG001|6 Month Visit|Withdrawal by Subject|1|||
27547915|NCT00297830|80197009|FG002|6 Month Visit|Withdrawal by Subject|1|||
27547916|NCT00297830|80197007|FG000|6 Month Visit|Adverse Event|0|||
27547917|NCT00297830|80197008|FG001|6 Month Visit|Adverse Event|1|||
27547918|NCT00297830|80197009|FG002|6 Month Visit|Adverse Event|0|||
27547919|NCT00297830|80197007|FG000|12 Month Visit|Lost to Follow-up|1|||
27547920|NCT00297830|80197008|FG001|12 Month Visit|Lost to Follow-up|0|||
27547921|NCT00297830|80197009|FG002|12 Month Visit|Lost to Follow-up|0|||
27547922|NCT00297830|80197007|FG000|12 Month Visit|Adverse Event|0|||
27547923|NCT00297830|80197008|FG001|12 Month Visit|Adverse Event|3|||
27547924|NCT00297830|80197009|FG002|12 Month Visit|Adverse Event|0|||
27547925|NCT00297830|80197007|FG000|12 Month Visit|Withdrawal by Subject|0|||
27547926|NCT00297830|80197008|FG001|12 Month Visit|Withdrawal by Subject|3|||
27640371|NCT04110054|80525885|FG003|Overall Study|Withdrawal by Subject|0|||
27640372|NCT04110054|80525882|FG000|Overall Study|Adverse Event|1|||
27640373|NCT04110054|80525883|FG001|Overall Study|Adverse Event|1|||
27640374|NCT04110054|80525884|FG002|Overall Study|Adverse Event|4|||
27640375|NCT04110054|80525885|FG003|Overall Study|Adverse Event|3|||
27640376|NCT01255670|80525889|FG000|Overall Study|Adverse Event|10|||
27640377|NCT01255670|80525890|FG001|Overall Study|Adverse Event|10|||
27640378|NCT01255670|80525889|FG000|Overall Study|Lost to Follow-up|16|||
27640379|NCT01255670|80525890|FG001|Overall Study|Lost to Follow-up|10|||
27640380|NCT01579916|80525891|FG000|Overall Study|Lost to Follow-up|6|||
27640381|NCT01579916|80525892|FG001|Overall Study|Lost to Follow-up|1|||
27640382|NCT01579916|80525891|FG000|Overall Study|Withdrawal by Subject|1|||
27640383|NCT01579916|80525892|FG001|Overall Study|Withdrawal by Subject|1|||
27547927|NCT00297830|80197009|FG002|12 Month Visit|Withdrawal by Subject|0|||
27547928|NCT00913497|80197019|FG000|Overall Study|Adverse Event|1|||
27547929|NCT00913497|80197019|FG000|Overall Study|Withdrawal by Subject|2|||
27547930|NCT03521934|80197020|FG000|Overall Study|Death|65|||
27640384|NCT01579916|80525891|FG000|Overall Study|Death|1|||
27640385|NCT01579916|80525892|FG001|Overall Study|Death|0|||
27928178|NCT03317496|81574729|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
27547931|NCT03521934|80197021|FG001|Overall Study|Death|73|||
27547932|NCT03521934|80197020|FG000|Overall Study|Withdrawal by Subject|18|||
27547933|NCT03521934|80197021|FG001|Overall Study|Withdrawal by Subject|23|||
27547934|NCT03521934|80197020|FG000|Overall Study|Site Terminated by Sponsor|39|||
27547935|NCT03521934|80197021|FG001|Overall Study|Site Terminated by Sponsor|35|||
27640386|NCT00799396|80525893|FG000|Clopidogrel Treatment|Adverse Event|6|||
27640387|NCT00799396|80525893|FG000|Clopidogrel Treatment|Physician Decision|5|||
27547936|NCT03521934|80197020|FG000|Overall Study|Study Terminated by Sponsor|483|||
27640388|NCT00799396|80525893|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
27640389|NCT00799396|80525893|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
27640390|NCT00799396|80525893|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
27640391|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
27640392|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
27640393|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
27640394|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
27640395|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
27640396|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
27640397|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
27640398|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
27640399|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
27640400|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
27640401|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
27640402|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
27640403|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
27640404|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
27928179|NCT03317496|81574730|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
27928180|NCT03317496|81574731|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
27928181|NCT03317496|81574732|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
27928182|NCT03317496|81574728|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
27928183|NCT03317496|81574729|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27928184|NCT03317496|81574730|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27928185|NCT03317496|81574731|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27928186|NCT03317496|81574732|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
27928187|NCT03317496|81574728|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27928188|NCT03317496|81574729|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27928189|NCT03317496|81574730|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
27928190|NCT03317496|81574731|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27928191|NCT03317496|81574732|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
27928192|NCT03317496|81574728|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
27928193|NCT03317496|81574729|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
27928194|NCT03317496|81574730|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
27928195|NCT03317496|81574731|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
27928196|NCT03317496|81574732|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
27928197|NCT03317496|81574728|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
27928198|NCT03317496|81574729|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
27928199|NCT03317496|81574730|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
27928200|NCT03317496|81574731|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
27928201|NCT03317496|81574732|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
27928202|NCT03317496|81574728|FG000|Phase 2: Treatment|Adverse Event|0|||
27928203|NCT03317496|81574729|FG001|Phase 2: Treatment|Adverse Event|0|||
27928204|NCT03317496|81574730|FG002|Phase 2: Treatment|Adverse Event|0|||
27928205|NCT03317496|81574731|FG003|Phase 2: Treatment|Adverse Event|0|||
27928206|NCT03317496|81574732|FG004|Phase 2: Treatment|Adverse Event|6|||
27928207|NCT03317496|81574728|FG000|Phase 2: Treatment|Progressive disease|0|||
27928208|NCT03317496|81574729|FG001|Phase 2: Treatment|Progressive disease|0|||
27928209|NCT03317496|81574730|FG002|Phase 2: Treatment|Progressive disease|0|||
27928210|NCT03317496|81574731|FG003|Phase 2: Treatment|Progressive disease|0|||
27928211|NCT03317496|81574732|FG004|Phase 2: Treatment|Progressive disease|22|||
27928212|NCT03317496|81574728|FG000|Phase 2: Treatment|Other|0|||
27928213|NCT03317496|81574729|FG001|Phase 2: Treatment|Other|0|||
27928214|NCT03317496|81574730|FG002|Phase 2: Treatment|Other|0|||
27928215|NCT03317496|81574731|FG003|Phase 2: Treatment|Other|0|||
27928216|NCT03317496|81574732|FG004|Phase 2: Treatment|Other|4|||
27928217|NCT03317496|81574728|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
27547937|NCT03521934|80197021|FG001|Overall Study|Study Terminated by Sponsor|477|||
27547938|NCT03521934|80197020|FG000|Overall Study|Reason not Specified|3|||
27547939|NCT03521934|80197021|FG001|Overall Study|Reason not Specified|6|||
27547940|NCT02634320|80197025|FG000|Overall Study|Adverse Event|2|||
27547941|NCT02634320|80197025|FG000|Overall Study|Lost to Follow-up|3|||
27547942|NCT02634320|80197025|FG000|Overall Study|Moved out of area|2|||
27547943|NCT02634320|80197025|FG000|Overall Study|Out of window for study visits|1|||
27547944|NCT02634320|80197025|FG000|Overall Study|Protocol Violation|1|||
27640405|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
27640406|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
27640407|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27928218|NCT03317496|81574729|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
27928219|NCT03317496|81574730|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
27928220|NCT03317496|81574731|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
27928221|NCT03317496|81574732|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
27928222|NCT03317496|81574728|FG000|Phase 2: Treatment|Physician Decision|0|||
27928223|NCT03317496|81574729|FG001|Phase 2: Treatment|Physician Decision|0|||
27928224|NCT03317496|81574730|FG002|Phase 2: Treatment|Physician Decision|0|||
27547945|NCT02634320|80197025|FG000|Overall Study|Withdrawal by Subject|5|||
27547946|NCT02634320|80197025|FG000|Overall Study|Lack of Efficacy|2|||
27640408|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27640409|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27640410|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27640411|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27547947|NCT03694821|80197026|FG000|Overall Study|Study terminated|4|||
27547948|NCT03694821|80197027|FG001|Overall Study|Study terminated|8|||
27547949|NCT03694821|80197028|FG002|Overall Study|Study terminated|4|||
27547950|NCT02006719|80197029|FG000|Overall Study|Withdrawal by Subject|10|||
27547951|NCT02006719|80197030|FG001|Overall Study|Withdrawal by Subject|2|||
27547952|NCT02006719|80197029|FG000|Overall Study|Lost to Follow-up|5|||
27547953|NCT02006719|80197030|FG001|Overall Study|Lost to Follow-up|1|||
27547954|NCT02006719|80197029|FG000|Overall Study|Protocol Violation|2|||
27547955|NCT02006719|80197030|FG001|Overall Study|Protocol Violation|0|||
27547956|NCT02006719|80197029|FG000|Overall Study|Adverse Event|1|||
27547957|NCT02006719|80197030|FG001|Overall Study|Adverse Event|1|||
27547958|NCT02006719|80197029|FG000|Overall Study|Other/Unknown|0|||
27547959|NCT02006719|80197030|FG001|Overall Study|Other/Unknown|1|||
27547960|NCT03766581|80197032|FG000|Randomization|Other reasons|2|||
27547961|NCT03766581|80197033|FG001|Randomization|Other reasons|1|||
27547962|NCT03766581|80197034|FG002|Randomization|Other reasons|0|||
27547963|NCT03766581|80197035|FG003|Randomization|Other reasons|1|||
27547964|NCT03766581|80197036|FG004|Randomization|Other reasons|0|||
27547965|NCT03766581|80197037|FG005|Randomization|Other reasons|0|||
27547966|NCT03766581|80197038|FG006|Randomization|Other reasons|0|||
27547967|NCT03766581|80197039|FG007|Randomization|Other reasons|0|||
27547968|NCT03766581|80197032|FG000|Randomization|Participant no longer meets study criteria|5|||
27547969|NCT03766581|80197033|FG001|Randomization|Participant no longer meets study criteria|3|||
27547970|NCT03766581|80197034|FG002|Randomization|Participant no longer meets study criteria|4|||
27547971|NCT03766581|80197035|FG003|Randomization|Participant no longer meets study criteria|0|||
27547972|NCT03766581|80197036|FG004|Randomization|Participant no longer meets study criteria|2|||
27547973|NCT03766581|80197037|FG005|Randomization|Participant no longer meets study criteria|3|||
27547974|NCT03766581|80197038|FG006|Randomization|Participant no longer meets study criteria|0|||
27547975|NCT03766581|80197039|FG007|Randomization|Participant no longer meets study criteria|1|||
27547976|NCT03766581|80197032|FG000|Randomization|Participant request to discontinue study treatment|1|||
27547977|NCT03766581|80197033|FG001|Randomization|Participant request to discontinue study treatment|0|||
27547978|NCT03766581|80197034|FG002|Randomization|Participant request to discontinue study treatment|0|||
27547979|NCT03766581|80197035|FG003|Randomization|Participant request to discontinue study treatment|0|||
27547980|NCT03766581|80197036|FG004|Randomization|Participant request to discontinue study treatment|1|||
27547981|NCT03766581|80197037|FG005|Randomization|Participant request to discontinue study treatment|2|||
27547982|NCT03766581|80197038|FG006|Randomization|Participant request to discontinue study treatment|0|||
27547983|NCT03766581|80197039|FG007|Randomization|Participant request to discontinue study treatment|0|||
27547984|NCT03766581|80197032|FG000|Randomization|Participant withdrew consent|1|||
27547985|NCT03766581|80197033|FG001|Randomization|Participant withdrew consent|0|||
27547986|NCT03766581|80197034|FG002|Randomization|Participant withdrew consent|1|||
27547987|NCT03766581|80197035|FG003|Randomization|Participant withdrew consent|2|||
27547988|NCT03766581|80197036|FG004|Randomization|Participant withdrew consent|1|||
27547989|NCT03766581|80197037|FG005|Randomization|Participant withdrew consent|1|||
27547990|NCT03766581|80197038|FG006|Randomization|Participant withdrew consent|0|||
27547991|NCT03766581|80197039|FG007|Randomization|Participant withdrew consent|0|||
27547992|NCT03766581|80197032|FG000|Treatment|Adverse Event|82|||
27547993|NCT03766581|80197033|FG001|Treatment|Adverse Event|44|||
27547994|NCT03766581|80197034|FG002|Treatment|Adverse Event|47|||
27547995|NCT03766581|80197035|FG003|Treatment|Adverse Event|46|||
27547996|NCT03766581|80197036|FG004|Treatment|Adverse Event|50|||
27547997|NCT03766581|80197037|FG005|Treatment|Adverse Event|77|||
27547998|NCT03766581|80197038|FG006|Treatment|Adverse Event|5|||
27547999|NCT03766581|80197039|FG007|Treatment|Adverse Event|2|||
27548000|NCT03766581|80197032|FG000|Treatment|Participant request to discontinue treatment|34|||
27548001|NCT03766581|80197033|FG001|Treatment|Participant request to discontinue treatment|6|||
27548002|NCT03766581|80197034|FG002|Treatment|Participant request to discontinue treatment|10|||
27548003|NCT03766581|80197035|FG003|Treatment|Participant request to discontinue treatment|10|||
27548004|NCT03766581|80197036|FG004|Treatment|Participant request to discontinue treatment|14|||
27548005|NCT03766581|80197037|FG005|Treatment|Participant request to discontinue treatment|15|||
27548006|NCT03766581|80197038|FG006|Treatment|Participant request to discontinue treatment|0|||
27548007|NCT03766581|80197039|FG007|Treatment|Participant request to discontinue treatment|1|||
27640412|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
27640413|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
27548008|NCT03766581|80197032|FG000|Treatment|Participant withdrew consent|11|||
27548009|NCT03766581|80197033|FG001|Treatment|Participant withdrew consent|4|||
27548010|NCT03766581|80197034|FG002|Treatment|Participant withdrew consent|5|||
27548011|NCT03766581|80197035|FG003|Treatment|Participant withdrew consent|5|||
27640414|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
27640415|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
27640416|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
27640417|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
27640418|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
27640419|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
27640420|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
27928225|NCT03317496|81574731|FG003|Phase 2: Treatment|Physician Decision|0|||
27928226|NCT03317496|81574732|FG004|Phase 2: Treatment|Physician Decision|1|||
27928227|NCT03317496|81574728|FG000|Phase 2: Treatment|Death|0|||
27548012|NCT03766581|80197036|FG004|Treatment|Participant withdrew consent|4|||
27548013|NCT03766581|80197037|FG005|Treatment|Participant withdrew consent|4|||
27548014|NCT03766581|80197038|FG006|Treatment|Participant withdrew consent|0|||
27548015|NCT03766581|80197039|FG007|Treatment|Participant withdrew consent|0|||
27548016|NCT03766581|80197032|FG000|Treatment|Death|1|||
27548017|NCT03766581|80197033|FG001|Treatment|Death|0|||
27548018|NCT03766581|80197034|FG002|Treatment|Death|0|||
27640421|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
27640422|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
27928228|NCT03317496|81574729|FG001|Phase 2: Treatment|Death|0|||
27928229|NCT03317496|81574730|FG002|Phase 2: Treatment|Death|0|||
27928230|NCT03317496|81574731|FG003|Phase 2: Treatment|Death|0|||
27928231|NCT03317496|81574732|FG004|Phase 2: Treatment|Death|1|||
27928232|NCT03317496|81574728|FG000|Phase 2: Follow-up|Death|0|||
27928233|NCT03317496|81574729|FG001|Phase 2: Follow-up|Death|0|||
27928234|NCT03317496|81574730|FG002|Phase 2: Follow-up|Death|0|||
27928235|NCT03317496|81574731|FG003|Phase 2: Follow-up|Death|0|||
27928236|NCT03317496|81574732|FG004|Phase 2: Follow-up|Death|24|||
27928237|NCT03317496|81574728|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
27928238|NCT03317496|81574729|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
27928239|NCT03317496|81574730|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
27928240|NCT03317496|81574731|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
27928241|NCT03317496|81574732|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
27928242|NCT03317496|81574728|FG000|Phase 2: Follow-up|Other|0|||
27928243|NCT03317496|81574729|FG001|Phase 2: Follow-up|Other|0|||
27928244|NCT03317496|81574730|FG002|Phase 2: Follow-up|Other|0|||
27928245|NCT03317496|81574731|FG003|Phase 2: Follow-up|Other|0|||
27928246|NCT03317496|81574732|FG004|Phase 2: Follow-up|Other|1|||
27928247|NCT03317496|81574728|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
27928248|NCT03317496|81574729|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
27928249|NCT03317496|81574730|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
27928250|NCT03317496|81574731|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
27928251|NCT03317496|81574732|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
27928252|NCT03188185|81574733|FG000|Stage 1|Adverse Event|4|||
27928253|NCT03188185|81574734|FG001|Stage 1|Adverse Event|12|||
27928254|NCT03188185|81574735|FG002|Stage 1|Adverse Event|0|||
27928255|NCT03188185|81574736|FG003|Stage 1|Adverse Event|0|||
27928256|NCT03188185|81574733|FG000|Stage 1|Lack of Efficacy|0|||
27928257|NCT03188185|81574734|FG001|Stage 1|Lack of Efficacy|2|||
27928258|NCT03188185|81574735|FG002|Stage 1|Lack of Efficacy|0|||
27928259|NCT03188185|81574736|FG003|Stage 1|Lack of Efficacy|0|||
27928260|NCT03188185|81574733|FG000|Stage 1|Lost to Follow-up|6|||
27928261|NCT03188185|81574734|FG001|Stage 1|Lost to Follow-up|1|||
27928262|NCT03188185|81574735|FG002|Stage 1|Lost to Follow-up|0|||
27928263|NCT03188185|81574736|FG003|Stage 1|Lost to Follow-up|0|||
27928264|NCT03188185|81574733|FG000|Stage 1|Withdrawal by Subject|9|||
27928265|NCT03188185|81574734|FG001|Stage 1|Withdrawal by Subject|0|||
27928266|NCT03188185|81574735|FG002|Stage 1|Withdrawal by Subject|0|||
27928267|NCT03188185|81574736|FG003|Stage 1|Withdrawal by Subject|0|||
27548019|NCT03766581|80197035|FG003|Treatment|Death|0|||
27548020|NCT03766581|80197036|FG004|Treatment|Death|0|||
27640423|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
27640424|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
27640425|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
27640426|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
27640427|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
27928268|NCT03188185|81574733|FG000|Stage 1|Identified as a professional patient|0|||
27548021|NCT03766581|80197037|FG005|Treatment|Death|0|||
27548022|NCT03766581|80197038|FG006|Treatment|Death|0|||
27548023|NCT03766581|80197039|FG007|Treatment|Death|0|||
27928269|NCT03188185|81574734|FG001|Stage 1|Identified as a professional patient|1|||
27548024|NCT03766581|80197032|FG000|Treatment|Lost to Follow-up|1|||
27548025|NCT03766581|80197033|FG001|Treatment|Lost to Follow-up|0|||
27928270|NCT03188185|81574735|FG002|Stage 1|Identified as a professional patient|0|||
27928271|NCT03188185|81574736|FG003|Stage 1|Identified as a professional patient|0|||
27928272|NCT03188185|81574733|FG000|Stage 2|Adverse Event|0|||
27928273|NCT03188185|81574734|FG001|Stage 2|Adverse Event|0|||
27928274|NCT03188185|81574735|FG002|Stage 2|Adverse Event|2|||
27928275|NCT03188185|81574736|FG003|Stage 2|Adverse Event|4|||
27928276|NCT03188185|81574733|FG000|Stage 2|Lack of Efficacy|0|||
27928277|NCT03188185|81574734|FG001|Stage 2|Lack of Efficacy|0|||
27928278|NCT03188185|81574735|FG002|Stage 2|Lack of Efficacy|3|||
27928279|NCT03188185|81574736|FG003|Stage 2|Lack of Efficacy|0|||
27928280|NCT03188185|81574733|FG000|Stage 2|Lost to Follow-up|0|||
27928281|NCT03188185|81574734|FG001|Stage 2|Lost to Follow-up|0|||
27928282|NCT03188185|81574735|FG002|Stage 2|Lost to Follow-up|1|||
27928283|NCT03188185|81574736|FG003|Stage 2|Lost to Follow-up|0|||
27928284|NCT03188185|81574733|FG000|Stage 2|Physician Decision|0|||
27928285|NCT03188185|81574734|FG001|Stage 2|Physician Decision|0|||
27928286|NCT03188185|81574735|FG002|Stage 2|Physician Decision|0|||
27928287|NCT03188185|81574736|FG003|Stage 2|Physician Decision|1|||
27928288|NCT03188185|81574733|FG000|Stage 2|Withdrawal by Subject|0|||
27928289|NCT03188185|81574734|FG001|Stage 2|Withdrawal by Subject|0|||
27928290|NCT03188185|81574735|FG002|Stage 2|Withdrawal by Subject|3|||
27928291|NCT03188185|81574736|FG003|Stage 2|Withdrawal by Subject|1|||
27928292|NCT02709369|81574740|FG000|Overall Study|Lost to Follow-up|15|||
27928293|NCT02709369|81574740|FG000|Overall Study|Withdrawal by Subject|10|||
27928294|NCT02709369|81574740|FG000|Overall Study|Did not received intervention|2|||
27928295|NCT02582632|81574743|FG000|Overall Study|Other|1|||
27928296|NCT02315625|81574744|FG000|First Intervention|Disease Progression|1|||
27928297|NCT02315625|81574745|FG001|First Intervention|Disease Progression|0|||
27928298|NCT02315625|81574744|FG000|Second Intervention|Physician Decision|2|||
27928299|NCT02315625|81574745|FG001|Second Intervention|Physician Decision|1|||
27928300|NCT02315625|81574744|FG000|Second Intervention|Study closure|1|||
27928301|NCT02315625|81574745|FG001|Second Intervention|Study closure|0|||
27928302|NCT02315625|81574744|FG000|Second Intervention|Disease Progression|1|||
27928303|NCT02315625|81574745|FG001|Second Intervention|Disease Progression|0|||
27928304|NCT00827242|81574746|FG000|Overall Study|Withdrawal by Subject|2|||
27928305|NCT00827242|81574747|FG001|Overall Study|Withdrawal by Subject|4|||
27928306|NCT00827242|81574746|FG000|Overall Study|Protocol Violation|1|||
27928307|NCT00827242|81574747|FG001|Overall Study|Protocol Violation|3|||
27928308|NCT00827242|81574746|FG000|Overall Study|Lost to Follow-up|0|||
27928309|NCT00827242|81574747|FG001|Overall Study|Lost to Follow-up|3|||
27928310|NCT00827242|81574746|FG000|Overall Study|Adverse Event Excluding Death|2|||
27928311|NCT00827242|81574747|FG001|Overall Study|Adverse Event Excluding Death|1|||
27928312|NCT00827242|81574746|FG000|Overall Study|Entry Criteria Not Met|4|||
27928313|NCT00827242|81574747|FG001|Overall Study|Entry Criteria Not Met|1|||
27928314|NCT00827242|81574746|FG000|Overall Study|Physician Decision|2|||
27928315|NCT00827242|81574747|FG001|Overall Study|Physician Decision|0|||
27928316|NCT00827242|81574746|FG000|Overall Study|Death|1|||
27928317|NCT00827242|81574747|FG001|Overall Study|Death|0|||
27928318|NCT00827242|81574746|FG000|Overall Study|Lack of Efficacy|1|||
27928319|NCT00827242|81574747|FG001|Overall Study|Lack of Efficacy|0|||
27928320|NCT04925934|81574750|FG000|Overall Study|Adverse Event|1|||
27928321|NCT04925934|81574751|FG001|Overall Study|Adverse Event|0|||
27548026|NCT03766581|80197034|FG002|Treatment|Lost to Follow-up|0|||
27548027|NCT03766581|80197035|FG003|Treatment|Lost to Follow-up|1|||
27548028|NCT03766581|80197036|FG004|Treatment|Lost to Follow-up|0|||
27548029|NCT03766581|80197037|FG005|Treatment|Lost to Follow-up|0|||
27548030|NCT03766581|80197038|FG006|Treatment|Lost to Follow-up|0|||
27928322|NCT04925934|81574752|FG002|Overall Study|Adverse Event|0|||
27928323|NCT04925934|81574750|FG000|Overall Study|Lost to Follow-up|2|||
27928324|NCT04925934|81574751|FG001|Overall Study|Lost to Follow-up|0|||
27928325|NCT04925934|81574752|FG002|Overall Study|Lost to Follow-up|1|||
27928326|NCT04925934|81574750|FG000|Overall Study|Death|0|||
27928327|NCT04925934|81574751|FG001|Overall Study|Death|1|||
27928328|NCT04925934|81574752|FG002|Overall Study|Death|0|||
27548031|NCT03766581|80197039|FG007|Treatment|Lost to Follow-up|0|||
27548032|NCT03766581|80197032|FG000|Treatment|Poor/Non compliance|2|||
27548033|NCT03766581|80197033|FG001|Treatment|Poor/Non compliance|2|||
27548034|NCT03766581|80197034|FG002|Treatment|Poor/Non compliance|1|||
27742511|NCT02732912|80886932|FG001|Overall Study|No outcome; discharged or refused|9|||
27928329|NCT04925934|81574750|FG000|Overall Study|Withdrawal by Subject|8|||
27928330|NCT04925934|81574751|FG001|Overall Study|Withdrawal by Subject|5|||
27928331|NCT04925934|81574752|FG002|Overall Study|Withdrawal by Subject|9|||
27928332|NCT04925934|81574750|FG000|Overall Study|Other|2|||
27928333|NCT04925934|81574751|FG001|Overall Study|Other|2|||
27928334|NCT04925934|81574752|FG002|Overall Study|Other|2|||
27928335|NCT04925934|81574750|FG000|Overall Study|Eastern European Conflict|7|||
27928336|NCT04925934|81574751|FG001|Overall Study|Eastern European Conflict|3|||
27548035|NCT03766581|80197035|FG003|Treatment|Poor/Non compliance|1|||
27742512|NCT03176966|80886933|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
27928337|NCT04925934|81574752|FG002|Overall Study|Eastern European Conflict|2|||
27928338|NCT00274456|81574755|FG000|Overall Study|Still on treatment|2|||
27928339|NCT00274456|81574756|FG001|Overall Study|Still on treatment|3|||
27928340|NCT00274456|81574757|FG002|Overall Study|Still on treatment|5|||
27928341|NCT00274456|81574758|FG003|Overall Study|Still on treatment|1|||
27548036|NCT03766581|80197036|FG004|Treatment|Poor/Non compliance|1|||
27928342|NCT00274456|81574755|FG000|Overall Study|Unacceptable toxicity|10|||
27928343|NCT00274456|81574756|FG001|Overall Study|Unacceptable toxicity|5|||
27928344|NCT00274456|81574757|FG002|Overall Study|Unacceptable toxicity|12|||
27928345|NCT00274456|81574758|FG003|Overall Study|Unacceptable toxicity|16|||
27928346|NCT00274456|81574755|FG000|Overall Study|Adverse Event|0|||
27928347|NCT00274456|81574756|FG001|Overall Study|Adverse Event|1|||
27928348|NCT00274456|81574757|FG002|Overall Study|Adverse Event|2|||
27548037|NCT03766581|80197037|FG005|Treatment|Poor/Non compliance|1|||
27548038|NCT03766581|80197038|FG006|Treatment|Poor/Non compliance|0|||
27548039|NCT03766581|80197039|FG007|Treatment|Poor/Non compliance|0|||
27548040|NCT03766581|80197032|FG000|Treatment|Participant no longer meets study criteria|9|||
27548041|NCT03766581|80197033|FG001|Treatment|Participant no longer meets study criteria|1|||
27548042|NCT03766581|80197034|FG002|Treatment|Participant no longer meets study criteria|5|||
27548043|NCT03766581|80197035|FG003|Treatment|Participant no longer meets study criteria|4|||
27548044|NCT03766581|80197036|FG004|Treatment|Participant no longer meets study criteria|4|||
27548045|NCT03766581|80197037|FG005|Treatment|Participant no longer meets study criteria|4|||
27548046|NCT03766581|80197038|FG006|Treatment|Participant no longer meets study criteria|2|||
27548047|NCT03766581|80197039|FG007|Treatment|Participant no longer meets study criteria|0|||
27548048|NCT03766581|80197032|FG000|Treatment|Other reasons|13|||
27548049|NCT03766581|80197033|FG001|Treatment|Other reasons|8|||
27548050|NCT03766581|80197034|FG002|Treatment|Other reasons|3|||
27548051|NCT03766581|80197035|FG003|Treatment|Other reasons|7|||
27548052|NCT03766581|80197036|FG004|Treatment|Other reasons|3|||
27548053|NCT03766581|80197037|FG005|Treatment|Other reasons|3|||
27548054|NCT03766581|80197038|FG006|Treatment|Other reasons|0|||
27548055|NCT03766581|80197039|FG007|Treatment|Other reasons|0|||
27548056|NCT05059600|80197040|FG000|Overall Study|Enrolled but not Treated|10|||
27548057|NCT01606436|80197041|FG000|Overall Study|Withdrawal by Subject|0|||
27548058|NCT01606436|80197042|FG001|Overall Study|Withdrawal by Subject|0|||
27548059|NCT01606436|80197043|FG002|Overall Study|Withdrawal by Subject|1|||
27548060|NCT01606436|80197044|FG003|Overall Study|Withdrawal by Subject|1|||
27548061|NCT01606436|80197045|FG004|Overall Study|Withdrawal by Subject|1|||
27548062|NCT01606436|80197046|FG005|Overall Study|Withdrawal by Subject|0|||
27548063|NCT01606436|80197041|FG000|Overall Study|Adverse Event|0|||
27548064|NCT01606436|80197042|FG001|Overall Study|Adverse Event|0|||
27548065|NCT01606436|80197043|FG002|Overall Study|Adverse Event|1|||
27548066|NCT01606436|80197044|FG003|Overall Study|Adverse Event|0|||
27548067|NCT01606436|80197045|FG004|Overall Study|Adverse Event|0|||
27548068|NCT01606436|80197046|FG005|Overall Study|Adverse Event|0|||
27548069|NCT01606436|80197041|FG000|Overall Study|Sponsor Decision|0|||
27548070|NCT01606436|80197042|FG001|Overall Study|Sponsor Decision|0|||
27548071|NCT01606436|80197043|FG002|Overall Study|Sponsor Decision|0|||
27548072|NCT01606436|80197044|FG003|Overall Study|Sponsor Decision|1|||
27548073|NCT01606436|80197045|FG004|Overall Study|Sponsor Decision|0|||
27548074|NCT01606436|80197046|FG005|Overall Study|Sponsor Decision|0|||
27548075|NCT03098550|80197047|FG000|Overall Study|Disease Progression|30|||
27548076|NCT03098550|80197048|FG001|Overall Study|Disease Progression|19|||
27548077|NCT03098550|80197049|FG002|Overall Study|Disease Progression|41|||
27548078|NCT03098550|80197047|FG000|Overall Study|Study Drug Toxicity|2|||
27548079|NCT03098550|80197048|FG001|Overall Study|Study Drug Toxicity|1|||
27548080|NCT03098550|80197049|FG002|Overall Study|Study Drug Toxicity|0|||
27548081|NCT03098550|80197047|FG000|Overall Study|Death|1|||
27548082|NCT03098550|80197048|FG001|Overall Study|Death|0|||
27548083|NCT03098550|80197049|FG002|Overall Study|Death|0|||
27548084|NCT03098550|80197047|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
27548085|NCT03098550|80197048|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
27548086|NCT03098550|80197049|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
27548087|NCT03098550|80197047|FG000|Overall Study|Administrative reason by sponsor|0|||
27548088|NCT03098550|80197048|FG001|Overall Study|Administrative reason by sponsor|0|||
27548089|NCT03098550|80197049|FG002|Overall Study|Administrative reason by sponsor|1|||
27548090|NCT03098550|80197047|FG000|Overall Study|Other reasons|2|||
27548091|NCT03098550|80197048|FG001|Overall Study|Other reasons|0|||
27548092|NCT03098550|80197049|FG002|Overall Study|Other reasons|0|||
27548093|NCT03798483|80197050|FG000|Overall Study|Lost to Follow-up|2|||
27548094|NCT03310021|80197051|FG000|Overall Study|Withdrawal by Subject|0|||
27548095|NCT03310021|80197052|FG001|Overall Study|Withdrawal by Subject|0|||
27548096|NCT03310021|80197053|FG002|Overall Study|Withdrawal by Subject|0|||
27548097|NCT03310021|80197054|FG003|Overall Study|Withdrawal by Subject|0|||
27548098|NCT03310021|80197055|FG004|Overall Study|Withdrawal by Subject|0|||
27928349|NCT00274456|81574758|FG003|Overall Study|Adverse Event|2|||
27548099|NCT03310021|80197056|FG005|Overall Study|Withdrawal by Subject|0|||
27548100|NCT03310021|80197057|FG006|Overall Study|Withdrawal by Subject|1|||
27548101|NCT03310021|80197058|FG007|Overall Study|Withdrawal by Subject|0|||
27548102|NCT03310021|80197059|FG008|Overall Study|Withdrawal by Subject|0|||
27548103|NCT03310021|80197060|FG009|Overall Study|Withdrawal by Subject|0|||
27548104|NCT03310021|80197061|FG010|Overall Study|Withdrawal by Subject|0|||
27548105|NCT03310021|80197062|FG011|Overall Study|Withdrawal by Subject|0|||
27548106|NCT03310021|80197063|FG012|Overall Study|Withdrawal by Subject|0|||
27548107|NCT03310021|80197064|FG013|Overall Study|Withdrawal by Subject|0|||
27928350|NCT00274456|81574755|FG000|Overall Study|Physician Decision|7|||
27548108|NCT03310021|80197065|FG014|Overall Study|Withdrawal by Subject|0|||
27548109|NCT03310021|80197066|FG015|Overall Study|Withdrawal by Subject|0|||
27548110|NCT03310021|80197067|FG016|Overall Study|Withdrawal by Subject|0|||
27548111|NCT03310021|80197068|FG017|Overall Study|Withdrawal by Subject|0|||
27548112|NCT03310021|80197069|FG018|Overall Study|Withdrawal by Subject|0|||
27548113|NCT03310021|80197070|FG019|Overall Study|Withdrawal by Subject|0|||
27548114|NCT03310021|80197051|FG000|Overall Study|Lost to Follow-up|0|||
27548115|NCT03310021|80197052|FG001|Overall Study|Lost to Follow-up|0|||
27548116|NCT03310021|80197053|FG002|Overall Study|Lost to Follow-up|0|||
27548117|NCT03310021|80197054|FG003|Overall Study|Lost to Follow-up|0|||
27548118|NCT03310021|80197055|FG004|Overall Study|Lost to Follow-up|0|||
27548119|NCT03310021|80197056|FG005|Overall Study|Lost to Follow-up|0|||
27548120|NCT03310021|80197057|FG006|Overall Study|Lost to Follow-up|0|||
27548121|NCT03310021|80197058|FG007|Overall Study|Lost to Follow-up|0|||
27548122|NCT03310021|80197059|FG008|Overall Study|Lost to Follow-up|0|||
27548123|NCT03310021|80197060|FG009|Overall Study|Lost to Follow-up|0|||
27548124|NCT03310021|80197061|FG010|Overall Study|Lost to Follow-up|1|||
27548125|NCT03310021|80197062|FG011|Overall Study|Lost to Follow-up|0|||
27548126|NCT03310021|80197063|FG012|Overall Study|Lost to Follow-up|0|||
27548127|NCT03310021|80197064|FG013|Overall Study|Lost to Follow-up|0|||
27548128|NCT03310021|80197065|FG014|Overall Study|Lost to Follow-up|0|||
27548129|NCT03310021|80197066|FG015|Overall Study|Lost to Follow-up|0|||
27548130|NCT03310021|80197067|FG016|Overall Study|Lost to Follow-up|0|||
27548131|NCT03310021|80197068|FG017|Overall Study|Lost to Follow-up|0|||
27548132|NCT03310021|80197069|FG018|Overall Study|Lost to Follow-up|0|||
27548133|NCT03310021|80197070|FG019|Overall Study|Lost to Follow-up|0|||
27928351|NCT00274456|81574756|FG001|Overall Study|Physician Decision|5|||
27928352|NCT00274456|81574757|FG002|Overall Study|Physician Decision|6|||
27928353|NCT00274456|81574758|FG003|Overall Study|Physician Decision|13|||
27928354|NCT00274456|81574755|FG000|Overall Study|Lost to Follow-up|0|||
27928355|NCT00274456|81574756|FG001|Overall Study|Lost to Follow-up|0|||
27928356|NCT00274456|81574757|FG002|Overall Study|Lost to Follow-up|1|||
27928357|NCT00274456|81574758|FG003|Overall Study|Lost to Follow-up|0|||
27928358|NCT00274456|81574755|FG000|Overall Study|Withdrawal by Subject|18|||
27928359|NCT00274456|81574756|FG001|Overall Study|Withdrawal by Subject|13|||
27928360|NCT00274456|81574757|FG002|Overall Study|Withdrawal by Subject|9|||
27928361|NCT00274456|81574758|FG003|Overall Study|Withdrawal by Subject|13|||
27928362|NCT02530242|81574759|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
27928363|NCT02530242|81574760|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
27928364|NCT05436288|81574761|FG000|Overall Study|Lost to Follow-up|1|||
27928365|NCT05436288|81574761|FG000|Overall Study|Adverse Event|1|||
27928366|NCT03483103|81574762|FG000|Pre-Treatment Phase|Other reasons|1|||
27928367|NCT03483103|81574762|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
27928368|NCT03483103|81574762|FG000|Pre-Treatment Phase|Disease-related complications|1|||
27928369|NCT03483103|81574762|FG000|Pre-Treatment Phase|Death|5|||
27928370|NCT03483103|81574762|FG000|Treatment Phase|Withdrawal by Subject|7|||
27928371|NCT03483103|81574762|FG000|Treatment Phase|Other reasons|1|||
27928372|NCT03483103|81574762|FG000|Treatment Phase|Death|23|||
27928373|NCT03483103|81574762|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
27928374|NCT03483103|81574762|FG000|Treatment Phase|Received nonconforming product|1|||
27928375|NCT01164475|81574763|FG000|Overall Study|Lack of Efficacy|1|||
27928376|NCT01164475|81574764|FG001|Overall Study|Lack of Efficacy|0|||
27928377|NCT01164475|81574763|FG000|Overall Study|Other|0|||
27928378|NCT01164475|81574764|FG001|Overall Study|Other|1|||
27928379|NCT01164475|81574763|FG000|Overall Study|Progressive disease|0|||
27928380|NCT01164475|81574764|FG001|Overall Study|Progressive disease|1|||
27928381|NCT01164475|81574763|FG000|Overall Study|Protocol Violation|1|||
27928382|NCT01164475|81574764|FG001|Overall Study|Protocol Violation|0|||
27928383|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
27928384|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
27928385|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
27548134|NCT04997161|80197075|FG000|Overall Study|Study terminated by sponsor|3|||
27548135|NCT03648541|80197078|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
27548136|NCT03648541|80197079|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
27548137|NCT03648541|80197078|FG000|Re-induction Period Only|Lack of Efficacy|7|||
27548138|NCT03648541|80197079|FG001|Re-induction Period Only|Lack of Efficacy|0|||
27640428|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
27640429|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
27928386|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
27928387|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
27928388|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
27928389|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
27928390|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
27928391|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
27928392|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
27928393|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
27928394|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
27928395|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
27928396|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
27928397|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
27928398|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
27928399|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
27928400|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
27928401|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
27928402|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
27928403|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
27928404|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
27928405|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
27928406|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
27928407|NCT00620542|81574766|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
27928408|NCT00620542|81574767|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
27928409|NCT00620542|81574768|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
27928410|NCT00620542|81574769|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
27928411|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
27928412|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
27928413|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
27928414|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
27928415|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
27928416|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
27928417|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
27928418|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
27928419|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
27928420|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
27928421|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
27928422|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
27928423|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
27928424|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
27928425|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
27928426|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
27928427|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
27928428|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
27928429|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
27928430|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
27928431|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
27928432|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
27928433|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
27548139|NCT03648541|80197078|FG000|Maintenance Period Only|Missing|0|||
27548140|NCT03648541|80197079|FG001|Maintenance Period Only|Missing|1|||
27548141|NCT03648541|80197078|FG000|Maintenance Period Only|Other not listed below|0|||
27548142|NCT03648541|80197079|FG001|Maintenance Period Only|Other not listed below|4|||
27548143|NCT03648541|80197078|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
27928434|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
27928435|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
27928436|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
27928437|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
27928438|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
27928439|NCT00620542|81574766|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
27548144|NCT03648541|80197079|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
27548145|NCT03648541|80197078|FG000|Maintenance Period Only|Protocol Violation|0|||
27548146|NCT03648541|80197079|FG001|Maintenance Period Only|Protocol Violation|1|||
27548147|NCT03648541|80197078|FG000|Maintenance Period Only|Lack of Efficacy|0|||
27548148|NCT03648541|80197079|FG001|Maintenance Period Only|Lack of Efficacy|18|||
27548149|NCT03648541|80197078|FG000|Maintenance Period Only|Adverse Event|0|||
27928440|NCT00620542|81574767|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
27928441|NCT00620542|81574768|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
27928442|NCT00620542|81574769|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
27928443|NCT01373229|81574773|FG000|Overall Study|Death|3|||
27928444|NCT01373229|81574773|FG000|Overall Study|Physician Decision|3|||
27928445|NCT00884949|81574774|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
27928446|NCT00884949|81574774|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
27928447|NCT02300610|81574777|FG000|Overall Study|Withdrawal by Subject|1|||
27928448|NCT02300610|81574778|FG001|Overall Study|Withdrawal by Subject|0|||
27928449|NCT02300610|81574779|FG002|Overall Study|Withdrawal by Subject|1|||
27928450|NCT01407367|81574780|FG000|Overall Study|Death|24|||
27928451|NCT01407367|81574781|FG001|Overall Study|Death|32|||
27928452|NCT01407367|81574780|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
27548150|NCT03648541|80197079|FG001|Maintenance Period Only|Adverse Event|4|||
27548151|NCT03648541|80197078|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
27928453|NCT01407367|81574781|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
27928454|NCT01407367|81574780|FG000|Overall Study|Withdrawal by Subject|4|||
27928455|NCT01407367|81574781|FG001|Overall Study|Withdrawal by Subject|15|||
27928456|NCT01407367|81574780|FG000|Overall Study|Lost to Follow-up|0|||
27928457|NCT01407367|81574781|FG001|Overall Study|Lost to Follow-up|2|||
27928458|NCT02568423|81574782|FG000|Overall Study|Lost to Follow-up|0|||
27928459|NCT02568423|81574783|FG001|Overall Study|Lost to Follow-up|2|||
27928460|NCT02568423|81574784|FG002|Overall Study|Lost to Follow-up|0|||
27928461|NCT02568423|81574785|FG003|Overall Study|Lost to Follow-up|0|||
27928462|NCT02568423|81574786|FG004|Overall Study|Lost to Follow-up|0|||
27928463|NCT02568423|81574787|FG005|Overall Study|Lost to Follow-up|0|||
27928464|NCT02568423|81574788|FG006|Overall Study|Lost to Follow-up|0|||
27928465|NCT02568423|81574789|FG007|Overall Study|Lost to Follow-up|0|||
27928466|NCT02568423|81574782|FG000|Overall Study|Physician Decision|0|||
27928467|NCT02568423|81574783|FG001|Overall Study|Physician Decision|0|||
27928468|NCT02568423|81574784|FG002|Overall Study|Physician Decision|0|||
27928469|NCT02568423|81574785|FG003|Overall Study|Physician Decision|0|||
27928470|NCT02568423|81574786|FG004|Overall Study|Physician Decision|0|||
27548152|NCT03648541|80197079|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
27548153|NCT01088997|80197080|FG000|Overall Study|Physician Decision|1|||
27548154|NCT01088997|80197081|FG001|Overall Study|Physician Decision|1|||
27928471|NCT02568423|81574787|FG005|Overall Study|Physician Decision|1|||
27928472|NCT02568423|81574788|FG006|Overall Study|Physician Decision|0|||
27928473|NCT02568423|81574789|FG007|Overall Study|Physician Decision|0|||
27928474|NCT02232698|81574790|FG000|Overall Study|Pregnancy|1|||
27928475|NCT02232698|81574791|FG001|Overall Study|Pregnancy|1|||
27928476|NCT02232698|81574790|FG000|Overall Study|Met exclusion criteria|1|||
27928477|NCT02232698|81574791|FG001|Overall Study|Met exclusion criteria|1|||
27928478|NCT02232698|81574790|FG000|Overall Study|Had device-associated symptoms|7|||
27928479|NCT02232698|81574791|FG001|Overall Study|Had device-associated symptoms|0|||
27928480|NCT02232698|81574790|FG000|Overall Study|Non-compliance with study device|1|||
27928481|NCT02232698|81574791|FG001|Overall Study|Non-compliance with study device|4|||
27928482|NCT02232698|81574790|FG000|Overall Study|Allocated to control group|0|||
27928483|NCT02232698|81574791|FG001|Overall Study|Allocated to control group|3|||
27928484|NCT02232698|81574790|FG000|Overall Study|Withdrawal by Subject|0|||
27928485|NCT02232698|81574791|FG001|Overall Study|Withdrawal by Subject|11|||
27928486|NCT02719327|81574792|FG000|Overall Study|Withdrawal by Subject|11|||
27928487|NCT02719327|81574793|FG001|Overall Study|Withdrawal by Subject|8|||
27928488|NCT02665117|81574794|FG000|Overall Study|Physician Decision|1|||
27928489|NCT02665117|81574795|FG001|Overall Study|Physician Decision|0|||
27928490|NCT01432951|81574797|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
27928491|NCT04666298|81574800|FG000|Overall Study|Subject decision|1|||
27928492|NCT04666298|81574801|FG001|Overall Study|Subject decision|0|||
27928493|NCT04666298|81574802|FG002|Overall Study|Subject decision|0|||
27928494|NCT04666298|81574803|FG003|Overall Study|Subject decision|2|||
27928495|NCT04666298|81574800|FG000|Overall Study|Death|1|||
27928496|NCT04666298|81574801|FG001|Overall Study|Death|0|||
27928497|NCT04666298|81574802|FG002|Overall Study|Death|0|||
27928498|NCT04666298|81574803|FG003|Overall Study|Death|0|||
27928499|NCT04666298|81574800|FG000|Overall Study|Lost to Follow-up|0|||
27928500|NCT04666298|81574801|FG001|Overall Study|Lost to Follow-up|0|||
27928501|NCT04666298|81574802|FG002|Overall Study|Lost to Follow-up|0|||
27928502|NCT04666298|81574803|FG003|Overall Study|Lost to Follow-up|1|||
27928503|NCT04666298|81574800|FG000|Overall Study|Physician Decision|0|||
27928504|NCT04666298|81574801|FG001|Overall Study|Physician Decision|0|||
27928505|NCT04666298|81574802|FG002|Overall Study|Physician Decision|0|||
27928506|NCT04666298|81574803|FG003|Overall Study|Physician Decision|1|||
27928507|NCT04666298|81574800|FG000|Overall Study|Protocol deviation|0|||
27548155|NCT01088997|80197080|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
27548156|NCT01088997|80197081|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
27548157|NCT01088997|80197080|FG000|Overall Study|Excluded prior to receiving drug|1|||
27548158|NCT01088997|80197081|FG001|Overall Study|Excluded prior to receiving drug|1|||
27548159|NCT00521014|80197082|FG000|Overall Study|Inevaluable, not treated|1|||
27548160|NCT00407797|80197083|FG000|Overall Study|Lost to Follow-up|2|||
27548161|NCT00407797|80197083|FG000|Overall Study|Adverse Event|6|||
27742513|NCT03176966|80886934|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
27928508|NCT04666298|81574801|FG001|Overall Study|Protocol deviation|0|||
27928509|NCT04666298|81574802|FG002|Overall Study|Protocol deviation|1|||
27928510|NCT04666298|81574803|FG003|Overall Study|Protocol deviation|0|||
27928511|NCT02693418|81574805|FG000|Overall Study|Lost to Follow-up|1|||
27928512|NCT02693418|81574806|FG001|Overall Study|Lost to Follow-up|2|||
27928513|NCT02693418|81574807|FG002|Overall Study|Lost to Follow-up|0|||
27928514|NCT02693418|81574808|FG003|Overall Study|Lost to Follow-up|0|||
27928515|NCT02693418|81574809|FG004|Overall Study|Lost to Follow-up|0|||
27928516|NCT02693418|81574805|FG000|Overall Study|Menses during study period|0|||
27928517|NCT02693418|81574806|FG001|Overall Study|Menses during study period|0|||
27928518|NCT02693418|81574807|FG002|Overall Study|Menses during study period|2|||
27928519|NCT02693418|81574808|FG003|Overall Study|Menses during study period|0|||
27640430|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
27640431|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640432|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640433|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640434|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
27640435|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640436|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640437|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640438|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
27640439|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
27640440|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
27640441|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
27640442|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
27640443|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
27548162|NCT00407797|80197083|FG000|Overall Study|Other|7|||
27548163|NCT00407797|80197083|FG000|Overall Study|Withdrawal by Subject|3|||
27548164|NCT03539081|80197084|FG000|Overall Study|Withdrawal by Subject|2|||
27548165|NCT03539081|80197085|FG001|Overall Study|Withdrawal by Subject|3|||
27548166|NCT03539081|80197086|FG002|Overall Study|Withdrawal by Subject|0|||
27548167|NCT03539081|80197084|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
27548168|NCT03539081|80197085|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
27548169|NCT03539081|80197086|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
27548170|NCT03706456|80197087|FG000|Overall Study|Adverse Event|1|||
27548171|NCT03706456|80197087|FG000|Overall Study|Lack of Efficacy|2|||
27548172|NCT01397084|80197088|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
27548173|NCT01397084|80197088|FG000|Overall Study|Protocol Violation|2|||
27548174|NCT01397084|80197088|FG000|Overall Study|Adverse Event|2|||
27548175|NCT01397084|80197088|FG000|Overall Study|Withdrawal by Subject|1|||
27548176|NCT01397084|80197088|FG000|Overall Study|Lost to Follow-up|1|||
27548177|NCT01397084|80197088|FG000|Overall Study|Used other proton pump inhibitor|1|||
27548178|NCT02228460|80197089|FG000|Overall Study|Adverse Event|1|||
27548179|NCT02228460|80197089|FG000|Overall Study|Lost to Follow-up|1|||
27548180|NCT01587001|80197091|FG000|Overall Study|Lost to Follow-up|2|||
27548181|NCT01587001|80197092|FG001|Overall Study|Lost to Follow-up|0|||
27548182|NCT01587001|80197091|FG000|Overall Study|Insufficient samples to complete testing|4|||
27548183|NCT01587001|80197092|FG001|Overall Study|Insufficient samples to complete testing|1|||
27548184|NCT02601469|80197093|FG000|Overall Study|Enrolled in Error|1|||
27548185|NCT02601469|80197094|FG001|Overall Study|Enrolled in Error|0|||
27548186|NCT02505867|80197095|FG000|Overall Study|Lack of Efficacy|6|||
27548187|NCT02505867|80197096|FG001|Overall Study|Lack of Efficacy|6|||
27548188|NCT00907777|80197101|FG000|Overall Study|Withdrawal by Subject|0|||
27548189|NCT00907777|80197102|FG001|Overall Study|Withdrawal by Subject|1|||
27548190|NCT02879305|80197103|FG000|Overall Study|Investigator Site Closed|55|||
27548191|NCT02879305|80197104|FG001|Overall Study|Investigator Site Closed|57|||
27548192|NCT02879305|80197103|FG000|Overall Study|Withdrawal by Subject|44|||
27548193|NCT02879305|80197104|FG001|Overall Study|Withdrawal by Subject|42|||
27548194|NCT02879305|80197103|FG000|Overall Study|Lost to Follow-up|17|||
27548195|NCT02879305|80197104|FG001|Overall Study|Lost to Follow-up|12|||
27548196|NCT02879305|80197103|FG000|Overall Study|Other|1|||
27548197|NCT02879305|80197104|FG001|Overall Study|Other|0|||
27548198|NCT01812174|80197105|FG000|Overall Study|Death|1|||
27548199|NCT01812174|80197106|FG001|Overall Study|Death|0|||
27548200|NCT01812174|80197105|FG000|Overall Study|Protocol Violation|2|||
27548201|NCT01812174|80197106|FG001|Overall Study|Protocol Violation|0|||
27548202|NCT00536198|80197107|FG000|Overall Study|Lost to Follow-up|15|||
27548203|NCT00536198|80197108|FG001|Overall Study|Lost to Follow-up|14|||
27548204|NCT00536198|80197107|FG000|Overall Study|Withdrawal by Subject|16|||
27548205|NCT00536198|80197108|FG001|Overall Study|Withdrawal by Subject|12|||
27548206|NCT00536198|80197107|FG000|Overall Study|Adverse Event|2|||
27548207|NCT00536198|80197108|FG001|Overall Study|Adverse Event|2|||
27548208|NCT00536198|80197107|FG000|Overall Study|Rescue|3|||
27548209|NCT00536198|80197108|FG001|Overall Study|Rescue|9|||
27548210|NCT00536198|80197107|FG000|Overall Study|Pregnancy|1|||
27640444|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
27548211|NCT00536198|80197108|FG001|Overall Study|Pregnancy|1|||
27548212|NCT00536198|80197107|FG000|Overall Study|Protocol Violation|0|||
27640445|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
27640446|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
27548213|NCT00536198|80197108|FG001|Overall Study|Protocol Violation|1|||
27548214|NCT03727347|80197111|FG000|Overall Study|Withdrawal by Subject|2|||
27548215|NCT03727347|80197111|FG000|Overall Study|Lost to Follow-up|1|||
27640447|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
27548216|NCT01845831|80197114|FG000|Inpatient Phase|Withdrawal by Subject|1|||
27548217|NCT01845831|80197115|FG001|Inpatient Phase|Withdrawal by Subject|1|||
27548218|NCT01845831|80197116|FG002|Inpatient Phase|Withdrawal by Subject|0|||
27928520|NCT02693418|81574809|FG004|Overall Study|Menses during study period|0|||
27548219|NCT01845831|80197117|FG003|Inpatient Phase|Withdrawal by Subject|0|||
27548220|NCT01845831|80197118|FG004|Inpatient Phase|Withdrawal by Subject|0|||
27548221|NCT02007109|80197121|FG000|Overall Study|Diary not returned or excluded|102|||
27548222|NCT02007109|80197121|FG000|Overall Study|Excluded - Age<7yo|9|||
27548223|NCT03930797|80197124|FG000|Overall Study|Lost to Follow-up|3|||
27548224|NCT03930797|80197125|FG001|Overall Study|Lost to Follow-up|10|||
27548225|NCT01500694|80197128|FG000|Overall Study|Adverse Event|4|||
27548226|NCT01500694|80197129|FG001|Overall Study|Adverse Event|3|||
27548227|NCT01500694|80197128|FG000|Overall Study|Protocol Violation|0|||
27548228|NCT01500694|80197129|FG001|Overall Study|Protocol Violation|1|||
27548229|NCT01500694|80197128|FG000|Overall Study|Withdrawal by Subject|23|||
27548230|NCT01500694|80197129|FG001|Overall Study|Withdrawal by Subject|14|||
27548231|NCT01500694|80197128|FG000|Overall Study|Lost to Follow-up|2|||
27548232|NCT01500694|80197129|FG001|Overall Study|Lost to Follow-up|3|||
27548233|NCT01500694|80197128|FG000|Overall Study|Lack of Efficacy|14|||
27548234|NCT01500694|80197129|FG001|Overall Study|Lack of Efficacy|5|||
27548235|NCT01500694|80197128|FG000|Overall Study|Other|9|||
27548236|NCT01500694|80197129|FG001|Overall Study|Other|3|||
27548237|NCT02340975|80197132|FG000|Overall Study|Death|6|||
27640448|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
27640449|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
27928521|NCT03329001|81574810|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
27928522|NCT03329001|81574811|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
27928523|NCT03329001|81574812|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
27928524|NCT03329001|81574813|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
27928525|NCT03329001|81574814|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
27928526|NCT03329001|81574815|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
27928527|NCT03329001|81574816|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
27928528|NCT03329001|81574817|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
27928529|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928530|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928531|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928532|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
27928533|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928534|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928535|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928536|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
27928537|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928538|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928539|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928540|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
27928541|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928542|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928543|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928544|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
27928545|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928546|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928547|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928548|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
27928549|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928550|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928551|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928552|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
27928553|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27928554|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27928555|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
27928556|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27928557|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27548238|NCT02340975|80197133|FG001|Overall Study|Death|23|||
27548239|NCT02340975|80197134|FG002|Overall Study|Death|21|||
27548240|NCT02340975|80197135|FG003|Overall Study|Death|7|||
27548241|NCT02340975|80197136|FG004|Overall Study|Death|21|||
27548242|NCT02340975|80197137|FG005|Overall Study|Death|13|||
27548243|NCT02340975|80197132|FG000|Overall Study|Lost to Follow-up|0|||
27548244|NCT02340975|80197133|FG001|Overall Study|Lost to Follow-up|0|||
27928558|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27928559|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27928560|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
27928561|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928562|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928563|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
27928564|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928565|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928566|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928567|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928568|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
27928569|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27640450|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
27640451|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
27640452|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
27640453|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
27640454|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
27640455|NCT03903822|80525894|FG000|Treatment Phase (6 Weeks)|Other|2|||
27640456|NCT03903822|80525895|FG001|Treatment Phase (6 Weeks)|Other|1|||
27928570|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27928571|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
27928572|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27928573|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27928574|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27928575|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27928576|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
27928577|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27928578|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27548245|NCT02340975|80197134|FG002|Overall Study|Lost to Follow-up|0|||
27548246|NCT02340975|80197135|FG003|Overall Study|Lost to Follow-up|0|||
27548247|NCT02340975|80197136|FG004|Overall Study|Lost to Follow-up|2|||
27548248|NCT02340975|80197137|FG005|Overall Study|Lost to Follow-up|0|||
27548249|NCT02340975|80197132|FG000|Overall Study|Withdrawal by Subject|0|||
27548250|NCT02340975|80197133|FG001|Overall Study|Withdrawal by Subject|0|||
27548251|NCT02340975|80197134|FG002|Overall Study|Withdrawal by Subject|3|||
27548252|NCT02340975|80197135|FG003|Overall Study|Withdrawal by Subject|3|||
27548253|NCT02340975|80197136|FG004|Overall Study|Withdrawal by Subject|2|||
27548254|NCT02340975|80197137|FG005|Overall Study|Withdrawal by Subject|0|||
27548255|NCT02340975|80197132|FG000|Overall Study|Other|0|||
27548256|NCT02340975|80197133|FG001|Overall Study|Other|4|||
27548257|NCT02340975|80197134|FG002|Overall Study|Other|0|||
27548258|NCT02340975|80197135|FG003|Overall Study|Other|2|||
27548259|NCT02340975|80197136|FG004|Overall Study|Other|0|||
27548260|NCT02340975|80197137|FG005|Overall Study|Other|6|||
27640457|NCT03903822|80525896|FG002|Treatment Phase (6 Weeks)|Other|0|||
27640458|NCT03903822|80525897|FG003|Treatment Phase (6 Weeks)|Other|0|||
27928579|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
27928580|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27928581|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27928582|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27928583|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27928584|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
27548261|NCT01367002|80197140|FG000|Overall Study|Withdrawal by Subject|1|||
27548262|NCT01367002|80197141|FG001|Overall Study|Withdrawal by Subject|0|||
27548263|NCT01367002|80197140|FG000|Overall Study|Physician Decision|0|||
27548264|NCT01367002|80197141|FG001|Overall Study|Physician Decision|2|||
27640459|NCT03903822|80525898|FG004|Treatment Phase (6 Weeks)|Other|1|||
27548265|NCT04115839|80197144|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
27548266|NCT04115839|80197145|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
27548267|NCT04115839|80197146|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
27548268|NCT04115839|80197147|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
27548269|NCT04115839|80197148|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
27548270|NCT04115839|80197149|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
27548271|NCT04115839|80197150|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
27548272|NCT04115839|80197144|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
27548273|NCT04115839|80197145|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
27548274|NCT04115839|80197146|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
27548275|NCT04115839|80197147|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
27548276|NCT04115839|80197148|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
27548277|NCT04115839|80197149|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
27548278|NCT04115839|80197150|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
27548279|NCT04115839|80197144|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
27548280|NCT04115839|80197145|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
27548281|NCT04115839|80197146|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
27548282|NCT04115839|80197147|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
27548283|NCT04115839|80197148|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
27548284|NCT04115839|80197149|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
27548285|NCT04115839|80197150|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
27548286|NCT04115839|80197144|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
27548287|NCT04115839|80197145|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
27548288|NCT04115839|80197146|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
27548289|NCT04115839|80197147|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
27548290|NCT04115839|80197148|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
27548291|NCT04115839|80197149|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
27548292|NCT04115839|80197150|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
27548293|NCT04115839|80197144|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
27548294|NCT04115839|80197145|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
27548295|NCT04115839|80197146|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
27548296|NCT04115839|80197147|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
27548297|NCT04115839|80197148|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
27548298|NCT04115839|80197149|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
27548299|NCT04115839|80197150|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
27548300|NCT04115839|80197144|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
27548301|NCT04115839|80197145|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
27548302|NCT04115839|80197146|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
27548303|NCT04115839|80197147|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
27548304|NCT04115839|80197148|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
27548305|NCT04115839|80197149|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
27548306|NCT04115839|80197150|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
27548307|NCT03033394|80197151|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
27548308|NCT03033394|80197151|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
27548309|NCT03033394|80197151|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
27548310|NCT03033394|80197151|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
27548311|NCT03033394|80197151|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
27548312|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
27548313|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
27548314|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
27548315|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548316|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548317|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548318|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548319|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548320|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548321|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548322|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
27548323|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
27548324|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27640460|NCT03903822|80525899|FG005|Treatment Phase (6 Weeks)|Other|1|||
27640461|NCT03903822|80525900|FG006|Treatment Phase (6 Weeks)|Other|0|||
27742514|NCT03176966|80886933|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
27742515|NCT03176966|80886934|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
27742516|NCT03176966|80886933|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
27742517|NCT03176966|80886934|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
27928585|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
27928586|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
27958651|NCT01791517|81680063|FG005|Phase II|Pre-Existing Ocular Issue|0|||
27928587|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
27928588|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
27928589|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
27548325|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
27548326|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27548327|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27548328|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27548329|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27742518|NCT03176966|80886933|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
27742519|NCT03176966|80886934|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
27742520|NCT03176966|80886933|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
27742521|NCT03176966|80886934|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
27742522|NCT03176966|80886933|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
27742523|NCT03176966|80886934|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
27742524|NCT03176966|80886933|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
27742525|NCT03176966|80886934|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
27742526|NCT03700892|80886937|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
27742527|NCT03700892|80886938|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
27742528|NCT03700892|80886939|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
27742529|NCT00790296|80886941|FG000|Overall Study|Did not meet study eligibility criteria|1|||
27742530|NCT00790296|80886942|FG001|Overall Study|Did not meet study eligibility criteria|1|||
27742531|NCT00790296|80886941|FG000|Overall Study|Adverse Event|0|||
27742532|NCT00790296|80886942|FG001|Overall Study|Adverse Event|1|||
27742533|NCT03704051|80886945|FG000|Overall Study|Withdrawal by Subject|4|||
27742534|NCT03704051|80886946|FG001|Overall Study|Withdrawal by Subject|0|||
27742535|NCT01277289|80886947|FG000|Overall Study|fragile vein|1|||
27742536|NCT01277289|80886948|FG001|Overall Study|fragile vein|0|||
27742537|NCT01277289|80886947|FG000|Overall Study|Physician Decision|1|||
27742538|NCT01277289|80886948|FG001|Overall Study|Physician Decision|0|||
27742539|NCT01277289|80886947|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
27742540|NCT01277289|80886948|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
27742541|NCT01277289|80886947|FG000|Overall Study|Protocol Violation|1|||
27742542|NCT01277289|80886948|FG001|Overall Study|Protocol Violation|1|||
27742543|NCT01277289|80886947|FG000|Overall Study|Adverse Event|2|||
27742544|NCT01277289|80886948|FG001|Overall Study|Adverse Event|1|||
27742545|NCT01277289|80886947|FG000|Overall Study|consent withdrawn|1|||
27742546|NCT01277289|80886948|FG001|Overall Study|consent withdrawn|1|||
27742547|NCT01277289|80886947|FG000|Overall Study|premature closure of the study|4|||
27742548|NCT01277289|80886948|FG001|Overall Study|premature closure of the study|2|||
27742549|NCT01276847|80886949|FG000|Overall Study|Withdrawal by Subject|1|||
27742550|NCT01276847|80886950|FG001|Overall Study|Withdrawal by Subject|0|||
27742551|NCT01276847|80886951|FG002|Overall Study|Withdrawal by Subject|0|||
27742552|NCT04773041|80886966|FG000|Overall Study|Unable to data match|1|||
27742553|NCT04773041|80886967|FG001|Overall Study|Unable to data match|0|||
27742554|NCT04773041|80886968|FG002|Overall Study|Unable to data match|0|||
27742555|NCT00719810|80886969|FG000|Overall Study|Adverse Event|0|||
27742556|NCT00719810|80886970|FG001|Overall Study|Adverse Event|2|||
27742557|NCT00719810|80886971|FG002|Overall Study|Adverse Event|3|||
27742558|NCT00719810|80886969|FG000|Overall Study|Lost to Follow-up|2|||
27742559|NCT00719810|80886970|FG001|Overall Study|Lost to Follow-up|0|||
27742560|NCT00719810|80886971|FG002|Overall Study|Lost to Follow-up|3|||
27742561|NCT00719810|80886969|FG000|Overall Study|Physician Decision|0|||
27742562|NCT00719810|80886970|FG001|Overall Study|Physician Decision|1|||
27742563|NCT00719810|80886971|FG002|Overall Study|Physician Decision|0|||
27742564|NCT00719810|80886969|FG000|Overall Study|Withdrawal by Subject|1|||
27742565|NCT00719810|80886970|FG001|Overall Study|Withdrawal by Subject|1|||
27742566|NCT00719810|80886971|FG002|Overall Study|Withdrawal by Subject|2|||
27742567|NCT01635933|80886972|FG000|Overall Study|Adverse Event|1|||
27742568|NCT01635933|80886973|FG001|Overall Study|Adverse Event|0|||
27742569|NCT01635933|80886972|FG000|Overall Study|Lost to Follow-up|0|||
27742570|NCT01635933|80886973|FG001|Overall Study|Lost to Follow-up|5|||
27742571|NCT01635933|80886972|FG000|Overall Study|Subject decision|1|||
27548330|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27742572|NCT01635933|80886973|FG001|Overall Study|Subject decision|1|||
27742573|NCT01635933|80886972|FG000|Overall Study|Noncompliance|0|||
27742574|NCT01635933|80886973|FG001|Overall Study|Noncompliance|1|||
27742575|NCT01635933|80886972|FG000|Overall Study|No longer had transportation|0|||
27742576|NCT01635933|80886973|FG001|Overall Study|No longer had transportation|1|||
27742577|NCT00744055|80886974|FG000|Overall Study|Withdrawal by Subject|6|||
27742578|NCT00744055|80886975|FG001|Overall Study|Withdrawal by Subject|9|||
27742579|NCT00744055|80886974|FG000|Overall Study|Lack of Efficacy|0|||
27742580|NCT00744055|80886975|FG001|Overall Study|Lack of Efficacy|1|||
27548331|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27548332|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27548333|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
27548334|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
27548335|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
27548336|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
27548337|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548338|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548339|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548340|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548341|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548342|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548343|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548344|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
27548345|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
27548346|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
27548347|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548348|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548349|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548350|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548351|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548352|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548353|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548354|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548355|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
27548356|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
27548357|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
27548358|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
27548359|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548360|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548361|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548362|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548363|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548364|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548365|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548366|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
27548367|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548368|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
27548369|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
27548370|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548371|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548372|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548373|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548374|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548375|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548376|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548377|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
27548378|NCT02207244|80197159|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548379|NCT02207244|80197160|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
27548380|NCT02207244|80197161|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548381|NCT02207244|80197162|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548382|NCT02207244|80197163|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548383|NCT02207244|80197164|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548384|NCT02207244|80197165|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548385|NCT02207244|80197166|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548386|NCT02207244|80197167|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548387|NCT02207244|80197168|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548388|NCT02207244|80197169|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
27548389|NCT02207244|80197159|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548390|NCT02207244|80197160|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548391|NCT02207244|80197161|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548392|NCT02207244|80197162|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27640462|NCT03903822|80525901|FG007|Treatment Phase (6 Weeks)|Other|0|||
27958652|NCT01791517|81680064|FG006|Phase II|Pre-Existing Ocular Issue|0|||
27640463|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
27640464|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
27548393|NCT02207244|80197163|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
27548394|NCT02207244|80197164|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
27548395|NCT02207244|80197165|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548396|NCT02207244|80197166|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548397|NCT02207244|80197167|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548398|NCT02207244|80197168|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548399|NCT02207244|80197169|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
27548400|NCT02207244|80197159|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548401|NCT02207244|80197160|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548402|NCT02207244|80197161|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548403|NCT02207244|80197162|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548404|NCT02207244|80197163|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548405|NCT02207244|80197164|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
27548406|NCT02207244|80197165|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548407|NCT02207244|80197166|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548408|NCT02207244|80197167|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548409|NCT02207244|80197168|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548410|NCT02207244|80197169|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
27548411|NCT02207244|80197159|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548412|NCT02207244|80197160|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548413|NCT02207244|80197161|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548414|NCT02207244|80197162|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
27548415|NCT02207244|80197163|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
27548416|NCT02207244|80197164|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
27548417|NCT02207244|80197165|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548418|NCT02207244|80197166|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548419|NCT02207244|80197167|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548420|NCT02207244|80197168|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548421|NCT02207244|80197169|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
27548422|NCT02207244|80197159|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548423|NCT02207244|80197160|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548424|NCT02207244|80197161|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548425|NCT02207244|80197162|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
27548426|NCT02207244|80197163|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
27548427|NCT02207244|80197164|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
27548428|NCT02207244|80197165|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548429|NCT02207244|80197166|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548430|NCT02207244|80197167|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548431|NCT02207244|80197168|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548432|NCT02207244|80197169|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
27548433|NCT02207244|80197159|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548434|NCT02207244|80197160|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548435|NCT02207244|80197161|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548436|NCT02207244|80197162|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
27548437|NCT02207244|80197163|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548438|NCT02207244|80197164|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
27548439|NCT02207244|80197165|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548440|NCT02207244|80197166|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548441|NCT02207244|80197167|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548442|NCT02207244|80197168|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548443|NCT02207244|80197169|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
27548444|NCT02207244|80197159|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548445|NCT02207244|80197160|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548446|NCT02207244|80197161|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548447|NCT02207244|80197162|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
27548448|NCT02207244|80197163|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548449|NCT02207244|80197164|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548450|NCT02207244|80197165|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
27928590|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
27928591|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
27958653|NCT01791517|81680065|FG007|Phase II|Pre-Existing Ocular Issue|0|||
27548451|NCT02207244|80197166|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548452|NCT02207244|80197167|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548453|NCT02207244|80197168|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
27742581|NCT00744055|80886974|FG000|Overall Study|Physician Decision|0|||
27548454|NCT02207244|80197169|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
27548455|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548456|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548457|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548458|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548459|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548460|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548461|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
27548462|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
27928592|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
27928593|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27548463|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
27548464|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
27548465|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
27548466|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548467|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548468|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548469|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548470|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548471|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548472|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548473|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
27548474|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548475|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548476|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
27548477|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548478|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548479|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548480|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548481|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548482|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548483|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
27548484|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
27548485|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
27548486|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
27548487|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
27548488|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548489|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548490|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27928594|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27928595|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
27928596|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27928597|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27548491|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548492|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548493|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548494|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
27548495|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
27548496|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548497|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
27548498|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
27548499|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548500|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548501|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548502|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548503|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548504|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548505|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
27548506|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
27548507|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
27548508|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
27548509|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
27548510|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548511|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27742582|NCT00744055|80886975|FG001|Overall Study|Physician Decision|2|||
27548512|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548513|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548514|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548515|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548516|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548517|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
27548518|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
27548519|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548520|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
27548521|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548522|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548523|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548524|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548525|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548526|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548527|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548528|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548529|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
27548530|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548531|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
27548532|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548533|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548534|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548535|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548536|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548537|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27928598|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27928599|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27928600|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
27928601|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
27928602|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
27928603|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
27928604|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
27928605|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
27928606|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
27928607|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
27928608|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
27928609|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
27928610|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
27928611|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
27928612|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
27928613|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
27548538|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548539|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
27548540|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27928614|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
27928615|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
27928616|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
27928617|NCT03329001|81574810|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
27928618|NCT03329001|81574811|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
27928619|NCT03329001|81574812|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
27928620|NCT03329001|81574813|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
27548541|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27548542|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
27640465|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
27548543|NCT02207244|80197159|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548544|NCT02207244|80197160|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548545|NCT02207244|80197161|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27640466|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
27548546|NCT02207244|80197162|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27640467|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
27640468|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
27640469|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
27928621|NCT03329001|81574814|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
27928622|NCT03329001|81574815|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
27548547|NCT02207244|80197163|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548548|NCT02207244|80197164|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548549|NCT02207244|80197165|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
27548550|NCT02207244|80197166|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548551|NCT02207244|80197167|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548552|NCT02207244|80197168|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548553|NCT02207244|80197169|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
27548554|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548555|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548556|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548557|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548558|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548559|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548560|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548561|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548562|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
27928623|NCT03329001|81574816|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
27928624|NCT03329001|81574817|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
27928625|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27928626|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27548563|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
27548564|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
27548565|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548566|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548567|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548568|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548569|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548570|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548571|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548572|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548573|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
27548574|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
27548575|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
27548576|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548577|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548578|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27640470|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
27742583|NCT00744055|80886974|FG000|Overall Study|Protocol Violation|1|||
27742584|NCT00744055|80886975|FG001|Overall Study|Protocol Violation|1|||
27742585|NCT00744055|80886974|FG000|Overall Study|Lost to Follow-up|0|||
27742586|NCT00744055|80886975|FG001|Overall Study|Lost to Follow-up|1|||
27742587|NCT04172831|80886978|FG000|Overall Study|Adverse Event|21|||
27742588|NCT04172831|80886979|FG001|Overall Study|Adverse Event|9|||
27928627|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27928628|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
27928629|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27928630|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27928631|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27928632|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
27928633|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928634|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928635|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928636|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
27928637|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928638|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928639|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928640|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
27928641|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27742589|NCT04172831|80886978|FG000|Overall Study|Lack of Efficacy|2|||
27742590|NCT04172831|80886979|FG001|Overall Study|Lack of Efficacy|8|||
27742591|NCT04172831|80886978|FG000|Overall Study|Physician Decision|0|||
27742592|NCT04172831|80886979|FG001|Overall Study|Physician Decision|1|||
27742593|NCT04172831|80886978|FG000|Overall Study|Withdrawal by Subject|12|||
27928642|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27742594|NCT04172831|80886979|FG001|Overall Study|Withdrawal by Subject|11|||
27928643|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
27928644|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27928645|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27928646|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27928647|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27928648|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
27928649|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
27928650|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
27928651|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
27928652|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
27928653|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
27928654|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
27928655|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
27928656|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
27928657|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27548579|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548580|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548581|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548582|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548583|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548584|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
27548585|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
27548586|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
27548587|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548588|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548589|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548590|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548591|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548592|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548593|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548594|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548595|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
27548596|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
27548597|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
27548598|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
27548599|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
27548600|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
27548601|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
27548602|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
27928658|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27928659|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
27928660|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27928661|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27928662|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27928663|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27928664|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
27928665|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928666|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928667|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
27928668|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928669|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928670|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928671|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928672|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
27928673|NCT03329001|81574810|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27928674|NCT03329001|81574811|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27928675|NCT03329001|81574812|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27548603|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
27548604|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
27548605|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
27928676|NCT03329001|81574813|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
27928677|NCT03329001|81574814|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27928678|NCT03329001|81574815|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27928679|NCT03329001|81574816|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27928680|NCT03329001|81574817|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
27928681|NCT03329001|81574810|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27928682|NCT03329001|81574811|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27928683|NCT03329001|81574812|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27928684|NCT03329001|81574813|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27928685|NCT03329001|81574814|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27928686|NCT03329001|81574815|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
27928687|NCT03329001|81574816|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27548606|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
27548607|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
27548608|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
27548609|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
27742595|NCT04172831|80886978|FG000|Overall Study|Lost to Follow-up|4|||
27928688|NCT03329001|81574817|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
27928689|NCT03329001|81574810|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928690|NCT03329001|81574811|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928691|NCT03329001|81574812|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928692|NCT03329001|81574813|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928693|NCT03329001|81574814|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
27928694|NCT03329001|81574815|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928695|NCT03329001|81574816|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928696|NCT03329001|81574817|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
27928697|NCT03329001|81574810|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
27928698|NCT03329001|81574811|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
27928699|NCT03329001|81574812|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
27928700|NCT03329001|81574813|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
27928701|NCT03329001|81574814|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
27928702|NCT03329001|81574815|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
27928703|NCT03329001|81574816|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
27928704|NCT03329001|81574817|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
27928705|NCT03329001|81574810|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928706|NCT03329001|81574811|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928707|NCT03329001|81574812|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928708|NCT03329001|81574813|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928709|NCT03329001|81574814|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
27928710|NCT03329001|81574815|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928711|NCT03329001|81574816|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928712|NCT03329001|81574817|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
27928713|NCT03329001|81574810|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
27928714|NCT03329001|81574811|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
27928715|NCT03329001|81574812|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
27928716|NCT03329001|81574813|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
27928717|NCT03329001|81574814|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
27928718|NCT03329001|81574815|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
27928719|NCT03329001|81574816|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
27928720|NCT03329001|81574817|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
27548610|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
27742596|NCT04172831|80886979|FG001|Overall Study|Lost to Follow-up|9|||
27742597|NCT04172831|80886978|FG000|Overall Study|COVID-19 related crisis|3|||
27742598|NCT04172831|80886979|FG001|Overall Study|COVID-19 related crisis|3|||
27742599|NCT04172831|80886978|FG000|Overall Study|Subject non-compliance|1|||
27742600|NCT04172831|80886979|FG001|Overall Study|Subject non-compliance|1|||
27742601|NCT04172831|80886978|FG000|Overall Study|Family emergency|1|||
27742602|NCT04172831|80886979|FG001|Overall Study|Family emergency|0|||
27742603|NCT01458340|80886988|FG000|Overall Study|Adverse Event|5|||
27742604|NCT01458340|80886989|FG001|Overall Study|Adverse Event|4|||
27742605|NCT01458340|80886990|FG002|Overall Study|Adverse Event|2|||
27742606|NCT01458340|80886988|FG000|Overall Study|Lost to Follow-up|3|||
27742607|NCT01458340|80886989|FG001|Overall Study|Lost to Follow-up|3|||
27742608|NCT01458340|80886990|FG002|Overall Study|Lost to Follow-up|10|||
27742609|NCT01458340|80886988|FG000|Overall Study|Miscellaneous|0|||
27742610|NCT01458340|80886989|FG001|Overall Study|Miscellaneous|1|||
27928721|NCT03329001|81574810|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
27928722|NCT03329001|81574811|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
27928723|NCT03329001|81574812|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
27928724|NCT03329001|81574813|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
27928725|NCT03329001|81574814|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
27928726|NCT03329001|81574815|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
27928727|NCT03329001|81574816|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
27928728|NCT03329001|81574817|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
27928729|NCT03329001|81574810|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928730|NCT03329001|81574811|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928731|NCT03329001|81574812|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928732|NCT03329001|81574813|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928733|NCT03329001|81574814|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928734|NCT03329001|81574815|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928735|NCT03329001|81574816|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
27928736|NCT03329001|81574817|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
27928737|NCT03329001|81574810|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
27928738|NCT03329001|81574811|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
27928739|NCT03329001|81574812|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
27928740|NCT03329001|81574813|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
27928741|NCT03329001|81574814|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
27928742|NCT03329001|81574815|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
27928743|NCT03329001|81574816|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
27928744|NCT03329001|81574817|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
27928745|NCT03329001|81574810|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
27928746|NCT03329001|81574811|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
27928747|NCT03329001|81574812|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
27928748|NCT03329001|81574813|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
27928749|NCT03329001|81574814|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
27928750|NCT03329001|81574815|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
27928751|NCT03329001|81574816|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
27928752|NCT03329001|81574817|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
27928753|NCT00805532|81574818|FG000|Overall Study|invalid data|0|||
27928754|NCT00805532|81574819|FG001|Overall Study|invalid data|1|||
27928755|NCT00866320|81574822|FG000|Overall Study|Withdrawal by Subject|4|||
27928756|NCT00866320|81574822|FG000|Overall Study|Death|2|||
27928757|NCT01136954|81574826|FG000|Overall Study|Adverse Event|3|||
27928758|NCT01136954|81574827|FG001|Overall Study|Adverse Event|2|||
27928759|NCT01136954|81574826|FG000|Overall Study|Withdrawal by Subject|6|||
27928760|NCT01136954|81574827|FG001|Overall Study|Withdrawal by Subject|2|||
27928761|NCT01136954|81574826|FG000|Overall Study|Lack of Efficacy|14|||
27928762|NCT01136954|81574827|FG001|Overall Study|Lack of Efficacy|13|||
27928763|NCT01136954|81574826|FG000|Overall Study|Physician Decision|0|||
27928764|NCT01136954|81574827|FG001|Overall Study|Physician Decision|1|||
27928765|NCT01136954|81574826|FG000|Overall Study|Other|1|||
27928766|NCT01136954|81574827|FG001|Overall Study|Other|3|||
27928767|NCT02711137|81574828|FG000|Overall Study|Death|1|||
27928768|NCT02711137|81574829|FG001|Overall Study|Death|4|||
27928769|NCT02711137|81574830|FG002|Overall Study|Death|5|||
27928770|NCT02711137|81574831|FG003|Overall Study|Death|5|||
27928771|NCT02711137|81574832|FG004|Overall Study|Death|3|||
27928772|NCT02711137|81574833|FG005|Overall Study|Death|1|||
27928773|NCT02711137|81574834|FG006|Overall Study|Death|61|||
27928774|NCT02711137|81574835|FG007|Overall Study|Death|3|||
27548611|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
27548612|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
27548613|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
27928775|NCT02711137|81574836|FG008|Overall Study|Death|0|||
27928776|NCT02711137|81574837|FG009|Overall Study|Death|1|||
27928777|NCT02711137|81574838|FG010|Overall Study|Death|1|||
27928778|NCT02711137|81574839|FG011|Overall Study|Death|1|||
27928779|NCT02711137|81574840|FG012|Overall Study|Death|0|||
27928780|NCT02711137|81574841|FG013|Overall Study|Death|0|||
27928781|NCT02711137|81574842|FG014|Overall Study|Death|0|||
27548614|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
27928782|NCT02711137|81574828|FG000|Overall Study|Study Terminated by Sponsor|0|||
27928783|NCT02711137|81574829|FG001|Overall Study|Study Terminated by Sponsor|0|||
27928784|NCT02711137|81574830|FG002|Overall Study|Study Terminated by Sponsor|1|||
27928785|NCT02711137|81574831|FG003|Overall Study|Study Terminated by Sponsor|0|||
27928786|NCT02711137|81574832|FG004|Overall Study|Study Terminated by Sponsor|0|||
27928787|NCT02711137|81574833|FG005|Overall Study|Study Terminated by Sponsor|0|||
27928788|NCT02711137|81574834|FG006|Overall Study|Study Terminated by Sponsor|1|||
27928789|NCT02711137|81574835|FG007|Overall Study|Study Terminated by Sponsor|0|||
27548615|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
27548616|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
27548617|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
27548618|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
27548619|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
27548620|NCT02207244|80197159|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548621|NCT02207244|80197160|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548622|NCT02207244|80197161|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548623|NCT02207244|80197162|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548624|NCT02207244|80197163|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548625|NCT02207244|80197164|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548626|NCT02207244|80197165|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548627|NCT02207244|80197166|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548628|NCT02207244|80197167|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548629|NCT02207244|80197168|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
27548630|NCT02207244|80197169|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
27548631|NCT02244606|80197170|FG000|Overall Study|Adverse Event|0|||
27548632|NCT02244606|80197171|FG001|Overall Study|Adverse Event|1|||
27548633|NCT02244606|80197172|FG002|Overall Study|Adverse Event|1|||
27548634|NCT02244606|80197173|FG003|Overall Study|Adverse Event|0|||
27548635|NCT02244606|80197170|FG000|Overall Study|Lost to Follow-up|2|||
27548636|NCT02244606|80197171|FG001|Overall Study|Lost to Follow-up|2|||
27548637|NCT02244606|80197172|FG002|Overall Study|Lost to Follow-up|1|||
27548638|NCT02244606|80197173|FG003|Overall Study|Lost to Follow-up|0|||
27548639|NCT02244606|80197170|FG000|Overall Study|Protocol Violation|0|||
27548640|NCT02244606|80197171|FG001|Overall Study|Protocol Violation|0|||
27548641|NCT02244606|80197172|FG002|Overall Study|Protocol Violation|0|||
27548642|NCT02244606|80197173|FG003|Overall Study|Protocol Violation|1|||
27548643|NCT02244606|80197170|FG000|Overall Study|Withdrawal by Subject|1|||
27548644|NCT02244606|80197171|FG001|Overall Study|Withdrawal by Subject|1|||
27548645|NCT02244606|80197172|FG002|Overall Study|Withdrawal by Subject|0|||
27548646|NCT02244606|80197173|FG003|Overall Study|Withdrawal by Subject|0|||
27548647|NCT02244606|80197170|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
27548648|NCT02244606|80197171|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
27548649|NCT02244606|80197172|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
27548650|NCT02244606|80197173|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
27548651|NCT01950741|80197174|FG000|Overall Study|Lost to Follow-up|1|||
27548652|NCT01950741|80197174|FG000|Overall Study|Death|1|||
27548653|NCT01950741|80197174|FG000|Overall Study|Withdrawal by Subject|1|||
27548654|NCT01691781|80197175|FG000|Overall Study|Withdrawal by Subject|4|||
27548655|NCT01691781|80197176|FG001|Overall Study|Withdrawal by Subject|3|||
27548656|NCT01691781|80197175|FG000|Overall Study|Physician Decision|1|||
27548657|NCT01691781|80197176|FG001|Overall Study|Physician Decision|1|||
27548658|NCT01691781|80197175|FG000|Overall Study|Protocol Violation|2|||
27548659|NCT01691781|80197176|FG001|Overall Study|Protocol Violation|2|||
27548660|NCT01691781|80197175|FG000|Overall Study|Adverse Event|0|||
27548661|NCT01691781|80197176|FG001|Overall Study|Adverse Event|1|||
27548662|NCT01385566|80197181|FG000|Overall Study|Lost to Follow-up|1|||
27548663|NCT01385566|80197182|FG001|Overall Study|Lost to Follow-up|0|||
27548664|NCT01385566|80197183|FG002|Overall Study|Lost to Follow-up|0|||
27548665|NCT01385566|80197184|FG003|Overall Study|Lost to Follow-up|0|||
27548666|NCT01385566|80197185|FG004|Overall Study|Lost to Follow-up|0|||
27548667|NCT01385566|80197186|FG005|Overall Study|Lost to Follow-up|0|||
27548668|NCT01385566|80197181|FG000|Overall Study|Withdrawal by Subject|0|||
27548669|NCT01385566|80197182|FG001|Overall Study|Withdrawal by Subject|0|||
27548670|NCT01385566|80197183|FG002|Overall Study|Withdrawal by Subject|0|||
27548671|NCT01385566|80197184|FG003|Overall Study|Withdrawal by Subject|1|||
27548672|NCT01385566|80197185|FG004|Overall Study|Withdrawal by Subject|0|||
27548673|NCT01385566|80197186|FG005|Overall Study|Withdrawal by Subject|0|||
27548674|NCT01484197|80197190|FG000|Treatment Period 1|Adverse Event|1|||
27548675|NCT01484197|80197191|FG001|Treatment Period 1|Adverse Event|0|||
27548676|NCT01484197|80197192|FG002|Treatment Period 1|Adverse Event|0|||
27548677|NCT01484197|80197193|FG003|Treatment Period 1|Adverse Event|0|||
27548678|NCT01484197|80197190|FG000|Treatment Period 2|Subject withdrew consent|0|||
27548679|NCT01484197|80197191|FG001|Treatment Period 2|Subject withdrew consent|0|||
27548680|NCT01484197|80197192|FG002|Treatment Period 2|Subject withdrew consent|0|||
27548681|NCT01484197|80197193|FG003|Treatment Period 2|Subject withdrew consent|1|||
27548682|NCT03217175|80197198|FG000|Overall Study|Physician Decision|4|||
27548683|NCT03217175|80197199|FG001|Overall Study|Physician Decision|1|||
27640471|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27742611|NCT01458340|80886990|FG002|Overall Study|Miscellaneous|0|||
27548684|NCT03129100|80197205|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
27548685|NCT03129100|80197206|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
27548686|NCT03129100|80197207|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
27548687|NCT03129100|80197208|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
27548688|NCT03129100|80197209|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
27928790|NCT02711137|81574836|FG008|Overall Study|Study Terminated by Sponsor|0|||
27928791|NCT02711137|81574837|FG009|Overall Study|Study Terminated by Sponsor|0|||
27928792|NCT02711137|81574838|FG010|Overall Study|Study Terminated by Sponsor|0|||
27928793|NCT02711137|81574839|FG011|Overall Study|Study Terminated by Sponsor|0|||
27928794|NCT02711137|81574840|FG012|Overall Study|Study Terminated by Sponsor|0|||
27928795|NCT02711137|81574841|FG013|Overall Study|Study Terminated by Sponsor|0|||
27928796|NCT02711137|81574842|FG014|Overall Study|Study Terminated by Sponsor|0|||
27928797|NCT02711137|81574828|FG000|Overall Study|Physician Decision|1|||
27928798|NCT02711137|81574829|FG001|Overall Study|Physician Decision|0|||
27928799|NCT02711137|81574830|FG002|Overall Study|Physician Decision|2|||
27928800|NCT02711137|81574831|FG003|Overall Study|Physician Decision|1|||
27928801|NCT02711137|81574832|FG004|Overall Study|Physician Decision|1|||
27928802|NCT02711137|81574833|FG005|Overall Study|Physician Decision|0|||
27928803|NCT02711137|81574834|FG006|Overall Study|Physician Decision|12|||
27928804|NCT02711137|81574835|FG007|Overall Study|Physician Decision|2|||
27928805|NCT02711137|81574836|FG008|Overall Study|Physician Decision|1|||
27928806|NCT02711137|81574837|FG009|Overall Study|Physician Decision|1|||
27928807|NCT02711137|81574838|FG010|Overall Study|Physician Decision|3|||
27928808|NCT02711137|81574839|FG011|Overall Study|Physician Decision|2|||
27928809|NCT02711137|81574840|FG012|Overall Study|Physician Decision|1|||
27928810|NCT02711137|81574841|FG013|Overall Study|Physician Decision|1|||
27928811|NCT02711137|81574842|FG014|Overall Study|Physician Decision|2|||
27928812|NCT02711137|81574828|FG000|Overall Study|Other|0|||
27928813|NCT02711137|81574829|FG001|Overall Study|Other|1|||
27928814|NCT02711137|81574830|FG002|Overall Study|Other|0|||
27928815|NCT02711137|81574831|FG003|Overall Study|Other|0|||
27928816|NCT02711137|81574832|FG004|Overall Study|Other|0|||
27928817|NCT02711137|81574833|FG005|Overall Study|Other|0|||
27928818|NCT02711137|81574834|FG006|Overall Study|Other|3|||
27928819|NCT02711137|81574835|FG007|Overall Study|Other|0|||
27928820|NCT02711137|81574836|FG008|Overall Study|Other|0|||
27928821|NCT02711137|81574837|FG009|Overall Study|Other|0|||
27928822|NCT02711137|81574838|FG010|Overall Study|Other|0|||
27928823|NCT02711137|81574839|FG011|Overall Study|Other|0|||
27928824|NCT02711137|81574840|FG012|Overall Study|Other|0|||
27928825|NCT02711137|81574841|FG013|Overall Study|Other|0|||
27928826|NCT02711137|81574842|FG014|Overall Study|Other|1|||
27928827|NCT02711137|81574828|FG000|Overall Study|Withdrawal by Subject|1|||
27928828|NCT02711137|81574829|FG001|Overall Study|Withdrawal by Subject|0|||
27928829|NCT02711137|81574830|FG002|Overall Study|Withdrawal by Subject|0|||
27928830|NCT02711137|81574831|FG003|Overall Study|Withdrawal by Subject|1|||
27928831|NCT02711137|81574832|FG004|Overall Study|Withdrawal by Subject|1|||
27928832|NCT02711137|81574833|FG005|Overall Study|Withdrawal by Subject|0|||
27928833|NCT02711137|81574834|FG006|Overall Study|Withdrawal by Subject|7|||
27928834|NCT02711137|81574835|FG007|Overall Study|Withdrawal by Subject|0|||
27928835|NCT02711137|81574836|FG008|Overall Study|Withdrawal by Subject|0|||
27928836|NCT02711137|81574837|FG009|Overall Study|Withdrawal by Subject|0|||
27928837|NCT02711137|81574838|FG010|Overall Study|Withdrawal by Subject|0|||
27928838|NCT02711137|81574839|FG011|Overall Study|Withdrawal by Subject|0|||
27928839|NCT02711137|81574840|FG012|Overall Study|Withdrawal by Subject|0|||
27928840|NCT02711137|81574841|FG013|Overall Study|Withdrawal by Subject|1|||
27928841|NCT02711137|81574842|FG014|Overall Study|Withdrawal by Subject|0|||
27928842|NCT02711137|81574828|FG000|Overall Study|Lost to Follow-up|1|||
27928843|NCT02711137|81574829|FG001|Overall Study|Lost to Follow-up|0|||
27928844|NCT02711137|81574830|FG002|Overall Study|Lost to Follow-up|0|||
27928845|NCT02711137|81574831|FG003|Overall Study|Lost to Follow-up|0|||
27928846|NCT02711137|81574832|FG004|Overall Study|Lost to Follow-up|0|||
27928847|NCT02711137|81574833|FG005|Overall Study|Lost to Follow-up|0|||
27928848|NCT02711137|81574834|FG006|Overall Study|Lost to Follow-up|2|||
27928849|NCT02711137|81574835|FG007|Overall Study|Lost to Follow-up|0|||
27928850|NCT02711137|81574836|FG008|Overall Study|Lost to Follow-up|0|||
27928851|NCT02711137|81574837|FG009|Overall Study|Lost to Follow-up|0|||
27928852|NCT02711137|81574838|FG010|Overall Study|Lost to Follow-up|0|||
27928853|NCT02711137|81574839|FG011|Overall Study|Lost to Follow-up|0|||
27928854|NCT02711137|81574840|FG012|Overall Study|Lost to Follow-up|0|||
27928855|NCT02711137|81574841|FG013|Overall Study|Lost to Follow-up|0|||
27928856|NCT02711137|81574842|FG014|Overall Study|Lost to Follow-up|0|||
27928857|NCT01091259|81574845|FG000|Overall Study|Adverse Event|3|||
27928858|NCT01091259|81574845|FG000|Overall Study|Lack of Efficacy|2|||
27928859|NCT01027845|81574849|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
27928860|NCT01027845|81574850|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
27928861|NCT01027845|81574851|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
27928862|NCT01027845|81574852|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
27928863|NCT01027845|81574849|FG000|Primary Vaccination Phase|Adverse Event|1|||
27928864|NCT01027845|81574850|FG001|Primary Vaccination Phase|Adverse Event|0|||
27928865|NCT01027845|81574851|FG002|Primary Vaccination Phase|Adverse Event|0|||
27928866|NCT01027845|81574852|FG003|Primary Vaccination Phase|Adverse Event|0|||
27928867|NCT01027845|81574849|FG000|Primary Vaccination Phase|Protocol Violation|1|||
27928868|NCT01027845|81574850|FG001|Primary Vaccination Phase|Protocol Violation|0|||
27548689|NCT03129100|80197210|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
27548690|NCT03129100|80197211|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
27548691|NCT03129100|80197212|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
27548692|NCT03129100|80197213|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
27548693|NCT03129100|80197214|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
27548694|NCT03129100|80197215|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
27928869|NCT01027845|81574851|FG002|Primary Vaccination Phase|Protocol Violation|0|||
27928870|NCT01027845|81574852|FG003|Primary Vaccination Phase|Protocol Violation|0|||
27928871|NCT01027845|81574849|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
27928872|NCT01027845|81574850|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
27928873|NCT01027845|81574851|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
27928874|NCT01027845|81574852|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
27928875|NCT01027845|81574849|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
27928876|NCT01027845|81574850|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
27928877|NCT01027845|81574851|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
27928878|NCT01027845|81574852|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
27928879|NCT01027845|81574849|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
27928880|NCT01027845|81574850|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
27928881|NCT01027845|81574851|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
27928882|NCT01027845|81574852|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
27928883|NCT00421993|81574853|FG000|Overall Study|Withdrawal by Subject|22|||
27928884|NCT00421993|81574854|FG001|Overall Study|Withdrawal by Subject|23|||
27928885|NCT00421993|81574855|FG002|Overall Study|Withdrawal by Subject|23|||
27928886|NCT00421993|81574856|FG003|Overall Study|Withdrawal by Subject|24|||
27928887|NCT00421993|81574853|FG000|Overall Study|Lost to Follow-up|18|||
27928888|NCT00421993|81574854|FG001|Overall Study|Lost to Follow-up|19|||
27928889|NCT00421993|81574855|FG002|Overall Study|Lost to Follow-up|22|||
27928890|NCT00421993|81574856|FG003|Overall Study|Lost to Follow-up|20|||
27928891|NCT00421993|81574853|FG000|Overall Study|Adverse Event|11|||
27928892|NCT00421993|81574854|FG001|Overall Study|Adverse Event|1|||
27928893|NCT00421993|81574855|FG002|Overall Study|Adverse Event|6|||
27928894|NCT00421993|81574856|FG003|Overall Study|Adverse Event|4|||
27928895|NCT00421993|81574853|FG000|Overall Study|Protocol Violation|2|||
27928896|NCT00421993|81574854|FG001|Overall Study|Protocol Violation|2|||
27928897|NCT00421993|81574855|FG002|Overall Study|Protocol Violation|0|||
27928898|NCT00421993|81574856|FG003|Overall Study|Protocol Violation|1|||
27928899|NCT00421993|81574853|FG000|Overall Study|Lack of Efficacy|0|||
27928900|NCT00421993|81574854|FG001|Overall Study|Lack of Efficacy|3|||
27928901|NCT00421993|81574855|FG002|Overall Study|Lack of Efficacy|0|||
27928902|NCT00421993|81574856|FG003|Overall Study|Lack of Efficacy|5|||
27928903|NCT00421993|81574853|FG000|Overall Study|Pregnancy|0|||
27928904|NCT00421993|81574854|FG001|Overall Study|Pregnancy|1|||
27928905|NCT00421993|81574855|FG002|Overall Study|Pregnancy|1|||
27928906|NCT00421993|81574856|FG003|Overall Study|Pregnancy|2|||
27548695|NCT03129100|80197216|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
27548696|NCT03129100|80197217|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
27548697|NCT03129100|80197218|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
27548698|NCT03129100|80197219|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
27548699|NCT03129100|80197220|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
27548700|NCT03129100|80197221|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
27548701|NCT03129100|80197222|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
27548702|NCT03129100|80197223|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
27548703|NCT03129100|80197224|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
27548704|NCT03129100|80197225|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
27548705|NCT03129100|80197226|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
27548706|NCT03129100|80197227|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
27548707|NCT03129100|80197228|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
27548708|NCT03129100|80197229|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
27548709|NCT03129100|80197230|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
27548710|NCT03129100|80197205|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
27548711|NCT03129100|80197206|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548712|NCT03129100|80197207|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548713|NCT03129100|80197208|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548714|NCT03129100|80197209|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548715|NCT03129100|80197210|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548716|NCT03129100|80197211|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548717|NCT03129100|80197212|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27640472|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27928907|NCT00421993|81574853|FG000|Overall Study|Subject transportation issues|0|||
27928908|NCT00421993|81574854|FG001|Overall Study|Subject transportation issues|0|||
27928909|NCT00421993|81574855|FG002|Overall Study|Subject transportation issues|0|||
27928910|NCT00421993|81574856|FG003|Overall Study|Subject transportation issues|1|||
27928911|NCT01875237|81574860|FG000|Overall Study|GVDH before DLI|1|||
27928912|NCT01875237|81574861|FG001|Overall Study|GVDH before DLI|0|||
27548718|NCT03129100|80197213|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548719|NCT03129100|80197214|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548720|NCT03129100|80197215|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27928913|NCT01875237|81574860|FG000|Overall Study|DLI cells could not be produced|1|||
27928914|NCT01875237|81574861|FG001|Overall Study|DLI cells could not be produced|0|||
27928915|NCT00976027|81574862|FG000|Overall Study|Serious Adverse Event|36|||
27928916|NCT00976027|81574863|FG001|Overall Study|Serious Adverse Event|17|||
27928917|NCT00976027|81574862|FG000|Overall Study|Adverse Event|0|||
27928918|NCT00976027|81574863|FG001|Overall Study|Adverse Event|2|||
27928919|NCT00976027|81574862|FG000|Overall Study|Protocol Violation|60|||
27928920|NCT00976027|81574863|FG001|Overall Study|Protocol Violation|27|||
27928921|NCT00976027|81574862|FG000|Overall Study|Lost to Follow-up|208|||
27928922|NCT00976027|81574863|FG001|Overall Study|Lost to Follow-up|103|||
27928923|NCT00976027|81574862|FG000|Overall Study|Withdrawal by Subject|107|||
27928924|NCT00976027|81574863|FG001|Overall Study|Withdrawal by Subject|66|||
27928925|NCT02336503|81574864|FG000|Overall Study|Lost to Follow-up|0|||
27928926|NCT02336503|81574865|FG001|Overall Study|Lost to Follow-up|3|||
27928927|NCT02336503|81574866|FG002|Overall Study|Lost to Follow-up|0|||
27928928|NCT02336503|81574867|FG003|Overall Study|Lost to Follow-up|2|||
27928929|NCT02336503|81574864|FG000|Overall Study|Withdrawal by Subject|2|||
27928930|NCT02336503|81574865|FG001|Overall Study|Withdrawal by Subject|0|||
27928931|NCT02336503|81574866|FG002|Overall Study|Withdrawal by Subject|0|||
27928932|NCT02336503|81574867|FG003|Overall Study|Withdrawal by Subject|4|||
27928933|NCT02336503|81574864|FG000|Overall Study|Adverse Event|0|||
27928934|NCT02336503|81574865|FG001|Overall Study|Adverse Event|0|||
27928935|NCT02336503|81574866|FG002|Overall Study|Adverse Event|1|||
27928936|NCT02336503|81574867|FG003|Overall Study|Adverse Event|0|||
27928937|NCT02006654|81574871|FG000|Overall Study|Withdrawal before treatment|4|||
27928938|NCT02006654|81574872|FG001|Overall Study|Withdrawal before treatment|2|||
27928939|NCT02006654|81574871|FG000|Overall Study|Adverse Event|16|||
27928940|NCT02006654|81574872|FG001|Overall Study|Adverse Event|17|||
27928941|NCT02006654|81574871|FG000|Overall Study|Death|1|||
27928942|NCT02006654|81574872|FG001|Overall Study|Death|0|||
27928943|NCT02006654|81574871|FG000|Overall Study|Withdrawal by Subject|14|||
27928944|NCT02006654|81574872|FG001|Overall Study|Withdrawal by Subject|12|||
27928945|NCT02006654|81574871|FG000|Overall Study|Protocol Violation|5|||
27928946|NCT02006654|81574872|FG001|Overall Study|Protocol Violation|8|||
27928947|NCT02006654|81574871|FG000|Overall Study|Lost to Follow-up|1|||
27548721|NCT03129100|80197216|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548722|NCT03129100|80197217|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548723|NCT03129100|80197218|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548724|NCT03129100|80197219|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548725|NCT03129100|80197220|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548726|NCT03129100|80197221|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548727|NCT03129100|80197222|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548728|NCT03129100|80197223|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548729|NCT03129100|80197224|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548730|NCT03129100|80197225|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548731|NCT03129100|80197226|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548732|NCT03129100|80197227|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548733|NCT03129100|80197228|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548734|NCT03129100|80197229|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548735|NCT03129100|80197230|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
27548736|NCT03129100|80197205|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
27548737|NCT03129100|80197206|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
27548738|NCT03129100|80197207|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548739|NCT03129100|80197208|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548740|NCT03129100|80197209|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548741|NCT03129100|80197210|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548742|NCT03129100|80197211|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548743|NCT03129100|80197212|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548744|NCT03129100|80197213|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27640473|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27742612|NCT01458340|80886988|FG000|Overall Study|Physician Decision|1|||
27548745|NCT03129100|80197214|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27928948|NCT02006654|81574872|FG001|Overall Study|Lost to Follow-up|0|||
27928949|NCT02006654|81574871|FG000|Overall Study|patient's will|2|||
27928950|NCT02006654|81574872|FG001|Overall Study|patient's will|1|||
27928951|NCT02006654|81574871|FG000|Overall Study|insufficient compliance|1|||
27928952|NCT02006654|81574872|FG001|Overall Study|insufficient compliance|0|||
27928953|NCT02006654|81574871|FG000|Overall Study|worsening cognitive condition|0|||
27928954|NCT02006654|81574872|FG001|Overall Study|worsening cognitive condition|1|||
27928955|NCT02006654|81574871|FG000|Overall Study|faecal incontinence|0|||
27928956|NCT02006654|81574872|FG001|Overall Study|faecal incontinence|1|||
27928957|NCT02006654|81574871|FG000|Overall Study|mood disorder|0|||
27928958|NCT02006654|81574872|FG001|Overall Study|mood disorder|1|||
27928959|NCT02006654|81574871|FG000|Overall Study|disallowed medication|1|||
27928960|NCT02006654|81574872|FG001|Overall Study|disallowed medication|0|||
27928961|NCT02006654|81574871|FG000|Overall Study|moving out of state|0|||
27928962|NCT02006654|81574872|FG001|Overall Study|moving out of state|1|||
27928963|NCT01922011|81578844|FG000|Overall Study|Protocol Violation|0|||
27928964|NCT01922011|81578845|FG001|Overall Study|Protocol Violation|1|||
27928965|NCT01922011|81578844|FG000|Overall Study|Physician Decision|0|||
27928966|NCT01922011|81578845|FG001|Overall Study|Physician Decision|1|||
27928967|NCT01922011|81578844|FG000|Overall Study|Parent/Guardian Decision|3|||
27928968|NCT01922011|81578845|FG001|Overall Study|Parent/Guardian Decision|0|||
27928969|NCT01922011|81578844|FG000|Overall Study|Lost to Follow-up|0|||
27928970|NCT01922011|81578845|FG001|Overall Study|Lost to Follow-up|1|||
27928971|NCT01922011|81578844|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
27928972|NCT01922011|81578845|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
27928973|NCT01922011|81578844|FG000|Overall Study|Not Treated|1|||
27928974|NCT01922011|81578845|FG001|Overall Study|Not Treated|0|||
27928975|NCT01922011|81578844|FG000|Overall Study|Lack of willing home health agency|1|||
27928976|NCT01922011|81578845|FG001|Overall Study|Lack of willing home health agency|0|||
27928977|NCT01922011|81578844|FG000|Overall Study|Randomized in error|1|||
27928978|NCT01922011|81578845|FG001|Overall Study|Randomized in error|0|||
27928979|NCT02265744|81578854|FG000|Overall Study|Poor/Non-compliance|1|||
27928980|NCT02265744|81578855|FG001|Overall Study|Poor/Non-compliance|1|||
27928981|NCT02265744|81578856|FG002|Overall Study|Poor/Non-compliance|0|||
27928982|NCT02265744|81578857|FG003|Overall Study|Poor/Non-compliance|0|||
27928983|NCT02265744|81578858|FG004|Overall Study|Poor/Non-compliance|2|||
27928984|NCT02265744|81578854|FG000|Overall Study|Lost to Follow-up|0|||
27928985|NCT02265744|81578855|FG001|Overall Study|Lost to Follow-up|0|||
27928986|NCT02265744|81578856|FG002|Overall Study|Lost to Follow-up|0|||
27928987|NCT02265744|81578857|FG003|Overall Study|Lost to Follow-up|1|||
27928988|NCT02265744|81578858|FG004|Overall Study|Lost to Follow-up|0|||
27928989|NCT02265744|81578854|FG000|Overall Study|Death|0|||
27928990|NCT02265744|81578855|FG001|Overall Study|Death|0|||
27928991|NCT02265744|81578856|FG002|Overall Study|Death|0|||
27928992|NCT02265744|81578857|FG003|Overall Study|Death|2|||
27928993|NCT02265744|81578858|FG004|Overall Study|Death|0|||
27928994|NCT02265744|81578854|FG000|Overall Study|Withdrawal by Subject|2|||
27928995|NCT02265744|81578855|FG001|Overall Study|Withdrawal by Subject|0|||
27928996|NCT02265744|81578856|FG002|Overall Study|Withdrawal by Subject|0|||
27928997|NCT02265744|81578857|FG003|Overall Study|Withdrawal by Subject|2|||
27928998|NCT02265744|81578858|FG004|Overall Study|Withdrawal by Subject|0|||
27928999|NCT02265744|81578854|FG000|Overall Study|Participant request to discontinue|2|||
27929000|NCT02265744|81578855|FG001|Overall Study|Participant request to discontinue|2|||
27929001|NCT02265744|81578856|FG002|Overall Study|Participant request to discontinue|2|||
27929002|NCT02265744|81578857|FG003|Overall Study|Participant request to discontinue|0|||
27929003|NCT02265744|81578858|FG004|Overall Study|Participant request to discontinue|0|||
27929004|NCT02265744|81578854|FG000|Overall Study|Adverse Event|8|||
27929005|NCT02265744|81578855|FG001|Overall Study|Adverse Event|4|||
27929006|NCT02265744|81578856|FG002|Overall Study|Adverse Event|9|||
27929007|NCT02265744|81578857|FG003|Overall Study|Adverse Event|8|||
27929008|NCT02265744|81578858|FG004|Overall Study|Adverse Event|2|||
27929009|NCT02265744|81578854|FG000|Overall Study|Lack of Efficacy|2|||
27929010|NCT02265744|81578855|FG001|Overall Study|Lack of Efficacy|4|||
27929011|NCT02265744|81578856|FG002|Overall Study|Lack of Efficacy|3|||
27548746|NCT03129100|80197215|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548747|NCT03129100|80197216|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548748|NCT03129100|80197217|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548749|NCT03129100|80197218|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548750|NCT03129100|80197219|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548751|NCT03129100|80197220|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548752|NCT03129100|80197221|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548753|NCT03129100|80197222|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548754|NCT03129100|80197223|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548755|NCT03129100|80197224|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548756|NCT03129100|80197225|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27929012|NCT02265744|81578857|FG003|Overall Study|Lack of Efficacy|4|||
27929013|NCT02265744|81578858|FG004|Overall Study|Lack of Efficacy|5|||
27929014|NCT02265744|81578854|FG000|Overall Study|Reason not provided by Investigator|1|||
27929015|NCT02265744|81578855|FG001|Overall Study|Reason not provided by Investigator|0|||
27929016|NCT02265744|81578856|FG002|Overall Study|Reason not provided by Investigator|0|||
27929017|NCT02265744|81578857|FG003|Overall Study|Reason not provided by Investigator|2|||
27929018|NCT02265744|81578858|FG004|Overall Study|Reason not provided by Investigator|0|||
27929019|NCT02265744|81578854|FG000|Overall Study|Administrative reason by sponsor|3|||
27929020|NCT02265744|81578855|FG001|Overall Study|Administrative reason by sponsor|2|||
27929021|NCT02265744|81578856|FG002|Overall Study|Administrative reason by sponsor|2|||
27929022|NCT02265744|81578857|FG003|Overall Study|Administrative reason by sponsor|3|||
27548757|NCT03129100|80197226|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548758|NCT03129100|80197227|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548759|NCT03129100|80197228|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548760|NCT03129100|80197229|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548761|NCT03129100|80197230|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
27548762|NCT03129100|80197205|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
27548763|NCT03129100|80197206|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
27548764|NCT03129100|80197207|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548765|NCT03129100|80197208|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548766|NCT03129100|80197209|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548767|NCT03129100|80197210|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548768|NCT03129100|80197211|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548769|NCT03129100|80197212|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548770|NCT03129100|80197213|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548771|NCT03129100|80197214|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548772|NCT03129100|80197215|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548773|NCT03129100|80197216|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548774|NCT03129100|80197217|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548775|NCT03129100|80197218|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548776|NCT03129100|80197219|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548777|NCT03129100|80197220|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548778|NCT03129100|80197221|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548779|NCT03129100|80197222|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548780|NCT03129100|80197223|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548781|NCT03129100|80197224|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548782|NCT03129100|80197225|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548783|NCT03129100|80197226|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548784|NCT03129100|80197227|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548785|NCT03129100|80197228|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548786|NCT03129100|80197229|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548787|NCT03129100|80197230|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
27548788|NCT03129100|80197205|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548789|NCT03129100|80197206|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
27548790|NCT03129100|80197207|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548791|NCT03129100|80197208|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548792|NCT03129100|80197209|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548793|NCT03129100|80197210|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548794|NCT03129100|80197211|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548795|NCT03129100|80197212|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548796|NCT03129100|80197213|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548797|NCT03129100|80197214|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548798|NCT03129100|80197215|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548799|NCT03129100|80197216|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548800|NCT03129100|80197217|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548801|NCT03129100|80197218|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548802|NCT03129100|80197219|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548803|NCT03129100|80197220|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548804|NCT03129100|80197221|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548805|NCT03129100|80197222|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548806|NCT03129100|80197223|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548807|NCT03129100|80197224|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548808|NCT03129100|80197225|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548809|NCT03129100|80197226|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548810|NCT03129100|80197227|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548811|NCT03129100|80197228|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548812|NCT03129100|80197229|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548813|NCT03129100|80197230|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
27548814|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548815|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548816|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
27548817|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
27548818|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548819|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
27548820|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548821|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548822|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548823|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548824|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548825|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27929023|NCT02265744|81578858|FG004|Overall Study|Administrative reason by sponsor|3|||
27929024|NCT02265744|81578854|FG000|Overall Study|Subject no longer meets study criteria|0|||
27929025|NCT02265744|81578855|FG001|Overall Study|Subject no longer meets study criteria|0|||
27929026|NCT02265744|81578856|FG002|Overall Study|Subject no longer meets study criteria|0|||
27929027|NCT02265744|81578857|FG003|Overall Study|Subject no longer meets study criteria|0|||
27929028|NCT02265744|81578858|FG004|Overall Study|Subject no longer meets study criteria|1|||
27929029|NCT02265744|81578854|FG000|Overall Study|Pregnancy|1|||
27929030|NCT02265744|81578855|FG001|Overall Study|Pregnancy|2|||
27929031|NCT02265744|81578856|FG002|Overall Study|Pregnancy|1|||
27929032|NCT02265744|81578857|FG003|Overall Study|Pregnancy|1|||
27929033|NCT02265744|81578858|FG004|Overall Study|Pregnancy|0|||
27929034|NCT00915525|81578859|FG000|Overall Study|Protocol Violation|9|||
27929035|NCT00915525|81578860|FG001|Overall Study|Protocol Violation|4|||
27929036|NCT00915525|81578859|FG000|Overall Study|Withdrawal by Subject|59|||
27929037|NCT00915525|81578860|FG001|Overall Study|Withdrawal by Subject|21|||
27929038|NCT00915525|81578859|FG000|Overall Study|Lost to Follow-up|27|||
27929039|NCT00915525|81578860|FG001|Overall Study|Lost to Follow-up|16|||
27929040|NCT00915525|81578859|FG000|Overall Study|Pregnancy|2|||
27929041|NCT00915525|81578860|FG001|Overall Study|Pregnancy|0|||
27929042|NCT00915525|81578859|FG000|Overall Study|Lack of Efficacy|15|||
27929043|NCT00915525|81578860|FG001|Overall Study|Lack of Efficacy|32|||
27929044|NCT00915525|81578859|FG000|Overall Study|Adverse Event|29|||
27929045|NCT00915525|81578860|FG001|Overall Study|Adverse Event|13|||
27929046|NCT00915525|81578859|FG000|Overall Study|Missing|12|||
27929047|NCT00915525|81578860|FG001|Overall Study|Missing|1|||
27929048|NCT00915525|81578859|FG000|Overall Study|Other Reason|35|||
27929049|NCT00915525|81578860|FG001|Overall Study|Other Reason|12|||
27929050|NCT00915525|81578859|FG000|Overall Study|Site Closed|27|||
27929051|NCT00915525|81578860|FG001|Overall Study|Site Closed|9|||
27929052|NCT00915525|81578859|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
27548826|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548827|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548828|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548829|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548830|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548831|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548832|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548833|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548834|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548835|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548836|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548837|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548838|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27640474|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27640475|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
27640476|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27640477|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27640478|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
27640479|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
27640480|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
27640481|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
27640482|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
27640483|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
27640484|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
27640485|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
27640486|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
27640487|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
27640488|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
27640489|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
27640490|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
27640491|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
27640492|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
27640493|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
27640494|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
27742613|NCT01458340|80886989|FG001|Overall Study|Physician Decision|1|||
27929053|NCT00915525|81578860|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
27929054|NCT00915525|81578859|FG000|Overall Study|Study Burden|28|||
27929055|NCT00915525|81578860|FG001|Overall Study|Study Burden|12|||
27929056|NCT00915525|81578859|FG000|Overall Study|Non-Compliance|3|||
27929057|NCT00915525|81578860|FG001|Overall Study|Non-Compliance|1|||
27929058|NCT00915525|81578859|FG000|Overall Study|Patient Moved|15|||
27929059|NCT00915525|81578860|FG001|Overall Study|Patient Moved|9|||
27929060|NCT00853385|81578861|FG000|Overall Study|Death|0|||
27929061|NCT00853385|81578862|FG001|Overall Study|Death|0|||
27929062|NCT00853385|81578863|FG002|Overall Study|Death|0|||
27929063|NCT00853385|81578864|FG003|Overall Study|Death|0|||
27929064|NCT00853385|81578865|FG004|Overall Study|Death|1|||
27929065|NCT00853385|81578861|FG000|Overall Study|Adverse Event|24|||
27929066|NCT00853385|81578862|FG001|Overall Study|Adverse Event|24|||
27929067|NCT00853385|81578863|FG002|Overall Study|Adverse Event|2|||
27929068|NCT00853385|81578864|FG003|Overall Study|Adverse Event|5|||
27929069|NCT00853385|81578865|FG004|Overall Study|Adverse Event|22|||
27929070|NCT00853385|81578861|FG000|Overall Study|Lack of Efficacy|6|||
27929071|NCT00853385|81578862|FG001|Overall Study|Lack of Efficacy|7|||
27929072|NCT00853385|81578863|FG002|Overall Study|Lack of Efficacy|3|||
27548839|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
27548840|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Death|0|||
27548841|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Death|0|||
27548842|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Death|1|||
27548843|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Death|0|||
27548844|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Death|0|||
27548845|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Death|0|||
27548846|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Death|0|||
27548847|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Death|0|||
27548848|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Death|0|||
27548849|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Death|0|||
27548850|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Death|0|||
27548851|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Death|0|||
27548852|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Death|0|||
27548853|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Death|0|||
27548854|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Death|0|||
27548855|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Death|0|||
27548856|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Death|0|||
27548857|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Death|0|||
27548858|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Death|0|||
27548859|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Death|0|||
27548860|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Death|0|||
27548861|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Death|0|||
27548862|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Death|0|||
27548863|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Death|0|||
27548864|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Death|0|||
27548865|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Death|0|||
27548866|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548867|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548868|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
27548869|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
27548870|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
27548871|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
27548872|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
27548873|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548874|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548875|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548876|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548877|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548878|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548879|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548880|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548881|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548882|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548883|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548884|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548885|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548886|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548887|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548888|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548889|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548890|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27548891|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
27929073|NCT00853385|81578864|FG003|Overall Study|Lack of Efficacy|3|||
27929074|NCT00853385|81578865|FG004|Overall Study|Lack of Efficacy|6|||
27929075|NCT00853385|81578861|FG000|Overall Study|Lost to Follow-up|2|||
27929076|NCT00853385|81578862|FG001|Overall Study|Lost to Follow-up|1|||
27929077|NCT00853385|81578863|FG002|Overall Study|Lost to Follow-up|0|||
27548892|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548893|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548894|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
27548895|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548896|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548897|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548898|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27929078|NCT00853385|81578864|FG003|Overall Study|Lost to Follow-up|0|||
27929079|NCT00853385|81578865|FG004|Overall Study|Lost to Follow-up|0|||
27929080|NCT00853385|81578861|FG000|Overall Study|Withdrawal by Subject|4|||
27929081|NCT00853385|81578862|FG001|Overall Study|Withdrawal by Subject|2|||
27929082|NCT00853385|81578863|FG002|Overall Study|Withdrawal by Subject|0|||
27929083|NCT00853385|81578864|FG003|Overall Study|Withdrawal by Subject|1|||
27929084|NCT00853385|81578865|FG004|Overall Study|Withdrawal by Subject|1|||
27929085|NCT00853385|81578861|FG000|Overall Study|Other|18|||
27929086|NCT00853385|81578862|FG001|Overall Study|Other|9|||
27929087|NCT00853385|81578863|FG002|Overall Study|Other|4|||
27929088|NCT00853385|81578864|FG003|Overall Study|Other|4|||
27929089|NCT00853385|81578865|FG004|Overall Study|Other|12|||
27929090|NCT00614393|81578866|FG000|Overall Study|Adverse Event|20|||
27929091|NCT00614393|81578867|FG001|Overall Study|Adverse Event|2|||
27929092|NCT00614393|81578868|FG002|Overall Study|Adverse Event|3|||
27929093|NCT00614393|81578869|FG003|Overall Study|Adverse Event|13|||
27929094|NCT00614393|81578870|FG004|Overall Study|Adverse Event|21|||
27929095|NCT00614393|81578866|FG000|Overall Study|Lost to Follow-up|0|||
27929096|NCT00614393|81578867|FG001|Overall Study|Lost to Follow-up|0|||
27929097|NCT00614393|81578868|FG002|Overall Study|Lost to Follow-up|0|||
27929098|NCT00614393|81578869|FG003|Overall Study|Lost to Follow-up|1|||
27929099|NCT00614393|81578870|FG004|Overall Study|Lost to Follow-up|2|||
27929100|NCT00614393|81578866|FG000|Overall Study|Physician Decision|17|||
27929101|NCT00614393|81578867|FG001|Overall Study|Physician Decision|0|||
27929102|NCT00614393|81578868|FG002|Overall Study|Physician Decision|1|||
27929103|NCT00614393|81578869|FG003|Overall Study|Physician Decision|8|||
27929104|NCT00614393|81578870|FG004|Overall Study|Physician Decision|9|||
27929105|NCT00614393|81578866|FG000|Overall Study|Progressive Disease|118|||
27929106|NCT00614393|81578867|FG001|Overall Study|Progressive Disease|5|||
27929107|NCT00614393|81578868|FG002|Overall Study|Progressive Disease|5|||
27929108|NCT00614393|81578869|FG003|Overall Study|Progressive Disease|138|||
27929109|NCT00614393|81578870|FG004|Overall Study|Progressive Disease|130|||
27929110|NCT00614393|81578866|FG000|Overall Study|Protocol Violation|1|||
27929111|NCT00614393|81578867|FG001|Overall Study|Protocol Violation|0|||
27929112|NCT00614393|81578868|FG002|Overall Study|Protocol Violation|0|||
27929113|NCT00614393|81578869|FG003|Overall Study|Protocol Violation|0|||
27929114|NCT00614393|81578870|FG004|Overall Study|Protocol Violation|0|||
27929115|NCT00614393|81578866|FG000|Overall Study|Terminated by Sponsor|0|||
27929116|NCT00614393|81578867|FG001|Overall Study|Terminated by Sponsor|0|||
27929117|NCT00614393|81578868|FG002|Overall Study|Terminated by Sponsor|0|||
27929118|NCT00614393|81578869|FG003|Overall Study|Terminated by Sponsor|0|||
27929119|NCT00614393|81578870|FG004|Overall Study|Terminated by Sponsor|1|||
27929120|NCT00614393|81578866|FG000|Overall Study|Withdrawal by Subject|20|||
27929121|NCT00614393|81578867|FG001|Overall Study|Withdrawal by Subject|1|||
27929122|NCT00614393|81578868|FG002|Overall Study|Withdrawal by Subject|1|||
27929123|NCT00614393|81578869|FG003|Overall Study|Withdrawal by Subject|16|||
27929124|NCT00614393|81578870|FG004|Overall Study|Withdrawal by Subject|13|||
27929125|NCT00614393|81578866|FG000|Overall Study|Other|4|||
27929126|NCT00614393|81578867|FG001|Overall Study|Other|0|||
27929127|NCT00614393|81578868|FG002|Overall Study|Other|0|||
27548899|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548900|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548901|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27640495|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
27548902|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27640496|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
27929128|NCT00614393|81578869|FG003|Overall Study|Other|4|||
27929129|NCT00614393|81578870|FG004|Overall Study|Other|2|||
27929130|NCT00614393|81578866|FG000|Overall Study|Not Treated|0|||
27929131|NCT00614393|81578867|FG001|Overall Study|Not Treated|0|||
27929132|NCT00614393|81578868|FG002|Overall Study|Not Treated|0|||
27929133|NCT00614393|81578869|FG003|Overall Study|Not Treated|0|||
27929134|NCT00614393|81578870|FG004|Overall Study|Not Treated|2|||
27929135|NCT02612155|81578871|FG000|Overall Study|Death|1|||
27929136|NCT02612155|81578872|FG001|Overall Study|Death|1|||
27929137|NCT02612155|81578871|FG000|Overall Study|Lost to Follow-up|2|||
27929138|NCT02612155|81578872|FG001|Overall Study|Lost to Follow-up|2|||
27929139|NCT04115059|81578873|FG000|Overall Study|Withdrawal by Subject|1|||
27929140|NCT04115059|81578873|FG000|Overall Study|Lack of Efficacy|2|||
27929141|NCT02807259|81578874|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
27929142|NCT02807259|81578875|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
27929143|NCT02807259|81578874|FG000|Midline (3 Months)|migration, refusal, not available|30|||
27929144|NCT02807259|81578875|FG001|Midline (3 Months)|migration, refusal, not available|34|||
27929145|NCT02807259|81578874|FG000|Endline (3 Months)|migration, refusal, not available|35|||
27929146|NCT02807259|81578875|FG001|Endline (3 Months)|migration, refusal, not available|87|||
27929147|NCT01732783|81578876|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
27929148|NCT01732783|81578877|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
27929149|NCT01732783|81578878|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
27929150|NCT01732783|81578876|FG000|Overall Study|Death|13|||
27929151|NCT01732783|81578877|FG001|Overall Study|Death|4|||
27929152|NCT01732783|81578878|FG002|Overall Study|Death|1|||
27929153|NCT01732783|81578876|FG000|Overall Study|Lost to Follow-up|7|||
27929154|NCT01732783|81578877|FG001|Overall Study|Lost to Follow-up|1|||
27929155|NCT01732783|81578878|FG002|Overall Study|Lost to Follow-up|1|||
27929156|NCT01732783|81578876|FG000|Overall Study|Administrative Decision|8|||
27929157|NCT01732783|81578877|FG001|Overall Study|Administrative Decision|2|||
27929158|NCT01732783|81578878|FG002|Overall Study|Administrative Decision|1|||
27929159|NCT01732783|81578876|FG000|Overall Study|Withdrawal by Subject|1|||
27929160|NCT01732783|81578877|FG001|Overall Study|Withdrawal by Subject|0|||
27929161|NCT01732783|81578878|FG002|Overall Study|Withdrawal by Subject|0|||
27929162|NCT00972738|81578883|FG000|Overall Study|Adverse Event|7|||
27929163|NCT00972738|81578884|FG001|Overall Study|Adverse Event|1|||
27929164|NCT00972738|81578885|FG002|Overall Study|Adverse Event|8|||
27929165|NCT00972738|81578883|FG000|Overall Study|Protocol Violation|2|||
27929166|NCT00972738|81578884|FG001|Overall Study|Protocol Violation|1|||
27929167|NCT00972738|81578885|FG002|Overall Study|Protocol Violation|3|||
27929168|NCT00972738|81578883|FG000|Overall Study|Lost to Follow-up|1|||
27929169|NCT00972738|81578884|FG001|Overall Study|Lost to Follow-up|0|||
27929170|NCT00972738|81578885|FG002|Overall Study|Lost to Follow-up|1|||
27929171|NCT00972738|81578883|FG000|Overall Study|Lack of Efficacy|5|||
27929172|NCT00972738|81578884|FG001|Overall Study|Lack of Efficacy|1|||
27929173|NCT00972738|81578885|FG002|Overall Study|Lack of Efficacy|11|||
27929174|NCT00972738|81578883|FG000|Overall Study|Withdrawal by Subject|5|||
27929175|NCT00972738|81578884|FG001|Overall Study|Withdrawal by Subject|1|||
27929176|NCT00972738|81578885|FG002|Overall Study|Withdrawal by Subject|4|||
27929177|NCT00972738|81578883|FG000|Overall Study|Moved|0|||
27929178|NCT00972738|81578884|FG001|Overall Study|Moved|0|||
27929179|NCT00972738|81578885|FG002|Overall Study|Moved|1|||
27929180|NCT00972738|81578883|FG000|Overall Study|Other|1|||
27929181|NCT00972738|81578884|FG001|Overall Study|Other|2|||
27929182|NCT00972738|81578885|FG002|Overall Study|Other|1|||
27929183|NCT02187055|81578886|FG000|Overall Study|Lack of Efficacy|10|||
27929184|NCT02187055|81578887|FG001|Overall Study|Lack of Efficacy|3|||
27929185|NCT02187055|81578888|FG002|Overall Study|Lack of Efficacy|7|||
27929186|NCT02187055|81578886|FG000|Overall Study|Lost to Follow-up|2|||
27929187|NCT02187055|81578887|FG001|Overall Study|Lost to Follow-up|7|||
27929188|NCT02187055|81578888|FG002|Overall Study|Lost to Follow-up|3|||
27929189|NCT02187055|81578886|FG000|Overall Study|No longer meets eligibility criteria|0|||
27929190|NCT02187055|81578887|FG001|Overall Study|No longer meets eligibility criteria|2|||
27929191|NCT02187055|81578888|FG002|Overall Study|No longer meets eligibility criteria|0|||
27929192|NCT02187055|81578886|FG000|Overall Study|No longer willing to participate|6|||
27929193|NCT02187055|81578887|FG001|Overall Study|No longer willing to participate|8|||
27929194|NCT02187055|81578888|FG002|Overall Study|No longer willing to participate|10|||
27929195|NCT02187055|81578886|FG000|Overall Study|Other|5|||
27929196|NCT02187055|81578887|FG001|Overall Study|Other|6|||
27929197|NCT02187055|81578888|FG002|Overall Study|Other|3|||
27929198|NCT02187055|81578886|FG000|Overall Study|Protocol Violation|9|||
27929199|NCT02187055|81578887|FG001|Overall Study|Protocol Violation|9|||
27929200|NCT02187055|81578888|FG002|Overall Study|Protocol Violation|4|||
27929201|NCT02187055|81578886|FG000|Overall Study|Pregnancy|3|||
27929202|NCT02187055|81578887|FG001|Overall Study|Pregnancy|1|||
27742614|NCT01458340|80886990|FG002|Overall Study|Physician Decision|2|||
27929203|NCT02187055|81578888|FG002|Overall Study|Pregnancy|0|||
27929204|NCT02187055|81578886|FG000|Overall Study|Withdrawal by Subject|11|||
27929205|NCT02187055|81578887|FG001|Overall Study|Withdrawal by Subject|11|||
27929206|NCT02187055|81578888|FG002|Overall Study|Withdrawal by Subject|11|||
27929207|NCT02187055|81578886|FG000|Overall Study|Adverse Event|21|||
27929208|NCT02187055|81578887|FG001|Overall Study|Adverse Event|26|||
27929209|NCT02187055|81578888|FG002|Overall Study|Adverse Event|36|||
27929210|NCT02187055|81578886|FG000|Overall Study|Death|2|||
27929211|NCT02187055|81578887|FG001|Overall Study|Death|0|||
27929212|NCT02187055|81578888|FG002|Overall Study|Death|0|||
27929213|NCT00393367|81578900|FG000|Overall Study|Protocol Violation|2|||
27929214|NCT00393367|81578901|FG001|Overall Study|Protocol Violation|5|||
27929215|NCT00393367|81578900|FG000|Overall Study|Withdrawal by Subject|0|||
27929216|NCT00393367|81578901|FG001|Overall Study|Withdrawal by Subject|2|||
27929217|NCT04333498|81578902|FG000|Overall Study|Lost to Follow-up|1|||
27929218|NCT04333498|81578903|FG001|Overall Study|Lost to Follow-up|0|||
27929219|NCT04333498|81578902|FG000|Overall Study|Lost to Follow-up|0|||
27929220|NCT04333498|81578903|FG001|Overall Study|Lost to Follow-up|1|||
27929221|NCT01001104|81578904|FG000|Overall Study|Adverse Event|2|||
27929222|NCT01001104|81578905|FG001|Overall Study|Adverse Event|1|||
27929223|NCT01001104|81578906|FG002|Overall Study|Adverse Event|0|||
27929224|NCT01001104|81578907|FG003|Overall Study|Adverse Event|0|||
27929225|NCT01001104|81578904|FG000|Overall Study|Lost to Follow-up|0|||
27929226|NCT01001104|81578905|FG001|Overall Study|Lost to Follow-up|0|||
27929227|NCT01001104|81578906|FG002|Overall Study|Lost to Follow-up|1|||
27929228|NCT01001104|81578907|FG003|Overall Study|Lost to Follow-up|0|||
27929229|NCT01001104|81578904|FG000|Overall Study|Entry Criteria Not Met|0|||
27929230|NCT01001104|81578905|FG001|Overall Study|Entry Criteria Not Met|0|||
27929231|NCT01001104|81578906|FG002|Overall Study|Entry Criteria Not Met|0|||
27929232|NCT01001104|81578907|FG003|Overall Study|Entry Criteria Not Met|1|||
27929233|NCT01001104|81578904|FG000|Overall Study|Withdrawal by Subject|0|||
27929234|NCT01001104|81578905|FG001|Overall Study|Withdrawal by Subject|0|||
27929235|NCT01001104|81578906|FG002|Overall Study|Withdrawal by Subject|0|||
27929236|NCT01001104|81578907|FG003|Overall Study|Withdrawal by Subject|2|||
27929237|NCT04913675|81578910|FG000|Main Study (Up to Week 36)|Death|0|||
27929238|NCT04913675|81578911|FG001|Main Study (Up to Week 36)|Death|2|||
27929239|NCT04913675|81578912|FG002|Main Study (Up to Week 36)|Death|2|||
27929240|NCT04913675|81578913|FG003|Main Study (Up to Week 36)|Death|0|||
27929241|NCT04913675|81578910|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
27929242|NCT04913675|81578911|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
27929243|NCT04913675|81578912|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
27929244|NCT04913675|81578913|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
27929245|NCT04913675|81578910|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
27929246|NCT04913675|81578911|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
27929247|NCT04913675|81578912|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
27929248|NCT04913675|81578913|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
27929249|NCT04913675|81578910|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
27929250|NCT04913675|81578911|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
27929251|NCT04913675|81578912|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
27929252|NCT04913675|81578913|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
27929253|NCT04913675|81578910|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
27929254|NCT04913675|81578911|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
27929255|NCT04913675|81578912|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
27929256|NCT04913675|81578913|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
27929257|NCT04167670|81578914|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
27929258|NCT04167670|81578915|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
27929259|NCT04167670|81578916|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
27929260|NCT04167670|81578914|FG000|Overall Study|Significant protocol deviation|3|||
27929261|NCT04167670|81578915|FG001|Overall Study|Significant protocol deviation|1|||
27929262|NCT04167670|81578916|FG002|Overall Study|Significant protocol deviation|0|||
27929263|NCT04167670|81578914|FG000|Overall Study|Lost to Follow-up|0|||
27929264|NCT04167670|81578915|FG001|Overall Study|Lost to Follow-up|3|||
27929265|NCT04167670|81578916|FG002|Overall Study|Lost to Follow-up|3|||
27929266|NCT04167670|81578914|FG000|Overall Study|Voluntary Withdrawal|0|||
27929267|NCT04167670|81578915|FG001|Overall Study|Voluntary Withdrawal|1|||
27929268|NCT04167670|81578916|FG002|Overall Study|Voluntary Withdrawal|1|||
27929269|NCT04167670|81578914|FG000|Overall Study|Withdrawal of Consent|4|||
27929270|NCT04167670|81578915|FG001|Overall Study|Withdrawal of Consent|1|||
27929271|NCT04167670|81578916|FG002|Overall Study|Withdrawal of Consent|3|||
27929272|NCT04167670|81578914|FG000|Overall Study|Miscellaneous|7|||
27929273|NCT04167670|81578915|FG001|Overall Study|Miscellaneous|5|||
27929274|NCT04167670|81578916|FG002|Overall Study|Miscellaneous|3|||
27929275|NCT00844519|81578926|FG000|Overall Study|Withdrawal by Subject|1|||
27929276|NCT00844519|81578927|FG001|Overall Study|Withdrawal by Subject|1|||
27929277|NCT00844519|81578926|FG000|Overall Study|Adverse Event|1|||
27929278|NCT00844519|81578927|FG001|Overall Study|Adverse Event|0|||
27929279|NCT00462462|81578928|FG000|Overall Study|Physician Decision|0|||
27929280|NCT00462462|81578929|FG001|Overall Study|Physician Decision|1|||
27929281|NCT01588509|81578930|FG000|Overall Study|Lost to Follow-up|1|||
27929282|NCT01588509|81578931|FG001|Overall Study|Lost to Follow-up|0|||
27929283|NCT00286455|81578932|FG000|Overall Study|Hyperglycemia rescue|19|||
27929284|NCT00286455|81578933|FG001|Overall Study|Hyperglycemia rescue|13|||
27929285|NCT00286455|81578934|FG002|Overall Study|Hyperglycemia rescue|10|||
27929286|NCT00286455|81578932|FG000|Overall Study|Adverse Event|1|||
27929287|NCT00286455|81578933|FG001|Overall Study|Adverse Event|3|||
27929288|NCT00286455|81578934|FG002|Overall Study|Adverse Event|2|||
27929289|NCT00286455|81578932|FG000|Overall Study|Lost to Follow-up|0|||
27929290|NCT00286455|81578933|FG001|Overall Study|Lost to Follow-up|3|||
27929291|NCT00286455|81578934|FG002|Overall Study|Lost to Follow-up|3|||
27929292|NCT00286455|81578932|FG000|Overall Study|Physician Decision|3|||
27929293|NCT00286455|81578933|FG001|Overall Study|Physician Decision|0|||
27929294|NCT00286455|81578934|FG002|Overall Study|Physician Decision|2|||
27929295|NCT00286455|81578932|FG000|Overall Study|Protocol Violation|1|||
27929296|NCT00286455|81578933|FG001|Overall Study|Protocol Violation|1|||
27929297|NCT00286455|81578934|FG002|Overall Study|Protocol Violation|0|||
27929298|NCT00286455|81578932|FG000|Overall Study|Participant Non-compliance|1|||
27929299|NCT00286455|81578933|FG001|Overall Study|Participant Non-compliance|0|||
27929300|NCT00286455|81578934|FG002|Overall Study|Participant Non-compliance|0|||
27929301|NCT00286455|81578932|FG000|Overall Study|Withdrawal by Subject|0|||
27929302|NCT00286455|81578933|FG001|Overall Study|Withdrawal by Subject|8|||
27929303|NCT00286455|81578934|FG002|Overall Study|Withdrawal by Subject|7|||
27929304|NCT02311478|81578935|FG000|Overall Study|Withdrawal by Subject|1|||
27929305|NCT02311478|81578935|FG000|Overall Study|Lost to Follow-up|5|||
27548903|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27929306|NCT02311478|81578935|FG000|Overall Study|Failed IUD Insertion|1|||
27929307|NCT00927472|81578936|FG000|Overall Study|Withdrawal by Subject|10|||
27929308|NCT00927472|81578937|FG001|Overall Study|Withdrawal by Subject|11|||
27929309|NCT00927472|81578936|FG000|Overall Study|Lost to Follow-up|1|||
27929310|NCT00927472|81578937|FG001|Overall Study|Lost to Follow-up|6|||
27929311|NCT00927472|81578936|FG000|Overall Study|Protocol Violation|0|||
27929312|NCT00927472|81578937|FG001|Overall Study|Protocol Violation|1|||
27929313|NCT00927472|81578936|FG000|Overall Study|Post treatment Assessment out of window|0|||
27929314|NCT00927472|81578937|FG001|Overall Study|Post treatment Assessment out of window|4|||
27548904|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548905|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548906|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548907|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548908|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548909|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548910|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548911|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548912|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548913|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548914|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548915|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548916|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548917|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
27548918|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548919|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548920|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
27548921|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548922|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548923|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548924|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548925|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548926|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548927|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548928|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548929|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548930|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548931|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548932|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548933|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548934|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548935|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548936|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548937|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548938|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548939|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548940|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548941|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548942|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548943|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
27548944|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548945|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27742615|NCT01458340|80886988|FG000|Overall Study|Protocol Violation|6|||
27929315|NCT02403271|81578938|FG000|Period 1|Other varied reasons|1|||
27929316|NCT02403271|81578939|FG001|Period 1|Other varied reasons|0|||
27929317|NCT02403271|81578938|FG000|Period 2|Withdrawal by Subject|0|||
27929318|NCT02403271|81578939|FG001|Period 2|Withdrawal by Subject|14|||
27929319|NCT02403271|81578938|FG000|Period 2|Death|0|||
27929320|NCT02403271|81578939|FG001|Period 2|Death|84|||
27929321|NCT02403271|81578938|FG000|Period 2|Lost to Follow-up|0|||
27929322|NCT02403271|81578939|FG001|Period 2|Lost to Follow-up|2|||
27929323|NCT02403271|81578938|FG000|Period 2|Study Terminated by Sponsor|0|||
27929324|NCT02403271|81578939|FG001|Period 2|Study Terminated by Sponsor|14|||
27640497|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
27640498|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
27640499|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
27548946|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
27548947|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548948|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548949|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548950|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548951|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548952|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548953|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548954|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548955|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548956|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548957|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548958|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548959|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27640500|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
27742616|NCT01458340|80886989|FG001|Overall Study|Protocol Violation|6|||
27548960|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548961|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548962|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27640501|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
27742617|NCT01458340|80886990|FG002|Overall Study|Protocol Violation|5|||
27742618|NCT01458340|80886988|FG000|Overall Study|Withdrawal by Subject|12|||
27742619|NCT01458340|80886989|FG001|Overall Study|Withdrawal by Subject|6|||
27742620|NCT01458340|80886990|FG002|Overall Study|Withdrawal by Subject|4|||
27742621|NCT02138110|80886994|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
27742622|NCT02138110|80886994|FG000|Overall Scaffold Implantation|Death|3|||
27742623|NCT03199911|80886995|FG000|Overall Study|Lost to Follow-up|5|||
27742624|NCT03199911|80886996|FG001|Overall Study|Lost to Follow-up|5|||
27742625|NCT03199911|80886995|FG000|Overall Study|Did not proceed with surgery|2|||
27742626|NCT03199911|80886996|FG001|Overall Study|Did not proceed with surgery|1|||
27742627|NCT01933672|80886997|FG000|Metformin Run-in Period|Adverse Event|1|||
27742628|NCT01933672|80886998|FG001|Metformin Run-in Period|Adverse Event|0|||
27742629|NCT01933672|80886999|FG002|Metformin Run-in Period|Adverse Event|0|||
27742630|NCT01933672|80887000|FG003|Metformin Run-in Period|Adverse Event|0|||
27742631|NCT01933672|80887001|FG004|Metformin Run-in Period|Adverse Event|0|||
27742632|NCT01933672|80887002|FG005|Metformin Run-in Period|Adverse Event|0|||
27929325|NCT02403271|81578938|FG000|Period 2|Other varied reasons|0|||
27929326|NCT02403271|81578939|FG001|Period 2|Other varied reasons|10|||
27929327|NCT00002874|81578940|FG000|Overall Study|Withdrawal by Subject|1|||
27929328|NCT00002874|81578941|FG001|Overall Study|Withdrawal by Subject|1|||
27929329|NCT00002874|81578940|FG000|Overall Study|Protocol Violation|44|||
27929330|NCT00002874|81578941|FG001|Overall Study|Protocol Violation|34|||
27929331|NCT03822416|81578943|FG000|Overall Study|Lost to Follow-up|1|||
27742633|NCT01933672|80887003|FG006|Metformin Run-in Period|Adverse Event|0|||
27742634|NCT01933672|80886997|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
27742635|NCT01933672|80886998|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27929332|NCT03822416|81578944|FG001|Overall Study|Lost to Follow-up|0|||
27929333|NCT03822416|81578943|FG000|Overall Study|Withdrawal by Subject|0|||
27929334|NCT03822416|81578944|FG001|Overall Study|Withdrawal by Subject|1|||
27929335|NCT01348698|81578945|FG000|Overall Study|Does not meet lesion size criteria|1|||
27929336|NCT01348698|81578945|FG000|Overall Study|Death|3|||
27929337|NCT01348698|81578945|FG000|Overall Study|PI decision to close study|68|||
27929338|NCT03325439|81578946|FG000|Overall Study|Ineligibility|3|||
27929339|NCT00898807|81578951|FG000|Overall Study|Withdrawal by Subject|5|||
27929340|NCT00898807|81578952|FG001|Overall Study|Withdrawal by Subject|3|||
27929341|NCT00898807|81578951|FG000|Overall Study|Family pressure to discontinue|2|||
27929342|NCT00898807|81578952|FG001|Overall Study|Family pressure to discontinue|2|||
27929343|NCT00898807|81578951|FG000|Overall Study|Lost to Follow-up|1|||
27742636|NCT01933672|80886999|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27929344|NCT00898807|81578952|FG001|Overall Study|Lost to Follow-up|3|||
27929345|NCT00898807|81578951|FG000|Overall Study|Death|0|||
27929346|NCT00898807|81578952|FG001|Overall Study|Death|1|||
27929347|NCT01860404|81578953|FG000|Overall Study|Lost to Follow-up|3|||
27742637|NCT01933672|80887000|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27742638|NCT01933672|80887001|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27742639|NCT01933672|80887002|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27742640|NCT01933672|80887003|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
27548963|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548964|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27742641|NCT01933672|80886997|FG000|Metformin Run-in Period|Other|5|||
27548965|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548966|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548967|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548968|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548969|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
27548970|NCT03129100|80197205|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548971|NCT03129100|80197206|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548972|NCT03129100|80197207|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548973|NCT03129100|80197208|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548974|NCT03129100|80197209|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
27548975|NCT03129100|80197210|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
27548976|NCT03129100|80197211|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
27548977|NCT03129100|80197212|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548978|NCT03129100|80197213|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548979|NCT03129100|80197214|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548980|NCT03129100|80197215|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548981|NCT03129100|80197216|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548982|NCT03129100|80197217|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548983|NCT03129100|80197218|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548984|NCT03129100|80197219|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548985|NCT03129100|80197220|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548986|NCT03129100|80197221|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548987|NCT03129100|80197222|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548988|NCT03129100|80197223|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548989|NCT03129100|80197224|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548990|NCT03129100|80197225|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548991|NCT03129100|80197226|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548992|NCT03129100|80197227|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548993|NCT03129100|80197228|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548994|NCT03129100|80197229|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548995|NCT03129100|80197230|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
27548996|NCT03129100|80197205|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27548997|NCT03129100|80197206|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27548998|NCT03129100|80197207|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27548999|NCT03129100|80197208|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549000|NCT03129100|80197209|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549001|NCT03129100|80197210|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549002|NCT03129100|80197211|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549003|NCT03129100|80197212|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549004|NCT03129100|80197213|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549005|NCT03129100|80197214|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
27549006|NCT03129100|80197215|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549007|NCT03129100|80197216|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549008|NCT03129100|80197217|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549009|NCT03129100|80197218|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549010|NCT03129100|80197219|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549011|NCT03129100|80197220|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549012|NCT03129100|80197221|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549013|NCT03129100|80197222|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549014|NCT03129100|80197223|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549015|NCT03129100|80197224|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549016|NCT03129100|80197225|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549017|NCT03129100|80197226|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549018|NCT03129100|80197227|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27929348|NCT01860404|81578954|FG001|Overall Study|Lost to Follow-up|4|||
27742642|NCT01933672|80886998|FG001|Metformin Run-in Period|Other|0|||
27742643|NCT01933672|80886999|FG002|Metformin Run-in Period|Other|0|||
27549019|NCT03129100|80197228|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549020|NCT03129100|80197229|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549021|NCT03129100|80197230|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
27549022|NCT03129100|80197205|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549023|NCT03129100|80197206|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549024|NCT03129100|80197207|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549025|NCT03129100|80197208|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549026|NCT03129100|80197209|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549027|NCT03129100|80197210|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549028|NCT03129100|80197211|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549029|NCT03129100|80197212|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549030|NCT03129100|80197213|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549031|NCT03129100|80197214|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549032|NCT03129100|80197215|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549033|NCT03129100|80197216|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
27549034|NCT03129100|80197217|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549035|NCT03129100|80197218|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549036|NCT03129100|80197219|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549037|NCT03129100|80197220|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549038|NCT03129100|80197221|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549039|NCT03129100|80197222|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549040|NCT03129100|80197223|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549041|NCT03129100|80197224|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549042|NCT03129100|80197225|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549043|NCT03129100|80197226|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549044|NCT03129100|80197227|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549045|NCT03129100|80197228|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549046|NCT03129100|80197229|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549047|NCT03129100|80197230|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
27549048|NCT03129100|80197205|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549049|NCT03129100|80197206|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549050|NCT03129100|80197207|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549051|NCT03129100|80197208|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549052|NCT03129100|80197209|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549053|NCT03129100|80197210|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549054|NCT03129100|80197211|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549055|NCT03129100|80197212|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549056|NCT03129100|80197213|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549057|NCT03129100|80197214|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549058|NCT03129100|80197215|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549059|NCT03129100|80197216|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
27549060|NCT03129100|80197217|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
27549061|NCT03129100|80197218|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
27549062|NCT03129100|80197219|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
27549063|NCT03129100|80197220|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549064|NCT03129100|80197221|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549065|NCT03129100|80197222|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549066|NCT03129100|80197223|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549067|NCT03129100|80197224|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549068|NCT03129100|80197225|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549069|NCT03129100|80197226|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549070|NCT03129100|80197227|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549071|NCT03129100|80197228|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549072|NCT03129100|80197229|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549073|NCT03129100|80197230|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
27549074|NCT03129100|80197205|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549075|NCT03129100|80197206|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549076|NCT03129100|80197207|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27742644|NCT01933672|80887000|FG003|Metformin Run-in Period|Other|0|||
27742645|NCT01933672|80887001|FG004|Metformin Run-in Period|Other|0|||
27742646|NCT01933672|80887002|FG005|Metformin Run-in Period|Other|0|||
27742647|NCT01933672|80887003|FG006|Metformin Run-in Period|Other|0|||
27929349|NCT01860404|81578955|FG002|Overall Study|Lost to Follow-up|1|||
27549077|NCT03129100|80197208|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549078|NCT03129100|80197209|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549079|NCT03129100|80197210|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549080|NCT03129100|80197211|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549081|NCT03129100|80197212|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549082|NCT03129100|80197213|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549083|NCT03129100|80197214|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549084|NCT03129100|80197215|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549085|NCT03129100|80197216|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
27549086|NCT03129100|80197217|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549087|NCT03129100|80197218|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
27549088|NCT03129100|80197219|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
27549089|NCT03129100|80197220|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549090|NCT03129100|80197221|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549091|NCT03129100|80197222|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549092|NCT03129100|80197223|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549093|NCT03129100|80197224|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549094|NCT03129100|80197225|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549095|NCT03129100|80197226|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549096|NCT03129100|80197227|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549097|NCT03129100|80197228|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549098|NCT03129100|80197229|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549099|NCT03129100|80197230|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
27549100|NCT03129100|80197205|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549101|NCT03129100|80197206|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549102|NCT03129100|80197207|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549103|NCT03129100|80197208|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549104|NCT03129100|80197209|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549105|NCT03129100|80197210|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549106|NCT03129100|80197211|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549107|NCT03129100|80197212|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549108|NCT03129100|80197213|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549109|NCT03129100|80197214|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549110|NCT03129100|80197215|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549111|NCT03129100|80197216|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549112|NCT03129100|80197217|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549113|NCT03129100|80197218|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549114|NCT03129100|80197219|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549115|NCT03129100|80197220|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
27549116|NCT03129100|80197221|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549117|NCT03129100|80197222|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549118|NCT03129100|80197223|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549119|NCT03129100|80197224|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549120|NCT03129100|80197225|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549121|NCT03129100|80197226|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549122|NCT03129100|80197227|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549123|NCT03129100|80197228|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549124|NCT03129100|80197229|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549125|NCT03129100|80197230|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
27549126|NCT03129100|80197205|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549127|NCT03129100|80197206|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549128|NCT03129100|80197207|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549129|NCT03129100|80197208|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549130|NCT03129100|80197209|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549131|NCT03129100|80197210|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549132|NCT03129100|80197211|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549133|NCT03129100|80197212|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549134|NCT03129100|80197213|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549135|NCT03129100|80197214|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549136|NCT03129100|80197215|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27929350|NCT01860404|81578956|FG003|Overall Study|Lost to Follow-up|6|||
27929351|NCT01860404|81578957|FG004|Overall Study|Lost to Follow-up|4|||
27929352|NCT01860404|81578953|FG000|Overall Study|Withdrawal by Subject|0|||
27929353|NCT01860404|81578954|FG001|Overall Study|Withdrawal by Subject|0|||
27549137|NCT03129100|80197216|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549138|NCT03129100|80197217|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
27549139|NCT03129100|80197218|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549140|NCT03129100|80197219|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
27549141|NCT03129100|80197220|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
27549142|NCT03129100|80197221|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549143|NCT03129100|80197222|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27929354|NCT01860404|81578955|FG002|Overall Study|Withdrawal by Subject|4|||
27929355|NCT01860404|81578956|FG003|Overall Study|Withdrawal by Subject|0|||
27929356|NCT01860404|81578957|FG004|Overall Study|Withdrawal by Subject|0|||
27929357|NCT01180777|81578960|FG000|Overall Study|Protocol Violation|6|||
27929358|NCT01180777|81578960|FG000|Overall Study|Poor lens fit|4|||
27929359|NCT01180777|81578960|FG000|Overall Study|Lost to Follow-up|1|||
27929360|NCT01180777|81578960|FG000|Overall Study|Adverse Event|1|||
27929361|NCT01696968|81578961|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
27929362|NCT01696968|81578962|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
27929363|NCT01696968|81578961|FG000|Overall Study|Died Before Randomization|3|||
27929364|NCT01696968|81578962|FG001|Overall Study|Died Before Randomization|8|||
27929365|NCT01696968|81578961|FG000|Overall Study|Died Before ASU (Control)|278|||
27929366|NCT01696968|81578962|FG001|Overall Study|Died Before ASU (Control)|0|||
27549144|NCT03129100|80197223|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549145|NCT03129100|80197224|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549146|NCT03129100|80197225|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549147|NCT03129100|80197226|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549148|NCT03129100|80197227|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549149|NCT03129100|80197228|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549150|NCT03129100|80197229|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549151|NCT03129100|80197230|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
27549152|NCT03129100|80197205|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549153|NCT03129100|80197206|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549154|NCT03129100|80197207|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549155|NCT03129100|80197208|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549156|NCT03129100|80197209|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549157|NCT03129100|80197210|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549158|NCT03129100|80197211|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549159|NCT03129100|80197212|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549160|NCT03129100|80197213|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549161|NCT03129100|80197214|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549162|NCT03129100|80197215|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549163|NCT03129100|80197216|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549164|NCT03129100|80197217|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549165|NCT03129100|80197218|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549166|NCT03129100|80197219|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549167|NCT03129100|80197220|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549168|NCT03129100|80197221|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549169|NCT03129100|80197222|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
27549170|NCT03129100|80197223|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549171|NCT03129100|80197224|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
27549172|NCT03129100|80197225|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549173|NCT03129100|80197226|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549174|NCT03129100|80197227|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27929367|NCT01696968|81578961|FG000|Overall Study|Refused ASU (Control)|920|||
27929368|NCT01696968|81578962|FG001|Overall Study|Refused ASU (Control)|0|||
27929369|NCT01696968|81578961|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
27929370|NCT01696968|81578962|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
27929371|NCT01564407|81578967|FG000|Overall Study|Lost to Follow-up|0|||
27929372|NCT01564407|81578968|FG001|Overall Study|Lost to Follow-up|1|||
27929373|NCT01564407|81578969|FG002|Overall Study|Lost to Follow-up|0|||
27929374|NCT01564407|81578970|FG003|Overall Study|Lost to Follow-up|0|||
27929375|NCT01564407|81578971|FG004|Overall Study|Lost to Follow-up|0|||
27929376|NCT01564407|81578967|FG000|Overall Study|Withdrawal by Subject|0|||
27929377|NCT01564407|81578968|FG001|Overall Study|Withdrawal by Subject|1|||
27549175|NCT03129100|80197228|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549176|NCT03129100|80197229|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549177|NCT03129100|80197230|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
27549178|NCT03129100|80197205|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27929378|NCT01564407|81578969|FG002|Overall Study|Withdrawal by Subject|0|||
27929379|NCT01564407|81578970|FG003|Overall Study|Withdrawal by Subject|0|||
27929380|NCT01564407|81578971|FG004|Overall Study|Withdrawal by Subject|0|||
27929381|NCT01564407|81578967|FG000|Overall Study|funding lost, study ended|0|||
27929382|NCT01564407|81578968|FG001|Overall Study|funding lost, study ended|0|||
27929383|NCT01564407|81578969|FG002|Overall Study|funding lost, study ended|0|||
27549179|NCT03129100|80197206|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549180|NCT03129100|80197207|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549181|NCT03129100|80197208|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549182|NCT03129100|80197209|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549183|NCT03129100|80197210|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549184|NCT03129100|80197211|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549185|NCT03129100|80197212|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549186|NCT03129100|80197213|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549187|NCT03129100|80197214|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549188|NCT03129100|80197215|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549189|NCT03129100|80197216|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549190|NCT03129100|80197217|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549191|NCT03129100|80197218|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549192|NCT03129100|80197219|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549193|NCT03129100|80197220|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549194|NCT03129100|80197221|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549195|NCT03129100|80197222|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549196|NCT03129100|80197223|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549197|NCT03129100|80197224|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549198|NCT03129100|80197225|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
27549199|NCT03129100|80197226|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549200|NCT03129100|80197227|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549201|NCT03129100|80197228|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549202|NCT03129100|80197229|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549203|NCT03129100|80197230|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
27549204|NCT03129100|80197205|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
27640502|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
27929384|NCT01564407|81578970|FG003|Overall Study|funding lost, study ended|1|||
27929385|NCT01564407|81578971|FG004|Overall Study|funding lost, study ended|0|||
27929386|NCT03572218|81578972|FG000|Overall Study|Lost to Follow-up|3|||
27929387|NCT03572218|81578973|FG001|Overall Study|Lost to Follow-up|2|||
27929388|NCT03572218|81578972|FG000|Overall Study|No longer available for study visits|2|||
27929389|NCT03572218|81578973|FG001|Overall Study|No longer available for study visits|1|||
27929390|NCT03572218|81578972|FG000|Overall Study|No longer interested|1|||
27929391|NCT03572218|81578973|FG001|Overall Study|No longer interested|2|||
27929392|NCT01970371|81578977|FG000|Overall Study|Death|8|||
27929393|NCT01970371|81578978|FG001|Overall Study|Death|13|||
27929394|NCT01970371|81578979|FG002|Overall Study|Death|12|||
27929395|NCT01970371|81578977|FG000|Overall Study|Lost to Follow-up|0|||
27929396|NCT01970371|81578978|FG001|Overall Study|Lost to Follow-up|0|||
27929397|NCT01970371|81578979|FG002|Overall Study|Lost to Follow-up|1|||
27929398|NCT02441283|81578980|FG000|Overall Study|Withdrew consent|15|||
27929399|NCT02441283|81578980|FG000|Overall Study|Lost to Follow-up|42|||
27929400|NCT02441283|81578980|FG000|Overall Study|Death|1|||
27929401|NCT02441283|81578980|FG000|Overall Study|Other, not specified|32|||
27929402|NCT00790933|81578981|FG000|Overall Study|Adverse Event|94|||
27929403|NCT00790933|81578982|FG001|Overall Study|Adverse Event|119|||
27929404|NCT00790933|81578983|FG002|Overall Study|Adverse Event|65|||
27929405|NCT00790933|81578984|FG003|Overall Study|Adverse Event|5|||
27929406|NCT00790933|81578985|FG004|Overall Study|Adverse Event|69|||
27929407|NCT00790933|81578981|FG000|Overall Study|Protocol Violation(s)|8|||
27929408|NCT00790933|81578982|FG001|Overall Study|Protocol Violation(s)|18|||
27929409|NCT00790933|81578983|FG002|Overall Study|Protocol Violation(s)|7|||
27929410|NCT00790933|81578984|FG003|Overall Study|Protocol Violation(s)|0|||
27929411|NCT00790933|81578985|FG004|Overall Study|Protocol Violation(s)|12|||
27929412|NCT00790933|81578981|FG000|Overall Study|Lack of Efficacy|192|||
27929413|NCT00790933|81578982|FG001|Overall Study|Lack of Efficacy|176|||
27929414|NCT00790933|81578983|FG002|Overall Study|Lack of Efficacy|130|||
27929415|NCT00790933|81578984|FG003|Overall Study|Lack of Efficacy|1|||
27549205|NCT03129100|80197206|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
27549206|NCT03129100|80197207|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
27640503|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27742648|NCT01933672|80886997|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742649|NCT01933672|80886998|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27929416|NCT00790933|81578985|FG004|Overall Study|Lack of Efficacy|121|||
27929417|NCT00790933|81578981|FG000|Overall Study|Study Terminated by Sponsor|0|||
27929418|NCT00790933|81578982|FG001|Overall Study|Study Terminated by Sponsor|0|||
27929419|NCT00790933|81578983|FG002|Overall Study|Study Terminated by Sponsor|1|||
27929420|NCT00790933|81578984|FG003|Overall Study|Study Terminated by Sponsor|0|||
27929421|NCT00790933|81578985|FG004|Overall Study|Study Terminated by Sponsor|0|||
27929422|NCT00790933|81578981|FG000|Overall Study|Withdrawal by Subject|123|||
27929423|NCT00790933|81578982|FG001|Overall Study|Withdrawal by Subject|120|||
27929424|NCT00790933|81578983|FG002|Overall Study|Withdrawal by Subject|52|||
27549207|NCT03129100|80197208|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
27549208|NCT03129100|80197209|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
27549209|NCT03129100|80197210|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
27549210|NCT03129100|80197211|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
27549211|NCT03129100|80197212|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
27549212|NCT03129100|80197213|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
27549213|NCT03129100|80197214|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
27549214|NCT03129100|80197215|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
27549215|NCT03129100|80197216|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
27549216|NCT03129100|80197217|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
27549217|NCT03129100|80197218|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
27549218|NCT03129100|80197219|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
27549219|NCT03129100|80197220|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
27549220|NCT03129100|80197221|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
27549221|NCT03129100|80197222|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
27549222|NCT03129100|80197223|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
27549223|NCT03129100|80197224|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
27549224|NCT03129100|80197225|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
27549225|NCT03129100|80197226|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
27549226|NCT03129100|80197227|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
27549227|NCT03129100|80197228|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
27549228|NCT03129100|80197229|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
27549229|NCT03129100|80197230|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
27549230|NCT03129100|80197205|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549231|NCT03129100|80197206|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549232|NCT03129100|80197207|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549233|NCT03129100|80197208|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549234|NCT03129100|80197209|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549235|NCT03129100|80197210|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549236|NCT03129100|80197211|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549237|NCT03129100|80197212|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549238|NCT03129100|80197213|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549239|NCT03129100|80197214|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549240|NCT03129100|80197215|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549241|NCT03129100|80197216|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549242|NCT03129100|80197217|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549243|NCT03129100|80197218|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549244|NCT03129100|80197219|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549245|NCT03129100|80197220|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549246|NCT03129100|80197221|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549247|NCT03129100|80197222|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549248|NCT03129100|80197223|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549249|NCT03129100|80197224|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549250|NCT03129100|80197225|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
27549251|NCT03129100|80197226|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549252|NCT03129100|80197227|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549253|NCT03129100|80197228|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549254|NCT03129100|80197229|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549255|NCT03129100|80197230|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
27549256|NCT03129100|80197205|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
27549257|NCT03129100|80197206|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
27549258|NCT03129100|80197207|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
27549259|NCT03129100|80197208|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
27549260|NCT03129100|80197209|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
27549261|NCT03129100|80197210|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
27549262|NCT03129100|80197211|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
27549263|NCT03129100|80197212|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
27549264|NCT03129100|80197213|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
27549265|NCT03129100|80197214|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
27549266|NCT03129100|80197215|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
27549267|NCT03129100|80197216|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
27549268|NCT03129100|80197217|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
27549269|NCT03129100|80197218|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
27549270|NCT03129100|80197219|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
27549271|NCT03129100|80197220|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
27549272|NCT03129100|80197221|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
27549273|NCT03129100|80197222|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
27549274|NCT03129100|80197223|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
27549275|NCT03129100|80197224|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
27549276|NCT03129100|80197225|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
27549277|NCT03129100|80197226|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
27549278|NCT03129100|80197227|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
27549279|NCT03129100|80197228|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
27549280|NCT03129100|80197229|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
27549281|NCT03129100|80197230|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
27549282|NCT03129100|80197205|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549283|NCT03129100|80197206|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549284|NCT03129100|80197207|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549285|NCT03129100|80197208|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549286|NCT03129100|80197209|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549287|NCT03129100|80197210|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549288|NCT03129100|80197211|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549289|NCT03129100|80197212|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549290|NCT03129100|80197213|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549291|NCT03129100|80197214|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549292|NCT03129100|80197215|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549293|NCT03129100|80197216|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549294|NCT03129100|80197217|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549295|NCT03129100|80197218|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549296|NCT03129100|80197219|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549297|NCT03129100|80197220|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549298|NCT03129100|80197221|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549299|NCT03129100|80197222|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549300|NCT03129100|80197223|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549301|NCT03129100|80197224|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549302|NCT03129100|80197225|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549303|NCT03129100|80197226|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549304|NCT03129100|80197227|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549305|NCT03129100|80197228|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
27549306|NCT03129100|80197229|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
27549307|NCT03129100|80197230|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
27549308|NCT03129100|80197205|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549309|NCT03129100|80197206|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549310|NCT03129100|80197207|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549311|NCT03129100|80197208|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549312|NCT03129100|80197209|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549313|NCT03129100|80197210|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549314|NCT03129100|80197211|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549315|NCT03129100|80197212|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549316|NCT03129100|80197213|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549317|NCT03129100|80197214|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549318|NCT03129100|80197215|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549319|NCT03129100|80197216|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549320|NCT03129100|80197217|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549321|NCT03129100|80197218|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549322|NCT03129100|80197219|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549323|NCT03129100|80197220|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549324|NCT03129100|80197221|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549325|NCT03129100|80197222|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549326|NCT03129100|80197223|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549327|NCT03129100|80197224|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549328|NCT03129100|80197225|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549329|NCT03129100|80197226|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549330|NCT03129100|80197227|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
27549331|NCT03129100|80197228|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
27549332|NCT03129100|80197229|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
27549333|NCT03129100|80197230|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
27549334|NCT03129100|80197205|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549335|NCT03129100|80197206|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27929425|NCT00790933|81578984|FG003|Overall Study|Withdrawal by Subject|6|||
27929426|NCT00790933|81578985|FG004|Overall Study|Withdrawal by Subject|50|||
27549336|NCT03129100|80197207|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549337|NCT03129100|80197208|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549338|NCT03129100|80197209|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549339|NCT03129100|80197210|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549340|NCT03129100|80197211|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549341|NCT03129100|80197212|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27742650|NCT01933672|80886999|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27929427|NCT00790933|81578981|FG000|Overall Study|Lost to Follow-up|13|||
27549342|NCT03129100|80197213|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549343|NCT03129100|80197214|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549344|NCT03129100|80197215|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549345|NCT03129100|80197216|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549346|NCT03129100|80197217|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549347|NCT03129100|80197218|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549348|NCT03129100|80197219|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549349|NCT03129100|80197220|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549350|NCT03129100|80197221|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549351|NCT03129100|80197222|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549352|NCT03129100|80197223|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549353|NCT03129100|80197224|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549354|NCT03129100|80197225|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549355|NCT03129100|80197226|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549356|NCT03129100|80197227|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549357|NCT03129100|80197228|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549358|NCT03129100|80197229|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
27549359|NCT03129100|80197230|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
27549360|NCT03129100|80197205|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549361|NCT03129100|80197206|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549362|NCT03129100|80197207|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549363|NCT03129100|80197208|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549364|NCT03129100|80197209|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549365|NCT03129100|80197210|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549366|NCT03129100|80197211|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549367|NCT03129100|80197212|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549368|NCT03129100|80197213|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549369|NCT03129100|80197214|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549370|NCT03129100|80197215|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549371|NCT03129100|80197216|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549372|NCT03129100|80197217|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549373|NCT03129100|80197218|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549374|NCT03129100|80197219|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549375|NCT03129100|80197220|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549376|NCT03129100|80197221|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549377|NCT03129100|80197222|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549378|NCT03129100|80197223|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549379|NCT03129100|80197224|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549380|NCT03129100|80197225|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549381|NCT03129100|80197226|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549382|NCT03129100|80197227|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549383|NCT03129100|80197228|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549384|NCT03129100|80197229|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
27549385|NCT03129100|80197230|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
27549386|NCT03129100|80197205|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
27549387|NCT03129100|80197206|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
27549388|NCT03129100|80197207|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
27549389|NCT03129100|80197208|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
27549390|NCT03129100|80197209|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
27549391|NCT03129100|80197210|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
27549392|NCT03129100|80197211|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
27549393|NCT03129100|80197212|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
27549394|NCT03129100|80197213|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
27549395|NCT03129100|80197214|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
27549396|NCT03129100|80197215|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
27549397|NCT03129100|80197216|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
27549398|NCT03129100|80197217|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
27549399|NCT03129100|80197218|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
27549400|NCT03129100|80197219|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
27549401|NCT03129100|80197220|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
27549402|NCT03129100|80197221|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
27549403|NCT03129100|80197222|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
27549404|NCT03129100|80197223|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
27549405|NCT03129100|80197224|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
27549406|NCT03129100|80197225|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
27549407|NCT03129100|80197226|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
27549408|NCT03129100|80197227|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
27549409|NCT03129100|80197228|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
27549410|NCT03129100|80197229|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
27549411|NCT03129100|80197230|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
27549412|NCT00729651|80197231|FG000|Overall Study|Withdrawal by Subject|5|||
27549413|NCT00729651|80197232|FG001|Overall Study|Withdrawal by Subject|6|||
27549414|NCT00729651|80197231|FG000|Overall Study|Lost to Follow-up|5|||
27549415|NCT00729651|80197232|FG001|Overall Study|Lost to Follow-up|4|||
27549416|NCT00729651|80197231|FG000|Overall Study|Protocol Violation|0|||
27549417|NCT00729651|80197232|FG001|Overall Study|Protocol Violation|1|||
27549418|NCT00729651|80197231|FG000|Overall Study|Adverse Event|7|||
27549419|NCT00729651|80197232|FG001|Overall Study|Adverse Event|3|||
27549420|NCT00729651|80197231|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
27549421|NCT00729651|80197232|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
27549422|NCT00729651|80197231|FG000|Overall Study|Subject's private reason|2|||
27549423|NCT00729651|80197232|FG001|Overall Study|Subject's private reason|0|||
27549424|NCT03208244|80197236|FG000|Overall Study|Death|1|||
27549425|NCT02206048|80197239|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
27549426|NCT04015336|80197242|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
27549427|NCT00630396|80197243|FG000|Overall Study|Death|4|||
27549428|NCT00630396|80197243|FG000|Overall Study|Lost to Follow-up|3|||
27549429|NCT02859454|80197244|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
27549430|NCT00353262|80197245|FG000|Overall Study|Adverse Event|8|||
27549431|NCT00353262|80197245|FG000|Overall Study|Withdrawal by Subject|2|||
27549432|NCT00353262|80197245|FG000|Overall Study|Insufficient Therapeutic Response|13|||
27549433|NCT00353262|80197245|FG000|Overall Study|Progression|1|||
27549434|NCT00353262|80197245|FG000|Overall Study|Surgery|4|||
27549435|NCT00353262|80197245|FG000|Overall Study|Break from Chemotherapy|1|||
27549436|NCT01751178|80197252|FG000|Overall Study|Adverse Event|2|||
27549437|NCT01751178|80197253|FG001|Overall Study|Adverse Event|0|||
27549438|NCT01751178|80197254|FG002|Overall Study|Adverse Event|0|||
27549439|NCT01751178|80197252|FG000|Overall Study|Other Reason (unknown)|1|||
27549440|NCT01751178|80197253|FG001|Overall Study|Other Reason (unknown)|0|||
27549441|NCT01751178|80197254|FG002|Overall Study|Other Reason (unknown)|2|||
27549442|NCT03633695|80197255|FG000|Overall Study|Lost to Follow-up|4|||
27549443|NCT03633695|80197256|FG001|Overall Study|Lost to Follow-up|5|||
27549444|NCT03633695|80197255|FG000|Overall Study|Discontinued|8|||
27549445|NCT03633695|80197256|FG001|Overall Study|Discontinued|4|||
27549446|NCT00291577|80197257|FG000|Overall Study|Adverse Event|1|||
27549447|NCT00291577|80197257|FG000|Overall Study|Other|4|||
27549448|NCT00291577|80197257|FG000|Overall Study|Withdrawal by Subject|2|||
27549449|NCT00291577|80197257|FG000|Overall Study|Lack of Efficacy|14|||
27549450|NCT01702805|80197258|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
27549451|NCT01702805|80197259|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
27549452|NCT01702805|80197258|FG000|Overall Study|Incomplete Follow-up|18|||
27549453|NCT01702805|80197259|FG001|Overall Study|Incomplete Follow-up|15|||
27549454|NCT01702805|80197258|FG000|Overall Study|Vital Status Assessment Only|40|||
27549455|NCT01702805|80197259|FG001|Overall Study|Vital Status Assessment Only|39|||
27549456|NCT01702805|80197258|FG000|Overall Study|Lost to Follow-up|5|||
27549457|NCT01702805|80197259|FG001|Overall Study|Lost to Follow-up|5|||
27549458|NCT04805541|80197265|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
27549459|NCT03066804|80197269|FG000|Overall Study|Physician Decision|0|||
27549460|NCT03066804|80197270|FG001|Overall Study|Physician Decision|4|||
27549461|NCT03066804|80197269|FG000|Overall Study|Death|23|||
27549462|NCT03066804|80197270|FG001|Overall Study|Death|17|||
27549463|NCT03066804|80197269|FG000|Overall Study|Withdrawal by Subject|19|||
27549464|NCT03066804|80197270|FG001|Overall Study|Withdrawal by Subject|25|||
27549465|NCT03066804|80197269|FG000|Overall Study|Lost to Follow-up|2|||
27549466|NCT03066804|80197270|FG001|Overall Study|Lost to Follow-up|0|||
27549467|NCT03066804|80197269|FG000|Overall Study|Adverse Event|2|||
27549468|NCT03066804|80197270|FG001|Overall Study|Adverse Event|3|||
27549469|NCT03066804|80197269|FG000|Overall Study|Technical problems|5|||
27549470|NCT03066804|80197270|FG001|Overall Study|Technical problems|1|||
27929428|NCT00790933|81578982|FG001|Overall Study|Lost to Follow-up|31|||
27549471|NCT01654536|80197274|FG000|Overall Study|Lost to Follow-up|5|||
27549472|NCT01654536|80197275|FG001|Overall Study|Lost to Follow-up|5|||
27549473|NCT01654536|80197274|FG000|Overall Study|Physician Decision|12|||
27549474|NCT01654536|80197275|FG001|Overall Study|Physician Decision|8|||
27549475|NCT01654536|80197274|FG000|Overall Study|Withdrawal by Subject|27|||
27549476|NCT01654536|80197275|FG001|Overall Study|Withdrawal by Subject|25|||
27549477|NCT00963937|80197278|FG000|Overall Study|Protocol Violation|1|||
27549478|NCT00963937|80197279|FG001|Overall Study|Protocol Violation|1|||
27549479|NCT00963937|80197280|FG002|Overall Study|Protocol Violation|0|||
27549480|NCT00963937|80197278|FG000|Overall Study|Physician Decision|18|||
27549481|NCT00963937|80197279|FG001|Overall Study|Physician Decision|10|||
27640504|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27742651|NCT01933672|80887000|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27929429|NCT00790933|81578983|FG002|Overall Study|Lost to Follow-up|10|||
27549482|NCT00963937|80197280|FG002|Overall Study|Physician Decision|4|||
27549483|NCT02468232|80197281|FG000|Core Part of Study|Adverse Event|0|||
27549484|NCT02468232|80197282|FG001|Core Part of Study|Adverse Event|1|||
27549485|NCT02468232|80197283|FG002|Core Part of Study|Adverse Event|0|||
27549486|NCT02468232|80197284|FG003|Core Part of Study|Adverse Event|0|||
27549487|NCT02468232|80197281|FG000|Core Part of Study|Death|20|||
27549488|NCT02468232|80197282|FG001|Core Part of Study|Death|17|||
27549489|NCT02468232|80197283|FG002|Core Part of Study|Death|0|||
27549490|NCT02468232|80197284|FG003|Core Part of Study|Death|0|||
27549491|NCT02468232|80197281|FG000|Core Part of Study|Technical Problems|1|||
27549492|NCT02468232|80197282|FG001|Core Part of Study|Technical Problems|1|||
27549493|NCT02468232|80197283|FG002|Core Part of Study|Technical Problems|0|||
27549494|NCT02468232|80197284|FG003|Core Part of Study|Technical Problems|0|||
27549495|NCT02468232|80197281|FG000|OLE Part of Study|Adverse Event|0|||
27549496|NCT02468232|80197282|FG001|OLE Part of Study|Adverse Event|0|||
27549497|NCT02468232|80197283|FG002|OLE Part of Study|Adverse Event|4|||
27549498|NCT02468232|80197284|FG003|OLE Part of Study|Adverse Event|5|||
27549499|NCT02468232|80197281|FG000|OLE Part of Study|Death|0|||
27549500|NCT02468232|80197282|FG001|OLE Part of Study|Death|0|||
27549501|NCT02468232|80197283|FG002|OLE Part of Study|Death|4|||
27549502|NCT02468232|80197284|FG003|OLE Part of Study|Death|2|||
27549503|NCT02468232|80197281|FG000|OLE Part of Study|Physician Decision|0|||
27549504|NCT02468232|80197282|FG001|OLE Part of Study|Physician Decision|0|||
27549505|NCT02468232|80197283|FG002|OLE Part of Study|Physician Decision|4|||
27549506|NCT02468232|80197284|FG003|OLE Part of Study|Physician Decision|0|||
27549507|NCT02468232|80197281|FG000|OLE Part of Study|Subject/Guardian decision|0|||
27549508|NCT02468232|80197282|FG001|OLE Part of Study|Subject/Guardian decision|0|||
27549509|NCT02468232|80197283|FG002|OLE Part of Study|Subject/Guardian decision|2|||
27549510|NCT02468232|80197284|FG003|OLE Part of Study|Subject/Guardian decision|5|||
27549511|NCT00381485|80197285|FG000|Open-Label Run-In Period|Adverse Event|9|||
27549512|NCT00381485|80197286|FG001|Open-Label Run-In Period|Adverse Event|0|||
27549513|NCT00381485|80197287|FG002|Open-Label Run-In Period|Adverse Event|0|||
27549514|NCT00381485|80197288|FG003|Open-Label Run-In Period|Adverse Event|0|||
27549515|NCT00381485|80197285|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
27549516|NCT00381485|80197286|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
27549517|NCT00381485|80197287|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
27549518|NCT00381485|80197288|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
27549519|NCT00381485|80197285|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
27549520|NCT00381485|80197286|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
27549521|NCT00381485|80197287|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
27549522|NCT00381485|80197288|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
27549523|NCT00381485|80197285|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
27549524|NCT00381485|80197286|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
27549525|NCT00381485|80197287|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
27549526|NCT00381485|80197288|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
27549527|NCT00381485|80197285|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
27549528|NCT00381485|80197286|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
27549529|NCT00381485|80197287|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
27549530|NCT00381485|80197288|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
27549531|NCT00381485|80197285|FG000|Open-Label Run-In Period|Treatment failure|1|||
27549532|NCT00381485|80197286|FG001|Open-Label Run-In Period|Treatment failure|0|||
27549533|NCT00381485|80197287|FG002|Open-Label Run-In Period|Treatment failure|0|||
27549534|NCT00381485|80197288|FG003|Open-Label Run-In Period|Treatment failure|0|||
27549535|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27549536|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Adverse Event|2|||
27549537|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Adverse Event|2|||
27549538|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Adverse Event|5|||
27549539|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
27549540|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
27549541|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
27549542|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
27549543|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27549544|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
27549545|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
27549546|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
27549547|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
27640505|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27640506|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27549548|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
27549549|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
27549550|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
27549551|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
27549552|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
27549553|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
27549554|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
27549555|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
27549556|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
27549557|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
27549558|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
27549559|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
27549560|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
27549561|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
27549562|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
27549563|NCT00381485|80197285|FG000|Double-Blind Treatment Period|Administrative|0|||
27549564|NCT00381485|80197286|FG001|Double-Blind Treatment Period|Administrative|1|||
27549565|NCT00381485|80197287|FG002|Double-Blind Treatment Period|Administrative|0|||
27549566|NCT00381485|80197288|FG003|Double-Blind Treatment Period|Administrative|1|||
27549567|NCT01678911|80197291|FG000|Second Intervention|Lost to Follow-up|2|||
27549568|NCT01678911|80197292|FG001|Second Intervention|Lost to Follow-up|0|||
27549569|NCT00963547|80197300|FG000|Overall Study|Adverse Event|0|||
27549570|NCT00963547|80197301|FG001|Overall Study|Adverse Event|1|||
27549571|NCT00963547|80197302|FG002|Overall Study|Adverse Event|0|||
27549572|NCT00963547|80197303|FG003|Overall Study|Adverse Event|1|||
27549573|NCT00963547|80197304|FG004|Overall Study|Adverse Event|0|||
27549574|NCT00963547|80197305|FG005|Overall Study|Adverse Event|0|||
27549575|NCT00963547|80197306|FG006|Overall Study|Adverse Event|0|||
27549576|NCT00963547|80197300|FG000|Overall Study|Physician Decision|1|||
27549577|NCT00963547|80197301|FG001|Overall Study|Physician Decision|1|||
27549578|NCT00963547|80197302|FG002|Overall Study|Physician Decision|0|||
27549579|NCT00963547|80197303|FG003|Overall Study|Physician Decision|0|||
27549580|NCT00963547|80197304|FG004|Overall Study|Physician Decision|0|||
27549581|NCT00963547|80197305|FG005|Overall Study|Physician Decision|0|||
27549582|NCT00963547|80197306|FG006|Overall Study|Physician Decision|0|||
27549583|NCT00963547|80197300|FG000|Overall Study|Progressive Disease|3|||
27549584|NCT00963547|80197301|FG001|Overall Study|Progressive Disease|8|||
27549585|NCT00963547|80197302|FG002|Overall Study|Progressive Disease|9|||
27549586|NCT00963547|80197303|FG003|Overall Study|Progressive Disease|5|||
27549587|NCT00963547|80197304|FG004|Overall Study|Progressive Disease|0|||
27549588|NCT00963547|80197305|FG005|Overall Study|Progressive Disease|0|||
27549589|NCT00963547|80197306|FG006|Overall Study|Progressive Disease|0|||
27549590|NCT00963547|80197300|FG000|Overall Study|Withdrawal by Subject|0|||
27549591|NCT00963547|80197301|FG001|Overall Study|Withdrawal by Subject|0|||
27549592|NCT00963547|80197302|FG002|Overall Study|Withdrawal by Subject|3|||
27549593|NCT00963547|80197303|FG003|Overall Study|Withdrawal by Subject|0|||
27549594|NCT00963547|80197304|FG004|Overall Study|Withdrawal by Subject|0|||
27549595|NCT00963547|80197305|FG005|Overall Study|Withdrawal by Subject|0|||
27549596|NCT00963547|80197306|FG006|Overall Study|Withdrawal by Subject|0|||
27549597|NCT00963547|80197300|FG000|Overall Study|Reason Unknown|0|||
27549598|NCT00963547|80197301|FG001|Overall Study|Reason Unknown|1|||
27549599|NCT00963547|80197302|FG002|Overall Study|Reason Unknown|0|||
27549600|NCT00963547|80197303|FG003|Overall Study|Reason Unknown|0|||
27549601|NCT00963547|80197304|FG004|Overall Study|Reason Unknown|0|||
27549602|NCT00963547|80197305|FG005|Overall Study|Reason Unknown|0|||
27549603|NCT00963547|80197306|FG006|Overall Study|Reason Unknown|0|||
27549604|NCT01473836|80197309|FG000|Overall Study|Adverse Event|4|||
27549605|NCT01473836|80197309|FG000|Overall Study|Lack of Efficacy|1|||
27549606|NCT01473836|80197309|FG000|Overall Study|Does not meet entrance criteria|1|||
27549607|NCT03334903|80197310|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
27549608|NCT03334903|80197311|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
27549609|NCT03334903|80197310|FG000|Overall Study|Protocol Violation|1|||
27549610|NCT03334903|80197311|FG001|Overall Study|Protocol Violation|3|||
27549611|NCT03334903|80197310|FG000|Overall Study|Surgery postponed|1|||
27549612|NCT03334903|80197311|FG001|Overall Study|Surgery postponed|0|||
27549613|NCT03334903|80197310|FG000|Overall Study|Adverse Event|1|||
27549614|NCT03334903|80197311|FG001|Overall Study|Adverse Event|1|||
27549615|NCT03334903|80197310|FG000|Overall Study|Withdrawal by Subject|0|||
27549616|NCT03334903|80197311|FG001|Overall Study|Withdrawal by Subject|1|||
27549617|NCT01537393|80197312|FG000|Overall Study|Exclude prior to study|32|||
27549618|NCT01537393|80197313|FG001|Overall Study|Exclude prior to study|44|||
27549619|NCT01537393|80197312|FG000|Overall Study|Death|20|||
27549620|NCT01537393|80197313|FG001|Overall Study|Death|32|||
27549621|NCT01537393|80197312|FG000|Overall Study|Withdrawal by Subject|18|||
27549622|NCT01537393|80197313|FG001|Overall Study|Withdrawal by Subject|17|||
27549623|NCT01537393|80197312|FG000|Overall Study|Lost to Follow-up|53|||
27549624|NCT01537393|80197313|FG001|Overall Study|Lost to Follow-up|48|||
27549625|NCT01537393|80197312|FG000|Overall Study|Failure - Regrafted|28|||
27549626|NCT01537393|80197313|FG001|Overall Study|Failure - Regrafted|43|||
27929430|NCT00790933|81578984|FG003|Overall Study|Lost to Follow-up|1|||
27549627|NCT01537393|80197312|FG000|Overall Study|Failure - Not regrafted|2|||
27549628|NCT01537393|80197313|FG001|Overall Study|Failure - Not regrafted|6|||
27549629|NCT01537393|80197312|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
27549630|NCT01537393|80197313|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
27549631|NCT04404361|80200121|FG000|Overall Study|Death|12|||
27549632|NCT04404361|80200122|FG001|Overall Study|Death|12|||
27549633|NCT04404361|80200121|FG000|Overall Study|Withdrawal by Subject|13|||
27549634|NCT04404361|80200122|FG001|Overall Study|Withdrawal by Subject|5|||
27549635|NCT04404361|80200121|FG000|Overall Study|Lost to Follow-up|6|||
27549636|NCT04404361|80200122|FG001|Overall Study|Lost to Follow-up|3|||
27549637|NCT04404361|80200121|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
27549638|NCT04404361|80200122|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
27549639|NCT00390468|80200123|FG000|Overall Study|Protocol Violation|2|||
27549640|NCT00390468|80200123|FG000|Overall Study|Lack of Efficacy|1|||
27549641|NCT03064451|80200124|FG000|Overall Study|Lost to Follow-up|1|||
27549642|NCT03064451|80200124|FG000|Overall Study|Mapping Failure|4|||
27549643|NCT03064451|80200124|FG000|Overall Study|Exited prior to procedure|8|||
27549644|NCT03064451|80200124|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
27549645|NCT04160195|80200127|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
27549646|NCT04160195|80200128|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
27549647|NCT00844831|80200132|FG000|Overall Study|Withdrawal by Subject|4|||
27549648|NCT00844831|80200132|FG000|Overall Study|Adverse Event|1|||
27549649|NCT00844831|80200132|FG000|Overall Study|Physician Decision|1|||
27549650|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
27549651|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
27549652|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
27549653|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
27549654|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
27549655|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
27549656|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
27549657|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
27549658|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Patient Request|1|||
27549659|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Patient Request|0|||
27549660|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
27549661|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
27549662|NCT04649060|80200133|FG000|Arm A/Arm B Treatment|Other|1|||
27549663|NCT04649060|80200134|FG001|Arm A/Arm B Treatment|Other|0|||
27549664|NCT04649060|80200133|FG000|Crossover (Arm B)|Adverse Event|0|||
27549665|NCT04649060|80200134|FG001|Crossover (Arm B)|Adverse Event|1|||
27549666|NCT04649060|80200133|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
27549667|NCT04649060|80200134|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
27549668|NCT02216591|80200135|FG000|Overall Study|Lost to Follow-up|0|||
27549669|NCT02216591|80200136|FG001|Overall Study|Lost to Follow-up|1|||
27549670|NCT01336764|80200155|FG000|Overall Study|Withdrawal by Subject|5|||
27549671|NCT01336764|80200156|FG001|Overall Study|Withdrawal by Subject|5|||
27549672|NCT02254486|80200159|FG000|Overall Study|Adverse Event|1|||
27549673|NCT02254486|80200160|FG001|Overall Study|Adverse Event|1|||
27549674|NCT02254486|80200159|FG000|Overall Study|Lack of Efficacy|1|||
27549675|NCT02254486|80200160|FG001|Overall Study|Lack of Efficacy|0|||
27549676|NCT02254486|80200159|FG000|Overall Study|Lost to Follow-up|2|||
27549677|NCT02254486|80200160|FG001|Overall Study|Lost to Follow-up|4|||
27549678|NCT02254486|80200159|FG000|Overall Study|Protocol Violation|1|||
27549679|NCT02254486|80200160|FG001|Overall Study|Protocol Violation|2|||
27549680|NCT02254486|80200159|FG000|Overall Study|Withdrawal by Subject|17|||
27549681|NCT02254486|80200160|FG001|Overall Study|Withdrawal by Subject|15|||
27549682|NCT02254486|80200159|FG000|Overall Study|GFR<60mL/min|16|||
27549683|NCT02254486|80200160|FG001|Overall Study|GFR<60mL/min|21|||
27549684|NCT02254486|80200159|FG000|Overall Study|Various|12|||
27549685|NCT02254486|80200160|FG001|Overall Study|Various|12|||
27549686|NCT00739674|80200164|FG000|Overall Study|Screening failures|19|||
27549687|NCT00739674|80200165|FG001|Overall Study|Screening failures|17|||
27549688|NCT00739674|80200164|FG000|Overall Study|Site 212 removal|19|||
27549689|NCT00739674|80200165|FG001|Overall Study|Site 212 removal|13|||
27549690|NCT00739674|80200164|FG000|Overall Study|No follow-up data|33|||
27929431|NCT00790933|81578985|FG004|Overall Study|Lost to Follow-up|15|||
27549691|NCT00739674|80200165|FG001|Overall Study|No follow-up data|18|||
27549692|NCT00739674|80200164|FG000|Overall Study|Dietician consultation >30 days|1|||
27549693|NCT00739674|80200165|FG001|Overall Study|Dietician consultation >30 days|9|||
27549694|NCT00739674|80200164|FG000|Overall Study|Adverse Event|22|||
27549695|NCT00739674|80200165|FG001|Overall Study|Adverse Event|13|||
27549696|NCT00739674|80200164|FG000|Overall Study|Death|1|||
27549697|NCT00739674|80200165|FG001|Overall Study|Death|0|||
27549698|NCT00739674|80200164|FG000|Overall Study|Lack of Efficacy|1|||
27549699|NCT00739674|80200165|FG001|Overall Study|Lack of Efficacy|0|||
27549700|NCT00739674|80200164|FG000|Overall Study|Lost to Follow-up|52|||
27549701|NCT00739674|80200165|FG001|Overall Study|Lost to Follow-up|30|||
27929432|NCT00790933|81578981|FG000|Overall Study|Reason Not Specified|8|||
27929433|NCT00790933|81578982|FG001|Overall Study|Reason Not Specified|16|||
27929434|NCT00790933|81578983|FG002|Overall Study|Reason Not Specified|4|||
27929435|NCT00790933|81578984|FG003|Overall Study|Reason Not Specified|1|||
27929436|NCT00790933|81578985|FG004|Overall Study|Reason Not Specified|9|||
27929437|NCT01947933|81578988|FG000|Overall Study|Withdrawal by Subject|0|||
27929438|NCT01947933|81578989|FG001|Overall Study|Withdrawal by Subject|0|||
27929439|NCT01947933|81578990|FG002|Overall Study|Withdrawal by Subject|1|||
27929440|NCT01947933|81578991|FG003|Overall Study|Withdrawal by Subject|0|||
27929441|NCT01947933|81578992|FG004|Overall Study|Withdrawal by Subject|0|||
27929442|NCT01947933|81578993|FG005|Overall Study|Withdrawal by Subject|0|||
27929443|NCT01947933|81578994|FG006|Overall Study|Withdrawal by Subject|0|||
27929444|NCT01947933|81578995|FG007|Overall Study|Withdrawal by Subject|0|||
27929445|NCT01947933|81578996|FG008|Overall Study|Withdrawal by Subject|0|||
27929446|NCT01947933|81578988|FG000|Overall Study|Lost to Follow-up|0|||
27549702|NCT00739674|80200164|FG000|Overall Study|Protocol Violation|5|||
27549703|NCT00739674|80200165|FG001|Overall Study|Protocol Violation|5|||
27549704|NCT00739674|80200164|FG000|Overall Study|Withdrawal by Subject|9|||
27549705|NCT00739674|80200165|FG001|Overall Study|Withdrawal by Subject|9|||
27549706|NCT00739674|80200164|FG000|Overall Study|Reason missing|2|||
27549707|NCT00739674|80200165|FG001|Overall Study|Reason missing|0|||
27549708|NCT00739674|80200164|FG000|Overall Study|Clinic closed|6|||
27549709|NCT00739674|80200165|FG001|Overall Study|Clinic closed|4|||
27549710|NCT00739674|80200164|FG000|Overall Study|Patient moved|3|||
27549711|NCT00739674|80200165|FG001|Overall Study|Patient moved|2|||
27549712|NCT00739674|80200164|FG000|Overall Study|Non compliant|4|||
27549713|NCT00739674|80200165|FG001|Overall Study|Non compliant|0|||
27549714|NCT00739674|80200164|FG000|Overall Study|Unable to attend visit|3|||
27549715|NCT00739674|80200165|FG001|Overall Study|Unable to attend visit|1|||
27549716|NCT00739674|80200164|FG000|Overall Study|Home monitoring off meds|1|||
27549717|NCT00739674|80200165|FG001|Overall Study|Home monitoring off meds|0|||
27549718|NCT00739674|80200164|FG000|Overall Study|Erectile dysfunction|0|||
27549719|NCT00739674|80200165|FG001|Overall Study|Erectile dysfunction|1|||
27549720|NCT02927431|80200168|FG000|Overall Study|Withdrawal by Subject|0|||
27549721|NCT02927431|80200169|FG001|Overall Study|Withdrawal by Subject|0|||
27549722|NCT02927431|80200170|FG002|Overall Study|Withdrawal by Subject|1|||
27549723|NCT00056316|80200171|FG000|Overall Study|Withdrawal by Subject|2|||
27549724|NCT00056316|80200172|FG001|Overall Study|Withdrawal by Subject|2|||
27549725|NCT00056316|80200171|FG000|Overall Study|Death/NH placement of pt|1|||
27549726|NCT00056316|80200172|FG001|Overall Study|Death/NH placement of pt|1|||
27549727|NCT00618072|80200177|FG000|Overall Study|Lost to Follow-up|2|||
27549728|NCT00618072|80200178|FG001|Overall Study|Lost to Follow-up|0|||
27549729|NCT00618072|80200179|FG002|Overall Study|Lost to Follow-up|3|||
27549730|NCT00618072|80200177|FG000|Overall Study|Physician Decision|0|||
27549731|NCT00618072|80200178|FG001|Overall Study|Physician Decision|1|||
27549732|NCT00618072|80200179|FG002|Overall Study|Physician Decision|1|||
27549733|NCT04221009|80200180|FG000|Overall Study|Withdrawal by Subject|4|||
27549734|NCT01384760|80200181|FG000|Overall Study|Lost to Follow-up|0|||
27549735|NCT01384760|80200182|FG001|Overall Study|Lost to Follow-up|6|||
27549736|NCT01384760|80200181|FG000|Overall Study|Protocol Violation|16|||
27549737|NCT01384760|80200182|FG001|Overall Study|Protocol Violation|0|||
27549738|NCT02980601|80200183|FG000|Overall Study|Lost to Follow-up|2|||
27549739|NCT02980601|80200184|FG001|Overall Study|Lost to Follow-up|2|||
27549740|NCT02980601|80200183|FG000|Overall Study|Death|0|||
27549741|NCT02980601|80200184|FG001|Overall Study|Death|1|||
27549742|NCT02980601|80200183|FG000|Overall Study|Graft loss|1|||
27549743|NCT02980601|80200184|FG001|Overall Study|Graft loss|0|||
27549744|NCT02980601|80200183|FG000|Overall Study|Failed to sign consent|2|||
27549745|NCT02980601|80200184|FG001|Overall Study|Failed to sign consent|0|||
27549746|NCT02170298|80200186|FG000|Overall Study|Withdrawal by Subject|0|||
27549747|NCT02170298|80200187|FG001|Overall Study|Withdrawal by Subject|1|||
27549748|NCT02170298|80200186|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
27549749|NCT02170298|80200187|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
27549750|NCT03926169|80200189|FG000|Period A|Adverse Event|2|||
27549751|NCT03926169|80200190|FG001|Period A|Adverse Event|2|||
27549752|NCT03926169|80200191|FG002|Period A|Adverse Event|1|||
27549753|NCT03926169|80200189|FG000|Period A|Withdrawal by Subject|2|||
27549754|NCT03926169|80200190|FG001|Period A|Withdrawal by Subject|2|||
27549755|NCT03926169|80200191|FG002|Period A|Withdrawal by Subject|2|||
27549756|NCT03926169|80200189|FG000|Period A|Lost to Follow-up|3|||
27549757|NCT03926169|80200190|FG001|Period A|Lost to Follow-up|1|||
27549758|NCT03926169|80200191|FG002|Period A|Lost to Follow-up|0|||
27549759|NCT03926169|80200189|FG000|Period A|Lack of Efficacy|0|||
27549760|NCT03926169|80200190|FG001|Period A|Lack of Efficacy|2|||
27549761|NCT03926169|80200191|FG002|Period A|Lack of Efficacy|2|||
27549762|NCT03926169|80200189|FG000|Period A|COVID-19 Infection|0|||
27929447|NCT01947933|81578989|FG001|Overall Study|Lost to Follow-up|0|||
27929448|NCT01947933|81578990|FG002|Overall Study|Lost to Follow-up|0|||
27929449|NCT01947933|81578991|FG003|Overall Study|Lost to Follow-up|0|||
27549763|NCT03926169|80200190|FG001|Period A|COVID-19 Infection|1|||
27549764|NCT03926169|80200191|FG002|Period A|COVID-19 Infection|0|||
27549765|NCT03926169|80200189|FG000|Period A|COVID-19 Logistical Restrictions|0|||
27549766|NCT03926169|80200190|FG001|Period A|COVID-19 Logistical Restrictions|2|||
27549767|NCT03926169|80200191|FG002|Period A|COVID-19 Logistical Restrictions|1|||
27929450|NCT01947933|81578992|FG004|Overall Study|Lost to Follow-up|0|||
27929451|NCT01947933|81578993|FG005|Overall Study|Lost to Follow-up|0|||
27929452|NCT01947933|81578994|FG006|Overall Study|Lost to Follow-up|0|||
27929453|NCT01947933|81578995|FG007|Overall Study|Lost to Follow-up|0|||
27929454|NCT01947933|81578996|FG008|Overall Study|Lost to Follow-up|1|||
27929455|NCT02932943|81578998|FG000|Overall Study|Lost to Follow-up|0|||
27929456|NCT02932943|81578999|FG001|Overall Study|Lost to Follow-up|2|||
27742652|NCT01933672|80887001|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
27549768|NCT03926169|80200189|FG000|Period A|Other, Not Specified|1|||
27549769|NCT03926169|80200190|FG001|Period A|Other, Not Specified|0|||
27549770|NCT03926169|80200191|FG002|Period A|Other, Not Specified|0|||
27549771|NCT03926169|80200189|FG000|Period B|Adverse Event|3|||
27549772|NCT03926169|80200190|FG001|Period B|Adverse Event|1|||
27549773|NCT03926169|80200191|FG002|Period B|Adverse Event|1|||
27742653|NCT01933672|80887002|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742654|NCT01933672|80887003|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742655|NCT01933672|80886997|FG000|First Intervention Period (12-16 Days)|Other|0|||
27742656|NCT01933672|80886998|FG001|First Intervention Period (12-16 Days)|Other|0|||
27742657|NCT01933672|80886999|FG002|First Intervention Period (12-16 Days)|Other|1|||
27742658|NCT01933672|80887000|FG003|First Intervention Period (12-16 Days)|Other|0|||
27742659|NCT01933672|80887001|FG004|First Intervention Period (12-16 Days)|Other|0|||
27742660|NCT01933672|80887002|FG005|First Intervention Period (12-16 Days)|Other|1|||
27742661|NCT01933672|80887003|FG006|First Intervention Period (12-16 Days)|Other|0|||
27742662|NCT01933672|80886997|FG000|Second Intervention Period (12-16 Days)|Other|0|||
27742663|NCT01933672|80886998|FG001|Second Intervention Period (12-16 Days)|Other|1|||
27742664|NCT01933672|80886999|FG002|Second Intervention Period (12-16 Days)|Other|1|||
27742665|NCT01933672|80887000|FG003|Second Intervention Period (12-16 Days)|Other|0|||
27742666|NCT01933672|80887001|FG004|Second Intervention Period (12-16 Days)|Other|0|||
27742667|NCT01933672|80887002|FG005|Second Intervention Period (12-16 Days)|Other|0|||
27742668|NCT01933672|80887003|FG006|Second Intervention Period (12-16 Days)|Other|0|||
27742669|NCT01933672|80886997|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742670|NCT01933672|80886998|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742671|NCT01933672|80886999|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742672|NCT01933672|80887000|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
27742673|NCT01933672|80887001|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742674|NCT01933672|80887002|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742675|NCT01933672|80887003|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
27742676|NCT01933672|80886997|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27742677|NCT01933672|80886998|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
27742678|NCT01933672|80886999|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27742679|NCT01933672|80887000|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27742680|NCT01933672|80887001|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27742681|NCT01933672|80887002|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27742682|NCT01933672|80887003|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
27742683|NCT00537823|80887004|FG000|Overall Study|Adverse Event|2|||
27742684|NCT00537823|80887005|FG001|Overall Study|Adverse Event|0|||
27929457|NCT02932943|81578998|FG000|Overall Study|Adverse Event|2|||
27929458|NCT02932943|81578999|FG001|Overall Study|Adverse Event|2|||
27929459|NCT02932943|81578998|FG000|Overall Study|Withdrawal by Subject|3|||
27929460|NCT02932943|81578999|FG001|Overall Study|Withdrawal by Subject|3|||
27929461|NCT01500096|81579000|FG000|Overall Study|Lost to Follow-up|1|||
27929462|NCT01500096|81579001|FG001|Overall Study|Lost to Follow-up|0|||
27929463|NCT01500096|81579002|FG002|Overall Study|Lost to Follow-up|0|||
27929464|NCT01500096|81579003|FG003|Overall Study|Lost to Follow-up|2|||
27929465|NCT04575324|81579004|FG000|Overall Study|Lost to Follow-up|29|||
27549774|NCT03926169|80200189|FG000|Period B|Withdrawal by Subject|1|||
27549775|NCT03926169|80200190|FG001|Period B|Withdrawal by Subject|3|||
27549776|NCT03926169|80200191|FG002|Period B|Withdrawal by Subject|0|||
27549777|NCT03926169|80200189|FG000|Period B|Lack of Efficacy|3|||
27549778|NCT03926169|80200190|FG001|Period B|Lack of Efficacy|1|||
27549779|NCT03926169|80200191|FG002|Period B|Lack of Efficacy|1|||
27549780|NCT03926169|80200189|FG000|Period B|Lost to Follow-up|1|||
27549781|NCT03926169|80200190|FG001|Period B|Lost to Follow-up|1|||
27549782|NCT03926169|80200191|FG002|Period B|Lost to Follow-up|4|||
27742685|NCT03396471|80887006|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
27929466|NCT04575324|81579005|FG001|Overall Study|Lost to Follow-up|25|||
27929467|NCT04575324|81579004|FG000|Overall Study|Death|1|||
27929468|NCT04575324|81579005|FG001|Overall Study|Death|2|||
27929469|NCT04575324|81579004|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
27549783|NCT03926169|80200189|FG000|Period B|Other, Not Specified|62|||
27549784|NCT03926169|80200190|FG001|Period B|Other, Not Specified|57|||
27549785|NCT03926169|80200191|FG002|Period B|Other, Not Specified|65|||
27549786|NCT00897104|80200192|FG000|Overall Study|Lost to Follow-up|12|||
27549787|NCT00897104|80200193|FG001|Overall Study|Lost to Follow-up|17|||
27549788|NCT00897104|80200194|FG002|Overall Study|Lost to Follow-up|2|||
27549789|NCT00897104|80200192|FG000|Overall Study|Pregnancy|0|||
27549790|NCT00897104|80200193|FG001|Overall Study|Pregnancy|1|||
27549791|NCT00897104|80200194|FG002|Overall Study|Pregnancy|0|||
27549792|NCT00897104|80200192|FG000|Overall Study|Protocol Violation|0|||
27549793|NCT00897104|80200193|FG001|Overall Study|Protocol Violation|1|||
27549794|NCT00897104|80200194|FG002|Overall Study|Protocol Violation|0|||
27549795|NCT00897104|80200192|FG000|Overall Study|Withdrawal by Subject|23|||
27549796|NCT00897104|80200193|FG001|Overall Study|Withdrawal by Subject|27|||
27549797|NCT00897104|80200194|FG002|Overall Study|Withdrawal by Subject|3|||
27549798|NCT00897104|80200192|FG000|Overall Study|Abnormal Prestudy Labs|2|||
27549799|NCT00897104|80200193|FG001|Overall Study|Abnormal Prestudy Labs|0|||
27549800|NCT00897104|80200194|FG002|Overall Study|Abnormal Prestudy Labs|0|||
27549801|NCT00897104|80200192|FG000|Overall Study|Abnormal Baseline ECG|2|||
27549802|NCT00897104|80200193|FG001|Overall Study|Abnormal Baseline ECG|2|||
27549803|NCT00897104|80200194|FG002|Overall Study|Abnormal Baseline ECG|0|||
27549804|NCT00897104|80200192|FG000|Overall Study|Need for Concom. Med.|0|||
27549805|NCT00897104|80200193|FG001|Overall Study|Need for Concom. Med.|1|||
27549806|NCT00897104|80200194|FG002|Overall Study|Need for Concom. Med.|1|||
27640507|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27640508|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
27640509|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27640510|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
27640511|NCT03903822|80525894|FG000|Follow up Phase (4 Weeks)|Other|1|||
27640512|NCT03903822|80525895|FG001|Follow up Phase (4 Weeks)|Other|1|||
27640513|NCT03903822|80525896|FG002|Follow up Phase (4 Weeks)|Other|0|||
27640514|NCT03903822|80525897|FG003|Follow up Phase (4 Weeks)|Other|0|||
27640515|NCT03903822|80525898|FG004|Follow up Phase (4 Weeks)|Other|0|||
27640516|NCT03903822|80525899|FG005|Follow up Phase (4 Weeks)|Other|0|||
27640517|NCT03903822|80525900|FG006|Follow up Phase (4 Weeks)|Other|0|||
27640518|NCT03903822|80525901|FG007|Follow up Phase (4 Weeks)|Other|0|||
27640519|NCT01185561|80525902|FG000|Overall Study|Lost to Follow-up|0|||
27640520|NCT01185561|80525903|FG001|Overall Study|Lost to Follow-up|4|||
27640521|NCT01185561|80525902|FG000|Overall Study|Withdrawal by Subject|2|||
27640522|NCT01185561|80525903|FG001|Overall Study|Withdrawal by Subject|8|||
27640523|NCT02374307|80525904|FG000|3-months Follow-up|Lost to Follow-up|1|||
27640524|NCT02374307|80525905|FG001|3-months Follow-up|Lost to Follow-up|2|||
27640525|NCT02374307|80525904|FG000|3-months Follow-up|Withdrawal by Subject|1|||
27640526|NCT02374307|80525905|FG001|3-months Follow-up|Withdrawal by Subject|4|||
27640527|NCT02374307|80525904|FG000|3-months Follow-up|Death|1|||
27640528|NCT02374307|80525905|FG001|3-months Follow-up|Death|2|||
27640529|NCT02374307|80525904|FG000|3-months Follow-up|Missed first follow-up|5|||
27640530|NCT02374307|80525905|FG001|3-months Follow-up|Missed first follow-up|1|||
27640531|NCT02374307|80525904|FG000|6-months Follow-up|Lost to Follow-up|1|||
27640532|NCT02374307|80525905|FG001|6-months Follow-up|Lost to Follow-up|2|||
27640533|NCT02374307|80525904|FG000|6-months Follow-up|Death|2|||
27640534|NCT02374307|80525905|FG001|6-months Follow-up|Death|1|||
27640535|NCT02374307|80525904|FG000|6-months Follow-up|Withdrawal by Subject|0|||
27640536|NCT02374307|80525905|FG001|6-months Follow-up|Withdrawal by Subject|3|||
27640537|NCT04048382|80525910|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
27640538|NCT04048382|80525911|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
27640539|NCT04048382|80525910|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
27640540|NCT04048382|80525911|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
27640541|NCT04048382|80525910|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
27640542|NCT04048382|80525911|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
27640543|NCT03664960|80525914|FG000|Overall Study|Adverse Event|0|||
27640544|NCT03664960|80525915|FG001|Overall Study|Adverse Event|3|||
27640545|NCT03664960|80525914|FG000|Overall Study|Lost to Follow-up|3|||
27640546|NCT03664960|80525915|FG001|Overall Study|Lost to Follow-up|2|||
27640547|NCT03664960|80525914|FG000|Overall Study|Physician Decision|1|||
27640548|NCT03664960|80525915|FG001|Overall Study|Physician Decision|0|||
27640549|NCT03664960|80525914|FG000|Overall Study|Withdrawal by Subject|3|||
27549807|NCT00897104|80200192|FG000|Overall Study|Lack of Migraine Attack|20|||
27549808|NCT00897104|80200193|FG001|Overall Study|Lack of Migraine Attack|22|||
27549809|NCT00897104|80200194|FG002|Overall Study|Lack of Migraine Attack|1|||
27549810|NCT00897104|80200192|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
27549811|NCT00897104|80200193|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27549812|NCT00897104|80200194|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
27640550|NCT03664960|80525915|FG001|Overall Study|Withdrawal by Subject|14|||
27640551|NCT03664960|80525914|FG000|Overall Study|Sponsor Decision|1|||
27640552|NCT03664960|80525915|FG001|Overall Study|Sponsor Decision|1|||
27640553|NCT03664960|80525914|FG000|Overall Study|Other|1|||
27640554|NCT03664960|80525915|FG001|Overall Study|Other|2|||
27640555|NCT01254188|80525922|FG000|Overall Study|Disease Progression|6|||
27640556|NCT01254188|80525922|FG000|Overall Study|Protocol Violation|6|||
27640557|NCT01254188|80525922|FG000|Overall Study|Pregnancy|2|||
27929470|NCT04575324|81579005|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
27929471|NCT04167462|81579006|FG000|Overall Study|Other reasons|3|||
27929472|NCT04167462|81579007|FG001|Overall Study|Other reasons|2|||
27929473|NCT04167462|81579006|FG000|Overall Study|Withdrawal by Subject|6|||
27929474|NCT04167462|81579007|FG001|Overall Study|Withdrawal by Subject|7|||
27929475|NCT04167462|81579006|FG000|Overall Study|Adverse Event|4|||
27929476|NCT04167462|81579007|FG001|Overall Study|Adverse Event|0|||
27929477|NCT04167462|81579006|FG000|Overall Study|Pregnancy|1|||
27929478|NCT04167462|81579007|FG001|Overall Study|Pregnancy|0|||
27929479|NCT04167462|81579006|FG000|Overall Study|Lack of Efficacy|0|||
27929480|NCT04167462|81579007|FG001|Overall Study|Lack of Efficacy|1|||
27929481|NCT03301714|81579008|FG000|Overall Study|Lost to Follow-up|10|||
27929482|NCT03301714|81579009|FG001|Overall Study|Lost to Follow-up|4|||
27929483|NCT03301714|81579010|FG002|Overall Study|Lost to Follow-up|4|||
27929484|NCT03301714|81579008|FG000|Overall Study|Did not receive allocated intervention|0|||
27929485|NCT03301714|81579009|FG001|Overall Study|Did not receive allocated intervention|2|||
27929486|NCT03301714|81579010|FG002|Overall Study|Did not receive allocated intervention|3|||
27929487|NCT02316613|81579012|FG000|Overall Study|Death|63|||
27929488|NCT02316613|81579012|FG000|Overall Study|Lost to Follow-up|9|||
27929489|NCT02316613|81579012|FG000|Overall Study|Lymphoma transformation|2|||
27929490|NCT02316613|81579012|FG000|Overall Study|Participant moved/changed medical team|11|||
27929491|NCT02316613|81579012|FG000|Overall Study|No data and duplicate cases|5|||
27929492|NCT02316613|81579012|FG000|Overall Study|Did not met selection criteria|14|||
27929493|NCT05177094|81579013|FG000|Overall Study|Adverse Event|5|||
27929494|NCT05177094|81579014|FG001|Overall Study|Adverse Event|5|||
27929495|NCT05177094|81579013|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
27929496|NCT05177094|81579014|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
27929497|NCT05177094|81579013|FG000|Overall Study|Protocol Deviation|3|||
27929498|NCT05177094|81579014|FG001|Overall Study|Protocol Deviation|0|||
27929499|NCT05177094|81579013|FG000|Overall Study|Withdrawal by Subject|6|||
27929500|NCT05177094|81579014|FG001|Overall Study|Withdrawal by Subject|3|||
27929501|NCT05177094|81579013|FG000|Overall Study|Participant could not tolerate long study visits|1|||
27929502|NCT05177094|81579014|FG001|Overall Study|Participant could not tolerate long study visits|0|||
27929503|NCT03387046|81579028|FG000|Overall Study|Adverse Event|1|||
27929504|NCT03387046|81579029|FG001|Overall Study|Adverse Event|1|||
27929505|NCT01800058|81579030|FG000|Overall Study|Lost to Follow-up|1|||
27929506|NCT00313170|81579031|FG000|Overall Study|Death|2|||
27929507|NCT00313170|81579032|FG001|Overall Study|Death|4|||
27929508|NCT00313170|81579033|FG002|Overall Study|Death|2|||
27929509|NCT00313170|81579031|FG000|Overall Study|Adverse Event|1|||
27929510|NCT00313170|81579032|FG001|Overall Study|Adverse Event|2|||
27929511|NCT00313170|81579033|FG002|Overall Study|Adverse Event|0|||
27929512|NCT00313170|81579031|FG000|Overall Study|Disease progression|31|||
27929513|NCT00313170|81579032|FG001|Overall Study|Disease progression|26|||
27929514|NCT00313170|81579033|FG002|Overall Study|Disease progression|27|||
27929515|NCT00313170|81579031|FG000|Overall Study|Withdrawal by Subject|1|||
27929516|NCT00313170|81579032|FG001|Overall Study|Withdrawal by Subject|0|||
27929517|NCT00313170|81579033|FG002|Overall Study|Withdrawal by Subject|1|||
27929518|NCT00313170|81579031|FG000|Overall Study|Incorrect enrollment|0|||
27929519|NCT00313170|81579032|FG001|Overall Study|Incorrect enrollment|2|||
27929520|NCT00313170|81579033|FG002|Overall Study|Incorrect enrollment|1|||
27929521|NCT00313170|81579031|FG000|Overall Study|Lost to Follow-up|0|||
27929522|NCT00313170|81579032|FG001|Overall Study|Lost to Follow-up|0|||
27929523|NCT00313170|81579033|FG002|Overall Study|Lost to Follow-up|1|||
27929524|NCT00313170|81579031|FG000|Overall Study|Progression (investigators opinion)|1|||
27929525|NCT00313170|81579032|FG001|Overall Study|Progression (investigators opinion)|0|||
27929526|NCT00313170|81579033|FG002|Overall Study|Progression (investigators opinion)|0|||
27929527|NCT00976898|81579035|FG000|Overall Study|Protocol Violation|1|||
27929528|NCT00976898|81579035|FG000|Overall Study|Adverse Event|1|||
27929529|NCT00976898|81579035|FG000|Overall Study|Physician Decision|1|||
27929530|NCT00976898|81579035|FG000|Overall Study|Liver Transplant|1|||
27929531|NCT00976898|81579035|FG000|Overall Study|Progressive Disease|1|||
27929532|NCT00992836|81579038|FG000|Overall Study|Lost to Follow-up|1|||
27929533|NCT00992836|81579038|FG000|Overall Study|Withdrawal by Subject|2|||
27929534|NCT00992836|81579038|FG000|Overall Study|Protocol Violation|2|||
27929535|NCT00081458|81579039|FG000|Overall Study|Adverse Event|1|||
27929536|NCT00081458|81579040|FG001|Overall Study|Adverse Event|5|||
27640558|NCT01254188|80525922|FG000|Overall Study|Death|4|||
27640559|NCT01254188|80525922|FG000|Overall Study|Lost to Follow-up|5|||
27929537|NCT00081458|81579041|FG002|Overall Study|Adverse Event|2|||
27929538|NCT00081458|81579039|FG000|Overall Study|Withdrawal by Subject|0|||
27929539|NCT00081458|81579040|FG001|Overall Study|Withdrawal by Subject|3|||
27929540|NCT00081458|81579041|FG002|Overall Study|Withdrawal by Subject|1|||
27640560|NCT01254188|80525922|FG000|Overall Study|Withdrawal by Subject|7|||
27640561|NCT01254188|80525922|FG000|Overall Study|Adverse Event|43|||
27640562|NCT01254188|80525922|FG000|Overall Study|per investigator discretion|20|||
27640563|NCT03764475|80525923|FG000|Overall Study|Adverse Event|11|||
27640564|NCT03764475|80525924|FG001|Overall Study|Adverse Event|2|||
27640565|NCT03764475|80525923|FG000|Overall Study|Lost to Follow-up|24|||
27640566|NCT03764475|80525924|FG001|Overall Study|Lost to Follow-up|10|||
27929541|NCT00081458|81579039|FG000|Overall Study|Randomized but not dosed|0|||
27929542|NCT00081458|81579040|FG001|Overall Study|Randomized but not dosed|0|||
27929543|NCT00081458|81579041|FG002|Overall Study|Randomized but not dosed|1|||
27929544|NCT02405962|81579042|FG000|Overall Study|Lost to Follow-up|1|||
27929545|NCT02405962|81579043|FG001|Overall Study|Lost to Follow-up|4|||
27929546|NCT02405962|81579042|FG000|Overall Study|A participant has moved to another place|0|||
27929547|NCT02405962|81579043|FG001|Overall Study|A participant has moved to another place|1|||
27929548|NCT00933933|81579044|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
27929549|NCT00933933|81579045|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
27929550|NCT00933933|81579046|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
27929551|NCT00933933|81579044|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
27929552|NCT00933933|81579045|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
27929553|NCT00933933|81579046|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
27929554|NCT00876343|81579047|FG000|Overall Study|Adverse Event|7|||
27929555|NCT00876343|81579048|FG001|Overall Study|Adverse Event|8|||
27929556|NCT00876343|81579049|FG002|Overall Study|Adverse Event|2|||
27929557|NCT00876343|81579047|FG000|Overall Study|Withdrawal by Subject|4|||
27929558|NCT00876343|81579048|FG001|Overall Study|Withdrawal by Subject|4|||
27929559|NCT00876343|81579049|FG002|Overall Study|Withdrawal by Subject|3|||
27929560|NCT00876343|81579047|FG000|Overall Study|Lack of Efficacy|0|||
27929561|NCT00876343|81579048|FG001|Overall Study|Lack of Efficacy|0|||
27929562|NCT00876343|81579049|FG002|Overall Study|Lack of Efficacy|1|||
27929563|NCT00876343|81579047|FG000|Overall Study|Protocol Violation|4|||
27929564|NCT00876343|81579048|FG001|Overall Study|Protocol Violation|1|||
27929565|NCT00876343|81579049|FG002|Overall Study|Protocol Violation|1|||
27929566|NCT00876343|81579047|FG000|Overall Study|Physician Decision|0|||
27929567|NCT00876343|81579048|FG001|Overall Study|Physician Decision|1|||
27929568|NCT00876343|81579049|FG002|Overall Study|Physician Decision|1|||
27929569|NCT00876343|81579047|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
27929570|NCT00876343|81579048|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
27929571|NCT00876343|81579049|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
27929572|NCT00876343|81579047|FG000|Overall Study|Change of residence or other commitments|2|||
27929573|NCT00876343|81579048|FG001|Overall Study|Change of residence or other commitments|2|||
27929574|NCT00876343|81579049|FG002|Overall Study|Change of residence or other commitments|3|||
27929575|NCT02378181|81579050|FG000|Overall Study|Lost to Follow-up|2|||
27929576|NCT02378181|81579051|FG001|Overall Study|Lost to Follow-up|5|||
27929577|NCT02378181|81579050|FG000|Overall Study|Withdrawal by Subject|1|||
27929578|NCT02378181|81579051|FG001|Overall Study|Withdrawal by Subject|1|||
27929579|NCT02378181|81579050|FG000|Overall Study|Incarcerated|0|||
27929580|NCT02378181|81579051|FG001|Overall Study|Incarcerated|1|||
27549813|NCT00897104|80200192|FG000|Overall Study|Other|3|||
27549814|NCT00897104|80200193|FG001|Overall Study|Other|0|||
27549815|NCT00897104|80200194|FG002|Overall Study|Other|0|||
27549816|NCT00897104|80200192|FG000|Overall Study|Protocol Violation|1|||
27549817|NCT00897104|80200193|FG001|Overall Study|Protocol Violation|0|||
27549818|NCT00897104|80200194|FG002|Overall Study|Protocol Violation|0|||
27549819|NCT00897104|80200192|FG000|Overall Study|Withdrawal by Subject|0|||
27549820|NCT00897104|80200193|FG001|Overall Study|Withdrawal by Subject|0|||
27549821|NCT00897104|80200194|FG002|Overall Study|Withdrawal by Subject|1|||
27549822|NCT04212650|80200195|FG000|Overall Study|Withdrawal by Subject|1|||
27549823|NCT04212650|80200196|FG001|Overall Study|Withdrawal by Subject|0|||
27549824|NCT03761277|80200202|FG000|Enrollment to Implant|Screen Failure|17|||
27549825|NCT03761277|80200202|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
27549826|NCT03761277|80200202|FG000|Enrollment to Implant|Physician Decision|2|||
27549827|NCT03761277|80200202|FG000|Enrollment to Implant|Site Closure|3|||
27549828|NCT03761277|80200202|FG000|Enrollment to Implant|Sponsor Request|2|||
27549829|NCT03761277|80200202|FG000|Post-Implant to 6 Months|Adverse Event|2|||
27549830|NCT03761277|80200202|FG000|Post-Implant to 6 Months|Death|1|||
27549831|NCT03761277|80200202|FG000|Post-Implant to 6 Months|Site Closure|2|||
27549832|NCT03761277|80200202|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
27549833|NCT03761277|80200202|FG000|6 Months to 12 Months|Physician Decision|2|||
27549834|NCT03761277|80200202|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
27549835|NCT02088047|80200207|FG000|Overall Study|Withdrawal by Subject|1|||
27549836|NCT02088047|80200208|FG001|Overall Study|Withdrawal by Subject|0|||
27549837|NCT00357968|80200209|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
27549838|NCT00357968|80200210|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
27640567|NCT03764475|80525923|FG000|Overall Study|Withdrawal by Subject|26|||
27640568|NCT03764475|80525924|FG001|Overall Study|Withdrawal by Subject|10|||
27929581|NCT01044498|81579057|FG000|Overall Study|Withdrew consent|1|||
27929582|NCT01044498|81579058|FG001|Overall Study|Withdrew consent|1|||
27929583|NCT01044498|81579057|FG000|Overall Study|Adverse Event|1|||
27929584|NCT01044498|81579058|FG001|Overall Study|Adverse Event|1|||
27929585|NCT01044498|81579057|FG000|Overall Study|Other|1|||
27929586|NCT01044498|81579058|FG001|Overall Study|Other|0|||
27929587|NCT03770455|81579063|FG000|Overall Study|Screen failures|3|||
27929588|NCT02447029|81579064|FG000|Overall Study|Withdrawal by Subject|3|||
27929589|NCT02447029|81579065|FG001|Overall Study|Withdrawal by Subject|2|||
27929590|NCT00954538|81579068|FG000|Part III|Withdrawal by Subject|0|||
27929591|NCT00954538|81579069|FG001|Part III|Withdrawal by Subject|0|||
27929592|NCT00954538|81579070|FG002|Part III|Withdrawal by Subject|0|||
27929593|NCT00954538|81579071|FG003|Part III|Withdrawal by Subject|0|||
27929594|NCT00954538|81579072|FG004|Part III|Withdrawal by Subject|1|||
27929595|NCT00954538|81579073|FG005|Part III|Withdrawal by Subject|0|||
27929596|NCT01625182|81579074|FG000|Overall Study|Administrative problems|1|||
27549839|NCT00357968|80200209|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
27549840|NCT00357968|80200210|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
27549841|NCT00439244|80200211|FG000|Overall Study|Adverse Event|5|||
27549842|NCT00439244|80200212|FG001|Overall Study|Adverse Event|2|||
27549843|NCT00439244|80200213|FG002|Overall Study|Adverse Event|3|||
27640569|NCT03764475|80525923|FG000|Overall Study|Lack of Efficacy|3|||
27929597|NCT01625182|81579075|FG001|Overall Study|Administrative problems|0|||
27549844|NCT00439244|80200211|FG000|Overall Study|Withdrawal by Subject|3|||
27549845|NCT00439244|80200212|FG001|Overall Study|Withdrawal by Subject|1|||
27549846|NCT00439244|80200213|FG002|Overall Study|Withdrawal by Subject|2|||
27549847|NCT00439244|80200211|FG000|Overall Study|Lost to Follow-up|2|||
27549848|NCT00439244|80200212|FG001|Overall Study|Lost to Follow-up|1|||
27549849|NCT00439244|80200213|FG002|Overall Study|Lost to Follow-up|2|||
27549850|NCT00439244|80200211|FG000|Overall Study|Death|0|||
27549851|NCT00439244|80200212|FG001|Overall Study|Death|1|||
27549852|NCT00439244|80200213|FG002|Overall Study|Death|0|||
27549853|NCT00439244|80200211|FG000|Overall Study|Protocol Violation|0|||
27549854|NCT00439244|80200212|FG001|Overall Study|Protocol Violation|1|||
27549855|NCT00439244|80200213|FG002|Overall Study|Protocol Violation|0|||
27549856|NCT00439244|80200211|FG000|Overall Study|Administrative problems|1|||
27549857|NCT00439244|80200212|FG001|Overall Study|Administrative problems|0|||
27549858|NCT00439244|80200213|FG002|Overall Study|Administrative problems|0|||
27549859|NCT00787891|80200214|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
27549860|NCT00787891|80200215|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
27549861|NCT00787891|80200214|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
27549862|NCT00787891|80200215|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
27549863|NCT00787891|80200214|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
27549864|NCT00787891|80200215|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
27549865|NCT00787891|80200214|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
27549866|NCT00787891|80200215|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
27549867|NCT00787891|80200214|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
27549868|NCT00787891|80200215|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
27549869|NCT00787891|80200214|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
27549870|NCT00787891|80200215|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
27549871|NCT00787891|80200214|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
27549872|NCT00787891|80200215|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
27549873|NCT00787891|80200214|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
27549874|NCT00787891|80200215|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
27549875|NCT00787891|80200214|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
27549876|NCT00787891|80200215|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
27549877|NCT00787891|80200214|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
27549878|NCT00787891|80200215|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
27549879|NCT00003499|80200220|FG000|Overall Study|Not evaluable|8|||
27640570|NCT03764475|80525924|FG001|Overall Study|Lack of Efficacy|0|||
27929598|NCT01625182|81579074|FG000|Overall Study|Protocol deviation|0|||
27929599|NCT01625182|81579075|FG001|Overall Study|Protocol deviation|2|||
27929600|NCT01625182|81579074|FG000|Overall Study|Adverse Event|2|||
27929601|NCT01625182|81579075|FG001|Overall Study|Adverse Event|0|||
27549880|NCT03032705|80200221|FG000|Overall Study|Lost to Follow-up|16|||
27549881|NCT03032705|80200222|FG001|Overall Study|Lost to Follow-up|17|||
27549882|NCT03032705|80200221|FG000|Overall Study|did not quality|6|||
27549883|NCT03032705|80200222|FG001|Overall Study|did not quality|6|||
27549884|NCT02550106|80200223|FG000|Overall Study|Adverse Event|1|||
27549885|NCT02550106|80200223|FG000|Overall Study|Lack of Efficacy|3|||
27929602|NCT01625182|81579074|FG000|Overall Study|Withdrawal by Subject|5|||
27929603|NCT01625182|81579075|FG001|Overall Study|Withdrawal by Subject|1|||
27929604|NCT01625182|81579074|FG000|Overall Study|Lack of Efficacy|12|||
27929605|NCT01625182|81579075|FG001|Overall Study|Lack of Efficacy|8|||
27929606|NCT04398134|81579076|FG000|Overall Study|Adverse Event|0|||
27929607|NCT04398134|81579077|FG001|Overall Study|Adverse Event|0|||
27929608|NCT04398134|81579078|FG002|Overall Study|Adverse Event|1|||
27929609|NCT04398134|81579079|FG003|Overall Study|Adverse Event|0|||
27929610|NCT04398134|81579076|FG000|Overall Study|Withdrawal by Subject|2|||
27929611|NCT04398134|81579077|FG001|Overall Study|Withdrawal by Subject|0|||
27929612|NCT04398134|81579078|FG002|Overall Study|Withdrawal by Subject|0|||
27929613|NCT04398134|81579079|FG003|Overall Study|Withdrawal by Subject|1|||
27929614|NCT04398134|81579076|FG000|Overall Study|Study Terminated by Sponsor|30|||
27929615|NCT04398134|81579077|FG001|Overall Study|Study Terminated by Sponsor|11|||
27929616|NCT04398134|81579078|FG002|Overall Study|Study Terminated by Sponsor|32|||
27929617|NCT04398134|81579079|FG003|Overall Study|Study Terminated by Sponsor|11|||
27929618|NCT03339453|81579085|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
27929619|NCT03339453|81579086|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
27929620|NCT03188705|81579088|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
27929621|NCT03188705|81579088|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
27929622|NCT03259308|81579089|FG000|Overall Study|Adverse Event|5|||
27929623|NCT03259308|81579090|FG001|Overall Study|Adverse Event|4|||
27929624|NCT03259308|81579091|FG002|Overall Study|Adverse Event|1|||
27929625|NCT03259308|81579089|FG000|Overall Study|Withdrawal by Subject|2|||
27929626|NCT03259308|81579090|FG001|Overall Study|Withdrawal by Subject|1|||
27929627|NCT03259308|81579091|FG002|Overall Study|Withdrawal by Subject|3|||
27929628|NCT03259308|81579089|FG000|Overall Study|Lost to Follow-up|0|||
27929629|NCT03259308|81579090|FG001|Overall Study|Lost to Follow-up|0|||
27929630|NCT03259308|81579091|FG002|Overall Study|Lost to Follow-up|1|||
27929631|NCT03259308|81579089|FG000|Overall Study|Pregnancy|0|||
27929632|NCT03259308|81579090|FG001|Overall Study|Pregnancy|0|||
27929633|NCT03259308|81579091|FG002|Overall Study|Pregnancy|1|||
27929634|NCT03259308|81579089|FG000|Overall Study|Protocol Deviation|0|||
27929635|NCT03259308|81579090|FG001|Overall Study|Protocol Deviation|3|||
27929636|NCT03259308|81579091|FG002|Overall Study|Protocol Deviation|0|||
27929637|NCT03259308|81579089|FG000|Overall Study|Lack of Efficacy|0|||
27929638|NCT03259308|81579090|FG001|Overall Study|Lack of Efficacy|0|||
27929639|NCT03259308|81579091|FG002|Overall Study|Lack of Efficacy|1|||
27929640|NCT01967277|81579092|FG000|Overall Study|Lost to Follow-up|1|||
27929641|NCT01967277|81579093|FG001|Overall Study|Lost to Follow-up|2|||
27929642|NCT01967277|81579092|FG000|Overall Study|Unrelated illness|0|||
27929643|NCT01967277|81579093|FG001|Overall Study|Unrelated illness|1|||
27929644|NCT02737618|81579094|FG000|Overall Study|Withdrawal by Subject|9|||
27929645|NCT00141921|81579098|FG000|Overall Study|Remain on Study|28|||
27929646|NCT00141921|81579098|FG000|Overall Study|Withdrawal by Subject|42|||
27929647|NCT00141921|81579098|FG000|Overall Study|Lost to Follow-up|19|||
27929648|NCT00141921|81579098|FG000|Overall Study|Noncompliance|17|||
27929649|NCT00141921|81579098|FG000|Overall Study|Disease Progression|7|||
27929650|NCT00141921|81579098|FG000|Overall Study|Protocol Deviation|7|||
27929651|NCT00141921|81579098|FG000|Overall Study|Adverse Event|5|||
27929652|NCT00141921|81579098|FG000|Overall Study|Administrative Decision|2|||
27929653|NCT00141921|81579098|FG000|Overall Study|Pregnancy|4|||
27929654|NCT00141921|81579098|FG000|Overall Study|Ineligibility Determined|2|||
27929655|NCT00141921|81579098|FG000|Overall Study|Other|8|||
27929656|NCT03720847|81579099|FG000|Washout|Physician Decision|1|||
27929657|NCT03720847|81579100|FG001|Washout|Physician Decision|2|||
27929658|NCT00191100|81579101|FG000|Overall Study|Adverse Event|18|||
27929659|NCT00191100|81579102|FG001|Overall Study|Adverse Event|1|||
27929660|NCT00191100|81579101|FG000|Overall Study|Lost to Follow-up|2|||
27929661|NCT00191100|81579102|FG001|Overall Study|Lost to Follow-up|0|||
27929662|NCT00191100|81579101|FG000|Overall Study|Patient Moved|0|||
27929663|NCT00191100|81579102|FG001|Overall Study|Patient Moved|1|||
27929664|NCT00191100|81579101|FG000|Overall Study|Withdrawal by Subject|9|||
27929665|NCT00191100|81579102|FG001|Overall Study|Withdrawal by Subject|3|||
27929666|NCT00191100|81579101|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
27929667|NCT00191100|81579102|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
27929668|NCT00191100|81579101|FG000|Overall Study|Clinical Relapse|2|||
27929669|NCT00191100|81579102|FG001|Overall Study|Clinical Relapse|1|||
27929670|NCT00191100|81579101|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
27929671|NCT00191100|81579102|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
27929672|NCT00191100|81579101|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
27929673|NCT00191100|81579102|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
27929674|NCT00191100|81579101|FG000|Overall Study|Physician Decision|3|||
27929675|NCT00191100|81579102|FG001|Overall Study|Physician Decision|1|||
27929676|NCT00191100|81579101|FG000|Overall Study|Death from Study Drug Toxicity|2|||
27929677|NCT00191100|81579102|FG001|Overall Study|Death from Study Drug Toxicity|0|||
27929678|NCT00191100|81579101|FG000|Overall Study|Protocol Violation|1|||
27929679|NCT00191100|81579102|FG001|Overall Study|Protocol Violation|1|||
27929680|NCT00191100|81579101|FG000|Overall Study|Death from Other Cause|1|||
27929681|NCT00191100|81579102|FG001|Overall Study|Death from Other Cause|0|||
27929682|NCT00191100|81579101|FG000|Overall Study|Reason Not Specified|0|||
27929683|NCT00191100|81579102|FG001|Overall Study|Reason Not Specified|1|||
27640571|NCT03764475|80525923|FG000|Overall Study|COVID-19 Disruption|2|||
27640572|NCT03764475|80525924|FG001|Overall Study|COVID-19 Disruption|0|||
27640573|NCT02407249|80525927|FG000|Overall Study|Did not complete 12-month follow-up|13|||
27640574|NCT02407249|80525927|FG000|Overall Study|Not treated|13|||
27640575|NCT03481816|80525932|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
27640576|NCT03481816|80525933|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
27640577|NCT03481816|80525932|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
27640578|NCT03481816|80525933|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
27640579|NCT03481816|80525932|FG000|Dose Expansion|Withdrawal by Subject|0|||
27640580|NCT03481816|80525933|FG001|Dose Expansion|Withdrawal by Subject|2|||
27640581|NCT03481816|80525932|FG000|Dose Expansion|Physician Decision|0|||
27640582|NCT03481816|80525933|FG001|Dose Expansion|Physician Decision|5|||
27640583|NCT00546754|80525934|FG000|Overall Study|Serious Adverse Event|1|||
27640584|NCT00546754|80525935|FG001|Overall Study|Serious Adverse Event|1|||
27640585|NCT00546754|80525934|FG000|Overall Study|Adverse Event|11|||
27640586|NCT00546754|80525935|FG001|Overall Study|Adverse Event|16|||
27640587|NCT00546754|80525934|FG000|Overall Study|Lack of Efficacy|1|||
27640588|NCT00546754|80525935|FG001|Overall Study|Lack of Efficacy|1|||
27640589|NCT00546754|80525934|FG000|Overall Study|Lost to Follow-up|9|||
27640590|NCT00546754|80525935|FG001|Overall Study|Lost to Follow-up|15|||
27640591|NCT00546754|80525934|FG000|Overall Study|Protocol Violation|3|||
27640592|NCT00546754|80525935|FG001|Overall Study|Protocol Violation|0|||
27640593|NCT00546754|80525934|FG000|Overall Study|Withdrawal by Subject|6|||
27640594|NCT00546754|80525935|FG001|Overall Study|Withdrawal by Subject|7|||
27640595|NCT00546754|80525934|FG000|Overall Study|Dyspnea|1|||
27640596|NCT00546754|80525935|FG001|Overall Study|Dyspnea|0|||
27640597|NCT00546754|80525934|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
27640598|NCT00546754|80525935|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
27640599|NCT00546754|80525934|FG000|Overall Study|Hip Replacement|1|||
27640600|NCT00546754|80525935|FG001|Overall Study|Hip Replacement|0|||
27640601|NCT00546754|80525934|FG000|Overall Study|Suicide|1|||
27640602|NCT00546754|80525935|FG001|Overall Study|Suicide|0|||
27640603|NCT00546754|80525934|FG000|Overall Study|Missing Cooperation|1|||
27640604|NCT00546754|80525935|FG001|Overall Study|Missing Cooperation|0|||
27640605|NCT00546754|80525934|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
27640606|NCT00546754|80525935|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
27640607|NCT00546754|80525934|FG000|Overall Study|Patient's Decision|0|||
27640608|NCT00546754|80525935|FG001|Overall Study|Patient's Decision|1|||
27640609|NCT00546754|80525934|FG000|Overall Study|Missing|14|||
27640610|NCT00546754|80525935|FG001|Overall Study|Missing|7|||
27640611|NCT00858117|80525939|FG000|Treatment on Study|Adverse Event|2|||
27640612|NCT00858117|80525939|FG000|Follow up for 5 Years|Death|4|||
27640613|NCT00858117|80525939|FG000|Follow up for 5 Years|No further data collected for study|9|||
27640614|NCT01421667|80525940|FG000|Overall Study|Withdrawal by Subject|0|||
27640615|NCT01421667|80525941|FG001|Overall Study|Withdrawal by Subject|1|||
27640616|NCT01421667|80525942|FG002|Overall Study|Withdrawal by Subject|2|||
27640617|NCT01421667|80525943|FG003|Overall Study|Withdrawal by Subject|1|||
27640618|NCT01421667|80525940|FG000|Overall Study|Lost to Follow-up|0|||
27640619|NCT01421667|80525941|FG001|Overall Study|Lost to Follow-up|1|||
27640620|NCT01421667|80525942|FG002|Overall Study|Lost to Follow-up|0|||
27640621|NCT01421667|80525943|FG003|Overall Study|Lost to Follow-up|0|||
27742686|NCT03396471|80887006|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
27742687|NCT03396471|80887006|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
27742688|NCT03396471|80887006|FG000|Study Treatment - Up to 22 Months|Death|2|||
27742689|NCT03396471|80887006|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
27742690|NCT03396471|80887006|FG000|Follow up - Up to 2 Years|Death|9|||
27742691|NCT03396471|80887006|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
27742692|NCT03396471|80887006|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
27742693|NCT03396471|80887006|FG000|Follow up - Up to 2 Years|study terminated|1|||
27742694|NCT03396471|80887006|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
27754922|NCT02065622|80929632|FG002|Maintenance Study|Subject Non-Compliance|1|||
27640622|NCT03771352|80525944|FG000|Overall Study|Screen failure|2|||
27640623|NCT03771352|80525944|FG000|Overall Study|Withdrawal by Subject|2|||
27640624|NCT00593489|80525946|FG000|Allocation|did not attend workshop; allocation not|2|||
27640625|NCT00593489|80525947|FG001|Allocation|did not attend workshop; allocation not|1|||
27640626|NCT01808339|80525948|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640627|NCT01808339|80525949|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640628|NCT01808339|80525950|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640629|NCT01808339|80525951|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
27640630|NCT01808339|80525952|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
27640631|NCT01808339|80525953|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
27640632|NCT01808339|80525948|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27640633|NCT01808339|80525949|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27640634|NCT01808339|80525950|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27640635|NCT01808339|80525951|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27640636|NCT01808339|80525952|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27640637|NCT01808339|80525953|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
27640638|NCT01808339|80525948|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640639|NCT01808339|80525949|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640640|NCT01808339|80525950|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
27640641|NCT01808339|80525951|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640642|NCT01808339|80525952|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640643|NCT01808339|80525953|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
27640644|NCT00703820|80525954|FG000|Overall Study|Adverse Event|12|||
27640645|NCT00703820|80525955|FG001|Overall Study|Adverse Event|17|||
27640646|NCT00703820|80525954|FG000|Overall Study|Death|5|||
27640647|NCT00703820|80525955|FG001|Overall Study|Death|0|||
27640648|NCT00703820|80525954|FG000|Overall Study|Lack of Efficacy|11|||
27640649|NCT00703820|80525955|FG001|Overall Study|Lack of Efficacy|11|||
27640650|NCT00703820|80525954|FG000|Overall Study|Received non-protocol therapy|1|||
27640651|NCT00703820|80525955|FG001|Overall Study|Received non-protocol therapy|0|||
27640652|NCT00703820|80525954|FG000|Overall Study|Physician Decision|4|||
27640653|NCT00703820|80525955|FG001|Overall Study|Physician Decision|5|||
27640654|NCT00703820|80525954|FG000|Overall Study|Withdrawal by Subject|2|||
27640655|NCT00703820|80525955|FG001|Overall Study|Withdrawal by Subject|1|||
27640656|NCT01007396|80525961|FG000|Overall Study|Lost to Follow-up|47|||
27640657|NCT01872078|80525962|FG000|Overall Study|Adverse Event|0|||
27640658|NCT01872078|80525963|FG001|Overall Study|Adverse Event|0|||
27640659|NCT01872078|80525964|FG002|Overall Study|Adverse Event|1|||
27640660|NCT01872078|80525965|FG003|Overall Study|Adverse Event|0|||
27640661|NCT01872078|80525962|FG000|Overall Study|Dose administration non-compliance|0|||
27640662|NCT01872078|80525963|FG001|Overall Study|Dose administration non-compliance|0|||
27640663|NCT01872078|80525964|FG002|Overall Study|Dose administration non-compliance|0|||
27640664|NCT01872078|80525965|FG003|Overall Study|Dose administration non-compliance|1|||
27640665|NCT01872078|80525962|FG000|Overall Study|Protocol Violation|0|||
27640666|NCT01872078|80525963|FG001|Overall Study|Protocol Violation|0|||
27640667|NCT01872078|80525964|FG002|Overall Study|Protocol Violation|1|||
27640668|NCT01872078|80525965|FG003|Overall Study|Protocol Violation|0|||
27640669|NCT01872078|80525962|FG000|Overall Study|Withdrawal by Subject|0|||
27640670|NCT01872078|80525963|FG001|Overall Study|Withdrawal by Subject|0|||
27640671|NCT01872078|80525964|FG002|Overall Study|Withdrawal by Subject|1|||
27640672|NCT01872078|80525965|FG003|Overall Study|Withdrawal by Subject|0|||
27640673|NCT01872078|80525962|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
27640674|NCT01872078|80525963|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
27640675|NCT01872078|80525964|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
27640676|NCT01872078|80525965|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
27640677|NCT01972724|80525967|FG000|Double-Blind|Rescue Criteria Met|1|||
27640678|NCT01972724|80525968|FG001|Double-Blind|Rescue Criteria Met|0|||
27640679|NCT01972724|80525969|FG002|Double-Blind|Rescue Criteria Met|0|||
27640680|NCT01972724|80525967|FG000|Double-Blind|Adverse Event|1|||
27640681|NCT01972724|80525968|FG001|Double-Blind|Adverse Event|0|||
27640682|NCT01972724|80525969|FG002|Double-Blind|Adverse Event|0|||
27640683|NCT01972724|80525967|FG000|Double-Blind|Withdrawal of Consent|2|||
27640684|NCT01972724|80525968|FG001|Double-Blind|Withdrawal of Consent|1|||
27640685|NCT01972724|80525969|FG002|Double-Blind|Withdrawal of Consent|0|||
27640686|NCT01972724|80525967|FG000|Double-Blind|Significant Protocol Deviation|5|||
27640687|NCT01972724|80525968|FG001|Double-Blind|Significant Protocol Deviation|8|||
27640688|NCT01972724|80525969|FG002|Double-Blind|Significant Protocol Deviation|0|||
27640689|NCT01972724|80525967|FG000|Open-Label|Withdrew Consent|0|||
27640690|NCT01972724|80525968|FG001|Open-Label|Withdrew Consent|0|||
27640691|NCT01972724|80525969|FG002|Open-Label|Withdrew Consent|3|||
27640692|NCT01972724|80525967|FG000|Open-Label|Significant Protocol Deviation|0|||
27640693|NCT01972724|80525968|FG001|Open-Label|Significant Protocol Deviation|0|||
27640694|NCT01972724|80525969|FG002|Open-Label|Significant Protocol Deviation|2|||
27640695|NCT00914589|80525974|FG000|Overall Study|Adverse Event|1|||
27640696|NCT00914589|80525975|FG001|Overall Study|Adverse Event|0|||
27640697|NCT00914589|80525976|FG002|Overall Study|Adverse Event|1|||
27640698|NCT00914589|80525974|FG000|Overall Study|Protocol Violation|8|||
27640699|NCT00914589|80525975|FG001|Overall Study|Protocol Violation|6|||
27640700|NCT00914589|80525976|FG002|Overall Study|Protocol Violation|3|||
27640701|NCT00914589|80525974|FG000|Overall Study|unclassified|16|||
27640702|NCT00914589|80525975|FG001|Overall Study|unclassified|9|||
27640703|NCT00914589|80525976|FG002|Overall Study|unclassified|7|||
27640704|NCT00914589|80525974|FG000|Overall Study|Death|0|||
27640705|NCT00914589|80525975|FG001|Overall Study|Death|1|||
27640706|NCT00914589|80525976|FG002|Overall Study|Death|1|||
27640707|NCT00274261|80525977|FG000|Overall Study|Adverse Event|19|||
27640708|NCT00274261|80525978|FG001|Overall Study|Adverse Event|11|||
27929684|NCT01181128|81579103|FG000|Overall Study|Withdrawal by Subject|2|||
27929685|NCT01181128|81579104|FG001|Overall Study|Withdrawal by Subject|2|||
27929686|NCT01181128|81579105|FG002|Overall Study|Withdrawal by Subject|0|||
27929687|NCT01181128|81579103|FG000|Overall Study|Death|1|||
27929688|NCT01181128|81579104|FG001|Overall Study|Death|0|||
27929689|NCT01181128|81579105|FG002|Overall Study|Death|0|||
27929690|NCT01181128|81579103|FG000|Overall Study|Physician Decision|2|||
27929691|NCT01181128|81579104|FG001|Overall Study|Physician Decision|0|||
27929692|NCT01181128|81579105|FG002|Overall Study|Physician Decision|0|||
27929693|NCT01181128|81579103|FG000|Overall Study|Adverse Event|0|||
27929694|NCT01181128|81579104|FG001|Overall Study|Adverse Event|2|||
27929695|NCT01181128|81579105|FG002|Overall Study|Adverse Event|0|||
27929696|NCT01181128|81579103|FG000|Overall Study|Other|1|||
27929697|NCT01181128|81579104|FG001|Overall Study|Other|1|||
27929698|NCT01181128|81579105|FG002|Overall Study|Other|1|||
27929699|NCT05607043|81579106|FG000|Overall Study|Lost to Follow-up|2|||
27929700|NCT00367458|81579107|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
27929701|NCT00367458|81579108|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
27929702|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
27929703|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
27929704|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
27929705|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
27929706|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
27929707|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
27929708|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
27929709|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
27929710|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
27929711|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
27929712|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
27929713|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
27929714|NCT00447278|81579109|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
27929715|NCT00447278|81579110|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
27929716|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
27929717|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
27929718|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
27929719|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
27929720|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
27929721|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
27929722|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
27929723|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
27929724|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
27929725|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
27929726|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
27929727|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
27929728|NCT00447278|81579109|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
27929729|NCT00447278|81579110|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
27929730|NCT03439839|81579111|FG000|Overall Study|Death|3|||
27929731|NCT03439839|81579112|FG001|Overall Study|Death|0|||
27929732|NCT01432327|81579113|FG000|Posttest 3 Months|depression|3|||
27929733|NCT01432327|81579114|FG001|Posttest 3 Months|depression|0|||
27929734|NCT01432327|81579115|FG002|Posttest 3 Months|depression|0|||
27929735|NCT01432327|81579116|FG003|Posttest 3 Months|depression|0|||
27929736|NCT01432327|81579113|FG000|Posttest 3 Months|Lost to Follow-up|1|||
27929737|NCT01432327|81579114|FG001|Posttest 3 Months|Lost to Follow-up|0|||
27929738|NCT01432327|81579115|FG002|Posttest 3 Months|Lost to Follow-up|2|||
27929739|NCT01432327|81579116|FG003|Posttest 3 Months|Lost to Follow-up|1|||
27929740|NCT01432327|81579113|FG000|Posttest 3 Months|Allergic reaction|0|||
27929741|NCT01432327|81579114|FG001|Posttest 3 Months|Allergic reaction|2|||
27929742|NCT01432327|81579115|FG002|Posttest 3 Months|Allergic reaction|0|||
27929743|NCT01432327|81579116|FG003|Posttest 3 Months|Allergic reaction|0|||
27929744|NCT01432327|81579113|FG000|Posttest 6 Months|Lost to Follow-up|0|||
27929745|NCT01432327|81579114|FG001|Posttest 6 Months|Lost to Follow-up|0|||
27929746|NCT01432327|81579115|FG002|Posttest 6 Months|Lost to Follow-up|3|||
27929747|NCT01432327|81579116|FG003|Posttest 6 Months|Lost to Follow-up|2|||
27929748|NCT01432327|81579113|FG000|Posttest 6 Months|Allergic reaction|0|||
27549886|NCT02550106|80200223|FG000|Overall Study|Protocol Violation|6|||
27640709|NCT00274261|80525977|FG000|Overall Study|Pregnancy|114|||
27929749|NCT01432327|81579114|FG001|Posttest 6 Months|Allergic reaction|0|||
27929750|NCT01432327|81579115|FG002|Posttest 6 Months|Allergic reaction|1|||
27929751|NCT01432327|81579116|FG003|Posttest 6 Months|Allergic reaction|0|||
27929752|NCT01432327|81579113|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
27929753|NCT01432327|81579114|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
27929754|NCT01432327|81579115|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
27640710|NCT00274261|80525978|FG001|Overall Study|Pregnancy|83|||
27640711|NCT00274261|80525977|FG000|Overall Study|Withdrawal by Subject|179|||
27640712|NCT00274261|80525978|FG001|Overall Study|Withdrawal by Subject|126|||
27640713|NCT00274261|80525977|FG000|Overall Study|Protocol Violation|71|||
27640714|NCT00274261|80525978|FG001|Overall Study|Protocol Violation|42|||
27640715|NCT00274261|80525977|FG000|Overall Study|Lost to Follow-up|106|||
27640716|NCT00274261|80525978|FG001|Overall Study|Lost to Follow-up|75|||
27640717|NCT00243503|80525979|FG000|Overall Study|Adverse Event|11|||
27640718|NCT00243503|80525979|FG000|Overall Study|Withdrawal by Subject|1|||
27640719|NCT00243503|80525979|FG000|Overall Study|Lack of Efficacy|44|||
27640720|NCT00243503|80525979|FG000|Overall Study|Death|1|||
27640721|NCT00243503|80525979|FG000|Overall Study|Other|1|||
27640722|NCT01839331|80525980|FG000|Overall Study|Early Termination|3|||
27640723|NCT01839331|80525981|FG001|Overall Study|Early Termination|0|||
27640724|NCT01839331|80525982|FG002|Overall Study|Early Termination|1|||
27640725|NCT01839331|80525983|FG003|Overall Study|Early Termination|2|||
27640726|NCT01839331|80525980|FG000|Overall Study|Protocol Violation|1|||
27640727|NCT01839331|80525981|FG001|Overall Study|Protocol Violation|6|||
27640728|NCT01839331|80525982|FG002|Overall Study|Protocol Violation|4|||
27640729|NCT01839331|80525983|FG003|Overall Study|Protocol Violation|3|||
27640730|NCT01036724|80525984|FG000|Overall Study|Adverse Event|1|||
27640731|NCT01036724|80525985|FG001|Overall Study|Adverse Event|2|||
27640732|NCT01036724|80525984|FG000|Overall Study|Lack of Efficacy|1|||
27640733|NCT01036724|80525985|FG001|Overall Study|Lack of Efficacy|1|||
27640734|NCT01036724|80525984|FG000|Overall Study|Protocol Violation|4|||
27640735|NCT01036724|80525985|FG001|Overall Study|Protocol Violation|5|||
27640736|NCT01184326|80525986|FG000|Overall Study|Adverse Event|1|||
27640737|NCT01184326|80525987|FG001|Overall Study|Adverse Event|2|||
27640738|NCT01184326|80525988|FG002|Overall Study|Adverse Event|0|||
27640739|NCT01184326|80525986|FG000|Overall Study|Death|0|||
27640740|NCT01184326|80525987|FG001|Overall Study|Death|0|||
27640741|NCT01184326|80525988|FG002|Overall Study|Death|1|||
27640742|NCT01184326|80525986|FG000|Overall Study|Withdrawal by Subject|0|||
27640743|NCT01184326|80525987|FG001|Overall Study|Withdrawal by Subject|0|||
27640744|NCT01184326|80525988|FG002|Overall Study|Withdrawal by Subject|1|||
27640745|NCT01184326|80525986|FG000|Overall Study|Physician Decision|1|||
27929755|NCT01432327|81579116|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
27929756|NCT01432327|81579113|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
27929757|NCT01432327|81579114|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
27929758|NCT01432327|81579115|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
27929759|NCT01432327|81579116|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
27929760|NCT01432327|81579113|FG000|Posttest 1 Year|Lost to Follow-up|0|||
27929761|NCT01432327|81579114|FG001|Posttest 1 Year|Lost to Follow-up|0|||
27929762|NCT01432327|81579115|FG002|Posttest 1 Year|Lost to Follow-up|4|||
27929763|NCT01432327|81579116|FG003|Posttest 1 Year|Lost to Follow-up|2|||
27929764|NCT01432327|81579113|FG000|Posttest 1 Year|Allergic reaction|0|||
27929765|NCT01432327|81579114|FG001|Posttest 1 Year|Allergic reaction|0|||
27929766|NCT01432327|81579115|FG002|Posttest 1 Year|Allergic reaction|1|||
27929767|NCT01432327|81579116|FG003|Posttest 1 Year|Allergic reaction|1|||
27929768|NCT01704079|81579117|FG000|Overall Study|Withdrawal by Subject|5|||
27929769|NCT01704079|81579118|FG001|Overall Study|Withdrawal by Subject|7|||
27929770|NCT01704079|81579117|FG000|Overall Study|Lost to Follow-up|2|||
27929771|NCT01704079|81579118|FG001|Overall Study|Lost to Follow-up|5|||
27929772|NCT01704079|81579117|FG000|Overall Study|Adverse Event|4|||
27929773|NCT01704079|81579118|FG001|Overall Study|Adverse Event|7|||
27929774|NCT01704079|81579117|FG000|Overall Study|Protocol Violation|1|||
27929775|NCT01704079|81579118|FG001|Overall Study|Protocol Violation|0|||
27929776|NCT01704079|81579117|FG000|Overall Study|Subject noncompliance|2|||
27929777|NCT01704079|81579118|FG001|Overall Study|Subject noncompliance|3|||
27929778|NCT01704079|81579117|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
27929779|NCT01704079|81579118|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
27640746|NCT01184326|80525987|FG001|Overall Study|Physician Decision|1|||
27640747|NCT01184326|80525988|FG002|Overall Study|Physician Decision|0|||
27640748|NCT01184326|80525986|FG000|Overall Study|Disease Progression|1|||
27640749|NCT01184326|80525987|FG001|Overall Study|Disease Progression|3|||
27640750|NCT01184326|80525988|FG002|Overall Study|Disease Progression|12|||
27640751|NCT01494922|80525989|FG000|Overall Study|Adverse Event|1|||
27640752|NCT03582722|80525992|FG000|Overall Study|Lost to Follow-up|1|||
27742695|NCT03396471|80887006|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
27640753|NCT03582722|80525993|FG001|Overall Study|Lost to Follow-up|4|||
27929780|NCT01107457|81579119|FG000|Part A|Adverse Event|1|||
27929781|NCT01107457|81579120|FG001|Part A|Adverse Event|2|||
27929782|NCT01107457|81579121|FG002|Part A|Adverse Event|1|||
27929783|NCT01107457|81579122|FG003|Part A|Adverse Event|0|||
27929784|NCT01107457|81579123|FG004|Part A|Adverse Event|0|||
27929785|NCT01107457|81579124|FG005|Part A|Adverse Event|0|||
27640754|NCT03582722|80525992|FG000|Overall Study|Withdrawal by Subject|3|||
27929786|NCT01107457|81579119|FG000|Part A|Withdrawal by Subject|3|||
27640755|NCT03582722|80525993|FG001|Overall Study|Withdrawal by Subject|3|||
27640756|NCT00975585|80525994|FG000|Overall Study|Adverse Event|0|||
27640757|NCT00975585|80525995|FG001|Overall Study|Adverse Event|4|||
27640758|NCT00975585|80525994|FG000|Overall Study|Lost to Follow-up|3|||
27640759|NCT00975585|80525995|FG001|Overall Study|Lost to Follow-up|5|||
27640760|NCT00975585|80525994|FG000|Overall Study|Withdrawal by Subject|2|||
27640761|NCT00975585|80525995|FG001|Overall Study|Withdrawal by Subject|1|||
27640762|NCT00975585|80525994|FG000|Overall Study|Lens issue|2|||
27640763|NCT00975585|80525995|FG001|Overall Study|Lens issue|2|||
27640764|NCT04019444|80526003|FG000|Overall Study|Withdrawal by Subject|0|||
27640765|NCT04019444|80526004|FG001|Overall Study|Withdrawal by Subject|1|||
27640766|NCT04019444|80526005|FG002|Overall Study|Withdrawal by Subject|0|||
27640767|NCT04019444|80526006|FG003|Overall Study|Withdrawal by Subject|1|||
27640768|NCT04019444|80526003|FG000|Overall Study|Solicited Event|0|||
27640769|NCT04019444|80526004|FG001|Overall Study|Solicited Event|0|||
27640770|NCT04019444|80526005|FG002|Overall Study|Solicited Event|2|||
27640771|NCT04019444|80526006|FG003|Overall Study|Solicited Event|0|||
27640772|NCT00998881|80526007|FG000|Overall Study|Adverse Event|2|||
27640773|NCT00998881|80526008|FG001|Overall Study|Adverse Event|2|||
27640774|NCT00998881|80526007|FG000|Overall Study|Lack of Efficacy|1|||
27640775|NCT00998881|80526008|FG001|Overall Study|Lack of Efficacy|0|||
27640776|NCT00998881|80526007|FG000|Overall Study|Physician Decision|3|||
27640777|NCT00998881|80526008|FG001|Overall Study|Physician Decision|0|||
27640778|NCT00998881|80526007|FG000|Overall Study|Withdrawal by Subject|1|||
27640779|NCT00998881|80526008|FG001|Overall Study|Withdrawal by Subject|0|||
27640780|NCT00998881|80526007|FG000|Overall Study|Personal matter|1|||
27640781|NCT00998881|80526008|FG001|Overall Study|Personal matter|0|||
27640782|NCT04766034|80526009|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
27640783|NCT04766034|80526010|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
27640784|NCT04766034|80526011|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
27640785|NCT04766034|80526012|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
27640786|NCT04766034|80526013|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
27640787|NCT04766034|80526009|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
27640788|NCT04766034|80526010|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
27640789|NCT04766034|80526011|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
27640790|NCT04766034|80526012|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
27640791|NCT04766034|80526013|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
27549887|NCT02550106|80200223|FG000|Overall Study|Withdrawal by Subject|2|||
27549888|NCT02820753|80200230|FG000|2 Month|Withdrawal by Subject|3|||
27549889|NCT02820753|80200231|FG001|2 Month|Withdrawal by Subject|3|||
27549890|NCT02820753|80200230|FG000|2 Month|Lost to Follow-up|24|||
27549891|NCT02820753|80200231|FG001|2 Month|Lost to Follow-up|26|||
27549892|NCT02820753|80200230|FG000|2 Month|Stopped per NIH Hold|51|||
27549893|NCT02820753|80200231|FG001|2 Month|Stopped per NIH Hold|13|||
27549894|NCT02820753|80200230|FG000|6 Month|Withdrawal by Subject|2|||
27549895|NCT02820753|80200231|FG001|6 Month|Withdrawal by Subject|2|||
27549896|NCT02820753|80200230|FG000|6 Month|Lost to Follow-up|20|||
27549897|NCT02820753|80200231|FG001|6 Month|Lost to Follow-up|27|||
27549898|NCT02820753|80200230|FG000|6 Month|Stopped per NIH Hold|81|||
27549899|NCT02820753|80200231|FG001|6 Month|Stopped per NIH Hold|81|||
27549900|NCT02820753|80200230|FG000|6 Month|Death|0|||
27549901|NCT02820753|80200231|FG001|6 Month|Death|1|||
27549902|NCT03978520|80200232|FG000|Overall Study|Adverse Event|2|||
27549903|NCT03978520|80200233|FG001|Overall Study|Adverse Event|5|||
27549904|NCT03978520|80200234|FG002|Overall Study|Adverse Event|3|||
27549905|NCT03978520|80200235|FG003|Overall Study|Adverse Event|5|||
27549906|NCT03978520|80200236|FG004|Overall Study|Adverse Event|6|||
27549907|NCT03978520|80200232|FG000|Overall Study|Withdrawal by Subject|10|||
27549908|NCT03978520|80200233|FG001|Overall Study|Withdrawal by Subject|4|||
27549909|NCT03978520|80200234|FG002|Overall Study|Withdrawal by Subject|5|||
27549910|NCT03978520|80200235|FG003|Overall Study|Withdrawal by Subject|6|||
27549911|NCT03978520|80200236|FG004|Overall Study|Withdrawal by Subject|5|||
27549912|NCT03978520|80200232|FG000|Overall Study|Lost to Follow-up|2|||
27549913|NCT03978520|80200233|FG001|Overall Study|Lost to Follow-up|2|||
27549914|NCT03978520|80200234|FG002|Overall Study|Lost to Follow-up|2|||
27549915|NCT03978520|80200235|FG003|Overall Study|Lost to Follow-up|0|||
27549916|NCT03978520|80200236|FG004|Overall Study|Lost to Follow-up|1|||
27640792|NCT04766034|80526009|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
27742696|NCT00552305|80887007|FG000|Overall Study|Adverse Event|43|||
27549917|NCT03978520|80200232|FG000|Overall Study|COVID-19 infection|0|||
27549918|NCT03978520|80200233|FG001|Overall Study|COVID-19 infection|1|||
27549919|NCT03978520|80200234|FG002|Overall Study|COVID-19 infection|0|||
27549920|NCT03978520|80200235|FG003|Overall Study|COVID-19 infection|0|||
27549921|NCT03978520|80200236|FG004|Overall Study|COVID-19 infection|0|||
27549922|NCT03978520|80200232|FG000|Overall Study|Other, not specified|9|||
27929787|NCT01107457|81579120|FG001|Part A|Withdrawal by Subject|3|||
27929788|NCT01107457|81579121|FG002|Part A|Withdrawal by Subject|0|||
27929789|NCT01107457|81579122|FG003|Part A|Withdrawal by Subject|3|||
27929790|NCT01107457|81579123|FG004|Part A|Withdrawal by Subject|1|||
27929791|NCT01107457|81579124|FG005|Part A|Withdrawal by Subject|0|||
27929792|NCT01107457|81579119|FG000|Part A|Lost to Follow-up|0|||
27929793|NCT01107457|81579120|FG001|Part A|Lost to Follow-up|1|||
27929794|NCT01107457|81579121|FG002|Part A|Lost to Follow-up|0|||
27929795|NCT01107457|81579122|FG003|Part A|Lost to Follow-up|0|||
27929796|NCT01107457|81579123|FG004|Part A|Lost to Follow-up|0|||
27929797|NCT01107457|81579124|FG005|Part A|Lost to Follow-up|0|||
27929798|NCT01107457|81579119|FG000|Part A|Lack of Efficacy|1|||
27929799|NCT01107457|81579120|FG001|Part A|Lack of Efficacy|0|||
27929800|NCT01107457|81579121|FG002|Part A|Lack of Efficacy|0|||
27929801|NCT01107457|81579122|FG003|Part A|Lack of Efficacy|0|||
27929802|NCT01107457|81579123|FG004|Part A|Lack of Efficacy|0|||
27929803|NCT01107457|81579124|FG005|Part A|Lack of Efficacy|0|||
27549923|NCT03978520|80200233|FG001|Overall Study|Other, not specified|4|||
27549924|NCT03978520|80200234|FG002|Overall Study|Other, not specified|1|||
27549925|NCT03978520|80200235|FG003|Overall Study|Other, not specified|1|||
27549926|NCT03978520|80200236|FG004|Overall Study|Other, not specified|2|||
27549927|NCT03978520|80200232|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
27549928|NCT03978520|80200233|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
27549929|NCT03978520|80200234|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
27549930|NCT03978520|80200235|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
27549931|NCT03978520|80200236|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
27549932|NCT00887978|80200238|FG000|Overall Study|Adverse Event|18|||
27549933|NCT00887978|80200239|FG001|Overall Study|Adverse Event|5|||
27549934|NCT00887978|80200238|FG000|Overall Study|Clinical Worsening|4|||
27549935|NCT00887978|80200239|FG001|Overall Study|Clinical Worsening|4|||
27549936|NCT00887978|80200238|FG000|Overall Study|Death|2|||
27549937|NCT00887978|80200239|FG001|Overall Study|Death|3|||
27549938|NCT00887978|80200238|FG000|Overall Study|Withdrawal by Subject|1|||
27549939|NCT00887978|80200239|FG001|Overall Study|Withdrawal by Subject|2|||
27549940|NCT00887978|80200238|FG000|Overall Study|Lost to Follow-up|0|||
27549941|NCT00887978|80200239|FG001|Overall Study|Lost to Follow-up|1|||
27549942|NCT00840450|80200242|FG000|Overall Study|Adverse Event|1|||
27549943|NCT00840450|80200242|FG000|Overall Study|Lack of Efficacy|2|||
27549944|NCT02837783|80200252|FG000|Overall Study|Adverse Event|1|||
27549945|NCT02837783|80200253|FG001|Overall Study|Adverse Event|0|||
27549946|NCT02837783|80200252|FG000|Overall Study|Other, Not Specified|1|||
27549947|NCT02837783|80200253|FG001|Overall Study|Other, Not Specified|2|||
27549948|NCT01664533|80200254|FG000|Overall Study|Death|42|||
27549949|NCT01664533|80200254|FG000|Overall Study|Lost to Follow-up|3|||
27549950|NCT01664533|80200254|FG000|Overall Study|Study termination|9|||
27549951|NCT01664533|80200254|FG000|Overall Study|Protocol Violation|3|||
27549952|NCT04669600|80200255|FG000|Overall Study|Withdrawal by Subject|1|||
27549953|NCT04669600|80200255|FG000|Overall Study|Other|6|||
27549954|NCT02010775|80200256|FG000|Overall Study|Adverse Event|0|||
27549955|NCT02010775|80200257|FG001|Overall Study|Adverse Event|0|||
27549956|NCT02010775|80200258|FG002|Overall Study|Adverse Event|0|||
27549957|NCT02010775|80200259|FG003|Overall Study|Adverse Event|0|||
27549958|NCT02010775|80200260|FG004|Overall Study|Adverse Event|1|||
27549959|NCT02010775|80200256|FG000|Overall Study|Pregnancy|0|||
27549960|NCT02010775|80200257|FG001|Overall Study|Pregnancy|0|||
27549961|NCT02010775|80200258|FG002|Overall Study|Pregnancy|2|||
27549962|NCT02010775|80200259|FG003|Overall Study|Pregnancy|0|||
27549963|NCT02010775|80200260|FG004|Overall Study|Pregnancy|0|||
27549964|NCT02010775|80200256|FG000|Overall Study|Lost to Follow-up|2|||
27549965|NCT02010775|80200257|FG001|Overall Study|Lost to Follow-up|0|||
27549966|NCT02010775|80200258|FG002|Overall Study|Lost to Follow-up|0|||
27549967|NCT02010775|80200259|FG003|Overall Study|Lost to Follow-up|1|||
27549968|NCT02010775|80200260|FG004|Overall Study|Lost to Follow-up|1|||
27549969|NCT02010775|80200256|FG000|Overall Study|Personal Reasons|3|||
27549970|NCT02010775|80200257|FG001|Overall Study|Personal Reasons|3|||
27549971|NCT02010775|80200258|FG002|Overall Study|Personal Reasons|1|||
27549972|NCT02010775|80200259|FG003|Overall Study|Personal Reasons|2|||
27549973|NCT02010775|80200260|FG004|Overall Study|Personal Reasons|4|||
27549974|NCT00855920|80200261|FG000|Overall Study|Protocol Violation|0|||
27549975|NCT00855920|80200262|FG001|Overall Study|Protocol Violation|0|||
27549976|NCT00855920|80200263|FG002|Overall Study|Protocol Violation|2|||
27549977|NCT00855920|80200261|FG000|Overall Study|Adverse Event|2|||
27549978|NCT00855920|80200262|FG001|Overall Study|Adverse Event|1|||
27549979|NCT00855920|80200263|FG002|Overall Study|Adverse Event|1|||
27929804|NCT01107457|81579119|FG000|Part A|Protocol Violation|0|||
27549980|NCT00855920|80200261|FG000|Overall Study|Lack of Efficacy|2|||
27549981|NCT00855920|80200262|FG001|Overall Study|Lack of Efficacy|2|||
27549982|NCT00855920|80200263|FG002|Overall Study|Lack of Efficacy|2|||
27929805|NCT01107457|81579120|FG001|Part A|Protocol Violation|1|||
27929806|NCT01107457|81579121|FG002|Part A|Protocol Violation|0|||
27929807|NCT01107457|81579122|FG003|Part A|Protocol Violation|0|||
27929808|NCT01107457|81579123|FG004|Part A|Protocol Violation|0|||
27929809|NCT01107457|81579124|FG005|Part A|Protocol Violation|0|||
27929810|NCT01107457|81579119|FG000|Part B and C|Adverse Event|0|||
27929811|NCT01107457|81579120|FG001|Part B and C|Adverse Event|0|||
27640793|NCT04766034|80526010|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
27640794|NCT04766034|80526011|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
27640795|NCT04766034|80526012|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
27640796|NCT04766034|80526013|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
27640797|NCT04766034|80526009|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
27640798|NCT04766034|80526010|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
27640799|NCT04766034|80526011|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
27640800|NCT04766034|80526012|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
27640801|NCT04766034|80526013|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
27640802|NCT02891915|80526017|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
27640803|NCT02891915|80526018|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
27640804|NCT02891915|80526017|FG000|Overall Study|Withdrawal by Subject|3|||
27640805|NCT02891915|80526018|FG001|Overall Study|Withdrawal by Subject|3|||
27640806|NCT02891915|80526017|FG000|Overall Study|Became Ineligible After Enrollment|2|||
27640807|NCT02891915|80526018|FG001|Overall Study|Became Ineligible After Enrollment|1|||
27640808|NCT02891915|80526017|FG000|Overall Study|Lost to Follow-up|1|||
27640809|NCT02891915|80526018|FG001|Overall Study|Lost to Follow-up|4|||
27640810|NCT02891915|80526017|FG000|Overall Study|Physician Decision|1|||
27640811|NCT02891915|80526018|FG001|Overall Study|Physician Decision|0|||
27640812|NCT03257410|80526019|FG000|Overall Study|Adverse Event|2|||
27640813|NCT03257410|80526020|FG001|Overall Study|Adverse Event|3|||
27640814|NCT03257410|80526019|FG000|Overall Study|Protocol Violation|1|||
27640815|NCT03257410|80526020|FG001|Overall Study|Protocol Violation|2|||
27640816|NCT03257410|80526019|FG000|Overall Study|Lost to Follow-up|1|||
27640817|NCT03257410|80526020|FG001|Overall Study|Lost to Follow-up|0|||
27640818|NCT03257410|80526019|FG000|Overall Study|Withdrawal by Subject|1|||
27640819|NCT03257410|80526020|FG001|Overall Study|Withdrawal by Subject|2|||
27640820|NCT03257410|80526019|FG000|Overall Study|Physician Decision|1|||
27640821|NCT03257410|80526020|FG001|Overall Study|Physician Decision|1|||
27640822|NCT03257410|80526019|FG000|Overall Study|Renal transplantation|2|||
27640823|NCT03257410|80526020|FG001|Overall Study|Renal transplantation|0|||
27640824|NCT03257410|80526019|FG000|Overall Study|Switch to peritoneal dialysis|1|||
27640825|NCT03257410|80526020|FG001|Overall Study|Switch to peritoneal dialysis|0|||
27640826|NCT03257410|80526019|FG000|Overall Study|Death|3|||
27640827|NCT03257410|80526020|FG001|Overall Study|Death|2|||
27640828|NCT03257410|80526019|FG000|Overall Study|Change to another dialysis center|2|||
27640829|NCT03257410|80526020|FG001|Overall Study|Change to another dialysis center|2|||
27640830|NCT03257410|80526019|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
27640831|NCT03257410|80526020|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
27640832|NCT03257410|80526019|FG000|Overall Study|Miscellaneous|2|||
27640833|NCT03257410|80526020|FG001|Overall Study|Miscellaneous|2|||
27640834|NCT03257410|80526019|FG000|Overall Study|Other|0|||
27640835|NCT03257410|80526020|FG001|Overall Study|Other|1|||
27640836|NCT00529789|80526021|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
27640837|NCT00529789|80526021|FG000|Study Period II/III|Adverse Event|3|||
27640838|NCT00529789|80526021|FG000|Study Period II/III|Lack of Efficacy|2|||
27640839|NCT00529789|80526021|FG000|Study Period II/III|Withdrawal by Subject|1|||
27640840|NCT00529789|80526021|FG000|Study Period II/III|Protocol Violation|3|||
27640841|NCT00529789|80526021|FG000|Study Period II/III|Physician Decision|3|||
27640842|NCT00529789|80526021|FG000|Study Period II/III|Lost to Follow-up|3|||
27640843|NCT00529789|80526021|FG000|Study Period IV|Parent/Caregiver Decision|1|||
27640844|NCT00529789|80526021|FG000|Study Period IV|Adverse Event|1|||
27742697|NCT00552305|80887007|FG000|Overall Study|Lack of Efficacy|120|||
27742698|NCT00552305|80887007|FG000|Overall Study|Lost to Follow-up|4|||
27640845|NCT00529789|80526021|FG000|Study Period IV|Lack of Efficacy|1|||
27640846|NCT00529789|80526021|FG000|Study Period IV|Lost to Follow-up|3|||
27640847|NCT00589875|80526022|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
27640848|NCT00589875|80526022|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
27640849|NCT02107261|80529034|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
27640850|NCT02107261|80529035|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
27640851|NCT02107261|80529034|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
27640852|NCT02107261|80529035|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
27742699|NCT00552305|80887007|FG000|Overall Study|Protocol Violation|3|||
27742700|NCT00552305|80887007|FG000|Overall Study|Withdrawal by Subject|44|||
27742701|NCT00552305|80887007|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
27549983|NCT00855920|80200261|FG000|Overall Study|Withdrawal by Subject|2|||
27640853|NCT02374463|80529036|FG000|Overall Study|Withdrawal by Subject|3|||
27640854|NCT02374463|80529037|FG001|Overall Study|Withdrawal by Subject|3|||
27640855|NCT03578536|80529038|FG000|Overall Study|Lost to Follow-up|1|||
27640856|NCT03580369|80529039|FG000|Overall Study|No treatment due to mis-randomization|1|||
27640857|NCT03580369|80529040|FG001|Overall Study|No treatment due to mis-randomization|0|||
27640858|NCT03580369|80529041|FG002|Overall Study|No treatment due to mis-randomization|0|||
27640859|NCT03580369|80529042|FG003|Overall Study|No treatment due to mis-randomization|0|||
27640860|NCT03580369|80529043|FG004|Overall Study|No treatment due to mis-randomization|3|||
27640861|NCT03580369|80529044|FG005|Overall Study|No treatment due to mis-randomization|0|||
27640862|NCT03580369|80529045|FG006|Overall Study|No treatment due to mis-randomization|0|||
27640863|NCT03580369|80529046|FG007|Overall Study|No treatment due to mis-randomization|0|||
27640864|NCT03580369|80529039|FG000|Overall Study|Reason unknown|0|||
27640865|NCT03580369|80529040|FG001|Overall Study|Reason unknown|0|||
27640866|NCT03580369|80529041|FG002|Overall Study|Reason unknown|1|||
27640867|NCT03580369|80529042|FG003|Overall Study|Reason unknown|0|||
27640868|NCT03580369|80529043|FG004|Overall Study|Reason unknown|0|||
27640869|NCT03580369|80529044|FG005|Overall Study|Reason unknown|0|||
27640870|NCT03580369|80529045|FG006|Overall Study|Reason unknown|0|||
27640871|NCT03580369|80529046|FG007|Overall Study|Reason unknown|0|||
27640872|NCT03580369|80529039|FG000|Overall Study|Technical problems|0|||
27640873|NCT03580369|80529040|FG001|Overall Study|Technical problems|0|||
27640874|NCT03580369|80529041|FG002|Overall Study|Technical problems|0|||
27640875|NCT03580369|80529042|FG003|Overall Study|Technical problems|0|||
27640876|NCT03580369|80529043|FG004|Overall Study|Technical problems|1|||
27640877|NCT03580369|80529044|FG005|Overall Study|Technical problems|0|||
27640878|NCT03580369|80529045|FG006|Overall Study|Technical problems|2|||
27640879|NCT03580369|80529046|FG007|Overall Study|Technical problems|0|||
27640880|NCT03580369|80529039|FG000|Overall Study|Pregnancy|2|||
27640881|NCT03580369|80529040|FG001|Overall Study|Pregnancy|0|||
27640882|NCT03580369|80529041|FG002|Overall Study|Pregnancy|3|||
27640883|NCT03580369|80529042|FG003|Overall Study|Pregnancy|0|||
27640884|NCT03580369|80529043|FG004|Overall Study|Pregnancy|2|||
27640885|NCT03580369|80529044|FG005|Overall Study|Pregnancy|0|||
27640886|NCT03580369|80529045|FG006|Overall Study|Pregnancy|0|||
27640887|NCT03580369|80529046|FG007|Overall Study|Pregnancy|0|||
27640888|NCT03580369|80529039|FG000|Overall Study|Lost to Follow-up|2|||
27640889|NCT03580369|80529040|FG001|Overall Study|Lost to Follow-up|0|||
27640890|NCT03580369|80529041|FG002|Overall Study|Lost to Follow-up|2|||
27640891|NCT03580369|80529042|FG003|Overall Study|Lost to Follow-up|0|||
27640892|NCT03580369|80529043|FG004|Overall Study|Lost to Follow-up|3|||
27640893|NCT03580369|80529044|FG005|Overall Study|Lost to Follow-up|0|||
27640894|NCT03580369|80529045|FG006|Overall Study|Lost to Follow-up|1|||
27640895|NCT03580369|80529046|FG007|Overall Study|Lost to Follow-up|0|||
27640896|NCT03580369|80529039|FG000|Overall Study|Physician Decision|4|||
27640897|NCT03580369|80529040|FG001|Overall Study|Physician Decision|0|||
27640898|NCT03580369|80529041|FG002|Overall Study|Physician Decision|4|||
27640899|NCT03580369|80529042|FG003|Overall Study|Physician Decision|1|||
27640900|NCT03580369|80529043|FG004|Overall Study|Physician Decision|1|||
27640901|NCT03580369|80529044|FG005|Overall Study|Physician Decision|0|||
27640902|NCT03580369|80529045|FG006|Overall Study|Physician Decision|0|||
27640903|NCT03580369|80529046|FG007|Overall Study|Physician Decision|0|||
27640904|NCT03580369|80529039|FG000|Overall Study|Lack of Efficacy|3|||
27640905|NCT03580369|80529040|FG001|Overall Study|Lack of Efficacy|0|||
27640906|NCT03580369|80529041|FG002|Overall Study|Lack of Efficacy|7|||
27640907|NCT03580369|80529042|FG003|Overall Study|Lack of Efficacy|0|||
27640908|NCT03580369|80529043|FG004|Overall Study|Lack of Efficacy|2|||
27640909|NCT03580369|80529044|FG005|Overall Study|Lack of Efficacy|0|||
27640910|NCT03580369|80529045|FG006|Overall Study|Lack of Efficacy|3|||
27640911|NCT03580369|80529046|FG007|Overall Study|Lack of Efficacy|0|||
27640912|NCT03580369|80529039|FG000|Overall Study|Protocol Violation|6|||
27929812|NCT01107457|81579121|FG002|Part B and C|Adverse Event|0|||
27640913|NCT03580369|80529040|FG001|Overall Study|Protocol Violation|0|||
27640914|NCT03580369|80529041|FG002|Overall Study|Protocol Violation|6|||
27640915|NCT03580369|80529042|FG003|Overall Study|Protocol Violation|1|||
27640916|NCT03580369|80529043|FG004|Overall Study|Protocol Violation|8|||
27640917|NCT03580369|80529044|FG005|Overall Study|Protocol Violation|2|||
27640918|NCT03580369|80529045|FG006|Overall Study|Protocol Violation|1|||
27640919|NCT03580369|80529046|FG007|Overall Study|Protocol Violation|0|||
27640920|NCT03580369|80529039|FG000|Overall Study|Adverse Event|7|||
27640921|NCT03580369|80529040|FG001|Overall Study|Adverse Event|0|||
27640922|NCT03580369|80529041|FG002|Overall Study|Adverse Event|14|||
27640923|NCT03580369|80529042|FG003|Overall Study|Adverse Event|1|||
27640924|NCT03580369|80529043|FG004|Overall Study|Adverse Event|6|||
27640925|NCT03580369|80529044|FG005|Overall Study|Adverse Event|0|||
27640926|NCT03580369|80529045|FG006|Overall Study|Adverse Event|1|||
27640927|NCT03580369|80529046|FG007|Overall Study|Adverse Event|0|||
27640928|NCT03580369|80529039|FG000|Overall Study|Withdrawal by Subject|19|||
27640929|NCT03580369|80529040|FG001|Overall Study|Withdrawal by Subject|0|||
27640930|NCT03580369|80529041|FG002|Overall Study|Withdrawal by Subject|17|||
27640931|NCT03580369|80529042|FG003|Overall Study|Withdrawal by Subject|0|||
27640932|NCT03580369|80529043|FG004|Overall Study|Withdrawal by Subject|16|||
27640933|NCT03580369|80529044|FG005|Overall Study|Withdrawal by Subject|1|||
27640934|NCT03580369|80529045|FG006|Overall Study|Withdrawal by Subject|7|||
27640935|NCT03580369|80529046|FG007|Overall Study|Withdrawal by Subject|0|||
27640936|NCT04425863|80529047|FG000|Overall Study|Death|0|||
27640937|NCT04425863|80529048|FG001|Overall Study|Death|0|||
27640938|NCT04425863|80529049|FG002|Overall Study|Death|1|||
27640939|NCT01532388|80529050|FG000|3-month Follow-up|Lost to Follow-up|68|||
27640940|NCT01532388|80529051|FG001|3-month Follow-up|Lost to Follow-up|68|||
27640941|NCT01532388|80529050|FG000|6-month Follow-up|Lost to Follow-up|74|||
27640942|NCT01532388|80529051|FG001|6-month Follow-up|Lost to Follow-up|66|||
27640943|NCT01532388|80529050|FG000|12-month Follow-up|Lost to Follow-up|69|||
27640944|NCT01532388|80529051|FG001|12-month Follow-up|Lost to Follow-up|67|||
27640945|NCT00557492|80529053|FG000|Overall Study|Change in health insurance|1|||
27640946|NCT01989455|80529054|FG000|Overall Study|Adverse Event|0|||
27640947|NCT01989455|80529055|FG001|Overall Study|Adverse Event|1|||
27640948|NCT01989455|80529056|FG002|Overall Study|Adverse Event|0|||
27640949|NCT01989455|80529057|FG003|Overall Study|Adverse Event|0|||
27640950|NCT01989455|80529058|FG004|Overall Study|Adverse Event|0|||
27640951|NCT01989455|80529054|FG000|Overall Study|Withdrawal by Subject|0|||
27640952|NCT01989455|80529055|FG001|Overall Study|Withdrawal by Subject|1|||
27640953|NCT01989455|80529056|FG002|Overall Study|Withdrawal by Subject|0|||
27640954|NCT01989455|80529057|FG003|Overall Study|Withdrawal by Subject|0|||
27640955|NCT01989455|80529058|FG004|Overall Study|Withdrawal by Subject|0|||
27640956|NCT01989455|80529054|FG000|Overall Study|Technical problems with infusion|0|||
27640957|NCT01989455|80529055|FG001|Overall Study|Technical problems with infusion|0|||
27640958|NCT01989455|80529056|FG002|Overall Study|Technical problems with infusion|1|||
27640959|NCT01989455|80529057|FG003|Overall Study|Technical problems with infusion|0|||
27640960|NCT01989455|80529058|FG004|Overall Study|Technical problems with infusion|1|||
27640961|NCT04436289|80529059|FG000|Overall Study|Death prior to hospital discharge|8|||
27640962|NCT04436289|80529060|FG001|Overall Study|Death prior to hospital discharge|5|||
27640963|NCT04436289|80529061|FG002|Overall Study|Death prior to hospital discharge|0|||
27640964|NCT04436289|80529062|FG003|Overall Study|Death prior to hospital discharge|1|||
27640965|NCT04436289|80529059|FG000|Overall Study|Withdrawal by Subject|0|||
27640966|NCT04436289|80529060|FG001|Overall Study|Withdrawal by Subject|1|||
27640967|NCT04436289|80529061|FG002|Overall Study|Withdrawal by Subject|4|||
27640968|NCT04436289|80529062|FG003|Overall Study|Withdrawal by Subject|0|||
27640969|NCT04436289|80529059|FG000|Overall Study|Extended hospital stay|0|||
27640970|NCT04436289|80529060|FG001|Overall Study|Extended hospital stay|1|||
27640971|NCT04436289|80529061|FG002|Overall Study|Extended hospital stay|0|||
27640972|NCT04436289|80529062|FG003|Overall Study|Extended hospital stay|0|||
27640973|NCT04436289|80529059|FG000|Overall Study|Lost to Follow-up|0|||
27640974|NCT04436289|80529060|FG001|Overall Study|Lost to Follow-up|4|||
27640975|NCT04436289|80529061|FG002|Overall Study|Lost to Follow-up|1|||
27640976|NCT04436289|80529062|FG003|Overall Study|Lost to Follow-up|3|||
27640977|NCT01227265|80529063|FG000|Overall Study|Did Not Receive Treatment|1|||
27640978|NCT01227265|80529064|FG001|Overall Study|Did Not Receive Treatment|2|||
27640979|NCT01227265|80529065|FG002|Overall Study|Did Not Receive Treatment|0|||
27640980|NCT01227265|80529063|FG000|Overall Study|Administrative|1|||
27640981|NCT01227265|80529064|FG001|Overall Study|Administrative|0|||
27640982|NCT01227265|80529065|FG002|Overall Study|Administrative|2|||
27640983|NCT01227265|80529063|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27640984|NCT01227265|80529064|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
27640985|NCT01227265|80529065|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
27640986|NCT01227265|80529063|FG000|Overall Study|Protocol Violation|2|||
27640987|NCT01227265|80529064|FG001|Overall Study|Protocol Violation|1|||
27640988|NCT01227265|80529065|FG002|Overall Study|Protocol Violation|0|||
27640989|NCT01227265|80529063|FG000|Overall Study|Withdrawal by Subject|7|||
27929813|NCT01107457|81579122|FG003|Part B and C|Adverse Event|0|||
27929814|NCT01107457|81579123|FG004|Part B and C|Adverse Event|0|||
27929815|NCT01107457|81579124|FG005|Part B and C|Adverse Event|12|||
27640990|NCT01227265|80529064|FG001|Overall Study|Withdrawal by Subject|7|||
27640991|NCT01227265|80529065|FG002|Overall Study|Withdrawal by Subject|3|||
27640992|NCT01227265|80529063|FG000|Overall Study|Lost to Follow-up|2|||
27640993|NCT01227265|80529064|FG001|Overall Study|Lost to Follow-up|0|||
27640994|NCT01227265|80529065|FG002|Overall Study|Lost to Follow-up|3|||
27640995|NCT01227265|80529063|FG000|Overall Study|Adverse Event|6|||
27640996|NCT01227265|80529064|FG001|Overall Study|Adverse Event|10|||
27640997|NCT01227265|80529065|FG002|Overall Study|Adverse Event|5|||
27640998|NCT00174252|80529066|FG000|Overall Study|Protocol Violation|2|||
27640999|NCT01582100|80529067|FG000|Overall Study|Adverse Event|1|||
27641000|NCT01582100|80529067|FG000|Overall Study|Withdrawal by Subject|1|||
27641001|NCT05262738|80529068|FG000|Overall Study|Withdrawal by Subject|1|||
27929816|NCT01107457|81579119|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27641002|NCT05262738|80529069|FG001|Overall Study|Withdrawal by Subject|0|||
27641003|NCT03801148|80529070|FG000|Period 1 (2 Days)|Adverse Event|1|||
27641004|NCT03801148|80529071|FG001|Period 1 (2 Days)|Adverse Event|1|||
27641005|NCT03801148|80529072|FG002|Period 1 (2 Days)|Adverse Event|0|||
27641006|NCT03801148|80529073|FG003|Period 1 (2 Days)|Adverse Event|0|||
27641007|NCT03801148|80529070|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
27641008|NCT03801148|80529071|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
27641009|NCT03801148|80529072|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
27641010|NCT03801148|80529073|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
27641011|NCT03801148|80529070|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27641012|NCT03801148|80529071|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27641013|NCT03801148|80529072|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
27641014|NCT03801148|80529073|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
27641015|NCT03801148|80529070|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
27641016|NCT03801148|80529071|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
27641017|NCT03801148|80529072|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
27641018|NCT03801148|80529073|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
27641019|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
27641020|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
27641021|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
27641022|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
27641023|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
27641024|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
27641025|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
27641026|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
27641027|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
27641028|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
27641029|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
27641030|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
27641031|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
27641032|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
27641033|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
27641034|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
27929817|NCT01107457|81579120|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27929818|NCT01107457|81579121|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27929819|NCT01107457|81579122|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27929820|NCT01107457|81579123|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
27929821|NCT01107457|81579124|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
27929822|NCT01107457|81579119|FG000|Part B and C|Physician Decision|0|||
27929823|NCT01107457|81579120|FG001|Part B and C|Physician Decision|0|||
27929824|NCT01107457|81579121|FG002|Part B and C|Physician Decision|0|||
27929825|NCT01107457|81579122|FG003|Part B and C|Physician Decision|0|||
27929826|NCT01107457|81579123|FG004|Part B and C|Physician Decision|0|||
27929827|NCT01107457|81579124|FG005|Part B and C|Physician Decision|3|||
27929828|NCT01107457|81579119|FG000|Part B and C|Lack of Efficacy|0|||
27929829|NCT01107457|81579120|FG001|Part B and C|Lack of Efficacy|0|||
27929830|NCT01107457|81579121|FG002|Part B and C|Lack of Efficacy|0|||
27929831|NCT01107457|81579122|FG003|Part B and C|Lack of Efficacy|0|||
27929832|NCT01107457|81579123|FG004|Part B and C|Lack of Efficacy|0|||
27929833|NCT01107457|81579124|FG005|Part B and C|Lack of Efficacy|7|||
27929834|NCT01107457|81579119|FG000|Part B and C|Lost to Follow-up|0|||
27929835|NCT01107457|81579120|FG001|Part B and C|Lost to Follow-up|0|||
27929836|NCT01107457|81579121|FG002|Part B and C|Lost to Follow-up|0|||
27929837|NCT01107457|81579122|FG003|Part B and C|Lost to Follow-up|0|||
27929838|NCT01107457|81579123|FG004|Part B and C|Lost to Follow-up|0|||
27929839|NCT01107457|81579124|FG005|Part B and C|Lost to Follow-up|10|||
27929840|NCT01107457|81579119|FG000|Part B and C|Protocol Violation|0|||
27929841|NCT01107457|81579120|FG001|Part B and C|Protocol Violation|0|||
27929842|NCT01107457|81579121|FG002|Part B and C|Protocol Violation|0|||
27929843|NCT01107457|81579122|FG003|Part B and C|Protocol Violation|0|||
27929844|NCT01107457|81579123|FG004|Part B and C|Protocol Violation|0|||
27929845|NCT01107457|81579124|FG005|Part B and C|Protocol Violation|1|||
27929846|NCT01107457|81579119|FG000|Part B and C|Sponsor Decision|0|||
27929847|NCT01107457|81579120|FG001|Part B and C|Sponsor Decision|0|||
27929848|NCT01107457|81579121|FG002|Part B and C|Sponsor Decision|0|||
27929849|NCT01107457|81579122|FG003|Part B and C|Sponsor Decision|0|||
27641035|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
27929850|NCT01107457|81579123|FG004|Part B and C|Sponsor Decision|0|||
27929851|NCT01107457|81579124|FG005|Part B and C|Sponsor Decision|66|||
27929852|NCT01107457|81579119|FG000|Part B and C|Withdrawal by Subject|0|||
27929853|NCT01107457|81579120|FG001|Part B and C|Withdrawal by Subject|0|||
27929854|NCT01107457|81579121|FG002|Part B and C|Withdrawal by Subject|0|||
27929855|NCT01107457|81579122|FG003|Part B and C|Withdrawal by Subject|0|||
27929856|NCT01107457|81579123|FG004|Part B and C|Withdrawal by Subject|0|||
27929857|NCT01107457|81579124|FG005|Part B and C|Withdrawal by Subject|16|||
27929858|NCT01107457|81579119|FG000|Part B and C|Clinical Relapse|0|||
27929859|NCT01107457|81579120|FG001|Part B and C|Clinical Relapse|0|||
27929860|NCT01107457|81579121|FG002|Part B and C|Clinical Relapse|0|||
27929861|NCT01107457|81579122|FG003|Part B and C|Clinical Relapse|0|||
27929862|NCT01107457|81579123|FG004|Part B and C|Clinical Relapse|0|||
27929863|NCT01107457|81579124|FG005|Part B and C|Clinical Relapse|4|||
27929864|NCT04615507|81579125|FG000|Period 1|Covid-19 exposure|2|||
27929865|NCT04615507|81579126|FG001|Period 1|Covid-19 exposure|1|||
27929866|NCT04615507|81579125|FG000|Period 2|Covid-19 exposure|0|||
27929867|NCT04615507|81579126|FG001|Period 2|Covid-19 exposure|1|||
27929868|NCT04615507|81579125|FG000|Period 2|Protocol Violation|1|||
27929869|NCT04615507|81579126|FG001|Period 2|Protocol Violation|0|||
27929870|NCT04615507|81579125|FG000|Period 2|Withdrawal by Subject|1|||
27929871|NCT04615507|81579126|FG001|Period 2|Withdrawal by Subject|0|||
27929872|NCT04615507|81579125|FG000|Period 2|Adverse Event|0|||
27929873|NCT04615507|81579126|FG001|Period 2|Adverse Event|1|||
27929874|NCT04615507|81579125|FG000|Period 3|Covid-19 exposure|0|||
27929875|NCT04615507|81579126|FG001|Period 3|Covid-19 exposure|1|||
27929876|NCT01771913|81579127|FG000|Overall Study|Withdrawal by Subject|1|||
27929877|NCT01771913|81579128|FG001|Overall Study|Withdrawal by Subject|0|||
27929878|NCT04625972|81579130|FG000|Overall Study|Death|3|||
27929879|NCT04625972|81579131|FG001|Overall Study|Death|2|||
27929880|NCT04625972|81579130|FG000|Overall Study|Lost to Follow-up|82|||
27929881|NCT04625972|81579131|FG001|Overall Study|Lost to Follow-up|38|||
27929882|NCT04625972|81579130|FG000|Overall Study|Physician Decision|2|||
27929883|NCT04625972|81579131|FG001|Overall Study|Physician Decision|0|||
27929884|NCT04625972|81579130|FG000|Overall Study|Protocol Violation|0|||
27929885|NCT04625972|81579131|FG001|Overall Study|Protocol Violation|1|||
27929886|NCT04625972|81579130|FG000|Overall Study|Withdrawal by Subject|37|||
27929887|NCT04625972|81579131|FG001|Overall Study|Withdrawal by Subject|24|||
27929888|NCT04625972|81579130|FG000|Overall Study|Not specified elsewhere|8|||
27929889|NCT04625972|81579131|FG001|Overall Study|Not specified elsewhere|6|||
27929890|NCT04602000|81582565|FG000|Overall Study|Withdrawal by Subject|3|||
27929891|NCT04602000|81582566|FG001|Overall Study|Withdrawal by Subject|6|||
27929892|NCT04602000|81582567|FG002|Overall Study|Withdrawal by Subject|3|||
27929893|NCT04602000|81582568|FG003|Overall Study|Withdrawal by Subject|27|||
27929894|NCT04602000|81582569|FG004|Overall Study|Withdrawal by Subject|39|||
27929895|NCT04602000|81582565|FG000|Overall Study|Physician Decision|1|||
27929896|NCT04602000|81582566|FG001|Overall Study|Physician Decision|0|||
27929897|NCT04602000|81582567|FG002|Overall Study|Physician Decision|0|||
27929898|NCT04602000|81582568|FG003|Overall Study|Physician Decision|2|||
27929899|NCT04602000|81582569|FG004|Overall Study|Physician Decision|2|||
27929900|NCT04602000|81582565|FG000|Overall Study|Death|0|||
27929901|NCT04602000|81582566|FG001|Overall Study|Death|1|||
27929902|NCT04602000|81582567|FG002|Overall Study|Death|0|||
27929903|NCT04602000|81582568|FG003|Overall Study|Death|1|||
27929904|NCT04602000|81582569|FG004|Overall Study|Death|2|||
27929905|NCT04602000|81582565|FG000|Overall Study|Lost to Follow-up|0|||
27929906|NCT04602000|81582566|FG001|Overall Study|Lost to Follow-up|0|||
27929907|NCT04602000|81582567|FG002|Overall Study|Lost to Follow-up|0|||
27929908|NCT04602000|81582568|FG003|Overall Study|Lost to Follow-up|3|||
27929909|NCT04602000|81582569|FG004|Overall Study|Lost to Follow-up|4|||
27929910|NCT04602000|81582565|FG000|Overall Study|Other|4|||
27929911|NCT04602000|81582566|FG001|Overall Study|Other|1|||
27929912|NCT04602000|81582567|FG002|Overall Study|Other|2|||
27929913|NCT04602000|81582568|FG003|Overall Study|Other|5|||
27929914|NCT04602000|81582569|FG004|Overall Study|Other|4|||
27929915|NCT04602000|81582565|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
27929916|NCT04602000|81582566|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
27929917|NCT04602000|81582567|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
27929918|NCT04602000|81582568|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
27929919|NCT04602000|81582569|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
27929920|NCT01145222|81582570|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
27549984|NCT00855920|80200262|FG001|Overall Study|Withdrawal by Subject|3|||
27549985|NCT00855920|80200263|FG002|Overall Study|Withdrawal by Subject|2|||
27929921|NCT01145222|81582571|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
27929922|NCT01145222|81582572|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
27929923|NCT01145222|81582573|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
27929924|NCT01145222|81582570|FG000|Overall Study|Poor bowel preparation|0|||
27929925|NCT01145222|81582571|FG001|Overall Study|Poor bowel preparation|0|||
27929926|NCT01145222|81582572|FG002|Overall Study|Poor bowel preparation|0|||
27929927|NCT01145222|81582573|FG003|Overall Study|Poor bowel preparation|1|||
27929928|NCT02412657|81582574|FG000|Overall Study|Lost to Follow-up|1|||
27929929|NCT02412657|81582575|FG001|Overall Study|Lost to Follow-up|0|||
27929930|NCT02412657|81582576|FG002|Overall Study|Lost to Follow-up|0|||
27929931|NCT02412657|81582574|FG000|Overall Study|Protocol Violation|0|||
27929932|NCT02412657|81582575|FG001|Overall Study|Protocol Violation|2|||
27929933|NCT02412657|81582576|FG002|Overall Study|Protocol Violation|3|||
27929934|NCT02782104|81582579|FG000|Overall Study|Other|215|||
27929935|NCT02782104|81582579|FG000|Overall Study|Induction Day 28 Non Responder|9|||
27929936|NCT02782104|81582579|FG000|Overall Study|Non-Compliance with Study Drug|2|||
27929937|NCT02782104|81582579|FG000|Overall Study|Death|8|||
27929938|NCT02782104|81582579|FG000|Overall Study|Pregnancy|6|||
27929939|NCT02782104|81582579|FG000|Overall Study|Withdrawal by Subject|63|||
27929940|NCT02782104|81582579|FG000|Overall Study|Protocol Violation|7|||
27929941|NCT02782104|81582579|FG000|Overall Study|Lack of Efficacy|61|||
27929942|NCT02782104|81582579|FG000|Overall Study|Lost to Follow-up|23|||
27929943|NCT02782104|81582579|FG000|Overall Study|Adverse Event|74|||
27929944|NCT00690898|81582580|FG000|SCREENING|Screen failure|18|||
27929945|NCT00690898|81582580|FG000|TREATMENT|Adverse Event|3|||
27929946|NCT00690898|81582580|FG000|TREATMENT|Lack of Efficacy|18|||
27929947|NCT00690898|81582580|FG000|TREATMENT|Withdrawal by Subject|4|||
27929948|NCT00690898|81582580|FG000|TREATMENT|Other (not otherwise specified)|1|||
27929949|NCT03097315|81582581|FG000|Overall Study|Withdrawal by Subject|1|||
27929950|NCT02406612|81582588|FG000|Overall Study|Screening Failure|3|||
27929951|NCT02406612|81582589|FG001|Overall Study|Screening Failure|0|||
27929952|NCT02406612|81582588|FG000|Overall Study|Intra-procedural Exclusion|1|||
27929953|NCT02406612|81582589|FG001|Overall Study|Intra-procedural Exclusion|3|||
27929954|NCT02406612|81582588|FG000|Overall Study|Guidewire Failure|0|||
27929955|NCT02406612|81582589|FG001|Overall Study|Guidewire Failure|1|||
27929956|NCT02260986|81582590|FG000|Overall Study|Adverse Event|24|||
27929957|NCT02260986|81582591|FG001|Overall Study|Adverse Event|0|||
27929958|NCT02260986|81582592|FG002|Overall Study|Adverse Event|11|||
27929959|NCT02260986|81582590|FG000|Overall Study|Lack of Efficacy|27|||
27929960|NCT02260986|81582591|FG001|Overall Study|Lack of Efficacy|3|||
27929961|NCT02260986|81582592|FG002|Overall Study|Lack of Efficacy|0|||
27929962|NCT02260986|81582590|FG000|Overall Study|Protocol Violation|14|||
27929963|NCT02260986|81582591|FG001|Overall Study|Protocol Violation|5|||
27929964|NCT02260986|81582592|FG002|Overall Study|Protocol Violation|16|||
27929965|NCT02260986|81582590|FG000|Overall Study|Car accident|0|||
27929966|NCT02260986|81582591|FG001|Overall Study|Car accident|0|||
27929967|NCT02260986|81582592|FG002|Overall Study|Car accident|1|||
27929968|NCT02260986|81582590|FG000|Overall Study|Withdrawal by Subject|17|||
27929969|NCT02260986|81582591|FG001|Overall Study|Withdrawal by Subject|4|||
27641036|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
27641037|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
27641038|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
27641039|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
27641040|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
27641041|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
27641042|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
27641043|NCT01074294|80529074|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
27641044|NCT01074294|80529075|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
27641045|NCT01074294|80529076|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
27641046|NCT01074294|80529077|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
27641047|NCT01074294|80529074|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
27641048|NCT01074294|80529075|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
27641049|NCT01074294|80529076|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
27641050|NCT01074294|80529077|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
27641051|NCT01074294|80529074|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
27641052|NCT01074294|80529075|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
27641053|NCT01074294|80529076|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
27641054|NCT01074294|80529077|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
27641055|NCT01074294|80529074|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
27641056|NCT01074294|80529075|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
27641057|NCT01074294|80529076|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
27641058|NCT01074294|80529077|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
27641059|NCT01074294|80529074|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
27641060|NCT01074294|80529075|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
27929970|NCT02260986|81582592|FG002|Overall Study|Withdrawal by Subject|9|||
27929971|NCT02260986|81582590|FG000|Overall Study|Incorrect randomization|0|||
27929972|NCT02260986|81582591|FG001|Overall Study|Incorrect randomization|1|||
27929973|NCT02260986|81582592|FG002|Overall Study|Incorrect randomization|0|||
27929974|NCT02260986|81582590|FG000|Overall Study|Lack of investigation product supply|2|||
27929975|NCT02260986|81582591|FG001|Overall Study|Lack of investigation product supply|0|||
27929976|NCT02260986|81582592|FG002|Overall Study|Lack of investigation product supply|1|||
27929977|NCT02260986|81582590|FG000|Overall Study|Lost to Follow-up|4|||
27929978|NCT02260986|81582591|FG001|Overall Study|Lost to Follow-up|0|||
27929979|NCT02260986|81582592|FG002|Overall Study|Lost to Follow-up|3|||
27929980|NCT02260986|81582590|FG000|Overall Study|Pregnancy|2|||
27929981|NCT02260986|81582591|FG001|Overall Study|Pregnancy|0|||
27641061|NCT01074294|80529076|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
27641062|NCT01074294|80529077|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
27641063|NCT01074294|80529074|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
27641064|NCT01074294|80529075|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
27641065|NCT01074294|80529076|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
27641066|NCT01074294|80529077|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
27929982|NCT02260986|81582592|FG002|Overall Study|Pregnancy|0|||
27929983|NCT02397837|81582593|FG000|Overall Study|Withdrawal by Subject|6|||
27641067|NCT01074294|80529074|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
27641068|NCT01074294|80529075|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
27641069|NCT01074294|80529076|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
27641070|NCT01074294|80529077|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
27929984|NCT02397837|81582594|FG001|Overall Study|Withdrawal by Subject|5|||
27929985|NCT02397837|81582593|FG000|Overall Study|Physician Decision|1|||
27929986|NCT02397837|81582594|FG001|Overall Study|Physician Decision|1|||
27929987|NCT02233413|81582595|FG000|Overall Study|Lost to Follow-up|7|||
27929988|NCT02233413|81582596|FG001|Overall Study|Lost to Follow-up|9|||
27929989|NCT02233413|81582595|FG000|Overall Study|Withdrawal by Subject|4|||
27929990|NCT02233413|81582596|FG001|Overall Study|Withdrawal by Subject|5|||
27929991|NCT02927145|81582597|FG000|Initial Recruitment|Withdrawal by Subject|0|||
27641071|NCT00205179|80529078|FG000|Overall Study|Death|0|||
27641072|NCT00205179|80529079|FG001|Overall Study|Death|2|||
27641073|NCT00205179|80529078|FG000|Overall Study|Physician Decision|1|||
27641074|NCT00205179|80529079|FG001|Overall Study|Physician Decision|1|||
27641075|NCT00205179|80529078|FG000|Overall Study|Adverse Event|1|||
27641076|NCT00205179|80529079|FG001|Overall Study|Adverse Event|1|||
27641077|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
27641078|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27641079|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27929992|NCT02927145|81582598|FG001|Initial Recruitment|Withdrawal by Subject|1|||
27929993|NCT02927145|81582599|FG002|Initial Recruitment|Withdrawal by Subject|1|||
27929994|NCT02927145|81582600|FG003|Initial Recruitment|Withdrawal by Subject|4|||
27929995|NCT02927145|81582601|FG004|Initial Recruitment|Withdrawal by Subject|1|||
27929996|NCT02927145|81582602|FG005|Initial Recruitment|Withdrawal by Subject|1|||
27929997|NCT02927145|81582603|FG006|Initial Recruitment|Withdrawal by Subject|0|||
27929998|NCT02927145|81582604|FG007|Initial Recruitment|Withdrawal by Subject|0|||
27929999|NCT02927145|81582605|FG008|Initial Recruitment|Withdrawal by Subject|2|||
27930000|NCT02927145|81582597|FG000|Initial Recruitment|Adverse Event|0|||
27930001|NCT02927145|81582598|FG001|Initial Recruitment|Adverse Event|0|||
27930002|NCT02927145|81582599|FG002|Initial Recruitment|Adverse Event|0|||
27930003|NCT02927145|81582600|FG003|Initial Recruitment|Adverse Event|0|||
27930004|NCT02927145|81582601|FG004|Initial Recruitment|Adverse Event|2|||
27930005|NCT02927145|81582602|FG005|Initial Recruitment|Adverse Event|0|||
27930006|NCT02927145|81582603|FG006|Initial Recruitment|Adverse Event|0|||
27930007|NCT02927145|81582604|FG007|Initial Recruitment|Adverse Event|0|||
27930008|NCT02927145|81582605|FG008|Initial Recruitment|Adverse Event|0|||
27930009|NCT02927145|81582597|FG000|Invitation for Additional Challenge|Pregnancy|0|||
27930010|NCT02927145|81582598|FG001|Invitation for Additional Challenge|Pregnancy|0|||
27930011|NCT02927145|81582599|FG002|Invitation for Additional Challenge|Pregnancy|0|||
27930012|NCT02927145|81582600|FG003|Invitation for Additional Challenge|Pregnancy|0|||
27930013|NCT02927145|81582601|FG004|Invitation for Additional Challenge|Pregnancy|0|||
27549986|NCT00855920|80200261|FG000|Overall Study|Lost to Follow-up|1|||
27549987|NCT00855920|80200262|FG001|Overall Study|Lost to Follow-up|0|||
27549988|NCT00855920|80200263|FG002|Overall Study|Lost to Follow-up|2|||
27549989|NCT00855920|80200261|FG000|Overall Study|Death|0|||
27549990|NCT00855920|80200262|FG001|Overall Study|Death|1|||
27549991|NCT00855920|80200263|FG002|Overall Study|Death|0|||
27549992|NCT00855920|80200261|FG000|Overall Study|Decision by the sponsor|0|||
27549993|NCT00855920|80200262|FG001|Overall Study|Decision by the sponsor|1|||
27549994|NCT00855920|80200263|FG002|Overall Study|Decision by the sponsor|1|||
27549995|NCT00855920|80200261|FG000|Overall Study|Other than specified above|1|||
27549996|NCT00855920|80200262|FG001|Overall Study|Other than specified above|1|||
27549997|NCT00855920|80200263|FG002|Overall Study|Other than specified above|1|||
27641080|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27930014|NCT02927145|81582602|FG005|Invitation for Additional Challenge|Pregnancy|0|||
27930015|NCT02927145|81582603|FG006|Invitation for Additional Challenge|Pregnancy|1|||
27930016|NCT02927145|81582604|FG007|Invitation for Additional Challenge|Pregnancy|0|||
27930017|NCT02927145|81582605|FG008|Invitation for Additional Challenge|Pregnancy|0|||
27930018|NCT01807520|81582608|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27930019|NCT01807520|81582609|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
27549998|NCT02397278|80200270|FG000|Overall Study|Withdrawal by Subject|0|||
27549999|NCT02397278|80200271|FG001|Overall Study|Withdrawal by Subject|2|||
27550000|NCT02397278|80200270|FG000|Overall Study|Deemed ineligible following surgery|1|||
27641081|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
27641082|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
27641083|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27641084|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27641085|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27641086|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
27641087|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
27641088|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27641089|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27641090|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27641091|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
27641092|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
27641093|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27930020|NCT01807520|81582610|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
27930021|NCT01807520|81582611|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27930022|NCT01807520|81582612|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27930023|NCT01807520|81582613|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27930024|NCT01807520|81582614|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
27930025|NCT01807520|81582608|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
27930026|NCT01807520|81582609|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27930027|NCT01807520|81582610|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
27930028|NCT01807520|81582611|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27930029|NCT01807520|81582612|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27930030|NCT01807520|81582613|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27930031|NCT01807520|81582614|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
27930032|NCT01807520|81582608|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27930033|NCT01807520|81582609|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27930034|NCT01807520|81582610|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
27930035|NCT01807520|81582611|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27930036|NCT01807520|81582612|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27930037|NCT01807520|81582613|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27930038|NCT01807520|81582614|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
27930039|NCT01807520|81582608|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
27930040|NCT01807520|81582609|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27930041|NCT01807520|81582610|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27930042|NCT01807520|81582611|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27930043|NCT01807520|81582612|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27930044|NCT01807520|81582613|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27930045|NCT01807520|81582614|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
27930046|NCT01807520|81582608|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27930047|NCT01807520|81582609|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27930048|NCT01807520|81582610|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
27930049|NCT01807520|81582611|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27930050|NCT01807520|81582612|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27930051|NCT01807520|81582613|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27930052|NCT01807520|81582614|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
27930053|NCT01807520|81582608|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
27930054|NCT01807520|81582609|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27930055|NCT01807520|81582610|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27930056|NCT01807520|81582611|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27930057|NCT01807520|81582612|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27930058|NCT01807520|81582613|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27930059|NCT01807520|81582614|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
27930060|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
27930061|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
27930062|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27930063|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27930064|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
27930065|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27930066|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
27930067|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27930068|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27641094|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27930069|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27930070|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
27930071|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27641095|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27641096|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
27641097|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
27641098|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27641099|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27930072|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27930073|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
27550001|NCT02397278|80200271|FG001|Overall Study|Deemed ineligible following surgery|1|||
27550002|NCT04851314|80200272|FG000|Overall Study|Unable to complete research set-up procedures|0|||
27550003|NCT04851314|80200273|FG001|Overall Study|Unable to complete research set-up procedures|2|||
27550004|NCT04851314|80200272|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
27550005|NCT04851314|80200273|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
27550006|NCT01516437|80200274|FG000|Overall Study|Reason not specified|0|||
27550007|NCT01516437|80200275|FG001|Overall Study|Reason not specified|0|||
27641100|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27641101|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
27641102|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
27641103|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27641104|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27641105|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27641106|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
27641107|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
27641108|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27641109|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27641110|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27641111|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
27641112|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
27641113|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27641114|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27641115|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27641116|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
27641117|NCT02409667|80529080|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
27641118|NCT02409667|80529081|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27641119|NCT02409667|80529082|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27641120|NCT02409667|80529083|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27641121|NCT02409667|80529084|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
27641122|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
27641123|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
27641124|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
27641125|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
27641126|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
27641127|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27641128|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27641129|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27641130|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
27641131|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
27641132|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
27641133|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
27641134|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
27641135|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
27641136|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
27641137|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
27641138|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
27641139|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
27641140|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
27742702|NCT00552305|80887007|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
27930074|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
27930075|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27550008|NCT01516437|80200276|FG002|Overall Study|Reason not specified|1|||
27550009|NCT01516437|80200277|FG003|Overall Study|Reason not specified|1|||
27550010|NCT00127660|80200278|FG000|Overall Study|Protocol Violation|3|||
27550011|NCT00127660|80200279|FG001|Overall Study|Protocol Violation|3|||
27550012|NCT00127660|80200280|FG002|Overall Study|Protocol Violation|5|||
27550013|NCT00127660|80200281|FG003|Overall Study|Protocol Violation|0|||
27550014|NCT02380677|80200283|FG000|Overall Study|Adverse Event|0|||
27930076|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27930077|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27930078|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27930079|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27930080|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
27930081|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27930082|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
27930083|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27930084|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27930085|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27930086|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27930087|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
27930088|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
27930089|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27641141|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
27641142|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
27641143|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
27641144|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
27641145|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
27641146|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
27641147|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
27641148|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
27641149|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
27641150|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
27742703|NCT00552305|80887007|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
27742704|NCT00552305|80887007|FG000|Overall Study|Unsatisfactory compliance|11|||
27742705|NCT00552305|80887007|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
27742706|NCT00552305|80887007|FG000|Overall Study|AE/Other: prohibited drug required|1|||
27742707|NCT00552305|80887007|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
27742708|NCT00552305|80887007|FG000|Overall Study|Other: Site closed|4|||
27742709|NCT00552305|80887007|FG000|Overall Study|Other: Personal problems|1|||
27742710|NCT00552305|80887007|FG000|Overall Study|Other: Unable to attend visits|1|||
27742711|NCT00552305|80887007|FG000|Overall Study|Other: Subject underwent surgery|4|||
27742712|NCT00552305|80887007|FG000|Overall Study|Other: Subject became pregnant|1|||
27742713|NCT00552305|80887007|FG000|Overall Study|Other: Health problems, not drug related|1|||
27742714|NCT00552305|80887007|FG000|Overall Study|Other: Subject moved from area|2|||
27742715|NCT00552305|80887007|FG000|Overall Study|Other: Subject incarcerated|1|||
27742716|NCT00552305|80887007|FG000|Overall Study|Other: Subject went to rehab|1|||
27742717|NCT02114203|80887008|FG000|Overall Study|Adverse Event|0|||
27641151|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
27641152|NCT02409667|80529080|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27742718|NCT02114203|80887009|FG001|Overall Study|Adverse Event|1|||
27742719|NCT02114203|80887010|FG002|Overall Study|Adverse Event|0|||
27742720|NCT02114203|80887008|FG000|Overall Study|Withdrawal by Subject|0|||
27742721|NCT02114203|80887009|FG001|Overall Study|Withdrawal by Subject|1|||
27742722|NCT02114203|80887010|FG002|Overall Study|Withdrawal by Subject|0|||
27742723|NCT03988751|80887011|FG000|Overall Study|Withdrawal by Subject|1|||
27742724|NCT03988751|80887012|FG001|Overall Study|Withdrawal by Subject|0|||
27930090|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27930091|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
27550015|NCT02380677|80200284|FG001|Overall Study|Adverse Event|0|||
27550016|NCT02380677|80200285|FG002|Overall Study|Adverse Event|0|||
27550017|NCT02380677|80200286|FG003|Overall Study|Adverse Event|1|||
27550018|NCT02380677|80200287|FG004|Overall Study|Adverse Event|1|||
27550019|NCT02380677|80200288|FG005|Overall Study|Adverse Event|4|||
27550020|NCT02380677|80200289|FG006|Overall Study|Adverse Event|2|||
27550021|NCT02380677|80200290|FG007|Overall Study|Adverse Event|2|||
27550022|NCT02380677|80200291|FG008|Overall Study|Adverse Event|2|||
27550023|NCT02380677|80200292|FG009|Overall Study|Adverse Event|1|||
27550024|NCT02380677|80200293|FG010|Overall Study|Adverse Event|2|||
27550025|NCT02380677|80200294|FG011|Overall Study|Adverse Event|1|||
27550026|NCT02380677|80200283|FG000|Overall Study|Physician Decision|1|||
27550027|NCT02380677|80200284|FG001|Overall Study|Physician Decision|0|||
27550028|NCT02380677|80200285|FG002|Overall Study|Physician Decision|1|||
27550029|NCT02380677|80200286|FG003|Overall Study|Physician Decision|1|||
27742725|NCT03988751|80887011|FG000|Overall Study|Protocol Violation|0|||
27742726|NCT03988751|80887012|FG001|Overall Study|Protocol Violation|1|||
27550030|NCT02380677|80200287|FG004|Overall Study|Physician Decision|0|||
27550031|NCT02380677|80200288|FG005|Overall Study|Physician Decision|0|||
27550032|NCT02380677|80200289|FG006|Overall Study|Physician Decision|0|||
27742727|NCT04983901|80887015|FG000|Overall Study|Death|1|||
27742728|NCT04983901|80887016|FG001|Overall Study|Death|4|||
27742729|NCT04983901|80887015|FG000|Overall Study|Lost to Follow-up|3|||
27742730|NCT04983901|80887016|FG001|Overall Study|Lost to Follow-up|0|||
27742731|NCT04983901|80887015|FG000|Overall Study|Protocol Violation|1|||
27742732|NCT04983901|80887016|FG001|Overall Study|Protocol Violation|0|||
27742733|NCT04983901|80887015|FG000|Overall Study|Withdrawal by Subject|1|||
27742734|NCT04983901|80887016|FG001|Overall Study|Withdrawal by Subject|2|||
27742735|NCT01364467|80887018|FG000|Overall Study|Lost to Follow-up|1|||
27742736|NCT01364467|80887019|FG001|Overall Study|Lost to Follow-up|2|||
27742737|NCT00570739|80887020|FG000|Overall Study|Adverse Event|8|||
27742738|NCT00570739|80887021|FG001|Overall Study|Adverse Event|6|||
27742739|NCT00570739|80887022|FG002|Overall Study|Adverse Event|2|||
27742740|NCT00570739|80887023|FG003|Overall Study|Adverse Event|2|||
27742741|NCT00570739|80887020|FG000|Overall Study|Lost to Follow-up|4|||
27742742|NCT00570739|80887021|FG001|Overall Study|Lost to Follow-up|5|||
27742743|NCT00570739|80887022|FG002|Overall Study|Lost to Follow-up|4|||
27641153|NCT02409667|80529081|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27641154|NCT02409667|80529082|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
27641155|NCT02409667|80529083|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27641156|NCT02409667|80529084|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
27641157|NCT00308997|80529085|FG000|Overall Study|Subject feigned clinical data|0|||
27641158|NCT00308997|80529086|FG001|Overall Study|Subject feigned clinical data|1|||
27641159|NCT00308997|80529085|FG000|Overall Study|Unable to tolerate intervention|1|||
27641160|NCT00308997|80529086|FG001|Overall Study|Unable to tolerate intervention|0|||
27641161|NCT03394885|80529087|FG000|Overall Study|Adverse Event|4|||
27641162|NCT03394885|80529087|FG000|Overall Study|Lack of Efficacy|1|||
27641163|NCT03394885|80529087|FG000|Overall Study|Physician Decision|1|||
27641164|NCT03394885|80529087|FG000|Overall Study|Withdrawal by Subject|8|||
27641165|NCT03394885|80529087|FG000|Overall Study|Alternative Therapy|1|||
27641166|NCT01639131|80529090|FG000|Overall Study|Disease Progression|6|||
27641167|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
27641168|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
27641169|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
27641170|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
27641171|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
27641172|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
27641173|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
27641174|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
27641175|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
27641176|NCT03939312|80529099|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
27641177|NCT03939312|80529099|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
27641178|NCT03939312|80529099|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
27641179|NCT01113931|80529100|FG000|Overall Study|Adverse Event|2|||
27641180|NCT01113931|80529101|FG001|Overall Study|Adverse Event|2|||
27641181|NCT01113931|80529100|FG000|Overall Study|Physician Decision|0|||
27641182|NCT01113931|80529101|FG001|Overall Study|Physician Decision|2|||
27641183|NCT01113931|80529100|FG000|Overall Study|Lost to Follow-up|12|||
27641184|NCT01113931|80529101|FG001|Overall Study|Lost to Follow-up|9|||
27641185|NCT01113931|80529100|FG000|Overall Study|Various|2|||
27641186|NCT01113931|80529101|FG001|Overall Study|Various|4|||
27641187|NCT01113931|80529100|FG000|Overall Study|Withdrawal by Subject|3|||
27641188|NCT01113931|80529101|FG001|Overall Study|Withdrawal by Subject|0|||
27641189|NCT00446459|80529108|FG000|8 Months|Protocol Violation|12|||
27641190|NCT00446459|80529108|FG000|12 Months|Protocol Violation|4|||
27641191|NCT00446459|80529108|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
27641192|NCT00077675|80529114|FG000|Overall Study|Adverse Event|1|||
27641193|NCT00077675|80529115|FG001|Overall Study|Adverse Event|2|||
27641194|NCT00077675|80529114|FG000|Overall Study|Lost to Follow-up|6|||
27742744|NCT00570739|80887023|FG003|Overall Study|Lost to Follow-up|1|||
27742745|NCT00570739|80887020|FG000|Overall Study|Physician Decision|1|||
27742746|NCT00570739|80887021|FG001|Overall Study|Physician Decision|1|||
27742747|NCT00570739|80887022|FG002|Overall Study|Physician Decision|0|||
27742748|NCT00570739|80887023|FG003|Overall Study|Physician Decision|0|||
27742749|NCT00570739|80887020|FG000|Overall Study|Withdrawal by Subject|7|||
27641195|NCT00077675|80529115|FG001|Overall Study|Lost to Follow-up|3|||
27641196|NCT00077675|80529114|FG000|Overall Study|Withdrawal by Subject|1|||
27641197|NCT00077675|80529115|FG001|Overall Study|Withdrawal by Subject|0|||
27742750|NCT00570739|80887021|FG001|Overall Study|Withdrawal by Subject|7|||
27742751|NCT00570739|80887022|FG002|Overall Study|Withdrawal by Subject|3|||
27742752|NCT00570739|80887023|FG003|Overall Study|Withdrawal by Subject|5|||
27742753|NCT00570739|80887020|FG000|Overall Study|Required restricted medication|0|||
27742754|NCT00570739|80887021|FG001|Overall Study|Required restricted medication|0|||
27641198|NCT00077675|80529114|FG000|Overall Study|Other|0|||
27742755|NCT00570739|80887022|FG002|Overall Study|Required restricted medication|1|||
27930092|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27930093|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27930094|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
27930095|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
27930096|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
27550033|NCT02380677|80200290|FG007|Overall Study|Physician Decision|0|||
27641199|NCT00077675|80529115|FG001|Overall Study|Other|1|||
27641200|NCT00077675|80529114|FG000|Overall Study|Never received study treatment|3|||
27641201|NCT00077675|80529115|FG001|Overall Study|Never received study treatment|3|||
27641202|NCT04512482|80529116|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
27641203|NCT04512482|80529117|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
27641204|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
27641205|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
27641206|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
27641207|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
27641208|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
27641209|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
27641210|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
27641211|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
27641212|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
27641213|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
27550034|NCT02380677|80200291|FG008|Overall Study|Physician Decision|0|||
27550035|NCT02380677|80200292|FG009|Overall Study|Physician Decision|0|||
27550036|NCT02380677|80200293|FG010|Overall Study|Physician Decision|0|||
27550037|NCT02380677|80200294|FG011|Overall Study|Physician Decision|0|||
27550038|NCT02380677|80200283|FG000|Overall Study|Lack of Efficacy|0|||
27550039|NCT02380677|80200284|FG001|Overall Study|Lack of Efficacy|1|||
27550040|NCT02380677|80200285|FG002|Overall Study|Lack of Efficacy|2|||
27550041|NCT02380677|80200286|FG003|Overall Study|Lack of Efficacy|0|||
27550042|NCT02380677|80200287|FG004|Overall Study|Lack of Efficacy|4|||
27550043|NCT02380677|80200288|FG005|Overall Study|Lack of Efficacy|1|||
27550044|NCT02380677|80200289|FG006|Overall Study|Lack of Efficacy|1|||
27550045|NCT02380677|80200290|FG007|Overall Study|Lack of Efficacy|2|||
27550046|NCT02380677|80200291|FG008|Overall Study|Lack of Efficacy|2|||
27550047|NCT02380677|80200292|FG009|Overall Study|Lack of Efficacy|0|||
27550048|NCT02380677|80200293|FG010|Overall Study|Lack of Efficacy|2|||
27550049|NCT02380677|80200294|FG011|Overall Study|Lack of Efficacy|1|||
27550050|NCT02380677|80200283|FG000|Overall Study|Withdrawal by Subject|0|||
27550051|NCT02380677|80200284|FG001|Overall Study|Withdrawal by Subject|0|||
27550052|NCT02380677|80200285|FG002|Overall Study|Withdrawal by Subject|0|||
27550053|NCT02380677|80200286|FG003|Overall Study|Withdrawal by Subject|0|||
27550054|NCT02380677|80200287|FG004|Overall Study|Withdrawal by Subject|0|||
27550055|NCT02380677|80200288|FG005|Overall Study|Withdrawal by Subject|0|||
27550056|NCT02380677|80200289|FG006|Overall Study|Withdrawal by Subject|0|||
27550057|NCT02380677|80200290|FG007|Overall Study|Withdrawal by Subject|0|||
27550058|NCT02380677|80200291|FG008|Overall Study|Withdrawal by Subject|0|||
27550059|NCT02380677|80200292|FG009|Overall Study|Withdrawal by Subject|1|||
27550060|NCT02380677|80200293|FG010|Overall Study|Withdrawal by Subject|0|||
27550061|NCT02380677|80200294|FG011|Overall Study|Withdrawal by Subject|3|||
27550062|NCT02380677|80200283|FG000|Overall Study|Other|0|||
27550063|NCT02380677|80200284|FG001|Overall Study|Other|0|||
27550064|NCT02380677|80200285|FG002|Overall Study|Other|0|||
27550065|NCT02380677|80200286|FG003|Overall Study|Other|1|||
27550066|NCT02380677|80200287|FG004|Overall Study|Other|1|||
27550067|NCT02380677|80200288|FG005|Overall Study|Other|1|||
27550068|NCT02380677|80200289|FG006|Overall Study|Other|0|||
27550069|NCT02380677|80200290|FG007|Overall Study|Other|0|||
27550070|NCT02380677|80200291|FG008|Overall Study|Other|0|||
27550071|NCT02380677|80200292|FG009|Overall Study|Other|0|||
27550072|NCT02380677|80200293|FG010|Overall Study|Other|0|||
27550073|NCT02380677|80200294|FG011|Overall Study|Other|0|||
27550074|NCT04502589|80200295|FG000|Overall Study|Physician Decision|1|||
27550075|NCT04502589|80200296|FG001|Overall Study|Physician Decision|0|||
27550076|NCT02101060|80200299|FG000|Overall Study|Adverse Event|1|||
27550077|NCT02101060|80200300|FG001|Overall Study|Adverse Event|0|||
27550078|NCT02101060|80200299|FG000|Overall Study|Withdrawal by Subject|1|||
27550079|NCT02101060|80200300|FG001|Overall Study|Withdrawal by Subject|1|||
27550080|NCT02101060|80200299|FG000|Overall Study|Lost to Follow-up|3|||
27550081|NCT02101060|80200300|FG001|Overall Study|Lost to Follow-up|3|||
27550082|NCT03470441|80200305|FG000|Overall Study|Death|0|||
27550083|NCT03470441|80200306|FG001|Overall Study|Death|1|||
27550084|NCT03470441|80200307|FG002|Overall Study|Death|1|||
27550085|NCT03470441|80200308|FG003|Overall Study|Death|0|||
27550086|NCT03470441|80200305|FG000|Overall Study|Adverse Event|0|||
27550087|NCT03470441|80200306|FG001|Overall Study|Adverse Event|0|||
27550088|NCT03470441|80200307|FG002|Overall Study|Adverse Event|0|||
27550089|NCT03470441|80200308|FG003|Overall Study|Adverse Event|1|||
27742756|NCT00570739|80887023|FG003|Overall Study|Required restricted medication|0|||
27742757|NCT00570739|80887020|FG000|Overall Study|Met discontinuation criteria|1|||
27742758|NCT00570739|80887021|FG001|Overall Study|Met discontinuation criteria|0|||
27742759|NCT00570739|80887022|FG002|Overall Study|Met discontinuation criteria|1|||
27742760|NCT00570739|80887023|FG003|Overall Study|Met discontinuation criteria|1|||
27742761|NCT00570739|80887020|FG000|Overall Study|Other|0|||
27742762|NCT00570739|80887021|FG001|Overall Study|Other|2|||
27742763|NCT00570739|80887022|FG002|Overall Study|Other|5|||
27742764|NCT00570739|80887023|FG003|Overall Study|Other|3|||
27742765|NCT02983292|80887030|FG000|Overall Study|Participant unwell & cannot travel|2|||
27742766|NCT02983292|80887030|FG000|Overall Study|Lost to Follow-up|3|||
27742767|NCT02983292|80887030|FG000|Overall Study|Participant withdrew consent|2|||
27742768|NCT02983292|80887030|FG000|Overall Study|Revision|7|||
27742769|NCT02983292|80887030|FG000|Overall Study|Death|1|||
27742770|NCT02983292|80887030|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
27742771|NCT02983292|80887030|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
27641214|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
27641215|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
27641216|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
27641217|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
27641218|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
27641219|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
27641220|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
27641221|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
27641222|NCT02222493|80529118|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
27641223|NCT02222493|80529119|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
27641224|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
27641225|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
27641226|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
27641227|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
27641228|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
27641229|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
27641230|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
27641231|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
27641232|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
27641233|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
27742772|NCT02983292|80887030|FG000|Overall Study|Participant relocation|1|||
27742773|NCT00399802|80887033|FG000|Overall Study|Adverse Event|0|||
27742774|NCT00399802|80887034|FG001|Overall Study|Adverse Event|2|||
27742775|NCT00399802|80887033|FG000|Overall Study|Participant discontinued by mistake|0|||
27742776|NCT00399802|80887034|FG001|Overall Study|Participant discontinued by mistake|1|||
27930097|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27930098|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27930099|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
27930100|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27930101|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
27930102|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
27930103|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
27930104|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27930105|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
27930106|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27930107|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27930108|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
27930109|NCT01807520|81582608|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
27930110|NCT01807520|81582609|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
27930111|NCT01807520|81582610|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
27550090|NCT03470441|80200305|FG000|Overall Study|Withdrawal by Subject|1|||
27550091|NCT03470441|80200306|FG001|Overall Study|Withdrawal by Subject|4|||
27550092|NCT03470441|80200307|FG002|Overall Study|Withdrawal by Subject|1|||
27550093|NCT03470441|80200308|FG003|Overall Study|Withdrawal by Subject|3|||
27550094|NCT03130257|80200309|FG000|Overall Study|Withdrawal by Subject|1|||
27550095|NCT03130257|80200310|FG001|Overall Study|Withdrawal by Subject|0|||
27550096|NCT03130257|80200311|FG002|Overall Study|Withdrawal by Subject|2|||
27550097|NCT02130570|80200314|FG000|Overall Study|Death|3|||
27550098|NCT02130570|80200315|FG001|Overall Study|Death|5|||
27550099|NCT02130570|80200314|FG000|Overall Study|Withdrawal by Subject|6|||
27742777|NCT02658656|80887037|FG000|Screening|Failed eligibility criteria|0|||
27550100|NCT02130570|80200315|FG001|Overall Study|Withdrawal by Subject|3|||
27550101|NCT02130570|80200314|FG000|Overall Study|Part of practice that discontinued study|0|||
27930112|NCT01807520|81582611|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
27930113|NCT01807520|81582612|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
27930114|NCT01807520|81582613|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
27641234|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
27641235|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
27641236|NCT02222493|80529118|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
27641237|NCT02222493|80529119|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
27641238|NCT02222493|80529118|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
27641239|NCT02222493|80529119|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
27641240|NCT02222493|80529118|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
27641241|NCT02222493|80529119|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
27641242|NCT02222493|80529118|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
27641243|NCT02222493|80529119|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
27641244|NCT02222493|80529118|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
27641245|NCT02222493|80529119|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
27641246|NCT02222493|80529118|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
27641247|NCT02222493|80529119|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
27641248|NCT00468052|80529120|FG000|Overall Study|Protocol Violation|7|||
27641249|NCT00468052|80529121|FG001|Overall Study|Protocol Violation|8|||
27641250|NCT00503906|80529122|FG000|Overall Study|Withdrawal by Subject|1|||
27641251|NCT02500758|80529123|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
27641252|NCT02500758|80529124|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
27641253|NCT02500758|80529123|FG000|Washout (1 Week)|Lost to Follow-up|2|||
27641254|NCT02500758|80529124|FG001|Washout (1 Week)|Lost to Follow-up|2|||
27641255|NCT02500758|80529123|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
27641256|NCT02500758|80529124|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
27641257|NCT02500758|80529123|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
27930115|NCT01807520|81582614|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
27641258|NCT02500758|80529124|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
27641259|NCT02500758|80529123|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
27641260|NCT02500758|80529124|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
27641261|NCT00249769|80529127|FG000|Overall Study|Withdrawal by Subject|1|||
27641262|NCT00249769|80529128|FG001|Overall Study|Withdrawal by Subject|10|||
27641263|NCT00249769|80529129|FG002|Overall Study|Withdrawal by Subject|6|||
27641264|NCT00249769|80529127|FG000|Overall Study|Migration from Study Area|1|||
27641265|NCT00249769|80529128|FG001|Overall Study|Migration from Study Area|3|||
27641266|NCT00249769|80529129|FG002|Overall Study|Migration from Study Area|14|||
27641267|NCT00249769|80529127|FG000|Overall Study|Miscellaneous|0|||
27641268|NCT00249769|80529128|FG001|Overall Study|Miscellaneous|2|||
27641269|NCT00249769|80529129|FG002|Overall Study|Miscellaneous|2|||
27641270|NCT00249769|80529127|FG000|Overall Study|Adverse Event|0|||
27641271|NCT00249769|80529128|FG001|Overall Study|Adverse Event|0|||
27641272|NCT00249769|80529129|FG002|Overall Study|Adverse Event|1|||
27930116|NCT01807520|81582608|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27930117|NCT01807520|81582609|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27930118|NCT01807520|81582610|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27930119|NCT01807520|81582611|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27930120|NCT01807520|81582612|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27930121|NCT01807520|81582613|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
27930122|NCT01807520|81582614|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
27930123|NCT01807520|81582608|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27930124|NCT01807520|81582609|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27930125|NCT01807520|81582610|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27930126|NCT01807520|81582611|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27930127|NCT01807520|81582612|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27930128|NCT01807520|81582613|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
27930129|NCT01807520|81582614|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
27930130|NCT01807520|81582608|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27930131|NCT01807520|81582609|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27930132|NCT01807520|81582610|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27930133|NCT01807520|81582611|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27930134|NCT01807520|81582612|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
27641273|NCT00249769|80529127|FG000|Overall Study|Physician Decision|0|||
27641274|NCT00249769|80529128|FG001|Overall Study|Physician Decision|0|||
27641275|NCT00249769|80529129|FG002|Overall Study|Physician Decision|2|||
27930135|NCT01807520|81582613|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
27930136|NCT01807520|81582614|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
27930137|NCT00849472|81582615|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
27930138|NCT00849472|81582615|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
27641276|NCT00249769|80529127|FG000|Overall Study|Lost to Follow-up|0|||
27641277|NCT00249769|80529128|FG001|Overall Study|Lost to Follow-up|0|||
27641278|NCT00249769|80529129|FG002|Overall Study|Lost to Follow-up|3|||
27641279|NCT02251652|80529134|FG000|Overall Study|Withdrawal by Subject|1|||
27641280|NCT01622868|80529135|FG000|Overall Study|Protocol Violation|7|||
27641281|NCT01622868|80529136|FG001|Overall Study|Protocol Violation|0|||
27641282|NCT04452318|80529137|FG000|Overall Study|Physician Decision|1|||
27641283|NCT04452318|80529138|FG001|Overall Study|Physician Decision|2|||
27641284|NCT04452318|80529139|FG002|Overall Study|Physician Decision|0|||
27641285|NCT04452318|80529140|FG003|Overall Study|Physician Decision|2|||
27742778|NCT02658656|80887038|FG001|Screening|Failed eligibility criteria|0|||
27742779|NCT02658656|80887039|FG002|Screening|Failed eligibility criteria|263|||
27742780|NCT02658656|80887037|FG000|Randomization|Withdrawal by Subject|8|||
27930139|NCT00849472|81582615|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
27930140|NCT00849472|81582615|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
27930141|NCT00849472|81582615|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
27930142|NCT00849472|81582615|FG000|Weekly Paclitaxel|Disease Progression|1|||
27930143|NCT00849472|81582615|FG000|Weekly Paclitaxel|Adverse Event|11|||
27930144|NCT00849472|81582615|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
27930145|NCT00849472|81582615|FG000|Weekly Paclitaxel|Physician Decision|3|||
27742781|NCT02658656|80887038|FG001|Randomization|Withdrawal by Subject|7|||
27742782|NCT02658656|80887039|FG002|Randomization|Withdrawal by Subject|0|||
27930146|NCT00849472|81582615|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
27930147|NCT00849472|81582615|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
27930148|NCT00849472|81582615|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
27930149|NCT00849472|81582615|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
27930150|NCT00849472|81582615|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
27930151|NCT00849472|81582615|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
27930152|NCT00849472|81582615|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
27930153|NCT00849472|81582615|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
27930154|NCT01363440|81582616|FG000|Overall Study|Adverse Event|5|||
27930155|NCT01363440|81582617|FG001|Overall Study|Adverse Event|4|||
27930156|NCT01363440|81582618|FG002|Overall Study|Adverse Event|4|||
27550102|NCT02130570|80200315|FG001|Overall Study|Part of practice that discontinued study|5|||
27550103|NCT00790023|80200330|FG000|Overall Study|Adverse Event|2|||
27550104|NCT00790023|80200331|FG001|Overall Study|Adverse Event|1|||
27550105|NCT00790023|80200332|FG002|Overall Study|Adverse Event|4|||
27550106|NCT00790023|80200330|FG000|Overall Study|Protocol Violation|2|||
27550107|NCT00790023|80200331|FG001|Overall Study|Protocol Violation|4|||
27550108|NCT00790023|80200332|FG002|Overall Study|Protocol Violation|2|||
27550109|NCT00790023|80200330|FG000|Overall Study|Withdrawal by Subject|2|||
27550110|NCT00790023|80200331|FG001|Overall Study|Withdrawal by Subject|0|||
27550111|NCT00790023|80200332|FG002|Overall Study|Withdrawal by Subject|6|||
27550112|NCT00790023|80200330|FG000|Overall Study|Lost to Follow-up|0|||
27550113|NCT00790023|80200331|FG001|Overall Study|Lost to Follow-up|0|||
27550114|NCT00790023|80200332|FG002|Overall Study|Lost to Follow-up|1|||
27550115|NCT00790023|80200330|FG000|Overall Study|Other|5|||
27550116|NCT00790023|80200331|FG001|Overall Study|Other|5|||
27550117|NCT00790023|80200332|FG002|Overall Study|Other|8|||
27550118|NCT00496054|80200335|FG000|Overall Study|Adverse Event|1|||
27550119|NCT00496054|80200335|FG000|Overall Study|Lost to Follow-up|7|||
27550120|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
27550121|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
27550122|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
27550123|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
27550124|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
27550125|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
27550126|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
27550127|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
27550128|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Other|1|||
27550129|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Other|4|||
27550130|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Other|3|||
27550131|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Other|6|||
27550132|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
27550133|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
27550134|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
27550135|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
27641286|NCT04452318|80529141|FG004|Overall Study|Physician Decision|0|||
27742783|NCT02658656|80887037|FG000|Randomization|Lost to Follow-up|1|||
27550136|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
27930157|NCT01363440|81582616|FG000|Overall Study|Death|3|||
27930158|NCT01363440|81582617|FG001|Overall Study|Death|7|||
27930159|NCT01363440|81582618|FG002|Overall Study|Death|5|||
27550137|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
27930160|NCT01363440|81582616|FG000|Overall Study|Withdrawal by Subject|9|||
27930161|NCT01363440|81582617|FG001|Overall Study|Withdrawal by Subject|11|||
27930162|NCT01363440|81582618|FG002|Overall Study|Withdrawal by Subject|11|||
27930163|NCT01363440|81582616|FG000|Overall Study|Lost to Follow-up|2|||
27930164|NCT01363440|81582617|FG001|Overall Study|Lost to Follow-up|4|||
27930165|NCT01363440|81582618|FG002|Overall Study|Lost to Follow-up|5|||
27930166|NCT01363440|81582616|FG000|Overall Study|Other|4|||
27930167|NCT01363440|81582617|FG001|Overall Study|Other|5|||
27930168|NCT01363440|81582618|FG002|Overall Study|Other|2|||
27930169|NCT03624036|81582627|FG000|Overall Study|Death|2|||
27930170|NCT03624036|81582628|FG001|Overall Study|Death|3|||
27930171|NCT03624036|81582629|FG002|Overall Study|Death|0|||
27930172|NCT03624036|81582630|FG003|Overall Study|Death|1|||
27930173|NCT03624036|81582627|FG000|Overall Study|Withdrawal by Subject|1|||
27930174|NCT03624036|81582628|FG001|Overall Study|Withdrawal by Subject|0|||
27930175|NCT03624036|81582629|FG002|Overall Study|Withdrawal by Subject|1|||
27930176|NCT03624036|81582630|FG003|Overall Study|Withdrawal by Subject|0|||
27930177|NCT03624036|81582627|FG000|Overall Study|Enrolled but Never Treated|1|||
27930178|NCT03624036|81582628|FG001|Overall Study|Enrolled but Never Treated|0|||
27930179|NCT03624036|81582629|FG002|Overall Study|Enrolled but Never Treated|0|||
27930180|NCT03624036|81582630|FG003|Overall Study|Enrolled but Never Treated|0|||
27930181|NCT03624036|81582627|FG000|Overall Study|Reason not Specified|3|||
27930182|NCT03624036|81582628|FG001|Overall Study|Reason not Specified|0|||
27930183|NCT03624036|81582629|FG002|Overall Study|Reason not Specified|2|||
27930184|NCT03624036|81582630|FG003|Overall Study|Reason not Specified|2|||
27930185|NCT03286504|81582631|FG000|Overall Study|Lost to Follow-up|19|||
27930186|NCT03286504|81582632|FG001|Overall Study|Lost to Follow-up|16|||
27930187|NCT01239680|81582633|FG000|Overall Study|Withdrawal by Subject|2|||
27930188|NCT01239680|81582634|FG001|Overall Study|Withdrawal by Subject|0|||
27930189|NCT01531153|81582641|FG000|Overall Study|Withdrawal by Subject|10|||
27930190|NCT01531153|81582642|FG001|Overall Study|Withdrawal by Subject|9|||
27930191|NCT01531153|81582643|FG002|Overall Study|Withdrawal by Subject|15|||
27930192|NCT04307394|81582644|FG000|Overall Study|Lost to Follow-up|3|||
27930193|NCT04307394|81582644|FG000|Overall Study|Withdrawal by Subject|2|||
27930194|NCT02393755|81582645|FG000|Overall Study|Withdrawal by Subject|0|||
27930195|NCT02393755|81582646|FG001|Overall Study|Withdrawal by Subject|3|||
27930196|NCT02393755|81582645|FG000|Overall Study|Adverse Event|0|||
27930197|NCT02393755|81582646|FG001|Overall Study|Adverse Event|2|||
27930198|NCT02393755|81582645|FG000|Overall Study|Physician Decision|0|||
27930199|NCT02393755|81582646|FG001|Overall Study|Physician Decision|2|||
27930200|NCT01334515|81582647|FG000|Overall Study|Adverse Event|1|||
27930201|NCT01334515|81582648|FG001|Overall Study|Adverse Event|6|||
27930202|NCT01334515|81582647|FG000|Overall Study|Death|1|||
27930203|NCT01334515|81582648|FG001|Overall Study|Death|0|||
27930204|NCT01334515|81582647|FG000|Overall Study|Lack of Efficacy|8|||
27930205|NCT01334515|81582648|FG001|Overall Study|Lack of Efficacy|21|||
27930206|NCT01334515|81582647|FG000|Overall Study|Physician Decision|1|||
27550138|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
27550139|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
27550140|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
27550141|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
27550142|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
27550143|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
27550144|NCT02925494|80200336|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
27550145|NCT02925494|80200337|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
27550146|NCT02925494|80200338|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
27550147|NCT02925494|80200339|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
27550148|NCT02706691|80200342|FG000|Overall Study|Adverse Event|1|||
27550149|NCT04051008|80200345|FG000|Overall Study|Withdrawal by Subject|2|||
27550150|NCT04051008|80200346|FG001|Overall Study|Withdrawal by Subject|0|||
27550151|NCT04051008|80200347|FG002|Overall Study|Withdrawal by Subject|1|||
27930207|NCT01334515|81582648|FG001|Overall Study|Physician Decision|1|||
27930208|NCT01334515|81582647|FG000|Overall Study|Withdrawal by Subject|1|||
27930209|NCT01334515|81582648|FG001|Overall Study|Withdrawal by Subject|1|||
27930210|NCT01311661|81582649|FG000|Overall Study|Adverse Event|2|||
27930211|NCT01311661|81582649|FG000|Overall Study|Protocol Violation|3|||
27930212|NCT01311661|81582649|FG000|Overall Study|Withdrawal by Subject|2|||
27930213|NCT02788045|81582650|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
27550152|NCT00867568|80200348|FG000|Overall Study|Lack of Efficacy|10|||
27550153|NCT00867568|80200348|FG000|Overall Study|Adverse Event|4|||
27550154|NCT00867568|80200348|FG000|Overall Study|Withdrawal by Subject|1|||
27550155|NCT00660023|80200354|FG000|Overall Study|Adverse Event|2|||
27550156|NCT00660023|80200354|FG000|Overall Study|Death|8|||
27930214|NCT02788045|81582651|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
27930215|NCT02788045|81582652|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
27930216|NCT02788045|81582650|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
27930217|NCT02788045|81582651|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
27930218|NCT02788045|81582652|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
27930219|NCT02788045|81582650|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
27930220|NCT02788045|81582651|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
27930221|NCT02788045|81582652|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
27930222|NCT02788045|81582650|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
27930223|NCT02788045|81582651|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
27930224|NCT02788045|81582652|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
27930225|NCT02788045|81582650|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
27930226|NCT02788045|81582651|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
27641287|NCT04452318|80529142|FG005|Overall Study|Physician Decision|2|||
27641288|NCT04452318|80529143|FG006|Overall Study|Physician Decision|5|||
27641289|NCT04452318|80529137|FG000|Overall Study|Death|2|||
27641290|NCT04452318|80529138|FG001|Overall Study|Death|3|||
27641291|NCT04452318|80529139|FG002|Overall Study|Death|0|||
27641292|NCT04452318|80529140|FG003|Overall Study|Death|0|||
27641293|NCT04452318|80529141|FG004|Overall Study|Death|0|||
27641294|NCT04452318|80529142|FG005|Overall Study|Death|0|||
27641295|NCT04452318|80529143|FG006|Overall Study|Death|0|||
27930227|NCT02788045|81582652|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
27641296|NCT04452318|80529137|FG000|Overall Study|Lost to Follow-up|38|||
27641297|NCT04452318|80529138|FG001|Overall Study|Lost to Follow-up|28|||
27641298|NCT04452318|80529139|FG002|Overall Study|Lost to Follow-up|0|||
27641299|NCT04452318|80529140|FG003|Overall Study|Lost to Follow-up|3|||
27641300|NCT04452318|80529141|FG004|Overall Study|Lost to Follow-up|3|||
27641301|NCT04452318|80529142|FG005|Overall Study|Lost to Follow-up|2|||
27641302|NCT04452318|80529143|FG006|Overall Study|Lost to Follow-up|1|||
27641303|NCT04452318|80529137|FG000|Overall Study|Withdrawal by Subject|46|||
27641304|NCT04452318|80529138|FG001|Overall Study|Withdrawal by Subject|40|||
27641305|NCT04452318|80529139|FG002|Overall Study|Withdrawal by Subject|0|||
27641306|NCT04452318|80529140|FG003|Overall Study|Withdrawal by Subject|18|||
27641307|NCT04452318|80529141|FG004|Overall Study|Withdrawal by Subject|6|||
27641308|NCT04452318|80529142|FG005|Overall Study|Withdrawal by Subject|8|||
27641309|NCT04452318|80529143|FG006|Overall Study|Withdrawal by Subject|6|||
27641310|NCT02426138|80529145|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27641311|NCT02426138|80529146|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
27641312|NCT02754596|80529147|FG000|Overall Study|Withdrawal by Subject|3|||
27641313|NCT02754596|80529148|FG001|Overall Study|Withdrawal by Subject|4|||
27641314|NCT02754596|80529149|FG002|Overall Study|Withdrawal by Subject|0|||
27641315|NCT02754596|80529147|FG000|Overall Study|Physician Decision|1|||
27641316|NCT02754596|80529148|FG001|Overall Study|Physician Decision|1|||
27641317|NCT02754596|80529149|FG002|Overall Study|Physician Decision|1|||
27641318|NCT02754596|80529147|FG000|Overall Study|Lost to Follow-up|1|||
27641319|NCT02754596|80529148|FG001|Overall Study|Lost to Follow-up|1|||
27641320|NCT02754596|80529149|FG002|Overall Study|Lost to Follow-up|2|||
27641321|NCT02754596|80529147|FG000|Overall Study|Death|0|||
27641322|NCT02754596|80529148|FG001|Overall Study|Death|2|||
27641323|NCT02754596|80529149|FG002|Overall Study|Death|0|||
27641324|NCT02754596|80529147|FG000|Overall Study|Adverse Event|1|||
27930228|NCT02788045|81582650|FG000|Main Study (Up to Week 72)|Other|3|||
27930229|NCT02788045|81582651|FG001|Main Study (Up to Week 72)|Other|0|||
27930230|NCT02788045|81582652|FG002|Main Study (Up to Week 72)|Other|0|||
27930231|NCT02788045|81582650|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
27930232|NCT02788045|81582651|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
27930233|NCT02788045|81582652|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
27930234|NCT02788045|81582650|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
27930235|NCT02788045|81582651|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
27930236|NCT02788045|81582652|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
27930237|NCT02788045|81582650|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
27930238|NCT02788045|81582651|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
27930239|NCT02788045|81582652|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
27930240|NCT01755637|81582654|FG000|Period 1|Adverse Event|0|||
27930241|NCT01755637|81582655|FG001|Period 1|Adverse Event|1|||
27930242|NCT02100631|81582656|FG000|Overall Study|Withdrawal by Subject|1|||
27641325|NCT02754596|80529148|FG001|Overall Study|Adverse Event|0|||
27641326|NCT02754596|80529149|FG002|Overall Study|Adverse Event|1|||
27641327|NCT02754596|80529147|FG000|Overall Study|Other|1|||
27641328|NCT02754596|80529148|FG001|Overall Study|Other|0|||
27742784|NCT02658656|80887038|FG001|Randomization|Lost to Follow-up|3|||
27930243|NCT02100631|81582657|FG001|Overall Study|Withdrawal by Subject|0|||
27930244|NCT02100631|81582658|FG002|Overall Study|Withdrawal by Subject|0|||
27641329|NCT02754596|80529149|FG002|Overall Study|Other|0|||
27641330|NCT03283371|80529155|FG000|Placebo-controlled|Adverse Event|1|||
27641331|NCT03283371|80529156|FG001|Placebo-controlled|Adverse Event|1|||
27641332|NCT03283371|80529157|FG002|Placebo-controlled|Adverse Event|0|||
27641333|NCT03283371|80529158|FG003|Placebo-controlled|Adverse Event|0|||
27641334|NCT03283371|80529155|FG000|Placebo-controlled|Lack of Efficacy|1|||
27641335|NCT03283371|80529156|FG001|Placebo-controlled|Lack of Efficacy|0|||
27742785|NCT02658656|80887039|FG002|Randomization|Lost to Follow-up|0|||
27742786|NCT02658656|80887037|FG000|Randomization|Adverse Event|4|||
27742787|NCT02658656|80887038|FG001|Randomization|Adverse Event|0|||
27742788|NCT02658656|80887039|FG002|Randomization|Adverse Event|0|||
27742789|NCT02658656|80887037|FG000|Randomization|Administrative Termination|3|||
27742790|NCT02658656|80887038|FG001|Randomization|Administrative Termination|1|||
27742791|NCT02658656|80887039|FG002|Randomization|Administrative Termination|0|||
27930245|NCT02100631|81582656|FG000|Overall Study|Lost to Follow-up|3|||
27930246|NCT02100631|81582657|FG001|Overall Study|Lost to Follow-up|4|||
27930247|NCT02100631|81582658|FG002|Overall Study|Lost to Follow-up|0|||
27930248|NCT02100631|81582656|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
27930249|NCT02100631|81582657|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
27930250|NCT02100631|81582658|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
27930251|NCT01901562|81582659|FG000|Overall Study|Protocol Violation|5|||
27930252|NCT01901562|81582659|FG000|Overall Study|Excluded intraoperatively|4|||
27930253|NCT01137812|81582660|FG000|Overall Study|Adverse Event|21|||
27930254|NCT01137812|81582661|FG001|Overall Study|Adverse Event|14|||
27742792|NCT02658656|80887037|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
27930255|NCT01137812|81582660|FG000|Overall Study|Lost to Follow-up|6|||
27930256|NCT01137812|81582661|FG001|Overall Study|Lost to Follow-up|8|||
27930257|NCT01137812|81582660|FG000|Overall Study|Physician Decision|25|||
27930258|NCT01137812|81582661|FG001|Overall Study|Physician Decision|17|||
27930259|NCT01137812|81582660|FG000|Overall Study|Protocol Violation|5|||
27930260|NCT01137812|81582661|FG001|Overall Study|Protocol Violation|4|||
27930261|NCT01137812|81582660|FG000|Overall Study|Withdrawal by Subject|5|||
27930262|NCT01137812|81582661|FG001|Overall Study|Withdrawal by Subject|13|||
27930263|NCT01137812|81582660|FG000|Overall Study|Death|2|||
27930264|NCT01137812|81582661|FG001|Overall Study|Death|0|||
27930265|NCT01137812|81582660|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
27930266|NCT01137812|81582661|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
27930267|NCT01137812|81582660|FG000|Overall Study|Other|19|||
27930268|NCT01137812|81582661|FG001|Overall Study|Other|27|||
27930269|NCT00221104|81582662|FG000|Overall Study|Adverse Event|1|||
27930270|NCT00221104|81582663|FG001|Overall Study|Adverse Event|0|||
27930271|NCT00221104|81582662|FG000|Overall Study|Physician Decision|1|||
27930272|NCT00221104|81582663|FG001|Overall Study|Physician Decision|0|||
27930273|NCT00221104|81582662|FG000|Overall Study|Protocol Violation|2|||
27930274|NCT00221104|81582663|FG001|Overall Study|Protocol Violation|0|||
27930275|NCT00221104|81582662|FG000|Overall Study|Withdrawal by Subject|42|||
27550157|NCT00660023|80200354|FG000|Overall Study|Blood Transfusion|5|||
27550158|NCT00660023|80200354|FG000|Overall Study|Renal Transplantation|3|||
27550159|NCT00660023|80200354|FG000|Overall Study|Withdrawal by Subject|1|||
27550160|NCT00660023|80200354|FG000|Overall Study|Missed Pregnancy Test|1|||
27550161|NCT00660023|80200354|FG000|Overall Study|Other Screening Failure|9|||
27550162|NCT00105469|80200357|FG000|Overall Study|Adverse Event|9|||
27550163|NCT00105469|80200358|FG001|Overall Study|Adverse Event|8|||
27550164|NCT00105469|80200357|FG000|Overall Study|Protocol Violation|4|||
27550165|NCT00105469|80200358|FG001|Overall Study|Protocol Violation|0|||
27550166|NCT00105469|80200357|FG000|Overall Study|Withdrawal by Subject|2|||
27550167|NCT00105469|80200358|FG001|Overall Study|Withdrawal by Subject|3|||
27550168|NCT00105469|80200357|FG000|Overall Study|Lost to Follow-up|1|||
27550169|NCT00105469|80200358|FG001|Overall Study|Lost to Follow-up|0|||
27550170|NCT00105469|80200357|FG000|Overall Study|Lack of Efficacy|2|||
27550171|NCT00105469|80200358|FG001|Overall Study|Lack of Efficacy|0|||
27550172|NCT00105469|80200357|FG000|Overall Study|Other Reason|4|||
27550173|NCT00105469|80200358|FG001|Overall Study|Other Reason|0|||
27550174|NCT03281577|80200359|FG000|Overall Study|Adverse Event|0|||
27550175|NCT03281577|80200360|FG001|Overall Study|Adverse Event|0|||
27550176|NCT03281577|80200361|FG002|Overall Study|Adverse Event|0|||
27550177|NCT03281577|80200362|FG003|Overall Study|Adverse Event|1|||
27550178|NCT03281577|80200359|FG000|Overall Study|Withdrawal by Subject|1|||
27550179|NCT03281577|80200360|FG001|Overall Study|Withdrawal by Subject|0|||
27550180|NCT03281577|80200361|FG002|Overall Study|Withdrawal by Subject|0|||
27550181|NCT03281577|80200362|FG003|Overall Study|Withdrawal by Subject|0|||
27550182|NCT02732119|80200369|FG000|Phase I|Adverse Event|1|||
27550183|NCT02732119|80200370|FG001|Phase I|Adverse Event|3|||
27550184|NCT02732119|80200371|FG002|Phase I|Adverse Event|1|||
27550185|NCT02732119|80200372|FG003|Phase I|Adverse Event|0|||
27930276|NCT00221104|81582663|FG001|Overall Study|Withdrawal by Subject|29|||
27930277|NCT00221104|81582662|FG000|Overall Study|Others|37|||
27930278|NCT00221104|81582663|FG001|Overall Study|Others|47|||
27930279|NCT05350423|81582664|FG000|Overall Study|Lost to Follow-up|3|||
27930280|NCT05350423|81582665|FG001|Overall Study|Lost to Follow-up|3|||
27930281|NCT05350423|81582664|FG000|Overall Study|screen failure|5|||
27930282|NCT05350423|81582665|FG001|Overall Study|screen failure|6|||
27930283|NCT00764517|81582670|FG000|Overall Study|Adverse Event|9|||
27550186|NCT02732119|80200373|FG004|Phase I|Adverse Event|0|||
27550187|NCT02732119|80200369|FG000|Phase I|Progressive disease|7|||
27641336|NCT03283371|80529157|FG002|Placebo-controlled|Lack of Efficacy|0|||
27641337|NCT03283371|80529158|FG003|Placebo-controlled|Lack of Efficacy|0|||
27641338|NCT03283371|80529155|FG000|Placebo-controlled|Withdrawal by Subject|1|||
27641339|NCT03283371|80529156|FG001|Placebo-controlled|Withdrawal by Subject|1|||
27641340|NCT03283371|80529157|FG002|Placebo-controlled|Withdrawal by Subject|0|||
27641341|NCT03283371|80529158|FG003|Placebo-controlled|Withdrawal by Subject|0|||
27641342|NCT03283371|80529155|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
27641343|NCT03283371|80529156|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
27641344|NCT03283371|80529157|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
27641345|NCT03283371|80529158|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
27641346|NCT03283371|80529155|FG000|Open-label Phase|Adverse Event|0|||
27641347|NCT03283371|80529156|FG001|Open-label Phase|Adverse Event|0|||
27641348|NCT03283371|80529157|FG002|Open-label Phase|Adverse Event|2|||
27641349|NCT03283371|80529158|FG003|Open-label Phase|Adverse Event|0|||
27641350|NCT03283371|80529155|FG000|Open-label Phase|Withdrawal by Subject|0|||
27641351|NCT03283371|80529156|FG001|Open-label Phase|Withdrawal by Subject|0|||
27641352|NCT03283371|80529157|FG002|Open-label Phase|Withdrawal by Subject|1|||
27641353|NCT03283371|80529158|FG003|Open-label Phase|Withdrawal by Subject|0|||
27641354|NCT03283371|80529155|FG000|Open-label Phase|Other|0|||
27641355|NCT03283371|80529156|FG001|Open-label Phase|Other|0|||
27641356|NCT03283371|80529157|FG002|Open-label Phase|Other|1|||
27641357|NCT03283371|80529158|FG003|Open-label Phase|Other|1|||
27641358|NCT02910713|80529159|FG000|Overall Study|Protocol Violation|2|||
27641359|NCT02910713|80529159|FG000|Overall Study|Subject Choice|4|||
27641360|NCT02910713|80529159|FG000|Overall Study|Received One Application|10|||
27641361|NCT02910713|80529159|FG000|Overall Study|Received Neither Application|18|||
27641362|NCT02910713|80529159|FG000|Overall Study|Enrollment cap|7|||
27641363|NCT02910713|80529159|FG000|Overall Study|Investigator Discretion|1|||
27641364|NCT00150813|80529160|FG000|Overall Study|Adverse Event|1|||
27641365|NCT00150813|80529160|FG000|Overall Study|Lack of Efficacy|1|||
27641366|NCT00150813|80529160|FG000|Overall Study|Lost to Follow-up|5|||
27641367|NCT00150813|80529160|FG000|Overall Study|Withdrawal by Subject|5|||
27641368|NCT00150813|80529160|FG000|Overall Study|Remission|3|||
27641369|NCT00150813|80529160|FG000|Overall Study|Planned pregancy|1|||
27641370|NCT00150813|80529160|FG000|Overall Study|Switch to commercially available LEV|2|||
27641371|NCT00709098|80529163|FG000|Double-blind Period|Withdrawal of consent|3|||
27641372|NCT00709098|80529164|FG001|Double-blind Period|Withdrawal of consent|3|||
27641373|NCT00709098|80529165|FG002|Double-blind Period|Withdrawal of consent|0|||
27641374|NCT00709098|80529163|FG000|Double-blind Period|Administrative reason|1|||
27641375|NCT00709098|80529164|FG001|Double-blind Period|Administrative reason|3|||
27641376|NCT00709098|80529165|FG002|Double-blind Period|Administrative reason|0|||
27641377|NCT00709098|80529163|FG000|Double-blind Period|Death|1|||
27641378|NCT00709098|80529164|FG001|Double-blind Period|Death|1|||
27641379|NCT00709098|80529165|FG002|Double-blind Period|Death|0|||
27641380|NCT00709098|80529163|FG000|Double-blind Period|Lost to Follow-up|1|||
27641381|NCT00709098|80529164|FG001|Double-blind Period|Lost to Follow-up|1|||
27641382|NCT00709098|80529165|FG002|Double-blind Period|Lost to Follow-up|0|||
27641383|NCT00709098|80529163|FG000|Open-label Period|Withdrawal of consent|0|||
27641384|NCT00709098|80529164|FG001|Open-label Period|Withdrawal of consent|0|||
27641385|NCT00709098|80529165|FG002|Open-label Period|Withdrawal of consent|7|||
27641386|NCT00709098|80529163|FG000|Open-label Period|Administrative reason|0|||
27641387|NCT00709098|80529164|FG001|Open-label Period|Administrative reason|0|||
27641388|NCT00709098|80529165|FG002|Open-label Period|Administrative reason|5|||
27641389|NCT00709098|80529163|FG000|Open-label Period|Death|0|||
27641390|NCT00709098|80529164|FG001|Open-label Period|Death|0|||
27641391|NCT00709098|80529165|FG002|Open-label Period|Death|1|||
27641392|NCT00709098|80529163|FG000|Open-label Period|Lost to Follow-up|0|||
27641393|NCT00709098|80529164|FG001|Open-label Period|Lost to Follow-up|0|||
27641394|NCT00709098|80529165|FG002|Open-label Period|Lost to Follow-up|1|||
27641395|NCT02029235|80529166|FG000|Overall Study|Non-compliance with study meds or diary|4|||
27641396|NCT02029235|80529167|FG001|Overall Study|Non-compliance with study meds or diary|1|||
27930284|NCT00764517|81582671|FG001|Overall Study|Adverse Event|3|||
27641397|NCT02463448|80529168|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
27641398|NCT02463448|80529168|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
27641399|NCT02463448|80529168|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
27930285|NCT00764517|81582670|FG000|Overall Study|Death|3|||
27641400|NCT02463448|80529168|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
27641401|NCT00603954|80529169|FG000|Overall Study|Protocol Violation|1|||
27641402|NCT00603954|80529170|FG001|Overall Study|Protocol Violation|2|||
27641403|NCT02379819|80529171|FG000|Overall Study|Withdrawal by Subject|10|||
27641404|NCT02379819|80529171|FG000|Overall Study|Death|2|||
27641405|NCT02379819|80529171|FG000|Overall Study|Lack of Efficacy|1|||
27641406|NCT02379819|80529171|FG000|Overall Study|Lost to Follow-up|1|||
27641407|NCT00611559|80529172|FG000|Overall Study|Lost to Follow-up|0|||
27641408|NCT00611559|80529173|FG001|Overall Study|Lost to Follow-up|1|||
27641409|NCT00611559|80529174|FG002|Overall Study|Lost to Follow-up|0|||
27641410|NCT00611559|80529172|FG000|Overall Study|Protocol Violation|1|||
27930286|NCT00764517|81582671|FG001|Overall Study|Death|11|||
27930287|NCT00764517|81582670|FG000|Overall Study|Physician Decision|3|||
27930288|NCT00764517|81582671|FG001|Overall Study|Physician Decision|0|||
27930289|NCT04518410|81582672|FG000|Overall Study|Lost to Follow-up|1|||
27930290|NCT04518410|81582673|FG001|Overall Study|Lost to Follow-up|1|||
27930291|NCT04518410|81582674|FG002|Overall Study|Lost to Follow-up|8|||
27930292|NCT04518410|81582675|FG003|Overall Study|Lost to Follow-up|5|||
27930293|NCT04518410|81582676|FG004|Overall Study|Lost to Follow-up|92|||
27930294|NCT04518410|81582677|FG005|Overall Study|Lost to Follow-up|25|||
27930295|NCT04518410|81582678|FG006|Overall Study|Lost to Follow-up|25|||
27930296|NCT04518410|81582679|FG007|Overall Study|Lost to Follow-up|3|||
27641411|NCT00611559|80529173|FG001|Overall Study|Protocol Violation|0|||
27641412|NCT00611559|80529174|FG002|Overall Study|Protocol Violation|1|||
27641413|NCT03644849|80529175|FG000|Overall Study|Lost to Follow-up|1|||
27641414|NCT03644849|80529176|FG001|Overall Study|Lost to Follow-up|3|||
27641415|NCT01236560|80529177|FG000|Overall Study|Adverse Event|0|||
27641416|NCT01236560|80529178|FG001|Overall Study|Adverse Event|2|||
27641417|NCT01236560|80529179|FG002|Overall Study|Adverse Event|1|||
27641418|NCT01236560|80529180|FG003|Overall Study|Adverse Event|3|||
27641419|NCT01236560|80529181|FG004|Overall Study|Adverse Event|0|||
27641420|NCT01236560|80529182|FG005|Overall Study|Adverse Event|0|||
27641421|NCT01236560|80529177|FG000|Overall Study|Death|0|||
27641422|NCT01236560|80529178|FG001|Overall Study|Death|1|||
27641423|NCT01236560|80529179|FG002|Overall Study|Death|0|||
27641424|NCT01236560|80529180|FG003|Overall Study|Death|1|||
27641425|NCT01236560|80529181|FG004|Overall Study|Death|0|||
27641426|NCT01236560|80529182|FG005|Overall Study|Death|0|||
27641427|NCT01236560|80529177|FG000|Overall Study|Lost to Follow-up|0|||
27641428|NCT01236560|80529178|FG001|Overall Study|Lost to Follow-up|1|||
27641429|NCT01236560|80529179|FG002|Overall Study|Lost to Follow-up|1|||
27641430|NCT01236560|80529180|FG003|Overall Study|Lost to Follow-up|0|||
27641431|NCT01236560|80529181|FG004|Overall Study|Lost to Follow-up|0|||
27641432|NCT01236560|80529182|FG005|Overall Study|Lost to Follow-up|0|||
27641433|NCT01236560|80529177|FG000|Overall Study|Physician Decision|0|||
27641434|NCT01236560|80529178|FG001|Overall Study|Physician Decision|1|||
27641435|NCT01236560|80529179|FG002|Overall Study|Physician Decision|8|||
27641436|NCT01236560|80529180|FG003|Overall Study|Physician Decision|0|||
27641437|NCT01236560|80529181|FG004|Overall Study|Physician Decision|0|||
27641438|NCT01236560|80529182|FG005|Overall Study|Physician Decision|0|||
27641439|NCT01236560|80529177|FG000|Overall Study|Withdrawal by Subject|0|||
27641440|NCT01236560|80529178|FG001|Overall Study|Withdrawal by Subject|0|||
27641441|NCT01236560|80529179|FG002|Overall Study|Withdrawal by Subject|1|||
27641442|NCT01236560|80529180|FG003|Overall Study|Withdrawal by Subject|2|||
27641443|NCT01236560|80529181|FG004|Overall Study|Withdrawal by Subject|0|||
27641444|NCT01236560|80529182|FG005|Overall Study|Withdrawal by Subject|0|||
27641445|NCT01236560|80529177|FG000|Overall Study|Progressive disease|5|||
27641446|NCT01236560|80529178|FG001|Overall Study|Progressive disease|19|||
27930297|NCT04518410|81582680|FG008|Overall Study|Lost to Follow-up|2|||
27930298|NCT04518410|81582681|FG009|Overall Study|Lost to Follow-up|13|||
27930299|NCT04518410|81582682|FG010|Overall Study|Lost to Follow-up|9|||
27930300|NCT04518410|81582683|FG011|Overall Study|Lost to Follow-up|13|||
27930301|NCT04518410|81582684|FG012|Overall Study|Lost to Follow-up|9|||
27930302|NCT04518410|81582685|FG013|Overall Study|Lost to Follow-up|13|||
27930303|NCT04518410|81582686|FG014|Overall Study|Lost to Follow-up|8|||
27930304|NCT04518410|81582687|FG015|Overall Study|Lost to Follow-up|10|||
27930305|NCT04518410|81582688|FG016|Overall Study|Lost to Follow-up|6|||
27930306|NCT04518410|81582689|FG017|Overall Study|Lost to Follow-up|13|||
27930307|NCT04518410|81582690|FG018|Overall Study|Lost to Follow-up|21|||
27930308|NCT04518410|81582691|FG019|Overall Study|Lost to Follow-up|6|||
27641447|NCT01236560|80529179|FG002|Overall Study|Progressive disease|9|||
27641448|NCT01236560|80529180|FG003|Overall Study|Progressive disease|16|||
27641449|NCT01236560|80529181|FG004|Overall Study|Progressive disease|0|||
27641450|NCT01236560|80529182|FG005|Overall Study|Progressive disease|0|||
27641451|NCT02499159|80529189|FG000|Randomization|Protocol Violation|1|||
27641452|NCT02499159|80529190|FG001|Randomization|Protocol Violation|1|||
27641453|NCT02499159|80529189|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
27641454|NCT02499159|80529190|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
27641455|NCT02499159|80529189|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
27641456|NCT02499159|80529190|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
27641457|NCT02499159|80529189|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
27641458|NCT02499159|80529190|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
27641459|NCT02499159|80529189|FG000|30-Day Follow-Up Phone Call|Other|1|||
27930309|NCT04518410|81582692|FG020|Overall Study|Lost to Follow-up|7|||
27930310|NCT04518410|81582693|FG021|Overall Study|Lost to Follow-up|21|||
27930311|NCT04518410|81582694|FG022|Overall Study|Lost to Follow-up|1|||
27930312|NCT04518410|81582695|FG023|Overall Study|Lost to Follow-up|7|||
27930313|NCT04518410|81582696|FG024|Overall Study|Lost to Follow-up|6|||
27930314|NCT04518410|81582672|FG000|Overall Study|Withdrawal by Subject|1|||
27930315|NCT04518410|81582673|FG001|Overall Study|Withdrawal by Subject|2|||
27930316|NCT04518410|81582674|FG002|Overall Study|Withdrawal by Subject|2|||
27930317|NCT04518410|81582675|FG003|Overall Study|Withdrawal by Subject|3|||
27930318|NCT04518410|81582676|FG004|Overall Study|Withdrawal by Subject|20|||
27930319|NCT04518410|81582677|FG005|Overall Study|Withdrawal by Subject|20|||
27930320|NCT04518410|81582678|FG006|Overall Study|Withdrawal by Subject|25|||
27930321|NCT04518410|81582679|FG007|Overall Study|Withdrawal by Subject|6|||
27930322|NCT04518410|81582680|FG008|Overall Study|Withdrawal by Subject|1|||
27930323|NCT04518410|81582681|FG009|Overall Study|Withdrawal by Subject|12|||
27930324|NCT04518410|81582682|FG010|Overall Study|Withdrawal by Subject|5|||
27930325|NCT04518410|81582683|FG011|Overall Study|Withdrawal by Subject|7|||
27930326|NCT04518410|81582684|FG012|Overall Study|Withdrawal by Subject|2|||
27550188|NCT02732119|80200370|FG001|Phase I|Progressive disease|3|||
27641460|NCT02499159|80529190|FG001|30-Day Follow-Up Phone Call|Other|0|||
27641461|NCT01808534|80529194|FG000|Overall Study|Disease progression|3|||
27930327|NCT04518410|81582685|FG013|Overall Study|Withdrawal by Subject|13|||
27550189|NCT02732119|80200371|FG002|Phase I|Progressive disease|2|||
27550190|NCT02732119|80200372|FG003|Phase I|Progressive disease|0|||
27550191|NCT02732119|80200373|FG004|Phase I|Progressive disease|0|||
27550192|NCT02732119|80200369|FG000|Phase I|Protocol deviation|0|||
27550193|NCT02732119|80200370|FG001|Phase I|Protocol deviation|1|||
27550194|NCT02732119|80200371|FG002|Phase I|Protocol deviation|0|||
27550195|NCT02732119|80200372|FG003|Phase I|Protocol deviation|0|||
27550196|NCT02732119|80200373|FG004|Phase I|Protocol deviation|0|||
27550197|NCT02732119|80200369|FG000|Phase I|Physician Decision|0|||
27550198|NCT02732119|80200370|FG001|Phase I|Physician Decision|3|||
27550199|NCT02732119|80200371|FG002|Phase I|Physician Decision|4|||
27550200|NCT02732119|80200372|FG003|Phase I|Physician Decision|0|||
27550201|NCT02732119|80200373|FG004|Phase I|Physician Decision|0|||
27550202|NCT02732119|80200369|FG000|Phase II|Adverse Event|0|||
27550203|NCT02732119|80200370|FG001|Phase II|Adverse Event|0|||
27550204|NCT02732119|80200371|FG002|Phase II|Adverse Event|0|||
27550205|NCT02732119|80200372|FG003|Phase II|Adverse Event|3|||
27550206|NCT02732119|80200373|FG004|Phase II|Adverse Event|3|||
27550207|NCT02732119|80200369|FG000|Phase II|Death|0|||
27550208|NCT02732119|80200370|FG001|Phase II|Death|0|||
27550209|NCT02732119|80200371|FG002|Phase II|Death|0|||
27550210|NCT02732119|80200372|FG003|Phase II|Death|1|||
27550211|NCT02732119|80200373|FG004|Phase II|Death|0|||
27550212|NCT02732119|80200369|FG000|Phase II|Progressive dissease|0|||
27550213|NCT02732119|80200370|FG001|Phase II|Progressive dissease|0|||
27550214|NCT02732119|80200371|FG002|Phase II|Progressive dissease|0|||
27550215|NCT02732119|80200372|FG003|Phase II|Progressive dissease|30|||
27550216|NCT02732119|80200373|FG004|Phase II|Progressive dissease|23|||
27550217|NCT02732119|80200369|FG000|Phase II|Study terminated by sponsor|0|||
27550218|NCT02732119|80200370|FG001|Phase II|Study terminated by sponsor|0|||
27550219|NCT02732119|80200371|FG002|Phase II|Study terminated by sponsor|0|||
27550220|NCT02732119|80200372|FG003|Phase II|Study terminated by sponsor|2|||
27550221|NCT02732119|80200373|FG004|Phase II|Study terminated by sponsor|2|||
27550222|NCT02732119|80200369|FG000|Phase II|Other|0|||
27550223|NCT02732119|80200370|FG001|Phase II|Other|0|||
27550224|NCT02732119|80200371|FG002|Phase II|Other|0|||
27550225|NCT02732119|80200372|FG003|Phase II|Other|2|||
27550226|NCT02732119|80200373|FG004|Phase II|Other|0|||
27550227|NCT02732119|80200369|FG000|Phase II|Physician Decision|0|||
27550228|NCT02732119|80200370|FG001|Phase II|Physician Decision|0|||
27550229|NCT02732119|80200371|FG002|Phase II|Physician Decision|0|||
27550230|NCT02732119|80200372|FG003|Phase II|Physician Decision|8|||
27550231|NCT02732119|80200373|FG004|Phase II|Physician Decision|5|||
27550232|NCT00403234|80200382|FG000|Overall Study|Withdrawal by Subject|0|||
27550233|NCT00403234|80200383|FG001|Overall Study|Withdrawal by Subject|1|||
27550234|NCT00403234|80200384|FG002|Overall Study|Withdrawal by Subject|0|||
27550235|NCT00403234|80200385|FG003|Overall Study|Withdrawal by Subject|0|||
27550236|NCT00403234|80200382|FG000|Overall Study|Adverse Event|1|||
27550237|NCT00403234|80200383|FG001|Overall Study|Adverse Event|0|||
27550238|NCT00403234|80200384|FG002|Overall Study|Adverse Event|1|||
27550239|NCT00403234|80200385|FG003|Overall Study|Adverse Event|0|||
27550240|NCT00662012|80200389|FG000|Overall Study|Lost to Follow-up|85|||
27550241|NCT00662012|80200389|FG000|Overall Study|Death|1|||
27550242|NCT00662012|80200389|FG000|Overall Study|Withdrawal by Subject|1|||
27550243|NCT02025621|80200393|FG000|Overall Study|Withdrawal by Subject|1|||
27550244|NCT02025621|80200394|FG001|Overall Study|Withdrawal by Subject|0|||
27550245|NCT02025621|80200393|FG000|Overall Study|Death|0|||
27930328|NCT04518410|81582686|FG014|Overall Study|Withdrawal by Subject|4|||
27550246|NCT02025621|80200394|FG001|Overall Study|Death|1|||
27550247|NCT02025621|80200393|FG000|Overall Study|No longer eligible|10|||
27754923|NCT02065622|80929633|FG003|Maintenance Study|Subject Non-Compliance|3|||
27641462|NCT01808534|80529194|FG000|Overall Study|Physician Decision|1|||
27930329|NCT04518410|81582687|FG015|Overall Study|Withdrawal by Subject|9|||
27930330|NCT04518410|81582688|FG016|Overall Study|Withdrawal by Subject|0|||
27550248|NCT02025621|80200394|FG001|Overall Study|No longer eligible|15|||
27550249|NCT02025621|80200393|FG000|Overall Study|Surgery initiated before infusion|3|||
27550250|NCT02025621|80200394|FG001|Overall Study|Surgery initiated before infusion|3|||
27930331|NCT04518410|81582689|FG017|Overall Study|Withdrawal by Subject|15|||
27930332|NCT04518410|81582690|FG018|Overall Study|Withdrawal by Subject|12|||
27930333|NCT04518410|81582691|FG019|Overall Study|Withdrawal by Subject|9|||
27930334|NCT04518410|81582692|FG020|Overall Study|Withdrawal by Subject|14|||
27930335|NCT04518410|81582693|FG021|Overall Study|Withdrawal by Subject|3|||
27930336|NCT04518410|81582694|FG022|Overall Study|Withdrawal by Subject|2|||
27930337|NCT04518410|81582695|FG023|Overall Study|Withdrawal by Subject|9|||
27930338|NCT04518410|81582696|FG024|Overall Study|Withdrawal by Subject|8|||
27930339|NCT04518410|81582672|FG000|Overall Study|Other|1|||
27930340|NCT04518410|81582673|FG001|Overall Study|Other|0|||
27930341|NCT04518410|81582674|FG002|Overall Study|Other|0|||
27930342|NCT04518410|81582675|FG003|Overall Study|Other|1|||
27930343|NCT04518410|81582676|FG004|Overall Study|Other|6|||
27930344|NCT04518410|81582677|FG005|Overall Study|Other|6|||
27930345|NCT04518410|81582678|FG006|Overall Study|Other|5|||
27930346|NCT04518410|81582679|FG007|Overall Study|Other|2|||
27930347|NCT04518410|81582680|FG008|Overall Study|Other|0|||
27930348|NCT04518410|81582681|FG009|Overall Study|Other|1|||
27930349|NCT04518410|81582682|FG010|Overall Study|Other|0|||
27930350|NCT04518410|81582683|FG011|Overall Study|Other|2|||
27930351|NCT04518410|81582684|FG012|Overall Study|Other|0|||
27930352|NCT04518410|81582685|FG013|Overall Study|Other|0|||
27930353|NCT04518410|81582686|FG014|Overall Study|Other|0|||
27930354|NCT04518410|81582687|FG015|Overall Study|Other|3|||
27930355|NCT04518410|81582688|FG016|Overall Study|Other|1|||
27930356|NCT04518410|81582689|FG017|Overall Study|Other|1|||
27930357|NCT04518410|81582690|FG018|Overall Study|Other|1|||
27930358|NCT04518410|81582691|FG019|Overall Study|Other|0|||
27930359|NCT04518410|81582692|FG020|Overall Study|Other|1|||
27930360|NCT04518410|81582693|FG021|Overall Study|Other|0|||
27930361|NCT04518410|81582694|FG022|Overall Study|Other|1|||
27930362|NCT04518410|81582695|FG023|Overall Study|Other|2|||
27930363|NCT04518410|81582696|FG024|Overall Study|Other|2|||
27930364|NCT04518410|81582672|FG000|Overall Study|Protocol Violation|0|||
27930365|NCT04518410|81582673|FG001|Overall Study|Protocol Violation|0|||
27930366|NCT04518410|81582674|FG002|Overall Study|Protocol Violation|0|||
27930367|NCT04518410|81582675|FG003|Overall Study|Protocol Violation|2|||
27930368|NCT04518410|81582676|FG004|Overall Study|Protocol Violation|17|||
27930369|NCT04518410|81582677|FG005|Overall Study|Protocol Violation|1|||
27930370|NCT04518410|81582678|FG006|Overall Study|Protocol Violation|2|||
27930371|NCT04518410|81582679|FG007|Overall Study|Protocol Violation|1|||
27930372|NCT04518410|81582680|FG008|Overall Study|Protocol Violation|0|||
27930373|NCT04518410|81582681|FG009|Overall Study|Protocol Violation|0|||
27930374|NCT04518410|81582682|FG010|Overall Study|Protocol Violation|0|||
27930375|NCT04518410|81582683|FG011|Overall Study|Protocol Violation|0|||
27930376|NCT04518410|81582684|FG012|Overall Study|Protocol Violation|0|||
27930377|NCT04518410|81582685|FG013|Overall Study|Protocol Violation|0|||
27930378|NCT04518410|81582686|FG014|Overall Study|Protocol Violation|0|||
27930379|NCT04518410|81582687|FG015|Overall Study|Protocol Violation|0|||
27930380|NCT04518410|81582688|FG016|Overall Study|Protocol Violation|1|||
27930381|NCT04518410|81582689|FG017|Overall Study|Protocol Violation|1|||
27930382|NCT04518410|81582690|FG018|Overall Study|Protocol Violation|0|||
27930383|NCT04518410|81582691|FG019|Overall Study|Protocol Violation|0|||
27930384|NCT04518410|81582692|FG020|Overall Study|Protocol Violation|1|||
27930385|NCT04518410|81582693|FG021|Overall Study|Protocol Violation|2|||
27641463|NCT02058108|80529195|FG000|Overall Study|Abnormal Laboratory Values|0|||
27641464|NCT02058108|80529196|FG001|Overall Study|Abnormal Laboratory Values|1|||
27641465|NCT02058108|80529195|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
27641466|NCT02058108|80529196|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27641467|NCT02058108|80529195|FG000|Overall Study|No longer requires study drug|0|||
27641468|NCT02058108|80529196|FG001|Overall Study|No longer requires study drug|1|||
27641469|NCT02058108|80529195|FG000|Overall Study|Withdrawal by Subject|1|||
27641470|NCT02058108|80529196|FG001|Overall Study|Withdrawal by Subject|0|||
27641471|NCT02058108|80529195|FG000|Overall Study|Administrative problems|3|||
27641472|NCT02058108|80529196|FG001|Overall Study|Administrative problems|3|||
27930386|NCT04518410|81582694|FG022|Overall Study|Protocol Violation|0|||
27930387|NCT04518410|81582695|FG023|Overall Study|Protocol Violation|3|||
27930388|NCT04518410|81582696|FG024|Overall Study|Protocol Violation|0|||
27930389|NCT04518410|81582672|FG000|Overall Study|Death|0|||
27930390|NCT04518410|81582673|FG001|Overall Study|Death|0|||
27930391|NCT04518410|81582674|FG002|Overall Study|Death|0|||
27930392|NCT04518410|81582675|FG003|Overall Study|Death|0|||
27930393|NCT04518410|81582676|FG004|Overall Study|Death|12|||
27930394|NCT04518410|81582677|FG005|Overall Study|Death|2|||
27930395|NCT04518410|81582678|FG006|Overall Study|Death|11|||
27930396|NCT04518410|81582679|FG007|Overall Study|Death|0|||
27930397|NCT04518410|81582680|FG008|Overall Study|Death|1|||
27930398|NCT04518410|81582681|FG009|Overall Study|Death|0|||
27930399|NCT04518410|81582682|FG010|Overall Study|Death|0|||
27930400|NCT04518410|81582683|FG011|Overall Study|Death|0|||
27930401|NCT04518410|81582684|FG012|Overall Study|Death|0|||
27930402|NCT04518410|81582685|FG013|Overall Study|Death|1|||
27930403|NCT04518410|81582686|FG014|Overall Study|Death|1|||
27742793|NCT02658656|80887038|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
27742794|NCT02658656|80887039|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
27742795|NCT02658656|80887037|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
27742796|NCT02658656|80887038|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
27742797|NCT02658656|80887039|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
27742798|NCT02658656|80887037|FG000|Randomization|Not eligible for Randomization|1|||
27742799|NCT02658656|80887038|FG001|Randomization|Not eligible for Randomization|0|||
27742800|NCT02658656|80887039|FG002|Randomization|Not eligible for Randomization|0|||
27742801|NCT02658656|80887037|FG000|Randomization|Protocol Violation|1|||
27742802|NCT02658656|80887038|FG001|Randomization|Protocol Violation|0|||
27742803|NCT02658656|80887039|FG002|Randomization|Protocol Violation|0|||
27742804|NCT01013883|80887041|FG000|Overall Study|Lost to Follow-up|2|||
27742805|NCT01013883|80887042|FG001|Overall Study|Lost to Follow-up|2|||
27742806|NCT00450866|80887045|FG000|Overall Study|Adverse Event|0|||
27742807|NCT00450866|80887046|FG001|Overall Study|Adverse Event|1|||
27742808|NCT00450866|80887045|FG000|Overall Study|Withdrawal by Subject|5|||
27742809|NCT00450866|80887046|FG001|Overall Study|Withdrawal by Subject|2|||
27742810|NCT00450866|80887045|FG000|Overall Study|Death|1|||
27742811|NCT00450866|80887046|FG001|Overall Study|Death|0|||
27742812|NCT00450866|80887045|FG000|Overall Study|Physician Decision|1|||
27742813|NCT00450866|80887046|FG001|Overall Study|Physician Decision|0|||
27742814|NCT02606877|80887047|FG000|Overall Study|Adverse Event|3|||
27742815|NCT02606877|80887048|FG001|Overall Study|Adverse Event|0|||
27742816|NCT02606877|80887047|FG000|Overall Study|Non-compliance with protocol|0|||
27742817|NCT02606877|80887048|FG001|Overall Study|Non-compliance with protocol|1|||
27742818|NCT02606877|80887047|FG000|Overall Study|Other than listed above|1|||
27742819|NCT02606877|80887048|FG001|Overall Study|Other than listed above|0|||
27742820|NCT01650779|80887062|FG000|Overall Study|Withdrawal by Subject|1|||
27742821|NCT01770353|80887063|FG000|Overall Study|Progressive disease|2|||
27742822|NCT01770353|80887064|FG001|Overall Study|Progressive disease|1|||
27742823|NCT01770353|80887063|FG000|Overall Study|Adverse Event|0|||
27742824|NCT01770353|80887064|FG001|Overall Study|Adverse Event|1|||
27930404|NCT04518410|81582687|FG015|Overall Study|Death|0|||
27930405|NCT04518410|81582688|FG016|Overall Study|Death|0|||
27930406|NCT04518410|81582689|FG017|Overall Study|Death|1|||
27930407|NCT04518410|81582690|FG018|Overall Study|Death|4|||
27930408|NCT04518410|81582691|FG019|Overall Study|Death|4|||
27930409|NCT04518410|81582692|FG020|Overall Study|Death|1|||
27930410|NCT04518410|81582693|FG021|Overall Study|Death|0|||
27930411|NCT04518410|81582694|FG022|Overall Study|Death|0|||
27930412|NCT04518410|81582695|FG023|Overall Study|Death|0|||
27930413|NCT04518410|81582696|FG024|Overall Study|Death|0|||
27930414|NCT04518410|81582672|FG000|Overall Study|Requirement to start alternative therapy|0|||
27930415|NCT04518410|81582673|FG001|Overall Study|Requirement to start alternative therapy|0|||
27930416|NCT04518410|81582674|FG002|Overall Study|Requirement to start alternative therapy|1|||
27930417|NCT04518410|81582675|FG003|Overall Study|Requirement to start alternative therapy|0|||
27930418|NCT04518410|81582676|FG004|Overall Study|Requirement to start alternative therapy|0|||
27930419|NCT04518410|81582677|FG005|Overall Study|Requirement to start alternative therapy|0|||
27930420|NCT04518410|81582678|FG006|Overall Study|Requirement to start alternative therapy|0|||
27930421|NCT04518410|81582679|FG007|Overall Study|Requirement to start alternative therapy|0|||
27930422|NCT04518410|81582680|FG008|Overall Study|Requirement to start alternative therapy|0|||
27930423|NCT04518410|81582681|FG009|Overall Study|Requirement to start alternative therapy|0|||
27930424|NCT04518410|81582682|FG010|Overall Study|Requirement to start alternative therapy|0|||
27930425|NCT04518410|81582683|FG011|Overall Study|Requirement to start alternative therapy|0|||
27930426|NCT04518410|81582684|FG012|Overall Study|Requirement to start alternative therapy|0|||
27550251|NCT02144012|80200395|FG000|Overall Study|Adverse Event|1|||
27550252|NCT02144012|80200396|FG001|Overall Study|Adverse Event|0|||
27550253|NCT02144012|80200395|FG000|Overall Study|Death|1|||
27550254|NCT02144012|80200396|FG001|Overall Study|Death|0|||
27550255|NCT02144012|80200395|FG000|Overall Study|Withdrawal by Subject|11|||
27550256|NCT02144012|80200396|FG001|Overall Study|Withdrawal by Subject|3|||
27550257|NCT02144012|80200395|FG000|Overall Study|Study Terminated by Sponsor|18|||
27550258|NCT02144012|80200396|FG001|Overall Study|Study Terminated by Sponsor|12|||
27550259|NCT02144012|80200395|FG000|Overall Study|Other|3|||
27550260|NCT02144012|80200396|FG001|Overall Study|Other|0|||
27550261|NCT02612727|80200397|FG000|Overall Study|Parent request|4|||
27550262|NCT02612727|80200398|FG001|Overall Study|Parent request|1|||
27742825|NCT01770353|80887063|FG000|Overall Study|Protocol Violation|1|||
27742826|NCT01770353|80887064|FG001|Overall Study|Protocol Violation|0|||
27742827|NCT01770353|80887063|FG000|Overall Study|Physician Decision|0|||
27930427|NCT04518410|81582685|FG013|Overall Study|Requirement to start alternative therapy|0|||
27930428|NCT04518410|81582686|FG014|Overall Study|Requirement to start alternative therapy|0|||
27550263|NCT02612727|80200397|FG000|Overall Study|Needed treatment incompatible with PT|1|||
27550264|NCT02612727|80200398|FG001|Overall Study|Needed treatment incompatible with PT|1|||
27930429|NCT04518410|81582687|FG015|Overall Study|Requirement to start alternative therapy|0|||
27930430|NCT04518410|81582688|FG016|Overall Study|Requirement to start alternative therapy|0|||
27930431|NCT04518410|81582689|FG017|Overall Study|Requirement to start alternative therapy|0|||
27930432|NCT04518410|81582690|FG018|Overall Study|Requirement to start alternative therapy|0|||
27930433|NCT04518410|81582691|FG019|Overall Study|Requirement to start alternative therapy|0|||
27930434|NCT04518410|81582692|FG020|Overall Study|Requirement to start alternative therapy|0|||
27930435|NCT04518410|81582693|FG021|Overall Study|Requirement to start alternative therapy|0|||
27930436|NCT04518410|81582694|FG022|Overall Study|Requirement to start alternative therapy|0|||
27930437|NCT04518410|81582695|FG023|Overall Study|Requirement to start alternative therapy|0|||
27930438|NCT04518410|81582696|FG024|Overall Study|Requirement to start alternative therapy|0|||
27930439|NCT04518410|81582672|FG000|Overall Study|Randomized but not treated|0|||
27930440|NCT04518410|81582673|FG001|Overall Study|Randomized but not treated|0|||
27930441|NCT04518410|81582674|FG002|Overall Study|Randomized but not treated|0|||
27930442|NCT04518410|81582675|FG003|Overall Study|Randomized but not treated|2|||
27930443|NCT04518410|81582676|FG004|Overall Study|Randomized but not treated|6|||
27930444|NCT04518410|81582677|FG005|Overall Study|Randomized but not treated|4|||
27930445|NCT04518410|81582678|FG006|Overall Study|Randomized but not treated|3|||
27930446|NCT04518410|81582679|FG007|Overall Study|Randomized but not treated|3|||
27930447|NCT04518410|81582680|FG008|Overall Study|Randomized but not treated|0|||
27930448|NCT04518410|81582681|FG009|Overall Study|Randomized but not treated|4|||
27930449|NCT04518410|81582682|FG010|Overall Study|Randomized but not treated|0|||
27930450|NCT04518410|81582683|FG011|Overall Study|Randomized but not treated|0|||
27930451|NCT04518410|81582684|FG012|Overall Study|Randomized but not treated|1|||
27930452|NCT04518410|81582685|FG013|Overall Study|Randomized but not treated|3|||
27930453|NCT04518410|81582686|FG014|Overall Study|Randomized but not treated|3|||
27930454|NCT04518410|81582687|FG015|Overall Study|Randomized but not treated|3|||
27930455|NCT04518410|81582688|FG016|Overall Study|Randomized but not treated|4|||
27930456|NCT04518410|81582689|FG017|Overall Study|Randomized but not treated|5|||
27930457|NCT04518410|81582690|FG018|Overall Study|Randomized but not treated|4|||
27930458|NCT04518410|81582691|FG019|Overall Study|Randomized but not treated|0|||
27930459|NCT04518410|81582692|FG020|Overall Study|Randomized but not treated|0|||
27930460|NCT04518410|81582693|FG021|Overall Study|Randomized but not treated|5|||
27641473|NCT02058108|80529195|FG000|Overall Study|Protocol Violation|0|||
27641474|NCT02058108|80529196|FG001|Overall Study|Protocol Violation|1|||
27641475|NCT00642850|80529197|FG000|Overall Study|Death|7|||
27641476|NCT00642850|80529197|FG000|Overall Study|Adverse Event|2|||
27641477|NCT00642850|80529197|FG000|Overall Study|Lack of Efficacy|1|||
27641478|NCT00642850|80529197|FG000|Overall Study|Protocol Violation|2|||
27641479|NCT00642850|80529197|FG000|Overall Study|Kidney transplantation|8|||
27641480|NCT00642850|80529197|FG000|Overall Study|Blood transfusion|6|||
27641481|NCT00642850|80529197|FG000|Overall Study|Other reasons|7|||
27641482|NCT02567656|80529198|FG000|Overall Study|Premature discontinuation due to PD|1|||
27641483|NCT02567656|80529199|FG001|Overall Study|Premature discontinuation due to PD|1|||
27641484|NCT02567656|80529200|FG002|Overall Study|Premature discontinuation due to PD|2|||
27641485|NCT02567656|80529201|FG003|Overall Study|Premature discontinuation due to PD|0|||
27641486|NCT02567656|80529202|FG004|Overall Study|Premature discontinuation due to PD|0|||
27641487|NCT02567656|80529203|FG005|Overall Study|Premature discontinuation due to PD|0|||
27641488|NCT02978716|80529204|FG000|Overall Study|Death|25|||
27641489|NCT02978716|80529205|FG001|Overall Study|Death|13|||
27641490|NCT02978716|80529206|FG002|Overall Study|Death|20|||
27641491|NCT02978716|80529204|FG000|Overall Study|Lost to Follow-up|0|||
27641492|NCT02978716|80529205|FG001|Overall Study|Lost to Follow-up|0|||
27641493|NCT02978716|80529206|FG002|Overall Study|Lost to Follow-up|1|||
27641494|NCT02978716|80529204|FG000|Overall Study|Withdrawal by Subject|6|||
27641495|NCT02978716|80529205|FG001|Overall Study|Withdrawal by Subject|4|||
27641496|NCT02978716|80529206|FG002|Overall Study|Withdrawal by Subject|5|||
27641497|NCT02978716|80529204|FG000|Overall Study|Sponsor terminated|2|||
27641498|NCT02978716|80529205|FG001|Overall Study|Sponsor terminated|13|||
27641499|NCT02978716|80529206|FG002|Overall Study|Sponsor terminated|9|||
27641500|NCT02978716|80529204|FG000|Overall Study|Other|1|||
27641501|NCT02978716|80529205|FG001|Overall Study|Other|3|||
27641502|NCT02978716|80529206|FG002|Overall Study|Other|0|||
27742828|NCT01770353|80887064|FG001|Overall Study|Physician Decision|3|||
27742829|NCT01770353|80887063|FG000|Overall Study|Clinical deterioration|3|||
27742830|NCT01770353|80887064|FG001|Overall Study|Clinical deterioration|6|||
27742831|NCT01770353|80887063|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
27930461|NCT04518410|81582694|FG022|Overall Study|Randomized but not treated|0|||
27641503|NCT02008916|80529208|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
27641504|NCT02008916|80529209|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
27641505|NCT02008916|80529210|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
27641506|NCT02008916|80529208|FG000|Week 16 - 156|Adverse Event|4|||
27641507|NCT02008916|80529209|FG001|Week 16 - 156|Adverse Event|2|||
27641508|NCT02008916|80529210|FG002|Week 16 - 156|Adverse Event|3|||
27930462|NCT04518410|81582695|FG023|Overall Study|Randomized but not treated|3|||
27930463|NCT04518410|81582696|FG024|Overall Study|Randomized but not treated|1|||
27641509|NCT02008916|80529208|FG000|Week 16 - 156|Withdrawal by Subject|7|||
27641510|NCT02008916|80529209|FG001|Week 16 - 156|Withdrawal by Subject|3|||
27641511|NCT02008916|80529210|FG002|Week 16 - 156|Withdrawal by Subject|5|||
27641512|NCT02008916|80529208|FG000|Week 16 - 156|No longer requires treatment|0|||
27641513|NCT02008916|80529209|FG001|Week 16 - 156|No longer requires treatment|1|||
27641514|NCT02008916|80529210|FG002|Week 16 - 156|No longer requires treatment|0|||
27641515|NCT02008916|80529208|FG000|Week 16 - 156|Lost to Follow-up|5|||
27641516|NCT02008916|80529209|FG001|Week 16 - 156|Lost to Follow-up|0|||
27641517|NCT02008916|80529210|FG002|Week 16 - 156|Lost to Follow-up|0|||
27641518|NCT02008916|80529208|FG000|Week 16 - 156|Lack of Efficacy|3|||
27641519|NCT02008916|80529209|FG001|Week 16 - 156|Lack of Efficacy|5|||
27641520|NCT02008916|80529210|FG002|Week 16 - 156|Lack of Efficacy|2|||
27641521|NCT02008916|80529208|FG000|Week 16 - 156|Pregnancy|0|||
27641522|NCT02008916|80529209|FG001|Week 16 - 156|Pregnancy|1|||
27641523|NCT02008916|80529210|FG002|Week 16 - 156|Pregnancy|0|||
27641524|NCT02008916|80529208|FG000|Week 16 - 156|Physician Decision|0|||
27641525|NCT02008916|80529209|FG001|Week 16 - 156|Physician Decision|1|||
27641526|NCT02008916|80529210|FG002|Week 16 - 156|Physician Decision|0|||
27641527|NCT02269475|80529215|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
27641528|NCT02269475|80529216|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
27641529|NCT02269475|80529215|FG000|Overall Study|Withdrawal by Subject|0|||
27641530|NCT02269475|80529216|FG001|Overall Study|Withdrawal by Subject|1|||
27641531|NCT01400958|80529217|FG000|Overall Study|Physician Decision|0|||
27641532|NCT01400958|80529218|FG001|Overall Study|Physician Decision|1|||
27641533|NCT01400958|80529217|FG000|Overall Study|Withdrawal by Subject|0|||
27930464|NCT04518410|81582672|FG000|Overall Study|Screen Fail but Randomized|0|||
27930465|NCT04518410|81582673|FG001|Overall Study|Screen Fail but Randomized|0|||
27641534|NCT01400958|80529218|FG001|Overall Study|Withdrawal by Subject|1|||
27641535|NCT01400958|80529217|FG000|Overall Study|Adverse Event|1|||
27641536|NCT01400958|80529218|FG001|Overall Study|Adverse Event|0|||
27641537|NCT00931710|80529219|FG000|Overall Study|Adverse Event|16|||
27641538|NCT00931710|80529220|FG001|Overall Study|Adverse Event|10|||
27641539|NCT00931710|80529219|FG000|Overall Study|Abnormal test procedure results|2|||
27641540|NCT00931710|80529220|FG001|Overall Study|Abnormal test procedure results|0|||
27641541|NCT00931710|80529219|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
27641542|NCT00931710|80529220|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
27641543|NCT00931710|80529219|FG000|Overall Study|Patient withdrew consent|4|||
27641544|NCT00931710|80529220|FG001|Overall Study|Patient withdrew consent|9|||
27641545|NCT00931710|80529219|FG000|Overall Study|Lost to Follow-up|6|||
27641546|NCT00931710|80529220|FG001|Overall Study|Lost to Follow-up|5|||
27641547|NCT00931710|80529219|FG000|Overall Study|Protocol deviation|1|||
27930466|NCT04518410|81582674|FG002|Overall Study|Screen Fail but Randomized|0|||
27930467|NCT04518410|81582675|FG003|Overall Study|Screen Fail but Randomized|0|||
27930468|NCT04518410|81582676|FG004|Overall Study|Screen Fail but Randomized|2|||
27930469|NCT04518410|81582677|FG005|Overall Study|Screen Fail but Randomized|0|||
27930470|NCT04518410|81582678|FG006|Overall Study|Screen Fail but Randomized|0|||
27930471|NCT04518410|81582679|FG007|Overall Study|Screen Fail but Randomized|0|||
27930472|NCT04518410|81582680|FG008|Overall Study|Screen Fail but Randomized|0|||
27550265|NCT02612727|80200397|FG000|Overall Study|Direct hyperbilirubinemia|0|||
27550266|NCT02612727|80200398|FG001|Overall Study|Direct hyperbilirubinemia|2|||
27550267|NCT01603355|80200403|FG000|Overall Study|Lack of Efficacy|2|||
27550268|NCT01844518|80200404|FG000|Overall Study|Adverse Event|7|||
27550269|NCT01844518|80200405|FG001|Overall Study|Adverse Event|1|||
27550270|NCT01844518|80200404|FG000|Overall Study|Lack of Efficacy|17|||
27550271|NCT01844518|80200405|FG001|Overall Study|Lack of Efficacy|5|||
27550272|NCT01844518|80200404|FG000|Overall Study|Participant's request to discontinue|4|||
27550273|NCT01844518|80200405|FG001|Overall Study|Participant's request to discontinue|1|||
27550274|NCT01844518|80200404|FG000|Overall Study|Poor/Non-compliance|1|||
27550275|NCT01844518|80200405|FG001|Overall Study|Poor/Non-compliance|0|||
27550276|NCT01844518|80200404|FG000|Overall Study|No Longer Met Study Criteria|2|||
27550277|NCT01844518|80200405|FG001|Overall Study|No Longer Met Study Criteria|0|||
27550278|NCT01844518|80200404|FG000|Overall Study|Withdrawal by Subject|9|||
27550279|NCT01844518|80200405|FG001|Overall Study|Withdrawal by Subject|0|||
27550280|NCT01844518|80200404|FG000|Overall Study|Pregnancy|1|||
27550281|NCT01844518|80200405|FG001|Overall Study|Pregnancy|0|||
27550282|NCT01350414|80200409|FG000|Overall Study|Lost to Follow-up|13|||
27550283|NCT01350414|80200409|FG000|Overall Study|Withdrawal by Subject|4|||
27641548|NCT00931710|80529220|FG001|Overall Study|Protocol deviation|2|||
27641549|NCT00402246|80529221|FG000|Overall Study|Death|62|||
27641550|NCT00402246|80529222|FG001|Overall Study|Death|58|||
27930473|NCT04518410|81582681|FG009|Overall Study|Screen Fail but Randomized|0|||
27930474|NCT04518410|81582682|FG010|Overall Study|Screen Fail but Randomized|0|||
27930475|NCT04518410|81582683|FG011|Overall Study|Screen Fail but Randomized|0|||
27930476|NCT04518410|81582684|FG012|Overall Study|Screen Fail but Randomized|0|||
27550284|NCT01350414|80200409|FG000|Overall Study|Physician Decision|2|||
27550285|NCT00471328|80200410|FG000|Core Phase|Adverse Event|18|||
27550286|NCT00471328|80200411|FG001|Core Phase|Adverse Event|6|||
27550287|NCT00471328|80200410|FG000|Core Phase|Death|8|||
27930477|NCT04518410|81582685|FG013|Overall Study|Screen Fail but Randomized|0|||
27930478|NCT04518410|81582686|FG014|Overall Study|Screen Fail but Randomized|0|||
27930479|NCT04518410|81582687|FG015|Overall Study|Screen Fail but Randomized|0|||
27930480|NCT04518410|81582688|FG016|Overall Study|Screen Fail but Randomized|0|||
27930481|NCT04518410|81582689|FG017|Overall Study|Screen Fail but Randomized|0|||
27930482|NCT04518410|81582690|FG018|Overall Study|Screen Fail but Randomized|0|||
27930483|NCT04518410|81582691|FG019|Overall Study|Screen Fail but Randomized|0|||
27930484|NCT04518410|81582692|FG020|Overall Study|Screen Fail but Randomized|0|||
27930485|NCT04518410|81582693|FG021|Overall Study|Screen Fail but Randomized|0|||
27930486|NCT04518410|81582694|FG022|Overall Study|Screen Fail but Randomized|0|||
27930487|NCT04518410|81582695|FG023|Overall Study|Screen Fail but Randomized|0|||
27930488|NCT04518410|81582696|FG024|Overall Study|Screen Fail but Randomized|0|||
27930489|NCT04518410|81582672|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930490|NCT04518410|81582673|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930491|NCT04518410|81582674|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930492|NCT04518410|81582675|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930493|NCT04518410|81582676|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
27930494|NCT04518410|81582677|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
27930495|NCT04518410|81582678|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
27930496|NCT04518410|81582679|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
27930497|NCT04518410|81582680|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
27930498|NCT04518410|81582681|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
27930499|NCT04518410|81582682|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
27930500|NCT04518410|81582683|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930501|NCT04518410|81582684|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930502|NCT04518410|81582685|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
27930503|NCT04518410|81582686|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
27930504|NCT04518410|81582687|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
27930505|NCT04518410|81582688|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
27930506|NCT04518410|81582689|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
27930507|NCT04518410|81582690|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
27930508|NCT04518410|81582691|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
27930509|NCT04518410|81582692|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
27930510|NCT04518410|81582693|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
27930511|NCT04518410|81582694|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
27930512|NCT04518410|81582695|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
27930513|NCT04518410|81582696|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
27930514|NCT04518410|81582672|FG000|Overall Study|Dual Enrolled Subject|0|||
27930515|NCT04518410|81582673|FG001|Overall Study|Dual Enrolled Subject|0|||
27930516|NCT04518410|81582674|FG002|Overall Study|Dual Enrolled Subject|0|||
27930517|NCT04518410|81582675|FG003|Overall Study|Dual Enrolled Subject|0|||
27930518|NCT04518410|81582676|FG004|Overall Study|Dual Enrolled Subject|0|||
27930519|NCT04518410|81582677|FG005|Overall Study|Dual Enrolled Subject|0|||
27930520|NCT04518410|81582678|FG006|Overall Study|Dual Enrolled Subject|0|||
27930521|NCT04518410|81582679|FG007|Overall Study|Dual Enrolled Subject|0|||
27930522|NCT04518410|81582680|FG008|Overall Study|Dual Enrolled Subject|0|||
27930523|NCT04518410|81582681|FG009|Overall Study|Dual Enrolled Subject|0|||
27930524|NCT04518410|81582682|FG010|Overall Study|Dual Enrolled Subject|0|||
27930525|NCT04518410|81582683|FG011|Overall Study|Dual Enrolled Subject|0|||
27930526|NCT04518410|81582684|FG012|Overall Study|Dual Enrolled Subject|0|||
27550288|NCT00471328|80200411|FG001|Core Phase|Death|4|||
27550289|NCT00471328|80200410|FG000|Core Phase|Withdrawal by Subject|2|||
27550290|NCT00471328|80200411|FG001|Core Phase|Withdrawal by Subject|2|||
27550291|NCT00471328|80200410|FG000|Core Phase|Abnormal laboratory value|1|||
27550292|NCT00471328|80200411|FG001|Core Phase|Abnormal laboratory value|0|||
27550293|NCT00471328|80200410|FG000|Core Phase|Disease Progression|78|||
27550294|NCT00471328|80200411|FG001|Core Phase|Disease Progression|53|||
27550295|NCT00471328|80200410|FG000|Core Phase|Administrative Problem|0|||
27641551|NCT00402246|80529221|FG000|Overall Study|Lost to Follow-up|20|||
27641552|NCT00402246|80529222|FG001|Overall Study|Lost to Follow-up|28|||
27641553|NCT00402246|80529221|FG000|Overall Study|Withdrawal by Subject|72|||
27641554|NCT00402246|80529222|FG001|Overall Study|Withdrawal by Subject|87|||
27641555|NCT00402246|80529221|FG000|Overall Study|Physician Decision|24|||
27641556|NCT00402246|80529222|FG001|Overall Study|Physician Decision|26|||
27641557|NCT00402246|80529221|FG000|Overall Study|Protocol Violation|25|||
27641558|NCT00402246|80529222|FG001|Overall Study|Protocol Violation|24|||
27641559|NCT00402246|80529221|FG000|Overall Study|Missed Final Visit|1|||
27641560|NCT00402246|80529222|FG001|Overall Study|Missed Final Visit|2|||
27641561|NCT00402246|80529221|FG000|Overall Study|Insurance Issues|2|||
27641562|NCT00402246|80529222|FG001|Overall Study|Insurance Issues|1|||
27641563|NCT00402246|80529221|FG000|Overall Study|Heart Transplant|0|||
27641564|NCT00402246|80529222|FG001|Overall Study|Heart Transplant|1|||
27641565|NCT00402246|80529221|FG000|Overall Study|Patient's device explanted|6|||
27641566|NCT00402246|80529222|FG001|Overall Study|Patient's device explanted|2|||
27641567|NCT00402246|80529221|FG000|Overall Study|Center Closure|5|||
27641568|NCT00402246|80529222|FG001|Overall Study|Center Closure|3|||
27641569|NCT00402246|80529221|FG000|Overall Study|Deterioriating Condition|3|||
27641570|NCT00402246|80529222|FG001|Overall Study|Deterioriating Condition|2|||
27641571|NCT03840902|80529223|FG000|Overall Study|Randomized but not treated|1|||
27641572|NCT03840902|80529224|FG001|Overall Study|Randomized but not treated|1|||
27641573|NCT00409838|80529225|FG000|Short-term Period|Adverse Event|0|||
27641574|NCT00409838|80529226|FG001|Short-term Period|Adverse Event|1|||
27641575|NCT00409838|80529225|FG000|Short-term Period|Lost to Follow-up|0|||
27641576|NCT00409838|80529226|FG001|Short-term Period|Lost to Follow-up|1|||
27641577|NCT00409838|80529225|FG000|Short-term Period|Withdrawal by Subject|2|||
27641578|NCT00409838|80529226|FG001|Short-term Period|Withdrawal by Subject|3|||
27930527|NCT04518410|81582685|FG013|Overall Study|Dual Enrolled Subject|0|||
27930528|NCT04518410|81582686|FG014|Overall Study|Dual Enrolled Subject|0|||
27930529|NCT04518410|81582687|FG015|Overall Study|Dual Enrolled Subject|0|||
27930530|NCT04518410|81582688|FG016|Overall Study|Dual Enrolled Subject|0|||
27930531|NCT04518410|81582689|FG017|Overall Study|Dual Enrolled Subject|1|||
27930532|NCT04518410|81582690|FG018|Overall Study|Dual Enrolled Subject|0|||
27930533|NCT04518410|81582691|FG019|Overall Study|Dual Enrolled Subject|0|||
27930534|NCT04518410|81582692|FG020|Overall Study|Dual Enrolled Subject|0|||
27930535|NCT04518410|81582693|FG021|Overall Study|Dual Enrolled Subject|0|||
27930536|NCT04518410|81582694|FG022|Overall Study|Dual Enrolled Subject|0|||
27930537|NCT04518410|81582695|FG023|Overall Study|Dual Enrolled Subject|0|||
27930538|NCT04518410|81582696|FG024|Overall Study|Dual Enrolled Subject|0|||
27930539|NCT01132755|81582697|FG000|Overall Study|Procedure not done due to medical reason|23|||
27930540|NCT01132755|81582697|FG000|Overall Study|Protocol Violation|15|||
27930541|NCT01132755|81582697|FG000|Overall Study|Withdrawal by Subject|4|||
27930542|NCT03298061|81582701|FG000|Overall Study|Adverse Event|3|||
27930543|NCT03298061|81582701|FG000|Overall Study|Lack of Efficacy|6|||
27930544|NCT03298061|81582701|FG000|Overall Study|Protocol Violation|1|||
27930545|NCT03298061|81582701|FG000|Overall Study|Physician Decision|7|||
27930546|NCT03298061|81582701|FG000|Overall Study|Withdrawal by Subject|10|||
27930547|NCT03349515|81582702|FG000|Overall Study|Lack of Efficacy|2|||
27930548|NCT03349515|81582703|FG001|Overall Study|Lack of Efficacy|0|||
27930549|NCT03349515|81582702|FG000|Overall Study|Physician Decision|3|||
27930550|NCT03349515|81582703|FG001|Overall Study|Physician Decision|1|||
27930551|NCT04810962|81582704|FG000|Overall Study|Adverse Event|0|||
27930552|NCT04810962|81582705|FG001|Overall Study|Adverse Event|1|||
27930553|NCT04810962|81582704|FG000|Overall Study|Lost to Follow-up|2|||
27930554|NCT04810962|81582705|FG001|Overall Study|Lost to Follow-up|1|||
27930555|NCT04810962|81582704|FG000|Overall Study|Physician Decision|1|||
27930556|NCT04810962|81582705|FG001|Overall Study|Physician Decision|0|||
27550296|NCT00471328|80200411|FG001|Core Phase|Administrative Problem|1|||
27550297|NCT00471328|80200410|FG000|Core Phase|Protocol Deviation|0|||
27550298|NCT00471328|80200411|FG001|Core Phase|Protocol Deviation|1|||
27550299|NCT00471328|80200410|FG000|Extension Phase|Adverse Event|3|||
27550300|NCT00471328|80200411|FG001|Extension Phase|Adverse Event|12|||
27550301|NCT00471328|80200410|FG000|Extension Phase|Withdrawal by Subject|0|||
27550302|NCT00471328|80200411|FG001|Extension Phase|Withdrawal by Subject|2|||
27550303|NCT00471328|80200410|FG000|Extension Phase|Death|1|||
27550304|NCT00471328|80200411|FG001|Extension Phase|Death|7|||
27550305|NCT00471328|80200410|FG000|Extension Phase|Protocol Deviation|3|||
27550306|NCT00471328|80200411|FG001|Extension Phase|Protocol Deviation|1|||
27550307|NCT00471328|80200410|FG000|Extension Phase|Treatment duration as per protocol|0|||
27550308|NCT00471328|80200411|FG001|Extension Phase|Treatment duration as per protocol|1|||
27550309|NCT00471328|80200410|FG000|Extension Phase|Disease Progression|32|||
27641579|NCT00409838|80529225|FG000|Short-term Period|Never Treated|1|||
27930557|NCT04810962|81582704|FG000|Overall Study|Withdrawal by Subject|1|||
27930558|NCT04810962|81582705|FG001|Overall Study|Withdrawal by Subject|3|||
27550310|NCT00471328|80200411|FG001|Extension Phase|Disease Progression|44|||
27550311|NCT00471328|80200410|FG000|Extension Phase|New cancer Therapy|1|||
27930559|NCT04810962|81582704|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
27930560|NCT04810962|81582705|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
27930561|NCT03601052|81582706|FG000|Overall Study|Lost to Follow-up|2|||
27930562|NCT01327703|81582709|FG000|Second Treatment Period|Adverse Event|1|||
27742832|NCT01770353|80887064|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
27742833|NCT02426086|80887068|FG000|Overall Study|Death|33|||
27742834|NCT02426086|80887069|FG001|Overall Study|Death|36|||
27930563|NCT01327703|81582710|FG001|Second Treatment Period|Adverse Event|1|||
27930564|NCT01327703|81582709|FG000|Second Treatment Period|Protocol Violation|0|||
27930565|NCT01327703|81582710|FG001|Second Treatment Period|Protocol Violation|1|||
27930566|NCT02638493|81582711|FG000|Overall Study|Inability to provide semen samples|2|||
27930567|NCT02638493|81582712|FG001|Overall Study|Inability to provide semen samples|0|||
27930568|NCT02638493|81582713|FG002|Overall Study|Inability to provide semen samples|0|||
27930569|NCT01900314|81582719|FG000|Overall Study|Lost to Follow-up|1|||
27930570|NCT01900314|81582720|FG001|Overall Study|Lost to Follow-up|0|||
27930571|NCT01900314|81582719|FG000|Overall Study|Protocol Violation|0|||
27930572|NCT01900314|81582720|FG001|Overall Study|Protocol Violation|1|||
27930573|NCT01900314|81582719|FG000|Overall Study|Withdrawal by Subject|3|||
27641580|NCT00409838|80529226|FG001|Short-term Period|Never Treated|0|||
27641581|NCT00409838|80529225|FG000|Long-term Extension Period|Adverse Event|10|||
27641582|NCT00409838|80529226|FG001|Long-term Extension Period|Adverse Event|0|||
27641583|NCT00409838|80529225|FG000|Long-term Extension Period|Death|1|||
27641584|NCT00409838|80529226|FG001|Long-term Extension Period|Death|0|||
27742835|NCT02426086|80887068|FG000|Overall Study|Lost to Follow-up|2|||
27930574|NCT01900314|81582720|FG001|Overall Study|Withdrawal by Subject|3|||
27930575|NCT00784875|81582724|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
27930576|NCT00784875|81582725|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
27930577|NCT00784875|81582726|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
27930578|NCT00784875|81582727|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
27930579|NCT00784875|81582724|FG000|Period A - Baseline|Adverse Event|0|||
27930580|NCT00784875|81582725|FG001|Period A - Baseline|Adverse Event|0|||
27930581|NCT00784875|81582726|FG002|Period A - Baseline|Adverse Event|0|||
27930582|NCT00784875|81582727|FG003|Period A - Baseline|Adverse Event|8|||
27930583|NCT00784875|81582724|FG000|Period A - Baseline|Protocol Violation|0|||
27930584|NCT00784875|81582725|FG001|Period A - Baseline|Protocol Violation|0|||
27930585|NCT00784875|81582726|FG002|Period A - Baseline|Protocol Violation|0|||
27930586|NCT00784875|81582727|FG003|Period A - Baseline|Protocol Violation|25|||
27930587|NCT00784875|81582724|FG000|Period A - Baseline|Withdrawal by Subject|0|||
27930588|NCT00784875|81582725|FG001|Period A - Baseline|Withdrawal by Subject|0|||
27930589|NCT00784875|81582726|FG002|Period A - Baseline|Withdrawal by Subject|0|||
27930590|NCT00784875|81582727|FG003|Period A - Baseline|Withdrawal by Subject|27|||
27930591|NCT00784875|81582724|FG000|Period A - Baseline|Physician Decision|0|||
27930592|NCT00784875|81582725|FG001|Period A - Baseline|Physician Decision|0|||
27930593|NCT00784875|81582726|FG002|Period A - Baseline|Physician Decision|0|||
27930594|NCT00784875|81582727|FG003|Period A - Baseline|Physician Decision|2|||
27930595|NCT00784875|81582724|FG000|Period A - Baseline|Sponsor Decision|0|||
27930596|NCT00784875|81582725|FG001|Period A - Baseline|Sponsor Decision|0|||
27930597|NCT00784875|81582726|FG002|Period A - Baseline|Sponsor Decision|0|||
27930598|NCT00784875|81582727|FG003|Period A - Baseline|Sponsor Decision|113|||
27930599|NCT00784875|81582724|FG000|Period A - Baseline|Lost to Follow-up|0|||
27930600|NCT00784875|81582725|FG001|Period A - Baseline|Lost to Follow-up|0|||
27930601|NCT00784875|81582726|FG002|Period A - Baseline|Lost to Follow-up|0|||
27930602|NCT00784875|81582727|FG003|Period A - Baseline|Lost to Follow-up|2|||
27930603|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
27930604|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
27930605|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
27930606|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
27930607|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
27930608|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
27930609|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
27930610|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
27930611|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
27550312|NCT00471328|80200411|FG001|Extension Phase|New cancer Therapy|0|||
27550313|NCT00471328|80200410|FG000|Extension Phase|Administrative Problem|1|||
27550314|NCT00471328|80200411|FG001|Extension Phase|Administrative Problem|0|||
27550315|NCT00563381|80200418|FG000|Overall Study|Adverse Event|264|||
27550316|NCT00563381|80200419|FG001|Overall Study|Adverse Event|292|||
27550317|NCT00563381|80200418|FG000|Overall Study|Protocol Violation|66|||
27550318|NCT00563381|80200419|FG001|Overall Study|Protocol Violation|74|||
27550319|NCT00563381|80200418|FG000|Overall Study|Lost to Follow-up|7|||
27550320|NCT00563381|80200419|FG001|Overall Study|Lost to Follow-up|15|||
27550321|NCT00563381|80200418|FG000|Overall Study|Withdrawal by Subject|192|||
27550322|NCT00563381|80200419|FG001|Overall Study|Withdrawal by Subject|209|||
27550323|NCT00563381|80200418|FG000|Overall Study|Lack of Efficacy|32|||
27930612|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
27930613|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
27930614|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
27930615|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
27930616|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
27930617|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
27930618|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
27641585|NCT00409838|80529225|FG000|Long-term Extension Period|Lack of Efficacy|2|||
27641586|NCT00409838|80529226|FG001|Long-term Extension Period|Lack of Efficacy|0|||
27641587|NCT00409838|80529225|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
27641588|NCT00409838|80529226|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
27641589|NCT00409838|80529225|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
27641590|NCT00409838|80529226|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
27641591|NCT00409838|80529225|FG000|Long-term Extension Period|Pregnancy|1|||
27641592|NCT00409838|80529226|FG001|Long-term Extension Period|Pregnancy|0|||
27930619|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
27930620|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
27930621|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
27930622|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
27930623|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
27930624|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
27930625|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
27930626|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
27930627|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
27930628|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
27930629|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
27930630|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
27930631|NCT00784875|81582724|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
27930632|NCT00784875|81582725|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
27930633|NCT00784875|81582726|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
27930634|NCT00784875|81582727|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
27930635|NCT00784875|81582724|FG000|Period C|Adverse Event|1|||
27930636|NCT00784875|81582725|FG001|Period C|Adverse Event|0|||
27930637|NCT00784875|81582726|FG002|Period C|Adverse Event|4|||
27930638|NCT00784875|81582727|FG003|Period C|Adverse Event|2|||
27930639|NCT00784875|81582724|FG000|Period C|Protocol Violation|0|||
27930640|NCT00784875|81582725|FG001|Period C|Protocol Violation|0|||
27930641|NCT00784875|81582726|FG002|Period C|Protocol Violation|1|||
27930642|NCT00784875|81582727|FG003|Period C|Protocol Violation|2|||
27930643|NCT00784875|81582724|FG000|Period C|Lack of Efficacy|0|||
27930644|NCT00784875|81582725|FG001|Period C|Lack of Efficacy|0|||
27930645|NCT00784875|81582726|FG002|Period C|Lack of Efficacy|1|||
27930646|NCT00784875|81582727|FG003|Period C|Lack of Efficacy|0|||
27930647|NCT00784875|81582724|FG000|Period C|Withdrawal by Subject|1|||
27930648|NCT00784875|81582725|FG001|Period C|Withdrawal by Subject|1|||
27930649|NCT00784875|81582726|FG002|Period C|Withdrawal by Subject|2|||
27930650|NCT00784875|81582727|FG003|Period C|Withdrawal by Subject|0|||
27930651|NCT00784875|81582724|FG000|Period C|Physician Decision|0|||
27930652|NCT00784875|81582725|FG001|Period C|Physician Decision|0|||
27930653|NCT00784875|81582726|FG002|Period C|Physician Decision|1|||
27930654|NCT00784875|81582727|FG003|Period C|Physician Decision|1|||
27930655|NCT00784875|81582724|FG000|Period C|Sponsor Decision|5|||
27930656|NCT00784875|81582725|FG001|Period C|Sponsor Decision|5|||
27550324|NCT00563381|80200419|FG001|Overall Study|Lack of Efficacy|24|||
27550325|NCT00563381|80200418|FG000|Overall Study|Individual different reasons|24|||
27550326|NCT00563381|80200419|FG001|Overall Study|Individual different reasons|34|||
27550327|NCT00160693|80200422|FG000|Overall Study|Adverse Event|97|||
27550328|NCT00160693|80200422|FG000|Overall Study|Lack of Efficacy|30|||
27550329|NCT00160693|80200422|FG000|Overall Study|Protocol Violation|24|||
27550330|NCT00160693|80200422|FG000|Overall Study|Lost to Follow-up|15|||
27930657|NCT00784875|81582726|FG002|Period C|Sponsor Decision|4|||
27930658|NCT00784875|81582727|FG003|Period C|Sponsor Decision|2|||
27930659|NCT00784875|81582724|FG000|Period D|Adverse Event|0|||
27930660|NCT00784875|81582725|FG001|Period D|Adverse Event|2|||
27930661|NCT00784875|81582726|FG002|Period D|Adverse Event|2|||
27930662|NCT00784875|81582727|FG003|Period D|Adverse Event|0|||
27930663|NCT00784875|81582724|FG000|Period D|Protocol Violation|1|||
27930664|NCT00784875|81582725|FG001|Period D|Protocol Violation|0|||
27930665|NCT00784875|81582726|FG002|Period D|Protocol Violation|0|||
27930666|NCT00784875|81582727|FG003|Period D|Protocol Violation|0|||
27930667|NCT00784875|81582724|FG000|Period D|Withdrawal by Subject|2|||
27930668|NCT00784875|81582725|FG001|Period D|Withdrawal by Subject|0|||
27930669|NCT00784875|81582726|FG002|Period D|Withdrawal by Subject|2|||
27930670|NCT00784875|81582727|FG003|Period D|Withdrawal by Subject|0|||
27550331|NCT00160693|80200422|FG000|Overall Study|Withdrawal by Subject|54|||
27550332|NCT00160693|80200422|FG000|Overall Study|Study terminated by sponsor|15|||
27550333|NCT02848651|80200423|FG000|Overall Study|Death|85|||
27930671|NCT00784875|81582724|FG000|Period D|Physician Decision|0|||
27930672|NCT00784875|81582725|FG001|Period D|Physician Decision|1|||
27930673|NCT00784875|81582726|FG002|Period D|Physician Decision|0|||
27930674|NCT00784875|81582727|FG003|Period D|Physician Decision|0|||
27930675|NCT00784875|81582724|FG000|Period D|Sponsor Decision|1|||
27930676|NCT00784875|81582725|FG001|Period D|Sponsor Decision|1|||
27930677|NCT00784875|81582726|FG002|Period D|Sponsor Decision|1|||
27930678|NCT00784875|81582727|FG003|Period D|Sponsor Decision|0|||
27930679|NCT00784875|81582724|FG000|Period D|Lost to Follow-up|1|||
27930680|NCT00784875|81582725|FG001|Period D|Lost to Follow-up|0|||
27930681|NCT00784875|81582726|FG002|Period D|Lost to Follow-up|1|||
27930682|NCT00784875|81582727|FG003|Period D|Lost to Follow-up|1|||
27641593|NCT01205048|80529233|FG000|Overall Study|Withdrawal by Subject|14|||
27641594|NCT01205048|80529233|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
27641595|NCT01205048|80529233|FG000|Overall Study|Lost to Follow-up|4|||
27641596|NCT01205048|80529233|FG000|Overall Study|Other|2|||
27641597|NCT03756571|80529234|FG000|Overall Study|Lost to Follow-up|1|||
27641598|NCT03756571|80529235|FG001|Overall Study|Lost to Follow-up|1|||
27641599|NCT00687219|80529236|FG000|Overall Study|Adverse Event|8|||
27641600|NCT00687219|80529236|FG000|Overall Study|Discontinuance criteria met|7|||
27641601|NCT00687219|80529236|FG000|Overall Study|HCV-RNA positive conversion|34|||
27641602|NCT00687219|80529236|FG000|Overall Study|Withdrawal by Subject|1|||
27641603|NCT00687219|80529236|FG000|Overall Study|Lack of Efficacy|1|||
27641604|NCT02422615|80529239|FG000|Treatment Period|Progressive disease|314|||
27641605|NCT02422615|80529240|FG001|Treatment Period|Progressive disease|200|||
27641606|NCT02422615|80529239|FG000|Treatment Period|Adverse Event|51|||
27641607|NCT02422615|80529240|FG001|Treatment Period|Adverse Event|9|||
27641608|NCT02422615|80529239|FG000|Treatment Period|Physician Decision|32|||
27641609|NCT02422615|80529240|FG001|Treatment Period|Physician Decision|8|||
27641610|NCT02422615|80529239|FG000|Treatment Period|Subject/guardian decision|38|||
27641611|NCT02422615|80529240|FG001|Treatment Period|Subject/guardian decision|8|||
27641612|NCT02422615|80529239|FG000|Treatment Period|Death|2|||
27641613|NCT02422615|80529240|FG001|Treatment Period|Death|1|||
27641614|NCT02422615|80529239|FG000|Treatment Period|Technical problems|0|||
27742836|NCT02426086|80887069|FG001|Overall Study|Lost to Follow-up|0|||
27742837|NCT02426086|80887068|FG000|Overall Study|Study Terminated by Sponsor|5|||
27930683|NCT00114777|81582731|FG000|Randomization to Month 36|Death|10|||
27930684|NCT00114777|81582732|FG001|Randomization to Month 36|Death|4|||
27930685|NCT00114777|81582733|FG002|Randomization to Month 36|Death|3|||
27930686|NCT00114777|81582731|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
27930687|NCT00114777|81582732|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
27930688|NCT00114777|81582733|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
27930689|NCT00114777|81582731|FG000|Randomization to Month 36|Lack of Efficacy|19|||
27930690|NCT00114777|81582732|FG001|Randomization to Month 36|Lack of Efficacy|15|||
27930691|NCT00114777|81582733|FG002|Randomization to Month 36|Lack of Efficacy|17|||
27930692|NCT00114777|81582731|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
27930693|NCT00114777|81582732|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
27930694|NCT00114777|81582733|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
27930695|NCT00114777|81582731|FG000|Randomization to Month 36|Adverse Event|34|||
27930696|NCT00114777|81582732|FG001|Randomization to Month 36|Adverse Event|35|||
27930697|NCT00114777|81582733|FG002|Randomization to Month 36|Adverse Event|44|||
27930698|NCT00114777|81582731|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
27930699|NCT00114777|81582732|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
27930700|NCT00114777|81582733|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
27930701|NCT00114777|81582731|FG000|Randomization to Month 36|Other|9|||
27930702|NCT00114777|81582732|FG001|Randomization to Month 36|Other|3|||
27930703|NCT00114777|81582733|FG002|Randomization to Month 36|Other|12|||
27930704|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Death|8|||
27930705|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Death|13|||
27930706|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Death|7|||
27930707|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
27930708|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
27930709|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
27930710|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
27930711|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
27930712|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
27930713|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
27930714|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
27930715|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
27930716|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
27930717|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
27930718|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
27641615|NCT02422615|80529240|FG001|Treatment Period|Technical problems|1|||
27641616|NCT02422615|80529239|FG000|Treatment Period|Protocol deviation|1|||
27641617|NCT02422615|80529240|FG001|Treatment Period|Protocol deviation|1|||
27930719|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
27930720|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
27930721|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
27930722|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
27930723|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
27930724|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
27930725|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
27930726|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
27930727|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
27930728|NCT00114777|81582731|FG000|Long-Term Extension to Month 84|Other|2|||
27930729|NCT00114777|81582732|FG001|Long-Term Extension to Month 84|Other|0|||
27930730|NCT00114777|81582733|FG002|Long-Term Extension to Month 84|Other|2|||
27930731|NCT00433537|81582734|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
27930732|NCT00433537|81582735|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
27930733|NCT00433537|81582736|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
27930734|NCT00433537|81582734|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
27930735|NCT00433537|81582735|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
27930736|NCT00433537|81582736|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
27930737|NCT00433537|81582734|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
27930738|NCT00433537|81582735|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
27930739|NCT00433537|81582736|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
27930740|NCT00433537|81582734|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
27930741|NCT00433537|81582735|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
27930742|NCT00433537|81582736|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
27930743|NCT00433537|81582734|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
27930744|NCT00433537|81582735|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
27930745|NCT00433537|81582736|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
27930746|NCT00433537|81582734|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
27930747|NCT00433537|81582735|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
27930748|NCT00433537|81582736|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
27930749|NCT00433537|81582734|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
27930750|NCT00433537|81582735|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
27930751|NCT00433537|81582736|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
27930752|NCT00433537|81582734|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
27930753|NCT00433537|81582735|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
27930754|NCT00433537|81582736|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
27930755|NCT00433537|81582734|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
27930756|NCT00433537|81582735|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
27930757|NCT00433537|81582736|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
27930758|NCT00774748|81582738|FG000|Overall Study|Lost to Follow-up|3|||
27930759|NCT00433290|81582739|FG000|Overall Study|Adverse Event|24|||
27930760|NCT00433290|81582740|FG001|Overall Study|Adverse Event|7|||
27930761|NCT00433290|81582739|FG000|Overall Study|Lack of Efficacy|1|||
27930762|NCT00433290|81582740|FG001|Overall Study|Lack of Efficacy|5|||
27930763|NCT00433290|81582739|FG000|Overall Study|Withdrawal by Subject|4|||
27930764|NCT00433290|81582740|FG001|Overall Study|Withdrawal by Subject|2|||
27930765|NCT00433290|81582739|FG000|Overall Study|Protocol Violation|3|||
27930766|NCT00433290|81582740|FG001|Overall Study|Protocol Violation|2|||
27930767|NCT00433290|81582739|FG000|Overall Study|Physician Decision|2|||
27930768|NCT00433290|81582740|FG001|Overall Study|Physician Decision|0|||
27930769|NCT00433290|81582739|FG000|Overall Study|Entry Criteria Not Met|0|||
27930770|NCT00433290|81582740|FG001|Overall Study|Entry Criteria Not Met|1|||
27930771|NCT00433290|81582739|FG000|Overall Study|Lost to Follow-up|1|||
27930772|NCT00433290|81582740|FG001|Overall Study|Lost to Follow-up|0|||
27930773|NCT01129128|81582745|FG000|Overall Study|Lost to Follow-up|2|||
27930774|NCT01129128|81582746|FG001|Overall Study|Lost to Follow-up|2|||
27930775|NCT01129128|81582747|FG002|Overall Study|Lost to Follow-up|1|||
27930776|NCT01129128|81582745|FG000|Overall Study|Protocol Violation|0|||
27930777|NCT01129128|81582746|FG001|Overall Study|Protocol Violation|1|||
27930778|NCT01129128|81582747|FG002|Overall Study|Protocol Violation|0|||
27930779|NCT01129128|81582745|FG000|Overall Study|Withdrawal by Subject|0|||
27930780|NCT01129128|81582746|FG001|Overall Study|Withdrawal by Subject|1|||
27930781|NCT01129128|81582747|FG002|Overall Study|Withdrawal by Subject|3|||
27930782|NCT01129128|81582745|FG000|Overall Study|Physician Decision|1|||
27930783|NCT01129128|81582746|FG001|Overall Study|Physician Decision|0|||
27930784|NCT01129128|81582747|FG002|Overall Study|Physician Decision|0|||
27930785|NCT01350973|81582750|FG000|Overall Study|Adverse Event|4|||
27930786|NCT01350973|81582751|FG001|Overall Study|Adverse Event|7|||
27930787|NCT01350973|81582752|FG002|Overall Study|Adverse Event|7|||
27930788|NCT01350973|81582750|FG000|Overall Study|Voluntary Withdrawal|2|||
27930789|NCT01350973|81582751|FG001|Overall Study|Voluntary Withdrawal|1|||
27930790|NCT01350973|81582752|FG002|Overall Study|Voluntary Withdrawal|1|||
27930791|NCT01774370|81582753|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
27930792|NCT01774370|81582753|FG000|Overall Study|Administered prior to the contract date|4|||
27930793|NCT01774370|81582753|FG000|Overall Study|Subjects of contraindications|34|||
27930794|NCT01774370|81582753|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
27930795|NCT01774370|81582753|FG000|Overall Study|Follow-up failure|34|||
27930796|NCT02547935|81582754|FG000|Overall Study|Other|0|||
27930797|NCT02547935|81582755|FG001|Overall Study|Other|1|||
27930798|NCT02547935|81582756|FG002|Overall Study|Other|0|||
27930799|NCT02547935|81582754|FG000|Overall Study|Withdrawal by Subject|2|||
27930800|NCT02547935|81582755|FG001|Overall Study|Withdrawal by Subject|3|||
27930801|NCT02547935|81582756|FG002|Overall Study|Withdrawal by Subject|4|||
27930802|NCT02547935|81582754|FG000|Overall Study|Screen Failure|2|||
27930803|NCT02547935|81582755|FG001|Overall Study|Screen Failure|0|||
27930804|NCT02547935|81582756|FG002|Overall Study|Screen Failure|0|||
27930805|NCT02547935|81582754|FG000|Overall Study|Physician Decision|0|||
27930806|NCT02547935|81582755|FG001|Overall Study|Physician Decision|1|||
27930807|NCT02547935|81582756|FG002|Overall Study|Physician Decision|0|||
27930808|NCT02547935|81582754|FG000|Overall Study|Lost to Follow-up|0|||
27930809|NCT02547935|81582755|FG001|Overall Study|Lost to Follow-up|2|||
27930810|NCT02547935|81582756|FG002|Overall Study|Lost to Follow-up|1|||
27930811|NCT02547935|81582754|FG000|Overall Study|Death|1|||
27930812|NCT02547935|81582755|FG001|Overall Study|Death|1|||
27930813|NCT02547935|81582756|FG002|Overall Study|Death|0|||
27930814|NCT00382070|81582764|FG000|Overall Study|No follow up data mapped to Other|17|||
27930815|NCT00382070|81582765|FG001|Overall Study|No follow up data mapped to Other|19|||
27930816|NCT00382070|81582764|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
27930817|NCT00382070|81582765|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
27930818|NCT00382070|81582764|FG000|Overall Study|No clinical assessment|9|||
27930819|NCT00382070|81582765|FG001|Overall Study|No clinical assessment|11|||
27930820|NCT00541229|81582766|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
27930821|NCT00541229|81582767|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
27930822|NCT00541229|81582768|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
27930823|NCT00541229|81582769|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
27930824|NCT00541229|81582770|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
27930825|NCT00541229|81582771|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
27930826|NCT00541229|81582766|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27930827|NCT00541229|81582767|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27930828|NCT00541229|81582768|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27930829|NCT00541229|81582769|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27930830|NCT00541229|81582770|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
27930831|NCT00541229|81582771|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
27930832|NCT00541229|81582766|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
27930833|NCT00541229|81582767|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
27930834|NCT00541229|81582768|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
27930835|NCT00541229|81582769|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
27930836|NCT00541229|81582770|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
27930837|NCT00541229|81582771|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
27930838|NCT00541229|81582766|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
27930839|NCT00541229|81582767|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
27930840|NCT00541229|81582768|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
27930841|NCT00541229|81582769|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
27930842|NCT00541229|81582770|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
27930843|NCT00541229|81582771|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
27930844|NCT00541229|81582766|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
27930845|NCT00541229|81582767|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
27930846|NCT00541229|81582768|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
27930847|NCT00541229|81582769|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
27930848|NCT00541229|81582770|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
27930849|NCT00541229|81582771|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
27930850|NCT00541229|81582766|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
27930851|NCT00541229|81582767|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
27930852|NCT00541229|81582768|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
27930853|NCT00541229|81582769|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
27930854|NCT00541229|81582770|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
27930855|NCT00541229|81582771|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
27930856|NCT00541229|81582766|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
27930857|NCT00541229|81582767|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
27930858|NCT00541229|81582768|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
27930859|NCT00541229|81582769|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
27930860|NCT00541229|81582770|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
27930861|NCT00541229|81582771|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
27930862|NCT00541229|81582766|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
27930863|NCT00541229|81582767|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
27930864|NCT00541229|81582768|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
27930865|NCT00541229|81582769|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
27930866|NCT00541229|81582770|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
27641618|NCT02422615|80529239|FG000|Treatment Period|Study terminated as per protocol|46|||
27641619|NCT02422615|80529240|FG001|Treatment Period|Study terminated as per protocol|14|||
27641620|NCT02422615|80529239|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
27641621|NCT02422615|80529240|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
27641622|NCT02422615|80529239|FG000|Post-treatment Efficacy Follow-up|Death|2|||
27641623|NCT02422615|80529240|FG001|Post-treatment Efficacy Follow-up|Death|1|||
27641624|NCT02422615|80529239|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27641625|NCT02422615|80529240|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27641626|NCT02422615|80529239|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
27641627|NCT02422615|80529240|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
27641628|NCT02422615|80529239|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
27930867|NCT00541229|81582771|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
27930868|NCT00541229|81582766|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
27930869|NCT00541229|81582767|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
27930870|NCT00541229|81582768|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
27930871|NCT00541229|81582769|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
27930872|NCT00541229|81582770|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
27930873|NCT00541229|81582771|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
27930874|NCT00541229|81582766|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
27930875|NCT00541229|81582767|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
27930876|NCT00541229|81582768|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
27930877|NCT00541229|81582769|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
27930878|NCT00541229|81582770|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
27930879|NCT00541229|81582771|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
27930880|NCT00541229|81582766|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
27930881|NCT00541229|81582767|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
27930882|NCT00541229|81582768|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
27930883|NCT00541229|81582769|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
27930884|NCT00541229|81582770|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
27930885|NCT00541229|81582771|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
27930886|NCT00541229|81582766|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
27930887|NCT00541229|81582767|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
27930888|NCT00541229|81582768|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
27930889|NCT00541229|81582769|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
27930890|NCT00541229|81582770|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
27930891|NCT00541229|81582771|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
27930892|NCT00541229|81582766|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
27930893|NCT00541229|81582767|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
27930894|NCT00541229|81582768|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
27930895|NCT00541229|81582769|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
27930896|NCT00541229|81582770|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
27930897|NCT00541229|81582771|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
27930898|NCT00541229|81582766|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
27930899|NCT00541229|81582767|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
27930900|NCT00541229|81582768|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
27930901|NCT00541229|81582769|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
27930902|NCT00541229|81582770|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
27930903|NCT00541229|81582771|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
27930904|NCT00541229|81582766|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
27930905|NCT00541229|81582767|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
27930906|NCT00541229|81582768|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
27930907|NCT00541229|81582769|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
27930908|NCT00541229|81582770|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
27930909|NCT00541229|81582771|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
27930910|NCT00541229|81582766|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
27930911|NCT00541229|81582767|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
27641629|NCT02422615|80529240|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
27641630|NCT02422615|80529239|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
27641631|NCT02422615|80529240|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
27641632|NCT02101281|80529243|FG000|Overall Study|Adverse Event|0|||
27641633|NCT02101281|80529244|FG001|Overall Study|Adverse Event|1|||
27641634|NCT00968149|80529248|FG000|Overall Study|Adverse Event|5|||
27641635|NCT00968149|80529249|FG001|Overall Study|Adverse Event|1|||
27930912|NCT00541229|81582768|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
27930913|NCT00541229|81582769|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
27930914|NCT00541229|81582770|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
27930915|NCT00541229|81582771|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
27930916|NCT00356590|81582772|FG000|Overall Study|Adverse Event|54|||
27930917|NCT00356590|81582772|FG000|Overall Study|Death|10|||
27930918|NCT00356590|81582772|FG000|Overall Study|Lost to Follow-up|35|||
27930919|NCT00356590|81582772|FG000|Overall Study|Physician Decision|46|||
27930920|NCT00356590|81582772|FG000|Overall Study|Withdrawal by Subject|41|||
27930921|NCT00356590|81582772|FG000|Overall Study|Completed month 12 only|2|||
27930922|NCT00356590|81582772|FG000|Overall Study|Protocol issues|6|||
27930923|NCT00356590|81582772|FG000|Overall Study|Response status|28|||
27930924|NCT00356590|81582772|FG000|Overall Study|Other|52|||
27930925|NCT01105130|81582777|FG000|Overall Study|Withdrawal by Subject|4|||
27930926|NCT01105130|81582778|FG001|Overall Study|Withdrawal by Subject|6|||
27930927|NCT01105130|81582779|FG002|Overall Study|Withdrawal by Subject|2|||
27930928|NCT01105130|81582777|FG000|Overall Study|Never Started|2|||
27930929|NCT01105130|81582778|FG001|Overall Study|Never Started|2|||
27930930|NCT01105130|81582779|FG002|Overall Study|Never Started|4|||
27930931|NCT01105130|81582777|FG000|Overall Study|Toxicity|1|||
27930932|NCT01105130|81582778|FG001|Overall Study|Toxicity|3|||
27930933|NCT01105130|81582779|FG002|Overall Study|Toxicity|2|||
27930934|NCT01105130|81582777|FG000|Overall Study|Multiple Reasons|3|||
27930935|NCT01105130|81582778|FG001|Overall Study|Multiple Reasons|0|||
27930936|NCT01105130|81582779|FG002|Overall Study|Multiple Reasons|2|||
27930937|NCT01668537|81582781|FG000|Overall Study|Request to Discontinue Prematurely|1|||
27930938|NCT01668537|81582782|FG001|Overall Study|Request to Discontinue Prematurely|1|||
27930939|NCT01668537|81582781|FG000|Overall Study|Subject unwilling/unable to comply|5|||
27930940|NCT01668537|81582782|FG001|Overall Study|Subject unwilling/unable to comply|0|||
27930941|NCT01668537|81582781|FG000|Overall Study|Reason Precludes Participation|1|||
27930942|NCT01668537|81582782|FG001|Overall Study|Reason Precludes Participation|0|||
27930943|NCT01668537|81582781|FG000|Overall Study|Lost to Follow-up|13|||
27930944|NCT01668537|81582782|FG001|Overall Study|Lost to Follow-up|6|||
27930945|NCT01668537|81582781|FG000|Overall Study|Other|2|||
27930946|NCT01668537|81582782|FG001|Overall Study|Other|3|||
27930947|NCT03111732|81582785|FG000|Overall Study|Enrolled in different study|1|||
27930948|NCT03111732|81582785|FG000|Overall Study|Progressive disease|3|||
27930949|NCT03111732|81582785|FG000|Overall Study|Withdrawal by Subject|1|||
27930950|NCT01136915|81582786|FG000|Overall Study|Lost to Follow-up|2|||
27930951|NCT01136915|81582787|FG001|Overall Study|Lost to Follow-up|0|||
27930952|NCT01136915|81582786|FG000|Overall Study|Exclusion criterion met|0|||
27930953|NCT01136915|81582787|FG001|Overall Study|Exclusion criterion met|1|||
27930954|NCT03723070|81582790|FG000|Overall Study|Lost to Follow-up|2|||
27930955|NCT03723070|81582790|FG000|Overall Study|Physician Decision|1|||
27930956|NCT03723070|81582790|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
27930957|NCT02513199|81582791|FG000|Treatment|Death|1|||
27742838|NCT02426086|80887069|FG001|Overall Study|Study Terminated by Sponsor|14|||
27742839|NCT02426086|80887068|FG000|Overall Study|Withdrawal by Subject|8|||
27742840|NCT02426086|80887069|FG001|Overall Study|Withdrawal by Subject|9|||
27742841|NCT01334125|80887070|FG000|Overall Study|Lost to Follow-up|3|||
27742842|NCT01334125|80887071|FG001|Overall Study|Lost to Follow-up|3|||
27930958|NCT02513199|81582791|FG000|Treatment|Lost to Follow-up|1|||
27930959|NCT02513199|81582791|FG000|Follow-Up|Death|11|||
27930960|NCT02153827|81582792|FG000|Overall Study|Lost to Follow-up|3|||
27930961|NCT02153827|81582793|FG001|Overall Study|Lost to Follow-up|9|||
27930962|NCT00460798|81582794|FG000|Overall Study|Death|59|||
27930963|NCT00460798|81582794|FG000|Overall Study|Adverse Event|27|||
27930964|NCT00460798|81582794|FG000|Overall Study|Lost to Follow-up|19|||
27930965|NCT00460798|81582794|FG000|Overall Study|Progressive Disease|99|||
27930966|NCT00460798|81582794|FG000|Overall Study|Other|27|||
27930967|NCT00460798|81582794|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
27742843|NCT01024465|80889377|FG000|Overall Study|Adverse Event|2|||
27742844|NCT01024465|80889377|FG000|Overall Study|Physician Decision|1|||
27742845|NCT00417612|80889378|FG000|Overall Study|Errant diagnosis|0|||
27742846|NCT00417612|80889379|FG001|Overall Study|Errant diagnosis|1|||
27930968|NCT00460798|81582794|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
27930969|NCT02323334|81582795|FG000|Period 3|Lost to Follow-up|0|||
27930970|NCT02323334|81582796|FG001|Period 3|Lost to Follow-up|0|||
27930971|NCT02323334|81582797|FG002|Period 3|Lost to Follow-up|1|||
27930972|NCT02323334|81582798|FG003|Period 3|Lost to Follow-up|0|||
27930973|NCT02323334|81582799|FG004|Period 3|Lost to Follow-up|0|||
27930974|NCT02323334|81582800|FG005|Period 3|Lost to Follow-up|0|||
27930975|NCT02323334|81582801|FG006|Period 3|Lost to Follow-up|0|||
27930976|NCT02323334|81582802|FG007|Period 3|Lost to Follow-up|0|||
27930977|NCT02323334|81582803|FG008|Period 3|Lost to Follow-up|0|||
27550334|NCT02848651|80200423|FG000|Overall Study|Lost to Follow-up|1|||
27930978|NCT02323334|81582804|FG009|Period 3|Lost to Follow-up|0|||
27930979|NCT02323334|81582805|FG010|Period 3|Lost to Follow-up|0|||
27930980|NCT02323334|81582806|FG011|Period 3|Lost to Follow-up|0|||
27930981|NCT02323334|81582807|FG012|Period 3|Lost to Follow-up|0|||
27930982|NCT02323334|81582808|FG013|Period 3|Lost to Follow-up|0|||
27930983|NCT02323334|81582809|FG014|Period 3|Lost to Follow-up|0|||
27930984|NCT02323334|81582810|FG015|Period 3|Lost to Follow-up|0|||
27930985|NCT02323334|81582811|FG016|Period 3|Lost to Follow-up|0|||
27930986|NCT02323334|81582795|FG000|Period 3|Withdrawal by Subject|1|||
27930987|NCT02323334|81582796|FG001|Period 3|Withdrawal by Subject|0|||
27930988|NCT02323334|81582797|FG002|Period 3|Withdrawal by Subject|0|||
27930989|NCT02323334|81582798|FG003|Period 3|Withdrawal by Subject|0|||
27930990|NCT02323334|81582799|FG004|Period 3|Withdrawal by Subject|0|||
27930991|NCT02323334|81582800|FG005|Period 3|Withdrawal by Subject|0|||
27930992|NCT02323334|81582801|FG006|Period 3|Withdrawal by Subject|0|||
27930993|NCT02323334|81582802|FG007|Period 3|Withdrawal by Subject|0|||
27930994|NCT02323334|81582803|FG008|Period 3|Withdrawal by Subject|0|||
27930995|NCT02323334|81582804|FG009|Period 3|Withdrawal by Subject|0|||
27930996|NCT02323334|81582805|FG010|Period 3|Withdrawal by Subject|0|||
27930997|NCT02323334|81582806|FG011|Period 3|Withdrawal by Subject|0|||
27930998|NCT02323334|81582807|FG012|Period 3|Withdrawal by Subject|0|||
27930999|NCT02323334|81582808|FG013|Period 3|Withdrawal by Subject|0|||
27931000|NCT02323334|81582809|FG014|Period 3|Withdrawal by Subject|0|||
27931001|NCT02323334|81582810|FG015|Period 3|Withdrawal by Subject|0|||
27931002|NCT02323334|81582811|FG016|Period 3|Withdrawal by Subject|0|||
27931003|NCT02068599|81582824|FG000|Overall Study|Adverse Event|4|||
27931004|NCT02068599|81582825|FG001|Overall Study|Adverse Event|1|||
27931005|NCT02068599|81582826|FG002|Overall Study|Adverse Event|1|||
27931006|NCT02068599|81582824|FG000|Overall Study|Withdrawal by Subject|2|||
27931007|NCT02068599|81582825|FG001|Overall Study|Withdrawal by Subject|7|||
27931008|NCT02068599|81582826|FG002|Overall Study|Withdrawal by Subject|5|||
27931009|NCT02068599|81582824|FG000|Overall Study|Protocol Violation|4|||
27931010|NCT02068599|81582825|FG001|Overall Study|Protocol Violation|2|||
27931011|NCT02068599|81582826|FG002|Overall Study|Protocol Violation|3|||
27931012|NCT02068599|81582824|FG000|Overall Study|Lost to Follow-up|1|||
27931013|NCT02068599|81582825|FG001|Overall Study|Lost to Follow-up|0|||
27931014|NCT02068599|81582826|FG002|Overall Study|Lost to Follow-up|0|||
27931015|NCT02068599|81582824|FG000|Overall Study|Lack of Efficacy|0|||
27931016|NCT02068599|81582825|FG001|Overall Study|Lack of Efficacy|0|||
27931017|NCT02068599|81582826|FG002|Overall Study|Lack of Efficacy|3|||
27931018|NCT02068599|81582824|FG000|Overall Study|Noncompliance|0|||
27931019|NCT02068599|81582825|FG001|Overall Study|Noncompliance|0|||
27931020|NCT02068599|81582826|FG002|Overall Study|Noncompliance|1|||
27931021|NCT01257542|81582829|FG000|Overall Study|Protocol Violation|3|||
27931022|NCT01257542|81582830|FG001|Overall Study|Protocol Violation|5|||
27931023|NCT01257542|81582829|FG000|Overall Study|Withdrawal by Subject|0|||
27931024|NCT01257542|81582830|FG001|Overall Study|Withdrawal by Subject|2|||
27931025|NCT02487199|81582831|FG000|Overall Study|Withdrew Consent|0|||
27931026|NCT02487199|81582832|FG001|Overall Study|Withdrew Consent|1|||
27931027|NCT02018887|81582833|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
27931028|NCT02018887|81582834|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931029|NCT02018887|81582835|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931030|NCT02018887|81582836|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931031|NCT02018887|81582837|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931032|NCT02018887|81582838|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931033|NCT02018887|81582839|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931034|NCT02018887|81582840|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931035|NCT02018887|81582841|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931036|NCT02018887|81582842|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931037|NCT02018887|81582843|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
27931038|NCT02018887|81582833|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27641636|NCT00968149|80529248|FG000|Overall Study|Lack of Efficacy|0|||
27641637|NCT00968149|80529249|FG001|Overall Study|Lack of Efficacy|4|||
27931039|NCT02018887|81582834|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931040|NCT02018887|81582835|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931041|NCT02018887|81582836|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931042|NCT02018887|81582837|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
27641638|NCT00968149|80529248|FG000|Overall Study|Lost to Follow-up|0|||
27931043|NCT02018887|81582838|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931044|NCT02018887|81582839|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
27931045|NCT02018887|81582840|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
27931046|NCT02018887|81582841|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931047|NCT02018887|81582842|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931048|NCT02018887|81582843|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
27931049|NCT02018887|81582833|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
27931050|NCT02018887|81582834|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
27931051|NCT02018887|81582835|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
27931052|NCT02018887|81582836|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
27742847|NCT00417612|80889378|FG000|Overall Study|Adverse Event|2|||
27931053|NCT02018887|81582837|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
27931054|NCT02018887|81582838|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
27931055|NCT02018887|81582839|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
27931056|NCT02018887|81582840|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
27931057|NCT02018887|81582841|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
27931058|NCT02018887|81582842|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
27931059|NCT02018887|81582843|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
27931060|NCT02018887|81582833|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
27931061|NCT02018887|81582834|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
27931062|NCT02018887|81582835|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
27931063|NCT02018887|81582836|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
27931064|NCT02018887|81582837|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
27931065|NCT02018887|81582838|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
27931066|NCT02018887|81582839|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
27931067|NCT02018887|81582840|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
27931068|NCT02018887|81582841|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
27931069|NCT02018887|81582842|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
27931070|NCT02018887|81582843|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
27931071|NCT00441896|81582844|FG000|Overall Study|Withdrawal by Subject|0|||
27931072|NCT00441896|81582845|FG001|Overall Study|Withdrawal by Subject|0|||
27931073|NCT00441896|81582846|FG002|Overall Study|Withdrawal by Subject|0|||
27931074|NCT00441896|81582847|FG003|Overall Study|Withdrawal by Subject|1|||
27931075|NCT00441896|81582848|FG004|Overall Study|Withdrawal by Subject|0|||
27931076|NCT00441896|81582849|FG005|Overall Study|Withdrawal by Subject|0|||
27931077|NCT00441896|81582850|FG006|Overall Study|Withdrawal by Subject|0|||
27931078|NCT00441896|81582851|FG007|Overall Study|Withdrawal by Subject|0|||
27931079|NCT00441896|81582852|FG008|Overall Study|Withdrawal by Subject|0|||
27931080|NCT00441896|81582853|FG009|Overall Study|Withdrawal by Subject|0|||
27931081|NCT00441896|81582844|FG000|Overall Study|Other|0|||
27931082|NCT00441896|81582845|FG001|Overall Study|Other|0|||
27931083|NCT00441896|81582846|FG002|Overall Study|Other|0|||
27931084|NCT00441896|81582847|FG003|Overall Study|Other|0|||
27931085|NCT00441896|81582848|FG004|Overall Study|Other|1|||
27931086|NCT00441896|81582849|FG005|Overall Study|Other|0|||
27931087|NCT00441896|81582850|FG006|Overall Study|Other|0|||
27931088|NCT00441896|81582851|FG007|Overall Study|Other|0|||
27931089|NCT00441896|81582852|FG008|Overall Study|Other|0|||
27931090|NCT00441896|81582853|FG009|Overall Study|Other|0|||
27931091|NCT01905683|81582854|FG000|Overall Study|Protocol Violation|1|||
27931092|NCT01905683|81582854|FG000|Overall Study|Re-injection criteria not met; others|13|||
27931093|NCT01905683|81582854|FG000|Overall Study|Physician Decision|1|||
27931094|NCT01905683|81582854|FG000|Overall Study|Lack of Efficacy|8|||
27931095|NCT01905683|81582854|FG000|Overall Study|Withdrawal by Subject|20|||
27931096|NCT01905683|81582854|FG000|Overall Study|Adverse Event|4|||
27931097|NCT01905683|81582854|FG000|Overall Study|Lost to Follow-up|4|||
27931098|NCT00968968|81582856|FG000|Overall Study|Study closed/terminated|10|||
27931099|NCT00968968|81582857|FG001|Overall Study|Study closed/terminated|10|||
27931100|NCT00968968|81582856|FG000|Overall Study|Protocol defined stopping criteria|3|||
27931101|NCT00968968|81582857|FG001|Overall Study|Protocol defined stopping criteria|1|||
27931102|NCT00968968|81582856|FG000|Overall Study|Withdrawal by Subject|2|||
27931103|NCT00968968|81582857|FG001|Overall Study|Withdrawal by Subject|0|||
27931104|NCT00968968|81582856|FG000|Overall Study|Physician Decision|1|||
27931105|NCT00968968|81582857|FG001|Overall Study|Physician Decision|2|||
27931106|NCT00968968|81582856|FG000|Overall Study|Lost to Follow-up|0|||
27931107|NCT00968968|81582857|FG001|Overall Study|Lost to Follow-up|1|||
27931108|NCT03637374|81582858|FG000|Overall Study|Death|2|||
27931109|NCT03637374|81582859|FG001|Overall Study|Death|0|||
27931110|NCT00498485|81582863|FG000|Overall Study|Adverse Event|1|||
27931111|NCT00498485|81582864|FG001|Overall Study|Adverse Event|5|||
27931112|NCT00853047|81582865|FG000|Core Phase|Participant Request|0|||
27931113|NCT00853047|81582866|FG001|Core Phase|Participant Request|0|||
27931114|NCT00853047|81582867|FG002|Core Phase|Participant Request|0|||
27931115|NCT00853047|81582868|FG003|Core Phase|Participant Request|1|||
27931116|NCT00853047|81582869|FG004|Core Phase|Participant Request|0|||
27931117|NCT00853047|81582870|FG005|Core Phase|Participant Request|0|||
27931118|NCT00853047|81582865|FG000|Open-Label Extension Phase|Participant Request|0|||
27742848|NCT00417612|80889379|FG001|Overall Study|Adverse Event|0|||
27742849|NCT00417612|80889378|FG000|Overall Study|Protocol Violation|0|||
27931119|NCT00853047|81582866|FG001|Open-Label Extension Phase|Participant Request|0|||
27931120|NCT00853047|81582867|FG002|Open-Label Extension Phase|Participant Request|0|||
27931121|NCT00853047|81582868|FG003|Open-Label Extension Phase|Participant Request|0|||
27931122|NCT00853047|81582869|FG004|Open-Label Extension Phase|Participant Request|0|||
27931123|NCT00853047|81582870|FG005|Open-Label Extension Phase|Participant Request|7|||
27742850|NCT00417612|80889379|FG001|Overall Study|Protocol Violation|2|||
27931124|NCT00853047|81582865|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27931125|NCT00853047|81582866|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27931126|NCT00853047|81582867|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
27550335|NCT02848651|80200423|FG000|Overall Study|Non-Compliance|1|||
27931127|NCT00853047|81582868|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
27931128|NCT00853047|81582869|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
27931129|NCT00853047|81582870|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
27931130|NCT00853047|81582865|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27931131|NCT00853047|81582866|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27931132|NCT00853047|81582867|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27931133|NCT00853047|81582868|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27931134|NCT00853047|81582869|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
27931135|NCT00853047|81582870|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
27931136|NCT00853047|81582865|FG000|Open-Label Extension Phase|Investigator Decision|0|||
27931137|NCT00853047|81582866|FG001|Open-Label Extension Phase|Investigator Decision|0|||
27931138|NCT00853047|81582867|FG002|Open-Label Extension Phase|Investigator Decision|0|||
27931139|NCT00853047|81582868|FG003|Open-Label Extension Phase|Investigator Decision|0|||
27931140|NCT00853047|81582869|FG004|Open-Label Extension Phase|Investigator Decision|0|||
27931141|NCT00853047|81582870|FG005|Open-Label Extension Phase|Investigator Decision|1|||
27931142|NCT00853047|81582865|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
27931143|NCT00853047|81582866|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
27931144|NCT00853047|81582867|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
27931145|NCT00853047|81582868|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
27931146|NCT00853047|81582869|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
27931147|NCT00853047|81582870|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
27931148|NCT01859741|81582872|FG000|Overall Study|Death|3|||
27931149|NCT01859741|81582873|FG001|Overall Study|Death|2|||
27931150|NCT01859741|81582874|FG002|Overall Study|Death|4|||
27931151|NCT01859741|81582875|FG003|Overall Study|Death|3|||
27931152|NCT01859741|81582876|FG004|Overall Study|Death|5|||
27931153|NCT01859741|81582877|FG005|Overall Study|Death|4|||
27931154|NCT01859741|81582878|FG006|Overall Study|Death|51|||
27931155|NCT01859741|81582879|FG007|Overall Study|Death|51|||
27931156|NCT01859741|81582872|FG000|Overall Study|Lost to Follow-up|0|||
27931157|NCT01859741|81582873|FG001|Overall Study|Lost to Follow-up|0|||
27931158|NCT01859741|81582874|FG002|Overall Study|Lost to Follow-up|0|||
27931159|NCT01859741|81582875|FG003|Overall Study|Lost to Follow-up|0|||
27931160|NCT01859741|81582876|FG004|Overall Study|Lost to Follow-up|0|||
27931161|NCT01859741|81582877|FG005|Overall Study|Lost to Follow-up|1|||
27931162|NCT01859741|81582878|FG006|Overall Study|Lost to Follow-up|0|||
27931163|NCT01859741|81582879|FG007|Overall Study|Lost to Follow-up|4|||
27931164|NCT01859741|81582872|FG000|Overall Study|Withdrawal by Subject|0|||
27931165|NCT01859741|81582873|FG001|Overall Study|Withdrawal by Subject|1|||
27931166|NCT01859741|81582874|FG002|Overall Study|Withdrawal by Subject|2|||
27931167|NCT01859741|81582875|FG003|Overall Study|Withdrawal by Subject|0|||
27931168|NCT01859741|81582876|FG004|Overall Study|Withdrawal by Subject|0|||
27931169|NCT01859741|81582877|FG005|Overall Study|Withdrawal by Subject|1|||
27931170|NCT01859741|81582878|FG006|Overall Study|Withdrawal by Subject|1|||
27931171|NCT01859741|81582879|FG007|Overall Study|Withdrawal by Subject|1|||
27931172|NCT01859741|81582872|FG000|Overall Study|Study Terminated by Sponsor|0|||
27931173|NCT01859741|81582873|FG001|Overall Study|Study Terminated by Sponsor|0|||
27931174|NCT01859741|81582874|FG002|Overall Study|Study Terminated by Sponsor|0|||
27931175|NCT01859741|81582875|FG003|Overall Study|Study Terminated by Sponsor|0|||
27931176|NCT01859741|81582876|FG004|Overall Study|Study Terminated by Sponsor|1|||
27931177|NCT01859741|81582877|FG005|Overall Study|Study Terminated by Sponsor|0|||
27931178|NCT01859741|81582878|FG006|Overall Study|Study Terminated by Sponsor|16|||
27931179|NCT01859741|81582879|FG007|Overall Study|Study Terminated by Sponsor|14|||
27931180|NCT01859741|81582872|FG000|Overall Study|Other|0|||
27931181|NCT01859741|81582873|FG001|Overall Study|Other|0|||
27931182|NCT01859741|81582874|FG002|Overall Study|Other|0|||
27931183|NCT01859741|81582875|FG003|Overall Study|Other|0|||
27931184|NCT01859741|81582876|FG004|Overall Study|Other|0|||
27931185|NCT01859741|81582877|FG005|Overall Study|Other|0|||
27931186|NCT01859741|81582878|FG006|Overall Study|Other|2|||
27550336|NCT02848651|80200423|FG000|Overall Study|Symptomatic Deterioration|1|||
27931187|NCT01859741|81582879|FG007|Overall Study|Other|0|||
27931188|NCT01028391|81582880|FG000|Overall Study|Adverse Event|4|||
27931189|NCT01028391|81582881|FG001|Overall Study|Adverse Event|0|||
27931190|NCT01028391|81582880|FG000|Overall Study|Lack of Efficacy|0|||
27931191|NCT01028391|81582881|FG001|Overall Study|Lack of Efficacy|2|||
27931192|NCT01028391|81582880|FG000|Overall Study|Lost to Follow-up|3|||
27931193|NCT01028391|81582881|FG001|Overall Study|Lost to Follow-up|4|||
27931194|NCT01028391|81582880|FG000|Overall Study|Physician Decision|0|||
27931195|NCT01028391|81582881|FG001|Overall Study|Physician Decision|1|||
27931196|NCT01028391|81582880|FG000|Overall Study|Withdrawal by Subject|6|||
27931197|NCT01028391|81582881|FG001|Overall Study|Withdrawal by Subject|3|||
27931198|NCT01028391|81582880|FG000|Overall Study|Needed excluded medication|1|||
27931199|NCT01028391|81582881|FG001|Overall Study|Needed excluded medication|1|||
27550337|NCT02848651|80200423|FG000|Overall Study|Physician Decision|4|||
27931200|NCT03320369|81582882|FG000|Overall Study|Adverse Event|1|||
27931201|NCT03320369|81582882|FG000|Overall Study|Withdrawal by Subject|2|||
27931202|NCT01200355|81582883|FG000|Overall Study|Death|7|||
27931203|NCT01200355|81582884|FG001|Overall Study|Death|2|||
27931204|NCT03123588|81585728|FG000|Overall Study|Study Terminated by Sponsor|2|||
27931205|NCT03123588|81585729|FG001|Overall Study|Study Terminated by Sponsor|5|||
27931206|NCT03123588|81585728|FG000|Overall Study|Withdrawal by Subject|1|||
27931207|NCT03123588|81585729|FG001|Overall Study|Withdrawal by Subject|0|||
27931208|NCT03123588|81585728|FG000|Overall Study|Adverse Event|1|||
27931209|NCT03123588|81585729|FG001|Overall Study|Adverse Event|0|||
27931210|NCT03123588|81585728|FG000|Overall Study|Physician Decision|2|||
27931211|NCT03123588|81585729|FG001|Overall Study|Physician Decision|1|||
27931212|NCT01851369|81585730|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931213|NCT01851369|81585731|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931214|NCT01851369|81585732|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931215|NCT01851369|81585733|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931216|NCT01851369|81585734|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931217|NCT01851369|81585735|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
27931218|NCT01851369|81585736|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931219|NCT01851369|81585737|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931220|NCT01851369|81585738|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931221|NCT01851369|81585739|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931222|NCT01851369|81585740|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931223|NCT01851369|81585741|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931224|NCT01851369|81585742|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
27931225|NCT00629239|81585745|FG000|Overall Study|Adverse Event|7|||
27931226|NCT00629239|81585746|FG001|Overall Study|Adverse Event|4|||
27931227|NCT00629239|81585745|FG000|Overall Study|Physician Decision|1|||
27931228|NCT00629239|81585746|FG001|Overall Study|Physician Decision|0|||
27931229|NCT00450749|81585747|FG000|Overall Study|Withdrawal by Subject|0|||
27931230|NCT00450749|81585748|FG001|Overall Study|Withdrawal by Subject|0|||
27931231|NCT00450749|81585749|FG002|Overall Study|Withdrawal by Subject|2|||
27931232|NCT00450749|81585747|FG000|Overall Study|Noncompliant|0|||
27931233|NCT00450749|81585748|FG001|Overall Study|Noncompliant|1|||
27931234|NCT00450749|81585749|FG002|Overall Study|Noncompliant|0|||
27931235|NCT01121926|81585750|FG000|First Intervention Period|Adverse Event|1|||
27931236|NCT01121926|81585751|FG001|First Intervention Period|Adverse Event|0|||
27931237|NCT01121926|81585750|FG000|Washout Period|Adverse Event|0|||
27931238|NCT01121926|81585751|FG001|Washout Period|Adverse Event|1|||
27931239|NCT01121926|81585750|FG000|Washout Period|Positive pregnancy test|0|||
27931240|NCT01121926|81585751|FG001|Washout Period|Positive pregnancy test|1|||
27931241|NCT00683384|81585754|FG000|Overall Study|Death|1|||
27931242|NCT00683384|81585754|FG000|Overall Study|Adverse Event|1|||
27931243|NCT00456612|81585765|FG000|Overall Study|Withdrawal by Subject|3|||
27931244|NCT02320396|81585772|FG000|Overall Study|Adverse Event|2|||
27931245|NCT02320396|81585773|FG001|Overall Study|Adverse Event|2|||
27931246|NCT02320396|81585772|FG000|Overall Study|Pregnancy|0|||
27931247|NCT02320396|81585773|FG001|Overall Study|Pregnancy|1|||
27931248|NCT02320396|81585772|FG000|Overall Study|Protocol Violation|0|||
27931249|NCT02320396|81585773|FG001|Overall Study|Protocol Violation|1|||
27931250|NCT02320396|81585772|FG000|Overall Study|Withdrawal by Subject|2|||
27931251|NCT02320396|81585773|FG001|Overall Study|Withdrawal by Subject|0|||
27931252|NCT00472641|81585776|FG000|Overall Study|Lack of Efficacy|3|||
27931253|NCT00472641|81585776|FG000|Overall Study|Adverse Event|3|||
27931254|NCT00472641|81585776|FG000|Overall Study|Lost to Follow-up|1|||
27931255|NCT00790036|81585777|FG000|Overall Study|Abnormal lab values|3|||
27931256|NCT00790036|81585778|FG001|Overall Study|Abnormal lab values|2|||
27931257|NCT00790036|81585777|FG000|Overall Study|Administrative problems|5|||
27931258|NCT00790036|81585778|FG001|Overall Study|Administrative problems|9|||
27931259|NCT00790036|81585777|FG000|Overall Study|Adverse Event|113|||
27931260|NCT00790036|81585778|FG001|Overall Study|Adverse Event|44|||
27931261|NCT00790036|81585777|FG000|Overall Study|Death|1|||
27931262|NCT00790036|81585778|FG001|Overall Study|Death|0|||
27931263|NCT00790036|81585777|FG000|Overall Study|Disease progression|24|||
27931264|NCT00790036|81585778|FG001|Overall Study|Disease progression|48|||
27931265|NCT00790036|81585777|FG000|Overall Study|Lost to Follow-up|1|||
27931266|NCT00790036|81585778|FG001|Overall Study|Lost to Follow-up|2|||
27931267|NCT00790036|81585777|FG000|Overall Study|Protocol Violation|10|||
27931268|NCT00790036|81585778|FG001|Overall Study|Protocol Violation|2|||
27931269|NCT00790036|81585777|FG000|Overall Study|Withdrawal by Subject|18|||
27931270|NCT00790036|81585778|FG001|Overall Study|Withdrawal by Subject|7|||
27931271|NCT00790036|81585777|FG000|Overall Study|Subject/guardian decision|20|||
27931272|NCT00790036|81585778|FG001|Overall Study|Subject/guardian decision|7|||
27931273|NCT02852434|81585779|FG000|Overall Study|Withdrawal by Subject|0|||
27931274|NCT02852434|81585780|FG001|Overall Study|Withdrawal by Subject|1|||
27931275|NCT02852434|81585779|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
27931276|NCT02852434|81585780|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
27931277|NCT00577408|81585782|FG000|Overall Study|Stopped attending study visits|9|||
27931278|NCT00577408|81585783|FG001|Overall Study|Stopped attending study visits|11|||
27641639|NCT00968149|80529249|FG001|Overall Study|Lost to Follow-up|1|||
27641640|NCT00968149|80529248|FG000|Overall Study|Protocol Violation|4|||
27641641|NCT00968149|80529249|FG001|Overall Study|Protocol Violation|0|||
27641642|NCT00968149|80529248|FG000|Overall Study|Withdrawal by Subject|2|||
27641643|NCT00968149|80529249|FG001|Overall Study|Withdrawal by Subject|0|||
27641644|NCT02119650|80529259|FG000|Overall Study|Adverse Event|3|||
27641645|NCT02119650|80529260|FG001|Overall Study|Adverse Event|4|||
27641646|NCT02119650|80529259|FG000|Overall Study|Subject decision|2|||
27641647|NCT02119650|80529260|FG001|Overall Study|Subject decision|3|||
27641648|NCT02119650|80529259|FG000|Overall Study|Disease progression|11|||
27641649|NCT02119650|80529260|FG001|Overall Study|Disease progression|14|||
27641650|NCT02119650|80529259|FG000|Overall Study|Death|5|||
27641651|NCT02119650|80529260|FG001|Overall Study|Death|1|||
27931279|NCT00577408|81585782|FG000|Overall Study|Continued opioid use|3|||
27641652|NCT02119650|80529259|FG000|Overall Study|Noncompliance with study treatment|1|||
27641653|NCT02119650|80529260|FG001|Overall Study|Noncompliance with study treatment|1|||
27641654|NCT02119650|80529259|FG000|Overall Study|Study terminated by the sponsor|1|||
27641655|NCT02119650|80529260|FG001|Overall Study|Study terminated by the sponsor|0|||
27641656|NCT02119650|80529259|FG000|Overall Study|Physician Decision|0|||
27641657|NCT02119650|80529260|FG001|Overall Study|Physician Decision|2|||
27641658|NCT02119650|80529259|FG000|Overall Study|Multiple reasons for termination|2|||
27641659|NCT02119650|80529260|FG001|Overall Study|Multiple reasons for termination|1|||
27641660|NCT02647905|80529261|FG000|Overall Study|Lost to Follow-up|1|||
27641661|NCT02647905|80529261|FG000|Overall Study|Withdrawal by Subject|2|||
27641662|NCT01391832|80529263|FG000|Overall Study|Withdrawal by Subject|21|||
27641663|NCT01391832|80529264|FG001|Overall Study|Withdrawal by Subject|22|||
27641664|NCT01391832|80529263|FG000|Overall Study|Lost to Follow-up|0|||
27641665|NCT01391832|80529264|FG001|Overall Study|Lost to Follow-up|1|||
27641666|NCT01951170|80529265|FG000|Overall Study|Investigator decision|1|||
27641667|NCT02034916|80529266|FG000|Overall Study|Death|39|||
27641668|NCT02034916|80529267|FG001|Overall Study|Death|28|||
27641669|NCT02034916|80529266|FG000|Overall Study|Withdrawal by Subject|2|||
27742851|NCT00417612|80889378|FG000|Overall Study|Lost to Follow-up|1|||
27742852|NCT00417612|80889379|FG001|Overall Study|Lost to Follow-up|0|||
27742853|NCT01494038|80889385|FG000|Overall Study|Protocol Violation|1|||
27931280|NCT00577408|81585783|FG001|Overall Study|Continued opioid use|2|||
27931281|NCT00577408|81585782|FG000|Overall Study|Non-compliance with study meds|0|||
27931282|NCT00577408|81585783|FG001|Overall Study|Non-compliance with study meds|3|||
27931283|NCT00577408|81585782|FG000|Overall Study|Refused Oral Naltrexone|0|||
27931284|NCT00577408|81585783|FG001|Overall Study|Refused Oral Naltrexone|1|||
27931285|NCT00577408|81585782|FG000|Overall Study|Moved out of state|0|||
27931286|NCT00577408|81585783|FG001|Overall Study|Moved out of state|1|||
27931287|NCT00577408|81585782|FG000|Overall Study|Scheduling Issues|0|||
27931288|NCT00577408|81585783|FG001|Overall Study|Scheduling Issues|3|||
27931289|NCT00577408|81585782|FG000|Overall Study|Death|0|||
27931290|NCT00577408|81585783|FG001|Overall Study|Death|1|||
27931291|NCT00577408|81585782|FG000|Overall Study|Psychiatric hospitalization|0|||
27931292|NCT00577408|81585783|FG001|Overall Study|Psychiatric hospitalization|1|||
27931293|NCT00032487|81585794|FG000|Overall Study|Withdrawal by Subject|67|||
27931294|NCT00032487|81585795|FG001|Overall Study|Withdrawal by Subject|43|||
27931295|NCT00032487|81585794|FG000|Overall Study|Adverse Event|3|||
27931296|NCT00032487|81585795|FG001|Overall Study|Adverse Event|7|||
27931297|NCT00032487|81585794|FG000|Overall Study|Lost to Follow-up|57|||
27931298|NCT00032487|81585795|FG001|Overall Study|Lost to Follow-up|58|||
27931299|NCT00032487|81585794|FG000|Overall Study|Had other reason|12|||
27931300|NCT00032487|81585795|FG001|Overall Study|Had other reason|12|||
27931301|NCT00962650|81585796|FG000|Overall Study|Transgastric DP was not completed|2|||
27931302|NCT01370538|81585797|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
27931303|NCT01370538|81585798|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
27931304|NCT01370538|81585797|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27931305|NCT01370538|81585798|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27931306|NCT01370538|81585797|FG000|Overall Study|Adverse Event|1|||
27931307|NCT01370538|81585798|FG001|Overall Study|Adverse Event|0|||
27931308|NCT01370538|81585797|FG000|Overall Study|Protocol Violation|8|||
27931309|NCT01370538|81585798|FG001|Overall Study|Protocol Violation|5|||
27641670|NCT02034916|80529267|FG001|Overall Study|Withdrawal by Subject|1|||
27641671|NCT02034916|80529266|FG000|Overall Study|Lost to Follow-up|4|||
27641672|NCT02034916|80529267|FG001|Overall Study|Lost to Follow-up|1|||
27641673|NCT02034916|80529266|FG000|Overall Study|Study terminated by sponsor|4|||
27641674|NCT02034916|80529267|FG001|Overall Study|Study terminated by sponsor|5|||
27931310|NCT01370538|81585797|FG000|Overall Study|Development of study specific withdrawal|1|||
27931311|NCT01370538|81585798|FG001|Overall Study|Development of study specific withdrawal|1|||
27742854|NCT01494038|80889386|FG001|Overall Study|Protocol Violation|1|||
27931312|NCT01370538|81585797|FG000|Overall Study|Lost to follow up|6|||
27641675|NCT01388361|80529269|FG000|Overall Study|Adverse Event|0|||
27641676|NCT01388361|80529270|FG001|Overall Study|Adverse Event|5|||
27641677|NCT01388361|80529271|FG002|Overall Study|Adverse Event|1|||
27641678|NCT01388361|80529269|FG000|Overall Study|Protocol Violation|0|||
27641679|NCT01388361|80529270|FG001|Overall Study|Protocol Violation|0|||
27641680|NCT01388361|80529271|FG002|Overall Study|Protocol Violation|2|||
27641681|NCT01388361|80529269|FG000|Overall Study|Withdrawal criteria|12|||
27641682|NCT01388361|80529270|FG001|Overall Study|Withdrawal criteria|7|||
27641683|NCT01388361|80529271|FG002|Overall Study|Withdrawal criteria|10|||
27641684|NCT01388361|80529269|FG000|Overall Study|Unclassified|0|||
27641685|NCT01388361|80529270|FG001|Overall Study|Unclassified|0|||
27641686|NCT01388361|80529271|FG002|Overall Study|Unclassified|1|||
27641687|NCT01095796|80529272|FG000|Overall Study|Randomized but Not Treated|5|||
27641688|NCT01095796|80529273|FG001|Overall Study|Randomized but Not Treated|2|||
27641689|NCT01095796|80529272|FG000|Overall Study|Adverse Event|9|||
27641690|NCT01095796|80529273|FG001|Overall Study|Adverse Event|19|||
27641691|NCT01095796|80529272|FG000|Overall Study|Death|3|||
27641692|NCT01095796|80529273|FG001|Overall Study|Death|2|||
27641693|NCT01095796|80529272|FG000|Overall Study|Pregnancy|2|||
27641694|NCT01095796|80529273|FG001|Overall Study|Pregnancy|0|||
27641695|NCT01095796|80529272|FG000|Overall Study|Lack of Efficacy|5|||
27641696|NCT01095796|80529273|FG001|Overall Study|Lack of Efficacy|3|||
27641697|NCT01095796|80529272|FG000|Overall Study|Investigator's Discretion|7|||
27641698|NCT01095796|80529273|FG001|Overall Study|Investigator's Discretion|2|||
27641699|NCT01095796|80529272|FG000|Overall Study|Withdrew Consent|16|||
27641700|NCT01095796|80529273|FG001|Overall Study|Withdrew Consent|22|||
27641701|NCT01095796|80529272|FG000|Overall Study|Lost to Follow-up|27|||
27641702|NCT01095796|80529273|FG001|Overall Study|Lost to Follow-up|29|||
27742855|NCT01494038|80889385|FG000|Overall Study|Lost to Follow-up|18|||
27742856|NCT01494038|80889386|FG001|Overall Study|Lost to Follow-up|20|||
27931313|NCT01370538|81585798|FG001|Overall Study|Lost to follow up|10|||
27931314|NCT00103506|81585799|FG000|Overall Study|Study closed by sponsor|34|||
27931315|NCT00103506|81585800|FG001|Overall Study|Study closed by sponsor|37|||
27931316|NCT00103506|81585799|FG000|Overall Study|Death|257|||
27931317|NCT00103506|81585800|FG001|Overall Study|Death|253|||
27931318|NCT00103506|81585799|FG000|Overall Study|Lost to Follow-up|13|||
27931319|NCT00103506|81585800|FG001|Overall Study|Lost to Follow-up|13|||
27931320|NCT00103506|81585799|FG000|Overall Study|Withdrawal by Subject|18|||
27931321|NCT00103506|81585800|FG001|Overall Study|Withdrawal by Subject|21|||
27931322|NCT00920816|81585801|FG000|Overall Study|Death|116|||
27931323|NCT00920816|81585802|FG001|Overall Study|Death|63|||
27931324|NCT00920816|81585803|FG002|Overall Study|Death|8|||
27550338|NCT02848651|80200423|FG000|Overall Study|Withdrawal by Subject|14|||
27550339|NCT00576927|80200424|FG000|Clinical Assessment|Lack of Efficacy|24|||
27550340|NCT00576927|80200424|FG000|Clinical Assessment|Death|1|||
27550341|NCT00576927|80200424|FG000|Clinical Assessment|Withdrawal by Subject|10|||
27550342|NCT00576927|80200424|FG000|Clinical Assessment|Physician Decision|1|||
27550343|NCT00576927|80200424|FG000|Baseline|Physician Decision|9|||
27550344|NCT00576927|80200424|FG000|Baseline|Medication Change by PCP of subject|1|||
27550345|NCT00576927|80200424|FG000|Baseline|Withdrawal by Subject|3|||
27550346|NCT00576927|80200424|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
27550347|NCT00576927|80200424|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
27550348|NCT00576927|80200424|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
27550349|NCT00576927|80200424|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
27550350|NCT00576927|80200424|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
27550351|NCT02151591|80200426|FG000|Overall Study|Lost to Follow-up|6|||
27550352|NCT02151591|80200427|FG001|Overall Study|Lost to Follow-up|3|||
27550353|NCT00612690|80200428|FG000|Overall Study|Lost to Follow-up|72|||
27550354|NCT00612690|80200429|FG001|Overall Study|Lost to Follow-up|98|||
27550355|NCT00612690|80200428|FG000|Overall Study|Withdrawal by Subject|32|||
27550356|NCT00612690|80200429|FG001|Overall Study|Withdrawal by Subject|20|||
27550357|NCT00612690|80200428|FG000|Overall Study|Withdrawal by Site|11|||
27550358|NCT00612690|80200429|FG001|Overall Study|Withdrawal by Site|0|||
27550359|NCT00578812|80200432|FG000|Overall Study|Not treated|6|||
27550360|NCT00578812|80200433|FG001|Overall Study|Not treated|7|||
27550361|NCT01854710|80200434|FG000|Overall Study|Withdrawal by Subject|2|||
27550362|NCT01854710|80200435|FG001|Overall Study|Withdrawal by Subject|1|||
27550363|NCT01854710|80200436|FG002|Overall Study|Withdrawal by Subject|0|||
27550364|NCT01854710|80200437|FG003|Overall Study|Withdrawal by Subject|0|||
27550365|NCT01854710|80200438|FG004|Overall Study|Withdrawal by Subject|0|||
27550366|NCT01854710|80200439|FG005|Overall Study|Withdrawal by Subject|0|||
27641703|NCT01095796|80529272|FG000|Overall Study|Participant Noncompliance|5|||
27641704|NCT01095796|80529273|FG001|Overall Study|Participant Noncompliance|10|||
27641705|NCT01095796|80529272|FG000|Overall Study|Protocol Violation|1|||
27931325|NCT00920816|81585804|FG003|Overall Study|Death|3|||
27931326|NCT00920816|81585801|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
27931327|NCT00920816|81585802|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
27641706|NCT01095796|80529273|FG001|Overall Study|Protocol Violation|0|||
27641707|NCT01095796|80529272|FG000|Overall Study|Participant Transferred to Another Study|215|||
27931328|NCT00920816|81585803|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
27931329|NCT00920816|81585804|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
27931330|NCT00920816|81585801|FG000|Overall Study|Global deterioration of health status|2|||
27931331|NCT00920816|81585802|FG001|Overall Study|Global deterioration of health status|0|||
27931332|NCT00920816|81585803|FG002|Overall Study|Global deterioration of health status|0|||
27931333|NCT00920816|81585804|FG003|Overall Study|Global deterioration of health status|0|||
27931334|NCT00920816|81585801|FG000|Overall Study|Objective progression or relapse|6|||
27931335|NCT00920816|81585802|FG001|Overall Study|Objective progression or relapse|2|||
27931336|NCT00920816|81585803|FG002|Overall Study|Objective progression or relapse|0|||
27931337|NCT00920816|81585804|FG003|Overall Study|Objective progression or relapse|0|||
27931338|NCT00920816|81585801|FG000|Overall Study|Other|26|||
27931339|NCT00920816|81585802|FG001|Overall Study|Other|15|||
27931340|NCT00920816|81585803|FG002|Overall Study|Other|1|||
27931341|NCT00920816|81585804|FG003|Overall Study|Other|2|||
27931342|NCT00920816|81585801|FG000|Overall Study|Lost to Follow-up|11|||
27931343|NCT00920816|81585802|FG001|Overall Study|Lost to Follow-up|2|||
27931344|NCT00920816|81585803|FG002|Overall Study|Lost to Follow-up|0|||
27641708|NCT01095796|80529273|FG001|Overall Study|Participant Transferred to Another Study|200|||
27641709|NCT00274469|80529274|FG000|Overall Study|Death|63|||
27931345|NCT00920816|81585804|FG003|Overall Study|Lost to Follow-up|0|||
27931346|NCT00920816|81585801|FG000|Overall Study|Adverse Event|1|||
27931347|NCT00920816|81585802|FG001|Overall Study|Adverse Event|1|||
27931348|NCT00920816|81585803|FG002|Overall Study|Adverse Event|1|||
27931349|NCT00920816|81585804|FG003|Overall Study|Adverse Event|0|||
27931350|NCT00920816|81585801|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
27931351|NCT00920816|81585802|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
27931352|NCT00920816|81585803|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
27931353|NCT00920816|81585804|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
27931354|NCT00920816|81585801|FG000|Overall Study|Randomized but not treated|3|||
27931355|NCT00920816|81585802|FG001|Overall Study|Randomized but not treated|0|||
27931356|NCT00920816|81585803|FG002|Overall Study|Randomized but not treated|0|||
27931357|NCT00920816|81585804|FG003|Overall Study|Randomized but not treated|0|||
27931358|NCT01312129|81585805|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
27931359|NCT01312129|81585806|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
27931360|NCT00296335|81585807|FG000|Overall Study|Recurrence|3|||
27931361|NCT00296335|81585808|FG001|Overall Study|Recurrence|51|||
27931362|NCT00296335|81585807|FG000|Overall Study|Adverse Event|17|||
27931363|NCT00296335|81585808|FG001|Overall Study|Adverse Event|27|||
27931364|NCT00296335|81585807|FG000|Overall Study|Lost to Follow-up|7|||
27931365|NCT00296335|81585808|FG001|Overall Study|Lost to Follow-up|33|||
27931366|NCT00296335|81585807|FG000|Overall Study|Physician Decision|3|||
27931367|NCT00296335|81585808|FG001|Overall Study|Physician Decision|11|||
27931368|NCT03147287|81585809|FG000|Overall Study|Randomized Not Treated|2|||
27931369|NCT03147287|81585810|FG001|Overall Study|Randomized Not Treated|1|||
27931370|NCT03147287|81585811|FG002|Overall Study|Randomized Not Treated|1|||
27931371|NCT03147287|81585809|FG000|Overall Study|Progressive Disease RECIST|31|||
27931372|NCT03147287|81585810|FG001|Overall Study|Progressive Disease RECIST|72|||
27931373|NCT03147287|81585811|FG002|Overall Study|Progressive Disease RECIST|32|||
27931374|NCT03147287|81585809|FG000|Overall Study|Progressive Disease not RECIST|13|||
27931375|NCT03147287|81585810|FG001|Overall Study|Progressive Disease not RECIST|21|||
27931376|NCT03147287|81585811|FG002|Overall Study|Progressive Disease not RECIST|13|||
27931377|NCT03147287|81585809|FG000|Overall Study|Physician Decision|1|||
27931378|NCT03147287|81585810|FG001|Overall Study|Physician Decision|2|||
27931379|NCT03147287|81585811|FG002|Overall Study|Physician Decision|1|||
27931380|NCT03147287|81585809|FG000|Overall Study|Intercurrent illness|0|||
27641710|NCT00274469|80529275|FG001|Overall Study|Death|74|||
27641711|NCT00274469|80529274|FG000|Overall Study|Did not consent to OS follow-up|16|||
27641712|NCT00274469|80529275|FG001|Overall Study|Did not consent to OS follow-up|19|||
27641713|NCT03785405|80529276|FG000|Overall Study|Adverse Event|16|||
27641714|NCT03785405|80529277|FG001|Overall Study|Adverse Event|1|||
27641715|NCT03785405|80529276|FG000|Overall Study|Death|6|||
27641716|NCT03785405|80529277|FG001|Overall Study|Death|4|||
27641717|NCT03785405|80529276|FG000|Overall Study|Guardian decision|4|||
27641718|NCT03785405|80529277|FG001|Overall Study|Guardian decision|1|||
27931381|NCT03147287|81585810|FG001|Overall Study|Intercurrent illness|1|||
27931382|NCT03147287|81585811|FG002|Overall Study|Intercurrent illness|0|||
27931383|NCT03147287|81585809|FG000|Overall Study|Withdrawal by Subject|2|||
27931384|NCT03147287|81585810|FG001|Overall Study|Withdrawal by Subject|3|||
27931385|NCT03147287|81585811|FG002|Overall Study|Withdrawal by Subject|2|||
27931386|NCT03147287|81585809|FG000|Overall Study|Patient Non-Compliance|0|||
27641719|NCT03785405|80529276|FG000|Overall Study|Lost to Follow-up|1|||
27641720|NCT03785405|80529277|FG001|Overall Study|Lost to Follow-up|0|||
27641721|NCT03785405|80529276|FG000|Overall Study|Physician Decision|8|||
27931387|NCT03147287|81585810|FG001|Overall Study|Patient Non-Compliance|2|||
27931388|NCT03147287|81585811|FG002|Overall Study|Patient Non-Compliance|0|||
27931389|NCT03147287|81585809|FG000|Overall Study|Patient moved|0|||
27931390|NCT03147287|81585810|FG001|Overall Study|Patient moved|1|||
27931391|NCT03147287|81585811|FG002|Overall Study|Patient moved|0|||
27931392|NCT03147287|81585809|FG000|Overall Study|Arm A crossover without PD|1|||
27931393|NCT03147287|81585810|FG001|Overall Study|Arm A crossover without PD|0|||
27931394|NCT03147287|81585811|FG002|Overall Study|Arm A crossover without PD|0|||
27931395|NCT03147287|81585809|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
27931396|NCT03147287|81585810|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
27931397|NCT03147287|81585811|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
27931398|NCT00363467|81585812|FG000|Overall Study|Physician Decision|1|||
27931399|NCT04727749|81585814|FG000|Overall Study|Lost to Follow-up|10|||
27931400|NCT04727749|81585815|FG001|Overall Study|Lost to Follow-up|3|||
27931401|NCT01756235|81585818|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
27931402|NCT01481779|81585819|FG000|Overall Study|Adverse Event|23|||
27931403|NCT01481779|81585820|FG001|Overall Study|Adverse Event|5|||
27931404|NCT01481779|81585819|FG000|Overall Study|Lost to Follow-up|3|||
27931405|NCT01481779|81585820|FG001|Overall Study|Lost to Follow-up|2|||
27931406|NCT01481779|81585819|FG000|Overall Study|Protocol Violation|2|||
27931407|NCT01481779|81585820|FG001|Overall Study|Protocol Violation|3|||
27931408|NCT01481779|81585819|FG000|Overall Study|Withdrawal by Subject|26|||
27931409|NCT01481779|81585820|FG001|Overall Study|Withdrawal by Subject|13|||
27931410|NCT01481779|81585819|FG000|Overall Study|Physician Decision|13|||
27931411|NCT01481779|81585820|FG001|Overall Study|Physician Decision|4|||
27931412|NCT01481779|81585819|FG000|Overall Study|Sponsor Decision|3|||
27931413|NCT01481779|81585820|FG001|Overall Study|Sponsor Decision|1|||
27931414|NCT02299167|81585824|FG000|Overall Study|patients were excluded from the study|11|||
27931415|NCT02762604|81585826|FG000|Overall Study|Lost to Follow-up|2|||
27931416|NCT02762604|81585827|FG001|Overall Study|Lost to Follow-up|7|||
27931417|NCT02762604|81585826|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
27931418|NCT02762604|81585827|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
27931419|NCT00088153|81585832|FG000|Overall Study|Physician Decision|3|||
27931420|NCT00088153|81585833|FG001|Overall Study|Physician Decision|3|||
27931421|NCT00088153|81585832|FG000|Overall Study|Withdrawal by Subject|10|||
27931422|NCT00088153|81585833|FG001|Overall Study|Withdrawal by Subject|10|||
27931423|NCT00088153|81585832|FG000|Overall Study|Lost to Follow-up|11|||
27931424|NCT00088153|81585833|FG001|Overall Study|Lost to Follow-up|12|||
27931425|NCT00455455|81585834|FG000|Washout|Withdrawal by Subject|0|||
27931426|NCT00455455|81585835|FG001|Washout|Withdrawal by Subject|1|||
27931427|NCT00455455|81585834|FG000|Washout|Withdrawal by Subject|1|||
27931428|NCT00455455|81585835|FG001|Washout|Withdrawal by Subject|0|||
27931429|NCT00337194|81585841|FG000|Overall Study|Adverse Event|5|||
27931430|NCT00337194|81585842|FG001|Overall Study|Adverse Event|1|||
27931431|NCT00337194|81585841|FG000|Overall Study|Death|2|||
27931432|NCT00337194|81585842|FG001|Overall Study|Death|0|||
27931433|NCT00337194|81585841|FG000|Overall Study|Withdrawal by Subject|1|||
27931434|NCT00337194|81585842|FG001|Overall Study|Withdrawal by Subject|0|||
27931435|NCT00337194|81585841|FG000|Overall Study|Disease progression|1|||
27931436|NCT00337194|81585842|FG001|Overall Study|Disease progression|2|||
27931437|NCT00337194|81585841|FG000|Overall Study|Subsequent non-protocol therapy|3|||
27931438|NCT00337194|81585842|FG001|Overall Study|Subsequent non-protocol therapy|1|||
27931439|NCT02293499|81585844|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
27931440|NCT02293499|81585845|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
27931441|NCT02293499|81585846|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
27550367|NCT01854710|80200434|FG000|Overall Study|CRI procedural error|2|||
27550368|NCT01854710|80200435|FG001|Overall Study|CRI procedural error|2|||
27550369|NCT01854710|80200436|FG002|Overall Study|CRI procedural error|2|||
27931442|NCT02293499|81585844|FG000|Intervention - Camp|Withdrawal by Subject|3|||
27931443|NCT02293499|81585845|FG001|Intervention - Camp|Withdrawal by Subject|6|||
27931444|NCT02293499|81585846|FG002|Intervention - Camp|Withdrawal by Subject|2|||
27931445|NCT02293499|81585844|FG000|Intervention - Camp|these are those not showing up at camp|24|||
27931446|NCT02293499|81585845|FG001|Intervention - Camp|these are those not showing up at camp|28|||
27931447|NCT02293499|81585846|FG002|Intervention - Camp|these are those not showing up at camp|4|||
27931448|NCT02293499|81585844|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
27931449|NCT02293499|81585845|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
27931450|NCT02293499|81585846|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
27931451|NCT02293499|81585844|FG000|3 Month Follow Up|Lost to Follow-up|14|||
27931452|NCT02293499|81585845|FG001|3 Month Follow Up|Lost to Follow-up|15|||
27931453|NCT02293499|81585846|FG002|3 Month Follow Up|Lost to Follow-up|6|||
27931454|NCT02293499|81585844|FG000|6 Month Follow Up|Lost to Follow-up|17|||
27931455|NCT02293499|81585845|FG001|6 Month Follow Up|Lost to Follow-up|27|||
27931456|NCT02293499|81585846|FG002|6 Month Follow Up|Lost to Follow-up|6|||
27641722|NCT03785405|80529277|FG001|Overall Study|Physician Decision|5|||
27931457|NCT02293499|81585844|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
27931458|NCT02293499|81585845|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
27931459|NCT02293499|81585846|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
27931460|NCT02293499|81585844|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
27931461|NCT02293499|81585845|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
27931462|NCT02293499|81585846|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
27931463|NCT02293499|81585844|FG000|9 Month Follow Up|Lost to Follow-up|24|||
27931464|NCT02293499|81585845|FG001|9 Month Follow Up|Lost to Follow-up|28|||
27931465|NCT02293499|81585846|FG002|9 Month Follow Up|Lost to Follow-up|4|||
27931466|NCT02293499|81585844|FG000|12 Month Follow Up|Lost to Follow-up|26|||
27931467|NCT02293499|81585845|FG001|12 Month Follow Up|Lost to Follow-up|25|||
27931468|NCT02293499|81585846|FG002|12 Month Follow Up|Lost to Follow-up|6|||
27931469|NCT02293499|81585844|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
27931470|NCT02293499|81585845|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
27931471|NCT02293499|81585846|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
27931472|NCT02293499|81585844|FG000|15 Month Follow Up|Lost to Follow-up|22|||
27931473|NCT02293499|81585845|FG001|15 Month Follow Up|Lost to Follow-up|22|||
27931474|NCT02293499|81585846|FG002|15 Month Follow Up|Lost to Follow-up|7|||
27931475|NCT01174459|81585847|FG000|Overall Study|case report form (CRF) not collected|5|||
27931476|NCT04401293|81585848|FG000|Overall Study|Withdrawal by Subject|1|||
27931477|NCT04401293|81585849|FG001|Overall Study|Withdrawal by Subject|3|||
27931478|NCT04795323|81585852|FG000|Overall Study|Did not interact with TARA|1|||
27931479|NCT04795323|81585853|FG001|Overall Study|Did not interact with TARA|0|||
27931480|NCT03595748|81585854|FG000|Overall Study|Death|11|||
27931481|NCT03595748|81585855|FG001|Overall Study|Death|12|||
27931482|NCT03595748|81585854|FG000|Overall Study|Withdrawal by Subject|28|||
27931483|NCT03595748|81585855|FG001|Overall Study|Withdrawal by Subject|29|||
27931484|NCT03595748|81585854|FG000|Overall Study|Protocol Violation|0|||
27931485|NCT03595748|81585855|FG001|Overall Study|Protocol Violation|1|||
27931486|NCT01111292|81585856|FG000|Treatment|Physician Decision|1|||
27931487|NCT01111292|81585857|FG001|Treatment|Physician Decision|1|||
27931488|NCT00694161|81585858|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
27931489|NCT00694161|81585858|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
27931490|NCT00694161|81585858|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
27931491|NCT01290731|81585864|FG000|Overall Study|Withdrawal by Subject|1|||
27931492|NCT00888849|81585865|FG000|Overall Study|Death|4|||
27931493|NCT00888849|81585866|FG001|Overall Study|Death|7|||
27931494|NCT00888849|81585865|FG000|Overall Study|Lost to Follow-up|1|||
27931495|NCT00888849|81585866|FG001|Overall Study|Lost to Follow-up|2|||
27931496|NCT02034591|81585867|FG000|Overall Study|Withdrawal by Subject|0|||
27931497|NCT02034591|81585868|FG001|Overall Study|Withdrawal by Subject|0|||
27931498|NCT02034591|81585869|FG002|Overall Study|Withdrawal by Subject|0|||
27931499|NCT02034591|81585870|FG003|Overall Study|Withdrawal by Subject|0|||
27931500|NCT02034591|81585871|FG004|Overall Study|Withdrawal by Subject|1|||
27931501|NCT02034591|81585872|FG005|Overall Study|Withdrawal by Subject|0|||
27931502|NCT01068912|81585873|FG000|Overall Study|Adverse Event|2|||
27931503|NCT01068912|81585874|FG001|Overall Study|Adverse Event|3|||
27931504|NCT01068912|81585875|FG002|Overall Study|Adverse Event|2|||
27931505|NCT01068912|81585873|FG000|Overall Study|Withdrawal by Subject|5|||
27931506|NCT01068912|81585874|FG001|Overall Study|Withdrawal by Subject|6|||
27931507|NCT01068912|81585875|FG002|Overall Study|Withdrawal by Subject|6|||
27931508|NCT01068912|81585873|FG000|Overall Study|Lost to Follow-up|3|||
27931509|NCT01068912|81585874|FG001|Overall Study|Lost to Follow-up|7|||
27931510|NCT01068912|81585875|FG002|Overall Study|Lost to Follow-up|3|||
27931511|NCT01068912|81585873|FG000|Overall Study|Protocol Violation|0|||
27931512|NCT01068912|81585874|FG001|Overall Study|Protocol Violation|2|||
27931513|NCT01068912|81585875|FG002|Overall Study|Protocol Violation|0|||
27931514|NCT01068912|81585873|FG000|Overall Study|aggravation influenza|1|||
27931515|NCT01068912|81585874|FG001|Overall Study|aggravation influenza|1|||
27931516|NCT01068912|81585875|FG002|Overall Study|aggravation influenza|1|||
27931517|NCT01068912|81585873|FG000|Overall Study|other underlying illness|0|||
27931518|NCT01068912|81585874|FG001|Overall Study|other underlying illness|3|||
27931519|NCT01068912|81585875|FG002|Overall Study|other underlying illness|3|||
27931520|NCT02506036|81585876|FG000|First Intervention (4-6 Weeks)|Death|1|||
27931521|NCT02506036|81585877|FG001|First Intervention (4-6 Weeks)|Death|0|||
27931522|NCT02506036|81585876|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
27931523|NCT02506036|81585877|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
27931524|NCT02506036|81585876|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
27931525|NCT02506036|81585877|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
27931526|NCT01149538|81585879|FG000|Overall Study|Lost to Follow-up|0|||
27931527|NCT01149538|81585880|FG001|Overall Study|Lost to Follow-up|1|||
27931528|NCT01149538|81585879|FG000|Overall Study|Withdrawal by Subject|5|||
27931529|NCT01149538|81585880|FG001|Overall Study|Withdrawal by Subject|3|||
27931530|NCT02536794|81585884|FG000|Reached 1st Response Assessment|Adverse Event|2|||
27931531|NCT02536794|81585884|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
27931532|NCT02536794|81585884|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
27931533|NCT02536794|81585884|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
27931534|NCT02536794|81585884|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
27931535|NCT02536794|81585884|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
27931536|NCT02609633|81585885|FG000|Overall Study|Consent Withdrawn|0|||
27931537|NCT02609633|81585886|FG001|Overall Study|Consent Withdrawn|1|||
27931538|NCT02609633|81585885|FG000|Overall Study|Protocol Deviation|1|||
27931539|NCT02609633|81585886|FG001|Overall Study|Protocol Deviation|0|||
27931540|NCT02609633|81585885|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
27931541|NCT02609633|81585886|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
27931542|NCT02609633|81585885|FG000|Overall Study|Reason not Specified|2|||
27931543|NCT02609633|81585886|FG001|Overall Study|Reason not Specified|1|||
27931544|NCT02497755|81585887|FG000|Overall Study|Protocol Violation|1|||
27931545|NCT02497755|81585888|FG001|Overall Study|Protocol Violation|0|||
27931546|NCT01757847|81585893|FG000|Overall Study|Withdrawal by Subject|3|||
27931547|NCT01757847|81585894|FG001|Overall Study|Withdrawal by Subject|4|||
27931548|NCT02448043|81585895|FG000|Overall Study|Withdrawal by Subject|2|||
27931549|NCT02448043|81585896|FG001|Overall Study|Withdrawal by Subject|2|||
27931550|NCT02448043|81585895|FG000|Overall Study|Protocol Violation|1|||
27931551|NCT02448043|81585896|FG001|Overall Study|Protocol Violation|2|||
27931552|NCT04914000|81585901|FG000|Overall Study|Lost to Follow-up|8|||
27931553|NCT04914000|81585901|FG000|Overall Study|Withdrawal by Subject|1|||
27931554|NCT01896986|81585902|FG000|Overall Study|samples lost|14|||
27931555|NCT01896986|81585903|FG001|Overall Study|samples lost|23|||
27931556|NCT04339972|81585906|FG000|Overall Study|Scheduling Issues|3|||
27931557|NCT04339972|81585907|FG001|Overall Study|Scheduling Issues|3|||
27931558|NCT04339972|81585906|FG000|Overall Study|dropout|1|||
27931559|NCT04339972|81585907|FG001|Overall Study|dropout|1|||
27931560|NCT04339972|81585906|FG000|Overall Study|Technical issues|1|||
27931561|NCT04339972|81585907|FG001|Overall Study|Technical issues|0|||
27931562|NCT04339972|81585906|FG000|Overall Study|Claustraphobia|0|||
27931563|NCT04339972|81585907|FG001|Overall Study|Claustraphobia|1|||
27931564|NCT01227395|81585908|FG000|Overall Study|Protocol Violation|0|||
27931565|NCT01227395|81585909|FG001|Overall Study|Protocol Violation|1|||
27931566|NCT00471354|81585915|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
27931567|NCT00471354|81585915|FG000|Overall Study|Adverse Event|13|||
27931568|NCT00471354|81585915|FG000|Overall Study|Protocol Violation|12|||
27931569|NCT00471354|81585915|FG000|Overall Study|Withdrawal by Subject|1|||
27931570|NCT00471354|81585915|FG000|Overall Study|Physician Decision|4|||
27931571|NCT00471354|81585915|FG000|Overall Study|Sponsor Decision|1|||
27931572|NCT00471354|81585915|FG000|Overall Study|Lost to Follow-up|3|||
27931573|NCT00471354|81585915|FG000|Overall Study|Lack of Efficacy|5|||
27931574|NCT00471354|81585915|FG000|Overall Study|Patient/Caregiver Decision|12|||
27931575|NCT01410604|81585916|FG000|Overall Study|Adverse Event|2|||
27931576|NCT01410604|81585917|FG001|Overall Study|Adverse Event|1|||
27931577|NCT01410604|81585916|FG000|Overall Study|Lost to Follow-up|1|||
27931578|NCT01410604|81585917|FG001|Overall Study|Lost to Follow-up|0|||
27931579|NCT01410604|81585916|FG000|Overall Study|Physician Decision|0|||
27931580|NCT01410604|81585917|FG001|Overall Study|Physician Decision|1|||
27931581|NCT00785629|81585921|FG000|Overall Study|Adverse Event|2|||
27931582|NCT00785629|81585922|FG001|Overall Study|Adverse Event|1|||
27931583|NCT00785629|81585923|FG002|Overall Study|Adverse Event|1|||
27931584|NCT00785629|81585924|FG003|Overall Study|Adverse Event|5|||
27931585|NCT00785629|81585921|FG000|Overall Study|Protocol Violation|1|||
27931586|NCT00785629|81585922|FG001|Overall Study|Protocol Violation|2|||
27931587|NCT00785629|81585923|FG002|Overall Study|Protocol Violation|4|||
27931588|NCT00785629|81585924|FG003|Overall Study|Protocol Violation|5|||
27931589|NCT00785629|81585921|FG000|Overall Study|administrative decision|5|||
27931590|NCT00785629|81585922|FG001|Overall Study|administrative decision|1|||
27931591|NCT00785629|81585923|FG002|Overall Study|administrative decision|3|||
27931592|NCT00785629|81585924|FG003|Overall Study|administrative decision|4|||
27931593|NCT00785629|81585921|FG000|Overall Study|Withdrawal by Subject|0|||
27931594|NCT00785629|81585922|FG001|Overall Study|Withdrawal by Subject|1|||
27931595|NCT00785629|81585923|FG002|Overall Study|Withdrawal by Subject|2|||
27931596|NCT00785629|81585924|FG003|Overall Study|Withdrawal by Subject|2|||
27931597|NCT02782468|81585926|FG000|Overall Study|Progressive Disease|2|||
27931598|NCT02782468|81585927|FG001|Overall Study|Progressive Disease|5|||
27931599|NCT02782468|81585928|FG002|Overall Study|Progressive Disease|0|||
27931600|NCT02782468|81585929|FG003|Overall Study|Progressive Disease|4|||
27931601|NCT02782468|81585926|FG000|Overall Study|Adverse Event|0|||
27931602|NCT02782468|81585927|FG001|Overall Study|Adverse Event|2|||
27931603|NCT02782468|81585928|FG002|Overall Study|Adverse Event|2|||
27742857|NCT01494038|80889385|FG000|Overall Study|Withdrawal by Subject|44|||
27931604|NCT02782468|81585929|FG003|Overall Study|Adverse Event|3|||
27931605|NCT02782468|81585926|FG000|Overall Study|Other|0|||
27931606|NCT02782468|81585927|FG001|Overall Study|Other|0|||
27931607|NCT02782468|81585928|FG002|Overall Study|Other|1|||
27931608|NCT02782468|81585929|FG003|Overall Study|Other|1|||
27931609|NCT02782468|81585926|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
27931610|NCT02782468|81585927|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
27931611|NCT02782468|81585928|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
27931612|NCT02782468|81585929|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
27931613|NCT02782468|81585926|FG000|Overall Study|Symptomatic Deterioration|0|||
27931614|NCT02782468|81585927|FG001|Overall Study|Symptomatic Deterioration|0|||
27931615|NCT02782468|81585928|FG002|Overall Study|Symptomatic Deterioration|0|||
27931616|NCT02782468|81585929|FG003|Overall Study|Symptomatic Deterioration|1|||
27931617|NCT02782468|81585926|FG000|Overall Study|Withdrawal by Subject|1|||
27931618|NCT02782468|81585927|FG001|Overall Study|Withdrawal by Subject|0|||
27931619|NCT02782468|81585928|FG002|Overall Study|Withdrawal by Subject|0|||
27931620|NCT02782468|81585929|FG003|Overall Study|Withdrawal by Subject|0|||
27931621|NCT01131585|81585932|FG000|Overall Study|Adverse Event|0|||
27931622|NCT01131585|81585933|FG001|Overall Study|Adverse Event|2|||
27931623|NCT01131585|81585932|FG000|Overall Study|Abnormal laboratory value|1|||
27931624|NCT01131585|81585933|FG001|Overall Study|Abnormal laboratory value|0|||
27931625|NCT01131585|81585932|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27931626|NCT01131585|81585933|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
27931627|NCT01131585|81585932|FG000|Overall Study|Protocol Violation|2|||
27931628|NCT01131585|81585933|FG001|Overall Study|Protocol Violation|1|||
27931629|NCT01131585|81585932|FG000|Overall Study|Withdrawal by Subject|3|||
27931630|NCT01131585|81585933|FG001|Overall Study|Withdrawal by Subject|3|||
27931631|NCT01131585|81585932|FG000|Overall Study|Lost to Follow-up|0|||
27931632|NCT01131585|81585933|FG001|Overall Study|Lost to Follow-up|1|||
27931633|NCT01131585|81585932|FG000|Overall Study|Administrative problems|1|||
27931634|NCT01131585|81585933|FG001|Overall Study|Administrative problems|1|||
27931635|NCT01131585|81585932|FG000|Overall Study|Study termination|78|||
27931636|NCT01131585|81585933|FG001|Overall Study|Study termination|32|||
27931637|NCT01671059|81585934|FG000|Overall Study|Adverse Event|4|||
27931638|NCT01671059|81585934|FG000|Overall Study|Lack of Efficacy|1|||
27931639|NCT00294398|81585936|FG000|Overall Study|Lost to Follow-up|21|||
27931640|NCT00294398|81585937|FG001|Overall Study|Lost to Follow-up|26|||
27931641|NCT00676052|81585940|FG000|Overall Study|Adverse Event|0|||
27931642|NCT00676052|81585941|FG001|Overall Study|Adverse Event|1|||
27931643|NCT00676052|81585942|FG002|Overall Study|Adverse Event|1|||
27931644|NCT00676052|81585943|FG003|Overall Study|Adverse Event|2|||
27931645|NCT00676052|81585944|FG004|Overall Study|Adverse Event|2|||
27931646|NCT00676052|81585945|FG005|Overall Study|Adverse Event|2|||
27931647|NCT00676052|81585940|FG000|Overall Study|Lack of Efficacy|2|||
27931648|NCT00676052|81585941|FG001|Overall Study|Lack of Efficacy|2|||
27931649|NCT00676052|81585942|FG002|Overall Study|Lack of Efficacy|1|||
27931650|NCT00676052|81585943|FG003|Overall Study|Lack of Efficacy|1|||
27931651|NCT00676052|81585944|FG004|Overall Study|Lack of Efficacy|2|||
27931652|NCT00676052|81585945|FG005|Overall Study|Lack of Efficacy|1|||
27931653|NCT00676052|81585940|FG000|Overall Study|Protocol Violation|5|||
27931654|NCT00676052|81585941|FG001|Overall Study|Protocol Violation|3|||
27931655|NCT00676052|81585942|FG002|Overall Study|Protocol Violation|2|||
27931656|NCT00676052|81585943|FG003|Overall Study|Protocol Violation|2|||
27931657|NCT00676052|81585944|FG004|Overall Study|Protocol Violation|1|||
27931658|NCT00676052|81585945|FG005|Overall Study|Protocol Violation|2|||
27931659|NCT00676052|81585940|FG000|Overall Study|Lost to Follow-up|0|||
27931660|NCT00676052|81585941|FG001|Overall Study|Lost to Follow-up|0|||
27931661|NCT00676052|81585942|FG002|Overall Study|Lost to Follow-up|0|||
27931662|NCT00676052|81585943|FG003|Overall Study|Lost to Follow-up|0|||
27931663|NCT00676052|81585944|FG004|Overall Study|Lost to Follow-up|1|||
27931664|NCT00676052|81585945|FG005|Overall Study|Lost to Follow-up|0|||
27931665|NCT00676052|81585940|FG000|Overall Study|Physician Decision|1|||
27931666|NCT00676052|81585941|FG001|Overall Study|Physician Decision|1|||
27931667|NCT00676052|81585942|FG002|Overall Study|Physician Decision|1|||
27931668|NCT00676052|81585943|FG003|Overall Study|Physician Decision|0|||
27931669|NCT00676052|81585944|FG004|Overall Study|Physician Decision|0|||
27931670|NCT00676052|81585945|FG005|Overall Study|Physician Decision|1|||
27931671|NCT00676052|81585940|FG000|Overall Study|Withdrawal by Subject|1|||
27931672|NCT00676052|81585941|FG001|Overall Study|Withdrawal by Subject|0|||
27931673|NCT00676052|81585942|FG002|Overall Study|Withdrawal by Subject|1|||
27931674|NCT00676052|81585943|FG003|Overall Study|Withdrawal by Subject|0|||
27931675|NCT00676052|81585944|FG004|Overall Study|Withdrawal by Subject|0|||
27931676|NCT00676052|81585945|FG005|Overall Study|Withdrawal by Subject|0|||
27931677|NCT01732692|81585946|FG000|Overall Study|Adverse Event|0|||
27931678|NCT01732692|81585947|FG001|Overall Study|Adverse Event|1|||
27931679|NCT01913470|81585948|FG000|Overall Study|Lost to Follow-up|0|||
27550370|NCT01854710|80200437|FG003|Overall Study|CRI procedural error|2|||
27931680|NCT01913470|81585949|FG001|Overall Study|Lost to Follow-up|1|||
27931681|NCT01913470|81585948|FG000|Overall Study|Physician Decision|0|||
27931682|NCT01913470|81585949|FG001|Overall Study|Physician Decision|1|||
27931683|NCT01913470|81585948|FG000|Overall Study|Withdrawal by Subject|0|||
27931684|NCT01913470|81585949|FG001|Overall Study|Withdrawal by Subject|1|||
27931685|NCT04149353|81585951|FG000|Overall Study|Study terminated|1|||
27931686|NCT01402700|81585952|FG000|Overall Study|Death|3|||
27931687|NCT01402700|81585952|FG000|Overall Study|Withdrawal by Subject|3|||
27931688|NCT01402700|81585952|FG000|Overall Study|Missed Visit|1|||
27931689|NCT00663351|81585953|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
27931690|NCT00663351|81585954|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
27931691|NCT00663351|81585953|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
27931692|NCT00663351|81585954|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
27931693|NCT00663351|81585953|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
27931694|NCT00663351|81585954|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
27931695|NCT00663351|81585953|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
27931696|NCT00663351|81585954|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
27931697|NCT00663351|81585953|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
27931698|NCT00663351|81585954|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
27931699|NCT00663351|81585953|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
27931700|NCT00663351|81585954|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
27931701|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
27931702|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
27931703|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
27931704|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
27931705|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
27931706|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
27931707|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
27931708|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
27931709|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
27931710|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
27931711|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
27931712|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
27931713|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
27931714|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
27931715|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
27931716|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
27931717|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
27931718|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
27931719|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
27931720|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
27931721|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
27931722|NCT02337946|81585956|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
27931723|NCT02337946|81585957|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
27931724|NCT02337946|81585958|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
27931725|NCT02337946|81585956|FG000|In-between Period|Without Informed Consent|1|||
27931726|NCT02337946|81585957|FG001|In-between Period|Without Informed Consent|0|||
27931727|NCT02337946|81585958|FG002|In-between Period|Without Informed Consent|0|||
27931728|NCT02337946|81585956|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
27931729|NCT02337946|81585957|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
27931730|NCT02337946|81585958|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
27931731|NCT02337946|81585956|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
27931732|NCT02337946|81585957|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
27931733|NCT02337946|81585958|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
27931734|NCT02337946|81585956|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
27931735|NCT02337946|81585957|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
27931736|NCT02337946|81585958|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
27931737|NCT02337946|81585956|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
27931738|NCT02337946|81585957|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
27931739|NCT02337946|81585958|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
27931740|NCT02337946|81585956|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
27931741|NCT02337946|81585957|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
27931742|NCT02337946|81585958|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
27931743|NCT02337946|81585956|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
27931744|NCT02337946|81585957|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
27931745|NCT02337946|81585958|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
27931746|NCT00429299|81585959|FG000|Overall Study|Disease Progression|1|||
27931747|NCT00429299|81585960|FG001|Overall Study|Disease Progression|1|||
27931748|NCT00429299|81585961|FG002|Overall Study|Disease Progression|0|||
27931749|NCT00429299|81585959|FG000|Overall Study|Adverse Event|2|||
27931750|NCT00429299|81585960|FG001|Overall Study|Adverse Event|5|||
27931751|NCT00429299|81585961|FG002|Overall Study|Adverse Event|1|||
27931752|NCT00429299|81585959|FG000|Overall Study|Protocol Violation|1|||
27931753|NCT00429299|81585960|FG001|Overall Study|Protocol Violation|0|||
27931754|NCT00429299|81585961|FG002|Overall Study|Protocol Violation|0|||
27931755|NCT00429299|81585959|FG000|Overall Study|Withdrawal by Subject|0|||
27931756|NCT00429299|81585960|FG001|Overall Study|Withdrawal by Subject|1|||
27931757|NCT00429299|81585961|FG002|Overall Study|Withdrawal by Subject|3|||
27931758|NCT01751685|81585970|FG000|6-mo Followup|Missed study visit|1|||
27931759|NCT01751685|81585971|FG001|6-mo Followup|Missed study visit|0|||
27931760|NCT01751685|81585970|FG000|6-mo Followup|Withdrawal by Subject|2|||
27931761|NCT01751685|81585971|FG001|6-mo Followup|Withdrawal by Subject|2|||
27931762|NCT01751685|81585970|FG000|6-mo Followup|Lost to Follow-up|0|||
27931763|NCT01751685|81585971|FG001|6-mo Followup|Lost to Follow-up|1|||
27931764|NCT01751685|81585970|FG000|12-mo Followup|Lost to Follow-up|5|||
27931765|NCT01751685|81585971|FG001|12-mo Followup|Lost to Follow-up|0|||
27931766|NCT04069520|81585976|FG000|Overall Study|Lost to Follow-up|0|||
27931767|NCT04069520|81585977|FG001|Overall Study|Lost to Follow-up|2|||
27931768|NCT04069520|81585976|FG000|Overall Study|Withdrawal by Subject|0|||
27931769|NCT04069520|81585977|FG001|Overall Study|Withdrawal by Subject|1|||
27931770|NCT04069520|81585976|FG000|Overall Study|Prior Injury|1|||
27931771|NCT04069520|81585977|FG001|Overall Study|Prior Injury|0|||
27931772|NCT04069520|81585976|FG000|Overall Study|Orthodontia|1|||
27931773|NCT04069520|81585977|FG001|Overall Study|Orthodontia|0|||
27931774|NCT04069520|81585976|FG000|Overall Study|Cut from team|0|||
27931775|NCT04069520|81585977|FG001|Overall Study|Cut from team|2|||
27931776|NCT01436500|81585978|FG000|Overall Study|Death|1|||
27931777|NCT01436500|81585979|FG001|Overall Study|Death|0|||
27931778|NCT01436500|81585980|FG002|Overall Study|Death|0|||
27931779|NCT01436500|81585981|FG003|Overall Study|Death|0|||
27931780|NCT01436500|81585982|FG004|Overall Study|Death|0|||
27931781|NCT01436500|81585978|FG000|Overall Study|Adverse Event|0|||
27931782|NCT01436500|81585979|FG001|Overall Study|Adverse Event|2|||
27931783|NCT01436500|81585980|FG002|Overall Study|Adverse Event|2|||
27931784|NCT01436500|81585981|FG003|Overall Study|Adverse Event|0|||
27931785|NCT01436500|81585982|FG004|Overall Study|Adverse Event|1|||
27931786|NCT01436500|81585978|FG000|Overall Study|Withdrawal by Subject|0|||
27931787|NCT01436500|81585979|FG001|Overall Study|Withdrawal by Subject|0|||
27931788|NCT01436500|81585980|FG002|Overall Study|Withdrawal by Subject|2|||
27931789|NCT01436500|81585981|FG003|Overall Study|Withdrawal by Subject|0|||
27931790|NCT01436500|81585982|FG004|Overall Study|Withdrawal by Subject|2|||
27931791|NCT01436500|81585978|FG000|Overall Study|Physician Decision|0|||
27931792|NCT01436500|81585979|FG001|Overall Study|Physician Decision|0|||
27931793|NCT01436500|81585980|FG002|Overall Study|Physician Decision|1|||
27931794|NCT01436500|81585981|FG003|Overall Study|Physician Decision|0|||
27931795|NCT01436500|81585982|FG004|Overall Study|Physician Decision|0|||
27931796|NCT01436500|81585978|FG000|Overall Study|liver transplant|1|||
27931797|NCT01436500|81585979|FG001|Overall Study|liver transplant|0|||
27931798|NCT01436500|81585980|FG002|Overall Study|liver transplant|0|||
27931799|NCT01436500|81585981|FG003|Overall Study|liver transplant|0|||
27931800|NCT01436500|81585982|FG004|Overall Study|liver transplant|0|||
27931801|NCT01436500|81585978|FG000|Overall Study|initiation of dialysis|0|||
27931802|NCT01436500|81585979|FG001|Overall Study|initiation of dialysis|0|||
27931803|NCT01436500|81585980|FG002|Overall Study|initiation of dialysis|0|||
27931804|NCT01436500|81585981|FG003|Overall Study|initiation of dialysis|0|||
27931805|NCT01436500|81585982|FG004|Overall Study|initiation of dialysis|1|||
27931806|NCT01436500|81585978|FG000|Overall Study|discontinued study drug|1|||
27931807|NCT01436500|81585979|FG001|Overall Study|discontinued study drug|0|||
27931808|NCT01436500|81585980|FG002|Overall Study|discontinued study drug|0|||
27931809|NCT01436500|81585981|FG003|Overall Study|discontinued study drug|0|||
27931810|NCT01436500|81585982|FG004|Overall Study|discontinued study drug|0|||
27931811|NCT01436500|81585978|FG000|Overall Study|Other|0|||
27931812|NCT01436500|81585979|FG001|Overall Study|Other|1|||
27931813|NCT01436500|81585980|FG002|Overall Study|Other|0|||
27931814|NCT01436500|81585981|FG003|Overall Study|Other|1|||
27931815|NCT01436500|81585982|FG004|Overall Study|Other|0|||
27931816|NCT01797185|81585983|FG000|Overall Study|Adverse Event|5|||
27931817|NCT01797185|81585984|FG001|Overall Study|Adverse Event|15|||
27931818|NCT01797185|81585985|FG002|Overall Study|Adverse Event|6|||
27931819|NCT01797185|81585983|FG000|Overall Study|Withdrawal by Subject|6|||
27931820|NCT01797185|81585984|FG001|Overall Study|Withdrawal by Subject|9|||
27931821|NCT01797185|81585985|FG002|Overall Study|Withdrawal by Subject|5|||
27931822|NCT01797185|81585983|FG000|Overall Study|Site terminated|8|||
27641723|NCT03785405|80529276|FG000|Overall Study|Participant decision|2|||
27931823|NCT01797185|81585984|FG001|Overall Study|Site terminated|4|||
27931824|NCT01797185|81585985|FG002|Overall Study|Site terminated|0|||
27931825|NCT01797185|81585983|FG000|Overall Study|Lost to Follow-up|2|||
27550371|NCT01854710|80200438|FG004|Overall Study|CRI procedural error|2|||
27641724|NCT03785405|80529277|FG001|Overall Study|Participant decision|0|||
27641725|NCT03785405|80529276|FG000|Overall Study|Other|1|||
27931826|NCT01797185|81585984|FG001|Overall Study|Lost to Follow-up|6|||
27931827|NCT01797185|81585985|FG002|Overall Study|Lost to Follow-up|1|||
27931828|NCT01797185|81585983|FG000|Overall Study|Withdrawn per sponsor|5|||
27931829|NCT01797185|81585984|FG001|Overall Study|Withdrawn per sponsor|0|||
27931830|NCT01797185|81585985|FG002|Overall Study|Withdrawn per sponsor|0|||
27931831|NCT01797185|81585983|FG000|Overall Study|Physician Decision|1|||
27931832|NCT01797185|81585984|FG001|Overall Study|Physician Decision|3|||
27931833|NCT01797185|81585985|FG002|Overall Study|Physician Decision|0|||
27931834|NCT01797185|81585983|FG000|Overall Study|Protocol Violation|1|||
27931835|NCT01797185|81585984|FG001|Overall Study|Protocol Violation|1|||
27931836|NCT01797185|81585985|FG002|Overall Study|Protocol Violation|0|||
27931837|NCT01049828|81585986|FG000|Overall Study|Claustrophibia and Frustration|2|||
27931838|NCT02989389|81585990|FG000|Period 1|Lost to Follow-up|0|||
27931839|NCT02989389|81585991|FG001|Period 1|Lost to Follow-up|1|||
27931840|NCT02989389|81585992|FG002|Period 1|Lost to Follow-up|0|||
27931841|NCT02989389|81585993|FG003|Period 1|Lost to Follow-up|0|||
27931842|NCT02989389|81585994|FG004|Period 1|Lost to Follow-up|0|||
27931843|NCT02989389|81585995|FG005|Period 1|Lost to Follow-up|0|||
27931844|NCT02989389|81585996|FG006|Period 1|Lost to Follow-up|0|||
27931845|NCT02989389|81585997|FG007|Period 1|Lost to Follow-up|0|||
27931846|NCT02989389|81585998|FG008|Period 1|Lost to Follow-up|0|||
27931847|NCT02989389|81585999|FG009|Period 1|Lost to Follow-up|0|||
27931848|NCT02989389|81585990|FG000|Period 1|Physician Decision|0|||
27931849|NCT02989389|81585991|FG001|Period 1|Physician Decision|0|||
27931850|NCT02989389|81585992|FG002|Period 1|Physician Decision|0|||
27931851|NCT02989389|81585993|FG003|Period 1|Physician Decision|0|||
27931852|NCT02989389|81585994|FG004|Period 1|Physician Decision|0|||
27931853|NCT02989389|81585995|FG005|Period 1|Physician Decision|0|||
27931854|NCT02989389|81585996|FG006|Period 1|Physician Decision|0|||
27931855|NCT02989389|81585997|FG007|Period 1|Physician Decision|0|||
27931856|NCT02989389|81585998|FG008|Period 1|Physician Decision|1|||
27931857|NCT02989389|81585999|FG009|Period 1|Physician Decision|0|||
27931858|NCT03520387|81586000|FG000|Pre-Randomization|Withdrawal by Subject|1|||
27931859|NCT03520387|81586001|FG001|Pre-Randomization|Withdrawal by Subject|0|||
27931860|NCT03520387|81586002|FG002|Pre-Randomization|Withdrawal by Subject|0|||
27931861|NCT03520387|81586003|FG003|Pre-Randomization|Withdrawal by Subject|0|||
27931862|NCT03520387|81586004|FG004|Pre-Randomization|Withdrawal by Subject|0|||
27931863|NCT03520387|81586000|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
27931864|NCT03520387|81586001|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
27931865|NCT03520387|81586002|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
27931866|NCT03520387|81586003|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
27931867|NCT03520387|81586004|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
27931868|NCT02134028|81586005|FG000|Overall Study|Lack of Efficacy|1|||
27931869|NCT02134028|81586006|FG001|Overall Study|Lack of Efficacy|0|||
27931870|NCT02134028|81586007|FG002|Overall Study|Lack of Efficacy|3|||
27931871|NCT02134028|81586008|FG003|Overall Study|Lack of Efficacy|2|||
27931872|NCT02134028|81586009|FG004|Overall Study|Lack of Efficacy|1|||
27931873|NCT02134028|81586010|FG005|Overall Study|Lack of Efficacy|2|||
27931874|NCT02134028|81586011|FG006|Overall Study|Lack of Efficacy|1|||
27931875|NCT02134028|81586012|FG007|Overall Study|Lack of Efficacy|0|||
27931876|NCT02134028|81586005|FG000|Overall Study|Poor compliance to protocol|1|||
27931877|NCT02134028|81586006|FG001|Overall Study|Poor compliance to protocol|1|||
27931878|NCT02134028|81586007|FG002|Overall Study|Poor compliance to protocol|3|||
27931879|NCT02134028|81586008|FG003|Overall Study|Poor compliance to protocol|7|||
27931880|NCT02134028|81586009|FG004|Overall Study|Poor compliance to protocol|1|||
27931881|NCT02134028|81586010|FG005|Overall Study|Poor compliance to protocol|1|||
27931882|NCT02134028|81586011|FG006|Overall Study|Poor compliance to protocol|0|||
27931883|NCT02134028|81586012|FG007|Overall Study|Poor compliance to protocol|0|||
27931884|NCT02134028|81586005|FG000|Overall Study|Other unspecified|4|||
27931885|NCT02134028|81586006|FG001|Overall Study|Other unspecified|22|||
27931886|NCT02134028|81586007|FG002|Overall Study|Other unspecified|33|||
27931887|NCT02134028|81586008|FG003|Overall Study|Other unspecified|64|||
27931888|NCT02134028|81586009|FG004|Overall Study|Other unspecified|8|||
27931889|NCT02134028|81586010|FG005|Overall Study|Other unspecified|6|||
27931890|NCT02134028|81586011|FG006|Overall Study|Other unspecified|2|||
27931891|NCT02134028|81586012|FG007|Overall Study|Other unspecified|1|||
27931892|NCT02134028|81586005|FG000|Overall Study|Adverse Event|3|||
27931893|NCT02134028|81586006|FG001|Overall Study|Adverse Event|19|||
27931894|NCT02134028|81586007|FG002|Overall Study|Adverse Event|13|||
27931895|NCT02134028|81586008|FG003|Overall Study|Adverse Event|32|||
27931896|NCT02134028|81586009|FG004|Overall Study|Adverse Event|4|||
27931897|NCT02134028|81586010|FG005|Overall Study|Adverse Event|5|||
27931898|NCT02134028|81586011|FG006|Overall Study|Adverse Event|1|||
27931899|NCT02134028|81586012|FG007|Overall Study|Adverse Event|2|||
27931900|NCT04491994|81586013|FG000|Overall Study|Withdrawal by Subject|10|||
27931901|NCT04491994|81586014|FG001|Overall Study|Withdrawal by Subject|5|||
27931902|NCT04491994|81586013|FG000|Overall Study|developed fever > 3 days|4|||
27931903|NCT04491994|81586014|FG001|Overall Study|developed fever > 3 days|1|||
27931904|NCT04491994|81586013|FG000|Overall Study|Protocol Violation|11|||
27931905|NCT04491994|81586014|FG001|Overall Study|Protocol Violation|2|||
27931906|NCT04491994|81586013|FG000|Overall Study|Lost to Follow-up|4|||
27931907|NCT04491994|81586014|FG001|Overall Study|Lost to Follow-up|3|||
27931908|NCT00986232|81586015|FG000|Overall Study|Adverse Event|1|||
27641726|NCT03785405|80529277|FG001|Overall Study|Other|0|||
27641727|NCT03785405|80529276|FG000|Overall Study|No treatment was received|0|||
27641728|NCT03785405|80529277|FG001|Overall Study|No treatment was received|1|||
27641729|NCT00093015|80529283|FG000|Overall Study|Withdrawal by Subject|194|||
27641730|NCT00093015|80529284|FG001|Overall Study|Withdrawal by Subject|171|||
27641731|NCT00093015|80529283|FG000|Overall Study|Lost to Follow-up|96|||
27641732|NCT00093015|80529284|FG001|Overall Study|Lost to Follow-up|108|||
27641733|NCT00093015|80529283|FG000|Overall Study|Death|375|||
27641734|NCT00093015|80529284|FG001|Overall Study|Death|385|||
27641735|NCT01094184|80529285|FG000|Overall Study|Death|35|||
27742858|NCT01494038|80889386|FG001|Overall Study|Withdrawal by Subject|34|||
27742859|NCT01494038|80889385|FG000|Overall Study|Not able to get to clinic|21|||
27742860|NCT01494038|80889386|FG001|Overall Study|Not able to get to clinic|15|||
27742861|NCT01494038|80889385|FG000|Overall Study|Not willing to adhere to reqs|2|||
27742862|NCT01494038|80889386|FG001|Overall Study|Not willing to adhere to reqs|9|||
27742863|NCT01494038|80889385|FG000|Overall Study|Death|2|||
27742864|NCT01494038|80889386|FG001|Overall Study|Death|4|||
27742865|NCT01260181|80889387|FG000|Overall Study|Decision of Investigator|1|||
27931909|NCT00986232|81586016|FG001|Overall Study|Adverse Event|2|||
27931910|NCT00986232|81586017|FG002|Overall Study|Adverse Event|3|||
27931911|NCT00986232|81586018|FG003|Overall Study|Adverse Event|0|||
27641736|NCT01094184|80529286|FG001|Overall Study|Death|11|||
27641737|NCT00976495|80529291|FG000|Overall Study|Withdrawal by Subject|0|||
27641738|NCT00976495|80529292|FG001|Overall Study|Withdrawal by Subject|1|||
27641739|NCT00976495|80529293|FG002|Overall Study|Withdrawal by Subject|0|||
27641740|NCT01609218|80529294|FG000|Period 1|Adverse Event|3|||
27641741|NCT01609218|80529295|FG001|Period 1|Adverse Event|5|||
27641742|NCT01609218|80529294|FG000|Period 1|Sponsor Decision|0|||
27641743|NCT01609218|80529295|FG001|Period 1|Sponsor Decision|1|||
27641744|NCT01609218|80529294|FG000|Period 2|Adverse Event|1|||
27931912|NCT00986232|81586015|FG000|Overall Study|Lost to Follow-up|19|||
27931913|NCT00986232|81586016|FG001|Overall Study|Lost to Follow-up|12|||
27931914|NCT00986232|81586017|FG002|Overall Study|Lost to Follow-up|12|||
27641745|NCT01609218|80529295|FG001|Period 2|Adverse Event|0|||
27641746|NCT00988858|80529298|FG000|Overall Study|Adverse Event|7|||
27641747|NCT00988858|80529298|FG000|Overall Study|Death|1|||
27641748|NCT00988858|80529298|FG000|Overall Study|Physician Decision|1|||
27641749|NCT00988858|80529298|FG000|Overall Study|Sponsor Decision|1|||
27641750|NCT00566735|80529299|FG000|Overall Study|Withdrawal by Subject|0|||
27641751|NCT00566735|80529300|FG001|Overall Study|Withdrawal by Subject|1|||
27641752|NCT00566735|80529299|FG000|Overall Study|Refused neuropsychological testing|2|||
27641753|NCT00566735|80529300|FG001|Overall Study|Refused neuropsychological testing|5|||
27641754|NCT00566735|80529299|FG000|Overall Study|Switched into a manic episode|0|||
27641755|NCT00566735|80529300|FG001|Overall Study|Switched into a manic episode|1|||
27641756|NCT02538341|80529303|FG000|Overall Study|Lost to Follow-up|51|||
27641757|NCT02538341|80529304|FG001|Overall Study|Lost to Follow-up|46|||
27641758|NCT02538341|80529303|FG000|Overall Study|Withdrawal by Subject|3|||
27931915|NCT00986232|81586018|FG003|Overall Study|Lost to Follow-up|7|||
27931916|NCT00986232|81586015|FG000|Overall Study|Protocol Violation|2|||
27931917|NCT00986232|81586016|FG001|Overall Study|Protocol Violation|3|||
27931918|NCT00986232|81586017|FG002|Overall Study|Protocol Violation|0|||
27641759|NCT02538341|80529304|FG001|Overall Study|Withdrawal by Subject|1|||
27641760|NCT02538341|80529303|FG000|Overall Study|Death|2|||
27641761|NCT02538341|80529304|FG001|Overall Study|Death|0|||
27641762|NCT03655262|80529305|FG000|Overall Study|Withdrawal by Subject|0|||
27641763|NCT03655262|80529306|FG001|Overall Study|Withdrawal by Subject|0|||
27641764|NCT03655262|80529307|FG002|Overall Study|Withdrawal by Subject|1|||
27641765|NCT01250769|80529309|FG000|Overall Study|Withdrawal by Subject|0|||
27931919|NCT00986232|81586018|FG003|Overall Study|Protocol Violation|1|||
27931920|NCT00986232|81586015|FG000|Overall Study|Withdrawal by Subject|13|||
27931921|NCT00986232|81586016|FG001|Overall Study|Withdrawal by Subject|16|||
27931922|NCT00986232|81586017|FG002|Overall Study|Withdrawal by Subject|12|||
27931923|NCT00986232|81586018|FG003|Overall Study|Withdrawal by Subject|3|||
27641766|NCT01250769|80529310|FG001|Overall Study|Withdrawal by Subject|1|||
27742866|NCT01863758|80889388|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
27931924|NCT00986232|81586015|FG000|Overall Study|Missed one or more bleeds|13|||
27931925|NCT00986232|81586016|FG001|Overall Study|Missed one or more bleeds|10|||
27931926|NCT00986232|81586017|FG002|Overall Study|Missed one or more bleeds|6|||
27931927|NCT00986232|81586018|FG003|Overall Study|Missed one or more bleeds|7|||
27931928|NCT00986232|81586015|FG000|Overall Study|Incomplete safety follow-up|3|||
27931929|NCT00986232|81586016|FG001|Overall Study|Incomplete safety follow-up|7|||
27641767|NCT01250769|80529311|FG002|Overall Study|Withdrawal by Subject|1|||
27641768|NCT01250769|80529312|FG003|Overall Study|Withdrawal by Subject|0|||
27641769|NCT01250769|80529309|FG000|Overall Study|Adverse Event|0|||
27641770|NCT01250769|80529310|FG001|Overall Study|Adverse Event|0|||
27641771|NCT01250769|80529311|FG002|Overall Study|Adverse Event|1|||
27641772|NCT01250769|80529312|FG003|Overall Study|Adverse Event|0|||
27641773|NCT01737021|80529313|FG000|Overall Study|Lost to Follow-up|5|||
27641774|NCT01737021|80529314|FG001|Overall Study|Lost to Follow-up|3|||
27641775|NCT02140645|80529315|FG000|Overall Study|Not linked|5489|||
27641776|NCT02140645|80529316|FG001|Overall Study|Not linked|61654|||
27641777|NCT02140645|80529317|FG002|Overall Study|Not linked|4236|||
27641778|NCT02140645|80529318|FG003|Overall Study|Not linked|13833|||
27641779|NCT02140645|80529319|FG004|Overall Study|Not linked|3286|||
27641780|NCT02140645|80529320|FG005|Overall Study|Not linked|70896|||
27641781|NCT01485887|80532357|FG000|Overall Study|Withdrawal by Subject|2|||
27641782|NCT01485887|80532357|FG000|Overall Study|Adverse Event|8|||
27641783|NCT01485887|80532357|FG000|Overall Study|Deterioration of primary disease|1|||
27641784|NCT01485887|80532357|FG000|Overall Study|Primary disease markedly improved|1|||
27641785|NCT02765100|80532358|FG000|Overall Study|subject found ineligible after baseline|1|||
27641786|NCT02765100|80532359|FG001|Overall Study|subject found ineligible after baseline|1|||
27641787|NCT02765100|80532358|FG000|Overall Study|Lost to Follow-up|0|||
27641788|NCT02765100|80532359|FG001|Overall Study|Lost to Follow-up|1|||
27641789|NCT00505934|80532362|FG000|Overall Study|Adverse Event|1|||
27641790|NCT00505934|80532362|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
27742867|NCT01863758|80889388|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
27742868|NCT00970294|80889389|FG000|Overall Study|Physician Decision|4|||
27742869|NCT00970294|80889389|FG000|Overall Study|Withdrawal by Subject|1|||
27742870|NCT01894516|80889390|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
27931930|NCT00986232|81586017|FG002|Overall Study|Incomplete safety follow-up|2|||
27931931|NCT00986232|81586018|FG003|Overall Study|Incomplete safety follow-up|2|||
27931932|NCT01567085|81586020|FG000|Overall Study|Death|6|||
27931933|NCT01567085|81586020|FG000|Overall Study|Adverse Event|6|||
27931934|NCT01567085|81586020|FG000|Overall Study|Lost to Follow-up|3|||
27931935|NCT01567085|81586020|FG000|Overall Study|Graft loss|2|||
27931936|NCT01567085|81586020|FG000|Overall Study|Renal transplantectomy|1|||
27931937|NCT01567085|81586020|FG000|Overall Study|Returned to chronic dialysis|1|||
27931938|NCT01567085|81586020|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
27931939|NCT03828383|81586021|FG000|Overall Study|Lost to Follow-up|3|||
27931940|NCT03828383|81586022|FG001|Overall Study|Lost to Follow-up|2|||
27931941|NCT03828383|81586021|FG000|Overall Study|Withdrawal by Subject|4|||
27931942|NCT03828383|81586022|FG001|Overall Study|Withdrawal by Subject|5|||
27931943|NCT01331005|81586023|FG000|Overall Study|Lost to Follow-up|2|||
27641791|NCT00505934|80532362|FG000|Overall Study|Other: IV dose needed to be changed|1|||
27641792|NCT04638816|80532363|FG000|Overall Study|Withdrawal by Subject|0|||
27931944|NCT01331005|81586024|FG001|Overall Study|Lost to Follow-up|1|||
27931945|NCT01331005|81586023|FG000|Overall Study|Withdrawal by Subject|2|||
27931946|NCT01331005|81586024|FG001|Overall Study|Withdrawal by Subject|3|||
27931947|NCT02606253|81586025|FG000|Overall Study|Adverse Event|2|||
27931948|NCT02606253|81586026|FG001|Overall Study|Adverse Event|0|||
27931949|NCT02606253|81586027|FG002|Overall Study|Adverse Event|0|||
27931950|NCT02606253|81586025|FG000|Overall Study|Protocol Violation|2|||
27931951|NCT02606253|81586026|FG001|Overall Study|Protocol Violation|1|||
27931952|NCT02606253|81586027|FG002|Overall Study|Protocol Violation|0|||
27931953|NCT02606253|81586025|FG000|Overall Study|Physician Decision|1|||
27931954|NCT02606253|81586026|FG001|Overall Study|Physician Decision|1|||
27931955|NCT02606253|81586027|FG002|Overall Study|Physician Decision|0|||
27931956|NCT03142750|81586036|FG000|Overall Study|Lost to Follow-up|4|||
27931957|NCT03142750|81586037|FG001|Overall Study|Lost to Follow-up|1|||
27931958|NCT00835978|81586038|FG000|Overall Study|Death|33|||
27931959|NCT00835978|81586039|FG001|Overall Study|Death|40|||
27641793|NCT04638816|80532364|FG001|Overall Study|Withdrawal by Subject|1|||
27641794|NCT04638816|80532363|FG000|Overall Study|Lost to Follow-up|0|||
27641795|NCT04638816|80532364|FG001|Overall Study|Lost to Follow-up|1|||
27641796|NCT01121991|80532366|FG000|Overall Study|Lack of Ovarian Response|2|||
27641797|NCT01121991|80532366|FG000|Overall Study|No Oocytes Retrieved|3|||
27641798|NCT01121991|80532366|FG000|Overall Study|No Fertilization|1|||
27641799|NCT00220740|80532367|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
27641800|NCT00220740|80532368|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
27641801|NCT00220740|80532367|FG000|Efficacy Period|Adverse Event|1|||
27641802|NCT00220740|80532368|FG001|Efficacy Period|Adverse Event|1|||
27641803|NCT00220740|80532367|FG000|Efficacy Period|Withdrawal by Subject|1|||
27641804|NCT00220740|80532368|FG001|Efficacy Period|Withdrawal by Subject|0|||
27931960|NCT00835978|81586040|FG002|Overall Study|Death|49|||
27931961|NCT00835978|81586041|FG003|Overall Study|Death|4|||
27931962|NCT00835978|81586038|FG000|Overall Study|Lost to Follow-up|3|||
27931963|NCT00835978|81586039|FG001|Overall Study|Lost to Follow-up|4|||
27931964|NCT00835978|81586040|FG002|Overall Study|Lost to Follow-up|2|||
27931965|NCT00835978|81586041|FG003|Overall Study|Lost to Follow-up|1|||
27931966|NCT00835978|81586038|FG000|Overall Study|Other|5|||
27931967|NCT00835978|81586039|FG001|Overall Study|Other|1|||
27931968|NCT00835978|81586040|FG002|Overall Study|Other|8|||
27931969|NCT00835978|81586041|FG003|Overall Study|Other|0|||
27931970|NCT00835978|81586038|FG000|Overall Study|Objective progression or relapse|2|||
27931971|NCT00835978|81586039|FG001|Overall Study|Objective progression or relapse|0|||
27641805|NCT00220740|80532367|FG000|Efficacy Period|Protocol Violation|1|||
27641806|NCT00220740|80532368|FG001|Efficacy Period|Protocol Violation|0|||
27641807|NCT00220740|80532367|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
27641808|NCT00220740|80532368|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
27641809|NCT00650104|80532369|FG000|Overall Study|Adverse Event|17|||
27641810|NCT00650104|80532369|FG000|Overall Study|Death|2|||
27641811|NCT00650104|80532369|FG000|Overall Study|Withdrawal by Subject|11|||
27641812|NCT00650104|80532369|FG000|Overall Study|Physician Decision|7|||
27641813|NCT00650104|80532369|FG000|Overall Study|Lost to Follow-up|1|||
27641814|NCT00650104|80532369|FG000|Overall Study|Non-compliance|2|||
27641815|NCT00650104|80532369|FG000|Overall Study|Sponsor Terminated Dosing|1|||
27641816|NCT00999167|80532370|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
27641817|NCT00999167|80532371|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
27641818|NCT00999167|80532372|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
27641819|NCT00999167|80532370|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
27641820|NCT00999167|80532371|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
27641821|NCT00999167|80532372|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
27641822|NCT00999167|80532370|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
27931972|NCT00835978|81586040|FG002|Overall Study|Objective progression or relapse|1|||
27931973|NCT00835978|81586041|FG003|Overall Study|Objective progression or relapse|0|||
27641823|NCT00999167|80532371|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
27641824|NCT00999167|80532372|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
27641825|NCT00999167|80532370|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
27641826|NCT00999167|80532371|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
27641827|NCT00999167|80532372|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
27641828|NCT00999167|80532370|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
27641829|NCT00999167|80532371|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
27641830|NCT00999167|80532372|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
27641831|NCT00999167|80532370|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
27641832|NCT00999167|80532371|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
27641833|NCT00999167|80532372|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
27742871|NCT01894516|80889391|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
27742872|NCT01894516|80889392|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
27742873|NCT01894516|80889393|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
27742874|NCT01894516|80889390|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
27931974|NCT00835978|81586038|FG000|Overall Study|Adverse Event|1|||
27931975|NCT00835978|81586039|FG001|Overall Study|Adverse Event|0|||
27931976|NCT00835978|81586040|FG002|Overall Study|Adverse Event|1|||
27931977|NCT00835978|81586041|FG003|Overall Study|Adverse Event|0|||
27931978|NCT00835978|81586038|FG000|Overall Study|Withdrawal by Subject|0|||
27931979|NCT00835978|81586039|FG001|Overall Study|Withdrawal by Subject|3|||
27931980|NCT00835978|81586040|FG002|Overall Study|Withdrawal by Subject|0|||
27931981|NCT00835978|81586041|FG003|Overall Study|Withdrawal by Subject|5|||
27931982|NCT00835978|81586038|FG000|Overall Study|Study terminated by sponsor|12|||
27742875|NCT01894516|80889391|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27742876|NCT01894516|80889392|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27742877|NCT01894516|80889393|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
27742878|NCT01894516|80889390|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
27742879|NCT01894516|80889391|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
27742880|NCT01894516|80889392|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
27931983|NCT00835978|81586039|FG001|Overall Study|Study terminated by sponsor|8|||
27931984|NCT00835978|81586040|FG002|Overall Study|Study terminated by sponsor|30|||
27931985|NCT00835978|81586041|FG003|Overall Study|Study terminated by sponsor|0|||
27931986|NCT02112552|81586042|FG000|Overall Study|Withdrawal by Subject|1|||
27931987|NCT02112552|81586042|FG000|Overall Study|Adverse Event|1|||
27931988|NCT02939781|81586043|FG000|Overall Study|Protocol Violation|8|||
27931989|NCT02939781|81586043|FG000|Overall Study|Withdrawal by Subject|1|||
27931990|NCT02384460|81586044|FG000|Overall Study|Protocol Violation|0|||
27931991|NCT02384460|81586045|FG001|Overall Study|Protocol Violation|1|||
27931992|NCT02384460|81586044|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
27931993|NCT02384460|81586045|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
27742881|NCT01894516|80889393|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
27742882|NCT01894516|80889390|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
27931994|NCT02384460|81586044|FG000|Overall Study|Adverse Event|5|||
27931995|NCT02384460|81586045|FG001|Overall Study|Adverse Event|2|||
27931996|NCT02384460|81586044|FG000|Overall Study|Withdrawal by Subject|0|||
27931997|NCT02384460|81586045|FG001|Overall Study|Withdrawal by Subject|3|||
27931998|NCT02384460|81586044|FG000|Overall Study|Elective medical treatment|1|||
27641834|NCT00999167|80532370|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
27641835|NCT00999167|80532371|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
27641836|NCT00999167|80532372|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
27931999|NCT02384460|81586045|FG001|Overall Study|Elective medical treatment|0|||
27932000|NCT02384460|81586044|FG000|Overall Study|Non-compliance|1|||
27932001|NCT02384460|81586045|FG001|Overall Study|Non-compliance|0|||
27932002|NCT03312907|81586052|FG000|Overall Study|Adverse Event|1|||
27932003|NCT03312907|81586053|FG001|Overall Study|Adverse Event|6|||
27932004|NCT03312907|81586054|FG002|Overall Study|Adverse Event|1|||
27932005|NCT03312907|81586052|FG000|Overall Study|Protocol Violation|2|||
27932006|NCT03312907|81586053|FG001|Overall Study|Protocol Violation|3|||
27641837|NCT00999167|80532370|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
27641838|NCT00999167|80532371|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
27641839|NCT00999167|80532372|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
27641840|NCT00739908|80532382|FG000|Overall Study|Adverse Event|5|||
27641841|NCT00739908|80532383|FG001|Overall Study|Adverse Event|6|||
27641842|NCT00739908|80532382|FG000|Overall Study|Withdrawal by Subject|4|||
27641843|NCT00739908|80532383|FG001|Overall Study|Withdrawal by Subject|2|||
27641844|NCT00739908|80532382|FG000|Overall Study|Lost to Follow-up|14|||
27641845|NCT00739908|80532383|FG001|Overall Study|Lost to Follow-up|9|||
27641846|NCT00739908|80532382|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
27641847|NCT00739908|80532383|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
27641848|NCT00739908|80532382|FG000|Overall Study|Non-Compliance With Study Medication|0|||
27641849|NCT00739908|80532383|FG001|Overall Study|Non-Compliance With Study Medication|3|||
27641850|NCT00739908|80532382|FG000|Overall Study|Lack of Efficacy|0|||
27641851|NCT00739908|80532383|FG001|Overall Study|Lack of Efficacy|1|||
27641852|NCT00739908|80532382|FG000|Overall Study|Relocation|0|||
27641853|NCT00739908|80532383|FG001|Overall Study|Relocation|1|||
27641854|NCT02555215|80532384|FG000|Overall Study|Other|1|||
27641855|NCT02555215|80532384|FG000|Overall Study|Investigator Decision|2|||
27641856|NCT01075152|80532387|FG000|Overall Study|Withdrawal by Subject|1|||
27641857|NCT01075152|80532388|FG001|Overall Study|Withdrawal by Subject|0|||
27641858|NCT00431834|80532389|FG000|Overall Study|Withdrawal by Subject|7|||
27641859|NCT00431834|80532389|FG000|Overall Study|Death|3|||
27742883|NCT01894516|80889391|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
27742884|NCT01894516|80889392|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
27742885|NCT01894516|80889393|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
27742886|NCT01894516|80889390|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
27742887|NCT01894516|80889391|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27742888|NCT01894516|80889392|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
27742889|NCT01894516|80889393|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
27742890|NCT01894516|80889390|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27742891|NCT01894516|80889391|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
27742892|NCT01894516|80889392|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
27742893|NCT01894516|80889393|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
27742894|NCT01894516|80889390|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
27742895|NCT01894516|80889391|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
27742896|NCT01894516|80889392|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
27742897|NCT01894516|80889393|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
27742898|NCT01894516|80889390|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27742899|NCT01894516|80889391|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27742900|NCT01894516|80889392|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
27742901|NCT01894516|80889393|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
27742902|NCT00882713|80889394|FG000|Overall Study|Adverse Event|2|||
27742903|NCT00882713|80889394|FG000|Overall Study|Death|3|||
27742904|NCT00882713|80889394|FG000|Overall Study|Administrative reasons|4|||
27742905|NCT00882713|80889394|FG000|Overall Study|refused treatment/withdrew consent|4|||
27742906|NCT00882713|80889394|FG000|Overall Study|Blood transfusion|2|||
27932007|NCT03312907|81586054|FG002|Overall Study|Protocol Violation|4|||
27932008|NCT03312907|81586052|FG000|Overall Study|Lost to Follow-up|2|||
27641860|NCT00431834|80532389|FG000|Overall Study|Missed Endpoint Visit|2|||
27641861|NCT00431834|80532389|FG000|Overall Study|Lost to Follow-up|1|||
27742907|NCT00882713|80889394|FG000|Overall Study|Insufficient therapeutic response|3|||
27742908|NCT00882713|80889394|FG000|Overall Study|Failure to return|2|||
27742909|NCT00882713|80889394|FG000|Overall Study|Other - Reasons|2|||
27742910|NCT02144220|80889396|FG000|Overall Study|technology incompatibility|9|||
27932009|NCT03312907|81586053|FG001|Overall Study|Lost to Follow-up|3|||
27932010|NCT03312907|81586054|FG002|Overall Study|Lost to Follow-up|2|||
27641862|NCT03246724|80532393|FG000|Overall Study|Withdrawal by Subject|5|||
27641863|NCT03246724|80532394|FG001|Overall Study|Withdrawal by Subject|2|||
27641864|NCT03246724|80532395|FG002|Overall Study|Withdrawal by Subject|4|||
27641865|NCT03246724|80532396|FG003|Overall Study|Withdrawal by Subject|2|||
27641866|NCT03246724|80532393|FG000|Overall Study|Ineligible on day of surgery|7|||
27641867|NCT03246724|80532394|FG001|Overall Study|Ineligible on day of surgery|2|||
27641868|NCT03246724|80532395|FG002|Overall Study|Ineligible on day of surgery|0|||
27742911|NCT02144220|80889396|FG000|Overall Study|Lack of Efficacy|4|||
27742912|NCT02144220|80889396|FG000|Overall Study|Physician Decision|3|||
27742913|NCT02144220|80889396|FG000|Overall Study|Withdrawal by Subject|2|||
27742914|NCT02144220|80889396|FG000|Overall Study|Protocol Violation|1|||
27742915|NCT03635190|80889397|FG000|Overall Study|Lost to Follow-up|4|||
27742916|NCT03635190|80889397|FG000|Overall Study|Death|3|||
27742917|NCT03635190|80889397|FG000|Overall Study|Withdrawal by Subject|1|||
27742918|NCT03635190|80889397|FG000|Overall Study|Patient moved and did not return for follow up|1|||
27742919|NCT02399475|80889398|FG000|Overall Study|Physician Decision|1|||
27742920|NCT02399475|80889399|FG001|Overall Study|Physician Decision|0|||
27742921|NCT02119104|80889402|FG000|Overall Study|Protocol Violation|16|||
27742922|NCT01272180|80889403|FG000|Overall Study|Adverse Event|0|||
27742923|NCT01272180|80889404|FG001|Overall Study|Adverse Event|0|||
27742924|NCT01272180|80889405|FG002|Overall Study|Adverse Event|1|||
27742925|NCT01272180|80889406|FG003|Overall Study|Adverse Event|0|||
27742926|NCT01272180|80889403|FG000|Overall Study|Withdrawal by Subject|2|||
27742927|NCT01272180|80889404|FG001|Overall Study|Withdrawal by Subject|6|||
27742928|NCT01272180|80889405|FG002|Overall Study|Withdrawal by Subject|3|||
27742929|NCT01272180|80889406|FG003|Overall Study|Withdrawal by Subject|2|||
27641869|NCT03246724|80532396|FG003|Overall Study|Ineligible on day of surgery|3|||
27641870|NCT03246724|80532393|FG000|Overall Study|Study completed before surgical date|2|||
27742930|NCT01272180|80889403|FG000|Overall Study|Lost to Follow-up|15|||
27742931|NCT01272180|80889404|FG001|Overall Study|Lost to Follow-up|14|||
27742932|NCT01272180|80889405|FG002|Overall Study|Lost to Follow-up|8|||
27742933|NCT01272180|80889406|FG003|Overall Study|Lost to Follow-up|10|||
27742934|NCT01272180|80889403|FG000|Overall Study|Inappropriate enrollment|0|||
27742935|NCT01272180|80889404|FG001|Overall Study|Inappropriate enrollment|0|||
27742936|NCT01272180|80889405|FG002|Overall Study|Inappropriate enrollment|1|||
27742937|NCT01272180|80889406|FG003|Overall Study|Inappropriate enrollment|1|||
27742938|NCT01272180|80889403|FG000|Overall Study|Protocol Violation|0|||
27742939|NCT01272180|80889404|FG001|Overall Study|Protocol Violation|1|||
27742940|NCT01272180|80889405|FG002|Overall Study|Protocol Violation|0|||
27742941|NCT01272180|80889406|FG003|Overall Study|Protocol Violation|1|||
27742942|NCT04238663|80889413|FG000|Overall Study|Lost to Follow-up|0|||
27742943|NCT04238663|80889414|FG001|Overall Study|Lost to Follow-up|1|||
27742944|NCT04238663|80889415|FG002|Overall Study|Lost to Follow-up|0|||
27742945|NCT01184989|80889419|FG000|Overall Study|Adverse Event|11|||
27742946|NCT01184989|80889419|FG000|Overall Study|Withdrawal by Subject|1|||
27932011|NCT03312907|81586052|FG000|Overall Study|Physician Decision|3|||
27641871|NCT03246724|80532394|FG001|Overall Study|Study completed before surgical date|1|||
27641872|NCT03246724|80532395|FG002|Overall Study|Study completed before surgical date|8|||
27641873|NCT03246724|80532396|FG003|Overall Study|Study completed before surgical date|1|||
27641874|NCT03246724|80532393|FG000|Overall Study|Transferred to other arm|0|||
27641875|NCT03246724|80532394|FG001|Overall Study|Transferred to other arm|0|||
27641876|NCT03246724|80532395|FG002|Overall Study|Transferred to other arm|1|||
27641877|NCT03246724|80532396|FG003|Overall Study|Transferred to other arm|0|||
27641878|NCT03246724|80532393|FG000|Overall Study|Unable to obtain medication timely|0|||
27641879|NCT03246724|80532394|FG001|Overall Study|Unable to obtain medication timely|2|||
27641880|NCT03246724|80532395|FG002|Overall Study|Unable to obtain medication timely|2|||
27641881|NCT03246724|80532396|FG003|Overall Study|Unable to obtain medication timely|1|||
27641882|NCT03246724|80532393|FG000|Overall Study|Re-consented to participate|0|||
27641883|NCT03246724|80532394|FG001|Overall Study|Re-consented to participate|0|||
27641884|NCT03246724|80532395|FG002|Overall Study|Re-consented to participate|0|||
27641885|NCT03246724|80532396|FG003|Overall Study|Re-consented to participate|1|||
27641886|NCT02006758|80532397|FG000|Overall Study|Protocol Violation|1|||
27641887|NCT02006758|80532397|FG000|Overall Study|Death|1|||
27641888|NCT02006758|80532397|FG000|Overall Study|Lost to Follow-up|4|||
27641889|NCT02006758|80532397|FG000|Overall Study|Withdrawal by Subject|4|||
27641890|NCT02006758|80532397|FG000|Overall Study|Procedurally excluded|1|||
27641891|NCT02006758|80532397|FG000|Overall Study|Other|2|||
27641892|NCT00419341|80532398|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
27742947|NCT01743027|80889420|FG000|Overall Study|Adverse Event|2|||
27742948|NCT01743027|80889421|FG001|Overall Study|Adverse Event|0|||
27742949|NCT01743027|80889422|FG002|Overall Study|Adverse Event|0|||
27932012|NCT03312907|81586053|FG001|Overall Study|Physician Decision|4|||
27550372|NCT01854710|80200439|FG005|Overall Study|CRI procedural error|2|||
27641893|NCT00419341|80532398|FG000|Wash in/Wash Out Period|Adverse Event|2|||
27641894|NCT00419341|80532398|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
27641895|NCT00419341|80532398|FG000|Efficacy Period|Withdrawal by Subject|6|||
27641896|NCT00419341|80532398|FG000|Efficacy Period|Protocol Violation|1|||
27641897|NCT00419341|80532398|FG000|Efficacy Period|Lost to Follow-up|1|||
27641898|NCT00419341|80532398|FG000|Efficacy Period|Non-compliance|1|||
27742950|NCT01743027|80889423|FG003|Overall Study|Adverse Event|0|||
27742951|NCT01743027|80889420|FG000|Overall Study|Lost to Follow-up|0|||
27742952|NCT01743027|80889421|FG001|Overall Study|Lost to Follow-up|0|||
27742953|NCT01743027|80889422|FG002|Overall Study|Lost to Follow-up|2|||
27742954|NCT01743027|80889423|FG003|Overall Study|Lost to Follow-up|0|||
27742955|NCT01743027|80889420|FG000|Overall Study|Progressive Disease|1|||
27742956|NCT01743027|80889421|FG001|Overall Study|Progressive Disease|4|||
27742957|NCT01743027|80889422|FG002|Overall Study|Progressive Disease|3|||
27742958|NCT01743027|80889423|FG003|Overall Study|Progressive Disease|0|||
27742959|NCT01743027|80889420|FG000|Overall Study|Protocol Violation|1|||
27932013|NCT03312907|81586054|FG002|Overall Study|Physician Decision|2|||
27932014|NCT03312907|81586052|FG000|Overall Study|Withdrawal by Subject|9|||
27932015|NCT03312907|81586053|FG001|Overall Study|Withdrawal by Subject|14|||
27932016|NCT03312907|81586054|FG002|Overall Study|Withdrawal by Subject|10|||
27932017|NCT03983109|81586055|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
27932018|NCT03983109|81586056|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
27932019|NCT02930941|81586059|FG000|Overall Study|Lost to Follow-up|1|||
27932020|NCT02930941|81586060|FG001|Overall Study|Lost to Follow-up|2|||
27932021|NCT02697422|81586061|FG000|Overall Study|Declined exit survey|9|||
27932022|NCT02697422|81586062|FG001|Overall Study|Declined exit survey|2|||
27742960|NCT01743027|80889421|FG001|Overall Study|Protocol Violation|1|||
27742961|NCT01743027|80889422|FG002|Overall Study|Protocol Violation|1|||
27742962|NCT01743027|80889423|FG003|Overall Study|Protocol Violation|0|||
27742963|NCT01743027|80889420|FG000|Overall Study|Withdrawal by Subject|1|||
27742964|NCT01743027|80889421|FG001|Overall Study|Withdrawal by Subject|0|||
27742965|NCT01743027|80889422|FG002|Overall Study|Withdrawal by Subject|3|||
27742966|NCT01743027|80889423|FG003|Overall Study|Withdrawal by Subject|1|||
27742967|NCT01651260|80889433|FG000|Overall Study|unable to apply product|3|||
27742968|NCT02117050|80889434|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
27742969|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
27742970|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
27742971|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
27742972|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
27742973|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
27742974|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
27742975|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
27742976|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
27742977|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
27550373|NCT00743340|80200441|FG000|Overall Study|Study medication non-compliance|1|||
27550374|NCT00743340|80200441|FG000|Overall Study|Lost to Follow-up|1|||
27550375|NCT00743340|80200441|FG000|Overall Study|Withdrawal from the Study|5|||
27550376|NCT00743340|80200441|FG000|Overall Study|Protocol Violation|1|||
27550377|NCT00743340|80200441|FG000|Overall Study|Virologic failure|8|||
27550378|NCT00743340|80200441|FG000|Overall Study|Pregnancy|1|||
27550379|NCT00743340|80200441|FG000|Overall Study|Rolled over to other Gilead Study|23|||
27550380|NCT00743340|80200441|FG000|Overall Study|Participant Relocated|1|||
27550381|NCT00491075|80200442|FG000|Overall Study|Withdrawal by Subject|1|||
27550382|NCT00491075|80200442|FG000|Overall Study|Physician Decision|1|||
27550383|NCT02547649|80200443|FG000|Overall Study|Lost to Follow-up|3|||
27550384|NCT02547649|80200444|FG001|Overall Study|Lost to Follow-up|1|||
27550385|NCT02547649|80200445|FG002|Overall Study|Lost to Follow-up|1|||
27550386|NCT02547649|80200443|FG000|Overall Study|Not vaccinated|0|||
27550387|NCT02547649|80200444|FG001|Overall Study|Not vaccinated|0|||
27550388|NCT02547649|80200445|FG002|Overall Study|Not vaccinated|1|||
27550389|NCT02547649|80200443|FG000|Overall Study|Withdrawal by Subject|0|||
27550390|NCT02547649|80200444|FG001|Overall Study|Withdrawal by Subject|4|||
27550391|NCT02547649|80200445|FG002|Overall Study|Withdrawal by Subject|2|||
27550392|NCT04967443|80203338|FG000|Open Label Treatment|Death|1|||
27550393|NCT04967443|80203339|FG001|Open Label Treatment|Death|0|||
27550394|NCT04967443|80203340|FG002|Open Label Treatment|Death|0|||
27550395|NCT04967443|80203341|FG003|Open Label Treatment|Death|0|||
27550396|NCT04967443|80203342|FG004|Open Label Treatment|Death|0|||
27550397|NCT04967443|80203343|FG005|Open Label Treatment|Death|0|||
27550398|NCT04967443|80203344|FG006|Open Label Treatment|Death|0|||
27550399|NCT04967443|80203345|FG007|Open Label Treatment|Death|0|||
27550400|NCT04967443|80203338|FG000|Open Label Treatment|Lost to Follow-up|0|||
27550401|NCT04967443|80203339|FG001|Open Label Treatment|Lost to Follow-up|0|||
27550402|NCT04967443|80203340|FG002|Open Label Treatment|Lost to Follow-up|1|||
27550403|NCT04967443|80203341|FG003|Open Label Treatment|Lost to Follow-up|0|||
27550404|NCT04967443|80203342|FG004|Open Label Treatment|Lost to Follow-up|0|||
27550405|NCT04967443|80203343|FG005|Open Label Treatment|Lost to Follow-up|0|||
27742978|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
27742979|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
27550406|NCT04967443|80203344|FG006|Open Label Treatment|Lost to Follow-up|0|||
27550407|NCT04967443|80203345|FG007|Open Label Treatment|Lost to Follow-up|0|||
27550408|NCT04967443|80203338|FG000|Open Label Treatment|Withdrawal by Subject|0|||
27550409|NCT04967443|80203339|FG001|Open Label Treatment|Withdrawal by Subject|1|||
27550410|NCT04967443|80203340|FG002|Open Label Treatment|Withdrawal by Subject|0|||
27550411|NCT04967443|80203341|FG003|Open Label Treatment|Withdrawal by Subject|1|||
27641899|NCT00419341|80532398|FG000|Efficacy Period|Termination of study site|1|||
27641900|NCT00448669|80532403|FG000|Overall Study|Lost to Follow-up|52|||
27641901|NCT00448669|80532404|FG001|Overall Study|Lost to Follow-up|63|||
27641902|NCT00448669|80532403|FG000|Overall Study|Withdrawal by Subject|90|||
27641903|NCT00448669|80532404|FG001|Overall Study|Withdrawal by Subject|74|||
27641904|NCT00448669|80532403|FG000|Overall Study|Relocated|49|||
27641905|NCT00448669|80532404|FG001|Overall Study|Relocated|36|||
27641906|NCT00448669|80532403|FG000|Overall Study|Were withdrawn by investigator|10|||
27641907|NCT00448669|80532404|FG001|Overall Study|Were withdrawn by investigator|6|||
27641908|NCT00448669|80532403|FG000|Overall Study|Death|2|||
27641909|NCT00448669|80532404|FG001|Overall Study|Death|4|||
27641910|NCT00448669|80532403|FG000|Overall Study|Had other reasons|5|||
27641911|NCT00448669|80532404|FG001|Overall Study|Had other reasons|6|||
27641912|NCT00448669|80532403|FG000|Overall Study|HIV-infected at enrollment|1|||
27641913|NCT00448669|80532404|FG001|Overall Study|HIV-infected at enrollment|2|||
27641914|NCT00448669|80532403|FG000|Overall Study|Never started drug|9|||
27641915|NCT00448669|80532404|FG001|Overall Study|Never started drug|7|||
27641916|NCT02376790|80532405|FG000|Overall Study|Withdrawal by Subject|43|||
27641917|NCT02376790|80532406|FG001|Overall Study|Withdrawal by Subject|36|||
27641918|NCT02376790|80532407|FG002|Overall Study|Withdrawal by Subject|37|||
27641919|NCT02376790|80532405|FG000|Overall Study|Decision by Sponsor|2|||
27641920|NCT02376790|80532406|FG001|Overall Study|Decision by Sponsor|1|||
27932023|NCT02697422|81586061|FG000|Overall Study|Lost to Follow-up|13|||
27932024|NCT02697422|81586062|FG001|Overall Study|Lost to Follow-up|8|||
27932025|NCT02697422|81586061|FG000|Overall Study|Death|2|||
27932026|NCT02697422|81586062|FG001|Overall Study|Death|1|||
27932027|NCT02697422|81586061|FG000|Overall Study|Withdrawal by Subject|0|||
27932028|NCT02697422|81586062|FG001|Overall Study|Withdrawal by Subject|1|||
27932029|NCT02697422|81586061|FG000|Overall Study|Physician Decision|1|||
27932030|NCT02697422|81586062|FG001|Overall Study|Physician Decision|1|||
27932031|NCT02697422|81586061|FG000|Overall Study|Exit survey data lost|1|||
27641921|NCT02376790|80532407|FG002|Overall Study|Decision by Sponsor|4|||
27641922|NCT02376790|80532405|FG000|Overall Study|Lost to Follow-up|15|||
27641923|NCT02376790|80532406|FG001|Overall Study|Lost to Follow-up|10|||
27641924|NCT02376790|80532407|FG002|Overall Study|Lost to Follow-up|12|||
27641925|NCT00676091|80532409|FG000|Infant Series|Parent or legal guardian request|10|||
27641926|NCT00676091|80532410|FG001|Infant Series|Parent or legal guardian request|8|||
27641927|NCT00676091|80532409|FG000|Infant Series|Protocol Violation|6|||
27932032|NCT02697422|81586062|FG001|Overall Study|Exit survey data lost|0|||
27641928|NCT00676091|80532410|FG001|Infant Series|Protocol Violation|3|||
27641929|NCT00676091|80532409|FG000|Infant Series|Adverse Event|2|||
27641930|NCT00676091|80532410|FG001|Infant Series|Adverse Event|3|||
27641931|NCT00676091|80532409|FG000|Infant Series|Failed to return|1|||
27641932|NCT00676091|80532410|FG001|Infant Series|Failed to return|3|||
27641933|NCT00676091|80532409|FG000|Infant Series|Lost to Follow-up|1|||
27641934|NCT00676091|80532410|FG001|Infant Series|Lost to Follow-up|0|||
27641935|NCT00676091|80532409|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
27641936|NCT00676091|80532410|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
27641937|NCT00676091|80532409|FG000|After Infant Series|Adverse Event|0|||
27641938|NCT00676091|80532410|FG001|After Infant Series|Adverse Event|1|||
27641939|NCT00676091|80532409|FG000|After Infant Series|Protocol Violation|0|||
27641940|NCT00676091|80532410|FG001|After Infant Series|Protocol Violation|1|||
27641941|NCT00676091|80532409|FG000|After Infant Series|Failed to return|1|||
27932033|NCT01026038|81586065|FG000|Overall Study|Lost to Follow-up|1|||
27932034|NCT01026038|81586066|FG001|Overall Study|Lost to Follow-up|1|||
27550412|NCT04967443|80203342|FG004|Open Label Treatment|Withdrawal by Subject|0|||
27550413|NCT04967443|80203343|FG005|Open Label Treatment|Withdrawal by Subject|1|||
27550414|NCT04967443|80203344|FG006|Open Label Treatment|Withdrawal by Subject|2|||
27550415|NCT04967443|80203345|FG007|Open Label Treatment|Withdrawal by Subject|3|||
27550416|NCT04967443|80203338|FG000|Follow-Up|Death|1|||
27550417|NCT04967443|80203339|FG001|Follow-Up|Death|0|||
27550418|NCT04967443|80203340|FG002|Follow-Up|Death|0|||
27550419|NCT04967443|80203341|FG003|Follow-Up|Death|0|||
27550420|NCT04967443|80203342|FG004|Follow-Up|Death|0|||
27550421|NCT04967443|80203343|FG005|Follow-Up|Death|0|||
27550422|NCT04967443|80203344|FG006|Follow-Up|Death|0|||
27550423|NCT04967443|80203345|FG007|Follow-Up|Death|0|||
27550424|NCT04967443|80203338|FG000|Follow-Up|Lost to Follow-up|0|||
27641942|NCT00676091|80532410|FG001|After Infant Series|Failed to return|1|||
27641943|NCT00676091|80532409|FG000|Toddler Dose|Failed to return|2|||
27641944|NCT00676091|80532410|FG001|Toddler Dose|Failed to return|0|||
27641945|NCT00676091|80532409|FG000|Toddler Dose|Parent or legal guardian request|1|||
27641946|NCT00676091|80532410|FG001|Toddler Dose|Parent or legal guardian request|0|||
27641947|NCT00350792|80532413|FG000|Overall Study|Adverse Event|11|||
27641948|NCT00350792|80532413|FG000|Overall Study|Death from Study Disease|1|||
27550425|NCT04967443|80203339|FG001|Follow-Up|Lost to Follow-up|0|||
27550426|NCT04967443|80203340|FG002|Follow-Up|Lost to Follow-up|1|||
27550427|NCT04967443|80203341|FG003|Follow-Up|Lost to Follow-up|1|||
27550428|NCT04967443|80203342|FG004|Follow-Up|Lost to Follow-up|0|||
27932035|NCT01026038|81586067|FG002|Overall Study|Lost to Follow-up|0|||
27742980|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27742981|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27742982|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27742983|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
27742984|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27742985|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
27742986|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27742987|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27742988|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
27742989|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
27742990|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
27742991|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
27742992|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
27742993|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
27742994|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
27932036|NCT01363076|81586068|FG000|Overall Study|Withdrawal by Subject|0|||
27550429|NCT04967443|80203343|FG005|Follow-Up|Lost to Follow-up|0|||
27550430|NCT04967443|80203344|FG006|Follow-Up|Lost to Follow-up|0|||
27550431|NCT04967443|80203345|FG007|Follow-Up|Lost to Follow-up|0|||
27550432|NCT04967443|80203338|FG000|Follow-Up|Withdrawal by Subject|0|||
27550433|NCT04967443|80203339|FG001|Follow-Up|Withdrawal by Subject|1|||
27550434|NCT04967443|80203340|FG002|Follow-Up|Withdrawal by Subject|0|||
27550435|NCT04967443|80203341|FG003|Follow-Up|Withdrawal by Subject|1|||
27550436|NCT04967443|80203342|FG004|Follow-Up|Withdrawal by Subject|0|||
27550437|NCT04967443|80203343|FG005|Follow-Up|Withdrawal by Subject|1|||
27550438|NCT04967443|80203344|FG006|Follow-Up|Withdrawal by Subject|2|||
27550439|NCT04967443|80203345|FG007|Follow-Up|Withdrawal by Subject|3|||
27550440|NCT02480114|80203346|FG000|Overall Study|Not completing surveys|3|||
27550441|NCT02480114|80203347|FG001|Overall Study|Not completing surveys|2|||
27550442|NCT02480114|80203346|FG000|Overall Study|Withdrawal by Subject|2|||
27550443|NCT02480114|80203347|FG001|Overall Study|Withdrawal by Subject|4|||
27550444|NCT02480114|80203346|FG000|Overall Study|Disease progression|3|||
27550445|NCT02480114|80203347|FG001|Overall Study|Disease progression|0|||
27550446|NCT02480114|80203346|FG000|Overall Study|Improper completion of survey|1|||
27550447|NCT02480114|80203347|FG001|Overall Study|Improper completion of survey|1|||
27550448|NCT02480114|80203346|FG000|Overall Study|Not eligible|0|||
27550449|NCT02480114|80203347|FG001|Overall Study|Not eligible|1|||
27550450|NCT01846416|80203348|FG000|Treatment Phase|Death|2|||
27550451|NCT01846416|80203349|FG001|Treatment Phase|Death|9|||
27550452|NCT01846416|80203350|FG002|Treatment Phase|Death|1|||
27550453|NCT01846416|80203348|FG000|Treatment Phase|Withdrawal by Subject|2|||
27550454|NCT01846416|80203349|FG001|Treatment Phase|Withdrawal by Subject|4|||
27550455|NCT01846416|80203350|FG002|Treatment Phase|Withdrawal by Subject|2|||
27550456|NCT01846416|80203348|FG000|Treatment Phase|Other|1|||
27550457|NCT01846416|80203349|FG001|Treatment Phase|Other|5|||
27550458|NCT01846416|80203350|FG002|Treatment Phase|Other|1|||
27550459|NCT01846416|80203348|FG000|Treatment Phase|Physician Decision|1|||
27550460|NCT01846416|80203349|FG001|Treatment Phase|Physician Decision|2|||
27550461|NCT01846416|80203350|FG002|Treatment Phase|Physician Decision|0|||
27550462|NCT01846416|80203348|FG000|Treatment Phase|Adverse Event|3|||
27550463|NCT01846416|80203349|FG001|Treatment Phase|Adverse Event|4|||
27550464|NCT01846416|80203350|FG002|Treatment Phase|Adverse Event|0|||
27550465|NCT01846416|80203348|FG000|Treatment Phase|Non-compliance|0|||
27550466|NCT01846416|80203349|FG001|Treatment Phase|Non-compliance|2|||
27550467|NCT01846416|80203350|FG002|Treatment Phase|Non-compliance|0|||
27550468|NCT01846416|80203348|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
27550469|NCT01846416|80203349|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
27550470|NCT01846416|80203350|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
27550471|NCT01846416|80203348|FG000|Treatment Phase|Progressive Disease|21|||
27550472|NCT01846416|80203349|FG001|Treatment Phase|Progressive Disease|63|||
27550473|NCT01846416|80203350|FG002|Treatment Phase|Progressive Disease|9|||
27550474|NCT01846416|80203348|FG000|Survival Follow-up|Death|21|||
27550475|NCT01846416|80203349|FG001|Survival Follow-up|Death|62|||
27550476|NCT01846416|80203350|FG002|Survival Follow-up|Death|9|||
27550477|NCT01846416|80203348|FG000|Survival Follow-up|Lost to Follow-up|0|||
27550478|NCT01846416|80203349|FG001|Survival Follow-up|Lost to Follow-up|2|||
27550479|NCT01846416|80203350|FG002|Survival Follow-up|Lost to Follow-up|2|||
27550480|NCT01846416|80203348|FG000|Survival Follow-up|Withdrawal by Subject|2|||
27550481|NCT01846416|80203349|FG001|Survival Follow-up|Withdrawal by Subject|7|||
27550482|NCT01846416|80203350|FG002|Survival Follow-up|Withdrawal by Subject|0|||
27550483|NCT01846416|80203348|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
27550484|NCT01846416|80203349|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
27550485|NCT01846416|80203350|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
27550486|NCT01846416|80203348|FG000|Survival Follow-up|Other|3|||
27550487|NCT01846416|80203349|FG001|Survival Follow-up|Other|1|||
27742995|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
27742996|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
27641949|NCT00350792|80532413|FG000|Overall Study|Death from Study Drug Toxicity|1|||
27641950|NCT00350792|80532413|FG000|Overall Study|Death Not Study Drug Related|2|||
27641951|NCT00350792|80532413|FG000|Overall Study|Protocol Violation|1|||
27641952|NCT00350792|80532413|FG000|Overall Study|Withdrawal by Subject|4|||
27641953|NCT00350792|80532413|FG000|Overall Study|Physician Decision|2|||
27641954|NCT00350792|80532413|FG000|Overall Study|Lack of Efficacy|11|||
27641955|NCT03101371|80532414|FG000|Overall Study|Physician Decision|0|||
27641956|NCT03101371|80532415|FG001|Overall Study|Physician Decision|1|||
27641957|NCT03101371|80532414|FG000|Overall Study|Lost to Follow-up|1|||
27641958|NCT03101371|80532415|FG001|Overall Study|Lost to Follow-up|4|||
27641959|NCT03101371|80532414|FG000|Overall Study|Did not meet eligibility criteria|2|||
27641960|NCT03101371|80532415|FG001|Overall Study|Did not meet eligibility criteria|1|||
27641961|NCT02291913|80532416|FG000|Overall Study|Progressive Disease|32|||
27641962|NCT02291913|80532416|FG000|Overall Study|Adverse Event|11|||
27641963|NCT02291913|80532416|FG000|Overall Study|Death|2|||
27641964|NCT02291913|80532416|FG000|Overall Study|Physician Decision|1|||
27641965|NCT02291913|80532416|FG000|Overall Study|Withdrawal by Subject|1|||
27641966|NCT02291913|80532416|FG000|Overall Study|Protocol Violation|1|||
27641967|NCT04048681|80532417|FG000|Overall Study|family emergency|0|||
27641968|NCT04048681|80532418|FG001|Overall Study|family emergency|0|||
27641969|NCT04048681|80532419|FG002|Overall Study|family emergency|0|||
27641970|NCT04048681|80532420|FG003|Overall Study|family emergency|1|||
27641971|NCT04048681|80532421|FG004|Overall Study|family emergency|0|||
27641972|NCT03752151|80532422|FG000|Overall Study|Withdrawal by Subject|1|||
27742997|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
27742998|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
27742999|NCT02660580|80889435|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
27743000|NCT02660580|80889436|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
27743001|NCT02660580|80889437|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
27743002|NCT02660580|80889438|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
27743003|NCT02660580|80889439|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
27743004|NCT02660580|80889435|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
27743005|NCT02660580|80889436|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
27743006|NCT02660580|80889437|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
27743007|NCT02660580|80889438|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
27743008|NCT02660580|80889439|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
27743009|NCT02660580|80889435|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
27743010|NCT02660580|80889436|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
27743011|NCT02660580|80889437|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
27743012|NCT02660580|80889438|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
27743013|NCT02660580|80889439|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
27743014|NCT02660580|80889435|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
27743015|NCT02660580|80889436|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
27743016|NCT02660580|80889437|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
27743017|NCT02660580|80889438|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
27743018|NCT02660580|80889439|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
27743019|NCT02660580|80889435|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
27743020|NCT02660580|80889436|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
27743021|NCT02660580|80889437|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
27743022|NCT02660580|80889438|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
27743023|NCT02660580|80889439|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
27743024|NCT02660580|80889435|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
27743025|NCT02660580|80889436|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
27743026|NCT02660580|80889437|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
27743027|NCT02660580|80889438|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
27743028|NCT02660580|80889439|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
27743029|NCT02660580|80889435|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
27743030|NCT02660580|80889436|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
27641973|NCT03752151|80532422|FG000|Overall Study|Protocol Violation|1|||
27641974|NCT02590432|80532423|FG000|Open-label Treatment Period|Adverse Event|97|||
27641975|NCT02590432|80532424|FG001|Open-label Treatment Period|Adverse Event|79|||
27641976|NCT02590432|80532425|FG002|Open-label Treatment Period|Adverse Event|0|||
27641977|NCT02590432|80532426|FG003|Open-label Treatment Period|Adverse Event|0|||
27743031|NCT02660580|80889437|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
27743032|NCT02660580|80889438|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
27743033|NCT02660580|80889439|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
27641978|NCT02590432|80532427|FG004|Open-label Treatment Period|Adverse Event|0|||
27641979|NCT02590432|80532428|FG005|Open-label Treatment Period|Adverse Event|0|||
27641980|NCT02590432|80532429|FG006|Open-label Treatment Period|Adverse Event|0|||
27641981|NCT02590432|80532430|FG007|Open-label Treatment Period|Adverse Event|0|||
27641982|NCT02590432|80532431|FG008|Open-label Treatment Period|Adverse Event|0|||
27641983|NCT02590432|80532423|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
27641984|NCT02590432|80532424|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
27641985|NCT02590432|80532425|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
27641986|NCT02590432|80532426|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
27641987|NCT02590432|80532427|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
27641988|NCT02590432|80532428|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
27641989|NCT02590432|80532429|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
27641990|NCT02590432|80532430|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
27932037|NCT01363076|81586069|FG001|Overall Study|Withdrawal by Subject|1|||
27932038|NCT00416949|81588895|FG000|Overall Study|Patients refused to participate|5|||
27641991|NCT02590432|80532431|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
27641992|NCT02590432|80532423|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
27641993|NCT02590432|80532424|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
27641994|NCT02590432|80532425|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
27641995|NCT02590432|80532426|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
27641996|NCT02590432|80532427|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
27641997|NCT02590432|80532428|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
27641998|NCT02590432|80532429|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
27641999|NCT02590432|80532430|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
27642000|NCT02590432|80532431|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
27642001|NCT02590432|80532423|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
27642002|NCT02590432|80532424|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
27642003|NCT02590432|80532425|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
27642004|NCT02590432|80532426|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
27642005|NCT02590432|80532427|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
27642006|NCT02590432|80532428|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
27642007|NCT02590432|80532429|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
27642008|NCT02590432|80532430|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
27642009|NCT02590432|80532431|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
27642010|NCT02590432|80532423|FG000|Open-label Treatment Period|Protocol Violation|10|||
27642011|NCT02590432|80532424|FG001|Open-label Treatment Period|Protocol Violation|4|||
27642012|NCT02590432|80532425|FG002|Open-label Treatment Period|Protocol Violation|0|||
27642013|NCT02590432|80532426|FG003|Open-label Treatment Period|Protocol Violation|0|||
27642014|NCT02590432|80532427|FG004|Open-label Treatment Period|Protocol Violation|0|||
27642015|NCT02590432|80532428|FG005|Open-label Treatment Period|Protocol Violation|0|||
27642016|NCT02590432|80532429|FG006|Open-label Treatment Period|Protocol Violation|0|||
27642017|NCT02590432|80532430|FG007|Open-label Treatment Period|Protocol Violation|0|||
27642018|NCT02590432|80532431|FG008|Open-label Treatment Period|Protocol Violation|0|||
27642019|NCT02590432|80532423|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
27642020|NCT02590432|80532424|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
27642021|NCT02590432|80532425|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642022|NCT02590432|80532426|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642023|NCT02590432|80532427|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642024|NCT02590432|80532428|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642025|NCT02590432|80532429|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642026|NCT02590432|80532430|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642027|NCT02590432|80532431|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
27642028|NCT02590432|80532423|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
27642029|NCT02590432|80532424|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
27642030|NCT02590432|80532425|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642031|NCT02590432|80532426|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642032|NCT02590432|80532427|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642033|NCT02590432|80532428|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642034|NCT02590432|80532429|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642035|NCT02590432|80532430|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642036|NCT02590432|80532431|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
27642037|NCT02590432|80532423|FG000|Double-blind Treatment Period|Adverse Event|0|||
27642038|NCT02590432|80532424|FG001|Double-blind Treatment Period|Adverse Event|0|||
27642039|NCT02590432|80532425|FG002|Double-blind Treatment Period|Adverse Event|14|||
27932039|NCT03093870|81588896|FG000|Overall Study|Withdrawal by Subject|2|||
27642040|NCT02590432|80532426|FG003|Double-blind Treatment Period|Adverse Event|12|||
27642041|NCT02590432|80532427|FG004|Double-blind Treatment Period|Adverse Event|6|||
27743034|NCT00258154|80889440|FG000|Overall Study|Adverse Event|1|||
27932040|NCT03093870|81588897|FG001|Overall Study|Withdrawal by Subject|6|||
27932041|NCT03093870|81588898|FG002|Overall Study|Withdrawal by Subject|5|||
27642042|NCT02590432|80532428|FG005|Double-blind Treatment Period|Adverse Event|22|||
27642043|NCT02590432|80532429|FG006|Double-blind Treatment Period|Adverse Event|20|||
27642044|NCT02590432|80532430|FG007|Double-blind Treatment Period|Adverse Event|0|||
27642045|NCT02590432|80532431|FG008|Double-blind Treatment Period|Adverse Event|0|||
27642046|NCT02590432|80532423|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27642047|NCT02590432|80532424|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
27642048|NCT02590432|80532425|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
27642049|NCT02590432|80532426|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
27642050|NCT02590432|80532427|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
27642051|NCT02590432|80532428|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
27642052|NCT02590432|80532429|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
27642053|NCT02590432|80532430|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
27642054|NCT02590432|80532431|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
27642055|NCT02590432|80532423|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
27642056|NCT02590432|80532424|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
27642057|NCT02590432|80532425|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
27642058|NCT02590432|80532426|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
27932042|NCT03093870|81588896|FG000|Overall Study|Death|1|||
27932043|NCT03093870|81588897|FG001|Overall Study|Death|35|||
27932044|NCT03093870|81588898|FG002|Overall Study|Death|35|||
27932045|NCT03093870|81588896|FG000|Overall Study|Radiographic disease progression|10|||
27932046|NCT03093870|81588897|FG001|Overall Study|Radiographic disease progression|0|||
27932047|NCT03093870|81588898|FG002|Overall Study|Radiographic disease progression|0|||
27932048|NCT03093870|81588896|FG000|Overall Study|Clinical disease progression|1|||
27932049|NCT03093870|81588897|FG001|Overall Study|Clinical disease progression|0|||
27932050|NCT03093870|81588898|FG002|Overall Study|Clinical disease progression|0|||
27932051|NCT03093870|81588896|FG000|Overall Study|Physician Decision|2|||
27932052|NCT03093870|81588897|FG001|Overall Study|Physician Decision|0|||
27932053|NCT03093870|81588898|FG002|Overall Study|Physician Decision|0|||
27932054|NCT03093870|81588896|FG000|Overall Study|Adverse Event|7|||
27932055|NCT03093870|81588897|FG001|Overall Study|Adverse Event|0|||
27932056|NCT03093870|81588898|FG002|Overall Study|Adverse Event|0|||
27932057|NCT03093870|81588896|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
27932058|NCT03093870|81588897|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
27932059|NCT03093870|81588898|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
27932060|NCT03093870|81588896|FG000|Overall Study|Lost to Follow-up|0|||
27550488|NCT01846416|80203350|FG002|Survival Follow-up|Other|1|||
27550489|NCT03555591|80203355|FG000|Overall Study|Protocol Violation|77|||
27550490|NCT00621985|80203356|FG000|Dexamethasone Admission|Adverse Event|1|||
27550491|NCT01828281|80203372|FG000|Overall Study|Withdrawal by Subject|1|||
27550492|NCT01828281|80203373|FG001|Overall Study|Withdrawal by Subject|0|||
27550493|NCT01830972|80203374|FG000|Part II|Withdrawal by Subject|2|||
27550494|NCT01830972|80203375|FG001|Part II|Withdrawal by Subject|2|||
27550495|NCT01830972|80203374|FG000|Part III|Withdrawal by Subject|1|||
27550496|NCT01830972|80203375|FG001|Part III|Withdrawal by Subject|0|||
27550497|NCT01830972|80203374|FG000|Part III|Noncompliance|1|||
27550498|NCT01830972|80203375|FG001|Part III|Noncompliance|0|||
27550499|NCT01830972|80203374|FG000|Part IV|Withdrawal by Subject|2|||
27550500|NCT01830972|80203375|FG001|Part IV|Withdrawal by Subject|1|||
27550501|NCT01830972|80203374|FG000|Part IV|Non-Compliance|1|||
27550502|NCT01830972|80203375|FG001|Part IV|Non-Compliance|0|||
27550503|NCT02599129|80203378|FG000|Overall Study|Lack of Efficacy|2|||
27550504|NCT02599129|80203379|FG001|Overall Study|Lack of Efficacy|2|||
27550505|NCT02599129|80203378|FG000|Overall Study|Lost to Follow-up|1|||
27550506|NCT02599129|80203379|FG001|Overall Study|Lost to Follow-up|0|||
27550507|NCT02599129|80203378|FG000|Overall Study|Withdrawal by Subject|2|||
27550508|NCT02599129|80203379|FG001|Overall Study|Withdrawal by Subject|1|||
27550509|NCT01673867|80203380|FG000|Randomization|Adverse event unrelated to study drug|1|||
27550510|NCT01673867|80203381|FG001|Randomization|Adverse event unrelated to study drug|0|||
27642059|NCT02590432|80532427|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
27642060|NCT02590432|80532428|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
27642061|NCT02590432|80532429|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
27932061|NCT03093870|81588897|FG001|Overall Study|Lost to Follow-up|0|||
27932062|NCT03093870|81588898|FG002|Overall Study|Lost to Follow-up|1|||
27550511|NCT01673867|80203380|FG000|Randomization|Participant request to discontinue study treatment|0|||
27550512|NCT01673867|80203381|FG001|Randomization|Participant request to discontinue study treatment|4|||
27550513|NCT01673867|80203380|FG000|Randomization|Withdrawal by participant|0|||
27550514|NCT01673867|80203381|FG001|Randomization|Withdrawal by participant|12|||
27550515|NCT01673867|80203380|FG000|Randomization|Lost to Follow-up|0|||
27550516|NCT01673867|80203381|FG001|Randomization|Lost to Follow-up|1|||
27550517|NCT01673867|80203380|FG000|Randomization|Participant no longer meets study criteria|4|||
27550518|NCT01673867|80203381|FG001|Randomization|Participant no longer meets study criteria|5|||
27550519|NCT01673867|80203380|FG000|Treatment|Disease Progression|208|||
27932063|NCT01793935|81588899|FG000|Overall Study|Pregnancy|1|||
27932064|NCT01793935|81588900|FG001|Overall Study|Pregnancy|0|||
27932065|NCT01793935|81588899|FG000|Overall Study|Protocol Violation|2|||
27932066|NCT01793935|81588900|FG001|Overall Study|Protocol Violation|1|||
27932067|NCT01793935|81588899|FG000|Overall Study|Adverse Event|2|||
27932068|NCT01793935|81588900|FG001|Overall Study|Adverse Event|0|||
27932069|NCT01793935|81588899|FG000|Overall Study|Patient did not take study medication|1|||
27932070|NCT01793935|81588900|FG001|Overall Study|Patient did not take study medication|1|||
27932071|NCT01793935|81588899|FG000|Overall Study|Lost to Follow-up|0|||
27932072|NCT01793935|81588900|FG001|Overall Study|Lost to Follow-up|1|||
27932073|NCT01945242|81588901|FG000|Overall Study|Physician Decision|3|||
27932074|NCT01945242|81588902|FG001|Overall Study|Physician Decision|3|||
27932075|NCT01472835|81588903|FG000|Overall Study|Lost to Follow-up|2|||
27932076|NCT01472835|81588904|FG001|Overall Study|Lost to Follow-up|0|||
27932077|NCT00837330|81588905|FG000|Overall Study|Lost to Follow-up|1|||
27932078|NCT00837330|81588906|FG001|Overall Study|Lost to Follow-up|3|||
27932079|NCT01011283|81588907|FG000|Overall Study|Adverse Event|4|||
27932080|NCT01011283|81588908|FG001|Overall Study|Adverse Event|2|||
27932081|NCT01011283|81588907|FG000|Overall Study|Progressive Disease|0|||
27932082|NCT01011283|81588908|FG001|Overall Study|Progressive Disease|2|||
27932083|NCT01011283|81588907|FG000|Overall Study|Terminated by Sponsor|5|||
27932084|NCT01011283|81588908|FG001|Overall Study|Terminated by Sponsor|5|||
27932085|NCT01011283|81588907|FG000|Overall Study|Other|2|||
27932086|NCT01011283|81588908|FG001|Overall Study|Other|2|||
27932087|NCT00407030|81588909|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
27932088|NCT00407030|81588910|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
27932089|NCT00407030|81588911|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
27932090|NCT00407030|81588909|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
27932091|NCT00407030|81588910|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
27932092|NCT00407030|81588911|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
27932093|NCT00407030|81588909|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
27932094|NCT00407030|81588910|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
27932095|NCT00407030|81588911|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
27932096|NCT00407030|81588909|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
27932097|NCT00407030|81588910|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
27932098|NCT00407030|81588911|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
27932099|NCT00407030|81588909|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
27932100|NCT00407030|81588910|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
27932101|NCT00407030|81588911|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
27932102|NCT00407030|81588909|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
27932103|NCT00407030|81588910|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
27932104|NCT00407030|81588911|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
27932105|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
27932106|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
27932107|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
27932108|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
27932109|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
27932110|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
27932111|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
27932112|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
27932113|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
27932114|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
27932115|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
27932116|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
27932117|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
27932118|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
27932119|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
27932120|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
27932121|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
27932122|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
27932123|NCT00407030|81588909|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
27932124|NCT00407030|81588910|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
27932125|NCT00407030|81588911|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
27932126|NCT03695094|81588912|FG000|Overall Study|Adverse Event|1|||
27932127|NCT03695094|81588913|FG001|Overall Study|Adverse Event|1|||
27932128|NCT03695094|81588912|FG000|Overall Study|Withdrawal by Subject|1|||
27932129|NCT03695094|81588913|FG001|Overall Study|Withdrawal by Subject|0|||
27932130|NCT01691482|81588917|FG000|Treatment Period 2|Adverse Event|0|||
27932131|NCT01691482|81588918|FG001|Treatment Period 2|Adverse Event|1|||
27932132|NCT01691482|81588917|FG000|Treatment Period 2|Protocol Violation|1|||
27932133|NCT01691482|81588918|FG001|Treatment Period 2|Protocol Violation|1|||
27932134|NCT04137887|81588927|FG000|Overall Study|Death|102|||
27932135|NCT04137887|81588928|FG001|Overall Study|Death|92|||
27932136|NCT04137887|81588927|FG000|Overall Study|Withdrawal by Subject|2|||
27932137|NCT04137887|81588928|FG001|Overall Study|Withdrawal by Subject|3|||
27932138|NCT04137887|81588927|FG000|Overall Study|Randomized but not treated|0|||
27932139|NCT04137887|81588928|FG001|Overall Study|Randomized but not treated|1|||
27932140|NCT01617967|81588929|FG000|Overall Study|Protocol Violation|0|||
27932141|NCT01617967|81588930|FG001|Overall Study|Protocol Violation|0|||
27932142|NCT01617967|81588931|FG002|Overall Study|Protocol Violation|0|||
27932143|NCT01617967|81588932|FG003|Overall Study|Protocol Violation|1|||
27932144|NCT01617967|81588933|FG004|Overall Study|Protocol Violation|0|||
27932145|NCT01617967|81588934|FG005|Overall Study|Protocol Violation|0|||
27932146|NCT01617967|81588929|FG000|Overall Study|Withdrawal by Subject|0|||
27932147|NCT01617967|81588930|FG001|Overall Study|Withdrawal by Subject|0|||
27932148|NCT01617967|81588931|FG002|Overall Study|Withdrawal by Subject|0|||
27932149|NCT01617967|81588932|FG003|Overall Study|Withdrawal by Subject|0|||
27932150|NCT01617967|81588933|FG004|Overall Study|Withdrawal by Subject|0|||
27932151|NCT01617967|81588934|FG005|Overall Study|Withdrawal by Subject|1|||
27932152|NCT01617967|81588929|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
27932153|NCT01617967|81588930|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
27932154|NCT01617967|81588931|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
27932155|NCT01617967|81588932|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
27932156|NCT01617967|81588933|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
27932157|NCT01617967|81588934|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
27932158|NCT03558672|81588937|FG000|Overall Study|Study Early Termination|10|||
27932159|NCT00454142|81588938|FG000|Overall Study|Withdrawal by Subject|1|||
27932160|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
27932161|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
27932162|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
27932163|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
27932164|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
27932165|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
27932166|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
27932167|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
27932168|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
27932169|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
27932170|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
27932171|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
27932172|NCT01243424|81588943|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
27932173|NCT01243424|81588944|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
27932174|NCT01243424|81588943|FG000|Discontinuation From Treatment|Not treated|5|||
27932175|NCT01243424|81588944|FG001|Discontinuation From Treatment|Not treated|4|||
27932176|NCT01243424|81588943|FG000|Discontinuation From Treatment|Adverse Event|457|||
27932177|NCT01243424|81588944|FG001|Discontinuation From Treatment|Adverse Event|523|||
27932178|NCT01243424|81588943|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
27932179|NCT01243424|81588944|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
27932180|NCT01243424|81588943|FG000|Discontinuation From Treatment|Protocol Violation|46|||
27932181|NCT01243424|81588944|FG001|Discontinuation From Treatment|Protocol Violation|47|||
27932182|NCT01243424|81588943|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
27932183|NCT01243424|81588944|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
27932184|NCT01243424|81588943|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
27932185|NCT01243424|81588944|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
27932186|NCT01243424|81588943|FG000|Discontinuation From Treatment|Other than listed above|230|||
27932187|NCT01243424|81588944|FG001|Discontinuation From Treatment|Other than listed above|211|||
27550520|NCT01673867|80203381|FG001|Treatment|Disease Progression|178|||
27550521|NCT01673867|80203380|FG000|Treatment|Study Drug Toxicity|23|||
27550522|NCT01673867|80203381|FG001|Treatment|Study Drug Toxicity|43|||
27550523|NCT01673867|80203380|FG000|Treatment|Death|2|||
27642062|NCT02590432|80532430|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
27932188|NCT00981175|81588949|FG000|Primary Dose Vaccination|Adverse Event|1|||
27932189|NCT00981175|81588950|FG001|Primary Dose Vaccination|Adverse Event|0|||
27932190|NCT00981175|81588949|FG000|Primary Dose Vaccination|Protocol Violation|0|||
27932191|NCT00981175|81588950|FG001|Primary Dose Vaccination|Protocol Violation|1|||
27550524|NCT01673867|80203381|FG001|Treatment|Death|3|||
27550525|NCT01673867|80203380|FG000|Treatment|Adverse event unrelated to study drug|23|||
27550526|NCT01673867|80203381|FG001|Treatment|Adverse event unrelated to study drug|10|||
27932192|NCT00981175|81588949|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
27932193|NCT00981175|81588950|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
27550527|NCT01673867|80203380|FG000|Treatment|Participant request to discontinue study treatment|7|||
27550528|NCT01673867|80203381|FG001|Treatment|Participant request to discontinue study treatment|17|||
27743035|NCT00258154|80889441|FG001|Overall Study|Adverse Event|0|||
27642063|NCT02590432|80532431|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
27642064|NCT02590432|80532423|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27642065|NCT02590432|80532424|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27642066|NCT02590432|80532425|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27642067|NCT02590432|80532426|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
27642068|NCT02590432|80532427|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
27642069|NCT02590432|80532428|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
27642070|NCT02590432|80532429|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
27642071|NCT02590432|80532430|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
27642072|NCT02590432|80532431|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
27642073|NCT02590432|80532423|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642074|NCT02590432|80532424|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642075|NCT02590432|80532425|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642076|NCT02590432|80532426|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642077|NCT02590432|80532427|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642078|NCT02590432|80532428|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
27642079|NCT02590432|80532429|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642080|NCT02590432|80532430|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642081|NCT02590432|80532431|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
27642082|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642083|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642084|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642085|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642086|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642087|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642088|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
27642089|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
27642090|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
27642091|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642092|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642093|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642094|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642095|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642096|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642097|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642098|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
27642099|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
27642100|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27642101|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27743036|NCT00258154|80889440|FG000|Overall Study|Lost to Follow-up|0|||
27743037|NCT00258154|80889441|FG001|Overall Study|Lost to Follow-up|1|||
27743038|NCT00258154|80889440|FG000|Overall Study|Protocol Violation|2|||
27743039|NCT00258154|80889441|FG001|Overall Study|Protocol Violation|1|||
27932194|NCT00981175|81588949|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
27932195|NCT00981175|81588950|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
27932196|NCT01028053|81588951|FG000|Overall Study|Screen Failure|113|||
27932197|NCT01028053|81588951|FG000|Overall Study|Patient Request|11|||
27932198|NCT01028053|81588951|FG000|Overall Study|Protocol Violation|1|||
27932199|NCT01028053|81588951|FG000|Overall Study|Physician Decision|2|||
27932200|NCT01028053|81588951|FG000|Overall Study|Technical Problem|1|||
27932201|NCT01028053|81588951|FG000|Overall Study|Terminated by Sponsor|1|||
27932202|NCT01028053|81588951|FG000|Overall Study|Various reasons|4|||
27932203|NCT01058005|81588954|FG000|Overall Study|Adverse Event|0|||
27932204|NCT01058005|81588955|FG001|Overall Study|Adverse Event|2|||
27932205|NCT01058005|81588956|FG002|Overall Study|Adverse Event|1|||
27932206|NCT01058005|81588954|FG000|Overall Study|Physician Decision|2|||
27932207|NCT01058005|81588955|FG001|Overall Study|Physician Decision|2|||
27932208|NCT01058005|81588956|FG002|Overall Study|Physician Decision|0|||
27932209|NCT01058005|81588954|FG000|Overall Study|Withdrawal by Subject|4|||
27932210|NCT01058005|81588955|FG001|Overall Study|Withdrawal by Subject|5|||
27743040|NCT00258154|80889440|FG000|Overall Study|Withdrawal by Subject|3|||
27743041|NCT00258154|80889441|FG001|Overall Study|Withdrawal by Subject|4|||
27743042|NCT00258154|80889440|FG000|Overall Study|Patient Moved|3|||
27642102|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27642103|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27743043|NCT00258154|80889441|FG001|Overall Study|Patient Moved|1|||
27743044|NCT05032157|80889442|FG000|Overall Study|Adverse Event|12|||
27932211|NCT01058005|81588956|FG002|Overall Study|Withdrawal by Subject|11|||
27932212|NCT01058005|81588954|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
27932213|NCT01058005|81588955|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
27932214|NCT01058005|81588956|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
27932215|NCT01058005|81588954|FG000|Overall Study|Reason Missing|5|||
27932216|NCT01058005|81588955|FG001|Overall Study|Reason Missing|3|||
27932217|NCT01058005|81588956|FG002|Overall Study|Reason Missing|1|||
27932218|NCT00025233|81588957|FG000|Overall Study|Ineligible: wrong cell type|1|||
27932219|NCT00025233|81588957|FG000|Overall Study|Ineligible: wrong primary|1|||
27932220|NCT00025233|81588957|FG000|Overall Study|Ineligible: improper prior treatment|1|||
27932221|NCT00025233|81588957|FG000|Overall Study|Never treated|1|||
27932222|NCT04964388|81588958|FG000|Overall Study|Lost to Follow-up|3|||
27932223|NCT04964388|81588959|FG001|Overall Study|Lost to Follow-up|2|||
27932224|NCT00290238|81588962|FG000|Overall Study|Study terminated|27|||
27932225|NCT00290238|81588963|FG001|Overall Study|Study terminated|27|||
27932226|NCT00290238|81588962|FG000|Overall Study|Lost to Follow-up|0|||
27932227|NCT00290238|81588963|FG001|Overall Study|Lost to Follow-up|1|||
27932228|NCT00290238|81588962|FG000|Overall Study|Withdrawal by Subject|15|||
27932229|NCT00290238|81588963|FG001|Overall Study|Withdrawal by Subject|13|||
27932230|NCT03422718|81588964|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
27932231|NCT03422718|81588965|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
27932232|NCT03422718|81588966|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
27932233|NCT03422718|81588967|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
27932234|NCT03422718|81588968|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
27932235|NCT03422718|81588969|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
27932236|NCT03422718|81588970|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
27932237|NCT03422718|81588971|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
27932238|NCT03422718|81588964|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
27932239|NCT03422718|81588965|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
27932240|NCT03422718|81588966|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
27932241|NCT03422718|81588967|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
27932242|NCT03422718|81588968|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
27932243|NCT03422718|81588969|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
27932244|NCT03422718|81588970|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
27932245|NCT03422718|81588971|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
27932246|NCT03422718|81588964|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
27932247|NCT03422718|81588965|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
27932248|NCT03422718|81588966|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
27932249|NCT03422718|81588967|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
27932250|NCT03422718|81588968|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
27932251|NCT03422718|81588969|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
27932252|NCT03422718|81588970|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
27932253|NCT03422718|81588971|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
27932254|NCT03422718|81588964|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
27932255|NCT03422718|81588965|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
27932256|NCT03422718|81588966|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
27932257|NCT03422718|81588967|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
27932258|NCT03422718|81588968|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
27932259|NCT03422718|81588969|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
27932260|NCT03422718|81588970|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
27932261|NCT03422718|81588971|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
27932262|NCT03422718|81588964|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
27932263|NCT03422718|81588965|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
27932264|NCT03422718|81588966|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
27932265|NCT03422718|81588967|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
27932266|NCT03422718|81588968|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
27932267|NCT03422718|81588969|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
27932268|NCT03422718|81588970|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
27932269|NCT03422718|81588971|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
27932270|NCT03422718|81588964|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
27932271|NCT03422718|81588965|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
27932272|NCT03422718|81588966|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
27932273|NCT03422718|81588967|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
27932274|NCT03422718|81588968|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
27932275|NCT03422718|81588969|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
27550529|NCT01673867|80203380|FG000|Treatment|Withdrawal by participant|5|||
27932276|NCT03422718|81588970|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
27932277|NCT03422718|81588971|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
27932278|NCT00153920|81588972|FG000|Overall Study|Adverse Event|9|||
27550530|NCT01673867|80203381|FG001|Treatment|Withdrawal by participant|5|||
27932279|NCT00153920|81588972|FG000|Overall Study|Progressive Disease|9|||
27932280|NCT00153920|81588972|FG000|Overall Study|Physician Decision|3|||
27932281|NCT00153920|81588972|FG000|Overall Study|Lack of Response|3|||
27932282|NCT00153920|81588972|FG000|Overall Study|Death|2|||
27932283|NCT00153920|81588972|FG000|Overall Study|Withdrawal by Subject|1|||
27743045|NCT05032157|80889443|FG001|Overall Study|Adverse Event|7|||
27932284|NCT00153920|81588972|FG000|Overall Study|Non-Protocol Therapy|1|||
27932285|NCT00153920|81588972|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
27932286|NCT00153920|81588972|FG000|Overall Study|Progressive Disease before Trt|1|||
27932287|NCT01483651|81588973|FG000|Overall Study|Withdrawal by Subject|0|||
27932288|NCT01483651|81588974|FG001|Overall Study|Withdrawal by Subject|1|||
27932289|NCT01483651|81588975|FG002|Overall Study|Withdrawal by Subject|1|||
27932290|NCT01483651|81588976|FG003|Overall Study|Withdrawal by Subject|0|||
27932291|NCT01483651|81588977|FG004|Overall Study|Withdrawal by Subject|0|||
27932292|NCT01483651|81588978|FG005|Overall Study|Withdrawal by Subject|1|||
27932293|NCT00530075|81588981|FG000|Overall Study|Adverse Event|1|||
27932294|NCT00530075|81588981|FG000|Overall Study|Death|1|||
27932295|NCT00530075|81588981|FG000|Overall Study|Lack of Efficacy|3|||
27743046|NCT05032157|80889442|FG000|Overall Study|Pregnancy|0|||
27743047|NCT05032157|80889443|FG001|Overall Study|Pregnancy|2|||
27743048|NCT05032157|80889442|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27743049|NCT05032157|80889443|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
27743050|NCT05032157|80889442|FG000|Overall Study|Protocol Deviation|8|||
27932296|NCT00530075|81588981|FG000|Overall Study|Protocol Violation|1|||
27932297|NCT00530075|81588981|FG000|Overall Study|Withdrawal by Subject|1|||
27932298|NCT00694122|81588982|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
27932299|NCT00694122|81588983|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
27932300|NCT00694122|81588982|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
27932301|NCT00694122|81588983|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
27932302|NCT00694122|81588982|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
27932303|NCT00694122|81588983|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
27932304|NCT03718000|81588984|FG000|Overall Study|Relocation|2|||
27932305|NCT03718000|81588985|FG001|Overall Study|Relocation|4|||
27743051|NCT05032157|80889443|FG001|Overall Study|Protocol Deviation|4|||
27743052|NCT05032157|80889442|FG000|Overall Study|Lost to Follow-up|1|||
27743053|NCT05032157|80889443|FG001|Overall Study|Lost to Follow-up|3|||
27932306|NCT03718000|81588984|FG000|Overall Study|Pregnancy|0|||
27932307|NCT03718000|81588985|FG001|Overall Study|Pregnancy|1|||
27932308|NCT03607695|81588988|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
27932309|NCT03607695|81588988|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
27932310|NCT00021255|81588989|FG000|Overall Study|Death|1|||
27932311|NCT00021255|81588990|FG001|Overall Study|Death|0|||
27932312|NCT00021255|81588991|FG002|Overall Study|Death|2|||
27932313|NCT00021255|81588989|FG000|Overall Study|Breast cancer relapse|5|||
27932314|NCT00021255|81588990|FG001|Overall Study|Breast cancer relapse|18|||
27932315|NCT00021255|81588991|FG002|Overall Study|Breast cancer relapse|11|||
27932316|NCT00021255|81588989|FG000|Overall Study|Second primary malignancy|0|||
27932317|NCT00021255|81588990|FG001|Overall Study|Second primary malignancy|4|||
27932318|NCT00021255|81588991|FG002|Overall Study|Second primary malignancy|1|||
27932319|NCT00021255|81588989|FG000|Overall Study|Withdrawal by Subject|41|||
27932320|NCT00021255|81588990|FG001|Overall Study|Withdrawal by Subject|64|||
27932321|NCT00021255|81588991|FG002|Overall Study|Withdrawal by Subject|26|||
27932322|NCT00021255|81588989|FG000|Overall Study|Lost to Follow-up|0|||
27932323|NCT00021255|81588990|FG001|Overall Study|Lost to Follow-up|2|||
27932324|NCT00021255|81588991|FG002|Overall Study|Lost to Follow-up|3|||
27932325|NCT00021255|81588989|FG000|Overall Study|Cardiac toxicity|0|||
27932326|NCT00021255|81588990|FG001|Overall Study|Cardiac toxicity|61|||
27932327|NCT00021255|81588991|FG002|Overall Study|Cardiac toxicity|32|||
27932328|NCT00021255|81588989|FG000|Overall Study|Herceptin toxicity|0|||
27932329|NCT00021255|81588990|FG001|Overall Study|Herceptin toxicity|22|||
27932330|NCT00021255|81588991|FG002|Overall Study|Herceptin toxicity|6|||
27932331|NCT00021255|81588989|FG000|Overall Study|Adverse Event|46|||
27932332|NCT00021255|81588990|FG001|Overall Study|Adverse Event|30|||
27932333|NCT00021255|81588991|FG002|Overall Study|Adverse Event|18|||
27642104|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27743054|NCT05032157|80889442|FG000|Overall Study|Physician Decision|7|||
27743055|NCT05032157|80889443|FG001|Overall Study|Physician Decision|2|||
27743056|NCT05032157|80889442|FG000|Overall Study|Patient Decision|38|||
27932334|NCT00021255|81588989|FG000|Overall Study|Protocol Violation|0|||
27932335|NCT00021255|81588990|FG001|Overall Study|Protocol Violation|2|||
27932336|NCT00021255|81588991|FG002|Overall Study|Protocol Violation|0|||
27932337|NCT00021255|81588989|FG000|Overall Study|Other than specified above|0|||
27932338|NCT00021255|81588990|FG001|Overall Study|Other than specified above|38|||
27932339|NCT00021255|81588991|FG002|Overall Study|Other than specified above|19|||
27743057|NCT05032157|80889443|FG001|Overall Study|Patient Decision|19|||
27932340|NCT00021255|81588989|FG000|Overall Study|Missing|0|||
27932341|NCT00021255|81588990|FG001|Overall Study|Missing|27|||
27642105|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27642106|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
27642107|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
27743058|NCT01056523|80889444|FG000|Overall Study|Death|1|||
27743059|NCT01056523|80889445|FG001|Overall Study|Death|0|||
27743060|NCT01056523|80889446|FG002|Overall Study|Death|2|||
27743061|NCT01056523|80889447|FG003|Overall Study|Death|3|||
27743062|NCT01056523|80889448|FG004|Overall Study|Death|0|||
27932342|NCT00021255|81588991|FG002|Overall Study|Missing|13|||
27932343|NCT00021255|81588989|FG000|Overall Study|Randomized but not treated|28|||
27932344|NCT00021255|81588990|FG001|Overall Study|Randomized but not treated|2|||
27932345|NCT00021255|81588991|FG002|Overall Study|Randomized but not treated|18|||
27932346|NCT00875667|81588992|FG000|Overall Study|Adverse Event|29|||
27932347|NCT00875667|81588993|FG001|Overall Study|Adverse Event|10|||
27932348|NCT00875667|81588992|FG000|Overall Study|Withdrawal by Subject|17|||
27932349|NCT00875667|81588993|FG001|Overall Study|Withdrawal by Subject|5|||
27932350|NCT00875667|81588992|FG000|Overall Study|Death|7|||
27932351|NCT00875667|81588993|FG001|Overall Study|Death|2|||
27642108|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
27932352|NCT00875667|81588992|FG000|Overall Study|Protocol Violation|2|||
27932353|NCT00875667|81588993|FG001|Overall Study|Protocol Violation|0|||
27932354|NCT00875667|81588992|FG000|Overall Study|Disease Progression|100|||
27932355|NCT00875667|81588993|FG001|Overall Study|Disease Progression|49|||
27932356|NCT00875667|81588992|FG000|Overall Study|Miscellaneous|12|||
27932357|NCT00875667|81588993|FG001|Overall Study|Miscellaneous|6|||
27932358|NCT00875667|81588992|FG000|Overall Study|Randomized but no Study Drug Given|3|||
27932359|NCT00875667|81588993|FG001|Overall Study|Randomized but no Study Drug Given|1|||
27932360|NCT03679884|81588998|FG000|Overall Study|Other|12|||
27932361|NCT03679884|81588999|FG001|Overall Study|Other|12|||
27932362|NCT03679884|81589000|FG002|Overall Study|Other|12|||
27932363|NCT03679884|81589001|FG003|Overall Study|Other|7|||
27932364|NCT03679884|81589002|FG004|Overall Study|Other|8|||
27932365|NCT03679884|81588998|FG000|Overall Study|Lack of Efficacy|15|||
27932366|NCT03679884|81588999|FG001|Overall Study|Lack of Efficacy|29|||
27932367|NCT03679884|81589000|FG002|Overall Study|Lack of Efficacy|13|||
27932368|NCT03679884|81589001|FG003|Overall Study|Lack of Efficacy|29|||
27932369|NCT03679884|81589002|FG004|Overall Study|Lack of Efficacy|10|||
27932370|NCT03679884|81588998|FG000|Overall Study|Death|1|||
27932371|NCT03679884|81588999|FG001|Overall Study|Death|0|||
27932372|NCT03679884|81589000|FG002|Overall Study|Death|0|||
27932373|NCT03679884|81589001|FG003|Overall Study|Death|0|||
27932374|NCT03679884|81589002|FG004|Overall Study|Death|0|||
27932375|NCT03679884|81588998|FG000|Overall Study|Adverse Event|2|||
27932376|NCT03679884|81588999|FG001|Overall Study|Adverse Event|10|||
27932377|NCT03679884|81589000|FG002|Overall Study|Adverse Event|9|||
27932378|NCT03679884|81589001|FG003|Overall Study|Adverse Event|6|||
27642109|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27550531|NCT01673867|80203380|FG000|Treatment|Maximum clinical benefit|1|||
27550532|NCT01673867|80203381|FG001|Treatment|Maximum clinical benefit|10|||
27550533|NCT01673867|80203380|FG000|Treatment|Participant no longer meets study criteria|2|||
27642110|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642111|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642112|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642113|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642114|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642115|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642116|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
27642117|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
27642118|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642119|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27743063|NCT01056523|80889449|FG005|Overall Study|Death|0|||
27743064|NCT01056523|80889450|FG006|Overall Study|Death|1|||
27743065|NCT00425438|80889452|FG000|Overall Study|Termination by Sponsor|25|||
27550534|NCT01673867|80203381|FG001|Treatment|Participant no longer meets study criteria|0|||
27550535|NCT01673867|80203380|FG000|Treatment|Administrative reason by sponsor|3|||
27550536|NCT01673867|80203381|FG001|Treatment|Administrative reason by sponsor|0|||
27932379|NCT03679884|81589002|FG004|Overall Study|Adverse Event|6|||
27932380|NCT03679884|81588998|FG000|Overall Study|Withdrawal by Subject|12|||
27932381|NCT03679884|81588999|FG001|Overall Study|Withdrawal by Subject|23|||
27932382|NCT03679884|81589000|FG002|Overall Study|Withdrawal by Subject|8|||
27932383|NCT03679884|81589001|FG003|Overall Study|Withdrawal by Subject|8|||
27932384|NCT03679884|81589002|FG004|Overall Study|Withdrawal by Subject|9|||
27932385|NCT03679884|81588998|FG000|Overall Study|Lost to Follow-up|1|||
27932386|NCT03679884|81588999|FG001|Overall Study|Lost to Follow-up|4|||
27932387|NCT03679884|81589000|FG002|Overall Study|Lost to Follow-up|2|||
27932388|NCT03679884|81589001|FG003|Overall Study|Lost to Follow-up|0|||
27642120|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642121|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642122|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642123|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642124|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642125|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
27642126|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
27642127|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642128|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642129|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642130|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642131|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642132|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27743066|NCT00425438|80889453|FG001|Overall Study|Termination by Sponsor|27|||
27743067|NCT04322682|80889454|FG000|Overall Study|Withdrawal by Subject|33|||
27932389|NCT03679884|81589002|FG004|Overall Study|Lost to Follow-up|3|||
27932390|NCT03033901|81589003|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
27932391|NCT03033901|81589003|FG000|Overall Study|Refused PSG|23|||
27932392|NCT03033901|81589003|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
27932393|NCT03033901|81589003|FG000|Overall Study|Missing Oximetry Data|3|||
27932394|NCT00250718|81589008|FG000|Overall Study|Death|1|||
27932395|NCT00250718|81589008|FG000|Overall Study|Adverse Event|1|||
27932396|NCT00250718|81589008|FG000|Overall Study|Withdrawal by Subject|1|||
27550537|NCT01673867|80203380|FG000|Treatment|Other reason|11|||
27550538|NCT01673867|80203381|FG001|Treatment|Other reason|2|||
27642133|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642134|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
27642135|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
27642136|NCT02590432|80532423|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642137|NCT02590432|80532424|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642138|NCT02590432|80532425|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642139|NCT02590432|80532426|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642140|NCT02590432|80532427|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642141|NCT02590432|80532428|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642142|NCT02590432|80532429|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642143|NCT02590432|80532430|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
27642144|NCT02590432|80532431|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
27642145|NCT00112359|80532434|FG000|Overall Study|Unrelated adverse event|16|||
27642146|NCT00112359|80532435|FG001|Overall Study|Unrelated adverse event|8|||
27642147|NCT00112359|80532434|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
27642148|NCT00112359|80532435|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
27642149|NCT00112359|80532434|FG000|Overall Study|Related adverse event|5|||
27642150|NCT00112359|80532435|FG001|Overall Study|Related adverse event|3|||
27642151|NCT00112359|80532434|FG000|Overall Study|Lost to Follow-up|0|||
27642152|NCT00112359|80532435|FG001|Overall Study|Lost to Follow-up|1|||
27743068|NCT04322682|80889455|FG001|Overall Study|Withdrawal by Subject|47|||
27550539|NCT02323113|80203390|FG000|Overall Study|Adverse Event|3|||
27932397|NCT00504309|81589009|FG000|Overall Study|Death|0|||
27932398|NCT00504309|81589010|FG001|Overall Study|Death|0|||
27932399|NCT00504309|81589011|FG002|Overall Study|Death|0|||
27932400|NCT00504309|81589012|FG003|Overall Study|Death|0|||
27550540|NCT02323113|80203391|FG001|Overall Study|Adverse Event|3|||
27550541|NCT02323113|80203392|FG002|Overall Study|Adverse Event|2|||
27550542|NCT02323113|80203393|FG003|Overall Study|Adverse Event|5|||
27550543|NCT02323113|80203394|FG004|Overall Study|Adverse Event|8|||
27550544|NCT02323113|80203395|FG005|Overall Study|Adverse Event|3|||
27550545|NCT02323113|80203396|FG006|Overall Study|Adverse Event|6|||
27550546|NCT02323113|80203397|FG007|Overall Study|Adverse Event|0|||
27550547|NCT02323113|80203390|FG000|Overall Study|Progressive Disease|0|||
27550548|NCT02323113|80203391|FG001|Overall Study|Progressive Disease|1|||
27550549|NCT02323113|80203392|FG002|Overall Study|Progressive Disease|1|||
27550550|NCT02323113|80203393|FG003|Overall Study|Progressive Disease|0|||
27550551|NCT02323113|80203394|FG004|Overall Study|Progressive Disease|0|||
27550552|NCT02323113|80203395|FG005|Overall Study|Progressive Disease|3|||
27550553|NCT02323113|80203396|FG006|Overall Study|Progressive Disease|0|||
27550554|NCT02323113|80203397|FG007|Overall Study|Progressive Disease|0|||
27550555|NCT02323113|80203390|FG000|Overall Study|Symptomatic Deterioration|0|||
27550556|NCT02323113|80203391|FG001|Overall Study|Symptomatic Deterioration|0|||
27550557|NCT02323113|80203392|FG002|Overall Study|Symptomatic Deterioration|1|||
27550558|NCT02323113|80203393|FG003|Overall Study|Symptomatic Deterioration|0|||
27932401|NCT00504309|81589013|FG004|Overall Study|Death|1|||
27932402|NCT00504309|81589014|FG005|Overall Study|Death|0|||
27932403|NCT00504309|81589009|FG000|Overall Study|Withdrawal by Subject|0|||
27932404|NCT00504309|81589010|FG001|Overall Study|Withdrawal by Subject|0|||
27932405|NCT00504309|81589011|FG002|Overall Study|Withdrawal by Subject|1|||
27932406|NCT00504309|81589012|FG003|Overall Study|Withdrawal by Subject|0|||
27932407|NCT00504309|81589013|FG004|Overall Study|Withdrawal by Subject|0|||
27932408|NCT00504309|81589014|FG005|Overall Study|Withdrawal by Subject|0|||
27932409|NCT03501277|81589015|FG000|Intervention Period 1 (4 Days)|Other|0|||
27932410|NCT03501277|81589016|FG001|Intervention Period 1 (4 Days)|Other|0|||
27932411|NCT03501277|81589017|FG002|Intervention Period 1 (4 Days)|Other|1|||
27932412|NCT03501277|81589018|FG003|Intervention Period 1 (4 Days)|Other|0|||
27932413|NCT03501277|81589015|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
27932414|NCT03501277|81589016|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
27932415|NCT03501277|81589017|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
27932416|NCT03501277|81589018|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
27932417|NCT03501277|81589015|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
27932418|NCT03501277|81589016|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
27932419|NCT03501277|81589017|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
27932420|NCT03501277|81589018|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
27932421|NCT03501277|81589015|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
27932422|NCT03501277|81589016|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
27932423|NCT03501277|81589017|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
27932424|NCT03501277|81589018|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
27932425|NCT00724503|81589019|FG000|Overall Study|Lost to Follow-up|4|||
27932426|NCT00724503|81589020|FG001|Overall Study|Lost to Follow-up|8|||
27932427|NCT00724503|81589019|FG000|Overall Study|Withdrawal by Subject|11|||
27932428|NCT00724503|81589020|FG001|Overall Study|Withdrawal by Subject|23|||
27932429|NCT00724503|81589019|FG000|Overall Study|Death|190|||
27932430|NCT00724503|81589020|FG001|Overall Study|Death|182|||
27932431|NCT00724503|81589019|FG000|Overall Study|Adverse Event|1|||
27932432|NCT00724503|81589020|FG001|Overall Study|Adverse Event|0|||
27932433|NCT00724503|81589019|FG000|Overall Study|Not otherwise specified|4|||
27932434|NCT00724503|81589020|FG001|Overall Study|Not otherwise specified|7|||
27932435|NCT02827708|81589021|FG000|Overall Study|Lost to Follow-up|3|||
27932436|NCT02827708|81589022|FG001|Overall Study|Lost to Follow-up|1|||
27932437|NCT02827708|81589021|FG000|Overall Study|Withdrawal by Subject|1|||
27932438|NCT02827708|81589022|FG001|Overall Study|Withdrawal by Subject|2|||
27932439|NCT02827708|81589021|FG000|Overall Study|Death|1|||
27932440|NCT02827708|81589022|FG001|Overall Study|Death|2|||
27932441|NCT03600428|81589025|FG000|Overall Study|Not eligible|0|||
27932442|NCT03600428|81589026|FG001|Overall Study|Not eligible|1|||
27932443|NCT03600428|81589025|FG000|Overall Study|Lost to Follow-up|5|||
27932444|NCT03600428|81589026|FG001|Overall Study|Lost to Follow-up|4|||
27932445|NCT01699685|81589029|FG000|Period 1|Adverse Event|1|||
27932446|NCT01699685|81589030|FG001|Period 1|Adverse Event|1|||
27932447|NCT01699685|81589029|FG000|Period 1|Medical or ethical, noncompliance|2|||
27932448|NCT01699685|81589030|FG001|Period 1|Medical or ethical, noncompliance|0|||
27932449|NCT01699685|81589029|FG000|Period 1|Other|0|||
27932450|NCT01699685|81589030|FG001|Period 1|Other|1|||
27932451|NCT01699685|81589029|FG000|Period 1|Patient request|0|||
27932452|NCT01699685|81589030|FG001|Period 1|Patient request|1|||
27932453|NCT01699685|81589029|FG000|Period 2|Lost to Follow-up|1|||
27550559|NCT02323113|80203394|FG004|Overall Study|Symptomatic Deterioration|1|||
27550560|NCT02323113|80203395|FG005|Overall Study|Symptomatic Deterioration|0|||
27550561|NCT02323113|80203396|FG006|Overall Study|Symptomatic Deterioration|0|||
27550562|NCT02323113|80203397|FG007|Overall Study|Symptomatic Deterioration|0|||
27550563|NCT02323113|80203390|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
27550564|NCT02323113|80203391|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
27932454|NCT01699685|81589030|FG001|Period 2|Lost to Follow-up|0|||
27932455|NCT01127061|81589031|FG000|Overall Study|Lost to Follow-up|7|||
27932456|NCT01127061|81589032|FG001|Overall Study|Lost to Follow-up|10|||
27932457|NCT01127061|81589031|FG000|Overall Study|Physician Decision|3|||
27932458|NCT01127061|81589032|FG001|Overall Study|Physician Decision|3|||
27932459|NCT01138046|81589047|FG000|Overall Study|Withdrawal due to death|6|||
27932460|NCT01814332|81589048|FG000|Overall Study|Adverse Event|8|||
27932461|NCT01814332|81589049|FG001|Overall Study|Adverse Event|3|||
27932462|NCT01814332|81589048|FG000|Overall Study|Withdrawal by Subject|3|||
27932463|NCT01814332|81589049|FG001|Overall Study|Withdrawal by Subject|8|||
27932464|NCT01814332|81589048|FG000|Overall Study|Protocol Violation|0|||
27932465|NCT01814332|81589049|FG001|Overall Study|Protocol Violation|4|||
27932466|NCT01814332|81589048|FG000|Overall Study|Lost to Follow-up|5|||
27932467|NCT01814332|81589049|FG001|Overall Study|Lost to Follow-up|1|||
27932468|NCT02547987|81589050|FG000|Overall Study|Withdrawal by Subject|1|||
27932469|NCT02547987|81589050|FG000|Overall Study|Adverse Event|2|||
27932470|NCT00266812|81589051|FG000|Overall Study|Disease Progression|9|||
27932471|NCT00266812|81589052|FG001|Overall Study|Disease Progression|3|||
27932472|NCT00266812|81589051|FG000|Overall Study|Death|5|||
27642153|NCT00112359|80532434|FG000|Overall Study|Personal/administrative|1|||
27642154|NCT00112359|80532435|FG001|Overall Study|Personal/administrative|1|||
27642155|NCT00112359|80532434|FG000|Overall Study|Other|3|||
27642156|NCT00112359|80532435|FG001|Overall Study|Other|0|||
27642157|NCT02962284|80532443|FG000|Overall Study|Death|2|||
27642158|NCT02962284|80532444|FG001|Overall Study|Death|0|||
27642159|NCT02962284|80532443|FG000|Overall Study|Progressive disease|2|||
27642160|NCT02962284|80532444|FG001|Overall Study|Progressive disease|3|||
27642161|NCT02962284|80532443|FG000|Overall Study|Withdrawal by Subject|1|||
27642162|NCT02962284|80532444|FG001|Overall Study|Withdrawal by Subject|0|||
27642163|NCT02652442|80532447|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
27642164|NCT00818246|80532448|FG000|Overall Study|Impossible to match pictures|5|||
27642165|NCT03333109|80532453|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
27642166|NCT03333109|80532454|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
27642167|NCT03333109|80532455|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
27642168|NCT03333109|80532453|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27642169|NCT03333109|80532454|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
27642170|NCT03333109|80532455|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
27642171|NCT03333109|80532453|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
27642172|NCT03333109|80532454|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
27642173|NCT03333109|80532455|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
27642174|NCT03333109|80532453|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
27642175|NCT03333109|80532454|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
27642176|NCT03333109|80532455|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
27642177|NCT03333109|80532453|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
27642178|NCT03333109|80532454|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
27642179|NCT03333109|80532455|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
27642180|NCT03333109|80532453|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
27642181|NCT03333109|80532454|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
27642182|NCT03333109|80532455|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
27642183|NCT03333109|80532453|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
27932473|NCT00266812|81589052|FG001|Overall Study|Death|4|||
27932474|NCT00266812|81589051|FG000|Overall Study|Adverse Event|3|||
27932475|NCT00266812|81589052|FG001|Overall Study|Adverse Event|1|||
27932476|NCT00266812|81589051|FG000|Overall Study|Protocol Violation|0|||
27932477|NCT00266812|81589052|FG001|Overall Study|Protocol Violation|1|||
27932478|NCT00266812|81589051|FG000|Overall Study|Withdrawal by Subject|0|||
27932479|NCT00266812|81589052|FG001|Overall Study|Withdrawal by Subject|2|||
27932480|NCT00266812|81589051|FG000|Overall Study|Discontinued before starting study drug|4|||
27932481|NCT00266812|81589052|FG001|Overall Study|Discontinued before starting study drug|0|||
27550565|NCT02323113|80203392|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
27550566|NCT02323113|80203393|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
27550567|NCT02323113|80203394|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
27550568|NCT02323113|80203395|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
27550569|NCT02323113|80203396|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
27550570|NCT02323113|80203397|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
27550571|NCT02323113|80203390|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550572|NCT02323113|80203391|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
27550573|NCT02323113|80203392|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550574|NCT02323113|80203393|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550575|NCT02323113|80203394|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550576|NCT02323113|80203395|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550577|NCT02323113|80203396|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550578|NCT02323113|80203397|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
27550579|NCT01985867|80203398|FG000|Overall Study|Lost to Follow-up|3|||
27642184|NCT03333109|80532454|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
27550580|NCT01985867|80203399|FG001|Overall Study|Lost to Follow-up|4|||
27550581|NCT01985867|80203398|FG000|Overall Study|Adverse Event|3|||
27550582|NCT01985867|80203399|FG001|Overall Study|Adverse Event|2|||
27550583|NCT01985867|80203398|FG000|Overall Study|Lack of Efficacy|1|||
27642185|NCT03333109|80532455|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
27550584|NCT01985867|80203399|FG001|Overall Study|Lack of Efficacy|0|||
27550585|NCT04605484|80203400|FG000|Overall Study|Lost to Follow-up|0|||
27932482|NCT00855582|81589053|FG000|Overall Study|Adverse Event|2|||
27932483|NCT00855582|81589054|FG001|Overall Study|Adverse Event|6|||
27932484|NCT00855582|81589055|FG002|Overall Study|Adverse Event|3|||
27642186|NCT03333109|80532453|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
27642187|NCT03333109|80532454|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
27550586|NCT04605484|80203401|FG001|Overall Study|Lost to Follow-up|1|||
27550587|NCT04605484|80203402|FG002|Overall Study|Lost to Follow-up|1|||
27550588|NCT04605484|80203400|FG000|Overall Study|Other|0|||
27550589|NCT04605484|80203401|FG001|Overall Study|Other|1|||
27550590|NCT04605484|80203402|FG002|Overall Study|Other|0|||
27550591|NCT00211809|80203407|FG000|Overall Study|Lack of Efficacy|1|||
27642188|NCT03333109|80532455|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
27642189|NCT01211184|80532456|FG000|Overall Study|Withdrawal by Subject|0|||
27932485|NCT00855582|81589053|FG000|Overall Study|Death|1|||
27932486|NCT00855582|81589054|FG001|Overall Study|Death|0|||
27932487|NCT00855582|81589055|FG002|Overall Study|Death|0|||
27932488|NCT00855582|81589053|FG000|Overall Study|Lack of Efficacy|1|||
27642190|NCT01211184|80532457|FG001|Overall Study|Withdrawal by Subject|2|||
27932489|NCT00855582|81589054|FG001|Overall Study|Lack of Efficacy|3|||
27932490|NCT00855582|81589055|FG002|Overall Study|Lack of Efficacy|8|||
27932491|NCT00855582|81589053|FG000|Overall Study|Lost to Follow-up|1|||
27932492|NCT00855582|81589054|FG001|Overall Study|Lost to Follow-up|3|||
27932493|NCT00855582|81589055|FG002|Overall Study|Lost to Follow-up|1|||
27550592|NCT00211809|80203407|FG000|Overall Study|Lost to Follow-up|2|||
27550593|NCT00211809|80203407|FG000|Overall Study|Pregnancy|1|||
27550594|NCT00211809|80203407|FG000|Overall Study|side effects|2|||
27550595|NCT01414855|80203408|FG000|Overall Study|Death|17|||
27550596|NCT01414855|80203408|FG000|Overall Study|Lost to Follow-up|5|||
27550597|NCT01414855|80203408|FG000|Overall Study|Withdrawal by Subject|7|||
27550598|NCT00187486|80203411|FG000|Overall Study|Protocol Violation|1|||
27550599|NCT01025752|80203412|FG000|Overall Study|Lost to Follow-up|7|||
27550600|NCT01025752|80203413|FG001|Overall Study|Lost to Follow-up|10|||
27550601|NCT01025752|80203412|FG000|Overall Study|Physician Decision|1|||
27550602|NCT01025752|80203413|FG001|Overall Study|Physician Decision|3|||
27550603|NCT01191801|80203414|FG000|Overall Study|Death|36|||
27550604|NCT01191801|80203415|FG001|Overall Study|Death|12|||
27550605|NCT01191801|80203414|FG000|Overall Study|Lack of Efficacy|176|||
27550606|NCT01191801|80203415|FG001|Overall Study|Lack of Efficacy|258|||
27550607|NCT01191801|80203414|FG000|Overall Study|Adverse Event|9|||
27550608|NCT01191801|80203415|FG001|Overall Study|Adverse Event|8|||
27550609|NCT01191801|80203414|FG000|Overall Study|Protocol Violation|2|||
27550610|NCT01191801|80203415|FG001|Overall Study|Protocol Violation|4|||
27550611|NCT01191801|80203414|FG000|Overall Study|Physician Decision|47|||
27550612|NCT01191801|80203415|FG001|Overall Study|Physician Decision|24|||
27550613|NCT01191801|80203414|FG000|Overall Study|Withdrawal by Subject|1|||
27550614|NCT01191801|80203415|FG001|Overall Study|Withdrawal by Subject|4|||
27550615|NCT01191801|80203414|FG000|Overall Study|Not Provided|45|||
27550616|NCT01191801|80203415|FG001|Overall Study|Not Provided|27|||
27550617|NCT03667924|80203419|FG000|Baseline Completed|Lost to Follow-up|0|||
27550618|NCT03667924|80203420|FG001|Baseline Completed|Lost to Follow-up|2|||
27642191|NCT01211184|80532458|FG002|Overall Study|Withdrawal by Subject|1|||
27642192|NCT00918203|80532459|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
27642193|NCT00918203|80532460|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
27642194|NCT00918203|80532461|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
27642195|NCT00918203|80532459|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
27642196|NCT00918203|80532460|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
27642197|NCT00918203|80532461|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
27642198|NCT00918203|80532459|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
27642199|NCT00918203|80532460|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
27642200|NCT00918203|80532461|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
27642201|NCT00918203|80532459|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
27642202|NCT00918203|80532460|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
27642203|NCT00918203|80532461|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
27642204|NCT02740231|80532462|FG000|Overall Study|Withdrawal by Subject|1|||
27642205|NCT02740231|80532463|FG001|Overall Study|Withdrawal by Subject|1|||
27642206|NCT02740231|80532464|FG002|Overall Study|Withdrawal by Subject|1|||
27642207|NCT02740231|80532465|FG003|Overall Study|Withdrawal by Subject|0|||
27642208|NCT02740231|80532462|FG000|Overall Study|Lack of Efficacy|0|||
27642209|NCT02740231|80532463|FG001|Overall Study|Lack of Efficacy|1|||
27642210|NCT02740231|80532464|FG002|Overall Study|Lack of Efficacy|0|||
27550619|NCT03667924|80203421|FG002|Baseline Completed|Lost to Follow-up|0|||
27550620|NCT03667924|80203419|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
27550621|NCT03667924|80203420|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
27642211|NCT02740231|80532465|FG003|Overall Study|Lack of Efficacy|4|||
27642212|NCT02740231|80532462|FG000|Overall Study|Lost to Follow-up|1|||
27932494|NCT00855582|81589053|FG000|Overall Study|Physician Decision|0|||
27932495|NCT00855582|81589054|FG001|Overall Study|Physician Decision|0|||
27550622|NCT03667924|80203421|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
27550623|NCT03667924|80203419|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
27550624|NCT03667924|80203420|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
27932496|NCT00855582|81589055|FG002|Overall Study|Physician Decision|1|||
27932497|NCT00855582|81589053|FG000|Overall Study|Protocol Violation|6|||
27932498|NCT00855582|81589054|FG001|Overall Study|Protocol Violation|2|||
27932499|NCT00855582|81589055|FG002|Overall Study|Protocol Violation|6|||
27932500|NCT00855582|81589053|FG000|Overall Study|Entry Criteria Not Met|8|||
27932501|NCT00855582|81589054|FG001|Overall Study|Entry Criteria Not Met|6|||
27932502|NCT00855582|81589055|FG002|Overall Study|Entry Criteria Not Met|3|||
27932503|NCT00855582|81589053|FG000|Overall Study|Withdrawal by Subject|7|||
27932504|NCT00855582|81589054|FG001|Overall Study|Withdrawal by Subject|4|||
27932505|NCT00855582|81589055|FG002|Overall Study|Withdrawal by Subject|8|||
27932506|NCT02314247|81589056|FG000|Overall Study|Adverse Event|2|||
27932507|NCT02314247|81589057|FG001|Overall Study|Adverse Event|1|||
27932508|NCT02314247|81589058|FG002|Overall Study|Adverse Event|0|||
27932509|NCT02314247|81589056|FG000|Overall Study|Withdrawal by Subject|1|||
27932510|NCT02314247|81589057|FG001|Overall Study|Withdrawal by Subject|3|||
27932511|NCT02314247|81589058|FG002|Overall Study|Withdrawal by Subject|1|||
27932512|NCT02314247|81589056|FG000|Overall Study|Progression of Disease|6|||
27932513|NCT02314247|81589057|FG001|Overall Study|Progression of Disease|2|||
27932514|NCT02314247|81589058|FG002|Overall Study|Progression of Disease|0|||
27932515|NCT01198548|81589059|FG000|Overall Study|Disease Progression|9|||
27932516|NCT01198548|81589059|FG000|Overall Study|Administrative Decision|1|||
27932517|NCT00308685|81589060|FG000|Overall Study|Lost to Follow-up|1|||
27932518|NCT00308685|81589061|FG001|Overall Study|Lost to Follow-up|0|||
27932519|NCT00308685|81589060|FG000|Overall Study|Need to administer prohibited medication|1|||
27932520|NCT00308685|81589061|FG001|Overall Study|Need to administer prohibited medication|2|||
27932521|NCT00308685|81589060|FG000|Overall Study|Other than specified|1|||
27932522|NCT00308685|81589061|FG001|Overall Study|Other than specified|3|||
27932523|NCT00726557|81589062|FG000|Overall Study|Screening failure|4|||
27932524|NCT00726557|81589062|FG000|Overall Study|No end of treatment documentation|37|||
27932525|NCT00726557|81589062|FG000|Overall Study|No follow-up documentation available|55|||
27932526|NCT00726557|81589062|FG000|Overall Study|Treatment less than 3 months|17|||
27932527|NCT00726557|81589062|FG000|Overall Study|Inclusion criteria not met|15|||
27932528|NCT00549328|81589063|FG000|Overall Study|Adverse Event|2|||
27932529|NCT00549328|81589063|FG000|Overall Study|Disease Progression|10|||
27932530|NCT00549328|81589063|FG000|Overall Study|Death|1|||
27932531|NCT00549328|81589063|FG000|Overall Study|Use of Prohibited Medication|1|||
27932532|NCT01716156|81589064|FG000|Overall Study|Protocol Violation|1|||
27932533|NCT01716156|81589065|FG001|Overall Study|Protocol Violation|0|||
27932534|NCT01716156|81589066|FG002|Overall Study|Protocol Violation|0|||
27932535|NCT01716156|81589064|FG000|Overall Study|Withdrawal by Subject|0|||
27932536|NCT01716156|81589065|FG001|Overall Study|Withdrawal by Subject|1|||
27932537|NCT01716156|81589066|FG002|Overall Study|Withdrawal by Subject|2|||
27932538|NCT01716156|81589064|FG000|Overall Study|Lost to Follow-up|1|||
27932539|NCT01716156|81589065|FG001|Overall Study|Lost to Follow-up|0|||
27932540|NCT01716156|81589066|FG002|Overall Study|Lost to Follow-up|0|||
27932541|NCT00541775|81589067|FG000|Overall Study|Adverse Event|3|||
27932542|NCT00541775|81589068|FG001|Overall Study|Adverse Event|2|||
27932543|NCT00541775|81589069|FG002|Overall Study|Adverse Event|1|||
27932544|NCT00541775|81589067|FG000|Overall Study|Lack of Efficacy|0|||
27932545|NCT00541775|81589068|FG001|Overall Study|Lack of Efficacy|0|||
27932546|NCT00541775|81589069|FG002|Overall Study|Lack of Efficacy|3|||
27932547|NCT00541775|81589067|FG000|Overall Study|Lost to Follow-up|0|||
27932548|NCT00541775|81589068|FG001|Overall Study|Lost to Follow-up|0|||
27932549|NCT00541775|81589069|FG002|Overall Study|Lost to Follow-up|2|||
27642213|NCT02740231|80532463|FG001|Overall Study|Lost to Follow-up|3|||
27642214|NCT02740231|80532464|FG002|Overall Study|Lost to Follow-up|0|||
27932550|NCT00541775|81589067|FG000|Overall Study|Protocol Violation|1|||
27932551|NCT00541775|81589068|FG001|Overall Study|Protocol Violation|0|||
27932552|NCT00541775|81589069|FG002|Overall Study|Protocol Violation|0|||
27932553|NCT00541775|81589067|FG000|Overall Study|Withdrawal by Subject and Other|5|||
27932554|NCT00541775|81589068|FG001|Overall Study|Withdrawal by Subject and Other|0|||
27932555|NCT00541775|81589069|FG002|Overall Study|Withdrawal by Subject and Other|2|||
27642215|NCT02740231|80532465|FG003|Overall Study|Lost to Follow-up|3|||
27932556|NCT00514917|81589070|FG000|Overall Study|Death|4|||
27932557|NCT00514917|81589071|FG001|Overall Study|Death|10|||
27932558|NCT00514917|81589070|FG000|Overall Study|Protocol Violation|1|||
27932559|NCT00514917|81589071|FG001|Overall Study|Protocol Violation|0|||
27932560|NCT00514917|81589070|FG000|Overall Study|Lost to Follow-up|4|||
27642216|NCT02740231|80532462|FG000|Overall Study|Adverse Event|0|||
27932561|NCT00514917|81589071|FG001|Overall Study|Lost to Follow-up|3|||
27932562|NCT00514917|81589070|FG000|Overall Study|Withdrawal by Subject|18|||
27932563|NCT00514917|81589071|FG001|Overall Study|Withdrawal by Subject|16|||
27932564|NCT00514917|81589070|FG000|Overall Study|Discontinued due to study closure|88|||
27932565|NCT00514917|81589071|FG001|Overall Study|Discontinued due to study closure|81|||
27932566|NCT00514917|81589070|FG000|Overall Study|Undefined|11|||
27932567|NCT00514917|81589071|FG001|Overall Study|Undefined|5|||
27932568|NCT01185366|81589072|FG000|First Line Therapy|Insurance Coverage Denied|1|||
27642217|NCT02740231|80532463|FG001|Overall Study|Adverse Event|1|||
27932569|NCT01185366|81589073|FG001|First Line Therapy|Insurance Coverage Denied|1|||
27932570|NCT01185366|81589072|FG000|First Line Therapy|Withdrawal by Subject|1|||
27932571|NCT01185366|81589073|FG001|First Line Therapy|Withdrawal by Subject|0|||
27932572|NCT01185366|81589072|FG000|First Line Therapy|Lack of Metastatic Site|1|||
27932573|NCT01185366|81589073|FG001|First Line Therapy|Lack of Metastatic Site|0|||
27932574|NCT01185366|81589072|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
27932575|NCT01185366|81589073|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
27932576|NCT01185366|81589072|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
27932577|NCT01185366|81589073|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
27932578|NCT01185366|81589072|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
27932579|NCT01185366|81589073|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
27932580|NCT01185366|81589072|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
27932581|NCT01185366|81589073|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
27932582|NCT01362270|81589077|FG000|Overall Study|Withdrawal by Subject|1|||
27932583|NCT01362270|81589078|FG001|Overall Study|Withdrawal by Subject|0|||
27932584|NCT01362270|81589077|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
27932585|NCT01362270|81589078|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
27932586|NCT01362270|81589077|FG000|Overall Study|Met excl. criteria before 1st session|1|||
27932587|NCT01362270|81589078|FG001|Overall Study|Met excl. criteria before 1st session|1|||
27932588|NCT01214720|81589081|FG000|Overall Study|Alive and still on treatment|34|||
27932589|NCT01214720|81589082|FG001|Overall Study|Alive and still on treatment|18|||
27932590|NCT01214720|81589081|FG000|Overall Study|Alive and in follow-up|45|||
27932591|NCT01214720|81589082|FG001|Overall Study|Alive and in follow-up|48|||
27932592|NCT01214720|81589081|FG000|Overall Study|Lost to Follow-up|6|||
27932593|NCT01214720|81589082|FG001|Overall Study|Lost to Follow-up|2|||
27932594|NCT02097277|81589087|FG000|Overall Study|Subject no longer meets study criteria|0|||
27932595|NCT02097277|81589088|FG001|Overall Study|Subject no longer meets study criteria|1|||
27932596|NCT02097277|81589089|FG002|Overall Study|Subject no longer meets study criteria|0|||
27932597|NCT02097277|81589090|FG003|Overall Study|Subject no longer meets study criteria|1|||
27932598|NCT02097277|81589091|FG004|Overall Study|Subject no longer meets study criteria|0|||
27932599|NCT02097277|81589087|FG000|Overall Study|Subject request to discontinue treatment|0|||
27932600|NCT02097277|81589088|FG001|Overall Study|Subject request to discontinue treatment|0|||
27932601|NCT02097277|81589089|FG002|Overall Study|Subject request to discontinue treatment|0|||
27932602|NCT02097277|81589090|FG003|Overall Study|Subject request to discontinue treatment|0|||
27932603|NCT02097277|81589091|FG004|Overall Study|Subject request to discontinue treatment|1|||
27932604|NCT02097277|81589087|FG000|Overall Study|Lost to Follow-up|0|||
27932605|NCT02097277|81589088|FG001|Overall Study|Lost to Follow-up|1|||
27932606|NCT02097277|81589089|FG002|Overall Study|Lost to Follow-up|1|||
27932607|NCT02097277|81589090|FG003|Overall Study|Lost to Follow-up|0|||
27932608|NCT02097277|81589091|FG004|Overall Study|Lost to Follow-up|0|||
27932609|NCT02097277|81589087|FG000|Overall Study|Withdrawal by Subject|2|||
27932610|NCT02097277|81589088|FG001|Overall Study|Withdrawal by Subject|1|||
27932611|NCT02097277|81589089|FG002|Overall Study|Withdrawal by Subject|0|||
27932612|NCT02097277|81589090|FG003|Overall Study|Withdrawal by Subject|1|||
27932613|NCT02097277|81589091|FG004|Overall Study|Withdrawal by Subject|0|||
27932614|NCT02097277|81589087|FG000|Overall Study|Adverse Event|0|||
27932615|NCT02097277|81589088|FG001|Overall Study|Adverse Event|0|||
27932616|NCT02097277|81589089|FG002|Overall Study|Adverse Event|1|||
27932617|NCT02097277|81589090|FG003|Overall Study|Adverse Event|2|||
27932618|NCT02097277|81589091|FG004|Overall Study|Adverse Event|0|||
27932619|NCT00086307|81589097|FG000|Overall Study|Lack of Efficacy|1|||
27932620|NCT00086307|81589098|FG001|Overall Study|Lack of Efficacy|1|||
27932621|NCT00086307|81589099|FG002|Overall Study|Lack of Efficacy|2|||
27932622|NCT00086307|81589097|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
27932623|NCT00086307|81589098|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
27932624|NCT00086307|81589099|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
27932625|NCT00086307|81589097|FG000|Overall Study|Nausea and headaches|0|||
27932626|NCT00086307|81589098|FG001|Overall Study|Nausea and headaches|0|||
27932627|NCT00086307|81589099|FG002|Overall Study|Nausea and headaches|1|||
27932628|NCT00086307|81589097|FG000|Overall Study|Constipation and sleepiness|0|||
27932629|NCT00086307|81589098|FG001|Overall Study|Constipation and sleepiness|0|||
27932630|NCT00086307|81589099|FG002|Overall Study|Constipation and sleepiness|1|||
27932631|NCT00086307|81589097|FG000|Overall Study|Suicidal ideation|0|||
27932632|NCT00086307|81589098|FG001|Overall Study|Suicidal ideation|0|||
27932633|NCT00086307|81589099|FG002|Overall Study|Suicidal ideation|1|||
27932634|NCT00086307|81589097|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
27932635|NCT00086307|81589098|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
27932636|NCT00086307|81589099|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
27932637|NCT00086307|81589097|FG000|Overall Study|Withdrawal by Subject|0|||
27932638|NCT00086307|81589098|FG001|Overall Study|Withdrawal by Subject|0|||
27932639|NCT00086307|81589099|FG002|Overall Study|Withdrawal by Subject|2|||
27932640|NCT01281306|81589102|FG000|Overall Study|Lack of Efficacy|0|||
27932641|NCT01281306|81589103|FG001|Overall Study|Lack of Efficacy|1|||
27932642|NCT01281306|81589104|FG002|Overall Study|Lack of Efficacy|3|||
27642218|NCT02740231|80532464|FG002|Overall Study|Adverse Event|0|||
27932643|NCT01281306|81589105|FG003|Overall Study|Lack of Efficacy|0|||
27932644|NCT01281306|81589106|FG004|Overall Study|Lack of Efficacy|2|||
27932645|NCT01281306|81589107|FG005|Overall Study|Lack of Efficacy|0|||
27932646|NCT01281306|81589108|FG006|Overall Study|Lack of Efficacy|1|||
27932647|NCT01281306|81589102|FG000|Overall Study|Withdrawal by Subject|1|||
27932648|NCT01281306|81589103|FG001|Overall Study|Withdrawal by Subject|0|||
27932649|NCT01281306|81589104|FG002|Overall Study|Withdrawal by Subject|2|||
27642219|NCT02740231|80532465|FG003|Overall Study|Adverse Event|1|||
27642220|NCT00701701|80532482|FG000|Overall Study|Withdrawal by Subject|0|||
27642221|NCT00701701|80532483|FG001|Overall Study|Withdrawal by Subject|1|||
27932650|NCT01281306|81589105|FG003|Overall Study|Withdrawal by Subject|4|||
27932651|NCT01281306|81589106|FG004|Overall Study|Withdrawal by Subject|1|||
27932652|NCT01281306|81589107|FG005|Overall Study|Withdrawal by Subject|3|||
27932653|NCT01281306|81589108|FG006|Overall Study|Withdrawal by Subject|1|||
27932654|NCT01281306|81589102|FG000|Overall Study|Protocol deviation|0|||
27932655|NCT01281306|81589103|FG001|Overall Study|Protocol deviation|1|||
27932656|NCT01281306|81589104|FG002|Overall Study|Protocol deviation|1|||
27932657|NCT01281306|81589105|FG003|Overall Study|Protocol deviation|1|||
27932658|NCT01281306|81589106|FG004|Overall Study|Protocol deviation|1|||
27932659|NCT01281306|81589107|FG005|Overall Study|Protocol deviation|0|||
27932660|NCT01281306|81589108|FG006|Overall Study|Protocol deviation|0|||
27932661|NCT01281306|81589102|FG000|Overall Study|Condition no longer requires study drug|1|||
27932662|NCT01281306|81589103|FG001|Overall Study|Condition no longer requires study drug|0|||
27932663|NCT01281306|81589104|FG002|Overall Study|Condition no longer requires study drug|0|||
27932664|NCT01281306|81589105|FG003|Overall Study|Condition no longer requires study drug|0|||
27932665|NCT01281306|81589106|FG004|Overall Study|Condition no longer requires study drug|0|||
27932666|NCT01281306|81589107|FG005|Overall Study|Condition no longer requires study drug|1|||
27932667|NCT01281306|81589108|FG006|Overall Study|Condition no longer requires study drug|1|||
27932668|NCT01281306|81589102|FG000|Overall Study|Lost to Follow-up|1|||
27932669|NCT01281306|81589103|FG001|Overall Study|Lost to Follow-up|0|||
27932670|NCT01281306|81589104|FG002|Overall Study|Lost to Follow-up|0|||
27932671|NCT01281306|81589105|FG003|Overall Study|Lost to Follow-up|2|||
27932672|NCT01281306|81589106|FG004|Overall Study|Lost to Follow-up|0|||
27932673|NCT01281306|81589107|FG005|Overall Study|Lost to Follow-up|0|||
27932674|NCT01281306|81589108|FG006|Overall Study|Lost to Follow-up|1|||
27932675|NCT01281306|81589102|FG000|Overall Study|Death|1|||
27932676|NCT01281306|81589103|FG001|Overall Study|Death|0|||
27932677|NCT01281306|81589104|FG002|Overall Study|Death|0|||
27932678|NCT01281306|81589105|FG003|Overall Study|Death|0|||
27932679|NCT01281306|81589106|FG004|Overall Study|Death|0|||
27932680|NCT01281306|81589107|FG005|Overall Study|Death|0|||
27932681|NCT01281306|81589108|FG006|Overall Study|Death|0|||
27932682|NCT01281306|81589102|FG000|Overall Study|Adverse Event|3|||
27932683|NCT01281306|81589103|FG001|Overall Study|Adverse Event|2|||
27932684|NCT01281306|81589104|FG002|Overall Study|Adverse Event|2|||
27932685|NCT01281306|81589105|FG003|Overall Study|Adverse Event|3|||
27932686|NCT01281306|81589106|FG004|Overall Study|Adverse Event|5|||
27932687|NCT01281306|81589107|FG005|Overall Study|Adverse Event|3|||
27932688|NCT01281306|81589108|FG006|Overall Study|Adverse Event|3|||
27932689|NCT01281306|81589102|FG000|Overall Study|Randomized in error|1|||
27932690|NCT01281306|81589103|FG001|Overall Study|Randomized in error|0|||
27932691|NCT01281306|81589104|FG002|Overall Study|Randomized in error|0|||
27932692|NCT01281306|81589105|FG003|Overall Study|Randomized in error|1|||
27932693|NCT01281306|81589106|FG004|Overall Study|Randomized in error|0|||
27642222|NCT00701701|80532482|FG000|Overall Study|Adverse Event|0|||
27642223|NCT00701701|80532483|FG001|Overall Study|Adverse Event|1|||
27932694|NCT01281306|81589107|FG005|Overall Study|Randomized in error|0|||
27932695|NCT01281306|81589108|FG006|Overall Study|Randomized in error|0|||
27932696|NCT00127933|81589111|FG000|Overall Study|Randomized but not dosed|1|||
27932697|NCT00127933|81589112|FG001|Overall Study|Randomized but not dosed|0|||
27932698|NCT02061592|81589116|FG000|Period 1|Withdrawal by Subject|1|||
27932699|NCT02061592|81589117|FG001|Period 1|Withdrawal by Subject|0|||
27932700|NCT02061592|81589116|FG000|Period 1|Protocol Violation|1|||
27932701|NCT02061592|81589117|FG001|Period 1|Protocol Violation|0|||
27932702|NCT02061592|81589116|FG000|Period 2|Lost to Follow-up|0|||
27932703|NCT02061592|81589117|FG001|Period 2|Lost to Follow-up|1|||
27932704|NCT01093885|81589118|FG000|Overall Study|Adverse Event|4|||
27932705|NCT01093885|81589118|FG000|Overall Study|Lost to Follow-up|1|||
27642224|NCT03750968|80532493|FG000|Overall Study|Adverse Event|2|||
27932706|NCT02280499|81589121|FG000|Overall Study|Death|14|||
27932707|NCT02280499|81589121|FG000|Overall Study|Lost to Follow-up|42|||
27932708|NCT02280499|81589121|FG000|Overall Study|Adverse Event|5|||
27932709|NCT00864513|81589126|FG000|Overall Study|Withdrawal by Subject|3|||
27932710|NCT00327171|81589127|FG000|Overall Study|Did not receive study medication|3|||
27932711|NCT00327171|81589128|FG001|Overall Study|Did not receive study medication|0|||
27932712|NCT00327171|81589127|FG000|Overall Study|Adverse Event|23|||
27932713|NCT00327171|81589128|FG001|Overall Study|Adverse Event|23|||
27932714|NCT00327171|81589127|FG000|Overall Study|Disease progression/lack of efficacy|68|||
27932715|NCT00327171|81589128|FG001|Overall Study|Disease progression/lack of efficacy|69|||
27932716|NCT00327171|81589127|FG000|Overall Study|Investigator/participant request|1|||
27932717|NCT00327171|81589128|FG001|Overall Study|Investigator/participant request|8|||
27932718|NCT00327171|81589127|FG000|Overall Study|Clinical progression|12|||
27932719|NCT00327171|81589128|FG001|Overall Study|Clinical progression|8|||
27932720|NCT00327171|81589127|FG000|Overall Study|Undisclosed history of ischemia|0|||
27932721|NCT00327171|81589128|FG001|Overall Study|Undisclosed history of ischemia|1|||
27932722|NCT00327171|81589127|FG000|Overall Study|Other|1|||
27932723|NCT00327171|81589128|FG001|Overall Study|Other|0|||
27932724|NCT04027946|81589135|FG000|Overall Study|Screen failures|3|||
27932725|NCT05161936|81589136|FG000|Overall Study|Study terminated by Sponsor|1|||
27932726|NCT05161936|81589137|FG001|Overall Study|Study terminated by Sponsor|0|||
27932727|NCT05161936|81589138|FG002|Overall Study|Study terminated by Sponsor|0|||
27932728|NCT05161936|81589136|FG000|Overall Study|Withdrawal by Subject|0|||
27932729|NCT05161936|81589137|FG001|Overall Study|Withdrawal by Subject|0|||
27932730|NCT05161936|81589138|FG002|Overall Study|Withdrawal by Subject|1|||
27932731|NCT03753542|81589141|FG000|Overall Study|Lost to Follow-up|9|||
27932732|NCT03753542|81589142|FG001|Overall Study|Lost to Follow-up|14|||
27932733|NCT00599313|81589143|FG000|Overall Study|Adverse Event|19|||
27932734|NCT00599313|81589143|FG000|Overall Study|Disease Progression|12|||
27932735|NCT00599313|81589143|FG000|Overall Study|Patient Request|4|||
27932736|NCT00599313|81589143|FG000|Overall Study|Ineligible|1|||
27932737|NCT03018938|81589144|FG000|Overall Study|Death|0|||
27932738|NCT03018938|81589145|FG001|Overall Study|Death|1|||
27932739|NCT03018938|81589144|FG000|Overall Study|Lost to Follow-up|21|||
27932740|NCT03018938|81589145|FG001|Overall Study|Lost to Follow-up|32|||
27932741|NCT03018938|81589144|FG000|Overall Study|Withdrawal by Subject|38|||
27932742|NCT03018938|81589145|FG001|Overall Study|Withdrawal by Subject|45|||
27932743|NCT03018938|81589144|FG000|Overall Study|Physician Decision|3|||
27932744|NCT03018938|81589145|FG001|Overall Study|Physician Decision|2|||
27932745|NCT03018938|81589144|FG000|Overall Study|Sponsor Decision|0|||
27932746|NCT03018938|81589145|FG001|Overall Study|Sponsor Decision|1|||
27932747|NCT03018938|81589144|FG000|Overall Study|Screen failure-After randomization|4|||
27932748|NCT03018938|81589145|FG001|Overall Study|Screen failure-After randomization|2|||
27932749|NCT03018938|81589144|FG000|Overall Study|Not recorded|0|||
27932750|NCT03018938|81589145|FG001|Overall Study|Not recorded|2|||
27932751|NCT01018953|81589147|FG000|Overall Study|Adverse Event|2|||
27932752|NCT01018953|81589147|FG000|Overall Study|Withdrawal by Subject|1|||
27932753|NCT01018953|81589147|FG000|Overall Study|Study termination by sponsor|5|||
27932754|NCT03345004|81589148|FG000|Overall Study|Physician Decision|1|||
27932755|NCT03345004|81589149|FG001|Overall Study|Physician Decision|0|||
27932756|NCT03345004|81589148|FG000|Overall Study|Withdrawal by Subject|0|||
27932757|NCT03345004|81589149|FG001|Overall Study|Withdrawal by Subject|1|||
27932758|NCT00927082|81589150|FG000|Overall Study|Lost to Follow-up|9|||
27932759|NCT00927082|81589151|FG001|Overall Study|Lost to Follow-up|8|||
27932760|NCT00927082|81589152|FG002|Overall Study|Lost to Follow-up|12|||
27932761|NCT00927082|81589153|FG003|Overall Study|Lost to Follow-up|16|||
27932762|NCT00927082|81589150|FG000|Overall Study|Withdrawal by Subject|3|||
27932763|NCT00927082|81589151|FG001|Overall Study|Withdrawal by Subject|2|||
27932764|NCT00927082|81589152|FG002|Overall Study|Withdrawal by Subject|7|||
27932765|NCT00927082|81589153|FG003|Overall Study|Withdrawal by Subject|2|||
27932766|NCT00927082|81589150|FG000|Overall Study|Death|0|||
27932767|NCT00927082|81589151|FG001|Overall Study|Death|0|||
27932768|NCT00927082|81589152|FG002|Overall Study|Death|1|||
27932769|NCT00927082|81589153|FG003|Overall Study|Death|0|||
27642225|NCT03750968|80532494|FG001|Overall Study|Adverse Event|0|||
27932770|NCT00927082|81589150|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
27932771|NCT00927082|81589151|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
27932772|NCT00927082|81589152|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
27932773|NCT00927082|81589153|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
27932774|NCT03684057|81589161|FG000|Overall Study|Withdrawal by Subject|4|||
27932775|NCT03684057|81589162|FG001|Overall Study|Withdrawal by Subject|5|||
27743069|NCT04322682|80889454|FG000|Overall Study|Death|5|||
27932776|NCT03418675|81589165|FG000|Overall Study|Lost to Follow-up|13|||
27932777|NCT03418675|81589166|FG001|Overall Study|Lost to Follow-up|10|||
27932778|NCT03418675|81589165|FG000|Overall Study|Adverse Event|2|||
27932779|NCT03418675|81589166|FG001|Overall Study|Adverse Event|0|||
27932780|NCT01555931|81589168|FG000|Overall Study|Lost to Follow-up|2|||
27932781|NCT01555931|81589169|FG001|Overall Study|Lost to Follow-up|5|||
27932782|NCT00601107|81589170|FG000|Overall Study|Adverse Event|0|||
27932783|NCT00601107|81589171|FG001|Overall Study|Adverse Event|1|||
27932784|NCT00601107|81589172|FG002|Overall Study|Adverse Event|3|||
27932785|NCT00601107|81589173|FG003|Overall Study|Adverse Event|0|||
27932786|NCT00601107|81589170|FG000|Overall Study|Withdrawal by Subject|5|||
27932787|NCT00601107|81589171|FG001|Overall Study|Withdrawal by Subject|4|||
27932788|NCT00601107|81589172|FG002|Overall Study|Withdrawal by Subject|7|||
27932789|NCT00601107|81589173|FG003|Overall Study|Withdrawal by Subject|4|||
27932790|NCT00601107|81589170|FG000|Overall Study|Lost to Follow-up|3|||
27932791|NCT00601107|81589171|FG001|Overall Study|Lost to Follow-up|3|||
27932792|NCT00601107|81589172|FG002|Overall Study|Lost to Follow-up|0|||
27932793|NCT00601107|81589173|FG003|Overall Study|Lost to Follow-up|3|||
27932794|NCT00601107|81589170|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
27932795|NCT00601107|81589171|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
27932796|NCT00601107|81589172|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
27932797|NCT00601107|81589173|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
27932798|NCT00601107|81589170|FG000|Overall Study|Worsening of Psoriasis|4|||
27932799|NCT00601107|81589171|FG001|Overall Study|Worsening of Psoriasis|1|||
27932800|NCT00601107|81589172|FG002|Overall Study|Worsening of Psoriasis|1|||
27932801|NCT00601107|81589173|FG003|Overall Study|Worsening of Psoriasis|4|||
27932802|NCT00601107|81589170|FG000|Overall Study|Undefined|1|||
27932803|NCT00601107|81589171|FG001|Overall Study|Undefined|0|||
27932804|NCT00601107|81589172|FG002|Overall Study|Undefined|1|||
27932805|NCT00601107|81589173|FG003|Overall Study|Undefined|0|||
27932806|NCT02413346|81589174|FG000|Overall Study|Adverse Event|6|||
27932807|NCT02413346|81589175|FG001|Overall Study|Adverse Event|6|||
27932808|NCT02413346|81589174|FG000|Overall Study|Withdrawal by Subject|30|||
27932809|NCT02413346|81589175|FG001|Overall Study|Withdrawal by Subject|40|||
27932810|NCT02413346|81589174|FG000|Overall Study|Lost to Follow-up|17|||
27932811|NCT02413346|81589175|FG001|Overall Study|Lost to Follow-up|21|||
27932812|NCT02413346|81589174|FG000|Overall Study|Protocol Violation|2|||
27932813|NCT02413346|81589175|FG001|Overall Study|Protocol Violation|0|||
27932814|NCT02413346|81589174|FG000|Overall Study|Other Miscellaneous Reasons|4|||
27932815|NCT02413346|81589175|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27932816|NCT00806026|81589178|FG000|Overall Study|Death|0|||
27932817|NCT00806026|81589179|FG001|Overall Study|Death|0|||
27932818|NCT00806026|81589180|FG002|Overall Study|Death|0|||
27932819|NCT00806026|81589181|FG003|Overall Study|Death|1|||
27932820|NCT00806026|81589182|FG004|Overall Study|Death|0|||
27932821|NCT00806026|81589183|FG005|Overall Study|Death|0|||
27932822|NCT00806026|81589178|FG000|Overall Study|Did not meet entrance criteria|4|||
27932823|NCT00806026|81589179|FG001|Overall Study|Did not meet entrance criteria|1|||
27932824|NCT00806026|81589180|FG002|Overall Study|Did not meet entrance criteria|2|||
27932825|NCT00806026|81589181|FG003|Overall Study|Did not meet entrance criteria|1|||
27932826|NCT00806026|81589182|FG004|Overall Study|Did not meet entrance criteria|0|||
27932827|NCT00806026|81589183|FG005|Overall Study|Did not meet entrance criteria|0|||
27932828|NCT00806026|81589178|FG000|Overall Study|Lack of Efficacy|5|||
27932829|NCT00806026|81589179|FG001|Overall Study|Lack of Efficacy|18|||
27932830|NCT00806026|81589180|FG002|Overall Study|Lack of Efficacy|13|||
27932831|NCT00806026|81589181|FG003|Overall Study|Lack of Efficacy|4|||
27932832|NCT00806026|81589182|FG004|Overall Study|Lack of Efficacy|8|||
27932833|NCT00806026|81589183|FG005|Overall Study|Lack of Efficacy|7|||
27932834|NCT00806026|81589178|FG000|Overall Study|Lost to Follow-up|8|||
27932835|NCT00806026|81589179|FG001|Overall Study|Lost to Follow-up|15|||
27550625|NCT03667924|80203421|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
27550626|NCT03667924|80203419|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
27932836|NCT00806026|81589180|FG002|Overall Study|Lost to Follow-up|8|||
27932837|NCT00806026|81589181|FG003|Overall Study|Lost to Follow-up|2|||
27932838|NCT00806026|81589182|FG004|Overall Study|Lost to Follow-up|6|||
27932839|NCT00806026|81589183|FG005|Overall Study|Lost to Follow-up|6|||
27932840|NCT00806026|81589178|FG000|Overall Study|Withdrawal by Subject|14|||
27932841|NCT00806026|81589179|FG001|Overall Study|Withdrawal by Subject|17|||
27932842|NCT00806026|81589180|FG002|Overall Study|Withdrawal by Subject|9|||
27932843|NCT00806026|81589181|FG003|Overall Study|Withdrawal by Subject|2|||
27932844|NCT00806026|81589182|FG004|Overall Study|Withdrawal by Subject|5|||
27550627|NCT03667924|80203420|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
27550628|NCT03667924|80203421|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
27550629|NCT03667924|80203419|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
27550630|NCT03667924|80203420|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
27550631|NCT03667924|80203421|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
27550632|NCT03667924|80203419|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
27550633|NCT03667924|80203420|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
27550634|NCT03667924|80203421|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
27932845|NCT00806026|81589183|FG005|Overall Study|Withdrawal by Subject|3|||
27932846|NCT00806026|81589178|FG000|Overall Study|Other|3|||
27932847|NCT00806026|81589179|FG001|Overall Study|Other|6|||
27932848|NCT00806026|81589180|FG002|Overall Study|Other|8|||
27932849|NCT00806026|81589181|FG003|Overall Study|Other|2|||
27932850|NCT00806026|81589182|FG004|Overall Study|Other|0|||
27932851|NCT00806026|81589183|FG005|Overall Study|Other|4|||
27932852|NCT00806026|81589178|FG000|Overall Study|Protocol Violation|6|||
27932853|NCT00806026|81589179|FG001|Overall Study|Protocol Violation|9|||
27932854|NCT00806026|81589180|FG002|Overall Study|Protocol Violation|9|||
27932855|NCT00806026|81589181|FG003|Overall Study|Protocol Violation|0|||
27932856|NCT00806026|81589182|FG004|Overall Study|Protocol Violation|2|||
27932857|NCT00806026|81589183|FG005|Overall Study|Protocol Violation|3|||
27932858|NCT00806026|81589178|FG000|Overall Study|Adverse Event|52|||
27932859|NCT00806026|81589179|FG001|Overall Study|Adverse Event|35|||
27932860|NCT00806026|81589180|FG002|Overall Study|Adverse Event|44|||
27932861|NCT00806026|81589181|FG003|Overall Study|Adverse Event|17|||
27932862|NCT00806026|81589182|FG004|Overall Study|Adverse Event|9|||
27932863|NCT00806026|81589183|FG005|Overall Study|Adverse Event|9|||
27932864|NCT00368849|81589185|FG000|Overall Study|Withdrawal by Subject|0|||
27932865|NCT00368849|81589186|FG001|Overall Study|Withdrawal by Subject|1|||
27932866|NCT00368849|81589185|FG000|Overall Study|Physician Decision|0|||
27932867|NCT00368849|81589186|FG001|Overall Study|Physician Decision|1|||
27932868|NCT00639379|81589189|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
27932869|NCT00639379|81589190|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
27932870|NCT00639379|81589189|FG000|Period 1 - 2 Weeks|lens issue|3|||
27932871|NCT00639379|81589190|FG001|Period 1 - 2 Weeks|lens issue|0|||
27932872|NCT03462563|81591959|FG000|Overall Study|Death|1|||
27932873|NCT03462563|81591960|FG001|Overall Study|Death|1|||
27932874|NCT03462563|81591959|FG000|Overall Study|Termination of study|2|||
27932875|NCT03462563|81591960|FG001|Overall Study|Termination of study|1|||
27932876|NCT03462563|81591959|FG000|Overall Study|Adverse Event|1|||
27932877|NCT03462563|81591960|FG001|Overall Study|Adverse Event|3|||
27932878|NCT03462563|81591959|FG000|Overall Study|Unspecified reason|10|||
27642226|NCT03750968|80532493|FG000|Overall Study|Lost to Follow-up|1|||
27642227|NCT03750968|80532494|FG001|Overall Study|Lost to Follow-up|3|||
27642228|NCT00879333|80532495|FG000|Overall Study|Adverse Event|94|||
27642229|NCT00879333|80532496|FG001|Overall Study|Adverse Event|34|||
27642230|NCT00879333|80532495|FG000|Overall Study|Abnormal Laboratory Value|1|||
27642231|NCT00879333|80532496|FG001|Overall Study|Abnormal Laboratory Value|0|||
27642232|NCT00879333|80532495|FG000|Overall Study|Withdrawal by Subject|20|||
27642233|NCT00879333|80532496|FG001|Overall Study|Withdrawal by Subject|7|||
27642234|NCT00879333|80532495|FG000|Overall Study|Lost to Follow-up|2|||
27642235|NCT00879333|80532496|FG001|Overall Study|Lost to Follow-up|1|||
27642236|NCT00879333|80532495|FG000|Overall Study|Administrative Problems|2|||
27642237|NCT00879333|80532496|FG001|Overall Study|Administrative Problems|0|||
27642238|NCT00879333|80532495|FG000|Overall Study|Death|16|||
27642239|NCT00879333|80532496|FG001|Overall Study|Death|5|||
27642240|NCT00879333|80532495|FG000|Overall Study|Disease Progression|292|||
27642241|NCT00879333|80532496|FG001|Overall Study|Disease Progression|169|||
27642242|NCT00879333|80532495|FG000|Overall Study|Protocol Violation|1|||
27642243|NCT00879333|80532496|FG001|Overall Study|Protocol Violation|1|||
27642244|NCT02462759|80532497|FG000|Part 1: Double Blind|Death|1|||
27642245|NCT02462759|80532498|FG001|Part 1: Double Blind|Death|0|||
27642246|NCT02462759|80532499|FG002|Part 1: Double Blind|Death|0|||
27642247|NCT00670046|80532500|FG000|Overall Study|Lost to Follow-up|1|||
27642248|NCT00670046|80532501|FG001|Overall Study|Lost to Follow-up|1|||
27642249|NCT00670046|80532500|FG000|Overall Study|Withdrawal by Subject|0|||
27642250|NCT00670046|80532501|FG001|Overall Study|Withdrawal by Subject|1|||
27642251|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
27642252|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
27642253|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
27642254|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
27642255|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
27642256|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
27642257|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
27642258|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
27642259|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
27642260|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
27642261|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
27932879|NCT03462563|81591960|FG001|Overall Study|Unspecified reason|12|||
27932880|NCT03462563|81591959|FG000|Overall Study|Physician Decision|1|||
27932881|NCT03462563|81591960|FG001|Overall Study|Physician Decision|0|||
27932882|NCT02923180|81591961|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
27932883|NCT02923180|81591961|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
27932884|NCT00834587|81591970|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
27932885|NCT00834587|81591971|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
27642262|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
27932886|NCT00923702|81591972|FG000|Overall Study|Ongoing enrollment|0|||
27932887|NCT00923702|81591973|FG001|Overall Study|Ongoing enrollment|0|||
27932888|NCT00923702|81591974|FG002|Overall Study|Ongoing enrollment|0|||
27932889|NCT00923702|81591975|FG003|Overall Study|Ongoing enrollment|0|||
27932890|NCT00923702|81591976|FG004|Overall Study|Ongoing enrollment|354|||
27642263|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27932891|NCT01155323|81591977|FG000|First Intervention|exclusion criteria|1|||
27932892|NCT01155323|81591978|FG001|First Intervention|exclusion criteria|1|||
27932893|NCT01155323|81591977|FG000|Second Intervention|Lost to Follow-up|1|||
27932894|NCT01155323|81591978|FG001|Second Intervention|Lost to Follow-up|1|||
27932895|NCT01902303|81591981|FG000|Overall Study|Adverse Event|0|||
27932896|NCT01902303|81591982|FG001|Overall Study|Adverse Event|1|||
27932897|NCT01902303|81591981|FG000|Overall Study|Lost to Follow-up|0|||
27932898|NCT01902303|81591982|FG001|Overall Study|Lost to Follow-up|1|||
27932899|NCT01902303|81591981|FG000|Overall Study|Protocol Violation|2|||
27932900|NCT01902303|81591982|FG001|Overall Study|Protocol Violation|2|||
27932901|NCT01902303|81591981|FG000|Overall Study|subject lost investigational product|0|||
27932902|NCT01902303|81591982|FG001|Overall Study|subject lost investigational product|1|||
27932903|NCT01902303|81591981|FG000|Overall Study|Did not develop a cold sore|21|||
27932904|NCT01902303|81591982|FG001|Overall Study|Did not develop a cold sore|19|||
27932905|NCT01108055|81591985|FG000|Overall Study|Ineligible|11|||
27932906|NCT01108055|81591985|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
27932907|NCT00552058|81591990|FG000|Overall Study|Adverse Event|8|||
27932908|NCT00552058|81591991|FG001|Overall Study|Adverse Event|7|||
27932909|NCT00552058|81591990|FG000|Overall Study|Lack of Efficacy|1|||
27932910|NCT00552058|81591991|FG001|Overall Study|Lack of Efficacy|5|||
27932911|NCT00552058|81591990|FG000|Overall Study|Lost to Follow-up|1|||
27932912|NCT00552058|81591991|FG001|Overall Study|Lost to Follow-up|0|||
27932913|NCT00552058|81591990|FG000|Overall Study|Withdrawal by Subject|4|||
27932914|NCT00552058|81591991|FG001|Overall Study|Withdrawal by Subject|4|||
27932915|NCT00552058|81591990|FG000|Overall Study|Other: Protocol Violation|0|||
27932916|NCT00552058|81591991|FG001|Overall Study|Other: Protocol Violation|1|||
27932917|NCT00552058|81591990|FG000|Overall Study|Other: Non Compliance|1|||
27932918|NCT00552058|81591991|FG001|Overall Study|Other: Non Compliance|2|||
27932919|NCT00552058|81591990|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
27932920|NCT00552058|81591991|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
27932921|NCT00552058|81591990|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
27932922|NCT00552058|81591991|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
27932923|NCT00552058|81591990|FG000|Overall Study|Other: Positive Stool Result|0|||
27932924|NCT00552058|81591991|FG001|Overall Study|Other: Positive Stool Result|1|||
27932925|NCT00552058|81591990|FG000|Overall Study|Other: Randomized in error|0|||
27932926|NCT00552058|81591991|FG001|Overall Study|Other: Randomized in error|1|||
27932927|NCT00552058|81591990|FG000|Overall Study|Other: Sponsors Decision|0|||
27932928|NCT00552058|81591991|FG001|Overall Study|Other: Sponsors Decision|1|||
27932929|NCT00552058|81591990|FG000|Overall Study|Other: Early Roll Over|1|||
27932930|NCT00552058|81591991|FG001|Overall Study|Other: Early Roll Over|0|||
27932931|NCT01027416|81591995|FG000|Overall Study|Withdrawal by Subject|0|||
27932932|NCT01027416|81591996|FG001|Overall Study|Withdrawal by Subject|1|||
27932933|NCT01027416|81591995|FG000|Overall Study|Physician Decision|1|||
27932934|NCT01027416|81591996|FG001|Overall Study|Physician Decision|4|||
27550635|NCT03667924|80203419|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
27550636|NCT03667924|80203420|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
27550637|NCT03667924|80203421|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
27550638|NCT00299975|80203423|FG000|Overall Study|Adverse Event|1|||
27550639|NCT00299975|80203424|FG001|Overall Study|Adverse Event|0|||
27550640|NCT00299975|80203425|FG002|Overall Study|Adverse Event|2|||
27550641|NCT00299975|80203423|FG000|Overall Study|Pregnancy|0|||
27550642|NCT00299975|80203424|FG001|Overall Study|Pregnancy|0|||
27550643|NCT00299975|80203425|FG002|Overall Study|Pregnancy|1|||
27550644|NCT00299975|80203423|FG000|Overall Study|Lack of Efficacy|1|||
27550645|NCT00299975|80203424|FG001|Overall Study|Lack of Efficacy|0|||
27550646|NCT00299975|80203425|FG002|Overall Study|Lack of Efficacy|1|||
27550647|NCT00299975|80203423|FG000|Overall Study|Lost to Follow-up|1|||
27550648|NCT00299975|80203424|FG001|Overall Study|Lost to Follow-up|0|||
27550649|NCT00299975|80203425|FG002|Overall Study|Lost to Follow-up|0|||
27550650|NCT00299975|80203423|FG000|Overall Study|Withdrawal by Subject|0|||
27550651|NCT00299975|80203424|FG001|Overall Study|Withdrawal by Subject|1|||
27550652|NCT00299975|80203425|FG002|Overall Study|Withdrawal by Subject|3|||
27550653|NCT00299975|80203423|FG000|Overall Study|Physician Decision|0|||
27550654|NCT00299975|80203424|FG001|Overall Study|Physician Decision|0|||
27550655|NCT00299975|80203425|FG002|Overall Study|Physician Decision|1|||
27743070|NCT04322682|80889455|FG001|Overall Study|Death|9|||
27932935|NCT01421134|81591999|FG000|Overall Study|Adverse Event|3|||
27932936|NCT01421134|81592000|FG001|Overall Study|Adverse Event|5|||
27932937|NCT01421134|81591999|FG000|Overall Study|Lack of Efficacy|2|||
27932938|NCT01421134|81592000|FG001|Overall Study|Lack of Efficacy|4|||
27932939|NCT01421134|81591999|FG000|Overall Study|Protocol Violation|0|||
27932940|NCT01421134|81592000|FG001|Overall Study|Protocol Violation|3|||
27550656|NCT02966028|80203426|FG000|Overall Study|Adverse Event|7|||
27550657|NCT02966028|80203427|FG001|Overall Study|Adverse Event|13|||
27550658|NCT02966028|80203428|FG002|Overall Study|Adverse Event|10|||
27932941|NCT01421134|81591999|FG000|Overall Study|Withdrawal by Subject|1|||
27932942|NCT01421134|81592000|FG001|Overall Study|Withdrawal by Subject|1|||
27932943|NCT01421134|81591999|FG000|Overall Study|Administrative|0|||
27932944|NCT01421134|81592000|FG001|Overall Study|Administrative|1|||
27743071|NCT04322682|80889454|FG000|Overall Study|Lost to Follow-up|4|||
27743072|NCT04322682|80889455|FG001|Overall Study|Lost to Follow-up|8|||
27743073|NCT04322682|80889454|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
27932945|NCT01421134|81591999|FG000|Overall Study|Lost to Follow-up|1|||
27932946|NCT01421134|81592000|FG001|Overall Study|Lost to Follow-up|1|||
27932947|NCT04073407|81592001|FG000|Part 1|Withdrawal by Subject|1|||
27932948|NCT04073407|81592002|FG001|Part 1|Withdrawal by Subject|0|||
27932949|NCT04073407|81592001|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
27932950|NCT04073407|81592002|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
27932951|NCT04073407|81592001|FG000|Part 2|Withdrawal by Subject|0|||
27932952|NCT04073407|81592002|FG001|Part 2|Withdrawal by Subject|1|||
27932953|NCT01370642|81592003|FG000|Overall Study|Adverse Event|2|||
27932954|NCT01370642|81592004|FG001|Overall Study|Adverse Event|1|||
27932955|NCT01370642|81592005|FG002|Overall Study|Adverse Event|1|||
27932956|NCT01370642|81592003|FG000|Overall Study|Detectable HCV RNA|0|||
27932957|NCT01370642|81592004|FG001|Overall Study|Detectable HCV RNA|0|||
27932958|NCT01370642|81592005|FG002|Overall Study|Detectable HCV RNA|22|||
27932959|NCT01370642|81592003|FG000|Overall Study|Lost to Follow-up|0|||
27932960|NCT01370642|81592004|FG001|Overall Study|Lost to Follow-up|0|||
27932961|NCT01370642|81592005|FG002|Overall Study|Lost to Follow-up|1|||
27932962|NCT01370642|81592003|FG000|Overall Study|Physician Decision|4|||
27932963|NCT01370642|81592004|FG001|Overall Study|Physician Decision|1|||
27932964|NCT01370642|81592005|FG002|Overall Study|Physician Decision|2|||
27932965|NCT01370642|81592003|FG000|Overall Study|Withdrawal by Subject|2|||
27932966|NCT01370642|81592004|FG001|Overall Study|Withdrawal by Subject|4|||
27932967|NCT01370642|81592005|FG002|Overall Study|Withdrawal by Subject|3|||
27932968|NCT05064800|81592006|FG000|Period 3|Withdrawal by Subject|0|||
27932969|NCT05064800|81592007|FG001|Period 3|Withdrawal by Subject|0|||
27932970|NCT05064800|81592008|FG002|Period 3|Withdrawal by Subject|0|||
27932971|NCT05064800|81592009|FG003|Period 3|Withdrawal by Subject|0|||
27932972|NCT05064800|81592010|FG004|Period 3|Withdrawal by Subject|1|||
27932973|NCT05064800|81592011|FG005|Period 3|Withdrawal by Subject|0|||
27932974|NCT00309244|81592012|FG000|Overall Study|Adverse Event|29|||
27932975|NCT00309244|81592013|FG001|Overall Study|Adverse Event|12|||
27932976|NCT00309244|81592012|FG000|Overall Study|Lost to Follow-up|6|||
27932977|NCT00309244|81592013|FG001|Overall Study|Lost to Follow-up|22|||
27932978|NCT00309244|81592012|FG000|Overall Study|Physician Decision|5|||
27932979|NCT00309244|81592013|FG001|Overall Study|Physician Decision|8|||
27932980|NCT00309244|81592012|FG000|Overall Study|Protocol Violation|6|||
27932981|NCT00309244|81592013|FG001|Overall Study|Protocol Violation|3|||
27932982|NCT00309244|81592012|FG000|Overall Study|Withdrawal by Subject|50|||
27932983|NCT00309244|81592013|FG001|Overall Study|Withdrawal by Subject|32|||
27932984|NCT00309244|81592012|FG000|Overall Study|Various|7|||
27932985|NCT00309244|81592013|FG001|Overall Study|Various|7|||
27932986|NCT00309244|81592012|FG000|Overall Study|Randomized but not dosed|11|||
27932987|NCT00309244|81592013|FG001|Overall Study|Randomized but not dosed|12|||
27932988|NCT00309244|81592012|FG000|Overall Study|Death|4|||
27932989|NCT00309244|81592013|FG001|Overall Study|Death|1|||
27932990|NCT00501085|81592014|FG000|Overall Study|Lost to Follow-up|195|||
27932991|NCT00501085|81592014|FG000|Overall Study|Withdrawal by Subject|34|||
27932992|NCT00501085|81592014|FG000|Overall Study|Subject Decision|1|||
27932993|NCT00501085|81592014|FG000|Overall Study|Revision Surgery|7|||
27932994|NCT00501085|81592014|FG000|Overall Study|Explantation Surgery|26|||
27932995|NCT00501085|81592014|FG000|Overall Study|Adverse Event|4|||
27932996|NCT00501085|81592014|FG000|Overall Study|Non-Compliance|24|||
27932997|NCT00501085|81592014|FG000|Overall Study|Study closed by sponsor|109|||
27550659|NCT02966028|80203426|FG000|Overall Study|Physician Decision|1|||
27550660|NCT02966028|80203427|FG001|Overall Study|Physician Decision|0|||
27550661|NCT02966028|80203428|FG002|Overall Study|Physician Decision|2|||
27550662|NCT02966028|80203426|FG000|Overall Study|Withdrawal by Subject|7|||
27550663|NCT02966028|80203427|FG001|Overall Study|Withdrawal by Subject|5|||
27550664|NCT02966028|80203428|FG002|Overall Study|Withdrawal by Subject|5|||
27550665|NCT02966028|80203426|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
27550666|NCT02966028|80203427|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
27550667|NCT02966028|80203428|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
27550668|NCT03052725|80203429|FG000|Overall Study|Adverse Event|2|||
27550669|NCT03052725|80203430|FG001|Overall Study|Adverse Event|0|||
27550670|NCT03052725|80203429|FG000|Overall Study|Withdrawal by Subject|3|||
27550671|NCT03052725|80203430|FG001|Overall Study|Withdrawal by Subject|4|||
27550672|NCT03052725|80203429|FG000|Overall Study|Pregnancy|0|||
27550673|NCT03052725|80203430|FG001|Overall Study|Pregnancy|1|||
27932998|NCT00501085|81592014|FG000|Overall Study|Other loss to follow-up|32|||
27550674|NCT03052725|80203429|FG000|Overall Study|Site closure|0|||
27550675|NCT03052725|80203430|FG001|Overall Study|Site closure|1|||
27550676|NCT03052725|80203429|FG000|Overall Study|Study terminated by sponsor|143|||
27932999|NCT00105508|81592015|FG000|Overall Study|Prephase Dropout|1|||
27933000|NCT00105508|81592016|FG001|Overall Study|Prephase Dropout|0|||
27933001|NCT00105508|81592015|FG000|Overall Study|Adverse Event|16|||
27743074|NCT04322682|80889455|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
27743075|NCT00864227|80889456|FG000|Overall Study|Withdrawal by Subject|1|||
27743076|NCT00864227|80889456|FG000|Overall Study|Disease Relapse/Progression|3|||
27743077|NCT01408537|80889457|FG000|Overall Study|Withdrawal by Subject|2|||
27743078|NCT01408537|80889457|FG000|Overall Study|Protocol Violation|3|||
27743079|NCT01408537|80889457|FG000|Overall Study|Lost to Follow-up|3|||
27743080|NCT03964415|80889458|FG000|Overall Study|Sponsor's decision|1563|||
27743081|NCT03964415|80889459|FG001|Overall Study|Sponsor's decision|1528|||
27743082|NCT03964415|80889458|FG000|Overall Study|Lost to Follow-up|139|||
27743083|NCT03964415|80889459|FG001|Overall Study|Lost to Follow-up|146|||
27743084|NCT03964415|80889458|FG000|Overall Study|Withdrawal by Subject|68|||
27743085|NCT03964415|80889459|FG001|Overall Study|Withdrawal by Subject|72|||
27743086|NCT03964415|80889458|FG000|Overall Study|Physician Decision|34|||
27743087|NCT03964415|80889459|FG001|Overall Study|Physician Decision|48|||
27743088|NCT03964415|80889458|FG000|Overall Study|Adverse Event|3|||
27743089|NCT03964415|80889459|FG001|Overall Study|Adverse Event|0|||
27933002|NCT00105508|81592016|FG001|Overall Study|Adverse Event|19|||
27933003|NCT00105508|81592015|FG000|Overall Study|Insufficient Efficacy|1|||
27933004|NCT00105508|81592016|FG001|Overall Study|Insufficient Efficacy|0|||
27933005|NCT00105508|81592015|FG000|Overall Study|Withdrawal by Subject|10|||
27933006|NCT00105508|81592016|FG001|Overall Study|Withdrawal by Subject|6|||
27642264|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27642265|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27642266|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27642267|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
27642268|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
27642269|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
27642270|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
27642271|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
27642272|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
27642273|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
27642274|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
27642275|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
27642276|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
27642277|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
27642278|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
27642279|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
27642280|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
27642281|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
27642282|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
27642283|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
27642284|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
27642285|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
27642286|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
27642287|NCT02392234|80532502|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
27642288|NCT02392234|80532503|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
27642289|NCT02392234|80532504|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
27642290|NCT02392234|80532505|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
27642291|NCT02392234|80532506|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
27642292|NCT02392234|80532507|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
27642293|NCT02392234|80532502|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
27642294|NCT02392234|80532503|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
27642295|NCT02392234|80532504|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
27642296|NCT02392234|80532505|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
27642297|NCT02392234|80532506|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
27642298|NCT02392234|80532507|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
27642299|NCT03912831|80532508|FG000|Overall Study|Death|1|||
27642300|NCT03912831|80532509|FG001|Overall Study|Death|1|||
27642301|NCT03912831|80532510|FG002|Overall Study|Death|1|||
27642302|NCT03912831|80532511|FG003|Overall Study|Death|1|||
27642303|NCT03912831|80532512|FG004|Overall Study|Death|1|||
27642304|NCT03912831|80532513|FG005|Overall Study|Death|1|||
27642305|NCT03912831|80532508|FG000|Overall Study|Reason not Specified|0|||
27743090|NCT03964415|80889458|FG000|Overall Study|Death|4|||
27743091|NCT03964415|80889459|FG001|Overall Study|Death|6|||
27933007|NCT00105508|81592015|FG000|Overall Study|Lost to Follow-up|3|||
27743092|NCT03964415|80889458|FG000|Overall Study|Protocol Violation|1|||
27743093|NCT03964415|80889459|FG001|Overall Study|Protocol Violation|4|||
27743094|NCT03964415|80889458|FG000|Overall Study|Other|35|||
27743095|NCT03964415|80889459|FG001|Overall Study|Other|38|||
27550677|NCT03052725|80203430|FG001|Overall Study|Study terminated by sponsor|144|||
27550678|NCT02014597|80203438|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
27550679|NCT02014597|80203439|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
27550680|NCT03132220|80203448|FG000|Overall Study|Lost to Follow-up|17|||
27550681|NCT03132220|80203449|FG001|Overall Study|Lost to Follow-up|8|||
27642306|NCT03912831|80532509|FG001|Overall Study|Reason not Specified|0|||
27642307|NCT03912831|80532510|FG002|Overall Study|Reason not Specified|0|||
27642308|NCT03912831|80532511|FG003|Overall Study|Reason not Specified|0|||
27642309|NCT03912831|80532512|FG004|Overall Study|Reason not Specified|1|||
27642310|NCT03912831|80532513|FG005|Overall Study|Reason not Specified|0|||
27642311|NCT03912831|80532508|FG000|Overall Study|Withdrawal by Participant|0|||
27642312|NCT03912831|80532509|FG001|Overall Study|Withdrawal by Participant|0|||
27642313|NCT03912831|80532510|FG002|Overall Study|Withdrawal by Participant|0|||
27642314|NCT03912831|80532511|FG003|Overall Study|Withdrawal by Participant|0|||
27642315|NCT03912831|80532512|FG004|Overall Study|Withdrawal by Participant|1|||
27642316|NCT03912831|80532513|FG005|Overall Study|Withdrawal by Participant|0|||
27642317|NCT03287622|80532515|FG000|Overall Study|Withdrawal by Subject|1|||
27642318|NCT03287622|80532516|FG001|Overall Study|Withdrawal by Subject|0|||
27642319|NCT03287622|80532515|FG000|Overall Study|Lost to Follow-up|27|||
27642320|NCT03287622|80532516|FG001|Overall Study|Lost to Follow-up|15|||
27743096|NCT03964415|80889458|FG000|Overall Study|Randomized but not treated|6|||
27743097|NCT03964415|80889459|FG001|Overall Study|Randomized but not treated|7|||
27743098|NCT00751881|80889460|FG000|Core Treatment Period|Not treated|1|||
27743099|NCT00751881|80889461|FG001|Core Treatment Period|Not treated|1|||
27743100|NCT00751881|80889462|FG002|Core Treatment Period|Not treated|2|||
27743101|NCT00751881|80889460|FG000|Core Treatment Period|Adverse Event|26|||
27743102|NCT00751881|80889461|FG001|Core Treatment Period|Adverse Event|54|||
27743103|NCT00751881|80889462|FG002|Core Treatment Period|Adverse Event|58|||
27743104|NCT00751881|80889460|FG000|Core Treatment Period|Lack of Efficacy|37|||
27642321|NCT03287622|80532515|FG000|Overall Study|No prescripion after surgery|28|||
27642322|NCT03287622|80532516|FG001|Overall Study|No prescripion after surgery|31|||
27642323|NCT03287622|80532515|FG000|Overall Study|prolonged Length of stay|2|||
27642324|NCT03287622|80532516|FG001|Overall Study|prolonged Length of stay|0|||
27642325|NCT03287622|80532515|FG000|Overall Study|surgery related|0|||
27642326|NCT03287622|80532516|FG001|Overall Study|surgery related|2|||
27642327|NCT00774397|80532518|FG000|Overall Study|Adverse Event|1|||
27642328|NCT00774397|80532519|FG001|Overall Study|Adverse Event|3|||
27642329|NCT00774397|80532520|FG002|Overall Study|Adverse Event|16|||
27642330|NCT00774397|80532521|FG003|Overall Study|Adverse Event|8|||
27743105|NCT00751881|80889461|FG001|Core Treatment Period|Lack of Efficacy|30|||
27743106|NCT00751881|80889462|FG002|Core Treatment Period|Lack of Efficacy|20|||
27743107|NCT00751881|80889460|FG000|Core Treatment Period|Poor compliance to protocol|15|||
27743108|NCT00751881|80889461|FG001|Core Treatment Period|Poor compliance to protocol|3|||
27743109|NCT00751881|80889462|FG002|Core Treatment Period|Poor compliance to protocol|4|||
27743110|NCT00751881|80889460|FG000|Core Treatment Period|Lost to Follow-up|6|||
27743111|NCT00751881|80889461|FG001|Core Treatment Period|Lost to Follow-up|4|||
27743112|NCT00751881|80889462|FG002|Core Treatment Period|Lost to Follow-up|3|||
27743113|NCT00751881|80889460|FG000|Core Treatment Period|Other: protocol deviation|3|||
27743114|NCT00751881|80889461|FG001|Core Treatment Period|Other: protocol deviation|3|||
27743115|NCT00751881|80889462|FG002|Core Treatment Period|Other: protocol deviation|7|||
27743116|NCT00751881|80889460|FG000|Core Treatment Period|Other: wish to parent|5|||
27743117|NCT00751881|80889461|FG001|Core Treatment Period|Other: wish to parent|7|||
27743118|NCT00751881|80889462|FG002|Core Treatment Period|Other: wish to parent|4|||
27743119|NCT00751881|80889460|FG000|Core Treatment Period|Other: personal/family constraints|6|||
27743120|NCT00751881|80889461|FG001|Core Treatment Period|Other: personal/family constraints|7|||
27743121|NCT00751881|80889462|FG002|Core Treatment Period|Other: personal/family constraints|10|||
27743122|NCT00751881|80889460|FG000|Core Treatment Period|Other: MS treatment change|6|||
27743123|NCT00751881|80889461|FG001|Core Treatment Period|Other: MS treatment change|4|||
27743124|NCT00751881|80889462|FG002|Core Treatment Period|Other: MS treatment change|4|||
27743125|NCT00751881|80889460|FG000|Core Treatment Period|Other: tolerability complaints|2|||
27743126|NCT00751881|80889461|FG001|Core Treatment Period|Other: tolerability complaints|0|||
27743127|NCT00751881|80889462|FG002|Core Treatment Period|Other: tolerability complaints|0|||
27743128|NCT00751881|80889460|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
27743129|NCT00751881|80889461|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
27642331|NCT00774397|80532522|FG004|Overall Study|Adverse Event|8|||
27642332|NCT00774397|80532523|FG005|Overall Study|Adverse Event|3|||
27642333|NCT00774397|80532524|FG006|Overall Study|Adverse Event|16|||
27642334|NCT00774397|80532518|FG000|Overall Study|Lack of Efficacy|11|||
27642335|NCT00774397|80532519|FG001|Overall Study|Lack of Efficacy|4|||
27642336|NCT00774397|80532520|FG002|Overall Study|Lack of Efficacy|5|||
27642337|NCT00774397|80532521|FG003|Overall Study|Lack of Efficacy|3|||
27743130|NCT00751881|80889462|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
27743131|NCT00751881|80889460|FG000|Extension Study Period|Adverse Event|18|||
27743132|NCT00751881|80889461|FG001|Extension Study Period|Adverse Event|20|||
27743133|NCT00751881|80889462|FG002|Extension Study Period|Adverse Event|21|||
27743134|NCT00751881|80889460|FG000|Extension Study Period|Lack of Efficacy|14|||
27743135|NCT00751881|80889461|FG001|Extension Study Period|Lack of Efficacy|10|||
27642338|NCT00774397|80532522|FG004|Overall Study|Lack of Efficacy|27|||
27642339|NCT00774397|80532523|FG005|Overall Study|Lack of Efficacy|15|||
27642340|NCT00774397|80532524|FG006|Overall Study|Lack of Efficacy|9|||
27642341|NCT00774397|80532518|FG000|Overall Study|Protocol Violation|0|||
27642342|NCT00774397|80532519|FG001|Overall Study|Protocol Violation|1|||
27642343|NCT00774397|80532520|FG002|Overall Study|Protocol Violation|3|||
27642344|NCT00774397|80532521|FG003|Overall Study|Protocol Violation|1|||
27642345|NCT00774397|80532522|FG004|Overall Study|Protocol Violation|2|||
27642346|NCT00774397|80532523|FG005|Overall Study|Protocol Violation|1|||
27642347|NCT00774397|80532524|FG006|Overall Study|Protocol Violation|0|||
27642348|NCT00774397|80532518|FG000|Overall Study|Lost to Follow-up|0|||
27642349|NCT00774397|80532519|FG001|Overall Study|Lost to Follow-up|1|||
27642350|NCT00774397|80532520|FG002|Overall Study|Lost to Follow-up|1|||
27642351|NCT00774397|80532521|FG003|Overall Study|Lost to Follow-up|1|||
27642352|NCT00774397|80532522|FG004|Overall Study|Lost to Follow-up|0|||
27642353|NCT00774397|80532523|FG005|Overall Study|Lost to Follow-up|1|||
27642354|NCT00774397|80532524|FG006|Overall Study|Lost to Follow-up|0|||
27642355|NCT00774397|80532518|FG000|Overall Study|Refused to continue trial medication|1|||
27642356|NCT00774397|80532519|FG001|Overall Study|Refused to continue trial medication|3|||
27642357|NCT00774397|80532520|FG002|Overall Study|Refused to continue trial medication|2|||
27642358|NCT00774397|80532521|FG003|Overall Study|Refused to continue trial medication|2|||
27642359|NCT00774397|80532522|FG004|Overall Study|Refused to continue trial medication|6|||
27642360|NCT00774397|80532523|FG005|Overall Study|Refused to continue trial medication|2|||
27642361|NCT00774397|80532524|FG006|Overall Study|Refused to continue trial medication|3|||
27642362|NCT00774397|80532518|FG000|Overall Study|Not treated|0|||
27642363|NCT00774397|80532519|FG001|Overall Study|Not treated|0|||
27642364|NCT00774397|80532520|FG002|Overall Study|Not treated|0|||
27642365|NCT00774397|80532521|FG003|Overall Study|Not treated|0|||
27642366|NCT00774397|80532522|FG004|Overall Study|Not treated|1|||
27642367|NCT00774397|80532523|FG005|Overall Study|Not treated|0|||
27642368|NCT00774397|80532524|FG006|Overall Study|Not treated|1|||
27642369|NCT00774397|80532518|FG000|Overall Study|Other than those stated above|1|||
27642370|NCT00774397|80532519|FG001|Overall Study|Other than those stated above|1|||
27642371|NCT00774397|80532520|FG002|Overall Study|Other than those stated above|3|||
27642372|NCT00774397|80532521|FG003|Overall Study|Other than those stated above|2|||
27642373|NCT00774397|80532522|FG004|Overall Study|Other than those stated above|2|||
27642374|NCT00774397|80532523|FG005|Overall Study|Other than those stated above|0|||
27642375|NCT00774397|80532524|FG006|Overall Study|Other than those stated above|1|||
27642376|NCT01376700|80532525|FG000|Overall Study|Sponsor terminated study early|8|||
27642377|NCT01376700|80532525|FG000|Overall Study|Low or high titer inhibitor|8|||
27642378|NCT00073749|80532526|FG000|Overall Study|Disease Progression|2|||
27642379|NCT00073749|80532527|FG001|Overall Study|Disease Progression|0|||
27642380|NCT00073749|80532528|FG002|Overall Study|Disease Progression|3|||
27642381|NCT00073749|80532529|FG003|Overall Study|Disease Progression|2|||
27642382|NCT00073749|80532530|FG004|Overall Study|Disease Progression|3|||
27642383|NCT00073749|80532531|FG005|Overall Study|Disease Progression|1|||
27642384|NCT00073749|80532532|FG006|Overall Study|Disease Progression|3|||
27642385|NCT00073749|80532526|FG000|Overall Study|Death|0|||
27642386|NCT00073749|80532527|FG001|Overall Study|Death|1|||
27642387|NCT00073749|80532528|FG002|Overall Study|Death|1|||
27642388|NCT00073749|80532529|FG003|Overall Study|Death|0|||
27642389|NCT00073749|80532530|FG004|Overall Study|Death|0|||
27642390|NCT00073749|80532531|FG005|Overall Study|Death|0|||
27642391|NCT00073749|80532532|FG006|Overall Study|Death|29|||
27642392|NCT00073749|80532526|FG000|Overall Study|Adverse Event|0|||
27642393|NCT00073749|80532527|FG001|Overall Study|Adverse Event|3|||
27642394|NCT00073749|80532528|FG002|Overall Study|Adverse Event|6|||
27642395|NCT00073749|80532529|FG003|Overall Study|Adverse Event|4|||
27933008|NCT00105508|81592016|FG001|Overall Study|Lost to Follow-up|0|||
27933009|NCT00105508|81592015|FG000|Overall Study|Protocol Violation|1|||
27642396|NCT00073749|80532530|FG004|Overall Study|Adverse Event|2|||
27642397|NCT00073749|80532531|FG005|Overall Study|Adverse Event|1|||
27642398|NCT00073749|80532532|FG006|Overall Study|Adverse Event|0|||
27642399|NCT00073749|80532526|FG000|Overall Study|Physician Decision|0|||
27642400|NCT00073749|80532527|FG001|Overall Study|Physician Decision|0|||
27642401|NCT00073749|80532528|FG002|Overall Study|Physician Decision|1|||
27642402|NCT00073749|80532529|FG003|Overall Study|Physician Decision|0|||
27642403|NCT00073749|80532530|FG004|Overall Study|Physician Decision|0|||
27642404|NCT00073749|80532531|FG005|Overall Study|Physician Decision|2|||
27642405|NCT00073749|80532532|FG006|Overall Study|Physician Decision|0|||
27642406|NCT00073749|80532526|FG000|Overall Study|Withdrawal by Subject|0|||
27642407|NCT00073749|80532527|FG001|Overall Study|Withdrawal by Subject|1|||
27933010|NCT00105508|81592016|FG001|Overall Study|Protocol Violation|2|||
27933011|NCT00105508|81592015|FG000|Overall Study|Other|8|||
27642408|NCT00073749|80532528|FG002|Overall Study|Withdrawal by Subject|0|||
27642409|NCT00073749|80532529|FG003|Overall Study|Withdrawal by Subject|0|||
27642410|NCT00073749|80532530|FG004|Overall Study|Withdrawal by Subject|1|||
27642411|NCT00073749|80532531|FG005|Overall Study|Withdrawal by Subject|0|||
27642412|NCT00073749|80532532|FG006|Overall Study|Withdrawal by Subject|2|||
27642413|NCT00073749|80532526|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
27933012|NCT00105508|81592016|FG001|Overall Study|Other|9|||
27642414|NCT00073749|80532527|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
27642415|NCT00073749|80532528|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
27642416|NCT00073749|80532529|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
27642417|NCT00073749|80532530|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
27642418|NCT00073749|80532531|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
27642419|NCT00073749|80532532|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
27642420|NCT00073749|80532526|FG000|Overall Study|Lost to Follow-up|0|||
27642421|NCT00073749|80532527|FG001|Overall Study|Lost to Follow-up|0|||
27642422|NCT00073749|80532528|FG002|Overall Study|Lost to Follow-up|0|||
27642423|NCT00073749|80532529|FG003|Overall Study|Lost to Follow-up|0|||
27642424|NCT00073749|80532530|FG004|Overall Study|Lost to Follow-up|0|||
27933013|NCT04243837|81592017|FG000|Overall Study|Adverse Event|2|||
27933014|NCT04243837|81592018|FG001|Overall Study|Adverse Event|1|||
27933015|NCT04243837|81592017|FG000|Overall Study|Withdrawal by Subject|4|||
27933016|NCT04243837|81592018|FG001|Overall Study|Withdrawal by Subject|2|||
27933017|NCT04243837|81592017|FG000|Overall Study|Covid-19 lock down|1|||
27933018|NCT04243837|81592018|FG001|Overall Study|Covid-19 lock down|0|||
27933019|NCT04243837|81592017|FG000|Overall Study|Study Terminated by Sponsor|11|||
27933020|NCT04243837|81592018|FG001|Overall Study|Study Terminated by Sponsor|12|||
27933021|NCT01121575|81592021|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
27933022|NCT01121575|81592022|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
27933023|NCT01121575|81592023|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
27933024|NCT01121575|81592024|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
27933025|NCT01121575|81592025|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
27933026|NCT01121575|81592026|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
27933027|NCT01121575|81592021|FG000|Overall Study|Unspecified Reasons|8|||
27933028|NCT01121575|81592022|FG001|Overall Study|Unspecified Reasons|6|||
27933029|NCT01121575|81592023|FG002|Overall Study|Unspecified Reasons|7|||
27933030|NCT01121575|81592024|FG003|Overall Study|Unspecified Reasons|5|||
27933031|NCT01121575|81592025|FG004|Overall Study|Unspecified Reasons|13|||
27933032|NCT01121575|81592026|FG005|Overall Study|Unspecified Reasons|10|||
27933033|NCT01121575|81592021|FG000|Overall Study|Death|6|||
27933034|NCT01121575|81592022|FG001|Overall Study|Death|0|||
27933035|NCT01121575|81592023|FG002|Overall Study|Death|0|||
27933036|NCT01121575|81592024|FG003|Overall Study|Death|1|||
27933037|NCT01121575|81592025|FG004|Overall Study|Death|7|||
27933038|NCT01121575|81592026|FG005|Overall Study|Death|1|||
27933039|NCT01479530|81592027|FG000|Overall Study|Adverse Event|5|||
27933040|NCT01479530|81592028|FG001|Overall Study|Adverse Event|6|||
27933041|NCT01479530|81592027|FG000|Overall Study|Lack of Efficacy|0|||
27933042|NCT01479530|81592028|FG001|Overall Study|Lack of Efficacy|1|||
27933043|NCT01479530|81592027|FG000|Overall Study|Protocol Violation|2|||
27933044|NCT01479530|81592028|FG001|Overall Study|Protocol Violation|3|||
27933045|NCT01479530|81592027|FG000|Overall Study|Withdrawal of Consent|3|||
27933046|NCT01479530|81592028|FG001|Overall Study|Withdrawal of Consent|2|||
27933047|NCT01452789|81592034|FG000|Overall Study|Withdrawal by Subject|3|||
27933048|NCT01452789|81592035|FG001|Overall Study|Withdrawal by Subject|2|||
27933049|NCT00326495|81592036|FG000|Overall Study|Switched to alternative treatment|1|||
27933050|NCT00326495|81592036|FG000|Overall Study|Disease progression before treatment|1|||
27933051|NCT00326495|81592036|FG000|Overall Study|Refused further treatment|2|||
27933052|NCT00326495|81592036|FG000|Overall Study|Subject off study before assessment|1|||
27933053|NCT00509600|81592039|FG000|Overall Study|Adverse Event|1|||
27642425|NCT00073749|80532531|FG005|Overall Study|Lost to Follow-up|0|||
27933054|NCT01646216|81592044|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
27933055|NCT01646216|81592045|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
27933056|NCT01646216|81592044|FG000|Overall Study|Did not complete training|0|||
27933057|NCT01646216|81592045|FG001|Overall Study|Did not complete training|2|||
27933058|NCT01646216|81592044|FG000|Overall Study|Investigator decision|1|||
27642426|NCT00073749|80532532|FG006|Overall Study|Lost to Follow-up|2|||
27642427|NCT00073749|80532526|FG000|Overall Study|Other|0|||
27642428|NCT00073749|80532527|FG001|Overall Study|Other|0|||
27642429|NCT00073749|80532528|FG002|Overall Study|Other|0|||
27933059|NCT01646216|81592045|FG001|Overall Study|Investigator decision|1|||
27933060|NCT01245049|81592049|FG000|Overall Study|Migrated/moved from study area|0|||
27933061|NCT01245049|81592050|FG001|Overall Study|Migrated/moved from study area|1|||
27642430|NCT00073749|80532529|FG003|Overall Study|Other|0|||
27642431|NCT00073749|80532530|FG004|Overall Study|Other|0|||
27642432|NCT00073749|80532531|FG005|Overall Study|Other|2|||
27642433|NCT00073749|80532532|FG006|Overall Study|Other|0|||
27933062|NCT01245049|81592049|FG000|Overall Study|Withdrawal by Subject|0|||
27933063|NCT01245049|81592050|FG001|Overall Study|Withdrawal by Subject|1|||
27933064|NCT01245049|81592049|FG000|Overall Study|Lost to Follow-up|1|||
27933065|NCT01245049|81592050|FG001|Overall Study|Lost to Follow-up|2|||
27933066|NCT02070991|81592051|FG000|Overall Study|Death|2|||
27933067|NCT02070991|81592052|FG001|Overall Study|Death|0|||
27933068|NCT02070991|81592051|FG000|Overall Study|Withdrawal by Subject|1|||
27933069|NCT02070991|81592052|FG001|Overall Study|Withdrawal by Subject|0|||
27642434|NCT00792636|80532538|FG000|Overall Study|Protocol Violation|17|||
27642435|NCT00792636|80532539|FG001|Overall Study|Protocol Violation|23|||
27743136|NCT00751881|80889462|FG002|Extension Study Period|Lack of Efficacy|20|||
27743137|NCT00751881|80889460|FG000|Extension Study Period|Lost to Follow-up|4|||
27743138|NCT00751881|80889461|FG001|Extension Study Period|Lost to Follow-up|9|||
27743139|NCT00751881|80889462|FG002|Extension Study Period|Lost to Follow-up|6|||
27743140|NCT00751881|80889460|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
27743141|NCT00751881|80889461|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
27743142|NCT00751881|80889462|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
27743143|NCT00751881|80889460|FG000|Extension Study Period|Other than specified above|26|||
27743144|NCT00751881|80889461|FG001|Extension Study Period|Other than specified above|30|||
27743145|NCT00751881|80889462|FG002|Extension Study Period|Other than specified above|18|||
27933070|NCT02400736|81592053|FG000|Overall Study|Lost to Follow-up|6|||
27933071|NCT02400736|81592054|FG001|Overall Study|Lost to Follow-up|6|||
27933072|NCT02400736|81592053|FG000|Overall Study|Withdrawal by Subject|2|||
27933073|NCT02400736|81592054|FG001|Overall Study|Withdrawal by Subject|1|||
27933074|NCT02400736|81592053|FG000|Overall Study|Moved from the area|3|||
27933075|NCT02400736|81592054|FG001|Overall Study|Moved from the area|1|||
27933076|NCT03020888|81592055|FG000|Overall Study|Physician Decision|4|||
27933077|NCT03020888|81592055|FG000|Overall Study|Withdrawal by Subject|6|||
27933078|NCT03020888|81592055|FG000|Overall Study|Insurance coverage|2|||
27933079|NCT03020888|81592055|FG000|Overall Study|Lost to Follow-up|1|||
27933080|NCT03336866|81592056|FG000|Overall Study|Lost to Follow-up|2|||
27933081|NCT03336866|81592057|FG001|Overall Study|Lost to Follow-up|0|||
27933082|NCT03336866|81592058|FG002|Overall Study|Lost to Follow-up|3|||
27933083|NCT03336866|81592056|FG000|Overall Study|Withdrawal by Subject|1|||
27933084|NCT03336866|81592057|FG001|Overall Study|Withdrawal by Subject|1|||
27933085|NCT03336866|81592058|FG002|Overall Study|Withdrawal by Subject|0|||
27933086|NCT03336866|81592056|FG000|Overall Study|Noncompliance with clinic house rules|0|||
27933087|NCT03336866|81592057|FG001|Overall Study|Noncompliance with clinic house rules|0|||
27933088|NCT03336866|81592058|FG002|Overall Study|Noncompliance with clinic house rules|1|||
27933089|NCT00770484|81592063|FG000|Overall Study|Withdrawal by Subject|1|||
27933090|NCT00770484|81592064|FG001|Overall Study|Withdrawal by Subject|0|||
27933091|NCT00997126|81592069|FG000|Overall Study|Physician Decision|7|||
27933092|NCT00997126|81592070|FG001|Overall Study|Physician Decision|11|||
27933093|NCT01016015|81592073|FG000|Overall Study|Not Treated|3|||
27933094|NCT01016015|81592073|FG000|Overall Study|Withdrawal by Subject|1|||
27933095|NCT01016015|81592073|FG000|Overall Study|Adverse Event|15|||
27933096|NCT01953354|81592076|FG000|Overall Study|Withdrawal by Subject|0|||
27933097|NCT01953354|81592077|FG001|Overall Study|Withdrawal by Subject|1|||
27933098|NCT01953354|81592076|FG000|Overall Study|Decision of Sponsor|0|||
27933099|NCT01953354|81592077|FG001|Overall Study|Decision of Sponsor|1|||
27933100|NCT01953354|81592076|FG000|Overall Study|Disease Exacerbation|1|||
27933101|NCT01953354|81592077|FG001|Overall Study|Disease Exacerbation|0|||
27933102|NCT03055195|81592078|FG000|Overall Study|Lack of Efficacy|1|||
27933103|NCT03055195|81592079|FG001|Overall Study|Lack of Efficacy|0|||
27933104|NCT03055195|81592078|FG000|Overall Study|Withdrawal by Subject|6|||
27933105|NCT03055195|81592079|FG001|Overall Study|Withdrawal by Subject|7|||
27933106|NCT03055195|81592078|FG000|Overall Study|Study Terminated by Sponsor|2|||
27933107|NCT03055195|81592079|FG001|Overall Study|Study Terminated by Sponsor|6|||
27933108|NCT03055195|81592078|FG000|Overall Study|Protocol Violation|2|||
27642436|NCT00792636|80532540|FG002|Overall Study|Protocol Violation|20|||
27642437|NCT00792636|80532538|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
27642438|NCT00792636|80532539|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
27642439|NCT00792636|80532540|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
27642440|NCT00792636|80532538|FG000|Overall Study|Lost to Follow-up|13|||
27642441|NCT00792636|80532539|FG001|Overall Study|Lost to Follow-up|19|||
27642442|NCT00792636|80532540|FG002|Overall Study|Lost to Follow-up|14|||
27642443|NCT00792636|80532538|FG000|Overall Study|Withdrew Consent|10|||
27642444|NCT00792636|80532539|FG001|Overall Study|Withdrew Consent|13|||
27642445|NCT00792636|80532540|FG002|Overall Study|Withdrew Consent|9|||
27642446|NCT00792636|80532538|FG000|Overall Study|Lack of Efficacy|3|||
27642447|NCT00792636|80532539|FG001|Overall Study|Lack of Efficacy|4|||
27743146|NCT00751101|80889463|FG000|Overall Study|Withdrawal by Subject|1|||
27642448|NCT00792636|80532540|FG002|Overall Study|Lack of Efficacy|13|||
27642449|NCT00792636|80532538|FG000|Overall Study|Adverse Event|4|||
27642450|NCT00792636|80532539|FG001|Overall Study|Adverse Event|2|||
27743147|NCT00751101|80889464|FG001|Overall Study|Withdrawal by Subject|0|||
27743148|NCT00751101|80889463|FG000|Overall Study|No HFS / Never Started Patch/|0|||
27933109|NCT03055195|81592079|FG001|Overall Study|Protocol Violation|1|||
27933110|NCT03055195|81592078|FG000|Overall Study|Physician Decision|1|||
27933111|NCT03055195|81592079|FG001|Overall Study|Physician Decision|0|||
27933112|NCT00604383|81592080|FG000|Overall Study|Withdrawal by Subject|33|||
27933113|NCT00604383|81592081|FG001|Overall Study|Withdrawal by Subject|31|||
27933114|NCT00604383|81592080|FG000|Overall Study|Lost to Follow-up|24|||
27933115|NCT00604383|81592081|FG001|Overall Study|Lost to Follow-up|19|||
27933116|NCT00604383|81592080|FG000|Overall Study|Death|14|||
27933117|NCT00604383|81592081|FG001|Overall Study|Death|22|||
27933118|NCT00604383|81592080|FG000|Overall Study|Adverse Event|16|||
27933119|NCT00604383|81592081|FG001|Overall Study|Adverse Event|9|||
27933120|NCT00604383|81592080|FG000|Overall Study|Physician Decision|0|||
27933121|NCT00604383|81592081|FG001|Overall Study|Physician Decision|3|||
27550682|NCT03132220|80203448|FG000|Overall Study|Withdrawal by Subject|1|||
27743149|NCT00751101|80889464|FG001|Overall Study|No HFS / Never Started Patch/|4|||
27743150|NCT00751101|80889463|FG000|Overall Study|Never began capecitabine|1|||
27743151|NCT00751101|80889464|FG001|Overall Study|Never began capecitabine|0|||
27933122|NCT00574951|81592087|FG000|Overall Study|Ineligible - improper prior treatment|1|||
27933123|NCT00066170|81592088|FG000|Overall Study|Adverse Event|2|||
27933124|NCT00066170|81592089|FG001|Overall Study|Adverse Event|4|||
27933125|NCT00066170|81592090|FG002|Overall Study|Adverse Event|1|||
27933126|NCT00066170|81592091|FG003|Overall Study|Adverse Event|7|||
27933127|NCT00066170|81592088|FG000|Overall Study|Serious Adverse Event|0|||
27933128|NCT00066170|81592089|FG001|Overall Study|Serious Adverse Event|0|||
27933129|NCT00066170|81592090|FG002|Overall Study|Serious Adverse Event|1|||
27933130|NCT00066170|81592091|FG003|Overall Study|Serious Adverse Event|1|||
27933131|NCT00066170|81592088|FG000|Overall Study|Lost to Follow-up|0|||
27550683|NCT03132220|80203449|FG001|Overall Study|Withdrawal by Subject|4|||
27743152|NCT00751101|80889463|FG000|Overall Study|Physician Decision|0|||
27743153|NCT00751101|80889464|FG001|Overall Study|Physician Decision|1|||
27550684|NCT02651922|80203454|FG000|Overall Study|due to exclusion criteria|2|||
27550685|NCT01153347|80203456|FG000|Overall Study|Withdrawal by Subject|7|||
27550686|NCT01153347|80203457|FG001|Overall Study|Withdrawal by Subject|7|||
27550687|NCT01153347|80203458|FG002|Overall Study|Withdrawal by Subject|7|||
27550688|NCT01153347|80203459|FG003|Overall Study|Withdrawal by Subject|7|||
27550689|NCT01153347|80203456|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
27550690|NCT01153347|80203457|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
27550691|NCT01153347|80203458|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
27550692|NCT01153347|80203459|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
27550693|NCT01153347|80203456|FG000|Overall Study|Adverse Event|3|||
27550694|NCT01153347|80203457|FG001|Overall Study|Adverse Event|9|||
27550695|NCT01153347|80203458|FG002|Overall Study|Adverse Event|21|||
27550696|NCT01153347|80203459|FG003|Overall Study|Adverse Event|7|||
27642451|NCT00792636|80532540|FG002|Overall Study|Adverse Event|3|||
27642452|NCT00792636|80532538|FG000|Overall Study|Investigator Discretion|2|||
27642453|NCT00792636|80532539|FG001|Overall Study|Investigator Discretion|0|||
27642454|NCT00792636|80532540|FG002|Overall Study|Investigator Discretion|2|||
27642455|NCT00623194|80532541|FG000|Overall Study|Lack of Efficacy|1|||
27642456|NCT00623194|80532541|FG000|Overall Study|Protocol Violation|3|||
27642457|NCT00623194|80532541|FG000|Overall Study|Unclassified|1|||
27642458|NCT01964300|80532542|FG000|Overall Study|Ineligible after enrollment|0|||
27642459|NCT01964300|80532543|FG001|Overall Study|Ineligible after enrollment|1|||
27642460|NCT01964300|80532542|FG000|Overall Study|Adverse Event|1|||
27642461|NCT01964300|80532543|FG001|Overall Study|Adverse Event|1|||
27642462|NCT01964300|80532542|FG000|Overall Study|Lack of Efficacy|3|||
27642463|NCT01964300|80532543|FG001|Overall Study|Lack of Efficacy|5|||
27642464|NCT01964300|80532542|FG000|Overall Study|Withdrawal by Subject|0|||
27642465|NCT01964300|80532543|FG001|Overall Study|Withdrawal by Subject|1|||
27642466|NCT01964300|80532542|FG000|Overall Study|To receive alternative therapy|1|||
27642467|NCT01964300|80532543|FG001|Overall Study|To receive alternative therapy|2|||
27642468|NCT01964300|80532542|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
27642469|NCT01964300|80532543|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
27642470|NCT01964300|80532542|FG000|Overall Study|Weight criteria not met|0|||
27642471|NCT01964300|80532543|FG001|Overall Study|Weight criteria not met|1|||
27642472|NCT02132949|80532547|FG000|Overall Study|Death|7|||
27642473|NCT02132949|80532548|FG001|Overall Study|Death|13|||
27642474|NCT02132949|80532547|FG000|Overall Study|Lost to Follow-up|14|||
27642475|NCT02132949|80532548|FG001|Overall Study|Lost to Follow-up|4|||
27642476|NCT02132949|80532547|FG000|Overall Study|Withdrawal by Subject|6|||
27642477|NCT02132949|80532548|FG001|Overall Study|Withdrawal by Subject|5|||
27642478|NCT02132949|80532547|FG000|Overall Study|Noncompliance|5|||
27642479|NCT02132949|80532548|FG001|Overall Study|Noncompliance|1|||
27642480|NCT02132949|80532547|FG000|Overall Study|Physician Decision|3|||
27642481|NCT02132949|80532548|FG001|Overall Study|Physician Decision|1|||
27642482|NCT02132949|80532547|FG000|Overall Study|Disease Progression|3|||
27642483|NCT02132949|80532548|FG001|Overall Study|Disease Progression|0|||
27642484|NCT02132949|80532547|FG000|Overall Study|Adverse Event|2|||
27642485|NCT02132949|80532548|FG001|Overall Study|Adverse Event|1|||
27642486|NCT02132949|80532547|FG000|Overall Study|Withdrew Prior to Treatment|1|||
27642487|NCT02132949|80532548|FG001|Overall Study|Withdrew Prior to Treatment|2|||
27743154|NCT03090737|80889469|FG000|Overall Study|Other reasons|1|||
27743155|NCT03090737|80889469|FG000|Overall Study|Completed treatment as per protocol|17|||
27933132|NCT00066170|81592089|FG001|Overall Study|Lost to Follow-up|1|||
27933133|NCT00066170|81592090|FG002|Overall Study|Lost to Follow-up|0|||
27933134|NCT00066170|81592091|FG003|Overall Study|Lost to Follow-up|0|||
27933135|NCT00066170|81592088|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
27933136|NCT00066170|81592089|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
27642488|NCT02132949|80532547|FG000|Overall Study|Reason Unspecified|0|||
27642489|NCT02132949|80532548|FG001|Overall Study|Reason Unspecified|1|||
27642490|NCT02633215|80532549|FG000|Overall Study|Lost to Follow-up|2|||
27642491|NCT02633215|80532550|FG001|Overall Study|Lost to Follow-up|3|||
27642492|NCT01637402|80532553|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
27642493|NCT01637402|80532554|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
27642494|NCT01637402|80532553|FG000|Standard Dose Regimen|Adverse Event|1|||
27642495|NCT01637402|80532554|FG001|Standard Dose Regimen|Adverse Event|0|||
27642496|NCT01637402|80532553|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
27642497|NCT01637402|80532554|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
27642498|NCT01637402|80532553|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
27642499|NCT01637402|80532554|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
27642500|NCT01637402|80532553|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
27642501|NCT01637402|80532554|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
27642502|NCT01637402|80532553|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
27642503|NCT01637402|80532554|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
27642504|NCT03014453|80532556|FG000|Overall Study|Lost to Follow-up|12|||
27642505|NCT03014453|80532556|FG000|Overall Study|Discontinued GER|3|||
27642506|NCT03014453|80532556|FG000|Overall Study|Excluded|19|||
27642507|NCT03014453|80532556|FG000|Overall Study|Refused to take part in|37|||
27642508|NCT03951805|80532566|FG000|Overall Study|Adverse Event|1|||
27642509|NCT03951805|80532567|FG001|Overall Study|Adverse Event|0|||
27642510|NCT03951805|80532568|FG002|Overall Study|Adverse Event|0|||
27642511|NCT03951805|80532569|FG003|Overall Study|Adverse Event|0|||
27642512|NCT00003222|80532570|FG000|Overall Study|Physician Decision|0|||
27642513|NCT00003222|80532571|FG001|Overall Study|Physician Decision|1|||
27642514|NCT04121546|80532572|FG000|Overall Study|Lost to Follow-up|1|||
27933137|NCT00066170|81592090|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
27933138|NCT00066170|81592091|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
27933139|NCT00066170|81592088|FG000|Overall Study|Protocol Violation|3|||
27933140|NCT00066170|81592089|FG001|Overall Study|Protocol Violation|0|||
27933141|NCT00066170|81592090|FG002|Overall Study|Protocol Violation|0|||
27933142|NCT00066170|81592091|FG003|Overall Study|Protocol Violation|0|||
27933143|NCT00066170|81592088|FG000|Overall Study|Other|1|||
27933144|NCT00066170|81592089|FG001|Overall Study|Other|5|||
27933145|NCT00066170|81592090|FG002|Overall Study|Other|2|||
27933146|NCT00066170|81592091|FG003|Overall Study|Other|0|||
27933147|NCT00812097|81592092|FG000|Overall Study|Death|3|||
27933148|NCT00812097|81592093|FG001|Overall Study|Death|10|||
27933149|NCT00812097|81592094|FG002|Overall Study|Death|3|||
27933150|NCT00812097|81592095|FG003|Overall Study|Death|3|||
27933151|NCT00812097|81592092|FG000|Overall Study|Withdrawal by Subject|14|||
27933152|NCT00812097|81592093|FG001|Overall Study|Withdrawal by Subject|12|||
27933153|NCT00812097|81592094|FG002|Overall Study|Withdrawal by Subject|8|||
27933154|NCT00812097|81592095|FG003|Overall Study|Withdrawal by Subject|2|||
27933155|NCT00812097|81592092|FG000|Overall Study|Lost to Follow-up|90|||
27933156|NCT00812097|81592093|FG001|Overall Study|Lost to Follow-up|14|||
27933157|NCT00812097|81592094|FG002|Overall Study|Lost to Follow-up|17|||
27933158|NCT00812097|81592095|FG003|Overall Study|Lost to Follow-up|5|||
27933159|NCT00812097|81592092|FG000|Overall Study|Explantation of study device(s)|27|||
27933160|NCT00812097|81592093|FG001|Overall Study|Explantation of study device(s)|29|||
27933161|NCT00812097|81592094|FG002|Overall Study|Explantation of study device(s)|14|||
27933162|NCT00812097|81592095|FG003|Overall Study|Explantation of study device(s)|20|||
27933163|NCT00812097|81592092|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
27933164|NCT00812097|81592093|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
27933165|NCT00812097|81592094|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
27933166|NCT00812097|81592095|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
27933167|NCT00871000|81592096|FG000|Overall Study|Withdrawal by Subject|1|||
27933168|NCT00871000|81592097|FG001|Overall Study|Withdrawal by Subject|0|||
27933169|NCT00977561|81592098|FG000|Overall Study|Death|3|||
27933170|NCT00977561|81592099|FG001|Overall Study|Death|2|||
27933171|NCT00977561|81592098|FG000|Overall Study|Study terminated|0|||
27933172|NCT00977561|81592099|FG001|Overall Study|Study terminated|2|||
27550697|NCT01153347|80203456|FG000|Overall Study|Severe non-compliance to protocol|6|||
27642515|NCT04121546|80532573|FG001|Overall Study|Lost to Follow-up|3|||
27642516|NCT01952366|80532578|FG000|Overall Study|Death|22|||
27642517|NCT01952366|80532578|FG000|Overall Study|Withdrawal by Subject|9|||
27933173|NCT00977561|81592098|FG000|Overall Study|Other|2|||
27933174|NCT00977561|81592099|FG001|Overall Study|Other|0|||
27933175|NCT01783938|81592102|FG000|Overall Study|Disease Progression|18|||
27933176|NCT01783938|81592103|FG001|Overall Study|Disease Progression|41|||
27933177|NCT01783938|81592102|FG000|Overall Study|Study Drug Toxicity|27|||
27933178|NCT01783938|81592103|FG001|Overall Study|Study Drug Toxicity|14|||
27933179|NCT01783938|81592102|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
27933180|NCT01783938|81592103|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
27933181|NCT01783938|81592102|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
27933182|NCT01783938|81592103|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
27933183|NCT01783938|81592102|FG000|Overall Study|Participant Withdrew Consent|2|||
27933184|NCT01783938|81592103|FG001|Overall Study|Participant Withdrew Consent|0|||
27933185|NCT01783938|81592102|FG000|Overall Study|Maximum Clinical Benefit|1|||
27642518|NCT00811941|80532579|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
27642519|NCT00811941|80532580|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
27642520|NCT00811941|80532579|FG000|All Treated Patients|Adverse Event|2|||
27642521|NCT00811941|80532580|FG001|All Treated Patients|Adverse Event|43|||
27642522|NCT00811941|80532579|FG000|All Treated Patients|Lack of Efficacy|2|||
27642523|NCT00811941|80532580|FG001|All Treated Patients|Lack of Efficacy|3|||
27642524|NCT00811941|80532579|FG000|All Treated Patients|Non-compliance|1|||
27642525|NCT00811941|80532580|FG001|All Treated Patients|Non-compliance|8|||
27642526|NCT00811941|80532579|FG000|All Treated Patients|Protocol Violation|5|||
27642527|NCT00811941|80532580|FG001|All Treated Patients|Protocol Violation|17|||
27642528|NCT00811941|80532579|FG000|All Treated Patients|Withdrawal by Subject|35|||
27743156|NCT03090737|80889469|FG000|Overall Study|Maximum clinical benefit|2|||
27743157|NCT03090737|80889469|FG000|Overall Study|Adverse event unrelated to study drug|7|||
27743158|NCT03090737|80889469|FG000|Overall Study|Study drug toxicity|4|||
27743159|NCT03090737|80889469|FG000|Overall Study|Disease progression|98|||
27743160|NCT00091390|80889472|FG000|Overall Study|Protocol Violation|1|||
27743161|NCT00091390|80889472|FG000|Overall Study|No protocol treatment|3|||
27743162|NCT01070303|80889474|FG000|Overall Study|Adverse Event|39|||
27743163|NCT01070303|80889474|FG000|Overall Study|Withdrawal by Subject|20|||
27743164|NCT01070303|80889474|FG000|Overall Study|Lost to Follow-up|9|||
27743165|NCT01070303|80889474|FG000|Overall Study|Protocol Violation|0|||
27933186|NCT01783938|81592103|FG001|Overall Study|Maximum Clinical Benefit|0|||
27933187|NCT01783938|81592102|FG000|Overall Study|Other Reasons|3|||
27933188|NCT01783938|81592103|FG001|Overall Study|Other Reasons|1|||
27933189|NCT01943825|81592109|FG000|Overall Study|Lost to Follow-up|9|||
27933190|NCT01943825|81592110|FG001|Overall Study|Lost to Follow-up|3|||
27933191|NCT01943825|81592111|FG002|Overall Study|Lost to Follow-up|12|||
27933192|NCT01943825|81592112|FG003|Overall Study|Lost to Follow-up|8|||
27933193|NCT01943825|81592109|FG000|Overall Study|Withdrawal by Subject|1|||
27933194|NCT01943825|81592110|FG001|Overall Study|Withdrawal by Subject|0|||
27933195|NCT01943825|81592111|FG002|Overall Study|Withdrawal by Subject|3|||
27933196|NCT01943825|81592112|FG003|Overall Study|Withdrawal by Subject|2|||
27933197|NCT01943825|81592109|FG000|Overall Study|Other than specified above|0|||
27933198|NCT01943825|81592110|FG001|Overall Study|Other than specified above|1|||
27933199|NCT01943825|81592111|FG002|Overall Study|Other than specified above|0|||
27933200|NCT01943825|81592112|FG003|Overall Study|Other than specified above|1|||
27933201|NCT01108796|81592113|FG000|Overall Study|Adverse Event|0|||
27933202|NCT01108796|81592114|FG001|Overall Study|Adverse Event|1|||
27933203|NCT01108796|81592113|FG000|Overall Study|Lost to Follow-up|7|||
27933204|NCT01108796|81592114|FG001|Overall Study|Lost to Follow-up|6|||
27933205|NCT03994120|81592115|FG000|Overall Study|Lost to Follow-up|3|||
27933206|NCT03994120|81592116|FG001|Overall Study|Lost to Follow-up|1|||
27933207|NCT01879852|81592117|FG000|Overall Study|Withdrawal by Subject|2|||
27933208|NCT01879852|81592118|FG001|Overall Study|Withdrawal by Subject|0|||
27933209|NCT01684033|81592120|FG000|Period 1, First 30 Days|Adverse Event|1|||
27933210|NCT01684033|81592121|FG001|Period 1, First 30 Days|Adverse Event|1|||
27933211|NCT01684033|81592120|FG000|Period 1, First 30 Days|Noncompliance|1|||
27933212|NCT01684033|81592121|FG001|Period 1, First 30 Days|Noncompliance|0|||
27933213|NCT01684033|81592120|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
27933214|NCT01684033|81592121|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
27933215|NCT01684033|81592120|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
27933216|NCT01684033|81592121|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
27933217|NCT01684033|81592120|FG000|Period 2, Second 30 Days|Adverse Event|1|||
27933218|NCT01684033|81592121|FG001|Period 2, Second 30 Days|Adverse Event|0|||
27933219|NCT02082483|81592122|FG000|Overall Study|Lost to Follow-up|1|||
27933220|NCT02082483|81592123|FG001|Overall Study|Lost to Follow-up|1|||
27642529|NCT00811941|80532580|FG001|All Treated Patients|Withdrawal by Subject|94|||
27642530|NCT00811941|80532579|FG000|All Treated Patients|Lost to Follow-up|3|||
27743166|NCT01070303|80889474|FG000|Overall Study|Lack of Efficacy|2|||
27743167|NCT01070303|80889474|FG000|Overall Study|Administrative Reason|1|||
27743168|NCT01070303|80889474|FG000|Overall Study|Other|18|||
27743169|NCT04579393|80889476|FG000|Overall Study|Withdrawal by Subject|2|||
27933221|NCT02082483|81592122|FG000|Overall Study|Withdrawal by Subject|2|||
27933222|NCT02082483|81592123|FG001|Overall Study|Withdrawal by Subject|1|||
27933223|NCT02082483|81592122|FG000|Overall Study|Physician Decision|1|||
27933224|NCT02082483|81592123|FG001|Overall Study|Physician Decision|1|||
27933225|NCT02082483|81592122|FG000|Overall Study|Death|2|||
27933226|NCT02082483|81592123|FG001|Overall Study|Death|3|||
27933227|NCT01750281|81592124|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
27933228|NCT01750281|81592125|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
27743170|NCT04579393|80889477|FG001|Overall Study|Withdrawal by Subject|2|||
27743171|NCT04579393|80889476|FG000|Overall Study|Death|1|||
27743172|NCT04579393|80889477|FG001|Overall Study|Death|3|||
27743173|NCT03515538|80889485|FG000|Overall Study|Lack of Efficacy|2|||
27743174|NCT03515538|80889486|FG001|Overall Study|Lack of Efficacy|0|||
27743175|NCT03515538|80889487|FG002|Overall Study|Lack of Efficacy|2|||
27743176|NCT03515538|80889488|FG003|Overall Study|Lack of Efficacy|0|||
27743177|NCT03515538|80889485|FG000|Overall Study|Death|0|||
27743178|NCT03515538|80889486|FG001|Overall Study|Death|0|||
27743179|NCT03515538|80889487|FG002|Overall Study|Death|1|||
27743180|NCT03515538|80889488|FG003|Overall Study|Death|0|||
27743181|NCT03515538|80889485|FG000|Overall Study|Protocol Violation|0|||
27743182|NCT03515538|80889486|FG001|Overall Study|Protocol Violation|0|||
27743183|NCT03515538|80889487|FG002|Overall Study|Protocol Violation|0|||
27743184|NCT03515538|80889488|FG003|Overall Study|Protocol Violation|1|||
27743185|NCT03515538|80889485|FG000|Overall Study|Screen failure (baseline dropout)|0|||
27743186|NCT03515538|80889486|FG001|Overall Study|Screen failure (baseline dropout)|1|||
27743187|NCT03515538|80889487|FG002|Overall Study|Screen failure (baseline dropout)|0|||
27743188|NCT03515538|80889488|FG003|Overall Study|Screen failure (baseline dropout)|0|||
27743189|NCT03515538|80889485|FG000|Overall Study|Withdrawal by Subject|2|||
27743190|NCT03515538|80889486|FG001|Overall Study|Withdrawal by Subject|2|||
27743191|NCT03515538|80889487|FG002|Overall Study|Withdrawal by Subject|1|||
27743192|NCT03515538|80889488|FG003|Overall Study|Withdrawal by Subject|3|||
27743193|NCT03515538|80889485|FG000|Overall Study|Physician Decision|1|||
27743194|NCT03515538|80889486|FG001|Overall Study|Physician Decision|0|||
27743195|NCT03515538|80889487|FG002|Overall Study|Physician Decision|0|||
27743196|NCT03515538|80889488|FG003|Overall Study|Physician Decision|1|||
27743197|NCT03238248|80889489|FG000|Overall Study|Death|5|||
27743198|NCT03238248|80889489|FG000|Overall Study|Withdrawal by Subject|7|||
27743199|NCT03238248|80889489|FG000|Overall Study|Participant proceeding to transplant|10|||
27743200|NCT03238248|80889489|FG000|Overall Study|Lack of Efficacy|4|||
27933229|NCT01750281|81592126|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
27933230|NCT01750281|81592124|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
27933231|NCT01750281|81592125|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
27933232|NCT01750281|81592126|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
27933233|NCT01750281|81592124|FG000|Overall Study|Did not receive treatment|0|||
27933234|NCT01750281|81592125|FG001|Overall Study|Did not receive treatment|1|||
27933235|NCT01750281|81592126|FG002|Overall Study|Did not receive treatment|0|||
27642531|NCT00811941|80532580|FG001|All Treated Patients|Lost to Follow-up|12|||
27642532|NCT00811941|80532579|FG000|All Treated Patients|Other Reason|4|||
27642533|NCT00811941|80532580|FG001|All Treated Patients|Other Reason|14|||
27642534|NCT01932970|80532599|FG000|Overall Study|Withdrawal by Subject|5|||
27642535|NCT01932970|80532599|FG000|Overall Study|Death|1|||
27642536|NCT01932970|80532599|FG000|Overall Study|Lost to Follow-up|2|||
27642537|NCT01932970|80532599|FG000|Overall Study|Protocol Specified Criteria|10|||
27642538|NCT00945321|80532600|FG000|Period 1|Adverse Event|0|||
27642539|NCT00945321|80532601|FG001|Period 1|Adverse Event|0|||
27642540|NCT00945321|80532602|FG002|Period 1|Adverse Event|0|||
27642541|NCT00945321|80532603|FG003|Period 1|Adverse Event|0|||
27642542|NCT00945321|80532604|FG004|Period 1|Adverse Event|1|||
27642543|NCT00945321|80532605|FG005|Period 1|Adverse Event|0|||
27642544|NCT00945321|80532600|FG000|Period 4|Lost to Follow-up|0|||
27743201|NCT03238248|80889489|FG000|Overall Study|Physician Decision|3|||
27743202|NCT03238248|80889489|FG000|Overall Study|Transitioning to another study|1|||
27743203|NCT03238248|80889489|FG000|Overall Study|No longer benefiting|1|||
27933236|NCT00887588|81592127|FG000|Core Period|Death|1|||
27933237|NCT00887588|81592128|FG001|Core Period|Death|1|||
27933238|NCT00887588|81592127|FG000|Core Period|Lost to Follow-up|3|||
27933239|NCT00887588|81592128|FG001|Core Period|Lost to Follow-up|1|||
27933240|NCT00887588|81592127|FG000|Core Period|Withdrawal by Subject|6|||
27933241|NCT00887588|81592128|FG001|Core Period|Withdrawal by Subject|8|||
27933242|NCT00887588|81592127|FG000|Core Period|Adverse Event|9|||
27933243|NCT00887588|81592128|FG001|Core Period|Adverse Event|11|||
27933244|NCT00887588|81592127|FG000|Extension Period|Adverse Event|4|||
27642545|NCT00945321|80532601|FG001|Period 4|Lost to Follow-up|0|||
27743204|NCT03238248|80889489|FG000|Overall Study|Other complicating disease|1|||
27743205|NCT03238248|80889489|FG000|Overall Study|Adverse Event|5|||
27743206|NCT03238248|80889489|FG000|Overall Study|Disease progression|26|||
27743207|NCT03238248|80889489|FG000|Overall Study|N/A participant is still on treatment|1|||
27642546|NCT00945321|80532602|FG002|Period 4|Lost to Follow-up|0|||
27743208|NCT03238248|80889489|FG000|Overall Study|Decline in condition|1|||
27743209|NCT03238248|80889489|FG000|Overall Study|Alternative therapy|2|||
27743210|NCT03237845|80889490|FG000|Overall Study|Adverse Event|0|||
27743211|NCT03237845|80889491|FG001|Overall Study|Adverse Event|1|||
27743212|NCT03237845|80889490|FG000|Overall Study|Lost to Follow-up|13|||
27743213|NCT03237845|80889491|FG001|Overall Study|Lost to Follow-up|10|||
27933245|NCT00887588|81592128|FG001|Extension Period|Adverse Event|4|||
27933246|NCT00887588|81592127|FG000|Extension Period|Death|0|||
27933247|NCT00887588|81592128|FG001|Extension Period|Death|1|||
27933248|NCT00887588|81592127|FG000|Extension Period|Protocol deviation|1|||
27933249|NCT00887588|81592128|FG001|Extension Period|Protocol deviation|0|||
27933250|NCT00887588|81592127|FG000|Extension Period|Lost to Follow-up|1|||
27933251|NCT00887588|81592128|FG001|Extension Period|Lost to Follow-up|0|||
27933252|NCT00896233|81592129|FG000|Overall Study|Claustrophobia during MRI|1|||
27933253|NCT03019588|81592130|FG000|Overall Study|Death|44|||
27933254|NCT03019588|81592131|FG001|Overall Study|Death|46|||
27933255|NCT03019588|81592130|FG000|Overall Study|Study terminated by Sponsor|3|||
27933256|NCT03019588|81592131|FG001|Overall Study|Study terminated by Sponsor|1|||
27933257|NCT01428128|81592132|FG000|Overall Study|Withdrawal by Subject|4|||
27933258|NCT01428128|81592132|FG000|Overall Study|Screen failure by p53|10|||
27933259|NCT01428128|81592132|FG000|Overall Study|Received Neulasta in one cycle|2|||
27933260|NCT01428128|81592132|FG000|Overall Study|Adverse Event|1|||
27933261|NCT02453191|81592133|FG000|Overall Study|Withdrawal by Subject|1|||
27933262|NCT00620035|81592134|FG000|Overall Study|Adverse Event|106|||
27933263|NCT00620035|81592134|FG000|Overall Study|Withdrawal of Informed Consent|1|||
27933264|NCT00620035|81592134|FG000|Overall Study|Other Reason|38|||
27933265|NCT02400580|81592137|FG000|Overall Study|Withdrawal by Subject|1|||
27933266|NCT02400580|81592138|FG001|Overall Study|Withdrawal by Subject|1|||
27933267|NCT02400580|81592137|FG000|Overall Study|Adverse Event|1|||
27933268|NCT02400580|81592138|FG001|Overall Study|Adverse Event|0|||
27933269|NCT00182637|81592140|FG000|Overall Study|Adverse Event|2|||
27933270|NCT00182637|81592140|FG000|Overall Study|Disease Progression|1|||
27933271|NCT00376506|81592141|FG000|Overall Study|Death|0|||
27743214|NCT03237845|80889490|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
27743215|NCT03237845|80889491|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
27743216|NCT03237845|80889490|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
27743217|NCT03237845|80889491|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
27933272|NCT00376506|81592142|FG001|Overall Study|Death|2|||
27933273|NCT03467945|81592144|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27933274|NCT03467945|81592145|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27933275|NCT03467945|81592146|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27933276|NCT03467945|81592147|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27933277|NCT03467945|81592144|FG000|Treatment Period 3|Withdrawal by Subject|1|||
27933278|NCT03467945|81592145|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27933279|NCT03467945|81592146|FG002|Treatment Period 3|Withdrawal by Subject|2|||
27933280|NCT03467945|81592147|FG003|Treatment Period 3|Withdrawal by Subject|1|||
27933281|NCT02958527|81592150|FG000|Overall Study|Not collected CRFs|12|||
27933282|NCT03331562|81592151|FG000|Overall Study|Adverse Event|2|||
27933283|NCT03331562|81592152|FG001|Overall Study|Adverse Event|0|||
27933284|NCT03331562|81592151|FG000|Overall Study|Death|1|||
27933285|NCT03331562|81592152|FG001|Overall Study|Death|0|||
27933286|NCT00471107|81592159|FG000|Overall Study|Technical problems/data loss|3|||
27933287|NCT00471107|81592160|FG001|Overall Study|Technical problems/data loss|1|||
27933288|NCT00471107|81592161|FG002|Overall Study|Technical problems/data loss|3|||
27933289|NCT01778985|81592162|FG000|Overall Study|Lost to Follow-up|1|||
27933290|NCT01778985|81592163|FG001|Overall Study|Lost to Follow-up|0|||
27933291|NCT01778985|81592162|FG000|Overall Study|Physician Decision|2|||
27933292|NCT01778985|81592163|FG001|Overall Study|Physician Decision|2|||
27933293|NCT01778985|81592162|FG000|Overall Study|Protocol Violation|4|||
27933294|NCT01778985|81592163|FG001|Overall Study|Protocol Violation|1|||
27933295|NCT03072875|81592164|FG000|Overall Study|Lost to Follow-up|1|||
27933296|NCT01986751|81592165|FG000|Overall Study|improperly consented|10|||
27933297|NCT01986751|81592166|FG001|Overall Study|improperly consented|2|||
27933298|NCT00710970|81592183|FG000|Overall Study|Never took drug|3|||
27933299|NCT00245570|81592189|FG000|Washout Between Periods III and IV|Adverse Event|0|||
27933300|NCT00245570|81592190|FG001|Washout Between Periods III and IV|Adverse Event|1|||
27933301|NCT00245570|81592191|FG002|Washout Between Periods III and IV|Adverse Event|0|||
27933302|NCT00245570|81592192|FG003|Washout Between Periods III and IV|Adverse Event|0|||
27933303|NCT00245570|81592193|FG004|Washout Between Periods III and IV|Adverse Event|0|||
27933304|NCT00245570|81592194|FG005|Washout Between Periods III and IV|Adverse Event|0|||
27933305|NCT00311168|81592201|FG000|First Intervention|Withdrawal by Subject|2|||
27933306|NCT00311168|81592202|FG001|First Intervention|Withdrawal by Subject|2|||
27933307|NCT00311168|81592201|FG000|First Intervention|Lost to Follow-up|1|||
27933308|NCT00311168|81592202|FG001|First Intervention|Lost to Follow-up|1|||
27933309|NCT00311168|81592201|FG000|First Intervention|Protocol Violation|1|||
27743218|NCT03237845|80889490|FG000|Overall Study|Physician Decision|1|||
27743219|NCT03237845|80889491|FG001|Overall Study|Physician Decision|2|||
27743220|NCT03237845|80889490|FG000|Overall Study|Pregnancy|1|||
27933310|NCT00311168|81592202|FG001|First Intervention|Protocol Violation|1|||
27933311|NCT00311168|81592201|FG000|First Intervention|Adverse Event|1|||
27933312|NCT00311168|81592202|FG001|First Intervention|Adverse Event|0|||
27933313|NCT00311168|81592201|FG000|First Intervention|Other|2|||
27933314|NCT00311168|81592202|FG001|First Intervention|Other|2|||
27933315|NCT00311168|81592201|FG000|Second Intervention|Lost to Follow-up|9|||
27933316|NCT00311168|81592202|FG001|Second Intervention|Lost to Follow-up|2|||
27933317|NCT00311168|81592201|FG000|Second Intervention|Withdrawal by Subject|0|||
27933318|NCT00311168|81592202|FG001|Second Intervention|Withdrawal by Subject|1|||
27933319|NCT00311168|81592201|FG000|Second Intervention|Other|1|||
27933320|NCT00311168|81592202|FG001|Second Intervention|Other|1|||
27933321|NCT01946802|81592209|FG000|Overall Study|Death|1|||
27933322|NCT01946802|81592209|FG000|Overall Study|Withdrawal by Subject|2|||
27933323|NCT01946802|81592209|FG000|Overall Study|Combined septic shock|1|||
27933324|NCT01946802|81592209|FG000|Overall Study|Protocol Violation|1|||
27933325|NCT00710554|81592210|FG000|Overall Study|Adverse Event|24|||
27933326|NCT00710554|81592211|FG001|Overall Study|Adverse Event|7|||
27933327|NCT00710554|81592210|FG000|Overall Study|Withdrawal by Subject|7|||
27933328|NCT00710554|81592211|FG001|Overall Study|Withdrawal by Subject|3|||
27933329|NCT00710554|81592210|FG000|Overall Study|Lost to Follow-up|7|||
27933330|NCT00710554|81592211|FG001|Overall Study|Lost to Follow-up|1|||
27933331|NCT00710554|81592210|FG000|Overall Study|Lack of Efficacy|11|||
27743221|NCT03237845|80889491|FG001|Overall Study|Pregnancy|0|||
27743222|NCT03237845|80889490|FG000|Overall Study|Protocol Deviation|0|||
27743223|NCT03237845|80889491|FG001|Overall Study|Protocol Deviation|1|||
27743224|NCT03237845|80889490|FG000|Overall Study|Technical Problems|8|||
27743225|NCT03237845|80889491|FG001|Overall Study|Technical Problems|1|||
27743226|NCT03237845|80889490|FG000|Overall Study|Withdrawal by Subject|3|||
27743227|NCT03237845|80889491|FG001|Overall Study|Withdrawal by Subject|3|||
27743228|NCT03237845|80889490|FG000|Overall Study|Other Reasons|4|||
27743229|NCT03237845|80889491|FG001|Overall Study|Other Reasons|0|||
27743230|NCT00803244|80889494|FG000|Overall Study|Adverse Event|1|||
27743231|NCT00803244|80889495|FG001|Overall Study|Adverse Event|2|||
27743232|NCT00803244|80889494|FG000|Overall Study|Withdrawal by Subject|2|||
27743233|NCT00803244|80889495|FG001|Overall Study|Withdrawal by Subject|3|||
27743234|NCT00803244|80889494|FG000|Overall Study|Any other reason not above-mentioned|4|||
27743235|NCT00803244|80889495|FG001|Overall Study|Any other reason not above-mentioned|10|||
27743236|NCT02465034|80889501|FG000|Overall Study|Withdrawal by Subject|1|||
27743237|NCT02465034|80889502|FG001|Overall Study|Withdrawal by Subject|1|||
27743238|NCT02465034|80889501|FG000|Overall Study|Screen fail|2|||
27743239|NCT02465034|80889502|FG001|Overall Study|Screen fail|0|||
27743240|NCT02465034|80889501|FG000|Overall Study|Could not be scheduled for study visit|0|||
27743241|NCT02465034|80889502|FG001|Overall Study|Could not be scheduled for study visit|5|||
27743242|NCT00616239|80889503|FG000|Overall Study|Withdrawal by Subject|2|||
27743243|NCT03043365|80889514|FG000|Weeks 0 to Week 8|Adverse Event|1|||
27743244|NCT03043365|80889515|FG001|Weeks 0 to Week 8|Adverse Event|3|||
27743245|NCT03043365|80889514|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
27743246|NCT03043365|80889515|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
27743247|NCT03043365|80889514|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
27743248|NCT03043365|80889515|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
27743249|NCT00081289|80889516|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
27743250|NCT00081289|80889517|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
27933332|NCT00710554|81592211|FG001|Overall Study|Lack of Efficacy|12|||
27933333|NCT00710554|81592210|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
27933334|NCT00710554|81592211|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
27933335|NCT02205359|81592212|FG000|Overall Study|Death|293|||
27933336|NCT02205359|81592213|FG001|Overall Study|Death|327|||
27933337|NCT02205359|81592212|FG000|Overall Study|Lost to Follow-up|182|||
27933338|NCT02205359|81592213|FG001|Overall Study|Lost to Follow-up|162|||
27933339|NCT02205359|81592212|FG000|Overall Study|Physician Decision|51|||
27933340|NCT02205359|81592213|FG001|Overall Study|Physician Decision|53|||
27933341|NCT02205359|81592212|FG000|Overall Study|Withdrawal by Subject|167|||
27933342|NCT02205359|81592213|FG001|Overall Study|Withdrawal by Subject|169|||
27933343|NCT00397930|81592214|FG000|Overall Study|Personal reasons|14|||
27933344|NCT00397930|81592215|FG001|Overall Study|Personal reasons|8|||
27933345|NCT00397930|81592214|FG000|Overall Study|Other medical|9|||
27933346|NCT00397930|81592215|FG001|Overall Study|Other medical|4|||
27933347|NCT00397930|81592214|FG000|Overall Study|Unknown reasons|9|||
27550698|NCT01153347|80203457|FG001|Overall Study|Severe non-compliance to protocol|7|||
27550699|NCT01153347|80203458|FG002|Overall Study|Severe non-compliance to protocol|4|||
27550700|NCT01153347|80203459|FG003|Overall Study|Severe non-compliance to protocol|3|||
27550701|NCT01153347|80203456|FG000|Overall Study|Condition under investigation worsened|1|||
27550702|NCT01153347|80203457|FG001|Overall Study|Condition under investigation worsened|1|||
27743251|NCT00081289|80889516|FG000|Overall Study|Ineligible / no protocol treatment|3|||
27743252|NCT00081289|80889517|FG001|Overall Study|Ineligible / no protocol treatment|4|||
27743253|NCT00734929|80889518|FG000|Overall Study|Lost to Follow-up|1|||
27550703|NCT01153347|80203458|FG002|Overall Study|Condition under investigation worsened|0|||
27550704|NCT01153347|80203459|FG003|Overall Study|Condition under investigation worsened|0|||
27550705|NCT01153347|80203456|FG000|Overall Study|Lack of Efficacy|2|||
27550706|NCT01153347|80203457|FG001|Overall Study|Lack of Efficacy|2|||
27550707|NCT01153347|80203458|FG002|Overall Study|Lack of Efficacy|0|||
27743254|NCT00734929|80889519|FG001|Overall Study|Lost to Follow-up|2|||
27743255|NCT00734929|80889518|FG000|Overall Study|No intervention/ screen fail|5|||
27933348|NCT00397930|81592215|FG001|Overall Study|Unknown reasons|14|||
27933349|NCT00397930|81592214|FG000|Overall Study|Noncompliant|3|||
27743256|NCT00734929|80889519|FG001|Overall Study|No intervention/ screen fail|3|||
27743257|NCT02749370|80889520|FG000|Overall Study|Withdrawal by Subject|11|||
27743258|NCT02749370|80889520|FG000|Overall Study|Lost to Follow-up|3|||
27743259|NCT00426751|80889521|FG000|Overall Study|Adverse Event|8|||
27743260|NCT00426751|80889522|FG001|Overall Study|Adverse Event|1|||
27642547|NCT00945321|80532603|FG003|Period 4|Lost to Follow-up|0|||
27642548|NCT00945321|80532604|FG004|Period 4|Lost to Follow-up|0|||
27642549|NCT00945321|80532605|FG005|Period 4|Lost to Follow-up|1|||
27642550|NCT00145470|80532623|FG000|Overall Study|Adverse Event|19|||
27642551|NCT00145470|80532624|FG001|Overall Study|Adverse Event|25|||
27642552|NCT00145470|80532623|FG000|Overall Study|Lack of Efficacy|27|||
27743261|NCT00426751|80889521|FG000|Overall Study|Lost to Follow-up|7|||
27743262|NCT00426751|80889522|FG001|Overall Study|Lost to Follow-up|6|||
27743263|NCT00426751|80889521|FG000|Overall Study|Consent Withdrawn|0|||
27743264|NCT00426751|80889522|FG001|Overall Study|Consent Withdrawn|1|||
27743265|NCT00426751|80889521|FG000|Overall Study|Other Reasons|7|||
27743266|NCT00426751|80889522|FG001|Overall Study|Other Reasons|12|||
27743267|NCT04493619|80889528|FG000|Overall Study|Death|4|||
27743268|NCT04493619|80889529|FG001|Overall Study|Death|3|||
27743269|NCT04493619|80889530|FG002|Overall Study|Death|3|||
27743270|NCT04493619|80889531|FG003|Overall Study|Death|4|||
27743271|NCT04493619|80889528|FG000|Overall Study|Study discontinued early|10|||
27743272|NCT04493619|80889529|FG001|Overall Study|Study discontinued early|0|||
27743273|NCT04493619|80889530|FG002|Overall Study|Study discontinued early|4|||
27743274|NCT04493619|80889531|FG003|Overall Study|Study discontinued early|8|||
27743275|NCT04493619|80889528|FG000|Overall Study|Lost to Follow-up|0|||
27743276|NCT04493619|80889529|FG001|Overall Study|Lost to Follow-up|0|||
27743277|NCT04493619|80889530|FG002|Overall Study|Lost to Follow-up|0|||
27743278|NCT04493619|80889531|FG003|Overall Study|Lost to Follow-up|1|||
27743279|NCT02927171|80889532|FG000|Overall Study|Lost to Follow-up|0|||
27743280|NCT02927171|80889533|FG001|Overall Study|Lost to Follow-up|1|||
27743281|NCT03126227|80889540|FG000|Overall Study|Adverse Event|43|||
27743282|NCT03126227|80889541|FG001|Overall Study|Adverse Event|4|||
27743283|NCT03126227|80889540|FG000|Overall Study|Death|0|||
27743284|NCT03126227|80889541|FG001|Overall Study|Death|1|||
27743285|NCT03126227|80889540|FG000|Overall Study|Lost to Follow-up|0|||
27743286|NCT03126227|80889541|FG001|Overall Study|Lost to Follow-up|1|||
27743287|NCT03126227|80889540|FG000|Overall Study|Physician Decision|2|||
27743288|NCT03126227|80889541|FG001|Overall Study|Physician Decision|0|||
27743289|NCT03126227|80889540|FG000|Overall Study|Protocol Violation|1|||
27743290|NCT03126227|80889541|FG001|Overall Study|Protocol Violation|0|||
27743291|NCT03126227|80889540|FG000|Overall Study|Withdrawal by Subject|19|||
27743292|NCT03126227|80889541|FG001|Overall Study|Withdrawal by Subject|3|||
27743293|NCT03126227|80889540|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
27743294|NCT03126227|80889541|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
27743295|NCT03126227|80889540|FG000|Overall Study|Lack of dosing compliance|2|||
27743296|NCT03126227|80889541|FG001|Overall Study|Lack of dosing compliance|0|||
27743297|NCT03126227|80889540|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
27743298|NCT03126227|80889541|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
27743299|NCT03126227|80889540|FG000|Overall Study|Scheduling conflict|1|||
27743300|NCT03126227|80889541|FG001|Overall Study|Scheduling conflict|0|||
27743301|NCT01469052|80889542|FG000|Overall Study|Adverse Event|2|||
27743302|NCT01469052|80889543|FG001|Overall Study|Adverse Event|3|||
27743303|NCT01469052|80889544|FG002|Overall Study|Adverse Event|0|||
27743304|NCT01469052|80889545|FG003|Overall Study|Adverse Event|2|||
27743305|NCT01469052|80889546|FG004|Overall Study|Adverse Event|0|||
27743306|NCT01469052|80889547|FG005|Overall Study|Adverse Event|1|||
27743307|NCT01469052|80889542|FG000|Overall Study|Progressive disease|3|||
27642553|NCT00145470|80532624|FG001|Overall Study|Lack of Efficacy|13|||
27642554|NCT00145470|80532623|FG000|Overall Study|Withdrawal by Subject|36|||
27743308|NCT01469052|80889543|FG001|Overall Study|Progressive disease|0|||
27743309|NCT01469052|80889544|FG002|Overall Study|Progressive disease|5|||
27743310|NCT01469052|80889545|FG003|Overall Study|Progressive disease|3|||
27743311|NCT01469052|80889546|FG004|Overall Study|Progressive disease|7|||
27743312|NCT01469052|80889547|FG005|Overall Study|Progressive disease|2|||
27642555|NCT00145470|80532624|FG001|Overall Study|Withdrawal by Subject|34|||
27743313|NCT01469052|80889542|FG000|Overall Study|Lack of Efficacy|0|||
27743314|NCT01469052|80889543|FG001|Overall Study|Lack of Efficacy|0|||
27743315|NCT01469052|80889544|FG002|Overall Study|Lack of Efficacy|0|||
27743316|NCT01469052|80889545|FG003|Overall Study|Lack of Efficacy|0|||
27743317|NCT01469052|80889546|FG004|Overall Study|Lack of Efficacy|0|||
27743318|NCT01469052|80889547|FG005|Overall Study|Lack of Efficacy|2|||
27743319|NCT01469052|80889542|FG000|Overall Study|Moved to rollover protocol|1|||
27743320|NCT01469052|80889543|FG001|Overall Study|Moved to rollover protocol|0|||
27743321|NCT01469052|80889544|FG002|Overall Study|Moved to rollover protocol|1|||
27743322|NCT01469052|80889545|FG003|Overall Study|Moved to rollover protocol|0|||
27743323|NCT01469052|80889546|FG004|Overall Study|Moved to rollover protocol|0|||
27743324|NCT01469052|80889547|FG005|Overall Study|Moved to rollover protocol|1|||
27743325|NCT01469052|80889542|FG000|Overall Study|Other|0|||
27743326|NCT01469052|80889543|FG001|Overall Study|Other|1|||
27743327|NCT01469052|80889544|FG002|Overall Study|Other|0|||
27743328|NCT01469052|80889545|FG003|Overall Study|Other|0|||
27743329|NCT01469052|80889546|FG004|Overall Study|Other|1|||
27743330|NCT01469052|80889547|FG005|Overall Study|Other|0|||
27743331|NCT00514449|80889548|FG000|Overall Study|Withdrawal by Subject|1|||
27743332|NCT00514449|80889549|FG001|Overall Study|Withdrawal by Subject|2|||
27743333|NCT00514449|80889548|FG000|Overall Study|Protocol Violation|1|||
27743334|NCT00514449|80889549|FG001|Overall Study|Protocol Violation|2|||
27743335|NCT00514449|80889548|FG000|Overall Study|Lost to Follow-up|1|||
27743336|NCT00514449|80889549|FG001|Overall Study|Lost to Follow-up|0|||
27743337|NCT00592501|80889553|FG000|Overall Study|Withdrawal by Subject|1|||
27743338|NCT00592501|80889553|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
27743339|NCT03184701|80889556|FG000|Overall Study|Death|3|||
27743340|NCT03184701|80889556|FG000|Overall Study|Physician Decision|3|||
27743341|NCT03184701|80889556|FG000|Overall Study|Withdrawal by Subject|6|||
27743342|NCT03184701|80889556|FG000|Overall Study|Lost to Follow-up|5|||
27743343|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
27743344|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
27743345|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
27743346|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
27743347|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
27743348|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
27743349|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
27743350|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
27743351|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
27743352|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
27743353|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
27743354|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
27743355|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
27743356|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
27743357|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
27743358|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
27743359|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
27743360|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
27743361|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Death|0|||
27743362|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Death|1|||
27743363|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Death|0|||
27743364|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
27743365|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
27743366|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
27743367|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
27743368|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
27743369|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
27743370|NCT00430781|80889557|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
27743371|NCT00430781|80889558|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
27743372|NCT00430781|80889559|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
27743373|NCT00430781|80889557|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
27743374|NCT00430781|80889558|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
27743375|NCT00430781|80889559|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
27743376|NCT00430781|80889557|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
27743377|NCT00430781|80889558|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
27743378|NCT00430781|80889559|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
27743379|NCT00430781|80889557|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
27743380|NCT00430781|80889558|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
27743381|NCT00430781|80889559|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
27743382|NCT00430781|80889557|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
27743383|NCT00430781|80889558|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
27743384|NCT00430781|80889559|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
27743385|NCT00430781|80889557|FG000|Final Analysis; 31 July 2008|Other|0|||
27743386|NCT00430781|80889558|FG001|Final Analysis; 31 July 2008|Other|1|||
27743387|NCT00430781|80889559|FG002|Final Analysis; 31 July 2008|Other|0|||
27743388|NCT00430781|80889557|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
27743389|NCT00430781|80889558|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
27743390|NCT00430781|80889559|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
27743391|NCT00430781|80889557|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
27743392|NCT00430781|80889558|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
27550708|NCT01153347|80203459|FG003|Overall Study|Lack of Efficacy|4|||
27743393|NCT00430781|80889559|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
27743394|NCT00430781|80889557|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
27743395|NCT00430781|80889558|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
27743396|NCT00430781|80889559|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
27743397|NCT00430781|80889557|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
27743398|NCT00430781|80889558|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
27743399|NCT00430781|80889559|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
27743400|NCT00430781|80889557|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
27743401|NCT00430781|80889558|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
27743402|NCT00430781|80889559|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
27743403|NCT00430781|80889557|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
27743404|NCT00430781|80889558|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
27743405|NCT00430781|80889559|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
27743406|NCT00430781|80889557|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
27743407|NCT00430781|80889558|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
27743408|NCT00430781|80889559|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
27743409|NCT01266148|80889566|FG000|Overall Study|Adverse Event|2|||
27743410|NCT01266148|80889567|FG001|Overall Study|Adverse Event|0|||
27743411|NCT01266148|80889566|FG000|Overall Study|Ongoing rejection|1|||
27743412|NCT01266148|80889567|FG001|Overall Study|Ongoing rejection|0|||
27743413|NCT01266148|80889566|FG000|Overall Study|2 2R rejections|1|||
27743414|NCT01266148|80889567|FG001|Overall Study|2 2R rejections|0|||
27743415|NCT01266148|80889566|FG000|Overall Study|Death|2|||
27743416|NCT01266148|80889567|FG001|Overall Study|Death|3|||
27743417|NCT01266148|80889566|FG000|Overall Study|missing mGFR value + AE|1|||
27743418|NCT01266148|80889567|FG001|Overall Study|missing mGFR value + AE|0|||
27743419|NCT00916721|80889568|FG000|Overall Study|Lost to Follow-up|0|||
27743420|NCT00916721|80889569|FG001|Overall Study|Lost to Follow-up|1|||
27743421|NCT00916721|80889568|FG000|Overall Study|Adverse Event|6|||
27743422|NCT00916721|80889569|FG001|Overall Study|Adverse Event|3|||
27743423|NCT00916721|80889568|FG000|Overall Study|Withdrawal by Subject|2|||
27743424|NCT00916721|80889569|FG001|Overall Study|Withdrawal by Subject|2|||
27743425|NCT00916721|80889568|FG000|Overall Study|Protocol Violation|2|||
27743426|NCT00916721|80889569|FG001|Overall Study|Protocol Violation|4|||
27743427|NCT01713036|80889570|FG000|Overall Study|Death|1|||
27743428|NCT01161524|80889572|FG000|Core Study (23 Weeks)|Adverse Event|3|||
27743429|NCT01161524|80889573|FG001|Core Study (23 Weeks)|Adverse Event|0|||
27743430|NCT01161524|80889574|FG002|Core Study (23 Weeks)|Adverse Event|0|||
27743431|NCT01161524|80889572|FG000|Core Study (23 Weeks)|Other|1|||
27743432|NCT01161524|80889573|FG001|Core Study (23 Weeks)|Other|0|||
27743433|NCT01161524|80889574|FG002|Core Study (23 Weeks)|Other|0|||
27743434|NCT01161524|80889572|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
27743435|NCT01161524|80889573|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
27743436|NCT01161524|80889574|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
27743437|NCT01161524|80889572|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
27743438|NCT01161524|80889573|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
27743439|NCT01161524|80889574|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
27743440|NCT01161524|80889572|FG000|Core Study (23 Weeks)|Subject Choice|3|||
27743441|NCT01161524|80889573|FG001|Core Study (23 Weeks)|Subject Choice|2|||
27743442|NCT01161524|80889574|FG002|Core Study (23 Weeks)|Subject Choice|0|||
27743443|NCT01161524|80889572|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
27743444|NCT01161524|80889573|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
27743445|NCT01161524|80889574|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
27743446|NCT01161524|80889572|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
27743447|NCT01161524|80889573|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
27743448|NCT01161524|80889574|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
27743449|NCT01161524|80889572|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
27743450|NCT01161524|80889573|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
27743451|NCT01161524|80889574|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
27933350|NCT00397930|81592215|FG001|Overall Study|Noncompliant|2|||
27933351|NCT00397930|81592214|FG000|Overall Study|Too time-consuming|2|||
27933352|NCT00397930|81592215|FG001|Overall Study|Too time-consuming|9|||
27933353|NCT00397930|81592214|FG000|Overall Study|Started own yoga program|1|||
27743452|NCT01161524|80889572|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
27743453|NCT01161524|80889573|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
27743454|NCT01161524|80889574|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
27743455|NCT01161524|80889572|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
27743456|NCT01161524|80889573|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
27743457|NCT01161524|80889574|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
27743458|NCT02616029|80889575|FG000|Overall Study|Adverse Event|1|||
27933354|NCT00397930|81592215|FG001|Overall Study|Started own yoga program|1|||
27933355|NCT00397930|81592214|FG000|Overall Study|Did not want to be in control group|0|||
27550709|NCT01153347|80203456|FG000|Overall Study|Study-specific withdrawal criteria|4|||
27743459|NCT02616029|80889576|FG001|Overall Study|Adverse Event|0|||
27743460|NCT02616029|80889575|FG000|Overall Study|Death|0|||
27743461|NCT02616029|80889576|FG001|Overall Study|Death|1|||
27743462|NCT02616029|80889575|FG000|Overall Study|Protocol Violation|1|||
27743463|NCT02616029|80889576|FG001|Overall Study|Protocol Violation|0|||
27743464|NCT02616029|80889575|FG000|Overall Study|Withdrew Consent|1|||
27743465|NCT02616029|80889576|FG001|Overall Study|Withdrew Consent|0|||
27743466|NCT02616029|80889575|FG000|Overall Study|Enrolled and Never Treated|1|||
27743467|NCT02616029|80889576|FG001|Overall Study|Enrolled and Never Treated|1|||
27743468|NCT04498910|80889579|FG000|Overall Study|Lost to Follow-up|0|||
27743469|NCT04498910|80889580|FG001|Overall Study|Lost to Follow-up|1|||
27743470|NCT04498910|80889579|FG000|Overall Study|Withdrawal by Subject|2|||
27743471|NCT04498910|80889580|FG001|Overall Study|Withdrawal by Subject|1|||
27743472|NCT04498910|80889579|FG000|Overall Study|Adverse Event|1|||
27743473|NCT04498910|80889580|FG001|Overall Study|Adverse Event|0|||
27743474|NCT02698423|80889585|FG000|Overall Study|Lost to Follow-up|19|||
27743475|NCT02698423|80889586|FG001|Overall Study|Lost to Follow-up|24|||
27743476|NCT02046564|80889588|FG000|Overall Study|Adverse Event|6|||
27743477|NCT02046564|80889589|FG001|Overall Study|Adverse Event|3|||
27743478|NCT02046564|80889588|FG000|Overall Study|Physician Decision|0|||
27743479|NCT02046564|80889589|FG001|Overall Study|Physician Decision|1|||
27933356|NCT00397930|81592215|FG001|Overall Study|Did not want to be in control group|1|||
27933357|NCT00397930|81592214|FG000|Overall Study|Withdrawal by Subject|0|||
27933358|NCT00397930|81592215|FG001|Overall Study|Withdrawal by Subject|8|||
27933359|NCT00397930|81592214|FG000|Overall Study|Missing data|0|||
27933360|NCT00397930|81592215|FG001|Overall Study|Missing data|4|||
27933361|NCT01283386|81592218|FG000|Overall Study|Death|2|||
27933362|NCT01283386|81592219|FG001|Overall Study|Death|0|||
27933363|NCT01283386|81592218|FG000|Overall Study|Withdrawal by Subject|2|||
27933364|NCT01283386|81592219|FG001|Overall Study|Withdrawal by Subject|1|||
27642556|NCT00145470|80532623|FG000|Overall Study|Lost to Follow-up|21|||
27642557|NCT00145470|80532624|FG001|Overall Study|Lost to Follow-up|17|||
27743480|NCT02046564|80889588|FG000|Overall Study|Protocol Violation|3|||
27743481|NCT02046564|80889589|FG001|Overall Study|Protocol Violation|1|||
27933365|NCT01283386|81592218|FG000|Overall Study|Relapse of underlying disease|1|||
27933366|NCT01283386|81592219|FG001|Overall Study|Relapse of underlying disease|3|||
27933367|NCT01283386|81592218|FG000|Overall Study|Progression of underlying disease|2|||
27933368|NCT01283386|81592219|FG001|Overall Study|Progression of underlying disease|7|||
27933369|NCT01283386|81592218|FG000|Overall Study|Reason not specified|1|||
27933370|NCT01283386|81592219|FG001|Overall Study|Reason not specified|0|||
27933371|NCT01283386|81592218|FG000|Overall Study|Protocol Violation|0|||
27933372|NCT01283386|81592219|FG001|Overall Study|Protocol Violation|1|||
27933373|NCT04706403|81592222|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
27933374|NCT04706403|81592223|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
27933375|NCT04706403|81592224|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
27933376|NCT04706403|81592225|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
27933377|NCT04706403|81592226|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
27933378|NCT00215553|81592229|FG000|Overall Study|Adverse Event|0|||
27933379|NCT00215553|81592230|FG001|Overall Study|Adverse Event|1|||
27933380|NCT00215553|81592231|FG002|Overall Study|Adverse Event|2|||
27933381|NCT00215553|81592232|FG003|Overall Study|Adverse Event|1|||
27933382|NCT00215553|81592233|FG004|Overall Study|Adverse Event|2|||
27933383|NCT00215553|81592234|FG005|Overall Study|Adverse Event|6|||
27933384|NCT00215553|81592235|FG006|Overall Study|Adverse Event|0|||
27933385|NCT01703221|81592243|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
27933386|NCT01703221|81592244|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
27933387|NCT01703221|81592245|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
27933388|NCT01703221|81592243|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
27933389|NCT01703221|81592244|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
27933390|NCT01703221|81592245|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
27933391|NCT01703221|81592243|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
27933392|NCT01703221|81592244|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27933393|NCT01703221|81592245|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
27933394|NCT01703221|81592243|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
27743482|NCT02046564|80889588|FG000|Overall Study|Withdrawal by Subject|4|||
27743483|NCT02046564|80889589|FG001|Overall Study|Withdrawal by Subject|10|||
27743484|NCT02046564|80889588|FG000|Overall Study|Subject met withdrawal criteria|2|||
27933395|NCT01703221|81592244|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
27933396|NCT01703221|81592245|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
27933397|NCT01703221|81592243|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27743485|NCT02046564|80889589|FG001|Overall Study|Subject met withdrawal criteria|5|||
27743486|NCT01544595|80889590|FG000|Status at Week 68|Adverse Event|3|||
27743487|NCT01544595|80889591|FG001|Status at Week 68|Adverse Event|2|||
27743488|NCT01544595|80889592|FG002|Status at Week 68|Adverse Event|1|||
27933398|NCT01703221|81592244|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
27933399|NCT01703221|81592245|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
27933400|NCT01703221|81592243|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
27933401|NCT01703221|81592244|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
27933402|NCT01703221|81592245|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
27933403|NCT01703221|81592243|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
27933404|NCT01703221|81592244|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
27933405|NCT01703221|81592245|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
27933406|NCT01703221|81592243|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
27933407|NCT01703221|81592244|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
27933408|NCT01703221|81592245|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
27933409|NCT00762788|81592246|FG000|Overall Study|Lost to Follow-up|26|||
27933410|NCT00762788|81592247|FG001|Overall Study|Lost to Follow-up|37|||
27933411|NCT00762788|81592248|FG002|Overall Study|Lost to Follow-up|21|||
27933412|NCT00762788|81592249|FG003|Overall Study|Lost to Follow-up|26|||
27933413|NCT00762788|81592250|FG004|Overall Study|Lost to Follow-up|13|||
27933414|NCT00762788|81592251|FG005|Overall Study|Lost to Follow-up|21|||
27933415|NCT01968785|81592252|FG000|Overall Study|Withdrawal by Subject|1|||
27933416|NCT01968785|81592253|FG001|Overall Study|Withdrawal by Subject|0|||
27933417|NCT02541903|81592255|FG000|Overall Study|Death|1|||
27933418|NCT00728182|81592256|FG000|Overall Study|Adverse Event|1|||
27933419|NCT00728182|81592257|FG001|Overall Study|Adverse Event|0|||
27933420|NCT00728182|81592256|FG000|Overall Study|Lost to Follow-up|2|||
27933421|NCT00728182|81592257|FG001|Overall Study|Lost to Follow-up|0|||
27933422|NCT00728182|81592256|FG000|Overall Study|Death|0|||
27933423|NCT00728182|81592257|FG001|Overall Study|Death|2|||
27933424|NCT00728182|81592256|FG000|Overall Study|Protocol Noncompliance|0|||
27933425|NCT00728182|81592257|FG001|Overall Study|Protocol Noncompliance|1|||
27933426|NCT02665455|81592263|FG000|Overall Study|Withdrawal by Subject|6|||
27933427|NCT02665455|81592263|FG000|Overall Study|Lost to Follow-up|1|||
27933428|NCT02665455|81592263|FG000|Overall Study|Adverse Event|1|||
27933429|NCT02665455|81592263|FG000|Overall Study|Protocol Violation|1|||
27933430|NCT00387127|81592268|FG000|Overall Study|Lost to Follow-up|0|||
27933431|NCT00387127|81592269|FG001|Overall Study|Lost to Follow-up|4|||
27933432|NCT00387127|81592268|FG000|Overall Study|Death|16|||
27933433|NCT00387127|81592269|FG001|Overall Study|Death|16|||
27933434|NCT00387127|81592268|FG000|Overall Study|Physician Decision|0|||
27933435|NCT00387127|81592269|FG001|Overall Study|Physician Decision|1|||
27933436|NCT00387127|81592268|FG000|Overall Study|Withdrawal by Subject|3|||
27933437|NCT00387127|81592269|FG001|Overall Study|Withdrawal by Subject|2|||
27933438|NCT00387127|81592268|FG000|Overall Study|Required by Protocol Amendment #4|12|||
27933439|NCT00387127|81592269|FG001|Overall Study|Required by Protocol Amendment #4|10|||
27933440|NCT00387127|81592268|FG000|Overall Study|Serious Adverse Event|1|||
27933441|NCT00387127|81592269|FG001|Overall Study|Serious Adverse Event|1|||
27933442|NCT00387127|81592268|FG000|Overall Study|Sponsor Unblinded|1|||
27933443|NCT00387127|81592269|FG001|Overall Study|Sponsor Unblinded|0|||
27933444|NCT01316900|81592270|FG000|Overall Study|Adverse Event|10|||
27933445|NCT01316900|81592271|FG001|Overall Study|Adverse Event|10|||
27933446|NCT01316900|81592272|FG002|Overall Study|Adverse Event|15|||
27933447|NCT01316900|81592273|FG003|Overall Study|Adverse Event|9|||
27933448|NCT01316900|81592270|FG000|Overall Study|Lack of Efficacy|17|||
27642558|NCT00145470|80532623|FG000|Overall Study|Reason Not Reported|9|||
27642559|NCT00145470|80532624|FG001|Overall Study|Reason Not Reported|9|||
27642560|NCT00090519|80532627|FG000|Overall Study|Adverse Event|5|||
27642561|NCT00090519|80532628|FG001|Overall Study|Adverse Event|4|||
27642562|NCT00090519|80532627|FG000|Overall Study|Death|9|||
27642563|NCT00090519|80532628|FG001|Overall Study|Death|9|||
27642564|NCT00090519|80532627|FG000|Overall Study|Lost to Follow-up|26|||
27642565|NCT00090519|80532628|FG001|Overall Study|Lost to Follow-up|29|||
27642566|NCT00090519|80532627|FG000|Overall Study|Withdrawal by Subject|28|||
27642567|NCT00090519|80532628|FG001|Overall Study|Withdrawal by Subject|29|||
27642568|NCT00090519|80532627|FG000|Overall Study|Physician Decision|2|||
27642569|NCT00090519|80532628|FG001|Overall Study|Physician Decision|3|||
27642570|NCT00090519|80532627|FG000|Overall Study|Sponsor Decision|3|||
27933449|NCT01316900|81592271|FG001|Overall Study|Lack of Efficacy|9|||
27933450|NCT01316900|81592272|FG002|Overall Study|Lack of Efficacy|5|||
27933451|NCT01316900|81592273|FG003|Overall Study|Lack of Efficacy|7|||
27933452|NCT01316900|81592270|FG000|Overall Study|Protocol Violation|7|||
27933453|NCT01316900|81592271|FG001|Overall Study|Protocol Violation|1|||
27933454|NCT01316900|81592272|FG002|Overall Study|Protocol Violation|4|||
27933455|NCT01316900|81592273|FG003|Overall Study|Protocol Violation|0|||
27933456|NCT01316900|81592270|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
27933457|NCT01316900|81592271|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
27642571|NCT00090519|80532628|FG001|Overall Study|Sponsor Decision|1|||
27642572|NCT00331136|80532633|FG000|Overall Study|Adverse Event|3|||
27642573|NCT00331136|80532634|FG001|Overall Study|Adverse Event|5|||
27642574|NCT00331136|80532635|FG002|Overall Study|Adverse Event|0|||
27933458|NCT01316900|81592272|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
27933459|NCT01316900|81592273|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
27933460|NCT01316900|81592270|FG000|Overall Study|Lost to Follow-up|1|||
27933461|NCT01316900|81592271|FG001|Overall Study|Lost to Follow-up|0|||
27933462|NCT01316900|81592272|FG002|Overall Study|Lost to Follow-up|1|||
27933463|NCT01316900|81592273|FG003|Overall Study|Lost to Follow-up|1|||
27933464|NCT01316900|81592270|FG000|Overall Study|Withdrawal by Subject|7|||
27933465|NCT01316900|81592271|FG001|Overall Study|Withdrawal by Subject|8|||
27933466|NCT01316900|81592272|FG002|Overall Study|Withdrawal by Subject|6|||
27933467|NCT01316900|81592273|FG003|Overall Study|Withdrawal by Subject|9|||
27933468|NCT01623752|81592274|FG000|Phase 1 (78 Weeks)|No Data|249|||
27933469|NCT01623752|81592275|FG001|Phase 1 (78 Weeks)|No Data|66|||
27933470|NCT01623752|81592276|FG002|Phase 1 (78 Weeks)|No Data|2|||
27933471|NCT01623752|81592274|FG000|Phase 1 (78 Weeks)|Other|33|||
27933472|NCT01623752|81592275|FG001|Phase 1 (78 Weeks)|Other|20|||
27933473|NCT01623752|81592276|FG002|Phase 1 (78 Weeks)|Other|0|||
27933474|NCT01623752|81592274|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
27933475|NCT01623752|81592275|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
27933476|NCT01623752|81592276|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
27933477|NCT01623752|81592274|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
27642575|NCT00331136|80532636|FG003|Overall Study|Adverse Event|1|||
27642576|NCT00331136|80532633|FG000|Overall Study|Withdrawal by Subject|0|||
27642577|NCT00331136|80532634|FG001|Overall Study|Withdrawal by Subject|1|||
27642578|NCT00331136|80532635|FG002|Overall Study|Withdrawal by Subject|0|||
27642579|NCT00331136|80532636|FG003|Overall Study|Withdrawal by Subject|0|||
27642580|NCT00331136|80532633|FG000|Overall Study|Lost to Follow-up|0|||
27642581|NCT00331136|80532634|FG001|Overall Study|Lost to Follow-up|1|||
27642582|NCT00331136|80532635|FG002|Overall Study|Lost to Follow-up|0|||
27642583|NCT00331136|80532636|FG003|Overall Study|Lost to Follow-up|0|||
27642584|NCT00331136|80532633|FG000|Overall Study|Protocol Violation|1|||
27642585|NCT00331136|80532634|FG001|Overall Study|Protocol Violation|0|||
27642586|NCT00331136|80532635|FG002|Overall Study|Protocol Violation|0|||
27642587|NCT00331136|80532636|FG003|Overall Study|Protocol Violation|0|||
27642588|NCT00331136|80532633|FG000|Overall Study|Not treated|1|||
27642589|NCT00331136|80532634|FG001|Overall Study|Not treated|0|||
27642590|NCT00331136|80532635|FG002|Overall Study|Not treated|0|||
27642591|NCT00331136|80532636|FG003|Overall Study|Not treated|0|||
27642592|NCT01721291|80532637|FG000|Overall Study|Withdrawal by Subject|1|||
27642593|NCT01721291|80532638|FG001|Overall Study|Withdrawal by Subject|0|||
27642594|NCT01721291|80532637|FG000|Overall Study|did not like the treatment|1|||
27642595|NCT01721291|80532638|FG001|Overall Study|did not like the treatment|0|||
27642596|NCT02852824|80532639|FG000|Overall Study|Withdrawal by Subject|1|||
27642597|NCT02852824|80532640|FG001|Overall Study|Withdrawal by Subject|0|||
27642598|NCT02852824|80532641|FG002|Overall Study|Withdrawal by Subject|0|||
27642599|NCT02852824|80532642|FG003|Overall Study|Withdrawal by Subject|0|||
27642600|NCT02852824|80532643|FG004|Overall Study|Withdrawal by Subject|0|||
27642601|NCT02852824|80532644|FG005|Overall Study|Withdrawal by Subject|0|||
27642602|NCT02852824|80532645|FG006|Overall Study|Withdrawal by Subject|0|||
27642603|NCT02852824|80532639|FG000|Overall Study|Adverse Event|0|||
27642604|NCT02852824|80532640|FG001|Overall Study|Adverse Event|0|||
27642605|NCT02852824|80532641|FG002|Overall Study|Adverse Event|0|||
27642606|NCT02852824|80532642|FG003|Overall Study|Adverse Event|0|||
27642607|NCT02852824|80532643|FG004|Overall Study|Adverse Event|2|||
27642608|NCT02852824|80532644|FG005|Overall Study|Adverse Event|0|||
27642609|NCT02852824|80532645|FG006|Overall Study|Adverse Event|0|||
27642610|NCT04337931|80532646|FG000|Overall Study|Death|4|||
27642611|NCT04337931|80532647|FG001|Overall Study|Death|1|||
27642612|NCT04337931|80532648|FG002|Overall Study|Death|7|||
27933478|NCT01623752|81592275|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
27933479|NCT01623752|81592276|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
27933480|NCT01623752|81592274|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
27933481|NCT01623752|81592275|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
27933482|NCT01623752|81592276|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
27642613|NCT04337931|80532646|FG000|Overall Study|Withdrawal by Subject|0|||
27642614|NCT04337931|80532647|FG001|Overall Study|Withdrawal by Subject|1|||
27642615|NCT04337931|80532648|FG002|Overall Study|Withdrawal by Subject|0|||
27933483|NCT01623752|81592274|FG000|Phase 2 (78 Weeks)|Other|5|||
27933484|NCT01623752|81592275|FG001|Phase 2 (78 Weeks)|Other|1|||
27933485|NCT01623752|81592276|FG002|Phase 2 (78 Weeks)|Other|0|||
27933486|NCT01623752|81592274|FG000|Phase 2 (78 Weeks)|No Data|43|||
27933487|NCT01623752|81592275|FG001|Phase 2 (78 Weeks)|No Data|11|||
27642616|NCT04337931|80532646|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
27642617|NCT04337931|80532647|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
27642618|NCT04337931|80532648|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
27642619|NCT04337931|80532646|FG000|Overall Study|Study terminated by sponsor|3|||
27642620|NCT04337931|80532647|FG001|Overall Study|Study terminated by sponsor|6|||
27642621|NCT04337931|80532648|FG002|Overall Study|Study terminated by sponsor|2|||
27743489|NCT01544595|80889593|FG003|Status at Week 68|Adverse Event|0|||
27933488|NCT01623752|81592276|FG002|Phase 2 (78 Weeks)|No Data|0|||
27933489|NCT01623752|81592274|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
27933490|NCT01623752|81592275|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
27933491|NCT01623752|81592276|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
27933492|NCT05085405|81595996|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27933493|NCT05085405|81595997|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27933494|NCT05085405|81595998|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
27933495|NCT05085405|81595999|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
27933496|NCT05085405|81596000|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27933497|NCT05085405|81596001|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
27933498|NCT05085405|81595996|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27933499|NCT05085405|81595997|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27933500|NCT05085405|81595998|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27642622|NCT04337931|80532646|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
27642623|NCT04337931|80532647|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
27642624|NCT04337931|80532648|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
27642625|NCT04337931|80532646|FG000|Overall Study|Colorectal cancer treatment|1|||
27642626|NCT04337931|80532647|FG001|Overall Study|Colorectal cancer treatment|0|||
27642627|NCT04337931|80532648|FG002|Overall Study|Colorectal cancer treatment|0|||
27642628|NCT04337931|80532646|FG000|Overall Study|Participant decision|0|||
27642629|NCT04337931|80532647|FG001|Overall Study|Participant decision|1|||
27642630|NCT04337931|80532648|FG002|Overall Study|Participant decision|0|||
27642631|NCT02928172|80532649|FG000|Overall Study|Device did not record data|1|||
27642632|NCT02438137|80532650|FG000|Overall Study|Lost to Follow-up|3|||
27642633|NCT02438137|80532651|FG001|Overall Study|Lost to Follow-up|2|||
27642634|NCT02438137|80532650|FG000|Overall Study|Adverse Event|1|||
27642635|NCT02438137|80532651|FG001|Overall Study|Adverse Event|0|||
27642636|NCT02438137|80532650|FG000|Overall Study|Withdrawal by Subject|4|||
27642637|NCT02438137|80532651|FG001|Overall Study|Withdrawal by Subject|3|||
27642638|NCT02438137|80532650|FG000|Overall Study|Physician Decision|0|||
27642639|NCT02438137|80532651|FG001|Overall Study|Physician Decision|1|||
27642640|NCT04679675|80532652|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
27642641|NCT04679675|80532653|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
27642642|NCT04679675|80532654|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
27642643|NCT04679675|80532655|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
27642644|NCT04679675|80532652|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
27642645|NCT04679675|80532653|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
27642646|NCT04679675|80532654|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
27642647|NCT04679675|80532655|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
27642648|NCT00467272|80532656|FG000|Overall Study|Pneumonia|2|||
27642649|NCT00467272|80532656|FG000|Overall Study|Thrombophlebitis|1|||
27642650|NCT02755805|80532661|FG000|Overall Study|Lost to Follow-up|1|||
27642651|NCT02755805|80532662|FG001|Overall Study|Lost to Follow-up|2|||
27642652|NCT02755805|80532661|FG000|Overall Study|Refused assessments|1|||
27642653|NCT02755805|80532662|FG001|Overall Study|Refused assessments|0|||
27642654|NCT02755805|80532661|FG000|Overall Study|Withdrawal by Subject|0|||
27642655|NCT02755805|80532662|FG001|Overall Study|Withdrawal by Subject|2|||
27642656|NCT00391898|80532663|FG000|Overall Study|Adverse Event|3|||
27642657|NCT00391898|80532664|FG001|Overall Study|Adverse Event|0|||
27642658|NCT00391898|80532663|FG000|Overall Study|Other|8|||
27642659|NCT00391898|80532664|FG001|Overall Study|Other|10|||
27642660|NCT03781375|80532667|FG000|Double-blind Phase|Adverse Event|0|||
27642661|NCT03781375|80532668|FG001|Double-blind Phase|Adverse Event|1|||
27642662|NCT03781375|80532667|FG000|Double-blind Phase|Lack of Response|6|||
27642663|NCT03781375|80532668|FG001|Double-blind Phase|Lack of Response|2|||
27642664|NCT03781375|80532667|FG000|Double-blind Phase|Other|1|||
27642665|NCT03781375|80532668|FG001|Double-blind Phase|Other|3|||
27642666|NCT03781375|80532667|FG000|Open-label Phase|Protocol Issues|0|||
27642667|NCT03781375|80532668|FG001|Open-label Phase|Protocol Issues|1|||
27642668|NCT03781375|80532667|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
27642669|NCT03781375|80532668|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
27642670|NCT03781375|80532667|FG000|Open-label Phase|Other|2|||
27642671|NCT03781375|80532668|FG001|Open-label Phase|Other|2|||
27642672|NCT03539952|80532671|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
27642673|NCT03539952|80532672|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
27642674|NCT03539952|80532671|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
27642675|NCT03539952|80532672|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
27642676|NCT03539952|80532671|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
27642677|NCT03539952|80532672|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
27642678|NCT03539952|80532671|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
27642679|NCT03539952|80532672|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
27642680|NCT03539952|80532671|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
27642681|NCT03539952|80532672|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
27642682|NCT03539952|80532671|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
27642683|NCT03539952|80532672|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
27642684|NCT03539952|80532671|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
27642685|NCT03539952|80532672|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
27642686|NCT01288443|80532675|FG000|Overall Study|Adverse Event|0|||
27642687|NCT01288443|80532676|FG001|Overall Study|Adverse Event|0|||
27642688|NCT01288443|80532677|FG002|Overall Study|Adverse Event|1|||
27642689|NCT01288443|80532678|FG003|Overall Study|Adverse Event|1|||
27642690|NCT01288443|80532679|FG004|Overall Study|Adverse Event|3|||
27642691|NCT01288443|80532680|FG005|Overall Study|Adverse Event|1|||
27642692|NCT01288443|80532675|FG000|Overall Study|Poor compliance to protocol|0|||
27642693|NCT01288443|80532676|FG001|Overall Study|Poor compliance to protocol|0|||
27642694|NCT01288443|80532677|FG002|Overall Study|Poor compliance to protocol|0|||
27642695|NCT01288443|80532678|FG003|Overall Study|Poor compliance to protocol|0|||
27642696|NCT01288443|80532679|FG004|Overall Study|Poor compliance to protocol|0|||
27642697|NCT01288443|80532680|FG005|Overall Study|Poor compliance to protocol|1|||
27642698|NCT01288443|80532675|FG000|Overall Study|Participant Moved|0|||
27642699|NCT01288443|80532676|FG001|Overall Study|Participant Moved|0|||
27642700|NCT01288443|80532677|FG002|Overall Study|Participant Moved|0|||
27642701|NCT01288443|80532678|FG003|Overall Study|Participant Moved|1|||
27642702|NCT01288443|80532679|FG004|Overall Study|Participant Moved|2|||
27642703|NCT01288443|80532680|FG005|Overall Study|Participant Moved|1|||
27642704|NCT01288443|80532675|FG000|Overall Study|Consent withdrawn by Participant|0|||
27642705|NCT01288443|80532676|FG001|Overall Study|Consent withdrawn by Participant|0|||
27642706|NCT01288443|80532677|FG002|Overall Study|Consent withdrawn by Participant|0|||
27642707|NCT01288443|80532678|FG003|Overall Study|Consent withdrawn by Participant|0|||
27642708|NCT01288443|80532679|FG004|Overall Study|Consent withdrawn by Participant|0|||
27642709|NCT01288443|80532680|FG005|Overall Study|Consent withdrawn by Participant|1|||
27642710|NCT01288443|80532675|FG000|Overall Study|Lost to Follow-up|0|||
27642711|NCT01288443|80532676|FG001|Overall Study|Lost to Follow-up|1|||
27642712|NCT01288443|80532677|FG002|Overall Study|Lost to Follow-up|0|||
27642713|NCT01288443|80532678|FG003|Overall Study|Lost to Follow-up|0|||
27642714|NCT01288443|80532679|FG004|Overall Study|Lost to Follow-up|0|||
27642715|NCT01288443|80532680|FG005|Overall Study|Lost to Follow-up|0|||
27642716|NCT01288443|80532675|FG000|Overall Study|Study drug auto-injector administration|0|||
27642717|NCT01288443|80532676|FG001|Overall Study|Study drug auto-injector administration|0|||
27642718|NCT01288443|80532677|FG002|Overall Study|Study drug auto-injector administration|0|||
27642719|NCT01288443|80532678|FG003|Overall Study|Study drug auto-injector administration|0|||
27743490|NCT01544595|80889594|FG004|Status at Week 68|Adverse Event|0|||
27743491|NCT01544595|80889595|FG005|Status at Week 68|Adverse Event|0|||
27743492|NCT01544595|80889590|FG000|Status at Week 68|Lack of Efficacy|1|||
27743493|NCT01544595|80889591|FG001|Status at Week 68|Lack of Efficacy|0|||
27743494|NCT01544595|80889592|FG002|Status at Week 68|Lack of Efficacy|0|||
27743495|NCT01544595|80889593|FG003|Status at Week 68|Lack of Efficacy|0|||
27933501|NCT05085405|81595999|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
27933502|NCT05085405|81596000|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27933503|NCT05085405|81596001|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
27933504|NCT00191152|81596004|FG000|Initial Treatment|Adverse Event|43|||
27933505|NCT00191152|81596005|FG001|Initial Treatment|Adverse Event|67|||
27933506|NCT00191152|81596004|FG000|Initial Treatment|Physician Decision|40|||
27933507|NCT00191152|81596005|FG001|Initial Treatment|Physician Decision|31|||
27933508|NCT00191152|81596004|FG000|Initial Treatment|Withdrawal by Subject|40|||
27933509|NCT00191152|81596005|FG001|Initial Treatment|Withdrawal by Subject|28|||
27933510|NCT00191152|81596004|FG000|Initial Treatment|Lost to Follow-up|0|||
27933511|NCT00191152|81596005|FG001|Initial Treatment|Lost to Follow-up|6|||
27933512|NCT00191152|81596004|FG000|Initial Treatment|Other|18|||
27933513|NCT00191152|81596005|FG001|Initial Treatment|Other|21|||
27933514|NCT00191152|81596004|FG000|Crossover Treatment|Adverse Event|8|||
27933515|NCT00191152|81596005|FG001|Crossover Treatment|Adverse Event|8|||
27933516|NCT00191152|81596004|FG000|Crossover Treatment|Physician Decision|7|||
27933517|NCT00191152|81596005|FG001|Crossover Treatment|Physician Decision|7|||
27933518|NCT00191152|81596004|FG000|Crossover Treatment|Withdrawal by Subject|6|||
27933519|NCT00191152|81596005|FG001|Crossover Treatment|Withdrawal by Subject|9|||
27933520|NCT00191152|81596004|FG000|Crossover Treatment|Lost to Follow-up|2|||
27933521|NCT00191152|81596005|FG001|Crossover Treatment|Lost to Follow-up|1|||
27933522|NCT00191152|81596004|FG000|Crossover Treatment|Other|4|||
27933523|NCT00191152|81596005|FG001|Crossover Treatment|Other|3|||
27933524|NCT03178942|81596006|FG000|Overall Study|Withdrawal by Subject|2|||
27642720|NCT01288443|80532679|FG004|Overall Study|Study drug auto-injector administration|1|||
27642721|NCT01288443|80532680|FG005|Overall Study|Study drug auto-injector administration|1|||
27642722|NCT01288443|80532675|FG000|Overall Study|Other than above|0|||
27642723|NCT01288443|80532676|FG001|Overall Study|Other than above|0|||
27933525|NCT03178942|81596007|FG001|Overall Study|Withdrawal by Subject|0|||
27550710|NCT01153347|80203457|FG001|Overall Study|Study-specific withdrawal criteria|3|||
27933526|NCT03178942|81596006|FG000|Overall Study|Lost to Follow-up|1|||
27933527|NCT03178942|81596007|FG001|Overall Study|Lost to Follow-up|2|||
27933528|NCT01666314|81596008|FG000|Overall Study|Adverse Event|3|||
27933529|NCT01666314|81596009|FG001|Overall Study|Adverse Event|13|||
27933530|NCT01666314|81596010|FG002|Overall Study|Adverse Event|7|||
27933531|NCT01666314|81596011|FG003|Overall Study|Adverse Event|7|||
27933532|NCT01666314|81596008|FG000|Overall Study|Progressive Disease|11|||
27933533|NCT01666314|81596009|FG001|Overall Study|Progressive Disease|9|||
27933534|NCT01666314|81596010|FG002|Overall Study|Progressive Disease|19|||
27933535|NCT01666314|81596011|FG003|Overall Study|Progressive Disease|20|||
27933536|NCT01666314|81596008|FG000|Overall Study|Symptomatic Deterioration|1|||
27933537|NCT01666314|81596009|FG001|Overall Study|Symptomatic Deterioration|0|||
27933538|NCT01666314|81596010|FG002|Overall Study|Symptomatic Deterioration|2|||
27933539|NCT01666314|81596011|FG003|Overall Study|Symptomatic Deterioration|0|||
27933540|NCT01666314|81596008|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
27933541|NCT01666314|81596009|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
27933542|NCT01666314|81596010|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
27933543|NCT01666314|81596011|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
27933544|NCT01666314|81596008|FG000|Overall Study|Withdrawal by Subject|1|||
27933545|NCT01666314|81596009|FG001|Overall Study|Withdrawal by Subject|1|||
27933546|NCT01666314|81596010|FG002|Overall Study|Withdrawal by Subject|2|||
27933547|NCT01666314|81596011|FG003|Overall Study|Withdrawal by Subject|3|||
27933548|NCT01666314|81596008|FG000|Overall Study|Reason not Specified|10|||
27933549|NCT01666314|81596009|FG001|Overall Study|Reason not Specified|7|||
27933550|NCT01666314|81596010|FG002|Overall Study|Reason not Specified|5|||
27933551|NCT01666314|81596011|FG003|Overall Study|Reason not Specified|5|||
27933552|NCT00366535|81596012|FG000|First Phase: 12 Weeks|Adverse Event|1|||
27933553|NCT00366535|81596013|FG001|First Phase: 12 Weeks|Adverse Event|3|||
27933554|NCT00366535|81596012|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
27933555|NCT00366535|81596013|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
27933556|NCT00366535|81596012|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
27933557|NCT00366535|81596013|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
27933558|NCT00366535|81596012|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
27933559|NCT00366535|81596013|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
27933560|NCT01960842|81596014|FG000|Overall Study|Adverse Event|1|||
27933561|NCT01960842|81596014|FG000|Overall Study|Withdrawal by Subject|2|||
27933562|NCT04193527|81596015|FG000|Overall Study|Other|1|||
27933563|NCT04193527|81596016|FG001|Overall Study|Other|1|||
27933564|NCT04193527|81596017|FG002|Overall Study|Other|0|||
27933565|NCT00669331|81596018|FG000|Randomisation to First Dose|Adverse Event|1|||
27933566|NCT00669331|81596019|FG001|Randomisation to First Dose|Adverse Event|0|||
27933567|NCT00669331|81596018|FG000|Randomisation to First Dose|Protocol Violation|1|||
27933568|NCT00669331|81596019|FG001|Randomisation to First Dose|Protocol Violation|0|||
27933569|NCT00669331|81596018|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
27933570|NCT00669331|81596019|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
27933571|NCT00669331|81596018|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
27933572|NCT00669331|81596019|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
27933573|NCT00669331|81596018|FG000|Randomisation to First Dose|Death|1|||
27933574|NCT00669331|81596019|FG001|Randomisation to First Dose|Death|0|||
27933575|NCT00669331|81596018|FG000|Randomisation to First Dose|Sponsor decision|0|||
27933576|NCT00669331|81596019|FG001|Randomisation to First Dose|Sponsor decision|1|||
27933577|NCT00669331|81596018|FG000|Randomisation to First Dose|Randomised in error|3|||
27933578|NCT00669331|81596019|FG001|Randomisation to First Dose|Randomised in error|10|||
27933579|NCT00669331|81596018|FG000|Blinded Treatment Period|Adverse Event|16|||
27933580|NCT00669331|81596019|FG001|Blinded Treatment Period|Adverse Event|10|||
27933581|NCT00669331|81596018|FG000|Blinded Treatment Period|Protocol Violation|1|||
27933582|NCT00669331|81596019|FG001|Blinded Treatment Period|Protocol Violation|1|||
27933583|NCT00669331|81596018|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
27933584|NCT00669331|81596019|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
27933585|NCT00669331|81596018|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
27933586|NCT00669331|81596019|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
27933587|NCT00669331|81596018|FG000|Blinded Treatment Period|Death|0|||
27933588|NCT00669331|81596019|FG001|Blinded Treatment Period|Death|2|||
27550711|NCT01153347|80203458|FG002|Overall Study|Study-specific withdrawal criteria|1|||
27550712|NCT01153347|80203459|FG003|Overall Study|Study-specific withdrawal criteria|2|||
27933589|NCT00669331|81596018|FG000|Blinded Treatment Period|Physician Decision|3|||
27933590|NCT00669331|81596019|FG001|Blinded Treatment Period|Physician Decision|3|||
27933591|NCT00669331|81596018|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
27550713|NCT01153347|80203456|FG000|Overall Study|Lost to Follow-up|4|||
27933592|NCT00669331|81596019|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
27933593|NCT00560404|81596020|FG000|Overall Study|Adverse Event|2|||
27933594|NCT00560404|81596021|FG001|Overall Study|Adverse Event|3|||
27933595|NCT00560404|81596020|FG000|Overall Study|Death|3|||
27933596|NCT00560404|81596021|FG001|Overall Study|Death|3|||
27933597|NCT00560404|81596020|FG000|Overall Study|Protocol Violation|12|||
27933598|NCT00560404|81596021|FG001|Overall Study|Protocol Violation|7|||
27933599|NCT00560404|81596020|FG000|Overall Study|Administrative Reasons|1|||
27933600|NCT00560404|81596021|FG001|Overall Study|Administrative Reasons|1|||
27933601|NCT00560404|81596020|FG000|Overall Study|Withdrew Consent|4|||
27933602|NCT00560404|81596021|FG001|Overall Study|Withdrew Consent|0|||
27933603|NCT00560404|81596020|FG000|Overall Study|Failure to return|1|||
27933604|NCT00560404|81596021|FG001|Overall Study|Failure to return|2|||
27933605|NCT00560404|81596020|FG000|Overall Study|Other withdrawal reason|13|||
27933606|NCT00560404|81596021|FG001|Overall Study|Other withdrawal reason|5|||
27743496|NCT01544595|80889594|FG004|Status at Week 68|Lack of Efficacy|0|||
27933607|NCT00004859|81596022|FG000|Overall Study|Lack of Efficacy|43|||
27933608|NCT00004859|81596023|FG001|Overall Study|Lack of Efficacy|113|||
27933609|NCT00004859|81596022|FG000|Overall Study|Adverse Event|31|||
27933610|NCT00004859|81596023|FG001|Overall Study|Adverse Event|93|||
27933611|NCT00004859|81596022|FG000|Overall Study|Death|5|||
27933612|NCT00004859|81596023|FG001|Overall Study|Death|5|||
27933613|NCT00004859|81596022|FG000|Overall Study|Withdrawal by Subject|7|||
27933614|NCT00004859|81596023|FG001|Overall Study|Withdrawal by Subject|33|||
27933615|NCT00004859|81596022|FG000|Overall Study|Protocol Violation|2|||
27933616|NCT00004859|81596023|FG001|Overall Study|Protocol Violation|2|||
27933617|NCT00004859|81596022|FG000|Overall Study|other disease|0|||
27933618|NCT00004859|81596023|FG001|Overall Study|other disease|3|||
27933619|NCT00004859|81596022|FG000|Overall Study|error|3|||
27933620|NCT00004859|81596023|FG001|Overall Study|error|1|||
27933621|NCT00004859|81596022|FG000|Overall Study|missing data|14|||
27933622|NCT00004859|81596023|FG001|Overall Study|missing data|11|||
27933623|NCT00004859|81596022|FG000|Overall Study|Other|13|||
27933624|NCT00004859|81596023|FG001|Overall Study|Other|21|||
27933625|NCT01698008|81596026|FG000|Overall Study|Withdrawal by Subject|1|||
27933626|NCT01698008|81596027|FG001|Overall Study|Withdrawal by Subject|2|||
27933627|NCT03473301|81596029|FG000|Overall Study|Protocol Violation|4|||
27933628|NCT03473301|81596030|FG001|Overall Study|Protocol Violation|0|||
27933629|NCT03473301|81596031|FG002|Overall Study|Protocol Violation|0|||
27743497|NCT01544595|80889595|FG005|Status at Week 68|Lack of Efficacy|0|||
27743498|NCT01544595|80889590|FG000|Status at Week 68|Lost to Follow-up|1|||
27743499|NCT01544595|80889591|FG001|Status at Week 68|Lost to Follow-up|1|||
27743500|NCT01544595|80889592|FG002|Status at Week 68|Lost to Follow-up|0|||
27743501|NCT01544595|80889593|FG003|Status at Week 68|Lost to Follow-up|0|||
27743502|NCT01544595|80889594|FG004|Status at Week 68|Lost to Follow-up|0|||
27743503|NCT01544595|80889595|FG005|Status at Week 68|Lost to Follow-up|0|||
27743504|NCT01544595|80889590|FG000|Status at Week 68|Non-compliance with study treatment|1|||
27743505|NCT01544595|80889591|FG001|Status at Week 68|Non-compliance with study treatment|0|||
27743506|NCT01544595|80889592|FG002|Status at Week 68|Non-compliance with study treatment|0|||
27743507|NCT01544595|80889593|FG003|Status at Week 68|Non-compliance with study treatment|1|||
27743508|NCT01544595|80889594|FG004|Status at Week 68|Non-compliance with study treatment|0|||
27743509|NCT01544595|80889595|FG005|Status at Week 68|Non-compliance with study treatment|0|||
27743510|NCT01544595|80889590|FG000|Status at Week 68|Protocol Violation|2|||
27743511|NCT01544595|80889591|FG001|Status at Week 68|Protocol Violation|0|||
27743512|NCT01544595|80889592|FG002|Status at Week 68|Protocol Violation|1|||
27743513|NCT01544595|80889593|FG003|Status at Week 68|Protocol Violation|1|||
27743514|NCT01544595|80889594|FG004|Status at Week 68|Protocol Violation|0|||
27743515|NCT01544595|80889595|FG005|Status at Week 68|Protocol Violation|0|||
27743516|NCT01544595|80889590|FG000|Status at Week 68|Technical problems|1|||
27743517|NCT01544595|80889591|FG001|Status at Week 68|Technical problems|0|||
27743518|NCT01544595|80889592|FG002|Status at Week 68|Technical problems|0|||
27743519|NCT01544595|80889593|FG003|Status at Week 68|Technical problems|1|||
27743520|NCT01544595|80889594|FG004|Status at Week 68|Technical problems|0|||
27933630|NCT03473301|81596029|FG000|Overall Study|Withdrawal by Subject|0|||
27933631|NCT03473301|81596030|FG001|Overall Study|Withdrawal by Subject|1|||
27933632|NCT03473301|81596031|FG002|Overall Study|Withdrawal by Subject|0|||
27550714|NCT01153347|80203457|FG001|Overall Study|Lost to Follow-up|9|||
27550715|NCT01153347|80203458|FG002|Overall Study|Lost to Follow-up|11|||
27550716|NCT01153347|80203459|FG003|Overall Study|Lost to Follow-up|8|||
27550717|NCT01153347|80203456|FG000|Overall Study|Other|5|||
27550718|NCT01153347|80203457|FG001|Overall Study|Other|5|||
27550719|NCT01153347|80203458|FG002|Overall Study|Other|4|||
27550720|NCT01153347|80203459|FG003|Overall Study|Other|0|||
27550721|NCT01153347|80203456|FG000|Overall Study|Death|1|||
27550722|NCT01153347|80203457|FG001|Overall Study|Death|0|||
27550723|NCT01153347|80203458|FG002|Overall Study|Death|0|||
27550724|NCT01153347|80203459|FG003|Overall Study|Death|0|||
27933633|NCT03473301|81596029|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
27933634|NCT03473301|81596030|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
27933635|NCT03473301|81596031|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
27933636|NCT03022630|81596036|FG000|Overall Study|Death|9|||
27933637|NCT03022630|81596037|FG001|Overall Study|Death|7|||
27933638|NCT03022630|81596036|FG000|Overall Study|Withdrawal by Subject|0|||
27933639|NCT03022630|81596037|FG001|Overall Study|Withdrawal by Subject|5|||
27933640|NCT03528577|81596040|FG000|Sequence 1|Failed Spirometry|1|||
27933641|NCT03528577|81596040|FG000|Sequence 1|Restricted medication|1|||
27933642|NCT03528577|81596040|FG000|Sequence 2|Adverse Event|1|||
27933643|NCT03528577|81596040|FG000|Sequence 2|Withdrawal by Subject|1|||
27933644|NCT03528577|81596040|FG000|Sequence 2|Failed Spirometry|1|||
27933645|NCT03528577|81596040|FG000|Sequence 3|Failed Spirometry|1|||
27933646|NCT03528577|81596040|FG000|Sequence 4|Failed Spirometry|2|||
27933647|NCT03528577|81596040|FG000|Sequence 4|Adverse Event|1|||
27933648|NCT01060111|81596041|FG000|Overall Study|Adverse Event|9|||
27933649|NCT01060111|81596042|FG001|Overall Study|Adverse Event|5|||
27933650|NCT01060111|81596043|FG002|Overall Study|Adverse Event|18|||
27933651|NCT01060111|81596041|FG000|Overall Study|Lack of Efficacy|2|||
27933652|NCT01060111|81596042|FG001|Overall Study|Lack of Efficacy|1|||
27933653|NCT01060111|81596043|FG002|Overall Study|Lack of Efficacy|0|||
27933654|NCT01060111|81596041|FG000|Overall Study|Inappropriate participant|5|||
27933655|NCT01060111|81596042|FG001|Overall Study|Inappropriate participant|4|||
27933656|NCT01060111|81596043|FG002|Overall Study|Inappropriate participant|5|||
27933657|NCT01060111|81596041|FG000|Overall Study|Participants' evasion for hospital visit|0|||
27933658|NCT01060111|81596042|FG001|Overall Study|Participants' evasion for hospital visit|3|||
27933659|NCT01060111|81596043|FG002|Overall Study|Participants' evasion for hospital visit|2|||
27933660|NCT01060111|81596041|FG000|Overall Study|Participants' non-cooperation|8|||
27933661|NCT01060111|81596042|FG001|Overall Study|Participants' non-cooperation|6|||
27933662|NCT01060111|81596043|FG002|Overall Study|Participants' non-cooperation|6|||
27933663|NCT01060111|81596041|FG000|Overall Study|Adverse event and insufficient effect|0|||
27933664|NCT01060111|81596042|FG001|Overall Study|Adverse event and insufficient effect|1|||
27933665|NCT01060111|81596043|FG002|Overall Study|Adverse event and insufficient effect|0|||
27933666|NCT01060111|81596041|FG000|Overall Study|Participants' non-cooperation|1|||
27933667|NCT01060111|81596042|FG001|Overall Study|Participants' non-cooperation|0|||
27933668|NCT01060111|81596043|FG002|Overall Study|Participants' non-cooperation|0|||
27933669|NCT01060111|81596041|FG000|Overall Study|Other|2|||
27933670|NCT01060111|81596042|FG001|Overall Study|Other|3|||
27933671|NCT01060111|81596043|FG002|Overall Study|Other|4|||
27933672|NCT03338023|81596049|FG000|Overall Study|Withdrawal by Subject|3|||
27933673|NCT03338023|81596050|FG001|Overall Study|Withdrawal by Subject|4|||
27933674|NCT03338023|81596049|FG000|Overall Study|Protocol Violation|3|||
27933675|NCT03338023|81596050|FG001|Overall Study|Protocol Violation|3|||
27933676|NCT03338023|81596049|FG000|Overall Study|Lost to Follow-up|2|||
27933677|NCT03338023|81596050|FG001|Overall Study|Lost to Follow-up|1|||
27933678|NCT03338023|81596049|FG000|Overall Study|Physician Decision|1|||
27933679|NCT03338023|81596050|FG001|Overall Study|Physician Decision|2|||
27933680|NCT01521364|81596053|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
27933681|NCT01521364|81596053|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
27933682|NCT02569242|81596061|FG000|Overall Study|Death|1|||
27933683|NCT02569242|81596062|FG001|Overall Study|Death|0|||
27933684|NCT02569242|81596061|FG000|Overall Study|Withdrawal by Subject|0|||
27933685|NCT02569242|81596062|FG001|Overall Study|Withdrawal by Subject|1|||
27933686|NCT03767894|81596069|FG000|Overall Study|Withdrawal by Subject|1|||
27933687|NCT02370394|81596070|FG000|Overall Study|Lost to Follow-up|2|||
27933688|NCT02370394|81596071|FG001|Overall Study|Lost to Follow-up|1|||
27743521|NCT01544595|80889595|FG005|Status at Week 68|Technical problems|0|||
27743522|NCT01544595|80889590|FG000|Status at Week 68|Withdrawal by Subject|0|||
27933689|NCT02370394|81596070|FG000|Overall Study|Withdrawal by Subject|0|||
27933690|NCT02370394|81596071|FG001|Overall Study|Withdrawal by Subject|1|||
27933691|NCT02545127|81596076|FG000|Overall Study|Lost to Follow-up|1|||
27933692|NCT02545127|81596077|FG001|Overall Study|Lost to Follow-up|0|||
27743523|NCT01544595|80889591|FG001|Status at Week 68|Withdrawal by Subject|1|||
27743524|NCT01544595|80889592|FG002|Status at Week 68|Withdrawal by Subject|1|||
27933693|NCT00776997|81596082|FG000|Overall Study|Adverse Event|2|||
27933694|NCT02755090|81596084|FG000|Overall Study|equipment malfunction|1|||
27933695|NCT02755090|81596085|FG001|Overall Study|equipment malfunction|0|||
27550725|NCT00191789|80203460|FG000|Overall Study|Adverse Event|5|||
27550726|NCT00191789|80203460|FG000|Overall Study|Patient: Satisfactory Response|5|||
27743525|NCT01544595|80889593|FG003|Status at Week 68|Withdrawal by Subject|2|||
27933696|NCT00145327|81596086|FG000|Overall Study|Withdrawal by Subject|77|||
27933697|NCT00145327|81596087|FG001|Overall Study|Withdrawal by Subject|72|||
27933698|NCT00145327|81596088|FG002|Overall Study|Withdrawal by Subject|164|||
27933699|NCT00145327|81596086|FG000|Overall Study|Death|26|||
27550727|NCT00191789|80203460|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
27550728|NCT00191789|80203460|FG000|Overall Study|Withdrawal by Subject|4|||
27743526|NCT01544595|80889594|FG004|Status at Week 68|Withdrawal by Subject|0|||
27933700|NCT00145327|81596087|FG001|Overall Study|Death|18|||
27933701|NCT00145327|81596088|FG002|Overall Study|Death|30|||
27933702|NCT00145327|81596086|FG000|Overall Study|Adverse Event|14|||
27933703|NCT00145327|81596087|FG001|Overall Study|Adverse Event|11|||
27933704|NCT00145327|81596088|FG002|Overall Study|Adverse Event|22|||
27933705|NCT00145327|81596086|FG000|Overall Study|Lost to Follow-up|9|||
27933706|NCT00145327|81596087|FG001|Overall Study|Lost to Follow-up|14|||
27933707|NCT00145327|81596088|FG002|Overall Study|Lost to Follow-up|14|||
27933708|NCT00145327|81596086|FG000|Overall Study|Administrative problems|12|||
27933709|NCT00145327|81596087|FG001|Overall Study|Administrative problems|9|||
27933710|NCT00145327|81596088|FG002|Overall Study|Administrative problems|13|||
27933711|NCT00145327|81596086|FG000|Overall Study|Protocol Violation|2|||
27933712|NCT00145327|81596087|FG001|Overall Study|Protocol Violation|0|||
27933713|NCT00145327|81596088|FG002|Overall Study|Protocol Violation|2|||
27933714|NCT00145327|81596086|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27933715|NCT00145327|81596087|FG001|Overall Study|Abnormal laboratory value(s)|0|||
27933716|NCT00145327|81596088|FG002|Overall Study|Abnormal laboratory value(s)|2|||
27933717|NCT00145327|81596086|FG000|Overall Study|Missing - not stated|1|||
27933718|NCT00145327|81596087|FG001|Overall Study|Missing - not stated|0|||
27933719|NCT00145327|81596088|FG002|Overall Study|Missing - not stated|1|||
27933720|NCT00284934|81596089|FG000|Overall Study|Adverse Event|1|||
27933721|NCT00284934|81596090|FG001|Overall Study|Adverse Event|2|||
27933722|NCT00284934|81596089|FG000|Overall Study|Other reasons|3|||
27933723|NCT00284934|81596090|FG001|Overall Study|Other reasons|1|||
27933724|NCT02460380|81596091|FG000|Overall Study|Withdrawal by Subject|10|||
27933725|NCT02460380|81596092|FG001|Overall Study|Withdrawal by Subject|5|||
27933726|NCT02493855|81596093|FG000|Overall Study|Non-compliance|1|||
27933727|NCT02493855|81596094|FG001|Overall Study|Non-compliance|0|||
27933728|NCT02493855|81596095|FG002|Overall Study|Non-compliance|0|||
27933729|NCT02493855|81596093|FG000|Overall Study|Adverse Event|0|||
27933730|NCT02493855|81596094|FG001|Overall Study|Adverse Event|1|||
27933731|NCT02493855|81596095|FG002|Overall Study|Adverse Event|0|||
27933732|NCT02493855|81596093|FG000|Overall Study|Withdrawal by Subject|1|||
27933733|NCT02493855|81596094|FG001|Overall Study|Withdrawal by Subject|0|||
27933734|NCT02493855|81596095|FG002|Overall Study|Withdrawal by Subject|0|||
27933735|NCT01208051|81596096|FG000|Total Enrollment|Withdrawal by Subject|0|||
27933736|NCT01208051|81596097|FG001|Total Enrollment|Withdrawal by Subject|1|||
27933737|NCT01208051|81596098|FG002|Total Enrollment|Withdrawal by Subject|0|||
27933738|NCT01208051|81596099|FG003|Total Enrollment|Withdrawal by Subject|0|||
27933739|NCT01208051|81596100|FG004|Total Enrollment|Withdrawal by Subject|2|||
27933740|NCT01208051|81596096|FG000|Total Enrollment|Brain metastases|0|||
27933741|NCT01208051|81596097|FG001|Total Enrollment|Brain metastases|0|||
27933742|NCT01208051|81596098|FG002|Total Enrollment|Brain metastases|1|||
27933743|NCT01208051|81596099|FG003|Total Enrollment|Brain metastases|0|||
27933744|NCT01208051|81596100|FG004|Total Enrollment|Brain metastases|0|||
27933745|NCT02821000|81596103|FG000|Overall Study|Death|89|||
27933746|NCT02821000|81596103|FG000|Overall Study|Sponsor Decision|12|||
27933747|NCT02821000|81596103|FG000|Overall Study|Withdrawal by Subject|2|||
27933748|NCT01186419|81596104|FG000|Overall Study|Withdrawal by Subject|5|||
27933749|NCT01186419|81596105|FG001|Overall Study|Withdrawal by Subject|3|||
27933750|NCT01186419|81596104|FG000|Overall Study|Adverse Event|1|||
27933751|NCT01186419|81596105|FG001|Overall Study|Adverse Event|2|||
27933752|NCT01186419|81596104|FG000|Overall Study|Physician Decision|0|||
27933753|NCT01186419|81596105|FG001|Overall Study|Physician Decision|3|||
27933754|NCT01186419|81596104|FG000|Overall Study|Other|1|||
27933755|NCT01186419|81596105|FG001|Overall Study|Other|1|||
27933756|NCT01829165|81596108|FG000|Overall Study|Did not complete intervention|2|||
27933757|NCT01829165|81596109|FG001|Overall Study|Did not complete intervention|0|||
27933758|NCT03439514|81596117|FG000|Double-Blind Treatment Period|Other|4|||
27933759|NCT03439514|81596118|FG001|Double-Blind Treatment Period|Other|1|||
27933760|NCT03439514|81596117|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
27933761|NCT03439514|81596118|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
27933762|NCT03439514|81596117|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
27933763|NCT03439514|81596118|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
27933764|NCT03439514|81596117|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
27933765|NCT03439514|81596118|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
27933766|NCT03439514|81596117|FG000|Double-Blind Treatment Period|Death|1|||
27933767|NCT03439514|81596118|FG001|Double-Blind Treatment Period|Death|2|||
27933768|NCT01089543|81596119|FG000|Overall Study|Withdrawal by Subject|2|||
27933769|NCT01089543|81596120|FG001|Overall Study|Withdrawal by Subject|3|||
27933770|NCT01089543|81596121|FG002|Overall Study|Withdrawal by Subject|3|||
27933771|NCT01089543|81596122|FG003|Overall Study|Withdrawal by Subject|1|||
27933772|NCT01089543|81596119|FG000|Overall Study|Physician Decision|1|||
27933773|NCT01089543|81596120|FG001|Overall Study|Physician Decision|0|||
27933774|NCT01089543|81596121|FG002|Overall Study|Physician Decision|0|||
27933775|NCT01089543|81596122|FG003|Overall Study|Physician Decision|1|||
27933776|NCT01089543|81596119|FG000|Overall Study|Adverse Event|0|||
27933777|NCT01089543|81596120|FG001|Overall Study|Adverse Event|1|||
27933778|NCT01089543|81596121|FG002|Overall Study|Adverse Event|0|||
27933779|NCT01089543|81596122|FG003|Overall Study|Adverse Event|0|||
27743527|NCT01544595|80889595|FG005|Status at Week 68|Withdrawal by Subject|0|||
27933780|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
27933781|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
27933782|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
27933783|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
27933784|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
27933785|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
27933786|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
27933787|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
27933788|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
27933789|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
27933790|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
27933791|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
27933792|NCT00290758|81596123|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
27933793|NCT00290758|81596124|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
27933794|NCT00290758|81596123|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
27933795|NCT00290758|81596124|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
27933796|NCT00585585|81596125|FG000|Overall Study|Adverse Event|1|||
27933797|NCT00356421|81596127|FG000|Overall Study|Lack of Efficacy|3|||
27933798|NCT00356421|81596128|FG001|Overall Study|Lack of Efficacy|0|||
27933799|NCT00356421|81596127|FG000|Overall Study|Withdrawal by Subject|9|||
27933800|NCT00356421|81596128|FG001|Overall Study|Withdrawal by Subject|2|||
27933801|NCT00356421|81596127|FG000|Overall Study|Related to study drug|15|||
27933802|NCT00356421|81596128|FG001|Overall Study|Related to study drug|12|||
27933803|NCT00356421|81596127|FG000|Overall Study|Not related to study drug|5|||
27933804|NCT00356421|81596128|FG001|Overall Study|Not related to study drug|3|||
27933805|NCT01905267|81596129|FG000|Overall Study|Physician Decision|2|||
27933806|NCT01905267|81596130|FG001|Overall Study|Physician Decision|2|||
27933807|NCT01657500|81596133|FG000|Overall Study|set impropperly matched|3|||
27933808|NCT01657500|81596134|FG001|Overall Study|set impropperly matched|3|||
27933809|NCT01657500|81596133|FG000|Overall Study|Lost to Follow-up|2|||
27933810|NCT01657500|81596134|FG001|Overall Study|Lost to Follow-up|2|||
27933811|NCT02568254|81596137|FG000|Period 2|Adverse Event|0|||
27933812|NCT02568254|81596138|FG001|Period 2|Adverse Event|0|||
27933813|NCT02568254|81596139|FG002|Period 2|Adverse Event|1|||
27933814|NCT02568254|81596140|FG003|Period 2|Adverse Event|0|||
27933815|NCT02568254|81596141|FG004|Period 2|Adverse Event|0|||
27933816|NCT02568254|81596142|FG005|Period 2|Adverse Event|0|||
27933817|NCT02568254|81596137|FG000|Period 3|Unstatisfactory Lens fitting|0|||
27933818|NCT02568254|81596138|FG001|Period 3|Unstatisfactory Lens fitting|0|||
27933819|NCT02568254|81596139|FG002|Period 3|Unstatisfactory Lens fitting|0|||
27933820|NCT02568254|81596140|FG003|Period 3|Unstatisfactory Lens fitting|0|||
27933821|NCT02568254|81596141|FG004|Period 3|Unstatisfactory Lens fitting|1|||
27933822|NCT02568254|81596142|FG005|Period 3|Unstatisfactory Lens fitting|0|||
27933823|NCT04389671|81596143|FG000|Overall Study|Death|7|||
27933824|NCT01795937|81596144|FG000|Overall Study|Withdrawal by Subject|1|||
27933825|NCT01795937|81596145|FG001|Overall Study|Withdrawal by Subject|0|||
27933826|NCT01795937|81596146|FG002|Overall Study|Withdrawal by Subject|0|||
27933827|NCT01795937|81596144|FG000|Overall Study|Physician Decision|0|||
27933828|NCT01795937|81596145|FG001|Overall Study|Physician Decision|1|||
27933829|NCT01795937|81596146|FG002|Overall Study|Physician Decision|0|||
27933830|NCT01727154|81596147|FG000|Overall Study|Death|17|||
27933831|NCT01727154|81596147|FG000|Overall Study|Withdrawal by Subject|14|||
27933832|NCT01727154|81596147|FG000|Overall Study|Subject Withdrew Consent|18|||
27933833|NCT01727154|81596147|FG000|Overall Study|Study Terminated|6|||
27933834|NCT01727154|81596147|FG000|Overall Study|No Discontinuation Documentation|4|||
27933835|NCT00985790|81596148|FG000|Overall Study|Withdrawal by Subject|1|||
27933836|NCT00985790|81596149|FG001|Overall Study|Withdrawal by Subject|1|||
27933837|NCT00985790|81596148|FG000|Overall Study|Lost to Follow-up|6|||
27933838|NCT00985790|81596149|FG001|Overall Study|Lost to Follow-up|7|||
27933839|NCT04495478|81596150|FG000|Overall Study|Withdrawal by Subject|0|||
27933840|NCT04495478|81596151|FG001|Overall Study|Withdrawal by Subject|0|||
27933841|NCT04495478|81596152|FG002|Overall Study|Withdrawal by Subject|0|||
27933842|NCT04495478|81596153|FG003|Overall Study|Withdrawal by Subject|1|||
27933843|NCT04495478|81596154|FG004|Overall Study|Withdrawal by Subject|0|||
27743528|NCT01544595|80889590|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
27933844|NCT04495478|81596155|FG005|Overall Study|Withdrawal by Subject|0|||
27933845|NCT04495478|81596156|FG006|Overall Study|Withdrawal by Subject|0|||
27933846|NCT04495478|81596150|FG000|Overall Study|Physician Decision|0|||
27933847|NCT04495478|81596151|FG001|Overall Study|Physician Decision|1|||
27933848|NCT04495478|81596152|FG002|Overall Study|Physician Decision|0|||
27933849|NCT04495478|81596153|FG003|Overall Study|Physician Decision|0|||
27933850|NCT04495478|81596154|FG004|Overall Study|Physician Decision|1|||
27933851|NCT04495478|81596155|FG005|Overall Study|Physician Decision|0|||
27933852|NCT04495478|81596156|FG006|Overall Study|Physician Decision|0|||
27933853|NCT03478787|81596157|FG000|Overall Study|Adverse Event|5|||
27933854|NCT03478787|81596158|FG001|Overall Study|Adverse Event|1|||
27933855|NCT03478787|81596157|FG000|Overall Study|Protocol Violation|3|||
27933856|NCT03478787|81596158|FG001|Overall Study|Protocol Violation|0|||
27933857|NCT03478787|81596157|FG000|Overall Study|Lack of Efficacy|7|||
27933858|NCT03478787|81596158|FG001|Overall Study|Lack of Efficacy|1|||
27933859|NCT03478787|81596157|FG000|Overall Study|Lost to Follow-up|9|||
27933860|NCT03478787|81596158|FG001|Overall Study|Lost to Follow-up|5|||
27933861|NCT03478787|81596157|FG000|Overall Study|Withdrawal by Subject|2|||
27933862|NCT03478787|81596158|FG001|Overall Study|Withdrawal by Subject|6|||
27933863|NCT03478787|81596157|FG000|Overall Study|Other, Not Specified|3|||
27933864|NCT03478787|81596158|FG001|Overall Study|Other, Not Specified|0|||
27933865|NCT01898091|81596159|FG000|Overall Study|Lost to Follow-up|1|||
27933866|NCT01898091|81596160|FG001|Overall Study|Lost to Follow-up|1|||
27933867|NCT01898091|81596159|FG000|Overall Study|Withdrawal by Subject|1|||
27933868|NCT01898091|81596160|FG001|Overall Study|Withdrawal by Subject|5|||
27933869|NCT00003456|81596164|FG000|Overall Study|Not evaluable|8|||
27933870|NCT00973973|81596167|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
27933871|NCT00973973|81596168|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
27933872|NCT00973973|81596167|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
27933873|NCT00973973|81596168|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
27933874|NCT00973973|81596167|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
27933875|NCT00973973|81596168|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
27933876|NCT00973973|81596167|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
27933877|NCT00973973|81596168|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
27933878|NCT00973973|81596167|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
27642724|NCT01288443|80532677|FG002|Overall Study|Other than above|0|||
27642725|NCT01288443|80532678|FG003|Overall Study|Other than above|2|||
27642726|NCT01288443|80532679|FG004|Overall Study|Other than above|1|||
27642727|NCT01288443|80532680|FG005|Overall Study|Other than above|0|||
27642728|NCT00586313|80532681|FG000|Overall Study|Lack of Efficacy|2|||
27642729|NCT02638337|80532684|FG000|Overall Study|Adverse Event|6|||
27642730|NCT02638337|80532685|FG001|Overall Study|Adverse Event|10|||
27642731|NCT02638337|80532684|FG000|Overall Study|Protocol Violation|3|||
27642732|NCT02638337|80532685|FG001|Overall Study|Protocol Violation|0|||
27642733|NCT02638337|80532684|FG000|Overall Study|Withdrawal by Subject|13|||
27642734|NCT02638337|80532685|FG001|Overall Study|Withdrawal by Subject|16|||
27642735|NCT02638337|80532684|FG000|Overall Study|Lost to Follow-up|7|||
27642736|NCT02638337|80532685|FG001|Overall Study|Lost to Follow-up|7|||
27642737|NCT02638337|80532684|FG000|Overall Study|Other - Miscellaneous|4|||
27642738|NCT02638337|80532685|FG001|Overall Study|Other - Miscellaneous|3|||
27642739|NCT00727909|80532688|FG000|Overall Study|Withdrawal by Subject|5|||
27642740|NCT00727909|80532689|FG001|Overall Study|Withdrawal by Subject|11|||
27642741|NCT00727909|80532690|FG002|Overall Study|Withdrawal by Subject|8|||
27642742|NCT00727909|80532691|FG003|Overall Study|Withdrawal by Subject|5|||
27642743|NCT00727909|80532688|FG000|Overall Study|Death|0|||
27642744|NCT00727909|80532689|FG001|Overall Study|Death|0|||
27642745|NCT00727909|80532690|FG002|Overall Study|Death|1|||
27642746|NCT00727909|80532691|FG003|Overall Study|Death|0|||
27642747|NCT00366249|80532692|FG000|Overall Study|Adverse Event|53|||
27642748|NCT00366249|80532693|FG001|Overall Study|Adverse Event|28|||
27642749|NCT00366249|80532692|FG000|Overall Study|Death|0|||
27642750|NCT00366249|80532693|FG001|Overall Study|Death|1|||
27642751|NCT00366249|80532692|FG000|Overall Study|Physician Decision|5|||
27642752|NCT00366249|80532693|FG001|Overall Study|Physician Decision|2|||
27642753|NCT00366249|80532692|FG000|Overall Study|Lost to Follow-up|2|||
27642754|NCT00366249|80532693|FG001|Overall Study|Lost to Follow-up|0|||
27642755|NCT00366249|80532692|FG000|Overall Study|Protocol Violation|1|||
27642756|NCT00366249|80532693|FG001|Overall Study|Protocol Violation|2|||
27642757|NCT00366249|80532692|FG000|Overall Study|Withdrawal by Subject|18|||
27642758|NCT00366249|80532693|FG001|Overall Study|Withdrawal by Subject|4|||
27642759|NCT00366249|80532692|FG000|Overall Study|Lack of Efficacy|21|||
27642760|NCT00366249|80532693|FG001|Overall Study|Lack of Efficacy|21|||
27642761|NCT00366249|80532692|FG000|Overall Study|Most due to osteomylitis status|31|||
27933879|NCT00973973|81596168|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
27933880|NCT00973973|81596167|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
27933881|NCT00973973|81596168|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
27933882|NCT00973973|81596167|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
27933883|NCT00973973|81596168|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
27642762|NCT00366249|80532693|FG001|Overall Study|Most due to osteomylitis status|20|||
27642763|NCT02538900|80532699|FG000|Overall Study|Death|2|||
27642764|NCT02538900|80532700|FG001|Overall Study|Death|2|||
27642765|NCT02538900|80532701|FG002|Overall Study|Death|2|||
27642766|NCT02538900|80532699|FG000|Overall Study|Withdrawal by Subject|18|||
27642767|NCT02538900|80532700|FG001|Overall Study|Withdrawal by Subject|16|||
27642768|NCT02538900|80532701|FG002|Overall Study|Withdrawal by Subject|15|||
27642769|NCT03624972|80532702|FG000|Overall Study|Lost to Follow-up|2|||
27642770|NCT03624972|80532703|FG001|Overall Study|Lost to Follow-up|0|||
27933884|NCT00973973|81596167|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
27933885|NCT00973973|81596168|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
27933886|NCT00973973|81596167|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
27933887|NCT00973973|81596168|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
27933888|NCT00973973|81596167|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
27933889|NCT00973973|81596168|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
27933890|NCT00973973|81596167|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
27933891|NCT00973973|81596168|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
27933892|NCT00973973|81596167|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
27933893|NCT00973973|81596168|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
27933894|NCT03722030|81596169|FG000|Overall Study|Withdrawal by Subject|1|||
27933895|NCT03722030|81596170|FG001|Overall Study|Withdrawal by Subject|0|||
27933896|NCT02945046|81596171|FG000|Overall Study|Adverse Event|1|||
27933897|NCT02945046|81596172|FG001|Overall Study|Adverse Event|0|||
27933898|NCT02945046|81596173|FG002|Overall Study|Adverse Event|2|||
27933899|NCT02945046|81596171|FG000|Overall Study|Withdrawal by Subject|3|||
27933900|NCT02945046|81596172|FG001|Overall Study|Withdrawal by Subject|3|||
27933901|NCT02945046|81596173|FG002|Overall Study|Withdrawal by Subject|3|||
27933902|NCT02945046|81596171|FG000|Overall Study|Protocol Violation|2|||
27933903|NCT02945046|81596172|FG001|Overall Study|Protocol Violation|3|||
27933904|NCT02945046|81596173|FG002|Overall Study|Protocol Violation|2|||
27933905|NCT02945046|81596171|FG000|Overall Study|Lost to Follow-up|1|||
27933906|NCT02945046|81596172|FG001|Overall Study|Lost to Follow-up|1|||
27933907|NCT02945046|81596173|FG002|Overall Study|Lost to Follow-up|0|||
27933908|NCT02945046|81596171|FG000|Overall Study|Lack of Efficacy|1|||
27933909|NCT02945046|81596172|FG001|Overall Study|Lack of Efficacy|2|||
27933910|NCT02945046|81596173|FG002|Overall Study|Lack of Efficacy|1|||
27933911|NCT02945046|81596171|FG000|Overall Study|Other than specified|5|||
27933912|NCT02945046|81596172|FG001|Overall Study|Other than specified|4|||
27933913|NCT02945046|81596173|FG002|Overall Study|Other than specified|7|||
27933914|NCT00120250|81596177|FG000|Overall Study|Lost to Follow-up|1|||
27933915|NCT00120250|81596178|FG001|Overall Study|Lost to Follow-up|1|||
27933916|NCT00120250|81596177|FG000|Overall Study|Protocol Violation|0|||
27933917|NCT00120250|81596178|FG001|Overall Study|Protocol Violation|1|||
27933918|NCT02391584|81596179|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
27933919|NCT02391584|81596180|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
27933920|NCT02391584|81596179|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
27933921|NCT02391584|81596180|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
27933922|NCT02391584|81596179|FG000|3 Month|Lost to Follow-up|1|||
27933923|NCT02391584|81596180|FG001|3 Month|Lost to Follow-up|0|||
27933924|NCT02391584|81596179|FG000|6 Month|Withdrawal by Subject|1|||
27933925|NCT02391584|81596180|FG001|6 Month|Withdrawal by Subject|0|||
27933926|NCT02391584|81596179|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
27933927|NCT02391584|81596180|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
27933928|NCT03808909|81596182|FG000|Overall Study|Lost to Follow-up|3|||
27933929|NCT03808909|81596183|FG001|Overall Study|Lost to Follow-up|0|||
27933930|NCT02218268|81596184|FG000|24 Hour Washout|Physician Decision|11|||
27933931|NCT02218268|81596185|FG001|24 Hour Washout|Physician Decision|9|||
27933932|NCT00122187|81596186|FG000|Overall Study|Withdrew because of resource limitations|2|||
27933933|NCT00122187|81596187|FG001|Overall Study|Withdrew because of resource limitations|2|||
27642771|NCT03624972|80532704|FG002|Overall Study|Lost to Follow-up|0|||
27642772|NCT03624972|80532702|FG000|Overall Study|Withdrawal by Subject|0|||
27933934|NCT00520572|81596198|FG000|Overall Study|Adverse Event|9|||
27933935|NCT00520572|81596199|FG001|Overall Study|Adverse Event|3|||
27933936|NCT00520572|81596200|FG002|Overall Study|Adverse Event|6|||
27933937|NCT00520572|81596201|FG003|Overall Study|Adverse Event|9|||
27933938|NCT00520572|81596202|FG004|Overall Study|Adverse Event|7|||
27933939|NCT00520572|81596203|FG005|Overall Study|Adverse Event|2|||
27933940|NCT00520572|81596198|FG000|Overall Study|Withdrawal by Subject|0|||
27933941|NCT00520572|81596199|FG001|Overall Study|Withdrawal by Subject|9|||
27933942|NCT00520572|81596200|FG002|Overall Study|Withdrawal by Subject|5|||
27933943|NCT00520572|81596201|FG003|Overall Study|Withdrawal by Subject|2|||
27933944|NCT00520572|81596202|FG004|Overall Study|Withdrawal by Subject|2|||
27933945|NCT00520572|81596203|FG005|Overall Study|Withdrawal by Subject|0|||
27933946|NCT00520572|81596198|FG000|Overall Study|Protocol Violation|0|||
27933947|NCT00520572|81596199|FG001|Overall Study|Protocol Violation|0|||
27933948|NCT00520572|81596200|FG002|Overall Study|Protocol Violation|1|||
27933949|NCT00520572|81596201|FG003|Overall Study|Protocol Violation|0|||
27642773|NCT03624972|80532703|FG001|Overall Study|Withdrawal by Subject|2|||
27933950|NCT00520572|81596202|FG004|Overall Study|Protocol Violation|0|||
27933951|NCT00520572|81596203|FG005|Overall Study|Protocol Violation|0|||
27933952|NCT00520572|81596198|FG000|Overall Study|Lack of Efficacy|1|||
27933953|NCT00520572|81596199|FG001|Overall Study|Lack of Efficacy|1|||
27933954|NCT00520572|81596200|FG002|Overall Study|Lack of Efficacy|1|||
27642774|NCT03624972|80532704|FG002|Overall Study|Withdrawal by Subject|0|||
27933955|NCT00520572|81596201|FG003|Overall Study|Lack of Efficacy|2|||
27933956|NCT00520572|81596202|FG004|Overall Study|Lack of Efficacy|1|||
27933957|NCT00520572|81596203|FG005|Overall Study|Lack of Efficacy|0|||
27933958|NCT00520572|81596198|FG000|Overall Study|Lost to Follow-up|0|||
27933959|NCT00520572|81596199|FG001|Overall Study|Lost to Follow-up|0|||
27933960|NCT00520572|81596200|FG002|Overall Study|Lost to Follow-up|0|||
27933961|NCT00520572|81596201|FG003|Overall Study|Lost to Follow-up|0|||
27933962|NCT00520572|81596202|FG004|Overall Study|Lost to Follow-up|1|||
27933963|NCT00520572|81596203|FG005|Overall Study|Lost to Follow-up|0|||
27933964|NCT00520572|81596198|FG000|Overall Study|Incorrect enrollment|1|||
27933965|NCT00520572|81596199|FG001|Overall Study|Incorrect enrollment|0|||
27933966|NCT00520572|81596200|FG002|Overall Study|Incorrect enrollment|1|||
27933967|NCT00520572|81596201|FG003|Overall Study|Incorrect enrollment|0|||
27933968|NCT00520572|81596202|FG004|Overall Study|Incorrect enrollment|1|||
27933969|NCT00520572|81596203|FG005|Overall Study|Incorrect enrollment|0|||
27933970|NCT00520572|81596198|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
27933971|NCT00520572|81596199|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
27933972|NCT00520572|81596200|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
27933973|NCT00520572|81596201|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
27933974|NCT00520572|81596202|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
27933975|NCT00520572|81596203|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
27933976|NCT00520572|81596198|FG000|Overall Study|Long break in taking Medication|0|||
27933977|NCT00520572|81596199|FG001|Overall Study|Long break in taking Medication|0|||
27933978|NCT00520572|81596200|FG002|Overall Study|Long break in taking Medication|0|||
27933979|NCT00520572|81596201|FG003|Overall Study|Long break in taking Medication|1|||
27933980|NCT00520572|81596202|FG004|Overall Study|Long break in taking Medication|0|||
27933981|NCT00520572|81596203|FG005|Overall Study|Long break in taking Medication|0|||
27933982|NCT00520572|81596198|FG000|Overall Study|Did not receive Treatment|1|||
27933983|NCT00520572|81596199|FG001|Overall Study|Did not receive Treatment|0|||
27933984|NCT00520572|81596200|FG002|Overall Study|Did not receive Treatment|1|||
27933985|NCT00520572|81596201|FG003|Overall Study|Did not receive Treatment|0|||
27933986|NCT00520572|81596202|FG004|Overall Study|Did not receive Treatment|0|||
27933987|NCT00520572|81596203|FG005|Overall Study|Did not receive Treatment|0|||
27933988|NCT04359680|81596204|FG000|Overall Study|Withdrawal by Subject|29|||
27933989|NCT04359680|81596205|FG001|Overall Study|Withdrawal by Subject|24|||
27933990|NCT04359680|81596204|FG000|Overall Study|Adverse Event|6|||
27933991|NCT04359680|81596205|FG001|Overall Study|Adverse Event|2|||
27933992|NCT04359680|81596204|FG000|Overall Study|Lost to Follow-up|56|||
27933993|NCT04359680|81596205|FG001|Overall Study|Lost to Follow-up|59|||
27933994|NCT04359680|81596204|FG000|Overall Study|Protocol Violation|3|||
27933995|NCT04359680|81596205|FG001|Overall Study|Protocol Violation|5|||
27933996|NCT04359680|81596204|FG000|Overall Study|Physician Decision|1|||
27933997|NCT04359680|81596205|FG001|Overall Study|Physician Decision|1|||
27933998|NCT04359680|81596204|FG000|Overall Study|Sponsor Decision|0|||
27933999|NCT04359680|81596205|FG001|Overall Study|Sponsor Decision|1|||
27934000|NCT01471574|81596206|FG000|Treatment Period|Lack of Efficacy|12|||
27934001|NCT01471574|81596207|FG001|Treatment Period|Lack of Efficacy|4|||
27934002|NCT01471574|81596208|FG002|Treatment Period|Lack of Efficacy|14|||
27934003|NCT01471574|81596209|FG003|Treatment Period|Lack of Efficacy|1|||
27934004|NCT01471574|81596206|FG000|Treatment Period|Adverse Event|7|||
27934005|NCT01471574|81596207|FG001|Treatment Period|Adverse Event|3|||
27934006|NCT01471574|81596208|FG002|Treatment Period|Adverse Event|6|||
27934007|NCT01471574|81596209|FG003|Treatment Period|Adverse Event|1|||
27934008|NCT01471574|81596206|FG000|Treatment Period|Withdrawal by Subject|5|||
27934009|NCT01471574|81596207|FG001|Treatment Period|Withdrawal by Subject|1|||
27934010|NCT01471574|81596208|FG002|Treatment Period|Withdrawal by Subject|1|||
27934011|NCT01471574|81596209|FG003|Treatment Period|Withdrawal by Subject|0|||
27934012|NCT01471574|81596206|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
27934013|NCT01471574|81596207|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
27934014|NCT01471574|81596208|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
27934015|NCT01471574|81596209|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
27934016|NCT01471574|81596206|FG000|Treatment Period|Lost to Follow-up|1|||
27934017|NCT01471574|81596207|FG001|Treatment Period|Lost to Follow-up|2|||
27934018|NCT01471574|81596208|FG002|Treatment Period|Lost to Follow-up|2|||
27934019|NCT01471574|81596209|FG003|Treatment Period|Lost to Follow-up|0|||
27934020|NCT01471574|81596206|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
27934021|NCT01471574|81596207|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
27934022|NCT01471574|81596208|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
27934023|NCT01471574|81596209|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
27934024|NCT01471574|81596206|FG000|Treatment Period|Other|1|||
27934025|NCT01471574|81596207|FG001|Treatment Period|Other|0|||
27934026|NCT01471574|81596208|FG002|Treatment Period|Other|0|||
27934027|NCT01471574|81596209|FG003|Treatment Period|Other|0|||
27934028|NCT01471574|81596206|FG000|Follow-up Period|Withdrawal by Subject|3|||
27934029|NCT01471574|81596207|FG001|Follow-up Period|Withdrawal by Subject|0|||
27934030|NCT01471574|81596208|FG002|Follow-up Period|Withdrawal by Subject|3|||
27934031|NCT01471574|81596209|FG003|Follow-up Period|Withdrawal by Subject|1|||
27934032|NCT01471574|81596206|FG000|Follow-up Period|Lost to Follow-up|4|||
27743529|NCT01544595|80889591|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
27743530|NCT01544595|80889592|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
27743531|NCT01544595|80889593|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
27743532|NCT01544595|80889594|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
27743533|NCT01544595|80889595|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
27743534|NCT01544595|80889590|FG000|Status at Week 156|Withdrawal by Subject|9|||
27743535|NCT01544595|80889591|FG001|Status at Week 156|Withdrawal by Subject|10|||
27743536|NCT01544595|80889592|FG002|Status at Week 156|Withdrawal by Subject|4|||
27743537|NCT01544595|80889593|FG003|Status at Week 156|Withdrawal by Subject|9|||
27743538|NCT01544595|80889594|FG004|Status at Week 156|Withdrawal by Subject|20|||
27743539|NCT01544595|80889595|FG005|Status at Week 156|Withdrawal by Subject|6|||
27743540|NCT01544595|80889590|FG000|Status at Week 156|Adverse Event|9|||
27934033|NCT01471574|81596207|FG001|Follow-up Period|Lost to Follow-up|1|||
27934034|NCT01471574|81596208|FG002|Follow-up Period|Lost to Follow-up|3|||
27934035|NCT01471574|81596209|FG003|Follow-up Period|Lost to Follow-up|2|||
27934036|NCT01471574|81596206|FG000|Follow-up Period|Death|0|||
27934037|NCT01471574|81596207|FG001|Follow-up Period|Death|0|||
27934038|NCT01471574|81596208|FG002|Follow-up Period|Death|1|||
27934039|NCT01471574|81596209|FG003|Follow-up Period|Death|0|||
27934040|NCT01471574|81596206|FG000|Follow-up Period|Follow-up no longer required|0|||
27934041|NCT01471574|81596207|FG001|Follow-up Period|Follow-up no longer required|1|||
27934042|NCT01471574|81596208|FG002|Follow-up Period|Follow-up no longer required|0|||
27934043|NCT01471574|81596209|FG003|Follow-up Period|Follow-up no longer required|0|||
27934044|NCT02528305|81596211|FG000|Overall Study|Withdrawal by Subject|1|||
27934045|NCT02528305|81596211|FG000|Overall Study|Adverse Event|1|||
27934046|NCT02528305|81596211|FG000|Overall Study|Physician Decision|1|||
27934047|NCT02489773|81596212|FG000|Overall Study|Lost to Follow-up|4|||
27934048|NCT02489773|81596213|FG001|Overall Study|Lost to Follow-up|1|||
27934049|NCT02489773|81596212|FG000|Overall Study|Physician Decision|1|||
27934050|NCT02489773|81596213|FG001|Overall Study|Physician Decision|0|||
27934051|NCT02489773|81596212|FG000|Overall Study|Withdrawal by Subject|1|||
27934052|NCT02489773|81596213|FG001|Overall Study|Withdrawal by Subject|0|||
27934053|NCT02489773|81596212|FG000|Overall Study|Leave the country or the state|1|||
27934054|NCT02489773|81596213|FG001|Overall Study|Leave the country or the state|1|||
27934055|NCT03197935|81596215|FG000|Overall Study|Death due to any cause|26|||
27934056|NCT03197935|81596216|FG001|Overall Study|Death due to any cause|15|||
27934057|NCT03197935|81596215|FG000|Overall Study|Lost to Follow-up|3|||
27934058|NCT03197935|81596216|FG001|Overall Study|Lost to Follow-up|5|||
27934059|NCT03197935|81596215|FG000|Overall Study|Physician Decision|2|||
27934060|NCT03197935|81596216|FG001|Overall Study|Physician Decision|1|||
27934061|NCT03197935|81596215|FG000|Overall Study|Withdrawal by Subject|16|||
27934062|NCT03197935|81596216|FG001|Overall Study|Withdrawal by Subject|8|||
27934063|NCT02175758|81596217|FG000|Treatment Phase|Lost to Follow-up|0|||
27934064|NCT02175758|81596218|FG001|Treatment Phase|Lost to Follow-up|1|||
27934065|NCT02175758|81596219|FG002|Treatment Phase|Lost to Follow-up|0|||
27934066|NCT02175758|81596220|FG003|Treatment Phase|Lost to Follow-up|0|||
27934067|NCT02175758|81596221|FG004|Treatment Phase|Lost to Follow-up|0|||
27934068|NCT02175758|81596222|FG005|Treatment Phase|Lost to Follow-up|0|||
27934069|NCT02175758|81596217|FG000|Treatment Phase|Adverse Event|0|||
27642775|NCT02767765|80536214|FG000|Overall Study|Adverse Event|4|||
27642776|NCT02767765|80536214|FG000|Overall Study|Death|1|||
27642777|NCT02767765|80536214|FG000|Overall Study|Insufficient response|1|||
27642778|NCT02767765|80536214|FG000|Overall Study|Lost to Follow-up|2|||
27642779|NCT02767765|80536214|FG000|Overall Study|Investigator decision|1|||
27642780|NCT02767765|80536214|FG000|Overall Study|Non-Compliance|1|||
27743541|NCT01544595|80889591|FG001|Status at Week 156|Adverse Event|11|||
27743542|NCT01544595|80889592|FG002|Status at Week 156|Adverse Event|1|||
27934070|NCT02175758|81596218|FG001|Treatment Phase|Adverse Event|0|||
27934071|NCT02175758|81596219|FG002|Treatment Phase|Adverse Event|0|||
27934072|NCT02175758|81596220|FG003|Treatment Phase|Adverse Event|0|||
27934073|NCT02175758|81596221|FG004|Treatment Phase|Adverse Event|1|||
27934074|NCT02175758|81596222|FG005|Treatment Phase|Adverse Event|0|||
27934075|NCT03156621|81596223|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
27934076|NCT03156621|81596224|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
27934077|NCT03156621|81596223|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
27934078|NCT03156621|81596224|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
27934079|NCT02287025|81596232|FG000|Overall Study|Not treated|2|||
27934080|NCT02287025|81596233|FG001|Overall Study|Not treated|0|||
27642781|NCT02767765|80536214|FG000|Overall Study|Withdrawal by Subject|1|||
27743543|NCT01544595|80889593|FG003|Status at Week 156|Adverse Event|3|||
27743544|NCT01544595|80889594|FG004|Status at Week 156|Adverse Event|4|||
27934081|NCT02287025|81596232|FG000|Overall Study|Progression of disease|3|||
27934082|NCT02287025|81596233|FG001|Overall Study|Progression of disease|2|||
27934083|NCT02287025|81596232|FG000|Overall Study|Adverse Event|2|||
27934084|NCT02287025|81596233|FG001|Overall Study|Adverse Event|4|||
27934085|NCT02287025|81596232|FG000|Overall Study|Withdrawal by Subject|2|||
27934086|NCT02287025|81596233|FG001|Overall Study|Withdrawal by Subject|2|||
27934087|NCT02287025|81596232|FG000|Overall Study|Screening failed|1|||
27934088|NCT02287025|81596233|FG001|Overall Study|Screening failed|1|||
27934089|NCT02691663|81596234|FG000|Overall Study|Screen failure after baseline|2|||
27934090|NCT02691663|81596235|FG001|Overall Study|Screen failure after baseline|2|||
27934091|NCT02691663|81596234|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
27934092|NCT02691663|81596235|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
27934093|NCT02691663|81596234|FG000|Overall Study|Withdrawn after Follow up 2|1|||
27934094|NCT02691663|81596235|FG001|Overall Study|Withdrawn after Follow up 2|1|||
27934095|NCT02691663|81596234|FG000|Overall Study|Lost to Follow-up|3|||
27934096|NCT02691663|81596235|FG001|Overall Study|Lost to Follow-up|2|||
27934097|NCT01769443|81596236|FG000|Overall Study|Study closure|1|||
27934098|NCT01769443|81596237|FG001|Overall Study|Study closure|0|||
27934099|NCT04090749|81596238|FG000|Open Label Pilot|Lost to Follow-up|1|||
27934100|NCT04090749|81596239|FG001|Open Label Pilot|Lost to Follow-up|0|||
27934101|NCT04090749|81596240|FG002|Open Label Pilot|Lost to Follow-up|0|||
27934102|NCT04090749|81596238|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
27934103|NCT04090749|81596239|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
27934104|NCT04090749|81596240|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
27934105|NCT04090749|81596238|FG000|Pilot Trial|Lost to Follow-up|0|||
27934106|NCT04090749|81596239|FG001|Pilot Trial|Lost to Follow-up|1|||
27934107|NCT04090749|81596240|FG002|Pilot Trial|Lost to Follow-up|1|||
27934108|NCT00195429|81596245|FG000|Overall Study|Adverse Event|2|||
27934109|NCT00195429|81596246|FG001|Overall Study|Adverse Event|4|||
27934110|NCT00195429|81596245|FG000|Overall Study|Lack of Efficacy|2|||
27934111|NCT00195429|81596246|FG001|Overall Study|Lack of Efficacy|1|||
27934112|NCT00195429|81596245|FG000|Overall Study|Lost to Follow-up|1|||
27642782|NCT04876417|80536217|FG000|Overall Study|Lost to Follow-up|5|||
27642783|NCT04876417|80536218|FG001|Overall Study|Lost to Follow-up|8|||
27642784|NCT04876417|80536219|FG002|Overall Study|Lost to Follow-up|0|||
27642785|NCT04876417|80536220|FG003|Overall Study|Lost to Follow-up|0|||
27642786|NCT00439270|80536221|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
27642787|NCT00439270|80536222|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
27642788|NCT00439270|80536223|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
27642789|NCT00439270|80536224|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
27642790|NCT00439270|80536225|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
27642791|NCT00439270|80536221|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
27743545|NCT01544595|80889595|FG005|Status at Week 156|Adverse Event|2|||
27743546|NCT01544595|80889590|FG000|Status at Week 156|Lost to Follow-up|4|||
27743547|NCT01544595|80889591|FG001|Status at Week 156|Lost to Follow-up|4|||
27743548|NCT01544595|80889592|FG002|Status at Week 156|Lost to Follow-up|0|||
27743549|NCT01544595|80889593|FG003|Status at Week 156|Lost to Follow-up|1|||
27743550|NCT01544595|80889594|FG004|Status at Week 156|Lost to Follow-up|4|||
27743551|NCT01544595|80889595|FG005|Status at Week 156|Lost to Follow-up|1|||
27743552|NCT01544595|80889590|FG000|Status at Week 156|Non-compliance with study treatement|0|||
27743553|NCT01544595|80889591|FG001|Status at Week 156|Non-compliance with study treatement|1|||
27743554|NCT01544595|80889592|FG002|Status at Week 156|Non-compliance with study treatement|0|||
27743555|NCT01544595|80889593|FG003|Status at Week 156|Non-compliance with study treatement|1|||
27743556|NCT01544595|80889594|FG004|Status at Week 156|Non-compliance with study treatement|0|||
27743557|NCT01544595|80889595|FG005|Status at Week 156|Non-compliance with study treatement|1|||
27743558|NCT01544595|80889590|FG000|Status at Week 156|Physician Decision|0|||
27743559|NCT01544595|80889591|FG001|Status at Week 156|Physician Decision|3|||
27743560|NCT01544595|80889592|FG002|Status at Week 156|Physician Decision|1|||
27743561|NCT01544595|80889593|FG003|Status at Week 156|Physician Decision|0|||
27642792|NCT00439270|80536222|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
27642793|NCT00439270|80536223|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
27642794|NCT00439270|80536224|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
27642795|NCT00439270|80536225|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
27743562|NCT01544595|80889594|FG004|Status at Week 156|Physician Decision|0|||
27743563|NCT01544595|80889595|FG005|Status at Week 156|Physician Decision|0|||
27743564|NCT01544595|80889590|FG000|Status at Week 156|Pregnancy|2|||
27934113|NCT00195429|81596246|FG001|Overall Study|Lost to Follow-up|0|||
27934114|NCT00504231|81596255|FG000|Overall Study|Discrepant chart documentation re route|0|||
27934115|NCT00504231|81596256|FG001|Overall Study|Discrepant chart documentation re route|0|||
27642796|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
27934116|NCT00504231|81596257|FG002|Overall Study|Discrepant chart documentation re route|1|||
27934117|NCT00504231|81596258|FG003|Overall Study|Discrepant chart documentation re route|0|||
27642797|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
27642798|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
27934118|NCT01390584|81596263|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
27934119|NCT01390584|81596264|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
27934120|NCT01390584|81596265|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
27743565|NCT01544595|80889591|FG001|Status at Week 156|Pregnancy|3|||
27743566|NCT01544595|80889592|FG002|Status at Week 156|Pregnancy|0|||
27743567|NCT01544595|80889593|FG003|Status at Week 156|Pregnancy|0|||
27743568|NCT01544595|80889594|FG004|Status at Week 156|Pregnancy|0|||
27743569|NCT01544595|80889595|FG005|Status at Week 156|Pregnancy|0|||
27743570|NCT01544595|80889590|FG000|Status at Week 156|Protocol Violation|3|||
27743571|NCT01544595|80889591|FG001|Status at Week 156|Protocol Violation|1|||
27934121|NCT01717859|81596268|FG000|Overall Study|Adverse Event|5|||
27934122|NCT01717859|81596268|FG000|Overall Study|Moved out of state|1|||
27934123|NCT01717859|81596268|FG000|Overall Study|Patient concerned about mental health|1|||
27934124|NCT01717859|81596268|FG000|Overall Study|Lost to Follow-up|1|||
27934125|NCT01717859|81596268|FG000|Overall Study|Withdrawal by Subject|2|||
27934126|NCT02573467|81596269|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
27934127|NCT02573467|81596270|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
27934128|NCT02573467|81596271|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
27934129|NCT02573467|81596272|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
27934130|NCT02573467|81596269|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
27934131|NCT02573467|81596270|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
27934132|NCT02573467|81596271|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
27934133|NCT02573467|81596272|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
27934134|NCT02573467|81596269|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
27934135|NCT02573467|81596270|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
27934136|NCT02573467|81596271|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
27934137|NCT02573467|81596272|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
27934138|NCT02573467|81596269|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
27934139|NCT02573467|81596270|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
27934140|NCT02573467|81596271|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
27934141|NCT02573467|81596272|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
27934142|NCT02573467|81596269|FG000|Post-treatment Follow up Epoch|Death|1|||
27550729|NCT00191789|80203460|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
27550730|NCT00191789|80203460|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
27550731|NCT00191789|80203460|FG000|Overall Study|Death - Not Study-Drug Related|1|||
27550732|NCT01192516|80203461|FG000|Overall Study|Lost to Follow-up|7|||
27550733|NCT01192516|80203462|FG001|Overall Study|Lost to Follow-up|10|||
27550734|NCT01192516|80203463|FG002|Overall Study|Lost to Follow-up|7|||
27550735|NCT01192516|80203461|FG000|Overall Study|Withdrawal by Subject|4|||
27550736|NCT01192516|80203462|FG001|Overall Study|Withdrawal by Subject|4|||
27550737|NCT01192516|80203463|FG002|Overall Study|Withdrawal by Subject|1|||
27550738|NCT01192516|80203461|FG000|Overall Study|started new treatment|5|||
27550739|NCT01192516|80203462|FG001|Overall Study|started new treatment|1|||
27550740|NCT01192516|80203463|FG002|Overall Study|started new treatment|0|||
27550741|NCT01192516|80203461|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
27550742|NCT01192516|80203462|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
27550743|NCT01192516|80203463|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
27550744|NCT03031678|80203466|FG000|Overall Study|Study closed prior to completion|1|||
27550745|NCT00688753|80203471|FG000|Overall Study|Disease progression|55|||
27550746|NCT00688753|80203471|FG000|Overall Study|Missing|1|||
27550747|NCT00688753|80203471|FG000|Overall Study|Death|9|||
27550748|NCT00688753|80203471|FG000|Overall Study|Withdrawal by Subject|3|||
27550749|NCT00688753|80203471|FG000|Overall Study|Adverse Event|20|||
27550750|NCT00688753|80203471|FG000|Overall Study|Protocol Violation|1|||
27550751|NCT00688753|80203471|FG000|Overall Study|Lost to Follow-up|3|||
27550752|NCT00171730|80203475|FG000|Overall Study|Adverse Event|3|||
27550753|NCT00171730|80203475|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
27550754|NCT00171730|80203475|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
27550755|NCT00171730|80203475|FG000|Overall Study|Withdrawal by Subject|3|||
27550756|NCT00600483|80203476|FG000|Overall Study|Lost to Follow-up|26|||
27550757|NCT00600483|80203477|FG001|Overall Study|Lost to Follow-up|47|||
27550758|NCT00600483|80203476|FG000|Overall Study|Randomized but not treated|10|||
27743572|NCT01544595|80889592|FG002|Status at Week 156|Protocol Violation|2|||
27743573|NCT01544595|80889593|FG003|Status at Week 156|Protocol Violation|2|||
27743574|NCT01544595|80889594|FG004|Status at Week 156|Protocol Violation|0|||
27934143|NCT02573467|81596270|FG001|Post-treatment Follow up Epoch|Death|1|||
27934144|NCT02573467|81596271|FG002|Post-treatment Follow up Epoch|Death|0|||
27934145|NCT02573467|81596272|FG003|Post-treatment Follow up Epoch|Death|1|||
27934146|NCT02573467|81596269|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
27934147|NCT02573467|81596270|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
27934148|NCT02573467|81596271|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
27934149|NCT02573467|81596272|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
27934150|NCT02573467|81596269|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
27934151|NCT02573467|81596270|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
27550759|NCT00600483|80203477|FG001|Overall Study|Randomized but not treated|0|||
27550760|NCT02220205|80203478|FG000|Overall Study|Withdrawal by Subject|1|||
27642799|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
27642800|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
27642801|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
27642802|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
27642803|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
27642804|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
27642805|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
27642806|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
27642807|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
27642808|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
27642809|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
27642810|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
27642811|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
27642812|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
27642813|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
27642814|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
27642815|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
27642816|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
27642817|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
27743575|NCT01544595|80889595|FG005|Status at Week 156|Protocol Violation|0|||
27743576|NCT01544595|80889590|FG000|Status at Week 156|Technical problems|3|||
27743577|NCT01544595|80889591|FG001|Status at Week 156|Technical problems|1|||
27743578|NCT01544595|80889592|FG002|Status at Week 156|Technical problems|0|||
27743579|NCT01544595|80889593|FG003|Status at Week 156|Technical problems|1|||
27743580|NCT01544595|80889594|FG004|Status at Week 156|Technical problems|0|||
27743581|NCT01544595|80889595|FG005|Status at Week 156|Technical problems|0|||
27743582|NCT01544595|80889590|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
27743583|NCT01544595|80889591|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
27743584|NCT01544595|80889592|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
27743585|NCT01544595|80889593|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
27743586|NCT01544595|80889594|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
27743587|NCT01544595|80889595|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
27743588|NCT01544595|80889590|FG000|Status at Week 156|Lack of Efficacy|1|||
27743589|NCT01544595|80889591|FG001|Status at Week 156|Lack of Efficacy|0|||
27934152|NCT02573467|81596271|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
27934153|NCT02573467|81596272|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
27642818|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
27642819|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
27642820|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
27642821|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
27642822|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
27642823|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
27642824|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
27642825|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
27642826|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
27642827|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
27642828|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
27642829|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
27642830|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
27642831|NCT00439270|80536221|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
27642832|NCT00439270|80536222|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
27642833|NCT00439270|80536223|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
27642834|NCT00439270|80536224|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
27642835|NCT00439270|80536225|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
27642836|NCT01426412|80536226|FG000|Overall Study|Withdrawal by Subject|1|||
27642837|NCT01426412|80536227|FG001|Overall Study|Withdrawal by Subject|0|||
27642838|NCT01426412|80536228|FG002|Overall Study|Withdrawal by Subject|0|||
27642839|NCT01426412|80536229|FG003|Overall Study|Withdrawal by Subject|0|||
27642840|NCT01426412|80536230|FG004|Overall Study|Withdrawal by Subject|1|||
27642841|NCT01426412|80536231|FG005|Overall Study|Withdrawal by Subject|0|||
27642842|NCT01426412|80536232|FG006|Overall Study|Withdrawal by Subject|0|||
27743590|NCT01544595|80889592|FG002|Status at Week 156|Lack of Efficacy|1|||
27934154|NCT01618708|81596273|FG000|Overall Study|Adverse Event|10|||
27550761|NCT02220205|80203479|FG001|Overall Study|Withdrawal by Subject|0|||
27642843|NCT01426412|80536233|FG007|Overall Study|Withdrawal by Subject|3|||
27642844|NCT01426412|80536234|FG008|Overall Study|Withdrawal by Subject|1|||
27642845|NCT00093496|80536237|FG000|Overall Study|Protocol Violation|1|||
27642846|NCT00093496|80536238|FG001|Overall Study|Protocol Violation|3|||
27642847|NCT04075396|80536239|FG000|Overall Study|Death|11|||
27642848|NCT04075396|80536240|FG001|Overall Study|Death|9|||
27642849|NCT04075396|80536239|FG000|Overall Study|Withdrawal by Subject|1|||
27642850|NCT04075396|80536240|FG001|Overall Study|Withdrawal by Subject|2|||
27642851|NCT04075396|80536239|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
27642852|NCT04075396|80536240|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
27642853|NCT04075396|80536239|FG000|Overall Study|Enrolled but not-treated|0|||
27642854|NCT04075396|80536240|FG001|Overall Study|Enrolled but not-treated|1|||
27642855|NCT02972359|80536241|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
27642856|NCT02972359|80536241|FG000|Overall Study|Lack of Efficacy|1|||
27642857|NCT02972359|80536241|FG000|Overall Study|Adverse Event|4|||
27642858|NCT02972359|80536241|FG000|Overall Study|Death|1|||
27642859|NCT02972359|80536241|FG000|Overall Study|Withdrawal by Subject|30|||
27934155|NCT01618708|81596274|FG001|Overall Study|Adverse Event|10|||
27934156|NCT01618708|81596273|FG000|Overall Study|Lost to Follow-up|3|||
27934157|NCT01618708|81596274|FG001|Overall Study|Lost to Follow-up|3|||
27934158|NCT01618708|81596273|FG000|Overall Study|Withdrawal by Subject|17|||
27934159|NCT01618708|81596274|FG001|Overall Study|Withdrawal by Subject|22|||
27934160|NCT01618708|81596273|FG000|Overall Study|Lack of Efficacy|8|||
27934161|NCT01618708|81596274|FG001|Overall Study|Lack of Efficacy|8|||
27934162|NCT01618708|81596273|FG000|Overall Study|Technical problems|2|||
27934163|NCT01618708|81596274|FG001|Overall Study|Technical problems|0|||
27934164|NCT01618708|81596273|FG000|Overall Study|Other than specified above|1|||
27934165|NCT01618708|81596274|FG001|Overall Study|Other than specified above|1|||
27934166|NCT01618708|81596273|FG000|Overall Study|Randomized but not treated|3|||
27934167|NCT01618708|81596274|FG001|Overall Study|Randomized but not treated|2|||
27934168|NCT00303628|81596275|FG000|Overall Study|Disease progression|0|||
27934169|NCT00303628|81596276|FG001|Overall Study|Disease progression|1|||
27934170|NCT00303628|81596275|FG000|Overall Study|Adverse Event|26|||
27934171|NCT00303628|81596276|FG001|Overall Study|Adverse Event|36|||
27934172|NCT00303628|81596275|FG000|Overall Study|Death|0|||
27934173|NCT00303628|81596276|FG001|Overall Study|Death|1|||
27934174|NCT00303628|81596275|FG000|Overall Study|Withdrawal by Subject|11|||
27934175|NCT00303628|81596276|FG001|Overall Study|Withdrawal by Subject|20|||
27934176|NCT00303628|81596275|FG000|Overall Study|Alternative therapy|2|||
27934177|NCT00303628|81596276|FG001|Overall Study|Alternative therapy|0|||
27934178|NCT00303628|81596275|FG000|Overall Study|Other complicating disease|0|||
27934179|NCT00303628|81596276|FG001|Overall Study|Other complicating disease|1|||
27934180|NCT00303628|81596275|FG000|Overall Study|Not start protocol therapy|3|||
27934181|NCT00303628|81596276|FG001|Overall Study|Not start protocol therapy|5|||
27934182|NCT00303628|81596275|FG000|Overall Study|Other|8|||
27934183|NCT00303628|81596276|FG001|Overall Study|Other|9|||
27934184|NCT03158311|81596280|FG000|Overall Study|Subject/Guardian Decision|10|||
27934185|NCT03158311|81596281|FG001|Overall Study|Subject/Guardian Decision|6|||
27934186|NCT03158311|81596282|FG002|Overall Study|Subject/Guardian Decision|11|||
27934187|NCT03158311|81596280|FG000|Overall Study|Adverse Event|5|||
27934188|NCT03158311|81596281|FG001|Overall Study|Adverse Event|3|||
27934189|NCT03158311|81596282|FG002|Overall Study|Adverse Event|3|||
27934190|NCT03158311|81596280|FG000|Overall Study|Techinical Problems|3|||
27934191|NCT03158311|81596281|FG001|Overall Study|Techinical Problems|1|||
27934192|NCT03158311|81596282|FG002|Overall Study|Techinical Problems|5|||
27934193|NCT03158311|81596280|FG000|Overall Study|Physician Decision|2|||
27934194|NCT03158311|81596281|FG001|Overall Study|Physician Decision|3|||
27934195|NCT03158311|81596282|FG002|Overall Study|Physician Decision|7|||
27550762|NCT01663532|80203480|FG000|Overall Study|Lost to Follow-up|9|||
27550763|NCT01663532|80203481|FG001|Overall Study|Lost to Follow-up|10|||
27550764|NCT01663532|80203480|FG000|Overall Study|Adverse Event|7|||
27550765|NCT01663532|80203481|FG001|Overall Study|Adverse Event|13|||
27550766|NCT01663532|80203480|FG000|Overall Study|Met Withdrawal Criteria|7|||
27550767|NCT01663532|80203481|FG001|Overall Study|Met Withdrawal Criteria|6|||
27550768|NCT01663532|80203480|FG000|Overall Study|Physician Decision|1|||
27550769|NCT01663532|80203481|FG001|Overall Study|Physician Decision|1|||
27550770|NCT01663532|80203480|FG000|Overall Study|Withdrawal by Subject|35|||
27550771|NCT01663532|80203481|FG001|Overall Study|Withdrawal by Subject|17|||
27550772|NCT01663532|80203480|FG000|Overall Study|Lack of Efficacy|15|||
27550773|NCT01663532|80203481|FG001|Overall Study|Lack of Efficacy|60|||
27550774|NCT01835587|80203482|FG000|Overall Study|Disease Recurrence or Relapse|0|||
27550775|NCT01835587|80203483|FG001|Overall Study|Disease Recurrence or Relapse|3|||
27550776|NCT01835587|80203484|FG002|Overall Study|Disease Recurrence or Relapse|0|||
27642860|NCT02972359|80536241|FG000|Overall Study|Protocol Violation|1|||
27934196|NCT03158311|81596280|FG000|Overall Study|Lost to Follow-up|1|||
27550777|NCT01835587|80203485|FG003|Overall Study|Disease Recurrence or Relapse|3|||
27642861|NCT02972359|80536241|FG000|Overall Study|Lost to Follow-up|26|||
27934197|NCT03158311|81596281|FG001|Overall Study|Lost to Follow-up|1|||
27934198|NCT03158311|81596282|FG002|Overall Study|Lost to Follow-up|1|||
27934199|NCT03158311|81596280|FG000|Overall Study|Sponsor decision|1|||
27934200|NCT03158311|81596281|FG001|Overall Study|Sponsor decision|0|||
27934201|NCT03158311|81596282|FG002|Overall Study|Sponsor decision|0|||
27934202|NCT03158311|81596280|FG000|Overall Study|Pregnancy|0|||
27934203|NCT03158311|81596281|FG001|Overall Study|Pregnancy|2|||
27934204|NCT03158311|81596282|FG002|Overall Study|Pregnancy|0|||
27934205|NCT03158311|81596280|FG000|Overall Study|Randomized in error|0|||
27934206|NCT03158311|81596281|FG001|Overall Study|Randomized in error|0|||
27934207|NCT03158311|81596282|FG002|Overall Study|Randomized in error|1|||
27934208|NCT00120874|81596283|FG000|Overall Study|Death|0|||
27934209|NCT00120874|81596284|FG001|Overall Study|Death|1|||
27934210|NCT02965976|81596285|FG000|Overall Study|Withdrawal by Subject|2|||
27934211|NCT02965976|81596286|FG001|Overall Study|Withdrawal by Subject|0|||
27934212|NCT01530256|81596287|FG000|Overall Study|Death|2|||
27934213|NCT00964678|81596289|FG000|Overall Study|Physician Decision|4|||
27934214|NCT04648241|81596295|FG000|Overall Study|Lost to Follow-up|1|||
27934215|NCT04648241|81596296|FG001|Overall Study|Lost to Follow-up|0|||
27934216|NCT04289298|81596298|FG000|Overall Study|Lost to Follow-up|5|||
27934217|NCT04289298|81596299|FG001|Overall Study|Lost to Follow-up|0|||
27550778|NCT01835587|80203482|FG000|Overall Study|Withdrawal by Subject|2|||
27550779|NCT01835587|80203483|FG001|Overall Study|Withdrawal by Subject|0|||
27642862|NCT02972359|80536241|FG000|Overall Study|Other reasons|5|||
27642863|NCT02972359|80536241|FG000|Overall Study|Missing|1|||
27642864|NCT02564744|80536242|FG000|Overall Study|Investigator decision|0|||
27642865|NCT02564744|80536243|FG001|Overall Study|Investigator decision|0|||
27642866|NCT02564744|80536244|FG002|Overall Study|Investigator decision|0|||
27642867|NCT02564744|80536245|FG003|Overall Study|Investigator decision|0|||
27642868|NCT02564744|80536246|FG004|Overall Study|Investigator decision|1|||
27642869|NCT02564744|80536242|FG000|Overall Study|Death|10|||
27642870|NCT02564744|80536243|FG001|Overall Study|Death|5|||
27642871|NCT02564744|80536244|FG002|Overall Study|Death|4|||
27642872|NCT02564744|80536245|FG003|Overall Study|Death|16|||
27642873|NCT02564744|80536246|FG004|Overall Study|Death|16|||
27642874|NCT02564744|80536242|FG000|Overall Study|End of study Page Missing|0|||
27642875|NCT02564744|80536243|FG001|Overall Study|End of study Page Missing|0|||
27743591|NCT01544595|80889593|FG003|Status at Week 156|Lack of Efficacy|4|||
27743592|NCT01544595|80889594|FG004|Status at Week 156|Lack of Efficacy|10|||
27743593|NCT01544595|80889595|FG005|Status at Week 156|Lack of Efficacy|5|||
27743594|NCT04222725|80889598|FG000|Overall Study|Adverse Event|0|||
27743595|NCT04222725|80889599|FG001|Overall Study|Adverse Event|1|||
27743596|NCT04222725|80889600|FG002|Overall Study|Adverse Event|0|||
27743597|NCT04222725|80889601|FG003|Overall Study|Adverse Event|0|||
27743598|NCT01595646|80889602|FG000|Overall Study|Withdrawal by Subject|1|||
27743599|NCT01595646|80889603|FG001|Overall Study|Withdrawal by Subject|0|||
27743600|NCT01595646|80889604|FG002|Overall Study|Withdrawal by Subject|0|||
27743601|NCT00500149|80889607|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
27743602|NCT00500149|80889608|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
27743603|NCT00500149|80889607|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
27743604|NCT00500149|80889608|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
27743605|NCT00500149|80889607|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
27743606|NCT00500149|80889608|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
27743607|NCT00500149|80889607|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
27743608|NCT00500149|80889608|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
27743609|NCT00500149|80889607|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
27743610|NCT00500149|80889608|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
27934218|NCT04289298|81596298|FG000|Overall Study|Withdrawal by Subject|2|||
27934219|NCT04289298|81596299|FG001|Overall Study|Withdrawal by Subject|0|||
27934220|NCT01112267|81596300|FG000|Overall Study|Adverse Event|24|||
27934221|NCT01112267|81596301|FG001|Overall Study|Adverse Event|6|||
27934222|NCT01112267|81596300|FG000|Overall Study|Withdrawal by Subject|3|||
27550780|NCT01835587|80203484|FG002|Overall Study|Withdrawal by Subject|0|||
27550781|NCT01835587|80203485|FG003|Overall Study|Withdrawal by Subject|3|||
27550782|NCT01835587|80203482|FG000|Overall Study|Adverse Event|0|||
27550783|NCT01835587|80203483|FG001|Overall Study|Adverse Event|0|||
27550784|NCT01835587|80203484|FG002|Overall Study|Adverse Event|2|||
27550785|NCT01835587|80203485|FG003|Overall Study|Adverse Event|2|||
27550786|NCT01835587|80203482|FG000|Overall Study|Death|0|||
27550787|NCT01835587|80203483|FG001|Overall Study|Death|0|||
27550788|NCT01835587|80203484|FG002|Overall Study|Death|0|||
27550789|NCT01835587|80203485|FG003|Overall Study|Death|1|||
27550790|NCT01835587|80203482|FG000|Overall Study|Miscellaneous|0|||
27550791|NCT01835587|80203483|FG001|Overall Study|Miscellaneous|1|||
27743611|NCT00500149|80889607|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
27743612|NCT00500149|80889608|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
27743613|NCT00500149|80889607|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
27550792|NCT01835587|80203484|FG002|Overall Study|Miscellaneous|0|||
27642876|NCT02564744|80536244|FG002|Overall Study|End of study Page Missing|3|||
27642877|NCT02564744|80536245|FG003|Overall Study|End of study Page Missing|3|||
27934223|NCT01112267|81596301|FG001|Overall Study|Withdrawal by Subject|5|||
27934224|NCT01112267|81596300|FG000|Overall Study|Protocol Violation|5|||
27934225|NCT01112267|81596301|FG001|Overall Study|Protocol Violation|3|||
27934226|NCT01112267|81596300|FG000|Overall Study|Participants not compliant|1|||
27934227|NCT01112267|81596301|FG001|Overall Study|Participants not compliant|2|||
27934228|NCT01112267|81596300|FG000|Overall Study|Participants not receive any study drug|1|||
27934229|NCT01112267|81596301|FG001|Overall Study|Participants not receive any study drug|2|||
27934230|NCT03548415|81596302|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
27934231|NCT03548415|81596303|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
27934232|NCT03548415|81596304|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
27934233|NCT03548415|81596305|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
27934234|NCT03548415|81596306|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
27934235|NCT01696214|81596311|FG000|Overall Study|Lost to Follow-up|1|||
27934236|NCT01696214|81596312|FG001|Overall Study|Lost to Follow-up|0|||
27934237|NCT01696214|81596313|FG002|Overall Study|Lost to Follow-up|0|||
27934238|NCT01696214|81596314|FG003|Overall Study|Lost to Follow-up|0|||
27934239|NCT03888482|81596315|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
27934240|NCT03888482|81596316|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
27934241|NCT03888482|81596315|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
27934242|NCT03888482|81596316|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
27934243|NCT00478140|81596317|FG000|Overall Study|Clinical Disease Progression|1|||
27934244|NCT01873833|81596318|FG000|Overall Study|Withdrawal by Subject|1|||
27934245|NCT02346370|81596325|FG000|Overall Study|Not treated|1|||
27934246|NCT02346370|81596326|FG001|Overall Study|Not treated|0|||
27934247|NCT02346370|81596327|FG002|Overall Study|Not treated|0|||
27934248|NCT02346370|81596325|FG000|Overall Study|Withdrawal of consent|1|||
27934249|NCT02346370|81596326|FG001|Overall Study|Withdrawal of consent|0|||
27934250|NCT02346370|81596327|FG002|Overall Study|Withdrawal of consent|0|||
27934251|NCT02346370|81596325|FG000|Overall Study|Death|1|||
27934252|NCT02346370|81596326|FG001|Overall Study|Death|3|||
27934253|NCT02346370|81596327|FG002|Overall Study|Death|1|||
27934254|NCT02346370|81596325|FG000|Overall Study|Sponsor discontinued study|5|||
27934255|NCT02346370|81596326|FG001|Overall Study|Sponsor discontinued study|0|||
27934256|NCT02346370|81596327|FG002|Overall Study|Sponsor discontinued study|2|||
27934257|NCT02346370|81596325|FG000|Overall Study|Radiologic progression|0|||
27934258|NCT02346370|81596326|FG001|Overall Study|Radiologic progression|0|||
27934259|NCT02346370|81596327|FG002|Overall Study|Radiologic progression|1|||
27934260|NCT02346370|81596325|FG000|Overall Study|Physician Decision|0|||
27934261|NCT02346370|81596326|FG001|Overall Study|Physician Decision|1|||
27934262|NCT02346370|81596327|FG002|Overall Study|Physician Decision|0|||
27934263|NCT02318277|81596328|FG000|Overall Study|Physician Decision|0|||
27934264|NCT02318277|81596329|FG001|Overall Study|Physician Decision|0|||
27934265|NCT02318277|81596330|FG002|Overall Study|Physician Decision|0|||
27934266|NCT02318277|81596331|FG003|Overall Study|Physician Decision|0|||
27934267|NCT02318277|81596332|FG004|Overall Study|Physician Decision|0|||
27934268|NCT02318277|81596333|FG005|Overall Study|Physician Decision|0|||
27934269|NCT02318277|81596334|FG006|Overall Study|Physician Decision|0|||
27934270|NCT02318277|81596335|FG007|Overall Study|Physician Decision|1|||
27934271|NCT02318277|81596328|FG000|Overall Study|Other|0|||
27934272|NCT02318277|81596329|FG001|Overall Study|Other|0|||
27934273|NCT02318277|81596330|FG002|Overall Study|Other|0|||
27934274|NCT02318277|81596331|FG003|Overall Study|Other|0|||
27934275|NCT02318277|81596332|FG004|Overall Study|Other|0|||
27934276|NCT02318277|81596333|FG005|Overall Study|Other|0|||
27934277|NCT02318277|81596334|FG006|Overall Study|Other|1|||
27550793|NCT01835587|80203485|FG003|Overall Study|Miscellaneous|0|||
27550794|NCT04656691|80203488|FG000|Overall Study|Adverse Event|1|||
27550795|NCT01605877|80203489|FG000|Overall Study|Withdrawal by Subject|1|||
27550796|NCT01129960|80203490|FG000|Overall Study|Withdrawal by Subject|3|||
27550797|NCT01129960|80203491|FG001|Overall Study|Withdrawal by Subject|0|||
27550798|NCT01129960|80203492|FG002|Overall Study|Withdrawal by Subject|3|||
27550799|NCT01129960|80203493|FG003|Overall Study|Withdrawal by Subject|2|||
27550800|NCT01129960|80203490|FG000|Overall Study|Lack of Efficacy|1|||
27550801|NCT01129960|80203491|FG001|Overall Study|Lack of Efficacy|1|||
27550802|NCT01129960|80203492|FG002|Overall Study|Lack of Efficacy|1|||
27550803|NCT01129960|80203493|FG003|Overall Study|Lack of Efficacy|1|||
27550804|NCT01129960|80203490|FG000|Overall Study|Adverse Event|23|||
27550805|NCT01129960|80203491|FG001|Overall Study|Adverse Event|16|||
27550806|NCT01129960|80203492|FG002|Overall Study|Adverse Event|16|||
27550807|NCT01129960|80203493|FG003|Overall Study|Adverse Event|7|||
27550808|NCT01129960|80203490|FG000|Overall Study|Protocol Violation|1|||
27550809|NCT01129960|80203491|FG001|Overall Study|Protocol Violation|2|||
27550810|NCT01129960|80203492|FG002|Overall Study|Protocol Violation|3|||
27934278|NCT02318277|81596335|FG007|Overall Study|Other|0|||
27934279|NCT02318277|81596328|FG000|Overall Study|Withdrawal by Subject|0|||
27934280|NCT02318277|81596329|FG001|Overall Study|Withdrawal by Subject|0|||
27934281|NCT02318277|81596330|FG002|Overall Study|Withdrawal by Subject|1|||
27550811|NCT01129960|80203493|FG003|Overall Study|Protocol Violation|0|||
27550812|NCT01129960|80203490|FG000|Overall Study|Lost to Follow-up|0|||
27934282|NCT02318277|81596331|FG003|Overall Study|Withdrawal by Subject|0|||
27934283|NCT02318277|81596332|FG004|Overall Study|Withdrawal by Subject|1|||
27934284|NCT02318277|81596333|FG005|Overall Study|Withdrawal by Subject|1|||
27934285|NCT02318277|81596334|FG006|Overall Study|Withdrawal by Subject|6|||
27934286|NCT02318277|81596335|FG007|Overall Study|Withdrawal by Subject|14|||
27934287|NCT02318277|81596328|FG000|Overall Study|Participant trial terminated by sponsor|0|||
27934288|NCT02318277|81596329|FG001|Overall Study|Participant trial terminated by sponsor|0|||
27934289|NCT02318277|81596330|FG002|Overall Study|Participant trial terminated by sponsor|1|||
27934290|NCT02318277|81596331|FG003|Overall Study|Participant trial terminated by sponsor|0|||
27934291|NCT02318277|81596332|FG004|Overall Study|Participant trial terminated by sponsor|1|||
27934292|NCT02318277|81596333|FG005|Overall Study|Participant trial terminated by sponsor|2|||
27934293|NCT02318277|81596334|FG006|Overall Study|Participant trial terminated by sponsor|5|||
27934294|NCT02318277|81596335|FG007|Overall Study|Participant trial terminated by sponsor|16|||
27934295|NCT02318277|81596328|FG000|Overall Study|Lost to Follow-up|1|||
27934296|NCT02318277|81596329|FG001|Overall Study|Lost to Follow-up|0|||
27934297|NCT02318277|81596330|FG002|Overall Study|Lost to Follow-up|1|||
27934298|NCT02318277|81596331|FG003|Overall Study|Lost to Follow-up|0|||
27934299|NCT02318277|81596332|FG004|Overall Study|Lost to Follow-up|0|||
27934300|NCT02318277|81596333|FG005|Overall Study|Lost to Follow-up|0|||
27934301|NCT02318277|81596334|FG006|Overall Study|Lost to Follow-up|3|||
27934302|NCT02318277|81596335|FG007|Overall Study|Lost to Follow-up|4|||
27934303|NCT02318277|81596328|FG000|Overall Study|Death|5|||
27934304|NCT02318277|81596329|FG001|Overall Study|Death|3|||
27934305|NCT02318277|81596330|FG002|Overall Study|Death|1|||
27934306|NCT02318277|81596331|FG003|Overall Study|Death|4|||
27934307|NCT02318277|81596332|FG004|Overall Study|Death|6|||
27934308|NCT02318277|81596333|FG005|Overall Study|Death|5|||
27934309|NCT02318277|81596334|FG006|Overall Study|Death|34|||
27934310|NCT02318277|81596335|FG007|Overall Study|Death|58|||
27934311|NCT02318277|81596328|FG000|Overall Study|Transitioned to Hospice|0|||
27934312|NCT02318277|81596329|FG001|Overall Study|Transitioned to Hospice|0|||
27934313|NCT02318277|81596330|FG002|Overall Study|Transitioned to Hospice|0|||
27934314|NCT02318277|81596331|FG003|Overall Study|Transitioned to Hospice|0|||
27934315|NCT02318277|81596332|FG004|Overall Study|Transitioned to Hospice|0|||
27934316|NCT02318277|81596333|FG005|Overall Study|Transitioned to Hospice|1|||
27934317|NCT02318277|81596334|FG006|Overall Study|Transitioned to Hospice|0|||
27934318|NCT02318277|81596335|FG007|Overall Study|Transitioned to Hospice|0|||
27934319|NCT01653262|81600609|FG000|Overall Study|Lack of Efficacy|1|||
27934320|NCT01653262|81600609|FG000|Overall Study|SAE, non-fatal|1|||
27934321|NCT01653262|81600609|FG000|Overall Study|AE, non-serious non-fatal|1|||
27934322|NCT01117350|81600610|FG000|Comparative Period|Not Treated|5|||
27934323|NCT01117350|81600611|FG001|Comparative Period|Not Treated|8|||
27934324|NCT01117350|81600610|FG000|Comparative Period|Adverse Event|6|||
27934325|NCT01117350|81600611|FG001|Comparative Period|Adverse Event|33|||
27934326|NCT01117350|81600610|FG000|Comparative Period|Lost to Follow-up|11|||
27934327|NCT01117350|81600611|FG001|Comparative Period|Lost to Follow-up|7|||
27934328|NCT01117350|81600610|FG000|Comparative Period|Withdrawal by Subject|9|||
27934329|NCT01117350|81600611|FG001|Comparative Period|Withdrawal by Subject|13|||
27934330|NCT01117350|81600610|FG000|Comparative Period|Protocol Violation|8|||
27934331|NCT01117350|81600611|FG001|Comparative Period|Protocol Violation|12|||
27934332|NCT01117350|81600610|FG000|Comparative Period|Lack of Efficacy|1|||
27934333|NCT01117350|81600611|FG001|Comparative Period|Lack of Efficacy|0|||
27642878|NCT02564744|80536246|FG004|Overall Study|End of study Page Missing|0|||
27642879|NCT02564744|80536242|FG000|Overall Study|Subject Withdrew Consent|1|||
27934334|NCT01117350|81600610|FG000|Comparative Period|Physician Decision|0|||
27934335|NCT01117350|81600611|FG001|Comparative Period|Physician Decision|1|||
27934336|NCT01117350|81600610|FG000|Comparative Period|Move to another city/country|2|||
27934337|NCT01117350|81600611|FG001|Comparative Period|Move to another city/country|1|||
27934338|NCT01117350|81600610|FG000|Extension Period|Not included in extension, not treated|0|||
27934339|NCT01117350|81600611|FG001|Extension Period|Not included in extension, not treated|50|||
27934340|NCT01117350|81600610|FG000|Extension Period|Adverse Event|0|||
27934341|NCT01117350|81600611|FG001|Extension Period|Adverse Event|2|||
27642880|NCT02564744|80536243|FG001|Overall Study|Subject Withdrew Consent|1|||
27642881|NCT02564744|80536244|FG002|Overall Study|Subject Withdrew Consent|1|||
27642882|NCT02564744|80536245|FG003|Overall Study|Subject Withdrew Consent|0|||
27642883|NCT02564744|80536246|FG004|Overall Study|Subject Withdrew Consent|2|||
27642884|NCT02564744|80536242|FG000|Overall Study|Lost to Follow-up|0|||
27642885|NCT02564744|80536243|FG001|Overall Study|Lost to Follow-up|1|||
27642886|NCT02564744|80536244|FG002|Overall Study|Lost to Follow-up|0|||
27934342|NCT01117350|81600610|FG000|Extension Period|Protocol Violation|0|||
27934343|NCT01117350|81600611|FG001|Extension Period|Protocol Violation|2|||
27934344|NCT01117350|81600610|FG000|Extension Period|Lost to Follow-up|0|||
27934345|NCT01117350|81600611|FG001|Extension Period|Lost to Follow-up|2|||
27934346|NCT01117350|81600610|FG000|Extension Period|Withdrawal by Subject|0|||
27934347|NCT01117350|81600611|FG001|Extension Period|Withdrawal by Subject|3|||
27934348|NCT01117350|81600610|FG000|Extension Period|Lack of Efficacy|0|||
27642887|NCT02564744|80536245|FG003|Overall Study|Lost to Follow-up|0|||
27642888|NCT02564744|80536246|FG004|Overall Study|Lost to Follow-up|1|||
27934349|NCT01117350|81600611|FG001|Extension Period|Lack of Efficacy|2|||
27934350|NCT01117350|81600610|FG000|Extension Period|Inclusion criteria not respected|0|||
27934351|NCT01117350|81600611|FG001|Extension Period|Inclusion criteria not respected|1|||
27934352|NCT01117350|81600610|FG000|Extension Period|Prohibited medication|0|||
27934353|NCT01117350|81600611|FG001|Extension Period|Prohibited medication|1|||
27934354|NCT00452400|81600612|FG000|Overall Study|Adverse Event|1|||
27934355|NCT00452400|81600613|FG001|Overall Study|Adverse Event|1|||
27934356|NCT00452400|81600614|FG002|Overall Study|Adverse Event|5|||
27934357|NCT00452400|81600615|FG003|Overall Study|Adverse Event|0|||
27934358|NCT00452400|81600616|FG004|Overall Study|Adverse Event|2|||
27934359|NCT00452400|81600612|FG000|Overall Study|Protocol Violation|0|||
27934360|NCT00452400|81600613|FG001|Overall Study|Protocol Violation|0|||
27934361|NCT00452400|81600614|FG002|Overall Study|Protocol Violation|1|||
27934362|NCT00452400|81600615|FG003|Overall Study|Protocol Violation|0|||
27934363|NCT00452400|81600616|FG004|Overall Study|Protocol Violation|0|||
27934364|NCT00452400|81600612|FG000|Overall Study|Lost to Follow-up|1|||
27934365|NCT00452400|81600613|FG001|Overall Study|Lost to Follow-up|0|||
27642889|NCT02564744|80536242|FG000|Overall Study|Reason not specified|1|||
27642890|NCT02564744|80536243|FG001|Overall Study|Reason not specified|0|||
27642891|NCT02564744|80536244|FG002|Overall Study|Reason not specified|0|||
27642892|NCT02564744|80536245|FG003|Overall Study|Reason not specified|0|||
27642893|NCT02564744|80536246|FG004|Overall Study|Reason not specified|0|||
27642894|NCT00604669|80536248|FG000|Overall Study|lack of information in chart|7|||
27642895|NCT00939510|80536253|FG000|Overall Study|Withdrawal by Subject|1|||
27642896|NCT01079949|80536279|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
27642897|NCT01079949|80536280|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
27642898|NCT01079949|80536279|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
27642899|NCT01079949|80536280|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
27642900|NCT01079949|80536279|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
27642901|NCT01079949|80536280|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
27642902|NCT01079949|80536279|FG000|Overall Study|Randomized but not treated|1|||
27642903|NCT01079949|80536280|FG001|Overall Study|Randomized but not treated|0|||
27642904|NCT02919449|80536281|FG000|Overall Study|Withdrawal by Subject|1|||
27642905|NCT02919449|80536281|FG000|Overall Study|Investigator decision|1|||
27642906|NCT01290341|80536282|FG000|Overall Study|Protocol Violation|7|||
27642907|NCT01290341|80536283|FG001|Overall Study|Protocol Violation|3|||
27642908|NCT01290341|80536282|FG000|Overall Study|Adverse Event|1|||
27642909|NCT01290341|80536283|FG001|Overall Study|Adverse Event|0|||
27642910|NCT01290341|80536282|FG000|Overall Study|Lost to Follow-up|21|||
27642911|NCT01290341|80536283|FG001|Overall Study|Lost to Follow-up|10|||
27743614|NCT00500149|80889608|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
27743615|NCT01302769|80889609|FG000|Overall Study|Lost to Follow-up|1|||
27743616|NCT01302769|80889610|FG001|Overall Study|Lost to Follow-up|1|||
27743617|NCT00784784|80889611|FG000|Overall Study|Withdrawal by Subject|2|||
27743618|NCT00784784|80889612|FG001|Overall Study|Withdrawal by Subject|2|||
27743619|NCT01996319|80892627|FG000|Overall Study|Protocol Violation|1|||
27743620|NCT01996319|80892628|FG001|Overall Study|Protocol Violation|0|||
27743621|NCT01996319|80892627|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
27743622|NCT01996319|80892628|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
27743623|NCT01996319|80892627|FG000|Overall Study|Adverse Event|2|||
27743624|NCT01996319|80892628|FG001|Overall Study|Adverse Event|2|||
27743625|NCT01422304|80892638|FG000|Overall Study|Adverse Event|0|||
27743626|NCT01422304|80892639|FG001|Overall Study|Adverse Event|1|||
27743627|NCT01422304|80892638|FG000|Overall Study|Lost to Follow-up|14|||
27743628|NCT01422304|80892639|FG001|Overall Study|Lost to Follow-up|20|||
27743629|NCT01422304|80892638|FG000|Overall Study|Never Entered Follow-up|2|||
27743630|NCT01422304|80892639|FG001|Overall Study|Never Entered Follow-up|1|||
27743631|NCT01422304|80892638|FG000|Overall Study|Protocol Violation|1|||
27743632|NCT01422304|80892639|FG001|Overall Study|Protocol Violation|0|||
27934366|NCT00452400|81600614|FG002|Overall Study|Lost to Follow-up|0|||
27934367|NCT00452400|81600615|FG003|Overall Study|Lost to Follow-up|0|||
27934368|NCT00452400|81600616|FG004|Overall Study|Lost to Follow-up|0|||
27934369|NCT00452400|81600612|FG000|Overall Study|Withdrawal by Subject|1|||
27934370|NCT00452400|81600613|FG001|Overall Study|Withdrawal by Subject|0|||
27934371|NCT00452400|81600614|FG002|Overall Study|Withdrawal by Subject|1|||
27934372|NCT00452400|81600615|FG003|Overall Study|Withdrawal by Subject|0|||
27934373|NCT00452400|81600616|FG004|Overall Study|Withdrawal by Subject|0|||
27934374|NCT00452400|81600612|FG000|Overall Study|Lack of Efficacy|2|||
27642912|NCT01290341|80536282|FG000|Overall Study|Withdrawal by Subject|19|||
27642913|NCT01290341|80536283|FG001|Overall Study|Withdrawal by Subject|5|||
27642914|NCT01290341|80536282|FG000|Overall Study|Negative baseline culture and others|44|||
27642915|NCT01290341|80536283|FG001|Overall Study|Negative baseline culture and others|11|||
27743633|NCT01422304|80892638|FG000|Overall Study|Withdrawal by Subject|4|||
27743634|NCT01422304|80892639|FG001|Overall Study|Withdrawal by Subject|2|||
27743635|NCT01422304|80892638|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
27934375|NCT00452400|81600613|FG001|Overall Study|Lack of Efficacy|0|||
27642916|NCT01700205|80536284|FG000|Overall Study|Withdrawal by Subject|13|||
27743636|NCT01422304|80892639|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
27934376|NCT00452400|81600614|FG002|Overall Study|Lack of Efficacy|0|||
27642917|NCT01700205|80536285|FG001|Overall Study|Withdrawal by Subject|13|||
27642918|NCT01700205|80536284|FG000|Overall Study|Protocol Violation|2|||
27642919|NCT01700205|80536285|FG001|Overall Study|Protocol Violation|2|||
27642920|NCT01695954|80536286|FG000|Overall Study|Withdrawal by Subject|4|||
27642921|NCT01695954|80536287|FG001|Overall Study|Withdrawal by Subject|0|||
27642922|NCT01695954|80536286|FG000|Overall Study|Adverse Event|0|||
27642923|NCT01695954|80536287|FG001|Overall Study|Adverse Event|2|||
27642924|NCT00894543|80536288|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
27642925|NCT00894543|80536289|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
27642926|NCT00894543|80536288|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
27642927|NCT00894543|80536289|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
27642928|NCT02789020|80536294|FG000|Overall Study|Withdrawal by Subject|6|||
27642929|NCT02789020|80536295|FG001|Overall Study|Withdrawal by Subject|5|||
27642930|NCT03803475|80536300|FG000|Overall Study|Physician Decision|1|||
27642931|NCT04492475|80536301|FG000|Overall Study|Enrolled but not treated|8|||
27642932|NCT04492475|80536302|FG001|Overall Study|Enrolled but not treated|8|||
27642933|NCT04492475|80536301|FG000|Overall Study|Withdrawal by Subject|4|||
27642934|NCT04492475|80536302|FG001|Overall Study|Withdrawal by Subject|0|||
27743637|NCT01422304|80892638|FG000|Overall Study|Not Treated|3|||
27743638|NCT01422304|80892639|FG001|Overall Study|Not Treated|11|||
27743639|NCT02504892|80892640|FG000|Overall Study|Adverse event-pneumonitis|2|||
27743640|NCT00469014|80892644|FG000|Initial Phase Randomization|Disease Progression|0|||
27743641|NCT00469014|80892645|FG001|Initial Phase Randomization|Disease Progression|1|||
27743642|NCT00469014|80892646|FG002|Initial Phase Randomization|Disease Progression|1|||
27743643|NCT00469014|80892647|FG003|Initial Phase Randomization|Disease Progression|0|||
27743644|NCT00469014|80892644|FG000|Initial Phase Randomization|No Response|1|||
27743645|NCT00469014|80892645|FG001|Initial Phase Randomization|No Response|0|||
27743646|NCT00469014|80892646|FG002|Initial Phase Randomization|No Response|0|||
27743647|NCT00469014|80892647|FG003|Initial Phase Randomization|No Response|1|||
27743648|NCT00469014|80892644|FG000|Adaptive Randomization|Not Evaluable|1|||
27743649|NCT00469014|80892645|FG001|Adaptive Randomization|Not Evaluable|0|||
27743650|NCT00469014|80892646|FG002|Adaptive Randomization|Not Evaluable|0|||
27743651|NCT00469014|80892647|FG003|Adaptive Randomization|Not Evaluable|1|||
27743652|NCT00469014|80892644|FG000|Adaptive Randomization|No Response|0|||
27743653|NCT00469014|80892645|FG001|Adaptive Randomization|No Response|1|||
27743654|NCT00469014|80892646|FG002|Adaptive Randomization|No Response|0|||
27743655|NCT00469014|80892647|FG003|Adaptive Randomization|No Response|0|||
27743656|NCT00469014|80892644|FG000|Adaptive Randomization|Death|0|||
27934377|NCT00452400|81600615|FG003|Overall Study|Lack of Efficacy|0|||
27934378|NCT00452400|81600616|FG004|Overall Study|Lack of Efficacy|0|||
27934379|NCT00452400|81600612|FG000|Overall Study|Other reasons not listed above|0|||
27934380|NCT00452400|81600613|FG001|Overall Study|Other reasons not listed above|0|||
27934381|NCT00452400|81600614|FG002|Overall Study|Other reasons not listed above|0|||
27934382|NCT00452400|81600615|FG003|Overall Study|Other reasons not listed above|1|||
27934383|NCT00452400|81600616|FG004|Overall Study|Other reasons not listed above|1|||
27934384|NCT01560988|81600617|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
27934385|NCT01560988|81600618|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
27934386|NCT01560988|81600617|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
27934387|NCT01560988|81600618|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
27934388|NCT01560988|81600617|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
27934389|NCT01560988|81600618|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
27934390|NCT01658735|81600619|FG000|Overall Study|Lack of Efficacy|1|||
27934391|NCT01658735|81600620|FG001|Overall Study|Lack of Efficacy|0|||
27934392|NCT01658735|81600621|FG002|Overall Study|Lack of Efficacy|1|||
27934393|NCT01658735|81600619|FG000|Overall Study|Lost to Follow-up|1|||
27934394|NCT01658735|81600620|FG001|Overall Study|Lost to Follow-up|1|||
27550813|NCT01129960|80203491|FG001|Overall Study|Lost to Follow-up|2|||
27550814|NCT01129960|80203492|FG002|Overall Study|Lost to Follow-up|3|||
27743657|NCT00469014|80892645|FG001|Adaptive Randomization|Death|0|||
27743658|NCT00469014|80892646|FG002|Adaptive Randomization|Death|1|||
27743659|NCT00469014|80892647|FG003|Adaptive Randomization|Death|0|||
27550815|NCT01129960|80203493|FG003|Overall Study|Lost to Follow-up|3|||
27934395|NCT01658735|81600621|FG002|Overall Study|Lost to Follow-up|0|||
27934396|NCT01658735|81600619|FG000|Overall Study|Protocol Violation|0|||
27550816|NCT01129960|80203490|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
27550817|NCT01129960|80203491|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
27550818|NCT01129960|80203492|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
27550819|NCT01129960|80203493|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
27550820|NCT01129960|80203490|FG000|Overall Study|Physician Decision|1|||
27550821|NCT01129960|80203491|FG001|Overall Study|Physician Decision|0|||
27934397|NCT01658735|81600620|FG001|Overall Study|Protocol Violation|1|||
27934398|NCT01658735|81600621|FG002|Overall Study|Protocol Violation|0|||
27934399|NCT01658735|81600619|FG000|Overall Study|Withdrawal by Subject|3|||
27934400|NCT01658735|81600620|FG001|Overall Study|Withdrawal by Subject|5|||
27934401|NCT01658735|81600621|FG002|Overall Study|Withdrawal by Subject|3|||
27934402|NCT00974233|81600622|FG000|Induction Chemoimmunotherapy|Death|2|||
27934403|NCT00974233|81600622|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
27934404|NCT00974233|81600622|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
27934405|NCT00974233|81600622|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
27934406|NCT00974233|81600622|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
27934407|NCT00974233|81600622|FG000|Maintenance Lenalidomide|Adverse Event|8|||
27934408|NCT00655746|81600623|FG000|Overall Study|Withdrawal by Subject|1|||
27934409|NCT01694771|81600624|FG000|Overall Study|Adverse Event|18|||
27934410|NCT01694771|81600625|FG001|Overall Study|Adverse Event|16|||
27934411|NCT01694771|81600624|FG000|Overall Study|Lack of Efficacy|1|||
27934412|NCT01694771|81600625|FG001|Overall Study|Lack of Efficacy|0|||
27934413|NCT01694771|81600624|FG000|Overall Study|Non compliance protocol|7|||
27934414|NCT01694771|81600625|FG001|Overall Study|Non compliance protocol|6|||
27934415|NCT01694771|81600624|FG000|Overall Study|Lost to Follow-up|2|||
27934416|NCT01694771|81600625|FG001|Overall Study|Lost to Follow-up|3|||
27934417|NCT01694771|81600624|FG000|Overall Study|Consent withdrawn|7|||
27934418|NCT01694771|81600625|FG001|Overall Study|Consent withdrawn|9|||
27934419|NCT01694771|81600624|FG000|Overall Study|Other reasons|5|||
27934420|NCT01694771|81600625|FG001|Overall Study|Other reasons|6|||
27934421|NCT00452530|81600626|FG000|Overall Study|Death|1|||
27934422|NCT00452530|81600627|FG001|Overall Study|Death|0|||
27934423|NCT00452530|81600626|FG000|Overall Study|Adverse Event|40|||
27934424|NCT00452530|81600627|FG001|Overall Study|Adverse Event|44|||
27934425|NCT00452530|81600626|FG000|Overall Study|Withdrawal by Subject|68|||
27934426|NCT00452530|81600627|FG001|Overall Study|Withdrawal by Subject|57|||
27934427|NCT00452530|81600626|FG000|Overall Study|Lost to Follow-up|1|||
27934428|NCT00452530|81600627|FG001|Overall Study|Lost to Follow-up|0|||
27934429|NCT00452530|81600626|FG000|Overall Study|Poor compliance/noncompliance|1|||
27934430|NCT00452530|81600627|FG001|Overall Study|Poor compliance/noncompliance|2|||
27934431|NCT00452530|81600626|FG000|Overall Study|No longer met study criteria|18|||
27934432|NCT00452530|81600627|FG001|Overall Study|No longer met study criteria|22|||
27934433|NCT00452530|81600626|FG000|Overall Study|Other|7|||
27934434|NCT00452530|81600627|FG001|Overall Study|Other|11|||
27934435|NCT02294019|81600631|FG000|Overall Study|Adverse Event|2|||
27934436|NCT02294019|81600631|FG000|Overall Study|Protocol Violation|68|||
27934437|NCT02294019|81600631|FG000|Overall Study|Lost to Follow-up|31|||
27934438|NCT02294019|81600631|FG000|Overall Study|Other|1|||
27934439|NCT02294019|81600631|FG000|Overall Study|Withdrawal by Subject|1|||
27934440|NCT00899847|81600632|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
27934441|NCT01712074|81600633|FG000|Placebo Run-in Period|Adverse Event|2|||
27934442|NCT01712074|81600634|FG001|Placebo Run-in Period|Adverse Event|0|||
27934443|NCT01712074|81600635|FG002|Placebo Run-in Period|Adverse Event|0|||
27934444|NCT01712074|81600633|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
27934445|NCT01712074|81600634|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
27934446|NCT01712074|81600635|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
27934447|NCT01712074|81600633|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
27934448|NCT01712074|81600634|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
27934449|NCT01712074|81600635|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
27934450|NCT01712074|81600633|FG000|Placebo Run-in Period|Other|1|||
27934451|NCT01712074|81600634|FG001|Placebo Run-in Period|Other|0|||
27934452|NCT01712074|81600635|FG002|Placebo Run-in Period|Other|0|||
27934453|NCT01712074|81600633|FG000|Placebo Run-in Period|No longer willing to participate|1|||
27934454|NCT01712074|81600634|FG001|Placebo Run-in Period|No longer willing to participate|0|||
27934455|NCT01712074|81600635|FG002|Placebo Run-in Period|No longer willing to participate|0|||
27934456|NCT01712074|81600633|FG000|Double Blind Period|Adverse Event|0|||
27934457|NCT01712074|81600634|FG001|Double Blind Period|Adverse Event|2|||
27934458|NCT01712074|81600635|FG002|Double Blind Period|Adverse Event|1|||
27934459|NCT01712074|81600633|FG000|Double Blind Period|No longer willing to participate|0|||
27934460|NCT01712074|81600634|FG001|Double Blind Period|No longer willing to participate|2|||
27934461|NCT01712074|81600635|FG002|Double Blind Period|No longer willing to participate|4|||
27934462|NCT01712074|81600633|FG000|Double Blind Period|Death|0|||
27934463|NCT01712074|81600634|FG001|Double Blind Period|Death|1|||
27934464|NCT01712074|81600635|FG002|Double Blind Period|Death|0|||
27934465|NCT01712074|81600633|FG000|Double Blind Period|Lost to Follow-up|0|||
27934466|NCT01712074|81600634|FG001|Double Blind Period|Lost to Follow-up|2|||
27934467|NCT01712074|81600635|FG002|Double Blind Period|Lost to Follow-up|1|||
27642935|NCT04492475|80536301|FG000|Overall Study|Became ineligible after enrollment|2|||
27743660|NCT02168946|80892648|FG000|Overall Study|Adverse Event|8|||
27934468|NCT01712074|81600633|FG000|Double Blind Period|Other|0|||
27934469|NCT01712074|81600634|FG001|Double Blind Period|Other|4|||
27934470|NCT01712074|81600635|FG002|Double Blind Period|Other|1|||
27934471|NCT01712074|81600633|FG000|Double Blind Period|Protocol Violation|0|||
27934472|NCT01712074|81600634|FG001|Double Blind Period|Protocol Violation|0|||
27934473|NCT01712074|81600635|FG002|Double Blind Period|Protocol Violation|1|||
27934474|NCT01712074|81600633|FG000|Double Blind Period|No longer met eligibility criteria|0|||
27934475|NCT01712074|81600634|FG001|Double Blind Period|No longer met eligibility criteria|3|||
27934476|NCT01712074|81600635|FG002|Double Blind Period|No longer met eligibility criteria|0|||
27934477|NCT00147537|81600641|FG000|Phase 1b|Death|0|||
27934478|NCT00147537|81600642|FG001|Phase 1b|Death|1|||
27934479|NCT00147537|81600643|FG002|Phase 1b|Death|2|||
27934480|NCT00147537|81600644|FG003|Phase 1b|Death|1|||
27934481|NCT00147537|81600645|FG004|Phase 1b|Death|2|||
27934482|NCT00147537|81600646|FG005|Phase 1b|Death|2|||
27934483|NCT00147537|81600647|FG006|Phase 1b|Death|1|||
27934484|NCT00147537|81600648|FG007|Phase 1b|Death|3|||
27934485|NCT00147537|81600649|FG008|Phase 1b|Death|9|||
27934486|NCT00147537|81600650|FG009|Phase 1b|Death|0|||
27934487|NCT00147537|81600651|FG010|Phase 1b|Death|0|||
27934488|NCT00147537|81600641|FG000|Phase 1b|Lost to Follow-up|2|||
27934489|NCT00147537|81600642|FG001|Phase 1b|Lost to Follow-up|1|||
27934490|NCT00147537|81600643|FG002|Phase 1b|Lost to Follow-up|0|||
27934491|NCT00147537|81600644|FG003|Phase 1b|Lost to Follow-up|0|||
27934492|NCT00147537|81600645|FG004|Phase 1b|Lost to Follow-up|0|||
27934493|NCT00147537|81600646|FG005|Phase 1b|Lost to Follow-up|0|||
27934494|NCT00147537|81600647|FG006|Phase 1b|Lost to Follow-up|2|||
27934495|NCT00147537|81600648|FG007|Phase 1b|Lost to Follow-up|0|||
27934496|NCT00147537|81600649|FG008|Phase 1b|Lost to Follow-up|1|||
27934497|NCT00147537|81600650|FG009|Phase 1b|Lost to Follow-up|0|||
27934498|NCT00147537|81600651|FG010|Phase 1b|Lost to Follow-up|0|||
27934499|NCT00147537|81600641|FG000|Phase 1b|Other|0|||
27934500|NCT00147537|81600642|FG001|Phase 1b|Other|0|||
27934501|NCT00147537|81600643|FG002|Phase 1b|Other|2|||
27934502|NCT00147537|81600644|FG003|Phase 1b|Other|1|||
27934503|NCT00147537|81600645|FG004|Phase 1b|Other|1|||
27934504|NCT00147537|81600646|FG005|Phase 1b|Other|1|||
27934505|NCT00147537|81600647|FG006|Phase 1b|Other|14|||
27934506|NCT00147537|81600648|FG007|Phase 1b|Other|4|||
27934507|NCT00147537|81600649|FG008|Phase 1b|Other|4|||
27934508|NCT00147537|81600650|FG009|Phase 1b|Other|0|||
27934509|NCT00147537|81600651|FG010|Phase 1b|Other|0|||
27934510|NCT00147537|81600641|FG000|Phase 1b|Withdrawal by Subject|0|||
27934511|NCT00147537|81600642|FG001|Phase 1b|Withdrawal by Subject|0|||
27934512|NCT00147537|81600643|FG002|Phase 1b|Withdrawal by Subject|0|||
27934513|NCT00147537|81600644|FG003|Phase 1b|Withdrawal by Subject|0|||
27934514|NCT00147537|81600645|FG004|Phase 1b|Withdrawal by Subject|0|||
27934515|NCT00147537|81600646|FG005|Phase 1b|Withdrawal by Subject|0|||
27934516|NCT00147537|81600647|FG006|Phase 1b|Withdrawal by Subject|0|||
27934517|NCT00147537|81600648|FG007|Phase 1b|Withdrawal by Subject|0|||
27934518|NCT00147537|81600649|FG008|Phase 1b|Withdrawal by Subject|2|||
27934519|NCT00147537|81600650|FG009|Phase 1b|Withdrawal by Subject|0|||
27934520|NCT00147537|81600651|FG010|Phase 1b|Withdrawal by Subject|0|||
27934521|NCT00147537|81600641|FG000|Phase 1b|Randomized but not treated|0|||
27934522|NCT00147537|81600642|FG001|Phase 1b|Randomized but not treated|0|||
27934523|NCT00147537|81600643|FG002|Phase 1b|Randomized but not treated|0|||
27934524|NCT00147537|81600644|FG003|Phase 1b|Randomized but not treated|0|||
27934525|NCT00147537|81600645|FG004|Phase 1b|Randomized but not treated|0|||
27934526|NCT00147537|81600646|FG005|Phase 1b|Randomized but not treated|0|||
27934527|NCT00147537|81600647|FG006|Phase 1b|Randomized but not treated|1|||
27934528|NCT00147537|81600648|FG007|Phase 1b|Randomized but not treated|0|||
27934529|NCT00147537|81600649|FG008|Phase 1b|Randomized but not treated|1|||
27934530|NCT00147537|81600650|FG009|Phase 1b|Randomized but not treated|0|||
27934531|NCT00147537|81600651|FG010|Phase 1b|Randomized but not treated|0|||
27934532|NCT00147537|81600641|FG000|Phase 2|Death|0|||
27934533|NCT00147537|81600642|FG001|Phase 2|Death|0|||
27934534|NCT00147537|81600643|FG002|Phase 2|Death|0|||
27934535|NCT00147537|81600644|FG003|Phase 2|Death|0|||
27934536|NCT00147537|81600645|FG004|Phase 2|Death|0|||
27934537|NCT00147537|81600646|FG005|Phase 2|Death|0|||
27934538|NCT00147537|81600647|FG006|Phase 2|Death|0|||
27934539|NCT00147537|81600648|FG007|Phase 2|Death|0|||
27934540|NCT00147537|81600649|FG008|Phase 2|Death|0|||
27934541|NCT00147537|81600650|FG009|Phase 2|Death|85|||
27934542|NCT00147537|81600651|FG010|Phase 2|Death|31|||
27934543|NCT00147537|81600641|FG000|Phase 2|Lost to Follow-up|0|||
27934544|NCT00147537|81600642|FG001|Phase 2|Lost to Follow-up|0|||
27934545|NCT00147537|81600643|FG002|Phase 2|Lost to Follow-up|0|||
27934546|NCT00147537|81600644|FG003|Phase 2|Lost to Follow-up|0|||
27934547|NCT00147537|81600645|FG004|Phase 2|Lost to Follow-up|0|||
27934548|NCT00147537|81600646|FG005|Phase 2|Lost to Follow-up|0|||
27934549|NCT00147537|81600647|FG006|Phase 2|Lost to Follow-up|0|||
27934550|NCT00147537|81600648|FG007|Phase 2|Lost to Follow-up|0|||
27934551|NCT00147537|81600649|FG008|Phase 2|Lost to Follow-up|0|||
27934552|NCT00147537|81600650|FG009|Phase 2|Lost to Follow-up|12|||
27934553|NCT00147537|81600651|FG010|Phase 2|Lost to Follow-up|4|||
27934554|NCT00147537|81600641|FG000|Phase 2|Other|0|||
27934555|NCT00147537|81600642|FG001|Phase 2|Other|0|||
27934556|NCT00147537|81600643|FG002|Phase 2|Other|0|||
27934557|NCT00147537|81600644|FG003|Phase 2|Other|0|||
27934558|NCT00147537|81600645|FG004|Phase 2|Other|0|||
27934559|NCT00147537|81600646|FG005|Phase 2|Other|0|||
27934560|NCT00147537|81600647|FG006|Phase 2|Other|0|||
27934561|NCT00147537|81600648|FG007|Phase 2|Other|0|||
27934562|NCT00147537|81600649|FG008|Phase 2|Other|0|||
27934563|NCT00147537|81600650|FG009|Phase 2|Other|47|||
27934564|NCT00147537|81600651|FG010|Phase 2|Other|12|||
27934565|NCT00147537|81600641|FG000|Phase 2|Withdrawal by Subject|0|||
27934566|NCT00147537|81600642|FG001|Phase 2|Withdrawal by Subject|0|||
27934567|NCT00147537|81600643|FG002|Phase 2|Withdrawal by Subject|0|||
27934568|NCT00147537|81600644|FG003|Phase 2|Withdrawal by Subject|0|||
27934569|NCT00147537|81600645|FG004|Phase 2|Withdrawal by Subject|0|||
27934570|NCT00147537|81600646|FG005|Phase 2|Withdrawal by Subject|0|||
27934571|NCT00147537|81600647|FG006|Phase 2|Withdrawal by Subject|0|||
27934572|NCT00147537|81600648|FG007|Phase 2|Withdrawal by Subject|0|||
27934573|NCT00147537|81600649|FG008|Phase 2|Withdrawal by Subject|0|||
27934574|NCT00147537|81600650|FG009|Phase 2|Withdrawal by Subject|16|||
27934575|NCT00147537|81600651|FG010|Phase 2|Withdrawal by Subject|4|||
27934576|NCT00147537|81600641|FG000|Phase 2|Randomized but not treated|0|||
27934577|NCT00147537|81600642|FG001|Phase 2|Randomized but not treated|0|||
27934578|NCT00147537|81600643|FG002|Phase 2|Randomized but not treated|0|||
27934579|NCT00147537|81600644|FG003|Phase 2|Randomized but not treated|0|||
27934580|NCT00147537|81600645|FG004|Phase 2|Randomized but not treated|0|||
27934581|NCT00147537|81600646|FG005|Phase 2|Randomized but not treated|0|||
27934582|NCT00147537|81600647|FG006|Phase 2|Randomized but not treated|0|||
27934583|NCT00147537|81600648|FG007|Phase 2|Randomized but not treated|0|||
27934584|NCT00147537|81600649|FG008|Phase 2|Randomized but not treated|0|||
27934585|NCT00147537|81600650|FG009|Phase 2|Randomized but not treated|1|||
27934586|NCT00147537|81600651|FG010|Phase 2|Randomized but not treated|1|||
27934587|NCT00625378|81600653|FG000|Overall Study|Adverse Event|22|||
27934588|NCT00625378|81600654|FG001|Overall Study|Adverse Event|0|||
27934589|NCT00625378|81600653|FG000|Overall Study|Withdrawal by Subject|16|||
27934590|NCT00625378|81600654|FG001|Overall Study|Withdrawal by Subject|0|||
27934591|NCT00625378|81600653|FG000|Overall Study|Death|38|||
27934592|NCT00625378|81600654|FG001|Overall Study|Death|0|||
27934593|NCT00625378|81600653|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
27934594|NCT00625378|81600654|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
27934595|NCT00625378|81600653|FG000|Overall Study|Lost to Follow-up|17|||
27934596|NCT00625378|81600654|FG001|Overall Study|Lost to Follow-up|0|||
27934597|NCT00625378|81600653|FG000|Overall Study|Non-compliant with study medication|3|||
27934598|NCT00625378|81600654|FG001|Overall Study|Non-compliant with study medication|0|||
27934599|NCT00625378|81600653|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
27934600|NCT00625378|81600654|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
27934601|NCT00625378|81600653|FG000|Overall Study|Medical decision|1|||
27934602|NCT00625378|81600654|FG001|Overall Study|Medical decision|0|||
27934603|NCT00625378|81600653|FG000|Overall Study|Multiple toxicities|1|||
27934604|NCT00625378|81600654|FG001|Overall Study|Multiple toxicities|0|||
27934605|NCT00625378|81600653|FG000|Overall Study|New cancer|1|||
27934606|NCT00625378|81600654|FG001|Overall Study|New cancer|0|||
27934607|NCT00625378|81600653|FG000|Overall Study|PTA program|2|||
27934608|NCT00625378|81600654|FG001|Overall Study|PTA program|0|||
27934609|NCT00625378|81600653|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
27934610|NCT00625378|81600654|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
27934611|NCT00625378|81600653|FG000|Overall Study|Sponsor decision|1|||
27934612|NCT00625378|81600654|FG001|Overall Study|Sponsor decision|0|||
27934613|NCT00625378|81600653|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
27934614|NCT00625378|81600654|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
27934615|NCT00625378|81600653|FG000|Overall Study|Switch to commercial drug|6|||
27934616|NCT00625378|81600654|FG001|Overall Study|Switch to commercial drug|1|||
27934617|NCT00625378|81600653|FG000|Overall Study|Missing|2|||
27934618|NCT00625378|81600654|FG001|Overall Study|Missing|0|||
27934619|NCT00625378|81600653|FG000|Overall Study|End of treatment not available|2|||
27934620|NCT00625378|81600654|FG001|Overall Study|End of treatment not available|0|||
27934621|NCT00625378|81600653|FG000|Overall Study|Never treated|2|||
27934622|NCT00625378|81600654|FG001|Overall Study|Never treated|0|||
27934623|NCT03073109|81600657|FG000|Overall Study|Adverse Event|0|||
27934624|NCT03073109|81600658|FG001|Overall Study|Adverse Event|1|||
27934625|NCT03073109|81600657|FG000|Overall Study|Other|2|||
27934626|NCT03073109|81600658|FG001|Overall Study|Other|0|||
27934627|NCT03073109|81600657|FG000|Overall Study|Lost to Follow-up|8|||
27934628|NCT03073109|81600658|FG001|Overall Study|Lost to Follow-up|1|||
27934629|NCT00183391|81600661|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
27934630|NCT00183391|81600662|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
27934631|NCT00183391|81600661|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
27934632|NCT00183391|81600662|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
27934633|NCT02176525|81600663|FG000|Overall Study|Adverse Event|0|||
27934634|NCT02176525|81600664|FG001|Overall Study|Adverse Event|0|||
27934635|NCT02176525|81600665|FG002|Overall Study|Adverse Event|0|||
27934636|NCT02176525|81600666|FG003|Overall Study|Adverse Event|1|||
27934637|NCT02176525|81600667|FG004|Overall Study|Adverse Event|1|||
27934638|NCT02176525|81600668|FG005|Overall Study|Adverse Event|0|||
27934639|NCT02176525|81600669|FG006|Overall Study|Adverse Event|1|||
27934640|NCT02176525|81600670|FG007|Overall Study|Adverse Event|0|||
27934641|NCT02176525|81600663|FG000|Overall Study|not treated|1|||
27934642|NCT02176525|81600664|FG001|Overall Study|not treated|0|||
27934643|NCT02176525|81600665|FG002|Overall Study|not treated|0|||
27934644|NCT02176525|81600666|FG003|Overall Study|not treated|0|||
27934645|NCT02176525|81600667|FG004|Overall Study|not treated|0|||
27934646|NCT02176525|81600668|FG005|Overall Study|not treated|1|||
27934647|NCT02176525|81600669|FG006|Overall Study|not treated|0|||
27934648|NCT02176525|81600670|FG007|Overall Study|not treated|0|||
27934649|NCT00507507|81600673|FG000|Treatment Period|Lost to Follow-up|0|||
27934650|NCT00507507|81600674|FG001|Treatment Period|Lost to Follow-up|2|||
27934651|NCT00507507|81600673|FG000|Treatment Period|Physician Decision|4|||
27934652|NCT00507507|81600674|FG001|Treatment Period|Physician Decision|1|||
27934653|NCT00507507|81600673|FG000|Treatment Period|Protocol Violation|1|||
27934654|NCT00507507|81600674|FG001|Treatment Period|Protocol Violation|2|||
27934655|NCT00507507|81600673|FG000|Treatment Period|Adverse Event|1|||
27934656|NCT00507507|81600674|FG001|Treatment Period|Adverse Event|1|||
27934657|NCT00507507|81600673|FG000|Treatment Period|Withdrawal by Subject|46|||
27934658|NCT00507507|81600674|FG001|Treatment Period|Withdrawal by Subject|47|||
27934659|NCT00507507|81600673|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
27934660|NCT00507507|81600674|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
27934661|NCT00507507|81600673|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
27934662|NCT00507507|81600674|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
27934663|NCT00507507|81600673|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
27934664|NCT00507507|81600674|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
27934665|NCT02191397|81600680|FG000|Overall Study|Adverse Event|28|||
27934666|NCT02191397|81600681|FG001|Overall Study|Adverse Event|17|||
27934667|NCT02191397|81600680|FG000|Overall Study|Lack of Efficacy|10|||
27934668|NCT02191397|81600681|FG001|Overall Study|Lack of Efficacy|5|||
27934669|NCT02191397|81600680|FG000|Overall Study|Protocol Violation|0|||
27934670|NCT02191397|81600681|FG001|Overall Study|Protocol Violation|3|||
27934671|NCT02191397|81600680|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
27934672|NCT02191397|81600681|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
27934673|NCT02191397|81600680|FG000|Overall Study|Lost to Follow-up|10|||
27934674|NCT02191397|81600681|FG001|Overall Study|Lost to Follow-up|11|||
27934675|NCT02191397|81600680|FG000|Overall Study|Physician Decision|8|||
27934676|NCT02191397|81600681|FG001|Overall Study|Physician Decision|3|||
27934677|NCT02191397|81600680|FG000|Overall Study|Withdrawal by Subject|22|||
27934678|NCT02191397|81600681|FG001|Overall Study|Withdrawal by Subject|27|||
27934679|NCT02151604|81600682|FG000|Overall Study|Lost to Follow-up|3|||
27934680|NCT02151604|81600682|FG000|Overall Study|Withdrawal by Subject|2|||
27934681|NCT02151604|81600682|FG000|Overall Study|Physician Decision|3|||
27934682|NCT02151604|81600682|FG000|Overall Study|Death|1|||
27934683|NCT01230814|81600683|FG000|Overall Study|Lost to Follow-up|11|||
27934684|NCT01230814|81600684|FG001|Overall Study|Lost to Follow-up|3|||
27934685|NCT01230814|81600683|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
27934686|NCT01230814|81600684|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
27934687|NCT01178411|81600685|FG000|Overall Study|Adverse Event|5|||
27934688|NCT01178411|81600685|FG000|Overall Study|Withdrawal by Subject|4|||
27934689|NCT01178411|81600685|FG000|Overall Study|Protocol Violation|1|||
27934690|NCT01178411|81600685|FG000|Overall Study|Progressive disease per RECIST|32|||
27934691|NCT01178411|81600685|FG000|Overall Study|Progressive disease per clinician|9|||
27934692|NCT01178411|81600685|FG000|Overall Study|Physician Decision|6|||
27934693|NCT01178411|81600685|FG000|Overall Study|Death|1|||
27934694|NCT01178411|81600685|FG000|Overall Study|No reason provided|1|||
27934695|NCT01178411|81600685|FG000|Overall Study|Drug manufacturing ended|1|||
27934696|NCT01297244|81600686|FG000|Overall Study|Progressive disease|22|||
27934697|NCT01297244|81600687|FG001|Overall Study|Progressive disease|3|||
27934698|NCT01297244|81600686|FG000|Overall Study|Adverse Event|9|||
27934699|NCT01297244|81600687|FG001|Overall Study|Adverse Event|1|||
27934700|NCT01297244|81600686|FG000|Overall Study|Death|1|||
27934701|NCT01297244|81600687|FG001|Overall Study|Death|1|||
27934702|NCT01297244|81600686|FG000|Overall Study|Clinical progression|1|||
27934703|NCT01297244|81600687|FG001|Overall Study|Clinical progression|1|||
27550822|NCT01129960|80203492|FG002|Overall Study|Physician Decision|0|||
27550823|NCT01129960|80203493|FG003|Overall Study|Physician Decision|0|||
27934704|NCT01297244|81600686|FG000|Overall Study|Withdrawal by Subject|2|||
27934705|NCT01297244|81600687|FG001|Overall Study|Withdrawal by Subject|0|||
27550824|NCT01129960|80203490|FG000|Overall Study|Pregnancy|1|||
27550825|NCT01129960|80203491|FG001|Overall Study|Pregnancy|0|||
27550826|NCT01129960|80203492|FG002|Overall Study|Pregnancy|0|||
27934706|NCT01898130|81600688|FG000|Treatment|Withdrawal by Subject|2|||
27934707|NCT01898130|81600688|FG000|Treatment|Progressive Disease|4|||
27934708|NCT01898130|81600688|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
27934709|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
27934710|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
27934711|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
27934712|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Adverse Event|5|||
27934713|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Adverse Event|1|||
27934714|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Adverse Event|0|||
27934715|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
27934716|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
27934717|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
27934718|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Death|8|||
27934719|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Death|24|||
27934720|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Death|0|||
27934721|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
27934722|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
27934723|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
27934724|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
27934725|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
27934726|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
27934727|NCT02931539|81600695|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
27934728|NCT02931539|81600696|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
27934729|NCT02931539|81600697|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
27934730|NCT02931539|81600695|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
27934731|NCT02931539|81600696|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
27934732|NCT02931539|81600697|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
27934733|NCT03142451|81600698|FG000|Overall Study|Adverse Event|5|||
27934734|NCT03142451|81600699|FG001|Overall Study|Adverse Event|2|||
27934735|NCT03142451|81600698|FG000|Overall Study|Lost to Follow-up|25|||
27934736|NCT03142451|81600699|FG001|Overall Study|Lost to Follow-up|8|||
27934737|NCT03142451|81600698|FG000|Overall Study|Participant request|24|||
27934738|NCT03142451|81600699|FG001|Overall Study|Participant request|12|||
27934739|NCT03142451|81600698|FG000|Overall Study|Protocol Violation|3|||
27934740|NCT03142451|81600699|FG001|Overall Study|Protocol Violation|1|||
27934741|NCT03142451|81600698|FG000|Overall Study|Other|1|||
27934742|NCT03142451|81600699|FG001|Overall Study|Other|1|||
27934743|NCT00927186|81600704|FG000|12 Months Primary Study|Adverse Event|5|||
27934744|NCT00927186|81600705|FG001|12 Months Primary Study|Adverse Event|2|||
27934745|NCT00927186|81600704|FG000|12 Months Primary Study|Lost to Follow-up|1|||
27934746|NCT00927186|81600705|FG001|12 Months Primary Study|Lost to Follow-up|0|||
27934747|NCT00927186|81600704|FG000|12 Months Primary Study|Protocol Violation|0|||
27934748|NCT00927186|81600705|FG001|12 Months Primary Study|Protocol Violation|1|||
27934749|NCT00927186|81600704|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
27934750|NCT00927186|81600705|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
27934751|NCT01429623|81600706|FG000|Overall Study|Death|1|||
27934752|NCT01429623|81600707|FG001|Overall Study|Death|0|||
27934753|NCT01429623|81600706|FG000|Overall Study|Adverse Event|7|||
27934754|NCT01429623|81600707|FG001|Overall Study|Adverse Event|14|||
27934755|NCT01429623|81600706|FG000|Overall Study|Withdrawal by Subject|19|||
27934756|NCT01429623|81600707|FG001|Overall Study|Withdrawal by Subject|13|||
27934757|NCT01429623|81600706|FG000|Overall Study|Physician Decision|2|||
27934758|NCT01429623|81600707|FG001|Overall Study|Physician Decision|3|||
27934759|NCT01429623|81600706|FG000|Overall Study|Protocol Violation|3|||
27934760|NCT01429623|81600707|FG001|Overall Study|Protocol Violation|2|||
27934761|NCT01429623|81600706|FG000|Overall Study|Assorted|1|||
27934762|NCT01429623|81600707|FG001|Overall Study|Assorted|2|||
27934763|NCT01429623|81600706|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
27934764|NCT01429623|81600707|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
27934765|NCT01429623|81600706|FG000|Overall Study|No post baseline data|4|||
27934766|NCT01429623|81600707|FG001|Overall Study|No post baseline data|4|||
27934767|NCT01133977|81600708|FG000|Overall Study|Adverse Event|0|||
27934768|NCT01133977|81600709|FG001|Overall Study|Adverse Event|0|||
27934769|NCT01133977|81600710|FG002|Overall Study|Adverse Event|1|||
27934770|NCT01133977|81600711|FG003|Overall Study|Adverse Event|0|||
27934771|NCT01133977|81600712|FG004|Overall Study|Adverse Event|0|||
27934772|NCT01133977|81600708|FG000|Overall Study|Death|1|||
27934773|NCT01133977|81600709|FG001|Overall Study|Death|1|||
27934774|NCT01133977|81600710|FG002|Overall Study|Death|1|||
27934775|NCT01133977|81600711|FG003|Overall Study|Death|7|||
27934776|NCT01133977|81600712|FG004|Overall Study|Death|3|||
27934777|NCT01133977|81600708|FG000|Overall Study|Started a New Line of Therapy|2|||
27934778|NCT01133977|81600709|FG001|Overall Study|Started a New Line of Therapy|6|||
27934779|NCT01133977|81600710|FG002|Overall Study|Started a New Line of Therapy|4|||
27934780|NCT01133977|81600711|FG003|Overall Study|Started a New Line of Therapy|25|||
27934781|NCT01133977|81600712|FG004|Overall Study|Started a New Line of Therapy|33|||
27934782|NCT01133977|81600708|FG000|Overall Study|Lost to Follow-up|0|||
27934783|NCT01133977|81600709|FG001|Overall Study|Lost to Follow-up|0|||
27934784|NCT01133977|81600710|FG002|Overall Study|Lost to Follow-up|0|||
27934785|NCT01133977|81600711|FG003|Overall Study|Lost to Follow-up|2|||
27934786|NCT01133977|81600712|FG004|Overall Study|Lost to Follow-up|1|||
27934787|NCT01133977|81600708|FG000|Overall Study|Withdrawal by Subject|0|||
27934788|NCT01133977|81600709|FG001|Overall Study|Withdrawal by Subject|0|||
27934789|NCT01133977|81600710|FG002|Overall Study|Withdrawal by Subject|0|||
27934790|NCT01133977|81600711|FG003|Overall Study|Withdrawal by Subject|5|||
27934791|NCT01133977|81600712|FG004|Overall Study|Withdrawal by Subject|1|||
27934792|NCT02872142|81600714|FG000|Overall Study|Adverse Event|2|||
27934793|NCT02872142|81600714|FG000|Overall Study|Death|1|||
27934794|NCT02872142|81600714|FG000|Overall Study|Participant Decision|3|||
27934795|NCT02619812|81600718|FG000|Overall Study|Withdrawal by Subject|0|||
27934796|NCT02619812|81600719|FG001|Overall Study|Withdrawal by Subject|0|||
27934797|NCT02619812|81600720|FG002|Overall Study|Withdrawal by Subject|1|||
27934798|NCT02619812|81600721|FG003|Overall Study|Withdrawal by Subject|2|||
27934799|NCT00003474|81600725|FG000|Overall Study|Not Evaluable|14|||
27934800|NCT01716559|81600726|FG000|Overall Study|Adverse Event|11|||
27934801|NCT01716559|81600726|FG000|Overall Study|Death|21|||
27934802|NCT01716559|81600726|FG000|Overall Study|Withdrawal by Subject|4|||
27934803|NCT01716559|81600726|FG000|Overall Study|Other withdrawal reason|75|||
27934804|NCT00263562|81600727|FG000|Overall Study|Protocol Violation|3|||
27934805|NCT00263562|81600728|FG001|Overall Study|Protocol Violation|0|||
27934806|NCT00500110|81600731|FG000|Overall Study|Withdrawal by Subject|3|||
27934807|NCT03302936|81600732|FG000|Overall Study|Protocol Violation|3|||
27934808|NCT03302936|81600733|FG001|Overall Study|Protocol Violation|4|||
27934809|NCT01451203|81600736|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
27934810|NCT01451203|81600737|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
27934811|NCT01451203|81600736|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
27934812|NCT01451203|81600737|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
27934813|NCT01451203|81600736|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
27934814|NCT01451203|81600737|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
27934815|NCT01451203|81600736|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
27934816|NCT01451203|81600737|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
27934817|NCT01451203|81600736|FG000|Double-blind Treatment Period|Adverse Event|6|||
27934818|NCT01451203|81600737|FG001|Double-blind Treatment Period|Adverse Event|9|||
27934819|NCT01451203|81600736|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
27934820|NCT01451203|81600737|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
27934821|NCT01451203|81600736|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
27934822|NCT01451203|81600737|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
27934823|NCT01451203|81600736|FG000|Double-blind Treatment Period|Investigator decision|2|||
27934824|NCT01451203|81600737|FG001|Double-blind Treatment Period|Investigator decision|0|||
27934825|NCT01451203|81600736|FG000|Post-treatment Period|Consent withdrawn|2|||
27934826|NCT01451203|81600737|FG001|Post-treatment Period|Consent withdrawn|4|||
27934827|NCT01451203|81600736|FG000|Post-treatment Period|Lack of Efficacy|12|||
27934828|NCT01451203|81600737|FG001|Post-treatment Period|Lack of Efficacy|28|||
27934829|NCT01451203|81600736|FG000|Post-treatment Period|Adverse Event|0|||
27934830|NCT01451203|81600737|FG001|Post-treatment Period|Adverse Event|1|||
27934831|NCT01451203|81600736|FG000|Post-treatment Period|Investigator decision|0|||
27934832|NCT01451203|81600737|FG001|Post-treatment Period|Investigator decision|1|||
27934833|NCT02056288|81600738|FG000|In-Hospital Data|Surgery cancelled|1|||
27934834|NCT02056288|81600739|FG001|In-Hospital Data|Surgery cancelled|0|||
27934835|NCT02056288|81600738|FG000|In-Hospital Data|Protocol Violation|3|||
27934836|NCT02056288|81600739|FG001|In-Hospital Data|Protocol Violation|0|||
27934837|NCT02056288|81600738|FG000|In-Hospital Data|Physician Decision|1|||
27934838|NCT02056288|81600739|FG001|In-Hospital Data|Physician Decision|0|||
27934839|NCT02056288|81600738|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
27934840|NCT02056288|81600739|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
27934841|NCT01489358|81600740|FG000|Overall Study|Lost to Follow-up|0|||
27934842|NCT01489358|81600741|FG001|Overall Study|Lost to Follow-up|0|||
27934843|NCT01489358|81600742|FG002|Overall Study|Lost to Follow-up|2|||
27934844|NCT00212355|81600743|FG000|Overall Study|Adverse Event|1|||
27934845|NCT00212355|81600743|FG000|Overall Study|Withdrawal by Subject|1|||
27934846|NCT00212355|81600743|FG000|Overall Study|A change of address|1|||
27934847|NCT00289900|81600747|FG000|Overall Study|Adverse Event|28|||
27642936|NCT04492475|80536302|FG001|Overall Study|Became ineligible after enrollment|0|||
27642937|NCT03611075|80536303|FG000|Overall Study|Physician Decision|0|||
27934848|NCT00289900|81600748|FG001|Overall Study|Adverse Event|40|||
27934849|NCT00289900|81600749|FG002|Overall Study|Adverse Event|13|||
27934850|NCT00289900|81600750|FG003|Overall Study|Adverse Event|19|||
27934851|NCT00289900|81600751|FG004|Overall Study|Adverse Event|20|||
27934852|NCT00289900|81600752|FG005|Overall Study|Adverse Event|33|||
27934853|NCT00289900|81600747|FG000|Overall Study|Lost to Follow-up|7|||
27934854|NCT00289900|81600748|FG001|Overall Study|Lost to Follow-up|7|||
27934855|NCT00289900|81600749|FG002|Overall Study|Lost to Follow-up|8|||
27934856|NCT00289900|81600750|FG003|Overall Study|Lost to Follow-up|8|||
27934857|NCT00289900|81600751|FG004|Overall Study|Lost to Follow-up|4|||
27934858|NCT00289900|81600752|FG005|Overall Study|Lost to Follow-up|8|||
27743661|NCT02168946|80892649|FG001|Overall Study|Adverse Event|5|||
27743662|NCT02168946|80892648|FG000|Overall Study|Lost to Follow-up|3|||
27743663|NCT02168946|80892649|FG001|Overall Study|Lost to Follow-up|0|||
27934859|NCT00289900|81600747|FG000|Overall Study|Participant had flushing|18|||
27934860|NCT00289900|81600748|FG001|Overall Study|Participant had flushing|42|||
27934861|NCT00289900|81600749|FG002|Overall Study|Participant had flushing|1|||
27934862|NCT00289900|81600750|FG003|Overall Study|Participant had flushing|2|||
27934863|NCT00289900|81600751|FG004|Overall Study|Participant had flushing|0|||
27934864|NCT00289900|81600752|FG005|Overall Study|Participant had flushing|4|||
27934865|NCT00289900|81600747|FG000|Overall Study|Other|0|||
27934866|NCT00289900|81600748|FG001|Overall Study|Other|0|||
27934867|NCT00289900|81600749|FG002|Overall Study|Other|0|||
27934868|NCT00289900|81600750|FG003|Overall Study|Other|5|||
27934869|NCT00289900|81600751|FG004|Overall Study|Other|1|||
27934870|NCT00289900|81600752|FG005|Overall Study|Other|0|||
27934871|NCT00289900|81600747|FG000|Overall Study|Participant moved|1|||
27934872|NCT00289900|81600748|FG001|Overall Study|Participant moved|0|||
27934873|NCT00289900|81600749|FG002|Overall Study|Participant moved|0|||
27934874|NCT00289900|81600750|FG003|Overall Study|Participant moved|1|||
27934875|NCT00289900|81600751|FG004|Overall Study|Participant moved|1|||
27934876|NCT00289900|81600752|FG005|Overall Study|Participant moved|1|||
27934877|NCT00289900|81600747|FG000|Overall Study|Withdrawal by Subject|10|||
27934878|NCT00289900|81600748|FG001|Overall Study|Withdrawal by Subject|21|||
27934879|NCT00289900|81600749|FG002|Overall Study|Withdrawal by Subject|8|||
27934880|NCT00289900|81600750|FG003|Overall Study|Withdrawal by Subject|18|||
27934881|NCT00289900|81600751|FG004|Overall Study|Withdrawal by Subject|12|||
27934882|NCT00289900|81600752|FG005|Overall Study|Withdrawal by Subject|11|||
27934883|NCT00289900|81600747|FG000|Overall Study|Protocol Violation|3|||
27934884|NCT00289900|81600748|FG001|Overall Study|Protocol Violation|9|||
27934885|NCT00289900|81600749|FG002|Overall Study|Protocol Violation|2|||
27934886|NCT00289900|81600750|FG003|Overall Study|Protocol Violation|6|||
27934887|NCT00289900|81600751|FG004|Overall Study|Protocol Violation|7|||
27934888|NCT00289900|81600752|FG005|Overall Study|Protocol Violation|4|||
27934889|NCT00289900|81600747|FG000|Overall Study|site terminated|1|||
27934890|NCT00289900|81600748|FG001|Overall Study|site terminated|0|||
27934891|NCT00289900|81600749|FG002|Overall Study|site terminated|1|||
27934892|NCT00289900|81600750|FG003|Overall Study|site terminated|0|||
27934893|NCT00289900|81600751|FG004|Overall Study|site terminated|0|||
27934894|NCT00289900|81600752|FG005|Overall Study|site terminated|0|||
27934895|NCT00289900|81600747|FG000|Overall Study|Not treated|0|||
27934896|NCT00289900|81600748|FG001|Overall Study|Not treated|1|||
27934897|NCT00289900|81600749|FG002|Overall Study|Not treated|0|||
27934898|NCT00289900|81600750|FG003|Overall Study|Not treated|0|||
27934899|NCT00289900|81600751|FG004|Overall Study|Not treated|0|||
27934900|NCT00289900|81600752|FG005|Overall Study|Not treated|0|||
27934901|NCT00176254|81600756|FG000|Overall Study|Lost to Follow-up|1|||
27934902|NCT00799864|81600759|FG000|Overall Study|Participant reached a virologic endpoint|9|||
27934903|NCT00799864|81600760|FG001|Overall Study|Participant reached a virologic endpoint|2|||
27934904|NCT00799864|81600761|FG002|Overall Study|Participant reached a virologic endpoint|2|||
27934905|NCT00799864|81600762|FG003|Overall Study|Participant reached a virologic endpoint|0|||
27934906|NCT00799864|81600763|FG004|Overall Study|Participant reached a virologic endpoint|0|||
27934907|NCT00799864|81600759|FG000|Overall Study|Other|2|||
27934908|NCT00799864|81600760|FG001|Overall Study|Other|1|||
27934909|NCT00799864|81600761|FG002|Overall Study|Other|0|||
27934910|NCT00799864|81600762|FG003|Overall Study|Other|0|||
27934911|NCT00799864|81600763|FG004|Overall Study|Other|0|||
27550827|NCT01129960|80203493|FG003|Overall Study|Pregnancy|0|||
27550828|NCT03020160|80203494|FG000|Overall Study|Withdrawal by Subject|1|||
27550829|NCT03020160|80203495|FG001|Overall Study|Withdrawal by Subject|0|||
27934912|NCT00474968|81600765|FG000|Overall Study|Withdrawal by Subject|8|||
27934913|NCT00474968|81600766|FG001|Overall Study|Withdrawal by Subject|7|||
27934914|NCT00474968|81600765|FG000|Overall Study|Protocol Violation|9|||
27550830|NCT01007812|80203500|FG000|Period 1, One Week|Lost to Follow-up|0|||
27550831|NCT01007812|80203501|FG001|Period 1, One Week|Lost to Follow-up|1|||
27550832|NCT01007812|80203500|FG000|Period 1, One Week|Discomfort|1|||
27550833|NCT01007812|80203501|FG001|Period 1, One Week|Discomfort|0|||
27550834|NCT03672747|80203508|FG000|Overall Study|Lost to Follow-up|1|||
27550835|NCT03672747|80203509|FG001|Overall Study|Lost to Follow-up|1|||
27550836|NCT03672747|80203510|FG002|Overall Study|Lost to Follow-up|2|||
27550837|NCT03672747|80203511|FG003|Overall Study|Lost to Follow-up|2|||
27934915|NCT00474968|81600766|FG001|Overall Study|Protocol Violation|8|||
27934916|NCT00474968|81600765|FG000|Overall Study|Sample not collected|1|||
27934917|NCT00474968|81600766|FG001|Overall Study|Sample not collected|1|||
27934918|NCT03520569|81600767|FG000|Overall Study|Withdrawal by Subject|1|||
27934919|NCT00689052|81600768|FG000|Overall Study|Adverse Event|4|||
27934920|NCT00689052|81600769|FG001|Overall Study|Adverse Event|6|||
27934921|NCT00689052|81600768|FG000|Overall Study|Protocol Violation|1|||
27934922|NCT00689052|81600769|FG001|Overall Study|Protocol Violation|0|||
27934923|NCT00689052|81600768|FG000|Overall Study|Lost to Follow-up|2|||
27934924|NCT00689052|81600769|FG001|Overall Study|Lost to Follow-up|0|||
27934925|NCT00689052|81600768|FG000|Overall Study|Withdrawal by Subject|2|||
27934926|NCT00689052|81600769|FG001|Overall Study|Withdrawal by Subject|0|||
27934927|NCT00689052|81600768|FG000|Overall Study|Early termination of the trial|22|||
27934928|NCT00689052|81600769|FG001|Overall Study|Early termination of the trial|24|||
27934929|NCT00621322|81600772|FG000|Overall Study|Lost to Follow-up|0|||
27934930|NCT00621322|81600773|FG001|Overall Study|Lost to Follow-up|0|||
27934931|NCT00621322|81600774|FG002|Overall Study|Lost to Follow-up|0|||
27934932|NCT00621322|81600775|FG003|Overall Study|Lost to Follow-up|0|||
27934933|NCT00621322|81600776|FG004|Overall Study|Lost to Follow-up|1|||
27934934|NCT00621322|81600777|FG005|Overall Study|Lost to Follow-up|0|||
27934935|NCT00621322|81600772|FG000|Overall Study|Physician Decision|0|||
27934936|NCT00621322|81600773|FG001|Overall Study|Physician Decision|0|||
27934937|NCT00621322|81600774|FG002|Overall Study|Physician Decision|1|||
27934938|NCT00621322|81600775|FG003|Overall Study|Physician Decision|1|||
27934939|NCT00621322|81600776|FG004|Overall Study|Physician Decision|0|||
27934940|NCT00621322|81600777|FG005|Overall Study|Physician Decision|0|||
27934941|NCT00621322|81600772|FG000|Overall Study|Withdrawal by Subject|0|||
27934942|NCT00621322|81600773|FG001|Overall Study|Withdrawal by Subject|0|||
27934943|NCT00621322|81600774|FG002|Overall Study|Withdrawal by Subject|0|||
27934944|NCT00621322|81600775|FG003|Overall Study|Withdrawal by Subject|1|||
27934945|NCT00621322|81600776|FG004|Overall Study|Withdrawal by Subject|0|||
27934946|NCT00621322|81600777|FG005|Overall Study|Withdrawal by Subject|2|||
27934947|NCT00621322|81600772|FG000|Overall Study|Migrated/moved from study area|1|||
27934948|NCT00621322|81600773|FG001|Overall Study|Migrated/moved from study area|0|||
27934949|NCT00621322|81600774|FG002|Overall Study|Migrated/moved from study area|1|||
27934950|NCT00621322|81600775|FG003|Overall Study|Migrated/moved from study area|1|||
27934951|NCT00621322|81600776|FG004|Overall Study|Migrated/moved from study area|0|||
27934952|NCT00621322|81600777|FG005|Overall Study|Migrated/moved from study area|2|||
27934953|NCT03511066|81600778|FG000|Overall Study|Withdrawal by Subject|1|||
27934954|NCT03511066|81600779|FG001|Overall Study|Withdrawal by Subject|2|||
27934955|NCT03511066|81600780|FG002|Overall Study|Withdrawal by Subject|3|||
27934956|NCT03511066|81600778|FG000|Overall Study|Lost to Follow-up|2|||
27934957|NCT03511066|81600779|FG001|Overall Study|Lost to Follow-up|3|||
27934958|NCT03511066|81600780|FG002|Overall Study|Lost to Follow-up|0|||
27934959|NCT01301001|81600781|FG000|First Intervention|Lost to Follow-up|4|||
27934960|NCT01301001|81600782|FG001|First Intervention|Lost to Follow-up|4|||
27934961|NCT01301001|81600781|FG000|First Intervention|Withdrawal by Subject|1|||
27934962|NCT01301001|81600782|FG001|First Intervention|Withdrawal by Subject|4|||
27934963|NCT01301001|81600781|FG000|First Intervention|Adverse Event|5|||
27934964|NCT01301001|81600782|FG001|First Intervention|Adverse Event|0|||
27934965|NCT01301001|81600781|FG000|First Intervention|Protocol Violation|0|||
27934966|NCT01301001|81600782|FG001|First Intervention|Protocol Violation|1|||
27934967|NCT01301001|81600781|FG000|Second Intervention|Adverse Event|2|||
27934968|NCT01301001|81600782|FG001|Second Intervention|Adverse Event|0|||
27934969|NCT01301001|81600781|FG000|Second Intervention|Withdrawal by Subject|2|||
27934970|NCT01301001|81600782|FG001|Second Intervention|Withdrawal by Subject|0|||
27934971|NCT01623154|81600783|FG000|Overall Study|Did not drink Pranactin Citric|4|||
27934972|NCT00924651|81600784|FG000|Overall Study|Chemo started too soon|2|||
27934973|NCT00924651|81600785|FG001|Overall Study|Chemo started too soon|3|||
27934974|NCT00924651|81600784|FG000|Overall Study|No Reason|3|||
27934975|NCT00924651|81600785|FG001|Overall Study|No Reason|7|||
27934976|NCT00924651|81600784|FG000|Overall Study|Overwhelmed|6|||
27934977|NCT00924651|81600785|FG001|Overall Study|Overwhelmed|6|||
27934978|NCT00924651|81600784|FG000|Overall Study|Noncompliant|1|||
27934979|NCT00924651|81600785|FG001|Overall Study|Noncompliant|4|||
27934980|NCT00924651|81600784|FG000|Overall Study|Medical|1|||
27934981|NCT00924651|81600785|FG001|Overall Study|Medical|3|||
27934982|NCT00924651|81600784|FG000|Overall Study|Changed Mind|10|||
27934983|NCT00924651|81600785|FG001|Overall Study|Changed Mind|1|||
27934984|NCT00924651|81600784|FG000|Overall Study|Incomplete Form|2|||
27934985|NCT00924651|81600785|FG001|Overall Study|Incomplete Form|1|||
27934986|NCT01783015|81600786|FG000|Blinded Treatment|Adverse Event|0|||
27934987|NCT01783015|81600787|FG001|Blinded Treatment|Adverse Event|1|||
27934988|NCT01783015|81600788|FG002|Blinded Treatment|Adverse Event|0|||
27934989|NCT01783015|81600786|FG000|Blinded Treatment|Protocol Violation|0|||
27934990|NCT01783015|81600787|FG001|Blinded Treatment|Protocol Violation|1|||
27934991|NCT01783015|81600788|FG002|Blinded Treatment|Protocol Violation|0|||
27934992|NCT01783015|81600786|FG000|Blinded Treatment|Withdrawal by Subject|0|||
27934993|NCT01783015|81600787|FG001|Blinded Treatment|Withdrawal by Subject|1|||
27934994|NCT01783015|81600788|FG002|Blinded Treatment|Withdrawal by Subject|0|||
27934995|NCT01783015|81600786|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
27934996|NCT01783015|81600787|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
27934997|NCT01783015|81600788|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
27934998|NCT01783015|81600786|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
27934999|NCT01783015|81600787|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
27935000|NCT01783015|81600788|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
27935001|NCT00421733|81600789|FG000|Overall Study|Adverse Event|4|||
27935002|NCT00421733|81600790|FG001|Overall Study|Adverse Event|9|||
27935003|NCT00421733|81600791|FG002|Overall Study|Adverse Event|2|||
27935004|NCT00421733|81600789|FG000|Overall Study|Lost to Follow-up|1|||
27935005|NCT00421733|81600790|FG001|Overall Study|Lost to Follow-up|2|||
27935006|NCT00421733|81600791|FG002|Overall Study|Lost to Follow-up|4|||
27935007|NCT00421733|81600789|FG000|Overall Study|Withdrawal by Subject|1|||
27935008|NCT00421733|81600790|FG001|Overall Study|Withdrawal by Subject|2|||
27935009|NCT00421733|81600791|FG002|Overall Study|Withdrawal by Subject|7|||
27935010|NCT00421733|81600789|FG000|Overall Study|Death|0|||
27935011|NCT00421733|81600790|FG001|Overall Study|Death|3|||
27935012|NCT00421733|81600791|FG002|Overall Study|Death|0|||
27935013|NCT00421733|81600789|FG000|Overall Study|Required dialysis|1|||
27935014|NCT00421733|81600790|FG001|Overall Study|Required dialysis|0|||
27935015|NCT00421733|81600791|FG002|Overall Study|Required dialysis|0|||
27935016|NCT00421733|81600789|FG000|Overall Study|Administrative|2|||
27935017|NCT00421733|81600790|FG001|Overall Study|Administrative|0|||
27935018|NCT00421733|81600791|FG002|Overall Study|Administrative|0|||
27935019|NCT00421733|81600789|FG000|Overall Study|Did not satisfy entry criteria|1|||
27935020|NCT00421733|81600790|FG001|Overall Study|Did not satisfy entry criteria|3|||
27935021|NCT00421733|81600791|FG002|Overall Study|Did not satisfy entry criteria|2|||
27935022|NCT00421733|81600789|FG000|Overall Study|Sponsor request|1|||
27935023|NCT00421733|81600790|FG001|Overall Study|Sponsor request|0|||
27935024|NCT00421733|81600791|FG002|Overall Study|Sponsor request|3|||
27935025|NCT00421733|81600789|FG000|Overall Study|Protocol deviation|4|||
27935026|NCT00421733|81600790|FG001|Overall Study|Protocol deviation|7|||
27935027|NCT00421733|81600791|FG002|Overall Study|Protocol deviation|2|||
27935028|NCT01129284|81600792|FG000|Overall Study|Adverse Event|2|||
27935029|NCT01129284|81600793|FG001|Overall Study|Adverse Event|0|||
27935030|NCT01129284|81600794|FG002|Overall Study|Adverse Event|1|||
27935031|NCT04091438|81600795|FG000|Treatment Period 1 (1 Day)|Other|1|||
27935032|NCT04091438|81600796|FG001|Treatment Period 1 (1 Day)|Other|0|||
27935033|NCT04091438|81600795|FG000|Washout Period (1 Day)|Protocol deviation|0|||
27935034|NCT04091438|81600796|FG001|Washout Period (1 Day)|Protocol deviation|1|||
27935035|NCT04091438|81600795|FG000|Washout Period (1 Day)|Other|0|||
27935036|NCT04091438|81600796|FG001|Washout Period (1 Day)|Other|1|||
27935037|NCT00562861|81600801|FG000|Overall Study|Adverse Event|1|||
27935038|NCT00562861|81600802|FG001|Overall Study|Adverse Event|1|||
27935039|NCT00562861|81600801|FG000|Overall Study|Lack of Efficacy|5|||
27935040|NCT00562861|81600802|FG001|Overall Study|Lack of Efficacy|5|||
27935041|NCT00562861|81600801|FG000|Overall Study|noncompliance, moved|7|||
27935042|NCT00562861|81600802|FG001|Overall Study|noncompliance, moved|2|||
27935043|NCT00562861|81600801|FG000|Overall Study|Lost to Follow-up|7|||
27935044|NCT00562861|81600802|FG001|Overall Study|Lost to Follow-up|3|||
27935045|NCT03164356|81600803|FG000|Overall Study|Lost to Follow-up|1|||
27935046|NCT03164356|81600804|FG001|Overall Study|Lost to Follow-up|1|||
27935047|NCT03164356|81600805|FG002|Overall Study|Lost to Follow-up|2|||
27935048|NCT03164356|81600806|FG003|Overall Study|Lost to Follow-up|1|||
27935049|NCT03164356|81600803|FG000|Overall Study|Physician Decision|0|||
27935050|NCT03164356|81600804|FG001|Overall Study|Physician Decision|0|||
27935051|NCT03164356|81600805|FG002|Overall Study|Physician Decision|3|||
27935052|NCT03164356|81600806|FG003|Overall Study|Physician Decision|0|||
27935053|NCT03164356|81600803|FG000|Overall Study|Protocol Violation|2|||
27935054|NCT03164356|81600804|FG001|Overall Study|Protocol Violation|1|||
27935055|NCT03164356|81600805|FG002|Overall Study|Protocol Violation|0|||
27935056|NCT03164356|81600806|FG003|Overall Study|Protocol Violation|0|||
27935057|NCT03164356|81600803|FG000|Overall Study|Withdrawal by Subject|1|||
27935058|NCT03164356|81600804|FG001|Overall Study|Withdrawal by Subject|0|||
27935059|NCT03164356|81600805|FG002|Overall Study|Withdrawal by Subject|0|||
27935060|NCT03164356|81600806|FG003|Overall Study|Withdrawal by Subject|0|||
27935061|NCT03164356|81600803|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
27935062|NCT03164356|81600804|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
27935063|NCT03164356|81600805|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
27935064|NCT03164356|81600806|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
27935065|NCT03164356|81600803|FG000|Overall Study|Subject Incarcerated|0|||
27935066|NCT03164356|81600804|FG001|Overall Study|Subject Incarcerated|1|||
27935067|NCT03164356|81600805|FG002|Overall Study|Subject Incarcerated|0|||
27935068|NCT03164356|81600806|FG003|Overall Study|Subject Incarcerated|0|||
27935069|NCT03164356|81600803|FG000|Overall Study|Prosthetist unable to participate|0|||
27642938|NCT03611075|80536304|FG001|Overall Study|Physician Decision|1|||
27642939|NCT03611075|80536305|FG002|Overall Study|Physician Decision|1|||
27935070|NCT03164356|81600804|FG001|Overall Study|Prosthetist unable to participate|2|||
27935071|NCT03164356|81600805|FG002|Overall Study|Prosthetist unable to participate|1|||
27935072|NCT03164356|81600806|FG003|Overall Study|Prosthetist unable to participate|0|||
27935073|NCT03437733|81600809|FG000|Overall Study|Eligibility criteria not met|0|||
27935074|NCT03437733|81600810|FG001|Overall Study|Eligibility criteria not met|3|||
27935075|NCT03335566|81600811|FG000|Overall Study|Adverse Event|0|||
27935076|NCT03335566|81600812|FG001|Overall Study|Adverse Event|1|||
27935077|NCT03335566|81600811|FG000|Overall Study|Lost to Follow-up|1|||
27935078|NCT03335566|81600812|FG001|Overall Study|Lost to Follow-up|0|||
27935079|NCT03335566|81600811|FG000|Overall Study|Technical Problems|1|||
27935080|NCT03335566|81600812|FG001|Overall Study|Technical Problems|0|||
27935081|NCT03335566|81600811|FG000|Overall Study|Protocol Violation|1|||
27935082|NCT03335566|81600812|FG001|Overall Study|Protocol Violation|0|||
27935083|NCT03335566|81600811|FG000|Overall Study|Other than specified above|1|||
27935084|NCT03335566|81600812|FG001|Overall Study|Other than specified above|2|||
27935085|NCT02739828|81600813|FG000|Overall Study|Adverse Event|1|||
27935086|NCT02739828|81600813|FG000|Overall Study|Lost to Follow-up|4|||
27935087|NCT01524705|81600814|FG000|Overall Study|Adverse Event|2|||
27935088|NCT01524705|81600815|FG001|Overall Study|Adverse Event|0|||
27935089|NCT01524705|81600814|FG000|Overall Study|Death|1|||
27935090|NCT01524705|81600815|FG001|Overall Study|Death|0|||
27935091|NCT01524705|81600814|FG000|Overall Study|Lost to Follow-up|0|||
27935092|NCT01524705|81600815|FG001|Overall Study|Lost to Follow-up|1|||
27935093|NCT01524705|81600814|FG000|Overall Study|Withdrawal by Subject|0|||
27935094|NCT01524705|81600815|FG001|Overall Study|Withdrawal by Subject|1|||
27935095|NCT01524705|81600814|FG000|Overall Study|Pancreatic Cancer|0|||
27935096|NCT01524705|81600815|FG001|Overall Study|Pancreatic Cancer|1|||
27935097|NCT00414609|81600818|FG000|Core Study|Adverse Event|9|||
27935098|NCT00414609|81600819|FG001|Core Study|Adverse Event|11|||
27935099|NCT00414609|81600820|FG002|Core Study|Adverse Event|0|||
27935100|NCT00414609|81600818|FG000|Core Study|Abnormal laboratory values|0|||
27935101|NCT00414609|81600819|FG001|Core Study|Abnormal laboratory values|1|||
27935102|NCT00414609|81600820|FG002|Core Study|Abnormal laboratory values|0|||
27642940|NCT03611075|80536306|FG003|Overall Study|Physician Decision|0|||
27642941|NCT03611075|80536307|FG004|Overall Study|Physician Decision|0|||
27642942|NCT03611075|80536308|FG005|Overall Study|Physician Decision|0|||
27642943|NCT03611075|80536309|FG006|Overall Study|Physician Decision|0|||
27642944|NCT03611075|80536310|FG007|Overall Study|Physician Decision|0|||
27642945|NCT03611075|80536311|FG008|Overall Study|Physician Decision|0|||
27642946|NCT03611075|80536303|FG000|Overall Study|Lost to Follow-up|1|||
27642947|NCT03611075|80536304|FG001|Overall Study|Lost to Follow-up|0|||
27550838|NCT03672747|80203512|FG004|Overall Study|Lost to Follow-up|2|||
27550839|NCT03672747|80203513|FG005|Overall Study|Lost to Follow-up|1|||
27550840|NCT01919723|80203514|FG000|Overall Study|Blood Samples Hemolyzed|2|||
27550841|NCT01919723|80203515|FG001|Overall Study|Blood Samples Hemolyzed|2|||
27550842|NCT02310568|80203517|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
27550843|NCT02310568|80203518|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
27550844|NCT02310568|80203519|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
27550845|NCT02310568|80203520|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
27550846|NCT02310568|80203521|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
27550847|NCT02310568|80203517|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
27550848|NCT02310568|80203518|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
27550849|NCT02310568|80203519|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
27550850|NCT02310568|80203520|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
27550851|NCT02310568|80203521|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
27550852|NCT02310568|80203517|FG000|Stage 1 ( 4 Weeks)|Other|1|||
27642948|NCT03611075|80536305|FG002|Overall Study|Lost to Follow-up|0|||
27642949|NCT03611075|80536306|FG003|Overall Study|Lost to Follow-up|2|||
27642950|NCT03611075|80536307|FG004|Overall Study|Lost to Follow-up|0|||
27642951|NCT03611075|80536308|FG005|Overall Study|Lost to Follow-up|0|||
27642952|NCT03611075|80536309|FG006|Overall Study|Lost to Follow-up|0|||
27642953|NCT03611075|80536310|FG007|Overall Study|Lost to Follow-up|0|||
27642954|NCT03611075|80536311|FG008|Overall Study|Lost to Follow-up|0|||
27642955|NCT03611075|80536303|FG000|Overall Study|Withdrawal by Subject|0|||
27642956|NCT03611075|80536304|FG001|Overall Study|Withdrawal by Subject|1|||
27642957|NCT03611075|80536305|FG002|Overall Study|Withdrawal by Subject|1|||
27642958|NCT03611075|80536306|FG003|Overall Study|Withdrawal by Subject|1|||
27642959|NCT03611075|80536307|FG004|Overall Study|Withdrawal by Subject|0|||
27642960|NCT03611075|80536308|FG005|Overall Study|Withdrawal by Subject|0|||
27642961|NCT03611075|80536309|FG006|Overall Study|Withdrawal by Subject|1|||
27642962|NCT03611075|80536310|FG007|Overall Study|Withdrawal by Subject|0|||
27642963|NCT03611075|80536311|FG008|Overall Study|Withdrawal by Subject|0|||
27642964|NCT03611075|80536303|FG000|Overall Study|Reason unknown|0|||
27743664|NCT02168946|80892648|FG000|Overall Study|Subject unable to come back for visits|1|||
27743665|NCT02168946|80892649|FG001|Overall Study|Subject unable to come back for visits|0|||
27642965|NCT03611075|80536304|FG001|Overall Study|Reason unknown|0|||
27642966|NCT03611075|80536305|FG002|Overall Study|Reason unknown|0|||
27642967|NCT03611075|80536306|FG003|Overall Study|Reason unknown|1|||
27935103|NCT00414609|81600818|FG000|Core Study|Abnormal test procedure results|1|||
27935104|NCT00414609|81600819|FG001|Core Study|Abnormal test procedure results|1|||
27935105|NCT00414609|81600820|FG002|Core Study|Abnormal test procedure results|0|||
27935106|NCT00414609|81600818|FG000|Core Study|Protocol deviation|0|||
27642968|NCT03611075|80536307|FG004|Overall Study|Reason unknown|0|||
27935107|NCT00414609|81600819|FG001|Core Study|Protocol deviation|1|||
27935108|NCT00414609|81600820|FG002|Core Study|Protocol deviation|0|||
27642969|NCT03611075|80536308|FG005|Overall Study|Reason unknown|0|||
27642970|NCT03611075|80536309|FG006|Overall Study|Reason unknown|1|||
27642971|NCT03611075|80536310|FG007|Overall Study|Reason unknown|0|||
27642972|NCT03611075|80536311|FG008|Overall Study|Reason unknown|0|||
27642973|NCT00989196|80536312|FG000|Treatment Period|Lost to Follow-up|1|||
27642974|NCT00989196|80536313|FG001|Treatment Period|Lost to Follow-up|0|||
27642975|NCT00246805|80536316|FG000|Phase 1|Lost to Follow-up|1|||
27642976|NCT00246805|80536317|FG001|Phase 1|Lost to Follow-up|0|||
27642977|NCT01953224|80536318|FG000|Overall Study|Lost to Follow-up|1|||
27642978|NCT01953224|80536319|FG001|Overall Study|Lost to Follow-up|1|||
27642979|NCT01953224|80536318|FG000|Overall Study|Withdrawal by Subject|1|||
27642980|NCT01953224|80536319|FG001|Overall Study|Withdrawal by Subject|2|||
27642981|NCT04579250|80536320|FG000|Overall Study|Withdrawal by Subject|1|||
27642982|NCT04579250|80536321|FG001|Overall Study|Withdrawal by Subject|1|||
27642983|NCT04579250|80536322|FG002|Overall Study|Withdrawal by Subject|0|||
27642984|NCT04579250|80536320|FG000|Overall Study|Lost to Follow-up|1|||
27642985|NCT04579250|80536321|FG001|Overall Study|Lost to Follow-up|1|||
27642986|NCT04579250|80536322|FG002|Overall Study|Lost to Follow-up|0|||
27642987|NCT04579250|80536320|FG000|Overall Study|Moved from area|0|||
27743666|NCT02213198|80892650|FG000|Baseline|No show for intake|7|||
27743667|NCT02213198|80892651|FG001|Baseline|No show for intake|9|||
27935109|NCT00414609|81600818|FG000|Core Study|Patient withdrew consent|10|||
27935110|NCT00414609|81600819|FG001|Core Study|Patient withdrew consent|11|||
27935111|NCT00414609|81600820|FG002|Core Study|Patient withdrew consent|0|||
27935112|NCT00414609|81600818|FG000|Core Study|Lost to Follow-up|7|||
27935113|NCT00414609|81600819|FG001|Core Study|Lost to Follow-up|4|||
27935114|NCT00414609|81600820|FG002|Core Study|Lost to Follow-up|0|||
27935115|NCT00414609|81600818|FG000|Core Study|Administrative problems|0|||
27935116|NCT00414609|81600819|FG001|Core Study|Administrative problems|2|||
27935117|NCT00414609|81600820|FG002|Core Study|Administrative problems|0|||
27935118|NCT00414609|81600818|FG000|Core Study|Death|7|||
27935119|NCT00414609|81600819|FG001|Core Study|Death|14|||
27935120|NCT00414609|81600820|FG002|Core Study|Death|0|||
27935121|NCT00414609|81600818|FG000|Extension Study|Adverse Event|0|||
27935122|NCT00414609|81600819|FG001|Extension Study|Adverse Event|0|||
27935123|NCT00414609|81600820|FG002|Extension Study|Adverse Event|14|||
27935124|NCT00414609|81600818|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
27935125|NCT00414609|81600819|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
27935126|NCT00414609|81600820|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
27935127|NCT00414609|81600818|FG000|Extension Study|Withdrawal by Subject|0|||
27935128|NCT00414609|81600819|FG001|Extension Study|Withdrawal by Subject|0|||
27935129|NCT00414609|81600820|FG002|Extension Study|Withdrawal by Subject|13|||
27935130|NCT00414609|81600818|FG000|Extension Study|Lost to Follow-up|0|||
27935131|NCT00414609|81600819|FG001|Extension Study|Lost to Follow-up|0|||
27935132|NCT00414609|81600820|FG002|Extension Study|Lost to Follow-up|10|||
27935133|NCT00414609|81600818|FG000|Extension Study|Administrative problems|0|||
27935134|NCT00414609|81600819|FG001|Extension Study|Administrative problems|0|||
27935135|NCT00414609|81600820|FG002|Extension Study|Administrative problems|1|||
27935136|NCT00414609|81600818|FG000|Extension Study|Death|0|||
27935137|NCT00414609|81600819|FG001|Extension Study|Death|0|||
27935138|NCT00414609|81600820|FG002|Extension Study|Death|17|||
27935139|NCT03055221|81600821|FG000|Overall Study|Adverse Event|2|||
27935140|NCT03055221|81600821|FG000|Overall Study|Withdrawal by Subject|4|||
27935141|NCT03055221|81600821|FG000|Overall Study|Death|6|||
27935142|NCT03055221|81600821|FG000|Overall Study|Physician Decision|1|||
27935143|NCT03055221|81600821|FG000|Overall Study|Study terminated by Sponsor|3|||
27935144|NCT03055221|81600821|FG000|Overall Study|Lost to Follow-up|4|||
27935145|NCT01441414|81600822|FG000|Overall Study|Participant died|9|||
27935146|NCT01441414|81600822|FG000|Overall Study|Other reasons|3|||
27935147|NCT01441414|81600822|FG000|Overall Study|Study terminated by sponsor|2|||
27935148|NCT01441414|81600822|FG000|Overall Study|Subject refused further follow-up|1|||
27935149|NCT01229111|81600823|FG000|Overall Study|Death|1|||
27935150|NCT03436420|81600830|FG000|Overall Study|Lack of Efficacy|3|||
27935151|NCT05059080|81600831|FG000|Overall Study|Withdrawal by Subject|3|||
27935152|NCT05059080|81600831|FG000|Overall Study|Study Terminated by Sponsor|64|||
27935153|NCT02369159|81600832|FG000|Overall Study|Adverse Event|0|||
27935154|NCT02369159|81600833|FG001|Overall Study|Adverse Event|1|||
27935155|NCT02369159|81600832|FG000|Overall Study|Lost to Follow-up|1|||
27935156|NCT02369159|81600833|FG001|Overall Study|Lost to Follow-up|1|||
27935157|NCT02369159|81600832|FG000|Overall Study|Withdrawal by Subject|7|||
27935158|NCT02369159|81600833|FG001|Overall Study|Withdrawal by Subject|0|||
27935159|NCT00395512|81600837|FG000|Overall Study|Adverse Event|3|||
27935160|NCT00395512|81600838|FG001|Overall Study|Adverse Event|8|||
27935161|NCT00395512|81600839|FG002|Overall Study|Adverse Event|6|||
27642988|NCT04579250|80536321|FG001|Overall Study|Moved from area|1|||
27642989|NCT04579250|80536322|FG002|Overall Study|Moved from area|2|||
27935162|NCT00395512|81600840|FG003|Overall Study|Adverse Event|6|||
27935163|NCT00395512|81600837|FG000|Overall Study|Protocol Violation|2|||
27935164|NCT00395512|81600838|FG001|Overall Study|Protocol Violation|3|||
27935165|NCT00395512|81600839|FG002|Overall Study|Protocol Violation|6|||
27935166|NCT00395512|81600840|FG003|Overall Study|Protocol Violation|7|||
27935167|NCT00395512|81600837|FG000|Overall Study|Lost to Follow-up|2|||
27935168|NCT00395512|81600838|FG001|Overall Study|Lost to Follow-up|6|||
27935169|NCT00395512|81600839|FG002|Overall Study|Lost to Follow-up|5|||
27935170|NCT00395512|81600840|FG003|Overall Study|Lost to Follow-up|5|||
27935171|NCT00395512|81600837|FG000|Overall Study|Withdrawal by Subject|6|||
27935172|NCT00395512|81600838|FG001|Overall Study|Withdrawal by Subject|5|||
27935173|NCT00395512|81600839|FG002|Overall Study|Withdrawal by Subject|5|||
27935174|NCT00395512|81600840|FG003|Overall Study|Withdrawal by Subject|12|||
27935175|NCT00395512|81600837|FG000|Overall Study|Physician Decision|6|||
27935176|NCT00395512|81600838|FG001|Overall Study|Physician Decision|4|||
27935177|NCT00395512|81600839|FG002|Overall Study|Physician Decision|2|||
27935178|NCT00395512|81600840|FG003|Overall Study|Physician Decision|2|||
27935179|NCT00395512|81600837|FG000|Overall Study|Other|1|||
27935180|NCT00395512|81600838|FG001|Overall Study|Other|1|||
27935181|NCT00395512|81600839|FG002|Overall Study|Other|0|||
27935182|NCT00395512|81600840|FG003|Overall Study|Other|0|||
27935183|NCT00395512|81600837|FG000|Overall Study|Hyperglycemic Rescue|18|||
27935184|NCT00395512|81600838|FG001|Overall Study|Hyperglycemic Rescue|10|||
27935185|NCT00395512|81600839|FG002|Overall Study|Hyperglycemic Rescue|4|||
27935186|NCT00395512|81600840|FG003|Overall Study|Hyperglycemic Rescue|6|||
27935187|NCT04621760|81600842|FG000|Overall Study|Lost to Follow-up|2|||
27935188|NCT04621760|81600843|FG001|Overall Study|Lost to Follow-up|4|||
27935189|NCT04621760|81600842|FG000|Overall Study|Withdrawal by Subject|1|||
27935190|NCT04621760|81600843|FG001|Overall Study|Withdrawal by Subject|0|||
27935191|NCT03174275|81600844|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
27935192|NCT03174275|81600844|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
27935193|NCT03174275|81600844|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
27935194|NCT03174275|81600844|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
27935195|NCT03174275|81600844|FG000|Adjuvant Chemotherapy|Progression|1|||
27935196|NCT03174275|81600844|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
27935197|NCT03174275|81600844|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
27935198|NCT03174275|81600844|FG000|Adjuvant Durvalumab|Progression|1|||
27935199|NCT03174275|81600844|FG000|Adjuvant Durvalumab|Adverse Event|3|||
27935200|NCT03174275|81600844|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
27935201|NCT03174275|81600844|FG000|Adjuvant Radiotherapy|Progression|1|||
27935202|NCT03174275|81600844|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
27935203|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
27935204|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
27935205|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
27935206|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
27935207|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
27642990|NCT03861052|80536325|FG000|Overall Study|Adverse Event|1|||
27642991|NCT03861052|80536326|FG001|Overall Study|Adverse Event|1|||
27642992|NCT03861052|80536327|FG002|Overall Study|Adverse Event|2|||
27642993|NCT03861052|80536328|FG003|Overall Study|Adverse Event|4|||
27642994|NCT03861052|80536325|FG000|Overall Study|Lost to Follow-up|0|||
27642995|NCT03861052|80536326|FG001|Overall Study|Lost to Follow-up|0|||
27642996|NCT03861052|80536327|FG002|Overall Study|Lost to Follow-up|0|||
27642997|NCT03861052|80536328|FG003|Overall Study|Lost to Follow-up|1|||
27743668|NCT02213198|80892650|FG000|Baseline|Withdrawal by Subject|34|||
27743669|NCT02213198|80892651|FG001|Baseline|Withdrawal by Subject|11|||
27743670|NCT02213198|80892650|FG000|Baseline|transferred out of clinic|7|||
27743671|NCT02213198|80892651|FG001|Baseline|transferred out of clinic|9|||
27743672|NCT02213198|80892650|FG000|Baseline|Lost to Follow-up|40|||
27743673|NCT02213198|80892651|FG001|Baseline|Lost to Follow-up|21|||
27743674|NCT02213198|80892650|FG000|Baseline|incarcerated,violent|0|||
27743675|NCT02213198|80892651|FG001|Baseline|incarcerated,violent|1|||
27743676|NCT02213198|80892650|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
27743677|NCT02213198|80892651|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
27935208|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
27935209|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
27935210|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
27935211|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
27743678|NCT02213198|80892650|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
27935212|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
27935213|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
27935214|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
27935215|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
27935216|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
27935217|NCT00976391|81600845|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
27642998|NCT03861052|80536325|FG000|Overall Study|Physician Decision|0|||
27642999|NCT03861052|80536326|FG001|Overall Study|Physician Decision|1|||
27643000|NCT03861052|80536327|FG002|Overall Study|Physician Decision|0|||
27643001|NCT03861052|80536328|FG003|Overall Study|Physician Decision|0|||
27643002|NCT03861052|80536325|FG000|Overall Study|Withdrawal by Subject|2|||
27743679|NCT02213198|80892651|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
27743680|NCT02213198|80892650|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
27743681|NCT02213198|80892651|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
27643003|NCT03861052|80536326|FG001|Overall Study|Withdrawal by Subject|5|||
27643004|NCT03861052|80536327|FG002|Overall Study|Withdrawal by Subject|3|||
27643005|NCT03861052|80536328|FG003|Overall Study|Withdrawal by Subject|0|||
27643006|NCT03861052|80536325|FG000|Overall Study|Relocation to other city|1|||
27643007|NCT03861052|80536326|FG001|Overall Study|Relocation to other city|0|||
27643008|NCT03861052|80536327|FG002|Overall Study|Relocation to other city|0|||
27643009|NCT03861052|80536328|FG003|Overall Study|Relocation to other city|0|||
27643010|NCT02023866|80536329|FG000|Overall Study|Non-compliance|2|||
27643011|NCT02023866|80536329|FG000|Overall Study|Adverse Event|3|||
27643012|NCT02023866|80536329|FG000|Overall Study|Withdrawal by Subject|1|||
27743682|NCT02213198|80892650|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
27743683|NCT02213198|80892651|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
27643013|NCT02675244|80536330|FG000|Overall Study|Death|9|||
27643014|NCT02675244|80536331|FG001|Overall Study|Death|6|||
27643015|NCT02675244|80536330|FG000|Overall Study|Withdrawal by Subject|3|||
27643016|NCT02675244|80536331|FG001|Overall Study|Withdrawal by Subject|6|||
27643017|NCT02675244|80536330|FG000|Overall Study|Lost to Follow-up|1|||
27643018|NCT02675244|80536331|FG001|Overall Study|Lost to Follow-up|1|||
27643019|NCT02675244|80536330|FG000|Overall Study|Ongoing at 2 Years|190|||
27643020|NCT02675244|80536331|FG001|Overall Study|Ongoing at 2 Years|185|||
27643021|NCT02285270|80536332|FG000|Overall Study|Lost to Follow-up|1|||
27643022|NCT02285270|80536332|FG000|Overall Study|Physician Decision|3|||
27643023|NCT02285270|80536332|FG000|Overall Study|Determined to be ineligible|1|||
27643024|NCT00943917|80536334|FG000|Stage I|Adverse Event|1|||
27643025|NCT00943917|80536335|FG001|Stage I|Adverse Event|2|||
27643026|NCT00943917|80536336|FG002|Stage I|Adverse Event|2|||
27643027|NCT00943917|80536337|FG003|Stage I|Adverse Event|0|||
27643028|NCT00943917|80536338|FG004|Stage I|Adverse Event|0|||
27643029|NCT00943917|80536339|FG005|Stage I|Adverse Event|0|||
27643030|NCT00943917|80536340|FG006|Stage I|Adverse Event|0|||
27743684|NCT02213198|80892650|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
27743685|NCT02213198|80892651|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
27743686|NCT02213198|80892650|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
27935218|NCT00976391|81600846|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
27935219|NCT00976391|81600845|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
27935220|NCT00976391|81600846|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
27935221|NCT00976391|81600845|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
27935222|NCT00976391|81600846|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
27935223|NCT00976391|81600845|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
27743687|NCT02213198|80892651|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
27743688|NCT02203838|80892652|FG000|Overall Study|Lack of Efficacy|7|||
27935224|NCT00976391|81600846|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
27935225|NCT00976391|81600845|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
27935226|NCT00976391|81600846|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
27935227|NCT00976391|81600845|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
27935228|NCT00976391|81600846|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
27935229|NCT00976391|81600845|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
27935230|NCT00976391|81600846|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
27935231|NCT05427916|81600847|FG000|Overall Study|Adverse Event|3|||
27935232|NCT05427916|81600848|FG001|Overall Study|Adverse Event|0|||
27935233|NCT05427916|81600847|FG000|Overall Study|Lack of Efficacy|6|||
27935234|NCT05427916|81600848|FG001|Overall Study|Lack of Efficacy|0|||
27935235|NCT05427916|81600847|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
27935236|NCT05427916|81600848|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
27935237|NCT01663987|81600849|FG000|Overall Study|Adverse Event|7|||
27935238|NCT01663987|81600850|FG001|Overall Study|Adverse Event|2|||
27935239|NCT01663987|81600849|FG000|Overall Study|Lost to Follow-up|1|||
27935240|NCT01663987|81600850|FG001|Overall Study|Lost to Follow-up|1|||
27935241|NCT01663987|81600849|FG000|Overall Study|Withdrawal by Subject|2|||
27935242|NCT01663987|81600850|FG001|Overall Study|Withdrawal by Subject|3|||
27935243|NCT01663987|81600849|FG000|Overall Study|Other reason not defined above|3|||
27935244|NCT01663987|81600850|FG001|Overall Study|Other reason not defined above|0|||
27935245|NCT00800384|81600851|FG000|Overall Study|Withdrawal by Subject|24|||
27935246|NCT00800384|81600852|FG001|Overall Study|Withdrawal by Subject|17|||
27743689|NCT02203838|80892653|FG001|Overall Study|Lack of Efficacy|0|||
27643031|NCT00943917|80536341|FG007|Stage I|Adverse Event|0|||
27743690|NCT02203838|80892654|FG002|Overall Study|Lack of Efficacy|1|||
27643032|NCT00943917|80536342|FG008|Stage I|Adverse Event|0|||
27643033|NCT00943917|80536343|FG009|Stage I|Adverse Event|0|||
27643034|NCT00943917|80536344|FG010|Stage I|Adverse Event|0|||
27643035|NCT00943917|80536345|FG011|Stage I|Adverse Event|0|||
27643036|NCT00943917|80536346|FG012|Stage I|Adverse Event|0|||
27935247|NCT00800384|81600851|FG000|Overall Study|Lost to Follow-up|17|||
27935248|NCT00800384|81600852|FG001|Overall Study|Lost to Follow-up|26|||
27935249|NCT00394472|81600853|FG000|Overall Study|Protocol Violation|1|||
27935250|NCT00394472|81600854|FG001|Overall Study|Protocol Violation|3|||
27935251|NCT00394472|81600853|FG000|Overall Study|incorrect enrolment|4|||
27935252|NCT00394472|81600854|FG001|Overall Study|incorrect enrolment|2|||
27743691|NCT02203838|80892655|FG003|Overall Study|Lack of Efficacy|1|||
27743692|NCT02203838|80892652|FG000|Overall Study|Adverse Event|46|||
27743693|NCT02203838|80892653|FG001|Overall Study|Adverse Event|6|||
27743694|NCT02203838|80892654|FG002|Overall Study|Adverse Event|3|||
27743695|NCT02203838|80892655|FG003|Overall Study|Adverse Event|2|||
27743696|NCT02203838|80892652|FG000|Overall Study|Lost to Follow-up|39|||
27743697|NCT02203838|80892653|FG001|Overall Study|Lost to Follow-up|3|||
27743698|NCT02203838|80892654|FG002|Overall Study|Lost to Follow-up|2|||
27743699|NCT02203838|80892655|FG003|Overall Study|Lost to Follow-up|1|||
27743700|NCT02203838|80892652|FG000|Overall Study|Protocol Violation|7|||
27743701|NCT02203838|80892653|FG001|Overall Study|Protocol Violation|3|||
27743702|NCT02203838|80892654|FG002|Overall Study|Protocol Violation|0|||
27743703|NCT02203838|80892655|FG003|Overall Study|Protocol Violation|0|||
27935253|NCT00394472|81600853|FG000|Overall Study|Adverse Event|4|||
27935254|NCT00394472|81600854|FG001|Overall Study|Adverse Event|2|||
27935255|NCT00394472|81600853|FG000|Overall Study|Withdrawal by Subject|0|||
27935256|NCT00394472|81600854|FG001|Overall Study|Withdrawal by Subject|2|||
27935257|NCT00394472|81600853|FG000|Overall Study|Physician Decision|0|||
27935258|NCT00394472|81600854|FG001|Overall Study|Physician Decision|1|||
27935259|NCT00394472|81600853|FG000|Overall Study|Lost to Follow-up|0|||
27935260|NCT00394472|81600854|FG001|Overall Study|Lost to Follow-up|1|||
27935261|NCT02383173|81600855|FG000|Overall Study|Palliative Care Team withdrew|0|||
27935262|NCT02383173|81600856|FG001|Overall Study|Palliative Care Team withdrew|2|||
27935263|NCT01529112|81600863|FG000|Overall Study|Adverse Event|2|||
27935264|NCT01529112|81600864|FG001|Overall Study|Adverse Event|0|||
27550853|NCT02310568|80203518|FG001|Stage 1 ( 4 Weeks)|Other|1|||
27550854|NCT02310568|80203519|FG002|Stage 1 ( 4 Weeks)|Other|0|||
27550855|NCT02310568|80203520|FG003|Stage 1 ( 4 Weeks)|Other|0|||
27550856|NCT02310568|80203521|FG004|Stage 1 ( 4 Weeks)|Other|0|||
27550857|NCT02310568|80203517|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
27550858|NCT02310568|80203518|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
27550859|NCT02310568|80203519|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
27550860|NCT02310568|80203520|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
27550861|NCT02310568|80203521|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
27550862|NCT02310568|80203517|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
27550863|NCT02310568|80203518|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
27550864|NCT02310568|80203519|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
27550865|NCT02310568|80203520|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
27550866|NCT02310568|80203521|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
27550867|NCT02310568|80203517|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
27550868|NCT02310568|80203518|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
27550869|NCT02310568|80203519|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
27550870|NCT02310568|80203520|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
27550871|NCT02310568|80203521|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
27550872|NCT02310568|80203517|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
27550873|NCT02310568|80203518|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
27550874|NCT02310568|80203519|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
27550875|NCT02310568|80203520|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
27550876|NCT02310568|80203521|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
27550877|NCT02310568|80203517|FG000|Stage 2 (4 Weeks)|Other|0|||
27550878|NCT02310568|80203518|FG001|Stage 2 (4 Weeks)|Other|1|||
27550879|NCT02310568|80203519|FG002|Stage 2 (4 Weeks)|Other|1|||
27550880|NCT02310568|80203520|FG003|Stage 2 (4 Weeks)|Other|0|||
27550881|NCT02310568|80203521|FG004|Stage 2 (4 Weeks)|Other|0|||
27550882|NCT02310568|80203517|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
27550883|NCT02310568|80203518|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
27550884|NCT02310568|80203519|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
27550885|NCT02310568|80203520|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
27550886|NCT02310568|80203521|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
27550887|NCT02310568|80203517|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
27550888|NCT02310568|80203518|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
27550889|NCT02310568|80203519|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
27550890|NCT02310568|80203520|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
27743704|NCT02203838|80892652|FG000|Overall Study|Withdrawal by Subject|83|||
27743705|NCT02203838|80892653|FG001|Overall Study|Withdrawal by Subject|10|||
27743706|NCT02203838|80892654|FG002|Overall Study|Withdrawal by Subject|8|||
27743707|NCT02203838|80892655|FG003|Overall Study|Withdrawal by Subject|11|||
27743708|NCT02203838|80892652|FG000|Overall Study|Physician Decision|27|||
27935265|NCT01529112|81600863|FG000|Overall Study|Death|59|||
27935266|NCT01529112|81600864|FG001|Overall Study|Death|38|||
27935267|NCT01529112|81600863|FG000|Overall Study|Protocol Violation|1|||
27935268|NCT01529112|81600864|FG001|Overall Study|Protocol Violation|0|||
27743709|NCT02203838|80892653|FG001|Overall Study|Physician Decision|0|||
27743710|NCT02203838|80892654|FG002|Overall Study|Physician Decision|2|||
27743711|NCT02203838|80892655|FG003|Overall Study|Physician Decision|3|||
27935269|NCT01529112|81600863|FG000|Overall Study|Withdrawal by Subject|7|||
27935270|NCT01529112|81600864|FG001|Overall Study|Withdrawal by Subject|3|||
27935271|NCT00378560|81600875|FG000|Overall Study|Adverse Event|1|||
27935272|NCT00378560|81600876|FG001|Overall Study|Adverse Event|0|||
27935273|NCT00378560|81600875|FG000|Overall Study|Lost to Follow-up|24|||
27935274|NCT00378560|81600876|FG001|Overall Study|Lost to Follow-up|29|||
27935275|NCT00378560|81600875|FG000|Overall Study|Protocol Violation|2|||
27935276|NCT00378560|81600876|FG001|Overall Study|Protocol Violation|0|||
27935277|NCT00378560|81600875|FG000|Overall Study|Withdrawal by Subject|17|||
27643037|NCT00943917|80536347|FG013|Stage I|Adverse Event|0|||
27643038|NCT00943917|80536348|FG014|Stage I|Adverse Event|0|||
27643039|NCT00943917|80536334|FG000|Stage I|Lost to Follow-up|0|||
27643040|NCT00943917|80536335|FG001|Stage I|Lost to Follow-up|0|||
27643041|NCT00943917|80536336|FG002|Stage I|Lost to Follow-up|1|||
27643042|NCT00943917|80536337|FG003|Stage I|Lost to Follow-up|0|||
27643043|NCT00943917|80536338|FG004|Stage I|Lost to Follow-up|0|||
27643044|NCT00943917|80536339|FG005|Stage I|Lost to Follow-up|0|||
27643045|NCT00943917|80536340|FG006|Stage I|Lost to Follow-up|0|||
27643046|NCT00943917|80536341|FG007|Stage I|Lost to Follow-up|0|||
27643047|NCT00943917|80536342|FG008|Stage I|Lost to Follow-up|0|||
27643048|NCT00943917|80536343|FG009|Stage I|Lost to Follow-up|0|||
27643049|NCT00943917|80536344|FG010|Stage I|Lost to Follow-up|0|||
27643050|NCT00943917|80536345|FG011|Stage I|Lost to Follow-up|0|||
27643051|NCT00943917|80536346|FG012|Stage I|Lost to Follow-up|0|||
27643052|NCT00943917|80536347|FG013|Stage I|Lost to Follow-up|0|||
27643053|NCT00943917|80536348|FG014|Stage I|Lost to Follow-up|0|||
27643054|NCT00943917|80536334|FG000|Stage I|hyperglycemia|0|||
27643055|NCT00943917|80536335|FG001|Stage I|hyperglycemia|0|||
27643056|NCT00943917|80536336|FG002|Stage I|hyperglycemia|1|||
27643057|NCT00943917|80536337|FG003|Stage I|hyperglycemia|0|||
27643058|NCT00943917|80536338|FG004|Stage I|hyperglycemia|0|||
27643059|NCT00943917|80536339|FG005|Stage I|hyperglycemia|0|||
27643060|NCT00943917|80536340|FG006|Stage I|hyperglycemia|0|||
27643061|NCT00943917|80536341|FG007|Stage I|hyperglycemia|0|||
27643062|NCT00943917|80536342|FG008|Stage I|hyperglycemia|0|||
27643063|NCT00943917|80536343|FG009|Stage I|hyperglycemia|0|||
27643064|NCT00943917|80536344|FG010|Stage I|hyperglycemia|0|||
27643065|NCT00943917|80536345|FG011|Stage I|hyperglycemia|0|||
27643066|NCT00943917|80536346|FG012|Stage I|hyperglycemia|0|||
27643067|NCT00943917|80536347|FG013|Stage I|hyperglycemia|0|||
27643068|NCT00943917|80536348|FG014|Stage I|hyperglycemia|0|||
27643069|NCT00943917|80536334|FG000|Stage I|A1C elevation|1|||
27643070|NCT00943917|80536335|FG001|Stage I|A1C elevation|0|||
27643071|NCT00943917|80536336|FG002|Stage I|A1C elevation|0|||
27643072|NCT00943917|80536337|FG003|Stage I|A1C elevation|0|||
27643073|NCT00943917|80536338|FG004|Stage I|A1C elevation|0|||
27643074|NCT00943917|80536339|FG005|Stage I|A1C elevation|0|||
27643075|NCT00943917|80536340|FG006|Stage I|A1C elevation|0|||
27643076|NCT00943917|80536341|FG007|Stage I|A1C elevation|0|||
27643077|NCT00943917|80536342|FG008|Stage I|A1C elevation|0|||
27643078|NCT00943917|80536343|FG009|Stage I|A1C elevation|0|||
27643079|NCT00943917|80536344|FG010|Stage I|A1C elevation|0|||
27643080|NCT00943917|80536345|FG011|Stage I|A1C elevation|0|||
27935278|NCT00378560|81600876|FG001|Overall Study|Withdrawal by Subject|21|||
27935279|NCT00378560|81600875|FG000|Overall Study|Moved|4|||
27935280|NCT00378560|81600876|FG001|Overall Study|Moved|3|||
27935281|NCT00378560|81600875|FG000|Overall Study|Pregnancy|7|||
27935282|NCT00378560|81600876|FG001|Overall Study|Pregnancy|5|||
27935283|NCT00378560|81600875|FG000|Overall Study|Laboratory test values abnormal|1|||
27643081|NCT00943917|80536346|FG012|Stage I|A1C elevation|0|||
27643082|NCT00943917|80536347|FG013|Stage I|A1C elevation|0|||
27643083|NCT00943917|80536348|FG014|Stage I|A1C elevation|0|||
27935284|NCT00378560|81600876|FG001|Overall Study|Laboratory test values abnormal|0|||
27643084|NCT00943917|80536334|FG000|Stage I|Withdrawal by Subject|2|||
27743712|NCT02203838|80892652|FG000|Overall Study|Other|1|||
27743713|NCT02203838|80892653|FG001|Overall Study|Other|0|||
27743714|NCT02203838|80892654|FG002|Overall Study|Other|0|||
27743715|NCT02203838|80892655|FG003|Overall Study|Other|0|||
27935285|NCT00300495|81600878|FG000|Overall Study|Protocol Violation|4|||
27643085|NCT00943917|80536335|FG001|Stage I|Withdrawal by Subject|1|||
27643086|NCT00943917|80536336|FG002|Stage I|Withdrawal by Subject|2|||
27643087|NCT00943917|80536337|FG003|Stage I|Withdrawal by Subject|0|||
27643088|NCT00943917|80536338|FG004|Stage I|Withdrawal by Subject|0|||
27643089|NCT00943917|80536339|FG005|Stage I|Withdrawal by Subject|0|||
27643090|NCT00943917|80536340|FG006|Stage I|Withdrawal by Subject|0|||
27743716|NCT00576693|80892662|FG000|Overall Study|Lost to Follow-up|7|||
27743717|NCT00576693|80892663|FG001|Overall Study|Lost to Follow-up|11|||
27643091|NCT00943917|80536341|FG007|Stage I|Withdrawal by Subject|0|||
27935286|NCT00300495|81600879|FG001|Overall Study|Protocol Violation|1|||
27935287|NCT00585169|81600880|FG000|Overall Study|Withdrawal by Subject|1|||
27935288|NCT00090402|81600881|FG000|Overall Study|Death|1|||
27935289|NCT00090402|81600882|FG001|Overall Study|Death|1|||
27643092|NCT00943917|80536342|FG008|Stage I|Withdrawal by Subject|0|||
27643093|NCT00943917|80536343|FG009|Stage I|Withdrawal by Subject|0|||
27643094|NCT00943917|80536344|FG010|Stage I|Withdrawal by Subject|0|||
27643095|NCT00943917|80536345|FG011|Stage I|Withdrawal by Subject|0|||
27643096|NCT00943917|80536346|FG012|Stage I|Withdrawal by Subject|0|||
27643097|NCT00943917|80536347|FG013|Stage I|Withdrawal by Subject|0|||
27643098|NCT00943917|80536348|FG014|Stage I|Withdrawal by Subject|0|||
27643099|NCT00943917|80536334|FG000|Stage II|Adverse Event|0|||
27643100|NCT00943917|80536335|FG001|Stage II|Adverse Event|0|||
27643101|NCT00943917|80536336|FG002|Stage II|Adverse Event|0|||
27643102|NCT00943917|80536337|FG003|Stage II|Adverse Event|0|||
27643103|NCT00943917|80536338|FG004|Stage II|Adverse Event|0|||
27643104|NCT00943917|80536339|FG005|Stage II|Adverse Event|1|||
27643105|NCT00943917|80536340|FG006|Stage II|Adverse Event|3|||
27643106|NCT00943917|80536341|FG007|Stage II|Adverse Event|0|||
27643107|NCT00943917|80536342|FG008|Stage II|Adverse Event|1|||
27643108|NCT00943917|80536343|FG009|Stage II|Adverse Event|0|||
27743718|NCT00576693|80892662|FG000|Overall Study|Withdrawal by Subject|3|||
27743719|NCT00576693|80892663|FG001|Overall Study|Withdrawal by Subject|13|||
27935290|NCT00090402|81600883|FG002|Overall Study|Death|0|||
27643109|NCT00943917|80536344|FG010|Stage II|Adverse Event|0|||
27643110|NCT00943917|80536345|FG011|Stage II|Adverse Event|0|||
27643111|NCT00943917|80536346|FG012|Stage II|Adverse Event|0|||
27643112|NCT00943917|80536347|FG013|Stage II|Adverse Event|0|||
27643113|NCT00943917|80536348|FG014|Stage II|Adverse Event|0|||
27643114|NCT00943917|80536334|FG000|Stage II|Withdrawal by Subject|0|||
27643115|NCT00943917|80536335|FG001|Stage II|Withdrawal by Subject|0|||
27643116|NCT00943917|80536336|FG002|Stage II|Withdrawal by Subject|0|||
27643117|NCT00943917|80536337|FG003|Stage II|Withdrawal by Subject|0|||
27643118|NCT00943917|80536338|FG004|Stage II|Withdrawal by Subject|0|||
27643119|NCT00943917|80536339|FG005|Stage II|Withdrawal by Subject|1|||
27643120|NCT00943917|80536340|FG006|Stage II|Withdrawal by Subject|0|||
27643121|NCT00943917|80536341|FG007|Stage II|Withdrawal by Subject|0|||
27643122|NCT00943917|80536342|FG008|Stage II|Withdrawal by Subject|0|||
27643123|NCT00943917|80536343|FG009|Stage II|Withdrawal by Subject|0|||
27643124|NCT00943917|80536344|FG010|Stage II|Withdrawal by Subject|0|||
27643125|NCT00943917|80536345|FG011|Stage II|Withdrawal by Subject|0|||
27643126|NCT00943917|80536346|FG012|Stage II|Withdrawal by Subject|0|||
27743720|NCT01797432|80892666|FG000|Overall Study|Lost to Follow-up|1|||
27743721|NCT01797432|80892666|FG000|Overall Study|Adverse Event|1|||
27743722|NCT01797432|80892666|FG000|Overall Study|Withdrawal by Subject|1|||
27743723|NCT01797432|80892666|FG000|Overall Study|lived too far from study site|1|||
27743724|NCT02940886|80892667|FG000|Overall Study|Adverse Event|7|||
27743725|NCT02940886|80892668|FG001|Overall Study|Adverse Event|3|||
27743726|NCT02940886|80892667|FG000|Overall Study|Protocol Violation|0|||
27935291|NCT00090402|81600881|FG000|Overall Study|subject moved|0|||
27935292|NCT00090402|81600882|FG001|Overall Study|subject moved|1|||
27935293|NCT00090402|81600883|FG002|Overall Study|subject moved|0|||
27935294|NCT00090402|81600881|FG000|Overall Study|stopped taking study medication|1|||
27935295|NCT00090402|81600882|FG001|Overall Study|stopped taking study medication|0|||
27935296|NCT00090402|81600883|FG002|Overall Study|stopped taking study medication|1|||
27550891|NCT02310568|80203521|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
27743727|NCT02940886|80892668|FG001|Overall Study|Protocol Violation|2|||
27743728|NCT02940886|80892667|FG000|Overall Study|Withdrawal by Subject|28|||
27743729|NCT02940886|80892668|FG001|Overall Study|Withdrawal by Subject|20|||
27743730|NCT02940886|80892667|FG000|Overall Study|Death|1|||
27743731|NCT02940886|80892668|FG001|Overall Study|Death|0|||
27743732|NCT02940886|80892667|FG000|Overall Study|Lack of Efficacy|1|||
27743733|NCT02940886|80892668|FG001|Overall Study|Lack of Efficacy|0|||
27743734|NCT02940886|80892667|FG000|Overall Study|Lost to Follow-up|49|||
27743735|NCT02940886|80892668|FG001|Overall Study|Lost to Follow-up|21|||
27743736|NCT02940886|80892667|FG000|Overall Study|Physician Decision|9|||
27743737|NCT02940886|80892668|FG001|Overall Study|Physician Decision|4|||
27743738|NCT02940886|80892667|FG000|Overall Study|Sponsor decision|0|||
27550892|NCT02310568|80203517|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
27550893|NCT02310568|80203518|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
27550894|NCT02310568|80203519|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
27550895|NCT02310568|80203520|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
27550896|NCT02310568|80203521|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
27550897|NCT00982878|80203522|FG000|Overall Study|Physician Decision|1|||
27550898|NCT01433991|80203523|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
27550899|NCT01433991|80203524|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
27643127|NCT00943917|80536347|FG013|Stage II|Withdrawal by Subject|0|||
27643128|NCT00943917|80536348|FG014|Stage II|Withdrawal by Subject|0|||
27643129|NCT00943917|80536334|FG000|Stage II|Pregnancy|0|||
27743739|NCT02940886|80892668|FG001|Overall Study|Sponsor decision|1|||
27935297|NCT01666652|81600884|FG000|Overall Study|Serious Adverse Event|0|||
27643130|NCT00943917|80536335|FG001|Stage II|Pregnancy|0|||
27643131|NCT00943917|80536336|FG002|Stage II|Pregnancy|0|||
27935298|NCT01666652|81600885|FG001|Overall Study|Serious Adverse Event|0|||
27935299|NCT01666652|81600886|FG002|Overall Study|Serious Adverse Event|0|||
27935300|NCT01666652|81600887|FG003|Overall Study|Serious Adverse Event|1|||
27935301|NCT01666652|81600888|FG004|Overall Study|Serious Adverse Event|0|||
27935302|NCT01666652|81600884|FG000|Overall Study|Withdrawal by Subject|0|||
27643132|NCT00943917|80536337|FG003|Stage II|Pregnancy|0|||
27643133|NCT00943917|80536338|FG004|Stage II|Pregnancy|0|||
27643134|NCT00943917|80536339|FG005|Stage II|Pregnancy|1|||
27643135|NCT00943917|80536340|FG006|Stage II|Pregnancy|0|||
27643136|NCT00943917|80536341|FG007|Stage II|Pregnancy|0|||
27643137|NCT00943917|80536342|FG008|Stage II|Pregnancy|0|||
27643138|NCT00943917|80536343|FG009|Stage II|Pregnancy|0|||
27643139|NCT00943917|80536344|FG010|Stage II|Pregnancy|0|||
27935303|NCT01666652|81600885|FG001|Overall Study|Withdrawal by Subject|0|||
27935304|NCT01666652|81600886|FG002|Overall Study|Withdrawal by Subject|0|||
27935305|NCT01666652|81600887|FG003|Overall Study|Withdrawal by Subject|0|||
27935306|NCT01666652|81600888|FG004|Overall Study|Withdrawal by Subject|1|||
27935307|NCT01666652|81600884|FG000|Overall Study|Moved from study area|1|||
27935308|NCT01666652|81600885|FG001|Overall Study|Moved from study area|0|||
27935309|NCT01666652|81600886|FG002|Overall Study|Moved from study area|0|||
27935310|NCT01666652|81600887|FG003|Overall Study|Moved from study area|2|||
27935311|NCT01666652|81600888|FG004|Overall Study|Moved from study area|0|||
27935312|NCT01666652|81600884|FG000|Overall Study|Lost to Follow-up|1|||
27935313|NCT01666652|81600885|FG001|Overall Study|Lost to Follow-up|1|||
27935314|NCT01666652|81600886|FG002|Overall Study|Lost to Follow-up|1|||
27935315|NCT01666652|81600887|FG003|Overall Study|Lost to Follow-up|1|||
27935316|NCT01666652|81600888|FG004|Overall Study|Lost to Follow-up|0|||
27935317|NCT01827943|81600889|FG000|Overall Study|Protocol Violation|8|||
27935318|NCT01827943|81600889|FG000|Overall Study|Never treated because of an rapid progression|1|||
27935319|NCT00362609|81600890|FG000|Overall Study|Withdrawal by Subject|0|||
27935320|NCT00362609|81600891|FG001|Overall Study|Withdrawal by Subject|1|||
27935321|NCT00362609|81600890|FG000|Overall Study|Protocol Violation|0|||
27935322|NCT00362609|81600891|FG001|Overall Study|Protocol Violation|1|||
27935323|NCT01210443|81600892|FG000|Overall Study|Study terminated by sponsor|2|||
27935324|NCT01975285|81600893|FG000|Overall Study|Failed Block and follow up|2|||
27935325|NCT01975285|81600894|FG001|Overall Study|Failed Block and follow up|2|||
27935326|NCT03518203|81600895|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
27935327|NCT03518203|81600895|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
27935328|NCT03016403|81600896|FG000|Baseline|Death|5|||
27935329|NCT03016403|81600897|FG001|Baseline|Death|8|||
27935330|NCT03016403|81600898|FG002|Baseline|Death|1|||
27935331|NCT03016403|81600899|FG003|Baseline|Death|0|||
27935332|NCT03016403|81600896|FG000|Baseline|Withdrawal by Subject|2|||
27935333|NCT03016403|81600897|FG001|Baseline|Withdrawal by Subject|8|||
27935334|NCT03016403|81600898|FG002|Baseline|Withdrawal by Subject|4|||
27935335|NCT03016403|81600899|FG003|Baseline|Withdrawal by Subject|10|||
27935336|NCT03016403|81600896|FG000|Baseline|Lost to Follow-up|9|||
27935337|NCT03016403|81600897|FG001|Baseline|Lost to Follow-up|11|||
27935338|NCT03016403|81600898|FG002|Baseline|Lost to Follow-up|6|||
27935339|NCT03016403|81600899|FG003|Baseline|Lost to Follow-up|24|||
27935340|NCT03016403|81600896|FG000|6-week Follow-up|Death|1|||
27935341|NCT03016403|81600897|FG001|6-week Follow-up|Death|4|||
27935342|NCT03016403|81600898|FG002|6-week Follow-up|Death|0|||
27935343|NCT03016403|81600899|FG003|6-week Follow-up|Death|0|||
27935344|NCT03016403|81600896|FG000|6-week Follow-up|Lost to Follow-up|2|||
27935345|NCT03016403|81600897|FG001|6-week Follow-up|Lost to Follow-up|7|||
27935346|NCT03016403|81600898|FG002|6-week Follow-up|Lost to Follow-up|4|||
27550900|NCT01433991|80203525|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
27550901|NCT01433991|80203526|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
27550902|NCT01433991|80203523|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
27550903|NCT01433991|80203524|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
27550904|NCT01433991|80203525|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
27550905|NCT01433991|80203526|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
27550906|NCT01433991|80203523|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
27550907|NCT01433991|80203524|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
27550908|NCT01433991|80203525|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
27550909|NCT01433991|80203526|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
27550910|NCT01433991|80203523|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
27643140|NCT00943917|80536345|FG011|Stage II|Pregnancy|0|||
27643141|NCT00943917|80536346|FG012|Stage II|Pregnancy|0|||
27935347|NCT03016403|81600899|FG003|6-week Follow-up|Lost to Follow-up|8|||
27935348|NCT03016403|81600896|FG000|6-week Follow-up|Withdrawal by Subject|0|||
27935349|NCT03016403|81600897|FG001|6-week Follow-up|Withdrawal by Subject|2|||
27935350|NCT03016403|81600898|FG002|6-week Follow-up|Withdrawal by Subject|0|||
27935351|NCT03016403|81600899|FG003|6-week Follow-up|Withdrawal by Subject|1|||
27935352|NCT03016403|81600896|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
27935353|NCT03016403|81600897|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
27643142|NCT00943917|80536347|FG013|Stage II|Pregnancy|0|||
27643143|NCT00943917|80536348|FG014|Stage II|Pregnancy|0|||
27643144|NCT00943917|80536334|FG000|Stage II Continuation|Adverse Event|0|||
27643145|NCT00943917|80536335|FG001|Stage II Continuation|Adverse Event|0|||
27643146|NCT00943917|80536336|FG002|Stage II Continuation|Adverse Event|0|||
27643147|NCT00943917|80536337|FG003|Stage II Continuation|Adverse Event|0|||
27643148|NCT00943917|80536338|FG004|Stage II Continuation|Adverse Event|0|||
27643149|NCT00943917|80536339|FG005|Stage II Continuation|Adverse Event|0|||
27643150|NCT00943917|80536340|FG006|Stage II Continuation|Adverse Event|0|||
27643151|NCT00943917|80536341|FG007|Stage II Continuation|Adverse Event|0|||
27643152|NCT00943917|80536342|FG008|Stage II Continuation|Adverse Event|0|||
27643153|NCT00943917|80536343|FG009|Stage II Continuation|Adverse Event|0|||
27643154|NCT00943917|80536344|FG010|Stage II Continuation|Adverse Event|0|||
27643155|NCT00943917|80536345|FG011|Stage II Continuation|Adverse Event|1|||
27643156|NCT00943917|80536346|FG012|Stage II Continuation|Adverse Event|2|||
27643157|NCT00943917|80536347|FG013|Stage II Continuation|Adverse Event|1|||
27643158|NCT00943917|80536348|FG014|Stage II Continuation|Adverse Event|1|||
27643159|NCT00943917|80536334|FG000|Stage II Continuation|Withdrawal by Subject|0|||
27643160|NCT00943917|80536335|FG001|Stage II Continuation|Withdrawal by Subject|0|||
27643161|NCT00943917|80536336|FG002|Stage II Continuation|Withdrawal by Subject|0|||
27643162|NCT00943917|80536337|FG003|Stage II Continuation|Withdrawal by Subject|0|||
27643163|NCT00943917|80536338|FG004|Stage II Continuation|Withdrawal by Subject|0|||
27643164|NCT00943917|80536339|FG005|Stage II Continuation|Withdrawal by Subject|0|||
27643165|NCT00943917|80536340|FG006|Stage II Continuation|Withdrawal by Subject|0|||
27643166|NCT00943917|80536341|FG007|Stage II Continuation|Withdrawal by Subject|0|||
27643167|NCT00943917|80536342|FG008|Stage II Continuation|Withdrawal by Subject|0|||
27643168|NCT00943917|80536343|FG009|Stage II Continuation|Withdrawal by Subject|0|||
27643169|NCT00943917|80536344|FG010|Stage II Continuation|Withdrawal by Subject|0|||
27643170|NCT00943917|80536345|FG011|Stage II Continuation|Withdrawal by Subject|0|||
27643171|NCT00943917|80536346|FG012|Stage II Continuation|Withdrawal by Subject|0|||
27643172|NCT00943917|80536347|FG013|Stage II Continuation|Withdrawal by Subject|1|||
27643173|NCT00943917|80536348|FG014|Stage II Continuation|Withdrawal by Subject|3|||
27643174|NCT00943917|80536334|FG000|Stage II Continuation|Protocol Violation|0|||
27643175|NCT00943917|80536335|FG001|Stage II Continuation|Protocol Violation|0|||
27643176|NCT00943917|80536336|FG002|Stage II Continuation|Protocol Violation|0|||
27643177|NCT00943917|80536337|FG003|Stage II Continuation|Protocol Violation|0|||
27643178|NCT00943917|80536338|FG004|Stage II Continuation|Protocol Violation|0|||
27643179|NCT00943917|80536339|FG005|Stage II Continuation|Protocol Violation|0|||
27643180|NCT00943917|80536340|FG006|Stage II Continuation|Protocol Violation|0|||
27935354|NCT03016403|81600898|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
27935355|NCT03016403|81600899|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
27935356|NCT03016403|81600896|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
27935357|NCT03016403|81600897|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
27935358|NCT03016403|81600898|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
27935359|NCT03016403|81600899|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
27935360|NCT03016403|81600896|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
27935361|NCT03016403|81600897|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
27935362|NCT03016403|81600898|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
27935363|NCT03016403|81600899|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
27935364|NCT00567112|81600900|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
27935365|NCT00567112|81600901|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
27935366|NCT00567112|81600902|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
27935367|NCT00567112|81600900|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
27935368|NCT00567112|81600901|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
27935369|NCT00567112|81600902|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
27935370|NCT00567112|81600900|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
27935371|NCT00567112|81600901|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
27935372|NCT00567112|81600902|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
27935373|NCT01734928|81600903|FG000|Randomization|Physician Decision|0|||
27935374|NCT01734928|81600904|FG001|Randomization|Physician Decision|1|||
27935375|NCT01734928|81600903|FG000|Randomization|clinical progression|0|||
27935376|NCT01734928|81600904|FG001|Randomization|clinical progression|1|||
27935377|NCT01734928|81600903|FG000|Randomization|progressive disease|0|||
27935378|NCT01734928|81600904|FG001|Randomization|progressive disease|2|||
27935379|NCT01734928|81600903|FG000|Randomization|Withdrew informed consent|0|||
27643181|NCT00943917|80536341|FG007|Stage II Continuation|Protocol Violation|0|||
27643182|NCT00943917|80536342|FG008|Stage II Continuation|Protocol Violation|0|||
27643183|NCT00943917|80536343|FG009|Stage II Continuation|Protocol Violation|1|||
27643184|NCT00943917|80536344|FG010|Stage II Continuation|Protocol Violation|0|||
27643185|NCT00943917|80536345|FG011|Stage II Continuation|Protocol Violation|1|||
27643186|NCT00943917|80536346|FG012|Stage II Continuation|Protocol Violation|0|||
27643187|NCT00943917|80536347|FG013|Stage II Continuation|Protocol Violation|0|||
27643188|NCT00943917|80536348|FG014|Stage II Continuation|Protocol Violation|0|||
27643189|NCT00943917|80536334|FG000|Stage II Continuation|hypoglycemia|0|||
27643190|NCT00943917|80536335|FG001|Stage II Continuation|hypoglycemia|0|||
27643191|NCT00943917|80536336|FG002|Stage II Continuation|hypoglycemia|0|||
27643192|NCT00943917|80536337|FG003|Stage II Continuation|hypoglycemia|0|||
27643193|NCT00943917|80536338|FG004|Stage II Continuation|hypoglycemia|0|||
27643194|NCT00943917|80536339|FG005|Stage II Continuation|hypoglycemia|0|||
27643195|NCT00943917|80536340|FG006|Stage II Continuation|hypoglycemia|0|||
27643196|NCT00943917|80536341|FG007|Stage II Continuation|hypoglycemia|0|||
27643197|NCT00943917|80536342|FG008|Stage II Continuation|hypoglycemia|0|||
27643198|NCT00943917|80536343|FG009|Stage II Continuation|hypoglycemia|0|||
27643199|NCT00943917|80536344|FG010|Stage II Continuation|hypoglycemia|0|||
27643200|NCT00943917|80536345|FG011|Stage II Continuation|hypoglycemia|0|||
27643201|NCT00943917|80536346|FG012|Stage II Continuation|hypoglycemia|1|||
27643202|NCT00943917|80536347|FG013|Stage II Continuation|hypoglycemia|0|||
27643203|NCT00943917|80536348|FG014|Stage II Continuation|hypoglycemia|0|||
27643204|NCT00943917|80536334|FG000|Stage II Continuation|A1C elevation|0|||
27643205|NCT00943917|80536335|FG001|Stage II Continuation|A1C elevation|0|||
27643206|NCT00943917|80536336|FG002|Stage II Continuation|A1C elevation|0|||
27643207|NCT00943917|80536337|FG003|Stage II Continuation|A1C elevation|0|||
27643208|NCT00943917|80536338|FG004|Stage II Continuation|A1C elevation|0|||
27643209|NCT00943917|80536339|FG005|Stage II Continuation|A1C elevation|0|||
27643210|NCT00943917|80536340|FG006|Stage II Continuation|A1C elevation|0|||
27643211|NCT00943917|80536341|FG007|Stage II Continuation|A1C elevation|0|||
27743740|NCT02940886|80892667|FG000|Overall Study|No treatment|7|||
27935380|NCT01734928|81600904|FG001|Randomization|Withdrew informed consent|4|||
27935381|NCT01734928|81600903|FG000|Randomization|Death|1|||
27935382|NCT01734928|81600904|FG001|Randomization|Death|0|||
27935383|NCT01734928|81600903|FG000|Randomization|Randomization error|1|||
27935384|NCT01734928|81600904|FG001|Randomization|Randomization error|0|||
27935385|NCT01734928|81600903|FG000|Randomization|Lost to Follow-up|1|||
27935386|NCT01734928|81600904|FG001|Randomization|Lost to Follow-up|0|||
27935387|NCT01734928|81600903|FG000|Treatment Period|Lost to Follow-up|0|||
27935388|NCT01734928|81600904|FG001|Treatment Period|Lost to Follow-up|2|||
27935389|NCT01734928|81600903|FG000|Treatment Period|Progressive Disease|167|||
27935390|NCT01734928|81600904|FG001|Treatment Period|Progressive Disease|165|||
27935391|NCT01734928|81600903|FG000|Treatment Period|Adverse Event|39|||
27935392|NCT01734928|81600904|FG001|Treatment Period|Adverse Event|52|||
27935393|NCT01734928|81600903|FG000|Treatment Period|Withdrawal of Consent|25|||
27935394|NCT01734928|81600904|FG001|Treatment Period|Withdrawal of Consent|22|||
27935395|NCT01734928|81600903|FG000|Treatment Period|Death|20|||
27935396|NCT01734928|81600904|FG001|Treatment Period|Death|9|||
27935397|NCT01734928|81600903|FG000|Treatment Period|Other Reasons|27|||
27935398|NCT01734928|81600904|FG001|Treatment Period|Other Reasons|19|||
27935399|NCT01734928|81600903|FG000|Treatment Period|Pregnancy|0|||
27935400|NCT01734928|81600904|FG001|Treatment Period|Pregnancy|1|||
27935401|NCT01259024|81600907|FG000|Overall Study|Physician Decision|1|||
27935402|NCT00676689|81600908|FG000|Overall Study|Screen Failure|2|||
27935403|NCT00676689|81600908|FG000|Overall Study|Death|2|||
27935404|NCT00676689|81600908|FG000|Overall Study|Lost to Follow-up|4|||
27935405|NCT00676689|81600908|FG000|Overall Study|Physician Decision|1|||
27935406|NCT00676689|81600908|FG000|Overall Study|Withdrawal by Subject|3|||
27935407|NCT00676689|81600908|FG000|Overall Study|Continuing FU|49|||
27935408|NCT00992394|81600909|FG000|Overall Study|Lack of Efficacy|6|||
27935409|NCT00992394|81600910|FG001|Overall Study|Lack of Efficacy|3|||
27935410|NCT00992394|81600909|FG000|Overall Study|Adverse Event|4|||
27935411|NCT00992394|81600910|FG001|Overall Study|Adverse Event|5|||
27935412|NCT00992394|81600909|FG000|Overall Study|Withdrawal by Subject|8|||
27935413|NCT00992394|81600910|FG001|Overall Study|Withdrawal by Subject|2|||
27935414|NCT00992394|81600909|FG000|Overall Study|Physician Decision|1|||
27550911|NCT01433991|80203524|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
27550912|NCT01433991|80203525|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
27550913|NCT01433991|80203526|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
27550914|NCT01433991|80203523|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
27550915|NCT01433991|80203524|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
27550916|NCT01433991|80203525|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
27550917|NCT01433991|80203526|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
27550918|NCT01433991|80203523|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
27550919|NCT01433991|80203524|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
27550920|NCT01433991|80203525|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
27550921|NCT01433991|80203526|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
27643212|NCT00943917|80536342|FG008|Stage II Continuation|A1C elevation|0|||
27643213|NCT00943917|80536343|FG009|Stage II Continuation|A1C elevation|0|||
27643214|NCT00943917|80536344|FG010|Stage II Continuation|A1C elevation|0|||
27643215|NCT00943917|80536345|FG011|Stage II Continuation|A1C elevation|0|||
27935415|NCT00992394|81600910|FG001|Overall Study|Physician Decision|0|||
27935416|NCT00992394|81600909|FG000|Overall Study|Protocol Violation|2|||
27935417|NCT00992394|81600910|FG001|Overall Study|Protocol Violation|4|||
27935418|NCT00992394|81600909|FG000|Overall Study|Lost to Follow-up|2|||
27643216|NCT00943917|80536346|FG012|Stage II Continuation|A1C elevation|0|||
27643217|NCT00943917|80536347|FG013|Stage II Continuation|A1C elevation|1|||
27643218|NCT00943917|80536348|FG014|Stage II Continuation|A1C elevation|0|||
27643219|NCT01083316|80536355|FG000|Overall Study|Adverse Event|2|||
27743741|NCT02940886|80892668|FG001|Overall Study|No treatment|2|||
27743742|NCT02940886|80892667|FG000|Overall Study|Enrolment error|0|||
27743743|NCT02940886|80892668|FG001|Overall Study|Enrolment error|1|||
27935419|NCT00992394|81600910|FG001|Overall Study|Lost to Follow-up|0|||
27935420|NCT00992394|81600909|FG000|Overall Study|Other event|1|||
27935421|NCT00992394|81600910|FG001|Overall Study|Other event|0|||
27935422|NCT00281580|81600911|FG000|Overall Study|Adverse Event|2|||
27935423|NCT00281580|81600912|FG001|Overall Study|Adverse Event|0|||
27935424|NCT00281580|81600913|FG002|Overall Study|Adverse Event|2|||
27935425|NCT00281580|81600914|FG003|Overall Study|Adverse Event|4|||
27935426|NCT00281580|81600915|FG004|Overall Study|Adverse Event|1|||
27935427|NCT00281580|81600916|FG005|Overall Study|Adverse Event|0|||
27935428|NCT00281580|81600917|FG006|Overall Study|Adverse Event|1|||
27935429|NCT00281580|81600918|FG007|Overall Study|Adverse Event|0|||
27935430|NCT00281580|81600919|FG008|Overall Study|Adverse Event|1|||
27935431|NCT00281580|81600920|FG009|Overall Study|Adverse Event|6|||
27935432|NCT00281580|81600921|FG010|Overall Study|Adverse Event|0|||
27935433|NCT00281580|81600922|FG011|Overall Study|Adverse Event|5|||
27935434|NCT00281580|81600923|FG012|Overall Study|Adverse Event|8|||
27935435|NCT00281580|81600924|FG013|Overall Study|Adverse Event|2|||
27935436|NCT00281580|81600925|FG014|Overall Study|Adverse Event|3|||
27935437|NCT00281580|81600926|FG015|Overall Study|Adverse Event|3|||
27935438|NCT00281580|81600911|FG000|Overall Study|Protocol Violation|0|||
27935439|NCT00281580|81600912|FG001|Overall Study|Protocol Violation|0|||
27935440|NCT00281580|81600913|FG002|Overall Study|Protocol Violation|1|||
27935441|NCT00281580|81600914|FG003|Overall Study|Protocol Violation|1|||
27935442|NCT00281580|81600915|FG004|Overall Study|Protocol Violation|0|||
27935443|NCT00281580|81600916|FG005|Overall Study|Protocol Violation|0|||
27935444|NCT00281580|81600917|FG006|Overall Study|Protocol Violation|1|||
27935445|NCT00281580|81600918|FG007|Overall Study|Protocol Violation|0|||
27935446|NCT00281580|81600919|FG008|Overall Study|Protocol Violation|2|||
27935447|NCT00281580|81600920|FG009|Overall Study|Protocol Violation|0|||
27935448|NCT00281580|81600921|FG010|Overall Study|Protocol Violation|1|||
27935449|NCT00281580|81600922|FG011|Overall Study|Protocol Violation|2|||
27935450|NCT00281580|81600923|FG012|Overall Study|Protocol Violation|0|||
27935451|NCT00281580|81600924|FG013|Overall Study|Protocol Violation|1|||
27935452|NCT00281580|81600925|FG014|Overall Study|Protocol Violation|1|||
27935453|NCT00281580|81600926|FG015|Overall Study|Protocol Violation|3|||
27935454|NCT00281580|81600911|FG000|Overall Study|Withdrawal by Subject|3|||
27935455|NCT00281580|81600912|FG001|Overall Study|Withdrawal by Subject|0|||
27935456|NCT00281580|81600913|FG002|Overall Study|Withdrawal by Subject|1|||
27935457|NCT00281580|81600914|FG003|Overall Study|Withdrawal by Subject|1|||
27743744|NCT00474630|80892669|FG000|Overall Study|Adverse Event|98|||
27743745|NCT00474630|80892670|FG001|Overall Study|Adverse Event|26|||
27743746|NCT00474630|80892669|FG000|Overall Study|Lost to Follow-up|22|||
27743747|NCT00474630|80892670|FG001|Overall Study|Lost to Follow-up|15|||
27743748|NCT00474630|80892669|FG000|Overall Study|Withdrawal by Subject|21|||
27743749|NCT00474630|80892670|FG001|Overall Study|Withdrawal by Subject|15|||
27743750|NCT00474630|80892669|FG000|Overall Study|Protocol Violation|3|||
27743751|NCT00474630|80892670|FG001|Overall Study|Protocol Violation|4|||
27743752|NCT00474630|80892669|FG000|Overall Study|Lack of Efficacy|5|||
27743753|NCT00474630|80892670|FG001|Overall Study|Lack of Efficacy|6|||
27743754|NCT00474630|80892669|FG000|Overall Study|Drug noncompliance, other|11|||
27743755|NCT00474630|80892670|FG001|Overall Study|Drug noncompliance, other|4|||
27743756|NCT00914628|80892673|FG000|Overall Study|Death|35|||
27935458|NCT00281580|81600915|FG004|Overall Study|Withdrawal by Subject|1|||
27643220|NCT01083316|80536355|FG000|Overall Study|Withdrawal by Subject|1|||
27643221|NCT00229658|80536356|FG000|Overall Study|Administrative|2|||
27743757|NCT00914628|80892674|FG001|Overall Study|Death|17|||
27743758|NCT00914628|80892673|FG000|Overall Study|Medical decision|4|||
27743759|NCT00914628|80892674|FG001|Overall Study|Medical decision|0|||
27743760|NCT00914628|80892673|FG000|Overall Study|Protocol Violation|1|||
27743761|NCT00914628|80892674|FG001|Overall Study|Protocol Violation|0|||
27935459|NCT00281580|81600916|FG005|Overall Study|Withdrawal by Subject|2|||
27935460|NCT00281580|81600917|FG006|Overall Study|Withdrawal by Subject|2|||
27935461|NCT00281580|81600918|FG007|Overall Study|Withdrawal by Subject|0|||
27935462|NCT00281580|81600919|FG008|Overall Study|Withdrawal by Subject|1|||
27935463|NCT00281580|81600920|FG009|Overall Study|Withdrawal by Subject|4|||
27935464|NCT00281580|81600921|FG010|Overall Study|Withdrawal by Subject|1|||
27935465|NCT00281580|81600922|FG011|Overall Study|Withdrawal by Subject|1|||
27935466|NCT00281580|81600923|FG012|Overall Study|Withdrawal by Subject|2|||
27935467|NCT00281580|81600924|FG013|Overall Study|Withdrawal by Subject|2|||
27935468|NCT00281580|81600925|FG014|Overall Study|Withdrawal by Subject|1|||
27643222|NCT00229658|80536357|FG001|Overall Study|Administrative|1|||
27643223|NCT00229658|80536356|FG000|Overall Study|Investigator decision|13|||
27643224|NCT00229658|80536357|FG001|Overall Study|Investigator decision|10|||
27643225|NCT00229658|80536356|FG000|Overall Study|Other|80|||
27643226|NCT00229658|80536357|FG001|Overall Study|Other|60|||
27643227|NCT00229658|80536356|FG000|Overall Study|Lost to Follow-up|82|||
27743762|NCT00914628|80892673|FG000|Overall Study|Lack of Efficacy|1|||
27935469|NCT00281580|81600926|FG015|Overall Study|Withdrawal by Subject|5|||
27935470|NCT00281580|81600911|FG000|Overall Study|Lack of Efficacy|2|||
27935471|NCT00281580|81600912|FG001|Overall Study|Lack of Efficacy|1|||
27935472|NCT00281580|81600913|FG002|Overall Study|Lack of Efficacy|1|||
27935473|NCT00281580|81600914|FG003|Overall Study|Lack of Efficacy|6|||
27935474|NCT00281580|81600915|FG004|Overall Study|Lack of Efficacy|2|||
27935475|NCT00281580|81600916|FG005|Overall Study|Lack of Efficacy|0|||
27935476|NCT00281580|81600917|FG006|Overall Study|Lack of Efficacy|0|||
27935477|NCT00281580|81600918|FG007|Overall Study|Lack of Efficacy|0|||
27935478|NCT00281580|81600919|FG008|Overall Study|Lack of Efficacy|0|||
27935479|NCT00281580|81600920|FG009|Overall Study|Lack of Efficacy|0|||
27935480|NCT00281580|81600921|FG010|Overall Study|Lack of Efficacy|0|||
27935481|NCT00281580|81600922|FG011|Overall Study|Lack of Efficacy|1|||
27935482|NCT00281580|81600923|FG012|Overall Study|Lack of Efficacy|0|||
27935483|NCT00281580|81600924|FG013|Overall Study|Lack of Efficacy|2|||
27935484|NCT00281580|81600925|FG014|Overall Study|Lack of Efficacy|1|||
27935485|NCT00281580|81600926|FG015|Overall Study|Lack of Efficacy|0|||
27935486|NCT00281580|81600911|FG000|Overall Study|Lost to Follow-up|0|||
27935487|NCT00281580|81600912|FG001|Overall Study|Lost to Follow-up|0|||
27935488|NCT00281580|81600913|FG002|Overall Study|Lost to Follow-up|0|||
27935489|NCT00281580|81600914|FG003|Overall Study|Lost to Follow-up|3|||
27935490|NCT00281580|81600915|FG004|Overall Study|Lost to Follow-up|0|||
27935491|NCT00281580|81600916|FG005|Overall Study|Lost to Follow-up|1|||
27935492|NCT00281580|81600917|FG006|Overall Study|Lost to Follow-up|0|||
27935493|NCT00281580|81600918|FG007|Overall Study|Lost to Follow-up|1|||
27935494|NCT00281580|81600919|FG008|Overall Study|Lost to Follow-up|2|||
27935495|NCT00281580|81600920|FG009|Overall Study|Lost to Follow-up|1|||
27935496|NCT00281580|81600921|FG010|Overall Study|Lost to Follow-up|1|||
27935497|NCT00281580|81600922|FG011|Overall Study|Lost to Follow-up|0|||
27935498|NCT00281580|81600923|FG012|Overall Study|Lost to Follow-up|1|||
27935499|NCT00281580|81600924|FG013|Overall Study|Lost to Follow-up|0|||
27935500|NCT00281580|81600925|FG014|Overall Study|Lost to Follow-up|0|||
27935501|NCT00281580|81600926|FG015|Overall Study|Lost to Follow-up|0|||
27935502|NCT00281580|81600911|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
27935503|NCT00281580|81600912|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
27935504|NCT00281580|81600913|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
27935505|NCT00281580|81600914|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
27935506|NCT00281580|81600915|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
27935507|NCT00281580|81600916|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
27935508|NCT00281580|81600917|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
27935509|NCT00281580|81600918|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
27935510|NCT00281580|81600919|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
27935511|NCT00281580|81600920|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
27935512|NCT00281580|81600921|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
27935513|NCT00281580|81600922|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
27935514|NCT00281580|81600923|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
27935515|NCT00281580|81600924|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
27935516|NCT00281580|81600925|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
27935517|NCT00281580|81600926|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
27935518|NCT01852214|81600940|FG000|Period 1|Adverse Event|1|||
27935519|NCT01852214|81600941|FG001|Period 1|Adverse Event|2|||
27935520|NCT01852214|81600940|FG000|Period 1|Withdrawal by Subject|0|||
27935521|NCT01852214|81600941|FG001|Period 1|Withdrawal by Subject|1|||
27935522|NCT01852214|81600940|FG000|Washout Period|Withdrawal by Subject|0|||
27935523|NCT01852214|81600941|FG001|Washout Period|Withdrawal by Subject|1|||
27935524|NCT01412983|81600942|FG000|1st Period|Ineligible|0|||
27643228|NCT00229658|80536357|FG001|Overall Study|Lost to Follow-up|55|||
27643229|NCT00229658|80536356|FG000|Overall Study|Serious Adverse Event|2|||
27743763|NCT00914628|80892674|FG001|Overall Study|Lack of Efficacy|0|||
27935525|NCT01412983|81600943|FG001|1st Period|Ineligible|1|||
27935526|NCT01412983|81600942|FG000|1st Period|Positive slit lamp finding|0|||
27935527|NCT01412983|81600943|FG001|1st Period|Positive slit lamp finding|1|||
27935528|NCT01412983|81600942|FG000|1st Period|Unacceptable lens movement|0|||
27935529|NCT01412983|81600943|FG001|1st Period|Unacceptable lens movement|1|||
27935530|NCT01412983|81600942|FG000|1st Period|Inability to maintain wear|0|||
27935531|NCT01412983|81600943|FG001|1st Period|Inability to maintain wear|1|||
27935532|NCT02639559|81600944|FG000|Overall Study|Mobilization failure|0|||
27935533|NCT02639559|81600945|FG001|Overall Study|Mobilization failure|3|||
27935534|NCT02639559|81600944|FG000|Overall Study|Issues with vascular acess|1|||
27643230|NCT00229658|80536357|FG001|Overall Study|Serious Adverse Event|2|||
27935535|NCT02639559|81600945|FG001|Overall Study|Issues with vascular acess|0|||
27935536|NCT00736476|81600946|FG000|Overall Study|Adverse Event|1|||
27935537|NCT00736476|81600947|FG001|Overall Study|Adverse Event|0|||
27935538|NCT02571244|81600951|FG000|Overall Study|Lost to Follow-up|0|||
27935539|NCT02571244|81600952|FG001|Overall Study|Lost to Follow-up|1|||
27935540|NCT02571244|81600951|FG000|Overall Study|Unable to reach out post discharge|3|||
27935541|NCT02571244|81600952|FG001|Overall Study|Unable to reach out post discharge|0|||
27935542|NCT01392495|81600953|FG000|Overall Study|Death|3|||
27935543|NCT01392495|81600953|FG000|Overall Study|Administrative problems|8|||
27935544|NCT01392495|81600953|FG000|Overall Study|Withdrawal by Subject|2|||
27935545|NCT01392495|81600953|FG000|Overall Study|Adverse Event|3|||
27935546|NCT02301429|81600954|FG000|Overall Study|not acceptable vascular anatomy|3|||
27935547|NCT01630811|81600955|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
27935548|NCT01630811|81600956|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
27935549|NCT01096186|81600967|FG000|Overall Study|Adverse Event|16|||
27935550|NCT01096186|81600967|FG000|Overall Study|Death|4|||
27935551|NCT01096186|81600967|FG000|Overall Study|Lack of Efficacy|4|||
27935552|NCT01096186|81600967|FG000|Overall Study|Lost to Follow-up|2|||
27935553|NCT01096186|81600967|FG000|Overall Study|Withdrawal by Subject|22|||
27935554|NCT01096186|81600967|FG000|Overall Study|Physician Decision|1|||
27935555|NCT01096186|81600967|FG000|Overall Study|Noncompliance with study drug|1|||
27935556|NCT03412890|81600970|FG000|Overall Study|Adverse Event|5|||
27935557|NCT03412890|81600971|FG001|Overall Study|Adverse Event|5|||
27935558|NCT03412890|81600972|FG002|Overall Study|Adverse Event|9|||
27935559|NCT03412890|81600970|FG000|Overall Study|Protocol deviation|2|||
27935560|NCT03412890|81600971|FG001|Overall Study|Protocol deviation|1|||
27935561|NCT03412890|81600972|FG002|Overall Study|Protocol deviation|2|||
27935562|NCT03412890|81600970|FG000|Overall Study|Lost to Follow-up|7|||
27935563|NCT03412890|81600971|FG001|Overall Study|Lost to Follow-up|10|||
27935564|NCT03412890|81600972|FG002|Overall Study|Lost to Follow-up|10|||
27935565|NCT03412890|81600970|FG000|Overall Study|Withdrawal by Subject|9|||
27935566|NCT03412890|81600971|FG001|Overall Study|Withdrawal by Subject|12|||
27935567|NCT03412890|81600972|FG002|Overall Study|Withdrawal by Subject|11|||
27935568|NCT03412890|81600970|FG000|Overall Study|Lack of Efficacy|2|||
27935569|NCT03412890|81600971|FG001|Overall Study|Lack of Efficacy|7|||
27935570|NCT03412890|81600972|FG002|Overall Study|Lack of Efficacy|5|||
27935571|NCT03412890|81600970|FG000|Overall Study|Other|5|||
27935572|NCT03412890|81600971|FG001|Overall Study|Other|6|||
27935573|NCT03412890|81600972|FG002|Overall Study|Other|5|||
27935574|NCT03412890|81600970|FG000|Overall Study|Participants who did not receive any study drug|0|||
27935575|NCT03412890|81600971|FG001|Overall Study|Participants who did not receive any study drug|1|||
27935576|NCT03412890|81600972|FG002|Overall Study|Participants who did not receive any study drug|0|||
27935577|NCT02186171|81604118|FG000|Overall Study|Withdrawal by Subject|1|||
27935578|NCT02186171|81604119|FG001|Overall Study|Withdrawal by Subject|9|||
27935579|NCT02186171|81604118|FG000|Overall Study|Lost to Follow-up|2|||
27935580|NCT02186171|81604119|FG001|Overall Study|Lost to Follow-up|2|||
27935581|NCT02186171|81604118|FG000|Overall Study|Death|1|||
27935582|NCT02186171|81604119|FG001|Overall Study|Death|2|||
27935583|NCT02186171|81604118|FG000|Overall Study|Protocol-specified Criteria|0|||
27935584|NCT02186171|81604119|FG001|Overall Study|Protocol-specified Criteria|2|||
27935585|NCT01292473|81604122|FG000|Overall Study|Adverse Event|1|||
27935586|NCT01292473|81604123|FG001|Overall Study|Adverse Event|0|||
27935587|NCT01292473|81604124|FG002|Overall Study|Adverse Event|1|||
27935588|NCT01292473|81604125|FG003|Overall Study|Adverse Event|1|||
27935589|NCT01292473|81604122|FG000|Overall Study|Lost to Follow-up|1|||
27935590|NCT01292473|81604123|FG001|Overall Study|Lost to Follow-up|1|||
27935591|NCT01292473|81604124|FG002|Overall Study|Lost to Follow-up|2|||
27935592|NCT01292473|81604125|FG003|Overall Study|Lost to Follow-up|2|||
27935593|NCT01292473|81604122|FG000|Overall Study|Withdrawal by Subject|3|||
27935594|NCT01292473|81604123|FG001|Overall Study|Withdrawal by Subject|4|||
27935595|NCT01292473|81604124|FG002|Overall Study|Withdrawal by Subject|3|||
27935596|NCT01292473|81604125|FG003|Overall Study|Withdrawal by Subject|3|||
27935597|NCT01292473|81604122|FG000|Overall Study|Physician Decision|0|||
27935598|NCT01292473|81604123|FG001|Overall Study|Physician Decision|1|||
27935599|NCT01292473|81604124|FG002|Overall Study|Physician Decision|0|||
27935600|NCT01292473|81604125|FG003|Overall Study|Physician Decision|0|||
27935601|NCT01292473|81604122|FG000|Overall Study|Disease Progression|0|||
27935602|NCT01292473|81604123|FG001|Overall Study|Disease Progression|1|||
27935603|NCT01292473|81604124|FG002|Overall Study|Disease Progression|3|||
27935604|NCT01292473|81604125|FG003|Overall Study|Disease Progression|6|||
27935605|NCT00553475|81604126|FG000|Overall Study|Adverse Event|7|||
27935606|NCT00553475|81604127|FG001|Overall Study|Adverse Event|17|||
27550922|NCT01433991|80203523|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
27550923|NCT01433991|80203524|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
27550924|NCT01433991|80203525|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
27935607|NCT00553475|81604128|FG002|Overall Study|Adverse Event|13|||
27935608|NCT00553475|81604126|FG000|Overall Study|Lack of Efficacy|7|||
27935609|NCT00553475|81604127|FG001|Overall Study|Lack of Efficacy|1|||
27935610|NCT00553475|81604128|FG002|Overall Study|Lack of Efficacy|0|||
27935611|NCT00553475|81604126|FG000|Overall Study|Withdrawal by Subject|1|||
27935612|NCT00553475|81604127|FG001|Overall Study|Withdrawal by Subject|1|||
27935613|NCT00553475|81604128|FG002|Overall Study|Withdrawal by Subject|0|||
27935614|NCT00553475|81604126|FG000|Overall Study|Physician Decision|1|||
27935615|NCT00553475|81604127|FG001|Overall Study|Physician Decision|0|||
27935616|NCT00553475|81604128|FG002|Overall Study|Physician Decision|0|||
27935617|NCT00553475|81604126|FG000|Overall Study|Due to moving|0|||
27935618|NCT00553475|81604127|FG001|Overall Study|Due to moving|1|||
27935619|NCT00553475|81604128|FG002|Overall Study|Due to moving|0|||
27935620|NCT00159874|81604132|FG000|Overall Study|Adverse Event|2|||
27935621|NCT00159874|81604133|FG001|Overall Study|Adverse Event|2|||
27935622|NCT00159874|81604134|FG002|Overall Study|Adverse Event|5|||
27935623|NCT00159874|81604135|FG003|Overall Study|Adverse Event|1|||
27935624|NCT00159874|81604136|FG004|Overall Study|Adverse Event|1|||
27935625|NCT00159874|81604137|FG005|Overall Study|Adverse Event|2|||
27935626|NCT00159874|81604138|FG006|Overall Study|Adverse Event|0|||
27935627|NCT00159874|81604132|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
27935628|NCT00159874|81604133|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
27935629|NCT00159874|81604134|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
27935630|NCT00159874|81604135|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
27935631|NCT00159874|81604136|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
27935632|NCT00159874|81604137|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
27935633|NCT00159874|81604138|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
27935634|NCT00159874|81604132|FG000|Overall Study|Lack of Efficacy|2|||
27935635|NCT00159874|81604133|FG001|Overall Study|Lack of Efficacy|0|||
27935636|NCT00159874|81604134|FG002|Overall Study|Lack of Efficacy|1|||
27935637|NCT00159874|81604135|FG003|Overall Study|Lack of Efficacy|1|||
27935638|NCT00159874|81604136|FG004|Overall Study|Lack of Efficacy|0|||
27935639|NCT00159874|81604137|FG005|Overall Study|Lack of Efficacy|3|||
27935640|NCT00159874|81604138|FG006|Overall Study|Lack of Efficacy|0|||
27935641|NCT00159874|81604132|FG000|Overall Study|Lost to Follow-up|1|||
27935642|NCT00159874|81604133|FG001|Overall Study|Lost to Follow-up|0|||
27935643|NCT00159874|81604134|FG002|Overall Study|Lost to Follow-up|3|||
27935644|NCT00159874|81604135|FG003|Overall Study|Lost to Follow-up|0|||
27935645|NCT00159874|81604136|FG004|Overall Study|Lost to Follow-up|1|||
27935646|NCT00159874|81604137|FG005|Overall Study|Lost to Follow-up|2|||
27935647|NCT00159874|81604138|FG006|Overall Study|Lost to Follow-up|1|||
27935648|NCT00159874|81604132|FG000|Overall Study|Other|8|||
27935649|NCT00159874|81604133|FG001|Overall Study|Other|8|||
27935650|NCT00159874|81604134|FG002|Overall Study|Other|8|||
27935651|NCT00159874|81604135|FG003|Overall Study|Other|0|||
27935652|NCT00159874|81604136|FG004|Overall Study|Other|2|||
27935653|NCT00159874|81604137|FG005|Overall Study|Other|1|||
27935654|NCT00159874|81604138|FG006|Overall Study|Other|3|||
27935655|NCT00159874|81604132|FG000|Overall Study|Protocol Violation|0|||
27935656|NCT00159874|81604133|FG001|Overall Study|Protocol Violation|5|||
27935657|NCT00159874|81604134|FG002|Overall Study|Protocol Violation|2|||
27935658|NCT00159874|81604135|FG003|Overall Study|Protocol Violation|0|||
27935659|NCT00159874|81604136|FG004|Overall Study|Protocol Violation|0|||
27935660|NCT00159874|81604137|FG005|Overall Study|Protocol Violation|0|||
27935661|NCT00159874|81604138|FG006|Overall Study|Protocol Violation|0|||
27935662|NCT00159874|81604132|FG000|Overall Study|Death|3|||
27935663|NCT00159874|81604133|FG001|Overall Study|Death|8|||
27935664|NCT00159874|81604134|FG002|Overall Study|Death|15|||
27935665|NCT00159874|81604135|FG003|Overall Study|Death|0|||
27935666|NCT00159874|81604136|FG004|Overall Study|Death|1|||
27935667|NCT00159874|81604137|FG005|Overall Study|Death|2|||
27935668|NCT00159874|81604138|FG006|Overall Study|Death|0|||
27935669|NCT00159874|81604132|FG000|Overall Study|Withdrawal by Subject|2|||
27935670|NCT00159874|81604133|FG001|Overall Study|Withdrawal by Subject|6|||
27935671|NCT00159874|81604134|FG002|Overall Study|Withdrawal by Subject|8|||
27935672|NCT00159874|81604135|FG003|Overall Study|Withdrawal by Subject|4|||
27935673|NCT00159874|81604136|FG004|Overall Study|Withdrawal by Subject|3|||
27935674|NCT00159874|81604137|FG005|Overall Study|Withdrawal by Subject|2|||
27935675|NCT00159874|81604138|FG006|Overall Study|Withdrawal by Subject|1|||
27935676|NCT00159874|81604132|FG000|Overall Study|Pregnancy|1|||
27935677|NCT00159874|81604133|FG001|Overall Study|Pregnancy|1|||
27935678|NCT00159874|81604134|FG002|Overall Study|Pregnancy|0|||
27935679|NCT00159874|81604135|FG003|Overall Study|Pregnancy|0|||
27935680|NCT00159874|81604136|FG004|Overall Study|Pregnancy|0|||
27935681|NCT00159874|81604137|FG005|Overall Study|Pregnancy|0|||
27935682|NCT00159874|81604138|FG006|Overall Study|Pregnancy|0|||
27550925|NCT01433991|80203526|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
27935683|NCT02916433|81604139|FG000|Overall Study|Withdrawal by Subject|1|||
27935684|NCT02916433|81604140|FG001|Overall Study|Withdrawal by Subject|0|||
27935685|NCT02916433|81604139|FG000|Overall Study|Physician Decision|1|||
27935686|NCT02916433|81604140|FG001|Overall Study|Physician Decision|0|||
27935687|NCT03315689|81604142|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
27935688|NCT03315689|81604143|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
27935689|NCT03315689|81604142|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
27935690|NCT03315689|81604143|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
27935691|NCT03315689|81604142|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
27935692|NCT03315689|81604143|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
27935693|NCT00682435|81604144|FG000|Overall Study|Insufficient data|5|||
27935694|NCT00682435|81604144|FG000|Overall Study|Erroneously enrolled twice|2|||
27935695|NCT01166945|81604146|FG000|Randomized|diagnosed with Group A strep|4|||
27935696|NCT01166945|81604147|FG001|Randomized|diagnosed with Group A strep|4|||
27935697|NCT01166945|81604146|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
27935698|NCT01166945|81604147|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
27935699|NCT01166945|81604146|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
27935700|NCT01166945|81604147|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
27935701|NCT01166945|81604146|FG000|Day 30|Lost to Follow-up|4|||
27935702|NCT01166945|81604147|FG001|Day 30|Lost to Follow-up|3|||
27935703|NCT01720602|81604148|FG000|Overall Study|Adverse Event|3|||
27935704|NCT01720602|81604148|FG000|Overall Study|Progressive disease on therapy|2|||
27935705|NCT04341662|81604149|FG000|Overall Study|Did not have source-verified blood loss data|423|||
27935706|NCT04341662|81604150|FG001|Overall Study|Did not have source-verified blood loss data|514|||
27935707|NCT02255279|81604152|FG000|Overall Study|Lost to Follow-up|2|||
27643231|NCT00229658|80536356|FG000|Overall Study|Withdrawal of consent|46|||
27643232|NCT00229658|80536357|FG001|Overall Study|Withdrawal of consent|39|||
27643233|NCT01939899|80536367|FG000|Lead-in Dose Finding Phase|Death|0|||
27643234|NCT01939899|80536368|FG001|Lead-in Dose Finding Phase|Death|3|||
27643235|NCT01939899|80536369|FG002|Lead-in Dose Finding Phase|Death|1|||
27643236|NCT01939899|80536370|FG003|Lead-in Dose Finding Phase|Death|0|||
27643237|NCT01939899|80536371|FG004|Lead-in Dose Finding Phase|Death|0|||
27643238|NCT01939899|80536367|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
27643239|NCT01939899|80536368|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
27643240|NCT01939899|80536369|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
27643241|NCT01939899|80536370|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
27643242|NCT01939899|80536371|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
27643243|NCT01939899|80536367|FG000|Lead-in Dose Finding Phase|Other|0|||
27643244|NCT01939899|80536368|FG001|Lead-in Dose Finding Phase|Other|0|||
27643245|NCT01939899|80536369|FG002|Lead-in Dose Finding Phase|Other|1|||
27643246|NCT01939899|80536370|FG003|Lead-in Dose Finding Phase|Other|0|||
27935708|NCT02255279|81604153|FG001|Overall Study|Lost to Follow-up|2|||
27935709|NCT02255279|81604152|FG000|Overall Study|Protocol Violation|0|||
27935710|NCT02255279|81604153|FG001|Overall Study|Protocol Violation|1|||
27935711|NCT02255279|81604152|FG000|Overall Study|Withdrawal by Subject|3|||
27935712|NCT02255279|81604153|FG001|Overall Study|Withdrawal by Subject|6|||
27935713|NCT00345592|81604161|FG000|Overall Study|Death|14|||
27935714|NCT00345592|81604162|FG001|Overall Study|Death|16|||
27935715|NCT00345592|81604161|FG000|Overall Study|Withdrawal by Subject|11|||
27935716|NCT00345592|81604162|FG001|Overall Study|Withdrawal by Subject|8|||
27935717|NCT03364686|81604163|FG000|Overall Study|Physician Decision|2|||
27935718|NCT01371565|81604164|FG000|Overall Study|Withdrawal by Subject|1|||
27935719|NCT01371565|81604164|FG000|Overall Study|Death|1|||
27935720|NCT01371565|81604164|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
27935721|NCT01936974|81604165|FG000|Overall Study|Physician Decision|2|||
27935722|NCT01936974|81604166|FG001|Overall Study|Physician Decision|5|||
27935723|NCT00420056|81604167|FG000|Overall Study|Objective progression or relapse|17|||
27935724|NCT01065766|81604168|FG000|Overall Study|Assessed before the contracted date|1|||
27935725|NCT01065766|81604168|FG000|Overall Study|Contraindication to administration|6|||
27935726|NCT01065766|81604168|FG000|Overall Study|Violated dosage/administration|25|||
27935727|NCT03632720|81604169|FG000|Overall Study|Adverse Event|2|||
27935728|NCT03632720|81604170|FG001|Overall Study|Adverse Event|0|||
27935729|NCT03632720|81604171|FG002|Overall Study|Adverse Event|0|||
27935730|NCT03632720|81604169|FG000|Overall Study|Lost to Follow-up|0|||
27935731|NCT03632720|81604170|FG001|Overall Study|Lost to Follow-up|1|||
27935732|NCT03632720|81604171|FG002|Overall Study|Lost to Follow-up|0|||
27935733|NCT03632720|81604169|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
27935734|NCT03632720|81604170|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
27935735|NCT03632720|81604171|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
27935736|NCT03632720|81604169|FG000|Overall Study|Screen failure|0|||
27935737|NCT03632720|81604170|FG001|Overall Study|Screen failure|1|||
27935738|NCT03632720|81604171|FG002|Overall Study|Screen failure|0|||
27935739|NCT02533674|81604172|FG000|Dose Level I|Progressive disease|1|||
27935740|NCT02533674|81604173|FG001|Dose Level I|Progressive disease|0|||
27935741|NCT02533674|81604174|FG002|Dose Level I|Progressive disease|0|||
27935742|NCT02533674|81604175|FG003|Dose Level I|Progressive disease|0|||
27935743|NCT02533674|81604176|FG004|Dose Level I|Progressive disease|0|||
27935744|NCT02533674|81604177|FG005|Dose Level I|Progressive disease|0|||
27935745|NCT02533674|81604178|FG006|Dose Level I|Progressive disease|0|||
27643247|NCT01939899|80536371|FG004|Lead-in Dose Finding Phase|Other|0|||
27643248|NCT01939899|80536367|FG000|Phase 2|Withdrawal by Subject|0|||
27935746|NCT02533674|81604179|FG007|Dose Level I|Progressive disease|0|||
27935747|NCT02533674|81604172|FG000|Dose Level I|Withdrawal by Subject|1|||
27935748|NCT02533674|81604173|FG001|Dose Level I|Withdrawal by Subject|0|||
27935749|NCT02533674|81604174|FG002|Dose Level I|Withdrawal by Subject|0|||
27935750|NCT02533674|81604175|FG003|Dose Level I|Withdrawal by Subject|0|||
27935751|NCT02533674|81604176|FG004|Dose Level I|Withdrawal by Subject|0|||
27935752|NCT02533674|81604177|FG005|Dose Level I|Withdrawal by Subject|0|||
27935753|NCT02533674|81604178|FG006|Dose Level I|Withdrawal by Subject|0|||
27935754|NCT02533674|81604179|FG007|Dose Level I|Withdrawal by Subject|0|||
27935755|NCT02533674|81604172|FG000|Dose Level I|Physician Decision|1|||
27935756|NCT02533674|81604173|FG001|Dose Level I|Physician Decision|0|||
27935757|NCT02533674|81604174|FG002|Dose Level I|Physician Decision|0|||
27935758|NCT02533674|81604175|FG003|Dose Level I|Physician Decision|0|||
27935759|NCT02533674|81604176|FG004|Dose Level I|Physician Decision|0|||
27935760|NCT02533674|81604177|FG005|Dose Level I|Physician Decision|0|||
27935761|NCT02533674|81604178|FG006|Dose Level I|Physician Decision|0|||
27935762|NCT02533674|81604179|FG007|Dose Level I|Physician Decision|0|||
27935763|NCT02533674|81604172|FG000|Dose Level I|Death|1|||
27935764|NCT02533674|81604173|FG001|Dose Level I|Death|0|||
27935765|NCT02533674|81604174|FG002|Dose Level I|Death|0|||
27935766|NCT02533674|81604175|FG003|Dose Level I|Death|0|||
27935767|NCT02533674|81604176|FG004|Dose Level I|Death|0|||
27935768|NCT02533674|81604177|FG005|Dose Level I|Death|0|||
27935769|NCT02533674|81604178|FG006|Dose Level I|Death|0|||
27935770|NCT02533674|81604179|FG007|Dose Level I|Death|0|||
27935771|NCT02533674|81604172|FG000|Dose Level I|Never Treated|1|||
27935772|NCT02533674|81604173|FG001|Dose Level I|Never Treated|0|||
27935773|NCT02533674|81604174|FG002|Dose Level I|Never Treated|0|||
27935774|NCT02533674|81604175|FG003|Dose Level I|Never Treated|0|||
27935775|NCT02533674|81604176|FG004|Dose Level I|Never Treated|0|||
27935776|NCT02533674|81604177|FG005|Dose Level I|Never Treated|0|||
27935777|NCT02533674|81604178|FG006|Dose Level I|Never Treated|0|||
27935778|NCT02533674|81604179|FG007|Dose Level I|Never Treated|0|||
27935779|NCT02533674|81604172|FG000|Dose Level II|Progressive disease|0|||
27935780|NCT02533674|81604173|FG001|Dose Level II|Progressive disease|3|||
27935781|NCT02533674|81604174|FG002|Dose Level II|Progressive disease|0|||
27935782|NCT02533674|81604175|FG003|Dose Level II|Progressive disease|0|||
27935783|NCT02533674|81604176|FG004|Dose Level II|Progressive disease|0|||
27935784|NCT02533674|81604177|FG005|Dose Level II|Progressive disease|0|||
27935785|NCT02533674|81604178|FG006|Dose Level II|Progressive disease|0|||
27935786|NCT02533674|81604179|FG007|Dose Level II|Progressive disease|0|||
27935787|NCT02533674|81604172|FG000|Dose Level II|Withdrawal by Subject|0|||
27935788|NCT02533674|81604173|FG001|Dose Level II|Withdrawal by Subject|1|||
27935789|NCT02533674|81604174|FG002|Dose Level II|Withdrawal by Subject|0|||
27935790|NCT02533674|81604175|FG003|Dose Level II|Withdrawal by Subject|0|||
27935791|NCT02533674|81604176|FG004|Dose Level II|Withdrawal by Subject|0|||
27935792|NCT02533674|81604177|FG005|Dose Level II|Withdrawal by Subject|0|||
27935793|NCT02533674|81604178|FG006|Dose Level II|Withdrawal by Subject|0|||
27935794|NCT02533674|81604179|FG007|Dose Level II|Withdrawal by Subject|0|||
27935795|NCT02533674|81604172|FG000|Dose Level II|Treatment-related AE|0|||
27935796|NCT02533674|81604173|FG001|Dose Level II|Treatment-related AE|1|||
27935797|NCT02533674|81604174|FG002|Dose Level II|Treatment-related AE|0|||
27935798|NCT02533674|81604175|FG003|Dose Level II|Treatment-related AE|0|||
27935799|NCT02533674|81604176|FG004|Dose Level II|Treatment-related AE|0|||
27935800|NCT02533674|81604177|FG005|Dose Level II|Treatment-related AE|0|||
27935801|NCT02533674|81604178|FG006|Dose Level II|Treatment-related AE|0|||
27935802|NCT02533674|81604179|FG007|Dose Level II|Treatment-related AE|0|||
27935803|NCT02533674|81604172|FG000|Dose Level II|Physician Decision|0|||
27935804|NCT02533674|81604173|FG001|Dose Level II|Physician Decision|1|||
27935805|NCT02533674|81604174|FG002|Dose Level II|Physician Decision|0|||
27935806|NCT02533674|81604175|FG003|Dose Level II|Physician Decision|0|||
27935807|NCT02533674|81604176|FG004|Dose Level II|Physician Decision|0|||
27643249|NCT01939899|80536368|FG001|Phase 2|Withdrawal by Subject|0|||
27643250|NCT01939899|80536369|FG002|Phase 2|Withdrawal by Subject|0|||
27643251|NCT01939899|80536370|FG003|Phase 2|Withdrawal by Subject|2|||
27643252|NCT01939899|80536371|FG004|Phase 2|Withdrawal by Subject|0|||
27643253|NCT01939899|80536367|FG000|Phase 2|Disease Progression|0|||
27935808|NCT02533674|81604177|FG005|Dose Level II|Physician Decision|0|||
27935809|NCT02533674|81604178|FG006|Dose Level II|Physician Decision|0|||
27935810|NCT02533674|81604179|FG007|Dose Level II|Physician Decision|0|||
27643254|NCT01939899|80536368|FG001|Phase 2|Disease Progression|0|||
27643255|NCT01939899|80536369|FG002|Phase 2|Disease Progression|0|||
27935811|NCT02533674|81604172|FG000|Dose Level II|Non-treatment-related AE|0|||
27935812|NCT02533674|81604173|FG001|Dose Level II|Non-treatment-related AE|1|||
27935813|NCT02533674|81604174|FG002|Dose Level II|Non-treatment-related AE|0|||
27935814|NCT02533674|81604175|FG003|Dose Level II|Non-treatment-related AE|0|||
27935815|NCT02533674|81604176|FG004|Dose Level II|Non-treatment-related AE|0|||
27935816|NCT02533674|81604177|FG005|Dose Level II|Non-treatment-related AE|0|||
27935817|NCT02533674|81604178|FG006|Dose Level II|Non-treatment-related AE|0|||
27935818|NCT02533674|81604179|FG007|Dose Level II|Non-treatment-related AE|0|||
27643256|NCT01939899|80536370|FG003|Phase 2|Disease Progression|9|||
27643257|NCT01939899|80536371|FG004|Phase 2|Disease Progression|1|||
27643258|NCT01998958|80536373|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643259|NCT01998958|80536374|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
27643260|NCT01998958|80536375|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643261|NCT01998958|80536376|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643262|NCT01998958|80536377|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27935819|NCT02533674|81604172|FG000|Dose Level III|Progressive disease|0|||
27935820|NCT02533674|81604173|FG001|Dose Level III|Progressive disease|0|||
27935821|NCT02533674|81604174|FG002|Dose Level III|Progressive disease|2|||
27935822|NCT02533674|81604175|FG003|Dose Level III|Progressive disease|0|||
27935823|NCT02533674|81604176|FG004|Dose Level III|Progressive disease|0|||
27935824|NCT02533674|81604177|FG005|Dose Level III|Progressive disease|0|||
27935825|NCT02533674|81604178|FG006|Dose Level III|Progressive disease|0|||
27935826|NCT02533674|81604179|FG007|Dose Level III|Progressive disease|0|||
27935827|NCT02533674|81604172|FG000|Dose Level III|Withdrawal by Subject|0|||
27643263|NCT01998958|80536378|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643264|NCT01998958|80536379|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643265|NCT01998958|80536380|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643266|NCT01998958|80536381|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643267|NCT01998958|80536382|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643268|NCT01998958|80536383|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643269|NCT01998958|80536384|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643270|NCT01998958|80536385|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643271|NCT01998958|80536386|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643272|NCT01998958|80536387|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643273|NCT01998958|80536388|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643274|NCT01998958|80536389|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643275|NCT01998958|80536390|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643276|NCT01998958|80536391|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643277|NCT01998958|80536392|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643278|NCT01998958|80536393|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643279|NCT01998958|80536394|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643280|NCT01998958|80536395|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643281|NCT01998958|80536396|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643282|NCT01998958|80536397|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643283|NCT01998958|80536398|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643284|NCT01998958|80536399|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643285|NCT01998958|80536400|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643286|NCT01998958|80536401|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643287|NCT01998958|80536402|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643288|NCT01998958|80536403|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643289|NCT01998958|80536404|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
27643290|NCT01998958|80536373|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643291|NCT01998958|80536374|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
27643292|NCT01998958|80536375|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643293|NCT01998958|80536376|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643294|NCT01998958|80536377|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643295|NCT01998958|80536378|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643296|NCT01998958|80536379|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643297|NCT01998958|80536380|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643298|NCT01998958|80536381|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643299|NCT01998958|80536382|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643300|NCT01998958|80536383|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643301|NCT01998958|80536384|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643302|NCT01998958|80536385|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643303|NCT01998958|80536386|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643304|NCT01998958|80536387|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643305|NCT01998958|80536388|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643306|NCT01998958|80536389|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643307|NCT01998958|80536390|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643308|NCT01998958|80536391|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643309|NCT01998958|80536392|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643310|NCT01998958|80536393|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643311|NCT01998958|80536394|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643312|NCT01998958|80536395|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643313|NCT01998958|80536396|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643314|NCT01998958|80536397|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643315|NCT01998958|80536398|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643316|NCT01998958|80536399|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643317|NCT01998958|80536400|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27935828|NCT02533674|81604173|FG001|Dose Level III|Withdrawal by Subject|0|||
27935829|NCT02533674|81604174|FG002|Dose Level III|Withdrawal by Subject|1|||
27935830|NCT02533674|81604175|FG003|Dose Level III|Withdrawal by Subject|0|||
27935831|NCT02533674|81604176|FG004|Dose Level III|Withdrawal by Subject|0|||
27935832|NCT02533674|81604177|FG005|Dose Level III|Withdrawal by Subject|0|||
27935833|NCT02533674|81604178|FG006|Dose Level III|Withdrawal by Subject|0|||
27935834|NCT02533674|81604179|FG007|Dose Level III|Withdrawal by Subject|0|||
27935835|NCT02533674|81604172|FG000|Dose Level III|Treatment-related AE|0|||
27935836|NCT02533674|81604173|FG001|Dose Level III|Treatment-related AE|0|||
27935837|NCT02533674|81604174|FG002|Dose Level III|Treatment-related AE|1|||
27935838|NCT02533674|81604175|FG003|Dose Level III|Treatment-related AE|0|||
27935839|NCT02533674|81604176|FG004|Dose Level III|Treatment-related AE|0|||
27935840|NCT02533674|81604177|FG005|Dose Level III|Treatment-related AE|0|||
27935841|NCT02533674|81604178|FG006|Dose Level III|Treatment-related AE|0|||
27935842|NCT02533674|81604179|FG007|Dose Level III|Treatment-related AE|0|||
27935843|NCT02533674|81604172|FG000|Dose Level IV|Progressive disease|0|||
27643318|NCT01998958|80536401|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643319|NCT01998958|80536402|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643320|NCT01998958|80536403|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27935844|NCT02533674|81604173|FG001|Dose Level IV|Progressive disease|0|||
27935845|NCT02533674|81604174|FG002|Dose Level IV|Progressive disease|0|||
27935846|NCT02533674|81604175|FG003|Dose Level IV|Progressive disease|3|||
27935847|NCT02533674|81604176|FG004|Dose Level IV|Progressive disease|0|||
27935848|NCT02533674|81604177|FG005|Dose Level IV|Progressive disease|0|||
27935849|NCT02533674|81604178|FG006|Dose Level IV|Progressive disease|0|||
27935850|NCT02533674|81604179|FG007|Dose Level IV|Progressive disease|0|||
27935851|NCT02533674|81604172|FG000|Dose Level IV|Withdrawal by Subject|0|||
27935852|NCT02533674|81604173|FG001|Dose Level IV|Withdrawal by Subject|0|||
27935853|NCT02533674|81604174|FG002|Dose Level IV|Withdrawal by Subject|0|||
27935854|NCT02533674|81604175|FG003|Dose Level IV|Withdrawal by Subject|1|||
27935855|NCT02533674|81604176|FG004|Dose Level IV|Withdrawal by Subject|0|||
27935856|NCT02533674|81604177|FG005|Dose Level IV|Withdrawal by Subject|0|||
27935857|NCT02533674|81604178|FG006|Dose Level IV|Withdrawal by Subject|0|||
27935858|NCT02533674|81604179|FG007|Dose Level IV|Withdrawal by Subject|0|||
27935859|NCT02533674|81604172|FG000|Dose Level IV|Physician Decision|0|||
27935860|NCT02533674|81604173|FG001|Dose Level IV|Physician Decision|0|||
27935861|NCT02533674|81604174|FG002|Dose Level IV|Physician Decision|0|||
27935862|NCT02533674|81604175|FG003|Dose Level IV|Physician Decision|1|||
27935863|NCT02533674|81604176|FG004|Dose Level IV|Physician Decision|0|||
27935864|NCT02533674|81604177|FG005|Dose Level IV|Physician Decision|0|||
27935865|NCT02533674|81604178|FG006|Dose Level IV|Physician Decision|0|||
27935866|NCT02533674|81604179|FG007|Dose Level IV|Physician Decision|0|||
27935867|NCT02533674|81604172|FG000|Dose Level V|Progressive disease|0|||
27935868|NCT02533674|81604173|FG001|Dose Level V|Progressive disease|0|||
27935869|NCT02533674|81604174|FG002|Dose Level V|Progressive disease|0|||
27935870|NCT02533674|81604175|FG003|Dose Level V|Progressive disease|0|||
27935871|NCT02533674|81604176|FG004|Dose Level V|Progressive disease|3|||
27935872|NCT02533674|81604177|FG005|Dose Level V|Progressive disease|0|||
27935873|NCT02533674|81604178|FG006|Dose Level V|Progressive disease|0|||
27935874|NCT02533674|81604179|FG007|Dose Level V|Progressive disease|0|||
27935875|NCT02533674|81604172|FG000|Dose Level V|Withdrawal by Subject|0|||
27935876|NCT02533674|81604173|FG001|Dose Level V|Withdrawal by Subject|0|||
27935877|NCT02533674|81604174|FG002|Dose Level V|Withdrawal by Subject|0|||
27935878|NCT02533674|81604175|FG003|Dose Level V|Withdrawal by Subject|0|||
27935879|NCT02533674|81604176|FG004|Dose Level V|Withdrawal by Subject|1|||
27935880|NCT02533674|81604177|FG005|Dose Level V|Withdrawal by Subject|0|||
27935881|NCT02533674|81604178|FG006|Dose Level V|Withdrawal by Subject|0|||
27935882|NCT02533674|81604179|FG007|Dose Level V|Withdrawal by Subject|0|||
27935883|NCT02533674|81604172|FG000|Dose Level V|Physician Decision|0|||
27935884|NCT02533674|81604173|FG001|Dose Level V|Physician Decision|0|||
27935885|NCT02533674|81604174|FG002|Dose Level V|Physician Decision|0|||
27935886|NCT02533674|81604175|FG003|Dose Level V|Physician Decision|0|||
27935887|NCT02533674|81604176|FG004|Dose Level V|Physician Decision|1|||
27935888|NCT02533674|81604177|FG005|Dose Level V|Physician Decision|0|||
27935889|NCT02533674|81604178|FG006|Dose Level V|Physician Decision|0|||
27935890|NCT02533674|81604179|FG007|Dose Level V|Physician Decision|0|||
27935891|NCT02533674|81604172|FG000|Dose Level VI|Progressive disease|0|||
27935892|NCT02533674|81604173|FG001|Dose Level VI|Progressive disease|0|||
27935893|NCT02533674|81604174|FG002|Dose Level VI|Progressive disease|0|||
27935894|NCT02533674|81604175|FG003|Dose Level VI|Progressive disease|0|||
27935895|NCT02533674|81604176|FG004|Dose Level VI|Progressive disease|0|||
27935896|NCT02533674|81604177|FG005|Dose Level VI|Progressive disease|7|||
27935897|NCT02533674|81604178|FG006|Dose Level VI|Progressive disease|0|||
27935898|NCT02533674|81604179|FG007|Dose Level VI|Progressive disease|0|||
27935899|NCT02533674|81604172|FG000|Dose Level VI|Withdrawal by Subject|0|||
27935900|NCT02533674|81604173|FG001|Dose Level VI|Withdrawal by Subject|0|||
27935901|NCT02533674|81604174|FG002|Dose Level VI|Withdrawal by Subject|0|||
27935902|NCT02533674|81604175|FG003|Dose Level VI|Withdrawal by Subject|0|||
27935903|NCT02533674|81604176|FG004|Dose Level VI|Withdrawal by Subject|0|||
27935904|NCT02533674|81604177|FG005|Dose Level VI|Withdrawal by Subject|1|||
27935905|NCT02533674|81604178|FG006|Dose Level VI|Withdrawal by Subject|0|||
27935906|NCT02533674|81604179|FG007|Dose Level VI|Withdrawal by Subject|0|||
27935907|NCT02533674|81604172|FG000|Dose Level VI|Treatment-related AE|0|||
27935908|NCT02533674|81604173|FG001|Dose Level VI|Treatment-related AE|0|||
27935909|NCT02533674|81604174|FG002|Dose Level VI|Treatment-related AE|0|||
27935910|NCT02533674|81604175|FG003|Dose Level VI|Treatment-related AE|0|||
27935911|NCT02533674|81604176|FG004|Dose Level VI|Treatment-related AE|0|||
27935912|NCT02533674|81604177|FG005|Dose Level VI|Treatment-related AE|1|||
27935913|NCT02533674|81604178|FG006|Dose Level VI|Treatment-related AE|0|||
27935914|NCT02533674|81604179|FG007|Dose Level VI|Treatment-related AE|0|||
27935915|NCT02533674|81604172|FG000|Dose Level VII|Progressive disease|0|||
27935916|NCT02533674|81604173|FG001|Dose Level VII|Progressive disease|0|||
27935917|NCT02533674|81604174|FG002|Dose Level VII|Progressive disease|0|||
27935918|NCT02533674|81604175|FG003|Dose Level VII|Progressive disease|0|||
27935919|NCT02533674|81604176|FG004|Dose Level VII|Progressive disease|0|||
27935920|NCT02533674|81604177|FG005|Dose Level VII|Progressive disease|0|||
27935921|NCT02533674|81604178|FG006|Dose Level VII|Progressive disease|10|||
27935922|NCT02533674|81604179|FG007|Dose Level VII|Progressive disease|0|||
27935923|NCT02533674|81604172|FG000|Dose Level VII|Withdrawal by Subject|0|||
27935924|NCT02533674|81604173|FG001|Dose Level VII|Withdrawal by Subject|0|||
27935925|NCT02533674|81604174|FG002|Dose Level VII|Withdrawal by Subject|0|||
27935926|NCT02533674|81604175|FG003|Dose Level VII|Withdrawal by Subject|0|||
27935927|NCT02533674|81604176|FG004|Dose Level VII|Withdrawal by Subject|0|||
27935928|NCT02533674|81604177|FG005|Dose Level VII|Withdrawal by Subject|0|||
27935929|NCT02533674|81604178|FG006|Dose Level VII|Withdrawal by Subject|3|||
27935930|NCT02533674|81604179|FG007|Dose Level VII|Withdrawal by Subject|0|||
27935931|NCT02533674|81604172|FG000|Dose Level VII|Treatment-related AE|0|||
27935932|NCT02533674|81604173|FG001|Dose Level VII|Treatment-related AE|0|||
27935933|NCT02533674|81604174|FG002|Dose Level VII|Treatment-related AE|0|||
27935934|NCT02533674|81604175|FG003|Dose Level VII|Treatment-related AE|0|||
27935935|NCT02533674|81604176|FG004|Dose Level VII|Treatment-related AE|0|||
27935936|NCT02533674|81604177|FG005|Dose Level VII|Treatment-related AE|0|||
27935937|NCT02533674|81604178|FG006|Dose Level VII|Treatment-related AE|1|||
27935938|NCT02533674|81604179|FG007|Dose Level VII|Treatment-related AE|0|||
27935939|NCT02533674|81604172|FG000|Dose Level VII|Death|0|||
27935940|NCT02533674|81604173|FG001|Dose Level VII|Death|0|||
27935941|NCT02533674|81604174|FG002|Dose Level VII|Death|0|||
27935942|NCT02533674|81604175|FG003|Dose Level VII|Death|0|||
27935943|NCT02533674|81604176|FG004|Dose Level VII|Death|0|||
27935944|NCT02533674|81604177|FG005|Dose Level VII|Death|0|||
27935945|NCT02533674|81604178|FG006|Dose Level VII|Death|2|||
27935946|NCT02533674|81604179|FG007|Dose Level VII|Death|0|||
27935947|NCT02533674|81604172|FG000|Dose Level VIII|Progressive disease|0|||
27935948|NCT02533674|81604173|FG001|Dose Level VIII|Progressive disease|0|||
27935949|NCT02533674|81604174|FG002|Dose Level VIII|Progressive disease|0|||
27935950|NCT02533674|81604175|FG003|Dose Level VIII|Progressive disease|0|||
27935951|NCT02533674|81604176|FG004|Dose Level VIII|Progressive disease|0|||
27935952|NCT02533674|81604177|FG005|Dose Level VIII|Progressive disease|0|||
27935953|NCT02533674|81604178|FG006|Dose Level VIII|Progressive disease|0|||
27935954|NCT02533674|81604179|FG007|Dose Level VIII|Progressive disease|3|||
27935955|NCT02533674|81604172|FG000|Dose Level VIII|Withdrawal by Subject|0|||
27935956|NCT02533674|81604173|FG001|Dose Level VIII|Withdrawal by Subject|0|||
27935957|NCT02533674|81604174|FG002|Dose Level VIII|Withdrawal by Subject|0|||
27935958|NCT02533674|81604175|FG003|Dose Level VIII|Withdrawal by Subject|0|||
27935959|NCT02533674|81604176|FG004|Dose Level VIII|Withdrawal by Subject|0|||
27935960|NCT02533674|81604177|FG005|Dose Level VIII|Withdrawal by Subject|0|||
27935961|NCT02533674|81604178|FG006|Dose Level VIII|Withdrawal by Subject|0|||
27935962|NCT02533674|81604179|FG007|Dose Level VIII|Withdrawal by Subject|1|||
27935963|NCT02533674|81604172|FG000|Dose Level VIII|Treatment-related AE|0|||
27935964|NCT02533674|81604173|FG001|Dose Level VIII|Treatment-related AE|0|||
27935965|NCT02533674|81604174|FG002|Dose Level VIII|Treatment-related AE|0|||
27935966|NCT02533674|81604175|FG003|Dose Level VIII|Treatment-related AE|0|||
27935967|NCT02533674|81604176|FG004|Dose Level VIII|Treatment-related AE|0|||
27935968|NCT02533674|81604177|FG005|Dose Level VIII|Treatment-related AE|0|||
27935969|NCT02533674|81604178|FG006|Dose Level VIII|Treatment-related AE|0|||
27550926|NCT02324569|80203527|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
27935970|NCT02533674|81604179|FG007|Dose Level VIII|Treatment-related AE|1|||
27935971|NCT02533674|81604172|FG000|Dose Level VIII|Never treated|0|||
27935972|NCT02533674|81604173|FG001|Dose Level VIII|Never treated|0|||
27935973|NCT02533674|81604174|FG002|Dose Level VIII|Never treated|0|||
27935974|NCT02533674|81604175|FG003|Dose Level VIII|Never treated|0|||
27935975|NCT02533674|81604176|FG004|Dose Level VIII|Never treated|0|||
27935976|NCT02533674|81604177|FG005|Dose Level VIII|Never treated|0|||
27935977|NCT02533674|81604178|FG006|Dose Level VIII|Never treated|0|||
27935978|NCT02533674|81604179|FG007|Dose Level VIII|Never treated|1|||
27935979|NCT02830087|81604180|FG000|Overall Study|No study staff to follow-up patients|4|||
27935980|NCT02830087|81604181|FG001|Overall Study|No study staff to follow-up patients|4|||
27935981|NCT02830087|81604182|FG002|Overall Study|No study staff to follow-up patients|4|||
27935982|NCT02830087|81604183|FG003|Overall Study|No study staff to follow-up patients|3|||
27935983|NCT02830087|81604184|FG004|Overall Study|No study staff to follow-up patients|3|||
27935984|NCT02830087|81604185|FG005|Overall Study|No study staff to follow-up patients|3|||
27935985|NCT01803737|81604186|FG000|Overall Study|Lack of Time|1|||
27935986|NCT01803737|81604187|FG001|Overall Study|Lack of Time|0|||
27935987|NCT01803737|81604186|FG000|Overall Study|Medical Reason|0|||
27935988|NCT01803737|81604187|FG001|Overall Study|Medical Reason|1|||
27935989|NCT01803737|81604186|FG000|Overall Study|Lost to Follow-up|0|||
27935990|NCT01803737|81604187|FG001|Overall Study|Lost to Follow-up|2|||
27935991|NCT00160615|81604189|FG000|Overall Study|Adverse Event|5|||
27935992|NCT00160615|81604190|FG001|Overall Study|Adverse Event|12|||
27935993|NCT00160615|81604189|FG000|Overall Study|Withdrawal by Subject|0|||
27935994|NCT00160615|81604190|FG001|Overall Study|Withdrawal by Subject|2|||
27935995|NCT00160615|81604189|FG000|Overall Study|Lack of Efficacy|11|||
27935996|NCT00160615|81604190|FG001|Overall Study|Lack of Efficacy|23|||
27935997|NCT00160615|81604189|FG000|Overall Study|Patient decision|1|||
27935998|NCT00160615|81604190|FG001|Overall Study|Patient decision|2|||
27935999|NCT00160615|81604189|FG000|Overall Study|Investigator decision|1|||
27936000|NCT00160615|81604190|FG001|Overall Study|Investigator decision|1|||
27643321|NCT01998958|80536404|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
27643322|NCT01998958|80536373|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
27643323|NCT01998958|80536374|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
27643324|NCT01998958|80536375|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
27643325|NCT01998958|80536376|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
27643326|NCT01998958|80536377|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
27643327|NCT01998958|80536378|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
27643328|NCT01998958|80536379|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
27743764|NCT00914628|80892673|FG000|Overall Study|non-randomized|1|||
27936001|NCT00160615|81604189|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
27936002|NCT00160615|81604190|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
27936003|NCT00160615|81604189|FG000|Overall Study|Switch to surgical treatment|0|||
27936004|NCT00160615|81604190|FG001|Overall Study|Switch to surgical treatment|2|||
27936005|NCT00160615|81604189|FG000|Overall Study|Non-compliance was suspected|0|||
27936006|NCT00160615|81604190|FG001|Overall Study|Non-compliance was suspected|1|||
27936007|NCT00160615|81604189|FG000|Overall Study|Poor compliance|0|||
27936008|NCT00160615|81604190|FG001|Overall Study|Poor compliance|1|||
27936009|NCT01184118|81604194|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
27936010|NCT01184118|81604194|FG000|Overall Study|No physiologic confirmation of asthma|8|||
27936011|NCT01184118|81604194|FG000|Overall Study|FEV1 <60% predicted|2|||
27936012|NCT01184118|81604194|FG000|Overall Study|Exclusionary medical condition|2|||
27936013|NCT01184118|81604194|FG000|Overall Study|Withdrawal by Subject|5|||
27936014|NCT03760068|81604195|FG000|Overall Study|Withdrawal by Subject|7|||
27936015|NCT03760068|81604196|FG001|Overall Study|Withdrawal by Subject|8|||
27936016|NCT03760068|81604195|FG000|Overall Study|Adverse Event|1|||
27936017|NCT03760068|81604196|FG001|Overall Study|Adverse Event|2|||
27936018|NCT03760068|81604195|FG000|Overall Study|Administrative Decision by Sponsor|0|||
27936019|NCT03760068|81604196|FG001|Overall Study|Administrative Decision by Sponsor|2|||
27936020|NCT03760068|81604195|FG000|Overall Study|Physician Decision|1|||
27936021|NCT03760068|81604196|FG001|Overall Study|Physician Decision|2|||
27936022|NCT03760068|81604195|FG000|Overall Study|Lost to Follow-up|4|||
27936023|NCT03760068|81604196|FG001|Overall Study|Lost to Follow-up|9|||
27936024|NCT03760068|81604195|FG000|Overall Study|Subject Moved Out of State|1|||
27936025|NCT03760068|81604196|FG001|Overall Study|Subject Moved Out of State|0|||
27936026|NCT00890097|81604198|FG000|Overall Study|Adverse Event|21|||
27643329|NCT01998958|80536380|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
27643330|NCT01998958|80536381|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
27643331|NCT01998958|80536382|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
27643332|NCT01998958|80536383|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
27643333|NCT01998958|80536384|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
27643334|NCT01998958|80536385|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
27643335|NCT01998958|80536386|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
27743765|NCT00914628|80892674|FG001|Overall Study|non-randomized|0|||
27743766|NCT00914628|80892673|FG000|Overall Study|Relapse|1|||
27743767|NCT00914628|80892674|FG001|Overall Study|Relapse|2|||
27936027|NCT00890097|81604199|FG001|Overall Study|Adverse Event|32|||
27936028|NCT00890097|81604200|FG002|Overall Study|Adverse Event|28|||
27936029|NCT00890097|81604198|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
27936030|NCT00890097|81604199|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
27936031|NCT00890097|81604200|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
27936032|NCT00890097|81604198|FG000|Overall Study|Withdrew Consent|9|||
27936033|NCT00890097|81604199|FG001|Overall Study|Withdrew Consent|6|||
27936034|NCT00890097|81604200|FG002|Overall Study|Withdrew Consent|9|||
27936035|NCT00890097|81604198|FG000|Overall Study|Lost to Follow-up|5|||
27936036|NCT00890097|81604199|FG001|Overall Study|Lost to Follow-up|5|||
27936037|NCT00890097|81604200|FG002|Overall Study|Lost to Follow-up|5|||
27936038|NCT00890097|81604198|FG000|Overall Study|Noncompliance|0|||
27936039|NCT00890097|81604199|FG001|Overall Study|Noncompliance|4|||
27936040|NCT00890097|81604200|FG002|Overall Study|Noncompliance|4|||
27936041|NCT00890097|81604198|FG000|Overall Study|Sponsor Decision|7|||
27936042|NCT00890097|81604199|FG001|Overall Study|Sponsor Decision|11|||
27936043|NCT00890097|81604200|FG002|Overall Study|Sponsor Decision|7|||
27936044|NCT00890097|81604198|FG000|Overall Study|Did not attend final visit|2|||
27936045|NCT00890097|81604199|FG001|Overall Study|Did not attend final visit|3|||
27936046|NCT00890097|81604200|FG002|Overall Study|Did not attend final visit|0|||
27936047|NCT00890097|81604198|FG000|Overall Study|Subject Decision|3|||
27936048|NCT00890097|81604199|FG001|Overall Study|Subject Decision|2|||
27936049|NCT00890097|81604200|FG002|Overall Study|Subject Decision|6|||
27936050|NCT00890097|81604198|FG000|Overall Study|Randomization Error|2|||
27936051|NCT00890097|81604199|FG001|Overall Study|Randomization Error|0|||
27936052|NCT00890097|81604200|FG002|Overall Study|Randomization Error|0|||
27936053|NCT00890097|81604198|FG000|Overall Study|Failed inclusion criteria|3|||
27936054|NCT00890097|81604199|FG001|Overall Study|Failed inclusion criteria|4|||
27936055|NCT00890097|81604200|FG002|Overall Study|Failed inclusion criteria|0|||
27936056|NCT00890097|81604198|FG000|Overall Study|Transportation|0|||
27643336|NCT01998958|80536387|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
27936057|NCT00890097|81604199|FG001|Overall Study|Transportation|2|||
27936058|NCT00890097|81604200|FG002|Overall Study|Transportation|0|||
27643337|NCT01998958|80536388|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
27643338|NCT01998958|80536389|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
27643339|NCT01998958|80536390|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
27643340|NCT01998958|80536391|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
27643341|NCT01998958|80536392|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
27643342|NCT01998958|80536393|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
27643343|NCT01998958|80536394|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
27643344|NCT01998958|80536395|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
27643345|NCT01998958|80536396|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
27643346|NCT01998958|80536397|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
27643347|NCT01998958|80536398|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
27643348|NCT01998958|80536399|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
27643349|NCT01998958|80536400|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
27936059|NCT00890097|81604198|FG000|Overall Study|Subject Moved|0|||
27936060|NCT00890097|81604199|FG001|Overall Study|Subject Moved|4|||
27936061|NCT00890097|81604200|FG002|Overall Study|Subject Moved|0|||
27936062|NCT00890097|81604198|FG000|Overall Study|Protocol Deviation|1|||
27936063|NCT00890097|81604199|FG001|Overall Study|Protocol Deviation|1|||
27936064|NCT00890097|81604200|FG002|Overall Study|Protocol Deviation|1|||
27936065|NCT00576407|81604201|FG000|Overall Study|Death|7|||
27936066|NCT00576407|81604201|FG000|Overall Study|Physician Decision|1|||
27936067|NCT01158404|81604202|FG000|Overall Study|Withdrawal by Subject|0|||
27936068|NCT01158404|81604203|FG001|Overall Study|Withdrawal by Subject|1|||
27936069|NCT01158404|81604204|FG002|Overall Study|Withdrawal by Subject|0|||
27936070|NCT01158404|81604205|FG003|Overall Study|Withdrawal by Subject|0|||
27936071|NCT01158404|81604206|FG004|Overall Study|Withdrawal by Subject|3|||
27936072|NCT01158404|81604207|FG005|Overall Study|Withdrawal by Subject|1|||
27936073|NCT01158404|81604208|FG006|Overall Study|Withdrawal by Subject|0|||
27936074|NCT01158404|81604209|FG007|Overall Study|Withdrawal by Subject|1|||
27550927|NCT02324569|80203528|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
27550928|NCT02324569|80203527|FG000|Overall Study|Voluntary Withdrawal|3|||
27550929|NCT02324569|80203528|FG001|Overall Study|Voluntary Withdrawal|6|||
27550930|NCT02324569|80203527|FG000|Overall Study|Lack of Efficacy|2|||
27550931|NCT02324569|80203528|FG001|Overall Study|Lack of Efficacy|3|||
27550932|NCT02324569|80203527|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
27550933|NCT02324569|80203528|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
27550934|NCT02324569|80203527|FG000|Overall Study|Inconvenient Schedule|2|||
27550935|NCT02324569|80203528|FG001|Overall Study|Inconvenient Schedule|0|||
27550936|NCT02268084|80203534|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
27550937|NCT02268084|80203535|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
27550938|NCT02268084|80203534|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
27643350|NCT01998958|80536401|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
27643351|NCT01998958|80536402|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
27936075|NCT01158404|81604202|FG000|Overall Study|Physician Decision|0|||
27936076|NCT01158404|81604203|FG001|Overall Study|Physician Decision|0|||
27936077|NCT01158404|81604204|FG002|Overall Study|Physician Decision|0|||
27936078|NCT01158404|81604205|FG003|Overall Study|Physician Decision|0|||
27936079|NCT01158404|81604206|FG004|Overall Study|Physician Decision|0|||
27936080|NCT01158404|81604207|FG005|Overall Study|Physician Decision|0|||
27936081|NCT01158404|81604208|FG006|Overall Study|Physician Decision|0|||
27936082|NCT01158404|81604209|FG007|Overall Study|Physician Decision|1|||
27936083|NCT01158404|81604202|FG000|Overall Study|Progressive Disease|0|||
27936084|NCT01158404|81604203|FG001|Overall Study|Progressive Disease|0|||
27936085|NCT01158404|81604204|FG002|Overall Study|Progressive Disease|0|||
27643352|NCT01998958|80536403|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
27643353|NCT01998958|80536404|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
27643354|NCT01998958|80536373|FG000|Period 1 (Panel A and B)|Other|1|||
27643355|NCT01998958|80536374|FG001|Period 1 (Panel A and B)|Other|0|||
27643356|NCT01998958|80536375|FG002|Period 1 (Panel A and B)|Other|0|||
27643357|NCT01998958|80536376|FG003|Period 1 (Panel A and B)|Other|0|||
27936086|NCT01158404|81604205|FG003|Overall Study|Progressive Disease|0|||
27936087|NCT01158404|81604206|FG004|Overall Study|Progressive Disease|0|||
27643358|NCT01998958|80536377|FG004|Period 1 (Panel A and B)|Other|0|||
27643359|NCT01998958|80536378|FG005|Period 1 (Panel A and B)|Other|0|||
27643360|NCT01998958|80536379|FG006|Period 1 (Panel A and B)|Other|0|||
27643361|NCT01998958|80536380|FG007|Period 1 (Panel A and B)|Other|0|||
27743768|NCT00914628|80892673|FG000|Overall Study|Study terminated by Sponsor|14|||
27743769|NCT00914628|80892674|FG001|Overall Study|Study terminated by Sponsor|8|||
27643362|NCT01998958|80536381|FG008|Period 1 (Panel A and B)|Other|0|||
27643363|NCT01998958|80536382|FG009|Period 1 (Panel A and B)|Other|0|||
27643364|NCT01998958|80536383|FG010|Period 1 (Panel A and B)|Other|0|||
27643365|NCT01998958|80536384|FG011|Period 1 (Panel A and B)|Other|0|||
27643366|NCT01998958|80536385|FG012|Period 1 (Panel A and B)|Other|0|||
27643367|NCT01998958|80536386|FG013|Period 1 (Panel A and B)|Other|0|||
27643368|NCT01998958|80536387|FG014|Period 1 (Panel A and B)|Other|0|||
27643369|NCT01998958|80536388|FG015|Period 1 (Panel A and B)|Other|0|||
27643370|NCT01998958|80536389|FG016|Period 1 (Panel A and B)|Other|0|||
27643371|NCT01998958|80536390|FG017|Period 1 (Panel A and B)|Other|0|||
27643372|NCT01998958|80536391|FG018|Period 1 (Panel A and B)|Other|0|||
27643373|NCT01998958|80536392|FG019|Period 1 (Panel A and B)|Other|0|||
27643374|NCT01998958|80536393|FG020|Period 1 (Panel A and B)|Other|0|||
27643375|NCT01998958|80536394|FG021|Period 1 (Panel A and B)|Other|0|||
27643376|NCT01998958|80536395|FG022|Period 1 (Panel A and B)|Other|0|||
27643377|NCT01998958|80536396|FG023|Period 1 (Panel A and B)|Other|0|||
27643378|NCT01998958|80536397|FG024|Period 1 (Panel A and B)|Other|0|||
27643379|NCT01998958|80536398|FG025|Period 1 (Panel A and B)|Other|0|||
27643380|NCT01998958|80536399|FG026|Period 1 (Panel A and B)|Other|0|||
27643381|NCT01998958|80536400|FG027|Period 1 (Panel A and B)|Other|0|||
27643382|NCT01998958|80536401|FG028|Period 1 (Panel A and B)|Other|0|||
27643383|NCT01998958|80536402|FG029|Period 1 (Panel A and B)|Other|0|||
27643384|NCT01998958|80536403|FG030|Period 1 (Panel A and B)|Other|0|||
27643385|NCT01998958|80536404|FG031|Period 1 (Panel A and B)|Other|0|||
27643386|NCT01998958|80536373|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
27643387|NCT01998958|80536374|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
27643388|NCT01998958|80536375|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
27643389|NCT01998958|80536376|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
27643390|NCT01998958|80536377|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
27643391|NCT01998958|80536378|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
27643392|NCT01998958|80536379|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
27643393|NCT01998958|80536380|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
27643394|NCT01998958|80536381|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
27643395|NCT01998958|80536382|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
27643396|NCT01998958|80536383|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
27643397|NCT01998958|80536384|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
27743770|NCT00914628|80892673|FG000|Overall Study|Patients who did not receive a single dose|7|||
27743771|NCT00914628|80892674|FG001|Overall Study|Patients who did not receive a single dose|1|||
27743772|NCT02239094|80892675|FG000|Overall Study|Withdrawal by Subject|1|||
27743773|NCT02239094|80892675|FG000|Overall Study|Remitted before started|1|||
27743774|NCT00909090|80892678|FG000|Overall Study|Lost to Follow-up|17|||
27743775|NCT00909090|80892679|FG001|Overall Study|Lost to Follow-up|17|||
27743776|NCT00455858|80892682|FG000|Overall Study|Lost to Follow-up|2|||
27743777|NCT00455858|80892682|FG000|Overall Study|Protocol Violation|1|||
27743778|NCT00455858|80892682|FG000|Overall Study|Lack of Efficacy|1|||
27743779|NCT00455858|80892682|FG000|Overall Study|Well controlled FPG without insulin|1|||
27743780|NCT00455858|80892682|FG000|Overall Study|Withdrawal|1|||
27743781|NCT00590681|80892683|FG000|Overall Study|Withdrawal by Subject|7|||
27936088|NCT01158404|81604207|FG005|Overall Study|Progressive Disease|0|||
27936089|NCT01158404|81604208|FG006|Overall Study|Progressive Disease|1|||
27936090|NCT01158404|81604209|FG007|Overall Study|Progressive Disease|0|||
27936091|NCT00609973|81604213|FG000|Overall Study|Adverse Event|2|||
27743782|NCT00590681|80892683|FG000|Overall Study|Adverse Event|8|||
27643398|NCT01998958|80536385|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
27643399|NCT01998958|80536386|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
27643400|NCT01998958|80536387|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
27643401|NCT01998958|80536388|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
27743783|NCT00590681|80892683|FG000|Overall Study|Death|3|||
27936092|NCT00609973|81604214|FG001|Overall Study|Adverse Event|1|||
27936093|NCT00609973|81604213|FG000|Overall Study|Protocol Violation|4|||
27936094|NCT00609973|81604214|FG001|Overall Study|Protocol Violation|3|||
27643402|NCT01998958|80536389|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
27643403|NCT01998958|80536390|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
27643404|NCT01998958|80536391|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
27643405|NCT01998958|80536392|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
27936095|NCT00609973|81604213|FG000|Overall Study|Lost to Follow-up|2|||
27936096|NCT00609973|81604214|FG001|Overall Study|Lost to Follow-up|1|||
27936097|NCT00609973|81604213|FG000|Overall Study|Withdrawal by Subject|0|||
27936098|NCT00609973|81604214|FG001|Overall Study|Withdrawal by Subject|1|||
27936099|NCT01654250|81604215|FG000|Overall Study|Lost to Follow-up|1|||
27936100|NCT01654250|81604216|FG001|Overall Study|Lost to Follow-up|0|||
27936101|NCT00930176|81604217|FG000|Overall Study|Death|1|||
27936102|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
27936103|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
27936104|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
27936105|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
27936106|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
27936107|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
27936108|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
27936109|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
27936110|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
27643406|NCT01998958|80536393|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
27643407|NCT01998958|80536394|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
27643408|NCT01998958|80536395|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
27643409|NCT01998958|80536396|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
27936111|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
27936112|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
27936113|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
27936114|NCT03446573|81604218|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
27936115|NCT03446573|81604219|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
27936116|NCT03446573|81604218|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
27936117|NCT03446573|81604219|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
27936118|NCT03446573|81604218|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
27936119|NCT03446573|81604219|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
27550939|NCT02268084|80203535|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
27550940|NCT01927367|80203540|FG000|Overall Study|Withdrawal by Subject|7|||
27550941|NCT01927367|80203541|FG001|Overall Study|Withdrawal by Subject|4|||
27550942|NCT01927367|80203540|FG000|Overall Study|No baseline data|0|||
27550943|NCT01927367|80203541|FG001|Overall Study|No baseline data|1|||
27643410|NCT01998958|80536397|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
27643411|NCT01998958|80536398|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
27643412|NCT01998958|80536399|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
27643413|NCT01998958|80536400|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
27550944|NCT02990910|80203542|FG000|Overall Study|Lack of Efficacy|6|||
27550945|NCT02990910|80203543|FG001|Overall Study|Lack of Efficacy|10|||
27550946|NCT01402544|80203544|FG000|Overall Study|Withdrawal by Subject|6|||
27550947|NCT00368355|80203547|FG000|Overall Study|Adverse Event|1|||
27550948|NCT00368355|80203548|FG001|Overall Study|Adverse Event|0|||
27550949|NCT00368355|80203547|FG000|Overall Study|Death|2|||
27550950|NCT00368355|80203548|FG001|Overall Study|Death|4|||
27550951|NCT00368355|80203547|FG000|Overall Study|Relapse|6|||
27550952|NCT00368355|80203548|FG001|Overall Study|Relapse|10|||
27550953|NCT00368355|80203547|FG000|Overall Study|Subsequent transplant|0|||
27550954|NCT00368355|80203548|FG001|Overall Study|Subsequent transplant|3|||
27550955|NCT00368355|80203547|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
27550956|NCT00368355|80203548|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
27550957|NCT00203996|80203549|FG000|Overall Study|Lost to Follow-up|0|||
27550958|NCT00203996|80203550|FG001|Overall Study|Lost to Follow-up|0|||
27550959|NCT00203996|80203551|FG002|Overall Study|Lost to Follow-up|0|||
27550960|NCT00203996|80203552|FG003|Overall Study|Lost to Follow-up|1|||
27550961|NCT00203996|80203553|FG004|Overall Study|Lost to Follow-up|0|||
27550962|NCT00203996|80203554|FG005|Overall Study|Lost to Follow-up|0|||
27550963|NCT00203996|80203555|FG006|Overall Study|Lost to Follow-up|0|||
27550964|NCT00203996|80203556|FG007|Overall Study|Lost to Follow-up|0|||
27550965|NCT00203996|80203557|FG008|Overall Study|Lost to Follow-up|0|||
27550966|NCT00203996|80203558|FG009|Overall Study|Lost to Follow-up|0|||
27550967|NCT00203996|80203549|FG000|Overall Study|Protocol Violation|0|||
27550968|NCT00203996|80203550|FG001|Overall Study|Protocol Violation|0|||
27550969|NCT00203996|80203551|FG002|Overall Study|Protocol Violation|0|||
27643414|NCT01998958|80536401|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
27643415|NCT01998958|80536402|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
27643416|NCT01998958|80536403|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
27550970|NCT00203996|80203552|FG003|Overall Study|Protocol Violation|6|||
27550971|NCT00203996|80203553|FG004|Overall Study|Protocol Violation|1|||
27550972|NCT00203996|80203554|FG005|Overall Study|Protocol Violation|0|||
27550973|NCT00203996|80203555|FG006|Overall Study|Protocol Violation|0|||
27550974|NCT00203996|80203556|FG007|Overall Study|Protocol Violation|0|||
27643417|NCT01998958|80536404|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
27643418|NCT01998958|80536373|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643419|NCT01998958|80536374|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643420|NCT01998958|80536375|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643421|NCT01998958|80536376|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643422|NCT01998958|80536377|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643423|NCT01998958|80536378|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643424|NCT01998958|80536379|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643425|NCT01998958|80536380|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643426|NCT01998958|80536381|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643427|NCT01998958|80536382|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643428|NCT01998958|80536383|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643429|NCT01998958|80536384|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643430|NCT01998958|80536385|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643431|NCT01998958|80536386|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643432|NCT01998958|80536387|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
27643433|NCT01998958|80536388|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643434|NCT01998958|80536389|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643435|NCT01998958|80536390|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643436|NCT01998958|80536391|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
27643437|NCT01998958|80536392|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643438|NCT01998958|80536393|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643439|NCT01998958|80536394|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643440|NCT01998958|80536395|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643441|NCT01998958|80536396|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643442|NCT01998958|80536397|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643443|NCT01998958|80536398|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643444|NCT01998958|80536399|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643445|NCT01998958|80536400|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643446|NCT01998958|80536401|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643447|NCT01998958|80536402|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643448|NCT01998958|80536403|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643449|NCT01998958|80536404|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
27643450|NCT01998958|80536373|FG000|Open Label Phase (Optional)|Adverse Event|0|||
27643451|NCT01998958|80536374|FG001|Open Label Phase (Optional)|Adverse Event|0|||
27643452|NCT01998958|80536375|FG002|Open Label Phase (Optional)|Adverse Event|0|||
27643453|NCT01998958|80536376|FG003|Open Label Phase (Optional)|Adverse Event|0|||
27643454|NCT01998958|80536377|FG004|Open Label Phase (Optional)|Adverse Event|0|||
27643455|NCT01998958|80536378|FG005|Open Label Phase (Optional)|Adverse Event|0|||
27643456|NCT01998958|80536379|FG006|Open Label Phase (Optional)|Adverse Event|0|||
27643457|NCT01998958|80536380|FG007|Open Label Phase (Optional)|Adverse Event|0|||
27643458|NCT01998958|80536381|FG008|Open Label Phase (Optional)|Adverse Event|0|||
27643459|NCT01998958|80536382|FG009|Open Label Phase (Optional)|Adverse Event|0|||
27643460|NCT01998958|80536383|FG010|Open Label Phase (Optional)|Adverse Event|0|||
27643461|NCT01998958|80536384|FG011|Open Label Phase (Optional)|Adverse Event|0|||
27643462|NCT01998958|80536385|FG012|Open Label Phase (Optional)|Adverse Event|0|||
27643463|NCT01998958|80536386|FG013|Open Label Phase (Optional)|Adverse Event|0|||
27643464|NCT01998958|80536387|FG014|Open Label Phase (Optional)|Adverse Event|0|||
27643465|NCT01998958|80536388|FG015|Open Label Phase (Optional)|Adverse Event|0|||
27643466|NCT01998958|80536389|FG016|Open Label Phase (Optional)|Adverse Event|0|||
27643467|NCT01998958|80536390|FG017|Open Label Phase (Optional)|Adverse Event|0|||
27643468|NCT01998958|80536391|FG018|Open Label Phase (Optional)|Adverse Event|0|||
27643469|NCT01998958|80536392|FG019|Open Label Phase (Optional)|Adverse Event|0|||
27643470|NCT01998958|80536393|FG020|Open Label Phase (Optional)|Adverse Event|0|||
27643471|NCT01998958|80536394|FG021|Open Label Phase (Optional)|Adverse Event|0|||
27643472|NCT01998958|80536395|FG022|Open Label Phase (Optional)|Adverse Event|0|||
27643473|NCT01998958|80536396|FG023|Open Label Phase (Optional)|Adverse Event|1|||
27643474|NCT01998958|80536397|FG024|Open Label Phase (Optional)|Adverse Event|0|||
27643475|NCT01998958|80536398|FG025|Open Label Phase (Optional)|Adverse Event|0|||
27643476|NCT01998958|80536399|FG026|Open Label Phase (Optional)|Adverse Event|0|||
27643477|NCT01998958|80536400|FG027|Open Label Phase (Optional)|Adverse Event|0|||
27643478|NCT01998958|80536401|FG028|Open Label Phase (Optional)|Adverse Event|0|||
27643479|NCT01998958|80536402|FG029|Open Label Phase (Optional)|Adverse Event|0|||
27643480|NCT01998958|80536403|FG030|Open Label Phase (Optional)|Adverse Event|0|||
27643481|NCT01998958|80536404|FG031|Open Label Phase (Optional)|Adverse Event|0|||
27643482|NCT01998958|80536373|FG000|Open Label Phase (Optional)|Other|0|||
27643483|NCT01998958|80536374|FG001|Open Label Phase (Optional)|Other|0|||
27643484|NCT01998958|80536375|FG002|Open Label Phase (Optional)|Other|0|||
27643485|NCT01998958|80536376|FG003|Open Label Phase (Optional)|Other|0|||
27643486|NCT01998958|80536377|FG004|Open Label Phase (Optional)|Other|0|||
27643487|NCT01998958|80536378|FG005|Open Label Phase (Optional)|Other|0|||
27643488|NCT01998958|80536379|FG006|Open Label Phase (Optional)|Other|0|||
27643489|NCT01998958|80536380|FG007|Open Label Phase (Optional)|Other|0|||
27643490|NCT01998958|80536381|FG008|Open Label Phase (Optional)|Other|0|||
27643491|NCT01998958|80536382|FG009|Open Label Phase (Optional)|Other|0|||
27643492|NCT01998958|80536383|FG010|Open Label Phase (Optional)|Other|0|||
27643493|NCT01998958|80536384|FG011|Open Label Phase (Optional)|Other|0|||
27643494|NCT01998958|80536385|FG012|Open Label Phase (Optional)|Other|0|||
27643495|NCT01998958|80536386|FG013|Open Label Phase (Optional)|Other|0|||
27643496|NCT01998958|80536387|FG014|Open Label Phase (Optional)|Other|0|||
27643497|NCT01998958|80536388|FG015|Open Label Phase (Optional)|Other|0|||
27643498|NCT01998958|80536389|FG016|Open Label Phase (Optional)|Other|0|||
27643499|NCT01998958|80536390|FG017|Open Label Phase (Optional)|Other|0|||
27643500|NCT01998958|80536391|FG018|Open Label Phase (Optional)|Other|0|||
27643501|NCT01998958|80536392|FG019|Open Label Phase (Optional)|Other|0|||
27643502|NCT01998958|80536393|FG020|Open Label Phase (Optional)|Other|0|||
27643503|NCT01998958|80536394|FG021|Open Label Phase (Optional)|Other|0|||
27643504|NCT01998958|80536395|FG022|Open Label Phase (Optional)|Other|5|||
27643505|NCT01998958|80536396|FG023|Open Label Phase (Optional)|Other|1|||
27643506|NCT01998958|80536397|FG024|Open Label Phase (Optional)|Other|0|||
27643507|NCT01998958|80536398|FG025|Open Label Phase (Optional)|Other|0|||
27643508|NCT01998958|80536399|FG026|Open Label Phase (Optional)|Other|0|||
27643509|NCT01998958|80536400|FG027|Open Label Phase (Optional)|Other|0|||
27643510|NCT01998958|80536401|FG028|Open Label Phase (Optional)|Other|0|||
27643511|NCT01998958|80536402|FG029|Open Label Phase (Optional)|Other|0|||
27643512|NCT01998958|80536403|FG030|Open Label Phase (Optional)|Other|0|||
27643513|NCT01998958|80536404|FG031|Open Label Phase (Optional)|Other|0|||
27643514|NCT01998958|80536373|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643515|NCT01998958|80536374|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643516|NCT01998958|80536375|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643517|NCT01998958|80536376|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643518|NCT01998958|80536377|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643519|NCT01998958|80536378|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643520|NCT01998958|80536379|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643521|NCT01998958|80536380|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643522|NCT01998958|80536381|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643523|NCT01998958|80536382|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643524|NCT01998958|80536383|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643525|NCT01998958|80536384|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643526|NCT01998958|80536385|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643527|NCT01998958|80536386|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643528|NCT01998958|80536387|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643529|NCT01998958|80536388|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643530|NCT01998958|80536389|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643531|NCT01998958|80536390|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643532|NCT01998958|80536391|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643533|NCT01998958|80536392|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643534|NCT01998958|80536393|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643535|NCT01998958|80536394|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643536|NCT01998958|80536395|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
27643537|NCT01998958|80536396|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643538|NCT01998958|80536397|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643539|NCT01998958|80536398|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643540|NCT01998958|80536399|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643541|NCT01998958|80536400|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643542|NCT01998958|80536401|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643543|NCT01998958|80536402|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643544|NCT01998958|80536403|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643545|NCT01998958|80536404|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
27643546|NCT01998958|80536373|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643547|NCT01998958|80536374|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643548|NCT01998958|80536375|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643549|NCT01998958|80536376|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643550|NCT01998958|80536377|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643551|NCT01998958|80536378|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643552|NCT01998958|80536379|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643553|NCT01998958|80536380|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643554|NCT01998958|80536381|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643555|NCT01998958|80536382|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643556|NCT01998958|80536383|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643557|NCT01998958|80536384|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643558|NCT01998958|80536385|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643559|NCT01998958|80536386|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643560|NCT01998958|80536387|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643561|NCT01998958|80536388|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643562|NCT01998958|80536389|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643563|NCT01998958|80536390|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643564|NCT01998958|80536391|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643565|NCT01998958|80536392|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643566|NCT01998958|80536393|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643567|NCT01998958|80536394|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
27643568|NCT01998958|80536395|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
27643569|NCT01998958|80536396|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
27936120|NCT03446573|81604218|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
27936121|NCT03446573|81604219|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
27936122|NCT03446573|81604218|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
27936123|NCT03446573|81604219|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
27936124|NCT03446573|81604218|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
27936125|NCT03446573|81604219|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
27936126|NCT03446573|81604218|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
27936127|NCT03446573|81604219|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
27936128|NCT01502072|81604220|FG000|Overall Study|Withdrawal by Subject|1|||
27936129|NCT01502072|81604221|FG001|Overall Study|Withdrawal by Subject|0|||
27936130|NCT01502072|81604222|FG002|Overall Study|Withdrawal by Subject|0|||
27936131|NCT01502072|81604220|FG000|Overall Study|Death|0|||
27936132|NCT01502072|81604221|FG001|Overall Study|Death|1|||
27936133|NCT01502072|81604222|FG002|Overall Study|Death|0|||
27936134|NCT00537082|81604223|FG000|Overall Study|Adverse Event|6|||
27936135|NCT00537082|81604224|FG001|Overall Study|Adverse Event|6|||
27936136|NCT00537082|81604225|FG002|Overall Study|Adverse Event|3|||
27936137|NCT00537082|81604223|FG000|Overall Study|Protocol Violation|0|||
27936138|NCT00537082|81604224|FG001|Overall Study|Protocol Violation|2|||
27936139|NCT00537082|81604225|FG002|Overall Study|Protocol Violation|1|||
27936140|NCT00537082|81604223|FG000|Overall Study|Lack of Efficacy|0|||
27936141|NCT00537082|81604224|FG001|Overall Study|Lack of Efficacy|0|||
27936142|NCT00537082|81604225|FG002|Overall Study|Lack of Efficacy|2|||
27936143|NCT00537082|81604223|FG000|Overall Study|Withdrawal by Subject|0|||
27936144|NCT00537082|81604224|FG001|Overall Study|Withdrawal by Subject|1|||
27936145|NCT00537082|81604225|FG002|Overall Study|Withdrawal by Subject|0|||
27936146|NCT00537082|81604223|FG000|Overall Study|Discontinued before initiating treatment|3|||
27936147|NCT00537082|81604224|FG001|Overall Study|Discontinued before initiating treatment|0|||
27936148|NCT00537082|81604225|FG002|Overall Study|Discontinued before initiating treatment|0|||
27936149|NCT01348490|81604227|FG000|Overall Study|Death|1|||
27936150|NCT01348490|81604227|FG000|Overall Study|Adverse Event|3|||
27936151|NCT01348490|81604227|FG000|Overall Study|Consent withdrawn|7|||
27936152|NCT01348490|81604227|FG000|Overall Study|Disease progression|3|||
27936153|NCT01348490|81604227|FG000|Overall Study|Lost to Follow-up|1|||
27643570|NCT01998958|80536397|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
27936154|NCT01348490|81604227|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
27643571|NCT01998958|80536398|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643572|NCT01998958|80536399|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643573|NCT01998958|80536400|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643574|NCT01998958|80536401|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643575|NCT01998958|80536402|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643576|NCT01998958|80536403|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643577|NCT01998958|80536404|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
27643578|NCT01998958|80536373|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643579|NCT01998958|80536374|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643580|NCT01998958|80536375|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643581|NCT01998958|80536376|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643582|NCT01998958|80536377|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643583|NCT01998958|80536378|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643584|NCT01998958|80536379|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643585|NCT01998958|80536380|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643586|NCT01998958|80536381|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27936155|NCT01348490|81604227|FG000|Overall Study|Other Unspecified|8|||
27936156|NCT01160744|81604230|FG000|Overall Study|Withdrawal by Subject|11|||
27936157|NCT01160744|81604231|FG001|Overall Study|Withdrawal by Subject|5|||
27936158|NCT01160744|81604232|FG002|Overall Study|Withdrawal by Subject|6|||
27936159|NCT01160744|81604233|FG003|Overall Study|Withdrawal by Subject|4|||
27936160|NCT01160744|81604230|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
27936161|NCT01160744|81604231|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
27936162|NCT01160744|81604232|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
27936163|NCT01160744|81604233|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
27936164|NCT00723944|81604234|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
27936165|NCT00723944|81604235|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
27936166|NCT00723944|81604234|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
27643587|NCT01998958|80536382|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27936167|NCT00723944|81604235|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
27936168|NCT00723944|81604234|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
27936169|NCT00723944|81604235|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
27936170|NCT01239745|81604236|FG000|Overall Study|Study terminated by sponsor|45|||
27936171|NCT01239745|81604236|FG000|Overall Study|Adverse Event|1|||
27936172|NCT00965094|81604240|FG000|Overall Study|Adverse Event|5|||
27936173|NCT00965094|81604241|FG001|Overall Study|Adverse Event|0|||
27936174|NCT00965094|81604240|FG000|Overall Study|Lost to Follow-up|0|||
27936175|NCT00965094|81604241|FG001|Overall Study|Lost to Follow-up|1|||
27936176|NCT01052428|81604242|FG000|Overall Study|Death|1|||
27936177|NCT01052428|81604243|FG001|Overall Study|Death|0|||
27936178|NCT01052428|81604242|FG000|Overall Study|Withdrawal by Subject|0|||
27936179|NCT01052428|81604243|FG001|Overall Study|Withdrawal by Subject|1|||
27936180|NCT00422461|81604246|FG000|Overall Study|Adverse Event|1|||
27936181|NCT00422461|81604247|FG001|Overall Study|Adverse Event|2|||
27936182|NCT00422461|81604248|FG002|Overall Study|Adverse Event|1|||
27936183|NCT00422461|81604249|FG003|Overall Study|Adverse Event|1|||
27936184|NCT00422461|81604246|FG000|Overall Study|Other|0|||
27936185|NCT00422461|81604247|FG001|Overall Study|Other|0|||
27936186|NCT00422461|81604248|FG002|Overall Study|Other|0|||
27936187|NCT00422461|81604249|FG003|Overall Study|Other|2|||
27936188|NCT00422461|81604246|FG000|Overall Study|Participants no longer willing to participate in study|1|||
27936189|NCT00422461|81604247|FG001|Overall Study|Participants no longer willing to participate in study|0|||
27936190|NCT00422461|81604248|FG002|Overall Study|Participants no longer willing to participate in study|0|||
27936191|NCT00422461|81604249|FG003|Overall Study|Participants no longer willing to participate in study|0|||
27936192|NCT00422461|81604246|FG000|Overall Study|Randomized but not treated|1|||
27936193|NCT00422461|81604247|FG001|Overall Study|Randomized but not treated|1|||
27936194|NCT00422461|81604248|FG002|Overall Study|Randomized but not treated|0|||
27936195|NCT00422461|81604249|FG003|Overall Study|Randomized but not treated|0|||
27936196|NCT01346709|81604250|FG000|Overall Study|Protocol Violation|35|||
27936197|NCT01346709|81604250|FG000|Overall Study|Lost to Follow-up|31|||
27936198|NCT01346709|81604250|FG000|Overall Study|Missing data in candidate risk factor|285|||
27936199|NCT03931785|81604251|FG000|Overall Study|Lost to Follow-up|4|||
27936200|NCT03931785|81604252|FG001|Overall Study|Lost to Follow-up|1|||
27936201|NCT03931785|81604253|FG002|Overall Study|Lost to Follow-up|4|||
27936202|NCT03931785|81604254|FG003|Overall Study|Lost to Follow-up|3|||
27743784|NCT00590681|80892683|FG000|Overall Study|Lost to Follow-up|1|||
27743785|NCT00590681|80892683|FG000|Overall Study|disease progression|1|||
27743786|NCT00443430|80892690|FG000|Overall Study|Lack of Efficacy|3|||
27743787|NCT00443430|80892691|FG001|Overall Study|Lack of Efficacy|3|||
27743788|NCT00443430|80892690|FG000|Overall Study|Adverse Event|1|||
27743789|NCT00443430|80892691|FG001|Overall Study|Adverse Event|1|||
27743790|NCT00394914|80892692|FG000|Treatment Period|Adverse Event|0|||
27743791|NCT00394914|80892693|FG001|Treatment Period|Adverse Event|3|||
27743792|NCT00394914|80892694|FG002|Treatment Period|Adverse Event|1|||
27743793|NCT00394914|80892692|FG000|Treatment Period|Lost to Follow-up|0|||
27743794|NCT00394914|80892693|FG001|Treatment Period|Lost to Follow-up|1|||
27743795|NCT00394914|80892694|FG002|Treatment Period|Lost to Follow-up|0|||
27743796|NCT00394914|80892692|FG000|Treatment Period|Withdrawal by Subject|0|||
27743797|NCT00394914|80892693|FG001|Treatment Period|Withdrawal by Subject|2|||
27743798|NCT00394914|80892694|FG002|Treatment Period|Withdrawal by Subject|2|||
27743799|NCT00394914|80892692|FG000|Treatment Period|Noncompliance with protocol|0|||
27743800|NCT00394914|80892693|FG001|Treatment Period|Noncompliance with protocol|3|||
27743801|NCT00394914|80892694|FG002|Treatment Period|Noncompliance with protocol|2|||
27743802|NCT00394914|80892692|FG000|Treatment Period|Did not meet protocol eligibility|0|||
27743803|NCT00394914|80892693|FG001|Treatment Period|Did not meet protocol eligibility|1|||
27936203|NCT03931785|81604251|FG000|Overall Study|Adverse Event|1|||
27936204|NCT03931785|81604252|FG001|Overall Study|Adverse Event|0|||
27936205|NCT03931785|81604253|FG002|Overall Study|Adverse Event|3|||
27743804|NCT00394914|80892694|FG002|Treatment Period|Did not meet protocol eligibility|1|||
27936206|NCT03931785|81604254|FG003|Overall Study|Adverse Event|4|||
27936207|NCT03931785|81604251|FG000|Overall Study|Protocol Violation|0|||
27936208|NCT03931785|81604252|FG001|Overall Study|Protocol Violation|1|||
27936209|NCT03931785|81604253|FG002|Overall Study|Protocol Violation|0|||
27743805|NCT02702193|80892696|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
27743806|NCT02702193|80892697|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
27743807|NCT02702193|80892696|FG000|4 Month Follow up|Withdrawal by Subject|1|||
27743808|NCT02702193|80892697|FG001|4 Month Follow up|Withdrawal by Subject|0|||
27743809|NCT02702193|80892696|FG000|4 Month Follow up|Lost to Follow-up|17|||
27936210|NCT03931785|81604254|FG003|Overall Study|Protocol Violation|0|||
27936211|NCT03931785|81604251|FG000|Overall Study|Noncompliance With Study drug|0|||
27936212|NCT03931785|81604252|FG001|Overall Study|Noncompliance With Study drug|1|||
27936213|NCT03931785|81604253|FG002|Overall Study|Noncompliance With Study drug|0|||
27936214|NCT03931785|81604254|FG003|Overall Study|Noncompliance With Study drug|0|||
27936215|NCT03931785|81604251|FG000|Overall Study|Other Not specified|0|||
27936216|NCT03931785|81604252|FG001|Overall Study|Other Not specified|2|||
27936217|NCT03931785|81604253|FG002|Overall Study|Other Not specified|2|||
27936218|NCT03931785|81604254|FG003|Overall Study|Other Not specified|2|||
27743810|NCT02702193|80892697|FG001|4 Month Follow up|Lost to Follow-up|18|||
27743811|NCT02702193|80892696|FG000|8 Month Follow up|Withdrawal by Subject|1|||
27743812|NCT02702193|80892697|FG001|8 Month Follow up|Withdrawal by Subject|0|||
27743813|NCT02702193|80892696|FG000|8 Month Follow up|Lost to Follow-up|14|||
27743814|NCT02702193|80892697|FG001|8 Month Follow up|Lost to Follow-up|18|||
27743815|NCT02702193|80892696|FG000|12 Month Follow up|Withdrawal by Subject|1|||
27743816|NCT02702193|80892697|FG001|12 Month Follow up|Withdrawal by Subject|0|||
27743817|NCT02702193|80892696|FG000|12 Month Follow up|Lost to Follow-up|16|||
27743818|NCT02702193|80892697|FG001|12 Month Follow up|Lost to Follow-up|18|||
27743819|NCT01264965|80892699|FG000|Overall Study|Withdrawal by Subject|10|||
27743820|NCT00726323|80892700|FG000|Overall Study|Withdrawal by Subject|3|||
27743821|NCT00726323|80892701|FG001|Overall Study|Withdrawal by Subject|1|||
27743822|NCT00726323|80892700|FG000|Overall Study|Physician Decision|1|||
27743823|NCT00726323|80892701|FG001|Overall Study|Physician Decision|0|||
27743824|NCT00726323|80892700|FG000|Overall Study|Progressive disease|23|||
27743825|NCT00726323|80892701|FG001|Overall Study|Progressive disease|16|||
27743826|NCT00726323|80892700|FG000|Overall Study|Clinical progression|0|||
27743827|NCT00726323|80892701|FG001|Overall Study|Clinical progression|3|||
27743828|NCT00726323|80892700|FG000|Overall Study|Adverse Event|9|||
27743829|NCT00726323|80892701|FG001|Overall Study|Adverse Event|9|||
27743830|NCT00726323|80892700|FG000|Overall Study|Death|1|||
27743831|NCT00726323|80892701|FG001|Overall Study|Death|0|||
27743832|NCT00726323|80892700|FG000|Overall Study|Participant wished to discontinue|0|||
27743833|NCT00726323|80892701|FG001|Overall Study|Participant wished to discontinue|1|||
27743834|NCT00726323|80892700|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
27743835|NCT00726323|80892701|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
27743836|NCT01022853|80892702|FG000|Overall Study|Progressive disease|2|||
27743837|NCT01022853|80892703|FG001|Overall Study|Progressive disease|3|||
27743838|NCT01022853|80892704|FG002|Overall Study|Progressive disease|11|||
27743839|NCT01022853|80892705|FG003|Overall Study|Progressive disease|7|||
27743840|NCT01022853|80892706|FG004|Overall Study|Progressive disease|1|||
27743841|NCT01022853|80892702|FG000|Overall Study|Dose-limiting toxicity|0|||
27743842|NCT01022853|80892703|FG001|Overall Study|Dose-limiting toxicity|0|||
27743843|NCT01022853|80892704|FG002|Overall Study|Dose-limiting toxicity|0|||
27743844|NCT01022853|80892705|FG003|Overall Study|Dose-limiting toxicity|0|||
27743845|NCT01022853|80892706|FG004|Overall Study|Dose-limiting toxicity|1|||
27743846|NCT01022853|80892702|FG000|Overall Study|Withdrawal by Subject|0|||
27743847|NCT01022853|80892703|FG001|Overall Study|Withdrawal by Subject|1|||
27743848|NCT01022853|80892704|FG002|Overall Study|Withdrawal by Subject|1|||
27743849|NCT01022853|80892705|FG003|Overall Study|Withdrawal by Subject|1|||
27743850|NCT01022853|80892706|FG004|Overall Study|Withdrawal by Subject|0|||
27743851|NCT01022853|80892702|FG000|Overall Study|Other not stated above|1|||
27743852|NCT01022853|80892703|FG001|Overall Study|Other not stated above|0|||
27743853|NCT01022853|80892704|FG002|Overall Study|Other not stated above|1|||
27743854|NCT01022853|80892705|FG003|Overall Study|Other not stated above|0|||
27743855|NCT01022853|80892706|FG004|Overall Study|Other not stated above|0|||
27743856|NCT02062151|80892707|FG000|Overall Study|screen failure|1|||
27743857|NCT00611130|80892708|FG000|Overall Study|Lost to Follow-up|25|||
27743858|NCT00611130|80892709|FG001|Overall Study|Lost to Follow-up|29|||
27743859|NCT00611130|80892708|FG000|Overall Study|Protocol noncompliance|7|||
27743860|NCT00611130|80892709|FG001|Overall Study|Protocol noncompliance|6|||
27743861|NCT00611130|80892708|FG000|Overall Study|Withdrawal by Subject|6|||
27743862|NCT00611130|80892709|FG001|Overall Study|Withdrawal by Subject|5|||
27743863|NCT00611130|80892708|FG000|Overall Study|Other|5|||
27743864|NCT00611130|80892709|FG001|Overall Study|Other|4|||
27743865|NCT00611130|80892708|FG000|Overall Study|Incarceration|3|||
27743866|NCT00611130|80892709|FG001|Overall Study|Incarceration|2|||
27743867|NCT00611130|80892708|FG000|Overall Study|Administrative|1|||
27743868|NCT00611130|80892709|FG001|Overall Study|Administrative|1|||
27743869|NCT00611130|80892708|FG000|Overall Study|Adverse Event|1|||
27743870|NCT00611130|80892709|FG001|Overall Study|Adverse Event|0|||
27743871|NCT00611130|80892708|FG000|Overall Study|Death|1|||
27743872|NCT00611130|80892709|FG001|Overall Study|Death|0|||
27743873|NCT00886821|80892710|FG000|Stage 2|Adverse Event|0|||
27743874|NCT00886821|80892711|FG001|Stage 2|Adverse Event|0|||
27743875|NCT00886821|80892712|FG002|Stage 2|Adverse Event|0|||
27743876|NCT00886821|80892713|FG003|Stage 2|Adverse Event|0|||
27743877|NCT00886821|80892714|FG004|Stage 2|Adverse Event|0|||
27743878|NCT00886821|80892715|FG005|Stage 2|Adverse Event|0|||
27743879|NCT00886821|80892716|FG006|Stage 2|Adverse Event|0|||
27743880|NCT00886821|80892717|FG007|Stage 2|Adverse Event|0|||
27743881|NCT00886821|80892718|FG008|Stage 2|Adverse Event|0|||
27743882|NCT00886821|80892719|FG009|Stage 2|Adverse Event|0|||
27743883|NCT00886821|80892720|FG010|Stage 2|Adverse Event|0|||
27743884|NCT00886821|80892721|FG011|Stage 2|Adverse Event|1|||
27743885|NCT00886821|80892722|FG012|Stage 2|Adverse Event|3|||
27743886|NCT00886821|80892723|FG013|Stage 2|Adverse Event|0|||
27743887|NCT00886821|80892710|FG000|Stage 2|Lost to Follow-up|0|||
27743888|NCT00886821|80892711|FG001|Stage 2|Lost to Follow-up|0|||
27743889|NCT00886821|80892712|FG002|Stage 2|Lost to Follow-up|0|||
27743890|NCT00886821|80892713|FG003|Stage 2|Lost to Follow-up|0|||
27743891|NCT00886821|80892714|FG004|Stage 2|Lost to Follow-up|0|||
27743892|NCT00886821|80892715|FG005|Stage 2|Lost to Follow-up|0|||
27743893|NCT00886821|80892716|FG006|Stage 2|Lost to Follow-up|0|||
27743894|NCT00886821|80892717|FG007|Stage 2|Lost to Follow-up|0|||
27743895|NCT00886821|80892718|FG008|Stage 2|Lost to Follow-up|0|||
27743896|NCT00886821|80892719|FG009|Stage 2|Lost to Follow-up|0|||
27743897|NCT00886821|80892720|FG010|Stage 2|Lost to Follow-up|0|||
27743898|NCT00886821|80892721|FG011|Stage 2|Lost to Follow-up|0|||
27743899|NCT00886821|80892722|FG012|Stage 2|Lost to Follow-up|2|||
27743900|NCT00886821|80892723|FG013|Stage 2|Lost to Follow-up|1|||
27743901|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
27743902|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
27743903|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
27743904|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
27743905|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
27743906|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
27743907|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
27743908|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
27743909|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
27743910|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
27743911|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
27743912|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
27743913|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
27743914|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
27743915|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
27743916|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
27743917|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
27743918|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
27743919|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
27743920|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
27743921|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
27743922|NCT00092547|80892725|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
27743923|NCT00092547|80892726|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
27743924|NCT00092547|80892727|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
27743925|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
27743926|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
27743927|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
27743928|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
27743929|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
27743930|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
27743931|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
27936219|NCT03931785|81604251|FG000|Overall Study|Withdrawal by Subject|0|||
27936220|NCT03931785|81604252|FG001|Overall Study|Withdrawal by Subject|2|||
27936221|NCT03931785|81604253|FG002|Overall Study|Withdrawal by Subject|4|||
27936222|NCT03931785|81604254|FG003|Overall Study|Withdrawal by Subject|1|||
27936223|NCT03931785|81604251|FG000|Overall Study|Pregnancy|0|||
27936224|NCT03931785|81604252|FG001|Overall Study|Pregnancy|0|||
27936225|NCT03931785|81604253|FG002|Overall Study|Pregnancy|0|||
27936226|NCT03931785|81604254|FG003|Overall Study|Pregnancy|1|||
27936227|NCT04233580|81604255|FG000|Overall Study|Adverse Event|3|||
27936228|NCT04233580|81604256|FG001|Overall Study|Adverse Event|3|||
27936229|NCT04233580|81604255|FG000|Overall Study|Withdrawal by Subject|2|||
27936230|NCT04233580|81604256|FG001|Overall Study|Withdrawal by Subject|1|||
27936231|NCT04560309|81604258|FG000|Overall Study|Meet drop out criteria|1|||
27936232|NCT04560309|81604259|FG001|Overall Study|Meet drop out criteria|1|||
27936233|NCT03309605|81604262|FG000|Overall Study|Adverse Event|0|||
27936234|NCT03309605|81604263|FG001|Overall Study|Adverse Event|0|||
27643588|NCT01998958|80536383|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643589|NCT01998958|80536384|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27936235|NCT03309605|81604264|FG002|Overall Study|Adverse Event|0|||
27936236|NCT03309605|81604265|FG003|Overall Study|Adverse Event|1|||
27936237|NCT03309605|81604266|FG004|Overall Study|Adverse Event|0|||
27643590|NCT01998958|80536385|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643591|NCT01998958|80536386|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643592|NCT01998958|80536387|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643593|NCT01998958|80536388|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643594|NCT01998958|80536389|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643595|NCT01998958|80536390|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643596|NCT01998958|80536391|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27936238|NCT03309605|81604267|FG005|Overall Study|Adverse Event|0|||
27936239|NCT03309605|81604268|FG006|Overall Study|Adverse Event|2|||
27743932|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
27743933|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
27743934|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
27743935|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
27743936|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
27743937|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
27743938|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
27743939|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
27743940|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
27743941|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
27743942|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
27743943|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
27743944|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
27743945|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
27743946|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
27743947|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
27743948|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
27743949|NCT00092547|80892725|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
27743950|NCT00092547|80892726|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
27743951|NCT00092547|80892727|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
27743952|NCT00092547|80892725|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
27743953|NCT00092547|80892726|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
27743954|NCT00092547|80892727|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
27743955|NCT00092547|80892725|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
27743956|NCT00092547|80892726|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
27743957|NCT00092547|80892727|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
27743958|NCT00092547|80892725|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
27743959|NCT00092547|80892726|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
27743960|NCT00092547|80892727|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
27743961|NCT00092547|80892725|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
27743962|NCT00092547|80892726|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
27743963|NCT00092547|80892727|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
27743964|NCT01588197|80892728|FG000|Overall Study|Lack of Efficacy|0|||
27743965|NCT01588197|80892729|FG001|Overall Study|Lack of Efficacy|1|||
27743966|NCT01588197|80892728|FG000|Overall Study|No MRI|1|||
27743967|NCT01588197|80892729|FG001|Overall Study|No MRI|0|||
27743968|NCT01751646|80892730|FG000|Overall Study|Lost to Follow-up|5|||
27743969|NCT01751646|80892731|FG001|Overall Study|Lost to Follow-up|1|||
27743970|NCT01751646|80892730|FG000|Overall Study|Withdrawal by Subject|0|||
27743971|NCT01751646|80892731|FG001|Overall Study|Withdrawal by Subject|4|||
27743972|NCT01751646|80892730|FG000|Overall Study|Starting hormone therapy|1|||
27743973|NCT01751646|80892731|FG001|Overall Study|Starting hormone therapy|0|||
27743974|NCT01751646|80892730|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
27743975|NCT01751646|80892731|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
27743976|NCT01751646|80892730|FG000|Overall Study|Inadvertent enrollment|1|||
27743977|NCT01751646|80892731|FG001|Overall Study|Inadvertent enrollment|1|||
27743978|NCT01751646|80892730|FG000|Overall Study|Moved out of the area|1|||
27743979|NCT01751646|80892731|FG001|Overall Study|Moved out of the area|5|||
27743980|NCT01751646|80892730|FG000|Overall Study|Inability to attend required visits|0|||
27743981|NCT01751646|80892731|FG001|Overall Study|Inability to attend required visits|1|||
27743982|NCT01751646|80892730|FG000|Overall Study|Off study due to multiple obligations|0|||
27743983|NCT01751646|80892731|FG001|Overall Study|Off study due to multiple obligations|1|||
27743984|NCT01751646|80892730|FG000|Overall Study|Fails to comply with study requirements|0|||
27743985|NCT01751646|80892731|FG001|Overall Study|Fails to comply with study requirements|1|||
27743986|NCT01751646|80892730|FG000|Overall Study|Childcare issues|1|||
27743987|NCT01751646|80892731|FG001|Overall Study|Childcare issues|1|||
27743988|NCT03894904|80892736|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
27743989|NCT03894904|80892737|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
27743990|NCT03894904|80892736|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
27743991|NCT03894904|80892737|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
27743992|NCT01062399|80892740|FG000|Overall Study|Protocol Violation|0|||
27743993|NCT01062399|80892741|FG001|Overall Study|Protocol Violation|1|||
27743994|NCT01062399|80892742|FG002|Overall Study|Protocol Violation|0|||
27936240|NCT03309605|81604269|FG007|Overall Study|Adverse Event|1|||
27936241|NCT03309605|81604262|FG000|Overall Study|Withdrawal by Subject|0|||
27550975|NCT00203996|80203557|FG008|Overall Study|Protocol Violation|0|||
27550976|NCT00203996|80203558|FG009|Overall Study|Protocol Violation|0|||
27550977|NCT00203996|80203549|FG000|Overall Study|Physician Decision|0|||
27743995|NCT01062399|80892743|FG003|Overall Study|Protocol Violation|6|||
27743996|NCT01062399|80892744|FG004|Overall Study|Protocol Violation|4|||
27743997|NCT00537940|80892745|FG000|Overall Study|Adverse Event|20|||
27743998|NCT00537940|80892746|FG001|Overall Study|Adverse Event|19|||
27743999|NCT00537940|80892745|FG000|Overall Study|Lack of Efficacy|8|||
27744000|NCT00537940|80892746|FG001|Overall Study|Lack of Efficacy|16|||
27744001|NCT00537940|80892745|FG000|Overall Study|Lost to Follow-up|23|||
27643597|NCT01998958|80536392|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643598|NCT01998958|80536393|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643599|NCT01998958|80536394|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
27643600|NCT01998958|80536395|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
27643601|NCT01998958|80536396|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
27643602|NCT01998958|80536397|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643603|NCT01998958|80536398|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643604|NCT01998958|80536399|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643605|NCT01998958|80536400|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643606|NCT01998958|80536401|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643607|NCT01998958|80536402|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643608|NCT01998958|80536403|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643609|NCT01998958|80536404|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
27643610|NCT02866942|80536410|FG000|Overall Study|Invalid consent|1|||
27643611|NCT00116649|80536413|FG000|Overall Study|Adverse Event|20|||
27643612|NCT00116649|80536413|FG000|Overall Study|Lack of Efficacy|1|||
27643613|NCT00116649|80536413|FG000|Overall Study|Lost to Follow-up|32|||
27643614|NCT00116649|80536413|FG000|Overall Study|Withdrawal by Subject|68|||
27643615|NCT00116649|80536413|FG000|Overall Study|Local Skin Reaction|9|||
27643616|NCT00116649|80536413|FG000|Overall Study|Various Reasons|18|||
27643617|NCT00116649|80536413|FG000|Overall Study|Protocol Specified|7|||
27643618|NCT00795184|80536414|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
27643619|NCT00795184|80536415|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
27643620|NCT01588951|80536416|FG000|Overall Study|Ineligible in retrospect|0|||
27643621|NCT01588951|80536417|FG001|Overall Study|Ineligible in retrospect|0|||
27643622|NCT01588951|80536418|FG002|Overall Study|Ineligible in retrospect|1|||
27643623|NCT01437319|80536419|FG000|Phase I|Lost to Follow-up|2|||
27643624|NCT01437319|80536420|FG001|Phase I|Lost to Follow-up|0|||
27643625|NCT01437319|80536421|FG002|Phase I|Lost to Follow-up|0|||
27643626|NCT01437319|80536419|FG000|Phase I|Protocol Violation|1|||
27643627|NCT01437319|80536420|FG001|Phase I|Protocol Violation|0|||
27643628|NCT01437319|80536421|FG002|Phase I|Protocol Violation|0|||
27643629|NCT01437319|80536419|FG000|Phase I|Study related symptoms/complaints|27|||
27643630|NCT01437319|80536420|FG001|Phase I|Study related symptoms/complaints|0|||
27643631|NCT01437319|80536421|FG002|Phase I|Study related symptoms/complaints|0|||
27643632|NCT01437319|80536419|FG000|Phase I|Withdrawal by Subject|25|||
27643633|NCT01437319|80536420|FG001|Phase I|Withdrawal by Subject|0|||
27643634|NCT01437319|80536421|FG002|Phase I|Withdrawal by Subject|0|||
27643635|NCT01437319|80536419|FG000|Phase II|Withdrawal by Subject|0|||
27643636|NCT01437319|80536420|FG001|Phase II|Withdrawal by Subject|8|||
27643637|NCT01437319|80536421|FG002|Phase II|Withdrawal by Subject|16|||
27643638|NCT01437319|80536419|FG000|Phase II|Lost to Follow-up|0|||
27643639|NCT01437319|80536420|FG001|Phase II|Lost to Follow-up|7|||
27643640|NCT01437319|80536421|FG002|Phase II|Lost to Follow-up|2|||
27643641|NCT01437319|80536419|FG000|Phase II|Study related symptoms/complaints|0|||
27643642|NCT01437319|80536420|FG001|Phase II|Study related symptoms/complaints|28|||
27643643|NCT01437319|80536421|FG002|Phase II|Study related symptoms/complaints|19|||
27643644|NCT01437319|80536419|FG000|Phase II|Protocol Violation|0|||
27643645|NCT01437319|80536420|FG001|Phase II|Protocol Violation|1|||
27643646|NCT01437319|80536421|FG002|Phase II|Protocol Violation|0|||
27643647|NCT00960141|80536424|FG000|Overall Study|Adverse Event|4|||
27643648|NCT00960141|80536425|FG001|Overall Study|Adverse Event|8|||
27643649|NCT00960141|80536426|FG002|Overall Study|Adverse Event|2|||
27643650|NCT00960141|80536424|FG000|Overall Study|Lack of Efficacy|3|||
27643651|NCT00960141|80536425|FG001|Overall Study|Lack of Efficacy|4|||
27643652|NCT00960141|80536426|FG002|Overall Study|Lack of Efficacy|2|||
27643653|NCT00960141|80536424|FG000|Overall Study|Lost to Follow-up|1|||
27643654|NCT00960141|80536425|FG001|Overall Study|Lost to Follow-up|0|||
27643655|NCT00960141|80536426|FG002|Overall Study|Lost to Follow-up|0|||
27744002|NCT00537940|80892746|FG001|Overall Study|Lost to Follow-up|29|||
27744003|NCT00537940|80892745|FG000|Overall Study|Withdrawal by Subject|113|||
27744004|NCT00537940|80892746|FG001|Overall Study|Withdrawal by Subject|95|||
27643656|NCT00960141|80536424|FG000|Overall Study|Protocol Violation|1|||
27643657|NCT00960141|80536425|FG001|Overall Study|Protocol Violation|3|||
27643658|NCT00960141|80536426|FG002|Overall Study|Protocol Violation|2|||
27643659|NCT00960141|80536424|FG000|Overall Study|Withdrawal by Subject|1|||
27643660|NCT00960141|80536425|FG001|Overall Study|Withdrawal by Subject|2|||
27744005|NCT00537940|80892745|FG000|Overall Study|Protocol Violation|6|||
27744006|NCT00537940|80892746|FG001|Overall Study|Protocol Violation|4|||
27744007|NCT00537940|80892745|FG000|Overall Study|Pregnancy|1|||
27744008|NCT00537940|80892746|FG001|Overall Study|Pregnancy|1|||
27643661|NCT00960141|80536426|FG002|Overall Study|Withdrawal by Subject|1|||
27643662|NCT01574716|80536427|FG000|Part 1|Death|3|||
27643663|NCT01574716|80536428|FG001|Part 1|Death|1|||
27643664|NCT01574716|80536429|FG002|Part 1|Death|8|||
27643665|NCT01574716|80536430|FG003|Part 1|Death|0|||
27643666|NCT01574716|80536431|FG004|Part 1|Death|0|||
27936242|NCT03309605|81604263|FG001|Overall Study|Withdrawal by Subject|0|||
27936243|NCT03309605|81604264|FG002|Overall Study|Withdrawal by Subject|0|||
27936244|NCT03309605|81604265|FG003|Overall Study|Withdrawal by Subject|0|||
27936245|NCT03309605|81604266|FG004|Overall Study|Withdrawal by Subject|1|||
27936246|NCT03309605|81604267|FG005|Overall Study|Withdrawal by Subject|0|||
27936247|NCT03309605|81604268|FG006|Overall Study|Withdrawal by Subject|1|||
27643667|NCT01574716|80536427|FG000|Part 1|Discontinuation of study by sponsor|0|||
27643668|NCT01574716|80536428|FG001|Part 1|Discontinuation of study by sponsor|0|||
27643669|NCT01574716|80536429|FG002|Part 1|Discontinuation of study by sponsor|1|||
27643670|NCT01574716|80536430|FG003|Part 1|Discontinuation of study by sponsor|0|||
27643671|NCT01574716|80536431|FG004|Part 1|Discontinuation of study by sponsor|0|||
27643672|NCT01574716|80536427|FG000|Part 1|Withdrawal by Subject|0|||
27643673|NCT01574716|80536428|FG001|Part 1|Withdrawal by Subject|2|||
27643674|NCT01574716|80536429|FG002|Part 1|Withdrawal by Subject|0|||
27643675|NCT01574716|80536430|FG003|Part 1|Withdrawal by Subject|0|||
27643676|NCT01574716|80536431|FG004|Part 1|Withdrawal by Subject|0|||
27643677|NCT01574716|80536427|FG000|Part 1|Lost to Follow-up|0|||
27643678|NCT01574716|80536428|FG001|Part 1|Lost to Follow-up|1|||
27643679|NCT01574716|80536429|FG002|Part 1|Lost to Follow-up|0|||
27643680|NCT01574716|80536430|FG003|Part 1|Lost to Follow-up|0|||
27643681|NCT01574716|80536431|FG004|Part 1|Lost to Follow-up|0|||
27643682|NCT01574716|80536427|FG000|Part 2|Progressive disease|0|||
27643683|NCT01574716|80536428|FG001|Part 2|Progressive disease|0|||
27643684|NCT01574716|80536429|FG002|Part 2|Progressive disease|0|||
27643685|NCT01574716|80536430|FG003|Part 2|Progressive disease|1|||
27643686|NCT01574716|80536431|FG004|Part 2|Progressive disease|0|||
27643687|NCT01574716|80536427|FG000|Part 2|Death|0|||
27643688|NCT01574716|80536428|FG001|Part 2|Death|0|||
27643689|NCT01574716|80536429|FG002|Part 2|Death|0|||
27643690|NCT01574716|80536430|FG003|Part 2|Death|76|||
27643691|NCT01574716|80536431|FG004|Part 2|Death|35|||
27643692|NCT01574716|80536427|FG000|Part 2|Discontinuation of study by sponsor|0|||
27643693|NCT01574716|80536428|FG001|Part 2|Discontinuation of study by sponsor|0|||
27643694|NCT01574716|80536429|FG002|Part 2|Discontinuation of study by sponsor|0|||
27643695|NCT01574716|80536430|FG003|Part 2|Discontinuation of study by sponsor|51|||
27643696|NCT01574716|80536431|FG004|Part 2|Discontinuation of study by sponsor|31|||
27643697|NCT01574716|80536427|FG000|Part 2|Withdrawal by Subject|0|||
27744009|NCT00537940|80892745|FG000|Overall Study|Study terminated by sponsor|2|||
27744010|NCT00537940|80892746|FG001|Overall Study|Study terminated by sponsor|3|||
27744011|NCT00537940|80892745|FG000|Overall Study|Other|10|||
27744012|NCT00537940|80892746|FG001|Overall Study|Other|12|||
27643698|NCT01574716|80536428|FG001|Part 2|Withdrawal by Subject|0|||
27643699|NCT01574716|80536429|FG002|Part 2|Withdrawal by Subject|0|||
27643700|NCT01574716|80536430|FG003|Part 2|Withdrawal by Subject|5|||
27643701|NCT01574716|80536431|FG004|Part 2|Withdrawal by Subject|4|||
27643702|NCT01574716|80536427|FG000|Part 2|Brain metastases|0|||
27643703|NCT01574716|80536428|FG001|Part 2|Brain metastases|0|||
27643704|NCT01574716|80536429|FG002|Part 2|Brain metastases|0|||
27643705|NCT01574716|80536430|FG003|Part 2|Brain metastases|1|||
27643706|NCT01574716|80536431|FG004|Part 2|Brain metastases|0|||
27643707|NCT01574716|80536427|FG000|Part 2|Lost to Follow-up|0|||
27643708|NCT01574716|80536428|FG001|Part 2|Lost to Follow-up|0|||
27744013|NCT00593112|80892747|FG000|Overall Study|Scan Anxiety|3|||
27744014|NCT00593112|80892748|FG001|Overall Study|Scan Anxiety|0|||
27744015|NCT00593112|80892747|FG000|Overall Study|Abnormal Scan|1|||
27744016|NCT00593112|80892748|FG001|Overall Study|Abnormal Scan|0|||
27744017|NCT00593112|80892747|FG000|Overall Study|Unreadable Scan|1|||
27744018|NCT00593112|80892748|FG001|Overall Study|Unreadable Scan|0|||
27744019|NCT00593112|80892747|FG000|Overall Study|Withdrawal by Subject|5|||
27936248|NCT03309605|81604269|FG007|Overall Study|Withdrawal by Subject|1|||
27643709|NCT01574716|80536429|FG002|Part 2|Lost to Follow-up|0|||
27936249|NCT04432298|81604272|FG000|Overall Study|Other than specified|1|||
27643710|NCT01574716|80536430|FG003|Part 2|Lost to Follow-up|3|||
27643711|NCT01574716|80536431|FG004|Part 2|Lost to Follow-up|0|||
27643712|NCT02130557|80536432|FG000|Overall Study|Withdrawal by Subject|12|||
27643713|NCT02130557|80536433|FG001|Overall Study|Withdrawal by Subject|12|||
27936250|NCT04432298|81604273|FG001|Overall Study|Other than specified|0|||
27936251|NCT04432298|81604272|FG000|Overall Study|Lost to Follow-up|0|||
27643714|NCT02130557|80536432|FG000|Overall Study|Investigator Request|0|||
27643715|NCT02130557|80536433|FG001|Overall Study|Investigator Request|2|||
27643716|NCT02130557|80536432|FG000|Overall Study|Deceased|14|||
27643717|NCT02130557|80536433|FG001|Overall Study|Deceased|14|||
27643718|NCT02130557|80536432|FG000|Overall Study|Lost to Follow-up|6|||
27643719|NCT02130557|80536433|FG001|Overall Study|Lost to Follow-up|7|||
27643720|NCT02130557|80536432|FG000|Overall Study|Other|2|||
27744020|NCT00593112|80892748|FG001|Overall Study|Withdrawal by Subject|0|||
27744021|NCT00719732|80892750|FG000|Overall Study|Lost to Follow-up|20|||
27744022|NCT00719732|80892750|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
27744023|NCT00719732|80892750|FG000|Overall Study|Illness not associated with device|1|||
27744024|NCT01781026|80892751|FG000|Overall Study|Lack of Efficacy|2|||
27744025|NCT00739297|80892752|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
27744026|NCT00739297|80892753|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
27744027|NCT00739297|80892754|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
27744028|NCT00739297|80892755|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
27744029|NCT00739297|80892756|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
27744030|NCT00739297|80892757|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
27744031|NCT00739297|80892758|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
27744032|NCT00739297|80892752|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27744033|NCT00739297|80892753|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27744034|NCT00739297|80892754|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27744035|NCT00739297|80892755|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27744036|NCT00739297|80892756|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
27744037|NCT00739297|80892757|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
27744038|NCT00739297|80892758|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
27744039|NCT03090191|80892768|FG000|Overall Study|Adverse Event|90|||
27744040|NCT03090191|80892769|FG001|Overall Study|Adverse Event|72|||
27744041|NCT03090191|80892768|FG000|Overall Study|Death|365|||
27744042|NCT03090191|80892769|FG001|Overall Study|Death|358|||
27744043|NCT03090191|80892768|FG000|Overall Study|Lost to Follow-up|382|||
27744044|NCT03090191|80892769|FG001|Overall Study|Lost to Follow-up|394|||
27744045|NCT03090191|80892768|FG000|Overall Study|Physician Decision|77|||
27744046|NCT03090191|80892769|FG001|Overall Study|Physician Decision|66|||
27744047|NCT03090191|80892768|FG000|Overall Study|Protocol Violation|43|||
27744048|NCT03090191|80892769|FG001|Overall Study|Protocol Violation|52|||
27744049|NCT03090191|80892768|FG000|Overall Study|Withdrawal by Subject|2160|||
27744050|NCT03090191|80892769|FG001|Overall Study|Withdrawal by Subject|2133|||
27744051|NCT03090191|80892768|FG000|Overall Study|Site terminated|7|||
27744052|NCT03090191|80892769|FG001|Overall Study|Site terminated|8|||
27744053|NCT03090191|80892768|FG000|Overall Study|Other|66|||
27744054|NCT03090191|80892769|FG001|Overall Study|Other|60|||
27744055|NCT03090191|80892768|FG000|Overall Study|Withdrawn before any study vaccination|43|||
27744056|NCT03090191|80892769|FG001|Overall Study|Withdrawn before any study vaccination|52|||
27744057|NCT00418886|80892774|FG000|Overall Study|discontinue treatment survival follow up|90|||
27744058|NCT00418886|80892775|FG001|Overall Study|discontinue treatment survival follow up|91|||
27744059|NCT00418886|80892774|FG000|Overall Study|Death|122|||
27744060|NCT00418886|80892775|FG001|Overall Study|Death|147|||
27744061|NCT00418886|80892774|FG000|Overall Study|Withdrawal by Subject|9|||
27744062|NCT00418886|80892775|FG001|Overall Study|Withdrawal by Subject|10|||
27744063|NCT00418886|80892774|FG000|Overall Study|Lost to Follow-up|4|||
27744064|NCT00418886|80892775|FG001|Overall Study|Lost to Follow-up|6|||
27744065|NCT00418886|80892774|FG000|Overall Study|withdrawn due to other reason|1|||
27744066|NCT00418886|80892775|FG001|Overall Study|withdrawn due to other reason|0|||
27744067|NCT00418886|80892774|FG000|Overall Study|randomised but no treatment received|0|||
27744068|NCT00418886|80892775|FG001|Overall Study|randomised but no treatment received|1|||
27744069|NCT05243550|80892781|FG000|Overall Study|Ongoing in the Study|171|||
27744070|NCT05243550|80892781|FG000|Overall Study|Withdrawal by Subject|10|||
27744071|NCT05243550|80892781|FG000|Overall Study|Lost to Follow-up|7|||
27744072|NCT05243550|80892781|FG000|Overall Study|Adverse Event|3|||
27744073|NCT05243550|80892781|FG000|Overall Study|Noncompliance|1|||
27744074|NCT05243550|80892781|FG000|Overall Study|Physician Decision|1|||
27744075|NCT05243550|80892781|FG000|Overall Study|Other Reason|4|||
27744076|NCT03290300|80892782|FG000|Overall Study|Lost to Follow-up|3|||
27744077|NCT00931892|80892783|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
27744078|NCT00931892|80892784|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
27744079|NCT00546819|80892787|FG000|Overall Study|Adverse Event|2|||
27744080|NCT00546819|80892788|FG001|Overall Study|Adverse Event|3|||
27744081|NCT00546819|80892787|FG000|Overall Study|Lost to Follow-up|2|||
27744082|NCT00546819|80892788|FG001|Overall Study|Lost to Follow-up|1|||
27936252|NCT04432298|81604273|FG001|Overall Study|Lost to Follow-up|1|||
27744083|NCT00546819|80892787|FG000|Overall Study|Withdrawal by Subject|4|||
27744084|NCT00546819|80892788|FG001|Overall Study|Withdrawal by Subject|2|||
27936253|NCT04432298|81604272|FG000|Overall Study|Death|3|||
27550978|NCT00203996|80203550|FG001|Overall Study|Physician Decision|0|||
27744085|NCT00077623|80892789|FG000|Overall Study|Adverse Event|1|||
27744086|NCT00077623|80892790|FG001|Overall Study|Adverse Event|0|||
27744087|NCT00077623|80892791|FG002|Overall Study|Adverse Event|1|||
27936254|NCT04432298|81604273|FG001|Overall Study|Death|2|||
27936255|NCT04432298|81604272|FG000|Overall Study|Withdrawal by Subject|2|||
27744088|NCT00077623|80892789|FG000|Overall Study|Withdrawal by Subject|2|||
27744089|NCT00077623|80892790|FG001|Overall Study|Withdrawal by Subject|10|||
27744090|NCT00077623|80892791|FG002|Overall Study|Withdrawal by Subject|1|||
27744091|NCT00077623|80892789|FG000|Overall Study|Other-Non safety reason|18|||
27744092|NCT00077623|80892790|FG001|Overall Study|Other-Non safety reason|15|||
27744093|NCT00077623|80892791|FG002|Overall Study|Other-Non safety reason|19|||
27744094|NCT00077623|80892789|FG000|Overall Study|Insufficient therapeutic response|2|||
27744095|NCT00077623|80892790|FG001|Overall Study|Insufficient therapeutic response|0|||
27744096|NCT00077623|80892791|FG002|Overall Study|Insufficient therapeutic response|0|||
27744097|NCT00077623|80892789|FG000|Overall Study|Death|12|||
27744098|NCT00077623|80892790|FG001|Overall Study|Death|18|||
27744099|NCT00077623|80892791|FG002|Overall Study|Death|11|||
27744100|NCT00077623|80892789|FG000|Overall Study|Failure to return|1|||
27744101|NCT00077623|80892790|FG001|Overall Study|Failure to return|0|||
27744102|NCT00077623|80892791|FG002|Overall Study|Failure to return|0|||
27744103|NCT01594476|80892793|FG000|Overall Study|Protocol Violation|1|||
27744104|NCT01594476|80892794|FG001|Overall Study|Protocol Violation|3|||
27744105|NCT01780389|80892795|FG000|Overall Study|Adverse Event|1|||
27744106|NCT03216265|80892796|FG000|Overall Study|Adverse Event|2|||
27744107|NCT03216265|80892797|FG001|Overall Study|Adverse Event|0|||
27744108|NCT03216265|80892798|FG002|Overall Study|Adverse Event|2|||
27744109|NCT03216265|80892796|FG000|Overall Study|Lost to Follow-up|0|||
27744110|NCT03216265|80892797|FG001|Overall Study|Lost to Follow-up|1|||
27744111|NCT03216265|80892798|FG002|Overall Study|Lost to Follow-up|0|||
27744112|NCT03216265|80892796|FG000|Overall Study|Withdrawal by Subject|0|||
27744113|NCT03216265|80892797|FG001|Overall Study|Withdrawal by Subject|0|||
27744114|NCT03216265|80892798|FG002|Overall Study|Withdrawal by Subject|1|||
27744115|NCT05468086|80892799|FG000|Overall Study|Withdrawal by Subject|3|||
27744116|NCT05468086|80892799|FG000|Overall Study|Subject was found ineligible after consent|1|||
27744117|NCT02760407|80892800|FG000|Overall Study|Death|2|||
27744118|NCT02760407|80892801|FG001|Overall Study|Death|3|||
27744119|NCT02760407|80892802|FG002|Overall Study|Death|1|||
27744120|NCT02760407|80892803|FG003|Overall Study|Death|1|||
27744121|NCT02760407|80892800|FG000|Overall Study|Lost to Follow-up|1|||
27744122|NCT02760407|80892801|FG001|Overall Study|Lost to Follow-up|7|||
27744123|NCT02760407|80892802|FG002|Overall Study|Lost to Follow-up|4|||
27744124|NCT02760407|80892803|FG003|Overall Study|Lost to Follow-up|6|||
27744125|NCT02760407|80892800|FG000|Overall Study|Withdrawal by Subject|25|||
27744126|NCT02760407|80892801|FG001|Overall Study|Withdrawal by Subject|31|||
27744127|NCT02760407|80892802|FG002|Overall Study|Withdrawal by Subject|37|||
27744128|NCT02760407|80892803|FG003|Overall Study|Withdrawal by Subject|25|||
27744129|NCT02760407|80892800|FG000|Overall Study|Violation of Eligibility criteria|0|||
27744130|NCT02760407|80892801|FG001|Overall Study|Violation of Eligibility criteria|0|||
27744131|NCT02760407|80892802|FG002|Overall Study|Violation of Eligibility criteria|1|||
27744132|NCT02760407|80892803|FG003|Overall Study|Violation of Eligibility criteria|1|||
27744133|NCT02760407|80892800|FG000|Overall Study|Personal reasons|0|||
27744134|NCT02760407|80892801|FG001|Overall Study|Personal reasons|0|||
27744135|NCT02760407|80892802|FG002|Overall Study|Personal reasons|0|||
27744136|NCT02760407|80892803|FG003|Overall Study|Personal reasons|1|||
27744137|NCT02760407|80892800|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
27744138|NCT02760407|80892801|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
27744139|NCT02760407|80892802|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
27744140|NCT02760407|80892803|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
27643721|NCT02130557|80536433|FG001|Overall Study|Other|1|||
27643722|NCT02130557|80536432|FG000|Overall Study|Missing|2|||
27643723|NCT02130557|80536433|FG001|Overall Study|Missing|1|||
27643724|NCT01268306|80536434|FG000|Overall Study|Lost to Follow-up|1|||
27643725|NCT02075554|80536435|FG000|Overall Study|Lost to Follow-up|7|||
27643726|NCT02075554|80536435|FG000|Overall Study|Withdrawal by Subject|5|||
27643727|NCT02075554|80536435|FG000|Overall Study|Physician Decision|3|||
27643728|NCT02461628|80536436|FG000|Overall Study|Refused to complete survey|4|||
27643729|NCT02461628|80536437|FG001|Overall Study|Refused to complete survey|7|||
27744141|NCT02760407|80892800|FG000|Overall Study|Use of prohibited Medication|0|||
27643730|NCT01619410|80536438|FG000|Overall Study|Lost to Follow-up|7|||
27643731|NCT01619410|80536439|FG001|Overall Study|Lost to Follow-up|4|||
27744142|NCT02760407|80892801|FG001|Overall Study|Use of prohibited Medication|0|||
27744143|NCT02760407|80892802|FG002|Overall Study|Use of prohibited Medication|1|||
27744144|NCT02760407|80892803|FG003|Overall Study|Use of prohibited Medication|0|||
27744145|NCT02760407|80892800|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
27744146|NCT02760407|80892801|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
27744147|NCT02760407|80892802|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
27744148|NCT02760407|80892803|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
27744149|NCT02760407|80892800|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
27744150|NCT02760407|80892801|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
27744151|NCT02760407|80892802|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
27744152|NCT02760407|80892803|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
27744153|NCT02760407|80892800|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
27744154|NCT02760407|80892801|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
27744155|NCT02760407|80892802|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
27643732|NCT00722046|80536440|FG000|Overall Study|Adverse Event|0|||
27643733|NCT00722046|80536441|FG001|Overall Study|Adverse Event|1|||
27643734|NCT00722046|80536442|FG002|Overall Study|Adverse Event|2|||
27643735|NCT00722046|80536443|FG003|Overall Study|Adverse Event|1|||
27643736|NCT00722046|80536444|FG004|Overall Study|Adverse Event|2|||
27643737|NCT00722046|80536445|FG005|Overall Study|Adverse Event|1|||
27643738|NCT00722046|80536446|FG006|Overall Study|Adverse Event|0|||
27643739|NCT00722046|80536440|FG000|Overall Study|Death|0|||
27643740|NCT00722046|80536441|FG001|Overall Study|Death|1|||
27643741|NCT00722046|80536442|FG002|Overall Study|Death|0|||
27643742|NCT00722046|80536443|FG003|Overall Study|Death|0|||
27643743|NCT00722046|80536444|FG004|Overall Study|Death|0|||
27643744|NCT00722046|80536445|FG005|Overall Study|Death|0|||
27643745|NCT00722046|80536446|FG006|Overall Study|Death|2|||
27643746|NCT00722046|80536440|FG000|Overall Study|Protocol Violation|1|||
27643747|NCT00722046|80536441|FG001|Overall Study|Protocol Violation|0|||
27643748|NCT00722046|80536442|FG002|Overall Study|Protocol Violation|0|||
27643749|NCT00722046|80536443|FG003|Overall Study|Protocol Violation|0|||
27643750|NCT00722046|80536444|FG004|Overall Study|Protocol Violation|0|||
27643751|NCT00722046|80536445|FG005|Overall Study|Protocol Violation|1|||
27643752|NCT00722046|80536446|FG006|Overall Study|Protocol Violation|0|||
27643753|NCT00722046|80536440|FG000|Overall Study|Withdrawal by Subject|3|||
27643754|NCT00722046|80536441|FG001|Overall Study|Withdrawal by Subject|3|||
27643755|NCT00722046|80536442|FG002|Overall Study|Withdrawal by Subject|4|||
27643756|NCT00722046|80536443|FG003|Overall Study|Withdrawal by Subject|4|||
27643757|NCT00722046|80536444|FG004|Overall Study|Withdrawal by Subject|4|||
27643758|NCT00722046|80536445|FG005|Overall Study|Withdrawal by Subject|7|||
27643759|NCT00722046|80536446|FG006|Overall Study|Withdrawal by Subject|3|||
27643760|NCT00722046|80536440|FG000|Overall Study|Randomized, but not treated|1|||
27643761|NCT00722046|80536441|FG001|Overall Study|Randomized, but not treated|1|||
27643762|NCT00722046|80536442|FG002|Overall Study|Randomized, but not treated|0|||
27643763|NCT00722046|80536443|FG003|Overall Study|Randomized, but not treated|2|||
27643764|NCT00722046|80536444|FG004|Overall Study|Randomized, but not treated|0|||
27643765|NCT00722046|80536445|FG005|Overall Study|Randomized, but not treated|0|||
27643766|NCT00722046|80536446|FG006|Overall Study|Randomized, but not treated|0|||
27643767|NCT00722046|80536440|FG000|Overall Study|Other|0|||
27643768|NCT00722046|80536441|FG001|Overall Study|Other|0|||
27643769|NCT00722046|80536442|FG002|Overall Study|Other|1|||
27643770|NCT00722046|80536443|FG003|Overall Study|Other|1|||
27643771|NCT00722046|80536444|FG004|Overall Study|Other|3|||
27744156|NCT02760407|80892803|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
27744157|NCT02760407|80892800|FG000|Overall Study|Inadequately Enrolled|0|||
27744158|NCT02760407|80892801|FG001|Overall Study|Inadequately Enrolled|0|||
27744159|NCT02760407|80892802|FG002|Overall Study|Inadequately Enrolled|0|||
27744160|NCT02760407|80892803|FG003|Overall Study|Inadequately Enrolled|1|||
27643772|NCT00722046|80536445|FG005|Overall Study|Other|2|||
27643773|NCT00722046|80536446|FG006|Overall Study|Other|1|||
27643774|NCT00879710|80536447|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
27643775|NCT00879710|80536448|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
27643776|NCT00879710|80536449|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
27643777|NCT00879710|80536450|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
27643778|NCT00879710|80536447|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
27643779|NCT00879710|80536448|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
27643780|NCT00879710|80536449|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
27643781|NCT00879710|80536450|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
27643782|NCT01303510|80536451|FG000|Overall Study|Lost to Follow-up|1|||
27643783|NCT01303510|80536452|FG001|Overall Study|Lost to Follow-up|0|||
27643784|NCT01627561|80536456|FG000|Overall Study|Lost to Follow-up|1|||
27643785|NCT01627561|80536457|FG001|Overall Study|Lost to Follow-up|0|||
27643786|NCT01627561|80536456|FG000|Overall Study|Withdrawal by Subject|0|||
27643787|NCT01627561|80536457|FG001|Overall Study|Withdrawal by Subject|1|||
27643788|NCT01627561|80536456|FG000|Overall Study|Migrated/moved from study area|0|||
27643789|NCT01627561|80536457|FG001|Overall Study|Migrated/moved from study area|2|||
27643790|NCT01629589|80536458|FG000|Overall Study|Protocol Violation|4|||
27643791|NCT01629589|80536459|FG001|Overall Study|Protocol Violation|2|||
27744161|NCT02760407|80892800|FG000|Overall Study|Withdrawal By PI's Decision|0|||
27643792|NCT01629589|80536458|FG000|Overall Study|Lost to Follow-up|2|||
27643793|NCT01629589|80536459|FG001|Overall Study|Lost to Follow-up|1|||
27643794|NCT01629589|80536458|FG000|Overall Study|Withdrawal by Subject|2|||
27643795|NCT01629589|80536459|FG001|Overall Study|Withdrawal by Subject|3|||
27643796|NCT01629589|80536458|FG000|Overall Study|Did not receive study vaccine|0|||
27643797|NCT01629589|80536459|FG001|Overall Study|Did not receive study vaccine|1|||
27643798|NCT01340066|80536462|FG000|Placebo Run in Period|Screen Failures|27|||
27643799|NCT01340066|80536463|FG001|Placebo Run in Period|Screen Failures|0|||
27643800|NCT01340066|80536464|FG002|Placebo Run in Period|Screen Failures|0|||
27643801|NCT01340066|80536462|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
27643802|NCT01340066|80536463|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
27643803|NCT01340066|80536464|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
27643804|NCT01340066|80536462|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
27643805|NCT01340066|80536463|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
27643806|NCT01340066|80536464|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
27643807|NCT01340066|80536462|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
27643808|NCT01340066|80536463|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
27643809|NCT01340066|80536464|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
27643810|NCT01471691|80536470|FG000|Overall Study|Lack of Efficacy|0|||
27643811|NCT01471691|80536471|FG001|Overall Study|Lack of Efficacy|1|||
27643812|NCT02404441|80536472|FG000|Phase 1 Part|Adverse Event|1|||
27643813|NCT02404441|80536473|FG001|Phase 1 Part|Adverse Event|0|||
27643814|NCT02404441|80536474|FG002|Phase 1 Part|Adverse Event|0|||
27643815|NCT02404441|80536475|FG003|Phase 1 Part|Adverse Event|0|||
27643816|NCT02404441|80536476|FG004|Phase 1 Part|Adverse Event|0|||
27643817|NCT02404441|80536477|FG005|Phase 1 Part|Adverse Event|0|||
27643818|NCT02404441|80536478|FG006|Phase 1 Part|Adverse Event|0|||
27643819|NCT02404441|80536479|FG007|Phase 1 Part|Adverse Event|0|||
27643820|NCT02404441|80536480|FG008|Phase 1 Part|Adverse Event|0|||
27643821|NCT02404441|80536481|FG009|Phase 1 Part|Adverse Event|0|||
27643822|NCT02404441|80536472|FG000|Phase 1 Part|Physician Decision|0|||
27643823|NCT02404441|80536473|FG001|Phase 1 Part|Physician Decision|1|||
27643824|NCT02404441|80536474|FG002|Phase 1 Part|Physician Decision|0|||
27643825|NCT02404441|80536475|FG003|Phase 1 Part|Physician Decision|0|||
27643826|NCT02404441|80536476|FG004|Phase 1 Part|Physician Decision|0|||
27643827|NCT02404441|80536477|FG005|Phase 1 Part|Physician Decision|0|||
27643828|NCT02404441|80536478|FG006|Phase 1 Part|Physician Decision|0|||
27643829|NCT02404441|80536479|FG007|Phase 1 Part|Physician Decision|0|||
27643830|NCT02404441|80536480|FG008|Phase 1 Part|Physician Decision|0|||
27643831|NCT02404441|80536481|FG009|Phase 1 Part|Physician Decision|0|||
27643832|NCT02404441|80536472|FG000|Phase 1 Part|Progressive Disease|14|||
27643833|NCT02404441|80536473|FG001|Phase 1 Part|Progressive Disease|11|||
27643834|NCT02404441|80536474|FG002|Phase 1 Part|Progressive Disease|7|||
27643835|NCT02404441|80536475|FG003|Phase 1 Part|Progressive Disease|6|||
27643836|NCT02404441|80536476|FG004|Phase 1 Part|Progressive Disease|9|||
27643837|NCT02404441|80536477|FG005|Phase 1 Part|Progressive Disease|0|||
27643838|NCT02404441|80536478|FG006|Phase 1 Part|Progressive Disease|0|||
27643839|NCT02404441|80536479|FG007|Phase 1 Part|Progressive Disease|0|||
27643840|NCT02404441|80536480|FG008|Phase 1 Part|Progressive Disease|0|||
27643841|NCT02404441|80536481|FG009|Phase 1 Part|Progressive Disease|0|||
27643842|NCT02404441|80536472|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
27643843|NCT02404441|80536473|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
27643844|NCT02404441|80536474|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
27643845|NCT02404441|80536475|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
27643846|NCT02404441|80536476|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
27643847|NCT02404441|80536477|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
27643848|NCT02404441|80536478|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
27643849|NCT02404441|80536479|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
27643850|NCT02404441|80536480|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
27643851|NCT02404441|80536481|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
27643852|NCT02404441|80536472|FG000|Phase 1 Part|Death|1|||
27643853|NCT02404441|80536473|FG001|Phase 1 Part|Death|1|||
27643854|NCT02404441|80536474|FG002|Phase 1 Part|Death|1|||
27643855|NCT02404441|80536475|FG003|Phase 1 Part|Death|0|||
27643856|NCT02404441|80536476|FG004|Phase 1 Part|Death|1|||
27643857|NCT02404441|80536477|FG005|Phase 1 Part|Death|0|||
27643858|NCT02404441|80536478|FG006|Phase 1 Part|Death|0|||
27643859|NCT02404441|80536479|FG007|Phase 1 Part|Death|0|||
27936256|NCT04432298|81604273|FG001|Overall Study|Withdrawal by Subject|0|||
27643860|NCT02404441|80536480|FG008|Phase 1 Part|Death|0|||
27643861|NCT02404441|80536481|FG009|Phase 1 Part|Death|0|||
27643862|NCT02404441|80536472|FG000|Phase 2 Part|Adverse Event|0|||
27643863|NCT02404441|80536473|FG001|Phase 2 Part|Adverse Event|0|||
27643864|NCT02404441|80536474|FG002|Phase 2 Part|Adverse Event|0|||
27643865|NCT02404441|80536475|FG003|Phase 2 Part|Adverse Event|0|||
27936257|NCT00758043|81604274|FG000|Overall Study|Adverse Event|1|||
27643866|NCT02404441|80536476|FG004|Phase 2 Part|Adverse Event|0|||
27643867|NCT02404441|80536477|FG005|Phase 2 Part|Adverse Event|2|||
27643868|NCT02404441|80536478|FG006|Phase 2 Part|Adverse Event|3|||
27643869|NCT02404441|80536479|FG007|Phase 2 Part|Adverse Event|3|||
27643870|NCT02404441|80536480|FG008|Phase 2 Part|Adverse Event|6|||
27643871|NCT02404441|80536481|FG009|Phase 2 Part|Adverse Event|1|||
27643872|NCT02404441|80536472|FG000|Phase 2 Part|Physician Decision|0|||
27643873|NCT02404441|80536473|FG001|Phase 2 Part|Physician Decision|0|||
27643874|NCT02404441|80536474|FG002|Phase 2 Part|Physician Decision|0|||
27936258|NCT00758043|81604275|FG001|Overall Study|Adverse Event|20|||
27936259|NCT00758043|81604276|FG002|Overall Study|Adverse Event|12|||
27936260|NCT00758043|81604277|FG003|Overall Study|Adverse Event|62|||
27936261|NCT00758043|81604274|FG000|Overall Study|Lack of Efficacy|0|||
27643875|NCT02404441|80536475|FG003|Phase 2 Part|Physician Decision|0|||
27643876|NCT02404441|80536476|FG004|Phase 2 Part|Physician Decision|0|||
27643877|NCT02404441|80536477|FG005|Phase 2 Part|Physician Decision|7|||
27643878|NCT02404441|80536478|FG006|Phase 2 Part|Physician Decision|9|||
27643879|NCT02404441|80536479|FG007|Phase 2 Part|Physician Decision|2|||
27643880|NCT02404441|80536480|FG008|Phase 2 Part|Physician Decision|1|||
27643881|NCT02404441|80536481|FG009|Phase 2 Part|Physician Decision|3|||
27643882|NCT02404441|80536472|FG000|Phase 2 Part|Progressive disease|0|||
27643883|NCT02404441|80536473|FG001|Phase 2 Part|Progressive disease|0|||
27643884|NCT02404441|80536474|FG002|Phase 2 Part|Progressive disease|0|||
27643885|NCT02404441|80536475|FG003|Phase 2 Part|Progressive disease|0|||
27643886|NCT02404441|80536476|FG004|Phase 2 Part|Progressive disease|0|||
27643887|NCT02404441|80536477|FG005|Phase 2 Part|Progressive disease|43|||
27936262|NCT00758043|81604275|FG001|Overall Study|Lack of Efficacy|6|||
27643888|NCT02404441|80536478|FG006|Phase 2 Part|Progressive disease|32|||
27643889|NCT02404441|80536479|FG007|Phase 2 Part|Progressive disease|31|||
27643890|NCT02404441|80536480|FG008|Phase 2 Part|Progressive disease|39|||
27643891|NCT02404441|80536481|FG009|Phase 2 Part|Progressive disease|27|||
27643892|NCT02404441|80536472|FG000|Phase 2 Part|Subject/guardian decision|0|||
27643893|NCT02404441|80536473|FG001|Phase 2 Part|Subject/guardian decision|0|||
27643894|NCT02404441|80536474|FG002|Phase 2 Part|Subject/guardian decision|0|||
27643895|NCT02404441|80536475|FG003|Phase 2 Part|Subject/guardian decision|0|||
27643896|NCT02404441|80536476|FG004|Phase 2 Part|Subject/guardian decision|0|||
27643897|NCT02404441|80536477|FG005|Phase 2 Part|Subject/guardian decision|3|||
27643898|NCT02404441|80536478|FG006|Phase 2 Part|Subject/guardian decision|9|||
27643899|NCT02404441|80536479|FG007|Phase 2 Part|Subject/guardian decision|0|||
27643900|NCT02404441|80536480|FG008|Phase 2 Part|Subject/guardian decision|3|||
27643901|NCT02404441|80536481|FG009|Phase 2 Part|Subject/guardian decision|2|||
27643902|NCT02404441|80536472|FG000|Phase 2 Part|Death|0|||
27643903|NCT02404441|80536473|FG001|Phase 2 Part|Death|0|||
27643904|NCT02404441|80536474|FG002|Phase 2 Part|Death|0|||
27643905|NCT02404441|80536475|FG003|Phase 2 Part|Death|0|||
27643906|NCT02404441|80536476|FG004|Phase 2 Part|Death|0|||
27643907|NCT02404441|80536477|FG005|Phase 2 Part|Death|4|||
27643908|NCT02404441|80536478|FG006|Phase 2 Part|Death|8|||
27643909|NCT02404441|80536479|FG007|Phase 2 Part|Death|4|||
27643910|NCT02404441|80536480|FG008|Phase 2 Part|Death|10|||
27643911|NCT02404441|80536481|FG009|Phase 2 Part|Death|9|||
27643912|NCT02128113|80536483|FG000|Overall Study|Withdrawal by Subject|3|||
27643913|NCT02128113|80536484|FG001|Overall Study|Withdrawal by Subject|1|||
27643914|NCT02128113|80536485|FG002|Overall Study|Withdrawal by Subject|0|||
27643915|NCT02128113|80536483|FG000|Overall Study|Protocol Violation|0|||
27643916|NCT02128113|80536484|FG001|Overall Study|Protocol Violation|1|||
27643917|NCT02128113|80536485|FG002|Overall Study|Protocol Violation|0|||
27643918|NCT02128113|80536483|FG000|Overall Study|Surgery cancelled|0|||
27643919|NCT02128113|80536484|FG001|Overall Study|Surgery cancelled|1|||
27643920|NCT02128113|80536485|FG002|Overall Study|Surgery cancelled|0|||
27643921|NCT02128113|80536483|FG000|Overall Study|Adverse Event|0|||
27643922|NCT02128113|80536484|FG001|Overall Study|Adverse Event|0|||
27643923|NCT02128113|80536485|FG002|Overall Study|Adverse Event|1|||
27643924|NCT02964741|80536486|FG000|Overall Study|Protocol Violation|1|||
27643925|NCT02964741|80536487|FG001|Overall Study|Protocol Violation|0|||
27744162|NCT02760407|80892801|FG001|Overall Study|Withdrawal By PI's Decision|1|||
27744163|NCT02760407|80892802|FG002|Overall Study|Withdrawal By PI's Decision|0|||
27744164|NCT02760407|80892803|FG003|Overall Study|Withdrawal By PI's Decision|0|||
27744165|NCT02760407|80892800|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
27744166|NCT02760407|80892801|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
27754924|NCT02065622|80929634|FG004|Maintenance Study|Subject Non-Compliance|2|||
27936263|NCT00758043|81604276|FG002|Overall Study|Lack of Efficacy|18|||
27643926|NCT02964741|80536488|FG002|Overall Study|Protocol Violation|0|||
27643927|NCT02964741|80536486|FG000|Overall Study|Withdrawal by Subject|0|||
27643928|NCT02964741|80536487|FG001|Overall Study|Withdrawal by Subject|1|||
27643929|NCT02964741|80536488|FG002|Overall Study|Withdrawal by Subject|0|||
27643930|NCT02964741|80536486|FG000|Overall Study|claustrophobia|1|||
27643931|NCT02964741|80536487|FG001|Overall Study|claustrophobia|0|||
27643932|NCT02964741|80536488|FG002|Overall Study|claustrophobia|0|||
27643933|NCT02284113|80536489|FG000|Overall Study|Adverse Event|1|||
27643934|NCT02284113|80536490|FG001|Overall Study|Adverse Event|0|||
27643935|NCT02284113|80536489|FG000|Overall Study|non-compliance|0|||
27643936|NCT02284113|80536490|FG001|Overall Study|non-compliance|1|||
27643937|NCT02284113|80536489|FG000|Overall Study|Withdrawal by Subject|0|||
27643938|NCT02284113|80536490|FG001|Overall Study|Withdrawal by Subject|1|||
27643939|NCT02284113|80536489|FG000|Overall Study|not provided|0|||
27643940|NCT02284113|80536490|FG001|Overall Study|not provided|1|||
27643941|NCT02284113|80536489|FG000|Overall Study|surgery cancelled|2|||
27643942|NCT02284113|80536490|FG001|Overall Study|surgery cancelled|0|||
27936264|NCT00758043|81604277|FG003|Overall Study|Lack of Efficacy|12|||
27936265|NCT00758043|81604274|FG000|Overall Study|Refused Further Treatment|0|||
27936266|NCT00758043|81604275|FG001|Overall Study|Refused Further Treatment|11|||
27936267|NCT00758043|81604276|FG002|Overall Study|Refused Further Treatment|5|||
27936268|NCT00758043|81604277|FG003|Overall Study|Refused Further Treatment|8|||
27936269|NCT00758043|81604274|FG000|Overall Study|Lost to Follow-up|0|||
27936270|NCT00758043|81604275|FG001|Overall Study|Lost to Follow-up|2|||
27936271|NCT00758043|81604276|FG002|Overall Study|Lost to Follow-up|2|||
27936272|NCT00758043|81604277|FG003|Overall Study|Lost to Follow-up|5|||
27936273|NCT00758043|81604274|FG000|Overall Study|Withdrawal by Subject|0|||
27936274|NCT00758043|81604275|FG001|Overall Study|Withdrawal by Subject|1|||
27936275|NCT00758043|81604276|FG002|Overall Study|Withdrawal by Subject|1|||
27936276|NCT00758043|81604277|FG003|Overall Study|Withdrawal by Subject|4|||
27936277|NCT00758043|81604274|FG000|Overall Study|Required Prohibited Medication|0|||
27936278|NCT00758043|81604275|FG001|Overall Study|Required Prohibited Medication|0|||
27936279|NCT00758043|81604276|FG002|Overall Study|Required Prohibited Medication|1|||
27936280|NCT00758043|81604277|FG003|Overall Study|Required Prohibited Medication|3|||
27936281|NCT00758043|81604274|FG000|Overall Study|Non-Compliant With study Drug|0|||
27936282|NCT00758043|81604275|FG001|Overall Study|Non-Compliant With study Drug|0|||
27936283|NCT00758043|81604276|FG002|Overall Study|Non-Compliant With study Drug|0|||
27936284|NCT00758043|81604277|FG003|Overall Study|Non-Compliant With study Drug|1|||
27936285|NCT00758043|81604274|FG000|Overall Study|Other Reasons|0|||
27936286|NCT00758043|81604275|FG001|Overall Study|Other Reasons|1|||
27936287|NCT00758043|81604276|FG002|Overall Study|Other Reasons|0|||
27936288|NCT00758043|81604277|FG003|Overall Study|Other Reasons|5|||
27936289|NCT02366130|81604278|FG000|Overall Study|Withdrawal by Subject|3|||
27936290|NCT02366130|81604278|FG000|Overall Study|Ineligible|6|||
27936291|NCT01964560|81604280|FG000|Overall Study|Adverse Event|23|||
27744167|NCT02760407|80892802|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
27744168|NCT02760407|80892803|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
27744169|NCT02760407|80892800|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
27744170|NCT02760407|80892801|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
27744171|NCT02760407|80892802|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
27744172|NCT02760407|80892803|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
27744173|NCT02760407|80892800|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
27744174|NCT02760407|80892801|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
27744175|NCT02760407|80892802|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
27744176|NCT02760407|80892803|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
27744177|NCT02760407|80892800|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
27744178|NCT02760407|80892801|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
27744179|NCT02760407|80892802|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
27744180|NCT02760407|80892803|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
27744181|NCT02760407|80892800|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
27744182|NCT02760407|80892801|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
27744183|NCT02760407|80892802|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
27744184|NCT02760407|80892803|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
27744185|NCT02760407|80892800|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
27744186|NCT02760407|80892801|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
27744187|NCT02760407|80892802|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
27744188|NCT02760407|80892803|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
27744189|NCT02760407|80892800|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
27936292|NCT01964560|81604280|FG000|Overall Study|Lack of Efficacy|46|||
27936293|NCT01964560|81604280|FG000|Overall Study|Protocol deviation|2|||
27936294|NCT01964560|81604280|FG000|Overall Study|Lost to Follow-up|4|||
27936295|NCT01964560|81604280|FG000|Overall Study|Withdrawal by Subject|64|||
27936296|NCT01964560|81604280|FG000|Overall Study|Surgery-hemispherotomy|1|||
27936297|NCT01964560|81604280|FG000|Overall Study|Surgery|1|||
27936298|NCT01964560|81604280|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
27643973|NCT05512962|80536504|FG000|Overall Study|Withdrawal by Subject|1|||
27643974|NCT05512962|80536505|FG001|Overall Study|Withdrawal by Subject|0|||
27643975|NCT03092726|80536506|FG000|Overall Study|Adverse Event|3|||
27643976|NCT03092726|80536507|FG001|Overall Study|Adverse Event|10|||
27643977|NCT03092726|80536506|FG000|Overall Study|Lack of Efficacy|0|||
27643978|NCT03092726|80536507|FG001|Overall Study|Lack of Efficacy|1|||
27643979|NCT03092726|80536506|FG000|Overall Study|Lost to Follow-up|1|||
27643980|NCT03092726|80536507|FG001|Overall Study|Lost to Follow-up|0|||
27643981|NCT03092726|80536506|FG000|Overall Study|Withdrawal by Subject|5|||
27643982|NCT03092726|80536507|FG001|Overall Study|Withdrawal by Subject|3|||
27643983|NCT03631407|80536508|FG000|Overall Study|Withdrawal by Subject|3|||
27643984|NCT03631407|80536509|FG001|Overall Study|Withdrawal by Subject|2|||
27643985|NCT03631407|80536508|FG000|Overall Study|Sponsor Decision|0|||
27643986|NCT03631407|80536509|FG001|Overall Study|Sponsor Decision|2|||
27643987|NCT03631407|80536508|FG000|Overall Study|Death|16|||
27643988|NCT03631407|80536509|FG001|Overall Study|Death|16|||
27643989|NCT03631407|80536508|FG000|Overall Study|Randomized by mistake without study treatment|1|||
27643990|NCT03631407|80536509|FG001|Overall Study|Randomized by mistake without study treatment|0|||
27936299|NCT01964560|81604280|FG000|Overall Study|Patient and Investigator choice|1|||
27936300|NCT01964560|81604280|FG000|Overall Study|Patient was prescribed CBD|1|||
27936301|NCT01964560|81604280|FG000|Overall Study|Participant moved to another country|1|||
27936302|NCT03566550|81604281|FG000|Overall Study|Withdrawal by Subject|0|||
27936303|NCT03566550|81604282|FG001|Overall Study|Withdrawal by Subject|1|||
27936304|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Adverse Event|14|||
27936305|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Adverse Event|27|||
27936306|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Adverse Event|60|||
27936307|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Adverse Event|0|||
27936308|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Adverse Event|0|||
27936309|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Pregnancy|0|||
27936310|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Pregnancy|7|||
27936311|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Pregnancy|9|||
27936312|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Pregnancy|0|||
27936313|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Pregnancy|0|||
27936314|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
27936315|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
27936316|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
27644009|NCT04287985|80536513|FG000|Overall Study|Adverse Event|1|||
27644010|NCT04287985|80536514|FG001|Overall Study|Adverse Event|0|||
27644011|NCT04287985|80536515|FG002|Overall Study|Adverse Event|0|||
27644012|NCT04287985|80536516|FG003|Overall Study|Adverse Event|0|||
27644013|NCT04287985|80536513|FG000|Overall Study|Protocol Violation|0|||
27644014|NCT04287985|80536514|FG001|Overall Study|Protocol Violation|1|||
27644015|NCT04287985|80536515|FG002|Overall Study|Protocol Violation|0|||
27644016|NCT04287985|80536516|FG003|Overall Study|Protocol Violation|0|||
27644017|NCT04287985|80536513|FG000|Overall Study|Physician Decision|0|||
27644018|NCT04287985|80536514|FG001|Overall Study|Physician Decision|0|||
27644019|NCT04287985|80536515|FG002|Overall Study|Physician Decision|0|||
27644020|NCT04287985|80536516|FG003|Overall Study|Physician Decision|1|||
27644021|NCT04287985|80536513|FG000|Overall Study|Withdrawal by Subject|2|||
27644022|NCT04287985|80536514|FG001|Overall Study|Withdrawal by Subject|1|||
27644023|NCT04287985|80536515|FG002|Overall Study|Withdrawal by Subject|1|||
27644024|NCT04287985|80536516|FG003|Overall Study|Withdrawal by Subject|2|||
27936317|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
27936318|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
27936319|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
27936320|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
27936321|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
27936322|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
27550979|NCT00203996|80203551|FG002|Overall Study|Physician Decision|0|||
27550980|NCT00203996|80203552|FG003|Overall Study|Physician Decision|2|||
27550981|NCT00203996|80203553|FG004|Overall Study|Physician Decision|0|||
27550982|NCT00203996|80203554|FG005|Overall Study|Physician Decision|0|||
27550983|NCT00203996|80203555|FG006|Overall Study|Physician Decision|0|||
27550984|NCT00203996|80203556|FG007|Overall Study|Physician Decision|0|||
27550985|NCT00203996|80203557|FG008|Overall Study|Physician Decision|0|||
27550986|NCT00203996|80203558|FG009|Overall Study|Physician Decision|1|||
27550987|NCT00203996|80203549|FG000|Overall Study|CPAP machine malfunction|0|||
27550988|NCT00203996|80203550|FG001|Overall Study|CPAP machine malfunction|0|||
27550989|NCT00203996|80203551|FG002|Overall Study|CPAP machine malfunction|0|||
27550990|NCT00203996|80203552|FG003|Overall Study|CPAP machine malfunction|1|||
27550991|NCT00203996|80203553|FG004|Overall Study|CPAP machine malfunction|0|||
27550992|NCT00203996|80203554|FG005|Overall Study|CPAP machine malfunction|0|||
27550993|NCT00203996|80203555|FG006|Overall Study|CPAP machine malfunction|0|||
27550994|NCT00203996|80203556|FG007|Overall Study|CPAP machine malfunction|0|||
27936323|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
27936324|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Death|1|||
27936325|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Death|2|||
27936326|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Death|2|||
27936327|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Death|0|||
27936328|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Death|0|||
27936329|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
27936330|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
27936331|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
27936332|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
27936333|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
27936334|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
27936335|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
27936336|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
27936337|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
27744190|NCT02760407|80892801|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
27744191|NCT02760407|80892802|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
27744192|NCT02760407|80892803|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
27744193|NCT02760407|80892800|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
27744194|NCT02760407|80892801|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
27744195|NCT02760407|80892802|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
27744196|NCT02760407|80892803|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
27744197|NCT02760407|80892800|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
27744198|NCT02760407|80892801|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
27744199|NCT02760407|80892802|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
27744200|NCT02760407|80892803|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
27744201|NCT01597193|80892804|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
27744202|NCT01597193|80892805|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
27744203|NCT01597193|80892806|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27744204|NCT01597193|80892807|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27744205|NCT01597193|80892808|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27744206|NCT01597193|80892809|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27936338|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
27936339|NCT00098293|81604283|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
27744207|NCT01597193|80892810|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
27744208|NCT01597193|80892804|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27744209|NCT01597193|80892805|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27744210|NCT01597193|80892806|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27744211|NCT01597193|80892807|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
27744212|NCT01597193|80892808|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
27744213|NCT01597193|80892809|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
27744214|NCT01597193|80892810|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
27936340|NCT00098293|81604284|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
27936341|NCT00098293|81604285|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
27936342|NCT00098293|81604286|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
27936343|NCT00098293|81604287|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
27936344|NCT00098293|81604283|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
27936345|NCT00098293|81604284|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
27936346|NCT00098293|81604285|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
27936347|NCT00098293|81604286|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
27936348|NCT00098293|81604287|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
27936349|NCT00098293|81604283|FG000|Open-label (OL) Phase|Adverse Event|0|||
27936350|NCT00098293|81604284|FG001|Open-label (OL) Phase|Adverse Event|3|||
27936351|NCT00098293|81604285|FG002|Open-label (OL) Phase|Adverse Event|7|||
27936352|NCT00098293|81604286|FG003|Open-label (OL) Phase|Adverse Event|6|||
27936353|NCT00098293|81604287|FG004|Open-label (OL) Phase|Adverse Event|0|||
27936354|NCT00098293|81604283|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
27936355|NCT00098293|81604284|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
27936356|NCT00098293|81604285|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
27936357|NCT00098293|81604286|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
27936358|NCT00098293|81604287|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
27936359|NCT00098293|81604283|FG000|Open-label (OL) Phase|Pregnancy|0|||
27936360|NCT00098293|81604284|FG001|Open-label (OL) Phase|Pregnancy|1|||
27936361|NCT00098293|81604285|FG002|Open-label (OL) Phase|Pregnancy|0|||
27936362|NCT00098293|81604286|FG003|Open-label (OL) Phase|Pregnancy|3|||
27936363|NCT00098293|81604287|FG004|Open-label (OL) Phase|Pregnancy|0|||
27936364|NCT00098293|81604283|FG000|Open-label (OL) Phase|Protocol Violation|0|||
27936365|NCT00098293|81604284|FG001|Open-label (OL) Phase|Protocol Violation|6|||
27936366|NCT00098293|81604285|FG002|Open-label (OL) Phase|Protocol Violation|13|||
27936367|NCT00098293|81604286|FG003|Open-label (OL) Phase|Protocol Violation|16|||
27936368|NCT00098293|81604287|FG004|Open-label (OL) Phase|Protocol Violation|0|||
27936369|NCT00098293|81604283|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
27936370|NCT00098293|81604284|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
27936371|NCT00098293|81604285|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
27936372|NCT00098293|81604286|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
27936373|NCT00098293|81604287|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
27936374|NCT00098293|81604283|FG000|Open-label (OL) Phase|Death|0|||
27936375|NCT00098293|81604284|FG001|Open-label (OL) Phase|Death|2|||
27936376|NCT00098293|81604285|FG002|Open-label (OL) Phase|Death|3|||
27936377|NCT00098293|81604286|FG003|Open-label (OL) Phase|Death|0|||
27936378|NCT00098293|81604287|FG004|Open-label (OL) Phase|Death|0|||
27936379|NCT00098293|81604283|FG000|Supplemental Phase (SP)|Death|0|||
27936380|NCT00098293|81604284|FG001|Supplemental Phase (SP)|Death|0|||
27936381|NCT00098293|81604285|FG002|Supplemental Phase (SP)|Death|0|||
27936382|NCT00098293|81604286|FG003|Supplemental Phase (SP)|Death|0|||
27936383|NCT00098293|81604287|FG004|Supplemental Phase (SP)|Death|1|||
27936384|NCT00098293|81604283|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
27936385|NCT00098293|81604284|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
27936386|NCT00098293|81604285|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
27936387|NCT00098293|81604286|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
27936388|NCT00098293|81604287|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
27936389|NCT00098293|81604283|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
27936390|NCT00098293|81604284|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
27936391|NCT00098293|81604285|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
27936392|NCT00098293|81604286|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
27936393|NCT00098293|81604287|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
27936394|NCT00098293|81604283|FG000|Supplemental Phase (SP)|Other|0|||
27936395|NCT00098293|81604284|FG001|Supplemental Phase (SP)|Other|0|||
27936396|NCT00098293|81604285|FG002|Supplemental Phase (SP)|Other|0|||
27744215|NCT01597193|80892804|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
27936397|NCT00098293|81604286|FG003|Supplemental Phase (SP)|Other|0|||
27936398|NCT00098293|81604287|FG004|Supplemental Phase (SP)|Other|22|||
27936399|NCT01570192|81604293|FG000|Overall Study|no qualifying organism|6|||
27936400|NCT01570192|81604294|FG001|Overall Study|no qualifying organism|12|||
27936401|NCT01570192|81604293|FG000|Overall Study|changed to palliative care|1|||
27936402|NCT01570192|81604294|FG001|Overall Study|changed to palliative care|0|||
27936403|NCT01570192|81604293|FG000|Overall Study|Physician Decision|0|||
27936404|NCT01570192|81604294|FG001|Overall Study|Physician Decision|1|||
27936405|NCT02802865|81604295|FG000|Overall Study|Pregnancy|1|||
27936406|NCT02802865|81604296|FG001|Overall Study|Pregnancy|1|||
27936407|NCT02802865|81604295|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
27936408|NCT02802865|81604296|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
27936409|NCT00063999|81604297|FG000|Overall Study|Withdrawal by Subject|1|||
27936410|NCT00063999|81604298|FG001|Overall Study|Withdrawal by Subject|0|||
27936411|NCT00063999|81604297|FG000|Overall Study|Ineligible|44|||
27936412|NCT00063999|81604298|FG001|Overall Study|Ineligible|24|||
27744216|NCT01597193|80892805|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
27744217|NCT01597193|80892806|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
27744218|NCT01597193|80892807|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
27744219|NCT01597193|80892808|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
27744220|NCT01597193|80892809|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
27744221|NCT01597193|80892810|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
27744222|NCT01597193|80892804|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27744223|NCT01597193|80892805|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27744224|NCT01597193|80892806|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27744225|NCT01597193|80892807|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27744226|NCT01597193|80892808|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27744227|NCT01597193|80892809|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
27744228|NCT01597193|80892810|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
27744229|NCT01597193|80892804|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27744230|NCT01597193|80892805|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27744231|NCT01597193|80892806|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27744232|NCT01597193|80892807|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
27744233|NCT01597193|80892808|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27744234|NCT01597193|80892809|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
27744235|NCT01597193|80892810|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
27744236|NCT04439253|80892813|FG000|Overall Study|Adverse Event|1|||
27744237|NCT04439253|80892813|FG000|Overall Study|Disease progression|2|||
27744238|NCT04439253|80892813|FG000|Overall Study|Complicating disease|1|||
27744239|NCT00098345|80892816|FG000|Overall Study|Adverse Event|7|||
27744240|NCT00098345|80892816|FG000|Overall Study|Withdrawal by Subject|2|||
27744241|NCT00098345|80892816|FG000|Overall Study|progression|4|||
27744242|NCT03918642|80892817|FG000|Overall Study|Lost to Follow-up|12|||
27744243|NCT03918642|80892818|FG001|Overall Study|Lost to Follow-up|10|||
27744244|NCT00942877|80892819|FG000|Overall Study|Refused further treatment|1|||
27936413|NCT00784927|81604307|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
27936414|NCT00784927|81604307|FG000|Overall Study|Protocol Violation|1|||
27744245|NCT00942877|80892820|FG001|Overall Study|Refused further treatment|1|||
27744246|NCT00942877|80892819|FG000|Overall Study|Patient was not treated|1|||
27744247|NCT00942877|80892820|FG001|Overall Study|Patient was not treated|0|||
27936415|NCT00784927|81604307|FG000|Overall Study|Ineligible|1|||
27936416|NCT02636283|81604308|FG000|Overall Study|Adverse Event|2|||
27936417|NCT02636283|81604309|FG001|Overall Study|Adverse Event|0|||
27936418|NCT02636283|81604308|FG000|Overall Study|Trial Terminated Prematurely|0|||
27936419|NCT02636283|81604309|FG001|Overall Study|Trial Terminated Prematurely|3|||
27936420|NCT03048019|81604311|FG000|Overall Study|Adverse Event|1|||
27744248|NCT00942877|80892819|FG000|Overall Study|Adverse Event|1|||
27744249|NCT00942877|80892820|FG001|Overall Study|Adverse Event|0|||
27744250|NCT00942877|80892819|FG000|Overall Study|Progressive disease|42|||
27744251|NCT00942877|80892820|FG001|Overall Study|Progressive disease|3|||
27744252|NCT03141307|80892821|FG000|In-Hospital|Withdrawal by Subject|0|||
27744253|NCT03141307|80892822|FG001|In-Hospital|Withdrawal by Subject|2|||
27744254|NCT03141307|80892821|FG000|In-Hospital|Protocol Violation|4|||
27744255|NCT03141307|80892822|FG001|In-Hospital|Protocol Violation|0|||
27936421|NCT03048019|81604312|FG001|Overall Study|Adverse Event|0|||
27936422|NCT00825175|81604319|FG000|Overall Study|Withdrawal by Subject|0|||
27936423|NCT00825175|81604320|FG001|Overall Study|Withdrawal by Subject|5|||
27936424|NCT00754559|81604324|FG000|Overall Study|Adverse Event|15|||
27936425|NCT00754559|81604324|FG000|Overall Study|Protocol Violation|11|||
27936426|NCT00754559|81604324|FG000|Overall Study|Lack of Efficacy|10|||
27936427|NCT00754559|81604324|FG000|Overall Study|Lost to Follow-up|2|||
27936428|NCT00754559|81604324|FG000|Overall Study|Administrative reason|1|||
27936429|NCT00754559|81604324|FG000|Overall Study|Other|5|||
27936430|NCT00754559|81604324|FG000|Overall Study|Withdrawal by Subject|3|||
27936431|NCT01543503|81604325|FG000|Overall Study|Lost to Follow-up|32|||
27936432|NCT01543503|81604326|FG001|Overall Study|Lost to Follow-up|36|||
27936433|NCT01543503|81604325|FG000|Overall Study|Adverse Event|9|||
27936434|NCT01543503|81604326|FG001|Overall Study|Adverse Event|13|||
27936435|NCT01543503|81604325|FG000|Overall Study|Lack of Efficacy|4|||
27936436|NCT01543503|81604326|FG001|Overall Study|Lack of Efficacy|16|||
27936437|NCT01543503|81604325|FG000|Overall Study|Participant withdrew informed consent|8|||
27936438|NCT01543503|81604326|FG001|Overall Study|Participant withdrew informed consent|10|||
27936439|NCT01543503|81604325|FG000|Overall Study|Change of jobs|0|||
27936440|NCT01543503|81604326|FG001|Overall Study|Change of jobs|1|||
27936441|NCT01543503|81604325|FG000|Overall Study|Intolerance to the biologic treatment|0|||
27936442|NCT01543503|81604326|FG001|Overall Study|Intolerance to the biologic treatment|1|||
27936443|NCT01543503|81604325|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
27936444|NCT01543503|81604326|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
27936445|NCT01543503|81604325|FG000|Overall Study|Participant did not complete last visit|0|||
27936446|NCT01543503|81604326|FG001|Overall Study|Participant did not complete last visit|2|||
27936447|NCT01543503|81604325|FG000|Overall Study|Refused to continue treatment|7|||
27936448|NCT01543503|81604326|FG001|Overall Study|Refused to continue treatment|0|||
27936449|NCT01543503|81604325|FG000|Overall Study|Incorrect medication received|1|||
27936450|NCT01543503|81604326|FG001|Overall Study|Incorrect medication received|0|||
27936451|NCT01543503|81604325|FG000|Overall Study|Participant moved to another city|2|||
27936452|NCT01543503|81604326|FG001|Overall Study|Participant moved to another city|0|||
27936453|NCT01543503|81604325|FG000|Overall Study|Participant will not return for visits|0|||
27936454|NCT01543503|81604326|FG001|Overall Study|Participant will not return for visits|2|||
27936455|NCT01543503|81604325|FG000|Overall Study|Participant transferred to another city|1|||
27936456|NCT01543503|81604326|FG001|Overall Study|Participant transferred to another city|0|||
27936457|NCT01543503|81604325|FG000|Overall Study|Participant moved to Scotland|1|||
27936458|NCT01543503|81604326|FG001|Overall Study|Participant moved to Scotland|0|||
27936459|NCT01543503|81604325|FG000|Overall Study|Participant decision to stop treatment|1|||
27936460|NCT01543503|81604326|FG001|Overall Study|Participant decision to stop treatment|0|||
27936461|NCT01543503|81604325|FG000|Overall Study|Investigator did not wish to participate|1|||
27936462|NCT01543503|81604326|FG001|Overall Study|Investigator did not wish to participate|1|||
27936463|NCT01543503|81604325|FG000|Overall Study|Participant recruited after closing date|0|||
27936464|NCT01543503|81604326|FG001|Overall Study|Participant recruited after closing date|1|||
27936465|NCT01543503|81604325|FG000|Overall Study|Site stopped participation|5|||
27936466|NCT01543503|81604326|FG001|Overall Study|Site stopped participation|1|||
27644103|NCT04447287|80536530|FG000|Period 1: Run-in Period|Adverse Event|3|||
27644104|NCT04447287|80536531|FG001|Period 1: Run-in Period|Adverse Event|0|||
27644105|NCT04447287|80536532|FG002|Period 1: Run-in Period|Adverse Event|0|||
27644106|NCT04447287|80536530|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
27744256|NCT03141307|80892821|FG000|Follow-Up|Lost to Follow-up|97|||
27744257|NCT03141307|80892822|FG001|Follow-Up|Lost to Follow-up|54|||
27744258|NCT00149825|80892823|FG000|Overall Study|Intolerance to medication side effects|1|||
27644107|NCT04447287|80536531|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
27644108|NCT04447287|80536532|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
27644109|NCT04447287|80536530|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
27644110|NCT04447287|80536531|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
27644111|NCT04447287|80536532|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
27644112|NCT04154384|80536533|FG000|Overall Study|Lost to Follow-up|24|||
27744259|NCT00149825|80892824|FG001|Overall Study|Intolerance to medication side effects|2|||
27644113|NCT04154384|80536534|FG001|Overall Study|Lost to Follow-up|33|||
27644114|NCT04154384|80536535|FG002|Overall Study|Lost to Follow-up|0|||
27644115|NCT04154384|80536533|FG000|Overall Study|Withdrawal by Subject|7|||
27644116|NCT04154384|80536534|FG001|Overall Study|Withdrawal by Subject|18|||
27644117|NCT04154384|80536535|FG002|Overall Study|Withdrawal by Subject|0|||
27644118|NCT04154384|80536533|FG000|Overall Study|Missing outcome data|1|||
27644119|NCT04154384|80536534|FG001|Overall Study|Missing outcome data|0|||
27644120|NCT04154384|80536535|FG002|Overall Study|Missing outcome data|0|||
27936467|NCT01543503|81604325|FG000|Overall Study|Participant did not attend a visit|1|||
27936468|NCT01543503|81604326|FG001|Overall Study|Participant did not attend a visit|0|||
27644123|NCT03890289|80538946|FG000|Overall Study|Adverse Event|1|||
27744260|NCT00149825|80892823|FG000|Overall Study|Time commitments|2|||
27744261|NCT00149825|80892824|FG001|Overall Study|Time commitments|1|||
27744262|NCT00149825|80892823|FG000|Overall Study|Not liking insomnia therapy|1|||
27744263|NCT00149825|80892824|FG001|Overall Study|Not liking insomnia therapy|0|||
27744264|NCT00149825|80892823|FG000|Overall Study|Other|1|||
27744265|NCT00149825|80892824|FG001|Overall Study|Other|0|||
27744266|NCT00273858|80892827|FG000|Overall Study|Not completed 24 month observation time|334|||
27744267|NCT00273858|80892827|FG000|Overall Study|Lost to Follow-up|101|||
27744268|NCT00273858|80892827|FG000|Overall Study|Withdrawal by Subject|21|||
27744269|NCT00273858|80892827|FG000|Overall Study|Adverse Event|81|||
27744270|NCT04973228|80892828|FG000|Overall Study|Adverse Event|2|||
27744271|NCT04973228|80892829|FG001|Overall Study|Adverse Event|3|||
27744272|NCT04973228|80892828|FG000|Overall Study|Lack of Efficacy|1|||
27744273|NCT04973228|80892829|FG001|Overall Study|Lack of Efficacy|3|||
27744274|NCT04973228|80892828|FG000|Overall Study|Lost to Follow-up|12|||
27744275|NCT04973228|80892829|FG001|Overall Study|Lost to Follow-up|4|||
27744276|NCT04973228|80892828|FG000|Overall Study|Withdrawal by Subject|11|||
27744277|NCT04973228|80892829|FG001|Overall Study|Withdrawal by Subject|4|||
27744278|NCT04973228|80892828|FG000|Overall Study|Did not tolerate application|1|||
27744279|NCT04973228|80892829|FG001|Overall Study|Did not tolerate application|0|||
27744280|NCT04973228|80892828|FG000|Overall Study|Wanted to early terminate and use own product|0|||
27744281|NCT04973228|80892829|FG001|Overall Study|Wanted to early terminate and use own product|1|||
27744282|NCT04973228|80892828|FG000|Overall Study|Missed visits due to new work schedule|1|||
27744283|NCT04973228|80892829|FG001|Overall Study|Missed visits due to new work schedule|0|||
27744284|NCT01283581|80892830|FG000|Overall Study|Lost to Follow-up|8|||
27744285|NCT01283581|80892831|FG001|Overall Study|Lost to Follow-up|6|||
27744286|NCT01283581|80892832|FG002|Overall Study|Lost to Follow-up|8|||
27744287|NCT01283581|80892830|FG000|Overall Study|Withdrawal by Subject|2|||
27744288|NCT01283581|80892831|FG001|Overall Study|Withdrawal by Subject|5|||
27744289|NCT01283581|80892832|FG002|Overall Study|Withdrawal by Subject|2|||
27744290|NCT01283581|80892830|FG000|Overall Study|Adverse Event|1|||
27744291|NCT01283581|80892831|FG001|Overall Study|Adverse Event|1|||
27744292|NCT01283581|80892832|FG002|Overall Study|Adverse Event|4|||
27744293|NCT01283581|80892830|FG000|Overall Study|Physician Decision|0|||
27744294|NCT01283581|80892831|FG001|Overall Study|Physician Decision|1|||
27744295|NCT01283581|80892832|FG002|Overall Study|Physician Decision|2|||
27744296|NCT01283581|80892830|FG000|Overall Study|Protocol Violation|0|||
27744297|NCT01283581|80892831|FG001|Overall Study|Protocol Violation|1|||
27744298|NCT01283581|80892832|FG002|Overall Study|Protocol Violation|2|||
27744299|NCT01283581|80892830|FG000|Overall Study|Noncompliance|1|||
27744300|NCT01283581|80892831|FG001|Overall Study|Noncompliance|0|||
27744301|NCT01283581|80892832|FG002|Overall Study|Noncompliance|0|||
27744302|NCT01283581|80892830|FG000|Overall Study|Investigator unblinded|0|||
27744303|NCT01283581|80892831|FG001|Overall Study|Investigator unblinded|0|||
27744304|NCT01283581|80892832|FG002|Overall Study|Investigator unblinded|1|||
27744305|NCT01283581|80892830|FG000|Overall Study|"Early termination"|0|||
27744306|NCT01283581|80892831|FG001|Overall Study|"Early termination"|0|||
27936469|NCT01543503|81604325|FG000|Overall Study|Moved to other rheumatologic site|0|||
27936470|NCT01543503|81604326|FG001|Overall Study|Moved to other rheumatologic site|1|||
27644124|NCT03890289|80538946|FG000|Overall Study|Physician Decision|1|||
27744307|NCT01283581|80892832|FG002|Overall Study|"Early termination"|1|||
27744308|NCT04283461|80892833|FG000|Overall Study|Enrolled in separate trial|0|||
27744309|NCT04283461|80892834|FG001|Overall Study|Enrolled in separate trial|0|||
27744310|NCT04283461|80892835|FG002|Overall Study|Enrolled in separate trial|8|||
27744311|NCT04283461|80892836|FG003|Overall Study|Enrolled in separate trial|13|||
27744312|NCT04283461|80892837|FG004|Overall Study|Enrolled in separate trial|12|||
27744313|NCT04283461|80892838|FG005|Overall Study|Enrolled in separate trial|0|||
27744314|NCT04283461|80892839|FG006|Overall Study|Enrolled in separate trial|0|||
27744315|NCT04283461|80892840|FG007|Overall Study|Enrolled in separate trial|8|||
27550995|NCT00203996|80203557|FG008|Overall Study|CPAP machine malfunction|0|||
27644125|NCT03890289|80538946|FG000|Overall Study|Lack of Efficacy|2|||
27644126|NCT02397096|80538950|FG000|Day 1 to Week 24|Adverse Event|7|||
27644127|NCT02397096|80538951|FG001|Day 1 to Week 24|Adverse Event|1|||
27744316|NCT04283461|80892841|FG008|Overall Study|Enrolled in separate trial|0|||
27744317|NCT04283461|80892842|FG009|Overall Study|Enrolled in separate trial|0|||
27744318|NCT04283461|80892843|FG010|Overall Study|Enrolled in separate trial|0|||
27744319|NCT04283461|80892844|FG011|Overall Study|Enrolled in separate trial|7|||
27744320|NCT04283461|80892845|FG012|Overall Study|Enrolled in separate trial|0|||
27744321|NCT01696877|80892850|FG000|Overall Study|Adverse Event|0|||
27744322|NCT01696877|80892851|FG001|Overall Study|Adverse Event|1|||
27744323|NCT00128206|80892854|FG000|Overall Study|Lost to Follow-up|137|||
27744324|NCT00128206|80892855|FG001|Overall Study|Lost to Follow-up|118|||
27744325|NCT00128206|80892854|FG000|Overall Study|Adverse Event|0|||
27744326|NCT00128206|80892855|FG001|Overall Study|Adverse Event|2|||
27744327|NCT01188798|80892856|FG000|Overall Study|Death|0|||
27744328|NCT01188798|80892857|FG001|Overall Study|Death|1|||
27744329|NCT01188798|80892856|FG000|Overall Study|Required additional transplant|1|||
27744330|NCT01188798|80892857|FG001|Overall Study|Required additional transplant|1|||
27744331|NCT01188798|80892856|FG000|Overall Study|Protocol closure|1|||
27744332|NCT01188798|80892857|FG001|Overall Study|Protocol closure|1|||
27744333|NCT02874794|80892858|FG000|Overall Study|Physician Decision|3|||
27744334|NCT02874794|80892859|FG001|Overall Study|Physician Decision|2|||
27744335|NCT02874794|80892858|FG000|Overall Study|Withdrawal by Subject|2|||
27744336|NCT02874794|80892859|FG001|Overall Study|Withdrawal by Subject|8|||
27744337|NCT02874794|80892858|FG000|Overall Study|Death|2|||
27744338|NCT02874794|80892859|FG001|Overall Study|Death|1|||
27744339|NCT04370028|80892860|FG000|Overall Study|Withdrawal by Subject|695|||
27744340|NCT04370028|80892860|FG000|Overall Study|Protocol Violation|9|||
27744341|NCT04370028|80892860|FG000|Overall Study|Adverse Event|3|||
27744342|NCT03196297|80892862|FG000|Main Period|Withdrawal by Subject|4|||
27744343|NCT03196297|80892862|FG000|Extension Period|Withdrawal by Subject|1|||
27744344|NCT03196297|80892862|FG000|Extension Period|Lack of Efficacy|2|||
27744345|NCT00309777|80892870|FG000|Overall Study|Adverse Event|13|||
27744346|NCT00309777|80892871|FG001|Overall Study|Adverse Event|2|||
27744347|NCT00309777|80892872|FG002|Overall Study|Adverse Event|8|||
27550996|NCT00203996|80203558|FG009|Overall Study|CPAP machine malfunction|0|||
27550997|NCT00203996|80203549|FG000|Overall Study|Scheduling issue|0|||
27550998|NCT00203996|80203550|FG001|Overall Study|Scheduling issue|0|||
27644128|NCT02397096|80538950|FG000|Day 1 to Week 24|Death|1|||
27644129|NCT02397096|80538951|FG001|Day 1 to Week 24|Death|0|||
27644130|NCT02397096|80538950|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
27644131|NCT02397096|80538951|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
27644132|NCT02397096|80538950|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
27644133|NCT02397096|80538951|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
27644134|NCT02397096|80538950|FG000|Day 1 to Week 24|Physician Decision|2|||
27744348|NCT00309777|80892873|FG003|Overall Study|Adverse Event|1|||
27550999|NCT00203996|80203551|FG002|Overall Study|Scheduling issue|0|||
27551000|NCT00203996|80203552|FG003|Overall Study|Scheduling issue|0|||
27551001|NCT00203996|80203553|FG004|Overall Study|Scheduling issue|0|||
27551002|NCT00203996|80203554|FG005|Overall Study|Scheduling issue|0|||
27551003|NCT00203996|80203555|FG006|Overall Study|Scheduling issue|0|||
27551004|NCT00203996|80203556|FG007|Overall Study|Scheduling issue|2|||
27551005|NCT00203996|80203557|FG008|Overall Study|Scheduling issue|0|||
27551006|NCT00203996|80203558|FG009|Overall Study|Scheduling issue|0|||
27551007|NCT02028065|80203559|FG000|Randomization Through Start Treatment|Not treated|1|||
27551008|NCT02028065|80203560|FG001|Randomization Through Start Treatment|Not treated|3|||
27551009|NCT02028065|80203561|FG002|Randomization Through Start Treatment|Not treated|3|||
27551010|NCT02028065|80203559|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
27551011|NCT02028065|80203560|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
27551012|NCT02028065|80203561|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
27551013|NCT02028065|80203559|FG000|Treatment Through Study Completion|Physician Decision|1|||
27551014|NCT02028065|80203560|FG001|Treatment Through Study Completion|Physician Decision|0|||
27551015|NCT02028065|80203561|FG002|Treatment Through Study Completion|Physician Decision|0|||
27551016|NCT02028065|80203559|FG000|Treatment Through Study Completion|Protocol Violation|1|||
27551017|NCT02028065|80203560|FG001|Treatment Through Study Completion|Protocol Violation|4|||
27551018|NCT02028065|80203561|FG002|Treatment Through Study Completion|Protocol Violation|0|||
27551019|NCT02028065|80203559|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
27551020|NCT02028065|80203560|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
27551021|NCT02028065|80203561|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
27551022|NCT02028065|80203559|FG000|Treatment Through Study Completion|Adverse Event|3|||
27551023|NCT02028065|80203560|FG001|Treatment Through Study Completion|Adverse Event|3|||
27744349|NCT00309777|80892870|FG000|Overall Study|Protocol Violation|4|||
27744350|NCT00309777|80892871|FG001|Overall Study|Protocol Violation|1|||
27744351|NCT00309777|80892872|FG002|Overall Study|Protocol Violation|3|||
27744352|NCT00309777|80892873|FG003|Overall Study|Protocol Violation|1|||
27744353|NCT00309777|80892870|FG000|Overall Study|Withdrawal by Subject|6|||
27644135|NCT02397096|80538951|FG001|Day 1 to Week 24|Physician Decision|3|||
27644136|NCT02397096|80538950|FG000|Day 1 to Week 24|Protocol Violation|1|||
27744354|NCT00309777|80892871|FG001|Overall Study|Withdrawal by Subject|5|||
27744355|NCT00309777|80892872|FG002|Overall Study|Withdrawal by Subject|7|||
27744356|NCT00309777|80892873|FG003|Overall Study|Withdrawal by Subject|2|||
27744357|NCT00309777|80892870|FG000|Overall Study|Lost to Follow-up|0|||
27744358|NCT00309777|80892871|FG001|Overall Study|Lost to Follow-up|0|||
27744359|NCT00309777|80892872|FG002|Overall Study|Lost to Follow-up|1|||
27744360|NCT00309777|80892873|FG003|Overall Study|Lost to Follow-up|0|||
27744361|NCT00309777|80892870|FG000|Overall Study|Death|0|||
27744362|NCT00309777|80892871|FG001|Overall Study|Death|1|||
27744363|NCT00309777|80892872|FG002|Overall Study|Death|0|||
27744364|NCT00309777|80892873|FG003|Overall Study|Death|0|||
27744365|NCT02601001|80892874|FG000|Dosing Period 2|Adverse Event|0|||
27744366|NCT02601001|80892875|FG001|Dosing Period 2|Adverse Event|0|||
27744367|NCT02601001|80892876|FG002|Dosing Period 2|Adverse Event|0|||
27744368|NCT02601001|80892877|FG003|Dosing Period 2|Adverse Event|0|||
27744369|NCT02601001|80892878|FG004|Dosing Period 2|Adverse Event|0|||
27644137|NCT02397096|80538951|FG001|Day 1 to Week 24|Protocol Violation|4|||
27644138|NCT02397096|80538950|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
27644139|NCT02397096|80538951|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
27644140|NCT02397096|80538950|FG000|Day 1 to Week 24|Randomized, not treated|3|||
27644141|NCT02397096|80538951|FG001|Day 1 to Week 24|Randomized, not treated|0|||
27644142|NCT02397096|80538950|FG000|Week 24 to Week 48|Adverse Event|6|||
27644143|NCT02397096|80538951|FG001|Week 24 to Week 48|Adverse Event|2|||
27644144|NCT02397096|80538950|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
27644145|NCT02397096|80538951|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
27644146|NCT02397096|80538950|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
27644147|NCT02397096|80538951|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
27644148|NCT02397096|80538950|FG000|Week 24 to Week 48|Physician Decision|2|||
27644149|NCT02397096|80538951|FG001|Week 24 to Week 48|Physician Decision|1|||
27644150|NCT02397096|80538950|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
27644151|NCT02397096|80538951|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
27644152|NCT02397096|80538950|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
27644153|NCT02397096|80538951|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
27644154|NCT02397096|80538950|FG000|Study Extension 1|Adverse Event|7|||
27644155|NCT02397096|80538951|FG001|Study Extension 1|Adverse Event|5|||
27644156|NCT02397096|80538950|FG000|Study Extension 1|Death|1|||
27644157|NCT02397096|80538951|FG001|Study Extension 1|Death|0|||
27644158|NCT02397096|80538950|FG000|Study Extension 1|Lack of Efficacy|2|||
27644159|NCT02397096|80538951|FG001|Study Extension 1|Lack of Efficacy|5|||
27644160|NCT02397096|80538950|FG000|Study Extension 1|Lost to Follow-up|2|||
27644161|NCT02397096|80538951|FG001|Study Extension 1|Lost to Follow-up|3|||
27644162|NCT02397096|80538950|FG000|Study Extension 1|Non-compliance with study drug|3|||
27644163|NCT02397096|80538951|FG001|Study Extension 1|Non-compliance with study drug|0|||
27644164|NCT02397096|80538950|FG000|Study Extension 1|Physician Decision|4|||
27644165|NCT02397096|80538951|FG001|Study Extension 1|Physician Decision|2|||
27644166|NCT02397096|80538950|FG000|Study Extension 1|Pregnancy|1|||
27644167|NCT02397096|80538951|FG001|Study Extension 1|Pregnancy|0|||
27644168|NCT02397096|80538950|FG000|Study Extension 1|Protocol Violation|0|||
27644169|NCT02397096|80538951|FG001|Study Extension 1|Protocol Violation|1|||
27644170|NCT02397096|80538950|FG000|Study Extension 1|Withdrawal by Subject|21|||
27644171|NCT02397096|80538951|FG001|Study Extension 1|Withdrawal by Subject|7|||
27644172|NCT02397096|80538950|FG000|Study Extension 2|Adverse Event|3|||
27644173|NCT02397096|80538951|FG001|Study Extension 2|Adverse Event|3|||
27644174|NCT02397096|80538950|FG000|Study Extension 2|Availability of study medication locally|152|||
27644175|NCT02397096|80538951|FG001|Study Extension 2|Availability of study medication locally|64|||
27644176|NCT02397096|80538950|FG000|Study Extension 2|Death|2|||
27644177|NCT02397096|80538951|FG001|Study Extension 2|Death|0|||
27644178|NCT02397096|80538950|FG000|Study Extension 2|Lack of Efficacy|1|||
27644179|NCT02397096|80538951|FG001|Study Extension 2|Lack of Efficacy|0|||
27644180|NCT02397096|80538950|FG000|Study Extension 2|Lost to Follow-up|2|||
27644181|NCT02397096|80538951|FG001|Study Extension 2|Lost to Follow-up|1|||
27644182|NCT02397096|80538950|FG000|Study Extension 2|Non-compliance with study drug|1|||
27644183|NCT02397096|80538951|FG001|Study Extension 2|Non-compliance with study drug|0|||
27644184|NCT02397096|80538950|FG000|Study Extension 2|Physician Decision|2|||
27644185|NCT02397096|80538951|FG001|Study Extension 2|Physician Decision|5|||
27644186|NCT02397096|80538950|FG000|Study Extension 2|Pregnancy|1|||
27644187|NCT02397096|80538951|FG001|Study Extension 2|Pregnancy|0|||
27644188|NCT02397096|80538950|FG000|Study Extension 2|Withdrawal by Subject|10|||
27644189|NCT02397096|80538951|FG001|Study Extension 2|Withdrawal by Subject|3|||
27644190|NCT02397096|80538950|FG000|Study Extension 3|Adverse Event|1|||
27644191|NCT02397096|80538951|FG001|Study Extension 3|Adverse Event|0|||
27744370|NCT02601001|80892879|FG005|Dosing Period 2|Adverse Event|0|||
27744371|NCT02601001|80892880|FG006|Dosing Period 2|Adverse Event|1|||
27744372|NCT01312428|80892881|FG000|Overall Study|Study Termination|3|||
27744373|NCT01312428|80892882|FG001|Overall Study|Study Termination|4|||
27644192|NCT02397096|80538950|FG000|Study Extension 3|Availability of study medication locally|11|||
27644193|NCT02397096|80538951|FG001|Study Extension 3|Availability of study medication locally|3|||
27744374|NCT05372575|80892883|FG000|Overall Study|Protocol Violation|7|||
27744375|NCT05372575|80892884|FG001|Overall Study|Protocol Violation|16|||
27744376|NCT01558089|80892885|FG000|Overall Study|Adverse Event|1|||
27744377|NCT01558089|80892885|FG000|Overall Study|Lack of Efficacy|1|||
27744378|NCT01558089|80892885|FG000|Overall Study|Lost to Follow-up|5|||
27744379|NCT01558089|80892885|FG000|Overall Study|Withdrawal by Subject|6|||
27744380|NCT01712438|80892886|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
27744381|NCT01712438|80892886|FG000|Overall Study|Ongoing ITI treatment|6|||
27744382|NCT01712438|80892886|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
27744383|NCT01712438|80892886|FG000|Overall Study|Prematurely Discontinued|25|||
27744384|NCT01518192|80892887|FG000|Overall Study|Lost to Follow-up|29|||
27744385|NCT01518192|80892888|FG001|Overall Study|Lost to Follow-up|26|||
27744386|NCT01518192|80892889|FG002|Overall Study|Lost to Follow-up|35|||
27744387|NCT01721369|80892892|FG000|Overall Study|Not initial etiological diagnosis|12|||
27744388|NCT01319929|80892893|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
27744389|NCT01319929|80892894|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
27744390|NCT01319929|80892893|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
27744391|NCT01319929|80892894|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
27744392|NCT01319929|80892893|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
27744393|NCT01319929|80892894|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
27744394|NCT01319929|80892893|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
27744395|NCT01319929|80892894|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
27744396|NCT01319929|80892893|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
27744397|NCT01319929|80892894|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
27744398|NCT04329923|80892895|FG000|Overall Study|Withdrawal by Subject|1|||
27744399|NCT04329923|80892896|FG001|Overall Study|Withdrawal by Subject|4|||
27744400|NCT04329923|80892897|FG002|Overall Study|Withdrawal by Subject|1|||
27744401|NCT04329923|80892898|FG003|Overall Study|Withdrawal by Subject|1|||
27744402|NCT04329923|80892899|FG004|Overall Study|Withdrawal by Subject|1|||
27744403|NCT04329923|80892900|FG005|Overall Study|Withdrawal by Subject|1|||
27744404|NCT04329923|80892895|FG000|Overall Study|early termination of study|0|||
27744405|NCT04329923|80892896|FG001|Overall Study|early termination of study|0|||
27744406|NCT04329923|80892897|FG002|Overall Study|early termination of study|0|||
27744407|NCT04329923|80892898|FG003|Overall Study|early termination of study|0|||
27744408|NCT04329923|80892899|FG004|Overall Study|early termination of study|1|||
27744409|NCT04329923|80892900|FG005|Overall Study|early termination of study|2|||
27744410|NCT04329923|80892895|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
27744411|NCT04329923|80892896|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
27744412|NCT04329923|80892897|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
27744413|NCT04329923|80892898|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
27744414|NCT04329923|80892899|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
27744415|NCT04329923|80892900|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
27744416|NCT00778999|80892901|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
27744417|NCT00778999|80892902|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
27744418|NCT00778999|80892901|FG000|Overall Study|Did not receive recFSH|14|||
27744419|NCT00778999|80892902|FG001|Overall Study|Did not receive recFSH|20|||
27744420|NCT02421120|80892904|FG000|Overall Study|Adverse Event|1|||
27744421|NCT02717546|80892905|FG000|Overall Study|Lost to Follow-up|12|||
27744422|NCT00374907|80892906|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
27744423|NCT00374907|80892907|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
27744424|NCT00374907|80892906|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
27744425|NCT00374907|80892907|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
27744426|NCT00374907|80892906|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
27744427|NCT00374907|80892907|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
27744428|NCT00374907|80892906|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
27744429|NCT00374907|80892907|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
27744430|NCT00374907|80892906|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
27744431|NCT00374907|80892907|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
27744432|NCT01096550|80892908|FG000|Overall Study|discontinued site|10|||
27744433|NCT01096550|80892909|FG001|Overall Study|discontinued site|11|||
27744434|NCT01096550|80892908|FG000|Overall Study|non-regular treatment track at clinic|1|||
27744435|NCT01096550|80892909|FG001|Overall Study|non-regular treatment track at clinic|1|||
27744436|NCT01096550|80892908|FG000|Overall Study|clinic readmission|1|||
27744437|NCT01096550|80892909|FG001|Overall Study|clinic readmission|1|||
27744438|NCT01096550|80892908|FG000|Overall Study|Withdrawal by Subject|0|||
27744439|NCT01096550|80892909|FG001|Overall Study|Withdrawal by Subject|1|||
27744440|NCT01096550|80892908|FG000|Overall Study|non-African American participant|13|||
27744441|NCT01096550|80892909|FG001|Overall Study|non-African American participant|6|||
27744442|NCT01096550|80892908|FG000|Overall Study|Lost to Follow-up|12|||
27936471|NCT01543503|81604325|FG000|Overall Study|Participant consented to another study|0|||
27644194|NCT02397096|80538950|FG000|Study Extension 3|Lost to Follow-up|1|||
27644195|NCT02397096|80538951|FG001|Study Extension 3|Lost to Follow-up|0|||
27644196|NCT02397096|80538950|FG000|Study Extension 3|Withdrawal by Subject|2|||
27744443|NCT01096550|80892909|FG001|Overall Study|Lost to Follow-up|9|||
27744444|NCT01371838|80892914|FG000|Overall Study|Withdrawal by Subject|27|||
27936472|NCT01543503|81604326|FG001|Overall Study|Participant consented to another study|2|||
27744445|NCT01371838|80892915|FG001|Overall Study|Withdrawal by Subject|33|||
27744446|NCT01371838|80892914|FG000|Overall Study|Lost to Follow-up|10|||
27744447|NCT01371838|80892915|FG001|Overall Study|Lost to Follow-up|20|||
27744448|NCT01371838|80892914|FG000|Overall Study|Death|3|||
27744449|NCT01371838|80892915|FG001|Overall Study|Death|4|||
27744450|NCT01371838|80892914|FG000|Overall Study|Protocol Violation|3|||
27744451|NCT01371838|80892915|FG001|Overall Study|Protocol Violation|0|||
27744452|NCT01371838|80892914|FG000|Overall Study|Investigator Decision|3|||
27744453|NCT01371838|80892915|FG001|Overall Study|Investigator Decision|8|||
27744454|NCT01371838|80892914|FG000|Overall Study|Last follow-up visit not conducted|2|||
27744455|NCT01371838|80892915|FG001|Overall Study|Last follow-up visit not conducted|0|||
27744456|NCT01371838|80892914|FG000|Overall Study|Lack of therapeutic response|0|||
27744457|NCT01371838|80892915|FG001|Overall Study|Lack of therapeutic response|1|||
27744458|NCT01371838|80892914|FG000|Overall Study|Surgery|1|||
27744459|NCT01371838|80892915|FG001|Overall Study|Surgery|0|||
27644197|NCT02397096|80538951|FG001|Study Extension 3|Withdrawal by Subject|1|||
27644198|NCT02161146|80538953|FG000|Overall Study|Adverse Event|1|||
27644199|NCT02161146|80538954|FG001|Overall Study|Adverse Event|1|||
27644200|NCT02161146|80538955|FG002|Overall Study|Adverse Event|0|||
27744460|NCT02037919|80892917|FG000|Overall Study|Lost to Follow-up|30|||
27744461|NCT02037919|80892918|FG001|Overall Study|Lost to Follow-up|45|||
27744462|NCT01327339|80892920|FG000|Overall Study|Protocol Violation|8|||
27744463|NCT00001259|80892921|FG000|Study 2|Adverse Event|0|||
27744464|NCT00001259|80892922|FG001|Study 2|Adverse Event|0|||
27744465|NCT00001259|80892923|FG002|Study 2|Adverse Event|0|||
27744466|NCT00001259|80892924|FG003|Study 2|Adverse Event|0|||
27744467|NCT00001259|80892925|FG004|Study 2|Adverse Event|2|||
27744468|NCT00001259|80892926|FG005|Study 2|Adverse Event|0|||
27744469|NCT00001259|80892927|FG006|Study 2|Adverse Event|0|||
27744470|NCT01518699|80892928|FG000|Period 2|Protocol Violation|1|||
27744471|NCT01518699|80892929|FG001|Period 2|Protocol Violation|1|||
27744472|NCT01518699|80892930|FG002|Period 2|Protocol Violation|0|||
27744473|NCT01518699|80892931|FG003|Period 2|Protocol Violation|0|||
27744474|NCT01518699|80892932|FG004|Period 2|Protocol Violation|0|||
27744475|NCT01518699|80892933|FG005|Period 2|Protocol Violation|0|||
27744476|NCT01518699|80892928|FG000|Period 2|Lost to Follow-up|0|||
27744477|NCT01518699|80892929|FG001|Period 2|Lost to Follow-up|1|||
27744478|NCT01518699|80892930|FG002|Period 2|Lost to Follow-up|0|||
27744479|NCT01518699|80892931|FG003|Period 2|Lost to Follow-up|0|||
27744480|NCT01518699|80892932|FG004|Period 2|Lost to Follow-up|0|||
27744481|NCT01518699|80892933|FG005|Period 2|Lost to Follow-up|0|||
27744482|NCT01518699|80892928|FG000|Period 2|Adverse Event|1|||
27744483|NCT01518699|80892929|FG001|Period 2|Adverse Event|0|||
27744484|NCT01518699|80892930|FG002|Period 2|Adverse Event|0|||
27744485|NCT01518699|80892931|FG003|Period 2|Adverse Event|0|||
27744486|NCT01518699|80892932|FG004|Period 2|Adverse Event|0|||
27936473|NCT01543503|81604325|FG000|Overall Study|Participant went to United States|1|||
27936474|NCT01543503|81604326|FG001|Overall Study|Participant went to United States|0|||
27936475|NCT01543503|81604325|FG000|Overall Study|Screen failure|1|||
27936476|NCT01543503|81604326|FG001|Overall Study|Screen failure|0|||
27936477|NCT00425854|81604327|FG000|Overall Study|Progressive Disease|19|||
27936478|NCT00425854|81604328|FG001|Overall Study|Progressive Disease|12|||
27936479|NCT00425854|81604327|FG000|Overall Study|Dose reduction toxicity AE|8|||
27936480|NCT00425854|81604328|FG001|Overall Study|Dose reduction toxicity AE|7|||
27644201|NCT02161146|80538956|FG003|Overall Study|Adverse Event|1|||
27644202|NCT02161146|80538957|FG004|Overall Study|Adverse Event|0|||
27644203|NCT02161146|80538953|FG000|Overall Study|Lost to Follow-up|0|||
27644204|NCT02161146|80538954|FG001|Overall Study|Lost to Follow-up|1|||
27644205|NCT02161146|80538955|FG002|Overall Study|Lost to Follow-up|0|||
27644206|NCT02161146|80538956|FG003|Overall Study|Lost to Follow-up|0|||
27644207|NCT02161146|80538957|FG004|Overall Study|Lost to Follow-up|0|||
27644208|NCT02161146|80538953|FG000|Overall Study|Personal Reasons|0|||
27644209|NCT02161146|80538954|FG001|Overall Study|Personal Reasons|1|||
27644210|NCT02161146|80538955|FG002|Overall Study|Personal Reasons|0|||
27644211|NCT02161146|80538956|FG003|Overall Study|Personal Reasons|2|||
27644212|NCT02161146|80538957|FG004|Overall Study|Personal Reasons|1|||
27644213|NCT02161146|80538953|FG000|Overall Study|Other Miscellaneous Reasons|0|||
27644214|NCT02161146|80538954|FG001|Overall Study|Other Miscellaneous Reasons|1|||
27644215|NCT02161146|80538955|FG002|Overall Study|Other Miscellaneous Reasons|0|||
27644216|NCT02161146|80538956|FG003|Overall Study|Other Miscellaneous Reasons|0|||
27644217|NCT02161146|80538957|FG004|Overall Study|Other Miscellaneous Reasons|0|||
27644218|NCT00912964|80538959|FG000|Overall Study|Eligibility criterion not met|1|||
27644219|NCT00912964|80538960|FG001|Overall Study|Eligibility criterion not met|1|||
27744487|NCT01518699|80892933|FG005|Period 2|Adverse Event|0|||
27744488|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
27744489|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
27744490|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
27744491|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
27936481|NCT00425854|81604327|FG000|Overall Study|Other Adverse Event|2|||
27644220|NCT00912964|80538961|FG002|Overall Study|Eligibility criterion not met|0|||
27644221|NCT00912964|80538959|FG000|Overall Study|Adverse Event|15|||
27644222|NCT00912964|80538960|FG001|Overall Study|Adverse Event|18|||
27644223|NCT00912964|80538961|FG002|Overall Study|Adverse Event|12|||
27644224|NCT00912964|80538959|FG000|Overall Study|Lack of Efficacy|11|||
27644225|NCT00912964|80538960|FG001|Overall Study|Lack of Efficacy|4|||
27644226|NCT00912964|80538961|FG002|Overall Study|Lack of Efficacy|3|||
27644227|NCT00912964|80538959|FG000|Overall Study|Withdrawal by Subject|20|||
27644228|NCT00912964|80538960|FG001|Overall Study|Withdrawal by Subject|12|||
27644229|NCT00912964|80538961|FG002|Overall Study|Withdrawal by Subject|18|||
27644230|NCT00912964|80538959|FG000|Overall Study|Lost to Follow-up|4|||
27644231|NCT00912964|80538960|FG001|Overall Study|Lost to Follow-up|3|||
27644232|NCT00912964|80538961|FG002|Overall Study|Lost to Follow-up|3|||
27644233|NCT00912964|80538959|FG000|Overall Study|Protocol Violation|5|||
27644234|NCT00912964|80538960|FG001|Overall Study|Protocol Violation|3|||
27644235|NCT00912964|80538961|FG002|Overall Study|Protocol Violation|8|||
27644236|NCT00912964|80538959|FG000|Overall Study|Taking exclusionary medications|7|||
27644237|NCT00912964|80538960|FG001|Overall Study|Taking exclusionary medications|4|||
27644238|NCT00912964|80538961|FG002|Overall Study|Taking exclusionary medications|8|||
27644239|NCT00912964|80538959|FG000|Overall Study|Medical History|1|||
27644240|NCT00912964|80538960|FG001|Overall Study|Medical History|0|||
27644241|NCT00912964|80538961|FG002|Overall Study|Medical History|0|||
27644242|NCT00912964|80538959|FG000|Overall Study|Non-compliance with study procedures|2|||
27644243|NCT00912964|80538960|FG001|Overall Study|Non-compliance with study procedures|0|||
27644244|NCT00912964|80538961|FG002|Overall Study|Non-compliance with study procedures|0|||
27644245|NCT00912964|80538959|FG000|Overall Study|Violation of exclusion criterion|0|||
27644246|NCT00912964|80538960|FG001|Overall Study|Violation of exclusion criterion|0|||
27644247|NCT00912964|80538961|FG002|Overall Study|Violation of exclusion criterion|2|||
27644248|NCT00912964|80538959|FG000|Overall Study|Randomized but never received study drug|0|||
27644249|NCT00912964|80538960|FG001|Overall Study|Randomized but never received study drug|1|||
27644250|NCT00912964|80538961|FG002|Overall Study|Randomized but never received study drug|0|||
27936482|NCT00425854|81604328|FG001|Overall Study|Other Adverse Event|2|||
27936483|NCT03954938|81604329|FG000|Overall Study|Withdrawal by Subject|2|||
27936484|NCT03954938|81604329|FG000|Overall Study|Adverse Event|1|||
27936485|NCT03211832|81604330|FG000|Overall Study|No longer with agency|32|||
27936486|NCT03211832|81604331|FG001|Overall Study|No longer with agency|49|||
27936487|NCT03211832|81604332|FG002|Overall Study|No longer with agency|30|||
27936488|NCT03211832|81604330|FG000|Overall Study|Declined survey|3|||
27936489|NCT03211832|81604331|FG001|Overall Study|Declined survey|3|||
27936490|NCT03211832|81604332|FG002|Overall Study|Declined survey|2|||
27936491|NCT03211832|81604330|FG000|Overall Study|Not available during data collection|1|||
27936492|NCT03211832|81604331|FG001|Overall Study|Not available during data collection|0|||
27936493|NCT03211832|81604332|FG002|Overall Study|Not available during data collection|2|||
27936494|NCT00894647|81604333|FG000|Overall Study|Adverse Event|5|||
27936495|NCT00894647|81604334|FG001|Overall Study|Adverse Event|4|||
27936496|NCT00894647|81604333|FG000|Overall Study|Withdrawal by Subject|4|||
27936497|NCT00894647|81604334|FG001|Overall Study|Withdrawal by Subject|4|||
27936498|NCT00894647|81604333|FG000|Overall Study|Lost to Follow-up|0|||
27936499|NCT00894647|81604334|FG001|Overall Study|Lost to Follow-up|2|||
27936500|NCT00894647|81604333|FG000|Overall Study|Non-compliance with study procedures|0|||
27936501|NCT00894647|81604334|FG001|Overall Study|Non-compliance with study procedures|2|||
27936502|NCT00894647|81604333|FG000|Overall Study|Other, not due to AE|1|||
27936503|NCT00894647|81604334|FG001|Overall Study|Other, not due to AE|2|||
27936504|NCT02503865|81604335|FG000|Overall Study|Moved out of area|1|||
27936505|NCT02503865|81604336|FG001|Overall Study|Moved out of area|8|||
27936506|NCT02503865|81604337|FG002|Overall Study|Moved out of area|0|||
27936507|NCT02503865|81604335|FG000|Overall Study|Refused treatment|4|||
27936508|NCT02503865|81604336|FG001|Overall Study|Refused treatment|39|||
27936509|NCT02503865|81604337|FG002|Overall Study|Refused treatment|2|||
27936510|NCT01061710|81604340|FG000|Overall Study|Protocol Violation|14|||
27936511|NCT01454063|81604341|FG000|Randomized|Adverse Event|1|||
27744492|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
27936512|NCT01454063|81604342|FG001|Randomized|Adverse Event|1|||
27936513|NCT01454063|81604341|FG000|Randomized|Protocol Violation|0|||
27936514|NCT01454063|81604342|FG001|Randomized|Protocol Violation|1|||
27936515|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
27936516|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
27936517|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
27936518|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
27936519|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
27936520|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
27936521|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
27744493|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
27936522|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
27936523|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
27936524|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
27936525|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
27936526|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
27936527|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Other|6|||
27936528|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Other|3|||
27936529|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Other|0|||
27936530|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
27936531|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
27936532|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
27936533|NCT03636269|81604343|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
27936534|NCT03636269|81604344|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
27936535|NCT03636269|81604345|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
27936536|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Adverse Event|0|||
27936537|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Adverse Event|0|||
27936538|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Adverse Event|21|||
27936539|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
27936540|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
27936541|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
27936542|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
27936543|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
27936544|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
27936545|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
27936546|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
27936547|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
27936548|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Administrative|0|||
27936549|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Administrative|0|||
27744494|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
27936550|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Administrative|36|||
27936551|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Other|0|||
27936552|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Other|0|||
27936553|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Other|9|||
27936554|NCT03636269|81604343|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
27936555|NCT03636269|81604344|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
27936556|NCT03636269|81604345|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
27936557|NCT04102111|81604349|FG000|Overall Study|Withdrawal by Subject|2|||
27936558|NCT04102111|81604350|FG001|Overall Study|Withdrawal by Subject|3|||
27936559|NCT04102111|81604349|FG000|Overall Study|Adverse Event|1|||
27936560|NCT04102111|81604350|FG001|Overall Study|Adverse Event|1|||
27936561|NCT04102111|81604349|FG000|Overall Study|Study terminated by sponsor|1|||
27936562|NCT04102111|81604350|FG001|Overall Study|Study terminated by sponsor|3|||
27936563|NCT01691092|81604353|FG000|Overall Study|Lost to Follow-up|10|||
27936564|NCT01691092|81604353|FG000|Overall Study|Physician Decision|4|||
27936565|NCT01691092|81604353|FG000|Overall Study|Withdrawal by Subject|3|||
27936566|NCT01691092|81604353|FG000|Overall Study|non-compliance|3|||
27936567|NCT01691092|81604353|FG000|Overall Study|used for different study|2|||
27936568|NCT01691092|81604353|FG000|Overall Study|screen fail|19|||
27936569|NCT02441114|81604361|FG000|Washout2|Withdrawal by Subject|4|||
27936570|NCT03061214|81604362|FG000|Overall Study|Withdrawal by Subject|21|||
27936571|NCT03061214|81604363|FG001|Overall Study|Withdrawal by Subject|26|||
27936572|NCT03061214|81604364|FG002|Overall Study|Withdrawal by Subject|9|||
27936573|NCT03061214|81604362|FG000|Overall Study|Lost to Follow-up|3|||
27936574|NCT03061214|81604363|FG001|Overall Study|Lost to Follow-up|1|||
27936575|NCT03061214|81604364|FG002|Overall Study|Lost to Follow-up|1|||
27936576|NCT03061214|81604362|FG000|Overall Study|Death|1|||
27936577|NCT03061214|81604363|FG001|Overall Study|Death|1|||
27936578|NCT03061214|81604364|FG002|Overall Study|Death|0|||
27936579|NCT01786109|81604367|FG000|Overall Study|fail manometry barostat tube placement|1|||
27936580|NCT01786109|81604368|FG001|Overall Study|fail manometry barostat tube placement|0|||
27936581|NCT01786109|81604369|FG002|Overall Study|fail manometry barostat tube placement|0|||
27936582|NCT01786109|81604367|FG000|Overall Study|unrelated illness|0|||
27936583|NCT01786109|81604368|FG001|Overall Study|unrelated illness|0|||
27936584|NCT01786109|81604369|FG002|Overall Study|unrelated illness|1|||
27936585|NCT01786109|81604367|FG000|Overall Study|adverse effects colon preparation|0|||
27936586|NCT01786109|81604368|FG001|Overall Study|adverse effects colon preparation|0|||
27936587|NCT01786109|81604369|FG002|Overall Study|adverse effects colon preparation|1|||
27936588|NCT00819832|81604370|FG000|Overall Study|Sponsor Termination of Study|3|||
27744495|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
27936589|NCT00819832|81604371|FG001|Overall Study|Sponsor Termination of Study|0|||
27936590|NCT00819832|81604372|FG002|Overall Study|Sponsor Termination of Study|0|||
27936591|NCT00819832|81604373|FG003|Overall Study|Sponsor Termination of Study|0|||
27936592|NCT00819832|81604374|FG004|Overall Study|Sponsor Termination of Study|0|||
27936593|NCT00819832|81604375|FG005|Overall Study|Sponsor Termination of Study|0|||
27936594|NCT02004275|81604378|FG000|Phase 1|Ineligible|0|||
27936595|NCT02004275|81604379|FG001|Phase 1|Ineligible|0|||
27936596|NCT02004275|81604380|FG002|Phase 1|Ineligible|0|||
27936597|NCT02004275|81604381|FG003|Phase 1|Ineligible|1|||
27936598|NCT02004275|81604382|FG004|Phase 1|Ineligible|1|||
27936599|NCT02004275|81604383|FG005|Phase 1|Ineligible|0|||
27936600|NCT02004275|81604378|FG000|Phase 1|Protocol Violation|0|||
27936601|NCT02004275|81604379|FG001|Phase 1|Protocol Violation|0|||
27936602|NCT02004275|81604380|FG002|Phase 1|Protocol Violation|0|||
27936603|NCT02004275|81604381|FG003|Phase 1|Protocol Violation|1|||
27936604|NCT02004275|81604382|FG004|Phase 1|Protocol Violation|0|||
27936605|NCT02004275|81604383|FG005|Phase 1|Protocol Violation|5|||
27936606|NCT02004275|81604378|FG000|Phase 2 Part 1|Ineligible|6|||
27936607|NCT02004275|81604379|FG001|Phase 2 Part 1|Ineligible|9|||
27936608|NCT02004275|81604380|FG002|Phase 2 Part 1|Ineligible|0|||
27936609|NCT02004275|81604381|FG003|Phase 2 Part 1|Ineligible|0|||
27936610|NCT02004275|81604382|FG004|Phase 2 Part 1|Ineligible|0|||
27936611|NCT02004275|81604383|FG005|Phase 2 Part 1|Ineligible|0|||
27936612|NCT02004275|81604378|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
27936613|NCT02004275|81604379|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
27936614|NCT02004275|81604380|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
27936615|NCT02004275|81604381|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
27936616|NCT02004275|81604382|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
27936617|NCT02004275|81604383|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
27936618|NCT00617903|81604384|FG000|Overall Study|Withdrawal by Subject|2|||
27936619|NCT00617903|81604385|FG001|Overall Study|Withdrawal by Subject|3|||
27936620|NCT00617903|81604384|FG000|Overall Study|Lost to Follow-up|1|||
27936621|NCT00617903|81604385|FG001|Overall Study|Lost to Follow-up|1|||
27936622|NCT00617903|81604384|FG000|Overall Study|Lack of Efficacy|0|||
27936623|NCT00617903|81604385|FG001|Overall Study|Lack of Efficacy|1|||
27936624|NCT00617903|81604384|FG000|Overall Study|Adverse Event|0|||
27936625|NCT00617903|81604385|FG001|Overall Study|Adverse Event|1|||
27936626|NCT00617903|81604384|FG000|Overall Study|noncompliance|0|||
27936627|NCT00617903|81604385|FG001|Overall Study|noncompliance|1|||
27936628|NCT01263028|81604386|FG000|Overall Study|Withdrawal by Subject|1|||
27936629|NCT01263028|81604386|FG000|Overall Study|Adverse Event|1|||
27936630|NCT01263028|81604386|FG000|Overall Study|Study terminated due to low enrollment.|4|||
27936631|NCT02829957|81604387|FG000|Overall Study|Lost to Follow-up|2|||
27936632|NCT02829957|81604388|FG001|Overall Study|Lost to Follow-up|1|||
27936633|NCT04865978|81604389|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
27936634|NCT04865978|81604390|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
27958654|NCT01791517|81680066|FG008|Phase II|Pre-Existing Ocular Issue|0|||
27958655|NCT01791517|81680067|FG009|Phase II|Pre-Existing Ocular Issue|0|||
27958656|NCT01791517|81680068|FG010|Phase II|Pre-Existing Ocular Issue|0|||
27958657|NCT01791517|81680069|FG011|Phase II|Pre-Existing Ocular Issue|1|||
27958658|NCT01265992|81680073|FG000|Overall Study|Lost to Follow-up|1|||
27958659|NCT01265992|81680073|FG000|Overall Study|Withdrawal by Subject|1|||
27958660|NCT01265992|81680073|FG000|Overall Study|Adverse Event|1|||
27958661|NCT01265992|81680073|FG000|Overall Study|Administrative reasons|2|||
27958662|NCT01265992|81680073|FG000|Overall Study|Stopped treatment|3|||
27958663|NCT01265992|81680073|FG000|Overall Study|Did not receive treatment|1|||
27958664|NCT00465972|81680074|FG000|Overall Study|Withdrawal by Subject|2|||
27958665|NCT00465972|81680075|FG001|Overall Study|Withdrawal by Subject|1|||
27958666|NCT00130039|81683026|FG000|Overall Study|Withdrawal by Subject|15|||
27958667|NCT00130039|81683027|FG001|Overall Study|Withdrawal by Subject|11|||
27958668|NCT00130039|81683026|FG000|Overall Study|Lost to Follow-up|3|||
27958669|NCT00130039|81683027|FG001|Overall Study|Lost to Follow-up|1|||
27958670|NCT00130039|81683026|FG000|Overall Study|Adverse Event|4|||
27958671|NCT00130039|81683027|FG001|Overall Study|Adverse Event|2|||
27958672|NCT00130039|81683026|FG000|Overall Study|Physician Decision|3|||
27958673|NCT00130039|81683027|FG001|Overall Study|Physician Decision|0|||
27958674|NCT00130039|81683026|FG000|Overall Study|clinical events without follow up MRI|5|||
27958675|NCT00130039|81683027|FG001|Overall Study|clinical events without follow up MRI|4|||
27958676|NCT00420381|81683037|FG000|Overall Study|Protocol Violation|1|||
27958677|NCT02967679|81683039|FG000|Overall Study|Adverse Event|1|||
27958678|NCT01991483|81683040|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
27958679|NCT01991483|81683041|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
27958680|NCT01991483|81683042|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
27958681|NCT01991483|81683043|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
27958682|NCT01991483|81683040|FG000|Dose Level 600 mg|Physician Decision|0|||
27958683|NCT01991483|81683041|FG001|Dose Level 600 mg|Physician Decision|0|||
27958684|NCT01991483|81683042|FG002|Dose Level 600 mg|Physician Decision|1|||
27958685|NCT01991483|81683043|FG003|Dose Level 600 mg|Physician Decision|0|||
27958686|NCT01991483|81683040|FG000|Dose Level 1000 mg|Protocol Violation|0|||
27958687|NCT01991483|81683041|FG001|Dose Level 1000 mg|Protocol Violation|0|||
27958688|NCT01991483|81683042|FG002|Dose Level 1000 mg|Protocol Violation|0|||
27958689|NCT01991483|81683043|FG003|Dose Level 1000 mg|Protocol Violation|1|||
27958690|NCT02383862|81683044|FG000|3 Month Follow up|Lost to Follow-up|23|||
27936635|NCT02070380|81607096|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
27936636|NCT02070380|81607097|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
27936637|NCT02070380|81607098|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
27936638|NCT02070380|81607099|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
27936639|NCT02070380|81607096|FG000|Second Injection|Image sets missing or technically inadeq|0|||
27936640|NCT02070380|81607097|FG001|Second Injection|Image sets missing or technically inadeq|1|||
27936641|NCT02070380|81607098|FG002|Second Injection|Image sets missing or technically inadeq|0|||
27936642|NCT02070380|81607099|FG003|Second Injection|Image sets missing or technically inadeq|0|||
27936643|NCT02070380|81607096|FG000|Second Injection|Protocol Violation|0|||
27936644|NCT02070380|81607097|FG001|Second Injection|Protocol Violation|1|||
27936645|NCT02070380|81607098|FG002|Second Injection|Protocol Violation|1|||
27936646|NCT02070380|81607099|FG003|Second Injection|Protocol Violation|5|||
27936647|NCT02514746|81607103|FG000|Overall Study|Chronically Ill|1|||
27936648|NCT02514746|81607104|FG001|Overall Study|Chronically Ill|2|||
27936649|NCT02514746|81607103|FG000|Overall Study|Physician Decision|4|||
27936650|NCT02514746|81607104|FG001|Overall Study|Physician Decision|2|||
27936651|NCT02514746|81607103|FG000|Overall Study|Withdrawal by Subject|12|||
27936652|NCT02514746|81607104|FG001|Overall Study|Withdrawal by Subject|10|||
27936653|NCT02514746|81607103|FG000|Overall Study|Other|5|||
27936654|NCT02514746|81607104|FG001|Overall Study|Other|1|||
27936655|NCT02143778|81607105|FG000|Overall Study|Withdrawal by Subject|2|||
27936656|NCT02143778|81607105|FG000|Overall Study|Device malfunction|1|||
27936657|NCT00276380|81607106|FG000|Overall Study|Adverse Event|5|||
27936658|NCT00276380|81607107|FG001|Overall Study|Adverse Event|3|||
27936659|NCT00276380|81607106|FG000|Overall Study|Lost to Follow-up|1|||
27936660|NCT00276380|81607107|FG001|Overall Study|Lost to Follow-up|1|||
27936661|NCT00276380|81607106|FG000|Overall Study|Withdrawal by Subject|3|||
27936662|NCT00276380|81607107|FG001|Overall Study|Withdrawal by Subject|6|||
27936663|NCT00276380|81607106|FG000|Overall Study|Death|5|||
27936664|NCT00276380|81607107|FG001|Overall Study|Death|3|||
27936665|NCT00276380|81607106|FG000|Overall Study|Abnormal aPPT Levels|0|||
27936666|NCT00276380|81607107|FG001|Overall Study|Abnormal aPPT Levels|1|||
27936667|NCT02123511|81607108|FG000|Overall Study|Cancelled treatment|1|||
27936668|NCT02123511|81607109|FG001|Overall Study|Cancelled treatment|0|||
27936669|NCT02123511|81607108|FG000|Overall Study|Incomplete data|1|||
27936670|NCT02123511|81607109|FG001|Overall Study|Incomplete data|3|||
27936671|NCT02123511|81607108|FG000|Overall Study|Ineligible|0|||
27936672|NCT02123511|81607109|FG001|Overall Study|Ineligible|1|||
27936673|NCT00985192|81607112|FG000|Overall Study|Withdrawal by Subject|1|||
27936674|NCT00985192|81607112|FG000|Overall Study|Disease Progression|1|||
27744496|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
27744497|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
27744498|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
27744499|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
27744500|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
27744501|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
27744502|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
27744503|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
27744504|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
27744505|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
27744506|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
27744507|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
27744508|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
27744509|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
27744510|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
27744511|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
27744512|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
27744513|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
27744514|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
27744515|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
27744516|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
27744517|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
27744518|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
27744519|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
27936675|NCT00985192|81607112|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
27936676|NCT02583477|81607115|FG000|Overall Study|Adverse Event|0|||
27936677|NCT02583477|81607116|FG001|Overall Study|Adverse Event|2|||
27936678|NCT02583477|81607115|FG000|Overall Study|Death|1|||
27936679|NCT02583477|81607116|FG001|Overall Study|Death|16|||
27936680|NCT02583477|81607115|FG000|Overall Study|Study terminated|2|||
27936681|NCT02583477|81607116|FG001|Overall Study|Study terminated|2|||
27936682|NCT04146909|81607124|FG000|Overall Study|Withdrawal by Subject|3|||
27936683|NCT04146909|81607124|FG000|Overall Study|Did not qualify after consented|1|||
27744520|NCT00958568|80892934|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
27744521|NCT00958568|80892935|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
27744522|NCT00958568|80892936|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
27744523|NCT00958568|80892937|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
27744524|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
27744525|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
27744526|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
27744527|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
27744528|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
27744529|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
27744530|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
27744531|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
27744532|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
27744533|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
27744534|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
27744535|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
27744536|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
27744537|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
27744538|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
27744539|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
27744540|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
27744541|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
27744542|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
27744543|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
27744544|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
27744545|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
27744546|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
27744547|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
27744548|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
27744549|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
27744550|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
27744551|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
27744552|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
27744553|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
27744554|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
27744555|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
27744556|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
27744557|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
27744558|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
27744559|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
27744560|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
27744561|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
27744562|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
27744563|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
27744564|NCT00958568|80892934|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
27744565|NCT00958568|80892935|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
27744566|NCT00958568|80892936|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
27744567|NCT00958568|80892937|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
27744568|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
27744569|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
27744570|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
27744571|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
27744572|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
27744573|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
27744574|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
27744575|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
27744576|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
27744577|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
27744578|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
27936684|NCT02037984|81607125|FG000|Overall Study|Lack of Efficacy|0|||
27936685|NCT02037984|81607126|FG001|Overall Study|Lack of Efficacy|0|||
27936686|NCT02037984|81607127|FG002|Overall Study|Lack of Efficacy|3|||
27744579|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
27744580|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
27744581|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
27744582|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
27744583|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
27744584|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
27744585|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
27744586|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
27744587|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
27744588|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
27744589|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
27744590|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
27744591|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
27744592|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
27744593|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
27744594|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
27744595|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
27744596|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
27744597|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
27744598|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
27744599|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
27744600|NCT00958568|80892934|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
27744601|NCT00958568|80892935|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
27744602|NCT00958568|80892936|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
27744603|NCT00958568|80892937|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
27744604|NCT02574312|80892938|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
27744605|NCT02574312|80892939|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
27744606|NCT01254604|80896291|FG000|Overall Study|Lost to Follow-up|1|||
27744607|NCT01254604|80896292|FG001|Overall Study|Lost to Follow-up|1|||
27744608|NCT01254604|80896291|FG000|Overall Study|Protocol Violation|2|||
27744609|NCT01254604|80896292|FG001|Overall Study|Protocol Violation|2|||
27744610|NCT01254604|80896291|FG000|Overall Study|Withdrawal by Subject|2|||
27744611|NCT01254604|80896292|FG001|Overall Study|Withdrawal by Subject|4|||
27744612|NCT01254604|80896291|FG000|Overall Study|Adverse Event|3|||
27744613|NCT01254604|80896292|FG001|Overall Study|Adverse Event|2|||
27744614|NCT01981122|80896293|FG000|Overall Study|Withdrawal by Subject|0|||
27744615|NCT01981122|80896294|FG001|Overall Study|Withdrawal by Subject|2|||
27744616|NCT01981122|80896293|FG000|Overall Study|Protocol Violation|0|||
27744617|NCT01981122|80896294|FG001|Overall Study|Protocol Violation|1|||
27744618|NCT01981122|80896293|FG000|Overall Study|Lost to Follow-up|0|||
27744619|NCT01981122|80896294|FG001|Overall Study|Lost to Follow-up|1|||
27744620|NCT01981122|80896293|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
27744621|NCT01981122|80896294|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
27744622|NCT01981122|80896293|FG000|Overall Study|Death|14|||
27744623|NCT01981122|80896294|FG001|Overall Study|Death|15|||
27744624|NCT02341014|80896295|FG000|Overall Study|Adverse Event|0|||
27744625|NCT02341014|80896296|FG001|Overall Study|Adverse Event|1|||
27744626|NCT02341014|80896297|FG002|Overall Study|Adverse Event|0|||
27744627|NCT02341014|80896298|FG003|Overall Study|Adverse Event|0|||
27744628|NCT02341014|80896299|FG004|Overall Study|Adverse Event|2|||
27936687|NCT02037984|81607128|FG003|Overall Study|Lack of Efficacy|10|||
27936688|NCT02037984|81607129|FG004|Overall Study|Lack of Efficacy|2|||
27936689|NCT02037984|81607130|FG005|Overall Study|Lack of Efficacy|2|||
27936690|NCT02037984|81607131|FG006|Overall Study|Lack of Efficacy|4|||
27936691|NCT02037984|81607132|FG007|Overall Study|Lack of Efficacy|3|||
27936692|NCT02037984|81607125|FG000|Overall Study|Lost to Follow-up|1|||
27936693|NCT02037984|81607126|FG001|Overall Study|Lost to Follow-up|0|||
27936694|NCT02037984|81607127|FG002|Overall Study|Lost to Follow-up|3|||
27936695|NCT02037984|81607128|FG003|Overall Study|Lost to Follow-up|5|||
27744629|NCT01052012|80896301|FG000|Overall Study|Not treated|2|||
27936696|NCT02037984|81607129|FG004|Overall Study|Lost to Follow-up|2|||
27936697|NCT02037984|81607130|FG005|Overall Study|Lost to Follow-up|2|||
27936698|NCT02037984|81607131|FG006|Overall Study|Lost to Follow-up|2|||
27936699|NCT02037984|81607132|FG007|Overall Study|Lost to Follow-up|4|||
27936700|NCT02037984|81607125|FG000|Overall Study|Physician Decision|0|||
27936701|NCT02037984|81607126|FG001|Overall Study|Physician Decision|0|||
27936702|NCT02037984|81607127|FG002|Overall Study|Physician Decision|0|||
27744630|NCT01052012|80896302|FG001|Overall Study|Not treated|5|||
27744631|NCT01052012|80896303|FG002|Overall Study|Not treated|0|||
27936703|NCT02037984|81607128|FG003|Overall Study|Physician Decision|0|||
27744632|NCT01052012|80896304|FG003|Overall Study|Not treated|0|||
27744633|NCT01052012|80896305|FG004|Overall Study|Not treated|11|||
27936704|NCT02037984|81607129|FG004|Overall Study|Physician Decision|0|||
27936705|NCT02037984|81607130|FG005|Overall Study|Physician Decision|0|||
27936706|NCT02037984|81607131|FG006|Overall Study|Physician Decision|1|||
27744634|NCT01052012|80896306|FG005|Overall Study|Not treated|8|||
27744635|NCT01052012|80896301|FG000|Overall Study|Adverse Event|1|||
27744636|NCT01052012|80896302|FG001|Overall Study|Adverse Event|0|||
27744637|NCT01052012|80896303|FG002|Overall Study|Adverse Event|0|||
27744638|NCT01052012|80896304|FG003|Overall Study|Adverse Event|1|||
27744639|NCT01052012|80896305|FG004|Overall Study|Adverse Event|0|||
27744640|NCT01052012|80896306|FG005|Overall Study|Adverse Event|0|||
27744641|NCT01052012|80896301|FG000|Overall Study|Lost to Follow-up|0|||
27744642|NCT01052012|80896302|FG001|Overall Study|Lost to Follow-up|0|||
27744643|NCT01052012|80896303|FG002|Overall Study|Lost to Follow-up|0|||
27744644|NCT01052012|80896304|FG003|Overall Study|Lost to Follow-up|0|||
27744645|NCT01052012|80896305|FG004|Overall Study|Lost to Follow-up|1|||
27744646|NCT01052012|80896306|FG005|Overall Study|Lost to Follow-up|0|||
27744647|NCT01052012|80896301|FG000|Overall Study|Withdrawal by Subject|1|||
27744648|NCT01052012|80896302|FG001|Overall Study|Withdrawal by Subject|1|||
27744649|NCT01052012|80896303|FG002|Overall Study|Withdrawal by Subject|0|||
27744650|NCT01052012|80896304|FG003|Overall Study|Withdrawal by Subject|0|||
27744651|NCT01052012|80896305|FG004|Overall Study|Withdrawal by Subject|3|||
27744652|NCT01052012|80896306|FG005|Overall Study|Withdrawal by Subject|1|||
27744653|NCT01052012|80896301|FG000|Overall Study|Physician Decision|0|||
27744654|NCT01052012|80896302|FG001|Overall Study|Physician Decision|0|||
27744655|NCT01052012|80896303|FG002|Overall Study|Physician Decision|0|||
27744656|NCT01052012|80896304|FG003|Overall Study|Physician Decision|0|||
27744657|NCT01052012|80896305|FG004|Overall Study|Physician Decision|0|||
27744658|NCT01052012|80896306|FG005|Overall Study|Physician Decision|1|||
27744659|NCT01052012|80896301|FG000|Overall Study|Other|0|||
27744660|NCT01052012|80896302|FG001|Overall Study|Other|0|||
27744661|NCT01052012|80896303|FG002|Overall Study|Other|0|||
27744662|NCT01052012|80896304|FG003|Overall Study|Other|0|||
27744663|NCT01052012|80896305|FG004|Overall Study|Other|1|||
27744664|NCT01052012|80896306|FG005|Overall Study|Other|0|||
27744665|NCT02495077|80896312|FG000|Overall Study|Adverse Event|0|||
27744666|NCT02495077|80896313|FG001|Overall Study|Adverse Event|1|||
27744667|NCT02495077|80896314|FG002|Overall Study|Adverse Event|1|||
27744668|NCT02495077|80896315|FG003|Overall Study|Adverse Event|0|||
27744669|NCT02495077|80896312|FG000|Overall Study|Death|3|||
27744670|NCT02495077|80896313|FG001|Overall Study|Death|5|||
27744671|NCT02495077|80896314|FG002|Overall Study|Death|0|||
27744672|NCT02495077|80896315|FG003|Overall Study|Death|0|||
27744673|NCT02495077|80896312|FG000|Overall Study|Lost to Follow-up|6|||
27744674|NCT02495077|80896313|FG001|Overall Study|Lost to Follow-up|4|||
27744675|NCT02495077|80896314|FG002|Overall Study|Lost to Follow-up|0|||
27744676|NCT02495077|80896315|FG003|Overall Study|Lost to Follow-up|0|||
27744677|NCT02495077|80896312|FG000|Overall Study|Physician Decision|2|||
27744678|NCT02495077|80896313|FG001|Overall Study|Physician Decision|1|||
27744679|NCT02495077|80896314|FG002|Overall Study|Physician Decision|4|||
27744680|NCT02495077|80896315|FG003|Overall Study|Physician Decision|0|||
27744681|NCT02495077|80896312|FG000|Overall Study|Protocol Violation|0|||
27744682|NCT02495077|80896313|FG001|Overall Study|Protocol Violation|1|||
27744683|NCT02495077|80896314|FG002|Overall Study|Protocol Violation|0|||
27744684|NCT02495077|80896315|FG003|Overall Study|Protocol Violation|0|||
27744685|NCT02495077|80896312|FG000|Overall Study|Screen Failure|0|||
27744686|NCT02495077|80896313|FG001|Overall Study|Screen Failure|0|||
27744687|NCT02495077|80896314|FG002|Overall Study|Screen Failure|0|||
27744688|NCT02495077|80896315|FG003|Overall Study|Screen Failure|48|||
27744689|NCT02495077|80896312|FG000|Overall Study|Withdrawal by Subject|7|||
27744690|NCT02495077|80896313|FG001|Overall Study|Withdrawal by Subject|7|||
27744691|NCT02495077|80896314|FG002|Overall Study|Withdrawal by Subject|7|||
27744692|NCT02495077|80896315|FG003|Overall Study|Withdrawal by Subject|0|||
27744693|NCT02495077|80896312|FG000|Overall Study|Covid-19 research restrictions|1|||
27744694|NCT02495077|80896313|FG001|Overall Study|Covid-19 research restrictions|0|||
27744695|NCT02495077|80896314|FG002|Overall Study|Covid-19 research restrictions|0|||
27936707|NCT02037984|81607132|FG007|Overall Study|Physician Decision|0|||
27744696|NCT02495077|80896315|FG003|Overall Study|Covid-19 research restrictions|0|||
27744697|NCT02495077|80896312|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
27744698|NCT02495077|80896313|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
27744699|NCT02495077|80896314|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
27744700|NCT02495077|80896315|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
27744701|NCT02495077|80896312|FG000|Overall Study|Incarcerated|0|||
27744702|NCT02495077|80896313|FG001|Overall Study|Incarcerated|1|||
27744703|NCT02495077|80896314|FG002|Overall Study|Incarcerated|0|||
27936708|NCT02037984|81607125|FG000|Overall Study|Protocol Violation|0|||
27936709|NCT02037984|81607126|FG001|Overall Study|Protocol Violation|0|||
27744704|NCT02495077|80896315|FG003|Overall Study|Incarcerated|0|||
27744705|NCT02495077|80896312|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
27744706|NCT02495077|80896313|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
27744707|NCT02495077|80896314|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
27936710|NCT02037984|81607127|FG002|Overall Study|Protocol Violation|0|||
27936711|NCT02037984|81607128|FG003|Overall Study|Protocol Violation|0|||
27936712|NCT02037984|81607129|FG004|Overall Study|Protocol Violation|0|||
27936713|NCT02037984|81607130|FG005|Overall Study|Protocol Violation|1|||
27936714|NCT02037984|81607131|FG006|Overall Study|Protocol Violation|2|||
27936715|NCT02037984|81607132|FG007|Overall Study|Protocol Violation|0|||
27936716|NCT02037984|81607125|FG000|Overall Study|Technical Problems|0|||
27936717|NCT02037984|81607126|FG001|Overall Study|Technical Problems|0|||
27936718|NCT02037984|81607127|FG002|Overall Study|Technical Problems|3|||
27936719|NCT02037984|81607128|FG003|Overall Study|Technical Problems|3|||
27936720|NCT02037984|81607129|FG004|Overall Study|Technical Problems|2|||
27936721|NCT02037984|81607130|FG005|Overall Study|Technical Problems|3|||
27936722|NCT02037984|81607131|FG006|Overall Study|Technical Problems|4|||
27936723|NCT02037984|81607132|FG007|Overall Study|Technical Problems|2|||
27936724|NCT02037984|81607125|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27936725|NCT02037984|81607126|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27936726|NCT02037984|81607127|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
27936727|NCT02037984|81607128|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
27936728|NCT02037984|81607129|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
27936729|NCT02037984|81607130|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
27936730|NCT02037984|81607131|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
27936731|NCT02037984|81607132|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
27936732|NCT02037984|81607125|FG000|Overall Study|Withdrawal by Subject|0|||
27936733|NCT02037984|81607126|FG001|Overall Study|Withdrawal by Subject|0|||
27936734|NCT02037984|81607127|FG002|Overall Study|Withdrawal by Subject|0|||
27936735|NCT02037984|81607128|FG003|Overall Study|Withdrawal by Subject|1|||
27936736|NCT02037984|81607129|FG004|Overall Study|Withdrawal by Subject|1|||
27936737|NCT02037984|81607130|FG005|Overall Study|Withdrawal by Subject|3|||
27936738|NCT02037984|81607131|FG006|Overall Study|Withdrawal by Subject|0|||
27936739|NCT02037984|81607132|FG007|Overall Study|Withdrawal by Subject|1|||
27644337|NCT00914966|80538975|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
27644338|NCT00914966|80538975|FG000|Step 1: 1500 Units|Physician Decision|1|||
27644339|NCT00914966|80538975|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
27644340|NCT03102034|80538976|FG000|Overall Study|Withdrawal by Subject|1|||
27644341|NCT03102034|80538977|FG001|Overall Study|Withdrawal by Subject|0|||
27936740|NCT03681093|81607135|FG000|Overall Study|Subject decision|0|||
27936741|NCT03681093|81607136|FG001|Overall Study|Subject decision|2|||
27644344|NCT04102865|80538980|FG000|Overall Study|Adverse Event|4|||
27644345|NCT04102865|80538981|FG001|Overall Study|Adverse Event|0|||
27644346|NCT04102865|80538980|FG000|Overall Study|Lost to Follow-up|1|||
27644347|NCT04102865|80538981|FG001|Overall Study|Lost to Follow-up|0|||
27644348|NCT04102865|80538980|FG000|Overall Study|Withdrawal by Subject|2|||
27644349|NCT04102865|80538981|FG001|Overall Study|Withdrawal by Subject|0|||
27936742|NCT03681093|81607137|FG002|Overall Study|Subject decision|1|||
27936743|NCT03425188|81607138|FG000|Overall Study|Withdrawal by Subject|1|||
27936744|NCT00756314|81607139|FG000|Overall Study|Lost to Follow-up|2|||
27936745|NCT00756314|81607140|FG001|Overall Study|Lost to Follow-up|59|||
27644354|NCT05048186|80538984|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
27644355|NCT05048186|80538985|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
27644356|NCT05048186|80538984|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
27644357|NCT05048186|80538985|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
27644358|NCT02285114|80538986|FG000|Overall Study|Investigator's Discretion|0|||
27644359|NCT02285114|80538987|FG001|Overall Study|Investigator's Discretion|2|||
27644360|NCT02285114|80538988|FG002|Overall Study|Investigator's Discretion|0|||
27644361|NCT02285114|80538986|FG000|Overall Study|Withdrew Consent|0|||
27644362|NCT02285114|80538987|FG001|Overall Study|Withdrew Consent|0|||
27644363|NCT02285114|80538988|FG002|Overall Study|Withdrew Consent|1|||
27644364|NCT02285114|80538986|FG000|Overall Study|Enrolled but not treated|1|||
27644365|NCT02285114|80538987|FG001|Overall Study|Enrolled but not treated|0|||
27644366|NCT02285114|80538988|FG002|Overall Study|Enrolled but not treated|0|||
27644367|NCT02285114|80538986|FG000|Overall Study|Still on study|21|||
27644368|NCT02285114|80538987|FG001|Overall Study|Still on study|5|||
27644369|NCT02285114|80538988|FG002|Overall Study|Still on study|2|||
27644370|NCT01738438|80538989|FG000|Overall Study|Disease Progression|32|||
27644371|NCT01738438|80538989|FG000|Overall Study|Adverse Event|3|||
27936746|NCT01152385|81607141|FG000|Overall Study|Withdrawal by Subject|3|||
27936747|NCT01152385|81607142|FG001|Overall Study|Withdrawal by Subject|1|||
27936748|NCT01152385|81607143|FG002|Overall Study|Withdrawal by Subject|1|||
27644372|NCT01638000|80538990|FG000|Overall Study|Randomized but Never Received Drug|7|||
27644373|NCT01638000|80538991|FG001|Overall Study|Randomized but Never Received Drug|10|||
27644374|NCT01638000|80538990|FG000|Overall Study|Adverse Event|14|||
27936749|NCT01152385|81607144|FG003|Overall Study|Withdrawal by Subject|1|||
27644375|NCT01638000|80538991|FG001|Overall Study|Adverse Event|16|||
27936750|NCT01152385|81607141|FG000|Overall Study|Protocol Violation|0|||
27936751|NCT01152385|81607142|FG001|Overall Study|Protocol Violation|0|||
27936752|NCT01152385|81607143|FG002|Overall Study|Protocol Violation|0|||
27936753|NCT01152385|81607144|FG003|Overall Study|Protocol Violation|1|||
27744708|NCT02495077|80896315|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
27744709|NCT02495077|80896312|FG000|Overall Study|Timing of transplant and randomization|0|||
27744710|NCT02495077|80896313|FG001|Overall Study|Timing of transplant and randomization|0|||
27744711|NCT02495077|80896314|FG002|Overall Study|Timing of transplant and randomization|5|||
27744712|NCT02495077|80896315|FG003|Overall Study|Timing of transplant and randomization|0|||
27744713|NCT01400971|80896323|FG000|Overall Study|Death|82|||
27744714|NCT01400971|80896323|FG000|Overall Study|Lost to Follow-up|196|||
27744715|NCT01400971|80896323|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
27936754|NCT01152385|81607141|FG000|Overall Study|Adverse Event|1|||
27936755|NCT01152385|81607142|FG001|Overall Study|Adverse Event|1|||
27644376|NCT01638000|80538990|FG000|Overall Study|Lack of Efficacy|5|||
27644377|NCT01638000|80538991|FG001|Overall Study|Lack of Efficacy|6|||
27644378|NCT01638000|80538990|FG000|Overall Study|Protocol Violation|11|||
27644379|NCT01638000|80538991|FG001|Overall Study|Protocol Violation|13|||
27644380|NCT01638000|80538990|FG000|Overall Study|Withdrawal by Subject|21|||
27644381|NCT01638000|80538991|FG001|Overall Study|Withdrawal by Subject|24|||
27644382|NCT01638000|80538990|FG000|Overall Study|Miscellaneous|2|||
27644383|NCT01638000|80538991|FG001|Overall Study|Miscellaneous|2|||
27644384|NCT01701401|80538992|FG000|Overall Study|Randomized But Not Treated|3|||
27644385|NCT01701401|80538993|FG001|Overall Study|Randomized But Not Treated|1|||
27644386|NCT01701401|80538994|FG002|Overall Study|Randomized But Not Treated|0|||
27644387|NCT01701401|80538995|FG003|Overall Study|Randomized But Not Treated|1|||
27644388|NCT01701401|80538992|FG000|Overall Study|Lost to Follow-up|5|||
27644389|NCT01701401|80538993|FG001|Overall Study|Lost to Follow-up|5|||
27644390|NCT01701401|80538994|FG002|Overall Study|Lost to Follow-up|1|||
27644391|NCT01701401|80538995|FG003|Overall Study|Lost to Follow-up|3|||
27644392|NCT01701401|80538992|FG000|Overall Study|Withdrew Consent|0|||
27644393|NCT01701401|80538993|FG001|Overall Study|Withdrew Consent|3|||
27644394|NCT01701401|80538994|FG002|Overall Study|Withdrew Consent|1|||
27644395|NCT01701401|80538995|FG003|Overall Study|Withdrew Consent|2|||
27644396|NCT01701401|80538992|FG000|Overall Study|Lack of Efficacy|1|||
27644397|NCT01701401|80538993|FG001|Overall Study|Lack of Efficacy|0|||
27644398|NCT01701401|80538994|FG002|Overall Study|Lack of Efficacy|2|||
27644399|NCT01701401|80538995|FG003|Overall Study|Lack of Efficacy|0|||
27644400|NCT01701401|80538992|FG000|Overall Study|Adverse Event|1|||
27644401|NCT01701401|80538993|FG001|Overall Study|Adverse Event|0|||
27644402|NCT01701401|80538994|FG002|Overall Study|Adverse Event|0|||
27644403|NCT01701401|80538995|FG003|Overall Study|Adverse Event|0|||
27644404|NCT01701401|80538992|FG000|Overall Study|Protocol Violation|0|||
27644405|NCT01701401|80538993|FG001|Overall Study|Protocol Violation|0|||
27644406|NCT01701401|80538994|FG002|Overall Study|Protocol Violation|1|||
27644407|NCT01701401|80538995|FG003|Overall Study|Protocol Violation|0|||
27644408|NCT02787005|80538998|FG000|Overall Study|Adverse Event|24|||
27644409|NCT02787005|80538999|FG001|Overall Study|Adverse Event|9|||
27644410|NCT02787005|80539000|FG002|Overall Study|Adverse Event|9|||
27644411|NCT02787005|80539001|FG003|Overall Study|Adverse Event|7|||
27644412|NCT02787005|80539002|FG004|Overall Study|Adverse Event|2|||
27644413|NCT02787005|80538998|FG000|Overall Study|Death|100|||
27644414|NCT02787005|80538999|FG001|Overall Study|Death|53|||
27644415|NCT02787005|80539000|FG002|Overall Study|Death|48|||
27644416|NCT02787005|80539001|FG003|Overall Study|Death|69|||
27644417|NCT02787005|80539002|FG004|Overall Study|Death|38|||
27644418|NCT02787005|80538998|FG000|Overall Study|Sponsor Decision|7|||
27644419|NCT02787005|80538999|FG001|Overall Study|Sponsor Decision|4|||
27644420|NCT02787005|80539000|FG002|Overall Study|Sponsor Decision|0|||
27644421|NCT02787005|80539001|FG003|Overall Study|Sponsor Decision|4|||
27644422|NCT02787005|80539002|FG004|Overall Study|Sponsor Decision|5|||
27644423|NCT02787005|80538998|FG000|Overall Study|Withdrawal by Subject|2|||
27644424|NCT02787005|80538999|FG001|Overall Study|Withdrawal by Subject|1|||
27644425|NCT02787005|80539000|FG002|Overall Study|Withdrawal by Subject|1|||
27644426|NCT02787005|80539001|FG003|Overall Study|Withdrawal by Subject|0|||
27644427|NCT02787005|80539002|FG004|Overall Study|Withdrawal by Subject|1|||
27644428|NCT02787005|80538998|FG000|Overall Study|Screen Failure|0|||
27644429|NCT02787005|80538999|FG001|Overall Study|Screen Failure|2|||
27644430|NCT02787005|80539000|FG002|Overall Study|Screen Failure|0|||
27644431|NCT02787005|80539001|FG003|Overall Study|Screen Failure|0|||
27644432|NCT02787005|80539002|FG004|Overall Study|Screen Failure|1|||
27644433|NCT02787005|80538998|FG000|Overall Study|Lost to Follow-up|0|||
27644434|NCT02787005|80538999|FG001|Overall Study|Lost to Follow-up|0|||
27644435|NCT02787005|80539000|FG002|Overall Study|Lost to Follow-up|0|||
27936756|NCT01152385|81607143|FG002|Overall Study|Adverse Event|0|||
27644436|NCT02787005|80539001|FG003|Overall Study|Lost to Follow-up|1|||
27644437|NCT02787005|80539002|FG004|Overall Study|Lost to Follow-up|0|||
27936757|NCT01152385|81607144|FG003|Overall Study|Adverse Event|0|||
27936758|NCT01152385|81607141|FG000|Overall Study|Study-specific withdrawal criteria|1|||
27644441|NCT01948661|80539007|FG000|Overall Study|Withdrawal by Subject|2|||
27644442|NCT01948661|80539008|FG001|Overall Study|Withdrawal by Subject|4|||
27644443|NCT01367236|80539009|FG000|Overall Study|Withdrawal by Subject|3|||
27644444|NCT01367236|80539010|FG001|Overall Study|Withdrawal by Subject|1|||
27744716|NCT01400971|80896323|FG000|Overall Study|Physician Decision|57|||
27744717|NCT01400971|80896323|FG000|Overall Study|Withdrawal by Subject|158|||
27744718|NCT01400971|80896323|FG000|Overall Study|Other|422|||
27744719|NCT02815397|80896324|FG000|Overall Study|Physician Decision|2|||
27744720|NCT00370149|80896325|FG000|Overall Study|Physician Decision|16|||
27744721|NCT00370149|80896326|FG001|Overall Study|Physician Decision|16|||
27744722|NCT00370149|80896325|FG000|Overall Study|Protocol Violation|1|||
27744723|NCT00370149|80896326|FG001|Overall Study|Protocol Violation|0|||
27744724|NCT00370149|80896325|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
27744725|NCT00370149|80896326|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
27744726|NCT00370149|80896325|FG000|Overall Study|Pre-existing infection|0|||
27744727|NCT00370149|80896326|FG001|Overall Study|Pre-existing infection|1|||
27744728|NCT00370149|80896325|FG000|Overall Study|Antibiotic coated dressing placed|0|||
27744729|NCT00370149|80896326|FG001|Overall Study|Antibiotic coated dressing placed|1|||
27744730|NCT01678807|80896327|FG000|Overall Study|Adverse Event|4|||
27744731|NCT01678807|80896328|FG001|Overall Study|Adverse Event|4|||
27744732|NCT01678807|80896329|FG002|Overall Study|Adverse Event|0|||
27744733|NCT01678807|80896327|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
27744734|NCT01678807|80896328|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
27744735|NCT01678807|80896329|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
27744736|NCT00328198|80896334|FG000|Treatment|Adverse Event|21|||
27744737|NCT00328198|80896334|FG000|Treatment|Death|1|||
27744738|NCT00328198|80896334|FG000|Treatment|Physician Decision|5|||
27744739|NCT00328198|80896334|FG000|Treatment|Withdrawal by Subject|5|||
27744740|NCT00328198|80896334|FG000|Treatment|Evidence of disease progression|2|||
27744741|NCT00328198|80896334|FG000|Treatment|Non-compliance|1|||
27744742|NCT00328198|80896334|FG000|Treatment|Confirmed complete response, MRD -|3|||
27744743|NCT00328198|80896334|FG000|Follow-up|Lost to Follow-up|4|||
27744744|NCT00328198|80896334|FG000|Follow-up|Death|31|||
27744745|NCT03662334|80896335|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
27744746|NCT03662334|80896336|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
27744747|NCT00723840|80896340|FG000|Overall Study|Lost to Follow-up|2|||
27744748|NCT00723840|80896340|FG000|Overall Study|Failure to return|18|||
27744749|NCT00723840|80896340|FG000|Overall Study|Withdrawal by Subject|55|||
27744750|NCT00723840|80896340|FG000|Overall Study|Serious Adverse Events|3|||
27744751|NCT00723840|80896340|FG000|Overall Study|Other Medical Event|2|||
27744752|NCT00723840|80896340|FG000|Overall Study|Unspecified reason|2|||
27744753|NCT02345434|80896341|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
27744754|NCT02345434|80896342|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
27744755|NCT02241512|80896353|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
27744756|NCT02241512|80896354|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
27744757|NCT03510663|80896355|FG000|Overall Study|Withdrawal by Subject|0|||
27744758|NCT03510663|80896356|FG001|Overall Study|Withdrawal by Subject|1|||
27744759|NCT03510663|80896357|FG002|Overall Study|Withdrawal by Subject|0|||
27744760|NCT03510663|80896358|FG003|Overall Study|Withdrawal by Subject|0|||
27744761|NCT03510663|80896359|FG004|Overall Study|Withdrawal by Subject|0|||
27744762|NCT03510663|80896360|FG005|Overall Study|Withdrawal by Subject|0|||
27744763|NCT03510663|80896361|FG006|Overall Study|Withdrawal by Subject|0|||
27744764|NCT03510663|80896362|FG007|Overall Study|Withdrawal by Subject|0|||
27744765|NCT03666143|80896363|FG000|Overall Study|Death|158|||
27744766|NCT03666143|80896363|FG000|Overall Study|Sponsor Decision|31|||
27744767|NCT03666143|80896363|FG000|Overall Study|Withdrawal by Subject|11|||
27744768|NCT03666143|80896363|FG000|Overall Study|Lost to Follow-up|5|||
27744769|NCT03666143|80896363|FG000|Overall Study|Physician Decision|1|||
27744770|NCT03666143|80896363|FG000|Overall Study|Rolled into extension study|9|||
27744771|NCT03666143|80896363|FG000|Overall Study|Progressive Disease|1|||
27744772|NCT05091060|80896364|FG000|Overall Study|Lost to Follow-up|1|||
27744773|NCT01765764|80896367|FG000|Treatment Period|Adverse Event|1|||
27744774|NCT01765764|80896368|FG001|Treatment Period|Adverse Event|2|||
27744775|NCT01765764|80896369|FG002|Treatment Period|Adverse Event|1|||
27744776|NCT01765764|80896367|FG000|Treatment Period|Lost to Follow-up|0|||
27744777|NCT01765764|80896368|FG001|Treatment Period|Lost to Follow-up|3|||
27744778|NCT01765764|80896369|FG002|Treatment Period|Lost to Follow-up|2|||
27744779|NCT01765764|80896367|FG000|Treatment Period|Personal Reasons|1|||
27744780|NCT01765764|80896368|FG001|Treatment Period|Personal Reasons|2|||
27744781|NCT01765764|80896369|FG002|Treatment Period|Personal Reasons|1|||
27744782|NCT01765764|80896367|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
27744783|NCT01765764|80896368|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
27744784|NCT01765764|80896369|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
27744785|NCT03321929|80896370|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
27744786|NCT00053846|80896374|FG000|Overall Study|Changed mind|8|||
27744787|NCT00053846|80896375|FG001|Overall Study|Changed mind|13|||
27744788|NCT00053846|80896374|FG000|Overall Study|Became too ill|8|||
27744789|NCT00053846|80896375|FG001|Overall Study|Became too ill|7|||
27744790|NCT00053846|80896374|FG000|Overall Study|Expired|5|||
27744791|NCT00053846|80896375|FG001|Overall Study|Expired|0|||
27744792|NCT00053846|80896374|FG000|Overall Study|Became ineligible|3|||
27744793|NCT00053846|80896375|FG001|Overall Study|Became ineligible|1|||
27744794|NCT00053846|80896374|FG000|Overall Study|Did not return data|1|||
27744795|NCT00053846|80896375|FG001|Overall Study|Did not return data|2|||
27744796|NCT00053846|80896374|FG000|Overall Study|Quit due to side effects|1|||
27744797|NCT00053846|80896375|FG001|Overall Study|Quit due to side effects|3|||
27744798|NCT00053846|80896374|FG000|Overall Study|Pills too large|0|||
27744799|NCT00053846|80896375|FG001|Overall Study|Pills too large|1|||
27744800|NCT01306058|80896381|FG000|Overall Study|Death|1|||
27744801|NCT01306058|80896381|FG000|Overall Study|Enrolled but did not get treatment|1|||
27744802|NCT01095250|80896389|FG000|Overall Study|administrative reasons|8|||
27744803|NCT01095250|80896390|FG001|Overall Study|administrative reasons|10|||
27744804|NCT01095250|80896391|FG002|Overall Study|administrative reasons|7|||
27744805|NCT01095250|80896392|FG003|Overall Study|administrative reasons|5|||
27744806|NCT01095250|80896389|FG000|Overall Study|Withdrawal by Subject|0|||
27744807|NCT01095250|80896390|FG001|Overall Study|Withdrawal by Subject|0|||
27744808|NCT01095250|80896391|FG002|Overall Study|Withdrawal by Subject|1|||
27744809|NCT01095250|80896392|FG003|Overall Study|Withdrawal by Subject|0|||
27744810|NCT02225223|80896393|FG000|Overall Study|Death|10|||
27744811|NCT02225223|80896394|FG001|Overall Study|Death|1|||
27744812|NCT02225223|80896393|FG000|Overall Study|Lost to Follow-up|5|||
27744813|NCT02225223|80896394|FG001|Overall Study|Lost to Follow-up|0|||
27744814|NCT02225223|80896393|FG000|Overall Study|Other|1|||
27936759|NCT01152385|81607142|FG001|Overall Study|Study-specific withdrawal criteria|1|||
27936760|NCT01152385|81607143|FG002|Overall Study|Study-specific withdrawal criteria|2|||
27936761|NCT01152385|81607144|FG003|Overall Study|Study-specific withdrawal criteria|0|||
27936762|NCT01152385|81607141|FG000|Overall Study|Other|4|||
27936763|NCT01152385|81607142|FG001|Overall Study|Other|3|||
27936764|NCT01152385|81607143|FG002|Overall Study|Other|2|||
27936765|NCT01152385|81607144|FG003|Overall Study|Other|3|||
27936766|NCT01682603|81607145|FG000|Overall Study|Lost to Follow-up|3|||
27936767|NCT00348374|81607146|FG000|Overall Study|Adverse Event|1|||
27936768|NCT00348374|81607147|FG001|Overall Study|Adverse Event|4|||
27936769|NCT00348374|81607146|FG000|Overall Study|Lost to Follow-up|1|||
27936770|NCT00348374|81607147|FG001|Overall Study|Lost to Follow-up|3|||
27936771|NCT00348374|81607146|FG000|Overall Study|Withdrawal by Subject|5|||
27936772|NCT00348374|81607147|FG001|Overall Study|Withdrawal by Subject|5|||
27936773|NCT00348374|81607146|FG000|Overall Study|Other|11|||
27936774|NCT00348374|81607147|FG001|Overall Study|Other|12|||
27936775|NCT00348374|81607146|FG000|Overall Study|ongoing at date of cutoff|1|||
27936776|NCT00348374|81607147|FG001|Overall Study|ongoing at date of cutoff|1|||
27936777|NCT00348374|81607146|FG000|Overall Study|randomized but did not receive treatment|0|||
27936778|NCT00348374|81607147|FG001|Overall Study|randomized but did not receive treatment|7|||
27936779|NCT00862277|81607148|FG000|Overall Study|Protocol Violation|1|||
27936780|NCT00862277|81607149|FG001|Overall Study|Protocol Violation|2|||
27936781|NCT00862277|81607150|FG002|Overall Study|Protocol Violation|5|||
27936782|NCT01520714|81607151|FG000|Overall Study|Protocol Violation|0|||
27936783|NCT01520714|81607152|FG001|Overall Study|Protocol Violation|3|||
27936784|NCT01520714|81607151|FG000|Overall Study|Adverse Event|0|||
27936785|NCT01520714|81607152|FG001|Overall Study|Adverse Event|2|||
27936786|NCT01520714|81607151|FG000|Overall Study|Lack of Efficacy|0|||
27936787|NCT01520714|81607152|FG001|Overall Study|Lack of Efficacy|1|||
27936788|NCT03438656|81607153|FG000|Overall Study|Lost to Follow-up|2|||
27936789|NCT02539394|81607154|FG000|Overall Study|Protocol Violation|1|||
27936790|NCT02539394|81607155|FG001|Overall Study|Protocol Violation|3|||
27936791|NCT02539394|81607154|FG000|Overall Study|Lost to Follow-up|1|||
27936792|NCT02539394|81607155|FG001|Overall Study|Lost to Follow-up|2|||
27936793|NCT02539394|81607154|FG000|Overall Study|Incomplete dataset|6|||
27936794|NCT02539394|81607155|FG001|Overall Study|Incomplete dataset|6|||
27936795|NCT00601900|81607156|FG000|Overall Study|Withdrawal by Subject|0|||
27936796|NCT00601900|81607157|FG001|Overall Study|Withdrawal by Subject|3|||
27936797|NCT03056755|81607158|FG000|Treatment- Core Phase|Progressive disease|89|||
27551024|NCT02028065|80203561|FG002|Treatment Through Study Completion|Adverse Event|5|||
27744815|NCT02225223|80896394|FG001|Overall Study|Other|2|||
27744816|NCT02225223|80896393|FG000|Overall Study|Physician Decision|1|||
27936798|NCT03056755|81607159|FG001|Treatment- Core Phase|Progressive disease|88|||
27936799|NCT03056755|81607160|FG002|Treatment- Core Phase|Progressive disease|90|||
27936800|NCT03056755|81607158|FG000|Treatment- Core Phase|Adverse Event|20|||
27551025|NCT02233647|80203562|FG000|Overall Study|Adverse Event|1|||
27936801|NCT03056755|81607159|FG001|Treatment- Core Phase|Adverse Event|14|||
27936802|NCT03056755|81607160|FG002|Treatment- Core Phase|Adverse Event|13|||
27744817|NCT02225223|80896394|FG001|Overall Study|Physician Decision|0|||
27936803|NCT03056755|81607158|FG000|Treatment- Core Phase|Physician Decision|7|||
27936804|NCT03056755|81607159|FG001|Treatment- Core Phase|Physician Decision|13|||
27936805|NCT03056755|81607160|FG002|Treatment- Core Phase|Physician Decision|5|||
27936806|NCT03056755|81607158|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
27936807|NCT03056755|81607159|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
27936808|NCT03056755|81607160|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
27744818|NCT02225223|80896393|FG000|Overall Study|Withdrawal by Subject|2|||
27936809|NCT03056755|81607158|FG000|Treatment- Core Phase|Death|3|||
27936810|NCT03056755|81607159|FG001|Treatment- Core Phase|Death|2|||
27936811|NCT03056755|81607160|FG002|Treatment- Core Phase|Death|4|||
27936812|NCT03056755|81607158|FG000|Treatment- Core Phase|Protocol deviation|1|||
27936813|NCT03056755|81607159|FG001|Treatment- Core Phase|Protocol deviation|1|||
27936814|NCT03056755|81607160|FG002|Treatment- Core Phase|Protocol deviation|0|||
27936815|NCT03056755|81607158|FG000|Treatment- Core Phase|Technical problems|1|||
27936816|NCT03056755|81607159|FG001|Treatment- Core Phase|Technical problems|0|||
27936817|NCT03056755|81607160|FG002|Treatment- Core Phase|Technical problems|0|||
27936818|NCT03056755|81607158|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
27936819|NCT03056755|81607159|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
27936820|NCT03056755|81607160|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
27936821|NCT03056755|81607158|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
27936822|NCT03056755|81607159|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
27644453|NCT05580003|80539013|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644454|NCT05580003|80539014|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644455|NCT05580003|80539015|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644456|NCT05580003|80539016|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644457|NCT05580003|80539017|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644458|NCT05580003|80539018|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644459|NCT05580003|80539019|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
27644460|NCT05580003|80539020|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644461|NCT05580003|80539021|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644462|NCT05580003|80539022|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644463|NCT05580003|80539023|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644464|NCT05580003|80539024|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644465|NCT05580003|80539025|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644466|NCT05580003|80539026|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644467|NCT05580003|80539027|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644468|NCT05580003|80539028|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644469|NCT05580003|80539029|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644470|NCT05580003|80539030|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644471|NCT05580003|80539031|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644472|NCT05580003|80539032|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644473|NCT05580003|80539033|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644474|NCT05580003|80539034|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644475|NCT05580003|80539035|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644476|NCT05580003|80539036|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644477|NCT05580003|80539037|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644478|NCT05580003|80539038|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644479|NCT05580003|80539039|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644480|NCT05580003|80539040|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
27644481|NCT05580003|80539013|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644482|NCT05580003|80539014|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644483|NCT05580003|80539015|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644484|NCT05580003|80539016|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644485|NCT05580003|80539017|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644486|NCT05580003|80539018|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
27644487|NCT05580003|80539019|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644488|NCT05580003|80539020|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644489|NCT05580003|80539021|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644490|NCT05580003|80539022|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644491|NCT05580003|80539023|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644492|NCT05580003|80539024|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644493|NCT05580003|80539025|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644494|NCT05580003|80539026|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644495|NCT05580003|80539027|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644496|NCT05580003|80539028|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27744819|NCT02225223|80896394|FG001|Overall Study|Withdrawal by Subject|2|||
27644497|NCT05580003|80539029|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644498|NCT05580003|80539030|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644499|NCT05580003|80539031|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644500|NCT05580003|80539032|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27744820|NCT01413178|80896395|FG000|Overall Study|Toxicity|1|||
27744821|NCT01413178|80896396|FG001|Overall Study|Toxicity|0|||
27744822|NCT01413178|80896395|FG000|Overall Study|Ineligible|0|||
27744823|NCT01413178|80896396|FG001|Overall Study|Ineligible|2|||
27744824|NCT02275026|80896397|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
27744825|NCT02275026|80896397|FG000|Overall Study|Withdrawal by Subject|4|||
27744826|NCT02275026|80896397|FG000|Overall Study|Ineligible due to medical history|13|||
27744827|NCT02275026|80896397|FG000|Overall Study|MRI malfunction precluded testing|1|||
27744828|NCT02275026|80896397|FG000|Overall Study|Ineligible after MRI findings|1|||
27744829|NCT02275026|80896397|FG000|Overall Study|Lost to Follow-up|2|||
27744830|NCT02275026|80896397|FG000|Overall Study|Scanner failure|1|||
27744831|NCT02100657|80896398|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
27744832|NCT02100657|80896399|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
27744833|NCT02100657|80896400|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
27744834|NCT02100657|80896398|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
27744835|NCT02100657|80896399|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
27744836|NCT02100657|80896400|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
27744837|NCT02100657|80896398|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
27744838|NCT02100657|80896399|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
27744839|NCT02100657|80896400|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
27744840|NCT02100657|80896398|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
27744841|NCT02100657|80896399|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
27744842|NCT02100657|80896400|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
27744843|NCT02100657|80896398|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
27744844|NCT02100657|80896399|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
27744845|NCT02100657|80896400|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
27744846|NCT02100657|80896398|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
27744847|NCT02100657|80896399|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
27744848|NCT02100657|80896400|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
27744849|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
27744850|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
27744851|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
27744852|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Death|0|||
27744853|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Death|0|||
27744854|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Death|1|||
27744855|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
27744856|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
27744857|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
27744858|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
27744859|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
27744860|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
27744861|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
27744862|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
27744863|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
27744864|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
27744865|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
27744866|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
27744867|NCT02100657|80896398|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
27744868|NCT02100657|80896399|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
27744869|NCT02100657|80896400|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
27744870|NCT00390780|80896401|FG000|Overall Study|Not completed|10|||
27744871|NCT00390780|80896402|FG001|Overall Study|Not completed|4|||
27744872|NCT00390780|80896401|FG000|Overall Study|Protocol Violation|6|||
27936823|NCT03056755|81607160|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
27936824|NCT03056755|81607158|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
27936825|NCT03056755|81607159|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
27936826|NCT03056755|81607160|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
27936827|NCT03056755|81607158|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
27936828|NCT03056755|81607159|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
27936829|NCT03056755|81607160|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
27936830|NCT03721107|81607174|FG000|Overall Study|Adverse Event|1|||
27936831|NCT03721107|81607175|FG001|Overall Study|Adverse Event|1|||
27936832|NCT03721107|81607176|FG002|Overall Study|Adverse Event|6|||
27936833|NCT03721107|81607177|FG003|Overall Study|Adverse Event|5|||
27644501|NCT05580003|80539033|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644502|NCT05580003|80539034|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644503|NCT05580003|80539035|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27744873|NCT00390780|80896402|FG001|Overall Study|Protocol Violation|4|||
27744874|NCT00390780|80896401|FG000|Overall Study|Lost to Follow-up|3|||
27744875|NCT00390780|80896402|FG001|Overall Study|Lost to Follow-up|6|||
27936834|NCT03721107|81607174|FG000|Overall Study|Lost to Follow-up|2|||
27744876|NCT00390780|80896401|FG000|Overall Study|Adverse Event|2|||
27744877|NCT00390780|80896402|FG001|Overall Study|Adverse Event|3|||
27744878|NCT00390780|80896401|FG000|Overall Study|Death|1|||
27744879|NCT00390780|80896402|FG001|Overall Study|Death|3|||
27744880|NCT00390780|80896401|FG000|Overall Study|Withdrawal by Subject|1|||
27744881|NCT00390780|80896402|FG001|Overall Study|Withdrawal by Subject|2|||
27744882|NCT00390780|80896401|FG000|Overall Study|Inclusion criteria not satisfied|0|||
27744883|NCT00390780|80896402|FG001|Overall Study|Inclusion criteria not satisfied|2|||
27744884|NCT00390780|80896401|FG000|Overall Study|Lost to follow up and other reasons|0|||
27744885|NCT00390780|80896402|FG001|Overall Study|Lost to follow up and other reasons|1|||
27744886|NCT00390780|80896401|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
27744887|NCT00390780|80896402|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
27744888|NCT00390780|80896401|FG000|Overall Study|SAE, death|0|||
27744889|NCT00390780|80896402|FG001|Overall Study|SAE, death|1|||
27744890|NCT00829166|80896403|FG000|Overall Study|Death|305|||
27744891|NCT00829166|80896404|FG001|Overall Study|Death|333|||
27744892|NCT00829166|80896403|FG000|Overall Study|Lost to Follow-up|5|||
27744893|NCT00829166|80896404|FG001|Overall Study|Lost to Follow-up|4|||
27744894|NCT00829166|80896403|FG000|Overall Study|Physician's Decision|4|||
27744895|NCT00829166|80896404|FG001|Overall Study|Physician's Decision|3|||
27744896|NCT00829166|80896403|FG000|Overall Study|Subject's Decision|41|||
27744897|NCT00829166|80896404|FG001|Overall Study|Subject's Decision|55|||
27744898|NCT00829166|80896403|FG000|Overall Study|Sponsor's Decision|137|||
27744899|NCT00829166|80896404|FG001|Overall Study|Sponsor's Decision|98|||
27744900|NCT00829166|80896403|FG000|Overall Study|Reason Not Specified|3|||
27744901|NCT00829166|80896404|FG001|Overall Study|Reason Not Specified|3|||
27744902|NCT00592358|80896407|FG000|Overall Study|Withdrawal by Subject|2|||
27744903|NCT00592358|80896407|FG000|Overall Study|Adverse Event|1|||
27744904|NCT00592358|80896407|FG000|Overall Study|Lack of Efficacy|2|||
27744905|NCT00592358|80896407|FG000|Overall Study|Inability to swallow pills|1|||
27744906|NCT02229864|80896411|FG000|Overall Study|Death|2|||
27744907|NCT02229864|80896411|FG000|Overall Study|Lost to Follow-up|1|||
27744908|NCT02116972|80896412|FG000|Overall Study|Adverse Event|4|||
27744909|NCT02116972|80896413|FG001|Overall Study|Adverse Event|4|||
27744910|NCT02116972|80896414|FG002|Overall Study|Adverse Event|1|||
27744911|NCT02116972|80896412|FG000|Overall Study|Withdrawal by Subject|1|||
27744912|NCT02116972|80896413|FG001|Overall Study|Withdrawal by Subject|1|||
27744913|NCT02116972|80896414|FG002|Overall Study|Withdrawal by Subject|5|||
27744914|NCT02116972|80896412|FG000|Overall Study|Protocol Violation|1|||
27744915|NCT02116972|80896413|FG001|Overall Study|Protocol Violation|0|||
27744916|NCT02116972|80896414|FG002|Overall Study|Protocol Violation|1|||
27744917|NCT02116972|80896412|FG000|Overall Study|Lost to Follow-up|4|||
27744918|NCT02116972|80896413|FG001|Overall Study|Lost to Follow-up|3|||
27744919|NCT02116972|80896414|FG002|Overall Study|Lost to Follow-up|1|||
27744920|NCT02116972|80896412|FG000|Overall Study|Lack of Efficacy|6|||
27744921|NCT02116972|80896413|FG001|Overall Study|Lack of Efficacy|6|||
27744922|NCT02116972|80896414|FG002|Overall Study|Lack of Efficacy|5|||
27744923|NCT02116972|80896412|FG000|Overall Study|scheduling conflicts and relocation|3|||
27744924|NCT02116972|80896413|FG001|Overall Study|scheduling conflicts and relocation|3|||
27744925|NCT02116972|80896414|FG002|Overall Study|scheduling conflicts and relocation|6|||
27744926|NCT02429427|80896415|FG000|Overall Study|Adverse Event|220|||
27744927|NCT02429427|80896416|FG001|Overall Study|Adverse Event|92|||
27744928|NCT02429427|80896415|FG000|Overall Study|Protocol Violation|10|||
27744929|NCT02429427|80896416|FG001|Overall Study|Protocol Violation|6|||
27744930|NCT02429427|80896415|FG000|Overall Study|Lost to Follow-up|15|||
27744931|NCT02429427|80896416|FG001|Overall Study|Lost to Follow-up|6|||
27744932|NCT02429427|80896415|FG000|Overall Study|Withdrawal by Subject|64|||
27744933|NCT02429427|80896416|FG001|Overall Study|Withdrawal by Subject|34|||
27744934|NCT02429427|80896415|FG000|Overall Study|Other|62|||
27744935|NCT02429427|80896416|FG001|Overall Study|Other|41|||
27744936|NCT01512368|80896417|FG000|Overall Study|Protocol Violation|3|||
27744937|NCT01070784|80896420|FG000|Overall Study|Withdrawal by Subject|6|||
27744938|NCT01070784|80896421|FG001|Overall Study|Withdrawal by Subject|9|||
27744939|NCT01070784|80896420|FG000|Overall Study|Adverse Event|14|||
27744940|NCT01070784|80896421|FG001|Overall Study|Adverse Event|9|||
27744941|NCT00791128|80896422|FG000|Overall Study|Adverse Event|4|||
27744942|NCT00791128|80896422|FG000|Overall Study|Device migration|2|||
27744943|NCT00791128|80896422|FG000|Overall Study|non-compliance by subject|2|||
27744944|NCT00791128|80896422|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
27744945|NCT02747043|80896423|FG000|Overall Study|Other|1|||
27744946|NCT02747043|80896424|FG001|Overall Study|Other|1|||
27744947|NCT02747043|80896423|FG000|Overall Study|Adverse Event|3|||
27744948|NCT02747043|80896424|FG001|Overall Study|Adverse Event|1|||
27744949|NCT02747043|80896423|FG000|Overall Study|Withdrawal by Subject|1|||
27744950|NCT02747043|80896424|FG001|Overall Study|Withdrawal by Subject|1|||
27744951|NCT02747043|80896423|FG000|Overall Study|Physician Decision|1|||
27744952|NCT02747043|80896424|FG001|Overall Study|Physician Decision|1|||
27744953|NCT02747043|80896423|FG000|Overall Study|Protocol Violation|0|||
27744954|NCT02747043|80896424|FG001|Overall Study|Protocol Violation|1|||
27744955|NCT02747043|80896423|FG000|Overall Study|Disease progression|4|||
27744956|NCT02747043|80896424|FG001|Overall Study|Disease progression|0|||
27744957|NCT01943539|80896425|FG000|Overall Study|Non-compliance with at-home intervention|4|||
27744958|NCT01943539|80896426|FG001|Overall Study|Non-compliance with at-home intervention|0|||
27744959|NCT01671488|80896432|FG000|Overall Study|Withdrawal by Subject|1|||
27744960|NCT04156646|80896433|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
27744961|NCT04156646|80896434|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
27744962|NCT00224107|80896438|FG000|Overall Study|Adverse Event|20|||
27744963|NCT00224107|80896439|FG001|Overall Study|Adverse Event|6|||
27744964|NCT00224107|80896438|FG000|Overall Study|Protocol Violation|2|||
27744965|NCT00224107|80896439|FG001|Overall Study|Protocol Violation|3|||
27744966|NCT00224107|80896438|FG000|Overall Study|Withdrawal by Subject|1|||
27744967|NCT00224107|80896439|FG001|Overall Study|Withdrawal by Subject|4|||
27744968|NCT00224107|80896438|FG000|Overall Study|Lack of Efficacy|2|||
27744969|NCT00224107|80896439|FG001|Overall Study|Lack of Efficacy|0|||
27744970|NCT00224107|80896438|FG000|Overall Study|Lost to Follow-up|4|||
27744971|NCT00224107|80896439|FG001|Overall Study|Lost to Follow-up|0|||
27744972|NCT00224107|80896438|FG000|Overall Study|Physician Decision|1|||
27744973|NCT00224107|80896439|FG001|Overall Study|Physician Decision|0|||
27744974|NCT00224107|80896438|FG000|Overall Study|Other|1|||
27744975|NCT00224107|80896439|FG001|Overall Study|Other|1|||
27744976|NCT04590937|80896440|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
27744977|NCT01214616|80896443|FG000|Overall Study|Progressive disease|2|||
27744978|NCT01214616|80896444|FG001|Overall Study|Progressive disease|2|||
27744979|NCT01214616|80896445|FG002|Overall Study|Progressive disease|2|||
27744980|NCT01214616|80896446|FG003|Overall Study|Progressive disease|4|||
27744981|NCT01214616|80896443|FG000|Overall Study|Dose limiting toxicity|0|||
27744982|NCT01214616|80896444|FG001|Overall Study|Dose limiting toxicity|2|||
27744983|NCT01214616|80896445|FG002|Overall Study|Dose limiting toxicity|0|||
27744984|NCT01214616|80896446|FG003|Overall Study|Dose limiting toxicity|0|||
27744985|NCT01214616|80896443|FG000|Overall Study|Other adverse events|0|||
27744986|NCT01214616|80896444|FG001|Overall Study|Other adverse events|1|||
27744987|NCT01214616|80896445|FG002|Overall Study|Other adverse events|1|||
27744988|NCT01214616|80896446|FG003|Overall Study|Other adverse events|1|||
27936835|NCT03721107|81607175|FG001|Overall Study|Lost to Follow-up|0|||
27936836|NCT03721107|81607176|FG002|Overall Study|Lost to Follow-up|3|||
27936837|NCT03721107|81607177|FG003|Overall Study|Lost to Follow-up|0|||
27936838|NCT03721107|81607174|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
27936839|NCT03721107|81607175|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
27936840|NCT03721107|81607176|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
27936841|NCT03721107|81607177|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
27936842|NCT03721107|81607174|FG000|Overall Study|Physician Decision|0|||
27936843|NCT03721107|81607175|FG001|Overall Study|Physician Decision|1|||
27936844|NCT03721107|81607176|FG002|Overall Study|Physician Decision|0|||
27936845|NCT03721107|81607177|FG003|Overall Study|Physician Decision|0|||
27936846|NCT03721107|81607174|FG000|Overall Study|Pregnancy|0|||
27936847|NCT03721107|81607175|FG001|Overall Study|Pregnancy|0|||
27936848|NCT03721107|81607176|FG002|Overall Study|Pregnancy|1|||
27936849|NCT03721107|81607177|FG003|Overall Study|Pregnancy|0|||
27936850|NCT03721107|81607174|FG000|Overall Study|Withdrawal by Subject|1|||
27936851|NCT03721107|81607175|FG001|Overall Study|Withdrawal by Subject|1|||
27936852|NCT03721107|81607176|FG002|Overall Study|Withdrawal by Subject|5|||
27936853|NCT03721107|81607177|FG003|Overall Study|Withdrawal by Subject|5|||
27936854|NCT03721107|81607174|FG000|Overall Study|Other|1|||
27936855|NCT03721107|81607175|FG001|Overall Study|Other|0|||
27936856|NCT03721107|81607176|FG002|Overall Study|Other|0|||
27936857|NCT03721107|81607177|FG003|Overall Study|Other|1|||
27936858|NCT01655069|81607178|FG000|Overall Study|Physician Decision|0|||
27936859|NCT01655069|81607179|FG001|Overall Study|Physician Decision|0|||
27936860|NCT01655069|81607180|FG002|Overall Study|Physician Decision|0|||
27744989|NCT01214616|80896443|FG000|Overall Study|Withdrawal by Subject|1|||
27744990|NCT01214616|80896444|FG001|Overall Study|Withdrawal by Subject|0|||
27744991|NCT01214616|80896445|FG002|Overall Study|Withdrawal by Subject|0|||
27936861|NCT01655069|81607181|FG003|Overall Study|Physician Decision|1|||
27936862|NCT01655069|81607178|FG000|Overall Study|Adverse Event|6|||
27936863|NCT01655069|81607179|FG001|Overall Study|Adverse Event|7|||
27936864|NCT01655069|81607180|FG002|Overall Study|Adverse Event|2|||
27936865|NCT01655069|81607181|FG003|Overall Study|Adverse Event|3|||
27936866|NCT01655069|81607178|FG000|Overall Study|Lack of Efficacy|0|||
27936867|NCT01655069|81607179|FG001|Overall Study|Lack of Efficacy|1|||
27936868|NCT01655069|81607180|FG002|Overall Study|Lack of Efficacy|0|||
27936869|NCT01655069|81607181|FG003|Overall Study|Lack of Efficacy|0|||
27744992|NCT01214616|80896446|FG003|Overall Study|Withdrawal by Subject|1|||
27744993|NCT02090114|80896447|FG000|Overall Study|Withdrawal by Subject|3|||
27744994|NCT02090114|80896448|FG001|Overall Study|Withdrawal by Subject|6|||
27936870|NCT01655069|81607178|FG000|Overall Study|No Treatment Needed|0|||
27936871|NCT01655069|81607179|FG001|Overall Study|No Treatment Needed|1|||
27936872|NCT01655069|81607180|FG002|Overall Study|No Treatment Needed|0|||
27936873|NCT01655069|81607181|FG003|Overall Study|No Treatment Needed|0|||
27936874|NCT01655069|81607178|FG000|Overall Study|Withdrawal by Subject|2|||
27936875|NCT01655069|81607179|FG001|Overall Study|Withdrawal by Subject|3|||
27936876|NCT01655069|81607180|FG002|Overall Study|Withdrawal by Subject|0|||
27936877|NCT01655069|81607181|FG003|Overall Study|Withdrawal by Subject|0|||
27936878|NCT01682720|81607182|FG000|Overall Study|Randomized but Not Treated|0|||
27936879|NCT01682720|81607183|FG001|Overall Study|Randomized but Not Treated|1|||
27936880|NCT01682720|81607184|FG002|Overall Study|Randomized but Not Treated|1|||
27936881|NCT01682720|81607185|FG003|Overall Study|Randomized but Not Treated|0|||
27936882|NCT01682720|81607182|FG000|Overall Study|Terminated by Sponsor|83|||
27936883|NCT01682720|81607183|FG001|Overall Study|Terminated by Sponsor|0|||
27936884|NCT01682720|81607184|FG002|Overall Study|Terminated by Sponsor|0|||
27936885|NCT01682720|81607185|FG003|Overall Study|Terminated by Sponsor|0|||
27936886|NCT01682720|81607182|FG000|Overall Study|Efficacy Failure|0|||
27936887|NCT01682720|81607183|FG001|Overall Study|Efficacy Failure|3|||
27936888|NCT01682720|81607184|FG002|Overall Study|Efficacy Failure|3|||
27936889|NCT01682720|81607185|FG003|Overall Study|Efficacy Failure|30|||
27936890|NCT01682720|81607182|FG000|Overall Study|Lost to Follow-up|1|||
27936891|NCT01682720|81607183|FG001|Overall Study|Lost to Follow-up|1|||
27936892|NCT01682720|81607184|FG002|Overall Study|Lost to Follow-up|0|||
27936893|NCT01682720|81607185|FG003|Overall Study|Lost to Follow-up|6|||
27644504|NCT05580003|80539036|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27936894|NCT01682720|81607182|FG000|Overall Study|Subject Withdrew Consent|0|||
27936895|NCT01682720|81607183|FG001|Overall Study|Subject Withdrew Consent|0|||
27936896|NCT01682720|81607184|FG002|Overall Study|Subject Withdrew Consent|2|||
27936897|NCT01682720|81607185|FG003|Overall Study|Subject Withdrew Consent|2|||
27936898|NCT01682720|81607182|FG000|Overall Study|Adverse Event|1|||
27936899|NCT01682720|81607183|FG001|Overall Study|Adverse Event|0|||
27936900|NCT01682720|81607184|FG002|Overall Study|Adverse Event|1|||
27936901|NCT01682720|81607185|FG003|Overall Study|Adverse Event|1|||
27936902|NCT04189588|81607191|FG000|Overall Study|Death|0|||
27936903|NCT04189588|81607192|FG001|Overall Study|Death|1|||
27936904|NCT04189588|81607191|FG000|Overall Study|Lost to Follow-up|0|||
27936905|NCT04189588|81607192|FG001|Overall Study|Lost to Follow-up|1|||
27936906|NCT03021005|81607197|FG000|Overall Study|Lost to Follow-up|39|||
27936907|NCT03021005|81607198|FG001|Overall Study|Lost to Follow-up|26|||
27936908|NCT03142334|81607199|FG000|Overall Study|Death|18|||
27936909|NCT03142334|81607200|FG001|Overall Study|Death|33|||
27936910|NCT03142334|81607199|FG000|Overall Study|Withdrawal by Subject|15|||
27936911|NCT03142334|81607200|FG001|Overall Study|Withdrawal by Subject|11|||
27936912|NCT03142334|81607199|FG000|Overall Study|Ongoing on trial follow up|463|||
27936913|NCT03142334|81607200|FG001|Overall Study|Ongoing on trial follow up|454|||
27936914|NCT00292370|81607201|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
27936915|NCT00292370|81607202|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
27936916|NCT00292370|81607203|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
27936917|NCT00292370|81607201|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
27936918|NCT00292370|81607202|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
27936919|NCT00292370|81607203|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
27936920|NCT00292370|81607201|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
27936921|NCT00292370|81607202|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
27644505|NCT05580003|80539037|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644506|NCT05580003|80539038|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644507|NCT05580003|80539039|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644508|NCT05580003|80539040|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
27644509|NCT05580003|80539013|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644510|NCT05580003|80539014|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644511|NCT05580003|80539015|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644512|NCT05580003|80539016|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
27644513|NCT05580003|80539017|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644514|NCT05580003|80539018|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644515|NCT05580003|80539019|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644516|NCT05580003|80539020|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644517|NCT05580003|80539021|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644518|NCT05580003|80539022|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644519|NCT05580003|80539023|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644520|NCT05580003|80539024|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27936922|NCT00292370|81607203|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
27936923|NCT00292370|81607201|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
27936924|NCT00292370|81607202|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
27936925|NCT00292370|81607203|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
27936926|NCT00292370|81607201|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
27936927|NCT00292370|81607202|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
27936928|NCT00292370|81607203|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
27936929|NCT00292370|81607201|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
27644521|NCT05580003|80539025|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644522|NCT05580003|80539026|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644523|NCT05580003|80539027|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644524|NCT05580003|80539028|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644525|NCT05580003|80539029|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644526|NCT05580003|80539030|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644527|NCT05580003|80539031|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644528|NCT05580003|80539032|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644529|NCT05580003|80539033|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644530|NCT05580003|80539034|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644531|NCT05580003|80539035|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644532|NCT05580003|80539036|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644533|NCT05580003|80539037|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644534|NCT05580003|80539038|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644535|NCT05580003|80539039|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644536|NCT05580003|80539040|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
27644537|NCT05580003|80539013|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644538|NCT05580003|80539014|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
27644539|NCT05580003|80539015|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644540|NCT05580003|80539016|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644541|NCT05580003|80539017|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644542|NCT05580003|80539018|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644543|NCT05580003|80539019|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644544|NCT05580003|80539020|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644545|NCT05580003|80539021|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644546|NCT05580003|80539022|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644547|NCT05580003|80539023|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644548|NCT05580003|80539024|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27936930|NCT00292370|81607202|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
27936931|NCT00292370|81607203|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
27936932|NCT00225758|81607207|FG000|Overall Study|Adverse Event|4|||
27936933|NCT01927861|81607208|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
27936934|NCT01927861|81607209|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
27936935|NCT01927861|81607208|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
27936936|NCT01927861|81607209|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
27936937|NCT05529173|81607210|FG000|Overall Study|Physician Decision|3|||
27936938|NCT05529173|81607211|FG001|Overall Study|Physician Decision|6|||
27936939|NCT05529173|81607210|FG000|Overall Study|Sample shipment delay more than one day|4|||
27936940|NCT05529173|81607211|FG001|Overall Study|Sample shipment delay more than one day|0|||
27936941|NCT02562235|81607212|FG000|Overall Study|Adverse Event|3|||
27936942|NCT04605588|81607213|FG000|Overall Study|Withdrawal by Subject|1|||
27936943|NCT04605588|81607214|FG001|Overall Study|Withdrawal by Subject|0|||
27936944|NCT00564070|81607217|FG000|Overall Study|Lost to Follow-up|9|||
27936945|NCT00564070|81607218|FG001|Overall Study|Lost to Follow-up|7|||
27936946|NCT00564070|81607217|FG000|Overall Study|Worsening depression, referred to care|3|||
27936947|NCT00564070|81607218|FG001|Overall Study|Worsening depression, referred to care|0|||
27936948|NCT02562040|81607219|FG000|Overall Study|Lost to Follow-up|20|||
27936949|NCT02562040|81607220|FG001|Overall Study|Lost to Follow-up|28|||
27936950|NCT02562040|81607219|FG000|Overall Study|Withdrawal by Subject|8|||
27936951|NCT02562040|81607220|FG001|Overall Study|Withdrawal by Subject|7|||
27936952|NCT02562040|81607219|FG000|Overall Study|Adverse Event|1|||
27936953|NCT02562040|81607220|FG001|Overall Study|Adverse Event|0|||
27936954|NCT01362530|81607221|FG000|Base Study (Cycle 1)|Adverse Event|2|||
27936955|NCT01362530|81607222|FG001|Base Study (Cycle 1)|Adverse Event|0|||
27936956|NCT01362530|81607221|FG000|Base Study (Cycle 1)|Physician Decision|0|||
27936957|NCT01362530|81607222|FG001|Base Study (Cycle 1)|Physician Decision|1|||
27936958|NCT01362530|81607221|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
27936959|NCT01362530|81607222|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
27936960|NCT01362530|81607221|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
27936961|NCT01362530|81607222|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
27936962|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
27936963|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
27936964|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
27936965|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
27644549|NCT05580003|80539025|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644550|NCT05580003|80539026|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27936966|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
27936967|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
27936968|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
27936969|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
27936970|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
27936971|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
27936972|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
27936973|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
27936974|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
27936975|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
27936976|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
27936977|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
27936978|NCT01362530|81607221|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
27936979|NCT01362530|81607222|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
27936980|NCT02883049|81607223|FG000|Induction|Adverse Event|52|||
27936981|NCT02883049|81607224|FG001|Induction|Adverse Event|2|||
27936982|NCT02883049|81607225|FG002|Induction|Adverse Event|0|||
27936983|NCT02883049|81607226|FG003|Induction|Adverse Event|0|||
27936984|NCT02883049|81607227|FG004|Induction|Adverse Event|0|||
27936985|NCT02883049|81607228|FG005|Induction|Adverse Event|0|||
27936986|NCT02883049|81607229|FG006|Induction|Adverse Event|0|||
27936987|NCT02883049|81607230|FG007|Induction|Adverse Event|0|||
27936988|NCT02883049|81607231|FG008|Induction|Adverse Event|0|||
27936989|NCT02883049|81607232|FG009|Induction|Adverse Event|0|||
27936990|NCT02883049|81607233|FG010|Induction|Adverse Event|0|||
27936991|NCT02883049|81607234|FG011|Induction|Adverse Event|0|||
27936992|NCT02883049|81607235|FG012|Induction|Adverse Event|0|||
27936993|NCT02883049|81607236|FG013|Induction|Adverse Event|0|||
27936994|NCT02883049|81607237|FG014|Induction|Adverse Event|0|||
27936995|NCT02883049|81607238|FG015|Induction|Adverse Event|0|||
27936996|NCT02883049|81607223|FG000|Induction|Death|76|||
27936997|NCT02883049|81607224|FG001|Induction|Death|8|||
27936998|NCT02883049|81607225|FG002|Induction|Death|0|||
27936999|NCT02883049|81607226|FG003|Induction|Death|0|||
27937000|NCT02883049|81607227|FG004|Induction|Death|0|||
27937001|NCT02883049|81607228|FG005|Induction|Death|0|||
27937002|NCT02883049|81607229|FG006|Induction|Death|0|||
27937003|NCT02883049|81607230|FG007|Induction|Death|0|||
27937004|NCT02883049|81607231|FG008|Induction|Death|0|||
27937005|NCT02883049|81607232|FG009|Induction|Death|0|||
27937006|NCT02883049|81607233|FG010|Induction|Death|0|||
27937007|NCT02883049|81607234|FG011|Induction|Death|0|||
27937008|NCT02883049|81607235|FG012|Induction|Death|0|||
27937009|NCT02883049|81607236|FG013|Induction|Death|0|||
27937010|NCT02883049|81607237|FG014|Induction|Death|0|||
27937011|NCT02883049|81607238|FG015|Induction|Death|0|||
27937012|NCT02883049|81607223|FG000|Induction|Lost to Follow-up|2|||
27937013|NCT02883049|81607224|FG001|Induction|Lost to Follow-up|0|||
27937014|NCT02883049|81607225|FG002|Induction|Lost to Follow-up|0|||
27937015|NCT02883049|81607226|FG003|Induction|Lost to Follow-up|0|||
27937016|NCT02883049|81607227|FG004|Induction|Lost to Follow-up|0|||
27937017|NCT02883049|81607228|FG005|Induction|Lost to Follow-up|0|||
27937018|NCT02883049|81607229|FG006|Induction|Lost to Follow-up|0|||
27937019|NCT02883049|81607230|FG007|Induction|Lost to Follow-up|0|||
27937020|NCT02883049|81607231|FG008|Induction|Lost to Follow-up|0|||
27937021|NCT02883049|81607232|FG009|Induction|Lost to Follow-up|0|||
27937022|NCT02883049|81607233|FG010|Induction|Lost to Follow-up|0|||
27937023|NCT02883049|81607234|FG011|Induction|Lost to Follow-up|0|||
27937024|NCT02883049|81607235|FG012|Induction|Lost to Follow-up|0|||
27937025|NCT02883049|81607236|FG013|Induction|Lost to Follow-up|0|||
27937026|NCT02883049|81607237|FG014|Induction|Lost to Follow-up|0|||
27937027|NCT02883049|81607238|FG015|Induction|Lost to Follow-up|0|||
27937028|NCT02883049|81607223|FG000|Induction|Physician Decision|1407|||
27937029|NCT02883049|81607224|FG001|Induction|Physician Decision|8|||
27937030|NCT02883049|81607225|FG002|Induction|Physician Decision|0|||
27937031|NCT02883049|81607226|FG003|Induction|Physician Decision|0|||
27937032|NCT02883049|81607227|FG004|Induction|Physician Decision|0|||
27937033|NCT02883049|81607228|FG005|Induction|Physician Decision|0|||
27937034|NCT02883049|81607229|FG006|Induction|Physician Decision|0|||
27937035|NCT02883049|81607230|FG007|Induction|Physician Decision|0|||
27937036|NCT02883049|81607231|FG008|Induction|Physician Decision|0|||
27937037|NCT02883049|81607232|FG009|Induction|Physician Decision|0|||
27937038|NCT02883049|81607233|FG010|Induction|Physician Decision|0|||
27937039|NCT02883049|81607234|FG011|Induction|Physician Decision|0|||
27937040|NCT02883049|81607235|FG012|Induction|Physician Decision|0|||
27937041|NCT02883049|81607236|FG013|Induction|Physician Decision|0|||
27937042|NCT02883049|81607237|FG014|Induction|Physician Decision|0|||
27937043|NCT02883049|81607238|FG015|Induction|Physician Decision|0|||
27937044|NCT02883049|81607223|FG000|Induction|Protocol Violation|6|||
27937045|NCT02883049|81607224|FG001|Induction|Protocol Violation|0|||
27937046|NCT02883049|81607225|FG002|Induction|Protocol Violation|0|||
27937047|NCT02883049|81607226|FG003|Induction|Protocol Violation|0|||
27937048|NCT02883049|81607227|FG004|Induction|Protocol Violation|0|||
27937049|NCT02883049|81607228|FG005|Induction|Protocol Violation|0|||
27937050|NCT02883049|81607229|FG006|Induction|Protocol Violation|0|||
27937051|NCT02883049|81607230|FG007|Induction|Protocol Violation|0|||
27937052|NCT02883049|81607231|FG008|Induction|Protocol Violation|0|||
27937053|NCT02883049|81607232|FG009|Induction|Protocol Violation|0|||
27937054|NCT02883049|81607233|FG010|Induction|Protocol Violation|0|||
27937055|NCT02883049|81607234|FG011|Induction|Protocol Violation|0|||
27937056|NCT02883049|81607235|FG012|Induction|Protocol Violation|0|||
27937057|NCT02883049|81607236|FG013|Induction|Protocol Violation|0|||
27937058|NCT02883049|81607237|FG014|Induction|Protocol Violation|0|||
27937059|NCT02883049|81607238|FG015|Induction|Protocol Violation|0|||
27937060|NCT02883049|81607223|FG000|Induction|Withdrawal by Subject|6|||
27937061|NCT02883049|81607224|FG001|Induction|Withdrawal by Subject|0|||
27937062|NCT02883049|81607225|FG002|Induction|Withdrawal by Subject|0|||
27937063|NCT02883049|81607226|FG003|Induction|Withdrawal by Subject|0|||
27937064|NCT02883049|81607227|FG004|Induction|Withdrawal by Subject|0|||
27937065|NCT02883049|81607228|FG005|Induction|Withdrawal by Subject|0|||
27937066|NCT02883049|81607229|FG006|Induction|Withdrawal by Subject|0|||
27937067|NCT02883049|81607230|FG007|Induction|Withdrawal by Subject|0|||
27937068|NCT02883049|81607231|FG008|Induction|Withdrawal by Subject|0|||
27937069|NCT02883049|81607232|FG009|Induction|Withdrawal by Subject|0|||
27937070|NCT02883049|81607233|FG010|Induction|Withdrawal by Subject|0|||
27937071|NCT02883049|81607234|FG011|Induction|Withdrawal by Subject|0|||
27937072|NCT02883049|81607235|FG012|Induction|Withdrawal by Subject|0|||
27937073|NCT02883049|81607236|FG013|Induction|Withdrawal by Subject|0|||
27937074|NCT02883049|81607237|FG014|Induction|Withdrawal by Subject|0|||
27937075|NCT02883049|81607238|FG015|Induction|Withdrawal by Subject|0|||
27937076|NCT02883049|81607223|FG000|Induction|Ineligible|35|||
27937077|NCT02883049|81607224|FG001|Induction|Ineligible|1|||
27937078|NCT02883049|81607225|FG002|Induction|Ineligible|0|||
27937079|NCT02883049|81607226|FG003|Induction|Ineligible|0|||
27937080|NCT02883049|81607227|FG004|Induction|Ineligible|0|||
27937081|NCT02883049|81607228|FG005|Induction|Ineligible|0|||
27937082|NCT02883049|81607229|FG006|Induction|Ineligible|0|||
27937083|NCT02883049|81607230|FG007|Induction|Ineligible|0|||
27937084|NCT02883049|81607231|FG008|Induction|Ineligible|0|||
27937085|NCT02883049|81607232|FG009|Induction|Ineligible|0|||
27937086|NCT02883049|81607233|FG010|Induction|Ineligible|0|||
27937087|NCT02883049|81607234|FG011|Induction|Ineligible|0|||
27937088|NCT02883049|81607235|FG012|Induction|Ineligible|0|||
27937089|NCT02883049|81607236|FG013|Induction|Ineligible|0|||
27937090|NCT02883049|81607237|FG014|Induction|Ineligible|0|||
27937091|NCT02883049|81607238|FG015|Induction|Ineligible|0|||
27937092|NCT02883049|81607223|FG000|Induction|Refusal of further protocol therapy|466|||
27937093|NCT02883049|81607224|FG001|Induction|Refusal of further protocol therapy|2|||
27937094|NCT02883049|81607225|FG002|Induction|Refusal of further protocol therapy|0|||
27937095|NCT02883049|81607226|FG003|Induction|Refusal of further protocol therapy|0|||
27937096|NCT02883049|81607227|FG004|Induction|Refusal of further protocol therapy|0|||
27937097|NCT02883049|81607228|FG005|Induction|Refusal of further protocol therapy|0|||
27937098|NCT02883049|81607229|FG006|Induction|Refusal of further protocol therapy|0|||
27937099|NCT02883049|81607230|FG007|Induction|Refusal of further protocol therapy|0|||
27937100|NCT02883049|81607231|FG008|Induction|Refusal of further protocol therapy|0|||
27937101|NCT02883049|81607232|FG009|Induction|Refusal of further protocol therapy|0|||
27937102|NCT02883049|81607233|FG010|Induction|Refusal of further protocol therapy|0|||
27937103|NCT02883049|81607234|FG011|Induction|Refusal of further protocol therapy|0|||
27937104|NCT02883049|81607235|FG012|Induction|Refusal of further protocol therapy|0|||
27937105|NCT02883049|81607236|FG013|Induction|Refusal of further protocol therapy|0|||
27937106|NCT02883049|81607237|FG014|Induction|Refusal of further protocol therapy|0|||
27937107|NCT02883049|81607238|FG015|Induction|Refusal of further protocol therapy|0|||
27937108|NCT02883049|81607223|FG000|Induction|Identified as Ph+ patients|279|||
27937109|NCT02883049|81607224|FG001|Induction|Identified as Ph+ patients|1|||
27937110|NCT02883049|81607225|FG002|Induction|Identified as Ph+ patients|0|||
27937111|NCT02883049|81607226|FG003|Induction|Identified as Ph+ patients|0|||
27937112|NCT02883049|81607227|FG004|Induction|Identified as Ph+ patients|0|||
27937113|NCT02883049|81607228|FG005|Induction|Identified as Ph+ patients|0|||
27937114|NCT02883049|81607229|FG006|Induction|Identified as Ph+ patients|0|||
27937115|NCT02883049|81607230|FG007|Induction|Identified as Ph+ patients|0|||
27937116|NCT02883049|81607231|FG008|Induction|Identified as Ph+ patients|0|||
27937117|NCT02883049|81607232|FG009|Induction|Identified as Ph+ patients|0|||
27937118|NCT02883049|81607233|FG010|Induction|Identified as Ph+ patients|0|||
27937119|NCT02883049|81607234|FG011|Induction|Identified as Ph+ patients|0|||
27937120|NCT02883049|81607235|FG012|Induction|Identified as Ph+ patients|0|||
27937121|NCT02883049|81607236|FG013|Induction|Identified as Ph+ patients|0|||
27937122|NCT02883049|81607237|FG014|Induction|Identified as Ph+ patients|0|||
27937123|NCT02883049|81607238|FG015|Induction|Identified as Ph+ patients|0|||
27937124|NCT02883049|81607223|FG000|Induction|M3 Marrow at Day29|8|||
27937125|NCT02883049|81607224|FG001|Induction|M3 Marrow at Day29|1|||
27937126|NCT02883049|81607225|FG002|Induction|M3 Marrow at Day29|0|||
27937127|NCT02883049|81607226|FG003|Induction|M3 Marrow at Day29|0|||
27937128|NCT02883049|81607227|FG004|Induction|M3 Marrow at Day29|0|||
27937129|NCT02883049|81607228|FG005|Induction|M3 Marrow at Day29|0|||
27937130|NCT02883049|81607229|FG006|Induction|M3 Marrow at Day29|0|||
27937131|NCT02883049|81607230|FG007|Induction|M3 Marrow at Day29|0|||
27937132|NCT02883049|81607231|FG008|Induction|M3 Marrow at Day29|0|||
27937133|NCT02883049|81607232|FG009|Induction|M3 Marrow at Day29|0|||
27937134|NCT02883049|81607233|FG010|Induction|M3 Marrow at Day29|0|||
27937135|NCT02883049|81607234|FG011|Induction|M3 Marrow at Day29|0|||
27937136|NCT02883049|81607235|FG012|Induction|M3 Marrow at Day29|0|||
27937137|NCT02883049|81607236|FG013|Induction|M3 Marrow at Day29|0|||
27937138|NCT02883049|81607237|FG014|Induction|M3 Marrow at Day29|0|||
27644551|NCT05580003|80539027|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644552|NCT05580003|80539028|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644553|NCT05580003|80539029|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644554|NCT05580003|80539030|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27744995|NCT02090114|80896449|FG002|Overall Study|Withdrawal by Subject|2|||
27744996|NCT02090114|80896450|FG003|Overall Study|Withdrawal by Subject|1|||
27744997|NCT02090114|80896447|FG000|Overall Study|Physician Decision|5|||
27744998|NCT02090114|80896448|FG001|Overall Study|Physician Decision|0|||
27744999|NCT02090114|80896449|FG002|Overall Study|Physician Decision|1|||
27745000|NCT02090114|80896450|FG003|Overall Study|Physician Decision|1|||
27745001|NCT02090114|80896447|FG000|Overall Study|Adverse Event|1|||
27745002|NCT02090114|80896448|FG001|Overall Study|Adverse Event|2|||
27745003|NCT02090114|80896449|FG002|Overall Study|Adverse Event|2|||
27745004|NCT02090114|80896450|FG003|Overall Study|Adverse Event|0|||
27745005|NCT02090114|80896447|FG000|Overall Study|Progressive Disease|20|||
27745006|NCT02090114|80896448|FG001|Overall Study|Progressive Disease|21|||
27745007|NCT02090114|80896449|FG002|Overall Study|Progressive Disease|23|||
27745008|NCT02090114|80896450|FG003|Overall Study|Progressive Disease|6|||
27745009|NCT02090114|80896447|FG000|Overall Study|Death|1|||
27745010|NCT02090114|80896448|FG001|Overall Study|Death|0|||
27745011|NCT02090114|80896449|FG002|Overall Study|Death|1|||
27745012|NCT02090114|80896450|FG003|Overall Study|Death|0|||
27745013|NCT02335450|80896451|FG000|Overall Study|Pregnancy|1|||
27745014|NCT01165203|80896452|FG000|Active Phase|Serious Adverse Event|1|||
27745015|NCT01165203|80896453|FG001|Active Phase|Serious Adverse Event|0|||
27745016|NCT01165203|80896452|FG000|Active Phase|Withdrawal by Subject|2|||
27644555|NCT05580003|80539031|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644556|NCT05580003|80539032|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644557|NCT05580003|80539033|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644558|NCT05580003|80539034|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644559|NCT05580003|80539035|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644560|NCT05580003|80539036|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644561|NCT05580003|80539037|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644562|NCT05580003|80539038|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644563|NCT05580003|80539039|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644564|NCT05580003|80539040|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
27644565|NCT05580003|80539013|FG000|Part 2 (up to 10 Days)|Other|0|||
27644566|NCT05580003|80539014|FG001|Part 2 (up to 10 Days)|Other|0|||
27644567|NCT05580003|80539015|FG002|Part 2 (up to 10 Days)|Other|0|||
27644568|NCT05580003|80539016|FG003|Part 2 (up to 10 Days)|Other|0|||
27644569|NCT05580003|80539017|FG004|Part 2 (up to 10 Days)|Other|0|||
27644570|NCT05580003|80539018|FG005|Part 2 (up to 10 Days)|Other|0|||
27644571|NCT05580003|80539019|FG006|Part 2 (up to 10 Days)|Other|0|||
27644572|NCT05580003|80539020|FG007|Part 2 (up to 10 Days)|Other|0|||
27644573|NCT05580003|80539021|FG008|Part 2 (up to 10 Days)|Other|0|||
27644574|NCT05580003|80539022|FG009|Part 2 (up to 10 Days)|Other|1|||
27644575|NCT05580003|80539023|FG010|Part 2 (up to 10 Days)|Other|0|||
27644576|NCT05580003|80539024|FG011|Part 2 (up to 10 Days)|Other|0|||
27644577|NCT05580003|80539025|FG012|Part 2 (up to 10 Days)|Other|0|||
27644578|NCT05580003|80539026|FG013|Part 2 (up to 10 Days)|Other|0|||
27644579|NCT05580003|80539027|FG014|Part 2 (up to 10 Days)|Other|0|||
27644580|NCT05580003|80539028|FG015|Part 2 (up to 10 Days)|Other|0|||
27644581|NCT05580003|80539029|FG016|Part 2 (up to 10 Days)|Other|0|||
27644582|NCT05580003|80539030|FG017|Part 2 (up to 10 Days)|Other|0|||
27644583|NCT05580003|80539031|FG018|Part 2 (up to 10 Days)|Other|0|||
27644584|NCT05580003|80539032|FG019|Part 2 (up to 10 Days)|Other|0|||
27644585|NCT05580003|80539033|FG020|Part 2 (up to 10 Days)|Other|0|||
27644586|NCT05580003|80539034|FG021|Part 2 (up to 10 Days)|Other|0|||
27644587|NCT05580003|80539035|FG022|Part 2 (up to 10 Days)|Other|0|||
27644588|NCT05580003|80539036|FG023|Part 2 (up to 10 Days)|Other|0|||
27644589|NCT05580003|80539037|FG024|Part 2 (up to 10 Days)|Other|0|||
27745017|NCT01165203|80896453|FG001|Active Phase|Withdrawal by Subject|1|||
27745018|NCT01165203|80896452|FG000|Active Phase|Migrated/moved from study area|0|||
27745019|NCT01165203|80896453|FG001|Active Phase|Migrated/moved from study area|1|||
27745020|NCT01165203|80896452|FG000|Active Phase|Lost to Follow-up|2|||
27745021|NCT01165203|80896453|FG001|Active Phase|Lost to Follow-up|0|||
27745022|NCT01165203|80896452|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
27937139|NCT02883049|81607238|FG015|Induction|M3 Marrow at Day29|0|||
27937140|NCT02883049|81607223|FG000|Induction|Inevaluable|33|||
27937141|NCT02883049|81607224|FG001|Induction|Inevaluable|1|||
27937142|NCT02883049|81607225|FG002|Induction|Inevaluable|0|||
27937143|NCT02883049|81607226|FG003|Induction|Inevaluable|0|||
27745023|NCT01165203|80896453|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
27745024|NCT01165203|80896452|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
27745025|NCT01165203|80896453|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
27745026|NCT01165203|80896452|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
27745027|NCT01165203|80896453|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
27745028|NCT01165203|80896452|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
27745029|NCT01165203|80896453|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
27745030|NCT01165203|80896452|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
27745031|NCT01165203|80896453|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
27745032|NCT01988012|80896456|FG000|Overall Study|Adverse Event|5|||
27745033|NCT01988012|80896456|FG000|Overall Study|Insufficient Therapeutic Response|3|||
27745034|NCT01988012|80896456|FG000|Overall Study|Patient Withdrawal of Consent|4|||
27745035|NCT01988012|80896456|FG000|Overall Study|Lost to Follow-up|1|||
27745036|NCT01988012|80896456|FG000|Overall Study|Physician Decision|1|||
27745037|NCT01988012|80896456|FG000|Overall Study|Protocol Violation|1|||
27745038|NCT01769404|80896457|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
27745039|NCT01769404|80896458|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
27745040|NCT01769404|80896457|FG000|Treatment Period 1|Withdrawal by Subject|3|||
27745041|NCT01769404|80896458|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27745042|NCT01769404|80896457|FG000|Treatment Period 1|Sponsor decision|1|||
27745043|NCT01769404|80896458|FG001|Treatment Period 1|Sponsor decision|0|||
27745044|NCT01769404|80896457|FG000|Treatment Period 2|Sponsor decision|7|||
27745045|NCT01769404|80896458|FG001|Treatment Period 2|Sponsor decision|0|||
27745046|NCT02284906|80896465|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
27644590|NCT05580003|80539038|FG025|Part 2 (up to 10 Days)|Other|0|||
27644591|NCT05580003|80539039|FG026|Part 2 (up to 10 Days)|Other|0|||
27644592|NCT05580003|80539040|FG027|Part 2 (up to 10 Days)|Other|0|||
27644593|NCT05580003|80539013|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644594|NCT05580003|80539014|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644595|NCT05580003|80539015|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644596|NCT05580003|80539016|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644597|NCT05580003|80539017|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644598|NCT05580003|80539018|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644599|NCT05580003|80539019|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644600|NCT05580003|80539020|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644601|NCT05580003|80539021|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644602|NCT05580003|80539022|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644603|NCT05580003|80539023|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644604|NCT05580003|80539024|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644605|NCT05580003|80539025|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644606|NCT05580003|80539026|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644607|NCT05580003|80539027|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644608|NCT05580003|80539028|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644609|NCT05580003|80539029|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644610|NCT05580003|80539030|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644611|NCT05580003|80539031|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644612|NCT05580003|80539032|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
27644613|NCT05580003|80539033|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644614|NCT05580003|80539034|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644615|NCT05580003|80539035|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644616|NCT05580003|80539036|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644617|NCT05580003|80539037|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644618|NCT05580003|80539038|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644619|NCT05580003|80539039|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644620|NCT05580003|80539040|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
27644621|NCT05580003|80539013|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644622|NCT05580003|80539014|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644623|NCT05580003|80539015|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644624|NCT05580003|80539016|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644625|NCT05580003|80539017|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644626|NCT05580003|80539018|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644627|NCT05580003|80539019|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644628|NCT05580003|80539020|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644629|NCT05580003|80539021|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644630|NCT05580003|80539022|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644631|NCT05580003|80539023|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27745047|NCT02284906|80896466|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
27551026|NCT05466682|80203563|FG000|Overall Study|Withdrawal by Subject|0|||
27644632|NCT05580003|80539024|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644633|NCT05580003|80539025|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27745048|NCT02284906|80896467|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
27745049|NCT02284906|80896465|FG000|Overall Study|Major Protocol Deviation|0|||
27745050|NCT02284906|80896466|FG001|Overall Study|Major Protocol Deviation|1|||
27745051|NCT02284906|80896467|FG002|Overall Study|Major Protocol Deviation|0|||
27745052|NCT02284906|80896465|FG000|Overall Study|Voluntary Withdrawal|2|||
27745053|NCT02284906|80896466|FG001|Overall Study|Voluntary Withdrawal|4|||
27745054|NCT02284906|80896467|FG002|Overall Study|Voluntary Withdrawal|5|||
27745055|NCT02284906|80896465|FG000|Overall Study|Study Termination|0|||
27745056|NCT02284906|80896466|FG001|Overall Study|Study Termination|11|||
27745057|NCT02284906|80896467|FG002|Overall Study|Study Termination|14|||
27745058|NCT02284906|80896465|FG000|Overall Study|Reason not Specified|1|||
27745059|NCT02284906|80896466|FG001|Overall Study|Reason not Specified|1|||
27745060|NCT02284906|80896467|FG002|Overall Study|Reason not Specified|0|||
27745061|NCT00401973|80896475|FG000|Overall Study|Adverse Event|2|||
27745062|NCT00401973|80896476|FG001|Overall Study|Adverse Event|8|||
27745063|NCT00401973|80896477|FG002|Overall Study|Adverse Event|4|||
27745064|NCT00401973|80896475|FG000|Overall Study|Clinical Relapse|0|||
27745065|NCT00401973|80896476|FG001|Overall Study|Clinical Relapse|1|||
27745066|NCT00401973|80896477|FG002|Overall Study|Clinical Relapse|1|||
27745067|NCT00401973|80896475|FG000|Overall Study|Lack of Efficacy|0|||
27745068|NCT00401973|80896476|FG001|Overall Study|Lack of Efficacy|0|||
27745069|NCT00401973|80896477|FG002|Overall Study|Lack of Efficacy|3|||
27745070|NCT00401973|80896475|FG000|Overall Study|Lost to Follow-up|2|||
27745071|NCT00401973|80896476|FG001|Overall Study|Lost to Follow-up|2|||
27745072|NCT00401973|80896477|FG002|Overall Study|Lost to Follow-up|2|||
27745073|NCT00401973|80896475|FG000|Overall Study|Physician Decision|2|||
27745074|NCT00401973|80896476|FG001|Overall Study|Physician Decision|0|||
27745075|NCT00401973|80896477|FG002|Overall Study|Physician Decision|1|||
27745076|NCT00401973|80896475|FG000|Overall Study|Protocol Violation|1|||
27745077|NCT00401973|80896476|FG001|Overall Study|Protocol Violation|2|||
27745078|NCT00401973|80896477|FG002|Overall Study|Protocol Violation|3|||
27644634|NCT05580003|80539026|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644635|NCT05580003|80539027|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644636|NCT05580003|80539028|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644637|NCT05580003|80539029|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644638|NCT05580003|80539030|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644639|NCT05580003|80539031|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644640|NCT05580003|80539032|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644641|NCT05580003|80539033|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
27644642|NCT05580003|80539034|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644643|NCT05580003|80539035|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644644|NCT05580003|80539036|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644645|NCT05580003|80539037|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644646|NCT05580003|80539038|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644647|NCT05580003|80539039|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644648|NCT05580003|80539040|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
27644649|NCT05580003|80539013|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644650|NCT05580003|80539014|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644651|NCT05580003|80539015|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644652|NCT05580003|80539016|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644653|NCT05580003|80539017|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644654|NCT05580003|80539018|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644655|NCT05580003|80539019|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644656|NCT05580003|80539020|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644657|NCT05580003|80539021|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644658|NCT05580003|80539022|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644659|NCT05580003|80539023|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644660|NCT05580003|80539024|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644661|NCT05580003|80539025|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644662|NCT05580003|80539026|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644663|NCT05580003|80539027|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644664|NCT05580003|80539028|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644665|NCT05580003|80539029|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644666|NCT05580003|80539030|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644667|NCT05580003|80539031|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644668|NCT05580003|80539032|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27745079|NCT00401973|80896475|FG000|Overall Study|Sponsor Decision|0|||
27745080|NCT00401973|80896476|FG001|Overall Study|Sponsor Decision|1|||
27745081|NCT00401973|80896477|FG002|Overall Study|Sponsor Decision|0|||
27745082|NCT00401973|80896475|FG000|Overall Study|Withdrawal by Subject|4|||
27745083|NCT00401973|80896476|FG001|Overall Study|Withdrawal by Subject|12|||
27745084|NCT00401973|80896477|FG002|Overall Study|Withdrawal by Subject|9|||
27745085|NCT02296840|80896478|FG000|Overall Study|Adverse Event|1|||
27745086|NCT02296840|80896479|FG001|Overall Study|Adverse Event|1|||
27745087|NCT02296840|80896478|FG000|Overall Study|Protocol Violation|2|||
27745088|NCT02296840|80896479|FG001|Overall Study|Protocol Violation|1|||
27745089|NCT02296840|80896478|FG000|Overall Study|Lost to Follow-up|6|||
27745090|NCT02296840|80896479|FG001|Overall Study|Lost to Follow-up|17|||
27745091|NCT02401256|80896492|FG000|Overall Study|Adverse Event|5|||
27745092|NCT02401256|80896492|FG000|Overall Study|Withdrawal by Subject|12|||
27745093|NCT00783705|80896498|FG000|Overall Study|Adverse Event|2|||
27745094|NCT00783705|80896499|FG001|Overall Study|Adverse Event|0|||
27745095|NCT00783705|80896498|FG000|Overall Study|Withdrawal by Subject|3|||
27745096|NCT00783705|80896499|FG001|Overall Study|Withdrawal by Subject|2|||
27745097|NCT00783705|80896498|FG000|Overall Study|Lost to Follow-up|1|||
27745098|NCT00783705|80896499|FG001|Overall Study|Lost to Follow-up|3|||
27745099|NCT00151411|80896504|FG000|Overall Study|Lost to Follow-up|15|||
27745100|NCT00151411|80896505|FG001|Overall Study|Lost to Follow-up|19|||
27745101|NCT00151411|80896504|FG000|Overall Study|Withdrawal by Subject|12|||
27745102|NCT00151411|80896505|FG001|Overall Study|Withdrawal by Subject|20|||
27745103|NCT00151411|80896504|FG000|Overall Study|Adverse Event|6|||
27745104|NCT00151411|80896505|FG001|Overall Study|Adverse Event|0|||
27745105|NCT00151411|80896504|FG000|Overall Study|Pregnancy|0|||
27745106|NCT00151411|80896505|FG001|Overall Study|Pregnancy|4|||
27745107|NCT04705597|80896506|FG000|Overall Study|Death|16|||
27745108|NCT04705597|80896507|FG001|Overall Study|Death|9|||
27745109|NCT04705597|80896506|FG000|Overall Study|Lost to Follow-up|1|||
27745110|NCT04705597|80896507|FG001|Overall Study|Lost to Follow-up|0|||
27745111|NCT04705597|80896506|FG000|Overall Study|Withdrawal by Subject|1|||
27745112|NCT04705597|80896507|FG001|Overall Study|Withdrawal by Subject|2|||
27745113|NCT01582282|80896508|FG000|Overall Study|Adverse Event|1|||
27745114|NCT01582282|80896509|FG001|Overall Study|Adverse Event|1|||
27745115|NCT01582282|80896510|FG002|Overall Study|Adverse Event|0|||
27745116|NCT01582282|80896508|FG000|Overall Study|Lost to Follow-up|1|||
27745117|NCT01582282|80896509|FG001|Overall Study|Lost to Follow-up|0|||
27745118|NCT01582282|80896510|FG002|Overall Study|Lost to Follow-up|0|||
27745119|NCT01582282|80896508|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
27745120|NCT01582282|80896509|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
27745121|NCT01582282|80896510|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
27937144|NCT02883049|81607227|FG004|Induction|Inevaluable|0|||
27937145|NCT02883049|81607228|FG005|Induction|Inevaluable|0|||
27937146|NCT02883049|81607229|FG006|Induction|Inevaluable|0|||
27937147|NCT02883049|81607230|FG007|Induction|Inevaluable|0|||
27937148|NCT02883049|81607231|FG008|Induction|Inevaluable|0|||
27644669|NCT05580003|80539033|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644670|NCT05580003|80539034|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
27644671|NCT05580003|80539035|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644672|NCT05580003|80539036|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644673|NCT05580003|80539037|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644674|NCT05580003|80539038|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644675|NCT05580003|80539039|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644676|NCT05580003|80539040|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
27644677|NCT05580003|80539013|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644678|NCT05580003|80539014|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644679|NCT05580003|80539015|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644680|NCT05580003|80539016|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644681|NCT05580003|80539017|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644682|NCT05580003|80539018|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644683|NCT05580003|80539019|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644684|NCT05580003|80539020|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644685|NCT05580003|80539021|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644686|NCT05580003|80539022|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644687|NCT05580003|80539023|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644688|NCT05580003|80539024|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644689|NCT05580003|80539025|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644690|NCT05580003|80539026|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644691|NCT05580003|80539027|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27745122|NCT02948777|80896511|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
27745123|NCT03135028|80896512|FG000|Overall Study|Death|6|||
27745124|NCT03135028|80896512|FG000|Overall Study|Study Terminated by Sponsor|2|||
27745125|NCT03135028|80896512|FG000|Overall Study|Withdrew Consent|1|||
27745126|NCT04220866|80896513|FG000|Overall Study|Death|4|||
27745127|NCT04220866|80896514|FG001|Overall Study|Death|5|||
27745128|NCT04220866|80896513|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
27745129|NCT04220866|80896514|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
27745130|NCT04220866|80896513|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
27745131|NCT04220866|80896514|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
27937149|NCT02883049|81607232|FG009|Induction|Inevaluable|0|||
27937150|NCT02883049|81607233|FG010|Induction|Inevaluable|0|||
27937151|NCT02883049|81607234|FG011|Induction|Inevaluable|0|||
27644692|NCT05580003|80539028|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644693|NCT05580003|80539029|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644694|NCT05580003|80539030|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644695|NCT05580003|80539031|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644696|NCT05580003|80539032|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644697|NCT05580003|80539033|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644698|NCT05580003|80539034|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644699|NCT05580003|80539035|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644700|NCT05580003|80539036|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644701|NCT05580003|80539037|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644702|NCT05580003|80539038|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644703|NCT05580003|80539039|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
27644704|NCT05580003|80539040|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
27644705|NCT05580003|80539013|FG000|Part 6 Period 2 (Day 1)|Other|0|||
27745132|NCT04220866|80896513|FG000|Overall Study|Withdrawal by Subject|0|||
27745133|NCT04220866|80896514|FG001|Overall Study|Withdrawal by Subject|1|||
27745134|NCT03303339|80896521|FG000|Overall Study|Death|2|||
27745135|NCT03303339|80896522|FG001|Overall Study|Death|2|||
27745136|NCT03303339|80896523|FG002|Overall Study|Death|2|||
27745137|NCT03303339|80896524|FG003|Overall Study|Death|1|||
27745138|NCT03303339|80896525|FG004|Overall Study|Death|4|||
27745139|NCT03303339|80896526|FG005|Overall Study|Death|2|||
27745140|NCT03303339|80896527|FG006|Overall Study|Death|2|||
27745141|NCT03303339|80896528|FG007|Overall Study|Death|2|||
27745142|NCT03303339|80896529|FG008|Overall Study|Death|3|||
27745143|NCT03303339|80896530|FG009|Overall Study|Death|3|||
27745144|NCT03303339|80896531|FG010|Overall Study|Death|4|||
27745145|NCT03303339|80896532|FG011|Overall Study|Death|24|||
27745146|NCT03303339|80896521|FG000|Overall Study|Study Terminated by Sponsor|0|||
27745147|NCT03303339|80896522|FG001|Overall Study|Study Terminated by Sponsor|0|||
27745148|NCT03303339|80896523|FG002|Overall Study|Study Terminated by Sponsor|0|||
27745149|NCT03303339|80896524|FG003|Overall Study|Study Terminated by Sponsor|0|||
27745150|NCT03303339|80896525|FG004|Overall Study|Study Terminated by Sponsor|0|||
27745151|NCT03303339|80896526|FG005|Overall Study|Study Terminated by Sponsor|0|||
27745152|NCT03303339|80896527|FG006|Overall Study|Study Terminated by Sponsor|0|||
27745153|NCT03303339|80896528|FG007|Overall Study|Study Terminated by Sponsor|0|||
27745154|NCT03303339|80896529|FG008|Overall Study|Study Terminated by Sponsor|1|||
27745155|NCT03303339|80896530|FG009|Overall Study|Study Terminated by Sponsor|0|||
27745156|NCT03303339|80896531|FG010|Overall Study|Study Terminated by Sponsor|1|||
27745157|NCT03303339|80896532|FG011|Overall Study|Study Terminated by Sponsor|1|||
27745158|NCT03303339|80896521|FG000|Overall Study|Withdrawal by Subject|1|||
27745159|NCT03303339|80896522|FG001|Overall Study|Withdrawal by Subject|0|||
27745160|NCT03303339|80896523|FG002|Overall Study|Withdrawal by Subject|0|||
27745161|NCT03303339|80896524|FG003|Overall Study|Withdrawal by Subject|0|||
27745162|NCT03303339|80896525|FG004|Overall Study|Withdrawal by Subject|0|||
27745163|NCT03303339|80896526|FG005|Overall Study|Withdrawal by Subject|1|||
27745164|NCT03303339|80896527|FG006|Overall Study|Withdrawal by Subject|1|||
27644706|NCT05580003|80539014|FG001|Part 6 Period 2 (Day 1)|Other|0|||
27644707|NCT05580003|80539015|FG002|Part 6 Period 2 (Day 1)|Other|0|||
27644708|NCT05580003|80539016|FG003|Part 6 Period 2 (Day 1)|Other|0|||
27644709|NCT05580003|80539017|FG004|Part 6 Period 2 (Day 1)|Other|0|||
27644710|NCT05580003|80539018|FG005|Part 6 Period 2 (Day 1)|Other|0|||
27644711|NCT05580003|80539019|FG006|Part 6 Period 2 (Day 1)|Other|0|||
27644712|NCT05580003|80539020|FG007|Part 6 Period 2 (Day 1)|Other|0|||
27644713|NCT05580003|80539021|FG008|Part 6 Period 2 (Day 1)|Other|0|||
27644714|NCT05580003|80539022|FG009|Part 6 Period 2 (Day 1)|Other|0|||
27644715|NCT05580003|80539023|FG010|Part 6 Period 2 (Day 1)|Other|0|||
27644716|NCT05580003|80539024|FG011|Part 6 Period 2 (Day 1)|Other|0|||
27644717|NCT05580003|80539025|FG012|Part 6 Period 2 (Day 1)|Other|0|||
27644718|NCT05580003|80539026|FG013|Part 6 Period 2 (Day 1)|Other|0|||
27644719|NCT05580003|80539027|FG014|Part 6 Period 2 (Day 1)|Other|0|||
27644720|NCT05580003|80539028|FG015|Part 6 Period 2 (Day 1)|Other|0|||
27644721|NCT05580003|80539029|FG016|Part 6 Period 2 (Day 1)|Other|0|||
27644722|NCT05580003|80539030|FG017|Part 6 Period 2 (Day 1)|Other|0|||
27745165|NCT03303339|80896528|FG007|Overall Study|Withdrawal by Subject|0|||
27745166|NCT03303339|80896529|FG008|Overall Study|Withdrawal by Subject|0|||
27745167|NCT03303339|80896530|FG009|Overall Study|Withdrawal by Subject|0|||
27745168|NCT03303339|80896531|FG010|Overall Study|Withdrawal by Subject|0|||
27745169|NCT03303339|80896532|FG011|Overall Study|Withdrawal by Subject|2|||
27745170|NCT03303339|80896521|FG000|Overall Study|Physician Decision|0|||
27745171|NCT03303339|80896522|FG001|Overall Study|Physician Decision|0|||
27644723|NCT05580003|80539031|FG018|Part 6 Period 2 (Day 1)|Other|0|||
27644724|NCT05580003|80539032|FG019|Part 6 Period 2 (Day 1)|Other|0|||
27644725|NCT05580003|80539033|FG020|Part 6 Period 2 (Day 1)|Other|0|||
27644726|NCT05580003|80539034|FG021|Part 6 Period 2 (Day 1)|Other|0|||
27644727|NCT05580003|80539035|FG022|Part 6 Period 2 (Day 1)|Other|0|||
27644728|NCT05580003|80539036|FG023|Part 6 Period 2 (Day 1)|Other|0|||
27745172|NCT03303339|80896523|FG002|Overall Study|Physician Decision|0|||
27745173|NCT03303339|80896524|FG003|Overall Study|Physician Decision|0|||
27644729|NCT05580003|80539037|FG024|Part 6 Period 2 (Day 1)|Other|1|||
27644730|NCT05580003|80539038|FG025|Part 6 Period 2 (Day 1)|Other|0|||
27644731|NCT05580003|80539039|FG026|Part 6 Period 2 (Day 1)|Other|0|||
27745174|NCT03303339|80896525|FG004|Overall Study|Physician Decision|1|||
27745175|NCT03303339|80896526|FG005|Overall Study|Physician Decision|0|||
27745176|NCT03303339|80896527|FG006|Overall Study|Physician Decision|0|||
27745177|NCT03303339|80896528|FG007|Overall Study|Physician Decision|0|||
27745178|NCT03303339|80896529|FG008|Overall Study|Physician Decision|0|||
27745179|NCT03303339|80896530|FG009|Overall Study|Physician Decision|0|||
27745180|NCT03303339|80896531|FG010|Overall Study|Physician Decision|0|||
27745181|NCT03303339|80896532|FG011|Overall Study|Physician Decision|0|||
27937152|NCT02883049|81607235|FG012|Induction|Inevaluable|0|||
27937153|NCT02883049|81607236|FG013|Induction|Inevaluable|0|||
27937154|NCT02883049|81607237|FG014|Induction|Inevaluable|0|||
27937155|NCT02883049|81607238|FG015|Induction|Inevaluable|0|||
27937156|NCT02883049|81607223|FG000|Induction|Identified as VHR at end of Induction|244|||
27937157|NCT02883049|81607224|FG001|Induction|Identified as VHR at end of Induction|0|||
27937158|NCT02883049|81607225|FG002|Induction|Identified as VHR at end of Induction|0|||
27937159|NCT02883049|81607226|FG003|Induction|Identified as VHR at end of Induction|0|||
27937160|NCT02883049|81607227|FG004|Induction|Identified as VHR at end of Induction|0|||
27937161|NCT02883049|81607228|FG005|Induction|Identified as VHR at end of Induction|0|||
27937162|NCT02883049|81607229|FG006|Induction|Identified as VHR at end of Induction|0|||
27551027|NCT05466682|80203564|FG001|Overall Study|Withdrawal by Subject|2|||
27551028|NCT05466682|80203563|FG000|Overall Study|Lost to Follow-up|2|||
27551029|NCT05466682|80203564|FG001|Overall Study|Lost to Follow-up|1|||
27745182|NCT03303339|80896521|FG000|Overall Study|Safety/Non-compliance|0|||
27745183|NCT03303339|80896522|FG001|Overall Study|Safety/Non-compliance|0|||
27937163|NCT02883049|81607230|FG007|Induction|Identified as VHR at end of Induction|0|||
27937164|NCT02883049|81607231|FG008|Induction|Identified as VHR at end of Induction|0|||
27551030|NCT02760069|80203565|FG000|Overall Study|Withdrawal by Subject|0|||
27551031|NCT02760069|80203566|FG001|Overall Study|Withdrawal by Subject|1|||
27551032|NCT02760069|80203567|FG002|Overall Study|Withdrawal by Subject|1|||
27551033|NCT02627144|80203568|FG000|Overall Study|Serious adverse event|32|||
27551034|NCT02627144|80203568|FG000|Overall Study|Cancer progression|171|||
27551035|NCT02627144|80203568|FG000|Overall Study|Death from cancer|20|||
27551036|NCT02627144|80203568|FG000|Overall Study|Death from other cause|8|||
27551037|NCT02627144|80203568|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
27551038|NCT02627144|80203568|FG000|Overall Study|Administrative reasons|65|||
27551039|NCT02627144|80203568|FG000|Overall Study|Lost to Follow-up|8|||
27551040|NCT02627144|80203568|FG000|Overall Study|Enrolled, not treated|6|||
27551041|NCT02627144|80203568|FG000|Overall Study|Other|17|||
27551042|NCT00850564|80203569|FG000|Overall Study|Withdrawal by Subject|2|||
27551043|NCT01918085|80203570|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
27551044|NCT01918085|80203571|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
27551045|NCT01465997|80203572|FG000|Overall Study|Adverse Event|12|||
27551046|NCT01465997|80203573|FG001|Overall Study|Adverse Event|22|||
27551047|NCT01465997|80203572|FG000|Overall Study|Lack of Efficacy|13|||
27551048|NCT01465997|80203573|FG001|Overall Study|Lack of Efficacy|1|||
27551049|NCT01465997|80203572|FG000|Overall Study|Protocol Violation|1|||
27551050|NCT01465997|80203573|FG001|Overall Study|Protocol Violation|4|||
27551051|NCT01465997|80203572|FG000|Overall Study|Lost to Follow-up|6|||
27551052|NCT01465997|80203573|FG001|Overall Study|Lost to Follow-up|9|||
27551053|NCT01465997|80203572|FG000|Overall Study|Withdrawal by Subject|32|||
27551054|NCT01465997|80203573|FG001|Overall Study|Withdrawal by Subject|35|||
27551055|NCT01465997|80203572|FG000|Overall Study|investigator's decision|1|||
27551056|NCT01465997|80203573|FG001|Overall Study|investigator's decision|1|||
27551057|NCT01465997|80203572|FG000|Overall Study|Death|0|||
27551058|NCT01465997|80203573|FG001|Overall Study|Death|1|||
27644732|NCT05580003|80539040|FG027|Part 6 Period 2 (Day 1)|Other|0|||
27745184|NCT03303339|80896523|FG002|Overall Study|Safety/Non-compliance|0|||
27551059|NCT01465997|80203572|FG000|Overall Study|sponsor's decision|1|||
27551060|NCT01465997|80203573|FG001|Overall Study|sponsor's decision|1|||
27551061|NCT01465997|80203572|FG000|Overall Study|subject withdrew consent|1|||
27551062|NCT01465997|80203573|FG001|Overall Study|subject withdrew consent|0|||
27551063|NCT01465997|80203572|FG000|Overall Study|local lab unblinded site|1|||
27551064|NCT01465997|80203573|FG001|Overall Study|local lab unblinded site|0|||
27551065|NCT01465997|80203572|FG000|Overall Study|withdrew before follow-up|0|||
27551066|NCT01465997|80203573|FG001|Overall Study|withdrew before follow-up|13|||
27551067|NCT01465997|80203572|FG000|Overall Study|decision by site staff|0|||
27551068|NCT01465997|80203573|FG001|Overall Study|decision by site staff|1|||
27551069|NCT01465997|80203572|FG000|Overall Study|subject left participation SP0993|0|||
27551070|NCT01465997|80203573|FG001|Overall Study|subject left participation SP0993|1|||
27551071|NCT02532972|80203575|FG000|Overall Study|Withdrawal by Subject|1|||
27551072|NCT01833520|80203577|FG000|Overall Study|Lack of Efficacy|3|||
27644733|NCT03509909|80539041|FG000|Overall Study|Withdrawal by Subject|16|||
27937165|NCT02883049|81607232|FG009|Induction|Identified as VHR at end of Induction|0|||
27937166|NCT02883049|81607233|FG010|Induction|Identified as VHR at end of Induction|0|||
27644734|NCT03509909|80539042|FG001|Overall Study|Withdrawal by Subject|9|||
27644735|NCT03509909|80539041|FG000|Overall Study|Lost to Follow-up|3|||
27644736|NCT03509909|80539042|FG001|Overall Study|Lost to Follow-up|4|||
27644737|NCT03509909|80539041|FG000|Overall Study|Adverse Event|2|||
27644738|NCT03509909|80539042|FG001|Overall Study|Adverse Event|0|||
27644739|NCT00580866|80539048|FG000|Overall Study|Lost to Follow-up|2|||
27644740|NCT00580866|80539049|FG001|Overall Study|Lost to Follow-up|2|||
27644741|NCT05171777|80539050|FG000|Treatment Crossover Period|Adverse Event|9|||
27644742|NCT05171777|80539051|FG001|Treatment Crossover Period|Adverse Event|6|||
27644743|NCT05171777|80539052|FG002|Treatment Crossover Period|Adverse Event|0|||
27644744|NCT05171777|80539053|FG003|Treatment Crossover Period|Adverse Event|0|||
27644745|NCT05171777|80539050|FG000|Treatment Crossover Period|Death|5|||
27644746|NCT05171777|80539051|FG001|Treatment Crossover Period|Death|5|||
27644747|NCT05171777|80539052|FG002|Treatment Crossover Period|Death|0|||
27644748|NCT05171777|80539053|FG003|Treatment Crossover Period|Death|0|||
27644749|NCT05171777|80539050|FG000|Treatment Crossover Period|Disease Relapse|0|||
27937167|NCT02883049|81607234|FG011|Induction|Identified as VHR at end of Induction|0|||
27937168|NCT02883049|81607235|FG012|Induction|Identified as VHR at end of Induction|0|||
27937169|NCT02883049|81607236|FG013|Induction|Identified as VHR at end of Induction|0|||
27937170|NCT02883049|81607237|FG014|Induction|Identified as VHR at end of Induction|0|||
27937171|NCT02883049|81607238|FG015|Induction|Identified as VHR at end of Induction|0|||
27937172|NCT02883049|81607223|FG000|Induction|Moved to another non-COG institution|3|||
27937173|NCT02883049|81607224|FG001|Induction|Moved to another non-COG institution|0|||
27937174|NCT02883049|81607225|FG002|Induction|Moved to another non-COG institution|0|||
27937175|NCT02883049|81607226|FG003|Induction|Moved to another non-COG institution|0|||
27937176|NCT02883049|81607227|FG004|Induction|Moved to another non-COG institution|0|||
27937177|NCT02883049|81607228|FG005|Induction|Moved to another non-COG institution|0|||
27937178|NCT02883049|81607229|FG006|Induction|Moved to another non-COG institution|0|||
27937179|NCT02883049|81607230|FG007|Induction|Moved to another non-COG institution|0|||
27937180|NCT02883049|81607231|FG008|Induction|Moved to another non-COG institution|0|||
27937181|NCT02883049|81607232|FG009|Induction|Moved to another non-COG institution|0|||
27937182|NCT02883049|81607233|FG010|Induction|Moved to another non-COG institution|0|||
27937183|NCT02883049|81607234|FG011|Induction|Moved to another non-COG institution|0|||
27937184|NCT02883049|81607235|FG012|Induction|Moved to another non-COG institution|0|||
27937185|NCT02883049|81607236|FG013|Induction|Moved to another non-COG institution|0|||
27937186|NCT02883049|81607237|FG014|Induction|Moved to another non-COG institution|0|||
27937187|NCT02883049|81607238|FG015|Induction|Moved to another non-COG institution|0|||
27937188|NCT02883049|81607223|FG000|Induction|Randomization closed|41|||
27937189|NCT02883049|81607224|FG001|Induction|Randomization closed|0|||
27937190|NCT02883049|81607225|FG002|Induction|Randomization closed|0|||
27937191|NCT02883049|81607226|FG003|Induction|Randomization closed|0|||
27745185|NCT03303339|80896524|FG003|Overall Study|Safety/Non-compliance|0|||
27745186|NCT03303339|80896525|FG004|Overall Study|Safety/Non-compliance|0|||
27745187|NCT03303339|80896526|FG005|Overall Study|Safety/Non-compliance|0|||
27745188|NCT03303339|80896527|FG006|Overall Study|Safety/Non-compliance|0|||
27745189|NCT03303339|80896528|FG007|Overall Study|Safety/Non-compliance|0|||
27745190|NCT03303339|80896529|FG008|Overall Study|Safety/Non-compliance|0|||
27745191|NCT03303339|80896530|FG009|Overall Study|Safety/Non-compliance|0|||
27937192|NCT02883049|81607227|FG004|Induction|Randomization closed|0|||
27937193|NCT02883049|81607228|FG005|Induction|Randomization closed|0|||
27937194|NCT02883049|81607229|FG006|Induction|Randomization closed|0|||
27937195|NCT02883049|81607230|FG007|Induction|Randomization closed|0|||
27937196|NCT02883049|81607231|FG008|Induction|Randomization closed|0|||
27937197|NCT02883049|81607232|FG009|Induction|Randomization closed|0|||
27937198|NCT02883049|81607233|FG010|Induction|Randomization closed|0|||
27937199|NCT02883049|81607234|FG011|Induction|Randomization closed|0|||
27937200|NCT02883049|81607235|FG012|Induction|Randomization closed|0|||
27937201|NCT02883049|81607236|FG013|Induction|Randomization closed|0|||
27551073|NCT01833520|80203578|FG001|Overall Study|Lack of Efficacy|3|||
27551074|NCT01833520|80203579|FG002|Overall Study|Lack of Efficacy|8|||
27551075|NCT01833520|80203580|FG003|Overall Study|Lack of Efficacy|3|||
27551076|NCT00727025|80203581|FG000|Overall Study|Physician Decision|23|||
27551077|NCT00434330|80203584|FG000|Overall Study|Adverse Event|0|||
27551078|NCT00434330|80203585|FG001|Overall Study|Adverse Event|0|||
27551079|NCT00434330|80203586|FG002|Overall Study|Adverse Event|1|||
27551080|NCT00434330|80203587|FG003|Overall Study|Adverse Event|0|||
27551081|NCT00434330|80203588|FG004|Overall Study|Adverse Event|0|||
27551082|NCT00434330|80203589|FG005|Overall Study|Adverse Event|0|||
27745192|NCT03303339|80896531|FG010|Overall Study|Safety/Non-compliance|0|||
27937202|NCT02883049|81607237|FG014|Induction|Randomization closed|0|||
27937203|NCT02883049|81607238|FG015|Induction|Randomization closed|0|||
27551083|NCT00434330|80203584|FG000|Overall Study|Death|1|||
27551084|NCT00434330|80203585|FG001|Overall Study|Death|0|||
27551085|NCT00434330|80203586|FG002|Overall Study|Death|0|||
27644750|NCT05171777|80539051|FG001|Treatment Crossover Period|Disease Relapse|1|||
27644751|NCT05171777|80539052|FG002|Treatment Crossover Period|Disease Relapse|0|||
27937204|NCT02883049|81607223|FG000|Induction|MRD negative|36|||
27937205|NCT02883049|81607224|FG001|Induction|MRD negative|0|||
27937206|NCT02883049|81607225|FG002|Induction|MRD negative|0|||
27937207|NCT02883049|81607226|FG003|Induction|MRD negative|0|||
27937208|NCT02883049|81607227|FG004|Induction|MRD negative|0|||
27937209|NCT02883049|81607228|FG005|Induction|MRD negative|0|||
27937210|NCT02883049|81607229|FG006|Induction|MRD negative|0|||
27937211|NCT02883049|81607230|FG007|Induction|MRD negative|0|||
27937212|NCT02883049|81607231|FG008|Induction|MRD negative|0|||
27937213|NCT02883049|81607232|FG009|Induction|MRD negative|0|||
27937214|NCT02883049|81607233|FG010|Induction|MRD negative|0|||
27745193|NCT03303339|80896532|FG011|Overall Study|Safety/Non-compliance|1|||
27745194|NCT00515463|80896535|FG000|Overall Study|Physician Decision|4|||
27745195|NCT00515463|80896536|FG001|Overall Study|Physician Decision|2|||
27745196|NCT00515463|80896535|FG000|Overall Study|Adverse Event|1|||
27745197|NCT00515463|80896536|FG001|Overall Study|Adverse Event|2|||
27745198|NCT00515463|80896535|FG000|Overall Study|Withdrawal by Subject|3|||
27745199|NCT00515463|80896536|FG001|Overall Study|Withdrawal by Subject|4|||
27745200|NCT00515463|80896535|FG000|Overall Study|Lost to Follow-up|6|||
27745201|NCT00515463|80896536|FG001|Overall Study|Lost to Follow-up|5|||
27745202|NCT00515463|80896535|FG000|Overall Study|Other|0|||
27745203|NCT00515463|80896536|FG001|Overall Study|Other|1|||
27745204|NCT00234104|80896541|FG000|Overall Study|Adverse Event|4|||
27745205|NCT00234104|80896542|FG001|Overall Study|Adverse Event|0|||
27745206|NCT00234104|80896543|FG002|Overall Study|Adverse Event|3|||
27745207|NCT00234104|80896544|FG003|Overall Study|Adverse Event|5|||
27745208|NCT00234104|80896541|FG000|Overall Study|Protocol Violation|0|||
27745209|NCT00234104|80896542|FG001|Overall Study|Protocol Violation|0|||
27745210|NCT00234104|80896543|FG002|Overall Study|Protocol Violation|0|||
27937215|NCT02883049|81607234|FG011|Induction|MRD negative|0|||
27937216|NCT02883049|81607235|FG012|Induction|MRD negative|0|||
27937217|NCT02883049|81607236|FG013|Induction|MRD negative|0|||
27937218|NCT02883049|81607237|FG014|Induction|MRD negative|0|||
27937219|NCT02883049|81607238|FG015|Induction|MRD negative|0|||
27644752|NCT05171777|80539053|FG003|Treatment Crossover Period|Disease Relapse|0|||
27644753|NCT05171777|80539050|FG000|Treatment Crossover Period|Reason not Specified|2|||
27644754|NCT05171777|80539051|FG001|Treatment Crossover Period|Reason not Specified|1|||
27644755|NCT05171777|80539052|FG002|Treatment Crossover Period|Reason not Specified|0|||
27644756|NCT05171777|80539053|FG003|Treatment Crossover Period|Reason not Specified|0|||
27644757|NCT05171777|80539050|FG000|Treatment Crossover Period|Physician Decision|0|||
27644758|NCT05171777|80539051|FG001|Treatment Crossover Period|Physician Decision|1|||
27644759|NCT05171777|80539052|FG002|Treatment Crossover Period|Physician Decision|0|||
27644760|NCT05171777|80539053|FG003|Treatment Crossover Period|Physician Decision|0|||
27644761|NCT05171777|80539050|FG000|Treatment Crossover Period|Progressive Disease|13|||
27644762|NCT05171777|80539051|FG001|Treatment Crossover Period|Progressive Disease|9|||
27644763|NCT05171777|80539052|FG002|Treatment Crossover Period|Progressive Disease|0|||
27644764|NCT05171777|80539053|FG003|Treatment Crossover Period|Progressive Disease|0|||
27644765|NCT05171777|80539050|FG000|Treatment Crossover Period|Protocol Violation|0|||
27644766|NCT05171777|80539051|FG001|Treatment Crossover Period|Protocol Violation|2|||
27644767|NCT05171777|80539052|FG002|Treatment Crossover Period|Protocol Violation|0|||
27644768|NCT05171777|80539053|FG003|Treatment Crossover Period|Protocol Violation|0|||
27644769|NCT05171777|80539050|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
27644770|NCT05171777|80539051|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
27644771|NCT05171777|80539052|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
27644772|NCT05171777|80539053|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
27644773|NCT05171777|80539050|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
27644774|NCT05171777|80539051|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
27644775|NCT05171777|80539052|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
27644776|NCT05171777|80539053|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
27644777|NCT05171777|80539050|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
27644778|NCT05171777|80539051|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
27644779|NCT05171777|80539052|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
27644780|NCT05171777|80539053|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
27644781|NCT05171777|80539050|FG000|Treatment Continuation Period|Death|0|||
27644782|NCT05171777|80539051|FG001|Treatment Continuation Period|Death|0|||
27644783|NCT05171777|80539052|FG002|Treatment Continuation Period|Death|1|||
27644784|NCT05171777|80539053|FG003|Treatment Continuation Period|Death|6|||
27644785|NCT05171777|80539050|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
27644786|NCT05171777|80539051|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
27745211|NCT00234104|80896544|FG003|Overall Study|Protocol Violation|1|||
27745212|NCT00234104|80896541|FG000|Overall Study|Physician Decision|0|||
27745213|NCT00234104|80896542|FG001|Overall Study|Physician Decision|1|||
27745214|NCT00234104|80896543|FG002|Overall Study|Physician Decision|2|||
27937220|NCT02883049|81607223|FG000|Induction|Identified as HR patients|165|||
27937221|NCT02883049|81607224|FG001|Induction|Identified as HR patients|0|||
27937222|NCT02883049|81607225|FG002|Induction|Identified as HR patients|0|||
27745215|NCT00234104|80896544|FG003|Overall Study|Physician Decision|2|||
27745216|NCT04333433|80896547|FG000|Overall Study|Withdrawal by Subject|6|||
27745217|NCT04333433|80896548|FG001|Overall Study|Withdrawal by Subject|3|||
27745218|NCT04333433|80896547|FG000|Overall Study|Death|3|||
27745219|NCT04333433|80896548|FG001|Overall Study|Death|0|||
27745220|NCT04333433|80896547|FG000|Overall Study|Lost to Follow-up|6|||
27745221|NCT04333433|80896548|FG001|Overall Study|Lost to Follow-up|1|||
27745222|NCT04333433|80896547|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
27745223|NCT04333433|80896548|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
27745224|NCT04956692|80896549|FG000|Overall Study|Death|115|||
27745225|NCT04956692|80896550|FG001|Overall Study|Death|47|||
27745226|NCT04956692|80896549|FG000|Overall Study|Lost to Follow-up|0|||
27745227|NCT04956692|80896550|FG001|Overall Study|Lost to Follow-up|1|||
27745228|NCT04956692|80896549|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27745229|NCT04956692|80896550|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27745230|NCT04956692|80896549|FG000|Overall Study|Withdrawal by Subject|5|||
27745231|NCT04956692|80896550|FG001|Overall Study|Withdrawal by Subject|2|||
27745232|NCT04956692|80896549|FG000|Overall Study|Ongoing in Study|236|||
27745233|NCT04956692|80896550|FG001|Overall Study|Ongoing in Study|123|||
27745234|NCT02413398|80896552|FG000|Overall Study|Lost to Follow-up|2|||
27745235|NCT02413398|80896553|FG001|Overall Study|Lost to Follow-up|4|||
27745236|NCT02413398|80896552|FG000|Overall Study|Withdrawal by Subject|1|||
27745237|NCT02413398|80896553|FG001|Overall Study|Withdrawal by Subject|1|||
27745238|NCT02413398|80896552|FG000|Overall Study|Other Eligibility criteria|1|||
27745239|NCT02413398|80896553|FG001|Overall Study|Other Eligibility criteria|2|||
27745240|NCT01978912|80896554|FG000|Overall Study|Adverse Event|0|||
27745241|NCT01978912|80896555|FG001|Overall Study|Adverse Event|1|||
27745242|NCT01978912|80896556|FG002|Overall Study|Adverse Event|0|||
27745243|NCT01978912|80896557|FG003|Overall Study|Adverse Event|0|||
27745244|NCT01978912|80896554|FG000|Overall Study|Lost to Follow-up|1|||
27745245|NCT01978912|80896555|FG001|Overall Study|Lost to Follow-up|1|||
27745246|NCT01978912|80896556|FG002|Overall Study|Lost to Follow-up|0|||
27745247|NCT01978912|80896557|FG003|Overall Study|Lost to Follow-up|1|||
27745248|NCT01978912|80896554|FG000|Overall Study|Withdrawal by Subject|1|||
27745249|NCT01978912|80896555|FG001|Overall Study|Withdrawal by Subject|0|||
27745250|NCT01978912|80896556|FG002|Overall Study|Withdrawal by Subject|2|||
27745251|NCT01978912|80896557|FG003|Overall Study|Withdrawal by Subject|2|||
27745252|NCT01978912|80896554|FG000|Overall Study|Lumbar Surgery|1|||
27745253|NCT01978912|80896555|FG001|Overall Study|Lumbar Surgery|0|||
27745254|NCT01978912|80896556|FG002|Overall Study|Lumbar Surgery|1|||
27745255|NCT01978912|80896557|FG003|Overall Study|Lumbar Surgery|0|||
27745256|NCT01978912|80896554|FG000|Overall Study|Intradiscal Steroid Injection|0|||
27745257|NCT01978912|80896555|FG001|Overall Study|Intradiscal Steroid Injection|1|||
27745258|NCT01978912|80896556|FG002|Overall Study|Intradiscal Steroid Injection|0|||
27745259|NCT01978912|80896557|FG003|Overall Study|Intradiscal Steroid Injection|0|||
27745260|NCT02546856|80896558|FG000|4 Months Evaluation|Death|2|||
27745261|NCT02546856|80896559|FG001|4 Months Evaluation|Death|3|||
27745262|NCT02546856|80896558|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
27745263|NCT02546856|80896559|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
27745264|NCT02546856|80896558|FG000|4 Months Evaluation|Lost to Follow-up|3|||
27745265|NCT02546856|80896559|FG001|4 Months Evaluation|Lost to Follow-up|3|||
27745266|NCT02546856|80896558|FG000|4 Months Evaluation|Physician Decision|3|||
27745267|NCT02546856|80896559|FG001|4 Months Evaluation|Physician Decision|0|||
27745268|NCT02546856|80896558|FG000|4 Months Evaluation|Working or living abroad|5|||
27745269|NCT02546856|80896559|FG001|4 Months Evaluation|Working or living abroad|1|||
27745270|NCT02546856|80896558|FG000|4 Months Evaluation|reasons not due to titration|4|||
27745271|NCT02546856|80896559|FG001|4 Months Evaluation|reasons not due to titration|1|||
27745272|NCT02546856|80896558|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
27745273|NCT02546856|80896559|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
27745274|NCT02546856|80896558|FG000|6 Months Evaluation|Death|1|||
27745275|NCT02546856|80896559|FG001|6 Months Evaluation|Death|1|||
27745276|NCT02546856|80896558|FG000|6 Months Evaluation|Lost to Follow-up|1|||
27745277|NCT02546856|80896559|FG001|6 Months Evaluation|Lost to Follow-up|1|||
27937223|NCT02883049|81607226|FG003|Induction|Identified as HR patients|0|||
27937224|NCT02883049|81607227|FG004|Induction|Identified as HR patients|0|||
27551086|NCT00434330|80203587|FG003|Overall Study|Death|0|||
27745278|NCT02546856|80896558|FG000|6 Months Evaluation|Working or living abroad|6|||
27745279|NCT02546856|80896559|FG001|6 Months Evaluation|Working or living abroad|4|||
27745280|NCT02546856|80896558|FG000|6 Months Evaluation|reasons not due to titration|0|||
27745281|NCT02546856|80896559|FG001|6 Months Evaluation|reasons not due to titration|1|||
27745282|NCT03408873|80896560|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
27745283|NCT03408873|80896560|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
27937225|NCT02883049|81607228|FG005|Induction|Identified as HR patients|0|||
27745284|NCT03408873|80896560|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
27745285|NCT03408873|80896560|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
27937226|NCT02883049|81607229|FG006|Induction|Identified as HR patients|0|||
27745286|NCT03408873|80896560|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
27745287|NCT03408873|80896560|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
27745288|NCT00923091|80896561|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
27745289|NCT00923091|80896562|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
27745290|NCT00923091|80896563|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
27745291|NCT00923091|80896564|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
27745292|NCT00923091|80896565|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
27745293|NCT00923091|80896566|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
27745294|NCT00923091|80896567|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
27745295|NCT00923091|80896568|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
27745296|NCT00923091|80896569|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27745297|NCT00923091|80896570|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27745298|NCT00923091|80896571|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27745299|NCT00923091|80896572|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27745300|NCT00923091|80896573|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
27745301|NCT00923091|80896561|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
27745302|NCT00923091|80896562|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
27745303|NCT00923091|80896563|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
27745304|NCT00923091|80896564|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
27745305|NCT00923091|80896565|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
27745306|NCT00923091|80896566|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
27745307|NCT00923091|80896567|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
27745308|NCT00923091|80896568|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
27745309|NCT00923091|80896569|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27745310|NCT00923091|80896570|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27745311|NCT00923091|80896571|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27745312|NCT00923091|80896572|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27745313|NCT00923091|80896573|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
27745314|NCT00923091|80896561|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
27745315|NCT00923091|80896562|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
27745316|NCT00923091|80896563|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
27745317|NCT00923091|80896564|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
27745318|NCT00923091|80896565|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
27745319|NCT00923091|80896566|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
27745320|NCT00923091|80896567|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
27745321|NCT00923091|80896568|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
27745322|NCT00923091|80896569|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27745323|NCT00923091|80896570|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27745324|NCT00923091|80896571|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27745325|NCT00923091|80896572|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27745326|NCT00923091|80896573|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
27745327|NCT00923091|80896561|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745328|NCT00923091|80896562|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745329|NCT00923091|80896563|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745330|NCT00923091|80896564|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745331|NCT00923091|80896565|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745332|NCT00923091|80896566|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
27745333|NCT00923091|80896567|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745334|NCT00923091|80896568|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745335|NCT00923091|80896569|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745336|NCT00923091|80896570|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745337|NCT00923091|80896571|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745338|NCT00923091|80896572|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745339|NCT00923091|80896573|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
27745340|NCT00923091|80896561|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745341|NCT00923091|80896562|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
27745342|NCT00923091|80896563|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745343|NCT00923091|80896564|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
27745344|NCT00923091|80896565|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745345|NCT00923091|80896566|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
27745346|NCT00923091|80896567|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745347|NCT00923091|80896568|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745348|NCT00923091|80896569|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745349|NCT00923091|80896570|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745350|NCT00923091|80896571|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745351|NCT00923091|80896572|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745352|NCT00923091|80896573|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
27745353|NCT00923091|80896561|FG000|Period III (Single-Blind)|Adverse Event|5|||
27745354|NCT00923091|80896562|FG001|Period III (Single-Blind)|Adverse Event|0|||
27745355|NCT00923091|80896563|FG002|Period III (Single-Blind)|Adverse Event|0|||
27745356|NCT00923091|80896564|FG003|Period III (Single-Blind)|Adverse Event|0|||
27745357|NCT00923091|80896565|FG004|Period III (Single-Blind)|Adverse Event|0|||
27745358|NCT00923091|80896566|FG005|Period III (Single-Blind)|Adverse Event|0|||
27644787|NCT05171777|80539052|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
27644788|NCT05171777|80539053|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
27644789|NCT03488719|80539054|FG000|Overall Study|Adverse Event|0|||
27644790|NCT03488719|80539055|FG001|Overall Study|Adverse Event|4|||
27644791|NCT03488719|80539056|FG002|Overall Study|Adverse Event|2|||
27644792|NCT03488719|80539054|FG000|Overall Study|Other|0|||
27644793|NCT03488719|80539055|FG001|Overall Study|Other|0|||
27644794|NCT03488719|80539056|FG002|Overall Study|Other|5|||
27644795|NCT02717611|80539057|FG000|Overall Study|Death|13|||
27644796|NCT02717611|80539057|FG000|Overall Study|Withdrawal by Subject|6|||
27644797|NCT02717611|80539057|FG000|Overall Study|Active, not recruiting|40|||
27644798|NCT02717611|80539057|FG000|Overall Study|Complicating disease|1|||
27644799|NCT05484661|80539063|FG000|Overall Study|Withdrawal by Subject|1|||
27644800|NCT05484661|80539064|FG001|Overall Study|Withdrawal by Subject|0|||
27644801|NCT01880736|80539081|FG000|Overall Study|Adverse Event|0|||
27644802|NCT01880736|80539082|FG001|Overall Study|Adverse Event|0|||
27644803|NCT01880736|80539083|FG002|Overall Study|Adverse Event|0|||
27745359|NCT00923091|80896567|FG006|Period III (Single-Blind)|Adverse Event|0|||
27745360|NCT00923091|80896568|FG007|Period III (Single-Blind)|Adverse Event|0|||
27745361|NCT00923091|80896569|FG008|Period III (Single-Blind)|Adverse Event|0|||
27745362|NCT00923091|80896570|FG009|Period III (Single-Blind)|Adverse Event|0|||
27745363|NCT00923091|80896571|FG010|Period III (Single-Blind)|Adverse Event|0|||
27745364|NCT00923091|80896572|FG011|Period III (Single-Blind)|Adverse Event|0|||
27745365|NCT00923091|80896573|FG012|Period III (Single-Blind)|Adverse Event|0|||
27745366|NCT00923091|80896561|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
27745367|NCT00923091|80896562|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745368|NCT00923091|80896563|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745369|NCT00923091|80896564|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745370|NCT00923091|80896565|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
27937227|NCT02883049|81607230|FG007|Induction|Identified as HR patients|0|||
27937228|NCT02883049|81607231|FG008|Induction|Identified as HR patients|0|||
27937229|NCT02883049|81607232|FG009|Induction|Identified as HR patients|0|||
27937230|NCT02883049|81607233|FG010|Induction|Identified as HR patients|0|||
27937231|NCT02883049|81607234|FG011|Induction|Identified as HR patients|0|||
27937232|NCT02883049|81607235|FG012|Induction|Identified as HR patients|0|||
27937233|NCT02883049|81607236|FG013|Induction|Identified as HR patients|0|||
27937234|NCT02883049|81607237|FG014|Induction|Identified as HR patients|0|||
27644804|NCT01880736|80539084|FG003|Overall Study|Adverse Event|1|||
27644805|NCT01880736|80539081|FG000|Overall Study|Withdrawal Criteria|1|||
27745371|NCT00923091|80896566|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745372|NCT00923091|80896567|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745373|NCT00923091|80896568|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745374|NCT00923091|80896569|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745375|NCT00923091|80896570|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745376|NCT00923091|80896571|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745377|NCT00923091|80896572|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745378|NCT00923091|80896573|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
27745379|NCT00923091|80896561|FG000|Period III (Single-Blind)|Protocol Violation|3|||
27745380|NCT00923091|80896562|FG001|Period III (Single-Blind)|Protocol Violation|0|||
27745381|NCT00923091|80896563|FG002|Period III (Single-Blind)|Protocol Violation|0|||
27745382|NCT00923091|80896564|FG003|Period III (Single-Blind)|Protocol Violation|0|||
27745383|NCT00923091|80896565|FG004|Period III (Single-Blind)|Protocol Violation|0|||
27745384|NCT00923091|80896566|FG005|Period III (Single-Blind)|Protocol Violation|0|||
27745385|NCT00923091|80896567|FG006|Period III (Single-Blind)|Protocol Violation|0|||
27745386|NCT00923091|80896568|FG007|Period III (Single-Blind)|Protocol Violation|0|||
27745387|NCT00923091|80896569|FG008|Period III (Single-Blind)|Protocol Violation|0|||
27644806|NCT01880736|80539082|FG001|Overall Study|Withdrawal Criteria|2|||
27644807|NCT01880736|80539083|FG002|Overall Study|Withdrawal Criteria|1|||
27644808|NCT01880736|80539084|FG003|Overall Study|Withdrawal Criteria|5|||
27644809|NCT05824559|80539085|FG000|Overall Study|Adverse Event|2|||
27644810|NCT05824559|80539085|FG000|Overall Study|Physician Decision|2|||
27644811|NCT05824559|80539085|FG000|Overall Study|Progressive Disease|16|||
27745388|NCT00923091|80896570|FG009|Period III (Single-Blind)|Protocol Violation|0|||
27745389|NCT00923091|80896571|FG010|Period III (Single-Blind)|Protocol Violation|0|||
27745390|NCT00923091|80896572|FG011|Period III (Single-Blind)|Protocol Violation|0|||
27937235|NCT02883049|81607238|FG015|Induction|Identified as HR patients|0|||
27745391|NCT00923091|80896573|FG012|Period III (Single-Blind)|Protocol Violation|0|||
27745392|NCT00923091|80896561|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
27745393|NCT00923091|80896562|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
27745394|NCT00923091|80896563|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
27745395|NCT00923091|80896564|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
27745396|NCT00923091|80896565|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
27745397|NCT00923091|80896566|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
27745398|NCT00923091|80896567|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
27745399|NCT00923091|80896568|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
27745400|NCT00923091|80896569|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
27745401|NCT00923091|80896570|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
27745402|NCT00923091|80896571|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
27745403|NCT00923091|80896572|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
27745404|NCT00923091|80896573|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
27745405|NCT00923091|80896561|FG000|Period IV (Double-Blind)|Adverse Event|2|||
27745406|NCT00923091|80896562|FG001|Period IV (Double-Blind)|Adverse Event|0|||
27745407|NCT00923091|80896563|FG002|Period IV (Double-Blind)|Adverse Event|0|||
27745408|NCT00923091|80896564|FG003|Period IV (Double-Blind)|Adverse Event|0|||
27745409|NCT00923091|80896565|FG004|Period IV (Double-Blind)|Adverse Event|0|||
27745410|NCT00923091|80896566|FG005|Period IV (Double-Blind)|Adverse Event|0|||
27745411|NCT00923091|80896567|FG006|Period IV (Double-Blind)|Adverse Event|0|||
27745412|NCT00923091|80896568|FG007|Period IV (Double-Blind)|Adverse Event|0|||
27745413|NCT00923091|80896569|FG008|Period IV (Double-Blind)|Adverse Event|0|||
27745414|NCT00923091|80896570|FG009|Period IV (Double-Blind)|Adverse Event|0|||
27745415|NCT00923091|80896571|FG010|Period IV (Double-Blind)|Adverse Event|0|||
27745416|NCT00923091|80896572|FG011|Period IV (Double-Blind)|Adverse Event|0|||
27745417|NCT00923091|80896573|FG012|Period IV (Double-Blind)|Adverse Event|0|||
27745418|NCT00923091|80896561|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745419|NCT00923091|80896562|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
27745420|NCT00923091|80896563|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745421|NCT00923091|80896564|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745422|NCT00923091|80896565|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745423|NCT00923091|80896566|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745424|NCT00923091|80896567|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745425|NCT00923091|80896568|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745426|NCT00923091|80896569|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745427|NCT00923091|80896570|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745428|NCT00923091|80896571|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745429|NCT00923091|80896572|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745430|NCT00923091|80896573|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
27745431|NCT00923091|80896561|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
27745432|NCT00923091|80896562|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
27745433|NCT00923091|80896563|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
27745434|NCT00923091|80896564|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
27745435|NCT00923091|80896565|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
27745436|NCT00923091|80896566|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
27745437|NCT00923091|80896567|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
27745438|NCT00923091|80896568|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
27745439|NCT00923091|80896569|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
27745440|NCT00923091|80896570|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
27745441|NCT00923091|80896571|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
27745442|NCT00923091|80896572|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
27745443|NCT00923091|80896573|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
27745444|NCT00923091|80896561|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745445|NCT00923091|80896562|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745446|NCT00923091|80896563|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745447|NCT00923091|80896564|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745448|NCT00923091|80896565|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745449|NCT00923091|80896566|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745450|NCT00923091|80896567|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745451|NCT00923091|80896568|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745452|NCT00923091|80896569|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
27745453|NCT00923091|80896570|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745454|NCT00923091|80896571|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745455|NCT00923091|80896572|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
27745456|NCT00923091|80896573|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
27745457|NCT00923091|80896561|FG000|Period V (Double -Blind)|Protocol Violation|0|||
27745458|NCT00923091|80896562|FG001|Period V (Double -Blind)|Protocol Violation|0|||
27745459|NCT00923091|80896563|FG002|Period V (Double -Blind)|Protocol Violation|0|||
27745460|NCT00923091|80896564|FG003|Period V (Double -Blind)|Protocol Violation|0|||
27937236|NCT02883049|81607223|FG000|Induction|Developed SMN|0|||
27745461|NCT00923091|80896565|FG004|Period V (Double -Blind)|Protocol Violation|0|||
27745462|NCT00923091|80896566|FG005|Period V (Double -Blind)|Protocol Violation|0|||
27745463|NCT00923091|80896567|FG006|Period V (Double -Blind)|Protocol Violation|0|||
27745464|NCT00923091|80896568|FG007|Period V (Double -Blind)|Protocol Violation|0|||
27745465|NCT00923091|80896569|FG008|Period V (Double -Blind)|Protocol Violation|0|||
27745466|NCT00923091|80896570|FG009|Period V (Double -Blind)|Protocol Violation|0|||
27745467|NCT00923091|80896571|FG010|Period V (Double -Blind)|Protocol Violation|0|||
27745468|NCT00923091|80896572|FG011|Period V (Double -Blind)|Protocol Violation|0|||
27745469|NCT00923091|80896573|FG012|Period V (Double -Blind)|Protocol Violation|1|||
27745470|NCT00923091|80896561|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
27745471|NCT00923091|80896562|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
27745472|NCT00923091|80896563|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
27745473|NCT00923091|80896564|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
27745474|NCT00923091|80896565|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
27745475|NCT00923091|80896566|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
27745476|NCT00923091|80896567|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
27745477|NCT00923091|80896568|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
27745478|NCT00923091|80896569|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
27745479|NCT00923091|80896570|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
27745480|NCT00923091|80896571|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
27745481|NCT00923091|80896572|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
27745482|NCT00923091|80896573|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
27745483|NCT00923091|80896561|FG000|Period VI (Open-Label)|Adverse Event|17|||
27745484|NCT00923091|80896562|FG001|Period VI (Open-Label)|Adverse Event|0|||
27745485|NCT00923091|80896563|FG002|Period VI (Open-Label)|Adverse Event|4|||
27745486|NCT00923091|80896564|FG003|Period VI (Open-Label)|Adverse Event|1|||
27745487|NCT00923091|80896565|FG004|Period VI (Open-Label)|Adverse Event|1|||
27745488|NCT00923091|80896566|FG005|Period VI (Open-Label)|Adverse Event|0|||
27745489|NCT00923091|80896567|FG006|Period VI (Open-Label)|Adverse Event|0|||
27745490|NCT00923091|80896568|FG007|Period VI (Open-Label)|Adverse Event|0|||
27745491|NCT00923091|80896569|FG008|Period VI (Open-Label)|Adverse Event|0|||
27745492|NCT00923091|80896570|FG009|Period VI (Open-Label)|Adverse Event|0|||
27745493|NCT00923091|80896571|FG010|Period VI (Open-Label)|Adverse Event|0|||
27745494|NCT00923091|80896572|FG011|Period VI (Open-Label)|Adverse Event|0|||
27745495|NCT00923091|80896573|FG012|Period VI (Open-Label)|Adverse Event|0|||
27745496|NCT00923091|80896561|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
27745497|NCT00923091|80896562|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
27745498|NCT00923091|80896563|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
27745499|NCT00923091|80896564|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745500|NCT00923091|80896565|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
27745501|NCT00923091|80896566|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745502|NCT00923091|80896567|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745503|NCT00923091|80896568|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745504|NCT00923091|80896569|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745505|NCT00923091|80896570|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745506|NCT00923091|80896571|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745507|NCT00923091|80896572|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745508|NCT00923091|80896573|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
27745509|NCT00923091|80896561|FG000|Period VI (Open-Label)|Protocol Violation|6|||
27745510|NCT00923091|80896562|FG001|Period VI (Open-Label)|Protocol Violation|1|||
27745511|NCT00923091|80896563|FG002|Period VI (Open-Label)|Protocol Violation|3|||
27745512|NCT00923091|80896564|FG003|Period VI (Open-Label)|Protocol Violation|1|||
27745513|NCT00923091|80896565|FG004|Period VI (Open-Label)|Protocol Violation|4|||
27745514|NCT00923091|80896566|FG005|Period VI (Open-Label)|Protocol Violation|0|||
27745515|NCT00923091|80896567|FG006|Period VI (Open-Label)|Protocol Violation|0|||
27745516|NCT00923091|80896568|FG007|Period VI (Open-Label)|Protocol Violation|0|||
27745517|NCT00923091|80896569|FG008|Period VI (Open-Label)|Protocol Violation|0|||
27745518|NCT00923091|80896570|FG009|Period VI (Open-Label)|Protocol Violation|0|||
27745519|NCT00923091|80896571|FG010|Period VI (Open-Label)|Protocol Violation|0|||
27745520|NCT00923091|80896572|FG011|Period VI (Open-Label)|Protocol Violation|0|||
27745521|NCT00923091|80896573|FG012|Period VI (Open-Label)|Protocol Violation|0|||
27745522|NCT00923091|80896561|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
27745523|NCT00923091|80896562|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
27745524|NCT00923091|80896563|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
27745525|NCT00923091|80896564|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
27745526|NCT00923091|80896565|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
27745527|NCT00923091|80896566|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
27745528|NCT00923091|80896567|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
27745529|NCT00923091|80896568|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
27745530|NCT00923091|80896569|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
27745531|NCT00923091|80896570|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
27745532|NCT00923091|80896571|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
27745533|NCT00923091|80896572|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
27745534|NCT00923091|80896573|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
27745535|NCT00923091|80896561|FG000|Period VI (Open-Label)|Other Reason|0|||
27745536|NCT00923091|80896562|FG001|Period VI (Open-Label)|Other Reason|0|||
27745537|NCT00923091|80896563|FG002|Period VI (Open-Label)|Other Reason|0|||
27745538|NCT00923091|80896564|FG003|Period VI (Open-Label)|Other Reason|1|||
27745539|NCT00923091|80896565|FG004|Period VI (Open-Label)|Other Reason|1|||
27745540|NCT00923091|80896566|FG005|Period VI (Open-Label)|Other Reason|0|||
27745541|NCT00923091|80896567|FG006|Period VI (Open-Label)|Other Reason|0|||
27745542|NCT00923091|80896568|FG007|Period VI (Open-Label)|Other Reason|0|||
27745543|NCT00923091|80896569|FG008|Period VI (Open-Label)|Other Reason|0|||
27745544|NCT00923091|80896570|FG009|Period VI (Open-Label)|Other Reason|0|||
27745545|NCT00923091|80896571|FG010|Period VI (Open-Label)|Other Reason|0|||
27745546|NCT00923091|80896572|FG011|Period VI (Open-Label)|Other Reason|0|||
27745547|NCT00923091|80896573|FG012|Period VI (Open-Label)|Other Reason|0|||
27745548|NCT01214434|80896580|FG000|Overall Study|Withdrawal by Subject|1|||
27745549|NCT01214434|80896581|FG001|Overall Study|Withdrawal by Subject|0|||
27745550|NCT01214434|80896580|FG000|Overall Study|Lost to Follow-up|2|||
27745551|NCT01214434|80896581|FG001|Overall Study|Lost to Follow-up|2|||
27745552|NCT01214434|80896580|FG000|Overall Study|Site error|1|||
27745553|NCT01214434|80896581|FG001|Overall Study|Site error|0|||
27745554|NCT01070550|80899444|FG000|Overall Study|Adverse Event|43|||
27745555|NCT01070550|80899445|FG001|Overall Study|Adverse Event|1|||
27745556|NCT01070550|80899446|FG002|Overall Study|Adverse Event|3|||
27745557|NCT01070550|80899447|FG003|Overall Study|Adverse Event|0|||
27745558|NCT01070550|80899448|FG004|Overall Study|Adverse Event|0|||
27745559|NCT01070550|80899449|FG005|Overall Study|Adverse Event|0|||
27745560|NCT01070550|80899444|FG000|Overall Study|Death|20|||
27745561|NCT01070550|80899445|FG001|Overall Study|Death|4|||
27745562|NCT01070550|80899446|FG002|Overall Study|Death|3|||
27745563|NCT01070550|80899447|FG003|Overall Study|Death|0|||
27937237|NCT02883049|81607224|FG001|Induction|Developed SMN|1|||
27937238|NCT02883049|81607225|FG002|Induction|Developed SMN|0|||
27644812|NCT05824559|80539085|FG000|Overall Study|Study Terminated by Sponsor|1|||
27644813|NCT05824559|80539085|FG000|Overall Study|Withdrawal by Subject|2|||
27937239|NCT02883049|81607226|FG003|Induction|Developed SMN|0|||
27937240|NCT02883049|81607227|FG004|Induction|Developed SMN|0|||
27937241|NCT02883049|81607228|FG005|Induction|Developed SMN|0|||
27937242|NCT02883049|81607229|FG006|Induction|Developed SMN|0|||
27644818|NCT04503681|80539088|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
27644819|NCT04503681|80539089|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
27644820|NCT04029090|80539090|FG000|Overall Study|Protocol Violation|1|||
27644821|NCT04029090|80539091|FG001|Overall Study|Protocol Violation|0|||
27644822|NCT04029090|80539092|FG002|Overall Study|Protocol Violation|0|||
27644823|NCT04029090|80539090|FG000|Overall Study|Withdrawal by Subject|0|||
27745564|NCT01070550|80899448|FG004|Overall Study|Death|0|||
27745565|NCT01070550|80899449|FG005|Overall Study|Death|0|||
27745566|NCT01070550|80899444|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
27745567|NCT01070550|80899445|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27937243|NCT02883049|81607230|FG007|Induction|Developed SMN|0|||
27937244|NCT02883049|81607231|FG008|Induction|Developed SMN|0|||
27937245|NCT02883049|81607232|FG009|Induction|Developed SMN|0|||
27937246|NCT02883049|81607233|FG010|Induction|Developed SMN|0|||
27937247|NCT02883049|81607234|FG011|Induction|Developed SMN|0|||
27551087|NCT00434330|80203588|FG004|Overall Study|Death|1|||
27551088|NCT00434330|80203589|FG005|Overall Study|Death|1|||
27551089|NCT00434330|80203584|FG000|Overall Study|Withdrawal by Subject|0|||
27745568|NCT01070550|80899446|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27745569|NCT01070550|80899447|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27745570|NCT01070550|80899448|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27745571|NCT01070550|80899449|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27745572|NCT01070550|80899444|FG000|Overall Study|Early termination|3|||
27551090|NCT00434330|80203585|FG001|Overall Study|Withdrawal by Subject|0|||
27745573|NCT01070550|80899445|FG001|Overall Study|Early termination|0|||
27937248|NCT02883049|81607235|FG012|Induction|Developed SMN|0|||
27551091|NCT00434330|80203586|FG002|Overall Study|Withdrawal by Subject|1|||
27551092|NCT00434330|80203587|FG003|Overall Study|Withdrawal by Subject|1|||
27551093|NCT00434330|80203588|FG004|Overall Study|Withdrawal by Subject|0|||
27551094|NCT00434330|80203589|FG005|Overall Study|Withdrawal by Subject|0|||
27551095|NCT00434330|80203584|FG000|Overall Study|Renal transplant|0|||
27551096|NCT00434330|80203585|FG001|Overall Study|Renal transplant|0|||
27551097|NCT00434330|80203586|FG002|Overall Study|Renal transplant|0|||
27551098|NCT00434330|80203587|FG003|Overall Study|Renal transplant|1|||
27551099|NCT00434330|80203588|FG004|Overall Study|Renal transplant|0|||
27745574|NCT01070550|80899446|FG002|Overall Study|Early termination|0|||
27745575|NCT01070550|80899447|FG003|Overall Study|Early termination|0|||
27745576|NCT01070550|80899448|FG004|Overall Study|Early termination|0|||
27937249|NCT02883049|81607236|FG013|Induction|Developed SMN|0|||
27937250|NCT02883049|81607237|FG014|Induction|Developed SMN|0|||
27937251|NCT02883049|81607238|FG015|Induction|Developed SMN|0|||
27644824|NCT04029090|80539091|FG001|Overall Study|Withdrawal by Subject|1|||
27644825|NCT04029090|80539092|FG002|Overall Study|Withdrawal by Subject|0|||
27644826|NCT02844439|80539093|FG000|Overall Study|Withdrawal by Subject|1|||
27745577|NCT01070550|80899449|FG005|Overall Study|Early termination|0|||
27745578|NCT01070550|80899444|FG000|Overall Study|Failed to return|450|||
27745579|NCT01070550|80899445|FG001|Overall Study|Failed to return|33|||
27745580|NCT01070550|80899446|FG002|Overall Study|Failed to return|144|||
27745581|NCT01070550|80899447|FG003|Overall Study|Failed to return|40|||
27745582|NCT01070550|80899448|FG004|Overall Study|Failed to return|1|||
27644827|NCT02844439|80539093|FG000|Overall Study|Lost to Follow-up|2|||
27644828|NCT02844439|80539093|FG000|Overall Study|Termination by Sponsor|4|||
27644829|NCT02844439|80539093|FG000|Overall Study|Death|28|||
27644830|NCT02844439|80539093|FG000|Overall Study|Other|5|||
27644831|NCT02406092|80539098|FG000|Overall Study|Screen failure|10|||
27745583|NCT01070550|80899449|FG005|Overall Study|Failed to return|2|||
27745584|NCT01070550|80899444|FG000|Overall Study|Incomplete treatment|2|||
27745585|NCT01070550|80899445|FG001|Overall Study|Incomplete treatment|0|||
27745586|NCT01070550|80899446|FG002|Overall Study|Incomplete treatment|0|||
27745587|NCT01070550|80899447|FG003|Overall Study|Incomplete treatment|0|||
27745588|NCT01070550|80899448|FG004|Overall Study|Incomplete treatment|0|||
27745589|NCT01070550|80899449|FG005|Overall Study|Incomplete treatment|0|||
27745590|NCT01070550|80899444|FG000|Overall Study|Lab test not done|22|||
27745591|NCT01070550|80899445|FG001|Overall Study|Lab test not done|3|||
27745592|NCT01070550|80899446|FG002|Overall Study|Lab test not done|4|||
27745593|NCT01070550|80899447|FG003|Overall Study|Lab test not done|1|||
27745594|NCT01070550|80899448|FG004|Overall Study|Lab test not done|0|||
27745595|NCT01070550|80899449|FG005|Overall Study|Lab test not done|1|||
27745596|NCT01070550|80899444|FG000|Overall Study|Lack of Efficacy|65|||
27745597|NCT01070550|80899445|FG001|Overall Study|Lack of Efficacy|1|||
27745598|NCT01070550|80899446|FG002|Overall Study|Lack of Efficacy|5|||
27745599|NCT01070550|80899447|FG003|Overall Study|Lack of Efficacy|5|||
27745600|NCT01070550|80899448|FG004|Overall Study|Lack of Efficacy|0|||
27745601|NCT01070550|80899449|FG005|Overall Study|Lack of Efficacy|1|||
27745602|NCT01070550|80899444|FG000|Overall Study|Miscellaneous|12|||
27745603|NCT01070550|80899445|FG001|Overall Study|Miscellaneous|2|||
27745604|NCT01070550|80899446|FG002|Overall Study|Miscellaneous|3|||
27745605|NCT01070550|80899447|FG003|Overall Study|Miscellaneous|1|||
27745606|NCT01070550|80899448|FG004|Overall Study|Miscellaneous|0|||
27745607|NCT01070550|80899449|FG005|Overall Study|Miscellaneous|0|||
27745608|NCT01070550|80899444|FG000|Overall Study|New treatment started|3|||
27745609|NCT01070550|80899445|FG001|Overall Study|New treatment started|1|||
27745610|NCT01070550|80899446|FG002|Overall Study|New treatment started|0|||
27745611|NCT01070550|80899447|FG003|Overall Study|New treatment started|2|||
27745612|NCT01070550|80899448|FG004|Overall Study|New treatment started|0|||
27745613|NCT01070550|80899449|FG005|Overall Study|New treatment started|0|||
27745614|NCT01070550|80899444|FG000|Overall Study|Non-responders|493|||
27745615|NCT01070550|80899445|FG001|Overall Study|Non-responders|4|||
27745616|NCT01070550|80899446|FG002|Overall Study|Non-responders|21|||
27745617|NCT01070550|80899447|FG003|Overall Study|Non-responders|20|||
27745618|NCT01070550|80899448|FG004|Overall Study|Non-responders|0|||
27745619|NCT01070550|80899449|FG005|Overall Study|Non-responders|2|||
27745620|NCT01070550|80899444|FG000|Overall Study|Not categorized|33|||
27745621|NCT01070550|80899445|FG001|Overall Study|Not categorized|2|||
27745622|NCT01070550|80899446|FG002|Overall Study|Not categorized|6|||
27745623|NCT01070550|80899447|FG003|Overall Study|Not categorized|1|||
27745624|NCT01070550|80899448|FG004|Overall Study|Not categorized|0|||
27745625|NCT01070550|80899449|FG005|Overall Study|Not categorized|1|||
27745626|NCT01070550|80899444|FG000|Overall Study|Protocol Violation|15|||
27745627|NCT01070550|80899445|FG001|Overall Study|Protocol Violation|1|||
27937252|NCT02883049|81607223|FG000|Induction|Enrolled onto another COG study|72|||
27937253|NCT02883049|81607224|FG001|Induction|Enrolled onto another COG study|0|||
27745628|NCT01070550|80899446|FG002|Overall Study|Protocol Violation|1|||
27745629|NCT01070550|80899447|FG003|Overall Study|Protocol Violation|1|||
27745630|NCT01070550|80899448|FG004|Overall Study|Protocol Violation|0|||
27745631|NCT01070550|80899449|FG005|Overall Study|Protocol Violation|0|||
27745632|NCT01070550|80899444|FG000|Overall Study|Relapse|44|||
27745633|NCT01070550|80899445|FG001|Overall Study|Relapse|5|||
27745634|NCT01070550|80899446|FG002|Overall Study|Relapse|14|||
27745635|NCT01070550|80899447|FG003|Overall Study|Relapse|4|||
27551100|NCT00434330|80203589|FG005|Overall Study|Renal transplant|0|||
27644832|NCT02406092|80539099|FG001|Overall Study|Screen failure|7|||
27644833|NCT02406092|80539098|FG000|Overall Study|Death|22|||
27745636|NCT01070550|80899448|FG004|Overall Study|Relapse|0|||
27745637|NCT01070550|80899449|FG005|Overall Study|Relapse|0|||
27745638|NCT01070550|80899444|FG000|Overall Study|Result not available|3|||
27745639|NCT01070550|80899445|FG001|Overall Study|Result not available|1|||
27745640|NCT01070550|80899446|FG002|Overall Study|Result not available|3|||
27644834|NCT02406092|80539099|FG001|Overall Study|Death|5|||
27745641|NCT01070550|80899447|FG003|Overall Study|Result not available|0|||
27745642|NCT01070550|80899448|FG004|Overall Study|Result not available|0|||
27937254|NCT02883049|81607225|FG002|Induction|Enrolled onto another COG study|0|||
27937255|NCT02883049|81607226|FG003|Induction|Enrolled onto another COG study|0|||
27937256|NCT02883049|81607227|FG004|Induction|Enrolled onto another COG study|0|||
27937257|NCT02883049|81607228|FG005|Induction|Enrolled onto another COG study|0|||
27937258|NCT02883049|81607229|FG006|Induction|Enrolled onto another COG study|0|||
27937259|NCT02883049|81607230|FG007|Induction|Enrolled onto another COG study|0|||
27937260|NCT02883049|81607231|FG008|Induction|Enrolled onto another COG study|0|||
27937261|NCT02883049|81607232|FG009|Induction|Enrolled onto another COG study|0|||
27937262|NCT02883049|81607233|FG010|Induction|Enrolled onto another COG study|0|||
27937263|NCT02883049|81607234|FG011|Induction|Enrolled onto another COG study|0|||
27937264|NCT02883049|81607235|FG012|Induction|Enrolled onto another COG study|0|||
27937265|NCT02883049|81607236|FG013|Induction|Enrolled onto another COG study|0|||
27937266|NCT02883049|81607237|FG014|Induction|Enrolled onto another COG study|0|||
27937267|NCT02883049|81607238|FG015|Induction|Enrolled onto another COG study|0|||
27937268|NCT02883049|81607223|FG000|Induction|Incomplete induction data|17|||
27551101|NCT00434330|80203584|FG000|Overall Study|Subject Not Compliant With Study|0|||
27551102|NCT00434330|80203585|FG001|Overall Study|Subject Not Compliant With Study|0|||
27551103|NCT00434330|80203586|FG002|Overall Study|Subject Not Compliant With Study|1|||
27644835|NCT02406092|80539098|FG000|Overall Study|Lost to Follow-up|4|||
27644836|NCT02406092|80539099|FG001|Overall Study|Lost to Follow-up|1|||
27644837|NCT02406092|80539098|FG000|Overall Study|Adverse Event|1|||
27644838|NCT02406092|80539099|FG001|Overall Study|Adverse Event|0|||
27644839|NCT02406092|80539098|FG000|Overall Study|Withdrawal by Subject|1|||
27644840|NCT02406092|80539099|FG001|Overall Study|Withdrawal by Subject|0|||
27644841|NCT03351075|80539101|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
27644842|NCT03351075|80539102|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
27644843|NCT03351075|80539101|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
27644844|NCT03351075|80539102|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
27644845|NCT03351075|80539101|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
27644846|NCT03351075|80539102|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
27745643|NCT01070550|80899449|FG005|Overall Study|Result not available|0|||
27745644|NCT01070550|80899444|FG000|Overall Study|Screen failure|1|||
27745645|NCT01070550|80899445|FG001|Overall Study|Screen failure|0|||
27745646|NCT01070550|80899446|FG002|Overall Study|Screen failure|0|||
27551104|NCT00434330|80203587|FG003|Overall Study|Subject Not Compliant With Study|0|||
27551105|NCT00434330|80203588|FG004|Overall Study|Subject Not Compliant With Study|0|||
27551106|NCT00434330|80203589|FG005|Overall Study|Subject Not Compliant With Study|0|||
27551107|NCT02622321|80203590|FG000|Overall Study|Withdrawal by Subject|2|||
27551108|NCT02622321|80203591|FG001|Overall Study|Withdrawal by Subject|0|||
27551109|NCT02622321|80203592|FG002|Overall Study|Withdrawal by Subject|0|||
27551110|NCT02622321|80203593|FG003|Overall Study|Withdrawal by Subject|0|||
27551111|NCT02622321|80203590|FG000|Overall Study|Death|0|||
27551112|NCT02622321|80203591|FG001|Overall Study|Death|0|||
27551113|NCT02622321|80203592|FG002|Overall Study|Death|1|||
27551114|NCT02622321|80203593|FG003|Overall Study|Death|0|||
27551115|NCT02622321|80203590|FG000|Overall Study|Physician Decision|1|||
27551116|NCT02622321|80203591|FG001|Overall Study|Physician Decision|0|||
27551117|NCT02622321|80203592|FG002|Overall Study|Physician Decision|0|||
27551118|NCT02622321|80203593|FG003|Overall Study|Physician Decision|0|||
27551119|NCT01224431|80203594|FG000|Overall Study|not randomized|0|||
27551120|NCT01224431|80203595|FG001|Overall Study|not randomized|4|||
27551121|NCT01224431|80203594|FG000|Overall Study|no video record|0|||
27551122|NCT01224431|80203595|FG001|Overall Study|no video record|1|||
27551123|NCT02670837|80203603|FG000|Overall Study|Death|2|||
27551124|NCT02670837|80203604|FG001|Overall Study|Death|0|||
27551125|NCT02670837|80203605|FG002|Overall Study|Death|0|||
27551126|NCT01949506|80203611|FG000|Overall Study|Physician Decision|1|||
27551127|NCT01001377|80203617|FG000|Overall Study|Ineligibility determined|2|||
27551128|NCT01001377|80203618|FG001|Overall Study|Ineligibility determined|0|||
27551129|NCT01001377|80203617|FG000|Overall Study|Withdrawal by Subject|19|||
27551130|NCT01001377|80203618|FG001|Overall Study|Withdrawal by Subject|20|||
27551131|NCT01001377|80203617|FG000|Overall Study|Lost to Follow-up|14|||
27551132|NCT01001377|80203618|FG001|Overall Study|Lost to Follow-up|17|||
27644847|NCT03351075|80539101|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
27745647|NCT01070550|80899447|FG003|Overall Study|Screen failure|0|||
27937269|NCT02883049|81607224|FG001|Induction|Incomplete induction data|0|||
27937270|NCT02883049|81607225|FG002|Induction|Incomplete induction data|0|||
27937271|NCT02883049|81607226|FG003|Induction|Incomplete induction data|0|||
27937272|NCT02883049|81607227|FG004|Induction|Incomplete induction data|0|||
27937273|NCT02883049|81607228|FG005|Induction|Incomplete induction data|0|||
27937274|NCT02883049|81607229|FG006|Induction|Incomplete induction data|0|||
27551133|NCT01001377|80203617|FG000|Overall Study|Death|391|||
27551134|NCT01001377|80203618|FG001|Overall Study|Death|384|||
27551135|NCT03364023|80207367|FG000|Overall Study|Lost to Follow-up|3|||
27551136|NCT03364023|80207367|FG000|Overall Study|Death|14|||
27551137|NCT01029795|80207368|FG000|Overall Study|Entry Criteria Not Met|2|||
27644848|NCT03351075|80539102|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
27937275|NCT02883049|81607230|FG007|Induction|Incomplete induction data|0|||
27937276|NCT02883049|81607231|FG008|Induction|Incomplete induction data|0|||
27937277|NCT02883049|81607232|FG009|Induction|Incomplete induction data|0|||
27937278|NCT02883049|81607233|FG010|Induction|Incomplete induction data|0|||
27937279|NCT02883049|81607234|FG011|Induction|Incomplete induction data|0|||
27937280|NCT02883049|81607235|FG012|Induction|Incomplete induction data|0|||
27937281|NCT02883049|81607236|FG013|Induction|Incomplete induction data|0|||
27937282|NCT02883049|81607237|FG014|Induction|Incomplete induction data|0|||
27937283|NCT02883049|81607238|FG015|Induction|Incomplete induction data|0|||
27937284|NCT02883049|81607223|FG000|Post Induction|Adverse Event|0|||
27745648|NCT01070550|80899448|FG004|Overall Study|Screen failure|0|||
27745649|NCT01070550|80899449|FG005|Overall Study|Screen failure|0|||
27745650|NCT01070550|80899444|FG000|Overall Study|Sponsor decision|1|||
27745651|NCT01070550|80899445|FG001|Overall Study|Sponsor decision|0|||
27745652|NCT01070550|80899446|FG002|Overall Study|Sponsor decision|0|||
27745653|NCT01070550|80899447|FG003|Overall Study|Sponsor decision|0|||
27745654|NCT01070550|80899448|FG004|Overall Study|Sponsor decision|0|||
27745655|NCT01070550|80899449|FG005|Overall Study|Sponsor decision|0|||
27745656|NCT01070550|80899444|FG000|Overall Study|Treatment duration shortened|1|||
27745657|NCT01070550|80899445|FG001|Overall Study|Treatment duration shortened|0|||
27745658|NCT01070550|80899446|FG002|Overall Study|Treatment duration shortened|0|||
27745659|NCT01070550|80899447|FG003|Overall Study|Treatment duration shortened|0|||
27745660|NCT01070550|80899448|FG004|Overall Study|Treatment duration shortened|0|||
27745661|NCT01070550|80899449|FG005|Overall Study|Treatment duration shortened|0|||
27745662|NCT01070550|80899444|FG000|Overall Study|Treatment interrupted|7|||
27745663|NCT01070550|80899445|FG001|Overall Study|Treatment interrupted|0|||
27937285|NCT02883049|81607224|FG001|Post Induction|Adverse Event|0|||
27937286|NCT02883049|81607225|FG002|Post Induction|Adverse Event|0|||
27937287|NCT02883049|81607226|FG003|Post Induction|Adverse Event|7|||
27937288|NCT02883049|81607227|FG004|Post Induction|Adverse Event|8|||
27937289|NCT02883049|81607228|FG005|Post Induction|Adverse Event|3|||
27937290|NCT02883049|81607229|FG006|Post Induction|Adverse Event|4|||
27937291|NCT02883049|81607230|FG007|Post Induction|Adverse Event|5|||
27937292|NCT02883049|81607231|FG008|Post Induction|Adverse Event|6|||
27937293|NCT02883049|81607232|FG009|Post Induction|Adverse Event|7|||
27937294|NCT02883049|81607233|FG010|Post Induction|Adverse Event|2|||
27937295|NCT02883049|81607234|FG011|Post Induction|Adverse Event|2|||
27937296|NCT02883049|81607235|FG012|Post Induction|Adverse Event|0|||
27937297|NCT02883049|81607236|FG013|Post Induction|Adverse Event|0|||
27937298|NCT02883049|81607237|FG014|Post Induction|Adverse Event|5|||
27937299|NCT02883049|81607238|FG015|Post Induction|Adverse Event|2|||
27937300|NCT02883049|81607223|FG000|Post Induction|Death|0|||
27937301|NCT02883049|81607224|FG001|Post Induction|Death|0|||
27937302|NCT02883049|81607225|FG002|Post Induction|Death|0|||
27937303|NCT02883049|81607226|FG003|Post Induction|Death|9|||
27937304|NCT02883049|81607227|FG004|Post Induction|Death|9|||
27937305|NCT02883049|81607228|FG005|Post Induction|Death|0|||
27937306|NCT02883049|81607229|FG006|Post Induction|Death|1|||
27937307|NCT02883049|81607230|FG007|Post Induction|Death|6|||
27937308|NCT02883049|81607231|FG008|Post Induction|Death|5|||
27745664|NCT01070550|80899446|FG002|Overall Study|Treatment interrupted|1|||
27745665|NCT01070550|80899447|FG003|Overall Study|Treatment interrupted|1|||
27745666|NCT01070550|80899448|FG004|Overall Study|Treatment interrupted|0|||
27745667|NCT01070550|80899449|FG005|Overall Study|Treatment interrupted|0|||
27745668|NCT01070550|80899444|FG000|Overall Study|Treatment not started|14|||
27745669|NCT01070550|80899445|FG001|Overall Study|Treatment not started|2|||
27745670|NCT01070550|80899446|FG002|Overall Study|Treatment not started|4|||
27745671|NCT01070550|80899447|FG003|Overall Study|Treatment not started|0|||
27745672|NCT01070550|80899448|FG004|Overall Study|Treatment not started|0|||
27745673|NCT01070550|80899449|FG005|Overall Study|Treatment not started|0|||
27937309|NCT02883049|81607232|FG009|Post Induction|Death|3|||
27937310|NCT02883049|81607233|FG010|Post Induction|Death|1|||
27937311|NCT02883049|81607234|FG011|Post Induction|Death|0|||
27937312|NCT02883049|81607235|FG012|Post Induction|Death|1|||
27937313|NCT02883049|81607236|FG013|Post Induction|Death|1|||
27937314|NCT02883049|81607237|FG014|Post Induction|Death|10|||
27937315|NCT02883049|81607238|FG015|Post Induction|Death|2|||
27937316|NCT02883049|81607223|FG000|Post Induction|Lost to Follow-up|0|||
27937317|NCT02883049|81607224|FG001|Post Induction|Lost to Follow-up|0|||
27745674|NCT01070550|80899444|FG000|Overall Study|Treatment restarted|0|||
27745675|NCT01070550|80899445|FG001|Overall Study|Treatment restarted|1|||
27745676|NCT01070550|80899446|FG002|Overall Study|Treatment restarted|0|||
27745677|NCT01070550|80899447|FG003|Overall Study|Treatment restarted|0|||
27937318|NCT02883049|81607225|FG002|Post Induction|Lost to Follow-up|0|||
27937319|NCT02883049|81607226|FG003|Post Induction|Lost to Follow-up|0|||
27937320|NCT02883049|81607227|FG004|Post Induction|Lost to Follow-up|1|||
27745678|NCT01070550|80899448|FG004|Overall Study|Treatment restarted|0|||
27937321|NCT02883049|81607228|FG005|Post Induction|Lost to Follow-up|1|||
27937322|NCT02883049|81607229|FG006|Post Induction|Lost to Follow-up|0|||
27937323|NCT02883049|81607230|FG007|Post Induction|Lost to Follow-up|0|||
27745679|NCT01070550|80899449|FG005|Overall Study|Treatment restarted|0|||
27745680|NCT01070550|80899444|FG000|Overall Study|Treatment stopped|3|||
27745681|NCT01070550|80899445|FG001|Overall Study|Treatment stopped|0|||
27745682|NCT01070550|80899446|FG002|Overall Study|Treatment stopped|0|||
27745683|NCT01070550|80899447|FG003|Overall Study|Treatment stopped|0|||
27745684|NCT01070550|80899448|FG004|Overall Study|Treatment stopped|0|||
27937324|NCT02883049|81607231|FG008|Post Induction|Lost to Follow-up|3|||
27937325|NCT02883049|81607232|FG009|Post Induction|Lost to Follow-up|0|||
27937326|NCT02883049|81607233|FG010|Post Induction|Lost to Follow-up|1|||
27937327|NCT02883049|81607234|FG011|Post Induction|Lost to Follow-up|0|||
27937328|NCT02883049|81607235|FG012|Post Induction|Lost to Follow-up|0|||
27745685|NCT01070550|80899449|FG005|Overall Study|Treatment stopped|0|||
27745686|NCT01070550|80899444|FG000|Overall Study|Treatment unavailable|1|||
27745687|NCT01070550|80899445|FG001|Overall Study|Treatment unavailable|0|||
27745688|NCT01070550|80899446|FG002|Overall Study|Treatment unavailable|0|||
27745689|NCT01070550|80899447|FG003|Overall Study|Treatment unavailable|0|||
27745690|NCT01070550|80899448|FG004|Overall Study|Treatment unavailable|0|||
27937329|NCT02883049|81607236|FG013|Post Induction|Lost to Follow-up|0|||
27937330|NCT02883049|81607237|FG014|Post Induction|Lost to Follow-up|0|||
27937331|NCT02883049|81607238|FG015|Post Induction|Lost to Follow-up|0|||
27937332|NCT02883049|81607223|FG000|Post Induction|Physician Decision|0|||
27937333|NCT02883049|81607224|FG001|Post Induction|Physician Decision|0|||
27937334|NCT02883049|81607225|FG002|Post Induction|Physician Decision|0|||
27937335|NCT02883049|81607226|FG003|Post Induction|Physician Decision|27|||
27937336|NCT02883049|81607227|FG004|Post Induction|Physician Decision|27|||
27937337|NCT02883049|81607228|FG005|Post Induction|Physician Decision|23|||
27937338|NCT02883049|81607229|FG006|Post Induction|Physician Decision|30|||
27937339|NCT02883049|81607230|FG007|Post Induction|Physician Decision|56|||
27937340|NCT02883049|81607231|FG008|Post Induction|Physician Decision|85|||
27937341|NCT02883049|81607232|FG009|Post Induction|Physician Decision|12|||
27937342|NCT02883049|81607233|FG010|Post Induction|Physician Decision|5|||
27937343|NCT02883049|81607234|FG011|Post Induction|Physician Decision|14|||
27937344|NCT02883049|81607235|FG012|Post Induction|Physician Decision|1|||
27937345|NCT02883049|81607236|FG013|Post Induction|Physician Decision|11|||
27937346|NCT02883049|81607237|FG014|Post Induction|Physician Decision|19|||
27937347|NCT02883049|81607238|FG015|Post Induction|Physician Decision|5|||
27937348|NCT02883049|81607223|FG000|Post Induction|Protocol Violation|0|||
27937349|NCT02883049|81607224|FG001|Post Induction|Protocol Violation|0|||
27937350|NCT02883049|81607225|FG002|Post Induction|Protocol Violation|0|||
27937351|NCT02883049|81607226|FG003|Post Induction|Protocol Violation|0|||
27937352|NCT02883049|81607227|FG004|Post Induction|Protocol Violation|0|||
27937353|NCT02883049|81607228|FG005|Post Induction|Protocol Violation|0|||
27937354|NCT02883049|81607229|FG006|Post Induction|Protocol Violation|0|||
27745691|NCT01070550|80899449|FG005|Overall Study|Treatment unavailable|0|||
27745692|NCT01070550|80899444|FG000|Overall Study|Treatment was stopped early|7|||
27745693|NCT01070550|80899445|FG001|Overall Study|Treatment was stopped early|0|||
27745694|NCT01070550|80899446|FG002|Overall Study|Treatment was stopped early|0|||
27745695|NCT01070550|80899447|FG003|Overall Study|Treatment was stopped early|0|||
27745696|NCT01070550|80899448|FG004|Overall Study|Treatment was stopped early|0|||
27745697|NCT01070550|80899449|FG005|Overall Study|Treatment was stopped early|0|||
27745698|NCT01070550|80899444|FG000|Overall Study|Other|5|||
27745699|NCT01070550|80899445|FG001|Overall Study|Other|0|||
27745700|NCT01070550|80899446|FG002|Overall Study|Other|0|||
27745701|NCT01070550|80899447|FG003|Overall Study|Other|1|||
27745702|NCT01070550|80899448|FG004|Overall Study|Other|0|||
27745703|NCT01070550|80899449|FG005|Overall Study|Other|0|||
27745704|NCT01070550|80899444|FG000|Overall Study|Withdrawal by Subject|35|||
27745705|NCT01070550|80899445|FG001|Overall Study|Withdrawal by Subject|0|||
27745706|NCT01070550|80899446|FG002|Overall Study|Withdrawal by Subject|3|||
27745707|NCT01070550|80899447|FG003|Overall Study|Withdrawal by Subject|0|||
27745708|NCT01070550|80899448|FG004|Overall Study|Withdrawal by Subject|0|||
27745709|NCT01070550|80899449|FG005|Overall Study|Withdrawal by Subject|0|||
27745710|NCT03123939|80899450|FG000|Overall Study|Lack of Efficacy|6|||
27745711|NCT03123939|80899450|FG000|Overall Study|Death|5|||
27745712|NCT03123939|80899450|FG000|Overall Study|Physician Decision|2|||
27745713|NCT03123939|80899450|FG000|Overall Study|Subject/guardian decision|2|||
27745714|NCT03123939|80899450|FG000|Overall Study|Lost to Follow-up|1|||
27745715|NCT03123939|80899450|FG000|Overall Study|New therapy for study indication|1|||
27937355|NCT02883049|81607230|FG007|Post Induction|Protocol Violation|1|||
27644849|NCT02972034|80539119|FG000|Overall Study|Death|11|||
27745716|NCT03123939|80899450|FG000|Overall Study|Protocol deviation|1|||
27937356|NCT02883049|81607231|FG008|Post Induction|Protocol Violation|0|||
27937357|NCT02883049|81607232|FG009|Post Induction|Protocol Violation|0|||
27937358|NCT02883049|81607233|FG010|Post Induction|Protocol Violation|0|||
27745717|NCT03123939|80899450|FG000|Overall Study|Progressive disease|18|||
27745718|NCT03123939|80899450|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
27754925|NCT02065622|80929630|FG000|Maintenance Study|Other, Not Specified|0|||
27937359|NCT02883049|81607234|FG011|Post Induction|Protocol Violation|0|||
27937360|NCT02883049|81607235|FG012|Post Induction|Protocol Violation|0|||
27937361|NCT02883049|81607236|FG013|Post Induction|Protocol Violation|0|||
27745719|NCT03123939|80899450|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
27745720|NCT01844700|80899451|FG000|Overall Study|Lack of Efficacy|1|||
27745721|NCT01844700|80899452|FG001|Overall Study|Lack of Efficacy|0|||
27745722|NCT01844700|80899451|FG000|Overall Study|refused medication switch|1|||
27745723|NCT01844700|80899452|FG001|Overall Study|refused medication switch|0|||
27745724|NCT01844700|80899451|FG000|Overall Study|Withdrawal by Subject|1|||
27745725|NCT01844700|80899452|FG001|Overall Study|Withdrawal by Subject|0|||
27745726|NCT01844700|80899451|FG000|Overall Study|stopped taking meds|0|||
27644850|NCT02972034|80539120|FG001|Overall Study|Death|1|||
27644851|NCT02972034|80539121|FG002|Overall Study|Death|3|||
27644852|NCT02972034|80539122|FG003|Overall Study|Death|3|||
27644853|NCT02972034|80539123|FG004|Overall Study|Death|2|||
27644854|NCT02972034|80539124|FG005|Overall Study|Death|2|||
27644855|NCT02972034|80539125|FG006|Overall Study|Death|3|||
27644856|NCT02972034|80539126|FG007|Overall Study|Death|4|||
27644857|NCT02972034|80539127|FG008|Overall Study|Death|8|||
27644858|NCT02972034|80539128|FG009|Overall Study|Death|11|||
27644859|NCT02972034|80539129|FG010|Overall Study|Death|3|||
27644860|NCT02972034|80539130|FG011|Overall Study|Death|2|||
27644861|NCT02972034|80539131|FG012|Overall Study|Death|11|||
27644862|NCT02972034|80539132|FG013|Overall Study|Death|10|||
27644863|NCT02972034|80539133|FG014|Overall Study|Death|9|||
27644864|NCT02972034|80539119|FG000|Overall Study|Lost to Follow-up|0|||
27644865|NCT02972034|80539120|FG001|Overall Study|Lost to Follow-up|0|||
27644866|NCT02972034|80539121|FG002|Overall Study|Lost to Follow-up|0|||
27745727|NCT01844700|80899452|FG001|Overall Study|stopped taking meds|1|||
27745728|NCT02084134|80899453|FG000|Overall Study|Protocol Violation|4|||
27745729|NCT02084134|80899454|FG001|Overall Study|Protocol Violation|2|||
27745730|NCT02084134|80899453|FG000|Overall Study|Death|0|||
27745731|NCT02084134|80899454|FG001|Overall Study|Death|1|||
27745732|NCT01734993|80899455|FG000|Overall Study|Adverse Event|1|||
27745733|NCT01734993|80899455|FG000|Overall Study|Lack of Efficacy|1|||
27745734|NCT02834403|80899456|FG000|Overall Study|Physician Decision|2|||
27745735|NCT02834403|80899457|FG001|Overall Study|Physician Decision|1|||
27745736|NCT02834403|80899458|FG002|Overall Study|Physician Decision|2|||
27745737|NCT02834403|80899459|FG003|Overall Study|Physician Decision|1|||
27745738|NCT02834403|80899460|FG004|Overall Study|Physician Decision|1|||
27745739|NCT02834403|80899461|FG005|Overall Study|Physician Decision|2|||
27745740|NCT02834403|80899462|FG006|Overall Study|Physician Decision|12|||
27745741|NCT02834403|80899456|FG000|Overall Study|Adverse Event|0|||
27745742|NCT02834403|80899457|FG001|Overall Study|Adverse Event|0|||
27745743|NCT02834403|80899458|FG002|Overall Study|Adverse Event|0|||
27745744|NCT02834403|80899459|FG003|Overall Study|Adverse Event|0|||
27745745|NCT02834403|80899460|FG004|Overall Study|Adverse Event|1|||
27745746|NCT02834403|80899461|FG005|Overall Study|Adverse Event|1|||
27745747|NCT02834403|80899462|FG006|Overall Study|Adverse Event|3|||
27745748|NCT02834403|80899456|FG000|Overall Study|Withdrawal by Subject|0|||
27745749|NCT02834403|80899457|FG001|Overall Study|Withdrawal by Subject|1|||
27745750|NCT02834403|80899458|FG002|Overall Study|Withdrawal by Subject|0|||
27745751|NCT02834403|80899459|FG003|Overall Study|Withdrawal by Subject|0|||
27745752|NCT02834403|80899460|FG004|Overall Study|Withdrawal by Subject|1|||
27745753|NCT02834403|80899461|FG005|Overall Study|Withdrawal by Subject|0|||
27745754|NCT02834403|80899462|FG006|Overall Study|Withdrawal by Subject|0|||
27745755|NCT02834403|80899456|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
27745756|NCT02834403|80899457|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
27745757|NCT02834403|80899458|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
27745758|NCT02834403|80899459|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
27745759|NCT02834403|80899460|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
27745760|NCT02834403|80899461|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
27745761|NCT02834403|80899462|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
27745762|NCT01605071|80899463|FG000|Overall Study|Withdrawal by Subject|3|||
27745763|NCT01605071|80899464|FG001|Overall Study|Withdrawal by Subject|2|||
27745764|NCT01004146|80899468|FG000|Overall Study|Withdrawal by Subject|4|||
27745765|NCT01004146|80899469|FG001|Overall Study|Withdrawal by Subject|5|||
27745766|NCT00950690|80899470|FG000|Overall Study|Death|4|||
27745767|NCT00950690|80899470|FG000|Overall Study|Adverse Event|15|||
27745768|NCT00950690|80899470|FG000|Overall Study|Lack of Efficacy|22|||
27745769|NCT00950690|80899470|FG000|Overall Study|Lost to Follow-up|40|||
27745770|NCT00950690|80899470|FG000|Overall Study|Other|163|||
27745771|NCT02839746|80899471|FG000|Overall Study|Not met selection criteria|12|||
27745772|NCT01809262|80899472|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745773|NCT01809262|80899473|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745774|NCT01809262|80899474|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745775|NCT01809262|80899475|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
27644867|NCT02972034|80539122|FG003|Overall Study|Lost to Follow-up|0|||
27644868|NCT02972034|80539123|FG004|Overall Study|Lost to Follow-up|1|||
27644869|NCT02972034|80539124|FG005|Overall Study|Lost to Follow-up|0|||
27644870|NCT02972034|80539125|FG006|Overall Study|Lost to Follow-up|0|||
27745776|NCT01809262|80899476|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
27745777|NCT01809262|80899477|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745778|NCT01809262|80899478|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745779|NCT01809262|80899479|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745780|NCT01809262|80899480|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745781|NCT01809262|80899481|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
27745782|NCT01809262|80899472|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745783|NCT01809262|80899473|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
27745784|NCT01809262|80899474|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745785|NCT01809262|80899475|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745786|NCT01809262|80899476|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745787|NCT01809262|80899477|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745788|NCT01809262|80899478|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745789|NCT01809262|80899479|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745790|NCT01809262|80899480|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745791|NCT01809262|80899481|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
27745792|NCT02538666|80899482|FG000|Pre-Treatment|Disease progression|1|||
27745793|NCT02538666|80899483|FG001|Pre-Treatment|Disease progression|0|||
27745794|NCT02538666|80899484|FG002|Pre-Treatment|Disease progression|0|||
27745795|NCT02538666|80899482|FG000|Pre-Treatment|no longer meets study criteria|1|||
27745796|NCT02538666|80899483|FG001|Pre-Treatment|no longer meets study criteria|0|||
27745797|NCT02538666|80899484|FG002|Pre-Treatment|no longer meets study criteria|0|||
27745798|NCT02538666|80899482|FG000|Pre-Treatment|Withdrew Consent|0|||
27745799|NCT02538666|80899483|FG001|Pre-Treatment|Withdrew Consent|1|||
27745800|NCT02538666|80899484|FG002|Pre-Treatment|Withdrew Consent|1|||
27745801|NCT02538666|80899482|FG000|Treatment|Disease progression|270|||
27745802|NCT02538666|80899483|FG001|Treatment|Disease progression|227|||
27745803|NCT02538666|80899484|FG002|Treatment|Disease progression|165|||
27745804|NCT02538666|80899482|FG000|Treatment|Study drug toxicity|1|||
27745805|NCT02538666|80899483|FG001|Treatment|Study drug toxicity|29|||
27745806|NCT02538666|80899484|FG002|Treatment|Study drug toxicity|92|||
27745807|NCT02538666|80899482|FG000|Treatment|Death|0|||
27745808|NCT02538666|80899483|FG001|Treatment|Death|2|||
27551138|NCT01029795|80207369|FG001|Overall Study|Entry Criteria Not Met|1|||
27551139|NCT01029795|80207368|FG000|Overall Study|Physician Decision|2|||
27551140|NCT01029795|80207369|FG001|Overall Study|Physician Decision|1|||
27551141|NCT01029795|80207368|FG000|Overall Study|Sponsor Decision|11|||
27551142|NCT01029795|80207369|FG001|Overall Study|Sponsor Decision|17|||
27551143|NCT01029795|80207368|FG000|Overall Study|Withdrawal by Subject|1|||
27551144|NCT01029795|80207369|FG001|Overall Study|Withdrawal by Subject|3|||
27745809|NCT02538666|80899484|FG002|Treatment|Death|3|||
27745810|NCT02538666|80899482|FG000|Treatment|Adverse event unrelated to study drug|8|||
27745811|NCT02538666|80899483|FG001|Treatment|Adverse event unrelated to study drug|10|||
27745812|NCT02538666|80899484|FG002|Treatment|Adverse event unrelated to study drug|15|||
27745813|NCT02538666|80899482|FG000|Treatment|Participant request to discontinue study treatment|3|||
27745814|NCT02538666|80899483|FG001|Treatment|Participant request to discontinue study treatment|6|||
27745815|NCT02538666|80899484|FG002|Treatment|Participant request to discontinue study treatment|11|||
27745816|NCT02538666|80899482|FG000|Treatment|Participant withdrew consent|2|||
27745817|NCT02538666|80899483|FG001|Treatment|Participant withdrew consent|5|||
27937362|NCT02883049|81607237|FG014|Post Induction|Protocol Violation|0|||
27937363|NCT02883049|81607238|FG015|Post Induction|Protocol Violation|0|||
27937364|NCT02883049|81607223|FG000|Post Induction|Withdrawal by Subject|0|||
27937365|NCT02883049|81607224|FG001|Post Induction|Withdrawal by Subject|0|||
27937366|NCT02883049|81607225|FG002|Post Induction|Withdrawal by Subject|0|||
27937367|NCT02883049|81607226|FG003|Post Induction|Withdrawal by Subject|5|||
27937368|NCT02883049|81607227|FG004|Post Induction|Withdrawal by Subject|2|||
27937369|NCT02883049|81607228|FG005|Post Induction|Withdrawal by Subject|1|||
27745818|NCT02538666|80899484|FG002|Treatment|Participant withdrew consent|3|||
27745819|NCT02538666|80899482|FG000|Treatment|Lost to Follow-up|0|||
27745820|NCT02538666|80899483|FG001|Treatment|Lost to Follow-up|1|||
27745821|NCT02538666|80899484|FG002|Treatment|Lost to Follow-up|1|||
27745822|NCT02538666|80899482|FG000|Treatment|Maximum clinical benefit|4|||
27745823|NCT02538666|80899483|FG001|Treatment|Maximum clinical benefit|3|||
27745824|NCT02538666|80899484|FG002|Treatment|Maximum clinical benefit|4|||
27745825|NCT02538666|80899482|FG000|Treatment|Poor/non-compliance|0|||
27745826|NCT02538666|80899483|FG001|Treatment|Poor/non-compliance|1|||
27745827|NCT02538666|80899484|FG002|Treatment|Poor/non-compliance|0|||
27745828|NCT02538666|80899482|FG000|Treatment|Participant no longer meets study criteria|0|||
27937370|NCT02883049|81607229|FG006|Post Induction|Withdrawal by Subject|0|||
27551145|NCT01339429|80207370|FG000|Overall Study|Withdrawal by Subject|1|||
27551146|NCT01339429|80207370|FG000|Overall Study|Physician Decision|3|||
27745829|NCT02538666|80899483|FG001|Treatment|Participant no longer meets study criteria|2|||
27937371|NCT02883049|81607230|FG007|Post Induction|Withdrawal by Subject|0|||
27745830|NCT02538666|80899484|FG002|Treatment|Participant no longer meets study criteria|0|||
27745831|NCT02538666|80899482|FG000|Treatment|Administrative reason by sponsor|0|||
27745832|NCT02538666|80899483|FG001|Treatment|Administrative reason by sponsor|0|||
27745833|NCT02538666|80899484|FG002|Treatment|Administrative reason by sponsor|1|||
27745834|NCT02538666|80899482|FG000|Treatment|Other reasons|8|||
27745835|NCT02538666|80899483|FG001|Treatment|Other reasons|15|||
27745836|NCT02538666|80899484|FG002|Treatment|Other reasons|5|||
27745837|NCT02538666|80899482|FG000|Treatment|Not reported|2|||
27745838|NCT02538666|80899483|FG001|Treatment|Not reported|2|||
27745839|NCT02538666|80899484|FG002|Treatment|Not reported|2|||
27745840|NCT00849693|80899485|FG000|Acute Treatment Phase|Adverse Event|12|||
27745841|NCT00849693|80899486|FG001|Acute Treatment Phase|Adverse Event|7|||
27745842|NCT00849693|80899487|FG002|Acute Treatment Phase|Adverse Event|6|||
27745843|NCT00849693|80899488|FG003|Acute Treatment Phase|Adverse Event|4|||
27745844|NCT00849693|80899485|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
27745845|NCT00849693|80899486|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
27745846|NCT00849693|80899487|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
27745847|NCT00849693|80899488|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
27745848|NCT00849693|80899485|FG000|Acute Treatment Phase|Protocol Violation|1|||
27745849|NCT00849693|80899486|FG001|Acute Treatment Phase|Protocol Violation|5|||
27745850|NCT00849693|80899487|FG002|Acute Treatment Phase|Protocol Violation|2|||
27745851|NCT00849693|80899488|FG003|Acute Treatment Phase|Protocol Violation|6|||
27745852|NCT00849693|80899485|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
27745853|NCT00849693|80899486|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
27745854|NCT00849693|80899487|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
27745855|NCT00849693|80899488|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
27745856|NCT00849693|80899485|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
27745857|NCT00849693|80899486|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
27745858|NCT00849693|80899487|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
27745859|NCT00849693|80899488|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
27745860|NCT00849693|80899485|FG000|Acute Treatment Phase|Physician Decision|2|||
27745861|NCT00849693|80899486|FG001|Acute Treatment Phase|Physician Decision|1|||
27745862|NCT00849693|80899487|FG002|Acute Treatment Phase|Physician Decision|2|||
27745863|NCT00849693|80899488|FG003|Acute Treatment Phase|Physician Decision|1|||
27745864|NCT00849693|80899485|FG000|Acute Treatment Phase|Sponsor decision|0|||
27745865|NCT00849693|80899486|FG001|Acute Treatment Phase|Sponsor decision|0|||
27745866|NCT00849693|80899487|FG002|Acute Treatment Phase|Sponsor decision|1|||
27745867|NCT00849693|80899488|FG003|Acute Treatment Phase|Sponsor decision|0|||
27745868|NCT00849693|80899485|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
27745869|NCT00849693|80899486|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
27745870|NCT00849693|80899487|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
27745871|NCT00849693|80899488|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
27745872|NCT00849693|80899485|FG000|Extension Phase|Adverse Event|4|||
27745873|NCT00849693|80899486|FG001|Extension Phase|Adverse Event|6|||
27745874|NCT00849693|80899487|FG002|Extension Phase|Adverse Event|3|||
27745875|NCT00849693|80899488|FG003|Extension Phase|Adverse Event|7|||
27745876|NCT00849693|80899485|FG000|Extension Phase|Lost to Follow-up|7|||
27745877|NCT00849693|80899486|FG001|Extension Phase|Lost to Follow-up|5|||
27745878|NCT00849693|80899487|FG002|Extension Phase|Lost to Follow-up|6|||
27745879|NCT00849693|80899488|FG003|Extension Phase|Lost to Follow-up|6|||
27745880|NCT00849693|80899485|FG000|Extension Phase|Protocol Violation|0|||
27745881|NCT00849693|80899486|FG001|Extension Phase|Protocol Violation|3|||
27745882|NCT00849693|80899487|FG002|Extension Phase|Protocol Violation|2|||
27745883|NCT00849693|80899488|FG003|Extension Phase|Protocol Violation|3|||
27745884|NCT00849693|80899485|FG000|Extension Phase|Withdrawal by Subject|6|||
27745885|NCT00849693|80899486|FG001|Extension Phase|Withdrawal by Subject|9|||
27745886|NCT00849693|80899487|FG002|Extension Phase|Withdrawal by Subject|10|||
27745887|NCT00849693|80899488|FG003|Extension Phase|Withdrawal by Subject|15|||
27745888|NCT00849693|80899485|FG000|Extension Phase|Parent or caregiver decision|9|||
27745889|NCT00849693|80899486|FG001|Extension Phase|Parent or caregiver decision|4|||
27745890|NCT00849693|80899487|FG002|Extension Phase|Parent or caregiver decision|10|||
27745891|NCT00849693|80899488|FG003|Extension Phase|Parent or caregiver decision|5|||
27745892|NCT00849693|80899485|FG000|Extension Phase|Physician Decision|1|||
27745893|NCT00849693|80899486|FG001|Extension Phase|Physician Decision|1|||
27937372|NCT02883049|81607231|FG008|Post Induction|Withdrawal by Subject|2|||
27745894|NCT00849693|80899487|FG002|Extension Phase|Physician Decision|2|||
27745895|NCT00849693|80899488|FG003|Extension Phase|Physician Decision|0|||
27745896|NCT00849693|80899485|FG000|Extension Phase|Sponsor decision|1|||
27745897|NCT00849693|80899486|FG001|Extension Phase|Sponsor decision|0|||
27745898|NCT00849693|80899487|FG002|Extension Phase|Sponsor decision|0|||
27745899|NCT00849693|80899488|FG003|Extension Phase|Sponsor decision|1|||
27745900|NCT00849693|80899485|FG000|Extension Phase|Lack of Efficacy|2|||
27937373|NCT02883049|81607232|FG009|Post Induction|Withdrawal by Subject|0|||
27745901|NCT00849693|80899486|FG001|Extension Phase|Lack of Efficacy|2|||
27745902|NCT00849693|80899487|FG002|Extension Phase|Lack of Efficacy|2|||
27745903|NCT00849693|80899488|FG003|Extension Phase|Lack of Efficacy|1|||
27745904|NCT01486316|80899493|FG000|Overall Study|Device explanted with/without re-implant|3|||
27755001|NCT04937816|80929649|FG000|Overall Study|Adverse Event|303|||
27745905|NCT01486316|80899494|FG001|Overall Study|Device explanted with/without re-implant|2|||
27937374|NCT02883049|81607233|FG010|Post Induction|Withdrawal by Subject|1|||
27937375|NCT02883049|81607234|FG011|Post Induction|Withdrawal by Subject|1|||
27937376|NCT02883049|81607235|FG012|Post Induction|Withdrawal by Subject|0|||
27937377|NCT02883049|81607236|FG013|Post Induction|Withdrawal by Subject|0|||
27937378|NCT02883049|81607237|FG014|Post Induction|Withdrawal by Subject|1|||
27937379|NCT02883049|81607238|FG015|Post Induction|Withdrawal by Subject|0|||
27937380|NCT02883049|81607223|FG000|Post Induction|Ineligible|0|||
27937381|NCT02883049|81607224|FG001|Post Induction|Ineligible|0|||
27937382|NCT02883049|81607225|FG002|Post Induction|Ineligible|2|||
27937383|NCT02883049|81607226|FG003|Post Induction|Ineligible|0|||
27937384|NCT02883049|81607227|FG004|Post Induction|Ineligible|0|||
27745906|NCT01486316|80899495|FG002|Overall Study|Device explanted with/without re-implant|0|||
27745907|NCT01486316|80899496|FG003|Overall Study|Device explanted with/without re-implant|2|||
27745908|NCT01486316|80899493|FG000|Overall Study|Not meeting eligibility criteria|0|||
27745909|NCT01486316|80899494|FG001|Overall Study|Not meeting eligibility criteria|0|||
27745910|NCT01486316|80899495|FG002|Overall Study|Not meeting eligibility criteria|1|||
27745911|NCT01486316|80899496|FG003|Overall Study|Not meeting eligibility criteria|0|||
27745912|NCT01486316|80899493|FG000|Overall Study|Withdrawal by Subject|1|||
27745913|NCT01486316|80899494|FG001|Overall Study|Withdrawal by Subject|0|||
27745914|NCT01486316|80899495|FG002|Overall Study|Withdrawal by Subject|3|||
27745915|NCT01486316|80899496|FG003|Overall Study|Withdrawal by Subject|0|||
27745916|NCT01486316|80899493|FG000|Overall Study|Physician Decision|0|||
27745917|NCT01486316|80899494|FG001|Overall Study|Physician Decision|0|||
27745918|NCT01486316|80899495|FG002|Overall Study|Physician Decision|1|||
27745919|NCT01486316|80899496|FG003|Overall Study|Physician Decision|0|||
27745920|NCT01486316|80899493|FG000|Overall Study|Death|0|||
27745921|NCT01486316|80899494|FG001|Overall Study|Death|1|||
27745922|NCT01486316|80899495|FG002|Overall Study|Death|0|||
27745923|NCT01486316|80899496|FG003|Overall Study|Death|0|||
27745924|NCT02433210|80899499|FG000|Overall Study|Physician Decision|1|||
27745925|NCT02433210|80899500|FG001|Overall Study|Physician Decision|0|||
27745926|NCT02433210|80899501|FG002|Overall Study|Physician Decision|0|||
27937385|NCT02883049|81607228|FG005|Post Induction|Ineligible|0|||
27937386|NCT02883049|81607229|FG006|Post Induction|Ineligible|1|||
27937387|NCT02883049|81607230|FG007|Post Induction|Ineligible|0|||
27937388|NCT02883049|81607231|FG008|Post Induction|Ineligible|0|||
27937389|NCT02883049|81607232|FG009|Post Induction|Ineligible|0|||
27937390|NCT02883049|81607233|FG010|Post Induction|Ineligible|1|||
27937391|NCT02883049|81607234|FG011|Post Induction|Ineligible|0|||
27937392|NCT02883049|81607235|FG012|Post Induction|Ineligible|0|||
27937393|NCT02883049|81607236|FG013|Post Induction|Ineligible|0|||
27937394|NCT02883049|81607237|FG014|Post Induction|Ineligible|0|||
27937395|NCT02883049|81607238|FG015|Post Induction|Ineligible|1|||
27937396|NCT02883049|81607223|FG000|Post Induction|Refusal of further protocol therapy|0|||
27937397|NCT02883049|81607224|FG001|Post Induction|Refusal of further protocol therapy|0|||
27937398|NCT02883049|81607225|FG002|Post Induction|Refusal of further protocol therapy|0|||
27937399|NCT02883049|81607226|FG003|Post Induction|Refusal of further protocol therapy|11|||
27937400|NCT02883049|81607227|FG004|Post Induction|Refusal of further protocol therapy|15|||
27937401|NCT02883049|81607228|FG005|Post Induction|Refusal of further protocol therapy|9|||
27937402|NCT02883049|81607229|FG006|Post Induction|Refusal of further protocol therapy|13|||
27937403|NCT02883049|81607230|FG007|Post Induction|Refusal of further protocol therapy|5|||
27937404|NCT02883049|81607231|FG008|Post Induction|Refusal of further protocol therapy|21|||
27937405|NCT02883049|81607232|FG009|Post Induction|Refusal of further protocol therapy|7|||
27937406|NCT02883049|81607233|FG010|Post Induction|Refusal of further protocol therapy|0|||
27937407|NCT02883049|81607234|FG011|Post Induction|Refusal of further protocol therapy|7|||
27937408|NCT02883049|81607235|FG012|Post Induction|Refusal of further protocol therapy|3|||
27937409|NCT02883049|81607236|FG013|Post Induction|Refusal of further protocol therapy|0|||
27937410|NCT02883049|81607237|FG014|Post Induction|Refusal of further protocol therapy|4|||
27937411|NCT02883049|81607238|FG015|Post Induction|Refusal of further protocol therapy|1|||
27937412|NCT02883049|81607223|FG000|Post Induction|Inevaluable|0|||
27937413|NCT02883049|81607224|FG001|Post Induction|Inevaluable|0|||
27937414|NCT02883049|81607225|FG002|Post Induction|Inevaluable|0|||
27937415|NCT02883049|81607226|FG003|Post Induction|Inevaluable|1|||
27937416|NCT02883049|81607227|FG004|Post Induction|Inevaluable|1|||
27937417|NCT02883049|81607228|FG005|Post Induction|Inevaluable|2|||
27745927|NCT01323673|80899502|FG000|Overall Study|Adverse Event|0|||
27937418|NCT02883049|81607229|FG006|Post Induction|Inevaluable|7|||
27937419|NCT02883049|81607230|FG007|Post Induction|Inevaluable|6|||
27937420|NCT02883049|81607231|FG008|Post Induction|Inevaluable|4|||
27745928|NCT01323673|80899503|FG001|Overall Study|Adverse Event|1|||
27745929|NCT01323673|80899502|FG000|Overall Study|Lost to Follow-up|0|||
27745930|NCT01323673|80899503|FG001|Overall Study|Lost to Follow-up|1|||
27745931|NCT01323673|80899502|FG000|Overall Study|Protocol Violation|1|||
27745932|NCT01323673|80899503|FG001|Overall Study|Protocol Violation|0|||
27937421|NCT02883049|81607232|FG009|Post Induction|Inevaluable|4|||
27937422|NCT02883049|81607233|FG010|Post Induction|Inevaluable|1|||
27745933|NCT01323673|80899502|FG000|Overall Study|Withdrawal by Subject|2|||
27745934|NCT01323673|80899503|FG001|Overall Study|Withdrawal by Subject|3|||
27745935|NCT01197378|80899504|FG000|Overall Study|Adverse Event|3|||
27745936|NCT01197378|80899504|FG000|Overall Study|Withdrawal by Subject|1|||
27745937|NCT01197378|80899504|FG000|Overall Study|Physician Decision|1|||
27745938|NCT01197378|80899504|FG000|Overall Study|Other|2|||
27745939|NCT00844428|80899505|FG000|Screening Period|Screen Failure|3|||
27745940|NCT00844428|80899505|FG000|Extension Treatment Period|Death|1|||
27745941|NCT00844428|80899505|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
27745942|NCT00700752|80899507|FG000|First Intervention|Withdrawal by Subject|0|||
27745943|NCT00700752|80899508|FG001|First Intervention|Withdrawal by Subject|2|||
27745944|NCT01555463|80899509|FG000|Treatment|Adverse Event|6|||
27745945|NCT01555463|80899510|FG001|Treatment|Adverse Event|12|||
27745946|NCT01555463|80899509|FG000|Treatment|Withdrawal by Subject|24|||
27745947|NCT01555463|80899510|FG001|Treatment|Withdrawal by Subject|36|||
27745948|NCT01555463|80899509|FG000|Treatment|Lost to Follow-up|28|||
27745949|NCT01555463|80899510|FG001|Treatment|Lost to Follow-up|23|||
27745950|NCT01555463|80899509|FG000|Treatment|Protocol Violation|4|||
27745951|NCT01555463|80899510|FG001|Treatment|Protocol Violation|5|||
27745952|NCT01555463|80899509|FG000|Treatment|Other reason|2|||
27745953|NCT01555463|80899510|FG001|Treatment|Other reason|3|||
27745954|NCT01555463|80899509|FG000|Follow up|Adverse Event|2|||
27745955|NCT01555463|80899510|FG001|Follow up|Adverse Event|5|||
27745956|NCT01555463|80899509|FG000|Follow up|Death|0|||
27745957|NCT01555463|80899510|FG001|Follow up|Death|1|||
27745958|NCT01555463|80899509|FG000|Follow up|Withdrawal by Subject|22|||
27745959|NCT01555463|80899510|FG001|Follow up|Withdrawal by Subject|22|||
27745960|NCT01555463|80899509|FG000|Follow up|Lost to Follow-up|9|||
27745961|NCT01555463|80899510|FG001|Follow up|Lost to Follow-up|10|||
27745962|NCT01555463|80899509|FG000|Follow up|Protocol Violation|2|||
27745963|NCT01555463|80899510|FG001|Follow up|Protocol Violation|4|||
27937423|NCT02883049|81607234|FG011|Post Induction|Inevaluable|1|||
27644871|NCT02972034|80539126|FG007|Overall Study|Lost to Follow-up|1|||
27937424|NCT02883049|81607235|FG012|Post Induction|Inevaluable|2|||
27644872|NCT02972034|80539127|FG008|Overall Study|Lost to Follow-up|0|||
27644873|NCT02972034|80539128|FG009|Overall Study|Lost to Follow-up|0|||
27644874|NCT02972034|80539129|FG010|Overall Study|Lost to Follow-up|0|||
27644875|NCT02972034|80539130|FG011|Overall Study|Lost to Follow-up|0|||
27644876|NCT02972034|80539131|FG012|Overall Study|Lost to Follow-up|0|||
27644877|NCT02972034|80539132|FG013|Overall Study|Lost to Follow-up|0|||
27644878|NCT02972034|80539133|FG014|Overall Study|Lost to Follow-up|1|||
27644879|NCT02972034|80539119|FG000|Overall Study|Physician Decision|0|||
27644880|NCT02972034|80539120|FG001|Overall Study|Physician Decision|0|||
27644881|NCT02972034|80539121|FG002|Overall Study|Physician Decision|0|||
27644882|NCT02972034|80539122|FG003|Overall Study|Physician Decision|0|||
27644883|NCT02972034|80539123|FG004|Overall Study|Physician Decision|0|||
27644884|NCT02972034|80539124|FG005|Overall Study|Physician Decision|0|||
27644885|NCT02972034|80539125|FG006|Overall Study|Physician Decision|0|||
27644886|NCT02972034|80539126|FG007|Overall Study|Physician Decision|1|||
27644887|NCT02972034|80539127|FG008|Overall Study|Physician Decision|0|||
27644888|NCT02972034|80539128|FG009|Overall Study|Physician Decision|0|||
27644889|NCT02972034|80539129|FG010|Overall Study|Physician Decision|1|||
27644890|NCT02972034|80539130|FG011|Overall Study|Physician Decision|0|||
27644891|NCT02972034|80539131|FG012|Overall Study|Physician Decision|0|||
27644892|NCT02972034|80539132|FG013|Overall Study|Physician Decision|0|||
27644893|NCT02972034|80539133|FG014|Overall Study|Physician Decision|0|||
27644894|NCT02972034|80539119|FG000|Overall Study|Sponsor Decision|0|||
27644895|NCT02972034|80539120|FG001|Overall Study|Sponsor Decision|0|||
27644896|NCT02972034|80539121|FG002|Overall Study|Sponsor Decision|0|||
27745964|NCT01555463|80899509|FG000|Follow up|Other reason|3|||
27745965|NCT01555463|80899510|FG001|Follow up|Other reason|3|||
27745966|NCT00085540|80899525|FG000|Overall Study|Withdrawal by Subject|0|||
27745967|NCT00085540|80899526|FG001|Overall Study|Withdrawal by Subject|1|||
27745968|NCT00085540|80899525|FG000|Overall Study|Protocol Violation|0|||
27745969|NCT00085540|80899526|FG001|Overall Study|Protocol Violation|1|||
27745970|NCT02260193|80899537|FG000|Overall Study|Lack of Efficacy|0|||
27745971|NCT02260193|80899538|FG001|Overall Study|Lack of Efficacy|1|||
27644897|NCT02972034|80539122|FG003|Overall Study|Sponsor Decision|1|||
27644898|NCT02972034|80539123|FG004|Overall Study|Sponsor Decision|0|||
27644899|NCT02972034|80539124|FG005|Overall Study|Sponsor Decision|0|||
27644900|NCT02972034|80539125|FG006|Overall Study|Sponsor Decision|1|||
27644901|NCT02972034|80539126|FG007|Overall Study|Sponsor Decision|1|||
27644902|NCT02972034|80539127|FG008|Overall Study|Sponsor Decision|1|||
27937425|NCT02883049|81607236|FG013|Post Induction|Inevaluable|0|||
27644903|NCT02972034|80539128|FG009|Overall Study|Sponsor Decision|2|||
27644904|NCT02972034|80539129|FG010|Overall Study|Sponsor Decision|2|||
27644905|NCT02972034|80539130|FG011|Overall Study|Sponsor Decision|0|||
27644906|NCT02972034|80539131|FG012|Overall Study|Sponsor Decision|1|||
27644907|NCT02972034|80539132|FG013|Overall Study|Sponsor Decision|0|||
27745972|NCT02260193|80899539|FG002|Overall Study|Lack of Efficacy|6|||
27745973|NCT02260193|80899537|FG000|Overall Study|Adverse Event|3|||
27937426|NCT02883049|81607237|FG014|Post Induction|Inevaluable|0|||
27644908|NCT02972034|80539133|FG014|Overall Study|Sponsor Decision|1|||
27644909|NCT02972034|80539119|FG000|Overall Study|Withdrawal by Subject|3|||
27644910|NCT02972034|80539120|FG001|Overall Study|Withdrawal by Subject|0|||
27644911|NCT02972034|80539121|FG002|Overall Study|Withdrawal by Subject|0|||
27644912|NCT02972034|80539122|FG003|Overall Study|Withdrawal by Subject|0|||
27644913|NCT02972034|80539123|FG004|Overall Study|Withdrawal by Subject|1|||
27644914|NCT02972034|80539124|FG005|Overall Study|Withdrawal by Subject|1|||
27644915|NCT02972034|80539125|FG006|Overall Study|Withdrawal by Subject|0|||
27644916|NCT02972034|80539126|FG007|Overall Study|Withdrawal by Subject|0|||
27644917|NCT02972034|80539127|FG008|Overall Study|Withdrawal by Subject|1|||
27644918|NCT02972034|80539128|FG009|Overall Study|Withdrawal by Subject|1|||
27644919|NCT02972034|80539129|FG010|Overall Study|Withdrawal by Subject|2|||
27937427|NCT02883049|81607238|FG015|Post Induction|Inevaluable|1|||
27937428|NCT02883049|81607223|FG000|Post Induction|Moved to another non-COG institution|0|||
27937429|NCT02883049|81607224|FG001|Post Induction|Moved to another non-COG institution|0|||
27644920|NCT02972034|80539130|FG011|Overall Study|Withdrawal by Subject|1|||
27644921|NCT02972034|80539131|FG012|Overall Study|Withdrawal by Subject|1|||
27644922|NCT02972034|80539132|FG013|Overall Study|Withdrawal by Subject|1|||
27644923|NCT02972034|80539133|FG014|Overall Study|Withdrawal by Subject|0|||
27644924|NCT02972034|80539119|FG000|Overall Study|Screen Failure|0|||
27644925|NCT02972034|80539120|FG001|Overall Study|Screen Failure|0|||
27644926|NCT02972034|80539121|FG002|Overall Study|Screen Failure|0|||
27644927|NCT02972034|80539122|FG003|Overall Study|Screen Failure|0|||
27644928|NCT02972034|80539123|FG004|Overall Study|Screen Failure|0|||
27644929|NCT02972034|80539124|FG005|Overall Study|Screen Failure|0|||
27644930|NCT02972034|80539125|FG006|Overall Study|Screen Failure|0|||
27644931|NCT02972034|80539126|FG007|Overall Study|Screen Failure|0|||
27644932|NCT02972034|80539127|FG008|Overall Study|Screen Failure|0|||
27644933|NCT02972034|80539128|FG009|Overall Study|Screen Failure|0|||
27644934|NCT02972034|80539129|FG010|Overall Study|Screen Failure|0|||
27745974|NCT02260193|80899538|FG001|Overall Study|Adverse Event|4|||
27745975|NCT02260193|80899539|FG002|Overall Study|Adverse Event|1|||
27745976|NCT02260193|80899537|FG000|Overall Study|Protocol Violation|0|||
27745977|NCT02260193|80899538|FG001|Overall Study|Protocol Violation|4|||
27745978|NCT02260193|80899539|FG002|Overall Study|Protocol Violation|0|||
27745979|NCT02260193|80899537|FG000|Overall Study|Withdrawal by Subject|3|||
27745980|NCT02260193|80899538|FG001|Overall Study|Withdrawal by Subject|0|||
27745981|NCT02260193|80899539|FG002|Overall Study|Withdrawal by Subject|2|||
27745982|NCT02260193|80899537|FG000|Overall Study|Kidney Transplantation|0|||
27644935|NCT02972034|80539130|FG011|Overall Study|Screen Failure|0|||
27644936|NCT02972034|80539131|FG012|Overall Study|Screen Failure|1|||
27644937|NCT02972034|80539132|FG013|Overall Study|Screen Failure|0|||
27644938|NCT02972034|80539133|FG014|Overall Study|Screen Failure|0|||
27644939|NCT03093428|80539134|FG000|Overall Study|Not eligible for treatment|2|||
27644940|NCT03093428|80539135|FG001|Overall Study|Not eligible for treatment|1|||
27644941|NCT03093428|80539134|FG000|Overall Study|Progression|14|||
27644942|NCT03093428|80539135|FG001|Overall Study|Progression|4|||
27644943|NCT03093428|80539134|FG000|Overall Study|Death|1|||
27644944|NCT03093428|80539135|FG001|Overall Study|Death|0|||
27644945|NCT03093428|80539134|FG000|Overall Study|Adverse Event|1|||
27644946|NCT03093428|80539135|FG001|Overall Study|Adverse Event|0|||
27644947|NCT03093428|80539134|FG000|Overall Study|Withdrawal by Subject|1|||
27644948|NCT03093428|80539135|FG001|Overall Study|Withdrawal by Subject|1|||
27937430|NCT02883049|81607225|FG002|Post Induction|Moved to another non-COG institution|0|||
27937431|NCT02883049|81607226|FG003|Post Induction|Moved to another non-COG institution|0|||
27644951|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
27644952|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
27644953|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
27644954|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
27644955|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
27644956|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
27745983|NCT02260193|80899538|FG001|Overall Study|Kidney Transplantation|0|||
27745984|NCT02260193|80899539|FG002|Overall Study|Kidney Transplantation|1|||
27745985|NCT01000064|80899540|FG000|Overall Study|Withdrawal by Subject|1|||
27745986|NCT01000064|80899541|FG001|Overall Study|Withdrawal by Subject|1|||
27745987|NCT03502707|80899542|FG000|Overall Study|Adverse Event|0|||
27745988|NCT03502707|80899543|FG001|Overall Study|Adverse Event|0|||
27644957|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
27644958|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
27644959|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
27644960|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
27644961|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
27644962|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
27745989|NCT03502707|80899544|FG002|Overall Study|Adverse Event|0|||
27937432|NCT02883049|81607227|FG004|Post Induction|Moved to another non-COG institution|0|||
27745990|NCT03502707|80899545|FG003|Overall Study|Adverse Event|0|||
27745991|NCT03502707|80899546|FG004|Overall Study|Adverse Event|0|||
27745992|NCT03502707|80899547|FG005|Overall Study|Adverse Event|0|||
27745993|NCT03502707|80899548|FG006|Overall Study|Adverse Event|0|||
27937433|NCT02883049|81607228|FG005|Post Induction|Moved to another non-COG institution|0|||
27937434|NCT02883049|81607229|FG006|Post Induction|Moved to another non-COG institution|0|||
27937435|NCT02883049|81607230|FG007|Post Induction|Moved to another non-COG institution|2|||
27937436|NCT02883049|81607231|FG008|Post Induction|Moved to another non-COG institution|2|||
27937437|NCT02883049|81607232|FG009|Post Induction|Moved to another non-COG institution|0|||
27937438|NCT02883049|81607233|FG010|Post Induction|Moved to another non-COG institution|0|||
27937439|NCT02883049|81607234|FG011|Post Induction|Moved to another non-COG institution|1|||
27937440|NCT02883049|81607235|FG012|Post Induction|Moved to another non-COG institution|0|||
27937441|NCT02883049|81607236|FG013|Post Induction|Moved to another non-COG institution|0|||
27937442|NCT02883049|81607237|FG014|Post Induction|Moved to another non-COG institution|0|||
27937443|NCT02883049|81607238|FG015|Post Induction|Moved to another non-COG institution|0|||
27937444|NCT02883049|81607223|FG000|Post Induction|Randomization closed|0|||
27937445|NCT02883049|81607224|FG001|Post Induction|Randomization closed|0|||
27937446|NCT02883049|81607225|FG002|Post Induction|Randomization closed|0|||
27937447|NCT02883049|81607226|FG003|Post Induction|Randomization closed|0|||
27937448|NCT02883049|81607227|FG004|Post Induction|Randomization closed|0|||
27937449|NCT02883049|81607228|FG005|Post Induction|Randomization closed|0|||
27937450|NCT02883049|81607229|FG006|Post Induction|Randomization closed|0|||
27937451|NCT02883049|81607230|FG007|Post Induction|Randomization closed|20|||
27937452|NCT02883049|81607231|FG008|Post Induction|Randomization closed|0|||
27937453|NCT02883049|81607232|FG009|Post Induction|Randomization closed|0|||
27937454|NCT02883049|81607233|FG010|Post Induction|Randomization closed|0|||
27937455|NCT02883049|81607234|FG011|Post Induction|Randomization closed|0|||
27937456|NCT02883049|81607235|FG012|Post Induction|Randomization closed|0|||
27937457|NCT02883049|81607236|FG013|Post Induction|Randomization closed|0|||
27937458|NCT02883049|81607237|FG014|Post Induction|Randomization closed|0|||
27937459|NCT02883049|81607238|FG015|Post Induction|Randomization closed|0|||
27937460|NCT02883049|81607223|FG000|Post Induction|MRD negative|0|||
27937461|NCT02883049|81607224|FG001|Post Induction|MRD negative|0|||
27937462|NCT02883049|81607225|FG002|Post Induction|MRD negative|0|||
27644963|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
27644964|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
27644965|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
27644966|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
27644967|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
27644968|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
27644969|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
27644970|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
27644971|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
27644972|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
27644973|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
27644974|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
27644975|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
27644976|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
27644977|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
27644978|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
27644979|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
27644980|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
27644981|NCT04759833|80541435|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
27644982|NCT04759833|80541436|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
27644983|NCT04759833|80541437|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
27745994|NCT03502707|80899549|FG007|Overall Study|Adverse Event|0|||
27745995|NCT03502707|80899550|FG008|Overall Study|Adverse Event|0|||
27745996|NCT03502707|80899551|FG009|Overall Study|Adverse Event|0|||
27745997|NCT03502707|80899552|FG010|Overall Study|Adverse Event|0|||
27745998|NCT03502707|80899553|FG011|Overall Study|Adverse Event|0|||
27745999|NCT03502707|80899554|FG012|Overall Study|Adverse Event|0|||
27746000|NCT03502707|80899555|FG013|Overall Study|Adverse Event|0|||
27746001|NCT03502707|80899556|FG014|Overall Study|Adverse Event|0|||
27746002|NCT03502707|80899557|FG015|Overall Study|Adverse Event|1|||
27937463|NCT02883049|81607226|FG003|Post Induction|MRD negative|0|||
27937464|NCT02883049|81607227|FG004|Post Induction|MRD negative|0|||
27937465|NCT02883049|81607228|FG005|Post Induction|MRD negative|0|||
27937466|NCT02883049|81607229|FG006|Post Induction|MRD negative|0|||
27937467|NCT02883049|81607230|FG007|Post Induction|MRD negative|11|||
27746003|NCT03502707|80899558|FG016|Overall Study|Adverse Event|5|||
27746004|NCT03502707|80899559|FG017|Overall Study|Adverse Event|0|||
27746005|NCT03502707|80899542|FG000|Overall Study|Death|0|||
27746006|NCT03502707|80899543|FG001|Overall Study|Death|0|||
27746007|NCT03502707|80899544|FG002|Overall Study|Death|0|||
27746008|NCT03502707|80899545|FG003|Overall Study|Death|1|||
27746009|NCT03502707|80899546|FG004|Overall Study|Death|0|||
27746010|NCT03502707|80899547|FG005|Overall Study|Death|0|||
27746011|NCT03502707|80899548|FG006|Overall Study|Death|0|||
27746012|NCT03502707|80899549|FG007|Overall Study|Death|0|||
27746013|NCT03502707|80899550|FG008|Overall Study|Death|1|||
27746014|NCT03502707|80899551|FG009|Overall Study|Death|1|||
27746015|NCT03502707|80899552|FG010|Overall Study|Death|0|||
27746016|NCT03502707|80899553|FG011|Overall Study|Death|0|||
27746017|NCT03502707|80899554|FG012|Overall Study|Death|1|||
27746018|NCT03502707|80899555|FG013|Overall Study|Death|0|||
27746019|NCT03502707|80899556|FG014|Overall Study|Death|0|||
27746020|NCT03502707|80899557|FG015|Overall Study|Death|1|||
27746021|NCT03502707|80899558|FG016|Overall Study|Death|0|||
27746022|NCT03502707|80899559|FG017|Overall Study|Death|0|||
27746023|NCT03502707|80899542|FG000|Overall Study|Lost to Follow-up|0|||
27746024|NCT03502707|80899543|FG001|Overall Study|Lost to Follow-up|0|||
27746025|NCT03502707|80899544|FG002|Overall Study|Lost to Follow-up|0|||
27746026|NCT03502707|80899545|FG003|Overall Study|Lost to Follow-up|0|||
27746027|NCT03502707|80899546|FG004|Overall Study|Lost to Follow-up|0|||
27746028|NCT03502707|80899547|FG005|Overall Study|Lost to Follow-up|0|||
27746029|NCT03502707|80899548|FG006|Overall Study|Lost to Follow-up|0|||
27746030|NCT03502707|80899549|FG007|Overall Study|Lost to Follow-up|5|||
27746031|NCT03502707|80899550|FG008|Overall Study|Lost to Follow-up|0|||
27746032|NCT03502707|80899551|FG009|Overall Study|Lost to Follow-up|2|||
27746033|NCT03502707|80899552|FG010|Overall Study|Lost to Follow-up|1|||
27746034|NCT03502707|80899553|FG011|Overall Study|Lost to Follow-up|2|||
27746035|NCT03502707|80899554|FG012|Overall Study|Lost to Follow-up|1|||
27746036|NCT03502707|80899555|FG013|Overall Study|Lost to Follow-up|1|||
27746037|NCT03502707|80899556|FG014|Overall Study|Lost to Follow-up|0|||
27746038|NCT03502707|80899557|FG015|Overall Study|Lost to Follow-up|4|||
27746039|NCT03502707|80899558|FG016|Overall Study|Lost to Follow-up|9|||
27746040|NCT03502707|80899559|FG017|Overall Study|Lost to Follow-up|2|||
27746041|NCT03502707|80899542|FG000|Overall Study|Physician Decision|0|||
27746042|NCT03502707|80899543|FG001|Overall Study|Physician Decision|0|||
27746043|NCT03502707|80899544|FG002|Overall Study|Physician Decision|0|||
27746044|NCT03502707|80899545|FG003|Overall Study|Physician Decision|0|||
27746045|NCT03502707|80899546|FG004|Overall Study|Physician Decision|0|||
27746046|NCT03502707|80899547|FG005|Overall Study|Physician Decision|0|||
27746047|NCT03502707|80899548|FG006|Overall Study|Physician Decision|0|||
27746048|NCT03502707|80899549|FG007|Overall Study|Physician Decision|0|||
27746049|NCT03502707|80899550|FG008|Overall Study|Physician Decision|2|||
27746050|NCT03502707|80899551|FG009|Overall Study|Physician Decision|1|||
27746051|NCT03502707|80899552|FG010|Overall Study|Physician Decision|0|||
27746052|NCT03502707|80899553|FG011|Overall Study|Physician Decision|0|||
27746053|NCT03502707|80899554|FG012|Overall Study|Physician Decision|0|||
27746054|NCT03502707|80899555|FG013|Overall Study|Physician Decision|0|||
27746055|NCT03502707|80899556|FG014|Overall Study|Physician Decision|1|||
27746056|NCT03502707|80899557|FG015|Overall Study|Physician Decision|3|||
27746057|NCT03502707|80899558|FG016|Overall Study|Physician Decision|0|||
27746058|NCT03502707|80899559|FG017|Overall Study|Physician Decision|0|||
27746059|NCT03502707|80899542|FG000|Overall Study|Protocol Violation|0|||
27746060|NCT03502707|80899543|FG001|Overall Study|Protocol Violation|0|||
27746061|NCT03502707|80899544|FG002|Overall Study|Protocol Violation|0|||
27746062|NCT03502707|80899545|FG003|Overall Study|Protocol Violation|0|||
27937468|NCT02883049|81607231|FG008|Post Induction|MRD negative|0|||
27937469|NCT02883049|81607232|FG009|Post Induction|MRD negative|0|||
27746063|NCT03502707|80899546|FG004|Overall Study|Protocol Violation|0|||
27746064|NCT03502707|80899547|FG005|Overall Study|Protocol Violation|0|||
27746065|NCT03502707|80899548|FG006|Overall Study|Protocol Violation|0|||
27746066|NCT03502707|80899549|FG007|Overall Study|Protocol Violation|0|||
27746067|NCT03502707|80899550|FG008|Overall Study|Protocol Violation|0|||
27937470|NCT02883049|81607233|FG010|Post Induction|MRD negative|0|||
27746068|NCT03502707|80899551|FG009|Overall Study|Protocol Violation|0|||
27746069|NCT03502707|80899552|FG010|Overall Study|Protocol Violation|0|||
27746070|NCT03502707|80899553|FG011|Overall Study|Protocol Violation|0|||
27746071|NCT03502707|80899554|FG012|Overall Study|Protocol Violation|0|||
27746072|NCT03502707|80899555|FG013|Overall Study|Protocol Violation|0|||
27746073|NCT03502707|80899556|FG014|Overall Study|Protocol Violation|0|||
27746074|NCT03502707|80899557|FG015|Overall Study|Protocol Violation|1|||
27746075|NCT03502707|80899558|FG016|Overall Study|Protocol Violation|0|||
27746076|NCT03502707|80899559|FG017|Overall Study|Protocol Violation|0|||
27746077|NCT03502707|80899542|FG000|Overall Study|Withdrawal by Subject|1|||
27746078|NCT03502707|80899543|FG001|Overall Study|Withdrawal by Subject|1|||
27746079|NCT03502707|80899544|FG002|Overall Study|Withdrawal by Subject|0|||
27746080|NCT03502707|80899545|FG003|Overall Study|Withdrawal by Subject|0|||
27746081|NCT03502707|80899546|FG004|Overall Study|Withdrawal by Subject|0|||
27746082|NCT03502707|80899547|FG005|Overall Study|Withdrawal by Subject|2|||
27746083|NCT03502707|80899548|FG006|Overall Study|Withdrawal by Subject|0|||
27746084|NCT03502707|80899549|FG007|Overall Study|Withdrawal by Subject|3|||
27746085|NCT03502707|80899550|FG008|Overall Study|Withdrawal by Subject|1|||
27746086|NCT03502707|80899551|FG009|Overall Study|Withdrawal by Subject|2|||
27746087|NCT03502707|80899552|FG010|Overall Study|Withdrawal by Subject|12|||
27746088|NCT03502707|80899553|FG011|Overall Study|Withdrawal by Subject|23|||
27746089|NCT03502707|80899554|FG012|Overall Study|Withdrawal by Subject|5|||
27746090|NCT03502707|80899555|FG013|Overall Study|Withdrawal by Subject|3|||
27644984|NCT04759833|80541438|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
27644985|NCT04759833|80541439|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
27644986|NCT04759833|80541435|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
27644987|NCT04759833|80541436|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
27644988|NCT04759833|80541437|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
27644989|NCT04759833|80541438|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
27644990|NCT04759833|80541439|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
27644991|NCT04759833|80541435|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
27644992|NCT04759833|80541436|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
27644993|NCT04759833|80541437|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
27644994|NCT04759833|80541438|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
27644995|NCT04759833|80541439|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
27644996|NCT04759833|80541435|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
27644997|NCT04759833|80541436|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
27644998|NCT04759833|80541437|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
27644999|NCT04759833|80541438|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
27645000|NCT04759833|80541439|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
27645001|NCT04759833|80541435|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
27645002|NCT04759833|80541436|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
27645003|NCT04759833|80541437|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
27645004|NCT04759833|80541438|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
27645005|NCT04759833|80541439|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
27645006|NCT04759833|80541435|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
27645007|NCT04759833|80541436|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
27645008|NCT04759833|80541437|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
27645009|NCT04759833|80541438|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
27645010|NCT04759833|80541439|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
27645011|NCT04759833|80541435|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
27645012|NCT04759833|80541436|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
27645013|NCT04759833|80541437|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
27645014|NCT04759833|80541438|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
27645015|NCT04759833|80541439|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
27645016|NCT03876457|80541440|FG000|Overall Study|Lost to Follow-up|1|||
27645017|NCT03876457|80541441|FG001|Overall Study|Lost to Follow-up|3|||
27645018|NCT01046136|80541442|FG000|Overall Study|Withdrawal by Subject|0|||
27645019|NCT01046136|80541443|FG001|Overall Study|Withdrawal by Subject|4|||
27645020|NCT01046136|80541442|FG000|Overall Study|Physician Decision|1|||
27645021|NCT01046136|80541443|FG001|Overall Study|Physician Decision|1|||
27645022|NCT01046136|80541442|FG000|Overall Study|Lost to Follow-up|3|||
27645023|NCT01046136|80541443|FG001|Overall Study|Lost to Follow-up|3|||
27645024|NCT01854385|80541446|FG000|Pre-Treatment|Withdrawal by Subject|4|||
27645025|NCT01854385|80541446|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
27645026|NCT01854385|80541446|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
27645027|NCT01854385|80541446|FG000|Pre-Treatment|Unable to come for study visits|1|||
27645028|NCT01854385|80541446|FG000|Treatment|Lost to Follow-up|1|||
27645029|NCT01532648|80541447|FG000|Overall Study|Lost to Follow-up|3|||
27645030|NCT01532648|80541448|FG001|Overall Study|Lost to Follow-up|4|||
27746091|NCT03502707|80899556|FG014|Overall Study|Withdrawal by Subject|3|||
27746092|NCT03502707|80899557|FG015|Overall Study|Withdrawal by Subject|43|||
27645031|NCT01532648|80541447|FG000|Overall Study|Lack of Efficacy|4|||
27645032|NCT01532648|80541448|FG001|Overall Study|Lack of Efficacy|1|||
27645033|NCT01532648|80541447|FG000|Overall Study|Protocol Violation|1|||
27645034|NCT01532648|80541448|FG001|Overall Study|Protocol Violation|1|||
27645035|NCT01532648|80541447|FG000|Overall Study|Adverse Event|12|||
27645036|NCT01532648|80541448|FG001|Overall Study|Adverse Event|9|||
27746093|NCT03502707|80899558|FG016|Overall Study|Withdrawal by Subject|44|||
27746094|NCT03502707|80899559|FG017|Overall Study|Withdrawal by Subject|18|||
27645037|NCT01532648|80541447|FG000|Overall Study|Withdrawal by Subject|16|||
27746095|NCT03502707|80899542|FG000|Overall Study|Sponsor's Decision|1|||
27746096|NCT03502707|80899543|FG001|Overall Study|Sponsor's Decision|0|||
27746097|NCT03502707|80899544|FG002|Overall Study|Sponsor's Decision|0|||
27746098|NCT03502707|80899545|FG003|Overall Study|Sponsor's Decision|0|||
27746099|NCT03502707|80899546|FG004|Overall Study|Sponsor's Decision|0|||
27746100|NCT03502707|80899547|FG005|Overall Study|Sponsor's Decision|0|||
27746101|NCT03502707|80899548|FG006|Overall Study|Sponsor's Decision|0|||
27746102|NCT03502707|80899549|FG007|Overall Study|Sponsor's Decision|0|||
27746103|NCT03502707|80899550|FG008|Overall Study|Sponsor's Decision|0|||
27746104|NCT03502707|80899551|FG009|Overall Study|Sponsor's Decision|1|||
27746105|NCT03502707|80899552|FG010|Overall Study|Sponsor's Decision|0|||
27746106|NCT03502707|80899553|FG011|Overall Study|Sponsor's Decision|0|||
27937471|NCT02883049|81607234|FG011|Post Induction|MRD negative|0|||
27937472|NCT02883049|81607235|FG012|Post Induction|MRD negative|0|||
27937473|NCT02883049|81607236|FG013|Post Induction|MRD negative|0|||
27937474|NCT02883049|81607237|FG014|Post Induction|MRD negative|0|||
27937475|NCT02883049|81607238|FG015|Post Induction|MRD negative|0|||
27937476|NCT02883049|81607223|FG000|Post Induction|Developed SMN|0|||
27937477|NCT02883049|81607224|FG001|Post Induction|Developed SMN|0|||
27937478|NCT02883049|81607225|FG002|Post Induction|Developed SMN|0|||
27937479|NCT02883049|81607226|FG003|Post Induction|Developed SMN|0|||
27937480|NCT02883049|81607227|FG004|Post Induction|Developed SMN|1|||
27937481|NCT02883049|81607228|FG005|Post Induction|Developed SMN|0|||
27645038|NCT01532648|80541448|FG001|Overall Study|Withdrawal by Subject|2|||
27645039|NCT02189252|80541456|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
27645040|NCT02189252|80541457|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
27645041|NCT02189252|80541458|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
27937482|NCT02883049|81607229|FG006|Post Induction|Developed SMN|1|||
27937483|NCT02883049|81607230|FG007|Post Induction|Developed SMN|0|||
27937484|NCT02883049|81607231|FG008|Post Induction|Developed SMN|0|||
27937485|NCT02883049|81607232|FG009|Post Induction|Developed SMN|0|||
27937486|NCT02883049|81607233|FG010|Post Induction|Developed SMN|1|||
27937487|NCT02883049|81607234|FG011|Post Induction|Developed SMN|1|||
27937488|NCT02883049|81607235|FG012|Post Induction|Developed SMN|0|||
27551147|NCT00482612|80207371|FG000|In-treatment Period|No study medication administered|0|||
27551148|NCT00482612|80207372|FG001|In-treatment Period|No study medication administered|0|||
27551149|NCT00482612|80207373|FG002|In-treatment Period|No study medication administered|1|||
27551150|NCT00482612|80207374|FG003|In-treatment Period|No study medication administered|0|||
27551151|NCT00482612|80207371|FG000|Follow-up Period|Other|4|||
27551152|NCT00482612|80207372|FG001|Follow-up Period|Other|2|||
27551153|NCT00482612|80207373|FG002|Follow-up Period|Other|1|||
27551154|NCT00482612|80207374|FG003|Follow-up Period|Other|2|||
27645042|NCT02189252|80541459|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
27551155|NCT00482612|80207371|FG000|Follow-up Period|Lack of compliance|0|||
27551156|NCT00482612|80207372|FG001|Follow-up Period|Lack of compliance|0|||
27551157|NCT00482612|80207373|FG002|Follow-up Period|Lack of compliance|1|||
27551158|NCT00482612|80207374|FG003|Follow-up Period|Lack of compliance|0|||
27551159|NCT00482612|80207371|FG000|Follow-up Period|Lost to Follow-up|0|||
27551160|NCT00482612|80207372|FG001|Follow-up Period|Lost to Follow-up|4|||
27551161|NCT00482612|80207373|FG002|Follow-up Period|Lost to Follow-up|2|||
27551162|NCT00482612|80207374|FG003|Follow-up Period|Lost to Follow-up|1|||
27551163|NCT00482612|80207371|FG000|Follow-up Period|Adverse Event|4|||
27551164|NCT00482612|80207372|FG001|Follow-up Period|Adverse Event|7|||
27551165|NCT00482612|80207373|FG002|Follow-up Period|Adverse Event|9|||
27551166|NCT00482612|80207374|FG003|Follow-up Period|Adverse Event|0|||
27551167|NCT00482612|80207371|FG000|Follow-up Period|Lack of Efficacy|2|||
27551168|NCT00482612|80207372|FG001|Follow-up Period|Lack of Efficacy|0|||
27551169|NCT00482612|80207373|FG002|Follow-up Period|Lack of Efficacy|1|||
27551170|NCT00482612|80207374|FG003|Follow-up Period|Lack of Efficacy|0|||
27551171|NCT00482612|80207371|FG000|Follow-up Period|Withdrawal by Subject|3|||
27551172|NCT00482612|80207372|FG001|Follow-up Period|Withdrawal by Subject|5|||
27551173|NCT00482612|80207373|FG002|Follow-up Period|Withdrawal by Subject|7|||
27551174|NCT00482612|80207374|FG003|Follow-up Period|Withdrawal by Subject|2|||
27551175|NCT00482612|80207371|FG000|Follow-up Period|Reasons not related to trial|1|||
27551176|NCT00482612|80207372|FG001|Follow-up Period|Reasons not related to trial|0|||
27746107|NCT03502707|80899554|FG012|Overall Study|Sponsor's Decision|0|||
27746108|NCT03502707|80899555|FG013|Overall Study|Sponsor's Decision|0|||
27746109|NCT03502707|80899556|FG014|Overall Study|Sponsor's Decision|0|||
27551177|NCT00482612|80207373|FG002|Follow-up Period|Reasons not related to trial|1|||
27551178|NCT00482612|80207374|FG003|Follow-up Period|Reasons not related to trial|3|||
27551179|NCT00071513|80207383|FG000|Intervention Component|Withdrawal by Subject|2|||
27551180|NCT00071513|80207384|FG001|Intervention Component|Withdrawal by Subject|3|||
27746110|NCT03502707|80899557|FG015|Overall Study|Sponsor's Decision|2|||
27937489|NCT02883049|81607236|FG013|Post Induction|Developed SMN|0|||
27937490|NCT02883049|81607237|FG014|Post Induction|Developed SMN|1|||
27551181|NCT00071513|80207383|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
27746111|NCT03502707|80899558|FG016|Overall Study|Sponsor's Decision|1|||
27746112|NCT03502707|80899559|FG017|Overall Study|Sponsor's Decision|0|||
27755002|NCT04937816|80929650|FG001|Overall Study|Adverse Event|267|||
27937491|NCT02883049|81607238|FG015|Post Induction|Developed SMN|0|||
27937492|NCT02883049|81607223|FG000|Post Induction|Enrolled onto another COG study|0|||
27937493|NCT02883049|81607224|FG001|Post Induction|Enrolled onto another COG study|0|||
27937494|NCT02883049|81607225|FG002|Post Induction|Enrolled onto another COG study|0|||
27937495|NCT02883049|81607226|FG003|Post Induction|Enrolled onto another COG study|1|||
27937496|NCT02883049|81607227|FG004|Post Induction|Enrolled onto another COG study|1|||
27937497|NCT02883049|81607228|FG005|Post Induction|Enrolled onto another COG study|0|||
27937498|NCT02883049|81607229|FG006|Post Induction|Enrolled onto another COG study|0|||
27937499|NCT02883049|81607230|FG007|Post Induction|Enrolled onto another COG study|4|||
27937500|NCT02883049|81607231|FG008|Post Induction|Enrolled onto another COG study|0|||
27937501|NCT02883049|81607232|FG009|Post Induction|Enrolled onto another COG study|0|||
27937502|NCT02883049|81607233|FG010|Post Induction|Enrolled onto another COG study|0|||
27937503|NCT02883049|81607234|FG011|Post Induction|Enrolled onto another COG study|2|||
27937504|NCT02883049|81607235|FG012|Post Induction|Enrolled onto another COG study|0|||
27937505|NCT02883049|81607236|FG013|Post Induction|Enrolled onto another COG study|1|||
27937506|NCT02883049|81607237|FG014|Post Induction|Enrolled onto another COG study|0|||
27937507|NCT02883049|81607238|FG015|Post Induction|Enrolled onto another COG study|0|||
27937508|NCT02883049|81607223|FG000|Post Induction|Recurrent leukemia|0|||
27937509|NCT02883049|81607224|FG001|Post Induction|Recurrent leukemia|0|||
27937510|NCT02883049|81607225|FG002|Post Induction|Recurrent leukemia|0|||
27937511|NCT02883049|81607226|FG003|Post Induction|Recurrent leukemia|17|||
27937512|NCT02883049|81607227|FG004|Post Induction|Recurrent leukemia|12|||
27937513|NCT02883049|81607228|FG005|Post Induction|Recurrent leukemia|4|||
27937514|NCT02883049|81607229|FG006|Post Induction|Recurrent leukemia|1|||
27645043|NCT02189252|80541456|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
27645044|NCT02189252|80541457|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
27645045|NCT02189252|80541458|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
27746113|NCT03502707|80899542|FG000|Overall Study|Initiated Prohibited Medication|0|||
27937515|NCT02883049|81607230|FG007|Post Induction|Recurrent leukemia|13|||
27937516|NCT02883049|81607231|FG008|Post Induction|Recurrent leukemia|27|||
27937517|NCT02883049|81607232|FG009|Post Induction|Recurrent leukemia|5|||
27937518|NCT02883049|81607233|FG010|Post Induction|Recurrent leukemia|3|||
27937519|NCT02883049|81607234|FG011|Post Induction|Recurrent leukemia|12|||
27937520|NCT02883049|81607235|FG012|Post Induction|Recurrent leukemia|1|||
27937521|NCT02883049|81607236|FG013|Post Induction|Recurrent leukemia|1|||
27937522|NCT02883049|81607237|FG014|Post Induction|Recurrent leukemia|9|||
27937523|NCT02883049|81607238|FG015|Post Induction|Recurrent leukemia|3|||
27937524|NCT02883049|81607223|FG000|Post Induction|Induction Failure|0|||
27937525|NCT02883049|81607224|FG001|Post Induction|Induction Failure|0|||
27937526|NCT02883049|81607225|FG002|Post Induction|Induction Failure|0|||
27937527|NCT02883049|81607226|FG003|Post Induction|Induction Failure|0|||
27937528|NCT02883049|81607227|FG004|Post Induction|Induction Failure|0|||
27937529|NCT02883049|81607228|FG005|Post Induction|Induction Failure|0|||
27937530|NCT02883049|81607229|FG006|Post Induction|Induction Failure|0|||
27937531|NCT02883049|81607230|FG007|Post Induction|Induction Failure|2|||
27937532|NCT02883049|81607231|FG008|Post Induction|Induction Failure|2|||
27937533|NCT02883049|81607232|FG009|Post Induction|Induction Failure|0|||
27937534|NCT02883049|81607233|FG010|Post Induction|Induction Failure|0|||
27937535|NCT02883049|81607234|FG011|Post Induction|Induction Failure|0|||
27937536|NCT02883049|81607235|FG012|Post Induction|Induction Failure|0|||
27937537|NCT02883049|81607236|FG013|Post Induction|Induction Failure|2|||
27937538|NCT02883049|81607237|FG014|Post Induction|Induction Failure|0|||
27937539|NCT02883049|81607238|FG015|Post Induction|Induction Failure|0|||
27937540|NCT00527748|81607239|FG000|Overall Study|Other|3|||
27937541|NCT03760666|81607240|FG000|Overall Study|Adverse Event|2|||
27937542|NCT03760666|81607241|FG001|Overall Study|Adverse Event|4|||
27937543|NCT03760666|81607242|FG002|Overall Study|Adverse Event|1|||
27937544|NCT03760666|81607240|FG000|Overall Study|AML Disease Progression|3|||
27937545|NCT03760666|81607241|FG001|Overall Study|AML Disease Progression|3|||
27937546|NCT03760666|81607242|FG002|Overall Study|AML Disease Progression|0|||
27937547|NCT03760666|81607240|FG000|Overall Study|Physician Decision|0|||
27937548|NCT03760666|81607241|FG001|Overall Study|Physician Decision|3|||
27937549|NCT03760666|81607242|FG002|Overall Study|Physician Decision|0|||
27937550|NCT03760666|81607240|FG000|Overall Study|Withdrawal by Subject|0|||
27551182|NCT00071513|80207384|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
27937551|NCT03760666|81607241|FG001|Overall Study|Withdrawal by Subject|1|||
27937552|NCT03760666|81607242|FG002|Overall Study|Withdrawal by Subject|0|||
27937553|NCT03721965|81607243|FG000|Overall Study|Death|1|||
27937554|NCT03721965|81607243|FG000|Overall Study|Study Terminated by Sponsor|1|||
27937555|NCT04621786|81607244|FG000|Overall Study|Lost to Follow-up|9|||
27937556|NCT04621786|81607244|FG000|Overall Study|Protocol Violation|3|||
27937557|NCT04191733|81607245|FG000|Overall Study|Withdrawn due to study closure|13|||
27937558|NCT04191733|81607246|FG001|Overall Study|Withdrawn due to study closure|14|||
27937559|NCT04191733|81607245|FG000|Overall Study|Withdrawal by Subject|2|||
27551183|NCT00691015|80207387|FG000|Overall Study|Refused further treatment|1|||
27645046|NCT02189252|80541459|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
27937560|NCT04191733|81607246|FG001|Overall Study|Withdrawal by Subject|4|||
27937561|NCT04191733|81607245|FG000|Overall Study|Physician Decision|1|||
27937562|NCT04191733|81607246|FG001|Overall Study|Physician Decision|1|||
27746114|NCT03502707|80899543|FG001|Overall Study|Initiated Prohibited Medication|0|||
27746115|NCT03502707|80899544|FG002|Overall Study|Initiated Prohibited Medication|0|||
27746116|NCT03502707|80899545|FG003|Overall Study|Initiated Prohibited Medication|0|||
27746117|NCT03502707|80899546|FG004|Overall Study|Initiated Prohibited Medication|0|||
27746118|NCT03502707|80899547|FG005|Overall Study|Initiated Prohibited Medication|0|||
27746119|NCT03502707|80899548|FG006|Overall Study|Initiated Prohibited Medication|0|||
27746120|NCT03502707|80899549|FG007|Overall Study|Initiated Prohibited Medication|0|||
27746121|NCT03502707|80899550|FG008|Overall Study|Initiated Prohibited Medication|0|||
27746122|NCT03502707|80899551|FG009|Overall Study|Initiated Prohibited Medication|0|||
27746123|NCT03502707|80899552|FG010|Overall Study|Initiated Prohibited Medication|0|||
27746124|NCT03502707|80899553|FG011|Overall Study|Initiated Prohibited Medication|0|||
27746125|NCT03502707|80899554|FG012|Overall Study|Initiated Prohibited Medication|0|||
27746126|NCT03502707|80899555|FG013|Overall Study|Initiated Prohibited Medication|0|||
27746127|NCT03502707|80899556|FG014|Overall Study|Initiated Prohibited Medication|0|||
27746128|NCT03502707|80899557|FG015|Overall Study|Initiated Prohibited Medication|0|||
27746129|NCT03502707|80899558|FG016|Overall Study|Initiated Prohibited Medication|1|||
27746130|NCT03502707|80899559|FG017|Overall Study|Initiated Prohibited Medication|0|||
27746131|NCT03502707|80899542|FG000|Overall Study|Other|0|||
27746132|NCT03502707|80899543|FG001|Overall Study|Other|0|||
27746133|NCT03502707|80899544|FG002|Overall Study|Other|0|||
27746134|NCT03502707|80899545|FG003|Overall Study|Other|0|||
27746135|NCT03502707|80899546|FG004|Overall Study|Other|0|||
27746136|NCT03502707|80899547|FG005|Overall Study|Other|0|||
27746137|NCT03502707|80899548|FG006|Overall Study|Other|0|||
27746138|NCT03502707|80899549|FG007|Overall Study|Other|0|||
27746139|NCT03502707|80899550|FG008|Overall Study|Other|1|||
27746140|NCT03502707|80899551|FG009|Overall Study|Other|1|||
27746141|NCT03502707|80899552|FG010|Overall Study|Other|2|||
27746142|NCT03502707|80899553|FG011|Overall Study|Other|0|||
27746143|NCT03502707|80899554|FG012|Overall Study|Other|0|||
27746144|NCT03502707|80899555|FG013|Overall Study|Other|0|||
27746145|NCT03502707|80899556|FG014|Overall Study|Other|0|||
27746146|NCT03502707|80899557|FG015|Overall Study|Other|4|||
27746147|NCT03502707|80899558|FG016|Overall Study|Other|1|||
27746148|NCT03502707|80899559|FG017|Overall Study|Other|0|||
27746149|NCT03502707|80899542|FG000|Overall Study|Randomized but not vaccinated|0|||
27746150|NCT03502707|80899543|FG001|Overall Study|Randomized but not vaccinated|0|||
27746151|NCT03502707|80899544|FG002|Overall Study|Randomized but not vaccinated|0|||
27746152|NCT03502707|80899545|FG003|Overall Study|Randomized but not vaccinated|0|||
27746153|NCT03502707|80899546|FG004|Overall Study|Randomized but not vaccinated|0|||
27746154|NCT03502707|80899547|FG005|Overall Study|Randomized but not vaccinated|0|||
27746155|NCT03502707|80899548|FG006|Overall Study|Randomized but not vaccinated|0|||
27746156|NCT03502707|80899549|FG007|Overall Study|Randomized but not vaccinated|0|||
27746157|NCT03502707|80899550|FG008|Overall Study|Randomized but not vaccinated|0|||
27746158|NCT03502707|80899551|FG009|Overall Study|Randomized but not vaccinated|0|||
27746159|NCT03502707|80899552|FG010|Overall Study|Randomized but not vaccinated|0|||
27746160|NCT03502707|80899553|FG011|Overall Study|Randomized but not vaccinated|1|||
27746161|NCT03502707|80899554|FG012|Overall Study|Randomized but not vaccinated|0|||
27746162|NCT03502707|80899555|FG013|Overall Study|Randomized but not vaccinated|0|||
27746163|NCT03502707|80899556|FG014|Overall Study|Randomized but not vaccinated|0|||
27746164|NCT03502707|80899557|FG015|Overall Study|Randomized but not vaccinated|0|||
27746165|NCT03502707|80899558|FG016|Overall Study|Randomized but not vaccinated|0|||
27746166|NCT03502707|80899559|FG017|Overall Study|Randomized but not vaccinated|1|||
27746167|NCT01544114|80899560|FG000|Overall Study|Withdrawal by Subject|0|||
27746168|NCT01544114|80899561|FG001|Overall Study|Withdrawal by Subject|0|||
27746169|NCT01544114|80899562|FG002|Overall Study|Withdrawal by Subject|3|||
27746170|NCT01544114|80899560|FG000|Overall Study|Lost to Follow-up|0|||
27937563|NCT04191733|81607245|FG000|Overall Study|Lost to Follow-up|5|||
27937564|NCT04191733|81607246|FG001|Overall Study|Lost to Follow-up|6|||
27937565|NCT04191733|81607245|FG000|Overall Study|Death|0|||
27746171|NCT01544114|80899561|FG001|Overall Study|Lost to Follow-up|2|||
27746172|NCT01544114|80899562|FG002|Overall Study|Lost to Follow-up|0|||
27746173|NCT01544114|80899560|FG000|Overall Study|Adverse Event|1|||
27746174|NCT01544114|80899561|FG001|Overall Study|Adverse Event|1|||
27937566|NCT04191733|81607246|FG001|Overall Study|Death|1|||
27937567|NCT00983957|81607247|FG000|Overall Study|Adverse Event|1|||
27551184|NCT02573350|80207393|FG000|Overall Study|Lost to Follow-up|2|||
27551185|NCT02573350|80207394|FG001|Overall Study|Lost to Follow-up|1|||
27937568|NCT00983957|81607247|FG000|Overall Study|Personal Reasons|1|||
27746175|NCT01544114|80899562|FG002|Overall Study|Adverse Event|2|||
27746176|NCT01544114|80899560|FG000|Overall Study|Protocol Violation|0|||
27746177|NCT01544114|80899561|FG001|Overall Study|Protocol Violation|1|||
27746178|NCT01544114|80899562|FG002|Overall Study|Protocol Violation|0|||
27746179|NCT01912872|80899563|FG000|Overall Study|Lost to Follow-up|2|||
27937569|NCT04076579|81607250|FG000|Overall Study|Adverse Event|2|||
27937570|NCT04076579|81607251|FG001|Overall Study|Adverse Event|0|||
27937571|NCT04076579|81607250|FG000|Overall Study|discontinued due to toxicity|1|||
27937572|NCT04076579|81607251|FG001|Overall Study|discontinued due to toxicity|0|||
27937573|NCT04076579|81607250|FG000|Overall Study|Physician Decision|1|||
27937574|NCT04076579|81607251|FG001|Overall Study|Physician Decision|0|||
27937575|NCT04076579|81607250|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
27937576|NCT04076579|81607251|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
27937577|NCT04076579|81607250|FG000|Overall Study|Noncompliance|0|||
27937578|NCT04076579|81607251|FG001|Overall Study|Noncompliance|1|||
27937579|NCT04076579|81607250|FG000|Overall Study|Withdrawal by Subject|0|||
27937580|NCT04076579|81607251|FG001|Overall Study|Withdrawal by Subject|2|||
27937581|NCT02959892|81607256|FG000|Overall Study|PET tracer synthesis failure|1|||
27937582|NCT02959892|81607257|FG001|Overall Study|PET tracer synthesis failure|0|||
27937583|NCT02959892|81607256|FG000|Overall Study|Study termination|0|||
27937584|NCT02959892|81607257|FG001|Overall Study|Study termination|1|||
27937585|NCT03511209|81607258|FG000|Overall Study|Withdrawal by Subject|2|||
27937586|NCT03511209|81607259|FG001|Overall Study|Withdrawal by Subject|4|||
27937587|NCT03511209|81607258|FG000|Overall Study|Death|1|||
27937588|NCT03511209|81607259|FG001|Overall Study|Death|0|||
27937589|NCT03511209|81607258|FG000|Overall Study|Lost to Follow-up|0|||
27937590|NCT03511209|81607259|FG001|Overall Study|Lost to Follow-up|2|||
27937591|NCT02565186|81607262|FG000|Overall Study|Adverse Event|113|||
27937592|NCT02565186|81607263|FG001|Overall Study|Adverse Event|148|||
27937593|NCT02565186|81607262|FG000|Overall Study|Lost to Follow-up|102|||
27937594|NCT02565186|81607263|FG001|Overall Study|Lost to Follow-up|93|||
27937595|NCT02565186|81607262|FG000|Overall Study|Non-Compliance|57|||
27937596|NCT02565186|81607263|FG001|Overall Study|Non-Compliance|55|||
27937597|NCT02565186|81607262|FG000|Overall Study|Withdrawal by Subject|229|||
27937598|NCT02565186|81607263|FG001|Overall Study|Withdrawal by Subject|214|||
27937599|NCT02565186|81607262|FG000|Overall Study|Physician Decision|18|||
27937600|NCT02565186|81607263|FG001|Overall Study|Physician Decision|16|||
27937601|NCT02565186|81607262|FG000|Overall Study|Sponsor Request|5|||
27937602|NCT02565186|81607263|FG001|Overall Study|Sponsor Request|9|||
27937603|NCT02565186|81607262|FG000|Overall Study|Missing|1|||
27937604|NCT02565186|81607263|FG001|Overall Study|Missing|0|||
27937605|NCT02565186|81607262|FG000|Overall Study|Did Not Receive Study Drug|55|||
27937606|NCT02565186|81607263|FG001|Overall Study|Did Not Receive Study Drug|86|||
27937607|NCT00420407|81607266|FG000|Overall Study|Lost to Follow-up|0|||
27937608|NCT00420407|81607267|FG001|Overall Study|Lost to Follow-up|3|||
27937609|NCT00420407|81607266|FG000|Overall Study|Physician Decision|2|||
27937610|NCT00420407|81607267|FG001|Overall Study|Physician Decision|1|||
27937611|NCT00420407|81607266|FG000|Overall Study|subject identified as detainee|1|||
27937612|NCT00420407|81607267|FG001|Overall Study|subject identified as detainee|0|||
27937613|NCT00420407|81607266|FG000|Overall Study|subject identified as Jehovah's witness|1|||
27937614|NCT00420407|81607267|FG001|Overall Study|subject identified as Jehovah's witness|0|||
27937615|NCT00420407|81607266|FG000|Overall Study|Withdrawal by Subject|0|||
27937616|NCT00420407|81607267|FG001|Overall Study|Withdrawal by Subject|2|||
27937617|NCT04576949|81607269|FG000|Overall Study|Adverse Event|1|||
27937618|NCT04576949|81607270|FG001|Overall Study|Adverse Event|3|||
27937619|NCT04576949|81607271|FG002|Overall Study|Adverse Event|2|||
27937620|NCT04576949|81607269|FG000|Overall Study|Withdrawal by Subject|41|||
27937621|NCT04576949|81607270|FG001|Overall Study|Withdrawal by Subject|26|||
27937622|NCT04576949|81607271|FG002|Overall Study|Withdrawal by Subject|18|||
27937623|NCT04576949|81607269|FG000|Overall Study|Physician Decision|3|||
27937624|NCT04576949|81607270|FG001|Overall Study|Physician Decision|0|||
27937625|NCT04576949|81607271|FG002|Overall Study|Physician Decision|0|||
27937626|NCT04576949|81607269|FG000|Overall Study|Death|0|||
27937627|NCT04576949|81607270|FG001|Overall Study|Death|1|||
27937628|NCT04576949|81607271|FG002|Overall Study|Death|0|||
27937629|NCT04576949|81607269|FG000|Overall Study|Lost to Follow-up|29|||
27937630|NCT04576949|81607270|FG001|Overall Study|Lost to Follow-up|37|||
27937631|NCT04576949|81607271|FG002|Overall Study|Lost to Follow-up|24|||
27746180|NCT01912872|80899564|FG001|Overall Study|Lost to Follow-up|3|||
27746181|NCT01912872|80899565|FG002|Overall Study|Lost to Follow-up|5|||
27937632|NCT04576949|81607269|FG000|Overall Study|Other, Not Specified|2|||
27937633|NCT04576949|81607270|FG001|Overall Study|Other, Not Specified|3|||
27937634|NCT04576949|81607271|FG002|Overall Study|Other, Not Specified|1|||
27937635|NCT04576949|81607269|FG000|Overall Study|Other|1|||
27937636|NCT04576949|81607270|FG001|Overall Study|Other|0|||
27937637|NCT04576949|81607271|FG002|Overall Study|Other|0|||
27937638|NCT02476916|81607272|FG000|Core Period|Adverse Event|2|||
27937639|NCT02476916|81607273|FG001|Core Period|Adverse Event|2|||
27937640|NCT02476916|81607272|FG000|Core Period|Investigator decision|1|||
27937641|NCT02476916|81607273|FG001|Core Period|Investigator decision|1|||
27937642|NCT02476916|81607272|FG000|Core Period|Withdrawal by Subject|3|||
27551186|NCT02573350|80207393|FG000|Overall Study|Adverse Event|3|||
27937643|NCT02476916|81607273|FG001|Core Period|Withdrawal by Subject|0|||
27937644|NCT02476916|81607272|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
27937645|NCT02476916|81607273|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
27937646|NCT02476916|81607272|FG000|Extension Period|On Treatment|12|||
27937647|NCT02476916|81607273|FG001|Extension Period|On Treatment|17|||
27937648|NCT00052715|81607274|FG000|Overall Study|wrong histology|1|||
27937649|NCT02991859|81607275|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937650|NCT02991859|81607276|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
27937651|NCT02991859|81607277|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937652|NCT02991859|81607278|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937653|NCT02991859|81607279|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
27937654|NCT02991859|81607280|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937655|NCT02991859|81607281|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937656|NCT02991859|81607282|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937657|NCT02991859|81607283|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937658|NCT02991859|81607284|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937659|NCT02991859|81607285|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937660|NCT02991859|81607286|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937661|NCT02991859|81607287|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937662|NCT02991859|81607288|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937663|NCT02991859|81607289|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937664|NCT02991859|81607290|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937665|NCT02991859|81607291|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
27937666|NCT02991859|81607275|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937667|NCT02991859|81607276|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937668|NCT02991859|81607277|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937669|NCT02991859|81607278|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937670|NCT02991859|81607279|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937671|NCT02991859|81607280|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937672|NCT02991859|81607281|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937673|NCT02991859|81607282|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937674|NCT02991859|81607283|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937675|NCT02991859|81607284|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937676|NCT02991859|81607285|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937677|NCT02991859|81607286|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937678|NCT02991859|81607287|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
27937679|NCT02991859|81607288|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
27937680|NCT02991859|81607289|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937681|NCT02991859|81607290|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937682|NCT02991859|81607291|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
27937683|NCT02991859|81607275|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937684|NCT02991859|81607276|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937685|NCT02991859|81607277|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937686|NCT02991859|81607278|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937687|NCT02991859|81607279|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937688|NCT02991859|81607280|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
27937689|NCT02991859|81607281|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937690|NCT02991859|81607282|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937691|NCT02991859|81607283|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937692|NCT02991859|81607284|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937693|NCT02991859|81607285|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937694|NCT02991859|81607286|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937695|NCT02991859|81607287|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937696|NCT02991859|81607288|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937697|NCT02991859|81607289|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937698|NCT02991859|81607290|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937699|NCT02991859|81607291|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
27937700|NCT02991859|81607275|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937701|NCT02991859|81607276|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937702|NCT02991859|81607277|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937703|NCT02991859|81607278|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937704|NCT02991859|81607279|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937705|NCT02991859|81607280|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937706|NCT02991859|81607281|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937707|NCT02991859|81607282|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937708|NCT02991859|81607283|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27551187|NCT02573350|80207394|FG001|Overall Study|Adverse Event|4|||
27551188|NCT02573350|80207393|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
27937709|NCT02991859|81607284|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
27937710|NCT02991859|81607285|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937711|NCT02991859|81607286|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937712|NCT02991859|81607287|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937713|NCT02991859|81607288|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937714|NCT02991859|81607289|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937715|NCT02991859|81607290|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937716|NCT02991859|81607291|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
27937717|NCT02991859|81607275|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937718|NCT02991859|81607276|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937719|NCT02991859|81607277|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937720|NCT02991859|81607278|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937721|NCT02991859|81607279|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937722|NCT02991859|81607280|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937723|NCT02991859|81607281|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937724|NCT02991859|81607282|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937725|NCT02991859|81607283|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
27937726|NCT02991859|81607284|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937727|NCT02991859|81607285|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937728|NCT02991859|81607286|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937729|NCT02991859|81607287|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937730|NCT02991859|81607288|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937731|NCT02991859|81607289|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937732|NCT02991859|81607290|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937733|NCT02991859|81607291|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
27937734|NCT03769116|81607294|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
27937735|NCT03769116|81607295|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
27937736|NCT03769116|81607294|FG000|Part 3 - Open Label|Physician Decision|1|||
27937737|NCT03769116|81607295|FG001|Part 3 - Open Label|Physician Decision|0|||
27937738|NCT03769116|81607294|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
27937739|NCT03769116|81607295|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
27937740|NCT03180138|81607297|FG000|Overall Study|Mobile-phone could not be verified|2|||
27937741|NCT03180138|81607298|FG001|Overall Study|Mobile-phone could not be verified|13|||
27937742|NCT03180138|81607299|FG002|Overall Study|Mobile-phone could not be verified|15|||
27937743|NCT03180138|81607297|FG000|Overall Study|No prior immunization records|17|||
27937744|NCT03180138|81607298|FG001|Overall Study|No prior immunization records|0|||
27937745|NCT03180138|81607299|FG002|Overall Study|No prior immunization records|6|||
27937746|NCT03180138|81607297|FG000|Overall Study|Found to be >24 mon after randomization|3|||
27937747|NCT03180138|81607298|FG001|Overall Study|Found to be >24 mon after randomization|0|||
27937748|NCT03180138|81607299|FG002|Overall Study|Found to be >24 mon after randomization|3|||
27937749|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
27937750|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
27937751|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
27937752|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
27937753|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
27937754|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
27937755|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
27937756|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
27937757|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
27937758|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
27937759|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
27937760|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
27937761|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
27937762|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
27937763|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
27937764|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
27937765|NCT01755156|81607300|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
27937766|NCT01755156|81607301|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
27937767|NCT01755156|81607300|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
27937768|NCT01755156|81607301|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
27937769|NCT01755156|81607300|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
27937770|NCT01755156|81607301|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
27937771|NCT00231465|81607302|FG000|Overall Study|Completed only one cycle|1|||
27937772|NCT00231465|81607302|FG000|Overall Study|Did not have follow up CT scans|1|||
27937773|NCT01169337|81607303|FG000|Overall Study|Lack of Efficacy|5|||
27937774|NCT01169337|81607304|FG001|Overall Study|Lack of Efficacy|7|||
27937775|NCT01169337|81607305|FG002|Overall Study|Lack of Efficacy|0|||
27937776|NCT01169337|81607303|FG000|Overall Study|Adverse Event|12|||
27937777|NCT01169337|81607304|FG001|Overall Study|Adverse Event|18|||
27937778|NCT01169337|81607305|FG002|Overall Study|Adverse Event|0|||
27937779|NCT01169337|81607303|FG000|Overall Study|Death|2|||
27937780|NCT01169337|81607304|FG001|Overall Study|Death|0|||
27937781|NCT01169337|81607305|FG002|Overall Study|Death|0|||
27937782|NCT01169337|81607303|FG000|Overall Study|Withdrawal by Subject|11|||
27937783|NCT01169337|81607304|FG001|Overall Study|Withdrawal by Subject|11|||
27937784|NCT01169337|81607305|FG002|Overall Study|Withdrawal by Subject|6|||
27937785|NCT01169337|81607303|FG000|Overall Study|Noncompliance|2|||
27937786|NCT01169337|81607304|FG001|Overall Study|Noncompliance|0|||
27937787|NCT01169337|81607305|FG002|Overall Study|Noncompliance|0|||
27937788|NCT01169337|81607303|FG000|Overall Study|Other complicating disease|1|||
27937789|NCT01169337|81607304|FG001|Overall Study|Other complicating disease|1|||
27937790|NCT01169337|81607305|FG002|Overall Study|Other complicating disease|0|||
27937791|NCT01169337|81607303|FG000|Overall Study|Physician Decision|1|||
27937792|NCT01169337|81607304|FG001|Overall Study|Physician Decision|5|||
27937793|NCT01169337|81607305|FG002|Overall Study|Physician Decision|0|||
27937794|NCT01169337|81607303|FG000|Overall Study|Alternative therapy|0|||
27937795|NCT01169337|81607304|FG001|Overall Study|Alternative therapy|2|||
27937796|NCT01169337|81607305|FG002|Overall Study|Alternative therapy|0|||
27937797|NCT01169337|81607303|FG000|Overall Study|Changed hospital|0|||
27937798|NCT01169337|81607304|FG001|Overall Study|Changed hospital|1|||
27937799|NCT01169337|81607305|FG002|Overall Study|Changed hospital|0|||
27937800|NCT01169337|81607303|FG000|Overall Study|Never started treatment|0|||
27937801|NCT01169337|81607304|FG001|Overall Study|Never started treatment|2|||
27937802|NCT01169337|81607305|FG002|Overall Study|Never started treatment|0|||
27937803|NCT01169337|81607303|FG000|Overall Study|Reason not reported|1|||
27937804|NCT01169337|81607304|FG001|Overall Study|Reason not reported|0|||
27937805|NCT01169337|81607305|FG002|Overall Study|Reason not reported|0|||
27937806|NCT01169337|81607303|FG000|Overall Study|Continuing lenalidomide|9|||
27937807|NCT01169337|81607304|FG001|Overall Study|Continuing lenalidomide|43|||
27937808|NCT01169337|81607305|FG002|Overall Study|Continuing lenalidomide|0|||
27937809|NCT02469961|81607307|FG000|Overall Study|Physician Decision|4|||
27937810|NCT02469961|81607308|FG001|Overall Study|Physician Decision|1|||
27937811|NCT02166463|81607310|FG000|Overall Study|Lost to Follow-up|0|||
27937812|NCT02166463|81607311|FG001|Overall Study|Lost to Follow-up|1|||
27937813|NCT02166463|81607310|FG000|Overall Study|Physician Decision|10|||
27937814|NCT02166463|81607311|FG001|Overall Study|Physician Decision|10|||
27937815|NCT02166463|81607310|FG000|Overall Study|Ineligible|11|||
27937816|NCT02166463|81607311|FG001|Overall Study|Ineligible|2|||
27937817|NCT02166463|81607310|FG000|Overall Study|Progressive Disease|9|||
27937818|NCT02166463|81607311|FG001|Overall Study|Progressive Disease|6|||
27937819|NCT02166463|81607310|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
27937820|NCT02166463|81607311|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
27937821|NCT02166463|81607310|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
27937822|NCT02166463|81607311|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
27937823|NCT02166463|81607310|FG000|Overall Study|Refusal of further protocol therapy|5|||
27937824|NCT02166463|81607311|FG001|Overall Study|Refusal of further protocol therapy|6|||
27937825|NCT05938010|81607312|FG000|Overall Study|Lost to Follow-up|2|||
27937826|NCT05215847|81607313|FG000|Overall Study|Lost to Follow-up|1|||
27937827|NCT01633112|81607314|FG000|Overall Study|Lack of Efficacy|1|||
27937828|NCT01633112|81607315|FG001|Overall Study|Lack of Efficacy|6|||
27937829|NCT01633112|81607316|FG002|Overall Study|Lack of Efficacy|13|||
27937830|NCT01633112|81607314|FG000|Overall Study|Abnormal laboratory value(s)|3|||
27937831|NCT01633112|81607315|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27937832|NCT01633112|81607316|FG002|Overall Study|Abnormal laboratory value(s)|0|||
27937833|NCT01633112|81607314|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27937834|NCT01633112|81607315|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27937835|NCT01633112|81607316|FG002|Overall Study|Abnormal test procedure result(s)|0|||
27937836|NCT01633112|81607314|FG000|Overall Study|Administrative problems|1|||
27937837|NCT01633112|81607315|FG001|Overall Study|Administrative problems|2|||
27937838|NCT01633112|81607316|FG002|Overall Study|Administrative problems|5|||
27937839|NCT01633112|81607314|FG000|Overall Study|Adverse Event|16|||
27937840|NCT01633112|81607315|FG001|Overall Study|Adverse Event|18|||
27937841|NCT01633112|81607316|FG002|Overall Study|Adverse Event|20|||
27937842|NCT01633112|81607314|FG000|Overall Study|Lost to Follow-up|7|||
27937843|NCT01633112|81607315|FG001|Overall Study|Lost to Follow-up|19|||
27937844|NCT01633112|81607316|FG002|Overall Study|Lost to Follow-up|6|||
27937845|NCT01633112|81607314|FG000|Overall Study|Protocol Violation|4|||
27937846|NCT01633112|81607315|FG001|Overall Study|Protocol Violation|0|||
27937847|NCT01633112|81607316|FG002|Overall Study|Protocol Violation|2|||
27937848|NCT01633112|81607314|FG000|Overall Study|Subject no longer requires study drug|0|||
27937849|NCT01633112|81607315|FG001|Overall Study|Subject no longer requires study drug|0|||
27937850|NCT01633112|81607316|FG002|Overall Study|Subject no longer requires study drug|1|||
27937851|NCT01633112|81607314|FG000|Overall Study|Withdrawal by Subject|20|||
27937852|NCT01633112|81607315|FG001|Overall Study|Withdrawal by Subject|12|||
27937853|NCT01633112|81607316|FG002|Overall Study|Withdrawal by Subject|41|||
27937854|NCT01633112|81607314|FG000|Overall Study|missing Study Completion CRF|1|||
27937855|NCT01633112|81607315|FG001|Overall Study|missing Study Completion CRF|1|||
27937856|NCT01633112|81607316|FG002|Overall Study|missing Study Completion CRF|4|||
27937857|NCT01522976|81607320|FG000|Overall Study|Ineligible|4|||
27937858|NCT01522976|81607321|FG001|Overall Study|Ineligible|0|||
27937859|NCT01522976|81607322|FG002|Overall Study|Ineligible|1|||
27937860|NCT01522976|81607320|FG000|Overall Study|Death|7|||
27937861|NCT01522976|81607321|FG001|Overall Study|Death|6|||
27937862|NCT01522976|81607322|FG002|Overall Study|Death|2|||
27937863|NCT01522976|81607320|FG000|Overall Study|Still on treatment|9|||
27937864|NCT01522976|81607321|FG001|Overall Study|Still on treatment|9|||
27937865|NCT01522976|81607322|FG002|Overall Study|Still on treatment|6|||
27937866|NCT01522976|81607320|FG000|Overall Study|Disease progression|28|||
27937867|NCT01522976|81607321|FG001|Overall Study|Disease progression|30|||
27937868|NCT01522976|81607322|FG002|Overall Study|Disease progression|25|||
27937869|NCT01522976|81607320|FG000|Overall Study|Adverse Event|17|||
27937870|NCT01522976|81607321|FG001|Overall Study|Adverse Event|7|||
27937871|NCT01522976|81607322|FG002|Overall Study|Adverse Event|18|||
27937872|NCT01522976|81607320|FG000|Overall Study|Refusal unrelated to adverse event|10|||
27937873|NCT01522976|81607321|FG001|Overall Study|Refusal unrelated to adverse event|13|||
27937874|NCT01522976|81607322|FG002|Overall Study|Refusal unrelated to adverse event|14|||
27937875|NCT01522976|81607320|FG000|Overall Study|Not protocol specified|22|||
27937876|NCT01522976|81607321|FG001|Overall Study|Not protocol specified|27|||
27937877|NCT01522976|81607322|FG002|Overall Study|Not protocol specified|27|||
27937878|NCT04584554|81607323|FG000|Overall Study|Withdrawal by Subject|2|||
27937879|NCT04584554|81607324|FG001|Overall Study|Withdrawal by Subject|2|||
27937880|NCT05587998|81607325|FG000|Overall Study|Withdrawal by Subject|1|||
27937881|NCT05587998|81607326|FG001|Overall Study|Withdrawal by Subject|1|||
27937882|NCT05587998|81607325|FG000|Overall Study|Not treated|3|||
27937883|NCT05587998|81607326|FG001|Overall Study|Not treated|1|||
27937884|NCT05587998|81607325|FG000|Overall Study|Non-compliance with study procedures|0|||
27937885|NCT05587998|81607326|FG001|Overall Study|Non-compliance with study procedures|1|||
27937886|NCT01189227|81607330|FG000|Overall Study|Study terminated due to low accrual|6|||
27937887|NCT01189227|81607331|FG001|Overall Study|Study terminated due to low accrual|3|||
27937888|NCT03737994|81607332|FG000|Overall Study|Withdrawal by Subject|0|||
27937889|NCT03737994|81607333|FG001|Overall Study|Withdrawal by Subject|0|||
27937890|NCT03737994|81607334|FG002|Overall Study|Withdrawal by Subject|0|||
27937891|NCT03737994|81607335|FG003|Overall Study|Withdrawal by Subject|0|||
27937892|NCT03737994|81607336|FG004|Overall Study|Withdrawal by Subject|0|||
27937893|NCT03737994|81607337|FG005|Overall Study|Withdrawal by Subject|0|||
27937894|NCT03737994|81607338|FG006|Overall Study|Withdrawal by Subject|1|||
27937895|NCT02181621|81607339|FG000|Overall Study|Adverse Event|1|||
27937896|NCT02181621|81607340|FG001|Overall Study|Adverse Event|0|||
27937897|NCT02181621|81607339|FG000|Overall Study|Previously Enrolled|0|||
27746182|NCT01912872|80899566|FG003|Overall Study|Lost to Follow-up|5|||
27746183|NCT01912872|80899563|FG000|Overall Study|Other unspecified|3|||
27746184|NCT01912872|80899564|FG001|Overall Study|Other unspecified|1|||
27746185|NCT01912872|80899565|FG002|Overall Study|Other unspecified|3|||
27746186|NCT01912872|80899566|FG003|Overall Study|Other unspecified|0|||
27746187|NCT01912872|80899563|FG000|Overall Study|Informed consent withdrawn|0|||
27746188|NCT01912872|80899564|FG001|Overall Study|Informed consent withdrawn|0|||
27746189|NCT01912872|80899565|FG002|Overall Study|Informed consent withdrawn|1|||
27746190|NCT01912872|80899566|FG003|Overall Study|Informed consent withdrawn|1|||
27746191|NCT01912872|80899563|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
27746192|NCT01912872|80899564|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
27746193|NCT01912872|80899565|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
27746194|NCT01912872|80899566|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
27746195|NCT01912872|80899563|FG000|Overall Study|Protocol Violation|0|||
27746196|NCT01912872|80899564|FG001|Overall Study|Protocol Violation|0|||
27746197|NCT01912872|80899565|FG002|Overall Study|Protocol Violation|1|||
27746198|NCT01912872|80899566|FG003|Overall Study|Protocol Violation|0|||
27746199|NCT01912872|80899563|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27746200|NCT01912872|80899564|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27746201|NCT01912872|80899565|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27746202|NCT01912872|80899566|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
27746203|NCT01912872|80899563|FG000|Overall Study|Withdrawal of study medication|0|||
27746204|NCT01912872|80899564|FG001|Overall Study|Withdrawal of study medication|0|||
27746205|NCT01912872|80899565|FG002|Overall Study|Withdrawal of study medication|0|||
27746206|NCT01912872|80899566|FG003|Overall Study|Withdrawal of study medication|2|||
27746207|NCT01912872|80899563|FG000|Overall Study|Missing|0|||
27746208|NCT01912872|80899564|FG001|Overall Study|Missing|0|||
27746209|NCT01912872|80899565|FG002|Overall Study|Missing|0|||
27937898|NCT02181621|81607340|FG001|Overall Study|Previously Enrolled|1|||
27937899|NCT02181621|81607339|FG000|Overall Study|Enrollment Hold|1|||
27937900|NCT02181621|81607340|FG001|Overall Study|Enrollment Hold|1|||
27937901|NCT00602641|81607341|FG000|Overall Study|Never started protocol therapy|6|||
27937902|NCT00602641|81607342|FG001|Overall Study|Never started protocol therapy|2|||
27937903|NCT00602641|81607341|FG000|Overall Study|Still on treatment at time of analysis|8|||
27937904|NCT00602641|81607342|FG001|Overall Study|Still on treatment at time of analysis|15|||
27937905|NCT00602641|81607341|FG000|Overall Study|Adverse Event|62|||
27937906|NCT00602641|81607342|FG001|Overall Study|Adverse Event|53|||
27937907|NCT00602641|81607341|FG000|Overall Study|Disease progression|38|||
27937908|NCT00602641|81607342|FG001|Overall Study|Disease progression|55|||
27937909|NCT00602641|81607341|FG000|Overall Study|Death|6|||
27937910|NCT00602641|81607342|FG001|Overall Study|Death|5|||
27937911|NCT00602641|81607341|FG000|Overall Study|Withdrawal by Subject|15|||
27937912|NCT00602641|81607342|FG001|Overall Study|Withdrawal by Subject|12|||
27937913|NCT00602641|81607341|FG000|Overall Study|Alternative therapy|5|||
27937914|NCT00602641|81607342|FG001|Overall Study|Alternative therapy|2|||
27937915|NCT00602641|81607341|FG000|Overall Study|Other Complicating Disease|5|||
27937916|NCT00602641|81607342|FG001|Overall Study|Other Complicating Disease|2|||
27937917|NCT00602641|81607341|FG000|Overall Study|Physician Decision|5|||
27937918|NCT00602641|81607342|FG001|Overall Study|Physician Decision|4|||
27937919|NCT00602641|81607341|FG000|Overall Study|Administrative Closure|1|||
27937920|NCT00602641|81607342|FG001|Overall Study|Administrative Closure|1|||
27937921|NCT00602641|81607341|FG000|Overall Study|Other|3|||
27937922|NCT00602641|81607342|FG001|Overall Study|Other|1|||
27937923|NCT05156125|81607343|FG000|Overall Study|Lack of Efficacy|1|||
27937924|NCT05156125|81607344|FG001|Overall Study|Lack of Efficacy|1|||
27937925|NCT05156125|81607345|FG002|Overall Study|Lack of Efficacy|1|||
27937926|NCT05156125|81607343|FG000|Overall Study|Physician Decision|0|||
27937927|NCT05156125|81607344|FG001|Overall Study|Physician Decision|0|||
27937928|NCT05156125|81607345|FG002|Overall Study|Physician Decision|1|||
27937929|NCT05156125|81607343|FG000|Overall Study|Non-compliance|0|||
27937930|NCT05156125|81607344|FG001|Overall Study|Non-compliance|1|||
27937931|NCT05156125|81607345|FG002|Overall Study|Non-compliance|1|||
27937932|NCT05156125|81607343|FG000|Overall Study|Withdrawal by Subject|0|||
27937933|NCT05156125|81607344|FG001|Overall Study|Withdrawal by Subject|0|||
27937934|NCT05156125|81607345|FG002|Overall Study|Withdrawal by Subject|1|||
27937935|NCT05156125|81607343|FG000|Overall Study|Adverse Event|2|||
27937936|NCT05156125|81607344|FG001|Overall Study|Adverse Event|1|||
27937937|NCT05156125|81607345|FG002|Overall Study|Adverse Event|0|||
27937938|NCT02362412|81607346|FG000|Treatment Period III|Lost to Follow-up|0|||
27937939|NCT02362412|81607347|FG001|Treatment Period III|Lost to Follow-up|1|||
27937940|NCT04882215|81607348|FG000|Overall Study|Withdrawal by Subject|5|||
27937941|NCT04882215|81607349|FG001|Overall Study|Withdrawal by Subject|0|||
27937942|NCT01336972|81607350|FG000|Overall Study|Adverse Event|1|||
27937943|NCT01336972|81607351|FG001|Overall Study|Adverse Event|1|||
27937944|NCT01336972|81607352|FG002|Overall Study|Adverse Event|0|||
27937945|NCT01134614|81607353|FG000|Overall Study|Still on treatment as of March 2013|21|||
27937946|NCT01134614|81607354|FG001|Overall Study|Still on treatment as of March 2013|13|||
27937947|NCT01134614|81607353|FG000|Overall Study|Progressive disease|60|||
27937948|NCT01134614|81607354|FG001|Overall Study|Progressive disease|54|||
27937949|NCT01134614|81607353|FG000|Overall Study|Adverse Event|26|||
27937950|NCT01134614|81607354|FG001|Overall Study|Adverse Event|39|||
27937951|NCT01134614|81607353|FG000|Overall Study|Death|5|||
27937952|NCT01134614|81607354|FG001|Overall Study|Death|8|||
27937953|NCT01134614|81607353|FG000|Overall Study|Withdrawal by Subject|3|||
27937954|NCT01134614|81607354|FG001|Overall Study|Withdrawal by Subject|2|||
27937955|NCT01134614|81607353|FG000|Overall Study|Alternative therapy|2|||
27937956|NCT01134614|81607354|FG001|Overall Study|Alternative therapy|0|||
27937957|NCT01134614|81607353|FG000|Overall Study|Complicating disease|2|||
27937958|NCT01134614|81607354|FG001|Overall Study|Complicating disease|1|||
27937959|NCT01134614|81607353|FG000|Overall Study|Physician's decision|0|||
27937960|NCT01134614|81607354|FG001|Overall Study|Physician's decision|1|||
27937961|NCT01134614|81607353|FG000|Overall Study|Never started treatment|4|||
27937962|NCT01134614|81607354|FG001|Overall Study|Never started treatment|1|||
27937963|NCT01134614|81607353|FG000|Overall Study|Pt received tx not allowed on study|0|||
27937964|NCT01134614|81607354|FG001|Overall Study|Pt received tx not allowed on study|1|||
27937965|NCT01134614|81607353|FG000|Overall Study|Symptomatic deterioration|0|||
27937966|NCT01134614|81607354|FG001|Overall Study|Symptomatic deterioration|1|||
27937967|NCT01134614|81607353|FG000|Overall Study|Patient in hospice care|0|||
27937968|NCT01134614|81607354|FG001|Overall Study|Patient in hospice care|1|||
27937969|NCT00432991|81607355|FG000|Overall Study|Protocol Violation|7|||
27937970|NCT00432991|81607356|FG001|Overall Study|Protocol Violation|12|||
27937971|NCT02642042|81607357|FG000|Overall Study|Adverse Event|22|||
27937972|NCT02642042|81607357|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
27937973|NCT02642042|81607357|FG000|Overall Study|Progression/Relapse|28|||
27937974|NCT02642042|81607357|FG000|Overall Study|Death|1|||
27937975|NCT02642042|81607357|FG000|Overall Study|Not Protocol Specified|2|||
27937976|NCT02942407|81607360|FG000|Overall Study|Lost to Follow-up|3|||
27937977|NCT02942407|81607361|FG001|Overall Study|Lost to Follow-up|2|||
27937978|NCT02942407|81607360|FG000|Overall Study|Withdrawal by Subject|7|||
27937979|NCT02942407|81607361|FG001|Overall Study|Withdrawal by Subject|9|||
27937980|NCT02942407|81607360|FG000|Overall Study|Death|16|||
27937981|NCT02942407|81607361|FG001|Overall Study|Death|13|||
27937982|NCT03055013|81607364|FG000|Overall Study|Adverse Event|78|||
27937983|NCT03055013|81607365|FG001|Overall Study|Adverse Event|0|||
27937984|NCT03055013|81607364|FG000|Overall Study|Death|6|||
27937985|NCT03055013|81607365|FG001|Overall Study|Death|0|||
27937986|NCT03055013|81607364|FG000|Overall Study|Disease relapse|33|||
27937987|NCT03055013|81607365|FG001|Overall Study|Disease relapse|0|||
27937988|NCT03055013|81607364|FG000|Overall Study|Withdrawal by Subject|28|||
27937989|NCT03055013|81607365|FG001|Overall Study|Withdrawal by Subject|0|||
27937990|NCT03055013|81607364|FG000|Overall Study|Other complicating disease|5|||
27937991|NCT03055013|81607365|FG001|Overall Study|Other complicating disease|0|||
27937992|NCT03055013|81607364|FG000|Overall Study|Physician Decision|1|||
27937993|NCT03055013|81607365|FG001|Overall Study|Physician Decision|0|||
27937994|NCT03055013|81607364|FG000|Overall Study|Benign mass/non-RCC|4|||
27937995|NCT03055013|81607365|FG001|Overall Study|Benign mass/non-RCC|0|||
27937996|NCT03055013|81607364|FG000|Overall Study|Enrolled in another trial|1|||
27937997|NCT03055013|81607365|FG001|Overall Study|Enrolled in another trial|0|||
27937998|NCT03055013|81607364|FG000|Overall Study|Non-protocol therapy|1|||
27937999|NCT03055013|81607365|FG001|Overall Study|Non-protocol therapy|0|||
27938000|NCT03055013|81607364|FG000|Overall Study|Incompliance|1|||
27938001|NCT03055013|81607365|FG001|Overall Study|Incompliance|0|||
27938002|NCT03055013|81607364|FG000|Overall Study|Insurance issues|1|||
27938003|NCT03055013|81607365|FG001|Overall Study|Insurance issues|0|||
27938004|NCT03055013|81607364|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
27938005|NCT03055013|81607365|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
27645063|NCT00640159|80541471|FG000|Overall Study|Lost to Follow-up|2|||
27938006|NCT03055013|81607364|FG000|Overall Study|Did not receive nivolumab|10|||
27938007|NCT03055013|81607365|FG001|Overall Study|Did not receive nivolumab|0|||
27938008|NCT03055013|81607364|FG000|Overall Study|Did not receive surgery|0|||
27938009|NCT03055013|81607365|FG001|Overall Study|Did not receive surgery|28|||
27938010|NCT01748552|81607368|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
27938011|NCT01748552|81607369|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
27938012|NCT01748552|81607370|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
27938013|NCT01748552|81607371|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
27645072|NCT03936660|80541474|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
27645073|NCT03936660|80541475|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
27645074|NCT00754065|80541476|FG000|Overall Study|Never received treatment|12|||
27645075|NCT00754065|80541477|FG001|Overall Study|Never received treatment|2|||
27645076|NCT00754065|80541476|FG000|Overall Study|Adverse Event|19|||
27645077|NCT00754065|80541477|FG001|Overall Study|Adverse Event|25|||
27645078|NCT00754065|80541476|FG000|Overall Study|Lost to Follow-up|7|||
27645079|NCT00754065|80541477|FG001|Overall Study|Lost to Follow-up|11|||
27645080|NCT00754065|80541476|FG000|Overall Study|Protocol Violation|12|||
27645081|NCT00754065|80541477|FG001|Overall Study|Protocol Violation|10|||
27645082|NCT00754065|80541476|FG000|Overall Study|Withdrawal by Subject|4|||
27645083|NCT00754065|80541477|FG001|Overall Study|Withdrawal by Subject|5|||
27645084|NCT00754065|80541476|FG000|Overall Study|Pregnancy|6|||
27645085|NCT00754065|80541477|FG001|Overall Study|Pregnancy|0|||
27645086|NCT00754065|80541476|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
27645087|NCT00754065|80541477|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
27938014|NCT01748552|81607372|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
27938015|NCT01748552|81607373|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
27645090|NCT03613740|80541479|FG000|Overall Study|Lost to Follow-up|1|||
27645091|NCT03613740|80541480|FG001|Overall Study|Lost to Follow-up|1|||
27938016|NCT01748552|81607374|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
27938017|NCT01748552|81607375|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
27938018|NCT01748552|81607376|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
27938019|NCT01748552|81607377|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
27938020|NCT01748552|81607378|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
27938021|NCT01748552|81607379|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
27938022|NCT01748552|81607368|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938023|NCT01748552|81607369|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938024|NCT01748552|81607370|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938025|NCT01748552|81607371|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938026|NCT01748552|81607372|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27645103|NCT02157116|80541492|FG000|Overall Study|Withdrawal by Subject|4|||
27645104|NCT02157116|80541492|FG000|Overall Study|Physician Decision|3|||
27645105|NCT02157116|80541492|FG000|Overall Study|Failed Screening|2|||
27645106|NCT03274076|80541499|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
27645107|NCT03274076|80541500|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
27746210|NCT01912872|80899566|FG003|Overall Study|Missing|1|||
27645108|NCT03274076|80541501|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
27645109|NCT03274076|80541502|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
27645110|NCT03274076|80541499|FG000|24 Weeks Open Label|Adverse Event|0|||
27645111|NCT03274076|80541500|FG001|24 Weeks Open Label|Adverse Event|0|||
27645112|NCT03274076|80541501|FG002|24 Weeks Open Label|Adverse Event|2|||
27645113|NCT03274076|80541502|FG003|24 Weeks Open Label|Adverse Event|0|||
27645114|NCT03274076|80541499|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
27645115|NCT03274076|80541500|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
27645116|NCT03274076|80541501|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
27645117|NCT03274076|80541502|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
27645118|NCT00442104|80541510|FG000|Overall Study|Adverse Event|5|||
27645119|NCT00442104|80541510|FG000|Overall Study|Death|2|||
27645120|NCT00442104|80541510|FG000|Overall Study|Lost to Follow-up|3|||
27645121|NCT00442104|80541510|FG000|Overall Study|Withdrawal by Subject|5|||
27645122|NCT00442104|80541510|FG000|Overall Study|Insufficient Clinical Response|10|||
27645123|NCT00442104|80541510|FG000|Overall Study|Other|21|||
27645124|NCT00442104|80541510|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
27645125|NCT04989816|80541511|FG000|Overall Study|Death|77|||
27645126|NCT04989816|80541511|FG000|Overall Study|Lost to Follow-up|3|||
27645127|NCT00371345|80541516|FG000|Overall Study|Disease Progression|21|||
27645128|NCT00371345|80541517|FG001|Overall Study|Disease Progression|35|||
27645129|NCT00371345|80541516|FG000|Overall Study|Study Drug Toxicity|1|||
27645130|NCT00371345|80541517|FG001|Overall Study|Study Drug Toxicity|7|||
27645131|NCT00371345|80541516|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
27645132|NCT00371345|80541517|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
27645133|NCT00371345|80541516|FG000|Overall Study|Participant Request|1|||
27645134|NCT00371345|80541517|FG001|Overall Study|Participant Request|1|||
27645135|NCT00371345|80541516|FG000|Overall Study|Participant Withdrew Consent|0|||
27645136|NCT00371345|80541517|FG001|Overall Study|Participant Withdrew Consent|1|||
27645137|NCT02180724|80541518|FG000|Overall Study|Death|26|||
27938027|NCT01748552|81607373|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938028|NCT01748552|81607374|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
27938029|NCT01748552|81607375|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
27938030|NCT01748552|81607376|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
27938031|NCT01748552|81607377|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938032|NCT01748552|81607378|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938033|NCT01748552|81607379|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
27938034|NCT05029362|81609320|FG000|Overall Study|Lost to Follow-up|9|||
27938035|NCT04829214|81609321|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
27938036|NCT04829214|81609322|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
27938037|NCT04829214|81609321|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
27938038|NCT04829214|81609322|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
27938039|NCT02761057|81609324|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
27938040|NCT02761057|81609325|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
27938041|NCT02761057|81609326|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
27551189|NCT02573350|80207394|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
27551190|NCT02573350|80207393|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
27551191|NCT02573350|80207394|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
27551192|NCT02573350|80207393|FG000|Overall Study|Subject withdrew consent to participate|6|||
27551193|NCT02573350|80207394|FG001|Overall Study|Subject withdrew consent to participate|1|||
27551194|NCT02573350|80207393|FG000|Overall Study|Protocol Deviation|1|||
27551195|NCT02573350|80207394|FG001|Overall Study|Protocol Deviation|1|||
27551196|NCT02788357|80207397|FG000|Overall Study|Lost to Follow-up|3|||
27551197|NCT02788357|80207398|FG001|Overall Study|Lost to Follow-up|0|||
27551198|NCT02246660|80207406|FG000|Overall Study|Withdrawal by Subject|0|||
27551199|NCT02246660|80207407|FG001|Overall Study|Withdrawal by Subject|1|||
27551200|NCT02246660|80207408|FG002|Overall Study|Withdrawal by Subject|0|||
27551201|NCT02246660|80207406|FG000|Overall Study|Death|0|||
27551202|NCT02246660|80207407|FG001|Overall Study|Death|0|||
27551203|NCT02246660|80207408|FG002|Overall Study|Death|1|||
27551204|NCT02155608|80207409|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
27551205|NCT02155608|80207410|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
27551206|NCT02155608|80207409|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
27551207|NCT02155608|80207410|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
27551208|NCT02269241|80207415|FG000|Overall Study|Lost to Follow-up|269|||
27551209|NCT02269241|80207415|FG000|Overall Study|Withdrawal by Subject|155|||
27551210|NCT02269241|80207415|FG000|Overall Study|Protocol Violation|1|||
27551211|NCT02269241|80207415|FG000|Overall Study|Physician Decision|7|||
27551212|NCT02269241|80207415|FG000|Overall Study|Pregnancy|15|||
27551213|NCT02269241|80207415|FG000|Overall Study|Wish for pregnancy|5|||
27551214|NCT02269241|80207415|FG000|Overall Study|Development of an exclusion criteria|16|||
27645138|NCT02180724|80541519|FG001|Overall Study|Death|1|||
27645139|NCT02180724|80541518|FG000|Overall Study|Lost to Follow-up|3|||
27645140|NCT02180724|80541519|FG001|Overall Study|Lost to Follow-up|1|||
27645141|NCT02180724|80541518|FG000|Overall Study|Withdrawal by Subject|4|||
27645142|NCT02180724|80541519|FG001|Overall Study|Withdrawal by Subject|2|||
27645143|NCT02180724|80541518|FG000|Overall Study|PI Decision|5|||
27645144|NCT02180724|80541519|FG001|Overall Study|PI Decision|2|||
27645145|NCT02180724|80541518|FG000|Overall Study|Study terminated by sponsor|54|||
27645146|NCT02180724|80541519|FG001|Overall Study|Study terminated by sponsor|8|||
27645147|NCT02029443|80541521|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
27645148|NCT02029443|80541522|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
27938042|NCT02761057|81609327|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
27938043|NCT02761057|81609324|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
27938044|NCT02761057|81609325|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
27938045|NCT02761057|81609326|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
27938046|NCT02761057|81609327|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
27938047|NCT02761057|81609324|FG000|Overall Study|Currently On Study Treatment|0|||
27938048|NCT02761057|81609325|FG001|Overall Study|Currently On Study Treatment|3|||
27938049|NCT02761057|81609326|FG002|Overall Study|Currently On Study Treatment|0|||
27938050|NCT02761057|81609327|FG003|Overall Study|Currently On Study Treatment|0|||
27938051|NCT02761057|81609324|FG000|Overall Study|Adverse Event|11|||
27938052|NCT02761057|81609325|FG001|Overall Study|Adverse Event|9|||
27938053|NCT02761057|81609326|FG002|Overall Study|Adverse Event|5|||
27938054|NCT02761057|81609327|FG003|Overall Study|Adverse Event|3|||
27938055|NCT02761057|81609324|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
27938056|NCT02761057|81609325|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
27938057|NCT02761057|81609326|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
27938058|NCT02761057|81609327|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
27938059|NCT02761057|81609324|FG000|Overall Study|Progression/Relapse|29|||
27938060|NCT02761057|81609325|FG001|Overall Study|Progression/Relapse|27|||
27938061|NCT02761057|81609326|FG002|Overall Study|Progression/Relapse|20|||
27938062|NCT02761057|81609327|FG003|Overall Study|Progression/Relapse|23|||
27938063|NCT02761057|81609324|FG000|Overall Study|Death|2|||
27938064|NCT02761057|81609325|FG001|Overall Study|Death|2|||
27938065|NCT02761057|81609326|FG002|Overall Study|Death|1|||
27938066|NCT02761057|81609327|FG003|Overall Study|Death|1|||
27938067|NCT02761057|81609324|FG000|Overall Study|Other - Not Protocol Specified|2|||
27938068|NCT02761057|81609325|FG001|Overall Study|Other - Not Protocol Specified|1|||
27938069|NCT02761057|81609326|FG002|Overall Study|Other - Not Protocol Specified|2|||
27938070|NCT02761057|81609327|FG003|Overall Study|Other - Not Protocol Specified|0|||
27938071|NCT00861705|81609330|FG000|Overall Study|Never Began Treatment|7|||
27938072|NCT00861705|81609331|FG001|Overall Study|Never Began Treatment|3|||
27551215|NCT02269241|80207415|FG000|Overall Study|Adverse Event|113|||
27551216|NCT02269241|80207415|FG000|Overall Study|At the specific request of the sponsor|20|||
27551217|NCT02269241|80207415|FG000|Overall Study|Several reasons not classified|53|||
27551218|NCT02269241|80207415|FG000|Overall Study|Screening failures|546|||
27551219|NCT02034110|80207416|FG000|Overall Study|Physician Decision|0|||
27551220|NCT02034110|80207417|FG001|Overall Study|Physician Decision|0|||
27551221|NCT02034110|80207418|FG002|Overall Study|Physician Decision|0|||
27551222|NCT02034110|80207419|FG003|Overall Study|Physician Decision|0|||
27551223|NCT02034110|80207420|FG004|Overall Study|Physician Decision|2|||
27551224|NCT02034110|80207421|FG005|Overall Study|Physician Decision|0|||
27551225|NCT02034110|80207422|FG006|Overall Study|Physician Decision|1|||
27551226|NCT02034110|80207423|FG007|Overall Study|Physician Decision|0|||
27551227|NCT02034110|80207416|FG000|Overall Study|Lost to Follow-up|1|||
27551228|NCT02034110|80207417|FG001|Overall Study|Lost to Follow-up|0|||
27551229|NCT02034110|80207418|FG002|Overall Study|Lost to Follow-up|0|||
27551230|NCT02034110|80207419|FG003|Overall Study|Lost to Follow-up|0|||
27551231|NCT02034110|80207420|FG004|Overall Study|Lost to Follow-up|1|||
27551232|NCT02034110|80207421|FG005|Overall Study|Lost to Follow-up|0|||
27551233|NCT02034110|80207422|FG006|Overall Study|Lost to Follow-up|1|||
27551234|NCT02034110|80207423|FG007|Overall Study|Lost to Follow-up|0|||
27551235|NCT02034110|80207416|FG000|Overall Study|Withdrawal by Subject|5|||
27551236|NCT02034110|80207417|FG001|Overall Study|Withdrawal by Subject|7|||
27551237|NCT02034110|80207418|FG002|Overall Study|Withdrawal by Subject|0|||
27551238|NCT02034110|80207419|FG003|Overall Study|Withdrawal by Subject|3|||
27551239|NCT02034110|80207420|FG004|Overall Study|Withdrawal by Subject|7|||
27551240|NCT02034110|80207421|FG005|Overall Study|Withdrawal by Subject|0|||
27551241|NCT02034110|80207422|FG006|Overall Study|Withdrawal by Subject|3|||
27551242|NCT02034110|80207423|FG007|Overall Study|Withdrawal by Subject|1|||
27551243|NCT02034110|80207416|FG000|Overall Study|Study closed by sponsor|6|||
27551244|NCT02034110|80207417|FG001|Overall Study|Study closed by sponsor|2|||
27645149|NCT02029443|80541523|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
27938073|NCT00861705|81609332|FG002|Overall Study|Never Began Treatment|0|||
27938074|NCT00861705|81609333|FG003|Overall Study|Never Began Treatment|1|||
27938075|NCT00756444|81609339|FG000|Overall Study|Adverse Event|1|||
27938076|NCT00756444|81609340|FG001|Overall Study|Adverse Event|1|||
27938077|NCT00756444|81609339|FG000|Overall Study|Withdrawal by Subject|6|||
27938078|NCT00756444|81609340|FG001|Overall Study|Withdrawal by Subject|8|||
27938079|NCT00756444|81609339|FG000|Overall Study|Lost to Follow-up|0|||
27645150|NCT02029443|80541524|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
27645151|NCT02029443|80541525|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
27645152|NCT02029443|80541521|FG000|Overall Study|Death|13|||
27645153|NCT02029443|80541522|FG001|Overall Study|Death|2|||
27645154|NCT02029443|80541523|FG002|Overall Study|Death|2|||
27645155|NCT02029443|80541524|FG003|Overall Study|Death|11|||
27645156|NCT02029443|80541525|FG004|Overall Study|Death|2|||
27645157|NCT02029443|80541521|FG000|Overall Study|Lost to Follow-up|1|||
27645158|NCT02029443|80541522|FG001|Overall Study|Lost to Follow-up|0|||
27938080|NCT00756444|81609340|FG001|Overall Study|Lost to Follow-up|1|||
27938081|NCT00756444|81609339|FG000|Overall Study|Death|5|||
27938082|NCT00756444|81609340|FG001|Overall Study|Death|4|||
27645159|NCT02029443|80541523|FG002|Overall Study|Lost to Follow-up|1|||
27645160|NCT02029443|80541524|FG003|Overall Study|Lost to Follow-up|1|||
27645161|NCT02029443|80541525|FG004|Overall Study|Lost to Follow-up|0|||
27645162|NCT02029443|80541521|FG000|Overall Study|Started other anti-cancer therapy|17|||
27645163|NCT02029443|80541522|FG001|Overall Study|Started other anti-cancer therapy|4|||
27645164|NCT02029443|80541523|FG002|Overall Study|Started other anti-cancer therapy|7|||
27938083|NCT00756444|81609339|FG000|Overall Study|Disease Progression|2|||
27938084|NCT00756444|81609340|FG001|Overall Study|Disease Progression|7|||
27938085|NCT00756444|81609339|FG000|Overall Study|Ineligibility Determined|1|||
27938086|NCT00756444|81609340|FG001|Overall Study|Ineligibility Determined|0|||
27938087|NCT03656562|81609341|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
27938088|NCT03656562|81609342|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
27938089|NCT03656562|81609343|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
27938090|NCT03656562|81609344|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
27938091|NCT03656562|81609341|FG000|Overall Study|Physician Decision|1|||
27938092|NCT03656562|81609342|FG001|Overall Study|Physician Decision|2|||
27938093|NCT03656562|81609343|FG002|Overall Study|Physician Decision|0|||
27938094|NCT03656562|81609344|FG003|Overall Study|Physician Decision|0|||
27938095|NCT03656562|81609341|FG000|Overall Study|Subject Decision|3|||
27938096|NCT03656562|81609342|FG001|Overall Study|Subject Decision|5|||
27938097|NCT03656562|81609343|FG002|Overall Study|Subject Decision|0|||
27938098|NCT03656562|81609344|FG003|Overall Study|Subject Decision|2|||
27938099|NCT01286272|81609345|FG000|Overall Study|Ineligible after beginning treatment|1|||
27938100|NCT01286272|81609346|FG001|Overall Study|Ineligible after beginning treatment|3|||
27938101|NCT02168439|81609347|FG000|Overall Study|Protocol Violation|0|||
27938102|NCT02168439|81609348|FG001|Overall Study|Protocol Violation|2|||
27938103|NCT00770809|81609349|FG000|Overall Study|Adverse Event|9|||
27938104|NCT00770809|81609350|FG001|Overall Study|Adverse Event|1|||
27938105|NCT00770809|81609351|FG002|Overall Study|Adverse Event|12|||
27938106|NCT00770809|81609349|FG000|Overall Study|Death|1|||
27938107|NCT00770809|81609350|FG001|Overall Study|Death|0|||
27938108|NCT00770809|81609351|FG002|Overall Study|Death|0|||
27938109|NCT00770809|81609349|FG000|Overall Study|Withdrawal by Subject|3|||
27938110|NCT00770809|81609350|FG001|Overall Study|Withdrawal by Subject|3|||
27938111|NCT00770809|81609351|FG002|Overall Study|Withdrawal by Subject|7|||
27938112|NCT00770809|81609349|FG000|Overall Study|Progression|2|||
27938113|NCT00770809|81609350|FG001|Overall Study|Progression|2|||
27938114|NCT00770809|81609351|FG002|Overall Study|Progression|0|||
27938115|NCT00770809|81609349|FG000|Overall Study|Complicating illness|0|||
27938116|NCT00770809|81609350|FG001|Overall Study|Complicating illness|0|||
27938117|NCT00770809|81609351|FG002|Overall Study|Complicating illness|1|||
27938118|NCT00770809|81609349|FG000|Overall Study|Other Medical Reasons|2|||
27938119|NCT00770809|81609350|FG001|Overall Study|Other Medical Reasons|4|||
27938120|NCT00770809|81609351|FG002|Overall Study|Other Medical Reasons|3|||
27938121|NCT00070499|81609352|FG000|Overall Study|Adverse Event|6|||
27938122|NCT00070499|81609353|FG001|Overall Study|Adverse Event|6|||
27938123|NCT00070499|81609354|FG002|Overall Study|Adverse Event|19|||
27938124|NCT00070499|81609355|FG003|Overall Study|Adverse Event|15|||
27938125|NCT00070499|81609352|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
27938126|NCT00070499|81609353|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
27938127|NCT00070499|81609354|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
27938128|NCT00070499|81609355|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
27645165|NCT02029443|80541524|FG003|Overall Study|Started other anti-cancer therapy|9|||
27645166|NCT02029443|80541525|FG004|Overall Study|Started other anti-cancer therapy|3|||
27645167|NCT02029443|80541521|FG000|Overall Study|Withdrawal by Subject|3|||
27645168|NCT02029443|80541522|FG001|Overall Study|Withdrawal by Subject|1|||
27755003|NCT04937816|80929651|FG002|Overall Study|Adverse Event|273|||
27938129|NCT00070499|81609352|FG000|Overall Study|Progression/relapse|4|||
27938130|NCT00070499|81609353|FG001|Overall Study|Progression/relapse|2|||
27938131|NCT00070499|81609354|FG002|Overall Study|Progression/relapse|1|||
27938132|NCT00070499|81609355|FG003|Overall Study|Progression/relapse|4|||
27938133|NCT00070499|81609352|FG000|Overall Study|Death|1|||
27938134|NCT00070499|81609353|FG001|Overall Study|Death|1|||
27938135|NCT00070499|81609354|FG002|Overall Study|Death|1|||
27938136|NCT00070499|81609355|FG003|Overall Study|Death|2|||
27938137|NCT00070499|81609352|FG000|Overall Study|Other - not protocol specified|7|||
27938138|NCT00070499|81609353|FG001|Overall Study|Other - not protocol specified|3|||
27938139|NCT00070499|81609354|FG002|Overall Study|Other - not protocol specified|12|||
27938140|NCT00070499|81609355|FG003|Overall Study|Other - not protocol specified|20|||
27938141|NCT00070499|81609352|FG000|Overall Study|Still on protocol treatment|10|||
27938142|NCT00070499|81609353|FG001|Overall Study|Still on protocol treatment|4|||
27938143|NCT00070499|81609354|FG002|Overall Study|Still on protocol treatment|79|||
27938144|NCT00070499|81609355|FG003|Overall Study|Still on protocol treatment|57|||
27938145|NCT00070499|81609352|FG000|Overall Study|Did not start treatment|1|||
27645169|NCT02029443|80541523|FG002|Overall Study|Withdrawal by Subject|1|||
27645170|NCT02029443|80541524|FG003|Overall Study|Withdrawal by Subject|1|||
27645171|NCT02029443|80541525|FG004|Overall Study|Withdrawal by Subject|0|||
27645172|NCT02029443|80541521|FG000|Overall Study|Other|6|||
27645173|NCT02029443|80541522|FG001|Overall Study|Other|6|||
27645174|NCT02029443|80541523|FG002|Overall Study|Other|4|||
27645175|NCT02029443|80541524|FG003|Overall Study|Other|2|||
27645176|NCT02029443|80541525|FG004|Overall Study|Other|0|||
27938146|NCT00070499|81609353|FG001|Overall Study|Did not start treatment|0|||
27645178|NCT06571695|80541527|FG000|Overall Study|Lost to Follow-up|1|||
27645179|NCT06571695|80541528|FG001|Overall Study|Lost to Follow-up|6|||
27938147|NCT00070499|81609354|FG002|Overall Study|Did not start treatment|0|||
27938148|NCT00070499|81609355|FG003|Overall Study|Did not start treatment|2|||
27938149|NCT00070499|81609352|FG000|Overall Study|Not eligible|2|||
27938150|NCT00070499|81609353|FG001|Overall Study|Not eligible|5|||
27938151|NCT00070499|81609354|FG002|Overall Study|Not eligible|3|||
27938152|NCT00070499|81609355|FG003|Overall Study|Not eligible|2|||
27938153|NCT03268499|81609356|FG000|Overall Study|Withdrawal by Subject|2|||
27938154|NCT03268499|81609357|FG001|Overall Study|Withdrawal by Subject|1|||
27938155|NCT00933166|81609359|FG000|Overall Study|Lost to Follow-up|4|||
27938156|NCT00933166|81609359|FG000|Overall Study|Lack of Efficacy|9|||
27938157|NCT00933166|81609359|FG000|Overall Study|Unavailable|4|||
27938158|NCT00933166|81609359|FG000|Overall Study|Withdrawal by Subject|1|||
27938159|NCT00960856|81609361|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27938160|NCT00960856|81609362|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
27938161|NCT00960856|81609363|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
27938162|NCT00960856|81609364|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
27938163|NCT00960856|81609361|FG000|Washout Period of 7 Days|Adverse Event|0|||
27938164|NCT00960856|81609362|FG001|Washout Period of 7 Days|Adverse Event|0|||
27938165|NCT00960856|81609363|FG002|Washout Period of 7 Days|Adverse Event|1|||
27938166|NCT00960856|81609364|FG003|Washout Period of 7 Days|Adverse Event|0|||
27938167|NCT01433978|81609365|FG000|Core Study|Adverse Event, Non-Fatal|0|||
27938168|NCT01433978|81609366|FG001|Core Study|Adverse Event, Non-Fatal|1|||
27938169|NCT01433978|81609367|FG002|Core Study|Adverse Event, Non-Fatal|0|||
27938170|NCT01433978|81609365|FG000|Core Study|Lack of Efficacy|5|||
27938171|NCT01433978|81609366|FG001|Core Study|Lack of Efficacy|1|||
27938172|NCT01433978|81609367|FG002|Core Study|Lack of Efficacy|0|||
27938173|NCT01433978|81609365|FG000|Core Study|Study Terminated by Sponsor|6|||
27938174|NCT01433978|81609366|FG001|Core Study|Study Terminated by Sponsor|9|||
27938175|NCT01433978|81609367|FG002|Core Study|Study Terminated by Sponsor|0|||
27938176|NCT01433978|81609365|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
27938177|NCT01433978|81609366|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
27938178|NCT01433978|81609367|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
27938179|NCT01433978|81609365|FG000|Extension Phase|Lack of Efficacy|0|||
27938180|NCT01433978|81609366|FG001|Extension Phase|Lack of Efficacy|0|||
27938181|NCT01433978|81609367|FG002|Extension Phase|Lack of Efficacy|1|||
27938182|NCT01433978|81609365|FG000|Extension Phase|Study Terminated by Sponsor|0|||
27938183|NCT01433978|81609366|FG001|Extension Phase|Study Terminated by Sponsor|0|||
27938184|NCT01433978|81609367|FG002|Extension Phase|Study Terminated by Sponsor|4|||
27938185|NCT03759379|81609373|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
27938186|NCT03759379|81609374|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
27938187|NCT03759379|81609373|FG000|Treatment Period|Death|2|||
27938188|NCT03759379|81609374|FG001|Treatment Period|Death|3|||
27938189|NCT03759379|81609373|FG000|Treatment Period|Lost to Follow-up|1|||
27938190|NCT03759379|81609374|FG001|Treatment Period|Lost to Follow-up|0|||
27938191|NCT03759379|81609373|FG000|Treatment Period|Physician Decision|0|||
27938192|NCT03759379|81609374|FG001|Treatment Period|Physician Decision|1|||
27938193|NCT03382561|81609375|FG000|Overall Study|Disease progression|47|||
27938194|NCT03382561|81609376|FG001|Overall Study|Disease progression|6|||
27938195|NCT03382561|81609375|FG000|Overall Study|Adverse Event|10|||
27938196|NCT03382561|81609376|FG001|Overall Study|Adverse Event|2|||
27938197|NCT03382561|81609375|FG000|Overall Study|Death|8|||
27938198|NCT03382561|81609376|FG001|Overall Study|Death|3|||
27938199|NCT03382561|81609375|FG000|Overall Study|Withdrawal by Subject|6|||
27938200|NCT03382561|81609376|FG001|Overall Study|Withdrawal by Subject|5|||
27938201|NCT03382561|81609375|FG000|Overall Study|Alternative therapy|2|||
27938202|NCT03382561|81609376|FG001|Overall Study|Alternative therapy|8|||
27938203|NCT03382561|81609375|FG000|Overall Study|Never started treatment|3|||
27938204|NCT03382561|81609376|FG001|Overall Study|Never started treatment|6|||
27938205|NCT03382561|81609375|FG000|Overall Study|Lack of Efficacy|0|||
27938206|NCT03382561|81609376|FG001|Overall Study|Lack of Efficacy|1|||
27938207|NCT03382561|81609375|FG000|Overall Study|Physician Decision|0|||
27938208|NCT03382561|81609376|FG001|Overall Study|Physician Decision|1|||
27938209|NCT03382561|81609375|FG000|Overall Study|Other complicating disease|0|||
27938210|NCT03382561|81609376|FG001|Overall Study|Other complicating disease|1|||
27938211|NCT02057666|81609377|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
27938212|NCT02057666|81609378|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
27938213|NCT02057666|81609377|FG000|Double Blind Treatment Period|Poor tolerability|7|||
27938214|NCT02057666|81609378|FG001|Double Blind Treatment Period|Poor tolerability|2|||
27938215|NCT02057666|81609377|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
27938216|NCT02057666|81609378|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
27938217|NCT02057666|81609377|FG000|Double Blind Treatment Period|Physician Decision|1|||
27938218|NCT02057666|81609378|FG001|Double Blind Treatment Period|Physician Decision|0|||
27938219|NCT02057666|81609377|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
27938220|NCT02057666|81609378|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
27938221|NCT02057666|81609377|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
27938222|NCT02057666|81609378|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
27938223|NCT02057666|81609377|FG000|Double Blind Treatment Period|Sponsor's request|70|||
27938224|NCT02057666|81609378|FG001|Double Blind Treatment Period|Sponsor's request|34|||
27938225|NCT02057666|81609377|FG000|Open-Label Treatment Period|Poor tolerability|0|||
27938226|NCT02057666|81609378|FG001|Open-Label Treatment Period|Poor tolerability|1|||
27938227|NCT02057666|81609377|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
27938228|NCT02057666|81609378|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
27938229|NCT02057666|81609377|FG000|Open-Label Treatment Period|Sponsor's request|0|||
27938230|NCT02057666|81609378|FG001|Open-Label Treatment Period|Sponsor's request|4|||
27938231|NCT03570892|81609385|FG000|Overall Study|Death|51|||
27938232|NCT03570892|81609386|FG001|Overall Study|Death|45|||
27938233|NCT03570892|81609385|FG000|Overall Study|Subject decision|5|||
27938234|NCT03570892|81609386|FG001|Overall Study|Subject decision|3|||
27938235|NCT03570892|81609385|FG000|Overall Study|Protocol Violation|1|||
27938236|NCT03570892|81609386|FG001|Overall Study|Protocol Violation|4|||
27938237|NCT03570892|81609385|FG000|Overall Study|Physician Decision|0|||
27938238|NCT03570892|81609386|FG001|Overall Study|Physician Decision|2|||
27938239|NCT02152982|81609388|FG000|Overall Study|Ineligible|4|||
27938240|NCT02152982|81609389|FG001|Overall Study|Ineligible|4|||
27938241|NCT02152982|81609388|FG000|Overall Study|Did not start treatment|12|||
27938242|NCT02152982|81609389|FG001|Overall Study|Did not start treatment|6|||
27938243|NCT00937937|81609390|FG000|Overall Study|Adverse Event|6|||
27938244|NCT00937937|81609390|FG000|Overall Study|Withdrawal by Subject|2|||
27938245|NCT00937937|81609390|FG000|Overall Study|Progression/relapse|61|||
27938246|NCT00937937|81609390|FG000|Overall Study|Death|1|||
27938247|NCT00937937|81609390|FG000|Overall Study|Other|2|||
27938248|NCT04641975|81609392|FG000|Overall Study|Protocol Violation|1|||
27938249|NCT04641975|81609393|FG001|Overall Study|Protocol Violation|2|||
27938250|NCT04641975|81609394|FG002|Overall Study|Protocol Violation|0|||
27938251|NCT04641975|81609395|FG003|Overall Study|Protocol Violation|0|||
27938252|NCT04641975|81609392|FG000|Overall Study|Adverse Event|0|||
27938253|NCT04641975|81609393|FG001|Overall Study|Adverse Event|0|||
27938254|NCT04641975|81609394|FG002|Overall Study|Adverse Event|1|||
27938255|NCT04641975|81609395|FG003|Overall Study|Adverse Event|1|||
27938256|NCT04641975|81609392|FG000|Overall Study|Withdrawal by Subject|1|||
27938257|NCT04641975|81609393|FG001|Overall Study|Withdrawal by Subject|0|||
27938258|NCT04641975|81609394|FG002|Overall Study|Withdrawal by Subject|0|||
27938259|NCT04641975|81609395|FG003|Overall Study|Withdrawal by Subject|0|||
27938260|NCT03975647|81609398|FG000|Overall Study|Death|71|||
27938261|NCT03975647|81609399|FG001|Overall Study|Death|63|||
27938262|NCT03975647|81609398|FG000|Overall Study|Lost to Follow-up|2|||
27938263|NCT03975647|81609399|FG001|Overall Study|Lost to Follow-up|2|||
27938264|NCT03975647|81609398|FG000|Overall Study|Subject withdrawal of consent|7|||
27938265|NCT03975647|81609399|FG001|Overall Study|Subject withdrawal of consent|11|||
27938266|NCT01708954|81609402|FG000|Step 1|Disease progression|26|||
27938267|NCT01708954|81609403|FG001|Step 1|Disease progression|17|||
27551245|NCT02034110|80207418|FG002|Overall Study|Study closed by sponsor|0|||
27938268|NCT01708954|81609404|FG002|Step 1|Disease progression|14|||
27938269|NCT01708954|81609402|FG000|Step 1|Adverse Event|3|||
27938270|NCT01708954|81609403|FG001|Step 1|Adverse Event|11|||
27551246|NCT02034110|80207419|FG003|Overall Study|Study closed by sponsor|6|||
27551247|NCT02034110|80207420|FG004|Overall Study|Study closed by sponsor|7|||
27551248|NCT02034110|80207421|FG005|Overall Study|Study closed by sponsor|0|||
27551249|NCT02034110|80207422|FG006|Overall Study|Study closed by sponsor|42|||
27551250|NCT02034110|80207423|FG007|Overall Study|Study closed by sponsor|0|||
27938271|NCT01708954|81609404|FG002|Step 1|Adverse Event|13|||
27938272|NCT01708954|81609402|FG000|Step 1|Death|3|||
27938273|NCT01708954|81609403|FG001|Step 1|Death|2|||
27938274|NCT01708954|81609404|FG002|Step 1|Death|3|||
27938275|NCT01708954|81609402|FG000|Step 1|Withdrawal by Subject|2|||
27938276|NCT01708954|81609403|FG001|Step 1|Withdrawal by Subject|5|||
27938277|NCT01708954|81609404|FG002|Step 1|Withdrawal by Subject|3|||
27938278|NCT01708954|81609402|FG000|Step 1|Other complicating disease|0|||
27938279|NCT01708954|81609403|FG001|Step 1|Other complicating disease|2|||
27938280|NCT01708954|81609404|FG002|Step 1|Other complicating disease|0|||
27938281|NCT01708954|81609402|FG000|Step 1|Crossed over to Step 2|2|||
27938282|NCT01708954|81609403|FG001|Step 1|Crossed over to Step 2|0|||
27938283|NCT01708954|81609404|FG002|Step 1|Crossed over to Step 2|0|||
27938284|NCT01708954|81609402|FG000|Step 1|Symptomatic deterioration|1|||
27938285|NCT01708954|81609403|FG001|Step 1|Symptomatic deterioration|0|||
27938286|NCT01708954|81609404|FG002|Step 1|Symptomatic deterioration|1|||
27938287|NCT01708954|81609402|FG000|Step 1|Off-treatment reason not submitted|1|||
27938288|NCT01708954|81609403|FG001|Step 1|Off-treatment reason not submitted|1|||
27938289|NCT01708954|81609404|FG002|Step 1|Off-treatment reason not submitted|1|||
27938290|NCT01708954|81609402|FG000|Step 1|Ineligible or never received treatment|4|||
27938291|NCT01708954|81609403|FG001|Step 1|Ineligible or never received treatment|2|||
27938292|NCT01708954|81609404|FG002|Step 1|Ineligible or never received treatment|8|||
27938293|NCT01708954|81609402|FG000|Step 2|Disease progression|9|||
27938294|NCT01708954|81609403|FG001|Step 2|Disease progression|4|||
27938295|NCT01708954|81609404|FG002|Step 2|Disease progression|0|||
27938296|NCT01708954|81609402|FG000|Step 2|Adverse Event|3|||
27938297|NCT01708954|81609403|FG001|Step 2|Adverse Event|2|||
27938298|NCT01708954|81609404|FG002|Step 2|Adverse Event|0|||
27938299|NCT01708954|81609402|FG000|Step 2|Withdrawal by Subject|1|||
27938300|NCT01708954|81609403|FG001|Step 2|Withdrawal by Subject|1|||
27938301|NCT01708954|81609404|FG002|Step 2|Withdrawal by Subject|0|||
27938302|NCT06399471|81609405|FG000|Overall Study|Withdrawal by Subject|1|||
27938303|NCT01835431|81609406|FG000|Overall Study|Adverse Event|1|||
27938304|NCT01835431|81609407|FG001|Overall Study|Adverse Event|0|||
27938305|NCT01835431|81609406|FG000|Overall Study|other|0|||
27938306|NCT01835431|81609407|FG001|Overall Study|other|2|||
27938307|NCT01835431|81609406|FG000|Overall Study|Withdrawal by Subject|6|||
27938308|NCT01835431|81609407|FG001|Overall Study|Withdrawal by Subject|10|||
27938309|NCT01835431|81609406|FG000|Overall Study|Protocol Violation|1|||
27938310|NCT01835431|81609407|FG001|Overall Study|Protocol Violation|0|||
27938311|NCT01871727|81609408|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
27938312|NCT01871727|81609409|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
27938313|NCT01871727|81609410|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
27938314|NCT01871727|81609411|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
27938315|NCT01871727|81609412|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
27938316|NCT01871727|81609408|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
27938317|NCT01871727|81609409|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
27938318|NCT01871727|81609410|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
27938319|NCT01871727|81609411|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
27938320|NCT01871727|81609412|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
27938321|NCT01871727|81609408|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
27938322|NCT01871727|81609409|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
27938323|NCT01871727|81609410|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
27938324|NCT01871727|81609411|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
27938325|NCT01871727|81609412|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
27938326|NCT01871727|81609408|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
27938327|NCT01871727|81609409|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
27938328|NCT01871727|81609410|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
27938329|NCT01871727|81609411|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
27938330|NCT01871727|81609412|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
27938331|NCT01871727|81609408|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
27938332|NCT01871727|81609409|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
27938333|NCT01871727|81609410|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
27746211|NCT01937130|80899567|FG000|Overall Study|Withdrawal by Subject|0|||
27938334|NCT01871727|81609411|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
27938335|NCT01871727|81609412|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
27938336|NCT01871727|81609408|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
27938337|NCT01871727|81609409|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
27938338|NCT01871727|81609410|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
27938339|NCT01871727|81609411|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
27938340|NCT01871727|81609412|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
27938341|NCT01871727|81609408|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
27938342|NCT01871727|81609409|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
27938343|NCT01871727|81609410|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
27938344|NCT01871727|81609411|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
27938345|NCT01871727|81609412|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
27938346|NCT01565694|81609413|FG000|Dose-Titration Period|Adverse Event|4|||
27938347|NCT01565694|81609413|FG000|Dose-Titration Period|Protocol Violation|10|||
27938348|NCT01565694|81609413|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
27938349|NCT00433511|81609414|FG000|Step 1|Adverse Event|50|||
27938350|NCT00433511|81609415|FG001|Step 1|Adverse Event|157|||
27938351|NCT00433511|81609416|FG002|Step 1|Adverse Event|153|||
27938352|NCT00433511|81609414|FG000|Step 1|Withdrawal by Subject|45|||
27938353|NCT00433511|81609415|FG001|Step 1|Withdrawal by Subject|143|||
27938354|NCT00433511|81609416|FG002|Step 1|Withdrawal by Subject|154|||
27938355|NCT00433511|81609414|FG000|Step 1|Death|3|||
27938356|NCT00433511|81609415|FG001|Step 1|Death|1|||
27938357|NCT00433511|81609416|FG002|Step 1|Death|1|||
27938358|NCT00433511|81609414|FG000|Step 1|Physician Decision|1|||
27938359|NCT00433511|81609415|FG001|Step 1|Physician Decision|4|||
27938360|NCT00433511|81609416|FG002|Step 1|Physician Decision|3|||
27938361|NCT00433511|81609414|FG000|Step 1|Never started protocol therapy|28|||
27938362|NCT00433511|81609415|FG001|Step 1|Never started protocol therapy|64|||
27938363|NCT00433511|81609416|FG002|Step 1|Never started protocol therapy|66|||
27938364|NCT00433511|81609414|FG000|Step 1|Alternative therapy|2|||
27938365|NCT00433511|81609415|FG001|Step 1|Alternative therapy|1|||
27938366|NCT00433511|81609416|FG002|Step 1|Alternative therapy|3|||
27938367|NCT00433511|81609414|FG000|Step 1|Disease progression, relapse|5|||
27938368|NCT00433511|81609415|FG001|Step 1|Disease progression, relapse|3|||
27938369|NCT00433511|81609416|FG002|Step 1|Disease progression, relapse|3|||
27938370|NCT00433511|81609414|FG000|Step 1|Other complicating disease|2|||
27938371|NCT00433511|81609415|FG001|Step 1|Other complicating disease|6|||
27938372|NCT00433511|81609416|FG002|Step 1|Other complicating disease|3|||
27938373|NCT00433511|81609414|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
27938374|NCT00433511|81609415|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
27938375|NCT00433511|81609416|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
27938376|NCT00433511|81609414|FG000|Step 1|Suspected recurrence|0|||
27938377|NCT00433511|81609415|FG001|Step 1|Suspected recurrence|1|||
27938378|NCT00433511|81609416|FG002|Step 1|Suspected recurrence|0|||
27938379|NCT00433511|81609414|FG000|Step 1|Insurance/drug distribution issues|0|||
27938380|NCT00433511|81609415|FG001|Step 1|Insurance/drug distribution issues|1|||
27938381|NCT00433511|81609416|FG002|Step 1|Insurance/drug distribution issues|2|||
27938382|NCT00433511|81609414|FG000|Step 1|Patient moved|0|||
27938383|NCT00433511|81609415|FG001|Step 1|Patient moved|0|||
27938384|NCT00433511|81609416|FG002|Step 1|Patient moved|1|||
27938385|NCT00433511|81609414|FG000|Step 2 (Arm D)|Adverse Event|0|||
27938386|NCT00433511|81609415|FG001|Step 2 (Arm D)|Adverse Event|0|||
27938387|NCT00433511|81609416|FG002|Step 2 (Arm D)|Adverse Event|135|||
27938388|NCT00433511|81609414|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
27938389|NCT00433511|81609415|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
27938390|NCT00433511|81609416|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
27938391|NCT00433511|81609414|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
27938392|NCT00433511|81609415|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
27938393|NCT00433511|81609416|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
27938394|NCT00433511|81609414|FG000|Step 2 (Arm D)|Physician Decision|0|||
27938395|NCT00433511|81609415|FG001|Step 2 (Arm D)|Physician Decision|0|||
27938396|NCT00433511|81609416|FG002|Step 2 (Arm D)|Physician Decision|9|||
27938397|NCT00433511|81609414|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
27938398|NCT00433511|81609415|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
27938399|NCT00433511|81609416|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
27938400|NCT00433511|81609414|FG000|Step 2 (Arm D)|Other complicating disease|0|||
27938401|NCT00433511|81609415|FG001|Step 2 (Arm D)|Other complicating disease|0|||
27938402|NCT00433511|81609416|FG002|Step 2 (Arm D)|Other complicating disease|3|||
27938403|NCT00433511|81609414|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
27938404|NCT00433511|81609415|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
27938405|NCT00433511|81609416|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
27938406|NCT00433511|81609414|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
27938407|NCT00433511|81609415|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
27938408|NCT00433511|81609416|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
27938409|NCT00433511|81609414|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
27938410|NCT00433511|81609415|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
27938411|NCT00433511|81609416|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
27938412|NCT00433511|81609414|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
27938413|NCT00433511|81609415|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
27938414|NCT00433511|81609416|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
27938415|NCT03928704|81609417|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
27938416|NCT03928704|81609418|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
27938417|NCT03928704|81609419|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
27938418|NCT03928704|81609420|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
27938419|NCT03928704|81609421|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
27938420|NCT03928704|81609422|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
27938421|NCT03928704|81609417|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
27938422|NCT03928704|81609418|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
27938423|NCT03928704|81609419|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
27938424|NCT03928704|81609420|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
27938425|NCT03928704|81609421|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
27938426|NCT03928704|81609422|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
27938427|NCT03928704|81609417|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
27938428|NCT03928704|81609418|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
27938429|NCT03928704|81609419|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
27938430|NCT03928704|81609420|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
27938431|NCT03928704|81609421|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
27938432|NCT03928704|81609422|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
27938433|NCT03928704|81609417|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
27938434|NCT03928704|81609418|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
27938435|NCT03928704|81609419|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
27938436|NCT03928704|81609420|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
27938437|NCT03928704|81609421|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
27938438|NCT03928704|81609422|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
27938439|NCT03928704|81609417|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
27938440|NCT03928704|81609418|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
27938441|NCT03928704|81609419|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
27938442|NCT03928704|81609420|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
27938443|NCT03928704|81609421|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
27938444|NCT03928704|81609422|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
27938445|NCT03928704|81609417|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
27938446|NCT03928704|81609418|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
27938447|NCT03928704|81609419|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
27938448|NCT03928704|81609420|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
27938449|NCT03928704|81609421|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
27938450|NCT03928704|81609422|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
27938451|NCT03928704|81609417|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
27938452|NCT03928704|81609418|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
27938453|NCT03928704|81609419|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
27938454|NCT03928704|81609420|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
27938455|NCT03928704|81609421|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
27938456|NCT03928704|81609422|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
27938457|NCT03928704|81609417|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
27938458|NCT03928704|81609418|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
27938459|NCT03928704|81609419|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
27938460|NCT03928704|81609420|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
27938461|NCT03928704|81609421|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
27938462|NCT03928704|81609422|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
27938463|NCT03928704|81609417|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
27938464|NCT03928704|81609418|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
27938465|NCT03928704|81609419|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
27938466|NCT03928704|81609420|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
27938467|NCT03928704|81609421|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
27938468|NCT03928704|81609422|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
27938469|NCT03928704|81609417|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
27938470|NCT03928704|81609418|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
27938471|NCT03928704|81609419|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
27938472|NCT03928704|81609420|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
27938473|NCT03928704|81609421|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
27938474|NCT03928704|81609422|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
27938475|NCT02890355|81609423|FG000|Overall Study|Adverse Event|5|||
27938476|NCT02890355|81609424|FG001|Overall Study|Adverse Event|5|||
27938477|NCT02890355|81609423|FG000|Overall Study|Refusal unrelated to adverse event|5|||
27938478|NCT02890355|81609424|FG001|Overall Study|Refusal unrelated to adverse event|10|||
27938479|NCT02890355|81609423|FG000|Overall Study|Progression/relapse|46|||
27938480|NCT02890355|81609424|FG001|Overall Study|Progression/relapse|39|||
27938481|NCT02890355|81609423|FG000|Overall Study|Not protocol specified|3|||
27938482|NCT02890355|81609424|FG001|Overall Study|Not protocol specified|4|||
27938483|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
27938484|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
27938485|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
27938486|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
27938487|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
27938488|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
27938489|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
27938490|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
27938491|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
27938492|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
27938493|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
27938494|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
27938495|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
27938496|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
27938497|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
27938498|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
27938499|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
27938500|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
27938501|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
27938502|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
27938503|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
27938504|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
27938505|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
27938506|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
27938507|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
27938508|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
27938509|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
27938510|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
27938511|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
27938512|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
27938513|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
27938514|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
27938515|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938516|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938517|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
27938518|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938519|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938520|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938521|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
27938522|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938523|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
27938524|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
27938525|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
27938526|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
27938527|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
27938528|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
27938529|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
27938530|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
27938531|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
27938532|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
27938533|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
27938534|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
27938535|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
27938536|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
27938537|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
27938538|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
27938539|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27938540|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
27938541|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27938542|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27551251|NCT00309387|80207424|FG000|Overall Study|Death|72|||
27551252|NCT00309387|80207425|FG001|Overall Study|Death|73|||
27938543|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27938544|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27938545|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27938546|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
27938547|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938548|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938549|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938550|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938551|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
27938552|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938553|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938554|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
27938555|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938556|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938557|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938558|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938559|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938560|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
27938561|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938562|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
27938563|NCT03896503|81609425|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
27938564|NCT03896503|81609426|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
27938565|NCT03896503|81609427|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
27938566|NCT03896503|81609428|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
27938567|NCT03896503|81609429|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
27938568|NCT03896503|81609430|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
27938569|NCT03896503|81609431|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
27938570|NCT03896503|81609432|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
27938571|NCT02773537|81609433|FG000|Overall Study|Lost to Follow-up|0|||
27938572|NCT02773537|81609434|FG001|Overall Study|Lost to Follow-up|1|||
27938573|NCT02773537|81609435|FG002|Overall Study|Lost to Follow-up|4|||
27938574|NCT01478087|81609437|FG000|Overall Study|due to sponsor closing study|1|||
27938575|NCT02506153|81609438|FG000|Overall Study|Adverse Event|359|||
27938576|NCT02506153|81609439|FG001|Overall Study|Adverse Event|114|||
27938577|NCT02506153|81609438|FG000|Overall Study|Refused unrelated to adverse event|127|||
27938578|NCT02506153|81609439|FG001|Overall Study|Refused unrelated to adverse event|18|||
27938579|NCT02506153|81609438|FG000|Overall Study|Progression/relapse|91|||
27938580|NCT02506153|81609439|FG001|Overall Study|Progression/relapse|136|||
27938581|NCT02506153|81609438|FG000|Overall Study|Death|2|||
27938582|NCT02506153|81609439|FG001|Overall Study|Death|1|||
27938583|NCT02506153|81609438|FG000|Overall Study|Other - not protocol specified|23|||
27938584|NCT02506153|81609439|FG001|Overall Study|Other - not protocol specified|12|||
27938585|NCT01530997|81609445|FG000|Overall Study|Physician Decision|1|||
27938586|NCT01530997|81609445|FG000|Overall Study|Withdrawal by Subject|1|||
27938587|NCT04576481|81609448|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
27938588|NCT04576481|81609449|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
27938589|NCT04576481|81609450|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
27938590|NCT04576481|81609451|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
27938591|NCT02975700|81609452|FG000|Overall Study|Adverse Event|1|||
27551253|NCT00309387|80207424|FG000|Overall Study|Lost to Follow-up|70|||
27551254|NCT00309387|80207425|FG001|Overall Study|Lost to Follow-up|86|||
27551255|NCT03535844|80207426|FG000|Overall Study|Withdrawal by Subject|0|||
27551256|NCT03535844|80207427|FG001|Overall Study|Withdrawal by Subject|1|||
27551257|NCT05255068|80207430|FG000|Overall Study|Lost to Follow-up|0|||
27551258|NCT05255068|80207431|FG001|Overall Study|Lost to Follow-up|1|||
27551259|NCT02468414|80207432|FG000|Overall Study|Early Study Termination by Sponsor|1|||
27551260|NCT02468414|80207433|FG001|Overall Study|Early Study Termination by Sponsor|0|||
27551261|NCT02468414|80207432|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
27551262|NCT02468414|80207433|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
27551263|NCT02468414|80207432|FG000|Overall Study|Screen Failure|1|||
27551264|NCT02468414|80207433|FG001|Overall Study|Screen Failure|0|||
27551265|NCT00553644|80207434|FG000|Overall Study|Adverse Event|17|||
27551266|NCT00553644|80207434|FG000|Overall Study|Withdrawal by Subject|4|||
27551267|NCT00553644|80207434|FG000|Overall Study|Physician Decision|1|||
27551268|NCT00553644|80207434|FG000|Overall Study|Alternative therapy|6|||
27551269|NCT03715764|80207437|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
27551270|NCT03715764|80207438|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
27938592|NCT02975700|81609452|FG000|Overall Study|Progressive disease|3|||
27938593|NCT02975700|81609452|FG000|Overall Study|Failed screening criteria|2|||
27938594|NCT06074523|81609456|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
27938595|NCT06074523|81609456|FG000|Overall Study|Withdrawal by Subject|1|||
27938596|NCT01063881|81609468|FG000|Overall Study|Adverse Event|12|||
27938597|NCT01063881|81609469|FG001|Overall Study|Adverse Event|2|||
27938598|NCT01063881|81609470|FG002|Overall Study|Adverse Event|0|||
27938599|NCT01063881|81609468|FG000|Overall Study|Lost to Follow-up|13|||
27938600|NCT01063881|81609469|FG001|Overall Study|Lost to Follow-up|7|||
27938601|NCT01063881|81609470|FG002|Overall Study|Lost to Follow-up|1|||
27938602|NCT01063881|81609468|FG000|Overall Study|Withdrawal by Subject|25|||
27938603|NCT01063881|81609469|FG001|Overall Study|Withdrawal by Subject|1|||
27938604|NCT01063881|81609470|FG002|Overall Study|Withdrawal by Subject|0|||
27938605|NCT01063881|81609468|FG000|Overall Study|Reason for not completed not specified|5|||
27938606|NCT01063881|81609469|FG001|Overall Study|Reason for not completed not specified|1|||
27938607|NCT01063881|81609470|FG002|Overall Study|Reason for not completed not specified|0|||
27938608|NCT01399099|81609473|FG000|Overall Study|Lost to Follow-up|14|||
27938609|NCT01399099|81609473|FG000|Overall Study|Physician Decision|1|||
27938610|NCT01399099|81609473|FG000|Overall Study|Protocol Violation|1|||
27938611|NCT01399099|81609473|FG000|Overall Study|Skin Irritation|13|||
27938612|NCT01399099|81609473|FG000|Overall Study|Infection|1|||
27938613|NCT01399099|81609473|FG000|Overall Study|Miscellaneous|4|||
27938614|NCT05788328|81609475|FG000|Treatment Period 4 (5 Days)|Other|1|||
27938615|NCT05788328|81609475|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
27938616|NCT02003209|81609476|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
27938617|NCT02003209|81609477|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
27938618|NCT05463705|81609478|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
27938619|NCT05463705|81609479|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
27938620|NCT05463705|81609480|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
27746212|NCT01937130|80899568|FG001|Overall Study|Withdrawal by Subject|0|||
27746213|NCT01937130|80899569|FG002|Overall Study|Withdrawal by Subject|0|||
27746214|NCT01937130|80899570|FG003|Overall Study|Withdrawal by Subject|1|||
27746215|NCT01937130|80899567|FG000|Overall Study|Adverse Event|0|||
27746216|NCT01937130|80899568|FG001|Overall Study|Adverse Event|1|||
27746217|NCT01937130|80899569|FG002|Overall Study|Adverse Event|0|||
27746218|NCT01937130|80899570|FG003|Overall Study|Adverse Event|1|||
27746219|NCT01937130|80899567|FG000|Overall Study|Death|1|||
27746220|NCT01937130|80899568|FG001|Overall Study|Death|1|||
27746221|NCT01937130|80899569|FG002|Overall Study|Death|1|||
27746222|NCT01937130|80899570|FG003|Overall Study|Death|0|||
27746223|NCT01937130|80899567|FG000|Overall Study|Lost to Follow-up|2|||
27746224|NCT01937130|80899568|FG001|Overall Study|Lost to Follow-up|0|||
27746225|NCT01937130|80899569|FG002|Overall Study|Lost to Follow-up|2|||
27746226|NCT01937130|80899570|FG003|Overall Study|Lost to Follow-up|0|||
27746227|NCT01937130|80899567|FG000|Overall Study|Physician Decision|0|||
27746228|NCT01937130|80899568|FG001|Overall Study|Physician Decision|1|||
27746229|NCT01937130|80899569|FG002|Overall Study|Physician Decision|0|||
27938621|NCT05463705|81609481|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
27938622|NCT05463705|81609482|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
27645270|NCT03699163|80541539|FG000|Overall Study|Physician Decision|12|||
27645271|NCT03699163|80541540|FG001|Overall Study|Physician Decision|0|||
27645272|NCT03699163|80541539|FG000|Overall Study|failed QC measures|205|||
27645273|NCT03699163|80541540|FG001|Overall Study|failed QC measures|206|||
27645274|NCT02357966|80541541|FG000|Overall Study|Death|0|||
27645275|NCT02357966|80541542|FG001|Overall Study|Death|0|||
27645276|NCT02357966|80541543|FG002|Overall Study|Death|1|||
27645277|NCT02357966|80541544|FG003|Overall Study|Death|0|||
27645278|NCT02357966|80541545|FG004|Overall Study|Death|2|||
27645279|NCT02357966|80541546|FG005|Overall Study|Death|0|||
27645280|NCT02357966|80541541|FG000|Overall Study|Physician Decision|1|||
27645281|NCT02357966|80541542|FG001|Overall Study|Physician Decision|0|||
27645282|NCT02357966|80541543|FG002|Overall Study|Physician Decision|0|||
27645283|NCT02357966|80541544|FG003|Overall Study|Physician Decision|0|||
27645284|NCT02357966|80541545|FG004|Overall Study|Physician Decision|1|||
27645285|NCT02357966|80541546|FG005|Overall Study|Physician Decision|0|||
27938623|NCT05463705|81609483|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
27938624|NCT04595370|81609484|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
27645286|NCT03220724|80541549|FG000|Overall Study|Lost to Follow-up|2|||
27645287|NCT03220724|80541550|FG001|Overall Study|Lost to Follow-up|2|||
27645288|NCT03220724|80541551|FG002|Overall Study|Lost to Follow-up|0|||
27645289|NCT03220724|80541552|FG003|Overall Study|Lost to Follow-up|3|||
27645290|NCT03220724|80541553|FG004|Overall Study|Lost to Follow-up|1|||
27645291|NCT03220724|80541554|FG005|Overall Study|Lost to Follow-up|0|||
27746230|NCT01937130|80899570|FG003|Overall Study|Physician Decision|0|||
27746231|NCT01937130|80899567|FG000|Overall Study|Patients unable to swallow|0|||
27746232|NCT01937130|80899568|FG001|Overall Study|Patients unable to swallow|1|||
27938625|NCT04595370|81609485|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
27938626|NCT04595370|81609486|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
27938627|NCT04595370|81609487|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
27938628|NCT04595370|81609488|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
27938629|NCT04595370|81609489|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
27938630|NCT04595370|81609484|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
27938631|NCT04595370|81609485|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
27938632|NCT04595370|81609486|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
27938633|NCT04595370|81609487|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
27938634|NCT04595370|81609488|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
27938635|NCT04595370|81609489|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
27938636|NCT04595370|81609484|FG000|Overall Study|Adverse Event|0|||
27938637|NCT04595370|81609485|FG001|Overall Study|Adverse Event|4|||
27938638|NCT04595370|81609486|FG002|Overall Study|Adverse Event|3|||
27938639|NCT04595370|81609487|FG003|Overall Study|Adverse Event|1|||
27938640|NCT04595370|81609488|FG004|Overall Study|Adverse Event|1|||
27938641|NCT04595370|81609489|FG005|Overall Study|Adverse Event|1|||
27938642|NCT04595370|81609484|FG000|Overall Study|Withdrawal of Consent|1|||
27938643|NCT04595370|81609485|FG001|Overall Study|Withdrawal of Consent|1|||
27938644|NCT04595370|81609486|FG002|Overall Study|Withdrawal of Consent|1|||
27938645|NCT04595370|81609487|FG003|Overall Study|Withdrawal of Consent|0|||
27938646|NCT04595370|81609488|FG004|Overall Study|Withdrawal of Consent|0|||
27938647|NCT04595370|81609489|FG005|Overall Study|Withdrawal of Consent|0|||
27938648|NCT04595370|81609484|FG000|Overall Study|Death|0|||
27938649|NCT04595370|81609485|FG001|Overall Study|Death|1|||
27938650|NCT04595370|81609486|FG002|Overall Study|Death|0|||
27938651|NCT04595370|81609487|FG003|Overall Study|Death|0|||
27938652|NCT04595370|81609488|FG004|Overall Study|Death|1|||
27938653|NCT04595370|81609489|FG005|Overall Study|Death|0|||
27938654|NCT04595370|81609484|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27938655|NCT04595370|81609485|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27938656|NCT04595370|81609486|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
27938657|NCT04595370|81609487|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27938658|NCT04595370|81609488|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27938659|NCT04595370|81609489|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27938660|NCT04595370|81609484|FG000|Overall Study|Withdrawal by Subject|0|||
27938661|NCT04595370|81609485|FG001|Overall Study|Withdrawal by Subject|0|||
27938662|NCT04595370|81609486|FG002|Overall Study|Withdrawal by Subject|1|||
27938663|NCT04595370|81609487|FG003|Overall Study|Withdrawal by Subject|0|||
27938664|NCT04595370|81609488|FG004|Overall Study|Withdrawal by Subject|2|||
27938665|NCT04595370|81609489|FG005|Overall Study|Withdrawal by Subject|0|||
27938666|NCT04595370|81609484|FG000|Overall Study|Lost to Follow-up|0|||
27938667|NCT04595370|81609485|FG001|Overall Study|Lost to Follow-up|0|||
27938668|NCT04595370|81609486|FG002|Overall Study|Lost to Follow-up|0|||
27938669|NCT04595370|81609487|FG003|Overall Study|Lost to Follow-up|0|||
27938670|NCT04595370|81609488|FG004|Overall Study|Lost to Follow-up|1|||
27938671|NCT04595370|81609489|FG005|Overall Study|Lost to Follow-up|0|||
27938672|NCT04595370|81609484|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
27938673|NCT04595370|81609485|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
27938674|NCT04595370|81609486|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
27938675|NCT04595370|81609487|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
27938676|NCT04595370|81609488|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
27938677|NCT04595370|81609489|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
27938678|NCT03927846|81609497|FG000|Overall Study|Lost to Follow-up|10|||
27938679|NCT03927846|81609498|FG001|Overall Study|Lost to Follow-up|11|||
27938680|NCT03787212|81609499|FG000|Period 1|Study Termination|2|||
27938681|NCT03787212|81609500|FG001|Period 1|Study Termination|2|||
27938682|NCT04818086|81609501|FG000|Overall Study|Physician Decision|1|||
27938683|NCT04818086|81609502|FG001|Overall Study|Physician Decision|0|||
27938684|NCT04818086|81609501|FG000|Overall Study|Withdrawal by Subject|0|||
27938685|NCT04818086|81609502|FG001|Overall Study|Withdrawal by Subject|1|||
27938686|NCT01862029|81609503|FG000|Overall Study|Physician Decision|1|||
27938687|NCT05206604|81609504|FG000|Overall Study|Non-compliance with study drug|0|||
27645292|NCT03220724|80541555|FG006|Overall Study|Lost to Follow-up|2|||
27645293|NCT03220724|80541556|FG007|Overall Study|Lost to Follow-up|1|||
27645294|NCT03220724|80541557|FG008|Overall Study|Lost to Follow-up|0|||
27645295|NCT03220724|80541549|FG000|Overall Study|Withdrawal by Subject|1|||
27938688|NCT05206604|81609505|FG001|Overall Study|Non-compliance with study drug|0|||
27938689|NCT05206604|81609506|FG002|Overall Study|Non-compliance with study drug|0|||
27938690|NCT05206604|81609507|FG003|Overall Study|Non-compliance with study drug|0|||
27645296|NCT03220724|80541550|FG001|Overall Study|Withdrawal by Subject|0|||
27938691|NCT05206604|81609508|FG004|Overall Study|Non-compliance with study drug|0|||
27938692|NCT05206604|81609509|FG005|Overall Study|Non-compliance with study drug|1|||
27938693|NCT05206604|81609510|FG006|Overall Study|Non-compliance with study drug|0|||
27938694|NCT05206604|81609511|FG007|Overall Study|Non-compliance with study drug|0|||
27938695|NCT04135352|81609514|FG000|Overall Study|Not treated-randomization error|0|||
27938696|NCT04135352|81609515|FG001|Overall Study|Not treated-randomization error|0|||
27938697|NCT04135352|81609516|FG002|Overall Study|Not treated-randomization error|1|||
27938698|NCT04135352|81609517|FG003|Overall Study|Not treated-randomization error|0|||
27938699|NCT04135352|81609518|FG004|Overall Study|Not treated-randomization error|0|||
27938700|NCT04135352|81609519|FG005|Overall Study|Not treated-randomization error|0|||
27938701|NCT04135352|81609520|FG006|Overall Study|Not treated-randomization error|0|||
27938702|NCT04135352|81609521|FG007|Overall Study|Not treated-randomization error|0|||
27938703|NCT04135352|81609514|FG000|Overall Study|Withdrawal by Subject|0|||
27938704|NCT04135352|81609515|FG001|Overall Study|Withdrawal by Subject|0|||
27938705|NCT04135352|81609516|FG002|Overall Study|Withdrawal by Subject|2|||
27938706|NCT04135352|81609517|FG003|Overall Study|Withdrawal by Subject|0|||
27938707|NCT04135352|81609518|FG004|Overall Study|Withdrawal by Subject|0|||
27938708|NCT04135352|81609519|FG005|Overall Study|Withdrawal by Subject|0|||
27938709|NCT04135352|81609520|FG006|Overall Study|Withdrawal by Subject|0|||
27938710|NCT04135352|81609521|FG007|Overall Study|Withdrawal by Subject|0|||
27938711|NCT04135352|81609514|FG000|Overall Study|Sponsor Decision|0|||
27938712|NCT04135352|81609515|FG001|Overall Study|Sponsor Decision|0|||
27938713|NCT04135352|81609516|FG002|Overall Study|Sponsor Decision|2|||
27938714|NCT04135352|81609517|FG003|Overall Study|Sponsor Decision|5|||
27938715|NCT04135352|81609518|FG004|Overall Study|Sponsor Decision|1|||
27938716|NCT04135352|81609519|FG005|Overall Study|Sponsor Decision|4|||
27938717|NCT04135352|81609520|FG006|Overall Study|Sponsor Decision|0|||
27938718|NCT04135352|81609521|FG007|Overall Study|Sponsor Decision|0|||
27938719|NCT04135352|81609514|FG000|Overall Study|Physician Decision|0|||
27938720|NCT04135352|81609515|FG001|Overall Study|Physician Decision|0|||
27938721|NCT04135352|81609516|FG002|Overall Study|Physician Decision|1|||
27938722|NCT04135352|81609517|FG003|Overall Study|Physician Decision|0|||
27938723|NCT04135352|81609518|FG004|Overall Study|Physician Decision|1|||
27938724|NCT04135352|81609519|FG005|Overall Study|Physician Decision|0|||
27938725|NCT04135352|81609520|FG006|Overall Study|Physician Decision|0|||
27938726|NCT04135352|81609521|FG007|Overall Study|Physician Decision|0|||
27938727|NCT04135352|81609514|FG000|Overall Study|Death|3|||
27938728|NCT04135352|81609515|FG001|Overall Study|Death|4|||
27938729|NCT04135352|81609516|FG002|Overall Study|Death|7|||
27938730|NCT04135352|81609517|FG003|Overall Study|Death|0|||
27938731|NCT04135352|81609518|FG004|Overall Study|Death|3|||
27938732|NCT04135352|81609519|FG005|Overall Study|Death|1|||
27938733|NCT04135352|81609520|FG006|Overall Study|Death|0|||
27938734|NCT04135352|81609521|FG007|Overall Study|Death|0|||
27938735|NCT03760081|81612545|FG000|Overall Study|Miscellaneous|0|||
27645297|NCT03220724|80541551|FG002|Overall Study|Withdrawal by Subject|1|||
27645298|NCT03220724|80541552|FG003|Overall Study|Withdrawal by Subject|0|||
27645299|NCT03220724|80541553|FG004|Overall Study|Withdrawal by Subject|0|||
27645300|NCT03220724|80541554|FG005|Overall Study|Withdrawal by Subject|0|||
27645301|NCT03220724|80541555|FG006|Overall Study|Withdrawal by Subject|0|||
27645302|NCT03220724|80541556|FG007|Overall Study|Withdrawal by Subject|0|||
27645303|NCT03220724|80541557|FG008|Overall Study|Withdrawal by Subject|0|||
27645304|NCT01920932|80541558|FG000|Overall Study|Death|1|||
27645305|NCT01920932|80541558|FG000|Overall Study|Withdrawal of consent|1|||
27938736|NCT03760081|81612546|FG001|Overall Study|Miscellaneous|1|||
27938737|NCT03760081|81612545|FG000|Overall Study|Progressive Disease|5|||
27645308|NCT02575365|80541561|FG000|Overall Study|Lost to Follow-up|4|||
27938738|NCT03760081|81612546|FG001|Overall Study|Progressive Disease|10|||
27938739|NCT03760081|81612545|FG000|Overall Study|Death|1|||
27746233|NCT01937130|80899569|FG002|Overall Study|Patients unable to swallow|0|||
27938740|NCT03760081|81612546|FG001|Overall Study|Death|1|||
27938741|NCT03225989|81612547|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
27938742|NCT03225989|81612548|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
27938743|NCT03225989|81612549|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
27938744|NCT03225989|81612547|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
27938745|NCT03225989|81612548|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
27938746|NCT03225989|81612549|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
27938747|NCT03225989|81612547|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
27938748|NCT03225989|81612548|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
27938749|NCT03225989|81612549|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
27938750|NCT03225989|81612547|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
27938751|NCT03225989|81612548|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
27938752|NCT03225989|81612549|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
27938753|NCT03225989|81612547|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
27746234|NCT01937130|80899570|FG003|Overall Study|Patients unable to swallow|0|||
27938754|NCT03225989|81612548|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
27938755|NCT03225989|81612549|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
27938756|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
27938757|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
27938758|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
27938759|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
27938760|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
27938761|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
27645323|NCT03374254|80541569|FG000|Overall Study|Death|5|||
27645324|NCT03374254|80541570|FG001|Overall Study|Death|16|||
27645325|NCT03374254|80541571|FG002|Overall Study|Death|13|||
27645326|NCT03374254|80541572|FG003|Overall Study|Death|11|||
27645327|NCT03374254|80541573|FG004|Overall Study|Death|9|||
27645328|NCT03374254|80541574|FG005|Overall Study|Death|12|||
27645329|NCT03374254|80541575|FG006|Overall Study|Death|11|||
27645330|NCT03374254|80541576|FG007|Overall Study|Death|6|||
27645331|NCT03374254|80541577|FG008|Overall Study|Death|7|||
27645332|NCT03374254|80541569|FG000|Overall Study|Lost to Follow-up|0|||
27645333|NCT03374254|80541570|FG001|Overall Study|Lost to Follow-up|0|||
27645334|NCT03374254|80541571|FG002|Overall Study|Lost to Follow-up|0|||
27645335|NCT03374254|80541572|FG003|Overall Study|Lost to Follow-up|0|||
27645336|NCT03374254|80541573|FG004|Overall Study|Lost to Follow-up|0|||
27645337|NCT03374254|80541574|FG005|Overall Study|Lost to Follow-up|0|||
27645338|NCT03374254|80541575|FG006|Overall Study|Lost to Follow-up|2|||
27645339|NCT03374254|80541576|FG007|Overall Study|Lost to Follow-up|0|||
27645340|NCT03374254|80541577|FG008|Overall Study|Lost to Follow-up|0|||
27645341|NCT03374254|80541569|FG000|Overall Study|Sponsor Decision|1|||
27645342|NCT03374254|80541570|FG001|Overall Study|Sponsor Decision|0|||
27645343|NCT03374254|80541571|FG002|Overall Study|Sponsor Decision|2|||
27645344|NCT03374254|80541572|FG003|Overall Study|Sponsor Decision|3|||
27645345|NCT03374254|80541573|FG004|Overall Study|Sponsor Decision|2|||
27645346|NCT03374254|80541574|FG005|Overall Study|Sponsor Decision|3|||
27645347|NCT03374254|80541575|FG006|Overall Study|Sponsor Decision|3|||
27645348|NCT03374254|80541576|FG007|Overall Study|Sponsor Decision|3|||
27645349|NCT03374254|80541577|FG008|Overall Study|Sponsor Decision|4|||
27645350|NCT03374254|80541569|FG000|Overall Study|Withdrawal by Subject|0|||
27645351|NCT03374254|80541570|FG001|Overall Study|Withdrawal by Subject|0|||
27938762|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
27938763|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
27938764|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
27938765|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
27551271|NCT03715764|80207437|FG000|3 Month Follow-up|Lost to Follow-up|2|||
27551272|NCT03715764|80207438|FG001|3 Month Follow-up|Lost to Follow-up|2|||
27551273|NCT03715764|80207437|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
27551274|NCT03715764|80207438|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
27551275|NCT03715764|80207437|FG000|6 Month Follow-up|Lost to Follow-up|3|||
27551276|NCT03715764|80207438|FG001|6 Month Follow-up|Lost to Follow-up|0|||
27551277|NCT03715764|80207437|FG000|12 Month Follow-up|Lost to Follow-up|2|||
27551278|NCT03715764|80207438|FG001|12 Month Follow-up|Lost to Follow-up|3|||
27551279|NCT03715764|80207437|FG000|12 Month Follow-up|Pregnancy|0|||
27551280|NCT03715764|80207438|FG001|12 Month Follow-up|Pregnancy|1|||
27551281|NCT03715764|80207437|FG000|12 Month Follow-up|Surgery|2|||
27551282|NCT03715764|80207438|FG001|12 Month Follow-up|Surgery|0|||
27551283|NCT03715764|80207437|FG000|12 Month Follow-up|Wrong address|1|||
27551284|NCT03715764|80207438|FG001|12 Month Follow-up|Wrong address|0|||
27551285|NCT03715764|80207437|FG000|12 Month Follow-up|No symptoms|1|||
27551286|NCT03715764|80207438|FG001|12 Month Follow-up|No symptoms|0|||
27551287|NCT03715764|80207437|FG000|12 Month Follow-up|Changed primary care centre|0|||
27551288|NCT03715764|80207438|FG001|12 Month Follow-up|Changed primary care centre|1|||
27551289|NCT02056340|80207439|FG000|Overall Study|Lost to Follow-up|5|||
27551290|NCT02056340|80207440|FG001|Overall Study|Lost to Follow-up|5|||
27551291|NCT02056340|80207439|FG000|Overall Study|Withdrawal by Subject|2|||
27551292|NCT02056340|80207440|FG001|Overall Study|Withdrawal by Subject|6|||
27551293|NCT03211416|80207447|FG000|Overall Study|Adverse Event|7|||
27551294|NCT03211416|80207447|FG000|Overall Study|Lack of Efficacy|2|||
27551295|NCT03211416|80207447|FG000|Overall Study|Physician Decision|1|||
27551296|NCT00733408|80207448|FG000|Overall Study|Adverse Event|4|||
27551297|NCT01085591|80207449|FG000|Overall Study|Adverse Event|0|||
27551298|NCT01085591|80207450|FG001|Overall Study|Adverse Event|1|||
27645352|NCT03374254|80541571|FG002|Overall Study|Withdrawal by Subject|0|||
27645353|NCT03374254|80541572|FG003|Overall Study|Withdrawal by Subject|2|||
27645354|NCT03374254|80541573|FG004|Overall Study|Withdrawal by Subject|0|||
27645355|NCT03374254|80541574|FG005|Overall Study|Withdrawal by Subject|1|||
27645356|NCT03374254|80541575|FG006|Overall Study|Withdrawal by Subject|0|||
27645357|NCT03374254|80541576|FG007|Overall Study|Withdrawal by Subject|0|||
27645358|NCT03374254|80541577|FG008|Overall Study|Withdrawal by Subject|0|||
27645359|NCT00071799|80541578|FG000|Overall Study|Adverse Event|19|||
27645360|NCT00071799|80541579|FG001|Overall Study|Adverse Event|10|||
27645361|NCT00071799|80541578|FG000|Overall Study|Protocol Violation|1|||
27645362|NCT00071799|80541579|FG001|Overall Study|Protocol Violation|7|||
27645363|NCT00071799|80541578|FG000|Overall Study|Lost to Follow-up|1|||
27645364|NCT00071799|80541579|FG001|Overall Study|Lost to Follow-up|1|||
27645365|NCT00071799|80541578|FG000|Overall Study|Withdrawal by Subject|15|||
27645366|NCT00071799|80541579|FG001|Overall Study|Withdrawal by Subject|37|||
27645367|NCT00071799|80541578|FG000|Overall Study|Physician Decision|0|||
27645368|NCT00071799|80541579|FG001|Overall Study|Physician Decision|2|||
27645369|NCT00071799|80541578|FG000|Overall Study|Lack of Efficacy|11|||
27645370|NCT00071799|80541579|FG001|Overall Study|Lack of Efficacy|18|||
27645371|NCT00071799|80541578|FG000|Overall Study|Disease Progression|23|||
27645372|NCT00071799|80541579|FG001|Overall Study|Disease Progression|20|||
27645373|NCT00071799|80541578|FG000|Overall Study|Different Central+Local Pathology Review|0|||
27645374|NCT00071799|80541579|FG001|Overall Study|Different Central+Local Pathology Review|1|||
27645375|NCT00071799|80541578|FG000|Overall Study|Not Documented|0|||
27645376|NCT00071799|80541579|FG001|Overall Study|Not Documented|2|||
27938766|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
27938767|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
27938768|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
27938769|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
27938770|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
27938771|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
27938772|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
27938773|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
27938774|NCT03225989|81612547|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
27938775|NCT03225989|81612548|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
27938776|NCT03225989|81612549|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
27938777|NCT01142388|81612550|FG000|Overall Study|Lack of Efficacy|21|||
27938778|NCT01142388|81612551|FG001|Overall Study|Lack of Efficacy|31|||
27938779|NCT01142388|81612550|FG000|Overall Study|Adverse Event|9|||
27938780|NCT01142388|81612551|FG001|Overall Study|Adverse Event|5|||
27938781|NCT01142388|81612550|FG000|Overall Study|Death|3|||
27938782|NCT01142388|81612551|FG001|Overall Study|Death|2|||
27938783|NCT01142388|81612550|FG000|Overall Study|Withdrawal by Subject|5|||
27938784|NCT01142388|81612551|FG001|Overall Study|Withdrawal by Subject|3|||
27938785|NCT01142388|81612550|FG000|Overall Study|Alternative therapy|1|||
27938786|NCT01142388|81612551|FG001|Overall Study|Alternative therapy|0|||
27938787|NCT01142388|81612550|FG000|Overall Study|Other complications|0|||
27938788|NCT01142388|81612551|FG001|Overall Study|Other complications|2|||
27938789|NCT01142388|81612550|FG000|Overall Study|Other|1|||
27938790|NCT01142388|81612551|FG001|Overall Study|Other|1|||
27938791|NCT01142388|81612550|FG000|Overall Study|Never started therapy|7|||
27938792|NCT01142388|81612551|FG001|Overall Study|Never started therapy|3|||
27938793|NCT02852005|81612552|FG000|Overall Study|Lost to Follow-up|0|||
27938794|NCT02852005|81612553|FG001|Overall Study|Lost to Follow-up|0|||
27938795|NCT02852005|81612554|FG002|Overall Study|Lost to Follow-up|0|||
27938796|NCT02852005|81612555|FG003|Overall Study|Lost to Follow-up|0|||
27938797|NCT02852005|81612556|FG004|Overall Study|Lost to Follow-up|1|||
27938798|NCT02852005|81612552|FG000|Overall Study|Withdrawal by Subject|1|||
27938799|NCT02852005|81612553|FG001|Overall Study|Withdrawal by Subject|0|||
27938800|NCT02852005|81612554|FG002|Overall Study|Withdrawal by Subject|0|||
27938801|NCT02852005|81612555|FG003|Overall Study|Withdrawal by Subject|0|||
27938802|NCT02852005|81612556|FG004|Overall Study|Withdrawal by Subject|0|||
27938803|NCT01689649|81612557|FG000|Overall Study|Lack of Efficacy|3|||
27938804|NCT01689649|81612557|FG000|Overall Study|Non-compliance|11|||
27938805|NCT01689649|81612557|FG000|Overall Study|Protocol Violation|3|||
27938806|NCT01689649|81612557|FG000|Overall Study|Lost to Follow-up|5|||
27938807|NCT02642679|81612563|FG000|Overall Study|Withdrawal by Subject|1|||
27938808|NCT02642679|81612563|FG000|Overall Study|Physician Decision|1|||
27938809|NCT02642679|81612563|FG000|Overall Study|Physician Decision|1|||
27938810|NCT01886872|81612566|FG000|Overall Study|Ineligible|7|||
27938811|NCT01886872|81612567|FG001|Overall Study|Ineligible|4|||
27938812|NCT01886872|81612568|FG002|Overall Study|Ineligible|12|||
27938813|NCT03596983|81612574|FG000|Overall Study|Withdrawal by Subject|3|||
27938814|NCT03506633|81612575|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
27938815|NCT03506633|81612576|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
27938816|NCT03671148|81612577|FG000|Overall Study|Adverse Event|3|||
27938817|NCT03671148|81612578|FG001|Overall Study|Adverse Event|2|||
27938818|NCT03671148|81612577|FG000|Overall Study|Withdrawal by Subject|8|||
27938819|NCT03671148|81612578|FG001|Overall Study|Withdrawal by Subject|2|||
27938820|NCT03671148|81612577|FG000|Overall Study|Lost to Follow-up|1|||
27938821|NCT03671148|81612578|FG001|Overall Study|Lost to Follow-up|2|||
27938822|NCT03671148|81612577|FG000|Overall Study|Lack of Efficacy|7|||
27938823|NCT03671148|81612578|FG001|Overall Study|Lack of Efficacy|2|||
27938824|NCT03671148|81612577|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
27938825|NCT03671148|81612578|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
27938826|NCT03671148|81612577|FG000|Overall Study|Other|1|||
27938827|NCT03671148|81612578|FG001|Overall Study|Other|0|||
27938828|NCT03671148|81612577|FG000|Overall Study|Incomplete Randomization Visit|1|||
27938829|NCT03671148|81612578|FG001|Overall Study|Incomplete Randomization Visit|0|||
27938830|NCT01698905|81612581|FG000|Overall Study|Adverse Event|4|||
27938831|NCT01698905|81612581|FG000|Overall Study|Physician Decision|2|||
27938832|NCT01698905|81612581|FG000|Overall Study|Pregnancy|1|||
27938833|NCT01698905|81612581|FG000|Overall Study|Protocol Violation|1|||
27938834|NCT01698905|81612581|FG000|Overall Study|Subject/guardian decision|2|||
27938835|NCT01698905|81612581|FG000|Overall Study|Death|1|||
27938836|NCT01725308|81612582|FG000|Treatment Period I|Did Not Receive Drug|1|||
27938837|NCT01725308|81612583|FG001|Treatment Period I|Did Not Receive Drug|0|||
27938838|NCT01725308|81612584|FG002|Treatment Period I|Did Not Receive Drug|0|||
27938839|NCT01725308|81612582|FG000|Treatment Period I|Adverse Event|5|||
27938840|NCT01725308|81612583|FG001|Treatment Period I|Adverse Event|4|||
27938841|NCT01725308|81612584|FG002|Treatment Period I|Adverse Event|21|||
27938842|NCT01725308|81612582|FG000|Treatment Period I|Insufficient Response|7|||
27938843|NCT01725308|81612583|FG001|Treatment Period I|Insufficient Response|0|||
27938844|NCT01725308|81612584|FG002|Treatment Period I|Insufficient Response|5|||
27938845|NCT01725308|81612582|FG000|Treatment Period I|Worsening of the Target Disease|8|||
27938846|NCT01725308|81612583|FG001|Treatment Period I|Worsening of the Target Disease|0|||
27746235|NCT01937130|80899567|FG000|Overall Study|Patient lost to FU due to death|2|||
27746236|NCT01937130|80899568|FG001|Overall Study|Patient lost to FU due to death|0|||
27746237|NCT01937130|80899569|FG002|Overall Study|Patient lost to FU due to death|0|||
27746238|NCT01937130|80899570|FG003|Overall Study|Patient lost to FU due to death|0|||
27746239|NCT00524745|80899581|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
27746240|NCT00524745|80899582|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
27746241|NCT00524745|80899583|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
27746242|NCT00524745|80899584|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
27746243|NCT03242928|80899585|FG000|Overall Study|Adverse Event|2|||
27746244|NCT03242928|80899586|FG001|Overall Study|Adverse Event|1|||
27746245|NCT03242928|80899585|FG000|Overall Study|Lost to Follow-up|2|||
27746246|NCT03242928|80899586|FG001|Overall Study|Lost to Follow-up|0|||
27746247|NCT03242928|80899585|FG000|Overall Study|Physician Decision|0|||
27746248|NCT03242928|80899586|FG001|Overall Study|Physician Decision|1|||
27746249|NCT03242928|80899585|FG000|Overall Study|Withdrawal by Subject|5|||
27746250|NCT03242928|80899586|FG001|Overall Study|Withdrawal by Subject|3|||
27746251|NCT00798967|80899589|FG000|Overall Study|Adverse Event|2|||
27746252|NCT00798967|80899590|FG001|Overall Study|Adverse Event|3|||
27746253|NCT00798967|80899589|FG000|Overall Study|Withdrawal by Subject|0|||
27746254|NCT00798967|80899590|FG001|Overall Study|Withdrawal by Subject|1|||
27746255|NCT00798967|80899589|FG000|Overall Study|Physician Decision|1|||
27746256|NCT00798967|80899590|FG001|Overall Study|Physician Decision|0|||
27746257|NCT00798967|80899589|FG000|Overall Study|Randomized in error by site|1|||
27746258|NCT00798967|80899590|FG001|Overall Study|Randomized in error by site|0|||
27746259|NCT03643432|80899591|FG000|Overall Study|Lost to Follow-up|1|||
27746260|NCT03643432|80899592|FG001|Overall Study|Lost to Follow-up|0|||
27746261|NCT01605396|80899595|FG000|Overall Study|Adverse Event|5|||
27746262|NCT01605396|80899596|FG001|Overall Study|Adverse Event|3|||
27746263|NCT01605396|80899595|FG000|Overall Study|Lost to Follow-up|1|||
27746264|NCT01605396|80899596|FG001|Overall Study|Lost to Follow-up|0|||
27746265|NCT01605396|80899595|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27746266|NCT01605396|80899596|FG001|Overall Study|Non-Compliance With Study Drug|1|||
27746267|NCT01605396|80899595|FG000|Overall Study|Physician Decision|2|||
27746268|NCT01605396|80899596|FG001|Overall Study|Physician Decision|2|||
27746269|NCT01605396|80899595|FG000|Overall Study|Progressive Disease|23|||
27746270|NCT01605396|80899596|FG001|Overall Study|Progressive Disease|27|||
27746271|NCT01605396|80899595|FG000|Overall Study|Withdrawal by Subject|4|||
27746272|NCT01605396|80899596|FG001|Overall Study|Withdrawal by Subject|2|||
27746273|NCT01605396|80899595|FG000|Overall Study|Transfer Off Study|4|||
27746274|NCT01605396|80899596|FG001|Overall Study|Transfer Off Study|5|||
27938847|NCT01725308|81612584|FG002|Treatment Period I|Worsening of the Target Disease|2|||
27938848|NCT01725308|81612582|FG000|Treatment Period I|Changes in the Episodes|3|||
27938849|NCT01725308|81612583|FG001|Treatment Period I|Changes in the Episodes|0|||
27938850|NCT01725308|81612584|FG002|Treatment Period I|Changes in the Episodes|2|||
27938851|NCT01725308|81612582|FG000|Treatment Period I|Withdrawal of Consent|12|||
27746275|NCT00634543|80899597|FG000|Overall Study|Other|1|||
27746276|NCT00634543|80899598|FG001|Overall Study|Other|2|||
27746277|NCT00634543|80899597|FG000|Overall Study|Protocol Violation|3|||
27746278|NCT00634543|80899598|FG001|Overall Study|Protocol Violation|3|||
27746279|NCT00634543|80899597|FG000|Overall Study|Adverse Event|11|||
27746280|NCT00634543|80899598|FG001|Overall Study|Adverse Event|11|||
27746281|NCT00634543|80899597|FG000|Overall Study|Withdrawal by Subject|4|||
27938852|NCT01725308|81612583|FG001|Treatment Period I|Withdrawal of Consent|7|||
27938853|NCT01725308|81612584|FG002|Treatment Period I|Withdrawal of Consent|5|||
27938854|NCT01725308|81612582|FG000|Treatment Period I|Lost to Follow-up|3|||
27746282|NCT00634543|80899598|FG001|Overall Study|Withdrawal by Subject|4|||
27938855|NCT01725308|81612583|FG001|Treatment Period I|Lost to Follow-up|2|||
27938856|NCT01725308|81612584|FG002|Treatment Period I|Lost to Follow-up|2|||
27938857|NCT01725308|81612582|FG000|Treatment Period I|Protocol Deviations|3|||
27938858|NCT01725308|81612583|FG001|Treatment Period I|Protocol Deviations|1|||
27938859|NCT01725308|81612584|FG002|Treatment Period I|Protocol Deviations|1|||
27938860|NCT01725308|81612582|FG000|Treatment Period I|Miscellaneous|2|||
27938861|NCT01725308|81612583|FG001|Treatment Period I|Miscellaneous|0|||
27938862|NCT01725308|81612584|FG002|Treatment Period I|Miscellaneous|3|||
27938863|NCT01725308|81612582|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
27938864|NCT01725308|81612583|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
27938865|NCT01725308|81612584|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
27938866|NCT01725308|81612582|FG000|Treatment Period II|Did Not Receive Drug|4|||
27938867|NCT01725308|81612583|FG001|Treatment Period II|Did Not Receive Drug|0|||
27938868|NCT01725308|81612584|FG002|Treatment Period II|Did Not Receive Drug|0|||
27938869|NCT01725308|81612582|FG000|Treatment Period II|Adverse Event|13|||
27938870|NCT01725308|81612583|FG001|Treatment Period II|Adverse Event|8|||
27938871|NCT01725308|81612584|FG002|Treatment Period II|Adverse Event|20|||
27938872|NCT01725308|81612582|FG000|Treatment Period II|Insufficient Response|2|||
27938873|NCT01725308|81612583|FG001|Treatment Period II|Insufficient Response|4|||
27938874|NCT01725308|81612584|FG002|Treatment Period II|Insufficient Response|6|||
27938875|NCT01725308|81612582|FG000|Treatment Period II|Worsening of the Target Disease|1|||
27938876|NCT01725308|81612583|FG001|Treatment Period II|Worsening of the Target Disease|4|||
27938877|NCT01725308|81612584|FG002|Treatment Period II|Worsening of the Target Disease|2|||
27938878|NCT01725308|81612582|FG000|Treatment Period II|Changes in the Episodes|1|||
27938879|NCT01725308|81612583|FG001|Treatment Period II|Changes in the Episodes|0|||
27938880|NCT01725308|81612584|FG002|Treatment Period II|Changes in the Episodes|5|||
27938881|NCT01725308|81612582|FG000|Treatment Period II|Withdrawal of Consent|28|||
27938882|NCT01725308|81612583|FG001|Treatment Period II|Withdrawal of Consent|2|||
27938883|NCT01725308|81612584|FG002|Treatment Period II|Withdrawal of Consent|16|||
27938884|NCT01725308|81612582|FG000|Treatment Period II|Lost to Follow-up|1|||
27938885|NCT01725308|81612583|FG001|Treatment Period II|Lost to Follow-up|5|||
27938886|NCT01725308|81612584|FG002|Treatment Period II|Lost to Follow-up|3|||
27938887|NCT01725308|81612582|FG000|Treatment Period II|Protocol Deviations|0|||
27938888|NCT01725308|81612583|FG001|Treatment Period II|Protocol Deviations|0|||
27938889|NCT01725308|81612584|FG002|Treatment Period II|Protocol Deviations|1|||
27938890|NCT01725308|81612582|FG000|Treatment Period II|Miscellaneous|5|||
27938891|NCT01725308|81612583|FG001|Treatment Period II|Miscellaneous|3|||
27938892|NCT01725308|81612584|FG002|Treatment Period II|Miscellaneous|7|||
27938893|NCT02226653|81612588|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
27938894|NCT02226653|81612589|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
27938895|NCT02226653|81612588|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
27938896|NCT02226653|81612589|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
27938897|NCT02048813|81612592|FG000|Overall Study|Still on treatment|279|||
27938898|NCT02048813|81612593|FG001|Overall Study|Still on treatment|0|||
27938899|NCT02048813|81612592|FG000|Overall Study|Adverse Event|40|||
27938900|NCT02048813|81612593|FG001|Overall Study|Adverse Event|38|||
27938901|NCT02048813|81612592|FG000|Overall Study|Disease progression|13|||
27938902|NCT02048813|81612593|FG001|Overall Study|Disease progression|3|||
27938903|NCT02048813|81612592|FG000|Overall Study|Withdrawal by Subject|7|||
27938904|NCT02048813|81612593|FG001|Overall Study|Withdrawal by Subject|8|||
27938905|NCT02048813|81612592|FG000|Overall Study|Death|2|||
27938906|NCT02048813|81612593|FG001|Overall Study|Death|1|||
27938907|NCT02048813|81612592|FG000|Overall Study|Complication|2|||
27938908|NCT02048813|81612593|FG001|Overall Study|Complication|2|||
27938909|NCT02048813|81612592|FG000|Overall Study|Non-protocol therapy|0|||
27938910|NCT02048813|81612593|FG001|Overall Study|Non-protocol therapy|1|||
27938911|NCT02048813|81612592|FG000|Overall Study|Second primary cancer|2|||
27938912|NCT02048813|81612593|FG001|Overall Study|Second primary cancer|0|||
27938913|NCT02048813|81612592|FG000|Overall Study|Insurance|2|||
27938914|NCT02048813|81612593|FG001|Overall Study|Insurance|0|||
27938915|NCT02048813|81612592|FG000|Overall Study|Wound infection/healing|2|||
27938916|NCT02048813|81612593|FG001|Overall Study|Wound infection/healing|0|||
27938917|NCT02048813|81612592|FG000|Overall Study|Missed appointment|3|||
27938918|NCT02048813|81612593|FG001|Overall Study|Missed appointment|0|||
27938919|NCT02048813|81612592|FG000|Overall Study|Never started treatment|2|||
27938920|NCT02048813|81612593|FG001|Overall Study|Never started treatment|17|||
27938921|NCT04765384|81612594|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
27938922|NCT04765384|81612595|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
27938923|NCT04765384|81612596|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
27938924|NCT04765384|81612597|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
27938925|NCT04765384|81612598|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
27938926|NCT04765384|81612599|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
27938927|NCT04765384|81612594|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
27938928|NCT04765384|81612595|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
27938929|NCT04765384|81612596|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
27938930|NCT04765384|81612597|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
27938931|NCT04765384|81612598|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
27938932|NCT04765384|81612599|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
27938933|NCT04765384|81612594|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
27938934|NCT04765384|81612595|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
27938935|NCT04765384|81612596|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
27938936|NCT04765384|81612597|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
27938937|NCT04765384|81612598|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
27938938|NCT04765384|81612599|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
27938939|NCT04765384|81612594|FG000|Post-natal: Neonates and Infants|Death|0|||
27938940|NCT04765384|81612595|FG001|Post-natal: Neonates and Infants|Death|0|||
27938941|NCT04765384|81612596|FG002|Post-natal: Neonates and Infants|Death|0|||
27938942|NCT04765384|81612597|FG003|Post-natal: Neonates and Infants|Death|1|||
27938943|NCT04765384|81612598|FG004|Post-natal: Neonates and Infants|Death|0|||
27938944|NCT04765384|81612599|FG005|Post-natal: Neonates and Infants|Death|0|||
27938945|NCT04765384|81612594|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
27938946|NCT04765384|81612595|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
27938947|NCT04765384|81612596|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
27938948|NCT04765384|81612597|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
27938949|NCT04765384|81612598|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
27938950|NCT04765384|81612599|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
27938951|NCT04579380|81612600|FG000|Overall Study|Death|9|||
27938952|NCT04579380|81612601|FG001|Overall Study|Death|22|||
27938953|NCT04579380|81612602|FG002|Overall Study|Death|22|||
27938954|NCT04579380|81612603|FG003|Overall Study|Death|17|||
27938955|NCT04579380|81612604|FG004|Overall Study|Death|6|||
27938956|NCT04579380|81612605|FG005|Overall Study|Death|21|||
27938957|NCT04579380|81612606|FG006|Overall Study|Death|10|||
27938958|NCT04579380|81612607|FG007|Overall Study|Death|11|||
27938959|NCT04579380|81612608|FG008|Overall Study|Death|25|||
27938960|NCT04579380|81612600|FG000|Overall Study|Withdrawal by Subject|0|||
27938961|NCT04579380|81612601|FG001|Overall Study|Withdrawal by Subject|3|||
27938962|NCT04579380|81612602|FG002|Overall Study|Withdrawal by Subject|4|||
27938963|NCT04579380|81612603|FG003|Overall Study|Withdrawal by Subject|0|||
27938964|NCT04579380|81612604|FG004|Overall Study|Withdrawal by Subject|1|||
27938965|NCT04579380|81612605|FG005|Overall Study|Withdrawal by Subject|2|||
27938966|NCT04579380|81612606|FG006|Overall Study|Withdrawal by Subject|0|||
27938967|NCT04579380|81612607|FG007|Overall Study|Withdrawal by Subject|1|||
27938968|NCT04579380|81612608|FG008|Overall Study|Withdrawal by Subject|2|||
27938969|NCT04579380|81612600|FG000|Overall Study|Ongoing|2|||
27938970|NCT04579380|81612601|FG001|Overall Study|Ongoing|6|||
27938971|NCT04579380|81612602|FG002|Overall Study|Ongoing|4|||
27938972|NCT04579380|81612603|FG003|Overall Study|Ongoing|8|||
27938973|NCT04579380|81612604|FG004|Overall Study|Ongoing|5|||
27938974|NCT04579380|81612605|FG005|Overall Study|Ongoing|8|||
27938975|NCT04579380|81612606|FG006|Overall Study|Ongoing|3|||
27938976|NCT04579380|81612607|FG007|Overall Study|Ongoing|19|||
27938977|NCT04579380|81612608|FG008|Overall Study|Ongoing|6|||
27938978|NCT03892915|81612609|FG000|Overall Study|Lost to Follow-up|6|||
27938979|NCT03892915|81612610|FG001|Overall Study|Lost to Follow-up|12|||
27938980|NCT03892915|81612609|FG000|Overall Study|Death|0|||
27938981|NCT03892915|81612610|FG001|Overall Study|Death|2|||
27938982|NCT03892915|81612609|FG000|Overall Study|Withdrawal by Subject|1|||
27938983|NCT03892915|81612610|FG001|Overall Study|Withdrawal by Subject|1|||
27938984|NCT03892915|81612609|FG000|Overall Study|unsuccessful delivery|13|||
27938985|NCT03892915|81612610|FG001|Overall Study|unsuccessful delivery|18|||
27938986|NCT01725282|81612611|FG000|Overall Study|Adverse Event|1|||
27938987|NCT01725282|81612612|FG001|Overall Study|Adverse Event|3|||
27938988|NCT01725282|81612613|FG002|Overall Study|Adverse Event|6|||
27938989|NCT01725282|81612614|FG003|Overall Study|Adverse Event|4|||
27938990|NCT01725282|81612611|FG000|Overall Study|Exacerbation of Target Disease|1|||
27938991|NCT01725282|81612612|FG001|Overall Study|Exacerbation of Target Disease|0|||
27938992|NCT01725282|81612613|FG002|Overall Study|Exacerbation of Target Disease|0|||
27938993|NCT01725282|81612614|FG003|Overall Study|Exacerbation of Target Disease|1|||
27938994|NCT01725282|81612611|FG000|Overall Study|Met Exclusion Criteria|0|||
27938995|NCT01725282|81612612|FG001|Overall Study|Met Exclusion Criteria|0|||
27938996|NCT01725282|81612613|FG002|Overall Study|Met Exclusion Criteria|1|||
27938997|NCT01725282|81612614|FG003|Overall Study|Met Exclusion Criteria|0|||
27938998|NCT01725282|81612611|FG000|Overall Study|Study Site Withdrawal|0|||
27938999|NCT01725282|81612612|FG001|Overall Study|Study Site Withdrawal|1|||
27939000|NCT01725282|81612613|FG002|Overall Study|Study Site Withdrawal|0|||
27939001|NCT01725282|81612614|FG003|Overall Study|Study Site Withdrawal|0|||
27939002|NCT01725282|81612611|FG000|Overall Study|Withdrawal by Subject|0|||
27939003|NCT01725282|81612612|FG001|Overall Study|Withdrawal by Subject|0|||
27939004|NCT01725282|81612613|FG002|Overall Study|Withdrawal by Subject|1|||
27939005|NCT01725282|81612614|FG003|Overall Study|Withdrawal by Subject|1|||
27939006|NCT01725282|81612611|FG000|Overall Study|Lack of Efficacy|0|||
27939007|NCT01725282|81612612|FG001|Overall Study|Lack of Efficacy|1|||
27939008|NCT01725282|81612613|FG002|Overall Study|Lack of Efficacy|0|||
27939009|NCT01725282|81612614|FG003|Overall Study|Lack of Efficacy|1|||
27939010|NCT03033576|81612615|FG000|Overall Study|Ineligible|1|||
27939011|NCT03033576|81612616|FG001|Overall Study|Ineligible|1|||
27939012|NCT03033576|81612615|FG000|Overall Study|Adverse Event|4|||
27939013|NCT03033576|81612616|FG001|Overall Study|Adverse Event|20|||
27939014|NCT03033576|81612615|FG000|Overall Study|Progression/relapse|9|||
27939015|NCT03033576|81612616|FG001|Overall Study|Progression/relapse|36|||
27939016|NCT03033576|81612615|FG000|Overall Study|Death|1|||
27939017|NCT03033576|81612616|FG001|Overall Study|Death|1|||
27939018|NCT03033576|81612615|FG000|Overall Study|Patient refusal|1|||
27746283|NCT00634543|80899597|FG000|Overall Study|Lost to Follow-up|0|||
27939019|NCT03033576|81612616|FG001|Overall Study|Patient refusal|6|||
27939020|NCT03033576|81612615|FG000|Overall Study|Other, unspecified reasons|0|||
27939021|NCT03033576|81612616|FG001|Overall Study|Other, unspecified reasons|4|||
27939022|NCT03033576|81612615|FG000|Overall Study|Currently on protocol therapy|0|||
27939023|NCT03033576|81612616|FG001|Overall Study|Currently on protocol therapy|2|||
27939024|NCT02775851|81612617|FG000|Overall Study|Adverse Event|1|||
27939025|NCT02775851|81612618|FG001|Overall Study|Adverse Event|10|||
27939026|NCT02775851|81612617|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
27939027|NCT02775851|81612618|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
27939028|NCT02775851|81612617|FG000|Overall Study|Progression/Relapse|0|||
27939029|NCT02775851|81612618|FG001|Overall Study|Progression/Relapse|4|||
27939030|NCT02775851|81612617|FG000|Overall Study|Other - Not Protocol Specified|0|||
27939031|NCT02775851|81612618|FG001|Overall Study|Other - Not Protocol Specified|7|||
27939032|NCT02775851|81612617|FG000|Overall Study|Withdrawal by Subject|1|||
27939033|NCT02775851|81612618|FG001|Overall Study|Withdrawal by Subject|0|||
27939034|NCT05524948|81612619|FG000|Overall Study|Withdrawal by Subject|1|||
27939035|NCT05524948|81612620|FG001|Overall Study|Withdrawal by Subject|0|||
27939036|NCT05524948|81612619|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
27939037|NCT05524948|81612620|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
27939038|NCT02662582|81612623|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
27939039|NCT02662582|81612624|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
27939040|NCT02662582|81612623|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
27939041|NCT02662582|81612624|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
27939042|NCT02662582|81612623|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
27939043|NCT02662582|81612624|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
27939044|NCT02662582|81612623|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27939045|NCT02662582|81612624|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
27939046|NCT01274338|81612625|FG000|Overall Study|Lack of Efficacy|72|||
27939047|NCT01274338|81612626|FG001|Overall Study|Lack of Efficacy|108|||
27939048|NCT01274338|81612627|FG002|Overall Study|Lack of Efficacy|116|||
27939049|NCT01274338|81612628|FG003|Overall Study|Lack of Efficacy|0|||
27939050|NCT01274338|81612629|FG004|Overall Study|Lack of Efficacy|0|||
27939051|NCT01274338|81612630|FG005|Overall Study|Lack of Efficacy|0|||
27939052|NCT01274338|81612625|FG000|Overall Study|Adverse Event|272|||
27939053|NCT01274338|81612626|FG001|Overall Study|Adverse Event|105|||
27939054|NCT01274338|81612627|FG002|Overall Study|Adverse Event|180|||
27939055|NCT01274338|81612628|FG003|Overall Study|Adverse Event|1|||
27939056|NCT01274338|81612629|FG004|Overall Study|Adverse Event|0|||
27939057|NCT01274338|81612630|FG005|Overall Study|Adverse Event|0|||
27939058|NCT01274338|81612625|FG000|Overall Study|Death|8|||
27939059|NCT01274338|81612626|FG001|Overall Study|Death|1|||
27939060|NCT01274338|81612627|FG002|Overall Study|Death|0|||
27939061|NCT01274338|81612628|FG003|Overall Study|Death|0|||
27939062|NCT01274338|81612629|FG004|Overall Study|Death|0|||
27939063|NCT01274338|81612630|FG005|Overall Study|Death|0|||
27939064|NCT01274338|81612625|FG000|Overall Study|Withdrawal by Subject|27|||
27746284|NCT00634543|80899598|FG001|Overall Study|Lost to Follow-up|1|||
27939065|NCT01274338|81612626|FG001|Overall Study|Withdrawal by Subject|99|||
27939066|NCT01274338|81612627|FG002|Overall Study|Withdrawal by Subject|17|||
27939067|NCT01274338|81612628|FG003|Overall Study|Withdrawal by Subject|0|||
27939068|NCT01274338|81612629|FG004|Overall Study|Withdrawal by Subject|0|||
27939069|NCT01274338|81612630|FG005|Overall Study|Withdrawal by Subject|0|||
27939070|NCT01274338|81612625|FG000|Overall Study|Did not start treatment|8|||
27939071|NCT01274338|81612626|FG001|Overall Study|Did not start treatment|116|||
27939072|NCT01274338|81612627|FG002|Overall Study|Did not start treatment|7|||
27939073|NCT01274338|81612628|FG003|Overall Study|Did not start treatment|0|||
27939074|NCT01274338|81612629|FG004|Overall Study|Did not start treatment|0|||
27939075|NCT01274338|81612630|FG005|Overall Study|Did not start treatment|0|||
27746285|NCT01454401|80899599|FG000|Overall Study|Death|1|||
27939076|NCT01274338|81612625|FG000|Overall Study|Alternative therapy|0|||
27939077|NCT01274338|81612626|FG001|Overall Study|Alternative therapy|1|||
27939078|NCT01274338|81612627|FG002|Overall Study|Alternative therapy|0|||
27746286|NCT01454401|80899599|FG000|Overall Study|hospitalised|1|||
27645441|NCT01371994|80541586|FG000|Overall Study|Adverse Event|3|||
27645442|NCT01371994|80541587|FG001|Overall Study|Adverse Event|6|||
27645443|NCT01371994|80541586|FG000|Overall Study|Lack of Efficacy|3|||
27939079|NCT01274338|81612628|FG003|Overall Study|Alternative therapy|0|||
27939080|NCT01274338|81612629|FG004|Overall Study|Alternative therapy|0|||
27939081|NCT01274338|81612630|FG005|Overall Study|Alternative therapy|0|||
27939082|NCT01274338|81612625|FG000|Overall Study|Other complicating diseases|0|||
27939083|NCT01274338|81612626|FG001|Overall Study|Other complicating diseases|3|||
27939084|NCT01274338|81612627|FG002|Overall Study|Other complicating diseases|1|||
27939085|NCT01274338|81612628|FG003|Overall Study|Other complicating diseases|0|||
27939086|NCT01274338|81612629|FG004|Overall Study|Other complicating diseases|0|||
27939087|NCT01274338|81612630|FG005|Overall Study|Other complicating diseases|0|||
27939088|NCT01274338|81612625|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
27939089|NCT01274338|81612626|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
27939090|NCT01274338|81612627|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
27645444|NCT01371994|80541587|FG001|Overall Study|Lack of Efficacy|0|||
27645445|NCT01371994|80541586|FG000|Overall Study|Withdrawal by Subject|13|||
27645446|NCT01371994|80541587|FG001|Overall Study|Withdrawal by Subject|7|||
27645447|NCT01371994|80541586|FG000|Overall Study|Lost to Follow-up|1|||
27645448|NCT01371994|80541587|FG001|Overall Study|Lost to Follow-up|1|||
27645449|NCT01371994|80541586|FG000|Overall Study|Protocol Violation|24|||
27645450|NCT01371994|80541587|FG001|Overall Study|Protocol Violation|17|||
27645451|NCT01371994|80541586|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
27645452|NCT01371994|80541587|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
27645453|NCT01371994|80541586|FG000|Overall Study|Physician Decision|1|||
27645454|NCT01371994|80541587|FG001|Overall Study|Physician Decision|1|||
27645455|NCT01371994|80541586|FG000|Overall Study|Miscellaneous Reasons|6|||
27645456|NCT01371994|80541587|FG001|Overall Study|Miscellaneous Reasons|4|||
27645457|NCT01260896|80543599|FG000|First Intervention|Withdrawn Due to Emesis|2|||
27645458|NCT01260896|80543600|FG001|First Intervention|Withdrawn Due to Emesis|0|||
27645459|NCT01767467|80543601|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
27645460|NCT01767467|80543602|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
27645461|NCT01767467|80543601|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
27645462|NCT01767467|80543602|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
27645463|NCT01767467|80543601|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
27645464|NCT01767467|80543602|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
27645465|NCT01767467|80543601|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
27645466|NCT01767467|80543602|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
27645467|NCT01767467|80543601|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
27645468|NCT01767467|80543602|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
27645469|NCT01767467|80543601|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
27645470|NCT01767467|80543602|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
27645471|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
27939091|NCT01274338|81612628|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
27939092|NCT01274338|81612629|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
27939093|NCT01274338|81612630|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
27645472|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
27645473|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
27939094|NCT01274338|81612625|FG000|Overall Study|Pregnancy|0|||
27939095|NCT01274338|81612626|FG001|Overall Study|Pregnancy|0|||
27939096|NCT01274338|81612627|FG002|Overall Study|Pregnancy|1|||
27939097|NCT01274338|81612628|FG003|Overall Study|Pregnancy|0|||
27939098|NCT01274338|81612629|FG004|Overall Study|Pregnancy|0|||
27939099|NCT01274338|81612630|FG005|Overall Study|Pregnancy|0|||
27939100|NCT01274338|81612625|FG000|Overall Study|Reason not reported|12|||
27939101|NCT01274338|81612626|FG001|Overall Study|Reason not reported|21|||
27939102|NCT01274338|81612627|FG002|Overall Study|Reason not reported|3|||
27939103|NCT01274338|81612628|FG003|Overall Study|Reason not reported|0|||
27939104|NCT01274338|81612629|FG004|Overall Study|Reason not reported|1|||
27939105|NCT01274338|81612630|FG005|Overall Study|Reason not reported|0|||
27645474|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
27645475|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
27645476|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
27939106|NCT02100644|81612631|FG000|LTG Escalation Phase|Adverse Event|9|||
27645477|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
27645478|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
27645479|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
27746287|NCT01454401|80899599|FG000|Overall Study|osteomyelitis|2|||
27746288|NCT01454401|80899599|FG000|Overall Study|non-adherence|1|||
27939107|NCT02100644|81612632|FG001|LTG Escalation Phase|Adverse Event|0|||
27939108|NCT02100644|81612633|FG002|LTG Escalation Phase|Adverse Event|0|||
27939109|NCT02100644|81612631|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
27939110|NCT02100644|81612632|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
27939111|NCT02100644|81612633|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
27939112|NCT02100644|81612631|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
27939113|NCT02100644|81612632|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
27939114|NCT02100644|81612633|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
27939115|NCT03735498|81612634|FG000|Overall Study|Withdrawal by Subject|3|||
27939116|NCT03735498|81612634|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
27939117|NCT04525183|81612635|FG000|Overall Study|Withdrawal by Subject|0|||
27939118|NCT04525183|81612636|FG001|Overall Study|Withdrawal by Subject|0|||
27939119|NCT04525183|81612637|FG002|Overall Study|Withdrawal by Subject|3|||
27939120|NCT04525183|81612635|FG000|Overall Study|Study non-compliance|0|||
27939121|NCT04525183|81612636|FG001|Overall Study|Study non-compliance|0|||
27939122|NCT04525183|81612637|FG002|Overall Study|Study non-compliance|1|||
27939123|NCT04525183|81612635|FG000|Overall Study|Recurrent disease before starting on study|0|||
27939124|NCT04525183|81612636|FG001|Overall Study|Recurrent disease before starting on study|0|||
27939125|NCT04525183|81612637|FG002|Overall Study|Recurrent disease before starting on study|1|||
27939126|NCT00588770|81612638|FG000|Overall Study|Disease progression|85|||
27939127|NCT00588770|81612639|FG001|Overall Study|Disease progression|68|||
27939128|NCT00588770|81612638|FG000|Overall Study|Adverse Event|29|||
27939129|NCT00588770|81612639|FG001|Overall Study|Adverse Event|58|||
27939130|NCT00588770|81612638|FG000|Overall Study|Death|13|||
27939131|NCT00588770|81612639|FG001|Overall Study|Death|22|||
27939132|NCT00588770|81612638|FG000|Overall Study|Withdrawal by Subject|15|||
27939133|NCT00588770|81612639|FG001|Overall Study|Withdrawal by Subject|25|||
27939134|NCT00588770|81612638|FG000|Overall Study|Alternative therapy|2|||
27939135|NCT00588770|81612639|FG001|Overall Study|Alternative therapy|4|||
27939136|NCT00588770|81612638|FG000|Overall Study|Other complicating disease|3|||
27939137|NCT00588770|81612639|FG001|Overall Study|Other complicating disease|2|||
27939138|NCT00588770|81612638|FG000|Overall Study|Not start protocol therapy|0|||
27939139|NCT00588770|81612639|FG001|Overall Study|Not start protocol therapy|9|||
27939140|NCT00588770|81612638|FG000|Overall Study|Lack of Efficacy|8|||
27939141|NCT00588770|81612639|FG001|Overall Study|Lack of Efficacy|10|||
27939142|NCT00588770|81612638|FG000|Overall Study|Physician discretion|2|||
27939143|NCT00588770|81612639|FG001|Overall Study|Physician discretion|0|||
27939144|NCT00588770|81612638|FG000|Overall Study|Patient non-compliance|2|||
27939145|NCT00588770|81612639|FG001|Overall Study|Patient non-compliance|2|||
27939146|NCT01856192|81612643|FG000|Overall Study|Adverse Event|12|||
27939147|NCT01856192|81612644|FG001|Overall Study|Adverse Event|4|||
27939148|NCT01856192|81612643|FG000|Overall Study|Alternative therapy|0|||
27939149|NCT01856192|81612644|FG001|Overall Study|Alternative therapy|3|||
27939150|NCT01856192|81612643|FG000|Overall Study|Death|3|||
27939151|NCT01856192|81612644|FG001|Overall Study|Death|5|||
27939152|NCT01856192|81612643|FG000|Overall Study|Lack of Efficacy|0|||
27939153|NCT01856192|81612644|FG001|Overall Study|Lack of Efficacy|5|||
27939154|NCT01856192|81612643|FG000|Overall Study|Withdrawal by Subject|1|||
27939155|NCT01856192|81612644|FG001|Overall Study|Withdrawal by Subject|1|||
27939156|NCT01856192|81612643|FG000|Overall Study|Other diseases|1|||
27939157|NCT01856192|81612644|FG001|Overall Study|Other diseases|0|||
27939158|NCT01856192|81612643|FG000|Overall Study|Never started treatment|7|||
27939159|NCT01856192|81612644|FG001|Overall Study|Never started treatment|5|||
27939160|NCT01856192|81612643|FG000|Overall Study|Path ineligible|20|||
27939161|NCT01856192|81612644|FG001|Overall Study|Path ineligible|34|||
27939162|NCT01856192|81612643|FG000|Overall Study|Non-path ineligible|2|||
27939163|NCT01856192|81612644|FG001|Overall Study|Non-path ineligible|2|||
27939164|NCT01856192|81612643|FG000|Overall Study|Physician Decision|1|||
27939165|NCT01856192|81612644|FG001|Overall Study|Physician Decision|1|||
27939166|NCT01856192|81612643|FG000|Overall Study|Suspicion of progressive disease|1|||
27939167|NCT01856192|81612644|FG001|Overall Study|Suspicion of progressive disease|0|||
27939168|NCT01856192|81612643|FG000|Overall Study|Non-compliance|1|||
27939169|NCT01856192|81612644|FG001|Overall Study|Non-compliance|0|||
27939170|NCT00569127|81612645|FG000|Overall Study|Adverse Event|57|||
27939171|NCT00569127|81612646|FG001|Overall Study|Adverse Event|47|||
27939172|NCT00569127|81612645|FG000|Overall Study|Withdrawal by Subject|13|||
27939173|NCT00569127|81612646|FG001|Overall Study|Withdrawal by Subject|27|||
27939174|NCT00569127|81612645|FG000|Overall Study|Progression|99|||
27939175|NCT00569127|81612646|FG001|Overall Study|Progression|100|||
27939176|NCT00569127|81612645|FG000|Overall Study|Death|4|||
27645480|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
27645481|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
27939177|NCT00569127|81612646|FG001|Overall Study|Death|3|||
27939178|NCT00569127|81612645|FG000|Overall Study|Other|20|||
27939179|NCT00569127|81612646|FG001|Overall Study|Other|19|||
27939180|NCT00569127|81612645|FG000|Overall Study|Lost to Follow-up|0|||
27939181|NCT00569127|81612646|FG001|Overall Study|Lost to Follow-up|3|||
27939182|NCT00569127|81612645|FG000|Overall Study|Not Eligible|14|||
27939183|NCT00569127|81612646|FG001|Overall Study|Not Eligible|11|||
27939184|NCT00569127|81612645|FG000|Overall Study|Still on Treatment|7|||
27939185|NCT00569127|81612646|FG001|Overall Study|Still on Treatment|3|||
27939186|NCT03620981|81612653|FG000|Overall Study|Adverse Event|14|||
27939187|NCT03620981|81612654|FG001|Overall Study|Adverse Event|38|||
27939188|NCT03620981|81612655|FG002|Overall Study|Adverse Event|25|||
27939189|NCT03620981|81612653|FG000|Overall Study|Lack of Efficacy|2|||
27939190|NCT03620981|81612654|FG001|Overall Study|Lack of Efficacy|1|||
27939191|NCT03620981|81612655|FG002|Overall Study|Lack of Efficacy|1|||
27939192|NCT03620981|81612653|FG000|Overall Study|Physician Decision|7|||
27939193|NCT03620981|81612654|FG001|Overall Study|Physician Decision|4|||
27939194|NCT03620981|81612655|FG002|Overall Study|Physician Decision|4|||
27939195|NCT03620981|81612653|FG000|Overall Study|Protocol Violation|1|||
27939196|NCT03620981|81612654|FG001|Overall Study|Protocol Violation|2|||
27939197|NCT03620981|81612655|FG002|Overall Study|Protocol Violation|1|||
27939198|NCT03620981|81612653|FG000|Overall Study|Withdrawal by Legal Representative|2|||
27939199|NCT03620981|81612654|FG001|Overall Study|Withdrawal by Legal Representative|1|||
27939200|NCT03620981|81612655|FG002|Overall Study|Withdrawal by Legal Representative|1|||
27939201|NCT03620981|81612653|FG000|Overall Study|Withdrawal by Care Giver|2|||
27939202|NCT03620981|81612654|FG001|Overall Study|Withdrawal by Care Giver|0|||
27939203|NCT03620981|81612655|FG002|Overall Study|Withdrawal by Care Giver|1|||
27939204|NCT03620981|81612653|FG000|Overall Study|Non-compliance with Study Drug|1|||
27939205|NCT03620981|81612654|FG001|Overall Study|Non-compliance with Study Drug|1|||
27939206|NCT03620981|81612655|FG002|Overall Study|Non-compliance with Study Drug|0|||
27939207|NCT01064622|81612656|FG000|Randomized Phase II|Withdrawal by Subject|2|||
27939208|NCT01064622|81612657|FG001|Randomized Phase II|Withdrawal by Subject|2|||
27939209|NCT01064622|81612656|FG000|Randomized Phase II|Protocol Violation|0|||
27939210|NCT01064622|81612657|FG001|Randomized Phase II|Protocol Violation|1|||
27939211|NCT04181762|81612658|FG000|Overall Study|Adverse Event|1|||
27939212|NCT04181762|81612659|FG001|Overall Study|Adverse Event|3|||
27939213|NCT04181762|81612658|FG000|Overall Study|Lost to Follow-up|1|||
27939214|NCT04181762|81612659|FG001|Overall Study|Lost to Follow-up|1|||
27939215|NCT04181762|81612658|FG000|Overall Study|Physician Decision|1|||
27939216|NCT04181762|81612659|FG001|Overall Study|Physician Decision|3|||
27939217|NCT04181762|81612658|FG000|Overall Study|Pregnancy|0|||
27939218|NCT04181762|81612659|FG001|Overall Study|Pregnancy|1|||
27939219|NCT04181762|81612658|FG000|Overall Study|Lack of Efficacy|2|||
27939220|NCT04181762|81612659|FG001|Overall Study|Lack of Efficacy|2|||
27939221|NCT04181762|81612658|FG000|Overall Study|Study terminated by sponsor|95|||
27939222|NCT04181762|81612659|FG001|Overall Study|Study terminated by sponsor|97|||
27939223|NCT04181762|81612658|FG000|Overall Study|Subject decision|11|||
27939224|NCT04181762|81612659|FG001|Overall Study|Subject decision|4|||
27939225|NCT04181762|81612658|FG000|Overall Study|Death|1|||
27939226|NCT04181762|81612659|FG001|Overall Study|Death|1|||
27939227|NCT04181762|81612658|FG000|Overall Study|Protocol deviation|1|||
27939228|NCT04181762|81612659|FG001|Overall Study|Protocol deviation|0|||
27939229|NCT04181762|81612658|FG000|Overall Study|Withdrawal of informed consent|1|||
27939230|NCT04181762|81612659|FG001|Overall Study|Withdrawal of informed consent|3|||
27939231|NCT01386385|81612660|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
27939232|NCT01386385|81612661|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939233|NCT01386385|81612662|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939234|NCT01386385|81612663|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939235|NCT01386385|81612664|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939236|NCT01386385|81612665|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939237|NCT01386385|81612666|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939238|NCT01386385|81612667|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
27939239|NCT01386385|81612660|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
27939240|NCT01386385|81612661|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939241|NCT01386385|81612662|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939242|NCT01386385|81612663|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939243|NCT01386385|81612664|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939244|NCT01386385|81612665|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939245|NCT01386385|81612666|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939246|NCT01386385|81612667|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
27939247|NCT01386385|81612660|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27939248|NCT01386385|81612661|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27939249|NCT01386385|81612662|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
27939250|NCT01386385|81612663|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27939251|NCT01386385|81612664|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27939252|NCT01386385|81612665|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27939253|NCT01386385|81612666|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27645482|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
27939254|NCT01386385|81612667|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
27939255|NCT01386385|81612660|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939256|NCT01386385|81612661|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939257|NCT01386385|81612662|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939258|NCT01386385|81612663|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939259|NCT01386385|81612664|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
27939260|NCT01386385|81612665|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939261|NCT01386385|81612666|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939262|NCT01386385|81612667|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
27939263|NCT01386385|81612660|FG000|Phase II Concurrent CRT|Adverse Event|0|||
27939264|NCT01386385|81612661|FG001|Phase II Concurrent CRT|Adverse Event|0|||
27939265|NCT01386385|81612662|FG002|Phase II Concurrent CRT|Adverse Event|0|||
27939266|NCT01386385|81612663|FG003|Phase II Concurrent CRT|Adverse Event|0|||
27939267|NCT01386385|81612664|FG004|Phase II Concurrent CRT|Adverse Event|0|||
27939268|NCT01386385|81612665|FG005|Phase II Concurrent CRT|Adverse Event|0|||
27939269|NCT01386385|81612666|FG006|Phase II Concurrent CRT|Adverse Event|3|||
27939270|NCT01386385|81612667|FG007|Phase II Concurrent CRT|Adverse Event|3|||
27939271|NCT01386385|81612660|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939272|NCT01386385|81612661|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939273|NCT01386385|81612662|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939274|NCT01386385|81612663|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939275|NCT01386385|81612664|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939276|NCT01386385|81612665|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939277|NCT01386385|81612666|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
27939278|NCT01386385|81612667|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
27939279|NCT01386385|81612660|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
27939280|NCT01386385|81612661|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
27939281|NCT01386385|81612662|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
27939282|NCT01386385|81612663|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
27939283|NCT01386385|81612664|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
27939284|NCT01386385|81612665|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
27939285|NCT01386385|81612666|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
27939286|NCT01386385|81612667|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
27939287|NCT01386385|81612660|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939288|NCT01386385|81612661|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939289|NCT01386385|81612662|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939290|NCT01386385|81612663|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939291|NCT01386385|81612664|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939292|NCT01386385|81612665|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939293|NCT01386385|81612666|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
27939294|NCT01386385|81612667|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
27939295|NCT01386385|81612660|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
27939296|NCT01386385|81612661|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
27939297|NCT01386385|81612662|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
27939298|NCT01386385|81612663|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
27939299|NCT01386385|81612664|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
27939300|NCT01386385|81612665|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
27939301|NCT01386385|81612666|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
27939302|NCT01386385|81612667|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
27939303|NCT04971837|81612668|FG000|Overall Study|Long Term Illness|1|||
27939304|NCT04971837|81612668|FG000|Overall Study|BMI too low|9|||
27939305|NCT04971837|81612668|FG000|Overall Study|geographic location|1|||
27939306|NCT04971837|81612668|FG000|Overall Study|Discontinued scheduling conflict|1|||
27939307|NCT04439903|81612671|FG000|Overall Study|Withdrawal by Subject|2|||
27939308|NCT04439903|81612671|FG000|Overall Study|Screen Failure|1|||
27939309|NCT05463952|81612674|FG000|Treatment|Progressive disease|4|||
27939310|NCT05463952|81612674|FG000|Treatment|Ongoing|2|||
27939311|NCT01272037|81612677|FG000|Overall Study|Death|25|||
27939312|NCT01272037|81612678|FG001|Overall Study|Death|28|||
27939313|NCT01272037|81612677|FG000|Overall Study|Adverse Event|12|||
27939314|NCT01272037|81612678|FG001|Overall Study|Adverse Event|7|||
27939315|NCT01272037|81612677|FG000|Overall Study|Withdrawal by Subject|175|||
27939316|NCT01272037|81612678|FG001|Overall Study|Withdrawal by Subject|93|||
27939317|NCT01272037|81612677|FG000|Overall Study|Disease progression|70|||
27939318|NCT01272037|81612678|FG001|Overall Study|Disease progression|111|||
27939319|NCT01272037|81612677|FG000|Overall Study|Other reason|42|||
27939320|NCT01272037|81612678|FG001|Overall Study|Other reason|41|||
27939321|NCT01272037|81612677|FG000|Overall Study|Delinquent data|24|||
27939322|NCT01272037|81612678|FG001|Overall Study|Delinquent data|19|||
27939323|NCT01272037|81612677|FG000|Overall Study|Reason under review|33|||
27939324|NCT01272037|81612678|FG001|Overall Study|Reason under review|29|||
27939325|NCT01272037|81612677|FG000|Overall Study|On treatment|626|||
27939326|NCT01272037|81612678|FG001|Overall Study|On treatment|632|||
27939327|NCT03533491|81612680|FG000|Overall Study|Lost to Follow-up|2|||
27939328|NCT00972478|81612687|FG000|Overall Study|Adverse Event|3|||
27939329|NCT00972478|81612688|FG001|Overall Study|Adverse Event|16|||
27939330|NCT00972478|81612687|FG000|Overall Study|Withdrawal by Subject|1|||
27939331|NCT00972478|81612688|FG001|Overall Study|Withdrawal by Subject|8|||
27939332|NCT00972478|81612687|FG000|Overall Study|Progression/Relapse|0|||
27939333|NCT00972478|81612688|FG001|Overall Study|Progression/Relapse|2|||
27939334|NCT00972478|81612687|FG000|Overall Study|Death|0|||
27939335|NCT00972478|81612688|FG001|Overall Study|Death|2|||
27645483|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
27645484|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
27645485|NCT01767467|80543601|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
27645486|NCT01767467|80543602|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
27939336|NCT00972478|81612687|FG000|Overall Study|Not protocol specified|1|||
27939337|NCT00972478|81612688|FG001|Overall Study|Not protocol specified|1|||
27939338|NCT00972478|81612687|FG000|Overall Study|Ineligible|1|||
27939339|NCT00972478|81612688|FG001|Overall Study|Ineligible|7|||
27939340|NCT00972478|81612687|FG000|Overall Study|Not start protocol treatment|1|||
27939341|NCT00972478|81612688|FG001|Overall Study|Not start protocol treatment|2|||
27939342|NCT04941898|81612690|FG000|Overall Study|Protocol Violation|1|||
27939343|NCT02613507|81612693|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
27645487|NCT04919499|80543603|FG000|Overall Study|Adverse Event|0|||
27645488|NCT04919499|80543604|FG001|Overall Study|Adverse Event|0|||
27645489|NCT04919499|80543605|FG002|Overall Study|Adverse Event|0|||
27645490|NCT04919499|80543606|FG003|Overall Study|Adverse Event|0|||
27645491|NCT04919499|80543607|FG004|Overall Study|Adverse Event|2|||
27645492|NCT04919499|80543603|FG000|Overall Study|Not treated|0|||
27645493|NCT04919499|80543604|FG001|Overall Study|Not treated|0|||
27939344|NCT02613507|81612694|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
27939345|NCT02613507|81612693|FG000|Pre-Treamtent|Participant withdrew consent|0|||
27939346|NCT02613507|81612694|FG001|Pre-Treamtent|Participant withdrew consent|4|||
27939347|NCT02613507|81612693|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
27939348|NCT02613507|81612694|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
27939349|NCT02613507|81612693|FG000|Treatment|Not reported|3|||
27939350|NCT02613507|81612694|FG001|Treatment|Not reported|0|||
27939351|NCT02613507|81612693|FG000|Treatment|Other reasons|8|||
27939352|NCT02613507|81612694|FG001|Treatment|Other reasons|0|||
27939353|NCT02613507|81612693|FG000|Treatment|Participant no longer meets criteria|3|||
27939354|NCT02613507|81612694|FG001|Treatment|Participant no longer meets criteria|0|||
27939355|NCT02613507|81612693|FG000|Treatment|Maximum clinical benefit|5|||
27939356|NCT02613507|81612694|FG001|Treatment|Maximum clinical benefit|10|||
27939357|NCT02613507|81612693|FG000|Treatment|Lost to Follow-up|1|||
27939358|NCT02613507|81612694|FG001|Treatment|Lost to Follow-up|0|||
27939359|NCT02613507|81612693|FG000|Treatment|Participant withdrew consent|0|||
27939360|NCT02613507|81612694|FG001|Treatment|Participant withdrew consent|2|||
27939361|NCT02613507|81612693|FG000|Treatment|Participant request to discontinue study treatment|13|||
27939362|NCT02613507|81612694|FG001|Treatment|Participant request to discontinue study treatment|17|||
27939363|NCT02613507|81612693|FG000|Treatment|Adverse event unrelated to study drug|20|||
27939364|NCT02613507|81612694|FG001|Treatment|Adverse event unrelated to study drug|3|||
27939365|NCT02613507|81612693|FG000|Treatment|Death|2|||
27939366|NCT02613507|81612694|FG001|Treatment|Death|0|||
27939367|NCT02613507|81612693|FG000|Treatment|Study drug toxicity|19|||
27939368|NCT02613507|81612694|FG001|Treatment|Study drug toxicity|14|||
27939369|NCT02613507|81612693|FG000|Treatment|Disease progression|263|||
27939370|NCT02613507|81612694|FG001|Treatment|Disease progression|110|||
27939371|NCT02520154|81612695|FG000|Overall Study|Death|1|||
27939372|NCT02520154|81612695|FG000|Overall Study|Withdrawal by Subject|2|||
27939373|NCT02520154|81612695|FG000|Overall Study|Physician Decision|2|||
27939374|NCT01602666|81612696|FG000|Induction Chemotherapy|Death|2|||
27939375|NCT01602666|81612697|FG001|Induction Chemotherapy|Death|1|||
27939376|NCT01602666|81612696|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
27939377|NCT01602666|81612697|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
27939378|NCT01602666|81612696|FG000|Induction Chemotherapy|Physician Decision|12|||
27939379|NCT01602666|81612697|FG001|Induction Chemotherapy|Physician Decision|5|||
27939380|NCT01602666|81612696|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
27939381|NCT01602666|81612697|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
27939382|NCT01602666|81612696|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
27939383|NCT01602666|81612697|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
27939384|NCT01602666|81612696|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
27939385|NCT01602666|81612697|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
27939386|NCT01602666|81612696|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
27645494|NCT04919499|80543605|FG002|Overall Study|Not treated|0|||
27645495|NCT04919499|80543606|FG003|Overall Study|Not treated|1|||
27645496|NCT04919499|80543607|FG004|Overall Study|Not treated|0|||
27645497|NCT04097535|80543608|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
27645498|NCT04984889|80543611|FG000|Extension Part|Ongoing|5|||
27645499|NCT01170208|80543612|FG000|Overall Study|Withdrawal by Subject|5|||
27939387|NCT01602666|81612697|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
27939388|NCT01602666|81612696|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
27939389|NCT01602666|81612697|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
27939390|NCT01602666|81612696|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
27939391|NCT01602666|81612697|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
27939392|NCT01602666|81612696|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
27939393|NCT01602666|81612697|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
27939394|NCT01602666|81612696|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
27939395|NCT01602666|81612697|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
27939396|NCT04191096|81612698|FG000|Overall Study|Death|102|||
27939397|NCT04191096|81612699|FG001|Overall Study|Death|89|||
27939398|NCT04191096|81612698|FG000|Overall Study|Lost to Follow-up|1|||
27939399|NCT04191096|81612699|FG001|Overall Study|Lost to Follow-up|1|||
27939400|NCT04191096|81612698|FG000|Overall Study|Withdrawal by Subject|5|||
27939401|NCT04191096|81612699|FG001|Overall Study|Withdrawal by Subject|5|||
27939402|NCT04191096|81612698|FG000|Overall Study|Participants Ongoing|518|||
27939403|NCT04191096|81612699|FG001|Overall Study|Participants Ongoing|530|||
27939404|NCT00658814|81612700|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
27939405|NCT00658814|81612701|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
27939406|NCT00658814|81612700|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
27939407|NCT00658814|81612701|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
27939408|NCT00658814|81612700|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
27939409|NCT00658814|81612701|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
27939410|NCT00658814|81612700|FG000|Remission Induction Chemotherapy|Death|1|||
27939411|NCT00658814|81612701|FG001|Remission Induction Chemotherapy|Death|4|||
27939412|NCT00658814|81612700|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
27939413|NCT00658814|81612701|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
27939414|NCT00658814|81612700|FG000|Remission Induction Chemotherapy|Not eligible|1|||
27939415|NCT00658814|81612701|FG001|Remission Induction Chemotherapy|Not eligible|2|||
27939416|NCT00658814|81612700|FG000|Consolidation Therapy|Not protocol specified|0|||
27939417|NCT00658814|81612701|FG001|Consolidation Therapy|Not protocol specified|1|||
27939418|NCT00658814|81612700|FG000|Consolidation Therapy|Not eligible|2|||
27939419|NCT00658814|81612701|FG001|Consolidation Therapy|Not eligible|2|||
27939420|NCT00658814|81612700|FG000|Maintenance Therapy|Adverse Event|1|||
27939421|NCT00658814|81612701|FG001|Maintenance Therapy|Adverse Event|1|||
27939422|NCT00658814|81612700|FG000|Maintenance Therapy|Not protocol specified|1|||
27939423|NCT00658814|81612701|FG001|Maintenance Therapy|Not protocol specified|0|||
27939424|NCT00658814|81612700|FG000|Maintenance Therapy|Not eligible|1|||
27939425|NCT00658814|81612701|FG001|Maintenance Therapy|Not eligible|0|||
27939426|NCT00792948|81612704|FG000|Overall Study|Adverse Event|6|||
27939427|NCT00792948|81612704|FG000|Overall Study|Death|4|||
27939428|NCT00792948|81612704|FG000|Overall Study|Withdrawal by Subject|3|||
27939429|NCT00792948|81612704|FG000|Overall Study|Ineligible|2|||
27939430|NCT00792948|81612704|FG000|Overall Study|Insurance denial - not treated|1|||
27939431|NCT00792948|81612704|FG000|Overall Study|Physician Decision|11|||
27939432|NCT00792948|81612704|FG000|Overall Study|Protocol Violation|1|||
27939433|NCT02367040|81612705|FG000|Overall Study|Lost to Follow-up|1|||
27939434|NCT02367040|81612706|FG001|Overall Study|Lost to Follow-up|1|||
27939435|NCT02367040|81612705|FG000|Overall Study|Lack of Efficacy|1|||
27939436|NCT02367040|81612706|FG001|Overall Study|Lack of Efficacy|0|||
27939437|NCT02367040|81612705|FG000|Overall Study|Additional primary malignancy|0|||
27939438|NCT02367040|81612706|FG001|Overall Study|Additional primary malignancy|1|||
27939439|NCT02367040|81612705|FG000|Overall Study|AE not associated with clinical disease progression|114|||
27939440|NCT02367040|81612706|FG001|Overall Study|AE not associated with clinical disease progression|11|||
27939441|NCT02367040|81612705|FG000|Overall Study|AE associated with clinical disease progression|1|||
27939442|NCT02367040|81612706|FG001|Overall Study|AE associated with clinical disease progression|3|||
27939443|NCT02367040|81612705|FG000|Overall Study|Physician Decision|2|||
27939444|NCT02367040|81612706|FG001|Overall Study|Physician Decision|8|||
27939445|NCT02367040|81612705|FG000|Overall Study|Non-compliance with study drug|1|||
27939446|NCT02367040|81612706|FG001|Overall Study|Non-compliance with study drug|0|||
27939447|NCT02367040|81612705|FG000|Overall Study|Failure to meet continuation criteria|1|||
27939448|NCT02367040|81612706|FG001|Overall Study|Failure to meet continuation criteria|0|||
27939449|NCT02367040|81612705|FG000|Overall Study|Switching to other therapy|2|||
27939450|NCT02367040|81612706|FG001|Overall Study|Switching to other therapy|0|||
27939451|NCT02367040|81612705|FG000|Overall Study|Withdrawal by Subject|46|||
27939452|NCT02367040|81612706|FG001|Overall Study|Withdrawal by Subject|16|||
27939453|NCT02367040|81612705|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
27939454|NCT02367040|81612706|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
27939455|NCT02367040|81612705|FG000|Overall Study|Patient decision|39|||
27939456|NCT02367040|81612706|FG001|Overall Study|Patient decision|14|||
27939457|NCT02367040|81612705|FG000|Overall Study|Required procedure failed|1|||
27939458|NCT02367040|81612706|FG001|Overall Study|Required procedure failed|0|||
27939459|NCT02367040|81612705|FG000|Overall Study|Randomized by mistake with study treatment|1|||
27939460|NCT02367040|81612706|FG001|Overall Study|Randomized by mistake with study treatment|0|||
27939461|NCT02367040|81612705|FG000|Overall Study|Protocol Violation|1|||
27939462|NCT02367040|81612706|FG001|Overall Study|Protocol Violation|0|||
27939463|NCT02367040|81612705|FG000|Overall Study|Progressive disease - radiological progression|51|||
27939464|NCT02367040|81612706|FG001|Overall Study|Progressive disease - radiological progression|78|||
27939465|NCT02367040|81612705|FG000|Overall Study|Progressive disease - clinical progression|6|||
27939466|NCT02367040|81612706|FG001|Overall Study|Progressive disease - clinical progression|6|||
27939467|NCT02367040|81612705|FG000|Overall Study|Drug not administered|3|||
27939468|NCT02367040|81612706|FG001|Overall Study|Drug not administered|2|||
27939469|NCT02367040|81612705|FG000|Overall Study|Progressive disease|0|||
27939470|NCT02367040|81612706|FG001|Overall Study|Progressive disease|1|||
27939471|NCT02367040|81612705|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
27939472|NCT02367040|81612706|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
27939473|NCT02367040|81612705|FG000|Overall Study|Death|2|||
27939474|NCT02367040|81612706|FG001|Overall Study|Death|0|||
27939475|NCT02656173|81612709|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
27939476|NCT02656173|81612710|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
27939477|NCT02656173|81612709|FG000|Overall Study|Adverse Event|7|||
27939478|NCT02656173|81612710|FG001|Overall Study|Adverse Event|5|||
27939479|NCT02656173|81612709|FG000|Overall Study|Withdrawal by Subject|1|||
27939480|NCT02656173|81612710|FG001|Overall Study|Withdrawal by Subject|3|||
27939481|NCT02656173|81612709|FG000|Overall Study|Protocol Violation|0|||
27939482|NCT02656173|81612710|FG001|Overall Study|Protocol Violation|1|||
27939483|NCT02656173|81612709|FG000|Overall Study|Miscellaneous|2|||
27645500|NCT01170208|80543613|FG001|Overall Study|Withdrawal by Subject|0|||
27939484|NCT02656173|81612710|FG001|Overall Study|Miscellaneous|0|||
27939485|NCT04398706|81612711|FG000|Overall Study|Adverse Event|0|||
27939486|NCT04398706|81612712|FG001|Overall Study|Adverse Event|0|||
27939487|NCT04398706|81612713|FG002|Overall Study|Adverse Event|0|||
27939488|NCT04398706|81612714|FG003|Overall Study|Adverse Event|0|||
27939489|NCT04398706|81612715|FG004|Overall Study|Adverse Event|0|||
27939490|NCT04398706|81612716|FG005|Overall Study|Adverse Event|1|||
27939491|NCT04398706|81612717|FG006|Overall Study|Adverse Event|1|||
27939492|NCT04398706|81612718|FG007|Overall Study|Adverse Event|0|||
27939493|NCT04398706|81612711|FG000|Overall Study|Lost to Follow-up|0|||
27939494|NCT04398706|81612712|FG001|Overall Study|Lost to Follow-up|1|||
27939495|NCT04398706|81612713|FG002|Overall Study|Lost to Follow-up|2|||
27939496|NCT04398706|81612714|FG003|Overall Study|Lost to Follow-up|1|||
27939497|NCT04398706|81612715|FG004|Overall Study|Lost to Follow-up|6|||
27939498|NCT04398706|81612716|FG005|Overall Study|Lost to Follow-up|3|||
27939499|NCT04398706|81612717|FG006|Overall Study|Lost to Follow-up|8|||
27939500|NCT04398706|81612718|FG007|Overall Study|Lost to Follow-up|2|||
27939501|NCT04398706|81612711|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27939502|NCT04398706|81612712|FG001|Overall Study|Withdrawal by parent/guardian|2|||
27939503|NCT04398706|81612713|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27939504|NCT04398706|81612714|FG003|Overall Study|Withdrawal by parent/guardian|2|||
27939505|NCT04398706|81612715|FG004|Overall Study|Withdrawal by parent/guardian|19|||
27939506|NCT04398706|81612716|FG005|Overall Study|Withdrawal by parent/guardian|23|||
27939507|NCT04398706|81612717|FG006|Overall Study|Withdrawal by parent/guardian|13|||
27939508|NCT04398706|81612718|FG007|Overall Study|Withdrawal by parent/guardian|11|||
27939509|NCT04398706|81612711|FG000|Overall Study|Protocol deviation|0|||
27939510|NCT04398706|81612712|FG001|Overall Study|Protocol deviation|1|||
27939511|NCT04398706|81612713|FG002|Overall Study|Protocol deviation|0|||
27939512|NCT04398706|81612714|FG003|Overall Study|Protocol deviation|0|||
27939513|NCT04398706|81612715|FG004|Overall Study|Protocol deviation|6|||
27939514|NCT04398706|81612716|FG005|Overall Study|Protocol deviation|4|||
27939515|NCT04398706|81612717|FG006|Overall Study|Protocol deviation|6|||
27939516|NCT04398706|81612718|FG007|Overall Study|Protocol deviation|3|||
27939517|NCT02112916|81612719|FG000|Overall Study|Adverse Event|6|||
27939518|NCT02112916|81612720|FG001|Overall Study|Adverse Event|9|||
27939519|NCT02112916|81612721|FG002|Overall Study|Adverse Event|3|||
27939520|NCT02112916|81612722|FG003|Overall Study|Adverse Event|2|||
27939521|NCT02112916|81612719|FG000|Overall Study|Death|9|||
27939522|NCT02112916|81612720|FG001|Overall Study|Death|9|||
27939523|NCT02112916|81612721|FG002|Overall Study|Death|3|||
27939524|NCT02112916|81612722|FG003|Overall Study|Death|4|||
27645501|NCT01170208|80543614|FG002|Overall Study|Withdrawal by Subject|1|||
27939525|NCT02112916|81612719|FG000|Overall Study|Lost to Follow-up|1|||
27939526|NCT02112916|81612720|FG001|Overall Study|Lost to Follow-up|0|||
27939527|NCT02112916|81612721|FG002|Overall Study|Lost to Follow-up|0|||
27645502|NCT01170208|80543612|FG000|Overall Study|Protocol Violation|1|||
27939528|NCT02112916|81612722|FG003|Overall Study|Lost to Follow-up|0|||
27939529|NCT02112916|81612719|FG000|Overall Study|Physician Decision|94|||
27939530|NCT02112916|81612720|FG001|Overall Study|Physician Decision|72|||
27939531|NCT02112916|81612721|FG002|Overall Study|Physician Decision|24|||
27939532|NCT02112916|81612722|FG003|Overall Study|Physician Decision|15|||
27645503|NCT01170208|80543613|FG001|Overall Study|Protocol Violation|0|||
27939533|NCT02112916|81612719|FG000|Overall Study|Withdrawal by Subject|5|||
27939534|NCT02112916|81612720|FG001|Overall Study|Withdrawal by Subject|3|||
27939535|NCT02112916|81612721|FG002|Overall Study|Withdrawal by Subject|1|||
27939536|NCT02112916|81612722|FG003|Overall Study|Withdrawal by Subject|1|||
27939537|NCT02112916|81612719|FG000|Overall Study|Ineligible|4|||
27939538|NCT02112916|81612720|FG001|Overall Study|Ineligible|8|||
27939539|NCT02112916|81612721|FG002|Overall Study|Ineligible|3|||
27939540|NCT02112916|81612722|FG003|Overall Study|Ineligible|8|||
27939541|NCT02112916|81612719|FG000|Overall Study|Inevaluable|6|||
27939542|NCT02112916|81612720|FG001|Overall Study|Inevaluable|4|||
27939543|NCT02112916|81612721|FG002|Overall Study|Inevaluable|5|||
27939544|NCT02112916|81612722|FG003|Overall Study|Inevaluable|5|||
27939545|NCT02112916|81612719|FG000|Overall Study|Refusal of further protocol therapy|19|||
27939546|NCT02112916|81612720|FG001|Overall Study|Refusal of further protocol therapy|16|||
27939547|NCT02112916|81612721|FG002|Overall Study|Refusal of further protocol therapy|1|||
27939548|NCT02112916|81612722|FG003|Overall Study|Refusal of further protocol therapy|7|||
27939549|NCT02112916|81612719|FG000|Overall Study|Development of SMN|1|||
27939550|NCT02112916|81612720|FG001|Overall Study|Development of SMN|0|||
27939551|NCT02112916|81612721|FG002|Overall Study|Development of SMN|0|||
27939552|NCT02112916|81612722|FG003|Overall Study|Development of SMN|1|||
27939553|NCT02112916|81612719|FG000|Overall Study|Relapse/Progression|10|||
27939554|NCT02112916|81612720|FG001|Overall Study|Relapse/Progression|18|||
27939555|NCT02112916|81612721|FG002|Overall Study|Relapse/Progression|15|||
27939556|NCT02112916|81612722|FG003|Overall Study|Relapse/Progression|2|||
27939557|NCT02112916|81612719|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
27939558|NCT02112916|81612720|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
27939559|NCT02112916|81612721|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
27939560|NCT02112916|81612722|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
27939561|NCT02112916|81612719|FG000|Overall Study|Still on Therapy|44|||
27939562|NCT02112916|81612720|FG001|Overall Study|Still on Therapy|47|||
27939563|NCT02112916|81612721|FG002|Overall Study|Still on Therapy|3|||
27939564|NCT02112916|81612722|FG003|Overall Study|Still on Therapy|2|||
27939565|NCT02112916|81612719|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
27939566|NCT02112916|81612720|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
27939567|NCT02112916|81612721|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
27939568|NCT02112916|81612722|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
27939569|NCT02112916|81612719|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
27939570|NCT02112916|81612720|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
27939571|NCT02112916|81612721|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
27939572|NCT02112916|81612722|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
27939573|NCT01902173|81612724|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
27939574|NCT01902173|81612725|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
27939575|NCT01902173|81612726|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
27939576|NCT01902173|81612727|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
27939577|NCT01902173|81612728|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
27939578|NCT01902173|81612729|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
27939579|NCT01902173|81612724|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
27939580|NCT01902173|81612725|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
27939581|NCT01902173|81612726|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
27939582|NCT01902173|81612727|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
27939583|NCT01902173|81612728|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
27939584|NCT01902173|81612729|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
27939585|NCT01902173|81612724|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
27939586|NCT01902173|81612725|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
27939587|NCT01902173|81612726|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
27939588|NCT01902173|81612727|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
27939589|NCT01902173|81612728|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
27939590|NCT01902173|81612729|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
27939591|NCT01902173|81612724|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
27939592|NCT01902173|81612725|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
27939593|NCT01902173|81612726|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
27939594|NCT01902173|81612727|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
27939595|NCT01902173|81612728|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
27939596|NCT01902173|81612729|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
27939597|NCT01902173|81612724|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
27939598|NCT01902173|81612725|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
27939599|NCT01902173|81612726|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
27939600|NCT01902173|81612727|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
27939601|NCT01902173|81612728|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
27939602|NCT01902173|81612729|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
27939603|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
27939604|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
27939605|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
27939606|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
27939607|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
27939608|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
27939609|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
27939610|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
27939611|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
27939612|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
27939613|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
27939614|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
27939615|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
27939616|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
27939617|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
27939618|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
27939619|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
27939620|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
27939621|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
27939622|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
27939623|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
27939624|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
27939625|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
27939626|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
27939627|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
27939628|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
27939629|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
27939630|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
27939631|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
27939632|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
27939633|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
27939634|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
27939635|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
27939636|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
27939637|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
27939638|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
27939639|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
27939640|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
27939641|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
27939642|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
27939643|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
27939644|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
27939645|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
27939646|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
27939647|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
27939648|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
27939649|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
27939650|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
27939651|NCT01902173|81612724|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
27939652|NCT01902173|81612725|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
27939653|NCT01902173|81612726|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
27939654|NCT01902173|81612727|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
27939655|NCT01902173|81612728|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
27939656|NCT01902173|81612729|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
27939657|NCT04191616|81612730|FG000|Overall Study|Death|26|||
27939658|NCT04191616|81612730|FG000|Overall Study|Withdrawal by Subject|1|||
27939659|NCT04191616|81612730|FG000|Overall Study|Sponsor decision|2|||
27939660|NCT04191616|81612730|FG000|Overall Study|Continuing study|25|||
27939661|NCT02181413|81612731|FG000|Overall Study|Withdrawal by Subject|45|||
27939662|NCT02181413|81612732|FG001|Overall Study|Withdrawal by Subject|61|||
27939663|NCT02181413|81612731|FG000|Overall Study|Reason Not Specified|2|||
27939664|NCT02181413|81612732|FG001|Overall Study|Reason Not Specified|5|||
27939665|NCT02181413|81612731|FG000|Overall Study|Lost to Follow-up|8|||
27939666|NCT02181413|81612732|FG001|Overall Study|Lost to Follow-up|7|||
27939667|NCT04523207|81612733|FG000|Overall Study|Adverse Event|5|||
27939668|NCT04523207|81612734|FG001|Overall Study|Adverse Event|1|||
27939669|NCT04523207|81612733|FG000|Overall Study|Lost to Follow-up|2|||
27939670|NCT04523207|81612734|FG001|Overall Study|Lost to Follow-up|0|||
27939671|NCT04523207|81612733|FG000|Overall Study|Withdrawal by Subject|2|||
27939672|NCT04523207|81612734|FG001|Overall Study|Withdrawal by Subject|0|||
27939673|NCT04523207|81612733|FG000|Overall Study|Progressive Disease|2|||
27939674|NCT04523207|81612734|FG001|Overall Study|Progressive Disease|1|||
27939675|NCT04523207|81612733|FG000|Overall Study|Other|7|||
27939676|NCT04523207|81612734|FG001|Overall Study|Other|1|||
27551299|NCT01085591|80207451|FG002|Overall Study|Adverse Event|3|||
27551300|NCT01085591|80207449|FG000|Overall Study|Physician Decision|1|||
27551301|NCT01085591|80207450|FG001|Overall Study|Physician Decision|0|||
27551302|NCT01085591|80207451|FG002|Overall Study|Physician Decision|1|||
27551303|NCT01085591|80207449|FG000|Overall Study|Withdrawal by Subject|0|||
27551304|NCT01085591|80207450|FG001|Overall Study|Withdrawal by Subject|2|||
27551305|NCT01085591|80207451|FG002|Overall Study|Withdrawal by Subject|1|||
27551306|NCT01085591|80207449|FG000|Overall Study|Lost to Follow-up|0|||
27551307|NCT01085591|80207450|FG001|Overall Study|Lost to Follow-up|1|||
27551308|NCT01085591|80207451|FG002|Overall Study|Lost to Follow-up|1|||
27551309|NCT01085591|80207449|FG000|Overall Study|Protocol Violation|1|||
27551310|NCT01085591|80207450|FG001|Overall Study|Protocol Violation|1|||
27551311|NCT01085591|80207451|FG002|Overall Study|Protocol Violation|1|||
27551312|NCT01085591|80207449|FG000|Overall Study|Other|0|||
27551313|NCT01085591|80207450|FG001|Overall Study|Other|1|||
27551314|NCT01085591|80207451|FG002|Overall Study|Other|0|||
27551315|NCT01085591|80207449|FG000|Overall Study|Not Properly Consented|1|||
27551316|NCT01085591|80207450|FG001|Overall Study|Not Properly Consented|0|||
27551317|NCT01085591|80207451|FG002|Overall Study|Not Properly Consented|0|||
27551318|NCT00684593|80207452|FG000|Overall Study|Adverse Event|0|||
27551319|NCT00684593|80207453|FG001|Overall Study|Adverse Event|2|||
27551320|NCT01543698|80207458|FG000|Phase 1b|Disease progression|2|||
27551321|NCT01543698|80207459|FG001|Phase 1b|Disease progression|4|||
27551322|NCT01543698|80207460|FG002|Phase 1b|Disease progression|3|||
27551323|NCT01543698|80207461|FG003|Phase 1b|Disease progression|2|||
27551324|NCT01543698|80207462|FG004|Phase 1b|Disease progression|10|||
27551325|NCT01543698|80207463|FG005|Phase 1b|Disease progression|6|||
27551326|NCT01543698|80207464|FG006|Phase 1b|Disease progression|5|||
27551327|NCT01543698|80207465|FG007|Phase 1b|Disease progression|3|||
27551328|NCT01543698|80207466|FG008|Phase 1b|Disease progression|4|||
27551329|NCT01543698|80207467|FG009|Phase 1b|Disease progression|5|||
27551330|NCT01543698|80207468|FG010|Phase 1b|Disease progression|1|||
27551331|NCT01543698|80207469|FG011|Phase 1b|Disease progression|0|||
27551332|NCT01543698|80207470|FG012|Phase 1b|Disease progression|0|||
27551333|NCT01543698|80207471|FG013|Phase 1b|Disease progression|0|||
27551334|NCT01543698|80207472|FG014|Phase 1b|Disease progression|0|||
27551335|NCT01543698|80207458|FG000|Phase 1b|Death|0|||
27551336|NCT01543698|80207459|FG001|Phase 1b|Death|0|||
27551337|NCT01543698|80207460|FG002|Phase 1b|Death|1|||
27551338|NCT01543698|80207461|FG003|Phase 1b|Death|1|||
27551339|NCT01543698|80207462|FG004|Phase 1b|Death|0|||
27551340|NCT01543698|80207463|FG005|Phase 1b|Death|0|||
27551341|NCT01543698|80207464|FG006|Phase 1b|Death|0|||
27645504|NCT01170208|80543614|FG002|Overall Study|Protocol Violation|1|||
27645505|NCT03355573|80543615|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
27645506|NCT03355573|80543615|FG000|Overall Study|Sponsor's decision|1|||
27645507|NCT03355573|80543615|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
27645508|NCT03355573|80543615|FG000|Overall Study|PI's decision|2|||
27645509|NCT03355573|80543615|FG000|Overall Study|Withdrawal by Subject|23|||
27645510|NCT03355573|80543615|FG000|Overall Study|Lost to Follow-up|4|||
27645511|NCT03355573|80543615|FG000|Overall Study|Lack of Efficacy|2|||
27645512|NCT03355573|80543615|FG000|Overall Study|Adverse Event, non-fatal|17|||
27645513|NCT03355573|80543615|FG000|Overall Study|Adverse Event, serious fatal|2|||
27939677|NCT03745313|81612735|FG000|At 30 Days Follow-up|Death|2|||
27939678|NCT03745313|81612735|FG000|At 6 Months Follow-up|Death|1|||
27645516|NCT03459846|80543625|FG000|Overall Study|Death|52|||
27645517|NCT03459846|80543626|FG001|Overall Study|Death|46|||
27645518|NCT03459846|80543625|FG000|Overall Study|Study terminated by sponsor|24|||
27645519|NCT03459846|80543626|FG001|Overall Study|Study terminated by sponsor|28|||
27645520|NCT03459846|80543625|FG000|Overall Study|Withdrawal by Subject|2|||
27645521|NCT03459846|80543626|FG001|Overall Study|Withdrawal by Subject|2|||
27645522|NCT04433091|80543627|FG000|Overall Study|Lost to Follow-up|1|||
27645523|NCT04433091|80543628|FG001|Overall Study|Lost to Follow-up|0|||
27645524|NCT04433091|80543627|FG000|Overall Study|Withdrawn .|2|||
27645525|NCT04433091|80543628|FG001|Overall Study|Withdrawn .|4|||
27645526|NCT04448561|80543629|FG000|Overall Study|Noncompliance|1|||
27645527|NCT04448561|80543630|FG001|Overall Study|Noncompliance|0|||
27746289|NCT02416908|80899600|FG000|Dose Escalation Phase|Adverse Event|0|||
27551342|NCT01543698|80207465|FG007|Phase 1b|Death|0|||
27551343|NCT01543698|80207466|FG008|Phase 1b|Death|0|||
27551344|NCT01543698|80207467|FG009|Phase 1b|Death|0|||
27939679|NCT03745313|81612735|FG000|At 6 Months Follow-up|Missed Visit|1|||
27939680|NCT03745313|81612735|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
27939681|NCT03745313|81612735|FG000|At 1 Year Follow-up|Death|2|||
27939682|NCT03745313|81612735|FG000|At 1 Year Follow-up|Missed Visit|2|||
27939683|NCT03745313|81612735|FG000|At 2 Year Follow-up|Missed Visit|1|||
27755004|NCT04937816|80929652|FG003|Overall Study|Adverse Event|553|||
27939684|NCT04744831|81612736|FG000|Overall Study|Progressive Disease|31|||
27551345|NCT01543698|80207468|FG010|Phase 1b|Death|1|||
27551346|NCT01543698|80207469|FG011|Phase 1b|Death|0|||
27551347|NCT01543698|80207470|FG012|Phase 1b|Death|0|||
27939685|NCT04744831|81612737|FG001|Overall Study|Progressive Disease|27|||
27939686|NCT04744831|81612738|FG002|Overall Study|Progressive Disease|25|||
27939687|NCT04744831|81612736|FG000|Overall Study|Adverse Event|3|||
27939688|NCT04744831|81612737|FG001|Overall Study|Adverse Event|3|||
27939689|NCT04744831|81612738|FG002|Overall Study|Adverse Event|3|||
27939690|NCT04744831|81612736|FG000|Overall Study|Clinical Progression|3|||
27939691|NCT04744831|81612737|FG001|Overall Study|Clinical Progression|2|||
27939692|NCT04744831|81612738|FG002|Overall Study|Clinical Progression|5|||
27939693|NCT04744831|81612736|FG000|Overall Study|Other|0|||
27939694|NCT04744831|81612737|FG001|Overall Study|Other|2|||
27939695|NCT04744831|81612738|FG002|Overall Study|Other|1|||
27939696|NCT04744831|81612736|FG000|Overall Study|Death|0|||
27939697|NCT04744831|81612737|FG001|Overall Study|Death|2|||
27939698|NCT04744831|81612738|FG002|Overall Study|Death|1|||
27939699|NCT05652140|81612740|FG000|Overall Study|Lost to Follow-up|7|||
27939700|NCT05652140|81612741|FG001|Overall Study|Lost to Follow-up|16|||
27939701|NCT05652140|81612742|FG002|Overall Study|Lost to Follow-up|22|||
27939702|NCT05652140|81612743|FG003|Overall Study|Lost to Follow-up|31|||
27939703|NCT01385995|81612744|FG000|Period 1, 2 Months|Physician Decision|1|||
27939704|NCT01385995|81612745|FG001|Period 1, 2 Months|Physician Decision|0|||
27939705|NCT04380753|81612746|FG000|Overall Study|Participants continuing study|4|||
27939706|NCT04380753|81612746|FG000|Overall Study|Death|2|||
27939707|NCT02899754|81612747|FG000|Overall Study|Lost to Follow-up|7|||
27939708|NCT02899754|81612748|FG001|Overall Study|Lost to Follow-up|9|||
27939709|NCT03973489|81612749|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
27939710|NCT03973489|81612750|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
27939711|NCT03973489|81612751|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
27939712|NCT03973489|81612752|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
27939713|NCT03973489|81612753|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
27939714|NCT03973489|81612754|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
27939715|NCT03973489|81612755|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
27939716|NCT03973489|81612756|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
27939717|NCT03973489|81612749|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
27939718|NCT03973489|81612750|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
27939719|NCT03973489|81612751|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
27939720|NCT03973489|81612752|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
27939721|NCT03973489|81612753|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
27939722|NCT03973489|81612754|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
27939723|NCT03973489|81612755|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
27939724|NCT03973489|81612756|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
27939725|NCT03973489|81612749|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
27939726|NCT03973489|81612750|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
27939727|NCT03973489|81612751|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
27939728|NCT03973489|81612752|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
27939729|NCT03973489|81612753|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
27939730|NCT03973489|81612754|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
27939731|NCT03973489|81612755|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
27939732|NCT03973489|81612756|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
27939733|NCT03973489|81612749|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
27939734|NCT03973489|81612750|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
27939735|NCT03973489|81612751|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
27939736|NCT03973489|81612752|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
27939737|NCT03973489|81612753|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
27939738|NCT03973489|81612754|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
27939739|NCT03973489|81612755|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
27939740|NCT03973489|81612756|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
27939741|NCT03973489|81612749|FG000|Second Intervention (1 Day)|Adverse Event|0|||
27939742|NCT03973489|81612750|FG001|Second Intervention (1 Day)|Adverse Event|0|||
27939743|NCT03973489|81612751|FG002|Second Intervention (1 Day)|Adverse Event|0|||
27939744|NCT03973489|81612752|FG003|Second Intervention (1 Day)|Adverse Event|1|||
27939745|NCT03973489|81612753|FG004|Second Intervention (1 Day)|Adverse Event|0|||
27939746|NCT03973489|81612754|FG005|Second Intervention (1 Day)|Adverse Event|0|||
27939747|NCT03973489|81612755|FG006|Second Intervention (1 Day)|Adverse Event|0|||
27939748|NCT03973489|81612756|FG007|Second Intervention (1 Day)|Adverse Event|0|||
27939749|NCT02142803|81612757|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
27939750|NCT02142803|81612758|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
27939751|NCT02142803|81612759|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
27939752|NCT02142803|81612760|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
27939753|NCT04248829|81612761|FG000|Overall Study|Disease progression|44|||
27939754|NCT04248829|81612762|FG001|Overall Study|Disease progression|109|||
27939755|NCT04248829|81612761|FG000|Overall Study|Adverse Event|19|||
27939756|NCT04248829|81612762|FG001|Overall Study|Adverse Event|18|||
27939757|NCT04248829|81612761|FG000|Overall Study|Withdrawal by Subject|11|||
27939758|NCT04248829|81612762|FG001|Overall Study|Withdrawal by Subject|2|||
27939759|NCT04248829|81612761|FG000|Overall Study|Lost to Follow-up|0|||
27939760|NCT04248829|81612762|FG001|Overall Study|Lost to Follow-up|1|||
27939761|NCT04248829|81612761|FG000|Overall Study|Death|12|||
27939762|NCT04248829|81612762|FG001|Overall Study|Death|14|||
27939763|NCT04248829|81612761|FG000|Overall Study|Physician Decision|2|||
27939764|NCT04248829|81612762|FG001|Overall Study|Physician Decision|4|||
27939765|NCT04248829|81612761|FG000|Overall Study|Any reason not specifically recorded|0|||
27939766|NCT04248829|81612762|FG001|Overall Study|Any reason not specifically recorded|2|||
27939767|NCT03997383|81612765|FG000|Double-blind Treatment Period|Adverse Event|4|||
27939768|NCT03997383|81612766|FG001|Double-blind Treatment Period|Adverse Event|3|||
27939769|NCT03997383|81612765|FG000|Double-blind Treatment Period|Death|4|||
27939770|NCT03997383|81612766|FG001|Double-blind Treatment Period|Death|4|||
27939771|NCT03997383|81612765|FG000|Double-blind Treatment Period|Physician Decision|2|||
27939772|NCT03997383|81612766|FG001|Double-blind Treatment Period|Physician Decision|0|||
27939773|NCT03997383|81612765|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
27939774|NCT03997383|81612766|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
27939775|NCT03997383|81612765|FG000|Open-label Extension Period|Ongoing|148|||
27939776|NCT03997383|81612766|FG001|Open-label Extension Period|Ongoing|151|||
27939777|NCT03997383|81612765|FG000|Open-label Extension Period|Adverse Event|4|||
27939778|NCT03997383|81612766|FG001|Open-label Extension Period|Adverse Event|1|||
27939779|NCT03997383|81612765|FG000|Open-label Extension Period|Death|8|||
27939780|NCT03997383|81612766|FG001|Open-label Extension Period|Death|9|||
27939781|NCT03997383|81612765|FG000|Open-label Extension Period|Physician Decision|1|||
27939782|NCT03997383|81612766|FG001|Open-label Extension Period|Physician Decision|1|||
27939783|NCT03997383|81612765|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
27939784|NCT03997383|81612766|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
27939785|NCT03997383|81612765|FG000|Open-label Extension Period|Reason Not Specified|2|||
27939786|NCT03997383|81612766|FG001|Open-label Extension Period|Reason Not Specified|0|||
27939787|NCT05569954|81612783|FG000|Overall Study|Lost to Follow-up|3|||
27939788|NCT05569954|81612784|FG001|Overall Study|Lost to Follow-up|4|||
27939789|NCT05569954|81612783|FG000|Overall Study|Protocol Violation|1|||
27939790|NCT05569954|81612784|FG001|Overall Study|Protocol Violation|2|||
27939791|NCT05569954|81612783|FG000|Overall Study|Withdrawal by Subject|4|||
27939792|NCT05569954|81612784|FG001|Overall Study|Withdrawal by Subject|2|||
27939793|NCT04634331|81612785|FG000|Overall Study|Withdrawal by Subject|2|||
27939794|NCT04634331|81612786|FG001|Overall Study|Withdrawal by Subject|2|||
27939795|NCT00401830|81612787|FG000|Overall Study|Adverse Event|10|||
27939796|NCT00401830|81612788|FG001|Overall Study|Adverse Event|18|||
27939797|NCT00401830|81612787|FG000|Overall Study|Lack of Efficacy|11|||
27939798|NCT00401830|81612788|FG001|Overall Study|Lack of Efficacy|5|||
27939799|NCT00401830|81612787|FG000|Overall Study|Withdrawal by Subject|4|||
27939800|NCT00401830|81612788|FG001|Overall Study|Withdrawal by Subject|3|||
27939801|NCT00401830|81612787|FG000|Overall Study|Protocol Violation|3|||
27939802|NCT00401830|81612788|FG001|Overall Study|Protocol Violation|3|||
27939803|NCT00401830|81612787|FG000|Overall Study|Non-compliance with drug study|1|||
27939804|NCT00401830|81612788|FG001|Overall Study|Non-compliance with drug study|0|||
27939805|NCT00401830|81612787|FG000|Overall Study|Lost to Follow-up|1|||
27939806|NCT00401830|81612788|FG001|Overall Study|Lost to Follow-up|3|||
27939807|NCT00401830|81612787|FG000|Overall Study|Other: Personal / Family problems|1|||
27939808|NCT00401830|81612788|FG001|Overall Study|Other: Personal / Family problems|0|||
27939809|NCT03228537|81612789|FG000|Neoadjuvant|Adverse Event|2|||
27939810|NCT03228537|81612789|FG000|Neoadjuvant|Progression/Relapse|4|||
27939811|NCT03228537|81612789|FG000|Neoadjuvant|Death|1|||
27939812|NCT03228537|81612789|FG000|Surgery|Death|1|||
27939813|NCT03228537|81612789|FG000|Surgery|Other - Not Protocol Specified|2|||
27939814|NCT03228537|81612789|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
27939815|NCT03228537|81612789|FG000|Maintenance|Progression/Relapse|10|||
27939816|NCT03735979|81612792|FG000|Overall Study|Lost to Follow-up|1|||
27939817|NCT03735979|81612793|FG001|Overall Study|Lost to Follow-up|12|||
27939818|NCT03735979|81612794|FG002|Overall Study|Lost to Follow-up|14|||
27939819|NCT03735979|81612792|FG000|Overall Study|Withdrawal by Subject|1|||
27939820|NCT03735979|81612793|FG001|Overall Study|Withdrawal by Subject|5|||
27939821|NCT03735979|81612794|FG002|Overall Study|Withdrawal by Subject|2|||
27755005|NCT04937816|80929653|FG004|Overall Study|Adverse Event|575|||
27939822|NCT03735979|81612792|FG000|Overall Study|Not due to the above reasons|1|||
27939823|NCT03735979|81612793|FG001|Overall Study|Not due to the above reasons|0|||
27939824|NCT03735979|81612794|FG002|Overall Study|Not due to the above reasons|0|||
27939825|NCT03648372|81612795|FG000|Overall Study|Withdrawal by Subject|2|||
27939826|NCT03648372|81612796|FG001|Overall Study|Withdrawal by Subject|0|||
27939827|NCT03648372|81612797|FG002|Overall Study|Withdrawal by Subject|0|||
27939828|NCT03648372|81612798|FG003|Overall Study|Withdrawal by Subject|0|||
27939829|NCT03648372|81612799|FG004|Overall Study|Withdrawal by Subject|0|||
27939830|NCT03648372|81612800|FG005|Overall Study|Withdrawal by Subject|1|||
27939831|NCT03648372|81612801|FG006|Overall Study|Withdrawal by Subject|2|||
27939832|NCT03648372|81612802|FG007|Overall Study|Withdrawal by Subject|0|||
27939833|NCT03648372|81612803|FG008|Overall Study|Withdrawal by Subject|0|||
27939834|NCT03648372|81612804|FG009|Overall Study|Withdrawal by Subject|0|||
27939835|NCT03648372|81612805|FG010|Overall Study|Withdrawal by Subject|2|||
27939836|NCT03648372|81612806|FG011|Overall Study|Withdrawal by Subject|0|||
27939837|NCT03648372|81612807|FG012|Overall Study|Withdrawal by Subject|2|||
27939838|NCT03648372|81612808|FG013|Overall Study|Withdrawal by Subject|0|||
27939839|NCT03648372|81612809|FG014|Overall Study|Withdrawal by Subject|0|||
27939840|NCT03648372|81612810|FG015|Overall Study|Withdrawal by Subject|0|||
27939841|NCT03648372|81612811|FG016|Overall Study|Withdrawal by Subject|1|||
27939842|NCT03648372|81612812|FG017|Overall Study|Withdrawal by Subject|0|||
27939843|NCT03648372|81612813|FG018|Overall Study|Withdrawal by Subject|0|||
27939844|NCT03648372|81612814|FG019|Overall Study|Withdrawal by Subject|0|||
27939845|NCT03648372|81612815|FG020|Overall Study|Withdrawal by Subject|0|||
27939846|NCT03648372|81612795|FG000|Overall Study|Progressive Disease|2|||
27939847|NCT03648372|81612796|FG001|Overall Study|Progressive Disease|3|||
27939848|NCT03648372|81612797|FG002|Overall Study|Progressive Disease|4|||
27939849|NCT03648372|81612798|FG003|Overall Study|Progressive Disease|3|||
27939850|NCT03648372|81612799|FG004|Overall Study|Progressive Disease|2|||
27939851|NCT03648372|81612800|FG005|Overall Study|Progressive Disease|2|||
27939852|NCT03648372|81612801|FG006|Overall Study|Progressive Disease|3|||
27939853|NCT03648372|81612802|FG007|Overall Study|Progressive Disease|3|||
27939854|NCT03648372|81612803|FG008|Overall Study|Progressive Disease|5|||
27939855|NCT03648372|81612804|FG009|Overall Study|Progressive Disease|5|||
27939856|NCT03648372|81612805|FG010|Overall Study|Progressive Disease|2|||
27939857|NCT03648372|81612806|FG011|Overall Study|Progressive Disease|3|||
27939858|NCT03648372|81612807|FG012|Overall Study|Progressive Disease|3|||
27939859|NCT03648372|81612808|FG013|Overall Study|Progressive Disease|3|||
27939860|NCT03648372|81612809|FG014|Overall Study|Progressive Disease|6|||
27939861|NCT03648372|81612810|FG015|Overall Study|Progressive Disease|0|||
27939862|NCT03648372|81612811|FG016|Overall Study|Progressive Disease|0|||
27939863|NCT03648372|81612812|FG017|Overall Study|Progressive Disease|0|||
27939864|NCT03648372|81612813|FG018|Overall Study|Progressive Disease|0|||
27939865|NCT03648372|81612814|FG019|Overall Study|Progressive Disease|0|||
27939866|NCT03648372|81612815|FG020|Overall Study|Progressive Disease|0|||
27939867|NCT03648372|81612795|FG000|Overall Study|Other|0|||
27939868|NCT03648372|81612796|FG001|Overall Study|Other|0|||
27939869|NCT03648372|81612797|FG002|Overall Study|Other|0|||
27939870|NCT03648372|81612798|FG003|Overall Study|Other|0|||
27939871|NCT03648372|81612799|FG004|Overall Study|Other|1|||
27939872|NCT03648372|81612800|FG005|Overall Study|Other|0|||
27939873|NCT03648372|81612801|FG006|Overall Study|Other|0|||
27939874|NCT03648372|81612802|FG007|Overall Study|Other|0|||
27939875|NCT03648372|81612803|FG008|Overall Study|Other|0|||
27939876|NCT03648372|81612804|FG009|Overall Study|Other|0|||
27939877|NCT03648372|81612805|FG010|Overall Study|Other|1|||
27939878|NCT03648372|81612806|FG011|Overall Study|Other|2|||
27939879|NCT03648372|81612807|FG012|Overall Study|Other|1|||
27939880|NCT03648372|81612808|FG013|Overall Study|Other|3|||
27939881|NCT03648372|81612809|FG014|Overall Study|Other|0|||
27939882|NCT03648372|81612810|FG015|Overall Study|Other|5|||
27939883|NCT03648372|81612811|FG016|Overall Study|Other|1|||
27939884|NCT03648372|81612812|FG017|Overall Study|Other|5|||
27939885|NCT03648372|81612813|FG018|Overall Study|Other|0|||
27939886|NCT03648372|81612814|FG019|Overall Study|Other|1|||
27939887|NCT03648372|81612815|FG020|Overall Study|Other|0|||
27939888|NCT03648372|81612795|FG000|Overall Study|Lost to Follow-up|0|||
27939889|NCT03648372|81612796|FG001|Overall Study|Lost to Follow-up|0|||
27939890|NCT03648372|81612797|FG002|Overall Study|Lost to Follow-up|0|||
27939891|NCT03648372|81612798|FG003|Overall Study|Lost to Follow-up|0|||
27939892|NCT03648372|81612799|FG004|Overall Study|Lost to Follow-up|0|||
27939893|NCT03648372|81612800|FG005|Overall Study|Lost to Follow-up|0|||
27939894|NCT03648372|81612801|FG006|Overall Study|Lost to Follow-up|0|||
27939895|NCT03648372|81612802|FG007|Overall Study|Lost to Follow-up|0|||
27939896|NCT03648372|81612803|FG008|Overall Study|Lost to Follow-up|0|||
27939897|NCT03648372|81612804|FG009|Overall Study|Lost to Follow-up|0|||
27939898|NCT03648372|81612805|FG010|Overall Study|Lost to Follow-up|0|||
27939899|NCT03648372|81612806|FG011|Overall Study|Lost to Follow-up|0|||
27939900|NCT03648372|81612807|FG012|Overall Study|Lost to Follow-up|0|||
27939901|NCT03648372|81612808|FG013|Overall Study|Lost to Follow-up|1|||
27939902|NCT03648372|81612809|FG014|Overall Study|Lost to Follow-up|0|||
27939903|NCT03648372|81612810|FG015|Overall Study|Lost to Follow-up|1|||
27939904|NCT03648372|81612811|FG016|Overall Study|Lost to Follow-up|0|||
27939905|NCT03648372|81612812|FG017|Overall Study|Lost to Follow-up|1|||
27939906|NCT03648372|81612813|FG018|Overall Study|Lost to Follow-up|0|||
27939907|NCT03648372|81612814|FG019|Overall Study|Lost to Follow-up|0|||
27939908|NCT03648372|81612815|FG020|Overall Study|Lost to Follow-up|0|||
27939909|NCT03648372|81612795|FG000|Overall Study|Start of a New Systemic Treatment|0|||
27939910|NCT03648372|81612796|FG001|Overall Study|Start of a New Systemic Treatment|0|||
27939911|NCT03648372|81612797|FG002|Overall Study|Start of a New Systemic Treatment|0|||
27939912|NCT03648372|81612798|FG003|Overall Study|Start of a New Systemic Treatment|0|||
27939913|NCT03648372|81612799|FG004|Overall Study|Start of a New Systemic Treatment|0|||
27939914|NCT03648372|81612800|FG005|Overall Study|Start of a New Systemic Treatment|0|||
27939915|NCT03648372|81612801|FG006|Overall Study|Start of a New Systemic Treatment|0|||
27939916|NCT03648372|81612802|FG007|Overall Study|Start of a New Systemic Treatment|2|||
27939917|NCT03648372|81612803|FG008|Overall Study|Start of a New Systemic Treatment|0|||
27939918|NCT03648372|81612804|FG009|Overall Study|Start of a New Systemic Treatment|0|||
27939919|NCT03648372|81612805|FG010|Overall Study|Start of a New Systemic Treatment|1|||
27939920|NCT03648372|81612806|FG011|Overall Study|Start of a New Systemic Treatment|0|||
27939921|NCT03648372|81612807|FG012|Overall Study|Start of a New Systemic Treatment|0|||
27939922|NCT03648372|81612808|FG013|Overall Study|Start of a New Systemic Treatment|0|||
27939923|NCT03648372|81612809|FG014|Overall Study|Start of a New Systemic Treatment|0|||
27939924|NCT03648372|81612810|FG015|Overall Study|Start of a New Systemic Treatment|0|||
27939925|NCT03648372|81612811|FG016|Overall Study|Start of a New Systemic Treatment|0|||
27939926|NCT03648372|81612812|FG017|Overall Study|Start of a New Systemic Treatment|0|||
27939927|NCT03648372|81612813|FG018|Overall Study|Start of a New Systemic Treatment|0|||
27939928|NCT03648372|81612814|FG019|Overall Study|Start of a New Systemic Treatment|0|||
27939929|NCT03648372|81612815|FG020|Overall Study|Start of a New Systemic Treatment|0|||
27939930|NCT02614066|81612816|FG000|Overall Study|Death|6|||
27939931|NCT02614066|81612817|FG001|Overall Study|Death|14|||
27939932|NCT02614066|81612818|FG002|Overall Study|Death|11|||
27939933|NCT02614066|81612819|FG003|Overall Study|Death|29|||
27939934|NCT02614066|81612816|FG000|Overall Study|Full consent withdrawn|0|||
27939935|NCT02614066|81612817|FG001|Overall Study|Full consent withdrawn|1|||
27939936|NCT02614066|81612818|FG002|Overall Study|Full consent withdrawn|0|||
27939937|NCT02614066|81612819|FG003|Overall Study|Full consent withdrawn|8|||
27939938|NCT02614066|81612816|FG000|Overall Study|Lost to Follow-up|0|||
27939939|NCT02614066|81612817|FG001|Overall Study|Lost to Follow-up|2|||
27939940|NCT02614066|81612818|FG002|Overall Study|Lost to Follow-up|2|||
27939941|NCT02614066|81612819|FG003|Overall Study|Lost to Follow-up|2|||
27939942|NCT02614066|81612816|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
27939943|NCT02614066|81612817|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
27939944|NCT02614066|81612818|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
27939945|NCT02614066|81612819|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
27939946|NCT02614066|81612816|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
27939947|NCT02614066|81612817|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
27939948|NCT02614066|81612818|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
27939949|NCT02614066|81612819|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
27939950|NCT02614066|81612816|FG000|Overall Study|Reason not specified|0|||
27939951|NCT02614066|81612817|FG001|Overall Study|Reason not specified|2|||
27939952|NCT02614066|81612818|FG002|Overall Study|Reason not specified|1|||
27645560|NCT02823574|80543639|FG000|Randomization|Disease Progression|0|||
27645561|NCT02823574|80543640|FG001|Randomization|Disease Progression|0|||
27645562|NCT02823574|80543641|FG002|Randomization|Disease Progression|1|||
27645563|NCT02823574|80543642|FG003|Randomization|Disease Progression|0|||
27645564|NCT02823574|80543639|FG000|Randomization|AE unrelated to Study Drug|1|||
27645565|NCT02823574|80543640|FG001|Randomization|AE unrelated to Study Drug|0|||
27645566|NCT02823574|80543641|FG002|Randomization|AE unrelated to Study Drug|0|||
27645567|NCT02823574|80543642|FG003|Randomization|AE unrelated to Study Drug|0|||
27645568|NCT02823574|80543639|FG000|Treatment Period|Poor/Non Compliance|1|||
27645569|NCT02823574|80543640|FG001|Treatment Period|Poor/Non Compliance|0|||
27645570|NCT02823574|80543641|FG002|Treatment Period|Poor/Non Compliance|0|||
27645571|NCT02823574|80543642|FG003|Treatment Period|Poor/Non Compliance|1|||
27645572|NCT02823574|80543639|FG000|Treatment Period|Maximum Clinical Benefit|8|||
27645573|NCT02823574|80543640|FG001|Treatment Period|Maximum Clinical Benefit|4|||
27645574|NCT02823574|80543641|FG002|Treatment Period|Maximum Clinical Benefit|7|||
27645575|NCT02823574|80543642|FG003|Treatment Period|Maximum Clinical Benefit|1|||
27645576|NCT02823574|80543639|FG000|Treatment Period|Lost to Follow-up|1|||
27645577|NCT02823574|80543640|FG001|Treatment Period|Lost to Follow-up|1|||
27645578|NCT02823574|80543641|FG002|Treatment Period|Lost to Follow-up|0|||
27645579|NCT02823574|80543642|FG003|Treatment Period|Lost to Follow-up|0|||
27645580|NCT02823574|80543639|FG000|Treatment Period|Participant withdrew consent|4|||
27645581|NCT02823574|80543640|FG001|Treatment Period|Participant withdrew consent|0|||
27645582|NCT02823574|80543641|FG002|Treatment Period|Participant withdrew consent|0|||
27939953|NCT02614066|81612819|FG003|Overall Study|Reason not specified|1|||
27939954|NCT04209855|81612820|FG000|Overall Study|Adverse Event|20|||
27939955|NCT04209855|81612821|FG001|Overall Study|Adverse Event|28|||
27939956|NCT04209855|81612820|FG000|Overall Study|Death|3|||
27939957|NCT04209855|81612821|FG001|Overall Study|Death|1|||
27939958|NCT04209855|81612820|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
27645583|NCT02823574|80543642|FG003|Treatment Period|Participant withdrew consent|1|||
27645584|NCT02823574|80543639|FG000|Treatment Period|Participant request to discontinue|5|||
27645585|NCT02823574|80543640|FG001|Treatment Period|Participant request to discontinue|0|||
27939959|NCT04209855|81612821|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
27939960|NCT04209855|81612820|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
27939961|NCT04209855|81612821|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
27939962|NCT04209855|81612820|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
27939963|NCT04209855|81612821|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
27939964|NCT04209855|81612820|FG000|Overall Study|Progressive Disease|154|||
27939965|NCT04209855|81612821|FG001|Overall Study|Progressive Disease|145|||
27939966|NCT04209855|81612820|FG000|Overall Study|Protocol Deviation|1|||
27939967|NCT04209855|81612821|FG001|Overall Study|Protocol Deviation|1|||
27939968|NCT04209855|81612820|FG000|Overall Study|Other Than Specified|5|||
27939969|NCT04209855|81612821|FG001|Overall Study|Other Than Specified|10|||
27939970|NCT01740427|81612822|FG000|Overall Study|Objective Progression or Relapse|286|||
27939971|NCT01740427|81612823|FG001|Overall Study|Objective Progression or Relapse|172|||
27939972|NCT01740427|81612822|FG000|Overall Study|Adverse Event|32|||
27939973|NCT01740427|81612823|FG001|Overall Study|Adverse Event|9|||
27939974|NCT01740427|81612822|FG000|Overall Study|Global Deterioration of Health Status|28|||
27939975|NCT01740427|81612823|FG001|Overall Study|Global Deterioration of Health Status|12|||
27939976|NCT01740427|81612822|FG000|Overall Study|Participant Refused Continued Treatment|27|||
27939977|NCT01740427|81612823|FG001|Overall Study|Participant Refused Continued Treatment|15|||
27939978|NCT01740427|81612822|FG000|Overall Study|Unspecified reasons|52|||
27939979|NCT01740427|81612823|FG001|Overall Study|Unspecified reasons|8|||
27939980|NCT01740427|81612822|FG000|Overall Study|Death|10|||
27939981|NCT01740427|81612823|FG001|Overall Study|Death|3|||
27939982|NCT01740427|81612822|FG000|Overall Study|Protocol Violation|5|||
27939983|NCT01740427|81612823|FG001|Overall Study|Protocol Violation|3|||
27939984|NCT01740427|81612822|FG000|Overall Study|Lost to Follow-up|3|||
27939985|NCT01740427|81612823|FG001|Overall Study|Lost to Follow-up|0|||
27939986|NCT01740427|81612822|FG000|Overall Study|Site Terminated by Sponsor|1|||
27939987|NCT01740427|81612823|FG001|Overall Study|Site Terminated by Sponsor|0|||
27939988|NCT04042311|81612824|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
27939989|NCT04042311|81612824|FG000|Overall Study|Unable to tolerate|4|||
27939990|NCT04042311|81612824|FG000|Overall Study|Concurrent illness|2|||
27939991|NCT04042311|81612824|FG000|Overall Study|Adverse Event|2|||
27939992|NCT04042311|81612824|FG000|Overall Study|No longer meeting inclusion criteria|2|||
27939993|NCT04042311|81612824|FG000|Overall Study|No reason given|1|||
27939994|NCT04042311|81612824|FG000|Overall Study|Withdrawal by Subject|4|||
27939995|NCT05261490|81612825|FG000|Overall Study|Other|1|||
27939996|NCT05261490|81612826|FG001|Overall Study|Other|0|||
27939997|NCT05261490|81612827|FG002|Overall Study|Other|0|||
27939998|NCT05261490|81612825|FG000|Overall Study|Study Terminated by Sponsor|1|||
27939999|NCT05261490|81612826|FG001|Overall Study|Study Terminated by Sponsor|1|||
27940000|NCT05261490|81612827|FG002|Overall Study|Study Terminated by Sponsor|4|||
27940001|NCT05261490|81612825|FG000|Overall Study|Death|1|||
27940002|NCT05261490|81612826|FG001|Overall Study|Death|2|||
27940003|NCT05261490|81612827|FG002|Overall Study|Death|0|||
27645586|NCT02823574|80543641|FG002|Treatment Period|Participant request to discontinue|3|||
27645587|NCT02823574|80543642|FG003|Treatment Period|Participant request to discontinue|2|||
27940004|NCT02657551|81612828|FG000|Overall Study|Adverse Event|2|||
27940005|NCT02657551|81612828|FG000|Overall Study|Withdrawal by Subject|1|||
27940006|NCT02657551|81612828|FG000|Overall Study|Non-Compliance|1|||
27940007|NCT02657551|81612828|FG000|Overall Study|Progression / Relapse|4|||
27940008|NCT02757768|81614835|FG000|Overall Study|Randomized Never Received Study Drug|3|||
27940009|NCT02757768|81614836|FG001|Overall Study|Randomized Never Received Study Drug|4|||
27940010|NCT02757768|81614835|FG000|Overall Study|Adverse Event|5|||
27940011|NCT02757768|81614836|FG001|Overall Study|Adverse Event|3|||
27940012|NCT02757768|81614835|FG000|Overall Study|Lack of Efficacy|2|||
27940013|NCT02757768|81614836|FG001|Overall Study|Lack of Efficacy|1|||
27940014|NCT02757768|81614835|FG000|Overall Study|Lost to Follow-up|1|||
27940015|NCT02757768|81614836|FG001|Overall Study|Lost to Follow-up|0|||
27645588|NCT02823574|80543639|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
27645589|NCT02823574|80543640|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
27645590|NCT02823574|80543641|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
27645591|NCT02823574|80543642|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
27940016|NCT02757768|81614835|FG000|Overall Study|Protocol Deviation|2|||
27940017|NCT02757768|81614836|FG001|Overall Study|Protocol Deviation|9|||
27940018|NCT02757768|81614835|FG000|Overall Study|Withdrawal by Subject|16|||
27940019|NCT02757768|81614836|FG001|Overall Study|Withdrawal by Subject|9|||
27940020|NCT02757768|81614835|FG000|Overall Study|Miscellaneous|4|||
27940021|NCT02757768|81614836|FG001|Overall Study|Miscellaneous|2|||
27940022|NCT03976375|81614838|FG000|Overall Study|Death|147|||
27940023|NCT03976375|81614839|FG001|Overall Study|Death|150|||
27940024|NCT03976375|81614840|FG002|Overall Study|Death|38|||
27940025|NCT03976375|81614838|FG000|Overall Study|Lost to Follow-up|1|||
27940026|NCT03976375|81614839|FG001|Overall Study|Lost to Follow-up|1|||
27940027|NCT03976375|81614840|FG002|Overall Study|Lost to Follow-up|1|||
27940028|NCT03976375|81614838|FG000|Overall Study|Withdrawal by Subject|4|||
27940029|NCT03976375|81614839|FG001|Overall Study|Withdrawal by Subject|9|||
27940030|NCT03976375|81614840|FG002|Overall Study|Withdrawal by Subject|4|||
27940031|NCT03976375|81614838|FG000|Overall Study|Ongoing|33|||
27940032|NCT03976375|81614839|FG001|Overall Study|Ongoing|29|||
27940033|NCT03976375|81614840|FG002|Overall Study|Ongoing|5|||
27940034|NCT03249558|81614843|FG000|Overall Study|Lost to Follow-up|2|||
27940035|NCT03249558|81614844|FG001|Overall Study|Lost to Follow-up|1|||
27940036|NCT03249558|81614845|FG002|Overall Study|Lost to Follow-up|4|||
27940037|NCT03249558|81614843|FG000|Overall Study|Physician Decision|1|||
27940038|NCT03249558|81614844|FG001|Overall Study|Physician Decision|0|||
27940039|NCT03249558|81614845|FG002|Overall Study|Physician Decision|0|||
27940040|NCT03249558|81614843|FG000|Overall Study|Withdrawal by Subject|6|||
27940041|NCT03249558|81614844|FG001|Overall Study|Withdrawal by Subject|5|||
27940042|NCT03249558|81614845|FG002|Overall Study|Withdrawal by Subject|7|||
27940043|NCT03249558|81614843|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
27940044|NCT03249558|81614844|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
27940045|NCT03249558|81614845|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
27940046|NCT03249558|81614843|FG000|Overall Study|Protocol Violation|1|||
27940047|NCT03249558|81614844|FG001|Overall Study|Protocol Violation|1|||
27940048|NCT03249558|81614845|FG002|Overall Study|Protocol Violation|2|||
27940049|NCT02091960|81614846|FG000|Overall Study|Death|7|||
27940050|NCT02091960|81614846|FG000|Overall Study|Withdrawal by Subject|1|||
27940051|NCT02091960|81614846|FG000|Overall Study|Miscellaneous Reasons|31|||
27940052|NCT02091960|81614846|FG000|Overall Study|On Study at Data Cut-off|12|||
27940053|NCT02257528|81614847|FG000|Overall Study|Never received study treatment|1|||
27940054|NCT03163264|81614848|FG000|Overall Study|Withdrawal by Subject|13|||
27940055|NCT03163264|81614849|FG001|Overall Study|Withdrawal by Subject|3|||
27940056|NCT03163264|81614850|FG002|Overall Study|Withdrawal by Subject|4|||
27940057|NCT03163264|81614851|FG003|Overall Study|Withdrawal by Subject|2|||
27940058|NCT03163264|81614848|FG000|Overall Study|Lost to Follow-up|17|||
27940059|NCT03163264|81614849|FG001|Overall Study|Lost to Follow-up|20|||
27940060|NCT03163264|81614850|FG002|Overall Study|Lost to Follow-up|0|||
27940061|NCT03163264|81614851|FG003|Overall Study|Lost to Follow-up|0|||
27940062|NCT03163264|81614848|FG000|Overall Study|Death|0|||
27940063|NCT03163264|81614849|FG001|Overall Study|Death|2|||
27940064|NCT03163264|81614850|FG002|Overall Study|Death|0|||
27940065|NCT03163264|81614851|FG003|Overall Study|Death|0|||
27940066|NCT03921541|81614852|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
27940067|NCT03921541|81614853|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
27940068|NCT03238196|81614859|FG000|Overall Study|Adverse Event|3|||
27940069|NCT03238196|81614860|FG001|Overall Study|Adverse Event|0|||
27940070|NCT03238196|81614861|FG002|Overall Study|Adverse Event|2|||
27940071|NCT03238196|81614862|FG003|Overall Study|Adverse Event|2|||
27940072|NCT03238196|81614859|FG000|Overall Study|Withdrawal by Subject|4|||
27940073|NCT03238196|81614860|FG001|Overall Study|Withdrawal by Subject|1|||
27940074|NCT03238196|81614861|FG002|Overall Study|Withdrawal by Subject|1|||
27940075|NCT03238196|81614862|FG003|Overall Study|Withdrawal by Subject|0|||
27940076|NCT03238196|81614859|FG000|Overall Study|Disease progression|14|||
27940077|NCT03238196|81614860|FG001|Overall Study|Disease progression|2|||
27940078|NCT03238196|81614861|FG002|Overall Study|Disease progression|3|||
27940079|NCT03238196|81614862|FG003|Overall Study|Disease progression|2|||
27940080|NCT03238196|81614859|FG000|Overall Study|Still on treatment|1|||
27940081|NCT03238196|81614860|FG001|Overall Study|Still on treatment|0|||
27940082|NCT03238196|81614861|FG002|Overall Study|Still on treatment|0|||
27940083|NCT03238196|81614862|FG003|Overall Study|Still on treatment|0|||
27940084|NCT03688139|81614863|FG000|Overall Study|Lost to Follow-up|2|||
27940085|NCT03688139|81614864|FG001|Overall Study|Lost to Follow-up|0|||
27940086|NCT03688139|81614863|FG000|Overall Study|Physician Decision|0|||
27940087|NCT03688139|81614864|FG001|Overall Study|Physician Decision|1|||
27940088|NCT03688139|81614863|FG000|Overall Study|Withdrawal by Subject|2|||
27940089|NCT03688139|81614864|FG001|Overall Study|Withdrawal by Subject|3|||
27940090|NCT06083493|81614865|FG000|Overall Study|Technical issues with the interventional device|2|||
27940091|NCT06083493|81614866|FG001|Overall Study|Technical issues with the interventional device|2|||
27940092|NCT06083493|81614865|FG000|Overall Study|Performed incorrect visual task|1|||
27940093|NCT06083493|81614866|FG001|Overall Study|Performed incorrect visual task|0|||
27746290|NCT02416908|80899601|FG001|Dose Escalation Phase|Adverse Event|0|||
27940094|NCT06083493|81614865|FG000|Overall Study|Insufficient baseline performance|0|||
27940095|NCT06083493|81614866|FG001|Overall Study|Insufficient baseline performance|1|||
27940096|NCT00986102|81614867|FG000|Overall Study|Lost to Follow-up|0|||
27940097|NCT00986102|81614868|FG001|Overall Study|Lost to Follow-up|1|||
27746291|NCT02416908|80899602|FG002|Dose Escalation Phase|Adverse Event|3|||
27746292|NCT02416908|80899603|FG003|Dose Escalation Phase|Adverse Event|0|||
27940098|NCT00986102|81614869|FG002|Overall Study|Lost to Follow-up|0|||
27940099|NCT00986102|81614870|FG003|Overall Study|Lost to Follow-up|1|||
27940100|NCT00986102|81614867|FG000|Overall Study|Withdrawal by Subject|1|||
27940101|NCT00986102|81614868|FG001|Overall Study|Withdrawal by Subject|1|||
27940102|NCT00986102|81614869|FG002|Overall Study|Withdrawal by Subject|0|||
27645592|NCT02823574|80543639|FG000|Treatment Period|Study Drug Toxicity|11|||
27645593|NCT02823574|80543640|FG001|Treatment Period|Study Drug Toxicity|2|||
27645594|NCT02823574|80543641|FG002|Treatment Period|Study Drug Toxicity|14|||
27645595|NCT02823574|80543642|FG003|Treatment Period|Study Drug Toxicity|4|||
27645596|NCT02823574|80543639|FG000|Treatment Period|Disease Progression|113|||
27645597|NCT02823574|80543640|FG001|Treatment Period|Disease Progression|64|||
27645598|NCT02823574|80543641|FG002|Treatment Period|Disease Progression|82|||
27645599|NCT02823574|80543642|FG003|Treatment Period|Disease Progression|43|||
27940103|NCT00986102|81614870|FG003|Overall Study|Withdrawal by Subject|0|||
27940104|NCT04995419|81614871|FG000|Overall Study|Withdrawal by Subject|3|||
27940105|NCT04995419|81614871|FG000|Overall Study|Progressive Disease|19|||
27940106|NCT04995419|81614871|FG000|Overall Study|Adverse Event|2|||
27940107|NCT04995419|81614871|FG000|Overall Study|Ongoing|16|||
27940108|NCT02021318|81614872|FG000|Overall Study|Adverse Event|2|||
27940109|NCT02021318|81614873|FG001|Overall Study|Adverse Event|1|||
27940110|NCT02021318|81614872|FG000|Overall Study|Death|33|||
27940111|NCT02021318|81614873|FG001|Overall Study|Death|34|||
27940112|NCT02021318|81614872|FG000|Overall Study|Lost to Follow-up|3|||
27940113|NCT02021318|81614873|FG001|Overall Study|Lost to Follow-up|3|||
27940114|NCT02021318|81614872|FG000|Overall Study|Progressive Disease|0|||
27940115|NCT02021318|81614873|FG001|Overall Study|Progressive Disease|1|||
27940116|NCT02021318|81614872|FG000|Overall Study|Withdrawal by Subject|30|||
27940117|NCT02021318|81614873|FG001|Overall Study|Withdrawal by Subject|18|||
27940118|NCT02021318|81614872|FG000|Overall Study|Physician Decision|3|||
27940119|NCT02021318|81614873|FG001|Overall Study|Physician Decision|3|||
27940120|NCT02021318|81614872|FG000|Overall Study|Miscellaneous|2|||
27940121|NCT02021318|81614873|FG001|Overall Study|Miscellaneous|3|||
27940122|NCT01887600|81614876|FG000|Overall Study|Death|39|||
27940123|NCT01887600|81614877|FG001|Overall Study|Death|16|||
27940124|NCT01887600|81614876|FG000|Overall Study|Lack of Efficacy|3|||
27940125|NCT01887600|81614877|FG001|Overall Study|Lack of Efficacy|26|||
27940126|NCT01887600|81614876|FG000|Overall Study|Lost to Follow-up|5|||
27940127|NCT01887600|81614877|FG001|Overall Study|Lost to Follow-up|1|||
27940128|NCT01887600|81614876|FG000|Overall Study|Physician Decision|7|||
27645600|NCT02823574|80543639|FG000|Treatment Period|Other reasons|5|||
27940129|NCT01887600|81614877|FG001|Overall Study|Physician Decision|8|||
27940130|NCT01887600|81614876|FG000|Overall Study|Protocol Deviation|3|||
27940131|NCT01887600|81614877|FG001|Overall Study|Protocol Deviation|0|||
27940132|NCT01887600|81614876|FG000|Overall Study|Withdrawal by Subject|58|||
27645601|NCT02823574|80543640|FG001|Treatment Period|Other reasons|9|||
27645602|NCT02823574|80543641|FG002|Treatment Period|Other reasons|3|||
27645603|NCT02823574|80543642|FG003|Treatment Period|Other reasons|6|||
27645604|NCT02823574|80543639|FG000|Treatment Period|Participant no longer meets study criteria|0|||
27645605|NCT02823574|80543640|FG001|Treatment Period|Participant no longer meets study criteria|0|||
27645606|NCT02823574|80543641|FG002|Treatment Period|Participant no longer meets study criteria|1|||
27645607|NCT02823574|80543642|FG003|Treatment Period|Participant no longer meets study criteria|0|||
27645608|NCT02823574|80543639|FG000|Treatment Period|Death|0|||
27645609|NCT02823574|80543640|FG001|Treatment Period|Death|0|||
27645610|NCT02823574|80543641|FG002|Treatment Period|Death|3|||
27645611|NCT02823574|80543642|FG003|Treatment Period|Death|1|||
27645612|NCT03861234|80543645|FG000|Overall Study|Not treated|0|||
27645613|NCT03861234|80543646|FG001|Overall Study|Not treated|0|||
27940133|NCT01887600|81614877|FG001|Overall Study|Withdrawal by Subject|52|||
27940134|NCT01887600|81614876|FG000|Overall Study|Adverse Event|21|||
27940135|NCT01887600|81614877|FG001|Overall Study|Adverse Event|9|||
27940136|NCT01887600|81614876|FG000|Overall Study|Non-compliance with study drug|3|||
27940137|NCT01887600|81614877|FG001|Overall Study|Non-compliance with study drug|0|||
27940138|NCT01887600|81614876|FG000|Overall Study|Miscellaneous|6|||
27940139|NCT01887600|81614877|FG001|Overall Study|Miscellaneous|2|||
27940140|NCT01887600|81614876|FG000|Overall Study|Progressive Disease|1|||
27940141|NCT01887600|81614877|FG001|Overall Study|Progressive Disease|0|||
27940142|NCT03166631|81614878|FG000|Overall Study|Progressive disease|2|||
27940143|NCT03166631|81614879|FG001|Overall Study|Progressive disease|1|||
27645614|NCT03861234|80543647|FG002|Overall Study|Not treated|0|||
27746293|NCT02416908|80899600|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
27940144|NCT03166631|81614880|FG002|Overall Study|Progressive disease|3|||
27940145|NCT03166631|81614881|FG003|Overall Study|Progressive disease|4|||
27940146|NCT03166631|81614882|FG004|Overall Study|Progressive disease|2|||
27940147|NCT03166631|81614883|FG005|Overall Study|Progressive disease|2|||
27940148|NCT03166631|81614884|FG006|Overall Study|Progressive disease|5|||
27940149|NCT03166631|81614885|FG007|Overall Study|Progressive disease|6|||
27940150|NCT03166631|81614886|FG008|Overall Study|Progressive disease|11|||
27940151|NCT03166631|81614887|FG009|Overall Study|Progressive disease|5|||
27940152|NCT03166631|81614888|FG010|Overall Study|Progressive disease|7|||
27645615|NCT03861234|80543648|FG003|Overall Study|Not treated|0|||
27645616|NCT03861234|80543649|FG004|Overall Study|Not treated|0|||
27645617|NCT03861234|80543650|FG005|Overall Study|Not treated|1|||
27940153|NCT03166631|81614878|FG000|Overall Study|Physician Decision|0|||
27940154|NCT03166631|81614879|FG001|Overall Study|Physician Decision|0|||
27940155|NCT03166631|81614880|FG002|Overall Study|Physician Decision|0|||
27940156|NCT03166631|81614881|FG003|Overall Study|Physician Decision|0|||
27940157|NCT03166631|81614882|FG004|Overall Study|Physician Decision|0|||
27940158|NCT03166631|81614883|FG005|Overall Study|Physician Decision|0|||
27940159|NCT03166631|81614884|FG006|Overall Study|Physician Decision|1|||
27940160|NCT03166631|81614885|FG007|Overall Study|Physician Decision|0|||
27940161|NCT03166631|81614886|FG008|Overall Study|Physician Decision|1|||
27940162|NCT03166631|81614887|FG009|Overall Study|Physician Decision|0|||
27940163|NCT03166631|81614888|FG010|Overall Study|Physician Decision|1|||
27940164|NCT03166631|81614878|FG000|Overall Study|Death|0|||
27940165|NCT03166631|81614879|FG001|Overall Study|Death|0|||
27940166|NCT03166631|81614880|FG002|Overall Study|Death|0|||
27940167|NCT03166631|81614881|FG003|Overall Study|Death|0|||
27940168|NCT03166631|81614882|FG004|Overall Study|Death|1|||
27940169|NCT03166631|81614883|FG005|Overall Study|Death|0|||
27940170|NCT03166631|81614884|FG006|Overall Study|Death|1|||
27940171|NCT03166631|81614885|FG007|Overall Study|Death|0|||
27940172|NCT03166631|81614886|FG008|Overall Study|Death|0|||
27940173|NCT03166631|81614887|FG009|Overall Study|Death|0|||
27940174|NCT03166631|81614888|FG010|Overall Study|Death|0|||
27940175|NCT03166631|81614878|FG000|Overall Study|Adverse Event|1|||
27940176|NCT03166631|81614879|FG001|Overall Study|Adverse Event|0|||
27940177|NCT03166631|81614880|FG002|Overall Study|Adverse Event|0|||
27940178|NCT03166631|81614881|FG003|Overall Study|Adverse Event|0|||
27940179|NCT03166631|81614882|FG004|Overall Study|Adverse Event|0|||
27940180|NCT03166631|81614883|FG005|Overall Study|Adverse Event|1|||
27940181|NCT03166631|81614884|FG006|Overall Study|Adverse Event|1|||
27940182|NCT03166631|81614885|FG007|Overall Study|Adverse Event|0|||
27940183|NCT03166631|81614886|FG008|Overall Study|Adverse Event|1|||
27940184|NCT03166631|81614887|FG009|Overall Study|Adverse Event|2|||
27940185|NCT03166631|81614888|FG010|Overall Study|Adverse Event|1|||
27940186|NCT03166631|81614878|FG000|Overall Study|Withdrawal by Subject|0|||
27940187|NCT03166631|81614879|FG001|Overall Study|Withdrawal by Subject|0|||
27940188|NCT03166631|81614880|FG002|Overall Study|Withdrawal by Subject|0|||
27940189|NCT03166631|81614881|FG003|Overall Study|Withdrawal by Subject|0|||
27940190|NCT03166631|81614882|FG004|Overall Study|Withdrawal by Subject|0|||
27940191|NCT03166631|81614883|FG005|Overall Study|Withdrawal by Subject|0|||
27940192|NCT03166631|81614884|FG006|Overall Study|Withdrawal by Subject|0|||
27940193|NCT03166631|81614885|FG007|Overall Study|Withdrawal by Subject|0|||
27940194|NCT03166631|81614886|FG008|Overall Study|Withdrawal by Subject|1|||
27940195|NCT03166631|81614887|FG009|Overall Study|Withdrawal by Subject|1|||
27940196|NCT03166631|81614888|FG010|Overall Study|Withdrawal by Subject|0|||
27940197|NCT01844986|81614889|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
27940198|NCT01844986|81614890|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
27940199|NCT01844986|81614889|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
27940200|NCT01844986|81614890|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
27940201|NCT01844986|81614889|FG000|Overall Study (Global Cohort)|Death|55|||
27940202|NCT01844986|81614890|FG001|Overall Study (Global Cohort)|Death|26|||
27940203|NCT01844986|81614889|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
27940204|NCT01844986|81614890|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
27940205|NCT01844986|81614889|FG000|Overall Study (China Cohort)|Death|10|||
27940206|NCT01844986|81614890|FG001|Overall Study (China Cohort)|Death|6|||
27940207|NCT04739800|81614892|FG000|Overall Study|Adverse Event|2|||
27940208|NCT04739800|81614893|FG001|Overall Study|Adverse Event|1|||
27940209|NCT04739800|81614894|FG002|Overall Study|Adverse Event|4|||
27940210|NCT04739800|81614895|FG003|Overall Study|Adverse Event|5|||
27940211|NCT04739800|81614892|FG000|Overall Study|Never Treated|2|||
27940212|NCT04739800|81614893|FG001|Overall Study|Never Treated|0|||
27940213|NCT04739800|81614894|FG002|Overall Study|Never Treated|1|||
27940214|NCT04739800|81614895|FG003|Overall Study|Never Treated|1|||
27940215|NCT04739800|81614892|FG000|Overall Study|On Treatment|5|||
27940216|NCT04739800|81614893|FG001|Overall Study|On Treatment|9|||
27940217|NCT04739800|81614894|FG002|Overall Study|On Treatment|9|||
27940218|NCT04739800|81614895|FG003|Overall Study|On Treatment|9|||
27940219|NCT04739800|81614892|FG000|Overall Study|Symptomatic Deterioration|1|||
27940220|NCT04739800|81614893|FG001|Overall Study|Symptomatic Deterioration|1|||
27940221|NCT04739800|81614894|FG002|Overall Study|Symptomatic Deterioration|3|||
27940222|NCT04739800|81614895|FG003|Overall Study|Symptomatic Deterioration|0|||
27940223|NCT04739800|81614892|FG000|Overall Study|Withdrawal by Subject|1|||
27940224|NCT04739800|81614893|FG001|Overall Study|Withdrawal by Subject|2|||
27940225|NCT04739800|81614894|FG002|Overall Study|Withdrawal by Subject|1|||
27940226|NCT04739800|81614895|FG003|Overall Study|Withdrawal by Subject|3|||
27940227|NCT04739800|81614892|FG000|Overall Study|Other Reason|1|||
27940228|NCT04739800|81614893|FG001|Overall Study|Other Reason|3|||
27940229|NCT04739800|81614894|FG002|Overall Study|Other Reason|5|||
27940230|NCT04739800|81614895|FG003|Overall Study|Other Reason|4|||
27940231|NCT02446600|81614912|FG000|Overall Study|Never treated|20|||
27940232|NCT02446600|81614913|FG001|Overall Study|Never treated|2|||
27940233|NCT02446600|81614914|FG002|Overall Study|Never treated|6|||
27940234|NCT02446600|81614915|FG003|Overall Study|Never treated|0|||
27940235|NCT02446600|81614912|FG000|Overall Study|Withdrawal by Subject|19|||
27940236|NCT02446600|81614913|FG001|Overall Study|Withdrawal by Subject|5|||
27940237|NCT02446600|81614914|FG002|Overall Study|Withdrawal by Subject|17|||
27940238|NCT02446600|81614915|FG003|Overall Study|Withdrawal by Subject|0|||
27940239|NCT02446600|81614912|FG000|Overall Study|Ineligible|1|||
27940240|NCT02446600|81614913|FG001|Overall Study|Ineligible|4|||
27940241|NCT02446600|81614914|FG002|Overall Study|Ineligible|4|||
27940242|NCT02446600|81614915|FG003|Overall Study|Ineligible|1|||
27940243|NCT02446600|81614912|FG000|Overall Study|Duplicate Enrollment|0|||
27940244|NCT02446600|81614913|FG001|Overall Study|Duplicate Enrollment|1|||
27940245|NCT02446600|81614914|FG002|Overall Study|Duplicate Enrollment|0|||
27940246|NCT02446600|81614915|FG003|Overall Study|Duplicate Enrollment|0|||
27940247|NCT01659151|81614916|FG000|Overall Study|Inadequate TIL growth|1|||
27940248|NCT01340170|81614917|FG000|Overall Study|Lost to Follow-up|2|||
27940249|NCT01340170|81614918|FG001|Overall Study|Lost to Follow-up|4|||
27940250|NCT01340170|81614919|FG002|Overall Study|Lost to Follow-up|0|||
27940251|NCT01340170|81614917|FG000|Overall Study|Implant failure|1|||
27940252|NCT01340170|81614918|FG001|Overall Study|Implant failure|3|||
27940253|NCT01340170|81614919|FG002|Overall Study|Implant failure|0|||
27940254|NCT02595879|81614921|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
27940255|NCT02595879|81614922|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
27940256|NCT05430919|81614925|FG000|Overall Study|Protocol Violation|0|||
27940257|NCT05430919|81614926|FG001|Overall Study|Protocol Violation|0|||
27940258|NCT05430919|81614927|FG002|Overall Study|Protocol Violation|1|||
27940259|NCT05430919|81614928|FG003|Overall Study|Protocol Violation|0|||
27940260|NCT05430919|81614925|FG000|Overall Study|Lost to Follow-up|0|||
27940261|NCT05430919|81614926|FG001|Overall Study|Lost to Follow-up|1|||
27940262|NCT05430919|81614927|FG002|Overall Study|Lost to Follow-up|0|||
27940263|NCT05430919|81614928|FG003|Overall Study|Lost to Follow-up|0|||
27940264|NCT05430919|81614925|FG000|Overall Study|Withdrawal by Subject|3|||
27940265|NCT05430919|81614926|FG001|Overall Study|Withdrawal by Subject|0|||
27940266|NCT05430919|81614927|FG002|Overall Study|Withdrawal by Subject|0|||
27940267|NCT05430919|81614928|FG003|Overall Study|Withdrawal by Subject|1|||
27940268|NCT03734536|81614931|FG000|Overall Study|Withdrew Consent|1|||
27940269|NCT03734536|81614932|FG001|Overall Study|Withdrew Consent|5|||
27940270|NCT03734536|81614931|FG000|Overall Study|Lost to Follow-up|10|||
27940271|NCT03734536|81614932|FG001|Overall Study|Lost to Follow-up|7|||
27940272|NCT02268851|81614933|FG000|Overall Study|Death|0|||
27940273|NCT02268851|81614934|FG001|Overall Study|Death|0|||
27940274|NCT02268851|81614935|FG002|Overall Study|Death|0|||
27940275|NCT02268851|81614936|FG003|Overall Study|Death|1|||
27940276|NCT02268851|81614937|FG004|Overall Study|Death|2|||
27940277|NCT02268851|81614938|FG005|Overall Study|Death|1|||
27940278|NCT02268851|81614933|FG000|Overall Study|Adverse Event|0|||
27940279|NCT02268851|81614934|FG001|Overall Study|Adverse Event|0|||
27940280|NCT02268851|81614935|FG002|Overall Study|Adverse Event|0|||
27940281|NCT02268851|81614936|FG003|Overall Study|Adverse Event|0|||
27940282|NCT02268851|81614937|FG004|Overall Study|Adverse Event|2|||
27645618|NCT03861234|80543651|FG006|Overall Study|Not treated|0|||
27645619|NCT03861234|80543652|FG007|Overall Study|Not treated|0|||
27645620|NCT03861234|80543645|FG000|Overall Study|Adverse Event|0|||
27645621|NCT03861234|80543646|FG001|Overall Study|Adverse Event|0|||
27645622|NCT03861234|80543647|FG002|Overall Study|Adverse Event|0|||
27645623|NCT03861234|80543648|FG003|Overall Study|Adverse Event|0|||
27645624|NCT03861234|80543649|FG004|Overall Study|Adverse Event|0|||
27645625|NCT03861234|80543650|FG005|Overall Study|Adverse Event|1|||
27645626|NCT03861234|80543651|FG006|Overall Study|Adverse Event|0|||
27645627|NCT03861234|80543652|FG007|Overall Study|Adverse Event|0|||
27645628|NCT03861234|80543645|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
27645629|NCT03861234|80543646|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
27645630|NCT03861234|80543647|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
27645631|NCT03861234|80543648|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
27755006|NCT04937816|80929654|FG005|Overall Study|Adverse Event|343|||
27940283|NCT02268851|81614938|FG005|Overall Study|Adverse Event|2|||
27940284|NCT02268851|81614933|FG000|Overall Study|Withdrawal by Subject|0|||
27940285|NCT02268851|81614934|FG001|Overall Study|Withdrawal by Subject|0|||
27940286|NCT02268851|81614935|FG002|Overall Study|Withdrawal by Subject|0|||
27940287|NCT02268851|81614936|FG003|Overall Study|Withdrawal by Subject|2|||
27940288|NCT02268851|81614937|FG004|Overall Study|Withdrawal by Subject|0|||
27940289|NCT02268851|81614938|FG005|Overall Study|Withdrawal by Subject|1|||
27940290|NCT02268851|81614933|FG000|Overall Study|Progressive Disease|1|||
27940291|NCT02268851|81614934|FG001|Overall Study|Progressive Disease|3|||
27940292|NCT02268851|81614935|FG002|Overall Study|Progressive Disease|0|||
27940293|NCT02268851|81614936|FG003|Overall Study|Progressive Disease|0|||
27940294|NCT02268851|81614937|FG004|Overall Study|Progressive Disease|1|||
27940295|NCT02268851|81614938|FG005|Overall Study|Progressive Disease|4|||
27940296|NCT02268851|81614933|FG000|Overall Study|Physician Decision|0|||
27940297|NCT02268851|81614934|FG001|Overall Study|Physician Decision|0|||
27940298|NCT02268851|81614935|FG002|Overall Study|Physician Decision|1|||
27645632|NCT03861234|80543649|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
27645633|NCT03861234|80543650|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
27645634|NCT03861234|80543651|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
27645635|NCT03861234|80543652|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
27940299|NCT02268851|81614936|FG003|Overall Study|Physician Decision|0|||
27940300|NCT02268851|81614937|FG004|Overall Study|Physician Decision|0|||
27940301|NCT02268851|81614938|FG005|Overall Study|Physician Decision|1|||
27940302|NCT02268851|81614933|FG000|Overall Study|Patient Compliance|0|||
27940303|NCT02268851|81614934|FG001|Overall Study|Patient Compliance|0|||
27940304|NCT02268851|81614935|FG002|Overall Study|Patient Compliance|0|||
27940305|NCT02268851|81614936|FG003|Overall Study|Patient Compliance|0|||
27940306|NCT02268851|81614937|FG004|Overall Study|Patient Compliance|1|||
27940307|NCT02268851|81614938|FG005|Overall Study|Patient Compliance|1|||
27940308|NCT02268851|81614933|FG000|Overall Study|Co-Morbid Condition|0|||
27940309|NCT02268851|81614934|FG001|Overall Study|Co-Morbid Condition|0|||
27940310|NCT02268851|81614935|FG002|Overall Study|Co-Morbid Condition|0|||
27940311|NCT02268851|81614936|FG003|Overall Study|Co-Morbid Condition|0|||
27940312|NCT02268851|81614937|FG004|Overall Study|Co-Morbid Condition|1|||
27940313|NCT02268851|81614938|FG005|Overall Study|Co-Morbid Condition|1|||
27940314|NCT03258593|81614939|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
27940315|NCT03258593|81614940|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
27940316|NCT03258593|81614941|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
27940317|NCT03258593|81614942|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
27940318|NCT03258593|81614939|FG000|Run-In Maintenance Phase|Disease progression|3|||
27940319|NCT03258593|81614940|FG001|Run-In Maintenance Phase|Disease progression|0|||
27940320|NCT03258593|81614941|FG002|Run-In Maintenance Phase|Disease progression|0|||
27940321|NCT03258593|81614942|FG003|Run-In Maintenance Phase|Disease progression|0|||
27940322|NCT03258593|81614939|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
27940323|NCT03258593|81614940|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
27940324|NCT03258593|81614941|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
27940325|NCT03258593|81614942|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
27940326|NCT03258593|81614939|FG000|Expansion Maintenance Phase|Physician Decision|0|||
27940327|NCT03258593|81614940|FG001|Expansion Maintenance Phase|Physician Decision|1|||
27940328|NCT03258593|81614941|FG002|Expansion Maintenance Phase|Physician Decision|0|||
27940329|NCT03258593|81614942|FG003|Expansion Maintenance Phase|Physician Decision|0|||
27940330|NCT03941860|81614943|FG000|Overall Study|Withdrawal by Subject|0|||
27940331|NCT03941860|81614944|FG001|Overall Study|Withdrawal by Subject|1|||
27940332|NCT02025010|81614945|FG000|Overall Study|Symptomatic or radiographic progression|36|||
27940333|NCT02025010|81614945|FG000|Overall Study|Adverse Event|6|||
27645636|NCT03861234|80543645|FG000|Overall Study|As per sponsor decision|0|||
27645637|NCT03861234|80543646|FG001|Overall Study|As per sponsor decision|0|||
27645638|NCT03861234|80543647|FG002|Overall Study|As per sponsor decision|0|||
27940334|NCT02025010|81614945|FG000|Overall Study|Physician Decision|7|||
27940335|NCT02025010|81614945|FG000|Overall Study|Withdrawal by Subject|3|||
27940336|NCT02025010|81614945|FG000|Overall Study|Intercurrent illness|3|||
27940337|NCT02025010|81614945|FG000|Overall Study|Patients still on treatment|3|||
27940338|NCT02025010|81614945|FG000|Overall Study|Never initiate the treatment|2|||
27940339|NCT01708941|81614947|FG000|Overall Study|Adverse Event|4|||
27940340|NCT01708941|81614948|FG001|Overall Study|Adverse Event|6|||
27940341|NCT01708941|81614949|FG002|Overall Study|Adverse Event|1|||
27940342|NCT01708941|81614950|FG003|Overall Study|Adverse Event|0|||
27940343|NCT01708941|81614947|FG000|Overall Study|Death|1|||
27940344|NCT01708941|81614948|FG001|Overall Study|Death|1|||
27940345|NCT01708941|81614949|FG002|Overall Study|Death|2|||
27940346|NCT01708941|81614950|FG003|Overall Study|Death|14|||
27940347|NCT01708941|81614947|FG000|Overall Study|Withdrawal by Subject|1|||
27940348|NCT01708941|81614948|FG001|Overall Study|Withdrawal by Subject|0|||
27940349|NCT01708941|81614949|FG002|Overall Study|Withdrawal by Subject|3|||
27940350|NCT01708941|81614950|FG003|Overall Study|Withdrawal by Subject|4|||
27940351|NCT01708941|81614947|FG000|Overall Study|Disease progression|9|||
27940352|NCT01708941|81614948|FG001|Overall Study|Disease progression|10|||
27940353|NCT01708941|81614949|FG002|Overall Study|Disease progression|8|||
27940354|NCT01708941|81614950|FG003|Overall Study|Disease progression|0|||
27940355|NCT01708941|81614947|FG000|Overall Study|Alternative therapy|0|||
27645639|NCT03861234|80543648|FG003|Overall Study|As per sponsor decision|0|||
27645640|NCT03861234|80543649|FG004|Overall Study|As per sponsor decision|0|||
27940356|NCT01708941|81614948|FG001|Overall Study|Alternative therapy|0|||
27940357|NCT01708941|81614949|FG002|Overall Study|Alternative therapy|2|||
27940358|NCT01708941|81614950|FG003|Overall Study|Alternative therapy|0|||
27940359|NCT01708941|81614947|FG000|Overall Study|Ineligible and never started treatment|1|||
27940360|NCT01708941|81614948|FG001|Overall Study|Ineligible and never started treatment|0|||
27940361|NCT01708941|81614949|FG002|Overall Study|Ineligible and never started treatment|1|||
27940362|NCT01708941|81614950|FG003|Overall Study|Ineligible and never started treatment|0|||
27940363|NCT01708941|81614947|FG000|Overall Study|Never started treatment|2|||
27940364|NCT01708941|81614948|FG001|Overall Study|Never started treatment|1|||
27940365|NCT01708941|81614949|FG002|Overall Study|Never started treatment|0|||
27940366|NCT01708941|81614950|FG003|Overall Study|Never started treatment|0|||
27940367|NCT01708941|81614947|FG000|Overall Study|Ineligible|0|||
27940368|NCT01708941|81614948|FG001|Overall Study|Ineligible|0|||
27940369|NCT01708941|81614949|FG002|Overall Study|Ineligible|2|||
27940370|NCT01708941|81614950|FG003|Overall Study|Ineligible|0|||
27940371|NCT00769379|81614951|FG000|Overall Study|No follow up data mapped to Other.|3|||
27940372|NCT00769379|81614952|FG001|Overall Study|No follow up data mapped to Other.|13|||
27940373|NCT03382873|81614953|FG000|Overall Study|Lost to Follow-up|9|||
27940374|NCT03382873|81614954|FG001|Overall Study|Lost to Follow-up|10|||
27940375|NCT03382873|81614953|FG000|Overall Study|Withdrawal by Subject|6|||
27940376|NCT03382873|81614954|FG001|Overall Study|Withdrawal by Subject|11|||
27940377|NCT03382873|81614953|FG000|Overall Study|Visit not completed due to pandemic|16|||
27940378|NCT03382873|81614954|FG001|Overall Study|Visit not completed due to pandemic|41|||
27940379|NCT06048705|81614957|FG000|Overall Study|Physician Decision|1|||
27940380|NCT06048705|81614958|FG001|Overall Study|Physician Decision|0|||
27940381|NCT06048705|81614959|FG002|Overall Study|Physician Decision|0|||
27940382|NCT06048705|81614957|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
27940383|NCT06048705|81614958|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
27940384|NCT06048705|81614959|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
27940385|NCT06048705|81614957|FG000|Overall Study|Death prior to lymphodepletion|0|||
27940386|NCT06048705|81614958|FG001|Overall Study|Death prior to lymphodepletion|0|||
27940387|NCT06048705|81614959|FG002|Overall Study|Death prior to lymphodepletion|1|||
27940388|NCT04590963|81614960|FG000|Overall Study|Death|118|||
27940389|NCT04590963|81614961|FG001|Overall Study|Death|59|||
27940390|NCT04590963|81614960|FG000|Overall Study|Lost to Follow-up|1|||
27940391|NCT04590963|81614961|FG001|Overall Study|Lost to Follow-up|1|||
27940392|NCT04590963|81614960|FG000|Overall Study|Progressive disease|0|||
27940393|NCT04590963|81614961|FG001|Overall Study|Progressive disease|1|||
27940394|NCT04590963|81614960|FG000|Overall Study|Study terminated by sponsor|103|||
27940395|NCT04590963|81614961|FG001|Overall Study|Study terminated by sponsor|50|||
27940396|NCT04590963|81614960|FG000|Overall Study|Withdrawal by Subject|15|||
27940397|NCT04590963|81614961|FG001|Overall Study|Withdrawal by Subject|8|||
27940398|NCT04590963|81614960|FG000|Overall Study|Ongoing at data cut-off|9|||
27940399|NCT04590963|81614961|FG001|Overall Study|Ongoing at data cut-off|4|||
27940400|NCT04590963|81614960|FG000|Overall Study|Screen failure|1|||
27940401|NCT04590963|81614961|FG001|Overall Study|Screen failure|0|||
27940402|NCT04128228|81614963|FG000|Overall Study|Withdrawal by Subject|3|||
27940403|NCT04128228|81614964|FG001|Overall Study|Withdrawal by Subject|3|||
27940404|NCT04128228|81614965|FG002|Overall Study|Withdrawal by Subject|0|||
27940405|NCT04128228|81614966|FG003|Overall Study|Withdrawal by Subject|0|||
27940406|NCT04128228|81614963|FG000|Overall Study|noncompliance|2|||
27940407|NCT04128228|81614964|FG001|Overall Study|noncompliance|2|||
27940408|NCT04128228|81614965|FG002|Overall Study|noncompliance|0|||
27940409|NCT04128228|81614966|FG003|Overall Study|noncompliance|0|||
27940410|NCT05013905|81614967|FG000|Overall Study|Adverse Event|1|||
27940411|NCT05013905|81614967|FG000|Overall Study|Lack of Efficacy|1|||
27940412|NCT03569891|81614968|FG000|Lead-in|Ineligible during lead-in|8|||
27940413|NCT03569891|81614968|FG000|Lead-in|Withdrawal by Subject|3|||
27940414|NCT03569891|81614968|FG000|Lead-in|Risks related to COVID-19|2|||
27940415|NCT03569891|81614968|FG000|AMT-061|Adverse Event|1|||
27940416|NCT05071027|81614974|FG000|Overall Study|Lost to Follow-up|1|||
27940417|NCT05071027|81614975|FG001|Overall Study|Lost to Follow-up|4|||
27940418|NCT01950390|81614980|FG000|Overall Study|Never started treatment|3|||
27940419|NCT01950390|81614981|FG001|Overall Study|Never started treatment|2|||
27940420|NCT01950390|81614980|FG000|Overall Study|Disease progression|45|||
27940421|NCT01950390|81614981|FG001|Overall Study|Disease progression|52|||
27940422|NCT01950390|81614980|FG000|Overall Study|Adverse Event|22|||
27940423|NCT01950390|81614981|FG001|Overall Study|Adverse Event|16|||
27940424|NCT01950390|81614980|FG000|Overall Study|Death|5|||
27940425|NCT01950390|81614981|FG001|Overall Study|Death|3|||
27940426|NCT01950390|81614980|FG000|Overall Study|Withdrawal by Subject|5|||
27940427|NCT01950390|81614981|FG001|Overall Study|Withdrawal by Subject|1|||
27940428|NCT01950390|81614980|FG000|Overall Study|Alternative therapy|0|||
27645641|NCT03861234|80543650|FG005|Overall Study|As per sponsor decision|0|||
27645642|NCT03861234|80543651|FG006|Overall Study|As per sponsor decision|1|||
27645643|NCT03861234|80543652|FG007|Overall Study|As per sponsor decision|0|||
27940429|NCT01950390|81614981|FG001|Overall Study|Alternative therapy|3|||
27940430|NCT01950390|81614980|FG000|Overall Study|Complicating disease|1|||
27940431|NCT01950390|81614981|FG001|Overall Study|Complicating disease|0|||
27940432|NCT01950390|81614980|FG000|Overall Study|On treatment|1|||
27940433|NCT01950390|81614981|FG001|Overall Study|On treatment|0|||
27551348|NCT01543698|80207471|FG013|Phase 1b|Death|0|||
27940434|NCT01950390|81614980|FG000|Overall Study|Symptomatic deterioration|2|||
27940435|NCT01950390|81614981|FG001|Overall Study|Symptomatic deterioration|1|||
27551349|NCT01543698|80207472|FG014|Phase 1b|Death|0|||
27940436|NCT01950390|81614980|FG000|Overall Study|Physician Decision|0|||
27940437|NCT01950390|81614981|FG001|Overall Study|Physician Decision|4|||
27940438|NCT01950390|81614980|FG000|Overall Study|Lack of clinical benefit|0|||
27940439|NCT01950390|81614981|FG001|Overall Study|Lack of clinical benefit|1|||
27940440|NCT01950390|81614980|FG000|Overall Study|Maintained PR and moved to observation only|0|||
27645644|NCT03861234|80543645|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
27645645|NCT03861234|80543646|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
27645646|NCT03861234|80543647|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
27645647|NCT03861234|80543648|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
27645648|NCT03861234|80543649|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
27645649|NCT03861234|80543650|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
27645650|NCT03861234|80543651|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
27645651|NCT03861234|80543652|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
27645652|NCT05184062|80543662|FG000|Overall Study|Lost to Follow-up|5|||
27645653|NCT05184062|80543663|FG001|Overall Study|Lost to Follow-up|1|||
27940441|NCT01950390|81614981|FG001|Overall Study|Maintained PR and moved to observation only|1|||
27940442|NCT02844816|81614989|FG000|Overall Study|No protocol treatment received|5|||
27940443|NCT02844816|81614990|FG001|Overall Study|No protocol treatment received|1|||
27940444|NCT02844816|81614989|FG000|Overall Study|Ineligible|22|||
27940445|NCT02844816|81614990|FG001|Overall Study|Ineligible|15|||
27940446|NCT02844816|81614989|FG000|Overall Study|Participant refusal|5|||
27940447|NCT02844816|81614990|FG001|Overall Study|Participant refusal|5|||
27940448|NCT02844816|81614989|FG000|Overall Study|Adverse Event|5|||
27940449|NCT02844816|81614990|FG001|Overall Study|Adverse Event|4|||
27940450|NCT02844816|81614989|FG000|Overall Study|Death|0|||
27940451|NCT02844816|81614990|FG001|Overall Study|Death|1|||
27940452|NCT02844816|81614989|FG000|Overall Study|Disease progression/recurrence|50|||
27940453|NCT02844816|81614990|FG001|Overall Study|Disease progression/recurrence|24|||
27940454|NCT02844816|81614989|FG000|Overall Study|Physician Decision|1|||
27940455|NCT02844816|81614990|FG001|Overall Study|Physician Decision|1|||
27940456|NCT01064648|81614991|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
27940457|NCT01064648|81614992|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
27940458|NCT01064648|81614993|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
27940459|NCT01064648|81614994|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
27940460|NCT01064648|81614991|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
27940461|NCT01064648|81614992|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
27940462|NCT01064648|81614993|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
27645654|NCT05184062|80543662|FG000|Overall Study|Withdrawal by Subject|1|||
27645655|NCT05184062|80543663|FG001|Overall Study|Withdrawal by Subject|0|||
27645656|NCT02409680|80543664|FG000|Overall Study|Lost to Follow-up|15|||
27645657|NCT02409680|80543665|FG001|Overall Study|Lost to Follow-up|30|||
27645658|NCT02698475|80543670|FG000|Main Study Period|Lack of Efficacy|1|||
27645659|NCT02698475|80543670|FG000|Main Study Period|Protocol Violation|2|||
27645660|NCT02698475|80543670|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
27645661|NCT02698475|80543670|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
27645662|NCT02698475|80543670|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
27645663|NCT02698475|80543670|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
27645664|NCT02698475|80543670|FG000|Long-Term Extension Period|Other|1|||
27645665|NCT01171976|80543671|FG000|Overall Study|Protocol Violation|0|||
27645666|NCT01171976|80543672|FG001|Overall Study|Protocol Violation|0|||
27645667|NCT01171976|80543673|FG002|Overall Study|Protocol Violation|1|||
27645668|NCT01171976|80543671|FG000|Overall Study|Death|2|||
27645669|NCT01171976|80543672|FG001|Overall Study|Death|4|||
27645670|NCT01171976|80543673|FG002|Overall Study|Death|1|||
27645671|NCT01171976|80543671|FG000|Overall Study|Lost to Follow-up|4|||
27645672|NCT01171976|80543672|FG001|Overall Study|Lost to Follow-up|0|||
27645673|NCT01171976|80543673|FG002|Overall Study|Lost to Follow-up|2|||
27645674|NCT01171976|80543671|FG000|Overall Study|Withdrawal by Subject|1|||
27645675|NCT01171976|80543672|FG001|Overall Study|Withdrawal by Subject|5|||
27645676|NCT01171976|80543673|FG002|Overall Study|Withdrawal by Subject|6|||
27645677|NCT01171976|80543671|FG000|Overall Study|Abnormal test result|1|||
27645678|NCT01171976|80543672|FG001|Overall Study|Abnormal test result|0|||
27645679|NCT01171976|80543673|FG002|Overall Study|Abnormal test result|0|||
27645680|NCT01171976|80543671|FG000|Overall Study|Adverse Event|6|||
27645681|NCT01171976|80543672|FG001|Overall Study|Adverse Event|2|||
27645682|NCT01171976|80543673|FG002|Overall Study|Adverse Event|5|||
27645683|NCT02513667|80543674|FG000|Overall Study|Withdrawal by Subject|0|||
27645684|NCT02513667|80543675|FG001|Overall Study|Withdrawal by Subject|1|||
27645685|NCT00982644|80543678|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
27645686|NCT00982644|80543679|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
27645687|NCT00982644|80543678|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
27746294|NCT02416908|80899601|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
27746295|NCT02416908|80899602|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
27755007|NCT04937816|80929655|FG006|Overall Study|Adverse Event|337|||
27940463|NCT01064648|81614994|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
27940464|NCT01064648|81614991|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
27940465|NCT01064648|81614992|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
27940466|NCT01064648|81614993|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
27940467|NCT01064648|81614994|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
27940468|NCT01064648|81614991|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
27940469|NCT01064648|81614992|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
27940470|NCT01064648|81614993|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
27940471|NCT01064648|81614994|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
27940472|NCT01064648|81614991|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
27940473|NCT01064648|81614992|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
27940474|NCT01064648|81614993|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
27940475|NCT01064648|81614994|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
27940476|NCT01064648|81614991|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
27940477|NCT01064648|81614992|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
27940478|NCT01064648|81614993|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
27940479|NCT01064648|81614994|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
27940480|NCT01064648|81614991|FG000|Phase II|Adverse Event|0|||
27940481|NCT01064648|81614992|FG001|Phase II|Adverse Event|0|||
27940482|NCT01064648|81614993|FG002|Phase II|Adverse Event|15|||
27940483|NCT01064648|81614994|FG003|Phase II|Adverse Event|8|||
27940484|NCT01064648|81614991|FG000|Phase II|Death|0|||
27940485|NCT01064648|81614992|FG001|Phase II|Death|0|||
27940486|NCT01064648|81614993|FG002|Phase II|Death|4|||
27940487|NCT01064648|81614994|FG003|Phase II|Death|5|||
27940488|NCT01064648|81614991|FG000|Phase II|Withdrawal by Subject|0|||
27940489|NCT01064648|81614992|FG001|Phase II|Withdrawal by Subject|0|||
27940490|NCT01064648|81614993|FG002|Phase II|Withdrawal by Subject|2|||
27940491|NCT01064648|81614994|FG003|Phase II|Withdrawal by Subject|5|||
27940492|NCT01064648|81614991|FG000|Phase II|Progression|0|||
27940493|NCT01064648|81614992|FG001|Phase II|Progression|0|||
27940494|NCT01064648|81614993|FG002|Phase II|Progression|21|||
27940495|NCT01064648|81614994|FG003|Phase II|Progression|27|||
27940496|NCT01064648|81614991|FG000|Phase II|Non-protocol specified|0|||
27940497|NCT01064648|81614992|FG001|Phase II|Non-protocol specified|0|||
27940498|NCT01064648|81614993|FG002|Phase II|Non-protocol specified|5|||
27940499|NCT01064648|81614994|FG003|Phase II|Non-protocol specified|3|||
27940500|NCT01064648|81614991|FG000|Phase II|Under Review|0|||
27940501|NCT01064648|81614992|FG001|Phase II|Under Review|0|||
27940502|NCT01064648|81614993|FG002|Phase II|Under Review|2|||
27940503|NCT01064648|81614994|FG003|Phase II|Under Review|0|||
27940504|NCT03996395|81617022|FG000|Overall Study|Lost to Follow-up|4|||
27940505|NCT03996395|81617022|FG000|Overall Study|Withdrawal by Subject|1|||
27940506|NCT03996395|81617022|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
27940507|NCT03692052|81617025|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
27940508|NCT03692052|81617025|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
27940509|NCT03692052|81617025|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
27940510|NCT03692052|81617025|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
27940511|NCT04105725|81617026|FG000|Primary Intervention|Lost to Follow-up|0|||
27940512|NCT04105725|81617027|FG001|Primary Intervention|Lost to Follow-up|2|||
27940513|NCT04105725|81617026|FG000|Primary Intervention|Withdrawal by Subject|0|||
27940514|NCT04105725|81617027|FG001|Primary Intervention|Withdrawal by Subject|1|||
27940515|NCT01275677|81617028|FG000|Overall Study|Not at risk for recurrence.|1|||
27940516|NCT01275677|81617029|FG001|Overall Study|Not at risk for recurrence.|1|||
27940517|NCT01275677|81617028|FG000|Overall Study|No follow-up|26|||
27940518|NCT01275677|81617029|FG001|Overall Study|No follow-up|37|||
27940519|NCT01275677|81617028|FG000|Overall Study|No clinical follow up.|1|||
27940520|NCT01275677|81617029|FG001|Overall Study|No clinical follow up.|4|||
27940521|NCT03822468|81617031|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
27940522|NCT03822468|81617032|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
27940523|NCT03822468|81617031|FG000|Treatment Period|Progressive disease|50|||
27940524|NCT03822468|81617032|FG001|Treatment Period|Progressive disease|51|||
27940525|NCT03822468|81617031|FG000|Treatment Period|Adverse Event|16|||
27940526|NCT03822468|81617032|FG001|Treatment Period|Adverse Event|18|||
27940527|NCT03822468|81617031|FG000|Treatment Period|Patient decision|4|||
27940528|NCT03822468|81617032|FG001|Treatment Period|Patient decision|5|||
27940529|NCT03822468|81617031|FG000|Treatment Period|Physician Decision|4|||
27940530|NCT03822468|81617032|FG001|Treatment Period|Physician Decision|5|||
27940531|NCT03822468|81617031|FG000|Treatment Period|Protocol deviation|2|||
27940532|NCT03822468|81617032|FG001|Treatment Period|Protocol deviation|1|||
27940533|NCT03822468|81617031|FG000|Treatment Period|Death|1|||
27940534|NCT03822468|81617032|FG001|Treatment Period|Death|1|||
27940535|NCT03822468|81617031|FG000|Treatment Period|Lost to Follow-up|1|||
27940536|NCT03822468|81617032|FG001|Treatment Period|Lost to Follow-up|0|||
27940537|NCT03822468|81617031|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
27940538|NCT03822468|81617032|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
27940539|NCT03822468|81617031|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
27940540|NCT03822468|81617032|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
27940541|NCT03822468|81617031|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
27940542|NCT03822468|81617032|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
27940543|NCT03822468|81617031|FG000|Post-treatment Efficacy Follow-up|Death|1|||
27940544|NCT03822468|81617032|FG001|Post-treatment Efficacy Follow-up|Death|0|||
27940545|NCT03822468|81617031|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
27940546|NCT03822468|81617032|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
27940547|NCT02819518|81617033|FG000|Overall Study|Death|9|||
27645688|NCT00982644|80543679|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
27645689|NCT00982644|80543678|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
27645690|NCT00982644|80543679|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
27645691|NCT00982644|80543678|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
27645692|NCT00982644|80543679|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
27645693|NCT00982644|80543678|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
27645694|NCT00982644|80543679|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
27645695|NCT00982644|80543678|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
27645696|NCT00982644|80543679|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
27645697|NCT00982644|80543678|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
27645698|NCT00982644|80543679|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
27940548|NCT02819518|81617034|FG001|Overall Study|Death|12|||
27940549|NCT02819518|81617035|FG002|Overall Study|Death|9|||
27940550|NCT02819518|81617036|FG003|Overall Study|Death|475|||
27940551|NCT02819518|81617037|FG004|Overall Study|Death|244|||
27940552|NCT02819518|81617033|FG000|Overall Study|Withdrawal by Subject|0|||
27940553|NCT02819518|81617034|FG001|Overall Study|Withdrawal by Subject|0|||
27940554|NCT02819518|81617035|FG002|Overall Study|Withdrawal by Subject|0|||
27940555|NCT02819518|81617036|FG003|Overall Study|Withdrawal by Subject|25|||
27940556|NCT02819518|81617037|FG004|Overall Study|Withdrawal by Subject|8|||
27940557|NCT02819518|81617033|FG000|Overall Study|Lost to Follow-up|0|||
27940558|NCT02819518|81617034|FG001|Overall Study|Lost to Follow-up|0|||
27940559|NCT02819518|81617035|FG002|Overall Study|Lost to Follow-up|0|||
27940560|NCT02819518|81617036|FG003|Overall Study|Lost to Follow-up|0|||
27940561|NCT02819518|81617037|FG004|Overall Study|Lost to Follow-up|1|||
27940562|NCT02819518|81617033|FG000|Overall Study|Sponsor Decision|1|||
27940563|NCT02819518|81617034|FG001|Overall Study|Sponsor Decision|1|||
27940564|NCT02819518|81617035|FG002|Overall Study|Sponsor Decision|0|||
27940565|NCT02819518|81617036|FG003|Overall Study|Sponsor Decision|34|||
27940566|NCT02819518|81617037|FG004|Overall Study|Sponsor Decision|17|||
27940567|NCT02819518|81617033|FG000|Overall Study|Transferred to extension study|1|||
27940568|NCT02819518|81617034|FG001|Overall Study|Transferred to extension study|1|||
27940569|NCT02819518|81617035|FG002|Overall Study|Transferred to extension study|1|||
27940570|NCT02819518|81617036|FG003|Overall Study|Transferred to extension study|32|||
27940571|NCT02819518|81617037|FG004|Overall Study|Transferred to extension study|11|||
27940572|NCT04562090|81617038|FG000|Overall Study|Withdrawal by Subject|3|||
27940573|NCT04562090|81617039|FG001|Overall Study|Withdrawal by Subject|4|||
27940574|NCT04562090|81617038|FG000|Overall Study|Protocol Violation|2|||
27940575|NCT04562090|81617039|FG001|Overall Study|Protocol Violation|0|||
27940576|NCT04562090|81617038|FG000|Overall Study|Lack of Efficacy|0|||
27940577|NCT04562090|81617039|FG001|Overall Study|Lack of Efficacy|1|||
27940578|NCT04562090|81617038|FG000|Overall Study|Adverse Event|1|||
27940579|NCT04562090|81617039|FG001|Overall Study|Adverse Event|4|||
27940580|NCT04562090|81617038|FG000|Overall Study|Miscellaneous|0|||
27940581|NCT04562090|81617039|FG001|Overall Study|Miscellaneous|3|||
27940582|NCT04903093|81617040|FG000|Overall Study|Withdrawal by Subject|0|||
27940583|NCT04903093|81617041|FG001|Overall Study|Withdrawal by Subject|0|||
27940584|NCT04903093|81617042|FG002|Overall Study|Withdrawal by Subject|0|||
27940585|NCT04903093|81617043|FG003|Overall Study|Withdrawal by Subject|1|||
27940586|NCT04903093|81617044|FG004|Overall Study|Withdrawal by Subject|0|||
27940587|NCT04903093|81617045|FG005|Overall Study|Withdrawal by Subject|0|||
27940588|NCT01657942|81617046|FG000|Overall Study|Alternative Treatment|7|||
27940589|NCT01657942|81617046|FG000|Overall Study|Lost to Follow-up|1|||
27940590|NCT02115282|81617047|FG000|Overall Study|Disease progression during treatment|216|||
27645699|NCT00982644|80543678|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
27755008|NCT04937816|80929649|FG000|Overall Study|Not treated|4|||
27940591|NCT02115282|81617048|FG001|Overall Study|Disease progression during treatment|229|||
27940592|NCT02115282|81617047|FG000|Overall Study|Adverse Event|49|||
27940593|NCT02115282|81617048|FG001|Overall Study|Adverse Event|23|||
27940594|NCT02115282|81617047|FG000|Overall Study|Death|1|||
27940595|NCT02115282|81617048|FG001|Overall Study|Death|3|||
27940596|NCT02115282|81617047|FG000|Overall Study|Alternative therapy|1|||
27940597|NCT02115282|81617048|FG001|Overall Study|Alternative therapy|1|||
27940598|NCT02115282|81617047|FG000|Overall Study|Complicating disease|0|||
27940599|NCT02115282|81617048|FG001|Overall Study|Complicating disease|3|||
27940600|NCT02115282|81617047|FG000|Overall Study|Withdrawal by Subject|12|||
27940601|NCT02115282|81617048|FG001|Overall Study|Withdrawal by Subject|10|||
27940602|NCT02115282|81617047|FG000|Overall Study|Symptomatic progression/deterioration|7|||
27940603|NCT02115282|81617048|FG001|Overall Study|Symptomatic progression/deterioration|18|||
27940604|NCT02115282|81617047|FG000|Overall Study|Non-compliance|5|||
27940605|NCT02115282|81617048|FG001|Overall Study|Non-compliance|1|||
27940606|NCT02115282|81617047|FG000|Overall Study|Protocol Violation|2|||
27940607|NCT02115282|81617048|FG001|Overall Study|Protocol Violation|2|||
27940608|NCT02115282|81617047|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
27940609|NCT02115282|81617048|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
27940610|NCT02115282|81617047|FG000|Overall Study|Not start protocol therapy|9|||
27940611|NCT02115282|81617048|FG001|Overall Study|Not start protocol therapy|10|||
27940612|NCT04725188|81617050|FG000|Overall Study|Death|44|||
27940613|NCT04725188|81617051|FG001|Overall Study|Death|46|||
27940614|NCT04725188|81617052|FG002|Overall Study|Death|48|||
27940615|NCT04725188|81617050|FG000|Overall Study|Lost to Follow-up|0|||
27940616|NCT04725188|81617051|FG001|Overall Study|Lost to Follow-up|0|||
27940617|NCT04725188|81617052|FG002|Overall Study|Lost to Follow-up|1|||
27940618|NCT04725188|81617050|FG000|Overall Study|Withdrawal by Subject|2|||
27940619|NCT04725188|81617051|FG001|Overall Study|Withdrawal by Subject|2|||
27940620|NCT04725188|81617052|FG002|Overall Study|Withdrawal by Subject|1|||
27940621|NCT04725188|81617050|FG000|Overall Study|Participants ongoing in the study|41|||
27940622|NCT04725188|81617051|FG001|Overall Study|Participants ongoing in the study|35|||
27940623|NCT04725188|81617052|FG002|Overall Study|Participants ongoing in the study|35|||
27940624|NCT05287685|81617055|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
27940625|NCT05287685|81617056|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
27940626|NCT05287685|81617055|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
27940627|NCT05287685|81617056|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
27940628|NCT02766478|81617057|FG000|Overall Study|Withdrawal by Subject|1|||
27940629|NCT02766478|81617058|FG001|Overall Study|Withdrawal by Subject|1|||
27940630|NCT01575548|81617062|FG000|Overall Study|Adverse Event|15|||
27940631|NCT01575548|81617063|FG001|Overall Study|Adverse Event|2|||
27940632|NCT01575548|81617062|FG000|Overall Study|Disease progression|12|||
27940633|NCT01575548|81617063|FG001|Overall Study|Disease progression|25|||
27940634|NCT01575548|81617062|FG000|Overall Study|Death|1|||
27940635|NCT01575548|81617063|FG001|Overall Study|Death|0|||
27940636|NCT01575548|81617062|FG000|Overall Study|Other complicating disease|1|||
27940637|NCT01575548|81617063|FG001|Overall Study|Other complicating disease|0|||
27940638|NCT01575548|81617062|FG000|Overall Study|Withdrawal by Subject|7|||
27940639|NCT01575548|81617063|FG001|Overall Study|Withdrawal by Subject|3|||
27940640|NCT01575548|81617062|FG000|Overall Study|Noncompliance|1|||
27940641|NCT01575548|81617063|FG001|Overall Study|Noncompliance|0|||
27940642|NCT01575548|81617062|FG000|Overall Study|Anticipated surgery|0|||
27940643|NCT01575548|81617063|FG001|Overall Study|Anticipated surgery|1|||
27940644|NCT01575548|81617062|FG000|Overall Study|Never started protocol therapy|3|||
27940645|NCT01575548|81617063|FG001|Overall Study|Never started protocol therapy|2|||
27940646|NCT02771145|81617069|FG000|Overall Study|Adverse Event|3|||
27940647|NCT02771145|81617069|FG000|Overall Study|Lost to Follow-up|1|||
27940648|NCT03193437|81617072|FG000|Overall Study|Adverse Event|4|||
27940649|NCT03193437|81617072|FG000|Overall Study|Withdrawal by Subject|2|||
27940650|NCT03193437|81617072|FG000|Overall Study|Disease Progression|2|||
27940651|NCT03280615|81617073|FG000|Overall Study|Lost to Follow-up|1|||
27940652|NCT03280615|81617074|FG001|Overall Study|Lost to Follow-up|2|||
27940653|NCT03280615|81617073|FG000|Overall Study|Adverse Event|1|||
27940654|NCT03280615|81617074|FG001|Overall Study|Adverse Event|1|||
27940655|NCT03280615|81617073|FG000|Overall Study|Withdrawal by Subject|2|||
27746296|NCT02416908|80899603|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
27940656|NCT03280615|81617074|FG001|Overall Study|Withdrawal by Subject|2|||
27940657|NCT03581292|81617075|FG000|Overall Study|Physician Decision|9|||
27940658|NCT03581292|81617076|FG001|Overall Study|Physician Decision|5|||
27940659|NCT03581292|81617075|FG000|Overall Study|Withdrawal by Subject|3|||
27940660|NCT03581292|81617076|FG001|Overall Study|Withdrawal by Subject|0|||
27940661|NCT03581292|81617075|FG000|Overall Study|Withdrawal before Therapy Start|1|||
27940662|NCT03581292|81617076|FG001|Overall Study|Withdrawal before Therapy Start|0|||
27940663|NCT03769467|81617077|FG000|Overall Study|Adverse Event|1|||
27940664|NCT03769467|81617078|FG001|Overall Study|Adverse Event|1|||
27940665|NCT03769467|81617079|FG002|Overall Study|Adverse Event|0|||
27940666|NCT03769467|81617077|FG000|Overall Study|Death|3|||
27940667|NCT03769467|81617078|FG001|Overall Study|Death|3|||
27940668|NCT03769467|81617079|FG002|Overall Study|Death|0|||
27940669|NCT03769467|81617077|FG000|Overall Study|Study Terminated By Sponsor|2|||
27940670|NCT03769467|81617078|FG001|Overall Study|Study Terminated By Sponsor|1|||
27940671|NCT03769467|81617079|FG002|Overall Study|Study Terminated By Sponsor|0|||
27940672|NCT03769467|81617077|FG000|Overall Study|Withdrawal by Subject|0|||
27940673|NCT03769467|81617078|FG001|Overall Study|Withdrawal by Subject|1|||
27940674|NCT03769467|81617079|FG002|Overall Study|Withdrawal by Subject|0|||
27940675|NCT02633527|81617080|FG000|Overall Study|Failed to meet eligibility|0|||
27940676|NCT02633527|81617081|FG001|Overall Study|Failed to meet eligibility|1|||
27940677|NCT02633527|81617082|FG002|Overall Study|Failed to meet eligibility|1|||
27940678|NCT02633527|81617083|FG003|Overall Study|Failed to meet eligibility|0|||
27940679|NCT02633527|81617084|FG004|Overall Study|Failed to meet eligibility|1|||
27940680|NCT02633527|81617080|FG000|Overall Study|Adverse Event|0|||
27940681|NCT02633527|81617081|FG001|Overall Study|Adverse Event|4|||
27940682|NCT02633527|81617082|FG002|Overall Study|Adverse Event|3|||
27940683|NCT02633527|81617083|FG003|Overall Study|Adverse Event|1|||
27940684|NCT02633527|81617084|FG004|Overall Study|Adverse Event|5|||
27940685|NCT02633527|81617080|FG000|Overall Study|Lost to Follow-up|1|||
27940686|NCT02633527|81617081|FG001|Overall Study|Lost to Follow-up|2|||
27940687|NCT02633527|81617082|FG002|Overall Study|Lost to Follow-up|5|||
27940688|NCT02633527|81617083|FG003|Overall Study|Lost to Follow-up|5|||
27940689|NCT02633527|81617084|FG004|Overall Study|Lost to Follow-up|4|||
27940690|NCT02633527|81617080|FG000|Overall Study|Withdrawal by Subject|0|||
27940691|NCT02633527|81617081|FG001|Overall Study|Withdrawal by Subject|3|||
27645700|NCT00982644|80543679|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
27645701|NCT00982644|80543678|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
27645702|NCT00982644|80543679|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
27645703|NCT00982644|80543678|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
27940692|NCT02633527|81617082|FG002|Overall Study|Withdrawal by Subject|5|||
27940693|NCT02633527|81617083|FG003|Overall Study|Withdrawal by Subject|4|||
27940694|NCT02633527|81617084|FG004|Overall Study|Withdrawal by Subject|4|||
27940695|NCT02633527|81617080|FG000|Overall Study|Protocol Violation|0|||
27940696|NCT02633527|81617081|FG001|Overall Study|Protocol Violation|1|||
27940697|NCT02633527|81617082|FG002|Overall Study|Protocol Violation|1|||
27940698|NCT02633527|81617083|FG003|Overall Study|Protocol Violation|1|||
27940699|NCT02633527|81617084|FG004|Overall Study|Protocol Violation|1|||
27940700|NCT02633527|81617080|FG000|Overall Study|Physician Decision|0|||
27940701|NCT02633527|81617081|FG001|Overall Study|Physician Decision|0|||
27940702|NCT02633527|81617082|FG002|Overall Study|Physician Decision|0|||
27940703|NCT02633527|81617083|FG003|Overall Study|Physician Decision|0|||
27940704|NCT02633527|81617084|FG004|Overall Study|Physician Decision|1|||
27940705|NCT02633527|81617080|FG000|Overall Study|Administrative reason|1|||
27940706|NCT02633527|81617081|FG001|Overall Study|Administrative reason|0|||
27940707|NCT02633527|81617082|FG002|Overall Study|Administrative reason|0|||
27940708|NCT02633527|81617083|FG003|Overall Study|Administrative reason|1|||
27940709|NCT02633527|81617084|FG004|Overall Study|Administrative reason|0|||
27940710|NCT02633527|81617080|FG000|Overall Study|Multiple reasons|1|||
27940711|NCT02633527|81617081|FG001|Overall Study|Multiple reasons|0|||
27940712|NCT02633527|81617082|FG002|Overall Study|Multiple reasons|2|||
27645704|NCT00982644|80543679|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
27645705|NCT01968967|80543686|FG000|Treatment Period|Other|22|||
27645706|NCT01968967|80543687|FG001|Treatment Period|Other|22|||
27645707|NCT01968967|80543688|FG002|Treatment Period|Other|0|||
27645708|NCT01968967|80543689|FG003|Treatment Period|Other|0|||
27645709|NCT01968967|80543690|FG004|Treatment Period|Other|0|||
27645710|NCT01968967|80543686|FG000|Treatment Period|Withdrawal by Subject|71|||
27645711|NCT01968967|80543687|FG001|Treatment Period|Withdrawal by Subject|61|||
27645712|NCT01968967|80543688|FG002|Treatment Period|Withdrawal by Subject|0|||
27645713|NCT01968967|80543689|FG003|Treatment Period|Withdrawal by Subject|0|||
27645714|NCT01968967|80543690|FG004|Treatment Period|Withdrawal by Subject|0|||
27645715|NCT01968967|80543686|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
27645716|NCT01968967|80543687|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
27645717|NCT01968967|80543688|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
27645718|NCT01968967|80543689|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
27645719|NCT01968967|80543690|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
27645720|NCT01968967|80543686|FG000|Treatment Period|Lost to Follow-up|26|||
27645721|NCT01968967|80543687|FG001|Treatment Period|Lost to Follow-up|31|||
27645722|NCT01968967|80543688|FG002|Treatment Period|Lost to Follow-up|0|||
27645723|NCT01968967|80543689|FG003|Treatment Period|Lost to Follow-up|0|||
27645724|NCT01968967|80543690|FG004|Treatment Period|Lost to Follow-up|0|||
27645725|NCT01968967|80543686|FG000|Treatment Period|Protocol Violation|1|||
27645726|NCT01968967|80543687|FG001|Treatment Period|Protocol Violation|2|||
27645727|NCT01968967|80543688|FG002|Treatment Period|Protocol Violation|0|||
27645728|NCT01968967|80543689|FG003|Treatment Period|Protocol Violation|0|||
27645729|NCT01968967|80543690|FG004|Treatment Period|Protocol Violation|0|||
27645730|NCT01968967|80543686|FG000|Treatment Period|Adverse Event|9|||
27645731|NCT01968967|80543687|FG001|Treatment Period|Adverse Event|8|||
27645732|NCT01968967|80543688|FG002|Treatment Period|Adverse Event|0|||
27940713|NCT02633527|81617083|FG003|Overall Study|Multiple reasons|2|||
27940714|NCT02633527|81617084|FG004|Overall Study|Multiple reasons|1|||
27940715|NCT02536339|81617085|FG000|Overall Study|Death|20|||
27940716|NCT02536339|81617085|FG000|Overall Study|Withdrawal by Subject|3|||
27940717|NCT02536339|81617085|FG000|Overall Study|Lost to Follow-up|2|||
27940718|NCT02536339|81617085|FG000|Overall Study|Treatment discontinued|2|||
27940719|NCT02536339|81617085|FG000|Overall Study|Physician Decision|1|||
27940720|NCT05943990|81617086|FG000|Overall Study|Study Terminated by Sponsor|0|||
27940721|NCT05943990|81617087|FG001|Overall Study|Study Terminated by Sponsor|0|||
27940722|NCT05943990|81617088|FG002|Overall Study|Study Terminated by Sponsor|1|||
27940723|NCT00545948|81617089|FG000|Overall Study|Not Treated|1|||
27940724|NCT00545948|81617090|FG001|Overall Study|Not Treated|1|||
27940725|NCT00545948|81617091|FG002|Overall Study|Not Treated|7|||
27940726|NCT03878069|81617092|FG000|Overall Study|Death|0|||
27940727|NCT03878069|81617093|FG001|Overall Study|Death|1|||
27940728|NCT03878069|81617094|FG002|Overall Study|Death|0|||
27940729|NCT02410200|81617101|FG000|Overall Study|Adverse Event|2|||
27940730|NCT04755231|81617102|FG000|Overall Study|Lost to Follow-up|5|||
27940731|NCT04755231|81617102|FG000|Overall Study|Withdrawal by Subject|5|||
27940732|NCT03378635|81617103|FG000|Overall Study|Adverse Event|1|||
27940733|NCT03378635|81617104|FG001|Overall Study|Adverse Event|0|||
27940734|NCT03378635|81617105|FG002|Overall Study|Adverse Event|0|||
27940735|NCT03378635|81617103|FG000|Overall Study|Withdrawal by Subject|1|||
27940736|NCT03378635|81617104|FG001|Overall Study|Withdrawal by Subject|0|||
27940737|NCT03378635|81617105|FG002|Overall Study|Withdrawal by Subject|0|||
27940738|NCT00309946|81617106|FG000|Overall Study|Withdrawal by Subject|1|||
27940739|NCT04157738|81617107|FG000|Overall Study|Moved out of state|0|||
27940740|NCT04157738|81617108|FG001|Overall Study|Moved out of state|2|||
27940741|NCT04157738|81617107|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
27940742|NCT04157738|81617108|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
27940743|NCT01840163|81617109|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
27940744|NCT01840163|81617110|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
27940745|NCT01840163|81617109|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
27940746|NCT01840163|81617110|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
27940747|NCT01840163|81617109|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
27940748|NCT01840163|81617110|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
27940749|NCT02242903|81617113|FG000|Overall Study|Withdrawal by Subject|1|||
27940750|NCT02242903|81617114|FG001|Overall Study|Withdrawal by Subject|0|||
27940751|NCT02242903|81617115|FG002|Overall Study|Withdrawal by Subject|0|||
27940752|NCT02242903|81617116|FG003|Overall Study|Withdrawal by Subject|0|||
27940753|NCT02242903|81617117|FG004|Overall Study|Withdrawal by Subject|0|||
27940754|NCT02242903|81617118|FG005|Overall Study|Withdrawal by Subject|0|||
27940755|NCT02242903|81617119|FG006|Overall Study|Withdrawal by Subject|0|||
27940756|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
27940757|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
27940758|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
27940759|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
27645733|NCT01968967|80543689|FG003|Treatment Period|Adverse Event|0|||
27645734|NCT01968967|80543690|FG004|Treatment Period|Adverse Event|0|||
27645735|NCT01968967|80543686|FG000|Treatment Period|Death|9|||
27645736|NCT01968967|80543687|FG001|Treatment Period|Death|2|||
27645737|NCT01968967|80543688|FG002|Treatment Period|Death|0|||
27645738|NCT01968967|80543689|FG003|Treatment Period|Death|0|||
27645739|NCT01968967|80543690|FG004|Treatment Period|Death|0|||
27645740|NCT01968967|80543686|FG000|Treatment Period|Randomized Not Treated|6|||
27645741|NCT01968967|80543687|FG001|Treatment Period|Randomized Not Treated|5|||
27645742|NCT01968967|80543688|FG002|Treatment Period|Randomized Not Treated|0|||
27645743|NCT01968967|80543689|FG003|Treatment Period|Randomized Not Treated|0|||
27645744|NCT01968967|80543690|FG004|Treatment Period|Randomized Not Treated|0|||
27645745|NCT01968967|80543686|FG000|Extension Period|Withdrew Consent|0|||
27645746|NCT01968967|80543687|FG001|Extension Period|Withdrew Consent|0|||
27645747|NCT01968967|80543688|FG002|Extension Period|Withdrew Consent|2|||
27645748|NCT01968967|80543689|FG003|Extension Period|Withdrew Consent|0|||
27645749|NCT01968967|80543690|FG004|Extension Period|Withdrew Consent|5|||
27940760|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
27940761|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
27940762|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
27940763|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
27940764|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
27940765|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
27940766|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
27940767|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
27645750|NCT01593020|80543691|FG000|Overall Study|Adverse Event|1|||
27645751|NCT01593020|80543692|FG001|Overall Study|Adverse Event|1|||
27645752|NCT01593020|80543691|FG000|Overall Study|Death|0|||
27940768|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
27940769|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
27940770|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
27645753|NCT01593020|80543692|FG001|Overall Study|Death|1|||
27645754|NCT01593020|80543691|FG000|Overall Study|Ineligible|1|||
27645755|NCT01593020|80543692|FG001|Overall Study|Ineligible|0|||
27940771|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
27940772|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
27940773|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
27940774|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
27940775|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
27940776|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
27940777|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
27645756|NCT01972776|80543693|FG000|Part 1|Withdrawal by Subject|0|||
27645757|NCT01972776|80543694|FG001|Part 1|Withdrawal by Subject|0|||
27645758|NCT01972776|80543695|FG002|Part 1|Withdrawal by Subject|1|||
27645759|NCT01972776|80543696|FG003|Part 1|Withdrawal by Subject|0|||
27645760|NCT01972776|80543697|FG004|Part 1|Withdrawal by Subject|0|||
27645761|NCT01972776|80543698|FG005|Part 1|Withdrawal by Subject|0|||
27645762|NCT01972776|80543693|FG000|Part 1|Adverse Event|0|||
27645763|NCT01972776|80543694|FG001|Part 1|Adverse Event|0|||
27645764|NCT01972776|80543695|FG002|Part 1|Adverse Event|1|||
27940778|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
27940779|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
27940780|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
27940781|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
27940782|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
27940783|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
27940784|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
27645765|NCT01972776|80543696|FG003|Part 1|Adverse Event|1|||
27645766|NCT01972776|80543697|FG004|Part 1|Adverse Event|0|||
27645767|NCT01972776|80543698|FG005|Part 1|Adverse Event|0|||
27645768|NCT01972776|80543693|FG000|Part 2|Adverse Event|0|||
27645769|NCT01972776|80543694|FG001|Part 2|Adverse Event|0|||
27645770|NCT01972776|80543695|FG002|Part 2|Adverse Event|0|||
27645771|NCT01972776|80543696|FG003|Part 2|Adverse Event|0|||
27645772|NCT01972776|80543697|FG004|Part 2|Adverse Event|3|||
27645773|NCT01972776|80543698|FG005|Part 2|Adverse Event|0|||
27645774|NCT01972776|80543693|FG000|Part 2|Administrative problems|0|||
27645775|NCT01972776|80543694|FG001|Part 2|Administrative problems|0|||
27645776|NCT01972776|80543695|FG002|Part 2|Administrative problems|0|||
27940785|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
27940786|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
27940787|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
27940788|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
27940789|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
27940790|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
27645777|NCT01972776|80543696|FG003|Part 2|Administrative problems|0|||
27645778|NCT01972776|80543697|FG004|Part 2|Administrative problems|10|||
27645779|NCT01972776|80543698|FG005|Part 2|Administrative problems|7|||
27940791|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
27940792|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
27940793|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
27645780|NCT02147093|80543699|FG000|Period 1|Lost to Follow-up|0|||
27645781|NCT02147093|80543700|FG001|Period 1|Lost to Follow-up|1|||
27645782|NCT02147093|80543699|FG000|Period 2|Protocol Violation|2|||
27645783|NCT02147093|80543700|FG001|Period 2|Protocol Violation|0|||
27645784|NCT03689946|80543701|FG000|Overall Study|Withdrawal by Subject|3|||
27645785|NCT03689946|80543701|FG000|Overall Study|Lost to Follow-up|3|||
27645786|NCT03689946|80543701|FG000|Overall Study|Data corruption|2|||
27645787|NCT00491894|80543702|FG000|Overall Study|Adverse Event|14|||
27645788|NCT00491894|80543702|FG000|Overall Study|Withdrawal by Subject|5|||
27645789|NCT00491894|80543702|FG000|Overall Study|Death|3|||
27645790|NCT00491894|80543702|FG000|Overall Study|Lost to Follow-up|3|||
27645791|NCT00491894|80543702|FG000|Overall Study|Lack of Efficacy|2|||
27645792|NCT00491894|80543702|FG000|Overall Study|Other-Failed to meet any criteria|2|||
27645793|NCT00491894|80543702|FG000|Overall Study|Physician Decision|2|||
27645794|NCT00491894|80543702|FG000|Overall Study|Protocol Violation|2|||
27645795|NCT00491894|80543702|FG000|Overall Study|Other-Intake of prohibited medication|1|||
27645796|NCT01596972|80543705|FG000|Overall Study|Physician Decision|1|||
27645797|NCT01596972|80543706|FG001|Overall Study|Physician Decision|9|||
27645798|NCT01596972|80543705|FG000|Overall Study|Lost to Follow-up|0|||
27645799|NCT01596972|80543706|FG001|Overall Study|Lost to Follow-up|4|||
27645800|NCT01596972|80543705|FG000|Overall Study|Withdrawal by Subject|0|||
27645801|NCT01596972|80543706|FG001|Overall Study|Withdrawal by Subject|1|||
27645802|NCT03345095|80543709|FG000|Overall Study|Lack of Efficacy|184|||
27645803|NCT03345095|80543710|FG001|Overall Study|Lack of Efficacy|156|||
27645804|NCT03345095|80543709|FG000|Overall Study|Adverse Event|36|||
27645805|NCT03345095|80543710|FG001|Overall Study|Adverse Event|118|||
27645806|NCT03345095|80543709|FG000|Overall Study|Withdrawal by Subject|22|||
27645807|NCT03345095|80543710|FG001|Overall Study|Withdrawal by Subject|59|||
27940794|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
27940795|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
27940796|NCT02596893|81617124|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
27940797|NCT02596893|81617125|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
27940798|NCT02596893|81617126|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
27940799|NCT02596893|81617127|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
27940800|NCT05626686|81617128|FG000|Overall Study|Protocol Violation|3|||
27940801|NCT05626686|81617128|FG000|Overall Study|Withdrawal by Subject|3|||
27940802|NCT05346640|81617130|FG000|Overall Study|Lack of Efficacy|2|||
27940803|NCT05346640|81617130|FG000|Overall Study|Lost to Follow-up|14|||
27940804|NCT05346640|81617130|FG000|Overall Study|Protocol Violation|4|||
27940805|NCT05346640|81617130|FG000|Overall Study|Withdrawal by Subject|2|||
27940806|NCT05346640|81617130|FG000|Overall Study|Physiological Complications|3|||
27940807|NCT05346640|81617130|FG000|Overall Study|Other Reason|3|||
27940808|NCT03810495|81617131|FG000|Overall Study|Lost to Follow-up|2|||
27940809|NCT03810495|81617131|FG000|Overall Study|Withdrawal by Subject|1|||
27940810|NCT01034657|81617132|FG000|Core Phase|Withdrawal by Subject|1|||
27940811|NCT01034657|81617133|FG001|Core Phase|Withdrawal by Subject|0|||
27940812|NCT01034657|81617134|FG002|Core Phase|Withdrawal by Subject|0|||
27940813|NCT01034657|81617132|FG000|Core Phase|Lack of Efficacy|2|||
27940814|NCT01034657|81617133|FG001|Core Phase|Lack of Efficacy|0|||
27940815|NCT01034657|81617134|FG002|Core Phase|Lack of Efficacy|0|||
27940816|NCT01034657|81617132|FG000|Core Phase|Abnormal laboratory value|1|||
27940817|NCT01034657|81617133|FG001|Core Phase|Abnormal laboratory value|0|||
27940818|NCT01034657|81617134|FG002|Core Phase|Abnormal laboratory value|0|||
27940819|NCT01034657|81617132|FG000|Core Phase|Adverse Event|8|||
27940820|NCT01034657|81617133|FG001|Core Phase|Adverse Event|0|||
27940821|NCT01034657|81617134|FG002|Core Phase|Adverse Event|0|||
27940822|NCT01034657|81617132|FG000|Core Phase|Protocol Violation|2|||
27746297|NCT00436215|80899604|FG000|Overall Study|Refused further treatment|3|||
27940823|NCT01034657|81617133|FG001|Core Phase|Protocol Violation|0|||
27940824|NCT01034657|81617134|FG002|Core Phase|Protocol Violation|0|||
27940825|NCT01034657|81617132|FG000|Randomized Phase|Withdrawal by Subject|0|||
27940826|NCT01034657|81617133|FG001|Randomized Phase|Withdrawal by Subject|2|||
27940827|NCT01034657|81617134|FG002|Randomized Phase|Withdrawal by Subject|0|||
27940828|NCT01034657|81617132|FG000|Randomized Phase|Lack of Efficacy|5|||
27940829|NCT01034657|81617133|FG001|Randomized Phase|Lack of Efficacy|1|||
27940830|NCT01034657|81617134|FG002|Randomized Phase|Lack of Efficacy|0|||
27940831|NCT01034657|81617132|FG000|Randomized Phase|Abnormal laboratory value|0|||
27940832|NCT01034657|81617133|FG001|Randomized Phase|Abnormal laboratory value|1|||
27940833|NCT01034657|81617134|FG002|Randomized Phase|Abnormal laboratory value|0|||
27940834|NCT01034657|81617132|FG000|Randomized Phase|Adverse Event|0|||
27940835|NCT01034657|81617133|FG001|Randomized Phase|Adverse Event|2|||
27940836|NCT01034657|81617134|FG002|Randomized Phase|Adverse Event|1|||
27940837|NCT01093534|81617135|FG000|Overall Study|Adverse Event|2|||
27940838|NCT01093534|81617136|FG001|Overall Study|Adverse Event|5|||
27940839|NCT01093534|81617137|FG002|Overall Study|Adverse Event|2|||
27940840|NCT01093534|81617135|FG000|Overall Study|Lack of Efficacy|2|||
27940841|NCT01093534|81617136|FG001|Overall Study|Lack of Efficacy|1|||
27940842|NCT01093534|81617137|FG002|Overall Study|Lack of Efficacy|1|||
27940843|NCT01093534|81617135|FG000|Overall Study|Withdrawal by Subject|5|||
27940844|NCT01093534|81617136|FG001|Overall Study|Withdrawal by Subject|7|||
27940845|NCT01093534|81617137|FG002|Overall Study|Withdrawal by Subject|2|||
27940846|NCT01093534|81617135|FG000|Overall Study|Other|1|||
27940847|NCT01093534|81617136|FG001|Overall Study|Other|3|||
27940848|NCT01093534|81617137|FG002|Overall Study|Other|4|||
27940849|NCT04642079|81617138|FG000|Overall Study|Lost to Follow-up|2|||
27940850|NCT04642079|81617139|FG001|Overall Study|Lost to Follow-up|5|||
27940851|NCT04642079|81617140|FG002|Overall Study|Lost to Follow-up|2|||
27940852|NCT04642079|81617141|FG003|Overall Study|Lost to Follow-up|0|||
27940853|NCT04642079|81617138|FG000|Overall Study|Withdrawal by Subject|0|||
27940854|NCT04642079|81617139|FG001|Overall Study|Withdrawal by Subject|4|||
27940855|NCT04642079|81617140|FG002|Overall Study|Withdrawal by Subject|1|||
27940856|NCT04642079|81617141|FG003|Overall Study|Withdrawal by Subject|2|||
27940857|NCT04642079|81617138|FG000|Overall Study|Other|0|||
27940858|NCT04642079|81617139|FG001|Overall Study|Other|0|||
27940859|NCT04642079|81617140|FG002|Overall Study|Other|0|||
27940860|NCT04642079|81617141|FG003|Overall Study|Other|1|||
27940861|NCT04642079|81617138|FG000|Overall Study|No longer met eligibility criteria|1|||
27940862|NCT04642079|81617139|FG001|Overall Study|No longer met eligibility criteria|0|||
27940863|NCT04642079|81617140|FG002|Overall Study|No longer met eligibility criteria|1|||
27940864|NCT04642079|81617141|FG003|Overall Study|No longer met eligibility criteria|1|||
27940865|NCT01903733|81617142|FG000|Overall Study|Death|23|||
27940866|NCT01903733|81617143|FG001|Overall Study|Death|54|||
27940867|NCT01903733|81617144|FG002|Overall Study|Death|30|||
27940868|NCT01903733|81617145|FG003|Overall Study|Death|98|||
27940869|NCT01903733|81617142|FG000|Overall Study|Participant refused further follow-up|35|||
27940870|NCT01903733|81617143|FG001|Overall Study|Participant refused further follow-up|38|||
27940871|NCT01903733|81617144|FG002|Overall Study|Participant refused further follow-up|13|||
27940872|NCT01903733|81617145|FG003|Overall Study|Participant refused further follow-up|9|||
27940873|NCT01903733|81617142|FG000|Overall Study|Lost to Follow-up|18|||
27940874|NCT01903733|81617143|FG001|Overall Study|Lost to Follow-up|19|||
27940875|NCT01903733|81617144|FG002|Overall Study|Lost to Follow-up|6|||
27645808|NCT03345095|80543709|FG000|Overall Study|Physician Decision|3|||
27645809|NCT03345095|80543710|FG001|Overall Study|Physician Decision|18|||
27940876|NCT01903733|81617145|FG003|Overall Study|Lost to Follow-up|9|||
27940877|NCT01903733|81617142|FG000|Overall Study|Other|10|||
27940878|NCT01903733|81617143|FG001|Overall Study|Other|15|||
27940879|NCT01903733|81617144|FG002|Overall Study|Other|12|||
27940880|NCT01903733|81617145|FG003|Overall Study|Other|3|||
27645810|NCT03345095|80543709|FG000|Overall Study|Death|2|||
27940881|NCT01903733|81617142|FG000|Overall Study|Missing|2|||
27940882|NCT01903733|81617143|FG001|Overall Study|Missing|0|||
27940883|NCT01903733|81617144|FG002|Overall Study|Missing|0|||
27940884|NCT01903733|81617145|FG003|Overall Study|Missing|0|||
27645811|NCT03345095|80543710|FG001|Overall Study|Death|4|||
27645812|NCT03345095|80543709|FG000|Overall Study|Other reasons|2|||
27645813|NCT03345095|80543710|FG001|Overall Study|Other reasons|11|||
27645814|NCT03345095|80543709|FG000|Overall Study|Protocol Violation|0|||
27645815|NCT03345095|80543710|FG001|Overall Study|Protocol Violation|1|||
27645816|NCT02931396|80543711|FG000|Overall Study|Lost to Follow-up|3|||
27940885|NCT01903733|81617142|FG000|Overall Study|Investigator request|18|||
27940886|NCT01903733|81617143|FG001|Overall Study|Investigator request|0|||
27940887|NCT01903733|81617144|FG002|Overall Study|Investigator request|0|||
27940888|NCT01903733|81617145|FG003|Overall Study|Investigator request|0|||
27940889|NCT00397046|81617146|FG000|Overall Study|Disease Progression|3|||
27940890|NCT00397046|81617147|FG001|Overall Study|Disease Progression|3|||
27940891|NCT00397046|81617148|FG002|Overall Study|Disease Progression|10|||
27940892|NCT00397046|81617149|FG003|Overall Study|Disease Progression|5|||
27940893|NCT00203242|81617152|FG000|Overall Study|Lost to Follow-up|1|||
27940894|NCT00787800|81617153|FG000|Overall Study|Withdrawal by Subject|3|||
27940895|NCT00787800|81617154|FG001|Overall Study|Withdrawal by Subject|5|||
27940896|NCT00787800|81617153|FG000|Overall Study|Death|0|||
27940897|NCT00787800|81617154|FG001|Overall Study|Death|2|||
27940898|NCT04223687|81617155|FG000|Overall Study|Missing primary outcome|1|||
27940899|NCT04223687|81617156|FG001|Overall Study|Missing primary outcome|0|||
27940900|NCT01028560|81617157|FG000|Overall Study|Lack of Efficacy|3|||
27940901|NCT01028560|81617158|FG001|Overall Study|Lack of Efficacy|6|||
27940902|NCT01028560|81617157|FG000|Overall Study|Withdrawal by Subject|7|||
27940903|NCT01028560|81617158|FG001|Overall Study|Withdrawal by Subject|12|||
27940904|NCT02496156|81617165|FG000|Overall Study|Lost to Follow-up|5|||
27940905|NCT02496156|81617166|FG001|Overall Study|Lost to Follow-up|0|||
27645817|NCT02931396|80543712|FG001|Overall Study|Lost to Follow-up|0|||
27645818|NCT02931396|80543711|FG000|Overall Study|Withdrawal by Subject|2|||
27940906|NCT02496156|81617165|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
27940907|NCT02496156|81617166|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
27940908|NCT01903720|81617167|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
27940909|NCT01903720|81617167|FG000|Overall Study|Adverse Event|1|||
27940910|NCT01903720|81617167|FG000|Overall Study|Rescinding of informed consent|2|||
27940911|NCT01903720|81617167|FG000|Overall Study|Lost to Follow-up|2|||
27940912|NCT01903720|81617167|FG000|Overall Study|Treatment with alternative drug|1|||
27940913|NCT04821245|81617168|FG000|Overall Study|Withdrawal by Subject|3|||
27940914|NCT04821245|81617168|FG000|Overall Study|Physician Decision|1|||
27940915|NCT04821245|81617168|FG000|Overall Study|Protocol Violation|5|||
27940916|NCT01539525|81617169|FG000|Overall Study|Lost to Follow-up|19|||
27940917|NCT01539525|81617170|FG001|Overall Study|Lost to Follow-up|12|||
27940918|NCT01539525|81617171|FG002|Overall Study|Lost to Follow-up|11|||
27940919|NCT01539525|81617169|FG000|Overall Study|Withdrawal by Subject|0|||
27645819|NCT02931396|80543712|FG001|Overall Study|Withdrawal by Subject|0|||
27645820|NCT01988402|80543713|FG000|Overall Study|Adverse Event|1|||
27940920|NCT01539525|81617170|FG001|Overall Study|Withdrawal by Subject|3|||
27940921|NCT01539525|81617171|FG002|Overall Study|Withdrawal by Subject|2|||
27940922|NCT01539525|81617169|FG000|Overall Study|Protocol Violation|1|||
27940923|NCT01539525|81617170|FG001|Overall Study|Protocol Violation|1|||
27940924|NCT01539525|81617171|FG002|Overall Study|Protocol Violation|4|||
27940925|NCT00107614|81617172|FG000|Overall Study|Physician Decision|10|||
27940926|NCT00107614|81617172|FG000|Overall Study|Death|2|||
27645821|NCT01988402|80543714|FG001|Overall Study|Adverse Event|2|||
27645822|NCT01988402|80543713|FG000|Overall Study|Withdrawal by Subject|1|||
27940927|NCT00461812|81617173|FG000|Overall Study|study terminated|10|||
27940928|NCT03186378|81617174|FG000|Overall Study|Lost to Follow-up|1|||
27940929|NCT03186378|81617175|FG001|Overall Study|Lost to Follow-up|0|||
27940930|NCT02605967|81617176|FG000|Overall Study|subject / guardian decision|1|||
27940931|NCT02605967|81617177|FG001|Overall Study|subject / guardian decision|2|||
27940932|NCT02605967|81617176|FG000|Overall Study|Physician Decision|10|||
27940933|NCT02605967|81617177|FG001|Overall Study|Physician Decision|1|||
27940934|NCT02605967|81617176|FG000|Overall Study|Death|4|||
27645823|NCT01988402|80543714|FG001|Overall Study|Withdrawal by Subject|0|||
27645824|NCT03476798|80543715|FG000|Overall Study|Death|1|||
27645825|NCT03476798|80543715|FG000|Overall Study|Withdrawal by Subject|2|||
27645826|NCT03476798|80543715|FG000|Overall Study|Protocol Violation|2|||
27645827|NCT02022657|80543718|FG000|Overall Study|Withdrawal by Subject|2|||
27645828|NCT02022657|80543719|FG001|Overall Study|Withdrawal by Subject|0|||
27645829|NCT02022657|80543720|FG002|Overall Study|Withdrawal by Subject|1|||
27645830|NCT02022657|80543721|FG003|Overall Study|Withdrawal by Subject|0|||
27645831|NCT02022657|80543722|FG004|Overall Study|Withdrawal by Subject|0|||
27645832|NCT02022657|80543723|FG005|Overall Study|Withdrawal by Subject|0|||
27645833|NCT02022657|80543718|FG000|Overall Study|Physician Decision|0|||
27645834|NCT02022657|80543719|FG001|Overall Study|Physician Decision|0|||
27645835|NCT02022657|80543720|FG002|Overall Study|Physician Decision|0|||
27645836|NCT02022657|80543721|FG003|Overall Study|Physician Decision|0|||
27940935|NCT02605967|81617177|FG001|Overall Study|Death|2|||
27940936|NCT02605967|81617176|FG000|Overall Study|Adverse Event|1|||
27940937|NCT02605967|81617177|FG001|Overall Study|Adverse Event|0|||
27940938|NCT02605967|81617176|FG000|Overall Study|progressive disease|66|||
27940939|NCT02605967|81617177|FG001|Overall Study|progressive disease|35|||
27940940|NCT02412436|81617201|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
27940941|NCT02412436|81617201|FG000|Overall Study|Lost to Follow-up|6|||
27940942|NCT02412436|81617201|FG000|Overall Study|Unable to get to clinic|3|||
27940943|NCT02412436|81617201|FG000|Overall Study|Death|1|||
27940944|NCT02412436|81617201|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
27940945|NCT01248468|81617202|FG000|Overall Study|Administrative problem|1|||
27940946|NCT01248468|81617203|FG001|Overall Study|Administrative problem|0|||
27940947|NCT01248468|81617204|FG002|Overall Study|Administrative problem|0|||
27940948|NCT01248468|81617202|FG000|Overall Study|Lost to Follow-up|9|||
27940949|NCT01248468|81617203|FG001|Overall Study|Lost to Follow-up|12|||
27940950|NCT01248468|81617204|FG002|Overall Study|Lost to Follow-up|4|||
27940951|NCT01248468|81617202|FG000|Overall Study|Pregnancy|1|||
27940952|NCT01248468|81617203|FG001|Overall Study|Pregnancy|0|||
27940953|NCT01248468|81617204|FG002|Overall Study|Pregnancy|0|||
27940954|NCT01248468|81617202|FG000|Overall Study|Withdrawal by Subject|4|||
27940955|NCT01248468|81617203|FG001|Overall Study|Withdrawal by Subject|2|||
27940956|NCT01248468|81617204|FG002|Overall Study|Withdrawal by Subject|0|||
27940957|NCT03359395|81617210|FG000|First Intervention A / B|Withdrawal by Subject|1|||
27940958|NCT03359395|81617211|FG001|First Intervention A / B|Withdrawal by Subject|0|||
27940959|NCT03359395|81617210|FG000|First Intervention A / B|Lost to Follow-up|2|||
27940960|NCT03359395|81617211|FG001|First Intervention A / B|Lost to Follow-up|3|||
27940961|NCT03359395|81617210|FG000|Second Intervention B/A|Exclusion criteria|0|||
27940962|NCT03359395|81617211|FG001|Second Intervention B/A|Exclusion criteria|1|||
27940963|NCT03359395|81617210|FG000|Second Intervention B/A|Lost to Follow-up|3|||
27940964|NCT03359395|81617211|FG001|Second Intervention B/A|Lost to Follow-up|2|||
27940965|NCT00561821|81617212|FG000|Overall Study|Not treated|0|||
27940966|NCT00561821|81617213|FG001|Overall Study|Not treated|0|||
27940967|NCT00561821|81617214|FG002|Overall Study|Not treated|1|||
27940968|NCT00561821|81617215|FG003|Overall Study|Not treated|0|||
27940969|NCT00561821|81617212|FG000|Overall Study|Withdrawal by Subject|0|||
27645837|NCT02022657|80543722|FG004|Overall Study|Physician Decision|0|||
27645838|NCT02022657|80543723|FG005|Overall Study|Physician Decision|1|||
27645839|NCT01212744|80543727|FG000|Overall Study|Withdrawal by Subject|1|||
27645840|NCT03577106|80543728|FG000|Overall Study|Withdrawal by Subject|3|||
27746298|NCT00436215|80899604|FG000|Overall Study|Small bowel obstruction|1|||
27746299|NCT03345836|80899605|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
27746300|NCT03345836|80899606|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
27746301|NCT03345836|80899607|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
27746302|NCT03345836|80899608|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
27746303|NCT03345836|80899609|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
27746304|NCT03345836|80899610|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
27746305|NCT03345836|80899605|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
27746306|NCT03345836|80899606|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
27746307|NCT03345836|80899607|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
27645841|NCT01324310|80543729|FG000|Overall Study|Adverse Event|1|||
27746308|NCT03345836|80899608|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
27746309|NCT03345836|80899609|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
27755009|NCT04937816|80929650|FG001|Overall Study|Not treated|2|||
27940970|NCT00561821|81617213|FG001|Overall Study|Withdrawal by Subject|1|||
27940971|NCT00561821|81617214|FG002|Overall Study|Withdrawal by Subject|0|||
27940972|NCT00561821|81617215|FG003|Overall Study|Withdrawal by Subject|2|||
27940973|NCT00561821|81617212|FG000|Overall Study|Reasons not related to trial|2|||
27940974|NCT00561821|81617213|FG001|Overall Study|Reasons not related to trial|1|||
27940975|NCT00561821|81617214|FG002|Overall Study|Reasons not related to trial|0|||
27940976|NCT00561821|81617215|FG003|Overall Study|Reasons not related to trial|0|||
27551350|NCT01543698|80207458|FG000|Phase 1b|Withdrawal by Subject|0|||
27940977|NCT00561821|81617212|FG000|Overall Study|Other (reason not specified)|1|||
27940978|NCT00561821|81617213|FG001|Overall Study|Other (reason not specified)|1|||
27940979|NCT00561821|81617214|FG002|Overall Study|Other (reason not specified)|0|||
27940980|NCT00561821|81617215|FG003|Overall Study|Other (reason not specified)|0|||
27940981|NCT00561821|81617212|FG000|Overall Study|Adverse Event|2|||
27940982|NCT00561821|81617213|FG001|Overall Study|Adverse Event|3|||
27940983|NCT00561821|81617214|FG002|Overall Study|Adverse Event|1|||
27940984|NCT00561821|81617215|FG003|Overall Study|Adverse Event|1|||
27940985|NCT04191135|81617218|FG000|Induction Treatment|Not Treated|2|||
27940986|NCT04191135|81617219|FG001|Induction Treatment|Not Treated|0|||
27940987|NCT04191135|81617220|FG002|Induction Treatment|Not Treated|0|||
27940988|NCT04191135|81617218|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
27940989|NCT04191135|81617219|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
27940990|NCT04191135|81617220|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
27940991|NCT04191135|81617218|FG000|Induction Treatment|Adverse Event|25|||
27940992|NCT04191135|81617219|FG001|Induction Treatment|Adverse Event|0|||
27940993|NCT04191135|81617220|FG002|Induction Treatment|Adverse Event|0|||
27940994|NCT04191135|81617218|FG000|Induction Treatment|Clinical Progression|8|||
27940995|NCT04191135|81617219|FG001|Induction Treatment|Clinical Progression|0|||
27940996|NCT04191135|81617220|FG002|Induction Treatment|Clinical Progression|0|||
27940997|NCT04191135|81617218|FG000|Induction Treatment|Excluded Medication|1|||
27940998|NCT04191135|81617219|FG001|Induction Treatment|Excluded Medication|0|||
27940999|NCT04191135|81617220|FG002|Induction Treatment|Excluded Medication|0|||
27941000|NCT04191135|81617218|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
27941001|NCT04191135|81617219|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
27941002|NCT04191135|81617220|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
27941003|NCT04191135|81617218|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
27941004|NCT04191135|81617219|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
27941005|NCT04191135|81617220|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
27941006|NCT04191135|81617218|FG000|Induction Treatment|Physician Decision|2|||
27941007|NCT04191135|81617219|FG001|Induction Treatment|Physician Decision|0|||
27941008|NCT04191135|81617220|FG002|Induction Treatment|Physician Decision|0|||
27941009|NCT04191135|81617218|FG000|Induction Treatment|Progressive Disease|135|||
27941010|NCT04191135|81617219|FG001|Induction Treatment|Progressive Disease|0|||
27941011|NCT04191135|81617220|FG002|Induction Treatment|Progressive Disease|0|||
27941012|NCT04191135|81617218|FG000|Induction Treatment|Protocol Violation|10|||
27941013|NCT04191135|81617219|FG001|Induction Treatment|Protocol Violation|0|||
27941014|NCT04191135|81617220|FG002|Induction Treatment|Protocol Violation|0|||
27941015|NCT04191135|81617218|FG000|Induction Treatment|Withdrawal by Subject|4|||
27941016|NCT04191135|81617219|FG001|Induction Treatment|Withdrawal by Subject|0|||
27941017|NCT04191135|81617220|FG002|Induction Treatment|Withdrawal by Subject|0|||
27941018|NCT04191135|81617218|FG000|Randomized Treatment|Death|0|||
27941019|NCT04191135|81617219|FG001|Randomized Treatment|Death|50|||
27941020|NCT04191135|81617220|FG002|Randomized Treatment|Death|54|||
27941021|NCT04191135|81617218|FG000|Randomized Treatment|Lost to Follow-up|0|||
27941022|NCT04191135|81617219|FG001|Randomized Treatment|Lost to Follow-up|0|||
27941023|NCT04191135|81617220|FG002|Randomized Treatment|Lost to Follow-up|1|||
27941024|NCT04191135|81617218|FG000|Randomized Treatment|Withdrawal by Subject|0|||
27941025|NCT04191135|81617219|FG001|Randomized Treatment|Withdrawal by Subject|2|||
27941026|NCT04191135|81617220|FG002|Randomized Treatment|Withdrawal by Subject|0|||
27941027|NCT04191135|81617218|FG000|Randomized Treatment|Ongoing in Trial|0|||
27941028|NCT04191135|81617219|FG001|Randomized Treatment|Ongoing in Trial|83|||
27941029|NCT04191135|81617220|FG002|Randomized Treatment|Ongoing in Trial|81|||
27941030|NCT02184442|81617221|FG000|Overall Study|Death|61|||
27941031|NCT02184442|81617222|FG001|Overall Study|Death|65|||
27941032|NCT02184442|81617221|FG000|Overall Study|Withdrawal by Subject|3|||
27941033|NCT02184442|81617222|FG001|Overall Study|Withdrawal by Subject|11|||
27941034|NCT01517178|81617223|FG000|Period 1|Adverse Event|1|||
27941035|NCT01517178|81617224|FG001|Period 1|Adverse Event|2|||
27941036|NCT01517178|81617223|FG000|Period 1|Lack of Efficacy|0|||
27941037|NCT01517178|81617224|FG001|Period 1|Lack of Efficacy|1|||
27941038|NCT01517178|81617223|FG000|Period 1|E.g. study termination|3|||
27941039|NCT01517178|81617224|FG001|Period 1|E.g. study termination|1|||
27941040|NCT01517178|81617223|FG000|Period 1|Withdrawal by Subject|0|||
27941041|NCT01517178|81617224|FG001|Period 1|Withdrawal by Subject|1|||
27941042|NCT01517178|81617223|FG000|Period 2|Adverse Event|1|||
27941043|NCT01517178|81617224|FG001|Period 2|Adverse Event|0|||
27941044|NCT01517178|81617223|FG000|Period 2|Withdrawal by Subject|3|||
27941045|NCT01517178|81617224|FG001|Period 2|Withdrawal by Subject|0|||
27941046|NCT01517178|81617223|FG000|Period 2|E.g. study termination|2|||
27941047|NCT01517178|81617224|FG001|Period 2|E.g. study termination|2|||
27941048|NCT01335685|81617225|FG000|Overall Study|Study Terminated by Sponsor|2|||
27941049|NCT01335685|81617226|FG001|Overall Study|Study Terminated by Sponsor|1|||
27941050|NCT01335685|81617227|FG002|Overall Study|Study Terminated by Sponsor|1|||
27941051|NCT01335685|81617228|FG003|Overall Study|Study Terminated by Sponsor|10|||
27941052|NCT01335685|81617229|FG004|Overall Study|Study Terminated by Sponsor|0|||
27941053|NCT01335685|81617230|FG005|Overall Study|Study Terminated by Sponsor|4|||
27941054|NCT01335685|81617231|FG006|Overall Study|Study Terminated by Sponsor|2|||
27941055|NCT01335685|81617232|FG007|Overall Study|Study Terminated by Sponsor|3|||
27941056|NCT01335685|81617225|FG000|Overall Study|Withdrawal by Subject|1|||
27941057|NCT01335685|81617226|FG001|Overall Study|Withdrawal by Subject|0|||
27941058|NCT01335685|81617227|FG002|Overall Study|Withdrawal by Subject|0|||
27941059|NCT01335685|81617228|FG003|Overall Study|Withdrawal by Subject|1|||
27941060|NCT01335685|81617229|FG004|Overall Study|Withdrawal by Subject|0|||
27941061|NCT01335685|81617230|FG005|Overall Study|Withdrawal by Subject|0|||
27941062|NCT01335685|81617231|FG006|Overall Study|Withdrawal by Subject|0|||
27941063|NCT01335685|81617232|FG007|Overall Study|Withdrawal by Subject|0|||
27941064|NCT01335685|81617225|FG000|Overall Study|Reason not Specified|0|||
27941065|NCT01335685|81617226|FG001|Overall Study|Reason not Specified|0|||
27941066|NCT01335685|81617227|FG002|Overall Study|Reason not Specified|1|||
27941067|NCT01335685|81617228|FG003|Overall Study|Reason not Specified|0|||
27941068|NCT01335685|81617229|FG004|Overall Study|Reason not Specified|0|||
27941069|NCT01335685|81617230|FG005|Overall Study|Reason not Specified|1|||
27941070|NCT01335685|81617231|FG006|Overall Study|Reason not Specified|0|||
27941071|NCT01335685|81617232|FG007|Overall Study|Reason not Specified|0|||
27941072|NCT01104870|81617233|FG000|Overall Study|Adverse Event|1|||
27941073|NCT01104870|81617234|FG001|Overall Study|Adverse Event|1|||
27941074|NCT01104870|81617235|FG002|Overall Study|Adverse Event|0|||
27941075|NCT01104870|81617233|FG000|Overall Study|Death|0|||
27941076|NCT01104870|81617234|FG001|Overall Study|Death|0|||
27941077|NCT01104870|81617235|FG002|Overall Study|Death|1|||
27941078|NCT01104870|81617233|FG000|Overall Study|Withdrawal by Subject|0|||
27941079|NCT01104870|81617234|FG001|Overall Study|Withdrawal by Subject|0|||
27941080|NCT01104870|81617235|FG002|Overall Study|Withdrawal by Subject|1|||
27941081|NCT02365064|81617236|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
27941082|NCT02365064|81617237|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
27941083|NCT02365064|81617236|FG000|Overall Study|Withdrawal by Subject|6|||
27941084|NCT02365064|81617237|FG001|Overall Study|Withdrawal by Subject|9|||
27941085|NCT02365064|81617236|FG000|Overall Study|Treatment intolerance|2|||
27941086|NCT02365064|81617237|FG001|Overall Study|Treatment intolerance|4|||
27645842|NCT01324310|80543729|FG000|Overall Study|Disease Progression|1|||
27645843|NCT00582972|80543730|FG000|Overall Study|Protocol Violation|2|||
27645844|NCT00680771|80543731|FG000|Overall Study|Withdrawal by Subject|1|||
27645845|NCT00680771|80543732|FG001|Overall Study|Withdrawal by Subject|0|||
27645846|NCT00680771|80543731|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
27645847|NCT00680771|80543732|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
27645848|NCT00680771|80543731|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
27645849|NCT00680771|80543732|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
27941087|NCT02336555|81619360|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
27941088|NCT02336555|81619361|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
27941089|NCT02336555|81619360|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
27941090|NCT02336555|81619361|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
27941091|NCT02336555|81619360|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
27941092|NCT02336555|81619361|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
27941093|NCT01796470|81619362|FG000|Overall Study|Adverse Event|4|||
27941094|NCT01796470|81619363|FG001|Overall Study|Adverse Event|2|||
27941095|NCT01796470|81619364|FG002|Overall Study|Adverse Event|2|||
27941096|NCT01796470|81619365|FG003|Overall Study|Adverse Event|1|||
27941097|NCT01796470|81619366|FG004|Overall Study|Adverse Event|3|||
27941098|NCT01796470|81619362|FG000|Overall Study|Death|2|||
27941099|NCT01796470|81619363|FG001|Overall Study|Death|0|||
27941100|NCT01796470|81619364|FG002|Overall Study|Death|0|||
27941101|NCT01796470|81619365|FG003|Overall Study|Death|0|||
27941102|NCT01796470|81619366|FG004|Overall Study|Death|1|||
27941103|NCT01796470|81619362|FG000|Overall Study|Initiated New Therapy|9|||
27941104|NCT01796470|81619363|FG001|Overall Study|Initiated New Therapy|0|||
27941105|NCT01796470|81619364|FG002|Overall Study|Initiated New Therapy|0|||
27941106|NCT01796470|81619365|FG003|Overall Study|Initiated New Therapy|0|||
27941107|NCT01796470|81619366|FG004|Overall Study|Initiated New Therapy|2|||
27645850|NCT00734578|80543733|FG000|Overall Study|Adverse Event|4|||
27645851|NCT00734578|80543734|FG001|Overall Study|Adverse Event|6|||
27941108|NCT01796470|81619362|FG000|Overall Study|Lost to Follow-up|0|||
27941109|NCT01796470|81619363|FG001|Overall Study|Lost to Follow-up|1|||
27941110|NCT01796470|81619364|FG002|Overall Study|Lost to Follow-up|0|||
27941111|NCT01796470|81619365|FG003|Overall Study|Lost to Follow-up|0|||
27941112|NCT01796470|81619366|FG004|Overall Study|Lost to Follow-up|0|||
27645852|NCT00734578|80543735|FG002|Overall Study|Adverse Event|1|||
27941113|NCT01796470|81619362|FG000|Overall Study|Physician Decision|5|||
27941114|NCT01796470|81619363|FG001|Overall Study|Physician Decision|4|||
27941115|NCT01796470|81619364|FG002|Overall Study|Physician Decision|1|||
27941116|NCT01796470|81619365|FG003|Overall Study|Physician Decision|0|||
27941117|NCT01796470|81619366|FG004|Overall Study|Physician Decision|1|||
27551351|NCT01543698|80207459|FG001|Phase 1b|Withdrawal by Subject|1|||
27941118|NCT01796470|81619362|FG000|Overall Study|Progressive Disease|7|||
27941119|NCT01796470|81619363|FG001|Overall Study|Progressive Disease|7|||
27941120|NCT01796470|81619364|FG002|Overall Study|Progressive Disease|3|||
27941121|NCT01796470|81619365|FG003|Overall Study|Progressive Disease|2|||
27941122|NCT01796470|81619366|FG004|Overall Study|Progressive Disease|0|||
27941123|NCT01796470|81619362|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
27645853|NCT00734578|80543733|FG000|Overall Study|Protocol Violation|8|||
27645854|NCT00734578|80543734|FG001|Overall Study|Protocol Violation|6|||
27645855|NCT00734578|80543735|FG002|Overall Study|Protocol Violation|3|||
27645856|NCT00734578|80543733|FG000|Overall Study|Withdrawal by Subject|7|||
27645857|NCT00734578|80543734|FG001|Overall Study|Withdrawal by Subject|8|||
27645858|NCT00734578|80543735|FG002|Overall Study|Withdrawal by Subject|11|||
27645859|NCT00734578|80543733|FG000|Overall Study|Lost to Follow-up|9|||
27645860|NCT00734578|80543734|FG001|Overall Study|Lost to Follow-up|3|||
27645861|NCT00734578|80543735|FG002|Overall Study|Lost to Follow-up|5|||
27645862|NCT00734578|80543733|FG000|Overall Study|Lack of Efficacy|3|||
27941124|NCT01796470|81619363|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
27941125|NCT01796470|81619364|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
27941126|NCT01796470|81619365|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
27941127|NCT01796470|81619366|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
27941128|NCT01796470|81619362|FG000|Overall Study|Withdrawal by Subject|7|||
27941129|NCT01796470|81619363|FG001|Overall Study|Withdrawal by Subject|0|||
27645863|NCT00734578|80543734|FG001|Overall Study|Lack of Efficacy|2|||
27645864|NCT00734578|80543735|FG002|Overall Study|Lack of Efficacy|5|||
27645865|NCT00734578|80543733|FG000|Overall Study|Randomized in error|1|||
27645866|NCT00734578|80543734|FG001|Overall Study|Randomized in error|0|||
27645867|NCT00734578|80543735|FG002|Overall Study|Randomized in error|0|||
27645868|NCT00734578|80543733|FG000|Overall Study|Exclusion criteria|1|||
27645869|NCT00734578|80543734|FG001|Overall Study|Exclusion criteria|0|||
27645870|NCT00734578|80543735|FG002|Overall Study|Exclusion criteria|0|||
27941130|NCT01796470|81619364|FG002|Overall Study|Withdrawal by Subject|0|||
27941131|NCT01796470|81619365|FG003|Overall Study|Withdrawal by Subject|0|||
27941132|NCT01796470|81619366|FG004|Overall Study|Withdrawal by Subject|1|||
27941133|NCT05451329|81619369|FG000|Overall Study|Adverse Event|1|||
27941134|NCT05451329|81619370|FG001|Overall Study|Adverse Event|1|||
27941135|NCT05451329|81619371|FG002|Overall Study|Adverse Event|0|||
27941136|NCT05451329|81619369|FG000|Overall Study|Withdrawal by Subject|1|||
27941137|NCT05451329|81619370|FG001|Overall Study|Withdrawal by Subject|0|||
27941138|NCT05451329|81619371|FG002|Overall Study|Withdrawal by Subject|0|||
27941139|NCT05451329|81619369|FG000|Overall Study|Investigational Product Lot exchange|1|||
27941140|NCT05451329|81619370|FG001|Overall Study|Investigational Product Lot exchange|1|||
27941141|NCT05451329|81619371|FG002|Overall Study|Investigational Product Lot exchange|0|||
27941142|NCT02011542|81619374|FG000|Overall Study|Physician Decision|1|||
27941143|NCT03247673|81619380|FG000|Overall Study|Withdrawal by Subject|1|||
27941144|NCT03247673|81619381|FG001|Overall Study|Withdrawal by Subject|0|||
27941145|NCT03247673|81619382|FG002|Overall Study|Withdrawal by Subject|3|||
27941146|NCT03247673|81619380|FG000|Overall Study|Lost to Follow-up|0|||
27941147|NCT03247673|81619381|FG001|Overall Study|Lost to Follow-up|0|||
27941148|NCT03247673|81619382|FG002|Overall Study|Lost to Follow-up|1|||
27941149|NCT00079781|81619383|FG000|Pre-implant Period|Withdrawal by Subject|2|||
27941150|NCT00079781|81619384|FG001|Pre-implant Period|Withdrawal by Subject|0|||
27645871|NCT02022670|80543738|FG000|Overall Study|Adverse Event|1|||
27645872|NCT02022670|80543739|FG001|Overall Study|Adverse Event|0|||
27645873|NCT02022670|80543740|FG002|Overall Study|Adverse Event|1|||
27645874|NCT02593149|80543741|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
27645875|NCT02593149|80543742|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
27645876|NCT02593149|80543741|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
27645877|NCT02593149|80543742|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
27755010|NCT04937816|80929651|FG002|Overall Study|Not treated|2|||
27941151|NCT00079781|81619385|FG002|Pre-implant Period|Withdrawal by Subject|0|||
27941152|NCT00079781|81619383|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
27645878|NCT01177670|80543743|FG000|Overall Study|Study Terminated|115|||
27645879|NCT01177670|80543743|FG000|Overall Study|Physician Decision|50|||
27645880|NCT01177670|80543743|FG000|Overall Study|Withdrawal by Subject|4|||
27645881|NCT01359150|80543751|FG000|Overall Study|Lack of Efficacy|1|||
27645882|NCT01359150|80543752|FG001|Overall Study|Lack of Efficacy|1|||
27941153|NCT00079781|81619384|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
27941154|NCT00079781|81619385|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
27941155|NCT00079781|81619383|FG000|Follow-up Period|Withdrawal by Subject|3|||
27941156|NCT00079781|81619384|FG001|Follow-up Period|Withdrawal by Subject|0|||
27941157|NCT00079781|81619385|FG002|Follow-up Period|Withdrawal by Subject|1|||
27941158|NCT00079781|81619383|FG000|Follow-up Period|Lost to Follow-up|1|||
27941159|NCT00079781|81619384|FG001|Follow-up Period|Lost to Follow-up|0|||
27645883|NCT01359150|80543751|FG000|Overall Study|Withdrawal by Subject|1|||
27645884|NCT01359150|80543752|FG001|Overall Study|Withdrawal by Subject|1|||
27645885|NCT01359150|80543751|FG000|Overall Study|Adverse Event|4|||
27645886|NCT01359150|80543752|FG001|Overall Study|Adverse Event|3|||
27941160|NCT00079781|81619385|FG002|Follow-up Period|Lost to Follow-up|0|||
27941161|NCT00079781|81619383|FG000|Follow-up Period|Death|0|||
27941162|NCT00079781|81619384|FG001|Follow-up Period|Death|0|||
27941163|NCT00079781|81619385|FG002|Follow-up Period|Death|1|||
27941164|NCT01423084|81619388|FG000|Overall Study|Adverse Event|0|||
27941165|NCT01423084|81619389|FG001|Overall Study|Adverse Event|1|||
27941166|NCT01423084|81619388|FG000|Overall Study|Withdrawal by Subject|2|||
27941167|NCT01423084|81619389|FG001|Overall Study|Withdrawal by Subject|3|||
27941168|NCT00069953|81619390|FG000|Overall Study|Protocol Violation|2|||
27941169|NCT01341990|81619394|FG000|Overall Study|Adverse Event|0|||
27941170|NCT01341990|81619395|FG001|Overall Study|Adverse Event|1|||
27941171|NCT01341990|81619394|FG000|Overall Study|Torn Study Lens|1|||
27941172|NCT01341990|81619395|FG001|Overall Study|Torn Study Lens|0|||
27941173|NCT01341990|81619394|FG000|Overall Study|Withdrawal by Subject|2|||
27941174|NCT01341990|81619395|FG001|Overall Study|Withdrawal by Subject|0|||
27645887|NCT01359150|80543751|FG000|Overall Study|Other|1|||
27645888|NCT01359150|80543752|FG001|Overall Study|Other|0|||
27645889|NCT03875313|80543756|FG000|Overall Study|Withdrawal by Subject|1|||
27645890|NCT03875313|80543757|FG001|Overall Study|Withdrawal by Subject|3|||
27645891|NCT03875313|80543758|FG002|Overall Study|Withdrawal by Subject|0|||
27645892|NCT03875313|80543759|FG003|Overall Study|Withdrawal by Subject|0|||
27941175|NCT00395447|81619396|FG000|Overall Study|Death|37|||
27941176|NCT00395447|81619397|FG001|Overall Study|Death|32|||
27941177|NCT00395447|81619396|FG000|Overall Study|Lost to Follow-up|52|||
27941178|NCT00395447|81619397|FG001|Overall Study|Lost to Follow-up|43|||
27941179|NCT00395447|81619396|FG000|Overall Study|Withdrawal by Subject|24|||
27941180|NCT00395447|81619397|FG001|Overall Study|Withdrawal by Subject|19|||
27941181|NCT00395447|81619396|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
27941182|NCT00395447|81619397|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
27941183|NCT02451007|81619398|FG000|Overall Study|Withdrawal by Subject|4|||
27941184|NCT02451007|81619398|FG000|Overall Study|Adverse Event|1|||
27941185|NCT02451007|81619398|FG000|Overall Study|Disease Progression|2|||
27941186|NCT00866775|81619401|FG000|Overall Study|Adverse Event|5|||
27941187|NCT00866775|81619402|FG001|Overall Study|Adverse Event|19|||
27941188|NCT00866775|81619401|FG000|Overall Study|Death|1|||
27941189|NCT00866775|81619402|FG001|Overall Study|Death|0|||
27941190|NCT00866775|81619401|FG000|Overall Study|Lost to Follow-up|0|||
27941191|NCT00866775|81619402|FG001|Overall Study|Lost to Follow-up|4|||
27941192|NCT00866775|81619401|FG000|Overall Study|Physician Decision|0|||
27941193|NCT00866775|81619402|FG001|Overall Study|Physician Decision|3|||
27941194|NCT00866775|81619401|FG000|Overall Study|Protocol Violation|3|||
27941195|NCT00866775|81619402|FG001|Overall Study|Protocol Violation|4|||
27941196|NCT00866775|81619401|FG000|Overall Study|Withdrawal by Subject|4|||
27941197|NCT00866775|81619402|FG001|Overall Study|Withdrawal by Subject|4|||
27941198|NCT00866775|81619401|FG000|Overall Study|met exit criteria|23|||
27941199|NCT00866775|81619402|FG001|Overall Study|met exit criteria|17|||
27941200|NCT00866775|81619401|FG000|Overall Study|discontinued due to communication error|0|||
27941201|NCT00866775|81619402|FG001|Overall Study|discontinued due to communication error|1|||
27941202|NCT00692237|81619403|FG000|Overall Study|Withdrawal by Subject|1|||
27941203|NCT00692237|81619404|FG001|Overall Study|Withdrawal by Subject|3|||
27645893|NCT03875313|80543760|FG004|Overall Study|Withdrawal by Subject|0|||
27645894|NCT03875313|80543756|FG000|Overall Study|Death|0|||
27645895|NCT03875313|80543757|FG001|Overall Study|Death|0|||
27645896|NCT03875313|80543758|FG002|Overall Study|Death|0|||
27645897|NCT03875313|80543759|FG003|Overall Study|Death|0|||
27645898|NCT03875313|80543760|FG004|Overall Study|Death|1|||
27645899|NCT03875313|80543756|FG000|Overall Study|Lost to Follow-up|0|||
27645900|NCT03875313|80543757|FG001|Overall Study|Lost to Follow-up|0|||
27645901|NCT03875313|80543758|FG002|Overall Study|Lost to Follow-up|0|||
27645902|NCT03875313|80543759|FG003|Overall Study|Lost to Follow-up|0|||
27645903|NCT03875313|80543760|FG004|Overall Study|Lost to Follow-up|1|||
27645904|NCT03875313|80543756|FG000|Overall Study|Study Termination by Sponsor|0|||
27645905|NCT03875313|80543757|FG001|Overall Study|Study Termination by Sponsor|1|||
27645906|NCT03875313|80543758|FG002|Overall Study|Study Termination by Sponsor|1|||
27645907|NCT03875313|80543759|FG003|Overall Study|Study Termination by Sponsor|0|||
27645908|NCT03875313|80543760|FG004|Overall Study|Study Termination by Sponsor|1|||
27645909|NCT03875313|80543756|FG000|Overall Study|New Anticancer Treatment|0|||
27645910|NCT03875313|80543757|FG001|Overall Study|New Anticancer Treatment|1|||
27645911|NCT03875313|80543758|FG002|Overall Study|New Anticancer Treatment|2|||
27645912|NCT03875313|80543759|FG003|Overall Study|New Anticancer Treatment|1|||
27645913|NCT03875313|80543760|FG004|Overall Study|New Anticancer Treatment|0|||
27645914|NCT03875313|80543756|FG000|Overall Study|Other, Not Specified|2|||
27645915|NCT03875313|80543757|FG001|Overall Study|Other, Not Specified|11|||
27645916|NCT03875313|80543758|FG002|Overall Study|Other, Not Specified|3|||
27645917|NCT03875313|80543759|FG003|Overall Study|Other, Not Specified|3|||
27941204|NCT00692237|81619403|FG000|Overall Study|Adverse Event|0|||
27941205|NCT00692237|81619404|FG001|Overall Study|Adverse Event|1|||
27941206|NCT01272219|81619408|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
27755011|NCT04937816|80929652|FG003|Overall Study|Not treated|2|||
27645918|NCT03875313|80543760|FG004|Overall Study|Other, Not Specified|1|||
27941207|NCT01272219|81619409|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
27941208|NCT01272219|81619410|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
27941209|NCT01272219|81619411|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
27941210|NCT01272219|81619412|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
27941211|NCT01272219|81619413|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
27941212|NCT01272219|81619408|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
27941213|NCT01272219|81619409|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
27645919|NCT01823224|80543761|FG000|Overall Study|Lost to Follow-up|5|||
27645920|NCT01823224|80543762|FG001|Overall Study|Lost to Follow-up|6|||
27645921|NCT01823224|80543761|FG000|Overall Study|didn't qualify|1|||
27645922|NCT01823224|80543762|FG001|Overall Study|didn't qualify|2|||
27645923|NCT01823224|80543761|FG000|Overall Study|pharmacy error|0|||
27645924|NCT01823224|80543762|FG001|Overall Study|pharmacy error|1|||
27645925|NCT01823224|80543761|FG000|Overall Study|missed med dose|0|||
27645926|NCT01823224|80543762|FG001|Overall Study|missed med dose|1|||
27645927|NCT01823224|80543761|FG000|Overall Study|Withdrawal by Subject|0|||
27645928|NCT01823224|80543762|FG001|Overall Study|Withdrawal by Subject|1|||
27645929|NCT02561195|80543763|FG000|Vaccination 1 to 3|Adverse Event|4|||
27645930|NCT02561195|80543764|FG001|Vaccination 1 to 3|Adverse Event|5|||
27941214|NCT01272219|81619410|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
27941215|NCT01272219|81619411|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
27941216|NCT01272219|81619412|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
27645931|NCT02561195|80543765|FG002|Vaccination 1 to 3|Adverse Event|0|||
27941217|NCT01272219|81619413|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
27941218|NCT01272219|81619408|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
27941219|NCT01272219|81619409|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
27941220|NCT01272219|81619410|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
27941221|NCT01272219|81619411|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
27941222|NCT01272219|81619412|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
27941223|NCT01272219|81619413|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
27645932|NCT02561195|80543766|FG003|Vaccination 1 to 3|Adverse Event|3|||
27645933|NCT02561195|80543767|FG004|Vaccination 1 to 3|Adverse Event|4|||
27645934|NCT02561195|80543768|FG005|Vaccination 1 to 3|Adverse Event|0|||
27645935|NCT02561195|80543769|FG006|Vaccination 1 to 3|Adverse Event|0|||
27645936|NCT02561195|80543770|FG007|Vaccination 1 to 3|Adverse Event|0|||
27645937|NCT02561195|80543771|FG008|Vaccination 1 to 3|Adverse Event|0|||
27645938|NCT02561195|80543772|FG009|Vaccination 1 to 3|Adverse Event|0|||
27645939|NCT02561195|80543773|FG010|Vaccination 1 to 3|Adverse Event|0|||
27645940|NCT02561195|80543774|FG011|Vaccination 1 to 3|Adverse Event|0|||
27645941|NCT02561195|80543775|FG012|Vaccination 1 to 3|Adverse Event|0|||
27645942|NCT02561195|80543776|FG013|Vaccination 1 to 3|Adverse Event|0|||
27645943|NCT02561195|80543763|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
27645944|NCT02561195|80543764|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
27645945|NCT02561195|80543765|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
27645946|NCT02561195|80543766|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
27645947|NCT02561195|80543767|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
27941224|NCT01272219|81619408|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
27941225|NCT01272219|81619409|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
27941226|NCT01272219|81619410|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
27941227|NCT01272219|81619411|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
27941228|NCT01272219|81619412|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
27941229|NCT01272219|81619413|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
27941230|NCT01272219|81619408|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
27941231|NCT01272219|81619409|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
27941232|NCT01272219|81619410|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
27941233|NCT01272219|81619411|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
27941234|NCT01272219|81619412|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
27941235|NCT01272219|81619413|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
27645948|NCT02561195|80543768|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
27645949|NCT02561195|80543769|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
27645950|NCT02561195|80543770|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
27645951|NCT02561195|80543771|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
27645952|NCT02561195|80543772|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
27645953|NCT02561195|80543773|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
27645954|NCT02561195|80543774|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
27645955|NCT02561195|80543775|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
27645956|NCT02561195|80543776|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
27645957|NCT02561195|80543763|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645958|NCT02561195|80543764|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
27645959|NCT02561195|80543765|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645960|NCT02561195|80543766|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
27755012|NCT04937816|80929653|FG004|Overall Study|Not treated|1|||
27645961|NCT02561195|80543767|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
27645962|NCT02561195|80543768|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
27645963|NCT02561195|80543769|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645964|NCT02561195|80543770|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645965|NCT02561195|80543771|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645966|NCT02561195|80543772|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645967|NCT02561195|80543773|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645968|NCT02561195|80543774|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645969|NCT02561195|80543775|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645970|NCT02561195|80543776|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
27645971|NCT02561195|80543763|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
27645972|NCT02561195|80543764|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
27645973|NCT02561195|80543765|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
27645974|NCT02561195|80543766|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
27645975|NCT02561195|80543767|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
27645976|NCT02561195|80543768|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
27645977|NCT02561195|80543769|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
27645978|NCT02561195|80543770|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
27645979|NCT02561195|80543771|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
27645980|NCT02561195|80543772|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
27645981|NCT02561195|80543773|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
27645982|NCT02561195|80543774|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
27645983|NCT02561195|80543775|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
27645984|NCT02561195|80543776|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
27645985|NCT02561195|80543763|FG000|Vaccination 1 to 3|Other|7|||
27645986|NCT02561195|80543764|FG001|Vaccination 1 to 3|Other|3|||
27645987|NCT02561195|80543765|FG002|Vaccination 1 to 3|Other|1|||
27941236|NCT01272219|81619408|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
27941237|NCT01272219|81619409|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
27941238|NCT01272219|81619410|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
27941239|NCT01272219|81619411|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
27941240|NCT01272219|81619412|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
27941241|NCT01272219|81619413|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
27941242|NCT01272219|81619408|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27941243|NCT01272219|81619409|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27941244|NCT01272219|81619410|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27941245|NCT01272219|81619411|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
27941246|NCT01272219|81619412|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27941247|NCT01272219|81619413|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
27941248|NCT01272219|81619408|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27645988|NCT02561195|80543766|FG003|Vaccination 1 to 3|Other|7|||
27645989|NCT02561195|80543767|FG004|Vaccination 1 to 3|Other|5|||
27645990|NCT02561195|80543768|FG005|Vaccination 1 to 3|Other|1|||
27645991|NCT02561195|80543769|FG006|Vaccination 1 to 3|Other|0|||
27645992|NCT02561195|80543770|FG007|Vaccination 1 to 3|Other|0|||
27645993|NCT02561195|80543771|FG008|Vaccination 1 to 3|Other|0|||
27645994|NCT02561195|80543772|FG009|Vaccination 1 to 3|Other|0|||
27645995|NCT02561195|80543773|FG010|Vaccination 1 to 3|Other|0|||
27645996|NCT02561195|80543774|FG011|Vaccination 1 to 3|Other|0|||
27941249|NCT01272219|81619409|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
27941250|NCT01272219|81619410|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27941251|NCT01272219|81619411|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
27941252|NCT01272219|81619412|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27941253|NCT01272219|81619413|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
27941254|NCT01272219|81619408|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
27941255|NCT01272219|81619409|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
27941256|NCT01272219|81619410|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
27941257|NCT01272219|81619411|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
27941258|NCT01272219|81619412|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
27941259|NCT01272219|81619413|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
27941260|NCT01272219|81619408|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
27941261|NCT01272219|81619409|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
27941262|NCT01272219|81619410|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
27645997|NCT02561195|80543775|FG012|Vaccination 1 to 3|Other|0|||
27645998|NCT02561195|80543776|FG013|Vaccination 1 to 3|Other|0|||
27645999|NCT02561195|80543763|FG000|Vaccination 1 to 3|Protocol Violation|1|||
27646000|NCT02561195|80543764|FG001|Vaccination 1 to 3|Protocol Violation|0|||
27646001|NCT02561195|80543765|FG002|Vaccination 1 to 3|Protocol Violation|1|||
27941263|NCT01272219|81619411|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
27941264|NCT01272219|81619412|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
27941265|NCT01272219|81619413|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
27941266|NCT01272219|81619408|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
27941267|NCT01272219|81619409|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
27941268|NCT01272219|81619410|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
27941269|NCT01272219|81619411|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
27941270|NCT01272219|81619412|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
27941271|NCT01272219|81619413|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
27941272|NCT01272219|81619408|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27941273|NCT01272219|81619409|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27941274|NCT01272219|81619410|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27941275|NCT01272219|81619411|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
27941276|NCT01272219|81619412|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
27941277|NCT01272219|81619413|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
27941278|NCT01272219|81619408|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27941279|NCT01272219|81619409|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27941280|NCT01272219|81619410|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27941281|NCT01272219|81619411|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
27941282|NCT01272219|81619412|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
27941283|NCT01272219|81619413|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
27941284|NCT01272219|81619408|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27941285|NCT01272219|81619409|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27941286|NCT01272219|81619410|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27941287|NCT01272219|81619411|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
27941288|NCT01272219|81619412|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
27941289|NCT01272219|81619413|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
27941290|NCT01272219|81619408|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
27941291|NCT01272219|81619409|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
27941292|NCT01272219|81619410|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
27941293|NCT01272219|81619411|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
27941294|NCT01272219|81619412|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
27941295|NCT01272219|81619413|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
27941296|NCT01272219|81619408|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
27941297|NCT01272219|81619409|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
27941298|NCT01272219|81619410|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
27941299|NCT01272219|81619411|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
27941300|NCT01272219|81619412|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
27941301|NCT01272219|81619413|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
27941302|NCT02661815|81619414|FG000|Overall Study|Withdrawal by Subject|1|||
27941303|NCT02661815|81619415|FG001|Overall Study|Withdrawal by Subject|0|||
27941304|NCT02661815|81619416|FG002|Overall Study|Withdrawal by Subject|0|||
27941305|NCT02661815|81619417|FG003|Overall Study|Withdrawal by Subject|0|||
27941306|NCT00504556|81619418|FG000|Overall Study|Adverse Event|11|||
27941307|NCT00504556|81619419|FG001|Overall Study|Adverse Event|11|||
27941308|NCT00504556|81619420|FG002|Overall Study|Adverse Event|14|||
27941309|NCT00504556|81619421|FG003|Overall Study|Adverse Event|13|||
27941310|NCT00504556|81619422|FG004|Overall Study|Adverse Event|5|||
27941311|NCT00504556|81619418|FG000|Overall Study|Death|3|||
27941312|NCT00504556|81619419|FG001|Overall Study|Death|3|||
27941313|NCT00504556|81619420|FG002|Overall Study|Death|1|||
27941314|NCT00504556|81619421|FG003|Overall Study|Death|0|||
27941315|NCT00504556|81619422|FG004|Overall Study|Death|2|||
27941316|NCT00504556|81619418|FG000|Overall Study|Protocol Violation|1|||
27941317|NCT00504556|81619419|FG001|Overall Study|Protocol Violation|3|||
27941318|NCT00504556|81619420|FG002|Overall Study|Protocol Violation|2|||
27941319|NCT00504556|81619421|FG003|Overall Study|Protocol Violation|1|||
27941320|NCT00504556|81619422|FG004|Overall Study|Protocol Violation|2|||
27941321|NCT00504556|81619418|FG000|Overall Study|Lost to Follow-up|0|||
27941322|NCT00504556|81619419|FG001|Overall Study|Lost to Follow-up|0|||
27941323|NCT00504556|81619420|FG002|Overall Study|Lost to Follow-up|1|||
27941324|NCT00504556|81619421|FG003|Overall Study|Lost to Follow-up|1|||
27941325|NCT00504556|81619422|FG004|Overall Study|Lost to Follow-up|1|||
27941326|NCT00504556|81619418|FG000|Overall Study|Withdrawal by Subject|16|||
27941327|NCT00504556|81619419|FG001|Overall Study|Withdrawal by Subject|16|||
27941328|NCT00504556|81619420|FG002|Overall Study|Withdrawal by Subject|7|||
27941329|NCT00504556|81619421|FG003|Overall Study|Withdrawal by Subject|8|||
27941330|NCT00504556|81619422|FG004|Overall Study|Withdrawal by Subject|12|||
27941331|NCT00504556|81619418|FG000|Overall Study|administrative reasons|0|||
27941332|NCT00504556|81619419|FG001|Overall Study|administrative reasons|2|||
27941333|NCT00504556|81619420|FG002|Overall Study|administrative reasons|2|||
27551352|NCT01543698|80207460|FG002|Phase 1b|Withdrawal by Subject|0|||
27941334|NCT00504556|81619421|FG003|Overall Study|administrative reasons|1|||
27941335|NCT00504556|81619422|FG004|Overall Study|administrative reasons|2|||
27941336|NCT00504556|81619418|FG000|Overall Study|did not meet entry criteria|2|||
27941337|NCT00504556|81619419|FG001|Overall Study|did not meet entry criteria|0|||
27941338|NCT00504556|81619420|FG002|Overall Study|did not meet entry criteria|1|||
27941339|NCT00504556|81619421|FG003|Overall Study|did not meet entry criteria|1|||
27941340|NCT00504556|81619422|FG004|Overall Study|did not meet entry criteria|0|||
27941341|NCT00504556|81619418|FG000|Overall Study|data monitor committee decision|0|||
27941342|NCT00504556|81619419|FG001|Overall Study|data monitor committee decision|0|||
27941343|NCT00504556|81619420|FG002|Overall Study|data monitor committee decision|0|||
27941344|NCT00504556|81619421|FG003|Overall Study|data monitor committee decision|100|||
27646002|NCT02561195|80543766|FG003|Vaccination 1 to 3|Protocol Violation|2|||
27941345|NCT00504556|81619422|FG004|Overall Study|data monitor committee decision|0|||
27941346|NCT00504556|81619418|FG000|Overall Study|Other|2|||
27941347|NCT00504556|81619419|FG001|Overall Study|Other|2|||
27941348|NCT00504556|81619420|FG002|Overall Study|Other|2|||
27941349|NCT00504556|81619421|FG003|Overall Study|Other|3|||
27941350|NCT00504556|81619422|FG004|Overall Study|Other|0|||
27941351|NCT00504556|81619418|FG000|Overall Study|not in safety analysis set|0|||
27941352|NCT00504556|81619419|FG001|Overall Study|not in safety analysis set|1|||
27941353|NCT00504556|81619420|FG002|Overall Study|not in safety analysis set|1|||
27941354|NCT00504556|81619421|FG003|Overall Study|not in safety analysis set|0|||
27941355|NCT00504556|81619422|FG004|Overall Study|not in safety analysis set|1|||
27941356|NCT02544763|81619423|FG000|Overall Study|Adverse Event|8|||
27941357|NCT02544763|81619424|FG001|Overall Study|Adverse Event|8|||
27941358|NCT02544763|81619425|FG002|Overall Study|Adverse Event|0|||
27941359|NCT02544763|81619423|FG000|Overall Study|Withdrawn by parent/guardian|1|||
27941360|NCT02544763|81619424|FG001|Overall Study|Withdrawn by parent/guardian|1|||
27941361|NCT02544763|81619425|FG002|Overall Study|Withdrawn by parent/guardian|1|||
27941362|NCT02544763|81619423|FG000|Overall Study|Met withdrawal criteria|0|||
27941363|NCT02544763|81619424|FG001|Overall Study|Met withdrawal criteria|2|||
27941364|NCT02544763|81619425|FG002|Overall Study|Met withdrawal criteria|0|||
27941365|NCT02544763|81619423|FG000|Overall Study|Physician Decision|0|||
27941366|NCT02544763|81619424|FG001|Overall Study|Physician Decision|1|||
27941367|NCT02544763|81619425|FG002|Overall Study|Physician Decision|0|||
27941368|NCT02544763|81619423|FG000|Overall Study|Difficulties taking IMP|1|||
27941369|NCT02544763|81619424|FG001|Overall Study|Difficulties taking IMP|0|||
27941370|NCT02544763|81619425|FG002|Overall Study|Difficulties taking IMP|0|||
27941371|NCT00752219|81619426|FG000|Overall Study|Clinical failure|0|||
27941372|NCT00752219|81619427|FG001|Overall Study|Clinical failure|1|||
27941373|NCT00752219|81619426|FG000|Overall Study|Adverse Event|5|||
27941374|NCT00752219|81619427|FG001|Overall Study|Adverse Event|3|||
27941375|NCT00752219|81619426|FG000|Overall Study|Protocol deviation|1|||
27941376|NCT00752219|81619427|FG001|Overall Study|Protocol deviation|0|||
27941377|NCT00752219|81619426|FG000|Overall Study|Lost to Follow-up|1|||
27941378|NCT00752219|81619427|FG001|Overall Study|Lost to Follow-up|2|||
27941379|NCT00752219|81619426|FG000|Overall Study|Randomized but not treated|1|||
27646003|NCT02561195|80543767|FG004|Vaccination 1 to 3|Protocol Violation|5|||
27941380|NCT00752219|81619427|FG001|Overall Study|Randomized but not treated|0|||
27941381|NCT00752219|81619426|FG000|Overall Study|Other|3|||
27941382|NCT00752219|81619427|FG001|Overall Study|Other|0|||
27941383|NCT01908699|81619428|FG000|Overall Study|Adverse Event|8|||
27941384|NCT01908699|81619429|FG001|Overall Study|Adverse Event|12|||
27941385|NCT01908699|81619428|FG000|Overall Study|Lack of Efficacy|2|||
27941386|NCT01908699|81619429|FG001|Overall Study|Lack of Efficacy|2|||
27941387|NCT01908699|81619428|FG000|Overall Study|Lost to Follow-up|2|||
27941388|NCT01908699|81619429|FG001|Overall Study|Lost to Follow-up|4|||
27941389|NCT01908699|81619428|FG000|Overall Study|Physician Decision|8|||
27941390|NCT01908699|81619429|FG001|Overall Study|Physician Decision|8|||
27941391|NCT01908699|81619428|FG000|Overall Study|Withdrawal by Subject|15|||
27941392|NCT01908699|81619429|FG001|Overall Study|Withdrawal by Subject|10|||
27941393|NCT01908699|81619428|FG000|Overall Study|Pregnancy|0|||
27941394|NCT01908699|81619429|FG001|Overall Study|Pregnancy|1|||
27941395|NCT01908699|81619428|FG000|Overall Study|Randomized in Error|1|||
27646004|NCT02561195|80543768|FG005|Vaccination 1 to 3|Protocol Violation|2|||
27941396|NCT01908699|81619429|FG001|Overall Study|Randomized in Error|0|||
27941397|NCT01908699|81619428|FG000|Overall Study|Death|9|||
27941398|NCT01908699|81619429|FG001|Overall Study|Death|12|||
27941399|NCT01908699|81619428|FG000|Overall Study|Progressive Disease|30|||
27941400|NCT01908699|81619429|FG001|Overall Study|Progressive Disease|29|||
27941401|NCT01877278|81619433|FG000|Overall Study|Lost to Follow-up|3|||
27941402|NCT01877278|81619434|FG001|Overall Study|Lost to Follow-up|3|||
27646005|NCT02561195|80543769|FG006|Vaccination 1 to 3|Protocol Violation|0|||
27646006|NCT02561195|80543770|FG007|Vaccination 1 to 3|Protocol Violation|0|||
27755013|NCT04937816|80929654|FG005|Overall Study|Not treated|4|||
27941403|NCT05122143|81619435|FG000|Overall Study|Adverse Event|1|||
27941404|NCT05122143|81619436|FG001|Overall Study|Adverse Event|0|||
27941405|NCT05122143|81619437|FG002|Overall Study|Adverse Event|0|||
27941406|NCT05122143|81619438|FG003|Overall Study|Adverse Event|0|||
27941407|NCT05122143|81619439|FG004|Overall Study|Adverse Event|1|||
27941408|NCT05122143|81619440|FG005|Overall Study|Adverse Event|0|||
27941409|NCT05122143|81619435|FG000|Overall Study|Protocol non-compliance|0|||
27941410|NCT05122143|81619436|FG001|Overall Study|Protocol non-compliance|0|||
27941411|NCT05122143|81619437|FG002|Overall Study|Protocol non-compliance|1|||
27941412|NCT05122143|81619438|FG003|Overall Study|Protocol non-compliance|0|||
27941413|NCT05122143|81619439|FG004|Overall Study|Protocol non-compliance|0|||
27941414|NCT05122143|81619440|FG005|Overall Study|Protocol non-compliance|0|||
27941415|NCT05122143|81619435|FG000|Overall Study|Covid contact|0|||
27941416|NCT05122143|81619436|FG001|Overall Study|Covid contact|0|||
27941417|NCT05122143|81619437|FG002|Overall Study|Covid contact|0|||
27941418|NCT05122143|81619438|FG003|Overall Study|Covid contact|0|||
27941419|NCT05122143|81619439|FG004|Overall Study|Covid contact|1|||
27941420|NCT05122143|81619440|FG005|Overall Study|Covid contact|0|||
27941421|NCT02101853|81619445|FG000|Block 1 Induction|Adverse Event|11|||
27941422|NCT02101853|81619446|FG001|Block 1 Induction|Adverse Event|0|||
27941423|NCT02101853|81619447|FG002|Block 1 Induction|Adverse Event|0|||
27941424|NCT02101853|81619448|FG003|Block 1 Induction|Adverse Event|0|||
27941425|NCT02101853|81619449|FG004|Block 1 Induction|Adverse Event|0|||
27941426|NCT02101853|81619450|FG005|Block 1 Induction|Adverse Event|0|||
27941427|NCT02101853|81619445|FG000|Block 1 Induction|Death|20|||
27941428|NCT02101853|81619446|FG001|Block 1 Induction|Death|0|||
27941429|NCT02101853|81619447|FG002|Block 1 Induction|Death|0|||
27941430|NCT02101853|81619448|FG003|Block 1 Induction|Death|0|||
27941431|NCT02101853|81619449|FG004|Block 1 Induction|Death|0|||
27941432|NCT02101853|81619450|FG005|Block 1 Induction|Death|0|||
27941433|NCT02101853|81619445|FG000|Block 1 Induction|Lack of Efficacy|6|||
27941434|NCT02101853|81619446|FG001|Block 1 Induction|Lack of Efficacy|0|||
27941435|NCT02101853|81619447|FG002|Block 1 Induction|Lack of Efficacy|0|||
27941436|NCT02101853|81619448|FG003|Block 1 Induction|Lack of Efficacy|0|||
27941437|NCT02101853|81619449|FG004|Block 1 Induction|Lack of Efficacy|0|||
27941438|NCT02101853|81619450|FG005|Block 1 Induction|Lack of Efficacy|0|||
27941439|NCT02101853|81619445|FG000|Block 1 Induction|Physician Decision|61|||
27941440|NCT02101853|81619446|FG001|Block 1 Induction|Physician Decision|0|||
27941441|NCT02101853|81619447|FG002|Block 1 Induction|Physician Decision|0|||
27941442|NCT02101853|81619448|FG003|Block 1 Induction|Physician Decision|0|||
27941443|NCT02101853|81619449|FG004|Block 1 Induction|Physician Decision|0|||
27941444|NCT02101853|81619450|FG005|Block 1 Induction|Physician Decision|0|||
27941445|NCT02101853|81619445|FG000|Block 1 Induction|Protocol Violation|2|||
27941446|NCT02101853|81619446|FG001|Block 1 Induction|Protocol Violation|0|||
27941447|NCT02101853|81619447|FG002|Block 1 Induction|Protocol Violation|0|||
27941448|NCT02101853|81619448|FG003|Block 1 Induction|Protocol Violation|0|||
27941449|NCT02101853|81619449|FG004|Block 1 Induction|Protocol Violation|0|||
27941450|NCT02101853|81619450|FG005|Block 1 Induction|Protocol Violation|0|||
27941451|NCT02101853|81619445|FG000|Block 1 Induction|Withdrawal by Subject|65|||
27941452|NCT02101853|81619446|FG001|Block 1 Induction|Withdrawal by Subject|0|||
27941453|NCT02101853|81619447|FG002|Block 1 Induction|Withdrawal by Subject|0|||
27941454|NCT02101853|81619448|FG003|Block 1 Induction|Withdrawal by Subject|0|||
27941455|NCT02101853|81619449|FG004|Block 1 Induction|Withdrawal by Subject|0|||
27941456|NCT02101853|81619450|FG005|Block 1 Induction|Withdrawal by Subject|0|||
27941457|NCT02101853|81619445|FG000|Block 1 Induction|Ineligible|8|||
27941458|NCT02101853|81619446|FG001|Block 1 Induction|Ineligible|0|||
27941459|NCT02101853|81619447|FG002|Block 1 Induction|Ineligible|0|||
27941460|NCT02101853|81619448|FG003|Block 1 Induction|Ineligible|0|||
27941461|NCT02101853|81619449|FG004|Block 1 Induction|Ineligible|0|||
27941462|NCT02101853|81619450|FG005|Block 1 Induction|Ineligible|0|||
27941463|NCT02101853|81619445|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
27941464|NCT02101853|81619446|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
27941465|NCT02101853|81619447|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
27941466|NCT02101853|81619448|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
27941467|NCT02101853|81619449|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
27941468|NCT02101853|81619450|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
27941469|NCT02101853|81619445|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
27941470|NCT02101853|81619446|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941471|NCT02101853|81619447|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941472|NCT02101853|81619448|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941473|NCT02101853|81619449|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27755014|NCT04937816|80929655|FG006|Overall Study|Not treated|0|||
27941474|NCT02101853|81619450|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941475|NCT02101853|81619445|FG000|Post Induction Randomization|Adverse Event|0|||
27941476|NCT02101853|81619446|FG001|Post Induction Randomization|Adverse Event|3|||
27941477|NCT02101853|81619447|FG002|Post Induction Randomization|Adverse Event|8|||
27941478|NCT02101853|81619448|FG003|Post Induction Randomization|Adverse Event|4|||
27941479|NCT02101853|81619449|FG004|Post Induction Randomization|Adverse Event|4|||
27941480|NCT02101853|81619450|FG005|Post Induction Randomization|Adverse Event|0|||
27941481|NCT02101853|81619445|FG000|Post Induction Randomization|Death|0|||
27941482|NCT02101853|81619446|FG001|Post Induction Randomization|Death|9|||
27941483|NCT02101853|81619447|FG002|Post Induction Randomization|Death|2|||
27941484|NCT02101853|81619448|FG003|Post Induction Randomization|Death|2|||
27941485|NCT02101853|81619449|FG004|Post Induction Randomization|Death|0|||
27941486|NCT02101853|81619450|FG005|Post Induction Randomization|Death|0|||
27941487|NCT02101853|81619445|FG000|Post Induction Randomization|Lack of Efficacy|0|||
27941488|NCT02101853|81619446|FG001|Post Induction Randomization|Lack of Efficacy|14|||
27941489|NCT02101853|81619447|FG002|Post Induction Randomization|Lack of Efficacy|23|||
27941490|NCT02101853|81619448|FG003|Post Induction Randomization|Lack of Efficacy|18|||
27941491|NCT02101853|81619449|FG004|Post Induction Randomization|Lack of Efficacy|21|||
27941492|NCT02101853|81619450|FG005|Post Induction Randomization|Lack of Efficacy|0|||
27941493|NCT02101853|81619445|FG000|Post Induction Randomization|Physician Decision|0|||
27941494|NCT02101853|81619446|FG001|Post Induction Randomization|Physician Decision|43|||
27941495|NCT02101853|81619447|FG002|Post Induction Randomization|Physician Decision|23|||
27941496|NCT02101853|81619448|FG003|Post Induction Randomization|Physician Decision|14|||
27941497|NCT02101853|81619449|FG004|Post Induction Randomization|Physician Decision|14|||
27941498|NCT02101853|81619450|FG005|Post Induction Randomization|Physician Decision|0|||
27941499|NCT02101853|81619445|FG000|Post Induction Randomization|Protocol Violation|0|||
27941500|NCT02101853|81619446|FG001|Post Induction Randomization|Protocol Violation|3|||
27646007|NCT02561195|80543771|FG008|Vaccination 1 to 3|Protocol Violation|0|||
27646008|NCT02561195|80543772|FG009|Vaccination 1 to 3|Protocol Violation|0|||
27646009|NCT02561195|80543773|FG010|Vaccination 1 to 3|Protocol Violation|0|||
27646010|NCT02561195|80543774|FG011|Vaccination 1 to 3|Protocol Violation|0|||
27646011|NCT02561195|80543775|FG012|Vaccination 1 to 3|Protocol Violation|0|||
27646012|NCT02561195|80543776|FG013|Vaccination 1 to 3|Protocol Violation|0|||
27646013|NCT02561195|80543763|FG000|Vaccination 1 to 3|Death|2|||
27646014|NCT02561195|80543764|FG001|Vaccination 1 to 3|Death|1|||
27646015|NCT02561195|80543765|FG002|Vaccination 1 to 3|Death|0|||
27646016|NCT02561195|80543766|FG003|Vaccination 1 to 3|Death|2|||
27646017|NCT02561195|80543767|FG004|Vaccination 1 to 3|Death|0|||
27941501|NCT02101853|81619447|FG002|Post Induction Randomization|Protocol Violation|0|||
27941502|NCT02101853|81619448|FG003|Post Induction Randomization|Protocol Violation|0|||
27941503|NCT02101853|81619449|FG004|Post Induction Randomization|Protocol Violation|0|||
27941504|NCT02101853|81619450|FG005|Post Induction Randomization|Protocol Violation|0|||
27941505|NCT02101853|81619445|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
27941506|NCT02101853|81619446|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
27941507|NCT02101853|81619447|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
27941508|NCT02101853|81619448|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
27941509|NCT02101853|81619449|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
27941510|NCT02101853|81619450|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
27941511|NCT02101853|81619445|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941512|NCT02101853|81619446|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941513|NCT02101853|81619447|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941514|NCT02101853|81619448|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
27941515|NCT02101853|81619449|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941516|NCT02101853|81619450|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
27941517|NCT02101853|81619445|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
27941518|NCT02101853|81619446|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
27941519|NCT02101853|81619447|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
27941520|NCT02101853|81619448|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
27941521|NCT02101853|81619449|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
27941522|NCT02101853|81619450|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
27941523|NCT02101853|81619445|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
27941524|NCT02101853|81619446|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
27941525|NCT02101853|81619447|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
27941526|NCT02101853|81619448|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
27941527|NCT02101853|81619449|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
27941528|NCT02101853|81619450|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
27646018|NCT02561195|80543768|FG005|Vaccination 1 to 3|Death|0|||
27646019|NCT02561195|80543769|FG006|Vaccination 1 to 3|Death|0|||
27646020|NCT02561195|80543770|FG007|Vaccination 1 to 3|Death|0|||
27941529|NCT02101853|81619445|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
27941530|NCT02101853|81619446|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
27941531|NCT02101853|81619447|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
27941532|NCT02101853|81619448|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
27941533|NCT02101853|81619449|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
27941534|NCT02101853|81619450|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
27941535|NCT02101853|81619445|FG000|Blinatumomab Salvage Therapy|Death|0|||
27941536|NCT02101853|81619446|FG001|Blinatumomab Salvage Therapy|Death|0|||
27941537|NCT02101853|81619447|FG002|Blinatumomab Salvage Therapy|Death|0|||
27941538|NCT02101853|81619448|FG003|Blinatumomab Salvage Therapy|Death|0|||
27941539|NCT02101853|81619449|FG004|Blinatumomab Salvage Therapy|Death|0|||
27941540|NCT02101853|81619450|FG005|Blinatumomab Salvage Therapy|Death|2|||
27941541|NCT02101853|81619445|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
27941542|NCT02101853|81619446|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
27941543|NCT02101853|81619447|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
27941544|NCT02101853|81619448|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
27941545|NCT02101853|81619449|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
27941546|NCT02101853|81619450|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
27941547|NCT02101853|81619445|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
27941548|NCT02101853|81619446|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
27941549|NCT02101853|81619447|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
27941550|NCT02101853|81619448|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
27941551|NCT02101853|81619449|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
27941552|NCT02101853|81619450|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
27941553|NCT02101853|81619445|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
27941554|NCT02101853|81619446|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
27941555|NCT02101853|81619447|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
27941556|NCT02101853|81619448|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
27941557|NCT02101853|81619449|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
27941558|NCT02101853|81619450|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
27941559|NCT00480025|81619453|FG000|Overall Study|Protocol Violation|12|||
27941560|NCT00480025|81619454|FG001|Overall Study|Protocol Violation|7|||
27941561|NCT00480025|81619453|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
27941562|NCT00480025|81619454|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
27941563|NCT00480025|81619453|FG000|Overall Study|Disease Progression / Recurrence|449|||
27941564|NCT00480025|81619454|FG001|Overall Study|Disease Progression / Recurrence|224|||
27941565|NCT00480025|81619453|FG000|Overall Study|Adverse Event|44|||
27941566|NCT00480025|81619454|FG001|Overall Study|Adverse Event|12|||
27941567|NCT00480025|81619453|FG000|Overall Study|Other|70|||
27941568|NCT00480025|81619454|FG001|Overall Study|Other|29|||
27941569|NCT00480025|81619453|FG000|Overall Study|SAE including intercurrent illness|76|||
27941570|NCT00480025|81619454|FG001|Overall Study|SAE including intercurrent illness|42|||
27941571|NCT02965456|81619455|FG000|Overall Study|Lost to Follow-up|40|||
27941572|NCT02965456|81619456|FG001|Overall Study|Lost to Follow-up|18|||
27941573|NCT02965456|81619455|FG000|Overall Study|Subject Request|22|||
27941574|NCT02965456|81619456|FG001|Overall Study|Subject Request|13|||
27941575|NCT02965456|81619455|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
27941576|NCT02965456|81619456|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
27941577|NCT02965456|81619455|FG000|Overall Study|Adverse Event|3|||
27941578|NCT02965456|81619456|FG001|Overall Study|Adverse Event|0|||
27941579|NCT02965456|81619455|FG000|Overall Study|Noncompliance with Study Drug|1|||
27941580|NCT02965456|81619456|FG001|Overall Study|Noncompliance with Study Drug|1|||
27941581|NCT02965456|81619455|FG000|Overall Study|Worsening Condition|0|||
27941582|NCT02965456|81619456|FG001|Overall Study|Worsening Condition|2|||
27941583|NCT02965456|81619455|FG000|Overall Study|Lack of Efficacy|1|||
27941584|NCT02965456|81619456|FG001|Overall Study|Lack of Efficacy|0|||
27941585|NCT02965456|81619455|FG000|Overall Study|Physician Decision|0|||
27941586|NCT02965456|81619456|FG001|Overall Study|Physician Decision|1|||
27941587|NCT02965456|81619455|FG000|Overall Study|Pregnancy|1|||
27941588|NCT02965456|81619456|FG001|Overall Study|Pregnancy|0|||
27941589|NCT02965456|81619455|FG000|Overall Study|Protocol Violation|0|||
27646021|NCT02561195|80543771|FG008|Vaccination 1 to 3|Death|0|||
27646022|NCT02561195|80543772|FG009|Vaccination 1 to 3|Death|0|||
27941590|NCT02965456|81619456|FG001|Overall Study|Protocol Violation|1|||
27941591|NCT02965456|81619455|FG000|Overall Study|Participant ran out of study drug|0|||
27941592|NCT02965456|81619456|FG001|Overall Study|Participant ran out of study drug|1|||
27646023|NCT02561195|80543773|FG010|Vaccination 1 to 3|Death|0|||
27941593|NCT02180867|81619457|FG000|Overall Study|Adverse Event|3|||
27941594|NCT02180867|81619458|FG001|Overall Study|Adverse Event|4|||
27941595|NCT02180867|81619459|FG002|Overall Study|Adverse Event|1|||
27941596|NCT02180867|81619460|FG003|Overall Study|Adverse Event|5|||
27941597|NCT02180867|81619461|FG004|Overall Study|Adverse Event|0|||
27646024|NCT02561195|80543774|FG011|Vaccination 1 to 3|Death|0|||
27941598|NCT02180867|81619462|FG005|Overall Study|Adverse Event|0|||
27941599|NCT02180867|81619463|FG006|Overall Study|Adverse Event|0|||
27941600|NCT02180867|81619457|FG000|Overall Study|Death|0|||
27941601|NCT02180867|81619458|FG001|Overall Study|Death|0|||
27941602|NCT02180867|81619459|FG002|Overall Study|Death|0|||
27941603|NCT02180867|81619460|FG003|Overall Study|Death|0|||
27941604|NCT02180867|81619461|FG004|Overall Study|Death|1|||
27941605|NCT02180867|81619462|FG005|Overall Study|Death|0|||
27941606|NCT02180867|81619463|FG006|Overall Study|Death|0|||
27941607|NCT02180867|81619457|FG000|Overall Study|Lack of Efficacy|0|||
27941608|NCT02180867|81619458|FG001|Overall Study|Lack of Efficacy|2|||
27941609|NCT02180867|81619459|FG002|Overall Study|Lack of Efficacy|0|||
27941610|NCT02180867|81619460|FG003|Overall Study|Lack of Efficacy|1|||
27941611|NCT02180867|81619461|FG004|Overall Study|Lack of Efficacy|6|||
27941612|NCT02180867|81619462|FG005|Overall Study|Lack of Efficacy|0|||
27941613|NCT02180867|81619463|FG006|Overall Study|Lack of Efficacy|1|||
27941614|NCT02180867|81619457|FG000|Overall Study|Physician Decision|1|||
27941615|NCT02180867|81619458|FG001|Overall Study|Physician Decision|3|||
27941616|NCT02180867|81619459|FG002|Overall Study|Physician Decision|1|||
27941617|NCT02180867|81619460|FG003|Overall Study|Physician Decision|10|||
27941618|NCT02180867|81619461|FG004|Overall Study|Physician Decision|9|||
27941619|NCT02180867|81619462|FG005|Overall Study|Physician Decision|3|||
27941620|NCT02180867|81619463|FG006|Overall Study|Physician Decision|4|||
27941621|NCT02180867|81619457|FG000|Overall Study|Withdrawal by Subject|0|||
27941622|NCT02180867|81619458|FG001|Overall Study|Withdrawal by Subject|0|||
27941623|NCT02180867|81619459|FG002|Overall Study|Withdrawal by Subject|0|||
27941624|NCT02180867|81619460|FG003|Overall Study|Withdrawal by Subject|1|||
27941625|NCT02180867|81619461|FG004|Overall Study|Withdrawal by Subject|1|||
27941626|NCT02180867|81619462|FG005|Overall Study|Withdrawal by Subject|0|||
27941627|NCT02180867|81619463|FG006|Overall Study|Withdrawal by Subject|0|||
27941628|NCT02180867|81619457|FG000|Overall Study|Ineligible|1|||
27941629|NCT02180867|81619458|FG001|Overall Study|Ineligible|2|||
27941630|NCT02180867|81619459|FG002|Overall Study|Ineligible|0|||
27941631|NCT02180867|81619460|FG003|Overall Study|Ineligible|3|||
27941632|NCT02180867|81619461|FG004|Overall Study|Ineligible|5|||
27941633|NCT02180867|81619462|FG005|Overall Study|Ineligible|0|||
27646025|NCT02561195|80543775|FG012|Vaccination 1 to 3|Death|0|||
27646026|NCT02561195|80543776|FG013|Vaccination 1 to 3|Death|0|||
27646027|NCT02561195|80543763|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
27941634|NCT02180867|81619463|FG006|Overall Study|Ineligible|0|||
27941635|NCT02180867|81619457|FG000|Overall Study|Repeat Eligibility Studies|0|||
27941636|NCT02180867|81619458|FG001|Overall Study|Repeat Eligibility Studies|0|||
27941637|NCT02180867|81619459|FG002|Overall Study|Repeat Eligibility Studies|0|||
27941638|NCT02180867|81619460|FG003|Overall Study|Repeat Eligibility Studies|0|||
27941639|NCT02180867|81619461|FG004|Overall Study|Repeat Eligibility Studies|1|||
27941640|NCT02180867|81619462|FG005|Overall Study|Repeat Eligibility Studies|0|||
27941641|NCT02180867|81619463|FG006|Overall Study|Repeat Eligibility Studies|0|||
27941642|NCT02180867|81619457|FG000|Overall Study|Refusal of further protocol therapy|1|||
27941643|NCT02180867|81619458|FG001|Overall Study|Refusal of further protocol therapy|0|||
27941644|NCT02180867|81619459|FG002|Overall Study|Refusal of further protocol therapy|2|||
27941645|NCT02180867|81619460|FG003|Overall Study|Refusal of further protocol therapy|6|||
27941646|NCT02180867|81619461|FG004|Overall Study|Refusal of further protocol therapy|4|||
27941647|NCT02180867|81619462|FG005|Overall Study|Refusal of further protocol therapy|0|||
27941648|NCT02180867|81619463|FG006|Overall Study|Refusal of further protocol therapy|0|||
27941649|NCT01251861|81619464|FG000|Overall Study|Disease progression|6|||
27941650|NCT01251861|81619465|FG001|Overall Study|Disease progression|6|||
27941651|NCT01251861|81619464|FG000|Overall Study|Adverse Event|2|||
27941652|NCT01251861|81619465|FG001|Overall Study|Adverse Event|17|||
27941653|NCT01251861|81619464|FG000|Overall Study|Withdrawal by Subject|2|||
27941654|NCT01251861|81619465|FG001|Overall Study|Withdrawal by Subject|2|||
27941655|NCT01251861|81619464|FG000|Overall Study|Alternative therapy|1|||
27941656|NCT01251861|81619465|FG001|Overall Study|Alternative therapy|0|||
27941657|NCT01251861|81619464|FG000|Overall Study|Other complicating disease|0|||
27941658|NCT01251861|81619465|FG001|Overall Study|Other complicating disease|1|||
27646028|NCT02561195|80543764|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
27646029|NCT02561195|80543765|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
27941659|NCT01251861|81619464|FG000|Overall Study|Physician Decision|1|||
27941660|NCT01251861|81619465|FG001|Overall Study|Physician Decision|0|||
27941661|NCT01251861|81619464|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
27941662|NCT01251861|81619465|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
27941663|NCT01251861|81619464|FG000|Overall Study|Other|1|||
27941664|NCT01251861|81619465|FG001|Overall Study|Other|0|||
27941665|NCT01251861|81619464|FG000|Overall Study|Never started therapy|4|||
27941666|NCT01251861|81619465|FG001|Overall Study|Never started therapy|1|||
27941667|NCT01251861|81619464|FG000|Overall Study|Potential interaction of drugs|0|||
27941668|NCT01251861|81619465|FG001|Overall Study|Potential interaction of drugs|1|||
27551353|NCT01543698|80207461|FG003|Phase 1b|Withdrawal by Subject|1|||
27941669|NCT03984188|81619466|FG000|Overall Study|Death|2|||
27941670|NCT03984188|81619467|FG001|Overall Study|Death|4|||
27941671|NCT03984188|81619466|FG000|Overall Study|Physician Decision|0|||
27941672|NCT03984188|81619467|FG001|Overall Study|Physician Decision|2|||
27941673|NCT03984188|81619466|FG000|Overall Study|Lost to Follow-up|3|||
27941674|NCT03984188|81619467|FG001|Overall Study|Lost to Follow-up|2|||
27941675|NCT03984188|81619466|FG000|Overall Study|Withdrawal by Subject|6|||
27941676|NCT03984188|81619467|FG001|Overall Study|Withdrawal by Subject|0|||
27941677|NCT00421408|81619468|FG000|Overall Study|Lost to Follow-up|30|||
27941678|NCT00421408|81619469|FG001|Overall Study|Lost to Follow-up|20|||
27941679|NCT00421408|81619468|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
27941680|NCT00421408|81619469|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
27941681|NCT04065841|81619472|FG000|Overall Study|Adverse Event|4|||
27941682|NCT04065841|81619473|FG001|Overall Study|Adverse Event|2|||
27941683|NCT04065841|81619474|FG002|Overall Study|Adverse Event|10|||
27941684|NCT04065841|81619475|FG003|Overall Study|Adverse Event|1|||
27941685|NCT04065841|81619472|FG000|Overall Study|Lost to Follow-up|1|||
27941686|NCT04065841|81619473|FG001|Overall Study|Lost to Follow-up|2|||
27941687|NCT04065841|81619474|FG002|Overall Study|Lost to Follow-up|2|||
27941688|NCT04065841|81619475|FG003|Overall Study|Lost to Follow-up|2|||
27941689|NCT04065841|81619472|FG000|Overall Study|Physician Decision|1|||
27941690|NCT04065841|81619473|FG001|Overall Study|Physician Decision|0|||
27941691|NCT04065841|81619474|FG002|Overall Study|Physician Decision|0|||
27941692|NCT04065841|81619475|FG003|Overall Study|Physician Decision|0|||
27941693|NCT04065841|81619472|FG000|Overall Study|Protocol Violation|0|||
27646030|NCT02561195|80543766|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
27646031|NCT02561195|80543767|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
27646032|NCT02561195|80543768|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646033|NCT02561195|80543769|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646034|NCT02561195|80543770|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646035|NCT02561195|80543771|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646036|NCT02561195|80543772|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646037|NCT02561195|80543773|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646038|NCT02561195|80543774|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646039|NCT02561195|80543775|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646040|NCT02561195|80543776|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
27646041|NCT02561195|80543763|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
27646042|NCT02561195|80543764|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
27646043|NCT02561195|80543765|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
27646044|NCT02561195|80543766|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
27646045|NCT02561195|80543767|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
27646046|NCT02561195|80543768|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
27646047|NCT02561195|80543769|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
27646048|NCT02561195|80543770|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
27646049|NCT02561195|80543771|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
27646050|NCT02561195|80543772|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
27646051|NCT02561195|80543773|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
27646052|NCT02561195|80543774|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
27646053|NCT02561195|80543775|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
27646054|NCT02561195|80543776|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
27646055|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646056|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646057|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646058|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27941694|NCT04065841|81619473|FG001|Overall Study|Protocol Violation|1|||
27646059|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646060|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646061|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646062|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27646063|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
27646064|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
27646065|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
27646066|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
27646067|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
27646068|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
27941695|NCT04065841|81619474|FG002|Overall Study|Protocol Violation|0|||
27941696|NCT04065841|81619475|FG003|Overall Study|Protocol Violation|0|||
27646069|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
27941697|NCT04065841|81619472|FG000|Overall Study|Study terminated by Sponsor|22|||
27941698|NCT04065841|81619473|FG001|Overall Study|Study terminated by Sponsor|16|||
27941699|NCT04065841|81619474|FG002|Overall Study|Study terminated by Sponsor|28|||
27941700|NCT04065841|81619475|FG003|Overall Study|Study terminated by Sponsor|17|||
27646070|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646071|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
27755015|NCT03571256|80929664|FG000|Overall Study|Adverse Event|3|||
27941701|NCT04065841|81619472|FG000|Overall Study|Withdrawal by Subject|1|||
27646072|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646073|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646074|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646075|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646076|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646077|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646078|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646079|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646080|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646081|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
27646082|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
27646083|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|Death|0|||
27646084|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|Death|0|||
27646085|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|Death|0|||
27646086|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|Death|0|||
27646087|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|Death|0|||
27646088|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|Death|0|||
27646089|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|Death|0|||
27941702|NCT04065841|81619473|FG001|Overall Study|Withdrawal by Subject|1|||
27941703|NCT04065841|81619474|FG002|Overall Study|Withdrawal by Subject|2|||
27941704|NCT04065841|81619475|FG003|Overall Study|Withdrawal by Subject|0|||
27941705|NCT02595437|81619476|FG000|Triferic Via IV|Withdrawal by Subject|1|||
27941706|NCT00236197|81619479|FG000|Overall Study|Withdrawal by Subject|3|||
27646090|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|Death|0|||
27646091|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|Death|0|||
27646092|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|Death|1|||
27646093|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|Death|0|||
27646094|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|Death|0|||
27646095|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|Death|0|||
27646096|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|Death|0|||
27646097|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27941707|NCT00236197|81619480|FG001|Overall Study|Withdrawal by Subject|2|||
27646098|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646099|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646100|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646101|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646102|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646103|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27646104|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27646105|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646106|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
27646107|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
27646108|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27646109|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
27646110|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
27646111|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646112|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646113|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646114|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646115|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646116|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646117|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646118|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646119|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646120|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646121|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
27646122|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
27646123|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
27646124|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
27646125|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|Other|0|||
27646126|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|Other|0|||
27646127|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|Other|0|||
27646128|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|Other|0|||
27646129|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|Other|0|||
27646130|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|Other|0|||
27941708|NCT00236197|81619479|FG000|Overall Study|Lost to Follow-up|1|||
27646131|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|Other|0|||
27941709|NCT00236197|81619480|FG001|Overall Study|Lost to Follow-up|5|||
27551354|NCT01543698|80207462|FG004|Phase 1b|Withdrawal by Subject|0|||
27646132|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|Other|0|||
27646133|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|Other|0|||
27646134|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|Other|0|||
27646135|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|Other|2|||
27646136|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|Other|2|||
27646137|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|Other|1|||
27646138|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|Other|0|||
27646139|NCT02561195|80543763|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646140|NCT02561195|80543764|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646141|NCT02561195|80543765|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646142|NCT02561195|80543766|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646143|NCT02561195|80543767|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27941710|NCT00236197|81619479|FG000|Overall Study|Protocol Violation|0|||
27941711|NCT00236197|81619480|FG001|Overall Study|Protocol Violation|3|||
27941712|NCT00236197|81619479|FG000|Overall Study|Medication non-compliance|1|||
27941713|NCT00236197|81619480|FG001|Overall Study|Medication non-compliance|2|||
27941714|NCT00236197|81619479|FG000|Overall Study|Other|0|||
27941715|NCT00236197|81619480|FG001|Overall Study|Other|2|||
27941716|NCT02904265|81619484|FG000|Overall Study|Physician Decision|1|||
27646144|NCT02561195|80543768|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646145|NCT02561195|80543769|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
27646146|NCT02561195|80543770|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646147|NCT02561195|80543771|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646148|NCT02561195|80543772|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646149|NCT02561195|80543773|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
27646150|NCT02561195|80543774|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
27646151|NCT02561195|80543775|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
27646152|NCT02561195|80543776|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
27646153|NCT01057433|80543778|FG000|Overall Study|Adverse Event|1|||
27646154|NCT04060212|80543779|FG000|Overall Study|Withdrawal by Subject|7|||
27941717|NCT02904265|81619485|FG001|Overall Study|Physician Decision|2|||
27941718|NCT03537729|81619486|FG000|Overall Study|Death|2|||
27941719|NCT03537729|81619487|FG001|Overall Study|Death|2|||
27941720|NCT03537729|81619488|FG002|Overall Study|Death|7|||
27941721|NCT03537729|81619486|FG000|Overall Study|Withdrawal by Subject|3|||
27941722|NCT03537729|81619487|FG001|Overall Study|Withdrawal by Subject|3|||
27941723|NCT03537729|81619488|FG002|Overall Study|Withdrawal by Subject|0|||
27941724|NCT03537729|81619486|FG000|Overall Study|Subject Moved|8|||
27941725|NCT03537729|81619487|FG001|Overall Study|Subject Moved|5|||
27941726|NCT03537729|81619488|FG002|Overall Study|Subject Moved|4|||
27941727|NCT03537729|81619486|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
27941728|NCT03537729|81619487|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
27941729|NCT03537729|81619488|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
27941730|NCT03537729|81619486|FG000|Overall Study|COVID-19 Site Restrictions|11|||
27941731|NCT03537729|81619487|FG001|Overall Study|COVID-19 Site Restrictions|15|||
27941732|NCT03537729|81619488|FG002|Overall Study|COVID-19 Site Restrictions|18|||
27941733|NCT03537729|81619486|FG000|Overall Study|Decline in Health|5|||
27941734|NCT03537729|81619487|FG001|Overall Study|Decline in Health|9|||
27941735|NCT03537729|81619488|FG002|Overall Study|Decline in Health|4|||
27941736|NCT03537729|81619486|FG000|Overall Study|Determined Ineligible|0|||
27941737|NCT03537729|81619487|FG001|Overall Study|Determined Ineligible|0|||
27941738|NCT03537729|81619488|FG002|Overall Study|Determined Ineligible|1|||
27941739|NCT01569763|81619491|FG000|Overall Study|Lack of Efficacy|2|||
27941740|NCT01569763|81619492|FG001|Overall Study|Lack of Efficacy|7|||
27941741|NCT01569763|81619491|FG000|Overall Study|Adverse Event|1|||
27941742|NCT01569763|81619492|FG001|Overall Study|Adverse Event|0|||
27941743|NCT00124657|81619493|FG000|Overall Study|Toxicity|0|||
27941744|NCT00124657|81619494|FG001|Overall Study|Toxicity|0|||
27941745|NCT00124657|81619495|FG002|Overall Study|Toxicity|1|||
27941746|NCT00124657|81619493|FG000|Overall Study|Non-compliance|1|||
27941747|NCT00124657|81619494|FG001|Overall Study|Non-compliance|0|||
27941748|NCT00124657|81619495|FG002|Overall Study|Non-compliance|4|||
27941749|NCT00124657|81619493|FG000|Overall Study|Progressive disease|14|||
27941750|NCT00124657|81619494|FG001|Overall Study|Progressive disease|5|||
27646155|NCT01160354|80543780|FG000|Overall Study|Death|0|||
27646156|NCT01160354|80543781|FG001|Overall Study|Death|1|||
27646157|NCT01160354|80543782|FG002|Overall Study|Death|1|||
27941751|NCT00124657|81619495|FG002|Overall Study|Progressive disease|27|||
27941752|NCT00124657|81619493|FG000|Overall Study|Intercurrent illness|1|||
27941753|NCT00124657|81619494|FG001|Overall Study|Intercurrent illness|0|||
27941754|NCT00124657|81619495|FG002|Overall Study|Intercurrent illness|0|||
27941755|NCT00595075|81619502|FG000|Overall Study|Withdrawal by Subject|1|||
27941756|NCT00595075|81619503|FG001|Overall Study|Withdrawal by Subject|0|||
27941757|NCT03715829|81619504|FG000|Dose Ranging Period|Adverse Event|2|||
27941758|NCT03715829|81619505|FG001|Dose Ranging Period|Adverse Event|4|||
27941759|NCT03715829|81619506|FG002|Dose Ranging Period|Adverse Event|5|||
27941760|NCT03715829|81619507|FG003|Dose Ranging Period|Adverse Event|2|||
27941761|NCT03715829|81619508|FG004|Dose Ranging Period|Adverse Event|3|||
27941762|NCT03715829|81619509|FG005|Dose Ranging Period|Adverse Event|3|||
27941763|NCT03715829|81619510|FG006|Dose Ranging Period|Adverse Event|0|||
27941764|NCT03715829|81619511|FG007|Dose Ranging Period|Adverse Event|0|||
27941765|NCT03715829|81619512|FG008|Dose Ranging Period|Adverse Event|0|||
27941766|NCT03715829|81619513|FG009|Dose Ranging Period|Adverse Event|0|||
27941767|NCT03715829|81619514|FG010|Dose Ranging Period|Adverse Event|0|||
27941768|NCT03715829|81619504|FG000|Dose Ranging Period|Lack of Efficacy|0|||
27941769|NCT03715829|81619505|FG001|Dose Ranging Period|Lack of Efficacy|1|||
27941770|NCT03715829|81619506|FG002|Dose Ranging Period|Lack of Efficacy|0|||
27941771|NCT03715829|81619507|FG003|Dose Ranging Period|Lack of Efficacy|1|||
27941772|NCT03715829|81619508|FG004|Dose Ranging Period|Lack of Efficacy|0|||
27941773|NCT03715829|81619509|FG005|Dose Ranging Period|Lack of Efficacy|0|||
27941774|NCT03715829|81619510|FG006|Dose Ranging Period|Lack of Efficacy|0|||
27941775|NCT03715829|81619511|FG007|Dose Ranging Period|Lack of Efficacy|0|||
27941776|NCT03715829|81619512|FG008|Dose Ranging Period|Lack of Efficacy|0|||
27941777|NCT03715829|81619513|FG009|Dose Ranging Period|Lack of Efficacy|0|||
27941778|NCT03715829|81619514|FG010|Dose Ranging Period|Lack of Efficacy|0|||
27941779|NCT03715829|81619504|FG000|Dose Ranging Period|Lost to Follow-up|2|||
27941780|NCT03715829|81619505|FG001|Dose Ranging Period|Lost to Follow-up|0|||
27941781|NCT03715829|81619506|FG002|Dose Ranging Period|Lost to Follow-up|1|||
27941782|NCT03715829|81619507|FG003|Dose Ranging Period|Lost to Follow-up|1|||
27941783|NCT03715829|81619508|FG004|Dose Ranging Period|Lost to Follow-up|1|||
27941784|NCT03715829|81619509|FG005|Dose Ranging Period|Lost to Follow-up|2|||
27941785|NCT03715829|81619510|FG006|Dose Ranging Period|Lost to Follow-up|0|||
27941786|NCT03715829|81619511|FG007|Dose Ranging Period|Lost to Follow-up|0|||
27941787|NCT03715829|81619512|FG008|Dose Ranging Period|Lost to Follow-up|0|||
27941788|NCT03715829|81619513|FG009|Dose Ranging Period|Lost to Follow-up|0|||
27941789|NCT03715829|81619514|FG010|Dose Ranging Period|Lost to Follow-up|0|||
27941790|NCT03715829|81619504|FG000|Dose Ranging Period|Protocol Violation|0|||
27941791|NCT03715829|81619505|FG001|Dose Ranging Period|Protocol Violation|0|||
27941792|NCT03715829|81619506|FG002|Dose Ranging Period|Protocol Violation|0|||
27941793|NCT03715829|81619507|FG003|Dose Ranging Period|Protocol Violation|1|||
27941794|NCT03715829|81619508|FG004|Dose Ranging Period|Protocol Violation|0|||
27941795|NCT03715829|81619509|FG005|Dose Ranging Period|Protocol Violation|0|||
27941796|NCT03715829|81619510|FG006|Dose Ranging Period|Protocol Violation|0|||
27941797|NCT03715829|81619511|FG007|Dose Ranging Period|Protocol Violation|0|||
27941798|NCT03715829|81619512|FG008|Dose Ranging Period|Protocol Violation|0|||
27941799|NCT03715829|81619513|FG009|Dose Ranging Period|Protocol Violation|0|||
27941800|NCT03715829|81619514|FG010|Dose Ranging Period|Protocol Violation|0|||
27941801|NCT03715829|81619504|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
27941802|NCT03715829|81619505|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
27941803|NCT03715829|81619506|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
27941804|NCT03715829|81619507|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
27941805|NCT03715829|81619508|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
27941806|NCT03715829|81619509|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
27941807|NCT03715829|81619510|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
27941808|NCT03715829|81619511|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
27941809|NCT03715829|81619512|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
27941810|NCT03715829|81619513|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
27941811|NCT03715829|81619514|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
27941812|NCT03715829|81619504|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941813|NCT03715829|81619505|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941814|NCT03715829|81619506|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
27941815|NCT03715829|81619507|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941816|NCT03715829|81619508|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941817|NCT03715829|81619509|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941818|NCT03715829|81619510|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941819|NCT03715829|81619511|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941820|NCT03715829|81619512|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941821|NCT03715829|81619513|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941822|NCT03715829|81619514|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
27941823|NCT03715829|81619504|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941824|NCT03715829|81619505|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941825|NCT03715829|81619506|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
27941826|NCT03715829|81619507|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941827|NCT03715829|81619508|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
27941828|NCT03715829|81619509|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941829|NCT03715829|81619510|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941830|NCT03715829|81619511|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941831|NCT03715829|81619512|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941832|NCT03715829|81619513|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941833|NCT03715829|81619514|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
27941834|NCT03715829|81619504|FG000|Dose Ranging Period|Other|0|||
27941835|NCT03715829|81619505|FG001|Dose Ranging Period|Other|0|||
27941836|NCT03715829|81619506|FG002|Dose Ranging Period|Other|2|||
27941837|NCT03715829|81619507|FG003|Dose Ranging Period|Other|0|||
27941838|NCT03715829|81619508|FG004|Dose Ranging Period|Other|0|||
27941839|NCT03715829|81619509|FG005|Dose Ranging Period|Other|3|||
27941840|NCT03715829|81619510|FG006|Dose Ranging Period|Other|0|||
27941841|NCT03715829|81619511|FG007|Dose Ranging Period|Other|0|||
27941842|NCT03715829|81619512|FG008|Dose Ranging Period|Other|0|||
27941843|NCT03715829|81619513|FG009|Dose Ranging Period|Other|0|||
27941844|NCT03715829|81619514|FG010|Dose Ranging Period|Other|0|||
27941845|NCT03715829|81619504|FG000|Extension Period|Adverse Event|0|||
27941846|NCT03715829|81619505|FG001|Extension Period|Adverse Event|0|||
27646158|NCT03500549|80543784|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
27646159|NCT03500549|80543785|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
27646160|NCT03500549|80543784|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
27646161|NCT03500549|80543785|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
27646162|NCT02874534|80543786|FG000|Overall Study|Withdrawal by Subject|5|||
27646163|NCT02874534|80543787|FG001|Overall Study|Withdrawal by Subject|8|||
27646164|NCT02874534|80543786|FG000|Overall Study|Lost to Follow-up|2|||
27646165|NCT02874534|80543787|FG001|Overall Study|Lost to Follow-up|2|||
27646166|NCT02874534|80543786|FG000|Overall Study|Ongoing in study|1|||
27646167|NCT02874534|80543787|FG001|Overall Study|Ongoing in study|1|||
27646168|NCT01530334|80547543|FG000|Overall Study|Adverse Event|3|||
27646169|NCT01530334|80547543|FG000|Overall Study|unknown reason|1|||
27646170|NCT01530334|80547543|FG000|Overall Study|Progressive disease|47|||
27646171|NCT00512252|80547554|FG000|Overall Study|Lost to Follow-up|0|||
27646172|NCT00512252|80547555|FG001|Overall Study|Lost to Follow-up|0|||
27646173|NCT00512252|80547556|FG002|Overall Study|Lost to Follow-up|1|||
27646174|NCT00512252|80547554|FG000|Overall Study|Protocol Violation|0|||
27646175|NCT00512252|80547555|FG001|Overall Study|Protocol Violation|0|||
27646176|NCT00512252|80547556|FG002|Overall Study|Protocol Violation|1|||
27646177|NCT00512252|80547554|FG000|Overall Study|Death|0|||
27941847|NCT03715829|81619506|FG002|Extension Period|Adverse Event|0|||
27941848|NCT03715829|81619507|FG003|Extension Period|Adverse Event|0|||
27646178|NCT00512252|80547555|FG001|Overall Study|Death|0|||
27646179|NCT00512252|80547556|FG002|Overall Study|Death|1|||
27646180|NCT03478969|80547557|FG000|Overall Study|Withdrawal by Subject|4|||
27646181|NCT03478969|80547558|FG001|Overall Study|Withdrawal by Subject|7|||
27646182|NCT03478969|80547559|FG002|Overall Study|Withdrawal by Subject|6|||
27941849|NCT03715829|81619508|FG004|Extension Period|Adverse Event|0|||
27941850|NCT03715829|81619509|FG005|Extension Period|Adverse Event|0|||
27941851|NCT03715829|81619510|FG006|Extension Period|Adverse Event|3|||
27941852|NCT03715829|81619511|FG007|Extension Period|Adverse Event|1|||
27941853|NCT03715829|81619512|FG008|Extension Period|Adverse Event|6|||
27941854|NCT03715829|81619513|FG009|Extension Period|Adverse Event|0|||
27941855|NCT03715829|81619514|FG010|Extension Period|Adverse Event|0|||
27941856|NCT03715829|81619504|FG000|Extension Period|Lack of Efficacy|0|||
27941857|NCT03715829|81619505|FG001|Extension Period|Lack of Efficacy|0|||
27941858|NCT03715829|81619506|FG002|Extension Period|Lack of Efficacy|0|||
27941859|NCT03715829|81619507|FG003|Extension Period|Lack of Efficacy|0|||
27941860|NCT03715829|81619508|FG004|Extension Period|Lack of Efficacy|0|||
27941861|NCT03715829|81619509|FG005|Extension Period|Lack of Efficacy|0|||
27941862|NCT03715829|81619510|FG006|Extension Period|Lack of Efficacy|1|||
27941863|NCT03715829|81619511|FG007|Extension Period|Lack of Efficacy|9|||
27941864|NCT03715829|81619512|FG008|Extension Period|Lack of Efficacy|2|||
27941865|NCT03715829|81619513|FG009|Extension Period|Lack of Efficacy|0|||
27941866|NCT03715829|81619514|FG010|Extension Period|Lack of Efficacy|0|||
27941867|NCT03715829|81619504|FG000|Extension Period|Lost to Follow-up|0|||
27646183|NCT03478969|80547557|FG000|Overall Study|Adverse Event|2|||
27646184|NCT03478969|80547558|FG001|Overall Study|Adverse Event|0|||
27941868|NCT03715829|81619505|FG001|Extension Period|Lost to Follow-up|0|||
27941869|NCT03715829|81619506|FG002|Extension Period|Lost to Follow-up|0|||
27646185|NCT03478969|80547559|FG002|Overall Study|Adverse Event|1|||
27646186|NCT03478969|80547557|FG000|Overall Study|Pregnancy|1|||
27646187|NCT03478969|80547558|FG001|Overall Study|Pregnancy|0|||
27941870|NCT03715829|81619507|FG003|Extension Period|Lost to Follow-up|0|||
27941871|NCT03715829|81619508|FG004|Extension Period|Lost to Follow-up|0|||
27941872|NCT03715829|81619509|FG005|Extension Period|Lost to Follow-up|0|||
27941873|NCT03715829|81619510|FG006|Extension Period|Lost to Follow-up|0|||
27941874|NCT03715829|81619511|FG007|Extension Period|Lost to Follow-up|0|||
27646188|NCT03478969|80547559|FG002|Overall Study|Pregnancy|0|||
27746310|NCT03345836|80899610|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
27941875|NCT03715829|81619512|FG008|Extension Period|Lost to Follow-up|2|||
27941876|NCT03715829|81619513|FG009|Extension Period|Lost to Follow-up|0|||
27941877|NCT03715829|81619514|FG010|Extension Period|Lost to Follow-up|0|||
27941878|NCT03715829|81619504|FG000|Extension Period|Protocol Violation|0|||
27941879|NCT03715829|81619505|FG001|Extension Period|Protocol Violation|0|||
27941880|NCT03715829|81619506|FG002|Extension Period|Protocol Violation|0|||
27941881|NCT03715829|81619507|FG003|Extension Period|Protocol Violation|0|||
27941882|NCT03715829|81619508|FG004|Extension Period|Protocol Violation|0|||
27941883|NCT03715829|81619509|FG005|Extension Period|Protocol Violation|0|||
27941884|NCT03715829|81619510|FG006|Extension Period|Protocol Violation|0|||
27941885|NCT03715829|81619511|FG007|Extension Period|Protocol Violation|0|||
27941886|NCT03715829|81619512|FG008|Extension Period|Protocol Violation|1|||
27941887|NCT03715829|81619513|FG009|Extension Period|Protocol Violation|0|||
27941888|NCT03715829|81619514|FG010|Extension Period|Protocol Violation|0|||
27941889|NCT03715829|81619504|FG000|Extension Period|Withdrawal by Subject|0|||
27941890|NCT03715829|81619505|FG001|Extension Period|Withdrawal by Subject|0|||
27941891|NCT03715829|81619506|FG002|Extension Period|Withdrawal by Subject|0|||
27941892|NCT03715829|81619507|FG003|Extension Period|Withdrawal by Subject|0|||
27941893|NCT03715829|81619508|FG004|Extension Period|Withdrawal by Subject|0|||
27941894|NCT03715829|81619509|FG005|Extension Period|Withdrawal by Subject|0|||
27941895|NCT03715829|81619510|FG006|Extension Period|Withdrawal by Subject|3|||
27646189|NCT03478969|80547557|FG000|Overall Study|Personal Reasons|1|||
27646190|NCT03478969|80547558|FG001|Overall Study|Personal Reasons|0|||
27646191|NCT03478969|80547559|FG002|Overall Study|Personal Reasons|1|||
27646192|NCT03478969|80547557|FG000|Overall Study|Covid-19|1|||
27646193|NCT03478969|80547558|FG001|Overall Study|Covid-19|4|||
27646194|NCT03478969|80547559|FG002|Overall Study|Covid-19|3|||
27646195|NCT03478969|80547557|FG000|Overall Study|Multiple Reasons|0|||
27646196|NCT03478969|80547558|FG001|Overall Study|Multiple Reasons|1|||
27646197|NCT03478969|80547559|FG002|Overall Study|Multiple Reasons|1|||
27646198|NCT03478969|80547557|FG000|Overall Study|Eligibility Criteria|0|||
27646199|NCT03478969|80547558|FG001|Overall Study|Eligibility Criteria|0|||
27646200|NCT03478969|80547559|FG002|Overall Study|Eligibility Criteria|5|||
27646201|NCT03478969|80547557|FG000|Overall Study|Lost to Follow-up|0|||
27646202|NCT03478969|80547558|FG001|Overall Study|Lost to Follow-up|0|||
27646203|NCT03478969|80547559|FG002|Overall Study|Lost to Follow-up|1|||
27646204|NCT03709706|80547560|FG000|Overall Study|Adverse Event|0|||
27646205|NCT03709706|80547561|FG001|Overall Study|Adverse Event|1|||
27646206|NCT03709706|80547560|FG000|Overall Study|Physician Decision|14|||
27646207|NCT03709706|80547561|FG001|Overall Study|Physician Decision|8|||
27646208|NCT03709706|80547560|FG000|Overall Study|Withdrawal by Subject|2|||
27646209|NCT03709706|80547561|FG001|Overall Study|Withdrawal by Subject|1|||
27646210|NCT03709706|80547560|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
27646211|NCT03709706|80547561|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
27646212|NCT01185600|80547562|FG000|Overall Study|Adverse Event|1|||
27646213|NCT01185600|80547563|FG001|Overall Study|Adverse Event|1|||
27646214|NCT01185600|80547562|FG000|Overall Study|Death|0|||
27646215|NCT01185600|80547563|FG001|Overall Study|Death|1|||
27646216|NCT01185600|80547562|FG000|Overall Study|Lost to Follow-up|0|||
27646217|NCT01185600|80547563|FG001|Overall Study|Lost to Follow-up|5|||
27941896|NCT03715829|81619511|FG007|Extension Period|Withdrawal by Subject|3|||
27646218|NCT01185600|80547562|FG000|Overall Study|Physician Decision|29|||
27646219|NCT01185600|80547563|FG001|Overall Study|Physician Decision|35|||
27646220|NCT01185600|80547562|FG000|Overall Study|Withdrawal by Subject|1|||
27646221|NCT01185600|80547563|FG001|Overall Study|Withdrawal by Subject|1|||
27646222|NCT01185600|80547562|FG000|Overall Study|Hold by DSMB|1|||
27646223|NCT01185600|80547563|FG001|Overall Study|Hold by DSMB|2|||
27646224|NCT00336505|80547564|FG000|Overall Study|Adverse Event|10|||
27646225|NCT00336505|80547565|FG001|Overall Study|Adverse Event|9|||
27646226|NCT00336505|80547564|FG000|Overall Study|Lack of Efficacy|8|||
27646227|NCT00336505|80547565|FG001|Overall Study|Lack of Efficacy|4|||
27646228|NCT00336505|80547564|FG000|Overall Study|Lost to Follow-up|7|||
27646229|NCT00336505|80547565|FG001|Overall Study|Lost to Follow-up|4|||
27646230|NCT00336505|80547564|FG000|Overall Study|Withdrawal by Subject|5|||
27646231|NCT00336505|80547565|FG001|Overall Study|Withdrawal by Subject|3|||
27646232|NCT00336505|80547564|FG000|Overall Study|Other|7|||
27646233|NCT00336505|80547565|FG001|Overall Study|Other|7|||
27646234|NCT01323790|80547566|FG000|Overall Study|Other|3|||
27646235|NCT01323790|80547567|FG001|Overall Study|Other|2|||
27646236|NCT01323790|80547568|FG002|Overall Study|Other|1|||
27646237|NCT01323790|80547566|FG000|Overall Study|Lost to Follow-up|11|||
27646238|NCT01323790|80547567|FG001|Overall Study|Lost to Follow-up|9|||
27646239|NCT01323790|80547568|FG002|Overall Study|Lost to Follow-up|9|||
27646240|NCT01323790|80547566|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
27941897|NCT03715829|81619512|FG008|Extension Period|Withdrawal by Subject|12|||
27941898|NCT03715829|81619513|FG009|Extension Period|Withdrawal by Subject|3|||
27941899|NCT03715829|81619514|FG010|Extension Period|Withdrawal by Subject|0|||
27646241|NCT01323790|80547567|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
27646242|NCT01323790|80547568|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
27646243|NCT01323790|80547566|FG000|Overall Study|Lack of Efficacy|3|||
27646244|NCT01323790|80547567|FG001|Overall Study|Lack of Efficacy|0|||
27646245|NCT01323790|80547568|FG002|Overall Study|Lack of Efficacy|3|||
27646246|NCT01323790|80547566|FG000|Overall Study|Adverse Event|11|||
27646247|NCT01323790|80547567|FG001|Overall Study|Adverse Event|24|||
27646248|NCT01323790|80547568|FG002|Overall Study|Adverse Event|12|||
27646249|NCT01323790|80547566|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27646250|NCT01323790|80547567|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
27646251|NCT01323790|80547568|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
27646252|NCT01323790|80547566|FG000|Overall Study|Withdrawal by Subject|23|||
27646253|NCT01323790|80547567|FG001|Overall Study|Withdrawal by Subject|20|||
27646254|NCT01323790|80547568|FG002|Overall Study|Withdrawal by Subject|13|||
27646255|NCT01323790|80547566|FG000|Overall Study|Did Not Receive Treatment|2|||
27646256|NCT01323790|80547567|FG001|Overall Study|Did Not Receive Treatment|0|||
27646257|NCT01323790|80547568|FG002|Overall Study|Did Not Receive Treatment|1|||
27646258|NCT01323790|80547566|FG000|Overall Study|Severe non-compliance with protocol|2|||
27646259|NCT01323790|80547567|FG001|Overall Study|Severe non-compliance with protocol|2|||
27646260|NCT01323790|80547568|FG002|Overall Study|Severe non-compliance with protocol|2|||
27646261|NCT00210106|80547569|FG000|Overall Study|Death|1|||
27646262|NCT00210106|80547569|FG000|Overall Study|Protocol Violation|13|||
27646263|NCT03347396|80547570|FG000|Part A (26 Weeks)|Adverse Event|1|||
27646264|NCT03347396|80547571|FG001|Part A (26 Weeks)|Adverse Event|0|||
27941900|NCT03715829|81619504|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941901|NCT03715829|81619505|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941902|NCT03715829|81619506|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941903|NCT03715829|81619507|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941904|NCT03715829|81619508|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941905|NCT03715829|81619509|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941906|NCT03715829|81619510|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941907|NCT03715829|81619511|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
27941908|NCT03715829|81619512|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
27941909|NCT03715829|81619513|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941910|NCT03715829|81619514|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
27941911|NCT03715829|81619504|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941912|NCT03715829|81619505|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941913|NCT03715829|81619506|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
27646265|NCT03347396|80547570|FG000|Part A (26 Weeks)|Death|0|||
27646266|NCT03347396|80547571|FG001|Part A (26 Weeks)|Death|1|||
27646267|NCT03347396|80547570|FG000|Part B (149 Weeks)|Adverse Event|1|||
27646268|NCT03347396|80547571|FG001|Part B (149 Weeks)|Adverse Event|1|||
27646269|NCT03347396|80547570|FG000|Part B (149 Weeks)|Death|1|||
27646270|NCT03347396|80547571|FG001|Part B (149 Weeks)|Death|0|||
27646271|NCT02408887|80547572|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
27646272|NCT02408887|80547573|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
27646273|NCT02408887|80547572|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
27941914|NCT03715829|81619507|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941915|NCT03715829|81619508|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941916|NCT03715829|81619509|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941917|NCT03715829|81619510|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941918|NCT03715829|81619511|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941919|NCT03715829|81619512|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
27941920|NCT03715829|81619513|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941921|NCT03715829|81619514|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
27941922|NCT03715829|81619504|FG000|Extension Period|Other|0|||
27941923|NCT03715829|81619505|FG001|Extension Period|Other|0|||
27941924|NCT03715829|81619506|FG002|Extension Period|Other|0|||
27941925|NCT03715829|81619507|FG003|Extension Period|Other|0|||
27941926|NCT03715829|81619508|FG004|Extension Period|Other|0|||
27941927|NCT03715829|81619509|FG005|Extension Period|Other|0|||
27941928|NCT03715829|81619510|FG006|Extension Period|Other|1|||
27941929|NCT03715829|81619511|FG007|Extension Period|Other|2|||
27941930|NCT03715829|81619512|FG008|Extension Period|Other|4|||
27941931|NCT03715829|81619513|FG009|Extension Period|Other|0|||
27941932|NCT03715829|81619514|FG010|Extension Period|Other|0|||
27941933|NCT02940223|81619517|FG000|Overall Study|Failed Requirement|2|||
27941934|NCT02940223|81619518|FG001|Overall Study|Failed Requirement|0|||
27646274|NCT02408887|80547573|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
27646275|NCT00753545|80547574|FG000|Overall Study|Death|98|||
27646276|NCT00753545|80547575|FG001|Overall Study|Death|112|||
27746311|NCT03345836|80899605|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
27941935|NCT00720083|81619519|FG000|Overall Study|Ineligible|1|||
27646277|NCT00753545|80547574|FG000|Overall Study|Lost to Follow-up|2|||
27646278|NCT00753545|80547575|FG001|Overall Study|Lost to Follow-up|3|||
27941936|NCT00720083|81619520|FG001|Overall Study|Ineligible|2|||
27941937|NCT04309500|81619532|FG000|Overall Study|Lost to Follow-up|1|||
27941938|NCT04309500|81619533|FG001|Overall Study|Lost to Follow-up|0|||
27941939|NCT04309500|81619534|FG002|Overall Study|Lost to Follow-up|0|||
27941940|NCT04309500|81619535|FG003|Overall Study|Lost to Follow-up|0|||
27941941|NCT00489476|81619536|FG000|Overall Study|Lost to Follow-up|0|||
27941942|NCT00489476|81619537|FG001|Overall Study|Lost to Follow-up|1|||
27941943|NCT00489476|81619538|FG002|Overall Study|Lost to Follow-up|0|||
27941944|NCT00489476|81619539|FG003|Overall Study|Lost to Follow-up|0|||
27941945|NCT01848457|81619543|FG000|Overall Study|Death|1|||
27941946|NCT01848457|81619544|FG001|Overall Study|Death|0|||
27941947|NCT01848457|81619545|FG002|Overall Study|Death|0|||
27941948|NCT01848457|81619546|FG003|Overall Study|Death|0|||
27941949|NCT00655356|81619547|FG000|Overall Study|Withdrawal by Subject|3|||
27941950|NCT00655356|81619548|FG001|Overall Study|Withdrawal by Subject|4|||
27941951|NCT00655356|81619547|FG000|Overall Study|Sponsor Request|10|||
27941952|NCT00655356|81619548|FG001|Overall Study|Sponsor Request|4|||
27941953|NCT00655356|81619547|FG000|Overall Study|Adverse Event|1|||
27941954|NCT00655356|81619548|FG001|Overall Study|Adverse Event|1|||
27941955|NCT00655356|81619547|FG000|Overall Study|Protocol Violation|2|||
27941956|NCT00655356|81619548|FG001|Overall Study|Protocol Violation|1|||
27941957|NCT00655356|81619547|FG000|Overall Study|Other Reason|1|||
27941958|NCT00655356|81619548|FG001|Overall Study|Other Reason|0|||
27941959|NCT01093573|81619552|FG000|Overall Study|Physician Decision|0|||
27941960|NCT01093573|81619553|FG001|Overall Study|Physician Decision|0|||
27941961|NCT01093573|81619554|FG002|Overall Study|Physician Decision|1|||
27941962|NCT01093573|81619552|FG000|Overall Study|Insurance Denied|0|||
27941963|NCT01093573|81619553|FG001|Overall Study|Insurance Denied|0|||
27941964|NCT01093573|81619554|FG002|Overall Study|Insurance Denied|1|||
27941965|NCT05128929|81619555|FG000|Overall Study|Adverse Event|0|||
27941966|NCT05128929|81619556|FG001|Overall Study|Adverse Event|1|||
27646279|NCT00753545|80547574|FG000|Overall Study|Protocol Violation|1|||
27646280|NCT00753545|80547575|FG001|Overall Study|Protocol Violation|0|||
27646281|NCT00753545|80547574|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
27646282|NCT00753545|80547575|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
27646283|NCT00146172|80547576|FG000|Overall Study|Adverse Event|0|||
27646284|NCT00146172|80547577|FG001|Overall Study|Adverse Event|0|||
27646285|NCT00146172|80547578|FG002|Overall Study|Adverse Event|1|||
27646286|NCT00146172|80547579|FG003|Overall Study|Adverse Event|1|||
27646287|NCT00146172|80547580|FG004|Overall Study|Adverse Event|0|||
27646288|NCT00146172|80547581|FG005|Overall Study|Adverse Event|2|||
27646289|NCT00146172|80547582|FG006|Overall Study|Adverse Event|3|||
27646290|NCT00146172|80547583|FG007|Overall Study|Adverse Event|10|||
27646291|NCT00146172|80547576|FG000|Overall Study|Lost to Follow-up|0|||
27646292|NCT00146172|80547577|FG001|Overall Study|Lost to Follow-up|0|||
27646293|NCT00146172|80547578|FG002|Overall Study|Lost to Follow-up|0|||
27646294|NCT00146172|80547579|FG003|Overall Study|Lost to Follow-up|0|||
27941967|NCT04126174|81619557|FG000|Overall Study|Lost to Follow-up|3|||
27941968|NCT04126174|81619558|FG001|Overall Study|Lost to Follow-up|3|||
27941969|NCT04008069|81619561|FG000|Open-Label Period|Adverse Event|1|||
27941970|NCT04008069|81619562|FG001|Open-Label Period|Adverse Event|0|||
27941971|NCT04008069|81619563|FG002|Open-Label Period|Adverse Event|0|||
27941972|NCT04008069|81619561|FG000|Open-Label Period|Lack of Efficacy|4|||
27941973|NCT04008069|81619562|FG001|Open-Label Period|Lack of Efficacy|0|||
27941974|NCT04008069|81619563|FG002|Open-Label Period|Lack of Efficacy|0|||
27941975|NCT04008069|81619561|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
27941976|NCT04008069|81619562|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
27941977|NCT04008069|81619563|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
27941978|NCT04008069|81619561|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
27941979|NCT04008069|81619562|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
27646295|NCT00146172|80547580|FG004|Overall Study|Lost to Follow-up|0|||
27646296|NCT00146172|80547581|FG005|Overall Study|Lost to Follow-up|0|||
27646297|NCT00146172|80547582|FG006|Overall Study|Lost to Follow-up|0|||
27941980|NCT04008069|81619563|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
27941981|NCT02715856|81619566|FG000|Overall Study|Software Issues|12|||
27941982|NCT02715856|81619567|FG001|Overall Study|Software Issues|7|||
27941983|NCT02715856|81619566|FG000|Overall Study|Death|6|||
27646298|NCT00146172|80547583|FG007|Overall Study|Lost to Follow-up|1|||
27646299|NCT00146172|80547576|FG000|Overall Study|Disease Progression|2|||
27646300|NCT00146172|80547577|FG001|Overall Study|Disease Progression|4|||
27941984|NCT02715856|81619567|FG001|Overall Study|Death|5|||
27941985|NCT02715856|81619566|FG000|Overall Study|Non- Compliant|0|||
27941986|NCT02715856|81619567|FG001|Overall Study|Non- Compliant|40|||
27646301|NCT00146172|80547578|FG002|Overall Study|Disease Progression|2|||
27646302|NCT00146172|80547579|FG003|Overall Study|Disease Progression|5|||
27941987|NCT03810365|81619573|FG000|Overall Study|Lost to Follow-up|2|||
27941988|NCT03810365|81619574|FG001|Overall Study|Lost to Follow-up|2|||
27646303|NCT00146172|80547580|FG004|Overall Study|Disease Progression|2|||
27646304|NCT00146172|80547581|FG005|Overall Study|Disease Progression|2|||
27941989|NCT03810365|81619573|FG000|Overall Study|Withdrawal by Subject|4|||
27941990|NCT03810365|81619574|FG001|Overall Study|Withdrawal by Subject|5|||
27941991|NCT02502383|81619575|FG000|Overall Study|Lost to Follow-up|130|||
27941992|NCT02502383|81619576|FG001|Overall Study|Lost to Follow-up|131|||
27941993|NCT02502383|81619575|FG000|Overall Study|Withdrawal by Subject|31|||
27941994|NCT02502383|81619576|FG001|Overall Study|Withdrawal by Subject|24|||
27941995|NCT02741193|81619579|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
27941996|NCT02741193|81619579|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
27941997|NCT02769481|81619584|FG000|Overall Study|Protocol Violation|1|||
27941998|NCT02769481|81619585|FG001|Overall Study|Protocol Violation|0|||
27941999|NCT02769481|81619584|FG000|Overall Study|Adverse Event|3|||
27942000|NCT02769481|81619585|FG001|Overall Study|Adverse Event|6|||
27942001|NCT02769481|81619584|FG000|Overall Study|Entry Criteria Not Met|1|||
27942002|NCT02769481|81619585|FG001|Overall Study|Entry Criteria Not Met|2|||
27942003|NCT02769481|81619584|FG000|Overall Study|Withdrawal by Subject|14|||
27942004|NCT02769481|81619585|FG001|Overall Study|Withdrawal by Subject|16|||
27942005|NCT02769481|81619584|FG000|Overall Study|Lost to Follow-up|9|||
27942006|NCT02769481|81619585|FG001|Overall Study|Lost to Follow-up|9|||
27942007|NCT02769481|81619584|FG000|Overall Study|Physician Decision|0|||
27942008|NCT02769481|81619585|FG001|Overall Study|Physician Decision|1|||
27942009|NCT02769481|81619584|FG000|Overall Study|Terminated by Sponsor|1|||
27942010|NCT02769481|81619585|FG001|Overall Study|Terminated by Sponsor|0|||
27942011|NCT02769481|81619584|FG000|Overall Study|Death|0|||
27942012|NCT02769481|81619585|FG001|Overall Study|Death|1|||
27942013|NCT02769481|81619584|FG000|Overall Study|Undefined|4|||
27942014|NCT02769481|81619585|FG001|Overall Study|Undefined|1|||
27942015|NCT03829683|81619586|FG000|Overall Study|Lost to Follow-up|1|||
27942016|NCT03829683|81619587|FG001|Overall Study|Lost to Follow-up|0|||
27942017|NCT03829683|81619586|FG000|Overall Study|Physician Decision|3|||
27942018|NCT03829683|81619587|FG001|Overall Study|Physician Decision|1|||
27942019|NCT03829683|81619586|FG000|Overall Study|Withdrawal by Subject|0|||
27942020|NCT03829683|81619587|FG001|Overall Study|Withdrawal by Subject|1|||
27942021|NCT03829683|81619586|FG000|Overall Study|Discharge from hospital|1|||
27942022|NCT03829683|81619587|FG001|Overall Study|Discharge from hospital|0|||
27942023|NCT04551053|81619589|FG000|Overall Study|Death|9|||
27942024|NCT04551053|81619590|FG001|Overall Study|Death|9|||
27942025|NCT04551053|81619589|FG000|Overall Study|Lost to Follow-up|0|||
27942026|NCT04551053|81619590|FG001|Overall Study|Lost to Follow-up|2|||
27942027|NCT04551053|81619589|FG000|Overall Study|Study Terminated by Sponsor|53|||
27942028|NCT04551053|81619590|FG001|Overall Study|Study Terminated by Sponsor|63|||
27942029|NCT04551053|81619589|FG000|Overall Study|Withdrawal by Subject|12|||
27942030|NCT04551053|81619590|FG001|Overall Study|Withdrawal by Subject|5|||
27942031|NCT04551053|81619589|FG000|Overall Study|Adverse Event|1|||
27942032|NCT04551053|81619590|FG001|Overall Study|Adverse Event|0|||
27942033|NCT04551053|81619589|FG000|Overall Study|Lack of Efficacy|2|||
27942034|NCT04551053|81619590|FG001|Overall Study|Lack of Efficacy|0|||
27942035|NCT04551053|81619589|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
27942036|NCT04551053|81619590|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
27942037|NCT04551053|81619589|FG000|Overall Study|Splenapendectomi|1|||
27942038|NCT04551053|81619590|FG001|Overall Study|Splenapendectomi|0|||
27942039|NCT04551053|81619589|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
27942040|NCT04551053|81619590|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
27942041|NCT04551053|81619589|FG000|Overall Study|Medical Decision|0|||
27942042|NCT04551053|81619590|FG001|Overall Study|Medical Decision|1|||
27942043|NCT04551053|81619589|FG000|Overall Study|Ongoing|6|||
27942044|NCT04551053|81619590|FG001|Overall Study|Ongoing|4|||
27942045|NCT01608308|81619594|FG000|Overall Study|pretreatment medical and billing reasons|0|||
27942046|NCT01608308|81619595|FG001|Overall Study|pretreatment medical and billing reasons|2|||
27942047|NCT00903344|81619596|FG000|Overall Study|Pregnancy|2|||
27942048|NCT00903344|81619597|FG001|Overall Study|Pregnancy|3|||
27942049|NCT00903344|81619596|FG000|Overall Study|Lost to Follow-up|3|||
27942050|NCT00903344|81619597|FG001|Overall Study|Lost to Follow-up|0|||
27942051|NCT02554474|81619598|FG000|Overall Study|Protocol Violation|1|||
27942052|NCT02554474|81619599|FG001|Overall Study|Protocol Violation|1|||
27646305|NCT00146172|80547582|FG006|Overall Study|Disease Progression|1|||
27646306|NCT00146172|80547583|FG007|Overall Study|Disease Progression|22|||
27646307|NCT00146172|80547576|FG000|Overall Study|Death|0|||
27942053|NCT02554474|81619598|FG000|Overall Study|Health issue not related to the study|1|||
27942054|NCT02554474|81619599|FG001|Overall Study|Health issue not related to the study|0|||
27942055|NCT02554474|81619598|FG000|Overall Study|Withdrawal by Subject|1|||
27942056|NCT02554474|81619599|FG001|Overall Study|Withdrawal by Subject|1|||
27942057|NCT01217047|81619600|FG000|Overall Study|Lost to Follow-up|0|||
27942058|NCT01217047|81619601|FG001|Overall Study|Lost to Follow-up|1|||
27646308|NCT00146172|80547577|FG001|Overall Study|Death|0|||
27942059|NCT01217047|81619602|FG002|Overall Study|Lost to Follow-up|0|||
27942060|NCT03654326|81619603|FG000|Overall Study|Withdrawal by Subject|5|||
27646309|NCT00146172|80547578|FG002|Overall Study|Death|0|||
27942061|NCT03654326|81619604|FG001|Overall Study|Withdrawal by Subject|3|||
27942062|NCT03654326|81619603|FG000|Overall Study|Physician Decision|0|||
27942063|NCT03654326|81619604|FG001|Overall Study|Physician Decision|1|||
27942064|NCT03654326|81619603|FG000|Overall Study|Unable to adhere to study schedule|0|||
27942065|NCT03654326|81619604|FG001|Overall Study|Unable to adhere to study schedule|1|||
27942066|NCT03654326|81619603|FG000|Overall Study|Lost to Follow-up|1|||
27942067|NCT03654326|81619604|FG001|Overall Study|Lost to Follow-up|1|||
27942068|NCT01916226|81619610|FG000|Overall Study|Adverse Event|1|||
27646310|NCT00146172|80547579|FG003|Overall Study|Death|0|||
27646311|NCT00146172|80547580|FG004|Overall Study|Death|0|||
27646312|NCT00146172|80547581|FG005|Overall Study|Death|0|||
27646313|NCT00146172|80547582|FG006|Overall Study|Death|1|||
27646314|NCT00146172|80547583|FG007|Overall Study|Death|0|||
27646315|NCT00146172|80547576|FG000|Overall Study|Physician Decision|0|||
27942069|NCT01916226|81619611|FG001|Overall Study|Adverse Event|0|||
27942070|NCT01916226|81619612|FG002|Overall Study|Adverse Event|1|||
27942071|NCT01916226|81619613|FG003|Overall Study|Adverse Event|1|||
27942072|NCT01916226|81619610|FG000|Overall Study|Lack of Efficacy|0|||
27942073|NCT01916226|81619611|FG001|Overall Study|Lack of Efficacy|0|||
27942074|NCT01916226|81619612|FG002|Overall Study|Lack of Efficacy|2|||
27942075|NCT01916226|81619613|FG003|Overall Study|Lack of Efficacy|1|||
27942076|NCT01916226|81619610|FG000|Overall Study|Protocol Violation|0|||
27942077|NCT01916226|81619611|FG001|Overall Study|Protocol Violation|1|||
27942078|NCT01916226|81619612|FG002|Overall Study|Protocol Violation|0|||
27942079|NCT01916226|81619613|FG003|Overall Study|Protocol Violation|1|||
27942080|NCT01916226|81619610|FG000|Overall Study|Physician Decision|0|||
27942081|NCT01916226|81619611|FG001|Overall Study|Physician Decision|0|||
27942082|NCT01916226|81619612|FG002|Overall Study|Physician Decision|0|||
27942083|NCT01916226|81619613|FG003|Overall Study|Physician Decision|1|||
27942084|NCT02003898|81619614|FG000|Overall Study|Death|3|||
27942085|NCT02003898|81619614|FG000|Overall Study|Lost to Follow-up|12|||
27942086|NCT02003898|81619614|FG000|Overall Study|Withdrawal by Subject|52|||
27942087|NCT00088881|81619615|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
27942088|NCT00088881|81619615|FG000|Step 1 - R-CHOP|Adverse Event|1|||
27942089|NCT00088881|81619615|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
27942090|NCT00088881|81619615|FG000|Step 1 - R-CHOP|Physician Decision|1|||
27942091|NCT00088881|81619615|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
27942092|NCT00088881|81619615|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
27942093|NCT00088881|81619615|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
27942094|NCT00101400|81619620|FG000|Survival Follow-Up|Alive|7|||
27942095|NCT00912509|81619621|FG000|Overall Study|Lost to Follow-up|1|||
27942096|NCT00912509|81619622|FG001|Overall Study|Lost to Follow-up|0|||
27942097|NCT00912509|81619621|FG000|Overall Study|Lack of Efficacy|4|||
27942098|NCT00912509|81619622|FG001|Overall Study|Lack of Efficacy|3|||
27942099|NCT01421459|81622316|FG000|Overall Study|Adverse Event|6|||
27942100|NCT01421459|81622317|FG001|Overall Study|Adverse Event|10|||
27942101|NCT01421459|81622316|FG000|Overall Study|Death|1|||
27942102|NCT01421459|81622317|FG001|Overall Study|Death|1|||
27942103|NCT01421459|81622316|FG000|Overall Study|Lack of Efficacy|1|||
27942104|NCT01421459|81622317|FG001|Overall Study|Lack of Efficacy|2|||
27942105|NCT01421459|81622316|FG000|Overall Study|Lost to Follow-up|8|||
27942106|NCT01421459|81622317|FG001|Overall Study|Lost to Follow-up|9|||
27942107|NCT01421459|81622316|FG000|Overall Study|Physician Decision|9|||
27942108|NCT01421459|81622317|FG001|Overall Study|Physician Decision|9|||
27942109|NCT01421459|81622316|FG000|Overall Study|Protocol Violation|8|||
27942110|NCT01421459|81622317|FG001|Overall Study|Protocol Violation|5|||
27646316|NCT00146172|80547577|FG001|Overall Study|Physician Decision|0|||
27646317|NCT00146172|80547578|FG002|Overall Study|Physician Decision|0|||
27646318|NCT00146172|80547579|FG003|Overall Study|Physician Decision|0|||
27646319|NCT00146172|80547580|FG004|Overall Study|Physician Decision|0|||
27646320|NCT00146172|80547581|FG005|Overall Study|Physician Decision|0|||
27942111|NCT01421459|81622316|FG000|Overall Study|Withdrawal by Subject|12|||
27942112|NCT01421459|81622317|FG001|Overall Study|Withdrawal by Subject|16|||
27942113|NCT01084135|81622323|FG000|20 Week|Physician Decision|0|||
27646321|NCT00146172|80547582|FG006|Overall Study|Physician Decision|0|||
27646322|NCT00146172|80547583|FG007|Overall Study|Physician Decision|1|||
27942114|NCT01084135|81622324|FG001|20 Week|Physician Decision|1|||
27942115|NCT01379937|81622328|FG000|Overall Study|Protocol Violation|0|||
27942116|NCT01379937|81622329|FG001|Overall Study|Protocol Violation|0|||
27942117|NCT01379937|81622330|FG002|Overall Study|Protocol Violation|0|||
27942118|NCT01379937|81622331|FG003|Overall Study|Protocol Violation|1|||
27942119|NCT01379937|81622328|FG000|Overall Study|Consent withdrawal|0|||
27942120|NCT01379937|81622329|FG001|Overall Study|Consent withdrawal|1|||
27942121|NCT01379937|81622330|FG002|Overall Study|Consent withdrawal|0|||
27646323|NCT00146172|80547576|FG000|Overall Study|Withdrawal by Subject|0|||
27646324|NCT00146172|80547577|FG001|Overall Study|Withdrawal by Subject|0|||
27942122|NCT01379937|81622331|FG003|Overall Study|Consent withdrawal|0|||
27942123|NCT01379937|81622328|FG000|Overall Study|Lost to Follow-up|1|||
27942124|NCT01379937|81622329|FG001|Overall Study|Lost to Follow-up|2|||
27942125|NCT01379937|81622330|FG002|Overall Study|Lost to Follow-up|2|||
27646325|NCT00146172|80547578|FG002|Overall Study|Withdrawal by Subject|0|||
27942126|NCT01379937|81622331|FG003|Overall Study|Lost to Follow-up|0|||
27942127|NCT05333965|81622338|FG000|First Intervention|Adverse Event|0|||
27942128|NCT05333965|81622339|FG001|First Intervention|Adverse Event|1|||
27942129|NCT05333965|81622338|FG000|First Intervention|Withdrawal by Subject|0|||
27942130|NCT05333965|81622339|FG001|First Intervention|Withdrawal by Subject|1|||
27942131|NCT01687595|81622344|FG000|Overall Study|Withdrawal by Subject|8|||
27942132|NCT01687595|81622345|FG001|Overall Study|Withdrawal by Subject|0|||
27942133|NCT01687595|81622344|FG000|Overall Study|Lost to Follow-up|3|||
27942134|NCT01687595|81622345|FG001|Overall Study|Lost to Follow-up|1|||
27942135|NCT01687595|81622344|FG000|Overall Study|Investigator's decision|1|||
27942136|NCT01687595|81622345|FG001|Overall Study|Investigator's decision|0|||
27942137|NCT01687595|81622344|FG000|Overall Study|Sponsor's decision|1|||
27942138|NCT01687595|81622345|FG001|Overall Study|Sponsor's decision|0|||
27942139|NCT01687595|81622344|FG000|Overall Study|Noncompliance|1|||
27942140|NCT01687595|81622345|FG001|Overall Study|Noncompliance|2|||
27942141|NCT01687595|81622344|FG000|Overall Study|Other than specified|56|||
27942142|NCT01687595|81622345|FG001|Overall Study|Other than specified|7|||
27942143|NCT02799043|81622346|FG000|Overall Study|Adverse Event|0|||
27942144|NCT02799043|81622347|FG001|Overall Study|Adverse Event|1|||
27942145|NCT02799043|81622346|FG000|Overall Study|Death|1|||
27942146|NCT02799043|81622347|FG001|Overall Study|Death|1|||
27942147|NCT02799043|81622346|FG000|Overall Study|Lost to Follow-up|3|||
27942148|NCT02799043|81622347|FG001|Overall Study|Lost to Follow-up|6|||
27942149|NCT02799043|81622346|FG000|Overall Study|Withdrawal by Subject|4|||
27942150|NCT02799043|81622347|FG001|Overall Study|Withdrawal by Subject|4|||
27942151|NCT02799043|81622346|FG000|Overall Study|Moved to different country|0|||
27942152|NCT02799043|81622347|FG001|Overall Study|Moved to different country|1|||
27942153|NCT02799043|81622346|FG000|Overall Study|Trial Screen Failure|1|||
27942154|NCT02799043|81622347|FG001|Overall Study|Trial Screen Failure|0|||
27942155|NCT02799043|81622346|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
27942156|NCT02799043|81622347|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
27942157|NCT02529488|81622348|FG000|Overall Study|Adverse Event|1|||
27942158|NCT02529488|81622348|FG000|Overall Study|Death|3|||
27942159|NCT03111108|81622349|FG000|Overall Study|Death|0|||
27942160|NCT03111108|81622350|FG001|Overall Study|Death|1|||
27942161|NCT03111108|81622349|FG000|Overall Study|Withdrawal by Subject|1|||
27942162|NCT03111108|81622350|FG001|Overall Study|Withdrawal by Subject|0|||
27942163|NCT01386645|81622351|FG000|Overall Study|Physician Decision|0|||
27942164|NCT01386645|81622352|FG001|Overall Study|Physician Decision|0|||
27942165|NCT01386645|81622353|FG002|Overall Study|Physician Decision|1|||
27942166|NCT01386645|81622351|FG000|Overall Study|Withdrawal by Subject|0|||
27942167|NCT01386645|81622352|FG001|Overall Study|Withdrawal by Subject|1|||
27942168|NCT01386645|81622353|FG002|Overall Study|Withdrawal by Subject|1|||
27942169|NCT01347086|81622354|FG000|Overall Study|failed screening visit|0|||
27942170|NCT01347086|81622355|FG001|Overall Study|failed screening visit|0|||
27942171|NCT01347086|81622356|FG002|Overall Study|failed screening visit|1|||
27942172|NCT01347086|81622357|FG003|Overall Study|failed screening visit|0|||
27942173|NCT01347086|81622358|FG004|Overall Study|failed screening visit|0|||
27942174|NCT01347086|81622359|FG005|Overall Study|failed screening visit|0|||
27942175|NCT01347086|81622360|FG006|Overall Study|failed screening visit|1|||
27942176|NCT01347086|81622361|FG007|Overall Study|failed screening visit|1|||
27942177|NCT01347086|81622362|FG008|Overall Study|failed screening visit|0|||
27942178|NCT01347086|81622363|FG009|Overall Study|failed screening visit|1|||
27942179|NCT01897896|81622366|FG000|Overall Study|Death|1|||
27942180|NCT01897896|81622367|FG001|Overall Study|Death|0|||
27942181|NCT01897896|81622366|FG000|Overall Study|Adverse Event|11|||
27942182|NCT01897896|81622367|FG001|Overall Study|Adverse Event|1|||
27942183|NCT01897896|81622366|FG000|Overall Study|Lost to Follow-up|1|||
27942184|NCT01897896|81622367|FG001|Overall Study|Lost to Follow-up|0|||
27942185|NCT01897896|81622366|FG000|Overall Study|Non-compliance with study drug dosing|1|||
27942186|NCT01897896|81622367|FG001|Overall Study|Non-compliance with study drug dosing|1|||
27646326|NCT00146172|80547579|FG003|Overall Study|Withdrawal by Subject|0|||
27646327|NCT00146172|80547580|FG004|Overall Study|Withdrawal by Subject|0|||
27646328|NCT00146172|80547581|FG005|Overall Study|Withdrawal by Subject|1|||
27646329|NCT00146172|80547582|FG006|Overall Study|Withdrawal by Subject|1|||
27646330|NCT00146172|80547583|FG007|Overall Study|Withdrawal by Subject|4|||
27942187|NCT01897896|81622366|FG000|Overall Study|Withdrawal by Subject|7|||
27942188|NCT01897896|81622367|FG001|Overall Study|Withdrawal by Subject|1|||
27942189|NCT01897896|81622366|FG000|Overall Study|Require drug that interfere with study|1|||
27942190|NCT01897896|81622367|FG001|Overall Study|Require drug that interfere with study|4|||
27646331|NCT00146172|80547576|FG000|Overall Study|Symptomatic Deterioration|1|||
27755016|NCT03571256|80929665|FG001|Overall Study|Adverse Event|0|||
27942191|NCT01897896|81622366|FG000|Overall Study|Protocol Violation|1|||
27942192|NCT01897896|81622367|FG001|Overall Study|Protocol Violation|1|||
27646332|NCT00146172|80547577|FG001|Overall Study|Symptomatic Deterioration|0|||
27942193|NCT01897896|81622366|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
27942194|NCT01897896|81622367|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
27942195|NCT01897896|81622366|FG000|Overall Study|Caregiver can no longer participate|0|||
27646333|NCT00146172|80547578|FG002|Overall Study|Symptomatic Deterioration|1|||
27646334|NCT00146172|80547579|FG003|Overall Study|Symptomatic Deterioration|0|||
27646335|NCT00146172|80547580|FG004|Overall Study|Symptomatic Deterioration|1|||
27646336|NCT00146172|80547581|FG005|Overall Study|Symptomatic Deterioration|2|||
27646337|NCT00146172|80547582|FG006|Overall Study|Symptomatic Deterioration|0|||
27646338|NCT00146172|80547583|FG007|Overall Study|Symptomatic Deterioration|2|||
27646339|NCT04860505|80547586|FG000|Overall Study|Lost to Follow-up|2|||
27646340|NCT02807857|80547593|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
27646341|NCT02807857|80547593|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
27646342|NCT02807857|80547593|FG000|Follow-Up Set|Withdrawal by Subject|8|||
27646343|NCT02807857|80547593|FG000|Follow-Up Set|Lost to Follow-up|7|||
27646344|NCT02807857|80547593|FG000|Follow-Up Set|Physician Decision|6|||
27646345|NCT02807857|80547593|FG000|Follow-Up Set|Adverse Event|3|||
27646346|NCT02807857|80547593|FG000|Follow-Up Set|Death|27|||
27646347|NCT02807857|80547593|FG000|Follow-Up Set|Relocation|2|||
27646348|NCT03697603|80547594|FG000|Overall Study|Adverse Event|3|||
27646349|NCT03697603|80547595|FG001|Overall Study|Adverse Event|18|||
27646350|NCT03697603|80547596|FG002|Overall Study|Adverse Event|3|||
27646351|NCT03697603|80547594|FG000|Overall Study|Physician Decision|1|||
27646352|NCT03697603|80547595|FG001|Overall Study|Physician Decision|0|||
27646353|NCT03697603|80547596|FG002|Overall Study|Physician Decision|2|||
27646354|NCT03697603|80547594|FG000|Overall Study|Protocol Violation|3|||
27646355|NCT03697603|80547595|FG001|Overall Study|Protocol Violation|8|||
27646356|NCT03697603|80547596|FG002|Overall Study|Protocol Violation|5|||
27646357|NCT03697603|80547594|FG000|Overall Study|Withdrawal by Subject|5|||
27646358|NCT03697603|80547595|FG001|Overall Study|Withdrawal by Subject|1|||
27646359|NCT03697603|80547596|FG002|Overall Study|Withdrawal by Subject|1|||
27646360|NCT03697603|80547594|FG000|Overall Study|Protocol Violation|0|||
27646361|NCT03697603|80547595|FG001|Overall Study|Protocol Violation|0|||
27646362|NCT03697603|80547596|FG002|Overall Study|Protocol Violation|1|||
27646363|NCT03205566|80547597|FG000|Phase 1|Protocol Violation|1|||
27646364|NCT03205566|80547598|FG001|Phase 1|Protocol Violation|1|||
27646365|NCT02646618|80547601|FG000|Overall Study|Lost to Follow-up|10|||
27646366|NCT02646618|80547602|FG001|Overall Study|Lost to Follow-up|14|||
27646367|NCT00683800|80547603|FG000|Overall Study|Adverse Event|195|||
27646368|NCT00683800|80547604|FG001|Overall Study|Adverse Event|102|||
27646369|NCT00683800|80547603|FG000|Overall Study|Death|0|||
27646370|NCT00683800|80547604|FG001|Overall Study|Death|1|||
27646371|NCT00683800|80547603|FG000|Overall Study|Lost to Follow-up|57|||
27646372|NCT00683800|80547604|FG001|Overall Study|Lost to Follow-up|44|||
27646373|NCT00683800|80547603|FG000|Overall Study|Other|5|||
27646374|NCT00683800|80547604|FG001|Overall Study|Other|2|||
27646375|NCT00683800|80547603|FG000|Overall Study|Protocol Violation|13|||
27646376|NCT00683800|80547604|FG001|Overall Study|Protocol Violation|16|||
27646377|NCT00683800|80547603|FG000|Overall Study|Withdrawal by Subject|66|||
27646378|NCT00683800|80547604|FG001|Overall Study|Withdrawal by Subject|64|||
27646379|NCT00683800|80547603|FG000|Overall Study|Lack of Efficacy|61|||
27646380|NCT00683800|80547604|FG001|Overall Study|Lack of Efficacy|104|||
27646381|NCT00683800|80547603|FG000|Overall Study|Randomized, not treated|35|||
27646382|NCT00683800|80547604|FG001|Overall Study|Randomized, not treated|33|||
27646383|NCT01218009|80547605|FG000|Overall Study|Protocol Violation|2|||
27646384|NCT01218009|80547606|FG001|Overall Study|Protocol Violation|1|||
27646385|NCT01218009|80547605|FG000|Overall Study|Withdrawal by Subject|3|||
27646386|NCT01218009|80547606|FG001|Overall Study|Withdrawal by Subject|1|||
27646387|NCT01218009|80547605|FG000|Overall Study|Sponsor terminated study|161|||
27646388|NCT01218009|80547606|FG001|Overall Study|Sponsor terminated study|163|||
27646389|NCT02310581|80547607|FG000|Overall Study|Adverse Event|1|||
27646390|NCT02310581|80547608|FG001|Overall Study|Adverse Event|1|||
27646391|NCT02310581|80547609|FG002|Overall Study|Adverse Event|1|||
27646392|NCT02310581|80547610|FG003|Overall Study|Adverse Event|0|||
27646393|NCT02310581|80547607|FG000|Overall Study|Withdrawal by Subject|2|||
27646394|NCT02310581|80547608|FG001|Overall Study|Withdrawal by Subject|1|||
27646395|NCT02310581|80547609|FG002|Overall Study|Withdrawal by Subject|0|||
27646396|NCT02310581|80547610|FG003|Overall Study|Withdrawal by Subject|1|||
27646397|NCT03041090|80547613|FG000|Overall Study|technical error|0|||
27646398|NCT03041090|80547614|FG001|Overall Study|technical error|3|||
27646399|NCT02597920|80547615|FG000|Overall Study|Worsening of other pre-existing disease|0|||
27646400|NCT02597920|80547616|FG001|Overall Study|Worsening of other pre-existing disease|1|||
27646401|NCT02597920|80547617|FG002|Overall Study|Worsening of other pre-existing disease|0|||
27646402|NCT02597920|80547615|FG000|Overall Study|Other adverse event|20|||
27646403|NCT02597920|80547616|FG001|Overall Study|Other adverse event|30|||
27646404|NCT02597920|80547617|FG002|Overall Study|Other adverse event|0|||
27646405|NCT02597920|80547615|FG000|Overall Study|Lost to Follow-up|7|||
27646406|NCT02597920|80547616|FG001|Overall Study|Lost to Follow-up|9|||
27646407|NCT02597920|80547617|FG002|Overall Study|Lost to Follow-up|0|||
27646408|NCT02597920|80547615|FG000|Overall Study|Refuse to continue in the study|3|||
27646409|NCT02597920|80547616|FG001|Overall Study|Refuse to continue in the study|13|||
27646410|NCT02597920|80547617|FG002|Overall Study|Refuse to continue in the study|1|||
27646411|NCT02597920|80547615|FG000|Overall Study|Other than specified|10|||
27646412|NCT02597920|80547616|FG001|Overall Study|Other than specified|31|||
27646413|NCT02597920|80547617|FG002|Overall Study|Other than specified|5|||
27646414|NCT02597920|80547615|FG000|Overall Study|Other|1|||
27646415|NCT02597920|80547616|FG001|Overall Study|Other|0|||
27646416|NCT02597920|80547617|FG002|Overall Study|Other|0|||
27646417|NCT03113409|80547618|FG000|Overall Study|Withdrawal by Subject|5|||
27646418|NCT03113409|80547619|FG001|Overall Study|Withdrawal by Subject|0|||
27646419|NCT03113409|80547620|FG002|Overall Study|Withdrawal by Subject|0|||
27646420|NCT02325466|80547621|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
27646421|NCT02325466|80547622|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
27646422|NCT02325466|80547623|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
27646423|NCT02325466|80547621|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
27646424|NCT02325466|80547622|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
27646425|NCT02325466|80547623|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
27646426|NCT02325466|80547621|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
27646427|NCT02325466|80547622|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
27646428|NCT02325466|80547623|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
27646429|NCT02325466|80547621|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
27942196|NCT01897896|81622367|FG001|Overall Study|Caregiver can no longer participate|2|||
27942197|NCT01897896|81622366|FG000|Overall Study|Other than specified|2|||
27942198|NCT01897896|81622367|FG001|Overall Study|Other than specified|1|||
27942199|NCT03160573|81622370|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
27942200|NCT03160573|81622371|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
27942201|NCT03160573|81622372|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
27942202|NCT03160573|81622373|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
27942203|NCT01514422|81622376|FG000|Overall Study|Lost to Follow-up|1|||
27942204|NCT03301415|81622379|FG000|Overall Study|Lost to Follow-up|2|||
27942205|NCT03301415|81622379|FG000|Overall Study|Unable to comply with visit schedule|2|||
27942206|NCT01050218|81622380|FG000|Overall Study|Adverse Event|37|||
27942207|NCT01050218|81622380|FG000|Overall Study|Lack of Efficacy|8|||
27942208|NCT01050218|81622380|FG000|Overall Study|Protocol Violation|3|||
27942209|NCT01050218|81622380|FG000|Overall Study|Withdrawal by Subject|18|||
27942210|NCT01050218|81622380|FG000|Overall Study|Discontinued by sponsor|18|||
27942211|NCT01050218|81622380|FG000|Overall Study|Compliance|2|||
27942212|NCT01050218|81622380|FG000|Overall Study|Failed to return|7|||
27942213|NCT01050218|81622380|FG000|Overall Study|Serious Adverse Event|1|||
27942214|NCT01050218|81622380|FG000|Overall Study|Family emergency|1|||
27942215|NCT01903863|81622381|FG000|Overall Study|Physician Decision|2|||
27942216|NCT01903863|81622382|FG001|Overall Study|Physician Decision|0|||
27942217|NCT01027754|81622385|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
27942218|NCT01027754|81622386|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
27942219|NCT01027754|81622385|FG000|Overall Study|Withdrawal by Subject|0|||
27942220|NCT01027754|81622386|FG001|Overall Study|Withdrawal by Subject|5|||
27942221|NCT00392288|81622387|FG000|Overall Study|Adverse Event|17|||
27942222|NCT00392288|81622388|FG001|Overall Study|Adverse Event|7|||
27942223|NCT00392288|81622389|FG002|Overall Study|Adverse Event|8|||
27646430|NCT02325466|80547622|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
27646431|NCT02325466|80547623|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
27646432|NCT02325466|80547621|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
27646433|NCT02325466|80547622|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
27646434|NCT02325466|80547623|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
27646435|NCT02325466|80547621|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
27646436|NCT02325466|80547622|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
27646437|NCT02325466|80547623|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
27746312|NCT03345836|80899606|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
27942224|NCT00392288|81622387|FG000|Overall Study|Lack of Efficacy|8|||
27942225|NCT00392288|81622388|FG001|Overall Study|Lack of Efficacy|5|||
27942226|NCT00392288|81622389|FG002|Overall Study|Lack of Efficacy|3|||
27942227|NCT00392288|81622387|FG000|Overall Study|Protocol Violation|1|||
27942228|NCT00392288|81622388|FG001|Overall Study|Protocol Violation|3|||
27942229|NCT00392288|81622389|FG002|Overall Study|Protocol Violation|1|||
27942230|NCT00392288|81622387|FG000|Overall Study|Lost to Follow-up|1|||
27646438|NCT02325466|80547621|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
27942231|NCT00392288|81622388|FG001|Overall Study|Lost to Follow-up|1|||
27942232|NCT00392288|81622389|FG002|Overall Study|Lost to Follow-up|1|||
27942233|NCT00392288|81622387|FG000|Overall Study|Withdrawal by Subject|1|||
27942234|NCT00392288|81622388|FG001|Overall Study|Withdrawal by Subject|0|||
27942235|NCT00392288|81622389|FG002|Overall Study|Withdrawal by Subject|2|||
27942236|NCT00392288|81622387|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
27551355|NCT01543698|80207463|FG005|Phase 1b|Withdrawal by Subject|0|||
27551356|NCT01543698|80207464|FG006|Phase 1b|Withdrawal by Subject|1|||
27942237|NCT00392288|81622388|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
27942238|NCT00392288|81622389|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
27942239|NCT00392288|81622387|FG000|Overall Study|Other|3|||
27942240|NCT00392288|81622388|FG001|Overall Study|Other|4|||
27942241|NCT00392288|81622389|FG002|Overall Study|Other|1|||
27942242|NCT02698787|81622392|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
27942243|NCT02698787|81622393|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
27942244|NCT00911157|81622394|FG000|Overall Study|Adverse Event|4|||
27942245|NCT00911157|81622395|FG001|Overall Study|Adverse Event|1|||
27942246|NCT00911157|81622394|FG000|Overall Study|Withdrawal by Subject|1|||
27942247|NCT00911157|81622395|FG001|Overall Study|Withdrawal by Subject|1|||
27942248|NCT00911157|81622394|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
27942249|NCT00911157|81622395|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
27942250|NCT00911157|81622394|FG000|Overall Study|Need to treat for lung cancer|1|||
27942251|NCT00911157|81622395|FG001|Overall Study|Need to treat for lung cancer|0|||
27942252|NCT02402907|81622399|FG000|Overall Study|Delivered vaginally|9|||
27942253|NCT02402907|81622400|FG001|Overall Study|Delivered vaginally|3|||
27942254|NCT02402907|81622399|FG000|Overall Study|Delivered outside of Sinai|1|||
27942255|NCT02402907|81622400|FG001|Overall Study|Delivered outside of Sinai|1|||
27942256|NCT02402907|81622399|FG000|Overall Study|Lost to follow up after C-Section|10|||
27942257|NCT02402907|81622400|FG001|Overall Study|Lost to follow up after C-Section|23|||
27942258|NCT03773562|81622405|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
27942259|NCT03773562|81622405|FG000|Overall Study|Lost to Follow-up|10|||
27942260|NCT03773562|81622405|FG000|Overall Study|Withdrawal by Subject|1|||
27942261|NCT02829918|81622407|FG000|Overall Study|Death|2|||
27942262|NCT02829918|81622407|FG000|Overall Study|Withdrawal by Subject|4|||
27942263|NCT02829918|81622407|FG000|Overall Study|Adverse Event|1|||
27942264|NCT02829918|81622407|FG000|Overall Study|Progression|1|||
27942265|NCT05069415|81622408|FG000|Overall Study|Withdrawal by Subject|2|||
27942266|NCT05069415|81622409|FG001|Overall Study|Withdrawal by Subject|0|||
27942267|NCT05069415|81622408|FG000|Overall Study|Adverse Event|2|||
27942268|NCT05069415|81622409|FG001|Overall Study|Adverse Event|0|||
27942269|NCT02579759|81622410|FG000|Overall Study|Protocol Violation|2|||
27942270|NCT02579759|81622411|FG001|Overall Study|Protocol Violation|0|||
27942271|NCT02579759|81622412|FG002|Overall Study|Protocol Violation|0|||
27646439|NCT02325466|80547622|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
27942272|NCT02579759|81622410|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
27942273|NCT02579759|81622411|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
27942274|NCT02579759|81622412|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
27942275|NCT02579759|81622410|FG000|Overall Study|BfArM hold|13|||
27646440|NCT02325466|80547623|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
27646441|NCT02325466|80547621|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
27646442|NCT02325466|80547622|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
27942276|NCT02579759|81622411|FG001|Overall Study|BfArM hold|12|||
27942277|NCT02579759|81622412|FG002|Overall Study|BfArM hold|12|||
27942278|NCT02579759|81622410|FG000|Overall Study|Sponsor stopped Dose 2|0|||
27942279|NCT02579759|81622411|FG001|Overall Study|Sponsor stopped Dose 2|41|||
27942280|NCT02579759|81622412|FG002|Overall Study|Sponsor stopped Dose 2|0|||
27942281|NCT02579759|81622410|FG000|Overall Study|Non compliance|0|||
27942282|NCT02579759|81622411|FG001|Overall Study|Non compliance|1|||
27942283|NCT02579759|81622412|FG002|Overall Study|Non compliance|0|||
27942284|NCT02579759|81622410|FG000|Overall Study|Pregnancy|0|||
27942285|NCT02579759|81622411|FG001|Overall Study|Pregnancy|1|||
27646443|NCT02325466|80547623|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
27646444|NCT02325466|80547621|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
27942286|NCT02579759|81622412|FG002|Overall Study|Pregnancy|0|||
27942287|NCT02579759|81622410|FG000|Overall Study|Inclusion/exclusion criteria|0|||
27942288|NCT02579759|81622411|FG001|Overall Study|Inclusion/exclusion criteria|0|||
27942289|NCT02579759|81622412|FG002|Overall Study|Inclusion/exclusion criteria|1|||
27942290|NCT02579759|81622410|FG000|Overall Study|Adverse Event|4|||
27942291|NCT02579759|81622411|FG001|Overall Study|Adverse Event|3|||
27942292|NCT02579759|81622412|FG002|Overall Study|Adverse Event|1|||
27646445|NCT02325466|80547622|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
27646446|NCT02325466|80547623|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
27646447|NCT00866619|80547633|FG000|Overall Study|Adverse Event|112|||
27942293|NCT02579759|81622410|FG000|Overall Study|Withdrawal by Subject|3|||
27942294|NCT02579759|81622411|FG001|Overall Study|Withdrawal by Subject|3|||
27942295|NCT02579759|81622412|FG002|Overall Study|Withdrawal by Subject|5|||
27942296|NCT02579759|81622410|FG000|Overall Study|Lost to Follow-up|2|||
27942297|NCT02579759|81622411|FG001|Overall Study|Lost to Follow-up|2|||
27942298|NCT02579759|81622412|FG002|Overall Study|Lost to Follow-up|2|||
27942299|NCT00803049|81622414|FG000|Overall Study|Adverse Event|21|||
27942300|NCT00803049|81622415|FG001|Overall Study|Adverse Event|33|||
27646448|NCT00866619|80547634|FG001|Overall Study|Adverse Event|106|||
27942301|NCT00803049|81622416|FG002|Overall Study|Adverse Event|13|||
27942302|NCT00803049|81622417|FG003|Overall Study|Adverse Event|27|||
27942303|NCT00803049|81622414|FG000|Overall Study|Lack of Efficacy|10|||
27942304|NCT00803049|81622415|FG001|Overall Study|Lack of Efficacy|19|||
27942305|NCT00803049|81622416|FG002|Overall Study|Lack of Efficacy|6|||
27942306|NCT00803049|81622417|FG003|Overall Study|Lack of Efficacy|13|||
27646449|NCT00866619|80547635|FG002|Overall Study|Adverse Event|47|||
27646450|NCT00866619|80547636|FG003|Overall Study|Adverse Event|44|||
27646451|NCT00866619|80547633|FG000|Overall Study|Protocol Violation|2|||
27646452|NCT00866619|80547634|FG001|Overall Study|Protocol Violation|39|||
27646453|NCT00866619|80547635|FG002|Overall Study|Protocol Violation|2|||
27646454|NCT00866619|80547636|FG003|Overall Study|Protocol Violation|17|||
27646455|NCT00866619|80547633|FG000|Overall Study|Withdrawal by Subject|587|||
27646456|NCT00866619|80547634|FG001|Overall Study|Withdrawal by Subject|295|||
27942307|NCT00803049|81622414|FG000|Overall Study|Lost to Follow-up|0|||
27942308|NCT00803049|81622415|FG001|Overall Study|Lost to Follow-up|2|||
27942309|NCT00803049|81622416|FG002|Overall Study|Lost to Follow-up|0|||
27942310|NCT00803049|81622417|FG003|Overall Study|Lost to Follow-up|3|||
27942311|NCT00803049|81622414|FG000|Overall Study|Death|2|||
27942312|NCT00803049|81622415|FG001|Overall Study|Death|1|||
27942313|NCT00803049|81622416|FG002|Overall Study|Death|0|||
27942314|NCT00803049|81622417|FG003|Overall Study|Death|2|||
27942315|NCT00803049|81622414|FG000|Overall Study|Progressive Disease|6|||
27646457|NCT00866619|80547635|FG002|Overall Study|Withdrawal by Subject|272|||
27942316|NCT00803049|81622415|FG001|Overall Study|Progressive Disease|10|||
27646458|NCT00866619|80547636|FG003|Overall Study|Withdrawal by Subject|144|||
27646459|NCT00866619|80547633|FG000|Overall Study|Lost to Follow-up|1145|||
27646460|NCT00866619|80547634|FG001|Overall Study|Lost to Follow-up|830|||
27646461|NCT00866619|80547635|FG002|Overall Study|Lost to Follow-up|568|||
27646462|NCT00866619|80547636|FG003|Overall Study|Lost to Follow-up|425|||
27646463|NCT01555138|80547640|FG000|Overall Study|Death|0|||
27646464|NCT01555138|80547641|FG001|Overall Study|Death|1|||
27942317|NCT00803049|81622416|FG002|Overall Study|Progressive Disease|6|||
27942318|NCT00803049|81622417|FG003|Overall Study|Progressive Disease|6|||
27942319|NCT00803049|81622414|FG000|Overall Study|Withdrawal by Subject|19|||
27942320|NCT00803049|81622415|FG001|Overall Study|Withdrawal by Subject|43|||
27942321|NCT00803049|81622416|FG002|Overall Study|Withdrawal by Subject|16|||
27942322|NCT00803049|81622417|FG003|Overall Study|Withdrawal by Subject|44|||
27942323|NCT00803049|81622414|FG000|Overall Study|Protocol Violation|0|||
27942324|NCT00803049|81622415|FG001|Overall Study|Protocol Violation|1|||
27942325|NCT00803049|81622416|FG002|Overall Study|Protocol Violation|1|||
27942326|NCT00803049|81622417|FG003|Overall Study|Protocol Violation|0|||
27942327|NCT00803049|81622414|FG000|Overall Study|Randomized and Not Treated|0|||
27942328|NCT00803049|81622415|FG001|Overall Study|Randomized and Not Treated|0|||
27942329|NCT00803049|81622416|FG002|Overall Study|Randomized and Not Treated|0|||
27942330|NCT00803049|81622417|FG003|Overall Study|Randomized and Not Treated|2|||
27942331|NCT00803049|81622414|FG000|Overall Study|Other than Specified Above|3|||
27942332|NCT00803049|81622415|FG001|Overall Study|Other than Specified Above|9|||
27942333|NCT00803049|81622416|FG002|Overall Study|Other than Specified Above|2|||
27942334|NCT00803049|81622417|FG003|Overall Study|Other than Specified Above|5|||
27942335|NCT00128492|81622418|FG000|Overall Study|AE unrelated to study|2|||
27942336|NCT00128492|81622419|FG001|Overall Study|AE unrelated to study|9|||
27942337|NCT00128492|81622418|FG000|Overall Study|Study drug intolerance (AE)|2|||
27942338|NCT00128492|81622419|FG001|Overall Study|Study drug intolerance (AE)|8|||
27942339|NCT00128492|81622418|FG000|Overall Study|AE related to study|1|||
27942340|NCT00128492|81622419|FG001|Overall Study|AE related to study|4|||
27942341|NCT00128492|81622418|FG000|Overall Study|Death|1|||
27942342|NCT00128492|81622419|FG001|Overall Study|Death|0|||
27942343|NCT00128492|81622418|FG000|Overall Study|Lost to Follow-up|1|||
27942344|NCT00128492|81622419|FG001|Overall Study|Lost to Follow-up|5|||
27942345|NCT00128492|81622418|FG000|Overall Study|Noncompliance|0|||
27942346|NCT00128492|81622419|FG001|Overall Study|Noncompliance|5|||
27942347|NCT00128492|81622418|FG000|Overall Study|Personal or administrative|10|||
27942348|NCT00128492|81622419|FG001|Overall Study|Personal or administrative|22|||
27942349|NCT00128492|81622418|FG000|Overall Study|Withdrawal by Subject|3|||
27942350|NCT00128492|81622419|FG001|Overall Study|Withdrawal by Subject|5|||
27942351|NCT00128492|81622418|FG000|Overall Study|Pregnancy|0|||
27942352|NCT00128492|81622419|FG001|Overall Study|Pregnancy|1|||
27646465|NCT01555138|80547640|FG000|Overall Study|Lost to Follow-up|1|||
27646466|NCT01555138|80547641|FG001|Overall Study|Lost to Follow-up|0|||
27646467|NCT01555138|80547640|FG000|Overall Study|Abnormal Lab reults|1|||
27646468|NCT01555138|80547641|FG001|Overall Study|Abnormal Lab reults|3|||
27646469|NCT01555138|80547640|FG000|Overall Study|Lack of Efficacy|2|||
27942353|NCT03211858|81622420|FG000|Overall Study|Adverse Event|8|||
27942354|NCT03211858|81622421|FG001|Overall Study|Adverse Event|6|||
27942355|NCT03211858|81622420|FG000|Overall Study|Lack of Efficacy|0|||
27942356|NCT03211858|81622421|FG001|Overall Study|Lack of Efficacy|4|||
27942357|NCT03211858|81622420|FG000|Overall Study|Poor compliance to protocol|6|||
27942358|NCT03211858|81622421|FG001|Overall Study|Poor compliance to protocol|2|||
27942359|NCT03211858|81622420|FG000|Overall Study|Non-serious Hypoglycemia|1|||
27942360|NCT03211858|81622421|FG001|Overall Study|Non-serious Hypoglycemia|0|||
27942361|NCT03211858|81622420|FG000|Overall Study|Other than specified above|22|||
27942362|NCT03211858|81622421|FG001|Overall Study|Other than specified above|21|||
27942363|NCT01813357|81622422|FG000|Overall Study|Lost to Follow-up|5|||
27942364|NCT01813357|81622423|FG001|Overall Study|Lost to Follow-up|6|||
27942365|NCT00215657|81622424|FG000|Overall Study|Adverse Event|5|||
27942366|NCT00215657|81622425|FG001|Overall Study|Adverse Event|1|||
27942367|NCT00215657|81622426|FG002|Overall Study|Adverse Event|3|||
27942368|NCT00215657|81622427|FG003|Overall Study|Adverse Event|0|||
27942369|NCT00215657|81622428|FG004|Overall Study|Adverse Event|3|||
27942370|NCT00215657|81622429|FG005|Overall Study|Adverse Event|1|||
27942371|NCT00215657|81622430|FG006|Overall Study|Adverse Event|0|||
27942372|NCT00215657|81622431|FG007|Overall Study|Adverse Event|3|||
27942373|NCT00215657|81622424|FG000|Overall Study|Withdrawal by Subject|6|||
27942374|NCT00215657|81622425|FG001|Overall Study|Withdrawal by Subject|3|||
27942375|NCT00215657|81622426|FG002|Overall Study|Withdrawal by Subject|3|||
27942376|NCT00215657|81622427|FG003|Overall Study|Withdrawal by Subject|1|||
27942377|NCT00215657|81622428|FG004|Overall Study|Withdrawal by Subject|6|||
27942378|NCT00215657|81622429|FG005|Overall Study|Withdrawal by Subject|1|||
27942379|NCT00215657|81622430|FG006|Overall Study|Withdrawal by Subject|10|||
27942380|NCT00215657|81622431|FG007|Overall Study|Withdrawal by Subject|3|||
27942381|NCT00215657|81622424|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
27942382|NCT00215657|81622425|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
27942383|NCT00215657|81622426|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
27942384|NCT00215657|81622427|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
27942385|NCT00215657|81622428|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
27942386|NCT00215657|81622429|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
27942387|NCT00215657|81622430|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
27942388|NCT00215657|81622431|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
27942389|NCT00215657|81622424|FG000|Overall Study|Insufficient testosterone response|5|||
27942390|NCT00215657|81622425|FG001|Overall Study|Insufficient testosterone response|4|||
27942391|NCT00215657|81622426|FG002|Overall Study|Insufficient testosterone response|1|||
27942392|NCT00215657|81622427|FG003|Overall Study|Insufficient testosterone response|12|||
27942393|NCT00215657|81622428|FG004|Overall Study|Insufficient testosterone response|8|||
27942394|NCT00215657|81622429|FG005|Overall Study|Insufficient testosterone response|12|||
27942395|NCT00215657|81622430|FG006|Overall Study|Insufficient testosterone response|4|||
27942396|NCT00215657|81622431|FG007|Overall Study|Insufficient testosterone response|7|||
27942397|NCT00215657|81622424|FG000|Overall Study|Other|3|||
27942398|NCT00215657|81622425|FG001|Overall Study|Other|1|||
27942399|NCT00215657|81622426|FG002|Overall Study|Other|2|||
27942400|NCT00215657|81622427|FG003|Overall Study|Other|3|||
27942401|NCT00215657|81622428|FG004|Overall Study|Other|5|||
27942402|NCT00215657|81622429|FG005|Overall Study|Other|4|||
27942403|NCT00215657|81622430|FG006|Overall Study|Other|6|||
27942404|NCT00215657|81622431|FG007|Overall Study|Other|1|||
27942405|NCT04003142|81622435|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
27942406|NCT04003142|81622436|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
27942407|NCT04003142|81622437|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
27942408|NCT04003142|81622438|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
27942409|NCT04003142|81622439|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
27942410|NCT04003142|81622435|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
27942411|NCT04003142|81622436|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
27942412|NCT04003142|81622437|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
27942413|NCT04003142|81622438|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
27942414|NCT04003142|81622439|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
27942415|NCT04003142|81622435|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
27942416|NCT04003142|81622436|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
27942417|NCT04003142|81622437|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
27942418|NCT04003142|81622438|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
27942419|NCT04003142|81622439|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
27942420|NCT04003142|81622435|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
27942421|NCT04003142|81622436|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
27942422|NCT04003142|81622437|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
27942423|NCT04003142|81622438|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
27942424|NCT04003142|81622439|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
27942425|NCT04003142|81622435|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
27942426|NCT04003142|81622436|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
27942427|NCT04003142|81622437|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
27942428|NCT04003142|81622438|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
27942429|NCT04003142|81622439|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
27942430|NCT04003142|81622435|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
27942431|NCT04003142|81622436|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
27942432|NCT04003142|81622437|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
27942433|NCT04003142|81622438|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
27942434|NCT04003142|81622439|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
27942435|NCT04003142|81622435|FG000|Extension Period (40 Weeks)|Death|0|||
27942436|NCT04003142|81622436|FG001|Extension Period (40 Weeks)|Death|0|||
27942437|NCT04003142|81622437|FG002|Extension Period (40 Weeks)|Death|0|||
27942438|NCT04003142|81622438|FG003|Extension Period (40 Weeks)|Death|0|||
27942439|NCT04003142|81622439|FG004|Extension Period (40 Weeks)|Death|1|||
27942440|NCT04003142|81622435|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
27942441|NCT04003142|81622436|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
27942442|NCT04003142|81622437|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
27942443|NCT04003142|81622438|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
27942444|NCT04003142|81622439|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
27942445|NCT04003142|81622435|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
27942446|NCT04003142|81622436|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
27942447|NCT04003142|81622437|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
27942448|NCT04003142|81622438|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
27942449|NCT04003142|81622439|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
27942450|NCT04003142|81622435|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
27942451|NCT04003142|81622436|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
27942452|NCT04003142|81622437|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
27942453|NCT04003142|81622438|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
27942454|NCT04003142|81622439|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
27942455|NCT04003142|81622435|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
27942456|NCT04003142|81622436|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
27942457|NCT04003142|81622437|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
27942458|NCT04003142|81622438|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
27942459|NCT04003142|81622439|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
27942460|NCT01773889|81622440|FG000|Overall Study|lack of funding|2|||
27942461|NCT02244957|81622441|FG000|Overall Study|Lack of Efficacy|1|||
27942462|NCT02244957|81622442|FG001|Overall Study|Lack of Efficacy|0|||
27942463|NCT01550965|81622443|FG000|Overall Study|Adverse Event|26|||
27942464|NCT01550965|81622443|FG000|Overall Study|Withdrawal by Subject|10|||
27942465|NCT01550965|81622443|FG000|Overall Study|Lost to Follow-up|2|||
27942466|NCT01550965|81622443|FG000|Overall Study|Lack of Efficacy|59|||
27942467|NCT01550965|81622443|FG000|Overall Study|Other|13|||
27942468|NCT01767857|81622450|FG000|Overall Study|Adverse Event|27|||
27942469|NCT01767857|81622451|FG001|Overall Study|Adverse Event|7|||
27942470|NCT01767857|81622450|FG000|Overall Study|Death|28|||
27942471|NCT01767857|81622451|FG001|Overall Study|Death|13|||
27942472|NCT01767857|81622450|FG000|Overall Study|Lack of Efficacy|299|||
27942473|NCT01767857|81622451|FG001|Overall Study|Lack of Efficacy|151|||
27942474|NCT01767857|81622450|FG000|Overall Study|Lost to Follow-up|1|||
27942475|NCT01767857|81622451|FG001|Overall Study|Lost to Follow-up|1|||
27942476|NCT01767857|81622450|FG000|Overall Study|Withdrawal by Subject|38|||
27942477|NCT01767857|81622451|FG001|Overall Study|Withdrawal by Subject|18|||
27942478|NCT01767857|81622450|FG000|Overall Study|Physician Decision|17|||
27942479|NCT01767857|81622451|FG001|Overall Study|Physician Decision|10|||
27942480|NCT01767857|81622450|FG000|Overall Study|Protocol Terminated|1|||
27942481|NCT01767857|81622451|FG001|Overall Study|Protocol Terminated|0|||
27942482|NCT01767857|81622450|FG000|Overall Study|Randomized But Never Treated|19|||
27942483|NCT01767857|81622451|FG001|Overall Study|Randomized But Never Treated|13|||
27942484|NCT00004228|81622454|FG000|Overall Study|Adverse Event|0|||
27942485|NCT00004228|81622455|FG001|Overall Study|Adverse Event|1|||
27942486|NCT00004228|81622456|FG002|Overall Study|Adverse Event|0|||
27942487|NCT00004228|81622457|FG003|Overall Study|Adverse Event|0|||
27942488|NCT00004228|81622458|FG004|Overall Study|Adverse Event|1|||
27942489|NCT00004228|81622459|FG005|Overall Study|Adverse Event|0|||
27942490|NCT00004228|81622460|FG006|Overall Study|Adverse Event|0|||
27942491|NCT00004228|81622454|FG000|Overall Study|Death|0|||
27942492|NCT00004228|81622455|FG001|Overall Study|Death|1|||
27942493|NCT00004228|81622456|FG002|Overall Study|Death|2|||
27942494|NCT00004228|81622457|FG003|Overall Study|Death|0|||
27942495|NCT00004228|81622458|FG004|Overall Study|Death|1|||
27942496|NCT00004228|81622459|FG005|Overall Study|Death|0|||
27942497|NCT00004228|81622460|FG006|Overall Study|Death|0|||
27942498|NCT00004228|81622454|FG000|Overall Study|Lack of Efficacy|1|||
27942499|NCT00004228|81622455|FG001|Overall Study|Lack of Efficacy|6|||
27942500|NCT00004228|81622456|FG002|Overall Study|Lack of Efficacy|5|||
27942501|NCT00004228|81622457|FG003|Overall Study|Lack of Efficacy|3|||
27942502|NCT00004228|81622458|FG004|Overall Study|Lack of Efficacy|9|||
27942503|NCT00004228|81622459|FG005|Overall Study|Lack of Efficacy|8|||
27942504|NCT00004228|81622460|FG006|Overall Study|Lack of Efficacy|4|||
27942505|NCT00004228|81622454|FG000|Overall Study|Lost to Follow-up|0|||
27942506|NCT00004228|81622455|FG001|Overall Study|Lost to Follow-up|0|||
27942507|NCT00004228|81622456|FG002|Overall Study|Lost to Follow-up|1|||
27942508|NCT00004228|81622457|FG003|Overall Study|Lost to Follow-up|0|||
27942509|NCT00004228|81622458|FG004|Overall Study|Lost to Follow-up|0|||
27942510|NCT00004228|81622459|FG005|Overall Study|Lost to Follow-up|0|||
27942511|NCT00004228|81622460|FG006|Overall Study|Lost to Follow-up|0|||
27942512|NCT00004228|81622454|FG000|Overall Study|Physician Decision|1|||
27942513|NCT00004228|81622455|FG001|Overall Study|Physician Decision|0|||
27942514|NCT00004228|81622456|FG002|Overall Study|Physician Decision|3|||
27942515|NCT00004228|81622457|FG003|Overall Study|Physician Decision|2|||
27942516|NCT00004228|81622458|FG004|Overall Study|Physician Decision|1|||
27942517|NCT00004228|81622459|FG005|Overall Study|Physician Decision|1|||
27942518|NCT00004228|81622460|FG006|Overall Study|Physician Decision|1|||
27942519|NCT00004228|81622454|FG000|Overall Study|Protocol Violation|0|||
27942520|NCT00004228|81622455|FG001|Overall Study|Protocol Violation|5|||
27942521|NCT00004228|81622456|FG002|Overall Study|Protocol Violation|2|||
27942522|NCT00004228|81622457|FG003|Overall Study|Protocol Violation|1|||
27942523|NCT00004228|81622458|FG004|Overall Study|Protocol Violation|1|||
27942524|NCT00004228|81622459|FG005|Overall Study|Protocol Violation|2|||
27942525|NCT00004228|81622460|FG006|Overall Study|Protocol Violation|0|||
27942526|NCT00004228|81622454|FG000|Overall Study|Withdrawal by Subject|3|||
27942527|NCT00004228|81622455|FG001|Overall Study|Withdrawal by Subject|0|||
27942528|NCT00004228|81622456|FG002|Overall Study|Withdrawal by Subject|1|||
27942529|NCT00004228|81622457|FG003|Overall Study|Withdrawal by Subject|0|||
27942530|NCT00004228|81622458|FG004|Overall Study|Withdrawal by Subject|2|||
27942531|NCT00004228|81622459|FG005|Overall Study|Withdrawal by Subject|1|||
27646470|NCT01555138|80547641|FG001|Overall Study|Lack of Efficacy|2|||
27646471|NCT01555138|80547640|FG000|Overall Study|Protocol Violation|5|||
27646472|NCT01555138|80547641|FG001|Overall Study|Protocol Violation|3|||
27942532|NCT00004228|81622460|FG006|Overall Study|Withdrawal by Subject|2|||
27942533|NCT00004228|81622454|FG000|Overall Study|Other|0|||
27942534|NCT00004228|81622455|FG001|Overall Study|Other|0|||
27942535|NCT00004228|81622456|FG002|Overall Study|Other|1|||
27942536|NCT00004228|81622457|FG003|Overall Study|Other|0|||
27942537|NCT00004228|81622458|FG004|Overall Study|Other|0|||
27942538|NCT00004228|81622459|FG005|Overall Study|Other|0|||
27942539|NCT00004228|81622460|FG006|Overall Study|Other|0|||
27942540|NCT00004228|81622454|FG000|Overall Study|ineligible|4|||
27942541|NCT00004228|81622455|FG001|Overall Study|ineligible|2|||
27942542|NCT00004228|81622456|FG002|Overall Study|ineligible|4|||
27942543|NCT00004228|81622457|FG003|Overall Study|ineligible|1|||
27942544|NCT00004228|81622458|FG004|Overall Study|ineligible|1|||
27942545|NCT00004228|81622459|FG005|Overall Study|ineligible|2|||
27942546|NCT00004228|81622460|FG006|Overall Study|ineligible|5|||
27942547|NCT00836901|81622461|FG000|First Intervention|Withdrawal by Subject|1|||
27942548|NCT00836901|81622462|FG001|First Intervention|Withdrawal by Subject|0|||
27942549|NCT03253627|81622463|FG000|Overall Study|Lost to Follow-up|1|||
27942550|NCT03253627|81622464|FG001|Overall Study|Lost to Follow-up|2|||
27942551|NCT03253627|81622463|FG000|Overall Study|Withdrawal by Subject|0|||
27942552|NCT03253627|81622464|FG001|Overall Study|Withdrawal by Subject|2|||
27942553|NCT03253627|81622463|FG000|Overall Study|Inability to complete MRI|1|||
27942554|NCT03253627|81622464|FG001|Overall Study|Inability to complete MRI|0|||
27942555|NCT02837952|81622465|FG000|Overall Study|Adverse Event|0|||
27942556|NCT02837952|81622466|FG001|Overall Study|Adverse Event|1|||
27942557|NCT02837952|81622465|FG000|Overall Study|Withdrawal by Subject|4|||
27942558|NCT02837952|81622466|FG001|Overall Study|Withdrawal by Subject|5|||
27942559|NCT02837952|81622465|FG000|Overall Study|Medication Error|1|||
27942560|NCT02837952|81622466|FG001|Overall Study|Medication Error|0|||
27942561|NCT04101331|81622473|FG000|Overall Study|Adverse Event|9|||
27942562|NCT04101331|81622473|FG000|Overall Study|Disease progression|82|||
27942563|NCT04101331|81622473|FG000|Overall Study|Withdrawal by Subject|1|||
27942564|NCT04101331|81622473|FG000|Overall Study|Investigator decision|6|||
27942565|NCT04101331|81622473|FG000|Overall Study|Death|6|||
27942566|NCT04101331|81622473|FG000|Overall Study|Allogenic transplant|1|||
27942567|NCT02231580|81622474|FG000|Overall Study|Adverse Event|5|||
27942568|NCT02231580|81622475|FG001|Overall Study|Adverse Event|0|||
27942569|NCT02105012|81622476|FG000|Overall Study|Withdrawal by Subject|11|||
27942570|NCT02105012|81622476|FG000|Overall Study|Protocol Specified Criteria|9|||
27942571|NCT02105012|81622476|FG000|Overall Study|Lost to Follow-up|4|||
27942572|NCT02105012|81622476|FG000|Overall Study|Protocol Violation|4|||
27942573|NCT02105012|81622476|FG000|Overall Study|Physician Decision|3|||
27942574|NCT02105012|81622476|FG000|Overall Study|Adverse Event|1|||
27942575|NCT02105012|81622476|FG000|Overall Study|Lack of Efficacy|1|||
27646473|NCT01555138|80547640|FG000|Overall Study|Administrative problems|8|||
27646474|NCT01555138|80547641|FG001|Overall Study|Administrative problems|0|||
27942576|NCT04193176|81622481|FG000|Overall Study|Withdrawal by Subject|6|||
27942577|NCT04193176|81622482|FG001|Overall Study|Withdrawal by Subject|10|||
27942578|NCT04656275|81622483|FG000|Overall Study|Study terminated by sponsor|2|||
27942579|NCT04656275|81622484|FG001|Overall Study|Study terminated by sponsor|4|||
27942580|NCT05852470|81622485|FG000|Overall Study|Withdrawal by Subject|0|||
27942581|NCT05852470|81622486|FG001|Overall Study|Withdrawal by Subject|1|||
27942582|NCT04362254|81622489|FG000|Overall Study|Adverse Event|1|||
27942583|NCT04362254|81622489|FG000|Overall Study|Protocol Violation|1|||
27942584|NCT04362254|81622489|FG000|Overall Study|Due to early termination of the trial|10|||
27942585|NCT00773461|81622490|FG000|Overall Study|Adverse Event|1|||
27942586|NCT00773461|81622491|FG001|Overall Study|Adverse Event|3|||
27942587|NCT00773461|81622490|FG000|Overall Study|Withdrawal by Subject|4|||
27942588|NCT00773461|81622491|FG001|Overall Study|Withdrawal by Subject|1|||
27942589|NCT01013870|81622492|FG000|Overall Study|Lost to Follow-up|1|||
27942590|NCT01013870|81622493|FG001|Overall Study|Lost to Follow-up|3|||
27942591|NCT01629563|81622494|FG000|Overall Study|Adverse Event|16|||
27942592|NCT01629563|81622495|FG001|Overall Study|Adverse Event|16|||
27942593|NCT01629563|81622494|FG000|Overall Study|Death|2|||
27942594|NCT01629563|81622495|FG001|Overall Study|Death|0|||
27942595|NCT01629563|81622494|FG000|Overall Study|Lack of Efficacy|2|||
27942596|NCT01629563|81622495|FG001|Overall Study|Lack of Efficacy|3|||
27942597|NCT01629563|81622494|FG000|Overall Study|Lost to Follow-up|1|||
27942598|NCT01629563|81622495|FG001|Overall Study|Lost to Follow-up|0|||
27942599|NCT01629563|81622494|FG000|Overall Study|Pregnancy|1|||
27942600|NCT01629563|81622495|FG001|Overall Study|Pregnancy|2|||
27942601|NCT01629563|81622494|FG000|Overall Study|Protocol Violation|0|||
27942602|NCT01629563|81622495|FG001|Overall Study|Protocol Violation|1|||
27942603|NCT01629563|81622494|FG000|Overall Study|Withdrawal by Subject|27|||
27942604|NCT01629563|81622495|FG001|Overall Study|Withdrawal by Subject|20|||
27942605|NCT01629563|81622494|FG000|Overall Study|surgery|0|||
27942606|NCT01629563|81622495|FG001|Overall Study|surgery|3|||
27942607|NCT01629563|81622494|FG000|Overall Study|Lack of return of menses|12|||
27942608|NCT01629563|81622495|FG001|Overall Study|Lack of return of menses|7|||
27942609|NCT01629563|81622494|FG000|Overall Study|Protocol Violation|0|||
27942610|NCT01629563|81622495|FG001|Overall Study|Protocol Violation|1|||
27942611|NCT01149460|81622496|FG000|Overall Study|Withdrawal by Subject|0|||
27942612|NCT01149460|81622497|FG001|Overall Study|Withdrawal by Subject|2|||
27646475|NCT01555138|80547640|FG000|Overall Study|Withdrawal by Subject|16|||
27646476|NCT01555138|80547641|FG001|Overall Study|Withdrawal by Subject|15|||
27646477|NCT01555138|80547640|FG000|Overall Study|Adverse Event|14|||
27646478|NCT01555138|80547641|FG001|Overall Study|Adverse Event|14|||
27646479|NCT01353274|80547644|FG000|Overall Study|No case report form (CRF) collected|28|||
27646480|NCT02185794|80547645|FG000|Overall Study|Enrolled but Never Dosed|1|||
27646481|NCT02185794|80547646|FG001|Overall Study|Enrolled but Never Dosed|6|||
27646482|NCT02185794|80547647|FG002|Overall Study|Enrolled but Never Dosed|3|||
27646483|NCT02185794|80547648|FG003|Overall Study|Enrolled but Never Dosed|1|||
27646484|NCT02185794|80547649|FG004|Overall Study|Enrolled but Never Dosed|1|||
27646485|NCT02185794|80547650|FG005|Overall Study|Enrolled but Never Dosed|0|||
27646486|NCT02185794|80547645|FG000|Overall Study|Investigator's Discretion|1|||
27646487|NCT02185794|80547646|FG001|Overall Study|Investigator's Discretion|0|||
27646488|NCT02185794|80547647|FG002|Overall Study|Investigator's Discretion|1|||
27646489|NCT02185794|80547648|FG003|Overall Study|Investigator's Discretion|2|||
27646490|NCT02185794|80547649|FG004|Overall Study|Investigator's Discretion|2|||
27646491|NCT02185794|80547650|FG005|Overall Study|Investigator's Discretion|15|||
27646492|NCT02185794|80547645|FG000|Overall Study|Withdrew Consent|2|||
27646493|NCT02185794|80547646|FG001|Overall Study|Withdrew Consent|5|||
27646494|NCT02185794|80547647|FG002|Overall Study|Withdrew Consent|10|||
27646495|NCT02185794|80547648|FG003|Overall Study|Withdrew Consent|2|||
27646496|NCT02185794|80547649|FG004|Overall Study|Withdrew Consent|0|||
27646497|NCT02185794|80547650|FG005|Overall Study|Withdrew Consent|0|||
27646498|NCT02185794|80547645|FG000|Overall Study|Lost to Follow-up|1|||
27646499|NCT02185794|80547646|FG001|Overall Study|Lost to Follow-up|2|||
27646500|NCT02185794|80547647|FG002|Overall Study|Lost to Follow-up|2|||
27646501|NCT02185794|80547648|FG003|Overall Study|Lost to Follow-up|3|||
27646502|NCT02185794|80547649|FG004|Overall Study|Lost to Follow-up|0|||
27646503|NCT02185794|80547650|FG005|Overall Study|Lost to Follow-up|1|||
27646504|NCT02148705|80547651|FG000|Overall Study|Death|2|||
27646505|NCT02148705|80547652|FG001|Overall Study|Death|0|||
27646506|NCT02148705|80547653|FG002|Overall Study|Death|0|||
27646507|NCT02148705|80547651|FG000|Overall Study|Lost to Follow-up|13|||
27646508|NCT02148705|80547652|FG001|Overall Study|Lost to Follow-up|4|||
27942613|NCT00089583|81622498|FG000|Overall Study|Adverse Event|0|||
27646509|NCT02148705|80547653|FG002|Overall Study|Lost to Follow-up|10|||
27942614|NCT00089583|81622499|FG001|Overall Study|Adverse Event|3|||
27942615|NCT00089583|81622498|FG000|Overall Study|Insufficient Viral Load Response|5|||
27942616|NCT00089583|81622499|FG001|Overall Study|Insufficient Viral Load Response|5|||
27942617|NCT00089583|81622498|FG000|Overall Study|Withdrawal by Subject|0|||
27942618|NCT00089583|81622499|FG001|Overall Study|Withdrawal by Subject|4|||
27646510|NCT02148705|80547651|FG000|Overall Study|Withdrawal by Subject|3|||
27942619|NCT00089583|81622498|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
27942620|NCT00089583|81622499|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
27942621|NCT00089583|81622498|FG000|Overall Study|Participant Refused Study Medication|0|||
27942622|NCT00089583|81622499|FG001|Overall Study|Participant Refused Study Medication|2|||
27942623|NCT00089583|81622498|FG000|Overall Study|Non-Compliance|0|||
27942624|NCT00089583|81622499|FG001|Overall Study|Non-Compliance|4|||
27942625|NCT00089583|81622498|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
27942626|NCT00089583|81622499|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
27646511|NCT02148705|80547652|FG001|Overall Study|Withdrawal by Subject|0|||
27646512|NCT02148705|80547653|FG002|Overall Study|Withdrawal by Subject|2|||
27646513|NCT02148705|80547651|FG000|Overall Study|Not Treated|0|||
27646514|NCT02148705|80547652|FG001|Overall Study|Not Treated|1|||
27646515|NCT02148705|80547653|FG002|Overall Study|Not Treated|5|||
27942627|NCT00089583|81622498|FG000|Overall Study|Participant Management Criteria Met|0|||
27942628|NCT00089583|81622499|FG001|Overall Study|Participant Management Criteria Met|1|||
27942629|NCT00089583|81622498|FG000|Overall Study|Reason Not Provided|0|||
27942630|NCT00089583|81622499|FG001|Overall Study|Reason Not Provided|1|||
27942631|NCT00089583|81622498|FG000|Overall Study|Protocol Violation|0|||
27942632|NCT00089583|81622499|FG001|Overall Study|Protocol Violation|3|||
27942633|NCT00089583|81622498|FG000|Overall Study|Principal Investigator Decision|0|||
27942634|NCT00089583|81622499|FG001|Overall Study|Principal Investigator Decision|10|||
27942635|NCT00089583|81622498|FG000|Overall Study|Start of Disallowed Medication|0|||
27942636|NCT00089583|81622499|FG001|Overall Study|Start of Disallowed Medication|1|||
27942637|NCT00089583|81622498|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
27942638|NCT00089583|81622499|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
27942639|NCT00089583|81622498|FG000|Overall Study|Participant Incarcerated|0|||
27942640|NCT00089583|81622499|FG001|Overall Study|Participant Incarcerated|1|||
27942641|NCT04439357|81622500|FG000|Overall Study|Disease Progression|4|||
27942642|NCT02038647|81622501|FG000|Overall Study|Progressive Disease|50|||
27942643|NCT02038647|81622502|FG001|Overall Study|Progressive Disease|59|||
27942644|NCT02038647|81622501|FG000|Overall Study|Adverse Event|18|||
27942645|NCT02038647|81622502|FG001|Overall Study|Adverse Event|10|||
27942646|NCT02038647|81622501|FG000|Overall Study|Symptomatic Deterioration|7|||
27942647|NCT02038647|81622502|FG001|Overall Study|Symptomatic Deterioration|7|||
27942648|NCT02038647|81622501|FG000|Overall Study|Withdrawal by Subject|5|||
27942649|NCT02038647|81622502|FG001|Overall Study|Withdrawal by Subject|2|||
27942650|NCT02038647|81622501|FG000|Overall Study|Not Reported|0|||
27942651|NCT02038647|81622502|FG001|Overall Study|Not Reported|1|||
27942652|NCT02038647|81622501|FG000|Overall Study|Ongoing at Datacut|9|||
27942653|NCT02038647|81622502|FG001|Overall Study|Ongoing at Datacut|10|||
27942654|NCT01674062|81622509|FG000|Overall Study|Insufficient Therapeutic Response|56|||
27646516|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
27646517|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
27646518|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
27646519|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
27646520|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
27746313|NCT03345836|80899607|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
27755017|NCT03571256|80929666|FG002|Overall Study|Adverse Event|1|||
27646521|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
27646522|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
27646523|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
27646524|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
27646525|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
27646526|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
27646527|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
27646528|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Other|1|||
27646529|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Other|0|||
27646530|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Other|0|||
27646531|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
27646532|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
27646533|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
27646534|NCT00887224|80547655|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
27646535|NCT00887224|80547656|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
27646536|NCT00887224|80547657|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
27646537|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
27646538|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
27646539|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
27646540|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
27646541|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
27646542|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
27646543|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
27646544|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
27646545|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
27646546|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
27646547|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
27646548|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
27646549|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Other|1|||
27646550|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Other|0|||
27646551|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Other|0|||
27646552|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
27646553|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
27646554|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
27942655|NCT01674062|81622510|FG001|Overall Study|Insufficient Therapeutic Response|26|||
27942656|NCT01674062|81622509|FG000|Overall Study|Other|8|||
27942657|NCT01674062|81622510|FG001|Overall Study|Other|1|||
27942658|NCT01674062|81622509|FG000|Overall Study|Adverse Event|1|||
27942659|NCT01674062|81622510|FG001|Overall Study|Adverse Event|1|||
27942660|NCT01674062|81622509|FG000|Overall Study|Death|0|||
27942661|NCT01674062|81622510|FG001|Overall Study|Death|1|||
27942662|NCT01674062|81622509|FG000|Overall Study|Programming Error|1|||
27942663|NCT01674062|81622510|FG001|Overall Study|Programming Error|0|||
27942664|NCT00993473|81622522|FG000|Overall Study|Adverse Event|0|||
27942665|NCT00993473|81622523|FG001|Overall Study|Adverse Event|2|||
27942666|NCT00993473|81622522|FG000|Overall Study|Protocol Violation|1|||
27942667|NCT00993473|81622523|FG001|Overall Study|Protocol Violation|2|||
27942668|NCT00993473|81622522|FG000|Overall Study|Lost to Follow-up|1|||
27942669|NCT00993473|81622523|FG001|Overall Study|Lost to Follow-up|0|||
27942670|NCT00993473|81622522|FG000|Overall Study|Withdrawal by Subject|1|||
27942671|NCT00993473|81622523|FG001|Overall Study|Withdrawal by Subject|5|||
27942672|NCT00993473|81622522|FG000|Overall Study|Technical problem with CGM device|0|||
27942673|NCT00993473|81622523|FG001|Overall Study|Technical problem with CGM device|1|||
27942674|NCT00993473|81622522|FG000|Overall Study|Family event|1|||
27942675|NCT00993473|81622523|FG001|Overall Study|Family event|0|||
27942676|NCT02094885|81622524|FG000|Overall Study|Death|1|||
27942677|NCT02094885|81622525|FG001|Overall Study|Death|5|||
27942678|NCT02094885|81622524|FG000|Overall Study|Withdrawn due to age|1|||
27942679|NCT02094885|81622525|FG001|Overall Study|Withdrawn due to age|0|||
27942680|NCT00266032|81622526|FG000|Treatment|Adverse Event|42|||
27942681|NCT00266032|81622527|FG001|Treatment|Adverse Event|26|||
27942682|NCT00266032|81622528|FG002|Treatment|Adverse Event|10|||
27942683|NCT00266032|81622526|FG000|Treatment|Lost to Follow-up|19|||
27942684|NCT00266032|81622527|FG001|Treatment|Lost to Follow-up|4|||
27942685|NCT00266032|81622528|FG002|Treatment|Lost to Follow-up|2|||
27942686|NCT00266032|81622526|FG000|Treatment|Pregnancy|3|||
27942687|NCT00266032|81622527|FG001|Treatment|Pregnancy|2|||
27942688|NCT00266032|81622528|FG002|Treatment|Pregnancy|2|||
27942689|NCT00266032|81622526|FG000|Treatment|Protocol Violation|6|||
27942690|NCT00266032|81622527|FG001|Treatment|Protocol Violation|14|||
27942691|NCT00266032|81622528|FG002|Treatment|Protocol Violation|13|||
27942692|NCT00266032|81622526|FG000|Treatment|Withdrawal by Subject|28|||
27942693|NCT00266032|81622527|FG001|Treatment|Withdrawal by Subject|13|||
27942694|NCT00266032|81622528|FG002|Treatment|Withdrawal by Subject|12|||
27942695|NCT00266032|81622526|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
27942696|NCT00266032|81622527|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
27942697|NCT00266032|81622528|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
27942698|NCT00266032|81622526|FG000|Open-label Safety Extension|Adverse Event|5|||
27942699|NCT00266032|81622527|FG001|Open-label Safety Extension|Adverse Event|0|||
27942700|NCT00266032|81622528|FG002|Open-label Safety Extension|Adverse Event|4|||
27942701|NCT00266032|81622526|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
27942702|NCT00266032|81622527|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
27942703|NCT00266032|81622528|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
27942704|NCT00266032|81622526|FG000|Open-label Safety Extension|Pregnancy|4|||
27942705|NCT00266032|81622527|FG001|Open-label Safety Extension|Pregnancy|1|||
27942706|NCT00266032|81622528|FG002|Open-label Safety Extension|Pregnancy|2|||
27942707|NCT00266032|81622526|FG000|Open-label Safety Extension|Protocol Violation|1|||
27942708|NCT00266032|81622527|FG001|Open-label Safety Extension|Protocol Violation|3|||
27942709|NCT00266032|81622528|FG002|Open-label Safety Extension|Protocol Violation|2|||
27646555|NCT00887224|80547655|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
27646556|NCT00887224|80547656|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
27942710|NCT00266032|81622526|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
27942711|NCT00266032|81622527|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
27942712|NCT00266032|81622528|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
27646557|NCT00887224|80547657|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
27646558|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
27646559|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
27646560|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
27646561|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
27646562|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
27942713|NCT00266032|81622526|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
27646563|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
27942714|NCT00266032|81622527|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
27942715|NCT00266032|81622528|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
27942716|NCT01309100|81622529|FG000|Overall Study|Protocol Violation|1|||
27942717|NCT01309100|81622529|FG000|Overall Study|Positive Slit lamp finding|1|||
27942718|NCT02489045|81622530|FG000|Overall Study|unable to collect usable data|53|||
27646564|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
27942719|NCT02489045|81622530|FG000|Follow-up|Lost to Follow-up|10|||
27942720|NCT01546987|81622531|FG000|Overall Study|Protocol Violation|3|||
27942721|NCT01546987|81622532|FG001|Overall Study|Protocol Violation|4|||
27942722|NCT02217982|81622533|FG000|Overall Study|Trial discontinued|1|||
27646565|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
27646566|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
27646567|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
27646568|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
27646569|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
27646570|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Other|30|||
27646571|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Other|0|||
27646572|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Other|0|||
27646573|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
27646574|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
27646575|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
27646576|NCT00887224|80547655|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
27646577|NCT00887224|80547656|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
27646578|NCT00887224|80547657|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
27646579|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Adverse Event|0|||
27646580|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Adverse Event|7|||
27646581|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Adverse Event|2|||
27646582|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Failed to return|0|||
27646583|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Failed to return|2|||
27646584|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Failed to return|2|||
27646585|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
27646586|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
27646587|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
27646588|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
27646589|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
27646590|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
27646591|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Other|0|||
27646592|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Other|2|||
27646593|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Other|0|||
27646594|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
27646595|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
27646596|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
27646597|NCT00887224|80547655|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
27646598|NCT00887224|80547656|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
27646599|NCT00887224|80547657|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
27646600|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
27646601|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
27646602|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
27646603|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
27646604|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
27646605|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
27646606|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
27646607|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
27646608|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
27646609|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
27646610|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
27646611|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
27646612|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
27646613|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
27746314|NCT03345836|80899608|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
27942723|NCT02217982|81622534|FG001|Overall Study|Trial discontinued|0|||
27942724|NCT02217982|81622533|FG000|Overall Study|Adverse Event|0|||
27942725|NCT02217982|81622534|FG001|Overall Study|Adverse Event|1|||
27942726|NCT00855166|81622535|FG000|Overall Study|Adverse Event|0|||
27942727|NCT00855166|81622536|FG001|Overall Study|Adverse Event|2|||
27942728|NCT00855166|81622535|FG000|Overall Study|Death|0|||
27942729|NCT00855166|81622536|FG001|Overall Study|Death|1|||
27942730|NCT00855166|81622535|FG000|Overall Study|Withdrawal by Subject|1|||
27942731|NCT00855166|81622536|FG001|Overall Study|Withdrawal by Subject|4|||
27942732|NCT00855166|81622535|FG000|Overall Study|Poor/non-compliance|2|||
27646614|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
27646615|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
27646616|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
27646617|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
27646618|NCT00887224|80547655|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
27646619|NCT00887224|80547656|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
27646620|NCT00887224|80547657|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
27942733|NCT00855166|81622536|FG001|Overall Study|Poor/non-compliance|0|||
27942734|NCT00855166|81622535|FG000|Overall Study|Administrative reasons by sponsor|1|||
27942735|NCT00855166|81622536|FG001|Overall Study|Administrative reasons by sponsor|0|||
27942736|NCT00855166|81622535|FG000|Overall Study|Subject no longer meets study criteria|1|||
27646621|NCT00609869|80547661|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
27646622|NCT00609869|80547661|FG000|Overall Study|Severe hematologic toxicity|1|||
27942737|NCT00855166|81622536|FG001|Overall Study|Subject no longer meets study criteria|1|||
27942738|NCT04507269|81622537|FG000|Overall Study|Withdrawal by Subject|1|||
27942739|NCT04507269|81622538|FG001|Overall Study|Withdrawal by Subject|1|||
27942740|NCT04507269|81622539|FG002|Overall Study|Withdrawal by Subject|0|||
27942741|NCT04507269|81622540|FG003|Overall Study|Withdrawal by Subject|0|||
27942742|NCT04507269|81622541|FG004|Overall Study|Withdrawal by Subject|0|||
27942743|NCT04507269|81622542|FG005|Overall Study|Withdrawal by Subject|0|||
27942744|NCT04507269|81622537|FG000|Overall Study|Lost to Follow-up|0|||
27942745|NCT04507269|81622538|FG001|Overall Study|Lost to Follow-up|0|||
27942746|NCT04507269|81622539|FG002|Overall Study|Lost to Follow-up|0|||
27646623|NCT00609869|80547661|FG000|Overall Study|Withdrawal by Subject|1|||
27646624|NCT00609869|80547661|FG000|Overall Study|Seizures|1|||
27646625|NCT00609869|80547661|FG000|Overall Study|Severe tumor flare reaction|1|||
27646626|NCT00609869|80547661|FG000|Overall Study|Hepatitis B infection|1|||
27646627|NCT00609869|80547661|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
27646628|NCT00609869|80547661|FG000|Overall Study|Mantle cell: not evaluable|4|||
27646629|NCT00463229|80547666|FG000|Overall Study|Lost to Follow-up|5|||
27646630|NCT00463229|80547667|FG001|Overall Study|Lost to Follow-up|7|||
27646631|NCT00463229|80547666|FG000|Overall Study|Death|4|||
27646632|NCT00463229|80547667|FG001|Overall Study|Death|3|||
27646633|NCT00562094|80547668|FG000|Overall Study|Lost to Follow-up|62|||
27646634|NCT01860079|80547669|FG000|Overall Study|Physician Decision|14|||
27646635|NCT01860079|80547670|FG001|Overall Study|Physician Decision|22|||
27646636|NCT02079649|80547678|FG000|Overall Study|Lost to Follow-up|0|||
27646637|NCT02079649|80547679|FG001|Overall Study|Lost to Follow-up|0|||
27646638|NCT02079649|80547680|FG002|Overall Study|Lost to Follow-up|0|||
27646639|NCT02079649|80547681|FG003|Overall Study|Lost to Follow-up|1|||
27646640|NCT02079649|80547678|FG000|Overall Study|Withdrawal by Subject|0|||
27646641|NCT02079649|80547679|FG001|Overall Study|Withdrawal by Subject|0|||
27646642|NCT02079649|80547680|FG002|Overall Study|Withdrawal by Subject|0|||
27942747|NCT04507269|81622540|FG003|Overall Study|Lost to Follow-up|0|||
27942748|NCT04507269|81622541|FG004|Overall Study|Lost to Follow-up|1|||
27942749|NCT04507269|81622542|FG005|Overall Study|Lost to Follow-up|0|||
27942750|NCT00289978|81622543|FG000|Overall Study|Withdrawal by Subject|31|||
27942751|NCT00289978|81622544|FG001|Overall Study|Withdrawal by Subject|17|||
27942752|NCT00289978|81622545|FG002|Overall Study|Withdrawal by Subject|28|||
27942753|NCT00289978|81622543|FG000|Overall Study|Adverse Event|22|||
27942754|NCT00289978|81622544|FG001|Overall Study|Adverse Event|13|||
27942755|NCT00289978|81622545|FG002|Overall Study|Adverse Event|18|||
27942756|NCT00289978|81622543|FG000|Overall Study|Lack of Efficacy|13|||
27942757|NCT00289978|81622544|FG001|Overall Study|Lack of Efficacy|6|||
27942758|NCT00289978|81622545|FG002|Overall Study|Lack of Efficacy|25|||
27942759|NCT00289978|81622543|FG000|Overall Study|Abnormal laboratory value(s)|20|||
27942760|NCT00289978|81622544|FG001|Overall Study|Abnormal laboratory value(s)|9|||
27942761|NCT00289978|81622545|FG002|Overall Study|Abnormal laboratory value(s)|1|||
27942762|NCT00289978|81622543|FG000|Overall Study|Lost to Follow-up|3|||
27942763|NCT00289978|81622544|FG001|Overall Study|Lost to Follow-up|5|||
27942764|NCT00289978|81622545|FG002|Overall Study|Lost to Follow-up|7|||
27942765|NCT00289978|81622543|FG000|Overall Study|Protocol Violation|5|||
27942766|NCT00289978|81622544|FG001|Overall Study|Protocol Violation|5|||
27942767|NCT00289978|81622545|FG002|Overall Study|Protocol Violation|4|||
27942768|NCT00289978|81622543|FG000|Overall Study|Abnormal test procedure result(s)|2|||
27942769|NCT00289978|81622544|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27942770|NCT00289978|81622545|FG002|Overall Study|Abnormal test procedure result(s)|1|||
27646643|NCT02079649|80547681|FG003|Overall Study|Withdrawal by Subject|1|||
27646644|NCT02079649|80547678|FG000|Overall Study|Randomization error (prior to treatment)|1|||
27646645|NCT02079649|80547679|FG001|Overall Study|Randomization error (prior to treatment)|0|||
27646646|NCT02079649|80547680|FG002|Overall Study|Randomization error (prior to treatment)|1|||
27646647|NCT02079649|80547681|FG003|Overall Study|Randomization error (prior to treatment)|0|||
27646648|NCT01750684|80547682|FG000|Overall Study|Death|1|||
27646649|NCT01750684|80547683|FG001|Overall Study|Death|0|||
27646650|NCT01750684|80547682|FG000|Overall Study|Non-compliance with Study Drug|0|||
27646651|NCT01750684|80547683|FG001|Overall Study|Non-compliance with Study Drug|1|||
27646652|NCT01750684|80547682|FG000|Overall Study|Withdrawn by Sponsor|0|||
27646653|NCT01750684|80547683|FG001|Overall Study|Withdrawn by Sponsor|1|||
27646654|NCT01750684|80547682|FG000|Overall Study|Protocol Violation|1|||
27646655|NCT01750684|80547683|FG001|Overall Study|Protocol Violation|0|||
27646656|NCT03489369|80547684|FG000|Overall Study|Documented Progressive Disease|3|||
27646657|NCT03489369|80547685|FG001|Overall Study|Documented Progressive Disease|2|||
27646658|NCT03489369|80547686|FG002|Overall Study|Documented Progressive Disease|3|||
27646659|NCT03489369|80547687|FG003|Overall Study|Documented Progressive Disease|6|||
27942771|NCT00289978|81622543|FG000|Overall Study|Death|1|||
27942772|NCT00289978|81622544|FG001|Overall Study|Death|0|||
27942773|NCT00289978|81622545|FG002|Overall Study|Death|2|||
27942774|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
27942775|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27942776|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27942777|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27942778|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27942779|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
27942780|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27942781|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27942782|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27942783|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27942784|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
27942785|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27942786|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27942787|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27942788|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27942789|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
27942790|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27942791|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27942792|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27942793|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
27942794|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
27942795|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27942796|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27942797|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27942798|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
27942799|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
27942800|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27942801|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27942802|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27942803|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
27942804|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
27942805|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27942806|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27942807|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27942808|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27942809|NCT01111552|81622548|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
27942810|NCT01111552|81622549|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
27942811|NCT01111552|81622550|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
27942812|NCT01111552|81622551|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
27942813|NCT01111552|81622552|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
27942814|NCT01111552|81622548|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27942815|NCT01111552|81622549|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27942816|NCT01111552|81622550|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27942817|NCT01111552|81622551|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
27942818|NCT01111552|81622552|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27942819|NCT01111552|81622548|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
27942820|NCT01111552|81622549|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27942821|NCT01111552|81622550|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
27942822|NCT01111552|81622551|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
27942823|NCT01111552|81622552|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27942824|NCT01111552|81622548|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27942825|NCT01111552|81622549|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
27646660|NCT03489369|80547684|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
27646661|NCT03489369|80547685|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
27646662|NCT03489369|80547686|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
27646663|NCT03489369|80547687|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
27646664|NCT00523419|80547691|FG000|Overall Study|Adverse Event|1|||
27646665|NCT00523419|80547691|FG000|Overall Study|Withdrawal by Subject|1|||
27646666|NCT00523419|80547691|FG000|Overall Study|Physician Decision|2|||
27646667|NCT00523419|80547691|FG000|Overall Study|Progressive Disease|22|||
27646668|NCT00523419|80547691|FG000|Overall Study|Death due to Study Disease|4|||
27646669|NCT00523419|80547691|FG000|Overall Study|Death due to Adverse Event|2|||
27646670|NCT03520036|80547693|FG000|Overall Study|Adverse Event|1|||
27646671|NCT03520036|80547694|FG001|Overall Study|Adverse Event|2|||
27646672|NCT03520036|80547695|FG002|Overall Study|Adverse Event|0|||
27646673|NCT03520036|80547693|FG000|Overall Study|Protocol Violation|1|||
27646674|NCT03520036|80547694|FG001|Overall Study|Protocol Violation|0|||
27942826|NCT01111552|81622550|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27942827|NCT01111552|81622551|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27942828|NCT01111552|81622552|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
27942829|NCT01111552|81622548|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
27942830|NCT01111552|81622549|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
27942831|NCT01111552|81622550|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
27942832|NCT01111552|81622551|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
27942833|NCT01111552|81622552|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
27942834|NCT01111552|81622548|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27942835|NCT01111552|81622549|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
27942836|NCT01111552|81622550|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27942837|NCT01111552|81622551|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27942838|NCT01111552|81622552|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
27942839|NCT01111552|81622548|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27942840|NCT01111552|81622549|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27942841|NCT01111552|81622550|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
27942842|NCT01111552|81622551|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27942843|NCT01111552|81622552|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27942844|NCT00458705|81622566|FG000|Overall Study|Adverse Event|4|||
27942845|NCT00458705|81622566|FG000|Overall Study|Not Treated|1|||
27942846|NCT00050011|81622567|FG000|Overall Study|Adverse Event|41|||
27942847|NCT00050011|81622568|FG001|Overall Study|Adverse Event|46|||
27942848|NCT00050011|81622567|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27942849|NCT00050011|81622568|FG001|Overall Study|Abnormal laboratory value(s)|1|||
27942850|NCT00050011|81622567|FG000|Overall Study|Abnormal test procedure results|0|||
27942851|NCT00050011|81622568|FG001|Overall Study|Abnormal test procedure results|1|||
27942852|NCT00050011|81622567|FG000|Overall Study|Lack of Efficacy|16|||
27942853|NCT00050011|81622568|FG001|Overall Study|Lack of Efficacy|21|||
27942854|NCT00050011|81622567|FG000|Overall Study|Participant condition no longer required|1|||
27942855|NCT00050011|81622568|FG001|Overall Study|Participant condition no longer required|0|||
27942856|NCT00050011|81622567|FG000|Overall Study|Protocol Violation|4|||
27942857|NCT00050011|81622568|FG001|Overall Study|Protocol Violation|10|||
27942858|NCT00050011|81622567|FG000|Overall Study|Withdrawal by Subject|34|||
27942859|NCT00050011|81622568|FG001|Overall Study|Withdrawal by Subject|26|||
27942860|NCT00050011|81622567|FG000|Overall Study|Lost to Follow-up|7|||
27942861|NCT00050011|81622568|FG001|Overall Study|Lost to Follow-up|9|||
27942862|NCT00050011|81622567|FG000|Overall Study|Administrative problems|10|||
27942863|NCT00050011|81622568|FG001|Overall Study|Administrative problems|6|||
27942864|NCT00050011|81622567|FG000|Overall Study|Death|7|||
27942865|NCT00050011|81622568|FG001|Overall Study|Death|4|||
27942866|NCT00050011|81622567|FG000|Overall Study|Unknown - Reason is missing|0|||
27942867|NCT00050011|81622568|FG001|Overall Study|Unknown - Reason is missing|2|||
27942868|NCT00003907|81622569|FG000|Overall Study|Adverse Event|2|||
27942869|NCT00003907|81622570|FG001|Overall Study|Adverse Event|11|||
27942870|NCT00003907|81622569|FG000|Overall Study|Death|2|||
27942871|NCT00003907|81622570|FG001|Overall Study|Death|0|||
27942872|NCT00003907|81622569|FG000|Overall Study|Withdrawal by Subject|1|||
27942873|NCT00003907|81622570|FG001|Overall Study|Withdrawal by Subject|3|||
27942874|NCT00003907|81622569|FG000|Overall Study|Progressive disease|4|||
27942875|NCT00003907|81622570|FG001|Overall Study|Progressive disease|4|||
27942876|NCT00003907|81622569|FG000|Overall Study|Complicating disease|1|||
27942877|NCT00003907|81622570|FG001|Overall Study|Complicating disease|0|||
27942878|NCT00003907|81622569|FG000|Overall Study|Other|1|||
27942879|NCT00003907|81622570|FG001|Overall Study|Other|3|||
27942880|NCT00003907|81622569|FG000|Overall Study|ineligible or not treated|2|||
27942881|NCT00003907|81622570|FG001|Overall Study|ineligible or not treated|2|||
27942882|NCT01260311|81622573|FG000|Overall Study|Adverse Event|11|||
27942883|NCT01260311|81622573|FG000|Overall Study|Lack of Efficacy|4|||
27942884|NCT01260311|81622573|FG000|Overall Study|Lost to Follow-up|25|||
27942885|NCT01260311|81622573|FG000|Overall Study|Withdrawal by Subject|6|||
27942886|NCT01260311|81622573|FG000|Overall Study|Financial Constraints|77|||
27942887|NCT01260311|81622573|FG000|Overall Study|Gone to Province|2|||
27942888|NCT01260311|81622573|FG000|Overall Study|Medication Stopped|1|||
27942889|NCT01260311|81622573|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
27942890|NCT04691115|81622574|FG000|Overall Study|Withdrawal by Subject|0|||
27942891|NCT04691115|81622575|FG001|Overall Study|Withdrawal by Subject|0|||
27942892|NCT04691115|81622576|FG002|Overall Study|Withdrawal by Subject|0|||
27942893|NCT04691115|81622577|FG003|Overall Study|Withdrawal by Subject|0|||
27942894|NCT04691115|81622578|FG004|Overall Study|Withdrawal by Subject|0|||
27942895|NCT04691115|81622579|FG005|Overall Study|Withdrawal by Subject|1|||
27942896|NCT04691115|81622580|FG006|Overall Study|Withdrawal by Subject|0|||
27942897|NCT04691115|81622581|FG007|Overall Study|Withdrawal by Subject|0|||
27942898|NCT04691115|81622582|FG008|Overall Study|Withdrawal by Subject|0|||
27646675|NCT03520036|80547695|FG002|Overall Study|Protocol Violation|0|||
27646676|NCT03520036|80547693|FG000|Overall Study|Withdrawal by Subject|0|||
27646677|NCT03520036|80547694|FG001|Overall Study|Withdrawal by Subject|1|||
27646678|NCT03520036|80547695|FG002|Overall Study|Withdrawal by Subject|4|||
27646679|NCT03520036|80547693|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
27646680|NCT03520036|80547694|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
27646681|NCT03520036|80547695|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
27646682|NCT00293397|80547696|FG000|Overall Study|Death|2|||
27646683|NCT01662505|80547700|FG000|Overall Study|Progressive disease|6|||
27646684|NCT01662505|80547701|FG001|Overall Study|Progressive disease|1|||
27646685|NCT01662505|80547702|FG002|Overall Study|Progressive disease|5|||
27646686|NCT01662505|80547700|FG000|Overall Study|Refused cont. medication|0|||
27646687|NCT01662505|80547701|FG001|Overall Study|Refused cont. medication|0|||
27646688|NCT01662505|80547702|FG002|Overall Study|Refused cont. medication|1|||
27646689|NCT01662505|80547700|FG000|Overall Study|Not specified above|1|||
27646690|NCT01662505|80547701|FG001|Overall Study|Not specified above|3|||
27646691|NCT01662505|80547702|FG002|Overall Study|Not specified above|2|||
27646692|NCT00686595|80547705|FG000|Overall Study|Adverse Event|3|||
27646693|NCT00686595|80547705|FG000|Overall Study|Protocol Violation|1|||
27646694|NCT00686595|80547705|FG000|Overall Study|Lost to Follow-up|1|||
27646695|NCT00686595|80547705|FG000|Overall Study|Lack of Efficacy|1|||
27646696|NCT00686595|80547705|FG000|Overall Study|Poor Compliance|1|||
27942899|NCT04691115|81622583|FG009|Overall Study|Withdrawal by Subject|0|||
27942900|NCT04691115|81622584|FG010|Overall Study|Withdrawal by Subject|0|||
27942901|NCT04691115|81622585|FG011|Overall Study|Withdrawal by Subject|0|||
27942902|NCT04691115|81622586|FG012|Overall Study|Withdrawal by Subject|0|||
27646697|NCT01970007|80547714|FG000|Overall Study|Death|5|||
27646698|NCT01970007|80547714|FG000|Overall Study|Withdrawal by Subject|23|||
27646699|NCT01970007|80547714|FG000|Overall Study|Lost to Follow-up|24|||
27646700|NCT01970007|80547714|FG000|Overall Study|"Other endpoint"|3|||
27646701|NCT01856569|80547715|FG000|Overall Study|Other|1|||
27646702|NCT01856569|80547715|FG000|Overall Study|Changed Site/Structure|1|||
27646703|NCT01856569|80547715|FG000|Overall Study|Lost to Follow-up|3|||
27646704|NCT01856569|80547715|FG000|Overall Study|Did not met inclusion criteria|8|||
27646705|NCT00836498|80547716|FG000|Overall Study|Adverse Event|1|||
27646706|NCT00836498|80547717|FG001|Overall Study|Adverse Event|0|||
27646707|NCT00836498|80547716|FG000|Overall Study|Lost to Follow-up|1|||
27646708|NCT00836498|80547717|FG001|Overall Study|Lost to Follow-up|0|||
27646709|NCT00836498|80547716|FG000|Overall Study|Withdrawal by Subject|2|||
27646710|NCT00836498|80547717|FG001|Overall Study|Withdrawal by Subject|1|||
27646711|NCT00309166|80547718|FG000|Overall Study|Adverse event, non-fatal|1|||
27646712|NCT00309166|80547719|FG001|Overall Study|Adverse event, non-fatal|0|||
27646713|NCT00309166|80547718|FG000|Overall Study|Withdrawal by Subject|4|||
27646714|NCT00309166|80547719|FG001|Overall Study|Withdrawal by Subject|3|||
27646715|NCT01000805|80547723|FG000|Overall Study|Adverse Event|21|||
27646716|NCT01000805|80547724|FG001|Overall Study|Adverse Event|9|||
27646717|NCT01000805|80547723|FG000|Overall Study|Lack of Efficacy|5|||
27646718|NCT01000805|80547724|FG001|Overall Study|Lack of Efficacy|16|||
27646719|NCT01000805|80547723|FG000|Overall Study|Lost to Follow-up|16|||
27646720|NCT01000805|80547724|FG001|Overall Study|Lost to Follow-up|21|||
27646721|NCT01000805|80547723|FG000|Overall Study|Physician Decision|0|||
27646722|NCT01000805|80547724|FG001|Overall Study|Physician Decision|1|||
27646723|NCT01000805|80547723|FG000|Overall Study|Protocol Violation|12|||
27646724|NCT01000805|80547724|FG001|Overall Study|Protocol Violation|8|||
27646725|NCT01000805|80547723|FG000|Overall Study|Withdrawal by Subject|16|||
27646726|NCT01000805|80547724|FG001|Overall Study|Withdrawal by Subject|6|||
27646727|NCT01000805|80547723|FG000|Overall Study|Sponsor Decision|0|||
27646728|NCT01000805|80547724|FG001|Overall Study|Sponsor Decision|1|||
27646729|NCT03066609|80547727|FG000|INDUCTION|Pregnancy|0|||
27646730|NCT03066609|80547728|FG001|INDUCTION|Pregnancy|0|||
27646731|NCT03066609|80547729|FG002|INDUCTION|Pregnancy|1|||
27646732|NCT03066609|80547730|FG003|INDUCTION|Pregnancy|0|||
27646733|NCT03066609|80547727|FG000|INDUCTION|Lack of Efficacy|0|||
27646734|NCT03066609|80547728|FG001|INDUCTION|Lack of Efficacy|0|||
27646735|NCT03066609|80547729|FG002|INDUCTION|Lack of Efficacy|1|||
27746315|NCT03345836|80899609|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
27746316|NCT03345836|80899610|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
27746317|NCT03345836|80899605|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
27746318|NCT03345836|80899606|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
27942903|NCT04691115|81622587|FG013|Overall Study|Withdrawal by Subject|0|||
27646736|NCT03066609|80547730|FG003|INDUCTION|Lack of Efficacy|0|||
27646737|NCT03066609|80547727|FG000|INDUCTION|Adverse Event|2|||
27646738|NCT03066609|80547728|FG001|INDUCTION|Adverse Event|2|||
27646739|NCT03066609|80547729|FG002|INDUCTION|Adverse Event|0|||
27646740|NCT03066609|80547730|FG003|INDUCTION|Adverse Event|0|||
27646741|NCT03066609|80547727|FG000|MAINTENANCE|Adverse Event|0|||
27646742|NCT03066609|80547728|FG001|MAINTENANCE|Adverse Event|0|||
27646743|NCT03066609|80547729|FG002|MAINTENANCE|Adverse Event|0|||
27942904|NCT02691494|81622588|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
27942905|NCT02691494|81622589|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
27942906|NCT02691494|81622590|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
27942907|NCT02691494|81622588|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
27942908|NCT02691494|81622589|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
27942909|NCT02691494|81622590|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
27942910|NCT02691494|81622588|FG000|Post-Treatment Follow-Up Period|Other|2|||
27942911|NCT02691494|81622589|FG001|Post-Treatment Follow-Up Period|Other|1|||
27942912|NCT02691494|81622590|FG002|Post-Treatment Follow-Up Period|Other|1|||
27942913|NCT02691494|81622588|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
27942914|NCT02691494|81622589|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
27942915|NCT02691494|81622590|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
27942916|NCT02691494|81622588|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
27942917|NCT02691494|81622589|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
27942918|NCT02691494|81622590|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
27942919|NCT00468546|81622591|FG000|Week 24 Analysis|Lack of Efficacy|83|||
27942920|NCT00468546|81622592|FG001|Week 24 Analysis|Lack of Efficacy|37|||
27942921|NCT00468546|81622591|FG000|Week 24 Analysis|Refused treatment|5|||
27942922|NCT00468546|81622592|FG001|Week 24 Analysis|Refused treatment|5|||
27942923|NCT00468546|81622591|FG000|Week 24 Analysis|Adverse Event|1|||
27942924|NCT00468546|81622592|FG001|Week 24 Analysis|Adverse Event|8|||
27942925|NCT00468546|81622591|FG000|Week 24 Analysis|Failure to return|3|||
27942926|NCT00468546|81622592|FG001|Week 24 Analysis|Failure to return|4|||
27942927|NCT00468546|81622591|FG000|Week 24 Analysis|Rescue therapy|2|||
27942928|NCT00468546|81622592|FG001|Week 24 Analysis|Rescue therapy|0|||
27942929|NCT00468546|81622591|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
27942930|NCT00468546|81622592|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
27942931|NCT00468546|81622591|FG000|Week 24 Analysis|Due to clinical hold|1|||
27942932|NCT00468546|81622592|FG001|Week 24 Analysis|Due to clinical hold|0|||
27942933|NCT00468546|81622591|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
27942934|NCT00468546|81622592|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
27942935|NCT00468546|81622591|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
27942936|NCT00468546|81622592|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
27942937|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
27942938|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
27942939|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Death|1|||
27942940|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Death|0|||
27942941|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
27942942|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
27942943|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
27942944|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
27942945|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
27942946|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
27942947|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
27942948|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
27942949|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
27942950|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
27942951|NCT00468546|81622591|FG000|Week 24 to Week 104 Analysis|Other|17|||
27942952|NCT00468546|81622592|FG001|Week 24 to Week 104 Analysis|Other|14|||
27942953|NCT01772693|81622593|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
27942954|NCT01772693|81622594|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
27646744|NCT03066609|80547730|FG003|MAINTENANCE|Adverse Event|1|||
27646745|NCT03066609|80547727|FG000|MAINTENANCE|Withdrawal by Subject|4|||
27646746|NCT03066609|80547728|FG001|MAINTENANCE|Withdrawal by Subject|2|||
27646747|NCT03066609|80547729|FG002|MAINTENANCE|Withdrawal by Subject|1|||
27646748|NCT03066609|80547730|FG003|MAINTENANCE|Withdrawal by Subject|1|||
27646749|NCT03066609|80547727|FG000|MAINTENANCE|Lost to Follow-up|0|||
27646750|NCT03066609|80547728|FG001|MAINTENANCE|Lost to Follow-up|1|||
27646751|NCT03066609|80547729|FG002|MAINTENANCE|Lost to Follow-up|1|||
27646752|NCT03066609|80547730|FG003|MAINTENANCE|Lost to Follow-up|0|||
27646753|NCT03066609|80547727|FG000|MAINTENANCE|Pregnancy|1|||
27646754|NCT03066609|80547728|FG001|MAINTENANCE|Pregnancy|0|||
27646755|NCT03066609|80547729|FG002|MAINTENANCE|Pregnancy|0|||
27646756|NCT03066609|80547730|FG003|MAINTENANCE|Pregnancy|0|||
27646757|NCT03066609|80547727|FG000|MAINTENANCE|Lack of Efficacy|2|||
27942955|NCT01772693|81622593|FG000|Overall Study|Withdrawal by Subject|2|||
27942956|NCT01772693|81622594|FG001|Overall Study|Withdrawal by Subject|0|||
27646758|NCT03066609|80547728|FG001|MAINTENANCE|Lack of Efficacy|1|||
27646759|NCT03066609|80547729|FG002|MAINTENANCE|Lack of Efficacy|0|||
27646760|NCT03066609|80547730|FG003|MAINTENANCE|Lack of Efficacy|1|||
27646761|NCT03066609|80547727|FG000|OVERALL STUDY|Adverse Event|2|||
27942957|NCT01772693|81622593|FG000|Overall Study|Alternative Treatment|2|||
27646762|NCT03066609|80547728|FG001|OVERALL STUDY|Adverse Event|2|||
27646763|NCT03066609|80547729|FG002|OVERALL STUDY|Adverse Event|0|||
27942958|NCT01772693|81622594|FG001|Overall Study|Alternative Treatment|0|||
27942959|NCT03633058|81622599|FG000|Overall Study|Adverse Event|0|||
27942960|NCT03633058|81622600|FG001|Overall Study|Adverse Event|0|||
27942961|NCT03633058|81622601|FG002|Overall Study|Adverse Event|1|||
27942962|NCT03633058|81622602|FG003|Overall Study|Adverse Event|0|||
27942963|NCT01346592|81622606|FG000|Overall Study|Lost to Follow-up|62|||
27942964|NCT01346592|81622607|FG001|Overall Study|Lost to Follow-up|29|||
27942965|NCT01346592|81622608|FG002|Overall Study|Lost to Follow-up|29|||
27942966|NCT01346592|81622606|FG000|Overall Study|Protocol Violation|2|||
27942967|NCT01346592|81622607|FG001|Overall Study|Protocol Violation|1|||
27942968|NCT01346592|81622608|FG002|Overall Study|Protocol Violation|0|||
27942969|NCT01346592|81622606|FG000|Overall Study|Death|1|||
27942970|NCT01346592|81622607|FG001|Overall Study|Death|3|||
27942971|NCT01346592|81622608|FG002|Overall Study|Death|4|||
27942972|NCT01346592|81622606|FG000|Overall Study|Adverse Event|0|||
27942973|NCT01346592|81622607|FG001|Overall Study|Adverse Event|1|||
27942974|NCT01346592|81622608|FG002|Overall Study|Adverse Event|0|||
27942975|NCT01346592|81622606|FG000|Overall Study|Withdrawal by Subject|77|||
27942976|NCT01346592|81622607|FG001|Overall Study|Withdrawal by Subject|51|||
27942977|NCT01346592|81622608|FG002|Overall Study|Withdrawal by Subject|38|||
27942978|NCT01346592|81622606|FG000|Overall Study|Inappropriate enrollment|3|||
27942979|NCT01346592|81622607|FG001|Overall Study|Inappropriate enrollment|1|||
27942980|NCT01346592|81622608|FG002|Overall Study|Inappropriate enrollment|1|||
27942981|NCT01346592|81622606|FG000|Overall Study|Administrative reason|1|||
27942982|NCT01346592|81622607|FG001|Overall Study|Administrative reason|0|||
27942983|NCT01346592|81622608|FG002|Overall Study|Administrative reason|0|||
27942984|NCT01346592|81622606|FG000|Overall Study|Unable to Classify|7|||
27942985|NCT01346592|81622607|FG001|Overall Study|Unable to Classify|3|||
27942986|NCT01346592|81622608|FG002|Overall Study|Unable to Classify|6|||
27942987|NCT00987935|81624981|FG000|Overall Study|Progressive disease|3|||
27942988|NCT00987935|81624982|FG001|Overall Study|Progressive disease|2|||
27942989|NCT00987935|81624983|FG002|Overall Study|Progressive disease|3|||
27942990|NCT00987935|81624984|FG003|Overall Study|Progressive disease|2|||
27942991|NCT00987935|81624985|FG004|Overall Study|Progressive disease|5|||
27942992|NCT00987935|81624986|FG005|Overall Study|Progressive disease|3|||
27942993|NCT00987935|81624987|FG006|Overall Study|Progressive disease|9|||
27942994|NCT00987935|81624988|FG007|Overall Study|Progressive disease|48|||
27942995|NCT00987935|81624989|FG008|Overall Study|Progressive disease|23|||
27942996|NCT00987935|81624981|FG000|Overall Study|Adverse Event|0|||
27942997|NCT00987935|81624982|FG001|Overall Study|Adverse Event|1|||
27942998|NCT00987935|81624983|FG002|Overall Study|Adverse Event|0|||
27942999|NCT00987935|81624984|FG003|Overall Study|Adverse Event|1|||
27943000|NCT00987935|81624985|FG004|Overall Study|Adverse Event|1|||
27943001|NCT00987935|81624986|FG005|Overall Study|Adverse Event|0|||
27943002|NCT00987935|81624987|FG006|Overall Study|Adverse Event|2|||
27943003|NCT00987935|81624988|FG007|Overall Study|Adverse Event|10|||
27943004|NCT00987935|81624989|FG008|Overall Study|Adverse Event|6|||
27943005|NCT00987935|81624981|FG000|Overall Study|Refused to continue taking trial med.|1|||
27943006|NCT00987935|81624982|FG001|Overall Study|Refused to continue taking trial med.|0|||
27943007|NCT00987935|81624983|FG002|Overall Study|Refused to continue taking trial med.|0|||
27943008|NCT00987935|81624984|FG003|Overall Study|Refused to continue taking trial med.|0|||
27943009|NCT00987935|81624985|FG004|Overall Study|Refused to continue taking trial med.|1|||
27943010|NCT00987935|81624986|FG005|Overall Study|Refused to continue taking trial med.|0|||
27943011|NCT00987935|81624987|FG006|Overall Study|Refused to continue taking trial med.|4|||
27943012|NCT00987935|81624988|FG007|Overall Study|Refused to continue taking trial med.|4|||
27943013|NCT00987935|81624989|FG008|Overall Study|Refused to continue taking trial med.|2|||
27943014|NCT00987935|81624981|FG000|Overall Study|Reason other than those specified above|0|||
27943015|NCT00987935|81624982|FG001|Overall Study|Reason other than those specified above|0|||
27943016|NCT00987935|81624983|FG002|Overall Study|Reason other than those specified above|0|||
27943017|NCT00987935|81624984|FG003|Overall Study|Reason other than those specified above|0|||
27943018|NCT00987935|81624985|FG004|Overall Study|Reason other than those specified above|0|||
27943019|NCT00987935|81624986|FG005|Overall Study|Reason other than those specified above|0|||
27943020|NCT00987935|81624987|FG006|Overall Study|Reason other than those specified above|0|||
27943021|NCT00987935|81624988|FG007|Overall Study|Reason other than those specified above|0|||
27943022|NCT00987935|81624989|FG008|Overall Study|Reason other than those specified above|1|||
27943023|NCT00449787|81624993|FG000|Overall Study|Lost to Follow-up|10|||
27943024|NCT00449787|81624994|FG001|Overall Study|Lost to Follow-up|8|||
27943025|NCT00449787|81624993|FG000|Overall Study|Did not require medication|95|||
27943026|NCT00449787|81624994|FG001|Overall Study|Did not require medication|92|||
27943027|NCT05805150|81624999|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
27943028|NCT05805150|81625000|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
27943029|NCT01592747|81625005|FG000|Overall Study|Loss of Therapeutic Response|107|||
27943030|NCT01592747|81625006|FG001|Overall Study|Loss of Therapeutic Response|108|||
27943031|NCT01592747|81625007|FG002|Overall Study|Loss of Therapeutic Response|100|||
27646764|NCT03066609|80547730|FG003|OVERALL STUDY|Adverse Event|1|||
27646765|NCT03066609|80547727|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
27646766|NCT03066609|80547728|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
27646767|NCT03066609|80547729|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
27646768|NCT03066609|80547730|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
27646769|NCT03066609|80547727|FG000|OVERALL STUDY|Lost to Follow-up|1|||
27646770|NCT03066609|80547728|FG001|OVERALL STUDY|Lost to Follow-up|1|||
27646771|NCT03066609|80547729|FG002|OVERALL STUDY|Lost to Follow-up|1|||
27646772|NCT03066609|80547730|FG003|OVERALL STUDY|Lost to Follow-up|1|||
27646773|NCT03066609|80547727|FG000|OVERALL STUDY|Pregnancy|1|||
27646774|NCT03066609|80547728|FG001|OVERALL STUDY|Pregnancy|0|||
27646775|NCT03066609|80547729|FG002|OVERALL STUDY|Pregnancy|1|||
27646776|NCT03066609|80547730|FG003|OVERALL STUDY|Pregnancy|0|||
27646777|NCT03066609|80547727|FG000|OVERALL STUDY|Lack of Efficacy|2|||
27646778|NCT03066609|80547728|FG001|OVERALL STUDY|Lack of Efficacy|1|||
27646779|NCT03066609|80547729|FG002|OVERALL STUDY|Lack of Efficacy|1|||
27646780|NCT03066609|80547730|FG003|OVERALL STUDY|Lack of Efficacy|1|||
27646781|NCT03066609|80547727|FG000|OVERALL STUDY|discontinued follow up|0|||
27646782|NCT03066609|80547728|FG001|OVERALL STUDY|discontinued follow up|2|||
27646783|NCT03066609|80547729|FG002|OVERALL STUDY|discontinued follow up|0|||
27646784|NCT03066609|80547730|FG003|OVERALL STUDY|discontinued follow up|0|||
27646785|NCT02816398|80547736|FG000|Overall Study|Death|5|||
27646786|NCT02816398|80547736|FG000|Overall Study|Lack of Efficacy|8|||
27646787|NCT02816398|80547736|FG000|Overall Study|Lost to Follow-up|1|||
27646788|NCT02189759|80547737|FG000|Overall Study|Lost to Follow-up|0|||
27646789|NCT02189759|80547738|FG001|Overall Study|Lost to Follow-up|0|||
27646790|NCT02189759|80547739|FG002|Overall Study|Lost to Follow-up|2|||
27646791|NCT02189759|80547740|FG003|Overall Study|Lost to Follow-up|5|||
27646792|NCT00822120|80547743|FG000|Initial Registration|Adverse Event|1|||
27646793|NCT00822120|80547744|FG001|Initial Registration|Adverse Event|0|||
27646794|NCT00822120|80547745|FG002|Initial Registration|Adverse Event|0|||
27646795|NCT00822120|80547746|FG003|Initial Registration|Adverse Event|0|||
27646796|NCT00822120|80547747|FG004|Initial Registration|Adverse Event|0|||
27646797|NCT00822120|80547748|FG005|Initial Registration|Adverse Event|0|||
27646798|NCT00822120|80547743|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
27646799|NCT00822120|80547744|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27646800|NCT00822120|80547745|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27646801|NCT00822120|80547746|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27646802|NCT00822120|80547747|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27646803|NCT00822120|80547748|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
27646804|NCT00822120|80547743|FG000|Initial Registration|Reasons not Protocol Specified|2|||
27646805|NCT00822120|80547744|FG001|Initial Registration|Reasons not Protocol Specified|0|||
27646806|NCT00822120|80547745|FG002|Initial Registration|Reasons not Protocol Specified|0|||
27646807|NCT00822120|80547746|FG003|Initial Registration|Reasons not Protocol Specified|0|||
27646808|NCT00822120|80547747|FG004|Initial Registration|Reasons not Protocol Specified|0|||
27646809|NCT00822120|80547748|FG005|Initial Registration|Reasons not Protocol Specified|0|||
27646810|NCT00822120|80547743|FG000|Initial Registration|Ineligible|22|||
27646811|NCT00822120|80547744|FG001|Initial Registration|Ineligible|1|||
27943032|NCT01592747|81625005|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
27943033|NCT01592747|81625006|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
27943034|NCT01592747|81625007|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
27943035|NCT01592747|81625005|FG000|Overall Study|Adverse Event|1|||
27943036|NCT01592747|81625006|FG001|Overall Study|Adverse Event|0|||
27943037|NCT01592747|81625007|FG002|Overall Study|Adverse Event|0|||
27943038|NCT01592747|81625005|FG000|Overall Study|Protocol Violation|4|||
27943039|NCT01592747|81625006|FG001|Overall Study|Protocol Violation|0|||
27646812|NCT00822120|80547745|FG002|Initial Registration|Ineligible|0|||
27646813|NCT00822120|80547746|FG003|Initial Registration|Ineligible|0|||
27646814|NCT00822120|80547747|FG004|Initial Registration|Ineligible|0|||
27646815|NCT00822120|80547748|FG005|Initial Registration|Ineligible|0|||
27646816|NCT00822120|80547743|FG000|PET-directed Therapy|Adverse Event|0|||
27646817|NCT00822120|80547744|FG001|PET-directed Therapy|Adverse Event|0|||
27646818|NCT00822120|80547745|FG002|PET-directed Therapy|Adverse Event|0|||
27646819|NCT00822120|80547746|FG003|PET-directed Therapy|Adverse Event|1|||
27551357|NCT01543698|80207465|FG007|Phase 1b|Withdrawal by Subject|0|||
27646820|NCT00822120|80547747|FG004|PET-directed Therapy|Adverse Event|0|||
27646821|NCT00822120|80547748|FG005|PET-directed Therapy|Adverse Event|0|||
27646822|NCT00822120|80547743|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27646823|NCT00822120|80547744|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27646824|NCT00822120|80547745|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27646825|NCT00822120|80547746|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
27646826|NCT00822120|80547747|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27646827|NCT00822120|80547748|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
27646828|NCT00822120|80547743|FG000|PET-directed Therapy|Death|0|||
27646829|NCT00822120|80547744|FG001|PET-directed Therapy|Death|0|||
27646830|NCT00822120|80547745|FG002|PET-directed Therapy|Death|0|||
27646831|NCT00822120|80547746|FG003|PET-directed Therapy|Death|2|||
27646832|NCT00822120|80547747|FG004|PET-directed Therapy|Death|0|||
27646833|NCT00822120|80547748|FG005|PET-directed Therapy|Death|0|||
27646834|NCT00822120|80547743|FG000|PET-directed Therapy|Protocol Violation|0|||
27646835|NCT00822120|80547744|FG001|PET-directed Therapy|Protocol Violation|0|||
27646836|NCT00822120|80547745|FG002|PET-directed Therapy|Protocol Violation|0|||
27646837|NCT00822120|80547746|FG003|PET-directed Therapy|Protocol Violation|6|||
27646838|NCT00822120|80547747|FG004|PET-directed Therapy|Protocol Violation|0|||
27646839|NCT00822120|80547748|FG005|PET-directed Therapy|Protocol Violation|0|||
27646840|NCT04250636|80547752|FG000|Overall Study|Lost to Follow-up|2|||
27646841|NCT00526994|80547753|FG000|Overall Study|Lost to Follow-up|98|||
27646842|NCT00526994|80547754|FG001|Overall Study|Lost to Follow-up|108|||
27646843|NCT00526994|80547755|FG002|Overall Study|Lost to Follow-up|96|||
27646844|NCT00526994|80547753|FG000|Overall Study|Death|4|||
27646845|NCT00526994|80547754|FG001|Overall Study|Death|3|||
27646846|NCT00526994|80547755|FG002|Overall Study|Death|3|||
27646847|NCT00526994|80547753|FG000|Overall Study|Withdrawal by Subject|2|||
27646848|NCT00526994|80547754|FG001|Overall Study|Withdrawal by Subject|7|||
27646849|NCT00526994|80547755|FG002|Overall Study|Withdrawal by Subject|5|||
27646850|NCT00526994|80547753|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
27646851|NCT00526994|80547754|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
27646852|NCT00526994|80547755|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
27646853|NCT00452452|80547757|FG000|Overall Study|Protocol Violation|0|||
27646854|NCT00452452|80547758|FG001|Overall Study|Protocol Violation|0|||
27646855|NCT00452452|80547759|FG002|Overall Study|Protocol Violation|1|||
27646856|NCT00452452|80547757|FG000|Overall Study|Withdrawal by Subject|1|||
27646857|NCT00452452|80547758|FG001|Overall Study|Withdrawal by Subject|0|||
27646858|NCT00452452|80547759|FG002|Overall Study|Withdrawal by Subject|0|||
27646859|NCT00452452|80547757|FG000|Overall Study|Lost to Follow-up|1|||
27646860|NCT00452452|80547758|FG001|Overall Study|Lost to Follow-up|0|||
27646861|NCT00452452|80547759|FG002|Overall Study|Lost to Follow-up|0|||
27646862|NCT02260154|80547760|FG000|Overall Study|Screening failure|2|||
27646863|NCT03802994|80547764|FG000|Overall Study|Lost to Follow-up|0|||
27646864|NCT03802994|80547765|FG001|Overall Study|Lost to Follow-up|2|||
27646865|NCT03802994|80547766|FG002|Overall Study|Lost to Follow-up|3|||
27646866|NCT03802994|80547767|FG003|Overall Study|Lost to Follow-up|2|||
27646867|NCT03802994|80547768|FG004|Overall Study|Lost to Follow-up|2|||
27646868|NCT00345046|80547771|FG000|Overall Study|Protocol Violation|1|||
27646869|NCT00345046|80547772|FG001|Overall Study|Protocol Violation|1|||
27646870|NCT00345046|80547773|FG002|Overall Study|Protocol Violation|2|||
27646871|NCT01500200|80547776|FG000|Stage 1|Adverse Event|1|||
27646872|NCT01500200|80547777|FG001|Stage 1|Adverse Event|4|||
27646873|NCT01500200|80547778|FG002|Stage 1|Adverse Event|5|||
27646874|NCT01500200|80547779|FG003|Stage 1|Adverse Event|0|||
27646875|NCT01500200|80547780|FG004|Stage 1|Adverse Event|0|||
27646876|NCT01500200|80547781|FG005|Stage 1|Adverse Event|0|||
27646877|NCT01500200|80547776|FG000|Stage 1|Lost to Follow-up|2|||
27646878|NCT01500200|80547777|FG001|Stage 1|Lost to Follow-up|2|||
27646879|NCT01500200|80547778|FG002|Stage 1|Lost to Follow-up|1|||
27646880|NCT01500200|80547779|FG003|Stage 1|Lost to Follow-up|0|||
27646881|NCT01500200|80547780|FG004|Stage 1|Lost to Follow-up|0|||
27646882|NCT01500200|80547781|FG005|Stage 1|Lost to Follow-up|0|||
27646883|NCT01500200|80547776|FG000|Stage 1|Withdrawal by Subject|3|||
27646884|NCT01500200|80547777|FG001|Stage 1|Withdrawal by Subject|0|||
27646885|NCT01500200|80547778|FG002|Stage 1|Withdrawal by Subject|0|||
27646886|NCT01500200|80547779|FG003|Stage 1|Withdrawal by Subject|0|||
27943040|NCT01592747|81625007|FG002|Overall Study|Protocol Violation|4|||
27943041|NCT01592747|81625005|FG000|Overall Study|Lack of Efficacy|0|||
27943042|NCT01592747|81625006|FG001|Overall Study|Lack of Efficacy|1|||
27943043|NCT01592747|81625007|FG002|Overall Study|Lack of Efficacy|0|||
27646887|NCT01500200|80547780|FG004|Stage 1|Withdrawal by Subject|0|||
27646888|NCT01500200|80547781|FG005|Stage 1|Withdrawal by Subject|0|||
27646889|NCT01500200|80547776|FG000|Stage 1|Noncompliance with Study Drug|1|||
27646890|NCT01500200|80547777|FG001|Stage 1|Noncompliance with Study Drug|0|||
27646891|NCT01500200|80547778|FG002|Stage 1|Noncompliance with Study Drug|0|||
27646892|NCT01500200|80547779|FG003|Stage 1|Noncompliance with Study Drug|0|||
27646893|NCT01500200|80547780|FG004|Stage 1|Noncompliance with Study Drug|0|||
27646894|NCT01500200|80547781|FG005|Stage 1|Noncompliance with Study Drug|0|||
27646895|NCT01500200|80547776|FG000|Stage 1|Physician Decision|1|||
27646896|NCT01500200|80547777|FG001|Stage 1|Physician Decision|0|||
27646897|NCT01500200|80547778|FG002|Stage 1|Physician Decision|0|||
27646898|NCT01500200|80547779|FG003|Stage 1|Physician Decision|0|||
27646899|NCT01500200|80547780|FG004|Stage 1|Physician Decision|0|||
27646900|NCT01500200|80547781|FG005|Stage 1|Physician Decision|0|||
27646901|NCT01500200|80547776|FG000|Stage 2|Adverse Event|0|||
27646902|NCT01500200|80547777|FG001|Stage 2|Adverse Event|0|||
27646903|NCT01500200|80547778|FG002|Stage 2|Adverse Event|0|||
27646904|NCT01500200|80547779|FG003|Stage 2|Adverse Event|0|||
27646905|NCT01500200|80547780|FG004|Stage 2|Adverse Event|5|||
27943044|NCT01592747|81625005|FG000|Overall Study|Withdrawal by Subject|2|||
27943045|NCT01592747|81625006|FG001|Overall Study|Withdrawal by Subject|0|||
27943046|NCT01592747|81625007|FG002|Overall Study|Withdrawal by Subject|2|||
27943047|NCT01592747|81625005|FG000|Overall Study|Lost to Follow-up|1|||
27943048|NCT01592747|81625006|FG001|Overall Study|Lost to Follow-up|0|||
27943049|NCT01592747|81625007|FG002|Overall Study|Lost to Follow-up|1|||
27943050|NCT01592747|81625005|FG000|Overall Study|Other Reasons|1|||
27943051|NCT01592747|81625006|FG001|Overall Study|Other Reasons|1|||
27943052|NCT01592747|81625007|FG002|Overall Study|Other Reasons|0|||
27943053|NCT01959919|81625011|FG000|Overall Study|Did not meet the eligibility criteria|2|||
27943054|NCT01909453|81625012|FG000|Overall Study|Ongoing|118|||
27943055|NCT01909453|81625013|FG001|Overall Study|Ongoing|103|||
27943056|NCT01909453|81625014|FG002|Overall Study|Ongoing|83|||
27943057|NCT01909453|81625015|FG003|Overall Study|Ongoing|164|||
27943058|NCT01909453|81625016|FG004|Overall Study|Ongoing|50|||
27943059|NCT01909453|81625012|FG000|Overall Study|Death|69|||
27943060|NCT01909453|81625013|FG001|Overall Study|Death|74|||
27943061|NCT01909453|81625014|FG002|Overall Study|Death|88|||
27943062|NCT01909453|81625015|FG003|Overall Study|Death|86|||
27943063|NCT01909453|81625016|FG004|Overall Study|Death|29|||
27943064|NCT01909453|81625012|FG000|Overall Study|Lost to Follow-up|3|||
27943065|NCT01909453|81625013|FG001|Overall Study|Lost to Follow-up|4|||
27943066|NCT01909453|81625014|FG002|Overall Study|Lost to Follow-up|4|||
27943067|NCT01909453|81625015|FG003|Overall Study|Lost to Follow-up|3|||
27943068|NCT01909453|81625016|FG004|Overall Study|Lost to Follow-up|3|||
27943069|NCT01909453|81625012|FG000|Overall Study|Withdrawal by Subject|2|||
27943070|NCT01909453|81625013|FG001|Overall Study|Withdrawal by Subject|13|||
27943071|NCT01909453|81625014|FG002|Overall Study|Withdrawal by Subject|16|||
27943072|NCT01909453|81625015|FG003|Overall Study|Withdrawal by Subject|5|||
27943073|NCT01909453|81625016|FG004|Overall Study|Withdrawal by Subject|4|||
27943074|NCT03635996|81625019|FG000|Overall Study|Study terminated by Sponsor|94|||
27943075|NCT03635996|81625019|FG000|Overall Study|Withdrawal by Subject|20|||
27943076|NCT03635996|81625019|FG000|Overall Study|Ablation|26|||
27746319|NCT03345836|80899607|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
27746320|NCT03345836|80899608|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
27943077|NCT03635996|81625019|FG000|Overall Study|Adverse Event|7|||
27943078|NCT03635996|81625019|FG000|Overall Study|Physician Decision|3|||
27943079|NCT03635996|81625019|FG000|Overall Study|Prohibited medication|5|||
27943080|NCT03635996|81625019|FG000|Overall Study|Did not meet eligibility criteria|5|||
27943081|NCT03635996|81625019|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
27943082|NCT03635996|81625019|FG000|Overall Study|Protocol Violation|1|||
27943083|NCT03635996|81625019|FG000|Overall Study|Lost to Follow-up|1|||
27943084|NCT02272985|81625020|FG000|Overall Study|Withdrawal by Subject|1|||
27943085|NCT02272985|81625020|FG000|Overall Study|hip fracture|1|||
27943086|NCT02272985|81625020|FG000|Overall Study|kidney transplantation|1|||
27943087|NCT03052608|81625022|FG000|Treatment Phase|Adverse Event|10|||
27943088|NCT03052608|81625023|FG001|Treatment Phase|Adverse Event|12|||
27943089|NCT03052608|81625022|FG000|Treatment Phase|Death|6|||
27943090|NCT03052608|81625023|FG001|Treatment Phase|Death|4|||
27943091|NCT03052608|81625022|FG000|Treatment Phase|Withdrawal by Subject|4|||
27943092|NCT03052608|81625023|FG001|Treatment Phase|Withdrawal by Subject|12|||
27943093|NCT03052608|81625022|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
27943094|NCT03052608|81625023|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
27943095|NCT03052608|81625022|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
27943096|NCT03052608|81625023|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
27943097|NCT03052608|81625022|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
27943098|NCT03052608|81625023|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
27943099|NCT03052608|81625022|FG000|Treatment Phase|Ongoing|103|||
27943100|NCT03052608|81625023|FG001|Treatment Phase|Ongoing|31|||
27943101|NCT03052608|81625022|FG000|Long-Term Follow-up Phase|Death|23|||
27943102|NCT03052608|81625023|FG001|Long-Term Follow-up Phase|Death|28|||
27943103|NCT03052608|81625022|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
27943104|NCT03052608|81625023|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
27943105|NCT03052608|81625022|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
27943106|NCT03052608|81625023|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
27943107|NCT03052608|81625022|FG000|Long-Term Follow-up Phase|Ongoing|122|||
27943108|NCT03052608|81625023|FG001|Long-Term Follow-up Phase|Ongoing|99|||
27943109|NCT02904096|81625024|FG000|Overall Study|Adverse Event|1|||
27943110|NCT02904096|81625025|FG001|Overall Study|Adverse Event|0|||
27943111|NCT02904096|81625024|FG000|Overall Study|Withdrawal by Subject|4|||
27943112|NCT02904096|81625025|FG001|Overall Study|Withdrawal by Subject|3|||
27943113|NCT02904096|81625024|FG000|Overall Study|Lost to Follow-up|10|||
27943114|NCT02904096|81625025|FG001|Overall Study|Lost to Follow-up|17|||
27943115|NCT02904096|81625024|FG000|Overall Study|Non-compliant|3|||
27943116|NCT02904096|81625025|FG001|Overall Study|Non-compliant|1|||
27943117|NCT02904096|81625024|FG000|Overall Study|Sponsor instructed|1|||
27943118|NCT02904096|81625025|FG001|Overall Study|Sponsor instructed|0|||
27943119|NCT03794544|81625029|FG000|Overall Study|Withdrawal by Subject|1|||
27943120|NCT03794544|81625030|FG001|Overall Study|Withdrawal by Subject|1|||
27943121|NCT03794544|81625031|FG002|Overall Study|Withdrawal by Subject|0|||
27943122|NCT03794544|81625032|FG003|Overall Study|Withdrawal by Subject|0|||
27943123|NCT03794544|81625029|FG000|Overall Study|Death|0|||
27943124|NCT03794544|81625030|FG001|Overall Study|Death|0|||
27943125|NCT03794544|81625031|FG002|Overall Study|Death|0|||
27943126|NCT03794544|81625032|FG003|Overall Study|Death|1|||
27943127|NCT03794544|81625029|FG000|Overall Study|Lost to Follow-up|0|||
27943128|NCT03794544|81625030|FG001|Overall Study|Lost to Follow-up|1|||
27943129|NCT03794544|81625031|FG002|Overall Study|Lost to Follow-up|1|||
27943130|NCT03794544|81625032|FG003|Overall Study|Lost to Follow-up|0|||
27943131|NCT03794544|81625029|FG000|Overall Study|Other|0|||
27943132|NCT03794544|81625030|FG001|Overall Study|Other|1|||
27943133|NCT03794544|81625031|FG002|Overall Study|Other|0|||
27943134|NCT03794544|81625032|FG003|Overall Study|Other|0|||
27943135|NCT05252702|81625037|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
27943136|NCT05252702|81625037|FG000|Overall Study|Death|16|||
27943137|NCT05252702|81625037|FG000|Overall Study|System explant|5|||
27943138|NCT05252702|81625037|FG000|Overall Study|Lost to Follow-up|1|||
27943139|NCT05252702|81625037|FG000|Overall Study|Withdrawn by investigator|1|||
27943140|NCT05252702|81625037|FG000|Overall Study|Visit not due|306|||
27646906|NCT01500200|80547781|FG005|Stage 2|Adverse Event|4|||
27646907|NCT02613403|80547782|FG000|Overall Study|Lost to Follow-up|0|||
27646908|NCT02613403|80547783|FG001|Overall Study|Lost to Follow-up|1|||
27646909|NCT02613403|80547784|FG002|Overall Study|Lost to Follow-up|0|||
27943141|NCT05252702|81625037|FG000|Overall Study|Visit within window but not completed|92|||
27943142|NCT05252702|81625037|FG000|Overall Study|Unsuccessful implant|1|||
27943143|NCT00680914|81625038|FG000|Overall Study|Consent withdrawal|6|||
27943144|NCT00680914|81625039|FG001|Overall Study|Consent withdrawal|3|||
27943145|NCT00680914|81625038|FG000|Overall Study|Lost to Follow-up|4|||
27943146|NCT00680914|81625039|FG001|Overall Study|Lost to Follow-up|0|||
27943147|NCT00680914|81625038|FG000|Overall Study|serious adverse event (SAE)|0|||
27943148|NCT00680914|81625039|FG001|Overall Study|serious adverse event (SAE)|1|||
27943149|NCT04003389|81625040|FG000|Overall Study|Adverse Event|27|||
27943150|NCT04003389|81625041|FG001|Overall Study|Adverse Event|34|||
27943151|NCT04003389|81625042|FG002|Overall Study|Adverse Event|28|||
27943152|NCT04003389|81625040|FG000|Overall Study|Lost to Follow-up|39|||
27943153|NCT04003389|81625041|FG001|Overall Study|Lost to Follow-up|30|||
27943154|NCT04003389|81625042|FG002|Overall Study|Lost to Follow-up|33|||
27943155|NCT04003389|81625040|FG000|Overall Study|Protocol Violation|1|||
27943156|NCT04003389|81625041|FG001|Overall Study|Protocol Violation|6|||
27943157|NCT04003389|81625042|FG002|Overall Study|Protocol Violation|5|||
27943158|NCT04003389|81625040|FG000|Overall Study|Withdrawal by Subject|119|||
27943159|NCT04003389|81625041|FG001|Overall Study|Withdrawal by Subject|79|||
27943160|NCT04003389|81625042|FG002|Overall Study|Withdrawal by Subject|85|||
27943161|NCT04003389|81625040|FG000|Overall Study|Miscellaneous|14|||
27943162|NCT04003389|81625041|FG001|Overall Study|Miscellaneous|11|||
27943163|NCT04003389|81625042|FG002|Overall Study|Miscellaneous|14|||
27943164|NCT04003389|81625040|FG000|Overall Study|Participant did not receive study drug|1|||
27943165|NCT04003389|81625041|FG001|Overall Study|Participant did not receive study drug|0|||
27943166|NCT04003389|81625042|FG002|Overall Study|Participant did not receive study drug|0|||
27646910|NCT02613403|80547785|FG003|Overall Study|Lost to Follow-up|0|||
27646911|NCT02613403|80547786|FG004|Overall Study|Lost to Follow-up|0|||
27646912|NCT02613403|80547782|FG000|Overall Study|Withdrawal by Subject|2|||
27646913|NCT02613403|80547783|FG001|Overall Study|Withdrawal by Subject|0|||
27646914|NCT02613403|80547784|FG002|Overall Study|Withdrawal by Subject|0|||
27646915|NCT02613403|80547785|FG003|Overall Study|Withdrawal by Subject|0|||
27646916|NCT02613403|80547786|FG004|Overall Study|Withdrawal by Subject|0|||
27646917|NCT01091168|80547789|FG000|Overall Study|Progressive disease|250|||
27646918|NCT01091168|80547790|FG001|Overall Study|Progressive disease|234|||
27646919|NCT01091168|80547789|FG000|Overall Study|Adverse Event|21|||
27646920|NCT01091168|80547790|FG001|Overall Study|Adverse Event|24|||
27646921|NCT01091168|80547789|FG000|Overall Study|Lost to Follow-up|0|||
27746321|NCT03345836|80899609|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
27746322|NCT03345836|80899610|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
27943167|NCT01308788|81625052|FG000|2-year Treatment|medication change by treating physician|4|||
27646922|NCT01091168|80547790|FG001|Overall Study|Lost to Follow-up|1|||
27646923|NCT01091168|80547789|FG000|Overall Study|Physician, patient's decision, other|27|||
27646924|NCT01091168|80547790|FG001|Overall Study|Physician, patient's decision, other|37|||
27646925|NCT01641900|80547793|FG000|Overall Study|Withdrawal by Subject|2|||
27646926|NCT01641900|80547794|FG001|Overall Study|Withdrawal by Subject|2|||
27943168|NCT01308788|81625053|FG001|2-year Treatment|medication change by treating physician|11|||
27943169|NCT00663260|81625054|FG000|Overall Study|Lack of Efficacy|2|||
27943170|NCT00663260|81625055|FG001|Overall Study|Lack of Efficacy|0|||
27943171|NCT00663260|81625056|FG002|Overall Study|Lack of Efficacy|0|||
27943172|NCT00663260|81625054|FG000|Overall Study|Adverse Event|12|||
27943173|NCT00663260|81625055|FG001|Overall Study|Adverse Event|7|||
27646927|NCT02334215|80547798|FG000|Overall Study|Death|1|||
27646928|NCT02334215|80547799|FG001|Overall Study|Death|1|||
27646929|NCT02334215|80547800|FG002|Overall Study|Death|0|||
27646930|NCT02334215|80547798|FG000|Overall Study|Lost to Follow-up|1|||
27646931|NCT02334215|80547799|FG001|Overall Study|Lost to Follow-up|0|||
27646932|NCT02334215|80547800|FG002|Overall Study|Lost to Follow-up|4|||
27646933|NCT02334215|80547798|FG000|Overall Study|Withdrawal by Subject|2|||
27646934|NCT02334215|80547799|FG001|Overall Study|Withdrawal by Subject|2|||
27646935|NCT02334215|80547800|FG002|Overall Study|Withdrawal by Subject|1|||
27943174|NCT00663260|81625056|FG002|Overall Study|Adverse Event|6|||
27943175|NCT00663260|81625054|FG000|Overall Study|Withdrawal by Subject|3|||
27943176|NCT00663260|81625055|FG001|Overall Study|Withdrawal by Subject|1|||
27943177|NCT00663260|81625056|FG002|Overall Study|Withdrawal by Subject|6|||
27943178|NCT00663260|81625054|FG000|Overall Study|Death|1|||
27943179|NCT00663260|81625055|FG001|Overall Study|Death|0|||
27943180|NCT00663260|81625056|FG002|Overall Study|Death|1|||
27943181|NCT00663260|81625054|FG000|Overall Study|Lost to Follow-up|0|||
27943182|NCT00663260|81625055|FG001|Overall Study|Lost to Follow-up|1|||
27943183|NCT00663260|81625056|FG002|Overall Study|Lost to Follow-up|0|||
27943184|NCT00663260|81625054|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
27943185|NCT00663260|81625055|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
27943186|NCT00663260|81625056|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
27943187|NCT04875533|81625057|FG000|Overall Study|Adverse Event|6|||
27943188|NCT04875533|81625058|FG001|Overall Study|Adverse Event|4|||
27943189|NCT04875533|81625057|FG000|Overall Study|Protocol Violation|4|||
27943190|NCT04875533|81625058|FG001|Overall Study|Protocol Violation|0|||
27943191|NCT04875533|81625057|FG000|Overall Study|Withdrawal by Subject|8|||
27943192|NCT04875533|81625058|FG001|Overall Study|Withdrawal by Subject|5|||
27943193|NCT04875533|81625057|FG000|Overall Study|No longer meets eligibility criteria|1|||
27646936|NCT02334215|80547798|FG000|Overall Study|Not released from incarceration on time|3|||
27943194|NCT04875533|81625058|FG001|Overall Study|No longer meets eligibility criteria|0|||
27943195|NCT04875533|81625057|FG000|Overall Study|Other|0|||
27943196|NCT04875533|81625058|FG001|Overall Study|Other|2|||
27943197|NCT04985682|81625065|FG000|Overall Study|Withdrawal by Subject|1|||
27943198|NCT01882829|81625068|FG000|Overall Study|Adverse Event|4|||
27943199|NCT01882829|81625068|FG000|Overall Study|Protocol Violation|1|||
27646937|NCT02334215|80547799|FG001|Overall Study|Not released from incarceration on time|3|||
27646938|NCT02334215|80547800|FG002|Overall Study|Not released from incarceration on time|3|||
27943200|NCT01882829|81625068|FG000|Overall Study|Withdrawal by Subject|1|||
27943201|NCT04204902|81625073|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
27943202|NCT04204902|81625074|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
27646939|NCT02334215|80547798|FG000|Overall Study|Incarcerated|0|||
27646940|NCT02334215|80547799|FG001|Overall Study|Incarcerated|0|||
27646941|NCT02334215|80547800|FG002|Overall Study|Incarcerated|7|||
27646942|NCT01773993|80547801|FG000|Overall Study|No Visit After Treatment|35|||
27646943|NCT01084694|80547808|FG000|Overall Study|Withdrawal by Subject|2|||
27646944|NCT01084694|80547809|FG001|Overall Study|Withdrawal by Subject|1|||
27646945|NCT01084694|80547808|FG000|Overall Study|Death|2|||
27646946|NCT01084694|80547809|FG001|Overall Study|Death|12|||
27646947|NCT01084694|80547808|FG000|Overall Study|eligibility not maintained|2|||
27646948|NCT01084694|80547809|FG001|Overall Study|eligibility not maintained|7|||
27646949|NCT02502526|80547812|FG000|Overall Study|Lost to Follow-up|2|||
27646950|NCT02502526|80547813|FG001|Overall Study|Lost to Follow-up|2|||
27646951|NCT02502526|80547814|FG002|Overall Study|Lost to Follow-up|3|||
27646952|NCT02502526|80547812|FG000|Overall Study|Withdrawal by Subject|0|||
27646953|NCT02502526|80547813|FG001|Overall Study|Withdrawal by Subject|1|||
27646954|NCT02502526|80547814|FG002|Overall Study|Withdrawal by Subject|1|||
27646955|NCT02502526|80547812|FG000|Overall Study|Disqualified due to cataract grading|0|||
27646956|NCT02502526|80547813|FG001|Overall Study|Disqualified due to cataract grading|0|||
27646957|NCT02502526|80547814|FG002|Overall Study|Disqualified due to cataract grading|1|||
27646958|NCT02502526|80547812|FG000|Overall Study|Enrollment suspension|4|||
27746323|NCT03345836|80899605|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
27943203|NCT02363283|81625075|FG000|Overall Study|Withdrawal by Subject|1|||
27943204|NCT02363283|81625075|FG000|Overall Study|Not eligible due to transaminitis|1|||
27943205|NCT03574389|81625076|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
27943206|NCT03574389|81625077|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
27943207|NCT03574389|81625078|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
27646959|NCT02502526|80547813|FG001|Overall Study|Enrollment suspension|1|||
27943208|NCT03574389|81625079|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
27646960|NCT02502526|80547814|FG002|Overall Study|Enrollment suspension|1|||
27646961|NCT02568215|80547815|FG000|Overall Study|Death|1|||
27646962|NCT02568215|80547816|FG001|Overall Study|Death|2|||
27646963|NCT02568215|80547817|FG002|Overall Study|Death|0|||
27646964|NCT02568215|80547815|FG000|Overall Study|Physician Decision|2|||
27646965|NCT02568215|80547816|FG001|Overall Study|Physician Decision|2|||
27646966|NCT02568215|80547817|FG002|Overall Study|Physician Decision|2|||
27646967|NCT02568215|80547815|FG000|Overall Study|Lost to Follow-up|29|||
27646968|NCT02568215|80547816|FG001|Overall Study|Lost to Follow-up|32|||
27943209|NCT03574389|81625080|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
27943210|NCT03574389|81625081|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
27943211|NCT03574389|81625082|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
27943212|NCT03574389|81625076|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
27943213|NCT03574389|81625077|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
27943214|NCT03574389|81625078|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
27943215|NCT03574389|81625079|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
27943216|NCT03574389|81625080|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
27943217|NCT03574389|81625081|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
27943218|NCT03574389|81625082|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
27943219|NCT03574389|81625076|FG000|Vaccination Period|Other|6|||
27943220|NCT03574389|81625077|FG001|Vaccination Period|Other|0|||
27943221|NCT03574389|81625078|FG002|Vaccination Period|Other|0|||
27943222|NCT03574389|81625079|FG003|Vaccination Period|Other|0|||
27943223|NCT03574389|81625080|FG004|Vaccination Period|Other|0|||
27943224|NCT03574389|81625081|FG005|Vaccination Period|Other|0|||
27943225|NCT03574389|81625082|FG006|Vaccination Period|Other|0|||
27943226|NCT03574389|81625076|FG000|Vaccination Period|Adverse Event|0|||
27943227|NCT03574389|81625077|FG001|Vaccination Period|Adverse Event|1|||
27943228|NCT03574389|81625078|FG002|Vaccination Period|Adverse Event|0|||
27943229|NCT03574389|81625079|FG003|Vaccination Period|Adverse Event|0|||
27943230|NCT03574389|81625080|FG004|Vaccination Period|Adverse Event|0|||
27943231|NCT03574389|81625081|FG005|Vaccination Period|Adverse Event|0|||
27943232|NCT03574389|81625082|FG006|Vaccination Period|Adverse Event|0|||
27943233|NCT03574389|81625076|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
27943234|NCT03574389|81625077|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
27943235|NCT03574389|81625078|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
27943236|NCT03574389|81625079|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
27943237|NCT03574389|81625080|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
27943238|NCT03574389|81625081|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
27943239|NCT03574389|81625082|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
27943240|NCT04818229|81625083|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
27943241|NCT04818229|81625084|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
27943242|NCT04818229|81625085|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
27943243|NCT04818229|81625083|FG000|Overall Study|Adverse Event|3|||
27943244|NCT04818229|81625084|FG001|Overall Study|Adverse Event|1|||
27943245|NCT04818229|81625085|FG002|Overall Study|Adverse Event|1|||
27943246|NCT04818229|81625083|FG000|Overall Study|Withdrawal by Subject|0|||
27646969|NCT02568215|80547817|FG002|Overall Study|Lost to Follow-up|41|||
27943247|NCT04818229|81625084|FG001|Overall Study|Withdrawal by Subject|0|||
27943248|NCT04818229|81625085|FG002|Overall Study|Withdrawal by Subject|2|||
27943249|NCT04818229|81625083|FG000|Overall Study|Lost to Follow-up|0|||
27943250|NCT04818229|81625084|FG001|Overall Study|Lost to Follow-up|0|||
27943251|NCT04818229|81625085|FG002|Overall Study|Lost to Follow-up|1|||
27943252|NCT00563316|81625086|FG000|Overall Study|Adverse Event|2|||
27943253|NCT00563316|81625086|FG000|Overall Study|Physician Decision|1|||
27943254|NCT00563316|81625086|FG000|Overall Study|Lost to Follow-up|2|||
27943255|NCT00563316|81625086|FG000|Overall Study|Death|1|||
27943256|NCT00563316|81625086|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
27943257|NCT00563316|81625086|FG000|Overall Study|Other|1|||
27943258|NCT00662038|81625087|FG000|Overall Study|Reason not specified|3|||
27943259|NCT00662038|81625087|FG000|Overall Study|Withdrawn consent|22|||
27943260|NCT00662038|81625087|FG000|Overall Study|Withdrawal by Subject|83|||
27943261|NCT00662038|81625087|FG000|Overall Study|Sponsor decision|1|||
27943262|NCT00662038|81625087|FG000|Overall Study|Physician Decision|19|||
27943263|NCT00662038|81625087|FG000|Overall Study|Lung transplantation|44|||
27943264|NCT00662038|81625087|FG000|Overall Study|Lost to Follow-up|1|||
27943265|NCT00662038|81625087|FG000|Overall Study|Death|95|||
27943266|NCT00662038|81625087|FG000|Overall Study|Adverse Event|358|||
27943267|NCT00662038|81625087|FG000|Overall Study|Continued treatment|5|||
27943268|NCT01697501|81625088|FG000|Overall Study|Protocol Violation|2|||
27646970|NCT02568215|80547815|FG000|Overall Study|Withdrawal by Subject|21|||
27646971|NCT02568215|80547816|FG001|Overall Study|Withdrawal by Subject|19|||
27646972|NCT02568215|80547817|FG002|Overall Study|Withdrawal by Subject|22|||
27746324|NCT03345836|80899606|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
27646973|NCT02568215|80547815|FG000|Overall Study|Protocol Violation|1|||
27943269|NCT02395627|81625092|FG000|Overall Study|Withdrawal by Subject|0|||
27943270|NCT02395627|81625093|FG001|Overall Study|Withdrawal by Subject|2|||
27943271|NCT02395627|81625094|FG002|Overall Study|Withdrawal by Subject|0|||
27943272|NCT02395627|81625092|FG000|Overall Study|Did not receive pembrolizumab|3|||
27943273|NCT02395627|81625093|FG001|Overall Study|Did not receive pembrolizumab|1|||
27943274|NCT02395627|81625094|FG002|Overall Study|Did not receive pembrolizumab|0|||
27943275|NCT00661687|81625095|FG000|Overall Study|Study related symptoms and complaints|5|||
27943276|NCT00661687|81625095|FG000|Overall Study|Positive slit lamp findings|4|||
27943277|NCT00661687|81625095|FG000|Overall Study|Inability to maintain wearing schedule|3|||
27943278|NCT00661687|81625095|FG000|Overall Study|Physician Decision|1|||
27943279|NCT00661687|81625095|FG000|Overall Study|Adverse Event|2|||
27943280|NCT04487080|81625099|FG000|Overall Study|Withdrawal by Subject|19|||
27943281|NCT04487080|81625100|FG001|Overall Study|Withdrawal by Subject|18|||
27943282|NCT04487080|81625101|FG002|Overall Study|Withdrawal by Subject|13|||
27943283|NCT04487080|81625099|FG000|Overall Study|Lost to Follow-up|3|||
27943284|NCT04487080|81625100|FG001|Overall Study|Lost to Follow-up|1|||
27943285|NCT04487080|81625101|FG002|Overall Study|Lost to Follow-up|0|||
27943286|NCT04487080|81625099|FG000|Overall Study|Ongoing|313|||
27943287|NCT04487080|81625100|FG001|Overall Study|Ongoing|297|||
27943288|NCT04487080|81625101|FG002|Overall Study|Ongoing|149|||
27943289|NCT01122680|81625102|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
27943290|NCT01122680|81625103|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
27943291|NCT01122680|81625104|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
27943292|NCT01122680|81625105|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
27943293|NCT01122680|81625102|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
27943294|NCT01122680|81625103|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
27646974|NCT02568215|80547816|FG001|Overall Study|Protocol Violation|1|||
27646975|NCT02568215|80547817|FG002|Overall Study|Protocol Violation|0|||
27646976|NCT02568215|80547815|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
27646977|NCT02568215|80547816|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
27646978|NCT02568215|80547817|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
27646979|NCT02568215|80547815|FG000|Overall Study|Other|0|||
27646980|NCT02568215|80547816|FG001|Overall Study|Other|1|||
27646981|NCT02568215|80547817|FG002|Overall Study|Other|4|||
27646982|NCT01561300|80547818|FG000|Run in on Placebo|Adverse Event|1|||
27646983|NCT01561300|80547819|FG001|Run in on Placebo|Adverse Event|0|||
27646984|NCT02797132|80547822|FG000|Part A (15 Days)|Adverse Event|1|||
27646985|NCT02797132|80547822|FG000|Part B (24 Weeks)|Adverse Event|3|||
27646986|NCT01263496|80547823|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
27646987|NCT01263496|80547824|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27943295|NCT01122680|81625104|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
27943296|NCT01122680|81625105|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
27943297|NCT01122680|81625102|FG000|Period 1 (4 Weeks)|Other|1|||
27943298|NCT01122680|81625103|FG001|Period 1 (4 Weeks)|Other|1|||
27943299|NCT01122680|81625104|FG002|Period 1 (4 Weeks)|Other|0|||
27943300|NCT01122680|81625105|FG003|Period 1 (4 Weeks)|Other|0|||
27943301|NCT01122680|81625102|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
27943302|NCT01122680|81625103|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
27943303|NCT01122680|81625104|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
27943304|NCT01122680|81625105|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
27943305|NCT01122680|81625102|FG000|Period 2 (4 Weeks)|Other|1|||
27943306|NCT01122680|81625103|FG001|Period 2 (4 Weeks)|Other|0|||
27943307|NCT01122680|81625104|FG002|Period 2 (4 Weeks)|Other|0|||
27943308|NCT01122680|81625105|FG003|Period 2 (4 Weeks)|Other|0|||
27943309|NCT01122680|81625102|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
27943310|NCT01122680|81625103|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
27943311|NCT01122680|81625104|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
27943312|NCT01122680|81625105|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
27943313|NCT01122680|81625102|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27943314|NCT01122680|81625103|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
27943315|NCT01122680|81625104|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27943316|NCT01122680|81625105|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
27943317|NCT01791205|81625106|FG000|Phase II|Lack of Efficacy|6|||
27943318|NCT01791205|81625107|FG001|Phase II|Lack of Efficacy|0|||
27943319|NCT01791205|81625106|FG000|Phase II|Adverse Event|2|||
27943320|NCT01791205|81625107|FG001|Phase II|Adverse Event|0|||
27943321|NCT01791205|81625106|FG000|Phase II|Safety|1|||
27943322|NCT01791205|81625107|FG001|Phase II|Safety|0|||
27943323|NCT01791205|81625106|FG000|Phase II|Lost to Follow-up|1|||
27943324|NCT01791205|81625107|FG001|Phase II|Lost to Follow-up|0|||
27943325|NCT01791205|81625106|FG000|Phase II|Remission of disease|1|||
27943326|NCT01791205|81625107|FG001|Phase II|Remission of disease|0|||
27943327|NCT01791205|81625106|FG000|Phase II|Physician's decision|1|||
27943328|NCT01791205|81625107|FG001|Phase II|Physician's decision|0|||
27943329|NCT00913835|81625108|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
27943330|NCT00913835|81625109|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
27943331|NCT00913835|81625108|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
27943332|NCT00913835|81625109|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
27943333|NCT00913835|81625108|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
27943334|NCT00913835|81625109|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
27943335|NCT00913835|81625108|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
27943336|NCT00913835|81625109|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
27943337|NCT00913835|81625108|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
27943338|NCT00913835|81625109|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
27943339|NCT02202577|81625111|FG000|Overall Study|Lost to Follow-up|6|||
27943340|NCT02202577|81625112|FG001|Overall Study|Lost to Follow-up|16|||
27943341|NCT02202577|81625111|FG000|Overall Study|Protocol Violation|7|||
27943342|NCT02202577|81625112|FG001|Overall Study|Protocol Violation|3|||
27943343|NCT02727699|81625113|FG000|Overall Study|Adverse Event|2|||
27943344|NCT02727699|81625114|FG001|Overall Study|Adverse Event|0|||
27943345|NCT02727699|81625113|FG000|Overall Study|Withdrawal by Subject|5|||
27943346|NCT02727699|81625114|FG001|Overall Study|Withdrawal by Subject|3|||
27943347|NCT02727699|81625113|FG000|Overall Study|Protocol Violation|0|||
27943348|NCT02727699|81625114|FG001|Overall Study|Protocol Violation|1|||
27943349|NCT02727699|81625113|FG000|Overall Study|Physician Decision|0|||
27943350|NCT02727699|81625114|FG001|Overall Study|Physician Decision|1|||
27943351|NCT02727699|81625113|FG000|Overall Study|Lost to Follow-up|1|||
27943352|NCT02727699|81625114|FG001|Overall Study|Lost to Follow-up|0|||
27943353|NCT02727699|81625113|FG000|Overall Study|Sponsor Decision|1|||
27943354|NCT02727699|81625114|FG001|Overall Study|Sponsor Decision|0|||
27943355|NCT02180672|81625120|FG000|Overall Study|Lost to Follow-up|5|||
27943356|NCT02180672|81625121|FG001|Overall Study|Lost to Follow-up|7|||
27943357|NCT04629521|81625126|FG000|Overall Study|Death|1|||
27943358|NCT04629521|81625126|FG000|Overall Study|Lost to Follow-up|3|||
27943359|NCT04629521|81625126|FG000|Overall Study|Subject withdrew consent|3|||
27943360|NCT04629521|81625126|FG000|Overall Study|Enrolled in error|1|||
27943361|NCT01586910|81625127|FG000|Overall Study|Death|4|||
27943362|NCT01586910|81625128|FG001|Overall Study|Death|4|||
27943363|NCT01586910|81625127|FG000|Overall Study|Withdrawal by Subject|6|||
27943364|NCT01586910|81625128|FG001|Overall Study|Withdrawal by Subject|43|||
27943365|NCT01586910|81625127|FG000|Overall Study|Physician withdrew Subject|5|||
27943366|NCT01586910|81625128|FG001|Overall Study|Physician withdrew Subject|24|||
27943367|NCT01922895|81625129|FG000|Overall Study|Death|0|||
27943368|NCT01922895|81625130|FG001|Overall Study|Death|1|||
27943369|NCT01922895|81625129|FG000|Overall Study|Withdrawal by Subject|1|||
27646988|NCT01263496|80547825|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646989|NCT01263496|80547826|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646990|NCT01263496|80547827|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646991|NCT01263496|80547828|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646992|NCT01263496|80547829|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646993|NCT01263496|80547830|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646994|NCT01263496|80547831|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
27646995|NCT01263496|80547823|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27646996|NCT01263496|80547824|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27646997|NCT01263496|80547825|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27646998|NCT01263496|80547826|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
27646999|NCT01263496|80547827|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
27647000|NCT01263496|80547828|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27647001|NCT01263496|80547829|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27647002|NCT01263496|80547830|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27647003|NCT01263496|80547831|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
27647004|NCT01263496|80547823|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
27647005|NCT01263496|80547824|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
27647006|NCT01263496|80547825|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
27647007|NCT01263496|80547826|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
27943370|NCT01922895|81625130|FG001|Overall Study|Withdrawal by Subject|2|||
27943371|NCT01922895|81625129|FG000|Overall Study|Lost to Follow-up|5|||
27943372|NCT01922895|81625130|FG001|Overall Study|Lost to Follow-up|11|||
27943373|NCT00605657|81625133|FG000|Overall Study|Adverse Event|1|||
27943374|NCT00605657|81625133|FG000|Overall Study|Protocol Violation|1|||
27943375|NCT05715827|81625134|FG000|Overall Study|Physician Decision|0|||
27943376|NCT05715827|81625135|FG001|Overall Study|Physician Decision|1|||
27943377|NCT05715827|81625134|FG000|Overall Study|console communication error|0|||
27647008|NCT01263496|80547827|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
27647009|NCT01263496|80547828|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
27647010|NCT01263496|80547829|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
27647011|NCT01263496|80547830|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
27746325|NCT03345836|80899607|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
27746326|NCT03345836|80899608|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
27943378|NCT05715827|81625135|FG001|Overall Study|console communication error|1|||
27943379|NCT02093520|81625136|FG000|Overall Study|Not treated|6|||
27943380|NCT02093520|81625137|FG001|Overall Study|Not treated|22|||
27943381|NCT00635050|81625138|FG000|Overall Study|Withdrawal by Subject|1|||
27943382|NCT01730729|81625139|FG000|Overall Study|Adverse Event|1|||
27943383|NCT01730729|81625139|FG000|Overall Study|Death|1|||
27943384|NCT01730729|81625139|FG000|Overall Study|Progressive Disease|12|||
27943385|NCT04280783|81625140|FG000|Overall Study|Family issues unrelated to the study.|1|||
27943386|NCT04280783|81625141|FG001|Overall Study|Family issues unrelated to the study.|0|||
27943387|NCT04280783|81625140|FG000|Overall Study|Withdrawal by Subject|0|||
27943388|NCT04280783|81625141|FG001|Overall Study|Withdrawal by Subject|1|||
27943389|NCT00488293|81625142|FG000|Overall Study|Lost to Follow-up|28|||
27943390|NCT00488293|81625143|FG001|Overall Study|Lost to Follow-up|25|||
27647012|NCT01263496|80547831|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
27647013|NCT01263496|80547823|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647014|NCT01263496|80547824|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
27647015|NCT01263496|80547825|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647016|NCT01263496|80547826|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647017|NCT01263496|80547827|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647018|NCT01263496|80547828|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647019|NCT01263496|80547829|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647020|NCT01263496|80547830|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647021|NCT01263496|80547831|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
27647022|NCT01263496|80547823|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27647023|NCT01263496|80547824|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27647024|NCT01263496|80547825|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27647025|NCT01263496|80547826|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
27746327|NCT03345836|80899609|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
27746328|NCT03345836|80899610|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
27746329|NCT03345836|80899605|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
27746330|NCT03345836|80899606|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
27746331|NCT03345836|80899607|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
27746332|NCT03345836|80899608|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
27746333|NCT03345836|80899609|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
27746334|NCT03345836|80899610|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
27746335|NCT03345836|80899605|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
27746336|NCT03345836|80899606|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
27746337|NCT03345836|80899607|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
27746338|NCT03345836|80899608|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
27746339|NCT03345836|80899609|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
27746340|NCT03345836|80899610|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
27746341|NCT03345836|80899605|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
27746342|NCT03345836|80899606|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
27746343|NCT03345836|80899607|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
27746344|NCT03345836|80899608|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
27746345|NCT03345836|80899609|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
27746346|NCT03345836|80899610|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
27746347|NCT03345836|80899605|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
27746348|NCT03345836|80899606|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
27746349|NCT03345836|80899607|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
27746350|NCT03345836|80899608|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
27746351|NCT03345836|80899609|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
27746352|NCT03345836|80899610|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
27746353|NCT03345836|80899605|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
27746354|NCT03345836|80899606|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
27746355|NCT03345836|80899607|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
27746356|NCT03345836|80899608|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
27746357|NCT03345836|80899609|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
27943391|NCT00488293|81625142|FG000|Overall Study|Withdrawal by Subject|5|||
27943392|NCT00488293|81625143|FG001|Overall Study|Withdrawal by Subject|3|||
27943393|NCT00488293|81625142|FG000|Overall Study|Death|2|||
27943394|NCT00488293|81625143|FG001|Overall Study|Death|1|||
27943395|NCT00488293|81625142|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
27943396|NCT00488293|81625143|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
27943397|NCT03766906|81625144|FG000|Overall Study|Withdrawal by Subject|6|||
27943398|NCT04620668|81625145|FG000|Overall Study|Withdrawal by Subject|2|||
27943399|NCT04620668|81625146|FG001|Overall Study|Withdrawal by Subject|0|||
27943400|NCT04620668|81625145|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
27943401|NCT04620668|81625146|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
27647026|NCT01263496|80547827|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
27647027|NCT01263496|80547828|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27647028|NCT01263496|80547829|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27746358|NCT03345836|80899610|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
27943402|NCT04620668|81625145|FG000|Overall Study|Removed before analysis: missing data|2|||
27943403|NCT04620668|81625146|FG001|Overall Study|Removed before analysis: missing data|0|||
27647029|NCT01263496|80547830|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
27647030|NCT01263496|80547831|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
27647031|NCT01263496|80547823|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
27647032|NCT01263496|80547824|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
27647033|NCT01263496|80547825|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
27647034|NCT01263496|80547826|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27647035|NCT01263496|80547827|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
27647036|NCT01263496|80547828|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27647037|NCT01263496|80547829|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27647038|NCT01263496|80547830|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
27647039|NCT01263496|80547831|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
27647040|NCT01263496|80547823|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647041|NCT01263496|80547824|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647042|NCT01263496|80547825|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647043|NCT01263496|80547826|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647044|NCT01263496|80547827|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647045|NCT01263496|80547828|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647046|NCT01263496|80547829|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647047|NCT01263496|80547830|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
27647048|NCT01263496|80547831|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
27647049|NCT01736475|80547836|FG000|Overall Study|Adverse Event|4|||
27647050|NCT01736475|80547837|FG001|Overall Study|Adverse Event|0|||
27647051|NCT01736475|80547836|FG000|Overall Study|Withdrawal by Subject|2|||
27647052|NCT01736475|80547837|FG001|Overall Study|Withdrawal by Subject|0|||
27647053|NCT01736475|80547836|FG000|Overall Study|Protocol Violation|4|||
27647054|NCT01736475|80547837|FG001|Overall Study|Protocol Violation|0|||
27647055|NCT01736475|80547836|FG000|Overall Study|Other - Screen failure|1|||
27647056|NCT01736475|80547837|FG001|Overall Study|Other - Screen failure|0|||
27647057|NCT01736475|80547836|FG000|Overall Study|Other - Surgical procedure|1|||
27647058|NCT01736475|80547837|FG001|Overall Study|Other - Surgical procedure|0|||
27647059|NCT00372775|80547840|FG000|Overall Study|Adverse Event|8|||
27647060|NCT00372775|80547840|FG000|Overall Study|Death|15|||
27647061|NCT00372775|80547840|FG000|Overall Study|Objective progression or relapse|30|||
27647062|NCT00372775|80547840|FG000|Overall Study|Global deterioration of health status|6|||
27647063|NCT00372775|80547840|FG000|Overall Study|Withdrawal by Subject|1|||
27647064|NCT00372775|80547840|FG000|Overall Study|Other|1|||
27647065|NCT00372775|80547840|FG000|Overall Study|Not Treated|2|||
27647066|NCT02159352|80547841|FG000|Overall Study|Adverse Event|3|||
27647067|NCT02159352|80547842|FG001|Overall Study|Adverse Event|1|||
27647068|NCT02159352|80547841|FG000|Overall Study|Withdrawal by Subject|0|||
27943404|NCT04620668|81625145|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
27943405|NCT04620668|81625146|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
27943406|NCT04620668|81625145|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
27943407|NCT04620668|81625146|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
27943408|NCT01428713|81625148|FG000|Overall Study|Non-compliance|2|||
27943409|NCT01428713|81625149|FG001|Overall Study|Non-compliance|2|||
27943410|NCT01428713|81625148|FG000|Overall Study|Withdrawal by Subject|1|||
27943411|NCT01428713|81625149|FG001|Overall Study|Withdrawal by Subject|1|||
27943412|NCT01428713|81625148|FG000|Overall Study|Adverse Event|0|||
27943413|NCT01428713|81625149|FG001|Overall Study|Adverse Event|2|||
27943414|NCT03400787|81625150|FG000|Overall Study|Lost to Follow-up|1|||
27943415|NCT03400787|81625151|FG001|Overall Study|Lost to Follow-up|0|||
27943416|NCT03400787|81625150|FG000|Overall Study|Death|1|||
27943417|NCT03400787|81625151|FG001|Overall Study|Death|0|||
27943418|NCT03400787|81625150|FG000|Overall Study|Protocol Violation|0|||
27647069|NCT02159352|80547842|FG001|Overall Study|Withdrawal by Subject|1|||
27647070|NCT02347332|80547843|FG000|Overall Study|Not treated|5|||
27647071|NCT02347332|80547844|FG001|Overall Study|Not treated|2|||
27647072|NCT02347332|80547843|FG000|Overall Study|Progressive disease|141|||
27647073|NCT02347332|80547844|FG001|Overall Study|Progressive disease|159|||
27943419|NCT03400787|81625151|FG001|Overall Study|Protocol Violation|2|||
27943420|NCT03400787|81625150|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
27943421|NCT03400787|81625151|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
27943422|NCT00908141|81625152|FG000|Overall Study|Withdrawal by Subject|0|||
27943423|NCT00908141|81625153|FG001|Overall Study|Withdrawal by Subject|1|||
27943424|NCT01044459|81625154|FG000|Overall Study|Withdrawal by Subject|21|||
27647074|NCT02347332|80547843|FG000|Overall Study|Adverse Event|50|||
27647075|NCT02347332|80547844|FG001|Overall Study|Adverse Event|41|||
27647076|NCT02347332|80547843|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
27647077|NCT02347332|80547844|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
27647078|NCT02347332|80547843|FG000|Overall Study|Protocol Violation|1|||
27647079|NCT02347332|80547844|FG001|Overall Study|Protocol Violation|1|||
27647080|NCT02347332|80547843|FG000|Overall Study|Lost to Follow-up|2|||
27647081|NCT02347332|80547844|FG001|Overall Study|Lost to Follow-up|1|||
27647082|NCT02347332|80547843|FG000|Overall Study|Physician Decision|4|||
27647083|NCT02347332|80547844|FG001|Overall Study|Physician Decision|3|||
27647084|NCT02347332|80547843|FG000|Overall Study|Withdrawal by Subject|20|||
27647085|NCT02347332|80547844|FG001|Overall Study|Withdrawal by Subject|14|||
27647086|NCT02347332|80547843|FG000|Overall Study|Protocol requirement|1|||
27647087|NCT02347332|80547844|FG001|Overall Study|Protocol requirement|1|||
27647088|NCT02347332|80547843|FG000|Overall Study|Switch Post-Trial program|0|||
27647089|NCT02347332|80547844|FG001|Overall Study|Switch Post-Trial program|1|||
27647090|NCT03567616|80547845|FG000|Overall Study|Disease progression|4|||
27647091|NCT03567616|80547845|FG000|Overall Study|Withdrawal by Subject|1|||
27647092|NCT03567616|80547845|FG000|Overall Study|Physician Decision|1|||
27647093|NCT03567616|80547845|FG000|Overall Study|Death|1|||
27647094|NCT03567616|80547845|FG000|Overall Study|Adverse Event|1|||
27647095|NCT02063659|80547846|FG000|Double-Blind Treatment Period|Adverse Event|1|||
27647096|NCT02063659|80547847|FG001|Double-Blind Treatment Period|Adverse Event|2|||
27647097|NCT02063659|80547848|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27647098|NCT02063659|80547849|FG003|Double-Blind Treatment Period|Adverse Event|0|||
27647099|NCT02063659|80547846|FG000|Double-Blind Treatment Period|Physician Decision|1|||
27647100|NCT02063659|80547847|FG001|Double-Blind Treatment Period|Physician Decision|0|||
27647101|NCT02063659|80547848|FG002|Double-Blind Treatment Period|Physician Decision|0|||
27647102|NCT02063659|80547849|FG003|Double-Blind Treatment Period|Physician Decision|0|||
27647103|NCT02063659|80547846|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
27647104|NCT02063659|80547847|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
27647105|NCT02063659|80547848|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
27647106|NCT02063659|80547849|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
27647107|NCT02063659|80547846|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
27647108|NCT02063659|80547847|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
27647109|NCT02063659|80547848|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
27647110|NCT02063659|80547849|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
27647111|NCT02063659|80547846|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27647112|NCT02063659|80547847|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27647113|NCT02063659|80547848|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
27647114|NCT02063659|80547849|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
27647115|NCT02063659|80547846|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27647116|NCT02063659|80547847|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27647117|NCT02063659|80547848|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
27647118|NCT02063659|80547849|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
27647119|NCT02063659|80547846|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
27647120|NCT02063659|80547847|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
27647121|NCT02063659|80547848|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
27647122|NCT02063659|80547849|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
27647123|NCT02063659|80547846|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27647124|NCT02063659|80547847|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27647125|NCT02063659|80547848|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
27647126|NCT02063659|80547849|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
27647127|NCT02091752|80547855|FG000|Overall Study|Study terminated by Sponsor|2|||
27647128|NCT02091752|80547855|FG000|Overall Study|Adverse Event|1|||
27647129|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
27647130|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
27647131|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
27647132|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
27647133|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
27647134|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
27647135|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
27647136|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
27647137|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
27647138|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
27647139|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
27647140|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
27647141|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
27647142|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
27647143|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
27647144|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27647145|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
27647146|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27551358|NCT01543698|80207466|FG008|Phase 1b|Withdrawal by Subject|0|||
27647147|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27647148|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
27647149|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
27647150|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
27647151|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
27647152|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
27647153|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
27647154|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Other|1|||
27647155|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Other|0|||
27647156|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Other|0|||
27647157|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Other|0|||
27647158|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Other|0|||
27647159|NCT02386098|80547858|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
27647160|NCT02386098|80547859|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
27647161|NCT02386098|80547860|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
27647162|NCT02386098|80547861|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
27647163|NCT02386098|80547862|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
27647164|NCT00571649|80547863|FG000|Treatment Period|Adverse Event|438|||
27647165|NCT00571649|80547864|FG001|Treatment Period|Adverse Event|385|||
27647166|NCT00571649|80547863|FG000|Treatment Period|Clinical endpoint reached|50|||
27647167|NCT00571649|80547864|FG001|Treatment Period|Clinical endpoint reached|56|||
27943425|NCT01044459|81625155|FG001|Overall Study|Withdrawal by Subject|28|||
27943426|NCT01044459|81625154|FG000|Overall Study|Terminated by Sponsor|22|||
27943427|NCT01044459|81625155|FG001|Overall Study|Terminated by Sponsor|21|||
27943428|NCT01044459|81625154|FG000|Overall Study|Adverse Event|22|||
27943429|NCT01044459|81625155|FG001|Overall Study|Adverse Event|20|||
27943430|NCT01044459|81625154|FG000|Overall Study|Lack of Efficacy|23|||
27943431|NCT01044459|81625155|FG001|Overall Study|Lack of Efficacy|12|||
27943432|NCT01044459|81625154|FG000|Overall Study|Protocol Violation|11|||
27943433|NCT01044459|81625155|FG001|Overall Study|Protocol Violation|16|||
27943434|NCT01044459|81625154|FG000|Overall Study|Other Reason|7|||
27943435|NCT01044459|81625155|FG001|Overall Study|Other Reason|14|||
27943436|NCT01044459|81625154|FG000|Overall Study|COPD exacerbation|9|||
27943437|NCT01044459|81625155|FG001|Overall Study|COPD exacerbation|8|||
27943438|NCT01044459|81625154|FG000|Overall Study|Lost to Follow-up|18|||
27943439|NCT01044459|81625155|FG001|Overall Study|Lost to Follow-up|12|||
27943440|NCT02913326|81625156|FG000|Overall Study|Reason not listed|0|||
27943441|NCT02913326|81625157|FG001|Overall Study|Reason not listed|1|||
27943442|NCT02913326|81625156|FG000|Overall Study|Lost to Follow-up|0|||
27943443|NCT02913326|81625157|FG001|Overall Study|Lost to Follow-up|1|||
27943444|NCT02913326|81625156|FG000|Overall Study|Adverse Event|1|||
27943445|NCT02913326|81625157|FG001|Overall Study|Adverse Event|0|||
27943446|NCT00382863|81625161|FG000|Overall Study|Death|9|||
27943447|NCT00382863|81625162|FG001|Overall Study|Death|9|||
27943448|NCT00382863|81625161|FG000|Overall Study|Lost to Follow-up|1|||
27943449|NCT00382863|81625162|FG001|Overall Study|Lost to Follow-up|2|||
27943450|NCT00382863|81625161|FG000|Overall Study|Withdrawal by Subject|5|||
27943451|NCT00382863|81625162|FG001|Overall Study|Withdrawal by Subject|25|||
27943452|NCT01714063|81625163|FG000|Overall Study|Equipment malfunction|2|||
27943453|NCT02414841|81625164|FG000|Overall Study|Withdrawal by Subject|7|||
27943454|NCT02414841|81625165|FG001|Overall Study|Withdrawal by Subject|5|||
27943455|NCT02414841|81625164|FG000|Overall Study|Lost to Follow-up|13|||
27943456|NCT02414841|81625165|FG001|Overall Study|Lost to Follow-up|6|||
27943457|NCT02414841|81625164|FG000|Overall Study|Death|17|||
27943458|NCT02414841|81625165|FG001|Overall Study|Death|14|||
27943459|NCT02414841|81625164|FG000|Overall Study|Received a Kidney Transplant|13|||
27943460|NCT02414841|81625165|FG001|Overall Study|Received a Kidney Transplant|4|||
27943461|NCT02414841|81625164|FG000|Overall Study|Randomized But Not Treated|6|||
27551359|NCT01543698|80207467|FG009|Phase 1b|Withdrawal by Subject|0|||
27647168|NCT00571649|80547863|FG000|Treatment Period|Withdrawal by Subject|285|||
27647169|NCT00571649|80547864|FG001|Treatment Period|Withdrawal by Subject|255|||
27647170|NCT00571649|80547863|FG000|Treatment Period|Death|76|||
27647171|NCT00571649|80547864|FG001|Treatment Period|Death|59|||
27647172|NCT00571649|80547863|FG000|Treatment Period|Physician Decision|8|||
27647173|NCT00571649|80547864|FG001|Treatment Period|Physician Decision|9|||
27647174|NCT00571649|80547863|FG000|Treatment Period|Lost to Follow-up|43|||
27647175|NCT00571649|80547864|FG001|Treatment Period|Lost to Follow-up|41|||
27647176|NCT00571649|80547863|FG000|Treatment Period|Non-compliant with study medication|88|||
27647177|NCT00571649|80547864|FG001|Treatment Period|Non-compliant with study medication|89|||
27647178|NCT00571649|80547863|FG000|Treatment Period|Patient convenience|11|||
27647179|NCT00571649|80547864|FG001|Treatment Period|Patient convenience|13|||
27647180|NCT00571649|80547863|FG000|Treatment Period|Protocol Violation|90|||
27943462|NCT02414841|81625165|FG001|Overall Study|Randomized But Not Treated|4|||
27943463|NCT02757963|81625166|FG000|Overall Study|Adverse Event|3|||
27647181|NCT00571649|80547864|FG001|Treatment Period|Protocol Violation|92|||
27647182|NCT00571649|80547863|FG000|Treatment Period|Technical problems|3|||
27647183|NCT00571649|80547864|FG001|Treatment Period|Technical problems|5|||
27647184|NCT00571649|80547863|FG000|Follow-up Period|Adverse Event|46|||
27647185|NCT00571649|80547864|FG001|Follow-up Period|Adverse Event|40|||
27647186|NCT00571649|80547863|FG000|Follow-up Period|Clinical endpoint reached|5|||
27647187|NCT00571649|80547864|FG001|Follow-up Period|Clinical endpoint reached|2|||
27943464|NCT02757963|81625166|FG000|Overall Study|Reached Stopping Criteria|1054|||
27943465|NCT02757963|81625166|FG000|Overall Study|Lost to Follow-up|5|||
27647188|NCT00571649|80547863|FG000|Follow-up Period|Withdrawal by Subject|119|||
27647189|NCT00571649|80547864|FG001|Follow-up Period|Withdrawal by Subject|115|||
27647190|NCT00571649|80547863|FG000|Follow-up Period|Death|132|||
27647191|NCT00571649|80547864|FG001|Follow-up Period|Death|133|||
27647192|NCT00571649|80547863|FG000|Follow-up Period|Physician Decision|7|||
27647193|NCT00571649|80547864|FG001|Follow-up Period|Physician Decision|13|||
27647194|NCT00571649|80547863|FG000|Follow-up Period|Lost to Follow-up|95|||
27647195|NCT00571649|80547864|FG001|Follow-up Period|Lost to Follow-up|92|||
27647196|NCT00571649|80547863|FG000|Follow-up Period|Patient convenience|136|||
27647197|NCT00571649|80547864|FG001|Follow-up Period|Patient convenience|121|||
27647198|NCT00571649|80547863|FG000|Follow-up Period|Protocol Violation|5|||
27647199|NCT00571649|80547864|FG001|Follow-up Period|Protocol Violation|12|||
27647200|NCT00273052|80547865|FG000|Overall Study|Withdrawal by Subject|16|||
27647201|NCT00273052|80547866|FG001|Overall Study|Withdrawal by Subject|19|||
27647202|NCT00273052|80547865|FG000|Overall Study|Adverse Event|21|||
27647203|NCT00273052|80547866|FG001|Overall Study|Adverse Event|19|||
27647204|NCT00273052|80547865|FG000|Overall Study|Protocol Violation|14|||
27647205|NCT00273052|80547866|FG001|Overall Study|Protocol Violation|18|||
27647206|NCT00273052|80547865|FG000|Overall Study|Lost to Follow-up|7|||
27647207|NCT00273052|80547866|FG001|Overall Study|Lost to Follow-up|25|||
27647208|NCT00273052|80547865|FG000|Overall Study|Lack of Efficacy|6|||
27647209|NCT00273052|80547866|FG001|Overall Study|Lack of Efficacy|4|||
27647210|NCT00273052|80547865|FG000|Overall Study|Non-Compliance|3|||
27647211|NCT00273052|80547866|FG001|Overall Study|Non-Compliance|1|||
27647212|NCT00273052|80547865|FG000|Overall Study|Other|2|||
27647213|NCT00273052|80547866|FG001|Overall Study|Other|0|||
27647214|NCT00273052|80547865|FG000|Overall Study|Worsening serum lipid levels|0|||
27647215|NCT00273052|80547866|FG001|Overall Study|Worsening serum lipid levels|2|||
27647216|NCT01759862|80547875|FG000|Overall Study|Physician Decision|3|||
27647217|NCT01759862|80547876|FG001|Overall Study|Physician Decision|1|||
27647218|NCT01759862|80547875|FG000|Overall Study|Adverse Event|0|||
27647219|NCT01759862|80547876|FG001|Overall Study|Adverse Event|1|||
27647220|NCT00605306|80547878|FG000|Overall Study|Adverse Event|0|||
27647221|NCT00605306|80547879|FG001|Overall Study|Adverse Event|1|||
27647222|NCT00738400|80547882|FG000|Overall Study|Adverse Event|3|||
27647223|NCT00738400|80547883|FG001|Overall Study|Adverse Event|1|||
27943466|NCT02757963|81625166|FG000|Overall Study|Physician Decision|1|||
27943467|NCT02757963|81625166|FG000|Overall Study|Withdrawal by Subject|34|||
27943468|NCT04115293|81625167|FG000|Overall Study|Adverse Event|0|||
27943469|NCT04115293|81625168|FG001|Overall Study|Adverse Event|2|||
27647224|NCT00738400|80547882|FG000|Overall Study|Withdrawal by Subject|0|||
27647225|NCT00738400|80547883|FG001|Overall Study|Withdrawal by Subject|1|||
27647226|NCT00738400|80547882|FG000|Overall Study|Lack of Efficacy|0|||
27647227|NCT00738400|80547883|FG001|Overall Study|Lack of Efficacy|1|||
27647228|NCT00738400|80547882|FG000|Overall Study|Lost to Follow-up|0|||
27647229|NCT00738400|80547883|FG001|Overall Study|Lost to Follow-up|3|||
27746359|NCT03345836|80899605|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
27943470|NCT04115293|81625167|FG000|Overall Study|Withdrawal by Subject|2|||
27943471|NCT04115293|81625168|FG001|Overall Study|Withdrawal by Subject|1|||
27943472|NCT04115293|81625167|FG000|Overall Study|Physician Decision|1|||
27943473|NCT04115293|81625168|FG001|Overall Study|Physician Decision|0|||
27943474|NCT04115293|81625167|FG000|Overall Study|Death|1|||
27943475|NCT04115293|81625168|FG001|Overall Study|Death|1|||
27943476|NCT03004183|81625169|FG000|Overall Study|Adverse Event|7|||
27943477|NCT03004183|81625169|FG000|Overall Study|Lost to Follow-up|1|||
27943478|NCT03004183|81625169|FG000|Overall Study|Physician Decision|40|||
27943479|NCT03004183|81625169|FG000|Overall Study|Withdrawal by Subject|1|||
27943480|NCT03004183|81625169|FG000|Overall Study|COVID-19|1|||
27746360|NCT03345836|80899606|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
27746361|NCT03345836|80899607|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
27943481|NCT03882801|81625174|FG000|Period 1|Adverse Event|0|||
27943482|NCT03882801|81625175|FG001|Period 1|Adverse Event|1|||
27943483|NCT03882801|81625174|FG000|Period 1|Non-compliance with study drug|1|||
27943484|NCT03882801|81625175|FG001|Period 1|Non-compliance with study drug|1|||
27647230|NCT00738400|80547882|FG000|Overall Study|Protocol Violation|1|||
27647231|NCT00738400|80547883|FG001|Overall Study|Protocol Violation|0|||
27943485|NCT03882801|81625174|FG000|Period 1|Never treated with study drug|1|||
27943486|NCT03882801|81625175|FG001|Period 1|Never treated with study drug|0|||
27943487|NCT03882801|81625174|FG000|Washout Period|Physician Decision|0|||
27647232|NCT00738400|80547882|FG000|Overall Study|Non-compliant with study medication|0|||
27647233|NCT00738400|80547883|FG001|Overall Study|Non-compliant with study medication|1|||
27647234|NCT03170882|80547884|FG000|Overall Study|Death|17|||
27647235|NCT03170882|80547885|FG001|Overall Study|Death|29|||
27647236|NCT03170882|80547884|FG000|Overall Study|Lost to Follow-up|0|||
27647237|NCT03170882|80547885|FG001|Overall Study|Lost to Follow-up|1|||
27647238|NCT03170882|80547884|FG000|Overall Study|Withdrawal by Subject|4|||
27943488|NCT03882801|81625175|FG001|Washout Period|Physician Decision|1|||
27943489|NCT03882801|81625174|FG000|Period 2|Non-compliance with study drug|0|||
27943490|NCT03882801|81625175|FG001|Period 2|Non-compliance with study drug|1|||
27943491|NCT03791060|81625176|FG000|Overall Study|Withdrawal by Subject|1|||
27943492|NCT01892189|81625177|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
27943493|NCT01892189|81625178|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
27943494|NCT01892189|81625179|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
27943495|NCT01892189|81625180|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
27943496|NCT01892189|81625181|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
27943497|NCT01892189|81625182|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
27943498|NCT01892189|81625183|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
27943499|NCT01892189|81625184|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
27943500|NCT01892189|81625185|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
27943501|NCT01892189|81625177|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27943502|NCT01892189|81625178|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27943503|NCT01892189|81625179|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
27943504|NCT01892189|81625180|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27943505|NCT01892189|81625181|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27943506|NCT01892189|81625182|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27943507|NCT01892189|81625183|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27943508|NCT01892189|81625184|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27943509|NCT01892189|81625185|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27943510|NCT01892189|81625177|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943511|NCT01892189|81625178|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943512|NCT01892189|81625179|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943513|NCT01892189|81625180|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943514|NCT01892189|81625181|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27647239|NCT03170882|80547885|FG001|Overall Study|Withdrawal by Subject|7|||
27647240|NCT03170882|80547884|FG000|Overall Study|Reason not Specified|28|||
27647241|NCT03170882|80547885|FG001|Overall Study|Reason not Specified|36|||
27647242|NCT01898299|80547886|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
27647243|NCT01898299|80547887|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
27647244|NCT02628626|80547888|FG000|Overall Study|Withdrawal by Subject|2|||
27647245|NCT02628626|80547889|FG001|Overall Study|Withdrawal by Subject|2|||
27647246|NCT03739866|80547890|FG000|Overall Study|Lost to Follow-up|0|||
27647247|NCT03739866|80547891|FG001|Overall Study|Lost to Follow-up|0|||
27647248|NCT03739866|80547892|FG002|Overall Study|Lost to Follow-up|0|||
27647249|NCT03739866|80547893|FG003|Overall Study|Lost to Follow-up|1|||
27647250|NCT03739866|80547894|FG004|Overall Study|Lost to Follow-up|0|||
27647251|NCT03739866|80547895|FG005|Overall Study|Lost to Follow-up|0|||
27647252|NCT03739866|80547896|FG006|Overall Study|Lost to Follow-up|0|||
27647253|NCT03739866|80547897|FG007|Overall Study|Lost to Follow-up|0|||
27647254|NCT03739866|80547890|FG000|Overall Study|Enrolled but not treated|0|||
27943515|NCT01892189|81625182|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
27943516|NCT01892189|81625183|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943517|NCT01892189|81625184|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943518|NCT01892189|81625185|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
27943519|NCT04887285|81627518|FG000|Overall Study|Lost to Follow-up|0|||
27943520|NCT04887285|81627519|FG001|Overall Study|Lost to Follow-up|2|||
27943521|NCT04887285|81627520|FG002|Overall Study|Lost to Follow-up|3|||
27943522|NCT01832038|81627521|FG000|Overall Study|Death|5|||
27647255|NCT03739866|80547891|FG001|Overall Study|Enrolled but not treated|0|||
27943523|NCT01832038|81627521|FG000|Overall Study|Adverse Event|50|||
27943524|NCT01832038|81627521|FG000|Overall Study|Lack of Efficacy|81|||
27943525|NCT01832038|81627521|FG000|Overall Study|Protocol Violation|7|||
27943526|NCT01832038|81627521|FG000|Overall Study|Lost to Follow-up|10|||
27943527|NCT01832038|81627521|FG000|Overall Study|Withdrawal by Subject|49|||
27943528|NCT01832038|81627521|FG000|Overall Study|Visit non-compliance|2|||
27943529|NCT01832038|81627521|FG000|Overall Study|Subject refused to return visit|2|||
27943530|NCT01832038|81627521|FG000|Overall Study|Not convenient to come back to site|2|||
27943531|NCT01832038|81627521|FG000|Overall Study|Participant was asked to quit|5|||
27943532|NCT01832038|81627521|FG000|Overall Study|Back home|1|||
27943533|NCT01832038|81627521|FG000|Overall Study|Pregnancy|1|||
27943534|NCT01832038|81627521|FG000|Overall Study|Low compliance|3|||
27943535|NCT01832038|81627521|FG000|Overall Study|Prohibit procedure|2|||
27943536|NCT01832038|81627521|FG000|Overall Study|Not possible to visit the hospital|1|||
27943537|NCT01832038|81627521|FG000|Overall Study|Changes of implementation system|3|||
27943538|NCT01832038|81627521|FG000|Overall Study|Plan to pregnancy|7|||
27943539|NCT01832038|81627521|FG000|Overall Study|Bad mood and has suicidal thought|1|||
27943540|NCT01832038|81627521|FG000|Overall Study|Prohibited concomitant medication|1|||
27943541|NCT01832038|81627521|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
27943542|NCT01832038|81627521|FG000|Overall Study|Subject considered the efficacy was poor|1|||
27551360|NCT01543698|80207468|FG010|Phase 1b|Withdrawal by Subject|0|||
27647256|NCT03739866|80547892|FG002|Overall Study|Enrolled but not treated|1|||
27647257|NCT03739866|80547893|FG003|Overall Study|Enrolled but not treated|0|||
27943543|NCT02076009|81627522|FG000|Overall Study|Death|172|||
27943544|NCT02076009|81627523|FG001|Overall Study|Death|153|||
27943545|NCT02076009|81627522|FG000|Overall Study|Withdrawal by Subject|16|||
27943546|NCT02076009|81627523|FG001|Overall Study|Withdrawal by Subject|12|||
27943547|NCT02076009|81627522|FG000|Overall Study|Lost to Follow-up|4|||
27943548|NCT02076009|81627523|FG001|Overall Study|Lost to Follow-up|2|||
27943549|NCT02076009|81627522|FG000|Overall Study|Progressive Disease|1|||
27943550|NCT02076009|81627523|FG001|Overall Study|Progressive Disease|0|||
27943551|NCT02076009|81627522|FG000|Overall Study|Physician Decision|0|||
27943552|NCT02076009|81627523|FG001|Overall Study|Physician Decision|1|||
27943553|NCT02076009|81627522|FG000|Overall Study|End of data collection|90|||
27943554|NCT02076009|81627523|FG001|Overall Study|End of data collection|118|||
27943555|NCT03709472|81627524|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
27943556|NCT03709472|81627525|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
27943557|NCT03709472|81627524|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
27943558|NCT03709472|81627525|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
27943559|NCT00322218|81627528|FG000|Overall Study|Death|3|||
27943560|NCT00322218|81627529|FG001|Overall Study|Death|6|||
27943561|NCT01557569|81627532|FG000|Overall Study|Adverse Event|2|||
27943562|NCT01557569|81627533|FG001|Overall Study|Adverse Event|0|||
27943563|NCT01557569|81627532|FG000|Overall Study|high blood pressure|0|||
27943564|NCT01557569|81627533|FG001|Overall Study|high blood pressure|1|||
27943565|NCT01557569|81627532|FG000|Overall Study|Withdrawal by Subject|3|||
27943566|NCT01557569|81627533|FG001|Overall Study|Withdrawal by Subject|5|||
27943567|NCT01557569|81627532|FG000|Overall Study|noncompliance with rules of residential|0|||
27943568|NCT01557569|81627533|FG001|Overall Study|noncompliance with rules of residential|1|||
27943569|NCT02144337|81627538|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
27943570|NCT02144337|81627539|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
27943571|NCT02144337|81627538|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
27943572|NCT02144337|81627539|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
27943573|NCT02144337|81627538|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
27943574|NCT02144337|81627539|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
27943575|NCT02144337|81627538|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
27943576|NCT02144337|81627539|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
27943577|NCT02144337|81627538|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
27943578|NCT02144337|81627539|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
27943579|NCT01299961|81627553|FG000|Overall Study|Adverse Event|3|||
27943580|NCT01299961|81627553|FG000|Overall Study|Lack of Efficacy|2|||
27943581|NCT01299961|81627553|FG000|Overall Study|Lost to Follow-up|1|||
27943582|NCT00979407|81627554|FG000|Overall Study|Withdrawal by Subject|3|||
27943583|NCT00979407|81627555|FG001|Overall Study|Withdrawal by Subject|4|||
27943584|NCT00979407|81627554|FG000|Overall Study|Lost to Follow-up|3|||
27943585|NCT00979407|81627555|FG001|Overall Study|Lost to Follow-up|3|||
27943586|NCT03941093|81627556|FG000|Overall Study|Protocol Violation|0|||
27943587|NCT03941093|81627557|FG001|Overall Study|Protocol Violation|1|||
27943588|NCT03941093|81627556|FG000|Overall Study|Withdrawal by Subject|9|||
27943589|NCT03941093|81627557|FG001|Overall Study|Withdrawal by Subject|6|||
27943590|NCT02367885|81627558|FG000|Overall Study|Lost to Follow-up|1|||
27943591|NCT02367885|81627559|FG001|Overall Study|Lost to Follow-up|0|||
27943592|NCT02367885|81627560|FG002|Overall Study|Lost to Follow-up|0|||
27943593|NCT02367885|81627558|FG000|Overall Study|Withdrawal by Subject|1|||
27943594|NCT02367885|81627559|FG001|Overall Study|Withdrawal by Subject|0|||
27943595|NCT02367885|81627560|FG002|Overall Study|Withdrawal by Subject|0|||
27943596|NCT03510715|81627561|FG000|Overall Study|Adverse Event|1|||
27943597|NCT03510715|81627562|FG001|Overall Study|Adverse Event|0|||
27943598|NCT03460704|81627563|FG000|Overall Study|Withdrawal by Subject|11|||
27943599|NCT03460704|81627564|FG001|Overall Study|Withdrawal by Subject|14|||
27943600|NCT03460704|81627563|FG000|Overall Study|Study terminated by the Sponsor|29|||
27943601|NCT03460704|81627564|FG001|Overall Study|Study terminated by the Sponsor|19|||
27943602|NCT03460704|81627563|FG000|Overall Study|Adverse Event|10|||
27943603|NCT03460704|81627564|FG001|Overall Study|Adverse Event|5|||
27746362|NCT03345836|80899608|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
27746363|NCT03345836|80899609|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
27746364|NCT03345836|80899610|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
27943604|NCT03460704|81627563|FG000|Overall Study|Death|3|||
27943605|NCT03460704|81627564|FG001|Overall Study|Death|2|||
27943606|NCT03460704|81627563|FG000|Overall Study|Non-Compliance with Study Drug|3|||
27746365|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
27746366|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
27746367|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
27943607|NCT03460704|81627564|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27943608|NCT03460704|81627563|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
27943609|NCT03460704|81627564|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
27943610|NCT03460704|81627563|FG000|Overall Study|Other|2|||
27943611|NCT03460704|81627564|FG001|Overall Study|Other|1|||
27943612|NCT04976855|81627565|FG000|Part I|Withdrawal by Subject|0|||
27943613|NCT04976855|81627566|FG001|Part I|Withdrawal by Subject|1|||
27943614|NCT04976855|81627567|FG002|Part I|Withdrawal by Subject|0|||
27943615|NCT04976855|81627568|FG003|Part I|Withdrawal by Subject|0|||
27943616|NCT04976855|81627569|FG004|Part I|Withdrawal by Subject|0|||
27943617|NCT04976855|81627570|FG005|Part I|Withdrawal by Subject|0|||
27943618|NCT04976855|81627571|FG006|Part I|Withdrawal by Subject|0|||
27943619|NCT04976855|81627565|FG000|Part II|Adverse Event|0|||
27943620|NCT04976855|81627566|FG001|Part II|Adverse Event|0|||
27943621|NCT04976855|81627567|FG002|Part II|Adverse Event|0|||
27943622|NCT04976855|81627568|FG003|Part II|Adverse Event|1|||
27943623|NCT04976855|81627569|FG004|Part II|Adverse Event|0|||
27943624|NCT04976855|81627570|FG005|Part II|Adverse Event|0|||
27943625|NCT04976855|81627571|FG006|Part II|Adverse Event|0|||
27943626|NCT04976855|81627565|FG000|Part II|Withdrawal by Subject|0|||
27943627|NCT04976855|81627566|FG001|Part II|Withdrawal by Subject|0|||
27943628|NCT04976855|81627567|FG002|Part II|Withdrawal by Subject|0|||
27943629|NCT04976855|81627568|FG003|Part II|Withdrawal by Subject|0|||
27943630|NCT04976855|81627569|FG004|Part II|Withdrawal by Subject|1|||
27943631|NCT04976855|81627570|FG005|Part II|Withdrawal by Subject|0|||
27943632|NCT04976855|81627571|FG006|Part II|Withdrawal by Subject|0|||
27943633|NCT04976855|81627565|FG000|Part II|Lost to Follow-up|0|||
27943634|NCT04976855|81627566|FG001|Part II|Lost to Follow-up|0|||
27943635|NCT04976855|81627567|FG002|Part II|Lost to Follow-up|0|||
27943636|NCT04976855|81627568|FG003|Part II|Lost to Follow-up|0|||
27943637|NCT04976855|81627569|FG004|Part II|Lost to Follow-up|0|||
27943638|NCT04976855|81627570|FG005|Part II|Lost to Follow-up|1|||
27943639|NCT04976855|81627571|FG006|Part II|Lost to Follow-up|0|||
27943640|NCT00085735|81627572|FG000|Overall Study|Adverse Event|1|||
27943641|NCT00085735|81627573|FG001|Overall Study|Adverse Event|0|||
27943642|NCT00085735|81627574|FG002|Overall Study|Adverse Event|0|||
27943643|NCT00085735|81627575|FG003|Overall Study|Adverse Event|0|||
27943644|NCT00085735|81627576|FG004|Overall Study|Adverse Event|0|||
27943645|NCT00085735|81627577|FG005|Overall Study|Adverse Event|0|||
27943646|NCT00085735|81627572|FG000|Overall Study|Lack of Efficacy|2|||
27943647|NCT00085735|81627573|FG001|Overall Study|Lack of Efficacy|4|||
27647258|NCT03739866|80547894|FG004|Overall Study|Enrolled but not treated|1|||
27943648|NCT00085735|81627574|FG002|Overall Study|Lack of Efficacy|6|||
27943649|NCT00085735|81627575|FG003|Overall Study|Lack of Efficacy|3|||
27943650|NCT00085735|81627576|FG004|Overall Study|Lack of Efficacy|4|||
27943651|NCT00085735|81627577|FG005|Overall Study|Lack of Efficacy|3|||
27943652|NCT00085735|81627572|FG000|Overall Study|Lost to Follow-up|0|||
27943653|NCT00085735|81627573|FG001|Overall Study|Lost to Follow-up|1|||
27943654|NCT00085735|81627574|FG002|Overall Study|Lost to Follow-up|0|||
27943655|NCT00085735|81627575|FG003|Overall Study|Lost to Follow-up|0|||
27647259|NCT03739866|80547895|FG005|Overall Study|Enrolled but not treated|0|||
27647260|NCT03739866|80547896|FG006|Overall Study|Enrolled but not treated|0|||
27647261|NCT03739866|80547897|FG007|Overall Study|Enrolled but not treated|0|||
27647262|NCT02432274|80547898|FG000|Overall Study|Death|2|||
27647263|NCT02432274|80547899|FG001|Overall Study|Death|6|||
27647264|NCT02432274|80547900|FG002|Overall Study|Death|7|||
27647265|NCT02432274|80547901|FG003|Overall Study|Death|0|||
27647266|NCT02432274|80547902|FG004|Overall Study|Death|27|||
27647267|NCT02432274|80547903|FG005|Overall Study|Death|7|||
27647268|NCT02432274|80547904|FG006|Overall Study|Death|9|||
27647269|NCT02432274|80547905|FG007|Overall Study|Death|14|||
27647270|NCT02432274|80547898|FG000|Overall Study|Withdrawal of Consent|0|||
27647271|NCT02432274|80547899|FG001|Overall Study|Withdrawal of Consent|0|||
27647272|NCT02432274|80547900|FG002|Overall Study|Withdrawal of Consent|0|||
27647273|NCT02432274|80547901|FG003|Overall Study|Withdrawal of Consent|0|||
27647274|NCT02432274|80547902|FG004|Overall Study|Withdrawal of Consent|2|||
27647275|NCT02432274|80547903|FG005|Overall Study|Withdrawal of Consent|0|||
27647276|NCT02432274|80547904|FG006|Overall Study|Withdrawal of Consent|1|||
27647277|NCT02432274|80547905|FG007|Overall Study|Withdrawal of Consent|2|||
27647278|NCT01613417|80550712|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
27647279|NCT01613417|80550713|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
27943656|NCT00085735|81627576|FG004|Overall Study|Lost to Follow-up|1|||
27943657|NCT00085735|81627577|FG005|Overall Study|Lost to Follow-up|0|||
27943658|NCT00085735|81627572|FG000|Overall Study|Physician Decision|2|||
27943659|NCT00085735|81627573|FG001|Overall Study|Physician Decision|3|||
27943660|NCT00085735|81627574|FG002|Overall Study|Physician Decision|2|||
27943661|NCT00085735|81627575|FG003|Overall Study|Physician Decision|3|||
27943662|NCT00085735|81627576|FG004|Overall Study|Physician Decision|11|||
27943663|NCT00085735|81627577|FG005|Overall Study|Physician Decision|8|||
27647280|NCT01766206|80550716|FG000|Overall Study|Withdrawal by Subject|22|||
27647281|NCT01766206|80550716|FG000|Overall Study|Lost to Follow-up|10|||
27647282|NCT01766206|80550716|FG000|Overall Study|Inappropriate enrollment|18|||
27943664|NCT00085735|81627572|FG000|Overall Study|Protocol Violation|1|||
27943665|NCT00085735|81627573|FG001|Overall Study|Protocol Violation|0|||
27943666|NCT00085735|81627574|FG002|Overall Study|Protocol Violation|0|||
27943667|NCT00085735|81627575|FG003|Overall Study|Protocol Violation|0|||
27943668|NCT00085735|81627576|FG004|Overall Study|Protocol Violation|0|||
27943669|NCT00085735|81627577|FG005|Overall Study|Protocol Violation|0|||
27943670|NCT00085735|81627572|FG000|Overall Study|Withdrawal by Subject|1|||
27943671|NCT00085735|81627573|FG001|Overall Study|Withdrawal by Subject|0|||
27943672|NCT00085735|81627574|FG002|Overall Study|Withdrawal by Subject|4|||
27943673|NCT00085735|81627575|FG003|Overall Study|Withdrawal by Subject|5|||
27943674|NCT00085735|81627576|FG004|Overall Study|Withdrawal by Subject|7|||
27943675|NCT00085735|81627577|FG005|Overall Study|Withdrawal by Subject|8|||
27943676|NCT00085735|81627572|FG000|Overall Study|Patient ineligible|1|||
27943677|NCT00085735|81627573|FG001|Overall Study|Patient ineligible|0|||
27943678|NCT00085735|81627574|FG002|Overall Study|Patient ineligible|3|||
27943679|NCT00085735|81627575|FG003|Overall Study|Patient ineligible|7|||
27943680|NCT00085735|81627576|FG004|Overall Study|Patient ineligible|17|||
27943681|NCT00085735|81627577|FG005|Overall Study|Patient ineligible|8|||
27943682|NCT00085735|81627572|FG000|Overall Study|Excess residual disease|2|||
27943683|NCT00085735|81627573|FG001|Overall Study|Excess residual disease|2|||
27943684|NCT00085735|81627574|FG002|Overall Study|Excess residual disease|1|||
27943685|NCT00085735|81627575|FG003|Overall Study|Excess residual disease|1|||
27943686|NCT00085735|81627576|FG004|Overall Study|Excess residual disease|1|||
27943687|NCT00085735|81627577|FG005|Overall Study|Excess residual disease|4|||
27943688|NCT00085735|81627572|FG000|Overall Study|Reason not documented|1|||
27943689|NCT00085735|81627573|FG001|Overall Study|Reason not documented|0|||
27943690|NCT00085735|81627574|FG002|Overall Study|Reason not documented|1|||
27943691|NCT00085735|81627575|FG003|Overall Study|Reason not documented|0|||
27943692|NCT00085735|81627576|FG004|Overall Study|Reason not documented|1|||
27943693|NCT00085735|81627577|FG005|Overall Study|Reason not documented|0|||
27943694|NCT00085735|81627572|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
27943695|NCT00085735|81627573|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
27943696|NCT00085735|81627574|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
27943697|NCT00085735|81627575|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
27943698|NCT00085735|81627576|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
27943699|NCT00085735|81627577|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
27943700|NCT00619918|81627578|FG000|Overall Study|Withdrawal by Subject|4|||
27943701|NCT00619918|81627579|FG001|Overall Study|Withdrawal by Subject|3|||
27943702|NCT00619918|81627578|FG000|Overall Study|Physician Decision|2|||
27943703|NCT00619918|81627579|FG001|Overall Study|Physician Decision|4|||
27943704|NCT00619918|81627578|FG000|Overall Study|Transfer to outside facility|3|||
27943705|NCT00619918|81627579|FG001|Overall Study|Transfer to outside facility|3|||
27943706|NCT00619918|81627578|FG000|Overall Study|Left before receiving first dose|7|||
27943707|NCT00619918|81627579|FG001|Overall Study|Left before receiving first dose|6|||
27943708|NCT00619918|81627578|FG000|Overall Study|ICU admission|4|||
27943709|NCT00619918|81627579|FG001|Overall Study|ICU admission|6|||
27943710|NCT03411044|81627582|FG000|Overall Study|Death|30|||
27943711|NCT03411044|81627582|FG000|Overall Study|Withdrawal by Subject|48|||
27943712|NCT03411044|81627582|FG000|Overall Study|Lost to Follow-up|78|||
27943713|NCT03411044|81627582|FG000|Overall Study|Adverse Event|30|||
27943714|NCT03411044|81627582|FG000|Overall Study|Missing status|4|||
27943715|NCT01065454|81627585|FG000|Treatment|Adverse Event|7|||
27943716|NCT01065454|81627586|FG001|Treatment|Adverse Event|4|||
27943717|NCT01065454|81627587|FG002|Treatment|Adverse Event|3|||
27943718|NCT01065454|81627588|FG003|Treatment|Adverse Event|6|||
27943719|NCT01065454|81627585|FG000|Treatment|Death|1|||
27943720|NCT01065454|81627586|FG001|Treatment|Death|0|||
27943721|NCT01065454|81627587|FG002|Treatment|Death|0|||
27943722|NCT01065454|81627588|FG003|Treatment|Death|0|||
27943723|NCT01065454|81627585|FG000|Treatment|Non-compliance|1|||
27943724|NCT01065454|81627586|FG001|Treatment|Non-compliance|0|||
27943725|NCT01065454|81627587|FG002|Treatment|Non-compliance|0|||
27943726|NCT01065454|81627588|FG003|Treatment|Non-compliance|1|||
27943727|NCT01065454|81627585|FG000|Treatment|Protocol Decision|0|||
27943728|NCT01065454|81627586|FG001|Treatment|Protocol Decision|0|||
27943729|NCT01065454|81627587|FG002|Treatment|Protocol Decision|3|||
27943730|NCT01065454|81627588|FG003|Treatment|Protocol Decision|2|||
27943731|NCT01065454|81627585|FG000|Treatment|Protocol Violation|1|||
27647283|NCT01766206|80550716|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
27647284|NCT01394276|80550717|FG000|Overall Study|Related Adverse event (AEs)|15|||
27943732|NCT01065454|81627586|FG001|Treatment|Protocol Violation|0|||
27943733|NCT01065454|81627587|FG002|Treatment|Protocol Violation|1|||
27943734|NCT01065454|81627588|FG003|Treatment|Protocol Violation|0|||
27943735|NCT01065454|81627585|FG000|Treatment|Withdrawal by Subject|3|||
27943736|NCT01065454|81627586|FG001|Treatment|Withdrawal by Subject|1|||
27943737|NCT01065454|81627587|FG002|Treatment|Withdrawal by Subject|2|||
27943738|NCT01065454|81627588|FG003|Treatment|Withdrawal by Subject|3|||
27943739|NCT01065454|81627585|FG000|Follow up|Adverse Event|1|||
27943740|NCT01065454|81627586|FG001|Follow up|Adverse Event|0|||
27551361|NCT01543698|80207469|FG011|Phase 1b|Withdrawal by Subject|0|||
27943741|NCT01065454|81627587|FG002|Follow up|Adverse Event|0|||
27943742|NCT01065454|81627588|FG003|Follow up|Adverse Event|1|||
27943743|NCT01065454|81627585|FG000|Follow up|Death|0|||
27943744|NCT01065454|81627586|FG001|Follow up|Death|1|||
27943745|NCT01065454|81627587|FG002|Follow up|Death|1|||
27943746|NCT01065454|81627588|FG003|Follow up|Death|0|||
27943747|NCT01065454|81627585|FG000|Follow up|Lost to Follow-up|0|||
27943748|NCT01065454|81627586|FG001|Follow up|Lost to Follow-up|0|||
27943749|NCT01065454|81627587|FG002|Follow up|Lost to Follow-up|0|||
27943750|NCT01065454|81627588|FG003|Follow up|Lost to Follow-up|1|||
27943751|NCT01065454|81627585|FG000|Follow up|Progressive disease|0|||
27943752|NCT01065454|81627586|FG001|Follow up|Progressive disease|0|||
27943753|NCT01065454|81627587|FG002|Follow up|Progressive disease|0|||
27943754|NCT01065454|81627588|FG003|Follow up|Progressive disease|1|||
27943755|NCT01065454|81627585|FG000|Follow up|Withdrawal by Subject|1|||
27943756|NCT01065454|81627586|FG001|Follow up|Withdrawal by Subject|1|||
27943757|NCT01065454|81627587|FG002|Follow up|Withdrawal by Subject|1|||
27943758|NCT01065454|81627588|FG003|Follow up|Withdrawal by Subject|0|||
27943759|NCT01065454|81627585|FG000|Follow up|study ongoing|37|||
27943760|NCT01065454|81627586|FG001|Follow up|study ongoing|22|||
27943761|NCT01065454|81627587|FG002|Follow up|study ongoing|15|||
27943762|NCT01065454|81627588|FG003|Follow up|study ongoing|41|||
27943763|NCT05543174|81627593|FG000|Overall Study|Ongoing|7|||
27943764|NCT03464461|81627605|FG000|Overall Study|exclusionary medication given ,|1|||
27943765|NCT03464461|81627606|FG001|Overall Study|exclusionary medication given ,|2|||
27943766|NCT03464461|81627607|FG002|Overall Study|exclusionary medication given ,|0|||
27943767|NCT03464461|81627605|FG000|Overall Study|Physician Decision|0|||
27943768|NCT03464461|81627606|FG001|Overall Study|Physician Decision|1|||
27943769|NCT03464461|81627607|FG002|Overall Study|Physician Decision|0|||
27943770|NCT00489359|81627608|FG000|Overall Study|Death|0|||
27943771|NCT00489359|81627609|FG001|Overall Study|Death|2|||
27943772|NCT00489359|81627608|FG000|Overall Study|Progressive Disease|5|||
27943773|NCT00489359|81627609|FG001|Overall Study|Progressive Disease|6|||
27943774|NCT00489359|81627608|FG000|Overall Study|Lost to Follow-up|1|||
27943775|NCT00489359|81627609|FG001|Overall Study|Lost to Follow-up|0|||
27943776|NCT00489359|81627608|FG000|Overall Study|Withdrawal by Subject|1|||
27943777|NCT00489359|81627609|FG001|Overall Study|Withdrawal by Subject|5|||
27943778|NCT00489359|81627608|FG000|Overall Study|Adverse Event|0|||
27943779|NCT00489359|81627609|FG001|Overall Study|Adverse Event|16|||
27943780|NCT03375320|81627613|FG000|Overall Study|Adverse Event|34|||
27943781|NCT03375320|81627614|FG001|Overall Study|Adverse Event|9|||
27943782|NCT03375320|81627615|FG002|Overall Study|Adverse Event|10|||
27943783|NCT03375320|81627616|FG003|Overall Study|Adverse Event|0|||
27943784|NCT03375320|81627613|FG000|Overall Study|Death|6|||
27943785|NCT03375320|81627614|FG001|Overall Study|Death|3|||
27943786|NCT03375320|81627615|FG002|Overall Study|Death|0|||
27943787|NCT03375320|81627616|FG003|Overall Study|Death|0|||
27943788|NCT03375320|81627613|FG000|Overall Study|Withdrawal by Subject|7|||
27943789|NCT03375320|81627614|FG001|Overall Study|Withdrawal by Subject|4|||
27943790|NCT03375320|81627615|FG002|Overall Study|Withdrawal by Subject|5|||
27943791|NCT03375320|81627616|FG003|Overall Study|Withdrawal by Subject|4|||
27943792|NCT03375320|81627613|FG000|Overall Study|Progressive disease|55|||
27943793|NCT03375320|81627614|FG001|Overall Study|Progressive disease|41|||
27943794|NCT03375320|81627615|FG002|Overall Study|Progressive disease|29|||
27943795|NCT03375320|81627616|FG003|Overall Study|Progressive disease|24|||
27943796|NCT03375320|81627613|FG000|Overall Study|Alternative treatment|6|||
27943797|NCT03375320|81627614|FG001|Overall Study|Alternative treatment|1|||
27943798|NCT03375320|81627615|FG002|Overall Study|Alternative treatment|1|||
27943799|NCT03375320|81627616|FG003|Overall Study|Alternative treatment|0|||
27943800|NCT03375320|81627613|FG000|Overall Study|Other disease|1|||
27943801|NCT03375320|81627614|FG001|Overall Study|Other disease|1|||
27943802|NCT03375320|81627615|FG002|Overall Study|Other disease|3|||
27943803|NCT03375320|81627616|FG003|Overall Study|Other disease|0|||
27943804|NCT03375320|81627613|FG000|Overall Study|Withdrawal prior to initiation|2|||
27943805|NCT03375320|81627614|FG001|Overall Study|Withdrawal prior to initiation|2|||
27943806|NCT03375320|81627615|FG002|Overall Study|Withdrawal prior to initiation|1|||
27943807|NCT03375320|81627616|FG003|Overall Study|Withdrawal prior to initiation|0|||
27943808|NCT03375320|81627613|FG000|Overall Study|Physician Decision|1|||
27943809|NCT03375320|81627614|FG001|Overall Study|Physician Decision|1|||
27943810|NCT03375320|81627615|FG002|Overall Study|Physician Decision|1|||
27943811|NCT03375320|81627616|FG003|Overall Study|Physician Decision|1|||
27943812|NCT03375320|81627613|FG000|Overall Study|Non-compliance|1|||
27943813|NCT03375320|81627614|FG001|Overall Study|Non-compliance|0|||
27943814|NCT03375320|81627615|FG002|Overall Study|Non-compliance|0|||
27943815|NCT03375320|81627616|FG003|Overall Study|Non-compliance|0|||
27943816|NCT01472185|81627617|FG000|Overall Study|Randomized but Not Treated|0|||
27943817|NCT01472185|81627618|FG001|Overall Study|Randomized but Not Treated|1|||
27943818|NCT01472185|81627617|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
27943819|NCT01472185|81627618|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
27943820|NCT01472185|81627617|FG000|Overall Study|Hyperglycemia|5|||
27943821|NCT01472185|81627618|FG001|Overall Study|Hyperglycemia|2|||
27943822|NCT01472185|81627617|FG000|Overall Study|Investigator's Discretion|3|||
27943823|NCT01472185|81627618|FG001|Overall Study|Investigator's Discretion|1|||
27943824|NCT01472185|81627617|FG000|Overall Study|Lost to Follow-up|4|||
27943825|NCT01472185|81627618|FG001|Overall Study|Lost to Follow-up|1|||
27943826|NCT01472185|81627617|FG000|Overall Study|Protocol Violation|5|||
27943827|NCT01472185|81627618|FG001|Overall Study|Protocol Violation|1|||
27943828|NCT01472185|81627617|FG000|Overall Study|Subject Noncompliance|8|||
27943829|NCT01472185|81627618|FG001|Overall Study|Subject Noncompliance|15|||
27943830|NCT01472185|81627617|FG000|Overall Study|Subject Withdrew Consent|6|||
27943831|NCT01472185|81627618|FG001|Overall Study|Subject Withdrew Consent|3|||
27943832|NCT03449147|81627621|FG000|52-week Treatment Period|Death|0|||
27943833|NCT03449147|81627622|FG001|52-week Treatment Period|Death|1|||
27943834|NCT03449147|81627623|FG002|52-week Treatment Period|Death|0|||
27943835|NCT03449147|81627621|FG000|52-week Treatment Period|Lost to Follow-up|6|||
27943836|NCT03449147|81627622|FG001|52-week Treatment Period|Lost to Follow-up|2|||
27943837|NCT03449147|81627623|FG002|52-week Treatment Period|Lost to Follow-up|5|||
27943838|NCT03449147|81627621|FG000|52-week Treatment Period|Other|0|||
27943839|NCT03449147|81627622|FG001|52-week Treatment Period|Other|1|||
27943840|NCT03449147|81627623|FG002|52-week Treatment Period|Other|2|||
27943841|NCT03449147|81627621|FG000|52-week Treatment Period|Physician Decision|1|||
27943842|NCT03449147|81627622|FG001|52-week Treatment Period|Physician Decision|0|||
27943843|NCT03449147|81627623|FG002|52-week Treatment Period|Physician Decision|3|||
27943844|NCT03449147|81627621|FG000|52-week Treatment Period|Screen Failure|1|||
27943845|NCT03449147|81627622|FG001|52-week Treatment Period|Screen Failure|2|||
27943846|NCT03449147|81627623|FG002|52-week Treatment Period|Screen Failure|0|||
27943847|NCT03449147|81627621|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
27943848|NCT03449147|81627622|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
27746368|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
27943849|NCT03449147|81627623|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
27943850|NCT03449147|81627621|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
27943851|NCT03449147|81627622|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
27943852|NCT03449147|81627623|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
27943853|NCT03449147|81627621|FG000|12-Week Off-Treatment Durability Period|Other|0|||
27943854|NCT03449147|81627622|FG001|12-Week Off-Treatment Durability Period|Other|1|||
27943855|NCT03449147|81627623|FG002|12-Week Off-Treatment Durability Period|Other|0|||
27943856|NCT03934684|81627624|FG000|Overall Study|Participants continuing in study|11|||
27943857|NCT03934684|81627625|FG001|Overall Study|Participants continuing in study|4|||
27943858|NCT03934684|81627624|FG000|Overall Study|Discontinuation of carfilzomib|20|||
27647285|NCT01394276|80550717|FG000|Overall Study|Not related AEs|9|||
27647286|NCT01394276|80550717|FG000|Overall Study|Remission of disease|2|||
27647287|NCT01394276|80550717|FG000|Overall Study|Insufficient therapeutic effect|17|||
27647288|NCT01394276|80550717|FG000|Overall Study|Insufficient compliance|9|||
27647289|NCT01394276|80550717|FG000|Overall Study|Lost to Follow-up|5|||
27647290|NCT01394276|80550717|FG000|Overall Study|Participant moved to another site|1|||
27647291|NCT01394276|80550717|FG000|Overall Study|Pregnancy|1|||
27647292|NCT01394276|80550717|FG000|Overall Study|unavailability of drug at the Hospital|2|||
27647293|NCT01394276|80550717|FG000|Overall Study|Symptoms of concurrent diseases|1|||
27647294|NCT01583166|80550721|FG000|Overall Study|Withdrawal by Subject|4|||
27647295|NCT01583166|80550722|FG001|Overall Study|Withdrawal by Subject|6|||
27647296|NCT03589768|80550723|FG000|Overall Study|Death|1|||
27647297|NCT03589768|80550724|FG001|Overall Study|Death|0|||
27647298|NCT03589768|80550725|FG002|Overall Study|Death|8|||
27647299|NCT03589768|80550726|FG003|Overall Study|Death|3|||
27647300|NCT03589768|80550723|FG000|Overall Study|Withdrawal by Subject|2|||
27647301|NCT03589768|80550724|FG001|Overall Study|Withdrawal by Subject|0|||
27647302|NCT03589768|80550725|FG002|Overall Study|Withdrawal by Subject|0|||
27647303|NCT03589768|80550726|FG003|Overall Study|Withdrawal by Subject|0|||
27647304|NCT03589768|80550723|FG000|Overall Study|Protocol Violation|1|||
27647305|NCT03589768|80550724|FG001|Overall Study|Protocol Violation|0|||
27647306|NCT03589768|80550725|FG002|Overall Study|Protocol Violation|0|||
27647307|NCT03589768|80550726|FG003|Overall Study|Protocol Violation|0|||
27647308|NCT02158806|80550727|FG000|Overall Study|Death|2|||
27647309|NCT02158806|80550728|FG001|Overall Study|Death|0|||
27647310|NCT02158806|80550727|FG000|Overall Study|Withdrawal by Subject|2|||
27647311|NCT02158806|80550728|FG001|Overall Study|Withdrawal by Subject|0|||
27647312|NCT02158806|80550727|FG000|Overall Study|Lost to Follow-up|0|||
27647313|NCT02158806|80550728|FG001|Overall Study|Lost to Follow-up|3|||
27647314|NCT02158806|80550727|FG000|Overall Study|Moved out of area|0|||
27647315|NCT02158806|80550728|FG001|Overall Study|Moved out of area|1|||
27647316|NCT02158806|80550727|FG000|Overall Study|Transferred to palliative care|0|||
27647317|NCT02158806|80550728|FG001|Overall Study|Transferred to palliative care|1|||
27746369|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
27647318|NCT03403036|80550729|FG000|Overall Study|Lack of Efficacy|5|||
27647319|NCT01499849|80550730|FG000|Overall Study|Adverse Event|28|||
27647320|NCT01499849|80550731|FG001|Overall Study|Adverse Event|32|||
27647321|NCT01499849|80550730|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
27943859|NCT03934684|81627625|FG001|Overall Study|Discontinuation of carfilzomib|30|||
27943860|NCT03934684|81627624|FG000|Overall Study|Death|2|||
27943861|NCT03934684|81627625|FG001|Overall Study|Death|2|||
27943862|NCT03934684|81627624|FG000|Overall Study|Lost to Follow-up|2|||
27943863|NCT03934684|81627625|FG001|Overall Study|Lost to Follow-up|5|||
27943864|NCT03934684|81627624|FG000|Overall Study|Withdrawal by Subject|7|||
27943865|NCT03934684|81627625|FG001|Overall Study|Withdrawal by Subject|8|||
27647322|NCT01499849|80550731|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
27647323|NCT01499849|80550730|FG000|Overall Study|Withdrawal by Subject|43|||
27943866|NCT01475825|81627626|FG000|Overall Study|Adverse Event|41|||
27943867|NCT01475825|81627627|FG001|Overall Study|Adverse Event|15|||
27943868|NCT01475825|81627628|FG002|Overall Study|Adverse Event|27|||
27943869|NCT01475825|81627629|FG003|Overall Study|Adverse Event|11|||
27943870|NCT01475825|81627626|FG000|Overall Study|Death|1|||
27943871|NCT01475825|81627627|FG001|Overall Study|Death|0|||
27943872|NCT01475825|81627628|FG002|Overall Study|Death|1|||
27943873|NCT01475825|81627629|FG003|Overall Study|Death|0|||
27943874|NCT01475825|81627626|FG000|Overall Study|Lack of Efficacy|0|||
27943875|NCT01475825|81627627|FG001|Overall Study|Lack of Efficacy|0|||
27943876|NCT01475825|81627628|FG002|Overall Study|Lack of Efficacy|1|||
27943877|NCT01475825|81627629|FG003|Overall Study|Lack of Efficacy|0|||
27943878|NCT01475825|81627626|FG000|Overall Study|Lost to Follow-up|0|||
27943879|NCT01475825|81627627|FG001|Overall Study|Lost to Follow-up|0|||
27943880|NCT01475825|81627628|FG002|Overall Study|Lost to Follow-up|3|||
27943881|NCT01475825|81627629|FG003|Overall Study|Lost to Follow-up|1|||
27943882|NCT01475825|81627626|FG000|Overall Study|Non-compliance with Study Drug|1|||
27943883|NCT01475825|81627627|FG001|Overall Study|Non-compliance with Study Drug|2|||
27943884|NCT01475825|81627628|FG002|Overall Study|Non-compliance with Study Drug|4|||
27943885|NCT01475825|81627629|FG003|Overall Study|Non-compliance with Study Drug|0|||
27943886|NCT01475825|81627626|FG000|Overall Study|Other: Not available|0|||
27943887|NCT01475825|81627627|FG001|Overall Study|Other: Not available|0|||
27943888|NCT01475825|81627628|FG002|Overall Study|Other: Not available|2|||
27943889|NCT01475825|81627629|FG003|Overall Study|Other: Not available|0|||
27943890|NCT01475825|81627626|FG000|Overall Study|Protocol Violation|1|||
27647324|NCT01499849|80550731|FG001|Overall Study|Withdrawal by Subject|43|||
27647325|NCT01499849|80550730|FG000|Overall Study|Death|5|||
27647326|NCT01499849|80550731|FG001|Overall Study|Death|7|||
27647327|NCT01499849|80550730|FG000|Overall Study|Disease Progression|11|||
27647328|NCT01499849|80550731|FG001|Overall Study|Disease Progression|10|||
27647329|NCT01499849|80550730|FG000|Overall Study|Protocol Violation|11|||
27647330|NCT01499849|80550731|FG001|Overall Study|Protocol Violation|11|||
27647331|NCT01499849|80550730|FG000|Overall Study|Physician Decision|20|||
27647332|NCT01499849|80550731|FG001|Overall Study|Physician Decision|19|||
27647333|NCT01499849|80550730|FG000|Overall Study|Lack of Efficacy|3|||
27647334|NCT01499849|80550731|FG001|Overall Study|Lack of Efficacy|4|||
27647335|NCT01499849|80550730|FG000|Overall Study|Lost to Follow-up|6|||
27647336|NCT01499849|80550731|FG001|Overall Study|Lost to Follow-up|3|||
27647337|NCT01499849|80550730|FG000|Overall Study|Other Reasons|27|||
27647338|NCT01499849|80550731|FG001|Overall Study|Other Reasons|30|||
27647339|NCT00666705|80550732|FG000|Overall Study|Withdrawal by Subject|1|||
27647340|NCT03041233|80550733|FG000|Overall Study|Death|5|||
27647341|NCT03041233|80550733|FG000|Overall Study|Physician Decision|1|||
27647342|NCT03041233|80550733|FG000|Overall Study|Lost to Follow-up|16|||
27647343|NCT03041233|80550733|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
27647344|NCT03041233|80550733|FG000|Overall Study|Sponsor Request|1|||
27647345|NCT03041233|80550733|FG000|Overall Study|Duplicate subject|1|||
27647346|NCT03041233|80550733|FG000|Overall Study|Re-ablation|1|||
27647347|NCT01128595|80550736|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27647348|NCT01128595|80550737|FG001|Treatment Period 3|Withdrawal by Subject|1|||
27647349|NCT01128595|80550738|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27647350|NCT01128595|80550739|FG003|Treatment Period 3|Withdrawal by Subject|0|||
27647351|NCT01673594|80550744|FG000|Overall Study|Adverse Event|3|||
27943891|NCT01475825|81627627|FG001|Overall Study|Protocol Violation|0|||
27943892|NCT01475825|81627628|FG002|Overall Study|Protocol Violation|0|||
27943893|NCT01475825|81627629|FG003|Overall Study|Protocol Violation|0|||
27943894|NCT01475825|81627626|FG000|Overall Study|Physician Decision|0|||
27647352|NCT01673594|80550745|FG001|Overall Study|Adverse Event|1|||
27746370|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
27746371|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
27943895|NCT01475825|81627627|FG001|Overall Study|Physician Decision|1|||
27943896|NCT01475825|81627628|FG002|Overall Study|Physician Decision|0|||
27943897|NCT01475825|81627629|FG003|Overall Study|Physician Decision|0|||
27647353|NCT01673594|80550744|FG000|Overall Study|Lost to Follow-up|1|||
27647354|NCT01673594|80550745|FG001|Overall Study|Lost to Follow-up|0|||
27647355|NCT01673594|80550744|FG000|Overall Study|Physician Decision|2|||
27647356|NCT01673594|80550745|FG001|Overall Study|Physician Decision|4|||
27647357|NCT01673594|80550744|FG000|Overall Study|Withdrawal by Subject|0|||
27943898|NCT01475825|81627626|FG000|Overall Study|Withdrawal by Subject|8|||
27943899|NCT01475825|81627627|FG001|Overall Study|Withdrawal by Subject|3|||
27647358|NCT01673594|80550745|FG001|Overall Study|Withdrawal by Subject|1|||
27647359|NCT02988713|80550746|FG000|Overall Study|Withdrawal by Subject|1|||
27647360|NCT02988713|80550746|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
27647361|NCT02111096|80550747|FG000|Overall Study|Adverse Event|4|||
27647362|NCT02111096|80550748|FG001|Overall Study|Adverse Event|1|||
27647363|NCT02111096|80550749|FG002|Overall Study|Adverse Event|2|||
27647364|NCT02111096|80550747|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27647365|NCT02111096|80550748|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27647366|NCT02111096|80550749|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27647367|NCT02111096|80550747|FG000|Overall Study|Lost to Follow Up|1|||
27647368|NCT02111096|80550748|FG001|Overall Study|Lost to Follow Up|1|||
27647369|NCT02111096|80550749|FG002|Overall Study|Lost to Follow Up|1|||
27647370|NCT02111096|80550747|FG000|Overall Study|Physician Decision|0|||
27647371|NCT02111096|80550748|FG001|Overall Study|Physician Decision|1|||
27647372|NCT02111096|80550749|FG002|Overall Study|Physician Decision|0|||
27647373|NCT02111096|80550747|FG000|Overall Study|Protocol Violation|1|||
27647374|NCT02111096|80550748|FG001|Overall Study|Protocol Violation|0|||
27647375|NCT02111096|80550749|FG002|Overall Study|Protocol Violation|1|||
27647376|NCT02111096|80550747|FG000|Overall Study|Terminated by Sponsor|53|||
27647377|NCT02111096|80550748|FG001|Overall Study|Terminated by Sponsor|35|||
27647378|NCT02111096|80550749|FG002|Overall Study|Terminated by Sponsor|54|||
27647379|NCT02111096|80550747|FG000|Overall Study|Withdrawal by Subject|4|||
27647380|NCT02111096|80550748|FG001|Overall Study|Withdrawal by Subject|2|||
27647381|NCT02111096|80550749|FG002|Overall Study|Withdrawal by Subject|8|||
27647382|NCT01833455|80550750|FG000|Overall Study|Withdrawal by Subject|1|||
27647383|NCT01833455|80550751|FG001|Overall Study|Withdrawal by Subject|0|||
27647384|NCT02722434|80550754|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
27647385|NCT02722434|80550755|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
27943900|NCT01475825|81627628|FG002|Overall Study|Withdrawal by Subject|11|||
27943901|NCT01475825|81627629|FG003|Overall Study|Withdrawal by Subject|7|||
27943902|NCT01475825|81627626|FG000|Overall Study|Did not enter OLC|15|||
27943903|NCT01475825|81627627|FG001|Overall Study|Did not enter OLC|11|||
27943904|NCT01475825|81627628|FG002|Overall Study|Did not enter OLC|15|||
27943905|NCT01475825|81627629|FG003|Overall Study|Did not enter OLC|11|||
27943906|NCT03412591|81627630|FG000|Overall Study|Withdrawal by Subject|1|||
27943907|NCT03412591|81627631|FG001|Overall Study|Withdrawal by Subject|8|||
27943908|NCT03412591|81627630|FG000|Overall Study|Adverse Event|0|||
27943909|NCT03412591|81627631|FG001|Overall Study|Adverse Event|1|||
27943910|NCT01213251|81627632|FG000|Overall Study|Death|2|||
27943911|NCT01213251|81627633|FG001|Overall Study|Death|1|||
27943912|NCT01213251|81627634|FG002|Overall Study|Death|2|||
27943913|NCT01213251|81627632|FG000|Overall Study|Exit|3|||
27943914|NCT01213251|81627633|FG001|Overall Study|Exit|2|||
27647386|NCT02722434|80550754|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
27647387|NCT02722434|80550755|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
27647388|NCT02701296|80550775|FG000|Overall Study|Incomplete Data|0|||
27647389|NCT02701296|80550776|FG001|Overall Study|Incomplete Data|2|||
27647390|NCT00312208|80550777|FG000|Overall Study|Adverse Event|97|||
27647391|NCT00312208|80550778|FG001|Overall Study|Adverse Event|61|||
27647392|NCT00312208|80550777|FG000|Overall Study|Protocol Violation|5|||
27647393|NCT00312208|80550778|FG001|Overall Study|Protocol Violation|3|||
27647394|NCT00312208|80550777|FG000|Overall Study|Death|2|||
27647395|NCT00312208|80550778|FG001|Overall Study|Death|1|||
27647396|NCT00312208|80550777|FG000|Overall Study|Lack of Efficacy|7|||
27647397|NCT00312208|80550778|FG001|Overall Study|Lack of Efficacy|4|||
27647398|NCT00312208|80550777|FG000|Overall Study|Lost to Follow-up|3|||
27647399|NCT00312208|80550778|FG001|Overall Study|Lost to Follow-up|5|||
27647400|NCT00312208|80550777|FG000|Overall Study|Withdrawal by Subject|53|||
27647401|NCT00312208|80550778|FG001|Overall Study|Withdrawal by Subject|42|||
27647402|NCT00312208|80550777|FG000|Overall Study|Other|5|||
27647403|NCT00312208|80550778|FG001|Overall Study|Other|7|||
27647404|NCT01074242|80550787|FG000|Overall Study|Case report before date of contract|40|||
27647405|NCT01074242|80550787|FG000|Overall Study|Lost to Follow-up|1|||
27647406|NCT01074242|80550787|FG000|Overall Study|Case report unclear|6|||
27647407|NCT01074242|80550787|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
27647408|NCT01074242|80550787|FG000|Overall Study|Duplicate Case Report Form|5|||
27647409|NCT02605174|80550796|FG000|Overall Study|Adverse Event|0|||
27647410|NCT02605174|80550797|FG001|Overall Study|Adverse Event|0|||
27647411|NCT02605174|80550798|FG002|Overall Study|Adverse Event|1|||
27647412|NCT02605174|80550799|FG003|Overall Study|Adverse Event|0|||
27647413|NCT02605174|80550800|FG004|Overall Study|Adverse Event|4|||
27943915|NCT01213251|81627634|FG002|Overall Study|Exit|8|||
27943916|NCT01213251|81627632|FG000|Overall Study|Protocol Violation|1|||
27943917|NCT01213251|81627633|FG001|Overall Study|Protocol Violation|1|||
27647414|NCT02605174|80550801|FG005|Overall Study|Adverse Event|0|||
27647415|NCT02605174|80550802|FG006|Overall Study|Adverse Event|0|||
27647416|NCT02605174|80550796|FG000|Overall Study|Lost to Follow-up|20|||
27647417|NCT02605174|80550797|FG001|Overall Study|Lost to Follow-up|7|||
27943918|NCT01213251|81627634|FG002|Overall Study|Protocol Violation|0|||
27943919|NCT01213251|81627632|FG000|Overall Study|Missed 18-Month Follow-up|0|||
27943920|NCT01213251|81627633|FG001|Overall Study|Missed 18-Month Follow-up|0|||
27943921|NCT01213251|81627634|FG002|Overall Study|Missed 18-Month Follow-up|1|||
27943922|NCT02113878|81627635|FG000|Overall Study|Adverse Event|1|||
27943923|NCT02113878|81627636|FG001|Overall Study|Adverse Event|0|||
27943924|NCT02113878|81627635|FG000|Overall Study|Withdrawal by Subject|1|||
27943925|NCT02113878|81627636|FG001|Overall Study|Withdrawal by Subject|0|||
27943926|NCT02113878|81627635|FG000|Overall Study|patient non-compliance|1|||
27943927|NCT02113878|81627636|FG001|Overall Study|patient non-compliance|0|||
27943928|NCT00530257|81627637|FG000|Overall Study|Lost to Follow-up|1|||
27943929|NCT03627468|81627638|FG000|Overall Study|Adverse Event|5|||
27943930|NCT03627468|81627639|FG001|Overall Study|Adverse Event|33|||
27943931|NCT03627468|81627638|FG000|Overall Study|Withdrawal by Subject|13|||
27943932|NCT03627468|81627639|FG001|Overall Study|Withdrawal by Subject|23|||
27943933|NCT03627468|81627638|FG000|Overall Study|Physician Decision|1|||
27943934|NCT03627468|81627639|FG001|Overall Study|Physician Decision|0|||
27943935|NCT03627468|81627638|FG000|Overall Study|Protocol Violation|0|||
27943936|NCT03627468|81627639|FG001|Overall Study|Protocol Violation|2|||
27943937|NCT03627468|81627638|FG000|Overall Study|Lost to Follow-up|10|||
27943938|NCT03627468|81627639|FG001|Overall Study|Lost to Follow-up|16|||
27943939|NCT03627468|81627638|FG000|Overall Study|Death|1|||
27943940|NCT03627468|81627639|FG001|Overall Study|Death|0|||
27943941|NCT03627468|81627638|FG000|Overall Study|Pregnancy|1|||
27943942|NCT03627468|81627639|FG001|Overall Study|Pregnancy|1|||
27943943|NCT03627468|81627638|FG000|Overall Study|Lack of Efficacy|0|||
27943944|NCT03627468|81627639|FG001|Overall Study|Lack of Efficacy|2|||
27943945|NCT03627468|81627638|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
27943946|NCT03627468|81627639|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
27943947|NCT02679274|81627653|FG000|Overall Study|Withdrawal by Subject|1|||
27943948|NCT02679274|81627654|FG001|Overall Study|Withdrawal by Subject|0|||
27943949|NCT04535362|81627657|FG000|Overall Study|Lost to Follow-up|3|||
27943950|NCT04535362|81627658|FG001|Overall Study|Lost to Follow-up|1|||
27943951|NCT05486065|81627659|FG000|Overall Study|Withdrawal by Subject|1|||
27943952|NCT05486065|81627660|FG001|Overall Study|Withdrawal by Subject|5|||
27943953|NCT05486065|81627661|FG002|Overall Study|Withdrawal by Subject|4|||
27943954|NCT05486065|81627662|FG003|Overall Study|Withdrawal by Subject|3|||
27943955|NCT05486065|81627659|FG000|Overall Study|Lost to Follow-up|4|||
27943956|NCT05486065|81627660|FG001|Overall Study|Lost to Follow-up|2|||
27943957|NCT05486065|81627661|FG002|Overall Study|Lost to Follow-up|2|||
27943958|NCT05486065|81627662|FG003|Overall Study|Lost to Follow-up|2|||
27943959|NCT05486065|81627659|FG000|Overall Study|Physician Decision|0|||
27943960|NCT05486065|81627660|FG001|Overall Study|Physician Decision|1|||
27943961|NCT05486065|81627661|FG002|Overall Study|Physician Decision|1|||
27943962|NCT05486065|81627662|FG003|Overall Study|Physician Decision|0|||
27943963|NCT05486065|81627659|FG000|Overall Study|Failure to meet randomization criteria|0|||
27943964|NCT05486065|81627660|FG001|Overall Study|Failure to meet randomization criteria|0|||
27943965|NCT05486065|81627661|FG002|Overall Study|Failure to meet randomization criteria|0|||
27943966|NCT05486065|81627662|FG003|Overall Study|Failure to meet randomization criteria|1|||
27943967|NCT02967692|81627665|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
27943968|NCT02967692|81627666|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
27943969|NCT02967692|81627667|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
27943970|NCT02967692|81627668|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
27943971|NCT02967692|81627665|FG000|Overall Study|Progressive disease|3|||
27943972|NCT02967692|81627666|FG001|Overall Study|Progressive disease|15|||
27943973|NCT02967692|81627667|FG002|Overall Study|Progressive disease|99|||
27943974|NCT02967692|81627668|FG003|Overall Study|Progressive disease|128|||
27943975|NCT02967692|81627665|FG000|Overall Study|Subject/guardian decision|1|||
27943976|NCT02967692|81627666|FG001|Overall Study|Subject/guardian decision|1|||
27943977|NCT02967692|81627667|FG002|Overall Study|Subject/guardian decision|6|||
27943978|NCT02967692|81627668|FG003|Overall Study|Subject/guardian decision|13|||
27746372|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
27746373|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
27746374|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
27943979|NCT02967692|81627665|FG000|Overall Study|Death|0|||
27943980|NCT02967692|81627666|FG001|Overall Study|Death|1|||
27943981|NCT02967692|81627667|FG002|Overall Study|Death|10|||
27943982|NCT02967692|81627668|FG003|Overall Study|Death|9|||
27943983|NCT02967692|81627665|FG000|Overall Study|Protocol deviation|1|||
27943984|NCT02967692|81627666|FG001|Overall Study|Protocol deviation|0|||
27943985|NCT02967692|81627667|FG002|Overall Study|Protocol deviation|1|||
27943986|NCT02967692|81627668|FG003|Overall Study|Protocol deviation|1|||
27943987|NCT02967692|81627665|FG000|Overall Study|Lost to Follow-up|0|||
27943988|NCT02967692|81627666|FG001|Overall Study|Lost to Follow-up|0|||
27943989|NCT02967692|81627667|FG002|Overall Study|Lost to Follow-up|1|||
27551362|NCT01543698|80207470|FG012|Phase 1b|Withdrawal by Subject|0|||
27943990|NCT02967692|81627668|FG003|Overall Study|Lost to Follow-up|0|||
27943991|NCT02967692|81627665|FG000|Overall Study|Physician Decision|0|||
27943992|NCT02967692|81627666|FG001|Overall Study|Physician Decision|0|||
27943993|NCT02967692|81627667|FG002|Overall Study|Physician Decision|13|||
27943994|NCT02967692|81627668|FG003|Overall Study|Physician Decision|9|||
27943995|NCT02967692|81627665|FG000|Overall Study|Adverse Event|1|||
27943996|NCT02967692|81627666|FG001|Overall Study|Adverse Event|9|||
27943997|NCT02967692|81627667|FG002|Overall Study|Adverse Event|51|||
27943998|NCT02967692|81627668|FG003|Overall Study|Adverse Event|23|||
27943999|NCT00980798|81627669|FG000|Overall Study|Adverse Event|7|||
27944000|NCT00980798|81627670|FG001|Overall Study|Adverse Event|36|||
27944001|NCT00980798|81627669|FG000|Overall Study|Lack of Efficacy|16|||
27944002|NCT00980798|81627670|FG001|Overall Study|Lack of Efficacy|5|||
27944003|NCT00980798|81627669|FG000|Overall Study|Lost to Follow-up|0|||
27944004|NCT00980798|81627670|FG001|Overall Study|Lost to Follow-up|1|||
27944005|NCT00980798|81627669|FG000|Overall Study|Physician Decision|2|||
27944006|NCT00980798|81627670|FG001|Overall Study|Physician Decision|1|||
27944007|NCT00980798|81627669|FG000|Overall Study|Withdrawal by Subject|8|||
27944008|NCT00980798|81627670|FG001|Overall Study|Withdrawal by Subject|11|||
27944009|NCT00980798|81627669|FG000|Overall Study|Other|0|||
27944010|NCT00980798|81627670|FG001|Overall Study|Other|1|||
27944011|NCT05185453|81627674|FG000|Overall Study|Lost to Follow-up|13|||
27944012|NCT05185453|81627675|FG001|Overall Study|Lost to Follow-up|3|||
27944013|NCT04629196|81627676|FG000|Overall Study|Subject discontinued study drug|1|||
27944014|NCT04629196|81627677|FG001|Overall Study|Subject discontinued study drug|0|||
27944015|NCT04629196|81627676|FG000|Overall Study|Subject study drug dosing increased|1|||
27944016|NCT04629196|81627677|FG001|Overall Study|Subject study drug dosing increased|1|||
27944017|NCT04629196|81627676|FG000|Overall Study|Withdrawal by Subject|1|||
27944018|NCT04629196|81627677|FG001|Overall Study|Withdrawal by Subject|2|||
27944019|NCT03878602|81627678|FG000|Overall Study|cord blood donation|7|||
27944020|NCT03878602|81627679|FG001|Overall Study|cord blood donation|1|||
27944021|NCT03878602|81627678|FG000|Overall Study|incomplete data collection|2|||
27944022|NCT03878602|81627679|FG001|Overall Study|incomplete data collection|0|||
27944023|NCT02254460|81627681|FG000|Overall Study|Adverse Event|1|||
27944024|NCT02254460|81627682|FG001|Overall Study|Adverse Event|0|||
27944025|NCT00637156|81627683|FG000|Overall Study|Withdrawal by Subject|0|||
27944026|NCT00637156|81627684|FG001|Overall Study|Withdrawal by Subject|7|||
27944027|NCT00637156|81627683|FG000|Overall Study|Death|0|||
27944028|NCT00637156|81627684|FG001|Overall Study|Death|1|||
27647418|NCT02605174|80550798|FG002|Overall Study|Lost to Follow-up|27|||
27647419|NCT02605174|80550799|FG003|Overall Study|Lost to Follow-up|10|||
27944029|NCT00637156|81627683|FG000|Overall Study|Lost to Follow-up|10|||
27944030|NCT00637156|81627684|FG001|Overall Study|Lost to Follow-up|16|||
27944031|NCT03523585|81627685|FG000|Overall Study|Progressive Disease|174|||
27944032|NCT03523585|81627686|FG001|Overall Study|Progressive Disease|64|||
27944033|NCT03523585|81627687|FG002|Overall Study|Progressive Disease|77|||
27944034|NCT03523585|81627685|FG000|Overall Study|Adverse Event|74|||
27944035|NCT03523585|81627686|FG001|Overall Study|Adverse Event|5|||
27944036|NCT03523585|81627687|FG002|Overall Study|Adverse Event|9|||
27944037|NCT03523585|81627685|FG000|Overall Study|Withdrawal by Subject|30|||
27944038|NCT03523585|81627686|FG001|Overall Study|Withdrawal by Subject|11|||
27647420|NCT02605174|80550800|FG004|Overall Study|Lost to Follow-up|20|||
27647421|NCT02605174|80550801|FG005|Overall Study|Lost to Follow-up|10|||
27944039|NCT03523585|81627687|FG002|Overall Study|Withdrawal by Subject|6|||
27944040|NCT03523585|81627685|FG000|Overall Study|Clinical Progression|23|||
27944041|NCT03523585|81627686|FG001|Overall Study|Clinical Progression|5|||
27944042|NCT03523585|81627687|FG002|Overall Study|Clinical Progression|10|||
27944043|NCT03523585|81627685|FG000|Overall Study|Death|4|||
27944044|NCT03523585|81627686|FG001|Overall Study|Death|0|||
27944045|NCT03523585|81627687|FG002|Overall Study|Death|1|||
27944046|NCT03523585|81627685|FG000|Overall Study|Physician Decision|2|||
27944047|NCT03523585|81627686|FG001|Overall Study|Physician Decision|1|||
27944048|NCT03523585|81627687|FG002|Overall Study|Physician Decision|0|||
27944049|NCT03523585|81627685|FG000|Overall Study|Lost to Follow-up|1|||
27944050|NCT03523585|81627686|FG001|Overall Study|Lost to Follow-up|0|||
27944051|NCT03523585|81627687|FG002|Overall Study|Lost to Follow-up|0|||
27944052|NCT03523585|81627685|FG000|Overall Study|Miscellaneous|1|||
27944053|NCT03523585|81627686|FG001|Overall Study|Miscellaneous|0|||
27944054|NCT03523585|81627687|FG002|Overall Study|Miscellaneous|0|||
27944055|NCT03523585|81627685|FG000|Overall Study|Protocol Deviation|1|||
27944056|NCT03523585|81627686|FG001|Overall Study|Protocol Deviation|0|||
27647422|NCT02605174|80550802|FG006|Overall Study|Lost to Follow-up|29|||
27647423|NCT02605174|80550796|FG000|Overall Study|Protocol Violation|10|||
27944057|NCT03523585|81627687|FG002|Overall Study|Protocol Deviation|1|||
27944058|NCT03523585|81627685|FG000|Overall Study|Randomized But Not Treated|2|||
27944059|NCT03523585|81627686|FG001|Overall Study|Randomized But Not Treated|4|||
27944060|NCT03523585|81627687|FG002|Overall Study|Randomized But Not Treated|3|||
27944061|NCT03726879|81627688|FG000|Overall Study|Death|11|||
27944062|NCT03726879|81627689|FG001|Overall Study|Death|13|||
27944063|NCT03726879|81627688|FG000|Overall Study|Physician Decision|0|||
27944064|NCT03726879|81627689|FG001|Overall Study|Physician Decision|2|||
27944065|NCT03726879|81627688|FG000|Overall Study|Protocol Violation|0|||
27944066|NCT03726879|81627689|FG001|Overall Study|Protocol Violation|1|||
27944067|NCT03726879|81627688|FG000|Overall Study|Withdrawal by Subject|5|||
27944068|NCT03726879|81627689|FG001|Overall Study|Withdrawal by Subject|6|||
27944069|NCT03726879|81627688|FG000|Overall Study|TSH result is unstable|0|||
27944070|NCT03726879|81627689|FG001|Overall Study|TSH result is unstable|1|||
27944071|NCT03726879|81627688|FG000|Overall Study|Disease relapse|1|||
27944072|NCT03726879|81627689|FG001|Overall Study|Disease relapse|0|||
27944073|NCT03726879|81627688|FG000|Overall Study|Lost to Follow-up|3|||
27944074|NCT03726879|81627689|FG001|Overall Study|Lost to Follow-up|0|||
27944075|NCT02150863|81627690|FG000|Overall Study|Lost to Follow-up|0|||
27944076|NCT02150863|81627691|FG001|Overall Study|Lost to Follow-up|1|||
27944077|NCT02150863|81627692|FG002|Overall Study|Lost to Follow-up|0|||
27944078|NCT03647137|81627696|FG000|Overall Study|Scan Limitation|2|||
27944079|NCT03647137|81627697|FG001|Overall Study|Scan Limitation|1|||
27944080|NCT03647137|81627698|FG002|Overall Study|Scan Limitation|1|||
27944081|NCT03647137|81627699|FG003|Overall Study|Scan Limitation|2|||
27944082|NCT00552279|81627700|FG000|Overall Study|Adverse Event|0|||
27944083|NCT00552279|81627701|FG001|Overall Study|Adverse Event|1|||
27944084|NCT00552279|81627700|FG000|Overall Study|Withdrawal by Subject|12|||
27944085|NCT00552279|81627701|FG001|Overall Study|Withdrawal by Subject|1|||
27944086|NCT00552279|81627700|FG000|Overall Study|Lost to Follow-up|1|||
27944087|NCT00552279|81627701|FG001|Overall Study|Lost to Follow-up|0|||
27944088|NCT00552279|81627700|FG000|Overall Study|Other|1|||
27944089|NCT00552279|81627701|FG001|Overall Study|Other|1|||
27944090|NCT02936323|81627705|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27944091|NCT02936323|81627706|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27944092|NCT02936323|81627707|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27944093|NCT02936323|81627708|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27647424|NCT02605174|80550797|FG001|Overall Study|Protocol Violation|4|||
27647425|NCT02605174|80550798|FG002|Overall Study|Protocol Violation|14|||
27647426|NCT02605174|80550799|FG003|Overall Study|Protocol Violation|6|||
27647427|NCT02605174|80550800|FG004|Overall Study|Protocol Violation|7|||
27647428|NCT02605174|80550801|FG005|Overall Study|Protocol Violation|7|||
27647429|NCT02605174|80550802|FG006|Overall Study|Protocol Violation|12|||
27647430|NCT02605174|80550796|FG000|Overall Study|Pregnancy|1|||
27647431|NCT02605174|80550797|FG001|Overall Study|Pregnancy|0|||
27647432|NCT02605174|80550798|FG002|Overall Study|Pregnancy|0|||
27647433|NCT02605174|80550799|FG003|Overall Study|Pregnancy|2|||
27647434|NCT02605174|80550800|FG004|Overall Study|Pregnancy|0|||
27647435|NCT02605174|80550801|FG005|Overall Study|Pregnancy|0|||
27647436|NCT02605174|80550802|FG006|Overall Study|Pregnancy|0|||
27647437|NCT02605174|80550796|FG000|Overall Study|Withdrawal by Subject|9|||
27647438|NCT02605174|80550797|FG001|Overall Study|Withdrawal by Subject|6|||
27647439|NCT02605174|80550798|FG002|Overall Study|Withdrawal by Subject|14|||
27647440|NCT02605174|80550799|FG003|Overall Study|Withdrawal by Subject|11|||
27647441|NCT02605174|80550800|FG004|Overall Study|Withdrawal by Subject|6|||
27647442|NCT02605174|80550801|FG005|Overall Study|Withdrawal by Subject|4|||
27647443|NCT02605174|80550802|FG006|Overall Study|Withdrawal by Subject|15|||
27647444|NCT02605174|80550796|FG000|Overall Study|Physician Decision|2|||
27647445|NCT02605174|80550797|FG001|Overall Study|Physician Decision|0|||
27647446|NCT02605174|80550798|FG002|Overall Study|Physician Decision|0|||
27647447|NCT02605174|80550799|FG003|Overall Study|Physician Decision|0|||
27647448|NCT02605174|80550800|FG004|Overall Study|Physician Decision|0|||
27647449|NCT02605174|80550801|FG005|Overall Study|Physician Decision|0|||
27647450|NCT02605174|80550802|FG006|Overall Study|Physician Decision|3|||
27647451|NCT02605174|80550796|FG000|Overall Study|Randomization Failure|22|||
27647452|NCT02605174|80550797|FG001|Overall Study|Randomization Failure|6|||
27647453|NCT02605174|80550798|FG002|Overall Study|Randomization Failure|20|||
27647454|NCT02605174|80550799|FG003|Overall Study|Randomization Failure|7|||
27647455|NCT02605174|80550800|FG004|Overall Study|Randomization Failure|16|||
27647456|NCT02605174|80550801|FG005|Overall Study|Randomization Failure|11|||
27647457|NCT02605174|80550802|FG006|Overall Study|Randomization Failure|30|||
27647458|NCT04334317|80550804|FG000|Overall Study|Adverse Event|1|||
27647459|NCT04334317|80550805|FG001|Overall Study|Adverse Event|2|||
27647460|NCT04334317|80550806|FG002|Overall Study|Adverse Event|0|||
27647461|NCT04334317|80550807|FG003|Overall Study|Adverse Event|0|||
27647462|NCT04334317|80550804|FG000|Overall Study|Protocol Deviation|0|||
27647463|NCT04334317|80550805|FG001|Overall Study|Protocol Deviation|1|||
27647464|NCT04334317|80550806|FG002|Overall Study|Protocol Deviation|0|||
27647465|NCT04334317|80550807|FG003|Overall Study|Protocol Deviation|0|||
27647466|NCT04334317|80550804|FG000|Overall Study|Withdrawal by Subject|2|||
27647467|NCT04334317|80550805|FG001|Overall Study|Withdrawal by Subject|2|||
27647468|NCT04334317|80550806|FG002|Overall Study|Withdrawal by Subject|0|||
27647469|NCT04334317|80550807|FG003|Overall Study|Withdrawal by Subject|0|||
27647470|NCT03905642|80550809|FG000|Overall Study|Withdrawal by Subject|3|||
27647471|NCT03905642|80550809|FG000|Overall Study|Pregnancy|1|||
27944094|NCT02936323|81627709|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27944095|NCT02936323|81627710|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
27944096|NCT02936323|81627711|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27944097|NCT02936323|81627712|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27944098|NCT02936323|81627713|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27944099|NCT02936323|81627714|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
27944100|NCT02936323|81627705|FG000|Phase 1 Dose Escalation|Death|2|||
27944101|NCT02936323|81627706|FG001|Phase 1 Dose Escalation|Death|1|||
27944102|NCT02936323|81627707|FG002|Phase 1 Dose Escalation|Death|3|||
27944103|NCT02936323|81627708|FG003|Phase 1 Dose Escalation|Death|1|||
27944104|NCT02936323|81627709|FG004|Phase 1 Dose Escalation|Death|2|||
27944105|NCT02936323|81627710|FG005|Phase 1 Dose Escalation|Death|3|||
27944106|NCT02936323|81627711|FG006|Phase 1 Dose Escalation|Death|3|||
27944107|NCT02936323|81627712|FG007|Phase 1 Dose Escalation|Death|0|||
27944108|NCT02936323|81627713|FG008|Phase 1 Dose Escalation|Death|0|||
27944109|NCT02936323|81627714|FG009|Phase 1 Dose Escalation|Death|0|||
27944110|NCT02936323|81627705|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944111|NCT02936323|81627706|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944112|NCT02936323|81627707|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944113|NCT02936323|81627708|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944114|NCT02936323|81627709|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944115|NCT02936323|81627710|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
27944116|NCT02936323|81627711|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944117|NCT02936323|81627712|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944118|NCT02936323|81627713|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944119|NCT02936323|81627714|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
27944120|NCT02936323|81627705|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944121|NCT02936323|81627706|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944122|NCT02936323|81627707|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944123|NCT02936323|81627708|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944124|NCT02936323|81627709|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944125|NCT02936323|81627710|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944126|NCT02936323|81627711|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
27944127|NCT02936323|81627712|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
27944128|NCT02936323|81627713|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
27944129|NCT02936323|81627714|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
27944130|NCT02936323|81627705|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
27944131|NCT02936323|81627706|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
27944132|NCT02936323|81627707|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
27944133|NCT02936323|81627708|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
27944134|NCT02936323|81627709|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
27944135|NCT02936323|81627710|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
27944136|NCT02936323|81627711|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
27944137|NCT02936323|81627712|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
27944138|NCT02936323|81627713|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
27944139|NCT02936323|81627714|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
27944140|NCT02936323|81627705|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944141|NCT02936323|81627706|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944142|NCT02936323|81627707|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944143|NCT02936323|81627708|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944144|NCT02936323|81627709|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944145|NCT02936323|81627710|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944146|NCT02936323|81627711|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944147|NCT02936323|81627712|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
27944148|NCT02936323|81627713|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
27944149|NCT02936323|81627714|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
27944150|NCT02936323|81627705|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944151|NCT02936323|81627706|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944152|NCT02936323|81627707|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944153|NCT02936323|81627708|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944154|NCT02936323|81627709|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944155|NCT02936323|81627710|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944156|NCT02936323|81627711|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944157|NCT02936323|81627712|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944158|NCT02936323|81627713|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
27944159|NCT02936323|81627714|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
27944160|NCT02936323|81627705|FG000|Phase 2a Dose Expansion|Death|0|||
27944161|NCT02936323|81627706|FG001|Phase 2a Dose Expansion|Death|0|||
27944162|NCT02936323|81627707|FG002|Phase 2a Dose Expansion|Death|0|||
27944163|NCT02936323|81627708|FG003|Phase 2a Dose Expansion|Death|0|||
27944164|NCT02936323|81627709|FG004|Phase 2a Dose Expansion|Death|0|||
27944165|NCT02936323|81627710|FG005|Phase 2a Dose Expansion|Death|0|||
27944166|NCT02936323|81627711|FG006|Phase 2a Dose Expansion|Death|0|||
27944167|NCT02936323|81627712|FG007|Phase 2a Dose Expansion|Death|4|||
27944168|NCT02936323|81627713|FG008|Phase 2a Dose Expansion|Death|8|||
27944169|NCT02936323|81627714|FG009|Phase 2a Dose Expansion|Death|10|||
27944170|NCT03906071|81627715|FG000|Overall Study|Death|180|||
27944171|NCT03906071|81627716|FG001|Overall Study|Death|185|||
27944172|NCT03906071|81627715|FG000|Overall Study|Lost to Follow-up|3|||
27944173|NCT03906071|81627716|FG001|Overall Study|Lost to Follow-up|3|||
27944174|NCT03906071|81627715|FG000|Overall Study|Withdrawal by Subject|15|||
27944175|NCT03906071|81627716|FG001|Overall Study|Withdrawal by Subject|27|||
27944176|NCT03906071|81627715|FG000|Overall Study|Other|2|||
27944177|NCT03906071|81627716|FG001|Overall Study|Other|1|||
27944178|NCT05852340|81627721|FG000|Period 5|Not completing the meal|0|||
27944179|NCT05852340|81627722|FG001|Period 5|Not completing the meal|1|||
27944180|NCT05852340|81627723|FG002|Period 5|Not completing the meal|0|||
27944181|NCT05852340|81627724|FG003|Period 5|Not completing the meal|0|||
27944182|NCT05852340|81627721|FG000|Period 5|Adverse Event|0|||
27944183|NCT05852340|81627722|FG001|Period 5|Adverse Event|0|||
27944184|NCT05852340|81627723|FG002|Period 5|Adverse Event|0|||
27944185|NCT05852340|81627724|FG003|Period 5|Adverse Event|1|||
27944186|NCT05535972|81627725|FG000|Overall Study|Withdrawal by Subject|31|||
27944187|NCT05535972|81627725|FG000|Overall Study|Lost to Follow-up|5|||
27944188|NCT05535972|81627725|FG000|Overall Study|Adverse Event|6|||
27944189|NCT05535972|81627725|FG000|Overall Study|Protocol Deviation|2|||
27944190|NCT02971137|81627726|FG000|Overall Study|Lost to Follow-up|44|||
27944191|NCT02971137|81627727|FG001|Overall Study|Lost to Follow-up|56|||
27944192|NCT02462057|81627728|FG000|Overall Study|Left Vitality|32|||
27944193|NCT02462057|81627729|FG001|Overall Study|Left Vitality|27|||
27944194|NCT02462057|81627730|FG002|Overall Study|Left Vitality|23|||
27944195|NCT02462057|81627731|FG003|Overall Study|Left Vitality|35|||
27944196|NCT02462057|81627732|FG004|Overall Study|Left Vitality|33|||
27944197|NCT02462057|81627728|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
27944198|NCT02462057|81627729|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
27944199|NCT02462057|81627730|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
27944200|NCT02462057|81627731|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
27944201|NCT02462057|81627732|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
27944202|NCT02624687|81627733|FG000|Overall Study|Withdrawal by Subject|1|||
27944203|NCT02624687|81627734|FG001|Overall Study|Withdrawal by Subject|1|||
27944204|NCT02624687|81627733|FG000|Overall Study|medical leave from work|0|||
27944205|NCT02624687|81627734|FG001|Overall Study|medical leave from work|1|||
27944206|NCT00185614|81627735|FG000|Inter-treatment Period|Physician Decision|1|||
27944207|NCT00185614|81627735|FG000|Inter-treatment Period|Relapse|2|||
27944208|NCT00185614|81627735|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
27944209|NCT01381679|81627736|FG000|Overall Study|Adverse Event|3|||
27944210|NCT01381679|81627736|FG000|Overall Study|Lost to Follow-up|885|||
27944211|NCT03436732|81627737|FG000|Overall Study|Not treated-enrolled in different study|1|||
27944212|NCT03436732|81627738|FG001|Overall Study|Not treated-enrolled in different study|0|||
27944213|NCT03436732|81627737|FG000|Overall Study|Off study after cycle 1|1|||
27944214|NCT03436732|81627738|FG001|Overall Study|Off study after cycle 1|0|||
27944215|NCT03436732|81627737|FG000|Overall Study|Adverse Event|2|||
27944216|NCT03436732|81627738|FG001|Overall Study|Adverse Event|0|||
27944217|NCT03436732|81627737|FG000|Overall Study|Death|0|||
27944218|NCT03436732|81627738|FG001|Overall Study|Death|1|||
27944219|NCT05654181|81627739|FG000|Overall Study|Adverse Event|1|||
27944220|NCT05654181|81627740|FG001|Overall Study|Adverse Event|0|||
27944221|NCT05654181|81627741|FG002|Overall Study|Adverse Event|0|||
27944222|NCT05654181|81627742|FG003|Overall Study|Adverse Event|0|||
27944223|NCT05654181|81627743|FG004|Overall Study|Adverse Event|0|||
27944224|NCT05654181|81627744|FG005|Overall Study|Adverse Event|0|||
27944225|NCT05654181|81627745|FG006|Overall Study|Adverse Event|0|||
27944226|NCT05654181|81627746|FG007|Overall Study|Adverse Event|1|||
27944227|NCT05654181|81627747|FG008|Overall Study|Adverse Event|0|||
27944228|NCT05654181|81627748|FG009|Overall Study|Adverse Event|0|||
27944229|NCT05654181|81627739|FG000|Overall Study|Withdrawal by Subject|0|||
27944230|NCT05654181|81627740|FG001|Overall Study|Withdrawal by Subject|0|||
27944231|NCT05654181|81627741|FG002|Overall Study|Withdrawal by Subject|0|||
27944232|NCT05654181|81627742|FG003|Overall Study|Withdrawal by Subject|0|||
27944233|NCT05654181|81627743|FG004|Overall Study|Withdrawal by Subject|0|||
27944234|NCT05654181|81627744|FG005|Overall Study|Withdrawal by Subject|0|||
27944235|NCT05654181|81627745|FG006|Overall Study|Withdrawal by Subject|0|||
27944236|NCT05654181|81627746|FG007|Overall Study|Withdrawal by Subject|1|||
27944237|NCT05654181|81627747|FG008|Overall Study|Withdrawal by Subject|0|||
27944238|NCT05654181|81627748|FG009|Overall Study|Withdrawal by Subject|0|||
27944239|NCT05654181|81627739|FG000|Overall Study|Other|0|||
27944240|NCT05654181|81627740|FG001|Overall Study|Other|0|||
27944241|NCT05654181|81627741|FG002|Overall Study|Other|0|||
27944242|NCT05654181|81627742|FG003|Overall Study|Other|0|||
27944243|NCT05654181|81627743|FG004|Overall Study|Other|1|||
27944244|NCT05654181|81627744|FG005|Overall Study|Other|1|||
27944245|NCT05654181|81627745|FG006|Overall Study|Other|0|||
27944246|NCT05654181|81627746|FG007|Overall Study|Other|0|||
27944247|NCT05654181|81627747|FG008|Overall Study|Other|0|||
27944248|NCT05654181|81627748|FG009|Overall Study|Other|0|||
27944249|NCT00456365|81627755|FG000|Overall Study|Lost to Follow-up|1|||
27944250|NCT00456365|81627756|FG001|Overall Study|Lost to Follow-up|3|||
27944251|NCT00456365|81627755|FG000|Overall Study|Withdrawal by Subject|4|||
27944252|NCT00456365|81627756|FG001|Overall Study|Withdrawal by Subject|7|||
27944253|NCT00456365|81627755|FG000|Overall Study|Pregnancy|1|||
27944254|NCT00456365|81627756|FG001|Overall Study|Pregnancy|1|||
27944255|NCT00456365|81627755|FG000|Overall Study|oncologic diagnosis|1|||
27944256|NCT00456365|81627756|FG001|Overall Study|oncologic diagnosis|1|||
27944257|NCT02933151|81627757|FG000|Overall Study|Lost to Follow-up|19|||
27944258|NCT02933151|81627758|FG001|Overall Study|Lost to Follow-up|18|||
27944259|NCT02933151|81627757|FG000|Overall Study|Death|1732|||
27944260|NCT02933151|81627758|FG001|Overall Study|Death|1827|||
27944261|NCT02933151|81627757|FG000|Overall Study|Transplant|210|||
27944262|NCT02933151|81627758|FG001|Overall Study|Transplant|278|||
27944263|NCT02933151|81627757|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
27944264|NCT02933151|81627758|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
27944265|NCT02933151|81627757|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
27944266|NCT02933151|81627758|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
27944267|NCT02933151|81627757|FG000|Overall Study|Recovered Kidney Function|47|||
27944268|NCT02933151|81627758|FG001|Overall Study|Recovered Kidney Function|29|||
27944269|NCT03921528|81627759|FG000|Overall Study|Withdrawal by Subject|0|||
27944270|NCT03921528|81627760|FG001|Overall Study|Withdrawal by Subject|1|||
27944271|NCT03921528|81627761|FG002|Overall Study|Withdrawal by Subject|0|||
27944272|NCT03921528|81627762|FG003|Overall Study|Withdrawal by Subject|0|||
27944273|NCT03921528|81627763|FG004|Overall Study|Withdrawal by Subject|0|||
27944274|NCT02609503|81627764|FG000|Overall Study|Adverse Event|1|||
27944275|NCT02609503|81627764|FG000|Overall Study|Death|1|||
27944276|NCT02609503|81627764|FG000|Overall Study|Withdrawal by Subject|1|||
27944277|NCT02609503|81627764|FG000|Overall Study|Disease progression|1|||
27944278|NCT02743221|81627765|FG000|Overall Study|Progressive disease|29|||
27944279|NCT02743221|81627766|FG001|Overall Study|Progressive disease|38|||
27944280|NCT02743221|81627765|FG000|Overall Study|Adverse Event|17|||
27944281|NCT02743221|81627766|FG001|Overall Study|Adverse Event|14|||
27944282|NCT02743221|81627765|FG000|Overall Study|non medical reason|8|||
27944283|NCT02743221|81627766|FG001|Overall Study|non medical reason|2|||
27944284|NCT02743221|81627765|FG000|Overall Study|Physician Decision|2|||
27944285|NCT02743221|81627766|FG001|Overall Study|Physician Decision|5|||
27944286|NCT02743221|81627765|FG000|Overall Study|Patient not eligible, not treated|0|||
27944287|NCT02743221|81627766|FG001|Overall Study|Patient not eligible, not treated|1|||
27944288|NCT01926509|81627767|FG000|Overall Study|vital sign met discontinuation criteria|1|||
27944289|NCT01926509|81627768|FG001|Overall Study|vital sign met discontinuation criteria|0|||
27944290|NCT01926509|81627769|FG002|Overall Study|vital sign met discontinuation criteria|0|||
27944291|NCT01926509|81627770|FG003|Overall Study|vital sign met discontinuation criteria|0|||
27944292|NCT01793129|81627771|FG000|Overall Study|Lost to Follow-up|3|||
27944293|NCT01793129|81627772|FG001|Overall Study|Lost to Follow-up|7|||
27944294|NCT01793129|81627771|FG000|Overall Study|Withdrawal by Subject|0|||
27944295|NCT01793129|81627772|FG001|Overall Study|Withdrawal by Subject|2|||
27944296|NCT03312543|81627776|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
27944297|NCT03312543|81627777|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
27944298|NCT03312543|81627776|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
27944299|NCT03312543|81627777|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
27944300|NCT03312543|81627776|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
27944301|NCT03312543|81627777|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
27944302|NCT03312543|81627776|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
27944303|NCT03312543|81627777|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
27944304|NCT03312543|81627776|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
27944305|NCT03312543|81627777|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
27944306|NCT03312543|81627776|FG000|Regression (Week 12 to Week 24)|Death|0|||
27944307|NCT03312543|81627777|FG001|Regression (Week 12 to Week 24)|Death|1|||
27944308|NCT01681849|81630358|FG000|Overall Study|Protocol Violation|2|||
27944309|NCT01681849|81630359|FG001|Overall Study|Protocol Violation|0|||
27944310|NCT01681849|81630360|FG002|Overall Study|Protocol Violation|0|||
27944311|NCT01681849|81630358|FG000|Overall Study|Withdrawal by Subject|3|||
27944312|NCT01681849|81630359|FG001|Overall Study|Withdrawal by Subject|5|||
27944313|NCT01681849|81630360|FG002|Overall Study|Withdrawal by Subject|33|||
27944314|NCT01681849|81630358|FG000|Overall Study|Lost to Follow-up|3|||
27944315|NCT01681849|81630359|FG001|Overall Study|Lost to Follow-up|2|||
27944316|NCT01681849|81630360|FG002|Overall Study|Lost to Follow-up|6|||
27944317|NCT01487161|81630361|FG000|Overall Study|Adverse Event|1|||
27944318|NCT01487161|81630362|FG001|Overall Study|Adverse Event|0|||
27944319|NCT01487161|81630363|FG002|Overall Study|Adverse Event|0|||
27944320|NCT01487161|81630364|FG003|Overall Study|Adverse Event|0|||
27944321|NCT01487161|81630361|FG000|Overall Study|Withdrawal by Subject|1|||
27944322|NCT01487161|81630362|FG001|Overall Study|Withdrawal by Subject|1|||
27944323|NCT01487161|81630363|FG002|Overall Study|Withdrawal by Subject|1|||
27944324|NCT01487161|81630364|FG003|Overall Study|Withdrawal by Subject|2|||
27944325|NCT01487161|81630361|FG000|Overall Study|missing data|0|||
27944326|NCT01487161|81630362|FG001|Overall Study|missing data|1|||
27944327|NCT01487161|81630363|FG002|Overall Study|missing data|0|||
27944328|NCT01487161|81630364|FG003|Overall Study|missing data|0|||
27944329|NCT04909801|81630365|FG000|Overall Study|Lack of Efficacy|2|||
27944330|NCT04909801|81630366|FG001|Overall Study|Lack of Efficacy|1|||
27944331|NCT04909801|81630365|FG000|Overall Study|Adverse Event|1|||
27944332|NCT04909801|81630366|FG001|Overall Study|Adverse Event|2|||
27944333|NCT04909801|81630365|FG000|Overall Study|Participant request to discontinue study treatment|1|||
27944334|NCT04909801|81630366|FG001|Overall Study|Participant request to discontinue study treatment|2|||
27944335|NCT04909801|81630365|FG000|Overall Study|Withdrawal by Subject|2|||
27944336|NCT04909801|81630366|FG001|Overall Study|Withdrawal by Subject|1|||
27944337|NCT04909801|81630365|FG000|Overall Study|other reasons|1|||
27944338|NCT04909801|81630366|FG001|Overall Study|other reasons|1|||
27944339|NCT00493285|81630370|FG000|Overall Study|Lost to Follow-up|0|||
27944340|NCT00493285|81630371|FG001|Overall Study|Lost to Follow-up|0|||
27944341|NCT00493285|81630372|FG002|Overall Study|Lost to Follow-up|0|||
27944342|NCT00493285|81630373|FG003|Overall Study|Lost to Follow-up|0|||
27551363|NCT01543698|80207471|FG013|Phase 1b|Withdrawal by Subject|0|||
27647472|NCT03905642|80550809|FG000|Overall Study|Adverse Event|1|||
27647473|NCT03905642|80550809|FG000|Overall Study|Lack of Efficacy|1|||
27647474|NCT03905642|80550809|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
27647475|NCT03244800|80550810|FG000|Overall Study|Adverse Event|0|||
27647476|NCT03244800|80550811|FG001|Overall Study|Adverse Event|1|||
27647477|NCT03244800|80550812|FG002|Overall Study|Adverse Event|0|||
27647478|NCT03244800|80550813|FG003|Overall Study|Adverse Event|1|||
27647479|NCT03244800|80550810|FG000|Overall Study|Withdrew treatment|0|||
27647480|NCT03244800|80550811|FG001|Overall Study|Withdrew treatment|0|||
27647481|NCT03244800|80550812|FG002|Overall Study|Withdrew treatment|0|||
27647482|NCT03244800|80550813|FG003|Overall Study|Withdrew treatment|1|||
27647483|NCT03259568|80550815|FG000|Overall Study|Participant performance was low|3|||
27647484|NCT00326183|80550820|FG000|Overall Study|Lost to Follow-up|104|||
27647485|NCT00326183|80550821|FG001|Overall Study|Lost to Follow-up|56|||
27647486|NCT00326183|80550820|FG000|Overall Study|Protocol Violation|6|||
27647487|NCT00326183|80550821|FG001|Overall Study|Protocol Violation|3|||
27647488|NCT00326183|80550820|FG000|Overall Study|Withdrawal by Subject|35|||
27647489|NCT00326183|80550821|FG001|Overall Study|Withdrawal by Subject|7|||
27647490|NCT00326183|80550820|FG000|Overall Study|Subject Moved|7|||
27647491|NCT00326183|80550821|FG001|Overall Study|Subject Moved|4|||
27647492|NCT00326183|80550820|FG000|Overall Study|Other|47|||
27647493|NCT00326183|80550821|FG001|Overall Study|Other|13|||
27647494|NCT00326183|80550820|FG000|Overall Study|Adverse Event|1|||
27647495|NCT00326183|80550821|FG001|Overall Study|Adverse Event|0|||
27647496|NCT04248868|80550832|FG000|Overall Study|Death|1|||
27647497|NCT04248868|80550832|FG000|Overall Study|Lost to Follow-up|3|||
27647498|NCT04248868|80550832|FG000|Overall Study|Protocol Violation|2|||
27647499|NCT00337610|80550833|FG000|Overall Study|Adverse Event|2|||
27647500|NCT00337610|80550834|FG001|Overall Study|Adverse Event|2|||
27647501|NCT00337610|80550833|FG000|Overall Study|Death|0|||
27647502|NCT00337610|80550834|FG001|Overall Study|Death|1|||
27647503|NCT00337610|80550833|FG000|Overall Study|Lack of Efficacy|6|||
27647504|NCT00337610|80550834|FG001|Overall Study|Lack of Efficacy|3|||
27647505|NCT00337610|80550833|FG000|Overall Study|Lost to Follow-up|3|||
27647506|NCT00337610|80550834|FG001|Overall Study|Lost to Follow-up|3|||
27647507|NCT00337610|80550833|FG000|Overall Study|Withdrawal by Subject|6|||
27647508|NCT00337610|80550834|FG001|Overall Study|Withdrawal by Subject|5|||
27647509|NCT01957163|80550838|FG000|Overall Study|Adverse Event|5|||
27647510|NCT01957163|80550839|FG001|Overall Study|Adverse Event|2|||
27647511|NCT01957163|80550840|FG002|Overall Study|Adverse Event|4|||
27647512|NCT01957163|80550838|FG000|Overall Study|Lack of Efficacy|5|||
27647513|NCT01957163|80550839|FG001|Overall Study|Lack of Efficacy|4|||
27647514|NCT01957163|80550840|FG002|Overall Study|Lack of Efficacy|9|||
27647515|NCT01957163|80550838|FG000|Overall Study|Protocol Violation|1|||
27647516|NCT01957163|80550839|FG001|Overall Study|Protocol Violation|2|||
27647517|NCT01957163|80550840|FG002|Overall Study|Protocol Violation|0|||
27647518|NCT01957163|80550838|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
27647519|NCT01957163|80550839|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
27944343|NCT00493285|81630374|FG004|Overall Study|Lost to Follow-up|1|||
27944344|NCT00493285|81630375|FG005|Overall Study|Lost to Follow-up|0|||
27944345|NCT01491919|81630376|FG000|Overall Study|Insufficient PK sampling|1|||
27944346|NCT01491919|81630377|FG001|Overall Study|Insufficient PK sampling|2|||
27944347|NCT01491919|81630378|FG002|Overall Study|Insufficient PK sampling|1|||
27944348|NCT00814983|81630386|FG000|Overall Study|Screen failure|1|||
27647520|NCT01957163|80550840|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
27944349|NCT00814983|81630387|FG001|Overall Study|Screen failure|0|||
27944350|NCT00814983|81630386|FG000|Overall Study|Withdrawal by Subject|1|||
27944351|NCT00814983|81630387|FG001|Overall Study|Withdrawal by Subject|0|||
27944352|NCT00814983|81630386|FG000|Overall Study|Graft failure|1|||
27944353|NCT00814983|81630387|FG001|Overall Study|Graft failure|0|||
27944354|NCT01416831|81630390|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
27944355|NCT01416831|81630391|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
27944356|NCT04918771|81630392|FG000|Overall Study|Withdrawal by Subject|4|||
27944357|NCT04918771|81630393|FG001|Overall Study|Withdrawal by Subject|5|||
27944358|NCT04918771|81630392|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
27944359|NCT04918771|81630393|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
27944360|NCT02607722|81630394|FG000|Overall Study|No data reliability|1|||
27944361|NCT02607722|81630394|FG000|Overall Study|no patient visit|18|||
27944362|NCT02607722|81630394|FG000|Overall Study|missing info in CRF|13|||
27944363|NCT02607722|81630394|FG000|Overall Study|Withdrawal by Subject|616|||
27944364|NCT02607722|81630394|FG000|Overall Study|Lost to Follow-up|312|||
27944365|NCT02607722|81630394|FG000|Overall Study|Improved|22|||
27944366|NCT02607722|81630394|FG000|Overall Study|Lack of Efficacy|316|||
27944367|NCT02607722|81630394|FG000|Overall Study|Adverse Event|2553|||
27944368|NCT02607722|81630394|FG000|Overall Study|Not treated|1|||
27944369|NCT02607722|81630394|FG000|Overall Study|No CRF collected|138|||
27944370|NCT02607722|81630394|FG000|Overall Study|without CRF|4225|||
27944371|NCT02607722|81630394|FG000|Overall Study|Physician Decision|367|||
27944372|NCT02264821|81630395|FG000|Overall Study|Protocol Violation|1|||
27944373|NCT02264821|81630396|FG001|Overall Study|Protocol Violation|3|||
27944374|NCT02264821|81630397|FG002|Overall Study|Protocol Violation|6|||
27944375|NCT03579719|81630398|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
27944376|NCT01443026|81630400|FG000|Overall Study|Physician Decision|1|||
27944377|NCT01443026|81630401|FG001|Overall Study|Physician Decision|0|||
27944378|NCT01443026|81630400|FG000|Overall Study|Death|0|||
27944379|NCT01443026|81630401|FG001|Overall Study|Death|1|||
27944380|NCT01443026|81630400|FG000|Overall Study|Withdrawal by Subject|0|||
27944381|NCT01443026|81630401|FG001|Overall Study|Withdrawal by Subject|3|||
27944382|NCT01443026|81630400|FG000|Overall Study|Lost to Follow-up|2|||
27647521|NCT01957163|80550838|FG000|Overall Study|Lost to Follow-up|0|||
27647522|NCT01957163|80550839|FG001|Overall Study|Lost to Follow-up|1|||
27944383|NCT01443026|81630401|FG001|Overall Study|Lost to Follow-up|1|||
27944384|NCT00500331|81630411|FG000|Overall Study|Adverse Event|0|||
27944385|NCT00500331|81630412|FG001|Overall Study|Adverse Event|2|||
27944386|NCT00500331|81630413|FG002|Overall Study|Adverse Event|0|||
27944387|NCT00500331|81630414|FG003|Overall Study|Adverse Event|1|||
27944388|NCT00500331|81630415|FG004|Overall Study|Adverse Event|2|||
27944389|NCT00500331|81630416|FG005|Overall Study|Adverse Event|2|||
27944390|NCT00500331|81630417|FG006|Overall Study|Adverse Event|0|||
27944391|NCT00500331|81630411|FG000|Overall Study|Lost to Follow-up|1|||
27944392|NCT00500331|81630412|FG001|Overall Study|Lost to Follow-up|1|||
27647523|NCT01957163|80550840|FG002|Overall Study|Lost to Follow-up|0|||
27647524|NCT01957163|80550838|FG000|Overall Study|Withdrawal by Subject|4|||
27647525|NCT01957163|80550839|FG001|Overall Study|Withdrawal by Subject|2|||
27647526|NCT01957163|80550840|FG002|Overall Study|Withdrawal by Subject|4|||
27647527|NCT00692913|80550844|FG000|Overall Study|Adverse Event|8|||
27647528|NCT00692913|80550845|FG001|Overall Study|Adverse Event|4|||
27647529|NCT00692913|80550844|FG000|Overall Study|Lost to Follow-up|3|||
27647530|NCT00692913|80550845|FG001|Overall Study|Lost to Follow-up|5|||
27647531|NCT00692913|80550844|FG000|Overall Study|Physician Decision|2|||
27647532|NCT00692913|80550845|FG001|Overall Study|Physician Decision|0|||
27647533|NCT00692913|80550844|FG000|Overall Study|Protocol Violation|1|||
27647534|NCT00692913|80550845|FG001|Overall Study|Protocol Violation|1|||
27647535|NCT00692913|80550844|FG000|Overall Study|Withdrawal by Subject|15|||
27647536|NCT00692913|80550845|FG001|Overall Study|Withdrawal by Subject|20|||
27647537|NCT00747006|80550846|FG000|Overall Study|Adverse Event|1|||
27647538|NCT00747006|80550847|FG001|Overall Study|Adverse Event|0|||
27647539|NCT00747006|80550848|FG002|Overall Study|Adverse Event|0|||
27944393|NCT00500331|81630413|FG002|Overall Study|Lost to Follow-up|1|||
27944394|NCT00500331|81630414|FG003|Overall Study|Lost to Follow-up|2|||
27944395|NCT00500331|81630415|FG004|Overall Study|Lost to Follow-up|1|||
27944396|NCT00500331|81630416|FG005|Overall Study|Lost to Follow-up|0|||
27944397|NCT00500331|81630417|FG006|Overall Study|Lost to Follow-up|0|||
27944398|NCT00500331|81630411|FG000|Overall Study|Protocol Violation|3|||
27944399|NCT00500331|81630412|FG001|Overall Study|Protocol Violation|1|||
27944400|NCT00500331|81630413|FG002|Overall Study|Protocol Violation|1|||
27944401|NCT00500331|81630414|FG003|Overall Study|Protocol Violation|0|||
27944402|NCT00500331|81630415|FG004|Overall Study|Protocol Violation|1|||
27944403|NCT00500331|81630416|FG005|Overall Study|Protocol Violation|1|||
27944404|NCT00500331|81630417|FG006|Overall Study|Protocol Violation|1|||
27944405|NCT00500331|81630411|FG000|Overall Study|Withdrawal by Subject|4|||
27944406|NCT00500331|81630412|FG001|Overall Study|Withdrawal by Subject|0|||
27944407|NCT00500331|81630413|FG002|Overall Study|Withdrawal by Subject|1|||
27944408|NCT00500331|81630414|FG003|Overall Study|Withdrawal by Subject|5|||
27944409|NCT00500331|81630415|FG004|Overall Study|Withdrawal by Subject|0|||
27647540|NCT00747006|80550846|FG000|Overall Study|Lost to Follow-up|0|||
27647541|NCT00747006|80550847|FG001|Overall Study|Lost to Follow-up|1|||
27647542|NCT00747006|80550848|FG002|Overall Study|Lost to Follow-up|0|||
27647543|NCT00747006|80550846|FG000|Overall Study|Physician Decision|2|||
27647544|NCT00747006|80550847|FG001|Overall Study|Physician Decision|0|||
27647545|NCT00747006|80550848|FG002|Overall Study|Physician Decision|1|||
27647546|NCT03653364|80550849|FG000|Overall Study|Withdrawal by Subject|1|||
27647547|NCT03653364|80550849|FG000|Overall Study|Enrolled in Error|1|||
27647548|NCT03653364|80550849|FG000|Overall Study|Death|1|||
27647549|NCT03057600|80550854|FG000|Overall Study|Adverse Event|0|||
27647550|NCT03057600|80550855|FG001|Overall Study|Adverse Event|0|||
27647551|NCT03057600|80550856|FG002|Overall Study|Adverse Event|4|||
27647552|NCT03057600|80550857|FG003|Overall Study|Adverse Event|0|||
27944410|NCT00500331|81630416|FG005|Overall Study|Withdrawal by Subject|1|||
27944411|NCT00500331|81630417|FG006|Overall Study|Withdrawal by Subject|1|||
27944412|NCT00500331|81630411|FG000|Overall Study|Lack of Efficacy|3|||
27944413|NCT00500331|81630412|FG001|Overall Study|Lack of Efficacy|1|||
27944414|NCT00500331|81630413|FG002|Overall Study|Lack of Efficacy|0|||
27944415|NCT00500331|81630414|FG003|Overall Study|Lack of Efficacy|0|||
27944416|NCT00500331|81630415|FG004|Overall Study|Lack of Efficacy|0|||
27944417|NCT00500331|81630416|FG005|Overall Study|Lack of Efficacy|0|||
27944418|NCT00500331|81630417|FG006|Overall Study|Lack of Efficacy|0|||
27944419|NCT00500331|81630411|FG000|Overall Study|Liver function test abnormality|0|||
27944420|NCT00500331|81630412|FG001|Overall Study|Liver function test abnormality|0|||
27944421|NCT00500331|81630413|FG002|Overall Study|Liver function test abnormality|1|||
27944422|NCT00500331|81630414|FG003|Overall Study|Liver function test abnormality|0|||
27944423|NCT00500331|81630415|FG004|Overall Study|Liver function test abnormality|0|||
27944424|NCT00500331|81630416|FG005|Overall Study|Liver function test abnormality|0|||
27944425|NCT00500331|81630417|FG006|Overall Study|Liver function test abnormality|0|||
27944426|NCT00500331|81630411|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
27944427|NCT00500331|81630412|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
27647553|NCT03057600|80550854|FG000|Overall Study|Radiologic Disease Progression|8|||
27647554|NCT03057600|80550855|FG001|Overall Study|Radiologic Disease Progression|7|||
27647555|NCT03057600|80550856|FG002|Overall Study|Radiologic Disease Progression|13|||
27647556|NCT03057600|80550857|FG003|Overall Study|Radiologic Disease Progression|10|||
27647557|NCT03057600|80550854|FG000|Overall Study|Symptomatic Deterioration|0|||
27647558|NCT03057600|80550855|FG001|Overall Study|Symptomatic Deterioration|1|||
27647559|NCT03057600|80550856|FG002|Overall Study|Symptomatic Deterioration|1|||
27647560|NCT03057600|80550857|FG003|Overall Study|Symptomatic Deterioration|0|||
27647561|NCT03057600|80550854|FG000|Overall Study|Investigator Decision|0|||
27647562|NCT03057600|80550855|FG001|Overall Study|Investigator Decision|0|||
27647563|NCT03057600|80550856|FG002|Overall Study|Investigator Decision|1|||
27647564|NCT03057600|80550857|FG003|Overall Study|Investigator Decision|0|||
27647565|NCT03057600|80550854|FG000|Overall Study|Study Termination by Sponsor|0|||
27647566|NCT03057600|80550855|FG001|Overall Study|Study Termination by Sponsor|0|||
27647567|NCT03057600|80550856|FG002|Overall Study|Study Termination by Sponsor|0|||
27647568|NCT03057600|80550857|FG003|Overall Study|Study Termination by Sponsor|2|||
27647569|NCT03057600|80550854|FG000|Overall Study|Withdrawal by Subject|0|||
27647570|NCT03057600|80550855|FG001|Overall Study|Withdrawal by Subject|1|||
27647571|NCT03057600|80550856|FG002|Overall Study|Withdrawal by Subject|0|||
27647572|NCT03057600|80550857|FG003|Overall Study|Withdrawal by Subject|0|||
27647573|NCT03057600|80550854|FG000|Overall Study|Other, Not Specified|1|||
27647574|NCT03057600|80550855|FG001|Overall Study|Other, Not Specified|1|||
27647575|NCT03057600|80550856|FG002|Overall Study|Other, Not Specified|1|||
27647576|NCT03057600|80550857|FG003|Overall Study|Other, Not Specified|1|||
27647577|NCT01307800|80550858|FG000|Overall Study|Adverse Event|9|||
27647578|NCT01307800|80550859|FG001|Overall Study|Adverse Event|8|||
27647579|NCT01307800|80550860|FG002|Overall Study|Adverse Event|10|||
27647580|NCT01307800|80550861|FG003|Overall Study|Adverse Event|14|||
27647581|NCT01307800|80550858|FG000|Overall Study|Entry Criteria Not Met|0|||
27647582|NCT01307800|80550859|FG001|Overall Study|Entry Criteria Not Met|0|||
27746375|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
27647583|NCT01307800|80550860|FG002|Overall Study|Entry Criteria Not Met|0|||
27647584|NCT01307800|80550861|FG003|Overall Study|Entry Criteria Not Met|2|||
27647585|NCT01307800|80550858|FG000|Overall Study|Lost to Follow-up|5|||
27647586|NCT01307800|80550859|FG001|Overall Study|Lost to Follow-up|6|||
27746376|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
27746377|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
27746378|NCT02232516|80899613|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
27647587|NCT01307800|80550860|FG002|Overall Study|Lost to Follow-up|2|||
27647588|NCT01307800|80550861|FG003|Overall Study|Lost to Follow-up|8|||
27647589|NCT01307800|80550858|FG000|Overall Study|Perceived Lack of Efficacy|24|||
27647590|NCT01307800|80550859|FG001|Overall Study|Perceived Lack of Efficacy|23|||
27647591|NCT01307800|80550860|FG002|Overall Study|Perceived Lack of Efficacy|20|||
27944428|NCT00500331|81630413|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
27944429|NCT00500331|81630414|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
27944430|NCT00500331|81630415|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
27944431|NCT00500331|81630416|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
27944432|NCT00500331|81630417|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
27944433|NCT00500331|81630411|FG000|Overall Study|Didn't return for continuation of study|1|||
27944434|NCT00500331|81630412|FG001|Overall Study|Didn't return for continuation of study|0|||
27944435|NCT00500331|81630413|FG002|Overall Study|Didn't return for continuation of study|0|||
27944436|NCT00500331|81630414|FG003|Overall Study|Didn't return for continuation of study|0|||
27944437|NCT00500331|81630415|FG004|Overall Study|Didn't return for continuation of study|0|||
27944438|NCT00500331|81630416|FG005|Overall Study|Didn't return for continuation of study|0|||
27944439|NCT00500331|81630417|FG006|Overall Study|Didn't return for continuation of study|0|||
27944440|NCT00500331|81630411|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
27944441|NCT00500331|81630412|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
27944442|NCT00500331|81630413|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
27944443|NCT00500331|81630414|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
27944444|NCT00500331|81630415|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
27944445|NCT00500331|81630416|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
27944446|NCT00500331|81630417|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
27944447|NCT00500331|81630411|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
27944448|NCT00500331|81630412|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
27944449|NCT00500331|81630413|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
27944450|NCT00500331|81630414|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
27944451|NCT00500331|81630415|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
27944452|NCT00500331|81630416|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
27944453|NCT00500331|81630417|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
27944454|NCT00500331|81630411|FG000|Overall Study|Participant was randomized by mistake|1|||
27944455|NCT00500331|81630412|FG001|Overall Study|Participant was randomized by mistake|0|||
27944456|NCT00500331|81630413|FG002|Overall Study|Participant was randomized by mistake|0|||
27944457|NCT00500331|81630414|FG003|Overall Study|Participant was randomized by mistake|0|||
27944458|NCT00500331|81630415|FG004|Overall Study|Participant was randomized by mistake|0|||
27944459|NCT00500331|81630416|FG005|Overall Study|Participant was randomized by mistake|0|||
27944460|NCT00500331|81630417|FG006|Overall Study|Participant was randomized by mistake|0|||
27944461|NCT00500331|81630411|FG000|Overall Study|Diabetologist nurse in the study|0|||
27944462|NCT00500331|81630412|FG001|Overall Study|Diabetologist nurse in the study|0|||
27944463|NCT00500331|81630413|FG002|Overall Study|Diabetologist nurse in the study|1|||
27944464|NCT00500331|81630414|FG003|Overall Study|Diabetologist nurse in the study|0|||
27944465|NCT00500331|81630415|FG004|Overall Study|Diabetologist nurse in the study|0|||
27944466|NCT00500331|81630416|FG005|Overall Study|Diabetologist nurse in the study|0|||
27944467|NCT00500331|81630417|FG006|Overall Study|Diabetologist nurse in the study|0|||
27944468|NCT00500331|81630411|FG000|Overall Study|State ban of biological samples export|0|||
27944469|NCT00500331|81630412|FG001|Overall Study|State ban of biological samples export|0|||
27944470|NCT00500331|81630413|FG002|Overall Study|State ban of biological samples export|0|||
27944471|NCT00500331|81630414|FG003|Overall Study|State ban of biological samples export|1|||
27944472|NCT00500331|81630415|FG004|Overall Study|State ban of biological samples export|0|||
27944473|NCT00500331|81630416|FG005|Overall Study|State ban of biological samples export|0|||
27944474|NCT00500331|81630417|FG006|Overall Study|State ban of biological samples export|0|||
27944475|NCT00500331|81630411|FG000|Overall Study|Protocol violated|0|||
27944476|NCT00500331|81630412|FG001|Overall Study|Protocol violated|0|||
27944477|NCT00500331|81630413|FG002|Overall Study|Protocol violated|0|||
27944478|NCT00500331|81630414|FG003|Overall Study|Protocol violated|1|||
27944479|NCT00500331|81630415|FG004|Overall Study|Protocol violated|0|||
27944480|NCT00500331|81630416|FG005|Overall Study|Protocol violated|0|||
27944481|NCT00500331|81630417|FG006|Overall Study|Protocol violated|0|||
27944482|NCT02067156|81630420|FG000|Overall Study|Lost to Follow-up|4|||
27944483|NCT04650893|81630427|FG000|Overall Study|Lost to Follow-up|11|||
27944484|NCT04650893|81630428|FG001|Overall Study|Lost to Follow-up|10|||
27647592|NCT01307800|80550861|FG003|Overall Study|Perceived Lack of Efficacy|33|||
27647593|NCT01307800|80550858|FG000|Overall Study|Protocol Violation|0|||
27944485|NCT04650893|81630429|FG002|Overall Study|Lost to Follow-up|11|||
27944486|NCT02402647|81630433|FG000|Overall Study|Lost to Follow-up|13|||
27944487|NCT02402647|81630434|FG001|Overall Study|Lost to Follow-up|7|||
27944488|NCT02402647|81630433|FG000|Overall Study|Protocol Violation|1|||
27944489|NCT02402647|81630434|FG001|Overall Study|Protocol Violation|1|||
27944490|NCT02402647|81630433|FG000|Overall Study|scheduled and timed out|2|||
27944491|NCT02402647|81630434|FG001|Overall Study|scheduled and timed out|1|||
27944492|NCT02402647|81630433|FG000|Overall Study|medical illness|2|||
27944493|NCT02402647|81630434|FG001|Overall Study|medical illness|4|||
27944494|NCT02402647|81630433|FG000|Overall Study|Moved|2|||
27944495|NCT02402647|81630434|FG001|Overall Study|Moved|0|||
27944496|NCT02402647|81630433|FG000|Overall Study|loved one illness|1|||
27944497|NCT02402647|81630434|FG001|Overall Study|loved one illness|0|||
27944498|NCT02402647|81630433|FG000|Overall Study|deceased preexisting condition|2|||
27944499|NCT02402647|81630434|FG001|Overall Study|deceased preexisting condition|0|||
27944500|NCT02402647|81630433|FG000|Overall Study|Other|2|||
27944501|NCT02402647|81630434|FG001|Overall Study|Other|1|||
27944502|NCT02758626|81630438|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
27944503|NCT02758626|81630439|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
27944504|NCT02758626|81630438|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
27944505|NCT02758626|81630439|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
27944506|NCT02758626|81630438|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
27944507|NCT02758626|81630439|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
27944508|NCT02758626|81630438|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
27944509|NCT02758626|81630439|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
27944510|NCT03977155|81630440|FG000|Overall Study|Adverse Event|3|||
27944511|NCT03977155|81630441|FG001|Overall Study|Adverse Event|0|||
27944512|NCT03977155|81630442|FG002|Overall Study|Adverse Event|0|||
27944513|NCT03977155|81630440|FG000|Overall Study|Lost to Follow-up|0|||
27944514|NCT03977155|81630441|FG001|Overall Study|Lost to Follow-up|1|||
27944515|NCT03977155|81630442|FG002|Overall Study|Lost to Follow-up|0|||
27944516|NCT03977155|81630440|FG000|Overall Study|Withdrawal by Subject|1|||
27944517|NCT03977155|81630441|FG001|Overall Study|Withdrawal by Subject|1|||
27944518|NCT03977155|81630442|FG002|Overall Study|Withdrawal by Subject|2|||
27944519|NCT03977155|81630440|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
27944520|NCT03977155|81630441|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
27944521|NCT03977155|81630442|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
27944522|NCT00721110|81630443|FG000|Overall Study|Ultram use|1|||
27944523|NCT00721110|81630444|FG001|Overall Study|Ultram use|0|||
27944524|NCT00721110|81630445|FG002|Overall Study|Ultram use|0|||
27944525|NCT00721110|81630446|FG003|Overall Study|Ultram use|0|||
27944526|NCT00721110|81630443|FG000|Overall Study|vertical incision|0|||
27944527|NCT00721110|81630444|FG001|Overall Study|vertical incision|0|||
27944528|NCT00721110|81630445|FG002|Overall Study|vertical incision|1|||
27944529|NCT00721110|81630446|FG003|Overall Study|vertical incision|0|||
27647594|NCT01307800|80550859|FG001|Overall Study|Protocol Violation|3|||
27647595|NCT01307800|80550860|FG002|Overall Study|Protocol Violation|4|||
27647596|NCT01307800|80550861|FG003|Overall Study|Protocol Violation|5|||
27647597|NCT01307800|80550858|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
27647598|NCT01307800|80550859|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
27647599|NCT01307800|80550860|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
27647600|NCT01307800|80550861|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
27647601|NCT01307800|80550858|FG000|Overall Study|Sponsor Decision|6|||
27647602|NCT01307800|80550859|FG001|Overall Study|Sponsor Decision|9|||
27647603|NCT01307800|80550860|FG002|Overall Study|Sponsor Decision|12|||
27647604|NCT01307800|80550861|FG003|Overall Study|Sponsor Decision|28|||
27647605|NCT01307800|80550858|FG000|Overall Study|Withdrawal by Subject|10|||
27647606|NCT01307800|80550859|FG001|Overall Study|Withdrawal by Subject|11|||
27647607|NCT01307800|80550860|FG002|Overall Study|Withdrawal by Subject|8|||
27647608|NCT01307800|80550861|FG003|Overall Study|Withdrawal by Subject|15|||
27647609|NCT01307800|80550858|FG000|Overall Study|Participant Moved|0|||
27647610|NCT01307800|80550859|FG001|Overall Study|Participant Moved|2|||
27647611|NCT01307800|80550860|FG002|Overall Study|Participant Moved|1|||
27647612|NCT01307800|80550861|FG003|Overall Study|Participant Moved|3|||
27647613|NCT03601715|80550867|FG000|Second Intervention|Lost to Follow-up|1|||
27647614|NCT03601715|80550868|FG001|Second Intervention|Lost to Follow-up|1|||
27647615|NCT03601715|80550869|FG002|Second Intervention|Lost to Follow-up|0|||
27647616|NCT03683576|80550870|FG000|Overall Study|Withdrawal by Subject|2|||
27647617|NCT03683576|80550871|FG001|Overall Study|Withdrawal by Subject|0|||
27647618|NCT03683576|80550872|FG002|Overall Study|Withdrawal by Subject|8|||
27647619|NCT03683576|80550873|FG003|Overall Study|Withdrawal by Subject|3|||
27647620|NCT03683576|80550870|FG000|Overall Study|Adverse Event|3|||
27944530|NCT02276040|81630447|FG000|Overall Study|Physician Decision|15|||
27944531|NCT03518060|81630448|FG000|Overall Study|Death|1|||
27647621|NCT03683576|80550871|FG001|Overall Study|Adverse Event|0|||
27647622|NCT03683576|80550872|FG002|Overall Study|Adverse Event|0|||
27647623|NCT03683576|80550873|FG003|Overall Study|Adverse Event|4|||
27647624|NCT03683576|80550870|FG000|Overall Study|Lack of Efficacy|1|||
27647625|NCT03683576|80550871|FG001|Overall Study|Lack of Efficacy|0|||
27746379|NCT02232516|80899613|FG000|Survival Follow-up|Death|15|||
27944532|NCT03518060|81630448|FG000|Overall Study|Poor adherence|1|||
27944533|NCT03518060|81630448|FG000|Overall Study|Withdrawal of informed consent|2|||
27944534|NCT03518060|81630448|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
27944535|NCT03518060|81630448|FG000|Overall Study|Physician Decision|7|||
27944536|NCT03518060|81630448|FG000|Overall Study|Adverse drug reactions|23|||
27944537|NCT03518060|81630448|FG000|Overall Study|Withdrawal by Subject|25|||
27944538|NCT03518060|81630448|FG000|Overall Study|Lost to Follow-up|13|||
27647626|NCT03683576|80550872|FG002|Overall Study|Lack of Efficacy|1|||
27647627|NCT03683576|80550873|FG003|Overall Study|Lack of Efficacy|1|||
27647628|NCT03683576|80550870|FG000|Overall Study|Lost to Follow-up|0|||
27647629|NCT03683576|80550871|FG001|Overall Study|Lost to Follow-up|1|||
27647630|NCT03683576|80550872|FG002|Overall Study|Lost to Follow-up|2|||
27647631|NCT03683576|80550873|FG003|Overall Study|Lost to Follow-up|0|||
27647632|NCT03683576|80550870|FG000|Overall Study|Other, Not Specified|0|||
27647633|NCT03683576|80550871|FG001|Overall Study|Other, Not Specified|2|||
27647634|NCT03683576|80550872|FG002|Overall Study|Other, Not Specified|0|||
27647635|NCT03683576|80550873|FG003|Overall Study|Other, Not Specified|0|||
27647636|NCT03683576|80550870|FG000|Overall Study|Protocol Violation|0|||
27647637|NCT03683576|80550871|FG001|Overall Study|Protocol Violation|1|||
27647638|NCT03683576|80550872|FG002|Overall Study|Protocol Violation|1|||
27647639|NCT03683576|80550873|FG003|Overall Study|Protocol Violation|0|||
27944539|NCT03502200|81630450|FG000|Overall Study|Adverse Event|1|||
27944540|NCT03502200|81630451|FG001|Overall Study|Adverse Event|0|||
27944541|NCT03502200|81630450|FG000|Overall Study|Lost to Follow-up|36|||
27944542|NCT03502200|81630451|FG001|Overall Study|Lost to Follow-up|38|||
27944543|NCT03502200|81630450|FG000|Overall Study|Study Team Decision|1|||
27944544|NCT03502200|81630451|FG001|Overall Study|Study Team Decision|1|||
27944545|NCT03502200|81630450|FG000|Overall Study|Withdrawal by Subject|5|||
27944546|NCT03502200|81630451|FG001|Overall Study|Withdrawal by Subject|7|||
27944547|NCT03502200|81630450|FG000|Overall Study|Death|0|||
27944548|NCT03502200|81630451|FG001|Overall Study|Death|2|||
27944549|NCT03766399|81630455|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944550|NCT03766399|81630456|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944551|NCT03766399|81630457|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944552|NCT03766399|81630458|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944553|NCT03766399|81630459|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944554|NCT03766399|81630460|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944555|NCT03766399|81630461|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944556|NCT03766399|81630462|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944557|NCT03766399|81630463|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944558|NCT03766399|81630464|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944559|NCT03766399|81630465|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944560|NCT03766399|81630466|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944561|NCT03766399|81630467|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944562|NCT03766399|81630468|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
27944563|NCT03766399|81630469|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944564|NCT03766399|81630470|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944565|NCT03766399|81630471|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944566|NCT03766399|81630472|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
27944567|NCT01197300|81630479|FG000|Overall Study|Lost to Follow-up|0|||
27944568|NCT01197300|81630480|FG001|Overall Study|Lost to Follow-up|1|||
27944569|NCT01197300|81630479|FG000|Overall Study|Protocol Violation|0|||
27944570|NCT01197300|81630480|FG001|Overall Study|Protocol Violation|1|||
27944571|NCT01500135|81630481|FG000|Overall Study|Withdrawal of Consent|4|||
27944572|NCT01500135|81630482|FG001|Overall Study|Withdrawal of Consent|0|||
27944573|NCT01500135|81630481|FG000|Overall Study|Lost to Follow-up|6|||
27944574|NCT01500135|81630482|FG001|Overall Study|Lost to Follow-up|4|||
27944575|NCT01500135|81630481|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
27944576|NCT01500135|81630482|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
27944577|NCT01500135|81630481|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
27647640|NCT00776009|80550876|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
27647641|NCT00776009|80550877|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
27647642|NCT00776009|80550878|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
27647643|NCT00776009|80550879|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
27647644|NCT00776009|80550880|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
27647645|NCT00776009|80550881|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
27647646|NCT00776009|80550876|FG000|Period 1: First Intervention|Protocol Violation|0|||
27647647|NCT00776009|80550877|FG001|Period 1: First Intervention|Protocol Violation|1|||
27746380|NCT02232516|80899613|FG000|Survival Follow-up|Withdrawal by Subject|3|||
27746381|NCT02232516|80899613|FG000|Survival Follow-up|Lost to Follow-up|1|||
27944578|NCT01500135|81630482|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
27944579|NCT01500135|81630481|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
27944580|NCT01500135|81630482|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
27944581|NCT01500135|81630481|FG000|Overall Study|Participant was a Safety Concern|1|||
27944582|NCT01500135|81630482|FG001|Overall Study|Participant was a Safety Concern|0|||
27944583|NCT01500135|81630481|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
27944584|NCT01500135|81630482|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
27551364|NCT01543698|80207472|FG014|Phase 1b|Withdrawal by Subject|0|||
27647648|NCT00776009|80550878|FG002|Period 1: First Intervention|Protocol Violation|0|||
27647649|NCT00776009|80550879|FG003|Period 1: First Intervention|Protocol Violation|0|||
27647650|NCT00776009|80550880|FG004|Period 1: First Intervention|Protocol Violation|1|||
27647651|NCT00776009|80550881|FG005|Period 1: First Intervention|Protocol Violation|0|||
27944585|NCT01904279|81630495|FG000|Overall Study|Lack of Efficacy|2|||
27944586|NCT01904279|81630496|FG001|Overall Study|Lack of Efficacy|3|||
27944587|NCT01904279|81630495|FG000|Overall Study|Withdrawal by Subject|1|||
27944588|NCT01904279|81630496|FG001|Overall Study|Withdrawal by Subject|0|||
27944589|NCT01435356|81630497|FG000|Overall Study|Adverse Event|2|||
27944590|NCT01435356|81630498|FG001|Overall Study|Adverse Event|0|||
27944591|NCT01435356|81630497|FG000|Overall Study|Disease progression/recurrence|17|||
27944592|NCT01435356|81630498|FG001|Overall Study|Disease progression/recurrence|10|||
27944593|NCT01435356|81630497|FG000|Overall Study|Protocol Violation|0|||
27944594|NCT01435356|81630498|FG001|Overall Study|Protocol Violation|1|||
27944595|NCT01435356|81630497|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
27944596|NCT01435356|81630498|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
27944597|NCT01435356|81630497|FG000|Overall Study|Withdrawal by Subject|1|||
27944598|NCT01435356|81630498|FG001|Overall Study|Withdrawal by Subject|1|||
27944599|NCT01435356|81630497|FG000|Overall Study|Facial palsy|1|||
27944600|NCT01435356|81630498|FG001|Overall Study|Facial palsy|0|||
27647652|NCT00776009|80550876|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
27647653|NCT00776009|80550877|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
27647654|NCT00776009|80550878|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
27647655|NCT00776009|80550879|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
27647656|NCT00776009|80550880|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
27647657|NCT00776009|80550881|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
27647658|NCT00776009|80550876|FG000|Period 2: Second Intervention|Protocol Violation|1|||
27647659|NCT00776009|80550877|FG001|Period 2: Second Intervention|Protocol Violation|0|||
27944601|NCT01435356|81630497|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
27944602|NCT01435356|81630498|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
27944603|NCT01435356|81630497|FG000|Overall Study|Physician Decision|1|||
27944604|NCT01435356|81630498|FG001|Overall Study|Physician Decision|0|||
27944605|NCT01435356|81630497|FG000|Overall Study|Patient decision|3|||
27944606|NCT01435356|81630498|FG001|Overall Study|Patient decision|0|||
27944607|NCT01435356|81630497|FG000|Overall Study|Patient moved to another city|1|||
27944608|NCT01435356|81630498|FG001|Overall Study|Patient moved to another city|1|||
27944609|NCT05602727|81630499|FG000|Overall Study|Physician Decision|0|||
27944610|NCT05602727|81630500|FG001|Overall Study|Physician Decision|1|||
27647660|NCT00776009|80550878|FG002|Period 2: Second Intervention|Protocol Violation|1|||
27647661|NCT00776009|80550879|FG003|Period 2: Second Intervention|Protocol Violation|0|||
27647662|NCT00776009|80550880|FG004|Period 2: Second Intervention|Protocol Violation|0|||
27647663|NCT00776009|80550881|FG005|Period 2: Second Intervention|Protocol Violation|0|||
27647664|NCT00776009|80550876|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
27647665|NCT00776009|80550877|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
27746382|NCT02232516|80899613|FG000|Survival Follow-up|Still in follow-up|5|||
27944611|NCT05602727|81630501|FG002|Overall Study|Physician Decision|0|||
27944612|NCT05602727|81630499|FG000|Overall Study|Randomized by mistake without study medication|1|||
27944613|NCT05602727|81630500|FG001|Overall Study|Randomized by mistake without study medication|0|||
27944614|NCT05602727|81630501|FG002|Overall Study|Randomized by mistake without study medication|0|||
27944615|NCT05602727|81630499|FG000|Overall Study|Study termination by Sponsor|18|||
27944616|NCT05602727|81630500|FG001|Overall Study|Study termination by Sponsor|15|||
27944617|NCT05602727|81630501|FG002|Overall Study|Study termination by Sponsor|19|||
27944618|NCT05602727|81630499|FG000|Overall Study|Withdrawal by Subject|2|||
27944619|NCT05602727|81630500|FG001|Overall Study|Withdrawal by Subject|1|||
27944620|NCT05602727|81630501|FG002|Overall Study|Withdrawal by Subject|1|||
27944621|NCT05602727|81630499|FG000|Overall Study|Various reasons|1|||
27944622|NCT05602727|81630500|FG001|Overall Study|Various reasons|6|||
27944623|NCT05602727|81630501|FG002|Overall Study|Various reasons|1|||
27944624|NCT02781558|81630502|FG000|Overall Study|Lost to Follow-up|2|||
27944625|NCT02781558|81630503|FG001|Overall Study|Lost to Follow-up|2|||
27944626|NCT02781558|81630502|FG000|Overall Study|Adverse Event|1|||
27944627|NCT02781558|81630503|FG001|Overall Study|Adverse Event|0|||
27944628|NCT04730271|81630523|FG000|Overall Study|Adverse Event|0|||
27944629|NCT04730271|81630524|FG001|Overall Study|Adverse Event|2|||
27944630|NCT04730271|81630523|FG000|Overall Study|Withdrawal by Subject|1|||
27944631|NCT04730271|81630524|FG001|Overall Study|Withdrawal by Subject|1|||
27944632|NCT04730271|81630523|FG000|Overall Study|Protocol Violation|7|||
27944633|NCT04730271|81630524|FG001|Overall Study|Protocol Violation|13|||
27944634|NCT04730271|81630523|FG000|Overall Study|Lost to Follow-up|3|||
27944635|NCT04730271|81630524|FG001|Overall Study|Lost to Follow-up|3|||
27944636|NCT04730271|81630523|FG000|Overall Study|Death|1|||
27944637|NCT04730271|81630524|FG001|Overall Study|Death|0|||
27944638|NCT02082977|81630525|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
27944639|NCT02082977|81630526|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
27647666|NCT00776009|80550878|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
27944640|NCT02082977|81630527|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
27944641|NCT02082977|81630528|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
27944642|NCT02082977|81630529|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
27944643|NCT02082977|81630530|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
27944644|NCT02082977|81630531|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
27944645|NCT02082977|81630532|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
27944646|NCT02082977|81630533|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
27944647|NCT02082977|81630534|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
27944648|NCT02082977|81630525|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944649|NCT02082977|81630526|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944650|NCT02082977|81630527|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944651|NCT02082977|81630528|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944652|NCT02082977|81630529|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944653|NCT02082977|81630530|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944654|NCT02082977|81630531|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944655|NCT02082977|81630532|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
27944656|NCT02082977|81630533|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944657|NCT02082977|81630534|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
27944658|NCT02082977|81630525|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27944659|NCT02082977|81630526|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27944660|NCT02082977|81630527|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27944661|NCT02082977|81630528|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27647667|NCT00776009|80550879|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
27647668|NCT00776009|80550880|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
27647669|NCT00776009|80550881|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
27647670|NCT02644122|80550883|FG000|Overall Study|Withdrawal by Subject|1|||
27647671|NCT01034306|80550884|FG000|Overall Study|Adverse Event|1|||
27647672|NCT01034306|80550885|FG001|Overall Study|Adverse Event|0|||
27647673|NCT01034306|80550884|FG000|Overall Study|Lost to Follow-up|0|||
27647674|NCT01034306|80550885|FG001|Overall Study|Lost to Follow-up|1|||
27647675|NCT01034306|80550884|FG000|Overall Study|Withdrawal by Subject|2|||
27647676|NCT01034306|80550885|FG001|Overall Study|Withdrawal by Subject|2|||
27647677|NCT01034306|80550884|FG000|Overall Study|hospitalized and decided to stop|1|||
27647678|NCT01034306|80550885|FG001|Overall Study|hospitalized and decided to stop|0|||
27647679|NCT01034306|80550884|FG000|Overall Study|Noncomplience|1|||
27647680|NCT01034306|80550885|FG001|Overall Study|Noncomplience|0|||
27647681|NCT00918333|80550886|FG000|Overall Study|Drug not taken per protocol|1|||
27647682|NCT00918333|80550887|FG001|Overall Study|Drug not taken per protocol|0|||
27647683|NCT00918333|80550886|FG000|Overall Study|Inadequate amount of drugs provided|1|||
27647684|NCT00918333|80550887|FG001|Overall Study|Inadequate amount of drugs provided|4|||
27647685|NCT00918333|80550886|FG000|Overall Study|Ineligible|1|||
27647686|NCT00918333|80550887|FG001|Overall Study|Ineligible|0|||
27647687|NCT00918333|80550886|FG000|Overall Study|Withdrawal by Subject|0|||
27647688|NCT00918333|80550887|FG001|Overall Study|Withdrawal by Subject|1|||
27647689|NCT00895245|80550888|FG000|Overall Study|Lack of Efficacy|6|||
27647690|NCT01827839|80550891|FG000|Overall Study|Adverse Event|1|||
27647691|NCT01827839|80550891|FG000|Overall Study|Consent Withdrawal|2|||
27647692|NCT02824198|80550892|FG000|Overall Study|Non-compliance with the protocol|5|||
27647693|NCT02824198|80550893|FG001|Overall Study|Non-compliance with the protocol|1|||
27647694|NCT02824198|80550892|FG000|Overall Study|Lost to Follow-up|5|||
27647695|NCT02824198|80550893|FG001|Overall Study|Lost to Follow-up|2|||
27647696|NCT02824198|80550892|FG000|Overall Study|Withdrawal by Subject|5|||
27647697|NCT02824198|80550893|FG001|Overall Study|Withdrawal by Subject|0|||
27647698|NCT04748341|80550898|FG000|Overall Study|Lost to Follow-up|1|||
27647699|NCT04748341|80550899|FG001|Overall Study|Lost to Follow-up|1|||
27647700|NCT01478594|80550907|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
27647701|NCT01478594|80550908|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
27647702|NCT01478594|80550907|FG000|Overall Study|Death|45|||
27647703|NCT01478594|80550908|FG001|Overall Study|Death|18|||
27746383|NCT00863928|80899614|FG000|Overall Study|Protocol Violation|26|||
27746384|NCT00863928|80899615|FG001|Overall Study|Protocol Violation|0|||
27746385|NCT00863928|80899614|FG000|Overall Study|Withdrawal by Subject|3|||
27944662|NCT02082977|81630529|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27944663|NCT02082977|81630530|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
27944664|NCT02082977|81630531|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27944665|NCT02082977|81630532|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27647704|NCT01478594|80550907|FG000|Overall Study|Lost to Follow-up|3|||
27944666|NCT02082977|81630533|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27944667|NCT02082977|81630534|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
27647705|NCT01478594|80550908|FG001|Overall Study|Lost to Follow-up|1|||
27647706|NCT01478594|80550907|FG000|Overall Study|Withdrawal by Subject|9|||
27647707|NCT01478594|80550908|FG001|Overall Study|Withdrawal by Subject|3|||
27647708|NCT01478594|80550907|FG000|Overall Study|Study Closed by Sponsor|8|||
27647709|NCT01478594|80550908|FG001|Overall Study|Study Closed by Sponsor|5|||
27647710|NCT00890591|80550910|FG000|Overall Study|Lack of Efficacy|20|||
27647711|NCT00786864|80550911|FG000|Overall Study|Lost to Follow-up|0|||
27647712|NCT00786864|80550912|FG001|Overall Study|Lost to Follow-up|1|||
27647713|NCT00786864|80550911|FG000|Overall Study|Sustained serious back injury|1|||
27647714|NCT00786864|80550912|FG001|Overall Study|Sustained serious back injury|0|||
27647715|NCT01218594|80550921|FG000|Overall Study|Death|1|||
27647716|NCT01218594|80550921|FG000|Overall Study|Withdrawal by Subject|3|||
27647717|NCT01218594|80550921|FG000|Overall Study|Adverse Event|2|||
27647718|NCT01218594|80550921|FG000|Overall Study|Physician Decision|6|||
27647719|NCT01683409|80550924|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27944668|NCT02082977|81630525|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27944669|NCT02082977|81630526|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27944670|NCT02082977|81630527|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27944671|NCT02082977|81630528|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27944672|NCT02082977|81630529|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
27944673|NCT02082977|81630530|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
27944674|NCT02082977|81630531|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
27944675|NCT02082977|81630532|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
27944676|NCT02082977|81630533|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
27944677|NCT02082977|81630534|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
27944678|NCT02082977|81630525|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944679|NCT02082977|81630526|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944680|NCT02082977|81630527|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944681|NCT02082977|81630528|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944682|NCT02082977|81630529|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944683|NCT02082977|81630530|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944684|NCT02082977|81630531|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944685|NCT02082977|81630532|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
27944686|NCT02082977|81630533|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944687|NCT02082977|81630534|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
27944688|NCT02302222|81630535|FG000|Overall Study|Physician Decision|0|||
27944689|NCT02302222|81630536|FG001|Overall Study|Physician Decision|4|||
27944690|NCT02302222|81630535|FG000|Overall Study|Lost to Follow-up|1|||
27944691|NCT02302222|81630536|FG001|Overall Study|Lost to Follow-up|0|||
27944692|NCT02302222|81630535|FG000|Overall Study|Treatment discontinued before day 5|0|||
27944693|NCT02302222|81630536|FG001|Overall Study|Treatment discontinued before day 5|1|||
27944694|NCT02302222|81630535|FG000|Overall Study|Withdrawn prior to any treatment|0|||
27944695|NCT02302222|81630536|FG001|Overall Study|Withdrawn prior to any treatment|1|||
27944696|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
27944697|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
27944698|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
27944699|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
27944700|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
27944701|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
27944702|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
27944703|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
27944704|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
27944705|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
27944706|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
27944707|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
27944708|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
27944709|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
27944710|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
27944711|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
27944712|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
27944713|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
27944714|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
27944715|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
27944716|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
27944717|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
27944718|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
27944719|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
27944720|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
27944721|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
27944722|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
27647720|NCT01683409|80550925|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27647721|NCT01683409|80550926|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
27944723|NCT03093415|81630537|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
27944724|NCT03093415|81630538|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
27944725|NCT03093415|81630539|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
27944726|NCT03093415|81630537|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
27944727|NCT03093415|81630538|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
27944728|NCT03093415|81630539|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
27944729|NCT00833703|81630543|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
27944730|NCT00833703|81630544|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
27944731|NCT02951819|81630545|FG000|Overall Study|Death|9|||
27944732|NCT02951819|81630546|FG001|Overall Study|Death|7|||
27944733|NCT02951819|81630545|FG000|Overall Study|Withdrawal by Subject|3|||
27944734|NCT02951819|81630546|FG001|Overall Study|Withdrawal by Subject|0|||
27944735|NCT02951819|81630545|FG000|Overall Study|Adverse Event|1|||
27944736|NCT02951819|81630546|FG001|Overall Study|Adverse Event|0|||
27944737|NCT02951819|81630545|FG000|Overall Study|Lack of Efficacy|4|||
27944738|NCT02951819|81630546|FG001|Overall Study|Lack of Efficacy|0|||
27944739|NCT02951819|81630545|FG000|Overall Study|Lost to Follow-up|1|||
27944740|NCT02951819|81630546|FG001|Overall Study|Lost to Follow-up|0|||
27944741|NCT02951819|81630545|FG000|Overall Study|Progressive Disease|1|||
27944742|NCT02951819|81630546|FG001|Overall Study|Progressive Disease|0|||
27944743|NCT02951819|81630545|FG000|Overall Study|Other|9|||
27944744|NCT02951819|81630546|FG001|Overall Study|Other|0|||
27944745|NCT03101267|81630549|FG000|Primary Study Period|Withdrawal by Subject|1|||
27944746|NCT03101267|81630550|FG001|Primary Study Period|Withdrawal by Subject|2|||
27944747|NCT03101267|81630551|FG002|Primary Study Period|Withdrawal by Subject|3|||
27944748|NCT03101267|81630549|FG000|Primary Study Period|Miscellaneous|2|||
27944749|NCT03101267|81630550|FG001|Primary Study Period|Miscellaneous|0|||
27944750|NCT03101267|81630551|FG002|Primary Study Period|Miscellaneous|0|||
27647722|NCT01683409|80550927|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27647723|NCT01683409|80550928|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
27647724|NCT01683409|80550924|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
27647725|NCT01683409|80550925|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
27647726|NCT01683409|80550926|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
27647727|NCT01683409|80550927|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
27647728|NCT01683409|80550928|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
27647729|NCT01683409|80550924|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27647730|NCT01683409|80550925|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
27647731|NCT01683409|80550926|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27647732|NCT01683409|80550927|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27647733|NCT01683409|80550928|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
27647734|NCT01683409|80550924|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
27647735|NCT01683409|80550925|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
27647736|NCT01683409|80550926|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
27647737|NCT01683409|80550927|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
27647738|NCT01683409|80550928|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
27647739|NCT01683409|80550924|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27647740|NCT01683409|80550925|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27647741|NCT01683409|80550926|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
27647742|NCT01683409|80550927|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27647743|NCT01683409|80550928|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
27647744|NCT01683409|80550924|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
27647745|NCT01683409|80550925|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
27647746|NCT01683409|80550926|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
27647747|NCT01683409|80550927|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
27647748|NCT01683409|80550928|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
27647749|NCT01683409|80550924|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
27647750|NCT01683409|80550925|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
27647751|NCT01683409|80550926|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
27647752|NCT01683409|80550927|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
27647753|NCT01683409|80550928|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
27647754|NCT01683409|80550924|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
27944751|NCT03439072|81630552|FG000|Overall Study|Withdrawal by Subject|2|||
27944752|NCT03439072|81630553|FG001|Overall Study|Withdrawal by Subject|3|||
27944753|NCT03439072|81630552|FG000|Overall Study|Physician Decision|0|||
27944754|NCT03439072|81630553|FG001|Overall Study|Physician Decision|1|||
27647755|NCT01683409|80550925|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27944755|NCT01767987|81630556|FG000|Overall Study|Physician Decision|4|||
27944756|NCT01767987|81630557|FG001|Overall Study|Physician Decision|1|||
27944757|NCT02014103|81630558|FG000|Overall Study|Protocol Violation|7|||
27944758|NCT02014103|81630559|FG001|Overall Study|Protocol Violation|7|||
27944759|NCT02014103|81630558|FG000|Overall Study|Adverse Event|1|||
27647756|NCT01683409|80550926|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27944760|NCT02014103|81630559|FG001|Overall Study|Adverse Event|0|||
27944761|NCT02014103|81630558|FG000|Overall Study|Lost venous access|1|||
27944762|NCT02014103|81630559|FG001|Overall Study|Lost venous access|0|||
27944763|NCT02014103|81630558|FG000|Overall Study|Withdrawal by Subject|0|||
27944764|NCT02014103|81630559|FG001|Overall Study|Withdrawal by Subject|2|||
27944765|NCT00539500|81630561|FG000|Overall Study|Disease Progression|1|||
27944766|NCT00539500|81630561|FG000|Overall Study|Lost to Follow-up|2|||
27944767|NCT03701074|81630564|FG000|Overall Study|Physician Decision|1|||
27944768|NCT03701074|81630565|FG001|Overall Study|Physician Decision|0|||
27944769|NCT00835042|81630566|FG000|First Intervention|Withdrawal by Subject|3|||
27944770|NCT00835042|81630567|FG001|First Intervention|Withdrawal by Subject|0|||
27944771|NCT00835042|81630566|FG000|First Intervention|Adverse Event|1|||
27944772|NCT00835042|81630567|FG001|First Intervention|Adverse Event|2|||
27944773|NCT00835042|81630566|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
27944774|NCT00835042|81630567|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
27944775|NCT01027351|81630570|FG000|Overall Study|Withdrawal by Subject|1|||
27944776|NCT01027351|81630571|FG001|Overall Study|Withdrawal by Subject|0|||
27944777|NCT01027351|81630572|FG002|Overall Study|Withdrawal by Subject|1|||
27944778|NCT01027351|81630573|FG003|Overall Study|Withdrawal by Subject|0|||
27944779|NCT01027351|81630574|FG004|Overall Study|Withdrawal by Subject|3|||
27944780|NCT01027351|81630575|FG005|Overall Study|Withdrawal by Subject|5|||
27944781|NCT01027351|81630570|FG000|Overall Study|Lost to Follow-up|1|||
27944782|NCT01027351|81630571|FG001|Overall Study|Lost to Follow-up|1|||
27944783|NCT01027351|81630572|FG002|Overall Study|Lost to Follow-up|0|||
27944784|NCT01027351|81630573|FG003|Overall Study|Lost to Follow-up|1|||
27944785|NCT01027351|81630574|FG004|Overall Study|Lost to Follow-up|6|||
27944786|NCT01027351|81630575|FG005|Overall Study|Lost to Follow-up|0|||
27944787|NCT01027351|81630570|FG000|Overall Study|Inappropriate enrollment|0|||
27944788|NCT01027351|81630571|FG001|Overall Study|Inappropriate enrollment|0|||
27944789|NCT01027351|81630572|FG002|Overall Study|Inappropriate enrollment|0|||
27944790|NCT01027351|81630573|FG003|Overall Study|Inappropriate enrollment|0|||
27944791|NCT01027351|81630574|FG004|Overall Study|Inappropriate enrollment|1|||
27944792|NCT01027351|81630575|FG005|Overall Study|Inappropriate enrollment|0|||
27944793|NCT01027351|81630570|FG000|Overall Study|Protocol Violation|1|||
27944794|NCT01027351|81630571|FG001|Overall Study|Protocol Violation|0|||
27944795|NCT01027351|81630572|FG002|Overall Study|Protocol Violation|0|||
27944796|NCT01027351|81630573|FG003|Overall Study|Protocol Violation|1|||
27944797|NCT01027351|81630574|FG004|Overall Study|Protocol Violation|1|||
27944798|NCT01027351|81630575|FG005|Overall Study|Protocol Violation|0|||
27944799|NCT02298946|81630576|FG000|Overall Study|Did not receive treatment|2|||
27944800|NCT02298946|81630577|FG001|Overall Study|Did not receive treatment|0|||
27944801|NCT02298946|81630576|FG000|Overall Study|Unevaluable|2|||
27944802|NCT02298946|81630577|FG001|Overall Study|Unevaluable|1|||
27944803|NCT03443401|81630578|FG000|Overall Study|Lost to Follow-up|13|||
27944804|NCT03443401|81630578|FG000|Overall Study|Influential outlier|1|||
27944805|NCT02657343|81630581|FG000|Overall Study|Death|0|||
27944806|NCT02657343|81630582|FG001|Overall Study|Death|2|||
27944807|NCT02657343|81630583|FG002|Overall Study|Death|0|||
27944808|NCT02657343|81630584|FG003|Overall Study|Death|0|||
27944809|NCT02657343|81630585|FG004|Overall Study|Death|0|||
27944810|NCT02657343|81630586|FG005|Overall Study|Death|0|||
27944811|NCT02657343|81630581|FG000|Overall Study|Patient went to hospice|1|||
27944812|NCT02657343|81630582|FG001|Overall Study|Patient went to hospice|0|||
27944813|NCT02657343|81630583|FG002|Overall Study|Patient went to hospice|0|||
27944814|NCT02657343|81630584|FG003|Overall Study|Patient went to hospice|0|||
27944815|NCT02657343|81630585|FG004|Overall Study|Patient went to hospice|0|||
27944816|NCT02657343|81630586|FG005|Overall Study|Patient went to hospice|0|||
27944817|NCT02657343|81630581|FG000|Overall Study|Withdrawal by Subject|0|||
27944818|NCT02657343|81630582|FG001|Overall Study|Withdrawal by Subject|0|||
27944819|NCT02657343|81630583|FG002|Overall Study|Withdrawal by Subject|0|||
27944820|NCT02657343|81630584|FG003|Overall Study|Withdrawal by Subject|0|||
27944821|NCT02657343|81630585|FG004|Overall Study|Withdrawal by Subject|1|||
27944822|NCT02657343|81630586|FG005|Overall Study|Withdrawal by Subject|0|||
27944823|NCT03777020|81630591|FG000|Overall Study|Withdrawal by Subject|4|||
27944824|NCT03777020|81630592|FG001|Overall Study|Withdrawal by Subject|4|||
27944825|NCT03777020|81630591|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
27647757|NCT01683409|80550927|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27944826|NCT03777020|81630592|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
27944827|NCT02255656|81630593|FG000|Overall Study|Adverse Event|11|||
27944828|NCT02255656|81630593|FG000|Overall Study|Poor compliance to protocol|3|||
27944829|NCT02255656|81630593|FG000|Overall Study|Lost to Follow-up|30|||
27944830|NCT02255656|81630593|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
27944831|NCT02255656|81630593|FG000|Overall Study|Other|126|||
27944832|NCT01166646|81632774|FG000|Overall Study|Protocol Violation|0|||
27944833|NCT01166646|81632775|FG001|Overall Study|Protocol Violation|1|||
27944834|NCT01166646|81632774|FG000|Overall Study|Adverse Event|1|||
27944835|NCT01166646|81632775|FG001|Overall Study|Adverse Event|0|||
27944836|NCT01854775|81632777|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
27944837|NCT01854775|81632778|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
27944838|NCT01854775|81632779|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
27944839|NCT01854775|81632777|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
27944840|NCT01854775|81632778|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
27944841|NCT01854775|81632779|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
27944842|NCT01854775|81632777|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
27944843|NCT01854775|81632778|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
27944844|NCT01854775|81632779|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
27944845|NCT01854775|81632777|FG000|Extension Phase|Pregnancy|3|||
27944846|NCT01854775|81632778|FG001|Extension Phase|Pregnancy|0|||
27944847|NCT01854775|81632779|FG002|Extension Phase|Pregnancy|0|||
27944848|NCT01854775|81632777|FG000|Extension Phase|Investigator's Discretion|1|||
27944849|NCT01854775|81632778|FG001|Extension Phase|Investigator's Discretion|0|||
27944850|NCT01854775|81632779|FG002|Extension Phase|Investigator's Discretion|0|||
27944851|NCT01854775|81632777|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
27944852|NCT01854775|81632778|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
27944853|NCT01854775|81632779|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
27944854|NCT01854775|81632777|FG000|Extension Phase|Lost to Follow-up|2|||
27944855|NCT01854775|81632778|FG001|Extension Phase|Lost to Follow-up|0|||
27944856|NCT01854775|81632779|FG002|Extension Phase|Lost to Follow-up|0|||
27944857|NCT01854775|81632777|FG000|Extension Phase|Still on Study|32|||
27944858|NCT01854775|81632778|FG001|Extension Phase|Still on Study|47|||
27944859|NCT01854775|81632779|FG002|Extension Phase|Still on Study|18|||
27944860|NCT03735121|81632783|FG000|Overall Study|Death|3|||
27944861|NCT03735121|81632784|FG001|Overall Study|Death|6|||
27944862|NCT03735121|81632785|FG002|Overall Study|Death|8|||
27944863|NCT03735121|81632786|FG003|Overall Study|Death|37|||
27944864|NCT03735121|81632787|FG004|Overall Study|Death|86|||
27944865|NCT03735121|81632783|FG000|Overall Study|Withdrawal by Subject|1|||
27944866|NCT03735121|81632784|FG001|Overall Study|Withdrawal by Subject|1|||
27944867|NCT03735121|81632785|FG002|Overall Study|Withdrawal by Subject|3|||
27944868|NCT03735121|81632786|FG003|Overall Study|Withdrawal by Subject|4|||
27944869|NCT03735121|81632787|FG004|Overall Study|Withdrawal by Subject|2|||
27944870|NCT03735121|81632783|FG000|Overall Study|Progressive Disease|0|||
27944871|NCT03735121|81632784|FG001|Overall Study|Progressive Disease|0|||
27944872|NCT03735121|81632785|FG002|Overall Study|Progressive Disease|1|||
27944873|NCT03735121|81632786|FG003|Overall Study|Progressive Disease|0|||
27944874|NCT03735121|81632787|FG004|Overall Study|Progressive Disease|0|||
27944875|NCT03735121|81632783|FG000|Overall Study|Lost to Follow-up|0|||
27944876|NCT03735121|81632784|FG001|Overall Study|Lost to Follow-up|0|||
27944877|NCT03735121|81632785|FG002|Overall Study|Lost to Follow-up|0|||
27944878|NCT03735121|81632786|FG003|Overall Study|Lost to Follow-up|0|||
27944879|NCT03735121|81632787|FG004|Overall Study|Lost to Follow-up|1|||
27944880|NCT03735121|81632783|FG000|Overall Study|Ongoing|3|||
27944881|NCT03735121|81632784|FG001|Overall Study|Ongoing|3|||
27944882|NCT03735121|81632785|FG002|Overall Study|Ongoing|26|||
27944883|NCT03735121|81632786|FG003|Overall Study|Ongoing|83|||
27944884|NCT03735121|81632787|FG004|Overall Study|Ongoing|158|||
27944885|NCT00432965|81632788|FG000|Overall Study|Lost to Follow-up|22|||
27944886|NCT00432965|81632789|FG001|Overall Study|Lost to Follow-up|19|||
27944887|NCT00432965|81632788|FG000|Overall Study|Withdrawal by Subject|13|||
27944888|NCT00432965|81632789|FG001|Overall Study|Withdrawal by Subject|13|||
27944889|NCT00432965|81632788|FG000|Overall Study|Physician Decision|14|||
27944890|NCT00432965|81632789|FG001|Overall Study|Physician Decision|13|||
27944891|NCT00432965|81632788|FG000|Overall Study|Lack of Efficacy|8|||
27944892|NCT00432965|81632789|FG001|Overall Study|Lack of Efficacy|13|||
27944893|NCT00432965|81632788|FG000|Overall Study|Non-compliance|7|||
27944894|NCT00432965|81632789|FG001|Overall Study|Non-compliance|0|||
27944895|NCT00432965|81632788|FG000|Overall Study|Adverse Event|22|||
27944896|NCT00432965|81632789|FG001|Overall Study|Adverse Event|19|||
27944897|NCT00432965|81632788|FG000|Overall Study|Death|3|||
27944898|NCT00432965|81632789|FG001|Overall Study|Death|4|||
27944899|NCT00432965|81632788|FG000|Overall Study|Exclusionary Methods|1|||
27944900|NCT00432965|81632789|FG001|Overall Study|Exclusionary Methods|2|||
27746386|NCT00863928|80899615|FG001|Overall Study|Withdrawal by Subject|0|||
27746387|NCT00863928|80899614|FG000|Overall Study|surgery cancellation|4|||
27944901|NCT00432965|81632788|FG000|Overall Study|Incomplete Data|4|||
27944902|NCT00432965|81632789|FG001|Overall Study|Incomplete Data|3|||
27746388|NCT00863928|80899615|FG001|Overall Study|surgery cancellation|0|||
27944903|NCT02088554|81632792|FG000|Overall Study|Exited before procedure|130|||
27944904|NCT02088554|81632792|FG000|Overall Study|Attempted but not implanted|31|||
27944905|NCT02088554|81632792|FG000|Overall Study|Implant not attempted|19|||
27944906|NCT02088554|81632792|FG000|Overall Study|Pending next visit|532|||
27944907|NCT02088554|81632792|FG000|Overall Study|Death|170|||
27944908|NCT02088554|81632792|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
27944909|NCT02088554|81632792|FG000|Overall Study|Lost to Follow-up|23|||
27944910|NCT02088554|81632792|FG000|Overall Study|Explanted|32|||
27944911|NCT02088554|81632792|FG000|Overall Study|Any other reason not covered by previous categories|11|||
27647758|NCT01683409|80550928|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
27647759|NCT01683409|80550924|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
27647760|NCT01683409|80550925|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
27647761|NCT01683409|80550926|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
27647762|NCT01683409|80550927|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
27647763|NCT01683409|80550928|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
27647764|NCT01683409|80550924|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27647765|NCT01683409|80550925|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27647766|NCT01683409|80550926|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27647767|NCT01683409|80550927|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
27647768|NCT01683409|80550928|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
27647769|NCT01683409|80550924|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27647770|NCT01683409|80550925|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27647771|NCT01683409|80550926|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
27647772|NCT01683409|80550927|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27647773|NCT01683409|80550928|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
27647774|NCT01566890|80550929|FG000|Overall Study|Adverse Event|1|||
27647775|NCT01566890|80550930|FG001|Overall Study|Adverse Event|0|||
27647776|NCT01566890|80550931|FG002|Overall Study|Adverse Event|0|||
27647777|NCT01566890|80550932|FG003|Overall Study|Adverse Event|0|||
27647778|NCT01566890|80550933|FG004|Overall Study|Adverse Event|0|||
27647779|NCT01566890|80550929|FG000|Overall Study|Withdrawal by Subject|3|||
27647780|NCT01566890|80550930|FG001|Overall Study|Withdrawal by Subject|1|||
27647781|NCT01566890|80550931|FG002|Overall Study|Withdrawal by Subject|1|||
27647782|NCT01566890|80550932|FG003|Overall Study|Withdrawal by Subject|1|||
27647783|NCT01566890|80550933|FG004|Overall Study|Withdrawal by Subject|0|||
27647784|NCT01566890|80550929|FG000|Overall Study|Screen failure|6|||
27647785|NCT01566890|80550930|FG001|Overall Study|Screen failure|0|||
27647786|NCT01566890|80550931|FG002|Overall Study|Screen failure|1|||
27647787|NCT01566890|80550932|FG003|Overall Study|Screen failure|1|||
27647788|NCT01566890|80550933|FG004|Overall Study|Screen failure|0|||
27647789|NCT01566890|80550929|FG000|Overall Study|Incomplete CEU data|1|||
27647790|NCT01566890|80550930|FG001|Overall Study|Incomplete CEU data|3|||
27647791|NCT01566890|80550931|FG002|Overall Study|Incomplete CEU data|5|||
27647792|NCT01566890|80550932|FG003|Overall Study|Incomplete CEU data|8|||
27647793|NCT01566890|80550933|FG004|Overall Study|Incomplete CEU data|0|||
27647794|NCT01566890|80550929|FG000|Overall Study|Lost to Follow-up|0|||
27647795|NCT01566890|80550930|FG001|Overall Study|Lost to Follow-up|0|||
27647796|NCT01566890|80550931|FG002|Overall Study|Lost to Follow-up|4|||
27647797|NCT01566890|80550932|FG003|Overall Study|Lost to Follow-up|4|||
27647798|NCT01566890|80550933|FG004|Overall Study|Lost to Follow-up|0|||
27647799|NCT01566890|80550929|FG000|Overall Study|Other|0|||
27647800|NCT01566890|80550930|FG001|Overall Study|Other|0|||
27647801|NCT01566890|80550931|FG002|Overall Study|Other|0|||
27647802|NCT01566890|80550932|FG003|Overall Study|Other|0|||
27647803|NCT01566890|80550933|FG004|Overall Study|Other|7|||
27647804|NCT02634307|80550934|FG000|Overall Study|Adverse Event|50|||
27647805|NCT02634307|80550935|FG001|Overall Study|Adverse Event|24|||
27647806|NCT02634307|80550936|FG002|Overall Study|Adverse Event|14|||
27647807|NCT02634307|80550934|FG000|Overall Study|Lost to Follow-up|21|||
27647808|NCT02634307|80550935|FG001|Overall Study|Lost to Follow-up|5|||
27647809|NCT02634307|80550936|FG002|Overall Study|Lost to Follow-up|6|||
27647810|NCT02634307|80550934|FG000|Overall Study|Pregnancy|5|||
27647811|NCT02634307|80550935|FG001|Overall Study|Pregnancy|1|||
27647812|NCT02634307|80550936|FG002|Overall Study|Pregnancy|3|||
27647813|NCT02634307|80550934|FG000|Overall Study|Withdrawal by Subject|38|||
27647814|NCT02634307|80550935|FG001|Overall Study|Withdrawal by Subject|24|||
27647815|NCT02634307|80550936|FG002|Overall Study|Withdrawal by Subject|18|||
27647816|NCT02634307|80550934|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27647817|NCT02634307|80550935|FG001|Overall Study|Non-Compliance with Study Drug|2|||
27647818|NCT02634307|80550936|FG002|Overall Study|Non-Compliance with Study Drug|2|||
27647819|NCT02634307|80550934|FG000|Overall Study|Lack of Efficacy|1|||
27647820|NCT02634307|80550935|FG001|Overall Study|Lack of Efficacy|5|||
27647821|NCT02634307|80550936|FG002|Overall Study|Lack of Efficacy|3|||
27647822|NCT02634307|80550934|FG000|Overall Study|Physician Decision|7|||
27647823|NCT02634307|80550935|FG001|Overall Study|Physician Decision|5|||
27647824|NCT02634307|80550936|FG002|Overall Study|Physician Decision|5|||
27647825|NCT02634307|80550934|FG000|Overall Study|Reason not Specified|3|||
27647826|NCT02634307|80550935|FG001|Overall Study|Reason not Specified|5|||
27647827|NCT02634307|80550936|FG002|Overall Study|Reason not Specified|10|||
27647828|NCT00949117|80550938|FG000|Overall Study|Lack of Efficacy|2|||
27647829|NCT00949117|80550939|FG001|Overall Study|Lack of Efficacy|3|||
27647830|NCT00949117|80550938|FG000|Overall Study|Protocol Violation|1|||
27647831|NCT00949117|80550939|FG001|Overall Study|Protocol Violation|1|||
27647832|NCT00949117|80550938|FG000|Overall Study|Adverse Event|0|||
27647833|NCT00949117|80550939|FG001|Overall Study|Adverse Event|1|||
27647834|NCT02167451|80550940|FG000|Overall Study|Withdrawal by Subject|1|||
27647835|NCT05270460|80550947|FG000|Overall Study|Adverse Event|0|||
27944912|NCT03345550|81632794|FG000|Overall Study|Withdrawal by Subject|1|||
27944913|NCT03345550|81632795|FG001|Overall Study|Withdrawal by Subject|0|||
27944914|NCT03345550|81632794|FG000|Overall Study|Lost to Follow-up|4|||
27944915|NCT03345550|81632795|FG001|Overall Study|Lost to Follow-up|5|||
27944916|NCT01889251|81632797|FG000|Overall Study|Adverse Event|1|||
27944917|NCT01889251|81632798|FG001|Overall Study|Adverse Event|0|||
27944918|NCT00879398|81632799|FG000|Overall Study|Visit Stop|399|||
27944919|NCT00879398|81632799|FG000|Overall Study|Lack of Efficacy|64|||
27944920|NCT00879398|81632799|FG000|Overall Study|Adverse Event|41|||
27944921|NCT00879398|81632799|FG000|Overall Study|Other Reasons|171|||
27944922|NCT00267488|81632805|FG000|Overall Study|Sponsor Terminated Study|9|||
27944923|NCT00267488|81632805|FG000|Overall Study|Protocol Violation|1|||
27944924|NCT00267488|81632805|FG000|Overall Study|Other (Disease Progression)|1|||
27944925|NCT03847519|81632806|FG000|Overall Study|Death|5|||
27944926|NCT03847519|81632807|FG001|Overall Study|Death|8|||
27944927|NCT03847519|81632808|FG002|Overall Study|Death|1|||
27944928|NCT03847519|81632806|FG000|Overall Study|Lost to Follow-up|1|||
27944929|NCT03847519|81632807|FG001|Overall Study|Lost to Follow-up|2|||
27944930|NCT03847519|81632808|FG002|Overall Study|Lost to Follow-up|0|||
27944931|NCT03847519|81632806|FG000|Overall Study|Study Terminated by Sponsor|0|||
27944932|NCT03847519|81632807|FG001|Overall Study|Study Terminated by Sponsor|3|||
27944933|NCT03847519|81632808|FG002|Overall Study|Study Terminated by Sponsor|2|||
27944934|NCT03034044|81632809|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
27944935|NCT03163667|81632811|FG000|Overall Study|Death|15|||
27944936|NCT03163667|81632812|FG001|Overall Study|Death|27|||
27944937|NCT03163667|81632811|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
27944938|NCT03163667|81632812|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
27944939|NCT02457546|81632813|FG000|Overall Study|Other reasons|4|||
27944940|NCT02457546|81632814|FG001|Overall Study|Other reasons|1|||
27944941|NCT02457546|81632813|FG000|Overall Study|Refused to complete study/procedures|1|||
27944942|NCT02457546|81632814|FG001|Overall Study|Refused to complete study/procedures|1|||
27944943|NCT02457546|81632813|FG000|Overall Study|Lost to Follow-up|4|||
27944944|NCT02457546|81632814|FG001|Overall Study|Lost to Follow-up|1|||
27944945|NCT02457546|81632813|FG000|Overall Study|Adverse Event|0|||
27944946|NCT02457546|81632814|FG001|Overall Study|Adverse Event|1|||
27944947|NCT00944645|81632816|FG000|Period 2|Adverse Event|1|||
27944948|NCT00944645|81632817|FG001|Period 2|Adverse Event|0|||
27944949|NCT00944645|81632816|FG000|Period 2|Lost to Follow-up|0|||
27944950|NCT00944645|81632817|FG001|Period 2|Lost to Follow-up|3|||
27944951|NCT00944645|81632816|FG000|Period 2|Withdrawal by Subject|7|||
27944952|NCT00944645|81632817|FG001|Period 2|Withdrawal by Subject|6|||
27944953|NCT06582732|81632818|FG000|Initial Study Period|Adverse Event|0|||
27944954|NCT06582732|81632819|FG001|Initial Study Period|Adverse Event|0|||
27944955|NCT06582732|81632820|FG002|Initial Study Period|Adverse Event|0|||
27944956|NCT06582732|81632821|FG003|Initial Study Period|Adverse Event|2|||
27944957|NCT06582732|81632822|FG004|Initial Study Period|Adverse Event|0|||
27944958|NCT06582732|81632823|FG005|Initial Study Period|Adverse Event|0|||
27944959|NCT06582732|81632824|FG006|Initial Study Period|Adverse Event|0|||
27944960|NCT06582732|81632818|FG000|Initial Study Period|Death|1|||
27944961|NCT06582732|81632819|FG001|Initial Study Period|Death|0|||
27944962|NCT06582732|81632820|FG002|Initial Study Period|Death|0|||
27944963|NCT06582732|81632821|FG003|Initial Study Period|Death|0|||
27944964|NCT06582732|81632822|FG004|Initial Study Period|Death|1|||
27944965|NCT06582732|81632823|FG005|Initial Study Period|Death|0|||
27944966|NCT06582732|81632824|FG006|Initial Study Period|Death|0|||
27944967|NCT06582732|81632818|FG000|Initial Study Period|Lost to Follow-up|0|||
27944968|NCT06582732|81632819|FG001|Initial Study Period|Lost to Follow-up|0|||
27944969|NCT06582732|81632820|FG002|Initial Study Period|Lost to Follow-up|2|||
27944970|NCT06582732|81632821|FG003|Initial Study Period|Lost to Follow-up|0|||
27944971|NCT06582732|81632822|FG004|Initial Study Period|Lost to Follow-up|0|||
27647836|NCT05270460|80550948|FG001|Overall Study|Adverse Event|1|||
27647837|NCT05270460|80550949|FG002|Overall Study|Adverse Event|0|||
27647838|NCT05270460|80550947|FG000|Overall Study|Early Termination|0|||
27944972|NCT06582732|81632823|FG005|Initial Study Period|Lost to Follow-up|0|||
27944973|NCT06582732|81632824|FG006|Initial Study Period|Lost to Follow-up|0|||
27944974|NCT06582732|81632818|FG000|Initial Study Period|Withdrawal by Subject|0|||
27944975|NCT06582732|81632819|FG001|Initial Study Period|Withdrawal by Subject|1|||
27647839|NCT05270460|80550948|FG001|Overall Study|Early Termination|1|||
27944976|NCT06582732|81632820|FG002|Initial Study Period|Withdrawal by Subject|0|||
27944977|NCT06582732|81632821|FG003|Initial Study Period|Withdrawal by Subject|1|||
27944978|NCT06582732|81632822|FG004|Initial Study Period|Withdrawal by Subject|3|||
27944979|NCT06582732|81632823|FG005|Initial Study Period|Withdrawal by Subject|1|||
27944980|NCT06582732|81632824|FG006|Initial Study Period|Withdrawal by Subject|2|||
27944981|NCT06582732|81632818|FG000|Initial Study Period|Moved Away|0|||
27944982|NCT06582732|81632819|FG001|Initial Study Period|Moved Away|0|||
27944983|NCT06582732|81632820|FG002|Initial Study Period|Moved Away|0|||
27647840|NCT05270460|80550949|FG002|Overall Study|Early Termination|0|||
27647841|NCT02892019|80550950|FG000|Overall Study|randomized but not treated|0|||
27647842|NCT02892019|80550951|FG001|Overall Study|randomized but not treated|1|||
27647843|NCT02892019|80550950|FG000|Overall Study|Withdrawal by Subject|0|||
27647844|NCT02892019|80550951|FG001|Overall Study|Withdrawal by Subject|1|||
27647845|NCT02892019|80550950|FG000|Overall Study|Adverse Event|1|||
27647846|NCT02892019|80550951|FG001|Overall Study|Adverse Event|1|||
27647847|NCT00999596|80550952|FG000|Overall Study|Statistical population not required|101|||
27647848|NCT00777049|80550953|FG000|Overall Study|Withdrawal by Subject|1|||
27647849|NCT00777049|80550954|FG001|Overall Study|Withdrawal by Subject|0|||
27647850|NCT00777049|80550953|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
27647851|NCT00777049|80550954|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
27647852|NCT01218659|80550955|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
27647853|NCT01218659|80550956|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
27944984|NCT06582732|81632821|FG003|Initial Study Period|Moved Away|0|||
27944985|NCT06582732|81632822|FG004|Initial Study Period|Moved Away|1|||
27944986|NCT06582732|81632823|FG005|Initial Study Period|Moved Away|0|||
27944987|NCT06582732|81632824|FG006|Initial Study Period|Moved Away|0|||
27944988|NCT00959049|81632825|FG000|Overall Study|Adverse Event|1|||
27944989|NCT00959049|81632826|FG001|Overall Study|Adverse Event|0|||
27944990|NCT00959049|81632827|FG002|Overall Study|Adverse Event|0|||
27944991|NCT00959049|81632828|FG003|Overall Study|Adverse Event|0|||
27944992|NCT00959049|81632829|FG004|Overall Study|Adverse Event|0|||
27944993|NCT00959049|81632830|FG005|Overall Study|Adverse Event|0|||
27944994|NCT00959049|81632825|FG000|Overall Study|Lost to Follow-up|17|||
27944995|NCT00959049|81632826|FG001|Overall Study|Lost to Follow-up|5|||
27944996|NCT00959049|81632827|FG002|Overall Study|Lost to Follow-up|1|||
27944997|NCT00959049|81632828|FG003|Overall Study|Lost to Follow-up|10|||
27944998|NCT00959049|81632829|FG004|Overall Study|Lost to Follow-up|9|||
27944999|NCT00959049|81632830|FG005|Overall Study|Lost to Follow-up|1|||
27945000|NCT00959049|81632825|FG000|Overall Study|Contraindicated medication|0|||
27945001|NCT00959049|81632826|FG001|Overall Study|Contraindicated medication|0|||
27945002|NCT00959049|81632827|FG002|Overall Study|Contraindicated medication|0|||
27945003|NCT00959049|81632828|FG003|Overall Study|Contraindicated medication|1|||
27945004|NCT00959049|81632829|FG004|Overall Study|Contraindicated medication|0|||
27945005|NCT00959049|81632830|FG005|Overall Study|Contraindicated medication|0|||
27945006|NCT00959049|81632825|FG000|Overall Study|Withdrawal by Subject|0|||
27945007|NCT00959049|81632826|FG001|Overall Study|Withdrawal by Subject|2|||
27945008|NCT00959049|81632827|FG002|Overall Study|Withdrawal by Subject|0|||
27945009|NCT00959049|81632828|FG003|Overall Study|Withdrawal by Subject|0|||
27945010|NCT00959049|81632829|FG004|Overall Study|Withdrawal by Subject|0|||
27945011|NCT00959049|81632830|FG005|Overall Study|Withdrawal by Subject|0|||
27945012|NCT00023595|81632833|FG000|5 Year Follow up|Lost to Follow-up|2|||
27945013|NCT00023595|81632834|FG001|5 Year Follow up|Lost to Follow-up|2|||
27945014|NCT00023595|81632835|FG002|5 Year Follow up|Lost to Follow-up|1|||
27945015|NCT00023595|81632836|FG003|5 Year Follow up|Lost to Follow-up|7|||
27945016|NCT00023595|81632837|FG004|5 Year Follow up|Lost to Follow-up|3|||
27945017|NCT00023595|81632833|FG000|10 Year Follow up|Lost to Follow-up|12|||
27945018|NCT00023595|81632834|FG001|10 Year Follow up|Lost to Follow-up|10|||
27945019|NCT00023595|81632835|FG002|10 Year Follow up|Lost to Follow-up|3|||
27945020|NCT00023595|81632836|FG003|10 Year Follow up|Lost to Follow-up|0|||
27945021|NCT00023595|81632837|FG004|10 Year Follow up|Lost to Follow-up|0|||
27945022|NCT04349098|81632840|FG000|Overall Study|Death|16|||
27945023|NCT04349098|81632841|FG001|Overall Study|Death|8|||
27945024|NCT04349098|81632840|FG000|Overall Study|Lost to Follow-up|11|||
27945025|NCT04349098|81632841|FG001|Overall Study|Lost to Follow-up|8|||
27945026|NCT04349098|81632840|FG000|Overall Study|Withdrawal by Subject|8|||
27647854|NCT01218659|80550957|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
27647855|NCT01218659|80550955|FG000|18-Month Randomized Period|Did not receive study drug|0|||
27647856|NCT01218659|80550956|FG001|18-Month Randomized Period|Did not receive study drug|3|||
27647857|NCT01218659|80550957|FG002|18-Month Randomized Period|Did not receive study drug|0|||
27647858|NCT01218659|80550955|FG000|12-Month OLE|Withdrawal by Subject|0|||
27647859|NCT01218659|80550956|FG001|12-Month OLE|Withdrawal by Subject|0|||
27945027|NCT04349098|81632841|FG001|Overall Study|Withdrawal by Subject|5|||
27945028|NCT04349098|81632840|FG000|Overall Study|Other|3|||
27945029|NCT04349098|81632841|FG001|Overall Study|Other|5|||
27647860|NCT01218659|80550957|FG002|12-Month OLE|Withdrawal by Subject|2|||
27945030|NCT01356940|81632848|FG000|First Intervention (28 Days)|Adverse Event|1|||
27945031|NCT01356940|81632849|FG001|First Intervention (28 Days)|Adverse Event|0|||
27945032|NCT01356940|81632848|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
27945033|NCT01356940|81632849|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
27945034|NCT02763566|81632860|FG000|Overall Study|Lost to Follow-up|1|||
27945035|NCT02763566|81632861|FG001|Overall Study|Lost to Follow-up|4|||
27647861|NCT01218659|80550955|FG000|12-Month OLE|Physician Decision|0|||
27647862|NCT01218659|80550956|FG001|12-Month OLE|Physician Decision|0|||
27945036|NCT02763566|81632862|FG002|Overall Study|Lost to Follow-up|0|||
27945037|NCT02763566|81632863|FG003|Overall Study|Lost to Follow-up|1|||
27945038|NCT02763566|81632860|FG000|Overall Study|On study treatment at study conclusion|114|||
27945039|NCT02763566|81632861|FG001|Overall Study|On study treatment at study conclusion|34|||
27945040|NCT02763566|81632862|FG002|Overall Study|On study treatment at study conclusion|54|||
27945041|NCT02763566|81632863|FG003|Overall Study|On study treatment at study conclusion|13|||
27945042|NCT02763566|81632860|FG000|Overall Study|Withdrawal by Subject|3|||
27945043|NCT02763566|81632861|FG001|Overall Study|Withdrawal by Subject|1|||
27945044|NCT02763566|81632862|FG002|Overall Study|Withdrawal by Subject|0|||
27945045|NCT02763566|81632863|FG003|Overall Study|Withdrawal by Subject|0|||
27945046|NCT05130281|81632865|FG000|Overall Study|Withdrawal by Subject|0|||
27945047|NCT05130281|81632866|FG001|Overall Study|Withdrawal by Subject|0|||
27647863|NCT01218659|80550957|FG002|12-Month OLE|Physician Decision|1|||
27647864|NCT01218659|80550955|FG000|12-Month OLE|Lost to Follow-up|0|||
27647865|NCT01218659|80550956|FG001|12-Month OLE|Lost to Follow-up|0|||
27647866|NCT01218659|80550957|FG002|12-Month OLE|Lost to Follow-up|1|||
27945048|NCT05130281|81632867|FG002|Overall Study|Withdrawal by Subject|1|||
27945049|NCT02776735|81632868|FG000|Overall Study|Adverse Event|0|||
27945050|NCT02776735|81632869|FG001|Overall Study|Adverse Event|0|||
27945051|NCT02776735|81632870|FG002|Overall Study|Adverse Event|0|||
27945052|NCT02776735|81632871|FG003|Overall Study|Adverse Event|1|||
27945053|NCT02776735|81632872|FG004|Overall Study|Adverse Event|0|||
27945054|NCT02776735|81632873|FG005|Overall Study|Adverse Event|1|||
27945055|NCT02776735|81632868|FG000|Overall Study|Lost to Follow-up|0|||
27945056|NCT02776735|81632869|FG001|Overall Study|Lost to Follow-up|0|||
27945057|NCT02776735|81632870|FG002|Overall Study|Lost to Follow-up|0|||
27945058|NCT02776735|81632871|FG003|Overall Study|Lost to Follow-up|1|||
27945059|NCT02776735|81632872|FG004|Overall Study|Lost to Follow-up|0|||
27945060|NCT02776735|81632873|FG005|Overall Study|Lost to Follow-up|0|||
27945061|NCT02776735|81632868|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27945062|NCT02776735|81632869|FG001|Overall Study|Withdrawal by parent/guardian|0|||
27945063|NCT02776735|81632870|FG002|Overall Study|Withdrawal by parent/guardian|2|||
27945064|NCT02776735|81632871|FG003|Overall Study|Withdrawal by parent/guardian|2|||
27945065|NCT02776735|81632872|FG004|Overall Study|Withdrawal by parent/guardian|0|||
27945066|NCT02776735|81632873|FG005|Overall Study|Withdrawal by parent/guardian|0|||
27945067|NCT02776735|81632868|FG000|Overall Study|Withdrawal by Subject|1|||
27945068|NCT02776735|81632869|FG001|Overall Study|Withdrawal by Subject|0|||
27945069|NCT02776735|81632870|FG002|Overall Study|Withdrawal by Subject|0|||
27945070|NCT02776735|81632871|FG003|Overall Study|Withdrawal by Subject|0|||
27945071|NCT02776735|81632872|FG004|Overall Study|Withdrawal by Subject|0|||
27945072|NCT02776735|81632873|FG005|Overall Study|Withdrawal by Subject|1|||
27945073|NCT02776735|81632868|FG000|Overall Study|Other|0|||
27945074|NCT02776735|81632869|FG001|Overall Study|Other|0|||
27945075|NCT02776735|81632870|FG002|Overall Study|Other|3|||
27647867|NCT01218659|80550955|FG000|12-Month OLE|Pregnancy|0|||
27647868|NCT01218659|80550956|FG001|12-Month OLE|Pregnancy|0|||
27647869|NCT01218659|80550957|FG002|12-Month OLE|Pregnancy|1|||
27647870|NCT01218659|80550955|FG000|12-Month OLE|Lack of Efficacy|0|||
27647871|NCT01218659|80550956|FG001|12-Month OLE|Lack of Efficacy|0|||
27647872|NCT01218659|80550957|FG002|12-Month OLE|Lack of Efficacy|1|||
27647873|NCT01218659|80550955|FG000|12-Month OLE|Declined to participate in the OLE|0|||
27647874|NCT01218659|80550956|FG001|12-Month OLE|Declined to participate in the OLE|0|||
27647875|NCT01218659|80550957|FG002|12-Month OLE|Declined to participate in the OLE|4|||
27647876|NCT00853580|80550958|FG000|Overall Study|Lost to Follow-up|3|||
27647877|NCT00853580|80550959|FG001|Overall Study|Lost to Follow-up|5|||
27647878|NCT00853580|80550958|FG000|Overall Study|Protocol Violation|2|||
27647879|NCT00853580|80550959|FG001|Overall Study|Protocol Violation|1|||
27647880|NCT00853580|80550958|FG000|Overall Study|Withdrawal by Subject|2|||
27647881|NCT00853580|80550959|FG001|Overall Study|Withdrawal by Subject|8|||
27647882|NCT00853580|80550958|FG000|Overall Study|Commenced contraindicated therapy|0|||
27647883|NCT00853580|80550959|FG001|Overall Study|Commenced contraindicated therapy|2|||
27647884|NCT01822756|80550960|FG000|Overall Study|Adverse Event|0|||
27647885|NCT01822756|80550961|FG001|Overall Study|Adverse Event|0|||
27647886|NCT01822756|80550962|FG002|Overall Study|Adverse Event|0|||
27945076|NCT02776735|81632871|FG003|Overall Study|Other|0|||
27945077|NCT02776735|81632872|FG004|Overall Study|Other|0|||
27945078|NCT02776735|81632873|FG005|Overall Study|Other|0|||
27647887|NCT01822756|80550963|FG003|Overall Study|Adverse Event|2|||
27647888|NCT01822756|80550964|FG004|Overall Study|Adverse Event|0|||
27647889|NCT01822756|80550960|FG000|Overall Study|Disease progression|11|||
27647890|NCT01822756|80550961|FG001|Overall Study|Disease progression|1|||
27647891|NCT01822756|80550962|FG002|Overall Study|Disease progression|7|||
27945079|NCT05878067|81632875|FG000|Overall Study|Lost to Follow-up|2|||
27945080|NCT03274466|81632878|FG000|Overall Study|Withdrawal by Subject|7|||
27945081|NCT03274466|81632879|FG001|Overall Study|Withdrawal by Subject|3|||
27945082|NCT03274466|81632878|FG000|Overall Study|Protocol Specified Withdrawal|5|||
27945083|NCT03274466|81632879|FG001|Overall Study|Protocol Specified Withdrawal|11|||
27647892|NCT01822756|80550963|FG003|Overall Study|Disease progression|2|||
27647893|NCT01822756|80550964|FG004|Overall Study|Disease progression|6|||
27647894|NCT01822756|80550960|FG000|Overall Study|Death|2|||
27647895|NCT01822756|80550961|FG001|Overall Study|Death|2|||
27647896|NCT01822756|80550962|FG002|Overall Study|Death|1|||
27647897|NCT01822756|80550963|FG003|Overall Study|Death|0|||
27647898|NCT01822756|80550964|FG004|Overall Study|Death|0|||
27945084|NCT03274466|81632878|FG000|Overall Study|Lost to Follow-up|5|||
27945085|NCT03274466|81632879|FG001|Overall Study|Lost to Follow-up|7|||
27945086|NCT03274466|81632878|FG000|Overall Study|Subject Non-compliance|0|||
27945087|NCT03274466|81632879|FG001|Overall Study|Subject Non-compliance|1|||
27945088|NCT03274466|81632878|FG000|Overall Study|Adverse Event|3|||
27945089|NCT03274466|81632879|FG001|Overall Study|Adverse Event|3|||
27945090|NCT03274466|81632878|FG000|Overall Study|Physician Decision|0|||
27945091|NCT03274466|81632879|FG001|Overall Study|Physician Decision|1|||
27945092|NCT03274466|81632878|FG000|Overall Study|Protocol Violation|3|||
27945093|NCT03274466|81632879|FG001|Overall Study|Protocol Violation|3|||
27945094|NCT03880019|81632880|FG000|Overall Study|Competing disease|1|||
27945095|NCT01946880|81632881|FG000|Overall Study|Lost to Follow-up|1|||
27945096|NCT01946880|81632882|FG001|Overall Study|Lost to Follow-up|0|||
27945097|NCT01946880|81632881|FG000|Overall Study|Physician Decision|1|||
27945098|NCT01946880|81632882|FG001|Overall Study|Physician Decision|1|||
27945099|NCT01946880|81632881|FG000|Overall Study|Withdrawal by Subject|3|||
27945100|NCT01946880|81632882|FG001|Overall Study|Withdrawal by Subject|2|||
27945101|NCT01946880|81632881|FG000|Overall Study|Met Primary Endpoint|1|||
27945102|NCT01946880|81632882|FG001|Overall Study|Met Primary Endpoint|0|||
27945103|NCT01946880|81632881|FG000|Overall Study|Personal and Family Issues|1|||
27945104|NCT01946880|81632882|FG001|Overall Study|Personal and Family Issues|0|||
27945105|NCT02457793|81632883|FG000|Overall Study|Reason not specified|0|||
27945106|NCT02457793|81632884|FG001|Overall Study|Reason not specified|0|||
27945107|NCT02457793|81632885|FG002|Overall Study|Reason not specified|0|||
27945108|NCT02457793|81632886|FG003|Overall Study|Reason not specified|1|||
27945109|NCT02457793|81632887|FG004|Overall Study|Reason not specified|1|||
27945110|NCT02457793|81632888|FG005|Overall Study|Reason not specified|1|||
27945111|NCT02457793|81632883|FG000|Overall Study|Withdrawal by Subject|0|||
27945112|NCT02457793|81632884|FG001|Overall Study|Withdrawal by Subject|4|||
27945113|NCT02457793|81632885|FG002|Overall Study|Withdrawal by Subject|2|||
27945114|NCT02457793|81632886|FG003|Overall Study|Withdrawal by Subject|2|||
27945115|NCT02457793|81632887|FG004|Overall Study|Withdrawal by Subject|2|||
27945116|NCT02457793|81632888|FG005|Overall Study|Withdrawal by Subject|2|||
27945117|NCT02457793|81632883|FG000|Overall Study|Adverse Event|0|||
27945118|NCT02457793|81632884|FG001|Overall Study|Adverse Event|0|||
27945119|NCT02457793|81632885|FG002|Overall Study|Adverse Event|0|||
27945120|NCT02457793|81632886|FG003|Overall Study|Adverse Event|1|||
27945121|NCT02457793|81632887|FG004|Overall Study|Adverse Event|0|||
27945122|NCT02457793|81632888|FG005|Overall Study|Adverse Event|0|||
27945123|NCT02457793|81632883|FG000|Overall Study|Physician Decision|1|||
27945124|NCT02457793|81632884|FG001|Overall Study|Physician Decision|0|||
27945125|NCT02457793|81632885|FG002|Overall Study|Physician Decision|1|||
27945126|NCT02457793|81632886|FG003|Overall Study|Physician Decision|1|||
27945127|NCT02457793|81632887|FG004|Overall Study|Physician Decision|1|||
27945128|NCT02457793|81632888|FG005|Overall Study|Physician Decision|3|||
27945129|NCT02507934|81632890|FG000|Overall Study|Lost to Follow-up|2|||
27945130|NCT02507934|81632891|FG001|Overall Study|Lost to Follow-up|0|||
27945131|NCT02507934|81632890|FG000|Overall Study|Withdrawal by Subject|2|||
27945132|NCT02507934|81632891|FG001|Overall Study|Withdrawal by Subject|0|||
27945133|NCT02097225|81632892|FG000|Dose Level 4|Adverse Event|0|||
27945134|NCT02097225|81632893|FG001|Dose Level 4|Adverse Event|0|||
27945135|NCT02097225|81632894|FG002|Dose Level 4|Adverse Event|0|||
27945136|NCT02097225|81632895|FG003|Dose Level 4|Adverse Event|0|||
27945137|NCT02097225|81632896|FG004|Dose Level 4|Adverse Event|1|||
27945138|NCT03331354|81632903|FG000|Overall Study|Withdrawal by Subject|1|||
27945139|NCT03331354|81632904|FG001|Overall Study|Withdrawal by Subject|3|||
27945140|NCT03331354|81632903|FG000|Overall Study|Lost to Follow-up|3|||
27945141|NCT03331354|81632904|FG001|Overall Study|Lost to Follow-up|3|||
27551365|NCT01543698|80207458|FG000|Phase 1b|Adverse Event|1|||
27551366|NCT01543698|80207459|FG001|Phase 1b|Adverse Event|0|||
27551367|NCT01543698|80207460|FG002|Phase 1b|Adverse Event|0|||
27551368|NCT01543698|80207461|FG003|Phase 1b|Adverse Event|1|||
27551369|NCT01543698|80207462|FG004|Phase 1b|Adverse Event|2|||
27551370|NCT01543698|80207463|FG005|Phase 1b|Adverse Event|2|||
27551371|NCT01543698|80207464|FG006|Phase 1b|Adverse Event|0|||
27551372|NCT01543698|80207465|FG007|Phase 1b|Adverse Event|0|||
27551373|NCT01543698|80207466|FG008|Phase 1b|Adverse Event|1|||
27551374|NCT01543698|80207467|FG009|Phase 1b|Adverse Event|1|||
27551375|NCT01543698|80207468|FG010|Phase 1b|Adverse Event|2|||
27551376|NCT01543698|80207469|FG011|Phase 1b|Adverse Event|0|||
27551377|NCT01543698|80207470|FG012|Phase 1b|Adverse Event|0|||
27551378|NCT01543698|80207471|FG013|Phase 1b|Adverse Event|0|||
27551379|NCT01543698|80207472|FG014|Phase 1b|Adverse Event|0|||
27551380|NCT01543698|80207458|FG000|Phase 1b|Administrative problems|1|||
27945142|NCT03331354|81632903|FG000|Overall Study|Found employment before initiated active intervention|0|||
27945143|NCT03331354|81632904|FG001|Overall Study|Found employment before initiated active intervention|4|||
27945144|NCT02284893|81632909|FG000|26 Week (Short Term)|Adverse Event|1|||
27945145|NCT02284893|81632910|FG001|26 Week (Short Term)|Adverse Event|9|||
27945146|NCT02284893|81632909|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
27945147|NCT02284893|81632910|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
27945148|NCT02284893|81632909|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
27945149|NCT02284893|81632910|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
27647899|NCT01822756|80550960|FG000|Overall Study|Lost to Follow-up|1|||
27647900|NCT01822756|80550961|FG001|Overall Study|Lost to Follow-up|0|||
27647901|NCT01822756|80550962|FG002|Overall Study|Lost to Follow-up|1|||
27647902|NCT01822756|80550963|FG003|Overall Study|Lost to Follow-up|0|||
27647903|NCT01822756|80550964|FG004|Overall Study|Lost to Follow-up|1|||
27647904|NCT01822756|80550960|FG000|Overall Study|Physician Decision|0|||
27647905|NCT01822756|80550961|FG001|Overall Study|Physician Decision|1|||
27647906|NCT01822756|80550962|FG002|Overall Study|Physician Decision|0|||
27647907|NCT01822756|80550963|FG003|Overall Study|Physician Decision|0|||
27647908|NCT01822756|80550964|FG004|Overall Study|Physician Decision|0|||
27647909|NCT01822756|80550960|FG000|Overall Study|disease progression & patient preference|2|||
27647910|NCT01822756|80550961|FG001|Overall Study|disease progression & patient preference|0|||
27647911|NCT01822756|80550962|FG002|Overall Study|disease progression & patient preference|1|||
27647912|NCT01822756|80550963|FG003|Overall Study|disease progression & patient preference|0|||
27647913|NCT01822756|80550964|FG004|Overall Study|disease progression & patient preference|0|||
27647914|NCT01787032|80550965|FG000|Overall Study|Protocol Violation|0|||
27647915|NCT01787032|80550966|FG001|Overall Study|Protocol Violation|0|||
27647916|NCT01787032|80550967|FG002|Overall Study|Protocol Violation|0|||
27647917|NCT01787032|80550968|FG003|Overall Study|Protocol Violation|0|||
27647918|NCT01787032|80550969|FG004|Overall Study|Protocol Violation|1|||
27647919|NCT01787032|80550970|FG005|Overall Study|Protocol Violation|1|||
27647920|NCT01604824|80550971|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27647921|NCT01604824|80550972|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27647922|NCT01604824|80550973|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27647923|NCT01604824|80550974|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27647924|NCT01604824|80550975|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
27647925|NCT01604824|80550976|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
27647926|NCT01604824|80550971|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
27647927|NCT01604824|80550972|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
27647928|NCT01604824|80550973|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
27647929|NCT01604824|80550974|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
27647930|NCT01604824|80550975|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
27647931|NCT01604824|80550976|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
27647932|NCT01961609|80550977|FG000|Initiation|Missing|3|||
27647933|NCT01961609|80550978|FG001|Initiation|Missing|2|||
27647934|NCT01961609|80550979|FG002|Initiation|Missing|0|||
27647935|NCT01961609|80550980|FG003|Initiation|Missing|0|||
27647936|NCT01961609|80550977|FG000|Initiation|Protocol deviation|1|||
27647937|NCT01961609|80550978|FG001|Initiation|Protocol deviation|0|||
27647938|NCT01961609|80550979|FG002|Initiation|Protocol deviation|0|||
27647939|NCT01961609|80550980|FG003|Initiation|Protocol deviation|0|||
27647940|NCT01961609|80550977|FG000|Initiation|Death|0|||
27647941|NCT01961609|80550978|FG001|Initiation|Death|1|||
27647942|NCT01961609|80550979|FG002|Initiation|Death|0|||
27647943|NCT01961609|80550980|FG003|Initiation|Death|0|||
27647944|NCT01961609|80550977|FG000|Initiation|Administrative problems|1|||
27647945|NCT01961609|80550978|FG001|Initiation|Administrative problems|0|||
27647946|NCT01961609|80550979|FG002|Initiation|Administrative problems|0|||
27647947|NCT01961609|80550980|FG003|Initiation|Administrative problems|0|||
27647948|NCT01961609|80550977|FG000|Initiation|Withdrawal by Subject|1|||
27647949|NCT01961609|80550978|FG001|Initiation|Withdrawal by Subject|2|||
27647950|NCT01961609|80550979|FG002|Initiation|Withdrawal by Subject|0|||
27647951|NCT01961609|80550980|FG003|Initiation|Withdrawal by Subject|0|||
27647952|NCT01961609|80550977|FG000|Initiation|Lack of Efficacy|2|||
27647953|NCT01961609|80550978|FG001|Initiation|Lack of Efficacy|1|||
27647954|NCT01961609|80550979|FG002|Initiation|Lack of Efficacy|0|||
27647955|NCT01961609|80550980|FG003|Initiation|Lack of Efficacy|0|||
27647956|NCT01961609|80550977|FG000|Initiation|Abnormal lab values|0|||
27647957|NCT01961609|80550978|FG001|Initiation|Abnormal lab values|1|||
27647958|NCT01961609|80550979|FG002|Initiation|Abnormal lab values|0|||
27647959|NCT01961609|80550980|FG003|Initiation|Abnormal lab values|0|||
27945150|NCT02284893|81632909|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
27647960|NCT01961609|80550977|FG000|Initiation|Adverse Event|3|||
27647961|NCT01961609|80550978|FG001|Initiation|Adverse Event|5|||
27647962|NCT01961609|80550979|FG002|Initiation|Adverse Event|0|||
27647963|NCT01961609|80550980|FG003|Initiation|Adverse Event|0|||
27647964|NCT01961609|80550977|FG000|Initiation|Randomized but not treated|1|||
27746389|NCT00863928|80899614|FG000|Overall Study|medication allergy|3|||
27945151|NCT02284893|81632910|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
27945152|NCT02284893|81632909|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
27945153|NCT02284893|81632910|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
27945154|NCT02284893|81632909|FG000|26 Week (Short Term)|Other|1|||
27945155|NCT02284893|81632910|FG001|26 Week (Short Term)|Other|1|||
27945156|NCT02284893|81632909|FG000|52 Week (Long Term)|Adverse Event|3|||
27945157|NCT02284893|81632910|FG001|52 Week (Long Term)|Adverse Event|1|||
27945158|NCT02284893|81632909|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
27945159|NCT02284893|81632910|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
27945160|NCT02284893|81632909|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
27945161|NCT02284893|81632910|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
27945162|NCT02284893|81632909|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
27945163|NCT02284893|81632910|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
27945164|NCT02284893|81632909|FG000|52 Week (Long Term)|Non-Compliance|2|||
27945165|NCT02284893|81632910|FG001|52 Week (Long Term)|Non-Compliance|3|||
27945166|NCT00847730|81632911|FG000|Overall Study|Multiple interruptions in therapy|8|||
27945167|NCT01400412|81632916|FG000|Overall Study|Lost to Follow-up|4|||
27945168|NCT01400412|81632917|FG001|Overall Study|Lost to Follow-up|7|||
27945169|NCT01400412|81632916|FG000|Overall Study|Withdrawal by Subject|3|||
27945170|NCT01400412|81632917|FG001|Overall Study|Withdrawal by Subject|4|||
27945171|NCT01400412|81632916|FG000|Overall Study|Unable to complete|3|||
27945172|NCT01400412|81632917|FG001|Overall Study|Unable to complete|3|||
27945173|NCT01400412|81632916|FG000|Overall Study|Never started study treatment|0|||
27945174|NCT01400412|81632917|FG001|Overall Study|Never started study treatment|3|||
27945175|NCT05788991|81632918|FG000|Overall Study|Not treated with study medication|1|||
27945176|NCT05788991|81632919|FG001|Overall Study|Not treated with study medication|3|||
27945177|NCT05788991|81632918|FG000|Overall Study|Withdrawal by Subject|1|||
27945178|NCT05788991|81632919|FG001|Overall Study|Withdrawal by Subject|0|||
27945179|NCT05788991|81632918|FG000|Overall Study|Lack of Efficacy|0|||
27945180|NCT05788991|81632919|FG001|Overall Study|Lack of Efficacy|1|||
27945181|NCT05788991|81632918|FG000|Overall Study|Protocol Violation|1|||
27945182|NCT05788991|81632919|FG001|Overall Study|Protocol Violation|2|||
27945183|NCT00855335|81632922|FG000|Overall Study|Lost to Follow-up|0|||
27945184|NCT00855335|81632923|FG001|Overall Study|Lost to Follow-up|0|||
27945185|NCT00855335|81632924|FG002|Overall Study|Lost to Follow-up|3|||
27945186|NCT00855335|81632925|FG003|Overall Study|Lost to Follow-up|1|||
27945187|NCT00855335|81632926|FG004|Overall Study|Lost to Follow-up|0|||
27945188|NCT00855335|81632922|FG000|Overall Study|Withdrawal by Subject|0|||
27945189|NCT00855335|81632923|FG001|Overall Study|Withdrawal by Subject|0|||
27945190|NCT00855335|81632924|FG002|Overall Study|Withdrawal by Subject|0|||
27945191|NCT00855335|81632925|FG003|Overall Study|Withdrawal by Subject|1|||
27945192|NCT00855335|81632926|FG004|Overall Study|Withdrawal by Subject|0|||
27945193|NCT00855335|81632922|FG000|Overall Study|Adverse Event|2|||
27945194|NCT00855335|81632923|FG001|Overall Study|Adverse Event|0|||
27945195|NCT00855335|81632924|FG002|Overall Study|Adverse Event|0|||
27945196|NCT00855335|81632925|FG003|Overall Study|Adverse Event|0|||
27945197|NCT00855335|81632926|FG004|Overall Study|Adverse Event|0|||
27945198|NCT00855335|81632922|FG000|Overall Study|Physician Decision|1|||
27945199|NCT00855335|81632923|FG001|Overall Study|Physician Decision|1|||
27945200|NCT00855335|81632924|FG002|Overall Study|Physician Decision|0|||
27945201|NCT00855335|81632925|FG003|Overall Study|Physician Decision|0|||
27647965|NCT01961609|80550978|FG001|Initiation|Randomized but not treated|1|||
27647966|NCT01961609|80550979|FG002|Initiation|Randomized but not treated|0|||
27647967|NCT01961609|80550980|FG003|Initiation|Randomized but not treated|0|||
27647968|NCT01961609|80550977|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
27647969|NCT01961609|80550978|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
27647970|NCT01961609|80550979|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
27647971|NCT01961609|80550980|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
27647972|NCT01961609|80550977|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
27647973|NCT01961609|80550978|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
27647974|NCT01961609|80550979|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
27746390|NCT00863928|80899615|FG001|Overall Study|medication allergy|0|||
27945202|NCT00855335|81632926|FG004|Overall Study|Physician Decision|0|||
27945203|NCT00855335|81632922|FG000|Overall Study|Other|2|||
27647975|NCT01961609|80550980|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
27647976|NCT01961609|80550977|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
27945204|NCT00855335|81632923|FG001|Overall Study|Other|1|||
27945205|NCT00855335|81632924|FG002|Overall Study|Other|2|||
27945206|NCT00855335|81632925|FG003|Overall Study|Other|5|||
27945207|NCT00855335|81632926|FG004|Overall Study|Other|1|||
27945208|NCT00581919|81632927|FG000|Overall Study|Adverse Event|8|||
27945209|NCT00581919|81632927|FG000|Overall Study|Death|1|||
27945210|NCT00581919|81632927|FG000|Overall Study|Disease Progression|10|||
27945211|NCT00581919|81632927|FG000|Overall Study|Physician Decision|1|||
27945212|NCT00581919|81632927|FG000|Overall Study|Other Complicating Disease|1|||
27647977|NCT01961609|80550978|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
27647978|NCT01961609|80550979|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
27647979|NCT01961609|80550980|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
27647980|NCT01961609|80550977|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
27647981|NCT01961609|80550978|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
27647982|NCT01961609|80550979|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
27647983|NCT01961609|80550980|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
27647984|NCT01961609|80550977|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
27647985|NCT01961609|80550978|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
27647986|NCT01961609|80550979|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
27647987|NCT01961609|80550980|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
27647988|NCT01961609|80550977|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
27647989|NCT01961609|80550978|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
27647990|NCT01961609|80550979|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
27647991|NCT01961609|80550980|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
27647992|NCT01961609|80550977|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
27647993|NCT01961609|80550978|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
27647994|NCT01961609|80550979|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
27647995|NCT01961609|80550980|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
27647996|NCT01961609|80550977|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
27647997|NCT01961609|80550978|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
27647998|NCT01961609|80550979|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
27945213|NCT00581919|81632927|FG000|Overall Study|Started Non-Protocol Therapy|2|||
27945214|NCT00581919|81632927|FG000|Overall Study|Withdrawal by Subject|1|||
27945215|NCT03757715|81632936|FG000|Overall Study|Lost to Follow-up|4|||
27945216|NCT03757715|81632937|FG001|Overall Study|Lost to Follow-up|9|||
27945217|NCT03757715|81632936|FG000|Overall Study|Withdrawal by Subject|1|||
27945218|NCT03757715|81632937|FG001|Overall Study|Withdrawal by Subject|1|||
27945219|NCT04034927|81632942|FG000|Overall Study|Adverse Event|4|||
27945220|NCT04034927|81632943|FG001|Overall Study|Adverse Event|9|||
27945221|NCT04034927|81632942|FG000|Overall Study|Death|0|||
27945222|NCT04034927|81632943|FG001|Overall Study|Death|1|||
27945223|NCT04034927|81632942|FG000|Overall Study|Withdrawal by Subject|0|||
27945224|NCT04034927|81632943|FG001|Overall Study|Withdrawal by Subject|3|||
27945225|NCT04034927|81632942|FG000|Overall Study|Still on Treatment|2|||
27945226|NCT04034927|81632943|FG001|Overall Study|Still on Treatment|1|||
27945227|NCT04034927|81632942|FG000|Overall Study|Other|1|||
27945228|NCT04034927|81632943|FG001|Overall Study|Other|1|||
27945229|NCT01506726|81632959|FG000|Overall Study|Adverse Event|1|||
27945230|NCT01506726|81632960|FG001|Overall Study|Adverse Event|2|||
27945231|NCT03404960|81632961|FG000|Overall Study|Adverse Event|0|||
27945232|NCT03404960|81632962|FG001|Overall Study|Adverse Event|2|||
27945233|NCT03404960|81632961|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
27945234|NCT03404960|81632962|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
27945235|NCT03404960|81632961|FG000|Overall Study|Bowel obstruction|0|||
27945236|NCT03404960|81632962|FG001|Overall Study|Bowel obstruction|1|||
27945237|NCT03404960|81632961|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
27945238|NCT03404960|81632962|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
27945239|NCT01107496|81632963|FG000|Overall Study|Adverse Event|1|||
27945240|NCT01107496|81632964|FG001|Overall Study|Adverse Event|0|||
27945241|NCT01107496|81632963|FG000|Overall Study|Lack of Efficacy|1|||
27945242|NCT01107496|81632964|FG001|Overall Study|Lack of Efficacy|0|||
27945243|NCT01107496|81632963|FG000|Overall Study|Protocol Violation|0|||
27945244|NCT01107496|81632964|FG001|Overall Study|Protocol Violation|1|||
27945245|NCT01107496|81632963|FG000|Overall Study|Lost to Follow-up|0|||
27945246|NCT01107496|81632964|FG001|Overall Study|Lost to Follow-up|1|||
27945247|NCT03423979|81634999|FG000|Overall Study|Death|1|||
27945248|NCT02249949|81635002|FG000|Overall Study|Cancelled prior to treatment|2|||
27945249|NCT03896581|81635005|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
27945250|NCT03896581|81635006|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
27945251|NCT03896581|81635005|FG000|Overall Study|Withdrawal by Subject|4|||
27945252|NCT03896581|81635006|FG001|Overall Study|Withdrawal by Subject|1|||
27647999|NCT01961609|80550980|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
27648000|NCT01961609|80550977|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
27945253|NCT03896581|81635005|FG000|Overall Study|Lost to Follow-up|1|||
27945254|NCT03896581|81635006|FG001|Overall Study|Lost to Follow-up|0|||
27945255|NCT03896581|81635005|FG000|Overall Study|Lack of Efficacy|2|||
27945256|NCT03896581|81635006|FG001|Overall Study|Lack of Efficacy|1|||
27945257|NCT03896581|81635005|FG000|Overall Study|Adverse event, non-fatal|0|||
27945258|NCT03896581|81635006|FG001|Overall Study|Adverse event, non-fatal|2|||
27945259|NCT03038672|81635007|FG000|Initial Treatment|Unacceptable chemistry|0|||
27945260|NCT03038672|81635008|FG001|Initial Treatment|Unacceptable chemistry|1|||
27945261|NCT03038672|81635007|FG000|Initial Treatment|Progression prior to treatment|1|||
27945262|NCT03038672|81635008|FG001|Initial Treatment|Progression prior to treatment|0|||
27945263|NCT03038672|81635007|FG000|Initial Treatment|No treatment per protocol|1|||
27945264|NCT03038672|81635008|FG001|Initial Treatment|No treatment per protocol|0|||
27945265|NCT05752487|81635009|FG000|Overall Study|Randomized, not treated|9|||
27945266|NCT05752487|81635009|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
27945267|NCT05752487|81635009|FG000|Overall Study|Withdrawal by Subject|2|||
27945268|NCT05752487|81635009|FG000|Overall Study|Ongoing|137|||
27945269|NCT01380080|81635020|FG000|Overall Study|Death|36|||
27945270|NCT01380080|81635021|FG001|Overall Study|Death|44|||
27945271|NCT01380080|81635020|FG000|Overall Study|Site is closing|28|||
27945272|NCT01380080|81635021|FG001|Overall Study|Site is closing|31|||
27945273|NCT01380080|81635020|FG000|Overall Study|Not able to get to clinic|7|||
27945274|NCT01380080|81635021|FG001|Overall Study|Not able to get to clinic|1|||
27945275|NCT01380080|81635020|FG000|Overall Study|Not willing to adhere to requirements|6|||
27945276|NCT01380080|81635021|FG001|Overall Study|Not willing to adhere to requirements|2|||
27945277|NCT01380080|81635020|FG000|Overall Study|Withdrawal by Subject|5|||
27945278|NCT01380080|81635021|FG001|Overall Study|Withdrawal by Subject|2|||
27945279|NCT01380080|81635020|FG000|Overall Study|Lost to Follow-up|3|||
27945280|NCT01380080|81635021|FG001|Overall Study|Lost to Follow-up|3|||
27945281|NCT04347538|81635024|FG000|Overall Study|Lost to Follow-up|4|||
27945282|NCT04347538|81635025|FG001|Overall Study|Lost to Follow-up|5|||
27945283|NCT04347538|81635026|FG002|Overall Study|Lost to Follow-up|7|||
27945284|NCT01911260|81635029|FG000|Supplementation Period|transference or evasion of school|7|||
27945285|NCT01911260|81635030|FG001|Supplementation Period|transference or evasion of school|9|||
27945286|NCT01911260|81635031|FG002|Supplementation Period|transference or evasion of school|7|||
27945287|NCT01911260|81635032|FG003|Supplementation Period|transference or evasion of school|6|||
27945288|NCT01911260|81635029|FG000|Supplementation Period|Adverse Event|2|||
27945289|NCT01911260|81635030|FG001|Supplementation Period|Adverse Event|0|||
27945290|NCT01911260|81635031|FG002|Supplementation Period|Adverse Event|1|||
27945291|NCT01911260|81635032|FG003|Supplementation Period|Adverse Event|0|||
27945292|NCT01911260|81635029|FG000|Supplementation Period|refused to receive supplement|1|||
27945293|NCT01911260|81635030|FG001|Supplementation Period|refused to receive supplement|0|||
27945294|NCT01911260|81635031|FG002|Supplementation Period|refused to receive supplement|1|||
27945295|NCT01911260|81635032|FG003|Supplementation Period|refused to receive supplement|0|||
27945296|NCT01911260|81635029|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
27945297|NCT01911260|81635030|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
27945298|NCT01911260|81635031|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
27945299|NCT01911260|81635032|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
27945300|NCT01911260|81635029|FG000|Follow-up Period|transference or evasion of school|13|||
27945301|NCT01911260|81635030|FG001|Follow-up Period|transference or evasion of school|20|||
27945302|NCT01911260|81635031|FG002|Follow-up Period|transference or evasion of school|15|||
27945303|NCT01911260|81635032|FG003|Follow-up Period|transference or evasion of school|12|||
27945304|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
27945305|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27945306|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27945307|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27945308|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27945309|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
27945310|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
27945311|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
27945312|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27945313|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
27945314|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27945315|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27945316|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27648001|NCT01961609|80550978|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
27648002|NCT01961609|80550979|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
27648003|NCT01961609|80550980|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
27648004|NCT01961609|80550977|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
27648005|NCT01961609|80550978|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
27648006|NCT01961609|80550979|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
27945317|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
27945318|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
27945319|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27945320|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27945321|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27945322|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27945323|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27945324|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
27945325|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
27945326|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27945327|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27945328|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27945329|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27945330|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
27945331|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
27945332|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27945333|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
27945334|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27945335|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27945336|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27945337|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27945338|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
27945339|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27945340|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27945341|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27945342|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27945343|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
27945344|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
27945345|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
27945346|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27945347|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
27945348|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
27945349|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27945350|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27945351|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
27945352|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
27945353|NCT01557244|81635034|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
27945354|NCT01557244|81635035|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27945355|NCT01557244|81635036|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
27945356|NCT01557244|81635037|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27945357|NCT01557244|81635038|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27945358|NCT01557244|81635039|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27945359|NCT01557244|81635040|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
27945360|NCT01557244|81635034|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
27945361|NCT01557244|81635035|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
27945362|NCT01557244|81635036|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27945363|NCT01557244|81635037|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27945364|NCT01557244|81635038|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27945365|NCT01557244|81635039|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
27945366|NCT01557244|81635040|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
27648007|NCT01961609|80550980|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
27648008|NCT01961609|80550977|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
27648009|NCT01961609|80550978|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
27648010|NCT01961609|80550979|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
27648011|NCT01961609|80550980|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
27648012|NCT01961609|80550977|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
27648013|NCT01961609|80550978|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
27648014|NCT01961609|80550979|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
27648015|NCT01961609|80550980|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
27648016|NCT03335488|80550981|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
27648017|NCT03335488|80550982|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
27648018|NCT03335488|80550981|FG000|Safety Extension Period|Adverse Event|1|||
27648019|NCT03335488|80550982|FG001|Safety Extension Period|Adverse Event|0|||
27648020|NCT03335488|80550981|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
27648021|NCT03335488|80550982|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
27648022|NCT00822900|80550984|FG000|Overall Study|Withdrawal by Subject|14|||
27945367|NCT01557244|81635034|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
27945368|NCT01557244|81635035|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
27945369|NCT01557244|81635036|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27648023|NCT00822900|80550985|FG001|Overall Study|Withdrawal by Subject|14|||
27945370|NCT01557244|81635037|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27945371|NCT01557244|81635038|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27945372|NCT01557244|81635039|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27945373|NCT01557244|81635040|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
27945374|NCT01557244|81635034|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27945375|NCT01557244|81635035|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27945376|NCT01557244|81635036|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27945377|NCT01557244|81635037|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
27945378|NCT01557244|81635038|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27945379|NCT01557244|81635039|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27945380|NCT01557244|81635040|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
27945381|NCT01557244|81635034|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
27945382|NCT01557244|81635035|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
27945383|NCT01557244|81635036|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27945384|NCT01557244|81635037|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27945385|NCT01557244|81635038|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27945386|NCT01557244|81635039|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27945387|NCT01557244|81635040|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
27945388|NCT02034565|81635041|FG000|Overall Study|Adverse Event|1|||
27945389|NCT02034565|81635042|FG001|Overall Study|Adverse Event|0|||
27945390|NCT05473715|81635043|FG000|Overall Study|Trial terminate|2|||
27945391|NCT05473715|81635044|FG001|Overall Study|Trial terminate|1|||
27945392|NCT00642759|81635045|FG000|Overall Study|Protocol Violation|1|||
27945393|NCT02730169|81635054|FG000|Overall Study|Protocol Violation|1|||
27945394|NCT02730169|81635055|FG001|Overall Study|Protocol Violation|0|||
27945395|NCT02730169|81635056|FG002|Overall Study|Protocol Violation|0|||
27945396|NCT02730169|81635057|FG003|Overall Study|Protocol Violation|1|||
27945397|NCT02730169|81635054|FG000|Overall Study|Adverse Event|2|||
27945398|NCT02730169|81635055|FG001|Overall Study|Adverse Event|3|||
27945399|NCT02730169|81635056|FG002|Overall Study|Adverse Event|3|||
27945400|NCT02730169|81635057|FG003|Overall Study|Adverse Event|0|||
27945401|NCT02730169|81635054|FG000|Overall Study|Adverse Event of Special Interest|0|||
27945402|NCT02730169|81635055|FG001|Overall Study|Adverse Event of Special Interest|1|||
27945403|NCT02730169|81635056|FG002|Overall Study|Adverse Event of Special Interest|2|||
27945404|NCT02730169|81635057|FG003|Overall Study|Adverse Event of Special Interest|0|||
27945405|NCT02730169|81635054|FG000|Overall Study|Withdrawal by Subject|6|||
27945406|NCT02730169|81635055|FG001|Overall Study|Withdrawal by Subject|11|||
27945407|NCT02730169|81635056|FG002|Overall Study|Withdrawal by Subject|6|||
27945408|NCT02730169|81635057|FG003|Overall Study|Withdrawal by Subject|8|||
27945409|NCT02730169|81635054|FG000|Overall Study|Lost to Follow-up|5|||
27945410|NCT02730169|81635055|FG001|Overall Study|Lost to Follow-up|6|||
27945411|NCT02730169|81635056|FG002|Overall Study|Lost to Follow-up|5|||
27945412|NCT02730169|81635057|FG003|Overall Study|Lost to Follow-up|6|||
27648024|NCT00822900|80550984|FG000|Overall Study|Lost to Follow-up|9|||
27648025|NCT00822900|80550985|FG001|Overall Study|Lost to Follow-up|9|||
27648026|NCT00822900|80550984|FG000|Overall Study|Death|83|||
27648027|NCT00822900|80550985|FG001|Overall Study|Death|69|||
27648028|NCT00822900|80550984|FG000|Overall Study|Became a ward of the state|2|||
27648029|NCT00822900|80550985|FG001|Overall Study|Became a ward of the state|1|||
27648030|NCT01532999|80550988|FG000|Overall Study|Lost to Follow-up|14|||
27648031|NCT01532999|80550989|FG001|Overall Study|Lost to Follow-up|8|||
27648032|NCT01532999|80550988|FG000|Overall Study|Physician Decision|1|||
27945413|NCT02730169|81635054|FG000|Overall Study|Other|0|||
27945414|NCT02730169|81635055|FG001|Overall Study|Other|0|||
27945415|NCT02730169|81635056|FG002|Overall Study|Other|1|||
27945416|NCT02730169|81635057|FG003|Overall Study|Other|1|||
27945417|NCT02096354|81635058|FG000|Overall Study|Physician Decision|4|||
27551381|NCT01543698|80207459|FG001|Phase 1b|Administrative problems|0|||
27648033|NCT01532999|80550989|FG001|Overall Study|Physician Decision|2|||
27648034|NCT01532999|80550988|FG000|Overall Study|Withdrawal by Subject|5|||
27648035|NCT01532999|80550989|FG001|Overall Study|Withdrawal by Subject|0|||
27648036|NCT01532999|80550988|FG000|Overall Study|Relocated|2|||
27648037|NCT01532999|80550989|FG001|Overall Study|Relocated|0|||
27648038|NCT01532999|80550988|FG000|Overall Study|should not have been randomized|1|||
27648039|NCT01532999|80550989|FG001|Overall Study|should not have been randomized|0|||
27648040|NCT01532999|80550988|FG000|Overall Study|substantial noncompliance|2|||
27648041|NCT01532999|80550989|FG001|Overall Study|substantial noncompliance|0|||
27648042|NCT01532999|80550988|FG000|Overall Study|no show for week 9 assessments|6|||
27648043|NCT01532999|80550989|FG001|Overall Study|no show for week 9 assessments|4|||
27648044|NCT01532999|80550988|FG000|Overall Study|Adverse Event|0|||
27648045|NCT01532999|80550989|FG001|Overall Study|Adverse Event|1|||
27648046|NCT01532999|80550988|FG000|Overall Study|incarcerated|0|||
27648047|NCT01532999|80550989|FG001|Overall Study|incarcerated|1|||
27648048|NCT01532999|80550988|FG000|Overall Study|New job|0|||
27945418|NCT02096354|81635059|FG001|Overall Study|Physician Decision|5|||
27945419|NCT02096354|81635060|FG002|Overall Study|Physician Decision|0|||
27945420|NCT02096354|81635058|FG000|Overall Study|Withdrawal by Subject|3|||
27945421|NCT02096354|81635059|FG001|Overall Study|Withdrawal by Subject|1|||
27945422|NCT02096354|81635060|FG002|Overall Study|Withdrawal by Subject|0|||
27945423|NCT02096354|81635058|FG000|Overall Study|Adverse Event|7|||
27945424|NCT02096354|81635059|FG001|Overall Study|Adverse Event|4|||
27945425|NCT02096354|81635060|FG002|Overall Study|Adverse Event|0|||
27945426|NCT02096354|81635058|FG000|Overall Study|Ineligible|0|||
27945427|NCT02096354|81635059|FG001|Overall Study|Ineligible|0|||
27945428|NCT02096354|81635060|FG002|Overall Study|Ineligible|11|||
27945429|NCT04893811|81635063|FG000|Vaccination Phase|Death|1|||
27945430|NCT04893811|81635064|FG001|Vaccination Phase|Death|0|||
27945431|NCT04893811|81635063|FG000|Vaccination Phase|Lost to Follow-up|1|||
27945432|NCT04893811|81635064|FG001|Vaccination Phase|Lost to Follow-up|1|||
27945433|NCT04893811|81635063|FG000|Vaccination Phase|Protocol Violation|2|||
27945434|NCT04893811|81635064|FG001|Vaccination Phase|Protocol Violation|0|||
27945435|NCT04893811|81635063|FG000|Vaccination Phase|Withdrawal by Subject|2|||
27945436|NCT04893811|81635064|FG001|Vaccination Phase|Withdrawal by Subject|1|||
27945437|NCT04893811|81635063|FG000|Vaccination Phase|Other|0|||
27945438|NCT04893811|81635064|FG001|Vaccination Phase|Other|1|||
27945439|NCT04893811|81635063|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
27945440|NCT04893811|81635064|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
27945441|NCT04893811|81635063|FG000|Follow-up Phase|Lost to Follow-up|0|||
27945442|NCT04893811|81635064|FG001|Follow-up Phase|Lost to Follow-up|1|||
27945443|NCT04134936|81635066|FG000|Overall Study|Adverse Event|3|||
27945444|NCT04134936|81635067|FG001|Overall Study|Adverse Event|2|||
27945445|NCT04134936|81635066|FG000|Overall Study|Withdrawal by Subject|2|||
27945446|NCT04134936|81635067|FG001|Overall Study|Withdrawal by Subject|3|||
27945447|NCT04134936|81635066|FG000|Overall Study|Physician Decision|0|||
27945448|NCT04134936|81635067|FG001|Overall Study|Physician Decision|1|||
27945449|NCT04134936|81635066|FG000|Overall Study|Progressive disease, joined another trial|1|||
27945450|NCT04134936|81635067|FG001|Overall Study|Progressive disease, joined another trial|0|||
27945451|NCT04134936|81635066|FG000|Overall Study|Progressive disease|1|||
27945452|NCT04134936|81635067|FG001|Overall Study|Progressive disease|0|||
27945453|NCT03738228|81635070|FG000|Overall Study|Never received study treatment|2|||
27945454|NCT03738228|81635071|FG001|Overall Study|Never received study treatment|2|||
27945455|NCT05309291|81635076|FG000|Overall Study|Adverse Event|0|||
27945456|NCT05309291|81635077|FG001|Overall Study|Adverse Event|1|||
27945457|NCT01661595|81635081|FG000|Phase 1: Week 0-4|Adverse Event|1|||
27945458|NCT01661595|81635082|FG001|Phase 1: Week 0-4|Adverse Event|0|||
27945459|NCT01661595|81635083|FG002|Phase 1: Week 0-4|Adverse Event|0|||
27945460|NCT01661595|81635084|FG003|Phase 1: Week 0-4|Adverse Event|0|||
27945461|NCT01661595|81635081|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
27945462|NCT01661595|81635082|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
27945463|NCT01661595|81635083|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
27945464|NCT01661595|81635084|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
27945465|NCT00605189|81635085|FG000|Overall Study|Adverse Event|1|||
27945466|NCT00605189|81635086|FG001|Overall Study|Adverse Event|0|||
27945467|NCT00605189|81635087|FG002|Overall Study|Adverse Event|0|||
27945468|NCT00605189|81635085|FG000|Overall Study|Other|2|||
27945469|NCT00605189|81635086|FG001|Overall Study|Other|2|||
27945470|NCT00605189|81635087|FG002|Overall Study|Other|0|||
27648049|NCT01532999|80550989|FG001|Overall Study|New job|2|||
27648050|NCT00933270|80550991|FG000|Overall Study|Withdrawal by Subject|26|||
27648051|NCT00933270|80550991|FG000|Overall Study|Insufficient Follow-up|10|||
27648052|NCT00933270|80550991|FG000|Overall Study|Lost to Follow-up|14|||
27648053|NCT00933270|80550991|FG000|Overall Study|Adverse Event|1|||
27648054|NCT00933270|80550991|FG000|Overall Study|Missed Visit|2|||
27648055|NCT00933270|80550991|FG000|Overall Study|Death|24|||
27648056|NCT00933270|80550991|FG000|Overall Study|Moved or would not return|10|||
27648057|NCT00070317|80550992|FG000|Overall Study|Inevaluable (Never Treated)|1|||
27648058|NCT00070317|80550992|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
27648059|NCT00070317|80550992|FG000|Overall Study|Ineligible required test not done|1|||
27945471|NCT00112385|81635088|FG000|Overall Study|Lost to Follow-up|1|||
27945472|NCT00112385|81635089|FG001|Overall Study|Lost to Follow-up|0|||
27945473|NCT00112385|81635088|FG000|Overall Study|Withdrawal by Subject|0|||
27945474|NCT00112385|81635089|FG001|Overall Study|Withdrawal by Subject|1|||
27945475|NCT03427619|81635090|FG000|Overall Study|Physician Decision|3|||
27945476|NCT03427619|81635090|FG000|Overall Study|Withdrawal by Subject|4|||
27648060|NCT00070317|80550992|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
27945477|NCT03427619|81635090|FG000|Overall Study|Lost to Follow-up|5|||
27945478|NCT03427619|81635090|FG000|Overall Study|Administrative|4|||
27945479|NCT03427619|81635090|FG000|Overall Study|Other|2|||
27945480|NCT03427619|81635090|FG000|Overall Study|Unknown or Missing Completion Status|48|||
27945481|NCT03537508|81635091|FG000|Overall Study|Adverse Event|2|||
27945482|NCT03537508|81635092|FG001|Overall Study|Adverse Event|1|||
27648061|NCT00070317|80550992|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
27648062|NCT00739934|80550993|FG000|Voriconazole IV|Adverse Event|6|||
27648063|NCT00739934|80550993|FG000|Voriconazole Oral|Other|3|||
27648064|NCT00875706|80550997|FG000|Overall Study|Withdrawal by Subject|1|||
27648065|NCT00875706|80550998|FG001|Overall Study|Withdrawal by Subject|0|||
27648066|NCT00875706|80550999|FG002|Overall Study|Withdrawal by Subject|0|||
27648067|NCT04009291|80551000|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
27648068|NCT04009291|80551001|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
27648069|NCT04009291|80551002|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
27648070|NCT04009291|80551003|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
27648071|NCT04009291|80551004|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
27648072|NCT04009291|80551000|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
27648073|NCT04009291|80551001|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
27648074|NCT04009291|80551002|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
27648075|NCT04009291|80551003|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
27648076|NCT04009291|80551004|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
27648077|NCT02235298|80551005|FG000|Overall Study|Lost to Follow-up|6|||
27648078|NCT02235298|80551006|FG001|Overall Study|Lost to Follow-up|5|||
27648079|NCT02235298|80551005|FG000|Overall Study|Adverse Event|2|||
27648080|NCT02235298|80551006|FG001|Overall Study|Adverse Event|2|||
27648081|NCT02235298|80551005|FG000|Overall Study|Withdrawal by Subject|0|||
27648082|NCT02235298|80551006|FG001|Overall Study|Withdrawal by Subject|1|||
27648083|NCT00824408|80551013|FG000|Run-in Phase|Progressive disease|4|||
27648084|NCT00824408|80551014|FG001|Run-in Phase|Progressive disease|4|||
27648085|NCT00824408|80551015|FG002|Run-in Phase|Progressive disease|0|||
27648086|NCT00824408|80551016|FG003|Run-in Phase|Progressive disease|0|||
27648087|NCT00824408|80551017|FG004|Run-in Phase|Progressive disease|0|||
27648088|NCT00824408|80551013|FG000|Run-in Phase|Adverse Event|1|||
27648089|NCT00824408|80551014|FG001|Run-in Phase|Adverse Event|1|||
27648090|NCT00824408|80551015|FG002|Run-in Phase|Adverse Event|0|||
27648091|NCT00824408|80551016|FG003|Run-in Phase|Adverse Event|0|||
27648092|NCT00824408|80551017|FG004|Run-in Phase|Adverse Event|0|||
27648093|NCT00824408|80551013|FG000|Run-in Phase|Refused to continue medication|1|||
27648094|NCT00824408|80551014|FG001|Run-in Phase|Refused to continue medication|0|||
27648095|NCT00824408|80551015|FG002|Run-in Phase|Refused to continue medication|0|||
27648096|NCT00824408|80551016|FG003|Run-in Phase|Refused to continue medication|0|||
27648097|NCT00824408|80551017|FG004|Run-in Phase|Refused to continue medication|0|||
27648098|NCT00824408|80551013|FG000|Run-in Phase|Other reason not defined above|0|||
27648099|NCT00824408|80551014|FG001|Run-in Phase|Other reason not defined above|1|||
27648100|NCT00824408|80551015|FG002|Run-in Phase|Other reason not defined above|0|||
27648101|NCT00824408|80551016|FG003|Run-in Phase|Other reason not defined above|0|||
27648102|NCT00824408|80551017|FG004|Run-in Phase|Other reason not defined above|0|||
27648103|NCT00824408|80551013|FG000|Randomized Phase|Not treated|0|||
27648104|NCT00824408|80551014|FG001|Randomized Phase|Not treated|0|||
27648105|NCT00824408|80551015|FG002|Randomized Phase|Not treated|1|||
27648106|NCT00824408|80551016|FG003|Randomized Phase|Not treated|1|||
27648107|NCT00824408|80551017|FG004|Randomized Phase|Not treated|1|||
27648108|NCT00824408|80551013|FG000|Randomized Phase|Progressive disease|0|||
27648109|NCT00824408|80551014|FG001|Randomized Phase|Progressive disease|0|||
27648110|NCT00824408|80551015|FG002|Randomized Phase|Progressive disease|25|||
27648111|NCT00824408|80551016|FG003|Randomized Phase|Progressive disease|36|||
27648112|NCT00824408|80551017|FG004|Randomized Phase|Progressive disease|34|||
27648113|NCT00824408|80551013|FG000|Randomized Phase|Adverse Event|0|||
27648114|NCT00824408|80551014|FG001|Randomized Phase|Adverse Event|0|||
27648115|NCT00824408|80551015|FG002|Randomized Phase|Adverse Event|4|||
27648116|NCT00824408|80551016|FG003|Randomized Phase|Adverse Event|5|||
27648117|NCT00824408|80551017|FG004|Randomized Phase|Adverse Event|5|||
27648118|NCT00824408|80551013|FG000|Randomized Phase|Refused to continue medication|0|||
27648119|NCT00824408|80551014|FG001|Randomized Phase|Refused to continue medication|0|||
27648120|NCT00824408|80551015|FG002|Randomized Phase|Refused to continue medication|2|||
27648121|NCT00824408|80551016|FG003|Randomized Phase|Refused to continue medication|2|||
27648122|NCT00824408|80551017|FG004|Randomized Phase|Refused to continue medication|2|||
27648123|NCT00824408|80551013|FG000|Randomized Phase|Other reason not defined above|0|||
27648124|NCT00824408|80551014|FG001|Randomized Phase|Other reason not defined above|0|||
27648125|NCT00824408|80551015|FG002|Randomized Phase|Other reason not defined above|4|||
27648126|NCT00824408|80551016|FG003|Randomized Phase|Other reason not defined above|2|||
27945483|NCT03537508|81635091|FG000|Overall Study|Protocol Violation|65|||
27945484|NCT03537508|81635092|FG001|Overall Study|Protocol Violation|48|||
27648127|NCT00824408|80551017|FG004|Randomized Phase|Other reason not defined above|4|||
27648128|NCT02234141|80551019|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
27648129|NCT02234141|80551020|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
27648130|NCT02234141|80551021|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
27648131|NCT02234141|80551022|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
27945485|NCT03537508|81635091|FG000|Overall Study|Lost to Follow-up|86|||
27945486|NCT03537508|81635092|FG001|Overall Study|Lost to Follow-up|60|||
27945487|NCT03537508|81635091|FG000|Overall Study|Withdrawal by parent/guardian|263|||
27945488|NCT03537508|81635092|FG001|Overall Study|Withdrawal by parent/guardian|149|||
27945489|NCT04938427|81635093|FG000|Overall Study|Adverse Event|5|||
27945490|NCT04938427|81635094|FG001|Overall Study|Adverse Event|19|||
27945491|NCT04938427|81635093|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27945492|NCT04938427|81635094|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27945493|NCT04938427|81635093|FG000|Overall Study|Withdrawal by Subject|1|||
27945494|NCT04938427|81635094|FG001|Overall Study|Withdrawal by Subject|0|||
27945495|NCT04938427|81635093|FG000|Overall Study|Reason Not Specified|2|||
27945496|NCT04938427|81635094|FG001|Overall Study|Reason Not Specified|1|||
27945497|NCT02989857|81635109|FG000|Randomization Phase|Not Treated|3|||
27945498|NCT02989857|81635110|FG001|Randomization Phase|Not Treated|2|||
27945499|NCT02989857|81635111|FG002|Randomization Phase|Not Treated|0|||
27945500|NCT00137449|81635115|FG000|Overall Study|Disease Progression|8|||
27945501|NCT00137449|81635116|FG001|Overall Study|Disease Progression|13|||
27945502|NCT00137449|81635115|FG000|Overall Study|Death|4|||
27945503|NCT00137449|81635116|FG001|Overall Study|Death|3|||
27945504|NCT00137449|81635115|FG000|Overall Study|Adverse Event|3|||
27945505|NCT00137449|81635116|FG001|Overall Study|Adverse Event|1|||
27945506|NCT00137449|81635115|FG000|Overall Study|Withdrawal by Subject|1|||
27945507|NCT00137449|81635116|FG001|Overall Study|Withdrawal by Subject|1|||
27945508|NCT05837481|81635117|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
27945509|NCT05837481|81635118|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
27945510|NCT03729609|81635122|FG000|Overall Study|Protocol Violation|1|||
27945511|NCT02721732|81635124|FG000|Overall Study|Adverse Event|2|||
27945512|NCT02721732|81635125|FG001|Overall Study|Adverse Event|0|||
27945513|NCT02721732|81635126|FG002|Overall Study|Adverse Event|2|||
27945514|NCT02721732|81635127|FG003|Overall Study|Adverse Event|0|||
27945515|NCT02721732|81635128|FG004|Overall Study|Adverse Event|1|||
27945516|NCT02721732|81635129|FG005|Overall Study|Adverse Event|0|||
27945517|NCT02721732|81635130|FG006|Overall Study|Adverse Event|1|||
27945518|NCT02721732|81635131|FG007|Overall Study|Adverse Event|0|||
27945519|NCT02721732|81635132|FG008|Overall Study|Adverse Event|1|||
27945520|NCT02721732|81635133|FG009|Overall Study|Adverse Event|1|||
27945521|NCT02721732|81635124|FG000|Overall Study|Death|0|||
27945522|NCT02721732|81635125|FG001|Overall Study|Death|0|||
27945523|NCT02721732|81635126|FG002|Overall Study|Death|0|||
27945524|NCT02721732|81635127|FG003|Overall Study|Death|0|||
27945525|NCT02721732|81635128|FG004|Overall Study|Death|1|||
27945526|NCT02721732|81635129|FG005|Overall Study|Death|0|||
27945527|NCT02721732|81635130|FG006|Overall Study|Death|1|||
27945528|NCT02721732|81635131|FG007|Overall Study|Death|0|||
27945529|NCT02721732|81635132|FG008|Overall Study|Death|0|||
27945530|NCT02721732|81635133|FG009|Overall Study|Death|1|||
27945531|NCT02721732|81635124|FG000|Overall Study|Lack of Efficacy|12|||
27945532|NCT02721732|81635125|FG001|Overall Study|Lack of Efficacy|11|||
27945533|NCT02721732|81635126|FG002|Overall Study|Lack of Efficacy|18|||
27945534|NCT02721732|81635127|FG003|Overall Study|Lack of Efficacy|5|||
27945535|NCT02721732|81635128|FG004|Overall Study|Lack of Efficacy|21|||
27945536|NCT02721732|81635129|FG005|Overall Study|Lack of Efficacy|2|||
27945537|NCT02721732|81635130|FG006|Overall Study|Lack of Efficacy|8|||
27945538|NCT02721732|81635131|FG007|Overall Study|Lack of Efficacy|11|||
27945539|NCT02721732|81635132|FG008|Overall Study|Lack of Efficacy|10|||
27945540|NCT02721732|81635133|FG009|Overall Study|Lack of Efficacy|20|||
27945541|NCT02721732|81635124|FG000|Overall Study|Physician Decision|0|||
27945542|NCT02721732|81635125|FG001|Overall Study|Physician Decision|0|||
27945543|NCT02721732|81635126|FG002|Overall Study|Physician Decision|1|||
27945544|NCT02721732|81635127|FG003|Overall Study|Physician Decision|0|||
27945545|NCT02721732|81635128|FG004|Overall Study|Physician Decision|0|||
27945546|NCT02721732|81635129|FG005|Overall Study|Physician Decision|0|||
27945547|NCT02721732|81635130|FG006|Overall Study|Physician Decision|0|||
27945548|NCT02721732|81635131|FG007|Overall Study|Physician Decision|0|||
27945549|NCT02721732|81635132|FG008|Overall Study|Physician Decision|0|||
27746391|NCT02612077|80899616|FG000|Overall Study|Adverse Event|3|||
27945550|NCT02721732|81635133|FG009|Overall Study|Physician Decision|0|||
27945551|NCT02721732|81635124|FG000|Overall Study|Withdrawal by Subject|1|||
27945552|NCT02721732|81635125|FG001|Overall Study|Withdrawal by Subject|0|||
27945553|NCT02721732|81635126|FG002|Overall Study|Withdrawal by Subject|0|||
27945554|NCT02721732|81635127|FG003|Overall Study|Withdrawal by Subject|0|||
27945555|NCT02721732|81635128|FG004|Overall Study|Withdrawal by Subject|3|||
27945556|NCT02721732|81635129|FG005|Overall Study|Withdrawal by Subject|0|||
27945557|NCT02721732|81635130|FG006|Overall Study|Withdrawal by Subject|1|||
27945558|NCT02721732|81635131|FG007|Overall Study|Withdrawal by Subject|1|||
27945559|NCT02721732|81635132|FG008|Overall Study|Withdrawal by Subject|0|||
27945560|NCT02721732|81635133|FG009|Overall Study|Withdrawal by Subject|1|||
27945561|NCT02721732|81635124|FG000|Overall Study|Participant Choice|1|||
27945562|NCT02721732|81635125|FG001|Overall Study|Participant Choice|0|||
27945563|NCT02721732|81635126|FG002|Overall Study|Participant Choice|0|||
27648132|NCT02234141|80551023|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
27648133|NCT02234141|80551024|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
27648134|NCT02234141|80551025|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
27648135|NCT02234141|80551019|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27648136|NCT02234141|80551020|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
27648137|NCT02234141|80551021|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27648138|NCT02234141|80551022|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27648139|NCT02234141|80551023|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27648140|NCT02234141|80551024|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27648141|NCT02234141|80551025|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
27648142|NCT02234141|80551019|FG000|Treatment Period (24 Weeks)|Death|1|||
27648143|NCT02234141|80551020|FG001|Treatment Period (24 Weeks)|Death|2|||
27648144|NCT02234141|80551021|FG002|Treatment Period (24 Weeks)|Death|0|||
27648145|NCT02234141|80551022|FG003|Treatment Period (24 Weeks)|Death|1|||
27648146|NCT02234141|80551023|FG004|Treatment Period (24 Weeks)|Death|0|||
27648147|NCT02234141|80551024|FG005|Treatment Period (24 Weeks)|Death|0|||
27648148|NCT02234141|80551025|FG006|Treatment Period (24 Weeks)|Death|0|||
27648149|NCT02234141|80551019|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
27648150|NCT02234141|80551020|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
27648151|NCT02234141|80551021|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
27648152|NCT02234141|80551022|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
27648153|NCT02234141|80551023|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
27648154|NCT02234141|80551024|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
27648155|NCT02234141|80551025|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
27648156|NCT02234141|80551019|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27648157|NCT02234141|80551020|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
27648158|NCT02234141|80551021|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27648159|NCT02234141|80551022|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27648160|NCT02234141|80551023|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27648161|NCT02234141|80551024|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27648162|NCT02234141|80551025|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
27648163|NCT02234141|80551019|FG000|Long-Term Treatment Period|Death|0|||
27648164|NCT02234141|80551020|FG001|Long-Term Treatment Period|Death|0|||
27648165|NCT02234141|80551021|FG002|Long-Term Treatment Period|Death|0|||
27648166|NCT02234141|80551022|FG003|Long-Term Treatment Period|Death|0|||
27648167|NCT02234141|80551023|FG004|Long-Term Treatment Period|Death|0|||
27648168|NCT02234141|80551024|FG005|Long-Term Treatment Period|Death|1|||
27648169|NCT02234141|80551025|FG006|Long-Term Treatment Period|Death|0|||
27648170|NCT02234141|80551019|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
27648171|NCT02234141|80551020|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
27648172|NCT02234141|80551021|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
27648173|NCT02234141|80551022|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
27648174|NCT02234141|80551023|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
27648175|NCT02234141|80551024|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
27648176|NCT02234141|80551025|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
27648177|NCT02234141|80551019|FG000|Long-Term Treatment Period|Adverse Event|4|||
27648178|NCT02234141|80551020|FG001|Long-Term Treatment Period|Adverse Event|0|||
27648179|NCT02234141|80551021|FG002|Long-Term Treatment Period|Adverse Event|5|||
27648180|NCT02234141|80551022|FG003|Long-Term Treatment Period|Adverse Event|0|||
27648181|NCT02234141|80551023|FG004|Long-Term Treatment Period|Adverse Event|1|||
27648182|NCT02234141|80551024|FG005|Long-Term Treatment Period|Adverse Event|1|||
27648183|NCT02234141|80551025|FG006|Long-Term Treatment Period|Adverse Event|1|||
27648184|NCT02234141|80551019|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
27648185|NCT02234141|80551020|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
27648186|NCT02234141|80551021|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
27648187|NCT02234141|80551022|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
27648188|NCT02234141|80551023|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
27648189|NCT02234141|80551024|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
27648190|NCT02234141|80551025|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
27648191|NCT02234141|80551019|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
27648192|NCT02234141|80551020|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
27648193|NCT02234141|80551021|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
27648194|NCT02234141|80551022|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
27648195|NCT02234141|80551023|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
27648196|NCT02234141|80551024|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
27648197|NCT02234141|80551025|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
27648198|NCT03451422|80551027|FG000|Overall Study|Lost to Follow-up|0|||
27648199|NCT03451422|80551028|FG001|Overall Study|Lost to Follow-up|0|||
27648200|NCT03451422|80551029|FG002|Overall Study|Lost to Follow-up|0|||
27648201|NCT03451422|80551030|FG003|Overall Study|Lost to Follow-up|0|||
27648202|NCT03451422|80551031|FG004|Overall Study|Lost to Follow-up|0|||
27648203|NCT03451422|80551032|FG005|Overall Study|Lost to Follow-up|1|||
27648204|NCT03451422|80551027|FG000|Overall Study|Decision by sponsor|1|||
27648205|NCT03451422|80551028|FG001|Overall Study|Decision by sponsor|0|||
27648206|NCT03451422|80551029|FG002|Overall Study|Decision by sponsor|1|||
27648207|NCT03451422|80551030|FG003|Overall Study|Decision by sponsor|0|||
27648208|NCT03451422|80551031|FG004|Overall Study|Decision by sponsor|0|||
27648209|NCT03451422|80551032|FG005|Overall Study|Decision by sponsor|0|||
27648210|NCT03451422|80551027|FG000|Overall Study|Withdrawal by Subject|0|||
27648211|NCT03451422|80551028|FG001|Overall Study|Withdrawal by Subject|0|||
27648212|NCT03451422|80551029|FG002|Overall Study|Withdrawal by Subject|2|||
27648213|NCT03451422|80551030|FG003|Overall Study|Withdrawal by Subject|3|||
27648214|NCT03451422|80551031|FG004|Overall Study|Withdrawal by Subject|2|||
27648215|NCT03451422|80551032|FG005|Overall Study|Withdrawal by Subject|1|||
27648216|NCT01436175|80553731|FG000|Overall Study|Adverse Event|111|||
27648217|NCT01436175|80553731|FG000|Overall Study|Protocol Violation|49|||
27648218|NCT01436175|80553731|FG000|Overall Study|Withdrawal by Subject|108|||
27648219|NCT01436175|80553731|FG000|Overall Study|Lost to Follow-up|89|||
27648220|NCT01436175|80553731|FG000|Overall Study|Lack of Efficacy|24|||
27648221|NCT01436175|80553731|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
27648222|NCT01436175|80553731|FG000|Overall Study|Other|826|||
27648223|NCT00667732|80553734|FG000|Run -In (8 Weeks)|Adverse Event|4|||
27648224|NCT00667732|80553735|FG001|Run -In (8 Weeks)|Adverse Event|0|||
27648225|NCT00667732|80553736|FG002|Run -In (8 Weeks)|Adverse Event|0|||
27648226|NCT00667732|80553734|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
27648227|NCT00667732|80553735|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
27648228|NCT00667732|80553736|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
27648229|NCT00667732|80553734|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
27648230|NCT00667732|80553735|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
27648231|NCT00667732|80553736|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
27648232|NCT00403494|80553743|FG000|Overall Study|Adverse Event|10|||
27945564|NCT02721732|81635127|FG003|Overall Study|Participant Choice|0|||
27945565|NCT02721732|81635128|FG004|Overall Study|Participant Choice|0|||
27945566|NCT02721732|81635129|FG005|Overall Study|Participant Choice|0|||
27945567|NCT02721732|81635130|FG006|Overall Study|Participant Choice|0|||
27945568|NCT02721732|81635131|FG007|Overall Study|Participant Choice|0|||
27945569|NCT02721732|81635132|FG008|Overall Study|Participant Choice|0|||
27945570|NCT02721732|81635133|FG009|Overall Study|Participant Choice|1|||
27945571|NCT02721732|81635124|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945572|NCT02721732|81635125|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945573|NCT02721732|81635126|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
27945574|NCT02721732|81635127|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945575|NCT02721732|81635128|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945576|NCT02721732|81635129|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27648233|NCT00403494|80553744|FG001|Overall Study|Adverse Event|8|||
27648234|NCT00403494|80553743|FG000|Overall Study|Withdrew Consent|3|||
27648235|NCT00403494|80553744|FG001|Overall Study|Withdrew Consent|2|||
27648236|NCT00403494|80553743|FG000|Overall Study|Inappropriately enrolled|0|||
27648237|NCT00403494|80553744|FG001|Overall Study|Inappropriately enrolled|1|||
27648238|NCT00403494|80553743|FG000|Overall Study|Lost to Follow-up|0|||
27648239|NCT00403494|80553744|FG001|Overall Study|Lost to Follow-up|2|||
27648240|NCT00403494|80553743|FG000|Overall Study|Protocol noncompliance|0|||
27648241|NCT00403494|80553744|FG001|Overall Study|Protocol noncompliance|1|||
27648242|NCT00403494|80553743|FG000|Overall Study|Death|1|||
27648243|NCT00403494|80553744|FG001|Overall Study|Death|0|||
27648244|NCT00403494|80553743|FG000|Overall Study|Sponsor Request|1|||
27648245|NCT00403494|80553744|FG001|Overall Study|Sponsor Request|0|||
27648246|NCT01409837|80553746|FG000|Overall Study|Withdrawal by Subject|2|||
27648247|NCT01409837|80553747|FG001|Overall Study|Withdrawal by Subject|1|||
27648248|NCT01409837|80553746|FG000|Overall Study|Lost to Follow-up|1|||
27648249|NCT01409837|80553747|FG001|Overall Study|Lost to Follow-up|0|||
27648250|NCT01409837|80553746|FG000|Overall Study|Physician Decision|0|||
27648251|NCT01409837|80553747|FG001|Overall Study|Physician Decision|1|||
27648252|NCT00960206|80553751|FG000|Overall Study|Death|7|||
27648253|NCT00960206|80553752|FG001|Overall Study|Death|4|||
27648254|NCT00960206|80553753|FG002|Overall Study|Death|1|||
27648255|NCT00960206|80553751|FG000|Overall Study|Unwilling/Unable to return|1|||
27648256|NCT00960206|80553752|FG001|Overall Study|Unwilling/Unable to return|2|||
27648257|NCT00960206|80553753|FG002|Overall Study|Unwilling/Unable to return|0|||
27648258|NCT00960206|80553751|FG000|Overall Study|Lost to Follow-up|8|||
27648259|NCT00960206|80553752|FG001|Overall Study|Lost to Follow-up|14|||
27648260|NCT00960206|80553753|FG002|Overall Study|Lost to Follow-up|8|||
27648261|NCT00960206|80553751|FG000|Overall Study|Withdrawal by Subject|2|||
27648262|NCT00960206|80553752|FG001|Overall Study|Withdrawal by Subject|4|||
27648263|NCT00960206|80553753|FG002|Overall Study|Withdrawal by Subject|0|||
27648264|NCT00960206|80553751|FG000|Overall Study|Revision of study component|2|||
27648265|NCT00960206|80553752|FG001|Overall Study|Revision of study component|2|||
27648266|NCT00960206|80553753|FG002|Overall Study|Revision of study component|2|||
27945577|NCT02721732|81635130|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945578|NCT02721732|81635131|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945579|NCT02721732|81635132|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945580|NCT02721732|81635133|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
27945581|NCT02721732|81635124|FG000|Overall Study|Progression and withdrew consent|1|||
27945582|NCT02721732|81635125|FG001|Overall Study|Progression and withdrew consent|1|||
27945583|NCT02721732|81635126|FG002|Overall Study|Progression and withdrew consent|0|||
27945584|NCT02721732|81635127|FG003|Overall Study|Progression and withdrew consent|0|||
27945585|NCT02721732|81635128|FG004|Overall Study|Progression and withdrew consent|0|||
27945586|NCT02721732|81635129|FG005|Overall Study|Progression and withdrew consent|0|||
27945587|NCT02721732|81635130|FG006|Overall Study|Progression and withdrew consent|0|||
27945588|NCT02721732|81635131|FG007|Overall Study|Progression and withdrew consent|0|||
27945589|NCT02721732|81635132|FG008|Overall Study|Progression and withdrew consent|0|||
27945590|NCT02721732|81635133|FG009|Overall Study|Progression and withdrew consent|1|||
27945591|NCT02721732|81635124|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
27945592|NCT02721732|81635125|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
27945593|NCT02721732|81635126|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
27945594|NCT02721732|81635127|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
27945595|NCT02721732|81635128|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
27945596|NCT02721732|81635129|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
27945597|NCT02721732|81635130|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
27945598|NCT02721732|81635131|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
27945599|NCT02721732|81635132|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
27945600|NCT02721732|81635133|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
27945601|NCT04144517|81635136|FG000|Overall Study|Physician Decision|0|||
27945602|NCT04144517|81635137|FG001|Overall Study|Physician Decision|1|||
27945603|NCT04144517|81635136|FG000|Overall Study|Other|2|||
27945604|NCT04144517|81635137|FG001|Overall Study|Other|2|||
27945605|NCT04144517|81635136|FG000|Overall Study|Death|6|||
27945606|NCT04144517|81635137|FG001|Overall Study|Death|3|||
27945607|NCT00425555|81635147|FG000|Overall Study|Withdrawal by Subject|11|||
27945608|NCT00425555|81635148|FG001|Overall Study|Withdrawal by Subject|8|||
27945609|NCT00425555|81635147|FG000|Overall Study|Lost to Follow-up|0|||
27945610|NCT00425555|81635148|FG001|Overall Study|Lost to Follow-up|1|||
27945611|NCT00425555|81635147|FG000|Overall Study|Administrative problems|3|||
27945612|NCT00425555|81635148|FG001|Overall Study|Administrative problems|0|||
27945613|NCT00425555|81635147|FG000|Overall Study|Death|1|||
27945614|NCT00425555|81635148|FG001|Overall Study|Death|2|||
27945615|NCT00425555|81635147|FG000|Overall Study|New cancer therapy|2|||
27945616|NCT00425555|81635148|FG001|Overall Study|New cancer therapy|1|||
27945617|NCT00425555|81635147|FG000|Overall Study|Disease progression|36|||
27945618|NCT00425555|81635148|FG001|Overall Study|Disease progression|33|||
27945619|NCT00425555|81635147|FG000|Overall Study|Adverse Event|25|||
27945620|NCT00425555|81635148|FG001|Overall Study|Adverse Event|15|||
27945621|NCT00425555|81635147|FG000|Overall Study|Protocol Violation|1|||
27945622|NCT00425555|81635148|FG001|Overall Study|Protocol Violation|0|||
27945623|NCT05270863|81635149|FG000|Visit 2 First Intervention|Randomization error|0|||
27945624|NCT05270863|81635150|FG001|Visit 2 First Intervention|Randomization error|0|||
27945625|NCT05270863|81635151|FG002|Visit 2 First Intervention|Randomization error|0|||
27945626|NCT05270863|81635152|FG003|Visit 2 First Intervention|Randomization error|1|||
27945627|NCT05270863|81635153|FG004|Visit 2 First Intervention|Randomization error|0|||
27945628|NCT05270863|81635154|FG005|Visit 2 First Intervention|Randomization error|0|||
27945629|NCT05270863|81635149|FG000|First Washout|Withdrawal by Subject|0|||
27945630|NCT05270863|81635150|FG001|First Washout|Withdrawal by Subject|0|||
27945631|NCT05270863|81635151|FG002|First Washout|Withdrawal by Subject|0|||
27945632|NCT05270863|81635152|FG003|First Washout|Withdrawal by Subject|0|||
27945633|NCT05270863|81635153|FG004|First Washout|Withdrawal by Subject|1|||
27945634|NCT05270863|81635154|FG005|First Washout|Withdrawal by Subject|1|||
27945635|NCT05270863|81635149|FG000|First Washout|Lost to Follow-up|0|||
27945636|NCT05270863|81635150|FG001|First Washout|Lost to Follow-up|0|||
27945637|NCT05270863|81635151|FG002|First Washout|Lost to Follow-up|0|||
27945638|NCT05270863|81635152|FG003|First Washout|Lost to Follow-up|0|||
27945639|NCT05270863|81635153|FG004|First Washout|Lost to Follow-up|0|||
27945640|NCT05270863|81635154|FG005|First Washout|Lost to Follow-up|1|||
27945641|NCT05270863|81635149|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
27945642|NCT05270863|81635150|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
27945643|NCT05270863|81635151|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
27945644|NCT05270863|81635152|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
27945645|NCT05270863|81635153|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
27945646|NCT05270863|81635154|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
27945647|NCT05270863|81635149|FG000|Second Washout|Withdrawal by Subject|1|||
27945648|NCT05270863|81635150|FG001|Second Washout|Withdrawal by Subject|1|||
27945649|NCT05270863|81635151|FG002|Second Washout|Withdrawal by Subject|0|||
27945650|NCT05270863|81635152|FG003|Second Washout|Withdrawal by Subject|0|||
27945651|NCT05270863|81635153|FG004|Second Washout|Withdrawal by Subject|0|||
27945652|NCT05270863|81635154|FG005|Second Washout|Withdrawal by Subject|0|||
27945653|NCT05270863|81635149|FG000|Second Washout|Lost to Follow-up|0|||
27945654|NCT05270863|81635150|FG001|Second Washout|Lost to Follow-up|0|||
27945655|NCT05270863|81635151|FG002|Second Washout|Lost to Follow-up|0|||
27945656|NCT05270863|81635152|FG003|Second Washout|Lost to Follow-up|1|||
27945657|NCT05270863|81635153|FG004|Second Washout|Lost to Follow-up|0|||
27945658|NCT05270863|81635154|FG005|Second Washout|Lost to Follow-up|0|||
27945659|NCT03456076|81635155|FG000|Overall Study|Withdrawal by Subject|5|||
27945660|NCT03456076|81635156|FG001|Overall Study|Withdrawal by Subject|9|||
27945661|NCT03456076|81635155|FG000|Overall Study|Protocol deviation|0|||
27945662|NCT03456076|81635156|FG001|Overall Study|Protocol deviation|1|||
27945663|NCT03456076|81635155|FG000|Overall Study|Lost to Follow-up|0|||
27945664|NCT03456076|81635156|FG001|Overall Study|Lost to Follow-up|1|||
27945665|NCT03456076|81635155|FG000|Overall Study|Death|2|||
27945666|NCT03456076|81635156|FG001|Overall Study|Death|5|||
27945667|NCT03456076|81635155|FG000|Overall Study|Study ongoing|123|||
27945668|NCT03456076|81635156|FG001|Overall Study|Study ongoing|111|||
27945669|NCT05293717|81635157|FG000|Overall Study|Physician Decision|1|||
27945670|NCT03559530|81635158|FG000|Overall Study|non-location of medical records|44|||
27945671|NCT03559530|81635159|FG001|Overall Study|non-location of medical records|0|||
27945672|NCT03559530|81635158|FG000|Overall Study|culture results not considered for treat|29|||
27945673|NCT03559530|81635159|FG001|Overall Study|culture results not considered for treat|0|||
27945674|NCT03559530|81635158|FG000|Overall Study|duplicate cases|8|||
27945675|NCT03559530|81635159|FG001|Overall Study|duplicate cases|0|||
27945676|NCT03559530|81635158|FG000|Overall Study|other species of Acinetobacte|7|||
27945677|NCT03559530|81635159|FG001|Overall Study|other species of Acinetobacte|0|||
27945678|NCT03559530|81635158|FG000|Overall Study|contamination / colonization|3|||
27945679|NCT03559530|81635159|FG001|Overall Study|contamination / colonization|0|||
27945680|NCT03338790|81635160|FG000|Overall Study|Disease Progression|65|||
27945681|NCT03338790|81635161|FG001|Overall Study|Disease Progression|43|||
27945682|NCT03338790|81635162|FG002|Overall Study|Disease Progression|50|||
27945683|NCT03338790|81635163|FG003|Overall Study|Disease Progression|37|||
27945684|NCT03338790|81635160|FG000|Overall Study|Study Drug Toxicity|9|||
27945685|NCT03338790|81635161|FG001|Overall Study|Study Drug Toxicity|8|||
27945686|NCT03338790|81635162|FG002|Overall Study|Study Drug Toxicity|15|||
27945687|NCT03338790|81635163|FG003|Overall Study|Study Drug Toxicity|0|||
27945688|NCT03338790|81635160|FG000|Overall Study|Death|1|||
27945689|NCT03338790|81635161|FG001|Overall Study|Death|1|||
27945690|NCT03338790|81635162|FG002|Overall Study|Death|1|||
27945691|NCT03338790|81635163|FG003|Overall Study|Death|0|||
27945692|NCT03338790|81635160|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
27945693|NCT03338790|81635161|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
27945694|NCT03338790|81635162|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
27945695|NCT03338790|81635163|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
27945696|NCT03338790|81635160|FG000|Overall Study|Participant request to discontinue study treatment|3|||
27945697|NCT03338790|81635161|FG001|Overall Study|Participant request to discontinue study treatment|3|||
27945698|NCT03338790|81635162|FG002|Overall Study|Participant request to discontinue study treatment|2|||
27945699|NCT03338790|81635163|FG003|Overall Study|Participant request to discontinue study treatment|1|||
27945700|NCT03338790|81635160|FG000|Overall Study|Poor/non-compliance|0|||
27945701|NCT03338790|81635161|FG001|Overall Study|Poor/non-compliance|1|||
27945702|NCT03338790|81635162|FG002|Overall Study|Poor/non-compliance|0|||
27648267|NCT00960206|80553751|FG000|Overall Study|Missing 10 year data|20|||
27648268|NCT00960206|80553752|FG001|Overall Study|Missing 10 year data|1|||
27648269|NCT00960206|80553753|FG002|Overall Study|Missing 10 year data|1|||
27648270|NCT02915783|80553756|FG000|Overall Study|Death|21|||
27648271|NCT02915783|80553756|FG000|Overall Study|Lost to Follow-up|1|||
27648272|NCT02915783|80553756|FG000|Overall Study|Withdrawal by Subject|2|||
27648273|NCT00745875|80553757|FG000|Overall Study|Continuing study treatment|4|||
27648274|NCT00745875|80553758|FG001|Overall Study|Continuing study treatment|4|||
27648275|NCT01728324|80553759|FG000|Termination of DBV|Adverse Event|14|||
27648276|NCT01728324|80553760|FG001|Termination of DBV|Adverse Event|13|||
27945703|NCT03338790|81635163|FG003|Overall Study|Poor/non-compliance|0|||
27945704|NCT03338790|81635160|FG000|Overall Study|Participant withdrew consent|1|||
27648277|NCT01728324|80553761|FG002|Termination of DBV|Adverse Event|4|||
27648278|NCT01728324|80553759|FG000|Termination of DBV|Lack of Efficacy|14|||
27648279|NCT01728324|80553760|FG001|Termination of DBV|Lack of Efficacy|12|||
27648280|NCT01728324|80553761|FG002|Termination of DBV|Lack of Efficacy|8|||
27945705|NCT03338790|81635161|FG001|Overall Study|Participant withdrew consent|0|||
27945706|NCT03338790|81635162|FG002|Overall Study|Participant withdrew consent|1|||
27945707|NCT03338790|81635163|FG003|Overall Study|Participant withdrew consent|1|||
27945708|NCT03338790|81635160|FG000|Overall Study|Other reasons|0|||
27945709|NCT03338790|81635161|FG001|Overall Study|Other reasons|5|||
27945710|NCT03338790|81635162|FG002|Overall Study|Other reasons|0|||
27648281|NCT01728324|80553759|FG000|Termination of DBV|Withdrawal by Subject|9|||
27648282|NCT01728324|80553760|FG001|Termination of DBV|Withdrawal by Subject|6|||
27648283|NCT01728324|80553761|FG002|Termination of DBV|Withdrawal by Subject|2|||
27648284|NCT01728324|80553759|FG000|Termination of DBV|Other than stated|1|||
27648285|NCT01728324|80553760|FG001|Termination of DBV|Other than stated|3|||
27648286|NCT01728324|80553761|FG002|Termination of DBV|Other than stated|0|||
27648287|NCT01728324|80553759|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
27648288|NCT01728324|80553760|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
27648289|NCT01728324|80553761|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
27648290|NCT01728324|80553759|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
27648291|NCT01728324|80553760|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
27648292|NCT01728324|80553761|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
27648293|NCT01728324|80553759|FG000|Termination of FDV|Adverse Event|14|||
27648294|NCT01728324|80553760|FG001|Termination of FDV|Adverse Event|13|||
27648295|NCT01728324|80553761|FG002|Termination of FDV|Adverse Event|4|||
27648296|NCT01728324|80553759|FG000|Termination of FDV|Lack of Efficacy|14|||
27648297|NCT01728324|80553760|FG001|Termination of FDV|Lack of Efficacy|12|||
27648298|NCT01728324|80553761|FG002|Termination of FDV|Lack of Efficacy|8|||
27648299|NCT01728324|80553759|FG000|Termination of FDV|Withdrawal by Subject|9|||
27648300|NCT01728324|80553760|FG001|Termination of FDV|Withdrawal by Subject|6|||
27648301|NCT01728324|80553761|FG002|Termination of FDV|Withdrawal by Subject|2|||
27648302|NCT01728324|80553759|FG000|Termination of FDV|Other than stated|1|||
27945711|NCT03338790|81635163|FG003|Overall Study|Other reasons|2|||
27945712|NCT03338790|81635160|FG000|Overall Study|Not reported|0|||
27945713|NCT03338790|81635161|FG001|Overall Study|Not reported|0|||
27945714|NCT03338790|81635162|FG002|Overall Study|Not reported|1|||
27945715|NCT03338790|81635163|FG003|Overall Study|Not reported|0|||
27945716|NCT03338790|81635160|FG000|Overall Study|Completed treatment period|1|||
27945717|NCT03338790|81635161|FG001|Overall Study|Completed treatment period|2|||
27945718|NCT03338790|81635162|FG002|Overall Study|Completed treatment period|0|||
27945719|NCT03338790|81635163|FG003|Overall Study|Completed treatment period|0|||
27945720|NCT02185768|81635164|FG000|Overall Study|Patients were not treated|2|||
27945721|NCT02836249|81635165|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
27945722|NCT02836249|81635166|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
27945723|NCT02836249|81635167|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
27945724|NCT02836249|81635168|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
27945725|NCT02836249|81635165|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
27945726|NCT02836249|81635166|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
27945727|NCT02836249|81635167|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
27945728|NCT02836249|81635168|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
27945729|NCT02836249|81635165|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
27945730|NCT02836249|81635166|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
27945731|NCT02836249|81635167|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
27945732|NCT02836249|81635168|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
27945733|NCT02836249|81635165|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27945734|NCT02836249|81635166|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
27945735|NCT02836249|81635167|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27945736|NCT02836249|81635168|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
27945737|NCT02836249|81635165|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
27945738|NCT02836249|81635166|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
27945739|NCT02836249|81635167|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
27945740|NCT02836249|81635168|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
27945741|NCT02836249|81635165|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
27945742|NCT02836249|81635166|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
27945743|NCT02836249|81635167|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
27945744|NCT02836249|81635168|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
27945745|NCT02836249|81635165|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
27945746|NCT02836249|81635166|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
27945747|NCT02836249|81635167|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
27945748|NCT02836249|81635168|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
27945749|NCT02836249|81635165|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
27945750|NCT02836249|81635166|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
27648303|NCT01728324|80553760|FG001|Termination of FDV|Other than stated|3|||
27648304|NCT01728324|80553761|FG002|Termination of FDV|Other than stated|0|||
27746392|NCT02612077|80899616|FG000|Overall Study|Withdrawal by Subject|9|||
27746393|NCT02612077|80899616|FG000|Overall Study|Protocol Violation|28|||
27746394|NCT02612077|80899616|FG000|Overall Study|Lost to Follow-up|20|||
27746395|NCT02612077|80899616|FG000|Overall Study|Death|377|||
27945751|NCT02836249|81635167|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
27648305|NCT01728324|80553759|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
27648306|NCT01728324|80553760|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
27648307|NCT01728324|80553761|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
27945752|NCT02836249|81635168|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
27945753|NCT02836249|81635165|FG000|Open-Label TAF Treatment Phase|Death|0|||
27648308|NCT01728324|80553759|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
27648309|NCT01728324|80553760|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
27648310|NCT01728324|80553761|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
27945754|NCT02836249|81635166|FG001|Open-Label TAF Treatment Phase|Death|0|||
27945755|NCT02836249|81635167|FG002|Open-Label TAF Treatment Phase|Death|1|||
27945756|NCT02836249|81635168|FG003|Open-Label TAF Treatment Phase|Death|0|||
27945757|NCT02836249|81635165|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
27945758|NCT02836249|81635166|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
27945759|NCT02836249|81635167|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
27945760|NCT02836249|81635168|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
27945761|NCT02836249|81635165|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
27945762|NCT02836249|81635166|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
27945763|NCT02836249|81635167|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
27945764|NCT02836249|81635168|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
27648311|NCT01728324|80553759|FG000|Termination of RBV|Adverse Event|15|||
27648312|NCT01728324|80553760|FG001|Termination of RBV|Adverse Event|16|||
27648313|NCT01728324|80553761|FG002|Termination of RBV|Adverse Event|5|||
27648314|NCT01728324|80553759|FG000|Termination of RBV|Lack of Efficacy|14|||
27648315|NCT01728324|80553760|FG001|Termination of RBV|Lack of Efficacy|11|||
27648316|NCT01728324|80553761|FG002|Termination of RBV|Lack of Efficacy|7|||
27648317|NCT01728324|80553759|FG000|Termination of RBV|Withdrawal by Subject|9|||
27648318|NCT01728324|80553760|FG001|Termination of RBV|Withdrawal by Subject|5|||
27648319|NCT01728324|80553761|FG002|Termination of RBV|Withdrawal by Subject|2|||
27648320|NCT01728324|80553759|FG000|Termination of RBV|Other than stated|1|||
27648321|NCT01728324|80553760|FG001|Termination of RBV|Other than stated|3|||
27648322|NCT01728324|80553761|FG002|Termination of RBV|Other than stated|1|||
27648323|NCT01728324|80553759|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
27648324|NCT01728324|80553760|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
27648325|NCT01728324|80553761|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
27648326|NCT01728324|80553759|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
27648327|NCT01728324|80553760|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
27648328|NCT01728324|80553761|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
27648329|NCT02941549|80553764|FG000|Overall Study|Adverse Event|1|||
27648330|NCT02941549|80553765|FG001|Overall Study|Adverse Event|0|||
27648331|NCT02941549|80553766|FG002|Overall Study|Adverse Event|0|||
27648332|NCT02941549|80553764|FG000|Overall Study|Withdrawal by Subject|2|||
27648333|NCT02941549|80553765|FG001|Overall Study|Withdrawal by Subject|1|||
27648334|NCT02941549|80553766|FG002|Overall Study|Withdrawal by Subject|2|||
27648335|NCT03675321|80553769|FG000|Overall Study|Lack of Efficacy|2|||
27648336|NCT03675321|80553770|FG001|Overall Study|Lack of Efficacy|2|||
27648337|NCT03675321|80553769|FG000|Overall Study|Withdrawal by Subject|1|||
27648338|NCT03675321|80553770|FG001|Overall Study|Withdrawal by Subject|3|||
27648339|NCT00705159|80553771|FG000|Overall Study|Withdrawal by Subject|0|||
27648340|NCT00705159|80553772|FG001|Overall Study|Withdrawal by Subject|1|||
27648341|NCT00705159|80553773|FG002|Overall Study|Withdrawal by Subject|1|||
27648342|NCT00705159|80553774|FG003|Overall Study|Withdrawal by Subject|1|||
27648343|NCT00705159|80553771|FG000|Overall Study|Protocol Violation|0|||
27648344|NCT00705159|80553772|FG001|Overall Study|Protocol Violation|1|||
27648345|NCT00705159|80553773|FG002|Overall Study|Protocol Violation|0|||
27648346|NCT00705159|80553774|FG003|Overall Study|Protocol Violation|0|||
27648347|NCT00705159|80553771|FG000|Overall Study|Adverse Event|0|||
27648348|NCT00705159|80553772|FG001|Overall Study|Adverse Event|0|||
27648349|NCT00705159|80553773|FG002|Overall Study|Adverse Event|1|||
27648350|NCT00705159|80553774|FG003|Overall Study|Adverse Event|0|||
27648351|NCT00705159|80553771|FG000|Overall Study|Lost to Follow-up|0|||
27648352|NCT00705159|80553772|FG001|Overall Study|Lost to Follow-up|0|||
27648353|NCT00705159|80553773|FG002|Overall Study|Lost to Follow-up|3|||
27648354|NCT00705159|80553774|FG003|Overall Study|Lost to Follow-up|2|||
27648355|NCT00705159|80553771|FG000|Overall Study|Screen Failure|0|||
27648356|NCT00705159|80553772|FG001|Overall Study|Screen Failure|0|||
27648357|NCT00705159|80553773|FG002|Overall Study|Screen Failure|0|||
27648358|NCT00705159|80553774|FG003|Overall Study|Screen Failure|1|||
27648359|NCT03987074|80553775|FG000|Overall Study|Withdrew Consent|1|||
27648360|NCT03987074|80553776|FG001|Overall Study|Withdrew Consent|1|||
27648361|NCT03987074|80553777|FG002|Overall Study|Withdrew Consent|0|||
27648362|NCT03987074|80553778|FG003|Overall Study|Withdrew Consent|2|||
27648363|NCT03987074|80553779|FG004|Overall Study|Withdrew Consent|1|||
27945765|NCT05418426|81635169|FG000|Overall Study|Adverse Event|0|||
27648364|NCT03987074|80553775|FG000|Overall Study|Adverse Event|2|||
27648365|NCT03987074|80553776|FG001|Overall Study|Adverse Event|1|||
27648366|NCT03987074|80553777|FG002|Overall Study|Adverse Event|0|||
27648367|NCT03987074|80553778|FG003|Overall Study|Adverse Event|0|||
27648368|NCT03987074|80553779|FG004|Overall Study|Adverse Event|1|||
27945766|NCT05418426|81635170|FG001|Overall Study|Adverse Event|1|||
27648369|NCT03987074|80553775|FG000|Overall Study|Lost to Follow-up|0|||
27648370|NCT03987074|80553776|FG001|Overall Study|Lost to Follow-up|0|||
27945767|NCT05418426|81635171|FG002|Overall Study|Adverse Event|0|||
27945768|NCT05418426|81635169|FG000|Overall Study|Withdrawal by Subject|0|||
27945769|NCT05418426|81635170|FG001|Overall Study|Withdrawal by Subject|1|||
27945770|NCT05418426|81635171|FG002|Overall Study|Withdrawal by Subject|0|||
27945771|NCT05418426|81635169|FG000|Overall Study|Protocol Violation|0|||
27945772|NCT05418426|81635170|FG001|Overall Study|Protocol Violation|0|||
27945773|NCT05418426|81635171|FG002|Overall Study|Protocol Violation|1|||
27945774|NCT04573881|81635172|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
27945775|NCT02960893|81635173|FG000|Randomization Phase (8-week)|Adverse Event|5|||
27945776|NCT02960893|81635174|FG001|Randomization Phase (8-week)|Adverse Event|0|||
27945777|NCT02960893|81635173|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
27648371|NCT03987074|80553777|FG002|Overall Study|Lost to Follow-up|1|||
27648372|NCT03987074|80553778|FG003|Overall Study|Lost to Follow-up|1|||
27648373|NCT03987074|80553779|FG004|Overall Study|Lost to Follow-up|0|||
27648374|NCT03987074|80553775|FG000|Overall Study|Investigator's Discretion|0|||
27648375|NCT03987074|80553776|FG001|Overall Study|Investigator's Discretion|0|||
27648376|NCT03987074|80553777|FG002|Overall Study|Investigator's Discretion|0|||
27648377|NCT03987074|80553778|FG003|Overall Study|Investigator's Discretion|1|||
27648378|NCT03987074|80553779|FG004|Overall Study|Investigator's Discretion|0|||
27648379|NCT01634165|80553780|FG000|Period 2|Adverse Event|0|||
27648380|NCT01634165|80553781|FG001|Period 2|Adverse Event|1|||
27648381|NCT01634165|80553782|FG002|Period 2|Adverse Event|0|||
27648382|NCT01634165|80553783|FG003|Period 2|Adverse Event|0|||
27648383|NCT01227421|80553787|FG000|Overall Study|Lost to Follow-up|6|||
27648384|NCT01227421|80553788|FG001|Overall Study|Lost to Follow-up|7|||
27648385|NCT01227421|80553789|FG002|Overall Study|Lost to Follow-up|5|||
27648386|NCT01227421|80553787|FG000|Overall Study|Adverse Event|2|||
27648387|NCT01227421|80553788|FG001|Overall Study|Adverse Event|7|||
27945778|NCT02960893|81635174|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
27945779|NCT02960893|81635173|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
27945780|NCT02960893|81635174|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
27945781|NCT02960893|81635173|FG000|Extension Phase (48-week)|Adverse Event|2|||
27945782|NCT02960893|81635174|FG001|Extension Phase (48-week)|Adverse Event|3|||
27945783|NCT02960893|81635173|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
27945784|NCT02960893|81635174|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
27945785|NCT02960893|81635173|FG000|Extension Phase (48-week)|Other Reason|2|||
27945786|NCT02960893|81635174|FG001|Extension Phase (48-week)|Other Reason|1|||
27945787|NCT02960893|81635173|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
27945788|NCT02960893|81635174|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
27945789|NCT02960893|81635173|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
27945790|NCT02960893|81635174|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
27648388|NCT01227421|80553789|FG002|Overall Study|Adverse Event|2|||
27648389|NCT01227421|80553787|FG000|Overall Study|Withdrawal by Subject|1|||
27648390|NCT01227421|80553788|FG001|Overall Study|Withdrawal by Subject|2|||
27648391|NCT01227421|80553789|FG002|Overall Study|Withdrawal by Subject|1|||
27648392|NCT01227421|80553787|FG000|Overall Study|Protocol Violation|1|||
27648393|NCT01227421|80553788|FG001|Overall Study|Protocol Violation|1|||
27648394|NCT01227421|80553789|FG002|Overall Study|Protocol Violation|2|||
27648395|NCT01227421|80553787|FG000|Overall Study|Randomized in error|1|||
27648396|NCT01227421|80553788|FG001|Overall Study|Randomized in error|1|||
27648397|NCT01227421|80553789|FG002|Overall Study|Randomized in error|0|||
27648398|NCT02052440|80553791|FG000|Overall Study|Withdrawal by Subject|0|||
27648399|NCT02052440|80553792|FG001|Overall Study|Withdrawal by Subject|1|||
27648400|NCT01372085|80553795|FG000|Washout Period 2|Physician Decision|0|||
27648401|NCT01372085|80553796|FG001|Washout Period 2|Physician Decision|0|||
27648402|NCT01372085|80553797|FG002|Washout Period 2|Physician Decision|0|||
27648403|NCT01372085|80553798|FG003|Washout Period 2|Physician Decision|0|||
27648404|NCT01372085|80553799|FG004|Washout Period 2|Physician Decision|1|||
27648405|NCT01372085|80553800|FG005|Washout Period 2|Physician Decision|0|||
27648406|NCT01372085|80553801|FG006|Washout Period 2|Physician Decision|0|||
27648407|NCT01372085|80553802|FG007|Washout Period 2|Physician Decision|0|||
27648408|NCT01372085|80553803|FG008|Washout Period 2|Physician Decision|0|||
27648409|NCT01372085|80553804|FG009|Washout Period 2|Physician Decision|0|||
27648410|NCT01372085|80553795|FG000|Washout Period 3|Withdrawal by Subject|0|||
27648411|NCT01372085|80553796|FG001|Washout Period 3|Withdrawal by Subject|0|||
27648412|NCT01372085|80553797|FG002|Washout Period 3|Withdrawal by Subject|0|||
27648413|NCT01372085|80553798|FG003|Washout Period 3|Withdrawal by Subject|0|||
27648414|NCT01372085|80553799|FG004|Washout Period 3|Withdrawal by Subject|0|||
27648415|NCT01372085|80553800|FG005|Washout Period 3|Withdrawal by Subject|2|||
27945791|NCT05261126|81635178|FG000|Overall Study|Death|0|||
27945792|NCT05261126|81635179|FG001|Overall Study|Death|0|||
27945793|NCT05261126|81635180|FG002|Overall Study|Death|1|||
27945794|NCT05261126|81635181|FG003|Overall Study|Death|0|||
27945795|NCT05261126|81635182|FG004|Overall Study|Death|0|||
27945796|NCT05261126|81635178|FG000|Overall Study|Lost to Follow-up|0|||
27648416|NCT01372085|80553801|FG006|Washout Period 3|Withdrawal by Subject|0|||
27648417|NCT01372085|80553802|FG007|Washout Period 3|Withdrawal by Subject|0|||
27648418|NCT01372085|80553803|FG008|Washout Period 3|Withdrawal by Subject|0|||
27648419|NCT01372085|80553804|FG009|Washout Period 3|Withdrawal by Subject|0|||
27648420|NCT03418545|80553805|FG000|Overall Study|Withdrawal by Participant|2|||
27648421|NCT03418545|80553806|FG001|Overall Study|Withdrawal by Participant|4|||
27648422|NCT03418545|80553805|FG000|Overall Study|Lost to Follow-up|3|||
27648423|NCT03418545|80553806|FG001|Overall Study|Lost to Follow-up|5|||
27648424|NCT03418545|80553805|FG000|Overall Study|Reason Not Specified|0|||
27648425|NCT03418545|80553806|FG001|Overall Study|Reason Not Specified|1|||
27648426|NCT03418545|80553805|FG000|Overall Study|Missing Completion Status|0|||
27648427|NCT03418545|80553806|FG001|Overall Study|Missing Completion Status|1|||
27648428|NCT03547167|80553807|FG000|Overall Study|Withdrawal by Subject|34|||
27648429|NCT03547167|80553808|FG001|Overall Study|Withdrawal by Subject|12|||
27648430|NCT03547167|80553807|FG000|Overall Study|Screen Failure|0|||
27648431|NCT03547167|80553808|FG001|Overall Study|Screen Failure|1|||
27648432|NCT03547167|80553807|FG000|Overall Study|Lost to Follow-up|59|||
27648433|NCT03547167|80553808|FG001|Overall Study|Lost to Follow-up|15|||
27648434|NCT03547167|80553807|FG000|Overall Study|Death|4|||
27648435|NCT03547167|80553808|FG001|Overall Study|Death|2|||
27648436|NCT03035942|80553809|FG000|Overall Study|Adverse Event|8|||
27648437|NCT03035942|80553810|FG001|Overall Study|Adverse Event|4|||
27648438|NCT03035942|80553811|FG002|Overall Study|Adverse Event|5|||
27648439|NCT00597376|80553812|FG000|Overall Study|Withdrawal by Subject|4|||
27945797|NCT05261126|81635179|FG001|Overall Study|Lost to Follow-up|0|||
27945798|NCT05261126|81635180|FG002|Overall Study|Lost to Follow-up|0|||
27945799|NCT05261126|81635181|FG003|Overall Study|Lost to Follow-up|0|||
27945800|NCT05261126|81635182|FG004|Overall Study|Lost to Follow-up|1|||
27648440|NCT00597376|80553813|FG001|Overall Study|Withdrawal by Subject|3|||
27648441|NCT00597376|80553812|FG000|Overall Study|Adverse Event|4|||
27648442|NCT00597376|80553813|FG001|Overall Study|Adverse Event|1|||
27648443|NCT02760654|80553815|FG000|Overall Study|Lost to Follow-up|3|||
27648444|NCT02760654|80553816|FG001|Overall Study|Lost to Follow-up|3|||
27648445|NCT02760654|80553815|FG000|Overall Study|Withdrawal by Subject|4|||
27648446|NCT02760654|80553816|FG001|Overall Study|Withdrawal by Subject|3|||
27648447|NCT01262456|80553820|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
27648448|NCT01262456|80553821|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
27648449|NCT01262456|80553822|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
27648450|NCT01262456|80553820|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
27648451|NCT01262456|80553821|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
27648452|NCT01262456|80553822|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
27648453|NCT01262456|80553820|FG000|3-Month Double-Blind Period|Adverse Event|6|||
27648454|NCT01262456|80553821|FG001|3-Month Double-Blind Period|Adverse Event|4|||
27945801|NCT05261126|81635178|FG000|Overall Study|Physician Decision|1|||
27945802|NCT05261126|81635179|FG001|Overall Study|Physician Decision|0|||
27945803|NCT05261126|81635180|FG002|Overall Study|Physician Decision|0|||
27945804|NCT05261126|81635181|FG003|Overall Study|Physician Decision|0|||
27945805|NCT05261126|81635182|FG004|Overall Study|Physician Decision|0|||
27945806|NCT05261126|81635178|FG000|Overall Study|Screen Failure|0|||
27945807|NCT05261126|81635179|FG001|Overall Study|Screen Failure|0|||
27945808|NCT05261126|81635180|FG002|Overall Study|Screen Failure|0|||
27945809|NCT05261126|81635181|FG003|Overall Study|Screen Failure|0|||
27945810|NCT05261126|81635182|FG004|Overall Study|Screen Failure|1|||
27945811|NCT05261126|81635178|FG000|Overall Study|Withdrawal by Subject|1|||
27945812|NCT05261126|81635179|FG001|Overall Study|Withdrawal by Subject|0|||
27945813|NCT05261126|81635180|FG002|Overall Study|Withdrawal by Subject|1|||
27945814|NCT05261126|81635181|FG003|Overall Study|Withdrawal by Subject|1|||
27945815|NCT05261126|81635182|FG004|Overall Study|Withdrawal by Subject|0|||
27945816|NCT05261126|81635178|FG000|Overall Study|Not Recorded|0|||
27945817|NCT05261126|81635179|FG001|Overall Study|Not Recorded|0|||
27945818|NCT05261126|81635180|FG002|Overall Study|Not Recorded|0|||
27551382|NCT01543698|80207460|FG002|Phase 1b|Administrative problems|0|||
27648455|NCT01262456|80553822|FG002|3-Month Double-Blind Period|Adverse Event|8|||
27648456|NCT01262456|80553820|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
27648457|NCT01262456|80553821|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
27648458|NCT01262456|80553822|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
27648459|NCT01262456|80553820|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
27648460|NCT01262456|80553821|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
27648461|NCT01262456|80553822|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
27648462|NCT01262456|80553820|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
27648463|NCT01262456|80553821|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
27945819|NCT05261126|81635181|FG003|Overall Study|Not Recorded|1|||
27945820|NCT05261126|81635182|FG004|Overall Study|Not Recorded|0|||
27945821|NCT03900650|81635183|FG000|Overall Study|Withdrawal by Subject|1|||
27945822|NCT03900650|81635184|FG001|Overall Study|Withdrawal by Subject|1|||
27945823|NCT03900650|81635185|FG002|Overall Study|Withdrawal by Subject|0|||
27945824|NCT03900650|81635186|FG003|Overall Study|Withdrawal by Subject|0|||
27945825|NCT03900650|81635183|FG000|Overall Study|Withdrawn by staff|1|||
27945826|NCT03900650|81635184|FG001|Overall Study|Withdrawn by staff|0|||
27945827|NCT03900650|81635185|FG002|Overall Study|Withdrawn by staff|0|||
27945828|NCT03900650|81635186|FG003|Overall Study|Withdrawn by staff|0|||
27945829|NCT05375929|81635187|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
27945830|NCT05375929|81635188|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
27945831|NCT05375929|81635189|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
27945832|NCT05375929|81635190|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
27945833|NCT05375929|81635187|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
27945834|NCT05375929|81635188|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
27945835|NCT05375929|81635189|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
27945836|NCT05375929|81635190|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
27945837|NCT05375929|81635187|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
27945838|NCT05375929|81635188|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
27945839|NCT05375929|81635189|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
27945840|NCT05375929|81635190|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
27945841|NCT05375929|81635187|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
27945842|NCT05375929|81635188|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
27945843|NCT05375929|81635189|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
27945844|NCT05375929|81635190|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
27945845|NCT05375929|81635187|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
27648464|NCT01262456|80553822|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
27648465|NCT01262456|80553820|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
27648466|NCT01262456|80553821|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
27945846|NCT05375929|81635188|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
27945847|NCT05375929|81635189|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
27945848|NCT05375929|81635190|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
27945849|NCT05375929|81635187|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
27945850|NCT05375929|81635188|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
27945851|NCT05375929|81635189|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
27945852|NCT05375929|81635190|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
27945853|NCT05375929|81635187|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
27945854|NCT05375929|81635188|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
27945855|NCT05375929|81635189|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
27945856|NCT05375929|81635190|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
27945857|NCT05375929|81635187|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
27945858|NCT05375929|81635188|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
27945859|NCT05375929|81635189|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
27945860|NCT05375929|81635190|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
27945861|NCT05375929|81635187|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
27945862|NCT05375929|81635188|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
27945863|NCT05375929|81635189|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
27945864|NCT05375929|81635190|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
27945865|NCT05375929|81635187|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
27945866|NCT05375929|81635188|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
27648467|NCT01262456|80553822|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
27648468|NCT01262456|80553820|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
27648469|NCT01262456|80553821|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
27648470|NCT01262456|80553822|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
27648471|NCT01262456|80553820|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
27648472|NCT01262456|80553821|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
27648473|NCT01262456|80553822|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
27648474|NCT00022672|80553829|FG000|Main Phase: 24 Months|Adverse Event|6|||
27648475|NCT00022672|80553830|FG001|Main Phase: 24 Months|Adverse Event|0|||
27648476|NCT00022672|80553829|FG000|Main Phase: 24 Months|Death|0|||
27648477|NCT00022672|80553830|FG001|Main Phase: 24 Months|Death|3|||
27648478|NCT00022672|80553829|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
27648479|NCT00022672|80553830|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
27648480|NCT00022672|80553829|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
27648481|NCT00022672|80553830|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
27648482|NCT00022672|80553829|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
27945867|NCT05375929|81635189|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
27945868|NCT05375929|81635190|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
27945869|NCT05810597|81635196|FG000|Period 1|Adverse Event|2|||
27945870|NCT05810597|81635197|FG001|Period 1|Adverse Event|0|||
27945871|NCT05810597|81635196|FG000|Period 1|Physician Decision|1|||
27648483|NCT00022672|80553830|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
27648484|NCT00022672|80553829|FG000|Main Phase: 24 Months|Refused Treatment|3|||
27648485|NCT00022672|80553830|FG001|Main Phase: 24 Months|Refused Treatment|4|||
27945872|NCT05810597|81635197|FG001|Period 1|Physician Decision|0|||
27945873|NCT02251041|81635201|FG000|Overall Study|Did not receive intervention|15|||
27945874|NCT02251041|81635202|FG001|Overall Study|Did not receive intervention|4|||
27945875|NCT01450631|81635203|FG000|Overall Study|Lost to Follow-up|2|||
27945876|NCT01450631|81635204|FG001|Overall Study|Lost to Follow-up|4|||
27945877|NCT01450631|81635203|FG000|Overall Study|Withdrawal by Subject|1|||
27945878|NCT01450631|81635204|FG001|Overall Study|Withdrawal by Subject|0|||
27945879|NCT02420314|81635205|FG000|Overall Study|Withdrawal by Subject|1|||
27945880|NCT02420314|81635205|FG000|Overall Study|Protocol Violation|1|||
27945881|NCT01587196|81635206|FG000|Overall Study|Lost to Follow-up|50|||
27648486|NCT00022672|80553829|FG000|Main Phase: 24 Months|Failure to Return|1|||
27648487|NCT00022672|80553830|FG001|Main Phase: 24 Months|Failure to Return|1|||
27648488|NCT00022672|80553829|FG000|Main Phase: 24 Months|Other|1|||
27648489|NCT00022672|80553830|FG001|Main Phase: 24 Months|Other|0|||
27648490|NCT00022672|80553829|FG000|Extension Phase|Adverse Event|1|||
27648491|NCT00022672|80553830|FG001|Extension Phase|Adverse Event|3|||
27945882|NCT01587196|81635206|FG000|Overall Study|Withdrawal by Subject|4|||
27945883|NCT03913130|81635207|FG000|Overall Study|Sponsor Decision|1|||
27945884|NCT01817777|81635208|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
27945885|NCT01817777|81635209|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
27945886|NCT01817777|81635210|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
27945887|NCT01817777|81635208|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
27945888|NCT01817777|81635209|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
27945889|NCT01817777|81635210|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
27945890|NCT01817777|81635208|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
27945891|NCT01817777|81635209|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
27945892|NCT01817777|81635210|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
27945893|NCT01817777|81635208|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
27648492|NCT00022672|80553829|FG000|Extension Phase|Death|0|||
27648493|NCT00022672|80553830|FG001|Extension Phase|Death|1|||
27648494|NCT00022672|80553829|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
27648495|NCT00022672|80553830|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
27648496|NCT00022672|80553829|FG000|Extension Phase|Refused Treatment|0|||
27648497|NCT00022672|80553830|FG001|Extension Phase|Refused Treatment|2|||
27648498|NCT00022672|80553829|FG000|Extension Phase|Other|1|||
27648499|NCT00022672|80553830|FG001|Extension Phase|Other|1|||
27648500|NCT01429285|80553831|FG000|Overall Study|Protocol Violation|9|||
27648501|NCT01429285|80553832|FG001|Overall Study|Protocol Violation|4|||
27648502|NCT01429285|80553831|FG000|Overall Study|Missing Data|5|||
27648503|NCT01429285|80553832|FG001|Overall Study|Missing Data|3|||
27648504|NCT01429285|80553831|FG000|Overall Study|Erroneously Enrolled Twice|8|||
27648505|NCT01429285|80553832|FG001|Overall Study|Erroneously Enrolled Twice|2|||
27945894|NCT01817777|81635209|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
27945895|NCT01817777|81635210|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
27945896|NCT01817777|81635208|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
27945897|NCT01817777|81635209|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
27945898|NCT01817777|81635210|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
27945899|NCT03189719|81635213|FG000|Overall Study|Death|325|||
27945900|NCT03189719|81635214|FG001|Overall Study|Death|361|||
27945901|NCT03189719|81635213|FG000|Overall Study|Physician Decision|1|||
27551383|NCT01543698|80207461|FG003|Phase 1b|Administrative problems|0|||
27551384|NCT01543698|80207462|FG004|Phase 1b|Administrative problems|1|||
27551385|NCT01543698|80207463|FG005|Phase 1b|Administrative problems|0|||
27551386|NCT01543698|80207464|FG006|Phase 1b|Administrative problems|0|||
27648506|NCT00713596|80553833|FG000|Overall Study|Study was terminated|2|||
27648507|NCT00713596|80553834|FG001|Overall Study|Study was terminated|3|||
27551387|NCT01543698|80207465|FG007|Phase 1b|Administrative problems|1|||
27551388|NCT01543698|80207466|FG008|Phase 1b|Administrative problems|0|||
27648508|NCT00713596|80553835|FG002|Overall Study|Study was terminated|2|||
27648509|NCT00724126|80553836|FG000|Overall Study|Adverse Event|2|||
27648510|NCT00724126|80553837|FG001|Overall Study|Adverse Event|0|||
27648511|NCT00724126|80553836|FG000|Overall Study|Withdrawal by Subject|8|||
27551389|NCT01543698|80207467|FG009|Phase 1b|Administrative problems|0|||
27551390|NCT01543698|80207468|FG010|Phase 1b|Administrative problems|2|||
27648512|NCT00724126|80553837|FG001|Overall Study|Withdrawal by Subject|6|||
27648513|NCT00724126|80553836|FG000|Overall Study|Lost to Follow-up|6|||
27945902|NCT03189719|81635214|FG001|Overall Study|Physician Decision|0|||
27945903|NCT03189719|81635213|FG000|Overall Study|Sponsor Decision|40|||
27945904|NCT03189719|81635214|FG001|Overall Study|Sponsor Decision|12|||
27945905|NCT03189719|81635213|FG000|Overall Study|Withdrawal by Subject|7|||
27945906|NCT03189719|81635214|FG001|Overall Study|Withdrawal by Subject|3|||
27945907|NCT00323622|81637498|FG000|Overall Study|Other|30|||
27945908|NCT00323622|81637499|FG001|Overall Study|Other|91|||
27945909|NCT00323622|81637500|FG002|Overall Study|Other|4|||
27945910|NCT00323622|81637501|FG003|Overall Study|Other|12|||
27945911|NCT00323622|81637502|FG004|Overall Study|Other|32|||
27648514|NCT00724126|80553837|FG001|Overall Study|Lost to Follow-up|6|||
27648515|NCT00724126|80553836|FG000|Overall Study|Noncompliance|2|||
27945912|NCT00323622|81637503|FG005|Overall Study|Other|74|||
27648516|NCT00724126|80553837|FG001|Overall Study|Noncompliance|1|||
27648517|NCT00724126|80553836|FG000|Overall Study|Subject randomized although ineligible|1|||
27648518|NCT00724126|80553837|FG001|Overall Study|Subject randomized although ineligible|1|||
27648519|NCT00724126|80553836|FG000|Overall Study|Subject had to leave vicinity of site|0|||
27648520|NCT00724126|80553837|FG001|Overall Study|Subject had to leave vicinity of site|1|||
27648521|NCT02542943|80553838|FG000|Overall Study|Lost to Follow-up|1|||
27648522|NCT02542943|80553839|FG001|Overall Study|Lost to Follow-up|0|||
27648523|NCT02542943|80553840|FG002|Overall Study|Lost to Follow-up|0|||
27648524|NCT02542943|80553838|FG000|Overall Study|Withdrawal by Subject|0|||
27648525|NCT02542943|80553839|FG001|Overall Study|Withdrawal by Subject|1|||
27648526|NCT02542943|80553840|FG002|Overall Study|Withdrawal by Subject|0|||
27648527|NCT01579318|80553841|FG000|Overall Study|Disease Progression|1|||
27648528|NCT01278030|80553842|FG000|Overall Study|Withdrawal by Subject|8|||
27648529|NCT01278030|80553843|FG001|Overall Study|Withdrawal by Subject|4|||
27648530|NCT00595959|80553846|FG000|Overall Study|Withdrawal by Subject|1|||
27648531|NCT00595959|80553846|FG000|Overall Study|Lost to Follow-up|1|||
27648532|NCT01128959|80553849|FG000|Lead in Period|Adverse Event|3|||
27648533|NCT01128959|80553849|FG000|Treatment Period|Adverse Event|3|||
27945913|NCT00323622|81637504|FG006|Overall Study|Other|5|||
27945914|NCT00323622|81637505|FG007|Overall Study|Other|13|||
27945915|NCT00323622|81637498|FG000|Overall Study|Death|1|||
27945916|NCT00323622|81637499|FG001|Overall Study|Death|1|||
27945917|NCT00323622|81637500|FG002|Overall Study|Death|0|||
27945918|NCT00323622|81637501|FG003|Overall Study|Death|0|||
27945919|NCT00323622|81637502|FG004|Overall Study|Death|7|||
27945920|NCT00323622|81637503|FG005|Overall Study|Death|0|||
27945921|NCT00323622|81637504|FG006|Overall Study|Death|0|||
27945922|NCT00323622|81637505|FG007|Overall Study|Death|2|||
27648534|NCT01128959|80553849|FG000|Treatment Period|Withdrawal by Subject|1|||
27648535|NCT00263757|80553850|FG000|Overall Study|Withdrawal by Subject|5|||
27648536|NCT00263757|80553851|FG001|Overall Study|Withdrawal by Subject|4|||
27648537|NCT00263757|80553850|FG000|Overall Study|Screen failure|0|||
27648538|NCT00263757|80553851|FG001|Overall Study|Screen failure|1|||
27648539|NCT00263757|80553850|FG000|Overall Study|Adverse Event|3|||
27648540|NCT00263757|80553851|FG001|Overall Study|Adverse Event|3|||
27648541|NCT01079806|80553852|FG000|Day 1 to Week 96|Adverse Event|0|||
27648542|NCT01079806|80553853|FG001|Day 1 to Week 96|Adverse Event|3|||
27945923|NCT02592863|81637512|FG000|Overall Study|Withdrawal by Subject|2|||
27945924|NCT02592863|81637513|FG001|Overall Study|Withdrawal by Subject|2|||
27945925|NCT02592863|81637512|FG000|Overall Study|Lost to Follow-up|1|||
27945926|NCT02592863|81637513|FG001|Overall Study|Lost to Follow-up|1|||
27945927|NCT02496000|81637516|FG000|Overall Study|Withdrawal by Subject|1|||
27945928|NCT02496000|81637517|FG001|Overall Study|Withdrawal by Subject|2|||
27945929|NCT02496000|81637518|FG002|Overall Study|Withdrawal by Subject|0|||
27945930|NCT02496000|81637516|FG000|Overall Study|Lost to Follow-up|1|||
27945931|NCT02496000|81637517|FG001|Overall Study|Lost to Follow-up|0|||
27945932|NCT02496000|81637518|FG002|Overall Study|Lost to Follow-up|1|||
27945933|NCT02496000|81637516|FG000|Overall Study|Protocol Violation|0|||
27945934|NCT02496000|81637517|FG001|Overall Study|Protocol Violation|0|||
27945935|NCT02496000|81637518|FG002|Overall Study|Protocol Violation|1|||
27648543|NCT01079806|80553852|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
27648544|NCT01079806|80553853|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
27648545|NCT01079806|80553852|FG000|Day 1 to Week 96|Pregnancy|0|||
27648546|NCT01079806|80553853|FG001|Day 1 to Week 96|Pregnancy|1|||
27648547|NCT01079806|80553852|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
27648548|NCT01079806|80553853|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
27648549|NCT01079806|80553852|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
27648550|NCT01079806|80553853|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
27648551|NCT01079806|80553852|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
27648552|NCT01079806|80553853|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
27746396|NCT02612077|80899616|FG000|Overall Study|Moved or Changed Medical Team|23|||
27746397|NCT02612077|80899616|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
27746398|NCT02612077|80899616|FG000|Overall Study|Disease Progression|3|||
27746399|NCT02612077|80899616|FG000|Overall Study|Unknown reason|2|||
27945936|NCT02496000|81637516|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
27945937|NCT02496000|81637517|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
27945938|NCT02496000|81637518|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
27945939|NCT02496000|81637516|FG000|Overall Study|undetermined|0|||
27945940|NCT02496000|81637517|FG001|Overall Study|undetermined|1|||
27945941|NCT02496000|81637518|FG002|Overall Study|undetermined|0|||
27945942|NCT01313676|81637519|FG000|Overall Study|Adverse Event|395|||
27945943|NCT01313676|81637520|FG001|Overall Study|Adverse Event|365|||
27945944|NCT01313676|81637521|FG002|Overall Study|Adverse Event|372|||
27945945|NCT01313676|81637522|FG003|Overall Study|Adverse Event|333|||
27945946|NCT01313676|81637519|FG000|Overall Study|Lack of Efficacy|98|||
27945947|NCT01313676|81637520|FG001|Overall Study|Lack of Efficacy|90|||
27945948|NCT01313676|81637521|FG002|Overall Study|Lack of Efficacy|65|||
27945949|NCT01313676|81637522|FG003|Overall Study|Lack of Efficacy|46|||
27945950|NCT01313676|81637519|FG000|Overall Study|Protocol Violation|37|||
27945951|NCT01313676|81637520|FG001|Overall Study|Protocol Violation|44|||
27945952|NCT01313676|81637521|FG002|Overall Study|Protocol Violation|46|||
27945953|NCT01313676|81637522|FG003|Overall Study|Protocol Violation|44|||
27945954|NCT01313676|81637519|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
27945955|NCT01313676|81637520|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
27945956|NCT01313676|81637521|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
27945957|NCT01313676|81637522|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
27945958|NCT01313676|81637519|FG000|Overall Study|Study Closed/terminated|7|||
27945959|NCT01313676|81637520|FG001|Overall Study|Study Closed/terminated|6|||
27945960|NCT01313676|81637521|FG002|Overall Study|Study Closed/terminated|9|||
27945961|NCT01313676|81637522|FG003|Overall Study|Study Closed/terminated|9|||
27945962|NCT01313676|81637519|FG000|Overall Study|Lost to Follow-up|0|||
27945963|NCT01313676|81637520|FG001|Overall Study|Lost to Follow-up|0|||
27945964|NCT01313676|81637521|FG002|Overall Study|Lost to Follow-up|1|||
27945965|NCT01313676|81637522|FG003|Overall Study|Lost to Follow-up|0|||
27945966|NCT01313676|81637519|FG000|Overall Study|Physician Decision|53|||
27945967|NCT01313676|81637520|FG001|Overall Study|Physician Decision|64|||
27945968|NCT01313676|81637521|FG002|Overall Study|Physician Decision|62|||
27945969|NCT01313676|81637522|FG003|Overall Study|Physician Decision|48|||
27945970|NCT01313676|81637519|FG000|Overall Study|Decision by Participant or Proxy|643|||
27945971|NCT01313676|81637520|FG001|Overall Study|Decision by Participant or Proxy|527|||
27945972|NCT01313676|81637521|FG002|Overall Study|Decision by Participant or Proxy|515|||
27945973|NCT01313676|81637522|FG003|Overall Study|Decision by Participant or Proxy|492|||
27945974|NCT01313676|81637519|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
27945975|NCT01313676|81637520|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
27945976|NCT01313676|81637521|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
27945977|NCT01313676|81637522|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
27945978|NCT01313676|81637519|FG000|Overall Study|Investigator Site Closed|12|||
27945979|NCT01313676|81637520|FG001|Overall Study|Investigator Site Closed|11|||
27945980|NCT01313676|81637521|FG002|Overall Study|Investigator Site Closed|15|||
27945981|NCT01313676|81637522|FG003|Overall Study|Investigator Site Closed|10|||
27945982|NCT01313676|81637519|FG000|Overall Study|Missing|1|||
27945983|NCT01313676|81637520|FG001|Overall Study|Missing|1|||
27648553|NCT01079806|80553852|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
27648554|NCT01079806|80553853|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
27648555|NCT01079806|80553852|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
27648556|NCT01079806|80553853|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
27648557|NCT01079806|80553852|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
27648558|NCT01079806|80553853|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
27648559|NCT01079806|80553852|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
27648560|NCT01079806|80553853|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
27648561|NCT00536120|80553854|FG000|Overall Study|Lost to Follow-up|1|||
27648562|NCT00536120|80553855|FG001|Overall Study|Lost to Follow-up|0|||
27648563|NCT00536120|80553854|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
27648564|NCT00536120|80553855|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
27648565|NCT00536120|80553854|FG000|Overall Study|Non-compliance|1|||
27648566|NCT00536120|80553855|FG001|Overall Study|Non-compliance|0|||
27648567|NCT00536120|80553854|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
27648568|NCT00536120|80553855|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
27648569|NCT00536120|80553854|FG000|Overall Study|Steroid Use|0|||
27648570|NCT00536120|80553855|FG001|Overall Study|Steroid Use|2|||
27648571|NCT00536120|80553854|FG000|Overall Study|Missed Study Visit|0|||
27648572|NCT00536120|80553855|FG001|Overall Study|Missed Study Visit|1|||
27648573|NCT02630966|80553856|FG000|Overall Study|Adverse Event|1|||
27648574|NCT02630966|80553857|FG001|Overall Study|Adverse Event|3|||
27648575|NCT02630966|80553856|FG000|Overall Study|Significant Protocol Deviation|0|||
27648576|NCT02630966|80553857|FG001|Overall Study|Significant Protocol Deviation|2|||
27648577|NCT02630966|80553856|FG000|Overall Study|Voluntary Withdrawal|1|||
27648578|NCT02630966|80553857|FG001|Overall Study|Voluntary Withdrawal|1|||
27746400|NCT01790438|80899619|FG000|Overall Study|Adverse Event|3|||
27746401|NCT01790438|80899620|FG001|Overall Study|Adverse Event|2|||
27945984|NCT01313676|81637521|FG002|Overall Study|Missing|1|||
27945985|NCT01313676|81637522|FG003|Overall Study|Missing|0|||
27945986|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
27945987|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
27945988|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
27945989|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
27945990|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
27945991|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
27648579|NCT02630966|80553856|FG000|Overall Study|Lack of Efficacy|0|||
27648580|NCT02630966|80553857|FG001|Overall Study|Lack of Efficacy|2|||
27648581|NCT03392194|80553858|FG000|Overall Study|Withdrawal by Subject|1|||
27648582|NCT03392194|80553859|FG001|Overall Study|Withdrawal by Subject|2|||
27648583|NCT03392194|80553858|FG000|Overall Study|Conflicts with personal schedule|1|||
27648584|NCT03392194|80553859|FG001|Overall Study|Conflicts with personal schedule|0|||
27648585|NCT04652869|80553866|FG000|Overall Study|Withdrawal by Subject|0|||
27648586|NCT04652869|80553867|FG001|Overall Study|Withdrawal by Subject|2|||
27648587|NCT04652869|80553868|FG002|Overall Study|Withdrawal by Subject|0|||
27648588|NCT05405244|80553869|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
27648589|NCT05405244|80553870|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
27648590|NCT05405244|80553869|FG000|Washout (2 Weeks)|Adverse Event|2|||
27648591|NCT05405244|80553870|FG001|Washout (2 Weeks)|Adverse Event|0|||
27648592|NCT05405244|80553869|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
27648593|NCT05405244|80553870|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
27648594|NCT01332266|80553879|FG000|Phase 1b|Death|3|||
27648595|NCT01332266|80553880|FG001|Phase 1b|Death|3|||
27648596|NCT01332266|80553881|FG002|Phase 1b|Death|2|||
27648597|NCT01332266|80553882|FG003|Phase 1b|Death|0|||
27648598|NCT01332266|80553883|FG004|Phase 1b|Death|0|||
27648599|NCT01332266|80553879|FG000|Phase 1b|Lost to Follow-up|0|||
27648600|NCT01332266|80553880|FG001|Phase 1b|Lost to Follow-up|1|||
27648601|NCT01332266|80553881|FG002|Phase 1b|Lost to Follow-up|0|||
27648602|NCT01332266|80553882|FG003|Phase 1b|Lost to Follow-up|0|||
27945992|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
27945993|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
27945994|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
27945995|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
27945996|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
27945997|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
27945998|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
27648603|NCT01332266|80553883|FG004|Phase 1b|Lost to Follow-up|0|||
27648604|NCT01332266|80553879|FG000|Phase 1b|Withdrawal by Subject|1|||
27945999|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
27946000|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
27946001|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
27946002|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
27946003|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
27946004|NCT00086515|81637523|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
27946005|NCT00086515|81637524|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
27946006|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
27946007|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
27946008|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
27946009|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
27946010|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
27946011|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
27946012|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
27946013|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
27946014|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
27946015|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
27946016|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
27946017|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
27946018|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
27946019|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
27946020|NCT00086515|81637523|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
27946021|NCT00086515|81637524|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
27946022|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
27946023|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
27946024|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
27946025|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
27946026|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
27946027|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
27946028|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
27946029|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
27648605|NCT01332266|80553880|FG001|Phase 1b|Withdrawal by Subject|1|||
27648606|NCT01332266|80553881|FG002|Phase 1b|Withdrawal by Subject|1|||
27648607|NCT01332266|80553882|FG003|Phase 1b|Withdrawal by Subject|0|||
27648608|NCT01332266|80553883|FG004|Phase 1b|Withdrawal by Subject|0|||
27648609|NCT01332266|80553879|FG000|Phase 2|Death|0|||
27946030|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
27946031|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
27946032|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
27946033|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
27648610|NCT01332266|80553880|FG001|Phase 2|Death|0|||
27648611|NCT01332266|80553881|FG002|Phase 2|Death|0|||
27648612|NCT01332266|80553882|FG003|Phase 2|Death|33|||
27648613|NCT01332266|80553883|FG004|Phase 2|Death|36|||
27648614|NCT01332266|80553879|FG000|Phase 2|Lost to Follow-up|0|||
27648615|NCT01332266|80553880|FG001|Phase 2|Lost to Follow-up|0|||
27648616|NCT01332266|80553881|FG002|Phase 2|Lost to Follow-up|0|||
27648617|NCT01332266|80553882|FG003|Phase 2|Lost to Follow-up|2|||
27648618|NCT01332266|80553883|FG004|Phase 2|Lost to Follow-up|0|||
27648619|NCT01332266|80553879|FG000|Phase 2|Physician Decision|0|||
27648620|NCT01332266|80553880|FG001|Phase 2|Physician Decision|0|||
27648621|NCT01332266|80553881|FG002|Phase 2|Physician Decision|0|||
27648622|NCT01332266|80553882|FG003|Phase 2|Physician Decision|3|||
27648623|NCT01332266|80553883|FG004|Phase 2|Physician Decision|1|||
27648624|NCT01332266|80553879|FG000|Phase 2|Symptomatic deterioration|0|||
27648625|NCT01332266|80553880|FG001|Phase 2|Symptomatic deterioration|0|||
27648626|NCT01332266|80553881|FG002|Phase 2|Symptomatic deterioration|0|||
27648627|NCT01332266|80553882|FG003|Phase 2|Symptomatic deterioration|0|||
27648628|NCT01332266|80553883|FG004|Phase 2|Symptomatic deterioration|1|||
27648629|NCT01332266|80553879|FG000|Phase 2|Progression Disease|0|||
27648630|NCT01332266|80553880|FG001|Phase 2|Progression Disease|0|||
27648631|NCT01332266|80553881|FG002|Phase 2|Progression Disease|0|||
27648632|NCT01332266|80553882|FG003|Phase 2|Progression Disease|2|||
27648633|NCT01332266|80553883|FG004|Phase 2|Progression Disease|1|||
27648634|NCT01332266|80553879|FG000|Phase 2|Withdrawal by Subject|0|||
27648635|NCT01332266|80553880|FG001|Phase 2|Withdrawal by Subject|0|||
27648636|NCT01332266|80553881|FG002|Phase 2|Withdrawal by Subject|0|||
27648637|NCT01332266|80553882|FG003|Phase 2|Withdrawal by Subject|2|||
27648638|NCT01332266|80553883|FG004|Phase 2|Withdrawal by Subject|2|||
27648639|NCT00089791|80553890|FG000|Overall Study|Physician Decision|6|||
27648640|NCT00089791|80553891|FG001|Overall Study|Physician Decision|3|||
27648641|NCT00089791|80553890|FG000|Overall Study|Adverse Event|81|||
27648642|NCT00089791|80553891|FG001|Overall Study|Adverse Event|93|||
27648643|NCT00089791|80553890|FG000|Overall Study|Withdrawal by Subject|403|||
27648644|NCT00089791|80553891|FG001|Overall Study|Withdrawal by Subject|344|||
27648645|NCT00089791|80553890|FG000|Overall Study|Death|78|||
27648646|NCT00089791|80553891|FG001|Overall Study|Death|62|||
27648647|NCT00089791|80553890|FG000|Overall Study|Disease progression|7|||
27648648|NCT00089791|80553891|FG001|Overall Study|Disease progression|3|||
27648649|NCT00089791|80553890|FG000|Overall Study|Ineligibility determined|12|||
27648650|NCT00089791|80553891|FG001|Overall Study|Ineligibility determined|9|||
27648651|NCT00089791|80553890|FG000|Overall Study|Lost to Follow-up|57|||
27648652|NCT00089791|80553891|FG001|Overall Study|Lost to Follow-up|57|||
27648653|NCT00089791|80553890|FG000|Overall Study|Noncompliance|17|||
27648654|NCT00089791|80553891|FG001|Overall Study|Noncompliance|13|||
27648655|NCT00089791|80553890|FG000|Overall Study|Other|20|||
27648656|NCT00089791|80553891|FG001|Overall Study|Other|32|||
27648657|NCT00089791|80553890|FG000|Overall Study|Protocol deviation|12|||
27648658|NCT00089791|80553891|FG001|Overall Study|Protocol deviation|10|||
27648659|NCT00089791|80553890|FG000|Overall Study|Requirement for alternative therapy|7|||
27648660|NCT00089791|80553891|FG001|Overall Study|Requirement for alternative therapy|4|||
27946034|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
27946035|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
27648661|NCT04660799|80553892|FG000|Overall Study|Progressive Disease|1|||
27648662|NCT04660799|80553893|FG001|Overall Study|Progressive Disease|1|||
27946036|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
27946037|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
27946038|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
27946039|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
27946040|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
27648663|NCT04660799|80553892|FG000|Overall Study|Death|2|||
27946041|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
27946042|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
27648664|NCT04660799|80553893|FG001|Overall Study|Death|1|||
27648665|NCT04660799|80553892|FG000|Overall Study|Adverse Event|2|||
27648666|NCT04660799|80553893|FG001|Overall Study|Adverse Event|1|||
27648667|NCT04660799|80553892|FG000|Overall Study|Withdrawal by Subject|2|||
27648668|NCT04660799|80553893|FG001|Overall Study|Withdrawal by Subject|5|||
27648669|NCT03905512|80553896|FG000|Overall Study|Withdrawal by Subject|9|||
27648670|NCT03905512|80553897|FG001|Overall Study|Withdrawal by Subject|8|||
27648671|NCT03905512|80553896|FG000|Overall Study|Adverse Event|1|||
27648672|NCT03905512|80553897|FG001|Overall Study|Adverse Event|2|||
27648673|NCT03905512|80553896|FG000|Overall Study|Lost to Follow-up|4|||
27648674|NCT03905512|80553897|FG001|Overall Study|Lost to Follow-up|3|||
27648675|NCT03905512|80553896|FG000|Overall Study|Other than Specified|7|||
27648676|NCT03905512|80553897|FG001|Overall Study|Other than Specified|4|||
27648677|NCT00705406|80553899|FG000|Overall Study|Lost to Follow-up|3|||
27648678|NCT00705406|80553900|FG001|Overall Study|Lost to Follow-up|3|||
27648679|NCT00705406|80553899|FG000|Overall Study|Did not receive study drug|1|||
27648680|NCT00705406|80553900|FG001|Overall Study|Did not receive study drug|2|||
27648681|NCT00518206|80553901|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
27648682|NCT00518206|80553902|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
27648683|NCT00518206|80553901|FG000|Overall Study|Withdrawal by Subject|2|||
27648684|NCT00518206|80553902|FG001|Overall Study|Withdrawal by Subject|0|||
27648685|NCT00518206|80553901|FG000|Overall Study|Drug Supply Issue|1|||
27648686|NCT00518206|80553902|FG001|Overall Study|Drug Supply Issue|0|||
27648687|NCT00518206|80553901|FG000|Overall Study|Reason Unknown|1|||
27648688|NCT00518206|80553902|FG001|Overall Study|Reason Unknown|0|||
27648689|NCT00518206|80553901|FG000|Overall Study|Completion Status Unknown|1|||
27648690|NCT00518206|80553902|FG001|Overall Study|Completion Status Unknown|0|||
27648691|NCT00391170|80553903|FG000|Overall Study|Withdrawal by Subject|1|||
27648692|NCT00391170|80553904|FG001|Overall Study|Withdrawal by Subject|0|||
27648693|NCT00391170|80553903|FG000|Overall Study|Adverse Event|3|||
27648694|NCT00391170|80553904|FG001|Overall Study|Adverse Event|2|||
27648695|NCT00391170|80553903|FG000|Overall Study|Physician Decision|2|||
27648696|NCT00391170|80553904|FG001|Overall Study|Physician Decision|2|||
27648697|NCT02470806|80553905|FG000|Overall Study|Lost to Follow-up|1|||
27648698|NCT02470806|80553906|FG001|Overall Study|Lost to Follow-up|1|||
27648699|NCT02470806|80553905|FG000|Overall Study|Adverse Event|5|||
27648700|NCT02470806|80553906|FG001|Overall Study|Adverse Event|2|||
27648701|NCT02470806|80553905|FG000|Overall Study|Protocol Violation|4|||
27648702|NCT02470806|80553906|FG001|Overall Study|Protocol Violation|11|||
27648703|NCT02470806|80553905|FG000|Overall Study|Physician Decision|0|||
27648704|NCT02470806|80553906|FG001|Overall Study|Physician Decision|3|||
27648705|NCT02470806|80553905|FG000|Overall Study|Withdrawal by Subject|3|||
27648706|NCT02470806|80553906|FG001|Overall Study|Withdrawal by Subject|10|||
27648707|NCT02470806|80553905|FG000|Overall Study|Lack of Efficacy|5|||
27648708|NCT02470806|80553906|FG001|Overall Study|Lack of Efficacy|15|||
27648709|NCT02241785|80553907|FG000|Overall Study|Sponsor Termination|43|||
27648710|NCT02241785|80553907|FG000|Overall Study|Withdrawal by Subject|1|||
27648711|NCT02241785|80553907|FG000|Overall Study|Lost to Follow-up|2|||
27648712|NCT02241785|80553907|FG000|Overall Study|Adverse Event|1|||
27648713|NCT00452114|80553908|FG000|Overall Study|Physician Decision|3|||
27946043|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
27746402|NCT01790438|80899619|FG000|Overall Study|Death|4|||
27746403|NCT01790438|80899620|FG001|Overall Study|Death|0|||
27946044|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
27946045|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
27946046|NCT00086515|81637523|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
27946047|NCT00086515|81637524|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
27946048|NCT03770286|81637526|FG000|Overall Study|Lost to Follow-up|6|||
27946049|NCT03770286|81637527|FG001|Overall Study|Lost to Follow-up|4|||
27946050|NCT03770286|81637528|FG002|Overall Study|Lost to Follow-up|3|||
27946051|NCT03770286|81637526|FG000|Overall Study|Protocol Violation|1|||
27946052|NCT03770286|81637527|FG001|Overall Study|Protocol Violation|0|||
27946053|NCT03770286|81637528|FG002|Overall Study|Protocol Violation|2|||
27946054|NCT00526799|81637537|FG000|Overall Study|Withdrawal by Subject|1|||
27946055|NCT00526799|81637538|FG001|Overall Study|Withdrawal by Subject|0|||
27946056|NCT00526799|81637537|FG000|Overall Study|Intercurrent Complicating Disease|0|||
27946057|NCT00526799|81637538|FG001|Overall Study|Intercurrent Complicating Disease|1|||
27946058|NCT06351371|81637539|FG000|Overall Study|Mutation Status Not Confirmed|9|||
27648714|NCT00452114|80553909|FG001|Overall Study|Physician Decision|3|||
27648715|NCT00667017|80553916|FG000|Overall Study|Withdrawal by Subject|1|||
27648716|NCT00655824|80553921|FG000|Overall Study|Adverse Event|3|||
27648717|NCT00655824|80553921|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
27648718|NCT00655824|80553921|FG000|Overall Study|Protocol Violation|1|||
27648719|NCT00655824|80553921|FG000|Overall Study|Withdrawal by Subject|4|||
27648720|NCT00655824|80553921|FG000|Overall Study|Deterioration of Trial Disease|2|||
27648721|NCT03352713|80553923|FG000|Overall Study|Lost to Follow-up|8|||
27648722|NCT03352713|80553923|FG000|Overall Study|Withdrawn by investigator|5|||
27648723|NCT03352713|80553923|FG000|Overall Study|Completed 0 EMAs|8|||
27648724|NCT03352713|80553923|FG000|Overall Study|Device incompatible/stolen|5|||
27648725|NCT02399449|80553924|FG000|Overall Study|Withdrawal by Subject|3|||
27648726|NCT02399449|80553925|FG001|Overall Study|Withdrawal by Subject|9|||
27746404|NCT01790438|80899619|FG000|Overall Study|Lost to Follow-up|5|||
27946059|NCT06351371|81637539|FG000|Overall Study|Ineligible|1|||
27648727|NCT02399449|80553924|FG000|Overall Study|Physician Decision|0|||
27648728|NCT02399449|80553925|FG001|Overall Study|Physician Decision|1|||
27648729|NCT00491400|80553928|FG000|Overall Study|Withdrawal by Subject|5|||
27648730|NCT00491400|80553929|FG001|Overall Study|Withdrawal by Subject|4|||
27648731|NCT00857766|80553931|FG000|Overall Study|Adverse Event|13|||
27648732|NCT00857766|80553932|FG001|Overall Study|Adverse Event|12|||
27746405|NCT01790438|80899620|FG001|Overall Study|Lost to Follow-up|2|||
27746406|NCT01790438|80899619|FG000|Overall Study|Withdrawal by Subject|13|||
27946060|NCT06351371|81637539|FG000|Overall Study|Adverse Event|4|||
27946061|NCT06351371|81637539|FG000|Overall Study|Death|1|||
27946062|NCT06351371|81637539|FG000|Overall Study|Disease progression|14|||
27648733|NCT00857766|80553931|FG000|Overall Study|Protocol Violation|11|||
27946063|NCT06351371|81637539|FG000|Overall Study|Withdrawal by Subject|3|||
27946064|NCT06351371|81637539|FG000|Overall Study|Physician Decision|3|||
27946065|NCT03599713|81637541|FG000|Overall Study|Death|26|||
27946066|NCT03599713|81637542|FG001|Overall Study|Death|3|||
27946067|NCT03599713|81637541|FG000|Overall Study|Withdrawal by Subject|6|||
27648734|NCT00857766|80553932|FG001|Overall Study|Protocol Violation|11|||
27648735|NCT00857766|80553931|FG000|Overall Study|Lost to Follow-up|1|||
27648736|NCT00857766|80553932|FG001|Overall Study|Lost to Follow-up|0|||
27648737|NCT00857766|80553931|FG000|Overall Study|Investigator Discretion|2|||
27648738|NCT00857766|80553932|FG001|Overall Study|Investigator Discretion|3|||
27648739|NCT00857766|80553931|FG000|Overall Study|Participant Withdrew Consent|4|||
27648740|NCT00857766|80553932|FG001|Overall Study|Participant Withdrew Consent|4|||
27648741|NCT01105975|80553933|FG000|Overall Study|Adverse Event|2|||
27648742|NCT01105975|80553934|FG001|Overall Study|Adverse Event|1|||
27648743|NCT01105975|80553935|FG002|Overall Study|Adverse Event|5|||
27648744|NCT01105975|80553936|FG003|Overall Study|Adverse Event|1|||
27648745|NCT01105975|80553937|FG004|Overall Study|Adverse Event|0|||
27648746|NCT01105975|80553938|FG005|Overall Study|Adverse Event|1|||
27648747|NCT01105975|80553939|FG006|Overall Study|Adverse Event|2|||
27648748|NCT01105975|80553940|FG007|Overall Study|Adverse Event|4|||
27648749|NCT01105975|80553941|FG008|Overall Study|Adverse Event|1|||
27648750|NCT01105975|80553942|FG009|Overall Study|Adverse Event|4|||
27946068|NCT03599713|81637542|FG001|Overall Study|Withdrawal by Subject|0|||
27946069|NCT03599713|81637541|FG000|Overall Study|Ongoing|69|||
27946070|NCT03599713|81637542|FG001|Overall Study|Ongoing|3|||
27946071|NCT04197583|81637543|FG000|Overall Study|Study Stent Replacement|34|||
27946072|NCT04197583|81637544|FG001|Overall Study|Study Stent Replacement|8|||
27946073|NCT04197583|81637543|FG000|Overall Study|Lost to Follow-up|14|||
27946074|NCT04197583|81637544|FG001|Overall Study|Lost to Follow-up|3|||
27946075|NCT04197583|81637543|FG000|Overall Study|Death|3|||
27946076|NCT04197583|81637544|FG001|Overall Study|Death|0|||
27946077|NCT04197583|81637543|FG000|Overall Study|Physician Decision|1|||
27946078|NCT04197583|81637544|FG001|Overall Study|Physician Decision|0|||
27946079|NCT04197583|81637543|FG000|Overall Study|Withdrawal by Subject|1|||
27946080|NCT04197583|81637544|FG001|Overall Study|Withdrawal by Subject|1|||
27946081|NCT04197583|81637543|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
27946082|NCT04197583|81637544|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
27946083|NCT04197583|81637543|FG000|Overall Study|Screen Failure|0|||
27946084|NCT04197583|81637544|FG001|Overall Study|Screen Failure|20|||
27946085|NCT04035486|81637549|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
27946086|NCT04035486|81637550|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
27946087|NCT04035486|81637551|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
27946088|NCT04035486|81637552|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
27648751|NCT01105975|80553933|FG000|Overall Study|Withdrawal by Subject|2|||
27648752|NCT01105975|80553934|FG001|Overall Study|Withdrawal by Subject|2|||
27648753|NCT01105975|80553935|FG002|Overall Study|Withdrawal by Subject|2|||
27648754|NCT01105975|80553936|FG003|Overall Study|Withdrawal by Subject|0|||
27648755|NCT01105975|80553937|FG004|Overall Study|Withdrawal by Subject|4|||
27648756|NCT01105975|80553938|FG005|Overall Study|Withdrawal by Subject|1|||
27648757|NCT01105975|80553939|FG006|Overall Study|Withdrawal by Subject|2|||
27648758|NCT01105975|80553940|FG007|Overall Study|Withdrawal by Subject|1|||
27648759|NCT01105975|80553941|FG008|Overall Study|Withdrawal by Subject|0|||
27648760|NCT01105975|80553942|FG009|Overall Study|Withdrawal by Subject|3|||
27648761|NCT01105975|80553933|FG000|Overall Study|Lost to Follow-up|1|||
27648762|NCT01105975|80553934|FG001|Overall Study|Lost to Follow-up|0|||
27648763|NCT01105975|80553935|FG002|Overall Study|Lost to Follow-up|0|||
27648764|NCT01105975|80553936|FG003|Overall Study|Lost to Follow-up|1|||
27648765|NCT01105975|80553937|FG004|Overall Study|Lost to Follow-up|1|||
27648766|NCT01105975|80553938|FG005|Overall Study|Lost to Follow-up|0|||
27648767|NCT01105975|80553939|FG006|Overall Study|Lost to Follow-up|0|||
27648768|NCT01105975|80553940|FG007|Overall Study|Lost to Follow-up|0|||
27648769|NCT01105975|80553941|FG008|Overall Study|Lost to Follow-up|1|||
27746407|NCT01790438|80899620|FG001|Overall Study|Withdrawal by Subject|2|||
27746408|NCT01790438|80899619|FG000|Overall Study|Physician Decision|3|||
27746409|NCT01790438|80899620|FG001|Overall Study|Physician Decision|1|||
27746410|NCT01790438|80899619|FG000|Overall Study|Sponsor Decision|0|||
27946089|NCT04035486|81637549|FG000|Overall Study|Death|6|||
27648770|NCT01105975|80553942|FG009|Overall Study|Lost to Follow-up|0|||
27648771|NCT01105975|80553933|FG000|Overall Study|Physician Decision|0|||
27648772|NCT01105975|80553934|FG001|Overall Study|Physician Decision|0|||
27648773|NCT01105975|80553935|FG002|Overall Study|Physician Decision|0|||
27648774|NCT01105975|80553936|FG003|Overall Study|Physician Decision|0|||
27746411|NCT01790438|80899620|FG001|Overall Study|Sponsor Decision|3|||
27946090|NCT04035486|81637550|FG001|Overall Study|Death|3|||
27946091|NCT04035486|81637551|FG002|Overall Study|Death|70|||
27946092|NCT04035486|81637552|FG003|Overall Study|Death|77|||
27946093|NCT04035486|81637549|FG000|Overall Study|Screen Failure|0|||
27946094|NCT04035486|81637550|FG001|Overall Study|Screen Failure|0|||
27946095|NCT04035486|81637551|FG002|Overall Study|Screen Failure|1|||
27946096|NCT04035486|81637552|FG003|Overall Study|Screen Failure|1|||
27946097|NCT04035486|81637549|FG000|Overall Study|Withdrawal by Subject|1|||
27946098|NCT04035486|81637550|FG001|Overall Study|Withdrawal by Subject|1|||
27946099|NCT04035486|81637551|FG002|Overall Study|Withdrawal by Subject|11|||
27946100|NCT04035486|81637552|FG003|Overall Study|Withdrawal by Subject|9|||
27946101|NCT00265122|81637553|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
27946102|NCT00265122|81637554|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
27946103|NCT00265122|81637555|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
27946104|NCT00265122|81637556|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
27946105|NCT00265122|81637557|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
27946106|NCT00265122|81637558|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
27946107|NCT00265122|81637553|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
27946108|NCT00265122|81637554|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
27946109|NCT00265122|81637555|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
27946110|NCT00265122|81637556|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
27946111|NCT00265122|81637557|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
27946112|NCT00265122|81637558|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
27946113|NCT00265122|81637553|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
27946114|NCT00265122|81637554|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
27946115|NCT00265122|81637555|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
27946116|NCT00265122|81637556|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
27946117|NCT00265122|81637557|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
27946118|NCT00265122|81637558|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
27946119|NCT00265122|81637553|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
27946120|NCT00265122|81637554|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
27946121|NCT00265122|81637555|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
27946122|NCT00265122|81637556|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
27946123|NCT00265122|81637557|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
27946124|NCT00265122|81637558|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
27946125|NCT00265122|81637553|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
27946126|NCT00265122|81637554|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
27946127|NCT00265122|81637555|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
27946128|NCT00265122|81637556|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
27946129|NCT00265122|81637557|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
27946130|NCT00265122|81637558|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
27946131|NCT00265122|81637553|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
27946132|NCT00265122|81637554|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
27946133|NCT00265122|81637555|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
27946134|NCT00265122|81637556|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
27946135|NCT00265122|81637557|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
27946136|NCT00265122|81637558|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
27946137|NCT03440411|81637559|FG000|Overall Study|Adverse Event|0|||
27946138|NCT03440411|81637560|FG001|Overall Study|Adverse Event|0|||
27946139|NCT03440411|81637561|FG002|Overall Study|Adverse Event|1|||
27946140|NCT03440411|81637562|FG003|Overall Study|Adverse Event|0|||
27946141|NCT03440411|81637559|FG000|Overall Study|PD|2|||
27946142|NCT03440411|81637560|FG001|Overall Study|PD|1|||
27946143|NCT03440411|81637561|FG002|Overall Study|PD|1|||
27946144|NCT03440411|81637562|FG003|Overall Study|PD|1|||
27946145|NCT03440411|81637559|FG000|Overall Study|Withdrawal by Subject|1|||
27946146|NCT03440411|81637560|FG001|Overall Study|Withdrawal by Subject|0|||
27946147|NCT03440411|81637561|FG002|Overall Study|Withdrawal by Subject|0|||
27946148|NCT03440411|81637562|FG003|Overall Study|Withdrawal by Subject|0|||
27946149|NCT03440411|81637559|FG000|Overall Study|Closed study by sponsor|0|||
27946150|NCT03440411|81637560|FG001|Overall Study|Closed study by sponsor|0|||
27946151|NCT03440411|81637561|FG002|Overall Study|Closed study by sponsor|0|||
27946152|NCT03440411|81637562|FG003|Overall Study|Closed study by sponsor|1|||
27946153|NCT05305651|81637563|FG000|Overall Study|Death|1|||
27946154|NCT05305651|81637563|FG000|Overall Study|Withdrawal by Subject|4|||
27946155|NCT05305651|81637563|FG000|Overall Study|Lost to Follow-up|4|||
27946156|NCT00492050|81637566|FG000|Overall Study|Adverse Event|1|||
27946157|NCT00492050|81637566|FG000|Overall Study|Lack of Efficacy|1|||
27946158|NCT00492050|81637566|FG000|Overall Study|Withdrawal by Subject|3|||
27946159|NCT00492050|81637566|FG000|Overall Study|Unable to collect SCT|2|||
27946160|NCT00492050|81637566|FG000|Overall Study|Progressive Disease|2|||
27946161|NCT04756531|81637569|FG000|Overall Study|Adverse Event|0|||
27946162|NCT04756531|81637570|FG001|Overall Study|Adverse Event|0|||
27946163|NCT04756531|81637571|FG002|Overall Study|Adverse Event|0|||
27946164|NCT04756531|81637572|FG003|Overall Study|Adverse Event|0|||
27946165|NCT04756531|81637573|FG004|Overall Study|Adverse Event|1|||
27946166|NCT04756531|81637574|FG005|Overall Study|Adverse Event|0|||
27946167|NCT04756531|81637575|FG006|Overall Study|Adverse Event|0|||
27946168|NCT04756531|81637576|FG007|Overall Study|Adverse Event|0|||
27946169|NCT04756531|81637577|FG008|Overall Study|Adverse Event|0|||
27946170|NCT04756531|81637578|FG009|Overall Study|Adverse Event|0|||
27946171|NCT04756531|81637579|FG010|Overall Study|Adverse Event|0|||
27946172|NCT04756531|81637580|FG011|Overall Study|Adverse Event|0|||
27946173|NCT04756531|81637581|FG012|Overall Study|Adverse Event|0|||
27946174|NCT04756531|81637582|FG013|Overall Study|Adverse Event|0|||
27946175|NCT04756531|81637583|FG014|Overall Study|Adverse Event|0|||
27946176|NCT04756531|81637584|FG015|Overall Study|Adverse Event|0|||
27946177|NCT04756531|81637585|FG016|Overall Study|Adverse Event|0|||
27946178|NCT04756531|81637586|FG017|Overall Study|Adverse Event|0|||
27946179|NCT04756531|81637569|FG000|Overall Study|Withdrawal by Subject|0|||
27946180|NCT04756531|81637570|FG001|Overall Study|Withdrawal by Subject|0|||
27946181|NCT04756531|81637571|FG002|Overall Study|Withdrawal by Subject|0|||
27946182|NCT04756531|81637572|FG003|Overall Study|Withdrawal by Subject|0|||
27946183|NCT04756531|81637573|FG004|Overall Study|Withdrawal by Subject|0|||
27946184|NCT04756531|81637574|FG005|Overall Study|Withdrawal by Subject|0|||
27946185|NCT04756531|81637575|FG006|Overall Study|Withdrawal by Subject|1|||
27946186|NCT04756531|81637576|FG007|Overall Study|Withdrawal by Subject|0|||
27946187|NCT04756531|81637577|FG008|Overall Study|Withdrawal by Subject|0|||
27946188|NCT04756531|81637578|FG009|Overall Study|Withdrawal by Subject|0|||
27946189|NCT04756531|81637579|FG010|Overall Study|Withdrawal by Subject|0|||
27946190|NCT04756531|81637580|FG011|Overall Study|Withdrawal by Subject|0|||
27946191|NCT04756531|81637581|FG012|Overall Study|Withdrawal by Subject|0|||
27946192|NCT04756531|81637582|FG013|Overall Study|Withdrawal by Subject|0|||
27946193|NCT04756531|81637583|FG014|Overall Study|Withdrawal by Subject|0|||
27946194|NCT04756531|81637584|FG015|Overall Study|Withdrawal by Subject|0|||
27946195|NCT04756531|81637585|FG016|Overall Study|Withdrawal by Subject|0|||
27946196|NCT04756531|81637586|FG017|Overall Study|Withdrawal by Subject|0|||
27946197|NCT01969058|81637587|FG000|Overall Study|Withdrawal by Subject|2|||
27946198|NCT01969058|81637588|FG001|Overall Study|Withdrawal by Subject|0|||
27946199|NCT01969058|81637587|FG000|Overall Study|Adverse Event|1|||
27946200|NCT01969058|81637588|FG001|Overall Study|Adverse Event|0|||
27946201|NCT02734004|81637590|FG000|Overall Study|Death|36|||
27946202|NCT02734004|81637591|FG001|Overall Study|Death|24|||
27946203|NCT02734004|81637592|FG002|Overall Study|Death|26|||
27946204|NCT02734004|81637593|FG003|Overall Study|Death|35|||
27946205|NCT02734004|81637594|FG004|Overall Study|Death|13|||
27946206|NCT02734004|81637595|FG005|Overall Study|Death|17|||
27946207|NCT02734004|81637596|FG006|Overall Study|Death|20|||
27946208|NCT02734004|81637590|FG000|Overall Study|Lost to Follow-up|1|||
27946209|NCT02734004|81637591|FG001|Overall Study|Lost to Follow-up|1|||
27946210|NCT02734004|81637592|FG002|Overall Study|Lost to Follow-up|0|||
27946211|NCT02734004|81637593|FG003|Overall Study|Lost to Follow-up|0|||
27946212|NCT02734004|81637594|FG004|Overall Study|Lost to Follow-up|1|||
27946213|NCT02734004|81637595|FG005|Overall Study|Lost to Follow-up|0|||
27946214|NCT02734004|81637596|FG006|Overall Study|Lost to Follow-up|0|||
27946215|NCT02734004|81637590|FG000|Overall Study|Withdrawal by Subject|3|||
27946216|NCT02734004|81637591|FG001|Overall Study|Withdrawal by Subject|1|||
27946217|NCT02734004|81637592|FG002|Overall Study|Withdrawal by Subject|1|||
27946218|NCT02734004|81637593|FG003|Overall Study|Withdrawal by Subject|1|||
27946219|NCT02734004|81637594|FG004|Overall Study|Withdrawal by Subject|3|||
27946220|NCT02734004|81637595|FG005|Overall Study|Withdrawal by Subject|0|||
27946221|NCT02734004|81637596|FG006|Overall Study|Withdrawal by Subject|2|||
27946222|NCT02734004|81637590|FG000|Overall Study|Other|0|||
27946223|NCT02734004|81637591|FG001|Overall Study|Other|8|||
27946224|NCT02734004|81637592|FG002|Overall Study|Other|7|||
27946225|NCT02734004|81637593|FG003|Overall Study|Other|4|||
27946226|NCT02734004|81637594|FG004|Overall Study|Other|34|||
27946227|NCT02734004|81637595|FG005|Overall Study|Other|14|||
27946228|NCT02734004|81637596|FG006|Overall Study|Other|10|||
27946229|NCT00830336|81637597|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
27946230|NCT00830336|81637598|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
27946231|NCT00645658|81637599|FG000|Overall Study|Withdrawal by Subject|1|||
27946232|NCT00645658|81637600|FG001|Overall Study|Withdrawal by Subject|0|||
27648775|NCT01105975|80553937|FG004|Overall Study|Physician Decision|0|||
27946233|NCT00645658|81637599|FG000|Overall Study|Did not complete all assesments|0|||
27946234|NCT00645658|81637600|FG001|Overall Study|Did not complete all assesments|2|||
27946235|NCT02321514|81637601|FG000|Overall Study|Death|15|||
27648776|NCT01105975|80553938|FG005|Overall Study|Physician Decision|0|||
27946236|NCT02321514|81637601|FG000|Overall Study|Missed Visit|7|||
27946237|NCT02321514|81637601|FG000|Overall Study|Study Exit|3|||
27946238|NCT02014467|81637602|FG000|Overall Study|Adverse Event|4|||
27946239|NCT02014467|81637603|FG001|Overall Study|Adverse Event|0|||
27946240|NCT02014467|81637602|FG000|Overall Study|Protocol Violation|3|||
27946241|NCT02014467|81637603|FG001|Overall Study|Protocol Violation|0|||
27946242|NCT02014467|81637602|FG000|Overall Study|Physician Decision|2|||
27946243|NCT02014467|81637603|FG001|Overall Study|Physician Decision|3|||
27946244|NCT02014467|81637602|FG000|Overall Study|Withdrawal by Subject|16|||
27946245|NCT02014467|81637603|FG001|Overall Study|Withdrawal by Subject|4|||
27946246|NCT03524157|81637604|FG000|Overall Study|cytology not readable|0|||
27946247|NCT03524157|81637605|FG001|Overall Study|cytology not readable|0|||
27946248|NCT03524157|81637606|FG002|Overall Study|cytology not readable|1|||
27946249|NCT04770285|81637607|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
27946250|NCT04770285|81637608|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
27648777|NCT01105975|80553939|FG006|Overall Study|Physician Decision|2|||
27648778|NCT01105975|80553940|FG007|Overall Study|Physician Decision|0|||
27648779|NCT01105975|80553941|FG008|Overall Study|Physician Decision|0|||
27648780|NCT01105975|80553942|FG009|Overall Study|Physician Decision|0|||
27648781|NCT01105975|80553933|FG000|Overall Study|Protocol Violation|0|||
27648782|NCT01105975|80553934|FG001|Overall Study|Protocol Violation|2|||
27648783|NCT01105975|80553935|FG002|Overall Study|Protocol Violation|2|||
27648784|NCT01105975|80553936|FG003|Overall Study|Protocol Violation|0|||
27648785|NCT01105975|80553937|FG004|Overall Study|Protocol Violation|1|||
27648786|NCT01105975|80553938|FG005|Overall Study|Protocol Violation|1|||
27648787|NCT01105975|80553939|FG006|Overall Study|Protocol Violation|1|||
27648788|NCT01105975|80553940|FG007|Overall Study|Protocol Violation|1|||
27648789|NCT01105975|80553941|FG008|Overall Study|Protocol Violation|2|||
27946251|NCT04770285|81637607|FG000|Overall Study|Lack of Efficacy|0|||
27946252|NCT04770285|81637608|FG001|Overall Study|Lack of Efficacy|1|||
27946253|NCT04770285|81637607|FG000|Overall Study|Lost to Follow-up|11|||
27946254|NCT04770285|81637608|FG001|Overall Study|Lost to Follow-up|8|||
27946255|NCT04770285|81637607|FG000|Overall Study|Protocol Deviation|6|||
27946256|NCT04770285|81637608|FG001|Overall Study|Protocol Deviation|6|||
27946257|NCT04770285|81637607|FG000|Overall Study|Technical Problem|0|||
27946258|NCT04770285|81637608|FG001|Overall Study|Technical Problem|1|||
27946259|NCT04770285|81637607|FG000|Overall Study|Withdrawal by Subject|9|||
27946260|NCT04770285|81637608|FG001|Overall Study|Withdrawal by Subject|8|||
27946261|NCT04770285|81637607|FG000|Overall Study|Reason Not Specified|0|||
27946262|NCT04770285|81637608|FG001|Overall Study|Reason Not Specified|1|||
27946263|NCT03384966|81637609|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
27946264|NCT03384966|81637610|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
27551391|NCT01543698|80207469|FG011|Phase 1b|Administrative problems|0|||
27648790|NCT01105975|80553942|FG009|Overall Study|Protocol Violation|2|||
27648791|NCT01105975|80553933|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27648792|NCT01105975|80553934|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27648793|NCT01105975|80553935|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27648794|NCT01105975|80553936|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27648795|NCT01105975|80553937|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27946265|NCT03384966|81637611|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
27946266|NCT03384966|81637609|FG000|Follow-up Period|Adverse Event|1|||
27551392|NCT01543698|80207470|FG012|Phase 1b|Administrative problems|0|||
27551393|NCT01543698|80207471|FG013|Phase 1b|Administrative problems|0|||
27551394|NCT01543698|80207472|FG014|Phase 1b|Administrative problems|0|||
27551395|NCT01543698|80207458|FG000|Phase 1b|Protocol Violation|2|||
27551396|NCT01543698|80207459|FG001|Phase 1b|Protocol Violation|0|||
27551397|NCT01543698|80207460|FG002|Phase 1b|Protocol Violation|0|||
27551398|NCT01543698|80207461|FG003|Phase 1b|Protocol Violation|0|||
27551399|NCT01543698|80207462|FG004|Phase 1b|Protocol Violation|0|||
27551400|NCT01543698|80207463|FG005|Phase 1b|Protocol Violation|0|||
27551401|NCT01543698|80207464|FG006|Phase 1b|Protocol Violation|0|||
27551402|NCT01543698|80207465|FG007|Phase 1b|Protocol Violation|0|||
27551403|NCT01543698|80207466|FG008|Phase 1b|Protocol Violation|0|||
27551404|NCT01543698|80207467|FG009|Phase 1b|Protocol Violation|0|||
27551405|NCT01543698|80207468|FG010|Phase 1b|Protocol Violation|0|||
27551406|NCT01543698|80207469|FG011|Phase 1b|Protocol Violation|0|||
27551407|NCT01543698|80207470|FG012|Phase 1b|Protocol Violation|0|||
27551408|NCT01543698|80207471|FG013|Phase 1b|Protocol Violation|0|||
27551409|NCT01543698|80207472|FG014|Phase 1b|Protocol Violation|0|||
27551410|NCT01543698|80207458|FG000|Phase 2|Protocol Violation|0|||
27551411|NCT01543698|80207459|FG001|Phase 2|Protocol Violation|0|||
27551412|NCT01543698|80207460|FG002|Phase 2|Protocol Violation|0|||
27551413|NCT01543698|80207461|FG003|Phase 2|Protocol Violation|0|||
27551414|NCT01543698|80207462|FG004|Phase 2|Protocol Violation|0|||
27551415|NCT01543698|80207463|FG005|Phase 2|Protocol Violation|0|||
27551416|NCT01543698|80207464|FG006|Phase 2|Protocol Violation|0|||
27551417|NCT01543698|80207465|FG007|Phase 2|Protocol Violation|0|||
27551418|NCT01543698|80207466|FG008|Phase 2|Protocol Violation|0|||
27551419|NCT01543698|80207467|FG009|Phase 2|Protocol Violation|0|||
27551420|NCT01543698|80207468|FG010|Phase 2|Protocol Violation|0|||
27551421|NCT01543698|80207469|FG011|Phase 2|Protocol Violation|0|||
27551422|NCT01543698|80207470|FG012|Phase 2|Protocol Violation|1|||
27551423|NCT01543698|80207471|FG013|Phase 2|Protocol Violation|0|||
27551424|NCT01543698|80207472|FG014|Phase 2|Protocol Violation|0|||
27648796|NCT01105975|80553938|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
27946267|NCT03384966|81637610|FG001|Follow-up Period|Adverse Event|0|||
27946268|NCT03384966|81637611|FG002|Follow-up Period|Adverse Event|0|||
27946269|NCT01355627|81637612|FG000|Overall Study|Request By the Patient to Discontinue|5|||
27946270|NCT01355627|81637613|FG001|Overall Study|Request By the Patient to Discontinue|7|||
27946271|NCT01355627|81637612|FG000|Overall Study|Lost to Follow-up|8|||
27946272|NCT01355627|81637613|FG001|Overall Study|Lost to Follow-up|7|||
27946273|NCT01355627|81637612|FG000|Overall Study|Fatal Adverse Event|19|||
27946274|NCT01355627|81637613|FG001|Overall Study|Fatal Adverse Event|23|||
27946275|NCT01355627|81637612|FG000|Overall Study|Other|1|||
27946276|NCT01355627|81637613|FG001|Overall Study|Other|1|||
27946277|NCT00618787|81637620|FG000|Overall Study|Adverse Event|0|||
27946278|NCT00618787|81637621|FG001|Overall Study|Adverse Event|1|||
27946279|NCT00618787|81637620|FG000|Overall Study|Withdrawal by Subject|2|||
27946280|NCT00618787|81637621|FG001|Overall Study|Withdrawal by Subject|1|||
27946281|NCT00618787|81637620|FG000|Overall Study|Lost to Follow-up|1|||
27946282|NCT00618787|81637621|FG001|Overall Study|Lost to Follow-up|0|||
27946283|NCT01649869|81637634|FG000|Overall Study|Family member illness|1|||
27946284|NCT01649869|81637635|FG001|Overall Study|Family member illness|0|||
27946285|NCT01649869|81637634|FG000|Overall Study|Required treatment outside protocol|1|||
27946286|NCT01649869|81637635|FG001|Overall Study|Required treatment outside protocol|0|||
27946287|NCT01649869|81637634|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
27946288|NCT01649869|81637635|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
27946289|NCT01702298|81637636|FG000|Overall Study|Withdrawal by Subject|1|||
27946290|NCT03952559|81637641|FG000|Double Blind Treatment Period|Adverse Event|0|||
27946291|NCT03952559|81637642|FG001|Double Blind Treatment Period|Adverse Event|2|||
27946292|NCT03952559|81637643|FG002|Double Blind Treatment Period|Adverse Event|1|||
27946293|NCT03952559|81637644|FG003|Double Blind Treatment Period|Adverse Event|0|||
27946294|NCT03952559|81637645|FG004|Double Blind Treatment Period|Adverse Event|1|||
27946295|NCT03952559|81637641|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
27946296|NCT03952559|81637642|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
27946297|NCT03952559|81637643|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
27946298|NCT03952559|81637644|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
27946299|NCT03952559|81637645|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
27946300|NCT03952559|81637641|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
27946301|NCT03952559|81637642|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
27946302|NCT03952559|81637643|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
27946303|NCT03952559|81637644|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
27946304|NCT03952559|81637645|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
27946305|NCT03952559|81637641|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
27946306|NCT03952559|81637642|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
27946307|NCT03952559|81637643|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
27946308|NCT03952559|81637644|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
27946309|NCT03952559|81637645|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
27946310|NCT04237584|81637649|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
27946311|NCT04237584|81637650|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
27946312|NCT04237584|81637651|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
27946313|NCT04237584|81637652|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
27946314|NCT04237584|81637649|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
27946315|NCT04237584|81637650|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
27946316|NCT04237584|81637651|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
27946317|NCT04237584|81637652|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
27946318|NCT04237584|81637649|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
27946319|NCT04237584|81637650|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
27946320|NCT04237584|81637651|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
27946321|NCT04237584|81637652|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
27946322|NCT04237584|81637649|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
27946323|NCT04237584|81637650|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
27946324|NCT04237584|81637651|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
27946325|NCT04237584|81637652|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
27946326|NCT04237584|81637649|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
27946327|NCT04237584|81637650|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
27946328|NCT04237584|81637651|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
27946329|NCT04237584|81637652|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
27946330|NCT02971163|81637653|FG000|Overall Study|Lost to Follow-up|4|||
27946331|NCT02971163|81637654|FG001|Overall Study|Lost to Follow-up|2|||
27946332|NCT00522379|81637656|FG000|Overall Study|Adverse Event|12|||
27946333|NCT00522379|81637657|FG001|Overall Study|Adverse Event|15|||
27946334|NCT00522379|81637658|FG002|Overall Study|Adverse Event|12|||
27946335|NCT00522379|81637659|FG003|Overall Study|Adverse Event|5|||
27946336|NCT00522379|81637660|FG004|Overall Study|Adverse Event|17|||
27946337|NCT00522379|81637656|FG000|Overall Study|Lack of Efficacy|3|||
27946338|NCT00522379|81637657|FG001|Overall Study|Lack of Efficacy|0|||
27648797|NCT01105975|80553939|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27648798|NCT01105975|80553940|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
27648799|NCT01105975|80553941|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
27648800|NCT01105975|80553942|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
27648801|NCT03032198|80553946|FG000|Overall Study|Screen Fail|1|||
27648802|NCT01885559|80553947|FG000|Overall Study|Lost to Follow-up|15|||
27648803|NCT01885559|80553948|FG001|Overall Study|Lost to Follow-up|16|||
27648804|NCT01885559|80553947|FG000|Overall Study|Less than full participation|9|||
27946339|NCT00522379|81637658|FG002|Overall Study|Lack of Efficacy|2|||
27946340|NCT00522379|81637659|FG003|Overall Study|Lack of Efficacy|2|||
27946341|NCT00522379|81637660|FG004|Overall Study|Lack of Efficacy|7|||
27946342|NCT00522379|81637656|FG000|Overall Study|Withdrawal by Subject|2|||
27946343|NCT00522379|81637657|FG001|Overall Study|Withdrawal by Subject|3|||
27946344|NCT00522379|81637658|FG002|Overall Study|Withdrawal by Subject|1|||
27946345|NCT00522379|81637659|FG003|Overall Study|Withdrawal by Subject|2|||
27946346|NCT00522379|81637660|FG004|Overall Study|Withdrawal by Subject|0|||
27946347|NCT00522379|81637656|FG000|Overall Study|Protocol Violation|1|||
27946348|NCT00522379|81637657|FG001|Overall Study|Protocol Violation|1|||
27946349|NCT00522379|81637658|FG002|Overall Study|Protocol Violation|2|||
27946350|NCT00522379|81637659|FG003|Overall Study|Protocol Violation|0|||
27648805|NCT01885559|80553948|FG001|Overall Study|Less than full participation|19|||
27648806|NCT01885559|80553947|FG000|Overall Study|Protocol Violation|0|||
27648807|NCT01885559|80553948|FG001|Overall Study|Protocol Violation|1|||
27746412|NCT01790438|80899619|FG000|Overall Study|Protocol Required Discontinuation|7|||
27746413|NCT01790438|80899620|FG001|Overall Study|Protocol Required Discontinuation|1|||
27746414|NCT01302041|80899621|FG000|Overall Study|Death|5|||
27746415|NCT01302041|80899621|FG000|Overall Study|Withdrawal by Subject|4|||
27746416|NCT01302041|80899621|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
27946351|NCT00522379|81637660|FG004|Overall Study|Protocol Violation|0|||
27946352|NCT00522379|81637656|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
27946353|NCT00522379|81637657|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
27946354|NCT00522379|81637658|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
27946355|NCT00522379|81637659|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
27946356|NCT00522379|81637660|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
27946357|NCT00522379|81637656|FG000|Overall Study|Lost to Follow-up|1|||
27946358|NCT00522379|81637657|FG001|Overall Study|Lost to Follow-up|0|||
27946359|NCT00522379|81637658|FG002|Overall Study|Lost to Follow-up|4|||
27946360|NCT00522379|81637659|FG003|Overall Study|Lost to Follow-up|2|||
27946361|NCT00522379|81637660|FG004|Overall Study|Lost to Follow-up|2|||
27946362|NCT00522379|81637656|FG000|Overall Study|Randomization error|0|||
27946363|NCT00522379|81637657|FG001|Overall Study|Randomization error|0|||
27946364|NCT00522379|81637658|FG002|Overall Study|Randomization error|0|||
27946365|NCT00522379|81637659|FG003|Overall Study|Randomization error|0|||
27946366|NCT00522379|81637660|FG004|Overall Study|Randomization error|1|||
27946367|NCT00522379|81637656|FG000|Overall Study|Dispensing error|1|||
27946368|NCT00522379|81637657|FG001|Overall Study|Dispensing error|0|||
27946369|NCT00522379|81637658|FG002|Overall Study|Dispensing error|0|||
27946370|NCT00522379|81637659|FG003|Overall Study|Dispensing error|1|||
27946371|NCT00522379|81637660|FG004|Overall Study|Dispensing error|0|||
27946372|NCT00522379|81637656|FG000|Overall Study|Subject Moved|1|||
27946373|NCT00522379|81637657|FG001|Overall Study|Subject Moved|1|||
27946374|NCT00522379|81637658|FG002|Overall Study|Subject Moved|0|||
27946375|NCT00522379|81637659|FG003|Overall Study|Subject Moved|0|||
27946376|NCT00522379|81637660|FG004|Overall Study|Subject Moved|0|||
27946377|NCT00522379|81637656|FG000|Overall Study|Sponsor Request|0|||
27946378|NCT00522379|81637657|FG001|Overall Study|Sponsor Request|1|||
27946379|NCT00522379|81637658|FG002|Overall Study|Sponsor Request|0|||
27746417|NCT01302041|80899621|FG000|Overall Study|Other-Miscellaneous Reason|2|||
27746418|NCT02052960|80899626|FG000|Overall Study|Adverse Event|19|||
27946380|NCT00522379|81637659|FG003|Overall Study|Sponsor Request|0|||
27946381|NCT00522379|81637660|FG004|Overall Study|Sponsor Request|0|||
27946382|NCT00522379|81637656|FG000|Overall Study|Family Problem|0|||
27946383|NCT00522379|81637657|FG001|Overall Study|Family Problem|0|||
27946384|NCT00522379|81637658|FG002|Overall Study|Family Problem|1|||
27946385|NCT00522379|81637659|FG003|Overall Study|Family Problem|0|||
27946386|NCT00522379|81637660|FG004|Overall Study|Family Problem|0|||
27946387|NCT00522379|81637656|FG000|Overall Study|Site Closed|0|||
27946388|NCT00522379|81637657|FG001|Overall Study|Site Closed|0|||
27946389|NCT00522379|81637658|FG002|Overall Study|Site Closed|0|||
27946390|NCT00522379|81637659|FG003|Overall Study|Site Closed|1|||
27946391|NCT00522379|81637660|FG004|Overall Study|Site Closed|0|||
27946392|NCT00522379|81637656|FG000|Overall Study|Subject Withdrawal|0|||
27648808|NCT00622700|80553951|FG000|Core Treatment Period|Randomized but Not Treated|0|||
27946393|NCT00522379|81637657|FG001|Overall Study|Subject Withdrawal|0|||
27946394|NCT00522379|81637658|FG002|Overall Study|Subject Withdrawal|0|||
27946395|NCT00522379|81637659|FG003|Overall Study|Subject Withdrawal|1|||
27946396|NCT00522379|81637660|FG004|Overall Study|Subject Withdrawal|0|||
27946397|NCT00835549|81637661|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
27946398|NCT00835549|81637662|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
27946399|NCT03110562|81637674|FG000|Initial Treatment Period|Disease Progression|1|||
27946400|NCT03110562|81637675|FG001|Initial Treatment Period|Disease Progression|1|||
27946401|NCT03110562|81637676|FG002|Initial Treatment Period|Disease Progression|0|||
27946402|NCT03110562|81637677|FG003|Initial Treatment Period|Disease Progression|0|||
27946403|NCT03110562|81637674|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
27946404|NCT03110562|81637675|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
27946405|NCT03110562|81637676|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
27946406|NCT03110562|81637677|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
27946407|NCT03110562|81637674|FG000|Initial Treatment Period|Adverse Event|1|||
27946408|NCT03110562|81637675|FG001|Initial Treatment Period|Adverse Event|0|||
27946409|NCT03110562|81637676|FG002|Initial Treatment Period|Adverse Event|0|||
27946410|NCT03110562|81637677|FG003|Initial Treatment Period|Adverse Event|0|||
27946411|NCT03110562|81637674|FG000|Initial Treatment Period|Death|74|||
27946412|NCT03110562|81637675|FG001|Initial Treatment Period|Death|82|||
27946413|NCT03110562|81637676|FG002|Initial Treatment Period|Death|0|||
27946414|NCT03110562|81637677|FG003|Initial Treatment Period|Death|0|||
27946415|NCT03110562|81637674|FG000|Initial Treatment Period|Lost to Follow-up|13|||
27946416|NCT03110562|81637675|FG001|Initial Treatment Period|Lost to Follow-up|8|||
27946417|NCT03110562|81637676|FG002|Initial Treatment Period|Lost to Follow-up|0|||
27946418|NCT03110562|81637677|FG003|Initial Treatment Period|Lost to Follow-up|0|||
27946419|NCT03110562|81637674|FG000|Initial Treatment Period|Protocol Deviation|1|||
27946420|NCT03110562|81637675|FG001|Initial Treatment Period|Protocol Deviation|0|||
27946421|NCT03110562|81637676|FG002|Initial Treatment Period|Protocol Deviation|0|||
27946422|NCT03110562|81637677|FG003|Initial Treatment Period|Protocol Deviation|0|||
27946423|NCT03110562|81637674|FG000|Initial Treatment Period|Physician Decision|2|||
27946424|NCT03110562|81637675|FG001|Initial Treatment Period|Physician Decision|1|||
27946425|NCT03110562|81637676|FG002|Initial Treatment Period|Physician Decision|0|||
27946426|NCT03110562|81637677|FG003|Initial Treatment Period|Physician Decision|0|||
27946427|NCT03110562|81637674|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
27946428|NCT03110562|81637675|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
27946429|NCT03110562|81637676|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
27946430|NCT03110562|81637677|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
27946431|NCT03110562|81637674|FG000|Initial Treatment Period|Other|5|||
27946432|NCT03110562|81637675|FG001|Initial Treatment Period|Other|4|||
27946433|NCT03110562|81637676|FG002|Initial Treatment Period|Other|0|||
27946434|NCT03110562|81637677|FG003|Initial Treatment Period|Other|0|||
27946435|NCT03110562|81637674|FG000|Initial Treatment Period|Randomized but never treated|0|||
27946436|NCT03110562|81637675|FG001|Initial Treatment Period|Randomized but never treated|3|||
27946437|NCT03110562|81637676|FG002|Initial Treatment Period|Randomized but never treated|0|||
27946438|NCT03110562|81637677|FG003|Initial Treatment Period|Randomized but never treated|0|||
27946439|NCT03110562|81637674|FG000|Crossover Period|Disease Progression|0|||
27946440|NCT03110562|81637675|FG001|Crossover Period|Disease Progression|0|||
27946441|NCT03110562|81637676|FG002|Crossover Period|Disease Progression|1|||
27946442|NCT03110562|81637677|FG003|Crossover Period|Disease Progression|0|||
27946443|NCT03110562|81637674|FG000|Crossover Period|Withdrawal by Subject|0|||
27946444|NCT03110562|81637675|FG001|Crossover Period|Withdrawal by Subject|0|||
27946445|NCT03110562|81637676|FG002|Crossover Period|Withdrawal by Subject|8|||
27946446|NCT03110562|81637677|FG003|Crossover Period|Withdrawal by Subject|6|||
27946447|NCT03110562|81637674|FG000|Crossover Period|Death|0|||
27946448|NCT03110562|81637675|FG001|Crossover Period|Death|0|||
27946449|NCT03110562|81637676|FG002|Crossover Period|Death|37|||
27946450|NCT03110562|81637677|FG003|Crossover Period|Death|3|||
27946451|NCT03110562|81637674|FG000|Crossover Period|Lost to Follow-up|0|||
27946452|NCT03110562|81637675|FG001|Crossover Period|Lost to Follow-up|0|||
27946453|NCT03110562|81637676|FG002|Crossover Period|Lost to Follow-up|0|||
27946454|NCT03110562|81637677|FG003|Crossover Period|Lost to Follow-up|1|||
27946455|NCT03110562|81637674|FG000|Crossover Period|Other|0|||
27946456|NCT03110562|81637675|FG001|Crossover Period|Other|0|||
27946457|NCT03110562|81637676|FG002|Crossover Period|Other|1|||
27946458|NCT03110562|81637677|FG003|Crossover Period|Other|1|||
27946459|NCT03110562|81637674|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
27946460|NCT03110562|81637675|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
27946461|NCT03110562|81637676|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
27946462|NCT03110562|81637677|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
27946463|NCT01422382|81637678|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
27946464|NCT03204812|81637686|FG000|Overall Study|Adverse Event|3|||
27946465|NCT00511199|81637690|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
27946466|NCT00511199|81637691|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
27946467|NCT00511199|81637690|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
27946468|NCT00511199|81637691|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
27946469|NCT00511199|81637690|FG000|Overall Study|Withdrawal of Informed Consent|19|||
27946470|NCT00511199|81637691|FG001|Overall Study|Withdrawal of Informed Consent|4|||
27946471|NCT00511199|81637690|FG000|Overall Study|Pregnancy|6|||
27946472|NCT00511199|81637691|FG001|Overall Study|Pregnancy|3|||
27946473|NCT00511199|81637690|FG000|Overall Study|Pregnancy Wish|16|||
27946474|NCT00511199|81637691|FG001|Overall Study|Pregnancy Wish|8|||
27946475|NCT00511199|81637690|FG000|Overall Study|Lost to Follow-up|40|||
27946476|NCT00511199|81637691|FG001|Overall Study|Lost to Follow-up|17|||
27946477|NCT00511199|81637690|FG000|Overall Study|Other Reason|78|||
27946478|NCT00511199|81637691|FG001|Overall Study|Other Reason|37|||
27946479|NCT02135133|81637696|FG000|Overall Study|Adverse Event|10|||
27946480|NCT02135133|81637696|FG000|Overall Study|regulatory mandate|5|||
27946481|NCT03312114|81637704|FG000|Overall Study|All the five enrolled dropped out of the|5|||
27946482|NCT00734032|81637718|FG000|Overall Study|Adverse Event|0|||
27946483|NCT00734032|81637719|FG001|Overall Study|Adverse Event|1|||
27946484|NCT00734032|81637720|FG002|Overall Study|Adverse Event|0|||
27946485|NCT00734032|81637721|FG003|Overall Study|Adverse Event|0|||
27946486|NCT03379870|81637726|FG000|Overall Study|Lost to Follow-up|1|||
27946487|NCT03379870|81637727|FG001|Overall Study|Lost to Follow-up|0|||
27946488|NCT03379870|81637726|FG000|Overall Study|Protocol Violation|1|||
27946489|NCT03379870|81637727|FG001|Overall Study|Protocol Violation|1|||
27946490|NCT05360784|81637728|FG000|Overall Study|Discontinued|25|||
27946491|NCT05360784|81637729|FG001|Overall Study|Discontinued|11|||
27946492|NCT04116489|81637730|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
27946493|NCT04116489|81637730|FG000|Overall Study|Withdrawal by Subject|1|||
27946494|NCT00835354|81637733|FG000|First Intervention|Adverse Event|0|||
27946495|NCT00835354|81637734|FG001|First Intervention|Adverse Event|1|||
27946496|NCT00381641|81637737|FG000|Overall Study|Withdrawal by Subject|0|||
27946497|NCT00381641|81637738|FG001|Overall Study|Withdrawal by Subject|2|||
27946498|NCT00668642|81637742|FG000|First Off-cycle|Cancer progression|1|||
27946499|NCT00668642|81637743|FG001|First Off-cycle|Cancer progression|0|||
27946500|NCT00668642|81637742|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
27946501|NCT00668642|81637743|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
27946502|NCT03559556|81637744|FG000|Overall Study|Withdrawal by Subject|1|||
27946503|NCT00836706|81640457|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
27946504|NCT00836706|81640458|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
27946505|NCT02310321|81640462|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
27946506|NCT02310321|81640463|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
27946507|NCT02310321|81640464|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
27946508|NCT02310321|81640462|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
27946509|NCT02310321|81640463|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
27946510|NCT02310321|81640464|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
27946511|NCT02310321|81640462|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
27946512|NCT02310321|81640463|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
27946513|NCT02310321|81640464|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
27946514|NCT02310321|81640462|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
27946515|NCT02310321|81640463|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
27946516|NCT02310321|81640464|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
27946517|NCT02310321|81640462|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
27946518|NCT02310321|81640463|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
27946519|NCT02310321|81640464|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
27946520|NCT02310321|81640462|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
27946521|NCT02310321|81640463|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
27946522|NCT02310321|81640464|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
27946523|NCT02310321|81640462|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
27946524|NCT02310321|81640463|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
27946525|NCT02310321|81640464|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
27946526|NCT02310321|81640462|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
27946527|NCT02310321|81640463|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
27946528|NCT02310321|81640464|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
27946529|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
27946530|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
27946531|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
27648809|NCT00622700|80553952|FG001|Core Treatment Period|Randomized but Not Treated|2|||
27648810|NCT00622700|80553953|FG002|Core Treatment Period|Randomized but Not Treated|2|||
27648811|NCT00622700|80553954|FG003|Core Treatment Period|Randomized but Not Treated|0|||
27946532|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
27648812|NCT00622700|80553955|FG004|Core Treatment Period|Randomized but Not Treated|0|||
27648813|NCT00622700|80553956|FG005|Core Treatment Period|Randomized but Not Treated|0|||
27946533|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
27946534|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
27946535|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
27946536|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
27946537|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
27946538|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
27946539|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
27946540|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
27946541|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
27946542|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
27946543|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
27946544|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
27946545|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
27946546|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
27946547|NCT02310321|81640462|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
27946548|NCT02310321|81640463|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
27946549|NCT02310321|81640464|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
27946550|NCT02310321|81640462|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
27946551|NCT02310321|81640463|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
27946552|NCT02310321|81640464|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
27946553|NCT02310321|81640462|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
27946554|NCT02310321|81640463|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
27946555|NCT02310321|81640464|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
27946556|NCT02310321|81640462|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
27946557|NCT02310321|81640463|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
27946558|NCT02310321|81640464|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
27946559|NCT02310321|81640462|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
27946560|NCT02310321|81640463|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
27946561|NCT02310321|81640464|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
27946562|NCT02310321|81640462|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
27946563|NCT02310321|81640463|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
27946564|NCT02310321|81640464|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
27946565|NCT02310321|81640462|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
27946566|NCT02310321|81640463|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
27946567|NCT02310321|81640464|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
27946568|NCT02310321|81640462|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
27946569|NCT02310321|81640463|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
27946570|NCT02310321|81640464|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
27946571|NCT01150357|81640465|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
27946572|NCT01150357|81640466|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
27946573|NCT01150357|81640467|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
27946574|NCT01150357|81640465|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
27946575|NCT01150357|81640466|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
27946576|NCT01150357|81640467|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
27946577|NCT01150357|81640465|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
27946578|NCT01150357|81640466|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
27946579|NCT01150357|81640467|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
27946580|NCT01150357|81640465|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
27946581|NCT01150357|81640466|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
27946582|NCT01150357|81640467|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
27946583|NCT01150357|81640465|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
27946584|NCT01150357|81640466|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
27946585|NCT01150357|81640467|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
27946586|NCT01150357|81640465|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
27946587|NCT01150357|81640466|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
27946588|NCT01150357|81640467|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
27946589|NCT01150357|81640465|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
27946590|NCT01150357|81640466|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
27946591|NCT01150357|81640467|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
27946592|NCT02697448|81640470|FG000|Overall Study|Protocol Violation|2|||
27946593|NCT02697448|81640471|FG001|Overall Study|Protocol Violation|4|||
27946594|NCT02697448|81640470|FG000|Overall Study|Clinical concerns during ablation|1|||
27946595|NCT02697448|81640471|FG001|Overall Study|Clinical concerns during ablation|1|||
27946596|NCT02697448|81640470|FG000|Overall Study|No data collected|2|||
27946597|NCT02697448|81640471|FG001|Overall Study|No data collected|0|||
27551425|NCT01543698|80207458|FG000|Phase 2|Disease progression|0|||
27946598|NCT02526290|81640472|FG000|Overall Study|Adverse Event|3|||
27946599|NCT02526290|81640472|FG000|Overall Study|Withdrawal by Subject|4|||
27946600|NCT02526290|81640472|FG000|Overall Study|Physician Decision|1|||
27946601|NCT00363298|81640473|FG000|First Study Week|Lack of Efficacy|6|||
27946602|NCT00363298|81640474|FG001|First Study Week|Lack of Efficacy|5|||
27946603|NCT00363298|81640473|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
27946604|NCT00363298|81640474|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
27946605|NCT01088906|81640476|FG000|Overall Study|Inclusion error|1|||
27946606|NCT01088906|81640476|FG000|Overall Study|Did not receive study treatment|3|||
27946607|NCT01088906|81640476|FG000|Overall Study|Missing data|1|||
27648814|NCT00622700|80553957|FG006|Core Treatment Period|Randomized but Not Treated|0|||
27648815|NCT00622700|80553951|FG000|Core Treatment Period|Adverse Event|18|||
27648816|NCT00622700|80553952|FG001|Core Treatment Period|Adverse Event|25|||
27648817|NCT00622700|80553953|FG002|Core Treatment Period|Adverse Event|18|||
27946608|NCT03232567|81640479|FG000|Overall Study|Withdrawal by Subject|0|||
27946609|NCT03232567|81640480|FG001|Overall Study|Withdrawal by Subject|1|||
27946610|NCT03232567|81640481|FG002|Overall Study|Withdrawal by Subject|0|||
27946611|NCT03232567|81640482|FG003|Overall Study|Withdrawal by Subject|0|||
27946612|NCT01554904|81640484|FG000|Overall Study|Withdrawal by Subject|3|||
27946613|NCT01554904|81640484|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
27946614|NCT03552029|81640485|FG000|Overall Study|Death|3|||
27946615|NCT03552029|81640486|FG001|Overall Study|Death|0|||
27946616|NCT03552029|81640485|FG000|Overall Study|Adverse Event|1|||
27946617|NCT03552029|81640486|FG001|Overall Study|Adverse Event|0|||
27946618|NCT03552029|81640485|FG000|Overall Study|Lack of Efficacy|0|||
27946619|NCT03552029|81640486|FG001|Overall Study|Lack of Efficacy|2|||
27946620|NCT03552029|81640485|FG000|Overall Study|Physician Decision|0|||
27946621|NCT03552029|81640486|FG001|Overall Study|Physician Decision|1|||
27946622|NCT03552029|81640485|FG000|Overall Study|Study terminated by Sponsor|0|||
27946623|NCT03552029|81640486|FG001|Overall Study|Study terminated by Sponsor|1|||
27946624|NCT03552029|81640485|FG000|Overall Study|Other|0|||
27946625|NCT03552029|81640486|FG001|Overall Study|Other|2|||
27946626|NCT03636022|81640487|FG000|Overall Study|Withdrawal by Subject|1|||
27946627|NCT03636022|81640488|FG001|Overall Study|Withdrawal by Subject|3|||
27946628|NCT01174563|81640489|FG000|Overall Study|Progressive Disease|45|||
27946629|NCT01174563|81640489|FG000|Overall Study|Death|5|||
27946630|NCT01174563|81640489|FG000|Overall Study|Investigator's Discretion|5|||
27946631|NCT01174563|81640489|FG000|Overall Study|Participant Withdrew Consent|3|||
27946632|NCT01174563|81640489|FG000|Overall Study|Rash Adverse Event|1|||
27946633|NCT01174563|81640489|FG000|Overall Study|Sponsor's decision|1|||
27946634|NCT04581395|81640492|FG000|Overall Study|Protocol Violation|4|||
27946635|NCT04581395|81640493|FG001|Overall Study|Protocol Violation|3|||
27946636|NCT04581395|81640494|FG002|Overall Study|Protocol Violation|2|||
27946637|NCT04581395|81640492|FG000|Overall Study|Physician Decision|0|||
27946638|NCT04581395|81640493|FG001|Overall Study|Physician Decision|1|||
27946639|NCT04581395|81640494|FG002|Overall Study|Physician Decision|0|||
27946640|NCT03802396|81640495|FG000|Overall Study|Withdrawal by Subject|2|||
27946641|NCT03802396|81640496|FG001|Overall Study|Withdrawal by Subject|0|||
27946642|NCT03802396|81640495|FG000|Overall Study|Surgery Cancelled|1|||
27946643|NCT03802396|81640496|FG001|Overall Study|Surgery Cancelled|0|||
27946644|NCT00939185|81640497|FG000|Overall Study|Adverse Event|3|||
27946645|NCT00939185|81640497|FG000|Overall Study|Lack of Efficacy|1|||
27946646|NCT00939185|81640497|FG000|Overall Study|Lost to Follow-up|6|||
27946647|NCT00939185|81640497|FG000|Overall Study|Other|3|||
27946648|NCT00939185|81640497|FG000|Overall Study|Withdrawal by Subject|2|||
27946649|NCT00939185|81640497|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
27946650|NCT03132467|81640498|FG000|Overall Study|Adverse Event|2|||
27946651|NCT03132467|81640498|FG000|Overall Study|Withdrawal by Subject|2|||
27946652|NCT02022202|81640503|FG000|Overall Study|Withdrawal by Subject|2|||
27946653|NCT02022202|81640503|FG000|Overall Study|Disease Progression|3|||
27946654|NCT02022202|81640503|FG000|Overall Study|Desire go to immediately to surgery|3|||
27946655|NCT01585025|81640506|FG000|Overall Study|Withdrawal by Subject|0|||
27946656|NCT01585025|81640507|FG001|Overall Study|Withdrawal by Subject|3|||
27946657|NCT01585025|81640508|FG002|Overall Study|Withdrawal by Subject|4|||
27946658|NCT00480532|81640509|FG000|Overall Study|Withdrawal by Subject|2|||
27946659|NCT00480532|81640510|FG001|Overall Study|Withdrawal by Subject|4|||
27946660|NCT00480532|81640511|FG002|Overall Study|Withdrawal by Subject|3|||
27946661|NCT00480532|81640512|FG003|Overall Study|Withdrawal by Subject|1|||
27946662|NCT00480532|81640509|FG000|Overall Study|Protocol Violation|0|||
27946663|NCT00480532|81640510|FG001|Overall Study|Protocol Violation|0|||
27946664|NCT00480532|81640511|FG002|Overall Study|Protocol Violation|1|||
27946665|NCT00480532|81640512|FG003|Overall Study|Protocol Violation|0|||
27946666|NCT00759395|81640518|FG000|Overall Study|Adverse Event|1|||
27946667|NCT00759395|81640519|FG001|Overall Study|Adverse Event|0|||
27946668|NCT00759395|81640518|FG000|Overall Study|Withdrawal by Subject|1|||
27946669|NCT00759395|81640519|FG001|Overall Study|Withdrawal by Subject|0|||
27946670|NCT00759395|81640518|FG000|Overall Study|Lack of Efficacy|0|||
27648818|NCT00622700|80553954|FG003|Core Treatment Period|Adverse Event|0|||
27946671|NCT00759395|81640519|FG001|Overall Study|Lack of Efficacy|2|||
27946672|NCT00105066|81640520|FG000|Overall Study|Adverse Event|2|||
27946673|NCT00105066|81640521|FG001|Overall Study|Adverse Event|5|||
27946674|NCT05014919|81640524|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
27946675|NCT05014919|81640525|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
27648819|NCT00622700|80553955|FG004|Core Treatment Period|Adverse Event|0|||
27648820|NCT00622700|80553956|FG005|Core Treatment Period|Adverse Event|0|||
27648821|NCT00622700|80553957|FG006|Core Treatment Period|Adverse Event|0|||
27648822|NCT00622700|80553951|FG000|Core Treatment Period|Lack of Efficacy|19|||
27946676|NCT05014919|81640526|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
27946677|NCT05014919|81640524|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
27946678|NCT05014919|81640525|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
27946679|NCT05014919|81640526|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
27946680|NCT05014919|81640524|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
27946681|NCT05014919|81640525|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
27946682|NCT05014919|81640526|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
27946683|NCT05014919|81640524|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
27946684|NCT05014919|81640525|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
27946685|NCT05014919|81640526|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
27946686|NCT05014919|81640524|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
27946687|NCT05014919|81640525|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
27946688|NCT05014919|81640526|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
27946689|NCT05014919|81640524|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
27946690|NCT05014919|81640525|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
27946691|NCT05014919|81640526|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
27946692|NCT05014919|81640524|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
27946693|NCT05014919|81640525|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
27946694|NCT05014919|81640526|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
27946695|NCT05014919|81640524|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
27946696|NCT05014919|81640525|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
27946697|NCT05014919|81640526|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
27946698|NCT01437189|81640528|FG000|Overall Study|Adverse Event|3|||
27946699|NCT01437189|81640528|FG000|Overall Study|Lack of Efficacy|4|||
27946700|NCT01437189|81640528|FG000|Overall Study|Withdrawal by Subject|8|||
27946701|NCT00867035|81640529|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
27946702|NCT00867035|81640530|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
27946703|NCT00867035|81640529|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
27946704|NCT00867035|81640530|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
27946705|NCT03553836|81640531|FG000|Overall Study|Ongoing in Study|460|||
27946706|NCT03553836|81640532|FG001|Overall Study|Ongoing in Study|459|||
27946707|NCT03553836|81640531|FG000|Overall Study|Withdrawal by Subject|9|||
27946708|NCT03553836|81640532|FG001|Overall Study|Withdrawal by Subject|10|||
27946709|NCT03553836|81640531|FG000|Overall Study|Lost to Follow-up|1|||
27946710|NCT03553836|81640532|FG001|Overall Study|Lost to Follow-up|3|||
27946711|NCT03553836|81640531|FG000|Overall Study|Death|17|||
27946712|NCT03553836|81640532|FG001|Overall Study|Death|17|||
27946713|NCT01052779|81640536|FG000|Overall Study|Adverse Event|1|||
27946714|NCT01052779|81640537|FG001|Overall Study|Adverse Event|4|||
27946715|NCT01052779|81640536|FG000|Overall Study|Withdrawal by Subject|1|||
27946716|NCT01052779|81640537|FG001|Overall Study|Withdrawal by Subject|2|||
27648823|NCT00622700|80553952|FG001|Core Treatment Period|Lack of Efficacy|6|||
27648824|NCT00622700|80553953|FG002|Core Treatment Period|Lack of Efficacy|12|||
27648825|NCT00622700|80553954|FG003|Core Treatment Period|Lack of Efficacy|0|||
27648826|NCT00622700|80553955|FG004|Core Treatment Period|Lack of Efficacy|0|||
27648827|NCT00622700|80553956|FG005|Core Treatment Period|Lack of Efficacy|0|||
27648828|NCT00622700|80553957|FG006|Core Treatment Period|Lack of Efficacy|0|||
27648829|NCT00622700|80553951|FG000|Core Treatment Period|Lost to Follow-up|1|||
27648830|NCT00622700|80553952|FG001|Core Treatment Period|Lost to Follow-up|1|||
27648831|NCT00622700|80553953|FG002|Core Treatment Period|Lost to Follow-up|1|||
27648832|NCT00622700|80553954|FG003|Core Treatment Period|Lost to Follow-up|0|||
27648833|NCT00622700|80553955|FG004|Core Treatment Period|Lost to Follow-up|0|||
27648834|NCT00622700|80553956|FG005|Core Treatment Period|Lost to Follow-up|0|||
27946717|NCT01052779|81640536|FG000|Overall Study|Other-Protocol Violation|1|||
27946718|NCT01052779|81640537|FG001|Overall Study|Other-Protocol Violation|1|||
27946719|NCT01052779|81640536|FG000|Overall Study|Other-Surgery|0|||
27946720|NCT01052779|81640537|FG001|Overall Study|Other-Surgery|2|||
27946721|NCT01052779|81640536|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
27946722|NCT01052779|81640537|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
27946723|NCT02314923|81640538|FG000|Overall Study|Death|0|||
27946724|NCT02314923|81640539|FG001|Overall Study|Death|0|||
27648835|NCT00622700|80553957|FG006|Core Treatment Period|Lost to Follow-up|0|||
27648836|NCT00622700|80553951|FG000|Core Treatment Period|Death|1|||
27946725|NCT02314923|81640540|FG002|Overall Study|Death|0|||
27946726|NCT02314923|81640541|FG003|Overall Study|Death|1|||
27946727|NCT02314923|81640542|FG004|Overall Study|Death|0|||
27946728|NCT02314923|81640543|FG005|Overall Study|Death|0|||
27946729|NCT02314923|81640544|FG006|Overall Study|Death|0|||
27946730|NCT02314923|81640545|FG007|Overall Study|Death|0|||
27946731|NCT02314923|81640546|FG008|Overall Study|Death|0|||
27946732|NCT02314923|81640547|FG009|Overall Study|Death|0|||
27946733|NCT02314923|81640538|FG000|Overall Study|Lost to Follow-up|2|||
27946734|NCT02314923|81640539|FG001|Overall Study|Lost to Follow-up|3|||
27946735|NCT02314923|81640540|FG002|Overall Study|Lost to Follow-up|1|||
27946736|NCT02314923|81640541|FG003|Overall Study|Lost to Follow-up|0|||
27648837|NCT00622700|80553952|FG001|Core Treatment Period|Death|0|||
27648838|NCT00622700|80553953|FG002|Core Treatment Period|Death|0|||
27648839|NCT00622700|80553954|FG003|Core Treatment Period|Death|0|||
27648840|NCT00622700|80553955|FG004|Core Treatment Period|Death|0|||
27946737|NCT02314923|81640542|FG004|Overall Study|Lost to Follow-up|0|||
27946738|NCT02314923|81640543|FG005|Overall Study|Lost to Follow-up|0|||
27946739|NCT02314923|81640544|FG006|Overall Study|Lost to Follow-up|3|||
27946740|NCT02314923|81640545|FG007|Overall Study|Lost to Follow-up|4|||
27946741|NCT02314923|81640546|FG008|Overall Study|Lost to Follow-up|2|||
27946742|NCT02314923|81640547|FG009|Overall Study|Lost to Follow-up|0|||
27946743|NCT02314923|81640538|FG000|Overall Study|Withdrawal by Subject|0|||
27946744|NCT02314923|81640539|FG001|Overall Study|Withdrawal by Subject|0|||
27946745|NCT02314923|81640540|FG002|Overall Study|Withdrawal by Subject|1|||
27946746|NCT02314923|81640541|FG003|Overall Study|Withdrawal by Subject|0|||
27946747|NCT02314923|81640542|FG004|Overall Study|Withdrawal by Subject|1|||
27946748|NCT02314923|81640543|FG005|Overall Study|Withdrawal by Subject|0|||
27946749|NCT02314923|81640544|FG006|Overall Study|Withdrawal by Subject|1|||
27946750|NCT02314923|81640545|FG007|Overall Study|Withdrawal by Subject|0|||
27946751|NCT02314923|81640546|FG008|Overall Study|Withdrawal by Subject|0|||
27946752|NCT02314923|81640547|FG009|Overall Study|Withdrawal by Subject|0|||
27946753|NCT02314923|81640538|FG000|Overall Study|Physician Decision|0|||
27946754|NCT02314923|81640539|FG001|Overall Study|Physician Decision|1|||
27946755|NCT02314923|81640540|FG002|Overall Study|Physician Decision|0|||
27946756|NCT02314923|81640541|FG003|Overall Study|Physician Decision|0|||
27946757|NCT02314923|81640542|FG004|Overall Study|Physician Decision|0|||
27946758|NCT02314923|81640543|FG005|Overall Study|Physician Decision|0|||
27946759|NCT02314923|81640544|FG006|Overall Study|Physician Decision|0|||
27946760|NCT02314923|81640545|FG007|Overall Study|Physician Decision|0|||
27946761|NCT02314923|81640546|FG008|Overall Study|Physician Decision|0|||
27946762|NCT02314923|81640547|FG009|Overall Study|Physician Decision|0|||
27946763|NCT02314923|81640538|FG000|Overall Study|Participant unavailable|0|||
27946764|NCT02314923|81640539|FG001|Overall Study|Participant unavailable|0|||
27946765|NCT02314923|81640540|FG002|Overall Study|Participant unavailable|0|||
27946766|NCT02314923|81640541|FG003|Overall Study|Participant unavailable|0|||
27946767|NCT02314923|81640542|FG004|Overall Study|Participant unavailable|0|||
27946768|NCT02314923|81640543|FG005|Overall Study|Participant unavailable|1|||
27946769|NCT02314923|81640544|FG006|Overall Study|Participant unavailable|0|||
27946770|NCT02314923|81640545|FG007|Overall Study|Participant unavailable|0|||
27946771|NCT02314923|81640546|FG008|Overall Study|Participant unavailable|0|||
27946772|NCT02314923|81640547|FG009|Overall Study|Participant unavailable|0|||
27946773|NCT02314923|81640538|FG000|Overall Study|Screen failure|0|||
27946774|NCT02314923|81640539|FG001|Overall Study|Screen failure|0|||
27946775|NCT02314923|81640540|FG002|Overall Study|Screen failure|0|||
27946776|NCT02314923|81640541|FG003|Overall Study|Screen failure|0|||
27946777|NCT02314923|81640542|FG004|Overall Study|Screen failure|0|||
27946778|NCT02314923|81640543|FG005|Overall Study|Screen failure|0|||
27946779|NCT02314923|81640544|FG006|Overall Study|Screen failure|1|||
27648841|NCT00622700|80553956|FG005|Core Treatment Period|Death|0|||
27648842|NCT00622700|80553957|FG006|Core Treatment Period|Death|0|||
27648843|NCT00622700|80553951|FG000|Core Treatment Period|Progressive Disease|3|||
27946780|NCT02314923|81640545|FG007|Overall Study|Screen failure|0|||
27946781|NCT02314923|81640546|FG008|Overall Study|Screen failure|0|||
27946782|NCT02314923|81640547|FG009|Overall Study|Screen failure|0|||
27946783|NCT02314923|81640538|FG000|Overall Study|Participant relocation|1|||
27946784|NCT02314923|81640539|FG001|Overall Study|Participant relocation|0|||
27946785|NCT02314923|81640540|FG002|Overall Study|Participant relocation|0|||
27946786|NCT02314923|81640541|FG003|Overall Study|Participant relocation|0|||
27946787|NCT02314923|81640542|FG004|Overall Study|Participant relocation|0|||
27946788|NCT02314923|81640543|FG005|Overall Study|Participant relocation|0|||
27946789|NCT02314923|81640544|FG006|Overall Study|Participant relocation|0|||
27946790|NCT02314923|81640545|FG007|Overall Study|Participant relocation|1|||
27946791|NCT02314923|81640546|FG008|Overall Study|Participant relocation|0|||
27946792|NCT02314923|81640547|FG009|Overall Study|Participant relocation|0|||
27946793|NCT04890509|81640548|FG000|Overall Study|Death|4|||
27946794|NCT04890509|81640549|FG001|Overall Study|Death|4|||
27648844|NCT00622700|80553952|FG001|Core Treatment Period|Progressive Disease|1|||
27648845|NCT00622700|80553953|FG002|Core Treatment Period|Progressive Disease|0|||
27946795|NCT00835172|81640555|FG000|Washout|Protocol Violation|0|||
27946796|NCT00835172|81640556|FG001|Washout|Protocol Violation|1|||
27946797|NCT01979185|81640557|FG000|Period 2|Other|0|||
27946798|NCT01979185|81640558|FG001|Period 2|Other|1|||
27946799|NCT02943473|81640559|FG000|Overall Study|enrolled but not dosed|1|||
27946800|NCT02943473|81640559|FG000|Overall Study|screen failure|1|||
27946801|NCT02943473|81640559|FG000|Overall Study|Physician Decision|4|||
27946802|NCT02706392|81640560|FG000|Overall Study|Death|1|||
27946803|NCT02706392|81640561|FG001|Overall Study|Death|0|||
27946804|NCT02706392|81640562|FG002|Overall Study|Death|2|||
27648846|NCT00622700|80553954|FG003|Core Treatment Period|Progressive Disease|0|||
27648847|NCT00622700|80553955|FG004|Core Treatment Period|Progressive Disease|0|||
27648848|NCT00622700|80553956|FG005|Core Treatment Period|Progressive Disease|0|||
27648849|NCT00622700|80553957|FG006|Core Treatment Period|Progressive Disease|0|||
27648850|NCT00622700|80553951|FG000|Core Treatment Period|Withdrawal by Subject|12|||
27946805|NCT02706392|81640563|FG003|Overall Study|Death|2|||
27946806|NCT02706392|81640564|FG004|Overall Study|Death|5|||
27946807|NCT02706392|81640565|FG005|Overall Study|Death|2|||
27946808|NCT04100018|81640566|FG000|Pre-Treatment Period|Not Reported|0|||
27946809|NCT04100018|81640567|FG001|Pre-Treatment Period|Not Reported|4|||
27946810|NCT04100018|81640566|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
27946811|NCT04100018|81640567|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
27946812|NCT04100018|81640566|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
27946813|NCT04100018|81640567|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
27946814|NCT04100018|81640566|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
27946815|NCT04100018|81640567|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
27946816|NCT04100018|81640566|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
27946817|NCT04100018|81640567|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
27946818|NCT04100018|81640566|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
27946819|NCT04100018|81640567|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
27946820|NCT04100018|81640566|FG000|Treatment Period|Other Reason|18|||
27946821|NCT04100018|81640567|FG001|Treatment Period|Other Reason|29|||
27946822|NCT04100018|81640566|FG000|Treatment Period|Completed treatment as per protocol|0|||
27946823|NCT04100018|81640567|FG001|Treatment Period|Completed treatment as per protocol|1|||
27946824|NCT04100018|81640566|FG000|Treatment Period|Maximum clinical benefit|3|||
27946825|NCT04100018|81640567|FG001|Treatment Period|Maximum clinical benefit|0|||
27946826|NCT04100018|81640566|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
27946827|NCT04100018|81640567|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
27946828|NCT04100018|81640566|FG000|Treatment Period|Study drug toxicity|67|||
27946829|NCT04100018|81640567|FG001|Treatment Period|Study drug toxicity|28|||
27946830|NCT04100018|81640566|FG000|Treatment Period|Disease Progression|269|||
27946831|NCT04100018|81640567|FG001|Treatment Period|Disease Progression|318|||
27946832|NCT04100018|81640566|FG000|Treatment Period|Administrative reasons by sponsor|1|||
27946833|NCT04100018|81640567|FG001|Treatment Period|Administrative reasons by sponsor|1|||
27946834|NCT04100018|81640566|FG000|Treatment Period|Poor/Non-Compliance|1|||
27946835|NCT04100018|81640567|FG001|Treatment Period|Poor/Non-Compliance|0|||
27946836|NCT04100018|81640566|FG000|Treatment Period|Lost to Follow-up|2|||
27946837|NCT04100018|81640567|FG001|Treatment Period|Lost to Follow-up|2|||
27946838|NCT04100018|81640566|FG000|Treatment Period|Death|14|||
27946839|NCT04100018|81640567|FG001|Treatment Period|Death|11|||
27946840|NCT04100018|81640566|FG000|Treatment Period|Participant withdrew consent|8|||
27946841|NCT04100018|81640567|FG001|Treatment Period|Participant withdrew consent|10|||
27946842|NCT04100018|81640566|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
27946843|NCT04100018|81640567|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
27946844|NCT04100018|81640566|FG000|Treatment Period|Adverse Event|12|||
27946845|NCT04100018|81640567|FG001|Treatment Period|Adverse Event|6|||
27946846|NCT04100018|81640566|FG000|Treatment Period|Lack of Efficacy|4|||
27946847|NCT04100018|81640567|FG001|Treatment Period|Lack of Efficacy|2|||
27946848|NCT02853136|81640580|FG000|Wash-out|Adverse Event|0|||
27946849|NCT02853136|81640581|FG001|Wash-out|Adverse Event|0|||
27946850|NCT02853136|81640582|FG002|Wash-out|Adverse Event|0|||
27946851|NCT02853136|81640583|FG003|Wash-out|Adverse Event|1|||
27946852|NCT02439957|81640584|FG000|Overall Study|Study Terminated|3|||
27946853|NCT02439957|81640585|FG001|Overall Study|Study Terminated|3|||
27946854|NCT04442269|81640588|FG000|Overall Study|Adverse Event|1|||
27946855|NCT04442269|81640589|FG001|Overall Study|Adverse Event|0|||
27946856|NCT04442269|81640588|FG000|Overall Study|Death|0|||
27648851|NCT00622700|80553952|FG001|Core Treatment Period|Withdrawal by Subject|18|||
27648852|NCT00622700|80553953|FG002|Core Treatment Period|Withdrawal by Subject|15|||
27648853|NCT00622700|80553954|FG003|Core Treatment Period|Withdrawal by Subject|0|||
27946857|NCT04442269|81640589|FG001|Overall Study|Death|1|||
27946858|NCT04442269|81640588|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
27946859|NCT04442269|81640589|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
27946860|NCT04442269|81640588|FG000|Overall Study|Lost to Follow-up|1|||
27946861|NCT04442269|81640589|FG001|Overall Study|Lost to Follow-up|0|||
27946862|NCT04442269|81640588|FG000|Overall Study|Withdrawal by Subject|3|||
27648854|NCT00622700|80553955|FG004|Core Treatment Period|Withdrawal by Subject|0|||
27946863|NCT04442269|81640589|FG001|Overall Study|Withdrawal by Subject|2|||
27946864|NCT04442269|81640588|FG000|Overall Study|Protocol Deviation|0|||
27946865|NCT04442269|81640589|FG001|Overall Study|Protocol Deviation|1|||
27946866|NCT04442269|81640588|FG000|Overall Study|Travel Limitations|1|||
27946867|NCT04442269|81640589|FG001|Overall Study|Travel Limitations|1|||
27946868|NCT03332056|81640598|FG000|Overall Study|Incomplete questionnaires|8|||
27946869|NCT03332056|81640599|FG001|Overall Study|Incomplete questionnaires|9|||
27946870|NCT03332056|81640598|FG000|Overall Study|Passed stone prior to surgery date|1|||
27946871|NCT03332056|81640599|FG001|Overall Study|Passed stone prior to surgery date|0|||
27946872|NCT03332056|81640598|FG000|Overall Study|Did not require a ureteral stent|0|||
27946873|NCT03332056|81640599|FG001|Overall Study|Did not require a ureteral stent|1|||
27946874|NCT00835367|81640600|FG000|Washout|Adverse Event|2|||
27946875|NCT00835367|81640601|FG001|Washout|Adverse Event|0|||
27946876|NCT00835367|81640600|FG000|Washout|Withdrawal by Subject|1|||
27946877|NCT00835367|81640601|FG001|Washout|Withdrawal by Subject|0|||
27946878|NCT00835367|81640600|FG000|Second Intervention|Adverse Event|1|||
27946879|NCT00835367|81640601|FG001|Second Intervention|Adverse Event|1|||
27946880|NCT00443456|81640605|FG000|Overall Study|Adverse Event|16|||
27946881|NCT00443456|81640605|FG000|Overall Study|Move|1|||
27946882|NCT00443456|81640605|FG000|Overall Study|Withdrawal by Subject|1|||
27946883|NCT02495883|81640606|FG000|Overall Study|Excessive head motion|1|||
27946884|NCT02495883|81640607|FG001|Overall Study|Excessive head motion|0|||
27946885|NCT03257657|81640608|FG000|Overall Study|Lost to Follow-up|0|||
27946886|NCT03257657|81640609|FG001|Overall Study|Lost to Follow-up|3|||
27946887|NCT03257657|81640608|FG000|Overall Study|Withdrawn|0|||
27946888|NCT03257657|81640609|FG001|Overall Study|Withdrawn|1|||
27946889|NCT03257657|81640608|FG000|Overall Study|Noted not eligible right after enrolled|0|||
27946890|NCT03257657|81640609|FG001|Overall Study|Noted not eligible right after enrolled|1|||
27648855|NCT00622700|80553956|FG005|Core Treatment Period|Withdrawal by Subject|0|||
27648856|NCT00622700|80553957|FG006|Core Treatment Period|Withdrawal by Subject|0|||
27648857|NCT00622700|80553951|FG000|Core Treatment Period|Other than specified above|2|||
27648858|NCT00622700|80553952|FG001|Core Treatment Period|Other than specified above|2|||
27648859|NCT00622700|80553953|FG002|Core Treatment Period|Other than specified above|5|||
27648860|NCT00622700|80553954|FG003|Core Treatment Period|Other than specified above|0|||
27648861|NCT00622700|80553955|FG004|Core Treatment Period|Other than specified above|0|||
27648862|NCT00622700|80553956|FG005|Core Treatment Period|Other than specified above|0|||
27648863|NCT00622700|80553957|FG006|Core Treatment Period|Other than specified above|0|||
27648864|NCT00622700|80553951|FG000|Extension Treatment Period|Adverse Event|0|||
27648865|NCT00622700|80553952|FG001|Extension Treatment Period|Adverse Event|0|||
27648866|NCT00622700|80553953|FG002|Extension Treatment Period|Adverse Event|0|||
27648867|NCT00622700|80553954|FG003|Extension Treatment Period|Adverse Event|5|||
27648868|NCT00622700|80553955|FG004|Extension Treatment Period|Adverse Event|9|||
27648869|NCT00622700|80553956|FG005|Extension Treatment Period|Adverse Event|6|||
27648870|NCT00622700|80553957|FG006|Extension Treatment Period|Adverse Event|8|||
27648871|NCT00622700|80553951|FG000|Extension Treatment Period|Lack of Efficacy|0|||
27648872|NCT00622700|80553952|FG001|Extension Treatment Period|Lack of Efficacy|0|||
27648873|NCT00622700|80553953|FG002|Extension Treatment Period|Lack of Efficacy|0|||
27648874|NCT00622700|80553954|FG003|Extension Treatment Period|Lack of Efficacy|2|||
27648875|NCT00622700|80553955|FG004|Extension Treatment Period|Lack of Efficacy|8|||
27648876|NCT00622700|80553956|FG005|Extension Treatment Period|Lack of Efficacy|1|||
27648877|NCT00622700|80553957|FG006|Extension Treatment Period|Lack of Efficacy|9|||
27648878|NCT00622700|80553951|FG000|Extension Treatment Period|Protocol Violation|0|||
27648879|NCT00622700|80553952|FG001|Extension Treatment Period|Protocol Violation|0|||
27648880|NCT00622700|80553953|FG002|Extension Treatment Period|Protocol Violation|0|||
27648881|NCT00622700|80553954|FG003|Extension Treatment Period|Protocol Violation|0|||
27648882|NCT00622700|80553955|FG004|Extension Treatment Period|Protocol Violation|0|||
27648883|NCT00622700|80553956|FG005|Extension Treatment Period|Protocol Violation|2|||
27648884|NCT00622700|80553957|FG006|Extension Treatment Period|Protocol Violation|0|||
27648885|NCT00622700|80553951|FG000|Extension Treatment Period|Lost to Follow-up|0|||
27648886|NCT00622700|80553952|FG001|Extension Treatment Period|Lost to Follow-up|0|||
27648887|NCT00622700|80553953|FG002|Extension Treatment Period|Lost to Follow-up|0|||
27648888|NCT00622700|80553954|FG003|Extension Treatment Period|Lost to Follow-up|0|||
27648889|NCT00622700|80553955|FG004|Extension Treatment Period|Lost to Follow-up|1|||
27648890|NCT00622700|80553956|FG005|Extension Treatment Period|Lost to Follow-up|0|||
27946891|NCT03639935|81640611|FG000|Overall Study|Death|3|||
27946892|NCT03639935|81640611|FG000|Overall Study|Adverse Event|1|||
27946893|NCT02374255|81640612|FG000|Overall Study|Withdrawal by Subject|2|||
27946894|NCT02374255|81640613|FG001|Overall Study|Withdrawal by Subject|0|||
27946895|NCT02374255|81640614|FG002|Overall Study|Withdrawal by Subject|0|||
27648891|NCT00622700|80553957|FG006|Extension Treatment Period|Lost to Follow-up|0|||
27648892|NCT00622700|80553951|FG000|Extension Treatment Period|Progressive Disease|0|||
27648893|NCT00622700|80553952|FG001|Extension Treatment Period|Progressive Disease|0|||
27648894|NCT00622700|80553953|FG002|Extension Treatment Period|Progressive Disease|0|||
27746419|NCT02052960|80899627|FG001|Overall Study|Adverse Event|17|||
27648895|NCT00622700|80553954|FG003|Extension Treatment Period|Progressive Disease|1|||
27648896|NCT00622700|80553955|FG004|Extension Treatment Period|Progressive Disease|2|||
27648897|NCT00622700|80553956|FG005|Extension Treatment Period|Progressive Disease|0|||
27648898|NCT00622700|80553957|FG006|Extension Treatment Period|Progressive Disease|2|||
27648899|NCT00622700|80553951|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
27648900|NCT00622700|80553952|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
27648901|NCT00622700|80553953|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
27648902|NCT00622700|80553954|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
27648903|NCT00622700|80553955|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
27648904|NCT00622700|80553956|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
27946896|NCT02374255|81640615|FG003|Overall Study|Withdrawal by Subject|0|||
27946897|NCT00770679|81640616|FG000|Overall Study|Lost to Follow-up|3|||
27946898|NCT00770679|81640616|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
27946899|NCT03242434|81640619|FG000|Overall Study|Death|0|||
27946900|NCT03242434|81640620|FG001|Overall Study|Death|2|||
27946901|NCT01948427|81640621|FG000|Overall Study|Serious Adverse Event|3|||
27946902|NCT01948427|81640622|FG001|Overall Study|Serious Adverse Event|0|||
27946903|NCT01948427|81640623|FG002|Overall Study|Serious Adverse Event|0|||
27946904|NCT01948427|81640624|FG003|Overall Study|Serious Adverse Event|0|||
27946905|NCT01948427|81640625|FG004|Overall Study|Serious Adverse Event|1|||
27946906|NCT01948427|81640621|FG000|Overall Study|Investigator Request|0|||
27946907|NCT01948427|81640622|FG001|Overall Study|Investigator Request|8|||
27946908|NCT01948427|81640623|FG002|Overall Study|Investigator Request|0|||
27946909|NCT01948427|81640624|FG003|Overall Study|Investigator Request|0|||
27946910|NCT01948427|81640625|FG004|Overall Study|Investigator Request|6|||
27946911|NCT01948427|81640621|FG000|Overall Study|Lost to Follow-up|1|||
27946912|NCT01948427|81640622|FG001|Overall Study|Lost to Follow-up|0|||
27946913|NCT01948427|81640623|FG002|Overall Study|Lost to Follow-up|0|||
27946914|NCT01948427|81640624|FG003|Overall Study|Lost to Follow-up|0|||
27946915|NCT01948427|81640625|FG004|Overall Study|Lost to Follow-up|4|||
27946916|NCT01948427|81640621|FG000|Overall Study|Withdrawal by Subject|2|||
27946917|NCT01948427|81640622|FG001|Overall Study|Withdrawal by Subject|0|||
27946918|NCT01948427|81640623|FG002|Overall Study|Withdrawal by Subject|0|||
27946919|NCT01948427|81640624|FG003|Overall Study|Withdrawal by Subject|0|||
27946920|NCT01948427|81640625|FG004|Overall Study|Withdrawal by Subject|1|||
27946921|NCT01948427|81640621|FG000|Overall Study|Other, Not Specified|1|||
27648905|NCT00622700|80553957|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
27648906|NCT00622700|80553951|FG000|Extension Treatment Period|Missing|0|||
27648907|NCT00622700|80553952|FG001|Extension Treatment Period|Missing|0|||
27648908|NCT00622700|80553953|FG002|Extension Treatment Period|Missing|0|||
27648909|NCT00622700|80553954|FG003|Extension Treatment Period|Missing|2|||
27946922|NCT01948427|81640622|FG001|Overall Study|Other, Not Specified|9|||
27946923|NCT01948427|81640623|FG002|Overall Study|Other, Not Specified|0|||
27946924|NCT01948427|81640624|FG003|Overall Study|Other, Not Specified|0|||
27946925|NCT01948427|81640625|FG004|Overall Study|Other, Not Specified|2|||
27946926|NCT02448381|81640626|FG000|Overall Study|Adverse Event|2|||
27946927|NCT02448381|81640627|FG001|Overall Study|Adverse Event|0|||
27946928|NCT02448381|81640626|FG000|Overall Study|Lost to Follow-up|16|||
27946929|NCT02448381|81640627|FG001|Overall Study|Lost to Follow-up|9|||
27946930|NCT02448381|81640626|FG000|Overall Study|Physician Decision|1|||
27946931|NCT02448381|81640627|FG001|Overall Study|Physician Decision|1|||
27946932|NCT02448381|81640626|FG000|Overall Study|Pregnancy|1|||
27946933|NCT02448381|81640627|FG001|Overall Study|Pregnancy|0|||
27946934|NCT02448381|81640626|FG000|Overall Study|Withdrawal by Subject|13|||
27946935|NCT02448381|81640627|FG001|Overall Study|Withdrawal by Subject|9|||
27946936|NCT02448381|81640626|FG000|Overall Study|Noncompliance with Study Procedures|2|||
27946937|NCT02448381|81640627|FG001|Overall Study|Noncompliance with Study Procedures|0|||
27946938|NCT03078868|81640629|FG000|Overall Study|Physician Decision|3|||
27946939|NCT02038036|81640636|FG000|Core Study|Adverse Event|7|||
27946940|NCT02038036|81640637|FG001|Core Study|Adverse Event|7|||
27946941|NCT02038036|81640636|FG000|Core Study|Death|1|||
27946942|NCT02038036|81640637|FG001|Core Study|Death|1|||
27946943|NCT02038036|81640636|FG000|Core Study|Disease progression|2|||
27946944|NCT02038036|81640637|FG001|Core Study|Disease progression|2|||
27946945|NCT02038036|81640636|FG000|Core Study|Lost to Follow-up|0|||
27946946|NCT02038036|81640637|FG001|Core Study|Lost to Follow-up|1|||
27946947|NCT02038036|81640636|FG000|Core Study|Physician Decision|2|||
27946948|NCT02038036|81640637|FG001|Core Study|Physician Decision|1|||
27648910|NCT00622700|80553955|FG004|Extension Treatment Period|Missing|3|||
27648911|NCT00622700|80553956|FG005|Extension Treatment Period|Missing|1|||
27648912|NCT00622700|80553957|FG006|Extension Treatment Period|Missing|0|||
27648913|NCT00622700|80553951|FG000|Extension Treatment Period|Other than specified above|0|||
27746420|NCT02052960|80899626|FG000|Overall Study|Protocol Violation|4|||
27946949|NCT02038036|81640636|FG000|Core Study|Subject/guardian decision|0|||
27946950|NCT02038036|81640637|FG001|Core Study|Subject/guardian decision|1|||
27946951|NCT02038036|81640636|FG000|Core Study|Withdrawal by Subject|3|||
27946952|NCT02038036|81640637|FG001|Core Study|Withdrawal by Subject|1|||
27946953|NCT02038036|81640636|FG000|Crossover Period|Withdrawal by Subject|0|||
27946954|NCT02038036|81640637|FG001|Crossover Period|Withdrawal by Subject|3|||
27946955|NCT02038036|81640636|FG000|Crossover Period|Adverse Event|0|||
27946956|NCT02038036|81640637|FG001|Crossover Period|Adverse Event|9|||
27946957|NCT02038036|81640636|FG000|Crossover Period|Death|0|||
27946958|NCT02038036|81640637|FG001|Crossover Period|Death|2|||
27946959|NCT02038036|81640636|FG000|Crossover Period|Disease progression|0|||
27946960|NCT02038036|81640637|FG001|Crossover Period|Disease progression|3|||
27946961|NCT02038036|81640636|FG000|Crossover Period|Lost to Follow-up|0|||
27946962|NCT02038036|81640637|FG001|Crossover Period|Lost to Follow-up|1|||
27946963|NCT02038036|81640636|FG000|Crossover Period|Physician Decision|0|||
27946964|NCT02038036|81640637|FG001|Crossover Period|Physician Decision|2|||
27946965|NCT01542788|81640638|FG000|Overall Study|Randomized but Not Treated|2|||
27946966|NCT01542788|81640639|FG001|Overall Study|Randomized but Not Treated|0|||
27946967|NCT01542788|81640638|FG000|Overall Study|Lack of Efficacy|41|||
27946968|NCT01542788|81640639|FG001|Overall Study|Lack of Efficacy|71|||
27946969|NCT01542788|81640638|FG000|Overall Study|Lost to Follow-up|5|||
27946970|NCT01542788|81640639|FG001|Overall Study|Lost to Follow-up|0|||
27946971|NCT01542788|81640638|FG000|Overall Study|Death|3|||
27946972|NCT01542788|81640639|FG001|Overall Study|Death|0|||
27648914|NCT00622700|80553952|FG001|Extension Treatment Period|Other than specified above|0|||
27648915|NCT00622700|80553953|FG002|Extension Treatment Period|Other than specified above|0|||
27648916|NCT00622700|80553954|FG003|Extension Treatment Period|Other than specified above|0|||
27648917|NCT00622700|80553955|FG004|Extension Treatment Period|Other than specified above|0|||
27648918|NCT00622700|80553956|FG005|Extension Treatment Period|Other than specified above|1|||
27648919|NCT00622700|80553957|FG006|Extension Treatment Period|Other than specified above|1|||
27648920|NCT00655499|80553958|FG000|Overall Study|not eligible|4|||
27648921|NCT02384382|80553959|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
27648922|NCT02384382|80553959|FG000|Overall Study|Death|1|||
27648923|NCT02384382|80553959|FG000|Overall Study|Adverse Event|1|||
27648924|NCT02384382|80553959|FG000|Overall Study|Disease progression|16|||
27648925|NCT03184987|80553960|FG000|Overall Study|Withdrawal by Subject|0|||
27648926|NCT03184987|80553961|FG001|Overall Study|Withdrawal by Subject|1|||
27648927|NCT03184987|80553962|FG002|Overall Study|Withdrawal by Subject|2|||
27648928|NCT03184987|80553960|FG000|Overall Study|Physician Decision|0|||
27648929|NCT03184987|80553961|FG001|Overall Study|Physician Decision|0|||
27648930|NCT03184987|80553962|FG002|Overall Study|Physician Decision|1|||
27648931|NCT03184987|80553960|FG000|Overall Study|Adverse Event|1|||
27648932|NCT03184987|80553961|FG001|Overall Study|Adverse Event|0|||
27648933|NCT03184987|80553962|FG002|Overall Study|Adverse Event|1|||
27648934|NCT01976507|80553963|FG000|Overall Study|Adverse Event|6|||
27648935|NCT01976507|80553963|FG000|Overall Study|ablation not done, drug not given|1|||
27648936|NCT02236611|80553967|FG000|Overall Study|Adverse Event|10|||
27648937|NCT02236611|80553968|FG001|Overall Study|Adverse Event|16|||
27648938|NCT02236611|80553967|FG000|Overall Study|Lack of Efficacy|4|||
27648939|NCT02236611|80553968|FG001|Overall Study|Lack of Efficacy|7|||
27648940|NCT02236611|80553967|FG000|Overall Study|Lost to Follow-up|0|||
27746421|NCT02052960|80899627|FG001|Overall Study|Protocol Violation|3|||
27946973|NCT01542788|81640638|FG000|Overall Study|Protocol Violation|2|||
27946974|NCT01542788|81640639|FG001|Overall Study|Protocol Violation|0|||
27946975|NCT01542788|81640638|FG000|Overall Study|Physician Decision|1|||
27946976|NCT01542788|81640639|FG001|Overall Study|Physician Decision|0|||
27946977|NCT01542788|81640638|FG000|Overall Study|Withdrawal by Subject|1|||
27946978|NCT01542788|81640639|FG001|Overall Study|Withdrawal by Subject|0|||
27946979|NCT01394185|81640640|FG000|Overall Study|Withdrawal by Subject|2|||
27946980|NCT01394185|81640641|FG001|Overall Study|Withdrawal by Subject|0|||
27946981|NCT01394185|81640642|FG002|Overall Study|Withdrawal by Subject|0|||
27946982|NCT01394185|81640643|FG003|Overall Study|Withdrawal by Subject|0|||
27946983|NCT01394185|81640644|FG004|Overall Study|Withdrawal by Subject|1|||
27946984|NCT01394185|81640645|FG005|Overall Study|Withdrawal by Subject|0|||
27946985|NCT01394185|81640640|FG000|Overall Study|Change in protocol|3|||
27946986|NCT01394185|81640641|FG001|Overall Study|Change in protocol|0|||
27946987|NCT01394185|81640642|FG002|Overall Study|Change in protocol|0|||
27648941|NCT02236611|80553968|FG001|Overall Study|Lost to Follow-up|2|||
27648942|NCT02236611|80553967|FG000|Overall Study|Protocol deviation|3|||
27648943|NCT02236611|80553968|FG001|Overall Study|Protocol deviation|5|||
27648944|NCT02236611|80553967|FG000|Overall Study|Withdrew consent|9|||
27648945|NCT02236611|80553968|FG001|Overall Study|Withdrew consent|4|||
27648946|NCT01779050|80553969|FG000|Overall Study|Withdrawal by Subject|1|||
27648947|NCT01779050|80553970|FG001|Overall Study|Withdrawal by Subject|0|||
27946988|NCT01394185|81640643|FG003|Overall Study|Change in protocol|0|||
27648948|NCT03939897|80553971|FG000|Overall Study|Still receiving active treatment|0|||
27648949|NCT03939897|80553972|FG001|Overall Study|Still receiving active treatment|0|||
27946989|NCT01394185|81640644|FG004|Overall Study|Change in protocol|3|||
27946990|NCT01394185|81640645|FG005|Overall Study|Change in protocol|0|||
27946991|NCT01394185|81640640|FG000|Overall Study|Protocol Violation|1|||
27946992|NCT01394185|81640641|FG001|Overall Study|Protocol Violation|0|||
27946993|NCT01394185|81640642|FG002|Overall Study|Protocol Violation|0|||
27946994|NCT01394185|81640643|FG003|Overall Study|Protocol Violation|1|||
27946995|NCT01394185|81640644|FG004|Overall Study|Protocol Violation|0|||
27946996|NCT01394185|81640645|FG005|Overall Study|Protocol Violation|1|||
27946997|NCT02919618|81640649|FG000|Overall Study|Death|1|||
27946998|NCT00329420|81640650|FG000|Re-induction Phase|Lack of Efficacy|0|||
27946999|NCT00329420|81640651|FG001|Re-induction Phase|Lack of Efficacy|1|||
27947000|NCT00329420|81640652|FG002|Re-induction Phase|Lack of Efficacy|0|||
27947001|NCT00329420|81640650|FG000|Re-induction Phase|Withdrawal of Consent|0|||
27947002|NCT00329420|81640651|FG001|Re-induction Phase|Withdrawal of Consent|0|||
27947003|NCT00329420|81640652|FG002|Re-induction Phase|Withdrawal of Consent|1|||
27947004|NCT00329420|81640650|FG000|Re-induction Phase|Did not respond to re-induction|6|||
27947005|NCT00329420|81640651|FG001|Re-induction Phase|Did not respond to re-induction|5|||
27947006|NCT00329420|81640652|FG002|Re-induction Phase|Did not respond to re-induction|7|||
27947007|NCT00329420|81640650|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
27947008|NCT00329420|81640651|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
27947009|NCT00329420|81640652|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
27947010|NCT00329420|81640650|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
27947011|NCT00329420|81640651|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
27947012|NCT00329420|81640652|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
27947013|NCT00329420|81640650|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
27947014|NCT00329420|81640651|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
27947015|NCT00329420|81640652|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
27947016|NCT00397540|81640653|FG000|Overall Study|short follow-up duration < 12 months|1|||
27947017|NCT00397540|81640654|FG001|Overall Study|short follow-up duration < 12 months|0|||
27947018|NCT04507204|81640657|FG000|Overall Study|Adverse Event|8|||
27947019|NCT04507204|81640658|FG001|Overall Study|Adverse Event|13|||
27947020|NCT04507204|81640657|FG000|Overall Study|Death|0|||
27947021|NCT04507204|81640658|FG001|Overall Study|Death|1|||
27947022|NCT04507204|81640657|FG000|Overall Study|Lost to Follow-up|15|||
27947023|NCT04507204|81640658|FG001|Overall Study|Lost to Follow-up|14|||
27947024|NCT04507204|81640657|FG000|Overall Study|Poor Compliance with Protocol|2|||
27947025|NCT04507204|81640658|FG001|Overall Study|Poor Compliance with Protocol|4|||
27947026|NCT04507204|81640657|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
27947027|NCT04507204|81640658|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
27947028|NCT04507204|81640657|FG000|Overall Study|Withdrawal of Patient Consent|21|||
27947029|NCT04507204|81640658|FG001|Overall Study|Withdrawal of Patient Consent|13|||
27947030|NCT01344226|81640665|FG000|Overall Study|Protocol Violation|2|||
27947031|NCT01344226|81640665|FG000|Overall Study|Withdrawal by Subject|3|||
27947032|NCT01344226|81640665|FG000|Overall Study|Lack of Efficacy|3|||
27947033|NCT01168596|81640670|FG000|Overall Study|Withdrawal by Subject|3|||
27947034|NCT01168596|81640671|FG001|Overall Study|Withdrawal by Subject|1|||
27947035|NCT04129398|81640673|FG000|Overall Study|Physician Decision|2|||
27947036|NCT00815633|81640675|FG000|Overall Study|study terminated|1|||
27947037|NCT04617860|81640679|FG000|Overall Study|Adverse Event|0|||
27947038|NCT04617860|81640680|FG001|Overall Study|Adverse Event|2|||
27947039|NCT04617860|81640681|FG002|Overall Study|Adverse Event|2|||
27947040|NCT04617860|81640679|FG000|Overall Study|Withdrawal by Subject|0|||
27947041|NCT04617860|81640680|FG001|Overall Study|Withdrawal by Subject|0|||
27947042|NCT04617860|81640681|FG002|Overall Study|Withdrawal by Subject|2|||
27947043|NCT04617860|81640679|FG000|Overall Study|Physician Decision|0|||
27947044|NCT04617860|81640680|FG001|Overall Study|Physician Decision|1|||
27947045|NCT04617860|81640681|FG002|Overall Study|Physician Decision|0|||
27947046|NCT04617860|81640679|FG000|Overall Study|Sponsor Decision|0|||
27947047|NCT04617860|81640680|FG001|Overall Study|Sponsor Decision|3|||
27947048|NCT04617860|81640681|FG002|Overall Study|Sponsor Decision|1|||
27947049|NCT04617860|81640679|FG000|Overall Study|Termination of Study by Sponsor|8|||
27947050|NCT04617860|81640680|FG001|Overall Study|Termination of Study by Sponsor|4|||
27947051|NCT04617860|81640681|FG002|Overall Study|Termination of Study by Sponsor|13|||
27947052|NCT05166902|81640682|FG000|First Intervention|Lost to Follow-up|0|||
27947053|NCT05166902|81640683|FG001|First Intervention|Lost to Follow-up|1|||
27746422|NCT02052960|80899626|FG000|Overall Study|Withdrawal by Subject|6|||
27947054|NCT01358734|81640686|FG000|Overall Study|Adverse Event|4|||
27947055|NCT01358734|81640687|FG001|Overall Study|Adverse Event|7|||
27947056|NCT01358734|81640688|FG002|Overall Study|Adverse Event|3|||
27947057|NCT01358734|81640686|FG000|Overall Study|Lack of Efficacy|0|||
27947058|NCT01358734|81640687|FG001|Overall Study|Lack of Efficacy|1|||
27947059|NCT01358734|81640688|FG002|Overall Study|Lack of Efficacy|3|||
27947060|NCT01358734|81640686|FG000|Overall Study|Withdrawal by Subject|1|||
27947061|NCT01358734|81640687|FG001|Overall Study|Withdrawal by Subject|6|||
27947062|NCT01358734|81640688|FG002|Overall Study|Withdrawal by Subject|3|||
27947063|NCT01358734|81640686|FG000|Overall Study|Death|3|||
27947064|NCT01358734|81640687|FG001|Overall Study|Death|7|||
27947065|NCT01358734|81640688|FG002|Overall Study|Death|2|||
27947066|NCT01358734|81640686|FG000|Overall Study|Progressive Disease|5|||
27947067|NCT01358734|81640687|FG001|Overall Study|Progressive Disease|13|||
27947068|NCT01358734|81640688|FG002|Overall Study|Progressive Disease|16|||
27947069|NCT01358734|81640686|FG000|Overall Study|Non-compliance with study drug|0|||
27947070|NCT01358734|81640687|FG001|Overall Study|Non-compliance with study drug|0|||
27947071|NCT01358734|81640688|FG002|Overall Study|Non-compliance with study drug|1|||
27648950|NCT03939897|80553973|FG002|Overall Study|Still receiving active treatment|1|||
27648951|NCT03939897|80553974|FG003|Overall Study|Still receiving active treatment|0|||
27648952|NCT03939897|80553975|FG004|Overall Study|Still receiving active treatment|0|||
27648953|NCT03939897|80553976|FG005|Overall Study|Still receiving active treatment|0|||
27648954|NCT02040870|80553978|FG000|Overall Study|Completed treatment phase|6|||
27648955|NCT02040870|80553978|FG000|Overall Study|Adverse Event|7|||
27648956|NCT02040870|80553978|FG000|Overall Study|Progressive disease|58|||
27648957|NCT02040870|80553978|FG000|Overall Study|Physician Decision|6|||
27648958|NCT02040870|80553978|FG000|Overall Study|Subject/guardian decision|10|||
27648959|NCT02040870|80553978|FG000|Overall Study|Lost to Follow-up|3|||
27648960|NCT02040870|80553978|FG000|Overall Study|Death|13|||
27648961|NCT01619059|80553979|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
27648962|NCT01619059|80553980|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
27648963|NCT01619059|80553979|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
27648964|NCT01619059|80553980|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
27648965|NCT01619059|80553979|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
27648966|NCT01619059|80553980|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
27648967|NCT01619059|80553979|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
27947072|NCT01358734|81640686|FG000|Overall Study|Other|2|||
27947073|NCT01358734|81640687|FG001|Overall Study|Other|5|||
27947074|NCT01358734|81640688|FG002|Overall Study|Other|4|||
27947075|NCT01358734|81640686|FG000|Overall Study|Protocol Violation|0|||
27947076|NCT01358734|81640687|FG001|Overall Study|Protocol Violation|0|||
27947077|NCT01358734|81640688|FG002|Overall Study|Protocol Violation|2|||
27947078|NCT00656370|81640689|FG000|Overall Study|Screen Failures|7|||
27947079|NCT00656370|81640689|FG000|Overall Study|Alternates|3|||
27947080|NCT01217892|81640690|FG000|Overall Study|Adverse Event|1|||
27947081|NCT01217892|81640691|FG001|Overall Study|Adverse Event|1|||
27947082|NCT01217892|81640692|FG002|Overall Study|Adverse Event|1|||
27947083|NCT01217892|81640693|FG003|Overall Study|Adverse Event|0|||
27947084|NCT01217892|81640690|FG000|Overall Study|Withdrawal by Subject|0|||
27947085|NCT01217892|81640691|FG001|Overall Study|Withdrawal by Subject|2|||
27947086|NCT01217892|81640692|FG002|Overall Study|Withdrawal by Subject|1|||
27947087|NCT01217892|81640693|FG003|Overall Study|Withdrawal by Subject|0|||
27947088|NCT01217892|81640690|FG000|Overall Study|Lab value|1|||
27947089|NCT01217892|81640691|FG001|Overall Study|Lab value|0|||
27947090|NCT01217892|81640692|FG002|Overall Study|Lab value|1|||
27947091|NCT01217892|81640693|FG003|Overall Study|Lab value|0|||
27947092|NCT01217892|81640690|FG000|Overall Study|Subject no longer meets study criteria|5|||
27947093|NCT01217892|81640691|FG001|Overall Study|Subject no longer meets study criteria|2|||
27947094|NCT01217892|81640692|FG002|Overall Study|Subject no longer meets study criteria|4|||
27947095|NCT01217892|81640693|FG003|Overall Study|Subject no longer meets study criteria|8|||
27947096|NCT01217892|81640690|FG000|Overall Study|Incorrect enrollment|0|||
27947097|NCT01217892|81640691|FG001|Overall Study|Incorrect enrollment|1|||
27947098|NCT01217892|81640692|FG002|Overall Study|Incorrect enrollment|1|||
27947099|NCT01217892|81640693|FG003|Overall Study|Incorrect enrollment|0|||
27947100|NCT01217892|81640690|FG000|Overall Study|Poor/Non-Compliance|0|||
27947101|NCT01217892|81640691|FG001|Overall Study|Poor/Non-Compliance|0|||
27947102|NCT01217892|81640692|FG002|Overall Study|Poor/Non-Compliance|1|||
27947103|NCT01217892|81640693|FG003|Overall Study|Poor/Non-Compliance|0|||
27947104|NCT05538728|81640698|FG000|Overall Study|Withdrawal by Subject|1|||
27947105|NCT05538728|81640699|FG001|Overall Study|Withdrawal by Subject|1|||
27947106|NCT03033784|81640700|FG000|Overall Study|Anxiety related to MRI scanner|0|||
27947107|NCT03033784|81640701|FG001|Overall Study|Anxiety related to MRI scanner|1|||
27947108|NCT03033784|81640702|FG002|Overall Study|Anxiety related to MRI scanner|0|||
27947109|NCT03033784|81640703|FG003|Overall Study|Anxiety related to MRI scanner|0|||
27947110|NCT03033784|81640704|FG004|Overall Study|Anxiety related to MRI scanner|0|||
27947111|NCT03033784|81640705|FG005|Overall Study|Anxiety related to MRI scanner|0|||
27947112|NCT03033784|81640706|FG006|Overall Study|Anxiety related to MRI scanner|0|||
27947113|NCT03033784|81640707|FG007|Overall Study|Anxiety related to MRI scanner|0|||
27947114|NCT03033784|81640708|FG008|Overall Study|Anxiety related to MRI scanner|0|||
27947115|NCT03033784|81640709|FG009|Overall Study|Anxiety related to MRI scanner|0|||
27947116|NCT03033784|81640710|FG010|Overall Study|Anxiety related to MRI scanner|0|||
27947117|NCT03033784|81640711|FG011|Overall Study|Anxiety related to MRI scanner|0|||
27947118|NCT03033784|81640712|FG012|Overall Study|Anxiety related to MRI scanner|0|||
27947119|NCT03033784|81640700|FG000|Overall Study|Withdrawal by Subject|0|||
27947120|NCT03033784|81640701|FG001|Overall Study|Withdrawal by Subject|0|||
27947121|NCT03033784|81640702|FG002|Overall Study|Withdrawal by Subject|0|||
27947122|NCT03033784|81640703|FG003|Overall Study|Withdrawal by Subject|0|||
27947123|NCT03033784|81640704|FG004|Overall Study|Withdrawal by Subject|0|||
27947124|NCT03033784|81640705|FG005|Overall Study|Withdrawal by Subject|0|||
27648968|NCT01619059|80553980|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
27947125|NCT03033784|81640706|FG006|Overall Study|Withdrawal by Subject|0|||
27947126|NCT03033784|81640707|FG007|Overall Study|Withdrawal by Subject|0|||
27947127|NCT03033784|81640708|FG008|Overall Study|Withdrawal by Subject|0|||
27947128|NCT03033784|81640709|FG009|Overall Study|Withdrawal by Subject|0|||
27947129|NCT03033784|81640710|FG010|Overall Study|Withdrawal by Subject|0|||
27947130|NCT03033784|81640711|FG011|Overall Study|Withdrawal by Subject|0|||
27947131|NCT03033784|81640712|FG012|Overall Study|Withdrawal by Subject|2|||
27947132|NCT00553254|81640713|FG000|Overall Study|Death|3|||
27947133|NCT00553254|81640714|FG001|Overall Study|Death|6|||
27947134|NCT00553254|81640715|FG002|Overall Study|Death|25|||
27947135|NCT00553254|81640713|FG000|Overall Study|Lost to Follow-up|0|||
27947136|NCT00553254|81640714|FG001|Overall Study|Lost to Follow-up|0|||
27947137|NCT00553254|81640715|FG002|Overall Study|Lost to Follow-up|2|||
27947138|NCT00553254|81640713|FG000|Overall Study|Withdrawal by Subject|2|||
27947139|NCT00553254|81640714|FG001|Overall Study|Withdrawal by Subject|0|||
27947140|NCT00553254|81640715|FG002|Overall Study|Withdrawal by Subject|2|||
27947141|NCT00553254|81640713|FG000|Overall Study|Study terminated by Sponsor|0|||
27947142|NCT00553254|81640714|FG001|Overall Study|Study terminated by Sponsor|0|||
27947143|NCT00553254|81640715|FG002|Overall Study|Study terminated by Sponsor|1|||
27947144|NCT00553254|81640713|FG000|Overall Study|Other|1|||
27947145|NCT00553254|81640714|FG001|Overall Study|Other|0|||
27947146|NCT00553254|81640715|FG002|Overall Study|Other|13|||
27947147|NCT02801578|81640716|FG000|Overall Study|Adverse Event|2|||
27947148|NCT03787615|81640718|FG000|Overall Study|Withdrawal by Subject|2|||
27947149|NCT03787615|81640718|FG000|Overall Study|Lost to Follow-up|2|||
27947150|NCT00113373|81640719|FG000|Overall Study|Ineligible: wrong primary|1|||
27947151|NCT00113373|81640719|FG000|Overall Study|Ineligible: second primary|1|||
27947152|NCT00113373|81640719|FG000|Overall Study|Never Treated|1|||
27947153|NCT03289039|81640725|FG000|Overall Study|Withdrawal by Subject|0|||
27947154|NCT03289039|81640726|FG001|Overall Study|Withdrawal by Subject|1|||
27947155|NCT03289039|81640725|FG000|Overall Study|Became ineligible prior to treatment start|0|||
27947156|NCT03289039|81640726|FG001|Overall Study|Became ineligible prior to treatment start|1|||
27947157|NCT03289039|81640725|FG000|Overall Study|progressed before treatment start|1|||
27947158|NCT03289039|81640726|FG001|Overall Study|progressed before treatment start|0|||
27947159|NCT01969409|81644052|FG000|Overall Study|Death|2|||
27947160|NCT01969409|81644053|FG001|Overall Study|Death|2|||
27947161|NCT01969409|81644052|FG000|Overall Study|Transplant|1|||
27947162|NCT01969409|81644053|FG001|Overall Study|Transplant|1|||
27947163|NCT01969409|81644052|FG000|Overall Study|Withdrawal by Subject|0|||
27947164|NCT01969409|81644053|FG001|Overall Study|Withdrawal by Subject|1|||
27947165|NCT03814044|81644056|FG000|Overall Study|Protocol deviation|1|||
27947166|NCT01651208|81644057|FG000|Overall Study|Lost to Follow-up|14|||
27947167|NCT01651208|81644058|FG001|Overall Study|Lost to Follow-up|16|||
27947168|NCT04164901|81644059|FG000|Overall Study|Withdrawal by Subject|4|||
27947169|NCT04164901|81644060|FG001|Overall Study|Withdrawal by Subject|4|||
27947170|NCT04576455|81644065|FG000|Overall Study|Ongoing in the Study|122|||
27947171|NCT04576455|81644066|FG001|Overall Study|Ongoing in the Study|135|||
27947172|NCT04576455|81644065|FG000|Overall Study|Death|18|||
27947173|NCT04576455|81644066|FG001|Overall Study|Death|12|||
27947174|NCT04576455|81644065|FG000|Overall Study|Lost to Follow-up|1|||
27947175|NCT04576455|81644066|FG001|Overall Study|Lost to Follow-up|0|||
27947176|NCT04576455|81644065|FG000|Overall Study|Withdrawal by Subject|10|||
27947177|NCT04576455|81644066|FG001|Overall Study|Withdrawal by Subject|5|||
27947178|NCT01405196|81644067|FG000|Overall Study|Study Terminated by Sponsor|0|||
27947179|NCT01405196|81644068|FG001|Overall Study|Study Terminated by Sponsor|0|||
27947180|NCT01405196|81644069|FG002|Overall Study|Study Terminated by Sponsor|9|||
27947181|NCT01405196|81644070|FG003|Overall Study|Study Terminated by Sponsor|0|||
27947182|NCT01405196|81644067|FG000|Overall Study|Other|2|||
27947183|NCT01405196|81644068|FG001|Overall Study|Other|2|||
27947184|NCT01405196|81644069|FG002|Overall Study|Other|5|||
27947185|NCT01405196|81644070|FG003|Overall Study|Other|0|||
27648969|NCT01619059|80553979|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
27648970|NCT01619059|80553980|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
27947186|NCT01405196|81644067|FG000|Overall Study|Withdrawal by Subject|4|||
27648971|NCT01619059|80553979|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
27648972|NCT01619059|80553980|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
27648973|NCT01619059|80553979|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
27648974|NCT01619059|80553980|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
27947187|NCT01405196|81644068|FG001|Overall Study|Withdrawal by Subject|6|||
27947188|NCT01405196|81644069|FG002|Overall Study|Withdrawal by Subject|3|||
27947189|NCT01405196|81644070|FG003|Overall Study|Withdrawal by Subject|6|||
27947190|NCT01405196|81644067|FG000|Overall Study|Adverse Event|2|||
27947191|NCT01405196|81644068|FG001|Overall Study|Adverse Event|2|||
27947192|NCT01405196|81644069|FG002|Overall Study|Adverse Event|0|||
27947193|NCT01405196|81644070|FG003|Overall Study|Adverse Event|2|||
27947194|NCT01405196|81644067|FG000|Overall Study|Death|1|||
27947195|NCT01405196|81644068|FG001|Overall Study|Death|0|||
27947196|NCT01405196|81644069|FG002|Overall Study|Death|3|||
27947197|NCT01405196|81644070|FG003|Overall Study|Death|0|||
27947198|NCT01405196|81644067|FG000|Overall Study|Lost to Follow-up|2|||
27947199|NCT01405196|81644068|FG001|Overall Study|Lost to Follow-up|2|||
27947200|NCT01405196|81644069|FG002|Overall Study|Lost to Follow-up|3|||
27947201|NCT01405196|81644070|FG003|Overall Study|Lost to Follow-up|1|||
27947202|NCT00654732|81644071|FG000|Overall Study|Adverse Event|4|||
27947203|NCT00654732|81644072|FG001|Overall Study|Adverse Event|6|||
27947204|NCT03895372|81644081|FG000|Investigational Treatment Period|Adverse Event|1|||
27947205|NCT03895372|81644082|FG001|Investigational Treatment Period|Adverse Event|0|||
27947206|NCT03895372|81644083|FG002|Investigational Treatment Period|Adverse Event|0|||
27947207|NCT03895372|81644084|FG003|Investigational Treatment Period|Adverse Event|0|||
27947208|NCT03895372|81644085|FG004|Investigational Treatment Period|Adverse Event|0|||
27947209|NCT03895372|81644086|FG005|Investigational Treatment Period|Adverse Event|0|||
27947210|NCT03895372|81644087|FG006|Investigational Treatment Period|Adverse Event|4|||
27947211|NCT03895372|81644088|FG007|Investigational Treatment Period|Adverse Event|3|||
27947212|NCT03895372|81644081|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
27947213|NCT03895372|81644082|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
27947214|NCT03895372|81644083|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
27947215|NCT03895372|81644084|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
27947216|NCT03895372|81644085|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
27947217|NCT03895372|81644086|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
27947218|NCT03895372|81644087|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
27947219|NCT03895372|81644088|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
27947220|NCT03895372|81644081|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
27947221|NCT03895372|81644082|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
27947222|NCT03895372|81644083|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
27947223|NCT03895372|81644084|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
27947224|NCT03895372|81644085|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
27947225|NCT03895372|81644086|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
27947226|NCT03895372|81644087|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
27947227|NCT03895372|81644088|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
27947228|NCT03895372|81644081|FG000|Investigational Treatment Period|Other|0|||
27947229|NCT03895372|81644082|FG001|Investigational Treatment Period|Other|0|||
27947230|NCT03895372|81644083|FG002|Investigational Treatment Period|Other|0|||
27947231|NCT03895372|81644084|FG003|Investigational Treatment Period|Other|0|||
27947232|NCT03895372|81644085|FG004|Investigational Treatment Period|Other|0|||
27947233|NCT03895372|81644086|FG005|Investigational Treatment Period|Other|1|||
27947234|NCT03895372|81644087|FG006|Investigational Treatment Period|Other|0|||
27947235|NCT03895372|81644088|FG007|Investigational Treatment Period|Other|2|||
27947236|NCT03895372|81644081|FG000|Investigational Treatment Period|Protocol Violation|0|||
27947237|NCT03895372|81644082|FG001|Investigational Treatment Period|Protocol Violation|0|||
27648975|NCT01619059|80553979|FG000|Long-Term (LT) Treatment Period|Death|1|||
27648976|NCT01619059|80553980|FG001|Long-Term (LT) Treatment Period|Death|0|||
27648977|NCT01619059|80553979|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
27648978|NCT01619059|80553980|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
27648979|NCT01619059|80553979|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
27648980|NCT01619059|80553980|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
27648981|NCT01812759|80553999|FG000|Overall Study|Physician Decision|0|||
27648982|NCT01812759|80554000|FG001|Overall Study|Physician Decision|0|||
27648983|NCT01812759|80554001|FG002|Overall Study|Physician Decision|1|||
27947238|NCT03895372|81644083|FG002|Investigational Treatment Period|Protocol Violation|0|||
27947239|NCT03895372|81644084|FG003|Investigational Treatment Period|Protocol Violation|1|||
27947240|NCT03895372|81644085|FG004|Investigational Treatment Period|Protocol Violation|0|||
27947241|NCT03895372|81644086|FG005|Investigational Treatment Period|Protocol Violation|0|||
27947242|NCT03895372|81644087|FG006|Investigational Treatment Period|Protocol Violation|0|||
27947243|NCT03895372|81644088|FG007|Investigational Treatment Period|Protocol Violation|0|||
27947244|NCT03895372|81644081|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
27551426|NCT01543698|80207459|FG001|Phase 2|Disease progression|0|||
27648984|NCT01801007|80554002|FG000|Overall Study|Adverse Event|2|||
27648985|NCT01801007|80554002|FG000|Overall Study|Lost to Follow-up|4|||
27648986|NCT01801007|80554002|FG000|Overall Study|Withdrawal by Subject|5|||
27648987|NCT01794299|80554003|FG000|Overall Study|ATIR manufacturing not possible|1|||
27648988|NCT01794299|80554003|FG000|Overall Study|Death|14|||
27648989|NCT01794299|80554003|FG000|Overall Study|Graft failure|1|||
27648990|NCT01794299|80554003|FG000|Overall Study|ATIR batch rejected|2|||
27648991|NCT01794299|80554003|FG000|Overall Study|Relapse|2|||
27648992|NCT01794299|80554003|FG000|Overall Study|Discontinued from active follow-up|1|||
27648993|NCT01794299|80554003|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
27648994|NCT03960645|80554004|FG000|Overall Study|Protocol Violation|1|||
27648995|NCT03960645|80554005|FG001|Overall Study|Protocol Violation|0|||
27648996|NCT01989689|80554013|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
27648997|NCT01989689|80554014|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
27648998|NCT01989689|80554013|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
27648999|NCT01989689|80554014|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
27649000|NCT02161458|80554015|FG000|Overall Study|Withdrawal by Subject|0|||
27649001|NCT02161458|80554016|FG001|Overall Study|Withdrawal by Subject|4|||
27649002|NCT02161458|80554017|FG002|Overall Study|Withdrawal by Subject|4|||
27649003|NCT02161458|80554018|FG003|Overall Study|Withdrawal by Subject|0|||
27649004|NCT02161458|80554015|FG000|Overall Study|Lost to Follow-up|0|||
27649005|NCT02161458|80554016|FG001|Overall Study|Lost to Follow-up|2|||
27649006|NCT02161458|80554017|FG002|Overall Study|Lost to Follow-up|1|||
27649007|NCT02161458|80554018|FG003|Overall Study|Lost to Follow-up|0|||
27649008|NCT02454959|80554020|FG000|Overall Study|Protocol-Specified Criteria|3|||
27649009|NCT02454959|80554020|FG000|Overall Study|Physician Decision|1|||
27649010|NCT02454959|80554020|FG000|Overall Study|Withdrawal by Subject|3|||
27649011|NCT02454959|80554020|FG000|Overall Study|Adverse Event|2|||
27649012|NCT01915914|80554023|FG000|Acute Phase|Withdrawal by Subject|4|||
27649013|NCT01915914|80554024|FG001|Acute Phase|Withdrawal by Subject|0|||
27649014|NCT01915914|80554025|FG002|Acute Phase|Withdrawal by Subject|0|||
27649015|NCT01915914|80554026|FG003|Acute Phase|Withdrawal by Subject|0|||
27649016|NCT01915914|80554023|FG000|Acute Phase|Lost to Follow-up|4|||
27649017|NCT01915914|80554024|FG001|Acute Phase|Lost to Follow-up|0|||
27649018|NCT01915914|80554025|FG002|Acute Phase|Lost to Follow-up|0|||
27649019|NCT01915914|80554026|FG003|Acute Phase|Lost to Follow-up|0|||
27649020|NCT01915914|80554023|FG000|Acute Phase|Physician Decision|1|||
27649021|NCT01915914|80554024|FG001|Acute Phase|Physician Decision|0|||
27649022|NCT01915914|80554025|FG002|Acute Phase|Physician Decision|0|||
27649023|NCT01915914|80554026|FG003|Acute Phase|Physician Decision|0|||
27649024|NCT01915914|80554023|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
27649025|NCT01915914|80554024|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
27649026|NCT01915914|80554025|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
27649027|NCT01915914|80554026|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
27649028|NCT01915914|80554023|FG000|Acute Phase|"Not Achieved treatment success"|1|||
27649029|NCT01915914|80554024|FG001|Acute Phase|"Not Achieved treatment success"|0|||
27649030|NCT01915914|80554025|FG002|Acute Phase|"Not Achieved treatment success"|0|||
27947245|NCT03895372|81644082|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
27649031|NCT01915914|80554026|FG003|Acute Phase|"Not Achieved treatment success"|0|||
27649032|NCT01915914|80554023|FG000|Acute Phase|Missing|1|||
27649033|NCT01915914|80554024|FG001|Acute Phase|Missing|0|||
27649034|NCT01915914|80554025|FG002|Acute Phase|Missing|0|||
27649035|NCT01915914|80554026|FG003|Acute Phase|Missing|0|||
27947246|NCT03895372|81644083|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
27947247|NCT03895372|81644084|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
27947248|NCT03895372|81644085|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
27947249|NCT03895372|81644086|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
27947250|NCT03895372|81644087|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
27649036|NCT01915914|80554023|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27649037|NCT01915914|80554024|FG001|Maintenance Phase|Withdrawal by Subject|1|||
27649038|NCT01915914|80554025|FG002|Maintenance Phase|Withdrawal by Subject|1|||
27649039|NCT01915914|80554026|FG003|Maintenance Phase|Withdrawal by Subject|0|||
27649040|NCT01915914|80554023|FG000|Maintenance Phase|Lost to Follow-up|0|||
27649041|NCT01915914|80554024|FG001|Maintenance Phase|Lost to Follow-up|4|||
27649042|NCT01915914|80554025|FG002|Maintenance Phase|Lost to Follow-up|1|||
27649043|NCT01915914|80554026|FG003|Maintenance Phase|Lost to Follow-up|0|||
27649044|NCT01915914|80554023|FG000|Maintenance Phase|Missing|0|||
27649045|NCT01915914|80554024|FG001|Maintenance Phase|Missing|1|||
27649046|NCT01915914|80554025|FG002|Maintenance Phase|Missing|0|||
27649047|NCT01915914|80554026|FG003|Maintenance Phase|Missing|0|||
27947251|NCT03895372|81644088|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
27947252|NCT03895372|81644081|FG000|Extension Treatment Period|Adverse Event|0|||
27947253|NCT03895372|81644082|FG001|Extension Treatment Period|Adverse Event|1|||
27947254|NCT03895372|81644083|FG002|Extension Treatment Period|Adverse Event|0|||
27947255|NCT03895372|81644084|FG003|Extension Treatment Period|Adverse Event|1|||
27947256|NCT03895372|81644085|FG004|Extension Treatment Period|Adverse Event|0|||
27947257|NCT03895372|81644086|FG005|Extension Treatment Period|Adverse Event|0|||
27649048|NCT01915914|80554023|FG000|Follow-up Phase|Withdrawal by Subject|0|||
27649049|NCT01915914|80554024|FG001|Follow-up Phase|Withdrawal by Subject|0|||
27649050|NCT01915914|80554025|FG002|Follow-up Phase|Withdrawal by Subject|0|||
27649051|NCT01915914|80554026|FG003|Follow-up Phase|Withdrawal by Subject|1|||
27649052|NCT01915914|80554023|FG000|Follow-up Phase|Physician Decision|0|||
27649053|NCT01915914|80554024|FG001|Follow-up Phase|Physician Decision|0|||
27649054|NCT01915914|80554025|FG002|Follow-up Phase|Physician Decision|0|||
27649055|NCT01915914|80554026|FG003|Follow-up Phase|Physician Decision|1|||
27649056|NCT02744066|80554027|FG000|Overall Study|Withdrawal by parent|0|||
27649057|NCT02744066|80554028|FG001|Overall Study|Withdrawal by parent|1|||
27649058|NCT02744066|80554027|FG000|Overall Study|Discharged from NICU prior to completion|0|||
27947258|NCT03895372|81644087|FG006|Extension Treatment Period|Adverse Event|3|||
27947259|NCT03895372|81644088|FG007|Extension Treatment Period|Adverse Event|3|||
27947260|NCT03895372|81644081|FG000|Extension Treatment Period|Other|1|||
27947261|NCT03895372|81644082|FG001|Extension Treatment Period|Other|3|||
27947262|NCT03895372|81644083|FG002|Extension Treatment Period|Other|0|||
27947263|NCT03895372|81644084|FG003|Extension Treatment Period|Other|0|||
27947264|NCT03895372|81644085|FG004|Extension Treatment Period|Other|1|||
27947265|NCT03895372|81644086|FG005|Extension Treatment Period|Other|0|||
27947266|NCT03895372|81644087|FG006|Extension Treatment Period|Other|0|||
27947267|NCT03895372|81644088|FG007|Extension Treatment Period|Other|2|||
27947268|NCT03895372|81644081|FG000|Extension Treatment Period|Pregnancy|0|||
27947269|NCT03895372|81644082|FG001|Extension Treatment Period|Pregnancy|0|||
27947270|NCT03895372|81644083|FG002|Extension Treatment Period|Pregnancy|0|||
27947271|NCT03895372|81644084|FG003|Extension Treatment Period|Pregnancy|0|||
27947272|NCT03895372|81644085|FG004|Extension Treatment Period|Pregnancy|1|||
27947273|NCT03895372|81644086|FG005|Extension Treatment Period|Pregnancy|0|||
27947274|NCT03895372|81644087|FG006|Extension Treatment Period|Pregnancy|0|||
27947275|NCT03895372|81644088|FG007|Extension Treatment Period|Pregnancy|0|||
27947276|NCT03895372|81644081|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
27947277|NCT03895372|81644082|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
27947278|NCT03895372|81644083|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
27947279|NCT03895372|81644084|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
27947280|NCT03895372|81644085|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
27947281|NCT03895372|81644086|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
27947282|NCT03895372|81644087|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
27947283|NCT03895372|81644088|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
27947284|NCT00936936|81644089|FG000|Overall Study|Adverse Event|7|||
27947285|NCT00936936|81644090|FG001|Overall Study|Adverse Event|1|||
27947286|NCT00936936|81644089|FG000|Overall Study|Disease Progression|2|||
27947287|NCT00936936|81644090|FG001|Overall Study|Disease Progression|2|||
27947288|NCT00936936|81644089|FG000|Overall Study|Unrelated|3|||
27947289|NCT00936936|81644090|FG001|Overall Study|Unrelated|1|||
27947290|NCT02213926|81644091|FG000|Overall Study|Death|59|||
27947291|NCT02213926|81644091|FG000|Overall Study|Withdrawal by Subject|10|||
27947292|NCT02213926|81644091|FG000|Overall Study|study terminated by sponsor|51|||
27947293|NCT02213926|81644091|FG000|Overall Study|Lost to Follow-up|3|||
27947294|NCT02213926|81644091|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
27947295|NCT00829998|81644095|FG000|Washout|Adverse Event|0|||
27947296|NCT00829998|81644096|FG001|Washout|Adverse Event|1|||
27947297|NCT01188967|81644097|FG000|Overall Study|Withdrawal by Subject|1|||
27947298|NCT01188967|81644098|FG001|Overall Study|Withdrawal by Subject|1|||
27947299|NCT01188967|81644097|FG000|Overall Study|Physician Decision|1|||
27947300|NCT01188967|81644098|FG001|Overall Study|Physician Decision|1|||
27947301|NCT01188967|81644097|FG000|Overall Study|Lost to Follow-up|3|||
27947302|NCT01188967|81644098|FG001|Overall Study|Lost to Follow-up|2|||
27947303|NCT00754572|81644099|FG000|Overall Study|Adverse Event|19|||
27947304|NCT00754572|81644099|FG000|Overall Study|Other|39|||
27947305|NCT00754572|81644099|FG000|Overall Study|Protocol Violation|3|||
27947306|NCT00754572|81644099|FG000|Overall Study|Withdrawal by Subject|3|||
27947307|NCT00754572|81644099|FG000|Overall Study|Lack of Efficacy|2|||
27947308|NCT00754572|81644099|FG000|Overall Study|Death|1|||
27649059|NCT02744066|80554028|FG001|Overall Study|Discharged from NICU prior to completion|4|||
27649060|NCT03490032|80554029|FG000|Overall Study|family issue (child custody)|1|||
27649061|NCT03490032|80554030|FG001|Overall Study|family issue (child custody)|0|||
27649062|NCT03490032|80554031|FG002|Overall Study|family issue (child custody)|0|||
27649063|NCT00380250|80554032|FG000|Overall Study|Withdrawal by Subject|39|||
27649064|NCT00380250|80554033|FG001|Overall Study|Withdrawal by Subject|28|||
27649065|NCT00380250|80554032|FG000|Overall Study|Adverse Event|20|||
27649066|NCT00380250|80554033|FG001|Overall Study|Adverse Event|9|||
27649067|NCT00380250|80554032|FG000|Overall Study|Lack of Efficacy|10|||
27649068|NCT00380250|80554033|FG001|Overall Study|Lack of Efficacy|8|||
27746423|NCT02052960|80899627|FG001|Overall Study|Withdrawal by Subject|11|||
27947309|NCT00754572|81644099|FG000|Overall Study|Administrative Reason|3|||
27947310|NCT00754572|81644099|FG000|Overall Study|Lost to Follow-up|1|||
27947311|NCT00095576|81644100|FG000|Overall Study|Adverse Event|5|||
27947312|NCT00095576|81644101|FG001|Overall Study|Adverse Event|3|||
27649069|NCT00380250|80554032|FG000|Overall Study|Protocol Violation|15|||
27947313|NCT00095576|81644100|FG000|Overall Study|Lost to Follow-up|233|||
27947314|NCT00095576|81644101|FG001|Overall Study|Lost to Follow-up|229|||
27947315|NCT00095576|81644100|FG000|Overall Study|Protocol Violation|1|||
27947316|NCT00095576|81644101|FG001|Overall Study|Protocol Violation|0|||
27947317|NCT00095576|81644100|FG000|Overall Study|Withdrawal by Subject|34|||
27947318|NCT00095576|81644101|FG001|Overall Study|Withdrawal by Subject|47|||
27947319|NCT00095576|81644100|FG000|Overall Study|Option to switch to a rollover study|1097|||
27947320|NCT00095576|81644101|FG001|Overall Study|Option to switch to a rollover study|1099|||
27649070|NCT00380250|80554033|FG001|Overall Study|Protocol Violation|5|||
27649071|NCT00380250|80554032|FG000|Overall Study|Lost to Follow-up|14|||
27947321|NCT00095576|81644100|FG000|Overall Study|Site terminated|75|||
27649072|NCT00380250|80554033|FG001|Overall Study|Lost to Follow-up|5|||
27649073|NCT00380250|80554032|FG000|Overall Study|Physician Decision|1|||
27649074|NCT00380250|80554033|FG001|Overall Study|Physician Decision|0|||
27649075|NCT01779700|80554034|FG000|Overall Study|Adverse Event|4|||
27649076|NCT01779700|80554035|FG001|Overall Study|Adverse Event|3|||
27649077|NCT01779700|80554034|FG000|Overall Study|Withdrawal by Subject|0|||
27649078|NCT01779700|80554035|FG001|Overall Study|Withdrawal by Subject|2|||
27649079|NCT02208843|80554038|FG000|Overall Study|Clinical symptoms of progression|2|||
27649080|NCT02208843|80554038|FG000|Overall Study|Progression disease according to RECIST|24|||
27649081|NCT02208843|80554038|FG000|Overall Study|Adverse Event|12|||
27649082|NCT02208843|80554038|FG000|Overall Study|Protocol Violation|1|||
27649083|NCT02208843|80554038|FG000|Overall Study|Withdrawal by Subject|1|||
27649084|NCT02208843|80554038|FG000|Overall Study|Switched to commercial afatinib|20|||
27649085|NCT02106884|80554039|FG000|Overall Study|Change of diagnosis/exclusion|0|||
27649086|NCT02106884|80554040|FG001|Overall Study|Change of diagnosis/exclusion|1|||
27649087|NCT00570505|80554044|FG000|Overall Study|Adverse Event|7|||
27649088|NCT00570505|80554044|FG000|Overall Study|Withdrawal by Subject|7|||
27649089|NCT00570505|80554044|FG000|Overall Study|Lost to Follow-up|23|||
27649090|NCT00570505|80554044|FG000|Overall Study|Other loss to follow-up|4|||
27649091|NCT00065182|80554046|FG000|Overall Study|Adverse Event|24|||
27649092|NCT00065182|80554047|FG001|Overall Study|Adverse Event|17|||
27947322|NCT00095576|81644101|FG001|Overall Study|Site terminated|67|||
27947323|NCT00095576|81644100|FG000|Overall Study|Subject moved|30|||
27947324|NCT00095576|81644101|FG001|Overall Study|Subject moved|36|||
27947325|NCT02278003|81644104|FG000|Overall Study|Withdrawal by Subject|11|||
27947326|NCT02278003|81644105|FG001|Overall Study|Withdrawal by Subject|0|||
27947327|NCT02278003|81644104|FG000|Overall Study|Not Treated|1|||
27947328|NCT02278003|81644105|FG001|Overall Study|Not Treated|0|||
27947329|NCT02278003|81644104|FG000|Overall Study|Recognition task improperly completed|7|||
27947330|NCT02278003|81644105|FG001|Overall Study|Recognition task improperly completed|0|||
27947331|NCT00071032|81644106|FG000|Overall Study|Lost to Follow-up|1|||
27947332|NCT00071032|81644107|FG001|Overall Study|Lost to Follow-up|1|||
27947333|NCT00071032|81644106|FG000|Overall Study|Withdrawal by Subject|8|||
27947334|NCT00071032|81644107|FG001|Overall Study|Withdrawal by Subject|6|||
27947335|NCT00071032|81644106|FG000|Overall Study|Missing Primary Outcome|0|||
27947336|NCT00071032|81644107|FG001|Overall Study|Missing Primary Outcome|1|||
27947337|NCT00829868|81644108|FG000|Washout|Physician Decision|1|||
27947338|NCT00829868|81644109|FG001|Washout|Physician Decision|0|||
27947339|NCT03468998|81644120|FG000|Overall Study|Withdrawal by Subject|1|||
27947340|NCT03468998|81644121|FG001|Overall Study|Withdrawal by Subject|1|||
27947341|NCT03468998|81644122|FG002|Overall Study|Withdrawal by Subject|0|||
27947342|NCT03468998|81644123|FG003|Overall Study|Withdrawal by Subject|4|||
27947343|NCT03468998|81644124|FG004|Overall Study|Withdrawal by Subject|1|||
27947344|NCT03468998|81644125|FG005|Overall Study|Withdrawal by Subject|0|||
27947345|NCT01992757|81644126|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
27947346|NCT03391882|81644130|FG000|Study Overall|Adverse Event|3|||
27947347|NCT03391882|81644131|FG001|Study Overall|Adverse Event|6|||
27947348|NCT03391882|81644132|FG002|Study Overall|Adverse Event|1|||
27947349|NCT03391882|81644133|FG003|Study Overall|Adverse Event|1|||
27947350|NCT03391882|81644134|FG004|Study Overall|Adverse Event|3|||
27947351|NCT03391882|81644135|FG005|Study Overall|Adverse Event|1|||
27947352|NCT03391882|81644130|FG000|Study Overall|Lack of Efficacy|13|||
27947353|NCT03391882|81644131|FG001|Study Overall|Lack of Efficacy|9|||
27947354|NCT03391882|81644132|FG002|Study Overall|Lack of Efficacy|0|||
27947355|NCT03391882|81644133|FG003|Study Overall|Lack of Efficacy|0|||
27947356|NCT03391882|81644134|FG004|Study Overall|Lack of Efficacy|0|||
27947357|NCT03391882|81644135|FG005|Study Overall|Lack of Efficacy|0|||
27947358|NCT03391882|81644130|FG000|Study Overall|Withdrawal by Subject|3|||
27947359|NCT03391882|81644131|FG001|Study Overall|Withdrawal by Subject|3|||
27947360|NCT03391882|81644132|FG002|Study Overall|Withdrawal by Subject|2|||
27947361|NCT03391882|81644133|FG003|Study Overall|Withdrawal by Subject|2|||
27947362|NCT03391882|81644134|FG004|Study Overall|Withdrawal by Subject|1|||
27649093|NCT00065182|80554046|FG000|Overall Study|Lost to Follow-up|0|||
27649094|NCT00065182|80554047|FG001|Overall Study|Lost to Follow-up|4|||
27947363|NCT03391882|81644135|FG005|Study Overall|Withdrawal by Subject|3|||
27649095|NCT00065182|80554046|FG000|Overall Study|Protocol Violation|3|||
27649096|NCT00065182|80554047|FG001|Overall Study|Protocol Violation|4|||
27649097|NCT00065182|80554046|FG000|Overall Study|Serious adverse events (SAE)|1|||
27947364|NCT03391882|81644130|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27947365|NCT03391882|81644131|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
27947366|NCT03391882|81644132|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27947367|NCT03391882|81644133|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27947368|NCT03391882|81644134|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27947369|NCT03391882|81644135|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
27947370|NCT03391882|81644130|FG000|Study Overall|Protocol Violation|1|||
27947371|NCT03391882|81644131|FG001|Study Overall|Protocol Violation|0|||
27947372|NCT03391882|81644132|FG002|Study Overall|Protocol Violation|0|||
27947373|NCT03391882|81644133|FG003|Study Overall|Protocol Violation|0|||
27947374|NCT03391882|81644134|FG004|Study Overall|Protocol Violation|0|||
27947375|NCT03391882|81644135|FG005|Study Overall|Protocol Violation|0|||
27947376|NCT03391882|81644130|FG000|Part A - Titration Phase|Adverse Event|3|||
27947377|NCT03391882|81644131|FG001|Part A - Titration Phase|Adverse Event|6|||
27947378|NCT03391882|81644132|FG002|Part A - Titration Phase|Adverse Event|0|||
27947379|NCT03391882|81644133|FG003|Part A - Titration Phase|Adverse Event|0|||
27947380|NCT03391882|81644134|FG004|Part A - Titration Phase|Adverse Event|0|||
27947381|NCT03391882|81644135|FG005|Part A - Titration Phase|Adverse Event|0|||
27947382|NCT03391882|81644130|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
27947383|NCT03391882|81644131|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
27947384|NCT03391882|81644132|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
27947385|NCT03391882|81644133|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
27947386|NCT03391882|81644134|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
27947387|NCT03391882|81644135|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
27947388|NCT03391882|81644130|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
27947389|NCT03391882|81644131|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
27947390|NCT03391882|81644132|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
27947391|NCT03391882|81644133|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
27947392|NCT03391882|81644134|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
27947393|NCT03391882|81644135|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
27947394|NCT03391882|81644130|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27947395|NCT03391882|81644131|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
27947396|NCT03391882|81644132|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27947397|NCT03391882|81644133|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27947398|NCT03391882|81644134|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27947399|NCT03391882|81644135|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
27947400|NCT03391882|81644130|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
27947401|NCT03391882|81644131|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
27947402|NCT03391882|81644132|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
27947403|NCT03391882|81644133|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
27947404|NCT03391882|81644134|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
27947405|NCT03391882|81644135|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
27947406|NCT03391882|81644130|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
27947407|NCT03391882|81644131|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
27947408|NCT03391882|81644132|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
27947409|NCT03391882|81644133|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
27947410|NCT03391882|81644134|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
27947411|NCT03391882|81644135|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
27947412|NCT03391882|81644130|FG000|Part B - Treatment Phase|Adverse Event|0|||
27947413|NCT03391882|81644131|FG001|Part B - Treatment Phase|Adverse Event|0|||
27947414|NCT03391882|81644132|FG002|Part B - Treatment Phase|Adverse Event|1|||
27947415|NCT03391882|81644133|FG003|Part B - Treatment Phase|Adverse Event|1|||
27947416|NCT03391882|81644134|FG004|Part B - Treatment Phase|Adverse Event|3|||
27947417|NCT03391882|81644135|FG005|Part B - Treatment Phase|Adverse Event|1|||
27947418|NCT03391882|81644130|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
27947419|NCT03391882|81644131|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
27947420|NCT03391882|81644132|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
27947421|NCT03391882|81644133|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
27947422|NCT03391882|81644134|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
27947423|NCT03391882|81644135|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
27947424|NCT03131479|81644136|FG000|Overall Study|Adverse Event|0|||
27947425|NCT03131479|81644137|FG001|Overall Study|Adverse Event|0|||
27947426|NCT03131479|81644138|FG002|Overall Study|Adverse Event|1|||
27947427|NCT03131479|81644139|FG003|Overall Study|Adverse Event|1|||
27947428|NCT03131479|81644140|FG004|Overall Study|Adverse Event|0|||
27947429|NCT03131479|81644136|FG000|Overall Study|Subject/Guardian Decision|0|||
27947430|NCT03131479|81644137|FG001|Overall Study|Subject/Guardian Decision|0|||
27947431|NCT03131479|81644138|FG002|Overall Study|Subject/Guardian Decision|0|||
27947432|NCT03131479|81644139|FG003|Overall Study|Subject/Guardian Decision|1|||
27947433|NCT03131479|81644140|FG004|Overall Study|Subject/Guardian Decision|0|||
27947434|NCT02263547|81644141|FG000|Overall Study|Adverse Event|1|||
27947435|NCT02263547|81644141|FG000|Overall Study|Lost to Follow-up|2|||
27947436|NCT01538199|81644144|FG000|Overall Study|Lost to Follow-up|1|||
27947437|NCT01538199|81644145|FG001|Overall Study|Lost to Follow-up|2|||
27947438|NCT01538199|81644146|FG002|Overall Study|Lost to Follow-up|1|||
27947439|NCT01538199|81644147|FG003|Overall Study|Lost to Follow-up|0|||
27947440|NCT01538199|81644144|FG000|Overall Study|participant did not have time|1|||
27947441|NCT01538199|81644145|FG001|Overall Study|participant did not have time|0|||
27947442|NCT01538199|81644146|FG002|Overall Study|participant did not have time|0|||
27551427|NCT01543698|80207460|FG002|Phase 2|Disease progression|0|||
27947443|NCT01538199|81644147|FG003|Overall Study|participant did not have time|2|||
27947444|NCT01538199|81644144|FG000|Overall Study|Lack of Efficacy|0|||
27947445|NCT01538199|81644145|FG001|Overall Study|Lack of Efficacy|1|||
27947446|NCT01538199|81644146|FG002|Overall Study|Lack of Efficacy|0|||
27947447|NCT01538199|81644147|FG003|Overall Study|Lack of Efficacy|0|||
27947448|NCT04123704|81644149|FG000|Overall Study|Disease progression|2|||
27947449|NCT02467270|81644153|FG000|Overall Study|Participants Never Treated|0|||
27947450|NCT02467270|81644154|FG001|Overall Study|Participants Never Treated|1|||
27947451|NCT02467270|81644155|FG002|Overall Study|Participants Never Treated|0|||
27947452|NCT02467270|81644153|FG000|Overall Study|Ongoing|50|||
27947453|NCT02467270|81644154|FG001|Overall Study|Ongoing|41|||
27947454|NCT02467270|81644155|FG002|Overall Study|Ongoing|43|||
27947455|NCT02467270|81644153|FG000|Overall Study|Adverse Event|16|||
27947456|NCT02467270|81644154|FG001|Overall Study|Adverse Event|15|||
27947457|NCT02467270|81644155|FG002|Overall Study|Adverse Event|14|||
27947458|NCT02467270|81644153|FG000|Overall Study|Progressive Disease|7|||
27947459|NCT02467270|81644154|FG001|Overall Study|Progressive Disease|7|||
27947460|NCT02467270|81644155|FG002|Overall Study|Progressive Disease|4|||
27947461|NCT02467270|81644153|FG000|Overall Study|Death|2|||
27947462|NCT02467270|81644154|FG001|Overall Study|Death|0|||
27947463|NCT02467270|81644155|FG002|Overall Study|Death|2|||
27947464|NCT02467270|81644153|FG000|Overall Study|Lack of Efficacy|12|||
27947465|NCT02467270|81644154|FG001|Overall Study|Lack of Efficacy|18|||
27947466|NCT02467270|81644155|FG002|Overall Study|Lack of Efficacy|23|||
27947467|NCT02467270|81644153|FG000|Overall Study|Non-compliance With Study Drug|0|||
27947468|NCT02467270|81644154|FG001|Overall Study|Non-compliance With Study Drug|2|||
27947469|NCT02467270|81644155|FG002|Overall Study|Non-compliance With Study Drug|1|||
27947470|NCT02467270|81644153|FG000|Overall Study|Lost to Follow-up|2|||
27947471|NCT02467270|81644154|FG001|Overall Study|Lost to Follow-up|1|||
27947472|NCT02467270|81644155|FG002|Overall Study|Lost to Follow-up|0|||
27947473|NCT02467270|81644153|FG000|Overall Study|Pregnancy|0|||
27947474|NCT02467270|81644154|FG001|Overall Study|Pregnancy|1|||
27947475|NCT02467270|81644155|FG002|Overall Study|Pregnancy|0|||
27947476|NCT02467270|81644153|FG000|Overall Study|Physician Decision|0|||
27947477|NCT02467270|81644154|FG001|Overall Study|Physician Decision|4|||
27947478|NCT02467270|81644155|FG002|Overall Study|Physician Decision|1|||
27947479|NCT02467270|81644153|FG000|Overall Study|Withdrawal by Subject|4|||
27947480|NCT02467270|81644154|FG001|Overall Study|Withdrawal by Subject|3|||
27947481|NCT02467270|81644155|FG002|Overall Study|Withdrawal by Subject|5|||
27947482|NCT02467270|81644153|FG000|Overall Study|Reason not Specified|1|||
27947483|NCT02467270|81644154|FG001|Overall Study|Reason not Specified|2|||
27947484|NCT02467270|81644155|FG002|Overall Study|Reason not Specified|1|||
27947485|NCT03058952|81644156|FG000|Overall Study|Adverse Event|1|||
27947486|NCT03058952|81644157|FG001|Overall Study|Adverse Event|0|||
27947487|NCT03058952|81644156|FG000|Overall Study|Lost to Follow-up|15|||
27947488|NCT03058952|81644157|FG001|Overall Study|Lost to Follow-up|15|||
27947489|NCT03058952|81644156|FG000|Overall Study|Withdrawal by Subject|7|||
27947490|NCT03058952|81644157|FG001|Overall Study|Withdrawal by Subject|11|||
27649098|NCT00065182|80554047|FG001|Overall Study|Serious adverse events (SAE)|0|||
27649099|NCT00065182|80554046|FG000|Overall Study|Sponsor Decision|11|||
27649100|NCT00065182|80554047|FG001|Overall Study|Sponsor Decision|7|||
27649101|NCT00065182|80554046|FG000|Overall Study|Withdrawal by Subject|8|||
27649102|NCT00065182|80554047|FG001|Overall Study|Withdrawal by Subject|3|||
27649103|NCT00065182|80554046|FG000|Overall Study|No clinical benefit|1|||
27649104|NCT00065182|80554047|FG001|Overall Study|No clinical benefit|0|||
27649105|NCT00065182|80554046|FG000|Overall Study|Death|0|||
27649106|NCT00065182|80554047|FG001|Overall Study|Death|1|||
27649107|NCT00065182|80554046|FG000|Overall Study|Decline in Status|0|||
27649108|NCT00065182|80554047|FG001|Overall Study|Decline in Status|1|||
27649109|NCT03340961|80554048|FG000|Overall Study|Adverse Event|1|||
27649110|NCT03340961|80554049|FG001|Overall Study|Adverse Event|3|||
27649111|NCT03340961|80554050|FG002|Overall Study|Adverse Event|2|||
27649112|NCT03340961|80554051|FG003|Overall Study|Adverse Event|4|||
27649113|NCT03340961|80554048|FG000|Overall Study|Lost to Follow-up|0|||
27649114|NCT03340961|80554049|FG001|Overall Study|Lost to Follow-up|1|||
27649115|NCT03340961|80554050|FG002|Overall Study|Lost to Follow-up|0|||
27649116|NCT03340961|80554051|FG003|Overall Study|Lost to Follow-up|1|||
27649117|NCT03340961|80554048|FG000|Overall Study|Withdrawal by Subject|3|||
27649118|NCT03340961|80554049|FG001|Overall Study|Withdrawal by Subject|2|||
27649119|NCT03340961|80554050|FG002|Overall Study|Withdrawal by Subject|4|||
27649120|NCT03340961|80554051|FG003|Overall Study|Withdrawal by Subject|7|||
27649121|NCT03340961|80554048|FG000|Overall Study|Use of prohibited treatment|0|||
27649122|NCT03340961|80554049|FG001|Overall Study|Use of prohibited treatment|3|||
27649123|NCT03340961|80554050|FG002|Overall Study|Use of prohibited treatment|2|||
27649124|NCT03340961|80554051|FG003|Overall Study|Use of prohibited treatment|4|||
27947491|NCT03931330|81644159|FG000|Overall Study|Physician Decision|1|||
27947492|NCT00457626|81644160|FG000|Overall Study|Adverse Event|3|||
27947493|NCT00457626|81644160|FG000|Overall Study|Administrative Problems|2|||
27947494|NCT00457626|81644160|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
27947495|NCT00730327|81644162|FG000|Overall Study|Lost to Follow-up|14|||
27947496|NCT00730327|81644163|FG001|Overall Study|Lost to Follow-up|16|||
27947497|NCT00730327|81644162|FG000|Overall Study|Adverse Event|8|||
27947498|NCT00730327|81644163|FG001|Overall Study|Adverse Event|1|||
27947499|NCT00730327|81644162|FG000|Overall Study|Withdrawal by Subject|3|||
27947500|NCT00730327|81644163|FG001|Overall Study|Withdrawal by Subject|13|||
27947501|NCT00730327|81644162|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
27947502|NCT00730327|81644163|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
27947503|NCT01107886|81644168|FG000|Overall Study|Lost to Follow-up|15|||
27947504|NCT01107886|81644169|FG001|Overall Study|Lost to Follow-up|13|||
27947505|NCT01107886|81644168|FG000|Overall Study|Withdrawal by Subject|180|||
27947506|NCT01107886|81644169|FG001|Overall Study|Withdrawal by Subject|196|||
27947507|NCT01107886|81644168|FG000|Overall Study|Administrative withdrawal of consent|7|||
27947508|NCT01107886|81644169|FG001|Overall Study|Administrative withdrawal of consent|5|||
27947509|NCT04110145|81644170|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
27947510|NCT04110145|81644171|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
27947511|NCT04110145|81644172|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
27947512|NCT04110145|81644173|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
27947513|NCT04110145|81644174|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
27947514|NCT00652834|81644175|FG000|Overall Study|Withdrawal by Subject|3|||
27947515|NCT00652834|81644175|FG000|Overall Study|Lost to Follow-up|2|||
27947516|NCT02216526|81644176|FG000|Overall Study|Adverse Event|1|||
27947517|NCT02216526|81644177|FG001|Overall Study|Adverse Event|1|||
27947518|NCT02216526|81644178|FG002|Overall Study|Adverse Event|0|||
27947519|NCT02216526|81644176|FG000|Overall Study|Death|0|||
27649125|NCT03340961|80554048|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
27649126|NCT03340961|80554049|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
27649127|NCT03340961|80554050|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
27649128|NCT03340961|80554051|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
27649129|NCT03340961|80554048|FG000|Overall Study|Subject developed an exclusion criterion|0|||
27649130|NCT03340961|80554049|FG001|Overall Study|Subject developed an exclusion criterion|1|||
27649131|NCT03340961|80554050|FG002|Overall Study|Subject developed an exclusion criterion|0|||
27649132|NCT03340961|80554051|FG003|Overall Study|Subject developed an exclusion criterion|0|||
27649133|NCT03340961|80554048|FG000|Overall Study|Protocol Violation|1|||
27649134|NCT03340961|80554049|FG001|Overall Study|Protocol Violation|0|||
27649135|NCT03340961|80554050|FG002|Overall Study|Protocol Violation|1|||
27649136|NCT03340961|80554051|FG003|Overall Study|Protocol Violation|0|||
27649137|NCT03340961|80554048|FG000|Overall Study|Adverse Event|1|||
27649138|NCT03340961|80554049|FG001|Overall Study|Adverse Event|1|||
27649139|NCT03340961|80554050|FG002|Overall Study|Adverse Event|0|||
27649140|NCT03340961|80554051|FG003|Overall Study|Adverse Event|0|||
27649141|NCT03340961|80554048|FG000|Overall Study|Lack of Efficacy|0|||
27649142|NCT03340961|80554049|FG001|Overall Study|Lack of Efficacy|0|||
27649143|NCT03340961|80554050|FG002|Overall Study|Lack of Efficacy|0|||
27649144|NCT03340961|80554051|FG003|Overall Study|Lack of Efficacy|1|||
27649145|NCT01228734|80556808|FG000|Overall Study|Randomized, but not treated|0|||
27649146|NCT01228734|80556809|FG001|Overall Study|Randomized, but not treated|4|||
27649147|NCT01670877|80556822|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27649148|NCT01670877|80556823|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
27649149|NCT01670877|80556824|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27649150|NCT01670877|80556825|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27649151|NCT01670877|80556826|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27649152|NCT01670877|80556827|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
27649153|NCT01670877|80556822|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27649154|NCT01670877|80556823|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27649155|NCT01670877|80556824|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
27649156|NCT01670877|80556825|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27649157|NCT01670877|80556826|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27649158|NCT01670877|80556827|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
27649159|NCT01670877|80556822|FG000|Part I and Part 2|Grade 2 vomiting|0|||
27649160|NCT01670877|80556823|FG001|Part I and Part 2|Grade 2 vomiting|0|||
27649161|NCT01670877|80556824|FG002|Part I and Part 2|Grade 2 vomiting|0|||
27649162|NCT01670877|80556825|FG003|Part I and Part 2|Grade 2 vomiting|1|||
27649163|NCT01670877|80556826|FG004|Part I and Part 2|Grade 2 vomiting|0|||
27649164|NCT01670877|80556827|FG005|Part I and Part 2|Grade 2 vomiting|0|||
27649165|NCT01670877|80556822|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27947520|NCT02216526|81644177|FG001|Overall Study|Death|1|||
27947521|NCT02216526|81644178|FG002|Overall Study|Death|3|||
27947522|NCT02216526|81644176|FG000|Overall Study|Protocol Violation|2|||
27947523|NCT02216526|81644177|FG001|Overall Study|Protocol Violation|0|||
27947524|NCT02216526|81644178|FG002|Overall Study|Protocol Violation|2|||
27947525|NCT02216526|81644176|FG000|Overall Study|Hospitalization|2|||
27947526|NCT02216526|81644177|FG001|Overall Study|Hospitalization|1|||
27947527|NCT02216526|81644178|FG002|Overall Study|Hospitalization|3|||
27947528|NCT04992273|81644183|FG000|Overall Study|Lost to Follow-up|0|||
27947529|NCT04992273|81644184|FG001|Overall Study|Lost to Follow-up|1|||
27947530|NCT00829244|81644187|FG000|Overall Study|Adverse Event|1|||
27947531|NCT00829244|81644188|FG001|Overall Study|Adverse Event|3|||
27947532|NCT00829244|81644187|FG000|Overall Study|Protocol Violation|1|||
27947533|NCT00829244|81644188|FG001|Overall Study|Protocol Violation|0|||
27947534|NCT00829244|81644187|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
27947535|NCT00829244|81644188|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
27947536|NCT00829244|81644187|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
27947537|NCT00829244|81644188|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
27947538|NCT00829244|81644187|FG000|Overall Study|No fertilization|2|||
27947539|NCT00829244|81644188|FG001|Overall Study|No fertilization|2|||
27947540|NCT00829244|81644187|FG000|Overall Study|All embryos discarded|0|||
27947541|NCT00829244|81644188|FG001|Overall Study|All embryos discarded|3|||
27947542|NCT00829244|81644187|FG000|Overall Study|No embryo cleavage|0|||
27947543|NCT00829244|81644188|FG001|Overall Study|No embryo cleavage|2|||
27947544|NCT02296125|81644190|FG000|Overall Study|Withdrawal by Subject|18|||
27947545|NCT02296125|81644191|FG001|Overall Study|Withdrawal by Subject|8|||
27947546|NCT02296125|81644192|FG002|Overall Study|Withdrawal by Subject|6|||
27947547|NCT02296125|81644193|FG003|Overall Study|Withdrawal by Subject|2|||
27947548|NCT02296125|81644190|FG000|Overall Study|Adverse Event|41|||
27947549|NCT02296125|81644191|FG001|Overall Study|Adverse Event|52|||
27947550|NCT02296125|81644192|FG002|Overall Study|Adverse Event|9|||
27947551|NCT02296125|81644193|FG003|Overall Study|Adverse Event|4|||
27947552|NCT02296125|81644190|FG000|Overall Study|Severe non-compliance to protocol|0|||
27947553|NCT02296125|81644191|FG001|Overall Study|Severe non-compliance to protocol|1|||
27649166|NCT01670877|80556823|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27649167|NCT01670877|80556824|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27649168|NCT01670877|80556825|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
27649169|NCT01670877|80556826|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27649170|NCT01670877|80556827|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
27649171|NCT01670877|80556822|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27649172|NCT01670877|80556823|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27649173|NCT01670877|80556824|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27649174|NCT01670877|80556825|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
27649175|NCT01670877|80556826|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27649176|NCT01670877|80556827|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
27649177|NCT01240590|80556828|FG000|Phase I|Refused further treatment|0|||
27649178|NCT01240590|80556829|FG001|Phase I|Refused further treatment|0|||
27649179|NCT01240590|80556830|FG002|Phase I|Refused further treatment|3|||
27649180|NCT01240590|80556831|FG003|Phase I|Refused further treatment|0|||
27649181|NCT01240590|80556832|FG004|Phase I|Refused further treatment|0|||
27649182|NCT01240590|80556828|FG000|Phase II|Refused further treatment|0|||
27649183|NCT01240590|80556829|FG001|Phase II|Refused further treatment|0|||
27649184|NCT01240590|80556830|FG002|Phase II|Refused further treatment|0|||
27649185|NCT01240590|80556831|FG003|Phase II|Refused further treatment|2|||
27649186|NCT01240590|80556832|FG004|Phase II|Refused further treatment|1|||
27649187|NCT03735849|80556836|FG000|Overall Study|Lost to Follow-up|1|||
27649188|NCT03735849|80556837|FG001|Overall Study|Lost to Follow-up|0|||
27649189|NCT03735849|80556838|FG002|Overall Study|Lost to Follow-up|0|||
27649190|NCT03735849|80556836|FG000|Overall Study|Participant unable to adhere to visit|1|||
27649191|NCT03735849|80556837|FG001|Overall Study|Participant unable to adhere to visit|0|||
27649192|NCT03735849|80556838|FG002|Overall Study|Participant unable to adhere to visit|0|||
27649193|NCT03735849|80556836|FG000|Overall Study|Not Randomized|0|||
27649194|NCT03735849|80556837|FG001|Overall Study|Not Randomized|0|||
27947554|NCT02296125|81644192|FG002|Overall Study|Severe non-compliance to protocol|0|||
27947555|NCT02296125|81644193|FG003|Overall Study|Severe non-compliance to protocol|0|||
27947556|NCT02296125|81644190|FG000|Overall Study|Condition under investigation worsened|153|||
27947557|NCT02296125|81644191|FG001|Overall Study|Condition under investigation worsened|199|||
27947558|NCT02296125|81644192|FG002|Overall Study|Condition under investigation worsened|39|||
27947559|NCT02296125|81644193|FG003|Overall Study|Condition under investigation worsened|56|||
27947560|NCT02296125|81644190|FG000|Overall Study|Any reason not specifically recorded|6|||
27947561|NCT02296125|81644191|FG001|Overall Study|Any reason not specifically recorded|4|||
27649195|NCT03735849|80556838|FG002|Overall Study|Not Randomized|4|||
27947562|NCT02296125|81644192|FG002|Overall Study|Any reason not specifically recorded|2|||
27947563|NCT02296125|81644193|FG003|Overall Study|Any reason not specifically recorded|0|||
27947564|NCT03514134|81644194|FG000|Overall Study|Lost to Follow-up|0|||
27947565|NCT03514134|81644195|FG001|Overall Study|Lost to Follow-up|1|||
27947566|NCT01514357|81644196|FG000|Overall Study|Screen failure|2|||
27551428|NCT01543698|80207461|FG003|Phase 2|Disease progression|0|||
27649196|NCT00266656|80556839|FG000|Overall Study|Death|1|||
27649197|NCT00266656|80556840|FG001|Overall Study|Death|0|||
27649198|NCT00266656|80556839|FG000|Overall Study|Lost to Follow-up|4|||
27947567|NCT01514357|81644197|FG001|Overall Study|Screen failure|0|||
27947568|NCT01514357|81644196|FG000|Overall Study|Withdrawal by Subject|2|||
27947569|NCT01514357|81644197|FG001|Overall Study|Withdrawal by Subject|0|||
27947570|NCT00863304|81644212|FG000|Overall Study|Adverse Event|10|||
27947571|NCT00863304|81644213|FG001|Overall Study|Adverse Event|4|||
27947572|NCT00863304|81644214|FG002|Overall Study|Adverse Event|14|||
27947573|NCT00863304|81644215|FG003|Overall Study|Adverse Event|16|||
27947574|NCT00863304|81644212|FG000|Overall Study|Lost to Follow-up|1|||
27947575|NCT00863304|81644213|FG001|Overall Study|Lost to Follow-up|5|||
27947576|NCT00863304|81644214|FG002|Overall Study|Lost to Follow-up|4|||
27947577|NCT00863304|81644215|FG003|Overall Study|Lost to Follow-up|2|||
27947578|NCT00863304|81644212|FG000|Overall Study|Lack of Efficacy|57|||
27947579|NCT00863304|81644213|FG001|Overall Study|Lack of Efficacy|26|||
27947580|NCT00863304|81644214|FG002|Overall Study|Lack of Efficacy|30|||
27947581|NCT00863304|81644215|FG003|Overall Study|Lack of Efficacy|28|||
27947582|NCT00863304|81644212|FG000|Overall Study|Withdrawal by Subject|19|||
27947583|NCT00863304|81644213|FG001|Overall Study|Withdrawal by Subject|14|||
27947584|NCT00863304|81644214|FG002|Overall Study|Withdrawal by Subject|20|||
27947585|NCT00863304|81644215|FG003|Overall Study|Withdrawal by Subject|18|||
27947586|NCT00863304|81644212|FG000|Overall Study|Other|1|||
27947587|NCT00863304|81644213|FG001|Overall Study|Other|0|||
27947588|NCT00863304|81644214|FG002|Overall Study|Other|0|||
27947589|NCT00863304|81644215|FG003|Overall Study|Other|1|||
27947590|NCT00863304|81644212|FG000|Overall Study|Protocol Violation|2|||
27947591|NCT00863304|81644213|FG001|Overall Study|Protocol Violation|6|||
27947592|NCT00863304|81644214|FG002|Overall Study|Protocol Violation|2|||
27947593|NCT00863304|81644215|FG003|Overall Study|Protocol Violation|0|||
27947594|NCT00863304|81644212|FG000|Overall Study|Randomized, but not Treated|3|||
27947595|NCT00863304|81644213|FG001|Overall Study|Randomized, but not Treated|1|||
27947596|NCT00863304|81644214|FG002|Overall Study|Randomized, but not Treated|4|||
27947597|NCT00863304|81644215|FG003|Overall Study|Randomized, but not Treated|1|||
27947598|NCT00863304|81644212|FG000|Overall Study|Entered extension study|101|||
27947599|NCT00863304|81644213|FG001|Overall Study|Entered extension study|129|||
27947600|NCT00863304|81644214|FG002|Overall Study|Entered extension study|113|||
27947601|NCT00863304|81644215|FG003|Overall Study|Entered extension study|125|||
27947602|NCT00415636|81644216|FG000|Overall Study|Symptomatic deterioration|1|||
27947603|NCT00415636|81644217|FG001|Overall Study|Symptomatic deterioration|0|||
27947604|NCT00415636|81644218|FG002|Overall Study|Symptomatic deterioration|1|||
27947605|NCT00415636|81644219|FG003|Overall Study|Symptomatic deterioration|2|||
27947606|NCT00415636|81644220|FG004|Overall Study|Symptomatic deterioration|0|||
27947607|NCT00415636|81644221|FG005|Overall Study|Symptomatic deterioration|1|||
27947608|NCT00415636|81644216|FG000|Overall Study|Adverse Event|0|||
27947609|NCT00415636|81644217|FG001|Overall Study|Adverse Event|0|||
27947610|NCT00415636|81644218|FG002|Overall Study|Adverse Event|0|||
27947611|NCT00415636|81644219|FG003|Overall Study|Adverse Event|1|||
27947612|NCT00415636|81644220|FG004|Overall Study|Adverse Event|1|||
27947613|NCT00415636|81644221|FG005|Overall Study|Adverse Event|0|||
27947614|NCT00415636|81644216|FG000|Overall Study|Withdrawal by Subject|0|||
27649199|NCT00266656|80556840|FG001|Overall Study|Lost to Follow-up|1|||
27649200|NCT00266656|80556839|FG000|Overall Study|Withdrawal by Subject|4|||
27649201|NCT00266656|80556840|FG001|Overall Study|Withdrawal by Subject|2|||
27649202|NCT00266656|80556839|FG000|Overall Study|Did Not Reach Final Height|4|||
27649203|NCT00266656|80556840|FG001|Overall Study|Did Not Reach Final Height|8|||
27649204|NCT00266656|80556839|FG000|Overall Study|Parent/Caregiver Decision|1|||
27947615|NCT00415636|81644217|FG001|Overall Study|Withdrawal by Subject|0|||
27947616|NCT00415636|81644218|FG002|Overall Study|Withdrawal by Subject|0|||
27947617|NCT00415636|81644219|FG003|Overall Study|Withdrawal by Subject|0|||
27947618|NCT00415636|81644220|FG004|Overall Study|Withdrawal by Subject|1|||
27947619|NCT00415636|81644221|FG005|Overall Study|Withdrawal by Subject|0|||
27947620|NCT00415636|81644216|FG000|Overall Study|Disease progression|0|||
27947621|NCT00415636|81644217|FG001|Overall Study|Disease progression|0|||
27947622|NCT00415636|81644218|FG002|Overall Study|Disease progression|0|||
27947623|NCT00415636|81644219|FG003|Overall Study|Disease progression|3|||
27947624|NCT00415636|81644220|FG004|Overall Study|Disease progression|0|||
27947625|NCT00415636|81644221|FG005|Overall Study|Disease progression|1|||
27947626|NCT01153516|81644226|FG000|Overall Study|Both subjects refused surgery|2|||
27947627|NCT01153516|81644227|FG001|Overall Study|Both subjects refused surgery|0|||
27947628|NCT01605097|81644228|FG000|Overall Study|Protocol Violation|1|||
27947629|NCT04282148|81644229|FG000|Overall Study|Death|1|||
27947630|NCT04282148|81644229|FG000|Overall Study|Withdrawal by Subject|1|||
27947631|NCT04282148|81644229|FG000|Overall Study|Physician Decision|1|||
27947632|NCT00779909|81644232|FG000|Overall Study|Lost to Follow-up|1|||
27947633|NCT00779909|81644233|FG001|Overall Study|Lost to Follow-up|0|||
27947634|NCT00779909|81644234|FG002|Overall Study|Lost to Follow-up|0|||
27947635|NCT00779909|81644235|FG003|Overall Study|Lost to Follow-up|1|||
27649205|NCT00266656|80556840|FG001|Overall Study|Parent/Caregiver Decision|2|||
27947636|NCT00779909|81644232|FG000|Overall Study|Withdrawal by Subject|0|||
27947637|NCT00779909|81644233|FG001|Overall Study|Withdrawal by Subject|1|||
27649206|NCT01021748|80556843|FG000|Overall Study|Adverse Event|2|||
27649207|NCT01021748|80556844|FG001|Overall Study|Adverse Event|1|||
27649208|NCT01021748|80556845|FG002|Overall Study|Adverse Event|2|||
27649209|NCT01021748|80556846|FG003|Overall Study|Adverse Event|0|||
27649210|NCT01021748|80556847|FG004|Overall Study|Adverse Event|2|||
27649211|NCT01021748|80556848|FG005|Overall Study|Adverse Event|0|||
27649212|NCT01021748|80556849|FG006|Overall Study|Adverse Event|1|||
27947638|NCT00779909|81644234|FG002|Overall Study|Withdrawal by Subject|0|||
27947639|NCT00779909|81644235|FG003|Overall Study|Withdrawal by Subject|0|||
27947640|NCT01155050|81644237|FG000|Overall Study|Lost to Follow-up|15|||
27947641|NCT01155050|81644238|FG001|Overall Study|Lost to Follow-up|20|||
27947642|NCT01155050|81644239|FG002|Overall Study|Lost to Follow-up|19|||
27947643|NCT01155050|81644240|FG003|Overall Study|Lost to Follow-up|22|||
27947644|NCT00856557|81644241|FG000|Overall Study|No patients with contextual flags|12|||
27947645|NCT00856557|81644242|FG001|Overall Study|No patients with contextual flags|16|||
27947646|NCT01634152|81644243|FG000|Overall Study|Adverse Event|2|||
27947647|NCT01634152|81644244|FG001|Overall Study|Adverse Event|0|||
27947648|NCT01634152|81644245|FG002|Overall Study|Adverse Event|2|||
27947649|NCT01634152|81644243|FG000|Overall Study|Consent withdrawn not due to AE|1|||
27947650|NCT01634152|81644244|FG001|Overall Study|Consent withdrawn not due to AE|0|||
27947651|NCT01634152|81644245|FG002|Overall Study|Consent withdrawn not due to AE|1|||
27947652|NCT01634152|81644243|FG000|Overall Study|Not treated|0|||
27947653|NCT01634152|81644244|FG001|Overall Study|Not treated|1|||
27947654|NCT01634152|81644245|FG002|Overall Study|Not treated|0|||
27947655|NCT01634152|81644243|FG000|Overall Study|Other reason not defined above|1|||
27947656|NCT01634152|81644244|FG001|Overall Study|Other reason not defined above|0|||
27947657|NCT01634152|81644245|FG002|Overall Study|Other reason not defined above|1|||
27947658|NCT00129974|81644249|FG000|Overall Study|Other|1|||
27947659|NCT03485157|81644250|FG000|Double Blind Phase|Lost to Follow-up|4|||
27947660|NCT03485157|81644251|FG001|Double Blind Phase|Lost to Follow-up|4|||
27947661|NCT03485157|81644250|FG000|Double Blind Phase|Adverse Event|2|||
27947662|NCT03485157|81644251|FG001|Double Blind Phase|Adverse Event|1|||
27947663|NCT03485157|81644250|FG000|Double Blind Phase|Withdrawal by Subject|6|||
27947664|NCT03485157|81644251|FG001|Double Blind Phase|Withdrawal by Subject|9|||
27947665|NCT03485157|81644250|FG000|Double Blind Phase|Removal by PI|3|||
27947666|NCT03485157|81644251|FG001|Double Blind Phase|Removal by PI|7|||
27947667|NCT03485157|81644250|FG000|Open Label Phase|Lost to Follow-up|1|||
27947668|NCT03485157|81644251|FG001|Open Label Phase|Lost to Follow-up|2|||
27947669|NCT03485157|81644250|FG000|Open Label Phase|Adverse Event|0|||
27947670|NCT03485157|81644251|FG001|Open Label Phase|Adverse Event|1|||
27947671|NCT03485157|81644250|FG000|Open Label Phase|Withdrawal by Subject|1|||
27947672|NCT03485157|81644251|FG001|Open Label Phase|Withdrawal by Subject|2|||
27947673|NCT03485157|81644250|FG000|Open Label Phase|Removal by PI|2|||
27947674|NCT03485157|81644251|FG001|Open Label Phase|Removal by PI|0|||
27947675|NCT00654355|81644252|FG000|Overall Study|Lost to Follow-up|2|||
27947676|NCT00654355|81644253|FG001|Overall Study|Lost to Follow-up|2|||
27947677|NCT01537432|81644256|FG000|Overall Study|Lost to Follow-up|3|||
27947678|NCT01537432|81644257|FG001|Overall Study|Lost to Follow-up|1|||
27947679|NCT01537432|81644256|FG000|Overall Study|Withdrawal by Subject|0|||
27947680|NCT01537432|81644257|FG001|Overall Study|Withdrawal by Subject|1|||
27947681|NCT01537432|81644256|FG000|Overall Study|Administrative problems|1|||
27947682|NCT01537432|81644257|FG001|Overall Study|Administrative problems|0|||
27947683|NCT01537432|81644256|FG000|Overall Study|Adverse Event|1|||
27947684|NCT01537432|81644257|FG001|Overall Study|Adverse Event|0|||
27947685|NCT01537432|81644256|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
27947686|NCT01537432|81644257|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
27947687|NCT02014376|81644258|FG000|Overall Study|Adverse Event|1|||
27947688|NCT02014376|81644259|FG001|Overall Study|Adverse Event|1|||
27947689|NCT02014376|81644260|FG002|Overall Study|Adverse Event|0|||
27947690|NCT02014376|81644258|FG000|Overall Study|Lost to Follow-up|2|||
27947691|NCT02014376|81644259|FG001|Overall Study|Lost to Follow-up|0|||
27947692|NCT02014376|81644260|FG002|Overall Study|Lost to Follow-up|0|||
27947693|NCT03707821|81644268|FG000|Overall Study|Protocol Violation|0|||
27947694|NCT03707821|81644269|FG001|Overall Study|Protocol Violation|1|||
27947695|NCT03707821|81644268|FG000|Overall Study|Unsatisfactory Visual Response|1|||
27947696|NCT03707821|81644269|FG001|Overall Study|Unsatisfactory Visual Response|0|||
27947697|NCT03707821|81644268|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
27947698|NCT03707821|81644269|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
27649213|NCT01021748|80556850|FG007|Overall Study|Adverse Event|0|||
27649214|NCT01021748|80556851|FG008|Overall Study|Adverse Event|7|||
27649215|NCT01021748|80556843|FG000|Overall Study|Physician Decision|1|||
27947699|NCT04103450|81644270|FG000|Overall Study|Adverse Event|4|||
27947700|NCT04103450|81644271|FG001|Overall Study|Adverse Event|2|||
27947701|NCT04103450|81644270|FG000|Overall Study|Lack of Efficacy|3|||
27947702|NCT04103450|81644271|FG001|Overall Study|Lack of Efficacy|0|||
27649216|NCT01021748|80556844|FG001|Overall Study|Physician Decision|0|||
27649217|NCT01021748|80556845|FG002|Overall Study|Physician Decision|1|||
27947703|NCT04103450|81644270|FG000|Overall Study|Withdrawal by Subject|5|||
27947704|NCT04103450|81644271|FG001|Overall Study|Withdrawal by Subject|3|||
27947705|NCT04103450|81644270|FG000|Overall Study|Lost to Follow-up|1|||
27947706|NCT04103450|81644271|FG001|Overall Study|Lost to Follow-up|2|||
27947707|NCT04103450|81644270|FG000|Overall Study|Physician Decision|1|||
27947708|NCT04103450|81644271|FG001|Overall Study|Physician Decision|2|||
27947709|NCT04103450|81644270|FG000|Overall Study|Protocol Violation|1|||
27947710|NCT04103450|81644271|FG001|Overall Study|Protocol Violation|0|||
27947711|NCT04103450|81644270|FG000|Overall Study|Other|1|||
27947712|NCT04103450|81644271|FG001|Overall Study|Other|1|||
27947713|NCT00321932|81644272|FG000|Overall Study|Death|3|||
27947714|NCT00321932|81644273|FG001|Overall Study|Death|6|||
27947715|NCT00321932|81644272|FG000|Overall Study|Withdrawal by Subject|3|||
27947716|NCT00321932|81644273|FG001|Overall Study|Withdrawal by Subject|6|||
27947717|NCT00321932|81644272|FG000|Overall Study|Early relapse|2|||
27947718|NCT00321932|81644273|FG001|Overall Study|Early relapse|8|||
27947719|NCT00321932|81644272|FG000|Overall Study|Missing data|2|||
27947720|NCT00321932|81644273|FG001|Overall Study|Missing data|1|||
27947721|NCT03802916|81644274|FG000|Overall Study|Adverse Event|0|||
27947722|NCT03802916|81644275|FG001|Overall Study|Adverse Event|1|||
27947723|NCT03802916|81644274|FG000|Overall Study|Withdrawal by Subject|0|||
27947724|NCT03802916|81644275|FG001|Overall Study|Withdrawal by Subject|1|||
27947725|NCT00581100|81644276|FG000|Overall Study|Death|1|||
27947726|NCT00581100|81644277|FG001|Overall Study|Death|0|||
27947727|NCT00581100|81644276|FG000|Overall Study|Adverse Event|2|||
27947728|NCT00581100|81644277|FG001|Overall Study|Adverse Event|1|||
27947729|NCT00581100|81644276|FG000|Overall Study|Withdrawal by Subject|1|||
27947730|NCT00581100|81644277|FG001|Overall Study|Withdrawal by Subject|4|||
27947731|NCT00581100|81644276|FG000|Overall Study|Other|3|||
27947732|NCT00581100|81644277|FG001|Overall Study|Other|0|||
27947733|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947734|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
27947735|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947736|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
27947737|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
27947738|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
27947739|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
27947740|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947741|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947742|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947743|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947744|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947745|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947746|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947747|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947748|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
27947749|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
27947750|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
27947751|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
27947752|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
27947753|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
27947754|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
27947755|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
27947756|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
27947757|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
27947758|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
27947759|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
27947760|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
27947761|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
27947762|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
27947763|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
27649218|NCT01021748|80556846|FG003|Overall Study|Physician Decision|1|||
27947764|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
27947765|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
27947766|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
27947767|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947768|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947769|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27649219|NCT01021748|80556847|FG004|Overall Study|Physician Decision|0|||
27947770|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947771|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947772|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947773|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947774|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947775|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947776|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947777|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27649220|NCT01021748|80556848|FG005|Overall Study|Physician Decision|0|||
27649221|NCT01021748|80556849|FG006|Overall Study|Physician Decision|1|||
27649222|NCT01021748|80556850|FG007|Overall Study|Physician Decision|1|||
27649223|NCT01021748|80556851|FG008|Overall Study|Physician Decision|2|||
27649224|NCT01021748|80556843|FG000|Overall Study|Progressive Disease|3|||
27649225|NCT01021748|80556844|FG001|Overall Study|Progressive Disease|3|||
27649226|NCT01021748|80556845|FG002|Overall Study|Progressive Disease|4|||
27649227|NCT01021748|80556846|FG003|Overall Study|Progressive Disease|6|||
27649228|NCT01021748|80556847|FG004|Overall Study|Progressive Disease|7|||
27649229|NCT01021748|80556848|FG005|Overall Study|Progressive Disease|3|||
27649230|NCT01021748|80556849|FG006|Overall Study|Progressive Disease|0|||
27649231|NCT01021748|80556850|FG007|Overall Study|Progressive Disease|5|||
27649232|NCT01021748|80556851|FG008|Overall Study|Progressive Disease|6|||
27649233|NCT01021748|80556843|FG000|Overall Study|Withdrawal by Subject|0|||
27649234|NCT01021748|80556844|FG001|Overall Study|Withdrawal by Subject|0|||
27649235|NCT01021748|80556845|FG002|Overall Study|Withdrawal by Subject|0|||
27649236|NCT01021748|80556846|FG003|Overall Study|Withdrawal by Subject|0|||
27649237|NCT01021748|80556847|FG004|Overall Study|Withdrawal by Subject|0|||
27649238|NCT01021748|80556848|FG005|Overall Study|Withdrawal by Subject|0|||
27649239|NCT01021748|80556849|FG006|Overall Study|Withdrawal by Subject|1|||
27649240|NCT01021748|80556850|FG007|Overall Study|Withdrawal by Subject|0|||
27649241|NCT01021748|80556851|FG008|Overall Study|Withdrawal by Subject|1|||
27649242|NCT01021748|80556843|FG000|Overall Study|Not Treated|0|||
27649243|NCT01021748|80556844|FG001|Overall Study|Not Treated|1|||
27649244|NCT01021748|80556845|FG002|Overall Study|Not Treated|0|||
27649245|NCT01021748|80556846|FG003|Overall Study|Not Treated|0|||
27649246|NCT01021748|80556847|FG004|Overall Study|Not Treated|0|||
27649247|NCT01021748|80556848|FG005|Overall Study|Not Treated|0|||
27649248|NCT01021748|80556849|FG006|Overall Study|Not Treated|0|||
27649249|NCT01021748|80556850|FG007|Overall Study|Not Treated|0|||
27649250|NCT01021748|80556851|FG008|Overall Study|Not Treated|0|||
27649251|NCT04867382|80556853|FG000|Overall Study|Did not complete the survey|2|||
27649252|NCT04867382|80556854|FG001|Overall Study|Did not complete the survey|1|||
27649253|NCT01567852|80556855|FG000|Overall Study|Withdrawal by Subject|3|||
27649254|NCT01567852|80556856|FG001|Overall Study|Withdrawal by Subject|6|||
27649255|NCT01567852|80556855|FG000|Overall Study|ECT discontinued|1|||
27649256|NCT01567852|80556856|FG001|Overall Study|ECT discontinued|1|||
27649257|NCT02455557|80556861|FG000|Overall Study|Withdrawal by Subject|2|||
27649258|NCT00600353|80556862|FG000|Overall Study|history of malignancy within 5 years|1|||
27649259|NCT00600353|80556863|FG001|Overall Study|history of malignancy within 5 years|0|||
27649260|NCT00600353|80556862|FG000|Overall Study|History of prepartive regimen|0|||
27649261|NCT00600353|80556863|FG001|Overall Study|History of prepartive regimen|1|||
27649262|NCT05445557|80556868|FG000|Double Blind Part|Lost to Follow-up|1|||
27649263|NCT00853593|80556869|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
27649264|NCT00853593|80556869|FG000|Overall Study|Model 4396 lead not attempted|29|||
27649265|NCT00853593|80556869|FG000|Overall Study|Implant not attempted|4|||
27649266|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
27649267|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
27649268|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
27649269|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
27649270|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
27649271|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
27649272|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
27649273|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
27649274|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
27947778|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947779|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947780|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
27947781|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
27947782|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947783|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
27947784|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
27947785|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
27649275|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
27649276|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
27649277|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
27649278|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
27649279|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
27649280|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
27947786|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
27649281|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
27947787|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
27649282|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
27649283|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
27649284|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
27649285|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
27649286|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
27649287|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
27649288|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
27649289|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
27649290|NCT02203032|80556870|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
27649291|NCT02203032|80556871|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
27649292|NCT02203032|80556872|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
27649293|NCT02203032|80556873|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
27649294|NCT02203032|80556870|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
27649295|NCT02203032|80556871|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
27649296|NCT02203032|80556872|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
27649297|NCT02203032|80556873|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
27649298|NCT02203032|80556870|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
27649299|NCT02203032|80556871|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
27649300|NCT02203032|80556872|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
27649301|NCT02203032|80556873|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
27649302|NCT02203032|80556870|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
27649303|NCT02203032|80556871|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
27649304|NCT02203032|80556872|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
27649305|NCT02203032|80556873|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
27649306|NCT02203032|80556870|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
27649307|NCT02203032|80556871|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
27649308|NCT02203032|80556872|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
27649309|NCT02203032|80556873|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
27649310|NCT02203032|80556870|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
27649311|NCT02203032|80556871|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
27649312|NCT02203032|80556872|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
27649313|NCT02203032|80556873|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
27649314|NCT03909100|80556880|FG000|Overall Study|Protocol Deviation|2|||
27649315|NCT03909100|80556880|FG000|Overall Study|Technical Problems|4|||
27649316|NCT03909100|80556880|FG000|Overall Study|Withdrawal by Subject|4|||
27649317|NCT03909100|80556880|FG000|Overall Study|Lost to Follow-up|1|||
27649318|NCT03909100|80556880|FG000|Overall Study|Reason not Specified|4|||
27649319|NCT00513071|80556881|FG000|Overall Study|Adverse Event|1|||
27649320|NCT00513071|80556881|FG000|Overall Study|Withdrawal by Subject|1|||
27649321|NCT00513071|80556881|FG000|Overall Study|Physician Decision|3|||
27649322|NCT00360269|80556886|FG000|Overall Study|Lost to Follow-up|7|||
27649323|NCT00360269|80556887|FG001|Overall Study|Lost to Follow-up|9|||
27649324|NCT00360269|80556886|FG000|Overall Study|Physician Decision|1|||
27649325|NCT00360269|80556887|FG001|Overall Study|Physician Decision|2|||
27649326|NCT00360269|80556886|FG000|Overall Study|Adverse Event|1|||
27649327|NCT00360269|80556887|FG001|Overall Study|Adverse Event|0|||
27649328|NCT00360269|80556886|FG000|Overall Study|Withdrawal by Subject|1|||
27649329|NCT00360269|80556887|FG001|Overall Study|Withdrawal by Subject|1|||
27649330|NCT00761267|80556888|FG000|Overall Study|Death|1|||
27649331|NCT00761267|80556889|FG001|Overall Study|Death|2|||
27649332|NCT00761267|80556890|FG002|Overall Study|Death|5|||
27649333|NCT00761267|80556888|FG000|Overall Study|Lost to Follow-up|0|||
27649334|NCT00761267|80556889|FG001|Overall Study|Lost to Follow-up|0|||
27649335|NCT00761267|80556890|FG002|Overall Study|Lost to Follow-up|1|||
27649336|NCT00761267|80556888|FG000|Overall Study|Randomized but not treated|1|||
27649337|NCT00761267|80556889|FG001|Overall Study|Randomized but not treated|1|||
27649338|NCT00761267|80556890|FG002|Overall Study|Randomized but not treated|0|||
27649339|NCT00761267|80556888|FG000|Overall Study|Withdrawal by Subject|0|||
27649340|NCT00761267|80556889|FG001|Overall Study|Withdrawal by Subject|1|||
27649341|NCT00761267|80556890|FG002|Overall Study|Withdrawal by Subject|0|||
27649342|NCT02707952|80556891|FG000|Overall Study|Adverse Event|1|||
27649343|NCT02707952|80556892|FG001|Overall Study|Adverse Event|0|||
27649344|NCT02707952|80556893|FG002|Overall Study|Adverse Event|0|||
27649345|NCT02707952|80556894|FG003|Overall Study|Adverse Event|0|||
27649346|NCT02707952|80556891|FG000|Overall Study|Lost to Follow-up|1|||
27649347|NCT02707952|80556892|FG001|Overall Study|Lost to Follow-up|0|||
27649348|NCT02707952|80556893|FG002|Overall Study|Lost to Follow-up|0|||
27649349|NCT02707952|80556894|FG003|Overall Study|Lost to Follow-up|0|||
27649350|NCT02707952|80556891|FG000|Overall Study|Withdrawal by Subject|0|||
27649351|NCT02707952|80556892|FG001|Overall Study|Withdrawal by Subject|1|||
27649352|NCT02707952|80556893|FG002|Overall Study|Withdrawal by Subject|2|||
27649353|NCT02707952|80556894|FG003|Overall Study|Withdrawal by Subject|0|||
27649354|NCT01092416|80556895|FG000|Enrollment|Atherectomy device not inserted|3|||
27649355|NCT01092416|80556895|FG000|30-Day Follow-up|Death|2|||
27649356|NCT01092416|80556895|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
27649357|NCT01092416|80556895|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
27649358|NCT01092416|80556895|FG000|12-Month Follow-up|Death|16|||
27649359|NCT01092416|80556895|FG000|12-Month Follow-up|Lost to Follow-up|4|||
27649360|NCT01092416|80556895|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
27649361|NCT01092416|80556895|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
27649362|NCT01092416|80556895|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
27649363|NCT03938272|80556896|FG000|Overall Study|Withdrawal by Subject|1|||
27649364|NCT03938272|80556897|FG001|Overall Study|Withdrawal by Subject|0|||
27649365|NCT03938272|80556896|FG000|Overall Study|Physician Decision|0|||
27649366|NCT03938272|80556897|FG001|Overall Study|Physician Decision|2|||
27649367|NCT03938272|80556896|FG000|Overall Study|Study termination by sponsor|10|||
27649368|NCT03938272|80556897|FG001|Overall Study|Study termination by sponsor|8|||
27649369|NCT01005914|80556898|FG000|Overall Study|Adverse Event|4|||
27649370|NCT01005914|80556898|FG000|Overall Study|Death|4|||
27649371|NCT01005914|80556898|FG000|Overall Study|Lack of Efficacy|1|||
27649372|NCT01005914|80556898|FG000|Overall Study|Withdrawal by Subject|1|||
27649373|NCT00109031|80556899|FG000|Overall Study|Adverse Event|0|||
27649374|NCT00109031|80556900|FG001|Overall Study|Adverse Event|0|||
27649375|NCT00109031|80556901|FG002|Overall Study|Adverse Event|1|||
27649376|NCT00109031|80556902|FG003|Overall Study|Adverse Event|0|||
27649377|NCT00109031|80556899|FG000|Overall Study|Withdrawal by Subject|0|||
27649378|NCT00109031|80556900|FG001|Overall Study|Withdrawal by Subject|1|||
27649379|NCT00109031|80556901|FG002|Overall Study|Withdrawal by Subject|0|||
27649380|NCT00109031|80556902|FG003|Overall Study|Withdrawal by Subject|0|||
27649381|NCT00109031|80556899|FG000|Overall Study|Physician Decision|0|||
27649382|NCT00109031|80556900|FG001|Overall Study|Physician Decision|1|||
27649383|NCT00109031|80556901|FG002|Overall Study|Physician Decision|0|||
27649384|NCT00109031|80556902|FG003|Overall Study|Physician Decision|0|||
27649385|NCT00109031|80556899|FG000|Overall Study|Protocol Violation|0|||
27649386|NCT00109031|80556900|FG001|Overall Study|Protocol Violation|0|||
27649387|NCT00109031|80556901|FG002|Overall Study|Protocol Violation|1|||
27649388|NCT00109031|80556902|FG003|Overall Study|Protocol Violation|0|||
27649389|NCT02169414|80556907|FG000|Overall Study|Withdrawal by Subject|1|||
27649390|NCT02169414|80556908|FG001|Overall Study|Withdrawal by Subject|0|||
27649391|NCT02169414|80556909|FG002|Overall Study|Withdrawal by Subject|0|||
27649392|NCT02169414|80556910|FG003|Overall Study|Withdrawal by Subject|0|||
27649393|NCT02169414|80556907|FG000|Overall Study|Adverse Event|0|||
27649394|NCT02169414|80556908|FG001|Overall Study|Adverse Event|1|||
27649395|NCT02169414|80556909|FG002|Overall Study|Adverse Event|0|||
27649396|NCT02169414|80556910|FG003|Overall Study|Adverse Event|0|||
27649397|NCT02114515|80556911|FG000|Overall Study|Lost to Follow-up|52|||
27649398|NCT02114515|80556912|FG001|Overall Study|Lost to Follow-up|55|||
27649399|NCT02114515|80556911|FG000|Overall Study|Death|12|||
27649400|NCT02114515|80556912|FG001|Overall Study|Death|12|||
27649401|NCT02114515|80556911|FG000|Overall Study|Withdrawal by Subject|4|||
27649402|NCT02114515|80556912|FG001|Overall Study|Withdrawal by Subject|22|||
27649403|NCT02114515|80556911|FG000|Overall Study|Other|65|||
27649404|NCT02114515|80556912|FG001|Overall Study|Other|61|||
27649405|NCT03075878|80556913|FG000|Overall Study|Physician Decision|1|||
27649406|NCT04820491|80556914|FG000|Overall Study|Withdrawal by Subject|1|||
27649407|NCT04820491|80556915|FG001|Overall Study|Withdrawal by Subject|0|||
27649408|NCT04070105|80556916|FG000|Overall Study|Lost to Follow-up|0|||
27649409|NCT04070105|80556917|FG001|Overall Study|Lost to Follow-up|0|||
27649410|NCT04070105|80556918|FG002|Overall Study|Lost to Follow-up|0|||
27649411|NCT04070105|80556919|FG003|Overall Study|Lost to Follow-up|0|||
27649412|NCT04070105|80556920|FG004|Overall Study|Lost to Follow-up|0|||
27649413|NCT04070105|80556921|FG005|Overall Study|Lost to Follow-up|1|||
27649414|NCT01989104|80556922|FG000|Overall Study|Withdrawal by Subject|3|||
27649415|NCT01989104|80556923|FG001|Overall Study|Withdrawal by Subject|0|||
27746424|NCT02052960|80899626|FG000|Overall Study|Other|25|||
27746425|NCT02052960|80899627|FG001|Overall Study|Other|15|||
27649416|NCT01989104|80556924|FG002|Overall Study|Withdrawal by Subject|0|||
27649417|NCT01989104|80556925|FG003|Overall Study|Withdrawal by Subject|0|||
27746426|NCT02805907|80899628|FG000|Overall Study|Lost to Follow-up|3|||
27649418|NCT01989104|80556926|FG004|Overall Study|Withdrawal by Subject|0|||
27649419|NCT00357994|80556927|FG000|Overall Study|Adverse Event|1|||
27649420|NCT00357994|80556928|FG001|Overall Study|Adverse Event|2|||
27649421|NCT00357994|80556927|FG000|Overall Study|Lack of Efficacy|0|||
27649422|NCT00357994|80556928|FG001|Overall Study|Lack of Efficacy|1|||
27649423|NCT00357994|80556927|FG000|Overall Study|Protocol Violation|1|||
27649424|NCT00357994|80556928|FG001|Overall Study|Protocol Violation|0|||
27649425|NCT00428714|80556934|FG000|Overall Study|Progressive Disease|28|||
27649426|NCT00428714|80556935|FG001|Overall Study|Progressive Disease|36|||
27947788|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27649427|NCT00428714|80556934|FG000|Overall Study|Withdrawal by Subject|0|||
27649428|NCT00428714|80556935|FG001|Overall Study|Withdrawal by Subject|3|||
27746427|NCT02805907|80899629|FG001|Overall Study|Lost to Follow-up|3|||
27649429|NCT00428714|80556934|FG000|Overall Study|Adverse Event|0|||
27649430|NCT00428714|80556935|FG001|Overall Study|Adverse Event|2|||
27649431|NCT00428714|80556934|FG000|Overall Study|Physician Decision|1|||
27649432|NCT00428714|80556935|FG001|Overall Study|Physician Decision|1|||
27649433|NCT00428714|80556934|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
27649434|NCT00428714|80556935|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
27649435|NCT00428714|80556934|FG000|Overall Study|Death due to other then PD|1|||
27649436|NCT00428714|80556935|FG001|Overall Study|Death due to other then PD|0|||
27649437|NCT02410278|80556936|FG000|Run-in Period|Adverse Event|5|||
27649438|NCT02410278|80556937|FG001|Run-in Period|Adverse Event|0|||
27649439|NCT02410278|80556938|FG002|Run-in Period|Adverse Event|0|||
27649440|NCT02410278|80556936|FG000|Run-in Period|GSRS Threshold Not Met|30|||
27649441|NCT02410278|80556937|FG001|Run-in Period|GSRS Threshold Not Met|0|||
27649442|NCT02410278|80556938|FG002|Run-in Period|GSRS Threshold Not Met|0|||
27947789|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27649443|NCT02410278|80556936|FG000|Run-in Period|Lost to Follow-up|1|||
27649444|NCT02410278|80556937|FG001|Run-in Period|Lost to Follow-up|0|||
27649445|NCT02410278|80556938|FG002|Run-in Period|Lost to Follow-up|0|||
27649446|NCT02410278|80556936|FG000|Run-in Period|Withdrawal by Subject|1|||
27649447|NCT02410278|80556937|FG001|Run-in Period|Withdrawal by Subject|0|||
27649448|NCT02410278|80556938|FG002|Run-in Period|Withdrawal by Subject|0|||
27649449|NCT02410278|80556936|FG000|Run-in Period|Pregnancy|1|||
27649450|NCT02410278|80556937|FG001|Run-in Period|Pregnancy|0|||
27649451|NCT02410278|80556938|FG002|Run-in Period|Pregnancy|0|||
27649452|NCT02410278|80556936|FG000|Study Treatment Period|Adverse Event|0|||
27649453|NCT02410278|80556937|FG001|Study Treatment Period|Adverse Event|6|||
27649454|NCT02410278|80556938|FG002|Study Treatment Period|Adverse Event|3|||
27649455|NCT02410278|80556936|FG000|Study Treatment Period|Physician Decision|0|||
27649456|NCT02410278|80556937|FG001|Study Treatment Period|Physician Decision|0|||
27649457|NCT02410278|80556938|FG002|Study Treatment Period|Physician Decision|1|||
27649458|NCT02410278|80556936|FG000|Study Treatment Period|Withdrawal by Subject|0|||
27649459|NCT02410278|80556937|FG001|Study Treatment Period|Withdrawal by Subject|1|||
27649460|NCT02410278|80556938|FG002|Study Treatment Period|Withdrawal by Subject|0|||
27649461|NCT02410278|80556936|FG000|Study Treatment Period|Other|0|||
27649462|NCT02410278|80556937|FG001|Study Treatment Period|Other|3|||
27649463|NCT02410278|80556938|FG002|Study Treatment Period|Other|0|||
27649464|NCT02410278|80556936|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
27649465|NCT02410278|80556937|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
27649466|NCT02410278|80556938|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
27649467|NCT02157948|80556939|FG000|Overall Study|Withdrawal by Subject|4|||
27649468|NCT02157948|80556940|FG001|Overall Study|Withdrawal by Subject|5|||
27649469|NCT02157948|80556939|FG000|Overall Study|Lost to Follow-up|3|||
27649470|NCT02157948|80556940|FG001|Overall Study|Lost to Follow-up|2|||
27649471|NCT02157948|80556939|FG000|Overall Study|Protocol Specified Criteria|2|||
27649472|NCT02157948|80556940|FG001|Overall Study|Protocol Specified Criteria|1|||
27649473|NCT02157948|80556939|FG000|Overall Study|Decision by Sponsor|0|||
27649474|NCT02157948|80556940|FG001|Overall Study|Decision by Sponsor|1|||
27947790|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27649475|NCT01229176|80556947|FG000|Overall Study|Withdrawal by Subject|0|||
27649476|NCT01229176|80556948|FG001|Overall Study|Withdrawal by Subject|0|||
27947791|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947792|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947793|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947794|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947795|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947796|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27947797|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947798|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947799|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947800|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
27649477|NCT01229176|80556949|FG002|Overall Study|Withdrawal by Subject|0|||
27649478|NCT01229176|80556950|FG003|Overall Study|Withdrawal by Subject|1|||
27649479|NCT01229176|80556951|FG004|Overall Study|Withdrawal by Subject|1|||
27649480|NCT01229176|80556952|FG005|Overall Study|Withdrawal by Subject|1|||
27649481|NCT01229176|80556953|FG006|Overall Study|Withdrawal by Subject|0|||
27649482|NCT01229176|80556954|FG007|Overall Study|Withdrawal by Subject|1|||
27649483|NCT01229176|80556947|FG000|Overall Study|Lost to Follow-up|0|||
27649484|NCT01229176|80556948|FG001|Overall Study|Lost to Follow-up|3|||
27649485|NCT01229176|80556949|FG002|Overall Study|Lost to Follow-up|0|||
27649486|NCT01229176|80556950|FG003|Overall Study|Lost to Follow-up|0|||
27649487|NCT01229176|80556951|FG004|Overall Study|Lost to Follow-up|1|||
27649488|NCT01229176|80556952|FG005|Overall Study|Lost to Follow-up|1|||
27649489|NCT01229176|80556953|FG006|Overall Study|Lost to Follow-up|0|||
27649490|NCT01229176|80556954|FG007|Overall Study|Lost to Follow-up|2|||
27649491|NCT01686152|80556955|FG000|Overall Study|Withdrawal by Subject|11|||
27649492|NCT01686152|80556956|FG001|Overall Study|Withdrawal by Subject|11|||
27649493|NCT01686152|80556957|FG002|Overall Study|Withdrawal by Subject|3|||
27649494|NCT01686152|80556955|FG000|Overall Study|Drug Code Unblinded|0|||
27649495|NCT01686152|80556956|FG001|Overall Study|Drug Code Unblinded|1|||
27649496|NCT01686152|80556957|FG002|Overall Study|Drug Code Unblinded|0|||
27649497|NCT01686152|80556955|FG000|Overall Study|Protocol Violation|6|||
27649498|NCT01686152|80556956|FG001|Overall Study|Protocol Violation|1|||
27649499|NCT01686152|80556957|FG002|Overall Study|Protocol Violation|0|||
27649500|NCT01686152|80556955|FG000|Overall Study|Adverse Event|12|||
27947801|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947802|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947803|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
27947804|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947805|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947806|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947807|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947808|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947809|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947810|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947811|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947812|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
27947813|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947814|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947815|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
27947816|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947817|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947818|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947819|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947820|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947821|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947822|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947823|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947824|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947825|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947826|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947827|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947828|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
27947829|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
27947830|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
27649501|NCT01686152|80556956|FG001|Overall Study|Adverse Event|11|||
27649502|NCT01686152|80556957|FG002|Overall Study|Adverse Event|0|||
27649503|NCT01686152|80556955|FG000|Overall Study|Lack of Efficacy|0|||
27649504|NCT01686152|80556956|FG001|Overall Study|Lack of Efficacy|0|||
27649505|NCT01686152|80556957|FG002|Overall Study|Lack of Efficacy|1|||
27649506|NCT01686152|80556955|FG000|Overall Study|IP Non-compliance|5|||
27649507|NCT01686152|80556956|FG001|Overall Study|IP Non-compliance|5|||
27649508|NCT01686152|80556957|FG002|Overall Study|IP Non-compliance|0|||
27649509|NCT01686152|80556955|FG000|Overall Study|Lost to Follow-up|7|||
27649510|NCT01686152|80556956|FG001|Overall Study|Lost to Follow-up|6|||
27649511|NCT01686152|80556957|FG002|Overall Study|Lost to Follow-up|5|||
27649512|NCT01640951|80556958|FG000|Overall Study|Adverse Event|8|||
27649513|NCT01640951|80556959|FG001|Overall Study|Adverse Event|3|||
27649514|NCT01640951|80556960|FG002|Overall Study|Adverse Event|10|||
27649515|NCT01640951|80556961|FG003|Overall Study|Adverse Event|6|||
27649516|NCT01640951|80556962|FG004|Overall Study|Adverse Event|1|||
27649517|NCT01640951|80556963|FG005|Overall Study|Adverse Event|11|||
27649518|NCT01640951|80556964|FG006|Overall Study|Adverse Event|1|||
27649519|NCT01640951|80556965|FG007|Overall Study|Adverse Event|3|||
27649520|NCT01640951|80556958|FG000|Overall Study|Lack of Efficacy|20|||
27649521|NCT01640951|80556959|FG001|Overall Study|Lack of Efficacy|1|||
27649522|NCT01640951|80556960|FG002|Overall Study|Lack of Efficacy|7|||
27649523|NCT01640951|80556961|FG003|Overall Study|Lack of Efficacy|14|||
27649524|NCT01640951|80556962|FG004|Overall Study|Lack of Efficacy|0|||
27649525|NCT01640951|80556963|FG005|Overall Study|Lack of Efficacy|6|||
27649526|NCT01640951|80556964|FG006|Overall Study|Lack of Efficacy|5|||
27649527|NCT01640951|80556965|FG007|Overall Study|Lack of Efficacy|6|||
27649528|NCT01640951|80556958|FG000|Overall Study|Lost to Follow-up|1|||
27649529|NCT01640951|80556959|FG001|Overall Study|Lost to Follow-up|0|||
27649530|NCT01640951|80556960|FG002|Overall Study|Lost to Follow-up|6|||
27649531|NCT01640951|80556961|FG003|Overall Study|Lost to Follow-up|2|||
27947831|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
27947832|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947833|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947834|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27649532|NCT01640951|80556962|FG004|Overall Study|Lost to Follow-up|2|||
27649533|NCT01640951|80556963|FG005|Overall Study|Lost to Follow-up|3|||
27649534|NCT01640951|80556964|FG006|Overall Study|Lost to Follow-up|1|||
27649535|NCT01640951|80556965|FG007|Overall Study|Lost to Follow-up|1|||
27649536|NCT01640951|80556958|FG000|Overall Study|Non-compliance with study treatment|0|||
27649537|NCT01640951|80556959|FG001|Overall Study|Non-compliance with study treatment|0|||
27649538|NCT01640951|80556960|FG002|Overall Study|Non-compliance with study treatment|1|||
27649539|NCT01640951|80556961|FG003|Overall Study|Non-compliance with study treatment|1|||
27649540|NCT01640951|80556962|FG004|Overall Study|Non-compliance with study treatment|1|||
27649541|NCT01640951|80556963|FG005|Overall Study|Non-compliance with study treatment|4|||
27649542|NCT01640951|80556964|FG006|Overall Study|Non-compliance with study treatment|1|||
27649543|NCT01640951|80556965|FG007|Overall Study|Non-compliance with study treatment|0|||
27649544|NCT01640951|80556958|FG000|Overall Study|Physician Decision|2|||
27649545|NCT01640951|80556959|FG001|Overall Study|Physician Decision|5|||
27649546|NCT01640951|80556960|FG002|Overall Study|Physician Decision|2|||
27649547|NCT01640951|80556961|FG003|Overall Study|Physician Decision|2|||
27649548|NCT01640951|80556962|FG004|Overall Study|Physician Decision|2|||
27649549|NCT01640951|80556963|FG005|Overall Study|Physician Decision|3|||
27649550|NCT01640951|80556964|FG006|Overall Study|Physician Decision|3|||
27649551|NCT01640951|80556965|FG007|Overall Study|Physician Decision|0|||
27649552|NCT01640951|80556958|FG000|Overall Study|Pregnancy|3|||
27649553|NCT01640951|80556959|FG001|Overall Study|Pregnancy|0|||
27649554|NCT01640951|80556960|FG002|Overall Study|Pregnancy|0|||
27649555|NCT01640951|80556961|FG003|Overall Study|Pregnancy|4|||
27649556|NCT01640951|80556962|FG004|Overall Study|Pregnancy|0|||
27649557|NCT01640951|80556963|FG005|Overall Study|Pregnancy|0|||
27649558|NCT01640951|80556964|FG006|Overall Study|Pregnancy|2|||
27649559|NCT01640951|80556965|FG007|Overall Study|Pregnancy|0|||
27649560|NCT01640951|80556958|FG000|Overall Study|Protocol Deviation|0|||
27649561|NCT01640951|80556959|FG001|Overall Study|Protocol Deviation|1|||
27947835|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947836|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947837|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947838|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947839|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947840|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947841|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947842|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947843|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947844|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27947845|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
27947846|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
27947847|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
27947848|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
27947849|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
27947850|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
27947851|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
27649562|NCT01640951|80556960|FG002|Overall Study|Protocol Deviation|2|||
27649563|NCT01640951|80556961|FG003|Overall Study|Protocol Deviation|1|||
27649564|NCT01640951|80556962|FG004|Overall Study|Protocol Deviation|0|||
27649565|NCT01640951|80556963|FG005|Overall Study|Protocol Deviation|1|||
27649566|NCT01640951|80556964|FG006|Overall Study|Protocol Deviation|0|||
27649567|NCT01640951|80556965|FG007|Overall Study|Protocol Deviation|0|||
27649568|NCT01640951|80556958|FG000|Overall Study|Subject/Guardian decision|12|||
27649569|NCT01640951|80556959|FG001|Overall Study|Subject/Guardian decision|4|||
27649570|NCT01640951|80556960|FG002|Overall Study|Subject/Guardian decision|13|||
27649571|NCT01640951|80556961|FG003|Overall Study|Subject/Guardian decision|15|||
27649572|NCT01640951|80556962|FG004|Overall Study|Subject/Guardian decision|7|||
27947852|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
27649573|NCT01640951|80556963|FG005|Overall Study|Subject/Guardian decision|19|||
27649574|NCT01640951|80556964|FG006|Overall Study|Subject/Guardian decision|5|||
27649575|NCT01640951|80556965|FG007|Overall Study|Subject/Guardian decision|4|||
27649576|NCT01640951|80556958|FG000|Overall Study|Death|0|||
27649577|NCT01640951|80556959|FG001|Overall Study|Death|1|||
27649578|NCT01640951|80556960|FG002|Overall Study|Death|1|||
27649579|NCT01640951|80556961|FG003|Overall Study|Death|0|||
27649580|NCT01640951|80556962|FG004|Overall Study|Death|0|||
27649581|NCT01640951|80556963|FG005|Overall Study|Death|0|||
27649582|NCT01640951|80556964|FG006|Overall Study|Death|0|||
27649583|NCT01640951|80556965|FG007|Overall Study|Death|2|||
27649584|NCT01450007|80556966|FG000|Overall Study|Late exclusion before treatment|2|||
27649585|NCT01450007|80556967|FG001|Overall Study|Late exclusion before treatment|3|||
27649586|NCT01450007|80556968|FG002|Overall Study|Late exclusion before treatment|2|||
27649587|NCT01450007|80556966|FG000|Overall Study|Protocol Violation|0|||
27649588|NCT01450007|80556967|FG001|Overall Study|Protocol Violation|1|||
27649589|NCT01450007|80556968|FG002|Overall Study|Protocol Violation|1|||
27649590|NCT01450007|80556966|FG000|Overall Study|Adverse Event|0|||
27649591|NCT01450007|80556967|FG001|Overall Study|Adverse Event|1|||
27649592|NCT01450007|80556968|FG002|Overall Study|Adverse Event|0|||
27649593|NCT00620854|80556969|FG000|Washout 1|Withdrawal by Subject|0|||
27649594|NCT00620854|80556970|FG001|Washout 1|Withdrawal by Subject|0|||
27649595|NCT00620854|80556971|FG002|Washout 1|Withdrawal by Subject|1|||
27649596|NCT00620854|80556972|FG003|Washout 1|Withdrawal by Subject|1|||
27649597|NCT00620854|80556973|FG004|Washout 1|Withdrawal by Subject|0|||
27649598|NCT00620854|80556974|FG005|Washout 1|Withdrawal by Subject|0|||
27649599|NCT00068107|80556976|FG000|Overall Study|end-stage renal disease|6|||
27649600|NCT00068107|80556976|FG000|Overall Study|Death|2|||
27649601|NCT00068107|80556976|FG000|Overall Study|Withdrawal by Subject|1|||
27649602|NCT01719172|80556984|FG000|Overall Study|Lost to Follow-up|1|||
27649603|NCT01719172|80556984|FG000|Overall Study|Death|1|||
27649604|NCT02255474|80556985|FG000|Overall Study|Lost to Follow-up|1|||
27649605|NCT02255474|80556986|FG001|Overall Study|Lost to Follow-up|1|||
27649606|NCT02255474|80556987|FG002|Overall Study|Lost to Follow-up|3|||
27649607|NCT02255474|80556985|FG000|Overall Study|Withdrawal by Subject|1|||
27649608|NCT02255474|80556986|FG001|Overall Study|Withdrawal by Subject|1|||
27649609|NCT02255474|80556987|FG002|Overall Study|Withdrawal by Subject|0|||
27649610|NCT02165202|80556988|FG000|Oral Phase|Refused further participation|5|||
27649611|NCT02165202|80556989|FG001|Oral Phase|Refused further participation|1|||
27649612|NCT02165202|80556988|FG000|Oral Phase|Study product Related Toxicity|1|||
27649613|NCT02165202|80556989|FG001|Oral Phase|Study product Related Toxicity|0|||
27947853|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
27947854|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
27947855|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
27947856|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
27947857|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
27947858|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
27947859|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
27947860|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
27947861|NCT02958865|81644278|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947862|NCT02958865|81644279|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947863|NCT02958865|81644280|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947864|NCT02958865|81644281|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947865|NCT02958865|81644282|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
27947866|NCT02958865|81644283|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947867|NCT02958865|81644284|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947868|NCT02958865|81644285|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947869|NCT02958865|81644286|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947870|NCT02958865|81644287|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947871|NCT02958865|81644288|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947872|NCT02958865|81644289|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947873|NCT02958865|81644290|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947874|NCT02958865|81644291|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947875|NCT02958865|81644292|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947876|NCT02958865|81644293|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27947877|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947878|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947879|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947880|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947881|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947882|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947883|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947884|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
27947885|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
27947886|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
27947887|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
27947888|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
27947889|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
27947890|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
27947891|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
27947892|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
27746428|NCT02926573|80899630|FG000|Overall Study|Nausea|1|||
27947893|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947894|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27649614|NCT02165202|80556988|FG000|Oral Phase|Unable to contact Participant|1|||
27649615|NCT02165202|80556989|FG001|Oral Phase|Unable to contact Participant|1|||
27947895|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947896|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947897|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947898|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947899|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947900|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947901|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
27947902|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
27947903|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947904|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
27947905|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947906|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
27947907|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
27947908|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
27947909|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27649616|NCT02165202|80556988|FG000|Oral Phase|Clinical reasons|1|||
27649617|NCT02165202|80556989|FG001|Oral Phase|Clinical reasons|0|||
27649618|NCT02165202|80556988|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
27649619|NCT02165202|80556989|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
27649620|NCT02165202|80556988|FG000|Oral Phase|CMC advised termination|1|||
27649621|NCT02165202|80556989|FG001|Oral Phase|CMC advised termination|0|||
27649622|NCT02165202|80556988|FG000|Oral Phase|Relocated, no follow-up planned|1|||
27947910|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947911|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947912|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947913|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947914|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947915|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947916|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947917|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947918|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
27947919|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947920|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947921|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947922|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947923|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
27947924|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
27649623|NCT02165202|80556989|FG001|Oral Phase|Relocated, no follow-up planned|0|||
27649624|NCT02165202|80556988|FG000|Oral Phase|Abnormal EKG|0|||
27649625|NCT02165202|80556989|FG001|Oral Phase|Abnormal EKG|1|||
27649626|NCT02165202|80556988|FG000|Injection Phase|Abnormal Lab Value|5|||
27649627|NCT02165202|80556989|FG001|Injection Phase|Abnormal Lab Value|1|||
27649628|NCT02165202|80556988|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
27649629|NCT02165202|80556989|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
27649630|NCT02165202|80556988|FG000|Injection Phase|Unable to attend within Visit Window|1|||
27649631|NCT02165202|80556989|FG001|Injection Phase|Unable to attend within Visit Window|0|||
27649632|NCT02165202|80556988|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
27649633|NCT02165202|80556989|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
27649634|NCT02165202|80556988|FG000|Injection Phase|End of Study|2|||
27649635|NCT02165202|80556989|FG001|Injection Phase|End of Study|1|||
27649636|NCT02165202|80556988|FG000|Injection Phase|Study Product related Toxicity|1|||
27649637|NCT02165202|80556989|FG001|Injection Phase|Study Product related Toxicity|0|||
27649638|NCT02165202|80556988|FG000|Injection Phase|No longer interested|0|||
27649639|NCT02165202|80556989|FG001|Injection Phase|No longer interested|1|||
27649640|NCT02165202|80556988|FG000|Injection Phase|Participant unwilling to comply|1|||
27649641|NCT02165202|80556989|FG001|Injection Phase|Participant unwilling to comply|0|||
27649642|NCT03136861|80556990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
27649643|NCT03136861|80556991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
27649644|NCT03136861|80556992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
27649645|NCT03136861|80556993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
27649646|NCT03136861|80556994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
27649647|NCT03136861|80556995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
27649648|NCT03136861|80556996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
27649649|NCT03136861|80556990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
27649650|NCT03136861|80556991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
27649651|NCT03136861|80556992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
27649652|NCT03136861|80556993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
27649653|NCT03136861|80556994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
27947925|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947926|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947927|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947928|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947929|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947930|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947931|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947932|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947933|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947934|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947935|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
27947936|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
27947937|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
27947938|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
27947939|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
27947940|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
27947941|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
27947942|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
27947943|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
27947944|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
27947945|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
27947946|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
27947947|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
27947948|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
27947949|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
27947950|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
27947951|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
27947952|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
27947953|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
27947954|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
27947955|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
27947956|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
27947957|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947958|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947959|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947960|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947961|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947962|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947963|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947964|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947965|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947966|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947967|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947968|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947969|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947970|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
27947971|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947972|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
27947973|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947974|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947975|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947976|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947977|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947978|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947979|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947980|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947981|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947982|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947983|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947984|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947985|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947986|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
27947987|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947988|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
27947989|NCT02958865|81644278|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947990|NCT02958865|81644279|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27746429|NCT02926573|80899631|FG001|Overall Study|Nausea|0|||
27649654|NCT03136861|80556995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
27947991|NCT02958865|81644280|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947992|NCT02958865|81644281|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947993|NCT02958865|81644282|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947994|NCT02958865|81644283|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947995|NCT02958865|81644284|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947996|NCT02958865|81644285|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947997|NCT02958865|81644286|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27947998|NCT02958865|81644287|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
27947999|NCT02958865|81644288|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27948000|NCT02958865|81644289|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27948001|NCT02958865|81644290|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27948002|NCT02958865|81644291|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27948003|NCT02958865|81644292|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27948004|NCT02958865|81644293|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
27948005|NCT03685149|81644294|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
27948006|NCT03685149|81644295|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
27948007|NCT03685149|81644294|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
27948008|NCT03685149|81644295|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
27948009|NCT03685149|81644294|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
27948010|NCT03685149|81644295|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
27948011|NCT03360344|81644300|FG000|Overall Study|Withdrawal by Subject|0|||
27948012|NCT03360344|81644301|FG001|Overall Study|Withdrawal by Subject|1|||
27948013|NCT03360344|81644302|FG002|Overall Study|Withdrawal by Subject|1|||
27948014|NCT04724837|81644303|FG000|Overall Study|Other|4|||
27948015|NCT04724837|81644304|FG001|Overall Study|Other|16|||
27948016|NCT04724837|81644305|FG002|Overall Study|Other|0|||
27948017|NCT04724837|81644303|FG000|Overall Study|Withdrawal by Subject|2|||
27948018|NCT04724837|81644304|FG001|Overall Study|Withdrawal by Subject|9|||
27948019|NCT04724837|81644305|FG002|Overall Study|Withdrawal by Subject|9|||
27948020|NCT04724837|81644303|FG000|Overall Study|Adverse Event|2|||
27948021|NCT04724837|81644304|FG001|Overall Study|Adverse Event|7|||
27948022|NCT04724837|81644305|FG002|Overall Study|Adverse Event|4|||
27948023|NCT04724837|81644303|FG000|Overall Study|Lost to Follow-up|0|||
27948024|NCT04724837|81644304|FG001|Overall Study|Lost to Follow-up|1|||
27649655|NCT03136861|80556996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
27649656|NCT03136861|80556990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
27649657|NCT03136861|80556991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
27649658|NCT03136861|80556992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
27948025|NCT04724837|81644305|FG002|Overall Study|Lost to Follow-up|3|||
27948026|NCT04724837|81644303|FG000|Overall Study|Physician Decision|1|||
27948027|NCT04724837|81644304|FG001|Overall Study|Physician Decision|2|||
27948028|NCT04724837|81644305|FG002|Overall Study|Physician Decision|0|||
27948029|NCT04724837|81644303|FG000|Overall Study|Death|0|||
27948030|NCT04724837|81644304|FG001|Overall Study|Death|0|||
27948031|NCT04724837|81644305|FG002|Overall Study|Death|1|||
27948032|NCT04724837|81644303|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
27948033|NCT04724837|81644304|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
27948034|NCT04724837|81644305|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
27948035|NCT04724837|81644303|FG000|Overall Study|Study Terminated by Sponsor|0|||
27948036|NCT04724837|81644304|FG001|Overall Study|Study Terminated by Sponsor|1|||
27948037|NCT04724837|81644305|FG002|Overall Study|Study Terminated by Sponsor|0|||
27948038|NCT02997202|81644311|FG000|Overall Study|Miscellaneous|2|||
27948039|NCT02997202|81644312|FG001|Overall Study|Miscellaneous|2|||
27948040|NCT02997202|81644311|FG000|Overall Study|Withdrawal by Subject|8|||
27948041|NCT02997202|81644312|FG001|Overall Study|Withdrawal by Subject|12|||
27948042|NCT02997202|81644311|FG000|Overall Study|Lost to Follow-up|5|||
27948043|NCT02997202|81644312|FG001|Overall Study|Lost to Follow-up|3|||
27649659|NCT03136861|80556993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
27649660|NCT03136861|80556994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
27649661|NCT03136861|80556995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
27649662|NCT03136861|80556996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
27649663|NCT03136861|80556990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
27649664|NCT03136861|80556991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
27649665|NCT03136861|80556992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
27948044|NCT02997202|81644311|FG000|Overall Study|Death|41|||
27948045|NCT02997202|81644312|FG001|Overall Study|Death|45|||
27948046|NCT02367456|81644314|FG000|Overall Study|Death|8|||
27948047|NCT02367456|81644315|FG001|Overall Study|Death|24|||
27948048|NCT02367456|81644316|FG002|Overall Study|Death|17|||
27948049|NCT02367456|81644314|FG000|Overall Study|Lost to Follow-up|1|||
27948050|NCT02367456|81644315|FG001|Overall Study|Lost to Follow-up|3|||
27948051|NCT02367456|81644316|FG002|Overall Study|Lost to Follow-up|1|||
27948052|NCT02367456|81644314|FG000|Overall Study|Other reason|3|||
27649666|NCT03136861|80556993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
27649667|NCT03136861|80556994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
27948053|NCT02367456|81644315|FG001|Overall Study|Other reason|3|||
27948054|NCT02367456|81644316|FG002|Overall Study|Other reason|9|||
27948055|NCT02367456|81644314|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
27948056|NCT02367456|81644315|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
27948057|NCT02367456|81644316|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
27948058|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
27948059|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27948060|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27948061|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27948062|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27948063|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27948064|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
27948065|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
27948066|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
27948067|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
27948068|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
27948069|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
27948070|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
27948071|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
27948072|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
27948073|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
27948074|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
27948075|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
27948076|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
27948077|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
27948078|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
27948079|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
27948080|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
27948081|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
27948082|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
27948083|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
27948084|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
27948085|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
27948086|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
27948087|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
27948088|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
27948089|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
27948090|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
27948091|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
27948092|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
27948093|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
27948094|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
27948095|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
27948096|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
27948097|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
27948098|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
27948099|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
27948100|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
27948101|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27948102|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27948103|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27948104|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27948105|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27948106|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
27948107|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27948108|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
27948109|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27948110|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27649668|NCT03136861|80556995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
27649669|NCT03136861|80556996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
27649670|NCT03136861|80556990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
27649671|NCT03136861|80556991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
27746430|NCT02926573|80899630|FG000|Overall Study|Remain intubated|2|||
27948111|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27948112|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27948113|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
27948114|NCT01362790|81644319|FG000|Pilot Phase & Phase 2|Death on study|0|||
27948115|NCT01362790|81644320|FG001|Pilot Phase & Phase 2|Death on study|0|||
27948116|NCT01362790|81644321|FG002|Pilot Phase & Phase 2|Death on study|0|||
27948117|NCT01362790|81644322|FG003|Pilot Phase & Phase 2|Death on study|1|||
27948118|NCT01362790|81644323|FG004|Pilot Phase & Phase 2|Death on study|0|||
27948119|NCT01362790|81644324|FG005|Pilot Phase & Phase 2|Death on study|0|||
27948120|NCT01362790|81644325|FG006|Pilot Phase & Phase 2|Death on study|0|||
27948121|NCT01362790|81644319|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
27948122|NCT01362790|81644320|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
27948123|NCT01362790|81644321|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
27948124|NCT01362790|81644322|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
27948125|NCT01362790|81644323|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
27948126|NCT01362790|81644324|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
27948127|NCT01362790|81644325|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
27948128|NCT01362790|81644319|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27948129|NCT01362790|81644320|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27948130|NCT01362790|81644321|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27948131|NCT01362790|81644322|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27948132|NCT01362790|81644323|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
27649672|NCT03136861|80556992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
27649673|NCT03136861|80556993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
27948133|NCT01362790|81644324|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27948134|NCT01362790|81644325|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
27948135|NCT01362790|81644319|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
27948136|NCT01362790|81644320|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
27948137|NCT01362790|81644321|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
27948138|NCT01362790|81644322|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
27948139|NCT01362790|81644323|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
27948140|NCT01362790|81644324|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
27948141|NCT01362790|81644325|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
27948142|NCT01085214|81644326|FG000|Overall Study|Alternate treatment required|1|||
27948143|NCT03610048|81644327|FG000|Overall Study|Study terminated by sponsor|84|||
27948144|NCT03610048|81644327|FG000|Overall Study|Adverse Event|32|||
27948145|NCT03610048|81644327|FG000|Overall Study|Withdrawal by Subject|31|||
27948146|NCT03610048|81644327|FG000|Overall Study|Lost to Follow-up|8|||
27948147|NCT03610048|81644327|FG000|Overall Study|Other|4|||
27649674|NCT03136861|80556994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
27649675|NCT03136861|80556995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
27649676|NCT03136861|80556996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
27948148|NCT03610048|81644327|FG000|Overall Study|Physician Decision|1|||
27948149|NCT03610048|81644327|FG000|Overall Study|Pregnancy|1|||
27948150|NCT02327169|81644330|FG000|Overall Study|Progressive Disease|1|||
27948151|NCT02327169|81644331|FG001|Overall Study|Progressive Disease|3|||
27948152|NCT02327169|81644332|FG002|Overall Study|Progressive Disease|4|||
27948153|NCT02327169|81644333|FG003|Overall Study|Progressive Disease|3|||
27948154|NCT02327169|81644334|FG004|Overall Study|Progressive Disease|4|||
27948155|NCT02327169|81644335|FG005|Overall Study|Progressive Disease|3|||
27948156|NCT02327169|81644336|FG006|Overall Study|Progressive Disease|3|||
27948157|NCT02327169|81644337|FG007|Overall Study|Progressive Disease|3|||
27948158|NCT02327169|81644338|FG008|Overall Study|Progressive Disease|4|||
27948159|NCT02327169|81644339|FG009|Overall Study|Progressive Disease|4|||
27948160|NCT02327169|81644340|FG010|Overall Study|Progressive Disease|4|||
27948161|NCT02327169|81644341|FG011|Overall Study|Progressive Disease|3|||
27948162|NCT02327169|81644342|FG012|Overall Study|Progressive Disease|1|||
27948163|NCT02327169|81644343|FG013|Overall Study|Progressive Disease|3|||
27948164|NCT02327169|81644344|FG014|Overall Study|Progressive Disease|3|||
27948165|NCT02327169|81644330|FG000|Overall Study|Adverse Event|2|||
27948166|NCT02327169|81644331|FG001|Overall Study|Adverse Event|0|||
27948167|NCT02327169|81644332|FG002|Overall Study|Adverse Event|1|||
27948168|NCT02327169|81644333|FG003|Overall Study|Adverse Event|0|||
27948169|NCT02327169|81644334|FG004|Overall Study|Adverse Event|1|||
27746431|NCT02926573|80899631|FG001|Overall Study|Remain intubated|2|||
27948170|NCT02327169|81644335|FG005|Overall Study|Adverse Event|0|||
27948171|NCT02327169|81644336|FG006|Overall Study|Adverse Event|0|||
27948172|NCT02327169|81644337|FG007|Overall Study|Adverse Event|0|||
27948173|NCT02327169|81644338|FG008|Overall Study|Adverse Event|0|||
27551429|NCT01543698|80207462|FG004|Phase 2|Disease progression|0|||
27948174|NCT02327169|81644339|FG009|Overall Study|Adverse Event|2|||
27948175|NCT02327169|81644340|FG010|Overall Study|Adverse Event|0|||
27948176|NCT02327169|81644341|FG011|Overall Study|Adverse Event|3|||
27649677|NCT03136861|80556990|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
27649678|NCT03136861|80556991|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
27948177|NCT02327169|81644342|FG012|Overall Study|Adverse Event|0|||
27948178|NCT02327169|81644343|FG013|Overall Study|Adverse Event|2|||
27948179|NCT02327169|81644344|FG014|Overall Study|Adverse Event|1|||
27948180|NCT02327169|81644330|FG000|Overall Study|Symptomatic Deterioration|0|||
27948181|NCT02327169|81644331|FG001|Overall Study|Symptomatic Deterioration|0|||
27948182|NCT02327169|81644332|FG002|Overall Study|Symptomatic Deterioration|1|||
27948183|NCT02327169|81644333|FG003|Overall Study|Symptomatic Deterioration|0|||
27948184|NCT02327169|81644334|FG004|Overall Study|Symptomatic Deterioration|1|||
27948185|NCT02327169|81644335|FG005|Overall Study|Symptomatic Deterioration|1|||
27948186|NCT02327169|81644336|FG006|Overall Study|Symptomatic Deterioration|0|||
27948187|NCT02327169|81644337|FG007|Overall Study|Symptomatic Deterioration|0|||
27948188|NCT02327169|81644338|FG008|Overall Study|Symptomatic Deterioration|2|||
27948189|NCT02327169|81644339|FG009|Overall Study|Symptomatic Deterioration|1|||
27948190|NCT02327169|81644340|FG010|Overall Study|Symptomatic Deterioration|0|||
27948191|NCT02327169|81644341|FG011|Overall Study|Symptomatic Deterioration|0|||
27948192|NCT02327169|81644342|FG012|Overall Study|Symptomatic Deterioration|0|||
27948193|NCT02327169|81644343|FG013|Overall Study|Symptomatic Deterioration|2|||
27948194|NCT02327169|81644344|FG014|Overall Study|Symptomatic Deterioration|1|||
27948195|NCT02327169|81644330|FG000|Overall Study|Reason Not Specified|0|||
27948196|NCT02327169|81644331|FG001|Overall Study|Reason Not Specified|0|||
27948197|NCT02327169|81644332|FG002|Overall Study|Reason Not Specified|1|||
27948198|NCT02327169|81644333|FG003|Overall Study|Reason Not Specified|0|||
27948199|NCT02327169|81644334|FG004|Overall Study|Reason Not Specified|0|||
27948200|NCT02327169|81644335|FG005|Overall Study|Reason Not Specified|0|||
27948201|NCT02327169|81644336|FG006|Overall Study|Reason Not Specified|0|||
27948202|NCT02327169|81644337|FG007|Overall Study|Reason Not Specified|0|||
27948203|NCT02327169|81644338|FG008|Overall Study|Reason Not Specified|0|||
27948204|NCT02327169|81644339|FG009|Overall Study|Reason Not Specified|1|||
27948205|NCT02327169|81644340|FG010|Overall Study|Reason Not Specified|2|||
27948206|NCT02327169|81644341|FG011|Overall Study|Reason Not Specified|1|||
27948207|NCT02327169|81644342|FG012|Overall Study|Reason Not Specified|0|||
27948208|NCT02327169|81644343|FG013|Overall Study|Reason Not Specified|0|||
27948209|NCT02327169|81644344|FG014|Overall Study|Reason Not Specified|2|||
27948210|NCT02327169|81644330|FG000|Overall Study|Withdrawal by Subject|1|||
27948211|NCT02327169|81644331|FG001|Overall Study|Withdrawal by Subject|0|||
27948212|NCT02327169|81644332|FG002|Overall Study|Withdrawal by Subject|0|||
27948213|NCT02327169|81644333|FG003|Overall Study|Withdrawal by Subject|0|||
27948214|NCT02327169|81644334|FG004|Overall Study|Withdrawal by Subject|1|||
27948215|NCT02327169|81644335|FG005|Overall Study|Withdrawal by Subject|0|||
27948216|NCT02327169|81644336|FG006|Overall Study|Withdrawal by Subject|0|||
27948217|NCT02327169|81644337|FG007|Overall Study|Withdrawal by Subject|1|||
27948218|NCT02327169|81644338|FG008|Overall Study|Withdrawal by Subject|0|||
27948219|NCT02327169|81644339|FG009|Overall Study|Withdrawal by Subject|0|||
27948220|NCT02327169|81644340|FG010|Overall Study|Withdrawal by Subject|0|||
27948221|NCT02327169|81644341|FG011|Overall Study|Withdrawal by Subject|0|||
27948222|NCT02327169|81644342|FG012|Overall Study|Withdrawal by Subject|0|||
27948223|NCT02327169|81644343|FG013|Overall Study|Withdrawal by Subject|0|||
27948224|NCT02327169|81644344|FG014|Overall Study|Withdrawal by Subject|3|||
27948225|NCT02327169|81644330|FG000|Overall Study|Lost to Follow-up|0|||
27948226|NCT02327169|81644331|FG001|Overall Study|Lost to Follow-up|0|||
27948227|NCT02327169|81644332|FG002|Overall Study|Lost to Follow-up|0|||
27948228|NCT02327169|81644333|FG003|Overall Study|Lost to Follow-up|0|||
27948229|NCT02327169|81644334|FG004|Overall Study|Lost to Follow-up|1|||
27948230|NCT02327169|81644335|FG005|Overall Study|Lost to Follow-up|0|||
27948231|NCT02327169|81644336|FG006|Overall Study|Lost to Follow-up|0|||
27948232|NCT02327169|81644337|FG007|Overall Study|Lost to Follow-up|0|||
27948233|NCT02327169|81644338|FG008|Overall Study|Lost to Follow-up|0|||
27948234|NCT02327169|81644339|FG009|Overall Study|Lost to Follow-up|0|||
27948235|NCT02327169|81644340|FG010|Overall Study|Lost to Follow-up|0|||
27948236|NCT02327169|81644341|FG011|Overall Study|Lost to Follow-up|0|||
27948237|NCT02327169|81644342|FG012|Overall Study|Lost to Follow-up|0|||
27948238|NCT02327169|81644343|FG013|Overall Study|Lost to Follow-up|0|||
27948239|NCT02327169|81644344|FG014|Overall Study|Lost to Follow-up|0|||
27948240|NCT04540367|81644345|FG000|Overall Study|Withdrawal by Subject|0|||
27948241|NCT04540367|81644346|FG001|Overall Study|Withdrawal by Subject|0|||
27649679|NCT03136861|80556992|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
27649680|NCT03136861|80556993|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
27746432|NCT02926573|80899630|FG000|Overall Study|Change in surgery plan|3|||
27746433|NCT02926573|80899631|FG001|Overall Study|Change in surgery plan|1|||
27948242|NCT04540367|81644347|FG002|Overall Study|Withdrawal by Subject|0|||
27948243|NCT04540367|81644348|FG003|Overall Study|Withdrawal by Subject|2|||
27948244|NCT04540367|81644345|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
27948245|NCT04540367|81644346|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
27948246|NCT04540367|81644347|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
27948247|NCT04540367|81644348|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
27948248|NCT04540367|81644345|FG000|Overall Study|Adverse Event|0|||
27948249|NCT04540367|81644346|FG001|Overall Study|Adverse Event|0|||
27948250|NCT04540367|81644347|FG002|Overall Study|Adverse Event|1|||
27948251|NCT04540367|81644348|FG003|Overall Study|Adverse Event|1|||
27948252|NCT01936831|81644349|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948253|NCT01936831|81644350|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948254|NCT01936831|81644351|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948255|NCT01936831|81644352|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948256|NCT01936831|81644353|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948257|NCT01936831|81644354|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
27948258|NCT01936831|81644355|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948259|NCT01936831|81644356|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948260|NCT01936831|81644357|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
27948261|NCT01344356|81644359|FG000|Overall Study|Physician Decision|0|||
27948262|NCT01344356|81644360|FG001|Overall Study|Physician Decision|3|||
27948263|NCT01344356|81644359|FG000|Overall Study|Lost to Follow-up|0|||
27948264|NCT01344356|81644360|FG001|Overall Study|Lost to Follow-up|6|||
27948265|NCT04023487|81644363|FG000|Overall Study|Lost to Follow-up|5|||
27948266|NCT04023487|81644364|FG001|Overall Study|Lost to Follow-up|4|||
27948267|NCT04023487|81644363|FG000|Overall Study|Pregnancy|1|||
27948268|NCT04023487|81644364|FG001|Overall Study|Pregnancy|2|||
27948269|NCT04023487|81644363|FG000|Overall Study|Withdrawal by Subject|4|||
27948270|NCT04023487|81644364|FG001|Overall Study|Withdrawal by Subject|5|||
27948271|NCT04023487|81644363|FG000|Overall Study|Partially completed testing|8|||
27948272|NCT04023487|81644364|FG001|Overall Study|Partially completed testing|4|||
27948273|NCT02090764|81644371|FG000|Overall Study|Adverse Event|1|||
27948274|NCT02090764|81644372|FG001|Overall Study|Adverse Event|3|||
27948275|NCT02090764|81644371|FG000|Overall Study|Lack of Efficacy|0|||
27948276|NCT02090764|81644372|FG001|Overall Study|Lack of Efficacy|13|||
27948277|NCT02090764|81644371|FG000|Overall Study|Withdrawal by Subject|2|||
27948278|NCT02090764|81644372|FG001|Overall Study|Withdrawal by Subject|1|||
27948279|NCT02090764|81644371|FG000|Overall Study|Intercurrent illness and other|1|||
27948280|NCT02090764|81644372|FG001|Overall Study|Intercurrent illness and other|1|||
27948281|NCT02090764|81644371|FG000|Overall Study|Lost to Follow-up|2|||
27948282|NCT02090764|81644372|FG001|Overall Study|Lost to Follow-up|2|||
27948283|NCT00954447|81644373|FG000|Overall Study|Adverse Event|33|||
27948284|NCT00954447|81644374|FG001|Overall Study|Adverse Event|25|||
27948285|NCT00954447|81644373|FG000|Overall Study|Lack of Efficacy|17|||
27948286|NCT00954447|81644374|FG001|Overall Study|Lack of Efficacy|3|||
27948287|NCT00954447|81644373|FG000|Overall Study|Protocol Violation|5|||
27948288|NCT00954447|81644374|FG001|Overall Study|Protocol Violation|7|||
27948289|NCT00954447|81644373|FG000|Overall Study|Lost to Follow-up|8|||
27948290|NCT00954447|81644374|FG001|Overall Study|Lost to Follow-up|14|||
27948291|NCT00954447|81644373|FG000|Overall Study|Withdrawal by Subject|26|||
27948292|NCT00954447|81644374|FG001|Overall Study|Withdrawal by Subject|21|||
27948293|NCT00954447|81644373|FG000|Overall Study|Other|21|||
27948294|NCT00954447|81644374|FG001|Overall Study|Other|18|||
27948295|NCT03682367|81644376|FG000|Overall Study|Protocol Violation|2|||
27948296|NCT03682367|81644377|FG001|Overall Study|Protocol Violation|1|||
27948297|NCT03682367|81644376|FG000|Overall Study|Closed Study Early|0|||
27948298|NCT03682367|81644377|FG001|Overall Study|Closed Study Early|3|||
27948299|NCT03498716|81644379|FG000|Overall Study|Withdrawal by Subject|88|||
27948300|NCT03498716|81644380|FG001|Overall Study|Withdrawal by Subject|73|||
27948301|NCT03498716|81644379|FG000|Overall Study|Study Terminated By Sponsor|933|||
27948302|NCT03498716|81644380|FG001|Overall Study|Study Terminated By Sponsor|927|||
27948303|NCT03498716|81644379|FG000|Overall Study|Lost to Follow-up|15|||
27948304|NCT03498716|81644380|FG001|Overall Study|Lost to Follow-up|26|||
27948305|NCT03498716|81644379|FG000|Overall Study|Disease Relapse|0|||
27948306|NCT03498716|81644380|FG001|Overall Study|Disease Relapse|1|||
27948307|NCT03498716|81644379|FG000|Overall Study|Death|58|||
27948308|NCT03498716|81644380|FG001|Overall Study|Death|72|||
27649681|NCT03136861|80556994|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
27746434|NCT02926573|80899630|FG000|Overall Study|Change to outpatient status|5|||
27746435|NCT02926573|80899631|FG001|Overall Study|Change to outpatient status|1|||
27948309|NCT03498716|81644379|FG000|Overall Study|Physician Decision|4|||
27948310|NCT03498716|81644380|FG001|Overall Study|Physician Decision|2|||
27948311|NCT00543985|81644381|FG000|Overall Study|Withdrawal by Subject|4|||
27948312|NCT02757430|81644382|FG000|Overall Study|Physician Decision|6|||
27948313|NCT02757430|81644382|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
27948314|NCT02757430|81644382|FG000|Overall Study|No informed consent|1|||
27948315|NCT02757430|81644382|FG000|Overall Study|No procedure performed|2|||
27948316|NCT03773484|81644392|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
27948317|NCT03958331|81644395|FG000|Overall Study|Withdrawal by Subject|3|||
27948318|NCT03958331|81644396|FG001|Overall Study|Withdrawal by Subject|1|||
27948319|NCT03958331|81644397|FG002|Overall Study|Withdrawal by Subject|5|||
27948320|NCT03958331|81644395|FG000|Overall Study|Weaned from medicine|2|||
27948321|NCT03958331|81644396|FG001|Overall Study|Weaned from medicine|0|||
27948322|NCT03958331|81644397|FG002|Overall Study|Weaned from medicine|0|||
27948323|NCT03958331|81644395|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
27948324|NCT03958331|81644396|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
27948325|NCT03958331|81644397|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
27948326|NCT01121757|81644399|FG000|First Drug|Death|1|||
27948327|NCT01121757|81644400|FG001|First Drug|Death|0|||
27948328|NCT01121757|81644399|FG000|First Drug|Disease Progression|0|||
27948329|NCT01121757|81644400|FG001|First Drug|Disease Progression|2|||
27948330|NCT01121757|81644399|FG000|Combination|Physician Decision|0|||
27948331|NCT01121757|81644400|FG001|Combination|Physician Decision|1|||
27948332|NCT01121757|81644399|FG000|Combination|Disease Progression|2|||
27948333|NCT01121757|81644400|FG001|Combination|Disease Progression|0|||
27948334|NCT02164864|81644401|FG000|Overall Study|Trial disease worsening|7|||
27948335|NCT02164864|81644402|FG001|Overall Study|Trial disease worsening|5|||
27948336|NCT02164864|81644403|FG002|Overall Study|Trial disease worsening|1|||
27948337|NCT02164864|81644401|FG000|Overall Study|Other pre-existing disease worsening|6|||
27948338|NCT02164864|81644402|FG001|Overall Study|Other pre-existing disease worsening|4|||
27948339|NCT02164864|81644403|FG002|Overall Study|Other pre-existing disease worsening|9|||
27948340|NCT02164864|81644401|FG000|Overall Study|Other Adverse Event (AE)|52|||
27948341|NCT02164864|81644402|FG001|Overall Study|Other Adverse Event (AE)|32|||
27948342|NCT02164864|81644403|FG002|Overall Study|Other Adverse Event (AE)|49|||
27948343|NCT02164864|81644401|FG000|Overall Study|Protocol Violation|2|||
27948344|NCT02164864|81644402|FG001|Overall Study|Protocol Violation|4|||
27948345|NCT02164864|81644403|FG002|Overall Study|Protocol Violation|1|||
27948346|NCT02164864|81644401|FG000|Overall Study|Lost to Follow-up|4|||
27948347|NCT02164864|81644402|FG001|Overall Study|Lost to Follow-up|3|||
27948348|NCT02164864|81644403|FG002|Overall Study|Lost to Follow-up|2|||
27948349|NCT02164864|81644401|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
27948350|NCT02164864|81644402|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
27948351|NCT02164864|81644403|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
27948352|NCT02164864|81644401|FG000|Overall Study|Other than stated|3|||
27948353|NCT02164864|81644402|FG001|Overall Study|Other than stated|4|||
27948354|NCT02164864|81644403|FG002|Overall Study|Other than stated|14|||
27948355|NCT00982280|81644404|FG000|Observation Period|Not eligible to be dosed|19|||
27948356|NCT00982280|81644404|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
27948357|NCT00982280|81644404|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
27948358|NCT00982280|81644404|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
27948359|NCT00982280|81644404|FG000|Maintenance Period|Adverse Event|1|||
27948360|NCT01073293|81647783|FG000|Overall Study|Lost to Follow-up|0|||
27948361|NCT01073293|81647784|FG001|Overall Study|Lost to Follow-up|1|||
27948362|NCT01073293|81647783|FG000|Overall Study|Withdrawal by Subject|5|||
27948363|NCT01073293|81647784|FG001|Overall Study|Withdrawal by Subject|10|||
27948364|NCT03032484|81647785|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
27948365|NCT03032484|81647786|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
27948366|NCT03032484|81647785|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
27948367|NCT03032484|81647786|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
27948368|NCT01148771|81647787|FG000|Washout Period|Withdrawal by Subject|0|||
27948369|NCT01148771|81647788|FG001|Washout Period|Withdrawal by Subject|1|||
27948370|NCT03069716|81647789|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
27948371|NCT03069716|81647790|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
27948372|NCT03069716|81647791|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
27948373|NCT03069716|81647789|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
27948374|NCT03069716|81647790|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
27948375|NCT03069716|81647791|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
27948376|NCT03069716|81647789|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
27948377|NCT03069716|81647790|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
27948378|NCT03069716|81647791|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
27948379|NCT03069716|81647789|FG000|Randomized Treatment|Withdrawal by Subject|0|||
27948380|NCT03069716|81647790|FG001|Randomized Treatment|Withdrawal by Subject|2|||
27948381|NCT03069716|81647791|FG002|Randomized Treatment|Withdrawal by Subject|0|||
27948382|NCT00505687|81647796|FG000|Overall Study|Important protocol violation|2|||
27649682|NCT03136861|80556995|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
27948383|NCT00505687|81647796|FG000|Overall Study|Lack of Efficacy|15|||
27948384|NCT00505687|81647796|FG000|Overall Study|Adverse Event|48|||
27948385|NCT00505687|81647796|FG000|Overall Study|Subject withdrew consent|15|||
27746436|NCT02926573|80899630|FG000|Overall Study|Withdrawal by Subject|0|||
27746437|NCT02926573|80899631|FG001|Overall Study|Withdrawal by Subject|2|||
27948386|NCT00505687|81647796|FG000|Overall Study|Lost to Follow-up|1|||
27948387|NCT00505687|81647796|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
27948388|NCT00505687|81647796|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
27948389|NCT00505687|81647796|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
27948390|NCT00505687|81647796|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
27948391|NCT00505687|81647796|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
27948392|NCT00505687|81647796|FG000|Overall Study|Other: Disease Progression|1|||
27948393|NCT00505687|81647796|FG000|Overall Study|Other: As Per Sponsor|8|||
27948394|NCT04016714|81647797|FG000|Overall Study|Death|1|||
27948395|NCT04016714|81647798|FG001|Overall Study|Death|0|||
27948396|NCT04016714|81647797|FG000|Overall Study|Lost to Follow-up|3|||
27948397|NCT04016714|81647798|FG001|Overall Study|Lost to Follow-up|1|||
27948398|NCT04016714|81647797|FG000|Overall Study|Physician Decision|3|||
27948399|NCT04016714|81647798|FG001|Overall Study|Physician Decision|3|||
27948400|NCT04016714|81647797|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
27948401|NCT04016714|81647798|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
27948402|NCT01285102|81647799|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
27948403|NCT00643279|81647802|FG000|Overall Study|Death|13|||
27948404|NCT00643279|81647803|FG001|Overall Study|Death|11|||
27948405|NCT00643279|81647802|FG000|Overall Study|Withdrawal by Subject|3|||
27948406|NCT00643279|81647803|FG001|Overall Study|Withdrawal by Subject|0|||
27649683|NCT03136861|80556996|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
27649684|NCT03136861|80556990|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
27649685|NCT03136861|80556991|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
27649686|NCT03136861|80556992|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
27649687|NCT03136861|80556993|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
27649688|NCT03136861|80556994|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
27649689|NCT03136861|80556995|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
27649690|NCT03136861|80556996|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
27649691|NCT03136861|80556990|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27649692|NCT03136861|80556991|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27649693|NCT03136861|80556992|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
27649694|NCT03136861|80556993|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27649695|NCT03136861|80556994|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27649696|NCT03136861|80556995|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27649697|NCT03136861|80556996|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
27649698|NCT00790569|80556997|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
27649699|NCT00790569|80556998|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
27649700|NCT00790569|80556999|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
27649701|NCT00790569|80556997|FG000|End of Treatment (6 Month Interview)|Death|0|||
27649702|NCT00790569|80556998|FG001|End of Treatment (6 Month Interview)|Death|2|||
27948407|NCT00643279|81647802|FG000|Overall Study|Lost to Follow-up|0|||
27948408|NCT00643279|81647803|FG001|Overall Study|Lost to Follow-up|1|||
27948409|NCT00643279|81647802|FG000|Overall Study|Physician Decision|0|||
27948410|NCT00643279|81647803|FG001|Overall Study|Physician Decision|1|||
27948411|NCT02921256|81647806|FG000|Arm 1a v. Arm II|Adverse Event|6|||
27948412|NCT02921256|81647807|FG001|Arm 1a v. Arm II|Adverse Event|15|||
27948413|NCT02921256|81647808|FG002|Arm 1a v. Arm II|Adverse Event|0|||
27948414|NCT02921256|81647806|FG000|Arm 1a v. Arm II|Death|0|||
27948415|NCT02921256|81647807|FG001|Arm 1a v. Arm II|Death|2|||
27948416|NCT02921256|81647808|FG002|Arm 1a v. Arm II|Death|0|||
27948417|NCT02921256|81647806|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
27948418|NCT02921256|81647807|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
27948419|NCT02921256|81647808|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
27948420|NCT02921256|81647806|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
27948421|NCT02921256|81647807|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
27948422|NCT02921256|81647808|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
27948423|NCT02921256|81647806|FG000|Arm 1a v. Arm II|Physician Decision|1|||
27948424|NCT02921256|81647807|FG001|Arm 1a v. Arm II|Physician Decision|1|||
27948425|NCT02921256|81647808|FG002|Arm 1a v. Arm II|Physician Decision|0|||
27948426|NCT02921256|81647806|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
27948427|NCT02921256|81647807|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
27948428|NCT02921256|81647808|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
27948429|NCT02921256|81647806|FG000|Arm Ib v Arm III|Adverse Event|9|||
27948430|NCT02921256|81647807|FG001|Arm Ib v Arm III|Adverse Event|0|||
27948431|NCT02921256|81647808|FG002|Arm Ib v Arm III|Adverse Event|4|||
27948432|NCT02921256|81647806|FG000|Arm Ib v Arm III|Death|1|||
27948433|NCT02921256|81647807|FG001|Arm Ib v Arm III|Death|0|||
27948434|NCT02921256|81647808|FG002|Arm Ib v Arm III|Death|1|||
27948435|NCT02921256|81647806|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
27948436|NCT02921256|81647807|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
27948437|NCT02921256|81647808|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
27948438|NCT02921256|81647806|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
27948439|NCT02921256|81647807|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
27948440|NCT02921256|81647808|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
27948441|NCT02921256|81647806|FG000|Arm Ib v Arm III|Physician Decision|4|||
27948442|NCT02921256|81647807|FG001|Arm Ib v Arm III|Physician Decision|0|||
27948443|NCT02921256|81647808|FG002|Arm Ib v Arm III|Physician Decision|1|||
27948444|NCT02921256|81647806|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
27948445|NCT02921256|81647807|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
27948446|NCT02921256|81647808|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
27948447|NCT02546323|81647809|FG000|Overall Study|Withdrawal by Subject|36|||
27948448|NCT02546323|81647810|FG001|Overall Study|Withdrawal by Subject|33|||
27948449|NCT02546323|81647809|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
27948450|NCT02546323|81647810|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
27948451|NCT02546323|81647809|FG000|Overall Study|Adverse Event|17|||
27948452|NCT02546323|81647810|FG001|Overall Study|Adverse Event|11|||
27948453|NCT02546323|81647809|FG000|Overall Study|Patient Specific Reasons|1|||
27948454|NCT02546323|81647810|FG001|Overall Study|Patient Specific Reasons|2|||
27948455|NCT02546323|81647809|FG000|Overall Study|Lost to Follow-up|2|||
27948456|NCT02546323|81647810|FG001|Overall Study|Lost to Follow-up|3|||
27948457|NCT02546323|81647809|FG000|Overall Study|Non-compliance with Study Drug|2|||
27948458|NCT02546323|81647810|FG001|Overall Study|Non-compliance with Study Drug|2|||
27948459|NCT02546323|81647809|FG000|Overall Study|Met Withdrawal Criteria|2|||
27649703|NCT00790569|80556999|FG002|End of Treatment (6 Month Interview)|Death|1|||
27649704|NCT00790569|80556997|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
27649705|NCT00790569|80556998|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
27649706|NCT00790569|80556999|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
27649707|NCT00790569|80556997|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
27649708|NCT00790569|80556998|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
27649709|NCT00790569|80556999|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
27649710|NCT00790569|80556997|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
27649711|NCT00790569|80556998|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
27649712|NCT00790569|80556999|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
27649713|NCT00790569|80556997|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
27649714|NCT00790569|80556998|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
27649715|NCT00790569|80556999|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
27649716|NCT01256359|80557000|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
27649717|NCT01256359|80557001|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
27649718|NCT01256359|80557000|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
27649719|NCT01256359|80557001|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
27649720|NCT00599196|80557002|FG000|Overall Study|Lack of Efficacy|22|||
27649721|NCT00599196|80557002|FG000|Overall Study|Adverse Event|93|||
27649722|NCT00599196|80557002|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
27649723|NCT00599196|80557002|FG000|Overall Study|Subject withdrew consent|43|||
27649724|NCT00599196|80557002|FG000|Overall Study|Study ended per sponsor|197|||
27649725|NCT00599196|80557002|FG000|Overall Study|Lost to Follow-up|17|||
27649726|NCT00599196|80557002|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
27649727|NCT00599196|80557002|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
27649728|NCT00599196|80557002|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
27649729|NCT00599196|80557002|FG000|Overall Study|Other: Pt Moved To Australia|1|||
27649730|NCT00599196|80557002|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
27649731|NCT00599196|80557002|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
27649732|NCT02095678|80557003|FG000|Overall Study|Withdrawal by Subject|0|||
27649733|NCT02095678|80557004|FG001|Overall Study|Withdrawal by Subject|1|||
27649734|NCT02095678|80557003|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
27649735|NCT02095678|80557004|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
27649736|NCT02095678|80557003|FG000|Overall Study|lesion impacted by previous treatment|1|||
27649737|NCT02095678|80557004|FG001|Overall Study|lesion impacted by previous treatment|1|||
27649738|NCT02095678|80557003|FG000|Overall Study|No Confirmed Diagnosis|0|||
27649739|NCT02095678|80557004|FG001|Overall Study|No Confirmed Diagnosis|3|||
27649740|NCT02095678|80557003|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
27649741|NCT02095678|80557004|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
27649742|NCT02095678|80557003|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
27649743|NCT02095678|80557004|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
27649744|NCT01670526|80557005|FG000|Overall Study|Withdrawal by Subject|3|||
27649745|NCT01670526|80557006|FG001|Overall Study|Withdrawal by Subject|1|||
27649746|NCT01670526|80557005|FG000|Overall Study|Lost to Follow-up|9|||
27649747|NCT01670526|80557006|FG001|Overall Study|Lost to Follow-up|5|||
27649748|NCT00845520|80557007|FG000|Overall Study|Death|1|||
27649749|NCT00845520|80557008|FG001|Overall Study|Death|2|||
27649750|NCT00845520|80557009|FG002|Overall Study|Death|0|||
27948460|NCT02546323|81647810|FG001|Overall Study|Met Withdrawal Criteria|14|||
27948461|NCT01959932|81647811|FG000|Overall Study|Withdrawal by Subject|1|||
27948462|NCT01959932|81647812|FG001|Overall Study|Withdrawal by Subject|0|||
27948463|NCT01959932|81647813|FG002|Overall Study|Withdrawal by Subject|0|||
27948464|NCT00791648|81647819|FG000|Overall Study|Physician Decision|0|||
27948465|NCT00791648|81647820|FG001|Overall Study|Physician Decision|1|||
27948466|NCT00791648|81647819|FG000|Overall Study|Withdrawal by Subject|0|||
27948467|NCT00791648|81647820|FG001|Overall Study|Withdrawal by Subject|1|||
27948468|NCT02457065|81647821|FG000|Overall Study|Lost to Follow-up|9|||
27948469|NCT02457065|81647822|FG001|Overall Study|Lost to Follow-up|11|||
27948470|NCT00967499|81647825|FG000|Overall Study|Adverse Event|0|||
27948471|NCT00967499|81647826|FG001|Overall Study|Adverse Event|1|||
27649751|NCT00845520|80557007|FG000|Overall Study|Lost to Follow-up|1|||
27649752|NCT00845520|80557008|FG001|Overall Study|Lost to Follow-up|0|||
27649753|NCT00845520|80557009|FG002|Overall Study|Lost to Follow-up|0|||
27649754|NCT00845520|80557007|FG000|Overall Study|Adverse Event|0|||
27649755|NCT00845520|80557008|FG001|Overall Study|Adverse Event|0|||
27948472|NCT00967499|81647825|FG000|Overall Study|Protocol Violation|1|||
27948473|NCT00967499|81647826|FG001|Overall Study|Protocol Violation|0|||
27948474|NCT00967499|81647825|FG000|Overall Study|Sponsor Decision|1|||
27948475|NCT00967499|81647826|FG001|Overall Study|Sponsor Decision|0|||
27948476|NCT00967499|81647825|FG000|Overall Study|Randomized but not treated|63|||
27948477|NCT00967499|81647826|FG001|Overall Study|Randomized but not treated|59|||
27948478|NCT02489279|81647827|FG000|Overall Study|Lost to Follow-up|12|||
27948479|NCT02489279|81647828|FG001|Overall Study|Lost to Follow-up|10|||
27948480|NCT00347269|81647831|FG000|Overall Study|Lost to Follow-up|74|||
27948481|NCT00347269|81647832|FG001|Overall Study|Lost to Follow-up|65|||
27948482|NCT00347269|81647831|FG000|Overall Study|Withdrawal by Subject|18|||
27948483|NCT00347269|81647832|FG001|Overall Study|Withdrawal by Subject|38|||
27948484|NCT00347269|81647831|FG000|Overall Study|Death|2|||
27948485|NCT00347269|81647832|FG001|Overall Study|Death|3|||
27948486|NCT04380142|81647833|FG000|LD/CD Stabilization Period|Adverse Event|3|||
27948487|NCT04380142|81647834|FG001|LD/CD Stabilization Period|Adverse Event|0|||
27948488|NCT04380142|81647835|FG002|LD/CD Stabilization Period|Adverse Event|0|||
27948489|NCT04380142|81647833|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
27948490|NCT04380142|81647834|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
27948491|NCT04380142|81647835|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
27948492|NCT04380142|81647833|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
27948493|NCT04380142|81647834|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
27948494|NCT04380142|81647835|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
27948495|NCT04380142|81647833|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
27948496|NCT04380142|81647834|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
27948497|NCT04380142|81647835|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
27948498|NCT04380142|81647833|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
27948499|NCT04380142|81647834|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
27948500|NCT04380142|81647835|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
27948501|NCT04380142|81647833|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
27948502|NCT04380142|81647834|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
27948503|NCT04380142|81647835|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
27948504|NCT04380142|81647833|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27948505|NCT04380142|81647834|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27948506|NCT04380142|81647835|FG002|Double-Blind Treatment Period|Adverse Event|14|||
27948507|NCT04380142|81647833|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
27948508|NCT04380142|81647834|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
27948509|NCT04380142|81647835|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
27948510|NCT04380142|81647833|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
27948511|NCT04380142|81647834|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
27948512|NCT04380142|81647835|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
27948513|NCT04380142|81647833|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
27948514|NCT04380142|81647834|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
27948515|NCT04380142|81647835|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
27948516|NCT04380142|81647833|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
27948517|NCT04380142|81647834|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
27948518|NCT04380142|81647835|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
27948519|NCT04380142|81647833|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
27948520|NCT04380142|81647834|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
27948521|NCT04380142|81647835|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
27948522|NCT03386773|81647836|FG000|Overall Study|Lost to Follow-up|24|||
27948523|NCT03386773|81647837|FG001|Overall Study|Lost to Follow-up|33|||
27948524|NCT03386773|81647836|FG000|Overall Study|Withdrawal by Subject|3|||
27948525|NCT03386773|81647837|FG001|Overall Study|Withdrawal by Subject|2|||
27948526|NCT03801525|81647838|FG000|Overall Study|Adverse Event|17|||
27649756|NCT00845520|80557009|FG002|Overall Study|Adverse Event|1|||
27649757|NCT00148122|80557010|FG000|Overall Study|Withdrawal by Subject|2|||
27948527|NCT03801525|81647839|FG001|Overall Study|Adverse Event|1|||
27649758|NCT02659540|80557011|FG000|Overall Study|Adverse Event|3|||
27649759|NCT02659540|80557012|FG001|Overall Study|Adverse Event|2|||
27948528|NCT03801525|81647840|FG002|Overall Study|Adverse Event|0|||
27948529|NCT03801525|81647838|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
27948530|NCT03801525|81647839|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
27948531|NCT03801525|81647840|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
27948532|NCT03801525|81647838|FG000|Overall Study|Death|29|||
27948533|NCT03801525|81647839|FG001|Overall Study|Death|1|||
27948534|NCT03801525|81647840|FG002|Overall Study|Death|4|||
27948535|NCT03801525|81647838|FG000|Overall Study|Disease Progression|6|||
27649760|NCT02659540|80557011|FG000|Overall Study|Death|1|||
27649761|NCT02659540|80557012|FG001|Overall Study|Death|0|||
27649762|NCT02659540|80557011|FG000|Overall Study|Progressive disease|2|||
27649763|NCT02659540|80557012|FG001|Overall Study|Progressive disease|6|||
27649764|NCT01313663|80557013|FG000|Overall Study|Study Closed/Terminated|2|||
27649765|NCT01313663|80557014|FG001|Overall Study|Study Closed/Terminated|4|||
27649766|NCT01313663|80557013|FG000|Overall Study|Lost to Follow-up|0|||
27649767|NCT01313663|80557014|FG001|Overall Study|Lost to Follow-up|1|||
27649768|NCT01313663|80557013|FG000|Overall Study|Physician Decision|0|||
27649769|NCT01313663|80557014|FG001|Overall Study|Physician Decision|2|||
27649770|NCT01313663|80557013|FG000|Overall Study|Withdrawal by Subject|2|||
27649771|NCT01313663|80557014|FG001|Overall Study|Withdrawal by Subject|1|||
27649772|NCT03055988|80557015|FG000|Period 1|Adverse Event|0|||
27649773|NCT03055988|80557016|FG001|Period 1|Adverse Event|1|||
27649774|NCT03055988|80557015|FG000|Period 1|Lost to Follow-up|1|||
27649775|NCT03055988|80557016|FG001|Period 1|Lost to Follow-up|0|||
27649776|NCT03055988|80557015|FG000|Period 1|Withdrawal by Subject|0|||
27649777|NCT03055988|80557016|FG001|Period 1|Withdrawal by Subject|4|||
27649778|NCT03055988|80557015|FG000|Period 2|Adverse Event|0|||
27649779|NCT03055988|80557016|FG001|Period 2|Adverse Event|1|||
27649780|NCT03055988|80557015|FG000|Period 2|Other than listed|1|||
27649781|NCT03055988|80557016|FG001|Period 2|Other than listed|1|||
27649782|NCT03292406|80557018|FG000|Overall Study|Progressive Disease|6|||
27649783|NCT03292406|80557019|FG001|Overall Study|Progressive Disease|3|||
27649784|NCT03292406|80557020|FG002|Overall Study|Progressive Disease|4|||
27649785|NCT03292406|80557018|FG000|Overall Study|Adverse Event|7|||
27649786|NCT03292406|80557019|FG001|Overall Study|Adverse Event|1|||
27649787|NCT03292406|80557020|FG002|Overall Study|Adverse Event|4|||
27948536|NCT03801525|81647839|FG001|Overall Study|Disease Progression|0|||
27948537|NCT03801525|81647840|FG002|Overall Study|Disease Progression|1|||
27948538|NCT03801525|81647838|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
27948539|NCT03801525|81647839|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
27948540|NCT03801525|81647840|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
27948541|NCT03801525|81647838|FG000|Overall Study|Investigator Decision|18|||
27948542|NCT03801525|81647839|FG001|Overall Study|Investigator Decision|1|||
27948543|NCT03801525|81647840|FG002|Overall Study|Investigator Decision|0|||
27948544|NCT03801525|81647838|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
27948545|NCT03801525|81647839|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
27948546|NCT03801525|81647840|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
27948547|NCT03801525|81647838|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
27948548|NCT03801525|81647839|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
27948549|NCT03801525|81647840|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
27948550|NCT03801525|81647838|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
27948551|NCT03801525|81647839|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
27948552|NCT03801525|81647840|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
27948553|NCT03801525|81647838|FG000|Overall Study|Withdrawal of Subject Consent|38|||
27948554|NCT03801525|81647839|FG001|Overall Study|Withdrawal of Subject Consent|2|||
27948555|NCT03801525|81647840|FG002|Overall Study|Withdrawal of Subject Consent|1|||
27948556|NCT03801525|81647838|FG000|Overall Study|Reason not Specified|4|||
27649788|NCT03292406|80557018|FG000|Overall Study|Withdrawal by Subject|0|||
27649789|NCT03292406|80557019|FG001|Overall Study|Withdrawal by Subject|7|||
27649790|NCT03292406|80557020|FG002|Overall Study|Withdrawal by Subject|2|||
27649791|NCT03292406|80557018|FG000|Overall Study|Protocol Violation|0|||
27649792|NCT03292406|80557019|FG001|Overall Study|Protocol Violation|1|||
27649793|NCT03292406|80557020|FG002|Overall Study|Protocol Violation|1|||
27649794|NCT03292406|80557018|FG000|Overall Study|Other|0|||
27948557|NCT03801525|81647839|FG001|Overall Study|Reason not Specified|0|||
27948558|NCT03801525|81647840|FG002|Overall Study|Reason not Specified|4|||
27948559|NCT01448616|81647841|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
27948560|NCT01448616|81647842|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
27948561|NCT01448616|81647843|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
27649795|NCT03292406|80557019|FG001|Overall Study|Other|1|||
27649796|NCT03292406|80557020|FG002|Overall Study|Other|2|||
27649797|NCT04809623|80557021|FG000|Overall Study|Study Terminated by Sponsor|1|||
27649798|NCT04809623|80557022|FG001|Overall Study|Study Terminated by Sponsor|0|||
27649799|NCT01147471|80557027|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
27948562|NCT01448616|81647844|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
27948563|NCT01448616|81647841|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
27948564|NCT01448616|81647842|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
27948565|NCT01448616|81647843|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
27948566|NCT01448616|81647844|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
27948567|NCT01448616|81647841|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
27948568|NCT01448616|81647842|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
27948569|NCT01448616|81647843|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
27948570|NCT01448616|81647844|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
27948571|NCT01448616|81647841|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
27948572|NCT01448616|81647842|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
27948573|NCT01448616|81647843|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
27948574|NCT01448616|81647844|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
27948575|NCT01448616|81647841|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
27649800|NCT01147471|80557028|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
27649801|NCT01147471|80557027|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
27649802|NCT01147471|80557028|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
27649803|NCT01147471|80557027|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
27649804|NCT01147471|80557028|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
27948576|NCT01448616|81647842|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
27649805|NCT01147471|80557027|FG000|3 Month Follow Up|Lost to Follow-up|1|||
27649806|NCT01147471|80557028|FG001|3 Month Follow Up|Lost to Follow-up|1|||
27649807|NCT01147471|80557027|FG000|3 Month Follow Up|Physician Decision|0|||
27948577|NCT01448616|81647843|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
27948578|NCT01448616|81647844|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
27948579|NCT00567502|81647845|FG000|Overall Study|Lost to Follow-up|91|||
27948580|NCT00567502|81647846|FG001|Overall Study|Lost to Follow-up|14|||
27649808|NCT01147471|80557028|FG001|3 Month Follow Up|Physician Decision|1|||
27649809|NCT01147471|80557027|FG000|6 Month Follow Up|Lost to Follow-up|4|||
27649810|NCT01147471|80557028|FG001|6 Month Follow Up|Lost to Follow-up|2|||
27649811|NCT00553332|80557029|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
27649812|NCT01536093|80557032|FG000|Overall Study|Death|1|||
27649813|NCT01536093|80557033|FG001|Overall Study|Death|2|||
27649814|NCT01536093|80557032|FG000|Overall Study|absence of maternal colostrum|2|||
27649815|NCT01536093|80557033|FG001|Overall Study|absence of maternal colostrum|0|||
27649816|NCT01536093|80557032|FG000|Overall Study|Withdrawal by Subject|0|||
27649817|NCT01536093|80557033|FG001|Overall Study|Withdrawal by Subject|1|||
27649818|NCT04658784|80557034|FG000|6-month Follow-up|Lost to Follow-up|2|||
27649819|NCT04658784|80557035|FG001|6-month Follow-up|Lost to Follow-up|5|||
27649820|NCT03883828|80557036|FG000|Overall Study|Did not start radiotherapy|1|||
27649821|NCT03883828|80557037|FG001|Overall Study|Did not start radiotherapy|2|||
27649822|NCT01855399|80557038|FG000|6 Month|Lost to Follow-up|12|||
27649823|NCT01855399|80557039|FG001|6 Month|Lost to Follow-up|9|||
27649824|NCT01855399|80557038|FG000|6 Month|Withdrawal by Subject|8|||
27649825|NCT01855399|80557039|FG001|6 Month|Withdrawal by Subject|6|||
27649826|NCT01855399|80557038|FG000|12 Month|Lost to Follow-up|7|||
27649827|NCT01855399|80557039|FG001|12 Month|Lost to Follow-up|11|||
27649828|NCT04017611|80557040|FG000|Overall Study|Withdrawn prior to completion|1|||
27649829|NCT01523392|80557041|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27649830|NCT01523392|80557042|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27649831|NCT01523392|80557041|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
27649832|NCT01523392|80557042|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
27649833|NCT01523392|80557041|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
27649834|NCT01523392|80557042|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
27649835|NCT03019289|80557043|FG000|Overall Study|Adverse Event|1|||
27649836|NCT03019289|80557044|FG001|Overall Study|Adverse Event|0|||
27649837|NCT03019289|80557045|FG002|Overall Study|Adverse Event|0|||
27649838|NCT03019289|80557046|FG003|Overall Study|Adverse Event|0|||
27649839|NCT03019289|80557047|FG004|Overall Study|Adverse Event|0|||
27649840|NCT03019289|80557048|FG005|Overall Study|Adverse Event|0|||
27649841|NCT03019289|80557049|FG006|Overall Study|Adverse Event|0|||
27649842|NCT03019289|80557050|FG007|Overall Study|Adverse Event|0|||
27649843|NCT03019289|80557051|FG008|Overall Study|Adverse Event|1|||
27948581|NCT00567502|81647847|FG002|Overall Study|Lost to Follow-up|351|||
27649844|NCT03019289|80557043|FG000|Overall Study|Other|1|||
27649845|NCT03019289|80557044|FG001|Overall Study|Other|0|||
27649846|NCT03019289|80557045|FG002|Overall Study|Other|0|||
27649847|NCT03019289|80557046|FG003|Overall Study|Other|0|||
27649848|NCT03019289|80557047|FG004|Overall Study|Other|0|||
27948582|NCT00567502|81647848|FG003|Overall Study|Lost to Follow-up|2|||
27649849|NCT03019289|80557048|FG005|Overall Study|Other|0|||
27649850|NCT03019289|80557049|FG006|Overall Study|Other|0|||
27649851|NCT03019289|80557050|FG007|Overall Study|Other|0|||
27649852|NCT03019289|80557051|FG008|Overall Study|Other|0|||
27649853|NCT00454194|80557057|FG000|Overall Study|Adverse Event|7|||
27649854|NCT00454194|80557058|FG001|Overall Study|Adverse Event|2|||
27649855|NCT00454194|80557057|FG000|Overall Study|Withdrawal by Subject|12|||
27649856|NCT00454194|80557058|FG001|Overall Study|Withdrawal by Subject|8|||
27746438|NCT02926573|80899630|FG000|Overall Study|Return to operating room|0|||
27746439|NCT02926573|80899631|FG001|Overall Study|Return to operating room|2|||
27746440|NCT02926573|80899630|FG000|Overall Study|Delirium|0|||
27746441|NCT02926573|80899631|FG001|Overall Study|Delirium|1|||
27746442|NCT03117049|80899632|FG000|Overall Study|Continued the follow-up period|109|||
27746443|NCT03117049|80899633|FG001|Overall Study|Continued the follow-up period|129|||
27746444|NCT03117049|80899632|FG000|Overall Study|Died|82|||
27746445|NCT03117049|80899633|FG001|Overall Study|Died|93|||
27746446|NCT03117049|80899632|FG000|Overall Study|Consent withdrawal|7|||
27746447|NCT03117049|80899633|FG001|Overall Study|Consent withdrawal|6|||
27746448|NCT03117049|80899632|FG000|Overall Study|Missing contact|3|||
27948583|NCT00567502|81647845|FG000|Overall Study|Death|65|||
27948584|NCT00567502|81647846|FG001|Overall Study|Death|16|||
27948585|NCT00567502|81647847|FG002|Overall Study|Death|360|||
27948586|NCT00567502|81647848|FG003|Overall Study|Death|5|||
27746449|NCT03117049|80899633|FG001|Overall Study|Missing contact|3|||
27746450|NCT01259297|80899636|FG000|Double Blind Randomized Period|Death|1|||
27746451|NCT01259297|80899637|FG001|Double Blind Randomized Period|Death|1|||
27746452|NCT01259297|80899638|FG002|Double Blind Randomized Period|Death|1|||
27746453|NCT01259297|80899639|FG003|Double Blind Randomized Period|Death|2|||
27746454|NCT01259297|80899640|FG004|Double Blind Randomized Period|Death|1|||
27746455|NCT01259297|80899641|FG005|Double Blind Randomized Period|Death|5|||
27746456|NCT01259297|80899642|FG006|Double Blind Randomized Period|Death|2|||
27746457|NCT01259297|80899643|FG007|Double Blind Randomized Period|Death|1|||
27746458|NCT01259297|80899636|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27746459|NCT01259297|80899637|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27746460|NCT01259297|80899638|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
27746461|NCT01259297|80899639|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
27746462|NCT01259297|80899640|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
27746463|NCT01259297|80899641|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27746464|NCT01259297|80899642|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27746465|NCT01259297|80899643|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
27746466|NCT01259297|80899636|FG000|Double Blind Randomized Period|Other reasons|0|||
27746467|NCT01259297|80899637|FG001|Double Blind Randomized Period|Other reasons|1|||
27746468|NCT01259297|80899638|FG002|Double Blind Randomized Period|Other reasons|0|||
27746469|NCT01259297|80899639|FG003|Double Blind Randomized Period|Other reasons|0|||
27746470|NCT01259297|80899640|FG004|Double Blind Randomized Period|Other reasons|1|||
27948587|NCT00567502|81647845|FG000|Overall Study|Other|64|||
27948588|NCT00567502|81647846|FG001|Overall Study|Other|2|||
27948589|NCT00567502|81647847|FG002|Overall Study|Other|134|||
27948590|NCT00567502|81647848|FG003|Overall Study|Other|6|||
27948591|NCT00567502|81647845|FG000|Overall Study|Participant request|12|||
27948592|NCT00567502|81647846|FG001|Overall Study|Participant request|1|||
27948593|NCT00567502|81647847|FG002|Overall Study|Participant request|33|||
27948594|NCT00567502|81647848|FG003|Overall Study|Participant request|1|||
27948595|NCT00567502|81647845|FG000|Overall Study|Sponsor request|9|||
27948596|NCT00567502|81647846|FG001|Overall Study|Sponsor request|0|||
27948597|NCT00567502|81647847|FG002|Overall Study|Sponsor request|30|||
27948598|NCT00567502|81647848|FG003|Overall Study|Sponsor request|1|||
27948599|NCT00567502|81647845|FG000|Overall Study|Never Initiated Treatment|0|||
27948600|NCT00567502|81647846|FG001|Overall Study|Never Initiated Treatment|0|||
27948601|NCT00567502|81647847|FG002|Overall Study|Never Initiated Treatment|0|||
27948602|NCT00567502|81647848|FG003|Overall Study|Never Initiated Treatment|72|||
27948603|NCT00437073|81647851|FG000|Overall Study|Sponsor Terminated Study|1|||
27551430|NCT01543698|80207463|FG005|Phase 2|Disease progression|0|||
27551431|NCT01543698|80207464|FG006|Phase 2|Disease progression|0|||
27551432|NCT01543698|80207465|FG007|Phase 2|Disease progression|0|||
27551433|NCT01543698|80207466|FG008|Phase 2|Disease progression|0|||
27551434|NCT01543698|80207467|FG009|Phase 2|Disease progression|0|||
27551435|NCT01543698|80207468|FG010|Phase 2|Disease progression|0|||
27551436|NCT01543698|80207469|FG011|Phase 2|Disease progression|10|||
27551437|NCT01543698|80207470|FG012|Phase 2|Disease progression|21|||
27551438|NCT01543698|80207471|FG013|Phase 2|Disease progression|30|||
27551439|NCT01543698|80207472|FG014|Phase 2|Disease progression|25|||
27551440|NCT01543698|80207458|FG000|Phase 2|Death|0|||
27551441|NCT01543698|80207459|FG001|Phase 2|Death|0|||
27551442|NCT01543698|80207460|FG002|Phase 2|Death|0|||
27551443|NCT01543698|80207461|FG003|Phase 2|Death|0|||
27551444|NCT01543698|80207462|FG004|Phase 2|Death|0|||
27551445|NCT01543698|80207463|FG005|Phase 2|Death|0|||
27551446|NCT01543698|80207464|FG006|Phase 2|Death|0|||
27551447|NCT01543698|80207465|FG007|Phase 2|Death|0|||
27551448|NCT01543698|80207466|FG008|Phase 2|Death|0|||
27551449|NCT01543698|80207467|FG009|Phase 2|Death|0|||
27948604|NCT00437073|81647852|FG001|Overall Study|Sponsor Terminated Study|0|||
27948605|NCT00437073|81647851|FG000|Overall Study|Physician Decision|0|||
27948606|NCT00437073|81647852|FG001|Overall Study|Physician Decision|1|||
27948607|NCT00619866|81647853|FG000|Weeks 1 - 12|Adverse Event|0|||
27948608|NCT00619866|81647854|FG001|Weeks 1 - 12|Adverse Event|1|||
27948609|NCT00619866|81647855|FG002|Weeks 1 - 12|Adverse Event|2|||
27948610|NCT00619866|81647856|FG003|Weeks 1 - 12|Adverse Event|0|||
27948611|NCT00619866|81647857|FG004|Weeks 1 - 12|Adverse Event|0|||
27948612|NCT00619866|81647853|FG000|Weeks 1 - 12|Non-compliance|0|||
27948613|NCT00619866|81647854|FG001|Weeks 1 - 12|Non-compliance|0|||
27948614|NCT00619866|81647855|FG002|Weeks 1 - 12|Non-compliance|1|||
27948615|NCT00619866|81647856|FG003|Weeks 1 - 12|Non-compliance|0|||
27948616|NCT00619866|81647857|FG004|Weeks 1 - 12|Non-compliance|0|||
27948617|NCT00619866|81647853|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
27649857|NCT00454194|80557057|FG000|Overall Study|Other Medical Problems|1|||
27649858|NCT00454194|80557058|FG001|Overall Study|Other Medical Problems|2|||
27649859|NCT00454194|80557057|FG000|Overall Study|Other Unspecified Reason|2|||
27649860|NCT00454194|80557058|FG001|Overall Study|Other Unspecified Reason|2|||
27649861|NCT00786188|80557059|FG000|Overall Study|Adverse Event|3|||
27649862|NCT00786188|80557060|FG001|Overall Study|Adverse Event|1|||
27649863|NCT00786188|80557059|FG000|Overall Study|Withdrawal by Subject|2|||
27649864|NCT00786188|80557060|FG001|Overall Study|Withdrawal by Subject|0|||
27649865|NCT00689351|80557063|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
27649866|NCT00689351|80557064|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
27649867|NCT00689351|80557063|FG000|Infant Series of Dosing|Adverse Event|1|||
27649868|NCT00689351|80557064|FG001|Infant Series of Dosing|Adverse Event|0|||
27649869|NCT00689351|80557063|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
27649870|NCT00689351|80557064|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
27649871|NCT00689351|80557063|FG000|After Infant Series|Parent/legal guardian request|1|||
27649872|NCT00689351|80557064|FG001|After Infant Series|Parent/legal guardian request|0|||
27948618|NCT00619866|81647854|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
27948619|NCT00619866|81647855|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
27649873|NCT03131713|80557065|FG000|Overall Study|Lost to Follow-up|5|||
27649874|NCT03131713|80557066|FG001|Overall Study|Lost to Follow-up|0|||
27649875|NCT01313884|80557067|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
27649876|NCT00756574|80557070|FG000|Overall Study|Withdrawal by Subject|9|||
27649877|NCT00756574|80557071|FG001|Overall Study|Withdrawal by Subject|7|||
27649878|NCT00756574|80557070|FG000|Overall Study|Lost to Follow-up|4|||
27649879|NCT00756574|80557071|FG001|Overall Study|Lost to Follow-up|4|||
27649880|NCT00569166|80557072|FG000|Overall Study|Withdrawal by Subject|7|||
27649881|NCT00569166|80557073|FG001|Overall Study|Withdrawal by Subject|5|||
27649882|NCT00569166|80557074|FG002|Overall Study|Withdrawal by Subject|3|||
27649883|NCT00569166|80557072|FG000|Overall Study|Lost to Follow-up|2|||
27649884|NCT00569166|80557073|FG001|Overall Study|Lost to Follow-up|1|||
27649885|NCT00569166|80557074|FG002|Overall Study|Lost to Follow-up|1|||
27649886|NCT01328496|80557077|FG000|Overall Study|Significant Change in Health Status|1|||
27649887|NCT01328496|80557078|FG001|Overall Study|Significant Change in Health Status|0|||
27649888|NCT02950961|80557079|FG000|Overall Study|Study had to stop due to COVID.|7|||
27649889|NCT04183491|80557081|FG000|Overall Study|Withdrawal by Subject|0|||
27649890|NCT04183491|80557082|FG001|Overall Study|Withdrawal by Subject|0|||
27649891|NCT04183491|80557083|FG002|Overall Study|Withdrawal by Subject|1|||
27649892|NCT04183491|80557084|FG003|Overall Study|Withdrawal by Subject|0|||
27649893|NCT04183491|80557085|FG004|Overall Study|Withdrawal by Subject|0|||
27649894|NCT04183491|80557086|FG005|Overall Study|Withdrawal by Subject|1|||
27649895|NCT04183491|80557087|FG006|Overall Study|Withdrawal by Subject|0|||
27948620|NCT00619866|81647856|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
27551450|NCT01543698|80207468|FG010|Phase 2|Death|0|||
27551451|NCT01543698|80207469|FG011|Phase 2|Death|0|||
27551452|NCT01543698|80207470|FG012|Phase 2|Death|1|||
27551453|NCT01543698|80207471|FG013|Phase 2|Death|1|||
27551454|NCT01543698|80207472|FG014|Phase 2|Death|1|||
27551455|NCT01543698|80207458|FG000|Phase 2|Administrative problems|0|||
27551456|NCT01543698|80207459|FG001|Phase 2|Administrative problems|0|||
27551457|NCT01543698|80207460|FG002|Phase 2|Administrative problems|0|||
27551458|NCT01543698|80207461|FG003|Phase 2|Administrative problems|0|||
27551459|NCT01543698|80207462|FG004|Phase 2|Administrative problems|0|||
27551460|NCT01543698|80207463|FG005|Phase 2|Administrative problems|0|||
27551461|NCT01543698|80207464|FG006|Phase 2|Administrative problems|0|||
27551462|NCT01543698|80207465|FG007|Phase 2|Administrative problems|0|||
27551463|NCT01543698|80207466|FG008|Phase 2|Administrative problems|0|||
27551464|NCT01543698|80207467|FG009|Phase 2|Administrative problems|0|||
27551465|NCT01543698|80207468|FG010|Phase 2|Administrative problems|0|||
27551466|NCT01543698|80207469|FG011|Phase 2|Administrative problems|0|||
27551467|NCT01543698|80207470|FG012|Phase 2|Administrative problems|0|||
27551468|NCT01543698|80207471|FG013|Phase 2|Administrative problems|3|||
27551469|NCT01543698|80207472|FG014|Phase 2|Administrative problems|1|||
27551470|NCT01543698|80207458|FG000|Phase 2|Withdrawal by Subject|0|||
27649896|NCT00390884|80557088|FG000|Overall Study|Withdrawal by Subject|2|||
27649897|NCT00390884|80557089|FG001|Overall Study|Withdrawal by Subject|2|||
27649898|NCT02309294|80557090|FG000|Overall Study|Withdrawal by Subject|2|||
27649899|NCT01529632|80557091|FG000|Overall Study|Administrative problem|2|||
27649900|NCT01529632|80557092|FG001|Overall Study|Administrative problem|1|||
27649901|NCT01529632|80557091|FG000|Overall Study|Protocol Violation|0|||
27649902|NCT01529632|80557092|FG001|Overall Study|Protocol Violation|1|||
27649903|NCT01529632|80557091|FG000|Overall Study|Adverse Event|1|||
27649904|NCT01529632|80557092|FG001|Overall Study|Adverse Event|1|||
27746471|NCT01259297|80899641|FG005|Double Blind Randomized Period|Other reasons|2|||
27948621|NCT00619866|81647857|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
27948622|NCT00619866|81647853|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
27948623|NCT00619866|81647854|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
27948624|NCT00619866|81647855|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
27948625|NCT00619866|81647856|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
27948626|NCT00619866|81647857|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
27948627|NCT00619866|81647853|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
27948628|NCT00619866|81647854|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
27948629|NCT00619866|81647855|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
27948630|NCT00619866|81647856|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
27948631|NCT00619866|81647857|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
27948632|NCT00619866|81647853|FG000|Weeks 1 - 12|Sponsor Decision|0|||
27948633|NCT00619866|81647854|FG001|Weeks 1 - 12|Sponsor Decision|1|||
27948634|NCT00619866|81647855|FG002|Weeks 1 - 12|Sponsor Decision|0|||
27948635|NCT00619866|81647856|FG003|Weeks 1 - 12|Sponsor Decision|0|||
27948636|NCT00619866|81647857|FG004|Weeks 1 - 12|Sponsor Decision|0|||
27948637|NCT00619866|81647853|FG000|Weeks 13 - 24|Adverse Event|0|||
27948638|NCT00619866|81647854|FG001|Weeks 13 - 24|Adverse Event|0|||
27948639|NCT00619866|81647855|FG002|Weeks 13 - 24|Adverse Event|2|||
27948640|NCT00619866|81647856|FG003|Weeks 13 - 24|Adverse Event|1|||
27948641|NCT00619866|81647857|FG004|Weeks 13 - 24|Adverse Event|0|||
27948642|NCT00619866|81647853|FG000|Weeks 13 - 24|Protocol Deviation|0|||
27948643|NCT00619866|81647854|FG001|Weeks 13 - 24|Protocol Deviation|0|||
27948644|NCT00619866|81647855|FG002|Weeks 13 - 24|Protocol Deviation|0|||
27948645|NCT00619866|81647856|FG003|Weeks 13 - 24|Protocol Deviation|1|||
27948646|NCT00619866|81647857|FG004|Weeks 13 - 24|Protocol Deviation|0|||
27948647|NCT00619866|81647853|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
27948648|NCT00619866|81647854|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
27948649|NCT00619866|81647855|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
27948650|NCT00619866|81647856|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
27948651|NCT00619866|81647857|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
27948652|NCT00619866|81647853|FG000|Weeks 13 - 24|Non-compliance|0|||
27948653|NCT00619866|81647854|FG001|Weeks 13 - 24|Non-compliance|1|||
27948654|NCT00619866|81647855|FG002|Weeks 13 - 24|Non-compliance|1|||
27948655|NCT00619866|81647856|FG003|Weeks 13 - 24|Non-compliance|0|||
27948656|NCT00619866|81647857|FG004|Weeks 13 - 24|Non-compliance|0|||
27948657|NCT00619866|81647853|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
27948658|NCT00619866|81647854|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
27948659|NCT00619866|81647855|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
27948660|NCT00619866|81647856|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
27948661|NCT00619866|81647857|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
27948662|NCT01156844|81647860|FG000|Overall Study|Adverse Event|0|||
27948663|NCT01156844|81647861|FG001|Overall Study|Adverse Event|0|||
27948664|NCT01156844|81647862|FG002|Overall Study|Adverse Event|1|||
27948665|NCT01156844|81647863|FG003|Overall Study|Adverse Event|1|||
27948666|NCT01156844|81647860|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27948667|NCT01156844|81647861|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27948668|NCT01156844|81647862|FG002|Overall Study|Abnormal test procedure result(s)|2|||
27948669|NCT01156844|81647863|FG003|Overall Study|Abnormal test procedure result(s)|2|||
27948670|NCT01156844|81647860|FG000|Overall Study|Withdrawal by Subject|0|||
27948671|NCT01156844|81647861|FG001|Overall Study|Withdrawal by Subject|0|||
27948672|NCT01156844|81647862|FG002|Overall Study|Withdrawal by Subject|2|||
27649905|NCT00681109|80557095|FG000|Overall Study|Lost to Follow-up|2|||
27948673|NCT01156844|81647863|FG003|Overall Study|Withdrawal by Subject|2|||
27948674|NCT01156844|81647860|FG000|Overall Study|Lost to Follow-up|0|||
27948675|NCT01156844|81647861|FG001|Overall Study|Lost to Follow-up|0|||
27948676|NCT01156844|81647862|FG002|Overall Study|Lost to Follow-up|1|||
27948677|NCT01156844|81647863|FG003|Overall Study|Lost to Follow-up|0|||
27948678|NCT01156844|81647860|FG000|Overall Study|Administrative problems|0|||
27649906|NCT00681109|80557096|FG001|Overall Study|Lost to Follow-up|6|||
27649907|NCT00681109|80557097|FG002|Overall Study|Lost to Follow-up|0|||
27649908|NCT03137784|80557098|FG000|Overall Study|Adverse Event|1|||
27948679|NCT01156844|81647861|FG001|Overall Study|Administrative problems|1|||
27948680|NCT01156844|81647862|FG002|Overall Study|Administrative problems|0|||
27948681|NCT01156844|81647863|FG003|Overall Study|Administrative problems|1|||
27948682|NCT01156844|81647860|FG000|Overall Study|Protocol deviation|2|||
27948683|NCT01156844|81647861|FG001|Overall Study|Protocol deviation|0|||
27649909|NCT03137784|80557099|FG001|Overall Study|Adverse Event|1|||
27948684|NCT01156844|81647862|FG002|Overall Study|Protocol deviation|0|||
27948685|NCT01156844|81647863|FG003|Overall Study|Protocol deviation|0|||
27948686|NCT03038087|81647864|FG000|Overall Study|lost data|1|||
27948687|NCT02743962|81647865|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
27948688|NCT02743962|81647866|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
27948689|NCT00518180|81647868|FG000|Overall Study|Withdrawal by Subject|29|||
27948690|NCT00518180|81647869|FG001|Overall Study|Withdrawal by Subject|30|||
27948691|NCT00518180|81647870|FG002|Overall Study|Withdrawal by Subject|42|||
27948692|NCT00518180|81647868|FG000|Overall Study|Lost to Follow-up|30|||
27948693|NCT00518180|81647869|FG001|Overall Study|Lost to Follow-up|28|||
27948694|NCT00518180|81647870|FG002|Overall Study|Lost to Follow-up|34|||
27948695|NCT00518180|81647868|FG000|Overall Study|Administrative reason|0|||
27948696|NCT00518180|81647869|FG001|Overall Study|Administrative reason|2|||
27948697|NCT00518180|81647870|FG002|Overall Study|Administrative reason|2|||
27948698|NCT00518180|81647868|FG000|Overall Study|Protocol Violation|5|||
27948699|NCT00518180|81647869|FG001|Overall Study|Protocol Violation|7|||
27948700|NCT00518180|81647870|FG002|Overall Study|Protocol Violation|4|||
27948701|NCT00518180|81647868|FG000|Overall Study|Unable to classify|0|||
27948702|NCT00518180|81647869|FG001|Overall Study|Unable to classify|2|||
27948703|NCT00518180|81647870|FG002|Overall Study|Unable to classify|0|||
27948704|NCT00518180|81647868|FG000|Overall Study|Adverse Event|1|||
27948705|NCT00518180|81647869|FG001|Overall Study|Adverse Event|0|||
27948706|NCT00518180|81647870|FG002|Overall Study|Adverse Event|0|||
27948707|NCT03556891|81647871|FG000|Overall Study|Adverse Event|4|||
27948708|NCT03556891|81647871|FG000|Overall Study|MRI Need|3|||
27948709|NCT03556891|81647871|FG000|Overall Study|Device Failure|1|||
27948710|NCT03556891|81647871|FG000|Overall Study|Death|1|||
27948711|NCT03556891|81647871|FG000|Overall Study|Lost to Follow-up|1|||
27948712|NCT03556891|81647871|FG000|Overall Study|Missing at random|1|||
27948713|NCT03556891|81647871|FG000|Overall Study|Missing due to COVID|1|||
27948714|NCT03556891|81647871|FG000|Overall Study|Protocol Violation|1|||
27948715|NCT00851084|81647872|FG000|Overall Study|Randomized but not treated|1|||
27948716|NCT00851084|81647873|FG001|Overall Study|Randomized but not treated|0|||
27948717|NCT00851084|81647872|FG000|Overall Study|Adverse Event|26|||
27948718|NCT00851084|81647873|FG001|Overall Study|Adverse Event|36|||
27948719|NCT00851084|81647872|FG000|Overall Study|Disease progression|52|||
27948720|NCT00851084|81647873|FG001|Overall Study|Disease progression|47|||
27948721|NCT00851084|81647872|FG000|Overall Study|Poor compliance to protocol|1|||
27948722|NCT00851084|81647873|FG001|Overall Study|Poor compliance to protocol|1|||
27948723|NCT00851084|81647872|FG000|Overall Study|Physician Decision|13|||
27948724|NCT00851084|81647873|FG001|Overall Study|Physician Decision|14|||
27948725|NCT00851084|81647872|FG000|Overall Study|Consent withdrawn|0|||
27948726|NCT00851084|81647873|FG001|Overall Study|Consent withdrawn|2|||
27948727|NCT00851084|81647872|FG000|Overall Study|Withdrawal by Subject|11|||
27948728|NCT00851084|81647873|FG001|Overall Study|Withdrawal by Subject|12|||
27948729|NCT00851084|81647872|FG000|Overall Study|Metastatic surgery|6|||
27948730|NCT00851084|81647873|FG001|Overall Study|Metastatic surgery|6|||
27948731|NCT00851084|81647872|FG000|Overall Study|Other|7|||
27948732|NCT00851084|81647873|FG001|Overall Study|Other|1|||
27948733|NCT01728246|81647876|FG000|Overall Study|Participant needed rescue medication|1|||
27948734|NCT01728246|81647877|FG001|Overall Study|Participant needed rescue medication|5|||
27948735|NCT01728246|81647876|FG000|Overall Study|Protocol Violation|1|||
27948736|NCT01728246|81647877|FG001|Overall Study|Protocol Violation|0|||
27948737|NCT01728246|81647876|FG000|Overall Study|Withdrawal by Subject|2|||
27948738|NCT01728246|81647877|FG001|Overall Study|Withdrawal by Subject|3|||
27948739|NCT01728246|81647876|FG000|Overall Study|Lost to Follow-up|23|||
27948740|NCT01728246|81647877|FG001|Overall Study|Lost to Follow-up|22|||
27948741|NCT01728246|81647876|FG000|Overall Study|Lack of Efficacy|1|||
27948742|NCT01728246|81647877|FG001|Overall Study|Lack of Efficacy|1|||
27948743|NCT01728246|81647876|FG000|Overall Study|Adverse Event|8|||
27948744|NCT01728246|81647877|FG001|Overall Study|Adverse Event|5|||
27948745|NCT02796651|81647878|FG000|Overall Study|Adverse Event|6|||
27948746|NCT02796651|81647878|FG000|Overall Study|Lost to Follow-up|1|||
27948747|NCT02796651|81647878|FG000|Overall Study|Withdrawal by Subject|4|||
27948748|NCT02796651|81647878|FG000|Overall Study|Protocol Violation|4|||
27948749|NCT02796651|81647878|FG000|Overall Study|Lack of Efficacy|1|||
27948750|NCT02796651|81647878|FG000|Overall Study|Other|10|||
27948751|NCT02371889|81647879|FG000|Overall Study|Adverse medication effect|11|||
27649910|NCT03137784|80557100|FG002|Overall Study|Adverse Event|0|||
27746472|NCT01259297|80899642|FG006|Double Blind Randomized Period|Other reasons|3|||
27948752|NCT02371889|81647880|FG001|Overall Study|Adverse medication effect|2|||
27948753|NCT02371889|81647879|FG000|Overall Study|Lost to Follow-up|6|||
27948754|NCT02371889|81647880|FG001|Overall Study|Lost to Follow-up|5|||
27948755|NCT02371889|81647879|FG000|Overall Study|Personal time constraints|2|||
27948756|NCT02371889|81647880|FG001|Overall Study|Personal time constraints|4|||
27948757|NCT02371889|81647879|FG000|Overall Study|Lack of Efficacy|0|||
27948758|NCT02371889|81647880|FG001|Overall Study|Lack of Efficacy|2|||
27948759|NCT02371889|81647879|FG000|Overall Study|Relapse|0|||
27948760|NCT02371889|81647880|FG001|Overall Study|Relapse|1|||
27948761|NCT03309202|81647884|FG000|Overall Study|Lost to Follow-up|1|||
27948762|NCT03309202|81647885|FG001|Overall Study|Lost to Follow-up|0|||
27948763|NCT03309202|81647886|FG002|Overall Study|Lost to Follow-up|0|||
27948764|NCT03309202|81647887|FG003|Overall Study|Lost to Follow-up|0|||
27948765|NCT00209131|81647888|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
27948766|NCT00209131|81647889|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
27948767|NCT00567580|81647892|FG000|Overall Study|Protocol Violation|28|||
27948768|NCT00567580|81647893|FG001|Overall Study|Protocol Violation|24|||
27948769|NCT00567580|81647894|FG002|Overall Study|Protocol Violation|24|||
27948770|NCT03014089|81647895|FG000|Overall Study|Withdrawal by Subject|0|||
27948771|NCT03014089|81647896|FG001|Overall Study|Withdrawal by Subject|1|||
27948772|NCT03014089|81647897|FG002|Overall Study|Withdrawal by Subject|1|||
27948773|NCT03014089|81647898|FG003|Overall Study|Withdrawal by Subject|1|||
27948774|NCT03014089|81647895|FG000|Overall Study|Lost to Follow-up|1|||
27948775|NCT03014089|81647896|FG001|Overall Study|Lost to Follow-up|0|||
27948776|NCT03014089|81647897|FG002|Overall Study|Lost to Follow-up|0|||
27948777|NCT03014089|81647898|FG003|Overall Study|Lost to Follow-up|0|||
27948778|NCT03014089|81647895|FG000|Overall Study|Adverse Event|1|||
27948779|NCT03014089|81647896|FG001|Overall Study|Adverse Event|0|||
27948780|NCT03014089|81647897|FG002|Overall Study|Adverse Event|1|||
27948781|NCT03014089|81647898|FG003|Overall Study|Adverse Event|0|||
27948782|NCT01230060|81647899|FG000|Overall Study|Withdrawal by Subject|1|||
27948783|NCT00474903|81647900|FG000|Overall Study|Protocol Violation|1|||
27948784|NCT00474903|81647901|FG001|Overall Study|Protocol Violation|5|||
27948785|NCT00474903|81647902|FG002|Overall Study|Protocol Violation|2|||
27948786|NCT00565747|81647906|FG000|Overall Study|No embryo transfer|67|||
27948787|NCT00565747|81647907|FG001|Overall Study|No embryo transfer|73|||
27948788|NCT02106832|81647912|FG000|Overall Study|Adverse Event|1|||
27948789|NCT02106832|81647913|FG001|Overall Study|Adverse Event|2|||
27948790|NCT02106832|81647914|FG002|Overall Study|Adverse Event|3|||
27948791|NCT02106832|81647915|FG003|Overall Study|Adverse Event|0|||
27948792|NCT02106832|81647912|FG000|Overall Study|Death|4|||
27948793|NCT02106832|81647913|FG001|Overall Study|Death|4|||
27948794|NCT02106832|81647914|FG002|Overall Study|Death|1|||
27948795|NCT02106832|81647915|FG003|Overall Study|Death|4|||
27948796|NCT02106832|81647912|FG000|Overall Study|Deterioration of general conditions|0|||
27948797|NCT02106832|81647913|FG001|Overall Study|Deterioration of general conditions|0|||
27948798|NCT02106832|81647914|FG002|Overall Study|Deterioration of general conditions|1|||
27948799|NCT02106832|81647915|FG003|Overall Study|Deterioration of general conditions|0|||
27948800|NCT02106832|81647912|FG000|Overall Study|Lost to Follow-up|0|||
27948801|NCT02106832|81647913|FG001|Overall Study|Lost to Follow-up|1|||
27948802|NCT02106832|81647914|FG002|Overall Study|Lost to Follow-up|1|||
27948803|NCT02106832|81647915|FG003|Overall Study|Lost to Follow-up|3|||
27948804|NCT02106832|81647912|FG000|Overall Study|Physician Decision|1|||
27948805|NCT02106832|81647913|FG001|Overall Study|Physician Decision|0|||
27948806|NCT02106832|81647914|FG002|Overall Study|Physician Decision|0|||
27948807|NCT02106832|81647915|FG003|Overall Study|Physician Decision|0|||
27948808|NCT02106832|81647912|FG000|Overall Study|Protocol Violation|0|||
27948809|NCT02106832|81647913|FG001|Overall Study|Protocol Violation|0|||
27948810|NCT02106832|81647914|FG002|Overall Study|Protocol Violation|0|||
27948811|NCT02106832|81647915|FG003|Overall Study|Protocol Violation|1|||
27948812|NCT02106832|81647912|FG000|Overall Study|Withdrawal by Subject|17|||
27948813|NCT02106832|81647913|FG001|Overall Study|Withdrawal by Subject|17|||
27948814|NCT02106832|81647914|FG002|Overall Study|Withdrawal by Subject|10|||
27948815|NCT02106832|81647915|FG003|Overall Study|Withdrawal by Subject|7|||
27948816|NCT02106832|81647912|FG000|Overall Study|Technical problems|0|||
27948817|NCT02106832|81647913|FG001|Overall Study|Technical problems|1|||
27948818|NCT02106832|81647914|FG002|Overall Study|Technical problems|0|||
27948819|NCT02106832|81647915|FG003|Overall Study|Technical problems|0|||
27948820|NCT03402841|81647918|FG000|Overall Study|Withdrawal by Subject|3|||
27948821|NCT03402841|81647918|FG000|Overall Study|Lost to Follow-up|2|||
27948822|NCT03402841|81647918|FG000|Overall Study|Death|146|||
27948823|NCT01722669|81647919|FG000|Overall Study|Withdrawal by Subject|0|||
27948824|NCT01722669|81647920|FG001|Overall Study|Withdrawal by Subject|0|||
27948825|NCT01722669|81647921|FG002|Overall Study|Withdrawal by Subject|0|||
27948826|NCT01722669|81647922|FG003|Overall Study|Withdrawal by Subject|0|||
27948827|NCT01722669|81647923|FG004|Overall Study|Withdrawal by Subject|0|||
27948828|NCT01722669|81647924|FG005|Overall Study|Withdrawal by Subject|2|||
27948829|NCT02257684|81647927|FG000|Overall Study|Adverse Event|2|||
27948830|NCT02257684|81647927|FG000|Overall Study|Lack of Efficacy|1|||
27948831|NCT02257684|81647927|FG000|Overall Study|Sponsor's Decision|1|||
27948832|NCT04339062|81647928|FG000|Overall Study|Death|0|||
27948833|NCT04339062|81647929|FG001|Overall Study|Death|1|||
27948834|NCT04856527|81647930|FG000|Overall Study|Unable to complete experimental task|2|||
27948835|NCT04856527|81647931|FG001|Overall Study|Unable to complete experimental task|0|||
27948836|NCT04138056|81647934|FG000|Primary Study|Lost to Follow-up|3|||
27948837|NCT04138056|81647935|FG001|Primary Study|Lost to Follow-up|4|||
27948838|NCT04138056|81647936|FG002|Primary Study|Lost to Follow-up|1|||
27948839|NCT04138056|81647937|FG003|Primary Study|Lost to Follow-up|1|||
27948840|NCT04138056|81647938|FG004|Primary Study|Lost to Follow-up|4|||
27948841|NCT04138056|81647934|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
27948842|NCT04138056|81647935|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
27948843|NCT04138056|81647936|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
27948844|NCT04138056|81647937|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
27649911|NCT03137784|80557101|FG003|Overall Study|Adverse Event|0|||
27649912|NCT03137784|80557102|FG004|Overall Study|Adverse Event|0|||
27948845|NCT04138056|81647938|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
27948846|NCT04138056|81647934|FG000|Extension Study|Lost to Follow-up|1|||
27948847|NCT04138056|81647935|FG001|Extension Study|Lost to Follow-up|2|||
27948848|NCT04138056|81647936|FG002|Extension Study|Lost to Follow-up|1|||
27948849|NCT04138056|81647937|FG003|Extension Study|Lost to Follow-up|0|||
27948850|NCT04138056|81647938|FG004|Extension Study|Lost to Follow-up|1|||
27948851|NCT03038620|81647939|FG000|Overall Study|Lost to Follow-up|18|||
27948852|NCT03038620|81647940|FG001|Overall Study|Lost to Follow-up|23|||
27948853|NCT03038620|81647939|FG000|Overall Study|Withdrawal by Subject|0|||
27948854|NCT03038620|81647940|FG001|Overall Study|Withdrawal by Subject|15|||
27948855|NCT03038620|81647939|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
27948856|NCT03038620|81647940|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
27948857|NCT04881760|81647943|FG000|Overall Study|Adverse Event|0|||
27948858|NCT04881760|81647944|FG001|Overall Study|Adverse Event|1|||
27948859|NCT04881760|81647945|FG002|Overall Study|Adverse Event|1|||
27948860|NCT04881760|81647946|FG003|Overall Study|Adverse Event|0|||
27948861|NCT04881760|81647947|FG004|Overall Study|Adverse Event|1|||
27948862|NCT04881760|81647948|FG005|Overall Study|Adverse Event|1|||
27948863|NCT04881760|81647949|FG006|Overall Study|Adverse Event|2|||
27948864|NCT04881760|81647943|FG000|Overall Study|Death|0|||
27649913|NCT03137784|80557103|FG005|Overall Study|Adverse Event|0|||
27649914|NCT03137784|80557098|FG000|Overall Study|Subject/guardian decision|1|||
27649915|NCT03137784|80557099|FG001|Overall Study|Subject/guardian decision|0|||
27649916|NCT03137784|80557100|FG002|Overall Study|Subject/guardian decision|0|||
27649917|NCT03137784|80557101|FG003|Overall Study|Subject/guardian decision|0|||
27649918|NCT03137784|80557102|FG004|Overall Study|Subject/guardian decision|0|||
27649919|NCT03137784|80557103|FG005|Overall Study|Subject/guardian decision|0|||
27649920|NCT03137784|80557098|FG000|Overall Study|Non-compliance with study treatment|0|||
27649921|NCT03137784|80557099|FG001|Overall Study|Non-compliance with study treatment|0|||
27649922|NCT03137784|80557100|FG002|Overall Study|Non-compliance with study treatment|0|||
27649923|NCT03137784|80557101|FG003|Overall Study|Non-compliance with study treatment|0|||
27649924|NCT03137784|80557102|FG004|Overall Study|Non-compliance with study treatment|1|||
27649925|NCT03137784|80557103|FG005|Overall Study|Non-compliance with study treatment|0|||
27649926|NCT02736188|80557104|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
27649927|NCT02736188|80557104|FG000|Overall Study|Adverse Event|1|||
27649928|NCT02736188|80557104|FG000|Overall Study|Withdrawal by Subject|1|||
27649929|NCT02736188|80557104|FG000|Overall Study|Other|6|||
27649930|NCT01852045|80557105|FG000|Overall Study|Adverse Event|1|||
27649931|NCT01852045|80557106|FG001|Overall Study|Adverse Event|0|||
27649932|NCT01852045|80557107|FG002|Overall Study|Adverse Event|0|||
27649933|NCT01852045|80557105|FG000|Overall Study|Lack of Efficacy|3|||
27649934|NCT01852045|80557106|FG001|Overall Study|Lack of Efficacy|0|||
27649935|NCT01852045|80557107|FG002|Overall Study|Lack of Efficacy|0|||
27649936|NCT01852045|80557105|FG000|Overall Study|Lost to Follow-up|0|||
27649937|NCT01852045|80557106|FG001|Overall Study|Lost to Follow-up|1|||
27649938|NCT01852045|80557107|FG002|Overall Study|Lost to Follow-up|1|||
27649939|NCT01852045|80557105|FG000|Overall Study|Withdrawal by Subject|1|||
27649940|NCT01852045|80557106|FG001|Overall Study|Withdrawal by Subject|0|||
27948865|NCT04881760|81647944|FG001|Overall Study|Death|0|||
27649941|NCT01852045|80557107|FG002|Overall Study|Withdrawal by Subject|1|||
27649942|NCT01852045|80557105|FG000|Overall Study|Other Miscellaneous Reasons|1|||
27649943|NCT01852045|80557106|FG001|Overall Study|Other Miscellaneous Reasons|3|||
27649944|NCT01852045|80557107|FG002|Overall Study|Other Miscellaneous Reasons|2|||
27649945|NCT03775213|80557108|FG000|Overall Study|Withdrawal by Subject|51|||
27649946|NCT03775213|80557109|FG001|Overall Study|Withdrawal by Subject|53|||
27649947|NCT03775213|80557108|FG000|Overall Study|Incomplete Survey|7|||
27649948|NCT03775213|80557109|FG001|Overall Study|Incomplete Survey|7|||
27649949|NCT01698918|80557110|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
27649950|NCT01698918|80557110|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
27649951|NCT01698918|80557110|FG000|First Line Treatment (Core+Extension)|Death|2|||
27649952|NCT01698918|80557110|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
27948866|NCT04881760|81647945|FG002|Overall Study|Death|0|||
27948867|NCT04881760|81647946|FG003|Overall Study|Death|1|||
27948868|NCT04881760|81647947|FG004|Overall Study|Death|0|||
27551471|NCT01543698|80207459|FG001|Phase 2|Withdrawal by Subject|0|||
27551472|NCT01543698|80207460|FG002|Phase 2|Withdrawal by Subject|0|||
27551473|NCT01543698|80207461|FG003|Phase 2|Withdrawal by Subject|0|||
27551474|NCT01543698|80207462|FG004|Phase 2|Withdrawal by Subject|0|||
27551475|NCT01543698|80207463|FG005|Phase 2|Withdrawal by Subject|0|||
27649953|NCT01698918|80557110|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
27649954|NCT01698918|80557110|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
27649955|NCT01698918|80557110|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
27649956|NCT01698918|80557110|FG000|Second Line Treatment (Core+Extension)|Death|1|||
27649957|NCT01698918|80557110|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
27649958|NCT01698918|80557110|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
27649959|NCT02326220|80557111|FG000|Double-blind Treatment Period|Adverse Event|1|||
27948869|NCT04881760|81647948|FG005|Overall Study|Death|0|||
27948870|NCT04881760|81647949|FG006|Overall Study|Death|0|||
27948871|NCT04881760|81647943|FG000|Overall Study|Lost to Follow-up|5|||
27948872|NCT04881760|81647944|FG001|Overall Study|Lost to Follow-up|7|||
27948873|NCT04881760|81647945|FG002|Overall Study|Lost to Follow-up|5|||
27948874|NCT04881760|81647946|FG003|Overall Study|Lost to Follow-up|1|||
27948875|NCT04881760|81647947|FG004|Overall Study|Lost to Follow-up|2|||
27948876|NCT04881760|81647948|FG005|Overall Study|Lost to Follow-up|4|||
27948877|NCT04881760|81647949|FG006|Overall Study|Lost to Follow-up|4|||
27948878|NCT04881760|81647943|FG000|Overall Study|Withdrawal by Subject|13|||
27948879|NCT04881760|81647944|FG001|Overall Study|Withdrawal by Subject|1|||
27948880|NCT04881760|81647945|FG002|Overall Study|Withdrawal by Subject|1|||
27948881|NCT04881760|81647946|FG003|Overall Study|Withdrawal by Subject|4|||
27948882|NCT04881760|81647947|FG004|Overall Study|Withdrawal by Subject|2|||
27948883|NCT04881760|81647948|FG005|Overall Study|Withdrawal by Subject|1|||
27948884|NCT04881760|81647949|FG006|Overall Study|Withdrawal by Subject|2|||
27948885|NCT04881760|81647943|FG000|Overall Study|Randomized but Never Treated|0|||
27948886|NCT04881760|81647944|FG001|Overall Study|Randomized but Never Treated|0|||
27948887|NCT04881760|81647945|FG002|Overall Study|Randomized but Never Treated|0|||
27948888|NCT04881760|81647946|FG003|Overall Study|Randomized but Never Treated|1|||
27948889|NCT04881760|81647947|FG004|Overall Study|Randomized but Never Treated|0|||
27948890|NCT04881760|81647948|FG005|Overall Study|Randomized but Never Treated|0|||
27948891|NCT04881760|81647949|FG006|Overall Study|Randomized but Never Treated|0|||
27948892|NCT04881760|81647943|FG000|Overall Study|Inadvertent Enrollment|2|||
27948893|NCT04881760|81647944|FG001|Overall Study|Inadvertent Enrollment|0|||
27948894|NCT04881760|81647945|FG002|Overall Study|Inadvertent Enrollment|0|||
27948895|NCT04881760|81647946|FG003|Overall Study|Inadvertent Enrollment|0|||
27948896|NCT04881760|81647947|FG004|Overall Study|Inadvertent Enrollment|0|||
27948897|NCT04881760|81647948|FG005|Overall Study|Inadvertent Enrollment|0|||
27649960|NCT02326220|80557112|FG001|Double-blind Treatment Period|Adverse Event|2|||
27649961|NCT02326220|80557113|FG002|Double-blind Treatment Period|Adverse Event|0|||
27649962|NCT02326220|80557111|FG000|Double-blind Treatment Period|Protocol Violation|0|||
27649963|NCT02326220|80557112|FG001|Double-blind Treatment Period|Protocol Violation|1|||
27649964|NCT02326220|80557113|FG002|Double-blind Treatment Period|Protocol Violation|0|||
27649965|NCT02326220|80557111|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27649966|NCT02326220|80557112|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27649967|NCT02326220|80557113|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27649968|NCT02326220|80557111|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
27649969|NCT02326220|80557112|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27649970|NCT02326220|80557113|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
27649971|NCT02326220|80557111|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27649972|NCT02326220|80557112|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
27649973|NCT02326220|80557113|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
27649974|NCT02340806|80557114|FG000|Overall Study|Protocol Violation|2|||
27649975|NCT02340806|80557115|FG001|Overall Study|Protocol Violation|0|||
27649976|NCT02340806|80557114|FG000|Overall Study|epidural catheter replaced|2|||
27649977|NCT02340806|80557115|FG001|Overall Study|epidural catheter replaced|1|||
27649978|NCT02340806|80557114|FG000|Overall Study|history of chronic pain medication|1|||
27649979|NCT02340806|80557115|FG001|Overall Study|history of chronic pain medication|0|||
27649980|NCT02340806|80557114|FG000|Overall Study|re-dose < 90 min of CSE|1|||
27649981|NCT02340806|80557115|FG001|Overall Study|re-dose < 90 min of CSE|3|||
27649982|NCT03140670|80557121|FG000|Overall Study|Withdrawal by Subject|2|||
27948898|NCT04881760|81647949|FG006|Overall Study|Inadvertent Enrollment|0|||
27948899|NCT04881760|81647943|FG000|Overall Study|Site Closure|0|||
27948900|NCT04881760|81647944|FG001|Overall Study|Site Closure|0|||
27649983|NCT03140670|80557121|FG000|Overall Study|Lost to Follow-up|1|||
27948901|NCT04881760|81647945|FG002|Overall Study|Site Closure|0|||
27948902|NCT04881760|81647946|FG003|Overall Study|Site Closure|1|||
27649984|NCT03140670|80557121|FG000|Overall Study|Physician Decision|1|||
27649985|NCT03418922|80557122|FG000|Overall Study|Withdrawal by Subject|0|||
27948903|NCT04881760|81647947|FG004|Overall Study|Site Closure|0|||
27948904|NCT04881760|81647948|FG005|Overall Study|Site Closure|0|||
27948905|NCT04881760|81647949|FG006|Overall Study|Site Closure|0|||
27948906|NCT02154061|81647951|FG000|Overall Study|Pregnancy|1|||
27948907|NCT02154061|81647952|FG001|Overall Study|Pregnancy|0|||
27948908|NCT02154061|81647951|FG000|Overall Study|enrolled but not vaccinated|1|||
27649986|NCT03418922|80557123|FG001|Overall Study|Withdrawal by Subject|2|||
27649987|NCT03418922|80557122|FG000|Overall Study|Adverse Event|2|||
27649988|NCT03418922|80557123|FG001|Overall Study|Adverse Event|2|||
27649989|NCT03418922|80557122|FG000|Overall Study|Death|0|||
27649990|NCT03418922|80557123|FG001|Overall Study|Death|1|||
27948909|NCT02154061|81647952|FG001|Overall Study|enrolled but not vaccinated|0|||
27948910|NCT01055028|81647953|FG000|Screening|Screen Failure|1|||
27948911|NCT01055028|81647954|FG001|Screening|Screen Failure|1|||
27948912|NCT01055028|81647953|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
27948913|NCT01055028|81647954|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
27948914|NCT01055028|81647953|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
27948915|NCT01055028|81647954|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
27948916|NCT01055028|81647953|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
27948917|NCT01055028|81647954|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
27948918|NCT03612570|81647955|FG000|Overall Study|Lost to Follow-up|1|||
27948919|NCT00573768|81647958|FG000|Overall Study|Adverse Event|1|||
27948920|NCT00573768|81647959|FG001|Overall Study|Adverse Event|1|||
27948921|NCT00573768|81647960|FG002|Overall Study|Adverse Event|2|||
27948922|NCT00573768|81647958|FG000|Overall Study|Protocol Violation|1|||
27948923|NCT00573768|81647959|FG001|Overall Study|Protocol Violation|0|||
27948924|NCT00573768|81647960|FG002|Overall Study|Protocol Violation|1|||
27948925|NCT00573768|81647958|FG000|Overall Study|Withdrawal by Subject|0|||
27948926|NCT00573768|81647959|FG001|Overall Study|Withdrawal by Subject|1|||
27948927|NCT00573768|81647960|FG002|Overall Study|Withdrawal by Subject|0|||
27948928|NCT00573768|81647958|FG000|Overall Study|Lost to Follow-up|0|||
27948929|NCT00573768|81647959|FG001|Overall Study|Lost to Follow-up|0|||
27948930|NCT00573768|81647960|FG002|Overall Study|Lost to Follow-up|1|||
27948931|NCT04466891|81647965|FG000|Overall Study|Death|52|||
27948932|NCT04466891|81647966|FG001|Overall Study|Death|5|||
27948933|NCT04466891|81647965|FG000|Overall Study|Withdrawal by Subject|8|||
27948934|NCT04466891|81647966|FG001|Overall Study|Withdrawal by Subject|1|||
27948935|NCT04549454|81647969|FG000|T1 to T2|Lost to Follow-up|22|||
27948936|NCT04549454|81647970|FG001|T1 to T2|Lost to Follow-up|26|||
27948937|NCT04549454|81647969|FG000|T1 to T3|Lost to Follow-up|31|||
27948938|NCT04549454|81647970|FG001|T1 to T3|Lost to Follow-up|36|||
27948939|NCT01170663|81647974|FG000|Overall Study|Lost to Follow-up|3|||
27948940|NCT01170663|81647975|FG001|Overall Study|Lost to Follow-up|9|||
27948941|NCT01170663|81647974|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
27948942|NCT01170663|81647975|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
27948943|NCT00746811|81647977|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
27948944|NCT00746811|81647978|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
27948945|NCT01475721|81647981|FG000|Overall Study|Death|3|||
27948946|NCT01475721|81647982|FG001|Overall Study|Death|6|||
27948947|NCT01475721|81647981|FG000|Overall Study|Withdrawal by Subject|8|||
27948948|NCT01475721|81647982|FG001|Overall Study|Withdrawal by Subject|8|||
27948949|NCT00104884|81647983|FG000|Overall Study|Disease progression|4|||
27948950|NCT00833690|81647984|FG000|Overall Study|Withdrawal by Subject|1|||
27948951|NCT00833690|81647985|FG001|Overall Study|Withdrawal by Subject|0|||
27948952|NCT00833690|81647986|FG002|Overall Study|Withdrawal by Subject|0|||
27948953|NCT00833690|81647984|FG000|Overall Study|Discontinued study drug|3|||
27948954|NCT00833690|81647985|FG001|Overall Study|Discontinued study drug|2|||
27948955|NCT00833690|81647986|FG002|Overall Study|Discontinued study drug|0|||
27948956|NCT04388826|81647987|FG000|Overall Study|Lost to Follow-up|3|||
27948957|NCT04388826|81647988|FG001|Overall Study|Lost to Follow-up|2|||
27948958|NCT04388826|81647987|FG000|Overall Study|Adverse Event|1|||
27948959|NCT04388826|81647988|FG001|Overall Study|Adverse Event|0|||
27948960|NCT01832727|81647989|FG000|Overall Study|Adverse Event|4|||
27948961|NCT01832727|81647990|FG001|Overall Study|Adverse Event|6|||
27948962|NCT01832727|81647991|FG002|Overall Study|Adverse Event|1|||
27948963|NCT01832727|81647992|FG003|Overall Study|Adverse Event|0|||
27649991|NCT03418922|80557122|FG000|Overall Study|Physician Decision|0|||
27948964|NCT01832727|81647993|FG004|Overall Study|Adverse Event|1|||
27948965|NCT01832727|81647994|FG005|Overall Study|Adverse Event|1|||
27948966|NCT01832727|81647995|FG006|Overall Study|Adverse Event|2|||
27948967|NCT01832727|81647996|FG007|Overall Study|Adverse Event|1|||
27948968|NCT01832727|81647997|FG008|Overall Study|Adverse Event|9|||
27649992|NCT03418922|80557123|FG001|Overall Study|Physician Decision|1|||
27948969|NCT01832727|81647989|FG000|Overall Study|Disease progression|3|||
27948970|NCT01832727|81647990|FG001|Overall Study|Disease progression|0|||
27948971|NCT01832727|81647991|FG002|Overall Study|Disease progression|2|||
27948972|NCT01832727|81647992|FG003|Overall Study|Disease progression|1|||
27948973|NCT01832727|81647993|FG004|Overall Study|Disease progression|3|||
27948974|NCT01832727|81647994|FG005|Overall Study|Disease progression|3|||
27948975|NCT01832727|81647995|FG006|Overall Study|Disease progression|6|||
27948976|NCT01832727|81647996|FG007|Overall Study|Disease progression|2|||
27948977|NCT01832727|81647997|FG008|Overall Study|Disease progression|7|||
27948978|NCT01832727|81647989|FG000|Overall Study|Lost to Follow-up|0|||
27948979|NCT01832727|81647990|FG001|Overall Study|Lost to Follow-up|0|||
27948980|NCT01832727|81647991|FG002|Overall Study|Lost to Follow-up|0|||
27948981|NCT01832727|81647992|FG003|Overall Study|Lost to Follow-up|1|||
27948982|NCT01832727|81647993|FG004|Overall Study|Lost to Follow-up|0|||
27948983|NCT01832727|81647994|FG005|Overall Study|Lost to Follow-up|0|||
27948984|NCT01832727|81647995|FG006|Overall Study|Lost to Follow-up|0|||
27948985|NCT01832727|81647996|FG007|Overall Study|Lost to Follow-up|0|||
27948986|NCT01832727|81647997|FG008|Overall Study|Lost to Follow-up|0|||
27948987|NCT01832727|81647989|FG000|Overall Study|Physician Decision|1|||
27948988|NCT01832727|81647990|FG001|Overall Study|Physician Decision|0|||
27948989|NCT01832727|81647991|FG002|Overall Study|Physician Decision|0|||
27948990|NCT01832727|81647992|FG003|Overall Study|Physician Decision|1|||
27948991|NCT01832727|81647993|FG004|Overall Study|Physician Decision|0|||
27948992|NCT01832727|81647994|FG005|Overall Study|Physician Decision|1|||
27948993|NCT01832727|81647995|FG006|Overall Study|Physician Decision|0|||
27948994|NCT01832727|81647996|FG007|Overall Study|Physician Decision|0|||
27948995|NCT01832727|81647997|FG008|Overall Study|Physician Decision|0|||
27948996|NCT01832727|81647989|FG000|Overall Study|Withdrawal by Subject|1|||
27948997|NCT01832727|81647990|FG001|Overall Study|Withdrawal by Subject|1|||
27948998|NCT01832727|81647991|FG002|Overall Study|Withdrawal by Subject|0|||
27948999|NCT01832727|81647992|FG003|Overall Study|Withdrawal by Subject|1|||
27949000|NCT01832727|81647993|FG004|Overall Study|Withdrawal by Subject|0|||
27949001|NCT01832727|81647994|FG005|Overall Study|Withdrawal by Subject|1|||
27949002|NCT01832727|81647995|FG006|Overall Study|Withdrawal by Subject|0|||
27949003|NCT01832727|81647996|FG007|Overall Study|Withdrawal by Subject|2|||
27949004|NCT01832727|81647997|FG008|Overall Study|Withdrawal by Subject|1|||
27949005|NCT01832727|81647989|FG000|Overall Study|Study terminated by sponsor|0|||
27949006|NCT01832727|81647990|FG001|Overall Study|Study terminated by sponsor|0|||
27949007|NCT01832727|81647991|FG002|Overall Study|Study terminated by sponsor|0|||
27949008|NCT01832727|81647992|FG003|Overall Study|Study terminated by sponsor|0|||
27949009|NCT01832727|81647993|FG004|Overall Study|Study terminated by sponsor|0|||
27949010|NCT01832727|81647994|FG005|Overall Study|Study terminated by sponsor|0|||
27949011|NCT01832727|81647995|FG006|Overall Study|Study terminated by sponsor|0|||
27949012|NCT01832727|81647996|FG007|Overall Study|Study terminated by sponsor|1|||
27949013|NCT01832727|81647997|FG008|Overall Study|Study terminated by sponsor|1|||
27949014|NCT03322566|81647998|FG000|Overall Study|Death|34|||
27949015|NCT03322566|81647999|FG001|Overall Study|Death|35|||
27949016|NCT03322566|81648000|FG002|Overall Study|Death|23|||
27949017|NCT03322566|81647998|FG000|Overall Study|Physician Decision|6|||
27949018|NCT03322566|81647999|FG001|Overall Study|Physician Decision|7|||
27949019|NCT03322566|81648000|FG002|Overall Study|Physician Decision|2|||
27949020|NCT03322566|81647998|FG000|Overall Study|Withdrawal by Subject|4|||
27949021|NCT03322566|81647999|FG001|Overall Study|Withdrawal by Subject|3|||
27949022|NCT03322566|81648000|FG002|Overall Study|Withdrawal by Subject|6|||
27949023|NCT03322566|81647998|FG000|Overall Study|Lost to Follow-up|0|||
27949024|NCT03322566|81647999|FG001|Overall Study|Lost to Follow-up|0|||
27949025|NCT03322566|81648000|FG002|Overall Study|Lost to Follow-up|1|||
27949026|NCT03322566|81647998|FG000|Overall Study|Study terminated by sponsor|1|||
27949027|NCT03322566|81647999|FG001|Overall Study|Study terminated by sponsor|0|||
27949028|NCT03322566|81648000|FG002|Overall Study|Study terminated by sponsor|1|||
27949029|NCT02735200|81648001|FG000|Overall Study|Lost to Follow-up|0|||
27949030|NCT02735200|81648002|FG001|Overall Study|Lost to Follow-up|5|||
27949031|NCT02735200|81648001|FG000|Overall Study|Withdrawal by Subject|8|||
27949032|NCT02735200|81648002|FG001|Overall Study|Withdrawal by Subject|0|||
27949033|NCT02112656|81648003|FG000|Overall Study|Death|78|||
27949034|NCT02112656|81648004|FG001|Overall Study|Death|82|||
27949035|NCT02112656|81648003|FG000|Overall Study|Withdrawal by Subject|9|||
27949036|NCT02112656|81648004|FG001|Overall Study|Withdrawal by Subject|11|||
27949037|NCT02112656|81648003|FG000|Overall Study|Lost to Follow-up|2|||
27949038|NCT02112656|81648004|FG001|Overall Study|Lost to Follow-up|4|||
27949039|NCT02112656|81648003|FG000|Overall Study|Noncompliance|1|||
27949040|NCT02112656|81648004|FG001|Overall Study|Noncompliance|2|||
27949041|NCT02746809|81648005|FG000|Enrollment|Inclusion Exclusion not met|9|||
27949042|NCT02746809|81648005|FG000|Enrollment|Withdrawal by Subject|1|||
27949043|NCT02746809|81648005|FG000|Enrollment|Expected Enrollment Met|2|||
27949044|NCT02746809|81648005|FG000|Procedure|Death|1|||
27949045|NCT02746809|81648005|FG000|1-Month|Death|5|||
27746473|NCT01259297|80899643|FG007|Double Blind Randomized Period|Other reasons|1|||
27949046|NCT02746809|81648005|FG000|6-Month|Death|2|||
27949047|NCT02746809|81648005|FG000|6-Month|Withdrawal by Subject|1|||
27949048|NCT02746809|81648005|FG000|12-Month|Death|3|||
27949049|NCT02746809|81648005|FG000|12-Month|Withdrawal by Subject|2|||
27949050|NCT02746809|81648005|FG000|24-Month|Death|1|||
27949051|NCT02746809|81648005|FG000|24-Month|Withdrawal by Subject|1|||
27949052|NCT02746809|81648005|FG000|36-Month|Death|8|||
27949053|NCT02746809|81648005|FG000|36-Month|Withdrawal by Subject|1|||
27949054|NCT02746809|81648005|FG000|48-Month|Death|7|||
27949055|NCT02746809|81648005|FG000|48-Month|Withdrawal by Subject|1|||
27949056|NCT02746809|81648005|FG000|60-Month|Death|1|||
27949057|NCT02746809|81648005|FG000|60-Month|Lost to Follow-up|2|||
27949058|NCT04618471|81648007|FG000|Overall Study|Screen Failure|62|||
27949059|NCT04618471|81648007|FG000|Overall Study|Withdrawal by Subject|6|||
27949060|NCT04618471|81648007|FG000|Overall Study|Physician Decision|2|||
27949061|NCT04618471|81648007|FG000|Overall Study|Lost to Follow-up|1|||
27949062|NCT04618471|81648007|FG000|Overall Study|Various other reasons|2|||
27949063|NCT04618471|81648007|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
27949064|NCT03950856|81648008|FG000|Overall Study|Death|1|||
27649993|NCT03138499|80557126|FG000|Overall Study|Lost to Follow-up|1|||
27949065|NCT03950856|81648009|FG001|Overall Study|Death|2|||
27949066|NCT03950856|81648010|FG002|Overall Study|Death|0|||
27949067|NCT03950856|81648011|FG003|Overall Study|Death|0|||
27949068|NCT03950856|81648008|FG000|Overall Study|Lost to Follow-up|5|||
27949069|NCT03950856|81648009|FG001|Overall Study|Lost to Follow-up|6|||
27949070|NCT03950856|81648010|FG002|Overall Study|Lost to Follow-up|8|||
27949071|NCT03950856|81648011|FG003|Overall Study|Lost to Follow-up|2|||
27949072|NCT03950856|81648008|FG000|Overall Study|Protocol Violation|2|||
27949073|NCT03950856|81648009|FG001|Overall Study|Protocol Violation|0|||
27949074|NCT03950856|81648010|FG002|Overall Study|Protocol Violation|0|||
27949075|NCT03950856|81648011|FG003|Overall Study|Protocol Violation|1|||
27949076|NCT03950856|81648008|FG000|Overall Study|Withdrawal by Subject|4|||
27949077|NCT03950856|81648009|FG001|Overall Study|Withdrawal by Subject|1|||
27949078|NCT03950856|81648010|FG002|Overall Study|Withdrawal by Subject|3|||
27949079|NCT03950856|81648011|FG003|Overall Study|Withdrawal by Subject|1|||
27949080|NCT03950856|81648008|FG000|Overall Study|Unable to phone|7|||
27649994|NCT03138499|80557127|FG001|Overall Study|Lost to Follow-up|0|||
27649995|NCT03138499|80557126|FG000|Overall Study|Participants withdrew consent|1|||
27649996|NCT03138499|80557127|FG001|Overall Study|Participants withdrew consent|0|||
27949081|NCT03950856|81648009|FG001|Overall Study|Unable to phone|6|||
27949082|NCT03950856|81648010|FG002|Overall Study|Unable to phone|7|||
27949083|NCT03950856|81648011|FG003|Overall Study|Unable to phone|2|||
27949084|NCT03235050|81648013|FG000|Overall Study|Adverse Event|0|||
27949085|NCT03235050|81648014|FG001|Overall Study|Adverse Event|0|||
27949086|NCT03235050|81648015|FG002|Overall Study|Adverse Event|1|||
27949087|NCT03235050|81648016|FG003|Overall Study|Adverse Event|4|||
27949088|NCT03235050|81648017|FG004|Overall Study|Adverse Event|1|||
27949089|NCT03235050|81648013|FG000|Overall Study|Death|0|||
27949090|NCT03235050|81648014|FG001|Overall Study|Death|0|||
27949091|NCT03235050|81648015|FG002|Overall Study|Death|0|||
27949092|NCT03235050|81648016|FG003|Overall Study|Death|2|||
27949093|NCT03235050|81648017|FG004|Overall Study|Death|1|||
27949094|NCT03235050|81648013|FG000|Overall Study|Lost to Follow-up|1|||
27949095|NCT03235050|81648014|FG001|Overall Study|Lost to Follow-up|2|||
27949096|NCT03235050|81648015|FG002|Overall Study|Lost to Follow-up|1|||
27949097|NCT03235050|81648016|FG003|Overall Study|Lost to Follow-up|2|||
27949098|NCT03235050|81648017|FG004|Overall Study|Lost to Follow-up|0|||
27949099|NCT03235050|81648013|FG000|Overall Study|Withdrawal by Subject|3|||
27949100|NCT03235050|81648014|FG001|Overall Study|Withdrawal by Subject|2|||
27949101|NCT03235050|81648015|FG002|Overall Study|Withdrawal by Subject|2|||
27949102|NCT03235050|81648016|FG003|Overall Study|Withdrawal by Subject|5|||
27949103|NCT03235050|81648017|FG004|Overall Study|Withdrawal by Subject|7|||
27949104|NCT03235050|81648013|FG000|Overall Study|Other reasons|0|||
27949105|NCT03235050|81648014|FG001|Overall Study|Other reasons|1|||
27949106|NCT03235050|81648015|FG002|Overall Study|Other reasons|0|||
27949107|NCT03235050|81648016|FG003|Overall Study|Other reasons|1|||
27949108|NCT03235050|81648017|FG004|Overall Study|Other reasons|2|||
27949109|NCT04577781|81648018|FG000|Overall Study|Adverse Event|2|||
27949110|NCT04577781|81648019|FG001|Overall Study|Adverse Event|2|||
27949111|NCT04577781|81648018|FG000|Overall Study|Physician Decision|1|||
27949112|NCT04577781|81648019|FG001|Overall Study|Physician Decision|0|||
27949113|NCT05896748|81648022|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
27649997|NCT03138499|80557126|FG000|Overall Study|Participant discontinued study before treatment|0|||
27649998|NCT03138499|80557127|FG001|Overall Study|Participant discontinued study before treatment|1|||
27949114|NCT05896748|81648022|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
27949115|NCT05896748|81648022|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
27949116|NCT05896748|81648022|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
27949117|NCT05896748|81648022|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
27949118|NCT01463033|81648023|FG000|Overall Study|Lost to Follow-up|4|||
27649999|NCT03138499|80557126|FG000|Overall Study|Disease Progression|2|||
27949119|NCT01463033|81648024|FG001|Overall Study|Lost to Follow-up|4|||
27949120|NCT01463033|81648023|FG000|Overall Study|Death|3|||
27949121|NCT01463033|81648024|FG001|Overall Study|Death|2|||
27949122|NCT02234362|81648025|FG000|Overall Study|Not eligible after first screening visit|17|||
27949123|NCT02234362|81648025|FG000|Overall Study|Lost to Follow-up|6|||
27949124|NCT02234362|81648025|FG000|Overall Study|Withdrawal by Subject|3|||
27949125|NCT01853280|81648026|FG000|Overall Study|Lack of Efficacy|2|||
27949126|NCT01853280|81648027|FG001|Overall Study|Lack of Efficacy|2|||
27949127|NCT01853280|81648026|FG000|Overall Study|Lost to Follow-up|0|||
27949128|NCT01853280|81648027|FG001|Overall Study|Lost to Follow-up|1|||
27949129|NCT01853280|81648026|FG000|Overall Study|Physician Decision|0|||
27949130|NCT01853280|81648027|FG001|Overall Study|Physician Decision|1|||
27949131|NCT01853280|81648026|FG000|Overall Study|Withdrawal by Subject|0|||
27949132|NCT01853280|81648027|FG001|Overall Study|Withdrawal by Subject|1|||
27949133|NCT01853280|81648026|FG000|Overall Study|Ineligible|0|||
27949134|NCT01853280|81648027|FG001|Overall Study|Ineligible|1|||
27949135|NCT02191618|81648033|FG000|Overall Study|Withdrawal by Subject|3|||
27949136|NCT02191618|81648033|FG000|Overall Study|Missed Visit|4|||
27949137|NCT02317627|81648034|FG000|Overall Study|Withdrawal by Subject|0|||
27949138|NCT02317627|81648035|FG001|Overall Study|Withdrawal by Subject|1|||
27949139|NCT02317627|81648036|FG002|Overall Study|Withdrawal by Subject|1|||
27949140|NCT02317627|81648034|FG000|Overall Study|Lost to Follow-up|2|||
27949141|NCT02317627|81648035|FG001|Overall Study|Lost to Follow-up|0|||
27949142|NCT02317627|81648036|FG002|Overall Study|Lost to Follow-up|0|||
27949143|NCT02317627|81648034|FG000|Overall Study|Stopped by Investigator|0|||
27949144|NCT02317627|81648035|FG001|Overall Study|Stopped by Investigator|1|||
27949145|NCT02317627|81648036|FG002|Overall Study|Stopped by Investigator|0|||
27949146|NCT02317627|81648034|FG000|Overall Study|Adverse Event|0|||
27949147|NCT02317627|81648035|FG001|Overall Study|Adverse Event|2|||
27949148|NCT02317627|81648036|FG002|Overall Study|Adverse Event|3|||
27949149|NCT02317627|81648034|FG000|Overall Study|Non-compliance with study drug|0|||
27949150|NCT02317627|81648035|FG001|Overall Study|Non-compliance with study drug|1|||
27949151|NCT02317627|81648036|FG002|Overall Study|Non-compliance with study drug|0|||
27949152|NCT02284191|81648041|FG000|Overall Study|Withdrawal by Subject|1|||
27949153|NCT02284191|81648042|FG001|Overall Study|Withdrawal by Subject|3|||
27949154|NCT02284191|81648041|FG000|Overall Study|Lost to Follow-up|1|||
27949155|NCT02284191|81648042|FG001|Overall Study|Lost to Follow-up|0|||
27650000|NCT03138499|80557127|FG001|Overall Study|Disease Progression|6|||
27650001|NCT03138499|80557126|FG000|Overall Study|Study drug toxicity|2|||
27650002|NCT03138499|80557127|FG001|Overall Study|Study drug toxicity|2|||
27650003|NCT03138499|80557126|FG000|Overall Study|Participant request to discontinue study treatment|1|||
27650004|NCT03138499|80557127|FG001|Overall Study|Participant request to discontinue study treatment|1|||
27650005|NCT03138499|80557126|FG000|Overall Study|Other reasons|2|||
27650006|NCT03138499|80557127|FG001|Overall Study|Other reasons|0|||
27650007|NCT01159600|80557130|FG000|Overall Study|Not treated|0|||
27650008|NCT01159600|80557131|FG001|Overall Study|Not treated|0|||
27650009|NCT01159600|80557132|FG002|Overall Study|Not treated|1|||
27650010|NCT01159600|80557133|FG003|Overall Study|Not treated|0|||
27650011|NCT01159600|80557134|FG004|Overall Study|Not treated|0|||
27949156|NCT02437318|81648045|FG000|Overall Study|Progressive disease|173|||
27949157|NCT02437318|81648046|FG001|Overall Study|Progressive disease|208|||
27949158|NCT02437318|81648045|FG000|Overall Study|Subject/guardian decision|22|||
27949159|NCT02437318|81648046|FG001|Overall Study|Subject/guardian decision|10|||
27949160|NCT02437318|81648045|FG000|Overall Study|Physician Decision|11|||
27949161|NCT02437318|81648046|FG001|Overall Study|Physician Decision|10|||
27949162|NCT02437318|81648045|FG000|Overall Study|Adverse Event|14|||
27949163|NCT02437318|81648046|FG001|Overall Study|Adverse Event|3|||
27949164|NCT02437318|81648045|FG000|Overall Study|Death|4|||
27949165|NCT02437318|81648046|FG001|Overall Study|Death|4|||
27949166|NCT02437318|81648045|FG000|Overall Study|Protocol Violation|5|||
27650012|NCT01159600|80557135|FG005|Overall Study|Not treated|1|||
27650013|NCT01159600|80557136|FG006|Overall Study|Not treated|2|||
27650014|NCT01159600|80557137|FG007|Overall Study|Not treated|2|||
27650015|NCT01159600|80557130|FG000|Overall Study|Adverse Event|7|||
27650016|NCT01159600|80557131|FG001|Overall Study|Adverse Event|2|||
27650017|NCT01159600|80557132|FG002|Overall Study|Adverse Event|5|||
27650018|NCT01159600|80557133|FG003|Overall Study|Adverse Event|1|||
27949167|NCT02437318|81648046|FG001|Overall Study|Protocol Violation|6|||
27949168|NCT02437318|81648045|FG000|Overall Study|Untreated|0|||
27949169|NCT02437318|81648046|FG001|Overall Study|Untreated|1|||
27949170|NCT00862940|81648047|FG000|Overall Study|Adverse Event|15|||
27949171|NCT00862940|81648048|FG001|Overall Study|Adverse Event|12|||
27650019|NCT01159600|80557134|FG004|Overall Study|Adverse Event|8|||
27650020|NCT01159600|80557135|FG005|Overall Study|Adverse Event|6|||
27949172|NCT00862940|81648047|FG000|Overall Study|Lack of Efficacy|1|||
27949173|NCT00862940|81648048|FG001|Overall Study|Lack of Efficacy|3|||
27650021|NCT01159600|80557136|FG006|Overall Study|Adverse Event|7|||
27949174|NCT00862940|81648047|FG000|Overall Study|Protocol Violation|2|||
27949175|NCT00862940|81648048|FG001|Overall Study|Protocol Violation|5|||
27949176|NCT00862940|81648047|FG000|Overall Study|Withdrawal by Subject|4|||
27949177|NCT00862940|81648048|FG001|Overall Study|Withdrawal by Subject|6|||
27949178|NCT00862940|81648047|FG000|Overall Study|Non-compliance|4|||
27949179|NCT00862940|81648048|FG001|Overall Study|Non-compliance|0|||
27949180|NCT00862940|81648047|FG000|Overall Study|Lost to Follow-up|0|||
27949181|NCT00862940|81648048|FG001|Overall Study|Lost to Follow-up|1|||
27949182|NCT00862940|81648047|FG000|Overall Study|Administrative or other reason(s)|4|||
27551476|NCT01543698|80207464|FG006|Phase 2|Withdrawal by Subject|0|||
27650022|NCT01159600|80557137|FG007|Overall Study|Adverse Event|5|||
27650023|NCT01159600|80557130|FG000|Overall Study|Lack of Efficacy|0|||
27650024|NCT01159600|80557131|FG001|Overall Study|Lack of Efficacy|0|||
27650025|NCT01159600|80557132|FG002|Overall Study|Lack of Efficacy|0|||
27949183|NCT00862940|81648048|FG001|Overall Study|Administrative or other reason(s)|3|||
27949184|NCT00928668|81648049|FG000|Overall Study|Adverse Event|1|||
27949185|NCT00928668|81648050|FG001|Overall Study|Adverse Event|0|||
27949186|NCT00928668|81648051|FG002|Overall Study|Adverse Event|0|||
27949187|NCT00928668|81648052|FG003|Overall Study|Adverse Event|0|||
27949188|NCT00928668|81648053|FG004|Overall Study|Adverse Event|0|||
27949189|NCT00928668|81648049|FG000|Overall Study|Protocol Violation|0|||
27949190|NCT00928668|81648050|FG001|Overall Study|Protocol Violation|0|||
27949191|NCT00928668|81648051|FG002|Overall Study|Protocol Violation|0|||
27949192|NCT00928668|81648052|FG003|Overall Study|Protocol Violation|0|||
27949193|NCT00928668|81648053|FG004|Overall Study|Protocol Violation|1|||
27949194|NCT00928668|81648049|FG000|Overall Study|Withdrawal by Subject|0|||
27949195|NCT00928668|81648050|FG001|Overall Study|Withdrawal by Subject|1|||
27650026|NCT01159600|80557133|FG003|Overall Study|Lack of Efficacy|0|||
27650027|NCT01159600|80557134|FG004|Overall Study|Lack of Efficacy|2|||
27650028|NCT01159600|80557135|FG005|Overall Study|Lack of Efficacy|0|||
27650029|NCT01159600|80557136|FG006|Overall Study|Lack of Efficacy|0|||
27650030|NCT01159600|80557137|FG007|Overall Study|Lack of Efficacy|1|||
27650031|NCT01159600|80557130|FG000|Overall Study|Non compliant with protocol|2|||
27650032|NCT01159600|80557131|FG001|Overall Study|Non compliant with protocol|1|||
27650033|NCT01159600|80557132|FG002|Overall Study|Non compliant with protocol|0|||
27650034|NCT01159600|80557133|FG003|Overall Study|Non compliant with protocol|0|||
27650035|NCT01159600|80557134|FG004|Overall Study|Non compliant with protocol|2|||
27650036|NCT01159600|80557135|FG005|Overall Study|Non compliant with protocol|0|||
27949196|NCT00928668|81648051|FG002|Overall Study|Withdrawal by Subject|1|||
27949197|NCT00928668|81648052|FG003|Overall Study|Withdrawal by Subject|0|||
27949198|NCT00928668|81648053|FG004|Overall Study|Withdrawal by Subject|0|||
27949199|NCT00928668|81648049|FG000|Overall Study|Other reasons not listed above|0|||
27949200|NCT00928668|81648050|FG001|Overall Study|Other reasons not listed above|0|||
27949201|NCT00928668|81648051|FG002|Overall Study|Other reasons not listed above|0|||
27949202|NCT00928668|81648052|FG003|Overall Study|Other reasons not listed above|1|||
27949203|NCT00928668|81648053|FG004|Overall Study|Other reasons not listed above|0|||
27949204|NCT04704193|81648056|FG000|Overall Study|Withdrawal by Subject|1|||
27949205|NCT02993263|81648057|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
27949206|NCT00478257|81648058|FG000|Overall Study|Withdrawal by Subject|8|||
27949207|NCT00478257|81648059|FG001|Overall Study|Withdrawal by Subject|3|||
27949208|NCT00725985|81648062|FG000|ITP- Treatment Disposition|Adverse Event|20|||
27949209|NCT00725985|81648063|FG001|ITP- Treatment Disposition|Adverse Event|10|||
27949210|NCT00725985|81648064|FG002|ITP- Treatment Disposition|Adverse Event|5|||
27949211|NCT00725985|81648065|FG003|ITP- Treatment Disposition|Adverse Event|0|||
27949212|NCT00725985|81648066|FG004|ITP- Treatment Disposition|Adverse Event|0|||
27949213|NCT00725985|81648067|FG005|ITP- Treatment Disposition|Adverse Event|0|||
27949214|NCT00725985|81648068|FG006|ITP- Treatment Disposition|Adverse Event|0|||
27949215|NCT00725985|81648069|FG007|ITP- Treatment Disposition|Adverse Event|0|||
27949216|NCT00725985|81648070|FG008|ITP- Treatment Disposition|Adverse Event|0|||
27949217|NCT00725985|81648071|FG009|ITP- Treatment Disposition|Adverse Event|0|||
27949218|NCT00725985|81648072|FG010|ITP- Treatment Disposition|Adverse Event|0|||
27949219|NCT00725985|81648073|FG011|ITP- Treatment Disposition|Adverse Event|0|||
27949220|NCT00725985|81648062|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949221|NCT00725985|81648063|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949222|NCT00725985|81648064|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
27949223|NCT00725985|81648065|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949224|NCT00725985|81648066|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949225|NCT00725985|81648067|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949226|NCT00725985|81648068|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949227|NCT00725985|81648069|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949228|NCT00725985|81648070|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949229|NCT00725985|81648071|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949230|NCT00725985|81648072|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
27650037|NCT01159600|80557136|FG006|Overall Study|Non compliant with protocol|2|||
27650038|NCT01159600|80557137|FG007|Overall Study|Non compliant with protocol|0|||
27650039|NCT01159600|80557130|FG000|Overall Study|Lost to Follow-up|2|||
27650040|NCT01159600|80557131|FG001|Overall Study|Lost to Follow-up|3|||
27949231|NCT00725985|81648073|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
27949232|NCT00725985|81648062|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
27949233|NCT00725985|81648063|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
27949234|NCT00725985|81648064|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
27949235|NCT00725985|81648065|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
27949236|NCT00725985|81648066|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
27949237|NCT00725985|81648067|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
27949238|NCT00725985|81648068|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
27949239|NCT00725985|81648069|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
27949240|NCT00725985|81648070|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
27650041|NCT01159600|80557132|FG002|Overall Study|Lost to Follow-up|4|||
27650042|NCT01159600|80557133|FG003|Overall Study|Lost to Follow-up|3|||
27746474|NCT04760314|80899644|FG000|Induction Period|Withdrawal by Subject|0|||
27949241|NCT00725985|81648071|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
27949242|NCT00725985|81648072|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
27949243|NCT00725985|81648073|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
27949244|NCT00725985|81648062|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
27949245|NCT00725985|81648063|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
27949246|NCT00725985|81648064|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
27949247|NCT00725985|81648065|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
27949248|NCT00725985|81648066|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
27949249|NCT00725985|81648067|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
27949250|NCT00725985|81648068|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
27949251|NCT00725985|81648069|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
27949252|NCT00725985|81648070|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
27949253|NCT00725985|81648071|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
27949254|NCT00725985|81648072|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
27949255|NCT00725985|81648073|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
27949256|NCT00725985|81648062|FG000|ITP- Treatment Disposition|Other|50|||
27949257|NCT00725985|81648063|FG001|ITP- Treatment Disposition|Other|38|||
27949258|NCT00725985|81648064|FG002|ITP- Treatment Disposition|Other|24|||
27949259|NCT00725985|81648065|FG003|ITP- Treatment Disposition|Other|0|||
27949260|NCT00725985|81648066|FG004|ITP- Treatment Disposition|Other|0|||
27949261|NCT00725985|81648067|FG005|ITP- Treatment Disposition|Other|0|||
27949262|NCT00725985|81648068|FG006|ITP- Treatment Disposition|Other|0|||
27949263|NCT00725985|81648069|FG007|ITP- Treatment Disposition|Other|0|||
27949264|NCT00725985|81648070|FG008|ITP- Treatment Disposition|Other|0|||
27949265|NCT00725985|81648071|FG009|ITP- Treatment Disposition|Other|0|||
27949266|NCT00725985|81648072|FG010|ITP- Treatment Disposition|Other|0|||
27949267|NCT00725985|81648073|FG011|ITP- Treatment Disposition|Other|0|||
27949268|NCT00725985|81648062|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949269|NCT00725985|81648063|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949270|NCT00725985|81648064|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949271|NCT00725985|81648065|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
27949272|NCT00725985|81648066|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
27949273|NCT00725985|81648067|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
27949274|NCT00725985|81648068|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949275|NCT00725985|81648069|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949276|NCT00725985|81648070|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949277|NCT00725985|81648071|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949278|NCT00725985|81648072|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949279|NCT00725985|81648073|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
27949280|NCT00725985|81648062|FG000|OLMP (Up to 96 Weeks)|Death|0|||
27949281|NCT00725985|81648063|FG001|OLMP (Up to 96 Weeks)|Death|0|||
27949282|NCT00725985|81648064|FG002|OLMP (Up to 96 Weeks)|Death|0|||
27949283|NCT00725985|81648065|FG003|OLMP (Up to 96 Weeks)|Death|0|||
27949284|NCT00725985|81648066|FG004|OLMP (Up to 96 Weeks)|Death|1|||
27949285|NCT00725985|81648067|FG005|OLMP (Up to 96 Weeks)|Death|0|||
27949286|NCT00725985|81648068|FG006|OLMP (Up to 96 Weeks)|Death|0|||
27949287|NCT00725985|81648069|FG007|OLMP (Up to 96 Weeks)|Death|0|||
27949288|NCT00725985|81648070|FG008|OLMP (Up to 96 Weeks)|Death|0|||
27949289|NCT00725985|81648071|FG009|OLMP (Up to 96 Weeks)|Death|0|||
27949290|NCT00725985|81648072|FG010|OLMP (Up to 96 Weeks)|Death|0|||
27949291|NCT00725985|81648073|FG011|OLMP (Up to 96 Weeks)|Death|0|||
27949292|NCT00725985|81648062|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949293|NCT00725985|81648063|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949294|NCT00725985|81648064|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949295|NCT00725985|81648065|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
27949296|NCT00725985|81648066|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949297|NCT00725985|81648067|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949298|NCT00725985|81648068|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949299|NCT00725985|81648069|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949300|NCT00725985|81648070|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949301|NCT00725985|81648071|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949302|NCT00725985|81648072|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949303|NCT00725985|81648073|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
27949304|NCT00725985|81648062|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949305|NCT00725985|81648063|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949306|NCT00725985|81648064|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
27650043|NCT01159600|80557134|FG004|Overall Study|Lost to Follow-up|3|||
27650044|NCT01159600|80557135|FG005|Overall Study|Lost to Follow-up|0|||
27650045|NCT01159600|80557136|FG006|Overall Study|Lost to Follow-up|3|||
27949307|NCT00725985|81648065|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949308|NCT00725985|81648066|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949309|NCT00725985|81648067|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
27949310|NCT00725985|81648068|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949311|NCT00725985|81648069|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949312|NCT00725985|81648070|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
27650046|NCT01159600|80557137|FG007|Overall Study|Lost to Follow-up|2|||
27650047|NCT01159600|80557130|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
27650048|NCT01159600|80557131|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
27650049|NCT01159600|80557132|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
27650050|NCT01159600|80557133|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
27650051|NCT01159600|80557134|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
27650052|NCT01159600|80557135|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
27949313|NCT00725985|81648071|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949314|NCT00725985|81648072|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949315|NCT00725985|81648073|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
27949316|NCT00725985|81648062|FG000|OLMP (Up to 96 Weeks)|Other|0|||
27949317|NCT00725985|81648063|FG001|OLMP (Up to 96 Weeks)|Other|0|||
27949318|NCT00725985|81648064|FG002|OLMP (Up to 96 Weeks)|Other|0|||
27949319|NCT00725985|81648065|FG003|OLMP (Up to 96 Weeks)|Other|15|||
27949320|NCT00725985|81648066|FG004|OLMP (Up to 96 Weeks)|Other|20|||
27949321|NCT00725985|81648067|FG005|OLMP (Up to 96 Weeks)|Other|44|||
27949322|NCT00725985|81648068|FG006|OLMP (Up to 96 Weeks)|Other|0|||
27949323|NCT00725985|81648069|FG007|OLMP (Up to 96 Weeks)|Other|0|||
27949324|NCT00725985|81648070|FG008|OLMP (Up to 96 Weeks)|Other|0|||
27949325|NCT00725985|81648071|FG009|OLMP (Up to 96 Weeks)|Other|0|||
27949326|NCT00725985|81648072|FG010|OLMP (Up to 96 Weeks)|Other|0|||
27949327|NCT00725985|81648073|FG011|OLMP (Up to 96 Weeks)|Other|0|||
27949328|NCT00725985|81648062|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949329|NCT00725985|81648063|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949330|NCT00725985|81648064|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949331|NCT00725985|81648065|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949332|NCT00725985|81648066|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949333|NCT00725985|81648067|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949334|NCT00725985|81648068|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949335|NCT00725985|81648069|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
27949336|NCT00725985|81648070|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949337|NCT00725985|81648071|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949338|NCT00725985|81648072|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27949339|NCT00725985|81648073|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
27650053|NCT01159600|80557136|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
27650054|NCT01159600|80557137|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
27949340|NCT00725985|81648062|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949341|NCT00725985|81648063|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949342|NCT00725985|81648064|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27650055|NCT01159600|80557130|FG000|Overall Study|Other reason not defined above|3|||
27650056|NCT01159600|80557131|FG001|Overall Study|Other reason not defined above|0|||
27650057|NCT01159600|80557132|FG002|Overall Study|Other reason not defined above|4|||
27650058|NCT01159600|80557133|FG003|Overall Study|Other reason not defined above|2|||
27650059|NCT01159600|80557134|FG004|Overall Study|Other reason not defined above|5|||
27650060|NCT01159600|80557135|FG005|Overall Study|Other reason not defined above|7|||
27949343|NCT00725985|81648065|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949344|NCT00725985|81648066|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949345|NCT00725985|81648067|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949346|NCT00725985|81648068|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949347|NCT00725985|81648069|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949348|NCT00725985|81648070|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
27949349|NCT00725985|81648071|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27650061|NCT01159600|80557136|FG006|Overall Study|Other reason not defined above|3|||
27650062|NCT01159600|80557137|FG007|Overall Study|Other reason not defined above|3|||
27650063|NCT02196259|80557138|FG000|Overall Study|Researcher choice|0|||
27650064|NCT02196259|80557139|FG001|Overall Study|Researcher choice|0|||
27650065|NCT02196259|80557140|FG002|Overall Study|Researcher choice|1|||
27650066|NCT02196259|80557138|FG000|Overall Study|Partial data analysis|0|||
27650067|NCT02196259|80557139|FG001|Overall Study|Partial data analysis|3|||
27650068|NCT02196259|80557140|FG002|Overall Study|Partial data analysis|0|||
27650069|NCT02038049|80560319|FG000|Overall Study|Lost to Follow-up|1|||
27650070|NCT02038049|80560320|FG001|Overall Study|Lost to Follow-up|0|||
27650071|NCT00645411|80560321|FG000|Overall Study|Adverse Event|0|||
27650072|NCT00645411|80560322|FG001|Overall Study|Adverse Event|0|||
27650073|NCT00645411|80560323|FG002|Overall Study|Adverse Event|0|||
27650074|NCT00645411|80560324|FG003|Overall Study|Adverse Event|2|||
27949350|NCT00725985|81648072|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27949351|NCT00725985|81648073|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
27650075|NCT00645411|80560321|FG000|Overall Study|Withdrawal by Subject|2|||
27650076|NCT00645411|80560322|FG001|Overall Study|Withdrawal by Subject|1|||
27949352|NCT00725985|81648062|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949353|NCT00725985|81648063|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949354|NCT00725985|81648064|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949355|NCT00725985|81648065|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949356|NCT00725985|81648066|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949357|NCT00725985|81648067|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949358|NCT00725985|81648068|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
27949359|NCT00725985|81648069|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
27949360|NCT00725985|81648070|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
27949361|NCT00725985|81648071|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949362|NCT00725985|81648072|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949363|NCT00725985|81648073|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
27949364|NCT00725985|81648062|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949365|NCT00725985|81648063|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949366|NCT00725985|81648064|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949367|NCT00725985|81648065|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949368|NCT00725985|81648066|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949369|NCT00725985|81648067|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949370|NCT00725985|81648068|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949371|NCT00725985|81648069|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949372|NCT00725985|81648070|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
27949373|NCT00725985|81648071|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
27949374|NCT00725985|81648072|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
27949375|NCT00725985|81648073|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
27949376|NCT00404248|81648074|FG000|Overall Study|pts declining status|0|||
27949377|NCT00404248|81648075|FG001|Overall Study|pts declining status|1|||
27949378|NCT00404248|81648076|FG002|Overall Study|pts declining status|0|||
27949379|NCT00404248|81648077|FG003|Overall Study|pts declining status|0|||
27949380|NCT00404248|81648078|FG004|Overall Study|pts declining status|0|||
27949381|NCT00404248|81648079|FG005|Overall Study|pts declining status|0|||
27949382|NCT00404248|81648080|FG006|Overall Study|pts declining status|0|||
27949383|NCT00404248|81648081|FG007|Overall Study|pts declining status|0|||
27949384|NCT00404248|81648082|FG008|Overall Study|pts declining status|0|||
27949385|NCT00163189|81648088|FG000|Overall Study|Other|6|||
27949386|NCT00163189|81648088|FG000|Overall Study|Lost to Follow-up|1|||
27949387|NCT00163189|81648088|FG000|Overall Study|Protocol Violation|2|||
27949388|NCT00163189|81648088|FG000|Overall Study|Death|3|||
27949389|NCT00163189|81648088|FG000|Overall Study|Adverse Event|6|||
27949390|NCT00163189|81648088|FG000|Overall Study|Lack of Efficacy|7|||
27949391|NCT00163189|81648088|FG000|Overall Study|Study terminated by sponsor|11|||
27949392|NCT00163189|81648088|FG000|Overall Study|Withdrawal by Subject|11|||
27949393|NCT00163189|81648088|FG000|Overall Study|Did not meet continuation criterion|16|||
27949394|NCT00841815|81648089|FG000|Washout|Withdrawal by Subject|0|||
27949395|NCT00841815|81648090|FG001|Washout|Withdrawal by Subject|1|||
27949396|NCT00666263|81648091|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
27949397|NCT00666263|81648092|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
27949398|NCT00666263|81648091|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
27949399|NCT00666263|81648092|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
27949400|NCT00666263|81648091|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
27949401|NCT00666263|81648092|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
27949402|NCT03341936|81648093|FG000|Overall Study|Ineligible|1|||
27949403|NCT03341936|81648093|FG000|Overall Study|Disease Progression|2|||
27949404|NCT03341936|81648093|FG000|Overall Study|Withdrew Consent|4|||
27949405|NCT03341936|81648093|FG000|Overall Study|Non-Compliance|1|||
27949406|NCT03341936|81648093|FG000|Overall Study|Physician Decision|1|||
27949407|NCT03341936|81648093|FG000|Overall Study|Withdrawal by Subject|1|||
27949408|NCT03341936|81648093|FG000|Overall Study|Other|1|||
27949409|NCT02415556|81648094|FG000|Overall Study|Adverse Event|3|||
27949410|NCT02415556|81648095|FG001|Overall Study|Adverse Event|4|||
27949411|NCT02415556|81648096|FG002|Overall Study|Adverse Event|2|||
27949412|NCT02415556|81648097|FG003|Overall Study|Adverse Event|4|||
27949413|NCT02415556|81648094|FG000|Overall Study|Lost to Follow-up|4|||
27949414|NCT02415556|81648095|FG001|Overall Study|Lost to Follow-up|5|||
27949415|NCT02415556|81648096|FG002|Overall Study|Lost to Follow-up|4|||
27949416|NCT02415556|81648097|FG003|Overall Study|Lost to Follow-up|1|||
27949417|NCT02415556|81648094|FG000|Overall Study|Withdrawal by Subject|13|||
27949418|NCT02415556|81648095|FG001|Overall Study|Withdrawal by Subject|4|||
27949419|NCT02415556|81648096|FG002|Overall Study|Withdrawal by Subject|14|||
27949420|NCT02415556|81648097|FG003|Overall Study|Withdrawal by Subject|12|||
27949421|NCT02415556|81648094|FG000|Overall Study|Physician Decision|1|||
27949422|NCT02415556|81648095|FG001|Overall Study|Physician Decision|3|||
27949423|NCT02415556|81648096|FG002|Overall Study|Physician Decision|1|||
27949424|NCT02415556|81648097|FG003|Overall Study|Physician Decision|2|||
27949425|NCT02415556|81648094|FG000|Overall Study|Censored - study completion|4|||
27949426|NCT02415556|81648095|FG001|Overall Study|Censored - study completion|5|||
27949427|NCT02415556|81648096|FG002|Overall Study|Censored - study completion|1|||
27949428|NCT02415556|81648097|FG003|Overall Study|Censored - study completion|0|||
27949429|NCT02415556|81648094|FG000|Overall Study|Family-related issues|0|||
27650077|NCT00645411|80560323|FG002|Overall Study|Withdrawal by Subject|19|||
27746475|NCT04760314|80899645|FG001|Induction Period|Withdrawal by Subject|1|||
27949430|NCT02415556|81648095|FG001|Overall Study|Family-related issues|0|||
27949431|NCT02415556|81648096|FG002|Overall Study|Family-related issues|0|||
27949432|NCT02415556|81648097|FG003|Overall Study|Family-related issues|1|||
27949433|NCT00399529|81648098|FG000|Overall Study|Off Study Prior to Treatment|2|||
27949434|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
27949435|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
27949436|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
27949437|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
27949438|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
27949439|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
27949440|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
27949441|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
27949442|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
27949443|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
27949444|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
27949445|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
27949446|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
27949447|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
27949448|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
27949449|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
27949450|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
27949451|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
27949452|NCT01432444|81648099|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
27949453|NCT01432444|81648100|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
27949454|NCT01432444|81648101|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
27949455|NCT01432444|81648099|FG000|Treatment Phase|Lost to Follow-up|0|||
27949456|NCT01432444|81648100|FG001|Treatment Phase|Lost to Follow-up|33|||
27949457|NCT01432444|81648101|FG002|Treatment Phase|Lost to Follow-up|0|||
27949458|NCT01432444|81648099|FG000|Treatment Phase|Adverse Event|0|||
27949459|NCT01432444|81648100|FG001|Treatment Phase|Adverse Event|37|||
27949460|NCT01432444|81648101|FG002|Treatment Phase|Adverse Event|0|||
27650078|NCT00645411|80560324|FG003|Overall Study|Withdrawal by Subject|21|||
27650079|NCT00645411|80560321|FG000|Overall Study|Lost to Follow-up|10|||
27650080|NCT00645411|80560322|FG001|Overall Study|Lost to Follow-up|5|||
27650081|NCT00645411|80560323|FG002|Overall Study|Lost to Follow-up|124|||
27650082|NCT00645411|80560324|FG003|Overall Study|Lost to Follow-up|75|||
27650083|NCT00645411|80560321|FG000|Overall Study|Protocol Violation|1|||
27650084|NCT00645411|80560322|FG001|Overall Study|Protocol Violation|0|||
27650085|NCT00645411|80560323|FG002|Overall Study|Protocol Violation|1|||
27650086|NCT00645411|80560324|FG003|Overall Study|Protocol Violation|0|||
27650087|NCT00645411|80560321|FG000|Overall Study|Inappropriate enrollment|0|||
27650088|NCT00645411|80560322|FG001|Overall Study|Inappropriate enrollment|0|||
27650089|NCT00645411|80560323|FG002|Overall Study|Inappropriate enrollment|4|||
27650090|NCT00645411|80560324|FG003|Overall Study|Inappropriate enrollment|1|||
27650091|NCT00645411|80560321|FG000|Overall Study|Unable to classify|0|||
27650092|NCT00645411|80560322|FG001|Overall Study|Unable to classify|0|||
27650093|NCT00645411|80560323|FG002|Overall Study|Unable to classify|3|||
27650094|NCT00645411|80560324|FG003|Overall Study|Unable to classify|4|||
27650095|NCT00590759|80560330|FG000|Overall Study|Death|52|||
27650096|NCT00590759|80560330|FG000|Overall Study|Lost to Follow-up|28|||
27650097|NCT02000752|80560331|FG000|Overall Study|Dystocic delivery|19|||
27650098|NCT02000752|80560332|FG001|Overall Study|Dystocic delivery|8|||
27650099|NCT02000752|80560331|FG000|Overall Study|Shift Changes|12|||
27650100|NCT02000752|80560332|FG001|Overall Study|Shift Changes|5|||
27650101|NCT02202317|80560335|FG000|Overall Study|Lost to Follow-up|1|||
27650102|NCT03964974|80560339|FG000|Overall Study|Lost to Follow-up|3|||
27650103|NCT03964974|80560340|FG001|Overall Study|Lost to Follow-up|2|||
27650104|NCT03964974|80560339|FG000|Overall Study|Withdrawal by Subject|0|||
27650105|NCT03964974|80560340|FG001|Overall Study|Withdrawal by Subject|3|||
27650106|NCT01549951|80560343|FG000|Overall Study|Adverse Event|15|||
27650107|NCT01549951|80560343|FG000|Overall Study|Withdrawal by Subject|2|||
27650108|NCT01549951|80560343|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
27650109|NCT01549951|80560343|FG000|Overall Study|Progressive disease|29|||
27746476|NCT04760314|80899646|FG002|Induction Period|Withdrawal by Subject|1|||
27949461|NCT01432444|81648099|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
27650110|NCT01549951|80560343|FG000|Overall Study|Symptomatic deterioration|1|||
27650111|NCT01549951|80560343|FG000|Overall Study|Other|2|||
27650112|NCT02923349|80560344|FG000|Overall Study|Other|1|||
27650113|NCT02923349|80560345|FG001|Overall Study|Other|2|||
27650114|NCT02923349|80560346|FG002|Overall Study|Other|4|||
27650115|NCT02923349|80560347|FG003|Overall Study|Other|1|||
27650116|NCT02923349|80560348|FG004|Overall Study|Other|3|||
27650117|NCT02923349|80560349|FG005|Overall Study|Other|0|||
27949462|NCT01432444|81648100|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
27949463|NCT01432444|81648101|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
27949464|NCT01432444|81648099|FG000|Treatment Phase|Physician Decision|0|||
27949465|NCT01432444|81648100|FG001|Treatment Phase|Physician Decision|5|||
27949466|NCT01432444|81648101|FG002|Treatment Phase|Physician Decision|0|||
27949467|NCT01432444|81648099|FG000|Treatment Phase|Withdrawal by Subject|0|||
27949468|NCT01432444|81648100|FG001|Treatment Phase|Withdrawal by Subject|41|||
27949469|NCT01432444|81648101|FG002|Treatment Phase|Withdrawal by Subject|0|||
27949470|NCT01432444|81648099|FG000|Treatment Phase|Protocol Deviation|0|||
27949471|NCT01432444|81648100|FG001|Treatment Phase|Protocol Deviation|3|||
27949472|NCT01432444|81648101|FG002|Treatment Phase|Protocol Deviation|0|||
27949473|NCT01432444|81648099|FG000|Treatment Phase|Lack of Efficacy|0|||
27650118|NCT02923349|80560350|FG006|Overall Study|Other|1|||
27949474|NCT01432444|81648100|FG001|Treatment Phase|Lack of Efficacy|10|||
27949475|NCT01432444|81648101|FG002|Treatment Phase|Lack of Efficacy|0|||
27949476|NCT01432444|81648099|FG000|Extension Phase|Lost to Follow-up|0|||
27949477|NCT01432444|81648100|FG001|Extension Phase|Lost to Follow-up|0|||
27949478|NCT01432444|81648101|FG002|Extension Phase|Lost to Follow-up|17|||
27949479|NCT01432444|81648099|FG000|Extension Phase|Adverse Event|0|||
27650119|NCT02923349|80560344|FG000|Overall Study|Withdrawal by Subject|2|||
27650120|NCT02923349|80560345|FG001|Overall Study|Withdrawal by Subject|2|||
27650121|NCT02923349|80560346|FG002|Overall Study|Withdrawal by Subject|8|||
27650122|NCT02923349|80560347|FG003|Overall Study|Withdrawal by Subject|10|||
27650123|NCT02923349|80560348|FG004|Overall Study|Withdrawal by Subject|12|||
27650124|NCT02923349|80560349|FG005|Overall Study|Withdrawal by Subject|3|||
27650125|NCT02923349|80560350|FG006|Overall Study|Withdrawal by Subject|0|||
27650126|NCT02923349|80560344|FG000|Overall Study|Physician Decision|0|||
27650127|NCT02923349|80560345|FG001|Overall Study|Physician Decision|0|||
27650128|NCT02923349|80560346|FG002|Overall Study|Physician Decision|0|||
27650129|NCT02923349|80560347|FG003|Overall Study|Physician Decision|1|||
27650130|NCT02923349|80560348|FG004|Overall Study|Physician Decision|1|||
27650131|NCT02923349|80560349|FG005|Overall Study|Physician Decision|0|||
27650132|NCT02923349|80560350|FG006|Overall Study|Physician Decision|2|||
27650133|NCT02923349|80560344|FG000|Overall Study|Lost to Follow-up|0|||
27650134|NCT02923349|80560345|FG001|Overall Study|Lost to Follow-up|0|||
27650135|NCT02923349|80560346|FG002|Overall Study|Lost to Follow-up|3|||
27650136|NCT02923349|80560347|FG003|Overall Study|Lost to Follow-up|0|||
27650137|NCT02923349|80560348|FG004|Overall Study|Lost to Follow-up|1|||
27650138|NCT02923349|80560349|FG005|Overall Study|Lost to Follow-up|1|||
27650139|NCT02923349|80560350|FG006|Overall Study|Lost to Follow-up|0|||
27650140|NCT02923349|80560344|FG000|Overall Study|Death|1|||
27650141|NCT02923349|80560345|FG001|Overall Study|Death|0|||
27949480|NCT01432444|81648100|FG001|Extension Phase|Adverse Event|0|||
27949481|NCT01432444|81648101|FG002|Extension Phase|Adverse Event|10|||
27949482|NCT01432444|81648099|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
27949483|NCT01432444|81648100|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
27949484|NCT01432444|81648101|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
27949485|NCT01432444|81648099|FG000|Extension Phase|Met Withdrawal Criteria|0|||
27949486|NCT01432444|81648100|FG001|Extension Phase|Met Withdrawal Criteria|0|||
27949487|NCT01432444|81648101|FG002|Extension Phase|Met Withdrawal Criteria|144|||
27949488|NCT01432444|81648099|FG000|Extension Phase|Physician Decision|0|||
27949489|NCT01432444|81648100|FG001|Extension Phase|Physician Decision|0|||
27949490|NCT01432444|81648101|FG002|Extension Phase|Physician Decision|1|||
27949491|NCT01432444|81648099|FG000|Extension Phase|Withdrawal by Subject|0|||
27949492|NCT01432444|81648100|FG001|Extension Phase|Withdrawal by Subject|0|||
27949493|NCT01432444|81648101|FG002|Extension Phase|Withdrawal by Subject|13|||
27949494|NCT01570387|81651293|FG000|Overall Study|Adverse Event|1|||
27949495|NCT01570387|81651294|FG001|Overall Study|Adverse Event|0|||
27650142|NCT02923349|80560346|FG002|Overall Study|Death|2|||
27650143|NCT02923349|80560347|FG003|Overall Study|Death|4|||
27650144|NCT02923349|80560348|FG004|Overall Study|Death|2|||
27949496|NCT01570387|81651295|FG002|Overall Study|Adverse Event|0|||
27949497|NCT01570387|81651296|FG003|Overall Study|Adverse Event|0|||
27650145|NCT02923349|80560349|FG005|Overall Study|Death|3|||
27650146|NCT02923349|80560350|FG006|Overall Study|Death|0|||
27650147|NCT00047385|80560351|FG000|Overall Study|Death before any screening|2|||
27650148|NCT00047385|80560352|FG001|Overall Study|Death before any screening|5|||
27650149|NCT00047385|80560351|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
27650150|NCT00047385|80560352|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
27650151|NCT00047385|80560351|FG000|Overall Study|Eligible for screening but had no screen|260|||
27650152|NCT00047385|80560352|FG001|Overall Study|Eligible for screening but had no screen|492|||
27949498|NCT01570387|81651293|FG000|Overall Study|Death|0|||
27949499|NCT01570387|81651294|FG001|Overall Study|Death|0|||
27949500|NCT01570387|81651295|FG002|Overall Study|Death|0|||
27949501|NCT01570387|81651296|FG003|Overall Study|Death|1|||
27650153|NCT01286311|80560353|FG000|Overall Study|Physician did not want outreach sent|14|||
27949502|NCT01570387|81651293|FG000|Overall Study|Withdrawal by Subject|0|||
27949503|NCT01570387|81651294|FG001|Overall Study|Withdrawal by Subject|0|||
27949504|NCT01570387|81651295|FG002|Overall Study|Withdrawal by Subject|0|||
27949505|NCT01570387|81651296|FG003|Overall Study|Withdrawal by Subject|1|||
27949506|NCT04068922|81651297|FG000|Overall Study|Lost to Follow-up|5|||
27949507|NCT04068922|81651297|FG000|Overall Study|Withdrawal by Subject|7|||
27949508|NCT04068922|81651297|FG000|Overall Study|Adverse Event|1|||
27949509|NCT04573972|81651298|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
27949510|NCT04573972|81651299|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
27949511|NCT02552225|81651302|FG000|Overall Study|Withdrawal by Subject|1|||
27949512|NCT02552225|81651303|FG001|Overall Study|Withdrawal by Subject|0|||
27949513|NCT00889005|81651304|FG000|Overall Study|Lost to Follow-up|4|||
27949514|NCT00889005|81651305|FG001|Overall Study|Lost to Follow-up|2|||
27949515|NCT00889005|81651304|FG000|Overall Study|Withdrawal by Subject|4|||
27949516|NCT00889005|81651305|FG001|Overall Study|Withdrawal by Subject|0|||
27949517|NCT02006927|81651307|FG000|Overall Study|Adverse Event|2|||
27949518|NCT02006927|81651307|FG000|Overall Study|Withdrawal by Subject|1|||
27949519|NCT02519842|81651308|FG000|Base Study: Cycle 1|Screening Failure|1|||
27949520|NCT02519842|81651309|FG001|Base Study: Cycle 1|Screening Failure|1|||
27949521|NCT02519842|81651310|FG002|Base Study: Cycle 1|Screening Failure|0|||
27949522|NCT02519842|81651308|FG000|Base Study: Cycle 1|Adverse Event|1|||
27949523|NCT02519842|81651309|FG001|Base Study: Cycle 1|Adverse Event|0|||
27949524|NCT02519842|81651310|FG002|Base Study: Cycle 1|Adverse Event|0|||
27949525|NCT02519842|81651308|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
27949526|NCT02519842|81651309|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
27949527|NCT02519842|81651310|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
27949528|NCT02519842|81651308|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
27949529|NCT02519842|81651309|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
27949530|NCT02519842|81651310|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
27949531|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
27949532|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
27949533|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
27949534|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
27949535|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
27949536|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
27949537|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27949538|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
27949539|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
27949540|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
27949541|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
27949542|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
27949543|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Death|0|||
27949544|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Death|0|||
27949545|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Death|1|||
27949546|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
27949547|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
27949548|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
27949549|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
27949550|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
27949551|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
27949552|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
27949553|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
27949554|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
27949555|NCT02519842|81651308|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
27949556|NCT02519842|81651309|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
27949557|NCT02519842|81651310|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
27949558|NCT02561962|81651316|FG000|Overall Study|Withdrawal by Subject|1|||
27949559|NCT02561962|81651317|FG001|Overall Study|Withdrawal by Subject|0|||
27949560|NCT02561962|81651318|FG002|Overall Study|Withdrawal by Subject|0|||
27949561|NCT02561962|81651319|FG003|Overall Study|Withdrawal by Subject|0|||
27949562|NCT02561962|81651320|FG004|Overall Study|Withdrawal by Subject|1|||
27949563|NCT02561962|81651321|FG005|Overall Study|Withdrawal by Subject|1|||
27949564|NCT02561962|81651322|FG006|Overall Study|Withdrawal by Subject|2|||
27650154|NCT01286311|80560354|FG001|Overall Study|Physician did not want outreach sent|0|||
27949565|NCT02561962|81651323|FG007|Overall Study|Withdrawal by Subject|1|||
27949566|NCT02561962|81651324|FG008|Overall Study|Withdrawal by Subject|0|||
27949567|NCT02561962|81651316|FG000|Overall Study|Decision by sponsor|0|||
27949568|NCT02561962|81651317|FG001|Overall Study|Decision by sponsor|0|||
27949569|NCT02561962|81651318|FG002|Overall Study|Decision by sponsor|0|||
27949570|NCT02561962|81651319|FG003|Overall Study|Decision by sponsor|0|||
27949571|NCT02561962|81651320|FG004|Overall Study|Decision by sponsor|1|||
27650155|NCT02077374|80560357|FG000|Overall Study|Withdrawal by Subject|0|||
27949572|NCT02561962|81651321|FG005|Overall Study|Decision by sponsor|1|||
27949573|NCT02561962|81651322|FG006|Overall Study|Decision by sponsor|0|||
27949574|NCT02561962|81651323|FG007|Overall Study|Decision by sponsor|3|||
27949575|NCT02561962|81651324|FG008|Overall Study|Decision by sponsor|0|||
27949576|NCT02561962|81651316|FG000|Overall Study|Lost to Follow-up|0|||
27949577|NCT02561962|81651317|FG001|Overall Study|Lost to Follow-up|0|||
27949578|NCT02561962|81651318|FG002|Overall Study|Lost to Follow-up|0|||
27949579|NCT02561962|81651319|FG003|Overall Study|Lost to Follow-up|0|||
27949580|NCT02561962|81651320|FG004|Overall Study|Lost to Follow-up|0|||
27949581|NCT02561962|81651321|FG005|Overall Study|Lost to Follow-up|1|||
27949582|NCT02561962|81651322|FG006|Overall Study|Lost to Follow-up|0|||
27949583|NCT02561962|81651323|FG007|Overall Study|Lost to Follow-up|0|||
27949584|NCT02561962|81651324|FG008|Overall Study|Lost to Follow-up|0|||
27949585|NCT00718315|81651327|FG000|Overall Study|Adverse Event|1|||
27949586|NCT00718315|81651328|FG001|Overall Study|Adverse Event|2|||
27949587|NCT00718315|81651329|FG002|Overall Study|Adverse Event|3|||
27949588|NCT00718315|81651327|FG000|Overall Study|Death|6|||
27949589|NCT00718315|81651328|FG001|Overall Study|Death|6|||
27949590|NCT00718315|81651329|FG002|Overall Study|Death|5|||
27949591|NCT00718315|81651327|FG000|Overall Study|Lost to Follow-up|2|||
27949592|NCT00718315|81651328|FG001|Overall Study|Lost to Follow-up|3|||
27949593|NCT00718315|81651329|FG002|Overall Study|Lost to Follow-up|4|||
27949594|NCT00718315|81651327|FG000|Overall Study|Protocol Violation|5|||
27949595|NCT00718315|81651328|FG001|Overall Study|Protocol Violation|5|||
27949596|NCT00718315|81651329|FG002|Overall Study|Protocol Violation|3|||
27949597|NCT00718315|81651327|FG000|Overall Study|Erlotinib dose decreased|4|||
27949598|NCT00718315|81651328|FG001|Overall Study|Erlotinib dose decreased|3|||
27949599|NCT00718315|81651329|FG002|Overall Study|Erlotinib dose decreased|1|||
27949600|NCT00718315|81651327|FG000|Overall Study|Use of Minocyclin|1|||
27949601|NCT00718315|81651328|FG001|Overall Study|Use of Minocyclin|1|||
27949602|NCT00718315|81651329|FG002|Overall Study|Use of Minocyclin|1|||
27949603|NCT00718315|81651327|FG000|Overall Study|Disease progression|0|||
27949604|NCT00718315|81651328|FG001|Overall Study|Disease progression|1|||
27949605|NCT00718315|81651329|FG002|Overall Study|Disease progression|1|||
27949606|NCT00718315|81651327|FG000|Overall Study|Other|0|||
27949607|NCT00718315|81651328|FG001|Overall Study|Other|0|||
27949608|NCT00718315|81651329|FG002|Overall Study|Other|1|||
27949609|NCT00718315|81651327|FG000|Overall Study|Use of ATB and Corticoids|0|||
27949610|NCT00718315|81651328|FG001|Overall Study|Use of ATB and Corticoids|1|||
27949611|NCT00718315|81651329|FG002|Overall Study|Use of ATB and Corticoids|2|||
27949612|NCT03122184|81651332|FG000|Overall Study|Lost to Follow-up|4|||
27949613|NCT03122184|81651333|FG001|Overall Study|Lost to Follow-up|6|||
27949614|NCT03122184|81651332|FG000|Overall Study|Withdrawal by Subject|3|||
27949615|NCT03122184|81651333|FG001|Overall Study|Withdrawal by Subject|0|||
27949616|NCT03122184|81651332|FG000|Overall Study|Terminated due to cognitive problem|1|||
27949617|NCT03122184|81651333|FG001|Overall Study|Terminated due to cognitive problem|0|||
27949618|NCT02441218|81651334|FG000|Overall Study|Death|503|||
27949619|NCT02441218|81651335|FG001|Overall Study|Death|553|||
27949620|NCT02441218|81651334|FG000|Overall Study|Withdrawal by Subject|73|||
27949621|NCT02441218|81651335|FG001|Overall Study|Withdrawal by Subject|58|||
27949622|NCT02441218|81651334|FG000|Overall Study|Lost to Follow-up|2|||
27949623|NCT02441218|81651335|FG001|Overall Study|Lost to Follow-up|1|||
27949624|NCT00688740|81651336|FG000|Overall Study|Adverse Event|45|||
27949625|NCT00688740|81651337|FG001|Overall Study|Adverse Event|8|||
27650156|NCT02077374|80560358|FG001|Overall Study|Withdrawal by Subject|1|||
27650157|NCT02077374|80560357|FG000|Overall Study|Protocol Violation|0|||
27650158|NCT02077374|80560358|FG001|Overall Study|Protocol Violation|1|||
27650159|NCT03200574|80560361|FG000|Overall Study|Death|4|||
27650160|NCT03200574|80560361|FG000|Overall Study|Withdrawal by Subject|8|||
27650161|NCT03200574|80560361|FG000|Overall Study|Long-Term need for anticoagulation|1|||
27650162|NCT03200574|80560361|FG000|Overall Study|Relocation|2|||
27650163|NCT03200574|80560361|FG000|Overall Study|Lost to Follow-up|2|||
27650164|NCT03132636|80560362|FG000|Overall Study|Adverse Event|1|||
27650165|NCT03132636|80560363|FG001|Overall Study|Adverse Event|2|||
27949626|NCT00688740|81651336|FG000|Overall Study|Death|2|||
27949627|NCT00688740|81651337|FG001|Overall Study|Death|2|||
27650166|NCT03132636|80560362|FG000|Overall Study|Death|4|||
27650167|NCT03132636|80560363|FG001|Overall Study|Death|7|||
27650168|NCT03132636|80560362|FG000|Overall Study|Lost to Follow-up|3|||
27949628|NCT00688740|81651336|FG000|Overall Study|Lost to Follow-up|0|||
27949629|NCT00688740|81651337|FG001|Overall Study|Lost to Follow-up|1|||
27949630|NCT00688740|81651336|FG000|Overall Study|Consent Withdrawn|17|||
27650169|NCT03132636|80560363|FG001|Overall Study|Lost to Follow-up|2|||
27650170|NCT03132636|80560362|FG000|Overall Study|Non compliance with protocol by participant|1|||
27949631|NCT00688740|81651337|FG001|Overall Study|Consent Withdrawn|17|||
27949632|NCT00688740|81651336|FG000|Overall Study|Breast Cancer Relapse|1|||
27949633|NCT00688740|81651337|FG001|Overall Study|Breast Cancer Relapse|4|||
27949634|NCT00688740|81651336|FG000|Overall Study|Violation of Inclusion Criteria|1|||
27949635|NCT00688740|81651337|FG001|Overall Study|Violation of Inclusion Criteria|3|||
27949636|NCT02629861|81651339|FG000|Overall Study|Adverse Event|7|||
27949637|NCT02629861|81651340|FG001|Overall Study|Adverse Event|5|||
27650171|NCT03132636|80560363|FG001|Overall Study|Non compliance with protocol by participant|1|||
27650172|NCT03132636|80560362|FG000|Overall Study|Subject decision|1|||
27650173|NCT03132636|80560363|FG001|Overall Study|Subject decision|9|||
27650174|NCT03132636|80560362|FG000|Overall Study|Sponsor decision|0|||
27949638|NCT02629861|81651341|FG002|Overall Study|Adverse Event|4|||
27949639|NCT02629861|81651339|FG000|Overall Study|Withdrawal by Subject|5|||
27949640|NCT02629861|81651340|FG001|Overall Study|Withdrawal by Subject|8|||
27949641|NCT02629861|81651341|FG002|Overall Study|Withdrawal by Subject|13|||
27949642|NCT02629861|81651339|FG000|Overall Study|Protocol Violation|2|||
27949643|NCT02629861|81651340|FG001|Overall Study|Protocol Violation|3|||
27949644|NCT02629861|81651341|FG002|Overall Study|Protocol Violation|7|||
27949645|NCT02629861|81651339|FG000|Overall Study|Lost to Follow-up|12|||
27949646|NCT02629861|81651340|FG001|Overall Study|Lost to Follow-up|9|||
27949647|NCT02629861|81651341|FG002|Overall Study|Lost to Follow-up|4|||
27949648|NCT02629861|81651339|FG000|Overall Study|Other|1|||
27949649|NCT02629861|81651340|FG001|Overall Study|Other|1|||
27949650|NCT02629861|81651341|FG002|Overall Study|Other|0|||
27949651|NCT02629861|81651339|FG000|Overall Study|Pregnancy|2|||
27949652|NCT02629861|81651340|FG001|Overall Study|Pregnancy|1|||
27949653|NCT02629861|81651341|FG002|Overall Study|Pregnancy|0|||
27949654|NCT01972659|81651355|FG000|Overall Study|Protocol Violation|2|||
27949655|NCT01972659|81651356|FG001|Overall Study|Protocol Violation|2|||
27949656|NCT01972659|81651355|FG000|Overall Study|problems realted to acceleromyograph|2|||
27949657|NCT01972659|81651356|FG001|Overall Study|problems realted to acceleromyograph|1|||
27949658|NCT01998477|81651357|FG000|Overall Study|Lost to Follow-up|4|||
27949659|NCT01998477|81651358|FG001|Overall Study|Lost to Follow-up|5|||
27949660|NCT01998477|81651357|FG000|Overall Study|Withdrawal by Subject|6|||
27949661|NCT01998477|81651358|FG001|Overall Study|Withdrawal by Subject|0|||
27949662|NCT04507763|81651359|FG000|Overall Study|Participants did not meet entrance criteria|201|||
27949663|NCT03283241|81651360|FG000|Overall Study|Adverse Event|4|||
27949664|NCT03283241|81651361|FG001|Overall Study|Adverse Event|1|||
27949665|NCT03283241|81651360|FG000|Overall Study|Withdrawal by Subject|0|||
27949666|NCT03283241|81651361|FG001|Overall Study|Withdrawal by Subject|1|||
27949667|NCT03283241|81651360|FG000|Overall Study|Subject relocated to Finland|0|||
27949668|NCT03283241|81651361|FG001|Overall Study|Subject relocated to Finland|1|||
27949669|NCT01696643|81651364|FG000|Overall Study|Adverse Event|15|||
27650175|NCT03132636|80560363|FG001|Overall Study|Sponsor decision|1|||
27650176|NCT03132636|80560362|FG000|Overall Study|Physician Decision|1|||
27650177|NCT03132636|80560363|FG001|Overall Study|Physician Decision|0|||
27650178|NCT03132636|80560362|FG000|Overall Study|Progressive disease|33|||
27650179|NCT03132636|80560363|FG001|Overall Study|Progressive disease|36|||
27650180|NCT03132636|80560362|FG000|Overall Study|Withdrawal of consent|2|||
27650181|NCT03132636|80560363|FG001|Overall Study|Withdrawal of consent|5|||
27650182|NCT03132636|80560362|FG000|Overall Study|Did not re-consent|1|||
27650183|NCT03132636|80560363|FG001|Overall Study|Did not re-consent|0|||
27650184|NCT03132636|80560362|FG000|Overall Study|Lost insurance coverage|1|||
27746477|NCT04760314|80899647|FG003|Induction Period|Withdrawal by Subject|0|||
27746478|NCT04760314|80899648|FG004|Induction Period|Withdrawal by Subject|0|||
27746479|NCT04760314|80899649|FG005|Induction Period|Withdrawal by Subject|0|||
27746480|NCT04760314|80899650|FG006|Induction Period|Withdrawal by Subject|0|||
27746481|NCT04760314|80899651|FG007|Induction Period|Withdrawal by Subject|0|||
27746482|NCT04760314|80899652|FG008|Induction Period|Withdrawal by Subject|0|||
27746483|NCT04760314|80899653|FG009|Induction Period|Withdrawal by Subject|0|||
27746484|NCT04760314|80899654|FG010|Induction Period|Withdrawal by Subject|0|||
27746485|NCT04760314|80899644|FG000|Induction Period|Adverse Event|0|||
27746486|NCT04760314|80899645|FG001|Induction Period|Adverse Event|0|||
27746487|NCT04760314|80899646|FG002|Induction Period|Adverse Event|2|||
27746488|NCT04760314|80899647|FG003|Induction Period|Adverse Event|0|||
27746489|NCT04760314|80899648|FG004|Induction Period|Adverse Event|0|||
27746490|NCT04760314|80899649|FG005|Induction Period|Adverse Event|0|||
27746491|NCT04760314|80899650|FG006|Induction Period|Adverse Event|0|||
27746492|NCT04760314|80899651|FG007|Induction Period|Adverse Event|0|||
27650185|NCT03132636|80560363|FG001|Overall Study|Lost insurance coverage|0|||
27650186|NCT03132636|80560362|FG000|Overall Study|Related to radiological outcomes|0|||
27650187|NCT03132636|80560363|FG001|Overall Study|Related to radiological outcomes|1|||
27650188|NCT03132636|80560362|FG000|Overall Study|Unable to come to site for continued visits|0|||
27650189|NCT03132636|80560363|FG001|Overall Study|Unable to come to site for continued visits|1|||
27650190|NCT03865732|80560369|FG000|Overall Study|Adverse Event|0|||
27650191|NCT03865732|80560370|FG001|Overall Study|Adverse Event|1|||
27650192|NCT03009344|80560372|FG000|Overall Study|Lack of Efficacy|5|||
27746493|NCT04760314|80899652|FG008|Induction Period|Adverse Event|0|||
27650193|NCT03009344|80560372|FG000|Overall Study|Withdrawal by Subject|1|||
27949670|NCT01696643|81651365|FG001|Overall Study|Adverse Event|7|||
27949671|NCT01696643|81651364|FG000|Overall Study|Death|1|||
27949672|NCT01696643|81651365|FG001|Overall Study|Death|2|||
27949673|NCT01696643|81651364|FG000|Overall Study|Lack of Efficacy|3|||
27949674|NCT01696643|81651365|FG001|Overall Study|Lack of Efficacy|0|||
27949675|NCT01696643|81651364|FG000|Overall Study|Lost to Follow-up|67|||
27746494|NCT04760314|80899653|FG009|Induction Period|Adverse Event|0|||
27746495|NCT04760314|80899654|FG010|Induction Period|Adverse Event|0|||
27746496|NCT04760314|80899644|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
27949676|NCT01696643|81651365|FG001|Overall Study|Lost to Follow-up|67|||
27949677|NCT01696643|81651364|FG000|Overall Study|Physician Decision|3|||
27949678|NCT01696643|81651365|FG001|Overall Study|Physician Decision|2|||
27949679|NCT01696643|81651364|FG000|Overall Study|Pregnancy|0|||
27949680|NCT01696643|81651365|FG001|Overall Study|Pregnancy|1|||
27949681|NCT01696643|81651364|FG000|Overall Study|Protocol Violation|7|||
27949682|NCT01696643|81651365|FG001|Overall Study|Protocol Violation|7|||
27949683|NCT01696643|81651364|FG000|Overall Study|Study Terminated by Sponsor|286|||
27949684|NCT01696643|81651365|FG001|Overall Study|Study Terminated by Sponsor|294|||
27949685|NCT01696643|81651364|FG000|Overall Study|Withdrawal by Subject|142|||
27949686|NCT01696643|81651365|FG001|Overall Study|Withdrawal by Subject|149|||
27949687|NCT01696643|81651364|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
27949688|NCT01696643|81651365|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
27949689|NCT01696643|81651364|FG000|Overall Study|Site Error|2|||
27949690|NCT01696643|81651365|FG001|Overall Study|Site Error|1|||
27949691|NCT01696643|81651364|FG000|Overall Study|Participant Incarcerated|0|||
27949692|NCT01696643|81651365|FG001|Overall Study|Participant Incarcerated|1|||
27949693|NCT01696643|81651364|FG000|Overall Study|Medical Monitor Decision|0|||
27949694|NCT01696643|81651365|FG001|Overall Study|Medical Monitor Decision|2|||
27949695|NCT01696643|81651364|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
27949696|NCT01696643|81651365|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
27746497|NCT04760314|80899645|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
27746498|NCT04760314|80899646|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
27746499|NCT04760314|80899647|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
27949697|NCT00575666|81651366|FG000|Overall Study|Withdrawal by Subject|3|||
27949698|NCT00575666|81651367|FG001|Overall Study|Withdrawal by Subject|2|||
27949699|NCT00575666|81651366|FG000|Overall Study|Physician Decision|1|||
27949700|NCT00575666|81651367|FG001|Overall Study|Physician Decision|1|||
27949701|NCT00560417|81651368|FG000|Overall Study|Adverse Event|3|||
27949702|NCT00560417|81651369|FG001|Overall Study|Adverse Event|2|||
27949703|NCT00560417|81651368|FG000|Overall Study|Entry Criteria Not Met|1|||
27949704|NCT00560417|81651369|FG001|Overall Study|Entry Criteria Not Met|0|||
27949705|NCT00560417|81651368|FG000|Overall Study|Lost to Follow-up|0|||
27949706|NCT00560417|81651369|FG001|Overall Study|Lost to Follow-up|1|||
27949707|NCT00560417|81651368|FG000|Overall Study|Physician Decision|2|||
27949708|NCT00560417|81651369|FG001|Overall Study|Physician Decision|6|||
27949709|NCT00560417|81651368|FG000|Overall Study|Protocol Violation|6|||
27949710|NCT00560417|81651369|FG001|Overall Study|Protocol Violation|5|||
27949711|NCT00560417|81651368|FG000|Overall Study|Sponsor Decision|2|||
27949712|NCT00560417|81651369|FG001|Overall Study|Sponsor Decision|0|||
27949713|NCT00560417|81651368|FG000|Overall Study|Withdrawal by Subject|3|||
27949714|NCT00560417|81651369|FG001|Overall Study|Withdrawal by Subject|3|||
27746500|NCT04760314|80899648|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
27746501|NCT04760314|80899649|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
27746502|NCT04760314|80899650|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
27746503|NCT04760314|80899651|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
27746504|NCT04760314|80899652|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
27746505|NCT04760314|80899653|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
27746506|NCT04760314|80899654|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
27949715|NCT04749914|81651370|FG000|Period 1|Adverse Event|1|||
27949716|NCT04749914|81651371|FG001|Period 1|Adverse Event|0|||
27949717|NCT04749914|81651372|FG002|Period 1|Adverse Event|0|||
27949718|NCT04749914|81651373|FG003|Period 1|Adverse Event|0|||
27949719|NCT04749914|81651370|FG000|Period 1|Withdrawal by Subject|1|||
27949720|NCT04749914|81651371|FG001|Period 1|Withdrawal by Subject|0|||
27650194|NCT03009344|80560372|FG000|Overall Study|Adverse Event|1|||
27746507|NCT04760314|80899644|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746508|NCT04760314|80899645|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746509|NCT04760314|80899646|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746510|NCT04760314|80899647|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
27746511|NCT04760314|80899648|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746512|NCT04760314|80899649|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
27949721|NCT04749914|81651372|FG002|Period 1|Withdrawal by Subject|1|||
27949722|NCT04749914|81651373|FG003|Period 1|Withdrawal by Subject|0|||
27949723|NCT00787150|81651374|FG000|Overall Study|Adverse Event|4|||
27949724|NCT00787150|81651375|FG001|Overall Study|Adverse Event|4|||
27949725|NCT00787150|81651376|FG002|Overall Study|Adverse Event|4|||
27949726|NCT00787150|81651374|FG000|Overall Study|Physician Decision|1|||
27949727|NCT00787150|81651375|FG001|Overall Study|Physician Decision|2|||
27949728|NCT00787150|81651376|FG002|Overall Study|Physician Decision|1|||
27650195|NCT02833948|80560373|FG000|Overall Study|Death|2|||
27650196|NCT02833948|80560374|FG001|Overall Study|Death|3|||
27949729|NCT00787150|81651374|FG000|Overall Study|Withdrawal by Subject|2|||
27949730|NCT00787150|81651375|FG001|Overall Study|Withdrawal by Subject|1|||
27746513|NCT04760314|80899650|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
27746514|NCT04760314|80899651|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746515|NCT04760314|80899652|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746516|NCT04760314|80899653|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746517|NCT04760314|80899654|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
27746518|NCT04760314|80899644|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746519|NCT04760314|80899645|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746520|NCT04760314|80899646|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746521|NCT04760314|80899647|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746522|NCT04760314|80899648|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
27746523|NCT04760314|80899649|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746524|NCT04760314|80899650|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746525|NCT04760314|80899651|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746526|NCT04760314|80899652|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746527|NCT04760314|80899653|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27949731|NCT00787150|81651376|FG002|Overall Study|Withdrawal by Subject|0|||
27949732|NCT00787150|81651374|FG000|Overall Study|Dosing incorrect study durg|2|||
27949733|NCT00787150|81651375|FG001|Overall Study|Dosing incorrect study durg|0|||
27949734|NCT00787150|81651376|FG002|Overall Study|Dosing incorrect study durg|0|||
27949735|NCT01198587|81651377|FG000|Overall Study|Lost to Follow-up|8|||
27949736|NCT01198587|81651378|FG001|Overall Study|Lost to Follow-up|0|||
27949737|NCT01198587|81651379|FG002|Overall Study|Lost to Follow-up|9|||
27949738|NCT01198587|81651380|FG003|Overall Study|Lost to Follow-up|0|||
27949739|NCT02271880|81651386|FG000|Overall Study|Premature discontinuation of study|3|||
27949740|NCT02271880|81651387|FG001|Overall Study|Premature discontinuation of study|4|||
27949741|NCT04064905|81651388|FG000|Overall Study|Lost to Follow-up|0|||
27949742|NCT04064905|81651389|FG001|Overall Study|Lost to Follow-up|3|||
27949743|NCT04064905|81651390|FG002|Overall Study|Lost to Follow-up|1|||
27949744|NCT04064905|81651391|FG003|Overall Study|Lost to Follow-up|4|||
27949745|NCT04064905|81651392|FG004|Overall Study|Lost to Follow-up|2|||
27949746|NCT01561976|81651393|FG000|Period 1|Adverse Event|0|||
27949747|NCT01561976|81651394|FG001|Period 1|Adverse Event|0|||
27949748|NCT01561976|81651395|FG002|Period 1|Adverse Event|1|||
27949749|NCT01561976|81651396|FG003|Period 1|Adverse Event|0|||
27949750|NCT01561976|81651397|FG004|Period 1|Adverse Event|0|||
27949751|NCT01561976|81651398|FG005|Period 1|Adverse Event|0|||
27949752|NCT01561976|81651393|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
27949753|NCT01561976|81651394|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
27949754|NCT01561976|81651395|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
27949755|NCT01561976|81651396|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
27949756|NCT01561976|81651397|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
27949757|NCT01561976|81651398|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
27949758|NCT01561976|81651393|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27949759|NCT01561976|81651394|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27949760|NCT01561976|81651395|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27949761|NCT01561976|81651396|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27949762|NCT01561976|81651397|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
27949763|NCT01561976|81651398|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
27949764|NCT01561976|81651393|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
27949765|NCT01561976|81651394|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
27949766|NCT01561976|81651395|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
27949767|NCT01561976|81651396|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
27949768|NCT01561976|81651397|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
27949769|NCT01561976|81651398|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
27949770|NCT02390076|81651399|FG000|Overall Study|Lost to Follow-up|2|||
27949771|NCT02390076|81651400|FG001|Overall Study|Lost to Follow-up|1|||
27650197|NCT02833948|80560373|FG000|Overall Study|were not scanned|8|||
27949772|NCT02390076|81651401|FG002|Overall Study|Lost to Follow-up|4|||
27949773|NCT00776230|81651403|FG000|Overall Study|Lost to Follow-up|2|||
27949774|NCT00776230|81651404|FG001|Overall Study|Lost to Follow-up|1|||
27949775|NCT00776230|81651405|FG002|Overall Study|Lost to Follow-up|5|||
27650198|NCT02833948|80560374|FG001|Overall Study|were not scanned|13|||
27650199|NCT02833948|80560373|FG000|Overall Study|scans could not be evaluated|5|||
27650200|NCT02833948|80560374|FG001|Overall Study|scans could not be evaluated|2|||
27650201|NCT03547154|80560375|FG000|Overall Study|Disease Progression/Recurrence|6|||
27650202|NCT03547154|80560376|FG001|Overall Study|Disease Progression/Recurrence|14|||
27650203|NCT03547154|80560375|FG000|Overall Study|Adverse Event|26|||
27650204|NCT03547154|80560376|FG001|Overall Study|Adverse Event|31|||
27650205|NCT03547154|80560375|FG000|Overall Study|Protocol Violation|6|||
27650206|NCT03547154|80560376|FG001|Overall Study|Protocol Violation|1|||
27650207|NCT03547154|80560375|FG000|Overall Study|Physician Decision|4|||
27650208|NCT03547154|80560376|FG001|Overall Study|Physician Decision|3|||
27650209|NCT03547154|80560375|FG000|Overall Study|Insufficient Therapeutic Response|13|||
27650210|NCT03547154|80560376|FG001|Overall Study|Insufficient Therapeutic Response|10|||
27650211|NCT03547154|80560375|FG000|Overall Study|Withdrawal by Subject|10|||
27949776|NCT00776230|81651403|FG000|Overall Study|Not vaccinated at Day 0|1|||
27949777|NCT00776230|81651404|FG001|Overall Study|Not vaccinated at Day 0|0|||
27949778|NCT00776230|81651405|FG002|Overall Study|Not vaccinated at Day 0|0|||
27949779|NCT00776230|81651403|FG000|Overall Study|Withdrawal by Subject|0|||
27949780|NCT00776230|81651404|FG001|Overall Study|Withdrawal by Subject|1|||
27949781|NCT00776230|81651405|FG002|Overall Study|Withdrawal by Subject|0|||
27949782|NCT00776230|81651403|FG000|Overall Study|Subject missed Visit 4|0|||
27949783|NCT00776230|81651404|FG001|Overall Study|Subject missed Visit 4|1|||
27949784|NCT00776230|81651405|FG002|Overall Study|Subject missed Visit 4|0|||
27949785|NCT00622726|81651406|FG000|March, 2008 to August, 2010|Death|5|||
27949786|NCT00622726|81651407|FG001|March, 2008 to August, 2010|Death|2|||
27949787|NCT00622726|81651406|FG000|August, 2010 to April, 2013|Death|1|||
27949788|NCT00622726|81651407|FG001|August, 2010 to April, 2013|Death|5|||
27949789|NCT00427700|81651408|FG000|Overall Study|Lost to Follow-up|2|||
27949790|NCT00427700|81651409|FG001|Overall Study|Lost to Follow-up|5|||
27949791|NCT00427700|81651408|FG000|Overall Study|no induction of menses|1|||
27949792|NCT00427700|81651409|FG001|Overall Study|no induction of menses|4|||
27949793|NCT00427700|81651408|FG000|Overall Study|Pregnancy|0|||
27949794|NCT00427700|81651409|FG001|Overall Study|Pregnancy|2|||
27949795|NCT02037529|81651410|FG000|Overall Study|Withdrawal by Subject|1|||
27949796|NCT02037529|81651411|FG001|Overall Study|Withdrawal by Subject|3|||
27949797|NCT02037529|81651410|FG000|Overall Study|Adverse Event|0|||
27949798|NCT02037529|81651411|FG001|Overall Study|Adverse Event|1|||
27746528|NCT04760314|80899654|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
27746529|NCT04760314|80899644|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
27746530|NCT04760314|80899645|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
27746531|NCT04760314|80899646|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
27746532|NCT04760314|80899647|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
27746533|NCT04760314|80899648|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
27746534|NCT04760314|80899649|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
27746535|NCT04760314|80899650|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
27746536|NCT04760314|80899651|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
27746537|NCT04760314|80899652|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
27746538|NCT04760314|80899653|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
27746539|NCT04760314|80899654|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
27746540|NCT04760314|80899644|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746541|NCT04760314|80899645|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746542|NCT04760314|80899646|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746543|NCT04760314|80899647|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746544|NCT04760314|80899648|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746545|NCT04760314|80899649|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746546|NCT04760314|80899650|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27746547|NCT04760314|80899651|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
27746548|NCT04760314|80899652|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
27949799|NCT02891226|81651412|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
27949800|NCT02891226|81651413|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
27949801|NCT02891226|81651414|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
27949802|NCT02891226|81651415|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949803|NCT02891226|81651416|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949804|NCT02891226|81651417|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949805|NCT02891226|81651418|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949806|NCT02891226|81651419|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949807|NCT02891226|81651420|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949808|NCT02891226|81651421|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949809|NCT02891226|81651422|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949810|NCT02891226|81651423|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949811|NCT02891226|81651424|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949812|NCT02891226|81651425|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949813|NCT02891226|81651426|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949814|NCT02891226|81651427|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
27949815|NCT02891226|81651412|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
27949816|NCT02891226|81651413|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
27949817|NCT02891226|81651414|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949818|NCT02891226|81651415|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27746549|NCT04760314|80899653|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
27949819|NCT02891226|81651416|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949820|NCT02891226|81651417|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949821|NCT02891226|81651418|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949822|NCT02891226|81651419|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949823|NCT02891226|81651420|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949824|NCT02891226|81651421|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949825|NCT02891226|81651422|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27551477|NCT01543698|80207465|FG007|Phase 2|Withdrawal by Subject|0|||
27949826|NCT02891226|81651423|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949827|NCT02891226|81651424|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949828|NCT02891226|81651425|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949829|NCT02891226|81651426|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949830|NCT02891226|81651427|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27949831|NCT02891226|81651412|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949832|NCT02891226|81651413|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949833|NCT02891226|81651414|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949834|NCT02891226|81651415|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
27949835|NCT02891226|81651416|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949836|NCT02891226|81651417|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949837|NCT02891226|81651418|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949838|NCT02891226|81651419|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949839|NCT02891226|81651420|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949840|NCT02891226|81651421|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949841|NCT02891226|81651422|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949842|NCT02891226|81651423|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949843|NCT02891226|81651424|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949844|NCT02891226|81651425|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949845|NCT02891226|81651426|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949846|NCT02891226|81651427|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27949847|NCT02891226|81651412|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949848|NCT02891226|81651413|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949849|NCT02891226|81651414|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
27949850|NCT02891226|81651415|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949851|NCT02891226|81651416|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949852|NCT02891226|81651417|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949853|NCT02891226|81651418|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949854|NCT02891226|81651419|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949855|NCT02891226|81651420|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949856|NCT02891226|81651421|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949857|NCT02891226|81651422|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949858|NCT02891226|81651423|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949859|NCT02891226|81651424|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949860|NCT02891226|81651425|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949861|NCT02891226|81651426|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949862|NCT02891226|81651427|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
27949863|NCT02891226|81651412|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949864|NCT02891226|81651413|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949865|NCT02891226|81651414|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949866|NCT02891226|81651415|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
27949867|NCT02891226|81651416|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949868|NCT02891226|81651417|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949869|NCT02891226|81651418|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949870|NCT02891226|81651419|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949871|NCT02891226|81651420|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949872|NCT02891226|81651421|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949873|NCT02891226|81651422|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949874|NCT02891226|81651423|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949875|NCT02891226|81651424|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949876|NCT02891226|81651425|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949877|NCT02891226|81651426|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949878|NCT02891226|81651427|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
27949879|NCT02891226|81651412|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949880|NCT02891226|81651413|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949881|NCT02891226|81651414|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949882|NCT02891226|81651415|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
27949883|NCT02891226|81651416|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949884|NCT02891226|81651417|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949885|NCT02891226|81651418|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949886|NCT02891226|81651419|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949887|NCT02891226|81651420|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949888|NCT02891226|81651421|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949889|NCT02891226|81651422|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949890|NCT02891226|81651423|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949891|NCT02891226|81651424|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949892|NCT02891226|81651425|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949893|NCT02891226|81651426|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949894|NCT02891226|81651427|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
27949895|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949896|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27551478|NCT01543698|80207466|FG008|Phase 2|Withdrawal by Subject|0|||
27949897|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949898|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949899|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949900|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949901|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
27949902|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
27949903|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
27949904|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
27949905|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949906|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949907|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949908|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949909|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949910|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
27949911|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949912|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949913|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949914|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949915|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949916|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
27949917|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949918|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949919|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949920|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
27949921|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949922|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949923|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949924|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949925|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949926|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
27949927|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949928|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949929|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27746550|NCT04760314|80899654|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
27746551|NCT04760314|80899644|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746552|NCT04760314|80899645|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746553|NCT04760314|80899646|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746554|NCT04760314|80899647|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746555|NCT04760314|80899648|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746556|NCT04760314|80899649|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746557|NCT04760314|80899650|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746558|NCT04760314|80899651|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
27949930|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949931|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949932|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949933|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
27949934|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
27949935|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
27949936|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
27949937|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949938|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949939|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949940|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949941|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949942|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
27949943|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949944|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949945|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949946|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949947|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
27949948|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949949|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949950|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949951|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27746559|NCT04760314|80899652|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
27949952|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949953|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949954|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949955|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949956|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949957|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949958|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
27949959|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949960|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949961|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949962|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949963|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949964|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949965|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
27949966|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949967|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949968|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949969|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949970|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949971|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949972|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949973|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949974|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
27949975|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949976|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949977|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27746560|NCT04760314|80899653|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
27746561|NCT04760314|80899654|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
27746562|NCT04760314|80899644|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746563|NCT04760314|80899645|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746564|NCT04760314|80899646|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746565|NCT04760314|80899647|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746566|NCT04760314|80899648|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746567|NCT04760314|80899649|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746568|NCT04760314|80899650|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746569|NCT04760314|80899651|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
27746570|NCT04760314|80899652|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746571|NCT04760314|80899653|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746572|NCT04760314|80899654|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
27746573|NCT04760314|80899644|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746574|NCT04760314|80899645|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746575|NCT04760314|80899646|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746576|NCT04760314|80899647|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746577|NCT04760314|80899648|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746578|NCT04760314|80899649|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746579|NCT04760314|80899650|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746580|NCT04760314|80899651|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746581|NCT04760314|80899652|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
27746582|NCT04760314|80899653|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
27746583|NCT04760314|80899654|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
27746584|NCT04983940|80899655|FG000|Overall Study|Lost to Follow-up|14|||
27746585|NCT04983940|80899655|FG000|Overall Study|Lack of Efficacy|2|||
27746586|NCT00992446|80899656|FG000|Overall Study|Disease Progression|1|||
27746587|NCT00992446|80899656|FG000|Overall Study|Withdrawal by Subject|2|||
27746588|NCT00992446|80899656|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
27746589|NCT00320385|80899659|FG000|Overall Study|Lost to Follow-up|7|||
27746590|NCT00320385|80899660|FG001|Overall Study|Lost to Follow-up|10|||
27746591|NCT00320385|80899659|FG000|Overall Study|Withdrawal by Subject|6|||
27746592|NCT00320385|80899660|FG001|Overall Study|Withdrawal by Subject|7|||
27746593|NCT00320385|80899659|FG000|Overall Study|Sponsor Terminated Study|2|||
27949978|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949979|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949980|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949981|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949982|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
27949983|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
27949984|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
27746594|NCT00320385|80899660|FG001|Overall Study|Sponsor Terminated Study|1|||
27746595|NCT00320385|80899659|FG000|Overall Study|Investigator Decision|0|||
27949985|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949986|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949987|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949988|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949989|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949990|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
27949991|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949992|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949993|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949994|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949995|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949996|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949997|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27949998|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
27949999|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950000|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950001|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950002|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950003|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950004|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950005|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950006|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
27950007|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950008|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950009|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950010|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950011|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950012|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950013|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950014|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950015|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
27950016|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950017|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950018|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950019|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950020|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950021|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950022|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
27950023|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950024|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950025|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950026|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950027|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950028|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950029|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950030|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950031|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950032|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
27950033|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950034|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950035|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950036|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950037|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27746596|NCT00320385|80899660|FG001|Overall Study|Investigator Decision|1|||
27746597|NCT00320385|80899659|FG000|Overall Study|Death|1|||
27746598|NCT00320385|80899660|FG001|Overall Study|Death|2|||
27746599|NCT00320385|80899659|FG000|Overall Study|Serious Adverse Event|1|||
27746600|NCT00320385|80899660|FG001|Overall Study|Serious Adverse Event|0|||
27746601|NCT00320385|80899659|FG000|Overall Study|Withdrew Consent|1|||
27746602|NCT00320385|80899660|FG001|Overall Study|Withdrew Consent|0|||
27746603|NCT00320385|80899659|FG000|Overall Study|Adverse Event|0|||
27650212|NCT03547154|80560376|FG001|Overall Study|Withdrawal by Subject|6|||
27746604|NCT00320385|80899660|FG001|Overall Study|Adverse Event|1|||
27950038|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
27950039|NCT02891226|81651412|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950040|NCT02891226|81651413|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950041|NCT02891226|81651414|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950042|NCT02891226|81651415|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27746605|NCT00504166|80899661|FG000|Overall Study|Adverse Event|1|||
27746606|NCT00504166|80899662|FG001|Overall Study|Adverse Event|4|||
27950043|NCT02891226|81651416|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950044|NCT02891226|81651417|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950045|NCT02891226|81651418|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950046|NCT02891226|81651419|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950047|NCT02891226|81651420|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950048|NCT02891226|81651421|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
27950049|NCT02891226|81651422|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950050|NCT02891226|81651423|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950051|NCT02891226|81651424|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950052|NCT02891226|81651425|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27950053|NCT02891226|81651426|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27650213|NCT03547154|80560375|FG000|Overall Study|Not Selected|0|||
27650214|NCT03547154|80560376|FG001|Overall Study|Not Selected|1|||
27746607|NCT00504166|80899661|FG000|Overall Study|Withdrawal by Subject|3|||
27746608|NCT00504166|80899662|FG001|Overall Study|Withdrawal by Subject|6|||
27746609|NCT00504166|80899661|FG000|Overall Study|Physician Decision|1|||
27746610|NCT00504166|80899662|FG001|Overall Study|Physician Decision|1|||
27746611|NCT00504166|80899661|FG000|Overall Study|Lost to Follow-up|1|||
27746612|NCT00504166|80899662|FG001|Overall Study|Lost to Follow-up|3|||
27746613|NCT00222729|80899664|FG000|Overall Study|Adverse Event|3|||
27746614|NCT03268746|80899666|FG000|Overall Study|Withdrawal by Subject|1|||
27746615|NCT01505491|80899668|FG000|Overall Study|Other reason not listed|1|||
27746616|NCT01505491|80899669|FG001|Overall Study|Other reason not listed|0|||
27746617|NCT01505491|80899670|FG002|Overall Study|Other reason not listed|0|||
27746618|NCT01505491|80899668|FG000|Overall Study|Withdrawal by Subject|1|||
27746619|NCT01505491|80899669|FG001|Overall Study|Withdrawal by Subject|1|||
27746620|NCT01505491|80899670|FG002|Overall Study|Withdrawal by Subject|4|||
27746621|NCT01505491|80899668|FG000|Overall Study|Lost to Follow-up|0|||
27746622|NCT01505491|80899669|FG001|Overall Study|Lost to Follow-up|0|||
27746623|NCT01505491|80899670|FG002|Overall Study|Lost to Follow-up|1|||
27746624|NCT03880227|80899679|FG000|First Visit|Withdrawal by Subject|1|||
27746625|NCT03880227|80899680|FG001|First Visit|Withdrawal by Subject|0|||
27746626|NCT03880227|80899681|FG002|First Visit|Withdrawal by Subject|0|||
27746627|NCT03880227|80899682|FG003|First Visit|Withdrawal by Subject|0|||
27746628|NCT03880227|80899679|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
27746629|NCT03880227|80899680|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
27746630|NCT03880227|80899681|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
27746631|NCT03880227|80899682|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
27746632|NCT03880227|80899679|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
27746633|NCT03880227|80899680|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
27746634|NCT03880227|80899681|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
27746635|NCT03880227|80899682|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
27746636|NCT03880227|80899679|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
27746637|NCT03880227|80899680|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
27746638|NCT03880227|80899681|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
27746639|NCT03880227|80899682|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
27746640|NCT00064662|80899683|FG000|Overall Study|Death|1|||
27746641|NCT00064662|80899684|FG001|Overall Study|Death|1|||
27746642|NCT00064662|80899683|FG000|Overall Study|Lost to Follow-up|57|||
27746643|NCT00064662|80899684|FG001|Overall Study|Lost to Follow-up|44|||
27746644|NCT00064662|80899683|FG000|Overall Study|Withdrawal by Subject|14|||
27746645|NCT00064662|80899684|FG001|Overall Study|Withdrawal by Subject|14|||
27746646|NCT00064662|80899683|FG000|Overall Study|Administratively withdrawn|2|||
27746647|NCT00064662|80899684|FG001|Overall Study|Administratively withdrawn|2|||
27746648|NCT01208662|80899687|FG000|Induction and Consolidation|Disease Progression|23|||
27746649|NCT01208662|80899688|FG001|Induction and Consolidation|Disease Progression|13|||
27746650|NCT01208662|80899689|FG002|Induction and Consolidation|Disease Progression|0|||
27746651|NCT01208662|80899687|FG000|Induction and Consolidation|Adverse Event|16|||
27650215|NCT03547154|80560375|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
27746652|NCT01208662|80899688|FG001|Induction and Consolidation|Adverse Event|18|||
27746653|NCT01208662|80899689|FG002|Induction and Consolidation|Adverse Event|2|||
27746654|NCT01208662|80899687|FG000|Induction and Consolidation|MD or Participant Decision|16|||
27650216|NCT03547154|80560376|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
27746655|NCT01208662|80899688|FG001|Induction and Consolidation|MD or Participant Decision|34|||
27746656|NCT01208662|80899689|FG002|Induction and Consolidation|MD or Participant Decision|4|||
27746657|NCT01208662|80899687|FG000|Induction and Consolidation|Death|1|||
27746658|NCT01208662|80899688|FG001|Induction and Consolidation|Death|3|||
27746659|NCT01208662|80899689|FG002|Induction and Consolidation|Death|1|||
27650217|NCT00800176|80560377|FG000|Overall Study|Adverse Event|2|||
27650218|NCT00800176|80560378|FG001|Overall Study|Adverse Event|1|||
27650219|NCT00800176|80560379|FG002|Overall Study|Adverse Event|0|||
27650220|NCT00800176|80560380|FG003|Overall Study|Adverse Event|2|||
27650221|NCT00800176|80560381|FG004|Overall Study|Adverse Event|1|||
27650222|NCT00800176|80560382|FG005|Overall Study|Adverse Event|1|||
27650223|NCT00800176|80560377|FG000|Overall Study|Refused treatment|3|||
27650224|NCT00800176|80560378|FG001|Overall Study|Refused treatment|2|||
27650225|NCT00800176|80560379|FG002|Overall Study|Refused treatment|0|||
27650226|NCT00800176|80560380|FG003|Overall Study|Refused treatment|0|||
27650227|NCT00800176|80560381|FG004|Overall Study|Refused treatment|1|||
27650228|NCT00800176|80560382|FG005|Overall Study|Refused treatment|4|||
27650229|NCT00800176|80560377|FG000|Overall Study|Failure to return|3|||
27650230|NCT00800176|80560378|FG001|Overall Study|Failure to return|3|||
27650231|NCT00800176|80560379|FG002|Overall Study|Failure to return|0|||
27650232|NCT00800176|80560380|FG003|Overall Study|Failure to return|2|||
27650233|NCT00800176|80560381|FG004|Overall Study|Failure to return|0|||
27650234|NCT00800176|80560382|FG005|Overall Study|Failure to return|0|||
27650235|NCT00800176|80560377|FG000|Overall Study|Other|1|||
27650236|NCT00800176|80560378|FG001|Overall Study|Other|0|||
27650237|NCT00800176|80560379|FG002|Overall Study|Other|0|||
27650238|NCT00800176|80560380|FG003|Overall Study|Other|0|||
27650239|NCT00800176|80560381|FG004|Overall Study|Other|2|||
27650240|NCT00800176|80560382|FG005|Overall Study|Other|0|||
27650241|NCT03136159|80560385|FG000|Overall Study|chorioamnionitis|2|||
27650242|NCT03136159|80560386|FG001|Overall Study|chorioamnionitis|0|||
27650243|NCT03136159|80560385|FG000|Overall Study|vertical skin incision|1|||
27650244|NCT03136159|80560386|FG001|Overall Study|vertical skin incision|0|||
27650245|NCT03136159|80560385|FG000|Overall Study|additional dressing|1|||
27650246|NCT03136159|80560386|FG001|Overall Study|additional dressing|0|||
27650247|NCT03136159|80560385|FG000|Overall Study|never got dressing placed|1|||
27650248|NCT03136159|80560386|FG001|Overall Study|never got dressing placed|0|||
27650249|NCT01828021|80560387|FG000|Overall Study|Adverse Event|5|||
27650250|NCT01828021|80560387|FG000|Overall Study|Lack of Efficacy|17|||
27650251|NCT01828021|80560387|FG000|Overall Study|Withdrawal by Subject|2|||
27650252|NCT01828021|80560387|FG000|Overall Study|Ileal obstruction, unrelated|1|||
27650253|NCT02542696|80560390|FG000|Overall Study|Adverse Event|167|||
27650254|NCT02542696|80560390|FG000|Overall Study|Lack of Efficacy|26|||
27650255|NCT02542696|80560390|FG000|Overall Study|Lost to Follow-up|6|||
27650256|NCT02542696|80560390|FG000|Overall Study|Withdrawal by Subject|104|||
27650257|NCT02542696|80560390|FG000|Overall Study|Protocol Violation|5|||
27650258|NCT02542696|80560390|FG000|Overall Study|Death|8|||
27650259|NCT02542696|80560390|FG000|Overall Study|DECREASED OFF TIME|1|||
27650260|NCT02542696|80560390|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
27650261|NCT02542696|80560390|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
27650262|NCT02542696|80560390|FG000|Overall Study|MEDICAL HISTORY|1|||
27650263|NCT02542696|80560390|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
27650264|NCT02542696|80560390|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
27650265|NCT02542696|80560390|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
27650266|NCT02542696|80560390|FG000|Overall Study|SPONSOR DECISION|3|||
27650267|NCT02542696|80560390|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
27650268|NCT02542696|80560390|FG000|Overall Study|SUBJECT DECISION|2|||
27650269|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
27650270|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
27650271|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
27650272|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
27650273|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
27650274|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
27650275|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
27650276|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
27650277|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27650278|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
27650279|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
27650280|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
27650281|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27650282|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
27650283|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
27650284|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
27650285|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
27650286|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
27650287|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
27650288|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
27746660|NCT01208662|80899687|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
27746661|NCT01208662|80899688|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
27746662|NCT01208662|80899689|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
27746663|NCT01208662|80899687|FG000|Maintenance|Disease Progression|156|||
27746664|NCT01208662|80899688|FG001|Maintenance|Disease Progression|102|||
27746665|NCT01208662|80899689|FG002|Maintenance|Disease Progression|0|||
27746666|NCT01208662|80899687|FG000|Maintenance|Adverse Event|12|||
27746667|NCT01208662|80899688|FG001|Maintenance|Adverse Event|28|||
27746668|NCT01208662|80899689|FG002|Maintenance|Adverse Event|0|||
27746669|NCT01208662|80899687|FG000|Maintenance|MD or Participant Decision|24|||
27746670|NCT01208662|80899688|FG001|Maintenance|MD or Participant Decision|36|||
27746671|NCT01208662|80899689|FG002|Maintenance|MD or Participant Decision|0|||
27746672|NCT01208662|80899687|FG000|Maintenance|Death|0|||
27746673|NCT01208662|80899688|FG001|Maintenance|Death|3|||
27746674|NCT01208662|80899689|FG002|Maintenance|Death|0|||
27746675|NCT01208662|80899687|FG000|Maintenance|Discontinued for other reasons|21|||
27746676|NCT01208662|80899688|FG001|Maintenance|Discontinued for other reasons|31|||
27746677|NCT01208662|80899689|FG002|Maintenance|Discontinued for other reasons|0|||
27746678|NCT01208662|80899687|FG000|Maintenance|Still on Treatment|78|||
27746679|NCT01208662|80899688|FG001|Maintenance|Still on Treatment|89|||
27746680|NCT01208662|80899689|FG002|Maintenance|Still on Treatment|0|||
27746681|NCT01221233|80899695|FG000|Overall Study|Withdrawal by Subject|3|||
27746682|NCT01221233|80899696|FG001|Overall Study|Withdrawal by Subject|1|||
27746683|NCT05094154|80899697|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
27746684|NCT05094154|80899698|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
27746685|NCT05094154|80899697|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
27746686|NCT05094154|80899698|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
27746687|NCT01356602|80899699|FG000|Overall Study|Protocol Deviation|0|||
27746688|NCT01356602|80899700|FG001|Overall Study|Protocol Deviation|1|||
27746689|NCT01356602|80899701|FG002|Overall Study|Protocol Deviation|1|||
27746690|NCT01356602|80899699|FG000|Overall Study|Administrative Problems|1|||
27746691|NCT01356602|80899700|FG001|Overall Study|Administrative Problems|4|||
27746692|NCT01356602|80899701|FG002|Overall Study|Administrative Problems|5|||
27746693|NCT01356602|80899699|FG000|Overall Study|Lost to Follow-up|4|||
27746694|NCT01356602|80899700|FG001|Overall Study|Lost to Follow-up|5|||
27746695|NCT01356602|80899701|FG002|Overall Study|Lost to Follow-up|6|||
27746696|NCT01356602|80899699|FG000|Overall Study|Withdrawal by Subject|4|||
27746697|NCT01356602|80899700|FG001|Overall Study|Withdrawal by Subject|3|||
27746698|NCT01356602|80899701|FG002|Overall Study|Withdrawal by Subject|7|||
27746699|NCT01356602|80899699|FG000|Overall Study|Lack of Efficacy|0|||
27746700|NCT01356602|80899700|FG001|Overall Study|Lack of Efficacy|1|||
27746701|NCT01356602|80899701|FG002|Overall Study|Lack of Efficacy|4|||
27746702|NCT01356602|80899699|FG000|Overall Study|Adverse Event|0|||
27746703|NCT01356602|80899700|FG001|Overall Study|Adverse Event|1|||
27746704|NCT01356602|80899701|FG002|Overall Study|Adverse Event|1|||
27746705|NCT01519427|80899702|FG000|Overall Study|disease progression|2|||
27746706|NCT03692910|80899705|FG000|Overall Study|Lost to Follow-up|4|||
27746707|NCT03692910|80899706|FG001|Overall Study|Lost to Follow-up|0|||
27746708|NCT03692910|80899707|FG002|Overall Study|Lost to Follow-up|0|||
27746709|NCT03692910|80899705|FG000|Overall Study|Withdrawal by Subject|2|||
27746710|NCT03692910|80899706|FG001|Overall Study|Withdrawal by Subject|0|||
27746711|NCT03692910|80899707|FG002|Overall Study|Withdrawal by Subject|0|||
27746712|NCT03844633|80899708|FG000|1 Week FU|Lost to Follow-up|0|||
27746713|NCT03844633|80899709|FG001|1 Week FU|Lost to Follow-up|1|||
27746714|NCT03844633|80899710|FG002|1 Week FU|Lost to Follow-up|4|||
27746715|NCT03844633|80899708|FG000|12-month Follow-up|Lost to Follow-up|7|||
27746716|NCT03844633|80899709|FG001|12-month Follow-up|Lost to Follow-up|5|||
27746717|NCT03844633|80899710|FG002|12-month Follow-up|Lost to Follow-up|8|||
27746718|NCT01936649|80899711|FG000|Overall Study|Withdrawal by Subject|4|||
27746719|NCT01936649|80899711|FG000|Overall Study|Physician Decision|2|||
27746720|NCT01936649|80899711|FG000|Overall Study|Protocol Violation|2|||
27746721|NCT01936649|80899711|FG000|Overall Study|Other than specified above|5|||
27746722|NCT00938327|80899712|FG000|Overall Study|Adverse Event|2|||
27746723|NCT00938327|80899712|FG000|Overall Study|Protocol Violation|1|||
27746724|NCT00938327|80899712|FG000|Overall Study|Withdrawal by Subject|4|||
27746725|NCT00938327|80899712|FG000|Overall Study|Lost to Follow-up|37|||
27746726|NCT00938327|80899712|FG000|Overall Study|2nd dose received outside of the study|7|||
27746727|NCT00938327|80899712|FG000|Overall Study|Vaccine not received as out of stock|9|||
27746728|NCT02508701|80899713|FG000|Overall Study|Lost to Follow-up|9|||
27746729|NCT02508701|80899714|FG001|Overall Study|Lost to Follow-up|5|||
27746730|NCT02508701|80899715|FG002|Overall Study|Lost to Follow-up|5|||
27746731|NCT02508701|80899716|FG003|Overall Study|Lost to Follow-up|3|||
27746732|NCT02075255|80899717|FG000|Overall Study|Study specific withdrawal criteria|0|||
27746733|NCT02075255|80899718|FG001|Overall Study|Study specific withdrawal criteria|1|||
27746734|NCT02075255|80899719|FG002|Overall Study|Study specific withdrawal criteria|1|||
27746735|NCT02075255|80899717|FG000|Overall Study|Withdrawal by Subject|4|||
27746736|NCT02075255|80899718|FG001|Overall Study|Withdrawal by Subject|1|||
27746737|NCT02075255|80899719|FG002|Overall Study|Withdrawal by Subject|0|||
27746738|NCT02075255|80899717|FG000|Overall Study|Lost to Follow-up|0|||
27746739|NCT02075255|80899718|FG001|Overall Study|Lost to Follow-up|0|||
27746740|NCT02075255|80899719|FG002|Overall Study|Lost to Follow-up|1|||
27746741|NCT02075255|80899717|FG000|Overall Study|Adverse Event|0|||
27746742|NCT02075255|80899718|FG001|Overall Study|Adverse Event|0|||
27746743|NCT02075255|80899719|FG002|Overall Study|Adverse Event|1|||
27746744|NCT02075255|80899717|FG000|Overall Study|Death|0|||
27746745|NCT02075255|80899718|FG001|Overall Study|Death|2|||
27746746|NCT02075255|80899719|FG002|Overall Study|Death|0|||
27746747|NCT02050048|80899728|FG000|Overall Study|Lost to Follow-up|0|||
27746748|NCT02050048|80899729|FG001|Overall Study|Lost to Follow-up|1|||
27746749|NCT02050048|80899728|FG000|Overall Study|Death|1|||
27746750|NCT02050048|80899729|FG001|Overall Study|Death|0|||
27746751|NCT02050048|80899728|FG000|Overall Study|Ineligible after ERCP|4|||
27746752|NCT02050048|80899729|FG001|Overall Study|Ineligible after ERCP|1|||
27650289|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
27650290|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
27650291|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
27650292|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
27650293|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
27650294|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
27650295|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
27650296|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
27650297|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
27650298|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
27650299|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
27650300|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
27650301|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
27650302|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
27650303|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
27650304|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
27650305|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
27650306|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
27650307|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
27650308|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
27650309|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
27746753|NCT05258058|80899731|FG000|Overall Study|Withdrawal by Subject|2|||
27746754|NCT01798706|80899732|FG000|Overall Study|Adverse Event|15|||
27746755|NCT01798706|80899733|FG001|Overall Study|Adverse Event|10|||
27746756|NCT01798706|80899732|FG000|Overall Study|Lack of Efficacy|0|||
27746757|NCT01798706|80899733|FG001|Overall Study|Lack of Efficacy|2|||
27746758|NCT01798706|80899732|FG000|Overall Study|Poor compliance to protocol|1|||
27746759|NCT01798706|80899733|FG001|Overall Study|Poor compliance to protocol|0|||
27746760|NCT01798706|80899732|FG000|Overall Study|Other than specified above|5|||
27746761|NCT01798706|80899733|FG001|Overall Study|Other than specified above|9|||
27746762|NCT01166659|80899736|FG000|Overall Study|Subject Decision|8|||
27746763|NCT01166659|80899736|FG000|Overall Study|Investigator Decision|2|||
27746764|NCT01166659|80899736|FG000|Overall Study|Death|1|||
27746765|NCT01166659|80899736|FG000|Overall Study|Lost to Follow-up|1|||
27746766|NCT01166659|80899736|FG000|Overall Study|Study Closed at Site|1|||
27746767|NCT01733316|80899738|FG000|RP103 Phase|Non-compliance|1|||
27746768|NCT01733316|80899738|FG000|Long Term Extension Phase|Adverse Event|1|||
27746769|NCT01733316|80899738|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
27746770|NCT01733316|80899738|FG000|Long Term Extension Phase|Sponsor Decision|2|||
27746771|NCT02190435|80899739|FG000|Overall Study|First 12 patients were lead-ins|12|||
27746772|NCT02190435|80899740|FG001|Overall Study|First 12 patients were lead-ins|0|||
27746773|NCT02190435|80899739|FG000|Overall Study|3 consented screen fails|3|||
27746774|NCT02190435|80899740|FG001|Overall Study|3 consented screen fails|0|||
27746775|NCT00109733|80899741|FG000|Overall Study|Protocol Violation|0|||
27746776|NCT00109733|80899742|FG001|Overall Study|Protocol Violation|1|||
27746777|NCT00109733|80899741|FG000|Overall Study|Stopped taking study drug|1|||
27746778|NCT00109733|80899742|FG001|Overall Study|Stopped taking study drug|1|||
27746779|NCT00109733|80899741|FG000|Overall Study|Non-compliant|0|||
27746780|NCT00109733|80899742|FG001|Overall Study|Non-compliant|1|||
27746781|NCT00109733|80899741|FG000|Overall Study|Could not commit time for study|1|||
27746782|NCT00109733|80899742|FG001|Overall Study|Could not commit time for study|1|||
27746783|NCT01345786|80899747|FG000|Overall Study|Adverse Event|0|||
27746784|NCT01345786|80899748|FG001|Overall Study|Adverse Event|1|||
27746785|NCT01345786|80899749|FG002|Overall Study|Adverse Event|3|||
27746786|NCT01345786|80899750|FG003|Overall Study|Adverse Event|1|||
27746787|NCT01345786|80899747|FG000|Overall Study|Subject withdrew consent|2|||
27746788|NCT01345786|80899748|FG001|Overall Study|Subject withdrew consent|2|||
27746789|NCT01345786|80899749|FG002|Overall Study|Subject withdrew consent|1|||
27746790|NCT01345786|80899750|FG003|Overall Study|Subject withdrew consent|0|||
27746791|NCT01345786|80899747|FG000|Overall Study|Noncompliance with protocol|1|||
27746792|NCT01345786|80899748|FG001|Overall Study|Noncompliance with protocol|0|||
27746793|NCT01345786|80899749|FG002|Overall Study|Noncompliance with protocol|1|||
27746794|NCT01345786|80899750|FG003|Overall Study|Noncompliance with protocol|0|||
27746795|NCT01345786|80899747|FG000|Overall Study|Administrative|3|||
27746796|NCT01345786|80899748|FG001|Overall Study|Administrative|5|||
27746797|NCT01345786|80899749|FG002|Overall Study|Administrative|0|||
27746798|NCT01345786|80899750|FG003|Overall Study|Administrative|0|||
27746799|NCT01345786|80899747|FG000|Overall Study|Lost to Follow-up|0|||
27746800|NCT01345786|80899748|FG001|Overall Study|Lost to Follow-up|0|||
27746801|NCT01345786|80899749|FG002|Overall Study|Lost to Follow-up|0|||
27746802|NCT01345786|80899750|FG003|Overall Study|Lost to Follow-up|2|||
27746803|NCT00641043|80899751|FG000|Overall Study|Adverse Event|6|||
27746804|NCT00641043|80899752|FG001|Overall Study|Adverse Event|4|||
27746805|NCT00641043|80899751|FG000|Overall Study|Protocol Violation|2|||
27746806|NCT00641043|80899752|FG001|Overall Study|Protocol Violation|3|||
27746807|NCT00641043|80899751|FG000|Overall Study|Lost to Follow-up|3|||
27746808|NCT00641043|80899752|FG001|Overall Study|Lost to Follow-up|2|||
27746809|NCT00641043|80899751|FG000|Overall Study|Withdrawal by Subject|4|||
27746810|NCT00641043|80899752|FG001|Overall Study|Withdrawal by Subject|4|||
27746811|NCT00641043|80899751|FG000|Overall Study|Other incl. lack of efficacy|4|||
27746812|NCT00641043|80899752|FG001|Overall Study|Other incl. lack of efficacy|2|||
27746813|NCT00858702|80899753|FG000|Overall Study|Lack of Efficacy|1|||
27746814|NCT00858702|80899754|FG001|Overall Study|Lack of Efficacy|0|||
27746815|NCT00858702|80899753|FG000|Overall Study|Protocol Violation|1|||
27746816|NCT00858702|80899754|FG001|Overall Study|Protocol Violation|1|||
27746817|NCT00858702|80899753|FG000|Overall Study|Other|2|||
27746818|NCT00858702|80899754|FG001|Overall Study|Other|1|||
27746819|NCT00858702|80899753|FG000|Overall Study|Withdrawal by Subject|1|||
27746820|NCT00858702|80899754|FG001|Overall Study|Withdrawal by Subject|0|||
27746821|NCT03792750|80899757|FG000|Overall Study|Death|3|||
27746822|NCT02375698|80899762|FG000|Overall Study|Withdrawal by Subject|0|||
27746823|NCT02375698|80899763|FG001|Overall Study|Withdrawal by Subject|2|||
27746824|NCT02375698|80899762|FG000|Overall Study|Physician Decision|2|||
27746825|NCT02375698|80899763|FG001|Overall Study|Physician Decision|0|||
27746826|NCT01126619|80899766|FG000|Overall Study|Not eligible for the study|2|||
27746827|NCT01126619|80899766|FG000|Overall Study|Investigator decision|4|||
27746828|NCT01126619|80899766|FG000|Overall Study|Serious adverse event|1|||
27746829|NCT01126619|80899766|FG000|Overall Study|Withdrawal by Subject|9|||
27746830|NCT01126619|80899766|FG000|Overall Study|Non-compliance|1|||
27746831|NCT00301067|80899771|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
27746832|NCT00301067|80899772|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
27746833|NCT00301067|80899773|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
27746834|NCT00301067|80899774|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
27746835|NCT00301067|80899771|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
27746836|NCT00301067|80899772|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
27746837|NCT00301067|80899773|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
27746838|NCT00301067|80899774|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
27746839|NCT00301067|80899771|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
27746840|NCT00301067|80899772|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
27746841|NCT00301067|80899773|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
27746842|NCT00301067|80899774|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
27746843|NCT00301067|80899771|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
27746844|NCT00301067|80899772|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
27746845|NCT00301067|80899773|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
27746846|NCT00301067|80899774|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
27746847|NCT00301067|80899771|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
27746848|NCT00301067|80899772|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
27746849|NCT00301067|80899773|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
27746850|NCT00301067|80899774|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
27746851|NCT00301067|80899771|FG000|Follow up Until Death|Alive at last data cut point|1|||
27746852|NCT00301067|80899772|FG001|Follow up Until Death|Alive at last data cut point|0|||
27746853|NCT00301067|80899773|FG002|Follow up Until Death|Alive at last data cut point|0|||
27746854|NCT00301067|80899774|FG003|Follow up Until Death|Alive at last data cut point|1|||
27746855|NCT02065869|80902123|FG000|Overall Study|Death|7|||
27746856|NCT02065869|80902123|FG000|Overall Study|Disease relapse|16|||
27746857|NCT02065869|80902123|FG000|Overall Study|Lost to Follow-up|4|||
27746858|NCT02065869|80902123|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
27746859|NCT02065869|80902123|FG000|Overall Study|Withdrawal by Subject|1|||
27746860|NCT02582749|80902124|FG000|Overall Study|Study terminated by funder|5|||
27746861|NCT02582749|80902125|FG001|Overall Study|Study terminated by funder|10|||
27746862|NCT02582749|80902124|FG000|Overall Study|Withdrawal by Subject|0|||
27746863|NCT02582749|80902125|FG001|Overall Study|Withdrawal by Subject|1|||
27746864|NCT00069095|80902126|FG000|Primary Treatment Phase|Ongoing|0|||
27746865|NCT00069095|80902127|FG001|Primary Treatment Phase|Ongoing|0|||
27746866|NCT00069095|80902128|FG002|Primary Treatment Phase|Ongoing|5|||
27650310|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
27650311|NCT03732807|80560391|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27650312|NCT03732807|80560392|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27650313|NCT03732807|80560393|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27650314|NCT03732807|80560394|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27650315|NCT03732807|80560395|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27650316|NCT03732807|80560396|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
27650317|NCT03732807|80560397|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
27650318|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
27650319|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
27650320|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
27650321|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
27650322|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
27650323|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
27650324|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
27650325|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
27650326|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
27650327|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
27650328|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
27650329|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
27650330|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
27650331|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
27650332|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
27650333|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
27650334|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
27650335|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
27650336|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
27650337|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
27650338|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
27650339|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
27650340|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
27650341|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
27650342|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
27650343|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
27650344|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
27650345|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
27650346|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
27650347|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
27650348|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
27650349|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
27650350|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
27650351|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
27650352|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
27650353|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
27650354|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
27650355|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
27650356|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
27650357|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
27650358|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
27650359|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
27650360|NCT03732807|80560391|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
27650361|NCT03732807|80560392|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
27650362|NCT03732807|80560393|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
27650363|NCT03732807|80560394|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
27650364|NCT03732807|80560395|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
27650365|NCT03732807|80560396|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
27650366|NCT03732807|80560397|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
27650367|NCT02392507|80560400|FG000|Induction Regimen|Death|3|||
27650368|NCT02392507|80560400|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
27650369|NCT02392507|80560400|FG000|Induction Regimen|Physician Decision|1|||
27650370|NCT02392507|80560400|FG000|Induction Regimen|Withdrawal by Subject|2|||
27650371|NCT02392507|80560400|FG000|Maintenance Regimen|Death|1|||
27650372|NCT02392507|80560400|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
27746867|NCT00069095|80902129|FG003|Primary Treatment Phase|Ongoing|7|||
27746868|NCT00069095|80902130|FG004|Primary Treatment Phase|Ongoing|7|||
27746869|NCT00069095|80902131|FG005|Primary Treatment Phase|Ongoing|4|||
27746870|NCT00069095|80902126|FG000|Primary Treatment Phase|Admin/Other|29|||
27746871|NCT00069095|80902127|FG001|Primary Treatment Phase|Admin/Other|38|||
27746872|NCT00069095|80902128|FG002|Primary Treatment Phase|Admin/Other|31|||
27746873|NCT00069095|80902129|FG003|Primary Treatment Phase|Admin/Other|45|||
27746874|NCT00069095|80902130|FG004|Primary Treatment Phase|Admin/Other|48|||
27746875|NCT00069095|80902131|FG005|Primary Treatment Phase|Admin/Other|42|||
27746876|NCT00069095|80902126|FG000|Primary Treatment Phase|Adverse Event|99|||
27746877|NCT00069095|80902127|FG001|Primary Treatment Phase|Adverse Event|92|||
27746878|NCT00069095|80902128|FG002|Primary Treatment Phase|Adverse Event|71|||
27746879|NCT00069095|80902129|FG003|Primary Treatment Phase|Adverse Event|72|||
27746880|NCT00069095|80902130|FG004|Primary Treatment Phase|Adverse Event|109|||
27746881|NCT00069095|80902131|FG005|Primary Treatment Phase|Adverse Event|101|||
27746882|NCT00069095|80902126|FG000|Primary Treatment Phase|Death|14|||
27746883|NCT00069095|80902127|FG001|Primary Treatment Phase|Death|8|||
27746884|NCT00069095|80902128|FG002|Primary Treatment Phase|Death|2|||
27746885|NCT00069095|80902129|FG003|Primary Treatment Phase|Death|5|||
27746886|NCT00069095|80902130|FG004|Primary Treatment Phase|Death|8|||
27746887|NCT00069095|80902131|FG005|Primary Treatment Phase|Death|8|||
27746888|NCT00069095|80902126|FG000|Primary Treatment Phase|Failure to return|5|||
27746889|NCT00069095|80902127|FG001|Primary Treatment Phase|Failure to return|5|||
27746890|NCT00069095|80902128|FG002|Primary Treatment Phase|Failure to return|0|||
27746891|NCT00069095|80902129|FG003|Primary Treatment Phase|Failure to return|0|||
27746892|NCT00069095|80902130|FG004|Primary Treatment Phase|Failure to return|0|||
27746893|NCT00069095|80902131|FG005|Primary Treatment Phase|Failure to return|2|||
27746894|NCT00069095|80902126|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
27746895|NCT00069095|80902127|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
27746896|NCT00069095|80902128|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
27950054|NCT02891226|81651427|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
27650373|NCT02991118|80560401|FG000|Overall Study|Death|3|||
27650374|NCT02991118|80560402|FG001|Overall Study|Death|8|||
27650375|NCT02991118|80560401|FG000|Overall Study|Protocol Violation|0|||
27650376|NCT02991118|80560402|FG001|Overall Study|Protocol Violation|3|||
27650377|NCT02991118|80560401|FG000|Overall Study|Physician Decision|0|||
27650378|NCT02991118|80560402|FG001|Overall Study|Physician Decision|1|||
27650379|NCT02991118|80560401|FG000|Overall Study|Moved out of the country|0|||
27650380|NCT02991118|80560402|FG001|Overall Study|Moved out of the country|1|||
27650381|NCT02991118|80560401|FG000|Overall Study|Adverse Event|2|||
27650382|NCT02991118|80560402|FG001|Overall Study|Adverse Event|2|||
27650383|NCT02991118|80560401|FG000|Overall Study|Withdrawal by Subject|1|||
27650384|NCT02991118|80560402|FG001|Overall Study|Withdrawal by Subject|7|||
27650385|NCT02991118|80560401|FG000|Overall Study|Could not attend study visits|0|||
27650386|NCT02991118|80560402|FG001|Overall Study|Could not attend study visits|1|||
27650387|NCT02991118|80560401|FG000|Overall Study|Lost to Follow-up|1|||
27746897|NCT00069095|80902129|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
27746898|NCT00069095|80902130|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
27746899|NCT00069095|80902131|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
27746900|NCT00069095|80902126|FG000|Primary Treatment Phase|Refused treatment|15|||
27746901|NCT00069095|80902127|FG001|Primary Treatment Phase|Refused treatment|26|||
27746902|NCT00069095|80902128|FG002|Primary Treatment Phase|Refused treatment|17|||
27650388|NCT02991118|80560402|FG001|Overall Study|Lost to Follow-up|9|||
27650389|NCT00019604|80560414|FG000|Overall Study|Death|1|||
27650390|NCT00019604|80560414|FG000|Overall Study|Progressive disease|23|||
27650391|NCT00019604|80560414|FG000|Overall Study|Refused treatment|1|||
27650392|NCT00019604|80560414|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
27650393|NCT00019604|80560414|FG000|Overall Study|Going to have liver transplant|1|||
27650394|NCT00019604|80560414|FG000|Overall Study|Move to a different study|1|||
27650395|NCT00019604|80560414|FG000|Overall Study|Non compliant on systemic CH|1|||
27650396|NCT00019604|80560414|FG000|Overall Study|Non compliant|1|||
27650397|NCT00019604|80560414|FG000|Overall Study|Resectable disease|1|||
27650398|NCT00019604|80560414|FG000|Overall Study|Started new chemo regimen|1|||
27650399|NCT00019604|80560414|FG000|Overall Study|Pt going to immunotherapy study|1|||
27650400|NCT00019604|80560414|FG000|Overall Study|Too much disease|1|||
27650401|NCT00019604|80560414|FG000|Overall Study|Unable to evaluate|1|||
27650402|NCT00019604|80560414|FG000|Overall Study|Details for other not available|4|||
27650403|NCT02067663|80560415|FG000|Overall Study|Lost to Follow-up|13|||
27650404|NCT02067663|80560416|FG001|Overall Study|Lost to Follow-up|14|||
27650405|NCT01240785|80560421|FG000|Overall Study|Lost to Follow-up|1|||
27650406|NCT01240785|80560422|FG001|Overall Study|Lost to Follow-up|0|||
27650407|NCT01240785|80560421|FG000|Overall Study|Protocol Violation|0|||
27650408|NCT01240785|80560422|FG001|Overall Study|Protocol Violation|3|||
27650409|NCT03176407|80560423|FG000|Overall Study|Protocol Violation|1|||
27650410|NCT03176407|80560423|FG000|Overall Study|human failure|1|||
27650411|NCT03176407|80560423|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
27746903|NCT00069095|80902129|FG003|Primary Treatment Phase|Refused treatment|31|||
27746904|NCT00069095|80902130|FG004|Primary Treatment Phase|Refused treatment|24|||
27746905|NCT00069095|80902131|FG005|Primary Treatment Phase|Refused treatment|27|||
27746906|NCT00069095|80902126|FG000|Primary Treatment Phase|Withdrew|2|||
27746907|NCT00069095|80902127|FG001|Primary Treatment Phase|Withdrew|3|||
27746908|NCT00069095|80902128|FG002|Primary Treatment Phase|Withdrew|8|||
27746909|NCT00069095|80902129|FG003|Primary Treatment Phase|Withdrew|2|||
27746910|NCT00069095|80902130|FG004|Primary Treatment Phase|Withdrew|4|||
27746911|NCT00069095|80902131|FG005|Primary Treatment Phase|Withdrew|9|||
27746912|NCT00069095|80902126|FG000|Primary Treatment Phase|Other Violation|0|||
27746913|NCT00069095|80902127|FG001|Primary Treatment Phase|Other Violation|1|||
27746914|NCT00069095|80902128|FG002|Primary Treatment Phase|Other Violation|1|||
27746915|NCT00069095|80902129|FG003|Primary Treatment Phase|Other Violation|1|||
27746916|NCT00069095|80902130|FG004|Primary Treatment Phase|Other Violation|0|||
27746917|NCT00069095|80902131|FG005|Primary Treatment Phase|Other Violation|1|||
27746918|NCT00069095|80902126|FG000|Primary Treatment Phase|Violation criteria|0|||
27746919|NCT00069095|80902127|FG001|Primary Treatment Phase|Violation criteria|2|||
27746920|NCT00069095|80902128|FG002|Primary Treatment Phase|Violation criteria|4|||
27746921|NCT00069095|80902129|FG003|Primary Treatment Phase|Violation criteria|3|||
27746922|NCT00069095|80902130|FG004|Primary Treatment Phase|Violation criteria|1|||
27746923|NCT00069095|80902131|FG005|Primary Treatment Phase|Violation criteria|5|||
27746924|NCT00069095|80902126|FG000|Post-study Treatment Phase|Missing reason|1|||
27746925|NCT00069095|80902127|FG001|Post-study Treatment Phase|Missing reason|3|||
27746926|NCT00069095|80902128|FG002|Post-study Treatment Phase|Missing reason|12|||
27746927|NCT00069095|80902129|FG003|Post-study Treatment Phase|Missing reason|8|||
27746928|NCT00069095|80902130|FG004|Post-study Treatment Phase|Missing reason|18|||
27746929|NCT00069095|80902131|FG005|Post-study Treatment Phase|Missing reason|17|||
27746930|NCT00069095|80902126|FG000|Post-study Treatment Phase|Adverse Event|2|||
27746931|NCT00069095|80902127|FG001|Post-study Treatment Phase|Adverse Event|3|||
27746932|NCT00069095|80902128|FG002|Post-study Treatment Phase|Adverse Event|1|||
27746933|NCT00069095|80902129|FG003|Post-study Treatment Phase|Adverse Event|0|||
27746934|NCT00069095|80902130|FG004|Post-study Treatment Phase|Adverse Event|5|||
27746935|NCT00069095|80902131|FG005|Post-study Treatment Phase|Adverse Event|1|||
27746936|NCT00069095|80902126|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
27746937|NCT00069095|80902127|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
27746938|NCT00069095|80902128|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
27746939|NCT00069095|80902129|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
27746940|NCT00069095|80902130|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
27746941|NCT00069095|80902131|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
27746942|NCT00069095|80902126|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
27746943|NCT00069095|80902127|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
27746944|NCT00069095|80902128|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
27746945|NCT00069095|80902129|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
27746946|NCT00069095|80902130|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
27746947|NCT00069095|80902131|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
27746948|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
27746949|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
27746950|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
27746951|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
27746952|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
27746953|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
27746954|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant had complete response|1|||
27746955|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant had complete response|1|||
27746956|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant had complete response|0|||
27746957|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant had complete response|0|||
27746958|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant had complete response|0|||
27746959|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant had complete response|0|||
27746960|NCT00069095|80902126|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
27746961|NCT00069095|80902127|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
27746962|NCT00069095|80902128|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
27746963|NCT00069095|80902129|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
27746964|NCT00069095|80902130|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
27950055|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950056|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950057|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950058|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27746965|NCT00069095|80902131|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
27950059|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950060|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27746966|NCT00069095|80902126|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
27746967|NCT00069095|80902127|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
27746968|NCT00069095|80902128|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
27746969|NCT00069095|80902129|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
27746970|NCT00069095|80902130|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
27746971|NCT00069095|80902131|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
27746972|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
27746973|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
27746974|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
27746975|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
27746976|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
27746977|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
27746978|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
27746979|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
27746980|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
27746981|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
27746982|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
27746983|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
27746984|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
27746985|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
27746986|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
27746987|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
27746988|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
27746989|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
27746990|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
27746991|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
27746992|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
27746993|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
27746994|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
27746995|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
27746996|NCT00069095|80902126|FG000|Post-study Treatment Phase|Surgery|0|||
27746997|NCT00069095|80902127|FG001|Post-study Treatment Phase|Surgery|0|||
27746998|NCT00069095|80902128|FG002|Post-study Treatment Phase|Surgery|0|||
27746999|NCT00069095|80902129|FG003|Post-study Treatment Phase|Surgery|1|||
27747000|NCT00069095|80902130|FG004|Post-study Treatment Phase|Surgery|1|||
27747001|NCT00069095|80902131|FG005|Post-study Treatment Phase|Surgery|0|||
27747002|NCT00069095|80902126|FG000|Post-study Treatment Phase|Death|0|||
27747003|NCT00069095|80902127|FG001|Post-study Treatment Phase|Death|0|||
27747004|NCT00069095|80902128|FG002|Post-study Treatment Phase|Death|0|||
27747005|NCT00069095|80902129|FG003|Post-study Treatment Phase|Death|0|||
27747006|NCT00069095|80902130|FG004|Post-study Treatment Phase|Death|1|||
27747007|NCT00069095|80902131|FG005|Post-study Treatment Phase|Death|0|||
27747008|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
27747009|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
27747010|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
27747011|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
27747012|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
27747013|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
27747014|NCT00069095|80902126|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
27747015|NCT00069095|80902127|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
27747016|NCT00069095|80902128|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
27747017|NCT00069095|80902129|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
27747018|NCT00069095|80902130|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
27747019|NCT00069095|80902131|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
27747020|NCT00069095|80902126|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
27747021|NCT00069095|80902127|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
27747022|NCT00069095|80902128|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
27747023|NCT00069095|80902129|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
27747024|NCT00069095|80902130|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
27747025|NCT00069095|80902131|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
27747026|NCT00069095|80902126|FG000|Post-study Treatment Phase|Investigator decision|0|||
27747027|NCT00069095|80902127|FG001|Post-study Treatment Phase|Investigator decision|0|||
27747028|NCT00069095|80902128|FG002|Post-study Treatment Phase|Investigator decision|0|||
27747029|NCT00069095|80902129|FG003|Post-study Treatment Phase|Investigator decision|0|||
27747030|NCT00069095|80902130|FG004|Post-study Treatment Phase|Investigator decision|0|||
27747031|NCT00069095|80902131|FG005|Post-study Treatment Phase|Investigator decision|1|||
27747032|NCT00069095|80902126|FG000|Follow-up Phase|Death|174|||
27747033|NCT00069095|80902127|FG001|Follow-up Phase|Death|206|||
27747034|NCT00069095|80902128|FG002|Follow-up Phase|Death|120|||
27747035|NCT00069095|80902129|FG003|Follow-up Phase|Death|112|||
27747036|NCT00069095|80902130|FG004|Follow-up Phase|Death|92|||
27747037|NCT00069095|80902131|FG005|Follow-up Phase|Death|101|||
27747038|NCT03865407|80902132|FG000|Overall Study|Adverse Event|1|||
27747039|NCT03865407|80902133|FG001|Overall Study|Adverse Event|0|||
27747040|NCT03865407|80902132|FG000|Overall Study|Withdrawal by Subject|1|||
27747041|NCT03865407|80902133|FG001|Overall Study|Withdrawal by Subject|0|||
27747042|NCT03865407|80902132|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
27747043|NCT03865407|80902133|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
27747044|NCT03567291|80902134|FG000|Period I|Adverse Event|14|||
27747045|NCT03567291|80902135|FG001|Period I|Adverse Event|0|||
27747046|NCT03567291|80902136|FG002|Period I|Adverse Event|0|||
27747047|NCT03567291|80902137|FG003|Period I|Adverse Event|0|||
27747048|NCT03567291|80902134|FG000|Period I|Protocol Violation|1|||
27747049|NCT03567291|80902135|FG001|Period I|Protocol Violation|0|||
27747050|NCT03567291|80902136|FG002|Period I|Protocol Violation|0|||
27747051|NCT03567291|80902137|FG003|Period I|Protocol Violation|0|||
27747052|NCT03567291|80902134|FG000|Period I|Withdrawal by Subject|23|||
27747053|NCT03567291|80902135|FG001|Period I|Withdrawal by Subject|0|||
27747054|NCT03567291|80902136|FG002|Period I|Withdrawal by Subject|0|||
27747055|NCT03567291|80902137|FG003|Period I|Withdrawal by Subject|0|||
27747056|NCT03567291|80902134|FG000|Period I|Lost to Follow-up|2|||
27747057|NCT03567291|80902135|FG001|Period I|Lost to Follow-up|0|||
27747058|NCT03567291|80902136|FG002|Period I|Lost to Follow-up|0|||
27747059|NCT03567291|80902137|FG003|Period I|Lost to Follow-up|0|||
27747060|NCT03567291|80902134|FG000|Period I|Terminated by sponsor|44|||
27747061|NCT03567291|80902135|FG001|Period I|Terminated by sponsor|0|||
27747062|NCT03567291|80902136|FG002|Period I|Terminated by sponsor|0|||
27747063|NCT03567291|80902137|FG003|Period I|Terminated by sponsor|0|||
27747064|NCT03567291|80902134|FG000|Period I|Missing or unknown|7|||
27747065|NCT03567291|80902135|FG001|Period I|Missing or unknown|0|||
27747066|NCT03567291|80902136|FG002|Period I|Missing or unknown|0|||
27747067|NCT03567291|80902137|FG003|Period I|Missing or unknown|0|||
27747068|NCT03567291|80902134|FG000|Period II|Adverse Event|0|||
27747069|NCT03567291|80902135|FG001|Period II|Adverse Event|1|||
27747070|NCT03567291|80902136|FG002|Period II|Adverse Event|0|||
27747071|NCT03567291|80902137|FG003|Period II|Adverse Event|0|||
27747072|NCT03567291|80902134|FG000|Period II|Missing or unknown|0|||
27747073|NCT03567291|80902135|FG001|Period II|Missing or unknown|2|||
27747074|NCT03567291|80902136|FG002|Period II|Missing or unknown|1|||
27747075|NCT03567291|80902137|FG003|Period II|Missing or unknown|0|||
27747076|NCT03567291|80902134|FG000|Period III|Adverse Event|0|||
27747077|NCT03567291|80902135|FG001|Period III|Adverse Event|0|||
27747078|NCT03567291|80902136|FG002|Period III|Adverse Event|0|||
27747079|NCT03567291|80902137|FG003|Period III|Adverse Event|4|||
27747080|NCT03567291|80902134|FG000|Period III|Withdrawal by Subject|0|||
27747081|NCT03567291|80902135|FG001|Period III|Withdrawal by Subject|0|||
27747082|NCT03567291|80902136|FG002|Period III|Withdrawal by Subject|0|||
27747083|NCT03567291|80902137|FG003|Period III|Withdrawal by Subject|4|||
27747084|NCT03567291|80902134|FG000|Period III|Lost to Follow-up|0|||
27747085|NCT03567291|80902135|FG001|Period III|Lost to Follow-up|0|||
27747086|NCT03567291|80902136|FG002|Period III|Lost to Follow-up|0|||
27747087|NCT03567291|80902137|FG003|Period III|Lost to Follow-up|1|||
27747088|NCT03567291|80902134|FG000|Period III|Terminated by sponsor|0|||
27747089|NCT03567291|80902135|FG001|Period III|Terminated by sponsor|0|||
27747090|NCT03567291|80902136|FG002|Period III|Terminated by sponsor|0|||
27950061|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950062|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950063|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27747091|NCT03567291|80902137|FG003|Period III|Terminated by sponsor|68|||
27747092|NCT03567291|80902134|FG000|Period III|Missing or unknown|0|||
27747093|NCT03567291|80902135|FG001|Period III|Missing or unknown|0|||
27747094|NCT03567291|80902136|FG002|Period III|Missing or unknown|0|||
27747095|NCT03567291|80902137|FG003|Period III|Missing or unknown|8|||
27747096|NCT02552355|80902138|FG000|Overall Study|Adverse Event|0|||
27950064|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27747097|NCT02552355|80902139|FG001|Overall Study|Adverse Event|2|||
27747098|NCT02552355|80902140|FG002|Overall Study|Adverse Event|2|||
27747099|NCT02552355|80902141|FG003|Overall Study|Adverse Event|0|||
27747100|NCT02552355|80902138|FG000|Overall Study|Withdrawal by Subject|0|||
27747101|NCT02552355|80902139|FG001|Overall Study|Withdrawal by Subject|0|||
27747102|NCT02552355|80902140|FG002|Overall Study|Withdrawal by Subject|0|||
27747103|NCT02552355|80902141|FG003|Overall Study|Withdrawal by Subject|1|||
27747104|NCT00450372|80902148|FG000|Overall Study|Physician Decision|1|||
27747105|NCT01100307|80902149|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
27747106|NCT01100307|80902150|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
27747107|NCT01100307|80902149|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
27747108|NCT01100307|80902150|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
27747109|NCT01100307|80902149|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
27747110|NCT01100307|80902150|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
27747111|NCT01100307|80902149|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
27747112|NCT01100307|80902150|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
27747113|NCT01100307|80902149|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
27747114|NCT01100307|80902150|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
27747115|NCT01100307|80902149|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
27747116|NCT01100307|80902150|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
27747117|NCT04359823|80902153|FG000|Overall Study|Lost to Follow-up|0|||
27747118|NCT04359823|80902154|FG001|Overall Study|Lost to Follow-up|1|||
27747119|NCT04359823|80902153|FG000|Overall Study|Withdrawal by Subject|0|||
27747120|NCT04359823|80902154|FG001|Overall Study|Withdrawal by Subject|1|||
27747121|NCT02691247|80902155|FG000|Overall Study|Withdrawal by Subject|1|||
27747122|NCT02691247|80902156|FG001|Overall Study|Withdrawal by Subject|2|||
27747123|NCT02691247|80902157|FG002|Overall Study|Withdrawal by Subject|2|||
27747124|NCT02691247|80902155|FG000|Overall Study|Lost to Follow-up|2|||
27747125|NCT02691247|80902156|FG001|Overall Study|Lost to Follow-up|0|||
27747126|NCT02691247|80902157|FG002|Overall Study|Lost to Follow-up|1|||
27747127|NCT00718861|80902158|FG000|Overall Study|Withdrawal by Subject|15|||
27747128|NCT00718861|80902159|FG001|Overall Study|Withdrawal by Subject|10|||
27747129|NCT00718861|80902158|FG000|Overall Study|Adverse Event|2|||
27747130|NCT00718861|80902159|FG001|Overall Study|Adverse Event|1|||
27747131|NCT00718861|80902158|FG000|Overall Study|Lost to Follow-up|2|||
27747132|NCT00718861|80902159|FG001|Overall Study|Lost to Follow-up|1|||
27747133|NCT00718861|80902158|FG000|Overall Study|Administrative Problems|1|||
27747134|NCT00718861|80902159|FG001|Overall Study|Administrative Problems|1|||
27747135|NCT00718861|80902158|FG000|Overall Study|Death|1|||
27747136|NCT00718861|80902159|FG001|Overall Study|Death|5|||
27747137|NCT01108809|80902160|FG000|Overall Study|Adverse Event|3|||
27747138|NCT01108809|80902160|FG000|Overall Study|Lost to Follow-up|1|||
27747139|NCT00698516|80902169|FG000|Overall Study|Study Termination|2|||
27747140|NCT00698516|80902169|FG000|Overall Study|Withdrawal by Subject|3|||
27747141|NCT02606045|80902173|FG000|Overall Study|Study closed before treament could begin|1|||
27747142|NCT02606045|80902174|FG001|Overall Study|Study closed before treament could begin|2|||
27747143|NCT05301322|80902175|FG000|Overall Study|Adverse Event|7|||
27747144|NCT05301322|80902176|FG001|Overall Study|Adverse Event|3|||
27747145|NCT05301322|80902175|FG000|Overall Study|Death|0|||
27747146|NCT05301322|80902176|FG001|Overall Study|Death|1|||
27747147|NCT05301322|80902175|FG000|Overall Study|Lost to Follow-up|2|||
27747148|NCT05301322|80902176|FG001|Overall Study|Lost to Follow-up|1|||
27747149|NCT05301322|80902175|FG000|Overall Study|Protocol Violation|3|||
27747150|NCT05301322|80902176|FG001|Overall Study|Protocol Violation|1|||
27747151|NCT05301322|80902175|FG000|Overall Study|Withdrawal by Subject|3|||
27747152|NCT05301322|80902176|FG001|Overall Study|Withdrawal by Subject|0|||
27747153|NCT05301322|80902175|FG000|Overall Study|Other|4|||
27747154|NCT05301322|80902176|FG001|Overall Study|Other|0|||
27747155|NCT00496873|80902177|FG000|Overall Study|Ineligible|2|||
27747156|NCT00496873|80902177|FG000|Overall Study|Death|2|||
27747157|NCT00496873|80902177|FG000|Overall Study|Withdrawal by Subject|3|||
27747158|NCT00633139|80902184|FG000|Overall Study|Non compliance|0|||
27747159|NCT00633139|80902185|FG001|Overall Study|Non compliance|0|||
27747160|NCT00633139|80902186|FG002|Overall Study|Non compliance|1|||
27747161|NCT00633139|80902184|FG000|Overall Study|Withdrawal by Subject|0|||
27747162|NCT00633139|80902185|FG001|Overall Study|Withdrawal by Subject|1|||
27747163|NCT00633139|80902186|FG002|Overall Study|Withdrawal by Subject|0|||
27747164|NCT02028338|80902187|FG000|Overall Study|Withdrawal by Subject|3|||
27747165|NCT02028338|80902188|FG001|Overall Study|Withdrawal by Subject|1|||
27747166|NCT02028338|80902187|FG000|Overall Study|Unable to contact participant|1|||
27747167|NCT02028338|80902188|FG001|Overall Study|Unable to contact participant|0|||
27747168|NCT00406315|80902189|FG000|Overall Study|Death|1|||
27747169|NCT00406315|80902189|FG000|Overall Study|Adverse Event|39|||
27747170|NCT00406315|80902189|FG000|Overall Study|Laboratory Abnormality|4|||
27747171|NCT00406315|80902189|FG000|Overall Study|Lack of Efficacy|13|||
27747172|NCT00406315|80902189|FG000|Overall Study|Other|33|||
27747173|NCT00406315|80902189|FG000|Overall Study|Lost to Follow-up|21|||
27747174|NCT00406315|80902189|FG000|Overall Study|Withdrawal by Subject|30|||
27747175|NCT01905397|80902190|FG000|Overall Study|Death|0|||
27747176|NCT01905397|80902191|FG001|Overall Study|Death|1|||
27747177|NCT01905397|80902190|FG000|Overall Study|Withdrawal by Subject|2|||
27747178|NCT01905397|80902191|FG001|Overall Study|Withdrawal by Subject|0|||
27747179|NCT01905397|80902190|FG000|Overall Study|Surgery canceled/aborted|9|||
27747180|NCT01905397|80902191|FG001|Overall Study|Surgery canceled/aborted|5|||
27747181|NCT01905397|80902190|FG000|Overall Study|Incision < 7 cm|2|||
27747182|NCT01905397|80902191|FG001|Overall Study|Incision < 7 cm|0|||
27747183|NCT01905397|80902190|FG000|Overall Study|Wrong treatment|1|||
27747184|NCT01905397|80902191|FG001|Overall Study|Wrong treatment|1|||
27747185|NCT01905397|80902190|FG000|Overall Study|Device not applied|3|||
27650412|NCT05376397|80560425|FG000|Overall Study|Lost to Follow-up|1|||
27650413|NCT02630186|80560426|FG000|Overall Study|Withdrawal by Subject|1|||
27650414|NCT01951703|80560427|FG000|First Intervention|Withdrawal by Subject|1|||
27650415|NCT01951703|80560428|FG001|First Intervention|Withdrawal by Subject|0|||
27650416|NCT01951703|80560427|FG000|First Intervention|Subject was not compliant|1|||
27650417|NCT01951703|80560428|FG001|First Intervention|Subject was not compliant|1|||
27650418|NCT01951703|80560427|FG000|First Intervention|Physician Decision|1|||
27650419|NCT01951703|80560428|FG001|First Intervention|Physician Decision|0|||
27650420|NCT01951703|80560427|FG000|Second Intervention|Protocol Violation|0|||
27650421|NCT01951703|80560428|FG001|Second Intervention|Protocol Violation|1|||
27650422|NCT01951703|80560427|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
27650423|NCT01951703|80560428|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
27650424|NCT04559698|80560433|FG000|Overall Study|Lost to Follow-up|14|||
27650425|NCT04559698|80560434|FG001|Overall Study|Lost to Follow-up|15|||
27650426|NCT04559698|80560433|FG000|Overall Study|Withdrawal by Subject|0|||
27650427|NCT04559698|80560434|FG001|Overall Study|Withdrawal by Subject|1|||
27650428|NCT00701415|80560435|FG000|Overall Study|Adverse Event|0|||
27650429|NCT00701415|80560436|FG001|Overall Study|Adverse Event|1|||
27650430|NCT00701415|80560435|FG000|Overall Study|Social/family issues and needle phobia|1|||
27650431|NCT00701415|80560436|FG001|Overall Study|Social/family issues and needle phobia|0|||
27650432|NCT02538094|80560437|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
27650433|NCT02538094|80560438|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
27650434|NCT02538094|80560437|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
27650435|NCT02538094|80560438|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
27650436|NCT03146845|80560442|FG000|Overall Study|Reference ulcer healed|1|||
27650437|NCT03146845|80560443|FG001|Overall Study|Reference ulcer healed|0|||
27650438|NCT03146845|80560442|FG000|Overall Study|Physician Decision|1|||
27650439|NCT03146845|80560443|FG001|Overall Study|Physician Decision|0|||
27650440|NCT03146845|80560442|FG000|Overall Study|Adverse Event|1|||
27650441|NCT03146845|80560443|FG001|Overall Study|Adverse Event|0|||
27650442|NCT03146845|80560442|FG000|Overall Study|Withdrawal by Subject|2|||
27650443|NCT03146845|80560443|FG001|Overall Study|Withdrawal by Subject|0|||
27650444|NCT03146845|80560442|FG000|Overall Study|Noncompliance|0|||
27650445|NCT03146845|80560443|FG001|Overall Study|Noncompliance|1|||
27650446|NCT03146845|80560442|FG000|Overall Study|Protocol Violation|0|||
27650447|NCT03146845|80560443|FG001|Overall Study|Protocol Violation|2|||
27650448|NCT03146845|80560442|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
27650449|NCT03146845|80560443|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
27650450|NCT02102724|80560448|FG000|Overall Study|Lost to Follow-up|1|||
27650451|NCT02102724|80560449|FG001|Overall Study|Lost to Follow-up|0|||
27650452|NCT02102724|80560448|FG000|Overall Study|surgery for brain aneurysm|1|||
27650453|NCT02102724|80560449|FG001|Overall Study|surgery for brain aneurysm|1|||
27650454|NCT03042767|80560450|FG000|Overall Study|Lost to Follow-up|1|||
27650455|NCT03042767|80560451|FG001|Overall Study|Lost to Follow-up|2|||
27650456|NCT04108858|80560452|FG000|Overall Study|Adverse Event|1|||
27650457|NCT02113449|80560453|FG000|Overall Study|Adverse Event|4|||
27650458|NCT01109979|80560454|FG000|Overall Study|Physician Decision|2|||
27650459|NCT01109979|80560455|FG001|Overall Study|Physician Decision|0|||
27650460|NCT01109979|80560454|FG000|Overall Study|Withdrawal by Subject|0|||
27650461|NCT01109979|80560455|FG001|Overall Study|Withdrawal by Subject|1|||
27650462|NCT01970878|80560456|FG000|Overall Study|Withdrawal by Subject|11|||
27650463|NCT01970878|80560457|FG001|Overall Study|Withdrawal by Subject|10|||
27650464|NCT01970878|80560458|FG002|Overall Study|Withdrawal by Subject|14|||
27650465|NCT01970878|80560459|FG003|Overall Study|Withdrawal by Subject|7|||
27650466|NCT01970878|80560456|FG000|Overall Study|Lost to Follow-up|1|||
27650467|NCT01970878|80560457|FG001|Overall Study|Lost to Follow-up|3|||
27650468|NCT01970878|80560458|FG002|Overall Study|Lost to Follow-up|2|||
27650469|NCT01970878|80560459|FG003|Overall Study|Lost to Follow-up|4|||
27650470|NCT01970878|80560456|FG000|Overall Study|Administrative Reasons|1|||
27650471|NCT01970878|80560457|FG001|Overall Study|Administrative Reasons|0|||
27650472|NCT01970878|80560458|FG002|Overall Study|Administrative Reasons|0|||
27650473|NCT01970878|80560459|FG003|Overall Study|Administrative Reasons|4|||
27650474|NCT01970878|80560456|FG000|Overall Study|Lack of Efficacy|2|||
27650475|NCT01970878|80560457|FG001|Overall Study|Lack of Efficacy|1|||
27650476|NCT01970878|80560458|FG002|Overall Study|Lack of Efficacy|2|||
27650477|NCT01970878|80560459|FG003|Overall Study|Lack of Efficacy|0|||
27747186|NCT01905397|80902191|FG001|Overall Study|Device not applied|0|||
27650478|NCT01970878|80560456|FG000|Overall Study|Adverse Event|12|||
27650479|NCT01970878|80560457|FG001|Overall Study|Adverse Event|7|||
27650480|NCT01970878|80560458|FG002|Overall Study|Adverse Event|4|||
27650481|NCT01970878|80560459|FG003|Overall Study|Adverse Event|3|||
27650482|NCT01970878|80560456|FG000|Overall Study|Protocol Specified Criteria|10|||
27650483|NCT01970878|80560457|FG001|Overall Study|Protocol Specified Criteria|4|||
27650484|NCT01970878|80560458|FG002|Overall Study|Protocol Specified Criteria|3|||
27650485|NCT01970878|80560459|FG003|Overall Study|Protocol Specified Criteria|6|||
27650486|NCT01970878|80560456|FG000|Overall Study|Physician Decision|0|||
27650487|NCT01970878|80560457|FG001|Overall Study|Physician Decision|1|||
27650488|NCT01970878|80560458|FG002|Overall Study|Physician Decision|1|||
27650489|NCT01970878|80560459|FG003|Overall Study|Physician Decision|0|||
27650490|NCT01970878|80560456|FG000|Overall Study|No Completion Status|0|||
27650491|NCT01970878|80560457|FG001|Overall Study|No Completion Status|1|||
27650492|NCT01970878|80560458|FG002|Overall Study|No Completion Status|0|||
27650493|NCT01970878|80560459|FG003|Overall Study|No Completion Status|0|||
27650494|NCT03100370|80560460|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27650495|NCT03100370|80560461|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27650496|NCT03100370|80560462|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27650497|NCT03100370|80560463|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
27650498|NCT03100370|80560464|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27650499|NCT03100370|80560465|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
27650500|NCT01916109|80560466|FG000|Overall Study|Withdrawal by Subject|1|||
27650501|NCT04895085|80560467|FG000|Overall Study|Death|1|||
27650502|NCT04895085|80560467|FG000|Overall Study|Withdrawal by Subject|1|||
27650503|NCT04895085|80560467|FG000|Overall Study|No longer eligible: Moved from area|1|||
27650504|NCT00985088|80560473|FG000|Overall Study|Serious Adverse Event|1|||
27650505|NCT00985088|80560474|FG001|Overall Study|Serious Adverse Event|1|||
27650506|NCT00985088|80560475|FG002|Overall Study|Serious Adverse Event|0|||
27650507|NCT00985088|80560476|FG003|Overall Study|Serious Adverse Event|0|||
27650508|NCT00985088|80560477|FG004|Overall Study|Serious Adverse Event|0|||
27650509|NCT00985088|80560478|FG005|Overall Study|Serious Adverse Event|0|||
27650510|NCT00985088|80560479|FG006|Overall Study|Serious Adverse Event|0|||
27650511|NCT00985088|80560480|FG007|Overall Study|Serious Adverse Event|1|||
27650512|NCT00985088|80560473|FG000|Overall Study|Adverse Event|0|||
27650513|NCT00985088|80560474|FG001|Overall Study|Adverse Event|0|||
27650514|NCT00985088|80560475|FG002|Overall Study|Adverse Event|1|||
27650515|NCT00985088|80560476|FG003|Overall Study|Adverse Event|0|||
27650516|NCT00985088|80560477|FG004|Overall Study|Adverse Event|0|||
27650517|NCT00985088|80560478|FG005|Overall Study|Adverse Event|0|||
27650518|NCT00985088|80560479|FG006|Overall Study|Adverse Event|0|||
27650519|NCT00985088|80560480|FG007|Overall Study|Adverse Event|0|||
27650520|NCT00985088|80560473|FG000|Overall Study|Withdrawal by Subject|4|||
27650521|NCT00985088|80560474|FG001|Overall Study|Withdrawal by Subject|0|||
27650522|NCT00985088|80560475|FG002|Overall Study|Withdrawal by Subject|0|||
27650523|NCT00985088|80560476|FG003|Overall Study|Withdrawal by Subject|1|||
27650524|NCT00985088|80560477|FG004|Overall Study|Withdrawal by Subject|3|||
27650525|NCT00985088|80560478|FG005|Overall Study|Withdrawal by Subject|2|||
27650526|NCT00985088|80560479|FG006|Overall Study|Withdrawal by Subject|1|||
27650527|NCT00985088|80560480|FG007|Overall Study|Withdrawal by Subject|2|||
27650528|NCT00985088|80560473|FG000|Overall Study|Migrated/moved from study area|0|||
27650529|NCT00985088|80560474|FG001|Overall Study|Migrated/moved from study area|0|||
27650530|NCT00985088|80560475|FG002|Overall Study|Migrated/moved from study area|1|||
27650531|NCT00985088|80560476|FG003|Overall Study|Migrated/moved from study area|0|||
27650532|NCT00985088|80560477|FG004|Overall Study|Migrated/moved from study area|0|||
27650533|NCT00985088|80560478|FG005|Overall Study|Migrated/moved from study area|0|||
27650534|NCT00985088|80560479|FG006|Overall Study|Migrated/moved from study area|0|||
27650535|NCT00985088|80560480|FG007|Overall Study|Migrated/moved from study area|1|||
27650536|NCT00985088|80560473|FG000|Overall Study|Lost to Follow-up|6|||
27650537|NCT00985088|80560474|FG001|Overall Study|Lost to Follow-up|1|||
27747187|NCT01905397|80902190|FG000|Overall Study|Dressing not applied in operating room|1|||
27747188|NCT01905397|80902191|FG001|Overall Study|Dressing not applied in operating room|0|||
27747189|NCT01905397|80902190|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
27747190|NCT01905397|80902191|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
27747191|NCT01465178|80902192|FG000|Overall Study|Withdrawal by Subject|1|||
27747192|NCT01465178|80902193|FG001|Overall Study|Withdrawal by Subject|0|||
27747193|NCT04070378|80902194|FG000|Overall Study|Withdrawal by Subject|2|||
27747194|NCT04070378|80902194|FG000|Overall Study|Screen Failure|6|||
27747195|NCT04070378|80902194|FG000|Overall Study|Physician Decision|1|||
27747196|NCT04070378|80902194|FG000|Overall Study|Adverse Event|1|||
27747197|NCT01797783|80902195|FG000|Overall Study|Adverse Event|1|||
27747198|NCT01797783|80902196|FG001|Overall Study|Adverse Event|1|||
27747199|NCT01797783|80902195|FG000|Overall Study|Withdrawal by Subject|1|||
27950065|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
27950066|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27650538|NCT00985088|80560475|FG002|Overall Study|Lost to Follow-up|2|||
27650539|NCT00985088|80560476|FG003|Overall Study|Lost to Follow-up|6|||
27650540|NCT00985088|80560477|FG004|Overall Study|Lost to Follow-up|6|||
27650541|NCT00985088|80560478|FG005|Overall Study|Lost to Follow-up|5|||
27650542|NCT00985088|80560479|FG006|Overall Study|Lost to Follow-up|3|||
27650543|NCT00985088|80560480|FG007|Overall Study|Lost to Follow-up|2|||
27747200|NCT01797783|80902196|FG001|Overall Study|Withdrawal by Subject|0|||
27747201|NCT03074162|80902203|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
27747202|NCT03074162|80902204|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
27747203|NCT03074162|80902205|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
27747204|NCT03074162|80902206|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
27747205|NCT03074162|80902207|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
27747206|NCT03074162|80902208|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
27747207|NCT03074162|80902203|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
27747208|NCT03074162|80902204|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
27747209|NCT03074162|80902205|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
27747210|NCT03074162|80902206|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
27747211|NCT03074162|80902207|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
27747212|NCT03074162|80902208|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
27747213|NCT03074162|80902203|FG000|Period 3|Withdrawal by Subject|1|||
27747214|NCT03074162|80902204|FG001|Period 3|Withdrawal by Subject|0|||
27747215|NCT03074162|80902205|FG002|Period 3|Withdrawal by Subject|0|||
27747216|NCT03074162|80902206|FG003|Period 3|Withdrawal by Subject|0|||
27747217|NCT03074162|80902207|FG004|Period 3|Withdrawal by Subject|1|||
27747218|NCT03074162|80902208|FG005|Period 3|Withdrawal by Subject|0|||
27747219|NCT01158534|80902209|FG000|Overall Study|Withdrawal by Subject|1|||
27747220|NCT01158534|80902209|FG000|Overall Study|Death|1|||
27747221|NCT01158534|80902209|FG000|Overall Study|Other|1|||
27747222|NCT00515008|80902212|FG000|Overall Study|Lost to Follow-up|1|||
27747223|NCT00515008|80902213|FG001|Overall Study|Lost to Follow-up|0|||
27747224|NCT00515008|80902212|FG000|Overall Study|Declined|0|||
27747225|NCT00515008|80902213|FG001|Overall Study|Declined|3|||
27747226|NCT00515008|80902212|FG000|Overall Study|Left the Boston Area|1|||
27747227|NCT00515008|80902213|FG001|Overall Study|Left the Boston Area|1|||
27747228|NCT00515008|80902212|FG000|Overall Study|Scheduling conflict|1|||
27747229|NCT00515008|80902213|FG001|Overall Study|Scheduling conflict|0|||
27747230|NCT00589472|80902214|FG000|Overall Study|Adverse Event|1|||
27747231|NCT02778867|80902215|FG000|Phase 1|Withdrawal by Subject|2|||
27747232|NCT02778867|80902216|FG001|Phase 1|Withdrawal by Subject|3|||
27747233|NCT02778867|80902217|FG002|Phase 1|Withdrawal by Subject|0|||
27747234|NCT02778867|80902218|FG003|Phase 1|Withdrawal by Subject|0|||
27747235|NCT02778867|80902215|FG000|Phase 2|Withdrawal by Subject|0|||
27747236|NCT02778867|80902216|FG001|Phase 2|Withdrawal by Subject|0|||
27747237|NCT02778867|80902217|FG002|Phase 2|Withdrawal by Subject|1|||
27747238|NCT02778867|80902218|FG003|Phase 2|Withdrawal by Subject|0|||
27747239|NCT02778867|80902215|FG000|Phase 2|Physician Decision|0|||
27747240|NCT02778867|80902216|FG001|Phase 2|Physician Decision|0|||
27747241|NCT02778867|80902217|FG002|Phase 2|Physician Decision|0|||
27747242|NCT02778867|80902218|FG003|Phase 2|Physician Decision|1|||
27747243|NCT02778867|80902215|FG000|Phase 2|Adverse Event|0|||
27747244|NCT02778867|80902216|FG001|Phase 2|Adverse Event|0|||
27747245|NCT02778867|80902217|FG002|Phase 2|Adverse Event|0|||
27747246|NCT02778867|80902218|FG003|Phase 2|Adverse Event|1|||
27747247|NCT01915849|80902219|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
27747248|NCT01915849|80902220|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
27747249|NCT01915849|80902221|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
27747250|NCT01915849|80902222|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
27747251|NCT01915849|80902219|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
27747252|NCT01915849|80902220|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27747253|NCT01915849|80902221|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27747254|NCT01915849|80902222|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
27747255|NCT02564120|80902223|FG000|Overall Study|Did not return release forms|160|||
27747256|NCT02564120|80902223|FG000|Overall Study|Death|58|||
27747257|NCT02564120|80902223|FG000|Overall Study|Withdrawal by Subject|204|||
27747258|NCT02564120|80902223|FG000|Overall Study|Other medical condition|24|||
27747259|NCT01873742|80902224|FG000|Overall Study|Lost to Follow-up|68|||
27747260|NCT01873742|80902225|FG001|Overall Study|Lost to Follow-up|76|||
27747261|NCT04229446|80902226|FG000|Overall Study|Death|12|||
27747262|NCT04229446|80902227|FG001|Overall Study|Death|10|||
27747263|NCT04229446|80902226|FG000|Overall Study|Lost to Follow-up|5|||
27747264|NCT04229446|80902227|FG001|Overall Study|Lost to Follow-up|8|||
27747265|NCT02379923|80902228|FG000|Overall Study|Death|5|||
27747266|NCT00907478|80902231|FG000|Overall Study|Ineligibility determined|0|||
27747267|NCT00907478|80902232|FG001|Overall Study|Ineligibility determined|0|||
27747268|NCT00907478|80902233|FG002|Overall Study|Ineligibility determined|1|||
27747269|NCT00907478|80902231|FG000|Overall Study|Noncompliance|0|||
27747270|NCT00907478|80902232|FG001|Overall Study|Noncompliance|0|||
27747271|NCT00907478|80902233|FG002|Overall Study|Noncompliance|1|||
27747272|NCT00907478|80902231|FG000|Overall Study|Adverse Event|3|||
27747273|NCT00907478|80902232|FG001|Overall Study|Adverse Event|1|||
27747274|NCT00907478|80902233|FG002|Overall Study|Adverse Event|2|||
27747275|NCT00907478|80902231|FG000|Overall Study|Withdrawal by Subject|8|||
27747276|NCT00907478|80902232|FG001|Overall Study|Withdrawal by Subject|9|||
27747277|NCT00907478|80902233|FG002|Overall Study|Withdrawal by Subject|6|||
27747278|NCT00907478|80902231|FG000|Overall Study|Requirement for alternative therapy|1|||
27747279|NCT00907478|80902232|FG001|Overall Study|Requirement for alternative therapy|2|||
27747280|NCT00907478|80902233|FG002|Overall Study|Requirement for alternative therapy|3|||
27747281|NCT00907478|80902231|FG000|Overall Study|Physician Decision|2|||
27747282|NCT00907478|80902232|FG001|Overall Study|Physician Decision|0|||
27747283|NCT00907478|80902233|FG002|Overall Study|Physician Decision|3|||
27747284|NCT00907478|80902231|FG000|Overall Study|Death|4|||
27747285|NCT00907478|80902232|FG001|Overall Study|Death|2|||
27747286|NCT00907478|80902233|FG002|Overall Study|Death|1|||
27747287|NCT00907478|80902231|FG000|Overall Study|Protocol-specified criteria|5|||
27747288|NCT00907478|80902232|FG001|Overall Study|Protocol-specified criteria|2|||
27747289|NCT00907478|80902233|FG002|Overall Study|Protocol-specified criteria|3|||
27747290|NCT00907478|80902231|FG000|Overall Study|Pregnancy|0|||
27747291|NCT00907478|80902232|FG001|Overall Study|Pregnancy|1|||
27747292|NCT00907478|80902233|FG002|Overall Study|Pregnancy|1|||
27747293|NCT00907478|80902231|FG000|Overall Study|Lost to Follow-up|1|||
27747294|NCT00907478|80902232|FG001|Overall Study|Lost to Follow-up|0|||
27747295|NCT00907478|80902233|FG002|Overall Study|Lost to Follow-up|0|||
27747296|NCT00907478|80902231|FG000|Overall Study|Other|3|||
27747297|NCT00907478|80902232|FG001|Overall Study|Other|0|||
27747298|NCT00907478|80902233|FG002|Overall Study|Other|1|||
27747299|NCT03010423|80902234|FG000|Overall Study|Study termination|8|||
27747300|NCT00486226|80902235|FG000|Overall Study|Death|3|||
27747301|NCT00486226|80902235|FG000|Overall Study|Adverse Event|1|||
27747302|NCT00486226|80902235|FG000|Overall Study|Withdrawal by Subject|1|||
27747303|NCT00486226|80902235|FG000|Overall Study|Lost to Follow-up|8|||
27747304|NCT02518620|80902236|FG000|Overall Study|Adverse Event|23|||
27747305|NCT02518620|80902237|FG001|Overall Study|Adverse Event|11|||
27747306|NCT02518620|80902236|FG000|Overall Study|Lack of Efficacy|2|||
27747307|NCT02518620|80902237|FG001|Overall Study|Lack of Efficacy|0|||
27747308|NCT02518620|80902236|FG000|Overall Study|Non-Compliance with Study Drug|1|||
27747309|NCT02518620|80902237|FG001|Overall Study|Non-Compliance with Study Drug|0|||
27747310|NCT02518620|80902236|FG000|Overall Study|Physician Decision|1|||
27747311|NCT02518620|80902237|FG001|Overall Study|Physician Decision|1|||
27747312|NCT02518620|80902236|FG000|Overall Study|Sponsor's Decision|0|||
27747313|NCT02518620|80902237|FG001|Overall Study|Sponsor's Decision|3|||
27747314|NCT02518620|80902236|FG000|Overall Study|Lost to Follow-up|1|||
27747315|NCT02518620|80902237|FG001|Overall Study|Lost to Follow-up|1|||
27747316|NCT02518620|80902236|FG000|Overall Study|Withdrawal by Subject|17|||
27747317|NCT02518620|80902237|FG001|Overall Study|Withdrawal by Subject|9|||
27747318|NCT02518620|80902236|FG000|Overall Study|Death|1|||
27747319|NCT02518620|80902237|FG001|Overall Study|Death|0|||
27747320|NCT02518620|80902236|FG000|Overall Study|Pregnancy Wish|3|||
27747321|NCT02518620|80902237|FG001|Overall Study|Pregnancy Wish|0|||
27747322|NCT02518620|80902236|FG000|Overall Study|Pregnancy|1|||
27747323|NCT02518620|80902237|FG001|Overall Study|Pregnancy|0|||
27747324|NCT02518620|80902236|FG000|Overall Study|Relocation|2|||
27747325|NCT02518620|80902237|FG001|Overall Study|Relocation|1|||
27747326|NCT00521339|80902238|FG000|Treatment Phase|Adverse Event|2|||
27747327|NCT00521339|80902239|FG001|Treatment Phase|Adverse Event|0|||
27747328|NCT00521339|80902240|FG002|Treatment Phase|Adverse Event|0|||
27747329|NCT00521339|80902238|FG000|Treatment Phase|Intolerability to study drug|2|||
27747330|NCT00521339|80902239|FG001|Treatment Phase|Intolerability to study drug|0|||
27747331|NCT00521339|80902240|FG002|Treatment Phase|Intolerability to study drug|0|||
27747332|NCT00521339|80902238|FG000|Treatment Phase|Lack of Efficacy|3|||
27747333|NCT00521339|80902239|FG001|Treatment Phase|Lack of Efficacy|0|||
27747334|NCT00521339|80902240|FG002|Treatment Phase|Lack of Efficacy|0|||
27747335|NCT00521339|80902238|FG000|Treatment Phase|Withdrawal by Subject|3|||
27747336|NCT00521339|80902239|FG001|Treatment Phase|Withdrawal by Subject|0|||
27950067|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950068|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950069|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27950070|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
27747337|NCT00521339|80902240|FG002|Treatment Phase|Withdrawal by Subject|0|||
27747338|NCT00521339|80902238|FG000|Treatment Phase|Lost to Follow-up|1|||
27747339|NCT00521339|80902239|FG001|Treatment Phase|Lost to Follow-up|0|||
27747340|NCT00521339|80902240|FG002|Treatment Phase|Lost to Follow-up|0|||
27747341|NCT00521339|80902238|FG000|Treatment Phase|Protocol Violation|1|||
27747342|NCT00521339|80902239|FG001|Treatment Phase|Protocol Violation|0|||
27747343|NCT00521339|80902240|FG002|Treatment Phase|Protocol Violation|0|||
27950071|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950072|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27747344|NCT00521339|80902238|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
27747345|NCT00521339|80902239|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
27747346|NCT00521339|80902240|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
27747347|NCT00521339|80902238|FG000|Treatment Extension Phase|Death|0|||
27747348|NCT00521339|80902239|FG001|Treatment Extension Phase|Death|0|||
27747349|NCT00521339|80902240|FG002|Treatment Extension Phase|Death|1|||
27747350|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
27747351|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
27747352|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
27747353|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27747354|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27747355|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27747356|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27747357|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
27747358|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
27747359|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
27747360|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
27747361|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27747362|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27747363|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27747364|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27747365|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
27747366|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
27747367|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
27747368|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
27747369|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27747370|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27747371|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27747372|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27747373|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
27747374|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
27747375|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
27747376|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27747377|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27747378|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27747379|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27747380|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27747381|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
27747382|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
27747383|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
27747384|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
27747385|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27747386|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27747387|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27747388|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27747389|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
27747390|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
27747391|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
27747392|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27747393|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27747394|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27747395|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27747396|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27650544|NCT03851094|80560482|FG000|Overall Study|Withdrawal by Subject|0|||
27650545|NCT03851094|80560483|FG001|Overall Study|Withdrawal by Subject|1|||
27650546|NCT03851094|80560482|FG000|Overall Study|Participant lost device|0|||
27650547|NCT03851094|80560483|FG001|Overall Study|Participant lost device|1|||
27650548|NCT03851094|80560482|FG000|Overall Study|Participant returned device|0|||
27650549|NCT03851094|80560483|FG001|Overall Study|Participant returned device|2|||
27650550|NCT04328467|80560484|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
27650551|NCT04328467|80560485|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
27650552|NCT04328467|80560486|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
27650553|NCT03390166|80560489|FG000|Overall Study|Death|0|||
27650554|NCT03390166|80560490|FG001|Overall Study|Death|1|||
27650555|NCT03390166|80560489|FG000|Overall Study|Lost to Follow-up|6|||
27650556|NCT03390166|80560490|FG001|Overall Study|Lost to Follow-up|4|||
27650557|NCT03390166|80560489|FG000|Overall Study|Physician Decision|2|||
27650558|NCT03390166|80560490|FG001|Overall Study|Physician Decision|1|||
27650559|NCT03390166|80560489|FG000|Overall Study|Move from study area|3|||
27650560|NCT03390166|80560490|FG001|Overall Study|Move from study area|2|||
27650561|NCT03390166|80560489|FG000|Overall Study|To militarycamp for conscript|1|||
27650562|NCT03390166|80560490|FG001|Overall Study|To militarycamp for conscript|0|||
27650563|NCT03390166|80560489|FG000|Overall Study|To drug therapy course|0|||
27747397|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
27747398|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
27747399|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
27747400|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27747401|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27747402|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27747403|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27747404|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27747405|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
27747406|NCT01097616|80902241|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747407|NCT01097616|80902242|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747408|NCT01097616|80902243|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
27747409|NCT01097616|80902244|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747410|NCT01097616|80902245|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747411|NCT01097616|80902246|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747412|NCT01097616|80902247|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747413|NCT01097616|80902248|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
27747414|NCT01097616|80902241|FG000|Optional DB EXT Phase|Adverse Event|0|||
27747415|NCT01097616|80902242|FG001|Optional DB EXT Phase|Adverse Event|7|||
27747416|NCT01097616|80902243|FG002|Optional DB EXT Phase|Adverse Event|2|||
27747417|NCT01097616|80902244|FG003|Optional DB EXT Phase|Adverse Event|0|||
27747418|NCT01097616|80902245|FG004|Optional DB EXT Phase|Adverse Event|0|||
27747419|NCT01097616|80902246|FG005|Optional DB EXT Phase|Adverse Event|0|||
27747420|NCT01097616|80902247|FG006|Optional DB EXT Phase|Adverse Event|0|||
27747421|NCT01097616|80902248|FG007|Optional DB EXT Phase|Adverse Event|0|||
27747422|NCT01097616|80902241|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
27747423|NCT01097616|80902242|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
27747424|NCT01097616|80902243|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
27747425|NCT01097616|80902244|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
27747426|NCT01097616|80902245|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
27747427|NCT01097616|80902246|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
27747428|NCT01097616|80902247|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
27747429|NCT01097616|80902248|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
27747430|NCT01097616|80902241|FG000|Optional DB EXT Phase|Protocol Violation|0|||
27747431|NCT01097616|80902242|FG001|Optional DB EXT Phase|Protocol Violation|2|||
27747432|NCT01097616|80902243|FG002|Optional DB EXT Phase|Protocol Violation|3|||
27747433|NCT01097616|80902244|FG003|Optional DB EXT Phase|Protocol Violation|0|||
27747434|NCT01097616|80902245|FG004|Optional DB EXT Phase|Protocol Violation|0|||
27747435|NCT01097616|80902246|FG005|Optional DB EXT Phase|Protocol Violation|0|||
27747436|NCT01097616|80902247|FG006|Optional DB EXT Phase|Protocol Violation|0|||
27747437|NCT01097616|80902248|FG007|Optional DB EXT Phase|Protocol Violation|0|||
27747438|NCT01097616|80902241|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
27747439|NCT01097616|80902242|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
27747440|NCT01097616|80902243|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
27747441|NCT01097616|80902244|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
27747442|NCT01097616|80902245|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
27747443|NCT01097616|80902246|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
27747444|NCT01097616|80902247|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
27747445|NCT01097616|80902248|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
27747446|NCT01097616|80902241|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
27747447|NCT01097616|80902242|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
27747448|NCT01097616|80902243|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
27747449|NCT01097616|80902244|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
27747450|NCT01097616|80902245|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
27747451|NCT01097616|80902246|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
27747452|NCT01097616|80902247|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
27747453|NCT01097616|80902248|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
27747454|NCT01097616|80902241|FG000|Optional DB EXT Phase|Physician Decision|1|||
27747455|NCT01097616|80902242|FG001|Optional DB EXT Phase|Physician Decision|0|||
27747456|NCT01097616|80902243|FG002|Optional DB EXT Phase|Physician Decision|0|||
27747457|NCT01097616|80902244|FG003|Optional DB EXT Phase|Physician Decision|0|||
27747458|NCT01097616|80902245|FG004|Optional DB EXT Phase|Physician Decision|0|||
27747459|NCT01097616|80902246|FG005|Optional DB EXT Phase|Physician Decision|0|||
27747460|NCT01097616|80902247|FG006|Optional DB EXT Phase|Physician Decision|0|||
27747461|NCT01097616|80902248|FG007|Optional DB EXT Phase|Physician Decision|0|||
27747462|NCT01097616|80902241|FG000|DB RO Phase|Adverse Event|0|||
27747463|NCT01097616|80902242|FG001|DB RO Phase|Adverse Event|0|||
27747464|NCT01097616|80902243|FG002|DB RO Phase|Adverse Event|0|||
27747465|NCT01097616|80902244|FG003|DB RO Phase|Adverse Event|0|||
27747466|NCT01097616|80902245|FG004|DB RO Phase|Adverse Event|0|||
27747467|NCT01097616|80902246|FG005|DB RO Phase|Adverse Event|0|||
27747468|NCT01097616|80902247|FG006|DB RO Phase|Adverse Event|1|||
27747469|NCT01097616|80902248|FG007|DB RO Phase|Adverse Event|0|||
27747470|NCT01097616|80902241|FG000|DB RO Phase|Withdrawal by Subject|0|||
27747471|NCT01097616|80902242|FG001|DB RO Phase|Withdrawal by Subject|0|||
27747472|NCT01097616|80902243|FG002|DB RO Phase|Withdrawal by Subject|0|||
27747473|NCT01097616|80902244|FG003|DB RO Phase|Withdrawal by Subject|0|||
27747474|NCT01097616|80902245|FG004|DB RO Phase|Withdrawal by Subject|0|||
27747475|NCT01097616|80902246|FG005|DB RO Phase|Withdrawal by Subject|1|||
27747476|NCT01097616|80902247|FG006|DB RO Phase|Withdrawal by Subject|0|||
27747477|NCT01097616|80902248|FG007|DB RO Phase|Withdrawal by Subject|0|||
27747478|NCT01097616|80902241|FG000|DB RO Phase|Lost to Follow-up|0|||
27747479|NCT01097616|80902242|FG001|DB RO Phase|Lost to Follow-up|0|||
27747480|NCT01097616|80902243|FG002|DB RO Phase|Lost to Follow-up|0|||
27747481|NCT01097616|80902244|FG003|DB RO Phase|Lost to Follow-up|1|||
27747482|NCT01097616|80902245|FG004|DB RO Phase|Lost to Follow-up|1|||
27747483|NCT01097616|80902246|FG005|DB RO Phase|Lost to Follow-up|0|||
27747484|NCT01097616|80902247|FG006|DB RO Phase|Lost to Follow-up|0|||
27747485|NCT01097616|80902248|FG007|DB RO Phase|Lost to Follow-up|1|||
27747486|NCT01097616|80902241|FG000|DB RO Phase|Not Treated in RO|0|||
27747487|NCT01097616|80902242|FG001|DB RO Phase|Not Treated in RO|0|||
27747488|NCT01097616|80902243|FG002|DB RO Phase|Not Treated in RO|0|||
27747489|NCT01097616|80902244|FG003|DB RO Phase|Not Treated in RO|0|||
27747490|NCT01097616|80902245|FG004|DB RO Phase|Not Treated in RO|0|||
27747491|NCT01097616|80902246|FG005|DB RO Phase|Not Treated in RO|1|||
27747492|NCT01097616|80902247|FG006|DB RO Phase|Not Treated in RO|0|||
27747493|NCT01097616|80902248|FG007|DB RO Phase|Not Treated in RO|0|||
27747494|NCT00769704|80902249|FG000|Overall Study|Lost to Follow-up|3|||
27747495|NCT00769704|80902250|FG001|Overall Study|Lost to Follow-up|2|||
27747496|NCT00769704|80902249|FG000|Overall Study|Death|95|||
27747497|NCT00769704|80902250|FG001|Overall Study|Death|190|||
27747498|NCT00769704|80902249|FG000|Overall Study|Withdrawal by Subject|12|||
27747499|NCT00769704|80902250|FG001|Overall Study|Withdrawal by Subject|5|||
27747500|NCT00769704|80902249|FG000|Overall Study|Other|1|||
27747501|NCT00769704|80902250|FG001|Overall Study|Other|2|||
27747502|NCT00935220|80902251|FG000|Overall Study|Adverse Event|1|||
27747503|NCT00935220|80902251|FG000|Overall Study|Other reason (not specified)|1|||
27747504|NCT03648996|80902252|FG000|Overall Study|Withdrawal by Subject|0|||
27747505|NCT03648996|80902253|FG001|Overall Study|Withdrawal by Subject|2|||
27747506|NCT03648996|80902254|FG002|Overall Study|Withdrawal by Subject|2|||
27747507|NCT03648996|80902252|FG000|Overall Study|Physician Decision|2|||
27747508|NCT03648996|80902253|FG001|Overall Study|Physician Decision|0|||
27747509|NCT03648996|80902254|FG002|Overall Study|Physician Decision|0|||
27747510|NCT00893113|80902255|FG000|Overall Study|Lost to Follow-up|4|||
27747511|NCT00893113|80902256|FG001|Overall Study|Lost to Follow-up|8|||
27747512|NCT00893113|80902255|FG000|Overall Study|Early Termination|1|||
27747513|NCT00893113|80902256|FG001|Overall Study|Early Termination|1|||
27747514|NCT00893113|80902255|FG000|Overall Study|Withdrew Consent|8|||
27747515|NCT00893113|80902256|FG001|Overall Study|Withdrew Consent|7|||
27747516|NCT01152450|80902257|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
27747517|NCT01152450|80902258|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
27747518|NCT01152450|80902259|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
27747519|NCT01152450|80902260|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
27747520|NCT01152450|80902261|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
27747521|NCT01152450|80902262|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
27747522|NCT01152450|80902257|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
27747523|NCT01152450|80902258|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
27747524|NCT01152450|80902259|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
27747525|NCT01152450|80902260|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
27747526|NCT01152450|80902261|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
27747527|NCT01152450|80902262|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
27747528|NCT01152450|80902257|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27747529|NCT01152450|80902258|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
27747530|NCT01152450|80902259|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
27747531|NCT01152450|80902260|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27747532|NCT01152450|80902261|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27747533|NCT01152450|80902262|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
27747534|NCT01671085|80902263|FG000|Overall Study|Withdrawal by Subject|1|||
27747535|NCT01671085|80902264|FG001|Overall Study|Withdrawal by Subject|0|||
27747536|NCT00365976|80902271|FG000|Overall Study|Withdrawal by Subject|1|||
27747537|NCT00365976|80902272|FG001|Overall Study|Withdrawal by Subject|5|||
27747538|NCT00114972|80902275|FG000|Overall Study|Withdrawal by Subject|40|||
27747539|NCT00114972|80902276|FG001|Overall Study|Withdrawal by Subject|7|||
27747540|NCT00114972|80902275|FG000|Overall Study|Lost to Follow-up|8|||
27747541|NCT00114972|80902276|FG001|Overall Study|Lost to Follow-up|5|||
27747542|NCT04743635|80902277|FG000|Overall Study|Lost to Follow-up|2|||
27747543|NCT04743635|80902278|FG001|Overall Study|Lost to Follow-up|0|||
27747544|NCT01703819|80902281|FG000|Overall Study|Adverse Event|0|||
27747545|NCT01703819|80902282|FG001|Overall Study|Adverse Event|1|||
27747546|NCT01703819|80902281|FG000|Overall Study|Withdrawal by Subject|0|||
27747547|NCT01703819|80902282|FG001|Overall Study|Withdrawal by Subject|1|||
27747548|NCT01757704|80902283|FG000|Overall Study|Protocol Violation|1|||
27747549|NCT01757704|80902284|FG001|Overall Study|Protocol Violation|3|||
27747550|NCT04328623|80902285|FG000|Overall Study|Protocol Violation|0|||
27747551|NCT04328623|80902286|FG001|Overall Study|Protocol Violation|1|||
27747552|NCT02584634|80902288|FG000|Overall Study|Adverse Event|3|||
27747553|NCT02584634|80902289|FG001|Overall Study|Adverse Event|5|||
27747554|NCT02584634|80902288|FG000|Overall Study|Death|0|||
27747555|NCT02584634|80902289|FG001|Overall Study|Death|1|||
27747556|NCT02584634|80902288|FG000|Overall Study|Lost to Follow-up|0|||
27747557|NCT02584634|80902289|FG001|Overall Study|Lost to Follow-up|1|||
27747558|NCT02584634|80902288|FG000|Overall Study|Physician Decision|1|||
27747559|NCT02584634|80902289|FG001|Overall Study|Physician Decision|2|||
27747560|NCT02584634|80902288|FG000|Overall Study|Progressive disease|7|||
27747561|NCT02584634|80902289|FG001|Overall Study|Progressive disease|15|||
27747562|NCT02584634|80902288|FG000|Overall Study|Withdrawal by Subject|1|||
27747563|NCT02584634|80902289|FG001|Overall Study|Withdrawal by Subject|1|||
27747564|NCT02584634|80902288|FG000|Overall Study|Other|0|||
27747565|NCT02584634|80902289|FG001|Overall Study|Other|6|||
27747566|NCT01666444|80902291|FG000|Overall Study|Did not initiate treatment|2|||
27747567|NCT01666444|80902292|FG001|Overall Study|Did not initiate treatment|1|||
27747568|NCT03153111|80902293|FG000|Overall Study|Death|2|||
27747569|NCT03153111|80902294|FG001|Overall Study|Death|5|||
27747570|NCT03153111|80902293|FG000|Overall Study|Lost to Follow-up|1|||
27747571|NCT03153111|80902294|FG001|Overall Study|Lost to Follow-up|0|||
27747572|NCT03153111|80902293|FG000|Overall Study|Physician Decision|5|||
27747573|NCT03153111|80902294|FG001|Overall Study|Physician Decision|1|||
27747574|NCT03153111|80902293|FG000|Overall Study|Withdrawal by Subject|3|||
27747575|NCT03153111|80902294|FG001|Overall Study|Withdrawal by Subject|3|||
27747576|NCT01097330|80902299|FG000|Overall Study|Study terminated early|7|||
27747577|NCT01097330|80902300|FG001|Overall Study|Study terminated early|5|||
27747578|NCT00536731|80902301|FG000|Overall Study|Adverse Event|3|||
27747579|NCT00536731|80902302|FG001|Overall Study|Adverse Event|2|||
27747580|NCT00536731|80902303|FG002|Overall Study|Adverse Event|3|||
27747581|NCT00536731|80902301|FG000|Overall Study|Withdrawal by Subject|0|||
27747582|NCT00536731|80902302|FG001|Overall Study|Withdrawal by Subject|2|||
27747583|NCT00536731|80902303|FG002|Overall Study|Withdrawal by Subject|0|||
27747584|NCT00536731|80902301|FG000|Overall Study|Intake of prohibited conc. medication|0|||
27747585|NCT00536731|80902302|FG001|Overall Study|Intake of prohibited conc. medication|0|||
27747586|NCT00536731|80902303|FG002|Overall Study|Intake of prohibited conc. medication|1|||
27747587|NCT00536731|80902301|FG000|Overall Study|Safety reasons|0|||
27747588|NCT00536731|80902302|FG001|Overall Study|Safety reasons|0|||
27747589|NCT00536731|80902303|FG002|Overall Study|Safety reasons|1|||
27747590|NCT00536731|80902301|FG000|Overall Study|Other|1|||
27747591|NCT00536731|80902302|FG001|Overall Study|Other|1|||
27747592|NCT00536731|80902303|FG002|Overall Study|Other|0|||
27747593|NCT01520324|80902304|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
27747594|NCT02650284|80902305|FG000|Overall Study|Lost to Follow-up|3|||
27747595|NCT02650284|80902306|FG001|Overall Study|Lost to Follow-up|3|||
27747596|NCT02650284|80902305|FG000|Overall Study|Consent incorrectly taken|0|||
27747597|NCT02650284|80902306|FG001|Overall Study|Consent incorrectly taken|1|||
27747598|NCT00878072|80902307|FG000|Overall Study|Withdrew consent|2|||
27747599|NCT00651118|80902308|FG000|Overall Study|Adverse Event|4|||
27747600|NCT00651118|80902309|FG001|Overall Study|Adverse Event|0|||
27747601|NCT00651118|80902310|FG002|Overall Study|Adverse Event|1|||
27747602|NCT00651118|80902311|FG003|Overall Study|Adverse Event|1|||
27747603|NCT00651118|80902308|FG000|Overall Study|Protocol Violation|2|||
27747604|NCT00651118|80902309|FG001|Overall Study|Protocol Violation|2|||
27747605|NCT00651118|80902310|FG002|Overall Study|Protocol Violation|6|||
27747606|NCT00651118|80902311|FG003|Overall Study|Protocol Violation|2|||
27747607|NCT00651118|80902308|FG000|Overall Study|Lost to Follow-up|2|||
27747608|NCT00651118|80902309|FG001|Overall Study|Lost to Follow-up|0|||
27747609|NCT00651118|80902310|FG002|Overall Study|Lost to Follow-up|1|||
27747610|NCT00651118|80902311|FG003|Overall Study|Lost to Follow-up|2|||
27747611|NCT00651118|80902308|FG000|Overall Study|administrative|1|||
27747612|NCT00651118|80902309|FG001|Overall Study|administrative|4|||
27747613|NCT00651118|80902310|FG002|Overall Study|administrative|2|||
27747614|NCT00651118|80902311|FG003|Overall Study|administrative|1|||
27747615|NCT00651118|80902308|FG000|Overall Study|Withdrawal by Subject|0|||
27747616|NCT00651118|80902309|FG001|Overall Study|Withdrawal by Subject|1|||
27747617|NCT00651118|80902310|FG002|Overall Study|Withdrawal by Subject|1|||
27747618|NCT00651118|80902311|FG003|Overall Study|Withdrawal by Subject|1|||
27747619|NCT00804193|80902318|FG000|Overall Study|Lack of baseline fungus|32|||
27747620|NCT00804193|80902319|FG001|Overall Study|Lack of baseline fungus|31|||
27747621|NCT00804193|80902320|FG002|Overall Study|Lack of baseline fungus|19|||
27747622|NCT00804193|80902318|FG000|Overall Study|Adverse Event|0|||
27747623|NCT00804193|80902319|FG001|Overall Study|Adverse Event|0|||
27747624|NCT00804193|80902320|FG002|Overall Study|Adverse Event|2|||
27747625|NCT00804193|80902318|FG000|Overall Study|Lack of Efficacy|1|||
27747626|NCT00804193|80902319|FG001|Overall Study|Lack of Efficacy|1|||
27747627|NCT00804193|80902320|FG002|Overall Study|Lack of Efficacy|3|||
27747628|NCT00804193|80902318|FG000|Overall Study|Protocol Violation|0|||
27747629|NCT00804193|80902319|FG001|Overall Study|Protocol Violation|8|||
27747630|NCT00804193|80902320|FG002|Overall Study|Protocol Violation|2|||
27747631|NCT00804193|80902318|FG000|Overall Study|Lost to Follow-up|3|||
27747632|NCT00804193|80902319|FG001|Overall Study|Lost to Follow-up|3|||
27747633|NCT00804193|80902320|FG002|Overall Study|Lost to Follow-up|4|||
27747634|NCT00804193|80902318|FG000|Overall Study|Withdrawal by Subject|3|||
27747635|NCT00804193|80902319|FG001|Overall Study|Withdrawal by Subject|1|||
27747636|NCT00804193|80902320|FG002|Overall Study|Withdrawal by Subject|2|||
27747637|NCT01372878|80902321|FG000|Overall Study|Withdrawal by Subject|63|||
27747638|NCT01372878|80902321|FG000|Overall Study|Protocol Violation|17|||
27747639|NCT01372878|80902321|FG000|Overall Study|incomplete study procedure|104|||
27747640|NCT02092389|80902323|FG000|Overall Study|Adverse Event|1|||
27747641|NCT02092389|80902323|FG000|Overall Study|Other|5|||
27747642|NCT01753115|80902324|FG000|Overall Study|Lost to Follow-up|3|||
27747643|NCT01753115|80902325|FG001|Overall Study|Lost to Follow-up|6|||
27747644|NCT01753115|80902326|FG002|Overall Study|Lost to Follow-up|8|||
27747645|NCT01753115|80902324|FG000|Overall Study|Withdrawal by Subject|6|||
27747646|NCT01753115|80902325|FG001|Overall Study|Withdrawal by Subject|5|||
27747647|NCT01753115|80902326|FG002|Overall Study|Withdrawal by Subject|6|||
27747648|NCT01753115|80902324|FG000|Overall Study|Subject non-compliant|3|||
27747649|NCT01753115|80902325|FG001|Overall Study|Subject non-compliant|3|||
27747650|NCT01753115|80902326|FG002|Overall Study|Subject non-compliant|0|||
27747651|NCT01753115|80902324|FG000|Overall Study|Used excluded drug|0|||
27747652|NCT01753115|80902325|FG001|Overall Study|Used excluded drug|1|||
27747653|NCT01753115|80902326|FG002|Overall Study|Used excluded drug|0|||
27747654|NCT02160977|80902329|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
27747655|NCT02160977|80902330|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
27747656|NCT02160977|80902329|FG000|Three Months After Surgery|Lost to Follow-up|0|||
27747657|NCT02160977|80902330|FG001|Three Months After Surgery|Lost to Follow-up|2|||
27747658|NCT02160977|80902329|FG000|Six Months After Surgery|Lost to Follow-up|2|||
27747659|NCT02160977|80902330|FG001|Six Months After Surgery|Lost to Follow-up|1|||
27747660|NCT02207530|80902331|FG000|Overall Study|Worsening condition under investigation|78|||
27747661|NCT02207530|80902331|FG000|Overall Study|Patient decision to stop study treatment|5|||
27747662|NCT02207530|80902331|FG000|Overall Study|Adverse Event|8|||
27747663|NCT02807454|80902334|FG000|Overall Study|Adverse Event|1|||
27747664|NCT02807454|80902335|FG001|Overall Study|Adverse Event|0|||
27747665|NCT02807454|80902334|FG000|Overall Study|Withdrawal by Subject|0|||
27747666|NCT02807454|80902335|FG001|Overall Study|Withdrawal by Subject|1|||
27747667|NCT02807454|80902334|FG000|Overall Study|Progressive Disease|30|||
27747668|NCT02807454|80902335|FG001|Overall Study|Progressive Disease|3|||
27747669|NCT02807454|80902334|FG000|Overall Study|Other Reasons|1|||
27747670|NCT02807454|80902335|FG001|Overall Study|Other Reasons|1|||
27747671|NCT01629667|80902336|FG000|Overall Study|Lost to Follow-up|0|||
27747672|NCT01629667|80902337|FG001|Overall Study|Lost to Follow-up|1|||
27747673|NCT01629667|80902338|FG002|Overall Study|Lost to Follow-up|1|||
27747674|NCT01629667|80902336|FG000|Overall Study|Withdrawal by Subject|31|||
27747675|NCT01629667|80902337|FG001|Overall Study|Withdrawal by Subject|20|||
27747676|NCT01629667|80902338|FG002|Overall Study|Withdrawal by Subject|28|||
27747677|NCT01629667|80902336|FG000|Overall Study|Death|1|||
27747678|NCT01629667|80902337|FG001|Overall Study|Death|5|||
27747679|NCT01629667|80902338|FG002|Overall Study|Death|3|||
27747680|NCT01629667|80902336|FG000|Overall Study|Randomized, not treated|2|||
27747681|NCT01629667|80902337|FG001|Overall Study|Randomized, not treated|1|||
27747682|NCT01629667|80902338|FG002|Overall Study|Randomized, not treated|0|||
27747683|NCT01629667|80902336|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
27747684|NCT01629667|80902337|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
27747685|NCT01629667|80902338|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
27747686|NCT01629667|80902336|FG000|Overall Study|Requiring lung transplant|2|||
27747687|NCT01629667|80902337|FG001|Overall Study|Requiring lung transplant|1|||
27747688|NCT01629667|80902338|FG002|Overall Study|Requiring lung transplant|3|||
27747689|NCT01629667|80902336|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
27747690|NCT01629667|80902337|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
27747691|NCT01629667|80902338|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
27747692|NCT01629667|80902336|FG000|Overall Study|Started other medicine|1|||
27747693|NCT01629667|80902337|FG001|Overall Study|Started other medicine|0|||
27747694|NCT01629667|80902338|FG002|Overall Study|Started other medicine|1|||
27747695|NCT01629667|80902336|FG000|Overall Study|Site error in safety follow-up|0|||
27747696|NCT01629667|80902337|FG001|Overall Study|Site error in safety follow-up|0|||
27747697|NCT01629667|80902338|FG002|Overall Study|Site error in safety follow-up|1|||
27747698|NCT01629667|80902336|FG000|Overall Study|Enrolled in another clinical study|0|||
27747699|NCT01629667|80902337|FG001|Overall Study|Enrolled in another clinical study|1|||
27747700|NCT01629667|80902338|FG002|Overall Study|Enrolled in another clinical study|0|||
27747701|NCT01629667|80902336|FG000|Overall Study|Code break|1|||
27747702|NCT01629667|80902337|FG001|Overall Study|Code break|0|||
27747703|NCT01629667|80902338|FG002|Overall Study|Code break|0|||
27747704|NCT01539837|80902339|FG000|Overall Study|reduce neutrophil level|0|||
27747705|NCT01539837|80902340|FG001|Overall Study|reduce neutrophil level|1|||
27747706|NCT01539837|80902341|FG002|Overall Study|reduce neutrophil level|1|||
27747707|NCT01539837|80902339|FG000|Overall Study|bad compliance|0|||
27747708|NCT01539837|80902340|FG001|Overall Study|bad compliance|0|||
27747709|NCT01539837|80902341|FG002|Overall Study|bad compliance|1|||
27747710|NCT00637273|80902342|FG000|Overall Study|Adverse Event|11|||
27747711|NCT00637273|80902343|FG001|Overall Study|Adverse Event|5|||
27747712|NCT00637273|80902344|FG002|Overall Study|Adverse Event|7|||
27747713|NCT00637273|80902342|FG000|Overall Study|Lost to Follow-up|8|||
27747714|NCT00637273|80902343|FG001|Overall Study|Lost to Follow-up|9|||
27747715|NCT00637273|80902344|FG002|Overall Study|Lost to Follow-up|13|||
27747716|NCT00637273|80902342|FG000|Overall Study|Protocol Violation|2|||
27747717|NCT00637273|80902343|FG001|Overall Study|Protocol Violation|4|||
27747718|NCT00637273|80902344|FG002|Overall Study|Protocol Violation|1|||
27747719|NCT00637273|80902342|FG000|Overall Study|Withdrawal of Consent|18|||
27747720|NCT00637273|80902343|FG001|Overall Study|Withdrawal of Consent|6|||
27747721|NCT00637273|80902344|FG002|Overall Study|Withdrawal of Consent|18|||
27747722|NCT00637273|80902342|FG000|Overall Study|Investigator Decision|1|||
27747723|NCT00637273|80902343|FG001|Overall Study|Investigator Decision|3|||
27747724|NCT00637273|80902344|FG002|Overall Study|Investigator Decision|1|||
27747725|NCT00637273|80902342|FG000|Overall Study|Administrative|2|||
27747726|NCT00637273|80902343|FG001|Overall Study|Administrative|0|||
27747727|NCT00637273|80902344|FG002|Overall Study|Administrative|0|||
27747728|NCT00637273|80902342|FG000|Overall Study|Loss of Glucose Control|1|||
27747729|NCT00637273|80902343|FG001|Overall Study|Loss of Glucose Control|1|||
27747730|NCT00637273|80902344|FG002|Overall Study|Loss of Glucose Control|1|||
27747731|NCT01106534|80902345|FG000|Overall Study|Withdrawal by Subject|18|||
27747732|NCT01106534|80902345|FG000|Overall Study|Lost to Follow-up|2|||
27747733|NCT01106534|80902345|FG000|Overall Study|Death|16|||
27747734|NCT01106534|80902345|FG000|Overall Study|Physician Decision|1|||
27747735|NCT01963117|80902346|FG000|Overall Study|Death|1|||
27747736|NCT02452970|80902354|FG000|Overall Study|Adverse Event|1|||
27747737|NCT02209597|80902360|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
27747738|NCT02209597|80902360|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
27747739|NCT02209597|80902360|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
27747740|NCT02209597|80902360|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
27747741|NCT03042611|80902365|FG000|Core Phase|Withdrawal by Subject|13|||
27747742|NCT03042611|80902366|FG001|Core Phase|Withdrawal by Subject|4|||
27747743|NCT03042611|80902367|FG002|Core Phase|Withdrawal by Subject|0|||
27747744|NCT03042611|80902368|FG003|Core Phase|Withdrawal by Subject|0|||
27747745|NCT03042611|80902365|FG000|Core Phase|Death|232|||
27747746|NCT03042611|80902366|FG001|Core Phase|Death|110|||
27747747|NCT03042611|80902367|FG002|Core Phase|Death|0|||
27747748|NCT03042611|80902368|FG003|Core Phase|Death|0|||
27747749|NCT03042611|80902365|FG000|Core Phase|Lost to Follow-up|4|||
27747750|NCT03042611|80902366|FG001|Core Phase|Lost to Follow-up|7|||
27747751|NCT03042611|80902367|FG002|Core Phase|Lost to Follow-up|0|||
27747752|NCT03042611|80902368|FG003|Core Phase|Lost to Follow-up|0|||
27747753|NCT03042611|80902365|FG000|Core Phase|Physician Decision|7|||
27747754|NCT03042611|80902366|FG001|Core Phase|Physician Decision|2|||
27747755|NCT03042611|80902367|FG002|Core Phase|Physician Decision|0|||
27747756|NCT03042611|80902368|FG003|Core Phase|Physician Decision|0|||
27747757|NCT03042611|80902365|FG000|Core Phase|Study Closed|0|||
27747758|NCT03042611|80902366|FG001|Core Phase|Study Closed|1|||
27747759|NCT03042611|80902367|FG002|Core Phase|Study Closed|0|||
27747760|NCT03042611|80902368|FG003|Core Phase|Study Closed|0|||
27747761|NCT03042611|80902365|FG000|Extension Phase|Death|0|||
27747762|NCT03042611|80902366|FG001|Extension Phase|Death|0|||
27747763|NCT03042611|80902367|FG002|Extension Phase|Death|34|||
27747764|NCT03042611|80902368|FG003|Extension Phase|Death|16|||
27747765|NCT03042611|80902365|FG000|Extension Phase|Lost to Follow-up|0|||
27747766|NCT03042611|80902366|FG001|Extension Phase|Lost to Follow-up|0|||
27747767|NCT03042611|80902367|FG002|Extension Phase|Lost to Follow-up|1|||
27747768|NCT03042611|80902368|FG003|Extension Phase|Lost to Follow-up|1|||
27650564|NCT03390166|80560490|FG001|Overall Study|To drug therapy course|1|||
27747769|NCT03042611|80902365|FG000|Extension Phase|Study Closed|0|||
27747770|NCT03042611|80902366|FG001|Extension Phase|Study Closed|0|||
27747771|NCT03042611|80902367|FG002|Extension Phase|Study Closed|17|||
27747772|NCT03042611|80902368|FG003|Extension Phase|Study Closed|11|||
27747773|NCT02619253|80902369|FG000|Overall Study|Adverse Event|0|||
27747774|NCT02619253|80902370|FG001|Overall Study|Adverse Event|0|||
27650565|NCT03390166|80560489|FG000|Overall Study|Move to work oversea|0|||
27747775|NCT02619253|80902371|FG002|Overall Study|Adverse Event|1|||
27747776|NCT02619253|80902372|FG003|Overall Study|Adverse Event|1|||
27747777|NCT02619253|80902373|FG004|Overall Study|Adverse Event|3|||
27747778|NCT02619253|80902369|FG000|Overall Study|Alternative Therapy|0|||
27747779|NCT02619253|80902370|FG001|Overall Study|Alternative Therapy|0|||
27650566|NCT03390166|80560490|FG001|Overall Study|Move to work oversea|1|||
27650567|NCT00963924|80560491|FG000|Overall Study|Adverse Event|1|||
27747780|NCT02619253|80902371|FG002|Overall Study|Alternative Therapy|1|||
27747781|NCT02619253|80902372|FG003|Overall Study|Alternative Therapy|0|||
27747782|NCT02619253|80902373|FG004|Overall Study|Alternative Therapy|0|||
27747783|NCT02619253|80902369|FG000|Overall Study|Death|0|||
27747784|NCT02619253|80902370|FG001|Overall Study|Death|0|||
27747785|NCT02619253|80902371|FG002|Overall Study|Death|0|||
27747786|NCT02619253|80902372|FG003|Overall Study|Death|1|||
27747787|NCT02619253|80902373|FG004|Overall Study|Death|0|||
27747788|NCT02619253|80902369|FG000|Overall Study|Disease Progression|4|||
27747789|NCT02619253|80902370|FG001|Overall Study|Disease Progression|2|||
27747790|NCT02619253|80902371|FG002|Overall Study|Disease Progression|8|||
27747791|NCT02619253|80902372|FG003|Overall Study|Disease Progression|9|||
27747792|NCT02619253|80902373|FG004|Overall Study|Disease Progression|10|||
27747793|NCT02619253|80902369|FG000|Overall Study|Needed a disqualifying therapy|0|||
27747794|NCT02619253|80902370|FG001|Overall Study|Needed a disqualifying therapy|0|||
27747795|NCT02619253|80902371|FG002|Overall Study|Needed a disqualifying therapy|1|||
27747796|NCT02619253|80902372|FG003|Overall Study|Needed a disqualifying therapy|0|||
27747797|NCT02619253|80902373|FG004|Overall Study|Needed a disqualifying therapy|0|||
27747798|NCT02619253|80902369|FG000|Overall Study|Transferred to hospice|0|||
27747799|NCT02619253|80902370|FG001|Overall Study|Transferred to hospice|0|||
27747800|NCT02619253|80902371|FG002|Overall Study|Transferred to hospice|1|||
27747801|NCT02619253|80902372|FG003|Overall Study|Transferred to hospice|0|||
27747802|NCT02619253|80902373|FG004|Overall Study|Transferred to hospice|0|||
27747803|NCT02619253|80902369|FG000|Overall Study|Physician Decision|0|||
27747804|NCT02619253|80902370|FG001|Overall Study|Physician Decision|1|||
27747805|NCT02619253|80902371|FG002|Overall Study|Physician Decision|2|||
27747806|NCT02619253|80902372|FG003|Overall Study|Physician Decision|3|||
27747807|NCT02619253|80902373|FG004|Overall Study|Physician Decision|0|||
27747808|NCT02619253|80902369|FG000|Overall Study|Withdrawal by Subject|0|||
27747809|NCT02619253|80902370|FG001|Overall Study|Withdrawal by Subject|1|||
27747810|NCT02619253|80902371|FG002|Overall Study|Withdrawal by Subject|0|||
27747811|NCT02619253|80902372|FG003|Overall Study|Withdrawal by Subject|0|||
27747812|NCT02619253|80902373|FG004|Overall Study|Withdrawal by Subject|2|||
27747813|NCT02853331|80903686|FG000|Overall Study|Death|59|||
27747814|NCT02853331|80903687|FG001|Overall Study|Death|95|||
27747815|NCT02853331|80903686|FG000|Overall Study|Withdrawal by Subject|5|||
27747816|NCT02853331|80903687|FG001|Overall Study|Withdrawal by Subject|9|||
27747817|NCT02853331|80903686|FG000|Overall Study|Ongoing in study|368|||
27747818|NCT02853331|80903687|FG001|Overall Study|Ongoing in study|325|||
27747819|NCT03762850|80903688|FG000|Overall Study|Death|0|||
27747820|NCT03762850|80903689|FG001|Overall Study|Death|1|||
27747821|NCT03762850|80903688|FG000|Overall Study|Lost to Follow-up|0|||
27747822|NCT03762850|80903689|FG001|Overall Study|Lost to Follow-up|1|||
27747823|NCT03762850|80903688|FG000|Overall Study|Physician Decision|0|||
27747824|NCT03762850|80903689|FG001|Overall Study|Physician Decision|1|||
27747825|NCT03762850|80903688|FG000|Overall Study|Withdrawal by Subject|4|||
27747826|NCT03762850|80903689|FG001|Overall Study|Withdrawal by Subject|9|||
27747827|NCT04752189|80903690|FG000|Overall Study|Withdrawal by Subject|0|||
27747828|NCT04752189|80903691|FG001|Overall Study|Withdrawal by Subject|150|||
27747829|NCT04752189|80903690|FG000|Overall Study|Lost to Follow-up|261|||
27747830|NCT04752189|80903691|FG001|Overall Study|Lost to Follow-up|126|||
27747831|NCT00611455|80903696|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
27747832|NCT00611455|80903697|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
27747833|NCT00611455|80903698|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
27747834|NCT00611455|80903696|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
27747835|NCT00611455|80903697|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27747836|NCT00611455|80903698|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
27747837|NCT00611455|80903696|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
27747838|NCT00611455|80903697|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
27747839|NCT00611455|80903698|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
27747840|NCT00611455|80903696|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
27747841|NCT00611455|80903697|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
27747842|NCT00611455|80903698|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
27747843|NCT00611455|80903696|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
27747844|NCT00611455|80903697|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
27747845|NCT00611455|80903698|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
27747846|NCT00611455|80903696|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
27747847|NCT00611455|80903697|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
27747848|NCT00611455|80903698|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
27747849|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27747850|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
27747851|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
27747852|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27747853|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
27747854|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
27747855|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27747856|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
27747857|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
27747858|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27747859|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
27747860|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
27747861|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27747862|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
27747863|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
27747864|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
27747865|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
27747866|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
27747867|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27747868|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
27747869|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
27747870|NCT00611455|80903696|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27747871|NCT00611455|80903697|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
27747872|NCT00611455|80903698|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
27747873|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
27747874|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
27747875|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
27747876|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
27747877|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
27747878|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
27747879|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
27747880|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
27747881|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
27747882|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
27747883|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
27747884|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
27747885|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
27747886|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
27747887|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
27747888|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
27747889|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
27747890|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
27747891|NCT00611455|80903696|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
27747892|NCT00611455|80903697|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
27747893|NCT00611455|80903698|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
27747894|NCT03422133|80903699|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
27747895|NCT03422133|80903700|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
27747896|NCT04003636|80903701|FG000|Overall Study|Death|409|||
27747897|NCT04003636|80903702|FG001|Overall Study|Death|443|||
27747898|NCT04003636|80903701|FG000|Overall Study|Lost to Follow-up|0|||
27747899|NCT04003636|80903702|FG001|Overall Study|Lost to Follow-up|1|||
27747900|NCT04003636|80903701|FG000|Overall Study|Withdrawal by Subject|5|||
27747901|NCT04003636|80903702|FG001|Overall Study|Withdrawal by Subject|2|||
27747902|NCT04003636|80903701|FG000|Overall Study|Participant On-going|119|||
27747903|NCT04003636|80903702|FG001|Overall Study|Participant On-going|90|||
27747904|NCT05232097|80903703|FG000|Overall Study|Physician Decision|1|||
27747905|NCT04489771|80903704|FG000|Overall Study|Death|27|||
27747906|NCT04489771|80903705|FG001|Overall Study|Death|25|||
27747907|NCT04489771|80903704|FG000|Overall Study|Withdrawal by Subject|1|||
27747908|NCT04489771|80903705|FG001|Overall Study|Withdrawal by Subject|0|||
27747909|NCT04489771|80903704|FG000|Overall Study|Participants Ongoing in Study|50|||
27747910|NCT04489771|80903705|FG001|Overall Study|Participants Ongoing in Study|51|||
27747911|NCT03493685|80903706|FG000|Overall Study|Death|4|||
27747912|NCT03493685|80903707|FG001|Overall Study|Death|3|||
27747913|NCT03493685|80903706|FG000|Overall Study|Lost to Follow-up|3|||
27747914|NCT03493685|80903707|FG001|Overall Study|Lost to Follow-up|2|||
27747915|NCT03493685|80903706|FG000|Overall Study|Physician Decision|2|||
27747916|NCT03493685|80903707|FG001|Overall Study|Physician Decision|0|||
27747917|NCT03493685|80903706|FG000|Overall Study|Withdrawal by Subject|7|||
27950073|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950074|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950075|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27551479|NCT01543698|80207467|FG009|Phase 2|Withdrawal by Subject|0|||
27747918|NCT03493685|80903707|FG001|Overall Study|Withdrawal by Subject|11|||
27747919|NCT03884101|80903714|FG000|Overall Study|Participant Ongoing in Study|202|||
27747920|NCT03884101|80903715|FG001|Overall Study|Participant Ongoing in Study|186|||
27747921|NCT03884101|80903714|FG000|Overall Study|Death|212|||
27747922|NCT03884101|80903715|FG001|Overall Study|Death|224|||
27747923|NCT03884101|80903714|FG000|Overall Study|Lost to Follow-up|0|||
27747924|NCT03884101|80903715|FG001|Overall Study|Lost to Follow-up|1|||
27747925|NCT03884101|80903714|FG000|Overall Study|Withdrawal by Subject|6|||
27747926|NCT03884101|80903715|FG001|Overall Study|Withdrawal by Subject|11|||
27747927|NCT01259492|80903716|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
27747928|NCT01259492|80903717|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
27747929|NCT01259492|80903718|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
27747930|NCT01259492|80903719|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
27747931|NCT01259492|80903716|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
27747932|NCT01259492|80903717|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
27747933|NCT01259492|80903718|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
27747934|NCT01259492|80903719|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
27747935|NCT01259492|80903716|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
27747936|NCT01259492|80903717|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
27747937|NCT01259492|80903718|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
27747938|NCT01259492|80903719|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
27747939|NCT01259492|80903716|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
27747940|NCT01259492|80903717|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
27747941|NCT01259492|80903718|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
27747942|NCT01259492|80903719|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
27747943|NCT01259492|80903716|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
27747944|NCT01259492|80903717|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
27747945|NCT01259492|80903718|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
27747946|NCT01259492|80903719|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
27747947|NCT01259492|80903716|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
27747948|NCT01259492|80903717|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
27747949|NCT01259492|80903718|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
27747950|NCT01259492|80903719|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
27747951|NCT01259492|80903716|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
27747952|NCT01259492|80903717|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
27747953|NCT01259492|80903718|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
27747954|NCT01259492|80903719|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
27747955|NCT01259492|80903716|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
27747956|NCT01259492|80903717|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
27747957|NCT01259492|80903718|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
27747958|NCT01259492|80903719|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
27747959|NCT01259492|80903716|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
27747960|NCT01259492|80903717|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
27747961|NCT01259492|80903718|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
27747962|NCT01259492|80903719|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
27747963|NCT01259492|80903716|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
27747964|NCT01259492|80903717|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
27747965|NCT01259492|80903718|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
27747966|NCT01259492|80903719|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
27747967|NCT01259492|80903716|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
27747968|NCT01259492|80903717|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
27747969|NCT01259492|80903718|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
27747970|NCT01259492|80903719|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
27747971|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
27747972|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
27747973|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
27747974|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
27747975|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
27747976|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
27747977|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
27747978|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
27747979|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
27747980|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
27747981|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
27747982|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
27747983|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
27747984|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
27747985|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
27747986|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
27747987|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
27747988|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
27747989|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
27747990|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
27747991|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
27747992|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
27747993|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
27747994|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
27747995|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
27747996|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
27747997|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
27747998|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
27747999|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
27748000|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
27748001|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
27748002|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
27748003|NCT01259492|80903716|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
27748004|NCT01259492|80903717|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
27748005|NCT01259492|80903718|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
27748006|NCT01259492|80903719|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
27748007|NCT04267562|80903722|FG000|Assessed for Eligibility|Screen Failure|64|||
27748008|NCT04267562|80903722|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
27748009|NCT04267562|80903722|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
27748010|NCT04267562|80903722|FG000|Assessed for Eligibility|Site closure|6|||
27748011|NCT04267562|80903722|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
27748012|NCT04267562|80903722|FG000|Assessed for Eligibility|Physician Decision|1|||
27748013|NCT04267562|80903722|FG000|Month 24|Elective hysterectomy|1|||
27748014|NCT04267562|80903722|FG000|Month 24|Lost to Follow-up|1|||
27748015|NCT04267562|80903722|FG000|Month 36|Elective hysterectomy|2|||
27748016|NCT04267562|80903722|FG000|Month 36|Lost to Follow-up|3|||
27748017|NCT01215734|80903723|FG000|Overall Study|Death|0|||
27748018|NCT01215734|80903724|FG001|Overall Study|Death|1|||
27748019|NCT02639182|80903729|FG000|Overall Study|Disease Progression|50|||
27748020|NCT02639182|80903730|FG001|Overall Study|Disease Progression|49|||
27748021|NCT02639182|80903729|FG000|Overall Study|Adverse Event|7|||
27748022|NCT02639182|80903730|FG001|Overall Study|Adverse Event|5|||
27748023|NCT02639182|80903729|FG000|Overall Study|Physician Decision|3|||
27748024|NCT02639182|80903730|FG001|Overall Study|Physician Decision|3|||
27748025|NCT02639182|80903729|FG000|Overall Study|Withdrew Consent|5|||
27748026|NCT02639182|80903730|FG001|Overall Study|Withdrew Consent|4|||
27748027|NCT02639182|80903729|FG000|Overall Study|Lost to Follow-up|0|||
27748028|NCT02639182|80903730|FG001|Overall Study|Lost to Follow-up|1|||
27748029|NCT02639182|80903729|FG000|Overall Study|Study Closure|1|||
27748030|NCT02639182|80903730|FG001|Overall Study|Study Closure|2|||
27748031|NCT02639182|80903729|FG000|Overall Study|Sponsor Ended Study|0|||
27748032|NCT02639182|80903730|FG001|Overall Study|Sponsor Ended Study|1|||
27748033|NCT02639182|80903729|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
27748034|NCT02639182|80903730|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
27748035|NCT03238235|80903733|FG000|Overall Study|Adverse Event|2|||
27748036|NCT03238235|80903734|FG001|Overall Study|Adverse Event|0|||
27748037|NCT03238235|80903733|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
27748038|NCT03238235|80903734|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
27748039|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
27748040|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
27748041|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748042|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748043|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748044|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
27748045|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
27748046|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748047|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748048|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748049|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748050|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748051|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748052|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
27748053|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748054|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748055|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748056|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748057|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748058|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
27748059|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
27748060|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748061|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748062|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748063|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748064|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748065|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748066|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
27748067|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
27748068|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748069|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748070|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748071|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748072|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748073|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
27748074|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748075|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748076|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748077|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748078|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748079|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748080|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
27748081|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748082|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748083|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748084|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748085|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748086|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
27748087|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
27748088|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748089|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748090|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748091|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748092|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748093|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748094|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
27748095|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748096|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748097|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748098|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748099|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748100|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748101|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
27748102|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748103|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748104|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748105|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748106|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748107|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748108|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
27748109|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
27748110|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
27748111|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
27748112|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748113|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748114|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
27748115|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
27748116|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748117|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748118|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748119|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748120|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748121|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27551480|NCT01543698|80207468|FG010|Phase 2|Withdrawal by Subject|0|||
27748122|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
27748123|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748124|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
27748125|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748126|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748127|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748128|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
27748129|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748130|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748131|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748132|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748133|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748134|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748135|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748136|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
27748137|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
27748138|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748139|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748140|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748141|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748142|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
27748143|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748144|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748145|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748146|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748147|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748148|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748149|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748150|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
27748151|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748152|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748153|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748154|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
27748155|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
27748156|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748157|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748158|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
27748159|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
27748160|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748161|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748162|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748163|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748164|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
27748165|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748166|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748167|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748168|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748169|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748170|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748171|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748172|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
27748173|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
27748174|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748175|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748176|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748177|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748178|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
27748179|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748180|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748181|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748182|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748183|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748184|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748185|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748186|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748187|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
27748188|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748189|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748190|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748191|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27650568|NCT00963924|80560492|FG001|Overall Study|Adverse Event|0|||
27748192|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
27748193|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748194|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748195|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748196|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
27748197|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748198|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748199|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748200|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748201|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748202|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748203|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748204|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748205|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748206|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
27748207|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748208|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748209|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748210|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748211|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748212|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748213|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748214|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
27748215|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
27748216|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748217|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748218|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748219|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748220|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
27748221|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748222|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748223|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748224|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748225|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748226|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27950076|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950077|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950078|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950079|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27650569|NCT00963924|80560491|FG000|Overall Study|Withdrawal by Subject|0|||
27650570|NCT00963924|80560492|FG001|Overall Study|Withdrawal by Subject|1|||
27650571|NCT00963924|80560491|FG000|Overall Study|Changed antipsychotic|0|||
27650572|NCT00963924|80560492|FG001|Overall Study|Changed antipsychotic|1|||
27650573|NCT00963924|80560491|FG000|Overall Study|Lost to Follow-up|0|||
27650574|NCT00963924|80560492|FG001|Overall Study|Lost to Follow-up|1|||
27650575|NCT02060487|80560493|FG000|Overall Study|Other|1|||
27650576|NCT02060487|80560494|FG001|Overall Study|Other|2|||
27650577|NCT02060487|80560495|FG002|Overall Study|Other|1|||
27650578|NCT02060487|80560493|FG000|Overall Study|Lack of Efficacy|0|||
27650579|NCT02060487|80560494|FG001|Overall Study|Lack of Efficacy|1|||
27650580|NCT02060487|80560495|FG002|Overall Study|Lack of Efficacy|0|||
27650581|NCT02060487|80560493|FG000|Overall Study|Withdrawal by Subject|3|||
27650582|NCT02060487|80560494|FG001|Overall Study|Withdrawal by Subject|10|||
27650583|NCT02060487|80560495|FG002|Overall Study|Withdrawal by Subject|4|||
27650584|NCT02060487|80560493|FG000|Overall Study|Study Terminated By Sponsor|87|||
27650585|NCT02060487|80560494|FG001|Overall Study|Study Terminated By Sponsor|89|||
27650586|NCT02060487|80560495|FG002|Overall Study|Study Terminated By Sponsor|100|||
27650587|NCT02060487|80560493|FG000|Overall Study|Randomized in error|1|||
27650588|NCT02060487|80560494|FG001|Overall Study|Randomized in error|0|||
27650589|NCT02060487|80560495|FG002|Overall Study|Randomized in error|0|||
27650590|NCT02060487|80560493|FG000|Overall Study|Protocol Violation|0|||
27650591|NCT02060487|80560494|FG001|Overall Study|Protocol Violation|1|||
27650592|NCT02060487|80560495|FG002|Overall Study|Protocol Violation|1|||
27748227|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748228|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
27748229|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748230|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748231|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748232|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748233|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748234|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
27748235|NCT04033445|80903739|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748236|NCT04033445|80903740|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748237|NCT04033445|80903741|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748238|NCT04033445|80903742|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748239|NCT04033445|80903743|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748240|NCT04033445|80903744|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748241|NCT04033445|80903745|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748242|NCT04033445|80903746|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
27748243|NCT04033445|80903747|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748244|NCT04033445|80903748|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748245|NCT04033445|80903749|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748246|NCT04033445|80903750|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748247|NCT04033445|80903751|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748248|NCT04033445|80903752|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
27748249|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748250|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748251|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748252|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748253|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748254|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748255|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748256|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748257|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
27748258|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
27748259|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
27748260|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
27748261|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
27748262|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
27748263|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748264|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748265|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748266|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748267|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748268|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748269|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748270|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748271|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
27748272|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
27748273|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
27748274|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
27748275|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
27748276|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
27748277|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748278|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748279|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748280|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748281|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748282|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748283|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748284|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748285|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748286|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27748287|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
27748288|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
27748289|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
27551481|NCT01543698|80207469|FG011|Phase 2|Withdrawal by Subject|0|||
27748290|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
27748291|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748292|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748293|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748294|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748295|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748296|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748297|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748298|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748299|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748300|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
27748301|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
27748302|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
27748303|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
27748304|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
27748305|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748306|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748307|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748308|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748309|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748310|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748311|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748312|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748313|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
27748314|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
27748315|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
27748316|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
27748317|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
27748318|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
27748319|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748320|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748321|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748322|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748323|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748324|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748325|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748326|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748327|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748328|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748329|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748330|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748331|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
27748332|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
27748333|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748334|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748335|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748336|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748337|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748338|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748339|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748340|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748341|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
27748342|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
27748343|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
27748344|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
27748345|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
27748346|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
27748347|NCT04033445|80903739|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748348|NCT04033445|80903740|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748349|NCT04033445|80903741|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748350|NCT04033445|80903742|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27650593|NCT02060487|80560493|FG000|Overall Study|Lost to Follow-up|3|||
27650594|NCT02060487|80560494|FG001|Overall Study|Lost to Follow-up|0|||
27748351|NCT04033445|80903743|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27950080|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950081|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
27950082|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950083|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950084|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950085|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950086|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
27950087|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950088|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950089|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950090|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950091|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950092|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950093|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950094|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950095|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950096|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950097|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
27950098|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950099|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950100|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950101|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950102|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
27950103|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950104|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950105|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950106|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950107|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950108|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950109|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950110|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950111|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950112|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950113|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
27950114|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950115|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950116|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950117|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950118|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
27950119|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950120|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950121|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950122|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950123|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950124|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950125|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950126|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950127|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950128|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950129|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
27950130|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950131|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950132|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950133|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950134|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
27950135|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950136|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950137|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950138|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950139|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950140|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950141|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27551482|NCT01543698|80207470|FG012|Phase 2|Withdrawal by Subject|0|||
27748352|NCT04033445|80903744|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748353|NCT04033445|80903745|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748354|NCT04033445|80903746|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748355|NCT04033445|80903747|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748356|NCT04033445|80903748|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
27748357|NCT04033445|80903749|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748358|NCT04033445|80903750|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
27748359|NCT04033445|80903751|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
27748360|NCT04033445|80903752|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
27748361|NCT03539458|80903753|FG000|Overall Study|Death|1|||
27748362|NCT02699515|80903754|FG000|Overall Study|Death|3|||
27748363|NCT02699515|80903755|FG001|Overall Study|Death|3|||
27748364|NCT02699515|80903756|FG002|Overall Study|Death|3|||
27748365|NCT02699515|80903757|FG003|Overall Study|Death|23|||
27748366|NCT02699515|80903758|FG004|Overall Study|Death|22|||
27748367|NCT02699515|80903759|FG005|Overall Study|Death|23|||
27748368|NCT02699515|80903760|FG006|Overall Study|Death|3|||
27748369|NCT02699515|80903761|FG007|Overall Study|Death|5|||
27748370|NCT02699515|80903754|FG000|Overall Study|Withdrawal by Subject|0|||
27748371|NCT02699515|80903755|FG001|Overall Study|Withdrawal by Subject|0|||
27748372|NCT02699515|80903756|FG002|Overall Study|Withdrawal by Subject|3|||
27748373|NCT02699515|80903757|FG003|Overall Study|Withdrawal by Subject|1|||
27748374|NCT02699515|80903758|FG004|Overall Study|Withdrawal by Subject|5|||
27748375|NCT02699515|80903759|FG005|Overall Study|Withdrawal by Subject|3|||
27748376|NCT02699515|80903760|FG006|Overall Study|Withdrawal by Subject|0|||
27748377|NCT02699515|80903761|FG007|Overall Study|Withdrawal by Subject|1|||
27748378|NCT02699515|80903754|FG000|Overall Study|Other|1|||
27748379|NCT02699515|80903755|FG001|Overall Study|Other|0|||
27748380|NCT02699515|80903756|FG002|Overall Study|Other|1|||
27748381|NCT02699515|80903757|FG003|Overall Study|Other|6|||
27748382|NCT02699515|80903758|FG004|Overall Study|Other|4|||
27748383|NCT02699515|80903759|FG005|Overall Study|Other|3|||
27748384|NCT02699515|80903760|FG006|Overall Study|Other|0|||
27748385|NCT02699515|80903761|FG007|Overall Study|Other|0|||
27748386|NCT01881620|80903762|FG000|Overall Study|Protocol Violation|4|||
27748387|NCT03229759|80903764|FG000|Overall Study|Screen Failure|30|||
27748388|NCT00540449|80903765|FG000|Overall Study|Adverse Event|12|||
27748389|NCT00540449|80903766|FG001|Overall Study|Adverse Event|32|||
27748390|NCT00540449|80903765|FG000|Overall Study|Sponsor's Decision|1|||
27748391|NCT00540449|80903766|FG001|Overall Study|Sponsor's Decision|1|||
27748392|NCT00540449|80903765|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
27748393|NCT00540449|80903766|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
27748394|NCT00540449|80903765|FG000|Overall Study|Lost to Follow-up|19|||
27748395|NCT00540449|80903766|FG001|Overall Study|Lost to Follow-up|17|||
27748396|NCT00540449|80903765|FG000|Overall Study|Subject Non-Compliant|7|||
27748397|NCT00540449|80903766|FG001|Overall Study|Subject Non-Compliant|5|||
27748398|NCT00540449|80903765|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
27748399|NCT00540449|80903766|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
27748400|NCT00540449|80903765|FG000|Overall Study|Withdrawal by Subject|10|||
27748401|NCT00540449|80903766|FG001|Overall Study|Withdrawal by Subject|10|||
27748402|NCT00540449|80903765|FG000|Overall Study|Other|1|||
27748403|NCT00540449|80903766|FG001|Overall Study|Other|4|||
27748404|NCT00406640|80903770|FG000|Acute Phase|Adverse Event|18|||
27748405|NCT00406640|80903771|FG001|Acute Phase|Adverse Event|13|||
27748406|NCT00406640|80903770|FG000|Acute Phase|Failed to Return|5|||
27748407|NCT00406640|80903771|FG001|Acute Phase|Failed to Return|1|||
27748408|NCT00406640|80903770|FG000|Acute Phase|Physician Decision|0|||
27748409|NCT00406640|80903771|FG001|Acute Phase|Physician Decision|1|||
27748410|NCT00406640|80903770|FG000|Acute Phase|Lost to Follow-up|7|||
27748411|NCT00406640|80903771|FG001|Acute Phase|Lost to Follow-up|4|||
27748412|NCT00406640|80903770|FG000|Acute Phase|Protocol deviation|4|||
27748413|NCT00406640|80903771|FG001|Acute Phase|Protocol deviation|10|||
27748414|NCT00406640|80903770|FG000|Acute Phase|Protocol Violation|3|||
27748415|NCT00406640|80903771|FG001|Acute Phase|Protocol Violation|2|||
27748416|NCT00406640|80903770|FG000|Acute Phase|Withdrawal by Subject|11|||
27748417|NCT00406640|80903771|FG001|Acute Phase|Withdrawal by Subject|9|||
27748418|NCT00406640|80903770|FG000|Acute Phase|Lack of Efficacy|3|||
27748419|NCT00406640|80903771|FG001|Acute Phase|Lack of Efficacy|3|||
27748420|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
27748421|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
27748422|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Death|1|||
27748423|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Death|0|||
27551483|NCT01543698|80207471|FG013|Phase 2|Withdrawal by Subject|3|||
27748424|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
27748425|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
27748426|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
27748427|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
27748428|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
27748429|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
27748430|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|non-compliance|7|||
27748431|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|non-compliance|5|||
27748432|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
27748433|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
27748434|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
27748435|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
27748436|NCT00406640|80903770|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
27748437|NCT00406640|80903771|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
27748438|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
27748439|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
27748440|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
27748441|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
27748442|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
27748443|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
27748444|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
27748445|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
27748446|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
27748447|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
27748448|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
27748449|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
27748450|NCT00406640|80903770|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
27748451|NCT00406640|80903771|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
27748452|NCT02086565|80903774|FG000|Overall Study|Lost to Follow-up|9|||
27748453|NCT02086565|80903775|FG001|Overall Study|Lost to Follow-up|7|||
27748454|NCT02086565|80903774|FG000|Overall Study|Withdrawal by Subject|2|||
27748455|NCT02086565|80903775|FG001|Overall Study|Withdrawal by Subject|1|||
27748456|NCT02086565|80903774|FG000|Overall Study|Death|3|||
27748457|NCT02086565|80903775|FG001|Overall Study|Death|2|||
27748458|NCT02086565|80903774|FG000|Overall Study|withdrawn by research team|2|||
27748459|NCT02086565|80903775|FG001|Overall Study|withdrawn by research team|2|||
27748460|NCT02137772|80903778|FG000|Overall Study|Adverse Event|6|||
27748461|NCT02137772|80903779|FG001|Overall Study|Adverse Event|3|||
27748462|NCT02137772|80903778|FG000|Overall Study|Death|71|||
27748463|NCT02137772|80903779|FG001|Overall Study|Death|44|||
27748464|NCT02137772|80903778|FG000|Overall Study|Lost to Follow-up|8|||
27748465|NCT02137772|80903779|FG001|Overall Study|Lost to Follow-up|4|||
27748466|NCT02137772|80903778|FG000|Overall Study|Physician Decision|15|||
27748467|NCT02137772|80903779|FG001|Overall Study|Physician Decision|5|||
27748468|NCT02137772|80903778|FG000|Overall Study|Withdrawal by Subject|28|||
27748469|NCT02137772|80903779|FG001|Overall Study|Withdrawal by Subject|17|||
27748470|NCT02137772|80903778|FG000|Overall Study|Non-compliance with study drug|1|||
27748471|NCT02137772|80903779|FG001|Overall Study|Non-compliance with study drug|0|||
27748472|NCT02137772|80903778|FG000|Overall Study|Not treated|3|||
27748473|NCT02137772|80903779|FG001|Overall Study|Not treated|2|||
27748474|NCT01998581|80903780|FG000|Overall Study|Refused repeat treatment|20|||
27748475|NCT01998581|80903781|FG001|Overall Study|Refused repeat treatment|4|||
27748476|NCT01998581|80903780|FG000|Overall Study|Protocol Violation|1|||
27748477|NCT01998581|80903781|FG001|Overall Study|Protocol Violation|0|||
27748478|NCT01998581|80903780|FG000|Overall Study|Withdrawal by Subject|8|||
27748479|NCT01998581|80903781|FG001|Overall Study|Withdrawal by Subject|1|||
27748480|NCT01998581|80903780|FG000|Overall Study|Lost to Follow-up|12|||
27748481|NCT01998581|80903781|FG001|Overall Study|Lost to Follow-up|4|||
27748482|NCT01998581|80903780|FG000|Overall Study|Adverse Event|1|||
27748483|NCT01998581|80903781|FG001|Overall Study|Adverse Event|1|||
27748484|NCT01998581|80903780|FG000|Overall Study|Other reasons|3|||
27748485|NCT01998581|80903781|FG001|Overall Study|Other reasons|2|||
27748486|NCT01998581|80903780|FG000|Overall Study|Randomized but withdrew before treatment|1|||
27748487|NCT01998581|80903781|FG001|Overall Study|Randomized but withdrew before treatment|0|||
27748488|NCT02761993|80903784|FG000|Overall Study|Adverse Event|0|||
27748489|NCT02761993|80903785|FG001|Overall Study|Adverse Event|2|||
27748490|NCT02761993|80903786|FG002|Overall Study|Adverse Event|0|||
27748491|NCT02761993|80903784|FG000|Overall Study|Lost to Follow-up|1|||
27748492|NCT02761993|80903785|FG001|Overall Study|Lost to Follow-up|3|||
27650595|NCT02060487|80560495|FG002|Overall Study|Lost to Follow-up|2|||
27650596|NCT02060487|80560493|FG000|Overall Study|Death|34|||
27650597|NCT02060487|80560494|FG001|Overall Study|Death|25|||
27650598|NCT02060487|80560495|FG002|Overall Study|Death|19|||
27650599|NCT02060487|80560493|FG000|Overall Study|Adverse Event|0|||
27650600|NCT02060487|80560494|FG001|Overall Study|Adverse Event|0|||
27650601|NCT02060487|80560495|FG002|Overall Study|Adverse Event|1|||
27650602|NCT01947491|80560496|FG000|Overall Study|Lost to Follow-up|5|||
27748493|NCT02761993|80903786|FG002|Overall Study|Lost to Follow-up|2|||
27748494|NCT02761993|80903784|FG000|Overall Study|Withdrawal by Subject|1|||
27748495|NCT02761993|80903785|FG001|Overall Study|Withdrawal by Subject|1|||
27748496|NCT02761993|80903786|FG002|Overall Study|Withdrawal by Subject|2|||
27748497|NCT00130208|80903789|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
27748498|NCT00130208|80903790|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
27748499|NCT00130208|80903789|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
27748500|NCT00130208|80903790|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
27748501|NCT00130208|80903789|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
27748502|NCT00130208|80903790|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
27748503|NCT00130208|80903789|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
27748504|NCT00130208|80903790|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
27748505|NCT00130208|80903789|FG000|Maintenance Period (26 Weeks)|Other|1|||
27748506|NCT00130208|80903790|FG001|Maintenance Period (26 Weeks)|Other|1|||
27748507|NCT00130208|80903789|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
27748508|NCT00130208|80903790|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
27748509|NCT00130208|80903789|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
27748510|NCT00130208|80903790|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
27748511|NCT00130208|80903789|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
27748512|NCT00130208|80903790|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
27748513|NCT00130208|80903789|FG000|Washout Period (8 Weeks)|Other|1|||
27748514|NCT00130208|80903790|FG001|Washout Period (8 Weeks)|Other|1|||
27748515|NCT02817555|80903791|FG000|Overall Study|Death|1|||
27748516|NCT02817555|80903792|FG001|Overall Study|Death|3|||
27748517|NCT02817555|80903791|FG000|Overall Study|moved away|1|||
27748518|NCT02817555|80903792|FG001|Overall Study|moved away|0|||
27748519|NCT02817555|80903791|FG000|Overall Study|transplant|1|||
27748520|NCT02817555|80903792|FG001|Overall Study|transplant|1|||
27748521|NCT02817555|80903791|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
27748522|NCT02817555|80903792|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
27748523|NCT02399813|80903793|FG000|Overall Study|Progressive Disease-Radiographic|2|||
27748524|NCT02399813|80903793|FG000|Overall Study|Death|20|||
27748525|NCT02399813|80903793|FG000|Overall Study|Withdrawal by Subject|3|||
27748526|NCT02399813|80903793|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
27748527|NCT02399813|80903793|FG000|Overall Study|Lost to Follow-up|2|||
27748528|NCT02399813|80903793|FG000|Overall Study|Other than specified|5|||
27748529|NCT00257192|80903794|FG000|Overall Study|Adverse Event|21|||
27748530|NCT00257192|80903795|FG001|Overall Study|Adverse Event|10|||
27748531|NCT00257192|80903794|FG000|Overall Study|Laboratory abnormality|1|||
27748532|NCT00257192|80903795|FG001|Overall Study|Laboratory abnormality|1|||
27748533|NCT00257192|80903794|FG000|Overall Study|Lost to Follow-up|3|||
27748534|NCT00257192|80903795|FG001|Overall Study|Lost to Follow-up|3|||
27748535|NCT00257192|80903794|FG000|Overall Study|Insufficient clinical response|18|||
27748536|NCT00257192|80903795|FG001|Overall Study|Insufficient clinical response|18|||
27748537|NCT00257192|80903794|FG000|Overall Study|Withdrawal by Subject|14|||
27748538|NCT00257192|80903795|FG001|Overall Study|Withdrawal by Subject|2|||
27748539|NCT00257192|80903794|FG000|Overall Study|Randomized but not treated|0|||
27748540|NCT00257192|80903795|FG001|Overall Study|Randomized but not treated|1|||
27748541|NCT00257192|80903794|FG000|Overall Study|Study terminated by sponsor|1|||
27748542|NCT00257192|80903795|FG001|Overall Study|Study terminated by sponsor|0|||
27748543|NCT00257192|80903794|FG000|Overall Study|Miscellaneous|0|||
27748544|NCT00257192|80903795|FG001|Overall Study|Miscellaneous|4|||
27748545|NCT01842620|80903796|FG000|Period 1|Withdrawal by Subject|1|||
27748546|NCT01842620|80903797|FG001|Period 1|Withdrawal by Subject|0|||
27748547|NCT01921270|80903799|FG000|Overall Study|Withdrawal by Subject|1|||
27748548|NCT02402218|80903800|FG000|Overall Study|Did not pickup study medication|12|||
27748549|NCT02402218|80903801|FG001|Overall Study|Did not pickup study medication|9|||
27748550|NCT02402218|80903802|FG002|Overall Study|Did not pickup study medication|13|||
27748551|NCT02402218|80903800|FG000|Overall Study|Lack of Efficacy|0|||
27748552|NCT02402218|80903801|FG001|Overall Study|Lack of Efficacy|1|||
27748553|NCT02402218|80903802|FG002|Overall Study|Lack of Efficacy|1|||
27748554|NCT02402218|80903800|FG000|Overall Study|Death|1|||
27748555|NCT02402218|80903801|FG001|Overall Study|Death|0|||
27748556|NCT02402218|80903802|FG002|Overall Study|Death|0|||
27748557|NCT02402218|80903800|FG000|Overall Study|Reinfection|0|||
27748558|NCT02402218|80903801|FG001|Overall Study|Reinfection|0|||
27748559|NCT02402218|80903802|FG002|Overall Study|Reinfection|1|||
27748560|NCT02402218|80903800|FG000|Overall Study|Adverse Event|0|||
27748561|NCT02402218|80903801|FG001|Overall Study|Adverse Event|2|||
27748562|NCT02402218|80903802|FG002|Overall Study|Adverse Event|1|||
27748563|NCT02402218|80903800|FG000|Overall Study|Withdrawal by Subject|1|||
27748564|NCT02402218|80903801|FG001|Overall Study|Withdrawal by Subject|1|||
27748565|NCT02402218|80903802|FG002|Overall Study|Withdrawal by Subject|1|||
27748566|NCT01103349|80903803|FG000|Overall Study|Adverse Event|8|||
27748567|NCT01103349|80903804|FG001|Overall Study|Adverse Event|5|||
27748568|NCT01103349|80903805|FG002|Overall Study|Adverse Event|3|||
27748569|NCT01103349|80903803|FG000|Overall Study|Consent withdrawn|1|||
27748570|NCT01103349|80903804|FG001|Overall Study|Consent withdrawn|0|||
27748571|NCT01103349|80903805|FG002|Overall Study|Consent withdrawn|0|||
27748572|NCT01103349|80903803|FG000|Overall Study|Incorrectly included in the trial|1|||
27748573|NCT01103349|80903804|FG001|Overall Study|Incorrectly included in the trial|0|||
27748574|NCT01103349|80903805|FG002|Overall Study|Incorrectly included in the trial|0|||
27748575|NCT01103349|80903803|FG000|Overall Study|Withdrawal by Subject|1|||
27748576|NCT01103349|80903804|FG001|Overall Study|Withdrawal by Subject|1|||
27748577|NCT01103349|80903805|FG002|Overall Study|Withdrawal by Subject|0|||
27748578|NCT01103349|80903803|FG000|Overall Study|did not want to take trial medication|0|||
27748579|NCT01103349|80903804|FG001|Overall Study|did not want to take trial medication|1|||
27748580|NCT01103349|80903805|FG002|Overall Study|did not want to take trial medication|0|||
27748581|NCT01103349|80903803|FG000|Overall Study|forgot to take medication|0|||
27748582|NCT01103349|80903804|FG001|Overall Study|forgot to take medication|0|||
27748583|NCT01103349|80903805|FG002|Overall Study|forgot to take medication|1|||
27748584|NCT04598165|80903814|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
27748585|NCT04598165|80903815|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
27748586|NCT04598165|80903814|FG000|Completed 6-week Follow-up|Death|2|||
27748587|NCT04598165|80903815|FG001|Completed 6-week Follow-up|Death|1|||
27748588|NCT04598165|80903814|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
27748589|NCT04598165|80903815|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
27748590|NCT04598165|80903814|FG000|Completed 6-week Follow-up|Ineligible|4|||
27748591|NCT04598165|80903815|FG001|Completed 6-week Follow-up|Ineligible|3|||
27748592|NCT04598165|80903814|FG000|Completed 6-week Follow-up|Partner refusal|0|||
27748593|NCT04598165|80903815|FG001|Completed 6-week Follow-up|Partner refusal|1|||
27748594|NCT04598165|80903814|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
27748595|NCT04598165|80903815|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
27748596|NCT04429503|80906185|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
27748597|NCT04429503|80906186|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
27748598|NCT04429503|80906187|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
27748599|NCT04429503|80906185|FG000|Overall Study|Adverse Event|1|||
27748600|NCT04429503|80906186|FG001|Overall Study|Adverse Event|9|||
27748601|NCT04429503|80906187|FG002|Overall Study|Adverse Event|2|||
27748602|NCT04429503|80906185|FG000|Overall Study|Decision by the investigator/sponsor|2|||
27748603|NCT04429503|80906186|FG001|Overall Study|Decision by the investigator/sponsor|9|||
27748604|NCT04429503|80906187|FG002|Overall Study|Decision by the investigator/sponsor|3|||
27748605|NCT04429503|80906185|FG000|Overall Study|Withdrawal by Subject|9|||
27748606|NCT04429503|80906186|FG001|Overall Study|Withdrawal by Subject|17|||
27748607|NCT04429503|80906187|FG002|Overall Study|Withdrawal by Subject|8|||
27748608|NCT04429503|80906185|FG000|Overall Study|Lost to Follow-up|5|||
27748609|NCT04429503|80906186|FG001|Overall Study|Lost to Follow-up|19|||
27748610|NCT04429503|80906187|FG002|Overall Study|Lost to Follow-up|7|||
27748611|NCT04429503|80906185|FG000|Overall Study|Death|9|||
27650603|NCT01947491|80560497|FG001|Overall Study|Lost to Follow-up|3|||
27650604|NCT01947491|80560498|FG002|Overall Study|Lost to Follow-up|1|||
27650605|NCT01947491|80560499|FG003|Overall Study|Lost to Follow-up|2|||
27650606|NCT01947491|80560496|FG000|Overall Study|Lack of Efficacy|1|||
27650607|NCT01947491|80560497|FG001|Overall Study|Lack of Efficacy|0|||
27650608|NCT01947491|80560498|FG002|Overall Study|Lack of Efficacy|0|||
27650609|NCT01947491|80560499|FG003|Overall Study|Lack of Efficacy|1|||
27650610|NCT01947491|80560496|FG000|Overall Study|Protocol Violation|1|||
27650611|NCT01947491|80560497|FG001|Overall Study|Protocol Violation|0|||
27650612|NCT01947491|80560498|FG002|Overall Study|Protocol Violation|0|||
27650613|NCT01947491|80560499|FG003|Overall Study|Protocol Violation|0|||
27650614|NCT01947491|80560496|FG000|Overall Study|Withdrawal by Subject|1|||
27650615|NCT01947491|80560497|FG001|Overall Study|Withdrawal by Subject|1|||
27650616|NCT01947491|80560498|FG002|Overall Study|Withdrawal by Subject|1|||
27650617|NCT01947491|80560499|FG003|Overall Study|Withdrawal by Subject|0|||
27650618|NCT01947491|80560496|FG000|Overall Study|Worsening of condition|0|||
27650619|NCT01947491|80560497|FG001|Overall Study|Worsening of condition|1|||
27650620|NCT01947491|80560498|FG002|Overall Study|Worsening of condition|0|||
27650621|NCT01947491|80560499|FG003|Overall Study|Worsening of condition|0|||
27650622|NCT01947491|80560496|FG000|Overall Study|Adverse Event|0|||
27650623|NCT01947491|80560497|FG001|Overall Study|Adverse Event|1|||
27650624|NCT01947491|80560498|FG002|Overall Study|Adverse Event|0|||
27650625|NCT01947491|80560499|FG003|Overall Study|Adverse Event|2|||
27748612|NCT04429503|80906186|FG001|Overall Study|Death|18|||
27748613|NCT04429503|80906187|FG002|Overall Study|Death|5|||
27748614|NCT00243230|80906193|FG000|Double-Blind Period|Adverse Event|0|||
27748615|NCT00243230|80906194|FG001|Double-Blind Period|Adverse Event|2|||
27650626|NCT01918033|80560500|FG000|Overall Study|Adverse Event|1|||
27650627|NCT01918033|80560501|FG001|Overall Study|Adverse Event|0|||
27650628|NCT01918033|80560502|FG002|Overall Study|Adverse Event|2|||
27650629|NCT01918033|80560500|FG000|Overall Study|Lost to Follow-up|0|||
27650630|NCT01918033|80560501|FG001|Overall Study|Lost to Follow-up|1|||
27650631|NCT01918033|80560502|FG002|Overall Study|Lost to Follow-up|0|||
27748616|NCT00243230|80906195|FG002|Double-Blind Period|Adverse Event|2|||
27748617|NCT00243230|80906196|FG003|Double-Blind Period|Adverse Event|0|||
27748618|NCT00243230|80906193|FG000|Double-Blind Period|Withdrawal by Subject|1|||
27748619|NCT00243230|80906194|FG001|Double-Blind Period|Withdrawal by Subject|0|||
27748620|NCT00243230|80906195|FG002|Double-Blind Period|Withdrawal by Subject|0|||
27748621|NCT00243230|80906196|FG003|Double-Blind Period|Withdrawal by Subject|0|||
27748622|NCT00243230|80906193|FG000|Double-Blind Period|Protocol Violation|0|||
27748623|NCT00243230|80906194|FG001|Double-Blind Period|Protocol Violation|0|||
27748624|NCT00243230|80906195|FG002|Double-Blind Period|Protocol Violation|1|||
27748625|NCT00243230|80906196|FG003|Double-Blind Period|Protocol Violation|0|||
27748626|NCT00243230|80906193|FG000|Double-Blind Period|Randomized but Not Treated|0|||
27748627|NCT00243230|80906194|FG001|Double-Blind Period|Randomized but Not Treated|0|||
27748628|NCT00243230|80906195|FG002|Double-Blind Period|Randomized but Not Treated|2|||
27748629|NCT00243230|80906196|FG003|Double-Blind Period|Randomized but Not Treated|0|||
27748630|NCT00243230|80906193|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
27748631|NCT00243230|80906194|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
27748632|NCT00243230|80906195|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
27748633|NCT00243230|80906196|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
27748634|NCT00243230|80906193|FG000|Open Label Period|Adverse Event|0|||
27748635|NCT00243230|80906194|FG001|Open Label Period|Adverse Event|0|||
27748636|NCT00243230|80906195|FG002|Open Label Period|Adverse Event|0|||
27748637|NCT00243230|80906196|FG003|Open Label Period|Adverse Event|2|||
27748638|NCT00243230|80906193|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
27748639|NCT00243230|80906194|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
27748640|NCT00243230|80906195|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
27748641|NCT00243230|80906196|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
27748642|NCT00243230|80906193|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
27748643|NCT00243230|80906194|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
27748644|NCT00243230|80906195|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
27748645|NCT00243230|80906196|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
27748646|NCT00243230|80906193|FG000|Open Label Period|Lost to Follow-up|0|||
27748647|NCT00243230|80906194|FG001|Open Label Period|Lost to Follow-up|0|||
27748648|NCT00243230|80906195|FG002|Open Label Period|Lost to Follow-up|0|||
27748649|NCT00243230|80906196|FG003|Open Label Period|Lost to Follow-up|2|||
27748650|NCT00243230|80906193|FG000|Open Label Period|Withdrawal by Subject|0|||
27748651|NCT00243230|80906194|FG001|Open Label Period|Withdrawal by Subject|0|||
27748652|NCT00243230|80906195|FG002|Open Label Period|Withdrawal by Subject|0|||
27748653|NCT00243230|80906196|FG003|Open Label Period|Withdrawal by Subject|2|||
27748654|NCT00243230|80906193|FG000|Open Label Period|Protocol Violation|0|||
27748655|NCT00243230|80906194|FG001|Open Label Period|Protocol Violation|0|||
27748656|NCT00243230|80906195|FG002|Open Label Period|Protocol Violation|0|||
27748657|NCT00243230|80906196|FG003|Open Label Period|Protocol Violation|2|||
27748658|NCT00243230|80906193|FG000|Open Label Period|Administrative Reason|0|||
27748659|NCT00243230|80906194|FG001|Open Label Period|Administrative Reason|0|||
27748660|NCT00243230|80906195|FG002|Open Label Period|Administrative Reason|0|||
27748661|NCT00243230|80906196|FG003|Open Label Period|Administrative Reason|63|||
27748662|NCT02371759|80906197|FG000|Overall Study|Protocol Violation|3|||
27748663|NCT02371759|80906198|FG001|Overall Study|Protocol Violation|1|||
27748664|NCT02371759|80906199|FG002|Overall Study|Protocol Violation|1|||
27748665|NCT02371759|80906200|FG003|Overall Study|Protocol Violation|0|||
27748666|NCT02371759|80906201|FG004|Overall Study|Protocol Violation|3|||
27748667|NCT02371759|80906202|FG005|Overall Study|Protocol Violation|1|||
27748668|NCT02371759|80906203|FG006|Overall Study|Protocol Violation|0|||
27748669|NCT02371759|80906204|FG007|Overall Study|Protocol Violation|3|||
27748670|NCT02371759|80906197|FG000|Overall Study|Withdrawal by Subject|0|||
27748671|NCT02371759|80906198|FG001|Overall Study|Withdrawal by Subject|0|||
27748672|NCT02371759|80906199|FG002|Overall Study|Withdrawal by Subject|0|||
27748673|NCT02371759|80906200|FG003|Overall Study|Withdrawal by Subject|0|||
27748674|NCT02371759|80906201|FG004|Overall Study|Withdrawal by Subject|0|||
27748675|NCT02371759|80906202|FG005|Overall Study|Withdrawal by Subject|0|||
27748676|NCT02371759|80906203|FG006|Overall Study|Withdrawal by Subject|0|||
27748677|NCT02371759|80906204|FG007|Overall Study|Withdrawal by Subject|1|||
27748678|NCT04346628|80906205|FG000|Overall Study|Lost to Follow-up|4|||
27748679|NCT04346628|80906206|FG001|Overall Study|Lost to Follow-up|4|||
27748680|NCT04346628|80906205|FG000|Overall Study|Withdrew (had personal reasons)|2|||
27748681|NCT04346628|80906206|FG001|Overall Study|Withdrew (had personal reasons)|5|||
27748682|NCT04346628|80906205|FG000|Overall Study|Withdrew (medication intolerant)|0|||
27748683|NCT04346628|80906206|FG001|Overall Study|Withdrew (medication intolerant)|3|||
27748684|NCT04346628|80906205|FG000|Overall Study|Withdrew (declined intervention)|0|||
27748685|NCT04346628|80906206|FG001|Overall Study|Withdrew (declined intervention)|1|||
27650632|NCT01918033|80560500|FG000|Overall Study|Protocol Violation|2|||
27748686|NCT01617434|80906214|FG000|Overall Study|Adverse Event|12|||
27748687|NCT01617434|80906215|FG001|Overall Study|Adverse Event|3|||
27748688|NCT01617434|80906214|FG000|Overall Study|Protocol Violation|8|||
27748689|NCT01617434|80906215|FG001|Overall Study|Protocol Violation|7|||
27748690|NCT01617434|80906214|FG000|Overall Study|Withdrawal Criteria|12|||
27748691|NCT01617434|80906215|FG001|Overall Study|Withdrawal Criteria|37|||
27748692|NCT01617434|80906214|FG000|Overall Study|Unclassified|3|||
27748693|NCT01617434|80906215|FG001|Overall Study|Unclassified|4|||
27748694|NCT00833248|80906223|FG000|Overall Study|Adverse Event|3|||
27748695|NCT00833248|80906224|FG001|Overall Study|Adverse Event|0|||
27748696|NCT00833248|80906223|FG000|Overall Study|Protocol Violation|1|||
27748697|NCT00833248|80906224|FG001|Overall Study|Protocol Violation|2|||
27748698|NCT00833248|80906223|FG000|Overall Study|Withdrawal by Subject|0|||
27748699|NCT00833248|80906224|FG001|Overall Study|Withdrawal by Subject|1|||
27748700|NCT03041116|80906225|FG000|Double-blind|Death|0|||
27748701|NCT03041116|80906226|FG001|Double-blind|Death|2|||
27748702|NCT03041116|80906225|FG000|Double-blind|Withdrawal by Subject|0|||
27748703|NCT03041116|80906226|FG001|Double-blind|Withdrawal by Subject|4|||
27748704|NCT03041116|80906225|FG000|Open-label|Death|1|||
27748705|NCT03041116|80906226|FG001|Open-label|Death|0|||
27748706|NCT03041116|80906225|FG000|Open-label|Termination of the study by Sponsor|39|||
27748707|NCT03041116|80906226|FG001|Open-label|Termination of the study by Sponsor|37|||
27748708|NCT03041116|80906225|FG000|Open-label|Withdrawal by Subject|1|||
27748709|NCT03041116|80906226|FG001|Open-label|Withdrawal by Subject|0|||
27748710|NCT03032068|80906227|FG000|Overall Study|Adverse Event|1|||
27748711|NCT01993329|80906228|FG000|Period 2|Adverse Event|0|||
27748712|NCT01993329|80906229|FG001|Period 2|Adverse Event|0|||
27748713|NCT01993329|80906230|FG002|Period 2|Adverse Event|0|||
27748714|NCT01993329|80906231|FG003|Period 2|Adverse Event|0|||
27748715|NCT01993329|80906232|FG004|Period 2|Adverse Event|0|||
27748716|NCT01993329|80906233|FG005|Period 2|Adverse Event|1|||
27748717|NCT01993329|80906228|FG000|Wash-out|Personal reasons|0|||
27748718|NCT01993329|80906229|FG001|Wash-out|Personal reasons|1|||
27748719|NCT01993329|80906230|FG002|Wash-out|Personal reasons|0|||
27748720|NCT01993329|80906231|FG003|Wash-out|Personal reasons|0|||
27748721|NCT01993329|80906232|FG004|Wash-out|Personal reasons|0|||
27650633|NCT01918033|80560501|FG001|Overall Study|Protocol Violation|0|||
27650634|NCT01918033|80560502|FG002|Overall Study|Protocol Violation|1|||
27650635|NCT01918033|80560500|FG000|Overall Study|Withdrawal by Subject|2|||
27650636|NCT01918033|80560501|FG001|Overall Study|Withdrawal by Subject|1|||
27650637|NCT01918033|80560502|FG002|Overall Study|Withdrawal by Subject|0|||
27650638|NCT00641537|80560503|FG000|96-week Period|Adverse Event|0|||
27650639|NCT00641537|80560504|FG001|96-week Period|Adverse Event|1|||
27650640|NCT00641537|80560505|FG002|96-week Period|Adverse Event|3|||
27650641|NCT00641537|80560506|FG003|96-week Period|Adverse Event|0|||
27650642|NCT00641537|80560507|FG004|96-week Period|Adverse Event|2|||
27650643|NCT00641537|80560508|FG005|96-week Period|Adverse Event|0|||
27650644|NCT00641537|80560509|FG006|96-week Period|Adverse Event|0|||
27650645|NCT00641537|80560510|FG007|96-week Period|Adverse Event|0|||
27650646|NCT00641537|80560503|FG000|96-week Period|Lost to Follow-up|3|||
27650647|NCT00641537|80560504|FG001|96-week Period|Lost to Follow-up|1|||
27650648|NCT00641537|80560505|FG002|96-week Period|Lost to Follow-up|2|||
27650649|NCT00641537|80560506|FG003|96-week Period|Lost to Follow-up|2|||
27650650|NCT00641537|80560507|FG004|96-week Period|Lost to Follow-up|4|||
27650651|NCT00641537|80560508|FG005|96-week Period|Lost to Follow-up|0|||
27650652|NCT00641537|80560509|FG006|96-week Period|Lost to Follow-up|1|||
27650653|NCT00641537|80560510|FG007|96-week Period|Lost to Follow-up|0|||
27650654|NCT00641537|80560503|FG000|96-week Period|Protocol Violation|0|||
27650655|NCT00641537|80560504|FG001|96-week Period|Protocol Violation|1|||
27650656|NCT00641537|80560505|FG002|96-week Period|Protocol Violation|0|||
27650657|NCT00641537|80560506|FG003|96-week Period|Protocol Violation|1|||
27650658|NCT00641537|80560507|FG004|96-week Period|Protocol Violation|0|||
27650659|NCT00641537|80560508|FG005|96-week Period|Protocol Violation|1|||
27650660|NCT00641537|80560509|FG006|96-week Period|Protocol Violation|0|||
27650661|NCT00641537|80560510|FG007|96-week Period|Protocol Violation|0|||
27650662|NCT00641537|80560503|FG000|96-week Period|Death|2|||
27650663|NCT00641537|80560504|FG001|96-week Period|Death|0|||
27650664|NCT00641537|80560505|FG002|96-week Period|Death|1|||
27650665|NCT00641537|80560506|FG003|96-week Period|Death|0|||
27748722|NCT01993329|80906233|FG005|Wash-out|Personal reasons|0|||
27748723|NCT03288779|80906236|FG000|Overall Study|Withdrawal by Subject|3|||
27748724|NCT05523362|80906237|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
27650666|NCT00641537|80560507|FG004|96-week Period|Death|0|||
27650667|NCT00641537|80560508|FG005|96-week Period|Death|0|||
27650668|NCT00641537|80560509|FG006|96-week Period|Death|0|||
27650669|NCT00641537|80560510|FG007|96-week Period|Death|0|||
27650670|NCT00641537|80560503|FG000|96-week Period|Other|4|||
27650671|NCT00641537|80560504|FG001|96-week Period|Other|7|||
27650672|NCT00641537|80560505|FG002|96-week Period|Other|14|||
27650673|NCT00641537|80560506|FG003|96-week Period|Other|9|||
27650674|NCT00641537|80560507|FG004|96-week Period|Other|11|||
27748725|NCT05523362|80906237|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
27748726|NCT05523362|80906237|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
27748727|NCT05523362|80906237|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
27748728|NCT01234402|80906238|FG000|Overall Study|Lost to Follow-up|0|||
27748729|NCT01234402|80906239|FG001|Overall Study|Lost to Follow-up|1|||
27748730|NCT01234402|80906240|FG002|Overall Study|Lost to Follow-up|3|||
27748731|NCT01234402|80906238|FG000|Overall Study|Withdrawal by Subject|1|||
27748732|NCT01234402|80906239|FG001|Overall Study|Withdrawal by Subject|3|||
27748733|NCT01234402|80906240|FG002|Overall Study|Withdrawal by Subject|4|||
27748734|NCT01234402|80906238|FG000|Overall Study|Never treated: Death|0|||
27748735|NCT01234402|80906239|FG001|Overall Study|Never treated: Death|0|||
27748736|NCT01234402|80906240|FG002|Overall Study|Never treated: Death|1|||
27748737|NCT01234402|80906238|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
27748738|NCT01234402|80906239|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
27748739|NCT01234402|80906240|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
27748740|NCT01234402|80906238|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
27748741|NCT01234402|80906239|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
27748742|NCT01234402|80906240|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
27748743|NCT04160468|80906241|FG000|Overall Study|Lost to Follow-up|19|||
27748744|NCT04160468|80906242|FG001|Overall Study|Lost to Follow-up|4|||
27748745|NCT04160468|80906241|FG000|Overall Study|Randomized but not dosed|6|||
27748746|NCT04160468|80906242|FG001|Overall Study|Randomized but not dosed|0|||
27748747|NCT04160468|80906241|FG000|Overall Study|Withdrawal by Subject|4|||
27748748|NCT04160468|80906242|FG001|Overall Study|Withdrawal by Subject|1|||
27748749|NCT04160468|80906241|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
27748750|NCT04160468|80906242|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
27748751|NCT04160468|80906241|FG000|Overall Study|Participant incarcerated|1|||
27748752|NCT04160468|80906242|FG001|Overall Study|Participant incarcerated|0|||
27748753|NCT01971476|80906243|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
27748754|NCT01971476|80906244|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
27748755|NCT01971476|80906245|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
27748756|NCT01971476|80906243|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
27748757|NCT01971476|80906244|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
27748758|NCT01971476|80906245|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
27748759|NCT01971476|80906243|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
27748760|NCT01971476|80906244|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
27748761|NCT01971476|80906245|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
27748762|NCT03011840|80906246|FG000|Overall Study|Not received PIL in post PIL phase|0|||
27748763|NCT03011840|80906247|FG001|Overall Study|Not received PIL in post PIL phase|21|||
27748764|NCT02214186|80906248|FG000|Overall Study|Lost to Follow-up|1|||
27748765|NCT02214186|80906249|FG001|Overall Study|Lost to Follow-up|1|||
27748766|NCT02214186|80906248|FG000|Overall Study|Protocol Violation|1|||
27748767|NCT02214186|80906249|FG001|Overall Study|Protocol Violation|1|||
27748768|NCT00520676|80906254|FG000|Overall Study|Death|84|||
27748769|NCT00520676|80906255|FG001|Overall Study|Death|81|||
27748770|NCT00520676|80906254|FG000|Overall Study|Lost to Follow-up|6|||
27748771|NCT00520676|80906255|FG001|Overall Study|Lost to Follow-up|10|||
27748772|NCT00520676|80906254|FG000|Overall Study|Physician Decision|4|||
27748773|NCT00520676|80906255|FG001|Overall Study|Physician Decision|1|||
27748774|NCT00520676|80906254|FG000|Overall Study|Withdrawal by Subject|7|||
27748775|NCT00520676|80906255|FG001|Overall Study|Withdrawal by Subject|11|||
27748776|NCT03191396|80906256|FG000|Overall Study|Lost to Follow-up|0|||
27748777|NCT03191396|80906257|FG001|Overall Study|Lost to Follow-up|3|||
27748778|NCT03191396|80906256|FG000|Overall Study|Withdrawal by Subject|3|||
27748779|NCT03191396|80906257|FG001|Overall Study|Withdrawal by Subject|2|||
27748780|NCT02775864|80906260|FG000|Overall Study|Data ended end of 2010|1764|||
27748781|NCT02775864|80906261|FG001|Overall Study|Data ended end of 2010|2880|||
27748782|NCT02775864|80906262|FG002|Overall Study|Data ended end of 2010|1140|||
27748783|NCT02775864|80906263|FG003|Overall Study|Data ended end of 2010|1194|||
27748784|NCT02775864|80906260|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
27748785|NCT02775864|80906261|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
27748786|NCT02775864|80906262|FG002|Overall Study|Medicaid eligibility discontinued|720|||
27748787|NCT02775864|80906263|FG003|Overall Study|Medicaid eligibility discontinued|890|||
27748788|NCT00850759|80906264|FG000|Overall Study|Lost to Follow-up|7|||
27748789|NCT00850759|80906265|FG001|Overall Study|Lost to Follow-up|5|||
27748790|NCT00850759|80906266|FG002|Overall Study|Lost to Follow-up|5|||
27748791|NCT00850759|80906267|FG003|Overall Study|Lost to Follow-up|3|||
27748792|NCT00705224|80906268|FG000|Overall Study|Adverse Event|1|||
27748793|NCT00705224|80906268|FG000|Overall Study|Lack of Efficacy|2|||
27748794|NCT00705224|80906268|FG000|Overall Study|Withdrawal by Subject|3|||
27748795|NCT00705224|80906268|FG000|Overall Study|Lost to Follow-up|5|||
27748796|NCT01318083|80906270|FG000|Overall Study|Adverse Event|4|||
27748797|NCT01318083|80906271|FG001|Overall Study|Adverse Event|1|||
27748798|NCT01318083|80906272|FG002|Overall Study|Adverse Event|2|||
27748799|NCT01318083|80906270|FG000|Overall Study|Withdrawal by Subject|1|||
27748800|NCT01318083|80906271|FG001|Overall Study|Withdrawal by Subject|0|||
27748801|NCT01318083|80906272|FG002|Overall Study|Withdrawal by Subject|2|||
27748802|NCT01318083|80906270|FG000|Overall Study|Lack of Efficacy|0|||
27748803|NCT01318083|80906271|FG001|Overall Study|Lack of Efficacy|0|||
27748804|NCT01318083|80906272|FG002|Overall Study|Lack of Efficacy|1|||
27748805|NCT01318083|80906270|FG000|Overall Study|Treatment Complications|1|||
27748806|NCT01318083|80906271|FG001|Overall Study|Treatment Complications|0|||
27748807|NCT01318083|80906272|FG002|Overall Study|Treatment Complications|0|||
27748808|NCT01318083|80906270|FG000|Overall Study|Lack of Study Medication Compliance|0|||
27748809|NCT01318083|80906271|FG001|Overall Study|Lack of Study Medication Compliance|1|||
27748810|NCT01318083|80906272|FG002|Overall Study|Lack of Study Medication Compliance|0|||
27748811|NCT03552549|80906273|FG000|Overall Study|Disease progression|25|||
27748812|NCT03552549|80906274|FG001|Overall Study|Disease progression|17|||
27748813|NCT03552549|80906273|FG000|Overall Study|Adverse event in first 12 months|12|||
27748814|NCT03552549|80906274|FG001|Overall Study|Adverse event in first 12 months|8|||
27748815|NCT03552549|80906273|FG000|Overall Study|Withdrawal by Subject|7|||
27748816|NCT03552549|80906274|FG001|Overall Study|Withdrawal by Subject|7|||
27748817|NCT03552549|80906273|FG000|Overall Study|Unknown (no reason provided)|4|||
27748818|NCT03552549|80906274|FG001|Overall Study|Unknown (no reason provided)|2|||
27748819|NCT03552549|80906273|FG000|Overall Study|Not in participant's best interest|2|||
27748820|NCT03552549|80906274|FG001|Overall Study|Not in participant's best interest|1|||
27748821|NCT03552549|80906273|FG000|Overall Study|Did not complete study treatment|2|||
27748822|NCT03552549|80906274|FG001|Overall Study|Did not complete study treatment|3|||
27748823|NCT03552549|80906273|FG000|Overall Study|Did not meet eligibility criteria|1|||
27748824|NCT03552549|80906274|FG001|Overall Study|Did not meet eligibility criteria|0|||
27748825|NCT03552549|80906273|FG000|Overall Study|Administrative|0|||
27748826|NCT03552549|80906274|FG001|Overall Study|Administrative|14|||
27748827|NCT01931462|80906275|FG000|Overall Study|Withdrawal by Subject|1|||
27748828|NCT01614769|80906280|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
27748829|NCT01614769|80906281|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
27748830|NCT01614769|80906282|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
27748831|NCT01614769|80906283|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
27748832|NCT01614769|80906284|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
27748833|NCT01614769|80906285|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
27748834|NCT01614769|80906280|FG000|Period 1|Protocol Violation|0|||
27748835|NCT01614769|80906281|FG001|Period 1|Protocol Violation|0|||
27748836|NCT01614769|80906282|FG002|Period 1|Protocol Violation|0|||
27748837|NCT01614769|80906283|FG003|Period 1|Protocol Violation|1|||
27748838|NCT01614769|80906284|FG004|Period 1|Protocol Violation|0|||
27748839|NCT01614769|80906285|FG005|Period 1|Protocol Violation|0|||
27748840|NCT01614769|80906280|FG000|Period 1|Withdrawal by Subject|1|||
27748841|NCT01614769|80906281|FG001|Period 1|Withdrawal by Subject|0|||
27748842|NCT01614769|80906282|FG002|Period 1|Withdrawal by Subject|0|||
27748843|NCT01614769|80906283|FG003|Period 1|Withdrawal by Subject|0|||
27748844|NCT01614769|80906284|FG004|Period 1|Withdrawal by Subject|0|||
27748845|NCT01614769|80906285|FG005|Period 1|Withdrawal by Subject|0|||
27748846|NCT01614769|80906280|FG000|Period 3|Withdrawal by Subject|0|||
27748847|NCT01614769|80906281|FG001|Period 3|Withdrawal by Subject|0|||
27748848|NCT01614769|80906282|FG002|Period 3|Withdrawal by Subject|1|||
27748849|NCT01614769|80906283|FG003|Period 3|Withdrawal by Subject|0|||
27748850|NCT01614769|80906284|FG004|Period 3|Withdrawal by Subject|0|||
27748851|NCT01614769|80906285|FG005|Period 3|Withdrawal by Subject|0|||
27748852|NCT02951988|80906286|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
27748853|NCT02951988|80906287|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
27748854|NCT02951988|80906288|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
27748855|NCT02951988|80906289|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
27748856|NCT02951988|80906286|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
27748857|NCT02951988|80906287|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
27748858|NCT02951988|80906288|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
27748859|NCT02951988|80906289|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
27748860|NCT02951988|80906286|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
27748861|NCT02951988|80906287|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
27748862|NCT02951988|80906288|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
27950142|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950143|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27748863|NCT02951988|80906289|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
27748864|NCT02951988|80906286|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
27748865|NCT02951988|80906287|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
27748866|NCT02951988|80906288|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
27748867|NCT02951988|80906289|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
27748868|NCT02951988|80906286|FG000|Open-Label Treatment Period|Protocol Violation|22|||
27748869|NCT02951988|80906287|FG001|Open-Label Treatment Period|Protocol Violation|0|||
27748870|NCT02951988|80906288|FG002|Open-Label Treatment Period|Protocol Violation|0|||
27748871|NCT02951988|80906289|FG003|Open-Label Treatment Period|Protocol Violation|0|||
27748872|NCT02951988|80906286|FG000|Open-Label Treatment Period|Pregnancy|2|||
27950144|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27748873|NCT02951988|80906287|FG001|Open-Label Treatment Period|Pregnancy|0|||
27748874|NCT02951988|80906288|FG002|Open-Label Treatment Period|Pregnancy|0|||
27748875|NCT02951988|80906289|FG003|Open-Label Treatment Period|Pregnancy|0|||
27748876|NCT02951988|80906286|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
27748877|NCT02951988|80906287|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
27748878|NCT02951988|80906288|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
27748879|NCT02951988|80906289|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
27748880|NCT02951988|80906286|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
27748881|NCT02951988|80906287|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
27748882|NCT02951988|80906288|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
27748883|NCT02951988|80906289|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
27650675|NCT00641537|80560508|FG005|96-week Period|Other|6|||
27650676|NCT00641537|80560509|FG006|96-week Period|Other|4|||
27650677|NCT00641537|80560510|FG007|96-week Period|Other|6|||
27650678|NCT00641537|80560503|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
27650679|NCT00641537|80560504|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
27650680|NCT00641537|80560505|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
27650681|NCT00641537|80560506|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
27650682|NCT00641537|80560507|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
27650683|NCT00641537|80560508|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
27650684|NCT00641537|80560509|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
27650685|NCT00641537|80560510|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
27650686|NCT00641537|80560503|FG000|24-Week Supplemental Follow-up Period|Other|0|||
27650687|NCT00641537|80560504|FG001|24-Week Supplemental Follow-up Period|Other|2|||
27650688|NCT00641537|80560505|FG002|24-Week Supplemental Follow-up Period|Other|2|||
27650689|NCT00641537|80560506|FG003|24-Week Supplemental Follow-up Period|Other|1|||
27650690|NCT00641537|80560507|FG004|24-Week Supplemental Follow-up Period|Other|3|||
27650691|NCT00641537|80560508|FG005|24-Week Supplemental Follow-up Period|Other|0|||
27650692|NCT00641537|80560509|FG006|24-Week Supplemental Follow-up Period|Other|1|||
27650693|NCT00641537|80560510|FG007|24-Week Supplemental Follow-up Period|Other|1|||
27650694|NCT03065400|80560511|FG000|Overall Study|Adverse Event|1|||
27650695|NCT03065400|80560511|FG000|Overall Study|Physician Decision|3|||
27650696|NCT03065400|80560511|FG000|Overall Study|Withdrawal by Subject|1|||
27650697|NCT03065400|80560511|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
27650698|NCT03890484|80560512|FG000|Overall Study|Lost to Follow-up|1|||
27650699|NCT03890484|80560513|FG001|Overall Study|Lost to Follow-up|1|||
27650700|NCT04213807|80560514|FG000|Overall Study|Physician Decision|0|||
27650701|NCT04213807|80560515|FG001|Overall Study|Physician Decision|0|||
27650702|NCT04213807|80560516|FG002|Overall Study|Physician Decision|1|||
27650703|NCT01138657|80560519|FG000|Overall Study|Adverse Event|3|||
27650704|NCT01138657|80560520|FG001|Overall Study|Adverse Event|10|||
27650705|NCT01138657|80560519|FG000|Overall Study|Lack of Efficacy|2|||
27650706|NCT01138657|80560520|FG001|Overall Study|Lack of Efficacy|1|||
27650707|NCT01138657|80560519|FG000|Overall Study|Lost to Follow-up|0|||
27650708|NCT01138657|80560520|FG001|Overall Study|Lost to Follow-up|3|||
27650709|NCT01138657|80560519|FG000|Overall Study|Miscellaneous Reasons|3|||
27650710|NCT01138657|80560520|FG001|Overall Study|Miscellaneous Reasons|4|||
27650711|NCT03150589|80560521|FG000|Overall Study|Withdrawal by Subject|16|||
27650712|NCT03150589|80560522|FG001|Overall Study|Withdrawal by Subject|9|||
27650713|NCT03150589|80560521|FG000|Overall Study|Adverse Event|7|||
27650714|NCT03150589|80560522|FG001|Overall Study|Adverse Event|6|||
27650715|NCT03150589|80560521|FG000|Overall Study|Protocol Violation|4|||
27650716|NCT03150589|80560522|FG001|Overall Study|Protocol Violation|3|||
27650717|NCT03150589|80560521|FG000|Overall Study|Lost to Follow-up|3|||
27650718|NCT03150589|80560522|FG001|Overall Study|Lost to Follow-up|3|||
27650719|NCT03150589|80560521|FG000|Overall Study|Death|2|||
27650720|NCT03150589|80560522|FG001|Overall Study|Death|3|||
27650721|NCT03150589|80560521|FG000|Overall Study|IP non-compliance and other reasons|12|||
27650722|NCT03150589|80560522|FG001|Overall Study|IP non-compliance and other reasons|3|||
27650723|NCT03820024|80560525|FG000|Overall Study|Physician Decision|1|||
27650724|NCT03820024|80560526|FG001|Overall Study|Physician Decision|2|||
27650725|NCT00983294|80560527|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
27748884|NCT02951988|80906286|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
27650726|NCT00983294|80560527|FG000|Colchicine With Azithromycin|Adverse Event|1|||
27650727|NCT02442622|80560531|FG000|Overall Study|Withdrawal by Subject|3|||
27650728|NCT02442622|80560532|FG001|Overall Study|Withdrawal by Subject|1|||
27650729|NCT01419184|80560536|FG000|Overall Study|Site data not available|3|||
27650730|NCT01419184|80560537|FG001|Overall Study|Site data not available|2|||
27650731|NCT01419184|80560536|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
27650732|NCT01419184|80560537|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
27650733|NCT01419184|80560536|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
27650734|NCT01419184|80560537|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
27650735|NCT01419184|80560536|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
27650736|NCT01419184|80560537|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
27748885|NCT02951988|80906287|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
27748886|NCT02951988|80906288|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
27748887|NCT02951988|80906289|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
27748888|NCT02951988|80906286|FG000|Open-Label Treatment Period|Adverse Event|45|||
27748889|NCT02951988|80906287|FG001|Open-Label Treatment Period|Adverse Event|0|||
27748890|NCT02951988|80906288|FG002|Open-Label Treatment Period|Adverse Event|0|||
27748891|NCT02951988|80906289|FG003|Open-Label Treatment Period|Adverse Event|0|||
27748892|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
27748893|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
27748894|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
27748895|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
27748896|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
27748897|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
27748898|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
27748899|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
27748900|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
27748901|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
27748902|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
27748903|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
27748904|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
27748905|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
27748906|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
27748907|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
27748908|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Pregnancy|0|||
27748909|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Pregnancy|1|||
27748910|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Pregnancy|1|||
27748911|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Pregnancy|0|||
27748912|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
27748913|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
27748914|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
27748915|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
27748916|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
27650737|NCT01419184|80560536|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
27650738|NCT01419184|80560537|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
27650739|NCT01419184|80560536|FG000|Overall Study|Participant randomized, not treated|1|||
27650740|NCT01419184|80560537|FG001|Overall Study|Participant randomized, not treated|0|||
27650741|NCT03345979|80560542|FG000|Overall Study|Withdrawal by Subject|20|||
27650742|NCT03345979|80560543|FG001|Overall Study|Withdrawal by Subject|31|||
27650743|NCT03345979|80560542|FG000|Overall Study|Adverse Event|10|||
27650744|NCT03345979|80560543|FG001|Overall Study|Adverse Event|11|||
27650745|NCT03345979|80560542|FG000|Overall Study|Lost to Follow-up|8|||
27650746|NCT03345979|80560543|FG001|Overall Study|Lost to Follow-up|9|||
27650747|NCT03345979|80560542|FG000|Overall Study|Lack of Efficacy|4|||
27650748|NCT03345979|80560543|FG001|Overall Study|Lack of Efficacy|2|||
27650749|NCT03345979|80560542|FG000|Overall Study|Protocol Violation|1|||
27650750|NCT03345979|80560543|FG001|Overall Study|Protocol Violation|3|||
27650751|NCT03345979|80560542|FG000|Overall Study|Physician Decision|0|||
27650752|NCT03345979|80560543|FG001|Overall Study|Physician Decision|2|||
27650753|NCT03128099|80560546|FG000|Overall Study|High dose task was too long|0|||
27650754|NCT03128099|80560547|FG001|Overall Study|High dose task was too long|4|||
27650755|NCT03128099|80560548|FG002|Overall Study|High dose task was too long|0|||
27650756|NCT03128099|80560546|FG000|Overall Study|Participant got a full time job.|1|||
27650757|NCT03128099|80560547|FG001|Overall Study|Participant got a full time job.|0|||
27650758|NCT03128099|80560548|FG002|Overall Study|Participant got a full time job.|0|||
27650759|NCT03128099|80560546|FG000|Overall Study|Became homeless and lost contact|1|||
27650760|NCT03128099|80560547|FG001|Overall Study|Became homeless and lost contact|0|||
27650761|NCT03128099|80560548|FG002|Overall Study|Became homeless and lost contact|0|||
27650762|NCT03128099|80560546|FG000|Overall Study|Did not complete all the assessments|0|||
27650763|NCT03128099|80560547|FG001|Overall Study|Did not complete all the assessments|0|||
27650764|NCT03128099|80560548|FG002|Overall Study|Did not complete all the assessments|1|||
27650765|NCT02232737|80560549|FG000|Overall Study|Lost to Follow-up|18|||
27650766|NCT02232737|80560550|FG001|Overall Study|Lost to Follow-up|28|||
27748917|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
27748918|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
27650767|NCT02232737|80560551|FG002|Overall Study|Lost to Follow-up|33|||
27650768|NCT02232737|80560549|FG000|Overall Study|Personal reasons|7|||
27650769|NCT02232737|80560550|FG001|Overall Study|Personal reasons|8|||
27650770|NCT02232737|80560551|FG002|Overall Study|Personal reasons|14|||
27650771|NCT02232737|80560549|FG000|Overall Study|Adverse Event|6|||
27650772|NCT02232737|80560550|FG001|Overall Study|Adverse Event|3|||
27650773|NCT02232737|80560551|FG002|Overall Study|Adverse Event|8|||
27748919|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
27748920|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27748921|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Adverse Event|8|||
27748922|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Adverse Event|3|||
27748923|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Adverse Event|6|||
27748924|NCT02951988|80906286|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
27748925|NCT02951988|80906287|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
27748926|NCT02951988|80906288|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
27748927|NCT02951988|80906289|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
27748928|NCT03201198|80906290|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
27748929|NCT03201198|80906291|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
27748930|NCT03201198|80906290|FG000|Overall Study|Withdrawal by Subject|2|||
27748931|NCT03201198|80906291|FG001|Overall Study|Withdrawal by Subject|3|||
27748932|NCT01849250|80906292|FG000|Overall Study|Withdrawal by Subject|1|||
27748933|NCT01849250|80906293|FG001|Overall Study|Withdrawal by Subject|0|||
27748934|NCT01849250|80906292|FG000|Overall Study|Not Evaluable|5|||
27748935|NCT01849250|80906293|FG001|Overall Study|Not Evaluable|3|||
27748936|NCT01849250|80906292|FG000|Overall Study|Screen Failure|1|||
27748937|NCT01849250|80906293|FG001|Overall Study|Screen Failure|0|||
27748938|NCT01954121|80906296|FG000|Overall Study|Lack of Efficacy|94|||
27748939|NCT01954121|80906297|FG001|Overall Study|Lack of Efficacy|41|||
27748940|NCT01954121|80906296|FG000|Overall Study|Protocol Violation|0|||
27748941|NCT01954121|80906297|FG001|Overall Study|Protocol Violation|2|||
27748942|NCT01954121|80906296|FG000|Overall Study|Lost to Follow-up|5|||
27748943|NCT01954121|80906297|FG001|Overall Study|Lost to Follow-up|6|||
27748944|NCT01954121|80906296|FG000|Overall Study|Withdrawal by Subject|18|||
27748945|NCT01954121|80906297|FG001|Overall Study|Withdrawal by Subject|12|||
27748946|NCT01954121|80906296|FG000|Overall Study|Pregnancy|1|||
27748947|NCT01954121|80906297|FG001|Overall Study|Pregnancy|1|||
27748948|NCT01954121|80906296|FG000|Overall Study|AE, serious fatal|1|||
27748949|NCT01954121|80906297|FG001|Overall Study|AE, serious fatal|0|||
27950145|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
27650774|NCT02232737|80560549|FG000|Overall Study|Incarcerated|2|||
27650775|NCT02232737|80560550|FG001|Overall Study|Incarcerated|1|||
27650776|NCT02232737|80560551|FG002|Overall Study|Incarcerated|2|||
27650777|NCT02232737|80560549|FG000|Overall Study|Withdrawal by Subject|0|||
27650778|NCT02232737|80560550|FG001|Overall Study|Withdrawal by Subject|1|||
27650779|NCT02232737|80560551|FG002|Overall Study|Withdrawal by Subject|2|||
27650780|NCT02232737|80560549|FG000|Overall Study|Death|0|||
27650781|NCT02232737|80560550|FG001|Overall Study|Death|1|||
27650782|NCT02232737|80560551|FG002|Overall Study|Death|1|||
27650783|NCT02232737|80560549|FG000|Overall Study|Physician Decision|1|||
27650784|NCT02232737|80560550|FG001|Overall Study|Physician Decision|3|||
27650785|NCT02232737|80560551|FG002|Overall Study|Physician Decision|1|||
27650786|NCT02232737|80560549|FG000|Overall Study|Protocol Violation|1|||
27650787|NCT02232737|80560550|FG001|Overall Study|Protocol Violation|0|||
27650788|NCT02232737|80560551|FG002|Overall Study|Protocol Violation|1|||
27650789|NCT02232737|80560549|FG000|Overall Study|Reason unknown|1|||
27650790|NCT02232737|80560550|FG001|Overall Study|Reason unknown|0|||
27650791|NCT02232737|80560551|FG002|Overall Study|Reason unknown|0|||
27650792|NCT03652610|80560554|FG000|Overall Study|Lost to Follow-up|1|||
27650793|NCT03652610|80560555|FG001|Overall Study|Lost to Follow-up|0|||
27650794|NCT03652610|80560554|FG000|Overall Study|Withdrawal by Subject|3|||
27650795|NCT03652610|80560555|FG001|Overall Study|Withdrawal by Subject|5|||
27650796|NCT02993926|80560556|FG000|Enantone Treatment Phase|Adverse Event|1|||
27650797|NCT02993926|80560557|FG001|Enantone Treatment Phase|Adverse Event|0|||
27650798|NCT02993926|80560558|FG002|Enantone Treatment Phase|Adverse Event|0|||
27650799|NCT02993926|80560556|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
27650800|NCT02993926|80560557|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
27650801|NCT02993926|80560558|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
27650802|NCT02993926|80560556|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
27650803|NCT02993926|80560557|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
27650804|NCT02993926|80560558|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
27748950|NCT01954121|80906296|FG000|Overall Study|AE, non-serious non-fatal|5|||
27748951|NCT01954121|80906297|FG001|Overall Study|AE, non-serious non-fatal|22|||
27748952|NCT01954121|80906296|FG000|Overall Study|SAE, non-fatal|1|||
27748953|NCT01954121|80906297|FG001|Overall Study|SAE, non-fatal|4|||
27748954|NCT01954121|80906296|FG000|Overall Study|Non-compliant with study procedures|1|||
27748955|NCT01954121|80906297|FG001|Overall Study|Non-compliant with study procedures|0|||
27650805|NCT02993926|80560556|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
27650806|NCT02993926|80560557|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
27650807|NCT02993926|80560558|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
27650808|NCT02203799|80560559|FG000|Overall Study|Withdrawal by Subject|3|||
27650809|NCT04803734|80560561|FG000|Overall Study|Withdrawal by Subject|0|||
27748956|NCT01954121|80906296|FG000|Overall Study|Non-compliant patient|1|||
27748957|NCT01954121|80906297|FG001|Overall Study|Non-compliant patient|1|||
27748958|NCT01954121|80906296|FG000|Overall Study|Subject did not follow instructions|0|||
27748959|NCT01954121|80906297|FG001|Overall Study|Subject did not follow instructions|2|||
27748960|NCT00084682|80906298|FG000|Overall Study|Withdrawal by Subject|1|||
27748961|NCT02750813|80906299|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
27748962|NCT02750813|80906300|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
27748963|NCT02750813|80906299|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
27748964|NCT02750813|80906300|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
27748965|NCT01984346|80906301|FG000|Overall Study|Physician Decision|4|||
27748966|NCT01984346|80906302|FG001|Overall Study|Physician Decision|2|||
27748967|NCT01984346|80906301|FG000|Overall Study|Withdrawal by Subject|2|||
27748968|NCT01984346|80906302|FG001|Overall Study|Withdrawal by Subject|2|||
27748969|NCT01984346|80906301|FG000|Overall Study|Enrollment Closed|8|||
27748970|NCT01984346|80906302|FG001|Overall Study|Enrollment Closed|1|||
27748971|NCT01984346|80906301|FG000|Overall Study|Insurance Coverage|1|||
27748972|NCT01984346|80906302|FG001|Overall Study|Insurance Coverage|0|||
27748973|NCT01984346|80906301|FG000|Overall Study|Intra-operative Exclusion|2|||
27748974|NCT01984346|80906302|FG001|Overall Study|Intra-operative Exclusion|0|||
27748975|NCT02179515|80906303|FG000|Overall Study|switched to alternative treatment|0|||
27748976|NCT02179515|80906304|FG001|Overall Study|switched to alternative treatment|1|||
27748977|NCT02179515|80906305|FG002|Overall Study|switched to alternative treatment|1|||
27748978|NCT02179515|80906303|FG000|Overall Study|Death|0|||
27748979|NCT02179515|80906304|FG001|Overall Study|Death|1|||
27748980|NCT02179515|80906305|FG002|Overall Study|Death|1|||
27748981|NCT02179515|80906303|FG000|Overall Study|refused further treatment|0|||
27748982|NCT02179515|80906304|FG001|Overall Study|refused further treatment|3|||
27748983|NCT02179515|80906305|FG002|Overall Study|refused further treatment|4|||
27748984|NCT02179515|80906303|FG000|Overall Study|Disease progression on study|2|||
27748985|NCT02179515|80906304|FG001|Overall Study|Disease progression on study|11|||
27748986|NCT02179515|80906305|FG002|Overall Study|Disease progression on study|8|||
27748987|NCT00872170|80906309|FG000|Overall Study|Adverse Event|1|||
27748988|NCT00872170|80906310|FG001|Overall Study|Adverse Event|0|||
27748989|NCT01295905|80906311|FG000|Overall Study|Did not meet inclusion criteria|1|||
27748990|NCT01295905|80906312|FG001|Overall Study|Did not meet inclusion criteria|0|||
27748991|NCT01295905|80906311|FG000|Overall Study|Met exclusion criteria|1|||
27748992|NCT01295905|80906312|FG001|Overall Study|Met exclusion criteria|0|||
27748993|NCT02869867|80906313|FG000|Overall Study|Protocol Violation|1|||
27748994|NCT02869867|80906314|FG001|Overall Study|Protocol Violation|0|||
27748995|NCT02869867|80906313|FG000|Overall Study|Lost to Follow-up|5|||
27748996|NCT02869867|80906314|FG001|Overall Study|Lost to Follow-up|5|||
27748997|NCT01879618|80906315|FG000|Overall Study|Does not meet entrance criteria|1|||
27748998|NCT01879618|80906315|FG000|Overall Study|Withdrawal by Subject|1|||
27748999|NCT01879618|80906315|FG000|Overall Study|Surgery;changed schedule; not available|8|||
27749000|NCT01879618|80906315|FG000|Overall Study|Protocol Violation|6|||
27749001|NCT01879618|80906315|FG000|Overall Study|Adverse Event|5|||
27749002|NCT00540436|80906322|FG000|First 12-Week Treatment Period|Adverse Event|1|||
27749003|NCT00540436|80906322|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
27749004|NCT00540436|80906322|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
27749005|NCT00540436|80906322|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
27749006|NCT00001262|80906328|FG000|Overall Study|Death|10|||
27749007|NCT00001262|80906329|FG001|Overall Study|Death|11|||
27749008|NCT00001262|80906330|FG002|Overall Study|Death|0|||
27749009|NCT00001262|80906328|FG000|Overall Study|Withdrawal by Subject|0|||
27749010|NCT00001262|80906329|FG001|Overall Study|Withdrawal by Subject|3|||
27749011|NCT00001262|80906330|FG002|Overall Study|Withdrawal by Subject|0|||
27749012|NCT03283163|80906331|FG000|Overall Study|Lost to Follow-up|1|||
27749013|NCT03283163|80906331|FG000|Overall Study|other life commitments|6|||
27749014|NCT03283163|80906331|FG000|Overall Study|COVID-19 institution wide halting|1|||
27749015|NCT03283163|80906331|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
27749016|NCT03283163|80906331|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
27749017|NCT01199263|80906332|FG000|Overall Study|Ineligible|0|||
27749018|NCT01199263|80906333|FG001|Overall Study|Ineligible|2|||
27749019|NCT01199263|80906332|FG000|Overall Study|Never Treated|6|||
27749020|NCT01199263|80906333|FG001|Overall Study|Never Treated|0|||
27749021|NCT01455428|80906341|FG000|Overall Study|Protocol Violation|2|||
27749022|NCT01455428|80906342|FG001|Overall Study|Protocol Violation|1|||
27749023|NCT01455428|80906341|FG000|Overall Study|Adverse Event|6|||
27749024|NCT01455428|80906342|FG001|Overall Study|Adverse Event|2|||
27749025|NCT01455428|80906341|FG000|Overall Study|Lost to Follow-up|1|||
27749026|NCT01455428|80906342|FG001|Overall Study|Lost to Follow-up|1|||
27749027|NCT01455428|80906341|FG000|Overall Study|Withdrawal by Subject|2|||
27749028|NCT01455428|80906342|FG001|Overall Study|Withdrawal by Subject|5|||
27749029|NCT01455428|80906341|FG000|Overall Study|Did not meet entrance criteria|0|||
27749030|NCT01455428|80906342|FG001|Overall Study|Did not meet entrance criteria|2|||
27749031|NCT01455428|80906341|FG000|Overall Study|Insufficient clinical response|0|||
27749032|NCT01455428|80906342|FG001|Overall Study|Insufficient clinical response|2|||
27749033|NCT01455428|80906341|FG000|Overall Study|Did not receive treatment|1|||
27749034|NCT01455428|80906342|FG001|Overall Study|Did not receive treatment|1|||
27749035|NCT01455428|80906341|FG000|Overall Study|Other|2|||
27749036|NCT01455428|80906342|FG001|Overall Study|Other|4|||
27749037|NCT02460822|80906345|FG000|Overall Study|Withdrawal by Subject|1|||
27749038|NCT01930799|80906348|FG000|Overall Study|Withdrawal by Subject|3|||
27749039|NCT01930799|80906348|FG000|Overall Study|Lost to Follow-up|5|||
27749040|NCT00392171|80906349|FG000|Overall Study|Did not meet inclusion criteria|4|||
27749041|NCT00392171|80906349|FG000|Overall Study|Disease progression|101|||
27749042|NCT04436822|80906351|FG000|Overall Study|Physician Decision|2|||
27749043|NCT04436822|80906352|FG001|Overall Study|Physician Decision|0|||
27749044|NCT04436822|80906351|FG000|Overall Study|Sponsor request|1|||
27749045|NCT04436822|80906352|FG001|Overall Study|Sponsor request|0|||
27749046|NCT04436822|80906351|FG000|Overall Study|Withdrawal by parent/guardian|0|||
27749047|NCT04436822|80906352|FG001|Overall Study|Withdrawal by parent/guardian|3|||
27749048|NCT04436822|80906351|FG000|Overall Study|Unsuccessful procedure|0|||
27749049|NCT04436822|80906352|FG001|Overall Study|Unsuccessful procedure|1|||
27749050|NCT04436822|80906351|FG000|Overall Study|Withdrawal due to Covid-19|8|||
27749051|NCT04436822|80906352|FG001|Overall Study|Withdrawal due to Covid-19|1|||
27749052|NCT04436822|80906351|FG000|Overall Study|Withdrawal by Subject|1|||
27749053|NCT04436822|80906352|FG001|Overall Study|Withdrawal by Subject|0|||
27749054|NCT04436822|80906351|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
27749055|NCT04436822|80906352|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
27749056|NCT00321984|80906353|FG000|Overall Study|Adverse Event|9|||
27749057|NCT00321984|80906354|FG001|Overall Study|Adverse Event|6|||
27749058|NCT00321984|80906355|FG002|Overall Study|Adverse Event|8|||
27749059|NCT00321984|80906353|FG000|Overall Study|Protocol Violation|0|||
27749060|NCT00321984|80906354|FG001|Overall Study|Protocol Violation|1|||
27749061|NCT00321984|80906355|FG002|Overall Study|Protocol Violation|1|||
27749062|NCT00321984|80906353|FG000|Overall Study|Lost to Follow-up|2|||
27749063|NCT00321984|80906354|FG001|Overall Study|Lost to Follow-up|4|||
27749064|NCT00321984|80906355|FG002|Overall Study|Lost to Follow-up|2|||
27749065|NCT00321984|80906353|FG000|Overall Study|Withdrawal by Subject|8|||
27749066|NCT00321984|80906354|FG001|Overall Study|Withdrawal by Subject|6|||
27749067|NCT00321984|80906355|FG002|Overall Study|Withdrawal by Subject|5|||
27749068|NCT00321984|80906353|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
27749069|NCT00321984|80906354|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
27749070|NCT00321984|80906355|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
27749071|NCT00321984|80906353|FG000|Overall Study|Lack of Efficacy|3|||
27749072|NCT00321984|80906354|FG001|Overall Study|Lack of Efficacy|1|||
27749073|NCT00321984|80906355|FG002|Overall Study|Lack of Efficacy|3|||
27749074|NCT00321984|80906353|FG000|Overall Study|Noncompliant|0|||
27749075|NCT00321984|80906354|FG001|Overall Study|Noncompliant|0|||
27749076|NCT00321984|80906355|FG002|Overall Study|Noncompliant|2|||
27749077|NCT00321984|80906353|FG000|Overall Study|Pregnancy|0|||
27749078|NCT00321984|80906354|FG001|Overall Study|Pregnancy|1|||
27749079|NCT00321984|80906355|FG002|Overall Study|Pregnancy|0|||
27749080|NCT00321984|80906353|FG000|Overall Study|Per Subject Request|1|||
27749081|NCT00321984|80906354|FG001|Overall Study|Per Subject Request|0|||
27749082|NCT00321984|80906355|FG002|Overall Study|Per Subject Request|0|||
27749083|NCT00321984|80906353|FG000|Overall Study|Per Investigator Request|1|||
27749084|NCT00321984|80906354|FG001|Overall Study|Per Investigator Request|0|||
27749085|NCT00321984|80906355|FG002|Overall Study|Per Investigator Request|0|||
27749086|NCT00321984|80906353|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
27749087|NCT00321984|80906354|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
27749088|NCT00321984|80906355|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
27749089|NCT01721408|80906358|FG000|Overall Study|Adverse Event|6|||
27749090|NCT01721408|80906359|FG001|Overall Study|Adverse Event|1|||
27749091|NCT01721408|80906358|FG000|Overall Study|Death|1|||
27749092|NCT01721408|80906359|FG001|Overall Study|Death|0|||
27749093|NCT01721408|80906358|FG000|Overall Study|Insufficient clinical response|15|||
27749094|NCT01721408|80906359|FG001|Overall Study|Insufficient clinical response|6|||
27749095|NCT01721408|80906358|FG000|Overall Study|No longer willing to participate study|9|||
27749096|NCT01721408|80906359|FG001|Overall Study|No longer willing to participate study|10|||
27749097|NCT01721408|80906358|FG000|Overall Study|Protocol Violation|0|||
27749098|NCT01721408|80906359|FG001|Overall Study|Protocol Violation|2|||
27749099|NCT01721408|80906358|FG000|Overall Study|Other|3|||
27749100|NCT01721408|80906359|FG001|Overall Study|Other|3|||
27749101|NCT01721408|80906358|FG000|Overall Study|Lost to Follow-up|1|||
27749102|NCT01721408|80906359|FG001|Overall Study|Lost to Follow-up|2|||
27749103|NCT01721408|80906358|FG000|Overall Study|Does not meet entrance criteria|1|||
27749104|NCT01721408|80906359|FG001|Overall Study|Does not meet entrance criteria|0|||
27749105|NCT01850563|80906360|FG000|Overall Study|Not eligible|3|||
27749106|NCT01850563|80906361|FG001|Overall Study|Not eligible|0|||
27749107|NCT01912729|80906376|FG000|Overall Study|Withdrawal by Subject|0|||
27749108|NCT01912729|80906377|FG001|Overall Study|Withdrawal by Subject|1|||
27749109|NCT00303108|80906378|FG000|Overall Study|Adverse Event|5|||
27749110|NCT00303108|80906379|FG001|Overall Study|Adverse Event|6|||
27749111|NCT00303108|80906380|FG002|Overall Study|Adverse Event|7|||
27749112|NCT00303108|80906378|FG000|Overall Study|Patient Request|4|||
27749113|NCT00303108|80906379|FG001|Overall Study|Patient Request|2|||
27749114|NCT00303108|80906380|FG002|Overall Study|Patient Request|8|||
27749115|NCT00303108|80906378|FG000|Overall Study|Failed Entry|1|||
27749116|NCT00303108|80906379|FG001|Overall Study|Failed Entry|0|||
27749117|NCT00303108|80906380|FG002|Overall Study|Failed Entry|1|||
27749118|NCT00303108|80906378|FG000|Overall Study|ineligible|2|||
27749119|NCT00303108|80906379|FG001|Overall Study|ineligible|1|||
27749120|NCT00303108|80906380|FG002|Overall Study|ineligible|0|||
27749121|NCT02742649|80906381|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
27749122|NCT02742649|80906382|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27749123|NCT02742649|80906383|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27749124|NCT02742649|80906384|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27749125|NCT02742649|80906385|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
27749126|NCT02742649|80906381|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27749127|NCT02742649|80906382|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27749128|NCT02742649|80906383|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27749129|NCT02742649|80906384|FG003|Double-Blind Treatment Period|Adverse Event|0|||
27749130|NCT02742649|80906385|FG004|Double-Blind Treatment Period|Adverse Event|0|||
27749131|NCT02742649|80906381|FG000|Open-Label Period|Lost to Follow-up|0|||
27749132|NCT02742649|80906382|FG001|Open-Label Period|Lost to Follow-up|0|||
27749133|NCT02742649|80906383|FG002|Open-Label Period|Lost to Follow-up|0|||
27749134|NCT02742649|80906384|FG003|Open-Label Period|Lost to Follow-up|0|||
27749135|NCT02742649|80906385|FG004|Open-Label Period|Lost to Follow-up|1|||
27749136|NCT01035606|80906389|FG000|Overall Study|change in health, job demands,family|3|||
27749137|NCT01035606|80906390|FG001|Overall Study|change in health, job demands,family|3|||
27749138|NCT01035606|80906391|FG002|Overall Study|change in health, job demands,family|4|||
27749139|NCT03072719|80906392|FG000|Overall Study|Adverse Event|1|||
27749140|NCT03072719|80906393|FG001|Overall Study|Adverse Event|1|||
27749141|NCT00527111|80906394|FG000|Overall Study|Adverse Event|14|||
27749142|NCT00527111|80906395|FG001|Overall Study|Adverse Event|13|||
27749143|NCT00527111|80906394|FG000|Overall Study|Death|0|||
27749144|NCT00527111|80906395|FG001|Overall Study|Death|1|||
27749145|NCT00527111|80906394|FG000|Overall Study|Investigator Request|2|||
27749146|NCT00527111|80906395|FG001|Overall Study|Investigator Request|1|||
27749147|NCT00527111|80906394|FG000|Overall Study|Patient Request|2|||
27749148|NCT00527111|80906395|FG001|Overall Study|Patient Request|5|||
27749149|NCT00527111|80906394|FG000|Overall Study|Other|2|||
27749150|NCT00527111|80906395|FG001|Overall Study|Other|2|||
27749151|NCT02435277|80906401|FG000|Overall Study|Adverse Event|1|||
27749152|NCT02435277|80906402|FG001|Overall Study|Adverse Event|1|||
27749153|NCT02435277|80906403|FG002|Overall Study|Adverse Event|0|||
27749154|NCT02435277|80906404|FG003|Overall Study|Adverse Event|0|||
27749155|NCT02435277|80906401|FG000|Overall Study|Withdrawal by Subject|1|||
27749156|NCT02435277|80906402|FG001|Overall Study|Withdrawal by Subject|0|||
27749157|NCT02435277|80906403|FG002|Overall Study|Withdrawal by Subject|0|||
27749158|NCT02435277|80906404|FG003|Overall Study|Withdrawal by Subject|0|||
27749159|NCT00748540|80906407|FG000|Overall Study|Physician Decision|1|||
27749160|NCT00913978|80906409|FG000|Overall Study|Surgeon choice|1|||
27749161|NCT00913978|80906410|FG001|Overall Study|Surgeon choice|3|||
27749162|NCT03161678|80906418|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
27749163|NCT03161678|80906419|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
27749164|NCT03161678|80906420|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
27749165|NCT03161678|80906421|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
27749166|NCT03161678|80906422|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
27749167|NCT03161678|80906423|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
27749168|NCT03161678|80906418|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
27749169|NCT03161678|80906419|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
27749170|NCT03161678|80906420|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
27749171|NCT03161678|80906421|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
27749172|NCT03161678|80906422|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
27749173|NCT03161678|80906423|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
27749174|NCT03161678|80906418|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
27749175|NCT03161678|80906419|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
27749176|NCT03161678|80906420|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
27749177|NCT03161678|80906421|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
27749178|NCT03161678|80906422|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
27749179|NCT03161678|80906423|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
27749180|NCT03161678|80906418|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
27749181|NCT03161678|80906419|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
27749182|NCT03161678|80906420|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
27749183|NCT03161678|80906421|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
27749184|NCT03161678|80906422|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
27749185|NCT03161678|80906423|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
27749186|NCT00960440|80906425|FG000|Overall Study|Death|0|||
27749187|NCT00960440|80906426|FG001|Overall Study|Death|0|||
27749188|NCT00960440|80906427|FG002|Overall Study|Death|0|||
27749189|NCT00960440|80906428|FG003|Overall Study|Death|1|||
27749190|NCT00960440|80906425|FG000|Overall Study|Adverse Event|12|||
27749191|NCT00960440|80906426|FG001|Overall Study|Adverse Event|12|||
27749192|NCT00960440|80906427|FG002|Overall Study|Adverse Event|4|||
27749193|NCT00960440|80906428|FG003|Overall Study|Adverse Event|4|||
27749194|NCT00960440|80906425|FG000|Overall Study|Lack of Efficacy|2|||
27749195|NCT00960440|80906426|FG001|Overall Study|Lack of Efficacy|5|||
27749196|NCT00960440|80906427|FG002|Overall Study|Lack of Efficacy|3|||
27749197|NCT00960440|80906428|FG003|Overall Study|Lack of Efficacy|8|||
27749198|NCT00960440|80906425|FG000|Overall Study|Protocol Violation|2|||
27749199|NCT00960440|80906426|FG001|Overall Study|Protocol Violation|8|||
27749200|NCT00960440|80906427|FG002|Overall Study|Protocol Violation|3|||
27749201|NCT00960440|80906428|FG003|Overall Study|Protocol Violation|4|||
27749202|NCT00960440|80906425|FG000|Overall Study|Withdrawal by Subject|9|||
27749203|NCT00960440|80906426|FG001|Overall Study|Withdrawal by Subject|5|||
27749204|NCT00960440|80906427|FG002|Overall Study|Withdrawal by Subject|2|||
27749205|NCT00960440|80906428|FG003|Overall Study|Withdrawal by Subject|1|||
27749206|NCT00960440|80906425|FG000|Overall Study|Other|1|||
27749207|NCT00960440|80906426|FG001|Overall Study|Other|1|||
27749208|NCT00960440|80906427|FG002|Overall Study|Other|1|||
27749209|NCT00960440|80906428|FG003|Overall Study|Other|0|||
27749210|NCT02411201|80906429|FG000|Overall Study|Adverse Event|2|||
27749211|NCT02411201|80906429|FG000|Overall Study|Withdrawal by Subject|2|||
27749212|NCT02411201|80906429|FG000|Overall Study|Age group completed|2|||
27950146|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950147|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950148|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950149|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950150|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
27950151|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950152|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950153|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950154|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950155|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950156|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950157|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950158|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950159|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950160|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950161|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
27950162|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950163|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950164|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950165|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950166|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
27950167|NCT02891226|81651412|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950168|NCT02891226|81651413|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950169|NCT02891226|81651414|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950170|NCT02891226|81651415|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950171|NCT02891226|81651416|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950172|NCT02891226|81651417|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950173|NCT02891226|81651418|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950174|NCT02891226|81651419|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950175|NCT02891226|81651420|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950176|NCT02891226|81651421|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27749213|NCT01543490|80906431|FG000|Overall Study|Adverse Event|4|||
27749214|NCT01543490|80906432|FG001|Overall Study|Adverse Event|0|||
27749215|NCT01543490|80906431|FG000|Overall Study|Physician Decision|1|||
27749216|NCT01543490|80906432|FG001|Overall Study|Physician Decision|0|||
27749217|NCT01543490|80906431|FG000|Overall Study|Lack of Efficacy|3|||
27749218|NCT01543490|80906432|FG001|Overall Study|Lack of Efficacy|3|||
27749219|NCT01543490|80906431|FG000|Overall Study|Lost to Follow-up|5|||
27749220|NCT01543490|80906432|FG001|Overall Study|Lost to Follow-up|0|||
27749221|NCT01543490|80906431|FG000|Overall Study|Withdrawal by Subject|2|||
27749222|NCT01543490|80906432|FG001|Overall Study|Withdrawal by Subject|0|||
27749223|NCT01543490|80906431|FG000|Overall Study|Other-Various Administrative Reasons|1|||
27749224|NCT01543490|80906432|FG001|Overall Study|Other-Various Administrative Reasons|2|||
27749225|NCT01617681|80906433|FG000|Period 1 Double Blind|Adverse Event|2|||
27749226|NCT01617681|80906434|FG001|Period 1 Double Blind|Adverse Event|0|||
27749227|NCT01617681|80906435|FG002|Period 1 Double Blind|Adverse Event|0|||
27749228|NCT01617681|80906436|FG003|Period 1 Double Blind|Adverse Event|2|||
27749229|NCT01617681|80906437|FG004|Period 1 Double Blind|Adverse Event|0|||
27749230|NCT01617681|80906433|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
27749231|NCT01617681|80906434|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
27749232|NCT01617681|80906435|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
27749233|NCT01617681|80906436|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
27749234|NCT01617681|80906437|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
27749235|NCT01617681|80906433|FG000|Period 2 Open Label|Adverse Event|0|||
27749236|NCT01617681|80906434|FG001|Period 2 Open Label|Adverse Event|0|||
27749237|NCT01617681|80906435|FG002|Period 2 Open Label|Adverse Event|0|||
27749238|NCT01617681|80906436|FG003|Period 2 Open Label|Adverse Event|0|||
27749239|NCT01617681|80906437|FG004|Period 2 Open Label|Adverse Event|3|||
27749240|NCT01617681|80906433|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
27749241|NCT01617681|80906434|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
27749242|NCT01617681|80906435|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
27749243|NCT01617681|80906436|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
27749244|NCT01617681|80906437|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
27749245|NCT00883558|80906438|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
27749246|NCT00883558|80906439|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
27749247|NCT00883558|80906440|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
27749248|NCT00883558|80906438|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
27749249|NCT00883558|80906439|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
27749250|NCT00883558|80906440|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
27749251|NCT00883558|80906438|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
27749252|NCT00883558|80906439|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
27749253|NCT00883558|80906440|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
27749254|NCT00883558|80906438|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
27749255|NCT00883558|80906439|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
27749256|NCT00883558|80906440|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
27749257|NCT00883558|80906438|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
27749258|NCT00883558|80906439|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
27749259|NCT00883558|80906440|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
27749260|NCT00875017|80906441|FG000|First Intervention|Withdrawal by Subject|1|||
27749261|NCT00875017|80906442|FG001|First Intervention|Withdrawal by Subject|0|||
27749262|NCT00875017|80906443|FG002|First Intervention|Withdrawal by Subject|1|||
27749263|NCT00875017|80906444|FG003|First Intervention|Withdrawal by Subject|0|||
27749264|NCT00875017|80906445|FG004|First Intervention|Withdrawal by Subject|0|||
27749265|NCT00875017|80906446|FG005|First Intervention|Withdrawal by Subject|0|||
27749266|NCT00875017|80906441|FG000|First Intervention|Adverse Event|0|||
27749267|NCT00875017|80906442|FG001|First Intervention|Adverse Event|0|||
27749268|NCT00875017|80906443|FG002|First Intervention|Adverse Event|0|||
27749269|NCT00875017|80906444|FG003|First Intervention|Adverse Event|1|||
27749270|NCT00875017|80906445|FG004|First Intervention|Adverse Event|0|||
27749271|NCT00875017|80906446|FG005|First Intervention|Adverse Event|0|||
27749272|NCT00875017|80906441|FG000|First Intervention|Problems collecting rectal effluent|1|||
27749273|NCT00875017|80906442|FG001|First Intervention|Problems collecting rectal effluent|0|||
27749274|NCT00875017|80906443|FG002|First Intervention|Problems collecting rectal effluent|0|||
27749275|NCT00875017|80906444|FG003|First Intervention|Problems collecting rectal effluent|0|||
27749276|NCT00875017|80906445|FG004|First Intervention|Problems collecting rectal effluent|0|||
27749277|NCT00875017|80906446|FG005|First Intervention|Problems collecting rectal effluent|0|||
27749278|NCT00875017|80906441|FG000|First Intervention|Intolerance to nasogastric tube|0|||
27749279|NCT00875017|80906442|FG001|First Intervention|Intolerance to nasogastric tube|0|||
27749280|NCT00875017|80906443|FG002|First Intervention|Intolerance to nasogastric tube|0|||
27749281|NCT00875017|80906444|FG003|First Intervention|Intolerance to nasogastric tube|0|||
27749282|NCT00875017|80906445|FG004|First Intervention|Intolerance to nasogastric tube|1|||
27749283|NCT00875017|80906446|FG005|First Intervention|Intolerance to nasogastric tube|0|||
27749284|NCT00875017|80906441|FG000|Washout|Problem collecting rectal effluent|0|||
27749285|NCT00875017|80906442|FG001|Washout|Problem collecting rectal effluent|0|||
27749286|NCT00875017|80906443|FG002|Washout|Problem collecting rectal effluent|1|||
27749287|NCT00875017|80906444|FG003|Washout|Problem collecting rectal effluent|0|||
27749288|NCT00875017|80906445|FG004|Washout|Problem collecting rectal effluent|0|||
27749289|NCT00875017|80906446|FG005|Washout|Problem collecting rectal effluent|0|||
27749290|NCT00875017|80906441|FG000|Second Intervention|Adverse Event|0|||
27749291|NCT00875017|80906442|FG001|Second Intervention|Adverse Event|0|||
27749292|NCT00875017|80906443|FG002|Second Intervention|Adverse Event|0|||
27749293|NCT00875017|80906444|FG003|Second Intervention|Adverse Event|1|||
27749294|NCT00875017|80906445|FG004|Second Intervention|Adverse Event|0|||
27749295|NCT00875017|80906446|FG005|Second Intervention|Adverse Event|0|||
27749296|NCT00875017|80906441|FG000|Washout|Problems collecting rectal effluent|0|||
27749297|NCT00875017|80906442|FG001|Washout|Problems collecting rectal effluent|1|||
27749298|NCT00875017|80906443|FG002|Washout|Problems collecting rectal effluent|0|||
27749299|NCT00875017|80906444|FG003|Washout|Problems collecting rectal effluent|0|||
27749300|NCT00875017|80906445|FG004|Washout|Problems collecting rectal effluent|0|||
27749301|NCT00875017|80906446|FG005|Washout|Problems collecting rectal effluent|0|||
27749302|NCT00875017|80906441|FG000|Third Intervention|Adverse Event|0|||
27749303|NCT00875017|80906442|FG001|Third Intervention|Adverse Event|1|||
27749304|NCT00875017|80906443|FG002|Third Intervention|Adverse Event|1|||
27749305|NCT00875017|80906444|FG003|Third Intervention|Adverse Event|0|||
27749306|NCT00875017|80906445|FG004|Third Intervention|Adverse Event|0|||
27749307|NCT00875017|80906446|FG005|Third Intervention|Adverse Event|0|||
27749308|NCT00875017|80906441|FG000|Washout|Withdrawal by Subject|0|||
27749309|NCT00875017|80906442|FG001|Washout|Withdrawal by Subject|0|||
27749310|NCT00875017|80906443|FG002|Washout|Withdrawal by Subject|0|||
27749311|NCT00875017|80906444|FG003|Washout|Withdrawal by Subject|0|||
27749312|NCT00875017|80906445|FG004|Washout|Withdrawal by Subject|1|||
27749313|NCT00875017|80906446|FG005|Washout|Withdrawal by Subject|0|||
27749314|NCT00875017|80906441|FG000|Fourth Intervention|Inability to comply with fasting|0|||
27749315|NCT00875017|80906442|FG001|Fourth Intervention|Inability to comply with fasting|0|||
27749316|NCT00875017|80906443|FG002|Fourth Intervention|Inability to comply with fasting|0|||
27749317|NCT00875017|80906444|FG003|Fourth Intervention|Inability to comply with fasting|0|||
27749318|NCT00875017|80906445|FG004|Fourth Intervention|Inability to comply with fasting|0|||
27749319|NCT00875017|80906446|FG005|Fourth Intervention|Inability to comply with fasting|1|||
27749320|NCT02234583|80906447|FG000|Overall Study|Adverse Event|172|||
27749321|NCT02234583|80906448|FG001|Overall Study|Adverse Event|156|||
27749322|NCT02234583|80906447|FG000|Overall Study|Withdrawal by Subject|109|||
27749323|NCT02234583|80906448|FG001|Overall Study|Withdrawal by Subject|157|||
27749324|NCT02234583|80906447|FG000|Overall Study|Lost to Follow-up|0|||
27749325|NCT02234583|80906448|FG001|Overall Study|Lost to Follow-up|1|||
27749326|NCT02234583|80906447|FG000|Overall Study|Lack of Efficacy|58|||
27749327|NCT02234583|80906448|FG001|Overall Study|Lack of Efficacy|103|||
27749328|NCT02234583|80906447|FG000|Overall Study|Protocol Violation|35|||
27749329|NCT02234583|80906448|FG001|Overall Study|Protocol Violation|42|||
27749330|NCT02234583|80906447|FG000|Overall Study|Other|39|||
27749331|NCT02234583|80906448|FG001|Overall Study|Other|97|||
27749332|NCT03827473|80906449|FG000|Overall Study|Withdrawal by Subject|1|||
27749333|NCT03827473|80906450|FG001|Overall Study|Withdrawal by Subject|0|||
27749334|NCT01355068|80906451|FG000|First Intervention Period|Adverse Event|0|||
27749335|NCT01355068|80906452|FG001|First Intervention Period|Adverse Event|1|||
27749336|NCT01355068|80906451|FG000|First Intervention Period|Withdrawal by Subject|0|||
27749337|NCT01355068|80906452|FG001|First Intervention Period|Withdrawal by Subject|1|||
27749338|NCT04230486|80906454|FG000|Overall Study|Screen Failure|1|||
27749339|NCT03382899|80906455|FG000|Overall Study|Ineligibility Determined|0|||
27749340|NCT03382899|80906456|FG001|Overall Study|Ineligibility Determined|1|||
27749341|NCT03382899|80906455|FG000|Overall Study|Lost to Follow-up|0|||
27749342|NCT03382899|80906456|FG001|Overall Study|Lost to Follow-up|1|||
27749343|NCT03382899|80906455|FG000|Overall Study|Sponsor's decision|31|||
27749344|NCT03382899|80906456|FG001|Overall Study|Sponsor's decision|28|||
27749345|NCT03382899|80906455|FG000|Overall Study|Withdrawal by Subject|0|||
27749346|NCT03382899|80906456|FG001|Overall Study|Withdrawal by Subject|5|||
27749347|NCT00740779|80906459|FG000|Overall Study|Adverse Event|4|||
27749348|NCT00740779|80906460|FG001|Overall Study|Adverse Event|6|||
27749349|NCT00740779|80906461|FG002|Overall Study|Adverse Event|3|||
27749350|NCT00740779|80906459|FG000|Overall Study|Protocol Violation|1|||
27749351|NCT00740779|80906460|FG001|Overall Study|Protocol Violation|1|||
27749352|NCT00740779|80906461|FG002|Overall Study|Protocol Violation|1|||
27950177|NCT02891226|81651422|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
27958691|NCT02383862|81683045|FG001|3 Month Follow up|Lost to Follow-up|21|||
27749353|NCT00740779|80906459|FG000|Overall Study|Lack of Efficacy|0|||
27749354|NCT00740779|80906460|FG001|Overall Study|Lack of Efficacy|0|||
27749355|NCT00740779|80906461|FG002|Overall Study|Lack of Efficacy|2|||
27749356|NCT00740779|80906459|FG000|Overall Study|Withdrawal by Subject|2|||
27749357|NCT00740779|80906460|FG001|Overall Study|Withdrawal by Subject|4|||
27749358|NCT00740779|80906461|FG002|Overall Study|Withdrawal by Subject|2|||
27749359|NCT00740779|80906459|FG000|Overall Study|Lost to Follow-up|2|||
27749360|NCT00740779|80906460|FG001|Overall Study|Lost to Follow-up|3|||
27749361|NCT00740779|80906461|FG002|Overall Study|Lost to Follow-up|5|||
27749362|NCT03375112|80909549|FG000|Overall Study|Withdrawal by Subject|3|||
27749363|NCT03375112|80909550|FG001|Overall Study|Withdrawal by Subject|0|||
27749364|NCT05131451|80909553|FG000|Overall Study|Protocol Violation|1|||
27749365|NCT05131451|80909554|FG001|Overall Study|Protocol Violation|0|||
27749366|NCT02042404|80909556|FG000|Overall Study|Death|1|||
27749367|NCT02042404|80909557|FG001|Overall Study|Death|0|||
27749368|NCT02042404|80909556|FG000|Overall Study|Unrelated Adverse Event|3|||
27749369|NCT02042404|80909557|FG001|Overall Study|Unrelated Adverse Event|0|||
27749370|NCT02042404|80909556|FG000|Overall Study|Inability to meet time requirements|1|||
27749371|NCT02042404|80909557|FG001|Overall Study|Inability to meet time requirements|0|||
27749372|NCT04095286|80909558|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749373|NCT04095286|80909559|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
27749374|NCT04095286|80909560|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749375|NCT04095286|80909561|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749376|NCT04095286|80909562|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749377|NCT04095286|80909563|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749378|NCT04095286|80909558|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
27749379|NCT04095286|80909559|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
27749380|NCT04095286|80909560|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
27749381|NCT04095286|80909561|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
27749382|NCT04095286|80909562|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
27749383|NCT04095286|80909563|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
27749384|NCT04095286|80909558|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
27749385|NCT04095286|80909559|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
27749386|NCT04095286|80909560|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
27749387|NCT04095286|80909561|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
27749388|NCT04095286|80909562|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
27749389|NCT04095286|80909563|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
27749390|NCT04095286|80909558|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749391|NCT04095286|80909559|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749392|NCT04095286|80909560|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
27749393|NCT04095286|80909561|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749394|NCT04095286|80909562|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749395|NCT04095286|80909563|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
27749396|NCT04095286|80909558|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
27749397|NCT04095286|80909559|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
27749398|NCT04095286|80909560|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
27749399|NCT04095286|80909561|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
27749400|NCT04095286|80909562|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
27749401|NCT04095286|80909563|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
27749402|NCT01193348|80909567|FG000|Screening Period|Screen Failure|5|||
27749403|NCT01193348|80909567|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
27749404|NCT01193348|80909567|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
27749405|NCT01193348|80909567|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
27749406|NCT01193348|80909567|FG000|Extension Treatment Period|Physician Decision|1|||
27749407|NCT01193348|80909567|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
27749408|NCT02928406|80909571|FG000|Overall Study|Death|780|||
27749409|NCT02928406|80909571|FG000|Overall Study|Progressive disease|3|||
27749410|NCT02928406|80909571|FG000|Overall Study|Lost to Follow-up|49|||
27749411|NCT02928406|80909571|FG000|Overall Study|Non-compliance|2|||
27749412|NCT02928406|80909571|FG000|Overall Study|Withdrawal by Subject|40|||
27749413|NCT02928406|80909571|FG000|Overall Study|Study terminated by sponsor|57|||
27749414|NCT02928406|80909571|FG000|Overall Study|Physician Decision|1|||
27749415|NCT02928406|80909571|FG000|Overall Study|Various reasons|72|||
27749416|NCT01703286|80909572|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
27749417|NCT01703286|80909573|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
27749418|NCT01703286|80909574|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
27749419|NCT01703286|80909575|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
27749420|NCT01703286|80909576|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
27749421|NCT01703286|80909577|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
27749422|NCT01703286|80909572|FG000|Period 2 Including Washout|Adverse Event|0|||
27749423|NCT01703286|80909573|FG001|Period 2 Including Washout|Adverse Event|0|||
27749424|NCT01703286|80909574|FG002|Period 2 Including Washout|Adverse Event|0|||
27749425|NCT01703286|80909575|FG003|Period 2 Including Washout|Adverse Event|1|||
27749426|NCT01703286|80909576|FG004|Period 2 Including Washout|Adverse Event|0|||
27749427|NCT01703286|80909577|FG005|Period 2 Including Washout|Adverse Event|0|||
27749428|NCT01402284|80909578|FG000|Overall Study|Withdrawal consent|2|||
27749429|NCT01402284|80909578|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
27749430|NCT01402284|80909578|FG000|Overall Study|Physician Decision|1|||
27950178|NCT02891226|81651423|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27749431|NCT01402284|80909578|FG000|Overall Study|Disease progression on study|10|||
27749432|NCT01929044|80909579|FG000|Overall Study|Adverse Event|1|||
27749433|NCT01929044|80909580|FG001|Overall Study|Adverse Event|0|||
27749434|NCT01929044|80909579|FG000|Overall Study|Protocol Violation|9|||
27950179|NCT02891226|81651424|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950180|NCT02891226|81651425|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950181|NCT02891226|81651426|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950182|NCT02891226|81651427|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
27950183|NCT02891226|81651412|FG000|Follow-up Period|Withdrawal by Subject|0|||
27950184|NCT02891226|81651413|FG001|Follow-up Period|Withdrawal by Subject|0|||
27950185|NCT02891226|81651414|FG002|Follow-up Period|Withdrawal by Subject|0|||
27950186|NCT02891226|81651415|FG003|Follow-up Period|Withdrawal by Subject|0|||
27950187|NCT02891226|81651416|FG004|Follow-up Period|Withdrawal by Subject|0|||
27950188|NCT02891226|81651417|FG005|Follow-up Period|Withdrawal by Subject|0|||
27950189|NCT02891226|81651418|FG006|Follow-up Period|Withdrawal by Subject|0|||
27950190|NCT02891226|81651419|FG007|Follow-up Period|Withdrawal by Subject|0|||
27950191|NCT02891226|81651420|FG008|Follow-up Period|Withdrawal by Subject|0|||
27950192|NCT02891226|81651421|FG009|Follow-up Period|Withdrawal by Subject|0|||
27650810|NCT04803734|80560562|FG001|Overall Study|Withdrawal by Subject|1|||
27650811|NCT04803734|80560561|FG000|Overall Study|Protocol Violation|0|||
27650812|NCT04803734|80560562|FG001|Overall Study|Protocol Violation|1|||
27650813|NCT01536704|80560563|FG000|Washout Period 1|Withdrawal by Subject|1|||
27650814|NCT01536704|80560564|FG001|Washout Period 1|Withdrawal by Subject|2|||
27650815|NCT01536704|80560565|FG002|Washout Period 1|Withdrawal by Subject|0|||
27650816|NCT01536704|80560566|FG003|Washout Period 1|Withdrawal by Subject|0|||
27650817|NCT01536704|80560563|FG000|Washout Period 2|Adverse Event|1|||
27650818|NCT01536704|80560564|FG001|Washout Period 2|Adverse Event|0|||
27650819|NCT01536704|80560565|FG002|Washout Period 2|Adverse Event|0|||
27650820|NCT01536704|80560566|FG003|Washout Period 2|Adverse Event|0|||
27650821|NCT01536704|80560563|FG000|Washout Period 2|Withdrawal by Subject|0|||
27650822|NCT01536704|80560564|FG001|Washout Period 2|Withdrawal by Subject|0|||
27650823|NCT01536704|80560565|FG002|Washout Period 2|Withdrawal by Subject|0|||
27650824|NCT01536704|80560566|FG003|Washout Period 2|Withdrawal by Subject|1|||
27650825|NCT01536704|80560563|FG000|Period 3|Adverse Event|0|||
27650826|NCT01536704|80560564|FG001|Period 3|Adverse Event|0|||
27650827|NCT01536704|80560565|FG002|Period 3|Adverse Event|0|||
27650828|NCT01536704|80560566|FG003|Period 3|Adverse Event|1|||
27650829|NCT01536704|80560563|FG000|Washout Period 3|Adverse Event|0|||
27650830|NCT01536704|80560564|FG001|Washout Period 3|Adverse Event|0|||
27650831|NCT01536704|80560565|FG002|Washout Period 3|Adverse Event|1|||
27650832|NCT01536704|80560566|FG003|Washout Period 3|Adverse Event|0|||
27650833|NCT01380145|80560567|FG000|Overall Study|Progressive disease|4|||
27650834|NCT03611556|80560568|FG000|Overall Study|Death|7|||
27650835|NCT03611556|80560569|FG001|Overall Study|Death|7|||
27650836|NCT03611556|80560570|FG002|Overall Study|Death|3|||
27650837|NCT03611556|80560571|FG003|Overall Study|Death|8|||
27650838|NCT03611556|80560572|FG004|Overall Study|Death|47|||
27650839|NCT03611556|80560573|FG005|Overall Study|Death|32|||
27650840|NCT03611556|80560574|FG006|Overall Study|Death|53|||
27650841|NCT03611556|80560568|FG000|Overall Study|Withdrawal by Subject|0|||
27650842|NCT03611556|80560569|FG001|Overall Study|Withdrawal by Subject|0|||
27650843|NCT03611556|80560570|FG002|Overall Study|Withdrawal by Subject|0|||
27650844|NCT03611556|80560571|FG003|Overall Study|Withdrawal by Subject|0|||
27650845|NCT03611556|80560572|FG004|Overall Study|Withdrawal by Subject|4|||
27650846|NCT03611556|80560573|FG005|Overall Study|Withdrawal by Subject|2|||
27650847|NCT03611556|80560574|FG006|Overall Study|Withdrawal by Subject|4|||
27650848|NCT03611556|80560568|FG000|Overall Study|Sponsor decision|0|||
27650849|NCT03611556|80560569|FG001|Overall Study|Sponsor decision|0|||
27650850|NCT03611556|80560570|FG002|Overall Study|Sponsor decision|0|||
27650851|NCT03611556|80560571|FG003|Overall Study|Sponsor decision|0|||
27650852|NCT03611556|80560572|FG004|Overall Study|Sponsor decision|9|||
27650853|NCT03611556|80560573|FG005|Overall Study|Sponsor decision|4|||
27749435|NCT01929044|80909580|FG001|Overall Study|Protocol Violation|14|||
27950193|NCT02891226|81651422|FG010|Follow-up Period|Withdrawal by Subject|0|||
27950194|NCT02891226|81651423|FG011|Follow-up Period|Withdrawal by Subject|1|||
27650854|NCT03611556|80560574|FG006|Overall Study|Sponsor decision|12|||
27650855|NCT03611556|80560568|FG000|Overall Study|Reasons|0|||
27650856|NCT03611556|80560569|FG001|Overall Study|Reasons|0|||
27650857|NCT03611556|80560570|FG002|Overall Study|Reasons|0|||
27650858|NCT03611556|80560571|FG003|Overall Study|Reasons|0|||
27650859|NCT03611556|80560572|FG004|Overall Study|Reasons|2|||
27650860|NCT03611556|80560573|FG005|Overall Study|Reasons|0|||
27650861|NCT03611556|80560574|FG006|Overall Study|Reasons|1|||
27650862|NCT02699099|80560575|FG000|Overall Study|Adverse Event|1|||
27650863|NCT02699099|80560576|FG001|Overall Study|Adverse Event|0|||
27650864|NCT02699099|80560577|FG002|Overall Study|Adverse Event|2|||
27650865|NCT02699099|80560575|FG000|Overall Study|Lost to Follow-up|0|||
27650866|NCT02699099|80560576|FG001|Overall Study|Lost to Follow-up|1|||
27650867|NCT02699099|80560577|FG002|Overall Study|Lost to Follow-up|0|||
27950195|NCT02891226|81651424|FG012|Follow-up Period|Withdrawal by Subject|0|||
27950196|NCT02891226|81651425|FG013|Follow-up Period|Withdrawal by Subject|0|||
27950197|NCT02891226|81651426|FG014|Follow-up Period|Withdrawal by Subject|1|||
27950198|NCT02891226|81651427|FG015|Follow-up Period|Withdrawal by Subject|1|||
27950199|NCT00806585|81651433|FG000|Overall Study|Study terminated by Sponsor|0|||
27950200|NCT00806585|81651434|FG001|Overall Study|Study terminated by Sponsor|0|||
27950201|NCT00806585|81651435|FG002|Overall Study|Study terminated by Sponsor|1|||
27950202|NCT00806585|81651436|FG003|Overall Study|Study terminated by Sponsor|2|||
27950203|NCT00806585|81651437|FG004|Overall Study|Study terminated by Sponsor|0|||
27950204|NCT00806585|81651433|FG000|Overall Study|Protocol Violation|3|||
27950205|NCT00806585|81651434|FG001|Overall Study|Protocol Violation|1|||
27950206|NCT00806585|81651435|FG002|Overall Study|Protocol Violation|2|||
27749436|NCT01929044|80909579|FG000|Overall Study|Not Treated|1|||
27749437|NCT01929044|80909580|FG001|Overall Study|Not Treated|3|||
27749438|NCT02626819|80909581|FG000|Overall Study|Lost to Follow-up|3|||
27749439|NCT02626819|80909582|FG001|Overall Study|Lost to Follow-up|2|||
27749440|NCT02626819|80909581|FG000|Overall Study|Withdrawal by Subject|1|||
27749441|NCT02626819|80909582|FG001|Overall Study|Withdrawal by Subject|0|||
27749442|NCT02626819|80909581|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
27749443|NCT02626819|80909582|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
27749444|NCT02184143|80909583|FG000|Overall Study|Withdrawal by Subject|4|||
27749445|NCT02184143|80909584|FG001|Overall Study|Withdrawal by Subject|4|||
27749446|NCT02184143|80909583|FG000|Overall Study|Lost to Follow-up|5|||
27749447|NCT02184143|80909584|FG001|Overall Study|Lost to Follow-up|3|||
27749448|NCT02184143|80909583|FG000|Overall Study|Death|1|||
27749449|NCT02184143|80909584|FG001|Overall Study|Death|0|||
27749450|NCT03097328|80909585|FG000|Overall Study|Still on Therapy|2|||
27749451|NCT03097328|80909585|FG000|Overall Study|Progressive Disease|29|||
27950207|NCT00806585|81651436|FG003|Overall Study|Protocol Violation|0|||
27950208|NCT00806585|81651437|FG004|Overall Study|Protocol Violation|0|||
27950209|NCT00806585|81651433|FG000|Overall Study|Physician Decision|0|||
27950210|NCT00806585|81651434|FG001|Overall Study|Physician Decision|2|||
27950211|NCT00806585|81651435|FG002|Overall Study|Physician Decision|3|||
27950212|NCT00806585|81651436|FG003|Overall Study|Physician Decision|0|||
27950213|NCT00806585|81651437|FG004|Overall Study|Physician Decision|1|||
27950214|NCT00806585|81651433|FG000|Overall Study|Lost to Follow-up|2|||
27950215|NCT00806585|81651434|FG001|Overall Study|Lost to Follow-up|1|||
27950216|NCT00806585|81651435|FG002|Overall Study|Lost to Follow-up|2|||
27950217|NCT00806585|81651436|FG003|Overall Study|Lost to Follow-up|2|||
27950218|NCT00806585|81651437|FG004|Overall Study|Lost to Follow-up|5|||
27950219|NCT00806585|81651433|FG000|Overall Study|Lack of Efficacy|1|||
27950220|NCT00806585|81651434|FG001|Overall Study|Lack of Efficacy|0|||
27749452|NCT03097328|80909585|FG000|Overall Study|Adverse Event|4|||
27950221|NCT00806585|81651435|FG002|Overall Study|Lack of Efficacy|0|||
27950222|NCT00806585|81651436|FG003|Overall Study|Lack of Efficacy|0|||
27950223|NCT00806585|81651437|FG004|Overall Study|Lack of Efficacy|0|||
27950224|NCT00806585|81651433|FG000|Overall Study|Adverse Event|1|||
27950225|NCT00806585|81651434|FG001|Overall Study|Adverse Event|5|||
27950226|NCT00806585|81651435|FG002|Overall Study|Adverse Event|3|||
27950227|NCT00806585|81651436|FG003|Overall Study|Adverse Event|4|||
27950228|NCT00806585|81651437|FG004|Overall Study|Adverse Event|2|||
27950229|NCT00806585|81651433|FG000|Overall Study|Withdrawal by Subject|10|||
27950230|NCT00806585|81651434|FG001|Overall Study|Withdrawal by Subject|8|||
27950231|NCT00806585|81651435|FG002|Overall Study|Withdrawal by Subject|9|||
27950232|NCT00806585|81651436|FG003|Overall Study|Withdrawal by Subject|3|||
27950233|NCT00806585|81651437|FG004|Overall Study|Withdrawal by Subject|11|||
27950234|NCT00806585|81651433|FG000|Overall Study|Completion status unknown|15|||
27950235|NCT00806585|81651434|FG001|Overall Study|Completion status unknown|14|||
27950236|NCT00806585|81651435|FG002|Overall Study|Completion status unknown|12|||
27950237|NCT00806585|81651436|FG003|Overall Study|Completion status unknown|4|||
27950238|NCT00806585|81651437|FG004|Overall Study|Completion status unknown|12|||
27950239|NCT00949533|81651440|FG000|Overall Study|Lost to Follow-up|0|||
27950240|NCT00949533|81651441|FG001|Overall Study|Lost to Follow-up|1|||
27950241|NCT00907621|81651442|FG000|Overall Study|Lost to Follow-up|6|||
27950242|NCT00907621|81651443|FG001|Overall Study|Lost to Follow-up|3|||
27950243|NCT00907621|81651442|FG000|Overall Study|intercurrent febrile illness|1|||
27950244|NCT00907621|81651443|FG001|Overall Study|intercurrent febrile illness|1|||
27749453|NCT03097328|80909585|FG000|Overall Study|Withdrawal by Subject|1|||
27749454|NCT03097328|80909585|FG000|Overall Study|Physician Decision|1|||
27749455|NCT03097328|80909585|FG000|Overall Study|Patient Decision|1|||
27749456|NCT03097328|80909585|FG000|Overall Study|Ineligible for Study Drug|1|||
27950245|NCT00431964|81651444|FG000|Overall Study|Adverse Event|1|||
27950246|NCT00431964|81651445|FG001|Overall Study|Adverse Event|0|||
27950247|NCT00431964|81651444|FG000|Overall Study|Lost to Follow-up|1|||
27950248|NCT00431964|81651445|FG001|Overall Study|Lost to Follow-up|2|||
27950249|NCT00431964|81651444|FG000|Overall Study|Physician Decision|2|||
27950250|NCT00431964|81651445|FG001|Overall Study|Physician Decision|2|||
27950251|NCT00431964|81651444|FG000|Overall Study|Withdrawal by Subject|2|||
27950252|NCT00431964|81651445|FG001|Overall Study|Withdrawal by Subject|1|||
27650868|NCT02699099|80560575|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
27650869|NCT02699099|80560576|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
27650870|NCT02699099|80560577|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
27650871|NCT04693637|80564517|FG000|Overall Study|Death|4|||
27650872|NCT04693637|80564517|FG000|Overall Study|Withdrawal by Subject|3|||
27650873|NCT04693637|80564517|FG000|Overall Study|Physician Decision|2|||
27650874|NCT04693637|80564517|FG000|Overall Study|Lost to Follow-up|1|||
27650875|NCT03979040|80564518|FG000|Overall Study|Withdrawal by Subject|24|||
27650876|NCT03979040|80564519|FG001|Overall Study|Withdrawal by Subject|32|||
27650877|NCT03979040|80564518|FG000|Overall Study|randomized but never started treatment|32|||
27650878|NCT03979040|80564519|FG001|Overall Study|randomized but never started treatment|39|||
27650879|NCT03979040|80564518|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
27650880|NCT03979040|80564519|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
27650881|NCT03052517|80564520|FG000|Overall Study|Study Terminated By Sponsor|928|||
27650882|NCT03052517|80564521|FG001|Overall Study|Study Terminated By Sponsor|938|||
27650883|NCT03052517|80564522|FG002|Overall Study|Study Terminated By Sponsor|296|||
27650884|NCT03052517|80564520|FG000|Overall Study|Subject/Guardian Decision|50|||
27650885|NCT03052517|80564521|FG001|Overall Study|Subject/Guardian Decision|45|||
27650886|NCT03052517|80564522|FG002|Overall Study|Subject/Guardian Decision|22|||
27650887|NCT03052517|80564520|FG000|Overall Study|Lack of Efficacy|23|||
27650888|NCT03052517|80564521|FG001|Overall Study|Lack of Efficacy|14|||
27650889|NCT03052517|80564522|FG002|Overall Study|Lack of Efficacy|7|||
27650890|NCT03052517|80564520|FG000|Overall Study|Adverse Event|6|||
27650891|NCT03052517|80564521|FG001|Overall Study|Adverse Event|5|||
27650892|NCT03052517|80564522|FG002|Overall Study|Adverse Event|0|||
27650893|NCT03052517|80564520|FG000|Overall Study|Physician Decision|4|||
27650894|NCT03052517|80564521|FG001|Overall Study|Physician Decision|5|||
27749457|NCT01096446|80909586|FG000|Overall Study|Death|1|||
27749458|NCT01096446|80909587|FG001|Overall Study|Death|0|||
27749459|NCT01096446|80909586|FG000|Overall Study|Protocol Violation|2|||
27749460|NCT01096446|80909587|FG001|Overall Study|Protocol Violation|0|||
27749461|NCT01958671|80909588|FG000|Overall Study|Adverse Event|1|||
27749462|NCT01958671|80909589|FG001|Overall Study|Adverse Event|1|||
27749463|NCT01958671|80909590|FG002|Overall Study|Adverse Event|5|||
27749464|NCT01958671|80909588|FG000|Overall Study|Death|1|||
27749465|NCT01958671|80909589|FG001|Overall Study|Death|0|||
27749466|NCT01958671|80909590|FG002|Overall Study|Death|0|||
27749467|NCT01958671|80909588|FG000|Overall Study|Excluded medication|0|||
27749468|NCT01958671|80909589|FG001|Overall Study|Excluded medication|0|||
27749469|NCT01958671|80909590|FG002|Overall Study|Excluded medication|1|||
27749470|NCT01958671|80909588|FG000|Overall Study|Hyperglycemia|0|||
27749471|NCT01958671|80909589|FG001|Overall Study|Hyperglycemia|0|||
27749472|NCT01958671|80909590|FG002|Overall Study|Hyperglycemia|2|||
27749473|NCT01958671|80909588|FG000|Overall Study|Lost to Follow-up|7|||
27749474|NCT01958671|80909589|FG001|Overall Study|Lost to Follow-up|11|||
27749475|NCT01958671|80909590|FG002|Overall Study|Lost to Follow-up|7|||
27749476|NCT01958671|80909588|FG000|Overall Study|Non-compliance with study drug|1|||
27749477|NCT01958671|80909589|FG001|Overall Study|Non-compliance with study drug|1|||
27749478|NCT01958671|80909590|FG002|Overall Study|Non-compliance with study drug|1|||
27749479|NCT01958671|80909588|FG000|Overall Study|Pregnancy|0|||
27749480|NCT01958671|80909589|FG001|Overall Study|Pregnancy|0|||
27749481|NCT01958671|80909590|FG002|Overall Study|Pregnancy|1|||
27749482|NCT01958671|80909588|FG000|Overall Study|Protocol Violation|0|||
27749483|NCT01958671|80909589|FG001|Overall Study|Protocol Violation|1|||
27749484|NCT01958671|80909590|FG002|Overall Study|Protocol Violation|0|||
27749485|NCT01958671|80909588|FG000|Overall Study|Study site terminated by sponsor|1|||
27950253|NCT00431964|81651444|FG000|Overall Study|Parental Consent Withdrawn|0|||
27950254|NCT00431964|81651445|FG001|Overall Study|Parental Consent Withdrawn|2|||
27950255|NCT00431964|81651444|FG000|Overall Study|Due to Unstable Health|0|||
27950256|NCT00431964|81651445|FG001|Overall Study|Due to Unstable Health|1|||
27950257|NCT02471144|81651450|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
27950258|NCT02471144|81651451|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
27950259|NCT02471144|81651452|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
27749486|NCT01958671|80909589|FG001|Overall Study|Study site terminated by sponsor|0|||
27950260|NCT02471144|81651453|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
27950261|NCT02471144|81651454|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
27749487|NCT01958671|80909590|FG002|Overall Study|Study site terminated by sponsor|1|||
27950262|NCT02471144|81651455|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
27650895|NCT03052517|80564522|FG002|Overall Study|Physician Decision|1|||
27650896|NCT03052517|80564520|FG000|Overall Study|Death|3|||
27650897|NCT03052517|80564521|FG001|Overall Study|Death|0|||
27650898|NCT03052517|80564522|FG002|Overall Study|Death|1|||
27749488|NCT01958671|80909588|FG000|Overall Study|Participant moved|0|||
27749489|NCT01958671|80909589|FG001|Overall Study|Participant moved|0|||
27749490|NCT01958671|80909590|FG002|Overall Study|Participant moved|1|||
27749491|NCT01958671|80909588|FG000|Overall Study|Withdrawal by Subject|8|||
27950263|NCT02471144|81651456|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
27950264|NCT02471144|81651457|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
27950265|NCT02471144|81651458|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
27950266|NCT02471144|81651459|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
27950267|NCT02471144|81651460|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
27950268|NCT02471144|81651450|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950269|NCT02471144|81651451|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950270|NCT02471144|81651452|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950271|NCT02471144|81651453|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
27950272|NCT02471144|81651454|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950273|NCT02471144|81651455|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950274|NCT02471144|81651456|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950275|NCT02471144|81651457|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950276|NCT02471144|81651458|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950277|NCT02471144|81651459|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950278|NCT02471144|81651460|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
27950279|NCT02471144|81651450|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950280|NCT02471144|81651451|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950281|NCT02471144|81651452|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
27950282|NCT02471144|81651453|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950283|NCT02471144|81651454|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950284|NCT02471144|81651455|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950285|NCT02471144|81651456|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950286|NCT02471144|81651457|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950287|NCT02471144|81651458|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950288|NCT02471144|81651459|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950289|NCT02471144|81651460|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
27950290|NCT02471144|81651450|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
27950291|NCT02471144|81651451|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
27950292|NCT02471144|81651452|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950293|NCT02471144|81651453|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950294|NCT02471144|81651454|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950295|NCT02471144|81651455|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950296|NCT02471144|81651456|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950297|NCT02471144|81651457|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950298|NCT02471144|81651458|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950299|NCT02471144|81651459|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950300|NCT02471144|81651460|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
27950301|NCT02471144|81651450|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950302|NCT02471144|81651451|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950303|NCT02471144|81651452|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950304|NCT02471144|81651453|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950305|NCT02471144|81651454|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
27950306|NCT02471144|81651455|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950307|NCT02471144|81651456|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
27950308|NCT02471144|81651457|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950309|NCT02471144|81651458|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
27950310|NCT02471144|81651459|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950311|NCT02471144|81651460|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
27950312|NCT02471144|81651450|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950313|NCT02471144|81651451|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950314|NCT02471144|81651452|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950315|NCT02471144|81651453|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950316|NCT02471144|81651454|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950317|NCT02471144|81651455|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
27950318|NCT02471144|81651456|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950319|NCT02471144|81651457|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950320|NCT02471144|81651458|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
27950321|NCT02471144|81651459|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950322|NCT02471144|81651460|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
27950323|NCT02471144|81651450|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950324|NCT02471144|81651451|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950325|NCT02471144|81651452|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950326|NCT02471144|81651453|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950327|NCT02471144|81651454|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950328|NCT02471144|81651455|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950329|NCT02471144|81651456|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950330|NCT02471144|81651457|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950331|NCT02471144|81651458|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
27950332|NCT02471144|81651459|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950333|NCT02471144|81651460|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
27950334|NCT02471144|81651450|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950335|NCT02471144|81651451|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950336|NCT02471144|81651452|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950337|NCT02471144|81651453|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950338|NCT02471144|81651454|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950339|NCT02471144|81651455|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950340|NCT02471144|81651456|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950341|NCT02471144|81651457|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
27950342|NCT02471144|81651458|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
27950343|NCT02471144|81651459|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950344|NCT02471144|81651460|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
27950345|NCT02471144|81651450|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950346|NCT02471144|81651451|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950347|NCT02471144|81651452|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950348|NCT02471144|81651453|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950349|NCT02471144|81651454|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950350|NCT02471144|81651455|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950351|NCT02471144|81651456|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950352|NCT02471144|81651457|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27950353|NCT02471144|81651458|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
27749492|NCT01958671|80909589|FG001|Overall Study|Withdrawal by Subject|10|||
27749493|NCT01958671|80909590|FG002|Overall Study|Withdrawal by Subject|13|||
27749494|NCT00988559|80909591|FG000|Overall Study|Withdrawal by Subject|1|||
27749495|NCT00988559|80909592|FG001|Overall Study|Withdrawal by Subject|1|||
27749496|NCT00988559|80909593|FG002|Overall Study|Withdrawal by Subject|0|||
27749497|NCT00988559|80909594|FG003|Overall Study|Withdrawal by Subject|1|||
27749498|NCT00988559|80909591|FG000|Overall Study|Pregnancy|0|||
27749499|NCT00988559|80909592|FG001|Overall Study|Pregnancy|1|||
27749500|NCT00988559|80909593|FG002|Overall Study|Pregnancy|1|||
27749501|NCT00988559|80909594|FG003|Overall Study|Pregnancy|0|||
27749502|NCT00988559|80909591|FG000|Overall Study|Lost to Follow-up|0|||
27749503|NCT00988559|80909592|FG001|Overall Study|Lost to Follow-up|0|||
27749504|NCT00988559|80909593|FG002|Overall Study|Lost to Follow-up|1|||
27749505|NCT00988559|80909594|FG003|Overall Study|Lost to Follow-up|0|||
27749506|NCT01798134|80909595|FG000|Overall Study|Lost to Follow-up|1|||
27749507|NCT01798134|80909595|FG000|Overall Study|Withdrawal by Subject|3|||
27749508|NCT01798134|80909595|FG000|Overall Study|Death|2|||
27749509|NCT01798134|80909595|FG000|Overall Study|Adverse Event|3|||
27749510|NCT01798134|80909595|FG000|Overall Study|Physician Decision|3|||
27749511|NCT01798134|80909595|FG000|Overall Study|Liver transplant/surgery|4|||
27749512|NCT04964063|80909596|FG000|Overall Study|Adverse Event|4|||
27749513|NCT04964063|80909596|FG000|Overall Study|Lost to Follow-up|47|||
27749514|NCT04964063|80909596|FG000|Overall Study|Withdrawal by Subject|5|||
27749515|NCT04964063|80909596|FG000|Overall Study|Baseline Tasks Expired|41|||
27749516|NCT04964063|80909596|FG000|Overall Study|Participant withdrawn in error|1|||
27749517|NCT01058369|80909600|FG000|Overall Study|Adverse Event|1|||
27749518|NCT01058369|80909600|FG000|Overall Study|Early termination study|1|||
27749519|NCT01814800|80909601|FG000|Overall Study|Adverse Event|2|||
27749520|NCT01814800|80909601|FG000|Overall Study|Pregnancy|1|||
27749521|NCT01814800|80909601|FG000|Overall Study|Sponsor decision|1|||
27749522|NCT01814800|80909601|FG000|Overall Study|Subject relocation|1|||
27749523|NCT01029002|80909602|FG000|Overall Study|Lost to Follow-up|2|||
27749524|NCT01029002|80909603|FG001|Overall Study|Lost to Follow-up|4|||
27749525|NCT00337467|80909604|FG000|Overall Study|Adverse Event|3|||
27749526|NCT00337467|80909604|FG000|Overall Study|Subject Withdrew Consent|2|||
27950354|NCT02471144|81651459|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
27950355|NCT02471144|81651460|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
27950356|NCT02471144|81651450|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950357|NCT02471144|81651451|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950358|NCT02471144|81651452|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27749527|NCT00337467|80909604|FG000|Overall Study|Pregnancy|1|||
27749528|NCT00337467|80909604|FG000|Overall Study|Lost to Follow-up|2|||
27749529|NCT00337467|80909604|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
27749530|NCT00972244|80909606|FG000|Overall Study|Incorrect Enrolment|1|||
27749531|NCT00972244|80909607|FG001|Overall Study|Incorrect Enrolment|0|||
27749532|NCT00972244|80909608|FG002|Overall Study|Incorrect Enrolment|0|||
27749533|NCT00972244|80909609|FG003|Overall Study|Incorrect Enrolment|0|||
27749534|NCT00972244|80909610|FG004|Overall Study|Incorrect Enrolment|0|||
27749535|NCT00972244|80909606|FG000|Overall Study|Adverse Event|0|||
27950359|NCT02471144|81651453|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950360|NCT02471144|81651454|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950361|NCT02471144|81651455|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950362|NCT02471144|81651456|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950363|NCT02471144|81651457|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950364|NCT02471144|81651458|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950365|NCT02471144|81651459|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
27950366|NCT02471144|81651460|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
27950367|NCT02471144|81651450|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950368|NCT02471144|81651451|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950369|NCT02471144|81651452|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950370|NCT02471144|81651453|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950371|NCT02471144|81651454|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950372|NCT02471144|81651455|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950373|NCT02471144|81651456|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950374|NCT02471144|81651457|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950375|NCT02471144|81651458|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950376|NCT02471144|81651459|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
27950377|NCT02471144|81651460|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
27950378|NCT02471144|81651450|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950379|NCT02471144|81651451|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950380|NCT02471144|81651452|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950381|NCT02471144|81651453|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950382|NCT02471144|81651454|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950383|NCT02471144|81651455|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950384|NCT02471144|81651456|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950385|NCT02471144|81651457|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950386|NCT02471144|81651458|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
27950387|NCT02471144|81651459|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
27950388|NCT02471144|81651460|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
27950389|NCT02471144|81651450|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950390|NCT02471144|81651451|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950391|NCT02471144|81651452|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950392|NCT02471144|81651453|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950393|NCT02471144|81651454|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950394|NCT02471144|81651455|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950395|NCT02471144|81651456|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950396|NCT02471144|81651457|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950397|NCT02471144|81651458|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950398|NCT02471144|81651459|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
27950399|NCT02471144|81651460|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
27950400|NCT02471144|81651450|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950401|NCT02471144|81651451|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950402|NCT02471144|81651452|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950403|NCT02471144|81651453|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950404|NCT02471144|81651454|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950405|NCT02471144|81651455|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950406|NCT02471144|81651456|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950407|NCT02471144|81651457|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950408|NCT02471144|81651458|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
27950409|NCT02471144|81651459|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
27950410|NCT02471144|81651460|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
27950411|NCT02297516|81651461|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
27950412|NCT02297516|81651462|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
27950413|NCT02297516|81651461|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
27950414|NCT02297516|81651462|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
27950415|NCT02297516|81651461|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
27950416|NCT02297516|81651462|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
27950417|NCT01280968|81651463|FG000|Overall Study|Lost to Follow-up|8|||
27950418|NCT01280968|81651464|FG001|Overall Study|Lost to Follow-up|2|||
27950419|NCT01280968|81651463|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
27950420|NCT01280968|81651464|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
27950421|NCT01280968|81651463|FG000|Overall Study|Commuting Problems|2|||
27950422|NCT01280968|81651464|FG001|Overall Study|Commuting Problems|0|||
27950423|NCT01280968|81651463|FG000|Overall Study|Anxiety|2|||
27950424|NCT01280968|81651464|FG001|Overall Study|Anxiety|0|||
27950425|NCT01280968|81651463|FG000|Overall Study|Adverse Event|1|||
27950426|NCT01280968|81651464|FG001|Overall Study|Adverse Event|0|||
27950427|NCT01280968|81651463|FG000|Overall Study|Scheduling Conflicts|1|||
27950428|NCT01280968|81651464|FG001|Overall Study|Scheduling Conflicts|1|||
27950429|NCT01280968|81651463|FG000|Overall Study|Pre-existing Neurological Condition|1|||
27950430|NCT01280968|81651464|FG001|Overall Study|Pre-existing Neurological Condition|0|||
27950431|NCT01280968|81651463|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
27950432|NCT01280968|81651464|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
27950433|NCT01152437|81651465|FG000|Overall Study|Other Adverse Event|8|||
27950434|NCT01152437|81651466|FG001|Overall Study|Other Adverse Event|1|||
27950435|NCT01152437|81651467|FG002|Overall Study|Other Adverse Event|7|||
27950436|NCT01152437|81651465|FG000|Overall Study|Not treated|0|||
27950437|NCT01152437|81651466|FG001|Overall Study|Not treated|1|||
27950438|NCT01152437|81651467|FG002|Overall Study|Not treated|2|||
27950439|NCT01152437|81651465|FG000|Overall Study|Progressive disease|27|||
27950440|NCT01152437|81651466|FG001|Overall Study|Progressive disease|13|||
27950441|NCT01152437|81651467|FG002|Overall Study|Progressive disease|32|||
27950442|NCT01152437|81651465|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
27950443|NCT01152437|81651466|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
27950444|NCT01152437|81651467|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
27950445|NCT00582907|81651468|FG000|1st Course|Withdrawal by Subject|1|||
27950446|NCT00582907|81651469|FG001|1st Course|Withdrawal by Subject|0|||
27950447|NCT00582907|81651470|FG002|1st Course|Withdrawal by Subject|0|||
27950448|NCT00582907|81651471|FG003|1st Course|Withdrawal by Subject|0|||
27950449|NCT00582907|81651468|FG000|1st Course|Lost to Follow-up|0|||
27950450|NCT00582907|81651469|FG001|1st Course|Lost to Follow-up|0|||
27950451|NCT00582907|81651470|FG002|1st Course|Lost to Follow-up|0|||
27950452|NCT00582907|81651471|FG003|1st Course|Lost to Follow-up|1|||
27950453|NCT00582907|81651468|FG000|2nd Course|Lack of Efficacy|1|||
27950454|NCT00582907|81651469|FG001|2nd Course|Lack of Efficacy|0|||
27950455|NCT00582907|81651470|FG002|2nd Course|Lack of Efficacy|0|||
27950456|NCT00582907|81651471|FG003|2nd Course|Lack of Efficacy|0|||
27950457|NCT00523978|81651472|FG000|Overall Study|Withdrawal by Subject|3|||
27950458|NCT00523978|81651473|FG001|Overall Study|Withdrawal by Subject|7|||
27950459|NCT00523978|81651472|FG000|Overall Study|Screen Failures|5|||
27950460|NCT00523978|81651473|FG001|Overall Study|Screen Failures|1|||
27950461|NCT00523978|81651472|FG000|Overall Study|Death|1|||
27950462|NCT00523978|81651473|FG001|Overall Study|Death|0|||
27950463|NCT01677988|81651474|FG000|Overall Study|Lack of Efficacy|2|||
27950464|NCT01784029|81651475|FG000|Overall Study|Lost to Follow-up|19|||
27950465|NCT01784029|81651476|FG001|Overall Study|Lost to Follow-up|20|||
27950466|NCT01784029|81651477|FG002|Overall Study|Lost to Follow-up|22|||
27950467|NCT02434081|81651478|FG000|Overall Study|Death (never started treatment)|2|||
27950468|NCT02434081|81651478|FG000|Overall Study|Death|2|||
27950469|NCT02434081|81651478|FG000|Overall Study|Progression|20|||
27950470|NCT02434081|81651478|FG000|Overall Study|Adverse Event|20|||
27950471|NCT02434081|81651478|FG000|Overall Study|Physician Decision|2|||
27950472|NCT02434081|81651478|FG000|Overall Study|Withdrawal by Subject|1|||
27950473|NCT02434081|81651478|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
27950474|NCT03674281|81651482|FG000|Overall Study|screen failure|2|||
27950475|NCT03674281|81651483|FG001|Overall Study|screen failure|0|||
27950476|NCT03674281|81651484|FG002|Overall Study|screen failure|0|||
27950477|NCT03674281|81651482|FG000|Overall Study|Withdrawal by Subject|1|||
27950478|NCT03674281|81651483|FG001|Overall Study|Withdrawal by Subject|3|||
27950479|NCT03674281|81651484|FG002|Overall Study|Withdrawal by Subject|3|||
27950480|NCT03663582|81651485|FG000|Overall Study|Physician Decision|1|||
27950481|NCT00789555|81651488|FG000|Overall Study|Protocol Amendment|78|||
27950482|NCT00789555|81651489|FG001|Overall Study|Protocol Amendment|76|||
27950483|NCT00789555|81651490|FG002|Overall Study|Protocol Amendment|80|||
27950484|NCT00789555|81651488|FG000|Overall Study|Adverse Event|17|||
27950485|NCT00789555|81651489|FG001|Overall Study|Adverse Event|7|||
27950486|NCT00789555|81651490|FG002|Overall Study|Adverse Event|10|||
27950487|NCT00789555|81651488|FG000|Overall Study|Lost to Follow-up|9|||
27950488|NCT00789555|81651489|FG001|Overall Study|Lost to Follow-up|10|||
27950489|NCT00789555|81651490|FG002|Overall Study|Lost to Follow-up|18|||
27950490|NCT00789555|81651488|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
27950491|NCT00789555|81651489|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
27950492|NCT00789555|81651490|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
27950493|NCT00789555|81651488|FG000|Overall Study|Treatment failure|11|||
27950494|NCT00789555|81651489|FG001|Overall Study|Treatment failure|8|||
27950495|NCT00789555|81651490|FG002|Overall Study|Treatment failure|12|||
27950496|NCT00789555|81651488|FG000|Overall Study|Protocol Violation|6|||
27950497|NCT00789555|81651489|FG001|Overall Study|Protocol Violation|9|||
27950498|NCT00789555|81651490|FG002|Overall Study|Protocol Violation|13|||
27950499|NCT03342560|81651491|FG000|Overall Study|Lost to Follow-up|2|||
27950500|NCT01441960|81651492|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
27950501|NCT01441960|81651493|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
27950502|NCT01441960|81651492|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
27950503|NCT01441960|81651493|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
27950504|NCT01441960|81651492|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
27950505|NCT01441960|81651493|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
27950506|NCT01664624|81651494|FG000|Overall Study|Adverse Event|0|||
27950507|NCT01664624|81651495|FG001|Overall Study|Adverse Event|1|||
27950508|NCT01664624|81651496|FG002|Overall Study|Adverse Event|0|||
27950509|NCT01664624|81651497|FG003|Overall Study|Adverse Event|0|||
27950510|NCT03837509|81651498|FG000|Phase 1|Death|5|||
27950511|NCT03837509|81651499|FG001|Phase 1|Death|2|||
27950512|NCT03837509|81651500|FG002|Phase 1|Death|0|||
27950513|NCT03837509|81651501|FG003|Phase 1|Death|0|||
27950514|NCT03837509|81651502|FG004|Phase 1|Death|0|||
27950515|NCT03837509|81651498|FG000|Phase 2|Death|0|||
27950516|NCT03837509|81651499|FG001|Phase 2|Death|0|||
27950517|NCT03837509|81651500|FG002|Phase 2|Death|0|||
27950518|NCT03837509|81651501|FG003|Phase 2|Death|1|||
27950519|NCT03837509|81651502|FG004|Phase 2|Death|1|||
27950520|NCT00060944|81651503|FG000|Overall Study|Adverse Event|12|||
27950521|NCT00060944|81651504|FG001|Overall Study|Adverse Event|10|||
27950522|NCT00060944|81651503|FG000|Overall Study|Death|2|||
27950523|NCT00060944|81651504|FG001|Overall Study|Death|3|||
27950524|NCT00060944|81651503|FG000|Overall Study|Withdrawal by Subject|18|||
27950525|NCT00060944|81651504|FG001|Overall Study|Withdrawal by Subject|5|||
27950526|NCT00060944|81651503|FG000|Overall Study|Disease Progression|93|||
27950527|NCT00060944|81651504|FG001|Overall Study|Disease Progression|94|||
27950528|NCT00060944|81651503|FG000|Overall Study|Lost to Follow-up|1|||
27950529|NCT00060944|81651504|FG001|Overall Study|Lost to Follow-up|0|||
27950530|NCT00060944|81651503|FG000|Overall Study|Subject Ineligible To Continue|2|||
27950531|NCT00060944|81651504|FG001|Overall Study|Subject Ineligible To Continue|1|||
27950532|NCT00060944|81651503|FG000|Overall Study|Treatment Switch|0|||
27950533|NCT00060944|81651504|FG001|Overall Study|Treatment Switch|13|||
27950534|NCT00060944|81651503|FG000|Overall Study|Other|2|||
27950535|NCT00060944|81651504|FG001|Overall Study|Other|4|||
27950536|NCT00060944|81651503|FG000|Overall Study|randomized but not treated|6|||
27950537|NCT00060944|81651504|FG001|Overall Study|randomized but not treated|4|||
27950538|NCT02511106|81651509|FG000|Overall Study|Lost to Follow-up|6|||
27950539|NCT02511106|81651510|FG001|Overall Study|Lost to Follow-up|4|||
27950540|NCT02511106|81651509|FG000|Overall Study|Withdrawal by Subject|24|||
27950541|NCT02511106|81651510|FG001|Overall Study|Withdrawal by Subject|21|||
27950542|NCT02511106|81651509|FG000|Overall Study|Death|42|||
27950543|NCT02511106|81651510|FG001|Overall Study|Death|82|||
27950544|NCT02511106|81651509|FG000|Overall Study|Ongoing study at data cut-off|3|||
27950545|NCT02511106|81651510|FG001|Overall Study|Ongoing study at data cut-off|2|||
27950546|NCT02511106|81651509|FG000|Overall Study|Without specified reason|3|||
27950547|NCT02511106|81651510|FG001|Overall Study|Without specified reason|0|||
27950548|NCT02378480|81651517|FG000|Overall Study|Physician Decision|1|||
27950549|NCT02378480|81651518|FG001|Overall Study|Physician Decision|1|||
27950550|NCT02378480|81651517|FG000|Overall Study|Death|1|||
27950551|NCT02378480|81651518|FG001|Overall Study|Death|2|||
27950552|NCT02378480|81651517|FG000|Overall Study|Randomized, but Not Treated|6|||
27950553|NCT02378480|81651518|FG001|Overall Study|Randomized, but Not Treated|4|||
27950554|NCT02378480|81651517|FG000|Overall Study|Adverse Event|0|||
27950555|NCT02378480|81651518|FG001|Overall Study|Adverse Event|1|||
27950556|NCT02378480|81651517|FG000|Overall Study|Missed EOT/PTE Visit|1|||
27950557|NCT02378480|81651518|FG001|Overall Study|Missed EOT/PTE Visit|2|||
27950558|NCT02378480|81651517|FG000|Overall Study|Withdrawal by Subject|9|||
27950559|NCT02378480|81651518|FG001|Overall Study|Withdrawal by Subject|4|||
27950560|NCT02378480|81651517|FG000|Overall Study|Lost to Follow-up|10|||
27950561|NCT02378480|81651518|FG001|Overall Study|Lost to Follow-up|18|||
27950562|NCT00902330|81651519|FG000|Overall Study|Too overwhelmed by treatment|2|||
27950563|NCT00902330|81651520|FG001|Overall Study|Too overwhelmed by treatment|5|||
27950564|NCT00902330|81651519|FG000|Overall Study|Adverse Event|1|||
27950565|NCT00902330|81651520|FG001|Overall Study|Adverse Event|0|||
27950566|NCT00902330|81651519|FG000|Overall Study|No post baseline data|1|||
27950567|NCT00902330|81651520|FG001|Overall Study|No post baseline data|0|||
27950568|NCT00867334|81651526|FG000|Overall Study|Withdrawal by Subject|0|||
27950569|NCT00867334|81651527|FG001|Overall Study|Withdrawal by Subject|1|||
27950570|NCT00867334|81651526|FG000|Overall Study|Withdrawal by Subject|1|||
27950571|NCT00867334|81651527|FG001|Overall Study|Withdrawal by Subject|0|||
27950572|NCT00867334|81651526|FG000|Overall Study|Withdrawal by Subject|1|||
27950573|NCT00867334|81651527|FG001|Overall Study|Withdrawal by Subject|0|||
27950574|NCT00876447|81651528|FG000|Overall Study|Other miscellaneous reasons|3|||
27950575|NCT00876447|81651529|FG001|Overall Study|Other miscellaneous reasons|8|||
27950576|NCT00876447|81651528|FG000|Overall Study|Site closure|19|||
27950577|NCT00876447|81651529|FG001|Overall Study|Site closure|14|||
27950578|NCT00876447|81651528|FG000|Overall Study|Protocol Violation|9|||
27950579|NCT00876447|81651529|FG001|Overall Study|Protocol Violation|3|||
27950580|NCT00876447|81651528|FG000|Overall Study|Personal reasons|30|||
27950581|NCT00876447|81651529|FG001|Overall Study|Personal reasons|28|||
27950582|NCT00876447|81651528|FG000|Overall Study|Lost to Follow-up|6|||
27950583|NCT00876447|81651529|FG001|Overall Study|Lost to Follow-up|15|||
27950584|NCT00876447|81651528|FG000|Overall Study|Pregnancy|4|||
27950585|NCT00876447|81651529|FG001|Overall Study|Pregnancy|2|||
27950586|NCT00876447|81651528|FG000|Overall Study|Lack of Efficacy|5|||
27950587|NCT00876447|81651529|FG001|Overall Study|Lack of Efficacy|3|||
27950588|NCT00876447|81651528|FG000|Overall Study|Adverse Event|4|||
27950589|NCT00876447|81651529|FG001|Overall Study|Adverse Event|8|||
27950590|NCT00492557|81651542|FG000|Overall Study|Subject request|12|||
27950591|NCT00492557|81651543|FG001|Overall Study|Subject request|11|||
27950592|NCT00492557|81651542|FG000|Overall Study|Protocol Violation|7|||
27950593|NCT00492557|81651543|FG001|Overall Study|Protocol Violation|8|||
27950594|NCT00492557|81651542|FG000|Overall Study|Other|2|||
27950595|NCT00492557|81651543|FG001|Overall Study|Other|2|||
27950596|NCT00492557|81651542|FG000|Overall Study|Death|1|||
27950597|NCT00492557|81651543|FG001|Overall Study|Death|1|||
27950598|NCT00492557|81651542|FG000|Overall Study|Adverse Event|1|||
27950599|NCT00492557|81651543|FG001|Overall Study|Adverse Event|0|||
27950600|NCT00492557|81651542|FG000|Overall Study|Failed to return|1|||
27950601|NCT00492557|81651543|FG001|Overall Study|Failed to return|0|||
27950602|NCT00492557|81651542|FG000|Overall Study|Lost to Follow-up|0|||
27950603|NCT00492557|81651543|FG001|Overall Study|Lost to Follow-up|1|||
27950604|NCT00542178|81651544|FG000|Overall Study|did not complete year 4 follow-up|75|||
27950605|NCT00542178|81651545|FG001|Overall Study|did not complete year 4 follow-up|80|||
27950606|NCT00542178|81651546|FG002|Overall Study|did not complete year 4 follow-up|74|||
27950607|NCT00542178|81651547|FG003|Overall Study|did not complete year 4 follow-up|62|||
27950608|NCT00542178|81651548|FG004|Overall Study|did not complete year 4 follow-up|64|||
27950609|NCT00542178|81651549|FG005|Overall Study|did not complete year 4 follow-up|89|||
27950610|NCT00542178|81651550|FG006|Overall Study|did not complete year 4 follow-up|87|||
27950611|NCT00542178|81651551|FG007|Overall Study|did not complete year 4 follow-up|85|||
27950612|NCT00337168|81651554|FG000|Overall Study|Death|5|||
27950613|NCT00337168|81651554|FG000|Overall Study|Not protocol specified|2|||
27950614|NCT00337168|81651554|FG000|Overall Study|Did not start therapy|1|||
27950615|NCT04194450|81651555|FG000|Overall Study|not eligible|1|||
27950616|NCT04194450|81651556|FG001|Overall Study|not eligible|0|||
27950617|NCT01673126|81651557|FG000|Overall Study|change of diagnosis|4|||
27950618|NCT01673126|81651558|FG001|Overall Study|change of diagnosis|3|||
27950619|NCT01047540|81651559|FG000|Overall Study|Protocol Violation|1|||
27950620|NCT01047540|81651560|FG001|Overall Study|Protocol Violation|0|||
27950621|NCT01047540|81651561|FG002|Overall Study|Protocol Violation|0|||
27950622|NCT01047540|81651562|FG003|Overall Study|Protocol Violation|0|||
27950623|NCT01047540|81651563|FG004|Overall Study|Protocol Violation|0|||
27950624|NCT01047540|81651559|FG000|Overall Study|Lost to Follow-up|1|||
27950625|NCT01047540|81651560|FG001|Overall Study|Lost to Follow-up|0|||
27950626|NCT01047540|81651561|FG002|Overall Study|Lost to Follow-up|0|||
27950627|NCT01047540|81651562|FG003|Overall Study|Lost to Follow-up|0|||
27950628|NCT01047540|81651563|FG004|Overall Study|Lost to Follow-up|0|||
27950629|NCT01047540|81651559|FG000|Overall Study|Withdrawal by Subject|1|||
27950630|NCT01047540|81651560|FG001|Overall Study|Withdrawal by Subject|0|||
27950631|NCT01047540|81651561|FG002|Overall Study|Withdrawal by Subject|3|||
27950632|NCT01047540|81651562|FG003|Overall Study|Withdrawal by Subject|0|||
27950633|NCT01047540|81651563|FG004|Overall Study|Withdrawal by Subject|1|||
27950634|NCT01047540|81651559|FG000|Overall Study|Pregnancy|1|||
27950635|NCT01047540|81651560|FG001|Overall Study|Pregnancy|0|||
27950636|NCT01047540|81651561|FG002|Overall Study|Pregnancy|0|||
27950637|NCT01047540|81651562|FG003|Overall Study|Pregnancy|0|||
27950638|NCT01047540|81651563|FG004|Overall Study|Pregnancy|0|||
27950639|NCT01047540|81651559|FG000|Overall Study|Adverse Event|1|||
27950640|NCT01047540|81651560|FG001|Overall Study|Adverse Event|0|||
27950641|NCT01047540|81651561|FG002|Overall Study|Adverse Event|0|||
27950642|NCT01047540|81651562|FG003|Overall Study|Adverse Event|0|||
27950643|NCT01047540|81651563|FG004|Overall Study|Adverse Event|0|||
27950644|NCT00557440|81651564|FG000|Treatment Period 1|Adverse Event|0|||
27950645|NCT00557440|81651565|FG001|Treatment Period 1|Adverse Event|0|||
27950646|NCT00557440|81651566|FG002|Treatment Period 1|Adverse Event|1|||
27650899|NCT03052517|80564520|FG000|Overall Study|Lost to Follow-up|2|||
27950647|NCT00127855|81651571|FG000|Primary Vaccination Course|Adverse Event|0|||
27950648|NCT00127855|81651572|FG001|Primary Vaccination Course|Adverse Event|0|||
27950649|NCT00127855|81651573|FG002|Primary Vaccination Course|Adverse Event|1|||
27950650|NCT00127855|81651574|FG003|Primary Vaccination Course|Adverse Event|0|||
27950651|NCT00127855|81651575|FG004|Primary Vaccination Course|Adverse Event|0|||
27950652|NCT00127855|81651571|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
27950653|NCT00127855|81651572|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
27950654|NCT00127855|81651573|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
27950655|NCT00127855|81651574|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
27950656|NCT00127855|81651575|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
27950657|NCT00127855|81651571|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
27950658|NCT00127855|81651572|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
27950659|NCT00127855|81651573|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
27959000|NCT01485796|81683169|FG000|Period 2: Epoch 2|Adverse Event|3|||
27950660|NCT00127855|81651574|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
27950661|NCT00127855|81651575|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
27950662|NCT00127855|81651571|FG000|Primary Vaccination Course|Other|0|||
27950663|NCT00127855|81651572|FG001|Primary Vaccination Course|Other|0|||
27950664|NCT00127855|81651573|FG002|Primary Vaccination Course|Other|0|||
27950665|NCT00127855|81651574|FG003|Primary Vaccination Course|Other|0|||
27950666|NCT00127855|81651575|FG004|Primary Vaccination Course|Other|1|||
27950667|NCT01209767|81651576|FG000|Overall Study|Withdrawal by Subject|1|||
27950668|NCT01209767|81651576|FG000|Overall Study|Lost to Follow-up|3|||
27650900|NCT03052517|80564521|FG001|Overall Study|Lost to Follow-up|4|||
27650901|NCT03052517|80564522|FG002|Overall Study|Lost to Follow-up|0|||
27650902|NCT03052517|80564520|FG000|Overall Study|Pregnancy|1|||
27650903|NCT03052517|80564521|FG001|Overall Study|Pregnancy|0|||
27650904|NCT03052517|80564522|FG002|Overall Study|Pregnancy|1|||
27650905|NCT03052517|80564520|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
27650906|NCT03052517|80564521|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
27650907|NCT03052517|80564522|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
27650908|NCT03052517|80564520|FG000|Overall Study|Technical Problems|0|||
27650909|NCT03052517|80564521|FG001|Overall Study|Technical Problems|1|||
27650910|NCT03052517|80564522|FG002|Overall Study|Technical Problems|0|||
27650911|NCT01294644|80564526|FG000|Overall Study|Adverse Event|2|||
27650912|NCT01294644|80564527|FG001|Overall Study|Adverse Event|0|||
27650913|NCT01294644|80564528|FG002|Overall Study|Adverse Event|1|||
27650914|NCT01294644|80564526|FG000|Overall Study|Withdrawal by Subject|3|||
27650915|NCT01294644|80564527|FG001|Overall Study|Withdrawal by Subject|7|||
27650916|NCT01294644|80564528|FG002|Overall Study|Withdrawal by Subject|4|||
27650917|NCT01294644|80564526|FG000|Overall Study|Lost to Follow-up|3|||
27650918|NCT01294644|80564527|FG001|Overall Study|Lost to Follow-up|2|||
27650919|NCT01294644|80564528|FG002|Overall Study|Lost to Follow-up|5|||
27650920|NCT01294644|80564526|FG000|Overall Study|Miscellaneous Reason|2|||
27650921|NCT01294644|80564527|FG001|Overall Study|Miscellaneous Reason|1|||
27650922|NCT01294644|80564528|FG002|Overall Study|Miscellaneous Reason|4|||
27650923|NCT00736502|80564530|FG000|Overall Study|Adverse Event|22|||
27650924|NCT00736502|80564530|FG000|Overall Study|Lack of Efficacy|16|||
27650925|NCT00736502|80564530|FG000|Overall Study|Lost to Follow-up|27|||
27650926|NCT00048932|80564536|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
27650927|NCT00048932|80564537|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
27650928|NCT00048932|80564538|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
27650929|NCT00048932|80564536|FG000|Double Blind Period (DB)|Adverse Event|51|||
27650930|NCT00048932|80564537|FG001|Double Blind Period (DB)|Adverse Event|19|||
27650931|NCT00048932|80564538|FG002|Double Blind Period (DB)|Adverse Event|0|||
27650932|NCT00048932|80564536|FG000|Double Blind Period (DB)|Death|5|||
27650933|NCT00048932|80564537|FG001|Double Blind Period (DB)|Death|3|||
27650934|NCT00048932|80564538|FG002|Double Blind Period (DB)|Death|0|||
27650935|NCT00048932|80564536|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
27650936|NCT00048932|80564537|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
27650937|NCT00048932|80564538|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
27650938|NCT00048932|80564536|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
27650939|NCT00048932|80564537|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
27650940|NCT00048932|80564538|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
27650941|NCT00048932|80564536|FG000|Double Blind Period (DB)|Relocation|1|||
27650942|NCT00048932|80564537|FG001|Double Blind Period (DB)|Relocation|0|||
27650943|NCT00048932|80564538|FG002|Double Blind Period (DB)|Relocation|0|||
27650944|NCT00048932|80564536|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
27650945|NCT00048932|80564537|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
27650946|NCT00048932|80564538|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
27650947|NCT00048932|80564536|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
27650948|NCT00048932|80564537|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
27650949|NCT00048932|80564538|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
27650950|NCT00048932|80564536|FG000|Double Blind Period (DB)|Pregnancy|1|||
27650951|NCT00048932|80564537|FG001|Double Blind Period (DB)|Pregnancy|0|||
27650952|NCT00048932|80564538|FG002|Double Blind Period (DB)|Pregnancy|0|||
27650953|NCT00048932|80564536|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
27650954|NCT00048932|80564537|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
27650955|NCT00048932|80564538|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
27650956|NCT00048932|80564536|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
27650957|NCT00048932|80564537|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
27950669|NCT01567722|81651577|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
27950670|NCT01567722|81651578|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
27650958|NCT00048932|80564538|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
27650959|NCT00048932|80564536|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
27650960|NCT00048932|80564537|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
27650961|NCT00048932|80564538|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
27950671|NCT01567722|81651579|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
27950672|NCT01567722|81651577|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
27950673|NCT01567722|81651578|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
27950674|NCT01567722|81651579|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
27950675|NCT01567722|81651577|FG000|Overall Study|Protocol closure by the OCG|2|||
27950676|NCT01567722|81651578|FG001|Overall Study|Protocol closure by the OCG|0|||
27950677|NCT01567722|81651579|FG002|Overall Study|Protocol closure by the OCG|0|||
27950678|NCT01567722|81651577|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
27950679|NCT01567722|81651578|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
27950680|NCT01567722|81651579|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
27950681|NCT01051661|81651580|FG000|Overall Study|Adverse Event|1|||
27950682|NCT01051661|81651581|FG001|Overall Study|Adverse Event|1|||
27950683|NCT01051661|81651582|FG002|Overall Study|Adverse Event|1|||
27950684|NCT01051661|81651583|FG003|Overall Study|Adverse Event|1|||
27950685|NCT01051661|81651584|FG004|Overall Study|Adverse Event|0|||
27950686|NCT01051661|81651585|FG005|Overall Study|Adverse Event|0|||
27950687|NCT01051661|81651580|FG000|Overall Study|Lost to Follow-up|13|||
27950688|NCT01051661|81651581|FG001|Overall Study|Lost to Follow-up|22|||
27950689|NCT01051661|81651582|FG002|Overall Study|Lost to Follow-up|15|||
27950690|NCT01051661|81651583|FG003|Overall Study|Lost to Follow-up|17|||
27950691|NCT01051661|81651584|FG004|Overall Study|Lost to Follow-up|10|||
27950692|NCT01051661|81651585|FG005|Overall Study|Lost to Follow-up|24|||
27950693|NCT01051661|81651580|FG000|Overall Study|Migrated/moved from study area|1|||
27950694|NCT01051661|81651581|FG001|Overall Study|Migrated/moved from study area|6|||
27950695|NCT01051661|81651582|FG002|Overall Study|Migrated/moved from study area|6|||
27950696|NCT01051661|81651583|FG003|Overall Study|Migrated/moved from study area|8|||
27950697|NCT01051661|81651584|FG004|Overall Study|Migrated/moved from study area|7|||
27950698|NCT01051661|81651585|FG005|Overall Study|Migrated/moved from study area|3|||
27950699|NCT01051661|81651580|FG000|Overall Study|Refused blood sampling|0|||
27950700|NCT01051661|81651581|FG001|Overall Study|Refused blood sampling|0|||
27950701|NCT01051661|81651582|FG002|Overall Study|Refused blood sampling|0|||
27950702|NCT01051661|81651583|FG003|Overall Study|Refused blood sampling|0|||
27950703|NCT01051661|81651584|FG004|Overall Study|Refused blood sampling|0|||
27950704|NCT01051661|81651585|FG005|Overall Study|Refused blood sampling|1|||
27950705|NCT01051661|81651580|FG000|Overall Study|Data not reliable|1|||
27950706|NCT01051661|81651581|FG001|Overall Study|Data not reliable|0|||
27950707|NCT01051661|81651582|FG002|Overall Study|Data not reliable|0|||
27950708|NCT01051661|81651583|FG003|Overall Study|Data not reliable|0|||
27950709|NCT01051661|81651584|FG004|Overall Study|Data not reliable|0|||
27950710|NCT01051661|81651585|FG005|Overall Study|Data not reliable|1|||
27950711|NCT01051661|81651580|FG000|Overall Study|Unable to attend visit(s)|2|||
27950712|NCT01051661|81651581|FG001|Overall Study|Unable to attend visit(s)|4|||
27950713|NCT01051661|81651582|FG002|Overall Study|Unable to attend visit(s)|2|||
27950714|NCT01051661|81651583|FG003|Overall Study|Unable to attend visit(s)|1|||
27950715|NCT01051661|81651584|FG004|Overall Study|Unable to attend visit(s)|3|||
27950716|NCT01051661|81651585|FG005|Overall Study|Unable to attend visit(s)|2|||
27950717|NCT01051661|81651580|FG000|Overall Study|Consent not received from both parents|0|||
27950718|NCT01051661|81651581|FG001|Overall Study|Consent not received from both parents|0|||
27950719|NCT01051661|81651582|FG002|Overall Study|Consent not received from both parents|0|||
27950720|NCT01051661|81651583|FG003|Overall Study|Consent not received from both parents|0|||
27950721|NCT01051661|81651584|FG004|Overall Study|Consent not received from both parents|0|||
27950722|NCT01051661|81651585|FG005|Overall Study|Consent not received from both parents|1|||
27950723|NCT01051661|81651580|FG000|Overall Study|Failure to comply with protocol|0|||
27950724|NCT01051661|81651581|FG001|Overall Study|Failure to comply with protocol|0|||
27950725|NCT01051661|81651582|FG002|Overall Study|Failure to comply with protocol|2|||
27950726|NCT01051661|81651583|FG003|Overall Study|Failure to comply with protocol|0|||
27950727|NCT01051661|81651584|FG004|Overall Study|Failure to comply with protocol|0|||
27950728|NCT01051661|81651585|FG005|Overall Study|Failure to comply with protocol|0|||
27950729|NCT01051661|81651580|FG000|Overall Study|Subject lost legal representation|0|||
27950730|NCT01051661|81651581|FG001|Overall Study|Subject lost legal representation|0|||
27950731|NCT01051661|81651582|FG002|Overall Study|Subject lost legal representation|0|||
27950732|NCT01051661|81651583|FG003|Overall Study|Subject lost legal representation|0|||
27950733|NCT01051661|81651584|FG004|Overall Study|Subject lost legal representation|1|||
27950734|NCT01051661|81651585|FG005|Overall Study|Subject lost legal representation|0|||
27950735|NCT01051661|81651580|FG000|Overall Study|Protocol Violation|0|||
27950736|NCT01051661|81651581|FG001|Overall Study|Protocol Violation|0|||
27950737|NCT01051661|81651582|FG002|Overall Study|Protocol Violation|0|||
27950738|NCT01051661|81651583|FG003|Overall Study|Protocol Violation|1|||
27950739|NCT01051661|81651584|FG004|Overall Study|Protocol Violation|2|||
27950740|NCT01051661|81651585|FG005|Overall Study|Protocol Violation|1|||
27950741|NCT01051661|81651580|FG000|Overall Study|Withdrawal by Subject|16|||
27950742|NCT01051661|81651581|FG001|Overall Study|Withdrawal by Subject|30|||
27950743|NCT01051661|81651582|FG002|Overall Study|Withdrawal by Subject|13|||
27950744|NCT01051661|81651583|FG003|Overall Study|Withdrawal by Subject|28|||
27950745|NCT01051661|81651584|FG004|Overall Study|Withdrawal by Subject|12|||
27950746|NCT01051661|81651585|FG005|Overall Study|Withdrawal by Subject|34|||
27950747|NCT00485173|81651586|FG000|Overall Study|Death|4|||
27950748|NCT00485173|81651587|FG001|Overall Study|Death|3|||
27950749|NCT00485173|81651586|FG000|Overall Study|Lost to Follow-up|32|||
27950750|NCT00485173|81651587|FG001|Overall Study|Lost to Follow-up|61|||
27950751|NCT03673176|81651588|FG000|Overall Study|Death prior to intervention|1|||
27950752|NCT03673176|81651588|FG000|Overall Study|Death following intervention|3|||
27950753|NCT03673176|81651588|FG000|Overall Study|Withdrawal by Subject|1|||
27950754|NCT01734902|81651589|FG000|Overall Study|Other than listed|0|||
27950755|NCT01734902|81651590|FG001|Overall Study|Other than listed|2|||
27950756|NCT01404234|81651595|FG000|Overall Study|Withdrawal by Subject|2|||
27950757|NCT03383666|81651598|FG000|Overall Study|Withdrawal by Subject|2|||
27950758|NCT03383666|81651598|FG000|Overall Study|Lost to Follow-up|2|||
27950759|NCT02287610|81651599|FG000|Overall Study|Lost to Follow-up|3|||
27950760|NCT02287610|81651599|FG000|Overall Study|Withdrawal by Subject|8|||
27950761|NCT02287610|81651599|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
27950762|NCT00659425|81651608|FG000|Overall Study|Disease progression|1|||
27950763|NCT00659425|81651609|FG001|Overall Study|Disease progression|0|||
27950764|NCT00659425|81651610|FG002|Overall Study|Disease progression|0|||
27950765|NCT00659425|81651611|FG003|Overall Study|Disease progression|1|||
27950766|NCT00659425|81651612|FG004|Overall Study|Disease progression|0|||
27950767|NCT00659425|81651613|FG005|Overall Study|Disease progression|2|||
27950768|NCT00659425|81651614|FG006|Overall Study|Disease progression|4|||
27950769|NCT00659425|81651615|FG007|Overall Study|Disease progression|3|||
27950770|NCT00659425|81651616|FG008|Overall Study|Disease progression|5|||
27950771|NCT00659425|81651617|FG009|Overall Study|Disease progression|3|||
27950772|NCT00659425|81651608|FG000|Overall Study|Death|0|||
27950773|NCT00659425|81651609|FG001|Overall Study|Death|0|||
27950774|NCT00659425|81651610|FG002|Overall Study|Death|0|||
27950775|NCT00659425|81651611|FG003|Overall Study|Death|1|||
27950776|NCT00659425|81651612|FG004|Overall Study|Death|0|||
27950777|NCT00659425|81651613|FG005|Overall Study|Death|0|||
27950778|NCT00659425|81651614|FG006|Overall Study|Death|1|||
27950779|NCT00659425|81651615|FG007|Overall Study|Death|0|||
27950780|NCT00659425|81651616|FG008|Overall Study|Death|0|||
27950781|NCT00659425|81651617|FG009|Overall Study|Death|0|||
27950782|NCT00659425|81651608|FG000|Overall Study|Adverse Event|0|||
27950783|NCT00659425|81651609|FG001|Overall Study|Adverse Event|0|||
27950784|NCT00659425|81651610|FG002|Overall Study|Adverse Event|0|||
27950785|NCT00659425|81651611|FG003|Overall Study|Adverse Event|0|||
27950786|NCT00659425|81651612|FG004|Overall Study|Adverse Event|0|||
27950787|NCT00659425|81651613|FG005|Overall Study|Adverse Event|1|||
27950788|NCT00659425|81651614|FG006|Overall Study|Adverse Event|0|||
27950789|NCT00659425|81651615|FG007|Overall Study|Adverse Event|3|||
27950790|NCT00659425|81651616|FG008|Overall Study|Adverse Event|1|||
27950791|NCT00659425|81651617|FG009|Overall Study|Adverse Event|4|||
27950792|NCT00659425|81651608|FG000|Overall Study|Investigator Discretion|0|||
27950793|NCT00659425|81651609|FG001|Overall Study|Investigator Discretion|0|||
27950794|NCT00659425|81651610|FG002|Overall Study|Investigator Discretion|0|||
27950795|NCT00659425|81651611|FG003|Overall Study|Investigator Discretion|0|||
27950796|NCT00659425|81651612|FG004|Overall Study|Investigator Discretion|0|||
27950797|NCT00659425|81651613|FG005|Overall Study|Investigator Discretion|1|||
27950798|NCT00659425|81651614|FG006|Overall Study|Investigator Discretion|0|||
27950799|NCT00659425|81651615|FG007|Overall Study|Investigator Discretion|3|||
27950800|NCT00659425|81651616|FG008|Overall Study|Investigator Discretion|0|||
27950801|NCT00659425|81651617|FG009|Overall Study|Investigator Discretion|0|||
27950802|NCT00659425|81651608|FG000|Overall Study|Other|0|||
27950803|NCT00659425|81651609|FG001|Overall Study|Other|1|||
27950804|NCT00659425|81651610|FG002|Overall Study|Other|1|||
27950805|NCT00659425|81651611|FG003|Overall Study|Other|2|||
27950806|NCT00659425|81651612|FG004|Overall Study|Other|4|||
27950807|NCT00659425|81651613|FG005|Overall Study|Other|0|||
27950808|NCT00659425|81651614|FG006|Overall Study|Other|3|||
27950809|NCT00659425|81651615|FG007|Overall Study|Other|2|||
27950810|NCT00659425|81651616|FG008|Overall Study|Other|0|||
27950811|NCT00659425|81651617|FG009|Overall Study|Other|6|||
27950812|NCT01693367|81651620|FG000|Overall Study|Withdrawal by Subject|1|||
27950813|NCT01693367|81651621|FG001|Overall Study|Withdrawal by Subject|1|||
27950814|NCT01693367|81651620|FG000|Overall Study|Physician Decision|0|||
27950815|NCT01693367|81651621|FG001|Overall Study|Physician Decision|1|||
27950816|NCT02157610|81651627|FG000|Overall Study|Death|4|||
27950817|NCT02157610|81651628|FG001|Overall Study|Death|4|||
27950818|NCT04436744|81651629|FG000|Overall Study|Adverse Event|1|||
27950819|NCT04436744|81651630|FG001|Overall Study|Adverse Event|1|||
27950820|NCT04436744|81651629|FG000|Overall Study|Death|1|||
27950821|NCT04436744|81651630|FG001|Overall Study|Death|0|||
27950822|NCT04436744|81651629|FG000|Overall Study|Lost to Follow-up|0|||
27950823|NCT04436744|81651630|FG001|Overall Study|Lost to Follow-up|2|||
27950824|NCT04436744|81651629|FG000|Overall Study|Physician Decision|0|||
27950825|NCT04436744|81651630|FG001|Overall Study|Physician Decision|1|||
27950826|NCT04436744|81651629|FG000|Overall Study|Progressive Disease|0|||
27950827|NCT04436744|81651630|FG001|Overall Study|Progressive Disease|4|||
27950828|NCT04436744|81651629|FG000|Overall Study|Protocol Deviation|1|||
27950829|NCT04436744|81651630|FG001|Overall Study|Protocol Deviation|1|||
27950830|NCT04436744|81651629|FG000|Overall Study|Withdrawal by Subject|1|||
27950831|NCT04436744|81651630|FG001|Overall Study|Withdrawal by Subject|2|||
27950832|NCT01602484|81651632|FG000|Overall Study|Airway issues unrelated to study|0|||
27950833|NCT01602484|81651633|FG001|Overall Study|Airway issues unrelated to study|1|||
27950834|NCT04976777|81651634|FG000|Overall Study|COVID-19 Infection|1|||
27950835|NCT04976777|81651635|FG001|Overall Study|COVID-19 Infection|0|||
27950836|NCT04570384|81651636|FG000|Overall Study|Adverse Event|2|||
27950837|NCT04570384|81651637|FG001|Overall Study|Adverse Event|1|||
27950838|NCT04570384|81651636|FG000|Overall Study|Death|2|||
27950839|NCT04570384|81651637|FG001|Overall Study|Death|5|||
27950840|NCT04570384|81651636|FG000|Overall Study|Lost to Follow-up|1|||
27950841|NCT04570384|81651637|FG001|Overall Study|Lost to Follow-up|0|||
27950842|NCT04570384|81651636|FG000|Overall Study|Other|1|||
27950843|NCT04570384|81651637|FG001|Overall Study|Other|0|||
27950844|NCT04570384|81651636|FG000|Overall Study|Protocol Violation|0|||
27950845|NCT04570384|81651637|FG001|Overall Study|Protocol Violation|1|||
27950846|NCT04570384|81651636|FG000|Overall Study|Sponsor Decision|1|||
27950847|NCT04570384|81651637|FG001|Overall Study|Sponsor Decision|0|||
27950848|NCT04570384|81651636|FG000|Overall Study|Withdrawal by Subject|4|||
27950849|NCT04570384|81651637|FG001|Overall Study|Withdrawal by Subject|2|||
27950850|NCT00183248|81651639|FG000|Overall Study|Lost to Follow-up|0|||
27950851|NCT00183248|81651640|FG001|Overall Study|Lost to Follow-up|1|||
27950852|NCT00183248|81651639|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
27950853|NCT00183248|81651640|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
27950854|NCT04290624|81651641|FG000|Overall Study|Adverse Event|1|||
27950855|NCT04290624|81651642|FG001|Overall Study|Adverse Event|0|||
27950856|NCT02394561|81651643|FG000|CORE Phase|Adverse Event|7|||
27950857|NCT02394561|81651644|FG001|CORE Phase|Adverse Event|9|||
27950858|NCT02394561|81651643|FG000|CORE Phase|Death|0|||
27950859|NCT02394561|81651644|FG001|CORE Phase|Death|1|||
27950860|NCT02394561|81651643|FG000|CORE Phase|Pregnancy|1|||
27950861|NCT02394561|81651644|FG001|CORE Phase|Pregnancy|0|||
27950862|NCT02394561|81651643|FG000|CORE Phase|Lost to Follow-up|1|||
27950863|NCT02394561|81651644|FG001|CORE Phase|Lost to Follow-up|0|||
27950864|NCT02394561|81651643|FG000|CORE Phase|Physician Decision|1|||
27950865|NCT02394561|81651644|FG001|CORE Phase|Physician Decision|1|||
27950866|NCT02394561|81651643|FG000|CORE Phase|Withdrawal by Subject|2|||
27950867|NCT02394561|81651644|FG001|CORE Phase|Withdrawal by Subject|2|||
27950868|NCT02394561|81651643|FG000|CORE Phase|Lack of Efficacy|1|||
27950869|NCT02394561|81651644|FG001|CORE Phase|Lack of Efficacy|6|||
27950870|NCT02394561|81651643|FG000|Extension Phase|Adverse Event|6|||
27950871|NCT02394561|81651644|FG001|Extension Phase|Adverse Event|1|||
27950872|NCT02394561|81651643|FG000|Extension Phase|Death|0|||
27950873|NCT02394561|81651644|FG001|Extension Phase|Death|1|||
27950874|NCT02394561|81651643|FG000|Extension Phase|Protocol Violation|1|||
27950875|NCT02394561|81651644|FG001|Extension Phase|Protocol Violation|0|||
27950876|NCT02394561|81651643|FG000|Extension Phase|Lost to Follow-up|1|||
27950877|NCT02394561|81651644|FG001|Extension Phase|Lost to Follow-up|0|||
27950878|NCT02394561|81651643|FG000|Extension Phase|Physician Decision|0|||
27950879|NCT02394561|81651644|FG001|Extension Phase|Physician Decision|2|||
27950880|NCT02394561|81651643|FG000|Extension Phase|Withdrawal by Subject|0|||
27950881|NCT02394561|81651644|FG001|Extension Phase|Withdrawal by Subject|5|||
27950882|NCT02394561|81651643|FG000|Extension Phase|Lack of Efficacy|3|||
27950883|NCT02394561|81651644|FG001|Extension Phase|Lack of Efficacy|3|||
27950884|NCT02724839|81651645|FG000|Overall Study|Withdrawal by Subject|1|||
27950885|NCT02724839|81651646|FG001|Overall Study|Withdrawal by Subject|1|||
27950886|NCT02724839|81651647|FG002|Overall Study|Withdrawal by Subject|0|||
27950887|NCT02724839|81651645|FG000|Overall Study|Lost to Follow-up|0|||
27950888|NCT02724839|81651646|FG001|Overall Study|Lost to Follow-up|3|||
27650962|NCT00048932|80564536|FG000|Open Label Period (OL)|Death|0|||
27950889|NCT02724839|81651647|FG002|Overall Study|Lost to Follow-up|2|||
27950890|NCT02724839|81651645|FG000|Overall Study|Physician Decision|0|||
27950891|NCT02724839|81651646|FG001|Overall Study|Physician Decision|0|||
27950892|NCT02724839|81651647|FG002|Overall Study|Physician Decision|3|||
27950893|NCT02684461|81655595|FG000|Overall Study|Adverse Event|1|||
27950894|NCT02684461|81655596|FG001|Overall Study|Adverse Event|0|||
27950895|NCT02684461|81655597|FG002|Overall Study|Adverse Event|0|||
27950896|NCT02684461|81655595|FG000|Overall Study|Lack of Efficacy|1|||
27950897|NCT02684461|81655596|FG001|Overall Study|Lack of Efficacy|2|||
27950898|NCT02684461|81655597|FG002|Overall Study|Lack of Efficacy|0|||
27950899|NCT00419744|81655600|FG000|Overall Study|Adverse Event|39|||
27950900|NCT00419744|81655601|FG001|Overall Study|Adverse Event|40|||
27950901|NCT00419744|81655602|FG002|Overall Study|Adverse Event|50|||
27950902|NCT00419744|81655600|FG000|Overall Study|Withdrawal by Subject|45|||
27950903|NCT00419744|81655601|FG001|Overall Study|Withdrawal by Subject|49|||
27950904|NCT00419744|81655602|FG002|Overall Study|Withdrawal by Subject|52|||
27950905|NCT00419744|81655600|FG000|Overall Study|Lost to Follow-up|8|||
27950906|NCT00419744|81655601|FG001|Overall Study|Lost to Follow-up|10|||
27950907|NCT00419744|81655602|FG002|Overall Study|Lost to Follow-up|6|||
27950908|NCT00419744|81655600|FG000|Overall Study|Protocol Violation|4|||
27950909|NCT00419744|81655601|FG001|Overall Study|Protocol Violation|7|||
27950910|NCT00419744|81655602|FG002|Overall Study|Protocol Violation|8|||
27950911|NCT00419744|81655600|FG000|Overall Study|Randomized in error|9|||
27950912|NCT00419744|81655601|FG001|Overall Study|Randomized in error|6|||
27950913|NCT00419744|81655602|FG002|Overall Study|Randomized in error|7|||
27950914|NCT00419744|81655600|FG000|Overall Study|Moving out of state|2|||
27950915|NCT00419744|81655601|FG001|Overall Study|Moving out of state|0|||
27950916|NCT00419744|81655602|FG002|Overall Study|Moving out of state|1|||
27950917|NCT00419744|81655600|FG000|Overall Study|Physician Decision|10|||
27950918|NCT00419744|81655601|FG001|Overall Study|Physician Decision|5|||
27950919|NCT00419744|81655602|FG002|Overall Study|Physician Decision|6|||
27950920|NCT00419744|81655600|FG000|Overall Study|Spirometry mouthpiece issues|0|||
27950921|NCT00419744|81655601|FG001|Overall Study|Spirometry mouthpiece issues|1|||
27950922|NCT00419744|81655602|FG002|Overall Study|Spirometry mouthpiece issues|2|||
27950923|NCT00419744|81655600|FG000|Overall Study|Incorrect medication kit dispensed|0|||
27950924|NCT00419744|81655601|FG001|Overall Study|Incorrect medication kit dispensed|0|||
27950925|NCT00419744|81655602|FG002|Overall Study|Incorrect medication kit dispensed|1|||
27950926|NCT04622592|81655603|FG000|Overall Study|Death|0|||
27950927|NCT04622592|81655604|FG001|Overall Study|Death|0|||
27950928|NCT04622592|81655605|FG002|Overall Study|Death|1|||
27950929|NCT04622592|81655606|FG003|Overall Study|Death|0|||
27950930|NCT04622592|81655607|FG004|Overall Study|Death|0|||
27950931|NCT04622592|81655608|FG005|Overall Study|Death|0|||
27950932|NCT04622592|81655609|FG006|Overall Study|Death|0|||
27950933|NCT04622592|81655610|FG007|Overall Study|Death|1|||
27950934|NCT04622592|81655603|FG000|Overall Study|Lost to Follow-up|0|||
27950935|NCT04622592|81655604|FG001|Overall Study|Lost to Follow-up|0|||
27950936|NCT04622592|81655605|FG002|Overall Study|Lost to Follow-up|0|||
27950937|NCT04622592|81655606|FG003|Overall Study|Lost to Follow-up|3|||
27950938|NCT04622592|81655607|FG004|Overall Study|Lost to Follow-up|1|||
27950939|NCT04622592|81655608|FG005|Overall Study|Lost to Follow-up|0|||
27950940|NCT04622592|81655609|FG006|Overall Study|Lost to Follow-up|2|||
27950941|NCT04622592|81655610|FG007|Overall Study|Lost to Follow-up|2|||
27950942|NCT04622592|81655603|FG000|Overall Study|Physician Decision|0|||
27950943|NCT04622592|81655604|FG001|Overall Study|Physician Decision|0|||
27950944|NCT04622592|81655605|FG002|Overall Study|Physician Decision|0|||
27950945|NCT04622592|81655606|FG003|Overall Study|Physician Decision|0|||
27950946|NCT04622592|81655607|FG004|Overall Study|Physician Decision|1|||
27950947|NCT04622592|81655608|FG005|Overall Study|Physician Decision|0|||
27950948|NCT04622592|81655609|FG006|Overall Study|Physician Decision|0|||
27950949|NCT04622592|81655610|FG007|Overall Study|Physician Decision|0|||
27950950|NCT04622592|81655603|FG000|Overall Study|Withdrawal by Subject|1|||
27950951|NCT04622592|81655604|FG001|Overall Study|Withdrawal by Subject|0|||
27950952|NCT04622592|81655605|FG002|Overall Study|Withdrawal by Subject|2|||
27950953|NCT04622592|81655606|FG003|Overall Study|Withdrawal by Subject|0|||
27950954|NCT04622592|81655607|FG004|Overall Study|Withdrawal by Subject|0|||
27950955|NCT04622592|81655608|FG005|Overall Study|Withdrawal by Subject|0|||
27950956|NCT04622592|81655609|FG006|Overall Study|Withdrawal by Subject|1|||
27950957|NCT04622592|81655610|FG007|Overall Study|Withdrawal by Subject|4|||
27950958|NCT04622592|81655603|FG000|Overall Study|Other than specified above|0|||
27950959|NCT04622592|81655604|FG001|Overall Study|Other than specified above|0|||
27950960|NCT04622592|81655605|FG002|Overall Study|Other than specified above|1|||
27950961|NCT04622592|81655606|FG003|Overall Study|Other than specified above|0|||
27950962|NCT04622592|81655607|FG004|Overall Study|Other than specified above|0|||
27950963|NCT04622592|81655608|FG005|Overall Study|Other than specified above|0|||
27950964|NCT04622592|81655609|FG006|Overall Study|Other than specified above|0|||
27950965|NCT04622592|81655610|FG007|Overall Study|Other than specified above|0|||
27950966|NCT00160563|81655616|FG000|Overall Study|Adverse Event|1|||
27950967|NCT00160563|81655617|FG001|Overall Study|Adverse Event|1|||
27950968|NCT00160563|81655618|FG002|Overall Study|Adverse Event|1|||
27950969|NCT00160563|81655616|FG000|Overall Study|Lost to Follow-up|1|||
27950970|NCT00160563|81655617|FG001|Overall Study|Lost to Follow-up|1|||
27950971|NCT00160563|81655618|FG002|Overall Study|Lost to Follow-up|2|||
27950972|NCT00160563|81655616|FG000|Overall Study|Protocol Violation|0|||
27950973|NCT00160563|81655617|FG001|Overall Study|Protocol Violation|0|||
27950974|NCT00160563|81655618|FG002|Overall Study|Protocol Violation|3|||
27950975|NCT00160563|81655616|FG000|Overall Study|Withdrawal by Subject|1|||
27950976|NCT00160563|81655617|FG001|Overall Study|Withdrawal by Subject|2|||
27950977|NCT00160563|81655618|FG002|Overall Study|Withdrawal by Subject|3|||
27950978|NCT00160563|81655616|FG000|Overall Study|Other (listed in the study report)|48|||
27950979|NCT00160563|81655617|FG001|Overall Study|Other (listed in the study report)|40|||
27950980|NCT00160563|81655618|FG002|Overall Study|Other (listed in the study report)|81|||
27950981|NCT00160563|81655616|FG000|Overall Study|Missing reason|0|||
27950982|NCT00160563|81655617|FG001|Overall Study|Missing reason|1|||
27950983|NCT00160563|81655618|FG002|Overall Study|Missing reason|0|||
27950984|NCT01038323|81655619|FG000|Overall Study|Withdrawal by Subject|3|||
27950985|NCT01038323|81655620|FG001|Overall Study|Withdrawal by Subject|2|||
27950986|NCT01038323|81655621|FG002|Overall Study|Withdrawal by Subject|4|||
27950987|NCT00760552|81655623|FG000|Overall Study|Death|2|||
27950988|NCT00760552|81655624|FG001|Overall Study|Death|0|||
27950989|NCT00760552|81655623|FG000|Overall Study|Lost to Follow-up|11|||
27950990|NCT00760552|81655624|FG001|Overall Study|Lost to Follow-up|10|||
27950991|NCT01365455|81655625|FG000|Induction Period|Adverse Event|5|||
27950992|NCT01365455|81655626|FG001|Induction Period|Adverse Event|3|||
27950993|NCT01365455|81655627|FG002|Induction Period|Adverse Event|4|||
27950994|NCT01365455|81655628|FG003|Induction Period|Adverse Event|0|||
27950995|NCT01365455|81655629|FG004|Induction Period|Adverse Event|0|||
27950996|NCT01365455|81655625|FG000|Induction Period|Lack of Efficacy|1|||
27950997|NCT01365455|81655626|FG001|Induction Period|Lack of Efficacy|1|||
27950998|NCT01365455|81655627|FG002|Induction Period|Lack of Efficacy|0|||
27950999|NCT01365455|81655628|FG003|Induction Period|Lack of Efficacy|0|||
27951000|NCT01365455|81655629|FG004|Induction Period|Lack of Efficacy|0|||
27951001|NCT01365455|81655625|FG000|Induction Period|Pregnancy|0|||
27951002|NCT01365455|81655626|FG001|Induction Period|Pregnancy|1|||
27951003|NCT01365455|81655627|FG002|Induction Period|Pregnancy|0|||
27951004|NCT01365455|81655628|FG003|Induction Period|Pregnancy|0|||
27951005|NCT01365455|81655629|FG004|Induction Period|Pregnancy|0|||
27951006|NCT01365455|81655625|FG000|Induction Period|Protocol deviation|0|||
27951007|NCT01365455|81655626|FG001|Induction Period|Protocol deviation|1|||
27951008|NCT01365455|81655627|FG002|Induction Period|Protocol deviation|1|||
27951009|NCT01365455|81655628|FG003|Induction Period|Protocol deviation|0|||
27951010|NCT01365455|81655629|FG004|Induction Period|Protocol deviation|0|||
27951011|NCT01365455|81655625|FG000|Induction Period|Subject/guardian decision|9|||
27951012|NCT01365455|81655626|FG001|Induction Period|Subject/guardian decision|1|||
27951013|NCT01365455|81655627|FG002|Induction Period|Subject/guardian decision|8|||
27951014|NCT01365455|81655628|FG003|Induction Period|Subject/guardian decision|0|||
27951015|NCT01365455|81655629|FG004|Induction Period|Subject/guardian decision|0|||
27951016|NCT01365455|81655625|FG000|Induction Period|Lost to Follow-up|0|||
27951017|NCT01365455|81655626|FG001|Induction Period|Lost to Follow-up|0|||
27951018|NCT01365455|81655627|FG002|Induction Period|Lost to Follow-up|3|||
27951019|NCT01365455|81655628|FG003|Induction Period|Lost to Follow-up|0|||
27951020|NCT01365455|81655629|FG004|Induction Period|Lost to Follow-up|0|||
27951021|NCT01365455|81655625|FG000|Maintenance Period|Adverse Event|12|||
27951022|NCT01365455|81655626|FG001|Maintenance Period|Adverse Event|5|||
27951023|NCT01365455|81655627|FG002|Maintenance Period|Adverse Event|1|||
27951024|NCT01365455|81655628|FG003|Maintenance Period|Adverse Event|2|||
27951025|NCT01365455|81655629|FG004|Maintenance Period|Adverse Event|4|||
27951026|NCT01365455|81655625|FG000|Maintenance Period|Lack of Efficacy|10|||
27951027|NCT01365455|81655626|FG001|Maintenance Period|Lack of Efficacy|2|||
27951028|NCT01365455|81655627|FG002|Maintenance Period|Lack of Efficacy|0|||
27951029|NCT01365455|81655628|FG003|Maintenance Period|Lack of Efficacy|2|||
27951030|NCT01365455|81655629|FG004|Maintenance Period|Lack of Efficacy|2|||
27951031|NCT01365455|81655625|FG000|Maintenance Period|Lost to Follow-up|2|||
27951032|NCT01365455|81655626|FG001|Maintenance Period|Lost to Follow-up|4|||
27951033|NCT01365455|81655627|FG002|Maintenance Period|Lost to Follow-up|0|||
27951034|NCT01365455|81655628|FG003|Maintenance Period|Lost to Follow-up|0|||
27951035|NCT01365455|81655629|FG004|Maintenance Period|Lost to Follow-up|3|||
27951036|NCT01365455|81655625|FG000|Maintenance Period|Non-compliance with study treatment|0|||
27951037|NCT01365455|81655626|FG001|Maintenance Period|Non-compliance with study treatment|0|||
27951038|NCT01365455|81655627|FG002|Maintenance Period|Non-compliance with study treatment|0|||
27951039|NCT01365455|81655628|FG003|Maintenance Period|Non-compliance with study treatment|1|||
27951040|NCT01365455|81655629|FG004|Maintenance Period|Non-compliance with study treatment|0|||
27951041|NCT01365455|81655625|FG000|Maintenance Period|Physician Decision|0|||
27951042|NCT01365455|81655626|FG001|Maintenance Period|Physician Decision|1|||
27951043|NCT01365455|81655627|FG002|Maintenance Period|Physician Decision|0|||
27951044|NCT01365455|81655628|FG003|Maintenance Period|Physician Decision|0|||
27951045|NCT01365455|81655629|FG004|Maintenance Period|Physician Decision|1|||
27951046|NCT01365455|81655625|FG000|Maintenance Period|Pregnancy|0|||
27951047|NCT01365455|81655626|FG001|Maintenance Period|Pregnancy|4|||
27951048|NCT01365455|81655627|FG002|Maintenance Period|Pregnancy|0|||
27951049|NCT01365455|81655628|FG003|Maintenance Period|Pregnancy|0|||
27951050|NCT01365455|81655629|FG004|Maintenance Period|Pregnancy|2|||
27951051|NCT01365455|81655625|FG000|Maintenance Period|Protocol deviation|1|||
27951052|NCT01365455|81655626|FG001|Maintenance Period|Protocol deviation|1|||
27951053|NCT01365455|81655627|FG002|Maintenance Period|Protocol deviation|0|||
27951054|NCT01365455|81655628|FG003|Maintenance Period|Protocol deviation|0|||
27951055|NCT01365455|81655629|FG004|Maintenance Period|Protocol deviation|0|||
27951056|NCT01365455|81655625|FG000|Maintenance Period|Subject/guardian decision|4|||
27951057|NCT01365455|81655626|FG001|Maintenance Period|Subject/guardian decision|6|||
27951058|NCT01365455|81655627|FG002|Maintenance Period|Subject/guardian decision|2|||
27951059|NCT01365455|81655628|FG003|Maintenance Period|Subject/guardian decision|4|||
27951060|NCT01365455|81655629|FG004|Maintenance Period|Subject/guardian decision|1|||
27951061|NCT00133705|81655633|FG000|Overall Study|Withdrawal by Subject|2|||
27951062|NCT00133705|81655634|FG001|Overall Study|Withdrawal by Subject|3|||
27951063|NCT01263119|81655635|FG000|Period 1|Protocol Violation|2|||
27951064|NCT01263119|81655635|FG000|Period 2|Adverse Event|2|||
27951065|NCT02704208|81655636|FG000|Overall Study|Lost to Follow-up|42|||
27951066|NCT02704208|81655637|FG001|Overall Study|Lost to Follow-up|37|||
27951067|NCT00557193|81655638|FG000|Induction|Adverse Event|2|||
27951068|NCT00557193|81655639|FG001|Induction|Adverse Event|0|||
27951069|NCT00557193|81655640|FG002|Induction|Adverse Event|0|||
27951070|NCT00557193|81655641|FG003|Induction|Adverse Event|0|||
27951071|NCT00557193|81655642|FG004|Induction|Adverse Event|0|||
27951072|NCT00557193|81655643|FG005|Induction|Adverse Event|0|||
27951073|NCT00557193|81655638|FG000|Induction|Death|6|||
27951074|NCT00557193|81655639|FG001|Induction|Death|0|||
27951075|NCT00557193|81655640|FG002|Induction|Death|0|||
27951076|NCT00557193|81655641|FG003|Induction|Death|0|||
27951077|NCT00557193|81655642|FG004|Induction|Death|0|||
27951078|NCT00557193|81655643|FG005|Induction|Death|0|||
27951079|NCT00557193|81655638|FG000|Induction|Physician Decision|3|||
27951080|NCT00557193|81655639|FG001|Induction|Physician Decision|0|||
27951081|NCT00557193|81655640|FG002|Induction|Physician Decision|0|||
27951082|NCT00557193|81655641|FG003|Induction|Physician Decision|0|||
27951083|NCT00557193|81655642|FG004|Induction|Physician Decision|0|||
27951084|NCT00557193|81655643|FG005|Induction|Physician Decision|0|||
27951085|NCT00557193|81655638|FG000|Induction|Withdrawal by Subject|1|||
27951086|NCT00557193|81655639|FG001|Induction|Withdrawal by Subject|0|||
27951087|NCT00557193|81655640|FG002|Induction|Withdrawal by Subject|0|||
27951088|NCT00557193|81655641|FG003|Induction|Withdrawal by Subject|0|||
27951089|NCT00557193|81655642|FG004|Induction|Withdrawal by Subject|0|||
27951090|NCT00557193|81655643|FG005|Induction|Withdrawal by Subject|0|||
27951091|NCT00557193|81655638|FG000|Induction|Refusal of Further Protocol Therapy|2|||
27951092|NCT00557193|81655639|FG001|Induction|Refusal of Further Protocol Therapy|0|||
27951093|NCT00557193|81655640|FG002|Induction|Refusal of Further Protocol Therapy|0|||
27951094|NCT00557193|81655641|FG003|Induction|Refusal of Further Protocol Therapy|0|||
27951095|NCT00557193|81655642|FG004|Induction|Refusal of Further Protocol Therapy|0|||
27951096|NCT00557193|81655643|FG005|Induction|Refusal of Further Protocol Therapy|0|||
27951097|NCT00557193|81655638|FG000|Induction|Ineligible|8|||
27951098|NCT00557193|81655639|FG001|Induction|Ineligible|0|||
27951099|NCT00557193|81655640|FG002|Induction|Ineligible|0|||
27951100|NCT00557193|81655641|FG003|Induction|Ineligible|0|||
27951101|NCT00557193|81655642|FG004|Induction|Ineligible|0|||
27951102|NCT00557193|81655643|FG005|Induction|Ineligible|0|||
27951103|NCT00557193|81655638|FG000|Induction|Inevaluable for post Induction|2|||
27951104|NCT00557193|81655639|FG001|Induction|Inevaluable for post Induction|0|||
27951105|NCT00557193|81655640|FG002|Induction|Inevaluable for post Induction|0|||
27951106|NCT00557193|81655641|FG003|Induction|Inevaluable for post Induction|0|||
27951107|NCT00557193|81655642|FG004|Induction|Inevaluable for post Induction|0|||
27951108|NCT00557193|81655643|FG005|Induction|Inevaluable for post Induction|0|||
27951109|NCT00557193|81655638|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
27951110|NCT00557193|81655639|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27951111|NCT00557193|81655640|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27951112|NCT00557193|81655641|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27951113|NCT00557193|81655642|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27951114|NCT00557193|81655643|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
27951115|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27951116|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
27951117|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
27951118|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
27951119|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
27951120|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
27951121|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
27951122|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
27951123|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
27951124|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
27951125|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
27951126|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
27951127|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
27951128|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
27951129|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
27951130|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
27951131|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
27951132|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
27951133|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
27951134|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
27951135|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
27951136|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
27951137|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
27951138|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
27951139|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
27951140|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
27951141|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
27951142|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
27951143|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
27951144|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
27951145|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27951146|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27951147|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
27951148|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27951149|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27951150|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
27951151|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27951152|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27951153|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
27951154|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27951155|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27951156|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
27951157|NCT00557193|81655638|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27951158|NCT00557193|81655639|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27951159|NCT00557193|81655640|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
27951160|NCT00557193|81655641|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27951161|NCT00557193|81655642|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
27951162|NCT00557193|81655643|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
27951163|NCT01133847|81655644|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
27951164|NCT01133847|81655645|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
27951165|NCT01133847|81655646|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
27951166|NCT01133847|81655644|FG000|Follow-Up Phase|Lost to Follow-up|1|||
27951167|NCT01133847|81655645|FG001|Follow-Up Phase|Lost to Follow-up|3|||
27951168|NCT01133847|81655646|FG002|Follow-Up Phase|Lost to Follow-up|7|||
27951169|NCT00462826|81655647|FG000|Overall Study|Ineligible - second primary|1|||
27951170|NCT00462826|81655647|FG000|Overall Study|Ineligible - wrong cell type|1|||
27951171|NCT00462826|81655647|FG000|Overall Study|Ineligible - wrong primary|2|||
27951172|NCT00462826|81655647|FG000|Overall Study|Never treated|1|||
27951173|NCT04476784|81655648|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
27951174|NCT04476784|81655649|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
27951175|NCT00800735|81655658|FG000|Overall Study|Administrative/Other|2|||
27951176|NCT00800735|81655658|FG000|Overall Study|Insufficient Therapeutic Response|2|||
27951177|NCT00800735|81655658|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
27951178|NCT00800735|81655658|FG000|Overall Study|Withdrew Consent|3|||
27951179|NCT02806414|81655659|FG000|Overall Study|Lost to Follow-up|2|||
27951180|NCT01994876|81655662|FG000|Test Period 1|Withdrawal by Subject|0|||
27951181|NCT01994876|81655663|FG001|Test Period 1|Withdrawal by Subject|1|||
27951182|NCT01994876|81655662|FG000|Test Period 1|Adverse Event|0|||
27951183|NCT01994876|81655663|FG001|Test Period 1|Adverse Event|1|||
27951184|NCT01994876|81655662|FG000|Test Period 2|Adverse Event|1|||
27951185|NCT01994876|81655663|FG001|Test Period 2|Adverse Event|0|||
27951186|NCT01994876|81655662|FG000|Test Period 2|Protocol Violation|0|||
27951187|NCT01994876|81655663|FG001|Test Period 2|Protocol Violation|1|||
27951188|NCT00332696|81655668|FG000|Overall Study|Death|24|||
27951189|NCT00332696|81655669|FG001|Overall Study|Death|14|||
27951190|NCT00332696|81655668|FG000|Overall Study|Insufficient therapeutic effect|4|||
27951191|NCT00332696|81655669|FG001|Overall Study|Insufficient therapeutic effect|11|||
27951192|NCT00332696|81655668|FG000|Overall Study|Adverse Event|1|||
27951193|NCT00332696|81655669|FG001|Overall Study|Adverse Event|2|||
27951194|NCT00332696|81655668|FG000|Overall Study|Condition does not justify treatment|0|||
27951195|NCT00332696|81655669|FG001|Overall Study|Condition does not justify treatment|2|||
27951196|NCT00332696|81655668|FG000|Overall Study|Lost to Follow-up|0|||
27951197|NCT00332696|81655669|FG001|Overall Study|Lost to Follow-up|1|||
27951198|NCT00332696|81655668|FG000|Overall Study|Withdrawal by Subject|1|||
27650963|NCT00048932|80564537|FG001|Open Label Period (OL)|Death|0|||
27951199|NCT00332696|81655669|FG001|Overall Study|Withdrawal by Subject|0|||
27951200|NCT02835690|81655674|FG000|Overall Study|Death|12|||
27951201|NCT02835690|81655675|FG001|Overall Study|Death|11|||
27951202|NCT02835690|81655676|FG002|Overall Study|Death|13|||
27951203|NCT02835690|81655674|FG000|Overall Study|Transferred to Extension Study|2|||
27951204|NCT02835690|81655675|FG001|Overall Study|Transferred to Extension Study|2|||
27951205|NCT02835690|81655676|FG002|Overall Study|Transferred to Extension Study|1|||
27951206|NCT02835690|81655674|FG000|Overall Study|Did Not Continue on Extension Study|0|||
27951207|NCT02835690|81655675|FG001|Overall Study|Did Not Continue on Extension Study|0|||
27951208|NCT02835690|81655676|FG002|Overall Study|Did Not Continue on Extension Study|1|||
27951209|NCT02835690|81655674|FG000|Overall Study|Not Treated|0|||
27951210|NCT02835690|81655675|FG001|Overall Study|Not Treated|2|||
27951211|NCT02835690|81655676|FG002|Overall Study|Not Treated|0|||
27951212|NCT01928433|81655679|FG000|Overall Study|Adverse Event|5|||
27951213|NCT01928433|81655680|FG001|Overall Study|Adverse Event|2|||
27951214|NCT01928433|81655681|FG002|Overall Study|Adverse Event|5|||
27951215|NCT01928433|81655679|FG000|Overall Study|Protocol Violation|0|||
27951216|NCT01928433|81655680|FG001|Overall Study|Protocol Violation|0|||
27951217|NCT01928433|81655681|FG002|Overall Study|Protocol Violation|2|||
27951218|NCT01928433|81655679|FG000|Overall Study|Lack of Efficacy|5|||
27951219|NCT01928433|81655680|FG001|Overall Study|Lack of Efficacy|4|||
27951220|NCT01928433|81655681|FG002|Overall Study|Lack of Efficacy|4|||
27951221|NCT01928433|81655679|FG000|Overall Study|Withdrawal by Subject|0|||
27951222|NCT01928433|81655680|FG001|Overall Study|Withdrawal by Subject|4|||
27951223|NCT01928433|81655681|FG002|Overall Study|Withdrawal by Subject|0|||
27951224|NCT01928433|81655679|FG000|Overall Study|Negative screening urine culture|7|||
27951225|NCT01928433|81655680|FG001|Overall Study|Negative screening urine culture|6|||
27951226|NCT01928433|81655681|FG002|Overall Study|Negative screening urine culture|10|||
27951227|NCT01928433|81655679|FG000|Overall Study|Lost to Follow-up|0|||
27951228|NCT01928433|81655680|FG001|Overall Study|Lost to Follow-up|2|||
27951229|NCT01928433|81655681|FG002|Overall Study|Lost to Follow-up|3|||
27951230|NCT01928433|81655679|FG000|Overall Study|Other reasons|3|||
27951231|NCT01928433|81655680|FG001|Overall Study|Other reasons|3|||
27951232|NCT01928433|81655681|FG002|Overall Study|Other reasons|4|||
27951233|NCT02259114|81655682|FG000|Overall Study|Progressive Disease|14|||
27951234|NCT02259114|81655683|FG001|Overall Study|Progressive Disease|2|||
27951235|NCT02259114|81655684|FG002|Overall Study|Progressive Disease|10|||
27951236|NCT02259114|81655685|FG003|Overall Study|Progressive Disease|2|||
27951237|NCT02259114|81655686|FG004|Overall Study|Progressive Disease|5|||
27951238|NCT02259114|81655682|FG000|Overall Study|Adverse Event|2|||
27951239|NCT02259114|81655683|FG001|Overall Study|Adverse Event|1|||
27951240|NCT02259114|81655684|FG002|Overall Study|Adverse Event|0|||
27951241|NCT02259114|81655685|FG003|Overall Study|Adverse Event|0|||
27951242|NCT02259114|81655686|FG004|Overall Study|Adverse Event|1|||
27951243|NCT02259114|81655682|FG000|Overall Study|Death|3|||
27951244|NCT02259114|81655683|FG001|Overall Study|Death|0|||
27951245|NCT02259114|81655684|FG002|Overall Study|Death|1|||
27951246|NCT02259114|81655685|FG003|Overall Study|Death|0|||
27951247|NCT02259114|81655686|FG004|Overall Study|Death|0|||
27951248|NCT02259114|81655682|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27951249|NCT02259114|81655683|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27951250|NCT02259114|81655684|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
27951251|NCT02259114|81655685|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27951252|NCT02259114|81655686|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
27951253|NCT02259114|81655682|FG000|Overall Study|Withdrawal by Subject|0|||
27951254|NCT02259114|81655683|FG001|Overall Study|Withdrawal by Subject|0|||
27951255|NCT02259114|81655684|FG002|Overall Study|Withdrawal by Subject|1|||
27951256|NCT02259114|81655685|FG003|Overall Study|Withdrawal by Subject|1|||
27951257|NCT02259114|81655686|FG004|Overall Study|Withdrawal by Subject|0|||
27951258|NCT02259114|81655682|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
27951259|NCT02259114|81655683|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
27951260|NCT02259114|81655684|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
27951261|NCT02259114|81655685|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
27951262|NCT02259114|81655686|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
27951263|NCT02259114|81655682|FG000|Overall Study|Not Treated|1|||
27951264|NCT02259114|81655683|FG001|Overall Study|Not Treated|0|||
27951265|NCT02259114|81655684|FG002|Overall Study|Not Treated|0|||
27951266|NCT02259114|81655685|FG003|Overall Study|Not Treated|0|||
27951267|NCT02259114|81655686|FG004|Overall Study|Not Treated|0|||
27951268|NCT02604511|81655687|FG000|Overall Study|Adverse Event|3|||
27951269|NCT02604511|81655687|FG000|Overall Study|Disease Progression|4|||
27951270|NCT02604511|81655687|FG000|Overall Study|Withdrawal by Subject|3|||
27951271|NCT02604511|81655687|FG000|Overall Study|Participant ineligible|1|||
27951272|NCT02604511|81655687|FG000|Overall Study|Intercurrent illness|1|||
27951273|NCT04047446|81655688|FG000|Overall Study|Physician Decision|1|||
27951274|NCT04047446|81655689|FG001|Overall Study|Physician Decision|0|||
27951275|NCT00448448|81655690|FG000|Overall Study|Withdrawal by Subject|13|||
27951276|NCT00448448|81655691|FG001|Overall Study|Withdrawal by Subject|2|||
27951277|NCT00448448|81655690|FG000|Overall Study|On protocol when study ended|83|||
27951278|NCT00448448|81655691|FG001|Overall Study|On protocol when study ended|36|||
27951279|NCT00448448|81655690|FG000|Overall Study|Lost to Follow-up|2|||
27951280|NCT00448448|81655691|FG001|Overall Study|Lost to Follow-up|1|||
27951281|NCT00448448|81655690|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
27951282|NCT00448448|81655691|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
27951283|NCT00448448|81655690|FG000|Overall Study|Signed consent lost|0|||
27951284|NCT00448448|81655691|FG001|Overall Study|Signed consent lost|1|||
27951285|NCT05201807|81655692|FG000|Overall Study|Adverse Event|1|||
27951286|NCT05201807|81655692|FG000|Overall Study|COVID-19 Related|1|||
27951287|NCT01849276|81655693|FG000|Followed for Survival for 5 Years|Death|1|||
27951288|NCT01849276|81655693|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
27951289|NCT01397253|81655699|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
27951290|NCT01397253|81655700|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
27951291|NCT02133573|81655701|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
27951292|NCT02133573|81655702|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
27951293|NCT02133573|81655701|FG000|Overall Study|Child Deaths|3|||
27951294|NCT02133573|81655702|FG001|Overall Study|Child Deaths|5|||
27951295|NCT02133573|81655701|FG000|Overall Study|Child Declined Follow Ups|2|||
27951296|NCT02133573|81655702|FG001|Overall Study|Child Declined Follow Ups|1|||
27951297|NCT02133573|81655701|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
27951298|NCT02133573|81655702|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
27951299|NCT02081586|81655703|FG000|Overall Study|Lost to Follow-up|0|||
27951300|NCT02081586|81655704|FG001|Overall Study|Lost to Follow-up|1|||
27951301|NCT02081586|81655705|FG002|Overall Study|Lost to Follow-up|0|||
27951302|NCT02081586|81655706|FG003|Overall Study|Lost to Follow-up|1|||
27951303|NCT02081586|81655703|FG000|Overall Study|Head injury not related to study|0|||
27951304|NCT02081586|81655704|FG001|Overall Study|Head injury not related to study|0|||
27951305|NCT02081586|81655705|FG002|Overall Study|Head injury not related to study|1|||
27951306|NCT02081586|81655706|FG003|Overall Study|Head injury not related to study|0|||
27951307|NCT01246960|81655709|FG000|Overall Study|Lost to Follow-up|3|||
27951308|NCT01246960|81655710|FG001|Overall Study|Lost to Follow-up|1|||
27951309|NCT01246960|81655709|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
27951310|NCT01246960|81655710|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
27951311|NCT01214837|81655725|FG000|Overall Study|Death|0|||
27951312|NCT01214837|81655726|FG001|Overall Study|Death|0|||
27951313|NCT01214837|81655727|FG002|Overall Study|Death|1|||
27951314|NCT01214837|81655725|FG000|Overall Study|Adverse Event|1|||
27951315|NCT01214837|81655726|FG001|Overall Study|Adverse Event|2|||
27951316|NCT01214837|81655727|FG002|Overall Study|Adverse Event|1|||
27951317|NCT01214837|81655725|FG000|Overall Study|Withdrawal by Subject|27|||
27951318|NCT01214837|81655726|FG001|Overall Study|Withdrawal by Subject|36|||
27951319|NCT01214837|81655727|FG002|Overall Study|Withdrawal by Subject|28|||
27951320|NCT01214837|81655725|FG000|Overall Study|Lost to Follow-up|20|||
27951321|NCT01214837|81655726|FG001|Overall Study|Lost to Follow-up|15|||
27951322|NCT01214837|81655727|FG002|Overall Study|Lost to Follow-up|21|||
27951323|NCT01214837|81655725|FG000|Overall Study|Inappropriate Enrolment|0|||
27951324|NCT01214837|81655726|FG001|Overall Study|Inappropriate Enrolment|1|||
27951325|NCT01214837|81655727|FG002|Overall Study|Inappropriate Enrolment|2|||
27951326|NCT01214837|81655725|FG000|Overall Study|Administrative Reason|2|||
27951327|NCT01214837|81655726|FG001|Overall Study|Administrative Reason|6|||
27951328|NCT01214837|81655727|FG002|Overall Study|Administrative Reason|4|||
27951329|NCT01214837|81655725|FG000|Overall Study|Protocol Violation|3|||
27951330|NCT01214837|81655726|FG001|Overall Study|Protocol Violation|1|||
27951331|NCT01214837|81655727|FG002|Overall Study|Protocol Violation|5|||
27951332|NCT01214837|81655725|FG000|Overall Study|Unable to Classify|1|||
27951333|NCT01214837|81655726|FG001|Overall Study|Unable to Classify|3|||
27951334|NCT01214837|81655727|FG002|Overall Study|Unable to Classify|0|||
27951335|NCT00016354|81655728|FG000|Overall Study|Lack of Efficacy|0|||
27951336|NCT00016354|81655729|FG001|Overall Study|Lack of Efficacy|0|||
27951337|NCT00016354|81655730|FG002|Overall Study|Lack of Efficacy|0|||
27951338|NCT00016354|81655731|FG003|Overall Study|Lack of Efficacy|0|||
27951339|NCT00016354|81655732|FG004|Overall Study|Lack of Efficacy|0|||
27951340|NCT00016354|81655733|FG005|Overall Study|Lack of Efficacy|0|||
27951341|NCT00016354|81655734|FG006|Overall Study|Lack of Efficacy|0|||
27951342|NCT00016354|81655735|FG007|Overall Study|Lack of Efficacy|1|||
27951343|NCT00657267|81655736|FG000|Overall Study|Progressive disease|45|||
27951344|NCT00657267|81655736|FG000|Overall Study|Adverse Event|9|||
27951345|NCT00387088|81655737|FG000|Overall Study|Adverse Event|143|||
27951346|NCT00387088|81655738|FG001|Overall Study|Adverse Event|156|||
27951347|NCT00387088|81655737|FG000|Overall Study|Protocol Violation|47|||
27951348|NCT00387088|81655738|FG001|Overall Study|Protocol Violation|35|||
27951349|NCT00387088|81655737|FG000|Overall Study|Withdrawal by Subject|20|||
27551484|NCT01543698|80207472|FG014|Phase 2|Withdrawal by Subject|1|||
27951350|NCT00387088|81655738|FG001|Overall Study|Withdrawal by Subject|35|||
27951351|NCT00387088|81655737|FG000|Overall Study|Lack of Efficacy|28|||
27951352|NCT00387088|81655738|FG001|Overall Study|Lack of Efficacy|67|||
27951353|NCT00387088|81655737|FG000|Overall Study|Lost to Follow-up|22|||
27951354|NCT00387088|81655738|FG001|Overall Study|Lost to Follow-up|28|||
27951355|NCT00387088|81655737|FG000|Overall Study|Other|58|||
27951356|NCT00387088|81655738|FG001|Overall Study|Other|52|||
27951357|NCT01368614|81655742|FG000|Screening Period|Screen Failure|58|||
27951358|NCT01368614|81655743|FG001|Screening Period|Screen Failure|0|||
27951359|NCT01368614|81655744|FG002|Screening Period|Screen Failure|0|||
27951360|NCT01368614|81655745|FG003|Screening Period|Screen Failure|0|||
27951361|NCT01368614|81655742|FG000|Study Period|Withdrawal by Subject|0|||
27951362|NCT01368614|81655743|FG001|Study Period|Withdrawal by Subject|1|||
27951363|NCT01368614|81655744|FG002|Study Period|Withdrawal by Subject|1|||
27951364|NCT01368614|81655745|FG003|Study Period|Withdrawal by Subject|3|||
27951365|NCT01368614|81655742|FG000|Study Period|Lost to Follow-up|0|||
27951366|NCT01368614|81655743|FG001|Study Period|Lost to Follow-up|0|||
27951367|NCT01368614|81655744|FG002|Study Period|Lost to Follow-up|1|||
27951368|NCT01368614|81655745|FG003|Study Period|Lost to Follow-up|0|||
27951369|NCT02712788|81655746|FG000|Overall Study|Physician Decision|1|||
27951370|NCT02712788|81655747|FG001|Overall Study|Physician Decision|0|||
27951371|NCT02712788|81655746|FG000|Overall Study|Protocol Violation|1|||
27951372|NCT02712788|81655747|FG001|Overall Study|Protocol Violation|0|||
27951373|NCT00189423|81655750|FG000|Overall Study|Death|746|||
27951374|NCT00189423|81655751|FG001|Overall Study|Death|747|||
27951375|NCT00189423|81655750|FG000|Overall Study|Withdrawal by Subject|9|||
27951376|NCT00189423|81655751|FG001|Overall Study|Withdrawal by Subject|9|||
27951377|NCT00189423|81655750|FG000|Overall Study|Lost to Follow-up|10|||
27951378|NCT00189423|81655751|FG001|Overall Study|Lost to Follow-up|10|||
27951379|NCT01656161|81655752|FG000|Overall Study|Death|3|||
27951380|NCT01656161|81655752|FG000|Overall Study|Adverse Event|2|||
27951381|NCT01656161|81655752|FG000|Overall Study|Protocol Violation|1|||
27951382|NCT01656161|81655752|FG000|Overall Study|Withdrawal by Subject|1|||
27951383|NCT01876381|81655755|FG000|Overall Study|Lack of Efficacy|5|||
27951384|NCT01876381|81655755|FG000|Overall Study|Physician Decision|1|||
27951385|NCT01876381|81655755|FG000|Overall Study|Withdrawal by Subject|1|||
27951386|NCT00805389|81655756|FG000|Overall Study|Adverse Event|0|||
27951387|NCT00805389|81655757|FG001|Overall Study|Adverse Event|0|||
27951388|NCT00805389|81655758|FG002|Overall Study|Adverse Event|1|||
27951389|NCT00805389|81655759|FG003|Overall Study|Adverse Event|2|||
27951390|NCT00805389|81655760|FG004|Overall Study|Adverse Event|0|||
27951391|NCT00805389|81655756|FG000|Overall Study|Lost to Follow-up|4|||
27951392|NCT00805389|81655757|FG001|Overall Study|Lost to Follow-up|3|||
27951393|NCT00805389|81655758|FG002|Overall Study|Lost to Follow-up|6|||
27951394|NCT00805389|81655759|FG003|Overall Study|Lost to Follow-up|10|||
27951395|NCT00805389|81655760|FG004|Overall Study|Lost to Follow-up|9|||
27951396|NCT00805389|81655756|FG000|Overall Study|Protocol Violation|0|||
27951397|NCT00805389|81655757|FG001|Overall Study|Protocol Violation|0|||
27951398|NCT00805389|81655758|FG002|Overall Study|Protocol Violation|1|||
27951399|NCT00805389|81655759|FG003|Overall Study|Protocol Violation|0|||
27951400|NCT00805389|81655760|FG004|Overall Study|Protocol Violation|0|||
27951401|NCT00805389|81655756|FG000|Overall Study|Withdrawal by Subject|3|||
27951402|NCT00805389|81655757|FG001|Overall Study|Withdrawal by Subject|2|||
27951403|NCT00805389|81655758|FG002|Overall Study|Withdrawal by Subject|4|||
27951404|NCT00805389|81655759|FG003|Overall Study|Withdrawal by Subject|5|||
27951405|NCT00805389|81655760|FG004|Overall Study|Withdrawal by Subject|4|||
27951406|NCT00545779|81655761|FG000|Overall Study|Violation of selection criteria at entry|8|||
27951407|NCT00545779|81655761|FG000|Overall Study|Other protocol violation|1|||
27951408|NCT00545779|81655761|FG000|Overall Study|Did not cooperate|7|||
27951409|NCT00545779|81655761|FG000|Overall Study|Withdrawal by Subject|20|||
27951410|NCT00545779|81655761|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
27951411|NCT00545779|81655761|FG000|Overall Study|Failure to return|3|||
27951412|NCT02493764|81655762|FG000|Overall Study|Adverse Event|2|||
27951413|NCT02493764|81655763|FG001|Overall Study|Adverse Event|2|||
27951414|NCT02493764|81655762|FG000|Overall Study|Death|44|||
27951415|NCT02493764|81655763|FG001|Overall Study|Death|58|||
27951416|NCT02493764|81655762|FG000|Overall Study|Lost to Follow-up|2|||
27951417|NCT02493764|81655763|FG001|Overall Study|Lost to Follow-up|1|||
27951418|NCT02493764|81655762|FG000|Overall Study|Protocol Violation|6|||
27951419|NCT02493764|81655763|FG001|Overall Study|Protocol Violation|7|||
27951420|NCT02493764|81655762|FG000|Overall Study|Physician Decision|1|||
27951421|NCT02493764|81655763|FG001|Overall Study|Physician Decision|1|||
27951422|NCT02493764|81655762|FG000|Overall Study|Participant moved|17|||
27951423|NCT02493764|81655763|FG001|Overall Study|Participant moved|5|||
27951424|NCT02493764|81655762|FG000|Overall Study|Withdrawal parent/guardian|0|||
27951425|NCT02493764|81655763|FG001|Overall Study|Withdrawal parent/guardian|1|||
27951426|NCT02493764|81655762|FG000|Overall Study|Withdrawal by Subject|11|||
27951427|NCT02493764|81655763|FG001|Overall Study|Withdrawal by Subject|7|||
27951428|NCT01668004|81655764|FG000|Overall Study|Adverse Event|7|||
27951429|NCT01668004|81655764|FG000|Overall Study|Withdrawal by Subject|2|||
27951430|NCT01668004|81655764|FG000|Overall Study|Lost to Follow-up|5|||
27951431|NCT01668004|81655764|FG000|Overall Study|Lack of Efficacy|9|||
27951432|NCT01668004|81655764|FG000|Overall Study|Non-compliance with treatment|2|||
27951433|NCT02538614|81655765|FG000|Overall Study|Progressive Disease|2|||
27951434|NCT03434834|81655767|FG000|Overall Study|unable to swallow OCT probe|16|||
27951435|NCT00590317|81655773|FG000|Overall Study|Lack of Efficacy|1|||
27951436|NCT00590317|81655774|FG001|Overall Study|Lack of Efficacy|5|||
27951437|NCT00730886|81655780|FG000|Overall Study|Lost to Follow-up|1|||
27951438|NCT00730886|81655781|FG001|Overall Study|Lost to Follow-up|0|||
27951439|NCT00730886|81655780|FG000|Overall Study|Physician Decision|1|||
27951440|NCT00730886|81655781|FG001|Overall Study|Physician Decision|0|||
27951441|NCT03243084|81655785|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
27951442|NCT03243084|81655786|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
27951443|NCT01987557|81655787|FG000|Overall Study|Protocol Violation|1|||
27951444|NCT01987557|81655788|FG001|Overall Study|Protocol Violation|0|||
27951445|NCT01987557|81655789|FG002|Overall Study|Protocol Violation|1|||
27951446|NCT01987557|81655787|FG000|Overall Study|Withdrawal by Subject|2|||
27951447|NCT01987557|81655788|FG001|Overall Study|Withdrawal by Subject|1|||
27951448|NCT01987557|81655789|FG002|Overall Study|Withdrawal by Subject|2|||
27951449|NCT01987557|81655787|FG000|Overall Study|Adverse Event|0|||
27951450|NCT01987557|81655788|FG001|Overall Study|Adverse Event|2|||
27951451|NCT01987557|81655789|FG002|Overall Study|Adverse Event|0|||
27951452|NCT03983421|81655790|FG000|Overall Study|Lost to Follow-up|1|||
27951453|NCT00366457|81655793|FG000|Overall Study|never began study therapy|2|||
27951454|NCT03508050|81655794|FG000|Overall Study|Pleural adhesions|1|||
27951455|NCT03508050|81655795|FG001|Overall Study|Pleural adhesions|0|||
27951456|NCT03508050|81655794|FG000|Overall Study|Mucus plug|1|||
27951457|NCT03508050|81655795|FG001|Overall Study|Mucus plug|0|||
27951458|NCT03508050|81655794|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
27951459|NCT03508050|81655795|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
27951460|NCT03508050|81655794|FG000|Overall Study|Sustained desaturation|0|||
27951461|NCT03508050|81655795|FG001|Overall Study|Sustained desaturation|1|||
27951462|NCT01822925|81655801|FG000|Overall Study|Adverse Event|1|||
27951463|NCT01822925|81655802|FG001|Overall Study|Adverse Event|1|||
27951464|NCT01822925|81655803|FG002|Overall Study|Adverse Event|1|||
27951465|NCT01822925|81655804|FG003|Overall Study|Adverse Event|1|||
27951466|NCT01822925|81655801|FG000|Overall Study|Lost to Follow-up|0|||
27951467|NCT01822925|81655802|FG001|Overall Study|Lost to Follow-up|1|||
27951468|NCT01822925|81655803|FG002|Overall Study|Lost to Follow-up|0|||
27951469|NCT01822925|81655804|FG003|Overall Study|Lost to Follow-up|0|||
27951470|NCT01822925|81655801|FG000|Overall Study|Protocol Violation|1|||
27951471|NCT01822925|81655802|FG001|Overall Study|Protocol Violation|0|||
27951472|NCT01822925|81655803|FG002|Overall Study|Protocol Violation|0|||
27951473|NCT01822925|81655804|FG003|Overall Study|Protocol Violation|1|||
27951474|NCT01822925|81655801|FG000|Overall Study|Withdrawal by Subject|2|||
27951475|NCT01822925|81655802|FG001|Overall Study|Withdrawal by Subject|0|||
27951476|NCT01822925|81655803|FG002|Overall Study|Withdrawal by Subject|2|||
27951477|NCT01822925|81655804|FG003|Overall Study|Withdrawal by Subject|2|||
27951478|NCT01822925|81655801|FG000|Overall Study|Taking prohibited medication|2|||
27951479|NCT01822925|81655802|FG001|Overall Study|Taking prohibited medication|0|||
27951480|NCT01822925|81655803|FG002|Overall Study|Taking prohibited medication|0|||
27951481|NCT01822925|81655804|FG003|Overall Study|Taking prohibited medication|1|||
27951482|NCT02536664|81655807|FG000|Overall Study|Inadequate completion of documentation|2|||
27951483|NCT02536664|81655808|FG001|Overall Study|Inadequate completion of documentation|4|||
27951484|NCT02536664|81655807|FG000|Overall Study|Progression|13|||
27951485|NCT02536664|81655808|FG001|Overall Study|Progression|18|||
27951486|NCT02536664|81655807|FG000|Overall Study|Death due to lymphoma|2|||
27951487|NCT02536664|81655808|FG001|Overall Study|Death due to lymphoma|1|||
27951488|NCT02536664|81655807|FG000|Overall Study|Death due to other reason|3|||
27951489|NCT02536664|81655808|FG001|Overall Study|Death due to other reason|2|||
27951490|NCT02536664|81655807|FG000|Overall Study|Intolerability|8|||
27951491|NCT02536664|81655808|FG001|Overall Study|Intolerability|6|||
27951492|NCT02536664|81655807|FG000|Overall Study|Withdrawal by Subject|8|||
27951493|NCT02536664|81655808|FG001|Overall Study|Withdrawal by Subject|5|||
27951494|NCT02536664|81655807|FG000|Overall Study|Other|18|||
27951495|NCT02536664|81655808|FG001|Overall Study|Other|24|||
27951496|NCT02536664|81655807|FG000|Overall Study|Missing|53|||
27749536|NCT00972244|80909607|FG001|Overall Study|Adverse Event|1|||
27749537|NCT00972244|80909608|FG002|Overall Study|Adverse Event|1|||
27951497|NCT02536664|81655808|FG001|Overall Study|Missing|20|||
27951498|NCT03984825|81655809|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
27951499|NCT03984825|81655809|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
27951500|NCT03984825|81655809|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
27951501|NCT04490278|81655810|FG000|Overall Study|Lost to Follow-up|6|||
27951502|NCT04079738|81655811|FG000|Study Treatment|Death|1|||
27951503|NCT04079738|81655812|FG001|Study Treatment|Death|0|||
27951504|NCT04079738|81655813|FG002|Study Treatment|Death|0|||
27951505|NCT04079738|81655814|FG003|Study Treatment|Death|0|||
27951506|NCT04079738|81655811|FG000|Study Treatment|Adverse Event|2|||
27951507|NCT04079738|81655812|FG001|Study Treatment|Adverse Event|0|||
27951508|NCT04079738|81655813|FG002|Study Treatment|Adverse Event|0|||
27951509|NCT04079738|81655814|FG003|Study Treatment|Adverse Event|0|||
27951510|NCT04079738|81655811|FG000|Study Treatment|withdrawal before treatment|1|||
27951511|NCT04079738|81655812|FG001|Study Treatment|withdrawal before treatment|0|||
27951512|NCT04079738|81655813|FG002|Study Treatment|withdrawal before treatment|0|||
27951513|NCT04079738|81655814|FG003|Study Treatment|withdrawal before treatment|0|||
27951514|NCT04079738|81655811|FG000|Study Treatment|symptomatic deterioration|2|||
27951515|NCT04079738|81655812|FG001|Study Treatment|symptomatic deterioration|0|||
27951516|NCT04079738|81655813|FG002|Study Treatment|symptomatic deterioration|0|||
27951517|NCT04079738|81655814|FG003|Study Treatment|symptomatic deterioration|0|||
27951518|NCT04079738|81655811|FG000|Study Treatment|Disease Progression|1|||
27951519|NCT04079738|81655812|FG001|Study Treatment|Disease Progression|0|||
27951520|NCT04079738|81655813|FG002|Study Treatment|Disease Progression|0|||
27951521|NCT04079738|81655814|FG003|Study Treatment|Disease Progression|0|||
27951522|NCT04079738|81655811|FG000|Study Treatment|withdrawal after treatment|1|||
27951523|NCT04079738|81655812|FG001|Study Treatment|withdrawal after treatment|0|||
27951524|NCT04079738|81655813|FG002|Study Treatment|withdrawal after treatment|0|||
27951525|NCT04079738|81655814|FG003|Study Treatment|withdrawal after treatment|0|||
27951526|NCT04079738|81655811|FG000|Follow up|Withdrawal by Subject|3|||
27951527|NCT04079738|81655812|FG001|Follow up|Withdrawal by Subject|0|||
27951528|NCT04079738|81655813|FG002|Follow up|Withdrawal by Subject|0|||
27951529|NCT04079738|81655814|FG003|Follow up|Withdrawal by Subject|0|||
27951530|NCT04079738|81655811|FG000|Follow up|Death|5|||
27951531|NCT04079738|81655812|FG001|Follow up|Death|0|||
27951532|NCT04079738|81655813|FG002|Follow up|Death|0|||
27951533|NCT04079738|81655814|FG003|Follow up|Death|0|||
27951534|NCT03586973|81655815|FG000|Overall Study|Death|15|||
27951535|NCT03586973|81655816|FG001|Overall Study|Death|8|||
27951536|NCT03586973|81655815|FG000|Overall Study|Site Terminated by Sponsor|3|||
27951537|NCT03586973|81655816|FG001|Overall Study|Site Terminated by Sponsor|6|||
27951538|NCT03586973|81655815|FG000|Overall Study|Withdrawal by Subject|1|||
27951539|NCT03586973|81655816|FG001|Overall Study|Withdrawal by Subject|0|||
27951540|NCT03586973|81655815|FG000|Overall Study|Lost to Follow-up|1|||
27951541|NCT03586973|81655816|FG001|Overall Study|Lost to Follow-up|0|||
27951542|NCT01729039|81655818|FG000|Overall Study|disqualified|2|||
27951543|NCT01729039|81655819|FG001|Overall Study|disqualified|5|||
27951544|NCT01729039|81655818|FG000|Overall Study|Withdrawal by Subject|8|||
27951545|NCT01729039|81655819|FG001|Overall Study|Withdrawal by Subject|7|||
27951546|NCT00633126|81655820|FG000|Overall Study|Did not receive full dose|1|||
27951547|NCT00744861|81655821|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
27951548|NCT00744861|81655822|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
27951549|NCT00744861|81655823|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
27951550|NCT00744861|81655824|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
27951551|NCT00744861|81655821|FG000|Feasibility Stage 1|Pregnancy|0|||
27951552|NCT00744861|81655822|FG001|Feasibility Stage 1|Pregnancy|1|||
27951553|NCT00744861|81655823|FG002|Feasibility Stage 1|Pregnancy|0|||
27951554|NCT00744861|81655824|FG003|Feasibility Stage 1|Pregnancy|0|||
27951555|NCT00744861|81655821|FG000|Pivotal Stage 2|Adverse Event|0|||
27951556|NCT00744861|81655822|FG001|Pivotal Stage 2|Adverse Event|0|||
27951557|NCT00744861|81655823|FG002|Pivotal Stage 2|Adverse Event|6|||
27951558|NCT00744861|81655824|FG003|Pivotal Stage 2|Adverse Event|11|||
27951559|NCT00744861|81655821|FG000|Pivotal Stage 2|Death|0|||
27951560|NCT00744861|81655822|FG001|Pivotal Stage 2|Death|0|||
27951561|NCT00744861|81655823|FG002|Pivotal Stage 2|Death|0|||
27951562|NCT00744861|81655824|FG003|Pivotal Stage 2|Death|1|||
27951563|NCT00744861|81655821|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
27951564|NCT00744861|81655822|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
27951565|NCT00744861|81655823|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
27951566|NCT00744861|81655824|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
27951567|NCT00744861|81655821|FG000|Pivotal Stage 2|Physician Decision|0|||
27951568|NCT00744861|81655822|FG001|Pivotal Stage 2|Physician Decision|0|||
27951569|NCT00744861|81655823|FG002|Pivotal Stage 2|Physician Decision|3|||
27951570|NCT00744861|81655824|FG003|Pivotal Stage 2|Physician Decision|1|||
27951571|NCT00744861|81655821|FG000|Pivotal Stage 2|Protocol Violation|0|||
27951572|NCT00744861|81655822|FG001|Pivotal Stage 2|Protocol Violation|0|||
27951573|NCT00744861|81655823|FG002|Pivotal Stage 2|Protocol Violation|0|||
27951574|NCT00744861|81655824|FG003|Pivotal Stage 2|Protocol Violation|1|||
27951575|NCT00744861|81655821|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
27951576|NCT00744861|81655822|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
27951577|NCT00744861|81655823|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
27951578|NCT00744861|81655824|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
27951579|NCT00744861|81655821|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
27951580|NCT00744861|81655822|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
27951581|NCT00744861|81655823|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
27951582|NCT00744861|81655824|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
27951583|NCT02862574|81655825|FG000|Double-Blind Treatment Period|Adverse Event|0|||
27951584|NCT02862574|81655826|FG001|Double-Blind Treatment Period|Adverse Event|1|||
27959228|NCT01978145|81683257|FG001|Washout Period 1|Adverse Event|1|||
27951585|NCT02862574|81655827|FG002|Double-Blind Treatment Period|Adverse Event|0|||
27951586|NCT02862574|81655825|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
27951587|NCT02862574|81655826|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
27951588|NCT02862574|81655827|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
27951589|NCT02862574|81655825|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
27951590|NCT02862574|81655826|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
27951591|NCT02862574|81655827|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
27951592|NCT00967616|81655830|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
27951593|NCT00967616|81655831|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
27951594|NCT00967616|81655830|FG000|Overall Study|Death|0|||
27951595|NCT00967616|81655831|FG001|Overall Study|Death|3|||
27951596|NCT00967616|81655830|FG000|Overall Study|Withdrawal by Subject|8|||
27951597|NCT00967616|81655831|FG001|Overall Study|Withdrawal by Subject|4|||
27951598|NCT00967616|81655830|FG000|Overall Study|Progressive Disease|31|||
27951599|NCT00967616|81655831|FG001|Overall Study|Progressive Disease|18|||
27951600|NCT00967616|81655830|FG000|Overall Study|Other|8|||
27951601|NCT00967616|81655831|FG001|Overall Study|Other|8|||
27951602|NCT00967616|81655830|FG000|Overall Study|Protocol Violation|1|||
27951603|NCT00967616|81655831|FG001|Overall Study|Protocol Violation|0|||
27951604|NCT01225952|81655834|FG000|Overall Study|Lost to Follow-up|1|||
27951605|NCT01225952|81655835|FG001|Overall Study|Lost to Follow-up|0|||
27951606|NCT01225952|81655836|FG002|Overall Study|Lost to Follow-up|0|||
27749538|NCT00972244|80909609|FG003|Overall Study|Adverse Event|0|||
27749539|NCT00972244|80909610|FG004|Overall Study|Adverse Event|0|||
27749540|NCT00972244|80909606|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
27749541|NCT00972244|80909607|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
27749542|NCT00972244|80909608|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
27749543|NCT00972244|80909609|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
27749544|NCT00972244|80909610|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
27749545|NCT00972244|80909606|FG000|Overall Study|Withdrawal by Subject|1|||
27749546|NCT00972244|80909607|FG001|Overall Study|Withdrawal by Subject|2|||
27749547|NCT00972244|80909608|FG002|Overall Study|Withdrawal by Subject|1|||
27749548|NCT00972244|80909609|FG003|Overall Study|Withdrawal by Subject|0|||
27749549|NCT00972244|80909610|FG004|Overall Study|Withdrawal by Subject|1|||
27749550|NCT00972244|80909606|FG000|Overall Study|Safety|0|||
27749551|NCT00972244|80909607|FG001|Overall Study|Safety|0|||
27749552|NCT00972244|80909608|FG002|Overall Study|Safety|0|||
27749553|NCT00972244|80909609|FG003|Overall Study|Safety|0|||
27749554|NCT00972244|80909610|FG004|Overall Study|Safety|1|||
27749555|NCT00972244|80909606|FG000|Overall Study|Death|1|||
27749556|NCT00972244|80909607|FG001|Overall Study|Death|0|||
27749557|NCT00972244|80909608|FG002|Overall Study|Death|0|||
27749558|NCT00972244|80909609|FG003|Overall Study|Death|0|||
27749559|NCT00972244|80909610|FG004|Overall Study|Death|0|||
27749560|NCT00972244|80909606|FG000|Overall Study|Various|0|||
27749561|NCT00972244|80909607|FG001|Overall Study|Various|0|||
27749562|NCT00972244|80909608|FG002|Overall Study|Various|0|||
27749563|NCT00972244|80909609|FG003|Overall Study|Various|0|||
27749564|NCT00972244|80909610|FG004|Overall Study|Various|2|||
27749565|NCT02588248|80909611|FG000|Overall Study|Physician Decision|4|||
27749566|NCT02588248|80909612|FG001|Overall Study|Physician Decision|3|||
27749567|NCT05896761|80909615|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
27749568|NCT05896761|80909616|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
27749569|NCT05896761|80909615|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
27749570|NCT05896761|80909616|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
27749571|NCT03213626|80909622|FG000|Overall Study|Adverse Event|1|||
27749572|NCT03213626|80909622|FG000|Overall Study|Progressive Disease|6|||
27749573|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
27749574|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
27749575|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
27749576|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
27951607|NCT01225952|81655834|FG000|Overall Study|Study Eye Explanted|0|||
27951608|NCT01225952|81655835|FG001|Overall Study|Study Eye Explanted|0|||
27951609|NCT01225952|81655836|FG002|Overall Study|Study Eye Explanted|1|||
27951610|NCT01225952|81655834|FG000|Overall Study|Withdrawal by Subject|4|||
27951611|NCT01225952|81655835|FG001|Overall Study|Withdrawal by Subject|4|||
27951612|NCT01225952|81655836|FG002|Overall Study|Withdrawal by Subject|5|||
27951613|NCT01225952|81655834|FG000|Overall Study|Surgical complications|1|||
27749577|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
27749578|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
27749579|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
27749580|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
27749581|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
27749582|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
27749583|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
27749584|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
27749585|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
27749586|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
27749587|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
27749588|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
27749589|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
27749590|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
27749591|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
27749592|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
27749593|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
27749594|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Other|0|||
27749595|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Other|1|||
27749596|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Other|0|||
27749597|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Other|0|||
27749598|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Other|0|||
27749599|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Other|0|||
27749600|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Other|0|||
27749601|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
27749602|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
27749603|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
27749604|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
27749605|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
27749606|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
27749607|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
27749608|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
27749609|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
27749610|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
27749611|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
27749612|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
27749613|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
27749614|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
27749615|NCT00365716|80909628|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
27749616|NCT00365716|80909629|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
27749617|NCT00365716|80909630|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
27749618|NCT00365716|80909631|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
27749619|NCT00365716|80909632|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
27749620|NCT00365716|80909633|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
27749621|NCT00365716|80909634|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
27749622|NCT00365716|80909628|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
27749623|NCT00365716|80909629|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
27749624|NCT00365716|80909630|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
27749625|NCT00365716|80909631|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
27749626|NCT00365716|80909632|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
27749627|NCT00365716|80909633|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
27749628|NCT00365716|80909634|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
27749629|NCT00365716|80909628|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
27749630|NCT00365716|80909629|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
27749631|NCT00365716|80909630|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
27749632|NCT00365716|80909631|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
27749633|NCT00365716|80909632|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
27749634|NCT00365716|80909633|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
27749635|NCT00365716|80909634|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
27749636|NCT00365716|80909628|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
27749637|NCT00365716|80909629|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
27749638|NCT00365716|80909630|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
27749639|NCT00365716|80909631|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
27749640|NCT00365716|80909632|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
27749641|NCT00365716|80909633|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
27749642|NCT00365716|80909634|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
27749643|NCT00365716|80909628|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
27749644|NCT00365716|80909629|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
27749645|NCT00365716|80909630|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
27749646|NCT00365716|80909631|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
27749647|NCT00365716|80909632|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
27749648|NCT00365716|80909633|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
27749649|NCT00365716|80909634|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
27749650|NCT00365716|80909628|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
27951614|NCT01225952|81655835|FG001|Overall Study|Surgical complications|0|||
27959308|NCT02131662|81683269|FG000|Overall Study|Pregnancy|0|||
27749651|NCT00365716|80909629|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
27749652|NCT00365716|80909630|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
27749653|NCT00365716|80909631|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
27749654|NCT00365716|80909632|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
27749655|NCT00365716|80909633|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
27749656|NCT00365716|80909634|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
27749657|NCT00365716|80909628|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
27749658|NCT00365716|80909629|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
27749659|NCT00365716|80909630|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
27749660|NCT00365716|80909631|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
27749661|NCT00365716|80909632|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
27749662|NCT00365716|80909633|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
27749663|NCT00365716|80909634|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
27749664|NCT00365716|80909628|FG000|Extension 1|Lost to Follow-up|0|||
27749665|NCT00365716|80909629|FG001|Extension 1|Lost to Follow-up|0|||
27749666|NCT00365716|80909630|FG002|Extension 1|Lost to Follow-up|0|||
27749667|NCT00365716|80909631|FG003|Extension 1|Lost to Follow-up|0|||
27749668|NCT00365716|80909632|FG004|Extension 1|Lost to Follow-up|0|||
27749669|NCT00365716|80909633|FG005|Extension 1|Lost to Follow-up|1|||
27749670|NCT00365716|80909634|FG006|Extension 1|Lost to Follow-up|0|||
27749671|NCT00365716|80909628|FG000|Extension 1|Other|0|||
27749672|NCT00365716|80909629|FG001|Extension 1|Other|0|||
27749673|NCT00365716|80909630|FG002|Extension 1|Other|0|||
27749674|NCT00365716|80909631|FG003|Extension 1|Other|0|||
27749675|NCT00365716|80909632|FG004|Extension 1|Other|0|||
27749676|NCT00365716|80909633|FG005|Extension 1|Other|9|||
27749677|NCT00365716|80909634|FG006|Extension 1|Other|0|||
27749678|NCT00365716|80909628|FG000|Extension 1|Moved|0|||
27749679|NCT00365716|80909629|FG001|Extension 1|Moved|0|||
27749680|NCT00365716|80909630|FG002|Extension 1|Moved|0|||
27749681|NCT00365716|80909631|FG003|Extension 1|Moved|0|||
27749682|NCT00365716|80909632|FG004|Extension 1|Moved|0|||
27749683|NCT00365716|80909633|FG005|Extension 1|Moved|4|||
27749684|NCT00365716|80909634|FG006|Extension 1|Moved|0|||
27749685|NCT00365716|80909628|FG000|Extension 1|Withdrawal by Subject|0|||
27749686|NCT00365716|80909629|FG001|Extension 1|Withdrawal by Subject|0|||
27749687|NCT00365716|80909630|FG002|Extension 1|Withdrawal by Subject|0|||
27749688|NCT00365716|80909631|FG003|Extension 1|Withdrawal by Subject|0|||
27749689|NCT00365716|80909632|FG004|Extension 1|Withdrawal by Subject|0|||
27749690|NCT00365716|80909633|FG005|Extension 1|Withdrawal by Subject|3|||
27749691|NCT00365716|80909634|FG006|Extension 1|Withdrawal by Subject|0|||
27749692|NCT00365716|80909628|FG000|Extension 1|Pregnancy|0|||
27749693|NCT00365716|80909629|FG001|Extension 1|Pregnancy|0|||
27749694|NCT00365716|80909630|FG002|Extension 1|Pregnancy|0|||
27749695|NCT00365716|80909631|FG003|Extension 1|Pregnancy|0|||
27749696|NCT00365716|80909632|FG004|Extension 1|Pregnancy|0|||
27749697|NCT00365716|80909633|FG005|Extension 1|Pregnancy|4|||
27749698|NCT00365716|80909634|FG006|Extension 1|Pregnancy|0|||
27749699|NCT00365716|80909628|FG000|Extension 1|Protocol Violation|0|||
27749700|NCT00365716|80909629|FG001|Extension 1|Protocol Violation|0|||
27749701|NCT00365716|80909630|FG002|Extension 1|Protocol Violation|0|||
27749702|NCT00365716|80909631|FG003|Extension 1|Protocol Violation|0|||
27749703|NCT00365716|80909632|FG004|Extension 1|Protocol Violation|0|||
27749704|NCT00365716|80909633|FG005|Extension 1|Protocol Violation|1|||
27749705|NCT00365716|80909634|FG006|Extension 1|Protocol Violation|0|||
27749706|NCT00365716|80909628|FG000|Extension 2|Lost to Follow-up|0|||
27749707|NCT00365716|80909629|FG001|Extension 2|Lost to Follow-up|0|||
27749708|NCT00365716|80909630|FG002|Extension 2|Lost to Follow-up|0|||
27749709|NCT00365716|80909631|FG003|Extension 2|Lost to Follow-up|0|||
27749710|NCT00365716|80909632|FG004|Extension 2|Lost to Follow-up|0|||
27749711|NCT00365716|80909633|FG005|Extension 2|Lost to Follow-up|0|||
27749712|NCT00365716|80909634|FG006|Extension 2|Lost to Follow-up|2|||
27749713|NCT00365716|80909628|FG000|Extension 2|Other|0|||
27749714|NCT00365716|80909629|FG001|Extension 2|Other|0|||
27749715|NCT00365716|80909630|FG002|Extension 2|Other|0|||
27749716|NCT00365716|80909631|FG003|Extension 2|Other|0|||
27749717|NCT00365716|80909632|FG004|Extension 2|Other|0|||
27749718|NCT00365716|80909633|FG005|Extension 2|Other|0|||
27749719|NCT00365716|80909634|FG006|Extension 2|Other|3|||
27749720|NCT00365716|80909628|FG000|Extension 2|Withdrawal by Subject|0|||
27749721|NCT00365716|80909629|FG001|Extension 2|Withdrawal by Subject|0|||
27749722|NCT00365716|80909630|FG002|Extension 2|Withdrawal by Subject|0|||
27749723|NCT00365716|80909631|FG003|Extension 2|Withdrawal by Subject|0|||
27749724|NCT00365716|80909632|FG004|Extension 2|Withdrawal by Subject|0|||
27749725|NCT00365716|80909633|FG005|Extension 2|Withdrawal by Subject|0|||
27749726|NCT00365716|80909634|FG006|Extension 2|Withdrawal by Subject|5|||
27749727|NCT01701583|80909635|FG000|Overall Study|Withdrawal by Subject|2|||
27749728|NCT01701583|80909636|FG001|Overall Study|Withdrawal by Subject|0|||
27749729|NCT01253421|80909637|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
27749730|NCT01253421|80909638|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
27951615|NCT01225952|81655836|FG002|Overall Study|Surgical complications|0|||
27951616|NCT03639610|81655839|FG000|Overall Study|Adverse Event|7|||
27951617|NCT03639610|81655840|FG001|Overall Study|Adverse Event|1|||
27951618|NCT03639610|81655841|FG002|Overall Study|Adverse Event|0|||
27951619|NCT03639610|81655839|FG000|Overall Study|Physician Decision|3|||
27951620|NCT03639610|81655840|FG001|Overall Study|Physician Decision|1|||
27951621|NCT03639610|81655841|FG002|Overall Study|Physician Decision|0|||
27951622|NCT03639610|81655839|FG000|Overall Study|Disease progression|8|||
27951623|NCT03639610|81655840|FG001|Overall Study|Disease progression|5|||
27951624|NCT03639610|81655841|FG002|Overall Study|Disease progression|3|||
27951625|NCT03639610|81655839|FG000|Overall Study|Study terminated by sponsor|2|||
27951626|NCT03639610|81655840|FG001|Overall Study|Study terminated by sponsor|1|||
27951627|NCT03639610|81655841|FG002|Overall Study|Study terminated by sponsor|1|||
27951628|NCT03639610|81655839|FG000|Overall Study|Patient request to stop treatment|1|||
27951629|NCT03639610|81655840|FG001|Overall Study|Patient request to stop treatment|2|||
27951630|NCT03639610|81655841|FG002|Overall Study|Patient request to stop treatment|0|||
27951631|NCT00831389|81655845|FG000|Overall Study|Withdrawal by Subject|0|||
27951632|NCT00831389|81655846|FG001|Overall Study|Withdrawal by Subject|1|||
27951633|NCT00271544|81655852|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
27951634|NCT00271544|81655852|FG000|Overall Study|Model 4196 lead not attempted|9|||
27951635|NCT00271544|81655852|FG000|Overall Study|Implant not attempted|4|||
27951636|NCT01359956|81655853|FG000|Overall Study|Death|58|||
27951637|NCT01359956|81655854|FG001|Overall Study|Death|60|||
27951638|NCT01359956|81655855|FG002|Overall Study|Death|66|||
27951639|NCT01359956|81655856|FG003|Overall Study|Death|57|||
27951640|NCT01359956|81655853|FG000|Overall Study|Lost to Follow-up|3|||
27951641|NCT01359956|81655854|FG001|Overall Study|Lost to Follow-up|4|||
27951642|NCT01359956|81655855|FG002|Overall Study|Lost to Follow-up|1|||
27951643|NCT01359956|81655856|FG003|Overall Study|Lost to Follow-up|1|||
27951644|NCT03502681|81655859|FG000|Overall Study|Adverse Event|1|||
27951645|NCT03502681|81655860|FG001|Overall Study|Adverse Event|1|||
27951646|NCT03502681|81655859|FG000|Overall Study|Disease Progression|2|||
27951647|NCT03502681|81655860|FG001|Overall Study|Disease Progression|1|||
27951648|NCT00335829|81655862|FG000|Overall Study|Withdrawal by Subject|1|||
27951649|NCT00335829|81655862|FG000|Overall Study|Lost to Follow-up|1|||
27951650|NCT00335829|81655862|FG000|Overall Study|Adverse Event|1|||
27951651|NCT01646827|81655864|FG000|Overall Study|Lost to Follow-up|0|||
27951652|NCT01646827|81655865|FG001|Overall Study|Lost to Follow-up|3|||
27951653|NCT01646827|81655864|FG000|Overall Study|Physician Decision|1|||
27951654|NCT01646827|81655865|FG001|Overall Study|Physician Decision|2|||
27951655|NCT01646827|81655864|FG000|Overall Study|Withdrawal by Subject|1|||
27951656|NCT01646827|81655865|FG001|Overall Study|Withdrawal by Subject|0|||
27951657|NCT01968980|81655866|FG000|Overall Study|Death|0|||
27951658|NCT01968980|81655867|FG001|Overall Study|Death|1|||
27951659|NCT01968980|81655866|FG000|Overall Study|Adverse Event|1|||
27951660|NCT01968980|81655867|FG001|Overall Study|Adverse Event|3|||
27951661|NCT01968980|81655866|FG000|Overall Study|Does not meet entry criteria|1|||
27951662|NCT01968980|81655867|FG001|Overall Study|Does not meet entry criteria|3|||
27951663|NCT01968980|81655866|FG000|Overall Study|Withdrawal by Subject|13|||
27951664|NCT01968980|81655867|FG001|Overall Study|Withdrawal by Subject|5|||
27951665|NCT01968980|81655866|FG000|Overall Study|Other unspecified|1|||
27951666|NCT01968980|81655867|FG001|Overall Study|Other unspecified|2|||
27951667|NCT01983111|81655868|FG000|Overall Study|Withdrawal by Subject|8|||
27951668|NCT01983111|81655869|FG001|Overall Study|Withdrawal by Subject|6|||
27951669|NCT01983111|81655868|FG000|Overall Study|Adverse Event|4|||
27951670|NCT01983111|81655869|FG001|Overall Study|Adverse Event|0|||
27951671|NCT01983111|81655868|FG000|Overall Study|Protocol Violation|0|||
27951672|NCT01983111|81655869|FG001|Overall Study|Protocol Violation|1|||
27951673|NCT03412929|81655872|FG000|Overall Study|Protocol Violation|3|||
27951674|NCT00673920|81655873|FG000|Baseline up to Week 48|Withdrew consent|1|||
27951675|NCT00673920|81655874|FG001|Baseline up to Week 48|Withdrew consent|0|||
27951676|NCT00673920|81655875|FG002|Baseline up to Week 48|Withdrew consent|2|||
27951677|NCT00673920|81655876|FG003|Baseline up to Week 48|Withdrew consent|0|||
27650964|NCT00048932|80564538|FG002|Open Label Period (OL)|Death|25|||
27650965|NCT00048932|80564536|FG000|Open Label Period (OL)|Adverse Event|0|||
27650966|NCT00048932|80564537|FG001|Open Label Period (OL)|Adverse Event|0|||
27951678|NCT00673920|81655877|FG004|Baseline up to Week 48|Withdrew consent|0|||
27951679|NCT00673920|81655878|FG005|Baseline up to Week 48|Withdrew consent|0|||
27951680|NCT00673920|81655879|FG006|Baseline up to Week 48|Withdrew consent|0|||
27951681|NCT00673920|81655880|FG007|Baseline up to Week 48|Withdrew consent|0|||
27951682|NCT00673920|81655873|FG000|Baseline up to Week 48|Refused treatment|1|||
27951683|NCT00673920|81655874|FG001|Baseline up to Week 48|Refused treatment|0|||
27951684|NCT00673920|81655875|FG002|Baseline up to Week 48|Refused treatment|0|||
27951685|NCT00673920|81655876|FG003|Baseline up to Week 48|Refused treatment|0|||
27951686|NCT00673920|81655877|FG004|Baseline up to Week 48|Refused treatment|0|||
27951687|NCT00673920|81655878|FG005|Baseline up to Week 48|Refused treatment|0|||
27951688|NCT00673920|81655879|FG006|Baseline up to Week 48|Refused treatment|0|||
27951689|NCT00673920|81655880|FG007|Baseline up to Week 48|Refused treatment|0|||
27951690|NCT00673920|81655873|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
27951691|NCT00673920|81655874|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
27951692|NCT00673920|81655875|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
27951693|NCT00673920|81655876|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
27951694|NCT00673920|81655877|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
27951695|NCT00673920|81655878|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
27951696|NCT00673920|81655879|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
27951697|NCT00673920|81655880|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
27951698|NCT00673920|81655873|FG000|Baseline up to Week 48|Protocol Violation|0|||
27951699|NCT00673920|81655874|FG001|Baseline up to Week 48|Protocol Violation|0|||
27951700|NCT00673920|81655875|FG002|Baseline up to Week 48|Protocol Violation|1|||
27951701|NCT00673920|81655876|FG003|Baseline up to Week 48|Protocol Violation|0|||
27951702|NCT00673920|81655877|FG004|Baseline up to Week 48|Protocol Violation|0|||
27951703|NCT00673920|81655878|FG005|Baseline up to Week 48|Protocol Violation|0|||
27951704|NCT00673920|81655879|FG006|Baseline up to Week 48|Protocol Violation|0|||
27951705|NCT00673920|81655880|FG007|Baseline up to Week 48|Protocol Violation|0|||
27951706|NCT00673920|81655873|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951707|NCT00673920|81655874|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951708|NCT00673920|81655875|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
27951709|NCT00673920|81655876|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951710|NCT00673920|81655877|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951711|NCT00673920|81655878|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951712|NCT00673920|81655879|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951713|NCT00673920|81655880|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
27951714|NCT00673920|81655873|FG000|Baseline up to Week 48|Administrative/Other|0|||
27951715|NCT00673920|81655874|FG001|Baseline up to Week 48|Administrative/Other|1|||
27951716|NCT00673920|81655875|FG002|Baseline up to Week 48|Administrative/Other|2|||
27951717|NCT00673920|81655876|FG003|Baseline up to Week 48|Administrative/Other|0|||
27951718|NCT00673920|81655877|FG004|Baseline up to Week 48|Administrative/Other|0|||
27951719|NCT00673920|81655878|FG005|Baseline up to Week 48|Administrative/Other|0|||
27951720|NCT00673920|81655879|FG006|Baseline up to Week 48|Administrative/Other|0|||
27951721|NCT00673920|81655880|FG007|Baseline up to Week 48|Administrative/Other|0|||
27951722|NCT00673920|81655873|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
27951723|NCT00673920|81655874|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
27951724|NCT00673920|81655875|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
27951725|NCT00673920|81655876|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
27749731|NCT01253421|80909639|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
27749732|NCT01253421|80909640|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
27749733|NCT01253421|80909641|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
27749734|NCT01253421|80909637|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
27749735|NCT01253421|80909638|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
27749736|NCT01253421|80909639|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
27749737|NCT01253421|80909640|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
27749738|NCT01253421|80909641|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
27749739|NCT01253421|80909637|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
27749740|NCT01253421|80909638|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
27749741|NCT01253421|80909639|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
27749742|NCT01253421|80909640|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
27749743|NCT01253421|80909641|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
27749744|NCT01253421|80909637|FG000|Assessment and Scheduling|Physician Decision|1|||
27749745|NCT01253421|80909638|FG001|Assessment and Scheduling|Physician Decision|0|||
27749746|NCT01253421|80909639|FG002|Assessment and Scheduling|Physician Decision|0|||
27749747|NCT01253421|80909640|FG003|Assessment and Scheduling|Physician Decision|0|||
27749748|NCT01253421|80909641|FG004|Assessment and Scheduling|Physician Decision|0|||
27749749|NCT01253421|80909637|FG000|Drug+Scanning Visit|Physician Decision|0|||
27749750|NCT01253421|80909638|FG001|Drug+Scanning Visit|Physician Decision|0|||
27749751|NCT01253421|80909639|FG002|Drug+Scanning Visit|Physician Decision|0|||
27749752|NCT01253421|80909640|FG003|Drug+Scanning Visit|Physician Decision|0|||
27749753|NCT01253421|80909641|FG004|Drug+Scanning Visit|Physician Decision|1|||
27749754|NCT00536978|80909642|FG000|Overall Study|Not eligible for Adback Infusion|22|||
27749755|NCT00421343|80909643|FG000|Overall Study|Death|1|||
27749756|NCT00421343|80909643|FG000|Overall Study|Withdrawal by Subject|2|||
27749757|NCT00421343|80909643|FG000|Overall Study|Lost to Follow-up|3|||
27749758|NCT00718419|80909645|FG000|Overall Study|Adverse Event|2|||
27749759|NCT00718419|80909646|FG001|Overall Study|Adverse Event|1|||
27749760|NCT00718419|80909645|FG000|Overall Study|Physician Decision|1|||
27749761|NCT00718419|80909646|FG001|Overall Study|Physician Decision|6|||
27749762|NCT00718419|80909645|FG000|Overall Study|Sponsor decision|0|||
27749763|NCT00718419|80909646|FG001|Overall Study|Sponsor decision|1|||
27749764|NCT00718419|80909645|FG000|Overall Study|Withdrawal by Subject|0|||
27749765|NCT00718419|80909646|FG001|Overall Study|Withdrawal by Subject|5|||
27749766|NCT00718419|80909645|FG000|Overall Study|Progressive Disease|7|||
27749767|NCT00718419|80909646|FG001|Overall Study|Progressive Disease|25|||
27749768|NCT00718419|80909645|FG000|Overall Study|Death Due to Progressive Disease|2|||
27749769|NCT00718419|80909646|FG001|Overall Study|Death Due to Progressive Disease|0|||
27749770|NCT00718419|80909645|FG000|Overall Study|Death Due to Study Drug Related|0|||
27749771|NCT00718419|80909646|FG001|Overall Study|Death Due to Study Drug Related|1|||
27749772|NCT00718419|80909645|FG000|Overall Study|Death Due to Adverse Events|1|||
27749773|NCT00718419|80909646|FG001|Overall Study|Death Due to Adverse Events|0|||
27749774|NCT03977727|80909647|FG000|Second Treatment|Lost to Follow-up|0|||
27749775|NCT03977727|80909648|FG001|Second Treatment|Lost to Follow-up|3|||
27749776|NCT00553059|80909654|FG000|Overall Study|Deemed ineligible|1|||
27749777|NCT00553059|80909655|FG001|Overall Study|Deemed ineligible|1|||
27749778|NCT00553059|80909654|FG000|Overall Study|Drug supply not available|0|||
27749779|NCT00553059|80909655|FG001|Overall Study|Drug supply not available|1|||
27749780|NCT03885726|80909656|FG000|Overall Study|Staffing issues/lost interest|1|||
27749781|NCT03885726|80909656|FG000|Overall Study|Early discharge from hospital|3|||
27749782|NCT03987620|80909659|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
27749783|NCT03987620|80909660|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
27749784|NCT03987620|80909659|FG000|Overall Study|Adverse Event|3|||
27749785|NCT03987620|80909660|FG001|Overall Study|Adverse Event|0|||
27749786|NCT03987620|80909659|FG000|Overall Study|Lost to Follow-up|1|||
27749787|NCT03987620|80909660|FG001|Overall Study|Lost to Follow-up|2|||
27749788|NCT03987620|80909659|FG000|Overall Study|Physician Decision|0|||
27749789|NCT03987620|80909660|FG001|Overall Study|Physician Decision|1|||
27749790|NCT03987620|80909659|FG000|Overall Study|Pregnancy|1|||
27749791|NCT03987620|80909660|FG001|Overall Study|Pregnancy|0|||
27749792|NCT03987620|80909659|FG000|Overall Study|Withdrawal by Subject|7|||
27749793|NCT03987620|80909660|FG001|Overall Study|Withdrawal by Subject|1|||
27749794|NCT03987620|80909659|FG000|Overall Study|Other|2|||
27749795|NCT03987620|80909660|FG001|Overall Study|Other|5|||
27749796|NCT00907881|80909661|FG000|Overall Study|Lost to Follow-up|59|||
27749797|NCT00907881|80909661|FG000|Overall Study|Noncompliance|5|||
27749798|NCT00907881|80909661|FG000|Overall Study|Withdrawal by Subject|5|||
27749799|NCT00907881|80909661|FG000|Overall Study|Protocol Violation|1|||
27749800|NCT00907881|80909661|FG000|Overall Study|Missing discontinuation information|15|||
27749801|NCT01554956|80909662|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
27749802|NCT01554956|80909663|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
27749803|NCT01554956|80909664|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
27749804|NCT01554956|80909662|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
27749805|NCT01554956|80909663|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
27749806|NCT01554956|80909664|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
27749807|NCT01554956|80909662|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
27749808|NCT01554956|80909663|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
27749809|NCT01554956|80909664|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
27749810|NCT01754922|80909665|FG000|Overall Study|Adverse Event|0|||
27749811|NCT01754922|80909666|FG001|Overall Study|Adverse Event|1|||
27749812|NCT01005732|80909667|FG000|Overall Study|Lost to Follow-up|10|||
27749813|NCT01005732|80909667|FG000|Overall Study|Death|1|||
27749814|NCT02680847|80909668|FG000|Overall Study|Other|2|||
27749815|NCT02680847|80909669|FG001|Overall Study|Other|0|||
27749816|NCT02680847|80909670|FG002|Overall Study|Other|0|||
27749817|NCT02680847|80909668|FG000|Overall Study|No longer met eligibility criteria|2|||
27749818|NCT02680847|80909669|FG001|Overall Study|No longer met eligibility criteria|2|||
27749819|NCT02680847|80909670|FG002|Overall Study|No longer met eligibility criteria|0|||
27749820|NCT02680847|80909668|FG000|Overall Study|Unwilling to participate in study|1|||
27749821|NCT02680847|80909669|FG001|Overall Study|Unwilling to participate in study|1|||
27749822|NCT02680847|80909670|FG002|Overall Study|Unwilling to participate in study|0|||
27749823|NCT02680847|80909668|FG000|Overall Study|Lack of Efficacy|0|||
27749824|NCT02680847|80909669|FG001|Overall Study|Lack of Efficacy|0|||
27749825|NCT02680847|80909670|FG002|Overall Study|Lack of Efficacy|2|||
27749826|NCT02680847|80909668|FG000|Overall Study|Adverse Event|0|||
27749827|NCT02680847|80909669|FG001|Overall Study|Adverse Event|0|||
27749828|NCT02680847|80909670|FG002|Overall Study|Adverse Event|1|||
27749829|NCT03158688|80909678|FG000|Overall Study|Withdrawal by Subject|14|||
27749830|NCT03158688|80909679|FG001|Overall Study|Withdrawal by Subject|28|||
27951726|NCT00673920|81655877|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
27749831|NCT03158688|80909678|FG000|Overall Study|Decision by sponsor|13|||
27749832|NCT03158688|80909679|FG001|Overall Study|Decision by sponsor|37|||
27749833|NCT03158688|80909678|FG000|Overall Study|Lost to Follow-up|4|||
27749834|NCT03158688|80909679|FG001|Overall Study|Lost to Follow-up|3|||
27749835|NCT03158688|80909678|FG000|Overall Study|Death|74|||
27749836|NCT03158688|80909679|FG001|Overall Study|Death|142|||
27749837|NCT00601523|80909680|FG000|Overall Study|Adverse Event|42|||
27749838|NCT00601523|80909681|FG001|Overall Study|Adverse Event|14|||
27749839|NCT00601523|80909680|FG000|Overall Study|Lack of Efficacy|3|||
27749840|NCT00601523|80909681|FG001|Overall Study|Lack of Efficacy|0|||
27749841|NCT00601523|80909680|FG000|Overall Study|Protocol Violation|5|||
27749842|NCT00601523|80909681|FG001|Overall Study|Protocol Violation|1|||
27749843|NCT00601523|80909680|FG000|Overall Study|Lost to Follow-up|0|||
27749844|NCT00601523|80909681|FG001|Overall Study|Lost to Follow-up|1|||
27749845|NCT00601523|80909680|FG000|Overall Study|Withdrawal by Subject|18|||
27749846|NCT00601523|80909681|FG001|Overall Study|Withdrawal by Subject|9|||
27749847|NCT00601523|80909680|FG000|Overall Study|Other|9|||
27749848|NCT00601523|80909681|FG001|Overall Study|Other|1|||
27749849|NCT00702052|80909682|FG000|Overall Study|Adverse Event|23|||
27749850|NCT00702052|80909682|FG000|Overall Study|Disease Progression|30|||
27749851|NCT00702052|80909682|FG000|Overall Study|Withdrawal by Subject|5|||
27749852|NCT00532883|80909685|FG000|Overall Study|Adverse Event|1|||
27749853|NCT00532883|80909686|FG001|Overall Study|Adverse Event|0|||
27749854|NCT00532883|80909687|FG002|Overall Study|Adverse Event|0|||
27749855|NCT00532883|80909688|FG003|Overall Study|Adverse Event|1|||
27749856|NCT00532883|80909685|FG000|Overall Study|Lost to Follow-up|1|||
27749857|NCT00532883|80909686|FG001|Overall Study|Lost to Follow-up|1|||
27749858|NCT00532883|80909687|FG002|Overall Study|Lost to Follow-up|1|||
27749859|NCT00532883|80909688|FG003|Overall Study|Lost to Follow-up|0|||
27749860|NCT00532883|80909685|FG000|Overall Study|Withdrawal by Subject|0|||
27749861|NCT00532883|80909686|FG001|Overall Study|Withdrawal by Subject|1|||
27749862|NCT00532883|80909687|FG002|Overall Study|Withdrawal by Subject|1|||
27749863|NCT00532883|80909688|FG003|Overall Study|Withdrawal by Subject|0|||
27749864|NCT00532883|80909685|FG000|Overall Study|Subject was Nonadherent|0|||
27749865|NCT00532883|80909686|FG001|Overall Study|Subject was Nonadherent|1|||
27749866|NCT00532883|80909687|FG002|Overall Study|Subject was Nonadherent|1|||
27749867|NCT00532883|80909688|FG003|Overall Study|Subject was Nonadherent|0|||
27749868|NCT00532883|80909685|FG000|Overall Study|Early Study Termination|4|||
27749869|NCT00532883|80909686|FG001|Overall Study|Early Study Termination|4|||
27749870|NCT00532883|80909687|FG002|Overall Study|Early Study Termination|1|||
27749871|NCT00532883|80909688|FG003|Overall Study|Early Study Termination|4|||
27749872|NCT03596177|80909689|FG000|Single Blind Period|Withdrawal by Subject|1|||
27749873|NCT03596177|80909690|FG001|Single Blind Period|Withdrawal by Subject|1|||
27749874|NCT03596177|80909689|FG000|Single Blind Period|Other|1|||
27749875|NCT03596177|80909690|FG001|Single Blind Period|Other|0|||
27749876|NCT03596177|80909689|FG000|Double Blind Period|Withdrawal by Subject|0|||
27749877|NCT03596177|80909690|FG001|Double Blind Period|Withdrawal by Subject|1|||
27749878|NCT03596177|80909689|FG000|Double Blind Period|Other|0|||
27749879|NCT03596177|80909690|FG001|Double Blind Period|Other|4|||
27749880|NCT03596177|80909689|FG000|Double Blind Period|Death during safety follow-up|0|||
27749881|NCT03596177|80909690|FG001|Double Blind Period|Death during safety follow-up|1|||
27749882|NCT02426658|80909691|FG000|Overall Study|Withdrawal by Subject|1|||
27749883|NCT02426658|80909691|FG000|Overall Study|Patient expired before treatment|2|||
27749884|NCT04594239|80909692|FG000|Overall Study|Withdrawal by Subject|3|||
27749885|NCT04594239|80909693|FG001|Overall Study|Withdrawal by Subject|4|||
27749886|NCT04594239|80909694|FG002|Overall Study|Withdrawal by Subject|2|||
27749887|NCT04594239|80909695|FG003|Overall Study|Withdrawal by Subject|4|||
27749888|NCT04594239|80909692|FG000|Overall Study|Lost to Follow-up|8|||
27749889|NCT04594239|80909693|FG001|Overall Study|Lost to Follow-up|5|||
27749890|NCT04594239|80909694|FG002|Overall Study|Lost to Follow-up|4|||
27749891|NCT04594239|80909695|FG003|Overall Study|Lost to Follow-up|6|||
27749892|NCT04594239|80909692|FG000|Overall Study|Subject relocated|0|||
27749893|NCT04594239|80909693|FG001|Overall Study|Subject relocated|0|||
27749894|NCT04594239|80909694|FG002|Overall Study|Subject relocated|0|||
27749895|NCT04594239|80909695|FG003|Overall Study|Subject relocated|1|||
27749896|NCT01752842|80909696|FG000|Overall Study|Adverse Event|3|||
27749897|NCT01752842|80909697|FG001|Overall Study|Adverse Event|0|||
27749898|NCT01752842|80909696|FG000|Overall Study|Withdrawal by Subject|0|||
27749899|NCT01752842|80909697|FG001|Overall Study|Withdrawal by Subject|2|||
27749900|NCT00830037|80909698|FG000|Overall Study|Withdrawal by Subject|2|||
27749901|NCT00830037|80909699|FG001|Overall Study|Withdrawal by Subject|3|||
27749902|NCT00830037|80909698|FG000|Overall Study|Lost to Follow-up|1|||
27749903|NCT00830037|80909699|FG001|Overall Study|Lost to Follow-up|2|||
27749904|NCT00830037|80909698|FG000|Overall Study|Active when terminated by DSMB|15|||
27749905|NCT00830037|80909699|FG001|Overall Study|Active when terminated by DSMB|14|||
27749906|NCT02064439|80909700|FG000|Overall Study|Adverse Event|51|||
27749907|NCT02064439|80909701|FG001|Overall Study|Adverse Event|47|||
27749908|NCT02064439|80909702|FG002|Overall Study|Adverse Event|46|||
27749909|NCT02064439|80909700|FG000|Overall Study|Death|0|||
27749910|NCT02064439|80909701|FG001|Overall Study|Death|2|||
27749911|NCT02064439|80909702|FG002|Overall Study|Death|3|||
27749912|NCT02064439|80909700|FG000|Overall Study|Withdrawal by Subject|29|||
27749913|NCT02064439|80909701|FG001|Overall Study|Withdrawal by Subject|18|||
27749914|NCT02064439|80909702|FG002|Overall Study|Withdrawal by Subject|26|||
27749915|NCT02064439|80909700|FG000|Overall Study|Protocol Violation|3|||
27749916|NCT02064439|80909701|FG001|Overall Study|Protocol Violation|5|||
27749917|NCT02064439|80909702|FG002|Overall Study|Protocol Violation|3|||
27749918|NCT02064439|80909700|FG000|Overall Study|Lost to Follow-up|1|||
27749919|NCT02064439|80909701|FG001|Overall Study|Lost to Follow-up|3|||
27749920|NCT02064439|80909702|FG002|Overall Study|Lost to Follow-up|4|||
27749921|NCT02064439|80909700|FG000|Overall Study|Non-compliance with study medication|21|||
27749922|NCT02064439|80909701|FG001|Overall Study|Non-compliance with study medication|19|||
27749923|NCT02064439|80909702|FG002|Overall Study|Non-compliance with study medication|23|||
27749924|NCT02064439|80909700|FG000|Overall Study|Physician Decision|0|||
27749925|NCT02064439|80909701|FG001|Overall Study|Physician Decision|1|||
27749926|NCT02064439|80909702|FG002|Overall Study|Physician Decision|1|||
27749927|NCT02064439|80909700|FG000|Overall Study|Logistical difficulties|6|||
27749928|NCT02064439|80909701|FG001|Overall Study|Logistical difficulties|5|||
27749929|NCT02064439|80909702|FG002|Overall Study|Logistical difficulties|2|||
27749930|NCT02064439|80909700|FG000|Overall Study|Efficacy outcome reached|18|||
27749931|NCT02064439|80909701|FG001|Overall Study|Efficacy outcome reached|16|||
27749932|NCT02064439|80909702|FG002|Overall Study|Efficacy outcome reached|57|||
27749933|NCT02064439|80909700|FG000|Overall Study|Safety outcome reached|12|||
27749934|NCT02064439|80909701|FG001|Overall Study|Safety outcome reached|20|||
27749935|NCT02064439|80909702|FG002|Overall Study|Safety outcome reached|10|||
27749936|NCT02064439|80909700|FG000|Overall Study|Other|2|||
27749937|NCT02064439|80909701|FG001|Overall Study|Other|2|||
27749938|NCT02064439|80909702|FG002|Overall Study|Other|7|||
27749939|NCT01428063|80909703|FG000|Overall Study|Lack of Efficacy|8|||
27749940|NCT01428063|80909704|FG001|Overall Study|Lack of Efficacy|4|||
27749941|NCT01428063|80909705|FG002|Overall Study|Lack of Efficacy|1|||
27749942|NCT01428063|80909703|FG000|Overall Study|Adverse Event|2|||
27749943|NCT01428063|80909704|FG001|Overall Study|Adverse Event|3|||
27749944|NCT01428063|80909705|FG002|Overall Study|Adverse Event|0|||
27749945|NCT01428063|80909703|FG000|Overall Study|Lost to Follow-up|0|||
27749946|NCT01428063|80909704|FG001|Overall Study|Lost to Follow-up|2|||
27749947|NCT01428063|80909705|FG002|Overall Study|Lost to Follow-up|0|||
27749948|NCT01428063|80909703|FG000|Overall Study|No longer meets study criteria|0|||
27749949|NCT01428063|80909704|FG001|Overall Study|No longer meets study criteria|1|||
27749950|NCT01428063|80909705|FG002|Overall Study|No longer meets study criteria|0|||
27749951|NCT00631488|80909706|FG000|Overall Study|Adverse Event|1|||
27749952|NCT00631488|80909707|FG001|Overall Study|Adverse Event|0|||
27749953|NCT00631488|80909708|FG002|Overall Study|Adverse Event|0|||
27749954|NCT00631488|80909706|FG000|Overall Study|Lost to Follow-up|2|||
27749955|NCT00631488|80909707|FG001|Overall Study|Lost to Follow-up|2|||
27749956|NCT00631488|80909708|FG002|Overall Study|Lost to Follow-up|0|||
27749957|NCT00631488|80909706|FG000|Overall Study|Physician Decision|1|||
27749958|NCT00631488|80909707|FG001|Overall Study|Physician Decision|0|||
27749959|NCT00631488|80909708|FG002|Overall Study|Physician Decision|1|||
27749960|NCT00631488|80909706|FG000|Overall Study|Protocol Violation|0|||
27749961|NCT00631488|80909707|FG001|Overall Study|Protocol Violation|0|||
27749962|NCT00631488|80909708|FG002|Overall Study|Protocol Violation|1|||
27951727|NCT00673920|81655878|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
27951728|NCT00673920|81655879|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
27951729|NCT00673920|81655880|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
27951730|NCT00673920|81655873|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27951731|NCT00673920|81655874|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27951732|NCT00673920|81655875|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27951733|NCT00673920|81655876|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27951734|NCT00673920|81655877|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27951735|NCT00673920|81655878|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27951736|NCT00673920|81655879|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
27951737|NCT00673920|81655880|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
27749963|NCT03744676|80909710|FG000|Pre-Treatment Phase|Death|7|||
27749964|NCT03744676|80909710|FG000|Pre-Treatment Phase|Disease related complications|2|||
27749965|NCT03744676|80909710|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
27749966|NCT03744676|80909710|FG000|Pre-Treatment Phase|Other reasons|8|||
27749967|NCT03744676|80909710|FG000|Treatment Phase|Ongoing in study|18|||
27749968|NCT03744676|80909710|FG000|Treatment Phase|Death|31|||
27749969|NCT03744676|80909710|FG000|Treatment Phase|Withdrawal of consent|8|||
27749970|NCT03744676|80909710|FG000|Treatment Phase|Other reasons|6|||
27749971|NCT02739594|80909713|FG000|Overall Study|Undesired Event|3|||
27749972|NCT02739594|80909714|FG001|Overall Study|Undesired Event|4|||
27749973|NCT02739594|80909713|FG000|Overall Study|Violation of Eligibility Criteria|1|||
27749974|NCT02739594|80909714|FG001|Overall Study|Violation of Eligibility Criteria|2|||
27749975|NCT02739594|80909713|FG000|Overall Study|Protocol Violation|5|||
27749976|NCT02739594|80909714|FG001|Overall Study|Protocol Violation|6|||
27749977|NCT02739594|80909713|FG000|Overall Study|Death|4|||
27749978|NCT02739594|80909714|FG001|Overall Study|Death|2|||
27749979|NCT02739594|80909713|FG000|Overall Study|Renal Insufficiency|4|||
27749980|NCT02739594|80909714|FG001|Overall Study|Renal Insufficiency|6|||
27749981|NCT02739594|80909713|FG000|Overall Study|Administrative Reasons|1|||
27951738|NCT00673920|81655873|FG000|Week 24 to Week 48|Failure to return|0|||
27951739|NCT00673920|81655874|FG001|Week 24 to Week 48|Failure to return|0|||
27951740|NCT00673920|81655875|FG002|Week 24 to Week 48|Failure to return|0|||
27951741|NCT00673920|81655876|FG003|Week 24 to Week 48|Failure to return|0|||
27951742|NCT00673920|81655877|FG004|Week 24 to Week 48|Failure to return|0|||
27951743|NCT00673920|81655878|FG005|Week 24 to Week 48|Failure to return|1|||
27951744|NCT00673920|81655879|FG006|Week 24 to Week 48|Failure to return|0|||
27951745|NCT00673920|81655880|FG007|Week 24 to Week 48|Failure to return|0|||
27951746|NCT00673920|81655873|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951747|NCT00673920|81655874|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951748|NCT00673920|81655875|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951749|NCT00673920|81655876|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951750|NCT00673920|81655877|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951751|NCT00673920|81655878|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
27951752|NCT00673920|81655879|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951753|NCT00673920|81655880|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
27951754|NCT00673920|81655873|FG000|Week 24 to Week 48|Death|0|||
27951755|NCT00673920|81655874|FG001|Week 24 to Week 48|Death|0|||
27951756|NCT00673920|81655875|FG002|Week 24 to Week 48|Death|0|||
27951757|NCT00673920|81655876|FG003|Week 24 to Week 48|Death|0|||
27951758|NCT00673920|81655877|FG004|Week 24 to Week 48|Death|0|||
27951759|NCT00673920|81655878|FG005|Week 24 to Week 48|Death|1|||
27951760|NCT00673920|81655879|FG006|Week 24 to Week 48|Death|0|||
27951761|NCT00673920|81655880|FG007|Week 24 to Week 48|Death|0|||
27951762|NCT00673920|81655873|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
27951763|NCT00673920|81655874|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
27951764|NCT00673920|81655875|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
27951765|NCT00673920|81655876|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
27951766|NCT00673920|81655877|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
27951767|NCT00673920|81655878|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
27951768|NCT00673920|81655879|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
27951769|NCT00673920|81655880|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
27951770|NCT03213509|81655881|FG000|Overall Study|Did not consent for verbal autopsy|4|||
27951771|NCT03213509|81655882|FG001|Overall Study|Did not consent for verbal autopsy|5|||
27951772|NCT00261833|81655886|FG000|Overall Study|Death|1|||
27951773|NCT00261833|81655887|FG001|Overall Study|Death|3|||
27951774|NCT00261833|81655886|FG000|Overall Study|Adverse Event|1|||
27951775|NCT00261833|81655887|FG001|Overall Study|Adverse Event|4|||
27951776|NCT00261833|81655886|FG000|Overall Study|Withdrawal by Subject|5|||
27951777|NCT00261833|81655887|FG001|Overall Study|Withdrawal by Subject|7|||
27951778|NCT00261833|81655886|FG000|Overall Study|Protocol Violation|0|||
27951779|NCT00261833|81655887|FG001|Overall Study|Protocol Violation|1|||
27951780|NCT00261833|81655886|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
27951781|NCT00261833|81655887|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
27951782|NCT00261833|81655886|FG000|Overall Study|Lung transplantation|1|||
27951783|NCT00261833|81655887|FG001|Overall Study|Lung transplantation|1|||
27951784|NCT00261833|81655886|FG000|Overall Study|Missing reason|1|||
27951785|NCT00261833|81655887|FG001|Overall Study|Missing reason|0|||
27951786|NCT00261833|81655886|FG000|Overall Study|Not interested in being participant|0|||
27951787|NCT00261833|81655887|FG001|Overall Study|Not interested in being participant|1|||
27951788|NCT02660229|81655888|FG000|Overall Study|Adverse Event|2|||
27951789|NCT02660229|81655889|FG001|Overall Study|Adverse Event|0|||
27951790|NCT02660229|81655888|FG000|Overall Study|Withdrawal by Subject|0|||
27951791|NCT02660229|81655889|FG001|Overall Study|Withdrawal by Subject|1|||
27951792|NCT01736917|81655890|FG000|Overall Study|Adverse Event|1|||
27951793|NCT01736917|81655890|FG000|Overall Study|Protocol Violation|10|||
27951794|NCT04046939|81655891|FG000|Primary Assessment Period|Adverse Event|1|||
27951795|NCT04046939|81655892|FG001|Primary Assessment Period|Adverse Event|0|||
27951796|NCT04046939|81655893|FG002|Primary Assessment Period|Adverse Event|0|||
27951797|NCT04046939|81655894|FG003|Primary Assessment Period|Adverse Event|0|||
27951798|NCT04046939|81655891|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
27951799|NCT04046939|81655892|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
27951800|NCT04046939|81655893|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
27951801|NCT04046939|81655894|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
27951802|NCT04046939|81655891|FG000|Primary Assessment Period|Physician Decision|0|||
27951803|NCT04046939|81655892|FG001|Primary Assessment Period|Physician Decision|0|||
27951804|NCT04046939|81655893|FG002|Primary Assessment Period|Physician Decision|1|||
27951805|NCT04046939|81655894|FG003|Primary Assessment Period|Physician Decision|0|||
27951806|NCT04046939|81655891|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
27951807|NCT04046939|81655892|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
27951808|NCT04046939|81655893|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
27951809|NCT04046939|81655894|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
27951810|NCT00940602|81655895|FG000|Overall Study|Administrative problems|1|||
27951811|NCT00940602|81655896|FG001|Overall Study|Administrative problems|1|||
27951812|NCT00940602|81655895|FG000|Overall Study|Patient/guardian decision|13|||
27951813|NCT00940602|81655896|FG001|Overall Study|Patient/guardian decision|28|||
27951814|NCT00940602|81655895|FG000|Overall Study|Physician Decision|8|||
27951815|NCT00940602|81655896|FG001|Overall Study|Physician Decision|5|||
27951816|NCT00940602|81655895|FG000|Overall Study|Pregnancy|1|||
27951817|NCT00940602|81655896|FG001|Overall Study|Pregnancy|0|||
27951818|NCT00940602|81655895|FG000|Overall Study|Protocol Deviation (untreated)|1|||
27951819|NCT00940602|81655896|FG001|Overall Study|Protocol Deviation (untreated)|0|||
27951820|NCT00940602|81655895|FG000|Overall Study|Disease progression|8|||
27951821|NCT00940602|81655896|FG001|Overall Study|Disease progression|2|||
27951822|NCT00940602|81655895|FG000|Overall Study|Death|38|||
27951823|NCT00940602|81655896|FG001|Overall Study|Death|19|||
27951824|NCT00940602|81655895|FG000|Overall Study|Lost to Follow-up|3|||
27951825|NCT00940602|81655896|FG001|Overall Study|Lost to Follow-up|1|||
27951826|NCT00940602|81655895|FG000|Overall Study|Patient withdrew consent|26|||
27951827|NCT00940602|81655896|FG001|Overall Study|Patient withdrew consent|13|||
27951828|NCT00940602|81655895|FG000|Overall Study|Adverse Event|7|||
27951829|NCT00940602|81655896|FG001|Overall Study|Adverse Event|2|||
27951830|NCT00940602|81655895|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
27951831|NCT00940602|81655896|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
27951832|NCT00710593|81655897|FG000|Overall Study|Incarceration|1|||
27951833|NCT00710593|81655898|FG001|Overall Study|Incarceration|0|||
27951834|NCT00710593|81655897|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
27951835|NCT00710593|81655898|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
27951836|NCT00710593|81655897|FG000|Overall Study|Lost to Follow-up|3|||
27951837|NCT00710593|81655898|FG001|Overall Study|Lost to Follow-up|1|||
27951838|NCT00710593|81655897|FG000|Overall Study|Moved out of area|1|||
27951839|NCT00710593|81655898|FG001|Overall Study|Moved out of area|0|||
27951840|NCT00710593|81655897|FG000|Overall Study|Failure to adhere or complete study eval|1|||
27951841|NCT00710593|81655898|FG001|Overall Study|Failure to adhere or complete study eval|1|||
27951842|NCT00710593|81655897|FG000|Overall Study|Protocol Violation|1|||
27951843|NCT00710593|81655898|FG001|Overall Study|Protocol Violation|1|||
27951844|NCT00710593|81655897|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
27951845|NCT00710593|81655898|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
27951846|NCT01342094|81655899|FG000|Overall Study|Adverse Event|5|||
27951847|NCT01342094|81655900|FG001|Overall Study|Adverse Event|0|||
27951848|NCT01342094|81655899|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
27951849|NCT01342094|81655900|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
27951850|NCT01342094|81655899|FG000|Overall Study|Withdrawal by Subject|0|||
27951851|NCT01342094|81655900|FG001|Overall Study|Withdrawal by Subject|2|||
27951852|NCT03186638|81655903|FG000|Overall Study|Withdrawal by Subject|4|||
27951853|NCT03186638|81655904|FG001|Overall Study|Withdrawal by Subject|4|||
27951854|NCT03186638|81655903|FG000|Overall Study|Withdrawn due to medical problem|3|||
27951855|NCT03186638|81655904|FG001|Overall Study|Withdrawn due to medical problem|2|||
27951856|NCT03186638|81655903|FG000|Overall Study|Lost to Follow-up|1|||
27951857|NCT03186638|81655904|FG001|Overall Study|Lost to Follow-up|0|||
27951858|NCT01740687|81658940|FG000|Overall Study|Lost to Follow-up|11|||
27951859|NCT01740687|81658940|FG000|Overall Study|Withdrawal by Subject|2|||
27951860|NCT01740687|81658940|FG000|Overall Study|other reason|22|||
27951861|NCT01740687|81658940|FG000|Overall Study|treatment not received|2|||
27951862|NCT01071954|81658942|FG000|Overall Study|Noncompliance|4|||
27951863|NCT01071954|81658942|FG000|Overall Study|Adverse Event|1|||
27951864|NCT01071954|81658942|FG000|Overall Study|Withdrawal by Subject|11|||
27951865|NCT01071954|81658942|FG000|Overall Study|Requirement for Alternative Therapy|5|||
27951866|NCT01071954|81658942|FG000|Overall Study|Administrative Decision|5|||
27951867|NCT01071954|81658942|FG000|Overall Study|Protocol Specified Criteria|1|||
27951868|NCT00320606|81658945|FG000|Overall Study|Adverse Event|1|||
27951869|NCT00320606|81658945|FG000|Overall Study|Protocol Violation|1|||
27951870|NCT00320606|81658945|FG000|Overall Study|Withdrawal by Subject|1|||
27951871|NCT00402987|81658947|FG000|Overall Study|Lack of Efficacy|0|||
27951872|NCT00402987|81658948|FG001|Overall Study|Lack of Efficacy|0|||
27951873|NCT00402987|81658949|FG002|Overall Study|Lack of Efficacy|1|||
27951874|NCT00402987|81658950|FG003|Overall Study|Lack of Efficacy|0|||
27951875|NCT00613106|81658951|FG000|Overall Study|Adverse Event|3|||
27951876|NCT00613106|81658952|FG001|Overall Study|Adverse Event|1|||
27951877|NCT00613106|81658951|FG000|Overall Study|Withdrawal by Subject|6|||
27951878|NCT00613106|81658952|FG001|Overall Study|Withdrawal by Subject|3|||
27650967|NCT00048932|80564538|FG002|Open Label Period (OL)|Adverse Event|103|||
27951879|NCT00613106|81658951|FG000|Overall Study|Lost to Follow-up|7|||
27951880|NCT00613106|81658952|FG001|Overall Study|Lost to Follow-up|2|||
27951881|NCT00613106|81658951|FG000|Overall Study|misc|4|||
27650968|NCT00048932|80564536|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
27951882|NCT00613106|81658952|FG001|Overall Study|misc|3|||
27951883|NCT00442702|81658955|FG000|Titration Period|Adverse Event|2|||
27951884|NCT00442702|81658956|FG001|Titration Period|Adverse Event|0|||
27951885|NCT00442702|81658955|FG000|Titration Period|Death|3|||
27951886|NCT00442702|81658956|FG001|Titration Period|Death|2|||
27951887|NCT00442702|81658955|FG000|Titration Period|Insufficient Therapeutic Response|1|||
27951888|NCT00442702|81658956|FG001|Titration Period|Insufficient Therapeutic Response|0|||
27951889|NCT00442702|81658955|FG000|Titration Period|Refused Treatment|4|||
27951890|NCT00442702|81658956|FG001|Titration Period|Refused Treatment|1|||
27951891|NCT00442702|81658955|FG000|Titration Period|Failure to return|1|||
27951892|NCT00442702|81658956|FG001|Titration Period|Failure to return|0|||
27951893|NCT00442702|81658955|FG000|Titration Period|Hospitalized in another hospital|1|||
27951894|NCT00442702|81658956|FG001|Titration Period|Hospitalized in another hospital|0|||
27951895|NCT00442702|81658955|FG000|Evaluation Period|Adverse Event|1|||
27951896|NCT00442702|81658956|FG001|Evaluation Period|Adverse Event|0|||
27951897|NCT00442702|81658955|FG000|Evaluation Period|Death|1|||
27951898|NCT00442702|81658956|FG001|Evaluation Period|Death|1|||
27951899|NCT00442702|81658955|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
27951900|NCT00442702|81658956|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
27951901|NCT00442702|81658955|FG000|Evaluation Period|Refused treatment|1|||
27951902|NCT00442702|81658956|FG001|Evaluation Period|Refused treatment|1|||
27951903|NCT00442702|81658955|FG000|Evaluation Period|Renal transplant|0|||
27951904|NCT00442702|81658956|FG001|Evaluation Period|Renal transplant|1|||
27951905|NCT00442702|81658955|FG000|Evaluation Period|Failure to return|1|||
27951906|NCT00442702|81658956|FG001|Evaluation Period|Failure to return|0|||
27951907|NCT00442702|81658955|FG000|Evaluation Period|Site closure|0|||
27951908|NCT00442702|81658956|FG001|Evaluation Period|Site closure|1|||
27951909|NCT03139448|81658957|FG000|Overall Study|Lack of Efficacy|6|||
27951910|NCT03139448|81658958|FG001|Overall Study|Lack of Efficacy|7|||
27951911|NCT03139448|81658957|FG000|Overall Study|Location of procedure changed|2|||
27951912|NCT03139448|81658958|FG001|Overall Study|Location of procedure changed|8|||
27951913|NCT03139448|81658957|FG000|Overall Study|Withdrawal by Subject|3|||
27951914|NCT03139448|81658958|FG001|Overall Study|Withdrawal by Subject|6|||
27951915|NCT03139448|81658957|FG000|Overall Study|Screen fail|1|||
27951916|NCT03139448|81658958|FG001|Overall Study|Screen fail|3|||
27951917|NCT03139448|81658957|FG000|Overall Study|Physician Decision|0|||
27951918|NCT03139448|81658958|FG001|Overall Study|Physician Decision|2|||
27951919|NCT01307449|81658961|FG000|Overall Study|Adverse Event|1|||
27951920|NCT01307449|81658962|FG001|Overall Study|Adverse Event|0|||
27951921|NCT01307449|81658963|FG002|Overall Study|Adverse Event|0|||
27951922|NCT01307449|81658964|FG003|Overall Study|Adverse Event|0|||
27951923|NCT02670473|81658965|FG000|Overall Study|Withdrawal by Subject|1|||
27951924|NCT02114177|81658968|FG000|Overall Study|Lost to Follow-up|1|||
27951925|NCT02114177|81658969|FG001|Overall Study|Lost to Follow-up|2|||
27951926|NCT02114177|81658968|FG000|Overall Study|Withdrawal by Subject|6|||
27951927|NCT02114177|81658969|FG001|Overall Study|Withdrawal by Subject|1|||
27951928|NCT02114177|81658968|FG000|Overall Study|Other|2|||
27951929|NCT02114177|81658969|FG001|Overall Study|Other|1|||
27951930|NCT02095106|81658970|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27951931|NCT02095106|81658971|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27951932|NCT02286895|81658972|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
27951933|NCT02286895|81658973|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
27951934|NCT02286895|81658972|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
27951935|NCT02286895|81658973|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
27951936|NCT02286895|81658972|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
27951937|NCT02286895|81658973|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
27951938|NCT01823289|81658974|FG000|Overall Study|Lost to Follow-up|5|||
27951939|NCT01823289|81658974|FG000|Overall Study|Adverse Event|5|||
27951940|NCT01823289|81658974|FG000|Overall Study|Lack of Efficacy|1|||
27951941|NCT01823289|81658974|FG000|Overall Study|Physician Decision|9|||
27951942|NCT01823289|81658974|FG000|Overall Study|Administered contraindicated medicine|1|||
27951943|NCT01823289|81658974|FG000|Overall Study|Transaminase increased more than 3 times|1|||
27951944|NCT01823289|81658974|FG000|Overall Study|Drug affected efficacy and safety|1|||
27951945|NCT01823289|81658974|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
27951946|NCT04211363|81658975|FG000|Overall Study|Adverse Event|5|||
27951947|NCT04211363|81658976|FG001|Overall Study|Adverse Event|2|||
27951948|NCT04211363|81658975|FG000|Overall Study|Physician Decision|0|||
27951949|NCT04211363|81658976|FG001|Overall Study|Physician Decision|1|||
27951950|NCT04211363|81658975|FG000|Overall Study|Protocol Violation|1|||
27951951|NCT04211363|81658976|FG001|Overall Study|Protocol Violation|0|||
27951952|NCT04211363|81658975|FG000|Overall Study|Pregnancy|1|||
27650969|NCT00048932|80564537|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
27749982|NCT02739594|80909714|FG001|Overall Study|Administrative Reasons|3|||
27951953|NCT04211363|81658976|FG001|Overall Study|Pregnancy|0|||
27951954|NCT04211363|81658975|FG000|Overall Study|Lost to Follow-up|12|||
27951955|NCT04211363|81658976|FG001|Overall Study|Lost to Follow-up|4|||
27951956|NCT04211363|81658975|FG000|Overall Study|Withdrawal by Subject|11|||
27951957|NCT04211363|81658976|FG001|Overall Study|Withdrawal by Subject|11|||
27951958|NCT04211363|81658975|FG000|Overall Study|Other|1|||
27951959|NCT04211363|81658976|FG001|Overall Study|Other|2|||
27951960|NCT01887717|81658981|FG000|Overall Study|Withdrawal by Subject|1|||
27951961|NCT01887717|81658982|FG001|Overall Study|Withdrawal by Subject|7|||
27951962|NCT01887717|81658981|FG000|Overall Study|Physician Decision|0|||
27951963|NCT01887717|81658982|FG001|Overall Study|Physician Decision|2|||
27951964|NCT01887717|81658981|FG000|Overall Study|Administrative reasons|5|||
27951965|NCT01887717|81658982|FG001|Overall Study|Administrative reasons|2|||
27951966|NCT01215851|81658985|FG000|Treatment Period|Adverse Event|1|||
27951967|NCT01215851|81658986|FG001|Treatment Period|Adverse Event|1|||
27951968|NCT01215851|81658987|FG002|Treatment Period|Adverse Event|1|||
27951969|NCT01215851|81658988|FG003|Treatment Period|Adverse Event|3|||
27951970|NCT01215851|81658989|FG004|Treatment Period|Adverse Event|0|||
27951971|NCT01215851|81658990|FG005|Treatment Period|Adverse Event|1|||
27951972|NCT01215851|81658985|FG000|Follow up Period|Lost to Follow-up|0|||
27951973|NCT01215851|81658986|FG001|Follow up Period|Lost to Follow-up|0|||
27951974|NCT01215851|81658987|FG002|Follow up Period|Lost to Follow-up|0|||
27951975|NCT01215851|81658988|FG003|Follow up Period|Lost to Follow-up|0|||
27951976|NCT01215851|81658989|FG004|Follow up Period|Lost to Follow-up|0|||
27951977|NCT01215851|81658990|FG005|Follow up Period|Lost to Follow-up|1|||
27951978|NCT01541371|81658992|FG000|Overall Study|Withdrawal by Subject|14|||
27951979|NCT01541371|81658992|FG000|Overall Study|Lost to Follow-up|21|||
27951980|NCT01541371|81658992|FG000|Overall Study|Adverse Event|15|||
27951981|NCT01541371|81658992|FG000|Overall Study|Lack of Efficacy|12|||
27951982|NCT01541371|81658992|FG000|Overall Study|Protocol Violation|6|||
27951983|NCT01541371|81658992|FG000|Overall Study|Study medication non-compliance|3|||
27951984|NCT01541371|81658992|FG000|Overall Study|Other|6|||
27951985|NCT00854360|81658993|FG000|Overall Study|Adverse Event|0|||
27951986|NCT00854360|81658994|FG001|Overall Study|Adverse Event|1|||
27951987|NCT00854360|81658995|FG002|Overall Study|Adverse Event|2|||
27951988|NCT00854360|81658996|FG003|Overall Study|Adverse Event|6|||
27951989|NCT00854360|81658993|FG000|Overall Study|Withdrawal by Subject|0|||
27951990|NCT00854360|81658994|FG001|Overall Study|Withdrawal by Subject|0|||
27951991|NCT00854360|81658995|FG002|Overall Study|Withdrawal by Subject|0|||
27951992|NCT00854360|81658996|FG003|Overall Study|Withdrawal by Subject|1|||
27951993|NCT00854360|81658993|FG000|Overall Study|Pregnancy|0|||
27951994|NCT00854360|81658994|FG001|Overall Study|Pregnancy|1|||
27951995|NCT00854360|81658995|FG002|Overall Study|Pregnancy|0|||
27951996|NCT00854360|81658996|FG003|Overall Study|Pregnancy|0|||
27951997|NCT00854360|81658993|FG000|Overall Study|Lack of Efficacy|2|||
27951998|NCT00854360|81658994|FG001|Overall Study|Lack of Efficacy|1|||
27951999|NCT00854360|81658995|FG002|Overall Study|Lack of Efficacy|0|||
27952000|NCT00854360|81658996|FG003|Overall Study|Lack of Efficacy|0|||
27952001|NCT00854360|81658993|FG000|Overall Study|Other|0|||
27952002|NCT00854360|81658994|FG001|Overall Study|Other|0|||
27952003|NCT00854360|81658995|FG002|Overall Study|Other|0|||
27952004|NCT00854360|81658996|FG003|Overall Study|Other|3|||
27952005|NCT05223673|81658997|FG000|Overall Study|Protocol Violation|1|||
27952006|NCT05223673|81658997|FG000|Overall Study|Study termination|6|||
27952007|NCT00980044|81658998|FG000|Overall Study|Withdrawal by Subject|5|||
27952008|NCT00980044|81658999|FG001|Overall Study|Withdrawal by Subject|7|||
27952009|NCT00980044|81659000|FG002|Overall Study|Withdrawal by Subject|3|||
27952010|NCT00980044|81658998|FG000|Overall Study|Protocol Violation|0|||
27952011|NCT00980044|81658999|FG001|Overall Study|Protocol Violation|0|||
27952012|NCT00980044|81659000|FG002|Overall Study|Protocol Violation|2|||
27952013|NCT02639390|81659003|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
27952014|NCT02639390|81659004|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
27952015|NCT00444106|81659005|FG000|Overall Study|Lost to Follow-up|2|||
27952016|NCT00444106|81659006|FG001|Overall Study|Lost to Follow-up|1|||
27952017|NCT00444106|81659007|FG002|Overall Study|Lost to Follow-up|0|||
27952018|NCT00444106|81659005|FG000|Overall Study|Abnormal Test Procedure Results|0|||
27952019|NCT00444106|81659006|FG001|Overall Study|Abnormal Test Procedure Results|0|||
27952020|NCT00444106|81659007|FG002|Overall Study|Abnormal Test Procedure Results|1|||
27952021|NCT04484857|81659008|FG000|Overall Study|Adverse Event|2|||
27952022|NCT04484857|81659008|FG000|Overall Study|Death|10|||
27952023|NCT04484857|81659008|FG000|Overall Study|Withdrawal by Subject|3|||
27952024|NCT04484857|81659008|FG000|Overall Study|Transferred/Relocation|5|||
27952025|NCT04484857|81659008|FG000|Overall Study|Kidney Transplant|7|||
27952026|NCT04484857|81659008|FG000|Overall Study|Other than specified|4|||
27952027|NCT04484857|81659008|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
27952028|NCT03323164|81659009|FG000|Overall Study|Poor quality imaging/scans|2|||
27952029|NCT03323164|81659010|FG001|Overall Study|Poor quality imaging/scans|2|||
27749983|NCT02739594|80909713|FG000|Overall Study|Withdrawal by Subject|1|||
27952030|NCT00140140|81659015|FG000|Overall Study|Unacceptable toxicity|1|||
27952031|NCT00140140|81659016|FG001|Overall Study|Unacceptable toxicity|1|||
27952032|NCT00140140|81659017|FG002|Overall Study|Unacceptable toxicity|2|||
27952033|NCT00140140|81659015|FG000|Overall Study|Physician Decision|1|||
27952034|NCT00140140|81659016|FG001|Overall Study|Physician Decision|1|||
27551485|NCT01543698|80207458|FG000|Phase 2|Adverse Event|0|||
27952035|NCT00140140|81659017|FG002|Overall Study|Physician Decision|0|||
27952036|NCT00279214|81659018|FG000|Overall Study|Physician Decision|3|||
27952037|NCT00279214|81659019|FG001|Overall Study|Physician Decision|2|||
27952038|NCT04614324|81659020|FG000|Overall Study|Lost to Follow-up|3|||
27952039|NCT04614324|81659020|FG000|Overall Study|Physician Decision|1|||
27952040|NCT04614324|81659020|FG000|Overall Study|Withdrawal by Subject|2|||
27952041|NCT04614324|81659020|FG000|Overall Study|Remaining in Follow up|123|||
27952042|NCT01645176|81659025|FG000|Overall Study|Lack of Efficacy|4|||
27952043|NCT01645176|81659025|FG000|Overall Study|did not complete final MRI|1|||
27952044|NCT01816984|81659027|FG000|Overall Study|declining health status|1|||
27952045|NCT00027560|81659028|FG000|Overall Study|Withdrawal by Subject|1|||
27952046|NCT00461708|81659029|FG000|Overall Study|Adverse Event|17|||
27952047|NCT00461708|81659030|FG001|Overall Study|Adverse Event|7|||
27952048|NCT00461708|81659029|FG000|Overall Study|Lack of Efficacy|68|||
27952049|NCT00461708|81659030|FG001|Overall Study|Lack of Efficacy|20|||
27952050|NCT00461708|81659029|FG000|Overall Study|Physician Decision|10|||
27952051|NCT00461708|81659030|FG001|Overall Study|Physician Decision|4|||
27952052|NCT00461708|81659029|FG000|Overall Study|Withdrawal by Subject|8|||
27952053|NCT00461708|81659030|FG001|Overall Study|Withdrawal by Subject|2|||
27952054|NCT00461708|81659029|FG000|Overall Study|Other|4|||
27952055|NCT00461708|81659030|FG001|Overall Study|Other|4|||
27952056|NCT00461708|81659029|FG000|Overall Study|Death|8|||
27952057|NCT00461708|81659030|FG001|Overall Study|Death|1|||
27952058|NCT03580044|81659033|FG000|Overall Study|Death|2|||
27952059|NCT03580044|81659034|FG001|Overall Study|Death|1|||
27952060|NCT03580044|81659033|FG000|Overall Study|Withdrawal by Subject|1|||
27952061|NCT03580044|81659034|FG001|Overall Study|Withdrawal by Subject|1|||
27952062|NCT01880957|81659036|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
27952063|NCT01880957|81659037|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
27952064|NCT01880957|81659036|FG000|Overall Study|Lost to Follow-up|11|||
27952065|NCT01880957|81659037|FG001|Overall Study|Lost to Follow-up|0|||
27952066|NCT01880957|81659036|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
27952067|NCT01880957|81659037|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
27952068|NCT00698841|81659038|FG000|Overall Study|Withdrawal by Subject|2|||
27952069|NCT00698841|81659038|FG000|Overall Study|Adverse Event|3|||
27952070|NCT00698841|81659038|FG000|Overall Study|Disease progression|7|||
27952071|NCT00698841|81659038|FG000|Overall Study|Failure to meet eligibility criteria|2|||
27952072|NCT00698841|81659038|FG000|Overall Study|Study drug toxicity|2|||
27952073|NCT00698841|81659038|FG000|Overall Study|Other|2|||
27952074|NCT00506142|81659039|FG000|Overall Study|Adverse Event|8|||
27952075|NCT00506142|81659040|FG001|Overall Study|Adverse Event|7|||
27952076|NCT00506142|81659039|FG000|Overall Study|Lack of Efficacy|21|||
27952077|NCT00506142|81659040|FG001|Overall Study|Lack of Efficacy|7|||
27952078|NCT00506142|81659039|FG000|Overall Study|Withdrawal by Subject|4|||
27952079|NCT00506142|81659040|FG001|Overall Study|Withdrawal by Subject|5|||
27952080|NCT00506142|81659039|FG000|Overall Study|Physician Decision|1|||
27952081|NCT00506142|81659040|FG001|Overall Study|Physician Decision|0|||
27650970|NCT00048932|80564538|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
27650971|NCT00048932|80564536|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
27650972|NCT00048932|80564537|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
27650973|NCT00048932|80564538|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
27650974|NCT00048932|80564536|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
27650975|NCT00048932|80564537|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
27650976|NCT00048932|80564538|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
27650977|NCT00048932|80564536|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
27650978|NCT00048932|80564537|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
27650979|NCT00048932|80564538|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
27650980|NCT00048932|80564536|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
27650981|NCT00048932|80564537|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
27650982|NCT00048932|80564538|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
27650983|NCT00048932|80564536|FG000|Open Label Period (OL)|Pregnancy|0|||
27650984|NCT00048932|80564537|FG001|Open Label Period (OL)|Pregnancy|0|||
27650985|NCT00048932|80564538|FG002|Open Label Period (OL)|Pregnancy|6|||
27650986|NCT00048932|80564536|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
27650987|NCT00048932|80564537|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
27650988|NCT00048932|80564538|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
27749984|NCT02739594|80909714|FG001|Overall Study|Withdrawal by Subject|1|||
27749985|NCT02739594|80909713|FG000|Overall Study|Lost to Follow-up|0|||
27749986|NCT02739594|80909714|FG001|Overall Study|Lost to Follow-up|1|||
27749987|NCT02739594|80909713|FG000|Overall Study|Elevated Serum Creatinine|0|||
27749988|NCT02739594|80909714|FG001|Overall Study|Elevated Serum Creatinine|1|||
27749989|NCT02739594|80909713|FG000|Overall Study|Other|6|||
27952082|NCT00506142|81659039|FG000|Overall Study|New health condition|1|||
27952083|NCT00506142|81659040|FG001|Overall Study|New health condition|0|||
27952084|NCT03781414|81659041|FG000|Overall Study|Study terminated by sponsor|39|||
27952085|NCT03781414|81659042|FG001|Overall Study|Study terminated by sponsor|34|||
27952086|NCT03781414|81659043|FG002|Overall Study|Study terminated by sponsor|25|||
27749990|NCT02739594|80909714|FG001|Overall Study|Other|2|||
27952087|NCT03781414|81659041|FG000|Overall Study|Adverse Event|3|||
27952088|NCT03781414|81659042|FG001|Overall Study|Adverse Event|6|||
27952089|NCT03781414|81659043|FG002|Overall Study|Adverse Event|3|||
27952090|NCT03781414|81659041|FG000|Overall Study|Physician Decision|2|||
27952091|NCT03781414|81659042|FG001|Overall Study|Physician Decision|0|||
27952092|NCT03781414|81659043|FG002|Overall Study|Physician Decision|1|||
27952093|NCT03781414|81659041|FG000|Overall Study|Withdrawal by Subject|2|||
27952094|NCT03781414|81659042|FG001|Overall Study|Withdrawal by Subject|3|||
27952095|NCT03781414|81659043|FG002|Overall Study|Withdrawal by Subject|3|||
27952096|NCT03781414|81659041|FG000|Overall Study|Death|1|||
27952097|NCT03781414|81659042|FG001|Overall Study|Death|4|||
27952098|NCT03781414|81659043|FG002|Overall Study|Death|0|||
27952099|NCT03781414|81659041|FG000|Overall Study|Lost to Follow-up|1|||
27952100|NCT03781414|81659042|FG001|Overall Study|Lost to Follow-up|1|||
27952101|NCT03781414|81659043|FG002|Overall Study|Lost to Follow-up|0|||
27952102|NCT01164007|81659044|FG000|Overall Study|Adverse Event|5|||
27952103|NCT01164007|81659044|FG000|Overall Study|Progression of Disease|30|||
27952104|NCT01164007|81659044|FG000|Overall Study|Protocol Violation|1|||
27952105|NCT01164007|81659044|FG000|Overall Study|Withdrawal by Subject|1|||
27952106|NCT01164007|81659044|FG000|Overall Study|Medical Decision|3|||
27952107|NCT01373281|81659048|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
27952108|NCT01373281|81659049|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
27952109|NCT01373281|81659048|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
27952110|NCT01373281|81659049|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
27952111|NCT01373281|81659048|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
27952112|NCT01373281|81659049|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
27952113|NCT01373281|81659048|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
27952114|NCT01373281|81659049|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
27952115|NCT01373281|81659048|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
27952116|NCT01373281|81659049|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
27952117|NCT01373281|81659048|FG000|Surveillance Expansion Period|Protocol Violation|9|||
27952118|NCT01373281|81659049|FG001|Surveillance Expansion Period|Protocol Violation|1|||
27952119|NCT01373281|81659048|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
27952120|NCT01373281|81659049|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
27952121|NCT01373281|81659048|FG000|Surveillance Expansion Period|Serious adverse event|3|||
27952122|NCT01373281|81659049|FG001|Surveillance Expansion Period|Serious adverse event|4|||
27952123|NCT01378195|81659050|FG000|Overall Study|Lost to Follow-up|29|||
27952124|NCT01378195|81659051|FG001|Overall Study|Lost to Follow-up|18|||
27952125|NCT01323192|81659057|FG000|Overall Study|Adverse Event|6|||
27952126|NCT01323192|81659058|FG001|Overall Study|Adverse Event|1|||
27952127|NCT01323192|81659057|FG000|Overall Study|Withdrawal by Subject|3|||
27952128|NCT01323192|81659058|FG001|Overall Study|Withdrawal by Subject|1|||
27952129|NCT01323192|81659057|FG000|Overall Study|Noncompliance with study medication|0|||
27952130|NCT01323192|81659058|FG001|Overall Study|Noncompliance with study medication|3|||
27952131|NCT01323192|81659057|FG000|Overall Study|Nonmedical reasons|0|||
27952132|NCT01323192|81659058|FG001|Overall Study|Nonmedical reasons|1|||
27952133|NCT01276704|81659059|FG000|Overall Study|Lost to Follow-up|2|||
27952134|NCT01276704|81659060|FG001|Overall Study|Lost to Follow-up|3|||
27952135|NCT01276704|81659059|FG000|Overall Study|Non-compliant|2|||
27952136|NCT01276704|81659060|FG001|Overall Study|Non-compliant|2|||
27952137|NCT01276704|81659059|FG000|Overall Study|Withdrawal by Subject|7|||
27952138|NCT01276704|81659060|FG001|Overall Study|Withdrawal by Subject|1|||
27952139|NCT01276704|81659059|FG000|Overall Study|Physician Decision|3|||
27952140|NCT01276704|81659060|FG001|Overall Study|Physician Decision|5|||
27952141|NCT01346176|81659061|FG000|Recruited|Protocol Violation|1|||
27952142|NCT01346176|81659062|FG001|Recruited|Protocol Violation|0|||
27952143|NCT01346176|81659063|FG002|Recruited|Protocol Violation|0|||
27952144|NCT01346176|81659061|FG000|Completed Advance Directive|Death|3|||
27952145|NCT01346176|81659062|FG001|Completed Advance Directive|Death|2|||
27952146|NCT01346176|81659063|FG002|Completed Advance Directive|Death|2|||
27952147|NCT01346176|81659061|FG000|Completed Advance Directive|Became Ineligible|3|||
27952148|NCT01346176|81659062|FG001|Completed Advance Directive|Became Ineligible|0|||
27952149|NCT01346176|81659063|FG002|Completed Advance Directive|Became Ineligible|1|||
27952150|NCT01346176|81659061|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
27952151|NCT01346176|81659062|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
27952152|NCT01346176|81659063|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
27749991|NCT03488472|80909715|FG000|Overall Study|disease progression additional mets|1|||
27952153|NCT01346176|81659061|FG000|Completed Satisfaction Survey|Death|3|||
27952154|NCT01346176|81659062|FG001|Completed Satisfaction Survey|Death|0|||
27952155|NCT01346176|81659063|FG002|Completed Satisfaction Survey|Death|2|||
27952156|NCT01346176|81659061|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
27952157|NCT01346176|81659062|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
27952158|NCT01346176|81659063|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
27952159|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Death|2|||
27551486|NCT01543698|80207459|FG001|Phase 2|Adverse Event|0|||
27952160|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
27952161|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
27952162|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Physician Decision|1|||
27952163|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
27952164|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
27952165|NCT00786422|81659066|FG000|Rivaroxaban Treatment|Adverse Event|2|||
27952166|NCT00786422|81659066|FG000|Follow-up Period|Death|1|||
27952167|NCT00786422|81659066|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
27952168|NCT03728933|81659070|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
27952169|NCT03728933|81659071|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27952170|NCT03728933|81659072|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27952171|NCT03728933|81659070|FG000|Overall Study|Withdrawal by Subject|0|||
27952172|NCT03728933|81659071|FG001|Overall Study|Withdrawal by Subject|0|||
27952173|NCT03728933|81659072|FG002|Overall Study|Withdrawal by Subject|1|||
27952174|NCT03728933|81659070|FG000|Overall Study|Lost to Follow-up|0|||
27952175|NCT03728933|81659071|FG001|Overall Study|Lost to Follow-up|1|||
27952176|NCT03728933|81659072|FG002|Overall Study|Lost to Follow-up|0|||
27952177|NCT03728933|81659070|FG000|Overall Study|Adverse Event|1|||
27952178|NCT03728933|81659071|FG001|Overall Study|Adverse Event|0|||
27952179|NCT03728933|81659072|FG002|Overall Study|Adverse Event|0|||
27952180|NCT01074931|81659075|FG000|Overall Study|Economic reasons|1|||
27952181|NCT01074931|81659075|FG000|Overall Study|Death|5|||
27952182|NCT00586157|81659076|FG000|First Intervention|Worsening behavior|1|||
27952183|NCT00586157|81659077|FG001|First Intervention|Worsening behavior|0|||
27952184|NCT00586157|81659076|FG000|Second Intervention|Withdrawal by Subject|1|||
27952185|NCT00586157|81659077|FG001|Second Intervention|Withdrawal by Subject|0|||
27952186|NCT00586157|81659076|FG000|Second Intervention|Worsening behavior|1|||
27952187|NCT00586157|81659077|FG001|Second Intervention|Worsening behavior|0|||
27952188|NCT00586157|81659076|FG000|Second Intervention|Adverse Event|0|||
27952189|NCT00586157|81659077|FG001|Second Intervention|Adverse Event|1|||
27952190|NCT03247829|81659081|FG000|Overall Study|Death|3|||
27952191|NCT03247829|81659082|FG001|Overall Study|Death|4|||
27952192|NCT03247829|81659081|FG000|Overall Study|Enter Hospice Care|1|||
27952193|NCT03247829|81659082|FG001|Overall Study|Enter Hospice Care|0|||
27952194|NCT03247829|81659081|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
27952195|NCT03247829|81659082|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
27952196|NCT03247829|81659081|FG000|Overall Study|LVAD Explant|1|||
27952197|NCT03247829|81659082|FG001|Overall Study|LVAD Explant|1|||
27952198|NCT03247829|81659081|FG000|Overall Study|Transplant|1|||
27952199|NCT03247829|81659082|FG001|Overall Study|Transplant|1|||
27952200|NCT01463527|81659086|FG000|Overall Study|Protocol Violation|1|||
27952201|NCT01463527|81659087|FG001|Overall Study|Protocol Violation|1|||
27952202|NCT01463527|81659086|FG000|Overall Study|Crying >20% of sedation|5|||
27952203|NCT01463527|81659087|FG001|Overall Study|Crying >20% of sedation|6|||
27952204|NCT03559270|81659089|FG000|Overall Study|Adverse Event|6|||
27952205|NCT03559270|81659090|FG001|Overall Study|Adverse Event|5|||
27952206|NCT03559270|81659091|FG002|Overall Study|Adverse Event|3|||
27952207|NCT03559270|81659092|FG003|Overall Study|Adverse Event|0|||
27952208|NCT03559270|81659089|FG000|Overall Study|Lack of Efficacy|34|||
27952209|NCT03559270|81659090|FG001|Overall Study|Lack of Efficacy|52|||
27952210|NCT03559270|81659091|FG002|Overall Study|Lack of Efficacy|37|||
27952211|NCT03559270|81659092|FG003|Overall Study|Lack of Efficacy|2|||
27952212|NCT03559270|81659089|FG000|Overall Study|Death|0|||
27952213|NCT03559270|81659090|FG001|Overall Study|Death|2|||
27952214|NCT03559270|81659091|FG002|Overall Study|Death|0|||
27952215|NCT03559270|81659092|FG003|Overall Study|Death|0|||
27952216|NCT03559270|81659089|FG000|Overall Study|Lost to Follow-up|16|||
27952217|NCT03559270|81659090|FG001|Overall Study|Lost to Follow-up|4|||
27952218|NCT03559270|81659091|FG002|Overall Study|Lost to Follow-up|12|||
27952219|NCT03559270|81659092|FG003|Overall Study|Lost to Follow-up|3|||
27952220|NCT03559270|81659089|FG000|Overall Study|Sponsor Decision|38|||
27952221|NCT03559270|81659090|FG001|Overall Study|Sponsor Decision|31|||
27952222|NCT03559270|81659091|FG002|Overall Study|Sponsor Decision|35|||
27952223|NCT03559270|81659092|FG003|Overall Study|Sponsor Decision|18|||
27952224|NCT03559270|81659089|FG000|Overall Study|Withdrawal by Subject|19|||
27952225|NCT03559270|81659090|FG001|Overall Study|Withdrawal by Subject|21|||
27952226|NCT03559270|81659091|FG002|Overall Study|Withdrawal by Subject|18|||
27952227|NCT03559270|81659092|FG003|Overall Study|Withdrawal by Subject|7|||
27952228|NCT03559270|81659089|FG000|Overall Study|Physician Decision|3|||
27952229|NCT03559270|81659090|FG001|Overall Study|Physician Decision|2|||
27952230|NCT03559270|81659091|FG002|Overall Study|Physician Decision|1|||
27952231|NCT03559270|81659092|FG003|Overall Study|Physician Decision|0|||
27952232|NCT03559270|81659089|FG000|Overall Study|Pregnancy|0|||
27952233|NCT03559270|81659090|FG001|Overall Study|Pregnancy|1|||
27952234|NCT03559270|81659091|FG002|Overall Study|Pregnancy|0|||
27952235|NCT03559270|81659092|FG003|Overall Study|Pregnancy|0|||
27952236|NCT03559270|81659089|FG000|Overall Study|Protocol Violation|1|||
27952237|NCT03559270|81659090|FG001|Overall Study|Protocol Violation|0|||
27952238|NCT03559270|81659091|FG002|Overall Study|Protocol Violation|2|||
27952239|NCT03559270|81659092|FG003|Overall Study|Protocol Violation|0|||
27952240|NCT00953706|81659098|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
27952241|NCT00953706|81659099|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
27952242|NCT00953706|81659100|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
27952243|NCT00953706|81659101|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
27952244|NCT00953706|81659098|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
27952245|NCT00953706|81659099|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
27749992|NCT00859898|80909716|FG000|Overall Study|Lack of Efficacy|0|||
27749993|NCT00859898|80909717|FG001|Overall Study|Lack of Efficacy|1|||
27749994|NCT00859898|80909718|FG002|Overall Study|Lack of Efficacy|1|||
27749995|NCT00859898|80909716|FG000|Overall Study|Adverse Event|4|||
27749996|NCT00859898|80909717|FG001|Overall Study|Adverse Event|9|||
27749997|NCT00859898|80909718|FG002|Overall Study|Adverse Event|8|||
27749998|NCT00859898|80909716|FG000|Overall Study|Withdrawal by Subject|11|||
27749999|NCT00859898|80909717|FG001|Overall Study|Withdrawal by Subject|8|||
27750000|NCT00859898|80909718|FG002|Overall Study|Withdrawal by Subject|11|||
27750001|NCT00859898|80909716|FG000|Overall Study|Death|0|||
27750002|NCT00859898|80909717|FG001|Overall Study|Death|0|||
27750003|NCT00859898|80909718|FG002|Overall Study|Death|1|||
27750004|NCT00859898|80909716|FG000|Overall Study|Lost to Follow-up|10|||
27750005|NCT00859898|80909717|FG001|Overall Study|Lost to Follow-up|11|||
27750006|NCT00859898|80909718|FG002|Overall Study|Lost to Follow-up|5|||
27750007|NCT00859898|80909716|FG000|Overall Study|poor/non-compliance|2|||
27750008|NCT00859898|80909717|FG001|Overall Study|poor/non-compliance|0|||
27750009|NCT00859898|80909718|FG002|Overall Study|poor/non-compliance|0|||
27750010|NCT00859898|80909716|FG000|Overall Study|No longer meets criteria|0|||
27750011|NCT00859898|80909717|FG001|Overall Study|No longer meets criteria|1|||
27750012|NCT00859898|80909718|FG002|Overall Study|No longer meets criteria|0|||
27750013|NCT00859898|80909716|FG000|Overall Study|non-specified|1|||
27750014|NCT00859898|80909717|FG001|Overall Study|non-specified|1|||
27750015|NCT00859898|80909718|FG002|Overall Study|non-specified|1|||
27750016|NCT01474746|80909720|FG000|Overall Study|Lost to Follow-up|1|||
27750017|NCT01474746|80909721|FG001|Overall Study|Lost to Follow-up|1|||
27750018|NCT01474746|80909720|FG000|Overall Study|Withdrawal by Subject|2|||
27750019|NCT01474746|80909721|FG001|Overall Study|Withdrawal by Subject|1|||
27750020|NCT03352414|80909723|FG000|Overall Study|Ineligible by operative criteria|12|||
27750021|NCT03352414|80909724|FG001|Overall Study|Ineligible by operative criteria|10|||
27750022|NCT01912768|80909725|FG000|Overall Study|Adverse Event|2|||
27750023|NCT01912768|80909726|FG001|Overall Study|Adverse Event|0|||
27750024|NCT01912768|80909725|FG000|Overall Study|Lost to Follow-up|2|||
27750025|NCT01912768|80909726|FG001|Overall Study|Lost to Follow-up|1|||
27750026|NCT01912768|80909725|FG000|Overall Study|Withdrawal by Subject|5|||
27750027|NCT01912768|80909726|FG001|Overall Study|Withdrawal by Subject|3|||
27750028|NCT01912768|80909725|FG000|Overall Study|Randomized in error|1|||
27750029|NCT01912768|80909726|FG001|Overall Study|Randomized in error|0|||
27750030|NCT02689219|80909727|FG000|Overall Study|Death|1|||
27952246|NCT00953706|81659100|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
27952247|NCT00953706|81659101|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
27952248|NCT00953706|81659098|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
27952249|NCT00953706|81659099|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
27952250|NCT00953706|81659100|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
27952251|NCT00953706|81659101|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
27952252|NCT00953706|81659098|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
27952253|NCT00953706|81659099|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
27952254|NCT00953706|81659100|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
27952255|NCT00953706|81659101|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
27952256|NCT00953706|81659098|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
27952257|NCT00953706|81659099|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
27952258|NCT00953706|81659100|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
27952259|NCT00953706|81659101|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
27952260|NCT00953706|81659098|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
27952261|NCT00953706|81659099|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
27952262|NCT00953706|81659100|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
27952263|NCT00953706|81659101|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
27952264|NCT00953706|81659098|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
27952265|NCT00953706|81659099|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
27952266|NCT00953706|81659100|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
27952267|NCT00953706|81659101|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
27750031|NCT02689219|80909728|FG001|Overall Study|Death|1|||
27750032|NCT02689219|80909727|FG000|Overall Study|Disease Progression|10|||
27750033|NCT02689219|80909728|FG001|Overall Study|Disease Progression|6|||
27952268|NCT00953706|81659098|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
27952269|NCT00953706|81659099|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
27952270|NCT00953706|81659100|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
27952271|NCT00953706|81659101|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
27952272|NCT00953706|81659098|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
27952273|NCT00953706|81659099|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
27952274|NCT00953706|81659100|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
27952275|NCT00953706|81659101|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
27952276|NCT00953706|81659098|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
27952277|NCT00953706|81659099|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
27952278|NCT00953706|81659100|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
27952279|NCT00953706|81659101|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
27952280|NCT00953706|81659098|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
27952281|NCT00953706|81659099|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
27952282|NCT00953706|81659100|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
27952283|NCT00953706|81659101|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
27952284|NCT01077063|81659106|FG000|Overall Study|Adverse Event|3|||
27952285|NCT01077063|81659107|FG001|Overall Study|Adverse Event|0|||
27952286|NCT01077063|81659106|FG000|Overall Study|Death|1|||
27952287|NCT01077063|81659107|FG001|Overall Study|Death|1|||
27952288|NCT01077063|81659106|FG000|Overall Study|Withdrawal by Subject|0|||
27952289|NCT01077063|81659107|FG001|Overall Study|Withdrawal by Subject|2|||
27952290|NCT00639457|81659108|FG000|Overall Study|Withdrawal by Subject|2|||
27952291|NCT00639457|81659109|FG001|Overall Study|Withdrawal by Subject|3|||
27952292|NCT01957865|81659110|FG000|Overall Study|Found HIV negative|0|||
27952293|NCT01957865|81659111|FG001|Overall Study|Found HIV negative|0|||
27952294|NCT01957865|81659112|FG002|Overall Study|Found HIV negative|1|||
27952295|NCT01957865|81659110|FG000|Overall Study|Lost to Follow-up|0|||
27952296|NCT01957865|81659111|FG001|Overall Study|Lost to Follow-up|2|||
27952297|NCT01957865|81659112|FG002|Overall Study|Lost to Follow-up|2|||
27952298|NCT00457392|81659121|FG000|Overall Study|Objective Progression or Relapse|229|||
27952299|NCT00457392|81659122|FG001|Overall Study|Objective Progression or Relapse|296|||
27952300|NCT00457392|81659121|FG000|Overall Study|Death|106|||
27952301|NCT00457392|81659122|FG001|Overall Study|Death|106|||
27952302|NCT00457392|81659121|FG000|Overall Study|Adverse Event|84|||
27952303|NCT00457392|81659122|FG001|Overall Study|Adverse Event|41|||
27952304|NCT00457392|81659121|FG000|Overall Study|Global Deterioration of Health Status|22|||
27952305|NCT00457392|81659122|FG001|Overall Study|Global Deterioration of Health Status|8|||
27952306|NCT00457392|81659121|FG000|Overall Study|Withdrawal by Subject|14|||
27952307|NCT00457392|81659122|FG001|Overall Study|Withdrawal by Subject|8|||
27952308|NCT00457392|81659121|FG000|Overall Study|Lost to Follow-up|6|||
27952309|NCT00457392|81659122|FG001|Overall Study|Lost to Follow-up|7|||
27952310|NCT00457392|81659121|FG000|Overall Study|Protocol Violation|4|||
27952311|NCT00457392|81659122|FG001|Overall Study|Protocol Violation|3|||
27952312|NCT00457392|81659121|FG000|Overall Study|Other|7|||
27952313|NCT00457392|81659122|FG001|Overall Study|Other|4|||
27952314|NCT00457392|81659121|FG000|Overall Study|Study Terminated by Sponsor|1|||
27952315|NCT00457392|81659122|FG001|Overall Study|Study Terminated by Sponsor|4|||
27952316|NCT00457392|81659121|FG000|Overall Study|Randomized, Not Treated|7|||
27952317|NCT00457392|81659122|FG001|Overall Study|Randomized, Not Treated|3|||
27952318|NCT04778592|81659126|FG000|Overall Study|Adverse Event|1|||
27952319|NCT04778592|81659127|FG001|Overall Study|Adverse Event|2|||
27952320|NCT04778592|81659126|FG000|Overall Study|Withdrawal by Subject|1|||
27952321|NCT04778592|81659127|FG001|Overall Study|Withdrawal by Subject|2|||
27952322|NCT01593917|81659128|FG000|Overall Study|Death|67|||
27952323|NCT01593917|81659128|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
27952324|NCT01593917|81659128|FG000|Overall Study|Withdrawal by Subject|23|||
27952325|NCT01593917|81659128|FG000|Overall Study|Lost to Follow-up|12|||
27952326|NCT01593917|81659128|FG000|Overall Study|Protocol Violation|5|||
27952327|NCT01593917|81659128|FG000|Overall Study|Physician Decision|3|||
27952328|NCT01917318|81659134|FG000|First Treatment|Withdrawal by Subject|0|||
27952329|NCT01917318|81659135|FG001|First Treatment|Withdrawal by Subject|1|||
27952330|NCT02303262|81659136|FG000|Overall Study|Withdrawal by Subject|2|||
27952331|NCT04567524|81659137|FG000|Overall Study|Adverse Event|1|||
27952332|NCT04567524|81659138|FG001|Overall Study|Adverse Event|1|||
27952333|NCT04567524|81659139|FG002|Overall Study|Adverse Event|0|||
27952334|NCT04567524|81659140|FG003|Overall Study|Adverse Event|0|||
27952335|NCT04567524|81659137|FG000|Overall Study|Withdrawal by Subject|2|||
27952336|NCT04567524|81659138|FG001|Overall Study|Withdrawal by Subject|0|||
27952337|NCT04567524|81659139|FG002|Overall Study|Withdrawal by Subject|0|||
27952338|NCT04567524|81659140|FG003|Overall Study|Withdrawal by Subject|1|||
27952339|NCT01990742|81659147|FG000|Overall Study|Withdrawal by facility|407|||
27952340|NCT01990742|81659148|FG001|Overall Study|Withdrawal by facility|1083|||
27952341|NCT01990742|81659147|FG000|Overall Study|Facility closed|0|||
27952342|NCT01990742|81659148|FG001|Overall Study|Facility closed|270|||
27952343|NCT01083602|81659151|FG000|Overall Study|Adverse Event|11|||
27952344|NCT01083602|81659151|FG000|Overall Study|New Cancer Therapy|2|||
27952345|NCT01083602|81659151|FG000|Overall Study|Death|1|||
27952346|NCT01083602|81659151|FG000|Overall Study|Withdrawal by Subject|5|||
27952347|NCT01083602|81659151|FG000|Overall Study|Lack of Efficacy|36|||
27952348|NCT05489328|81659159|FG000|Overall Study|Lost to Follow-up|0|||
27952349|NCT05489328|81659160|FG001|Overall Study|Lost to Follow-up|0|||
27952350|NCT05489328|81659161|FG002|Overall Study|Lost to Follow-up|1|||
27952351|NCT05489328|81659162|FG003|Overall Study|Lost to Follow-up|0|||
27952352|NCT05489328|81659163|FG004|Overall Study|Lost to Follow-up|2|||
27952353|NCT05489328|81659164|FG005|Overall Study|Lost to Follow-up|0|||
27952354|NCT05489328|81659165|FG006|Overall Study|Lost to Follow-up|0|||
27952355|NCT05489328|81659166|FG007|Overall Study|Lost to Follow-up|1|||
27952356|NCT05489328|81659167|FG008|Overall Study|Lost to Follow-up|0|||
27952357|NCT05489328|81659159|FG000|Overall Study|Withdrawal by Subject|0|||
27952358|NCT05489328|81659160|FG001|Overall Study|Withdrawal by Subject|0|||
27952359|NCT05489328|81659161|FG002|Overall Study|Withdrawal by Subject|0|||
27952360|NCT05489328|81659162|FG003|Overall Study|Withdrawal by Subject|0|||
27952361|NCT05489328|81659163|FG004|Overall Study|Withdrawal by Subject|0|||
27952362|NCT05489328|81659164|FG005|Overall Study|Withdrawal by Subject|0|||
27952363|NCT05489328|81659165|FG006|Overall Study|Withdrawal by Subject|1|||
27952364|NCT05489328|81659166|FG007|Overall Study|Withdrawal by Subject|1|||
27952365|NCT05489328|81659167|FG008|Overall Study|Withdrawal by Subject|0|||
27952366|NCT05489328|81659159|FG000|Overall Study|Other|0|||
27952367|NCT05489328|81659160|FG001|Overall Study|Other|0|||
27952368|NCT05489328|81659161|FG002|Overall Study|Other|0|||
27952369|NCT05489328|81659162|FG003|Overall Study|Other|0|||
27952370|NCT05489328|81659163|FG004|Overall Study|Other|0|||
27952371|NCT05489328|81659164|FG005|Overall Study|Other|0|||
27952372|NCT05489328|81659165|FG006|Overall Study|Other|0|||
27952373|NCT05489328|81659166|FG007|Overall Study|Other|1|||
27952374|NCT05489328|81659167|FG008|Overall Study|Other|1|||
27952375|NCT03047135|81659170|FG000|Overall Study|Still being treated|3|||
27952376|NCT00976456|81659171|FG000|Overall Study|Adverse Event|17|||
27952377|NCT00976456|81659172|FG001|Overall Study|Adverse Event|22|||
27952378|NCT00976456|81659171|FG000|Overall Study|Death|7|||
27952379|NCT00976456|81659172|FG001|Overall Study|Death|9|||
27952380|NCT00976456|81659171|FG000|Overall Study|Lack of Efficacy|5|||
27952381|NCT00976456|81659172|FG001|Overall Study|Lack of Efficacy|2|||
27952382|NCT00976456|81659171|FG000|Overall Study|Withdrawal by Subject|3|||
27952383|NCT00976456|81659172|FG001|Overall Study|Withdrawal by Subject|1|||
27952384|NCT00976456|81659171|FG000|Overall Study|screening failure, unknown|11|||
27952385|NCT00976456|81659172|FG001|Overall Study|screening failure, unknown|4|||
27952386|NCT00716274|81659173|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
27952387|NCT00716274|81659174|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
27952388|NCT00716274|81659175|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
27952389|NCT00716274|81659176|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
27952390|NCT00716274|81659177|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
27952391|NCT00716274|81659178|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
27952392|NCT00716274|81659173|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
27952393|NCT00716274|81659174|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
27952394|NCT00716274|81659175|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
27952395|NCT00716274|81659176|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
27952396|NCT00716274|81659177|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
27952397|NCT00716274|81659178|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
27952398|NCT00716274|81659173|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
27952399|NCT00716274|81659174|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
27952400|NCT00716274|81659175|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
27952401|NCT00716274|81659176|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
27952402|NCT00716274|81659177|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
27952403|NCT00716274|81659178|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
27952404|NCT00716274|81659173|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
27650989|NCT00048932|80564536|FG000|Open Label Period (OL)|Investigator Retiring|0|||
27650990|NCT00048932|80564537|FG001|Open Label Period (OL)|Investigator Retiring|0|||
27650991|NCT00048932|80564538|FG002|Open Label Period (OL)|Investigator Retiring|2|||
27952405|NCT00716274|81659174|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
27952406|NCT00716274|81659175|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
27952407|NCT00716274|81659176|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
27952408|NCT00716274|81659177|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
27952409|NCT00716274|81659178|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
27952410|NCT00716274|81659173|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
27952411|NCT00716274|81659174|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
27952412|NCT00716274|81659175|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
27952413|NCT00716274|81659176|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
27952414|NCT00716274|81659177|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
27952415|NCT00716274|81659178|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
27952416|NCT00716274|81659173|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
27952417|NCT00716274|81659174|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
27952418|NCT00716274|81659175|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
27952419|NCT00716274|81659176|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
27952420|NCT00716274|81659177|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
27952421|NCT00716274|81659178|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
27952422|NCT00716274|81659173|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
27952423|NCT00716274|81659174|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
27952424|NCT00716274|81659175|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
27952425|NCT00716274|81659176|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
27952426|NCT00716274|81659177|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
27952427|NCT00716274|81659178|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
27952428|NCT00716274|81659173|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
27952429|NCT00716274|81659174|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
27952430|NCT00716274|81659175|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
27952431|NCT00716274|81659176|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
27952432|NCT00716274|81659177|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
27952433|NCT00716274|81659178|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
27952434|NCT00716274|81659173|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
27952435|NCT00716274|81659174|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
27952436|NCT00716274|81659175|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
27952437|NCT00716274|81659176|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
27952438|NCT00716274|81659177|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
27952439|NCT00716274|81659178|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
27952440|NCT00716274|81659173|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
27952441|NCT00716274|81659174|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
27952442|NCT00716274|81659175|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
27952443|NCT00716274|81659176|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
27952444|NCT00716274|81659177|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
27952445|NCT00716274|81659178|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
27952446|NCT00049543|81659179|FG000|Overall Study|still on treatment|2|||
27952447|NCT00049543|81659180|FG001|Overall Study|still on treatment|9|||
27952448|NCT01444781|81659193|FG000|Overall Study|Lost to Follow-up|0|||
27952449|NCT01444781|81659194|FG001|Overall Study|Lost to Follow-up|3|||
27952450|NCT01444781|81659195|FG002|Overall Study|Lost to Follow-up|1|||
27952451|NCT01444781|81659193|FG000|Overall Study|Withdrawal by Subject|3|||
27952452|NCT01444781|81659194|FG001|Overall Study|Withdrawal by Subject|1|||
27952453|NCT01444781|81659195|FG002|Overall Study|Withdrawal by Subject|2|||
27952454|NCT01182350|81659201|FG000|Overall Study|Adverse Event|5|||
27952455|NCT01182350|81659202|FG001|Overall Study|Adverse Event|0|||
27952456|NCT01182350|81659203|FG002|Overall Study|Adverse Event|0|||
27952457|NCT01182350|81659204|FG003|Overall Study|Adverse Event|0|||
27952458|NCT01182350|81659205|FG004|Overall Study|Adverse Event|0|||
27952459|NCT01182350|81659201|FG000|Overall Study|Disease Progression|15|||
27952460|NCT01182350|81659202|FG001|Overall Study|Disease Progression|12|||
27952461|NCT01182350|81659203|FG002|Overall Study|Disease Progression|0|||
27952462|NCT01182350|81659204|FG003|Overall Study|Disease Progression|1|||
27952463|NCT01182350|81659205|FG004|Overall Study|Disease Progression|0|||
27952464|NCT01182350|81659201|FG000|Overall Study|Death|0|||
27952465|NCT01182350|81659202|FG001|Overall Study|Death|1|||
27952466|NCT01182350|81659203|FG002|Overall Study|Death|1|||
27952467|NCT01182350|81659204|FG003|Overall Study|Death|0|||
27952468|NCT01182350|81659205|FG004|Overall Study|Death|0|||
27952469|NCT01182350|81659201|FG000|Overall Study|Withdrawal by Subject|3|||
27952470|NCT01182350|81659202|FG001|Overall Study|Withdrawal by Subject|1|||
27952471|NCT01182350|81659203|FG002|Overall Study|Withdrawal by Subject|0|||
27952472|NCT01182350|81659204|FG003|Overall Study|Withdrawal by Subject|1|||
27952473|NCT01182350|81659205|FG004|Overall Study|Withdrawal by Subject|0|||
27952474|NCT01182350|81659201|FG000|Overall Study|Alternative Therapy|2|||
27952475|NCT01182350|81659202|FG001|Overall Study|Alternative Therapy|0|||
27952476|NCT01182350|81659203|FG002|Overall Study|Alternative Therapy|1|||
27952477|NCT01182350|81659204|FG003|Overall Study|Alternative Therapy|0|||
27952478|NCT01182350|81659205|FG004|Overall Study|Alternative Therapy|0|||
27952479|NCT01182350|81659201|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
27952480|NCT01182350|81659202|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
27952481|NCT01182350|81659203|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
27952482|NCT01182350|81659204|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
27952483|NCT01182350|81659205|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
27952484|NCT01182350|81659201|FG000|Overall Study|Unevaluable for Biopsy|0|||
27952485|NCT01182350|81659202|FG001|Overall Study|Unevaluable for Biopsy|0|||
27952486|NCT01182350|81659203|FG002|Overall Study|Unevaluable for Biopsy|0|||
27952487|NCT01182350|81659204|FG003|Overall Study|Unevaluable for Biopsy|0|||
27952488|NCT01182350|81659205|FG004|Overall Study|Unevaluable for Biopsy|3|||
27952489|NCT02805790|81659206|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
27952490|NCT02805790|81659207|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
27650992|NCT00048932|80564536|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
27650993|NCT00048932|80564537|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
27650994|NCT00048932|80564538|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
27650995|NCT00048932|80564536|FG000|Open Label Period (OL)|Participant Relocated|0|||
27650996|NCT00048932|80564537|FG001|Open Label Period (OL)|Participant Relocated|0|||
27650997|NCT00048932|80564538|FG002|Open Label Period (OL)|Participant Relocated|6|||
27650998|NCT00048932|80564536|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
27650999|NCT00048932|80564537|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
27651000|NCT00048932|80564538|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
27651001|NCT00048932|80564536|FG000|Open Label Period (OL)|Site Closure|0|||
27651002|NCT00048932|80564537|FG001|Open Label Period (OL)|Site Closure|0|||
27651003|NCT00048932|80564538|FG002|Open Label Period (OL)|Site Closure|3|||
27651004|NCT00048932|80564536|FG000|Open Label Period (OL)|Trial Terminated|0|||
27651005|NCT00048932|80564537|FG001|Open Label Period (OL)|Trial Terminated|0|||
27651006|NCT00048932|80564538|FG002|Open Label Period (OL)|Trial Terminated|1|||
27651007|NCT00048932|80564536|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
27651008|NCT00048932|80564537|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
27651009|NCT00048932|80564538|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
27651010|NCT00048932|80564536|FG000|Open Label Period (OL)|Patient Decision|0|||
27651011|NCT00048932|80564537|FG001|Open Label Period (OL)|Patient Decision|0|||
27651012|NCT00048932|80564538|FG002|Open Label Period (OL)|Patient Decision|4|||
27651013|NCT00048932|80564536|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
27651014|NCT00048932|80564537|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
27651015|NCT00048932|80564538|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
27651016|NCT00048932|80564536|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
27651017|NCT00048932|80564537|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
27651018|NCT00048932|80564538|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
27651019|NCT00048932|80564536|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
27651020|NCT00048932|80564537|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
27651021|NCT00048932|80564538|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
27651022|NCT00048932|80564536|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
27651023|NCT00048932|80564537|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
27651024|NCT00048932|80564538|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
27651025|NCT00048932|80564536|FG000|Open Label Period (OL)|Investigator Decision|0|||
27651026|NCT00048932|80564537|FG001|Open Label Period (OL)|Investigator Decision|0|||
27651027|NCT00048932|80564538|FG002|Open Label Period (OL)|Investigator Decision|4|||
27651028|NCT00048932|80564536|FG000|Open Label Period (OL)|Site Staff Issues|0|||
27651029|NCT00048932|80564537|FG001|Open Label Period (OL)|Site Staff Issues|0|||
27651030|NCT00048932|80564538|FG002|Open Label Period (OL)|Site Staff Issues|2|||
27651031|NCT00048932|80564536|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
27651032|NCT00048932|80564537|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
27651033|NCT00048932|80564538|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
27651034|NCT00048932|80564536|FG000|Open Label Period (OL)|Participant Surgery|0|||
27651035|NCT00048932|80564537|FG001|Open Label Period (OL)|Participant Surgery|0|||
27651036|NCT00048932|80564538|FG002|Open Label Period (OL)|Participant Surgery|1|||
27651037|NCT03006393|80564539|FG000|Overall Study|Withdrawal by Subject|1|||
27651038|NCT03006393|80564540|FG001|Overall Study|Withdrawal by Subject|1|||
27651039|NCT03006393|80564539|FG000|Overall Study|Pregnancy|0|||
27651040|NCT03006393|80564540|FG001|Overall Study|Pregnancy|1|||
27651041|NCT03006393|80564539|FG000|Overall Study|Lost to Follow-up|0|||
27651042|NCT03006393|80564540|FG001|Overall Study|Lost to Follow-up|1|||
27651043|NCT02372799|80564541|FG000|Treatment Period|Adverse Event|3|||
27651044|NCT02372799|80564542|FG001|Treatment Period|Adverse Event|10|||
27651045|NCT02372799|80564543|FG002|Treatment Period|Adverse Event|6|||
27651046|NCT02372799|80564541|FG000|Treatment Period|Insufficient therapeutic response|2|||
27651047|NCT02372799|80564542|FG001|Treatment Period|Insufficient therapeutic response|2|||
27651048|NCT02372799|80564543|FG002|Treatment Period|Insufficient therapeutic response|0|||
27651049|NCT02372799|80564541|FG000|Treatment Period|Withdrawal by Subject|10|||
27651050|NCT02372799|80564542|FG001|Treatment Period|Withdrawal by Subject|10|||
27651051|NCT02372799|80564543|FG002|Treatment Period|Withdrawal by Subject|2|||
27651052|NCT02372799|80564541|FG000|Treatment Period|Lost to Follow-up|11|||
27651053|NCT02372799|80564542|FG001|Treatment Period|Lost to Follow-up|5|||
27651054|NCT02372799|80564543|FG002|Treatment Period|Lost to Follow-up|3|||
27952491|NCT01816295|81659208|FG000|Double Blind Phase|Adverse Event|11|||
27750034|NCT01655823|80909729|FG000|Overall Study|Lost to Follow-up|0|||
27952492|NCT01816295|81659209|FG001|Double Blind Phase|Adverse Event|8|||
27952493|NCT01816295|81659208|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
27750035|NCT01655823|80909730|FG001|Overall Study|Lost to Follow-up|1|||
27952494|NCT01816295|81659209|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
27952495|NCT01816295|81659208|FG000|Double Blind Phase|Lost to Follow-up|3|||
27952496|NCT01816295|81659209|FG001|Double Blind Phase|Lost to Follow-up|5|||
27952497|NCT01816295|81659208|FG000|Double Blind Phase|Physician Decision|2|||
27952498|NCT01816295|81659209|FG001|Double Blind Phase|Physician Decision|2|||
27952499|NCT01816295|81659208|FG000|Double Blind Phase|Protocol Violation|17|||
27952500|NCT01816295|81659209|FG001|Double Blind Phase|Protocol Violation|11|||
27952501|NCT01816295|81659208|FG000|Double Blind Phase|Sponsor Decision|8|||
27952502|NCT01816295|81659209|FG001|Double Blind Phase|Sponsor Decision|8|||
27952503|NCT01816295|81659208|FG000|Double Blind Phase|Withdrawal by Subject|22|||
27952504|NCT01816295|81659209|FG001|Double Blind Phase|Withdrawal by Subject|20|||
27952505|NCT01816295|81659208|FG000|OLE Phase|Adverse Event|17|||
27952506|NCT01816295|81659209|FG001|OLE Phase|Adverse Event|15|||
27952507|NCT01816295|81659208|FG000|OLE Phase|Death|1|||
27952508|NCT01816295|81659209|FG001|OLE Phase|Death|0|||
27952509|NCT01816295|81659208|FG000|OLE Phase|Entry Criteria Not Met|3|||
27952510|NCT01816295|81659209|FG001|OLE Phase|Entry Criteria Not Met|5|||
27952511|NCT01816295|81659208|FG000|OLE Phase|Lost to Follow-up|5|||
27952512|NCT01816295|81659209|FG001|OLE Phase|Lost to Follow-up|5|||
27952513|NCT01816295|81659208|FG000|OLE Phase|Physician Decision|3|||
27952514|NCT01816295|81659209|FG001|OLE Phase|Physician Decision|1|||
27952515|NCT01816295|81659208|FG000|OLE Phase|Protocol Violation|4|||
27952516|NCT01816295|81659209|FG001|OLE Phase|Protocol Violation|4|||
27952517|NCT01816295|81659208|FG000|OLE Phase|Sponsor Decision|7|||
27952518|NCT01816295|81659209|FG001|OLE Phase|Sponsor Decision|9|||
27952519|NCT01816295|81659208|FG000|OLE Phase|Withdrawal by Subject|10|||
27952520|NCT01816295|81659209|FG001|OLE Phase|Withdrawal by Subject|10|||
27952521|NCT01816295|81659208|FG000|OLE Phase|Lack of Efficacy|3|||
27952522|NCT01816295|81659209|FG001|OLE Phase|Lack of Efficacy|7|||
27952523|NCT00328172|81659210|FG000|Overall Study|Adverse Event|3|||
27952524|NCT00328172|81659211|FG001|Overall Study|Adverse Event|2|||
27952525|NCT00328172|81659212|FG002|Overall Study|Adverse Event|1|||
27952526|NCT00328172|81659213|FG003|Overall Study|Adverse Event|2|||
27952527|NCT00328172|81659214|FG004|Overall Study|Adverse Event|1|||
27952528|NCT00328172|81659210|FG000|Overall Study|Protocol Violation|0|||
27952529|NCT00328172|81659211|FG001|Overall Study|Protocol Violation|1|||
27952530|NCT00328172|81659212|FG002|Overall Study|Protocol Violation|1|||
27952531|NCT00328172|81659213|FG003|Overall Study|Protocol Violation|0|||
27952532|NCT00328172|81659214|FG004|Overall Study|Protocol Violation|0|||
27952533|NCT00328172|81659210|FG000|Overall Study|Lost to Follow-up|1|||
27952534|NCT00328172|81659211|FG001|Overall Study|Lost to Follow-up|1|||
27952535|NCT00328172|81659212|FG002|Overall Study|Lost to Follow-up|2|||
27952536|NCT00328172|81659213|FG003|Overall Study|Lost to Follow-up|1|||
27952537|NCT00328172|81659214|FG004|Overall Study|Lost to Follow-up|1|||
27952538|NCT00328172|81659210|FG000|Overall Study|Withdrawal by Subject|1|||
27952539|NCT00328172|81659211|FG001|Overall Study|Withdrawal by Subject|1|||
27952540|NCT00328172|81659212|FG002|Overall Study|Withdrawal by Subject|1|||
27952541|NCT00328172|81659213|FG003|Overall Study|Withdrawal by Subject|6|||
27952542|NCT00328172|81659214|FG004|Overall Study|Withdrawal by Subject|0|||
27952543|NCT00328172|81659210|FG000|Overall Study|Lack of Efficacy|14|||
27952544|NCT00328172|81659211|FG001|Overall Study|Lack of Efficacy|9|||
27952545|NCT00328172|81659212|FG002|Overall Study|Lack of Efficacy|4|||
27952546|NCT00328172|81659213|FG003|Overall Study|Lack of Efficacy|4|||
27952547|NCT00328172|81659214|FG004|Overall Study|Lack of Efficacy|3|||
27952548|NCT00328172|81659210|FG000|Overall Study|Other reason (not specified)|3|||
27952549|NCT00328172|81659211|FG001|Overall Study|Other reason (not specified)|0|||
27952550|NCT00328172|81659212|FG002|Overall Study|Other reason (not specified)|1|||
27952551|NCT00328172|81659213|FG003|Overall Study|Other reason (not specified)|0|||
27952552|NCT00328172|81659214|FG004|Overall Study|Other reason (not specified)|0|||
27750036|NCT01655823|80909731|FG002|Overall Study|Lost to Follow-up|0|||
27750037|NCT01655823|80909732|FG003|Overall Study|Lost to Follow-up|0|||
27750038|NCT01655823|80909733|FG004|Overall Study|Lost to Follow-up|1|||
27750039|NCT01655823|80909729|FG000|Overall Study|Withdrawal by Subject|0|||
27750040|NCT01655823|80909730|FG001|Overall Study|Withdrawal by Subject|1|||
27750041|NCT01655823|80909731|FG002|Overall Study|Withdrawal by Subject|0|||
27750042|NCT01655823|80909732|FG003|Overall Study|Withdrawal by Subject|1|||
27750043|NCT01655823|80909733|FG004|Overall Study|Withdrawal by Subject|0|||
27750044|NCT05118386|80909734|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
27750045|NCT05118386|80909735|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
27952553|NCT00529633|81659215|FG000|Overall Study|Withdrawal by Subject|1|||
27750046|NCT05118386|80909736|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
27952554|NCT00529633|81659216|FG001|Overall Study|Withdrawal by Subject|1|||
27952555|NCT01517984|81659217|FG000|Overall Study|Lost to Follow-up|0|||
27952556|NCT01517984|81659218|FG001|Overall Study|Lost to Follow-up|1|||
27952557|NCT01517984|81659219|FG002|Overall Study|Lost to Follow-up|0|||
27952558|NCT01517984|81659220|FG003|Overall Study|Lost to Follow-up|0|||
27952559|NCT01517984|81659217|FG000|Overall Study|Withdrawal by Subject|1|||
27952560|NCT01517984|81659218|FG001|Overall Study|Withdrawal by Subject|8|||
27952561|NCT01517984|81659219|FG002|Overall Study|Withdrawal by Subject|4|||
27952562|NCT01517984|81659220|FG003|Overall Study|Withdrawal by Subject|1|||
27952563|NCT01517984|81659217|FG000|Overall Study|Screen Failure|4|||
27952564|NCT01517984|81659218|FG001|Overall Study|Screen Failure|0|||
27952565|NCT01517984|81659219|FG002|Overall Study|Screen Failure|0|||
27952566|NCT01517984|81659220|FG003|Overall Study|Screen Failure|0|||
27952567|NCT01517984|81659217|FG000|Overall Study|Ineligible for randomization|0|||
27952568|NCT01517984|81659218|FG001|Overall Study|Ineligible for randomization|14|||
27952569|NCT01517984|81659219|FG002|Overall Study|Ineligible for randomization|0|||
27952570|NCT01517984|81659220|FG003|Overall Study|Ineligible for randomization|0|||
27952571|NCT03218917|81659225|FG000|Overall Study|Adverse Event|3|||
27952572|NCT03218917|81659226|FG001|Overall Study|Adverse Event|3|||
27952573|NCT03218917|81659227|FG002|Overall Study|Adverse Event|2|||
27952574|NCT03218917|81659225|FG000|Overall Study|Subject withdrew consent|2|||
27952575|NCT03218917|81659226|FG001|Overall Study|Subject withdrew consent|4|||
27952576|NCT03218917|81659227|FG002|Overall Study|Subject withdrew consent|10|||
27952577|NCT03218917|81659225|FG000|Overall Study|Physician Decision|0|||
27952578|NCT03218917|81659226|FG001|Overall Study|Physician Decision|1|||
27952579|NCT03218917|81659227|FG002|Overall Study|Physician Decision|1|||
27952580|NCT03218917|81659225|FG000|Overall Study|Lost to Follow-up|1|||
27952581|NCT03218917|81659226|FG001|Overall Study|Lost to Follow-up|0|||
27952582|NCT03218917|81659227|FG002|Overall Study|Lost to Follow-up|0|||
27952583|NCT03218917|81659225|FG000|Overall Study|Reason Missing|0|||
27952584|NCT03218917|81659226|FG001|Overall Study|Reason Missing|2|||
27952585|NCT03218917|81659227|FG002|Overall Study|Reason Missing|0|||
27952586|NCT03218917|81659225|FG000|Overall Study|Death|0|||
27952587|NCT03218917|81659226|FG001|Overall Study|Death|1|||
27952588|NCT03218917|81659227|FG002|Overall Study|Death|0|||
27952589|NCT03218917|81659225|FG000|Overall Study|Non-Compliance with Study Drug|0|||
27952590|NCT03218917|81659226|FG001|Overall Study|Non-Compliance with Study Drug|1|||
27952591|NCT03218917|81659227|FG002|Overall Study|Non-Compliance with Study Drug|0|||
27952592|NCT01242514|81659230|FG000|Overall Study|e.g., project closure|1042|||
27952593|NCT01242514|81659231|FG001|Overall Study|e.g., project closure|305|||
27952594|NCT01242514|81659232|FG002|Overall Study|e.g., project closure|171|||
27952595|NCT01242514|81659230|FG000|Overall Study|Subject decision|33|||
27952596|NCT01242514|81659231|FG001|Overall Study|Subject decision|8|||
27952597|NCT01242514|81659232|FG002|Overall Study|Subject decision|2|||
27952598|NCT01242514|81659230|FG000|Overall Study|Severe non-compliance to protocol|5|||
27952599|NCT01242514|81659231|FG001|Overall Study|Severe non-compliance to protocol|2|||
27952600|NCT01242514|81659232|FG002|Overall Study|Severe non-compliance to protocol|1|||
27952601|NCT01242514|81659230|FG000|Overall Study|Lack of therapeutic response|99|||
27952602|NCT01242514|81659231|FG001|Overall Study|Lack of therapeutic response|16|||
27952603|NCT01242514|81659232|FG002|Overall Study|Lack of therapeutic response|10|||
27952604|NCT01242514|81659230|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
27952605|NCT01242514|81659231|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
27952606|NCT01242514|81659232|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
27952607|NCT01242514|81659230|FG000|Overall Study|Lost to Follow-up|14|||
27952608|NCT01242514|81659231|FG001|Overall Study|Lost to Follow-up|5|||
27952609|NCT01242514|81659232|FG002|Overall Study|Lost to Follow-up|4|||
27952610|NCT01242514|81659230|FG000|Overall Study|Adverse Event|129|||
27952611|NCT01242514|81659231|FG001|Overall Study|Adverse Event|18|||
27952612|NCT01242514|81659232|FG002|Overall Study|Adverse Event|19|||
27952613|NCT01959529|81659239|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
27952614|NCT01959529|81659240|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
27952615|NCT01959529|81659239|FG000|Overall Study|Lost to Follow-up|4|||
27952616|NCT01959529|81659240|FG001|Overall Study|Lost to Follow-up|1|||
27952617|NCT01959529|81659239|FG000|Overall Study|Other|70|||
27952618|NCT01959529|81659240|FG001|Overall Study|Other|68|||
27952619|NCT01959529|81659239|FG000|Overall Study|Hypoglycaemia|1|||
27952620|NCT01959529|81659240|FG001|Overall Study|Hypoglycaemia|1|||
27952621|NCT01959529|81659239|FG000|Overall Study|Lack of glycaemic control|1|||
27952622|NCT01959529|81659240|FG001|Overall Study|Lack of glycaemic control|1|||
27952623|NCT01464879|81659241|FG000|Overall Study|Physician Decision|1|||
27952624|NCT01464879|81659241|FG000|Overall Study|Non-compliance|1|||
27952625|NCT01905540|81659242|FG000|Period 3|Other|1|||
27952626|NCT01905540|81659243|FG001|Period 3|Other|0|||
27952627|NCT01905540|81659244|FG002|Period 3|Other|1|||
27952628|NCT01905540|81659245|FG003|Period 3|Other|1|||
27952629|NCT02254291|81659248|FG000|Overall Study|Withdrawal by Subject|0|||
27952630|NCT02254291|81659249|FG001|Overall Study|Withdrawal by Subject|3|||
27952631|NCT02254291|81659250|FG002|Overall Study|Withdrawal by Subject|1|||
27952632|NCT02254291|81659248|FG000|Overall Study|Missing follow-up information|0|||
27952633|NCT02254291|81659249|FG001|Overall Study|Missing follow-up information|0|||
27952634|NCT02254291|81659250|FG002|Overall Study|Missing follow-up information|1|||
27952635|NCT04108273|81659251|FG000|Overall Study|COVID Pandemic|1|||
27651055|NCT02372799|80564541|FG000|Treatment Period|Protocol Violation|3|||
27952636|NCT04108273|81659252|FG001|Overall Study|COVID Pandemic|0|||
27959309|NCT02131662|81683270|FG001|Overall Study|Pregnancy|1|||
27952637|NCT02170064|81659253|FG000|Overall Study|Withdrawal by Subject|5|||
27952638|NCT02170064|81659254|FG001|Overall Study|Withdrawal by Subject|1|||
27952639|NCT02170064|81659255|FG002|Overall Study|Withdrawal by Subject|1|||
27952640|NCT02170064|81659253|FG000|Overall Study|Physician Decision|1|||
27952641|NCT02170064|81659254|FG001|Overall Study|Physician Decision|1|||
27952642|NCT02170064|81659255|FG002|Overall Study|Physician Decision|0|||
27952643|NCT00237042|81659256|FG000|Treatment|Became ineligible post-randomization|0|||
27952644|NCT00237042|81659257|FG001|Treatment|Became ineligible post-randomization|1|||
27952645|NCT00237042|81659258|FG002|Treatment|Became ineligible post-randomization|16|||
27952646|NCT00237042|81659256|FG000|Treatment|Moved out of state|1|||
27952647|NCT00237042|81659257|FG001|Treatment|Moved out of state|1|||
27952648|NCT00237042|81659258|FG002|Treatment|Moved out of state|1|||
27952649|NCT00237042|81659256|FG000|Treatment|Completed no treatment|5|||
27952650|NCT00237042|81659257|FG001|Treatment|Completed no treatment|5|||
27952651|NCT00237042|81659258|FG002|Treatment|Completed no treatment|21|||
27952652|NCT00237042|81659256|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
27952653|NCT00237042|81659257|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
27952654|NCT00237042|81659258|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
27952655|NCT00237042|81659256|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
27952656|NCT00237042|81659257|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
27952657|NCT00237042|81659258|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
27952658|NCT02951780|81659259|FG000|Period 1|Adverse Event|0|||
27952659|NCT02951780|81659260|FG001|Period 1|Adverse Event|0|||
27952660|NCT02951780|81659261|FG002|Period 1|Adverse Event|0|||
27952661|NCT02951780|81659262|FG003|Period 1|Adverse Event|1|||
27952662|NCT02951780|81659263|FG004|Period 1|Adverse Event|0|||
27952663|NCT02951780|81659264|FG005|Period 1|Adverse Event|0|||
27952664|NCT02951780|81659265|FG006|Period 1|Adverse Event|0|||
27952665|NCT02951780|81659266|FG007|Period 1|Adverse Event|0|||
27952666|NCT02951780|81659267|FG008|Period 1|Adverse Event|0|||
27952667|NCT02951780|81659259|FG000|Period 1|Scheduling Conflicts|0|||
27952668|NCT02951780|81659260|FG001|Period 1|Scheduling Conflicts|0|||
27952669|NCT02951780|81659261|FG002|Period 1|Scheduling Conflicts|0|||
27952670|NCT02951780|81659262|FG003|Period 1|Scheduling Conflicts|0|||
27952671|NCT02951780|81659263|FG004|Period 1|Scheduling Conflicts|0|||
27952672|NCT02951780|81659264|FG005|Period 1|Scheduling Conflicts|0|||
27952673|NCT02951780|81659265|FG006|Period 1|Scheduling Conflicts|0|||
27952674|NCT02951780|81659266|FG007|Period 1|Scheduling Conflicts|1|||
27952675|NCT02951780|81659267|FG008|Period 1|Scheduling Conflicts|0|||
27952676|NCT02951780|81659259|FG000|Period 2|Scheduling Conflicts|0|||
27952677|NCT02951780|81659260|FG001|Period 2|Scheduling Conflicts|0|||
27952678|NCT02951780|81659261|FG002|Period 2|Scheduling Conflicts|0|||
27952679|NCT02951780|81659262|FG003|Period 2|Scheduling Conflicts|0|||
27952680|NCT02951780|81659263|FG004|Period 2|Scheduling Conflicts|0|||
27952681|NCT02951780|81659264|FG005|Period 2|Scheduling Conflicts|0|||
27952682|NCT02951780|81659265|FG006|Period 2|Scheduling Conflicts|0|||
27952683|NCT02951780|81659266|FG007|Period 2|Scheduling Conflicts|1|||
27952684|NCT02951780|81659267|FG008|Period 2|Scheduling Conflicts|0|||
27952685|NCT03435380|81659270|FG000|Overall Study|Death|1|||
27952686|NCT03435380|81659271|FG001|Overall Study|Death|2|||
27952687|NCT03435380|81659272|FG002|Overall Study|Death|1|||
27952688|NCT03435380|81659270|FG000|Overall Study|Lost to Follow-up|12|||
27952689|NCT03435380|81659271|FG001|Overall Study|Lost to Follow-up|8|||
27952690|NCT03435380|81659272|FG002|Overall Study|Lost to Follow-up|6|||
27952691|NCT03435380|81659270|FG000|Overall Study|Physician Decision|1|||
27952692|NCT03435380|81659271|FG001|Overall Study|Physician Decision|0|||
27952693|NCT03435380|81659272|FG002|Overall Study|Physician Decision|0|||
27952694|NCT03435380|81659270|FG000|Overall Study|Withdrawal by Subject|0|||
27952695|NCT03435380|81659271|FG001|Overall Study|Withdrawal by Subject|1|||
27952696|NCT03435380|81659272|FG002|Overall Study|Withdrawal by Subject|1|||
27952697|NCT03435380|81659270|FG000|Overall Study|Ineligible|0|||
27952698|NCT03435380|81659271|FG001|Overall Study|Ineligible|1|||
27952699|NCT03435380|81659272|FG002|Overall Study|Ineligible|1|||
27952700|NCT00688597|81659273|FG000|Overall Study|Adverse Event|2|||
27952701|NCT00688597|81659274|FG001|Overall Study|Adverse Event|0|||
27952702|NCT00688597|81659275|FG002|Overall Study|Adverse Event|0|||
27952703|NCT00688597|81659273|FG000|Overall Study|Physician Decision|1|||
27952704|NCT00688597|81659274|FG001|Overall Study|Physician Decision|0|||
27952705|NCT00688597|81659275|FG002|Overall Study|Physician Decision|0|||
27952706|NCT01854528|81659277|FG000|Overall Study|Adverse Event|0|||
27952707|NCT01854528|81659278|FG001|Overall Study|Adverse Event|4|||
27952708|NCT01854528|81659277|FG000|Overall Study|Withdrawal by Subject|0|||
27952709|NCT01854528|81659278|FG001|Overall Study|Withdrawal by Subject|2|||
27952710|NCT01854528|81659277|FG000|Overall Study|Virologic Failure|0|||
27952711|NCT01854528|81659278|FG001|Overall Study|Virologic Failure|9|||
27952712|NCT03545672|81662340|FG000|Overall Study|Uncertain diagnosis|2|||
27952713|NCT03545672|81662341|FG001|Overall Study|Uncertain diagnosis|1|||
27952714|NCT03545672|81662340|FG000|Overall Study|Protocol Violation|2|||
27952715|NCT03545672|81662341|FG001|Overall Study|Protocol Violation|2|||
27952716|NCT01425814|81662346|FG000|Period 1|Stability criteria not fulfilled|0|||
27952717|NCT01425814|81662347|FG001|Period 1|Stability criteria not fulfilled|1|||
27952718|NCT01425814|81662348|FG002|Period 1|Stability criteria not fulfilled|0|||
27952719|NCT01425814|81662349|FG003|Period 1|Stability criteria not fulfilled|0|||
27952720|NCT01425814|81662350|FG004|Period 1|Stability criteria not fulfilled|0|||
27952721|NCT01425814|81662351|FG005|Period 1|Stability criteria not fulfilled|0|||
27952722|NCT01425814|81662346|FG000|Period 2|Stability criteria not fulfilled|0|||
27952723|NCT01425814|81662347|FG001|Period 2|Stability criteria not fulfilled|1|||
27952724|NCT01425814|81662348|FG002|Period 2|Stability criteria not fulfilled|0|||
27952725|NCT01425814|81662349|FG003|Period 2|Stability criteria not fulfilled|0|||
27952726|NCT01425814|81662350|FG004|Period 2|Stability criteria not fulfilled|0|||
27952727|NCT01425814|81662351|FG005|Period 2|Stability criteria not fulfilled|0|||
27952728|NCT01425814|81662346|FG000|Period 3|Adverse Event|0|||
27952729|NCT01425814|81662347|FG001|Period 3|Adverse Event|0|||
27952730|NCT01425814|81662348|FG002|Period 3|Adverse Event|0|||
27952731|NCT01425814|81662349|FG003|Period 3|Adverse Event|0|||
27952732|NCT01425814|81662350|FG004|Period 3|Adverse Event|0|||
27952733|NCT01425814|81662351|FG005|Period 3|Adverse Event|1|||
27952734|NCT01425814|81662346|FG000|Period 4|Adverse Event|1|||
27952735|NCT01425814|81662347|FG001|Period 4|Adverse Event|0|||
27952736|NCT01425814|81662348|FG002|Period 4|Adverse Event|1|||
27952737|NCT01425814|81662349|FG003|Period 4|Adverse Event|0|||
27952738|NCT01425814|81662350|FG004|Period 4|Adverse Event|0|||
27952739|NCT01425814|81662351|FG005|Period 4|Adverse Event|0|||
27952740|NCT01425814|81662346|FG000|Period 5|Stability criteria not fulfilled|0|||
27952741|NCT01425814|81662347|FG001|Period 5|Stability criteria not fulfilled|0|||
27952742|NCT01425814|81662348|FG002|Period 5|Stability criteria not fulfilled|1|||
27651056|NCT02372799|80564542|FG001|Treatment Period|Protocol Violation|0|||
27651057|NCT02372799|80564543|FG002|Treatment Period|Protocol Violation|0|||
27651058|NCT02372799|80564541|FG000|Treatment Period|Non-compliance with study drug|4|||
27651059|NCT02372799|80564542|FG001|Treatment Period|Non-compliance with study drug|4|||
27651060|NCT02372799|80564543|FG002|Treatment Period|Non-compliance with study drug|4|||
27651061|NCT02372799|80564541|FG000|Treatment Period|Miscellaneous Reasons|1|||
27651062|NCT02372799|80564542|FG001|Treatment Period|Miscellaneous Reasons|1|||
27651063|NCT02372799|80564543|FG002|Treatment Period|Miscellaneous Reasons|0|||
27651064|NCT02372799|80564541|FG000|Down-taper Period|Lost to Follow-up|1|||
27651065|NCT02372799|80564542|FG001|Down-taper Period|Lost to Follow-up|2|||
27651066|NCT02372799|80564543|FG002|Down-taper Period|Lost to Follow-up|2|||
27952743|NCT01425814|81662349|FG003|Period 5|Stability criteria not fulfilled|0|||
27952744|NCT01425814|81662350|FG004|Period 5|Stability criteria not fulfilled|0|||
27952745|NCT01425814|81662351|FG005|Period 5|Stability criteria not fulfilled|1|||
27952746|NCT00077974|81662355|FG000|Overall Study|Adverse Event|22|||
27952747|NCT00077974|81662355|FG000|Overall Study|Protocol Violation|1|||
27952748|NCT00077974|81662355|FG000|Overall Study|Withdrawal by Subject|3|||
27952749|NCT00077974|81662355|FG000|Overall Study|Lack of Efficacy|76|||
27952750|NCT00077974|81662355|FG000|Overall Study|Decision of Sponsor|2|||
27952751|NCT00904371|81662356|FG000|Overall Study|Adverse Event|2|||
27952752|NCT00904371|81662356|FG000|Overall Study|Lost to Follow-up|4|||
27952753|NCT00904371|81662356|FG000|Overall Study|Discontinued at target blood pressure|2|||
27952754|NCT00904371|81662356|FG000|Overall Study|Continued with Tritace|1|||
27952755|NCT01627691|81662360|FG000|Overall Study|Death|11|||
27952756|NCT01627691|81662360|FG000|Overall Study|Lost to Follow-up|3|||
27952757|NCT01627691|81662360|FG000|Overall Study|Withdrawal by Subject|1|||
27952758|NCT01627691|81662360|FG000|Overall Study|Missed the visit|3|||
27952759|NCT00325143|81662362|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
27952760|NCT00325143|81662362|FG000|Overall Study|Migrated/moved from study area|1|||
27952761|NCT00325143|81662362|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
27952762|NCT00325143|81662362|FG000|Overall Study|Withdrawal by Subject|8|||
27952763|NCT00508482|81662364|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
27952764|NCT00508482|81662365|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
27952765|NCT00508482|81662366|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
27952766|NCT00508482|81662364|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
27952767|NCT00508482|81662365|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
27952768|NCT00508482|81662366|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
27952769|NCT00508482|81662364|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
27952770|NCT00508482|81662365|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
27952771|NCT00508482|81662366|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
27952772|NCT03937479|81662367|FG000|Overall Study|Adverse Event|2|||
27952773|NCT03937479|81662368|FG001|Overall Study|Adverse Event|3|||
27952774|NCT03937479|81662369|FG002|Overall Study|Adverse Event|0|||
27952775|NCT03937479|81662370|FG003|Overall Study|Adverse Event|0|||
27952776|NCT03937479|81662371|FG004|Overall Study|Adverse Event|1|||
27952777|NCT03937479|81662367|FG000|Overall Study|Withdrawal by Subject|3|||
27952778|NCT03937479|81662368|FG001|Overall Study|Withdrawal by Subject|5|||
27952779|NCT03937479|81662369|FG002|Overall Study|Withdrawal by Subject|2|||
27651067|NCT03456856|80564544|FG000|Overall Study|Lost to Follow-up|2|||
27651068|NCT03456856|80564544|FG000|Overall Study|Withdrawal by Subject|1|||
27952780|NCT03937479|81662370|FG003|Overall Study|Withdrawal by Subject|2|||
27952781|NCT03937479|81662371|FG004|Overall Study|Withdrawal by Subject|1|||
27952782|NCT03937479|81662367|FG000|Overall Study|Protocol Violation|5|||
27952783|NCT03937479|81662368|FG001|Overall Study|Protocol Violation|6|||
27952784|NCT03937479|81662369|FG002|Overall Study|Protocol Violation|4|||
27952785|NCT03937479|81662370|FG003|Overall Study|Protocol Violation|3|||
27952786|NCT03937479|81662371|FG004|Overall Study|Protocol Violation|2|||
27952787|NCT03937479|81662367|FG000|Overall Study|Lost to Follow-up|0|||
27952788|NCT03937479|81662368|FG001|Overall Study|Lost to Follow-up|1|||
27952789|NCT03937479|81662369|FG002|Overall Study|Lost to Follow-up|0|||
27952790|NCT03937479|81662370|FG003|Overall Study|Lost to Follow-up|1|||
27952791|NCT03937479|81662371|FG004|Overall Study|Lost to Follow-up|0|||
27952792|NCT03937479|81662367|FG000|Overall Study|Physician Decision|0|||
27952793|NCT03937479|81662368|FG001|Overall Study|Physician Decision|0|||
27952794|NCT03937479|81662369|FG002|Overall Study|Physician Decision|1|||
27952795|NCT03937479|81662370|FG003|Overall Study|Physician Decision|0|||
27952796|NCT03937479|81662371|FG004|Overall Study|Physician Decision|1|||
27952797|NCT00256126|81662375|FG000|Overall Study|Adverse Event|1|||
27952798|NCT00256126|81662376|FG001|Overall Study|Adverse Event|0|||
27952799|NCT00256126|81662375|FG000|Overall Study|Other|1|||
27952800|NCT00256126|81662376|FG001|Overall Study|Other|2|||
27952801|NCT04409834|81662380|FG000|Overall Study|Death|55|||
27952802|NCT04409834|81662381|FG001|Overall Study|Death|62|||
27952803|NCT02750514|81662384|FG000|Track 1|Disease progression|20|||
27952804|NCT02750514|81662385|FG001|Track 1|Disease progression|1|||
27952805|NCT02750514|81662386|FG002|Track 1|Disease progression|0|||
27952806|NCT02750514|81662387|FG003|Track 1|Disease progression|1|||
27952807|NCT02750514|81662388|FG004|Track 1|Disease progression|0|||
27952808|NCT02750514|81662384|FG000|Track 1|Adverse event unrelated to study drug|1|||
27952809|NCT02750514|81662385|FG001|Track 1|Adverse event unrelated to study drug|0|||
27952810|NCT02750514|81662386|FG002|Track 1|Adverse event unrelated to study drug|0|||
27952811|NCT02750514|81662387|FG003|Track 1|Adverse event unrelated to study drug|0|||
27952812|NCT02750514|81662388|FG004|Track 1|Adverse event unrelated to study drug|0|||
27952813|NCT02750514|81662384|FG000|Track 1|Study drug toxicity|4|||
27952814|NCT02750514|81662385|FG001|Track 1|Study drug toxicity|1|||
27952815|NCT02750514|81662386|FG002|Track 1|Study drug toxicity|0|||
27952816|NCT02750514|81662387|FG003|Track 1|Study drug toxicity|1|||
27952817|NCT02750514|81662388|FG004|Track 1|Study drug toxicity|0|||
27952818|NCT02750514|81662384|FG000|Track 1|Participant request to discontinue|1|||
27952819|NCT02750514|81662385|FG001|Track 1|Participant request to discontinue|0|||
27952820|NCT02750514|81662386|FG002|Track 1|Participant request to discontinue|0|||
27952821|NCT02750514|81662387|FG003|Track 1|Participant request to discontinue|0|||
27952822|NCT02750514|81662388|FG004|Track 1|Participant request to discontinue|0|||
27952823|NCT02750514|81662384|FG000|Track 1|Other reasons|1|||
27952824|NCT02750514|81662385|FG001|Track 1|Other reasons|0|||
27952825|NCT02750514|81662386|FG002|Track 1|Other reasons|0|||
27952826|NCT02750514|81662387|FG003|Track 1|Other reasons|0|||
27952827|NCT02750514|81662388|FG004|Track 1|Other reasons|0|||
27952828|NCT02750514|81662384|FG000|Track 2|Disease progression|4|||
27952829|NCT02750514|81662385|FG001|Track 2|Disease progression|5|||
27952830|NCT02750514|81662386|FG002|Track 2|Disease progression|2|||
27952831|NCT02750514|81662387|FG003|Track 2|Disease progression|5|||
27952832|NCT02750514|81662388|FG004|Track 2|Disease progression|0|||
27952833|NCT02750514|81662384|FG000|Track 2|Adverse event unrelated to study drug|1|||
27952834|NCT02750514|81662385|FG001|Track 2|Adverse event unrelated to study drug|0|||
27952835|NCT02750514|81662386|FG002|Track 2|Adverse event unrelated to study drug|0|||
27952836|NCT02750514|81662387|FG003|Track 2|Adverse event unrelated to study drug|0|||
27952837|NCT02750514|81662388|FG004|Track 2|Adverse event unrelated to study drug|0|||
27952838|NCT02750514|81662384|FG000|Track 2|Study drug toxicity|1|||
27952839|NCT02750514|81662385|FG001|Track 2|Study drug toxicity|2|||
27952840|NCT02750514|81662386|FG002|Track 2|Study drug toxicity|0|||
27952841|NCT02750514|81662387|FG003|Track 2|Study drug toxicity|2|||
27952842|NCT02750514|81662388|FG004|Track 2|Study drug toxicity|0|||
27952843|NCT02750514|81662384|FG000|Track 2|Participant withdrew consent|0|||
27952844|NCT02750514|81662385|FG001|Track 2|Participant withdrew consent|1|||
27952845|NCT02750514|81662386|FG002|Track 2|Participant withdrew consent|0|||
27952846|NCT02750514|81662387|FG003|Track 2|Participant withdrew consent|0|||
27952847|NCT02750514|81662388|FG004|Track 2|Participant withdrew consent|0|||
27952848|NCT02750514|81662384|FG000|Track 3|Disease progression|0|||
27952849|NCT02750514|81662385|FG001|Track 3|Disease progression|24|||
27952850|NCT02750514|81662386|FG002|Track 3|Disease progression|13|||
27952851|NCT02750514|81662387|FG003|Track 3|Disease progression|14|||
27952852|NCT02750514|81662388|FG004|Track 3|Disease progression|0|||
27952853|NCT02750514|81662384|FG000|Track 3|Adverse event unrelated to study drug|0|||
27952854|NCT02750514|81662385|FG001|Track 3|Adverse event unrelated to study drug|1|||
27952855|NCT02750514|81662386|FG002|Track 3|Adverse event unrelated to study drug|1|||
27952856|NCT02750514|81662387|FG003|Track 3|Adverse event unrelated to study drug|1|||
27952857|NCT02750514|81662388|FG004|Track 3|Adverse event unrelated to study drug|0|||
27952858|NCT02750514|81662384|FG000|Track 3|Study drug toxicity|0|||
27952859|NCT02750514|81662385|FG001|Track 3|Study drug toxicity|3|||
27952860|NCT02750514|81662386|FG002|Track 3|Study drug toxicity|0|||
27952861|NCT02750514|81662387|FG003|Track 3|Study drug toxicity|1|||
27952862|NCT02750514|81662388|FG004|Track 3|Study drug toxicity|0|||
27952863|NCT02750514|81662384|FG000|Track 3|Participant request to discontinue|0|||
27952864|NCT02750514|81662385|FG001|Track 3|Participant request to discontinue|2|||
27952865|NCT02750514|81662386|FG002|Track 3|Participant request to discontinue|0|||
27952866|NCT02750514|81662387|FG003|Track 3|Participant request to discontinue|0|||
27952867|NCT02750514|81662388|FG004|Track 3|Participant request to discontinue|0|||
27952868|NCT02750514|81662384|FG000|Track 3|Participant withdrew consent|0|||
27952869|NCT02750514|81662385|FG001|Track 3|Participant withdrew consent|3|||
27952870|NCT02750514|81662386|FG002|Track 3|Participant withdrew consent|1|||
27952871|NCT02750514|81662387|FG003|Track 3|Participant withdrew consent|0|||
27952872|NCT02750514|81662388|FG004|Track 3|Participant withdrew consent|0|||
27952873|NCT02750514|81662384|FG000|Track 3|Other reasons|0|||
27952874|NCT02750514|81662385|FG001|Track 3|Other reasons|3|||
27952875|NCT02750514|81662386|FG002|Track 3|Other reasons|0|||
27952876|NCT02750514|81662387|FG003|Track 3|Other reasons|0|||
27952877|NCT02750514|81662388|FG004|Track 3|Other reasons|0|||
27952878|NCT02750514|81662384|FG000|Track 4|Study drug toxicity|0|||
27952879|NCT02750514|81662385|FG001|Track 4|Study drug toxicity|6|||
27952880|NCT02750514|81662386|FG002|Track 4|Study drug toxicity|0|||
27952881|NCT02750514|81662387|FG003|Track 4|Study drug toxicity|5|||
27952882|NCT02750514|81662388|FG004|Track 4|Study drug toxicity|0|||
27952883|NCT02750514|81662384|FG000|Track 4|Participant request to discontinue|0|||
27952884|NCT02750514|81662385|FG001|Track 4|Participant request to discontinue|1|||
27952885|NCT02750514|81662386|FG002|Track 4|Participant request to discontinue|0|||
27952886|NCT02750514|81662387|FG003|Track 4|Participant request to discontinue|1|||
27952887|NCT02750514|81662388|FG004|Track 4|Participant request to discontinue|0|||
27952888|NCT02750514|81662384|FG000|Track 4|Participant withdrew consent|0|||
27952889|NCT02750514|81662385|FG001|Track 4|Participant withdrew consent|1|||
27952890|NCT02750514|81662386|FG002|Track 4|Participant withdrew consent|0|||
27952891|NCT02750514|81662387|FG003|Track 4|Participant withdrew consent|0|||
27952892|NCT02750514|81662388|FG004|Track 4|Participant withdrew consent|0|||
27952893|NCT02750514|81662384|FG000|Track 4|Other reasons|0|||
27952894|NCT02750514|81662385|FG001|Track 4|Other reasons|5|||
27952895|NCT02750514|81662386|FG002|Track 4|Other reasons|0|||
27952896|NCT02750514|81662387|FG003|Track 4|Other reasons|3|||
27952897|NCT02750514|81662388|FG004|Track 4|Other reasons|0|||
27952898|NCT02750514|81662384|FG000|Track 4|Disease progression|0|||
27952899|NCT02750514|81662385|FG001|Track 4|Disease progression|33|||
27952900|NCT02750514|81662386|FG002|Track 4|Disease progression|0|||
27952901|NCT02750514|81662387|FG003|Track 4|Disease progression|32|||
27952902|NCT02750514|81662388|FG004|Track 4|Disease progression|0|||
27952903|NCT02750514|81662384|FG000|Track 4|Adverse event unrelated to study drug|0|||
27952904|NCT02750514|81662385|FG001|Track 4|Adverse event unrelated to study drug|5|||
27952905|NCT02750514|81662386|FG002|Track 4|Adverse event unrelated to study drug|0|||
27952906|NCT02750514|81662387|FG003|Track 4|Adverse event unrelated to study drug|0|||
27952907|NCT02750514|81662388|FG004|Track 4|Adverse event unrelated to study drug|0|||
27952908|NCT02750514|81662384|FG000|Track 4|Death|0|||
27952909|NCT02750514|81662385|FG001|Track 4|Death|0|||
27952910|NCT02750514|81662386|FG002|Track 4|Death|0|||
27952911|NCT02750514|81662387|FG003|Track 4|Death|1|||
27952912|NCT02750514|81662388|FG004|Track 4|Death|0|||
27952913|NCT02750514|81662384|FG000|Track 5|Disease progression|0|||
27952914|NCT02750514|81662385|FG001|Track 5|Disease progression|0|||
27952915|NCT02750514|81662386|FG002|Track 5|Disease progression|0|||
27952916|NCT02750514|81662387|FG003|Track 5|Disease progression|0|||
27952917|NCT02750514|81662388|FG004|Track 5|Disease progression|34|||
27952918|NCT02750514|81662384|FG000|Track 5|Adverse event unrelated to study drug|0|||
27952919|NCT02750514|81662385|FG001|Track 5|Adverse event unrelated to study drug|0|||
27952920|NCT02750514|81662386|FG002|Track 5|Adverse event unrelated to study drug|0|||
27952921|NCT02750514|81662387|FG003|Track 5|Adverse event unrelated to study drug|0|||
27952922|NCT02750514|81662388|FG004|Track 5|Adverse event unrelated to study drug|2|||
27952923|NCT02750514|81662384|FG000|Track 5|Study drug toxicity|0|||
27651069|NCT01706159|80564545|FG000|Overall Study|Withdrawal Criteria|2|||
27651070|NCT01706159|80564546|FG001|Overall Study|Withdrawal Criteria|1|||
27651071|NCT01706159|80564545|FG000|Overall Study|Unclassified|6|||
27952924|NCT02750514|81662385|FG001|Track 5|Study drug toxicity|0|||
27952925|NCT02750514|81662386|FG002|Track 5|Study drug toxicity|0|||
27952926|NCT02750514|81662387|FG003|Track 5|Study drug toxicity|0|||
27952927|NCT02750514|81662388|FG004|Track 5|Study drug toxicity|2|||
27952928|NCT02750514|81662384|FG000|Track 5|Participant request to discontinue|0|||
27952929|NCT02750514|81662385|FG001|Track 5|Participant request to discontinue|0|||
27952930|NCT02750514|81662386|FG002|Track 5|Participant request to discontinue|0|||
27952931|NCT02750514|81662387|FG003|Track 5|Participant request to discontinue|0|||
27651072|NCT01706159|80564546|FG001|Overall Study|Unclassified|1|||
27952932|NCT02750514|81662388|FG004|Track 5|Participant request to discontinue|3|||
27952933|NCT02750514|81662384|FG000|Track 5|Other reasons|0|||
27952934|NCT02750514|81662385|FG001|Track 5|Other reasons|0|||
27952935|NCT02750514|81662386|FG002|Track 5|Other reasons|0|||
27952936|NCT02750514|81662387|FG003|Track 5|Other reasons|0|||
27952937|NCT02750514|81662388|FG004|Track 5|Other reasons|2|||
27952938|NCT03507127|81662389|FG000|Overall Study|Withdrawal by Subject|1|||
27952939|NCT03507127|81662390|FG001|Overall Study|Withdrawal by Subject|0|||
27952940|NCT03507127|81662389|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
27952941|NCT03507127|81662390|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
27952942|NCT01171677|81662391|FG000|Overall Study|Withdrawal by Subject|0|||
27952943|NCT01171677|81662392|FG001|Overall Study|Withdrawal by Subject|3|||
27952944|NCT01171677|81662391|FG000|Overall Study|Adverse Event|1|||
27952945|NCT01171677|81662392|FG001|Overall Study|Adverse Event|0|||
27952946|NCT01171677|81662391|FG000|Overall Study|completed <70% IntenSati classes|5|||
27952947|NCT01171677|81662392|FG001|Overall Study|completed <70% IntenSati classes|0|||
27952948|NCT00943761|81662393|FG000|Overall Study|Lost to Follow-up|2|||
27952949|NCT00943761|81662394|FG001|Overall Study|Lost to Follow-up|0|||
27952950|NCT00943761|81662393|FG000|Overall Study|Withdrawal by Subject|2|||
27952951|NCT00943761|81662394|FG001|Overall Study|Withdrawal by Subject|1|||
27952952|NCT00590967|81662397|FG000|Overall Study|Withdrawal by Subject|1|||
27952953|NCT00590967|81662398|FG001|Overall Study|Withdrawal by Subject|1|||
27952954|NCT00590967|81662397|FG000|Overall Study|Ineligible|1|||
27952955|NCT00590967|81662398|FG001|Overall Study|Ineligible|0|||
27952956|NCT00590967|81662397|FG000|Overall Study|Poor performance status|0|||
27952957|NCT00590967|81662398|FG001|Overall Study|Poor performance status|1|||
27952958|NCT00590967|81662397|FG000|Overall Study|Non-compliant|0|||
27952959|NCT00590967|81662398|FG001|Overall Study|Non-compliant|2|||
27952960|NCT00590967|81662397|FG000|Overall Study|Did not sign consent form|0|||
27952961|NCT00590967|81662398|FG001|Overall Study|Did not sign consent form|1|||
27952962|NCT00590967|81662397|FG000|Overall Study|Did not receive chemo per protocol|1|||
27952963|NCT00590967|81662398|FG001|Overall Study|Did not receive chemo per protocol|0|||
27952964|NCT00370292|81662401|FG000|Overall Study|Disease Progression|4|||
27952965|NCT00370292|81662401|FG000|Overall Study|Adverse Event|7|||
27952966|NCT00370292|81662401|FG000|Overall Study|Physician Decision|2|||
27952967|NCT01193101|81662402|FG000|Overall Study|Adverse Event|0|||
27952968|NCT01193101|81662403|FG001|Overall Study|Adverse Event|1|||
27952969|NCT01193101|81662404|FG002|Overall Study|Adverse Event|1|||
27952970|NCT01193101|81662405|FG003|Overall Study|Adverse Event|3|||
27952971|NCT01193101|81662402|FG000|Overall Study|Lack of Efficacy|3|||
27952972|NCT01193101|81662403|FG001|Overall Study|Lack of Efficacy|1|||
27952973|NCT01193101|81662404|FG002|Overall Study|Lack of Efficacy|0|||
27952974|NCT01193101|81662405|FG003|Overall Study|Lack of Efficacy|8|||
27952975|NCT01193101|81662402|FG000|Overall Study|Withdrawal by Subject|2|||
27952976|NCT01193101|81662403|FG001|Overall Study|Withdrawal by Subject|4|||
27952977|NCT01193101|81662404|FG002|Overall Study|Withdrawal by Subject|1|||
27952978|NCT01193101|81662405|FG003|Overall Study|Withdrawal by Subject|1|||
27952979|NCT01193101|81662402|FG000|Overall Study|Administrative problems|0|||
27952980|NCT01193101|81662403|FG001|Overall Study|Administrative problems|0|||
27952981|NCT01193101|81662404|FG002|Overall Study|Administrative problems|1|||
27952982|NCT01193101|81662405|FG003|Overall Study|Administrative problems|0|||
27952983|NCT01193101|81662402|FG000|Overall Study|Abnormal test procedure results|0|||
27952984|NCT01193101|81662403|FG001|Overall Study|Abnormal test procedure results|1|||
27952985|NCT01193101|81662404|FG002|Overall Study|Abnormal test procedure results|0|||
27952986|NCT01193101|81662405|FG003|Overall Study|Abnormal test procedure results|0|||
27952987|NCT02569853|81662408|FG000|Overall Study|Adverse Event|2|||
27952988|NCT02569853|81662409|FG001|Overall Study|Adverse Event|0|||
27952989|NCT02569853|81662408|FG000|Overall Study|Withdrawal by Subject|3|||
27952990|NCT02569853|81662409|FG001|Overall Study|Withdrawal by Subject|2|||
27952991|NCT02569853|81662408|FG000|Overall Study|Lost to Follow-up|3|||
27952992|NCT02569853|81662409|FG001|Overall Study|Lost to Follow-up|3|||
27750047|NCT05118386|80909737|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
27952993|NCT02569853|81662408|FG000|Overall Study|Protocol Violation|1|||
27952994|NCT02569853|81662409|FG001|Overall Study|Protocol Violation|1|||
27952995|NCT02569853|81662408|FG000|Overall Study|Did not experience migraine attack|10|||
27952996|NCT02569853|81662409|FG001|Overall Study|Did not experience migraine attack|7|||
27952997|NCT02569853|81662408|FG000|Overall Study|Physician Decision|1|||
27952998|NCT02569853|81662409|FG001|Overall Study|Physician Decision|1|||
27952999|NCT04102007|81662416|FG000|Overall Study|Adverse Event|4|||
27953000|NCT04102007|81662416|FG000|Overall Study|Lost to Follow-up|3|||
27953001|NCT04102007|81662416|FG000|Overall Study|Withdrawal by Subject|12|||
27953002|NCT04102007|81662416|FG000|Overall Study|Eligibility Violation|5|||
27953003|NCT04102007|81662416|FG000|Overall Study|Lack of Efficacy|6|||
27953004|NCT04102007|81662416|FG000|Overall Study|Protocol Deviation|5|||
27953005|NCT04102007|81662416|FG000|Overall Study|Protocol Compliance|1|||
27953006|NCT04102007|81662416|FG000|Overall Study|Withdrew Treatment|2|||
27953007|NCT04102007|81662416|FG000|Overall Study|Pregnancy|1|||
27953008|NCT03961308|81662420|FG000|Overall Study|Withdrawal by Subject|1|||
27953009|NCT03961308|81662421|FG001|Overall Study|Withdrawal by Subject|0|||
27953010|NCT03961308|81662420|FG000|Overall Study|Other|1|||
27953011|NCT03961308|81662421|FG001|Overall Study|Other|0|||
27953012|NCT03961308|81662420|FG000|Overall Study|Lost to Follow-up|0|||
27953013|NCT03961308|81662421|FG001|Overall Study|Lost to Follow-up|1|||
27953014|NCT03961308|81662420|FG000|Overall Study|Adverse Event|0|||
27953015|NCT03961308|81662421|FG001|Overall Study|Adverse Event|1|||
27953016|NCT01029535|81662422|FG000|Overall Study|Lost to Follow-up|24|||
27953017|NCT01029535|81662422|FG000|Overall Study|Protocol Violation|2|||
27953018|NCT01029535|81662422|FG000|Overall Study|Participant Withdrew Consent|2|||
27953019|NCT01029535|81662422|FG000|Overall Study|Adverse Event|1|||
27953020|NCT01029535|81662422|FG000|Overall Study|Use of Another Treatment|1|||
27953021|NCT01029535|81662422|FG000|Overall Study|Death|1|||
27953022|NCT02359903|81662423|FG000|Overall Study|Adverse Event|0|||
27953023|NCT02359903|81662424|FG001|Overall Study|Adverse Event|2|||
27953024|NCT01657305|81662425|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
27953025|NCT01657305|81662425|FG000|Overall Study|Withdrawal by Subject|4|||
27953026|NCT01657305|81662425|FG000|Overall Study|Adverse Event|1|||
27953027|NCT01657305|81662425|FG000|Overall Study|Lost to Follow-up|1|||
27953028|NCT01657305|81662425|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
27953029|NCT02553629|81662426|FG000|Overall Study|Logistic reasons|3|||
27953030|NCT02553629|81662427|FG001|Overall Study|Logistic reasons|6|||
27953031|NCT03097289|81662432|FG000|Overall Study|Adverse Event|1|||
27953032|NCT03097289|81662432|FG000|Overall Study|Equipment failure|2|||
27953033|NCT03097289|81662432|FG000|Overall Study|Collected platelet product unusable|3|||
27953034|NCT00503984|81662438|FG000|Overall Study|Protocol Violation|0|||
27953035|NCT00503984|81662439|FG001|Overall Study|Protocol Violation|1|||
27953036|NCT00503984|81662440|FG002|Overall Study|Protocol Violation|0|||
27953037|NCT00503984|81662441|FG003|Overall Study|Protocol Violation|0|||
27953038|NCT00503984|81662442|FG004|Overall Study|Protocol Violation|0|||
27953039|NCT00503984|81662443|FG005|Overall Study|Protocol Violation|0|||
27953040|NCT00503984|81662438|FG000|Overall Study|Adverse Event|0|||
27953041|NCT00503984|81662439|FG001|Overall Study|Adverse Event|1|||
27953042|NCT00503984|81662440|FG002|Overall Study|Adverse Event|0|||
27953043|NCT00503984|81662441|FG003|Overall Study|Adverse Event|0|||
27953044|NCT00503984|81662442|FG004|Overall Study|Adverse Event|0|||
27953045|NCT00503984|81662443|FG005|Overall Study|Adverse Event|0|||
27953046|NCT00503984|81662438|FG000|Overall Study|Death|0|||
27953047|NCT00503984|81662439|FG001|Overall Study|Death|0|||
27953048|NCT00503984|81662440|FG002|Overall Study|Death|0|||
27953049|NCT00503984|81662441|FG003|Overall Study|Death|0|||
27953050|NCT00503984|81662442|FG004|Overall Study|Death|1|||
27953051|NCT00503984|81662443|FG005|Overall Study|Death|0|||
27953052|NCT03510273|81662444|FG000|Overall Study|Withdrawal by Subject|2|||
27953053|NCT03510273|81662444|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
27953054|NCT03510273|81662444|FG000|Overall Study|Moved away from study area|4|||
27953055|NCT01985022|81662453|FG000|Overall Study|Lost to Follow-up|0|||
27953056|NCT01985022|81662454|FG001|Overall Study|Lost to Follow-up|1|||
27953057|NCT01985022|81662453|FG000|Overall Study|Protocol Violation|0|||
27953058|NCT01985022|81662454|FG001|Overall Study|Protocol Violation|1|||
27953059|NCT01985022|81662453|FG000|Overall Study|Withdrawal by Subject|4|||
27953060|NCT01985022|81662454|FG001|Overall Study|Withdrawal by Subject|1|||
27953061|NCT00565409|81662455|FG000|Period 1 Open Label|Adverse Event|17|||
27953062|NCT00565409|81662456|FG001|Period 1 Open Label|Adverse Event|0|||
27953063|NCT00565409|81662457|FG002|Period 1 Open Label|Adverse Event|0|||
27953064|NCT00565409|81662458|FG003|Period 1 Open Label|Adverse Event|0|||
27953065|NCT00565409|81662455|FG000|Period 1 Open Label|Death|2|||
27953066|NCT00565409|81662456|FG001|Period 1 Open Label|Death|0|||
27953067|NCT00565409|81662457|FG002|Period 1 Open Label|Death|0|||
27953068|NCT00565409|81662458|FG003|Period 1 Open Label|Death|0|||
27953069|NCT00565409|81662455|FG000|Period 1 Open Label|Lost to Follow-up|1|||
27953070|NCT00565409|81662456|FG001|Period 1 Open Label|Lost to Follow-up|0|||
27953071|NCT00565409|81662457|FG002|Period 1 Open Label|Lost to Follow-up|0|||
27953072|NCT00565409|81662458|FG003|Period 1 Open Label|Lost to Follow-up|0|||
27953073|NCT00565409|81662455|FG000|Period 1 Open Label|Other|21|||
27953074|NCT00565409|81662456|FG001|Period 1 Open Label|Other|0|||
27953075|NCT00565409|81662457|FG002|Period 1 Open Label|Other|0|||
27953076|NCT00565409|81662458|FG003|Period 1 Open Label|Other|0|||
27953077|NCT00565409|81662455|FG000|Period 1 Open Label|Protocol Violation|14|||
27953078|NCT00565409|81662456|FG001|Period 1 Open Label|Protocol Violation|0|||
27953079|NCT00565409|81662457|FG002|Period 1 Open Label|Protocol Violation|0|||
27953080|NCT00565409|81662458|FG003|Period 1 Open Label|Protocol Violation|0|||
27953081|NCT00565409|81662455|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
27953082|NCT00565409|81662456|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
27953083|NCT00565409|81662457|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
27953084|NCT00565409|81662458|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
27953085|NCT00565409|81662455|FG000|Period 1 Open Label|no conclusion of participation record|1|||
27953086|NCT00565409|81662456|FG001|Period 1 Open Label|no conclusion of participation record|0|||
27953087|NCT00565409|81662457|FG002|Period 1 Open Label|no conclusion of participation record|0|||
27953088|NCT00565409|81662458|FG003|Period 1 Open Label|no conclusion of participation record|0|||
27953089|NCT00565409|81662455|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
27953090|NCT00565409|81662456|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
27953091|NCT00565409|81662457|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
27953092|NCT00565409|81662458|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
27953093|NCT00565409|81662455|FG000|Period 2 Double-Blind|Adverse Event|0|||
27953094|NCT00565409|81662456|FG001|Period 2 Double-Blind|Adverse Event|7|||
27953095|NCT00565409|81662457|FG002|Period 2 Double-Blind|Adverse Event|4|||
27953096|NCT00565409|81662458|FG003|Period 2 Double-Blind|Adverse Event|5|||
27750048|NCT05118386|80909738|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
27750049|NCT05118386|80909739|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
27750050|NCT05118386|80909734|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
27750051|NCT05118386|80909735|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
27750052|NCT05118386|80909736|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
27953097|NCT00565409|81662455|FG000|Period 2 Double-Blind|Death|0|||
27953098|NCT00565409|81662456|FG001|Period 2 Double-Blind|Death|2|||
27953099|NCT00565409|81662457|FG002|Period 2 Double-Blind|Death|0|||
27953100|NCT00565409|81662458|FG003|Period 2 Double-Blind|Death|0|||
27953101|NCT00565409|81662455|FG000|Period 2 Double-Blind|Protocol Violation|0|||
27953102|NCT00565409|81662456|FG001|Period 2 Double-Blind|Protocol Violation|4|||
27953103|NCT00565409|81662457|FG002|Period 2 Double-Blind|Protocol Violation|6|||
27953104|NCT00565409|81662458|FG003|Period 2 Double-Blind|Protocol Violation|2|||
27953105|NCT00565409|81662455|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
27953106|NCT00565409|81662456|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
27953107|NCT00565409|81662457|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
27953108|NCT00565409|81662458|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
27953109|NCT00565409|81662455|FG000|Period 2 Double-Blind|Other|0|||
27953110|NCT00565409|81662456|FG001|Period 2 Double-Blind|Other|4|||
27953111|NCT00565409|81662457|FG002|Period 2 Double-Blind|Other|5|||
27953112|NCT00565409|81662458|FG003|Period 2 Double-Blind|Other|9|||
27953113|NCT00565409|81662455|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
27953114|NCT00565409|81662456|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
27953115|NCT00565409|81662457|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
27953116|NCT00565409|81662458|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
27953117|NCT02573948|81662461|FG000|Longitudinal Cohort|Death|9|||
27953118|NCT02573948|81662461|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
27953119|NCT02573948|81662461|FG000|Longitudinal Cohort|Incarcerated|25|||
27953120|NCT01076010|81662465|FG000|Overall Study|Death|15|||
27953121|NCT01076010|81662466|FG001|Overall Study|Death|1|||
27953122|NCT01076010|81662467|FG002|Overall Study|Death|0|||
27953123|NCT01076010|81662465|FG000|Overall Study|Adverse Event|7|||
27953124|NCT01076010|81662466|FG001|Overall Study|Adverse Event|2|||
27953125|NCT01076010|81662467|FG002|Overall Study|Adverse Event|0|||
27953126|NCT01076010|81662465|FG000|Overall Study|Progressive disease|90|||
27953127|NCT01076010|81662466|FG001|Overall Study|Progressive disease|30|||
27953128|NCT01076010|81662467|FG002|Overall Study|Progressive disease|1|||
27953129|NCT01076010|81662465|FG000|Overall Study|Lack of Efficacy|4|||
27953130|NCT01076010|81662466|FG001|Overall Study|Lack of Efficacy|0|||
27953131|NCT01076010|81662467|FG002|Overall Study|Lack of Efficacy|0|||
27953132|NCT01076010|81662465|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
27953133|NCT01076010|81662466|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
27953134|NCT01076010|81662467|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
27953135|NCT01076010|81662465|FG000|Overall Study|Significant Surgical Procedure|0|||
27953136|NCT01076010|81662466|FG001|Overall Study|Significant Surgical Procedure|1|||
27953137|NCT01076010|81662467|FG002|Overall Study|Significant Surgical Procedure|0|||
27953138|NCT01076010|81662465|FG000|Overall Study|Protocol Violation|0|||
27953139|NCT01076010|81662466|FG001|Overall Study|Protocol Violation|1|||
27953140|NCT01076010|81662467|FG002|Overall Study|Protocol Violation|0|||
27953141|NCT01076010|81662465|FG000|Overall Study|Noncompliance|1|||
27953142|NCT01076010|81662466|FG001|Overall Study|Noncompliance|1|||
27651073|NCT02332824|80564550|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
27651074|NCT02332824|80564551|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
27953143|NCT01076010|81662467|FG002|Overall Study|Noncompliance|0|||
27953144|NCT01076010|81662465|FG000|Overall Study|Withdrawal by Subject|3|||
27953145|NCT01076010|81662466|FG001|Overall Study|Withdrawal by Subject|0|||
27953146|NCT01076010|81662467|FG002|Overall Study|Withdrawal by Subject|1|||
27953147|NCT01076010|81662465|FG000|Overall Study|Other|5|||
27953148|NCT01076010|81662466|FG001|Overall Study|Other|2|||
27953149|NCT01076010|81662467|FG002|Overall Study|Other|0|||
27953150|NCT02300233|81662468|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
27953151|NCT02300233|81662469|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
27953152|NCT02300233|81662470|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
27953153|NCT02300233|81662468|FG000|Overall Study|Withdrawal by Subject|1|||
27953154|NCT02300233|81662469|FG001|Overall Study|Withdrawal by Subject|0|||
27953155|NCT02300233|81662470|FG002|Overall Study|Withdrawal by Subject|3|||
27953156|NCT02300233|81662468|FG000|Overall Study|Investigator Judgement|0|||
27953157|NCT02300233|81662469|FG001|Overall Study|Investigator Judgement|0|||
27953158|NCT02300233|81662470|FG002|Overall Study|Investigator Judgement|1|||
27651075|NCT02332824|80564552|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
27651076|NCT02332824|80564553|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
27651077|NCT02332824|80564554|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
27651078|NCT02332824|80564555|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
27651079|NCT02332824|80564550|FG000|Overall Study|Voluntary Withdrawal|1|||
27651080|NCT02332824|80564551|FG001|Overall Study|Voluntary Withdrawal|0|||
27651081|NCT02332824|80564552|FG002|Overall Study|Voluntary Withdrawal|0|||
27651082|NCT02332824|80564553|FG003|Overall Study|Voluntary Withdrawal|0|||
27651083|NCT02332824|80564554|FG004|Overall Study|Voluntary Withdrawal|0|||
27651084|NCT02332824|80564555|FG005|Overall Study|Voluntary Withdrawal|0|||
27651085|NCT02332824|80564550|FG000|Overall Study|Inconvenient schedule|1|||
27651086|NCT02332824|80564551|FG001|Overall Study|Inconvenient schedule|1|||
27651087|NCT02332824|80564552|FG002|Overall Study|Inconvenient schedule|0|||
27651088|NCT02332824|80564553|FG003|Overall Study|Inconvenient schedule|0|||
27651089|NCT02332824|80564554|FG004|Overall Study|Inconvenient schedule|0|||
27651090|NCT02332824|80564555|FG005|Overall Study|Inconvenient schedule|0|||
27651091|NCT02332824|80564550|FG000|Overall Study|Transfer|0|||
27651092|NCT02332824|80564551|FG001|Overall Study|Transfer|0|||
27651093|NCT02332824|80564552|FG002|Overall Study|Transfer|1|||
27651094|NCT02332824|80564553|FG003|Overall Study|Transfer|1|||
27651095|NCT02332824|80564554|FG004|Overall Study|Transfer|0|||
27651096|NCT02332824|80564555|FG005|Overall Study|Transfer|0|||
27651097|NCT03875729|80564558|FG000|Overall Study|Adverse Event|0|||
27651098|NCT03875729|80564559|FG001|Overall Study|Adverse Event|5|||
27651099|NCT03875729|80564558|FG000|Overall Study|Withdrawal by Subject|8|||
27651100|NCT03875729|80564559|FG001|Overall Study|Withdrawal by Subject|11|||
27651101|NCT03875729|80564558|FG000|Overall Study|Pregnancy|0|||
27651102|NCT03875729|80564559|FG001|Overall Study|Pregnancy|1|||
27651103|NCT03875729|80564558|FG000|Overall Study|Lost to Follow-up|0|||
27651104|NCT03875729|80564559|FG001|Overall Study|Lost to Follow-up|5|||
27651105|NCT03875729|80564558|FG000|Overall Study|Personal reasons|2|||
27651106|NCT03875729|80564559|FG001|Overall Study|Personal reasons|0|||
27651107|NCT01584648|80564563|FG000|Overall Study|Death|136|||
27651108|NCT01584648|80564564|FG001|Overall Study|Death|146|||
27651109|NCT01584648|80564563|FG000|Overall Study|Lost to Follow-up|9|||
27651110|NCT01584648|80564564|FG001|Overall Study|Lost to Follow-up|9|||
27651111|NCT01584648|80564563|FG000|Overall Study|Investigator discretion|3|||
27651112|NCT01584648|80564564|FG001|Overall Study|Investigator discretion|2|||
27651113|NCT01584648|80564563|FG000|Overall Study|Withdrew consent|13|||
27651114|NCT01584648|80564564|FG001|Overall Study|Withdrew consent|4|||
27651115|NCT01584648|80564563|FG000|Overall Study|Study closed/terminated|50|||
27651116|NCT01584648|80564564|FG001|Overall Study|Study closed/terminated|23|||
27651117|NCT01584648|80564563|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
27651118|NCT01584648|80564564|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
27651119|NCT03265132|80564567|FG000|Overall Study|Adverse Event|0|||
27651120|NCT03265132|80564568|FG001|Overall Study|Adverse Event|1|||
27651121|NCT03265132|80564567|FG000|Overall Study|Lack of Efficacy|0|||
27651122|NCT03265132|80564568|FG001|Overall Study|Lack of Efficacy|2|||
27651123|NCT03265132|80564567|FG000|Overall Study|Progressive disease|0|||
27651124|NCT03265132|80564568|FG001|Overall Study|Progressive disease|2|||
27651125|NCT03265132|80564567|FG000|Overall Study|Withdrawal by Subject|0|||
27651126|NCT03265132|80564568|FG001|Overall Study|Withdrawal by Subject|1|||
27651127|NCT02924051|80564569|FG000|Overall Study|Withdrawal by Subject|1|||
27651128|NCT02924051|80564570|FG001|Overall Study|Withdrawal by Subject|9|||
27651129|NCT03288506|80564571|FG000|Overall Study|Withdrawal by Subject|52|||
27651130|NCT03026166|80564572|FG000|Overall Study|Death|22|||
27651131|NCT03026166|80564573|FG001|Overall Study|Death|7|||
27651132|NCT03026166|80564572|FG000|Overall Study|Physician Decision|2|||
27651133|NCT03026166|80564573|FG001|Overall Study|Physician Decision|0|||
27651134|NCT03026166|80564572|FG000|Overall Study|Withdrawal by Subject|1|||
27953159|NCT02300233|81662468|FG000|Overall Study|Reason Not Specified|0|||
27651135|NCT03026166|80564573|FG001|Overall Study|Withdrawal by Subject|2|||
27651136|NCT03026166|80564572|FG000|Overall Study|Lost to Follow-up|1|||
27651137|NCT03026166|80564573|FG001|Overall Study|Lost to Follow-up|0|||
27651138|NCT03026166|80564572|FG000|Overall Study|Study Terminated by Sponsor|3|||
27651139|NCT03026166|80564573|FG001|Overall Study|Study Terminated by Sponsor|3|||
27651140|NCT03026166|80564572|FG000|Overall Study|Other|1|||
27651141|NCT03026166|80564573|FG001|Overall Study|Other|0|||
27651142|NCT00703092|80564577|FG000|Overall Study|Withdrawal by Subject|2|||
27651143|NCT00088166|80564578|FG000|Overall Study|Adverse Event|11|||
27651144|NCT00088166|80564579|FG001|Overall Study|Adverse Event|9|||
27651145|NCT00088166|80564578|FG000|Overall Study|Death|3|||
27651146|NCT00088166|80564579|FG001|Overall Study|Death|1|||
27651147|NCT00088166|80564578|FG000|Overall Study|Lost to Follow-up|0|||
27651148|NCT00088166|80564579|FG001|Overall Study|Lost to Follow-up|1|||
27651149|NCT00088166|80564578|FG000|Overall Study|Physician Decision|4|||
27651150|NCT00088166|80564579|FG001|Overall Study|Physician Decision|1|||
27651151|NCT00088166|80564578|FG000|Overall Study|Protocol Violation|1|||
27651152|NCT00088166|80564579|FG001|Overall Study|Protocol Violation|5|||
27651153|NCT00088166|80564578|FG000|Overall Study|Patient deterioration|29|||
27651154|NCT00088166|80564579|FG001|Overall Study|Patient deterioration|39|||
27651155|NCT00088166|80564578|FG000|Overall Study|Withdrawal by Subject|5|||
27651156|NCT00088166|80564579|FG001|Overall Study|Withdrawal by Subject|5|||
27651157|NCT04323800|80564580|FG000|Overall Study|Withdrawal by Subject|4|||
27651158|NCT04323800|80564581|FG001|Overall Study|Withdrawal by Subject|4|||
27651159|NCT04323800|80564580|FG000|Overall Study|Incomplete transfusion|1|||
27651160|NCT04323800|80564581|FG001|Overall Study|Incomplete transfusion|0|||
27651161|NCT04323800|80564580|FG000|Overall Study|Other|0|||
27651162|NCT04323800|80564581|FG001|Overall Study|Other|1|||
27651163|NCT04323800|80564580|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
27651164|NCT04323800|80564581|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
27651165|NCT03678688|80564582|FG000|Overall Study|Reason not Specified|0|||
27651166|NCT03678688|80564583|FG001|Overall Study|Reason not Specified|0|||
27651167|NCT03678688|80564584|FG002|Overall Study|Reason not Specified|3|||
27651168|NCT03678688|80564585|FG003|Overall Study|Reason not Specified|0|||
27651169|NCT03678688|80564586|FG004|Overall Study|Reason not Specified|1|||
27651170|NCT03678688|80564587|FG005|Overall Study|Reason not Specified|0|||
27651171|NCT03678688|80564588|FG006|Overall Study|Reason not Specified|0|||
27651172|NCT03678688|80564589|FG007|Overall Study|Reason not Specified|0|||
27651173|NCT03678688|80564590|FG008|Overall Study|Reason not Specified|0|||
27651174|NCT03678688|80564582|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
27651175|NCT03678688|80564583|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
27651176|NCT03678688|80564584|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
27651177|NCT03678688|80564585|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
27651178|NCT03678688|80564586|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
27651179|NCT03678688|80564587|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
27651180|NCT03678688|80564588|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
27651181|NCT03678688|80564589|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
27651182|NCT03678688|80564590|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
27651183|NCT03678688|80564582|FG000|Overall Study|Covid Related Adverse Event|0|||
27651184|NCT03678688|80564583|FG001|Overall Study|Covid Related Adverse Event|0|||
27651185|NCT03678688|80564584|FG002|Overall Study|Covid Related Adverse Event|0|||
27651186|NCT03678688|80564585|FG003|Overall Study|Covid Related Adverse Event|0|||
27651187|NCT03678688|80564586|FG004|Overall Study|Covid Related Adverse Event|0|||
27651188|NCT03678688|80564587|FG005|Overall Study|Covid Related Adverse Event|3|||
27651189|NCT03678688|80564588|FG006|Overall Study|Covid Related Adverse Event|1|||
27651190|NCT03678688|80564589|FG007|Overall Study|Covid Related Adverse Event|1|||
27651191|NCT03678688|80564590|FG008|Overall Study|Covid Related Adverse Event|0|||
27651192|NCT03678688|80564582|FG000|Overall Study|Physician Decision|0|||
27651193|NCT03678688|80564583|FG001|Overall Study|Physician Decision|0|||
27651194|NCT03678688|80564584|FG002|Overall Study|Physician Decision|0|||
27651195|NCT03678688|80564585|FG003|Overall Study|Physician Decision|0|||
27651196|NCT03678688|80564586|FG004|Overall Study|Physician Decision|0|||
27651197|NCT03678688|80564587|FG005|Overall Study|Physician Decision|1|||
27651198|NCT03678688|80564588|FG006|Overall Study|Physician Decision|0|||
27651199|NCT03678688|80564589|FG007|Overall Study|Physician Decision|0|||
27651200|NCT03678688|80564590|FG008|Overall Study|Physician Decision|0|||
27651201|NCT03678688|80564582|FG000|Overall Study|Withdrawal by Subject|0|||
27651202|NCT03678688|80564583|FG001|Overall Study|Withdrawal by Subject|0|||
27651203|NCT03678688|80564584|FG002|Overall Study|Withdrawal by Subject|0|||
27651204|NCT03678688|80564585|FG003|Overall Study|Withdrawal by Subject|0|||
27651205|NCT03678688|80564586|FG004|Overall Study|Withdrawal by Subject|0|||
27651206|NCT03678688|80564587|FG005|Overall Study|Withdrawal by Subject|0|||
27651207|NCT03678688|80564588|FG006|Overall Study|Withdrawal by Subject|2|||
27651208|NCT03678688|80564589|FG007|Overall Study|Withdrawal by Subject|1|||
27651209|NCT03678688|80564590|FG008|Overall Study|Withdrawal by Subject|0|||
27651210|NCT02188459|80564592|FG000|Overall Study|Lost to Follow-up|3|||
27651211|NCT02188459|80564593|FG001|Overall Study|Lost to Follow-up|4|||
27651212|NCT02188459|80564592|FG000|Overall Study|Early Termination|0|||
27651213|NCT02188459|80564593|FG001|Overall Study|Early Termination|3|||
27651214|NCT00378898|80564595|FG000|Overall Study|Withdrawal by Subject|10|||
27651215|NCT00378898|80564596|FG001|Overall Study|Withdrawal by Subject|5|||
27651216|NCT00378898|80564595|FG000|Overall Study|Protocol Violation|1|||
27651217|NCT00378898|80564596|FG001|Overall Study|Protocol Violation|1|||
27651218|NCT01858688|80564597|FG000|Overall Study|Withdrawal by Subject|8|||
27651219|NCT01858688|80564597|FG000|Overall Study|Participant began another therapy|3|||
27651220|NCT01858688|80564597|FG000|Overall Study|Physician Decision|2|||
27651221|NCT01858688|80564597|FG000|Overall Study|Progressive Disease|2|||
27651222|NCT01858688|80564597|FG000|Overall Study|Reason not reproted|5|||
27651223|NCT01853384|80564598|FG000|Randomized|Adverse Event|5|||
27651224|NCT01853384|80564599|FG001|Randomized|Adverse Event|3|||
27651225|NCT01853384|80564598|FG000|Randomized|Death|1|||
27651226|NCT01853384|80564599|FG001|Randomized|Death|2|||
27651227|NCT01853384|80564598|FG000|Randomized|Lost to Follow-up|1|||
27651228|NCT01853384|80564599|FG001|Randomized|Lost to Follow-up|1|||
27651229|NCT01853384|80564598|FG000|Randomized|Withdrawal by Subject|5|||
27651230|NCT01853384|80564599|FG001|Randomized|Withdrawal by Subject|3|||
27651231|NCT01853384|80564598|FG000|Randomized|Sponsor Decision|47|||
27651232|NCT01853384|80564599|FG001|Randomized|Sponsor Decision|34|||
27651233|NCT01853384|80564598|FG000|Randomized|Other|3|||
27651234|NCT01853384|80564599|FG001|Randomized|Other|3|||
27651235|NCT01853384|80564598|FG000|Completed Follow up Visit 1|Early Termination|13|||
27651236|NCT01853384|80564599|FG001|Completed Follow up Visit 1|Early Termination|9|||
27651237|NCT01853384|80564598|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
27651238|NCT01853384|80564599|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
27651239|NCT01853384|80564598|FG000|Completed Follow up Visit 2|Adverse Event|1|||
27651240|NCT01853384|80564599|FG001|Completed Follow up Visit 2|Adverse Event|0|||
27651241|NCT01853384|80564598|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
27651242|NCT01853384|80564599|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
27651243|NCT01853384|80564598|FG000|Completed Follow up Visit 2|Death|1|||
27651244|NCT01853384|80564599|FG001|Completed Follow up Visit 2|Death|0|||
27651245|NCT01853384|80564598|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
27651246|NCT01853384|80564599|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
27651247|NCT04749797|80564603|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
27651248|NCT04749797|80564604|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
27651249|NCT04749797|80564605|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
27651250|NCT01930188|80564608|FG000|Overall Study|unclassified|4|||
27651251|NCT01930188|80564609|FG001|Overall Study|unclassified|5|||
27651252|NCT01930188|80564610|FG002|Overall Study|unclassified|3|||
27651253|NCT01930188|80564608|FG000|Overall Study|Missing follow-up information|2|||
27651254|NCT01930188|80564609|FG001|Overall Study|Missing follow-up information|2|||
27651255|NCT01930188|80564610|FG002|Overall Study|Missing follow-up information|3|||
27651256|NCT01930188|80564608|FG000|Overall Study|Lost to Follow-up|5|||
27651257|NCT01930188|80564609|FG001|Overall Study|Lost to Follow-up|2|||
27651258|NCT01930188|80564610|FG002|Overall Study|Lost to Follow-up|2|||
27651259|NCT01930188|80564608|FG000|Overall Study|Death|2|||
27651260|NCT01930188|80564609|FG001|Overall Study|Death|1|||
27651261|NCT01930188|80564610|FG002|Overall Study|Death|3|||
27651262|NCT01930188|80564608|FG000|Overall Study|Withdrawal by Subject|9|||
27651263|NCT01930188|80564609|FG001|Overall Study|Withdrawal by Subject|11|||
27651264|NCT01930188|80564610|FG002|Overall Study|Withdrawal by Subject|8|||
27651265|NCT00310037|80564612|FG000|Overall Study|Adverse Event|7|||
27651266|NCT00310037|80564613|FG001|Overall Study|Adverse Event|14|||
27651267|NCT00310037|80564612|FG000|Overall Study|Withdrawal by Subject|4|||
27651268|NCT00310037|80564613|FG001|Overall Study|Withdrawal by Subject|3|||
27651269|NCT00310037|80564612|FG000|Overall Study|Progression|6|||
27651270|NCT00310037|80564613|FG001|Overall Study|Progression|0|||
27651271|NCT00310037|80564612|FG000|Overall Study|Non-protocol treatment|1|||
27651272|NCT00310037|80564613|FG001|Overall Study|Non-protocol treatment|0|||
27651273|NCT03442777|80564614|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
27651274|NCT03442777|80564615|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
27651275|NCT03442777|80564616|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
27651276|NCT01052272|80564617|FG000|Overall Study|Death|0|||
27651277|NCT01052272|80564618|FG001|Overall Study|Death|0|||
27651278|NCT01052272|80564619|FG002|Overall Study|Death|1|||
27651279|NCT01052272|80564620|FG003|Overall Study|Death|1|||
27651280|NCT01052272|80564617|FG000|Overall Study|Physician Decision|0|||
27651281|NCT01052272|80564618|FG001|Overall Study|Physician Decision|1|||
27651282|NCT01052272|80564619|FG002|Overall Study|Physician Decision|0|||
27651283|NCT01052272|80564620|FG003|Overall Study|Physician Decision|0|||
27651284|NCT01052272|80564617|FG000|Overall Study|patient refuses follow-up|5|||
27651285|NCT01052272|80564618|FG001|Overall Study|patient refuses follow-up|4|||
27651286|NCT01052272|80564619|FG002|Overall Study|patient refuses follow-up|2|||
27651287|NCT01052272|80564620|FG003|Overall Study|patient refuses follow-up|4|||
27651288|NCT01052272|80564617|FG000|Overall Study|Withdrawal by Subject|0|||
27651289|NCT01052272|80564618|FG001|Overall Study|Withdrawal by Subject|2|||
27651290|NCT01052272|80564619|FG002|Overall Study|Withdrawal by Subject|3|||
27651291|NCT01052272|80564620|FG003|Overall Study|Withdrawal by Subject|2|||
27651292|NCT01052272|80564617|FG000|Overall Study|placed in long-term care|0|||
27651293|NCT01052272|80564618|FG001|Overall Study|placed in long-term care|0|||
27750053|NCT05118386|80909737|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
27959310|NCT02131662|81683271|FG002|Overall Study|Pregnancy|0|||
27651294|NCT01052272|80564619|FG002|Overall Study|placed in long-term care|1|||
27651295|NCT01052272|80564620|FG003|Overall Study|placed in long-term care|0|||
27651296|NCT01052272|80564617|FG000|Overall Study|decline in health|0|||
27651297|NCT01052272|80564618|FG001|Overall Study|decline in health|0|||
27651298|NCT01052272|80564619|FG002|Overall Study|decline in health|1|||
27651299|NCT01052272|80564620|FG003|Overall Study|decline in health|0|||
27651300|NCT01777932|80564621|FG000|Overall Study|Disease progression|136|||
27651301|NCT01777932|80564621|FG000|Overall Study|Death|3|||
27651302|NCT01777932|80564621|FG000|Overall Study|Adverse Event|34|||
27651303|NCT01777932|80564621|FG000|Overall Study|Lost to Follow-up|3|||
27651304|NCT01777932|80564621|FG000|Overall Study|Investigator decision|10|||
27651305|NCT01777932|80564621|FG000|Overall Study|Reimbursement limit|9|||
27651306|NCT01777932|80564621|FG000|Overall Study|Patient refused further treatment|10|||
27651307|NCT03205488|80564625|FG000|Overall Study|Adverse Event|1|||
27651308|NCT03205488|80564626|FG001|Overall Study|Adverse Event|2|||
27651309|NCT03205488|80564627|FG002|Overall Study|Adverse Event|4|||
27651310|NCT03205488|80564625|FG000|Overall Study|Protocol Violation|0|||
27651311|NCT03205488|80564626|FG001|Overall Study|Protocol Violation|0|||
27651312|NCT03205488|80564627|FG002|Overall Study|Protocol Violation|1|||
27651313|NCT03560206|80564628|FG000|Overall Study|Lost to Follow-up|19|||
27651314|NCT03560206|80564629|FG001|Overall Study|Lost to Follow-up|11|||
27651315|NCT03560206|80564628|FG000|Overall Study|Withdrawal by Subject|2|||
27651316|NCT03560206|80564629|FG001|Overall Study|Withdrawal by Subject|4|||
27651317|NCT03560206|80564628|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
27651318|NCT03560206|80564629|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
27651319|NCT03560206|80564628|FG000|Overall Study|Busy schedule|14|||
27651320|NCT03560206|80564629|FG001|Overall Study|Busy schedule|2|||
27651321|NCT03560206|80564628|FG000|Overall Study|patients' new health condition such as cancer|10|||
27651322|NCT03560206|80564629|FG001|Overall Study|patients' new health condition such as cancer|1|||
27651323|NCT00799409|80564630|FG000|Overall Study|Withdrawal by Subject|1|||
27651324|NCT00799409|80564631|FG001|Overall Study|Withdrawal by Subject|0|||
27651325|NCT00799409|80564632|FG002|Overall Study|Withdrawal by Subject|0|||
27651326|NCT00799409|80564630|FG000|Overall Study|Lost to Follow-up|1|||
27651327|NCT00799409|80564631|FG001|Overall Study|Lost to Follow-up|0|||
27651328|NCT00799409|80564632|FG002|Overall Study|Lost to Follow-up|0|||
27651329|NCT00799409|80564630|FG000|Overall Study|Optimal Dose Not Achieved|2|||
27651330|NCT00799409|80564631|FG001|Overall Study|Optimal Dose Not Achieved|0|||
27651331|NCT00799409|80564632|FG002|Overall Study|Optimal Dose Not Achieved|0|||
27651332|NCT00799409|80564630|FG000|Overall Study|Failure to follow study protocol)|1|||
27651333|NCT00799409|80564631|FG001|Overall Study|Failure to follow study protocol)|0|||
27651334|NCT00799409|80564632|FG002|Overall Study|Failure to follow study protocol)|0|||
27651335|NCT00799409|80564630|FG000|Overall Study|Did not attend lab school day 1|1|||
27651336|NCT00799409|80564631|FG001|Overall Study|Did not attend lab school day 1|0|||
27651337|NCT00799409|80564632|FG002|Overall Study|Did not attend lab school day 1|0|||
27651338|NCT00799409|80564630|FG000|Overall Study|medication compliance|1|||
27651339|NCT00799409|80564631|FG001|Overall Study|medication compliance|0|||
27651340|NCT00799409|80564632|FG002|Overall Study|medication compliance|0|||
27651341|NCT02095145|80564634|FG000|Overall Study|Withdrawal by Subject|1|||
27651342|NCT02095145|80564635|FG001|Overall Study|Withdrawal by Subject|0|||
27651343|NCT04131556|80564636|FG000|Overall Study|Adverse Event|1|||
27651344|NCT04131556|80564636|FG000|Overall Study|Withdrawal by Subject|1|||
27651345|NCT00687297|80564639|FG000|Randomization|Withdrawal by Subject|2|||
27651346|NCT00687297|80564640|FG001|Randomization|Withdrawal by Subject|0|||
27651347|NCT00687297|80564639|FG000|Randomization|Withdrew before treatment, ineligible|1|||
27651348|NCT00687297|80564640|FG001|Randomization|Withdrew before treatment, ineligible|1|||
27651349|NCT00687297|80564639|FG000|Induction|Withdrawal by Subject|4|||
27651350|NCT00687297|80564640|FG001|Induction|Withdrawal by Subject|4|||
27651351|NCT00687297|80564639|FG000|Induction|Adverse Event|16|||
27651352|NCT00687297|80564640|FG001|Induction|Adverse Event|15|||
27651353|NCT00687297|80564639|FG000|Induction|Death|7|||
27651354|NCT00687297|80564640|FG001|Induction|Death|11|||
27651355|NCT00687297|80564639|FG000|Induction|Lack of Efficacy|17|||
27651356|NCT00687297|80564640|FG001|Induction|Lack of Efficacy|21|||
27651357|NCT00687297|80564639|FG000|Induction|Ineligible|0|||
27651358|NCT00687297|80564640|FG001|Induction|Ineligible|1|||
27651359|NCT00687297|80564639|FG000|Induction|Patient Noncompliance|1|||
27651360|NCT00687297|80564640|FG001|Induction|Patient Noncompliance|0|||
27651361|NCT00687297|80564639|FG000|Induction|Physician Decision|0|||
27651362|NCT00687297|80564640|FG001|Induction|Physician Decision|2|||
27651363|NCT00687297|80564639|FG000|Induction|Other|0|||
27651364|NCT00687297|80564640|FG001|Induction|Other|1|||
27651365|NCT03737110|80564641|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
27651366|NCT03737110|80564642|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
27651367|NCT03737110|80564643|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
27651368|NCT03737110|80564644|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
27651369|NCT03737110|80564645|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
27651370|NCT03737110|80564646|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
27651371|NCT03737110|80564641|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
27651372|NCT03737110|80564642|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
27651373|NCT03737110|80564643|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
27651374|NCT03737110|80564644|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
27651375|NCT03737110|80564645|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
27651376|NCT03737110|80564646|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
27651377|NCT03737110|80564641|FG000|Run-in (RI) Period|Adverse Event|4|||
27651378|NCT03737110|80564642|FG001|Run-in (RI) Period|Adverse Event|0|||
27651379|NCT03737110|80564643|FG002|Run-in (RI) Period|Adverse Event|0|||
27651380|NCT03737110|80564644|FG003|Run-in (RI) Period|Adverse Event|0|||
27651381|NCT03737110|80564645|FG004|Run-in (RI) Period|Adverse Event|0|||
27651382|NCT03737110|80564646|FG005|Run-in (RI) Period|Adverse Event|0|||
27651383|NCT03737110|80564641|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
27651384|NCT03737110|80564642|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
27651385|NCT03737110|80564643|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
27651386|NCT03737110|80564644|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
27651387|NCT03737110|80564645|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
27651388|NCT03737110|80564646|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
27651389|NCT03737110|80564641|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27651390|NCT03737110|80564642|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27651391|NCT03737110|80564643|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
27651392|NCT03737110|80564644|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27651393|NCT03737110|80564645|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27651394|NCT03737110|80564646|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
27651395|NCT03737110|80564641|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27651396|NCT03737110|80564642|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27651397|NCT03737110|80564643|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27651398|NCT03737110|80564644|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
27651399|NCT03737110|80564645|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27651400|NCT03737110|80564646|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
27651401|NCT03737110|80564641|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
27651402|NCT03737110|80564642|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
27651403|NCT03737110|80564643|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
27651404|NCT03737110|80564644|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
27651405|NCT03737110|80564645|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
27651406|NCT03737110|80564646|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
27651407|NCT03737110|80564641|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
27651408|NCT03737110|80564642|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
27651409|NCT03737110|80564643|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
27651410|NCT03737110|80564644|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
27651411|NCT03737110|80564645|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
27651412|NCT03737110|80564646|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
27651413|NCT01052714|80564647|FG000|Overall Study|Adverse Event|6|||
27651414|NCT01052714|80564648|FG001|Overall Study|Adverse Event|3|||
27651415|NCT01052714|80564649|FG002|Overall Study|Adverse Event|0|||
27651416|NCT01052714|80564647|FG000|Overall Study|Death|1|||
27651417|NCT01052714|80564648|FG001|Overall Study|Death|2|||
27651418|NCT01052714|80564649|FG002|Overall Study|Death|0|||
27651419|NCT01052714|80564647|FG000|Overall Study|Lost to Follow-up|2|||
27651420|NCT01052714|80564648|FG001|Overall Study|Lost to Follow-up|3|||
27651421|NCT01052714|80564649|FG002|Overall Study|Lost to Follow-up|0|||
27651422|NCT01052714|80564647|FG000|Overall Study|Physician Decision|9|||
27651423|NCT01052714|80564648|FG001|Overall Study|Physician Decision|9|||
27651424|NCT01052714|80564649|FG002|Overall Study|Physician Decision|1|||
27651425|NCT01052714|80564647|FG000|Overall Study|Withdrawal by Subject|7|||
27651426|NCT01052714|80564648|FG001|Overall Study|Withdrawal by Subject|12|||
27651427|NCT01052714|80564649|FG002|Overall Study|Withdrawal by Subject|1|||
27651428|NCT03002194|80564650|FG000|Overall Study|Lost to Follow-up|6|||
27651429|NCT03002194|80564650|FG000|Overall Study|Adverse Event|1|||
27651430|NCT03002194|80564650|FG000|Overall Study|Lack of Efficacy|1|||
27651431|NCT03002194|80564650|FG000|Overall Study|Withdrawal by Subject|2|||
27651432|NCT01084772|80564651|FG000|Baseline|Withdrawal by Subject|7|||
27651433|NCT01084772|80564652|FG001|Baseline|Withdrawal by Subject|6|||
27651434|NCT01084772|80564651|FG000|3 Months|Death|1|||
27651435|NCT01084772|80564652|FG001|3 Months|Death|0|||
27651436|NCT01084772|80564651|FG000|3 Months|Study Termination|2|||
27651437|NCT01084772|80564652|FG001|3 Months|Study Termination|2|||
27651438|NCT01084772|80564651|FG000|1 Year|Withdrawal by Subject|0|||
27651439|NCT01084772|80564652|FG001|1 Year|Withdrawal by Subject|1|||
27651440|NCT01084772|80564651|FG000|1 Year|Lost to Follow-up|3|||
27651441|NCT01084772|80564652|FG001|1 Year|Lost to Follow-up|0|||
27651442|NCT01084772|80564651|FG000|1 Year|Study Termination|0|||
27651443|NCT01084772|80564652|FG001|1 Year|Study Termination|7|||
27750054|NCT05118386|80909738|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
27959311|NCT02131662|81683272|FG003|Overall Study|Pregnancy|1|||
27651444|NCT01084772|80564651|FG000|2 Years|Withdrawal by Subject|1|||
27651445|NCT01084772|80564652|FG001|2 Years|Withdrawal by Subject|0|||
27651446|NCT01084772|80564651|FG000|2 Years|Lost to Follow-up|5|||
27651447|NCT01084772|80564652|FG001|2 Years|Lost to Follow-up|2|||
27651448|NCT01084772|80564651|FG000|2 Years|Study Termination|3|||
27651449|NCT01084772|80564652|FG001|2 Years|Study Termination|2|||
27651450|NCT00089609|80564655|FG000|Overall Study|Withdrawal by Subject|3|||
27651451|NCT00089609|80564656|FG001|Overall Study|Withdrawal by Subject|1|||
27651452|NCT00321672|80564657|FG000|Overall Study|Withdrawal by Subject|5|||
27651453|NCT00321672|80564658|FG001|Overall Study|Withdrawal by Subject|1|||
27651454|NCT00321672|80564659|FG002|Overall Study|Withdrawal by Subject|2|||
27651455|NCT00321672|80564660|FG003|Overall Study|Withdrawal by Subject|0|||
27651456|NCT00321672|80564657|FG000|Overall Study|Noncompliance|1|||
27651457|NCT00321672|80564658|FG001|Overall Study|Noncompliance|2|||
27651458|NCT00321672|80564659|FG002|Overall Study|Noncompliance|1|||
27651459|NCT00321672|80564660|FG003|Overall Study|Noncompliance|0|||
27651460|NCT00321672|80564657|FG000|Overall Study|Adverse Event|1|||
27651461|NCT00321672|80564658|FG001|Overall Study|Adverse Event|1|||
27651462|NCT00321672|80564659|FG002|Overall Study|Adverse Event|0|||
27651463|NCT00321672|80564660|FG003|Overall Study|Adverse Event|0|||
27651464|NCT00321672|80564657|FG000|Overall Study|Lack of Efficacy|1|||
27651465|NCT00321672|80564658|FG001|Overall Study|Lack of Efficacy|1|||
27651466|NCT00321672|80564659|FG002|Overall Study|Lack of Efficacy|0|||
27651467|NCT00321672|80564660|FG003|Overall Study|Lack of Efficacy|0|||
27651468|NCT00321672|80564657|FG000|Overall Study|Lost to Follow-up|2|||
27651469|NCT00321672|80564658|FG001|Overall Study|Lost to Follow-up|0|||
27651470|NCT00321672|80564659|FG002|Overall Study|Lost to Follow-up|4|||
27651471|NCT00321672|80564660|FG003|Overall Study|Lost to Follow-up|2|||
27651472|NCT00321672|80564657|FG000|Overall Study|Death|1|||
27651473|NCT00321672|80564658|FG001|Overall Study|Death|0|||
27651474|NCT00321672|80564659|FG002|Overall Study|Death|0|||
27651475|NCT00321672|80564660|FG003|Overall Study|Death|0|||
27651476|NCT00321672|80564657|FG000|Overall Study|Too far to travel for visits|1|||
27651477|NCT00321672|80564658|FG001|Overall Study|Too far to travel for visits|0|||
27651478|NCT00321672|80564659|FG002|Overall Study|Too far to travel for visits|0|||
27651479|NCT00321672|80564660|FG003|Overall Study|Too far to travel for visits|0|||
27651480|NCT00321672|80564657|FG000|Overall Study|Incarcerated|0|||
27651481|NCT00321672|80564658|FG001|Overall Study|Incarcerated|0|||
27651482|NCT00321672|80564659|FG002|Overall Study|Incarcerated|2|||
27651483|NCT00321672|80564660|FG003|Overall Study|Incarcerated|0|||
27651484|NCT00321672|80564657|FG000|Overall Study|Moved out of state|0|||
27651485|NCT00321672|80564658|FG001|Overall Study|Moved out of state|1|||
27651486|NCT00321672|80564659|FG002|Overall Study|Moved out of state|1|||
27651487|NCT00321672|80564660|FG003|Overall Study|Moved out of state|0|||
27651488|NCT00321672|80564657|FG000|Overall Study|Protocol Violation|0|||
27651489|NCT00321672|80564658|FG001|Overall Study|Protocol Violation|0|||
27651490|NCT00321672|80564659|FG002|Overall Study|Protocol Violation|1|||
27651491|NCT00321672|80564660|FG003|Overall Study|Protocol Violation|0|||
27651492|NCT00321672|80564657|FG000|Overall Study|Diagnosis of testicular cancer|0|||
27651493|NCT00321672|80564658|FG001|Overall Study|Diagnosis of testicular cancer|1|||
27651494|NCT00321672|80564659|FG002|Overall Study|Diagnosis of testicular cancer|0|||
27651495|NCT00321672|80564660|FG003|Overall Study|Diagnosis of testicular cancer|0|||
27651496|NCT00321672|80564657|FG000|Overall Study|Extensive travel required for new job|0|||
27651497|NCT00321672|80564658|FG001|Overall Study|Extensive travel required for new job|1|||
27651498|NCT00321672|80564659|FG002|Overall Study|Extensive travel required for new job|0|||
27651499|NCT00321672|80564660|FG003|Overall Study|Extensive travel required for new job|0|||
27651500|NCT03015220|80564661|FG000|Overall Study|Withdrawal by Subject|3|||
27651501|NCT03015220|80564662|FG001|Overall Study|Withdrawal by Subject|2|||
27651502|NCT03015220|80564663|FG002|Overall Study|Withdrawal by Subject|2|||
27651503|NCT03015220|80564664|FG003|Overall Study|Withdrawal by Subject|2|||
27651504|NCT03015220|80564661|FG000|Overall Study|Lost to Follow-up|0|||
27651505|NCT03015220|80564662|FG001|Overall Study|Lost to Follow-up|0|||
27651506|NCT03015220|80564663|FG002|Overall Study|Lost to Follow-up|1|||
27651507|NCT03015220|80564664|FG003|Overall Study|Lost to Follow-up|0|||
27651508|NCT02827201|80564667|FG000|Overall Study|Death|1|||
27651509|NCT02827201|80564668|FG001|Overall Study|Death|2|||
27651510|NCT02827201|80564667|FG000|Overall Study|Patients not treated|1|||
27651511|NCT02827201|80564668|FG001|Overall Study|Patients not treated|1|||
27651512|NCT02006641|80564669|FG000|Overall Study|Withdrawal before treatment|2|||
27651513|NCT02006641|80564670|FG001|Overall Study|Withdrawal before treatment|5|||
27651514|NCT02006641|80564671|FG002|Overall Study|Withdrawal before treatment|3|||
27651515|NCT02006641|80564669|FG000|Overall Study|Adverse Event|15|||
27651516|NCT02006641|80564670|FG001|Overall Study|Adverse Event|11|||
27651517|NCT02006641|80564671|FG002|Overall Study|Adverse Event|15|||
27651518|NCT02006641|80564669|FG000|Overall Study|Protocol Violation|0|||
27651519|NCT02006641|80564670|FG001|Overall Study|Protocol Violation|2|||
27651520|NCT02006641|80564671|FG002|Overall Study|Protocol Violation|2|||
27651521|NCT02006641|80564669|FG000|Overall Study|Lost to Follow-up|0|||
27651522|NCT02006641|80564670|FG001|Overall Study|Lost to Follow-up|1|||
27651523|NCT02006641|80564671|FG002|Overall Study|Lost to Follow-up|0|||
27651524|NCT02006641|80564669|FG000|Overall Study|Withdrawal by Subject|7|||
27651525|NCT02006641|80564670|FG001|Overall Study|Withdrawal by Subject|12|||
27651526|NCT02006641|80564671|FG002|Overall Study|Withdrawal by Subject|11|||
27651527|NCT02006641|80564669|FG000|Overall Study|Other reason: patient didn't show up|1|||
27651528|NCT02006641|80564670|FG001|Overall Study|Other reason: patient didn't show up|0|||
27651529|NCT02006641|80564671|FG002|Overall Study|Other reason: patient didn't show up|0|||
27651530|NCT02006641|80564669|FG000|Overall Study|Other reason:patient didn't want to come|0|||
27651531|NCT02006641|80564670|FG001|Overall Study|Other reason:patient didn't want to come|0|||
27651532|NCT02006641|80564671|FG002|Overall Study|Other reason:patient didn't want to come|1|||
27651533|NCT02006641|80564669|FG000|Overall Study|Other reason: patient has moved|1|||
27651534|NCT02006641|80564670|FG001|Overall Study|Other reason: patient has moved|0|||
27651535|NCT02006641|80564671|FG002|Overall Study|Other reason: patient has moved|1|||
27651536|NCT02006641|80564669|FG000|Overall Study|Other reason: caregiver in hospital|0|||
27651537|NCT02006641|80564670|FG001|Overall Study|Other reason: caregiver in hospital|1|||
27651538|NCT02006641|80564671|FG002|Overall Study|Other reason: caregiver in hospital|0|||
27651539|NCT02006641|80564669|FG000|Overall Study|Other reason: patient's wife has died|0|||
27651540|NCT02006641|80564670|FG001|Overall Study|Other reason: patient's wife has died|0|||
27651541|NCT02006641|80564671|FG002|Overall Study|Other reason: patient's wife has died|1|||
27651542|NCT02006641|80564669|FG000|Overall Study|Other reason: hospitalisation|0|||
27651543|NCT02006641|80564670|FG001|Overall Study|Other reason: hospitalisation|1|||
27651544|NCT02006641|80564671|FG002|Overall Study|Other reason: hospitalisation|0|||
27651545|NCT02006641|80564669|FG000|Overall Study|Other reason: caregiver impossibility|0|||
27651546|NCT02006641|80564670|FG001|Overall Study|Other reason: caregiver impossibility|0|||
27651547|NCT02006641|80564671|FG002|Overall Study|Other reason: caregiver impossibility|1|||
27651548|NCT02006641|80564669|FG000|Overall Study|Other reason: protocol non-compliance|0|||
27651549|NCT02006641|80564670|FG001|Overall Study|Other reason: protocol non-compliance|0|||
27651550|NCT02006641|80564671|FG002|Overall Study|Other reason: protocol non-compliance|1|||
27651551|NCT03692871|80564672|FG000|Overall Study|Death|1|||
27651552|NCT03692871|80564673|FG001|Overall Study|Death|1|||
27651553|NCT03692871|80564672|FG000|Overall Study|Lost to Follow-up|24|||
27651554|NCT03692871|80564673|FG001|Overall Study|Lost to Follow-up|9|||
27651555|NCT03692871|80564672|FG000|Overall Study|Physician Decision|22|||
27651556|NCT03692871|80564673|FG001|Overall Study|Physician Decision|7|||
27651557|NCT03692871|80564672|FG000|Overall Study|Protocol Deviation|1|||
27651558|NCT03692871|80564673|FG001|Overall Study|Protocol Deviation|0|||
27651559|NCT03692871|80564672|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
27651560|NCT03692871|80564673|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
27651561|NCT00614614|80564674|FG000|Primary Vaccination Phase|Adverse Event|6|||
27651562|NCT00614614|80564675|FG001|Primary Vaccination Phase|Adverse Event|0|||
27651563|NCT00614614|80564676|FG002|Primary Vaccination Phase|Adverse Event|0|||
27651564|NCT00614614|80564677|FG003|Primary Vaccination Phase|Adverse Event|0|||
27651565|NCT00614614|80564678|FG004|Primary Vaccination Phase|Adverse Event|0|||
27651566|NCT00614614|80564674|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
27651567|NCT00614614|80564675|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
27651568|NCT00614614|80564676|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
27651569|NCT00614614|80564677|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
27651570|NCT00614614|80564678|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
27651571|NCT00614614|80564674|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
27651572|NCT00614614|80564675|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
27651573|NCT00614614|80564676|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
27651574|NCT00614614|80564677|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
27651575|NCT00614614|80564678|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
27651576|NCT00614614|80564674|FG000|Primary Vaccination Phase|Protocol Violation|9|||
27651577|NCT00614614|80564675|FG001|Primary Vaccination Phase|Protocol Violation|3|||
27651578|NCT00614614|80564676|FG002|Primary Vaccination Phase|Protocol Violation|0|||
27651579|NCT00614614|80564677|FG003|Primary Vaccination Phase|Protocol Violation|0|||
27651580|NCT00614614|80564678|FG004|Primary Vaccination Phase|Protocol Violation|0|||
27651581|NCT00614614|80564674|FG000|Primary Vaccination Phase|Other|4|||
27651582|NCT00614614|80564675|FG001|Primary Vaccination Phase|Other|0|||
27651583|NCT00614614|80564676|FG002|Primary Vaccination Phase|Other|0|||
27651584|NCT00614614|80564677|FG003|Primary Vaccination Phase|Other|0|||
27651585|NCT00614614|80564678|FG004|Primary Vaccination Phase|Other|0|||
27651586|NCT00614614|80564674|FG000|Booster Vaccination Phase|Adverse Event|0|||
27651587|NCT00614614|80564675|FG001|Booster Vaccination Phase|Adverse Event|0|||
27651588|NCT00614614|80564676|FG002|Booster Vaccination Phase|Adverse Event|1|||
27651589|NCT00614614|80564677|FG003|Booster Vaccination Phase|Adverse Event|1|||
27651590|NCT00614614|80564678|FG004|Booster Vaccination Phase|Adverse Event|0|||
27651591|NCT00614614|80564674|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
27651592|NCT00614614|80564675|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
27651593|NCT00614614|80564676|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
27651594|NCT00614614|80564677|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
27651595|NCT00614614|80564678|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
27651596|NCT00614614|80564674|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
27651597|NCT00614614|80564675|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
27651598|NCT00614614|80564676|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
27651599|NCT00614614|80564677|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
27651600|NCT00614614|80564678|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
27651601|NCT00614614|80564674|FG000|Booster Vaccination Phase|Protocol Violation|0|||
27651602|NCT00614614|80564675|FG001|Booster Vaccination Phase|Protocol Violation|0|||
27651603|NCT00614614|80564676|FG002|Booster Vaccination Phase|Protocol Violation|2|||
27651604|NCT00614614|80564677|FG003|Booster Vaccination Phase|Protocol Violation|3|||
27651605|NCT00614614|80564678|FG004|Booster Vaccination Phase|Protocol Violation|0|||
27651606|NCT00614614|80564674|FG000|Booster Vaccination Phase|Other|0|||
27651607|NCT00614614|80564675|FG001|Booster Vaccination Phase|Other|1|||
27651608|NCT00614614|80564676|FG002|Booster Vaccination Phase|Other|3|||
27651609|NCT00614614|80564677|FG003|Booster Vaccination Phase|Other|2|||
27651610|NCT00614614|80564678|FG004|Booster Vaccination Phase|Other|1|||
27651611|NCT02224755|80564680|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
27651612|NCT02224755|80564681|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
27651613|NCT02224755|80564680|FG000|Two Year Follow up Post-implant|Death|103|||
27651614|NCT02224755|80564681|FG001|Two Year Follow up Post-implant|Death|98|||
27651615|NCT02224755|80564680|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
27651616|NCT02224755|80564681|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
27651617|NCT02224755|80564680|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
27651618|NCT02224755|80564681|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
27651619|NCT02224755|80564680|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
27651620|NCT02224755|80564681|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
27651621|NCT00929526|80564682|FG000|Overall Study|Withdrawal by Subject|1|||
27651622|NCT00929526|80564683|FG001|Overall Study|Withdrawal by Subject|11|||
27651623|NCT00929526|80564682|FG000|Overall Study|Lost to Follow-up|8|||
27651624|NCT00929526|80564683|FG001|Overall Study|Lost to Follow-up|12|||
27651625|NCT00929526|80564682|FG000|Overall Study|Other|8|||
27651626|NCT00929526|80564683|FG001|Overall Study|Other|6|||
27651627|NCT03072862|80564684|FG000|Overall Study|Withdrawal by Subject|4|||
27651628|NCT03072862|80564684|FG000|Overall Study|Lost to Follow-up|6|||
27651629|NCT03072862|80564684|FG000|Overall Study|Protocol Violation|4|||
27651630|NCT03072862|80564684|FG000|Overall Study|Physician Decision|2|||
27651631|NCT03072862|80564684|FG000|Overall Study|Death|1|||
27651632|NCT03072862|80564684|FG000|Overall Study|Adverse Event|1|||
27651633|NCT04237792|80564686|FG000|Treatment (Day 1)|Adverse Event|1|||
27651634|NCT04237792|80564687|FG001|Treatment (Day 1)|Adverse Event|0|||
27651635|NCT04237792|80564688|FG002|Treatment (Day 1)|Adverse Event|0|||
27651636|NCT04237792|80564689|FG003|Treatment (Day 1)|Adverse Event|0|||
27651637|NCT04237792|80564690|FG004|Treatment (Day 1)|Adverse Event|1|||
27651638|NCT04237792|80564691|FG005|Treatment (Day 1)|Adverse Event|1|||
27651639|NCT04237792|80564686|FG000|Treatment (Day 1)|Other|0|||
27651640|NCT04237792|80564687|FG001|Treatment (Day 1)|Other|0|||
27651641|NCT04237792|80564688|FG002|Treatment (Day 1)|Other|1|||
27651642|NCT04237792|80564689|FG003|Treatment (Day 1)|Other|0|||
27651643|NCT04237792|80564690|FG004|Treatment (Day 1)|Other|0|||
27651644|NCT04237792|80564691|FG005|Treatment (Day 1)|Other|1|||
27651645|NCT04237792|80564686|FG000|Treatment (Day 1)|Not treated|1|||
27651646|NCT04237792|80564687|FG001|Treatment (Day 1)|Not treated|1|||
27651647|NCT04237792|80564688|FG002|Treatment (Day 1)|Not treated|2|||
27651648|NCT04237792|80564689|FG003|Treatment (Day 1)|Not treated|1|||
27651649|NCT04237792|80564690|FG004|Treatment (Day 1)|Not treated|0|||
27651650|NCT04237792|80564691|FG005|Treatment (Day 1)|Not treated|1|||
27651651|NCT02338999|80564695|FG000|First Intervention|Withdrawal by Subject|3|||
27651652|NCT02338999|80564696|FG001|First Intervention|Withdrawal by Subject|1|||
27651653|NCT02338999|80564695|FG000|Washout Period|Withdrawal by Subject|0|||
27651654|NCT02338999|80564696|FG001|Washout Period|Withdrawal by Subject|2|||
27651655|NCT02338999|80564695|FG000|Second Intervention|Withdrawal by Subject|0|||
27651656|NCT02338999|80564696|FG001|Second Intervention|Withdrawal by Subject|2|||
27651657|NCT02309515|80564698|FG000|Overall Study|Withdrawal by Subject|0|||
27651658|NCT02309515|80564699|FG001|Overall Study|Withdrawal by Subject|1|||
27651659|NCT00878189|80564700|FG000|Overall Study|Death|0|||
27651660|NCT00878189|80564701|FG001|Overall Study|Death|1|||
27651661|NCT00878189|80564702|FG002|Overall Study|Death|0|||
27651662|NCT00878189|80564703|FG003|Overall Study|Death|1|||
27651663|NCT00878189|80564704|FG004|Overall Study|Death|0|||
27651664|NCT00878189|80564705|FG005|Overall Study|Death|0|||
27651665|NCT00878189|80564706|FG006|Overall Study|Death|0|||
27651666|NCT00878189|80564707|FG007|Overall Study|Death|0|||
27651667|NCT00878189|80564708|FG008|Overall Study|Death|1|||
27651668|NCT00878189|80564700|FG000|Overall Study|Participant Refused to Follow-up|0|||
27651669|NCT00878189|80564701|FG001|Overall Study|Participant Refused to Follow-up|0|||
27651670|NCT00878189|80564702|FG002|Overall Study|Participant Refused to Follow-up|0|||
27651671|NCT00878189|80564703|FG003|Overall Study|Participant Refused to Follow-up|0|||
27651672|NCT00878189|80564704|FG004|Overall Study|Participant Refused to Follow-up|0|||
27651673|NCT00878189|80564705|FG005|Overall Study|Participant Refused to Follow-up|4|||
27651674|NCT00878189|80564706|FG006|Overall Study|Participant Refused to Follow-up|0|||
27651675|NCT00878189|80564707|FG007|Overall Study|Participant Refused to Follow-up|0|||
27651676|NCT00878189|80564708|FG008|Overall Study|Participant Refused to Follow-up|0|||
27651677|NCT00878189|80564700|FG000|Overall Study|Other|3|||
27651678|NCT00878189|80564701|FG001|Overall Study|Other|2|||
27651679|NCT00878189|80564702|FG002|Overall Study|Other|4|||
27651680|NCT00878189|80564703|FG003|Overall Study|Other|7|||
27651681|NCT00878189|80564704|FG004|Overall Study|Other|4|||
27651682|NCT00878189|80564705|FG005|Overall Study|Other|18|||
27651683|NCT00878189|80564706|FG006|Overall Study|Other|15|||
27651684|NCT00878189|80564707|FG007|Overall Study|Other|3|||
27651685|NCT00878189|80564708|FG008|Overall Study|Other|4|||
27651686|NCT00878189|80564700|FG000|Overall Study|Lost to Follow-up|0|||
27651687|NCT00878189|80564701|FG001|Overall Study|Lost to Follow-up|0|||
27651688|NCT00878189|80564702|FG002|Overall Study|Lost to Follow-up|0|||
27651689|NCT00878189|80564703|FG003|Overall Study|Lost to Follow-up|0|||
27651690|NCT00878189|80564704|FG004|Overall Study|Lost to Follow-up|0|||
27651691|NCT00878189|80564705|FG005|Overall Study|Lost to Follow-up|1|||
27651692|NCT00878189|80564706|FG006|Overall Study|Lost to Follow-up|1|||
27651693|NCT00878189|80564707|FG007|Overall Study|Lost to Follow-up|0|||
27651694|NCT00878189|80564708|FG008|Overall Study|Lost to Follow-up|0|||
27651695|NCT00878189|80564700|FG000|Overall Study|Objection Progression or Relapse|0|||
27651696|NCT00878189|80564701|FG001|Overall Study|Objection Progression or Relapse|0|||
27651697|NCT00878189|80564702|FG002|Overall Study|Objection Progression or Relapse|0|||
27651698|NCT00878189|80564703|FG003|Overall Study|Objection Progression or Relapse|0|||
27651699|NCT00878189|80564704|FG004|Overall Study|Objection Progression or Relapse|0|||
27651700|NCT00878189|80564705|FG005|Overall Study|Objection Progression or Relapse|0|||
27651701|NCT00878189|80564706|FG006|Overall Study|Objection Progression or Relapse|0|||
27651702|NCT00878189|80564707|FG007|Overall Study|Objection Progression or Relapse|0|||
27651703|NCT00878189|80564708|FG008|Overall Study|Objection Progression or Relapse|3|||
27651704|NCT01560429|80564714|FG000|Overall Study|Protocol Violation|3|||
27651705|NCT01560429|80564715|FG001|Overall Study|Protocol Violation|6|||
27651706|NCT01029704|80564716|FG000|Overall Study|Adverse Event|0|||
27651707|NCT01029704|80564717|FG001|Overall Study|Adverse Event|0|||
27651708|NCT01029704|80564718|FG002|Overall Study|Adverse Event|0|||
27651709|NCT01029704|80564719|FG003|Overall Study|Adverse Event|0|||
27651710|NCT01029704|80564720|FG004|Overall Study|Adverse Event|0|||
27651711|NCT01029704|80564721|FG005|Overall Study|Adverse Event|0|||
27651712|NCT01029704|80564722|FG006|Overall Study|Adverse Event|1|||
27651713|NCT01029704|80564723|FG007|Overall Study|Adverse Event|1|||
27651714|NCT01029704|80564724|FG008|Overall Study|Adverse Event|0|||
27651715|NCT01029704|80564716|FG000|Overall Study|Withdrawal by Subject|0|||
27651716|NCT01029704|80564717|FG001|Overall Study|Withdrawal by Subject|0|||
27651717|NCT01029704|80564718|FG002|Overall Study|Withdrawal by Subject|0|||
27651718|NCT01029704|80564719|FG003|Overall Study|Withdrawal by Subject|0|||
27651719|NCT01029704|80564720|FG004|Overall Study|Withdrawal by Subject|2|||
27651720|NCT01029704|80564721|FG005|Overall Study|Withdrawal by Subject|1|||
27651721|NCT01029704|80564722|FG006|Overall Study|Withdrawal by Subject|1|||
27651722|NCT01029704|80564723|FG007|Overall Study|Withdrawal by Subject|1|||
27651723|NCT01029704|80564724|FG008|Overall Study|Withdrawal by Subject|0|||
27651724|NCT01029704|80564716|FG000|Overall Study|Lost to Follow-up|0|||
27651725|NCT01029704|80564717|FG001|Overall Study|Lost to Follow-up|0|||
27651726|NCT01029704|80564718|FG002|Overall Study|Lost to Follow-up|0|||
27651727|NCT01029704|80564719|FG003|Overall Study|Lost to Follow-up|0|||
27651728|NCT01029704|80564720|FG004|Overall Study|Lost to Follow-up|0|||
27651729|NCT01029704|80564721|FG005|Overall Study|Lost to Follow-up|0|||
27651730|NCT01029704|80564722|FG006|Overall Study|Lost to Follow-up|1|||
27651731|NCT01029704|80564723|FG007|Overall Study|Lost to Follow-up|1|||
27651732|NCT01029704|80564724|FG008|Overall Study|Lost to Follow-up|1|||
27651733|NCT01029704|80564716|FG000|Overall Study|Lack of Efficacy|0|||
27651734|NCT01029704|80564717|FG001|Overall Study|Lack of Efficacy|0|||
27651735|NCT01029704|80564718|FG002|Overall Study|Lack of Efficacy|0|||
27651736|NCT01029704|80564719|FG003|Overall Study|Lack of Efficacy|0|||
27651737|NCT01029704|80564720|FG004|Overall Study|Lack of Efficacy|2|||
27651738|NCT01029704|80564721|FG005|Overall Study|Lack of Efficacy|3|||
27651739|NCT01029704|80564722|FG006|Overall Study|Lack of Efficacy|1|||
27651740|NCT01029704|80564723|FG007|Overall Study|Lack of Efficacy|2|||
27651741|NCT01029704|80564724|FG008|Overall Study|Lack of Efficacy|0|||
27651742|NCT01029704|80564716|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
27651743|NCT01029704|80564717|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
27651744|NCT01029704|80564718|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
27651745|NCT01029704|80564719|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
27651746|NCT01029704|80564720|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
27651747|NCT01029704|80564721|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
27651748|NCT01029704|80564722|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
27651749|NCT01029704|80564723|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
27651750|NCT01029704|80564724|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
27651751|NCT01214200|80564725|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
27651752|NCT01214200|80564725|FG000|Overall Study|Withdrawal by Subject|2|||
27651753|NCT01316913|80564726|FG000|Overall Study|Adverse Event|17|||
27651754|NCT01316913|80564727|FG001|Overall Study|Adverse Event|20|||
27651755|NCT01316913|80564728|FG002|Overall Study|Adverse Event|15|||
27651756|NCT01316913|80564729|FG003|Overall Study|Adverse Event|11|||
27651757|NCT01316913|80564726|FG000|Overall Study|Lack of Efficacy|22|||
27651758|NCT01316913|80564727|FG001|Overall Study|Lack of Efficacy|12|||
27651759|NCT01316913|80564728|FG002|Overall Study|Lack of Efficacy|9|||
27651760|NCT01316913|80564729|FG003|Overall Study|Lack of Efficacy|13|||
27651761|NCT01316913|80564726|FG000|Overall Study|Protocol Violation|1|||
27651762|NCT01316913|80564727|FG001|Overall Study|Protocol Violation|4|||
27651763|NCT01316913|80564728|FG002|Overall Study|Protocol Violation|4|||
27651764|NCT01316913|80564729|FG003|Overall Study|Protocol Violation|1|||
27651765|NCT01316913|80564726|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
27651766|NCT01316913|80564727|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
27651767|NCT01316913|80564728|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
27651768|NCT01316913|80564729|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
27651769|NCT01316913|80564726|FG000|Overall Study|Lost to Follow-up|0|||
27651770|NCT01316913|80564727|FG001|Overall Study|Lost to Follow-up|1|||
27651771|NCT01316913|80564728|FG002|Overall Study|Lost to Follow-up|0|||
27651772|NCT01316913|80564729|FG003|Overall Study|Lost to Follow-up|2|||
27651773|NCT01316913|80564726|FG000|Overall Study|Withdrawal by Subject|10|||
27651774|NCT01316913|80564727|FG001|Overall Study|Withdrawal by Subject|9|||
27651775|NCT01316913|80564728|FG002|Overall Study|Withdrawal by Subject|10|||
27651776|NCT01316913|80564729|FG003|Overall Study|Withdrawal by Subject|6|||
27651777|NCT02309892|80564730|FG000|Overall Study|Physician Decision|1|||
27651778|NCT02309892|80564731|FG001|Overall Study|Physician Decision|0|||
27651779|NCT02309892|80564732|FG002|Overall Study|Physician Decision|0|||
27651780|NCT02309892|80564733|FG003|Overall Study|Physician Decision|0|||
27651781|NCT02309892|80564734|FG004|Overall Study|Physician Decision|0|||
27651782|NCT02309892|80564735|FG005|Overall Study|Physician Decision|0|||
27651783|NCT02309892|80564736|FG006|Overall Study|Physician Decision|0|||
27651784|NCT02309892|80564730|FG000|Overall Study|Adverse Event|1|||
27651785|NCT02309892|80564731|FG001|Overall Study|Adverse Event|0|||
27651786|NCT02309892|80564732|FG002|Overall Study|Adverse Event|1|||
27651787|NCT02309892|80564733|FG003|Overall Study|Adverse Event|0|||
27651788|NCT02309892|80564734|FG004|Overall Study|Adverse Event|0|||
27651789|NCT02309892|80564735|FG005|Overall Study|Adverse Event|0|||
27651790|NCT02309892|80564736|FG006|Overall Study|Adverse Event|0|||
27651791|NCT02309892|80564730|FG000|Overall Study|Progressive Disease|0|||
27651792|NCT02309892|80564731|FG001|Overall Study|Progressive Disease|1|||
27651793|NCT02309892|80564732|FG002|Overall Study|Progressive Disease|0|||
27651794|NCT02309892|80564733|FG003|Overall Study|Progressive Disease|0|||
27651795|NCT02309892|80564734|FG004|Overall Study|Progressive Disease|1|||
27651796|NCT02309892|80564735|FG005|Overall Study|Progressive Disease|0|||
27651797|NCT02309892|80564736|FG006|Overall Study|Progressive Disease|0|||
27651798|NCT02309892|80564730|FG000|Overall Study|Death|0|||
27651799|NCT02309892|80564731|FG001|Overall Study|Death|0|||
27651800|NCT02309892|80564732|FG002|Overall Study|Death|0|||
27651801|NCT02309892|80564733|FG003|Overall Study|Death|0|||
27651802|NCT02309892|80564734|FG004|Overall Study|Death|0|||
27651803|NCT02309892|80564735|FG005|Overall Study|Death|1|||
27651804|NCT02309892|80564736|FG006|Overall Study|Death|0|||
27651805|NCT02367794|80564739|FG000|Overall Study|Death|252|||
27651806|NCT02367794|80564740|FG001|Overall Study|Death|245|||
27651807|NCT02367794|80564741|FG002|Overall Study|Death|243|||
27651808|NCT02367794|80564739|FG000|Overall Study|Lost to Follow-up|1|||
27651809|NCT02367794|80564740|FG001|Overall Study|Lost to Follow-up|2|||
27651810|NCT02367794|80564741|FG002|Overall Study|Lost to Follow-up|2|||
27651811|NCT02367794|80564739|FG000|Overall Study|Physician Decision|0|||
27651812|NCT02367794|80564740|FG001|Overall Study|Physician Decision|5|||
27750055|NCT05118386|80909739|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
27750056|NCT05058664|80909740|FG000|Overall Study|No follow-up data provided|4|||
27959312|NCT02131662|81683273|FG004|Overall Study|Pregnancy|0|||
27651813|NCT02367794|80564741|FG002|Overall Study|Physician Decision|3|||
27651814|NCT02367794|80564739|FG000|Overall Study|Protocol Violation|1|||
27651815|NCT02367794|80564740|FG001|Overall Study|Protocol Violation|0|||
27651816|NCT02367794|80564741|FG002|Overall Study|Protocol Violation|1|||
27651817|NCT02367794|80564739|FG000|Overall Study|Withdrawal by Subject|25|||
27651818|NCT02367794|80564740|FG001|Overall Study|Withdrawal by Subject|12|||
27651819|NCT02367794|80564741|FG002|Overall Study|Withdrawal by Subject|20|||
27651820|NCT02367794|80564739|FG000|Overall Study|Brain metastasis|1|||
27651821|NCT02367794|80564740|FG001|Overall Study|Brain metastasis|0|||
27651822|NCT02367794|80564741|FG002|Overall Study|Brain metastasis|0|||
27651823|NCT02367794|80564739|FG000|Overall Study|Randomized in error|0|||
27651824|NCT02367794|80564740|FG001|Overall Study|Randomized in error|0|||
27651825|NCT02367794|80564741|FG002|Overall Study|Randomized in error|1|||
27651826|NCT02367794|80564739|FG000|Overall Study|Patient unable to receive carboplatin|0|||
27651827|NCT02367794|80564740|FG001|Overall Study|Patient unable to receive carboplatin|0|||
27651828|NCT02367794|80564741|FG002|Overall Study|Patient unable to receive carboplatin|1|||
27651829|NCT02367794|80564739|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
27651830|NCT02367794|80564740|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
27651831|NCT02367794|80564741|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
27651832|NCT02367794|80564739|FG000|Overall Study|Adverse Event|0|||
27651833|NCT02367794|80564740|FG001|Overall Study|Adverse Event|0|||
27651834|NCT02367794|80564741|FG002|Overall Study|Adverse Event|2|||
27651835|NCT02367794|80564739|FG000|Overall Study|Study Terminated By Sponsor|0|||
27651836|NCT02367794|80564740|FG001|Overall Study|Study Terminated By Sponsor|1|||
27651837|NCT02367794|80564741|FG002|Overall Study|Study Terminated By Sponsor|1|||
27651838|NCT02367794|80564739|FG000|Overall Study|Moved to Roll-Over Study|0|||
27651839|NCT02367794|80564740|FG001|Overall Study|Moved to Roll-Over Study|15|||
27651840|NCT02367794|80564741|FG002|Overall Study|Moved to Roll-Over Study|13|||
27651841|NCT02367794|80564739|FG000|Overall Study|Sponsor Request|60|||
27651842|NCT02367794|80564740|FG001|Overall Study|Sponsor Request|57|||
27651843|NCT02367794|80564741|FG002|Overall Study|Sponsor Request|45|||
27651844|NCT02367794|80564739|FG000|Overall Study|Moved into PTAP Study|0|||
27651845|NCT02367794|80564740|FG001|Overall Study|Moved into PTAP Study|2|||
27651846|NCT02367794|80564741|FG002|Overall Study|Moved into PTAP Study|3|||
27651847|NCT02367794|80564739|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
27651848|NCT02367794|80564740|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
27651849|NCT02367794|80564741|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
27651850|NCT02367794|80564739|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
27750057|NCT05058664|80909741|FG001|Overall Study|No follow-up data provided|0|||
27750058|NCT05058664|80909742|FG002|Overall Study|No follow-up data provided|2|||
27750059|NCT05058664|80909740|FG000|Overall Study|Withdrawal by Subject|0|||
27750060|NCT05058664|80909741|FG001|Overall Study|Withdrawal by Subject|0|||
27953160|NCT02300233|81662469|FG001|Overall Study|Reason Not Specified|0|||
27953161|NCT02300233|81662470|FG002|Overall Study|Reason Not Specified|5|||
27551487|NCT01543698|80207460|FG002|Phase 2|Adverse Event|0|||
27551488|NCT01543698|80207461|FG003|Phase 2|Adverse Event|0|||
27551489|NCT01543698|80207462|FG004|Phase 2|Adverse Event|0|||
27551490|NCT01543698|80207463|FG005|Phase 2|Adverse Event|0|||
27551491|NCT01543698|80207464|FG006|Phase 2|Adverse Event|0|||
27551492|NCT01543698|80207465|FG007|Phase 2|Adverse Event|0|||
27551493|NCT01543698|80207466|FG008|Phase 2|Adverse Event|0|||
27551494|NCT01543698|80207467|FG009|Phase 2|Adverse Event|0|||
27551495|NCT01543698|80207468|FG010|Phase 2|Adverse Event|0|||
27551496|NCT01543698|80207469|FG011|Phase 2|Adverse Event|1|||
27551497|NCT01543698|80207470|FG012|Phase 2|Adverse Event|3|||
27551498|NCT01543698|80207471|FG013|Phase 2|Adverse Event|5|||
27551499|NCT01543698|80207472|FG014|Phase 2|Adverse Event|14|||
27551500|NCT00307294|80207473|FG000|Overall Study|Withdrawal by Subject|1|||
27551501|NCT01532414|80207476|FG000|Overall Study|Lost to Follow-up|3|||
27551502|NCT01532414|80207477|FG001|Overall Study|Lost to Follow-up|0|||
27551503|NCT01532414|80207478|FG002|Overall Study|Lost to Follow-up|1|||
27551504|NCT01532414|80207476|FG000|Overall Study|Withdrawal by Subject|3|||
27551505|NCT01532414|80207477|FG001|Overall Study|Withdrawal by Subject|0|||
27551506|NCT01532414|80207478|FG002|Overall Study|Withdrawal by Subject|0|||
27551507|NCT01532414|80207476|FG000|Overall Study|No V6 semen sample|0|||
27551508|NCT01532414|80207477|FG001|Overall Study|No V6 semen sample|1|||
27551509|NCT01532414|80207478|FG002|Overall Study|No V6 semen sample|0|||
27551510|NCT01532414|80207476|FG000|Overall Study|Adverse Event|0|||
27551511|NCT01532414|80207477|FG001|Overall Study|Adverse Event|1|||
27551512|NCT01532414|80207478|FG002|Overall Study|Adverse Event|1|||
27551513|NCT01532414|80207476|FG000|Overall Study|Unable to complete 24 hour PK|0|||
27551514|NCT01532414|80207477|FG001|Overall Study|Unable to complete 24 hour PK|0|||
27551515|NCT01532414|80207478|FG002|Overall Study|Unable to complete 24 hour PK|1|||
27551516|NCT01532414|80207476|FG000|Overall Study|Withdrawn by sponsor|1|||
27551517|NCT01532414|80207477|FG001|Overall Study|Withdrawn by sponsor|0|||
27551518|NCT01532414|80207478|FG002|Overall Study|Withdrawn by sponsor|0|||
27551519|NCT02270957|80207479|FG000|Overall Study|Lack of Efficacy|2|||
27551520|NCT02270957|80207480|FG001|Overall Study|Lack of Efficacy|4|||
27551521|NCT02270957|80207479|FG000|Overall Study|Adverse Event|2|||
27551522|NCT02270957|80207480|FG001|Overall Study|Adverse Event|0|||
27551523|NCT01482884|80207482|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
27551524|NCT01482884|80207483|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
27551525|NCT01482884|80207482|FG000|Overall Study|Protocol Violation|1|||
27551526|NCT01482884|80207483|FG001|Overall Study|Protocol Violation|0|||
27551527|NCT01482884|80207482|FG000|Overall Study|Lost to Follow-up|2|||
27551528|NCT01482884|80207483|FG001|Overall Study|Lost to Follow-up|2|||
27651851|NCT02367794|80564740|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
27651852|NCT02367794|80564741|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
27651853|NCT02367794|80564739|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
27750061|NCT05058664|80909742|FG002|Overall Study|Withdrawal by Subject|1|||
27750062|NCT04285346|80909743|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
27750063|NCT04285346|80909744|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
27953162|NCT02343302|81662473|FG000|Overall Study|Physician Decision|1|||
27953163|NCT02343302|81662474|FG001|Overall Study|Physician Decision|1|||
27953164|NCT01493414|81662476|FG000|Overall Study|Adverse Event|405|||
27953165|NCT01493414|81662476|FG000|Overall Study|Disease progression|204|||
27953166|NCT01493414|81662476|FG000|Overall Study|Death|101|||
27953167|NCT01493414|81662476|FG000|Overall Study|Physician Decision|93|||
27953168|NCT01493414|81662476|FG000|Overall Study|Withdrawal by Subject|79|||
27953169|NCT01493414|81662476|FG000|Overall Study|Protocol deviation|27|||
27953170|NCT01493414|81662476|FG000|Overall Study|Administrative problems|25|||
27953171|NCT01493414|81662476|FG000|Overall Study|Lost to Follow-up|16|||
27953172|NCT02379052|81662480|FG000|Overall Study|Protocol Violation|0|||
27953173|NCT02379052|81662481|FG001|Overall Study|Protocol Violation|1|||
27953174|NCT02379052|81662480|FG000|Overall Study|Adverse Event|0|||
27953175|NCT02379052|81662481|FG001|Overall Study|Adverse Event|1|||
27953176|NCT02379052|81662480|FG000|Overall Study|Physician Decision|1|||
27953177|NCT02379052|81662481|FG001|Overall Study|Physician Decision|1|||
27953178|NCT02379052|81662480|FG000|Overall Study|Withdrawal by Subject|2|||
27953179|NCT02379052|81662481|FG001|Overall Study|Withdrawal by Subject|0|||
27953180|NCT02379052|81662480|FG000|Overall Study|Lost to Follow-up|2|||
27953181|NCT02379052|81662481|FG001|Overall Study|Lost to Follow-up|1|||
27953182|NCT02379052|81662480|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
27953183|NCT02379052|81662481|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
27953184|NCT02379052|81662480|FG000|Overall Study|Subject was Incarcerated|0|||
27953185|NCT02379052|81662481|FG001|Overall Study|Subject was Incarcerated|1|||
27651854|NCT02367794|80564740|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
27651855|NCT02367794|80564741|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
27651856|NCT02367794|80564739|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
27651857|NCT02367794|80564740|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
27651858|NCT02367794|80564741|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
27651859|NCT00886834|80564742|FG000|Overall Study|Protocol Violation|0|||
27651860|NCT00886834|80564743|FG001|Overall Study|Protocol Violation|3|||
27651861|NCT00446095|80564744|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
27651862|NCT00446095|80564745|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
27651863|NCT00446095|80564746|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
27651864|NCT00446095|80564747|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
27651865|NCT00446095|80564748|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
27651866|NCT00446095|80564744|FG000|Phase II (8 Weeks)|Adverse Event|0|||
27651867|NCT00446095|80564745|FG001|Phase II (8 Weeks)|Adverse Event|1|||
27651868|NCT00446095|80564746|FG002|Phase II (8 Weeks)|Adverse Event|1|||
27651869|NCT00446095|80564747|FG003|Phase II (8 Weeks)|Adverse Event|0|||
27651870|NCT00446095|80564748|FG004|Phase II (8 Weeks)|Adverse Event|0|||
27651871|NCT00446095|80564744|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
27651872|NCT00446095|80564745|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27651873|NCT00446095|80564746|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27651874|NCT00446095|80564747|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27651875|NCT00446095|80564748|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
27651876|NCT00446095|80564744|FG000|Phase II (8 Weeks)|Physician Decision|1|||
27651877|NCT00446095|80564745|FG001|Phase II (8 Weeks)|Physician Decision|0|||
27651878|NCT00446095|80564746|FG002|Phase II (8 Weeks)|Physician Decision|0|||
27651879|NCT00446095|80564747|FG003|Phase II (8 Weeks)|Physician Decision|0|||
27651880|NCT00446095|80564748|FG004|Phase II (8 Weeks)|Physician Decision|0|||
27651881|NCT00446095|80564744|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
27651882|NCT00446095|80564745|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
27651883|NCT00446095|80564746|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
27651884|NCT00446095|80564747|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
27651885|NCT00446095|80564748|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
27651886|NCT00446095|80564744|FG000|Phase II (8 Weeks)|Ongoing|0|||
27651887|NCT00446095|80564745|FG001|Phase II (8 Weeks)|Ongoing|0|||
27651888|NCT00446095|80564746|FG002|Phase II (8 Weeks)|Ongoing|1|||
27651889|NCT00446095|80564747|FG003|Phase II (8 Weeks)|Ongoing|0|||
27651890|NCT00446095|80564748|FG004|Phase II (8 Weeks)|Ongoing|0|||
27651891|NCT00446095|80564744|FG000|Phase I (28 Days)|Adverse Event|0|||
27651892|NCT00446095|80564745|FG001|Phase I (28 Days)|Adverse Event|0|||
27750064|NCT04285346|80909743|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
27953186|NCT02297412|81662482|FG000|Overall Study|Canceled|1|||
27953187|NCT02297412|81662483|FG001|Overall Study|Canceled|1|||
27953188|NCT01882465|81662484|FG000|Period 1|Lens Discomfort|0|||
27953189|NCT01882465|81662485|FG001|Period 1|Lens Discomfort|0|||
27651893|NCT00446095|80564746|FG002|Phase I (28 Days)|Adverse Event|0|||
27651894|NCT00446095|80564747|FG003|Phase I (28 Days)|Adverse Event|1|||
27651895|NCT00446095|80564748|FG004|Phase I (28 Days)|Adverse Event|0|||
27651896|NCT00446095|80564744|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
27651897|NCT00446095|80564745|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
27953190|NCT01882465|81662486|FG002|Period 1|Lens Discomfort|0|||
27953191|NCT01882465|81662487|FG003|Period 1|Lens Discomfort|1|||
27953192|NCT01882465|81662488|FG004|Period 1|Lens Discomfort|0|||
27953193|NCT01882465|81662489|FG005|Period 1|Lens Discomfort|0|||
27953194|NCT01882465|81662490|FG006|Period 1|Lens Discomfort|0|||
27953195|NCT01882465|81662484|FG000|Period 1|Withdrawal by Subject|0|||
27953196|NCT01882465|81662485|FG001|Period 1|Withdrawal by Subject|0|||
27953197|NCT01882465|81662486|FG002|Period 1|Withdrawal by Subject|0|||
27953198|NCT01882465|81662487|FG003|Period 1|Withdrawal by Subject|0|||
27953199|NCT01882465|81662488|FG004|Period 1|Withdrawal by Subject|0|||
27953200|NCT01882465|81662489|FG005|Period 1|Withdrawal by Subject|0|||
27953201|NCT01882465|81662490|FG006|Period 1|Withdrawal by Subject|1|||
27953202|NCT01882465|81662484|FG000|Period 2|Protocol Violation|0|||
27953203|NCT01882465|81662485|FG001|Period 2|Protocol Violation|0|||
27953204|NCT01882465|81662486|FG002|Period 2|Protocol Violation|0|||
27953205|NCT01882465|81662487|FG003|Period 2|Protocol Violation|0|||
27953206|NCT01882465|81662488|FG004|Period 2|Protocol Violation|1|||
27953207|NCT01882465|81662489|FG005|Period 2|Protocol Violation|0|||
27953208|NCT01882465|81662490|FG006|Period 2|Protocol Violation|0|||
27953209|NCT01979614|81662498|FG000|Overall Study|Adverse Event|1|||
27953210|NCT01979614|81662499|FG001|Overall Study|Adverse Event|1|||
27953211|NCT01865487|81662505|FG000|Overall Study|Lost to Follow-up|0|||
27953212|NCT01865487|81662506|FG001|Overall Study|Lost to Follow-up|0|||
27953213|NCT01865487|81662507|FG002|Overall Study|Lost to Follow-up|0|||
27953214|NCT01865487|81662508|FG003|Overall Study|Lost to Follow-up|1|||
27953215|NCT01865487|81662509|FG004|Overall Study|Lost to Follow-up|0|||
27953216|NCT01865487|81662510|FG005|Overall Study|Lost to Follow-up|0|||
27953217|NCT01865487|81662511|FG006|Overall Study|Lost to Follow-up|1|||
27953218|NCT01865487|81662512|FG007|Overall Study|Lost to Follow-up|0|||
27953219|NCT01865487|81662513|FG008|Overall Study|Lost to Follow-up|0|||
27953220|NCT01865487|81662514|FG009|Overall Study|Lost to Follow-up|0|||
27953221|NCT01865487|81662505|FG000|Overall Study|Withdrawal by Subject|0|||
27953222|NCT01865487|81662506|FG001|Overall Study|Withdrawal by Subject|0|||
27953223|NCT01865487|81662507|FG002|Overall Study|Withdrawal by Subject|0|||
27953224|NCT01865487|81662508|FG003|Overall Study|Withdrawal by Subject|0|||
27953225|NCT01865487|81662509|FG004|Overall Study|Withdrawal by Subject|1|||
27953226|NCT01865487|81662510|FG005|Overall Study|Withdrawal by Subject|0|||
27953227|NCT01865487|81662511|FG006|Overall Study|Withdrawal by Subject|0|||
27953228|NCT01865487|81662512|FG007|Overall Study|Withdrawal by Subject|0|||
27953229|NCT01865487|81662513|FG008|Overall Study|Withdrawal by Subject|0|||
27953230|NCT01865487|81662514|FG009|Overall Study|Withdrawal by Subject|0|||
27953231|NCT02013609|81662517|FG000|Overall Study|Withdrawal by Subject|9|||
27953232|NCT02013609|81662517|FG000|Overall Study|Lost to Follow-up|3|||
27953233|NCT02013609|81662517|FG000|Overall Study|Adverse Event|3|||
27953234|NCT02013609|81662517|FG000|Overall Study|Met Withdrawal Criteria|3|||
27953235|NCT03692403|81662520|FG000|Overall Study|Withdrawal by Subject|1|||
27953236|NCT03692403|81662521|FG001|Overall Study|Withdrawal by Subject|0|||
27953237|NCT03692403|81662522|FG002|Overall Study|Withdrawal by Subject|1|||
27953238|NCT03692403|81662523|FG003|Overall Study|Withdrawal by Subject|0|||
27953239|NCT03692403|81662520|FG000|Overall Study|Adverse Event|0|||
27953240|NCT03692403|81662521|FG001|Overall Study|Adverse Event|0|||
27953241|NCT03692403|81662522|FG002|Overall Study|Adverse Event|0|||
27953242|NCT03692403|81662523|FG003|Overall Study|Adverse Event|1|||
27953243|NCT03692403|81662520|FG000|Overall Study|Pregnancy|0|||
27953244|NCT03692403|81662521|FG001|Overall Study|Pregnancy|1|||
27953245|NCT03692403|81662522|FG002|Overall Study|Pregnancy|0|||
27953246|NCT03692403|81662523|FG003|Overall Study|Pregnancy|0|||
27953247|NCT03692403|81662520|FG000|Overall Study|Other|0|||
27953248|NCT03692403|81662521|FG001|Overall Study|Other|0|||
27953249|NCT03692403|81662522|FG002|Overall Study|Other|1|||
27953250|NCT03692403|81662523|FG003|Overall Study|Other|0|||
27953251|NCT01250054|81662524|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
27953252|NCT01250054|81662525|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
27953253|NCT02761642|81662526|FG000|Overall Study|Did not Receive Study Treatment|3|||
27953254|NCT02761642|81662526|FG000|Overall Study|Adverse Event|13|||
27953255|NCT02761642|81662526|FG000|Overall Study|Withdrawal by Subject|2|||
27953256|NCT02761642|81662526|FG000|Overall Study|Non-compliant|7|||
27953257|NCT02761642|81662526|FG000|Overall Study|Death|3|||
27953258|NCT02761642|81662526|FG000|Overall Study|Lack of Efficacy|20|||
27953259|NCT02761642|81662526|FG000|Overall Study|Physician Decision|1|||
27953260|NCT02761642|81662526|FG000|Overall Study|Reason Unspecified|21|||
27953261|NCT01088503|81662533|FG000|Overall Study|Withdrawal by Subject|118|||
27953262|NCT01088503|81662534|FG001|Overall Study|Withdrawal by Subject|327|||
27953263|NCT01088503|81662535|FG002|Overall Study|Withdrawal by Subject|10|||
27953264|NCT01088503|81662533|FG000|Overall Study|Death|64|||
27953265|NCT01088503|81662534|FG001|Overall Study|Death|358|||
27953266|NCT01088503|81662535|FG002|Overall Study|Death|7|||
27953267|NCT00776789|81662536|FG000|Overall Study|Consent refusal|2|||
27953268|NCT00776789|81662537|FG001|Overall Study|Consent refusal|2|||
27953269|NCT00776789|81662536|FG000|Overall Study|Poor quality video|1|||
27953270|NCT00776789|81662537|FG001|Overall Study|Poor quality video|1|||
27953271|NCT00546481|81662540|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
27953272|NCT00546481|81662541|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
27953273|NCT00546481|81662542|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
27953274|NCT00546481|81662540|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
27953275|NCT00546481|81662541|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
27953276|NCT00546481|81662542|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
27953277|NCT00546481|81662540|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
27953278|NCT00546481|81662541|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
27953279|NCT00546481|81662542|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
27953280|NCT00546481|81662540|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
27953281|NCT00546481|81662541|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
27953282|NCT00546481|81662542|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
27953283|NCT00546481|81662540|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
27953284|NCT00546481|81662541|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
27953285|NCT00546481|81662542|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
27953286|NCT00546481|81662540|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
27953287|NCT00546481|81662541|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
27953288|NCT00546481|81662542|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
27953289|NCT00546481|81662540|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
27953290|NCT00546481|81662541|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
27953291|NCT00546481|81662542|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
27953292|NCT00546481|81662540|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
27953293|NCT00546481|81662541|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
27953294|NCT00546481|81662542|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
27953295|NCT00546481|81662540|FG000|Maintenance Phase (CERA)|Other Reason|0|||
27953296|NCT00546481|81662541|FG001|Maintenance Phase (CERA)|Other Reason|0|||
27953297|NCT00546481|81662542|FG002|Maintenance Phase (CERA)|Other Reason|1|||
27953298|NCT00244621|81662545|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
27953299|NCT00244621|81662546|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
27953300|NCT00244621|81662547|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
27953301|NCT00244621|81662545|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
27953302|NCT00244621|81662546|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
27953303|NCT00244621|81662547|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
27953304|NCT00244621|81662545|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
27953305|NCT00244621|81662546|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
27953306|NCT00244621|81662547|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
27953307|NCT00244621|81662545|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
27953308|NCT00244621|81662546|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
27953309|NCT00244621|81662547|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
27953310|NCT00244621|81662545|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
27953311|NCT00244621|81662546|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
27953312|NCT00244621|81662547|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
27953313|NCT00244621|81662545|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
27953314|NCT00244621|81662546|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
27953315|NCT00244621|81662547|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
27953316|NCT00244621|81662545|FG000|Open-label Treatment Period|Adverse Event|0|||
27953317|NCT00244621|81662546|FG001|Open-label Treatment Period|Adverse Event|0|||
27953318|NCT00244621|81662547|FG002|Open-label Treatment Period|Adverse Event|1|||
27953319|NCT00244621|81662545|FG000|Open-label Treatment Period|Moved abroad|0|||
27953320|NCT00244621|81662546|FG001|Open-label Treatment Period|Moved abroad|0|||
27953321|NCT00244621|81662547|FG002|Open-label Treatment Period|Moved abroad|1|||
27953322|NCT02136914|81662548|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
27953323|NCT02136914|81662549|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
27953324|NCT02136914|81662548|FG000|Overall Study|Withdrawal by Subject|3|||
27953325|NCT02136914|81662549|FG001|Overall Study|Withdrawal by Subject|10|||
27953326|NCT02136914|81662548|FG000|Overall Study|Subject Unwilling to Proceed|7|||
27953327|NCT02136914|81662549|FG001|Overall Study|Subject Unwilling to Proceed|2|||
27953328|NCT02136914|81662548|FG000|Overall Study|Lost to Follow-up|1|||
27953329|NCT02136914|81662549|FG001|Overall Study|Lost to Follow-up|1|||
27953330|NCT02136914|81662548|FG000|Overall Study|Did Not Receive Study Drug|2|||
27953331|NCT02136914|81662549|FG001|Overall Study|Did Not Receive Study Drug|0|||
27953332|NCT02136914|81662548|FG000|Overall Study|Lack of Efficacy|1|||
27953333|NCT02136914|81662549|FG001|Overall Study|Lack of Efficacy|0|||
27953334|NCT02136914|81662548|FG000|Overall Study|Death|0|||
27953335|NCT02136914|81662549|FG001|Overall Study|Death|1|||
27750065|NCT04285346|80909744|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
27953336|NCT01870869|81662550|FG000|Overall Study|Implanted with nonstudy device|1|||
27953337|NCT01870869|81662551|FG001|Overall Study|Implanted with nonstudy device|3|||
27750066|NCT04285346|80909743|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
27953338|NCT01870869|81662552|FG002|Overall Study|Implanted with nonstudy device|14|||
27953339|NCT01870869|81662553|FG003|Overall Study|Implanted with nonstudy device|4|||
27953340|NCT01870869|81662550|FG000|Overall Study|Death|0|||
27953341|NCT01870869|81662551|FG001|Overall Study|Death|0|||
27953342|NCT01870869|81662552|FG002|Overall Study|Death|7|||
27953343|NCT01870869|81662553|FG003|Overall Study|Death|1|||
27953344|NCT01870869|81662550|FG000|Overall Study|Subject choice|6|||
27953345|NCT01870869|81662551|FG001|Overall Study|Subject choice|2|||
27953346|NCT01870869|81662552|FG002|Overall Study|Subject choice|22|||
27953347|NCT01870869|81662553|FG003|Overall Study|Subject choice|8|||
27953348|NCT01870869|81662550|FG000|Overall Study|Lost to Follow-up|10|||
27953349|NCT01870869|81662551|FG001|Overall Study|Lost to Follow-up|2|||
27953350|NCT01870869|81662552|FG002|Overall Study|Lost to Follow-up|25|||
27953351|NCT01870869|81662553|FG003|Overall Study|Lost to Follow-up|3|||
27953352|NCT01870869|81662550|FG000|Overall Study|Reason not Specified|1|||
27953353|NCT01870869|81662551|FG001|Overall Study|Reason not Specified|2|||
27953354|NCT01870869|81662552|FG002|Overall Study|Reason not Specified|20|||
27953355|NCT01870869|81662553|FG003|Overall Study|Reason not Specified|4|||
27953356|NCT01870869|81662550|FG000|Overall Study|Not evaluable|10|||
27953357|NCT01870869|81662551|FG001|Overall Study|Not evaluable|5|||
27953358|NCT01870869|81662552|FG002|Overall Study|Not evaluable|42|||
27953359|NCT01870869|81662553|FG003|Overall Study|Not evaluable|10|||
27953360|NCT00403130|81662554|FG000|2 Years From Start of Treatment|Not Eligible|3|||
27953361|NCT00403130|81662554|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
27953362|NCT00403130|81662554|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
27953363|NCT00403130|81662554|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
27953364|NCT01932788|81662557|FG000|Overall Study|Protocol Violation|18|||
27953365|NCT01932788|81662558|FG001|Overall Study|Protocol Violation|0|||
27953366|NCT01932788|81662557|FG000|Overall Study|Lost to Follow-up|18|||
27953367|NCT01932788|81662558|FG001|Overall Study|Lost to Follow-up|46|||
27953368|NCT01932788|81662557|FG000|Overall Study|Lack of Efficacy|2|||
27953369|NCT01932788|81662558|FG001|Overall Study|Lack of Efficacy|0|||
27953370|NCT01932788|81662557|FG000|Overall Study|Withdrawal by Subject|0|||
27953371|NCT01932788|81662558|FG001|Overall Study|Withdrawal by Subject|5|||
27953372|NCT01913327|81662559|FG000|Overall Study|Withdrawal by Subject|0|||
27953373|NCT01913327|81662560|FG001|Overall Study|Withdrawal by Subject|1|||
27953374|NCT01392573|81662566|FG000|Overall Study|Adverse Event|1|||
27953375|NCT01392573|81662567|FG001|Overall Study|Adverse Event|3|||
27953376|NCT01392573|81662566|FG000|Overall Study|Lack of Efficacy|1|||
27953377|NCT01392573|81662567|FG001|Overall Study|Lack of Efficacy|2|||
27953378|NCT01392573|81662566|FG000|Overall Study|Protocol Violation|0|||
27953379|NCT01392573|81662567|FG001|Overall Study|Protocol Violation|2|||
27953380|NCT01392573|81662566|FG000|Overall Study|Withdrawal Criteria|13|||
27953381|NCT01392573|81662567|FG001|Overall Study|Withdrawal Criteria|15|||
27953382|NCT01392573|81662566|FG000|Overall Study|Site closure|8|||
27953383|NCT01392573|81662567|FG001|Overall Study|Site closure|7|||
27953384|NCT01392573|81662566|FG000|Overall Study|Unclassified|9|||
27953385|NCT01392573|81662567|FG001|Overall Study|Unclassified|6|||
27953386|NCT00069641|81662568|FG000|Overall Study|Death|1|||
27953387|NCT00069641|81662569|FG001|Overall Study|Death|0|||
27953388|NCT00069641|81662570|FG002|Overall Study|Death|1|||
27953389|NCT00714948|81662572|FG000|Overall Study|Adverse Event|2|||
27953390|NCT02393859|81662576|FG000|Overall Study|Decision by Sponsor|2|||
27953391|NCT02393859|81662577|FG001|Overall Study|Decision by Sponsor|4|||
27953392|NCT02393859|81662576|FG000|Overall Study|Withdrawal by Subject|11|||
27953393|NCT02393859|81662577|FG001|Overall Study|Withdrawal by Subject|6|||
27953394|NCT02393859|81662576|FG000|Overall Study|Death|27|||
27953395|NCT02393859|81662577|FG001|Overall Study|Death|10|||
27953396|NCT02393859|81662576|FG000|Overall Study|Lost to Follow-up|1|||
27953397|NCT02393859|81662577|FG001|Overall Study|Lost to Follow-up|1|||
27953398|NCT02138825|81662578|FG000|Main Study Treatment|Adverse Event|11|||
27953399|NCT02138825|81662579|FG001|Main Study Treatment|Adverse Event|3|||
27953400|NCT02138825|81662578|FG000|Main Study Treatment|Death|1|||
27953401|NCT02138825|81662579|FG001|Main Study Treatment|Death|2|||
27953402|NCT02138825|81662578|FG000|Main Study Treatment|Protocol Violation|2|||
27953403|NCT02138825|81662579|FG001|Main Study Treatment|Protocol Violation|2|||
27953404|NCT02138825|81662578|FG000|Main Study Treatment|Sponsor decision|12|||
27953405|NCT02138825|81662579|FG001|Main Study Treatment|Sponsor decision|18|||
27953406|NCT02138825|81662578|FG000|Main Study Treatment|Study terminated by sponsor|10|||
27953407|NCT02138825|81662579|FG001|Main Study Treatment|Study terminated by sponsor|9|||
27651898|NCT00446095|80564746|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
27953408|NCT02138825|81662578|FG000|Main Study Treatment|Withdrawal by Subject|3|||
27953409|NCT02138825|81662579|FG001|Main Study Treatment|Withdrawal by Subject|1|||
27953410|NCT02138825|81662578|FG000|Main Study Treatment|Medical decision|1|||
27651899|NCT00446095|80564747|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
27953411|NCT02138825|81662579|FG001|Main Study Treatment|Medical decision|0|||
27651900|NCT00446095|80564748|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
27953412|NCT02138825|81662578|FG000|Long-term Extension|Study termination by sponsor|32|||
27953413|NCT02138825|81662579|FG001|Long-term Extension|Study termination by sponsor|38|||
27953414|NCT02138825|81662578|FG000|Safety Follow-up|Adverse Event|4|||
27953415|NCT02138825|81662579|FG001|Safety Follow-up|Adverse Event|3|||
27953416|NCT02138825|81662578|FG000|Safety Follow-up|Death|11|||
27953417|NCT02138825|81662579|FG001|Safety Follow-up|Death|5|||
27953418|NCT02138825|81662578|FG000|Safety Follow-up|Withdrawal by Subject|5|||
27953419|NCT02138825|81662579|FG001|Safety Follow-up|Withdrawal by Subject|3|||
27953420|NCT02138825|81662578|FG000|Safety Follow-up|clinic worsening|1|||
27953421|NCT02138825|81662579|FG001|Safety Follow-up|clinic worsening|0|||
27953422|NCT02138825|81662578|FG000|Safety Follow-up|withdrawal by PI|1|||
27953423|NCT02138825|81662579|FG001|Safety Follow-up|withdrawal by PI|0|||
27953424|NCT02138825|81662578|FG000|Safety Follow-up|logistical difficulties|0|||
27953425|NCT02138825|81662579|FG001|Safety Follow-up|logistical difficulties|1|||
27953426|NCT02138825|81662578|FG000|Safety Follow-up|progressive disease|0|||
27953427|NCT02138825|81662579|FG001|Safety Follow-up|progressive disease|2|||
27953428|NCT02138825|81662578|FG000|Safety Follow-up|too unwell to attend the visit|0|||
27953429|NCT02138825|81662579|FG001|Safety Follow-up|too unwell to attend the visit|1|||
27953430|NCT02138825|81662578|FG000|Safety Follow-up|treatment unblinded|0|||
27953431|NCT02138825|81662579|FG001|Safety Follow-up|treatment unblinded|1|||
27953432|NCT02138825|81662578|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
27953433|NCT02138825|81662579|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
27953434|NCT00812955|81662580|FG000|Overall Study|Adverse Event|7|||
27953435|NCT00812955|81662581|FG001|Overall Study|Adverse Event|6|||
27953436|NCT00812955|81662582|FG002|Overall Study|Adverse Event|3|||
27953437|NCT00812955|81662583|FG003|Overall Study|Adverse Event|4|||
27953438|NCT00812955|81662580|FG000|Overall Study|Lost to Follow-up|2|||
27953439|NCT00812955|81662581|FG001|Overall Study|Lost to Follow-up|1|||
27953440|NCT00812955|81662582|FG002|Overall Study|Lost to Follow-up|1|||
27953441|NCT00812955|81662583|FG003|Overall Study|Lost to Follow-up|2|||
27953442|NCT00812955|81662580|FG000|Overall Study|Withdrawal by Subject|1|||
27953443|NCT00812955|81662581|FG001|Overall Study|Withdrawal by Subject|0|||
27953444|NCT00812955|81662582|FG002|Overall Study|Withdrawal by Subject|1|||
27953445|NCT00812955|81662583|FG003|Overall Study|Withdrawal by Subject|2|||
27953446|NCT00812955|81662580|FG000|Overall Study|randomized in error|0|||
27953447|NCT00812955|81662581|FG001|Overall Study|randomized in error|0|||
27953448|NCT00812955|81662582|FG002|Overall Study|randomized in error|1|||
27953449|NCT00812955|81662583|FG003|Overall Study|randomized in error|0|||
27953450|NCT04716894|81662584|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
27953451|NCT04716894|81662584|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
27953452|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
27953453|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
27953454|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
27953455|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Death|0|||
27953456|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Death|0|||
27953457|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Death|1|||
27953458|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
27953459|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
27953460|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
27953461|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
27953462|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
27953463|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
27953464|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
27953465|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
27953466|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
27953467|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Graft loss|0|||
27953468|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Graft loss|0|||
27953469|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Graft loss|7|||
27953470|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
27953471|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
27953472|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
27953473|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
27953474|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
27953475|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
27953476|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
27953477|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
27953478|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
27953479|NCT00956293|81662585|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
27953480|NCT00956293|81662586|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
27953481|NCT00956293|81662587|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
27651901|NCT00487240|80564749|FG000|Overall Study|Withdrawal by Subject|12|||
27953482|NCT00956293|81662585|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
27953483|NCT00956293|81662586|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
27953484|NCT00956293|81662587|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
27953485|NCT00956293|81662585|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
27953486|NCT00956293|81662586|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
27953487|NCT00956293|81662587|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
27953488|NCT00956293|81662585|FG000|Main Period (Randomization)|Adverse Event|0|||
27953489|NCT00956293|81662586|FG001|Main Period (Randomization)|Adverse Event|15|||
27953490|NCT00956293|81662587|FG002|Main Period (Randomization)|Adverse Event|0|||
27953491|NCT00956293|81662585|FG000|Follow-up Period|Follow-up period was terminated.|20|||
27953492|NCT00956293|81662586|FG001|Follow-up Period|Follow-up period was terminated.|32|||
27953493|NCT00956293|81662587|FG002|Follow-up Period|Follow-up period was terminated.|0|||
27953494|NCT02612311|81662588|FG000|Overall Study|Adverse Event|16|||
27953495|NCT02612311|81662589|FG001|Overall Study|Adverse Event|12|||
27953496|NCT02612311|81662590|FG002|Overall Study|Adverse Event|7|||
27953497|NCT02612311|81662591|FG003|Overall Study|Adverse Event|13|||
27953498|NCT02612311|81662588|FG000|Overall Study|Death|29|||
27953499|NCT02612311|81662589|FG001|Overall Study|Death|10|||
27953500|NCT02612311|81662590|FG002|Overall Study|Death|11|||
27953501|NCT02612311|81662591|FG003|Overall Study|Death|11|||
27953502|NCT02612311|81662588|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
27953503|NCT02612311|81662589|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
27953504|NCT02612311|81662590|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
27953505|NCT02612311|81662591|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
27953506|NCT02612311|81662588|FG000|Overall Study|Investigator's Decision|11|||
27953507|NCT02612311|81662589|FG001|Overall Study|Investigator's Decision|15|||
27953508|NCT02612311|81662590|FG002|Overall Study|Investigator's Decision|6|||
27953509|NCT02612311|81662591|FG003|Overall Study|Investigator's Decision|6|||
27953510|NCT02612311|81662588|FG000|Overall Study|Lack of Efficacy|0|||
27953511|NCT02612311|81662589|FG001|Overall Study|Lack of Efficacy|0|||
27953512|NCT02612311|81662590|FG002|Overall Study|Lack of Efficacy|1|||
27953513|NCT02612311|81662591|FG003|Overall Study|Lack of Efficacy|1|||
27953514|NCT02612311|81662588|FG000|Overall Study|Lost to Follow-up|2|||
27953515|NCT02612311|81662589|FG001|Overall Study|Lost to Follow-up|2|||
27953516|NCT02612311|81662590|FG002|Overall Study|Lost to Follow-up|1|||
27953517|NCT02612311|81662591|FG003|Overall Study|Lost to Follow-up|2|||
27953518|NCT02612311|81662588|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
27953519|NCT02612311|81662589|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
27953520|NCT02612311|81662590|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
27953521|NCT02612311|81662591|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
27953522|NCT02612311|81662588|FG000|Overall Study|Site Terminated by Sponsor|29|||
27953523|NCT02612311|81662589|FG001|Overall Study|Site Terminated by Sponsor|12|||
27953524|NCT02612311|81662590|FG002|Overall Study|Site Terminated by Sponsor|13|||
27953525|NCT02612311|81662591|FG003|Overall Study|Site Terminated by Sponsor|5|||
27953526|NCT02612311|81662588|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
27953527|NCT02612311|81662589|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
27953528|NCT02612311|81662590|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
27953529|NCT02612311|81662591|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
27953530|NCT02612311|81662588|FG000|Overall Study|Reason Not Specified|3|||
27953531|NCT02612311|81662589|FG001|Overall Study|Reason Not Specified|7|||
27953532|NCT02612311|81662590|FG002|Overall Study|Reason Not Specified|4|||
27953533|NCT02612311|81662591|FG003|Overall Study|Reason Not Specified|5|||
27953534|NCT02612311|81662588|FG000|Overall Study|Unknown/Missing|10|||
27953535|NCT02612311|81662589|FG001|Overall Study|Unknown/Missing|13|||
27953536|NCT02612311|81662590|FG002|Overall Study|Unknown/Missing|4|||
27953537|NCT02612311|81662591|FG003|Overall Study|Unknown/Missing|0|||
27953538|NCT02612311|81662588|FG000|Overall Study|Non-Compliance with Study|1|||
27953539|NCT02612311|81662589|FG001|Overall Study|Non-Compliance with Study|0|||
27953540|NCT02612311|81662590|FG002|Overall Study|Non-Compliance with Study|0|||
27953541|NCT02612311|81662591|FG003|Overall Study|Non-Compliance with Study|0|||
27953542|NCT00145626|81662592|FG000|Overall Study|Did not have NK infusions|2|||
27953543|NCT00145626|81662592|FG000|Overall Study|Turned 2 years old before treatment|1|||
27953544|NCT00145626|81662592|FG000|Overall Study|Death|1|||
27953545|NCT00145626|81662592|FG000|Overall Study|Withdrawal by Subject|1|||
27953546|NCT03366337|81662593|FG000|Overall Study|Lost to Follow-up|1|||
27651902|NCT00487240|80564750|FG001|Overall Study|Withdrawal by Subject|6|||
27651903|NCT00487240|80564749|FG000|Overall Study|Lost to Follow-up|7|||
27953547|NCT03366337|81662594|FG001|Overall Study|Lost to Follow-up|0|||
27953548|NCT03366337|81662595|FG002|Overall Study|Lost to Follow-up|1|||
27953549|NCT03366337|81662596|FG003|Overall Study|Lost to Follow-up|0|||
27953550|NCT03366337|81662593|FG000|Overall Study|Withdrawal by Subject|2|||
27953551|NCT03366337|81662594|FG001|Overall Study|Withdrawal by Subject|0|||
27953552|NCT03366337|81662595|FG002|Overall Study|Withdrawal by Subject|1|||
27551529|NCT01482884|80207482|FG000|Overall Study|Lack of Efficacy|0|||
27953553|NCT03366337|81662596|FG003|Overall Study|Withdrawal by Subject|1|||
27953554|NCT02301897|81662597|FG000|Treatment Course 1|Non-Compliance|0|||
27953555|NCT02301897|81662598|FG001|Treatment Course 1|Non-Compliance|0|||
27953556|NCT02301897|81662599|FG002|Treatment Course 1|Non-Compliance|1|||
27953557|NCT02301897|81662597|FG000|Treatment Course 1|Adverse Event|1|||
27953558|NCT02301897|81662598|FG001|Treatment Course 1|Adverse Event|1|||
27953559|NCT02301897|81662599|FG002|Treatment Course 1|Adverse Event|0|||
27953560|NCT02301897|81662597|FG000|Treatment Course 1|Lost to Follow-up|1|||
27953561|NCT02301897|81662598|FG001|Treatment Course 1|Lost to Follow-up|2|||
27953562|NCT02301897|81662599|FG002|Treatment Course 1|Lost to Follow-up|1|||
27953563|NCT02301897|81662597|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
27953564|NCT02301897|81662598|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
27953565|NCT02301897|81662599|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
27953566|NCT02301897|81662597|FG000|Treatment Course 1|Withdrawal by Subject|0|||
27953567|NCT02301897|81662598|FG001|Treatment Course 1|Withdrawal by Subject|0|||
27953568|NCT02301897|81662599|FG002|Treatment Course 1|Withdrawal by Subject|2|||
27953569|NCT02301897|81662597|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
27953570|NCT02301897|81662598|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
27953571|NCT02301897|81662599|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
27953572|NCT02301897|81662597|FG000|Treatment Course 2|Lost to Follow-up|0|||
27953573|NCT02301897|81662598|FG001|Treatment Course 2|Lost to Follow-up|2|||
27953574|NCT02301897|81662599|FG002|Treatment Course 2|Lost to Follow-up|0|||
27953575|NCT02301897|81662597|FG000|Treatment Course 2|Pregnancy|0|||
27953576|NCT02301897|81662598|FG001|Treatment Course 2|Pregnancy|1|||
27953577|NCT02301897|81662599|FG002|Treatment Course 2|Pregnancy|1|||
27953578|NCT02301897|81662597|FG000|Treatment Course 2|Withdrawal by Subject|0|||
27953579|NCT02301897|81662598|FG001|Treatment Course 2|Withdrawal by Subject|2|||
27953580|NCT02301897|81662599|FG002|Treatment Course 2|Withdrawal by Subject|0|||
27953581|NCT02301897|81662597|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
27953582|NCT02301897|81662598|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
27953583|NCT02301897|81662599|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
27953584|NCT00278161|81662600|FG000|Overall Study|Death|11|||
27953585|NCT02834819|81662603|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
27953586|NCT02834819|81662604|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
27953587|NCT02750930|81662605|FG000|Overall Study|Study closed/terminated|8|||
27953588|NCT01935947|81662608|FG000|Overall Study|Adverse Event|0|||
27953589|NCT01935947|81662609|FG001|Overall Study|Adverse Event|2|||
27953590|NCT01935947|81662610|FG002|Overall Study|Adverse Event|0|||
27953591|NCT01935947|81662608|FG000|Overall Study|Diease Progression|2|||
27953592|NCT01935947|81662609|FG001|Overall Study|Diease Progression|2|||
27953593|NCT01935947|81662610|FG002|Overall Study|Diease Progression|2|||
27953594|NCT01935947|81662608|FG000|Overall Study|Death|1|||
27953595|NCT01935947|81662609|FG001|Overall Study|Death|0|||
27953596|NCT01935947|81662610|FG002|Overall Study|Death|0|||
27953597|NCT01847443|81662611|FG000|Study Period 1|Withdrawal by Subject|0|||
27953598|NCT01847443|81662612|FG001|Study Period 1|Withdrawal by Subject|1|||
27953599|NCT01847443|81662613|FG002|Study Period 1|Withdrawal by Subject|0|||
27953600|NCT01847443|81662614|FG003|Study Period 1|Withdrawal by Subject|0|||
27953601|NCT01847443|81662611|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
27953602|NCT01847443|81662612|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
27953603|NCT01847443|81662613|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
27953604|NCT01847443|81662614|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
27953605|NCT01847443|81662611|FG000|Washout Period Before Study Period 2|Other reason|1|||
27953606|NCT01847443|81662612|FG001|Washout Period Before Study Period 2|Other reason|0|||
27953607|NCT01847443|81662613|FG002|Washout Period Before Study Period 2|Other reason|0|||
27953608|NCT01847443|81662614|FG003|Washout Period Before Study Period 2|Other reason|0|||
27953609|NCT01847443|81662611|FG000|Washout Period Before Study Period 3|Other reason|1|||
27953610|NCT01847443|81662612|FG001|Washout Period Before Study Period 3|Other reason|0|||
27953611|NCT01847443|81662613|FG002|Washout Period Before Study Period 3|Other reason|0|||
27953612|NCT01847443|81662614|FG003|Washout Period Before Study Period 3|Other reason|0|||
27953613|NCT01847443|81662611|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
27953614|NCT01847443|81662612|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
27953615|NCT01847443|81662613|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
27953616|NCT01847443|81662614|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
27953617|NCT01847443|81662611|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
27953618|NCT01847443|81662612|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
27953619|NCT01847443|81662613|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
27953620|NCT01847443|81662614|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
27953621|NCT01374425|81662615|FG000|Overall Study|Radiographic Disease Progression|86|||
27953622|NCT01374425|81662616|FG001|Overall Study|Radiographic Disease Progression|81|||
27651904|NCT00487240|80564750|FG001|Overall Study|Lost to Follow-up|6|||
27953623|NCT01374425|81662615|FG000|Overall Study|Clinical Disease Progression|9|||
27953624|NCT01374425|81662616|FG001|Overall Study|Clinical Disease Progression|6|||
27953625|NCT01374425|81662615|FG000|Overall Study|Adverse Event|29|||
27953626|NCT01374425|81662616|FG001|Overall Study|Adverse Event|18|||
27953627|NCT01374425|81662615|FG000|Overall Study|Death (Progression of Disease)|1|||
27953628|NCT01374425|81662616|FG001|Overall Study|Death (Progression of Disease)|0|||
27953629|NCT01374425|81662615|FG000|Overall Study|Death (Adverse Event)|2|||
27953630|NCT01374425|81662616|FG001|Overall Study|Death (Adverse Event)|4|||
27953631|NCT01374425|81662615|FG000|Overall Study|Withdrawal by Subject|6|||
27953632|NCT01374425|81662616|FG001|Overall Study|Withdrawal by Subject|7|||
27953633|NCT01374425|81662615|FG000|Overall Study|Refused Treatment|10|||
27953634|NCT01374425|81662616|FG001|Overall Study|Refused Treatment|24|||
27953635|NCT01374425|81662615|FG000|Overall Study|Protocol Violation|2|||
27953636|NCT01374425|81662616|FG001|Overall Study|Protocol Violation|3|||
27953637|NCT01374425|81662615|FG000|Overall Study|Sponsor Decision|0|||
27953638|NCT01374425|81662616|FG001|Overall Study|Sponsor Decision|1|||
27953639|NCT01374425|81662615|FG000|Overall Study|Lost to Follow-up|2|||
27953640|NCT01374425|81662616|FG001|Overall Study|Lost to Follow-up|1|||
27953641|NCT01374425|81662615|FG000|Overall Study|Other|41|||
27953642|NCT01374425|81662616|FG001|Overall Study|Other|43|||
27953643|NCT00276419|81662617|FG000|First Intervention|Adverse Event|1|||
27953644|NCT00276419|81662618|FG001|First Intervention|Adverse Event|0|||
27953645|NCT00276419|81662617|FG000|First Intervention|Withdrawal by Subject|0|||
27953646|NCT00276419|81662618|FG001|First Intervention|Withdrawal by Subject|2|||
27953647|NCT03605693|81662619|FG000|Overall Study|Lost to Follow-up|4|||
27953648|NCT03605693|81662620|FG001|Overall Study|Lost to Follow-up|0|||
27953649|NCT03605693|81662619|FG000|Overall Study|Physician Decision|1|||
27953650|NCT03605693|81662620|FG001|Overall Study|Physician Decision|0|||
27953651|NCT02131766|81662626|FG000|Overall Study|Withdrawal by Subject|4|||
27953652|NCT02412670|81662627|FG000|Overall Study|Adverse Event|4|||
27953653|NCT02412670|81662628|FG001|Overall Study|Adverse Event|1|||
27953654|NCT02412670|81662627|FG000|Overall Study|Physician Decision|1|||
27953655|NCT02412670|81662628|FG001|Overall Study|Physician Decision|0|||
27953656|NCT02412670|81662627|FG000|Overall Study|Withdrawal by Subject|1|||
27953657|NCT02412670|81662628|FG001|Overall Study|Withdrawal by Subject|0|||
27953658|NCT02412670|81662627|FG000|Overall Study|Ineligible|1|||
27953659|NCT02412670|81662628|FG001|Overall Study|Ineligible|0|||
27953660|NCT00002766|81665757|FG000|Overall Study|Withdrawal by Subject|0|||
27953661|NCT00002766|81665758|FG001|Overall Study|Withdrawal by Subject|1|||
27953662|NCT00002766|81665757|FG000|Overall Study|Patient Not Treated|1|||
27953663|NCT00002766|81665758|FG001|Overall Study|Patient Not Treated|2|||
27953664|NCT00002766|81665757|FG000|Overall Study|Adverse Event|1|||
27953665|NCT00002766|81665758|FG001|Overall Study|Adverse Event|1|||
27953666|NCT00002766|81665757|FG000|Overall Study|Protocol Violation|1|||
27953667|NCT00002766|81665758|FG001|Overall Study|Protocol Violation|0|||
27953668|NCT01822665|81665761|FG000|Overall Study|Adverse Event|3|||
27953669|NCT01822665|81665761|FG000|Overall Study|Other Reason|5|||
27953670|NCT00532844|81665765|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
27953671|NCT00532844|81665766|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
27953672|NCT00532844|81665765|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
27953673|NCT00532844|81665766|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
27953674|NCT00532844|81665765|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
27953675|NCT00532844|81665766|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
27953676|NCT00532844|81665765|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
27953677|NCT00532844|81665766|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
27953678|NCT00532844|81665765|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
27953679|NCT00532844|81665766|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
27953680|NCT02332928|81665767|FG000|Overall Study|Withdrawal by Subject|0|||
27953681|NCT02332928|81665768|FG001|Overall Study|Withdrawal by Subject|2|||
27953682|NCT02332928|81665767|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
27953683|NCT02332928|81665768|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
27953684|NCT00110214|81665769|FG000|Overall Study|Never started treatment|21|||
27953685|NCT00110214|81665770|FG001|Overall Study|Never started treatment|20|||
27953686|NCT00110214|81665769|FG000|Overall Study|Disease progression or death|260|||
27953687|NCT00110214|81665770|FG001|Overall Study|Disease progression or death|151|||
27953688|NCT00110214|81665769|FG000|Overall Study|Adverse Event|115|||
27953689|NCT00110214|81665770|FG001|Overall Study|Adverse Event|192|||
27953690|NCT00110214|81665769|FG000|Overall Study|Refused further treatment|52|||
27953691|NCT00110214|81665770|FG001|Overall Study|Refused further treatment|65|||
27953692|NCT00110214|81665769|FG000|Overall Study|Other (not specified)|61|||
27953693|NCT00110214|81665770|FG001|Overall Study|Other (not specified)|75|||
27953694|NCT02268383|81665771|FG000|Overall Study|Death|12|||
27953695|NCT02268383|81665771|FG000|Overall Study|Lost to Follow-up|2|||
27953696|NCT02268383|81665771|FG000|Overall Study|Withdrawal by Subject|9|||
27953697|NCT02268383|81665771|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
27953698|NCT02268383|81665771|FG000|Overall Study|Protocol deviation|3|||
27953699|NCT02268383|81665771|FG000|Overall Study|Sponsor decision|22|||
27953700|NCT02268383|81665771|FG000|Overall Study|Not reported|12|||
27953701|NCT01445847|81665776|FG000|Overall Study|Protocol Violation|13|||
27953702|NCT01445847|81665777|FG001|Overall Study|Protocol Violation|14|||
27953703|NCT01445847|81665776|FG000|Overall Study|Missed Data|1|||
27953704|NCT01445847|81665777|FG001|Overall Study|Missed Data|0|||
27953705|NCT03500211|81665778|FG000|Overall Study|Withdrawal by Subject|1|||
27953706|NCT03500211|81665779|FG001|Overall Study|Withdrawal by Subject|1|||
27953707|NCT02505425|81665780|FG000|Overall Study|Lost to Follow-up|41|||
27953708|NCT02505425|81665781|FG001|Overall Study|Lost to Follow-up|61|||
27953709|NCT02505425|81665782|FG002|Overall Study|Lost to Follow-up|31|||
27953710|NCT02505425|81665783|FG003|Overall Study|Lost to Follow-up|19|||
27953711|NCT02505425|81665780|FG000|Overall Study|Withdrawal by Subject|39|||
27953712|NCT02505425|81665781|FG001|Overall Study|Withdrawal by Subject|9|||
27953713|NCT02505425|81665782|FG002|Overall Study|Withdrawal by Subject|19|||
27953714|NCT02505425|81665783|FG003|Overall Study|Withdrawal by Subject|7|||
27953715|NCT02505425|81665780|FG000|Overall Study|Death|8|||
27953716|NCT02505425|81665781|FG001|Overall Study|Death|12|||
27953717|NCT02505425|81665782|FG002|Overall Study|Death|0|||
27953718|NCT02505425|81665783|FG003|Overall Study|Death|0|||
27953719|NCT04781816|81665784|FG000|Overall Study|Adverse Event|0|||
27953720|NCT04781816|81665785|FG001|Overall Study|Adverse Event|1|||
27953721|NCT04781816|81665784|FG000|Overall Study|Withdrawal by Subject|1|||
27953722|NCT04781816|81665785|FG001|Overall Study|Withdrawal by Subject|1|||
27953723|NCT04781816|81665784|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
27953724|NCT04781816|81665785|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
27953725|NCT05142306|81665788|FG000|Overall Study|Withdrawal by Subject|0|||
27953726|NCT05142306|81665789|FG001|Overall Study|Withdrawal by Subject|0|||
27953727|NCT05142306|81665790|FG002|Overall Study|Withdrawal by Subject|1|||
27953728|NCT01944020|81665792|FG000|Overall Study|Withdrawal by Subject|5|||
27953729|NCT01944020|81665793|FG001|Overall Study|Withdrawal by Subject|0|||
27953730|NCT02121509|81665794|FG000|Washout Period (35 Days)|Adverse Event|1|||
27953731|NCT02121509|81665795|FG001|Washout Period (35 Days)|Adverse Event|1|||
27953732|NCT02121509|81665796|FG002|Washout Period (35 Days)|Adverse Event|0|||
27953733|NCT02121509|81665797|FG003|Washout Period (35 Days)|Adverse Event|0|||
27953734|NCT02121509|81665794|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
27953735|NCT02121509|81665795|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
27953736|NCT02121509|81665796|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
27953737|NCT02121509|81665797|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
27953738|NCT02121509|81665794|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
27953739|NCT02121509|81665795|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
27953740|NCT02121509|81665796|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
27953741|NCT02121509|81665797|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
27953742|NCT01128569|81665798|FG000|Washout Period 1|Adverse Event|0|||
27953743|NCT01128569|81665799|FG001|Washout Period 1|Adverse Event|0|||
27953744|NCT01128569|81665800|FG002|Washout Period 1|Adverse Event|1|||
27953745|NCT01128569|81665801|FG003|Washout Period 1|Adverse Event|0|||
27953746|NCT01128569|81665802|FG004|Washout Period 1|Adverse Event|0|||
27953747|NCT01128569|81665803|FG005|Washout Period 1|Adverse Event|0|||
27953748|NCT01128569|81665798|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27953749|NCT01128569|81665799|FG001|Treatment Period 2|Withdrawal by Subject|1|||
27953750|NCT01128569|81665800|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27953751|NCT01128569|81665801|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27953752|NCT01128569|81665802|FG004|Treatment Period 2|Withdrawal by Subject|0|||
27953753|NCT01128569|81665803|FG005|Treatment Period 2|Withdrawal by Subject|0|||
27953754|NCT02197572|81665804|FG000|Overall Study|Progressive Disease|28|||
27953755|NCT02197572|81665804|FG000|Overall Study|Withdrawal by Subject|9|||
27953756|NCT02197572|81665804|FG000|Overall Study|Adverse Event|3|||
27953757|NCT02197572|81665804|FG000|Overall Study|Reason Not Specified|4|||
27953758|NCT03358030|81665805|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
27953759|NCT03358030|81665806|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
27953760|NCT03358030|81665807|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
27953761|NCT03358030|81665808|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
27953762|NCT03358030|81665805|FG000|Overall Study|Ineligibility|0|||
27953763|NCT03358030|81665806|FG001|Overall Study|Ineligibility|0|||
27953764|NCT03358030|81665807|FG002|Overall Study|Ineligibility|0|||
27953765|NCT03358030|81665808|FG003|Overall Study|Ineligibility|2|||
27953766|NCT03358030|81665805|FG000|Overall Study|Voluntary Withdrawal|1|||
27953767|NCT03358030|81665806|FG001|Overall Study|Voluntary Withdrawal|1|||
27953768|NCT03358030|81665807|FG002|Overall Study|Voluntary Withdrawal|3|||
27953769|NCT03358030|81665808|FG003|Overall Study|Voluntary Withdrawal|1|||
27953770|NCT03358030|81665805|FG000|Overall Study|Other|0|||
27953771|NCT03358030|81665806|FG001|Overall Study|Other|0|||
27953772|NCT03358030|81665807|FG002|Overall Study|Other|1|||
27953773|NCT03358030|81665808|FG003|Overall Study|Other|0|||
27953774|NCT01493089|81665810|FG000|Overall Study|Protocol Violation|2|||
27953775|NCT01493089|81665811|FG001|Overall Study|Protocol Violation|2|||
27953776|NCT01493089|81665810|FG000|Overall Study|Withdrawal by Subject|1|||
27953777|NCT01493089|81665811|FG001|Overall Study|Withdrawal by Subject|0|||
27953778|NCT01493089|81665810|FG000|Overall Study|Physician Decision|0|||
27953779|NCT01493089|81665811|FG001|Overall Study|Physician Decision|1|||
27953780|NCT00454116|81665814|FG000|Overall Study|Adverse Event|5|||
27953781|NCT00454116|81665815|FG001|Overall Study|Adverse Event|11|||
27953782|NCT00454116|81665816|FG002|Overall Study|Adverse Event|9|||
27953783|NCT00454116|81665814|FG000|Overall Study|Condition under investigation worsened|17|||
27953784|NCT00454116|81665815|FG001|Overall Study|Condition under investigation worsened|13|||
27953785|NCT00454116|81665816|FG002|Overall Study|Condition under investigation worsened|18|||
27953786|NCT00454116|81665814|FG000|Overall Study|Withdrawal by Subject|3|||
27953787|NCT00454116|81665815|FG001|Overall Study|Withdrawal by Subject|3|||
27953788|NCT00454116|81665816|FG002|Overall Study|Withdrawal by Subject|1|||
27953789|NCT00454116|81665814|FG000|Overall Study|Other|2|||
27953790|NCT00454116|81665815|FG001|Overall Study|Other|2|||
27953791|NCT00454116|81665816|FG002|Overall Study|Other|0|||
27953792|NCT01802788|81665817|FG000|Overall Study|Withdrawal by Subject|102|||
27953793|NCT01802788|81665818|FG001|Overall Study|Withdrawal by Subject|5|||
27953794|NCT01802788|81665817|FG000|Overall Study|Death|382|||
27953795|NCT01802788|81665818|FG001|Overall Study|Death|18|||
27953796|NCT01802788|81665817|FG000|Overall Study|Lost to Follow-up|31|||
27953797|NCT01802788|81665818|FG001|Overall Study|Lost to Follow-up|2|||
27953798|NCT01802788|81665817|FG000|Overall Study|Physician Decision|3|||
27953799|NCT01802788|81665818|FG001|Overall Study|Physician Decision|0|||
27953800|NCT01802788|81665817|FG000|Overall Study|Patient Non-Compliance|1|||
27953801|NCT01802788|81665818|FG001|Overall Study|Patient Non-Compliance|0|||
27953802|NCT01802788|81665817|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
27953803|NCT01802788|81665818|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
27953804|NCT01802788|81665817|FG000|Overall Study|Other Reasons|19|||
27953805|NCT01802788|81665818|FG001|Overall Study|Other Reasons|0|||
27953806|NCT02296476|81665825|FG000|Overall Study|Disease Progression|6|||
27953807|NCT02296476|81665826|FG001|Overall Study|Disease Progression|4|||
27953808|NCT02296476|81665827|FG002|Overall Study|Disease Progression|2|||
27953809|NCT01492088|81665828|FG000|Overall Study|Withdrawal by Patient|0|||
27953810|NCT01492088|81665829|FG001|Overall Study|Withdrawal by Patient|2|||
27953811|NCT01492088|81665830|FG002|Overall Study|Withdrawal by Patient|0|||
27953812|NCT01492088|81665828|FG000|Overall Study|Death|1|||
27953813|NCT01492088|81665829|FG001|Overall Study|Death|6|||
27953814|NCT01492088|81665830|FG002|Overall Study|Death|2|||
27953815|NCT01492088|81665828|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
27953816|NCT01492088|81665829|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
27953817|NCT01492088|81665830|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
27953818|NCT01492088|81665828|FG000|Overall Study|Alive at Last Follow-up|0|||
27953819|NCT01492088|81665829|FG001|Overall Study|Alive at Last Follow-up|6|||
27953820|NCT01492088|81665830|FG002|Overall Study|Alive at Last Follow-up|11|||
27953821|NCT03443687|81665831|FG000|Overall Study|Lost to Follow-up|3|||
27953822|NCT03443687|81665832|FG001|Overall Study|Lost to Follow-up|5|||
27953823|NCT03443687|81665831|FG000|Overall Study|Withdrawal by Subject|1|||
27953824|NCT03443687|81665832|FG001|Overall Study|Withdrawal by Subject|0|||
27953825|NCT03443687|81665831|FG000|Overall Study|Discontinued intervention|1|||
27953826|NCT03443687|81665832|FG001|Overall Study|Discontinued intervention|1|||
27953827|NCT00920556|81665833|FG000|Overall Study|Adverse Event|16|||
27953828|NCT00920556|81665833|FG000|Overall Study|Physician Decision|7|||
27953829|NCT00920556|81665833|FG000|Overall Study|Withdrawal by Subject|1|||
27953830|NCT01900665|81665834|FG000|Placebo Controlled Period|Death|9|||
27953831|NCT01900665|81665835|FG001|Placebo Controlled Period|Death|16|||
27953832|NCT01900665|81665834|FG000|Placebo Controlled Period|Adverse Event|48|||
27953833|NCT01900665|81665835|FG001|Placebo Controlled Period|Adverse Event|39|||
27953834|NCT01900665|81665834|FG000|Placebo Controlled Period|Protocol Violation|1|||
27953835|NCT01900665|81665835|FG001|Placebo Controlled Period|Protocol Violation|7|||
27953836|NCT01900665|81665834|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
27953837|NCT01900665|81665835|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
27953838|NCT01900665|81665834|FG000|Placebo Controlled Period|Physician Decision|11|||
27953839|NCT01900665|81665835|FG001|Placebo Controlled Period|Physician Decision|7|||
27953840|NCT01900665|81665834|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
27953841|NCT01900665|81665835|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
27953842|NCT01900665|81665834|FG000|Placebo Controlled Period|Caregiver Decision|33|||
27953843|NCT01900665|81665835|FG001|Placebo Controlled Period|Caregiver Decision|41|||
27953844|NCT01900665|81665834|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
27953845|NCT01900665|81665835|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
27953846|NCT01900665|81665834|FG000|Open Label Period|Adverse Event|16|||
27953847|NCT01900665|81665835|FG001|Open Label Period|Adverse Event|20|||
27953848|NCT01900665|81665834|FG000|Open Label Period|Death|5|||
27953849|NCT01900665|81665835|FG001|Open Label Period|Death|6|||
27953850|NCT01900665|81665834|FG000|Open Label Period|Lost to Follow-up|1|||
27953851|NCT01900665|81665835|FG001|Open Label Period|Lost to Follow-up|1|||
27953852|NCT01900665|81665834|FG000|Open Label Period|Parent/Caregiver Decision|33|||
27953853|NCT01900665|81665835|FG001|Open Label Period|Parent/Caregiver Decision|34|||
27953854|NCT01900665|81665834|FG000|Open Label Period|Physician Decision|4|||
27953855|NCT01900665|81665835|FG001|Open Label Period|Physician Decision|4|||
27953856|NCT01900665|81665834|FG000|Open Label Period|Protocol Violation|0|||
27953857|NCT01900665|81665835|FG001|Open Label Period|Protocol Violation|1|||
27953858|NCT01900665|81665834|FG000|Open Label Period|Sponsor Decision|802|||
27953859|NCT01900665|81665835|FG001|Open Label Period|Sponsor Decision|765|||
27953860|NCT01900665|81665834|FG000|Open Label Period|Withdrawal by Subject|20|||
27953861|NCT01900665|81665835|FG001|Open Label Period|Withdrawal by Subject|28|||
27953862|NCT00399035|81665838|FG000|Overall Study|Death|289|||
27953863|NCT00399035|81665839|FG001|Overall Study|Death|141|||
27953864|NCT00399035|81665840|FG002|Overall Study|Death|234|||
27953865|NCT00399035|81665838|FG000|Overall Study|Lost to Follow-up|2|||
27953866|NCT00399035|81665839|FG001|Overall Study|Lost to Follow-up|1|||
27953867|NCT00399035|81665840|FG002|Overall Study|Lost to Follow-up|5|||
27953868|NCT00399035|81665838|FG000|Overall Study|Withdrawal by Subject|19|||
27953869|NCT00399035|81665839|FG001|Overall Study|Withdrawal by Subject|15|||
27953870|NCT00399035|81665840|FG002|Overall Study|Withdrawal by Subject|12|||
27953871|NCT00399035|81665838|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
27953872|NCT00399035|81665839|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
27953873|NCT00399035|81665840|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
27953874|NCT00399035|81665838|FG000|Overall Study|Severe non-compliance with protocol|2|||
27953875|NCT00399035|81665839|FG001|Overall Study|Severe non-compliance with protocol|1|||
27953876|NCT00399035|81665840|FG002|Overall Study|Severe non-compliance with protocol|0|||
27953877|NCT01114737|81665845|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
27953878|NCT01114737|81665846|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
27953879|NCT01114737|81665845|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
27953880|NCT01114737|81665846|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
27953881|NCT01114737|81665845|FG000|Randomized Treatment Period|Pregnancy|1|||
27953882|NCT01114737|81665846|FG001|Randomized Treatment Period|Pregnancy|0|||
27953883|NCT01114737|81665845|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
27953884|NCT01114737|81665846|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
27953885|NCT01114737|81665845|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
27953886|NCT01114737|81665846|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
27953887|NCT01114737|81665845|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
27953888|NCT01114737|81665846|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
27953889|NCT01049373|81665847|FG000|Overall Study|Protocol Violation|9|||
27953890|NCT01049373|81665848|FG001|Overall Study|Protocol Violation|9|||
27953891|NCT01049373|81665847|FG000|Overall Study|Withdrawal by Subject|8|||
27953892|NCT01049373|81665848|FG001|Overall Study|Withdrawal by Subject|5|||
27953893|NCT01049373|81665847|FG000|Overall Study|Adverse Event|3|||
27953894|NCT01049373|81665848|FG001|Overall Study|Adverse Event|3|||
27953895|NCT01049373|81665847|FG000|Overall Study|Lost to Follow-up|9|||
27953896|NCT01049373|81665848|FG001|Overall Study|Lost to Follow-up|4|||
27953897|NCT01049373|81665847|FG000|Overall Study|no evaluable study values|9|||
27953898|NCT01049373|81665848|FG001|Overall Study|no evaluable study values|21|||
27953899|NCT01049373|81665847|FG000|Overall Study|Other|1|||
27953900|NCT01049373|81665848|FG001|Overall Study|Other|1|||
27953901|NCT01049373|81665847|FG000|Overall Study|Non-cooperation|0|||
27953902|NCT01049373|81665848|FG001|Overall Study|Non-cooperation|1|||
27953903|NCT02115321|81665849|FG000|Overall Study|Death|1|||
27953904|NCT02115321|81665850|FG001|Overall Study|Death|0|||
27953905|NCT00329030|81665859|FG000|Overall Study|Withdrawal by Subject|1|||
27953906|NCT00329030|81665860|FG001|Overall Study|Withdrawal by Subject|3|||
27953907|NCT00329030|81665859|FG000|Overall Study|Progressive Disease|6|||
27953908|NCT00329030|81665860|FG001|Overall Study|Progressive Disease|2|||
27953909|NCT00329030|81665859|FG000|Overall Study|Ineligible Pathology|1|||
27953910|NCT00329030|81665860|FG001|Overall Study|Ineligible Pathology|1|||
27953911|NCT00105534|81665864|FG000|Overall Study|Adverse Event|2|||
27953912|NCT00105534|81665865|FG001|Overall Study|Adverse Event|5|||
27953913|NCT00105534|81665864|FG000|Overall Study|Protocol Violation|1|||
27953914|NCT00105534|81665865|FG001|Overall Study|Protocol Violation|4|||
27651905|NCT00487240|80564749|FG000|Overall Study|Adverse Event|0|||
27651906|NCT00487240|80564750|FG001|Overall Study|Adverse Event|4|||
27651907|NCT00487240|80564749|FG000|Overall Study|Protocol Violation|5|||
27953915|NCT00105534|81665864|FG000|Overall Study|Withdrawal by Subject|6|||
27953916|NCT00105534|81665865|FG001|Overall Study|Withdrawal by Subject|6|||
27953917|NCT00105534|81665864|FG000|Overall Study|Lost to Follow-up|5|||
27953918|NCT00105534|81665865|FG001|Overall Study|Lost to Follow-up|1|||
27953919|NCT00105534|81665864|FG000|Overall Study|Lack of Efficacy|7|||
27953920|NCT00105534|81665865|FG001|Overall Study|Lack of Efficacy|15|||
27953921|NCT00105534|81665864|FG000|Overall Study|Treatment unmasked|1|||
27953922|NCT00105534|81665865|FG001|Overall Study|Treatment unmasked|0|||
27953923|NCT00105534|81665864|FG000|Overall Study|Other Reason|0|||
27953924|NCT00105534|81665865|FG001|Overall Study|Other Reason|2|||
27953925|NCT00501644|81665866|FG000|Overall Study|Adverse Event|4|||
27953926|NCT00501644|81665866|FG000|Overall Study|Withdrawal by Subject|1|||
27651908|NCT00487240|80564750|FG001|Overall Study|Protocol Violation|5|||
27953927|NCT02655887|81665867|FG000|Overall Study|Lost to Follow-up|3|||
27953928|NCT02655887|81665867|FG000|Overall Study|Death|4|||
27953929|NCT02655887|81665867|FG000|Overall Study|Withdrawal by Subject|3|||
27953930|NCT02655887|81665867|FG000|Overall Study|Missed 12-month follow-up visit|4|||
27953931|NCT01378117|81665869|FG000|Overall Study|withdrawal|2|||
27953932|NCT01378117|81665870|FG001|Overall Study|withdrawal|1|||
27953933|NCT01378117|81665871|FG002|Overall Study|withdrawal|2|||
27953934|NCT01378117|81665869|FG000|Overall Study|discharged before med given|2|||
27953935|NCT01378117|81665870|FG001|Overall Study|discharged before med given|0|||
27953936|NCT01378117|81665871|FG002|Overall Study|discharged before med given|1|||
27953937|NCT01847755|81665872|FG000|Overall Study|Adverse Event|2|||
27953938|NCT01847755|81665872|FG000|Overall Study|Withdrawal by Subject|2|||
27953939|NCT01847755|81665872|FG000|Overall Study|Physician Decision|1|||
27953940|NCT01812057|81665873|FG000|Overall Study|Protocol Violation|1|||
27953941|NCT01812057|81665874|FG001|Overall Study|Protocol Violation|0|||
27953942|NCT01812057|81665873|FG000|Overall Study|Physician Decision|1|||
27953943|NCT01812057|81665874|FG001|Overall Study|Physician Decision|0|||
27953944|NCT01342926|81665876|FG000|Overall Study|Adverse Event|5|||
27953945|NCT01342926|81665877|FG001|Overall Study|Adverse Event|8|||
27953946|NCT01342926|81665878|FG002|Overall Study|Adverse Event|10|||
27953947|NCT01342926|81665879|FG003|Overall Study|Adverse Event|7|||
27953948|NCT01342926|81665876|FG000|Overall Study|Lost to Follow-up|0|||
27953949|NCT01342926|81665877|FG001|Overall Study|Lost to Follow-up|1|||
27953950|NCT01342926|81665878|FG002|Overall Study|Lost to Follow-up|1|||
27953951|NCT01342926|81665879|FG003|Overall Study|Lost to Follow-up|0|||
27953952|NCT01342926|81665876|FG000|Overall Study|Investigator Discretion|2|||
27953953|NCT01342926|81665877|FG001|Overall Study|Investigator Discretion|2|||
27953954|NCT01342926|81665878|FG002|Overall Study|Investigator Discretion|0|||
27953955|NCT01342926|81665879|FG003|Overall Study|Investigator Discretion|0|||
27953956|NCT01342926|81665876|FG000|Overall Study|Withdrawal by Subject|2|||
27953957|NCT01342926|81665877|FG001|Overall Study|Withdrawal by Subject|4|||
27953958|NCT01342926|81665878|FG002|Overall Study|Withdrawal by Subject|3|||
27953959|NCT01342926|81665879|FG003|Overall Study|Withdrawal by Subject|5|||
27953960|NCT03389308|81665885|FG000|Overall Study|Withdrawal by Subject|5|||
27953961|NCT03389308|81665885|FG000|Overall Study|Lost to Follow-up|3|||
27953962|NCT03389308|81665885|FG000|Overall Study|Adverse Event|2|||
27953963|NCT03389308|81665885|FG000|Overall Study|Sponsor Request|2|||
27953964|NCT02185534|81665886|FG000|First Period|Withdrawal by Subject|0|||
27953965|NCT02185534|81665887|FG001|First Period|Withdrawal by Subject|0|||
27953966|NCT02185534|81665888|FG002|First Period|Withdrawal by Subject|0|||
27953967|NCT02185534|81665889|FG003|First Period|Withdrawal by Subject|1|||
27953968|NCT02185534|81665890|FG004|First Period|Withdrawal by Subject|0|||
27953969|NCT02185534|81665891|FG005|First Period|Withdrawal by Subject|0|||
27953970|NCT02185534|81665886|FG000|First Washout Period|Withdrawal by Subject|1|||
27953971|NCT02185534|81665887|FG001|First Washout Period|Withdrawal by Subject|0|||
27953972|NCT02185534|81665888|FG002|First Washout Period|Withdrawal by Subject|0|||
27953973|NCT02185534|81665889|FG003|First Washout Period|Withdrawal by Subject|0|||
27953974|NCT02185534|81665890|FG004|First Washout Period|Withdrawal by Subject|1|||
27953975|NCT02185534|81665891|FG005|First Washout Period|Withdrawal by Subject|0|||
27953976|NCT02185534|81665886|FG000|First Washout Period|Protocol Violation|0|||
27953977|NCT02185534|81665887|FG001|First Washout Period|Protocol Violation|0|||
27953978|NCT02185534|81665888|FG002|First Washout Period|Protocol Violation|0|||
27953979|NCT02185534|81665889|FG003|First Washout Period|Protocol Violation|0|||
27953980|NCT02185534|81665890|FG004|First Washout Period|Protocol Violation|0|||
27953981|NCT02185534|81665891|FG005|First Washout Period|Protocol Violation|1|||
27953982|NCT01459666|81665892|FG000|Overall Study|PI left institution|5|||
27953983|NCT01459666|81665893|FG001|Overall Study|PI left institution|4|||
27953984|NCT03314935|81665894|FG000|Phase 1|Death|4|||
27953985|NCT03314935|81665895|FG001|Phase 1|Death|2|||
27953986|NCT03314935|81665896|FG002|Phase 1|Death|5|||
27953987|NCT03314935|81665897|FG003|Phase 1|Death|4|||
27953988|NCT03314935|81665898|FG004|Phase 1|Death|3|||
27953989|NCT03314935|81665899|FG005|Phase 1|Death|4|||
27953990|NCT03314935|81665900|FG006|Phase 1|Death|5|||
27953991|NCT03314935|81665901|FG007|Phase 1|Death|4|||
27953992|NCT03314935|81665902|FG008|Phase 1|Death|3|||
27953993|NCT03314935|81665903|FG009|Phase 1|Death|0|||
27953994|NCT03314935|81665904|FG010|Phase 1|Death|0|||
27953995|NCT03314935|81665905|FG011|Phase 1|Death|0|||
27953996|NCT03314935|81665906|FG012|Phase 1|Death|0|||
27953997|NCT03314935|81665907|FG013|Phase 1|Death|0|||
27651909|NCT00487240|80564749|FG000|Overall Study|Entry Criteria Not Met|3|||
27953998|NCT03314935|81665908|FG014|Phase 1|Death|0|||
27953999|NCT03314935|81665894|FG000|Phase 1|Withdrawal by Subject|2|||
27954000|NCT03314935|81665895|FG001|Phase 1|Withdrawal by Subject|1|||
27954001|NCT03314935|81665896|FG002|Phase 1|Withdrawal by Subject|1|||
27954002|NCT03314935|81665897|FG003|Phase 1|Withdrawal by Subject|2|||
27954003|NCT03314935|81665898|FG004|Phase 1|Withdrawal by Subject|1|||
27954004|NCT03314935|81665899|FG005|Phase 1|Withdrawal by Subject|0|||
27954005|NCT03314935|81665900|FG006|Phase 1|Withdrawal by Subject|1|||
27954006|NCT03314935|81665901|FG007|Phase 1|Withdrawal by Subject|0|||
27954007|NCT03314935|81665902|FG008|Phase 1|Withdrawal by Subject|1|||
27954008|NCT03314935|81665903|FG009|Phase 1|Withdrawal by Subject|0|||
27954009|NCT03314935|81665904|FG010|Phase 1|Withdrawal by Subject|0|||
27954010|NCT03314935|81665905|FG011|Phase 1|Withdrawal by Subject|0|||
27954011|NCT03314935|81665906|FG012|Phase 1|Withdrawal by Subject|0|||
27954012|NCT03314935|81665907|FG013|Phase 1|Withdrawal by Subject|0|||
27954013|NCT03314935|81665908|FG014|Phase 1|Withdrawal by Subject|0|||
27954014|NCT03314935|81665894|FG000|Phase 1|Progressive Disease|2|||
27954015|NCT03314935|81665895|FG001|Phase 1|Progressive Disease|0|||
27954016|NCT03314935|81665896|FG002|Phase 1|Progressive Disease|0|||
27954017|NCT03314935|81665897|FG003|Phase 1|Progressive Disease|1|||
27954018|NCT03314935|81665898|FG004|Phase 1|Progressive Disease|0|||
27954019|NCT03314935|81665899|FG005|Phase 1|Progressive Disease|0|||
27954020|NCT03314935|81665900|FG006|Phase 1|Progressive Disease|0|||
27954021|NCT03314935|81665901|FG007|Phase 1|Progressive Disease|0|||
27954022|NCT03314935|81665902|FG008|Phase 1|Progressive Disease|0|||
27954023|NCT03314935|81665903|FG009|Phase 1|Progressive Disease|0|||
27954024|NCT03314935|81665904|FG010|Phase 1|Progressive Disease|0|||
27954025|NCT03314935|81665905|FG011|Phase 1|Progressive Disease|0|||
27954026|NCT03314935|81665906|FG012|Phase 1|Progressive Disease|0|||
27954027|NCT03314935|81665907|FG013|Phase 1|Progressive Disease|0|||
27954028|NCT03314935|81665908|FG014|Phase 1|Progressive Disease|0|||
27954029|NCT03314935|81665894|FG000|Phase 1|Study Terminated by Sponsor|0|||
27954030|NCT03314935|81665895|FG001|Phase 1|Study Terminated by Sponsor|1|||
27954031|NCT03314935|81665896|FG002|Phase 1|Study Terminated by Sponsor|0|||
27954032|NCT03314935|81665897|FG003|Phase 1|Study Terminated by Sponsor|0|||
27954033|NCT03314935|81665898|FG004|Phase 1|Study Terminated by Sponsor|0|||
27954034|NCT03314935|81665899|FG005|Phase 1|Study Terminated by Sponsor|0|||
27954035|NCT03314935|81665900|FG006|Phase 1|Study Terminated by Sponsor|0|||
27954036|NCT03314935|81665901|FG007|Phase 1|Study Terminated by Sponsor|0|||
27954037|NCT03314935|81665902|FG008|Phase 1|Study Terminated by Sponsor|1|||
27954038|NCT03314935|81665903|FG009|Phase 1|Study Terminated by Sponsor|0|||
27954039|NCT03314935|81665904|FG010|Phase 1|Study Terminated by Sponsor|0|||
27954040|NCT03314935|81665905|FG011|Phase 1|Study Terminated by Sponsor|0|||
27954041|NCT03314935|81665906|FG012|Phase 1|Study Terminated by Sponsor|0|||
27954042|NCT03314935|81665907|FG013|Phase 1|Study Terminated by Sponsor|0|||
27954043|NCT03314935|81665908|FG014|Phase 1|Study Terminated by Sponsor|0|||
27954044|NCT03314935|81665894|FG000|Phase 1|"Captured as Other in Database"|0|||
27954045|NCT03314935|81665895|FG001|Phase 1|"Captured as Other in Database"|2|||
27954046|NCT03314935|81665896|FG002|Phase 1|"Captured as Other in Database"|0|||
27954047|NCT03314935|81665897|FG003|Phase 1|"Captured as Other in Database"|0|||
27954048|NCT03314935|81665898|FG004|Phase 1|"Captured as Other in Database"|0|||
27954049|NCT03314935|81665899|FG005|Phase 1|"Captured as Other in Database"|0|||
27954050|NCT03314935|81665900|FG006|Phase 1|"Captured as Other in Database"|1|||
27954051|NCT03314935|81665901|FG007|Phase 1|"Captured as Other in Database"|1|||
27954052|NCT03314935|81665902|FG008|Phase 1|"Captured as Other in Database"|1|||
27954053|NCT03314935|81665903|FG009|Phase 1|"Captured as Other in Database"|0|||
27954054|NCT03314935|81665904|FG010|Phase 1|"Captured as Other in Database"|0|||
27954055|NCT03314935|81665905|FG011|Phase 1|"Captured as Other in Database"|0|||
27954056|NCT03314935|81665906|FG012|Phase 1|"Captured as Other in Database"|0|||
27954057|NCT03314935|81665907|FG013|Phase 1|"Captured as Other in Database"|0|||
27954058|NCT03314935|81665908|FG014|Phase 1|"Captured as Other in Database"|0|||
27954059|NCT03314935|81665894|FG000|Phase 1|Lost to Follow-up|0|||
27954060|NCT03314935|81665895|FG001|Phase 1|Lost to Follow-up|0|||
27954061|NCT03314935|81665896|FG002|Phase 1|Lost to Follow-up|0|||
27954062|NCT03314935|81665897|FG003|Phase 1|Lost to Follow-up|0|||
27954063|NCT03314935|81665898|FG004|Phase 1|Lost to Follow-up|0|||
27954064|NCT03314935|81665899|FG005|Phase 1|Lost to Follow-up|0|||
27954065|NCT03314935|81665900|FG006|Phase 1|Lost to Follow-up|0|||
27954066|NCT03314935|81665901|FG007|Phase 1|Lost to Follow-up|0|||
27954067|NCT03314935|81665902|FG008|Phase 1|Lost to Follow-up|1|||
27954068|NCT03314935|81665903|FG009|Phase 1|Lost to Follow-up|0|||
27954069|NCT03314935|81665904|FG010|Phase 1|Lost to Follow-up|0|||
27954070|NCT03314935|81665905|FG011|Phase 1|Lost to Follow-up|0|||
27954071|NCT03314935|81665906|FG012|Phase 1|Lost to Follow-up|0|||
27954072|NCT03314935|81665907|FG013|Phase 1|Lost to Follow-up|0|||
27954073|NCT03314935|81665908|FG014|Phase 1|Lost to Follow-up|0|||
27954074|NCT03314935|81665894|FG000|Phase 2|Death|0|||
27954075|NCT03314935|81665895|FG001|Phase 2|Death|0|||
27954076|NCT03314935|81665896|FG002|Phase 2|Death|0|||
27954077|NCT03314935|81665897|FG003|Phase 2|Death|0|||
27954078|NCT03314935|81665898|FG004|Phase 2|Death|0|||
27954079|NCT03314935|81665899|FG005|Phase 2|Death|0|||
27954080|NCT03314935|81665900|FG006|Phase 2|Death|0|||
27954081|NCT03314935|81665901|FG007|Phase 2|Death|0|||
27954082|NCT03314935|81665902|FG008|Phase 2|Death|0|||
27954083|NCT03314935|81665903|FG009|Phase 2|Death|5|||
27954084|NCT03314935|81665904|FG010|Phase 2|Death|20|||
27954085|NCT03314935|81665905|FG011|Phase 2|Death|6|||
27954086|NCT03314935|81665906|FG012|Phase 2|Death|7|||
27954087|NCT03314935|81665907|FG013|Phase 2|Death|6|||
27954088|NCT03314935|81665908|FG014|Phase 2|Death|17|||
27954089|NCT03314935|81665894|FG000|Phase 2|Withdrawal by Subject|0|||
27954090|NCT03314935|81665895|FG001|Phase 2|Withdrawal by Subject|0|||
27954091|NCT03314935|81665896|FG002|Phase 2|Withdrawal by Subject|0|||
27954092|NCT03314935|81665897|FG003|Phase 2|Withdrawal by Subject|0|||
27954093|NCT03314935|81665898|FG004|Phase 2|Withdrawal by Subject|0|||
27954094|NCT03314935|81665899|FG005|Phase 2|Withdrawal by Subject|0|||
27651910|NCT00487240|80564750|FG001|Overall Study|Entry Criteria Not Met|4|||
27651911|NCT00487240|80564749|FG000|Overall Study|Sponsor Decision|2|||
27651912|NCT00487240|80564750|FG001|Overall Study|Sponsor Decision|1|||
27651913|NCT00487240|80564749|FG000|Overall Study|Physician Decision|2|||
27954095|NCT03314935|81665900|FG006|Phase 2|Withdrawal by Subject|0|||
27954096|NCT03314935|81665901|FG007|Phase 2|Withdrawal by Subject|0|||
27954097|NCT03314935|81665902|FG008|Phase 2|Withdrawal by Subject|0|||
27954098|NCT03314935|81665903|FG009|Phase 2|Withdrawal by Subject|1|||
27954099|NCT03314935|81665904|FG010|Phase 2|Withdrawal by Subject|4|||
27954100|NCT03314935|81665905|FG011|Phase 2|Withdrawal by Subject|0|||
27954101|NCT03314935|81665906|FG012|Phase 2|Withdrawal by Subject|1|||
27954102|NCT03314935|81665907|FG013|Phase 2|Withdrawal by Subject|0|||
27954103|NCT03314935|81665908|FG014|Phase 2|Withdrawal by Subject|1|||
27954104|NCT03314935|81665894|FG000|Phase 2|Progressive Disease|0|||
27954105|NCT03314935|81665895|FG001|Phase 2|Progressive Disease|0|||
27954106|NCT03314935|81665896|FG002|Phase 2|Progressive Disease|0|||
27954107|NCT03314935|81665897|FG003|Phase 2|Progressive Disease|0|||
27954108|NCT03314935|81665898|FG004|Phase 2|Progressive Disease|0|||
27954109|NCT03314935|81665899|FG005|Phase 2|Progressive Disease|0|||
27954110|NCT03314935|81665900|FG006|Phase 2|Progressive Disease|0|||
27954111|NCT03314935|81665901|FG007|Phase 2|Progressive Disease|0|||
27954112|NCT03314935|81665902|FG008|Phase 2|Progressive Disease|0|||
27954113|NCT03314935|81665903|FG009|Phase 2|Progressive Disease|1|||
27954114|NCT03314935|81665904|FG010|Phase 2|Progressive Disease|1|||
27954115|NCT03314935|81665905|FG011|Phase 2|Progressive Disease|1|||
27954116|NCT03314935|81665906|FG012|Phase 2|Progressive Disease|2|||
27954117|NCT03314935|81665907|FG013|Phase 2|Progressive Disease|0|||
27954118|NCT03314935|81665908|FG014|Phase 2|Progressive Disease|1|||
27954119|NCT03314935|81665894|FG000|Phase 2|Study Terminated by Sponsor|0|||
27954120|NCT03314935|81665895|FG001|Phase 2|Study Terminated by Sponsor|0|||
27954121|NCT03314935|81665896|FG002|Phase 2|Study Terminated by Sponsor|0|||
27954122|NCT03314935|81665897|FG003|Phase 2|Study Terminated by Sponsor|0|||
27954123|NCT03314935|81665898|FG004|Phase 2|Study Terminated by Sponsor|0|||
27954124|NCT03314935|81665899|FG005|Phase 2|Study Terminated by Sponsor|0|||
27954125|NCT03314935|81665900|FG006|Phase 2|Study Terminated by Sponsor|0|||
27954126|NCT03314935|81665901|FG007|Phase 2|Study Terminated by Sponsor|0|||
27954127|NCT03314935|81665902|FG008|Phase 2|Study Terminated by Sponsor|0|||
27954128|NCT03314935|81665903|FG009|Phase 2|Study Terminated by Sponsor|0|||
27954129|NCT03314935|81665904|FG010|Phase 2|Study Terminated by Sponsor|7|||
27954130|NCT03314935|81665905|FG011|Phase 2|Study Terminated by Sponsor|2|||
27954131|NCT03314935|81665906|FG012|Phase 2|Study Terminated by Sponsor|1|||
27954132|NCT03314935|81665907|FG013|Phase 2|Study Terminated by Sponsor|4|||
27954133|NCT03314935|81665908|FG014|Phase 2|Study Terminated by Sponsor|4|||
27954134|NCT03314935|81665894|FG000|Phase 2|Lost to Follow-up|0|||
27954135|NCT03314935|81665895|FG001|Phase 2|Lost to Follow-up|0|||
27954136|NCT03314935|81665896|FG002|Phase 2|Lost to Follow-up|0|||
27954137|NCT03314935|81665897|FG003|Phase 2|Lost to Follow-up|0|||
27954138|NCT03314935|81665898|FG004|Phase 2|Lost to Follow-up|0|||
27954139|NCT03314935|81665899|FG005|Phase 2|Lost to Follow-up|0|||
27954140|NCT03314935|81665900|FG006|Phase 2|Lost to Follow-up|0|||
27954141|NCT03314935|81665901|FG007|Phase 2|Lost to Follow-up|0|||
27954142|NCT03314935|81665902|FG008|Phase 2|Lost to Follow-up|0|||
27954143|NCT03314935|81665903|FG009|Phase 2|Lost to Follow-up|1|||
27954144|NCT03314935|81665904|FG010|Phase 2|Lost to Follow-up|0|||
27954145|NCT03314935|81665905|FG011|Phase 2|Lost to Follow-up|0|||
27954146|NCT03314935|81665906|FG012|Phase 2|Lost to Follow-up|0|||
27954147|NCT03314935|81665907|FG013|Phase 2|Lost to Follow-up|0|||
27954148|NCT03314935|81665908|FG014|Phase 2|Lost to Follow-up|1|||
27954149|NCT03314935|81665894|FG000|Phase 2|Physician Decision|0|||
27954150|NCT03314935|81665895|FG001|Phase 2|Physician Decision|0|||
27954151|NCT03314935|81665896|FG002|Phase 2|Physician Decision|0|||
27954152|NCT03314935|81665897|FG003|Phase 2|Physician Decision|0|||
27954153|NCT03314935|81665898|FG004|Phase 2|Physician Decision|0|||
27954154|NCT03314935|81665899|FG005|Phase 2|Physician Decision|0|||
27954155|NCT03314935|81665900|FG006|Phase 2|Physician Decision|0|||
27954156|NCT03314935|81665901|FG007|Phase 2|Physician Decision|0|||
27954157|NCT03314935|81665902|FG008|Phase 2|Physician Decision|0|||
27954158|NCT03314935|81665903|FG009|Phase 2|Physician Decision|0|||
27954159|NCT03314935|81665904|FG010|Phase 2|Physician Decision|1|||
27954160|NCT03314935|81665905|FG011|Phase 2|Physician Decision|0|||
27954161|NCT03314935|81665906|FG012|Phase 2|Physician Decision|0|||
27954162|NCT03314935|81665907|FG013|Phase 2|Physician Decision|0|||
27954163|NCT03314935|81665908|FG014|Phase 2|Physician Decision|0|||
27651914|NCT00487240|80564750|FG001|Overall Study|Physician Decision|0|||
27651915|NCT03122548|80564752|FG000|Overall Study|Death|2|||
27954164|NCT00692003|81665910|FG000|Overall Study|Sponsor Decision|5|||
27954165|NCT00692003|81665911|FG001|Overall Study|Sponsor Decision|1|||
27651916|NCT03122548|80564752|FG000|Overall Study|Progression - subject went into hospice|1|||
27651917|NCT03122548|80564752|FG000|Overall Study|Study Terminated by Sponsor|2|||
27651918|NCT02332889|80564753|FG000|Overall Study|Physician Decision|1|||
27651919|NCT01124045|80564756|FG000|Overall Study|Lost to Follow-up|0|||
27651920|NCT01124045|80564757|FG001|Overall Study|Lost to Follow-up|1|||
27651921|NCT01124045|80564756|FG000|Overall Study|Physician Decision|0|||
27651922|NCT01124045|80564757|FG001|Overall Study|Physician Decision|2|||
27651923|NCT02958553|80564758|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
27651924|NCT02958553|80564758|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
27750067|NCT04285346|80909744|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
27750068|NCT01457118|80909745|FG000|Overall Study|Adverse Event|1|||
27750069|NCT01457118|80909746|FG001|Overall Study|Adverse Event|0|||
27750070|NCT01457118|80909747|FG002|Overall Study|Adverse Event|0|||
27750071|NCT01457118|80909748|FG003|Overall Study|Adverse Event|1|||
27750072|NCT01457118|80909745|FG000|Overall Study|Clinical Progression|0|||
27750073|NCT01457118|80909746|FG001|Overall Study|Clinical Progression|1|||
27750074|NCT01457118|80909747|FG002|Overall Study|Clinical Progression|0|||
27750075|NCT01457118|80909748|FG003|Overall Study|Clinical Progression|1|||
27750076|NCT01457118|80909745|FG000|Overall Study|Physician Decision|2|||
27750077|NCT01457118|80909746|FG001|Overall Study|Physician Decision|0|||
27750078|NCT01457118|80909747|FG002|Overall Study|Physician Decision|0|||
27750079|NCT01457118|80909748|FG003|Overall Study|Physician Decision|0|||
27750080|NCT01457118|80909745|FG000|Overall Study|Progressive Disease by RECIST|12|||
27750081|NCT01457118|80909746|FG001|Overall Study|Progressive Disease by RECIST|3|||
27750082|NCT01457118|80909747|FG002|Overall Study|Progressive Disease by RECIST|1|||
27750083|NCT01457118|80909748|FG003|Overall Study|Progressive Disease by RECIST|0|||
27750084|NCT01457118|80909745|FG000|Overall Study|Withdrawal by Subject|5|||
27750085|NCT01457118|80909746|FG001|Overall Study|Withdrawal by Subject|0|||
27750086|NCT01457118|80909747|FG002|Overall Study|Withdrawal by Subject|0|||
27750087|NCT01457118|80909748|FG003|Overall Study|Withdrawal by Subject|0|||
27750088|NCT01728584|80909749|FG000|Overall Study|Adverse Event|1|||
27750089|NCT01728584|80909750|FG001|Overall Study|Adverse Event|0|||
27750090|NCT01728584|80909751|FG002|Overall Study|Adverse Event|0|||
27954166|NCT02347085|81665912|FG000|Overall Study|Adverse Event|2|||
27651925|NCT00388726|80564759|FG000|Overall Study|Adverse Event|50|||
27651926|NCT00388726|80564760|FG001|Overall Study|Adverse Event|24|||
27651927|NCT00388726|80564759|FG000|Overall Study|Progressive Disease|336|||
27651928|NCT00388726|80564760|FG001|Overall Study|Progressive Disease|153|||
27651929|NCT00388726|80564759|FG000|Overall Study|Clinical Progression|61|||
27651930|NCT00388726|80564760|FG001|Overall Study|Clinical Progression|36|||
27651931|NCT00388726|80564759|FG000|Overall Study|Withdrawal by Subject|10|||
27651932|NCT00388726|80564760|FG001|Overall Study|Withdrawal by Subject|7|||
27651933|NCT00388726|80564759|FG000|Overall Study|Administrative|6|||
27651934|NCT00388726|80564760|FG001|Overall Study|Administrative|9|||
27651935|NCT00388726|80564759|FG000|Overall Study|Physician Decision|18|||
27651936|NCT00388726|80564760|FG001|Overall Study|Physician Decision|13|||
27651937|NCT00388726|80564759|FG000|Overall Study|Death|3|||
27651938|NCT00388726|80564760|FG001|Overall Study|Death|2|||
27651939|NCT00824850|80564761|FG000|Overall Study|Withdrawal by Subject|0|||
27651940|NCT00824850|80564762|FG001|Overall Study|Withdrawal by Subject|1|||
27651941|NCT03122860|80564767|FG000|Overall Study|Discontinued Before Treatment|1|||
27651942|NCT03122860|80564768|FG001|Overall Study|Discontinued Before Treatment|1|||
27651943|NCT03122860|80564769|FG002|Overall Study|Discontinued Before Treatment|2|||
27651944|NCT03122860|80564770|FG003|Overall Study|Discontinued Before Treatment|0|||
27651945|NCT03122860|80564771|FG004|Overall Study|Discontinued Before Treatment|1|||
27651946|NCT03122860|80564772|FG005|Overall Study|Discontinued Before Treatment|0|||
27651947|NCT03122860|80564767|FG000|Overall Study|Adverse Event|1|||
27651948|NCT03122860|80564768|FG001|Overall Study|Adverse Event|0|||
27651949|NCT03122860|80564769|FG002|Overall Study|Adverse Event|1|||
27651950|NCT03122860|80564770|FG003|Overall Study|Adverse Event|1|||
27651951|NCT03122860|80564771|FG004|Overall Study|Adverse Event|0|||
27651952|NCT03122860|80564772|FG005|Overall Study|Adverse Event|0|||
27651953|NCT03122860|80564767|FG000|Overall Study|Lost to Follow-up|5|||
27651954|NCT03122860|80564768|FG001|Overall Study|Lost to Follow-up|2|||
27651955|NCT03122860|80564769|FG002|Overall Study|Lost to Follow-up|3|||
27651956|NCT03122860|80564770|FG003|Overall Study|Lost to Follow-up|3|||
27651957|NCT03122860|80564771|FG004|Overall Study|Lost to Follow-up|5|||
27750091|NCT01728584|80909752|FG003|Overall Study|Adverse Event|0|||
27750092|NCT01728584|80909749|FG000|Overall Study|Physician Decision|4|||
27750093|NCT01728584|80909750|FG001|Overall Study|Physician Decision|0|||
27651958|NCT03122860|80564772|FG005|Overall Study|Lost to Follow-up|4|||
27651959|NCT03122860|80564767|FG000|Overall Study|Subject Non-Compliance|0|||
27651960|NCT03122860|80564768|FG001|Overall Study|Subject Non-Compliance|0|||
27651961|NCT03122860|80564769|FG002|Overall Study|Subject Non-Compliance|1|||
27651962|NCT03122860|80564770|FG003|Overall Study|Subject Non-Compliance|0|||
27651963|NCT03122860|80564771|FG004|Overall Study|Subject Non-Compliance|0|||
27651964|NCT03122860|80564772|FG005|Overall Study|Subject Non-Compliance|0|||
27750094|NCT01728584|80909751|FG002|Overall Study|Physician Decision|1|||
27750095|NCT01728584|80909752|FG003|Overall Study|Physician Decision|0|||
27750096|NCT01728584|80909749|FG000|Overall Study|Withdrawal by Subject|1|||
27750097|NCT01728584|80909750|FG001|Overall Study|Withdrawal by Subject|0|||
27750098|NCT01728584|80909751|FG002|Overall Study|Withdrawal by Subject|0|||
27750099|NCT01728584|80909752|FG003|Overall Study|Withdrawal by Subject|0|||
27750100|NCT01728584|80909749|FG000|Overall Study|Screen failure|1|||
27750101|NCT01728584|80909750|FG001|Overall Study|Screen failure|0|||
27750102|NCT01728584|80909751|FG002|Overall Study|Screen failure|0|||
27750103|NCT01728584|80909752|FG003|Overall Study|Screen failure|0|||
27750104|NCT01728584|80909749|FG000|Overall Study|Other reason (not specified)|1|||
27750105|NCT01728584|80909750|FG001|Overall Study|Other reason (not specified)|0|||
27750106|NCT01728584|80909751|FG002|Overall Study|Other reason (not specified)|0|||
27750107|NCT01728584|80909752|FG003|Overall Study|Other reason (not specified)|1|||
27750108|NCT03342469|80909755|FG000|Overall Study|Withdrawal by Subject|0|||
27750109|NCT03342469|80909756|FG001|Overall Study|Withdrawal by Subject|1|||
27750110|NCT03342469|80909757|FG002|Overall Study|Withdrawal by Subject|0|||
27750111|NCT03342469|80909758|FG003|Overall Study|Withdrawal by Subject|0|||
27750112|NCT00369668|80909759|FG000|Overall Study|Lack of Efficacy|4|||
27750113|NCT00369668|80909760|FG001|Overall Study|Lack of Efficacy|5|||
27750114|NCT00369668|80909761|FG002|Overall Study|Lack of Efficacy|7|||
27750115|NCT04360187|80909762|FG000|Double-Blind Treatment|Adverse Event|9|||
27750116|NCT04360187|80909763|FG001|Double-Blind Treatment|Adverse Event|11|||
27750117|NCT04360187|80909762|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
27750118|NCT04360187|80909763|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
27750119|NCT04360187|80909762|FG000|Double-Blind Treatment|Physician Decision|1|||
27750120|NCT04360187|80909763|FG001|Double-Blind Treatment|Physician Decision|0|||
27750121|NCT04360187|80909762|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
27750122|NCT04360187|80909763|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
27750123|NCT04360187|80909762|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
27750124|NCT04360187|80909763|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
27750125|NCT04360187|80909762|FG000|Follow-Up|Lost to Follow-up|1|||
27750126|NCT04360187|80909763|FG001|Follow-Up|Lost to Follow-up|0|||
27750127|NCT00532948|80909766|FG000|Overall Study|Protocol Violation|1|||
27750128|NCT00532948|80909767|FG001|Overall Study|Protocol Violation|0|||
27750129|NCT00532948|80909768|FG002|Overall Study|Protocol Violation|0|||
27750130|NCT00532948|80909766|FG000|Overall Study|Death|3|||
27750131|NCT00532948|80909767|FG001|Overall Study|Death|3|||
27750132|NCT00532948|80909768|FG002|Overall Study|Death|4|||
27750133|NCT00532948|80909766|FG000|Overall Study|Violation of selection criteria at entry|0|||
27750134|NCT00532948|80909767|FG001|Overall Study|Violation of selection criteria at entry|1|||
27750135|NCT00532948|80909768|FG002|Overall Study|Violation of selection criteria at entry|0|||
27750136|NCT00532948|80909766|FG000|Overall Study|Failure to return|0|||
27750137|NCT00532948|80909767|FG001|Overall Study|Failure to return|1|||
27750138|NCT00532948|80909768|FG002|Overall Study|Failure to return|0|||
27750139|NCT03569293|80909771|FG000|Overall Study|Adverse Event|4|||
27750140|NCT03569293|80909772|FG001|Overall Study|Adverse Event|1|||
27750141|NCT03569293|80909773|FG002|Overall Study|Adverse Event|5|||
27750142|NCT03569293|80909774|FG003|Overall Study|Adverse Event|1|||
27750143|NCT03569293|80909775|FG004|Overall Study|Adverse Event|0|||
27750144|NCT03569293|80909776|FG005|Overall Study|Adverse Event|0|||
27750145|NCT03569293|80909771|FG000|Overall Study|Withdrawal by Subject|16|||
27750146|NCT03569293|80909772|FG001|Overall Study|Withdrawal by Subject|2|||
27750147|NCT03569293|80909773|FG002|Overall Study|Withdrawal by Subject|4|||
27750148|NCT03569293|80909774|FG003|Overall Study|Withdrawal by Subject|1|||
27750149|NCT03569293|80909775|FG004|Overall Study|Withdrawal by Subject|0|||
27750150|NCT03569293|80909776|FG005|Overall Study|Withdrawal by Subject|0|||
27750151|NCT03569293|80909771|FG000|Overall Study|Lost to Follow-up|1|||
27750152|NCT03569293|80909772|FG001|Overall Study|Lost to Follow-up|3|||
27750153|NCT03569293|80909773|FG002|Overall Study|Lost to Follow-up|1|||
27750154|NCT03569293|80909774|FG003|Overall Study|Lost to Follow-up|1|||
27750155|NCT03569293|80909775|FG004|Overall Study|Lost to Follow-up|0|||
27750156|NCT03569293|80909776|FG005|Overall Study|Lost to Follow-up|0|||
27750157|NCT03569293|80909771|FG000|Overall Study|Other|8|||
27750158|NCT03569293|80909772|FG001|Overall Study|Other|2|||
27750159|NCT03569293|80909773|FG002|Overall Study|Other|1|||
27750160|NCT03569293|80909774|FG003|Overall Study|Other|1|||
27954167|NCT02347085|81665912|FG000|Overall Study|Lack of Efficacy|1|||
27750161|NCT03569293|80909775|FG004|Overall Study|Other|0|||
27750162|NCT03569293|80909776|FG005|Overall Study|Other|0|||
27750163|NCT03569293|80909771|FG000|Overall Study|Ongoing at Time of Analysis|8|||
27750164|NCT03569293|80909772|FG001|Overall Study|Ongoing at Time of Analysis|1|||
27750165|NCT03569293|80909773|FG002|Overall Study|Ongoing at Time of Analysis|3|||
27750166|NCT03569293|80909774|FG003|Overall Study|Ongoing at Time of Analysis|0|||
27750167|NCT03569293|80909775|FG004|Overall Study|Ongoing at Time of Analysis|0|||
27750168|NCT03569293|80909776|FG005|Overall Study|Ongoing at Time of Analysis|0|||
27750169|NCT03123354|80909779|FG000|Overall Study|Physician Decision|6|||
27750170|NCT00610935|80909785|FG000|Overall Study|Lost to Follow-up|0|||
27750171|NCT00610935|80909786|FG001|Overall Study|Lost to Follow-up|1|||
27750172|NCT00610935|80909785|FG000|Overall Study|Withdrawal by Subject|0|||
27750173|NCT00610935|80909786|FG001|Overall Study|Withdrawal by Subject|2|||
27750174|NCT00610935|80909785|FG000|Overall Study|Sponsor Discontinuation|1|||
27750175|NCT00610935|80909786|FG001|Overall Study|Sponsor Discontinuation|0|||
27750176|NCT05373706|80909787|FG000|Overall Study|Lost to Follow-up|2|||
27750177|NCT05373706|80909788|FG001|Overall Study|Lost to Follow-up|2|||
27750178|NCT00524316|80909790|FG000|Overall Study|Withdrawal by Subject|2|||
27750179|NCT00524316|80909790|FG000|Overall Study|Adverse Event|7|||
27750180|NCT00524316|80909790|FG000|Overall Study|Disease Progression|7|||
27750181|NCT01987986|80909791|FG000|Overall Study|Lost to Follow-up|1|||
27750182|NCT01987986|80909792|FG001|Overall Study|Lost to Follow-up|0|||
27750183|NCT01987986|80909793|FG002|Overall Study|Lost to Follow-up|0|||
27750184|NCT01987986|80909794|FG003|Overall Study|Lost to Follow-up|0|||
27750185|NCT01987986|80909791|FG000|Overall Study|Adverse Event|1|||
27750186|NCT01987986|80909792|FG001|Overall Study|Adverse Event|0|||
27750187|NCT01987986|80909793|FG002|Overall Study|Adverse Event|2|||
27750188|NCT01987986|80909794|FG003|Overall Study|Adverse Event|0|||
27750189|NCT00926796|80909804|FG000|Overall Study|Did not receive randomized treatment|4|||
27750190|NCT00926796|80909805|FG001|Overall Study|Did not receive randomized treatment|7|||
27750191|NCT00926796|80909804|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
27750192|NCT00926796|80909805|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
27750193|NCT00926796|80909804|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
27750194|NCT00926796|80909805|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
27750195|NCT00926796|80909804|FG000|Overall Study|Adverse Event|7|||
27750196|NCT00926796|80909805|FG001|Overall Study|Adverse Event|14|||
27750197|NCT00926796|80909804|FG000|Overall Study|Lost to Follow-up|22|||
27750198|NCT00926796|80909805|FG001|Overall Study|Lost to Follow-up|13|||
27750199|NCT00926796|80909804|FG000|Overall Study|Protocol Violation|15|||
27750200|NCT00926796|80909805|FG001|Overall Study|Protocol Violation|11|||
27750201|NCT00926796|80909804|FG000|Overall Study|Withdrawal by Subject|1|||
27750202|NCT00926796|80909805|FG001|Overall Study|Withdrawal by Subject|0|||
27750203|NCT03100942|80909806|FG000|Randomized Treatment Period|Withdrew Consent|4|||
27750204|NCT03100942|80909807|FG001|Randomized Treatment Period|Withdrew Consent|5|||
27750205|NCT03100942|80909808|FG002|Randomized Treatment Period|Withdrew Consent|3|||
27750206|NCT03100942|80909809|FG003|Randomized Treatment Period|Withdrew Consent|3|||
27750207|NCT03100942|80909810|FG004|Randomized Treatment Period|Withdrew Consent|0|||
27750208|NCT03100942|80909811|FG005|Randomized Treatment Period|Withdrew Consent|0|||
27750209|NCT03100942|80909812|FG006|Randomized Treatment Period|Withdrew Consent|0|||
27750210|NCT03100942|80909806|FG000|Randomized Treatment Period|Adverse Event|5|||
27750211|NCT03100942|80909807|FG001|Randomized Treatment Period|Adverse Event|2|||
27750212|NCT03100942|80909808|FG002|Randomized Treatment Period|Adverse Event|1|||
27750213|NCT03100942|80909809|FG003|Randomized Treatment Period|Adverse Event|0|||
27750214|NCT03100942|80909810|FG004|Randomized Treatment Period|Adverse Event|0|||
27750215|NCT03100942|80909811|FG005|Randomized Treatment Period|Adverse Event|0|||
27750216|NCT03100942|80909812|FG006|Randomized Treatment Period|Adverse Event|0|||
27750217|NCT03100942|80909806|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
27750218|NCT03100942|80909807|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
27750219|NCT03100942|80909808|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
27750220|NCT03100942|80909809|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
27750221|NCT03100942|80909810|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
27750222|NCT03100942|80909811|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
27750223|NCT03100942|80909812|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
27750224|NCT03100942|80909806|FG000|Randomized Treatment Period|Protocol Violation|0|||
27750225|NCT03100942|80909807|FG001|Randomized Treatment Period|Protocol Violation|1|||
27750226|NCT03100942|80909808|FG002|Randomized Treatment Period|Protocol Violation|1|||
27750227|NCT03100942|80909809|FG003|Randomized Treatment Period|Protocol Violation|1|||
27750228|NCT03100942|80909810|FG004|Randomized Treatment Period|Protocol Violation|0|||
27750229|NCT03100942|80909811|FG005|Randomized Treatment Period|Protocol Violation|0|||
27750230|NCT03100942|80909812|FG006|Randomized Treatment Period|Protocol Violation|0|||
27750231|NCT03100942|80909806|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
27750232|NCT03100942|80909807|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
27750233|NCT03100942|80909808|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
27750234|NCT03100942|80909809|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
27954168|NCT02347085|81665912|FG000|Overall Study|Withdrawal by Subject|4|||
27750235|NCT03100942|80909810|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
27750236|NCT03100942|80909811|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
27750237|NCT03100942|80909812|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
27750238|NCT03100942|80909806|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
27750239|NCT03100942|80909807|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
27750240|NCT03100942|80909808|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
27750241|NCT03100942|80909809|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
27750242|NCT03100942|80909810|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
27750243|NCT03100942|80909811|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
27750244|NCT03100942|80909812|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
27750245|NCT03100942|80909806|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
27750246|NCT03100942|80909807|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
27750247|NCT03100942|80909808|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
27750248|NCT03100942|80909809|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
27750249|NCT03100942|80909810|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
27750250|NCT03100942|80909811|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
27750251|NCT03100942|80909812|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
27750252|NCT04072146|80909813|FG000|Overall Study|Adverse Event|0|||
27750253|NCT04072146|80909814|FG001|Overall Study|Adverse Event|1|||
27750254|NCT01441440|80909817|FG000|Overall Study|Death|1|||
27750255|NCT01441440|80909818|FG001|Overall Study|Death|0|||
27750256|NCT01441440|80909819|FG002|Overall Study|Death|1|||
27750257|NCT01441440|80909817|FG000|Overall Study|Adverse Event|2|||
27750258|NCT01441440|80909818|FG001|Overall Study|Adverse Event|9|||
27750259|NCT01441440|80909819|FG002|Overall Study|Adverse Event|9|||
27750260|NCT01441440|80909817|FG000|Overall Study|Lost to Follow-up|0|||
27750261|NCT01441440|80909818|FG001|Overall Study|Lost to Follow-up|2|||
27750262|NCT01441440|80909819|FG002|Overall Study|Lost to Follow-up|1|||
27750263|NCT01441440|80909817|FG000|Overall Study|Withdrawal by Subject|11|||
27750264|NCT01441440|80909818|FG001|Overall Study|Withdrawal by Subject|9|||
27750265|NCT01441440|80909819|FG002|Overall Study|Withdrawal by Subject|9|||
27750266|NCT01441440|80909817|FG000|Overall Study|Pregnancy|1|||
27750267|NCT01441440|80909818|FG001|Overall Study|Pregnancy|0|||
27750268|NCT01441440|80909819|FG002|Overall Study|Pregnancy|0|||
27750269|NCT01441440|80909817|FG000|Overall Study|Lack of Efficacy|1|||
27750270|NCT01441440|80909818|FG001|Overall Study|Lack of Efficacy|0|||
27750271|NCT01441440|80909819|FG002|Overall Study|Lack of Efficacy|1|||
27750272|NCT01441440|80909817|FG000|Overall Study|Moving|0|||
27750273|NCT01441440|80909818|FG001|Overall Study|Moving|1|||
27750274|NCT01441440|80909819|FG002|Overall Study|Moving|1|||
27750275|NCT01441440|80909817|FG000|Overall Study|Work-related matter|0|||
27750276|NCT01441440|80909818|FG001|Overall Study|Work-related matter|1|||
27750277|NCT01441440|80909819|FG002|Overall Study|Work-related matter|0|||
27750278|NCT01441440|80909817|FG000|Overall Study|Difficllty in keeping the schedule|1|||
27750279|NCT01441440|80909818|FG001|Overall Study|Difficllty in keeping the schedule|1|||
27750280|NCT01441440|80909819|FG002|Overall Study|Difficllty in keeping the schedule|0|||
27750281|NCT04009096|80909820|FG000|Overall Study|Withdrawal by Subject|0|||
27750282|NCT04009096|80909821|FG001|Overall Study|Withdrawal by Subject|7|||
27750283|NCT04009096|80909822|FG002|Overall Study|Withdrawal by Subject|0|||
27750284|NCT04009096|80909820|FG000|Overall Study|Physician Decision|0|||
27750285|NCT04009096|80909821|FG001|Overall Study|Physician Decision|1|||
27750286|NCT04009096|80909822|FG002|Overall Study|Physician Decision|0|||
27750287|NCT03215264|80909823|FG000|Dose Level 2|Adverse Event|0|||
27750288|NCT03215264|80909824|FG001|Dose Level 2|Adverse Event|1|||
27750289|NCT03215264|80909825|FG002|Dose Level 2|Adverse Event|0|||
27750290|NCT03215264|80909823|FG000|Dose Level 3|Withdrawal by Subject|0|||
27750291|NCT03215264|80909824|FG001|Dose Level 3|Withdrawal by Subject|0|||
27750292|NCT03215264|80909825|FG002|Dose Level 3|Withdrawal by Subject|1|||
27750293|NCT02043301|80909826|FG000|Overall Study|Discontinued|0|||
27750294|NCT02043301|80909827|FG001|Overall Study|Discontinued|1|||
27750295|NCT02043301|80909828|FG002|Overall Study|Discontinued|0|||
27750296|NCT01597622|80909841|FG000|Overall Study|Adverse Event|7|||
27750297|NCT01597622|80909841|FG000|Overall Study|Lack of Efficacy|3|||
27750298|NCT01597622|80909841|FG000|Overall Study|Protocol Violation|1|||
27750299|NCT01597622|80909841|FG000|Overall Study|Lost to Follow-up|1|||
27750300|NCT01597622|80909841|FG000|Overall Study|Investigator Discretion|5|||
27750301|NCT01597622|80909841|FG000|Overall Study|Withdrawal by Subject|20|||
27750302|NCT01597622|80909841|FG000|Overall Study|Death|1|||
27750303|NCT03599141|80909846|FG000|Overall Study|Lost to Follow-up|3|||
27750304|NCT03599141|80909847|FG001|Overall Study|Lost to Follow-up|1|||
27750305|NCT03648476|80909848|FG000|Overall Study|Withdrawal by Subject|2|||
27750306|NCT03648476|80909849|FG001|Overall Study|Withdrawal by Subject|1|||
27651965|NCT03122860|80564767|FG000|Overall Study|Withdrawal by Subject|3|||
27750307|NCT01577160|80909850|FG000|Overall Study|Adverse Event|9|||
27750308|NCT01577160|80909850|FG000|Overall Study|Lack of Efficacy|15|||
27750309|NCT01577160|80909850|FG000|Overall Study|Lost to Follow-up|40|||
27750310|NCT01577160|80909850|FG000|Overall Study|Withdrawal by Subject|18|||
27750311|NCT01577160|80909850|FG000|Overall Study|Subject Uncooperative|7|||
27750312|NCT01577160|80909850|FG000|Overall Study|Other|9|||
27750313|NCT01576016|80909856|FG000|Lead Safety|Death|132|||
27750314|NCT01576016|80909857|FG001|Lead Safety|Death|0|||
27750315|NCT01576016|80909856|FG000|Lead Safety|Withdrawal by Subject|81|||
27750316|NCT01576016|80909857|FG001|Lead Safety|Withdrawal by Subject|0|||
27750317|NCT01576016|80909856|FG000|Lead Safety|System Explanted without Replacement|24|||
27750318|NCT01576016|80909857|FG001|Lead Safety|System Explanted without Replacement|0|||
27750319|NCT01576016|80909856|FG000|Lead Safety|Physician Decision|14|||
27750320|NCT01576016|80909857|FG001|Lead Safety|Physician Decision|0|||
27750321|NCT01576016|80909856|FG000|Lead Safety|Lost to Follow-up|13|||
27750322|NCT01576016|80909857|FG001|Lead Safety|Lost to Follow-up|0|||
27750323|NCT01576016|80909856|FG000|Lead Safety|Unsuccessful implant|2|||
27750324|NCT01576016|80909857|FG001|Lead Safety|Unsuccessful implant|0|||
27750325|NCT01576016|80909856|FG000|Lead Safety|Sponsor request|1|||
27750326|NCT01576016|80909857|FG001|Lead Safety|Sponsor request|0|||
27750327|NCT01576016|80909856|FG000|Lead Safety|Device replaced with CRT-D|1|||
27750328|NCT01576016|80909857|FG001|Lead Safety|Device replaced with CRT-D|0|||
27750329|NCT01576016|80909856|FG000|Lead Safety|Patient on Palliative Care|1|||
27750330|NCT01576016|80909857|FG001|Lead Safety|Patient on Palliative Care|0|||
27750331|NCT01576016|80909856|FG000|Lead Safety|Patient noncompliance|1|||
27750332|NCT01576016|80909857|FG001|Lead Safety|Patient noncompliance|0|||
27750333|NCT01576016|80909856|FG000|Lead Safety|Too far from study site|1|||
27750334|NCT01576016|80909857|FG001|Lead Safety|Too far from study site|0|||
27750335|NCT01576016|80909856|FG000|Lead Safety|System deactivated|1|||
27750336|NCT01576016|80909857|FG001|Lead Safety|System deactivated|0|||
27750337|NCT01576016|80909856|FG000|Lead Safety|Patient no longer followed by study PI|1|||
27750338|NCT01576016|80909857|FG001|Lead Safety|Patient no longer followed by study PI|0|||
27750339|NCT01576016|80909856|FG000|MRI Safety|Withdrawal by Subject|0|||
27750340|NCT01576016|80909857|FG001|MRI Safety|Withdrawal by Subject|10|||
27750341|NCT01576016|80909856|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
27750342|NCT01576016|80909857|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
27750343|NCT01576016|80909856|FG000|MRI Safety|Has not yet completed MRI scan|0|||
27750344|NCT01576016|80909857|FG001|MRI Safety|Has not yet completed MRI scan|56|||
27750345|NCT01576016|80909856|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
27750346|NCT01576016|80909857|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
27750347|NCT01839188|80909858|FG000|Overall Study|Withdrawal by Subject|1|||
27750348|NCT03484923|80909859|FG000|Overall Study|Adverse Event|3|||
27750349|NCT03484923|80909860|FG001|Overall Study|Adverse Event|3|||
27750350|NCT03484923|80909861|FG002|Overall Study|Adverse Event|5|||
27750351|NCT03484923|80909862|FG003|Overall Study|Adverse Event|11|||
27750352|NCT03484923|80909863|FG004|Overall Study|Adverse Event|1|||
27750353|NCT03484923|80909859|FG000|Overall Study|Death|2|||
27750354|NCT03484923|80909860|FG001|Overall Study|Death|2|||
27750355|NCT03484923|80909861|FG002|Overall Study|Death|3|||
27750356|NCT03484923|80909862|FG003|Overall Study|Death|0|||
27750357|NCT03484923|80909863|FG004|Overall Study|Death|1|||
27750358|NCT03484923|80909859|FG000|Overall Study|Physician Decision|6|||
27750359|NCT03484923|80909860|FG001|Overall Study|Physician Decision|7|||
27750360|NCT03484923|80909861|FG002|Overall Study|Physician Decision|6|||
27750361|NCT03484923|80909862|FG003|Overall Study|Physician Decision|3|||
27750362|NCT03484923|80909863|FG004|Overall Study|Physician Decision|2|||
27750363|NCT03484923|80909859|FG000|Overall Study|Progressive disease|33|||
27750364|NCT03484923|80909860|FG001|Overall Study|Progressive disease|28|||
27750365|NCT03484923|80909861|FG002|Overall Study|Progressive disease|26|||
27750366|NCT03484923|80909862|FG003|Overall Study|Progressive disease|30|||
27750367|NCT03484923|80909863|FG004|Overall Study|Progressive disease|16|||
27750368|NCT03484923|80909859|FG000|Overall Study|Subject Decision|1|||
27750369|NCT03484923|80909860|FG001|Overall Study|Subject Decision|3|||
27750370|NCT03484923|80909861|FG002|Overall Study|Subject Decision|3|||
27750371|NCT03484923|80909862|FG003|Overall Study|Subject Decision|0|||
27750372|NCT03484923|80909863|FG004|Overall Study|Subject Decision|1|||
27750373|NCT01120093|80909865|FG000|Treatment Period 1|Adverse Event|0|||
27750374|NCT01120093|80909866|FG001|Treatment Period 1|Adverse Event|0|||
27750375|NCT01120093|80909867|FG002|Treatment Period 1|Adverse Event|1|||
27750376|NCT01120093|80909868|FG003|Treatment Period 1|Adverse Event|0|||
27750377|NCT01120093|80909869|FG004|Treatment Period 1|Adverse Event|1|||
27750378|NCT01120093|80909865|FG000|Treatment Period 1|Withdrawal by Subject|0|||
27750379|NCT01120093|80909866|FG001|Treatment Period 1|Withdrawal by Subject|1|||
27750380|NCT01120093|80909867|FG002|Treatment Period 1|Withdrawal by Subject|0|||
27750381|NCT01120093|80909868|FG003|Treatment Period 1|Withdrawal by Subject|0|||
27750382|NCT01120093|80909869|FG004|Treatment Period 1|Withdrawal by Subject|0|||
27750383|NCT01120093|80909865|FG000|Treatment Period 2|Adverse Event|0|||
27750384|NCT01120093|80909866|FG001|Treatment Period 2|Adverse Event|0|||
27750385|NCT01120093|80909867|FG002|Treatment Period 2|Adverse Event|0|||
27750386|NCT01120093|80909868|FG003|Treatment Period 2|Adverse Event|1|||
27750387|NCT01120093|80909869|FG004|Treatment Period 2|Adverse Event|0|||
27750388|NCT01120093|80909865|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27750389|NCT01120093|80909866|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27750390|NCT01120093|80909867|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27750391|NCT01120093|80909868|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27750392|NCT01120093|80909869|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27750393|NCT01120093|80909865|FG000|Treatment Period 3|Lack of Efficacy|0|||
27750394|NCT01120093|80909866|FG001|Treatment Period 3|Lack of Efficacy|0|||
27750395|NCT01120093|80909867|FG002|Treatment Period 3|Lack of Efficacy|0|||
27750396|NCT01120093|80909868|FG003|Treatment Period 3|Lack of Efficacy|1|||
27750397|NCT01120093|80909869|FG004|Treatment Period 3|Lack of Efficacy|0|||
27750398|NCT01120093|80909865|FG000|Treatment Period 3|Adverse Event|0|||
27750399|NCT01120093|80909866|FG001|Treatment Period 3|Adverse Event|0|||
27750400|NCT01120093|80909867|FG002|Treatment Period 3|Adverse Event|0|||
27750401|NCT01120093|80909868|FG003|Treatment Period 3|Adverse Event|0|||
27750402|NCT01120093|80909869|FG004|Treatment Period 3|Adverse Event|1|||
27750403|NCT01120093|80909865|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27750404|NCT01120093|80909866|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27750405|NCT01120093|80909867|FG002|Treatment Period 3|Withdrawal by Subject|1|||
27750406|NCT01120093|80909868|FG003|Treatment Period 3|Withdrawal by Subject|0|||
27750407|NCT01120093|80909869|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27651966|NCT03122860|80564768|FG001|Overall Study|Withdrawal by Subject|2|||
27651967|NCT03122860|80564769|FG002|Overall Study|Withdrawal by Subject|5|||
27651968|NCT03122860|80564770|FG003|Overall Study|Withdrawal by Subject|7|||
27651969|NCT03122860|80564771|FG004|Overall Study|Withdrawal by Subject|9|||
27651970|NCT03122860|80564772|FG005|Overall Study|Withdrawal by Subject|8|||
27651971|NCT01019135|80564776|FG000|Overall Study|Did not receive allocated intervention|12|||
27651972|NCT01019135|80564777|FG001|Overall Study|Did not receive allocated intervention|6|||
27651973|NCT01019135|80564778|FG002|Overall Study|Did not receive allocated intervention|25|||
27651974|NCT01019135|80564776|FG000|Overall Study|Did not attend CR|8|||
27651975|NCT01019135|80564777|FG001|Overall Study|Did not attend CR|13|||
27651976|NCT01019135|80564778|FG002|Overall Study|Did not attend CR|6|||
27651977|NCT03695185|80564779|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
27651978|NCT03695185|80564779|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
27651979|NCT03695185|80564779|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
27651980|NCT03695185|80564779|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
27651981|NCT03695185|80564779|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
27651982|NCT03695185|80564779|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
27651983|NCT01867307|80564782|FG000|Overall Study|Protocol Violation|2|||
27651984|NCT01867307|80564783|FG001|Overall Study|Protocol Violation|0|||
27651985|NCT01867307|80564782|FG000|Overall Study|Other Adverse Event|1|||
27750408|NCT01120093|80909865|FG000|Treatment Period 4|Adverse Event|1|||
27750409|NCT01120093|80909866|FG001|Treatment Period 4|Adverse Event|0|||
27750410|NCT01120093|80909867|FG002|Treatment Period 4|Adverse Event|0|||
27750411|NCT01120093|80909868|FG003|Treatment Period 4|Adverse Event|0|||
27750412|NCT01120093|80909869|FG004|Treatment Period 4|Adverse Event|0|||
27750413|NCT01120093|80909865|FG000|Treatment Period 5|Adverse Event|0|||
27750414|NCT01120093|80909866|FG001|Treatment Period 5|Adverse Event|1|||
27750415|NCT01120093|80909867|FG002|Treatment Period 5|Adverse Event|0|||
27750416|NCT01120093|80909868|FG003|Treatment Period 5|Adverse Event|1|||
27750417|NCT01120093|80909869|FG004|Treatment Period 5|Adverse Event|0|||
27750418|NCT00488033|80909870|FG000|Overall Study|Withdrawal by Subject|1|||
27750419|NCT00488033|80909871|FG001|Overall Study|Withdrawal by Subject|0|||
27750420|NCT01469013|80913834|FG000|Part A (Treatment Period)|Adverse Event|1|||
27750421|NCT01469013|80913835|FG001|Part A (Treatment Period)|Adverse Event|0|||
27750422|NCT01469013|80913836|FG002|Part A (Treatment Period)|Adverse Event|0|||
27750423|NCT01469013|80913837|FG003|Part A (Treatment Period)|Adverse Event|0|||
27750424|NCT01469013|80913838|FG004|Part A (Treatment Period)|Adverse Event|1|||
27750425|NCT01469013|80913839|FG005|Part A (Treatment Period)|Adverse Event|0|||
27750426|NCT01469013|80913840|FG006|Part A (Treatment Period)|Adverse Event|0|||
27750427|NCT01469013|80913841|FG007|Part A (Treatment Period)|Adverse Event|0|||
27750428|NCT01469013|80913842|FG008|Part A (Treatment Period)|Adverse Event|0|||
27750429|NCT01469013|80913843|FG009|Part A (Treatment Period)|Adverse Event|0|||
27750430|NCT01469013|80913844|FG010|Part A (Treatment Period)|Adverse Event|0|||
27750431|NCT01469013|80913845|FG011|Part A (Treatment Period)|Adverse Event|0|||
27750432|NCT01469013|80913846|FG012|Part A (Treatment Period)|Adverse Event|0|||
27750433|NCT01469013|80913834|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750434|NCT01469013|80913835|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750435|NCT01469013|80913836|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
27750436|NCT01469013|80913837|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750437|NCT01469013|80913838|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750438|NCT01469013|80913839|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750439|NCT01469013|80913840|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750440|NCT01469013|80913841|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
27954169|NCT02347085|81665912|FG000|Overall Study|Lost to Follow-up|1|||
27750441|NCT01469013|80913842|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750442|NCT01469013|80913843|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750443|NCT01469013|80913844|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750444|NCT01469013|80913845|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750445|NCT01469013|80913846|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
27750446|NCT01469013|80913834|FG000|Part B (Extension Period)|Adverse Event|0|||
27750447|NCT01469013|80913835|FG001|Part B (Extension Period)|Adverse Event|0|||
27750448|NCT01469013|80913836|FG002|Part B (Extension Period)|Adverse Event|0|||
27651986|NCT01867307|80564783|FG001|Overall Study|Other Adverse Event|3|||
27651987|NCT04705051|80564784|FG000|Overall Study|Enrolled but not treated|1|||
27750449|NCT01469013|80913837|FG003|Part B (Extension Period)|Adverse Event|0|||
27750450|NCT01469013|80913838|FG004|Part B (Extension Period)|Adverse Event|0|||
27750451|NCT01469013|80913839|FG005|Part B (Extension Period)|Adverse Event|2|||
27750452|NCT01469013|80913840|FG006|Part B (Extension Period)|Adverse Event|5|||
27750453|NCT01469013|80913841|FG007|Part B (Extension Period)|Adverse Event|5|||
27750454|NCT01469013|80913842|FG008|Part B (Extension Period)|Adverse Event|3|||
27750455|NCT01469013|80913843|FG009|Part B (Extension Period)|Adverse Event|3|||
27750456|NCT01469013|80913844|FG010|Part B (Extension Period)|Adverse Event|1|||
27750457|NCT01469013|80913845|FG011|Part B (Extension Period)|Adverse Event|6|||
27750458|NCT01469013|80913846|FG012|Part B (Extension Period)|Adverse Event|3|||
27750459|NCT01469013|80913834|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
27750460|NCT01469013|80913835|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
27750461|NCT01469013|80913836|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
27750462|NCT01469013|80913837|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
27750463|NCT01469013|80913838|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
27750464|NCT01469013|80913839|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
27750465|NCT01469013|80913840|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
27750466|NCT01469013|80913841|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
27750467|NCT01469013|80913842|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
27750468|NCT01469013|80913843|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
27750469|NCT01469013|80913844|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
27750470|NCT01469013|80913845|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
27750471|NCT01469013|80913846|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
27750472|NCT03259334|80913848|FG000|Overall Study|Adverse Event|3|||
27750473|NCT03259334|80913849|FG001|Overall Study|Adverse Event|8|||
27750474|NCT03259334|80913850|FG002|Overall Study|Adverse Event|5|||
27750475|NCT03259334|80913848|FG000|Overall Study|Withdrawal by Subject|4|||
27750476|NCT03259334|80913849|FG001|Overall Study|Withdrawal by Subject|2|||
27750477|NCT03259334|80913850|FG002|Overall Study|Withdrawal by Subject|4|||
27750478|NCT03259334|80913848|FG000|Overall Study|Physician Decision|1|||
27750479|NCT03259334|80913849|FG001|Overall Study|Physician Decision|0|||
27750480|NCT03259334|80913850|FG002|Overall Study|Physician Decision|0|||
27750481|NCT03259334|80913848|FG000|Overall Study|Lost to Follow-up|0|||
27750482|NCT03259334|80913849|FG001|Overall Study|Lost to Follow-up|2|||
27750483|NCT03259334|80913850|FG002|Overall Study|Lost to Follow-up|1|||
27750484|NCT03259334|80913848|FG000|Overall Study|Protocol Deviation|0|||
27750485|NCT03259334|80913849|FG001|Overall Study|Protocol Deviation|3|||
27750486|NCT03259334|80913850|FG002|Overall Study|Protocol Deviation|2|||
27750487|NCT03259334|80913848|FG000|Overall Study|Lack of Efficacy|2|||
27750488|NCT03259334|80913849|FG001|Overall Study|Lack of Efficacy|0|||
27750489|NCT03259334|80913850|FG002|Overall Study|Lack of Efficacy|1|||
27750490|NCT03259334|80913848|FG000|Overall Study|Randomized but never treated|0|||
27750491|NCT03259334|80913849|FG001|Overall Study|Randomized but never treated|2|||
27750492|NCT03259334|80913850|FG002|Overall Study|Randomized but never treated|0|||
27750493|NCT01242020|80913857|FG000|Overall Study|Withdrawal by Subject|2|||
27750494|NCT01242020|80913858|FG001|Overall Study|Withdrawal by Subject|0|||
27750495|NCT01242020|80913857|FG000|Overall Study|Failed screening|1|||
27750496|NCT01242020|80913858|FG001|Overall Study|Failed screening|0|||
27750497|NCT01766336|80913859|FG000|Overall Study|Adverse Event|11|||
27750498|NCT01766336|80913860|FG001|Overall Study|Adverse Event|8|||
27750499|NCT01766336|80913859|FG000|Overall Study|Death|4|||
27750500|NCT01766336|80913860|FG001|Overall Study|Death|3|||
27750501|NCT01766336|80913859|FG000|Overall Study|Lost to Follow-up|1|||
27750502|NCT01766336|80913860|FG001|Overall Study|Lost to Follow-up|3|||
27750503|NCT01766336|80913859|FG000|Overall Study|Physician Decision|4|||
27750504|NCT01766336|80913860|FG001|Overall Study|Physician Decision|2|||
27750505|NCT01766336|80913859|FG000|Overall Study|Protocol Violation|0|||
27750506|NCT01766336|80913860|FG001|Overall Study|Protocol Violation|1|||
27750507|NCT01766336|80913859|FG000|Overall Study|Sponsor Decision|52|||
27750508|NCT01766336|80913860|FG001|Overall Study|Sponsor Decision|43|||
27750509|NCT01766336|80913859|FG000|Overall Study|Withdrawal by Subject|18|||
27750510|NCT01766336|80913860|FG001|Overall Study|Withdrawal by Subject|15|||
27750511|NCT05515601|80913861|FG000|Overall Study|Withdrawal by Subject|1|||
27551530|NCT01482884|80207483|FG001|Overall Study|Lack of Efficacy|1|||
27750512|NCT05515601|80913862|FG001|Overall Study|Withdrawal by Subject|3|||
27750513|NCT05515601|80913863|FG002|Overall Study|Withdrawal by Subject|2|||
27750514|NCT05515601|80913864|FG003|Overall Study|Withdrawal by Subject|1|||
27750515|NCT05515601|80913865|FG004|Overall Study|Withdrawal by Subject|1|||
27750516|NCT05515601|80913866|FG005|Overall Study|Withdrawal by Subject|1|||
27750517|NCT05515601|80913861|FG000|Overall Study|Lost to Follow-up|0|||
27750518|NCT05515601|80913862|FG001|Overall Study|Lost to Follow-up|0|||
27750519|NCT05515601|80913863|FG002|Overall Study|Lost to Follow-up|0|||
27750520|NCT05515601|80913864|FG003|Overall Study|Lost to Follow-up|0|||
27750521|NCT05515601|80913865|FG004|Overall Study|Lost to Follow-up|1|||
27750522|NCT05515601|80913866|FG005|Overall Study|Lost to Follow-up|0|||
27750523|NCT00118482|80913868|FG000|Overall Study|Lost to Follow-up|7|||
27750524|NCT00118482|80913869|FG001|Overall Study|Lost to Follow-up|7|||
27750525|NCT00118482|80913868|FG000|Overall Study|Withdrawal by Subject|23|||
27750526|NCT00118482|80913869|FG001|Overall Study|Withdrawal by Subject|22|||
27750527|NCT02575079|80913870|FG000|Overall Study|Death|3|||
27750528|NCT02575079|80913871|FG001|Overall Study|Death|0|||
27750529|NCT02575079|80913870|FG000|Overall Study|Withdrawal by Subject|3|||
27750530|NCT02575079|80913871|FG001|Overall Study|Withdrawal by Subject|0|||
27750531|NCT01081873|80913872|FG000|Overall Study|Death|86|||
27750532|NCT01081873|80913872|FG000|Overall Study|Withdrawal by Subject|10|||
27750533|NCT01081873|80913872|FG000|Overall Study|Lost to Follow-up|142|||
27750534|NCT01081873|80913872|FG000|Overall Study|Progression of prostate cancer|13|||
27750535|NCT01081873|80913872|FG000|Overall Study|Other|47|||
27750536|NCT00807846|80913873|FG000|Overall Study|Adverse Event|5|||
27750537|NCT00807846|80913874|FG001|Overall Study|Adverse Event|0|||
27750538|NCT00807846|80913873|FG000|Overall Study|Lack of Efficacy|2|||
27750539|NCT00807846|80913874|FG001|Overall Study|Lack of Efficacy|0|||
27750540|NCT00807846|80913873|FG000|Overall Study|Protocol Violation|2|||
27750541|NCT00807846|80913874|FG001|Overall Study|Protocol Violation|1|||
27750542|NCT00807846|80913873|FG000|Overall Study|Withdrawal by Subject|2|||
27750543|NCT00807846|80913874|FG001|Overall Study|Withdrawal by Subject|1|||
27750544|NCT00807846|80913873|FG000|Overall Study|Other|1|||
27750545|NCT00807846|80913874|FG001|Overall Study|Other|2|||
27750546|NCT01331239|80913876|FG000|Part II: Core Study|Adverse Event|0|||
27750547|NCT01331239|80913877|FG001|Part II: Core Study|Adverse Event|3|||
27750548|NCT01331239|80913878|FG002|Part II: Core Study|Adverse Event|0|||
27750549|NCT01331239|80913876|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
27750550|NCT01331239|80913877|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
27750551|NCT01331239|80913878|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
27750552|NCT01331239|80913876|FG000|Part II: Core Study|Withdrawal by Subject|0|||
27750553|NCT01331239|80913877|FG001|Part II: Core Study|Withdrawal by Subject|2|||
27750554|NCT01331239|80913878|FG002|Part II: Core Study|Withdrawal by Subject|0|||
27750555|NCT01331239|80913876|FG000|Part II: Core Study|Administrative problems|0|||
27750556|NCT01331239|80913877|FG001|Part II: Core Study|Administrative problems|1|||
27750557|NCT01331239|80913878|FG002|Part II: Core Study|Administrative problems|0|||
27750558|NCT02750800|80913879|FG000|Overall Study|Adverse Event|18|||
27750559|NCT02750800|80913879|FG000|Overall Study|Lost to Follow-up|12|||
27750560|NCT02750800|80913879|FG000|Overall Study|Investigator decision|53|||
27750561|NCT02750800|80913879|FG000|Overall Study|Patient request|12|||
27750562|NCT02750800|80913879|FG000|Overall Study|Other, not specified|3|||
27750563|NCT02427477|80913880|FG000|Period 1|Adverse Event|1|||
27750564|NCT02427477|80913881|FG001|Period 1|Adverse Event|0|||
27750565|NCT00603980|80913886|FG000|Study Qualification|Protocol Violation|3|||
27750566|NCT00603980|80913886|FG000|Study Qualification|Inconsistent data reporting|13|||
27750567|NCT00603980|80913886|FG000|Main Study|14th subject completed trial|1|||
27750568|NCT02280291|80913887|FG000|Overall Study|Lost to Follow-up|2|||
27750569|NCT02280291|80913888|FG001|Overall Study|Lost to Follow-up|1|||
27750570|NCT02280291|80913889|FG002|Overall Study|Lost to Follow-up|3|||
27750571|NCT02280291|80913890|FG003|Overall Study|Lost to Follow-up|8|||
27750572|NCT02280291|80913887|FG000|Overall Study|Protocol Violation|1|||
27750573|NCT02280291|80913888|FG001|Overall Study|Protocol Violation|0|||
27750574|NCT02280291|80913889|FG002|Overall Study|Protocol Violation|0|||
27750575|NCT02280291|80913890|FG003|Overall Study|Protocol Violation|0|||
27750576|NCT02280291|80913887|FG000|Overall Study|Other|1|||
27750577|NCT02280291|80913888|FG001|Overall Study|Other|1|||
27750578|NCT02280291|80913889|FG002|Overall Study|Other|0|||
27750579|NCT02280291|80913890|FG003|Overall Study|Other|0|||
27750580|NCT01808118|80913891|FG000|Period 1|Adverse Event|15|||
27750581|NCT01808118|80913892|FG001|Period 1|Adverse Event|0|||
27750582|NCT01808118|80913893|FG002|Period 1|Adverse Event|0|||
27750583|NCT01808118|80913891|FG000|Period 1|Withdrew consent|24|||
27750584|NCT01808118|80913892|FG001|Period 1|Withdrew consent|0|||
27750585|NCT01808118|80913893|FG002|Period 1|Withdrew consent|0|||
27750586|NCT01808118|80913891|FG000|Period 1|Lost to Follow-up|9|||
27750587|NCT01808118|80913892|FG001|Period 1|Lost to Follow-up|0|||
27750588|NCT01808118|80913893|FG002|Period 1|Lost to Follow-up|0|||
27750589|NCT01808118|80913891|FG000|Period 1|Did not meet criteria for remission|303|||
27750590|NCT01808118|80913892|FG001|Period 1|Did not meet criteria for remission|0|||
27750591|NCT01808118|80913893|FG002|Period 1|Did not meet criteria for remission|0|||
27750592|NCT01808118|80913891|FG000|Period 1|Enrolled in error|7|||
27750593|NCT01808118|80913892|FG001|Period 1|Enrolled in error|0|||
27750594|NCT01808118|80913893|FG002|Period 1|Enrolled in error|0|||
27750595|NCT01808118|80913891|FG000|Period 1|Did not meet inclusion criteria|3|||
27750596|NCT01808118|80913892|FG001|Period 1|Did not meet inclusion criteria|0|||
27750597|NCT01808118|80913893|FG002|Period 1|Did not meet inclusion criteria|0|||
27750598|NCT01808118|80913891|FG000|Period 1|Non-conformance with inclusion criteria|3|||
27750599|NCT01808118|80913892|FG001|Period 1|Non-conformance with inclusion criteria|0|||
27750600|NCT01808118|80913893|FG002|Period 1|Non-conformance with inclusion criteria|0|||
27750601|NCT01808118|80913891|FG000|Period 1|Investigator decision: site closure|2|||
27750602|NCT01808118|80913892|FG001|Period 1|Investigator decision: site closure|0|||
27750603|NCT01808118|80913893|FG002|Period 1|Investigator decision: site closure|0|||
27750604|NCT01808118|80913891|FG000|Period 1|Non-compliance per sponsor|1|||
27750605|NCT01808118|80913892|FG001|Period 1|Non-compliance per sponsor|0|||
27750606|NCT01808118|80913893|FG002|Period 1|Non-compliance per sponsor|0|||
27750607|NCT01808118|80913891|FG000|Period 1|Lack of Efficacy|1|||
27750608|NCT01808118|80913892|FG001|Period 1|Lack of Efficacy|0|||
27750609|NCT01808118|80913893|FG002|Period 1|Lack of Efficacy|0|||
27750610|NCT01808118|80913891|FG000|Period 2|Adverse Event|0|||
27750611|NCT01808118|80913892|FG001|Period 2|Adverse Event|4|||
27750612|NCT01808118|80913893|FG002|Period 2|Adverse Event|0|||
27750613|NCT01808118|80913891|FG000|Period 2|Withdrew consent|0|||
27750614|NCT01808118|80913892|FG001|Period 2|Withdrew consent|7|||
27750615|NCT01808118|80913893|FG002|Period 2|Withdrew consent|6|||
27750616|NCT01808118|80913891|FG000|Period 2|Lost to Follow-up|0|||
27750617|NCT01808118|80913892|FG001|Period 2|Lost to Follow-up|0|||
27750618|NCT01808118|80913893|FG002|Period 2|Lost to Follow-up|2|||
27750619|NCT01808118|80913891|FG000|Period 2|Investigator no longer conducting trials|0|||
27750620|NCT01808118|80913892|FG001|Period 2|Investigator no longer conducting trials|1|||
27750621|NCT01808118|80913893|FG002|Period 2|Investigator no longer conducting trials|0|||
27750622|NCT01808118|80913891|FG000|Period 2|Switched to other therapy|0|||
27750623|NCT01808118|80913892|FG001|Period 2|Switched to other therapy|1|||
27750624|NCT01808118|80913893|FG002|Period 2|Switched to other therapy|0|||
27750625|NCT00789477|80913894|FG000|Overall Study|Withdrawal by Subject|2|||
27750626|NCT00789477|80913895|FG001|Overall Study|Withdrawal by Subject|1|||
27750627|NCT00789477|80913896|FG002|Overall Study|Withdrawal by Subject|3|||
27750628|NCT00789477|80913897|FG003|Overall Study|Withdrawal by Subject|2|||
27750629|NCT00789477|80913898|FG004|Overall Study|Withdrawal by Subject|3|||
27750630|NCT00789477|80913894|FG000|Overall Study|Protocol Violation|1|||
27750631|NCT00789477|80913895|FG001|Overall Study|Protocol Violation|0|||
27750632|NCT00789477|80913896|FG002|Overall Study|Protocol Violation|0|||
27750633|NCT00789477|80913897|FG003|Overall Study|Protocol Violation|1|||
27750634|NCT00789477|80913898|FG004|Overall Study|Protocol Violation|0|||
27750635|NCT00789477|80913894|FG000|Overall Study|Adverse Event|3|||
27750636|NCT00789477|80913895|FG001|Overall Study|Adverse Event|3|||
27750637|NCT00789477|80913896|FG002|Overall Study|Adverse Event|1|||
27750638|NCT00789477|80913897|FG003|Overall Study|Adverse Event|0|||
27750639|NCT00789477|80913898|FG004|Overall Study|Adverse Event|0|||
27750640|NCT00789477|80913894|FG000|Overall Study|Death|1|||
27750641|NCT00789477|80913895|FG001|Overall Study|Death|1|||
27750642|NCT00789477|80913896|FG002|Overall Study|Death|2|||
27750643|NCT00789477|80913897|FG003|Overall Study|Death|2|||
27750644|NCT00789477|80913898|FG004|Overall Study|Death|0|||
27750645|NCT00789477|80913894|FG000|Overall Study|Lost to Follow-up|0|||
27750646|NCT00789477|80913895|FG001|Overall Study|Lost to Follow-up|1|||
27750647|NCT00789477|80913896|FG002|Overall Study|Lost to Follow-up|4|||
27750648|NCT00789477|80913897|FG003|Overall Study|Lost to Follow-up|2|||
27750649|NCT00789477|80913898|FG004|Overall Study|Lost to Follow-up|4|||
27750650|NCT00789477|80913894|FG000|Overall Study|Lack of Efficacy|2|||
27750651|NCT00789477|80913895|FG001|Overall Study|Lack of Efficacy|0|||
27750652|NCT00789477|80913896|FG002|Overall Study|Lack of Efficacy|0|||
27750653|NCT00789477|80913897|FG003|Overall Study|Lack of Efficacy|0|||
27750654|NCT00789477|80913898|FG004|Overall Study|Lack of Efficacy|0|||
27750655|NCT00789477|80913894|FG000|Overall Study|Other|2|||
27750656|NCT00789477|80913895|FG001|Overall Study|Other|0|||
27750657|NCT00789477|80913896|FG002|Overall Study|Other|1|||
27651988|NCT04705051|80564784|FG000|Overall Study|Study terminated by sponsor|23|||
27651989|NCT01829711|80564790|FG000|Overall Study|Lost to Follow-up|2|||
27651990|NCT01829711|80564790|FG000|Overall Study|Withdrawal by Subject|3|||
27651991|NCT01829711|80564790|FG000|Overall Study|Death|4|||
27651992|NCT01829711|80564790|FG000|Overall Study|Started new therapies|17|||
27651993|NCT01829711|80564790|FG000|Overall Study|Adverse Event|3|||
27651994|NCT01829711|80564790|FG000|Overall Study|Due to progression of disease|13|||
27651995|NCT01829711|80564790|FG000|Overall Study|Due to lack of response|1|||
27750658|NCT00789477|80913897|FG003|Overall Study|Other|3|||
27954170|NCT02347085|81665912|FG000|Overall Study|Protocol Criteria|2|||
27651996|NCT02085941|80564793|FG000|Overall Study|Lack of Efficacy|1|||
27651997|NCT02085941|80564794|FG001|Overall Study|Lack of Efficacy|0|||
27750659|NCT00789477|80913898|FG004|Overall Study|Other|0|||
27750660|NCT00620321|80913899|FG000|Overall Study|Adverse Event|1|||
27750661|NCT00620321|80913900|FG001|Overall Study|Adverse Event|1|||
27750662|NCT00620321|80913899|FG000|Overall Study|Death|1|||
27750663|NCT00620321|80913900|FG001|Overall Study|Death|1|||
27750664|NCT00620321|80913899|FG000|Overall Study|Physician Decision|0|||
27750665|NCT00620321|80913900|FG001|Overall Study|Physician Decision|7|||
27750666|NCT00620321|80913899|FG000|Overall Study|Progressive Disease|5|||
27750667|NCT00620321|80913900|FG001|Overall Study|Progressive Disease|5|||
27750668|NCT00620321|80913899|FG000|Overall Study|Sponsor Decision|0|||
27750669|NCT00620321|80913900|FG001|Overall Study|Sponsor Decision|1|||
27750670|NCT00620321|80913899|FG000|Overall Study|Withdrawal by Subject|1|||
27750671|NCT00620321|80913900|FG001|Overall Study|Withdrawal by Subject|1|||
27954171|NCT02701764|81665917|FG000|Overall Study|Lost to Follow-up|0|||
27750672|NCT00417976|80913901|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
27750673|NCT00417976|80913901|FG000|Overall Study|Treatment -related toxicity|2|||
27750674|NCT03471767|80913904|FG000|Overall Study|Withdrawal by Subject|3|||
27750675|NCT03471767|80913905|FG001|Overall Study|Withdrawal by Subject|1|||
27750676|NCT03471767|80913904|FG000|Overall Study|Adverse Event|1|||
27750677|NCT03471767|80913905|FG001|Overall Study|Adverse Event|0|||
27954172|NCT02701764|81665918|FG001|Overall Study|Lost to Follow-up|1|||
27954173|NCT01977222|81665919|FG000|Overall Study|Withdrawal by Subject|1|||
27954174|NCT01240863|81665920|FG000|Open-label Titration Period|Adverse Event|47|||
27954175|NCT01240863|81665921|FG001|Open-label Titration Period|Adverse Event|0|||
27954176|NCT01240863|81665922|FG002|Open-label Titration Period|Adverse Event|0|||
27954177|NCT01240863|81665920|FG000|Open-label Titration Period|Lack of Efficacy|19|||
27954178|NCT01240863|81665921|FG001|Open-label Titration Period|Lack of Efficacy|0|||
27954179|NCT01240863|81665922|FG002|Open-label Titration Period|Lack of Efficacy|0|||
27954180|NCT01240863|81665920|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
27954181|NCT01240863|81665921|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
27954182|NCT01240863|81665922|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
27954183|NCT01240863|81665920|FG000|Open-label Titration Period|Protocol Violation|7|||
27954184|NCT01240863|81665921|FG001|Open-label Titration Period|Protocol Violation|0|||
27954185|NCT01240863|81665922|FG002|Open-label Titration Period|Protocol Violation|0|||
27954186|NCT01240863|81665920|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
27954187|NCT01240863|81665921|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
27954188|NCT01240863|81665922|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
27954189|NCT01240863|81665920|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
27954190|NCT01240863|81665921|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
27954191|NCT01240863|81665922|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
27954192|NCT01240863|81665920|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
27954193|NCT01240863|81665921|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
27954194|NCT01240863|81665922|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
27954195|NCT01240863|81665920|FG000|Open-label Titration Period|Other|7|||
27954196|NCT01240863|81665921|FG001|Open-label Titration Period|Other|0|||
27954197|NCT01240863|81665922|FG002|Open-label Titration Period|Other|0|||
27954198|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
27954199|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
27954200|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
27954201|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
27954202|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
27651998|NCT02085941|80564793|FG000|Overall Study|Death|6|||
27651999|NCT02085941|80564794|FG001|Overall Study|Death|1|||
27652000|NCT02085941|80564793|FG000|Overall Study|Lost to Follow-up|1|||
27652001|NCT02085941|80564794|FG001|Overall Study|Lost to Follow-up|0|||
27652002|NCT02085941|80564793|FG000|Overall Study|Physician Decision|0|||
27750678|NCT03471767|80913904|FG000|Overall Study|Lost to Follow-up|1|||
27750679|NCT03471767|80913905|FG001|Overall Study|Lost to Follow-up|0|||
27750680|NCT03471767|80913904|FG000|Overall Study|PI Withdrawal|1|||
27750681|NCT03471767|80913905|FG001|Overall Study|PI Withdrawal|3|||
27750682|NCT00101192|80913910|FG000|Overall Study|Ineligible|6|||
27750683|NCT00101192|80913910|FG000|Overall Study|Inevaluable|1|||
27750684|NCT01689207|80913911|FG000|Overall Study|Adverse Event|0|||
27750685|NCT01689207|80913912|FG001|Overall Study|Adverse Event|1|||
27750686|NCT01689207|80913913|FG002|Overall Study|Adverse Event|0|||
27750687|NCT01689207|80913914|FG003|Overall Study|Adverse Event|0|||
27652003|NCT02085941|80564794|FG001|Overall Study|Physician Decision|2|||
27652004|NCT02637063|80564796|FG000|Overall Study|Lost to Follow-up|3|||
27652005|NCT02637063|80564797|FG001|Overall Study|Lost to Follow-up|2|||
27652006|NCT02637063|80564798|FG002|Overall Study|Lost to Follow-up|3|||
27652007|NCT02637063|80564796|FG000|Overall Study|Withdrawal by Subject|2|||
27652008|NCT02637063|80564797|FG001|Overall Study|Withdrawal by Subject|2|||
27652009|NCT02637063|80564798|FG002|Overall Study|Withdrawal by Subject|3|||
27652010|NCT01428583|80564802|FG000|Overall Study|Adverse Event|75|||
27750688|NCT01689207|80913915|FG004|Overall Study|Adverse Event|2|||
27750689|NCT01689207|80913916|FG005|Overall Study|Adverse Event|1|||
27750690|NCT01689207|80913917|FG006|Overall Study|Adverse Event|0|||
27954203|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
27954204|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
27954205|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
27954206|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
27551531|NCT01482884|80207482|FG000|Overall Study|Adverse Event|2|||
27652011|NCT01428583|80564802|FG000|Overall Study|Withdrawal by Subject|51|||
27652012|NCT01428583|80564802|FG000|Overall Study|Lack of Efficacy|37|||
27652013|NCT01428583|80564802|FG000|Overall Study|Lost to Follow-up|17|||
27652014|NCT01428583|80564802|FG000|Overall Study|Death|1|||
27750691|NCT01689207|80913918|FG007|Overall Study|Adverse Event|0|||
27750692|NCT01689207|80913919|FG008|Overall Study|Adverse Event|1|||
27750693|NCT01689207|80913920|FG009|Overall Study|Adverse Event|0|||
27750694|NCT01689207|80913921|FG010|Overall Study|Adverse Event|0|||
27750695|NCT03255291|80913922|FG000|Overall Study|Determined to be ineligible|10|||
27750696|NCT03255291|80913923|FG001|Overall Study|Determined to be ineligible|12|||
27750697|NCT03255291|80913924|FG002|Overall Study|Determined to be ineligible|6|||
27750698|NCT03255291|80913925|FG003|Overall Study|Determined to be ineligible|6|||
27750699|NCT03255291|80913926|FG004|Overall Study|Determined to be ineligible|5|||
27750700|NCT03255291|80913927|FG005|Overall Study|Determined to be ineligible|10|||
27750701|NCT03255291|80913922|FG000|Overall Study|Baseline data collection issues|3|||
27750702|NCT03255291|80913923|FG001|Overall Study|Baseline data collection issues|0|||
27750703|NCT03255291|80913924|FG002|Overall Study|Baseline data collection issues|0|||
27750704|NCT03255291|80913925|FG003|Overall Study|Baseline data collection issues|0|||
27750705|NCT03255291|80913926|FG004|Overall Study|Baseline data collection issues|2|||
27750706|NCT03255291|80913927|FG005|Overall Study|Baseline data collection issues|0|||
27750707|NCT03132805|80913928|FG000|Overall Study|Lost to Follow-up|142|||
27750708|NCT03132805|80913929|FG001|Overall Study|Lost to Follow-up|141|||
27750709|NCT03132805|80913930|FG002|Overall Study|Lost to Follow-up|113|||
27750710|NCT05836818|80913933|FG000|Overall Study|Physician Decision|1|||
27750711|NCT05836818|80913934|FG001|Overall Study|Physician Decision|1|||
27750712|NCT05836818|80913935|FG002|Overall Study|Physician Decision|0|||
27750713|NCT05836818|80913933|FG000|Overall Study|Withdrawal by Subject|0|||
27750714|NCT05836818|80913934|FG001|Overall Study|Withdrawal by Subject|0|||
27750715|NCT05836818|80913935|FG002|Overall Study|Withdrawal by Subject|1|||
27750716|NCT05836818|80913933|FG000|Overall Study|Later found to be previously vaccinated|0|||
27750717|NCT05836818|80913934|FG001|Overall Study|Later found to be previously vaccinated|1|||
27750718|NCT05836818|80913935|FG002|Overall Study|Later found to be previously vaccinated|3|||
27750719|NCT05836818|80913933|FG000|Overall Study|Pregnancy|0|||
27750720|NCT05836818|80913934|FG001|Overall Study|Pregnancy|1|||
27750721|NCT05836818|80913935|FG002|Overall Study|Pregnancy|0|||
27750722|NCT05836818|80913933|FG000|Overall Study|Allergic to vaccines|0|||
27750723|NCT05836818|80913934|FG001|Overall Study|Allergic to vaccines|1|||
27750724|NCT05836818|80913935|FG002|Overall Study|Allergic to vaccines|0|||
27750725|NCT00138151|80913936|FG000|Overall Study|Withdrawal by Subject|3|||
27750726|NCT00138151|80913936|FG000|Overall Study|Physician Decision|1|||
27750727|NCT02998554|80913937|FG000|Overall Study|Adverse Event|8|||
27750728|NCT02998554|80913938|FG001|Overall Study|Adverse Event|3|||
27750729|NCT02998554|80913937|FG000|Overall Study|Protocol deviation|1|||
27750730|NCT02998554|80913938|FG001|Overall Study|Protocol deviation|0|||
27750731|NCT02998554|80913937|FG000|Overall Study|Withdrawal by Subject|2|||
27750732|NCT02998554|80913938|FG001|Overall Study|Withdrawal by Subject|6|||
27750733|NCT02998554|80913937|FG000|Overall Study|Lost to Follow-up|0|||
27750734|NCT02998554|80913938|FG001|Overall Study|Lost to Follow-up|1|||
27750735|NCT02998554|80913937|FG000|Overall Study|Lack of Efficacy|0|||
27750736|NCT02998554|80913938|FG001|Overall Study|Lack of Efficacy|1|||
27750737|NCT00894413|80913939|FG000|Overall Study|Physician Decision|0|||
27750738|NCT00894413|80913940|FG001|Overall Study|Physician Decision|2|||
27750739|NCT00894413|80913939|FG000|Overall Study|Adverse Event|0|||
27750740|NCT00894413|80913940|FG001|Overall Study|Adverse Event|2|||
27750741|NCT00894413|80913939|FG000|Overall Study|Withdrawal by Subject|0|||
27750742|NCT00894413|80913940|FG001|Overall Study|Withdrawal by Subject|4|||
27750743|NCT02566525|80913941|FG000|Overall Study|Protocol Violation|3|||
27750744|NCT02566525|80913942|FG001|Overall Study|Protocol Violation|5|||
27750745|NCT00850460|80913943|FG000|Overall Study|Lost to Follow-up|4|||
27750746|NCT00850460|80913944|FG001|Overall Study|Lost to Follow-up|4|||
27750747|NCT00952289|80913949|FG000|All Participants|Death|9|||
27750748|NCT00952289|80913950|FG001|All Participants|Death|9|||
27750749|NCT00952289|80913949|FG000|All Participants|Adverse Event|8|||
27750750|NCT00952289|80913950|FG001|All Participants|Adverse Event|8|||
27750751|NCT00952289|80913949|FG000|All Participants|Disease progression|3|||
27750752|NCT00952289|80913950|FG001|All Participants|Disease progression|12|||
27750753|NCT00952289|80913949|FG000|All Participants|Withdrawal by Subject|1|||
27750754|NCT00952289|80913950|FG001|All Participants|Withdrawal by Subject|10|||
27750755|NCT00952289|80913949|FG000|All Participants|Data lost during site relocation|0|||
27750756|NCT00952289|80913950|FG001|All Participants|Data lost during site relocation|1|||
27750757|NCT00952289|80913949|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
27750758|NCT00952289|80913950|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
27750759|NCT00952289|80913949|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
27750760|NCT00952289|80913950|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
27750761|NCT00952289|80913949|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
27750762|NCT00952289|80913950|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
27750763|NCT00952289|80913949|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
27750764|NCT00952289|80913950|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
27750765|NCT00952289|80913949|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
27750766|NCT00952289|80913950|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
27959313|NCT02131662|81683269|FG000|Overall Study|Wish for pregnancy|0|||
27750767|NCT03738566|80913958|FG000|Initial Study Phase|Withdrawal by Subject|1|||
27750768|NCT03738566|80913959|FG001|Initial Study Phase|Withdrawal by Subject|1|||
27750769|NCT03738566|80913960|FG002|Initial Study Phase|Withdrawal by Subject|2|||
27750770|NCT03738566|80913961|FG003|Initial Study Phase|Withdrawal by Subject|0|||
27750771|NCT03738566|80913958|FG000|Initial Study Phase|Death|0|||
27750772|NCT03738566|80913959|FG001|Initial Study Phase|Death|1|||
27750773|NCT03738566|80913960|FG002|Initial Study Phase|Death|0|||
27750774|NCT03738566|80913961|FG003|Initial Study Phase|Death|0|||
27750775|NCT03738566|80913958|FG000|Initial Study Phase|Treatment failure|5|||
27750776|NCT03738566|80913959|FG001|Initial Study Phase|Treatment failure|0|||
27750777|NCT03738566|80913960|FG002|Initial Study Phase|Treatment failure|0|||
27750778|NCT03738566|80913961|FG003|Initial Study Phase|Treatment failure|0|||
27750779|NCT03738566|80913958|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
27750780|NCT03738566|80913959|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
27750781|NCT03738566|80913960|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
27652015|NCT01428583|80564802|FG000|Overall Study|Pregnancy|1|||
27652016|NCT01428583|80564802|FG000|Overall Study|Protocol Violation|1|||
27652017|NCT01428583|80564802|FG000|Overall Study|Physician Decision|12|||
27652018|NCT01428583|80564802|FG000|Overall Study|Non-compliant|25|||
27652019|NCT01428583|80564802|FG000|Overall Study|Confirmed positive urine drug test|8|||
27652020|NCT01428583|80564802|FG000|Overall Study|Sponsor's request|3|||
27652021|NCT01428583|80564802|FG000|Overall Study|Other|6|||
27652022|NCT01000649|80564805|FG000|Overall Study|Adverse Event|5|||
27652023|NCT01000649|80564806|FG001|Overall Study|Adverse Event|1|||
27652024|NCT01000649|80564807|FG002|Overall Study|Adverse Event|2|||
27652025|NCT01000649|80564808|FG003|Overall Study|Adverse Event|4|||
27652026|NCT01000649|80564805|FG000|Overall Study|Lost to Follow-up|0|||
27652027|NCT01000649|80564806|FG001|Overall Study|Lost to Follow-up|2|||
27652028|NCT01000649|80564807|FG002|Overall Study|Lost to Follow-up|0|||
27652029|NCT01000649|80564808|FG003|Overall Study|Lost to Follow-up|2|||
27652030|NCT01005602|80564809|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
27652031|NCT01005602|80564810|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
27652032|NCT01071317|80564811|FG000|Overall Study|Lost to Follow-up|2|||
27652033|NCT01071317|80564812|FG001|Overall Study|Lost to Follow-up|2|||
27652034|NCT00638456|80564813|FG000|Overall Study|Withdrawal by Subject|6|||
27652035|NCT00638456|80564814|FG001|Overall Study|Withdrawal by Subject|2|||
27652036|NCT04497415|80564815|FG000|Overall Study|Lost to Follow-up|43|||
27652037|NCT04497415|80564816|FG001|Overall Study|Lost to Follow-up|27|||
27652038|NCT02671266|80564819|FG000|Overall Study|Withdrawal by Subject|1|||
27652039|NCT02671266|80564820|FG001|Overall Study|Withdrawal by Subject|1|||
27652040|NCT02506192|80564821|FG000|Overall Study|Withdrawal by Subject|1|||
27652041|NCT02506192|80564822|FG001|Overall Study|Withdrawal by Subject|1|||
27652042|NCT02325154|80564825|FG000|Overall Study|Physician Decision|1|||
27652043|NCT03162614|80564826|FG000|Overall Study|Lost to Follow-up|2|||
27652044|NCT03162614|80564827|FG001|Overall Study|Lost to Follow-up|1|||
27652045|NCT03162614|80564828|FG002|Overall Study|Lost to Follow-up|1|||
27652046|NCT03162614|80564829|FG003|Overall Study|Lost to Follow-up|1|||
27652047|NCT03162614|80564830|FG004|Overall Study|Lost to Follow-up|2|||
27652048|NCT03162614|80564831|FG005|Overall Study|Lost to Follow-up|0|||
27652049|NCT03162614|80564826|FG000|Overall Study|Protocol Violation|0|||
27652050|NCT03162614|80564827|FG001|Overall Study|Protocol Violation|1|||
27652051|NCT03162614|80564828|FG002|Overall Study|Protocol Violation|0|||
27652052|NCT03162614|80564829|FG003|Overall Study|Protocol Violation|1|||
27652053|NCT03162614|80564830|FG004|Overall Study|Protocol Violation|0|||
27652054|NCT03162614|80564831|FG005|Overall Study|Protocol Violation|0|||
27652055|NCT03162614|80564826|FG000|Overall Study|Withdrawal by Subject|2|||
27652056|NCT03162614|80564827|FG001|Overall Study|Withdrawal by Subject|1|||
27652057|NCT03162614|80564828|FG002|Overall Study|Withdrawal by Subject|1|||
27652058|NCT03162614|80564829|FG003|Overall Study|Withdrawal by Subject|1|||
27652059|NCT03162614|80564830|FG004|Overall Study|Withdrawal by Subject|0|||
27652060|NCT03162614|80564831|FG005|Overall Study|Withdrawal by Subject|0|||
27652061|NCT03162614|80564826|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
27652062|NCT03162614|80564827|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
27652063|NCT03162614|80564828|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
27750782|NCT03738566|80913961|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
27652064|NCT03162614|80564829|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
27652065|NCT03162614|80564830|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
27652066|NCT03162614|80564831|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
27652067|NCT00392197|80564834|FG000|Overall Study|Adverse Event|4|||
27652068|NCT00392197|80564835|FG001|Overall Study|Adverse Event|12|||
27652069|NCT00392197|80564834|FG000|Overall Study|Lack of Efficacy|3|||
27652070|NCT00392197|80564835|FG001|Overall Study|Lack of Efficacy|4|||
27652071|NCT00392197|80564834|FG000|Overall Study|Lost to Follow-up|0|||
27652072|NCT00392197|80564835|FG001|Overall Study|Lost to Follow-up|1|||
27652073|NCT00392197|80564834|FG000|Overall Study|Physician Decision|3|||
27652074|NCT00392197|80564835|FG001|Overall Study|Physician Decision|2|||
27652075|NCT00392197|80564834|FG000|Overall Study|Protocol Violation|7|||
27750783|NCT04544709|80913962|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
27750784|NCT01187901|80913966|FG000|Overall Study|Protocol Violation|1|||
27750785|NCT01187901|80913967|FG001|Overall Study|Protocol Violation|0|||
27750786|NCT01187901|80913966|FG000|Overall Study|Lost to Follow-up|1|||
27750787|NCT01187901|80913967|FG001|Overall Study|Lost to Follow-up|2|||
27750788|NCT01187901|80913966|FG000|Overall Study|Unrelated Health Reasons|1|||
27750789|NCT01187901|80913967|FG001|Overall Study|Unrelated Health Reasons|2|||
27750790|NCT01187901|80913966|FG000|Overall Study|Suspected Allergic Reaction|1|||
27750791|NCT01187901|80913967|FG001|Overall Study|Suspected Allergic Reaction|1|||
27750792|NCT01187901|80913966|FG000|Overall Study|Adverse Event|3|||
27750793|NCT01187901|80913967|FG001|Overall Study|Adverse Event|0|||
27750794|NCT01187901|80913966|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
27750795|NCT01187901|80913967|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
27750796|NCT01187901|80913966|FG000|Overall Study|Pregnancy|0|||
27750797|NCT01187901|80913967|FG001|Overall Study|Pregnancy|2|||
27750798|NCT01228071|80913973|FG000|Overall Study|Protocol Violation|1|||
27750799|NCT01228071|80913973|FG000|Overall Study|Withdrawal by Subject|1|||
27750800|NCT01597557|80913981|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
27750801|NCT01597557|80913982|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
27750802|NCT01104584|80913983|FG000|Overall Study|Study drug never administered|21|||
27750803|NCT01104584|80913983|FG000|Overall Study|Study prematurely discontinued|2|||
27750804|NCT00051558|80913986|FG000|Overall Study|Adverse Event|30|||
27750805|NCT00051558|80913987|FG001|Overall Study|Adverse Event|18|||
27750806|NCT00051558|80913986|FG000|Overall Study|Withdrawal by Subject|29|||
27750807|NCT00051558|80913987|FG001|Overall Study|Withdrawal by Subject|42|||
27750808|NCT00051558|80913986|FG000|Overall Study|Death|9|||
27750809|NCT00051558|80913987|FG001|Overall Study|Death|15|||
27750810|NCT00051558|80913986|FG000|Overall Study|Lost to Follow-up|4|||
27750811|NCT00051558|80913987|FG001|Overall Study|Lost to Follow-up|13|||
27750812|NCT00051558|80913986|FG000|Overall Study|Protocol Violation|3|||
27750813|NCT00051558|80913987|FG001|Overall Study|Protocol Violation|4|||
27750814|NCT00051558|80913986|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
27750815|NCT00051558|80913987|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
27750816|NCT00051558|80913986|FG000|Overall Study|Sponsor Decision|6|||
27750817|NCT00051558|80913987|FG001|Overall Study|Sponsor Decision|1|||
27750818|NCT00051558|80913986|FG000|Overall Study|Other|2|||
27750819|NCT00051558|80913987|FG001|Overall Study|Other|1|||
27750820|NCT00051558|80913986|FG000|Overall Study|Significant Lab Value|2|||
27750821|NCT00051558|80913987|FG001|Overall Study|Significant Lab Value|0|||
27750822|NCT00051558|80913986|FG000|Overall Study|Physician Decision|5|||
27750823|NCT00051558|80913987|FG001|Overall Study|Physician Decision|0|||
27750824|NCT00431847|80913988|FG000|Overall Study|completion of less than two study visits|6|||
27750825|NCT00431847|80913989|FG001|Overall Study|completion of less than two study visits|3|||
27750826|NCT00431847|80913990|FG002|Overall Study|completion of less than two study visits|4|||
27750827|NCT00431847|80913991|FG003|Overall Study|completion of less than two study visits|14|||
27750828|NCT00431847|80913992|FG004|Overall Study|completion of less than two study visits|0|||
27750829|NCT00431847|80913988|FG000|Overall Study|Protocol Violation|0|||
27750830|NCT00431847|80913989|FG001|Overall Study|Protocol Violation|0|||
27750831|NCT00431847|80913990|FG002|Overall Study|Protocol Violation|0|||
27750832|NCT00431847|80913991|FG003|Overall Study|Protocol Violation|0|||
27750833|NCT00431847|80913992|FG004|Overall Study|Protocol Violation|1|||
27750834|NCT02196038|80913997|FG000|Overall Study|Death|16|||
27750835|NCT02196038|80913998|FG001|Overall Study|Death|21|||
27750836|NCT02196038|80913997|FG000|Overall Study|Withdrawal by Subject|0|||
27750837|NCT02196038|80913998|FG001|Overall Study|Withdrawal by Subject|1|||
27750838|NCT02196038|80913997|FG000|Overall Study|Lost to Follow-up|1|||
27750839|NCT02196038|80913998|FG001|Overall Study|Lost to Follow-up|0|||
27750840|NCT00237796|80913999|FG000|Overall Study|Baseline and one other ILSS required|10|||
27750841|NCT00237796|80914000|FG001|Overall Study|Baseline and one other ILSS required|5|||
27750842|NCT01585961|80914001|FG000|Overall Study|Death|6|||
27750843|NCT01585961|80914001|FG000|Overall Study|Physician Decision|1|||
27750844|NCT01585961|80914001|FG000|Overall Study|Decision to use non-study catheter|1|||
27750845|NCT01585961|80914001|FG000|Overall Study|Withdrawal by Subject|1|||
27750846|NCT01585961|80914001|FG000|Overall Study|Lost to Follow-up|23|||
27750847|NCT01585961|80914001|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
27750848|NCT02020031|80914004|FG000|Overall Study|Physician Decision|1|||
27750849|NCT02020031|80914005|FG001|Overall Study|Physician Decision|1|||
27750850|NCT01419665|80914006|FG000|Combination Treatment|Adverse Event|7|||
27750851|NCT01419665|80914007|FG001|Combination Treatment|Adverse Event|10|||
27750852|NCT01419665|80914006|FG000|Combination Treatment|Physician Decision|5|||
27750853|NCT01419665|80914007|FG001|Combination Treatment|Physician Decision|8|||
27750854|NCT01419665|80914006|FG000|Combination Treatment|Protocol Violation|6|||
27750855|NCT01419665|80914007|FG001|Combination Treatment|Protocol Violation|2|||
27750856|NCT01419665|80914006|FG000|Combination Treatment|disease progression|10|||
27750857|NCT01419665|80914007|FG001|Combination Treatment|disease progression|9|||
27750858|NCT01419665|80914006|FG000|Combination Treatment|Death|5|||
27750859|NCT01419665|80914007|FG001|Combination Treatment|Death|7|||
27750860|NCT01419665|80914006|FG000|Combination Treatment|administrative problems|0|||
27750861|NCT01419665|80914007|FG001|Combination Treatment|administrative problems|1|||
27750862|NCT01419665|80914006|FG000|Combination Treatment|Withdrawal by Subject|5|||
27750863|NCT01419665|80914007|FG001|Combination Treatment|Withdrawal by Subject|4|||
27750864|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
27750865|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
27750866|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
27750867|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
27750868|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
27750869|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
27750870|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
27750871|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
27750872|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
27750873|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
27750874|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
27750875|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
27750876|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|Death|1|||
27750877|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|Death|2|||
27750878|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
27750879|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
27750880|NCT01419665|80914006|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
27750881|NCT01419665|80914007|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
27750882|NCT01419665|80914006|FG000|Open Label Phase|Death|1|||
27750883|NCT01419665|80914007|FG001|Open Label Phase|Death|0|||
27750884|NCT01419665|80914006|FG000|Open Label Phase|disease progression|0|||
27750885|NCT01419665|80914007|FG001|Open Label Phase|disease progression|1|||
27750886|NCT01514188|80914008|FG000|Overall Study|Adverse Event|3|||
27750887|NCT01514188|80914009|FG001|Overall Study|Adverse Event|5|||
27750888|NCT01514188|80914008|FG000|Overall Study|Withdrawal by Subject|2|||
27750889|NCT01514188|80914009|FG001|Overall Study|Withdrawal by Subject|4|||
27750890|NCT01514188|80914008|FG000|Overall Study|Protocol Violation|2|||
27750891|NCT01514188|80914009|FG001|Overall Study|Protocol Violation|4|||
27750892|NCT01514188|80914008|FG000|Overall Study|Physician Decision|0|||
27750893|NCT01514188|80914009|FG001|Overall Study|Physician Decision|2|||
27750894|NCT01514188|80914008|FG000|Overall Study|Disease Progression|13|||
27750895|NCT01514188|80914009|FG001|Overall Study|Disease Progression|14|||
27750896|NCT01514188|80914008|FG000|Overall Study|Death|1|||
27750897|NCT01514188|80914009|FG001|Overall Study|Death|3|||
27750898|NCT01514188|80914008|FG000|Overall Study|Other|2|||
27750899|NCT01514188|80914009|FG001|Overall Study|Other|1|||
27750900|NCT04799405|80914015|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
27750901|NCT00943319|80914016|FG000|Overall Study|Death|1|||
27750902|NCT03807739|80914021|FG000|Overall Study|Adverse Event|1|||
27750903|NCT03807739|80914022|FG001|Overall Study|Adverse Event|0|||
27750904|NCT03807739|80914023|FG002|Overall Study|Adverse Event|0|||
27750905|NCT03807739|80914024|FG003|Overall Study|Adverse Event|0|||
27750906|NCT03807739|80914021|FG000|Overall Study|Withdrawal by Subject|1|||
27750907|NCT03807739|80914022|FG001|Overall Study|Withdrawal by Subject|0|||
27750908|NCT03807739|80914023|FG002|Overall Study|Withdrawal by Subject|0|||
27750909|NCT03807739|80914024|FG003|Overall Study|Withdrawal by Subject|0|||
27750910|NCT01989546|80914025|FG000|Overall Study|Clinical Progression|1|||
27750911|NCT01989546|80914025|FG000|Overall Study|Disease progression on study|8|||
27750912|NCT02361762|80914027|FG000|Overall Study|Withdrawal by Subject|0|||
27750913|NCT02361762|80914028|FG001|Overall Study|Withdrawal by Subject|1|||
27750914|NCT02361762|80914027|FG000|Overall Study|Lost to Follow-up|0|||
27750915|NCT02361762|80914028|FG001|Overall Study|Lost to Follow-up|1|||
27750916|NCT02531035|80914032|FG000|Overall Study|Death|0|||
27750917|NCT02531035|80914033|FG001|Overall Study|Death|1|||
27750918|NCT02531035|80914032|FG000|Overall Study|Protocol Violation|1|||
27750919|NCT02531035|80914033|FG001|Overall Study|Protocol Violation|1|||
27750920|NCT02531035|80914032|FG000|Overall Study|Noncompliance with study drug|8|||
27750921|NCT02531035|80914033|FG001|Overall Study|Noncompliance with study drug|3|||
27750922|NCT02531035|80914032|FG000|Overall Study|Physician Decision|1|||
27750923|NCT02531035|80914033|FG001|Overall Study|Physician Decision|0|||
27750924|NCT02531035|80914032|FG000|Overall Study|Adverse Event|16|||
27750925|NCT02531035|80914033|FG001|Overall Study|Adverse Event|45|||
27750926|NCT02531035|80914032|FG000|Overall Study|Other|3|||
27750927|NCT02531035|80914033|FG001|Overall Study|Other|2|||
27750928|NCT02531035|80914032|FG000|Overall Study|Withdrawal by Subject|42|||
27750929|NCT02531035|80914033|FG001|Overall Study|Withdrawal by Subject|32|||
27750930|NCT02531035|80914032|FG000|Overall Study|Lost to Follow-up|8|||
27750931|NCT02531035|80914033|FG001|Overall Study|Lost to Follow-up|10|||
27750932|NCT02531035|80914032|FG000|Overall Study|Randomized, not treated|2|||
27750933|NCT02531035|80914033|FG001|Overall Study|Randomized, not treated|1|||
27750934|NCT00940342|80914034|FG000|Overall Study|Adverse Event|0|||
27750935|NCT00940342|80914035|FG001|Overall Study|Adverse Event|2|||
27750936|NCT00940342|80914036|FG002|Overall Study|Adverse Event|1|||
27750937|NCT03691610|80914037|FG000|Overall Study|Adverse Event|0|||
27750938|NCT03691610|80914038|FG001|Overall Study|Adverse Event|1|||
27750939|NCT03691610|80914039|FG002|Overall Study|Adverse Event|0|||
27750940|NCT03691610|80914040|FG003|Overall Study|Adverse Event|0|||
27750941|NCT03691610|80914037|FG000|Overall Study|Protocol Deviation|15|||
27750942|NCT03691610|80914038|FG001|Overall Study|Protocol Deviation|8|||
27750943|NCT03691610|80914039|FG002|Overall Study|Protocol Deviation|1|||
27750944|NCT03691610|80914040|FG003|Overall Study|Protocol Deviation|2|||
27750945|NCT03691610|80914037|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
27750946|NCT03691610|80914038|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
27750947|NCT03691610|80914039|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
27750948|NCT03691610|80914040|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
27750949|NCT03691610|80914037|FG000|Overall Study|Lost to Follow-up|20|||
27750950|NCT03691610|80914038|FG001|Overall Study|Lost to Follow-up|11|||
27750951|NCT03691610|80914039|FG002|Overall Study|Lost to Follow-up|5|||
27750952|NCT03691610|80914040|FG003|Overall Study|Lost to Follow-up|2|||
27750953|NCT01552928|80914041|FG000|Period 3|Adverse Event|0|||
27750954|NCT01552928|80914042|FG001|Period 3|Adverse Event|0|||
27750955|NCT01552928|80914043|FG002|Period 3|Adverse Event|1|||
27750956|NCT01552928|80914044|FG003|Period 3|Adverse Event|0|||
27750957|NCT01863849|80914045|FG000|Overall Study|Lost to Follow-up|1|||
27750958|NCT01863849|80914046|FG001|Overall Study|Lost to Follow-up|0|||
27750959|NCT03141086|80914048|FG000|Overall Study|Study Terminated By Sponsor|1|||
27750960|NCT03141086|80914049|FG001|Overall Study|Study Terminated By Sponsor|1|||
27750961|NCT03141086|80914048|FG000|Overall Study|Withdrawal by Subject|0|||
27750962|NCT03141086|80914049|FG001|Overall Study|Withdrawal by Subject|1|||
27750963|NCT03141086|80914048|FG000|Overall Study|Protocol Violation|0|||
27750964|NCT03141086|80914049|FG001|Overall Study|Protocol Violation|1|||
27750965|NCT03141086|80914048|FG000|Overall Study|Adverse Event|0|||
27750966|NCT03141086|80914049|FG001|Overall Study|Adverse Event|2|||
27750967|NCT05038163|80914050|FG000|Stage 1|Did not complete survey|374|||
27750968|NCT05038163|80914051|FG001|Stage 1|Did not complete survey|0|||
27750969|NCT05038163|80914052|FG002|Stage 1|Did not complete survey|0|||
27750970|NCT05038163|80914053|FG003|Stage 1|Did not complete survey|0|||
27750971|NCT05038163|80914054|FG004|Stage 1|Did not complete survey|0|||
27750972|NCT05038163|80914055|FG005|Stage 1|Did not complete survey|0|||
27750973|NCT05038163|80914050|FG000|Stage 2|Did not complete Stage 2 survey|0|||
27750974|NCT05038163|80914051|FG001|Stage 2|Did not complete Stage 2 survey|29|||
27750975|NCT05038163|80914052|FG002|Stage 2|Did not complete Stage 2 survey|30|||
27750976|NCT05038163|80914053|FG003|Stage 2|Did not complete Stage 2 survey|24|||
27750977|NCT05038163|80914054|FG004|Stage 2|Did not complete Stage 2 survey|21|||
27750978|NCT05038163|80914055|FG005|Stage 2|Did not complete Stage 2 survey|100|||
27750979|NCT01793051|80914064|FG000|Overall Study|Withdrawal by Subject|6|||
27750980|NCT01793051|80914065|FG001|Overall Study|Withdrawal by Subject|4|||
27750981|NCT01793051|80914064|FG000|Overall Study|Adverse Event|0|||
27750982|NCT01793051|80914065|FG001|Overall Study|Adverse Event|2|||
27750983|NCT01793051|80914064|FG000|Overall Study|Too ill to continue|1|||
27750984|NCT01793051|80914065|FG001|Overall Study|Too ill to continue|0|||
27750985|NCT01793051|80914064|FG000|Overall Study|Switched chemo|1|||
27750986|NCT01793051|80914065|FG001|Overall Study|Switched chemo|1|||
27954207|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
27954208|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
27954209|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
27954210|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
27954211|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
27954212|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
27954213|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
27954214|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
27954215|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
27954216|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
27750987|NCT01793051|80914064|FG000|Overall Study|Lack of compliance|1|||
27750988|NCT01793051|80914065|FG001|Overall Study|Lack of compliance|0|||
27750989|NCT01793051|80914064|FG000|Overall Study|Requested to be removed from the study|1|||
27750990|NCT01793051|80914065|FG001|Overall Study|Requested to be removed from the study|1|||
27750991|NCT02819310|80914066|FG000|Overall Study|Withdrawal by Subject|37|||
27750992|NCT02819310|80914066|FG000|Overall Study|Lost to Follow-up|16|||
27954217|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
27954218|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
27750993|NCT02819310|80914066|FG000|Overall Study|Adverse Event|13|||
27750994|NCT02819310|80914066|FG000|Overall Study|Lack of Efficacy|5|||
27750995|NCT02819310|80914066|FG000|Overall Study|Physician Decision|8|||
27750996|NCT02819310|80914066|FG000|Overall Study|Protocol Violation|30|||
27954219|NCT01240863|81665920|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
27954220|NCT01240863|81665921|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
27954221|NCT01240863|81665922|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
27954222|NCT02986074|81665925|FG000|First Trial Period|Adverse Event|1|||
27954223|NCT02986074|81665926|FG001|First Trial Period|Adverse Event|0|||
27954224|NCT02986074|81665927|FG002|First Trial Period|Adverse Event|0|||
27954225|NCT02986074|81665928|FG003|First Trial Period|Adverse Event|0|||
27954226|NCT02986074|81665925|FG000|Follow up Period|system explant|0|||
27954227|NCT02986074|81665926|FG001|Follow up Period|system explant|0|||
27954228|NCT02986074|81665927|FG002|Follow up Period|system explant|1|||
27954229|NCT02986074|81665928|FG003|Follow up Period|system explant|2|||
27954230|NCT02986074|81665925|FG000|Follow up Period|Physician Decision|0|||
27954231|NCT02986074|81665926|FG001|Follow up Period|Physician Decision|0|||
27954232|NCT02986074|81665927|FG002|Follow up Period|Physician Decision|0|||
27954233|NCT02986074|81665928|FG003|Follow up Period|Physician Decision|1|||
27954234|NCT02935192|81665931|FG000|Overall Study|Withdrawal by Subject|8|||
27954235|NCT02935192|81665932|FG001|Overall Study|Withdrawal by Subject|4|||
27954236|NCT01299389|81665933|FG000|Double-blind|Adverse Event|45|||
27954237|NCT01299389|81665934|FG001|Double-blind|Adverse Event|27|||
27954238|NCT01299389|81665935|FG002|Double-blind|Adverse Event|0|||
27954239|NCT01299389|81665936|FG003|Double-blind|Adverse Event|0|||
27954240|NCT01299389|81665933|FG000|Double-blind|Lack of Efficacy|45|||
27954241|NCT01299389|81665934|FG001|Double-blind|Lack of Efficacy|21|||
27954242|NCT01299389|81665935|FG002|Double-blind|Lack of Efficacy|0|||
27954243|NCT01299389|81665936|FG003|Double-blind|Lack of Efficacy|0|||
27954244|NCT01299389|81665933|FG000|Double-blind|Lost to Follow-up|2|||
27954245|NCT01299389|81665934|FG001|Double-blind|Lost to Follow-up|1|||
27954246|NCT01299389|81665935|FG002|Double-blind|Lost to Follow-up|0|||
27954247|NCT01299389|81665936|FG003|Double-blind|Lost to Follow-up|0|||
27954248|NCT01299389|81665933|FG000|Double-blind|Withdrawal by Subject|16|||
27954249|NCT01299389|81665934|FG001|Double-blind|Withdrawal by Subject|13|||
27954250|NCT01299389|81665935|FG002|Double-blind|Withdrawal by Subject|0|||
27954251|NCT01299389|81665936|FG003|Double-blind|Withdrawal by Subject|0|||
27954252|NCT01299389|81665933|FG000|Double-blind|Other|1|||
27954253|NCT01299389|81665934|FG001|Double-blind|Other|1|||
27954254|NCT01299389|81665935|FG002|Double-blind|Other|0|||
27954255|NCT01299389|81665936|FG003|Double-blind|Other|0|||
27954256|NCT01299389|81665933|FG000|Double-blind|"fail to meet study population criteria"|0|||
27954257|NCT01299389|81665934|FG001|Double-blind|"fail to meet study population criteria"|1|||
27954258|NCT01299389|81665935|FG002|Double-blind|"fail to meet study population criteria"|0|||
27954259|NCT01299389|81665936|FG003|Double-blind|"fail to meet study population criteria"|0|||
27954260|NCT01299389|81665933|FG000|Post-observational|Other|0|||
27954261|NCT01299389|81665934|FG001|Post-observational|Other|0|||
27954262|NCT01299389|81665935|FG002|Post-observational|Other|12|||
27954263|NCT01299389|81665936|FG003|Post-observational|Other|6|||
27954264|NCT01173679|81665937|FG000|Overall Study|Death|1|||
27954265|NCT01897532|81665938|FG000|Discontinuation From Treatment|Not Treated|7|||
27954266|NCT01897532|81665939|FG001|Discontinuation From Treatment|Not Treated|5|||
27954267|NCT01897532|81665938|FG000|Discontinuation From Treatment|Other reason than specified|196|||
27954268|NCT01897532|81665939|FG001|Discontinuation From Treatment|Other reason than specified|176|||
27954269|NCT01897532|81665938|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
27954270|NCT01897532|81665939|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
27954271|NCT01897532|81665938|FG000|Discontinuation From Treatment|Non compliance|24|||
27954272|NCT01897532|81665939|FG001|Discontinuation From Treatment|Non compliance|15|||
27954273|NCT01897532|81665938|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
27954274|NCT01897532|81665939|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
27954275|NCT01897532|81665938|FG000|Discontinuation From Trial|Not Treated|7|||
27954276|NCT01897532|81665939|FG001|Discontinuation From Trial|Not Treated|5|||
27954277|NCT01897532|81665938|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
27954278|NCT01897532|81665939|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
27954279|NCT02031302|81665940|FG000|Overall Study|Death|115|||
27954280|NCT02031302|81665941|FG001|Overall Study|Death|0|||
27954281|NCT02031302|81665940|FG000|Overall Study|Not treated with study valve system|18|||
27954282|NCT02031302|81665941|FG001|Overall Study|Not treated with study valve system|0|||
27954283|NCT02031302|81665940|FG000|Overall Study|Missed Follow Up|27|||
27954284|NCT02031302|81665941|FG001|Overall Study|Missed Follow Up|0|||
27954285|NCT02031302|81665940|FG000|Overall Study|Lost to Follow-up|4|||
27954286|NCT02031302|81665941|FG001|Overall Study|Lost to Follow-up|0|||
27652076|NCT00392197|80564835|FG001|Overall Study|Protocol Violation|5|||
27954287|NCT04099277|81665945|FG000|Overall Study|Physician Decision|1|||
27954288|NCT04099277|81665945|FG000|Overall Study|Withdrawal by Subject|1|||
27954289|NCT00100802|81665946|FG000|Overall Study|Adverse Event|9|||
27954290|NCT00100802|81665946|FG000|Overall Study|Death|1|||
27954291|NCT00100802|81665946|FG000|Overall Study|Lack of Efficacy|47|||
27954292|NCT00100802|81665946|FG000|Overall Study|Physician Decision|5|||
27652077|NCT00392197|80564834|FG000|Overall Study|Withdrawal by Subject|4|||
27954293|NCT00100802|81665946|FG000|Overall Study|Protocol Violation|1|||
27954294|NCT00100802|81665946|FG000|Overall Study|Withdrawal by Subject|5|||
27954295|NCT00100802|81665946|FG000|Overall Study|Ineligible|12|||
27954296|NCT01644643|81665947|FG000|Overall Study|Death|1|||
27954297|NCT01644643|81665948|FG001|Overall Study|Death|0|||
27954298|NCT01644643|81665949|FG002|Overall Study|Death|3|||
27954299|NCT01644643|81665950|FG003|Overall Study|Death|3|||
27954300|NCT01644643|81665947|FG000|Overall Study|Lost to Follow-up|0|||
27954301|NCT01644643|81665948|FG001|Overall Study|Lost to Follow-up|0|||
27954302|NCT01644643|81665949|FG002|Overall Study|Lost to Follow-up|0|||
27954303|NCT01644643|81665950|FG003|Overall Study|Lost to Follow-up|4|||
27954304|NCT01644643|81665947|FG000|Overall Study|Withdrawal by Subject|1|||
27954305|NCT01644643|81665948|FG001|Overall Study|Withdrawal by Subject|0|||
27954306|NCT01644643|81665949|FG002|Overall Study|Withdrawal by Subject|2|||
27954307|NCT01644643|81665950|FG003|Overall Study|Withdrawal by Subject|1|||
27954308|NCT01644643|81665947|FG000|Overall Study|Other Eligibility criteria|0|||
27954309|NCT01644643|81665948|FG001|Overall Study|Other Eligibility criteria|0|||
27954310|NCT01644643|81665949|FG002|Overall Study|Other Eligibility criteria|0|||
27954311|NCT01644643|81665950|FG003|Overall Study|Other Eligibility criteria|2|||
27954312|NCT03423602|81665951|FG000|Overall Study|Death|1|||
27954313|NCT03423602|81665951|FG000|Overall Study|Lost to Follow-up|6|||
27954314|NCT03423602|81665951|FG000|Overall Study|Protocol Violation|1|||
27954315|NCT03423602|81665951|FG000|Overall Study|Withdrawal by Subject|4|||
27954316|NCT01816048|81665952|FG000|Overall Study|Adverse Event|1|||
27954317|NCT01816048|81665952|FG000|Overall Study|Death|1|||
27954318|NCT01816048|81665952|FG000|Overall Study|Withdrawal by Subject|1|||
27954319|NCT01816048|81665952|FG000|Overall Study|Disease Progression|3|||
27954320|NCT02961244|81665953|FG000|Overall Study|Protocol Violation|0|||
27954321|NCT02961244|81665954|FG001|Overall Study|Protocol Violation|1|||
27954322|NCT02961244|81665953|FG000|Overall Study|Withdrawal by Subject|1|||
27954323|NCT02961244|81665954|FG001|Overall Study|Withdrawal by Subject|2|||
27954324|NCT02961244|81665953|FG000|Overall Study|Surgery plan change after study approval|0|||
27954325|NCT02961244|81665954|FG001|Overall Study|Surgery plan change after study approval|2|||
27954326|NCT02961244|81665953|FG000|Overall Study|Lost to Follow-up|0|||
27954327|NCT02961244|81665954|FG001|Overall Study|Lost to Follow-up|2|||
27954328|NCT02961244|81665953|FG000|Overall Study|İnadequate data|0|||
27954329|NCT02961244|81665954|FG001|Overall Study|İnadequate data|2|||
27954330|NCT03698279|81665955|FG000|Overall Study|Withdrawal by parent/guardian|1|||
27954331|NCT03698279|81665956|FG001|Overall Study|Withdrawal by parent/guardian|1|||
27954332|NCT03698279|81665957|FG002|Overall Study|Withdrawal by parent/guardian|1|||
27954333|NCT03698279|81665958|FG003|Overall Study|Withdrawal by parent/guardian|1|||
27954334|NCT03698279|81665959|FG004|Overall Study|Withdrawal by parent/guardian|0|||
27954335|NCT03698279|81665960|FG005|Overall Study|Withdrawal by parent/guardian|0|||
27954336|NCT03698279|81665955|FG000|Overall Study|Protocol deviation|1|||
27954337|NCT03698279|81665956|FG001|Overall Study|Protocol deviation|0|||
27954338|NCT03698279|81665957|FG002|Overall Study|Protocol deviation|1|||
27954339|NCT03698279|81665958|FG003|Overall Study|Protocol deviation|0|||
27954340|NCT03698279|81665959|FG004|Overall Study|Protocol deviation|0|||
27954341|NCT03698279|81665960|FG005|Overall Study|Protocol deviation|0|||
27954342|NCT03698279|81665955|FG000|Overall Study|Withdrawal by Subject|0|||
27954343|NCT03698279|81665956|FG001|Overall Study|Withdrawal by Subject|0|||
27954344|NCT03698279|81665957|FG002|Overall Study|Withdrawal by Subject|1|||
27954345|NCT03698279|81665958|FG003|Overall Study|Withdrawal by Subject|0|||
27954346|NCT03698279|81665959|FG004|Overall Study|Withdrawal by Subject|0|||
27954347|NCT03698279|81665960|FG005|Overall Study|Withdrawal by Subject|0|||
27954348|NCT03698279|81665955|FG000|Overall Study|Lost to Follow-up|3|||
27954349|NCT03698279|81665956|FG001|Overall Study|Lost to Follow-up|1|||
27954350|NCT03698279|81665957|FG002|Overall Study|Lost to Follow-up|4|||
27954351|NCT03698279|81665958|FG003|Overall Study|Lost to Follow-up|5|||
27954352|NCT03698279|81665959|FG004|Overall Study|Lost to Follow-up|0|||
27954353|NCT03698279|81665960|FG005|Overall Study|Lost to Follow-up|0|||
27954354|NCT00881894|81665962|FG000|Overall Study|Consent withdrawn|0|||
27954355|NCT00881894|81665963|FG001|Overall Study|Consent withdrawn|1|||
27954356|NCT00881894|81665962|FG000|Overall Study|Other reasons for premature termination|1|||
27954357|NCT00881894|81665963|FG001|Overall Study|Other reasons for premature termination|2|||
27954358|NCT01152788|81665964|FG000|Overall Study|Withdrawal by Subject|0|||
27954359|NCT01152788|81665965|FG001|Overall Study|Withdrawal by Subject|3|||
27954360|NCT01152788|81665964|FG000|Overall Study|No treatment|0|||
27954361|NCT01152788|81665965|FG001|Overall Study|No treatment|1|||
27954362|NCT03768427|81665966|FG000|Overall Study|Death|0|||
27954363|NCT03768427|81665967|FG001|Overall Study|Death|0|||
27954364|NCT03768427|81665968|FG002|Overall Study|Death|1|||
27954365|NCT03768427|81665969|FG003|Overall Study|Death|0|||
27954366|NCT03768427|81665966|FG000|Overall Study|Lost to Follow-up|2|||
27954367|NCT03768427|81665967|FG001|Overall Study|Lost to Follow-up|0|||
27954368|NCT03768427|81665968|FG002|Overall Study|Lost to Follow-up|0|||
27954369|NCT03768427|81665969|FG003|Overall Study|Lost to Follow-up|0|||
27954370|NCT03768427|81665966|FG000|Overall Study|Physician Decision|3|||
27954371|NCT03768427|81665967|FG001|Overall Study|Physician Decision|2|||
27954372|NCT03768427|81665968|FG002|Overall Study|Physician Decision|4|||
27954373|NCT03768427|81665969|FG003|Overall Study|Physician Decision|4|||
27954374|NCT03768427|81665966|FG000|Overall Study|Withdrawal by Subject|7|||
27954375|NCT03768427|81665967|FG001|Overall Study|Withdrawal by Subject|2|||
27954376|NCT03768427|81665968|FG002|Overall Study|Withdrawal by Subject|6|||
27954377|NCT03768427|81665969|FG003|Overall Study|Withdrawal by Subject|7|||
27954378|NCT02239926|81665972|FG000|Overall Study|Withdrawal by Subject|0|||
27954379|NCT02239926|81665973|FG001|Overall Study|Withdrawal by Subject|1|||
27954380|NCT02949011|81665974|FG000|Overall Study|Adverse Event|6|||
27954381|NCT02949011|81665975|FG001|Overall Study|Adverse Event|7|||
27954382|NCT02949011|81665976|FG002|Overall Study|Adverse Event|3|||
27954383|NCT02949011|81665974|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
27954384|NCT02949011|81665975|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
27954385|NCT02949011|81665976|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
27954386|NCT02949011|81665974|FG000|Overall Study|Protocol Deviation|5|||
27954387|NCT02949011|81665975|FG001|Overall Study|Protocol Deviation|3|||
27954388|NCT02949011|81665976|FG002|Overall Study|Protocol Deviation|3|||
27954389|NCT02949011|81665974|FG000|Overall Study|Lack of Efficacy|0|||
27954390|NCT02949011|81665975|FG001|Overall Study|Lack of Efficacy|2|||
27954391|NCT02949011|81665976|FG002|Overall Study|Lack of Efficacy|0|||
27954392|NCT02949011|81665974|FG000|Overall Study|Withdrawal by Subject|13|||
27954393|NCT02949011|81665975|FG001|Overall Study|Withdrawal by Subject|13|||
27954394|NCT02949011|81665976|FG002|Overall Study|Withdrawal by Subject|21|||
27954395|NCT02949011|81665974|FG000|Overall Study|Lost to Follow-up|7|||
27954396|NCT02949011|81665975|FG001|Overall Study|Lost to Follow-up|5|||
27954397|NCT02949011|81665976|FG002|Overall Study|Lost to Follow-up|5|||
27954398|NCT02949011|81665974|FG000|Overall Study|Death|0|||
27954399|NCT02949011|81665975|FG001|Overall Study|Death|0|||
27954400|NCT02949011|81665976|FG002|Overall Study|Death|1|||
27954401|NCT02949011|81665974|FG000|Overall Study|Miscellaneous|2|||
27954402|NCT02949011|81665975|FG001|Overall Study|Miscellaneous|4|||
27954403|NCT02949011|81665976|FG002|Overall Study|Miscellaneous|6|||
27954404|NCT03493958|81665977|FG000|Overall Study|Withdrawal by Subject|6|||
27954405|NCT03493958|81665977|FG000|Overall Study|Lost to Follow-up|7|||
27954406|NCT03493958|81665977|FG000|Overall Study|Did not complete all required study procedures|2|||
27954407|NCT02030821|81665978|FG000|Overall Study|Physician Decision|2|||
27954408|NCT02030821|81665979|FG001|Overall Study|Physician Decision|2|||
27954409|NCT02030821|81665980|FG002|Overall Study|Physician Decision|5|||
27954410|NCT02030821|81665981|FG003|Overall Study|Physician Decision|2|||
27954411|NCT01446874|81665985|FG000|Overall Study|Not eligible|1|||
27954412|NCT01446874|81665986|FG001|Overall Study|Not eligible|0|||
27954413|NCT01446874|81665987|FG002|Overall Study|Not eligible|0|||
27954414|NCT01446874|81665985|FG000|Overall Study|No surgery/No qualifying surgery|1|||
27954415|NCT01446874|81665986|FG001|Overall Study|No surgery/No qualifying surgery|0|||
27954416|NCT01446874|81665987|FG002|Overall Study|No surgery/No qualifying surgery|12|||
27954417|NCT01446874|81665985|FG000|Overall Study|Non-compliance|0|||
27954418|NCT01446874|81665986|FG001|Overall Study|Non-compliance|4|||
27954419|NCT01446874|81665987|FG002|Overall Study|Non-compliance|0|||
27954420|NCT01446874|81665985|FG000|Overall Study|Antibiotics for pre-op infection|0|||
27954421|NCT01446874|81665986|FG001|Overall Study|Antibiotics for pre-op infection|0|||
27954422|NCT01446874|81665987|FG002|Overall Study|Antibiotics for pre-op infection|2|||
27954423|NCT01446874|81665985|FG000|Overall Study|Withdrawal by Subject|0|||
27954424|NCT01446874|81665986|FG001|Overall Study|Withdrawal by Subject|0|||
27954425|NCT01446874|81665987|FG002|Overall Study|Withdrawal by Subject|4|||
27954426|NCT01248793|81665990|FG000|Overall Study|Lost to Follow-up|0|||
27954427|NCT01248793|81665991|FG001|Overall Study|Lost to Follow-up|1|||
27954428|NCT01248793|81665990|FG000|Overall Study|Adverse Event|1|||
27954429|NCT01248793|81665991|FG001|Overall Study|Adverse Event|1|||
27954430|NCT01248793|81665990|FG000|Overall Study|Protocol Violation|0|||
27954431|NCT01248793|81665991|FG001|Overall Study|Protocol Violation|1|||
27954432|NCT01248793|81665990|FG000|Overall Study|Withdrawal by Subject|3|||
27954433|NCT01248793|81665991|FG001|Overall Study|Withdrawal by Subject|3|||
27954434|NCT00382174|81665993|FG000|Overall Study|Lost to Follow-up|1|||
27954435|NCT00382174|81665994|FG001|Overall Study|Lost to Follow-up|4|||
27954436|NCT00382174|81665995|FG002|Overall Study|Lost to Follow-up|5|||
27954437|NCT00382174|81665993|FG000|Overall Study|Adverse Event|1|||
27954438|NCT00382174|81665994|FG001|Overall Study|Adverse Event|4|||
27954439|NCT00382174|81665995|FG002|Overall Study|Adverse Event|5|||
27954440|NCT00382174|81665993|FG000|Overall Study|Withdrawal by Subject|1|||
27954441|NCT00382174|81665994|FG001|Overall Study|Withdrawal by Subject|4|||
27954442|NCT00382174|81665995|FG002|Overall Study|Withdrawal by Subject|5|||
27954443|NCT00382174|81665993|FG000|Overall Study|Non compliance|1|||
27750997|NCT00256867|80914067|FG000|Overall Study|Adverse Event|0|||
27954444|NCT00382174|81665994|FG001|Overall Study|Non compliance|0|||
27551532|NCT01482884|80207483|FG001|Overall Study|Adverse Event|1|||
27954445|NCT00382174|81665995|FG002|Overall Study|Non compliance|1|||
27954446|NCT00382174|81665993|FG000|Overall Study|Physician Decision|0|||
27954447|NCT00382174|81665994|FG001|Overall Study|Physician Decision|2|||
27954448|NCT00382174|81665995|FG002|Overall Study|Physician Decision|2|||
27954449|NCT00382174|81665993|FG000|Overall Study|Failed to meet criteria|0|||
27954450|NCT00382174|81665994|FG001|Overall Study|Failed to meet criteria|1|||
27954451|NCT00382174|81665995|FG002|Overall Study|Failed to meet criteria|1|||
27954452|NCT00382174|81665993|FG000|Overall Study|Wounds merged|0|||
27954453|NCT00382174|81665994|FG001|Overall Study|Wounds merged|2|||
27954454|NCT00382174|81665995|FG002|Overall Study|Wounds merged|2|||
27954455|NCT01657370|81666001|FG000|Overall Study|Withdrawal by Subject|0|||
27954456|NCT01657370|81666002|FG001|Overall Study|Withdrawal by Subject|0|||
27954457|NCT01657370|81666003|FG002|Overall Study|Withdrawal by Subject|1|||
27954458|NCT01657370|81666004|FG003|Overall Study|Withdrawal by Subject|0|||
27954459|NCT01657370|81666005|FG004|Overall Study|Withdrawal by Subject|0|||
27954460|NCT01657370|81666006|FG005|Overall Study|Withdrawal by Subject|1|||
27954461|NCT01657370|81666001|FG000|Overall Study|Physician Decision|2|||
27954462|NCT01657370|81666002|FG001|Overall Study|Physician Decision|3|||
27954463|NCT01657370|81666003|FG002|Overall Study|Physician Decision|1|||
27954464|NCT01657370|81666004|FG003|Overall Study|Physician Decision|2|||
27954465|NCT01657370|81666005|FG004|Overall Study|Physician Decision|5|||
27954466|NCT01657370|81666006|FG005|Overall Study|Physician Decision|0|||
27954467|NCT01657370|81666001|FG000|Overall Study|Lack of Qualifying Event|1|||
27954468|NCT01657370|81666002|FG001|Overall Study|Lack of Qualifying Event|0|||
27954469|NCT01657370|81666003|FG002|Overall Study|Lack of Qualifying Event|3|||
27954470|NCT01657370|81666004|FG003|Overall Study|Lack of Qualifying Event|2|||
27954471|NCT01657370|81666005|FG004|Overall Study|Lack of Qualifying Event|1|||
27954472|NCT01657370|81666006|FG005|Overall Study|Lack of Qualifying Event|2|||
27954473|NCT01657370|81666001|FG000|Overall Study|Adverse Event|0|||
27954474|NCT01657370|81666002|FG001|Overall Study|Adverse Event|0|||
27954475|NCT01657370|81666003|FG002|Overall Study|Adverse Event|0|||
27954476|NCT01657370|81666004|FG003|Overall Study|Adverse Event|0|||
27954477|NCT01657370|81666005|FG004|Overall Study|Adverse Event|1|||
27954478|NCT01657370|81666006|FG005|Overall Study|Adverse Event|0|||
27954479|NCT01657370|81666001|FG000|Overall Study|Protocol Violation|1|||
27954480|NCT01657370|81666002|FG001|Overall Study|Protocol Violation|1|||
27954481|NCT01657370|81666003|FG002|Overall Study|Protocol Violation|1|||
27954482|NCT01657370|81666004|FG003|Overall Study|Protocol Violation|1|||
27954483|NCT01657370|81666005|FG004|Overall Study|Protocol Violation|0|||
27954484|NCT01657370|81666006|FG005|Overall Study|Protocol Violation|0|||
27954485|NCT01657370|81666001|FG000|Overall Study|Lost to Follow-up|2|||
27954486|NCT01657370|81666002|FG001|Overall Study|Lost to Follow-up|0|||
27954487|NCT01657370|81666003|FG002|Overall Study|Lost to Follow-up|1|||
27954488|NCT01657370|81666004|FG003|Overall Study|Lost to Follow-up|0|||
27954489|NCT01657370|81666005|FG004|Overall Study|Lost to Follow-up|0|||
27954490|NCT01657370|81666006|FG005|Overall Study|Lost to Follow-up|1|||
27954491|NCT00583219|81666007|FG000|Phase 2|Withdrawal by Subject|1|||
27954492|NCT00959907|81666008|FG000|Overall Study|Protocol Violation|0|||
27954493|NCT00959907|81666009|FG001|Overall Study|Protocol Violation|1|||
27954494|NCT00959907|81666008|FG000|Overall Study|Adverse Event|1|||
27954495|NCT00959907|81666009|FG001|Overall Study|Adverse Event|0|||
27954496|NCT00959907|81666008|FG000|Overall Study|Withdrawal by Subject|2|||
27954497|NCT00959907|81666009|FG001|Overall Study|Withdrawal by Subject|0|||
27954498|NCT02756403|81666013|FG000|Overall Study|Unable to swallow medication|0|||
27954499|NCT02756403|81666014|FG001|Overall Study|Unable to swallow medication|1|||
27954500|NCT02756403|81666015|FG002|Overall Study|Unable to swallow medication|1|||
27954501|NCT02756403|81666016|FG003|Overall Study|Unable to swallow medication|1|||
27954502|NCT02756403|81666013|FG000|Overall Study|Did not complete Procedure|0|||
27954503|NCT02756403|81666014|FG001|Overall Study|Did not complete Procedure|1|||
27954504|NCT02756403|81666015|FG002|Overall Study|Did not complete Procedure|0|||
27954505|NCT02756403|81666016|FG003|Overall Study|Did not complete Procedure|0|||
27954506|NCT02756403|81666013|FG000|Overall Study|Changed Mind About Procedure|0|||
27954507|NCT02756403|81666014|FG001|Overall Study|Changed Mind About Procedure|0|||
27954508|NCT02756403|81666015|FG002|Overall Study|Changed Mind About Procedure|1|||
27954509|NCT02756403|81666016|FG003|Overall Study|Changed Mind About Procedure|0|||
27954510|NCT02756403|81666013|FG000|Overall Study|Protocol Violation|0|||
27954511|NCT02756403|81666014|FG001|Overall Study|Protocol Violation|1|||
27954512|NCT02756403|81666015|FG002|Overall Study|Protocol Violation|0|||
27954513|NCT02756403|81666016|FG003|Overall Study|Protocol Violation|1|||
27954514|NCT01276106|81666017|FG000|Overall Study|Adverse Event|3|||
27954515|NCT01276106|81666018|FG001|Overall Study|Adverse Event|3|||
27954516|NCT01276106|81666019|FG002|Overall Study|Adverse Event|11|||
27954517|NCT01276106|81666020|FG003|Overall Study|Adverse Event|3|||
27954518|NCT01276106|81666017|FG000|Overall Study|Withdrawal by Subject|6|||
27954519|NCT01276106|81666018|FG001|Overall Study|Withdrawal by Subject|3|||
27954520|NCT01276106|81666019|FG002|Overall Study|Withdrawal by Subject|1|||
27954521|NCT01276106|81666020|FG003|Overall Study|Withdrawal by Subject|6|||
27954522|NCT01276106|81666017|FG000|Overall Study|Lack of Efficacy|0|||
27954523|NCT01276106|81666018|FG001|Overall Study|Lack of Efficacy|1|||
27954524|NCT01276106|81666019|FG002|Overall Study|Lack of Efficacy|0|||
27954525|NCT01276106|81666020|FG003|Overall Study|Lack of Efficacy|1|||
27954526|NCT01276106|81666017|FG000|Overall Study|Lost to Follow-up|2|||
27954527|NCT01276106|81666018|FG001|Overall Study|Lost to Follow-up|1|||
27954528|NCT01276106|81666019|FG002|Overall Study|Lost to Follow-up|1|||
27954529|NCT01276106|81666020|FG003|Overall Study|Lost to Follow-up|0|||
27954530|NCT01276106|81666017|FG000|Overall Study|Physician Decision|0|||
27954531|NCT01276106|81666018|FG001|Overall Study|Physician Decision|0|||
27954532|NCT01276106|81666019|FG002|Overall Study|Physician Decision|1|||
27954533|NCT01276106|81666020|FG003|Overall Study|Physician Decision|1|||
27954534|NCT01276106|81666017|FG000|Overall Study|Protocol Violation|1|||
27954535|NCT01276106|81666018|FG001|Overall Study|Protocol Violation|1|||
27954536|NCT01276106|81666019|FG002|Overall Study|Protocol Violation|0|||
27954537|NCT01276106|81666020|FG003|Overall Study|Protocol Violation|2|||
27954538|NCT01276106|81666017|FG000|Overall Study|Insufficient therapeutic effects|0|||
27954539|NCT01276106|81666018|FG001|Overall Study|Insufficient therapeutic effects|0|||
27954540|NCT01276106|81666019|FG002|Overall Study|Insufficient therapeutic effects|2|||
27954541|NCT01276106|81666020|FG003|Overall Study|Insufficient therapeutic effects|0|||
27954542|NCT02012218|81666021|FG000|Overall Study|Withdrawal by Subject|1|||
27954543|NCT02012218|81666022|FG001|Overall Study|Withdrawal by Subject|0|||
27954544|NCT02012218|81666023|FG002|Overall Study|Withdrawal by Subject|1|||
27954545|NCT02012218|81666024|FG003|Overall Study|Withdrawal by Subject|1|||
27954546|NCT02012218|81666025|FG004|Overall Study|Withdrawal by Subject|1|||
27954547|NCT02012218|81666021|FG000|Overall Study|Adverse Event|1|||
27954548|NCT02012218|81666022|FG001|Overall Study|Adverse Event|0|||
27954549|NCT02012218|81666023|FG002|Overall Study|Adverse Event|0|||
27954550|NCT02012218|81666024|FG003|Overall Study|Adverse Event|1|||
27954551|NCT02012218|81666025|FG004|Overall Study|Adverse Event|0|||
27954552|NCT02012218|81666021|FG000|Overall Study|Lost to Follow-up|0|||
27954553|NCT02012218|81666022|FG001|Overall Study|Lost to Follow-up|1|||
27954554|NCT02012218|81666023|FG002|Overall Study|Lost to Follow-up|1|||
27954555|NCT02012218|81666024|FG003|Overall Study|Lost to Follow-up|0|||
27954556|NCT02012218|81666025|FG004|Overall Study|Lost to Follow-up|0|||
27954557|NCT02012218|81666021|FG000|Overall Study|Protocol Specified|1|||
27954558|NCT02012218|81666022|FG001|Overall Study|Protocol Specified|0|||
27954559|NCT02012218|81666023|FG002|Overall Study|Protocol Specified|0|||
27954560|NCT02012218|81666024|FG003|Overall Study|Protocol Specified|0|||
27954561|NCT02012218|81666025|FG004|Overall Study|Protocol Specified|0|||
27954562|NCT02012218|81666021|FG000|Overall Study|Protocol Deviation|1|||
27954563|NCT02012218|81666022|FG001|Overall Study|Protocol Deviation|0|||
27954564|NCT02012218|81666023|FG002|Overall Study|Protocol Deviation|0|||
27954565|NCT02012218|81666024|FG003|Overall Study|Protocol Deviation|0|||
27954566|NCT02012218|81666025|FG004|Overall Study|Protocol Deviation|0|||
27954567|NCT01282866|81666026|FG000|Overall Study|Adverse Event|1|||
27954568|NCT02329743|81666032|FG000|Overall Study|Adverse Event|1|||
27954569|NCT02329743|81666033|FG001|Overall Study|Adverse Event|1|||
27954570|NCT02329743|81666034|FG002|Overall Study|Adverse Event|3|||
27954571|NCT02329743|81666032|FG000|Overall Study|Lost to Follow-up|1|||
27954572|NCT02329743|81666033|FG001|Overall Study|Lost to Follow-up|0|||
27954573|NCT02329743|81666034|FG002|Overall Study|Lost to Follow-up|1|||
27954574|NCT02329743|81666032|FG000|Overall Study|Withdrawal by Subject|4|||
27954575|NCT02329743|81666033|FG001|Overall Study|Withdrawal by Subject|4|||
27954576|NCT02329743|81666034|FG002|Overall Study|Withdrawal by Subject|1|||
27954577|NCT02329743|81666032|FG000|Overall Study|Other|0|||
27954578|NCT02329743|81666033|FG001|Overall Study|Other|2|||
27954579|NCT02329743|81666034|FG002|Overall Study|Other|3|||
27954580|NCT00707993|81666041|FG000|Overall Study|Adverse Event|16|||
27954581|NCT00707993|81666042|FG001|Overall Study|Adverse Event|20|||
27954582|NCT00707993|81666041|FG000|Overall Study|Protocol Violation|4|||
27954583|NCT00707993|81666042|FG001|Overall Study|Protocol Violation|7|||
27954584|NCT00707993|81666041|FG000|Overall Study|Lost to Follow-up|0|||
27954585|NCT00707993|81666042|FG001|Overall Study|Lost to Follow-up|4|||
27954586|NCT00707993|81666041|FG000|Overall Study|Withdrawal by Subject|12|||
27954587|NCT00707993|81666042|FG001|Overall Study|Withdrawal by Subject|16|||
27954588|NCT00707993|81666041|FG000|Overall Study|Hyperglycemic Rescue|55|||
27954589|NCT00707993|81666042|FG001|Overall Study|Hyperglycemic Rescue|47|||
27954590|NCT00707993|81666041|FG000|Overall Study|Other|2|||
27954591|NCT00707993|81666042|FG001|Overall Study|Other|0|||
27954592|NCT03092479|81668837|FG000|Overall Study|Lost to Follow-up|3|||
27954593|NCT03092479|81668838|FG001|Overall Study|Lost to Follow-up|2|||
27954594|NCT03092479|81668837|FG000|Overall Study|Withdrawal by Subject|4|||
27954595|NCT03092479|81668838|FG001|Overall Study|Withdrawal by Subject|0|||
27954596|NCT01497197|81668839|FG000|Overall Study|Lost to Follow-up|1|||
27954597|NCT01497197|81668840|FG001|Overall Study|Lost to Follow-up|0|||
27954598|NCT01497197|81668839|FG000|Overall Study|Protocol Violation|0|||
27954599|NCT01497197|81668840|FG001|Overall Study|Protocol Violation|2|||
27652078|NCT00392197|80564835|FG001|Overall Study|Withdrawal by Subject|6|||
27954600|NCT01497197|81668839|FG000|Overall Study|Withdrawal by Subject|2|||
27954601|NCT01497197|81668840|FG001|Overall Study|Withdrawal by Subject|1|||
27954602|NCT01497197|81668839|FG000|Overall Study|Excessive/lack of response to treatment|1|||
27954603|NCT01497197|81668840|FG001|Overall Study|Excessive/lack of response to treatment|0|||
27954604|NCT01497197|81668839|FG000|Overall Study|Risk of OHSS|1|||
27954605|NCT01497197|81668840|FG001|Overall Study|Risk of OHSS|0|||
27954606|NCT01497197|81668839|FG000|Overall Study|No oocytes retrieved|3|||
27954607|NCT01497197|81668840|FG001|Overall Study|No oocytes retrieved|2|||
27954608|NCT01497197|81668839|FG000|Overall Study|No fertilisation|6|||
27954609|NCT01497197|81668840|FG001|Overall Study|No fertilisation|5|||
27954610|NCT01497197|81668839|FG000|Overall Study|Intention to freeze all embryos|0|||
27652079|NCT02009332|80564836|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27652080|NCT02009332|80564837|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
27652081|NCT02009332|80564838|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27652082|NCT02009332|80564839|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27652083|NCT02009332|80564840|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27652084|NCT02009332|80564841|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
27652085|NCT02009332|80564836|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27652086|NCT02009332|80564837|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27652087|NCT02009332|80564838|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27652088|NCT02009332|80564839|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27652089|NCT02009332|80564840|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
27652090|NCT02009332|80564841|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
27652091|NCT02009332|80564836|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27652092|NCT02009332|80564837|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27652093|NCT02009332|80564838|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27652094|NCT02009332|80564839|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27652095|NCT02009332|80564840|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
27652096|NCT02009332|80564841|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
27652097|NCT02137785|80564842|FG000|Overall Study|Lost to Follow-up|1|||
27652098|NCT02137785|80564843|FG001|Overall Study|Lost to Follow-up|0|||
27652099|NCT02137785|80564842|FG000|Overall Study|Withdrawal by Subject|1|||
27652100|NCT02137785|80564843|FG001|Overall Study|Withdrawal by Subject|4|||
27652101|NCT02137785|80564842|FG000|Overall Study|subject moved out of state|1|||
27652102|NCT02137785|80564843|FG001|Overall Study|subject moved out of state|0|||
27652103|NCT03693989|80564846|FG000|Overall Study|Protocol Violation|3|||
27652104|NCT03693989|80564847|FG001|Overall Study|Protocol Violation|4|||
27652105|NCT01661972|80564848|FG000|Overall Study|Adverse Event|1|||
27652106|NCT01661972|80564849|FG001|Overall Study|Adverse Event|2|||
27652107|NCT01661972|80564848|FG000|Overall Study|Death during Treatment period|1|||
27652108|NCT01661972|80564849|FG001|Overall Study|Death during Treatment period|1|||
27652109|NCT01661972|80564848|FG000|Overall Study|Withdrawal by Subject|0|||
27652110|NCT01661972|80564849|FG001|Overall Study|Withdrawal by Subject|1|||
27652111|NCT00617708|80564856|FG000|Overall Study|Adverse Event|0|||
27652112|NCT00617708|80564857|FG001|Overall Study|Adverse Event|6|||
27652113|NCT00617708|80564858|FG002|Overall Study|Adverse Event|9|||
27652114|NCT00617708|80564856|FG000|Overall Study|Withdrawal by Subject|1|||
27652115|NCT00617708|80564857|FG001|Overall Study|Withdrawal by Subject|1|||
27652116|NCT00617708|80564858|FG002|Overall Study|Withdrawal by Subject|7|||
27652117|NCT00617708|80564856|FG000|Overall Study|Death|0|||
27652118|NCT00617708|80564857|FG001|Overall Study|Death|6|||
27652119|NCT00617708|80564858|FG002|Overall Study|Death|5|||
27652120|NCT00617708|80564856|FG000|Overall Study|Progression/Relapse|7|||
27652121|NCT00617708|80564857|FG001|Overall Study|Progression/Relapse|40|||
27652122|NCT00617708|80564858|FG002|Overall Study|Progression/Relapse|36|||
27652123|NCT00617708|80564856|FG000|Overall Study|Not protocol specified|1|||
27652124|NCT00617708|80564857|FG001|Overall Study|Not protocol specified|4|||
27954611|NCT01497197|81668840|FG001|Overall Study|Intention to freeze all embryos|1|||
27954612|NCT01497197|81668839|FG000|Overall Study|All embryos discarded|0|||
27954613|NCT01497197|81668840|FG001|Overall Study|All embryos discarded|3|||
27954614|NCT01497197|81668839|FG000|Overall Study|Other|3|||
27954615|NCT01497197|81668840|FG001|Overall Study|Other|1|||
27954616|NCT01428219|81668842|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
27954617|NCT01819272|81668844|FG000|Overall Study|Adverse Event|1|||
27954618|NCT01819272|81668845|FG001|Overall Study|Adverse Event|0|||
27954619|NCT01819272|81668846|FG002|Overall Study|Adverse Event|0|||
27954620|NCT01819272|81668847|FG003|Overall Study|Adverse Event|2|||
27954621|NCT01819272|81668848|FG004|Overall Study|Adverse Event|0|||
27954622|NCT01819272|81668849|FG005|Overall Study|Adverse Event|0|||
27652125|NCT00617708|80564858|FG002|Overall Study|Not protocol specified|2|||
27652126|NCT00617708|80564856|FG000|Overall Study|Not eligible|1|||
27652127|NCT00617708|80564857|FG001|Overall Study|Not eligible|3|||
27652128|NCT00617708|80564858|FG002|Overall Study|Not eligible|5|||
27750998|NCT00256867|80914068|FG001|Overall Study|Adverse Event|1|||
27652129|NCT02066636|80564859|FG000|Overall Study|Disease progression|51|||
27652130|NCT02066636|80564860|FG001|Overall Study|Disease progression|60|||
27652131|NCT02066636|80564861|FG002|Overall Study|Disease progression|700|||
27652132|NCT02066636|80564859|FG000|Overall Study|Study drug toxicity|13|||
27954623|NCT01819272|81668844|FG000|Overall Study|Lost to Follow-up|3|||
27954624|NCT01819272|81668845|FG001|Overall Study|Lost to Follow-up|0|||
27954625|NCT01819272|81668846|FG002|Overall Study|Lost to Follow-up|1|||
27954626|NCT01819272|81668847|FG003|Overall Study|Lost to Follow-up|0|||
27954627|NCT01819272|81668848|FG004|Overall Study|Lost to Follow-up|0|||
27954628|NCT01819272|81668849|FG005|Overall Study|Lost to Follow-up|3|||
27954629|NCT01819272|81668844|FG000|Overall Study|Protocol Violation|0|||
27954630|NCT01819272|81668845|FG001|Overall Study|Protocol Violation|0|||
27954631|NCT01819272|81668846|FG002|Overall Study|Protocol Violation|0|||
27954632|NCT01819272|81668847|FG003|Overall Study|Protocol Violation|1|||
27954633|NCT01819272|81668848|FG004|Overall Study|Protocol Violation|2|||
27954634|NCT01819272|81668849|FG005|Overall Study|Protocol Violation|3|||
27954635|NCT01819272|81668844|FG000|Overall Study|Physician Decision|0|||
27954636|NCT01819272|81668845|FG001|Overall Study|Physician Decision|1|||
27954637|NCT01819272|81668846|FG002|Overall Study|Physician Decision|0|||
27954638|NCT01819272|81668847|FG003|Overall Study|Physician Decision|0|||
27954639|NCT01819272|81668848|FG004|Overall Study|Physician Decision|0|||
27954640|NCT01819272|81668849|FG005|Overall Study|Physician Decision|0|||
27954641|NCT01819272|81668844|FG000|Overall Study|Withdrawal of Consent|0|||
27954642|NCT01819272|81668845|FG001|Overall Study|Withdrawal of Consent|1|||
27954643|NCT01819272|81668846|FG002|Overall Study|Withdrawal of Consent|2|||
27954644|NCT01819272|81668847|FG003|Overall Study|Withdrawal of Consent|1|||
27954645|NCT01819272|81668848|FG004|Overall Study|Withdrawal of Consent|0|||
27954646|NCT01819272|81668849|FG005|Overall Study|Withdrawal of Consent|1|||
27954647|NCT01819272|81668844|FG000|Overall Study|Loss of Glucose Control|2|||
27954648|NCT01819272|81668845|FG001|Overall Study|Loss of Glucose Control|1|||
27954649|NCT01819272|81668846|FG002|Overall Study|Loss of Glucose Control|0|||
27954650|NCT01819272|81668847|FG003|Overall Study|Loss of Glucose Control|1|||
27954651|NCT01819272|81668848|FG004|Overall Study|Loss of Glucose Control|2|||
27954652|NCT01819272|81668849|FG005|Overall Study|Loss of Glucose Control|0|||
27954653|NCT00698828|81668850|FG000|Overall Study|Adverse Event|3|||
27954654|NCT00698828|81668851|FG001|Overall Study|Adverse Event|4|||
27954655|NCT00698828|81668852|FG002|Overall Study|Adverse Event|4|||
27954656|NCT00698828|81668850|FG000|Overall Study|Death|0|||
27954657|NCT00698828|81668851|FG001|Overall Study|Death|0|||
27954658|NCT00698828|81668852|FG002|Overall Study|Death|1|||
27954659|NCT00698828|81668850|FG000|Overall Study|Exacerbation of COPD|1|||
27954660|NCT00698828|81668851|FG001|Overall Study|Exacerbation of COPD|3|||
27954661|NCT00698828|81668852|FG002|Overall Study|Exacerbation of COPD|0|||
27954662|NCT00698828|81668850|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
27954663|NCT00698828|81668851|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
27954664|NCT00698828|81668852|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
27954665|NCT00698828|81668850|FG000|Overall Study|Investigator/Sponsor decision|1|||
27954666|NCT00698828|81668851|FG001|Overall Study|Investigator/Sponsor decision|0|||
27954667|NCT00698828|81668852|FG002|Overall Study|Investigator/Sponsor decision|2|||
27954668|NCT00698828|81668850|FG000|Overall Study|Lost to Follow-up|1|||
27954669|NCT00698828|81668851|FG001|Overall Study|Lost to Follow-up|1|||
27954670|NCT00698828|81668852|FG002|Overall Study|Lost to Follow-up|0|||
27954671|NCT00698828|81668850|FG000|Overall Study|Withdrew consent|0|||
27954672|NCT00698828|81668851|FG001|Overall Study|Withdrew consent|7|||
27954673|NCT00698828|81668852|FG002|Overall Study|Withdrew consent|4|||
27954674|NCT00698828|81668850|FG000|Overall Study|Withdrew consent (not treated)|2|||
27954675|NCT00698828|81668851|FG001|Overall Study|Withdrew consent (not treated)|0|||
27954676|NCT00698828|81668852|FG002|Overall Study|Withdrew consent (not treated)|0|||
27954677|NCT01143402|81668853|FG000|Overall Study|Rapid clinical decline|1|||
27954678|NCT01143402|81668854|FG001|Overall Study|Rapid clinical decline|1|||
27954679|NCT01143402|81668855|FG002|Overall Study|Rapid clinical decline|0|||
27954680|NCT01143402|81668853|FG000|Overall Study|Not Treated|0|||
27954681|NCT01143402|81668854|FG001|Overall Study|Not Treated|0|||
27954682|NCT01143402|81668855|FG002|Overall Study|Not Treated|1|||
27954683|NCT01732536|81668856|FG000|Overall Study|Withdrawal by Subject|1|||
27954684|NCT01732536|81668857|FG001|Overall Study|Withdrawal by Subject|1|||
27954685|NCT01621178|81668858|FG000|Overall Study|Adverse Event|5|||
27954686|NCT01621178|81668859|FG001|Overall Study|Adverse Event|2|||
27954687|NCT01621178|81668860|FG002|Overall Study|Adverse Event|8|||
27954688|NCT01621178|81668858|FG000|Overall Study|Death|6|||
27954689|NCT01621178|81668859|FG001|Overall Study|Death|7|||
27954690|NCT01621178|81668860|FG002|Overall Study|Death|2|||
27954691|NCT01621178|81668858|FG000|Overall Study|Lost to Follow-up|1|||
27954692|NCT01621178|81668859|FG001|Overall Study|Lost to Follow-up|2|||
27954693|NCT01621178|81668860|FG002|Overall Study|Lost to Follow-up|1|||
27954694|NCT01621178|81668858|FG000|Overall Study|Withdrawal by Subject|14|||
27954695|NCT01621178|81668859|FG001|Overall Study|Withdrawal by Subject|17|||
27954696|NCT01621178|81668860|FG002|Overall Study|Withdrawal by Subject|18|||
27954697|NCT01621178|81668858|FG000|Overall Study|Physician Decision|5|||
27954698|NCT01621178|81668859|FG001|Overall Study|Physician Decision|2|||
27954699|NCT01621178|81668860|FG002|Overall Study|Physician Decision|7|||
27954700|NCT02289469|81668864|FG000|Overall Study|Unable to match a control|6|||
27959314|NCT02131662|81683270|FG001|Overall Study|Wish for pregnancy|0|||
27954701|NCT02289469|81668865|FG001|Overall Study|Unable to match a control|0|||
27954702|NCT02431325|81668866|FG000|Overall Study|Adverse Event|3|||
27954703|NCT02431325|81668867|FG001|Overall Study|Adverse Event|0|||
27954704|NCT02431325|81668866|FG000|Overall Study|Lost to Follow-up|0|||
27954705|NCT02431325|81668867|FG001|Overall Study|Lost to Follow-up|1|||
27954706|NCT02431325|81668866|FG000|Overall Study|Withdrawal by Subject|1|||
27954707|NCT02431325|81668867|FG001|Overall Study|Withdrawal by Subject|2|||
27954708|NCT02431325|81668866|FG000|Overall Study|Declined to take study medication|1|||
27954709|NCT02431325|81668867|FG001|Overall Study|Declined to take study medication|0|||
27954710|NCT02431325|81668866|FG000|Overall Study|Withdrew before starting study medication|1|||
27954711|NCT02431325|81668867|FG001|Overall Study|Withdrew before starting study medication|0|||
27954712|NCT02431325|81668866|FG000|Overall Study|Placebo shortage|2|||
27954713|NCT02431325|81668867|FG001|Overall Study|Placebo shortage|0|||
27954714|NCT03376516|81668870|FG000|Overall Study|Not treated|1|||
27954715|NCT03376516|81668870|FG000|Overall Study|Consent withdrawn|1|||
27954716|NCT02803203|81668871|FG000|Overall Study|Adverse Event|4|||
27652133|NCT02066636|80564860|FG001|Overall Study|Study drug toxicity|2|||
27652134|NCT02066636|80564861|FG002|Overall Study|Study drug toxicity|58|||
27652135|NCT02066636|80564859|FG000|Overall Study|Death|4|||
27652136|NCT02066636|80564860|FG001|Overall Study|Death|2|||
27652137|NCT02066636|80564861|FG002|Overall Study|Death|158|||
27652138|NCT02066636|80564859|FG000|Overall Study|Adverse event unrelated to study drug|6|||
27652139|NCT02066636|80564860|FG001|Overall Study|Adverse event unrelated to study drug|4|||
27652140|NCT02066636|80564861|FG002|Overall Study|Adverse event unrelated to study drug|45|||
27652141|NCT02066636|80564859|FG000|Overall Study|Participant request to discontinue treatment|12|||
27652142|NCT02066636|80564860|FG001|Overall Study|Participant request to discontinue treatment|12|||
27652143|NCT02066636|80564861|FG002|Overall Study|Participant request to discontinue treatment|70|||
27652144|NCT02066636|80564859|FG000|Overall Study|Participant withdrew consent|10|||
27652145|NCT02066636|80564860|FG001|Overall Study|Participant withdrew consent|18|||
27652146|NCT02066636|80564861|FG002|Overall Study|Participant withdrew consent|61|||
27652147|NCT02066636|80564859|FG000|Overall Study|Lost to Follow-up|0|||
27652148|NCT02066636|80564860|FG001|Overall Study|Lost to Follow-up|2|||
27652149|NCT02066636|80564861|FG002|Overall Study|Lost to Follow-up|2|||
27652150|NCT02066636|80564859|FG000|Overall Study|Maximum clinical benefit|2|||
27652151|NCT02066636|80564860|FG001|Overall Study|Maximum clinical benefit|2|||
27652152|NCT02066636|80564861|FG002|Overall Study|Maximum clinical benefit|3|||
27652153|NCT02066636|80564859|FG000|Overall Study|Poor/non-compliance|2|||
27652154|NCT02066636|80564860|FG001|Overall Study|Poor/non-compliance|1|||
27652155|NCT02066636|80564861|FG002|Overall Study|Poor/non-compliance|1|||
27652156|NCT02066636|80564859|FG000|Overall Study|Participant no loner meets study criteria|3|||
27652157|NCT02066636|80564860|FG001|Overall Study|Participant no loner meets study criteria|2|||
27652158|NCT02066636|80564861|FG002|Overall Study|Participant no loner meets study criteria|28|||
27652159|NCT02066636|80564859|FG000|Overall Study|Administrative reasons by sponsor|8|||
27652160|NCT02066636|80564860|FG001|Overall Study|Administrative reasons by sponsor|5|||
27652161|NCT02066636|80564861|FG002|Overall Study|Administrative reasons by sponsor|0|||
27652162|NCT02066636|80564859|FG000|Overall Study|Other reasons|16|||
27652163|NCT02066636|80564860|FG001|Overall Study|Other reasons|15|||
27652164|NCT02066636|80564861|FG002|Overall Study|Other reasons|50|||
27652165|NCT00871715|80564862|FG000|Overall Study|Withdrawal by Subject|6|||
27652166|NCT00871715|80564863|FG001|Overall Study|Withdrawal by Subject|10|||
27652167|NCT00871715|80564864|FG002|Overall Study|Withdrawal by Subject|15|||
27652168|NCT00871715|80564862|FG000|Overall Study|Physician Decision|6|||
27652169|NCT00871715|80564863|FG001|Overall Study|Physician Decision|0|||
27652170|NCT00871715|80564864|FG002|Overall Study|Physician Decision|2|||
27652171|NCT00871715|80564862|FG000|Overall Study|Lost to Follow-up|3|||
27652172|NCT00871715|80564863|FG001|Overall Study|Lost to Follow-up|6|||
27652173|NCT00871715|80564864|FG002|Overall Study|Lost to Follow-up|9|||
27652174|NCT02584257|80564865|FG000|Period 1|Withdrawal by Subject|0|||
27652175|NCT02584257|80564866|FG001|Period 1|Withdrawal by Subject|0|||
27652176|NCT02584257|80564867|FG002|Period 1|Withdrawal by Subject|0|||
27652177|NCT02584257|80564868|FG003|Period 1|Withdrawal by Subject|0|||
27652178|NCT02584257|80564869|FG004|Period 1|Withdrawal by Subject|0|||
27652179|NCT02584257|80564870|FG005|Period 1|Withdrawal by Subject|0|||
27652180|NCT02584257|80564871|FG006|Period 1|Withdrawal by Subject|1|||
27652181|NCT02584257|80564872|FG007|Period 1|Withdrawal by Subject|0|||
27652182|NCT02584257|80564873|FG008|Period 1|Withdrawal by Subject|0|||
27652183|NCT02584257|80564865|FG000|Period 2|Physician Decision|1|||
27652184|NCT02584257|80564866|FG001|Period 2|Physician Decision|0|||
27652185|NCT02584257|80564867|FG002|Period 2|Physician Decision|0|||
27652186|NCT02584257|80564868|FG003|Period 2|Physician Decision|0|||
27652187|NCT02584257|80564869|FG004|Period 2|Physician Decision|0|||
27954717|NCT02803203|81668871|FG000|Overall Study|Death|4|||
27954718|NCT02803203|81668871|FG000|Overall Study|Progressive disease|29|||
27954719|NCT02803203|81668871|FG000|Overall Study|Withdrawal by Subject|8|||
27959315|NCT02131662|81683271|FG002|Overall Study|Wish for pregnancy|0|||
27652188|NCT02584257|80564870|FG005|Period 2|Physician Decision|0|||
27652189|NCT02584257|80564871|FG006|Period 2|Physician Decision|0|||
27652190|NCT02584257|80564872|FG007|Period 2|Physician Decision|0|||
27652191|NCT02584257|80564873|FG008|Period 2|Physician Decision|0|||
27652192|NCT02584257|80564865|FG000|Period 2|Adverse Event|0|||
27652193|NCT02584257|80564866|FG001|Period 2|Adverse Event|1|||
27652194|NCT02584257|80564867|FG002|Period 2|Adverse Event|0|||
27652195|NCT02584257|80564868|FG003|Period 2|Adverse Event|0|||
27652196|NCT02584257|80564869|FG004|Period 2|Adverse Event|0|||
27652197|NCT02584257|80564870|FG005|Period 2|Adverse Event|0|||
27652198|NCT02584257|80564871|FG006|Period 2|Adverse Event|0|||
27652199|NCT02584257|80564872|FG007|Period 2|Adverse Event|0|||
27652200|NCT02584257|80564873|FG008|Period 2|Adverse Event|0|||
27652201|NCT02058992|80567881|FG000|Overall Study|Lost to Follow-up|4|||
27652202|NCT02058992|80567881|FG000|Overall Study|Protocol Violation|92|||
27652203|NCT02058992|80567881|FG000|Overall Study|CRF Uncollected|20|||
27652204|NCT01186809|80567882|FG000|Overall Study|Death|30|||
27652205|NCT04633200|80567888|FG000|Overall Study|Lost to Follow-up|3|||
27652206|NCT04633200|80567889|FG001|Overall Study|Lost to Follow-up|5|||
27652207|NCT01986348|80567890|FG000|Overall Study|Death|8|||
27652208|NCT01986348|80567891|FG001|Overall Study|Death|22|||
27652209|NCT01986348|80567892|FG002|Overall Study|Death|10|||
27652210|NCT01986348|80567893|FG003|Overall Study|Death|21|||
27652211|NCT01986348|80567890|FG000|Overall Study|Lost to Follow-up|0|||
27652212|NCT01986348|80567891|FG001|Overall Study|Lost to Follow-up|0|||
27652213|NCT01986348|80567892|FG002|Overall Study|Lost to Follow-up|0|||
27652214|NCT01986348|80567893|FG003|Overall Study|Lost to Follow-up|2|||
27652215|NCT01986348|80567890|FG000|Overall Study|Physician Decision|0|||
27652216|NCT01986348|80567891|FG001|Overall Study|Physician Decision|0|||
27652217|NCT01986348|80567892|FG002|Overall Study|Physician Decision|0|||
27652218|NCT01986348|80567893|FG003|Overall Study|Physician Decision|1|||
27652219|NCT01986348|80567890|FG000|Overall Study|Progressive Disease|0|||
27652220|NCT01986348|80567891|FG001|Overall Study|Progressive Disease|0|||
27652221|NCT01986348|80567892|FG002|Overall Study|Progressive Disease|2|||
27652222|NCT01986348|80567893|FG003|Overall Study|Progressive Disease|0|||
27652223|NCT01986348|80567890|FG000|Overall Study|Withdrawal by Participant|0|||
27652224|NCT01986348|80567891|FG001|Overall Study|Withdrawal by Participant|1|||
27652225|NCT01986348|80567892|FG002|Overall Study|Withdrawal by Participant|2|||
27652226|NCT01986348|80567893|FG003|Overall Study|Withdrawal by Participant|1|||
27652227|NCT01986348|80567890|FG000|Overall Study|Study Terminated by Sponsor|0|||
27652228|NCT01986348|80567891|FG001|Overall Study|Study Terminated by Sponsor|0|||
27652229|NCT01986348|80567892|FG002|Overall Study|Study Terminated by Sponsor|0|||
27750999|NCT00256867|80914069|FG002|Overall Study|Adverse Event|1|||
27954720|NCT02803203|81668871|FG000|Overall Study|Complete resection of target disease|2|||
27954721|NCT02803203|81668871|FG000|Overall Study|Switched to commercial Osi|1|||
27954722|NCT02803203|81668871|FG000|Overall Study|Participant moved away|1|||
27954723|NCT00696878|81668872|FG000|Overall Study|Adverse Event|8|||
27954724|NCT00696878|81668872|FG000|Overall Study|Withdrawal by Subject|87|||
27954725|NCT00696878|81668872|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
27954726|NCT00696878|81668872|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
27954727|NCT00696878|81668872|FG000|Overall Study|Trial stopped|32|||
27954728|NCT00696878|81668872|FG000|Overall Study|Other reason (not specified)|55|||
27954729|NCT01788943|81668876|FG000|Overall Study|Withdrawal by Subject|1|||
27954730|NCT01788943|81668877|FG001|Overall Study|Withdrawal by Subject|0|||
27954731|NCT04592341|81668880|FG000|Overall Study|Physician Decision|5|||
27954732|NCT04592341|81668880|FG000|Overall Study|Study Terminated by Sponsor|5|||
27954733|NCT04592341|81668880|FG000|Overall Study|Withdrawal by Subject|53|||
27954734|NCT04592341|81668880|FG000|Overall Study|Lost to Follow-up|3|||
27652230|NCT01986348|80567893|FG003|Overall Study|Study Terminated by Sponsor|3|||
27652231|NCT01986348|80567890|FG000|Overall Study|Other-unspecified|0|||
27652232|NCT01986348|80567891|FG001|Overall Study|Other-unspecified|1|||
27652233|NCT01986348|80567892|FG002|Overall Study|Other-unspecified|0|||
27652234|NCT01986348|80567893|FG003|Overall Study|Other-unspecified|2|||
27652235|NCT00805441|80567894|FG000|Overall Study|Adverse Event|5|||
27652236|NCT00805441|80567895|FG001|Overall Study|Adverse Event|2|||
27652237|NCT00805441|80567894|FG000|Overall Study|Lack of Efficacy|0|||
27652238|NCT00805441|80567895|FG001|Overall Study|Lack of Efficacy|2|||
27751000|NCT00256867|80914070|FG003|Overall Study|Adverse Event|1|||
27751001|NCT00256867|80914071|FG004|Overall Study|Adverse Event|2|||
27751002|NCT00256867|80914072|FG005|Overall Study|Adverse Event|2|||
27751003|NCT00256867|80914073|FG006|Overall Study|Adverse Event|1|||
27751004|NCT00256867|80914074|FG007|Overall Study|Adverse Event|4|||
27751005|NCT00256867|80914067|FG000|Overall Study|Lost to Follow-up|2|||
27751006|NCT00256867|80914068|FG001|Overall Study|Lost to Follow-up|2|||
27751007|NCT00256867|80914069|FG002|Overall Study|Lost to Follow-up|2|||
27751008|NCT00256867|80914070|FG003|Overall Study|Lost to Follow-up|3|||
27652239|NCT00805441|80567894|FG000|Overall Study|Protocol Violation|4|||
27652240|NCT00805441|80567895|FG001|Overall Study|Protocol Violation|8|||
27652241|NCT00805441|80567894|FG000|Overall Study|Lost to Follow-up|10|||
27652242|NCT00805441|80567895|FG001|Overall Study|Lost to Follow-up|13|||
27652243|NCT00805441|80567894|FG000|Overall Study|Withdrawal by Subject|15|||
27751009|NCT00256867|80914071|FG004|Overall Study|Lost to Follow-up|2|||
27954735|NCT04592341|81668880|FG000|Overall Study|Death|1|||
27954736|NCT04592341|81668880|FG000|Overall Study|Adverse Event|5|||
27954737|NCT04592341|81668880|FG000|Overall Study|other|4|||
27954738|NCT00894387|81668881|FG000|Overall Study|Adverse Event|44|||
27954739|NCT00894387|81668882|FG001|Overall Study|Adverse Event|45|||
27954740|NCT00894387|81668881|FG000|Overall Study|Abnormal Laboratory values|2|||
27954741|NCT00894387|81668882|FG001|Overall Study|Abnormal Laboratory values|2|||
27954742|NCT00894387|81668881|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27954743|NCT00894387|81668882|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
27954744|NCT00894387|81668881|FG000|Overall Study|Lost to Follow-up|3|||
27954745|NCT00894387|81668882|FG001|Overall Study|Lost to Follow-up|5|||
27954746|NCT00894387|81668881|FG000|Overall Study|Administrative problems|2|||
27954747|NCT00894387|81668882|FG001|Overall Study|Administrative problems|2|||
27954748|NCT00894387|81668881|FG000|Overall Study|Death|77|||
27954749|NCT00894387|81668882|FG001|Overall Study|Death|76|||
27954750|NCT00894387|81668881|FG000|Overall Study|Protocol Deviation|4|||
27954751|NCT00894387|81668882|FG001|Overall Study|Protocol Deviation|0|||
27954752|NCT00894387|81668881|FG000|Overall Study|Patient's request|25|||
27954753|NCT00894387|81668882|FG001|Overall Study|Patient's request|30|||
27954754|NCT00894387|81668881|FG000|Overall Study|Other (Missing)|5|||
27954755|NCT00894387|81668882|FG001|Overall Study|Other (Missing)|3|||
27954756|NCT00894387|81668881|FG000|Overall Study|Mis-randomized|13|||
27954757|NCT00894387|81668882|FG001|Overall Study|Mis-randomized|9|||
27954758|NCT00894387|81668881|FG000|Overall Study|GCP non-compliance|0|||
27954759|NCT00894387|81668882|FG001|Overall Study|GCP non-compliance|2|||
27954760|NCT01783444|81668884|FG000|Treatment Phase|Adverse Event|9|||
27954761|NCT01783444|81668885|FG001|Treatment Phase|Adverse Event|20|||
27954762|NCT01783444|81668886|FG002|Treatment Phase|Adverse Event|19|||
27954763|NCT01783444|81668884|FG000|Treatment Phase|Disease Progression|76|||
27954764|NCT01783444|81668885|FG001|Treatment Phase|Disease Progression|66|||
27954765|NCT01783444|81668886|FG002|Treatment Phase|Disease Progression|64|||
27954766|NCT01783444|81668884|FG000|Treatment Phase|Death|2|||
27954767|NCT01783444|81668885|FG001|Treatment Phase|Death|2|||
27954768|NCT01783444|81668886|FG002|Treatment Phase|Death|2|||
27954769|NCT01783444|81668884|FG000|Treatment Phase|Protocol Violation|1|||
27954770|NCT01783444|81668885|FG001|Treatment Phase|Protocol Violation|1|||
27954771|NCT01783444|81668886|FG002|Treatment Phase|Protocol Violation|2|||
27954772|NCT01783444|81668884|FG000|Treatment Phase|Withdrawal by Subject|6|||
27954773|NCT01783444|81668885|FG001|Treatment Phase|Withdrawal by Subject|8|||
27954774|NCT01783444|81668886|FG002|Treatment Phase|Withdrawal by Subject|9|||
27954775|NCT01783444|81668884|FG000|Treatment Phase|Administrative problems|2|||
27954776|NCT01783444|81668885|FG001|Treatment Phase|Administrative problems|0|||
27954777|NCT01783444|81668886|FG002|Treatment Phase|Administrative problems|1|||
27954778|NCT01783444|81668884|FG000|Treatment Phase|Physician Decision|8|||
27954779|NCT01783444|81668885|FG001|Treatment Phase|Physician Decision|6|||
27954780|NCT01783444|81668886|FG002|Treatment Phase|Physician Decision|5|||
27954781|NCT01783444|81668884|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
27954782|NCT01783444|81668885|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
27954783|NCT01783444|81668886|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
27954784|NCT01783444|81668884|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
27954785|NCT01783444|81668885|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
27954786|NCT01783444|81668886|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
27954787|NCT01783444|81668884|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
27954788|NCT01783444|81668885|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
27954789|NCT01783444|81668886|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
27954790|NCT01783444|81668884|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
27954791|NCT01783444|81668885|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
27954792|NCT01783444|81668886|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
27954793|NCT01783444|81668884|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
27954794|NCT01783444|81668885|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
27954795|NCT01783444|81668886|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
27954796|NCT01783444|81668884|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
27954797|NCT01783444|81668885|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
27954798|NCT01783444|81668886|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
27954799|NCT00775268|81668887|FG000|Baseline|Drug not synthesize dose|1|||
27954800|NCT00775268|81668888|FG001|Baseline|Drug not synthesize dose|0|||
27954801|NCT00775268|81668887|FG000|Baseline|Not treated-ineligible per CT|0|||
27954802|NCT00775268|81668888|FG001|Baseline|Not treated-ineligible per CT|1|||
27954803|NCT00775268|81668887|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
27954804|NCT00775268|81668888|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
27652244|NCT00805441|80567895|FG001|Overall Study|Withdrawal by Subject|9|||
27652245|NCT00805441|80567894|FG000|Overall Study|Physician Decision|0|||
27652246|NCT00805441|80567895|FG001|Overall Study|Physician Decision|1|||
27954805|NCT00775268|81668887|FG000|After Completion|Participant missed scan appointment|1|||
27954806|NCT00775268|81668888|FG001|After Completion|Participant missed scan appointment|0|||
27954807|NCT00948688|81668891|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
27954808|NCT00948688|81668892|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
27954809|NCT00948688|81668891|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
27954810|NCT00948688|81668892|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
27954811|NCT00948688|81668891|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
27954812|NCT00948688|81668892|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
27954813|NCT04834726|81668893|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
27954814|NCT04834726|81668894|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
27954815|NCT04834726|81668895|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
27954816|NCT04834726|81668896|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
27954817|NCT04834726|81668897|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
27954818|NCT04834726|81668898|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
27954819|NCT04834726|81668899|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
27954820|NCT04834726|81668900|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
27954821|NCT04834726|81668901|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
27954822|NCT03783780|81668902|FG000|Overall Study|Withdrawn prior to completion|1|||
27954823|NCT01154452|81668903|FG000|Phase Ib|Not Treated|1|||
27954824|NCT01154452|81668904|FG001|Phase Ib|Not Treated|0|||
27954825|NCT01154452|81668905|FG002|Phase Ib|Not Treated|0|||
27954826|NCT01154452|81668906|FG003|Phase Ib|Not Treated|0|||
27954827|NCT01154452|81668903|FG000|Phase Ib|Adverse Event|2|||
27954828|NCT01154452|81668904|FG001|Phase Ib|Adverse Event|1|||
27954829|NCT01154452|81668905|FG002|Phase Ib|Adverse Event|0|||
27954830|NCT01154452|81668906|FG003|Phase Ib|Adverse Event|0|||
27954831|NCT01154452|81668903|FG000|Phase II|Withdrawal by Subject|0|||
27954832|NCT01154452|81668904|FG001|Phase II|Withdrawal by Subject|0|||
27954833|NCT01154452|81668905|FG002|Phase II|Withdrawal by Subject|1|||
27954834|NCT01154452|81668906|FG003|Phase II|Withdrawal by Subject|2|||
27954835|NCT01154452|81668903|FG000|Phase II|Adverse Event|0|||
27652247|NCT00805441|80567894|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
27652248|NCT00805441|80567895|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
27652249|NCT03345407|80567896|FG000|Overall Study|Withdrawal by Subject|11|||
27652250|NCT03345407|80567897|FG001|Overall Study|Withdrawal by Subject|1|||
27652251|NCT03345407|80567898|FG002|Overall Study|Withdrawal by Subject|5|||
27652252|NCT03345407|80567899|FG003|Overall Study|Withdrawal by Subject|6|||
27652253|NCT03345407|80567900|FG004|Overall Study|Withdrawal by Subject|3|||
27652254|NCT03345407|80567901|FG005|Overall Study|Withdrawal by Subject|6|||
27652255|NCT03345407|80567902|FG006|Overall Study|Withdrawal by Subject|16|||
27652256|NCT03345407|80567896|FG000|Overall Study|Physician Decision|3|||
27652257|NCT03345407|80567897|FG001|Overall Study|Physician Decision|1|||
27652258|NCT03345407|80567898|FG002|Overall Study|Physician Decision|0|||
27652259|NCT03345407|80567899|FG003|Overall Study|Physician Decision|0|||
27652260|NCT03345407|80567900|FG004|Overall Study|Physician Decision|1|||
27652261|NCT03345407|80567901|FG005|Overall Study|Physician Decision|2|||
27652262|NCT03345407|80567902|FG006|Overall Study|Physician Decision|3|||
27652263|NCT03345407|80567896|FG000|Overall Study|Lost to Follow-up|2|||
27652264|NCT03345407|80567897|FG001|Overall Study|Lost to Follow-up|0|||
27652265|NCT03345407|80567898|FG002|Overall Study|Lost to Follow-up|1|||
27652266|NCT03345407|80567899|FG003|Overall Study|Lost to Follow-up|0|||
27652267|NCT03345407|80567900|FG004|Overall Study|Lost to Follow-up|1|||
27652268|NCT03345407|80567901|FG005|Overall Study|Lost to Follow-up|2|||
27652269|NCT03345407|80567902|FG006|Overall Study|Lost to Follow-up|3|||
27652270|NCT03345407|80567896|FG000|Overall Study|Protocol-defined stopping criteria|9|||
27652271|NCT03345407|80567897|FG001|Overall Study|Protocol-defined stopping criteria|0|||
27652272|NCT03345407|80567898|FG002|Overall Study|Protocol-defined stopping criteria|0|||
27652273|NCT03345407|80567899|FG003|Overall Study|Protocol-defined stopping criteria|0|||
27652274|NCT03345407|80567900|FG004|Overall Study|Protocol-defined stopping criteria|2|||
27652275|NCT03345407|80567901|FG005|Overall Study|Protocol-defined stopping criteria|1|||
27652276|NCT03345407|80567902|FG006|Overall Study|Protocol-defined stopping criteria|1|||
27652277|NCT03345407|80567896|FG000|Overall Study|Protocol Violation|2|||
27652278|NCT03345407|80567897|FG001|Overall Study|Protocol Violation|0|||
27652279|NCT03345407|80567898|FG002|Overall Study|Protocol Violation|0|||
27652280|NCT03345407|80567899|FG003|Overall Study|Protocol Violation|0|||
27652281|NCT03345407|80567900|FG004|Overall Study|Protocol Violation|1|||
27652282|NCT03345407|80567901|FG005|Overall Study|Protocol Violation|0|||
27652283|NCT03345407|80567902|FG006|Overall Study|Protocol Violation|3|||
27652284|NCT03345407|80567896|FG000|Overall Study|Lack of Efficacy|1|||
27652285|NCT03345407|80567897|FG001|Overall Study|Lack of Efficacy|1|||
27954836|NCT01154452|81668904|FG001|Phase II|Adverse Event|0|||
27652286|NCT03345407|80567898|FG002|Overall Study|Lack of Efficacy|1|||
27652287|NCT03345407|80567899|FG003|Overall Study|Lack of Efficacy|1|||
27652288|NCT03345407|80567900|FG004|Overall Study|Lack of Efficacy|1|||
27751010|NCT00256867|80914072|FG005|Overall Study|Lost to Follow-up|0|||
27751011|NCT00256867|80914073|FG006|Overall Study|Lost to Follow-up|1|||
27751012|NCT00256867|80914074|FG007|Overall Study|Lost to Follow-up|2|||
27751013|NCT00256867|80914067|FG000|Overall Study|Protocol Violation|0|||
27751014|NCT00256867|80914068|FG001|Overall Study|Protocol Violation|0|||
27751015|NCT00256867|80914069|FG002|Overall Study|Protocol Violation|0|||
27751016|NCT00256867|80914070|FG003|Overall Study|Protocol Violation|1|||
27751017|NCT00256867|80914071|FG004|Overall Study|Protocol Violation|0|||
27751018|NCT00256867|80914072|FG005|Overall Study|Protocol Violation|1|||
27751019|NCT00256867|80914073|FG006|Overall Study|Protocol Violation|0|||
27751020|NCT00256867|80914074|FG007|Overall Study|Protocol Violation|1|||
27751021|NCT00256867|80914067|FG000|Overall Study|Withdrawal by Subject|0|||
27751022|NCT00256867|80914068|FG001|Overall Study|Withdrawal by Subject|0|||
27751023|NCT00256867|80914069|FG002|Overall Study|Withdrawal by Subject|1|||
27751024|NCT00256867|80914070|FG003|Overall Study|Withdrawal by Subject|1|||
27751025|NCT00256867|80914071|FG004|Overall Study|Withdrawal by Subject|2|||
27751026|NCT00256867|80914072|FG005|Overall Study|Withdrawal by Subject|2|||
27751027|NCT00256867|80914073|FG006|Overall Study|Withdrawal by Subject|3|||
27751028|NCT00256867|80914074|FG007|Overall Study|Withdrawal by Subject|2|||
27751029|NCT00256867|80914067|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751030|NCT00256867|80914068|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
27751031|NCT00256867|80914069|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751032|NCT00256867|80914070|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751033|NCT00256867|80914071|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751034|NCT00256867|80914072|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751035|NCT00256867|80914073|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751036|NCT00256867|80914074|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
27751037|NCT00256867|80914067|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751038|NCT00256867|80914068|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751039|NCT00256867|80914069|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751040|NCT00256867|80914070|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751041|NCT00256867|80914071|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751042|NCT00256867|80914072|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751043|NCT00256867|80914073|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
27751044|NCT00256867|80914074|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
27751045|NCT00256867|80914067|FG000|Overall Study|Investigator's Decision|0|||
27751046|NCT00256867|80914068|FG001|Overall Study|Investigator's Decision|0|||
27751047|NCT00256867|80914069|FG002|Overall Study|Investigator's Decision|0|||
27751048|NCT00256867|80914070|FG003|Overall Study|Investigator's Decision|0|||
27751049|NCT00256867|80914071|FG004|Overall Study|Investigator's Decision|1|||
27751050|NCT00256867|80914072|FG005|Overall Study|Investigator's Decision|0|||
27751051|NCT00256867|80914073|FG006|Overall Study|Investigator's Decision|0|||
27751052|NCT00256867|80914074|FG007|Overall Study|Investigator's Decision|0|||
27751053|NCT00256867|80914067|FG000|Overall Study|Non-compliance with study medication|0|||
27751054|NCT00256867|80914068|FG001|Overall Study|Non-compliance with study medication|0|||
27751055|NCT00256867|80914069|FG002|Overall Study|Non-compliance with study medication|0|||
27751056|NCT00256867|80914070|FG003|Overall Study|Non-compliance with study medication|0|||
27751057|NCT00256867|80914071|FG004|Overall Study|Non-compliance with study medication|0|||
27751058|NCT00256867|80914072|FG005|Overall Study|Non-compliance with study medication|0|||
27751059|NCT00256867|80914073|FG006|Overall Study|Non-compliance with study medication|0|||
27751060|NCT00256867|80914074|FG007|Overall Study|Non-compliance with study medication|1|||
27751061|NCT00256867|80914067|FG000|Overall Study|Participant travelled Overseas|0|||
27751062|NCT00256867|80914068|FG001|Overall Study|Participant travelled Overseas|1|||
27751063|NCT00256867|80914069|FG002|Overall Study|Participant travelled Overseas|0|||
27751064|NCT00256867|80914070|FG003|Overall Study|Participant travelled Overseas|0|||
27751065|NCT00256867|80914071|FG004|Overall Study|Participant travelled Overseas|0|||
27751066|NCT00256867|80914072|FG005|Overall Study|Participant travelled Overseas|0|||
27751067|NCT00256867|80914073|FG006|Overall Study|Participant travelled Overseas|0|||
27751068|NCT00256867|80914074|FG007|Overall Study|Participant travelled Overseas|0|||
27751069|NCT00256867|80914067|FG000|Overall Study|Participant out of assessment window|0|||
27751070|NCT00256867|80914068|FG001|Overall Study|Participant out of assessment window|0|||
27751071|NCT00256867|80914069|FG002|Overall Study|Participant out of assessment window|1|||
27751072|NCT00256867|80914070|FG003|Overall Study|Participant out of assessment window|0|||
27751073|NCT00256867|80914071|FG004|Overall Study|Participant out of assessment window|0|||
27751074|NCT00256867|80914072|FG005|Overall Study|Participant out of assessment window|0|||
27751075|NCT00256867|80914073|FG006|Overall Study|Participant out of assessment window|0|||
27751076|NCT00256867|80914074|FG007|Overall Study|Participant out of assessment window|0|||
27751077|NCT00256867|80914067|FG000|Overall Study|Withdrawal by participant|0|||
27751078|NCT00256867|80914068|FG001|Overall Study|Withdrawal by participant|0|||
27954837|NCT01154452|81668905|FG002|Phase II|Adverse Event|4|||
27954838|NCT01154452|81668906|FG003|Phase II|Adverse Event|4|||
27652289|NCT03345407|80567901|FG005|Overall Study|Lack of Efficacy|0|||
27751079|NCT00256867|80914069|FG002|Overall Study|Withdrawal by participant|0|||
27751080|NCT00256867|80914070|FG003|Overall Study|Withdrawal by participant|0|||
27751081|NCT00256867|80914071|FG004|Overall Study|Withdrawal by participant|0|||
27751082|NCT00256867|80914072|FG005|Overall Study|Withdrawal by participant|1|||
27751083|NCT00256867|80914073|FG006|Overall Study|Withdrawal by participant|0|||
27751084|NCT00256867|80914074|FG007|Overall Study|Withdrawal by participant|0|||
27751085|NCT00430521|80914077|FG000|Overall Study|Adverse Event|0|||
27751086|NCT00430521|80914078|FG001|Overall Study|Adverse Event|0|||
27751087|NCT00430521|80914079|FG002|Overall Study|Adverse Event|0|||
27751088|NCT00430521|80914080|FG003|Overall Study|Adverse Event|0|||
27751089|NCT00430521|80914081|FG004|Overall Study|Adverse Event|0|||
27751090|NCT00430521|80914082|FG005|Overall Study|Adverse Event|2|||
27751091|NCT00430521|80914083|FG006|Overall Study|Adverse Event|1|||
27751092|NCT00430521|80914084|FG007|Overall Study|Adverse Event|0|||
27751093|NCT00430521|80914077|FG000|Overall Study|Lost to Follow-up|7|||
27751094|NCT00430521|80914078|FG001|Overall Study|Lost to Follow-up|8|||
27751095|NCT00430521|80914079|FG002|Overall Study|Lost to Follow-up|3|||
27751096|NCT00430521|80914080|FG003|Overall Study|Lost to Follow-up|5|||
27751097|NCT00430521|80914081|FG004|Overall Study|Lost to Follow-up|5|||
27751098|NCT00430521|80914082|FG005|Overall Study|Lost to Follow-up|2|||
27751099|NCT00430521|80914083|FG006|Overall Study|Lost to Follow-up|8|||
27751100|NCT00430521|80914084|FG007|Overall Study|Lost to Follow-up|10|||
27751101|NCT00430521|80914077|FG000|Overall Study|Pregnancy|0|||
27751102|NCT00430521|80914078|FG001|Overall Study|Pregnancy|0|||
27751103|NCT00430521|80914079|FG002|Overall Study|Pregnancy|0|||
27751104|NCT00430521|80914080|FG003|Overall Study|Pregnancy|0|||
27751105|NCT00430521|80914081|FG004|Overall Study|Pregnancy|0|||
27751106|NCT00430521|80914082|FG005|Overall Study|Pregnancy|0|||
27751107|NCT00430521|80914083|FG006|Overall Study|Pregnancy|1|||
27751108|NCT00430521|80914084|FG007|Overall Study|Pregnancy|0|||
27751109|NCT00430521|80914077|FG000|Overall Study|Vaccine Expired|0|||
27751110|NCT00430521|80914078|FG001|Overall Study|Vaccine Expired|0|||
27751111|NCT00430521|80914079|FG002|Overall Study|Vaccine Expired|0|||
27751112|NCT00430521|80914080|FG003|Overall Study|Vaccine Expired|0|||
27751113|NCT00430521|80914081|FG004|Overall Study|Vaccine Expired|0|||
27751114|NCT00430521|80914082|FG005|Overall Study|Vaccine Expired|1|||
27751115|NCT00430521|80914083|FG006|Overall Study|Vaccine Expired|0|||
27751116|NCT00430521|80914084|FG007|Overall Study|Vaccine Expired|0|||
27751117|NCT00430521|80914077|FG000|Overall Study|Protocol Violation|1|||
27751118|NCT00430521|80914078|FG001|Overall Study|Protocol Violation|0|||
27751119|NCT00430521|80914079|FG002|Overall Study|Protocol Violation|0|||
27751120|NCT00430521|80914080|FG003|Overall Study|Protocol Violation|0|||
27751121|NCT00430521|80914081|FG004|Overall Study|Protocol Violation|0|||
27751122|NCT00430521|80914082|FG005|Overall Study|Protocol Violation|0|||
27751123|NCT00430521|80914083|FG006|Overall Study|Protocol Violation|0|||
27751124|NCT00430521|80914084|FG007|Overall Study|Protocol Violation|0|||
27751125|NCT00430521|80914077|FG000|Overall Study|Withdrawal by Subject|3|||
27751126|NCT00430521|80914078|FG001|Overall Study|Withdrawal by Subject|1|||
27751127|NCT00430521|80914079|FG002|Overall Study|Withdrawal by Subject|0|||
27751128|NCT00430521|80914080|FG003|Overall Study|Withdrawal by Subject|3|||
27751129|NCT00430521|80914081|FG004|Overall Study|Withdrawal by Subject|0|||
27751130|NCT00430521|80914082|FG005|Overall Study|Withdrawal by Subject|0|||
27751131|NCT00430521|80914083|FG006|Overall Study|Withdrawal by Subject|0|||
27751132|NCT00430521|80914084|FG007|Overall Study|Withdrawal by Subject|2|||
27751133|NCT01876732|80914085|FG000|Overall Study|MMA was not over 800mg/dL|75|||
27751134|NCT02116660|80914086|FG000|Overall Study|Deteriorating renal function|0|||
27751135|NCT02116660|80914087|FG001|Overall Study|Deteriorating renal function|1|||
27751136|NCT02116660|80914086|FG000|Overall Study|Adverse Event|1|||
27751137|NCT02116660|80914087|FG001|Overall Study|Adverse Event|1|||
27751138|NCT02116660|80914086|FG000|Overall Study|Withdrawal by Subject|0|||
27751139|NCT02116660|80914087|FG001|Overall Study|Withdrawal by Subject|2|||
27751140|NCT02116660|80914086|FG000|Overall Study|Organization reason|1|||
27751141|NCT02116660|80914087|FG001|Overall Study|Organization reason|0|||
27751142|NCT00632463|80914090|FG000|Overall Study|Adverse Event|0|||
27751143|NCT00632463|80914091|FG001|Overall Study|Adverse Event|1|||
27751144|NCT00632463|80914092|FG002|Overall Study|Adverse Event|0|||
27751145|NCT01258348|80914093|FG000|Overall Study|Adverse Event|1|||
27751146|NCT01258348|80914094|FG001|Overall Study|Adverse Event|1|||
27751147|NCT01258348|80914095|FG002|Overall Study|Adverse Event|3|||
27751148|NCT01258348|80914096|FG003|Overall Study|Adverse Event|2|||
27652290|NCT03345407|80567902|FG006|Overall Study|Lack of Efficacy|3|||
27751149|NCT01258348|80914097|FG004|Overall Study|Adverse Event|4|||
27751150|NCT01258348|80914093|FG000|Overall Study|Progressive Disease|0|||
27751151|NCT01258348|80914094|FG001|Overall Study|Progressive Disease|3|||
27751152|NCT01258348|80914095|FG002|Overall Study|Progressive Disease|0|||
27751153|NCT01258348|80914096|FG003|Overall Study|Progressive Disease|2|||
27751154|NCT01258348|80914097|FG004|Overall Study|Progressive Disease|2|||
27751155|NCT01258348|80914093|FG000|Overall Study|Physician Decision|0|||
27751156|NCT01258348|80914094|FG001|Overall Study|Physician Decision|0|||
27751157|NCT01258348|80914095|FG002|Overall Study|Physician Decision|0|||
27751158|NCT01258348|80914096|FG003|Overall Study|Physician Decision|2|||
27751159|NCT01258348|80914097|FG004|Overall Study|Physician Decision|0|||
27751160|NCT01258348|80914093|FG000|Overall Study|Withdrawal by Subject|0|||
27751161|NCT01258348|80914094|FG001|Overall Study|Withdrawal by Subject|1|||
27751162|NCT01258348|80914095|FG002|Overall Study|Withdrawal by Subject|0|||
27751163|NCT01258348|80914096|FG003|Overall Study|Withdrawal by Subject|0|||
27751164|NCT01258348|80914097|FG004|Overall Study|Withdrawal by Subject|0|||
27751165|NCT02108951|80914098|FG000|Overall Study|Lost to Follow-up|1|||
27751166|NCT02108951|80914098|FG000|Overall Study|Patient's/guardian's decision|1|||
27751167|NCT02108951|80914098|FG000|Overall Study|Study Terminated by Sponsor|14|||
27751168|NCT00089843|80914099|FG000|Overall Study|Withdrawal by Subject|1|||
27751169|NCT00089843|80914100|FG001|Overall Study|Withdrawal by Subject|4|||
27751170|NCT00089843|80914101|FG002|Overall Study|Withdrawal by Subject|5|||
27751171|NCT00089843|80914102|FG003|Overall Study|Withdrawal by Subject|6|||
27751172|NCT00089843|80914099|FG000|Overall Study|Physician Decision|1|||
27751173|NCT00089843|80914100|FG001|Overall Study|Physician Decision|0|||
27751174|NCT00089843|80914101|FG002|Overall Study|Physician Decision|0|||
27751175|NCT00089843|80914102|FG003|Overall Study|Physician Decision|1|||
27751176|NCT01599754|80914103|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
27751177|NCT01599754|80914104|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
27751178|NCT01599754|80914103|FG000|Overall Study|Participant noncompliance|4|||
27751179|NCT01599754|80914104|FG001|Overall Study|Participant noncompliance|4|||
27751180|NCT01599754|80914103|FG000|Overall Study|Lost to Follow-up|13|||
27751181|NCT01599754|80914104|FG001|Overall Study|Lost to Follow-up|6|||
27751182|NCT01599754|80914103|FG000|Overall Study|Death|31|||
27751183|NCT01599754|80914104|FG001|Overall Study|Death|33|||
27751184|NCT01599754|80914103|FG000|Overall Study|Adverse Event|3|||
27751185|NCT01599754|80914104|FG001|Overall Study|Adverse Event|2|||
27751186|NCT01599754|80914103|FG000|Overall Study|Investigator decision|1|||
27751187|NCT01599754|80914104|FG001|Overall Study|Investigator decision|3|||
27751188|NCT01599754|80914103|FG000|Overall Study|Withdrawal by Subject|24|||
27751189|NCT01599754|80914104|FG001|Overall Study|Withdrawal by Subject|25|||
27751190|NCT01599754|80914103|FG000|Overall Study|Study terminated by sponsor|282|||
27751191|NCT01599754|80914104|FG001|Overall Study|Study terminated by sponsor|285|||
27751192|NCT03650452|80914105|FG000|Overall Study|Physician Decision|1|||
27751193|NCT03650452|80914106|FG001|Overall Study|Physician Decision|0|||
27751194|NCT03650452|80914105|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
27751195|NCT03650452|80914106|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
27751196|NCT03650452|80914105|FG000|Overall Study|Adverse Event|3|||
27751197|NCT03650452|80914106|FG001|Overall Study|Adverse Event|4|||
27751198|NCT03650452|80914105|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
27751199|NCT03650452|80914106|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
27751200|NCT00316303|80914110|FG000|Overall Study|Lost to Follow-up|11|||
27751201|NCT00316303|80914111|FG001|Overall Study|Lost to Follow-up|16|||
27751202|NCT02632110|80914112|FG000|Overall Study|Withdrawal by Subject|1|||
27751203|NCT02632110|80914113|FG001|Overall Study|Withdrawal by Subject|1|||
27751204|NCT02632110|80914114|FG002|Overall Study|Withdrawal by Subject|0|||
27751205|NCT02632110|80914115|FG003|Overall Study|Withdrawal by Subject|0|||
27751206|NCT02632110|80914116|FG004|Overall Study|Withdrawal by Subject|1|||
27751207|NCT02632110|80914117|FG005|Overall Study|Withdrawal by Subject|1|||
27751208|NCT02632110|80914118|FG006|Overall Study|Withdrawal by Subject|3|||
27751209|NCT02632110|80914119|FG007|Overall Study|Withdrawal by Subject|3|||
27751210|NCT02632110|80914120|FG008|Overall Study|Withdrawal by Subject|1|||
27751211|NCT02632110|80914121|FG009|Overall Study|Withdrawal by Subject|1|||
27751212|NCT02596711|80914122|FG000|Overall Study|Lost to Follow-up|1|||
27751213|NCT02596711|80914123|FG001|Overall Study|Lost to Follow-up|2|||
27751214|NCT02596711|80914124|FG002|Overall Study|Lost to Follow-up|3|||
27751215|NCT04045613|80914125|FG000|Overall Study|Adverse Event|2|||
27751216|NCT04045613|80914126|FG001|Overall Study|Adverse Event|2|||
27751217|NCT04045613|80914127|FG002|Overall Study|Adverse Event|1|||
27751218|NCT04045613|80914128|FG003|Overall Study|Adverse Event|1|||
27751219|NCT04045613|80914129|FG004|Overall Study|Adverse Event|0|||
27751220|NCT04045613|80914130|FG005|Overall Study|Adverse Event|0|||
27751221|NCT04045613|80914131|FG006|Overall Study|Adverse Event|1|||
27751222|NCT04045613|80914125|FG000|Overall Study|Withdrawal by Subject|0|||
27751223|NCT04045613|80914126|FG001|Overall Study|Withdrawal by Subject|5|||
27751224|NCT04045613|80914127|FG002|Overall Study|Withdrawal by Subject|0|||
27751225|NCT04045613|80914128|FG003|Overall Study|Withdrawal by Subject|0|||
27751226|NCT04045613|80914129|FG004|Overall Study|Withdrawal by Subject|0|||
27751227|NCT04045613|80914130|FG005|Overall Study|Withdrawal by Subject|1|||
27751228|NCT04045613|80914131|FG006|Overall Study|Withdrawal by Subject|0|||
27751229|NCT04045613|80914125|FG000|Overall Study|Physician Decision|2|||
27751230|NCT04045613|80914126|FG001|Overall Study|Physician Decision|0|||
27751231|NCT04045613|80914127|FG002|Overall Study|Physician Decision|0|||
27751232|NCT04045613|80914128|FG003|Overall Study|Physician Decision|0|||
27751233|NCT04045613|80914129|FG004|Overall Study|Physician Decision|1|||
27751234|NCT04045613|80914130|FG005|Overall Study|Physician Decision|0|||
27751235|NCT04045613|80914131|FG006|Overall Study|Physician Decision|0|||
27751236|NCT04045613|80914125|FG000|Overall Study|Death|3|||
27751237|NCT04045613|80914126|FG001|Overall Study|Death|0|||
27751238|NCT04045613|80914127|FG002|Overall Study|Death|0|||
27751239|NCT04045613|80914128|FG003|Overall Study|Death|0|||
27751240|NCT04045613|80914129|FG004|Overall Study|Death|0|||
27751241|NCT04045613|80914130|FG005|Overall Study|Death|0|||
27751242|NCT04045613|80914131|FG006|Overall Study|Death|1|||
27751243|NCT04045613|80914125|FG000|Overall Study|Other reasons|0|||
27751244|NCT04045613|80914126|FG001|Overall Study|Other reasons|1|||
27751245|NCT04045613|80914127|FG002|Overall Study|Other reasons|0|||
27751246|NCT04045613|80914128|FG003|Overall Study|Other reasons|0|||
27751247|NCT04045613|80914129|FG004|Overall Study|Other reasons|0|||
27751248|NCT04045613|80914130|FG005|Overall Study|Other reasons|0|||
27751249|NCT04045613|80914131|FG006|Overall Study|Other reasons|1|||
27751250|NCT04045613|80914125|FG000|Overall Study|Progressive disease: Clinical progression|1|||
27751251|NCT04045613|80914126|FG001|Overall Study|Progressive disease: Clinical progression|0|||
27751252|NCT04045613|80914127|FG002|Overall Study|Progressive disease: Clinical progression|3|||
27751253|NCT04045613|80914128|FG003|Overall Study|Progressive disease: Clinical progression|1|||
27751254|NCT04045613|80914129|FG004|Overall Study|Progressive disease: Clinical progression|1|||
27751255|NCT04045613|80914130|FG005|Overall Study|Progressive disease: Clinical progression|3|||
27751256|NCT04045613|80914131|FG006|Overall Study|Progressive disease: Clinical progression|3|||
27751257|NCT04045613|80914125|FG000|Overall Study|Progressive disease: Radiological progression|24|||
27751258|NCT04045613|80914126|FG001|Overall Study|Progressive disease: Radiological progression|6|||
27751259|NCT04045613|80914127|FG002|Overall Study|Progressive disease: Radiological progression|8|||
27751260|NCT04045613|80914128|FG003|Overall Study|Progressive disease: Radiological progression|0|||
27751261|NCT04045613|80914129|FG004|Overall Study|Progressive disease: Radiological progression|6|||
27751262|NCT04045613|80914130|FG005|Overall Study|Progressive disease: Radiological progression|6|||
27751263|NCT04045613|80914131|FG006|Overall Study|Progressive disease: Radiological progression|11|||
27751264|NCT00968253|80914133|FG000|Overall Study|Death|0|||
27751265|NCT00968253|80914134|FG001|Overall Study|Death|0|||
27751266|NCT00968253|80914135|FG002|Overall Study|Death|2|||
27751267|NCT00968253|80914133|FG000|Overall Study|Withdrawal by Subject|0|||
27751268|NCT00968253|80914134|FG001|Overall Study|Withdrawal by Subject|0|||
27751269|NCT00968253|80914135|FG002|Overall Study|Withdrawal by Subject|1|||
27751270|NCT00968253|80914133|FG000|Overall Study|Disease Progression|0|||
27751271|NCT00968253|80914134|FG001|Overall Study|Disease Progression|3|||
27751272|NCT00968253|80914135|FG002|Overall Study|Disease Progression|3|||
27751273|NCT00968253|80914133|FG000|Overall Study|Adverse Event|0|||
27751274|NCT00968253|80914134|FG001|Overall Study|Adverse Event|0|||
27751275|NCT00968253|80914135|FG002|Overall Study|Adverse Event|1|||
27751276|NCT01379534|80914136|FG000|Treatment Phase|Withdrawal by Subject|2|||
27751277|NCT01379534|80914137|FG001|Treatment Phase|Withdrawal by Subject|2|||
27751278|NCT01379534|80914136|FG000|Treatment Phase|Progressive disease|13|||
27751279|NCT01379534|80914137|FG001|Treatment Phase|Progressive disease|22|||
27751280|NCT01379534|80914136|FG000|Treatment Phase|Adverse Event|7|||
27751281|NCT01379534|80914137|FG001|Treatment Phase|Adverse Event|7|||
27751282|NCT01379534|80914136|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
27751283|NCT01379534|80914137|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
27751284|NCT01379534|80914136|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
27751285|NCT01379534|80914137|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
27751286|NCT01379534|80914136|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
27751287|NCT01379534|80914137|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
27751288|NCT01379534|80914136|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
27751289|NCT01379534|80914137|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
27751290|NCT02164513|80914138|FG000|Overall Study|Adverse Event|162|||
27751291|NCT02164513|80914139|FG001|Overall Study|Adverse Event|180|||
27751292|NCT02164513|80914140|FG002|Overall Study|Adverse Event|111|||
27751293|NCT02164513|80914138|FG000|Overall Study|Other: Study Closed or terminated|5|||
27751294|NCT02164513|80914139|FG001|Overall Study|Other: Study Closed or terminated|2|||
27751295|NCT02164513|80914140|FG002|Overall Study|Other: Study Closed or terminated|4|||
27751296|NCT02164513|80914138|FG000|Overall Study|Lost to Follow-up|30|||
27751297|NCT02164513|80914139|FG001|Overall Study|Lost to Follow-up|36|||
27751298|NCT02164513|80914140|FG002|Overall Study|Lost to Follow-up|22|||
27751299|NCT02164513|80914138|FG000|Overall Study|Physician Decision|47|||
27751300|NCT02164513|80914139|FG001|Overall Study|Physician Decision|57|||
27751301|NCT02164513|80914140|FG002|Overall Study|Physician Decision|28|||
27751302|NCT02164513|80914138|FG000|Overall Study|Withdrawal by Subject|192|||
27751303|NCT02164513|80914139|FG001|Overall Study|Withdrawal by Subject|261|||
27751304|NCT02164513|80914140|FG002|Overall Study|Withdrawal by Subject|130|||
27751305|NCT02164513|80914138|FG000|Overall Study|Other: Reason not provided by site|1|||
27751306|NCT02164513|80914139|FG001|Overall Study|Other: Reason not provided by site|0|||
27751307|NCT02164513|80914140|FG002|Overall Study|Other: Reason not provided by site|0|||
27751308|NCT02145156|80914141|FG000|Overall Study|No match to vaccination records|60|||
27751309|NCT02145156|80914142|FG001|Overall Study|No match to vaccination records|52|||
27751310|NCT02145156|80914143|FG002|Overall Study|No match to vaccination records|41|||
27751311|NCT01515306|80914146|FG000|Overall Study|Adverse Event|3|||
27751312|NCT01515306|80914147|FG001|Overall Study|Adverse Event|2|||
27751313|NCT01515306|80914146|FG000|Overall Study|Progressive Disease|19|||
27751314|NCT01515306|80914147|FG001|Overall Study|Progressive Disease|9|||
27751315|NCT01515306|80914146|FG000|Overall Study|Withdrawal by Subject|1|||
27751316|NCT01515306|80914147|FG001|Overall Study|Withdrawal by Subject|2|||
27751317|NCT01515306|80914146|FG000|Overall Study|Physician Decision|1|||
27751318|NCT01515306|80914147|FG001|Overall Study|Physician Decision|1|||
27751319|NCT03136185|80914151|FG000|Overall Study|Adverse Event|0|||
27751320|NCT03136185|80914152|FG001|Overall Study|Adverse Event|1|||
27751321|NCT03136185|80914153|FG002|Overall Study|Adverse Event|3|||
27751322|NCT03136185|80914154|FG003|Overall Study|Adverse Event|1|||
27751323|NCT03136185|80914155|FG004|Overall Study|Adverse Event|2|||
27751324|NCT03136185|80914156|FG005|Overall Study|Adverse Event|2|||
27751325|NCT03136185|80914157|FG006|Overall Study|Adverse Event|5|||
27751326|NCT03136185|80914158|FG007|Overall Study|Adverse Event|1|||
27751327|NCT03136185|80914159|FG008|Overall Study|Adverse Event|1|||
27751328|NCT03136185|80914151|FG000|Overall Study|Death|0|||
27751329|NCT03136185|80914152|FG001|Overall Study|Death|0|||
27751330|NCT03136185|80914153|FG002|Overall Study|Death|0|||
27751331|NCT03136185|80914154|FG003|Overall Study|Death|1|||
27751332|NCT03136185|80914155|FG004|Overall Study|Death|1|||
27751333|NCT03136185|80914156|FG005|Overall Study|Death|0|||
27751334|NCT03136185|80914157|FG006|Overall Study|Death|1|||
27751335|NCT03136185|80914158|FG007|Overall Study|Death|0|||
27751336|NCT03136185|80914159|FG008|Overall Study|Death|0|||
27751337|NCT03136185|80914151|FG000|Overall Study|Physician Decision|3|||
27751338|NCT03136185|80914152|FG001|Overall Study|Physician Decision|1|||
27751339|NCT03136185|80914153|FG002|Overall Study|Physician Decision|1|||
27751340|NCT03136185|80914154|FG003|Overall Study|Physician Decision|2|||
27751341|NCT03136185|80914155|FG004|Overall Study|Physician Decision|1|||
27751342|NCT03136185|80914156|FG005|Overall Study|Physician Decision|2|||
27751343|NCT03136185|80914157|FG006|Overall Study|Physician Decision|1|||
27751344|NCT03136185|80914158|FG007|Overall Study|Physician Decision|0|||
27751345|NCT03136185|80914159|FG008|Overall Study|Physician Decision|1|||
27751346|NCT03136185|80914151|FG000|Overall Study|Protocol Defined Disease Progression|0|||
27751347|NCT03136185|80914152|FG001|Overall Study|Protocol Defined Disease Progression|0|||
27751348|NCT03136185|80914153|FG002|Overall Study|Protocol Defined Disease Progression|1|||
27751349|NCT03136185|80914154|FG003|Overall Study|Protocol Defined Disease Progression|0|||
27751350|NCT03136185|80914155|FG004|Overall Study|Protocol Defined Disease Progression|0|||
27751351|NCT03136185|80914156|FG005|Overall Study|Protocol Defined Disease Progression|1|||
27751352|NCT03136185|80914157|FG006|Overall Study|Protocol Defined Disease Progression|0|||
27751353|NCT03136185|80914158|FG007|Overall Study|Protocol Defined Disease Progression|1|||
27751354|NCT03136185|80914159|FG008|Overall Study|Protocol Defined Disease Progression|1|||
27751355|NCT03136185|80914151|FG000|Overall Study|Withdrawal by Subject|1|||
27751356|NCT03136185|80914152|FG001|Overall Study|Withdrawal by Subject|0|||
27751357|NCT03136185|80914153|FG002|Overall Study|Withdrawal by Subject|1|||
27751358|NCT03136185|80914154|FG003|Overall Study|Withdrawal by Subject|1|||
27751359|NCT03136185|80914155|FG004|Overall Study|Withdrawal by Subject|1|||
27751360|NCT03136185|80914156|FG005|Overall Study|Withdrawal by Subject|1|||
27751361|NCT03136185|80914157|FG006|Overall Study|Withdrawal by Subject|2|||
27751362|NCT03136185|80914158|FG007|Overall Study|Withdrawal by Subject|3|||
27751363|NCT03136185|80914159|FG008|Overall Study|Withdrawal by Subject|3|||
27751364|NCT03136185|80914151|FG000|Overall Study|Not Reported|4|||
27751365|NCT03136185|80914152|FG001|Overall Study|Not Reported|1|||
27751366|NCT03136185|80914153|FG002|Overall Study|Not Reported|0|||
27751367|NCT03136185|80914154|FG003|Overall Study|Not Reported|1|||
27751368|NCT03136185|80914155|FG004|Overall Study|Not Reported|0|||
27751369|NCT03136185|80914156|FG005|Overall Study|Not Reported|2|||
27751370|NCT03136185|80914157|FG006|Overall Study|Not Reported|1|||
27751371|NCT03136185|80914158|FG007|Overall Study|Not Reported|1|||
27751372|NCT03136185|80914159|FG008|Overall Study|Not Reported|0|||
27751373|NCT02488551|80914160|FG000|Overall Study|Lost to Follow-up|4|||
27751374|NCT02488551|80914161|FG001|Overall Study|Lost to Follow-up|7|||
27751375|NCT02488551|80914162|FG002|Overall Study|Lost to Follow-up|0|||
27954839|NCT02122380|81668907|FG000|First Intervention (30 Days)|Adverse Event|1|||
27954840|NCT02122380|81668908|FG001|First Intervention (30 Days)|Adverse Event|0|||
27751376|NCT02488551|80914163|FG003|Overall Study|Lost to Follow-up|0|||
27954841|NCT02122380|81668907|FG000|First Intervention (30 Days)|Physician Decision|0|||
27954842|NCT02122380|81668908|FG001|First Intervention (30 Days)|Physician Decision|1|||
27751377|NCT02488551|80914160|FG000|Overall Study|Military Deployment|1|||
27751378|NCT02488551|80914161|FG001|Overall Study|Military Deployment|1|||
27954843|NCT02122380|81668907|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
27954844|NCT02122380|81668908|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
27751379|NCT02488551|80914162|FG002|Overall Study|Military Deployment|0|||
27751380|NCT02488551|80914163|FG003|Overall Study|Military Deployment|0|||
27751381|NCT01345123|80914164|FG000|Overall Study|participants no longer with health plan|79|||
27751382|NCT01345123|80914165|FG001|Overall Study|participants no longer with health plan|85|||
27751383|NCT01345123|80914166|FG002|Overall Study|participants no longer with health plan|88|||
27652291|NCT03345407|80567896|FG000|Overall Study|Adverse Event|4|||
27652292|NCT03345407|80567897|FG001|Overall Study|Adverse Event|0|||
27652293|NCT03345407|80567898|FG002|Overall Study|Adverse Event|5|||
27652294|NCT03345407|80567899|FG003|Overall Study|Adverse Event|4|||
27652295|NCT03345407|80567900|FG004|Overall Study|Adverse Event|6|||
27652296|NCT03345407|80567901|FG005|Overall Study|Adverse Event|5|||
27652297|NCT03345407|80567902|FG006|Overall Study|Adverse Event|16|||
27652298|NCT02279732|80567903|FG000|Overall Study|Death|23|||
27652299|NCT02279732|80567904|FG001|Overall Study|Death|20|||
27652300|NCT02279732|80567903|FG000|Overall Study|Disease Progression|13|||
27652301|NCT02279732|80567904|FG001|Overall Study|Disease Progression|3|||
27652302|NCT02279732|80567903|FG000|Overall Study|Withdrawal by Subject|2|||
27652303|NCT02279732|80567904|FG001|Overall Study|Withdrawal by Subject|7|||
27652304|NCT02279732|80567903|FG000|Overall Study|Adverse Event|1|||
27652305|NCT02279732|80567904|FG001|Overall Study|Adverse Event|2|||
27652306|NCT02279732|80567903|FG000|Overall Study|Administrative Reason By Sponsor|0|||
27652307|NCT02279732|80567904|FG001|Overall Study|Administrative Reason By Sponsor|2|||
27652308|NCT02279732|80567903|FG000|Overall Study|Study Drug Toxicity|2|||
27652309|NCT02279732|80567904|FG001|Overall Study|Study Drug Toxicity|0|||
27652310|NCT02279732|80567903|FG000|Overall Study|Lost to Follow-up|0|||
27652311|NCT02279732|80567904|FG001|Overall Study|Lost to Follow-up|1|||
27652312|NCT02279732|80567903|FG000|Overall Study|Maximum Clinical Benefit|1|||
27652313|NCT02279732|80567904|FG001|Overall Study|Maximum Clinical Benefit|0|||
27652314|NCT02279732|80567903|FG000|Overall Study|Subject Requested to Discontinue|0|||
27652315|NCT02279732|80567904|FG001|Overall Study|Subject Requested to Discontinue|1|||
27652316|NCT02279732|80567903|FG000|Overall Study|Other|53|||
27652317|NCT02279732|80567904|FG001|Overall Study|Other|67|||
27652318|NCT02279732|80567903|FG000|Overall Study|Other|3|||
27652319|NCT02279732|80567904|FG001|Overall Study|Other|3|||
27652320|NCT01760876|80567905|FG000|Overall Study|Non-cardiac death (head injury)|1|||
27652321|NCT01760876|80567905|FG000|Overall Study|Carcinoma of prostate|1|||
27652322|NCT01760876|80567905|FG000|Overall Study|Impaired renal function|1|||
27652323|NCT01760876|80567905|FG000|Overall Study|Major depression|1|||
27652324|NCT01760876|80567905|FG000|Overall Study|Very poor baseline OCT quality|2|||
27652325|NCT02574286|80567906|FG000|Overall Study|Adverse Event|3|||
27652326|NCT02574286|80567906|FG000|Overall Study|Withdrawal by Subject|2|||
27652327|NCT04938453|80567912|FG000|Washout Period 1|Adverse Event|1|||
27652328|NCT04938453|80567913|FG001|Washout Period 1|Adverse Event|0|||
27652329|NCT04938453|80567912|FG000|Washout Period 1|Physician Decision|0|||
27652330|NCT04938453|80567913|FG001|Washout Period 1|Physician Decision|1|||
27652331|NCT00448344|80567914|FG000|Overall Study|Lost to Follow-up|20|||
27652332|NCT00448344|80567915|FG001|Overall Study|Lost to Follow-up|22|||
27652333|NCT00448344|80567914|FG000|Overall Study|Withdrawal by Subject|6|||
27652334|NCT00448344|80567915|FG001|Overall Study|Withdrawal by Subject|8|||
27652335|NCT00448344|80567914|FG000|Overall Study|Death|3|||
27652336|NCT00448344|80567915|FG001|Overall Study|Death|4|||
27652337|NCT00448344|80567914|FG000|Overall Study|Physician Decision|1|||
27652338|NCT00448344|80567915|FG001|Overall Study|Physician Decision|2|||
27652339|NCT00704340|80567916|FG000|Overall Study|Lost to Follow-up|2|||
27652340|NCT00704340|80567917|FG001|Overall Study|Lost to Follow-up|1|||
27652341|NCT00704340|80567916|FG000|Overall Study|Death|0|||
27652342|NCT00704340|80567917|FG001|Overall Study|Death|1|||
27652343|NCT00551421|80567918|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
27652344|NCT00754325|80567919|FG000|Initial Treatment|Continuing Active Treatment|4|||
27652345|NCT00754325|80567920|FG001|Initial Treatment|Continuing Active Treatment|5|||
27652346|NCT00754325|80567919|FG000|Initial Treatment|Adverse Event|7|||
27652347|NCT00754325|80567920|FG001|Initial Treatment|Adverse Event|6|||
27652348|NCT00754325|80567919|FG000|Initial Treatment|Withdrawal by Subject|2|||
27652349|NCT00754325|80567920|FG001|Initial Treatment|Withdrawal by Subject|2|||
27652350|NCT00754325|80567919|FG000|Initial Treatment|Physician Decision|2|||
27652351|NCT00754325|80567920|FG001|Initial Treatment|Physician Decision|0|||
27652352|NCT00754325|80567919|FG000|Initial Treatment|Sponsor Request|0|||
27652353|NCT00754325|80567920|FG001|Initial Treatment|Sponsor Request|1|||
27652354|NCT00754325|80567919|FG000|Initial Treatment|Disease Progression|35|||
27652355|NCT00754325|80567920|FG001|Initial Treatment|Disease Progression|35|||
27652356|NCT00659373|80567925|FG000|Overall Study|Withdrawal by Subject|3|||
27652357|NCT00659373|80567926|FG001|Overall Study|Withdrawal by Subject|5|||
27652358|NCT00659373|80567925|FG000|Overall Study|Assessment Missed|2|||
27652359|NCT00659373|80567926|FG001|Overall Study|Assessment Missed|2|||
27652360|NCT02771366|80567931|FG000|Period 1|Withdrawal by Subject|0|||
27652361|NCT02771366|80567932|FG001|Period 1|Withdrawal by Subject|2|||
27652362|NCT02771366|80567931|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
27751384|NCT01425190|80914178|FG000|Overall Study|Full dose not consumed.|1|||
27751385|NCT01425190|80914179|FG001|Overall Study|Full dose not consumed.|0|||
27751386|NCT01425190|80914180|FG002|Overall Study|Full dose not consumed.|0|||
27751387|NCT01675531|80914181|FG000|Overall Study|Adverse Event|9|||
27751388|NCT01675531|80914181|FG000|Overall Study|Withdrawal by Subject|7|||
27751389|NCT01675531|80914181|FG000|Overall Study|Lack of Efficacy|1|||
27751390|NCT01675531|80914181|FG000|Overall Study|Protocol Violation|8|||
27751391|NCT00488618|80914184|FG000|Overall Study|Adverse Event|13|||
27751392|NCT00488618|80914185|FG001|Overall Study|Adverse Event|17|||
27751393|NCT00488618|80914184|FG000|Overall Study|Insufficient Therapeutic Response|18|||
27751394|NCT00488618|80914185|FG001|Overall Study|Insufficient Therapeutic Response|11|||
27751395|NCT00488618|80914184|FG000|Overall Study|Protocol Violation|0|||
27751396|NCT00488618|80914185|FG001|Overall Study|Protocol Violation|2|||
27751397|NCT00488618|80914184|FG000|Overall Study|Withdrawal of Consent|15|||
27751398|NCT00488618|80914185|FG001|Overall Study|Withdrawal of Consent|13|||
27751399|NCT00488618|80914184|FG000|Overall Study|Lost to Follow-up|1|||
27751400|NCT00488618|80914185|FG001|Overall Study|Lost to Follow-up|0|||
27751401|NCT03276936|80914186|FG000|Overall Study|Adverse Event|4|||
27751402|NCT03276936|80914187|FG001|Overall Study|Adverse Event|2|||
27751403|NCT03276936|80914186|FG000|Overall Study|Lost to Follow-up|16|||
27751404|NCT03276936|80914187|FG001|Overall Study|Lost to Follow-up|13|||
27751405|NCT03276936|80914186|FG000|Overall Study|Withdrawal by Subject|30|||
27751406|NCT03276936|80914187|FG001|Overall Study|Withdrawal by Subject|20|||
27751407|NCT03276936|80914186|FG000|Overall Study|Not mentioned|6|||
27751408|NCT03276936|80914187|FG001|Overall Study|Not mentioned|3|||
27751409|NCT01028651|80914192|FG000|Overall Study|Death|2|||
27751410|NCT01028651|80914192|FG000|Overall Study|Adverse Event|1|||
27751411|NCT01921257|80914193|FG000|Overall Study|Adverse Event|1|||
27751412|NCT01921257|80914193|FG000|Overall Study|Protocol Violation|1|||
27751413|NCT01921257|80914193|FG000|Overall Study|Withdrawal by Subject|1|||
27751414|NCT05460871|80914194|FG000|Overall Study|Withdrawal by Subject|1|||
27751415|NCT05460871|80914195|FG001|Overall Study|Withdrawal by Subject|2|||
27751416|NCT00634244|80914196|FG000|Overall Study|Never started treatment|0|||
27751417|NCT00634244|80914197|FG001|Overall Study|Never started treatment|1|||
27751418|NCT00634244|80914198|FG002|Overall Study|Never started treatment|0|||
27751419|NCT00634244|80914196|FG000|Overall Study|Death|1|||
27751420|NCT00634244|80914197|FG001|Overall Study|Death|6|||
27751421|NCT00634244|80914198|FG002|Overall Study|Death|0|||
27751422|NCT00634244|80914196|FG000|Overall Study|Adverse Event|0|||
27751423|NCT00634244|80914197|FG001|Overall Study|Adverse Event|2|||
27751424|NCT00634244|80914198|FG002|Overall Study|Adverse Event|0|||
27751425|NCT00634244|80914196|FG000|Overall Study|Withdrawal by Subject|0|||
27652363|NCT02771366|80567932|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
27652364|NCT00508144|80567933|FG000|Overall Study|Not eligible|6|||
27652365|NCT00508144|80567933|FG000|Overall Study|Death|5|||
27652366|NCT03615404|80567936|FG000|Overall Study|Death|1|||
27652367|NCT03615404|80567936|FG000|Overall Study|vaccine did not pass quality assurance|1|||
27652374|NCT00195819|80567939|FG000|Double-Blind|Withdrawal by Subject|1|||
27652375|NCT00195819|80567940|FG001|Double-Blind|Withdrawal by Subject|0|||
27652376|NCT00195819|80567939|FG000|Double-Blind|Moved|1|||
27652377|NCT00195819|80567940|FG001|Double-Blind|Moved|0|||
27652378|NCT00195819|80567939|FG000|Open-label|Adverse Event|0|||
27652379|NCT00195819|80567940|FG001|Open-label|Adverse Event|9|||
27652380|NCT00195819|80567939|FG000|Open-label|Lack of Efficacy|0|||
27652381|NCT00195819|80567940|FG001|Open-label|Lack of Efficacy|2|||
27652382|NCT00195819|80567939|FG000|Open-label|Pregnancy|0|||
27652383|NCT00195819|80567940|FG001|Open-label|Pregnancy|1|||
27751426|NCT00634244|80914197|FG001|Overall Study|Withdrawal by Subject|1|||
27751427|NCT00634244|80914198|FG002|Overall Study|Withdrawal by Subject|0|||
27751428|NCT00634244|80914196|FG000|Overall Study|Physician Decision|0|||
27751429|NCT00634244|80914197|FG001|Overall Study|Physician Decision|1|||
27751430|NCT00634244|80914198|FG002|Overall Study|Physician Decision|0|||
27751431|NCT00634244|80914196|FG000|Overall Study|Disease progression/relapse|0|||
27751432|NCT00634244|80914197|FG001|Overall Study|Disease progression/relapse|1|||
27751433|NCT00634244|80914198|FG002|Overall Study|Disease progression/relapse|0|||
27751434|NCT00634244|80914196|FG000|Overall Study|Other complicating disease|0|||
27652384|NCT00195819|80567939|FG000|Open-label|Protocol Violation|0|||
27652385|NCT00195819|80567940|FG001|Open-label|Protocol Violation|2|||
27751435|NCT00634244|80914197|FG001|Overall Study|Other complicating disease|1|||
27751436|NCT00634244|80914198|FG002|Overall Study|Other complicating disease|0|||
27751437|NCT01426425|80914199|FG000|Overall Study|Exited prior to EP study|22|||
27751438|NCT01426425|80914199|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
27652386|NCT00195819|80567939|FG000|Open-label|Moved|0|||
27652387|NCT00195819|80567940|FG001|Open-label|Moved|1|||
27652388|NCT00195819|80567939|FG000|Open-label|Withdrawal by Subject|0|||
27652389|NCT00195819|80567940|FG001|Open-label|Withdrawal by Subject|5|||
27652390|NCT02365597|80567943|FG000|Overall Study|Lost to Follow-up|0|||
27652391|NCT02365597|80567944|FG001|Overall Study|Lost to Follow-up|1|||
27652392|NCT02365597|80567945|FG002|Overall Study|Lost to Follow-up|0|||
27652393|NCT02365597|80567946|FG003|Overall Study|Lost to Follow-up|1|||
27652394|NCT02365597|80567943|FG000|Overall Study|Withdrawal by Subject|1|||
27652395|NCT02365597|80567944|FG001|Overall Study|Withdrawal by Subject|8|||
27652396|NCT02365597|80567945|FG002|Overall Study|Withdrawal by Subject|5|||
27652397|NCT02365597|80567946|FG003|Overall Study|Withdrawal by Subject|1|||
27652398|NCT02365597|80567943|FG000|Overall Study|Sponsor's decision|1|||
27652399|NCT02365597|80567944|FG001|Overall Study|Sponsor's decision|3|||
27652400|NCT02365597|80567945|FG002|Overall Study|Sponsor's decision|13|||
27652401|NCT02365597|80567946|FG003|Overall Study|Sponsor's decision|0|||
27652402|NCT02365597|80567943|FG000|Overall Study|Other|0|||
27652403|NCT02365597|80567944|FG001|Overall Study|Other|4|||
27652404|NCT02365597|80567945|FG002|Overall Study|Other|0|||
27652405|NCT02365597|80567946|FG003|Overall Study|Other|0|||
27652406|NCT02365597|80567943|FG000|Overall Study|Enrolled but not treated|0|||
27652407|NCT02365597|80567944|FG001|Overall Study|Enrolled but not treated|1|||
27652408|NCT02365597|80567945|FG002|Overall Study|Enrolled but not treated|1|||
27652409|NCT02365597|80567946|FG003|Overall Study|Enrolled but not treated|0|||
27652410|NCT02365597|80567943|FG000|Overall Study|Ongoing|0|||
27652411|NCT02365597|80567944|FG001|Overall Study|Ongoing|0|||
27652412|NCT02365597|80567945|FG002|Overall Study|Ongoing|0|||
27652413|NCT02365597|80567946|FG003|Overall Study|Ongoing|17|||
27652414|NCT00942266|80567947|FG000|Overall Study|Withdrawal by Subject|1|||
27652415|NCT00942266|80567948|FG001|Overall Study|Withdrawal by Subject|0|||
27652416|NCT00942266|80567947|FG000|Overall Study|Adverse Event|2|||
27652417|NCT00942266|80567948|FG001|Overall Study|Adverse Event|1|||
27652418|NCT00942266|80567947|FG000|Overall Study|Disease Progression|38|||
27652419|NCT00942266|80567948|FG001|Overall Study|Disease Progression|11|||
27652420|NCT00942266|80567947|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
27652421|NCT00942266|80567948|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
27652422|NCT00942266|80567947|FG000|Overall Study|Intercurrent illness|0|||
27652423|NCT00942266|80567948|FG001|Overall Study|Intercurrent illness|1|||
27652424|NCT00942266|80567947|FG000|Overall Study|Physician Decision|2|||
27652425|NCT00942266|80567948|FG001|Overall Study|Physician Decision|0|||
27652426|NCT00942266|80567947|FG000|Overall Study|medical deterioration (pneumonia)|0|||
27652427|NCT00942266|80567948|FG001|Overall Study|medical deterioration (pneumonia)|1|||
27652428|NCT00813709|80567951|FG000|Double Blind Period|Adverse Event|4|||
27652429|NCT00813709|80567952|FG001|Double Blind Period|Adverse Event|1|||
27652430|NCT00813709|80567953|FG002|Double Blind Period|Adverse Event|4|||
27652431|NCT00813709|80567954|FG003|Double Blind Period|Adverse Event|0|||
27652432|NCT00813709|80567955|FG004|Double Blind Period|Adverse Event|0|||
27652433|NCT00813709|80567956|FG005|Double Blind Period|Adverse Event|0|||
27652434|NCT00813709|80567951|FG000|Double Blind Period|Lost to Follow-up|3|||
27652435|NCT00813709|80567952|FG001|Double Blind Period|Lost to Follow-up|2|||
27652436|NCT00813709|80567953|FG002|Double Blind Period|Lost to Follow-up|2|||
27652437|NCT00813709|80567954|FG003|Double Blind Period|Lost to Follow-up|0|||
27652438|NCT00813709|80567955|FG004|Double Blind Period|Lost to Follow-up|0|||
27652439|NCT00813709|80567956|FG005|Double Blind Period|Lost to Follow-up|0|||
27652440|NCT00813709|80567951|FG000|Double Blind Period|Switched to open label phase|9|||
27652441|NCT00813709|80567952|FG001|Double Blind Period|Switched to open label phase|26|||
27652442|NCT00813709|80567953|FG002|Double Blind Period|Switched to open label phase|18|||
27652443|NCT00813709|80567954|FG003|Double Blind Period|Switched to open label phase|0|||
27652444|NCT00813709|80567955|FG004|Double Blind Period|Switched to open label phase|0|||
27652445|NCT00813709|80567956|FG005|Double Blind Period|Switched to open label phase|0|||
27652446|NCT00813709|80567951|FG000|Double Blind Period|Randomized but not treated|1|||
27652447|NCT00813709|80567952|FG001|Double Blind Period|Randomized but not treated|3|||
27652448|NCT00813709|80567953|FG002|Double Blind Period|Randomized but not treated|1|||
27652449|NCT00813709|80567954|FG003|Double Blind Period|Randomized but not treated|0|||
27652450|NCT00813709|80567955|FG004|Double Blind Period|Randomized but not treated|0|||
27652451|NCT00813709|80567956|FG005|Double Blind Period|Randomized but not treated|0|||
27652452|NCT00813709|80567951|FG000|Double Blind Period|Other|14|||
27652453|NCT00813709|80567952|FG001|Double Blind Period|Other|9|||
27652454|NCT00813709|80567953|FG002|Double Blind Period|Other|6|||
27652455|NCT00813709|80567954|FG003|Double Blind Period|Other|0|||
27652456|NCT00813709|80567955|FG004|Double Blind Period|Other|0|||
27652457|NCT00813709|80567956|FG005|Double Blind Period|Other|0|||
27652458|NCT00813709|80567951|FG000|Open Label Period|Adverse Event|0|||
27652459|NCT00813709|80567952|FG001|Open Label Period|Adverse Event|0|||
27652460|NCT00813709|80567953|FG002|Open Label Period|Adverse Event|0|||
27652461|NCT00813709|80567954|FG003|Open Label Period|Adverse Event|5|||
27652462|NCT00813709|80567955|FG004|Open Label Period|Adverse Event|4|||
27652463|NCT00813709|80567956|FG005|Open Label Period|Adverse Event|3|||
27652464|NCT00813709|80567951|FG000|Open Label Period|Lack of Efficacy|0|||
27652465|NCT00813709|80567952|FG001|Open Label Period|Lack of Efficacy|0|||
27652466|NCT00813709|80567953|FG002|Open Label Period|Lack of Efficacy|0|||
27652467|NCT00813709|80567954|FG003|Open Label Period|Lack of Efficacy|3|||
27652468|NCT00813709|80567955|FG004|Open Label Period|Lack of Efficacy|1|||
27652469|NCT00813709|80567956|FG005|Open Label Period|Lack of Efficacy|1|||
27652470|NCT00813709|80567951|FG000|Open Label Period|Randomized but not treated|0|||
27652471|NCT00813709|80567952|FG001|Open Label Period|Randomized but not treated|0|||
27652472|NCT00813709|80567953|FG002|Open Label Period|Randomized but not treated|0|||
27652473|NCT00813709|80567954|FG003|Open Label Period|Randomized but not treated|1|||
27652474|NCT00813709|80567955|FG004|Open Label Period|Randomized but not treated|0|||
27652475|NCT00813709|80567956|FG005|Open Label Period|Randomized but not treated|1|||
27652476|NCT00813709|80567951|FG000|Open Label Period|Other|0|||
27652477|NCT00813709|80567952|FG001|Open Label Period|Other|0|||
27652478|NCT00813709|80567953|FG002|Open Label Period|Other|0|||
27652479|NCT00813709|80567954|FG003|Open Label Period|Other|11|||
27652480|NCT00813709|80567955|FG004|Open Label Period|Other|5|||
27652481|NCT00813709|80567956|FG005|Open Label Period|Other|6|||
27652482|NCT00458783|80567959|FG000|Overall Study|Protocol Violation|1228|||
27652483|NCT00458783|80567960|FG001|Overall Study|Protocol Violation|1220|||
27652484|NCT02312258|80567963|FG000|Overall Study|Lost to Follow-up|8|||
27652485|NCT02312258|80567964|FG001|Overall Study|Lost to Follow-up|8|||
27652486|NCT02312258|80567963|FG000|Overall Study|Withdrawal by Patient|49|||
27652487|NCT02312258|80567964|FG001|Overall Study|Withdrawal by Patient|76|||
27652488|NCT02312258|80567963|FG000|Overall Study|Reason not Specified|107|||
27652489|NCT02312258|80567964|FG001|Overall Study|Reason not Specified|159|||
27652490|NCT02312258|80567963|FG000|Overall Study|Missing|2|||
27652491|NCT02312258|80567964|FG001|Overall Study|Missing|1|||
27652492|NCT02312258|80567963|FG000|Overall Study|Death|115|||
27652493|NCT02312258|80567964|FG001|Overall Study|Death|181|||
27652494|NCT02009865|80567967|FG000|Overall Study|Adverse Event|0|||
27652495|NCT02009865|80567968|FG001|Overall Study|Adverse Event|2|||
27652496|NCT02009865|80567967|FG000|Overall Study|Protocol Violation|0|||
27652497|NCT02009865|80567968|FG001|Overall Study|Protocol Violation|2|||
27652498|NCT02009865|80567967|FG000|Overall Study|Withdrawal by Subject|1|||
27652499|NCT02009865|80567968|FG001|Overall Study|Withdrawal by Subject|1|||
27652500|NCT01220999|80567969|FG000|Overall Study|Progressive disease|0|||
27652501|NCT01220999|80567970|FG001|Overall Study|Progressive disease|0|||
27652502|NCT01220999|80567971|FG002|Overall Study|Progressive disease|1|||
27652503|NCT01220999|80567972|FG003|Overall Study|Progressive disease|0|||
27652504|NCT01220999|80567973|FG004|Overall Study|Progressive disease|0|||
27652505|NCT00658632|80567978|FG000|Overall Study|Adverse Event|13|||
27652506|NCT00658632|80567979|FG001|Overall Study|Adverse Event|11|||
27652507|NCT00658632|80567978|FG000|Overall Study|Lost to Follow-up|25|||
27652508|NCT00658632|80567979|FG001|Overall Study|Lost to Follow-up|23|||
27652509|NCT00658632|80567978|FG000|Overall Study|Withdrawal by Subject|10|||
27652510|NCT00658632|80567979|FG001|Overall Study|Withdrawal by Subject|7|||
27652511|NCT00658632|80567978|FG000|Overall Study|Lack of Efficacy|0|||
27652512|NCT00658632|80567979|FG001|Overall Study|Lack of Efficacy|1|||
27652513|NCT00658632|80567978|FG000|Overall Study|Withdrawal of consent|8|||
27652514|NCT00658632|80567979|FG001|Overall Study|Withdrawal of consent|14|||
27652515|NCT00658632|80567978|FG000|Overall Study|Pregnancy|1|||
27652516|NCT00658632|80567979|FG001|Overall Study|Pregnancy|1|||
27652517|NCT00658632|80567978|FG000|Overall Study|Other|7|||
27652518|NCT00658632|80567979|FG001|Overall Study|Other|8|||
27652519|NCT00990314|80567982|FG000|Overall Study|Death|2|||
27652520|NCT00990314|80567982|FG000|Overall Study|Adverse Event|2|||
27652521|NCT00990314|80567982|FG000|Overall Study|Withdrawal by Subject|3|||
27652522|NCT00990314|80567982|FG000|Overall Study|Non-Compliance|1|||
27652523|NCT00990314|80567982|FG000|Overall Study|Physician Decision|3|||
27652524|NCT00990314|80567982|FG000|Overall Study|Lack of Efficacy|1|||
27652525|NCT00807599|80567983|FG000|Overall Study|Not treated on protocol study|0|||
27652526|NCT00807599|80567984|FG001|Overall Study|Not treated on protocol study|0|||
27652527|NCT00807599|80567985|FG002|Overall Study|Not treated on protocol study|2|||
27652528|NCT00807599|80567983|FG000|Overall Study|Adverse Event|0|||
27652529|NCT00807599|80567984|FG001|Overall Study|Adverse Event|0|||
27751439|NCT01426425|80914199|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
27652530|NCT00807599|80567985|FG002|Overall Study|Adverse Event|5|||
27652531|NCT00807599|80567983|FG000|Overall Study|Inadequate response to induction|0|||
27652532|NCT00807599|80567984|FG001|Overall Study|Inadequate response to induction|0|||
27652533|NCT00807599|80567985|FG002|Overall Study|Inadequate response to induction|9|||
27652534|NCT00807599|80567983|FG000|Overall Study|Withdrawal by Subject|0|||
27652535|NCT00807599|80567984|FG001|Overall Study|Withdrawal by Subject|0|||
27652536|NCT00807599|80567985|FG002|Overall Study|Withdrawal by Subject|1|||
27652537|NCT00696241|80567986|FG000|Overall Study|Adverse Event|11|||
27652538|NCT00696241|80567987|FG001|Overall Study|Adverse Event|3|||
27652539|NCT00696241|80567988|FG002|Overall Study|Adverse Event|6|||
27652540|NCT00696241|80567989|FG003|Overall Study|Adverse Event|4|||
27652541|NCT00696241|80567990|FG004|Overall Study|Adverse Event|5|||
27652542|NCT00696241|80567986|FG000|Overall Study|Protocol Violation|1|||
27652543|NCT00696241|80567987|FG001|Overall Study|Protocol Violation|1|||
27652544|NCT00696241|80567988|FG002|Overall Study|Protocol Violation|2|||
27652545|NCT00696241|80567989|FG003|Overall Study|Protocol Violation|0|||
27652546|NCT00696241|80567990|FG004|Overall Study|Protocol Violation|3|||
27652547|NCT00696241|80567986|FG000|Overall Study|Lost to Follow-up|1|||
27652548|NCT00696241|80567987|FG001|Overall Study|Lost to Follow-up|4|||
27652549|NCT00696241|80567988|FG002|Overall Study|Lost to Follow-up|1|||
27652550|NCT00696241|80567989|FG003|Overall Study|Lost to Follow-up|2|||
27652551|NCT00696241|80567990|FG004|Overall Study|Lost to Follow-up|0|||
27652552|NCT00696241|80567986|FG000|Overall Study|Withdrawal by Subject|4|||
27652553|NCT00696241|80567987|FG001|Overall Study|Withdrawal by Subject|8|||
27652554|NCT00696241|80567988|FG002|Overall Study|Withdrawal by Subject|6|||
27652555|NCT00696241|80567989|FG003|Overall Study|Withdrawal by Subject|1|||
27652556|NCT00696241|80567990|FG004|Overall Study|Withdrawal by Subject|0|||
27652557|NCT00696241|80567986|FG000|Overall Study|Lack of Efficacy|1|||
27652558|NCT00696241|80567987|FG001|Overall Study|Lack of Efficacy|5|||
27652559|NCT00696241|80567988|FG002|Overall Study|Lack of Efficacy|4|||
27652560|NCT00696241|80567989|FG003|Overall Study|Lack of Efficacy|5|||
27652561|NCT00696241|80567990|FG004|Overall Study|Lack of Efficacy|3|||
27652562|NCT00696241|80567986|FG000|Overall Study|Other|6|||
27652563|NCT00696241|80567987|FG001|Overall Study|Other|1|||
27652564|NCT00696241|80567988|FG002|Overall Study|Other|5|||
27652565|NCT00696241|80567989|FG003|Overall Study|Other|2|||
27652566|NCT00696241|80567990|FG004|Overall Study|Other|1|||
27652567|NCT00578344|80567991|FG000|Overall Study|Insurance problems|1|||
27652568|NCT00578344|80567991|FG000|Overall Study|Graft failure|1|||
27652569|NCT03622580|80567992|FG000|Overall Study|Death|16|||
27652570|NCT03622580|80567993|FG001|Overall Study|Death|21|||
27652571|NCT03622580|80567994|FG002|Overall Study|Death|13|||
27652572|NCT03622580|80567992|FG000|Overall Study|Adverse Event|6|||
27652573|NCT03622580|80567993|FG001|Overall Study|Adverse Event|6|||
27652574|NCT03622580|80567994|FG002|Overall Study|Adverse Event|5|||
27652575|NCT03622580|80567992|FG000|Overall Study|Withdrawal by Subject|12|||
27652576|NCT03622580|80567993|FG001|Overall Study|Withdrawal by Subject|7|||
27652577|NCT03622580|80567994|FG002|Overall Study|Withdrawal by Subject|19|||
27652578|NCT03622580|80567992|FG000|Overall Study|Lost to Follow-up|12|||
27652579|NCT03622580|80567993|FG001|Overall Study|Lost to Follow-up|9|||
27652580|NCT03622580|80567994|FG002|Overall Study|Lost to Follow-up|9|||
27652581|NCT03622580|80567992|FG000|Overall Study|Protocol Violation|1|||
27652582|NCT03622580|80567993|FG001|Overall Study|Protocol Violation|0|||
27652583|NCT03622580|80567994|FG002|Overall Study|Protocol Violation|1|||
27652584|NCT03622580|80567992|FG000|Overall Study|Physician Decision|3|||
27652585|NCT03622580|80567993|FG001|Overall Study|Physician Decision|0|||
27652586|NCT03622580|80567994|FG002|Overall Study|Physician Decision|1|||
27652587|NCT03622580|80567992|FG000|Overall Study|Pregnancy|0|||
27652588|NCT03622580|80567993|FG001|Overall Study|Pregnancy|1|||
27652589|NCT03622580|80567994|FG002|Overall Study|Pregnancy|0|||
27652590|NCT03622580|80567992|FG000|Overall Study|Lack of Efficacy|0|||
27652591|NCT03622580|80567993|FG001|Overall Study|Lack of Efficacy|0|||
27652592|NCT03622580|80567994|FG002|Overall Study|Lack of Efficacy|1|||
27652593|NCT03622580|80567992|FG000|Overall Study|Other|2|||
27652594|NCT03622580|80567993|FG001|Overall Study|Other|0|||
27652595|NCT03622580|80567994|FG002|Overall Study|Other|3|||
27652596|NCT00240994|80567996|FG000|Overall Study|Lost to Follow-up|1|||
27652597|NCT00240994|80567996|FG000|Overall Study|Protocol Violation|1|||
27652598|NCT00240994|80567996|FG000|Overall Study|Graft failure|1|||
27652599|NCT00220805|80567997|FG000|Overall Study|Adverse Event|1|||
27652600|NCT00220805|80567998|FG001|Overall Study|Adverse Event|3|||
27652601|NCT00220805|80567997|FG000|Overall Study|Withdrawal by Subject|3|||
27652602|NCT00220805|80567998|FG001|Overall Study|Withdrawal by Subject|0|||
27652603|NCT00220805|80567997|FG000|Overall Study|Lack of Efficacy|1|||
27652604|NCT00220805|80567998|FG001|Overall Study|Lack of Efficacy|0|||
27652605|NCT00220805|80567997|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
27652606|NCT00220805|80567998|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
27652607|NCT01836523|80567999|FG000|Overall Study|Adverse Event|15|||
27652608|NCT01836523|80568000|FG001|Overall Study|Adverse Event|41|||
27652609|NCT01836523|80568001|FG002|Overall Study|Adverse Event|49|||
27652610|NCT01836523|80568002|FG003|Overall Study|Adverse Event|14|||
27652611|NCT01836523|80567999|FG000|Overall Study|Protocol Violation|6|||
27652612|NCT01836523|80568000|FG001|Overall Study|Protocol Violation|3|||
27652613|NCT01836523|80568001|FG002|Overall Study|Protocol Violation|2|||
27652614|NCT01836523|80568002|FG003|Overall Study|Protocol Violation|4|||
27652615|NCT01836523|80567999|FG000|Overall Study|Met Withdrawal Criteria|13|||
27652616|NCT01836523|80568000|FG001|Overall Study|Met Withdrawal Criteria|13|||
27652617|NCT01836523|80568001|FG002|Overall Study|Met Withdrawal Criteria|21|||
27652618|NCT01836523|80568002|FG003|Overall Study|Met Withdrawal Criteria|27|||
27652619|NCT01836523|80567999|FG000|Overall Study|Unclassified|17|||
27652620|NCT01836523|80568000|FG001|Overall Study|Unclassified|28|||
27652621|NCT01836523|80568001|FG002|Overall Study|Unclassified|19|||
27652622|NCT01836523|80568002|FG003|Overall Study|Unclassified|29|||
27652623|NCT02039401|80568003|FG000|Overall Study|Adverse Event|0|||
27652624|NCT02039401|80568004|FG001|Overall Study|Adverse Event|1|||
27652625|NCT02514824|80568005|FG000|Overall Study|Withdrawal by Subject|1|||
27652626|NCT02514824|80568006|FG001|Overall Study|Withdrawal by Subject|0|||
27652627|NCT02514824|80568007|FG002|Overall Study|Withdrawal by Subject|0|||
27652628|NCT02514824|80568008|FG003|Overall Study|Withdrawal by Subject|0|||
27652629|NCT02514824|80568005|FG000|Overall Study|Dose-Limiting Toxicity|0|||
27652630|NCT02514824|80568006|FG001|Overall Study|Dose-Limiting Toxicity|1|||
27652631|NCT02514824|80568007|FG002|Overall Study|Dose-Limiting Toxicity|0|||
27652632|NCT02514824|80568008|FG003|Overall Study|Dose-Limiting Toxicity|0|||
27751440|NCT00367640|80914201|FG000|Overall Study|Adverse Event|3|||
27751441|NCT00367640|80914202|FG001|Overall Study|Adverse Event|6|||
27751442|NCT00367640|80914203|FG002|Overall Study|Adverse Event|8|||
27751443|NCT00367640|80914204|FG003|Overall Study|Adverse Event|0|||
27751444|NCT00367640|80914201|FG000|Overall Study|Withdrawal by Subject|8|||
27751445|NCT00367640|80914202|FG001|Overall Study|Withdrawal by Subject|11|||
27751446|NCT00367640|80914203|FG002|Overall Study|Withdrawal by Subject|8|||
27751447|NCT00367640|80914204|FG003|Overall Study|Withdrawal by Subject|6|||
27751448|NCT00367640|80914201|FG000|Overall Study|Any other reason not above-mentioned|7|||
27751449|NCT00367640|80914202|FG001|Overall Study|Any other reason not above-mentioned|5|||
27751450|NCT00367640|80914203|FG002|Overall Study|Any other reason not above-mentioned|3|||
27751451|NCT00367640|80914204|FG003|Overall Study|Any other reason not above-mentioned|4|||
27751452|NCT03439748|80914205|FG000|Overall Study|Withdrawal by Subject|11|||
27751453|NCT03439748|80914206|FG001|Overall Study|Withdrawal by Subject|17|||
27751454|NCT01746732|80914207|FG000|Lead-In Period|Withdrawal by Subject|1|||
27751455|NCT01746732|80914208|FG001|Lead-In Period|Withdrawal by Subject|0|||
27751456|NCT01746732|80914209|FG002|Lead-In Period|Withdrawal by Subject|0|||
27751457|NCT01746732|80914207|FG000|Period 1|Physician Decision|0|||
27751458|NCT01746732|80914208|FG001|Period 1|Physician Decision|1|||
27751459|NCT01746732|80914209|FG002|Period 1|Physician Decision|0|||
27751460|NCT01746732|80914207|FG000|Period 2|Withdrawal by Subject|0|||
27751461|NCT01746732|80914208|FG001|Period 2|Withdrawal by Subject|0|||
27751462|NCT01746732|80914209|FG002|Period 2|Withdrawal by Subject|2|||
27751463|NCT01746732|80914207|FG000|Period 2|Adverse Event|0|||
27751464|NCT01746732|80914208|FG001|Period 2|Adverse Event|0|||
27751465|NCT01746732|80914209|FG002|Period 2|Adverse Event|1|||
27751466|NCT01746732|80914207|FG000|Period 2|Lost to Follow-up|0|||
27751467|NCT01746732|80914208|FG001|Period 2|Lost to Follow-up|0|||
27751468|NCT01746732|80914209|FG002|Period 2|Lost to Follow-up|1|||
27751469|NCT00142519|80914210|FG000|Overall Study|Not Treated|7|||
27751470|NCT00142519|80914211|FG001|Overall Study|Not Treated|9|||
27751471|NCT00142519|80914210|FG000|Overall Study|Protocol Violation|1|||
27751472|NCT00142519|80914211|FG001|Overall Study|Protocol Violation|0|||
27751473|NCT00142519|80914210|FG000|Overall Study|Withdrawal by Subject|10|||
27751474|NCT00142519|80914211|FG001|Overall Study|Withdrawal by Subject|7|||
27751475|NCT03196505|80914212|FG000|Overall Study|Physician Decision|26|||
27751476|NCT03196505|80914213|FG001|Overall Study|Physician Decision|26|||
27751477|NCT02849990|80914216|FG000|Overall Study|Adverse Event|1|||
27751478|NCT02849990|80914216|FG000|Overall Study|Withdrawal by Subject|1|||
27751479|NCT01551758|80914217|FG000|Overall Study|Adverse Event|29|||
27751480|NCT01551758|80914218|FG001|Overall Study|Adverse Event|43|||
27751481|NCT01551758|80914217|FG000|Overall Study|Lack of Efficacy|0|||
27751482|NCT01551758|80914218|FG001|Overall Study|Lack of Efficacy|1|||
27751483|NCT01551758|80914217|FG000|Overall Study|Protocol Violation|5|||
27751484|NCT01551758|80914218|FG001|Overall Study|Protocol Violation|6|||
27751485|NCT01551758|80914217|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
27751486|NCT01551758|80914218|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
27751487|NCT01551758|80914217|FG000|Overall Study|Lost to Follow-up|29|||
27751488|NCT01551758|80914218|FG001|Overall Study|Lost to Follow-up|25|||
27751489|NCT01551758|80914217|FG000|Overall Study|Physician Decision|9|||
27751490|NCT01551758|80914218|FG001|Overall Study|Physician Decision|3|||
27751491|NCT01551758|80914217|FG000|Overall Study|Withdrawal by Subject|14|||
27751492|NCT01551758|80914218|FG001|Overall Study|Withdrawal by Subject|17|||
27751493|NCT03670641|80918106|FG000|Overall Study|Lost to Follow-up|3|||
27751494|NCT03126539|80918107|FG000|Overall Study|Lost to Follow-up|1|||
27751495|NCT03126539|80918108|FG001|Overall Study|Lost to Follow-up|1|||
27751496|NCT03126539|80918109|FG002|Overall Study|Lost to Follow-up|1|||
27751497|NCT03126539|80918110|FG003|Overall Study|Lost to Follow-up|0|||
27751498|NCT03126539|80918111|FG004|Overall Study|Lost to Follow-up|0|||
27751499|NCT02245568|80918116|FG000|Overall Study|Study terminated by Sponsor|346|||
27751500|NCT02245568|80918116|FG000|Overall Study|Adverse Event|144|||
27751501|NCT02245568|80918116|FG000|Overall Study|Lack of Efficacy|98|||
27751502|NCT02245568|80918116|FG000|Overall Study|Withdrawal by Caregiver|85|||
27751503|NCT02245568|80918116|FG000|Overall Study|Withdrawal by Subject|77|||
27652633|NCT02446015|80568009|FG000|Overall Study|Adverse Event|0|||
27751504|NCT02245568|80918116|FG000|Overall Study|Withdrawal by Legal Representative|31|||
27751505|NCT02245568|80918116|FG000|Overall Study|Missing (Site closure)|16|||
27751506|NCT02245568|80918116|FG000|Overall Study|Physician Decision|14|||
27751507|NCT02245568|80918116|FG000|Overall Study|Non-compliance with study drug|11|||
27751508|NCT02245568|80918116|FG000|Overall Study|Death|9|||
27751509|NCT02245568|80918116|FG000|Overall Study|Blue staining|6|||
27751510|NCT02245568|80918116|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
27751511|NCT02245568|80918116|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
27751512|NCT02245568|80918116|FG000|Overall Study|Lost to Follow-up|5|||
27751514|NCT01043185|80918118|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
27751515|NCT01043185|80918119|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
27751516|NCT01043185|80918120|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
27751517|NCT01043185|80918121|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
27751518|NCT01043185|80918122|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
27751519|NCT01043185|80918123|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
27751520|NCT01043185|80918124|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
27751521|NCT01043185|80918125|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
27751522|NCT01043185|80918126|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
27751523|NCT01043185|80918127|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
27751524|NCT00339183|80918129|FG000|Overall Study|Adverse Event|5|||
27751525|NCT00339183|80918130|FG001|Overall Study|Adverse Event|3|||
27751526|NCT00339183|80918129|FG000|Overall Study|Withdrawal by Subject|16|||
27751527|NCT00339183|80918130|FG001|Overall Study|Withdrawal by Subject|19|||
27751528|NCT00339183|80918129|FG000|Overall Study|Physician Decision|2|||
27751529|NCT00339183|80918130|FG001|Overall Study|Physician Decision|4|||
27751530|NCT00339183|80918129|FG000|Overall Study|Lost to Follow-up|17|||
27751531|NCT00339183|80918130|FG001|Overall Study|Lost to Follow-up|17|||
27751532|NCT00339183|80918129|FG000|Overall Study|Protocol-specified criteria|12|||
27751533|NCT00339183|80918130|FG001|Overall Study|Protocol-specified criteria|8|||
27751534|NCT00339183|80918129|FG000|Overall Study|Missing reason|3|||
27751535|NCT00339183|80918130|FG001|Overall Study|Missing reason|1|||
27751536|NCT00339183|80918129|FG000|Overall Study|Other|46|||
27751537|NCT00339183|80918130|FG001|Overall Study|Other|40|||
27751538|NCT00339183|80918129|FG000|Overall Study|Ongoing|20|||
27751539|NCT00339183|80918130|FG001|Overall Study|Ongoing|13|||
27751540|NCT01496430|80918133|FG000|Overall Study|Adverse Event|0|||
27751541|NCT01496430|80918134|FG001|Overall Study|Adverse Event|0|||
27751542|NCT01496430|80918135|FG002|Overall Study|Adverse Event|1|||
27751543|NCT01496430|80918133|FG000|Overall Study|Major Protocol Deviation|0|||
27751544|NCT01496430|80918134|FG001|Overall Study|Major Protocol Deviation|0|||
27751545|NCT01496430|80918135|FG002|Overall Study|Major Protocol Deviation|1|||
27751546|NCT01496430|80918133|FG000|Overall Study|Lost to Follow-up|2|||
27751547|NCT01496430|80918134|FG001|Overall Study|Lost to Follow-up|3|||
27751548|NCT01496430|80918135|FG002|Overall Study|Lost to Follow-up|1|||
27751549|NCT01496430|80918133|FG000|Overall Study|Voluntary Withdrawal|2|||
27751550|NCT01496430|80918134|FG001|Overall Study|Voluntary Withdrawal|1|||
27751551|NCT01496430|80918135|FG002|Overall Study|Voluntary Withdrawal|6|||
27751552|NCT01496430|80918133|FG000|Overall Study|Principal Investigator Discretion|0|||
27751553|NCT01496430|80918134|FG001|Overall Study|Principal Investigator Discretion|1|||
27751554|NCT01496430|80918135|FG002|Overall Study|Principal Investigator Discretion|1|||
27751555|NCT01496430|80918133|FG000|Overall Study|Other|2|||
27751556|NCT01496430|80918134|FG001|Overall Study|Other|0|||
27751557|NCT01496430|80918135|FG002|Overall Study|Other|0|||
27751558|NCT01675011|80918136|FG000|Overall Study|Trial terminated by Sponsor|3|||
27751559|NCT01675011|80918137|FG001|Overall Study|Trial terminated by Sponsor|1|||
27751560|NCT01252134|80918138|FG000|Period 1, 8 Hours|Personal Reasons|0|||
27751561|NCT01252134|80918139|FG001|Period 1, 8 Hours|Personal Reasons|1|||
27751562|NCT01252134|80918140|FG002|Period 1, 8 Hours|Personal Reasons|1|||
27751563|NCT01252134|80918141|FG003|Period 1, 8 Hours|Personal Reasons|0|||
27751564|NCT01252134|80918142|FG004|Period 1, 8 Hours|Personal Reasons|0|||
27751565|NCT01252134|80918143|FG005|Period 1, 8 Hours|Personal Reasons|0|||
27751566|NCT01423617|80918157|FG000|Overall Study|Lost to Follow-up|0|||
27751567|NCT01423617|80918158|FG001|Overall Study|Lost to Follow-up|1|||
27751568|NCT03554005|80918159|FG000|Overall Study|Not in participant's best interest|0|||
27751569|NCT03554005|80918160|FG001|Overall Study|Not in participant's best interest|0|||
27751570|NCT03554005|80918161|FG002|Overall Study|Not in participant's best interest|0|||
27751571|NCT03554005|80918162|FG003|Overall Study|Not in participant's best interest|0|||
27751572|NCT03554005|80918163|FG004|Overall Study|Not in participant's best interest|0|||
27751573|NCT03554005|80918164|FG005|Overall Study|Not in participant's best interest|1|||
27751574|NCT03554005|80918159|FG000|Overall Study|Disease Progression|1|||
27751575|NCT03554005|80918160|FG001|Overall Study|Disease Progression|1|||
27751576|NCT03554005|80918161|FG002|Overall Study|Disease Progression|1|||
27751577|NCT03554005|80918162|FG003|Overall Study|Disease Progression|1|||
27652634|NCT02446015|80568010|FG001|Overall Study|Adverse Event|1|||
27652635|NCT02446015|80568009|FG000|Overall Study|Withdrawal by Subject|1|||
27652636|NCT02446015|80568010|FG001|Overall Study|Withdrawal by Subject|0|||
27652637|NCT03142932|80568017|FG000|Overall Study|Lost to Follow-up|2|||
27652638|NCT03142932|80568018|FG001|Overall Study|Lost to Follow-up|11|||
27751578|NCT03554005|80918163|FG004|Overall Study|Disease Progression|5|||
27751579|NCT03554005|80918164|FG005|Overall Study|Disease Progression|6|||
27751580|NCT03554005|80918159|FG000|Overall Study|Adverse Event|0|||
27751581|NCT03554005|80918160|FG001|Overall Study|Adverse Event|0|||
27751582|NCT03554005|80918161|FG002|Overall Study|Adverse Event|0|||
27751583|NCT03554005|80918162|FG003|Overall Study|Adverse Event|0|||
27751584|NCT03554005|80918163|FG004|Overall Study|Adverse Event|0|||
27751585|NCT03554005|80918164|FG005|Overall Study|Adverse Event|3|||
27751586|NCT03554005|80918159|FG000|Overall Study|Physician Decision|0|||
27751587|NCT03554005|80918160|FG001|Overall Study|Physician Decision|0|||
27751588|NCT03554005|80918161|FG002|Overall Study|Physician Decision|0|||
27751589|NCT03554005|80918162|FG003|Overall Study|Physician Decision|0|||
27751590|NCT03554005|80918163|FG004|Overall Study|Physician Decision|1|||
27751591|NCT03554005|80918164|FG005|Overall Study|Physician Decision|0|||
27751592|NCT03554005|80918159|FG000|Overall Study|Other|0|||
27751593|NCT03554005|80918160|FG001|Overall Study|Other|0|||
27751594|NCT03554005|80918161|FG002|Overall Study|Other|0|||
27751595|NCT03554005|80918162|FG003|Overall Study|Other|0|||
27751596|NCT03554005|80918163|FG004|Overall Study|Other|0|||
27751597|NCT03554005|80918164|FG005|Overall Study|Other|1|||
27751598|NCT01934192|80918171|FG000|Overall Study|Protocol Violation|0|||
27751599|NCT01934192|80918172|FG001|Overall Study|Protocol Violation|0|||
27751600|NCT01934192|80918173|FG002|Overall Study|Protocol Violation|0|||
27751601|NCT01934192|80918174|FG003|Overall Study|Protocol Violation|1|||
27751602|NCT01934192|80918171|FG000|Overall Study|Other: reached stopping criteria|6|||
27751603|NCT01934192|80918172|FG001|Overall Study|Other: reached stopping criteria|5|||
27751604|NCT01934192|80918173|FG002|Overall Study|Other: reached stopping criteria|1|||
27751605|NCT01934192|80918174|FG003|Overall Study|Other: reached stopping criteria|0|||
27751606|NCT01934192|80918171|FG000|Overall Study|Physician Decision|3|||
27751607|NCT01934192|80918172|FG001|Overall Study|Physician Decision|2|||
27751608|NCT01934192|80918173|FG002|Overall Study|Physician Decision|0|||
27751609|NCT01934192|80918174|FG003|Overall Study|Physician Decision|0|||
27751610|NCT04657016|80918176|FG000|Overall Study|Adverse Event|2|||
27751611|NCT04657016|80918177|FG001|Overall Study|Adverse Event|4|||
27954845|NCT02122380|81668907|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
27954846|NCT02122380|81668908|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
27954847|NCT02122380|81668907|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
27954848|NCT02122380|81668908|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
27954849|NCT00487981|81668913|FG000|Overall Study|Hypothyroidism diagnosis|1|||
27954850|NCT03745768|81668915|FG000|Overall Study|discontinued study|2|||
27954851|NCT03745768|81668916|FG001|Overall Study|discontinued study|0|||
27954852|NCT03192137|81668925|FG000|Overall Study|Adverse Event|10|||
27954853|NCT03192137|81668926|FG001|Overall Study|Adverse Event|11|||
27954854|NCT03192137|81668925|FG000|Overall Study|Physician Decision|1|||
27954855|NCT03192137|81668926|FG001|Overall Study|Physician Decision|0|||
27954856|NCT03192137|81668925|FG000|Overall Study|Lack of Efficacy|20|||
27954857|NCT03192137|81668926|FG001|Overall Study|Lack of Efficacy|37|||
27954858|NCT03192137|81668925|FG000|Overall Study|Withdrawal by Subject|3|||
27954859|NCT03192137|81668926|FG001|Overall Study|Withdrawal by Subject|3|||
27954860|NCT03192137|81668925|FG000|Overall Study|Protocol Violation|4|||
27954861|NCT03192137|81668926|FG001|Overall Study|Protocol Violation|3|||
27954862|NCT03192137|81668925|FG000|Overall Study|Surgery Cancelled|4|||
27954863|NCT03192137|81668926|FG001|Overall Study|Surgery Cancelled|1|||
27954864|NCT03192137|81668925|FG000|Overall Study|Other - Various Administrative Reasons|8|||
27954865|NCT03192137|81668926|FG001|Overall Study|Other - Various Administrative Reasons|3|||
27954866|NCT01343888|81668927|FG000|Overall Study|Adverse Event|12|||
27954867|NCT01343888|81668928|FG001|Overall Study|Adverse Event|22|||
27954868|NCT01343888|81668929|FG002|Overall Study|Adverse Event|5|||
27954869|NCT01343888|81668927|FG000|Overall Study|Lack of Efficacy|9|||
27954870|NCT01343888|81668928|FG001|Overall Study|Lack of Efficacy|9|||
27954871|NCT01343888|81668929|FG002|Overall Study|Lack of Efficacy|13|||
27954872|NCT01343888|81668927|FG000|Overall Study|Lost to Follow-up|0|||
27954873|NCT01343888|81668928|FG001|Overall Study|Lost to Follow-up|2|||
27954874|NCT01343888|81668929|FG002|Overall Study|Lost to Follow-up|1|||
27954875|NCT01343888|81668927|FG000|Overall Study|Protocol Violation|0|||
27751612|NCT04657016|80918176|FG000|Overall Study|Death|1|||
27751613|NCT04657016|80918177|FG001|Overall Study|Death|1|||
27751614|NCT04657016|80918176|FG000|Overall Study|Lost to Follow-up|24|||
27954876|NCT01343888|81668928|FG001|Overall Study|Protocol Violation|2|||
27954877|NCT01343888|81668929|FG002|Overall Study|Protocol Violation|0|||
27954878|NCT01343888|81668927|FG000|Overall Study|Withdrawal by Subject|4|||
27954879|NCT01343888|81668928|FG001|Overall Study|Withdrawal by Subject|4|||
27751615|NCT04657016|80918177|FG001|Overall Study|Lost to Follow-up|12|||
27751616|NCT04657016|80918176|FG000|Overall Study|Physician Decision|1|||
27751617|NCT04657016|80918177|FG001|Overall Study|Physician Decision|2|||
27751618|NCT04657016|80918176|FG000|Overall Study|Pregnancy|2|||
27954880|NCT01343888|81668929|FG002|Overall Study|Withdrawal by Subject|2|||
27954881|NCT01343888|81668927|FG000|Overall Study|other than stated above|0|||
27954882|NCT01343888|81668928|FG001|Overall Study|other than stated above|0|||
27954883|NCT01343888|81668929|FG002|Overall Study|other than stated above|1|||
27954884|NCT00972517|81668930|FG000|Overall Study|Adverse Event|0|||
27954885|NCT00972517|81668931|FG001|Overall Study|Adverse Event|0|||
27954886|NCT00972517|81668932|FG002|Overall Study|Adverse Event|0|||
27954887|NCT00972517|81668933|FG003|Overall Study|Adverse Event|1|||
27954888|NCT00972517|81668934|FG004|Overall Study|Adverse Event|0|||
27954889|NCT00972517|81668935|FG005|Overall Study|Adverse Event|0|||
27954890|NCT00972517|81668930|FG000|Overall Study|Withdrawal by Subject|0|||
27954891|NCT00972517|81668931|FG001|Overall Study|Withdrawal by Subject|1|||
27954892|NCT00972517|81668932|FG002|Overall Study|Withdrawal by Subject|0|||
27954893|NCT00972517|81668933|FG003|Overall Study|Withdrawal by Subject|2|||
27954894|NCT00972517|81668934|FG004|Overall Study|Withdrawal by Subject|1|||
27954895|NCT00972517|81668935|FG005|Overall Study|Withdrawal by Subject|0|||
27954896|NCT03423121|81668936|FG000|Overall Study|Lost to Follow-up|2|||
27954897|NCT03423121|81668937|FG001|Overall Study|Lost to Follow-up|6|||
27954898|NCT03423121|81668936|FG000|Overall Study|Adverse Event|1|||
27954899|NCT03423121|81668937|FG001|Overall Study|Adverse Event|0|||
27954900|NCT00441272|81668938|FG000|Overall Study|Study terminated prior to enrollment|25|||
27954901|NCT00441272|81668939|FG001|Overall Study|Study terminated prior to enrollment|25|||
27954902|NCT01061385|81668949|FG000|Overall Study|Lost to Follow-up|1|||
27954903|NCT01061385|81668950|FG001|Overall Study|Lost to Follow-up|0|||
27954904|NCT01061385|81668949|FG000|Overall Study|subject decision not related to AE|0|||
27954905|NCT01061385|81668950|FG001|Overall Study|subject decision not related to AE|1|||
27954906|NCT00598650|81668953|FG000|Overall Study|Withdrawal by Subject|3|||
27954907|NCT00598650|81668953|FG000|Overall Study|Adverse Event|18|||
27954908|NCT00598650|81668953|FG000|Overall Study|No treatment for 3 weeks|1|||
27954909|NCT00598650|81668953|FG000|Overall Study|Not eligible|1|||
27954910|NCT00598650|81668953|FG000|Overall Study|Prohibited Concomitant Medication|2|||
27954911|NCT00598650|81668953|FG000|Overall Study|Physician Decision|2|||
27954912|NCT05111145|81668958|FG000|Overall Study|Commercial drug is available for participant|76|||
27954913|NCT05111145|81668958|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
27954914|NCT00560508|81668961|FG000|12 Week Double-blind Period|Adverse Event|3|||
27954915|NCT00560508|81668962|FG001|12 Week Double-blind Period|Adverse Event|2|||
27954916|NCT00560508|81668961|FG000|12 Week Double-blind Period|Protocol Violation|1|||
27954917|NCT00560508|81668962|FG001|12 Week Double-blind Period|Protocol Violation|0|||
27954918|NCT00560508|81668961|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
27954919|NCT00560508|81668962|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
27954920|NCT00560508|81668961|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
27954921|NCT00560508|81668962|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
27954922|NCT00560508|81668961|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
27954923|NCT00560508|81668962|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
27954924|NCT00560508|81668961|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
27954925|NCT00560508|81668962|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
27954926|NCT00560508|81668961|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
27954927|NCT00560508|81668962|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
27954928|NCT02465931|81668965|FG000|Overall Study|Lost to Follow-up|9|||
27954929|NCT02465931|81668966|FG001|Overall Study|Lost to Follow-up|11|||
27954930|NCT02465931|81668965|FG000|Overall Study|Protocol Violation|1|||
27954931|NCT02465931|81668966|FG001|Overall Study|Protocol Violation|0|||
27954932|NCT02465931|81668965|FG000|Overall Study|Withdrawal by Subject|1|||
27954933|NCT02465931|81668966|FG001|Overall Study|Withdrawal by Subject|0|||
27954934|NCT00429182|81668967|FG000|Overall Study|Not evaluable, Disease Progression|2|||
27954935|NCT00429182|81668967|FG000|Overall Study|Not eligible|5|||
27954936|NCT01897493|81668968|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
27954937|NCT01436110|81668969|FG000|Overall Study|Lack of Efficacy|23|||
27954938|NCT01436110|81668970|FG001|Overall Study|Lack of Efficacy|14|||
27954939|NCT01436110|81668971|FG002|Overall Study|Lack of Efficacy|9|||
27954940|NCT01436110|81668969|FG000|Overall Study|Withdrawal by Subject|6|||
27954941|NCT01436110|81668970|FG001|Overall Study|Withdrawal by Subject|8|||
27954942|NCT01436110|81668971|FG002|Overall Study|Withdrawal by Subject|4|||
27954943|NCT01436110|81668969|FG000|Overall Study|Adverse Event|2|||
27954944|NCT01436110|81668970|FG001|Overall Study|Adverse Event|1|||
27954945|NCT01436110|81668971|FG002|Overall Study|Adverse Event|2|||
27954946|NCT01436110|81668969|FG000|Overall Study|Physician Decision|3|||
27954947|NCT01436110|81668970|FG001|Overall Study|Physician Decision|1|||
27954948|NCT01436110|81668971|FG002|Overall Study|Physician Decision|1|||
27954949|NCT01436110|81668969|FG000|Overall Study|Lost to Follow-up|1|||
27954950|NCT01436110|81668970|FG001|Overall Study|Lost to Follow-up|1|||
27954951|NCT01436110|81668971|FG002|Overall Study|Lost to Follow-up|3|||
27954952|NCT01436110|81668969|FG000|Overall Study|Protocol Violation|3|||
27954953|NCT01436110|81668970|FG001|Overall Study|Protocol Violation|1|||
27954954|NCT01436110|81668971|FG002|Overall Study|Protocol Violation|1|||
27954955|NCT01436110|81668969|FG000|Overall Study|Did Not Receive Trial Medication|1|||
27652639|NCT00346398|80568019|FG000|Overall Study|Lost to Follow-up|3|||
27954956|NCT01436110|81668970|FG001|Overall Study|Did Not Receive Trial Medication|0|||
27954957|NCT01436110|81668971|FG002|Overall Study|Did Not Receive Trial Medication|3|||
27954958|NCT02927795|81668976|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
27954959|NCT02927795|81668976|FG000|Overall Study|Not Treated|4|||
27954960|NCT05525910|81668977|FG000|Period 4|Per sponsor due to study timelines|0|||
27954961|NCT05525910|81668978|FG001|Period 4|Per sponsor due to study timelines|0|||
27954962|NCT05525910|81668979|FG002|Period 4|Per sponsor due to study timelines|1|||
27954963|NCT05525910|81668980|FG003|Period 4|Per sponsor due to study timelines|1|||
27954964|NCT05525910|81668981|FG004|Period 4|Per sponsor due to study timelines|1|||
27954965|NCT04846231|81668982|FG000|Overall Study|Lost to Follow-up|1|||
27954966|NCT04846231|81668983|FG001|Overall Study|Lost to Follow-up|0|||
27954967|NCT04846231|81668984|FG002|Overall Study|Lost to Follow-up|0|||
27954968|NCT04846231|81668985|FG003|Overall Study|Lost to Follow-up|0|||
27954969|NCT04846231|81668986|FG004|Overall Study|Lost to Follow-up|0|||
27954970|NCT04846231|81668987|FG005|Overall Study|Lost to Follow-up|0|||
27954971|NCT04846231|81668988|FG006|Overall Study|Lost to Follow-up|0|||
27954972|NCT04846231|81668989|FG007|Overall Study|Lost to Follow-up|1|||
27954973|NCT04846231|81668982|FG000|Overall Study|Withdrawal by Subject|0|||
27954974|NCT04846231|81668983|FG001|Overall Study|Withdrawal by Subject|1|||
27954975|NCT04846231|81668984|FG002|Overall Study|Withdrawal by Subject|2|||
27954976|NCT04846231|81668985|FG003|Overall Study|Withdrawal by Subject|1|||
27954977|NCT04846231|81668986|FG004|Overall Study|Withdrawal by Subject|0|||
27954978|NCT04846231|81668987|FG005|Overall Study|Withdrawal by Subject|0|||
27954979|NCT04846231|81668988|FG006|Overall Study|Withdrawal by Subject|0|||
27954980|NCT04846231|81668989|FG007|Overall Study|Withdrawal by Subject|0|||
27954981|NCT04846231|81668982|FG000|Overall Study|Protocol Violation|0|||
27954982|NCT04846231|81668983|FG001|Overall Study|Protocol Violation|1|||
27954983|NCT04846231|81668984|FG002|Overall Study|Protocol Violation|0|||
27954984|NCT04846231|81668985|FG003|Overall Study|Protocol Violation|0|||
27954985|NCT04846231|81668986|FG004|Overall Study|Protocol Violation|0|||
27954986|NCT04846231|81668987|FG005|Overall Study|Protocol Violation|0|||
27954987|NCT04846231|81668988|FG006|Overall Study|Protocol Violation|0|||
27954988|NCT04846231|81668989|FG007|Overall Study|Protocol Violation|0|||
27954989|NCT04846231|81668982|FG000|Overall Study|Adverse Event|0|||
27954990|NCT04846231|81668983|FG001|Overall Study|Adverse Event|0|||
27954991|NCT04846231|81668984|FG002|Overall Study|Adverse Event|0|||
27954992|NCT04846231|81668985|FG003|Overall Study|Adverse Event|0|||
27954993|NCT04846231|81668986|FG004|Overall Study|Adverse Event|0|||
27954994|NCT04846231|81668987|FG005|Overall Study|Adverse Event|0|||
27954995|NCT04846231|81668988|FG006|Overall Study|Adverse Event|1|||
27954996|NCT04846231|81668989|FG007|Overall Study|Adverse Event|1|||
27954997|NCT04940130|81668990|FG000|Overall Study|Travel|1|||
27954998|NCT04940130|81668991|FG001|Overall Study|Travel|0|||
27954999|NCT04940130|81668992|FG002|Overall Study|Travel|2|||
27955000|NCT04940130|81668990|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
27955001|NCT04940130|81668991|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
27955002|NCT04940130|81668992|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
27955003|NCT04940130|81668990|FG000|Overall Study|Adverse Event|0|||
27955004|NCT04940130|81668991|FG001|Overall Study|Adverse Event|0|||
27955005|NCT04940130|81668992|FG002|Overall Study|Adverse Event|2|||
27955006|NCT04940130|81668990|FG000|Overall Study|Disease progression/treatment failure|0|||
27955007|NCT04940130|81668991|FG001|Overall Study|Disease progression/treatment failure|0|||
27955008|NCT04940130|81668992|FG002|Overall Study|Disease progression/treatment failure|1|||
27955009|NCT04940130|81668990|FG000|Overall Study|Participant refusal|0|||
27955010|NCT04940130|81668991|FG001|Overall Study|Participant refusal|0|||
27955011|NCT04940130|81668992|FG002|Overall Study|Participant refusal|1|||
27955012|NCT01535287|81668993|FG000|Overall Study|drug not prepared in time|5|||
27955013|NCT01535287|81668994|FG001|Overall Study|drug not prepared in time|6|||
27955014|NCT01434654|81668995|FG000|Overall Study|Withdrawal by Subject|1|||
27955015|NCT01434654|81668996|FG001|Overall Study|Withdrawal by Subject|0|||
27955016|NCT01434654|81668995|FG000|Overall Study|Lost to Follow-up|1|||
27955017|NCT01434654|81668996|FG001|Overall Study|Lost to Follow-up|0|||
27955018|NCT01130337|81668997|FG000|Overall Study|Withdrawal by Subject|3|||
27955019|NCT01130337|81668997|FG000|Overall Study|Principal investigator decision|1|||
27955020|NCT01130337|81668997|FG000|Overall Study|Death|1|||
27955021|NCT01130337|81668997|FG000|Overall Study|Disease progression|1|||
27955022|NCT01130337|81668997|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
27955023|NCT01130337|81668997|FG000|Overall Study|Surgical resection (R2)|1|||
27955024|NCT00811720|81668998|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
27955025|NCT00811720|81668999|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
27955026|NCT00811720|81668998|FG000|All Treated Patients|Adverse Event|20|||
27955027|NCT00811720|81668999|FG001|All Treated Patients|Adverse Event|62|||
27955028|NCT00811720|81668998|FG000|All Treated Patients|Lack of Efficacy|22|||
27955029|NCT00811720|81668999|FG001|All Treated Patients|Lack of Efficacy|18|||
27955030|NCT00811720|81668998|FG000|All Treated Patients|Non-compliance|0|||
27955031|NCT00811720|81668999|FG001|All Treated Patients|Non-compliance|14|||
27955032|NCT00811720|81668998|FG000|All Treated Patients|Protocol Violation|9|||
27955033|NCT00811720|81668999|FG001|All Treated Patients|Protocol Violation|16|||
27955034|NCT00811720|81668998|FG000|All Treated Patients|Withdrawal by Subject|28|||
27955035|NCT00811720|81668999|FG001|All Treated Patients|Withdrawal by Subject|34|||
27955036|NCT00811720|81668998|FG000|All Treated Patients|Lost to Follow-up|10|||
27955037|NCT00811720|81668999|FG001|All Treated Patients|Lost to Follow-up|16|||
27955038|NCT00811720|81668998|FG000|All Treated Patients|Other Reason|7|||
27955039|NCT00811720|81668999|FG001|All Treated Patients|Other Reason|4|||
27955040|NCT01612676|81669000|FG000|Overall Study|Adverse Event|2|||
27955041|NCT01612676|81669001|FG001|Overall Study|Adverse Event|3|||
27955042|NCT01612676|81669002|FG002|Overall Study|Adverse Event|1|||
27955043|NCT01612676|81669003|FG003|Overall Study|Adverse Event|3|||
27955044|NCT01612676|81669000|FG000|Overall Study|Protocol Violation|0|||
27955045|NCT01612676|81669001|FG001|Overall Study|Protocol Violation|1|||
27955046|NCT01612676|81669002|FG002|Overall Study|Protocol Violation|0|||
27955047|NCT01612676|81669003|FG003|Overall Study|Protocol Violation|0|||
27955048|NCT03257358|81669005|FG000|Overall Study|Adverse Event|25|||
27955049|NCT03257358|81669006|FG001|Overall Study|Adverse Event|12|||
27955050|NCT03257358|81669005|FG000|Overall Study|Lack of Efficacy|1|||
27955051|NCT03257358|81669006|FG001|Overall Study|Lack of Efficacy|1|||
27955052|NCT03257358|81669005|FG000|Overall Study|Lost to Follow-up|12|||
27955053|NCT03257358|81669006|FG001|Overall Study|Lost to Follow-up|4|||
27955054|NCT03257358|81669005|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
27955055|NCT03257358|81669006|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
27955056|NCT03257358|81669005|FG000|Overall Study|Physician Decision|2|||
27955057|NCT03257358|81669006|FG001|Overall Study|Physician Decision|2|||
27955058|NCT03257358|81669005|FG000|Overall Study|Protocol Violation|5|||
27955059|NCT03257358|81669006|FG001|Overall Study|Protocol Violation|3|||
27955060|NCT03257358|81669005|FG000|Overall Study|Technical problems|4|||
27955061|NCT03257358|81669006|FG001|Overall Study|Technical problems|1|||
27955062|NCT03257358|81669005|FG000|Overall Study|Withdrawal by Subject|8|||
27955063|NCT03257358|81669006|FG001|Overall Study|Withdrawal by Subject|3|||
27955064|NCT03257358|81669005|FG000|Overall Study|Withdrawal of informed consent|9|||
27955065|NCT03257358|81669006|FG001|Overall Study|Withdrawal of informed consent|5|||
27955066|NCT03257358|81669005|FG000|Overall Study|New therapy for study indication|1|||
27955067|NCT03257358|81669006|FG001|Overall Study|New therapy for study indication|0|||
27955068|NCT03257358|81669005|FG000|Overall Study|No longer requires treatment|0|||
27652640|NCT00346398|80568020|FG001|Overall Study|Lost to Follow-up|0|||
27652641|NCT00346398|80568019|FG000|Overall Study|Withdrawal by Subject|0|||
27652642|NCT00346398|80568020|FG001|Overall Study|Withdrawal by Subject|2|||
27652643|NCT01334606|80568021|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
27652644|NCT01543204|80568022|FG000|Overall Study|Non-compliance|1|||
27652645|NCT01543204|80568022|FG000|Overall Study|Adverse Event|1|||
27652646|NCT01543204|80568022|FG000|Overall Study|Withdrawal by Subject|4|||
27652647|NCT01543204|80568022|FG000|Overall Study|Requirement for Alternative Therapy|1|||
27652648|NCT01543204|80568022|FG000|Overall Study|Lost to Follow-up|1|||
27652649|NCT03326856|80568023|FG000|Overall Study|Lost to Follow-up|1|||
27652650|NCT03326856|80568024|FG001|Overall Study|Lost to Follow-up|1|||
27652651|NCT03326856|80568025|FG002|Overall Study|Lost to Follow-up|0|||
27652652|NCT03326856|80568026|FG003|Overall Study|Lost to Follow-up|0|||
27652653|NCT03326856|80568027|FG004|Overall Study|Lost to Follow-up|0|||
27652654|NCT00512902|80568028|FG000|Overall Study|Adverse Event|7|||
27652655|NCT00512902|80568028|FG000|Overall Study|Lost to Follow-up|1|||
27652656|NCT02144285|80568033|FG000|Overall Study|Withdrawal by Subject|0|||
27652657|NCT02144285|80568034|FG001|Overall Study|Withdrawal by Subject|0|||
27652658|NCT02144285|80568035|FG002|Overall Study|Withdrawal by Subject|0|||
27652659|NCT02144285|80568036|FG003|Overall Study|Withdrawal by Subject|0|||
27652660|NCT02144285|80568037|FG004|Overall Study|Withdrawal by Subject|1|||
27652661|NCT02144285|80568038|FG005|Overall Study|Withdrawal by Subject|0|||
27652662|NCT02144285|80568039|FG006|Overall Study|Withdrawal by Subject|0|||
27652663|NCT02144285|80568040|FG007|Overall Study|Withdrawal by Subject|0|||
27652664|NCT02144285|80568041|FG008|Overall Study|Withdrawal by Subject|0|||
27652665|NCT02144285|80568042|FG009|Overall Study|Withdrawal by Subject|0|||
27652666|NCT01328756|80568043|FG000|Overall Study|Protocol Violation|4|||
27652667|NCT01328756|80568043|FG000|Overall Study|Adverse Event|39|||
27652668|NCT01328756|80568043|FG000|Overall Study|Lack of Efficacy|5|||
27652669|NCT01328756|80568043|FG000|Overall Study|Withdrawal by Subject|41|||
27652670|NCT01328756|80568043|FG000|Overall Study|Lost to Follow-up|5|||
27652671|NCT01328756|80568043|FG000|Overall Study|Other|29|||
27652672|NCT02889900|80568044|FG000|Overall Study|Adverse Event|11|||
27652673|NCT02889900|80568044|FG000|Overall Study|Condition under investigation worsened|32|||
27652674|NCT02889900|80568044|FG000|Overall Study|Other|5|||
27652675|NCT02889900|80568044|FG000|Overall Study|Withdrawal by Subject|7|||
27652676|NCT02889900|80568044|FG000|Overall Study|Not treated|2|||
27955069|NCT03257358|81669006|FG001|Overall Study|No longer requires treatment|1|||
27955070|NCT00552071|81669013|FG000|Overall Study|Adverse Event|1|||
27955071|NCT00552071|81669014|FG001|Overall Study|Adverse Event|0|||
27652677|NCT00237809|80568045|FG000|Overall Study|Lost to Follow-up|11|||
27955072|NCT00552071|81669013|FG000|Overall Study|Lack of Efficacy|1|||
27955073|NCT00552071|81669014|FG001|Overall Study|Lack of Efficacy|0|||
27955074|NCT00552071|81669013|FG000|Overall Study|Physician Decision|1|||
27955075|NCT00552071|81669014|FG001|Overall Study|Physician Decision|0|||
27955076|NCT00552071|81669013|FG000|Overall Study|Pregnancy|1|||
27955077|NCT00552071|81669014|FG001|Overall Study|Pregnancy|0|||
27955078|NCT00552071|81669013|FG000|Overall Study|Death|0|||
27955079|NCT00552071|81669014|FG001|Overall Study|Death|1|||
27955080|NCT00552071|81669013|FG000|Overall Study|Withdrawal by Subject|0|||
27955081|NCT00552071|81669014|FG001|Overall Study|Withdrawal by Subject|1|||
27955082|NCT04240886|81669015|FG000|Treatment Phase|Death|4|||
27955083|NCT04240886|81669015|FG000|Treatment Phase|Discontinuation by Subject|1|||
27955084|NCT04240886|81669015|FG000|Treatment Phase|Adverse Event|5|||
27955085|NCT04240886|81669015|FG000|Follow-up Phase|Withdrawal by Subject|1|||
27955086|NCT04240886|81669015|FG000|Follow-up Phase|Discontinuation by Subject|1|||
27955087|NCT04240886|81669015|FG000|Follow-up Phase|Death|2|||
27955088|NCT01908140|81669022|FG000|Overall Study|Other or Progressive Disease|5|||
27955089|NCT01908140|81669023|FG001|Overall Study|Other or Progressive Disease|12|||
27955090|NCT01908140|81669022|FG000|Overall Study|Lack of Efficacy|7|||
27955091|NCT01908140|81669023|FG001|Overall Study|Lack of Efficacy|5|||
27955092|NCT01908140|81669022|FG000|Overall Study|Withdrawal by Subject|23|||
27955093|NCT01908140|81669023|FG001|Overall Study|Withdrawal by Subject|24|||
27955094|NCT01908140|81669022|FG000|Overall Study|Lost to Follow-up|1|||
27955095|NCT01908140|81669023|FG001|Overall Study|Lost to Follow-up|6|||
27955096|NCT01908140|81669022|FG000|Overall Study|Protocol Violation|8|||
27955097|NCT01908140|81669023|FG001|Overall Study|Protocol Violation|9|||
27955098|NCT01908140|81669022|FG000|Overall Study|Adverse Event|22|||
27955099|NCT01908140|81669023|FG001|Overall Study|Adverse Event|23|||
27955100|NCT01182298|81669024|FG000|Overall Study|Lack of Efficacy|4|||
27955101|NCT01182298|81669024|FG000|Overall Study|Withdrawal by Subject|2|||
27955102|NCT00889707|81669025|FG000|Overall Study|Adverse Event|1|||
27955103|NCT00889707|81669026|FG001|Overall Study|Adverse Event|0|||
27955104|NCT00889707|81669025|FG000|Overall Study|Withdrawal by Subject|4|||
27955105|NCT00889707|81669026|FG001|Overall Study|Withdrawal by Subject|3|||
27955106|NCT00889707|81669025|FG000|Overall Study|Lost to Follow-up|0|||
27955107|NCT00889707|81669026|FG001|Overall Study|Lost to Follow-up|2|||
27955108|NCT00889707|81669025|FG000|Overall Study|Lack of Efficacy|2|||
27955109|NCT00889707|81669026|FG001|Overall Study|Lack of Efficacy|5|||
27955110|NCT03533660|81669031|FG000|Overall Study|Withdrawal by Subject|2|||
27955111|NCT03533660|81669032|FG001|Overall Study|Withdrawal by Subject|2|||
27955112|NCT03533660|81669031|FG000|Overall Study|Death|2|||
27955113|NCT03533660|81669032|FG001|Overall Study|Death|4|||
27955114|NCT03533660|81669031|FG000|Overall Study|Adverse Event|0|||
27955115|NCT03533660|81669032|FG001|Overall Study|Adverse Event|2|||
27955116|NCT00066690|81669039|FG000|Overall Study|Adverse Event|145|||
27955117|NCT00066690|81669040|FG001|Overall Study|Adverse Event|58|||
27955118|NCT00066690|81669041|FG002|Overall Study|Adverse Event|126|||
27955119|NCT00066690|81669039|FG000|Overall Study|Death|3|||
27955120|NCT00066690|81669040|FG001|Overall Study|Death|0|||
27955121|NCT00066690|81669041|FG002|Overall Study|Death|2|||
27955122|NCT00066690|81669039|FG000|Overall Study|Lack of Efficacy|114|||
27955123|NCT00066690|81669040|FG001|Overall Study|Lack of Efficacy|110|||
27955124|NCT00066690|81669041|FG002|Overall Study|Lack of Efficacy|76|||
27955125|NCT00066690|81669039|FG000|Overall Study|Lost to Follow-up|40|||
27955126|NCT00066690|81669040|FG001|Overall Study|Lost to Follow-up|21|||
27955127|NCT00066690|81669041|FG002|Overall Study|Lost to Follow-up|29|||
27955128|NCT00066690|81669039|FG000|Overall Study|Withdrawal by Subject|50|||
27955129|NCT00066690|81669040|FG001|Overall Study|Withdrawal by Subject|55|||
27955130|NCT00066690|81669041|FG002|Overall Study|Withdrawal by Subject|49|||
27955131|NCT00066690|81669039|FG000|Overall Study|Treatment Ongoing|246|||
27955132|NCT00066690|81669040|FG001|Overall Study|Treatment Ongoing|278|||
27955133|NCT00066690|81669041|FG002|Overall Study|Treatment Ongoing|282|||
27955134|NCT01349673|81669042|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
27955135|NCT01349673|81669042|FG000|Overall Study|No Longer Qualified For Study|1|||
27955136|NCT01349673|81669042|FG000|Overall Study|Site Closure|10|||
27955137|NCT01349673|81669042|FG000|Overall Study|Withdrawal by Subject|21|||
27955138|NCT01349673|81669042|FG000|Overall Study|Lost to Follow-up|6|||
27955139|NCT01349673|81669042|FG000|Overall Study|Adverse Event|17|||
27955140|NCT01349673|81669042|FG000|Overall Study|Study Terminated By Sponsor|50|||
27955141|NCT01349673|81669042|FG000|Overall Study|Lack of Efficacy|8|||
27955142|NCT03289533|81669043|FG000|Overall Study|Death|12|||
27955143|NCT03289533|81669043|FG000|Overall Study|Terminated from study by sponsor|10|||
27955144|NCT03710889|81669044|FG000|Overall Study|Adverse Event|2|||
27955145|NCT03710889|81669044|FG000|Overall Study|Protocol Deviation|1|||
27955146|NCT01976299|81669045|FG000|Overall Study|Withdrawal by Subject|3|||
27955147|NCT01976299|81669046|FG001|Overall Study|Withdrawal by Subject|1|||
27955148|NCT01976299|81669045|FG000|Overall Study|Death|4|||
27955149|NCT01976299|81669046|FG001|Overall Study|Death|2|||
27955150|NCT01976299|81669045|FG000|Overall Study|Lost to Follow-up|7|||
27955151|NCT01976299|81669046|FG001|Overall Study|Lost to Follow-up|1|||
27955152|NCT01976299|81669045|FG000|Overall Study|See clarification above in comments|9|||
27955153|NCT01976299|81669046|FG001|Overall Study|See clarification above in comments|2|||
27955154|NCT04502862|81669047|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
27955155|NCT04502862|81669048|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
27955156|NCT04502862|81669047|FG000|Overall Study|Withdrawal by Subject|1|||
27955157|NCT04502862|81669048|FG001|Overall Study|Withdrawal by Subject|0|||
27955158|NCT04502862|81669047|FG000|Overall Study|Adverse Event|1|||
27955159|NCT04502862|81669048|FG001|Overall Study|Adverse Event|1|||
27955160|NCT00488514|81669051|FG000|Overall Study|Adverse Event|41|||
27955161|NCT00488514|81669051|FG000|Overall Study|Lost to Follow-up|44|||
27955162|NCT00488514|81669051|FG000|Overall Study|Protocol Violation|32|||
27955163|NCT00488514|81669051|FG000|Overall Study|Withdrawal by Subject|106|||
27955164|NCT00488514|81669051|FG000|Overall Study|Lack of Efficacy|28|||
27955165|NCT00488514|81669051|FG000|Overall Study|Did not meet criteria for treatment|30|||
27955166|NCT00488514|81669051|FG000|Overall Study|Postive drug screen|1|||
27955167|NCT00488514|81669051|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
27955168|NCT00488514|81669051|FG000|Overall Study|Investigator decision|1|||
27955169|NCT00488514|81669051|FG000|Overall Study|Participant had too few migraines|5|||
27955170|NCT00488514|81669051|FG000|Overall Study|Increase in number of migraines|2|||
27955171|NCT00488514|81669051|FG000|Overall Study|Increased use of concomitant medication|1|||
27955172|NCT04067492|81669052|FG000|Overall Study|Lost to Follow-up|0|||
27955173|NCT04067492|81669053|FG001|Overall Study|Lost to Follow-up|0|||
27955174|NCT04067492|81669054|FG002|Overall Study|Lost to Follow-up|0|||
27955175|NCT04067492|81669055|FG003|Overall Study|Lost to Follow-up|0|||
27955176|NCT04067492|81669056|FG004|Overall Study|Lost to Follow-up|0|||
27955177|NCT04067492|81669057|FG005|Overall Study|Lost to Follow-up|1|||
27955178|NCT04067492|81669052|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
27955179|NCT04067492|81669053|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
27955180|NCT04067492|81669054|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
27955181|NCT04067492|81669055|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
27955182|NCT04067492|81669056|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
27955183|NCT04067492|81669057|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
27955184|NCT04067492|81669052|FG000|Overall Study|COVID-19 epidemiological situation|0|||
27955185|NCT04067492|81669053|FG001|Overall Study|COVID-19 epidemiological situation|0|||
27955186|NCT04067492|81669054|FG002|Overall Study|COVID-19 epidemiological situation|0|||
27955187|NCT04067492|81669055|FG003|Overall Study|COVID-19 epidemiological situation|1|||
27955188|NCT04067492|81669056|FG004|Overall Study|COVID-19 epidemiological situation|0|||
27955189|NCT04067492|81669057|FG005|Overall Study|COVID-19 epidemiological situation|0|||
27955190|NCT00558636|81669061|FG000|Treatment|Adverse Event|9|||
27955191|NCT00558636|81669062|FG001|Treatment|Adverse Event|2|||
27955192|NCT00558636|81669061|FG000|Treatment|Withdrawal by Subject|2|||
27955193|NCT00558636|81669062|FG001|Treatment|Withdrawal by Subject|0|||
27955194|NCT00558636|81669061|FG000|Treatment|Premature termination of the study|35|||
27955195|NCT00558636|81669062|FG001|Treatment|Premature termination of the study|37|||
27955196|NCT00558636|81669061|FG000|Treatment|Disease progression|1|||
27955197|NCT00558636|81669062|FG001|Treatment|Disease progression|5|||
27955198|NCT00558636|81669061|FG000|Follow-up|Premature termination of the study|12|||
27955199|NCT00558636|81669062|FG001|Follow-up|Premature termination of the study|7|||
27955200|NCT01466491|81669065|FG000|Overall Study|Protocol Violation|0|||
27955201|NCT01466491|81669066|FG001|Overall Study|Protocol Violation|3|||
27955202|NCT01466491|81669067|FG002|Overall Study|Protocol Violation|2|||
27955203|NCT01466491|81669068|FG003|Overall Study|Protocol Violation|0|||
27955204|NCT01466491|81669065|FG000|Overall Study|Missing Data|0|||
27955205|NCT01466491|81669066|FG001|Overall Study|Missing Data|0|||
27955206|NCT01466491|81669067|FG002|Overall Study|Missing Data|1|||
27955207|NCT01466491|81669068|FG003|Overall Study|Missing Data|0|||
27652678|NCT00237809|80568046|FG001|Overall Study|Lost to Follow-up|10|||
27652679|NCT00237809|80568047|FG002|Overall Study|Lost to Follow-up|9|||
27652680|NCT00237809|80568048|FG003|Overall Study|Lost to Follow-up|9|||
27652681|NCT01248715|80568050|FG000|Overall Study|Not influenza positive|501|||
27652682|NCT01248715|80568051|FG001|Overall Study|Not influenza positive|510|||
27652683|NCT01190124|80568052|FG000|Overall Study|Death|3|||
27652684|NCT01190124|80568053|FG001|Overall Study|Death|0|||
27652685|NCT01190124|80568054|FG002|Overall Study|Death|0|||
27652686|NCT01190124|80568052|FG000|Overall Study|Therapeutic Failure|12|||
27652687|NCT01190124|80568053|FG001|Overall Study|Therapeutic Failure|0|||
27652688|NCT01190124|80568054|FG002|Overall Study|Therapeutic Failure|1|||
27652689|NCT01190124|80568052|FG000|Overall Study|Lost to Follow-up|2|||
27652690|NCT01190124|80568053|FG001|Overall Study|Lost to Follow-up|0|||
27652691|NCT01190124|80568054|FG002|Overall Study|Lost to Follow-up|0|||
27652692|NCT00670488|80568056|FG000|Overall Study|Adverse Event|0|||
27652693|NCT00670488|80568057|FG001|Overall Study|Adverse Event|7|||
27652694|NCT00670488|80568058|FG002|Overall Study|Adverse Event|0|||
27652695|NCT00670488|80568059|FG003|Overall Study|Adverse Event|3|||
27652696|NCT00670488|80568060|FG004|Overall Study|Adverse Event|1|||
27652697|NCT00670488|80568061|FG005|Overall Study|Adverse Event|1|||
27652698|NCT00670488|80568062|FG006|Overall Study|Adverse Event|5|||
27652699|NCT00670488|80568063|FG007|Overall Study|Adverse Event|1|||
27652700|NCT00670488|80568064|FG008|Overall Study|Adverse Event|0|||
27652701|NCT00670488|80568065|FG009|Overall Study|Adverse Event|1|||
27955208|NCT02896257|81669069|FG000|Providers|Without eligible patients|21|||
27955209|NCT02896257|81669070|FG001|Providers|Without eligible patients|28|||
27955210|NCT02896257|81669069|FG000|Patients|PFT entry criteria not met|43|||
27955211|NCT02896257|81669070|FG001|Patients|PFT entry criteria not met|50|||
27955212|NCT02896257|81669069|FG000|Patients|No capacity to review|8|||
27955213|NCT02896257|81669070|FG001|Patients|No capacity to review|11|||
27955214|NCT02896257|81669069|FG000|Patients|Appointment rescheduled/cancelled|5|||
27955215|NCT02896257|81669070|FG001|Patients|Appointment rescheduled/cancelled|7|||
27955216|NCT02896257|81669069|FG000|Patients|PCP not assigned a clinic|4|||
27955217|NCT02896257|81669070|FG001|Patients|PCP not assigned a clinic|0|||
27955218|NCT02896257|81669069|FG000|Patients|No history of COPD|0|||
27955219|NCT02896257|81669070|FG001|Patients|No history of COPD|1|||
27955220|NCT02896257|81669069|FG000|Patients|Deceased between review and index date|0|||
27955221|NCT02896257|81669070|FG001|Patients|Deceased between review and index date|1|||
27955222|NCT02896257|81669069|FG000|Patients|No ICS Rx upon review|1|||
27955223|NCT02896257|81669070|FG001|Patients|No ICS Rx upon review|1|||
27955224|NCT02896257|81669069|FG000|Patients|Protocol Violation|2|||
27955225|NCT02896257|81669070|FG001|Patients|Protocol Violation|1|||
27955226|NCT02896257|81669069|FG000|Patients|Hospice care|0|||
27955227|NCT02896257|81669070|FG001|Patients|Hospice care|1|||
27955228|NCT00636181|81669071|FG000|Overall Study|Withdrawal by Subject|8|||
27955229|NCT00636181|81669072|FG001|Overall Study|Withdrawal by Subject|6|||
27955230|NCT00636181|81669073|FG002|Overall Study|Withdrawal by Subject|10|||
27955231|NCT03848416|81669091|FG000|Overall Study|Withdrawal by Subject|1|||
27955232|NCT03848416|81669092|FG001|Overall Study|Withdrawal by Subject|0|||
27955233|NCT03848416|81669093|FG002|Overall Study|Withdrawal by Subject|0|||
27955234|NCT03848416|81669091|FG000|Overall Study|Death|0|||
27955235|NCT03848416|81669092|FG001|Overall Study|Death|0|||
27955236|NCT03848416|81669093|FG002|Overall Study|Death|1|||
27955237|NCT02848092|81669099|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
27955238|NCT02848092|81669100|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
27955239|NCT02848092|81669099|FG000|1-month Post-training Follow-up|Adverse Event|2|||
27955240|NCT02848092|81669100|FG001|1-month Post-training Follow-up|Adverse Event|1|||
27955241|NCT02848092|81669099|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
27955242|NCT02848092|81669100|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
27955243|NCT02848092|81669099|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
27955244|NCT02848092|81669100|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
27955245|NCT02848092|81669099|FG000|1-month Post-training Follow-up|fatigue|0|||
27955246|NCT02848092|81669100|FG001|1-month Post-training Follow-up|fatigue|1|||
27955247|NCT02848092|81669099|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
27955248|NCT02848092|81669100|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
27955249|NCT02848092|81669099|FG000|6-month Post-training Follow-up|Adverse Event|1|||
27955250|NCT02848092|81669100|FG001|6-month Post-training Follow-up|Adverse Event|1|||
27955251|NCT02848092|81669099|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
27955252|NCT02848092|81669100|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
27955253|NCT02848092|81669099|FG000|6-month Post-training Follow-up|frustrated with task|1|||
27955254|NCT02848092|81669100|FG001|6-month Post-training Follow-up|frustrated with task|0|||
27955255|NCT02848092|81669099|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
27652702|NCT00670488|80568056|FG000|Overall Study|Physician Decision|1|||
27652703|NCT00670488|80568057|FG001|Overall Study|Physician Decision|9|||
27652704|NCT00670488|80568058|FG002|Overall Study|Physician Decision|0|||
27652705|NCT00670488|80568059|FG003|Overall Study|Physician Decision|1|||
27652706|NCT00670488|80568060|FG004|Overall Study|Physician Decision|0|||
27652707|NCT00670488|80568061|FG005|Overall Study|Physician Decision|0|||
27652708|NCT00670488|80568062|FG006|Overall Study|Physician Decision|0|||
27652709|NCT00670488|80568063|FG007|Overall Study|Physician Decision|0|||
27652710|NCT00670488|80568064|FG008|Overall Study|Physician Decision|0|||
27652711|NCT00670488|80568065|FG009|Overall Study|Physician Decision|0|||
27652712|NCT00670488|80568056|FG000|Overall Study|Progressive Disease|2|||
27652713|NCT00670488|80568057|FG001|Overall Study|Progressive Disease|41|||
27652714|NCT00670488|80568058|FG002|Overall Study|Progressive Disease|3|||
27652715|NCT00670488|80568059|FG003|Overall Study|Progressive Disease|2|||
27652716|NCT00670488|80568060|FG004|Overall Study|Progressive Disease|2|||
27955256|NCT02848092|81669100|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
27955257|NCT02848092|81669099|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
27955258|NCT02848092|81669100|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
27955259|NCT03108521|81669101|FG000|Overall Study|Lost to Follow-up|3|||
27955260|NCT03108521|81669102|FG001|Overall Study|Lost to Follow-up|0|||
27955261|NCT03108521|81669101|FG000|Overall Study|Lack of Efficacy|2|||
27652717|NCT00670488|80568061|FG005|Overall Study|Progressive Disease|4|||
27955262|NCT03108521|81669102|FG001|Overall Study|Lack of Efficacy|0|||
27955263|NCT03108521|81669101|FG000|Overall Study|Physician Decision|4|||
27955264|NCT03108521|81669102|FG001|Overall Study|Physician Decision|0|||
27955265|NCT03108521|81669101|FG000|Overall Study|Adverse Event|3|||
27955266|NCT03108521|81669102|FG001|Overall Study|Adverse Event|0|||
27955267|NCT03965403|81669104|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
27955268|NCT00527618|81669105|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
27955269|NCT00527618|81669106|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
27955270|NCT00527618|81669105|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
27955271|NCT00527618|81669106|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
27955272|NCT00527618|81669105|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
27955273|NCT00527618|81669106|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
27955274|NCT00527618|81669105|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
27955275|NCT00527618|81669106|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
27955276|NCT00527618|81669105|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
27955277|NCT00527618|81669106|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
27955278|NCT00527618|81669105|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
27955279|NCT00527618|81669106|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
27955280|NCT02026011|81669107|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
27955281|NCT02026011|81669108|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
27955282|NCT02026011|81669107|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
27955283|NCT02026011|81669108|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
27955284|NCT02026011|81669107|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
27955285|NCT02026011|81669108|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
27955286|NCT02026011|81669107|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
27955287|NCT02026011|81669108|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
27955288|NCT03110029|81669113|FG000|Overall Study|Withdrawal by Subject|1|||
27955289|NCT03110029|81669114|FG001|Overall Study|Withdrawal by Subject|1|||
27955290|NCT01576783|81669115|FG000|Overall Study|Change in Medical Care|1|||
27955291|NCT01576783|81669116|FG001|Overall Study|Change in Medical Care|0|||
27955292|NCT01576783|81669115|FG000|Overall Study|Lost to Follow-up|14|||
27955293|NCT01576783|81669116|FG001|Overall Study|Lost to Follow-up|16|||
27955294|NCT01576783|81669115|FG000|Overall Study|Withdrawal by Subject|5|||
27955295|NCT01576783|81669116|FG001|Overall Study|Withdrawal by Subject|1|||
27955296|NCT00846846|81669117|FG000|Overall Study|Death|56|||
27955297|NCT00846846|81669117|FG000|Overall Study|Withdrawal by Subject|19|||
27955298|NCT01669902|81669118|FG000|Overall Study|Adverse Event|11|||
27955299|NCT01669902|81669118|FG000|Overall Study|Lack of Efficacy|10|||
27955300|NCT01669902|81669118|FG000|Overall Study|Other|8|||
27955301|NCT02580877|81669119|FG000|Overall Study|Withdrawal by Subject|1|||
27955302|NCT02580877|81669120|FG001|Overall Study|Withdrawal by Subject|3|||
27955303|NCT02580877|81669119|FG000|Overall Study|Adverse Event|0|||
27955304|NCT02580877|81669120|FG001|Overall Study|Adverse Event|1|||
27955305|NCT03654274|81669121|FG000|Overall Study|Adverse Event|19|||
27955306|NCT03654274|81669122|FG001|Overall Study|Adverse Event|23|||
27955307|NCT03654274|81669123|FG002|Overall Study|Adverse Event|24|||
27955308|NCT03654274|81669121|FG000|Overall Study|Protocol Deviation|0|||
27955309|NCT03654274|81669122|FG001|Overall Study|Protocol Deviation|2|||
27955310|NCT03654274|81669123|FG002|Overall Study|Protocol Deviation|0|||
27955311|NCT03654274|81669121|FG000|Overall Study|Lost to Follow-up|8|||
27955312|NCT03654274|81669122|FG001|Overall Study|Lost to Follow-up|6|||
27955313|NCT03654274|81669123|FG002|Overall Study|Lost to Follow-up|5|||
27955314|NCT03654274|81669121|FG000|Overall Study|Withdrawal by Subject|46|||
27955315|NCT03654274|81669122|FG001|Overall Study|Withdrawal by Subject|25|||
27955316|NCT03654274|81669123|FG002|Overall Study|Withdrawal by Subject|33|||
27955317|NCT03654274|81669121|FG000|Overall Study|Lack of Efficacy|4|||
27955318|NCT03654274|81669122|FG001|Overall Study|Lack of Efficacy|5|||
27955319|NCT03654274|81669123|FG002|Overall Study|Lack of Efficacy|7|||
27955320|NCT03654274|81669121|FG000|Overall Study|Pregnancy|2|||
27955321|NCT03654274|81669122|FG001|Overall Study|Pregnancy|2|||
27955322|NCT03654274|81669123|FG002|Overall Study|Pregnancy|1|||
27955323|NCT03654274|81669121|FG000|Overall Study|Other|27|||
27955324|NCT03654274|81669122|FG001|Overall Study|Other|29|||
27955325|NCT03654274|81669123|FG002|Overall Study|Other|32|||
27955326|NCT03654274|81669121|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
27955327|NCT03654274|81669122|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
27955328|NCT03654274|81669123|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
27955329|NCT03782064|81672121|FG000|Overall Study|Lack of Efficacy|2|||
27955330|NCT03782064|81672121|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
27955331|NCT00305448|81672122|FG000|Overall Study|Protocol Violation|0|||
27955332|NCT00305448|81672123|FG001|Overall Study|Protocol Violation|1|||
27955333|NCT00305448|81672124|FG002|Overall Study|Protocol Violation|0|||
27955334|NCT00305448|81672122|FG000|Overall Study|Withdrawal by Subject|2|||
27955335|NCT00305448|81672123|FG001|Overall Study|Withdrawal by Subject|0|||
27955336|NCT00305448|81672124|FG002|Overall Study|Withdrawal by Subject|1|||
27955337|NCT00305448|81672122|FG000|Overall Study|Adverse Event|1|||
27955338|NCT00305448|81672123|FG001|Overall Study|Adverse Event|0|||
27955339|NCT00305448|81672124|FG002|Overall Study|Adverse Event|1|||
27955340|NCT00305448|81672122|FG000|Overall Study|Disease Progression|27|||
27955341|NCT00305448|81672123|FG001|Overall Study|Disease Progression|31|||
27955342|NCT00305448|81672124|FG002|Overall Study|Disease Progression|28|||
27955343|NCT00305448|81672122|FG000|Overall Study|Subjective Disease Progression|1|||
27955344|NCT00305448|81672123|FG001|Overall Study|Subjective Disease Progression|2|||
27955345|NCT00305448|81672124|FG002|Overall Study|Subjective Disease Progression|2|||
27955346|NCT00305448|81672122|FG000|Overall Study|Tumor Marker Elevation|0|||
27955347|NCT00305448|81672123|FG001|Overall Study|Tumor Marker Elevation|0|||
27955348|NCT00305448|81672124|FG002|Overall Study|Tumor Marker Elevation|1|||
27955349|NCT01840943|81672128|FG000|Overall Study|Withdrawal by Subject|5|||
27955350|NCT01840943|81672129|FG001|Overall Study|Withdrawal by Subject|6|||
27955351|NCT01840943|81672128|FG000|Overall Study|Physician Decision|4|||
27955352|NCT01840943|81672129|FG001|Overall Study|Physician Decision|2|||
27955353|NCT01840943|81672128|FG000|Overall Study|Lost to Follow-up|4|||
27955354|NCT01840943|81672129|FG001|Overall Study|Lost to Follow-up|4|||
27955355|NCT01147393|81672130|FG000|Dose Level 1|Dose limiting Toxicity|2|||
27955356|NCT01147393|81672130|FG000|Dose Level -1|Dose Limited Toxicity|1|||
27955357|NCT00939107|81672131|FG000|Overall Study|Lost to Follow-up|14|||
27955358|NCT00939107|81672132|FG001|Overall Study|Lost to Follow-up|12|||
27955359|NCT03824392|81672133|FG000|Overall Study|Adverse Event|1|||
27955360|NCT03824392|81672134|FG001|Overall Study|Adverse Event|0|||
27955361|NCT03824392|81672135|FG002|Overall Study|Adverse Event|0|||
27955362|NCT03824392|81672136|FG003|Overall Study|Adverse Event|0|||
27955363|NCT03824392|81672133|FG000|Overall Study|Investigator Decision|0|||
27955364|NCT03824392|81672134|FG001|Overall Study|Investigator Decision|1|||
27955365|NCT03824392|81672135|FG002|Overall Study|Investigator Decision|0|||
27955366|NCT03824392|81672136|FG003|Overall Study|Investigator Decision|0|||
27955367|NCT03824392|81672133|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
27955368|NCT03824392|81672134|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
27955369|NCT03824392|81672135|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
27955370|NCT03824392|81672136|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
27955371|NCT01261975|81672139|FG000|Overall Study|Surgical complication|1|||
27955372|NCT02332187|81672142|FG000|Overall Study|Withdrawal by Subject|2|||
27955373|NCT02332187|81672143|FG001|Overall Study|Withdrawal by Subject|2|||
27955374|NCT02332187|81672142|FG000|Overall Study|Adverse Event|0|||
27955375|NCT02332187|81672143|FG001|Overall Study|Adverse Event|1|||
27955376|NCT00436436|81672146|FG000|Overall Study|Progression|4|||
27955377|NCT00436436|81672146|FG000|Overall Study|Adverse Event|2|||
27955378|NCT00436436|81672146|FG000|Overall Study|Death|6|||
27955379|NCT01402869|81672147|FG000|Overall Study|Required Tooth Extraction|0|||
27955380|NCT01402869|81672148|FG001|Overall Study|Required Tooth Extraction|0|||
27955381|NCT01402869|81672149|FG002|Overall Study|Required Tooth Extraction|1|||
27955382|NCT00305877|81672150|FG000|Overall Study|Lack of Efficacy|6|||
27955383|NCT00305877|81672151|FG001|Overall Study|Lack of Efficacy|9|||
27955384|NCT00305877|81672150|FG000|Overall Study|Adverse Event|9|||
27955385|NCT00305877|81672151|FG001|Overall Study|Adverse Event|14|||
27955386|NCT00305877|81672150|FG000|Overall Study|Death|0|||
27955387|NCT00305877|81672151|FG001|Overall Study|Death|1|||
27955388|NCT00305877|81672150|FG000|Overall Study|Withdrawal by Subject|4|||
27955389|NCT00305877|81672151|FG001|Overall Study|Withdrawal by Subject|2|||
27955390|NCT00305877|81672150|FG000|Overall Study|Physician Decision|1|||
27955391|NCT00305877|81672151|FG001|Overall Study|Physician Decision|1|||
27955392|NCT00305877|81672150|FG000|Overall Study|Never start treatment|2|||
27955393|NCT00305877|81672151|FG001|Overall Study|Never start treatment|5|||
27955394|NCT00305877|81672150|FG000|Overall Study|Ineligible|2|||
27955395|NCT00305877|81672151|FG001|Overall Study|Ineligible|1|||
27955396|NCT00305877|81672150|FG000|Overall Study|Transportation issue with daily RT|0|||
27955397|NCT00305877|81672151|FG001|Overall Study|Transportation issue with daily RT|1|||
27955398|NCT02808429|81672156|FG000|Overall Study|Lost to Follow-up|1|||
27955399|NCT02808429|81672157|FG001|Overall Study|Lost to Follow-up|0|||
27955400|NCT02808429|81672158|FG002|Overall Study|Lost to Follow-up|0|||
27955401|NCT02808429|81672156|FG000|Overall Study|Protocol Violation|0|||
27955402|NCT02808429|81672157|FG001|Overall Study|Protocol Violation|1|||
27955403|NCT02808429|81672158|FG002|Overall Study|Protocol Violation|0|||
27955404|NCT02808429|81672156|FG000|Overall Study|Premature study termination by sponsor|2|||
27955405|NCT02808429|81672157|FG001|Overall Study|Premature study termination by sponsor|0|||
27955406|NCT02808429|81672158|FG002|Overall Study|Premature study termination by sponsor|1|||
27955407|NCT02808429|81672156|FG000|Overall Study|Relocation|0|||
27955408|NCT02808429|81672157|FG001|Overall Study|Relocation|0|||
27955409|NCT02808429|81672158|FG002|Overall Study|Relocation|1|||
27955410|NCT01213082|81672162|FG000|Overall Study|Lost to Follow-up|6|||
27955411|NCT01213082|81672163|FG001|Overall Study|Lost to Follow-up|7|||
27955412|NCT01213082|81672164|FG002|Overall Study|Lost to Follow-up|4|||
27955413|NCT01213082|81672162|FG000|Overall Study|Physician Decision|0|||
27955414|NCT01213082|81672163|FG001|Overall Study|Physician Decision|0|||
27955415|NCT01213082|81672164|FG002|Overall Study|Physician Decision|1|||
27955416|NCT01500317|81672165|FG000|Overall Study|Withdrawal by Subject|3|||
27955417|NCT01500317|81672166|FG001|Overall Study|Withdrawal by Subject|2|||
27955418|NCT01500317|81672167|FG002|Overall Study|Withdrawal by Subject|0|||
27955419|NCT01544348|81672168|FG000|Overall Study|Lost to Follow-up|1|||
27955420|NCT01544348|81672169|FG001|Overall Study|Lost to Follow-up|0|||
27955421|NCT01544348|81672170|FG002|Overall Study|Lost to Follow-up|0|||
27955422|NCT01544348|81672171|FG003|Overall Study|Lost to Follow-up|0|||
27955423|NCT01544348|81672172|FG004|Overall Study|Lost to Follow-up|0|||
27955424|NCT01544348|81672173|FG005|Overall Study|Lost to Follow-up|0|||
27955425|NCT01544348|81672174|FG006|Overall Study|Lost to Follow-up|1|||
27955426|NCT01544348|81672175|FG007|Overall Study|Lost to Follow-up|0|||
27955427|NCT01544348|81672168|FG000|Overall Study|Withdrawal by Subject|1|||
27955428|NCT01544348|81672169|FG001|Overall Study|Withdrawal by Subject|0|||
27955429|NCT01544348|81672170|FG002|Overall Study|Withdrawal by Subject|0|||
27955430|NCT01544348|81672171|FG003|Overall Study|Withdrawal by Subject|0|||
27955431|NCT01544348|81672172|FG004|Overall Study|Withdrawal by Subject|1|||
27955432|NCT01544348|81672173|FG005|Overall Study|Withdrawal by Subject|2|||
27955433|NCT01544348|81672174|FG006|Overall Study|Withdrawal by Subject|1|||
27955434|NCT01544348|81672175|FG007|Overall Study|Withdrawal by Subject|0|||
27955435|NCT01544348|81672168|FG000|Overall Study|Physician Decision|0|||
27955436|NCT01544348|81672169|FG001|Overall Study|Physician Decision|0|||
27955437|NCT01544348|81672170|FG002|Overall Study|Physician Decision|0|||
27955438|NCT01544348|81672171|FG003|Overall Study|Physician Decision|0|||
27955439|NCT01544348|81672172|FG004|Overall Study|Physician Decision|0|||
27955440|NCT01544348|81672173|FG005|Overall Study|Physician Decision|1|||
27955441|NCT01544348|81672174|FG006|Overall Study|Physician Decision|0|||
27955442|NCT01544348|81672175|FG007|Overall Study|Physician Decision|0|||
27955443|NCT02479880|81672176|FG000|Overall Study|Study Terminated by Sponsor|13|||
27955444|NCT02479880|81672177|FG001|Overall Study|Study Terminated by Sponsor|12|||
27955445|NCT02479880|81672176|FG000|Overall Study|Pregnancy|0|||
27955446|NCT02479880|81672177|FG001|Overall Study|Pregnancy|1|||
27955447|NCT01273038|81672178|FG000|Second Intervention (14 Days)|Adverse Event|0|||
27955448|NCT01273038|81672179|FG001|Second Intervention (14 Days)|Adverse Event|1|||
27955449|NCT01273038|81672178|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
27955450|NCT01273038|81672179|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
27955451|NCT02709720|81672180|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
27955452|NCT02709720|81672180|FG000|Overall Study|Protocol Violation|1|||
27955453|NCT02709720|81672180|FG000|Overall Study|Not take study medication|1|||
27955454|NCT02737501|81672181|FG000|Randomized Phase|Died|41|||
27955455|NCT02737501|81672182|FG001|Randomized Phase|Died|29|||
27955456|NCT02737501|81672183|FG002|Randomized Phase|Died|0|||
27955457|NCT02737501|81672181|FG000|Randomized Phase|Withdrawal by Subject|16|||
27955458|NCT02737501|81672182|FG001|Randomized Phase|Withdrawal by Subject|6|||
27955459|NCT02737501|81672183|FG002|Randomized Phase|Withdrawal by Subject|0|||
27955460|NCT02737501|81672181|FG000|Randomized Phase|Lost to Follow-up|0|||
27955461|NCT02737501|81672182|FG001|Randomized Phase|Lost to Follow-up|1|||
27955462|NCT02737501|81672183|FG002|Randomized Phase|Lost to Follow-up|0|||
27955463|NCT02737501|81672181|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
27955464|NCT02737501|81672182|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
27955465|NCT02737501|81672183|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
27955466|NCT02737501|81672181|FG000|Randomized Phase|Reason not Specified|1|||
27955467|NCT02737501|81672182|FG001|Randomized Phase|Reason not Specified|1|||
27955468|NCT02737501|81672183|FG002|Randomized Phase|Reason not Specified|0|||
27955469|NCT02737501|81672181|FG000|Randomized Phase|Never Treated|1|||
27955470|NCT02737501|81672182|FG001|Randomized Phase|Never Treated|1|||
27955471|NCT02737501|81672183|FG002|Randomized Phase|Never Treated|0|||
27955472|NCT02737501|81672181|FG000|Crossover Phase|Died|0|||
27955473|NCT02737501|81672182|FG001|Crossover Phase|Died|0|||
27955474|NCT02737501|81672183|FG002|Crossover Phase|Died|22|||
27955475|NCT02737501|81672181|FG000|Crossover Phase|Withdrew Consent|0|||
27955476|NCT02737501|81672182|FG001|Crossover Phase|Withdrew Consent|0|||
27955477|NCT02737501|81672183|FG002|Crossover Phase|Withdrew Consent|9|||
27955478|NCT02737501|81672181|FG000|Crossover Phase|Physician Decision|0|||
27652718|NCT00670488|80568062|FG006|Overall Study|Progressive Disease|11|||
27652719|NCT00670488|80568063|FG007|Overall Study|Progressive Disease|2|||
27652720|NCT00670488|80568064|FG008|Overall Study|Progressive Disease|2|||
27652721|NCT00670488|80568065|FG009|Overall Study|Progressive Disease|1|||
27652722|NCT00670488|80568056|FG000|Overall Study|Withdrawal by Subject|0|||
27955479|NCT02737501|81672182|FG001|Crossover Phase|Physician Decision|0|||
27955480|NCT02737501|81672183|FG002|Crossover Phase|Physician Decision|1|||
27652723|NCT00670488|80568057|FG001|Overall Study|Withdrawal by Subject|1|||
27652724|NCT00670488|80568058|FG002|Overall Study|Withdrawal by Subject|0|||
27955481|NCT02737501|81672181|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
27955482|NCT02737501|81672182|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
27652725|NCT00670488|80568059|FG003|Overall Study|Withdrawal by Subject|1|||
27652726|NCT00670488|80568060|FG004|Overall Study|Withdrawal by Subject|0|||
27652727|NCT00670488|80568061|FG005|Overall Study|Withdrawal by Subject|0|||
27652728|NCT00670488|80568062|FG006|Overall Study|Withdrawal by Subject|1|||
27652729|NCT00670488|80568063|FG007|Overall Study|Withdrawal by Subject|0|||
27652730|NCT00670488|80568064|FG008|Overall Study|Withdrawal by Subject|1|||
27652731|NCT00670488|80568065|FG009|Overall Study|Withdrawal by Subject|0|||
27652732|NCT01722097|80568067|FG000|Overall Study|Patient sheets not returned|6|||
27652733|NCT01722097|80568068|FG001|Overall Study|Patient sheets not returned|5|||
27652734|NCT05260437|80568069|FG000|Overall Study|Lost to Follow-up|5|||
27652735|NCT05260437|80568070|FG001|Overall Study|Lost to Follow-up|2|||
27652736|NCT05260437|80568071|FG002|Overall Study|Lost to Follow-up|1|||
27652737|NCT05260437|80568072|FG003|Overall Study|Lost to Follow-up|2|||
27652738|NCT05260437|80568073|FG004|Overall Study|Lost to Follow-up|2|||
27652739|NCT05260437|80568069|FG000|Overall Study|Withdrawal by Subject|3|||
27652740|NCT05260437|80568070|FG001|Overall Study|Withdrawal by Subject|0|||
27652741|NCT05260437|80568071|FG002|Overall Study|Withdrawal by Subject|4|||
27652742|NCT05260437|80568072|FG003|Overall Study|Withdrawal by Subject|5|||
27652743|NCT05260437|80568073|FG004|Overall Study|Withdrawal by Subject|0|||
27652744|NCT05260437|80568069|FG000|Overall Study|Vaccine Not Administered|0|||
27652745|NCT05260437|80568070|FG001|Overall Study|Vaccine Not Administered|1|||
27652746|NCT05260437|80568071|FG002|Overall Study|Vaccine Not Administered|0|||
27652747|NCT05260437|80568072|FG003|Overall Study|Vaccine Not Administered|0|||
27652748|NCT05260437|80568073|FG004|Overall Study|Vaccine Not Administered|0|||
27652749|NCT02674399|80568074|FG000|Overall Study|Lost to Follow-up|2|||
27652750|NCT02674399|80568075|FG001|Overall Study|Lost to Follow-up|0|||
27652751|NCT01020435|80568082|FG000|Overall Study|Lost to Follow-up|0|||
27652752|NCT01020435|80568083|FG001|Overall Study|Lost to Follow-up|1|||
27652753|NCT00257556|80568089|FG000|Overall Study|Adverse Event|1|||
27652754|NCT00257556|80568090|FG001|Overall Study|Adverse Event|4|||
27652755|NCT00257556|80568089|FG000|Overall Study|Physician Decision|6|||
27652756|NCT00257556|80568090|FG001|Overall Study|Physician Decision|0|||
27652757|NCT00257556|80568089|FG000|Overall Study|Did not meet hCG criterion|3|||
27652758|NCT00257556|80568090|FG001|Overall Study|Did not meet hCG criterion|0|||
27652759|NCT00257556|80568089|FG000|Overall Study|other reason|4|||
27652760|NCT00257556|80568090|FG001|Overall Study|other reason|6|||
27652761|NCT02128269|80568091|FG000|Treatment Period|Adverse Event|1|||
27652762|NCT02128269|80568091|FG000|Treatment Period|Physician Decision|1|||
27652763|NCT02382640|80568094|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
27652764|NCT02382640|80568095|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
27652765|NCT02382640|80568096|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
27652766|NCT02382640|80568097|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
27652767|NCT00439218|80568098|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
27652768|NCT03746015|80568106|FG000|Overall Study|Withdrawal of Consent|1|||
27652769|NCT03746015|80568107|FG001|Overall Study|Withdrawal of Consent|0|||
27652770|NCT03746015|80568108|FG002|Overall Study|Withdrawal of Consent|0|||
27652771|NCT01999335|80568109|FG000|Overall Study|Discontinued before receiving treatment|0|||
27652772|NCT01999335|80568110|FG001|Overall Study|Discontinued before receiving treatment|0|||
27652773|NCT01999335|80568111|FG002|Overall Study|Discontinued before receiving treatment|0|||
27652774|NCT01999335|80568112|FG003|Overall Study|Discontinued before receiving treatment|0|||
27652775|NCT01999335|80568113|FG004|Overall Study|Discontinued before receiving treatment|2|||
27652776|NCT01393600|80568114|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
27652777|NCT01393600|80568115|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
27652778|NCT01393600|80568116|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
27955483|NCT02737501|81672183|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
27955484|NCT01016132|81672184|FG000|Overall Study|Discomfort|1|||
27955485|NCT00742625|81672188|FG000|Remission Induction|Progression|6|||
27955486|NCT00742625|81672188|FG000|Remission Induction|Failed induction|8|||
27652779|NCT01393600|80568117|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
27652780|NCT01393600|80568114|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
27652781|NCT01393600|80568115|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
27652782|NCT01393600|80568116|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
27652783|NCT01393600|80568117|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
27652784|NCT01393600|80568114|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
27652785|NCT01393600|80568115|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
27652786|NCT01393600|80568116|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
27652787|NCT01393600|80568117|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
27652788|NCT01393600|80568114|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
27652789|NCT01393600|80568115|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
27652790|NCT01393600|80568116|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
27652791|NCT01393600|80568117|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
27652792|NCT01393600|80568114|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
27652793|NCT01393600|80568115|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
27652794|NCT01393600|80568116|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
27652795|NCT01393600|80568117|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
27652796|NCT01393600|80568114|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
27652797|NCT01393600|80568115|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
27652798|NCT01393600|80568116|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
27652799|NCT01393600|80568117|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
27652800|NCT01393600|80568114|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
27652801|NCT01393600|80568115|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
27652802|NCT01393600|80568116|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
27652803|NCT01393600|80568117|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
27652804|NCT01613599|80568122|FG000|Overall Study|Death|9|||
27652805|NCT01613599|80568122|FG000|Overall Study|Lost to Follow-up|5|||
27652806|NCT01613599|80568122|FG000|Overall Study|Withdrawal by Subject|8|||
27652807|NCT01613599|80568122|FG000|Overall Study|Reason not specified|3|||
27652808|NCT00648895|80568123|FG000|Overall Study|Lack of Efficacy|0|||
27652809|NCT00648895|80568124|FG001|Overall Study|Lack of Efficacy|1|||
27652810|NCT02010684|80568125|FG000|Overall Study|Lost to Follow-up|8|||
27652811|NCT02010684|80568126|FG001|Overall Study|Lost to Follow-up|18|||
27652812|NCT02010684|80568125|FG000|Overall Study|Withdrawal by Subject|4|||
27652813|NCT02010684|80568126|FG001|Overall Study|Withdrawal by Subject|5|||
27652814|NCT01065779|80568127|FG000|Overall Study|Duplicate Investigation|1|||
27652815|NCT01065779|80568127|FG000|Overall Study|Investigation Before Contract Date|37|||
27652816|NCT01065779|80568127|FG000|Overall Study|Non-enrollment Period Administration|10|||
27652817|NCT01065779|80568127|FG000|Overall Study|Not Administered With Study Drug|17|||
27652818|NCT01065779|80568127|FG000|Overall Study|Failed to Follow-up|10|||
27652819|NCT01065779|80568127|FG000|Overall Study|Inclusion Criteria Violation|7|||
27652820|NCT04222088|80568128|FG000|Overall Study|Lost to Follow-up|5|||
27652821|NCT04222088|80568129|FG001|Overall Study|Lost to Follow-up|1|||
27652822|NCT04222088|80568128|FG000|Overall Study|Withdrawal by Subject|4|||
27652823|NCT04222088|80568129|FG001|Overall Study|Withdrawal by Subject|0|||
27652824|NCT03005106|80568134|FG000|Overall Study|Lost to Follow-up|16|||
27652825|NCT03005106|80568134|FG000|Overall Study|Adverse Event|1|||
27652826|NCT03005106|80568134|FG000|Overall Study|Physician Decision|1|||
27652827|NCT03005106|80568134|FG000|Overall Study|Death|2|||
27652828|NCT01794689|80568135|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
27652829|NCT01794689|80568136|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
27652830|NCT01794689|80568137|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
27652831|NCT01794689|80568138|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
27652832|NCT01794689|80568135|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
27652833|NCT01794689|80568136|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
27652834|NCT01794689|80568137|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
27652835|NCT01794689|80568138|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
27652836|NCT01794689|80568135|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
27652837|NCT01794689|80568136|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
27652838|NCT01794689|80568137|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
27652839|NCT01794689|80568138|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
27652840|NCT01794689|80568135|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
27652841|NCT01794689|80568136|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
27652842|NCT01794689|80568137|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
27652843|NCT01794689|80568138|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
27652844|NCT01884571|80568140|FG000|Overall Study|Adverse Event|1|||
27652845|NCT01884571|80568140|FG000|Overall Study|Death|2|||
27652846|NCT01884571|80568140|FG000|Overall Study|Withdrawal by Subject|2|||
27652847|NCT01884571|80568140|FG000|Overall Study|Disease progression|3|||
27652848|NCT01681511|80568141|FG000|Overall Study|No Treatment Received|1|||
27652849|NCT01681511|80568142|FG001|Overall Study|No Treatment Received|3|||
27652850|NCT01681511|80568141|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
27652851|NCT01681511|80568142|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
27652852|NCT01681511|80568141|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
27652853|NCT01681511|80568142|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
27652854|NCT01681511|80568141|FG000|Overall Study|No Daily Urine Sample Collected|0|||
27652855|NCT01681511|80568142|FG001|Overall Study|No Daily Urine Sample Collected|1|||
27652856|NCT01681511|80568141|FG000|Overall Study|No post-catheter sample collected|11|||
27652857|NCT01681511|80568142|FG001|Overall Study|No post-catheter sample collected|4|||
27652858|NCT00721734|80568143|FG000|Overall Study|Progressive Disease|3|||
27652859|NCT00721734|80568144|FG001|Overall Study|Progressive Disease|10|||
27652860|NCT00721734|80568145|FG002|Overall Study|Progressive Disease|4|||
27652861|NCT00721734|80568146|FG003|Overall Study|Progressive Disease|5|||
27652862|NCT00721734|80568147|FG004|Overall Study|Progressive Disease|2|||
27652863|NCT00721734|80568143|FG000|Overall Study|Adverse Event|3|||
27652864|NCT00721734|80568144|FG001|Overall Study|Adverse Event|1|||
27652865|NCT00721734|80568145|FG002|Overall Study|Adverse Event|4|||
27652866|NCT00721734|80568146|FG003|Overall Study|Adverse Event|0|||
27652867|NCT00721734|80568147|FG004|Overall Study|Adverse Event|3|||
27652868|NCT00721734|80568143|FG000|Overall Study|Withdrawal by Subject|2|||
27652869|NCT00721734|80568144|FG001|Overall Study|Withdrawal by Subject|1|||
27652870|NCT00721734|80568145|FG002|Overall Study|Withdrawal by Subject|0|||
27652871|NCT00721734|80568146|FG003|Overall Study|Withdrawal by Subject|0|||
27652872|NCT00721734|80568147|FG004|Overall Study|Withdrawal by Subject|1|||
27652873|NCT00721734|80568143|FG000|Overall Study|Other|0|||
27652874|NCT00721734|80568144|FG001|Overall Study|Other|0|||
27652875|NCT00721734|80568145|FG002|Overall Study|Other|0|||
27652876|NCT00721734|80568146|FG003|Overall Study|Other|1|||
27652877|NCT00721734|80568147|FG004|Overall Study|Other|0|||
27652878|NCT00442559|80568148|FG000|Overall Study|Lost to Follow-up|32|||
27652879|NCT00442559|80568149|FG001|Overall Study|Lost to Follow-up|34|||
27652880|NCT00442559|80568148|FG000|Overall Study|Protocol Violation|1|||
27652881|NCT00442559|80568149|FG001|Overall Study|Protocol Violation|1|||
27652882|NCT00442559|80568148|FG000|Overall Study|Withdrawal by Subject|1|||
27652883|NCT00442559|80568149|FG001|Overall Study|Withdrawal by Subject|0|||
27652884|NCT04410445|80568152|FG000|Overall Study|Lost to Follow-up|3|||
27652885|NCT04410445|80568153|FG001|Overall Study|Lost to Follow-up|9|||
27652886|NCT04410445|80568152|FG000|Overall Study|Withdrawal by Subject|27|||
27652887|NCT04410445|80568153|FG001|Overall Study|Withdrawal by Subject|15|||
27652888|NCT01190436|80568154|FG000|Overall Study|Lost to Follow-up|35|||
27652889|NCT01190436|80568154|FG000|Overall Study|Other|4|||
27652890|NCT01009645|80570651|FG000|Overall Study|Lost to Follow-up|2|||
27652891|NCT01009645|80570652|FG001|Overall Study|Lost to Follow-up|8|||
27652892|NCT01009645|80570653|FG002|Overall Study|Lost to Follow-up|4|||
27652893|NCT01009645|80570654|FG003|Overall Study|Lost to Follow-up|5|||
27652894|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
27652895|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
27652896|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
27652897|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
27652898|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
27652899|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
27652900|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
27652901|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
27652902|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
27652903|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
27652904|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
27652905|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
27652906|NCT01494467|80570655|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
27652907|NCT01494467|80570656|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
27652908|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
27652909|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
27652910|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
27652911|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
27652912|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
27652913|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
27652914|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
27652915|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
27652916|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
27652917|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
27652918|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
27652919|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
27652920|NCT01494467|80570655|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
27652921|NCT01494467|80570656|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
27652922|NCT03029585|80570658|FG000|Overall Study|Death|1|||
27652923|NCT03029585|80570659|FG001|Overall Study|Death|1|||
27652924|NCT03029585|80570658|FG000|Overall Study|Withdrawal by Subject|1|||
27652925|NCT03029585|80570659|FG001|Overall Study|Withdrawal by Subject|0|||
27652926|NCT02138838|80570660|FG000|Overall Study|Study Closure|7|||
27652927|NCT02138838|80570661|FG001|Overall Study|Study Closure|6|||
27652928|NCT02138838|80570660|FG000|Overall Study|Withdrawal by Subject|1|||
27652929|NCT02138838|80570661|FG001|Overall Study|Withdrawal by Subject|5|||
27652930|NCT00091572|80570664|FG000|Overall Study|Lost to Follow-up|1|||
27652931|NCT00091572|80570665|FG001|Overall Study|Lost to Follow-up|1|||
27652932|NCT00091572|80570664|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
27652933|NCT00091572|80570665|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
27652934|NCT00091572|80570664|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
27652935|NCT00091572|80570665|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
27652936|NCT00091572|80570664|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
27652937|NCT00091572|80570665|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
27652938|NCT00091572|80570664|FG000|Overall Study|Other Reason|6|||
27652939|NCT00091572|80570665|FG001|Overall Study|Other Reason|13|||
27751619|NCT04657016|80918177|FG001|Overall Study|Pregnancy|2|||
27652940|NCT00091572|80570664|FG000|Overall Study|Ongoing (still on treatment)|8|||
27652941|NCT00091572|80570665|FG001|Overall Study|Ongoing (still on treatment)|12|||
27652942|NCT00091572|80570664|FG000|Overall Study|Major Protocol Violation|2|||
27652943|NCT00091572|80570665|FG001|Overall Study|Major Protocol Violation|0|||
27652944|NCT00091572|80570664|FG000|Overall Study|Toxicity (Related AE)|53|||
27652945|NCT00091572|80570665|FG001|Overall Study|Toxicity (Related AE)|9|||
27652946|NCT00990184|80570666|FG000|Overall Study|Physician Decision|1|||
27652947|NCT01322386|80570667|FG000|Overall Study|Protocol Violation|0|||
27652948|NCT01322386|80570668|FG001|Overall Study|Protocol Violation|1|||
27652949|NCT01322386|80570667|FG000|Overall Study|Physician Decision|0|||
27652950|NCT01322386|80570668|FG001|Overall Study|Physician Decision|1|||
27652951|NCT00624377|80570669|FG000|Overall Study|Lost to Follow-up|355|||
27652952|NCT00624377|80570669|FG000|Overall Study|Withdrawal by Subject|100|||
27652953|NCT00624377|80570669|FG000|Overall Study|Adverse Event|14|||
27652954|NCT00624377|80570669|FG000|Overall Study|Other|91|||
27652955|NCT00624377|80570669|FG000|Overall Study|Non-evaluable population|84|||
27652956|NCT01640288|80570670|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
27652957|NCT01640288|80570671|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
27652958|NCT01640288|80570670|FG000|Overall Study|Screen Failure|20|||
27652959|NCT01640288|80570671|FG001|Overall Study|Screen Failure|18|||
27652960|NCT01640288|80570670|FG000|Overall Study|Withdrawn by PI|5|||
27652961|NCT01640288|80570671|FG001|Overall Study|Withdrawn by PI|0|||
27652962|NCT01640288|80570670|FG000|Overall Study|Withdrawal by Subject|1|||
27652963|NCT01640288|80570671|FG001|Overall Study|Withdrawal by Subject|0|||
27652964|NCT00489554|80570672|FG000|Overall Study|Adverse Event|2|||
27652965|NCT00489554|80570672|FG000|Overall Study|Withdrawal by Subject|1|||
27652966|NCT00489554|80570672|FG000|Overall Study|Lost to Follow-up|1|||
27652967|NCT02152384|80570673|FG000|Period 1|Withdrawal by Subject|0|||
27652968|NCT02152384|80570674|FG001|Period 1|Withdrawal by Subject|1|||
27652969|NCT02152384|80570673|FG000|Period 1|Adverse Event|1|||
27652970|NCT02152384|80570674|FG001|Period 1|Adverse Event|1|||
27652971|NCT01697956|80570675|FG000|Overall Study|Protocol Violation|1|||
27652972|NCT01697956|80570676|FG001|Overall Study|Protocol Violation|1|||
27652973|NCT01970527|80570679|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
27652974|NCT01970527|80570680|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
27652975|NCT01970527|80570679|FG000|Treatment|Disease progression|0|||
27652976|NCT01970527|80570680|FG001|Treatment|Disease progression|1|||
27652977|NCT01970527|80570679|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
27652978|NCT01970527|80570680|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
27652979|NCT01970527|80570679|FG000|Treatment|Death|0|||
27652980|NCT01970527|80570680|FG001|Treatment|Death|1|||
27652981|NCT01970527|80570679|FG000|Follow-up Clinic Visit|Disease progression|1|||
27652982|NCT01970527|80570680|FG001|Follow-up Clinic Visit|Disease progression|1|||
27652983|NCT01970527|80570679|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
27652984|NCT01970527|80570680|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
27652985|NCT01970527|80570679|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
27652986|NCT01970527|80570680|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
27652987|NCT00417885|80570681|FG000|Overall Study|Adverse Event|1|||
27652988|NCT00417885|80570681|FG000|Overall Study|Objective Progression or Relapse|3|||
27652989|NCT00417885|80570681|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
27652990|NCT00584909|80570686|FG000|Overall Study|Adverse Event|4|||
27652991|NCT05124210|80570687|FG000|Overall Study|Lost to Follow-up|1|||
27652992|NCT05124210|80570688|FG001|Overall Study|Lost to Follow-up|0|||
27652993|NCT05124210|80570687|FG000|Overall Study|Withdrawal by Subject|1|||
27652994|NCT05124210|80570688|FG001|Overall Study|Withdrawal by Subject|0|||
27652995|NCT00980538|80570690|FG000|Overall Study|Lost to Follow-up|20|||
27652996|NCT00980538|80570690|FG000|Overall Study|Sponsor's Decision|4|||
27652997|NCT00980538|80570690|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
27652998|NCT00980538|80570690|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
27652999|NCT00980538|80570690|FG000|Overall Study|Switch to Commercially Available Medication|25|||
27653000|NCT00980538|80570690|FG000|Overall Study|Participant Non-Compliant|9|||
27653001|NCT00980538|80570690|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
27653002|NCT00980538|80570690|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
27653003|NCT00980538|80570690|FG000|Overall Study|Other|60|||
27653004|NCT00980538|80570690|FG000|Overall Study|Other|1|||
27653005|NCT00308308|80570693|FG000|Overall Study|Adverse Event|17|||
27653006|NCT00308308|80570694|FG001|Overall Study|Adverse Event|2|||
27653007|NCT00308308|80570693|FG000|Overall Study|Lost to Follow-up|5|||
27653008|NCT00308308|80570694|FG001|Overall Study|Lost to Follow-up|5|||
27653009|NCT00308308|80570693|FG000|Overall Study|Physician Decision|15|||
27653010|NCT00308308|80570694|FG001|Overall Study|Physician Decision|7|||
27653011|NCT00308308|80570693|FG000|Overall Study|Protocol Violation|3|||
27653012|NCT00308308|80570694|FG001|Overall Study|Protocol Violation|14|||
27653013|NCT00308308|80570693|FG000|Overall Study|Withdrawal by Subject|47|||
27653014|NCT00308308|80570694|FG001|Overall Study|Withdrawal by Subject|19|||
27653015|NCT00308308|80570693|FG000|Overall Study|Various|7|||
27653016|NCT00308308|80570694|FG001|Overall Study|Various|5|||
27653017|NCT00308308|80570693|FG000|Overall Study|Randomized but not dosed|8|||
27653018|NCT00308308|80570694|FG001|Overall Study|Randomized but not dosed|16|||
27653019|NCT00308308|80570693|FG000|Overall Study|Other|1|||
27653020|NCT00308308|80570694|FG001|Overall Study|Other|0|||
27653021|NCT03602053|80570695|FG000|Overall Study|Withdrawal by Subject|7|||
27653022|NCT03602053|80570696|FG001|Overall Study|Withdrawal by Subject|9|||
27653023|NCT03602053|80570697|FG002|Overall Study|Withdrawal by Subject|7|||
27653024|NCT03602053|80570695|FG000|Overall Study|Lost to Follow-up|5|||
27653025|NCT03602053|80570696|FG001|Overall Study|Lost to Follow-up|6|||
27653026|NCT03602053|80570697|FG002|Overall Study|Lost to Follow-up|0|||
27653027|NCT03602053|80570695|FG000|Overall Study|Protocol Violation|3|||
27653028|NCT03602053|80570696|FG001|Overall Study|Protocol Violation|0|||
27653029|NCT03602053|80570697|FG002|Overall Study|Protocol Violation|4|||
27653030|NCT03602053|80570695|FG000|Overall Study|Physician Decision|1|||
27653031|NCT03602053|80570696|FG001|Overall Study|Physician Decision|0|||
27653032|NCT03602053|80570697|FG002|Overall Study|Physician Decision|0|||
27653033|NCT03602053|80570695|FG000|Overall Study|migration|2|||
27653034|NCT03602053|80570696|FG001|Overall Study|migration|3|||
27653035|NCT03602053|80570697|FG002|Overall Study|migration|0|||
27653036|NCT03602053|80570695|FG000|Overall Study|Other|1|||
27653037|NCT03602053|80570696|FG001|Overall Study|Other|0|||
27653038|NCT03602053|80570697|FG002|Overall Study|Other|0|||
27653039|NCT01156675|80570701|FG000|Overall Study|Death|5|||
27653040|NCT01156675|80570702|FG001|Overall Study|Death|3|||
27653041|NCT01156675|80570703|FG002|Overall Study|Death|0|||
27653042|NCT01156675|80570701|FG000|Overall Study|No data|29|||
27653043|NCT01156675|80570702|FG001|Overall Study|No data|22|||
27653044|NCT01156675|80570703|FG002|Overall Study|No data|2|||
27653045|NCT02721147|80570713|FG000|Overall Study|Lost to Follow-up|2|||
27653046|NCT02721147|80570714|FG001|Overall Study|Lost to Follow-up|0|||
27653047|NCT02721147|80570715|FG002|Overall Study|Lost to Follow-up|0|||
27653048|NCT01802333|80570716|FG000|Overall Study|Ineligible|2|||
27653049|NCT01802333|80570717|FG001|Overall Study|Ineligible|6|||
27653050|NCT01802333|80570718|FG002|Overall Study|Ineligible|8|||
27653051|NCT01802333|80570716|FG000|Overall Study|Adverse Event|1|||
27653052|NCT01802333|80570717|FG001|Overall Study|Adverse Event|8|||
27653053|NCT01802333|80570718|FG002|Overall Study|Adverse Event|8|||
27653054|NCT01802333|80570716|FG000|Overall Study|Withdrawal by Subject|6|||
27653055|NCT01802333|80570717|FG001|Overall Study|Withdrawal by Subject|6|||
27653056|NCT01802333|80570718|FG002|Overall Study|Withdrawal by Subject|5|||
27653057|NCT01802333|80570716|FG000|Overall Study|Progression/relapse|1|||
27653058|NCT01802333|80570717|FG001|Overall Study|Progression/relapse|3|||
27653059|NCT01802333|80570718|FG002|Overall Study|Progression/relapse|0|||
27653060|NCT01802333|80570716|FG000|Overall Study|Death|7|||
27653061|NCT01802333|80570717|FG001|Overall Study|Death|14|||
27653062|NCT01802333|80570718|FG002|Overall Study|Death|13|||
27653063|NCT01802333|80570716|FG000|Overall Study|Other - not protocol specified|32|||
27653064|NCT01802333|80570717|FG001|Overall Study|Other - not protocol specified|22|||
27653065|NCT01802333|80570718|FG002|Overall Study|Other - not protocol specified|24|||
27653066|NCT01802333|80570716|FG000|Overall Study|Did not start treatment|0|||
27653067|NCT01802333|80570717|FG001|Overall Study|Did not start treatment|2|||
27653068|NCT01802333|80570718|FG002|Overall Study|Did not start treatment|5|||
27653069|NCT04311983|80570721|FG000|Overall Study|Lost to Follow-up|421|||
27653070|NCT04311983|80570722|FG001|Overall Study|Lost to Follow-up|456|||
27653071|NCT04311983|80570721|FG000|Overall Study|Incomplete survey|7|||
27653072|NCT04311983|80570722|FG001|Overall Study|Incomplete survey|9|||
27653073|NCT04311983|80570721|FG000|Overall Study|Death|1|||
27653074|NCT04311983|80570722|FG001|Overall Study|Death|0|||
27653075|NCT00952523|80570724|FG000|Overall Study|Withdrawal by Subject|7|||
27653076|NCT03953079|80570725|FG000|Core Study|Withdrawal by Subject|1|||
27653077|NCT03953079|80570726|FG001|Core Study|Withdrawal by Subject|2|||
27653078|NCT03953079|80570727|FG002|Core Study|Withdrawal by Subject|1|||
27653079|NCT03953079|80570725|FG000|Core Study|COVID-19|0|||
27653080|NCT03953079|80570726|FG001|Core Study|COVID-19|1|||
27653081|NCT03953079|80570727|FG002|Core Study|COVID-19|0|||
27653082|NCT03953079|80570725|FG000|Core Study|Difficulties leaving the house|0|||
27653083|NCT03953079|80570726|FG001|Core Study|Difficulties leaving the house|1|||
27653084|NCT03953079|80570727|FG002|Core Study|Difficulties leaving the house|0|||
27653085|NCT03953079|80570725|FG000|Extension Study|Withdrawal by Subject|1|||
27653086|NCT03953079|80570726|FG001|Extension Study|Withdrawal by Subject|0|||
27653087|NCT03953079|80570727|FG002|Extension Study|Withdrawal by Subject|0|||
27653088|NCT03953079|80570725|FG000|Extension Study|Received Rescue Treatment|5|||
27751620|NCT04657016|80918176|FG000|Overall Study|Protocol Deviation|1|||
27955487|NCT00742625|81672188|FG000|Remission Induction|Adverse Event|3|||
27653089|NCT03953079|80570726|FG001|Extension Study|Received Rescue Treatment|6|||
27653090|NCT03953079|80570727|FG002|Extension Study|Received Rescue Treatment|5|||
27653091|NCT02007070|80570730|FG000|Overall Study|Adverse Event|4|||
27653092|NCT02007070|80570730|FG000|Overall Study|Clinical Progression|4|||
27653093|NCT02007070|80570730|FG000|Overall Study|Death|1|||
27653094|NCT02007070|80570730|FG000|Overall Study|Protocol Violation|2|||
27653095|NCT02007070|80570730|FG000|Overall Study|Physician Decision|1|||
27653096|NCT02007070|80570730|FG000|Overall Study|Progressive Disease|21|||
27653097|NCT02106325|80570731|FG000|Phase 1|Lost to Follow-up|2|||
27653098|NCT02106325|80570732|FG001|Phase 1|Lost to Follow-up|2|||
27653099|NCT02106325|80570731|FG000|Phase 2|Lost to Follow-up|2|||
27653100|NCT02106325|80570732|FG001|Phase 2|Lost to Follow-up|3|||
27653101|NCT02106325|80570731|FG000|Phase 3|Lost to Follow-up|2|||
27653102|NCT02106325|80570732|FG001|Phase 3|Lost to Follow-up|1|||
27653103|NCT02362789|80570733|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
27653104|NCT02362789|80570734|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
27653105|NCT02362789|80570735|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
27653106|NCT02362789|80570733|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
27653107|NCT02362789|80570734|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
27653108|NCT02362789|80570735|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
27653109|NCT02362789|80570733|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
27653110|NCT02362789|80570734|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
27653111|NCT02362789|80570735|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
27653112|NCT02362789|80570733|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
27653113|NCT02362789|80570734|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
27653114|NCT02362789|80570735|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
27653115|NCT02362789|80570733|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
27653116|NCT02362789|80570734|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
27653117|NCT02362789|80570735|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
27653118|NCT01480258|80570744|FG000|Infant Series|Protocol Violation|2|||
27653119|NCT01480258|80570745|FG001|Infant Series|Protocol Violation|0|||
27653120|NCT01480258|80570744|FG000|Infant Series|Physician Decision|0|||
27653121|NCT01480258|80570745|FG001|Infant Series|Physician Decision|1|||
27653122|NCT01480258|80570744|FG000|Infant Series|Not Vaccinated|3|||
27653123|NCT01480258|80570745|FG001|Infant Series|Not Vaccinated|0|||
27653124|NCT01480258|80570744|FG000|Infant Series|Adverse Event|1|||
27653125|NCT01480258|80570745|FG001|Infant Series|Adverse Event|1|||
27653126|NCT01480258|80570744|FG000|Infant Series|Withdrawal by Subject|1|||
27653127|NCT01480258|80570745|FG001|Infant Series|Withdrawal by Subject|6|||
27653128|NCT01480258|80570744|FG000|Interim Period|Lost to Follow-up|0|||
27653129|NCT01480258|80570745|FG001|Interim Period|Lost to Follow-up|2|||
27653130|NCT01480258|80570744|FG000|Interim Period|Physician Decision|1|||
27653131|NCT01480258|80570745|FG001|Interim Period|Physician Decision|0|||
27653132|NCT01480258|80570744|FG000|Interim Period|Protocol Violation|0|||
27653133|NCT01480258|80570745|FG001|Interim Period|Protocol Violation|1|||
27653134|NCT01480258|80570744|FG000|Interim Period|Withdrawal by Subject|9|||
27653135|NCT01480258|80570745|FG001|Interim Period|Withdrawal by Subject|6|||
27653136|NCT03492177|80570750|FG000|Overall Study|Adverse Event|1|||
27653137|NCT03492177|80570751|FG001|Overall Study|Adverse Event|0|||
27653138|NCT03492177|80570752|FG002|Overall Study|Adverse Event|0|||
27653139|NCT03492177|80570750|FG000|Overall Study|Death|3|||
27653140|NCT03492177|80570751|FG001|Overall Study|Death|0|||
27653141|NCT03492177|80570752|FG002|Overall Study|Death|3|||
27653142|NCT03492177|80570750|FG000|Overall Study|Lack of Efficacy|1|||
27653143|NCT03492177|80570751|FG001|Overall Study|Lack of Efficacy|2|||
27653144|NCT03492177|80570752|FG002|Overall Study|Lack of Efficacy|0|||
27653145|NCT03492177|80570750|FG000|Overall Study|Other|1|||
27653146|NCT03492177|80570751|FG001|Overall Study|Other|0|||
27653147|NCT03492177|80570752|FG002|Overall Study|Other|0|||
27653148|NCT03492177|80570750|FG000|Overall Study|Ongoing|16|||
27653149|NCT03492177|80570751|FG001|Overall Study|Ongoing|19|||
27653150|NCT03492177|80570752|FG002|Overall Study|Ongoing|17|||
27653151|NCT01123200|80570753|FG000|Overall Study|Withdrawal by Subject|1|||
27653152|NCT00603798|80570754|FG000|Overall Study|Adverse Event|4|||
27653153|NCT00603798|80570755|FG001|Overall Study|Adverse Event|2|||
27653154|NCT00603798|80570756|FG002|Overall Study|Adverse Event|1|||
27653155|NCT00603798|80570754|FG000|Overall Study|Withdrawal by Subject|4|||
27653156|NCT00603798|80570755|FG001|Overall Study|Withdrawal by Subject|3|||
27653157|NCT00603798|80570756|FG002|Overall Study|Withdrawal by Subject|4|||
27653158|NCT00603798|80570754|FG000|Overall Study|Lost to Follow-up|1|||
27653159|NCT00603798|80570755|FG001|Overall Study|Lost to Follow-up|0|||
27653160|NCT00603798|80570756|FG002|Overall Study|Lost to Follow-up|1|||
27653161|NCT00603798|80570754|FG000|Overall Study|Non-compliance with study procedures|0|||
27653162|NCT00603798|80570755|FG001|Overall Study|Non-compliance with study procedures|1|||
27653163|NCT00603798|80570756|FG002|Overall Study|Non-compliance with study procedures|0|||
27653164|NCT00603798|80570754|FG000|Overall Study|Not due to AE|1|||
27653165|NCT00603798|80570755|FG001|Overall Study|Not due to AE|1|||
27653166|NCT00603798|80570756|FG002|Overall Study|Not due to AE|4|||
27653167|NCT00910962|80570757|FG000|Overall Study|Adverse Event|5|||
27653168|NCT00910962|80570758|FG001|Overall Study|Adverse Event|20|||
27653169|NCT00910962|80570759|FG002|Overall Study|Adverse Event|17|||
27653170|NCT00910962|80570757|FG000|Overall Study|Protocol Violation|1|||
27653171|NCT00910962|80570758|FG001|Overall Study|Protocol Violation|3|||
27653172|NCT00910962|80570759|FG002|Overall Study|Protocol Violation|3|||
27653173|NCT00910962|80570757|FG000|Overall Study|Lost to Follow-up|0|||
27653174|NCT00910962|80570758|FG001|Overall Study|Lost to Follow-up|3|||
27653175|NCT00910962|80570759|FG002|Overall Study|Lost to Follow-up|1|||
27653176|NCT00910962|80570757|FG000|Overall Study|Physician Decision|0|||
27653177|NCT00910962|80570758|FG001|Overall Study|Physician Decision|6|||
27653178|NCT00910962|80570759|FG002|Overall Study|Physician Decision|6|||
27653179|NCT00910962|80570757|FG000|Overall Study|Withdrawal by Subject|25|||
27653180|NCT00910962|80570758|FG001|Overall Study|Withdrawal by Subject|32|||
27653181|NCT00910962|80570759|FG002|Overall Study|Withdrawal by Subject|32|||
27653182|NCT00910962|80570757|FG000|Overall Study|Reached defined stopping criteria|12|||
27653183|NCT00910962|80570758|FG001|Overall Study|Reached defined stopping criteria|14|||
27653184|NCT00910962|80570759|FG002|Overall Study|Reached defined stopping criteria|17|||
27653185|NCT00925548|80570760|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
27653186|NCT00925548|80570761|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
27653187|NCT02555397|80570765|FG000|Overall Study|Withdrawal by Subject|1|||
27653188|NCT02555397|80570766|FG001|Overall Study|Withdrawal by Subject|0|||
27653189|NCT02555397|80570767|FG002|Overall Study|Withdrawal by Subject|0|||
27653190|NCT02555397|80570768|FG003|Overall Study|Withdrawal by Subject|0|||
27653191|NCT02555397|80570769|FG004|Overall Study|Withdrawal by Subject|0|||
27653192|NCT00787176|80570770|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
27653193|NCT00787176|80570771|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
27653194|NCT00787176|80570772|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
27653195|NCT00787176|80570773|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
27653196|NCT02400749|80570776|FG000|Week 0 -16|Withdrawal by Subject|5|||
27653197|NCT02400749|80570777|FG001|Week 0 -16|Withdrawal by Subject|5|||
27653198|NCT02400749|80570776|FG000|Week 0 -16|Adverse Event|3|||
27653199|NCT02400749|80570777|FG001|Week 0 -16|Adverse Event|1|||
27653200|NCT02400749|80570776|FG000|Week 0 -16|Lost to Follow-up|2|||
27653201|NCT02400749|80570777|FG001|Week 0 -16|Lost to Follow-up|0|||
27653202|NCT02400749|80570776|FG000|Week 0 -16|Protocol Violation|1|||
27653203|NCT02400749|80570777|FG001|Week 0 -16|Protocol Violation|0|||
27653204|NCT02400749|80570776|FG000|Week 17 - 32|Withdrawal by Subject|3|||
27653205|NCT02400749|80570777|FG001|Week 17 - 32|Withdrawal by Subject|2|||
27653206|NCT02400749|80570776|FG000|Week 17 - 32|Adverse Event|2|||
27653207|NCT02400749|80570777|FG001|Week 17 - 32|Adverse Event|1|||
27653208|NCT02764320|80570778|FG000|Overall Study|Withdrawal by Subject|35|||
27653209|NCT02764320|80570779|FG001|Overall Study|Withdrawal by Subject|38|||
27653210|NCT02764320|80570778|FG000|Overall Study|Protocol Violation|11|||
27653211|NCT02764320|80570779|FG001|Overall Study|Protocol Violation|6|||
27653212|NCT02764320|80570778|FG000|Overall Study|Adverse Event|2|||
27653213|NCT02764320|80570779|FG001|Overall Study|Adverse Event|0|||
27653214|NCT02764320|80570778|FG000|Overall Study|Health Issues unable to continue|2|||
27653215|NCT02764320|80570779|FG001|Overall Study|Health Issues unable to continue|0|||
27653216|NCT02764320|80570778|FG000|Overall Study|Did not meet inclusion criteria|1|||
27653217|NCT02764320|80570779|FG001|Overall Study|Did not meet inclusion criteria|0|||
27653218|NCT02764320|80570778|FG000|Overall Study|Subject moved|0|||
27653219|NCT02764320|80570779|FG001|Overall Study|Subject moved|2|||
27653220|NCT02764320|80570778|FG000|Overall Study|Overused medication unavailable|0|||
27653221|NCT02764320|80570779|FG001|Overall Study|Overused medication unavailable|1|||
27653222|NCT02764320|80570778|FG000|Overall Study|Seeking care outside site|0|||
27653223|NCT02764320|80570779|FG001|Overall Study|Seeking care outside site|1|||
27653224|NCT02764320|80570778|FG000|Overall Study|Technology barriers|0|||
27653225|NCT02764320|80570779|FG001|Overall Study|Technology barriers|1|||
27653226|NCT02981953|80570780|FG000|Overall Study|Death|9|||
27653227|NCT02981953|80570780|FG000|Overall Study|Withdrawal by Subject|1|||
27653228|NCT02981953|80570780|FG000|Overall Study|Withdrawal to non-compliance|1|||
27653229|NCT02354417|80570781|FG000|Overall Study|Physician Decision|1|||
27653230|NCT02706483|80570782|FG000|Overall Study|Adverse Event|97|||
27653231|NCT02706483|80570782|FG000|Overall Study|Death|1|||
27653232|NCT02706483|80570782|FG000|Overall Study|Lack of Efficacy|39|||
27653233|NCT02706483|80570782|FG000|Overall Study|Lost to Follow-up|101|||
27653234|NCT02706483|80570782|FG000|Overall Study|Non-compliance with study drug|15|||
27653235|NCT02706483|80570782|FG000|Overall Study|Physician Decision|6|||
27653236|NCT02706483|80570782|FG000|Overall Study|Pregnancy|6|||
27653237|NCT02706483|80570782|FG000|Overall Study|Protocol Violation|18|||
27653238|NCT02706483|80570782|FG000|Overall Study|Withdrawal by Subject|136|||
27653239|NCT02706483|80570782|FG000|Overall Study|Non-compliance with visits|6|||
27653240|NCT02706483|80570782|FG000|Overall Study|Site closure|4|||
27653241|NCT02706483|80570782|FG000|Overall Study|Subject moved|1|||
27653242|NCT00589628|80570787|FG000|Overall Study|Lost to Follow-up|0|||
27653243|NCT00589628|80570788|FG001|Overall Study|Lost to Follow-up|1|||
27653244|NCT00749944|80570791|FG000|Overall Study|Lost to Follow-up|2|||
27653245|NCT00749944|80570792|FG001|Overall Study|Lost to Follow-up|1|||
27653246|NCT00749944|80570791|FG000|Overall Study|Other|1|||
27653247|NCT00749944|80570792|FG001|Overall Study|Other|0|||
27653248|NCT00749944|80570791|FG000|Overall Study|Withdrawal by Subject|2|||
27653249|NCT00749944|80570792|FG001|Overall Study|Withdrawal by Subject|0|||
27653250|NCT00267865|80570793|FG000|Induction Treatment|Died before completing.|2|||
27653251|NCT00267865|80570793|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
27653252|NCT00603278|80570794|FG000|Overall Study|Lack of Efficacy|35|||
27653253|NCT00603278|80570795|FG001|Overall Study|Lack of Efficacy|10|||
27653254|NCT00603278|80570796|FG002|Overall Study|Lack of Efficacy|11|||
27653255|NCT00603278|80570797|FG003|Overall Study|Lack of Efficacy|8|||
27653256|NCT00603278|80570798|FG004|Overall Study|Lack of Efficacy|7|||
27653257|NCT00603278|80570799|FG005|Overall Study|Lack of Efficacy|14|||
27653258|NCT00603278|80570794|FG000|Overall Study|Adverse Event|0|||
27653259|NCT00603278|80570795|FG001|Overall Study|Adverse Event|3|||
27653260|NCT00603278|80570796|FG002|Overall Study|Adverse Event|1|||
27653261|NCT00603278|80570797|FG003|Overall Study|Adverse Event|0|||
27653262|NCT00603278|80570798|FG004|Overall Study|Adverse Event|2|||
27653263|NCT00603278|80570799|FG005|Overall Study|Adverse Event|1|||
27653264|NCT00603278|80570794|FG000|Overall Study|Withdrawal by Subject|2|||
27653265|NCT00603278|80570795|FG001|Overall Study|Withdrawal by Subject|3|||
27653266|NCT00603278|80570796|FG002|Overall Study|Withdrawal by Subject|1|||
27653267|NCT00603278|80570797|FG003|Overall Study|Withdrawal by Subject|2|||
27653268|NCT00603278|80570798|FG004|Overall Study|Withdrawal by Subject|1|||
27653269|NCT00603278|80570799|FG005|Overall Study|Withdrawal by Subject|2|||
27653270|NCT00603278|80570794|FG000|Overall Study|Protocol Violation|3|||
27653271|NCT00603278|80570795|FG001|Overall Study|Protocol Violation|0|||
27653272|NCT00603278|80570796|FG002|Overall Study|Protocol Violation|1|||
27653273|NCT00603278|80570797|FG003|Overall Study|Protocol Violation|1|||
27653274|NCT00603278|80570798|FG004|Overall Study|Protocol Violation|0|||
27653275|NCT00603278|80570799|FG005|Overall Study|Protocol Violation|1|||
27653276|NCT00603278|80570794|FG000|Overall Study|Physician Decision|0|||
27653277|NCT00603278|80570795|FG001|Overall Study|Physician Decision|1|||
27653278|NCT00603278|80570796|FG002|Overall Study|Physician Decision|0|||
27653279|NCT00603278|80570797|FG003|Overall Study|Physician Decision|0|||
27653280|NCT00603278|80570798|FG004|Overall Study|Physician Decision|2|||
27653281|NCT00603278|80570799|FG005|Overall Study|Physician Decision|1|||
27653282|NCT00603278|80570794|FG000|Overall Study|Lost to Follow-up|1|||
27653283|NCT00603278|80570795|FG001|Overall Study|Lost to Follow-up|0|||
27653284|NCT00603278|80570796|FG002|Overall Study|Lost to Follow-up|0|||
27653285|NCT00603278|80570797|FG003|Overall Study|Lost to Follow-up|0|||
27653286|NCT00603278|80570798|FG004|Overall Study|Lost to Follow-up|1|||
27653287|NCT00603278|80570799|FG005|Overall Study|Lost to Follow-up|0|||
27653288|NCT01205126|80570802|FG000|Titration Phase|Adverse Event|5|||
27653289|NCT01205126|80570803|FG001|Titration Phase|Adverse Event|3|||
27653290|NCT01205126|80570802|FG000|Titration Phase|Withdrawal by Subject|5|||
27653291|NCT01205126|80570803|FG001|Titration Phase|Withdrawal by Subject|5|||
27653292|NCT01205126|80570802|FG000|Titration Phase|Lost to Follow-up|2|||
27653293|NCT01205126|80570803|FG001|Titration Phase|Lost to Follow-up|2|||
27653294|NCT01205126|80570802|FG000|Titration Phase|No stable titration dose|1|||
27653295|NCT01205126|80570803|FG001|Titration Phase|No stable titration dose|0|||
27653296|NCT01205126|80570802|FG000|Titration Phase|More than maximum dosage required|2|||
27653297|NCT01205126|80570803|FG001|Titration Phase|More than maximum dosage required|3|||
27653298|NCT01205126|80570802|FG000|Titration Phase|Other|8|||
27653299|NCT01205126|80570803|FG001|Titration Phase|Other|6|||
27653300|NCT01205126|80570802|FG000|Between Titration & Maintenance Phase|Other|0|||
27653301|NCT01205126|80570803|FG001|Between Titration & Maintenance Phase|Other|4|||
27653302|NCT01205126|80570802|FG000|Maintenance Phase|Adverse Event|3|||
27653303|NCT01205126|80570803|FG001|Maintenance Phase|Adverse Event|7|||
27653304|NCT01205126|80570802|FG000|Maintenance Phase|Death|4|||
27653305|NCT01205126|80570803|FG001|Maintenance Phase|Death|4|||
27653306|NCT01205126|80570802|FG000|Maintenance Phase|More than the maximum dosage required|5|||
27653307|NCT01205126|80570803|FG001|Maintenance Phase|More than the maximum dosage required|5|||
27653308|NCT01205126|80570802|FG000|Maintenance Phase|Prohibited drugs used|1|||
27653309|NCT01205126|80570803|FG001|Maintenance Phase|Prohibited drugs used|0|||
27653310|NCT01205126|80570802|FG000|Maintenance Phase|Other|11|||
27653311|NCT01205126|80570803|FG001|Maintenance Phase|Other|8|||
27653312|NCT01205126|80570802|FG000|Maintenance Phase|Lost to Follow-up|5|||
27653313|NCT01205126|80570803|FG001|Maintenance Phase|Lost to Follow-up|5|||
27653314|NCT01205126|80570802|FG000|Maintenance Phase|Withdrawal by Subject|8|||
27653315|NCT01205126|80570803|FG001|Maintenance Phase|Withdrawal by Subject|11|||
27653316|NCT03137459|80570804|FG000|2-month Assessment|Withdrawal by Subject|13|||
27653317|NCT03137459|80570805|FG001|2-month Assessment|Withdrawal by Subject|3|||
27653318|NCT03137459|80570804|FG000|2-month Assessment|Unable to reach|42|||
27653319|NCT03137459|80570805|FG001|2-month Assessment|Unable to reach|32|||
27653320|NCT03137459|80570804|FG000|2-month Assessment|Refused assessment|7|||
27653321|NCT03137459|80570805|FG001|2-month Assessment|Refused assessment|5|||
27653322|NCT03137459|80570804|FG000|2-month Assessment|Acutely ill|6|||
27653323|NCT03137459|80570805|FG001|2-month Assessment|Acutely ill|2|||
27653324|NCT03137459|80570804|FG000|4-month Assessment|Death|4|||
27653325|NCT03137459|80570805|FG001|4-month Assessment|Death|2|||
27653326|NCT03137459|80570804|FG000|4-month Assessment|Withdrawal by Subject|4|||
27653327|NCT03137459|80570805|FG001|4-month Assessment|Withdrawal by Subject|2|||
27653328|NCT03137459|80570804|FG000|4-month Assessment|Unable to reach|44|||
27653329|NCT03137459|80570805|FG001|4-month Assessment|Unable to reach|29|||
27653330|NCT03137459|80570804|FG000|4-month Assessment|Refused assessment|24|||
27653331|NCT03137459|80570805|FG001|4-month Assessment|Refused assessment|10|||
27653332|NCT03137459|80570804|FG000|4-month Assessment|Acutely ill|2|||
27653333|NCT03137459|80570805|FG001|4-month Assessment|Acutely ill|3|||
27653334|NCT03137459|80570804|FG000|6-months|Lost to Follow-up|14|||
27653335|NCT03137459|80570805|FG001|6-months|Lost to Follow-up|11|||
27653336|NCT03137459|80570804|FG000|6-months|Death|0|||
27653337|NCT03137459|80570805|FG001|6-months|Death|2|||
27653338|NCT03137459|80570804|FG000|6-months|Refused assessment|6|||
27653339|NCT03137459|80570805|FG001|6-months|Refused assessment|3|||
27653340|NCT03137459|80570804|FG000|6-months|Acutely ill|1|||
27653341|NCT03137459|80570805|FG001|6-months|Acutely ill|1|||
27653342|NCT03242863|80570812|FG000|Study Week 1|Withdrawal by Subject|0|||
27653343|NCT03242863|80570813|FG001|Study Week 1|Withdrawal by Subject|1|||
27653344|NCT03242863|80570814|FG002|Study Week 1|Withdrawal by Subject|0|||
27653345|NCT03242863|80570815|FG003|Study Week 1|Withdrawal by Subject|0|||
27653346|NCT03242863|80570816|FG004|Study Week 1|Withdrawal by Subject|3|||
27653347|NCT03242863|80570817|FG005|Study Week 1|Withdrawal by Subject|0|||
27653348|NCT03349476|80570818|FG000|Overall Study|Physician Decision|3|||
27653349|NCT04710576|80570819|FG000|Overall Study|Participants still in the study|73|||
27653350|NCT04710576|80570820|FG001|Overall Study|Participants still in the study|70|||
27653351|NCT04710576|80570821|FG002|Overall Study|Participants still in the study|60|||
27653352|NCT04710576|80570819|FG000|Overall Study|Death|2|||
27653353|NCT04710576|80570820|FG001|Overall Study|Death|7|||
27653354|NCT04710576|80570821|FG002|Overall Study|Death|12|||
27653355|NCT04710576|80570819|FG000|Overall Study|Withdrawal by Subject|4|||
27653356|NCT04710576|80570820|FG001|Overall Study|Withdrawal by Subject|3|||
27653357|NCT04710576|80570821|FG002|Overall Study|Withdrawal by Subject|7|||
27653358|NCT04710576|80570819|FG000|Overall Study|Sponsor decision|1|||
27653359|NCT04710576|80570820|FG001|Overall Study|Sponsor decision|0|||
27653360|NCT04710576|80570821|FG002|Overall Study|Sponsor decision|0|||
27653361|NCT02598388|80570827|FG000|Overall Study|Lost to Follow-up|1|||
27653362|NCT02598388|80570828|FG001|Overall Study|Lost to Follow-up|0|||
27653363|NCT02598388|80570829|FG002|Overall Study|Lost to Follow-up|1|||
27653364|NCT02598388|80570830|FG003|Overall Study|Lost to Follow-up|0|||
27653365|NCT02598388|80570831|FG004|Overall Study|Lost to Follow-up|5|||
27653366|NCT02598388|80570832|FG005|Overall Study|Lost to Follow-up|1|||
27653367|NCT02598388|80570833|FG006|Overall Study|Lost to Follow-up|2|||
27653368|NCT02598388|80570834|FG007|Overall Study|Lost to Follow-up|1|||
27653369|NCT02598388|80570835|FG008|Overall Study|Lost to Follow-up|0|||
27653370|NCT02598388|80570836|FG009|Overall Study|Lost to Follow-up|0|||
27653371|NCT02598388|80570837|FG010|Overall Study|Lost to Follow-up|1|||
27653372|NCT02598388|80570838|FG011|Overall Study|Lost to Follow-up|0|||
27653373|NCT02598388|80570827|FG000|Overall Study|Withdrawal by Subject|0|||
27653374|NCT02598388|80570828|FG001|Overall Study|Withdrawal by Subject|0|||
27653375|NCT02598388|80570829|FG002|Overall Study|Withdrawal by Subject|0|||
27653376|NCT02598388|80570830|FG003|Overall Study|Withdrawal by Subject|0|||
27653377|NCT02598388|80570831|FG004|Overall Study|Withdrawal by Subject|2|||
27653378|NCT02598388|80570832|FG005|Overall Study|Withdrawal by Subject|0|||
27653379|NCT02598388|80570833|FG006|Overall Study|Withdrawal by Subject|2|||
27653380|NCT02598388|80570834|FG007|Overall Study|Withdrawal by Subject|0|||
27653381|NCT02598388|80570835|FG008|Overall Study|Withdrawal by Subject|0|||
27653382|NCT02598388|80570836|FG009|Overall Study|Withdrawal by Subject|1|||
27653383|NCT02598388|80570837|FG010|Overall Study|Withdrawal by Subject|0|||
27653384|NCT02598388|80570838|FG011|Overall Study|Withdrawal by Subject|0|||
27653385|NCT02598388|80570827|FG000|Overall Study|Other|0|||
27653386|NCT02598388|80570828|FG001|Overall Study|Other|0|||
27653387|NCT02598388|80570829|FG002|Overall Study|Other|1|||
27653388|NCT02598388|80570830|FG003|Overall Study|Other|0|||
27653389|NCT02598388|80570831|FG004|Overall Study|Other|3|||
27653390|NCT02598388|80570832|FG005|Overall Study|Other|0|||
27653391|NCT02598388|80570833|FG006|Overall Study|Other|1|||
27653392|NCT02598388|80570834|FG007|Overall Study|Other|0|||
27653393|NCT02598388|80570835|FG008|Overall Study|Other|0|||
27653394|NCT02598388|80570836|FG009|Overall Study|Other|0|||
27653395|NCT02598388|80570837|FG010|Overall Study|Other|0|||
27653396|NCT02598388|80570838|FG011|Overall Study|Other|0|||
27653397|NCT03262389|80570841|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
27653398|NCT03262389|80570841|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
27653399|NCT03262389|80570841|FG000|Overall Study|opted out of PET/MR|1|||
27653400|NCT01737398|80570842|FG000|Overall Study|Adverse event or SAE|16|||
27653401|NCT01737398|80570843|FG001|Overall Study|Adverse event or SAE|1|||
27653402|NCT01737398|80570842|FG000|Overall Study|Stopping rule met|2|||
27653403|NCT01737398|80570843|FG001|Overall Study|Stopping rule met|1|||
27653404|NCT01737398|80570842|FG000|Overall Study|Voluntary withdrawal|2|||
27653405|NCT01737398|80570843|FG001|Overall Study|Voluntary withdrawal|3|||
27653406|NCT01737398|80570842|FG000|Overall Study|Ineligibility|1|||
27653407|NCT01737398|80570843|FG001|Overall Study|Ineligibility|0|||
27653408|NCT01737398|80570842|FG000|Overall Study|Liver transplant|1|||
27653409|NCT01737398|80570843|FG001|Overall Study|Liver transplant|0|||
27653410|NCT01737398|80570842|FG000|Overall Study|Disease progression|2|||
27653411|NCT01737398|80570843|FG001|Overall Study|Disease progression|3|||
27653412|NCT01737398|80570842|FG000|Overall Study|Sponsor's decision|2|||
27653413|NCT01737398|80570843|FG001|Overall Study|Sponsor's decision|0|||
27653414|NCT01137682|80570844|FG000|Overall Study|Adverse Event-CORE|2|||
27653415|NCT01137682|80570845|FG001|Overall Study|Adverse Event-CORE|4|||
27653416|NCT01137682|80570846|FG002|Overall Study|Adverse Event-CORE|0|||
27653417|NCT01137682|80570844|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
27653418|NCT01137682|80570845|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
27653419|NCT01137682|80570846|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
27653420|NCT01137682|80570844|FG000|Overall Study|Administrative problems-CORE|2|||
27653421|NCT01137682|80570845|FG001|Overall Study|Administrative problems-CORE|1|||
27653422|NCT01137682|80570846|FG002|Overall Study|Administrative problems-CORE|0|||
27653423|NCT01137682|80570844|FG000|Overall Study|Protocol Violation-CORE|0|||
27653424|NCT01137682|80570845|FG001|Overall Study|Protocol Violation-CORE|1|||
27653425|NCT01137682|80570846|FG002|Overall Study|Protocol Violation-CORE|1|||
27653426|NCT01137682|80570844|FG000|Overall Study|Adverse Event-Extension|4|||
27653427|NCT01137682|80570845|FG001|Overall Study|Adverse Event-Extension|8|||
27653428|NCT01137682|80570846|FG002|Overall Study|Adverse Event-Extension|7|||
27653429|NCT01137682|80570844|FG000|Overall Study|Lack of Efficacy-Extension|15|||
27653430|NCT01137682|80570845|FG001|Overall Study|Lack of Efficacy-Extension|9|||
27653431|NCT01137682|80570846|FG002|Overall Study|Lack of Efficacy-Extension|13|||
27653432|NCT01137682|80570844|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
27653433|NCT01137682|80570845|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
27653434|NCT01137682|80570846|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
27653435|NCT01137682|80570844|FG000|Overall Study|Lost to Follow Up-Extension|0|||
27653436|NCT01137682|80570845|FG001|Overall Study|Lost to Follow Up-Extension|1|||
27653437|NCT01137682|80570846|FG002|Overall Study|Lost to Follow Up-Extension|0|||
27653438|NCT01137682|80570844|FG000|Overall Study|Administrative problems-Extension|0|||
27653439|NCT01137682|80570845|FG001|Overall Study|Administrative problems-Extension|2|||
27653440|NCT01137682|80570846|FG002|Overall Study|Administrative problems-Extension|0|||
27653441|NCT01137682|80570844|FG000|Overall Study|Death-Extension|2|||
27653442|NCT01137682|80570845|FG001|Overall Study|Death-Extension|0|||
27653443|NCT01137682|80570846|FG002|Overall Study|Death-Extension|0|||
27653444|NCT01137682|80570844|FG000|Overall Study|Protocol Violation-Extension|2|||
27653445|NCT01137682|80570845|FG001|Overall Study|Protocol Violation-Extension|1|||
27653446|NCT01137682|80570846|FG002|Overall Study|Protocol Violation-Extension|0|||
27653447|NCT01137682|80570844|FG000|Overall Study|Did not enter extension|2|||
27653448|NCT01137682|80570845|FG001|Overall Study|Did not enter extension|3|||
27653449|NCT01137682|80570846|FG002|Overall Study|Did not enter extension|2|||
27653450|NCT01137682|80570844|FG000|Overall Study|Did not receive treatment in extension|0|||
27653451|NCT01137682|80570845|FG001|Overall Study|Did not receive treatment in extension|0|||
27653452|NCT01137682|80570846|FG002|Overall Study|Did not receive treatment in extension|1|||
27653453|NCT00486954|80570847|FG000|Pilot Part|Adverse Event|4|||
27653454|NCT00486954|80570848|FG001|Pilot Part|Adverse Event|0|||
27653455|NCT00486954|80570849|FG002|Pilot Part|Adverse Event|5|||
27653456|NCT00486954|80570850|FG003|Pilot Part|Adverse Event|0|||
27653457|NCT00486954|80570851|FG004|Pilot Part|Adverse Event|0|||
27653458|NCT00486954|80570847|FG000|Pilot Part|Disease Progression|2|||
27653459|NCT00486954|80570848|FG001|Pilot Part|Disease Progression|0|||
27653460|NCT00486954|80570849|FG002|Pilot Part|Disease Progression|1|||
27653461|NCT00486954|80570850|FG003|Pilot Part|Disease Progression|0|||
27653462|NCT00486954|80570851|FG004|Pilot Part|Disease Progression|0|||
27653463|NCT00486954|80570847|FG000|Randomized Part|Lost to Follow-up|0|||
27653464|NCT00486954|80570848|FG001|Randomized Part|Lost to Follow-up|0|||
27653465|NCT00486954|80570849|FG002|Randomized Part|Lost to Follow-up|0|||
27653466|NCT00486954|80570850|FG003|Randomized Part|Lost to Follow-up|0|||
27653467|NCT00486954|80570851|FG004|Randomized Part|Lost to Follow-up|1|||
27653468|NCT00486954|80570847|FG000|Randomized Part|Withdrawal by Subject|0|||
27653469|NCT00486954|80570848|FG001|Randomized Part|Withdrawal by Subject|0|||
27653470|NCT00486954|80570849|FG002|Randomized Part|Withdrawal by Subject|0|||
27653471|NCT00486954|80570850|FG003|Randomized Part|Withdrawal by Subject|1|||
27653472|NCT00486954|80570851|FG004|Randomized Part|Withdrawal by Subject|0|||
27653473|NCT00486954|80570847|FG000|Randomized Part|Sponsor Terminated Study|0|||
27653474|NCT00486954|80570848|FG001|Randomized Part|Sponsor Terminated Study|0|||
27653475|NCT00486954|80570849|FG002|Randomized Part|Sponsor Terminated Study|0|||
27955488|NCT00742625|81672188|FG000|Remission Induction|Death|10|||
27653476|NCT00486954|80570850|FG003|Randomized Part|Sponsor Terminated Study|19|||
27653477|NCT00486954|80570851|FG004|Randomized Part|Sponsor Terminated Study|13|||
27653478|NCT01437540|80570855|FG000|Overall Study|Not listed below|7|||
27653479|NCT01437540|80570856|FG001|Overall Study|Not listed below|6|||
27653480|NCT01437540|80570855|FG000|Overall Study|COPD exacerbation|13|||
27653481|NCT01437540|80570856|FG001|Overall Study|COPD exacerbation|3|||
27653482|NCT01437540|80570855|FG000|Overall Study|Lost to Follow-up|3|||
27653483|NCT01437540|80570856|FG001|Overall Study|Lost to Follow-up|5|||
27653484|NCT01437540|80570855|FG000|Overall Study|Lack of Efficacy|23|||
27653485|NCT01437540|80570856|FG001|Overall Study|Lack of Efficacy|11|||
27653486|NCT01437540|80570855|FG000|Overall Study|Protocol Violation|24|||
27653487|NCT01437540|80570856|FG001|Overall Study|Protocol Violation|12|||
27653488|NCT01437540|80570855|FG000|Overall Study|Adverse Event|26|||
27653489|NCT01437540|80570856|FG001|Overall Study|Adverse Event|13|||
27653490|NCT01437540|80570855|FG000|Overall Study|Withdrawal by Subject|31|||
27653491|NCT01437540|80570856|FG001|Overall Study|Withdrawal by Subject|15|||
27653492|NCT04739306|80570857|FG000|Main Study Period|Adverse Event|6|||
27653493|NCT04739306|80570858|FG001|Main Study Period|Adverse Event|7|||
27653494|NCT04739306|80570857|FG000|Main Study Period|Lost to Follow-up|4|||
27653495|NCT04739306|80570858|FG001|Main Study Period|Lost to Follow-up|6|||
27653496|NCT04739306|80570857|FG000|Main Study Period|Physician Decision|1|||
27653497|NCT04739306|80570858|FG001|Main Study Period|Physician Decision|1|||
27653498|NCT04739306|80570857|FG000|Main Study Period|Withdrawal by Subject|8|||
27653499|NCT04739306|80570858|FG001|Main Study Period|Withdrawal by Subject|6|||
27653500|NCT04739306|80570857|FG000|Main Study Period|Protocol Violation|0|||
27653501|NCT04739306|80570858|FG001|Main Study Period|Protocol Violation|1|||
27653502|NCT04739306|80570857|FG000|Main Study Period|War in Ukraine|1|||
27653503|NCT04739306|80570858|FG001|Main Study Period|War in Ukraine|1|||
27653504|NCT01517282|80570863|FG000|Overall Study|Consent withdrawn|0|||
27653505|NCT01517282|80570864|FG001|Overall Study|Consent withdrawn|1|||
27653506|NCT01517282|80570865|FG002|Overall Study|Consent withdrawn|1|||
27653507|NCT01517282|80570866|FG003|Overall Study|Consent withdrawn|1|||
27653508|NCT01517282|80570863|FG000|Overall Study|Physician Decision|1|||
27653509|NCT01517282|80570864|FG001|Overall Study|Physician Decision|0|||
27653510|NCT01517282|80570865|FG002|Overall Study|Physician Decision|0|||
27653511|NCT01517282|80570866|FG003|Overall Study|Physician Decision|0|||
27653512|NCT00853957|80570867|FG000|Overall Study|Adverse Event|9|||
27653513|NCT00853957|80570868|FG001|Overall Study|Adverse Event|3|||
27653514|NCT00853957|80570867|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27653515|NCT00853957|80570868|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27653516|NCT00853957|80570867|FG000|Overall Study|Subject withdrew consent|4|||
27653517|NCT00853957|80570868|FG001|Overall Study|Subject withdrew consent|5|||
27653518|NCT00853957|80570867|FG000|Overall Study|Lost to Follow-up|1|||
27653519|NCT00853957|80570868|FG001|Overall Study|Lost to Follow-up|6|||
27653520|NCT00853957|80570867|FG000|Overall Study|Protocol deviation|0|||
27653521|NCT00853957|80570868|FG001|Overall Study|Protocol deviation|3|||
27653522|NCT01381549|80570881|FG000|Overall Study|Ineligible: No organisms isolated|0|||
27653523|NCT01381549|80570882|FG001|Overall Study|Ineligible: No organisms isolated|0|||
27653524|NCT01381549|80570883|FG002|Overall Study|Ineligible: No organisms isolated|1|||
27653525|NCT03541369|80570884|FG000|Overall Study|Death|0|||
27653526|NCT03541369|80570885|FG001|Overall Study|Death|0|||
27653527|NCT03541369|80570886|FG002|Overall Study|Death|0|||
27653528|NCT03541369|80570887|FG003|Overall Study|Death|0|||
27653529|NCT03541369|80570888|FG004|Overall Study|Death|1|||
27653530|NCT03541369|80570889|FG005|Overall Study|Death|1|||
27653531|NCT03541369|80570890|FG006|Overall Study|Death|0|||
27653532|NCT03541369|80570891|FG007|Overall Study|Death|2|||
27653533|NCT03541369|80570892|FG008|Overall Study|Death|1|||
27653534|NCT03541369|80570893|FG009|Overall Study|Death|2|||
27653535|NCT03541369|80570894|FG010|Overall Study|Death|1|||
27653536|NCT03541369|80570895|FG011|Overall Study|Death|0|||
27653537|NCT03541369|80570896|FG012|Overall Study|Death|2|||
27653538|NCT03541369|80570897|FG013|Overall Study|Death|1|||
27653539|NCT03541369|80570898|FG014|Overall Study|Death|1|||
27653540|NCT03541369|80570899|FG015|Overall Study|Death|1|||
27653541|NCT03541369|80570900|FG016|Overall Study|Death|0|||
27653542|NCT03541369|80570901|FG017|Overall Study|Death|1|||
27653543|NCT03541369|80570884|FG000|Overall Study|Decision by sponsor|0|||
27653544|NCT03541369|80570885|FG001|Overall Study|Decision by sponsor|0|||
27653545|NCT03541369|80570886|FG002|Overall Study|Decision by sponsor|0|||
27653546|NCT03541369|80570887|FG003|Overall Study|Decision by sponsor|1|||
27653547|NCT03541369|80570888|FG004|Overall Study|Decision by sponsor|0|||
27653548|NCT03541369|80570889|FG005|Overall Study|Decision by sponsor|2|||
27653549|NCT03541369|80570890|FG006|Overall Study|Decision by sponsor|0|||
27653550|NCT03541369|80570891|FG007|Overall Study|Decision by sponsor|1|||
27653551|NCT03541369|80570892|FG008|Overall Study|Decision by sponsor|2|||
27653552|NCT03541369|80570893|FG009|Overall Study|Decision by sponsor|0|||
27653553|NCT03541369|80570894|FG010|Overall Study|Decision by sponsor|0|||
27653554|NCT03541369|80570895|FG011|Overall Study|Decision by sponsor|0|||
27653555|NCT03541369|80570896|FG012|Overall Study|Decision by sponsor|2|||
27653556|NCT03541369|80570897|FG013|Overall Study|Decision by sponsor|2|||
27653557|NCT03541369|80570898|FG014|Overall Study|Decision by sponsor|0|||
27653558|NCT03541369|80570899|FG015|Overall Study|Decision by sponsor|1|||
27653559|NCT03541369|80570900|FG016|Overall Study|Decision by sponsor|1|||
27653560|NCT03541369|80570901|FG017|Overall Study|Decision by sponsor|1|||
27653561|NCT03541369|80570884|FG000|Overall Study|Withdrawal by Subject|0|||
27653562|NCT03541369|80570885|FG001|Overall Study|Withdrawal by Subject|0|||
27653563|NCT03541369|80570886|FG002|Overall Study|Withdrawal by Subject|0|||
27653564|NCT03541369|80570887|FG003|Overall Study|Withdrawal by Subject|0|||
27653565|NCT03541369|80570888|FG004|Overall Study|Withdrawal by Subject|0|||
27653566|NCT03541369|80570889|FG005|Overall Study|Withdrawal by Subject|0|||
27653567|NCT03541369|80570890|FG006|Overall Study|Withdrawal by Subject|1|||
27653568|NCT03541369|80570891|FG007|Overall Study|Withdrawal by Subject|0|||
27653569|NCT03541369|80570892|FG008|Overall Study|Withdrawal by Subject|0|||
27653570|NCT03541369|80570893|FG009|Overall Study|Withdrawal by Subject|0|||
27653571|NCT03541369|80570894|FG010|Overall Study|Withdrawal by Subject|0|||
27653572|NCT03541369|80570895|FG011|Overall Study|Withdrawal by Subject|1|||
27653573|NCT03541369|80570896|FG012|Overall Study|Withdrawal by Subject|0|||
27653574|NCT03541369|80570897|FG013|Overall Study|Withdrawal by Subject|0|||
27653575|NCT03541369|80570898|FG014|Overall Study|Withdrawal by Subject|3|||
27653576|NCT03541369|80570899|FG015|Overall Study|Withdrawal by Subject|0|||
27653577|NCT03541369|80570900|FG016|Overall Study|Withdrawal by Subject|4|||
27653578|NCT03541369|80570901|FG017|Overall Study|Withdrawal by Subject|2|||
27653579|NCT03541369|80570884|FG000|Overall Study|Lost to Follow-up|0|||
27653580|NCT03541369|80570885|FG001|Overall Study|Lost to Follow-up|0|||
27653581|NCT03541369|80570886|FG002|Overall Study|Lost to Follow-up|0|||
27653582|NCT03541369|80570887|FG003|Overall Study|Lost to Follow-up|0|||
27653583|NCT03541369|80570888|FG004|Overall Study|Lost to Follow-up|1|||
27653584|NCT03541369|80570889|FG005|Overall Study|Lost to Follow-up|0|||
27653585|NCT03541369|80570890|FG006|Overall Study|Lost to Follow-up|0|||
27653586|NCT03541369|80570891|FG007|Overall Study|Lost to Follow-up|0|||
27653587|NCT03541369|80570892|FG008|Overall Study|Lost to Follow-up|1|||
27653588|NCT03541369|80570893|FG009|Overall Study|Lost to Follow-up|0|||
27653589|NCT03541369|80570894|FG010|Overall Study|Lost to Follow-up|0|||
27653590|NCT03541369|80570895|FG011|Overall Study|Lost to Follow-up|0|||
27653591|NCT03541369|80570896|FG012|Overall Study|Lost to Follow-up|1|||
27653592|NCT03541369|80570897|FG013|Overall Study|Lost to Follow-up|0|||
27653593|NCT03541369|80570898|FG014|Overall Study|Lost to Follow-up|0|||
27653594|NCT03541369|80570899|FG015|Overall Study|Lost to Follow-up|0|||
27653595|NCT03541369|80570900|FG016|Overall Study|Lost to Follow-up|0|||
27653596|NCT03541369|80570901|FG017|Overall Study|Lost to Follow-up|0|||
27653597|NCT03823703|80570902|FG000|Overall Study|Sponsor request|0|||
27653598|NCT03823703|80570903|FG001|Overall Study|Sponsor request|3|||
27653599|NCT03823703|80570904|FG002|Overall Study|Sponsor request|4|||
27653600|NCT03823703|80570902|FG000|Overall Study|Adverse Event|3|||
27653601|NCT03823703|80570903|FG001|Overall Study|Adverse Event|1|||
27653602|NCT03823703|80570904|FG002|Overall Study|Adverse Event|0|||
27653603|NCT03823703|80570902|FG000|Overall Study|Withdrawal by Subject|0|||
27653604|NCT03823703|80570903|FG001|Overall Study|Withdrawal by Subject|1|||
27653605|NCT03823703|80570904|FG002|Overall Study|Withdrawal by Subject|0|||
27653606|NCT01416285|80570905|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
27653607|NCT01416285|80570906|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
27653608|NCT03236779|80570907|FG000|Overall Study|Lost to Follow-up|13|||
27653609|NCT03236779|80570908|FG001|Overall Study|Lost to Follow-up|21|||
27653610|NCT02291549|80570909|FG000|Overall Study|Lost to Follow-up|1|||
27653611|NCT02291549|80570910|FG001|Overall Study|Lost to Follow-up|0|||
27653612|NCT02291549|80570909|FG000|Overall Study|Withdrawal by Subject|0|||
27653613|NCT02291549|80570910|FG001|Overall Study|Withdrawal by Subject|1|||
27653614|NCT02170207|80570913|FG000|Overall Study|Case report forms unavailable|5|||
27653615|NCT01944774|80573928|FG000|Overall Study|Withdrawal by Subject|2|||
27653616|NCT01944774|80573929|FG001|Overall Study|Withdrawal by Subject|3|||
27653617|NCT01944774|80573930|FG002|Overall Study|Withdrawal by Subject|3|||
27653618|NCT01944774|80573928|FG000|Overall Study|Adverse Event|3|||
27653619|NCT01944774|80573929|FG001|Overall Study|Adverse Event|2|||
27653620|NCT01944774|80573930|FG002|Overall Study|Adverse Event|3|||
27653621|NCT01944774|80573928|FG000|Overall Study|Lack of Efficacy|1|||
27653622|NCT01944774|80573929|FG001|Overall Study|Lack of Efficacy|2|||
27653623|NCT01944774|80573930|FG002|Overall Study|Lack of Efficacy|2|||
27653624|NCT01944774|80573928|FG000|Overall Study|Lost to Follow-up|0|||
27653625|NCT01944774|80573929|FG001|Overall Study|Lost to Follow-up|1|||
27653626|NCT01944774|80573930|FG002|Overall Study|Lost to Follow-up|0|||
27653627|NCT00390806|80573931|FG000|Overall Study|Lost to Follow-up|7|||
27653628|NCT00390806|80573932|FG001|Overall Study|Lost to Follow-up|6|||
27653629|NCT00390806|80573931|FG000|Overall Study|Protocol Violation|2|||
27653630|NCT00390806|80573932|FG001|Overall Study|Protocol Violation|2|||
27653631|NCT00390806|80573931|FG000|Overall Study|Withdrawal by Subject|12|||
27653632|NCT00390806|80573932|FG001|Overall Study|Withdrawal by Subject|15|||
27653633|NCT00390806|80573931|FG000|Overall Study|Investigator Decision|4|||
27653634|NCT00390806|80573932|FG001|Overall Study|Investigator Decision|6|||
27653635|NCT00390806|80573931|FG000|Overall Study|Death|1|||
27653636|NCT00390806|80573932|FG001|Overall Study|Death|0|||
27653637|NCT00390806|80573931|FG000|Overall Study|Physician Decision|0|||
27653638|NCT00390806|80573932|FG001|Overall Study|Physician Decision|1|||
27653639|NCT00390806|80573931|FG000|Overall Study|Ongoing|4|||
27751621|NCT04657016|80918177|FG001|Overall Study|Protocol Deviation|0|||
27653640|NCT00390806|80573932|FG001|Overall Study|Ongoing|2|||
27653641|NCT02133131|80573933|FG000|Overall Study|Adverse Event|0|||
27653642|NCT02133131|80573934|FG001|Overall Study|Adverse Event|0|||
27653643|NCT02133131|80573935|FG002|Overall Study|Adverse Event|0|||
27653644|NCT02133131|80573936|FG003|Overall Study|Adverse Event|1|||
27653645|NCT02133131|80573937|FG004|Overall Study|Adverse Event|0|||
27653646|NCT02133131|80573938|FG005|Overall Study|Adverse Event|0|||
27653647|NCT02133131|80573939|FG006|Overall Study|Adverse Event|0|||
27653648|NCT02133131|80573933|FG000|Overall Study|Lost to Follow-up|1|||
27653649|NCT02133131|80573934|FG001|Overall Study|Lost to Follow-up|0|||
27653650|NCT02133131|80573935|FG002|Overall Study|Lost to Follow-up|0|||
27653651|NCT02133131|80573936|FG003|Overall Study|Lost to Follow-up|1|||
27653652|NCT02133131|80573937|FG004|Overall Study|Lost to Follow-up|0|||
27653653|NCT02133131|80573938|FG005|Overall Study|Lost to Follow-up|0|||
27653654|NCT02133131|80573939|FG006|Overall Study|Lost to Follow-up|0|||
27653655|NCT02133131|80573933|FG000|Overall Study|Status not recorded|4|||
27653656|NCT02133131|80573934|FG001|Overall Study|Status not recorded|5|||
27653657|NCT02133131|80573935|FG002|Overall Study|Status not recorded|1|||
27653658|NCT02133131|80573936|FG003|Overall Study|Status not recorded|4|||
27653659|NCT02133131|80573937|FG004|Overall Study|Status not recorded|0|||
27653660|NCT02133131|80573938|FG005|Overall Study|Status not recorded|0|||
27653661|NCT02133131|80573939|FG006|Overall Study|Status not recorded|0|||
27653662|NCT02133131|80573933|FG000|Overall Study|Ongoing in study|0|||
27653663|NCT02133131|80573934|FG001|Overall Study|Ongoing in study|0|||
27653664|NCT02133131|80573935|FG002|Overall Study|Ongoing in study|0|||
27653665|NCT02133131|80573936|FG003|Overall Study|Ongoing in study|0|||
27653666|NCT02133131|80573937|FG004|Overall Study|Ongoing in study|15|||
27653667|NCT02133131|80573938|FG005|Overall Study|Ongoing in study|14|||
27653668|NCT02133131|80573939|FG006|Overall Study|Ongoing in study|11|||
27653669|NCT02133131|80573933|FG000|Overall Study|Protocol Violation|0|||
27653670|NCT02133131|80573934|FG001|Overall Study|Protocol Violation|0|||
27653671|NCT02133131|80573935|FG002|Overall Study|Protocol Violation|0|||
27653672|NCT02133131|80573936|FG003|Overall Study|Protocol Violation|0|||
27653673|NCT02133131|80573937|FG004|Overall Study|Protocol Violation|0|||
27653674|NCT02133131|80573938|FG005|Overall Study|Protocol Violation|0|||
27653675|NCT02133131|80573939|FG006|Overall Study|Protocol Violation|1|||
27653676|NCT02002689|80573940|FG000|Overall Study|Disease Progression|7|||
27653677|NCT02002689|80573940|FG000|Overall Study|Adverse Event|3|||
27653678|NCT05005247|80573941|FG000|Overall Study|Withdrawal by Subject|0|||
27653679|NCT05005247|80573942|FG001|Overall Study|Withdrawal by Subject|1|||
27653680|NCT05005247|80573943|FG002|Overall Study|Withdrawal by Subject|0|||
27653681|NCT00595764|80573944|FG000|Overall Study|Protocol Violation|24|||
27653682|NCT00595764|80573945|FG001|Overall Study|Protocol Violation|19|||
27653683|NCT00595764|80573944|FG000|Overall Study|Missed Medication >1 week|10|||
27653684|NCT00595764|80573945|FG001|Overall Study|Missed Medication >1 week|17|||
27653685|NCT00595764|80573944|FG000|Overall Study|Missed 3 PM visits|1|||
27653686|NCT00595764|80573945|FG001|Overall Study|Missed 3 PM visits|7|||
27653687|NCT00595764|80573944|FG000|Overall Study|Withdrawal by Subject|4|||
27653688|NCT00595764|80573945|FG001|Overall Study|Withdrawal by Subject|0|||
27653689|NCT00882050|80573948|FG000|Overall Study|Physician Decision|1|||
27653690|NCT00882050|80573949|FG001|Overall Study|Physician Decision|0|||
27653691|NCT00882050|80573950|FG002|Overall Study|Physician Decision|0|||
27653692|NCT02607956|80573951|FG000|Double-Blinded Phase|Withdrew Consent|17|||
27653693|NCT02607956|80573952|FG001|Double-Blinded Phase|Withdrew Consent|19|||
27653694|NCT02607956|80573953|FG002|Double-Blinded Phase|Withdrew Consent|0|||
27653695|NCT02607956|80573954|FG003|Double-Blinded Phase|Withdrew Consent|0|||
27653696|NCT02607956|80573951|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
27653697|NCT02607956|80573952|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
27653698|NCT02607956|80573953|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
27653699|NCT02607956|80573954|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
27653700|NCT02607956|80573951|FG000|Double-Blinded Phase|Randomized but never treated|7|||
27653701|NCT02607956|80573952|FG001|Double-Blinded Phase|Randomized but never treated|5|||
27653702|NCT02607956|80573953|FG002|Double-Blinded Phase|Randomized but never treated|0|||
27653703|NCT02607956|80573954|FG003|Double-Blinded Phase|Randomized but never treated|0|||
27653704|NCT02607956|80573951|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
27653705|NCT02607956|80573952|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
27653706|NCT02607956|80573953|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
27653707|NCT02607956|80573954|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
27653708|NCT02607956|80573951|FG000|Double-Blinded Phase|Death|4|||
27653709|NCT02607956|80573952|FG001|Double-Blinded Phase|Death|4|||
27653710|NCT02607956|80573953|FG002|Double-Blinded Phase|Death|0|||
27653711|NCT02607956|80573954|FG003|Double-Blinded Phase|Death|0|||
27653712|NCT02607956|80573951|FG000|Double-Blinded Phase|Adverse Event|4|||
27653713|NCT02607956|80573952|FG001|Double-Blinded Phase|Adverse Event|3|||
27653714|NCT02607956|80573953|FG002|Double-Blinded Phase|Adverse Event|0|||
27653715|NCT02607956|80573954|FG003|Double-Blinded Phase|Adverse Event|0|||
27653716|NCT02607956|80573951|FG000|Double-Blinded Phase|Protocol Violation|3|||
27653717|NCT02607956|80573952|FG001|Double-Blinded Phase|Protocol Violation|1|||
27653718|NCT02607956|80573953|FG002|Double-Blinded Phase|Protocol Violation|0|||
27653719|NCT02607956|80573954|FG003|Double-Blinded Phase|Protocol Violation|0|||
27653720|NCT02607956|80573951|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
27653721|NCT02607956|80573952|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
27653722|NCT02607956|80573953|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
27653723|NCT02607956|80573954|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
27653724|NCT02607956|80573951|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
27653725|NCT02607956|80573952|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
27653726|NCT02607956|80573953|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
27653727|NCT02607956|80573954|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
27653728|NCT02607956|80573951|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
27653729|NCT02607956|80573952|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
27653730|NCT02607956|80573953|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
27653731|NCT02607956|80573954|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
27653732|NCT02607956|80573951|FG000|Open-Label Extension Phase|Death|0|||
27653733|NCT02607956|80573952|FG001|Open-Label Extension Phase|Death|0|||
27653734|NCT02607956|80573953|FG002|Open-Label Extension Phase|Death|1|||
27653735|NCT02607956|80573954|FG003|Open-Label Extension Phase|Death|3|||
27653736|NCT02607956|80573951|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
27653737|NCT02607956|80573952|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
27653738|NCT02607956|80573953|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
27653739|NCT02607956|80573954|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
27653740|NCT02607956|80573951|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
27653741|NCT02607956|80573952|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
27653742|NCT02607956|80573953|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
27653743|NCT02607956|80573954|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
27653744|NCT02607956|80573951|FG000|Open-Label Extension Phase|Protocol Violation|0|||
27653745|NCT02607956|80573952|FG001|Open-Label Extension Phase|Protocol Violation|0|||
27653746|NCT02607956|80573953|FG002|Open-Label Extension Phase|Protocol Violation|0|||
27653747|NCT02607956|80573954|FG003|Open-Label Extension Phase|Protocol Violation|2|||
27653748|NCT02607956|80573951|FG000|Open-Label Extension Phase|Pregnancy|0|||
27653749|NCT02607956|80573952|FG001|Open-Label Extension Phase|Pregnancy|0|||
27653750|NCT02607956|80573953|FG002|Open-Label Extension Phase|Pregnancy|0|||
27653751|NCT02607956|80573954|FG003|Open-Label Extension Phase|Pregnancy|1|||
27653752|NCT00671853|80573955|FG000|Overall Study|Lack of Efficacy|3|||
27653753|NCT00671853|80573956|FG001|Overall Study|Lack of Efficacy|7|||
27653754|NCT00671853|80573955|FG000|Overall Study|Adverse Event|7|||
27653755|NCT00671853|80573956|FG001|Overall Study|Adverse Event|1|||
27653756|NCT00671853|80573955|FG000|Overall Study|Withdrawal by Subject|1|||
27653757|NCT00671853|80573956|FG001|Overall Study|Withdrawal by Subject|5|||
27653758|NCT00671853|80573955|FG000|Overall Study|Lost to Follow-up|8|||
27653759|NCT00671853|80573956|FG001|Overall Study|Lost to Follow-up|8|||
27653760|NCT00671853|80573955|FG000|Overall Study|Physician Decision|0|||
27653761|NCT00671853|80573956|FG001|Overall Study|Physician Decision|2|||
27653762|NCT00671853|80573955|FG000|Overall Study|Non-adherence with study procedures|1|||
27653763|NCT00671853|80573956|FG001|Overall Study|Non-adherence with study procedures|4|||
27653764|NCT03070301|80573959|FG000|Overall Study|Progression of disease|16|||
27653765|NCT03070301|80573959|FG000|Overall Study|Physician Decision|3|||
27653766|NCT03070301|80573959|FG000|Overall Study|Withdrawal by Subject|1|||
27653767|NCT00805792|80573960|FG000|Overall Study|Death|3|||
27653768|NCT00805792|80573960|FG000|Overall Study|Lost to Follow-up|2|||
27653769|NCT02708498|80573962|FG000|Overall Study|Death|20|||
27653770|NCT02708498|80573963|FG001|Overall Study|Death|19|||
27653771|NCT02708498|80573964|FG002|Overall Study|Death|0|||
27653772|NCT02708498|80573965|FG003|Overall Study|Death|0|||
27653773|NCT02708498|80573966|FG004|Overall Study|Death|1|||
27653774|NCT02708498|80573967|FG005|Overall Study|Death|0|||
27653775|NCT02708498|80573968|FG006|Overall Study|Death|0|||
27653776|NCT02708498|80573969|FG007|Overall Study|Death|0|||
27653777|NCT02708498|80573962|FG000|Overall Study|Unknown reason, missing data|0|||
27653778|NCT02708498|80573963|FG001|Overall Study|Unknown reason, missing data|0|||
27653779|NCT02708498|80573964|FG002|Overall Study|Unknown reason, missing data|62|||
27653780|NCT02708498|80573965|FG003|Overall Study|Unknown reason, missing data|51|||
27653781|NCT02708498|80573966|FG004|Overall Study|Unknown reason, missing data|195|||
27653782|NCT02708498|80573967|FG005|Overall Study|Unknown reason, missing data|132|||
27653783|NCT02708498|80573968|FG006|Overall Study|Unknown reason, missing data|0|||
27653784|NCT02708498|80573969|FG007|Overall Study|Unknown reason, missing data|0|||
27653785|NCT02132195|80573974|FG000|Initial Assignment|Relapsed|14|||
27653786|NCT02132195|80573975|FG001|Initial Assignment|Relapsed|0|||
27653787|NCT02132195|80573976|FG002|Initial Assignment|Relapsed|0|||
27653788|NCT02132195|80573974|FG000|Rescue Therapy|Relapsed|0|||
27653789|NCT02132195|80573975|FG001|Rescue Therapy|Relapsed|0|||
27653790|NCT02132195|80573976|FG002|Rescue Therapy|Relapsed|7|||
27653791|NCT02132195|80573974|FG000|Rescue Therapy|Physician Decision|0|||
27653792|NCT02132195|80573975|FG001|Rescue Therapy|Physician Decision|0|||
27653793|NCT02132195|80573976|FG002|Rescue Therapy|Physician Decision|1|||
27653794|NCT02132195|80573974|FG000|Rescue Therapy|Withdrawal by Subject|0|||
27653795|NCT02132195|80573975|FG001|Rescue Therapy|Withdrawal by Subject|0|||
27653796|NCT02132195|80573976|FG002|Rescue Therapy|Withdrawal by Subject|1|||
27653797|NCT02132195|80573974|FG000|Rescue Therapy|Adverse Event|0|||
27653798|NCT02132195|80573975|FG001|Rescue Therapy|Adverse Event|0|||
27653799|NCT02132195|80573976|FG002|Rescue Therapy|Adverse Event|2|||
27653800|NCT00355784|80573977|FG000|Overall Study|Withdrawal by Subject|0|||
27653801|NCT00355784|80573978|FG001|Overall Study|Withdrawal by Subject|0|||
27653802|NCT00355784|80573979|FG002|Overall Study|Withdrawal by Subject|2|||
27653803|NCT02245620|80573980|FG000|Overall Study|Physician Decision|1|||
27653804|NCT02245620|80573981|FG001|Overall Study|Physician Decision|1|||
27653805|NCT03316170|80573982|FG000|Overall Study|Death|1|||
27653806|NCT03316170|80573983|FG001|Overall Study|Death|0|||
27653807|NCT03316170|80573982|FG000|Overall Study|Lost to Follow-up|6|||
27653808|NCT03316170|80573983|FG001|Overall Study|Lost to Follow-up|7|||
27653809|NCT01441596|80573986|FG000|Overall Study|Other reason not defined below|0|||
27653810|NCT01441596|80573987|FG001|Overall Study|Other reason not defined below|2|||
27653811|NCT01441596|80573988|FG002|Overall Study|Other reason not defined below|1|||
27653812|NCT01441596|80573986|FG000|Overall Study|Withdrawal by Subject|4|||
27653813|NCT01441596|80573987|FG001|Overall Study|Withdrawal by Subject|0|||
27653814|NCT01441596|80573988|FG002|Overall Study|Withdrawal by Subject|2|||
27653815|NCT01441596|80573986|FG000|Overall Study|Not treated|0|||
27653816|NCT01441596|80573987|FG001|Overall Study|Not treated|1|||
27653817|NCT01441596|80573988|FG002|Overall Study|Not treated|1|||
27653818|NCT00413283|80573989|FG000|Overall Study|Withdrawal by Subject|1|||
27653819|NCT00413283|80573990|FG001|Overall Study|Withdrawal by Subject|0|||
27653820|NCT00413283|80573991|FG002|Overall Study|Withdrawal by Subject|0|||
27653821|NCT00413283|80573992|FG003|Overall Study|Withdrawal by Subject|1|||
27653822|NCT00413283|80573989|FG000|Overall Study|Death|0|||
27653823|NCT00413283|80573990|FG001|Overall Study|Death|0|||
27653824|NCT00413283|80573991|FG002|Overall Study|Death|1|||
27653825|NCT00413283|80573992|FG003|Overall Study|Death|1|||
27653826|NCT00413283|80573989|FG000|Overall Study|Adverse Event|0|||
27653827|NCT00413283|80573990|FG001|Overall Study|Adverse Event|0|||
27653828|NCT00413283|80573991|FG002|Overall Study|Adverse Event|0|||
27653829|NCT00413283|80573992|FG003|Overall Study|Adverse Event|1|||
27653830|NCT00413283|80573989|FG000|Overall Study|Ineligibility determined|0|||
27653831|NCT00413283|80573990|FG001|Overall Study|Ineligibility determined|0|||
27653832|NCT00413283|80573991|FG002|Overall Study|Ineligibility determined|0|||
27653833|NCT00413283|80573992|FG003|Overall Study|Ineligibility determined|1|||
27653834|NCT00413283|80573989|FG000|Overall Study|Protocol deviation|0|||
27653835|NCT00413283|80573990|FG001|Overall Study|Protocol deviation|1|||
27653836|NCT00413283|80573991|FG002|Overall Study|Protocol deviation|0|||
27653837|NCT00413283|80573992|FG003|Overall Study|Protocol deviation|0|||
27653838|NCT00413283|80573989|FG000|Overall Study|Requirement for alternative therapy|0|||
27653839|NCT00413283|80573990|FG001|Overall Study|Requirement for alternative therapy|2|||
27653840|NCT00413283|80573991|FG002|Overall Study|Requirement for alternative therapy|0|||
27653841|NCT00413283|80573992|FG003|Overall Study|Requirement for alternative therapy|0|||
27653842|NCT00413283|80573989|FG000|Overall Study|Other|0|||
27653843|NCT00413283|80573990|FG001|Overall Study|Other|0|||
27653844|NCT00413283|80573991|FG002|Overall Study|Other|1|||
27653845|NCT00413283|80573992|FG003|Overall Study|Other|0|||
27653846|NCT01199302|80573993|FG000|Overall Study|Adverse Event|1|||
27653847|NCT01199302|80573994|FG001|Overall Study|Adverse Event|1|||
27653848|NCT01199302|80573995|FG002|Overall Study|Adverse Event|2|||
27653849|NCT01199302|80573996|FG003|Overall Study|Adverse Event|0|||
27653850|NCT01199302|80573993|FG000|Overall Study|Withdrawal by Subject|2|||
27653851|NCT01199302|80573994|FG001|Overall Study|Withdrawal by Subject|2|||
27653852|NCT01199302|80573995|FG002|Overall Study|Withdrawal by Subject|3|||
27653853|NCT01199302|80573996|FG003|Overall Study|Withdrawal by Subject|0|||
27653854|NCT01199302|80573993|FG000|Overall Study|Disease Progression|3|||
27653855|NCT01199302|80573994|FG001|Overall Study|Disease Progression|4|||
27653856|NCT01199302|80573995|FG002|Overall Study|Disease Progression|4|||
27653857|NCT01199302|80573996|FG003|Overall Study|Disease Progression|2|||
27653858|NCT01199302|80573993|FG000|Overall Study|Study Termination|13|||
27653859|NCT01199302|80573994|FG001|Overall Study|Study Termination|8|||
27653860|NCT01199302|80573995|FG002|Overall Study|Study Termination|11|||
27653861|NCT01199302|80573996|FG003|Overall Study|Study Termination|9|||
27653862|NCT01199302|80573993|FG000|Overall Study|Lost to Follow-up|0|||
27955489|NCT00742625|81672188|FG000|Remission Induction|Refusal|5|||
27653863|NCT01199302|80573994|FG001|Overall Study|Lost to Follow-up|1|||
27955490|NCT00742625|81672188|FG000|Remission Induction|Non protocol treatment|17|||
27653864|NCT01199302|80573995|FG002|Overall Study|Lost to Follow-up|0|||
27653865|NCT01199302|80573996|FG003|Overall Study|Lost to Follow-up|0|||
27653866|NCT01199302|80573993|FG000|Overall Study|Other|1|||
27653867|NCT01199302|80573994|FG001|Overall Study|Other|0|||
27653868|NCT01199302|80573995|FG002|Overall Study|Other|0|||
27653869|NCT01199302|80573996|FG003|Overall Study|Other|0|||
27653870|NCT03431350|80573999|FG000|Overall Study|ONGOING|0|||
27653871|NCT03431350|80574000|FG001|Overall Study|ONGOING|0|||
27653872|NCT03431350|80574001|FG002|Overall Study|ONGOING|2|||
27653873|NCT03431350|80574002|FG003|Overall Study|ONGOING|0|||
27653874|NCT03431350|80574003|FG004|Overall Study|ONGOING|1|||
27653875|NCT03431350|80574004|FG005|Overall Study|ONGOING|3|||
27653876|NCT03431350|80574005|FG006|Overall Study|ONGOING|0|||
27653877|NCT03431350|80574006|FG007|Overall Study|ONGOING|1|||
27653878|NCT03431350|80574007|FG008|Overall Study|ONGOING|3|||
27653879|NCT03431350|80574008|FG009|Overall Study|ONGOING|4|||
27653880|NCT03431350|80574009|FG010|Overall Study|ONGOING|2|||
27653881|NCT03431350|80574010|FG011|Overall Study|ONGOING|1|||
27653882|NCT03431350|80573999|FG000|Overall Study|Death|6|||
27653883|NCT03431350|80574000|FG001|Overall Study|Death|5|||
27653884|NCT03431350|80574001|FG002|Overall Study|Death|18|||
27653885|NCT03431350|80574002|FG003|Overall Study|Death|7|||
27653886|NCT03431350|80574003|FG004|Overall Study|Death|4|||
27653887|NCT03431350|80574004|FG005|Overall Study|Death|3|||
27653888|NCT03431350|80574005|FG006|Overall Study|Death|2|||
27653889|NCT03431350|80574006|FG007|Overall Study|Death|0|||
27653890|NCT03431350|80574007|FG008|Overall Study|Death|0|||
27653891|NCT03431350|80574008|FG009|Overall Study|Death|0|||
27653892|NCT03431350|80574009|FG010|Overall Study|Death|4|||
27653893|NCT03431350|80574010|FG011|Overall Study|Death|0|||
27653894|NCT03431350|80573999|FG000|Overall Study|Lost to Follow-up|0|||
27653895|NCT03431350|80574000|FG001|Overall Study|Lost to Follow-up|1|||
27653896|NCT03431350|80574001|FG002|Overall Study|Lost to Follow-up|0|||
27653897|NCT03431350|80574002|FG003|Overall Study|Lost to Follow-up|0|||
27653898|NCT03431350|80574003|FG004|Overall Study|Lost to Follow-up|0|||
27653899|NCT03431350|80574004|FG005|Overall Study|Lost to Follow-up|0|||
27653900|NCT03431350|80574005|FG006|Overall Study|Lost to Follow-up|0|||
27653901|NCT03431350|80574006|FG007|Overall Study|Lost to Follow-up|0|||
27653902|NCT03431350|80574007|FG008|Overall Study|Lost to Follow-up|0|||
27653903|NCT03431350|80574008|FG009|Overall Study|Lost to Follow-up|0|||
27653904|NCT03431350|80574009|FG010|Overall Study|Lost to Follow-up|0|||
27653905|NCT03431350|80574010|FG011|Overall Study|Lost to Follow-up|0|||
27653906|NCT03431350|80573999|FG000|Overall Study|Withdrawal by Subject|0|||
27653907|NCT03431350|80574000|FG001|Overall Study|Withdrawal by Subject|0|||
27653908|NCT03431350|80574001|FG002|Overall Study|Withdrawal by Subject|0|||
27653909|NCT03431350|80574002|FG003|Overall Study|Withdrawal by Subject|1|||
27653910|NCT03431350|80574003|FG004|Overall Study|Withdrawal by Subject|1|||
27653911|NCT03431350|80574004|FG005|Overall Study|Withdrawal by Subject|1|||
27653912|NCT03431350|80574005|FG006|Overall Study|Withdrawal by Subject|0|||
27653913|NCT03431350|80574006|FG007|Overall Study|Withdrawal by Subject|0|||
27653914|NCT03431350|80574007|FG008|Overall Study|Withdrawal by Subject|0|||
27653915|NCT03431350|80574008|FG009|Overall Study|Withdrawal by Subject|2|||
27653916|NCT03431350|80574009|FG010|Overall Study|Withdrawal by Subject|0|||
27653917|NCT03431350|80574010|FG011|Overall Study|Withdrawal by Subject|1|||
27653918|NCT03431350|80573999|FG000|Overall Study|Other|0|||
27653919|NCT03431350|80574000|FG001|Overall Study|Other|0|||
27653920|NCT03431350|80574001|FG002|Overall Study|Other|1|||
27653921|NCT03431350|80574002|FG003|Overall Study|Other|3|||
27653922|NCT03431350|80574003|FG004|Overall Study|Other|2|||
27653923|NCT03431350|80574004|FG005|Overall Study|Other|2|||
27653924|NCT03431350|80574005|FG006|Overall Study|Other|4|||
27653925|NCT03431350|80574006|FG007|Overall Study|Other|0|||
27653926|NCT03431350|80574007|FG008|Overall Study|Other|14|||
27653927|NCT03431350|80574008|FG009|Overall Study|Other|11|||
27653928|NCT03431350|80574009|FG010|Overall Study|Other|11|||
27653929|NCT03431350|80574010|FG011|Overall Study|Other|15|||
27653930|NCT00657709|80574011|FG000|Overall Study|AE or Death|7|||
27653931|NCT00657709|80574012|FG001|Overall Study|AE or Death|7|||
27653932|NCT00657709|80574013|FG002|Overall Study|AE or Death|6|||
27653933|NCT00657709|80574014|FG003|Overall Study|AE or Death|7|||
27653934|NCT00657709|80574015|FG004|Overall Study|AE or Death|1|||
27653935|NCT00657709|80574011|FG000|Overall Study|Withdrawal by Subject|7|||
27653936|NCT00657709|80574012|FG001|Overall Study|Withdrawal by Subject|15|||
27653937|NCT00657709|80574013|FG002|Overall Study|Withdrawal by Subject|15|||
27653938|NCT00657709|80574014|FG003|Overall Study|Withdrawal by Subject|5|||
27653939|NCT00657709|80574015|FG004|Overall Study|Withdrawal by Subject|9|||
27653940|NCT00657709|80574011|FG000|Overall Study|Lost to Follow-up|9|||
27653941|NCT00657709|80574012|FG001|Overall Study|Lost to Follow-up|9|||
27653942|NCT00657709|80574013|FG002|Overall Study|Lost to Follow-up|7|||
27653943|NCT00657709|80574014|FG003|Overall Study|Lost to Follow-up|1|||
27653944|NCT00657709|80574015|FG004|Overall Study|Lost to Follow-up|21|||
27653945|NCT00657709|80574011|FG000|Overall Study|Protocol Violation|0|||
27653946|NCT00657709|80574012|FG001|Overall Study|Protocol Violation|2|||
27653947|NCT00657709|80574013|FG002|Overall Study|Protocol Violation|0|||
27653948|NCT00657709|80574014|FG003|Overall Study|Protocol Violation|1|||
27653949|NCT00657709|80574015|FG004|Overall Study|Protocol Violation|2|||
27653950|NCT01721109|80574016|FG000|Overall Study|Lack of Efficacy|1|||
27653951|NCT01721109|80574016|FG000|Overall Study|Non- Compliance with Study Drug|3|||
27653952|NCT01721109|80574016|FG000|Overall Study|Withdrew Consent|1|||
27653953|NCT01721109|80574016|FG000|Overall Study|Lost to Follow-up|2|||
27653954|NCT04212299|80574017|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
27653955|NCT00424476|80574020|FG000|Overall Study|Withdrawal by Subject|7|||
27653956|NCT00424476|80574021|FG001|Overall Study|Withdrawal by Subject|6|||
27653957|NCT00424476|80574022|FG002|Overall Study|Withdrawal by Subject|3|||
27653958|NCT00424476|80574020|FG000|Overall Study|Adverse Event|19|||
27653959|NCT00424476|80574021|FG001|Overall Study|Adverse Event|16|||
27653960|NCT00424476|80574022|FG002|Overall Study|Adverse Event|15|||
27653961|NCT00424476|80574020|FG000|Overall Study|Lack of Efficacy|16|||
27653962|NCT00424476|80574021|FG001|Overall Study|Lack of Efficacy|12|||
27653963|NCT00424476|80574022|FG002|Overall Study|Lack of Efficacy|12|||
27653964|NCT00424476|80574020|FG000|Overall Study|Lack of Compliance|1|||
27653965|NCT00424476|80574021|FG001|Overall Study|Lack of Compliance|1|||
27653966|NCT00424476|80574022|FG002|Overall Study|Lack of Compliance|1|||
27653967|NCT00424476|80574020|FG000|Overall Study|Lost to Follow-up|4|||
27653968|NCT00424476|80574021|FG001|Overall Study|Lost to Follow-up|6|||
27653969|NCT00424476|80574022|FG002|Overall Study|Lost to Follow-up|3|||
27653970|NCT00424476|80574020|FG000|Overall Study|Protocol Violation|7|||
27653971|NCT00424476|80574021|FG001|Overall Study|Protocol Violation|2|||
27653972|NCT00424476|80574022|FG002|Overall Study|Protocol Violation|3|||
27653973|NCT00424476|80574020|FG000|Overall Study|Physician Decision|3|||
27653974|NCT00424476|80574021|FG001|Overall Study|Physician Decision|2|||
27653975|NCT00424476|80574022|FG002|Overall Study|Physician Decision|3|||
27653976|NCT00424476|80574020|FG000|Overall Study|Other|4|||
27653977|NCT00424476|80574021|FG001|Overall Study|Other|3|||
27653978|NCT00424476|80574022|FG002|Overall Study|Other|9|||
27653979|NCT00768755|80574023|FG000|Phase 1|Death|6|||
27653980|NCT00768755|80574024|FG001|Phase 1|Death|0|||
27653981|NCT00768755|80574025|FG002|Phase 1|Death|0|||
27653982|NCT00768755|80574026|FG003|Phase 1|Death|0|||
27653983|NCT00768755|80574023|FG000|Phase 1|Other|4|||
27653984|NCT00768755|80574024|FG001|Phase 1|Other|0|||
27653985|NCT00768755|80574025|FG002|Phase 1|Other|0|||
27653986|NCT00768755|80574026|FG003|Phase 1|Other|0|||
27653987|NCT00768755|80574023|FG000|Phase 2|Death|0|||
27653988|NCT00768755|80574024|FG001|Phase 2|Death|37|||
27653989|NCT00768755|80574025|FG002|Phase 2|Death|48|||
27653990|NCT00768755|80574026|FG003|Phase 2|Death|31|||
27653991|NCT00768755|80574023|FG000|Phase 2|Protocol Violation|0|||
27653992|NCT00768755|80574024|FG001|Phase 2|Protocol Violation|2|||
27653993|NCT00768755|80574025|FG002|Phase 2|Protocol Violation|0|||
27653994|NCT00768755|80574026|FG003|Phase 2|Protocol Violation|1|||
27653995|NCT00768755|80574023|FG000|Phase 2|Lost to Follow-up|0|||
27653996|NCT00768755|80574024|FG001|Phase 2|Lost to Follow-up|1|||
27653997|NCT00768755|80574025|FG002|Phase 2|Lost to Follow-up|1|||
27653998|NCT00768755|80574026|FG003|Phase 2|Lost to Follow-up|4|||
27653999|NCT00768755|80574023|FG000|Phase 2|Withdrawal by Subject|0|||
27654000|NCT00768755|80574024|FG001|Phase 2|Withdrawal by Subject|1|||
27654001|NCT00768755|80574025|FG002|Phase 2|Withdrawal by Subject|0|||
27654002|NCT00768755|80574026|FG003|Phase 2|Withdrawal by Subject|1|||
27654003|NCT00768755|80574023|FG000|Phase 2|Other|0|||
27654004|NCT00768755|80574024|FG001|Phase 2|Other|1|||
27654005|NCT00768755|80574025|FG002|Phase 2|Other|2|||
27654006|NCT00768755|80574026|FG003|Phase 2|Other|4|||
27654007|NCT00768755|80574023|FG000|Phase 2|Study Terminated by Sponsor|0|||
27654008|NCT00768755|80574024|FG001|Phase 2|Study Terminated by Sponsor|13|||
27654009|NCT00768755|80574025|FG002|Phase 2|Study Terminated by Sponsor|7|||
27654010|NCT00768755|80574026|FG003|Phase 2|Study Terminated by Sponsor|14|||
27654011|NCT00768755|80574023|FG000|Phase 2|Randomized but not treated|0|||
27654012|NCT00768755|80574024|FG001|Phase 2|Randomized but not treated|0|||
27654013|NCT00768755|80574025|FG002|Phase 2|Randomized but not treated|0|||
27654014|NCT00768755|80574026|FG003|Phase 2|Randomized but not treated|2|||
27654015|NCT01090739|80574029|FG000|Enrollment|Withdrawal by Subject|24|||
27654016|NCT01090739|80574029|FG000|Enrollment|Protocol Violation|14|||
27654017|NCT01090739|80574029|FG000|Enrollment|Lost to Follow-up|5|||
27654018|NCT01090739|80574029|FG000|Enrollment|Physician Decision|5|||
27654019|NCT01090739|80574029|FG000|Enrollment|Sponsor termination of site|4|||
27654020|NCT01090739|80574029|FG000|Enrollment|Study implant limit reached|2|||
27654021|NCT01090739|80574029|FG000|Enrollment|Adverse Event|1|||
27654022|NCT01090739|80574029|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
27955491|NCT00742625|81672188|FG000|Remission Induction|Other, not specified|5|||
27654023|NCT01090739|80574029|FG000|12 Month Follow-up|Lost to Follow-up|1|||
27654024|NCT01090739|80574029|FG000|12 Month Follow-up|Physician Decision|1|||
27654025|NCT01090739|80574029|FG000|12 Month Follow-up|Death|1|||
27654026|NCT01090739|80574029|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
27654027|NCT01090739|80574029|FG000|24 Month Follow-up|Lost to Follow-up|1|||
27654028|NCT01090739|80574029|FG000|24 Month Follow-up|Death|1|||
27654029|NCT01090739|80574029|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
27654030|NCT01090739|80574029|FG000|36 Month Follow-up|Visit still pending|17|||
27654031|NCT03031782|80574030|FG000|Treatment Period 1|Lack of Efficacy|3|||
27654032|NCT03031782|80574031|FG001|Treatment Period 1|Lack of Efficacy|0|||
27654033|NCT03031782|80574032|FG002|Treatment Period 1|Lack of Efficacy|0|||
27654034|NCT03031782|80574033|FG003|Treatment Period 1|Lack of Efficacy|0|||
27654035|NCT03031782|80574034|FG004|Treatment Period 1|Lack of Efficacy|0|||
27654036|NCT03031782|80574030|FG000|Treatment Period 2|Physician Decision|0|||
27654037|NCT03031782|80574031|FG001|Treatment Period 2|Physician Decision|1|||
27654038|NCT03031782|80574032|FG002|Treatment Period 2|Physician Decision|0|||
27654039|NCT03031782|80574033|FG003|Treatment Period 2|Physician Decision|0|||
27654040|NCT03031782|80574034|FG004|Treatment Period 2|Physician Decision|3|||
27654041|NCT03031782|80574030|FG000|Treatment Period 2|Lack of Efficacy|0|||
27654042|NCT03031782|80574031|FG001|Treatment Period 2|Lack of Efficacy|1|||
27654043|NCT03031782|80574032|FG002|Treatment Period 2|Lack of Efficacy|0|||
27654044|NCT03031782|80574033|FG003|Treatment Period 2|Lack of Efficacy|0|||
27654045|NCT03031782|80574034|FG004|Treatment Period 2|Lack of Efficacy|1|||
27654046|NCT03031782|80574030|FG000|Treatment Period 2|Withdrawal by Subject|0|||
27654047|NCT03031782|80574031|FG001|Treatment Period 2|Withdrawal by Subject|3|||
27654048|NCT03031782|80574032|FG002|Treatment Period 2|Withdrawal by Subject|0|||
27654049|NCT03031782|80574033|FG003|Treatment Period 2|Withdrawal by Subject|0|||
27654050|NCT03031782|80574034|FG004|Treatment Period 2|Withdrawal by Subject|1|||
27654051|NCT03031782|80574030|FG000|Treatment Period 2|Adverse Event|0|||
27654052|NCT03031782|80574031|FG001|Treatment Period 2|Adverse Event|1|||
27654053|NCT03031782|80574032|FG002|Treatment Period 2|Adverse Event|2|||
27654054|NCT03031782|80574033|FG003|Treatment Period 2|Adverse Event|0|||
27654055|NCT03031782|80574034|FG004|Treatment Period 2|Adverse Event|0|||
27654056|NCT03031782|80574030|FG000|Treatment Period 3|Withdrawal by Subject|0|||
27654057|NCT03031782|80574031|FG001|Treatment Period 3|Withdrawal by Subject|0|||
27654058|NCT03031782|80574032|FG002|Treatment Period 3|Withdrawal by Subject|0|||
27654059|NCT03031782|80574033|FG003|Treatment Period 3|Withdrawal by Subject|1|||
27654060|NCT03031782|80574034|FG004|Treatment Period 3|Withdrawal by Subject|0|||
27654061|NCT00484198|80574035|FG000|Overall Study|Participant Withdrew Consent|12|||
27654062|NCT00484198|80574036|FG001|Overall Study|Participant Withdrew Consent|21|||
27654063|NCT00484198|80574037|FG002|Overall Study|Participant Withdrew Consent|47|||
27654064|NCT00484198|80574038|FG003|Overall Study|Participant Withdrew Consent|59|||
27654065|NCT00484198|80574035|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
27654066|NCT00484198|80574036|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
27654067|NCT00484198|80574037|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
27654068|NCT00484198|80574038|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
27654069|NCT00484198|80574035|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
27654070|NCT00484198|80574036|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
27654071|NCT00484198|80574037|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
27654072|NCT00484198|80574038|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
27654073|NCT00484198|80574035|FG000|Overall Study|Adverse Event|3|||
27654074|NCT00484198|80574036|FG001|Overall Study|Adverse Event|11|||
27654075|NCT00484198|80574037|FG002|Overall Study|Adverse Event|32|||
27654076|NCT00484198|80574038|FG003|Overall Study|Adverse Event|31|||
27654077|NCT00484198|80574035|FG000|Overall Study|Protocol Violation|0|||
27654078|NCT00484198|80574036|FG001|Overall Study|Protocol Violation|5|||
27654079|NCT00484198|80574037|FG002|Overall Study|Protocol Violation|6|||
27654080|NCT00484198|80574038|FG003|Overall Study|Protocol Violation|8|||
27654081|NCT00484198|80574035|FG000|Overall Study|Other|7|||
27654082|NCT00484198|80574036|FG001|Overall Study|Other|10|||
27654083|NCT00484198|80574037|FG002|Overall Study|Other|31|||
27654084|NCT00484198|80574038|FG003|Overall Study|Other|28|||
27654085|NCT01288729|80574044|FG000|Overall Study|Withdrawal by Subject|1|||
27654086|NCT01288729|80574045|FG001|Overall Study|Withdrawal by Subject|0|||
27654087|NCT03989232|80574046|FG000|Overall Study|Lost to Follow-up|3|||
27654088|NCT03989232|80574047|FG001|Overall Study|Lost to Follow-up|10|||
27654089|NCT03989232|80574046|FG000|Overall Study|Withdrawal by Subject|6|||
27654090|NCT03989232|80574047|FG001|Overall Study|Withdrawal by Subject|6|||
27654091|NCT03989232|80574046|FG000|Overall Study|Death|1|||
27654092|NCT03989232|80574047|FG001|Overall Study|Death|2|||
27654093|NCT00923078|80574048|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
27654094|NCT00923078|80574049|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
27654095|NCT00923078|80574050|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
27654096|NCT00923078|80574048|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
27654097|NCT00923078|80574049|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
27654098|NCT00923078|80574050|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
27955492|NCT00742625|81672188|FG000|Consolidation|Progression|5|||
27955493|NCT00742625|81672188|FG000|Consolidation|Adverse Event|1|||
27654099|NCT00498797|80574051|FG000|Overall Study|Withdrawal by Subject|4|||
27654100|NCT00498797|80574052|FG001|Overall Study|Withdrawal by Subject|2|||
27654101|NCT00498797|80574051|FG000|Overall Study|Adverse Event|12|||
27654102|NCT00498797|80574052|FG001|Overall Study|Adverse Event|5|||
27654103|NCT00498797|80574051|FG000|Overall Study|Condition under investigation worsened|19|||
27654104|NCT00498797|80574052|FG001|Overall Study|Condition under investigation worsened|21|||
27654105|NCT00498797|80574051|FG000|Overall Study|Other|3|||
27654106|NCT00498797|80574052|FG001|Overall Study|Other|1|||
27955494|NCT00742625|81672188|FG000|Consolidation|Death|1|||
27654107|NCT03928743|80574053|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
27654108|NCT03928743|80574054|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
27654109|NCT03928743|80574055|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
27654110|NCT03928743|80574053|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
27654111|NCT03928743|80574054|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
27654112|NCT03928743|80574055|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
27654113|NCT03928743|80574053|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
27654114|NCT03928743|80574054|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
27654115|NCT03928743|80574055|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
27654116|NCT03928743|80574053|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
27654117|NCT03928743|80574054|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
27654118|NCT03928743|80574055|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
27654119|NCT03928743|80574053|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
27654120|NCT03928743|80574054|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
27654121|NCT03928743|80574055|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
27654122|NCT03928743|80574053|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
27654123|NCT03928743|80574054|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
27654124|NCT03928743|80574055|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
27654125|NCT03928743|80574053|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
27654126|NCT03928743|80574054|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
27654127|NCT03928743|80574055|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
27654128|NCT03928743|80574053|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
27654129|NCT03928743|80574054|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
27654130|NCT03928743|80574055|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
27654131|NCT03928743|80574053|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
27654132|NCT03928743|80574054|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
27654133|NCT03928743|80574055|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
27654134|NCT03928743|80574053|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
27654135|NCT03928743|80574054|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
27654136|NCT03928743|80574055|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
27654137|NCT03928743|80574053|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
27654138|NCT03928743|80574054|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
27654139|NCT03928743|80574055|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
27654140|NCT01115309|80574056|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
27654141|NCT01115309|80574056|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
27654142|NCT01115309|80574056|FG000|Long-term Follow-up|Lost to Follow-up|6|||
27654143|NCT01668355|80574057|FG000|Overall Study|Death|3|||
27654144|NCT01668355|80574058|FG001|Overall Study|Death|1|||
27654145|NCT01668355|80574057|FG000|Overall Study|Withdrawal by Subject|6|||
27654146|NCT01668355|80574058|FG001|Overall Study|Withdrawal by Subject|1|||
27654147|NCT04765046|80574059|FG000|Overall Study|Screen Failure|2|||
27654148|NCT04765046|80574059|FG000|Overall Study|Withdrawal by Subject|4|||
27654149|NCT04765046|80574059|FG000|Overall Study|Physician Decision|4|||
27654150|NCT04765046|80574059|FG000|Overall Study|Surgery Cancelled|8|||
27654151|NCT00537914|80574060|FG000|Overall Study|Death|1|||
27654152|NCT00537914|80574060|FG000|Overall Study|Adverse Event|7|||
27654153|NCT00537914|80574060|FG000|Overall Study|Treatment failure|10|||
27654154|NCT00537914|80574060|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
27654155|NCT00537914|80574060|FG000|Overall Study|Lost to Follow-up|19|||
27654156|NCT00537914|80574060|FG000|Overall Study|Withdrawal of informed consent|59|||
27654157|NCT02109172|80574061|FG000|Overall Study|Withdrawal by Subject|1|||
27654158|NCT02109172|80574062|FG001|Overall Study|Withdrawal by Subject|0|||
27654159|NCT02109172|80574063|FG002|Overall Study|Withdrawal by Subject|0|||
27654160|NCT02109172|80574064|FG003|Overall Study|Withdrawal by Subject|1|||
27654161|NCT02109172|80574065|FG004|Overall Study|Withdrawal by Subject|0|||
27654162|NCT02109172|80574066|FG005|Overall Study|Withdrawal by Subject|0|||
27654163|NCT02109172|80574061|FG000|Overall Study|Adverse Event|0|||
27654164|NCT02109172|80574062|FG001|Overall Study|Adverse Event|0|||
27654165|NCT02109172|80574063|FG002|Overall Study|Adverse Event|1|||
27654166|NCT02109172|80574064|FG003|Overall Study|Adverse Event|0|||
27654167|NCT02109172|80574065|FG004|Overall Study|Adverse Event|0|||
27654168|NCT02109172|80574066|FG005|Overall Study|Adverse Event|1|||
27654169|NCT02109172|80574061|FG000|Overall Study|Death|0|||
27654170|NCT02109172|80574062|FG001|Overall Study|Death|0|||
27654171|NCT02109172|80574063|FG002|Overall Study|Death|0|||
27654172|NCT02109172|80574064|FG003|Overall Study|Death|0|||
27654173|NCT02109172|80574065|FG004|Overall Study|Death|1|||
27654174|NCT02109172|80574066|FG005|Overall Study|Death|0|||
27654175|NCT00103857|80574067|FG000|54-Week Base Study|Adverse Event|12|||
27654176|NCT00103857|80574068|FG001|54-Week Base Study|Adverse Event|9|||
27654177|NCT00103857|80574069|FG002|54-Week Base Study|Adverse Event|11|||
27654178|NCT00103857|80574070|FG003|54-Week Base Study|Adverse Event|6|||
27654179|NCT00103857|80574071|FG004|54-Week Base Study|Adverse Event|5|||
27654180|NCT00103857|80574072|FG005|54-Week Base Study|Adverse Event|11|||
27654181|NCT00103857|80574073|FG006|54-Week Base Study|Adverse Event|3|||
27654182|NCT00103857|80574067|FG000|54-Week Base Study|Death|0|||
27654183|NCT00103857|80574068|FG001|54-Week Base Study|Death|0|||
27654184|NCT00103857|80574069|FG002|54-Week Base Study|Death|0|||
27654185|NCT00103857|80574070|FG003|54-Week Base Study|Death|0|||
27654186|NCT00103857|80574071|FG004|54-Week Base Study|Death|1|||
27654187|NCT00103857|80574072|FG005|54-Week Base Study|Death|1|||
27654188|NCT00103857|80574073|FG006|54-Week Base Study|Death|0|||
27654189|NCT00103857|80574067|FG000|54-Week Base Study|Lack of Efficacy|11|||
27654190|NCT00103857|80574068|FG001|54-Week Base Study|Lack of Efficacy|14|||
27654191|NCT00103857|80574069|FG002|54-Week Base Study|Lack of Efficacy|8|||
27654192|NCT00103857|80574070|FG003|54-Week Base Study|Lack of Efficacy|4|||
27654193|NCT00103857|80574071|FG004|54-Week Base Study|Lack of Efficacy|3|||
27654194|NCT00103857|80574072|FG005|54-Week Base Study|Lack of Efficacy|14|||
27654195|NCT00103857|80574073|FG006|54-Week Base Study|Lack of Efficacy|19|||
27654196|NCT00103857|80574067|FG000|54-Week Base Study|Lost to Follow-up|5|||
27654197|NCT00103857|80574068|FG001|54-Week Base Study|Lost to Follow-up|4|||
27654198|NCT00103857|80574069|FG002|54-Week Base Study|Lost to Follow-up|7|||
27654199|NCT00103857|80574070|FG003|54-Week Base Study|Lost to Follow-up|5|||
27654200|NCT00103857|80574071|FG004|54-Week Base Study|Lost to Follow-up|10|||
27654201|NCT00103857|80574072|FG005|54-Week Base Study|Lost to Follow-up|9|||
27654202|NCT00103857|80574073|FG006|54-Week Base Study|Lost to Follow-up|3|||
27654203|NCT00103857|80574067|FG000|54-Week Base Study|Physician Decision|1|||
27654204|NCT00103857|80574068|FG001|54-Week Base Study|Physician Decision|1|||
27654205|NCT00103857|80574069|FG002|54-Week Base Study|Physician Decision|0|||
27654206|NCT00103857|80574070|FG003|54-Week Base Study|Physician Decision|0|||
27654207|NCT00103857|80574071|FG004|54-Week Base Study|Physician Decision|1|||
27654208|NCT00103857|80574072|FG005|54-Week Base Study|Physician Decision|0|||
27654209|NCT00103857|80574073|FG006|54-Week Base Study|Physician Decision|0|||
27654210|NCT00103857|80574067|FG000|54-Week Base Study|Pregnancy|1|||
27654211|NCT00103857|80574068|FG001|54-Week Base Study|Pregnancy|0|||
27654212|NCT00103857|80574069|FG002|54-Week Base Study|Pregnancy|0|||
27654213|NCT00103857|80574070|FG003|54-Week Base Study|Pregnancy|0|||
27654214|NCT00103857|80574071|FG004|54-Week Base Study|Pregnancy|1|||
27654215|NCT00103857|80574072|FG005|54-Week Base Study|Pregnancy|0|||
27654216|NCT00103857|80574073|FG006|54-Week Base Study|Pregnancy|1|||
27654217|NCT00103857|80574067|FG000|54-Week Base Study|Protocol Violation|6|||
27654218|NCT00103857|80574068|FG001|54-Week Base Study|Protocol Violation|4|||
27654219|NCT00103857|80574069|FG002|54-Week Base Study|Protocol Violation|2|||
27654220|NCT00103857|80574070|FG003|54-Week Base Study|Protocol Violation|4|||
27654221|NCT00103857|80574071|FG004|54-Week Base Study|Protocol Violation|0|||
27654222|NCT00103857|80574072|FG005|54-Week Base Study|Protocol Violation|3|||
27654223|NCT00103857|80574073|FG006|54-Week Base Study|Protocol Violation|3|||
27654224|NCT00103857|80574067|FG000|54-Week Base Study|Withdrawal by Subject|17|||
27654225|NCT00103857|80574068|FG001|54-Week Base Study|Withdrawal by Subject|16|||
27654226|NCT00103857|80574069|FG002|54-Week Base Study|Withdrawal by Subject|16|||
27654227|NCT00103857|80574070|FG003|54-Week Base Study|Withdrawal by Subject|15|||
27654228|NCT00103857|80574071|FG004|54-Week Base Study|Withdrawal by Subject|10|||
27654229|NCT00103857|80574072|FG005|54-Week Base Study|Withdrawal by Subject|15|||
27654230|NCT00103857|80574073|FG006|54-Week Base Study|Withdrawal by Subject|4|||
27654231|NCT00103857|80574067|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
27654232|NCT00103857|80574068|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
27654233|NCT00103857|80574069|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
27654234|NCT00103857|80574070|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
27654235|NCT00103857|80574071|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
27654236|NCT00103857|80574072|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
27654237|NCT00103857|80574073|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
27654238|NCT00103857|80574067|FG000|54-Week Base Study|patient moved|0|||
27654239|NCT00103857|80574068|FG001|54-Week Base Study|patient moved|1|||
27654240|NCT00103857|80574069|FG002|54-Week Base Study|patient moved|1|||
27654241|NCT00103857|80574070|FG003|54-Week Base Study|patient moved|2|||
27654242|NCT00103857|80574071|FG004|54-Week Base Study|patient moved|3|||
27654243|NCT00103857|80574072|FG005|54-Week Base Study|patient moved|1|||
27654244|NCT00103857|80574073|FG006|54-Week Base Study|patient moved|0|||
27654245|NCT00103857|80574067|FG000|54-Week Base Study|non-compliance with study procedures|1|||
27654246|NCT00103857|80574068|FG001|54-Week Base Study|non-compliance with study procedures|2|||
27654247|NCT00103857|80574069|FG002|54-Week Base Study|non-compliance with study procedures|0|||
27654248|NCT00103857|80574070|FG003|54-Week Base Study|non-compliance with study procedures|0|||
27654249|NCT00103857|80574071|FG004|54-Week Base Study|non-compliance with study procedures|0|||
27654250|NCT00103857|80574072|FG005|54-Week Base Study|non-compliance with study procedures|2|||
27654251|NCT00103857|80574073|FG006|54-Week Base Study|non-compliance with study procedures|0|||
27654252|NCT00103857|80574067|FG000|54-Week Base Study|patient incarcerated|0|||
27654253|NCT00103857|80574068|FG001|54-Week Base Study|patient incarcerated|0|||
27654254|NCT00103857|80574069|FG002|54-Week Base Study|patient incarcerated|0|||
27654255|NCT00103857|80574070|FG003|54-Week Base Study|patient incarcerated|0|||
27654256|NCT00103857|80574071|FG004|54-Week Base Study|patient incarcerated|1|||
27654257|NCT00103857|80574072|FG005|54-Week Base Study|patient incarcerated|1|||
27654258|NCT00103857|80574073|FG006|54-Week Base Study|patient incarcerated|0|||
27654259|NCT00103857|80574067|FG000|54-Week Base Study|laboratory reporting error|0|||
27654260|NCT00103857|80574068|FG001|54-Week Base Study|laboratory reporting error|0|||
27654261|NCT00103857|80574069|FG002|54-Week Base Study|laboratory reporting error|0|||
27654262|NCT00103857|80574070|FG003|54-Week Base Study|laboratory reporting error|0|||
27654263|NCT00103857|80574071|FG004|54-Week Base Study|laboratory reporting error|1|||
27654264|NCT00103857|80574072|FG005|54-Week Base Study|laboratory reporting error|0|||
27654265|NCT00103857|80574073|FG006|54-Week Base Study|laboratory reporting error|0|||
27654266|NCT00103857|80574067|FG000|54-Week Base Study|site error|0|||
27654267|NCT00103857|80574068|FG001|54-Week Base Study|site error|0|||
27654268|NCT00103857|80574069|FG002|54-Week Base Study|site error|0|||
27654269|NCT00103857|80574070|FG003|54-Week Base Study|site error|0|||
27654270|NCT00103857|80574071|FG004|54-Week Base Study|site error|0|||
27654271|NCT00103857|80574072|FG005|54-Week Base Study|site error|1|||
27654272|NCT00103857|80574073|FG006|54-Week Base Study|site error|0|||
27654273|NCT00103857|80574067|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
27654274|NCT00103857|80574068|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
27654275|NCT00103857|80574069|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
27654276|NCT00103857|80574070|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
27654277|NCT00103857|80574071|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
27654278|NCT00103857|80574072|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
27654279|NCT00103857|80574073|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
27654280|NCT00103857|80574067|FG000|50-Week Extension Study|Adverse Event|2|||
27654281|NCT00103857|80574068|FG001|50-Week Extension Study|Adverse Event|3|||
27654282|NCT00103857|80574069|FG002|50-Week Extension Study|Adverse Event|2|||
27654283|NCT00103857|80574070|FG003|50-Week Extension Study|Adverse Event|0|||
27654284|NCT00103857|80574071|FG004|50-Week Extension Study|Adverse Event|1|||
27654285|NCT00103857|80574072|FG005|50-Week Extension Study|Adverse Event|1|||
27654286|NCT00103857|80574073|FG006|50-Week Extension Study|Adverse Event|0|||
27654287|NCT00103857|80574067|FG000|50-Week Extension Study|Death|0|||
27654288|NCT00103857|80574068|FG001|50-Week Extension Study|Death|0|||
27654289|NCT00103857|80574069|FG002|50-Week Extension Study|Death|0|||
27654290|NCT00103857|80574070|FG003|50-Week Extension Study|Death|1|||
27654291|NCT00103857|80574071|FG004|50-Week Extension Study|Death|0|||
27654292|NCT00103857|80574072|FG005|50-Week Extension Study|Death|1|||
27654293|NCT00103857|80574073|FG006|50-Week Extension Study|Death|0|||
27654294|NCT00103857|80574067|FG000|50-Week Extension Study|Lack of Efficacy|26|||
27654295|NCT00103857|80574068|FG001|50-Week Extension Study|Lack of Efficacy|15|||
27654296|NCT00103857|80574069|FG002|50-Week Extension Study|Lack of Efficacy|13|||
27654297|NCT00103857|80574070|FG003|50-Week Extension Study|Lack of Efficacy|16|||
27654298|NCT00103857|80574071|FG004|50-Week Extension Study|Lack of Efficacy|8|||
27654299|NCT00103857|80574072|FG005|50-Week Extension Study|Lack of Efficacy|8|||
27654300|NCT00103857|80574073|FG006|50-Week Extension Study|Lack of Efficacy|0|||
27654301|NCT00103857|80574067|FG000|50-Week Extension Study|Lost to Follow-up|4|||
27654302|NCT00103857|80574068|FG001|50-Week Extension Study|Lost to Follow-up|0|||
27654303|NCT00103857|80574069|FG002|50-Week Extension Study|Lost to Follow-up|1|||
27654304|NCT00103857|80574070|FG003|50-Week Extension Study|Lost to Follow-up|4|||
27654305|NCT00103857|80574071|FG004|50-Week Extension Study|Lost to Follow-up|3|||
27654306|NCT00103857|80574072|FG005|50-Week Extension Study|Lost to Follow-up|3|||
27654307|NCT00103857|80574073|FG006|50-Week Extension Study|Lost to Follow-up|0|||
27654308|NCT00103857|80574067|FG000|50-Week Extension Study|Physician Decision|0|||
27654309|NCT00103857|80574068|FG001|50-Week Extension Study|Physician Decision|1|||
27654310|NCT00103857|80574069|FG002|50-Week Extension Study|Physician Decision|1|||
27654311|NCT00103857|80574070|FG003|50-Week Extension Study|Physician Decision|0|||
27654312|NCT00103857|80574071|FG004|50-Week Extension Study|Physician Decision|0|||
27654313|NCT00103857|80574072|FG005|50-Week Extension Study|Physician Decision|0|||
27654314|NCT00103857|80574073|FG006|50-Week Extension Study|Physician Decision|0|||
27654315|NCT00103857|80574067|FG000|50-Week Extension Study|Pregnancy|0|||
27654316|NCT00103857|80574068|FG001|50-Week Extension Study|Pregnancy|0|||
27654317|NCT00103857|80574069|FG002|50-Week Extension Study|Pregnancy|1|||
27654318|NCT00103857|80574070|FG003|50-Week Extension Study|Pregnancy|0|||
27654319|NCT00103857|80574071|FG004|50-Week Extension Study|Pregnancy|1|||
27654320|NCT00103857|80574072|FG005|50-Week Extension Study|Pregnancy|0|||
27654321|NCT00103857|80574073|FG006|50-Week Extension Study|Pregnancy|0|||
27654322|NCT00103857|80574067|FG000|50-Week Extension Study|Protocol Violation|1|||
27654323|NCT00103857|80574068|FG001|50-Week Extension Study|Protocol Violation|1|||
27654324|NCT00103857|80574069|FG002|50-Week Extension Study|Protocol Violation|1|||
27654325|NCT00103857|80574070|FG003|50-Week Extension Study|Protocol Violation|2|||
27654326|NCT00103857|80574071|FG004|50-Week Extension Study|Protocol Violation|0|||
27654327|NCT00103857|80574072|FG005|50-Week Extension Study|Protocol Violation|1|||
27654328|NCT00103857|80574073|FG006|50-Week Extension Study|Protocol Violation|0|||
27654329|NCT00103857|80574067|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
27654330|NCT00103857|80574068|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
27654331|NCT00103857|80574069|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
27654332|NCT00103857|80574070|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
27654333|NCT00103857|80574071|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
27654334|NCT00103857|80574072|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
27654335|NCT00103857|80574073|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
27654336|NCT00103857|80574067|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
27654337|NCT00103857|80574068|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
27654338|NCT00103857|80574069|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
27654339|NCT00103857|80574070|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
27654340|NCT00103857|80574071|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
27654341|NCT00103857|80574072|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
27654342|NCT00103857|80574073|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
27654343|NCT00103857|80574067|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
27654344|NCT00103857|80574068|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
27654345|NCT00103857|80574069|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
27654346|NCT00103857|80574070|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
27654347|NCT00103857|80574071|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
27654348|NCT00103857|80574072|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
27654349|NCT00103857|80574073|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
27654350|NCT00103857|80574067|FG000|50-Week Extension Study|patient moved|0|||
27654351|NCT00103857|80574068|FG001|50-Week Extension Study|patient moved|0|||
27654352|NCT00103857|80574069|FG002|50-Week Extension Study|patient moved|1|||
27654353|NCT00103857|80574070|FG003|50-Week Extension Study|patient moved|2|||
27654354|NCT00103857|80574071|FG004|50-Week Extension Study|patient moved|0|||
27654355|NCT00103857|80574072|FG005|50-Week Extension Study|patient moved|0|||
27654356|NCT00103857|80574073|FG006|50-Week Extension Study|patient moved|0|||
27654357|NCT00103857|80574067|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
27654358|NCT00103857|80574068|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
27654359|NCT00103857|80574069|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
27654360|NCT00103857|80574070|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
27654361|NCT00103857|80574071|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
27654362|NCT00103857|80574072|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
27654363|NCT00103857|80574073|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
27654364|NCT00103857|80574067|FG000|50-Week Extension Study|reason unspecified|0|||
27654365|NCT00103857|80574068|FG001|50-Week Extension Study|reason unspecified|0|||
27654366|NCT00103857|80574069|FG002|50-Week Extension Study|reason unspecified|0|||
27654367|NCT00103857|80574070|FG003|50-Week Extension Study|reason unspecified|0|||
27654368|NCT00103857|80574071|FG004|50-Week Extension Study|reason unspecified|1|||
27654369|NCT00103857|80574072|FG005|50-Week Extension Study|reason unspecified|0|||
27654370|NCT00103857|80574073|FG006|50-Week Extension Study|reason unspecified|0|||
27654371|NCT02727998|80574076|FG000|Overall Study|Lost to Follow-up|3|||
27654372|NCT02727998|80574077|FG001|Overall Study|Lost to Follow-up|3|||
27654373|NCT02727998|80574076|FG000|Overall Study|Withdrawal by Subject|0|||
27654374|NCT02727998|80574077|FG001|Overall Study|Withdrawal by Subject|1|||
27654375|NCT01945086|80574080|FG000|Overall Study|Withdrawal by Subject|1|||
27654376|NCT01945086|80574081|FG001|Overall Study|Withdrawal by Subject|0|||
27654377|NCT01945086|80574082|FG002|Overall Study|Withdrawal by Subject|1|||
27654378|NCT01945086|80574080|FG000|Overall Study|Adverse Event|0|||
27654379|NCT01945086|80574081|FG001|Overall Study|Adverse Event|0|||
27654380|NCT01945086|80574082|FG002|Overall Study|Adverse Event|1|||
27654381|NCT00113529|80574083|FG000|Overall Study|Adverse Event|4|||
27654382|NCT00113529|80574083|FG000|Overall Study|Lack of Efficacy|20|||
27654383|NCT00113529|80574083|FG000|Overall Study|Decision of sponsor|6|||
27654384|NCT00113529|80574083|FG000|Overall Study|Withdrawal by Subject|4|||
27654385|NCT00936065|80574086|FG000|Overall Study|Adverse Event|1|||
27654386|NCT00936065|80574087|FG001|Overall Study|Adverse Event|0|||
27654387|NCT00936065|80574088|FG002|Overall Study|Adverse Event|1|||
27654388|NCT00936065|80574086|FG000|Overall Study|Lack of Efficacy|1|||
27654389|NCT00936065|80574087|FG001|Overall Study|Lack of Efficacy|0|||
27654390|NCT00936065|80574088|FG002|Overall Study|Lack of Efficacy|1|||
27654391|NCT00936065|80574086|FG000|Overall Study|Lost to Follow-up|1|||
27654392|NCT00936065|80574087|FG001|Overall Study|Lost to Follow-up|0|||
27654393|NCT00936065|80574088|FG002|Overall Study|Lost to Follow-up|0|||
27654394|NCT00936065|80574086|FG000|Overall Study|Protocol Violation|1|||
27654395|NCT00936065|80574087|FG001|Overall Study|Protocol Violation|2|||
27654396|NCT00936065|80574088|FG002|Overall Study|Protocol Violation|1|||
27654397|NCT00936065|80574086|FG000|Overall Study|Withdrawal by Subject|0|||
27654398|NCT00936065|80574087|FG001|Overall Study|Withdrawal by Subject|2|||
27654399|NCT00936065|80574088|FG002|Overall Study|Withdrawal by Subject|4|||
27654400|NCT00141271|80574089|FG000|Overall Study|Adverse Event|31|||
27654401|NCT00141271|80574090|FG001|Overall Study|Adverse Event|19|||
27654402|NCT00141271|80574091|FG002|Overall Study|Adverse Event|17|||
27654403|NCT00141271|80574089|FG000|Overall Study|Laboratory Abnormality|2|||
27654404|NCT00141271|80574090|FG001|Overall Study|Laboratory Abnormality|1|||
27654405|NCT00141271|80574091|FG002|Overall Study|Laboratory Abnormality|1|||
27654406|NCT00141271|80574089|FG000|Overall Study|Lack of Efficacy|7|||
27654407|NCT00141271|80574090|FG001|Overall Study|Lack of Efficacy|7|||
27654408|NCT00141271|80574091|FG002|Overall Study|Lack of Efficacy|3|||
27955495|NCT00742625|81672188|FG000|Consolidation|Refused|1|||
27955496|NCT00742625|81672188|FG000|Consolidation|Non protocol therapy|13|||
27955497|NCT00648037|81672198|FG000|Overall Study|Not Treated|1|||
27955498|NCT00648037|81672198|FG000|Overall Study|Withdrawal by Subject|1|||
27955499|NCT00648037|81672198|FG000|Overall Study|Adverse Event|11|||
27955500|NCT00648037|81672198|FG000|Overall Study|Relapse|2|||
27955501|NCT00648037|81672198|FG000|Overall Study|Other|1|||
27955502|NCT01126190|81672199|FG000|Double-Blind Phase|Death|0|||
27955503|NCT01126190|81672200|FG001|Double-Blind Phase|Death|1|||
27955504|NCT01126190|81672201|FG002|Double-Blind Phase|Death|0|||
27955505|NCT01126190|81672199|FG000|Double-Blind Phase|Adverse Event|1|||
27955506|NCT01126190|81672200|FG001|Double-Blind Phase|Adverse Event|2|||
27955507|NCT01126190|81672201|FG002|Double-Blind Phase|Adverse Event|0|||
27955508|NCT01126190|81672199|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
27955509|NCT01126190|81672200|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
27955510|NCT01126190|81672201|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
27955511|NCT01126190|81672199|FG000|Double-Blind Phase|Request of Investigator|1|||
27955512|NCT01126190|81672200|FG001|Double-Blind Phase|Request of Investigator|0|||
27955513|NCT01126190|81672201|FG002|Double-Blind Phase|Request of Investigator|0|||
27955514|NCT01126190|81672199|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
27955515|NCT01126190|81672200|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
27955516|NCT01126190|81672201|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
27955517|NCT01126190|81672199|FG000|Double-Blind Phase|Non-compliance|1|||
27955518|NCT01126190|81672200|FG001|Double-Blind Phase|Non-compliance|0|||
27955519|NCT01126190|81672201|FG002|Double-Blind Phase|Non-compliance|0|||
27955520|NCT01126190|81672199|FG000|Double-Blind Phase|Lost to Follow-up|1|||
27955521|NCT01126190|81672200|FG001|Double-Blind Phase|Lost to Follow-up|3|||
27955522|NCT01126190|81672201|FG002|Double-Blind Phase|Lost to Follow-up|0|||
27955523|NCT01126190|81672199|FG000|Open-Label Phase|Death|0|||
27955524|NCT01126190|81672200|FG001|Open-Label Phase|Death|0|||
27955525|NCT01126190|81672201|FG002|Open-Label Phase|Death|1|||
27955526|NCT01126190|81672199|FG000|Open-Label Phase|Adverse Event|0|||
27955527|NCT01126190|81672200|FG001|Open-Label Phase|Adverse Event|0|||
27955528|NCT01126190|81672201|FG002|Open-Label Phase|Adverse Event|4|||
27955529|NCT01126190|81672199|FG000|Open-Label Phase|Withdrawal by Subject|0|||
27955530|NCT01126190|81672200|FG001|Open-Label Phase|Withdrawal by Subject|0|||
27955531|NCT01126190|81672201|FG002|Open-Label Phase|Withdrawal by Subject|6|||
27955532|NCT04568603|81672202|FG000|Overall Study|Physician Decision|1|||
27955533|NCT00928187|81672203|FG000|Overall Study|Death|1|||
27955534|NCT00928187|81672204|FG001|Overall Study|Death|2|||
27955535|NCT00928187|81672205|FG002|Overall Study|Death|3|||
27955536|NCT00928187|81672203|FG000|Overall Study|Lost to Follow-up|1|||
27955537|NCT00928187|81672204|FG001|Overall Study|Lost to Follow-up|2|||
27654409|NCT00141271|80574089|FG000|Overall Study|Lost to Follow-up|15|||
27654410|NCT00141271|80574090|FG001|Overall Study|Lost to Follow-up|15|||
27654411|NCT00141271|80574091|FG002|Overall Study|Lost to Follow-up|21|||
27654412|NCT00141271|80574089|FG000|Overall Study|Withdrawal by Subject|14|||
27654413|NCT00141271|80574090|FG001|Overall Study|Withdrawal by Subject|9|||
27654414|NCT00141271|80574091|FG002|Overall Study|Withdrawal by Subject|10|||
27654415|NCT00141271|80574089|FG000|Overall Study|Other|11|||
27654416|NCT00141271|80574090|FG001|Overall Study|Other|12|||
27654417|NCT00141271|80574091|FG002|Overall Study|Other|5|||
27654418|NCT01287832|80574092|FG000|Overall Study|Adverse Event|1|||
27654419|NCT01287832|80574093|FG001|Overall Study|Adverse Event|0|||
27654420|NCT01287832|80574092|FG000|Overall Study|Death|0|||
27654421|NCT01287832|80574093|FG001|Overall Study|Death|1|||
27654422|NCT04766996|80574094|FG000|Overall Study|Withdrawal by Subject|1|||
27654423|NCT04766996|80574095|FG001|Overall Study|Withdrawal by Subject|0|||
27654424|NCT04766996|80574096|FG002|Overall Study|Withdrawal by Subject|13|||
27955538|NCT00928187|81672205|FG002|Overall Study|Lost to Follow-up|1|||
27955539|NCT00928187|81672203|FG000|Overall Study|Withdrawal by Subject|0|||
27955540|NCT00928187|81672204|FG001|Overall Study|Withdrawal by Subject|1|||
27955541|NCT00928187|81672205|FG002|Overall Study|Withdrawal by Subject|1|||
27654425|NCT02713594|80574099|FG000|Overall Study|Withdrawal by Subject|32|||
27654426|NCT02713594|80574100|FG001|Overall Study|Withdrawal by Subject|22|||
27654427|NCT02713594|80574099|FG000|Overall Study|Lost to Follow-up|358|||
27654428|NCT02713594|80574100|FG001|Overall Study|Lost to Follow-up|374|||
27654429|NCT00264576|80574102|FG000|Overall Study|Lost to Follow-up|1|||
27654430|NCT00264576|80574103|FG001|Overall Study|Lost to Follow-up|1|||
27654431|NCT02935673|80574104|FG000|Overall Study|Adverse Event|0|||
27654432|NCT02935673|80574105|FG001|Overall Study|Adverse Event|1|||
27654433|NCT02935673|80574106|FG002|Overall Study|Adverse Event|0|||
27654434|NCT02935673|80574104|FG000|Overall Study|Withdrawal by Subject|1|||
27654435|NCT02935673|80574105|FG001|Overall Study|Withdrawal by Subject|2|||
27955542|NCT00928187|81672203|FG000|Overall Study|Protocol Violation|0|||
27955543|NCT00928187|81672204|FG001|Overall Study|Protocol Violation|1|||
27955544|NCT00928187|81672205|FG002|Overall Study|Protocol Violation|0|||
27955545|NCT03281629|81672206|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
27955546|NCT03281629|81672207|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
27955547|NCT03281629|81672206|FG000|Overall Study|Death|0|||
27654436|NCT02935673|80574106|FG002|Overall Study|Withdrawal by Subject|0|||
27654437|NCT01468597|80574107|FG000|Overall Study|Found ineligible|17|||
27654438|NCT01468597|80574107|FG000|Overall Study|concomitant valves|12|||
27654439|NCT01468597|80574107|FG000|Overall Study|off-pump CABG|1|||
27654440|NCT01468597|80574107|FG000|Overall Study|no platelet function data|5|||
27654441|NCT03406507|80574109|FG000|Extension Period|Lack of Efficacy|0|||
27654442|NCT03406507|80574110|FG001|Extension Period|Lack of Efficacy|1|||
27654443|NCT02753075|80574111|FG000|Overall Study|Adverse Event|2|||
27654444|NCT02753075|80574112|FG001|Overall Study|Adverse Event|1|||
27955548|NCT03281629|81672207|FG001|Overall Study|Death|1|||
27955549|NCT03281629|81672206|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
27955550|NCT03281629|81672207|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
27955551|NCT00950651|81672210|FG000|Overall Study|Adverse Event|17|||
27955552|NCT00950651|81672211|FG001|Overall Study|Adverse Event|20|||
27955553|NCT00950651|81672210|FG000|Overall Study|Death|1|||
27955554|NCT00950651|81672211|FG001|Overall Study|Death|0|||
27955555|NCT00950651|81672210|FG000|Overall Study|Lack of Efficacy|2|||
27955556|NCT00950651|81672211|FG001|Overall Study|Lack of Efficacy|2|||
27955557|NCT00950651|81672210|FG000|Overall Study|Protocol Violation|3|||
27955558|NCT00950651|81672211|FG001|Overall Study|Protocol Violation|4|||
27955559|NCT00950651|81672210|FG000|Overall Study|Withdrawal by Subject|8|||
27955560|NCT00950651|81672211|FG001|Overall Study|Withdrawal by Subject|9|||
27955561|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
27955562|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
27955563|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
27955564|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
27955565|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
27955566|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
27955567|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
27955568|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
27955569|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
27955570|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
27955571|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
27955572|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
27955573|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
27955574|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
27955575|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
27955576|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
27955577|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
27955578|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
27955579|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
27955580|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
27955581|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
27955582|NCT04021290|81672212|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
27955583|NCT04021290|81672213|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
27955584|NCT04021290|81672214|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
27955585|NCT04021290|81672212|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
27955586|NCT04021290|81672213|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
27955587|NCT04021290|81672214|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
27955588|NCT04021290|81672212|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
27654445|NCT02753075|80574113|FG002|Overall Study|Adverse Event|0|||
27654446|NCT02753075|80574111|FG000|Overall Study|Lost to Follow-up|2|||
27654447|NCT02753075|80574112|FG001|Overall Study|Lost to Follow-up|0|||
27654448|NCT02753075|80574113|FG002|Overall Study|Lost to Follow-up|0|||
27654449|NCT02753075|80574111|FG000|Overall Study|Withdrawal of Consent|1|||
27654450|NCT02753075|80574112|FG001|Overall Study|Withdrawal of Consent|1|||
27654451|NCT02753075|80574113|FG002|Overall Study|Withdrawal of Consent|3|||
27654452|NCT02753075|80574111|FG000|Overall Study|Physician Decision|3|||
27654453|NCT02753075|80574112|FG001|Overall Study|Physician Decision|1|||
27654454|NCT02753075|80574113|FG002|Overall Study|Physician Decision|0|||
27654455|NCT03503188|80574114|FG000|Overall Study|Non eligible in the sub study|0|||
27654456|NCT03503188|80574115|FG001|Overall Study|Non eligible in the sub study|1|||
27654457|NCT01029925|80574127|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
27654458|NCT01029925|80574127|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
27654459|NCT01029925|80574127|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
27654460|NCT01535261|80574128|FG000|Overall Study|Physician Decision|8|||
27654461|NCT01535261|80574128|FG000|Overall Study|Protocol Violation|3|||
27654462|NCT01535261|80574128|FG000|Overall Study|Death|5|||
27654463|NCT01535261|80574128|FG000|Overall Study|Lost to Follow-up|8|||
27654464|NCT01535261|80574128|FG000|Overall Study|Withdrawal by Subject|14|||
27654465|NCT01535261|80574128|FG000|Overall Study|Adverse Event|12|||
27654466|NCT00608959|80574131|FG000|Part 1|Did not meet eligibility criteria|1|||
27654467|NCT00460434|80574132|FG000|Overall Study|Lost to Follow-up|3|||
27654468|NCT00460434|80574133|FG001|Overall Study|Lost to Follow-up|7|||
27654469|NCT03493282|80574134|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
27654470|NCT03493282|80574135|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
27654471|NCT03493282|80574136|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
27654472|NCT03493282|80574134|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
27654473|NCT03493282|80574135|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
27654474|NCT03493282|80574136|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
27654475|NCT00731692|80574137|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
27654476|NCT00731692|80574138|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
27654477|NCT00731692|80574139|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
27654478|NCT00731692|80574137|FG000|Core Study (36 Months)|Physician Decision|1|||
27654479|NCT00731692|80574138|FG001|Core Study (36 Months)|Physician Decision|0|||
27654480|NCT00731692|80574139|FG002|Core Study (36 Months)|Physician Decision|2|||
27654481|NCT00731692|80574137|FG000|Core Study (36 Months)|Death|2|||
27654482|NCT00731692|80574138|FG001|Core Study (36 Months)|Death|1|||
27654483|NCT00731692|80574139|FG002|Core Study (36 Months)|Death|2|||
27654484|NCT00731692|80574137|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
27654485|NCT00731692|80574138|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
27654486|NCT00731692|80574139|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
27654487|NCT00731692|80574137|FG000|Core Study (36 Months)|Administrative|2|||
27654488|NCT00731692|80574138|FG001|Core Study (36 Months)|Administrative|2|||
27654489|NCT00731692|80574139|FG002|Core Study (36 Months)|Administrative|6|||
27654490|NCT00731692|80574137|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
27654491|NCT00731692|80574138|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
27654492|NCT00731692|80574139|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
27654493|NCT00731692|80574137|FG000|Core Study (36 Months)|Protocol Violation|4|||
27654494|NCT00731692|80574138|FG001|Core Study (36 Months)|Protocol Violation|5|||
27654495|NCT00731692|80574139|FG002|Core Study (36 Months)|Protocol Violation|8|||
27654496|NCT00731692|80574137|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
27654497|NCT00731692|80574138|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
27654498|NCT00731692|80574139|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
27654499|NCT00731692|80574137|FG000|Core Study (36 Months)|Adverse Event|25|||
27654500|NCT00731692|80574138|FG001|Core Study (36 Months)|Adverse Event|28|||
27654501|NCT00731692|80574139|FG002|Core Study (36 Months)|Adverse Event|29|||
27654502|NCT00731692|80574137|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
27654503|NCT00731692|80574138|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
27654504|NCT00731692|80574139|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
27654505|NCT00731692|80574137|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
27654506|NCT00731692|80574138|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
27654507|NCT00731692|80574139|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
27654508|NCT00731692|80574137|FG000|Extension Phase|Abnormal test procedure|0|||
27654509|NCT00731692|80574138|FG001|Extension Phase|Abnormal test procedure|0|||
27654510|NCT00731692|80574139|FG002|Extension Phase|Abnormal test procedure|1|||
27654511|NCT00731692|80574137|FG000|Extension Phase|Abnormal lab values|0|||
27654512|NCT00731692|80574138|FG001|Extension Phase|Abnormal lab values|0|||
27654513|NCT00731692|80574139|FG002|Extension Phase|Abnormal lab values|1|||
27654514|NCT00731692|80574137|FG000|Extension Phase|Lost to Follow-up|0|||
27654515|NCT00731692|80574138|FG001|Extension Phase|Lost to Follow-up|1|||
27654516|NCT00731692|80574139|FG002|Extension Phase|Lost to Follow-up|4|||
27654517|NCT00731692|80574137|FG000|Extension Phase|Withdrawal by Subject|4|||
27654518|NCT00731692|80574138|FG001|Extension Phase|Withdrawal by Subject|5|||
27654519|NCT00731692|80574139|FG002|Extension Phase|Withdrawal by Subject|3|||
27654520|NCT00731692|80574137|FG000|Extension Phase|Adverse Event|1|||
27654521|NCT00731692|80574138|FG001|Extension Phase|Adverse Event|1|||
27654522|NCT00731692|80574139|FG002|Extension Phase|Adverse Event|15|||
27654523|NCT01894620|80574142|FG000|Overall Study|Withdrawal by Subject|0|||
27654524|NCT01894620|80574143|FG001|Overall Study|Withdrawal by Subject|1|||
27654525|NCT01757288|80574148|FG000|Overall Study|Consent withdrawal|0|||
27654526|NCT01757288|80574149|FG001|Overall Study|Consent withdrawal|4|||
27654527|NCT01757288|80574150|FG002|Overall Study|Consent withdrawal|4|||
27654528|NCT01757288|80574148|FG000|Overall Study|Patient off study, IRB hold.|0|||
27654529|NCT01757288|80574149|FG001|Overall Study|Patient off study, IRB hold.|0|||
27654530|NCT01757288|80574150|FG002|Overall Study|Patient off study, IRB hold.|1|||
27654531|NCT01757288|80574148|FG000|Overall Study|Patient death prior to starting treatment|0|||
27654532|NCT01757288|80574149|FG001|Overall Study|Patient death prior to starting treatment|0|||
27654533|NCT01757288|80574150|FG002|Overall Study|Patient death prior to starting treatment|1|||
27654534|NCT01757288|80574148|FG000|Overall Study|Wrong medication administered|0|||
27654535|NCT01757288|80574149|FG001|Overall Study|Wrong medication administered|1|||
27654536|NCT01757288|80574150|FG002|Overall Study|Wrong medication administered|0|||
27654537|NCT01757288|80574148|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
27654538|NCT01757288|80574149|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
27654539|NCT01757288|80574150|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
27654540|NCT01757288|80574148|FG000|Overall Study|Not meeting protocol constraints|0|||
27654541|NCT01757288|80574149|FG001|Overall Study|Not meeting protocol constraints|1|||
27654542|NCT01757288|80574150|FG002|Overall Study|Not meeting protocol constraints|1|||
27654543|NCT01757288|80574148|FG000|Overall Study|Multiple missed appointments|0|||
27654544|NCT01757288|80574149|FG001|Overall Study|Multiple missed appointments|1|||
27654545|NCT01757288|80574150|FG002|Overall Study|Multiple missed appointments|0|||
27654546|NCT01757288|80574148|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
27654547|NCT01757288|80574149|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
27654548|NCT01757288|80574150|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
27654549|NCT01757288|80574148|FG000|Overall Study|>2 weeks treatment break|0|||
27654550|NCT01757288|80574149|FG001|Overall Study|>2 weeks treatment break|0|||
27654551|NCT01757288|80574150|FG002|Overall Study|>2 weeks treatment break|1|||
27654552|NCT02037568|80574152|FG000|Overall Study|Withdrawal by Subject|17|||
27654553|NCT02037568|80574153|FG001|Overall Study|Withdrawal by Subject|24|||
27654554|NCT02037568|80574152|FG000|Overall Study|Lost to Follow-up|16|||
27654555|NCT02037568|80574153|FG001|Overall Study|Lost to Follow-up|13|||
27654556|NCT02037568|80574152|FG000|Overall Study|Screen Failure|3|||
27654557|NCT02037568|80574153|FG001|Overall Study|Screen Failure|1|||
27654558|NCT02037568|80574152|FG000|Overall Study|Patient did not receive transplant|0|||
27654559|NCT02037568|80574153|FG001|Overall Study|Patient did not receive transplant|1|||
27654560|NCT00818519|80574158|FG000|Overall Study|Adverse Event|2|||
27654561|NCT00818519|80574159|FG001|Overall Study|Adverse Event|2|||
27654562|NCT00818519|80574158|FG000|Overall Study|Lost to Follow-up|4|||
27654563|NCT00818519|80574159|FG001|Overall Study|Lost to Follow-up|6|||
27654564|NCT00818519|80574158|FG000|Overall Study|Protocol Violation|2|||
27654565|NCT00818519|80574159|FG001|Overall Study|Protocol Violation|1|||
27654566|NCT00818519|80574158|FG000|Overall Study|Pregnancy|0|||
27654567|NCT00818519|80574159|FG001|Overall Study|Pregnancy|1|||
27654568|NCT00818519|80574158|FG000|Overall Study|Withdrawal by Subject|4|||
27654569|NCT00818519|80574159|FG001|Overall Study|Withdrawal by Subject|9|||
27654570|NCT00818519|80574158|FG000|Overall Study|participant recovered completely|1|||
27654571|NCT00818519|80574159|FG001|Overall Study|participant recovered completely|0|||
27654572|NCT00818519|80574158|FG000|Overall Study|participant will leave for long tme|1|||
27654573|NCT00818519|80574159|FG001|Overall Study|participant will leave for long tme|0|||
27654574|NCT03840993|80574169|FG000|Overall Study|Adverse Event|1|||
27654575|NCT03840993|80574170|FG001|Overall Study|Adverse Event|0|||
27654576|NCT03840993|80574169|FG000|Overall Study|Lost to Follow-up|4|||
27654577|NCT03840993|80574170|FG001|Overall Study|Lost to Follow-up|0|||
27654578|NCT03840993|80574169|FG000|Overall Study|Physician Decision|0|||
27654579|NCT03840993|80574170|FG001|Overall Study|Physician Decision|1|||
27654580|NCT03840993|80574169|FG000|Overall Study|Pregnancy|0|||
27654581|NCT03840993|80574170|FG001|Overall Study|Pregnancy|1|||
27654582|NCT03840993|80574169|FG000|Overall Study|Withdrawal by Subject|1|||
27654583|NCT03840993|80574170|FG001|Overall Study|Withdrawal by Subject|3|||
27654584|NCT03840993|80574169|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
27654585|NCT03840993|80574170|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
27654586|NCT02691702|80574174|FG000|Overall Study|Adverse Event|1|||
27654587|NCT02691702|80574175|FG001|Overall Study|Adverse Event|0|||
27654588|NCT02691702|80574176|FG002|Overall Study|Adverse Event|0|||
27654589|NCT02691702|80574177|FG003|Overall Study|Adverse Event|0|||
27654590|NCT02691702|80574178|FG004|Overall Study|Adverse Event|0|||
27654591|NCT02691702|80574179|FG005|Overall Study|Adverse Event|0|||
27654592|NCT02691702|80574180|FG006|Overall Study|Adverse Event|0|||
27654593|NCT02691702|80574181|FG007|Overall Study|Adverse Event|0|||
27654594|NCT02691702|80574182|FG008|Overall Study|Adverse Event|1|||
27654595|NCT02691702|80574183|FG009|Overall Study|Adverse Event|0|||
27654596|NCT02691702|80574184|FG010|Overall Study|Adverse Event|1|||
27654597|NCT02691702|80574174|FG000|Overall Study|Lost to Follow-up|0|||
27654598|NCT02691702|80574175|FG001|Overall Study|Lost to Follow-up|0|||
27654599|NCT02691702|80574176|FG002|Overall Study|Lost to Follow-up|1|||
27654600|NCT02691702|80574177|FG003|Overall Study|Lost to Follow-up|0|||
27654601|NCT02691702|80574178|FG004|Overall Study|Lost to Follow-up|0|||
27654602|NCT02691702|80574179|FG005|Overall Study|Lost to Follow-up|2|||
27654603|NCT02691702|80574180|FG006|Overall Study|Lost to Follow-up|0|||
27654604|NCT02691702|80574181|FG007|Overall Study|Lost to Follow-up|0|||
27654605|NCT02691702|80574182|FG008|Overall Study|Lost to Follow-up|0|||
27654606|NCT02691702|80574183|FG009|Overall Study|Lost to Follow-up|0|||
27654607|NCT02691702|80574184|FG010|Overall Study|Lost to Follow-up|1|||
27654608|NCT02691702|80574174|FG000|Overall Study|Withdrawal by Subject|1|||
27654609|NCT02691702|80574175|FG001|Overall Study|Withdrawal by Subject|1|||
27654610|NCT02691702|80574176|FG002|Overall Study|Withdrawal by Subject|0|||
27654611|NCT02691702|80574177|FG003|Overall Study|Withdrawal by Subject|0|||
27654612|NCT02691702|80574178|FG004|Overall Study|Withdrawal by Subject|0|||
27654613|NCT02691702|80574179|FG005|Overall Study|Withdrawal by Subject|1|||
27654614|NCT02691702|80574180|FG006|Overall Study|Withdrawal by Subject|2|||
27654615|NCT02691702|80574181|FG007|Overall Study|Withdrawal by Subject|0|||
27654616|NCT02691702|80574182|FG008|Overall Study|Withdrawal by Subject|0|||
27654617|NCT02691702|80574183|FG009|Overall Study|Withdrawal by Subject|0|||
27654618|NCT02691702|80574184|FG010|Overall Study|Withdrawal by Subject|0|||
27654619|NCT02691702|80574174|FG000|Overall Study|Other|0|||
27654620|NCT02691702|80574175|FG001|Overall Study|Other|0|||
27654621|NCT02691702|80574176|FG002|Overall Study|Other|0|||
27654622|NCT02691702|80574177|FG003|Overall Study|Other|0|||
27654623|NCT02691702|80574178|FG004|Overall Study|Other|0|||
27654624|NCT02691702|80574179|FG005|Overall Study|Other|0|||
27654625|NCT02691702|80574180|FG006|Overall Study|Other|1|||
27654626|NCT02691702|80574181|FG007|Overall Study|Other|0|||
27654627|NCT02691702|80574182|FG008|Overall Study|Other|1|||
27654628|NCT02691702|80574183|FG009|Overall Study|Other|0|||
27654629|NCT02691702|80574184|FG010|Overall Study|Other|0|||
27654630|NCT02691702|80574174|FG000|Overall Study|Protocol Violation|0|||
27654631|NCT02691702|80574175|FG001|Overall Study|Protocol Violation|0|||
27654632|NCT02691702|80574176|FG002|Overall Study|Protocol Violation|0|||
27654633|NCT02691702|80574177|FG003|Overall Study|Protocol Violation|0|||
27654634|NCT02691702|80574178|FG004|Overall Study|Protocol Violation|0|||
27654635|NCT02691702|80574179|FG005|Overall Study|Protocol Violation|0|||
27654636|NCT02691702|80574180|FG006|Overall Study|Protocol Violation|0|||
27654637|NCT02691702|80574181|FG007|Overall Study|Protocol Violation|0|||
27654638|NCT02691702|80574182|FG008|Overall Study|Protocol Violation|0|||
27654639|NCT02691702|80574183|FG009|Overall Study|Protocol Violation|2|||
27654640|NCT02691702|80574184|FG010|Overall Study|Protocol Violation|0|||
27654641|NCT02481934|80574185|FG000|Overall Study|Death|2|||
27654642|NCT00636168|80574186|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
27654643|NCT00636168|80574187|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
27654644|NCT00636168|80574186|FG000|Randomized to Study Drug|Adverse Event|1|||
27654645|NCT00636168|80574187|FG001|Randomized to Study Drug|Adverse Event|0|||
27654646|NCT00636168|80574186|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
27654647|NCT00636168|80574187|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
27654648|NCT00636168|80574186|FG000|Treated With Study Drug|Recurrence of disease|135|||
27654649|NCT00636168|80574187|FG001|Treated With Study Drug|Recurrence of disease|282|||
27654650|NCT00636168|80574186|FG000|Treated With Study Drug|Adverse Event|250|||
27654651|NCT00636168|80574187|FG001|Treated With Study Drug|Adverse Event|22|||
27654652|NCT00636168|80574186|FG000|Treated With Study Drug|Participant withdrew consent|16|||
27654653|NCT00636168|80574187|FG001|Treated With Study Drug|Participant withdrew consent|21|||
27654654|NCT00636168|80574186|FG000|Treated With Study Drug|Poor/non-compliance|1|||
27654655|NCT00636168|80574187|FG001|Treated With Study Drug|Poor/non-compliance|3|||
27654656|NCT00636168|80574186|FG000|Treated With Study Drug|Death|3|||
27654657|NCT00636168|80574187|FG001|Treated With Study Drug|Death|0|||
27654658|NCT00636168|80574186|FG000|Treated With Study Drug|Pregnancy|1|||
27654659|NCT00636168|80574187|FG001|Treated With Study Drug|Pregnancy|0|||
27654660|NCT00636168|80574186|FG000|Treated With Study Drug|No longer meets study criteria|1|||
27654661|NCT00636168|80574187|FG001|Treated With Study Drug|No longer meets study criteria|0|||
27654662|NCT00636168|80574186|FG000|Treated With Study Drug|Other reason|1|||
27654663|NCT00636168|80574187|FG001|Treated With Study Drug|Other reason|3|||
27654664|NCT00636168|80574186|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
27654665|NCT00636168|80574187|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
27654666|NCT00636168|80574186|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
27654667|NCT00636168|80574187|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
27654668|NCT00636168|80574186|FG000|Long Term Follow-Up|Death|8|||
27654669|NCT00636168|80574187|FG001|Long Term Follow-Up|Death|9|||
27654670|NCT03689452|80574188|FG000|Overall Study|Lost to Follow-up|1|||
27654671|NCT03689452|80574189|FG001|Overall Study|Lost to Follow-up|1|||
27654672|NCT04382053|80574190|FG000|Overall Study|Death|6|||
27654673|NCT04382053|80574191|FG001|Overall Study|Death|8|||
27654674|NCT04382053|80574190|FG000|Overall Study|Lost to Follow-up|0|||
27654675|NCT04382053|80574191|FG001|Overall Study|Lost to Follow-up|2|||
27654676|NCT04382053|80574190|FG000|Overall Study|Protocol Deviation|1|||
27654677|NCT04382053|80574191|FG001|Overall Study|Protocol Deviation|2|||
27654678|NCT04382053|80574190|FG000|Overall Study|Withdrawal by Subject|2|||
27654679|NCT04382053|80574191|FG001|Overall Study|Withdrawal by Subject|1|||
27654680|NCT03060525|80574192|FG000|Overall Study|moved out of state|1|||
27654681|NCT03060525|80574193|FG001|Overall Study|moved out of state|1|||
27654682|NCT03060525|80574194|FG002|Overall Study|moved out of state|1|||
27654683|NCT03060525|80574195|FG003|Overall Study|moved out of state|1|||
27654684|NCT03060525|80574192|FG000|Overall Study|unable to meet time commitment required of study|2|||
27654685|NCT03060525|80574193|FG001|Overall Study|unable to meet time commitment required of study|3|||
27654686|NCT03060525|80574194|FG002|Overall Study|unable to meet time commitment required of study|3|||
27654687|NCT03060525|80574195|FG003|Overall Study|unable to meet time commitment required of study|1|||
27654688|NCT03060525|80574192|FG000|Overall Study|no longer interested in doing intervention|0|||
27654689|NCT03060525|80574193|FG001|Overall Study|no longer interested in doing intervention|0|||
27654690|NCT03060525|80574194|FG002|Overall Study|no longer interested in doing intervention|0|||
27654691|NCT03060525|80574195|FG003|Overall Study|no longer interested in doing intervention|1|||
27654692|NCT03884478|80574196|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
27654693|NCT03884478|80574197|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
27654694|NCT03884478|80574198|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
27654695|NCT03884478|80574196|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
27654696|NCT03884478|80574197|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
27654697|NCT03884478|80574198|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
27654698|NCT03884478|80574196|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
27654699|NCT03884478|80574197|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
27654700|NCT03884478|80574198|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
27654701|NCT03884478|80574196|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
27654702|NCT03884478|80574197|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
27654703|NCT03884478|80574198|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
27654704|NCT03166215|80574199|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
27654705|NCT03166215|80574200|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
27654706|NCT03166215|80574201|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
27654707|NCT03166215|80574199|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
27654708|NCT03166215|80574200|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
27654709|NCT03166215|80574201|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
27654710|NCT02676778|80574202|FG000|Overall Study|Disease Progression|7|||
27654711|NCT02676778|80574203|FG001|Overall Study|Disease Progression|3|||
27654712|NCT02676778|80574204|FG002|Overall Study|Disease Progression|1|||
27654713|NCT02676778|80574202|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
27654714|NCT02676778|80574203|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
27654715|NCT02676778|80574204|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
27654716|NCT02676778|80574202|FG000|Overall Study|Withdrawal by Subject|3|||
27654717|NCT02676778|80574203|FG001|Overall Study|Withdrawal by Subject|2|||
27654718|NCT02676778|80574204|FG002|Overall Study|Withdrawal by Subject|0|||
27654719|NCT02676778|80574202|FG000|Overall Study|Other|4|||
27654720|NCT02676778|80574203|FG001|Overall Study|Other|3|||
27654721|NCT02676778|80574204|FG002|Overall Study|Other|0|||
27654722|NCT02676778|80574202|FG000|Overall Study|Adverse Event|2|||
27654723|NCT02676778|80574203|FG001|Overall Study|Adverse Event|3|||
27654724|NCT02676778|80574204|FG002|Overall Study|Adverse Event|0|||
27654725|NCT01279447|80574205|FG000|Overall Study|Lost to Follow-up|3|||
27654726|NCT01279447|80574206|FG001|Overall Study|Lost to Follow-up|1|||
27654727|NCT00403845|80574207|FG000|Treatment Period 1|Subject withdrew consent|1|||
27654728|NCT00403845|80574208|FG001|Treatment Period 1|Subject withdrew consent|0|||
27654729|NCT00403845|80574209|FG002|Treatment Period 1|Subject withdrew consent|0|||
27654730|NCT00403845|80574210|FG003|Treatment Period 1|Subject withdrew consent|0|||
27654731|NCT00403845|80574207|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
27654732|NCT00403845|80574208|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
27654733|NCT00403845|80574209|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
27654734|NCT00403845|80574210|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
27654735|NCT00403845|80574207|FG000|Treatment Period 2|Subject withdrew consent|1|||
27654736|NCT00403845|80574208|FG001|Treatment Period 2|Subject withdrew consent|0|||
27654737|NCT00403845|80574209|FG002|Treatment Period 2|Subject withdrew consent|0|||
27654738|NCT00403845|80574210|FG003|Treatment Period 2|Subject withdrew consent|0|||
27654739|NCT00403845|80574207|FG000|Treatment Period 3|Subject withdrew consent|0|||
27654740|NCT00403845|80574208|FG001|Treatment Period 3|Subject withdrew consent|0|||
27654741|NCT00403845|80574209|FG002|Treatment Period 3|Subject withdrew consent|0|||
27654742|NCT00403845|80574210|FG003|Treatment Period 3|Subject withdrew consent|1|||
27654743|NCT00403845|80574207|FG000|Treatment Period 3|Adverse Event|0|||
27654744|NCT00403845|80574208|FG001|Treatment Period 3|Adverse Event|0|||
27654745|NCT00403845|80574209|FG002|Treatment Period 3|Adverse Event|0|||
27654746|NCT00403845|80574210|FG003|Treatment Period 3|Adverse Event|1|||
27654747|NCT01919489|80574211|FG000|Overall Study|Rejected the need of injections|4|||
27654748|NCT01919489|80574212|FG001|Overall Study|Rejected the need of injections|7|||
27654749|NCT01919489|80574211|FG000|Overall Study|Adverse Event|10|||
27654750|NCT01919489|80574212|FG001|Overall Study|Adverse Event|0|||
27654751|NCT01919489|80574211|FG000|Overall Study|Hospital readmission|2|||
27654752|NCT01919489|80574212|FG001|Overall Study|Hospital readmission|9|||
27654753|NCT01919489|80574211|FG000|Overall Study|Death|2|||
27654754|NCT01919489|80574212|FG001|Overall Study|Death|1|||
27654755|NCT01919489|80574211|FG000|Overall Study|Lost to Follow-up|38|||
27654756|NCT01919489|80574212|FG001|Overall Study|Lost to Follow-up|27|||
27654757|NCT00795639|80574213|FG000|Overall Study|Death|1|||
27654758|NCT00795639|80574214|FG001|Overall Study|Death|6|||
27654759|NCT00795639|80574213|FG000|Overall Study|Withdrawal by Subject|1|||
27654760|NCT00795639|80574214|FG001|Overall Study|Withdrawal by Subject|3|||
27654761|NCT00795639|80574213|FG000|Overall Study|Pregnancy|1|||
27654762|NCT00795639|80574214|FG001|Overall Study|Pregnancy|0|||
27654763|NCT00795639|80574213|FG000|Overall Study|Adverse Event|5|||
27654764|NCT00795639|80574214|FG001|Overall Study|Adverse Event|2|||
27654765|NCT00795639|80574213|FG000|Overall Study|Other|0|||
27654766|NCT00795639|80574214|FG001|Overall Study|Other|2|||
27654767|NCT00795639|80574213|FG000|Overall Study|Terminated by sponsor|13|||
27654768|NCT00795639|80574214|FG001|Overall Study|Terminated by sponsor|12|||
27654769|NCT00795639|80574213|FG000|Overall Study|Randomized and not treated|0|||
27654770|NCT00795639|80574214|FG001|Overall Study|Randomized and not treated|1|||
27654771|NCT00096278|80574215|FG000|Overall Study|No follow-up data|15|||
27654772|NCT00096278|80574216|FG001|Overall Study|No follow-up data|18|||
27654773|NCT00096278|80574215|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
27654774|NCT00096278|80574216|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
27654775|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
27654776|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27654777|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27654778|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
27654779|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
27654780|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27654781|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27654782|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
27654783|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
27654784|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27654785|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27654786|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
27654787|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
27654788|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27654789|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27654790|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
27654791|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
27654792|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27654793|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27654794|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
27654795|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
27654796|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27654797|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27654798|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
27654799|NCT01185340|80574217|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
27654800|NCT01185340|80574218|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27654801|NCT01185340|80574219|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27654802|NCT01185340|80574220|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
27654803|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
27654804|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
27654805|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
27654806|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
27654807|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
27654808|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
27654809|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
27654810|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
27654811|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
27654812|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
27654813|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
27654814|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
27654815|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27654816|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27654817|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
27654818|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
27654819|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
27654820|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27654821|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
27654822|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
27654823|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
27654824|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
27654825|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
27654826|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
27654827|NCT01185340|80574217|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27654828|NCT01185340|80574218|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
27654829|NCT01185340|80574219|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
27654830|NCT01185340|80574220|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
27751622|NCT04657016|80918176|FG000|Overall Study|Withdrawal by Subject|28|||
27751623|NCT04657016|80918177|FG001|Overall Study|Withdrawal by Subject|14|||
27751624|NCT04657016|80918176|FG000|Overall Study|Other - as reported by the investigator|6|||
27751625|NCT04657016|80918177|FG001|Overall Study|Other - as reported by the investigator|0|||
27751626|NCT01189435|80918180|FG000|Overall Study|Withdrawal by Subject|1|||
27751627|NCT01189435|80918180|FG000|Overall Study|Physician Decision|1|||
27751628|NCT00615290|80918181|FG000|Overall Study|Adverse Event|2|||
27751629|NCT00615290|80918181|FG000|Overall Study|Lost to Follow-up|3|||
27751630|NCT00615290|80918181|FG000|Overall Study|Withdrawal by Subject|1|||
27751631|NCT00615290|80918181|FG000|Overall Study|Other|2|||
27751632|NCT00069576|80918182|FG000|Original Trial|Lost to Follow-up|25|||
27751633|NCT00069576|80918183|FG001|Original Trial|Lost to Follow-up|33|||
27751634|NCT00069576|80918182|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
27751635|NCT00069576|80918183|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
27751636|NCT00506077|80918184|FG000|Treatment Period 1|Adverse Event|2|||
27751637|NCT00506077|80918185|FG001|Treatment Period 1|Adverse Event|1|||
27751638|NCT00506077|80918184|FG000|Treatment Period 1|Lost to Follow-up|0|||
27751639|NCT00506077|80918185|FG001|Treatment Period 1|Lost to Follow-up|2|||
27751640|NCT00506077|80918184|FG000|Treatment Period 1|Withdrawal by Subject|2|||
27751641|NCT00506077|80918185|FG001|Treatment Period 1|Withdrawal by Subject|0|||
27751642|NCT00506077|80918184|FG000|Treatment Period 2|Adverse Event|0|||
27751643|NCT00506077|80918185|FG001|Treatment Period 2|Adverse Event|1|||
27751644|NCT00506077|80918184|FG000|Treatment Period 2|Withdrawal by Subject|1|||
27751645|NCT00506077|80918185|FG001|Treatment Period 2|Withdrawal by Subject|0|||
27751646|NCT03430245|80918186|FG000|Overall Study|Withdrawal by Subject|6|||
27751647|NCT03430245|80918186|FG000|Overall Study|Lost to Follow-up|1|||
27751648|NCT01737840|80918187|FG000|Overall Study|Diagnosed with an other pathology|2|||
27751649|NCT01737840|80918188|FG001|Overall Study|Diagnosed with an other pathology|2|||
27751650|NCT01401010|80918189|FG000|Overall Study|Could not interpret assay results|1|||
27751651|NCT01401010|80918190|FG001|Overall Study|Could not interpret assay results|0|||
27751652|NCT01468909|80918191|FG000|Overall Study|Never Treated|2|||
27751653|NCT01468909|80918192|FG001|Overall Study|Never Treated|2|||
27751654|NCT02993224|80918193|FG000|Core Phase - Period 1|Adverse Event|4|||
27751655|NCT02993224|80918193|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
27751656|NCT02993224|80918193|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
27751657|NCT02993224|80918193|FG000|Core Phase- Period 2|Adverse Event|1|||
27751658|NCT02993224|80918193|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
27751659|NCT02993224|80918193|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
27751660|NCT02993224|80918193|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
27751661|NCT02993224|80918193|FG000|Extension Phase|Adverse Event|3|||
27751662|NCT02993224|80918193|FG000|Extension Phase|Withdrawal by Subject|3|||
27751663|NCT02993224|80918193|FG000|Extension Phase|Lost to Follow-up|2|||
27751664|NCT02993224|80918193|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
27751665|NCT03116399|80918194|FG000|Overall Study|Death|8|||
27751666|NCT03116399|80918195|FG001|Overall Study|Death|3|||
27751667|NCT03116399|80918194|FG000|Overall Study|Lost to Follow-up|7|||
27751668|NCT03116399|80918195|FG001|Overall Study|Lost to Follow-up|11|||
27751669|NCT03116399|80918194|FG000|Overall Study|Investigator Decision|1|||
27751670|NCT03116399|80918195|FG001|Overall Study|Investigator Decision|1|||
27751671|NCT03116399|80918194|FG000|Overall Study|Withdrawal by Subject|24|||
27751672|NCT03116399|80918195|FG001|Overall Study|Withdrawal by Subject|9|||
27751673|NCT00305006|80918198|FG000|Overall Study|Withdrawal by Subject|1|||
27751674|NCT00305006|80918199|FG001|Overall Study|Withdrawal by Subject|0|||
27751675|NCT00305006|80918198|FG000|Overall Study|Failure to complete pretest|0|||
27751676|NCT00305006|80918199|FG001|Overall Study|Failure to complete pretest|1|||
27751677|NCT01810042|80918203|FG000|Overall Study|Lost to Follow-up|10|||
27751678|NCT01115569|80918204|FG000|Conversion/Titration Phase|Adverse Event|59|||
27751679|NCT01115569|80918205|FG001|Conversion/Titration Phase|Adverse Event|0|||
27751680|NCT01115569|80918204|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
27751681|NCT01115569|80918205|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
27751682|NCT01115569|80918204|FG000|Conversion/Titration Phase|Physician Decision|5|||
27751683|NCT01115569|80918205|FG001|Conversion/Titration Phase|Physician Decision|0|||
27751684|NCT01115569|80918204|FG000|Conversion/Titration Phase|Protocol Violation|68|||
27751685|NCT01115569|80918205|FG001|Conversion/Titration Phase|Protocol Violation|0|||
27751686|NCT01115569|80918204|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
27751687|NCT01115569|80918205|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
27751688|NCT01115569|80918204|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
27751689|NCT01115569|80918205|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
27751690|NCT01115569|80918204|FG000|Maintenance Phase|Adverse Event|0|||
27751691|NCT01115569|80918205|FG001|Maintenance Phase|Adverse Event|43|||
27751692|NCT01115569|80918204|FG000|Maintenance Phase|Lost to Follow-up|0|||
27751693|NCT01115569|80918205|FG001|Maintenance Phase|Lost to Follow-up|8|||
27751694|NCT01115569|80918204|FG000|Maintenance Phase|Physician Decision|0|||
27751695|NCT01115569|80918205|FG001|Maintenance Phase|Physician Decision|3|||
27751696|NCT01115569|80918204|FG000|Maintenance Phase|Protocol Violation|0|||
27751697|NCT01115569|80918205|FG001|Maintenance Phase|Protocol Violation|9|||
27751698|NCT01115569|80918204|FG000|Maintenance Phase|Withdrawal by Subject|0|||
27751699|NCT01115569|80918205|FG001|Maintenance Phase|Withdrawal by Subject|27|||
27751700|NCT01115569|80918204|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
27751701|NCT01115569|80918205|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
27751702|NCT01115569|80918204|FG000|Maintenance Phase|Administrative|0|||
27751703|NCT01115569|80918205|FG001|Maintenance Phase|Administrative|1|||
27751704|NCT00516269|80918208|FG000|Overall Study|Adverse Event|2|||
27751705|NCT00516269|80918209|FG001|Overall Study|Adverse Event|1|||
27751706|NCT00516269|80918208|FG000|Overall Study|Lost to Follow-up|0|||
27751707|NCT00516269|80918209|FG001|Overall Study|Lost to Follow-up|1|||
27751708|NCT00516269|80918208|FG000|Overall Study|Protocol Violation|0|||
27751709|NCT00516269|80918209|FG001|Overall Study|Protocol Violation|1|||
27751710|NCT01341652|80918210|FG000|Overall Study|Incorrect Random Assignment|0|||
27751711|NCT01341652|80918211|FG001|Overall Study|Incorrect Random Assignment|1|||
27751712|NCT01341652|80918210|FG000|Overall Study|ineligible; presence metastatic disease|0|||
27751713|NCT01341652|80918211|FG001|Overall Study|ineligible; presence metastatic disease|1|||
27751714|NCT05142332|80918215|FG000|Overall Study|Withdrawal by Subject|0|||
27751715|NCT05142332|80918216|FG001|Overall Study|Withdrawal by Subject|1|||
27751716|NCT05142332|80918217|FG002|Overall Study|Withdrawal by Subject|2|||
27751717|NCT05142332|80918218|FG003|Overall Study|Withdrawal by Subject|0|||
27751718|NCT05142332|80918219|FG004|Overall Study|Withdrawal by Subject|0|||
27751719|NCT05142332|80918220|FG005|Overall Study|Withdrawal by Subject|2|||
27751720|NCT05142332|80918221|FG006|Overall Study|Withdrawal by Subject|6|||
27751721|NCT05142332|80918215|FG000|Overall Study|Left ED|3|||
27751722|NCT05142332|80918216|FG001|Overall Study|Left ED|0|||
27751723|NCT05142332|80918217|FG002|Overall Study|Left ED|4|||
27751724|NCT05142332|80918218|FG003|Overall Study|Left ED|6|||
27751725|NCT05142332|80918219|FG004|Overall Study|Left ED|1|||
27751726|NCT05142332|80918220|FG005|Overall Study|Left ED|2|||
27751727|NCT05142332|80918221|FG006|Overall Study|Left ED|6|||
27751728|NCT05142332|80918215|FG000|Overall Study|Physician Decision|0|||
27751729|NCT05142332|80918216|FG001|Overall Study|Physician Decision|0|||
27751730|NCT05142332|80918217|FG002|Overall Study|Physician Decision|2|||
27751731|NCT05142332|80918218|FG003|Overall Study|Physician Decision|1|||
27751732|NCT05142332|80918219|FG004|Overall Study|Physician Decision|0|||
27751733|NCT05142332|80918220|FG005|Overall Study|Physician Decision|0|||
27751734|NCT05142332|80918221|FG006|Overall Study|Physician Decision|3|||
27751735|NCT05142332|80918215|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
27751736|NCT05142332|80918216|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
27751737|NCT05142332|80918217|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
27751738|NCT05142332|80918218|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
27751739|NCT05142332|80918219|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
27751740|NCT05142332|80918220|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
27751741|NCT05142332|80918221|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
27751742|NCT03491553|80918224|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
27751743|NCT03491553|80918225|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
27751744|NCT03491553|80918226|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
27751745|NCT03491553|80918227|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
27751746|NCT03491553|80918228|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
27751747|NCT03491553|80918229|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
27751748|NCT03491553|80918224|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
27751749|NCT03491553|80918225|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
27751750|NCT03491553|80918226|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
27751751|NCT03491553|80918227|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
27751752|NCT03491553|80918228|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
27751753|NCT03491553|80918229|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
27751754|NCT01087528|80918231|FG000|Overall Study|Withdrawal by Subject|1|||
27751755|NCT01087528|80918231|FG000|Overall Study|Incomplete CE procedure|6|||
27751756|NCT02433288|80918232|FG000|Overall Study|Severe non-compliance to protocol|13|||
27751757|NCT02433288|80918233|FG001|Overall Study|Severe non-compliance to protocol|7|||
27751758|NCT02433288|80918232|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
27751759|NCT02433288|80918233|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
27751760|NCT02433288|80918232|FG000|Overall Study|Withdrawal by Subject|101|||
27751761|NCT02433288|80918233|FG001|Overall Study|Withdrawal by Subject|99|||
27751762|NCT02433288|80918232|FG000|Overall Study|Lost to Follow-up|2|||
27751763|NCT02433288|80918233|FG001|Overall Study|Lost to Follow-up|14|||
27751764|NCT02433288|80918232|FG000|Overall Study|Death|0|||
27751765|NCT02433288|80918233|FG001|Overall Study|Death|3|||
27751766|NCT00372190|80918234|FG000|Overall Study|Lost to Follow-up|3|||
27751767|NCT00372190|80918235|FG001|Overall Study|Lost to Follow-up|1|||
27751768|NCT04369430|80918236|FG000|Overall Study|Adverse Event|2|||
27751769|NCT04369430|80918237|FG001|Overall Study|Adverse Event|3|||
27751770|NCT04369430|80918236|FG000|Overall Study|Death|1|||
27751771|NCT04369430|80918237|FG001|Overall Study|Death|0|||
27751772|NCT04369430|80918236|FG000|Overall Study|Withdrawal by Subject|4|||
27751773|NCT04369430|80918237|FG001|Overall Study|Withdrawal by Subject|3|||
27751774|NCT04369430|80918236|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
27751775|NCT04369430|80918237|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
27751776|NCT04369430|80918236|FG000|Overall Study|Lost to Follow-up|0|||
27751777|NCT04369430|80918237|FG001|Overall Study|Lost to Follow-up|1|||
27751778|NCT00586924|80918238|FG000|Overall Study|Adverse event/serious adverse event|0|||
27751779|NCT00586924|80918239|FG001|Overall Study|Adverse event/serious adverse event|0|||
27751780|NCT00586924|80918240|FG002|Overall Study|Adverse event/serious adverse event|0|||
27751781|NCT00586924|80918241|FG003|Overall Study|Adverse event/serious adverse event|1|||
27751782|NCT00586924|80918242|FG004|Overall Study|Adverse event/serious adverse event|0|||
27751783|NCT00586924|80918243|FG005|Overall Study|Adverse event/serious adverse event|2|||
27751784|NCT00586924|80918238|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
27751785|NCT00586924|80918239|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
27751786|NCT00586924|80918240|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
27751787|NCT00586924|80918241|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
27751788|NCT00586924|80918242|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
27751789|NCT00586924|80918243|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
27751790|NCT00586924|80918238|FG000|Overall Study|Disease progression|0|||
27751791|NCT00586924|80918239|FG001|Overall Study|Disease progression|0|||
27751792|NCT00586924|80918240|FG002|Overall Study|Disease progression|0|||
27751793|NCT00586924|80918241|FG003|Overall Study|Disease progression|1|||
27751794|NCT00586924|80918242|FG004|Overall Study|Disease progression|1|||
27751795|NCT00586924|80918243|FG005|Overall Study|Disease progression|0|||
27751796|NCT00586924|80918238|FG000|Overall Study|Development of neutralizing antibodies|2|||
27751797|NCT00586924|80918239|FG001|Overall Study|Development of neutralizing antibodies|2|||
27751798|NCT00586924|80918240|FG002|Overall Study|Development of neutralizing antibodies|2|||
27751799|NCT00586924|80918241|FG003|Overall Study|Development of neutralizing antibodies|0|||
27751800|NCT00586924|80918242|FG004|Overall Study|Development of neutralizing antibodies|0|||
27751801|NCT00586924|80918243|FG005|Overall Study|Development of neutralizing antibodies|22|||
27751802|NCT00586924|80918238|FG000|Overall Study|Complete response|0|||
27751803|NCT00586924|80918239|FG001|Overall Study|Complete response|1|||
27751804|NCT00586924|80918240|FG002|Overall Study|Complete response|0|||
27751805|NCT00586924|80918241|FG003|Overall Study|Complete response|0|||
27751806|NCT00586924|80918242|FG004|Overall Study|Complete response|2|||
27751807|NCT00586924|80918243|FG005|Overall Study|Complete response|2|||
27751808|NCT00586924|80918238|FG000|Overall Study|Other|1|||
27751809|NCT00586924|80918239|FG001|Overall Study|Other|0|||
27751810|NCT00586924|80918240|FG002|Overall Study|Other|1|||
27751811|NCT00586924|80918241|FG003|Overall Study|Other|1|||
27751812|NCT00586924|80918242|FG004|Overall Study|Other|1|||
27751813|NCT00586924|80918243|FG005|Overall Study|Other|6|||
27751814|NCT01519245|80918247|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
27751815|NCT01519245|80918248|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
27751816|NCT02577406|80918249|FG000|Randomized Period|Death|1|||
27751817|NCT02577406|80918250|FG001|Randomized Period|Death|0|||
27751818|NCT02577406|80918249|FG000|Randomized Period|Other reasons|0|||
27751819|NCT02577406|80918250|FG001|Randomized Period|Other reasons|20|||
27751820|NCT02577406|80918249|FG000|Treatment Period|Transition to commercially available treatment|1|||
27751821|NCT02577406|80918250|FG001|Treatment Period|Transition to commercially available treatment|0|||
27751822|NCT02577406|80918249|FG000|Treatment Period|Progressive disease|47|||
27751823|NCT02577406|80918250|FG001|Treatment Period|Progressive disease|36|||
27751824|NCT02577406|80918249|FG000|Treatment Period|Death|36|||
27751825|NCT02577406|80918250|FG001|Treatment Period|Death|23|||
27751826|NCT02577406|80918249|FG000|Treatment Period|Other reasons|3|||
27751827|NCT02577406|80918250|FG001|Treatment Period|Other reasons|37|||
27751828|NCT02577406|80918249|FG000|Treatment Period|Withdrawal by Subject|10|||
27751829|NCT02577406|80918250|FG001|Treatment Period|Withdrawal by Subject|24|||
27751830|NCT02577406|80918249|FG000|Treatment Period|Adverse Event|17|||
27751831|NCT02577406|80918250|FG001|Treatment Period|Adverse Event|12|||
27751832|NCT02577406|80918249|FG000|Treatment Period|Disease relapse|27|||
27751833|NCT02577406|80918250|FG001|Treatment Period|Disease relapse|1|||
27751834|NCT02577406|80918249|FG000|Treatment Period|HSCT|6|||
27751835|NCT02577406|80918250|FG001|Treatment Period|HSCT|2|||
27751836|NCT02577406|80918249|FG000|Treatment Period|Lost to Follow-up|0|||
27751837|NCT02577406|80918250|FG001|Treatment Period|Lost to Follow-up|1|||
27751838|NCT02577406|80918249|FG000|Treatment Period|Protocol Violation|0|||
27751839|NCT02577406|80918250|FG001|Treatment Period|Protocol Violation|1|||
27751840|NCT01165021|80918254|FG000|Overall Study|Death|1|||
27751841|NCT00002663|80918255|FG000|Overall Study|Death|4|||
27751842|NCT00002663|80918256|FG001|Overall Study|Death|1|||
27751843|NCT00002663|80918257|FG002|Overall Study|Death|1|||
27751844|NCT00002663|80918258|FG003|Overall Study|Death|0|||
27751845|NCT00002663|80918259|FG004|Overall Study|Death|0|||
27751846|NCT00002663|80918260|FG005|Overall Study|Death|13|||
27751847|NCT00002663|80918261|FG006|Overall Study|Death|0|||
27751848|NCT00002663|80918262|FG007|Overall Study|Death|1|||
27751849|NCT00002663|80918263|FG008|Overall Study|Death|1|||
27751850|NCT00002663|80918264|FG009|Overall Study|Death|1|||
27751851|NCT00002663|80918255|FG000|Overall Study|Lost to Follow-up|3|||
27751852|NCT00002663|80918256|FG001|Overall Study|Lost to Follow-up|0|||
27751853|NCT00002663|80918257|FG002|Overall Study|Lost to Follow-up|0|||
27751854|NCT00002663|80918258|FG003|Overall Study|Lost to Follow-up|1|||
27751855|NCT00002663|80918259|FG004|Overall Study|Lost to Follow-up|0|||
27751856|NCT00002663|80918260|FG005|Overall Study|Lost to Follow-up|1|||
27751857|NCT00002663|80918261|FG006|Overall Study|Lost to Follow-up|0|||
27751858|NCT00002663|80918262|FG007|Overall Study|Lost to Follow-up|0|||
27751859|NCT00002663|80918263|FG008|Overall Study|Lost to Follow-up|0|||
27751860|NCT00002663|80918264|FG009|Overall Study|Lost to Follow-up|0|||
27751861|NCT00002663|80918255|FG000|Overall Study|Other|0|||
27751862|NCT00002663|80918256|FG001|Overall Study|Other|1|||
27751863|NCT00002663|80918257|FG002|Overall Study|Other|0|||
27751864|NCT00002663|80918258|FG003|Overall Study|Other|0|||
27751865|NCT00002663|80918259|FG004|Overall Study|Other|0|||
27751866|NCT00002663|80918260|FG005|Overall Study|Other|1|||
27751867|NCT00002663|80918261|FG006|Overall Study|Other|1|||
27751868|NCT00002663|80918262|FG007|Overall Study|Other|0|||
27751869|NCT00002663|80918263|FG008|Overall Study|Other|0|||
27751870|NCT00002663|80918264|FG009|Overall Study|Other|0|||
27751871|NCT00002663|80918255|FG000|Overall Study|Physician Decision|0|||
27751872|NCT00002663|80918256|FG001|Overall Study|Physician Decision|0|||
27751873|NCT00002663|80918257|FG002|Overall Study|Physician Decision|0|||
27751874|NCT00002663|80918258|FG003|Overall Study|Physician Decision|0|||
27751875|NCT00002663|80918259|FG004|Overall Study|Physician Decision|1|||
27751876|NCT00002663|80918260|FG005|Overall Study|Physician Decision|0|||
27751877|NCT00002663|80918261|FG006|Overall Study|Physician Decision|0|||
27751878|NCT00002663|80918262|FG007|Overall Study|Physician Decision|0|||
27751879|NCT00002663|80918263|FG008|Overall Study|Physician Decision|1|||
27751880|NCT00002663|80918264|FG009|Overall Study|Physician Decision|1|||
27751881|NCT00002663|80918255|FG000|Overall Study|Adverse Event|0|||
27751882|NCT00002663|80918256|FG001|Overall Study|Adverse Event|0|||
27751883|NCT00002663|80918257|FG002|Overall Study|Adverse Event|0|||
27751884|NCT00002663|80918258|FG003|Overall Study|Adverse Event|1|||
27751885|NCT00002663|80918259|FG004|Overall Study|Adverse Event|0|||
27751886|NCT00002663|80918260|FG005|Overall Study|Adverse Event|0|||
27751887|NCT00002663|80918261|FG006|Overall Study|Adverse Event|0|||
27751888|NCT00002663|80918262|FG007|Overall Study|Adverse Event|1|||
27751889|NCT00002663|80918263|FG008|Overall Study|Adverse Event|0|||
27751890|NCT00002663|80918264|FG009|Overall Study|Adverse Event|0|||
27751891|NCT01240811|80918268|FG000|Overall Study|Physician Decision|0|||
27751892|NCT01240811|80918269|FG001|Overall Study|Physician Decision|1|||
27751893|NCT01240811|80918270|FG002|Overall Study|Physician Decision|0|||
27751894|NCT01240811|80918268|FG000|Overall Study|Withdrawal by Subject|0|||
27751895|NCT01240811|80918269|FG001|Overall Study|Withdrawal by Subject|0|||
27751896|NCT01240811|80918270|FG002|Overall Study|Withdrawal by Subject|1|||
27751897|NCT02773238|80918272|FG000|Overall Study|Lack of Efficacy|4|||
27751898|NCT02935634|80918277|FG000|Randomization|Participant withdrew consent|0|||
27751899|NCT02935634|80918278|FG001|Randomization|Participant withdrew consent|1|||
27751900|NCT02935634|80918279|FG002|Randomization|Participant withdrew consent|0|||
27751901|NCT02935634|80918280|FG003|Randomization|Participant withdrew consent|0|||
27751902|NCT02935634|80918281|FG004|Randomization|Participant withdrew consent|0|||
27751903|NCT02935634|80918282|FG005|Randomization|Participant withdrew consent|0|||
27751904|NCT02935634|80918277|FG000|Randomization|Death|2|||
27751905|NCT02935634|80918278|FG001|Randomization|Death|1|||
27751906|NCT02935634|80918279|FG002|Randomization|Death|1|||
27751907|NCT02935634|80918280|FG003|Randomization|Death|0|||
27751908|NCT02935634|80918281|FG004|Randomization|Death|0|||
27751909|NCT02935634|80918282|FG005|Randomization|Death|0|||
27751910|NCT02935634|80918277|FG000|Randomization|Other reasons|0|||
27751911|NCT02935634|80918278|FG001|Randomization|Other reasons|2|||
27751912|NCT02935634|80918279|FG002|Randomization|Other reasons|2|||
27751913|NCT02935634|80918280|FG003|Randomization|Other reasons|0|||
27751914|NCT02935634|80918281|FG004|Randomization|Other reasons|0|||
27751915|NCT02935634|80918282|FG005|Randomization|Other reasons|0|||
27751916|NCT02935634|80918277|FG000|Treatment: Track 1|Disease progression|15|||
27751917|NCT02935634|80918278|FG001|Treatment: Track 1|Disease progression|17|||
27751918|NCT02935634|80918279|FG002|Treatment: Track 1|Disease progression|28|||
27751919|NCT02935634|80918280|FG003|Treatment: Track 1|Disease progression|4|||
27751920|NCT02935634|80918281|FG004|Treatment: Track 1|Disease progression|6|||
27751921|NCT02935634|80918282|FG005|Treatment: Track 1|Disease progression|2|||
27751922|NCT02935634|80918277|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
27751923|NCT02935634|80918278|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
27751924|NCT02935634|80918279|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
27751925|NCT02935634|80918280|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
27751926|NCT02935634|80918281|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
27751927|NCT02935634|80918282|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
27751928|NCT02935634|80918277|FG000|Treatment: Track 1|Lost to Follow-up|1|||
27751929|NCT02935634|80918278|FG001|Treatment: Track 1|Lost to Follow-up|0|||
27751930|NCT02935634|80918279|FG002|Treatment: Track 1|Lost to Follow-up|0|||
27751931|NCT02935634|80918280|FG003|Treatment: Track 1|Lost to Follow-up|0|||
27751932|NCT02935634|80918281|FG004|Treatment: Track 1|Lost to Follow-up|0|||
27751933|NCT02935634|80918282|FG005|Treatment: Track 1|Lost to Follow-up|0|||
27751934|NCT02935634|80918277|FG000|Treatment: Track 1|Study drug toxicity|2|||
27751935|NCT02935634|80918278|FG001|Treatment: Track 1|Study drug toxicity|1|||
27751936|NCT02935634|80918279|FG002|Treatment: Track 1|Study drug toxicity|3|||
27751937|NCT02935634|80918280|FG003|Treatment: Track 1|Study drug toxicity|0|||
27751938|NCT02935634|80918281|FG004|Treatment: Track 1|Study drug toxicity|0|||
27751939|NCT02935634|80918282|FG005|Treatment: Track 1|Study drug toxicity|1|||
27751940|NCT02935634|80918277|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
27751941|NCT02935634|80918278|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
27751942|NCT02935634|80918279|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
27751943|NCT02935634|80918280|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
27751944|NCT02935634|80918281|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
27751945|NCT02935634|80918282|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
27751946|NCT02935634|80918277|FG000|Treatment: Track 1|Participant withdrew consent|2|||
27751947|NCT02935634|80918278|FG001|Treatment: Track 1|Participant withdrew consent|0|||
27751948|NCT02935634|80918279|FG002|Treatment: Track 1|Participant withdrew consent|1|||
27751949|NCT02935634|80918280|FG003|Treatment: Track 1|Participant withdrew consent|0|||
27751950|NCT02935634|80918281|FG004|Treatment: Track 1|Participant withdrew consent|1|||
27751951|NCT02935634|80918282|FG005|Treatment: Track 1|Participant withdrew consent|0|||
27751952|NCT02935634|80918277|FG000|Treatment: Track 1|Other reasons|0|||
27751953|NCT02935634|80918278|FG001|Treatment: Track 1|Other reasons|0|||
27751954|NCT02935634|80918279|FG002|Treatment: Track 1|Other reasons|2|||
27751955|NCT02935634|80918280|FG003|Treatment: Track 1|Other reasons|0|||
27751956|NCT02935634|80918281|FG004|Treatment: Track 1|Other reasons|0|||
27751957|NCT02935634|80918282|FG005|Treatment: Track 1|Other reasons|0|||
27751958|NCT02935634|80918277|FG000|Treatment: Track 2|Disease progression|13|||
27751959|NCT02935634|80918278|FG001|Treatment: Track 2|Disease progression|26|||
27751960|NCT02935634|80918279|FG002|Treatment: Track 2|Disease progression|20|||
27751961|NCT02935634|80918280|FG003|Treatment: Track 2|Disease progression|5|||
27751962|NCT02935634|80918281|FG004|Treatment: Track 2|Disease progression|1|||
27751963|NCT02935634|80918282|FG005|Treatment: Track 2|Disease progression|4|||
27751964|NCT02935634|80918277|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
27751965|NCT02935634|80918278|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
27751966|NCT02935634|80918279|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27751967|NCT02935634|80918280|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27751968|NCT02935634|80918281|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27751969|NCT02935634|80918282|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
27751970|NCT02935634|80918277|FG000|Treatment: Track 2|Study drug toxicity|7|||
27751971|NCT02935634|80918278|FG001|Treatment: Track 2|Study drug toxicity|3|||
27751972|NCT02935634|80918279|FG002|Treatment: Track 2|Study drug toxicity|0|||
27751973|NCT02935634|80918280|FG003|Treatment: Track 2|Study drug toxicity|0|||
27751974|NCT02935634|80918281|FG004|Treatment: Track 2|Study drug toxicity|0|||
27751975|NCT02935634|80918282|FG005|Treatment: Track 2|Study drug toxicity|0|||
27751976|NCT02935634|80918277|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
27751977|NCT02935634|80918278|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
27751978|NCT02935634|80918279|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
27751979|NCT02935634|80918280|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
27751980|NCT02935634|80918281|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
27751981|NCT02935634|80918282|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
27751982|NCT02935634|80918277|FG000|Treatment: Track 2|Participant withdrew consent|0|||
27751983|NCT02935634|80918278|FG001|Treatment: Track 2|Participant withdrew consent|1|||
27751984|NCT02935634|80918279|FG002|Treatment: Track 2|Participant withdrew consent|1|||
27751985|NCT02935634|80918280|FG003|Treatment: Track 2|Participant withdrew consent|0|||
27751986|NCT02935634|80918281|FG004|Treatment: Track 2|Participant withdrew consent|1|||
27751987|NCT02935634|80918282|FG005|Treatment: Track 2|Participant withdrew consent|0|||
27751988|NCT01856595|80918285|FG000|Overall Study|Withdrawal by Subject|0|||
27751989|NCT01856595|80918286|FG001|Overall Study|Withdrawal by Subject|1|||
27751990|NCT01856595|80918287|FG002|Overall Study|Withdrawal by Subject|0|||
27751991|NCT01856595|80918288|FG003|Overall Study|Withdrawal by Subject|0|||
27751992|NCT01856595|80918289|FG004|Overall Study|Withdrawal by Subject|0|||
27751993|NCT01856595|80918290|FG005|Overall Study|Withdrawal by Subject|0|||
27751994|NCT01856595|80918291|FG006|Overall Study|Withdrawal by Subject|1|||
27751995|NCT01856595|80918292|FG007|Overall Study|Withdrawal by Subject|0|||
27751996|NCT01856595|80918293|FG008|Overall Study|Withdrawal by Subject|0|||
27751997|NCT01477892|80918294|FG000|Overall Study|Withdrawal by Subject|0|||
27751998|NCT01477892|80918295|FG001|Overall Study|Withdrawal by Subject|2|||
27751999|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
27752000|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
27752001|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Death|2|||
27752002|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Death|1|||
27752003|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
27752004|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
27752005|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
27752006|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
27752007|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
27752008|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
27752009|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
27752010|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
27752011|NCT03633227|80918296|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
27752012|NCT03633227|80918297|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
27752013|NCT03633227|80918296|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
27752014|NCT03633227|80918297|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
27752015|NCT03633227|80918296|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
27752016|NCT03633227|80918297|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
27752017|NCT03633227|80918296|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
27752018|NCT03633227|80918297|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
27752019|NCT03633227|80918296|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
27752020|NCT03633227|80918297|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
27752021|NCT03633227|80918296|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
27752022|NCT03633227|80918297|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
27752023|NCT02115815|80918304|FG000|Overall Study|Withdrawal by Subject|2|||
27752024|NCT02115815|80918305|FG001|Overall Study|Withdrawal by Subject|0|||
27752025|NCT02115815|80918306|FG002|Overall Study|Withdrawal by Subject|0|||
27752026|NCT02115815|80918307|FG003|Overall Study|Withdrawal by Subject|0|||
27752027|NCT02115815|80918308|FG004|Overall Study|Withdrawal by Subject|0|||
27752028|NCT02115815|80918309|FG005|Overall Study|Withdrawal by Subject|0|||
27752029|NCT02115815|80918310|FG006|Overall Study|Withdrawal by Subject|0|||
27752030|NCT02115815|80918304|FG000|Overall Study|Not enough drug to dose participant|0|||
27752031|NCT02115815|80918305|FG001|Overall Study|Not enough drug to dose participant|0|||
27752032|NCT02115815|80918306|FG002|Overall Study|Not enough drug to dose participant|0|||
27752033|NCT02115815|80918307|FG003|Overall Study|Not enough drug to dose participant|0|||
27752034|NCT02115815|80918308|FG004|Overall Study|Not enough drug to dose participant|0|||
27752035|NCT02115815|80918309|FG005|Overall Study|Not enough drug to dose participant|1|||
27752036|NCT02115815|80918310|FG006|Overall Study|Not enough drug to dose participant|0|||
27752037|NCT02115815|80918304|FG000|Overall Study|Missed appointment, randomized in error|0|||
27752038|NCT02115815|80918305|FG001|Overall Study|Missed appointment, randomized in error|0|||
27752039|NCT02115815|80918306|FG002|Overall Study|Missed appointment, randomized in error|0|||
27752040|NCT02115815|80918307|FG003|Overall Study|Missed appointment, randomized in error|0|||
27752041|NCT02115815|80918308|FG004|Overall Study|Missed appointment, randomized in error|0|||
27752042|NCT02115815|80918309|FG005|Overall Study|Missed appointment, randomized in error|1|||
27752043|NCT02115815|80918310|FG006|Overall Study|Missed appointment, randomized in error|0|||
27752044|NCT00678587|80918311|FG000|Overall Study|Adverse Event|3|||
27752045|NCT00678587|80918312|FG001|Overall Study|Adverse Event|3|||
27752046|NCT00678587|80918311|FG000|Overall Study|Lack of Efficacy|1|||
27752047|NCT00678587|80918312|FG001|Overall Study|Lack of Efficacy|0|||
27752048|NCT00678587|80918311|FG000|Overall Study|Protocol Violation|2|||
27752049|NCT00678587|80918312|FG001|Overall Study|Protocol Violation|1|||
27752050|NCT00678587|80918311|FG000|Overall Study|Study Closed/Terminated|1|||
27752051|NCT00678587|80918312|FG001|Overall Study|Study Closed/Terminated|0|||
27752052|NCT00678587|80918311|FG000|Overall Study|Lost to Follow-up|3|||
27752053|NCT00678587|80918312|FG001|Overall Study|Lost to Follow-up|5|||
27752054|NCT00678587|80918311|FG000|Overall Study|Investigator Discretion|2|||
27752055|NCT00678587|80918312|FG001|Overall Study|Investigator Discretion|6|||
27752056|NCT00678587|80918311|FG000|Overall Study|Withdrew Consent|8|||
27752057|NCT00678587|80918312|FG001|Overall Study|Withdrew Consent|3|||
27752058|NCT03294681|80918315|FG000|Overall Study|Withdrawal by Subject|1|||
27752059|NCT03165721|80918319|FG000|Overall Study|Refused further treatment|3|||
27752060|NCT03165721|80918320|FG001|Overall Study|Refused further treatment|0|||
27752061|NCT03165721|80918321|FG002|Overall Study|Refused further treatment|0|||
27752062|NCT03165721|80918319|FG000|Overall Study|Physician Decision|1|||
27752063|NCT03165721|80918320|FG001|Overall Study|Physician Decision|0|||
27752064|NCT03165721|80918321|FG002|Overall Study|Physician Decision|0|||
27752065|NCT04439838|80918322|FG000|Overall Study|Withdrawal by Subject|0|||
27752066|NCT04439838|80918323|FG001|Overall Study|Withdrawal by Subject|0|||
27752067|NCT04439838|80918324|FG002|Overall Study|Withdrawal by Subject|0|||
27752068|NCT04439838|80918325|FG003|Overall Study|Withdrawal by Subject|0|||
27752069|NCT04439838|80918326|FG004|Overall Study|Withdrawal by Subject|0|||
27752070|NCT04439838|80918327|FG005|Overall Study|Withdrawal by Subject|0|||
27752071|NCT04439838|80918328|FG006|Overall Study|Withdrawal by Subject|0|||
27752072|NCT04439838|80918329|FG007|Overall Study|Withdrawal by Subject|0|||
27752073|NCT04439838|80918330|FG008|Overall Study|Withdrawal by Subject|1|||
27752074|NCT03260205|80918332|FG000|Overall Study|Adverse Event|2|||
27752075|NCT03260205|80918333|FG001|Overall Study|Adverse Event|0|||
27752076|NCT03260205|80918334|FG002|Overall Study|Adverse Event|2|||
27752077|NCT03260205|80918335|FG003|Overall Study|Adverse Event|2|||
27752078|NCT03260205|80918336|FG004|Overall Study|Adverse Event|4|||
27752079|NCT03260205|80918332|FG000|Overall Study|Lost to Follow-up|2|||
27752080|NCT03260205|80918333|FG001|Overall Study|Lost to Follow-up|2|||
27752081|NCT03260205|80918334|FG002|Overall Study|Lost to Follow-up|1|||
27752082|NCT03260205|80918335|FG003|Overall Study|Lost to Follow-up|1|||
27752083|NCT03260205|80918336|FG004|Overall Study|Lost to Follow-up|5|||
27752084|NCT03260205|80918332|FG000|Overall Study|Protocol Violation|0|||
27752085|NCT03260205|80918333|FG001|Overall Study|Protocol Violation|0|||
27752086|NCT03260205|80918334|FG002|Overall Study|Protocol Violation|2|||
27752087|NCT03260205|80918335|FG003|Overall Study|Protocol Violation|0|||
27752088|NCT03260205|80918336|FG004|Overall Study|Protocol Violation|1|||
27752089|NCT03260205|80918332|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
27752090|NCT03260205|80918333|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
27752091|NCT03260205|80918334|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
27752092|NCT03260205|80918335|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
27752093|NCT03260205|80918336|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
27752094|NCT03260205|80918332|FG000|Overall Study|Other: Unspecified|0|||
27752095|NCT03260205|80918333|FG001|Overall Study|Other: Unspecified|0|||
27752096|NCT03260205|80918334|FG002|Overall Study|Other: Unspecified|3|||
27752097|NCT03260205|80918335|FG003|Overall Study|Other: Unspecified|1|||
27752098|NCT03260205|80918336|FG004|Overall Study|Other: Unspecified|1|||
27752099|NCT03260205|80918332|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
27752100|NCT03260205|80918333|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
27752101|NCT03260205|80918334|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
27752102|NCT03260205|80918335|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
27752103|NCT03260205|80918336|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
27752104|NCT01153763|80918337|FG000|Overall Study|Study Closed|16|||
27752105|NCT01153763|80918337|FG000|Overall Study|Lost to Follow-up|1|||
27752106|NCT01153763|80918337|FG000|Overall Study|Physician Decision|2|||
27752107|NCT01153763|80918337|FG000|Overall Study|Withdrawal by Subject|2|||
27752108|NCT00777491|80918344|FG000|Overall Study|Protocol Violation|0|||
27752109|NCT00777491|80918345|FG001|Overall Study|Protocol Violation|2|||
27752110|NCT00777491|80918344|FG000|Overall Study|Did not receive any protocol treatment|2|||
27752111|NCT00777491|80918345|FG001|Overall Study|Did not receive any protocol treatment|0|||
27752112|NCT03235544|80918346|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
27752113|NCT03235544|80918347|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
27752114|NCT03235544|80918348|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
27752115|NCT03235544|80918349|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
27752116|NCT03235544|80918346|FG000|Overall Study|Death|11|||
27752117|NCT03235544|80918347|FG001|Overall Study|Death|23|||
27752118|NCT03235544|80918348|FG002|Overall Study|Death|11|||
27752119|NCT03235544|80918349|FG003|Overall Study|Death|20|||
27752120|NCT03235544|80918346|FG000|Overall Study|Lost to Follow-up|0|||
27752121|NCT03235544|80918347|FG001|Overall Study|Lost to Follow-up|1|||
27752122|NCT03235544|80918348|FG002|Overall Study|Lost to Follow-up|0|||
27752123|NCT03235544|80918349|FG003|Overall Study|Lost to Follow-up|1|||
27752124|NCT03235544|80918346|FG000|Overall Study|Withdrawal by Participant|0|||
27752125|NCT03235544|80918347|FG001|Overall Study|Withdrawal by Participant|0|||
27752126|NCT03235544|80918348|FG002|Overall Study|Withdrawal by Participant|1|||
27752127|NCT03235544|80918349|FG003|Overall Study|Withdrawal by Participant|0|||
27752128|NCT03235544|80918346|FG000|Overall Study|Reason not Specified|0|||
27752129|NCT03235544|80918347|FG001|Overall Study|Reason not Specified|4|||
27752130|NCT03235544|80918348|FG002|Overall Study|Reason not Specified|0|||
27752131|NCT03235544|80918349|FG003|Overall Study|Reason not Specified|1|||
27752132|NCT02044159|80918352|FG000|Overall Study|Consent declined (deferred consent)|2|||
27752133|NCT02044159|80918353|FG001|Overall Study|Consent declined (deferred consent)|4|||
27752134|NCT02044159|80918352|FG000|Overall Study|No longer eligible, drug not given|1|||
27752135|NCT02044159|80918353|FG001|Overall Study|No longer eligible, drug not given|0|||
27752136|NCT02044159|80918352|FG000|Overall Study|Nurse declined to give study drug|1|||
27752137|NCT02044159|80918353|FG001|Overall Study|Nurse declined to give study drug|0|||
27752138|NCT00543569|80918356|FG000|Overall Study|Death|2|||
27752139|NCT00543569|80918357|FG001|Overall Study|Death|2|||
27752140|NCT00543569|80918358|FG002|Overall Study|Death|3|||
27752141|NCT00543569|80918359|FG003|Overall Study|Death|1|||
27752142|NCT00543569|80918356|FG000|Overall Study|Lost to Follow-up|0|||
27752143|NCT00543569|80918357|FG001|Overall Study|Lost to Follow-up|0|||
27752144|NCT00543569|80918358|FG002|Overall Study|Lost to Follow-up|1|||
27752145|NCT00543569|80918359|FG003|Overall Study|Lost to Follow-up|1|||
27752146|NCT00543569|80918356|FG000|Overall Study|Miscellaneous Reasons|7|||
27752147|NCT00543569|80918357|FG001|Overall Study|Miscellaneous Reasons|3|||
27752148|NCT00543569|80918358|FG002|Overall Study|Miscellaneous Reasons|11|||
27752149|NCT00543569|80918359|FG003|Overall Study|Miscellaneous Reasons|4|||
27752150|NCT00543569|80918356|FG000|Overall Study|Randomized but never received study drug|3|||
27752151|NCT00543569|80918357|FG001|Overall Study|Randomized but never received study drug|3|||
27752152|NCT00543569|80918358|FG002|Overall Study|Randomized but never received study drug|5|||
27752153|NCT00543569|80918359|FG003|Overall Study|Randomized but never received study drug|3|||
27752154|NCT00411788|80918364|FG000|Overall Study|Protocol Violation|1|||
27752155|NCT00411788|80918364|FG000|Overall Study|Adverse Event|1|||
27752156|NCT00905021|80918365|FG000|Overall Study|Adverse Event|2|||
27752157|NCT00905307|80918369|FG000|Overall Study|Switched to Open Label Rescue|7|||
27752158|NCT00905307|80918370|FG001|Overall Study|Switched to Open Label Rescue|17|||
27752159|NCT00905307|80918371|FG002|Overall Study|Switched to Open Label Rescue|11|||
27752160|NCT00905307|80918372|FG003|Overall Study|Switched to Open Label Rescue|11|||
27752161|NCT00905307|80918373|FG004|Overall Study|Switched to Open Label Rescue|4|||
27752162|NCT00905307|80918374|FG005|Overall Study|Switched to Open Label Rescue|15|||
27752163|NCT00905307|80918369|FG000|Overall Study|Lost to Follow-up|0|||
27752164|NCT00905307|80918370|FG001|Overall Study|Lost to Follow-up|0|||
27752165|NCT00905307|80918371|FG002|Overall Study|Lost to Follow-up|0|||
27752166|NCT00905307|80918372|FG003|Overall Study|Lost to Follow-up|0|||
27752167|NCT00905307|80918373|FG004|Overall Study|Lost to Follow-up|1|||
27752168|NCT00905307|80918374|FG005|Overall Study|Lost to Follow-up|1|||
27752169|NCT00905307|80918369|FG000|Overall Study|Adverse Event|3|||
27752170|NCT00905307|80918370|FG001|Overall Study|Adverse Event|4|||
27752171|NCT00905307|80918371|FG002|Overall Study|Adverse Event|5|||
27752172|NCT00905307|80918372|FG003|Overall Study|Adverse Event|11|||
27752173|NCT00905307|80918373|FG004|Overall Study|Adverse Event|3|||
27752174|NCT00905307|80918374|FG005|Overall Study|Adverse Event|5|||
27752175|NCT00905307|80918369|FG000|Overall Study|Withdrawal by Subject|5|||
27752176|NCT00905307|80918370|FG001|Overall Study|Withdrawal by Subject|13|||
27752177|NCT00905307|80918371|FG002|Overall Study|Withdrawal by Subject|15|||
27752178|NCT00905307|80918372|FG003|Overall Study|Withdrawal by Subject|11|||
27752179|NCT00905307|80918373|FG004|Overall Study|Withdrawal by Subject|4|||
27752180|NCT00905307|80918374|FG005|Overall Study|Withdrawal by Subject|13|||
27752181|NCT00905307|80918369|FG000|Overall Study|Protocol Violation|1|||
27752182|NCT00905307|80918370|FG001|Overall Study|Protocol Violation|0|||
27752183|NCT00905307|80918371|FG002|Overall Study|Protocol Violation|1|||
27752184|NCT00905307|80918372|FG003|Overall Study|Protocol Violation|0|||
27752185|NCT00905307|80918373|FG004|Overall Study|Protocol Violation|0|||
27752186|NCT00905307|80918374|FG005|Overall Study|Protocol Violation|0|||
27752187|NCT00905307|80918369|FG000|Overall Study|Lack of Efficacy|6|||
27752188|NCT00905307|80918370|FG001|Overall Study|Lack of Efficacy|3|||
27752189|NCT00905307|80918371|FG002|Overall Study|Lack of Efficacy|5|||
27752190|NCT00905307|80918372|FG003|Overall Study|Lack of Efficacy|4|||
27752191|NCT00905307|80918373|FG004|Overall Study|Lack of Efficacy|4|||
27752192|NCT00905307|80918374|FG005|Overall Study|Lack of Efficacy|8|||
27752193|NCT01740440|80918375|FG000|Overall Study|Lost to Follow-up|3|||
27752194|NCT02417233|80918376|FG000|Overall Study|Death|4|||
27752195|NCT02417233|80918377|FG001|Overall Study|Death|10|||
27752196|NCT02417233|80918378|FG002|Overall Study|Death|14|||
27752197|NCT02417233|80918376|FG000|Overall Study|Lost to Follow-up|27|||
27752198|NCT02417233|80918377|FG001|Overall Study|Lost to Follow-up|39|||
27752199|NCT02417233|80918378|FG002|Overall Study|Lost to Follow-up|34|||
27752200|NCT02417233|80918376|FG000|Overall Study|Protocol Violation|2|||
27752201|NCT02417233|80918377|FG001|Overall Study|Protocol Violation|0|||
27752202|NCT02417233|80918378|FG002|Overall Study|Protocol Violation|2|||
27752203|NCT02417233|80918376|FG000|Overall Study|Withdrawal by Subject|2|||
27955589|NCT04021290|81672213|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
27752204|NCT02417233|80918377|FG001|Overall Study|Withdrawal by Subject|1|||
27752205|NCT02417233|80918378|FG002|Overall Study|Withdrawal by Subject|8|||
27752206|NCT02417233|80918376|FG000|Overall Study|Relocation out of study area|1|||
27752207|NCT02417233|80918377|FG001|Overall Study|Relocation out of study area|0|||
27752208|NCT02417233|80918378|FG002|Overall Study|Relocation out of study area|1|||
27752209|NCT02417233|80918376|FG000|Overall Study|Mentally unstable|0|||
27752210|NCT02417233|80918377|FG001|Overall Study|Mentally unstable|1|||
27752211|NCT02417233|80918378|FG002|Overall Study|Mentally unstable|0|||
27752212|NCT02493426|80918379|FG000|Overall Study|Withdrawal by Subject|0|||
27752213|NCT02493426|80918380|FG001|Overall Study|Withdrawal by Subject|1|||
27752214|NCT03504774|80918383|FG000|Overall Study|Adverse Event|2|||
27752215|NCT03504774|80918384|FG001|Overall Study|Adverse Event|0|||
27752216|NCT03504774|80918383|FG000|Overall Study|Lost to Follow-up|0|||
27752217|NCT03504774|80918384|FG001|Overall Study|Lost to Follow-up|1|||
27752218|NCT03504774|80918383|FG000|Overall Study|Protocol Violation|11|||
27752219|NCT03504774|80918384|FG001|Overall Study|Protocol Violation|3|||
27752220|NCT03504774|80918383|FG000|Overall Study|failed wk 52 DBPCFC|1|||
27752221|NCT03504774|80918384|FG001|Overall Study|failed wk 52 DBPCFC|0|||
27752222|NCT01202227|80918385|FG000|Overall Study|Adverse Event|16|||
27752223|NCT01202227|80918385|FG000|Overall Study|Withdrawal by Subject|2|||
27752224|NCT01202227|80918385|FG000|Overall Study|Lack of Efficacy|1|||
27752225|NCT01029886|80918386|FG000|Overall Study|Adverse Event|12|||
27752226|NCT01029886|80918387|FG001|Overall Study|Adverse Event|25|||
27752227|NCT01029886|80918386|FG000|Overall Study|Lost to Follow-up|1|||
27752228|NCT01029886|80918387|FG001|Overall Study|Lost to Follow-up|0|||
27752229|NCT01029886|80918386|FG000|Overall Study|Physician Decision|2|||
27752230|NCT01029886|80918387|FG001|Overall Study|Physician Decision|6|||
27752231|NCT01029886|80918386|FG000|Overall Study|Protocol Violation|17|||
27752232|NCT01029886|80918387|FG001|Overall Study|Protocol Violation|5|||
27752233|NCT01029886|80918386|FG000|Overall Study|Withdrawal by Subject|8|||
27752234|NCT01029886|80918387|FG001|Overall Study|Withdrawal by Subject|18|||
27752235|NCT01029886|80918386|FG000|Overall Study|Entry Criteria Not Met|13|||
27752236|NCT01029886|80918387|FG001|Overall Study|Entry Criteria Not Met|5|||
27752237|NCT01029886|80918386|FG000|Overall Study|Sponsor Decision|1|||
27752238|NCT01029886|80918387|FG001|Overall Study|Sponsor Decision|0|||
27752239|NCT01029886|80918386|FG000|Overall Study|Loss Glucose Control|7|||
27752240|NCT01029886|80918387|FG001|Overall Study|Loss Glucose Control|1|||
27752241|NCT01260467|80918390|FG000|Overall Study|Withdrawal by Subject|2|||
27752242|NCT00786838|80918391|FG000|Overall Study|Physician Decision|4|||
27752243|NCT00786838|80918391|FG000|Overall Study|Death|4|||
27752244|NCT00786838|80918391|FG000|Overall Study|Adverse Event|6|||
27752245|NCT00786838|80918391|FG000|Overall Study|Progressive disease|31|||
27752246|NCT00786838|80918391|FG000|Overall Study|Withdrawal by Subject|4|||
27752247|NCT01328249|80918397|FG000|Overall Study|Adverse Event|3|||
27752248|NCT01328249|80918398|FG001|Overall Study|Adverse Event|0|||
27752249|NCT01328249|80918397|FG000|Overall Study|Disease progression|1|||
27752250|NCT01328249|80918398|FG001|Overall Study|Disease progression|0|||
27752251|NCT01328249|80918397|FG000|Overall Study|Withdrawal by Subject|1|||
27752252|NCT01328249|80918398|FG001|Overall Study|Withdrawal by Subject|1|||
27752253|NCT01328249|80918397|FG000|Overall Study|Moved before end of treatment visit|1|||
27752254|NCT01328249|80918398|FG001|Overall Study|Moved before end of treatment visit|0|||
27752255|NCT01328249|80918397|FG000|Overall Study|Subject choice|1|||
27752256|NCT01328249|80918398|FG001|Overall Study|Subject choice|1|||
27752257|NCT01328249|80918397|FG000|Overall Study|Protocol Violation|0|||
27752258|NCT01328249|80918398|FG001|Overall Study|Protocol Violation|1|||
27752259|NCT02626533|80918399|FG000|Overall Study|Protocol Violation|14|||
27752260|NCT02626533|80918399|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
27752261|NCT02626533|80918399|FG000|Overall Study|Withdrawal by Subject|1|||
27752262|NCT00525148|80918414|FG000|Overall Study|Other Adverse Event|3|||
27752263|NCT00525148|80918415|FG001|Overall Study|Other Adverse Event|5|||
27752264|NCT00525148|80918416|FG002|Overall Study|Other Adverse Event|1|||
27752265|NCT00525148|80918417|FG003|Overall Study|Other Adverse Event|8|||
27752266|NCT00525148|80918414|FG000|Overall Study|Progressive disease|18|||
27752267|NCT00525148|80918415|FG001|Overall Study|Progressive disease|30|||
27752268|NCT00525148|80918416|FG002|Overall Study|Progressive disease|6|||
27752269|NCT00525148|80918417|FG003|Overall Study|Progressive disease|49|||
27752270|NCT00525148|80918414|FG000|Overall Study|Refused continuation of study medication|0|||
27752271|NCT00525148|80918415|FG001|Overall Study|Refused continuation of study medication|2|||
27752272|NCT00525148|80918416|FG002|Overall Study|Refused continuation of study medication|0|||
27752273|NCT00525148|80918417|FG003|Overall Study|Refused continuation of study medication|1|||
27752274|NCT00525148|80918414|FG000|Overall Study|Other than stated|2|||
27752275|NCT00525148|80918415|FG001|Overall Study|Other than stated|1|||
27752276|NCT00525148|80918416|FG002|Overall Study|Other than stated|0|||
27752277|NCT00525148|80918417|FG003|Overall Study|Other than stated|3|||
27752278|NCT02678741|80918424|FG000|Overall Study|Death|4|||
27752279|NCT02678741|80918424|FG000|Overall Study|Withdrawal by Subject|1|||
27752280|NCT02678741|80918424|FG000|Overall Study|ineligible|3|||
27752281|NCT02678741|80918424|FG000|Overall Study|Not RECIST Measurable|2|||
27752282|NCT02678741|80918424|FG000|Overall Study|Lack of Efficacy|10|||
27752283|NCT00115349|80918427|FG000|Overall Study|Study closed due to low enrollment.|11|||
27752284|NCT00115349|80918428|FG001|Overall Study|Study closed due to low enrollment.|9|||
27752285|NCT02370498|80918431|FG000|Overall Study|Adverse Event|10|||
27752286|NCT02370498|80918432|FG001|Overall Study|Adverse Event|8|||
27752287|NCT02370498|80918431|FG000|Overall Study|Death|263|||
27752288|NCT02370498|80918432|FG001|Overall Study|Death|265|||
27752289|NCT02370498|80918431|FG000|Overall Study|Protocol Violation|1|||
27752290|NCT02370498|80918432|FG001|Overall Study|Protocol Violation|2|||
27752291|NCT02370498|80918431|FG000|Overall Study|Withdrawal by Subject|7|||
27752292|NCT02370498|80918432|FG001|Overall Study|Withdrawal by Subject|12|||
27752293|NCT02370498|80918431|FG000|Overall Study|Sponsor's decision|15|||
27752294|NCT02370498|80918432|FG001|Overall Study|Sponsor's decision|9|||
27752295|NCT02488759|80918437|FG000|Overall Study|Disease progression|73|||
27752296|NCT02488759|80918438|FG001|Overall Study|Disease progression|111|||
27752297|NCT02488759|80918439|FG002|Overall Study|Disease progression|62|||
27752298|NCT02488759|80918440|FG003|Overall Study|Disease progression|7|||
27752299|NCT02488759|80918441|FG004|Overall Study|Disease progression|4|||
27752300|NCT02488759|80918442|FG005|Overall Study|Disease progression|2|||
27752301|NCT02488759|80918437|FG000|Overall Study|Study drug toxicity|11|||
27752302|NCT02488759|80918438|FG001|Overall Study|Study drug toxicity|33|||
27752303|NCT02488759|80918439|FG002|Overall Study|Study drug toxicity|31|||
27752304|NCT02488759|80918440|FG003|Overall Study|Study drug toxicity|0|||
27752305|NCT02488759|80918441|FG004|Overall Study|Study drug toxicity|0|||
27752306|NCT02488759|80918442|FG005|Overall Study|Study drug toxicity|2|||
27752307|NCT02488759|80918437|FG000|Overall Study|Adverse event unrelated to study drug|9|||
27752308|NCT02488759|80918438|FG001|Overall Study|Adverse event unrelated to study drug|11|||
27752309|NCT02488759|80918439|FG002|Overall Study|Adverse event unrelated to study drug|7|||
27752310|NCT02488759|80918440|FG003|Overall Study|Adverse event unrelated to study drug|0|||
27752311|NCT02488759|80918441|FG004|Overall Study|Adverse event unrelated to study drug|1|||
27752312|NCT02488759|80918442|FG005|Overall Study|Adverse event unrelated to study drug|0|||
27752313|NCT02488759|80918437|FG000|Overall Study|Participant request to discontinue study treatment|6|||
27955590|NCT04021290|81672214|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
27955591|NCT04021290|81672212|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
27955592|NCT04021290|81672213|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
27955593|NCT04021290|81672214|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
27752314|NCT02488759|80918438|FG001|Overall Study|Participant request to discontinue study treatment|8|||
27752315|NCT02488759|80918439|FG002|Overall Study|Participant request to discontinue study treatment|4|||
27752316|NCT02488759|80918440|FG003|Overall Study|Participant request to discontinue study treatment|0|||
27955594|NCT04021290|81672212|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
27955595|NCT04021290|81672213|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
27955596|NCT04021290|81672214|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
27955597|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
27955598|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
27955599|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
27955600|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
27955601|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
27955602|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
27955603|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
27955604|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
27955605|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
27955606|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
27955607|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
27955608|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
27955609|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
27955610|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
27955611|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
27955612|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
27955613|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
27955614|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
27955615|NCT03789292|81672220|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
27955616|NCT03789292|81672221|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
27955617|NCT03789292|81672222|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
27955618|NCT03789292|81672220|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
27955619|NCT03789292|81672221|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
27955620|NCT03789292|81672222|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
27955621|NCT03789292|81672220|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
27955622|NCT03789292|81672221|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
27955623|NCT03789292|81672222|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
27955624|NCT03789292|81672220|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
27955625|NCT03789292|81672221|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
27955626|NCT03789292|81672222|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
27752317|NCT02488759|80918441|FG004|Overall Study|Participant request to discontinue study treatment|0|||
27955627|NCT03789292|81672220|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
27955628|NCT03789292|81672221|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
27955629|NCT03789292|81672222|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
27955630|NCT03789292|81672220|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
27955631|NCT03789292|81672221|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
27955632|NCT03789292|81672222|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
27955633|NCT03789292|81672220|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
27955634|NCT03789292|81672221|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
27955635|NCT03789292|81672222|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
27955636|NCT05173974|81672223|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
27955637|NCT05173974|81672224|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
27955638|NCT05173974|81672225|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
27955639|NCT05173974|81672226|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
27955640|NCT05173974|81672223|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
27955641|NCT05173974|81672224|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
27955642|NCT05173974|81672225|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
27955643|NCT05173974|81672226|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
27955644|NCT01881789|81672231|FG000|Overall Study|Withdrawal by Subject|0|||
27955645|NCT01881789|81672232|FG001|Overall Study|Withdrawal by Subject|2|||
27955646|NCT01881789|81672233|FG002|Overall Study|Withdrawal by Subject|1|||
27955647|NCT01881789|81672234|FG003|Overall Study|Withdrawal by Subject|0|||
27955648|NCT01881789|81672235|FG004|Overall Study|Withdrawal by Subject|1|||
27955649|NCT01881789|81672236|FG005|Overall Study|Withdrawal by Subject|1|||
27955650|NCT01881789|81672231|FG000|Overall Study|Study Terminated by Sponsor|0|||
27955651|NCT01881789|81672232|FG001|Overall Study|Study Terminated by Sponsor|0|||
27955652|NCT01881789|81672233|FG002|Overall Study|Study Terminated by Sponsor|0|||
27955653|NCT01881789|81672234|FG003|Overall Study|Study Terminated by Sponsor|0|||
27955654|NCT01881789|81672235|FG004|Overall Study|Study Terminated by Sponsor|0|||
27955655|NCT01881789|81672236|FG005|Overall Study|Study Terminated by Sponsor|1|||
27955656|NCT01881789|81672231|FG000|Overall Study|Other|3|||
27955657|NCT01881789|81672232|FG001|Overall Study|Other|5|||
27955658|NCT01881789|81672233|FG002|Overall Study|Other|2|||
27955659|NCT01881789|81672234|FG003|Overall Study|Other|3|||
27955660|NCT01881789|81672235|FG004|Overall Study|Other|1|||
27955661|NCT01881789|81672236|FG005|Overall Study|Other|1|||
27955662|NCT00421148|81672237|FG000|Overall Study|Lost to Follow-up|0|||
27955663|NCT00421148|81672238|FG001|Overall Study|Lost to Follow-up|0|||
27955664|NCT00421148|81672239|FG002|Overall Study|Lost to Follow-up|0|||
27955665|NCT00421148|81672240|FG003|Overall Study|Lost to Follow-up|0|||
27955666|NCT00421148|81672241|FG004|Overall Study|Lost to Follow-up|0|||
27955667|NCT00421148|81672242|FG005|Overall Study|Lost to Follow-up|0|||
27955668|NCT00421148|81672243|FG006|Overall Study|Lost to Follow-up|0|||
27955669|NCT00421148|81672244|FG007|Overall Study|Lost to Follow-up|0|||
27955670|NCT00421148|81672245|FG008|Overall Study|Lost to Follow-up|0|||
27955671|NCT00421148|81672246|FG009|Overall Study|Lost to Follow-up|0|||
27955672|NCT00421148|81672247|FG010|Overall Study|Lost to Follow-up|0|||
27955673|NCT00421148|81672248|FG011|Overall Study|Lost to Follow-up|0|||
27955674|NCT00421148|81672249|FG012|Overall Study|Lost to Follow-up|0|||
27955675|NCT00421148|81672250|FG013|Overall Study|Lost to Follow-up|0|||
27955676|NCT00421148|81672251|FG014|Overall Study|Lost to Follow-up|0|||
27955677|NCT00421148|81672252|FG015|Overall Study|Lost to Follow-up|0|||
27955678|NCT00421148|81672253|FG016|Overall Study|Lost to Follow-up|0|||
27955679|NCT00421148|81672254|FG017|Overall Study|Lost to Follow-up|1|||
27955680|NCT00421148|81672255|FG018|Overall Study|Lost to Follow-up|0|||
27955681|NCT00421148|81672256|FG019|Overall Study|Lost to Follow-up|0|||
27955682|NCT00421148|81672237|FG000|Overall Study|Withdrawal by Subject|0|||
27955683|NCT00421148|81672238|FG001|Overall Study|Withdrawal by Subject|0|||
27955684|NCT00421148|81672239|FG002|Overall Study|Withdrawal by Subject|0|||
27955685|NCT00421148|81672240|FG003|Overall Study|Withdrawal by Subject|0|||
27955686|NCT00421148|81672241|FG004|Overall Study|Withdrawal by Subject|0|||
27955687|NCT00421148|81672242|FG005|Overall Study|Withdrawal by Subject|0|||
27955688|NCT00421148|81672243|FG006|Overall Study|Withdrawal by Subject|0|||
27955689|NCT00421148|81672244|FG007|Overall Study|Withdrawal by Subject|0|||
27955690|NCT00421148|81672245|FG008|Overall Study|Withdrawal by Subject|0|||
27955691|NCT00421148|81672246|FG009|Overall Study|Withdrawal by Subject|0|||
27955692|NCT00421148|81672247|FG010|Overall Study|Withdrawal by Subject|0|||
27752318|NCT02488759|80918442|FG005|Overall Study|Participant request to discontinue study treatment|0|||
27752319|NCT02488759|80918437|FG000|Overall Study|Withdrawal by Subject|4|||
27752320|NCT02488759|80918438|FG001|Overall Study|Withdrawal by Subject|0|||
27752321|NCT02488759|80918439|FG002|Overall Study|Withdrawal by Subject|3|||
27752322|NCT02488759|80918440|FG003|Overall Study|Withdrawal by Subject|0|||
27752323|NCT02488759|80918441|FG004|Overall Study|Withdrawal by Subject|0|||
27752324|NCT02488759|80918442|FG005|Overall Study|Withdrawal by Subject|2|||
27752325|NCT02488759|80918437|FG000|Overall Study|Lost to Follow-up|0|||
27752326|NCT02488759|80918438|FG001|Overall Study|Lost to Follow-up|0|||
27752327|NCT02488759|80918439|FG002|Overall Study|Lost to Follow-up|2|||
27752328|NCT02488759|80918440|FG003|Overall Study|Lost to Follow-up|0|||
27752329|NCT02488759|80918441|FG004|Overall Study|Lost to Follow-up|0|||
27752330|NCT02488759|80918442|FG005|Overall Study|Lost to Follow-up|0|||
27752331|NCT02488759|80918437|FG000|Overall Study|Maximum clinical benefit|3|||
27752332|NCT02488759|80918438|FG001|Overall Study|Maximum clinical benefit|0|||
27752333|NCT02488759|80918439|FG002|Overall Study|Maximum clinical benefit|1|||
27752334|NCT02488759|80918440|FG003|Overall Study|Maximum clinical benefit|0|||
27752335|NCT02488759|80918441|FG004|Overall Study|Maximum clinical benefit|0|||
27752336|NCT02488759|80918442|FG005|Overall Study|Maximum clinical benefit|0|||
27752337|NCT02488759|80918437|FG000|Overall Study|Other reasons|7|||
27752338|NCT02488759|80918438|FG001|Overall Study|Other reasons|32|||
27752339|NCT02488759|80918439|FG002|Overall Study|Other reasons|23|||
27752340|NCT02488759|80918440|FG003|Overall Study|Other reasons|1|||
27752341|NCT02488759|80918441|FG004|Overall Study|Other reasons|1|||
27752342|NCT02488759|80918442|FG005|Overall Study|Other reasons|1|||
27752343|NCT02651194|80918443|FG000|Overall Study|Lost to Follow-up|3|||
27752344|NCT02651194|80918443|FG000|Overall Study|Other|2|||
27752345|NCT02202031|80918444|FG000|Overall Study|Lost to Follow-up|1|||
27752346|NCT02202031|80918445|FG001|Overall Study|Lost to Follow-up|0|||
27752347|NCT02202031|80918444|FG000|Overall Study|Too Busy|1|||
27752348|NCT02202031|80918445|FG001|Overall Study|Too Busy|3|||
27752349|NCT02202031|80918444|FG000|Overall Study|Illness/Medical Reason|0|||
27752350|NCT02202031|80918445|FG001|Overall Study|Illness/Medical Reason|2|||
27752351|NCT02202031|80918444|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
27752352|NCT02202031|80918445|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
27752353|NCT00696657|80922297|FG000|Overall Study|Protocol Violation|0|||
27752354|NCT00696657|80922298|FG001|Overall Study|Protocol Violation|0|||
27752355|NCT00696657|80922299|FG002|Overall Study|Protocol Violation|0|||
27752356|NCT00696657|80922300|FG003|Overall Study|Protocol Violation|0|||
27752357|NCT00696657|80922301|FG004|Overall Study|Protocol Violation|0|||
27752358|NCT00696657|80922302|FG005|Overall Study|Protocol Violation|1|||
27752359|NCT00696657|80922303|FG006|Overall Study|Protocol Violation|0|||
27752360|NCT00696657|80922304|FG007|Overall Study|Protocol Violation|0|||
27752361|NCT00696657|80922305|FG008|Overall Study|Protocol Violation|1|||
27752362|NCT00696657|80922297|FG000|Overall Study|Lack of Efficacy|0|||
27752363|NCT00696657|80922298|FG001|Overall Study|Lack of Efficacy|1|||
27752364|NCT00696657|80922299|FG002|Overall Study|Lack of Efficacy|0|||
27752365|NCT00696657|80922300|FG003|Overall Study|Lack of Efficacy|0|||
27752366|NCT00696657|80922301|FG004|Overall Study|Lack of Efficacy|0|||
27752367|NCT00696657|80922302|FG005|Overall Study|Lack of Efficacy|0|||
27752368|NCT00696657|80922303|FG006|Overall Study|Lack of Efficacy|0|||
27752369|NCT00696657|80922304|FG007|Overall Study|Lack of Efficacy|0|||
27752370|NCT00696657|80922305|FG008|Overall Study|Lack of Efficacy|0|||
27752371|NCT00696657|80922297|FG000|Overall Study|Withdrawal criteria|1|||
27752372|NCT00696657|80922298|FG001|Overall Study|Withdrawal criteria|3|||
27752373|NCT00696657|80922299|FG002|Overall Study|Withdrawal criteria|2|||
27752374|NCT00696657|80922300|FG003|Overall Study|Withdrawal criteria|2|||
27752375|NCT00696657|80922301|FG004|Overall Study|Withdrawal criteria|0|||
27752376|NCT00696657|80922302|FG005|Overall Study|Withdrawal criteria|0|||
27752377|NCT00696657|80922303|FG006|Overall Study|Withdrawal criteria|1|||
27752378|NCT00696657|80922304|FG007|Overall Study|Withdrawal criteria|1|||
27752379|NCT00696657|80922305|FG008|Overall Study|Withdrawal criteria|2|||
27752380|NCT00696657|80922297|FG000|Overall Study|Unclassified|0|||
27752381|NCT00696657|80922298|FG001|Overall Study|Unclassified|1|||
27752382|NCT00696657|80922299|FG002|Overall Study|Unclassified|3|||
27752383|NCT00696657|80922300|FG003|Overall Study|Unclassified|2|||
27752384|NCT00696657|80922301|FG004|Overall Study|Unclassified|4|||
27752385|NCT00696657|80922302|FG005|Overall Study|Unclassified|2|||
27752386|NCT00696657|80922303|FG006|Overall Study|Unclassified|0|||
27752387|NCT00696657|80922304|FG007|Overall Study|Unclassified|0|||
27752388|NCT00696657|80922305|FG008|Overall Study|Unclassified|1|||
27752389|NCT00696657|80922297|FG000|Overall Study|Adverse Event|0|||
27752390|NCT00696657|80922298|FG001|Overall Study|Adverse Event|0|||
27752391|NCT00696657|80922299|FG002|Overall Study|Adverse Event|3|||
27752392|NCT00696657|80922300|FG003|Overall Study|Adverse Event|7|||
27752393|NCT00696657|80922301|FG004|Overall Study|Adverse Event|6|||
27752394|NCT00696657|80922302|FG005|Overall Study|Adverse Event|9|||
27752395|NCT00696657|80922303|FG006|Overall Study|Adverse Event|14|||
27752396|NCT00696657|80922304|FG007|Overall Study|Adverse Event|2|||
27752397|NCT00696657|80922305|FG008|Overall Study|Adverse Event|5|||
27752398|NCT03029650|80922306|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
27752399|NCT03029650|80922307|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
27752400|NCT03029650|80922306|FG000|Washout (1 Week)|Physician Decision|0|||
27752401|NCT03029650|80922307|FG001|Washout (1 Week)|Physician Decision|1|||
27752402|NCT04863014|80922308|FG000|Overall Study|Lost to Follow-up|3|||
27752403|NCT04863014|80922309|FG001|Overall Study|Lost to Follow-up|2|||
27752404|NCT04863014|80922308|FG000|Overall Study|Subject Decision|0|||
27752405|NCT04863014|80922309|FG001|Overall Study|Subject Decision|4|||
27752406|NCT01035255|80922310|FG000|Overall Study|Death|724|||
27752407|NCT01035255|80922311|FG001|Overall Study|Death|844|||
27752408|NCT01035255|80922310|FG000|Overall Study|Lost to Follow-up|2|||
27752409|NCT01035255|80922311|FG001|Overall Study|Lost to Follow-up|5|||
27752410|NCT01035255|80922310|FG000|Overall Study|patient's request|15|||
27752411|NCT01035255|80922311|FG001|Overall Study|patient's request|13|||
27752412|NCT01586156|80922313|FG000|Overall Study|Pregnancy|0|||
27752413|NCT01586156|80922314|FG001|Overall Study|Pregnancy|1|||
27752414|NCT01586156|80922315|FG002|Overall Study|Pregnancy|0|||
27752415|NCT00975195|80922316|FG000|Overall Study|Adverse Event|108|||
27752416|NCT00975195|80922317|FG001|Overall Study|Adverse Event|101|||
27752417|NCT00975195|80922316|FG000|Overall Study|Lack of Efficacy|6|||
27752418|NCT00975195|80922317|FG001|Overall Study|Lack of Efficacy|6|||
27752419|NCT00975195|80922316|FG000|Overall Study|Protocol Violation|27|||
27752420|NCT00975195|80922317|FG001|Overall Study|Protocol Violation|23|||
27752421|NCT00975195|80922316|FG000|Overall Study|Lost to Follow-up|9|||
27752422|NCT00975195|80922317|FG001|Overall Study|Lost to Follow-up|7|||
27752423|NCT00975195|80922316|FG000|Overall Study|Withdrawal by Subject|48|||
27752424|NCT00975195|80922317|FG001|Overall Study|Withdrawal by Subject|61|||
27752425|NCT00975195|80922316|FG000|Overall Study|Other reason not defined above|29|||
27752426|NCT00975195|80922317|FG001|Overall Study|Other reason not defined above|33|||
27752427|NCT00975195|80922316|FG000|Overall Study|Not treated|1|||
27752428|NCT00975195|80922317|FG001|Overall Study|Not treated|2|||
27752429|NCT02635737|80922318|FG000|Overall Study|Protocol Violation|1|||
27752430|NCT03521687|80922319|FG000|Overall Study|Adverse Event|4|||
27752431|NCT03521687|80922319|FG000|Overall Study|Physician Decision|1|||
27752432|NCT03699631|80922320|FG000|Overall Study|Adverse Event|3|||
27752433|NCT03703375|80922321|FG000|Randomization Period|Withdrawal by Subject|0|||
27752434|NCT03703375|80922322|FG001|Randomization Period|Withdrawal by Subject|0|||
27752435|NCT03703375|80922323|FG002|Randomization Period|Withdrawal by Subject|0|||
27752436|NCT03703375|80922324|FG003|Randomization Period|Withdrawal by Subject|1|||
27752437|NCT03703375|80922321|FG000|Randomization Period|Completed safety run-in treatment|7|||
27752438|NCT03703375|80922322|FG001|Randomization Period|Completed safety run-in treatment|0|||
27752439|NCT03703375|80922323|FG002|Randomization Period|Completed safety run-in treatment|0|||
27752440|NCT03703375|80922324|FG003|Randomization Period|Completed safety run-in treatment|0|||
27752441|NCT03703375|80922321|FG000|Treatment Period|Other Reasons|0|||
27752442|NCT03703375|80922322|FG001|Treatment Period|Other Reasons|1|||
27752443|NCT03703375|80922323|FG002|Treatment Period|Other Reasons|0|||
27752444|NCT03703375|80922324|FG003|Treatment Period|Other Reasons|3|||
27752445|NCT03703375|80922321|FG000|Treatment Period|Consent Withdrawal|0|||
27752446|NCT03703375|80922322|FG001|Treatment Period|Consent Withdrawal|0|||
27752447|NCT03703375|80922323|FG002|Treatment Period|Consent Withdrawal|0|||
27752448|NCT03703375|80922324|FG003|Treatment Period|Consent Withdrawal|1|||
27752449|NCT03703375|80922321|FG000|Treatment Period|Death|1|||
27752450|NCT03703375|80922322|FG001|Treatment Period|Death|0|||
27752451|NCT03703375|80922323|FG002|Treatment Period|Death|1|||
27752452|NCT03703375|80922324|FG003|Treatment Period|Death|2|||
27752453|NCT03703375|80922321|FG000|Treatment Period|Toxicity of Study Treatment|2|||
27752454|NCT03703375|80922322|FG001|Treatment Period|Toxicity of Study Treatment|0|||
27752455|NCT03703375|80922323|FG002|Treatment Period|Toxicity of Study Treatment|4|||
27752456|NCT03703375|80922324|FG003|Treatment Period|Toxicity of Study Treatment|1|||
27752457|NCT03703375|80922321|FG000|Treatment Period|Progression|32|||
27752458|NCT03703375|80922322|FG001|Treatment Period|Progression|1|||
27752459|NCT03703375|80922323|FG002|Treatment Period|Progression|7|||
27752460|NCT03703375|80922324|FG003|Treatment Period|Progression|11|||
27752461|NCT03703375|80922321|FG000|Treatment Period|Completed treatment|7|||
27752462|NCT03703375|80922322|FG001|Treatment Period|Completed treatment|2|||
27752463|NCT03703375|80922323|FG002|Treatment Period|Completed treatment|0|||
27752464|NCT03703375|80922324|FG003|Treatment Period|Completed treatment|0|||
27752465|NCT01716533|80922327|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
27752466|NCT01716533|80922328|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
27752467|NCT01716533|80922329|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
27752468|NCT01716533|80922330|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
27752469|NCT01716533|80922327|FG000|Overall Study|Withdrawal by Subject|0|||
27752470|NCT01716533|80922328|FG001|Overall Study|Withdrawal by Subject|0|||
27752471|NCT01716533|80922329|FG002|Overall Study|Withdrawal by Subject|0|||
27752472|NCT01716533|80922330|FG003|Overall Study|Withdrawal by Subject|5|||
27752473|NCT01716533|80922327|FG000|Overall Study|Death|0|||
27752474|NCT01716533|80922328|FG001|Overall Study|Death|0|||
27752475|NCT01716533|80922329|FG002|Overall Study|Death|0|||
27752476|NCT01716533|80922330|FG003|Overall Study|Death|2|||
27752477|NCT01716533|80922327|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
27752478|NCT01716533|80922328|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
27752479|NCT01716533|80922329|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
27752480|NCT01716533|80922330|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
27752481|NCT00915005|80922331|FG000|Overall Study|Withdrawal by Subject|4|||
27752482|NCT00915005|80922332|FG001|Overall Study|Withdrawal by Subject|4|||
27752483|NCT00915005|80922331|FG000|Overall Study|Patient preferred protons therapy|6|||
27752484|NCT00915005|80922332|FG001|Overall Study|Patient preferred protons therapy|0|||
27752485|NCT00915005|80922331|FG000|Overall Study|Insurance denial|3|||
27752486|NCT00915005|80922332|FG001|Overall Study|Insurance denial|15|||
27752487|NCT02130427|80922333|FG000|Overall Study|Imaging results not interpretable|30|||
27752488|NCT00137436|80922337|FG000|Overall Study|Adverse Event|13|||
27752489|NCT00137436|80922337|FG000|Overall Study|Death|2|||
27752490|NCT00137436|80922337|FG000|Overall Study|Lack of Efficacy|17|||
27752491|NCT00137436|80922337|FG000|Overall Study|Withdrawal by Subject|6|||
27752492|NCT00137436|80922337|FG000|Overall Study|Other|5|||
27752493|NCT01781429|80922338|FG000|Overall Study|Death|0|||
27752494|NCT01781429|80922339|FG001|Overall Study|Death|0|||
27752495|NCT01781429|80922340|FG002|Overall Study|Death|0|||
27752496|NCT01781429|80922341|FG003|Overall Study|Death|0|||
27752497|NCT01781429|80922342|FG004|Overall Study|Death|0|||
27752498|NCT01781429|80922343|FG005|Overall Study|Death|0|||
27752499|NCT01781429|80922344|FG006|Overall Study|Death|0|||
27752500|NCT01781429|80922345|FG007|Overall Study|Death|0|||
27752501|NCT01781429|80922346|FG008|Overall Study|Death|0|||
27752502|NCT01781429|80922347|FG009|Overall Study|Death|1|||
27752503|NCT01781429|80922348|FG010|Overall Study|Death|0|||
27752504|NCT01781429|80922349|FG011|Overall Study|Death|0|||
27752505|NCT01781429|80922350|FG012|Overall Study|Death|1|||
27752506|NCT01781429|80922351|FG013|Overall Study|Death|0|||
27752507|NCT01781429|80922352|FG014|Overall Study|Death|1|||
27752508|NCT01781429|80922353|FG015|Overall Study|Death|0|||
27752509|NCT01781429|80922338|FG000|Overall Study|Withdrawal by Subject|0|||
27752510|NCT01781429|80922339|FG001|Overall Study|Withdrawal by Subject|0|||
27752511|NCT01781429|80922340|FG002|Overall Study|Withdrawal by Subject|0|||
27752512|NCT01781429|80922341|FG003|Overall Study|Withdrawal by Subject|0|||
27752513|NCT01781429|80922342|FG004|Overall Study|Withdrawal by Subject|0|||
27752514|NCT01781429|80922343|FG005|Overall Study|Withdrawal by Subject|0|||
27752515|NCT01781429|80922344|FG006|Overall Study|Withdrawal by Subject|0|||
27752516|NCT01781429|80922345|FG007|Overall Study|Withdrawal by Subject|0|||
27752517|NCT01781429|80922346|FG008|Overall Study|Withdrawal by Subject|1|||
27752518|NCT01781429|80922347|FG009|Overall Study|Withdrawal by Subject|3|||
27752519|NCT01781429|80922348|FG010|Overall Study|Withdrawal by Subject|1|||
27752520|NCT01781429|80922349|FG011|Overall Study|Withdrawal by Subject|1|||
27752521|NCT01781429|80922350|FG012|Overall Study|Withdrawal by Subject|5|||
27752522|NCT01781429|80922351|FG013|Overall Study|Withdrawal by Subject|2|||
27752523|NCT01781429|80922352|FG014|Overall Study|Withdrawal by Subject|3|||
27752524|NCT01781429|80922353|FG015|Overall Study|Withdrawal by Subject|0|||
27752525|NCT01781429|80922338|FG000|Overall Study|Disease Progression|1|||
27752526|NCT01781429|80922339|FG001|Overall Study|Disease Progression|0|||
27752527|NCT01781429|80922340|FG002|Overall Study|Disease Progression|1|||
27752528|NCT01781429|80922341|FG003|Overall Study|Disease Progression|1|||
27752529|NCT01781429|80922342|FG004|Overall Study|Disease Progression|1|||
27752530|NCT01781429|80922343|FG005|Overall Study|Disease Progression|4|||
27752531|NCT01781429|80922344|FG006|Overall Study|Disease Progression|7|||
27752532|NCT01781429|80922345|FG007|Overall Study|Disease Progression|4|||
27752533|NCT01781429|80922346|FG008|Overall Study|Disease Progression|6|||
27752534|NCT01781429|80922347|FG009|Overall Study|Disease Progression|15|||
27752535|NCT01781429|80922348|FG010|Overall Study|Disease Progression|15|||
27752536|NCT01781429|80922349|FG011|Overall Study|Disease Progression|15|||
27752537|NCT01781429|80922350|FG012|Overall Study|Disease Progression|15|||
27752538|NCT01781429|80922351|FG013|Overall Study|Disease Progression|4|||
27752539|NCT01781429|80922352|FG014|Overall Study|Disease Progression|11|||
27752540|NCT01781429|80922353|FG015|Overall Study|Disease Progression|0|||
27752541|NCT01781429|80922338|FG000|Overall Study|Unacceptable Toxicity|0|||
27752542|NCT01781429|80922339|FG001|Overall Study|Unacceptable Toxicity|0|||
27752543|NCT01781429|80922340|FG002|Overall Study|Unacceptable Toxicity|0|||
27752544|NCT01781429|80922341|FG003|Overall Study|Unacceptable Toxicity|0|||
27752545|NCT01781429|80922342|FG004|Overall Study|Unacceptable Toxicity|0|||
27752546|NCT01781429|80922343|FG005|Overall Study|Unacceptable Toxicity|0|||
27752547|NCT01781429|80922344|FG006|Overall Study|Unacceptable Toxicity|0|||
27752548|NCT01781429|80922345|FG007|Overall Study|Unacceptable Toxicity|0|||
27752549|NCT01781429|80922346|FG008|Overall Study|Unacceptable Toxicity|0|||
27752550|NCT01781429|80922347|FG009|Overall Study|Unacceptable Toxicity|0|||
27752551|NCT01781429|80922348|FG010|Overall Study|Unacceptable Toxicity|0|||
27752552|NCT01781429|80922349|FG011|Overall Study|Unacceptable Toxicity|2|||
27752553|NCT01781429|80922350|FG012|Overall Study|Unacceptable Toxicity|0|||
27752554|NCT01781429|80922351|FG013|Overall Study|Unacceptable Toxicity|0|||
27752555|NCT01781429|80922352|FG014|Overall Study|Unacceptable Toxicity|0|||
27752556|NCT01781429|80922353|FG015|Overall Study|Unacceptable Toxicity|0|||
27752557|NCT01781429|80922338|FG000|Overall Study|Patient Condition Changed|0|||
27752558|NCT01781429|80922339|FG001|Overall Study|Patient Condition Changed|0|||
27752559|NCT01781429|80922340|FG002|Overall Study|Patient Condition Changed|0|||
27752560|NCT01781429|80922341|FG003|Overall Study|Patient Condition Changed|0|||
27752561|NCT01781429|80922342|FG004|Overall Study|Patient Condition Changed|0|||
27752562|NCT01781429|80922343|FG005|Overall Study|Patient Condition Changed|0|||
27752563|NCT01781429|80922344|FG006|Overall Study|Patient Condition Changed|0|||
27752564|NCT01781429|80922345|FG007|Overall Study|Patient Condition Changed|0|||
27752565|NCT01781429|80922346|FG008|Overall Study|Patient Condition Changed|0|||
27752566|NCT01781429|80922347|FG009|Overall Study|Patient Condition Changed|4|||
27752567|NCT01781429|80922348|FG010|Overall Study|Patient Condition Changed|0|||
27752568|NCT01781429|80922349|FG011|Overall Study|Patient Condition Changed|1|||
27752569|NCT01781429|80922350|FG012|Overall Study|Patient Condition Changed|0|||
27752570|NCT01781429|80922351|FG013|Overall Study|Patient Condition Changed|1|||
27752571|NCT01781429|80922352|FG014|Overall Study|Patient Condition Changed|0|||
27752572|NCT01781429|80922353|FG015|Overall Study|Patient Condition Changed|0|||
27752573|NCT01781429|80922338|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
27752574|NCT01781429|80922339|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
27752575|NCT01781429|80922340|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
27752576|NCT01781429|80922341|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
27752577|NCT01781429|80922342|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
27752578|NCT01781429|80922343|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
27752579|NCT01781429|80922344|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
27752580|NCT01781429|80922345|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
27752581|NCT01781429|80922346|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
27752582|NCT01781429|80922347|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
27752583|NCT01781429|80922348|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
27752584|NCT01781429|80922349|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
27752585|NCT01781429|80922350|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
27752586|NCT01781429|80922351|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
27752587|NCT01781429|80922352|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
27752588|NCT01781429|80922353|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
27752589|NCT01781429|80922338|FG000|Overall Study|Enrolled, but not treated|0|||
27752590|NCT01781429|80922339|FG001|Overall Study|Enrolled, but not treated|0|||
27752591|NCT01781429|80922340|FG002|Overall Study|Enrolled, but not treated|0|||
27752592|NCT01781429|80922341|FG003|Overall Study|Enrolled, but not treated|0|||
27752593|NCT01781429|80922342|FG004|Overall Study|Enrolled, but not treated|0|||
27752594|NCT01781429|80922343|FG005|Overall Study|Enrolled, but not treated|0|||
27752595|NCT01781429|80922344|FG006|Overall Study|Enrolled, but not treated|0|||
27752596|NCT01781429|80922345|FG007|Overall Study|Enrolled, but not treated|0|||
27752597|NCT01781429|80922346|FG008|Overall Study|Enrolled, but not treated|0|||
27752598|NCT01781429|80922347|FG009|Overall Study|Enrolled, but not treated|0|||
27752599|NCT01781429|80922348|FG010|Overall Study|Enrolled, but not treated|1|||
27752600|NCT01781429|80922349|FG011|Overall Study|Enrolled, but not treated|0|||
27752601|NCT01781429|80922350|FG012|Overall Study|Enrolled, but not treated|0|||
27752602|NCT01781429|80922351|FG013|Overall Study|Enrolled, but not treated|0|||
27752603|NCT01781429|80922352|FG014|Overall Study|Enrolled, but not treated|0|||
27752604|NCT01781429|80922353|FG015|Overall Study|Enrolled, but not treated|0|||
27752605|NCT01395368|80922354|FG000|Overall Study|Physician Decision|14|||
27752606|NCT01395368|80922354|FG000|Overall Study|Withdrawal by Subject|2|||
27752607|NCT01745393|80922355|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
27752608|NCT01745393|80922356|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
27752609|NCT01745393|80922355|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
27752610|NCT01745393|80922356|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
27752611|NCT01745393|80922355|FG000|12-month Follow-up|Lost to Follow-up|6|||
27752612|NCT01745393|80922356|FG001|12-month Follow-up|Lost to Follow-up|5|||
27752613|NCT00487084|80922359|FG000|Overall Study|Did not receive intervention|4|||
27752614|NCT00487084|80922360|FG001|Overall Study|Did not receive intervention|3|||
27752615|NCT00487084|80922361|FG002|Overall Study|Did not receive intervention|5|||
27752616|NCT02433379|80922370|FG000|Overall Study|Screen Failures|55|||
27752617|NCT02433379|80922370|FG000|Overall Study|Death|57|||
27752618|NCT02433379|80922370|FG000|Overall Study|Total Withdrawals|209|||
27752619|NCT03442829|80922371|FG000|Overall Study|Scheduling clash|3|||
27752620|NCT03442829|80922372|FG001|Overall Study|Scheduling clash|1|||
27752621|NCT03442829|80922371|FG000|Overall Study|Illness unrelated to study|1|||
27752622|NCT03442829|80922372|FG001|Overall Study|Illness unrelated to study|1|||
27752623|NCT01263691|80922378|FG000|Overall Study|Lost to Follow-up|1|||
27752624|NCT01263691|80922379|FG001|Overall Study|Lost to Follow-up|0|||
27752625|NCT01263691|80922380|FG002|Overall Study|Lost to Follow-up|1|||
27752626|NCT01263691|80922381|FG003|Overall Study|Lost to Follow-up|1|||
27752627|NCT01263691|80922382|FG004|Overall Study|Lost to Follow-up|0|||
27752628|NCT01263691|80922383|FG005|Overall Study|Lost to Follow-up|0|||
27752629|NCT01263691|80922378|FG000|Overall Study|Withdrawal by Subject|1|||
27752630|NCT01263691|80922379|FG001|Overall Study|Withdrawal by Subject|0|||
27752631|NCT01263691|80922380|FG002|Overall Study|Withdrawal by Subject|0|||
27752632|NCT01263691|80922381|FG003|Overall Study|Withdrawal by Subject|0|||
27752633|NCT01263691|80922382|FG004|Overall Study|Withdrawal by Subject|0|||
27752634|NCT01263691|80922383|FG005|Overall Study|Withdrawal by Subject|0|||
27752635|NCT01263691|80922378|FG000|Overall Study|Adverse Event|1|||
27752636|NCT01263691|80922379|FG001|Overall Study|Adverse Event|0|||
27752637|NCT01263691|80922380|FG002|Overall Study|Adverse Event|0|||
27752638|NCT01263691|80922381|FG003|Overall Study|Adverse Event|0|||
27752639|NCT01263691|80922382|FG004|Overall Study|Adverse Event|0|||
27752640|NCT01263691|80922383|FG005|Overall Study|Adverse Event|0|||
27752641|NCT01994226|80922400|FG000|Overall Study|Protocol Violation|13|||
27752642|NCT01994226|80922401|FG001|Overall Study|Protocol Violation|10|||
27752643|NCT01994226|80922400|FG000|Overall Study|Early Cessation of treatment|6|||
27752644|NCT01994226|80922401|FG001|Overall Study|Early Cessation of treatment|11|||
27752645|NCT03622593|80922403|FG000|Overall Study|Withdrawal by Subject|11|||
27752646|NCT03622593|80922404|FG001|Overall Study|Withdrawal by Subject|9|||
27752647|NCT03622593|80922405|FG002|Overall Study|Withdrawal by Subject|13|||
27752648|NCT03622593|80922403|FG000|Overall Study|Death|12|||
27752649|NCT03622593|80922404|FG001|Overall Study|Death|9|||
27752650|NCT03622593|80922405|FG002|Overall Study|Death|10|||
27752651|NCT03622593|80922403|FG000|Overall Study|Lost to Follow-up|11|||
27752652|NCT03622593|80922404|FG001|Overall Study|Lost to Follow-up|5|||
27752653|NCT03622593|80922405|FG002|Overall Study|Lost to Follow-up|8|||
27752654|NCT03622593|80922403|FG000|Overall Study|Adverse Event|4|||
27752655|NCT03622593|80922404|FG001|Overall Study|Adverse Event|5|||
27752656|NCT03622593|80922405|FG002|Overall Study|Adverse Event|6|||
27752657|NCT03622593|80922403|FG000|Overall Study|Physician Decision|2|||
27752658|NCT03622593|80922404|FG001|Overall Study|Physician Decision|1|||
27752659|NCT03622593|80922405|FG002|Overall Study|Physician Decision|6|||
27752660|NCT03622593|80922403|FG000|Overall Study|Other|2|||
27752661|NCT03622593|80922404|FG001|Overall Study|Other|2|||
27752662|NCT03622593|80922405|FG002|Overall Study|Other|3|||
27752663|NCT03622593|80922403|FG000|Overall Study|Protocol Violation|0|||
27752664|NCT03622593|80922404|FG001|Overall Study|Protocol Violation|0|||
27752665|NCT03622593|80922405|FG002|Overall Study|Protocol Violation|1|||
27752666|NCT03622593|80922403|FG000|Overall Study|Pregnancy|0|||
27752667|NCT03622593|80922404|FG001|Overall Study|Pregnancy|0|||
27752668|NCT03622593|80922405|FG002|Overall Study|Pregnancy|1|||
27752669|NCT00771030|80922406|FG000|Overall Study|Adverse Event|0|||
27752670|NCT00771030|80922407|FG001|Overall Study|Adverse Event|1|||
27752671|NCT00771030|80922408|FG002|Overall Study|Adverse Event|0|||
27752672|NCT00771030|80922409|FG003|Overall Study|Adverse Event|0|||
27752673|NCT00771030|80922410|FG004|Overall Study|Adverse Event|0|||
27752674|NCT00771030|80922411|FG005|Overall Study|Adverse Event|0|||
27752675|NCT00771030|80922412|FG006|Overall Study|Adverse Event|0|||
27752676|NCT02720016|80922418|FG000|Overall Study|Separation of couple|6|||
27752677|NCT02720016|80922419|FG001|Overall Study|Separation of couple|8|||
27752678|NCT02720016|80922420|FG002|Overall Study|Separation of couple|2|||
27752679|NCT02720016|80922418|FG000|Overall Study|Withdrawal by Subject|6|||
27752680|NCT02720016|80922419|FG001|Overall Study|Withdrawal by Subject|6|||
27752681|NCT02720016|80922420|FG002|Overall Study|Withdrawal by Subject|4|||
27752682|NCT02720016|80922418|FG000|Overall Study|Scheduling issues|2|||
27752683|NCT02720016|80922419|FG001|Overall Study|Scheduling issues|4|||
27752684|NCT02720016|80922420|FG002|Overall Study|Scheduling issues|7|||
27752685|NCT02720016|80922418|FG000|Overall Study|Childcare|2|||
27752686|NCT02720016|80922419|FG001|Overall Study|Childcare|0|||
27752687|NCT02720016|80922420|FG002|Overall Study|Childcare|2|||
27752688|NCT02720016|80922418|FG000|Overall Study|Withdrawal by PI|2|||
27752689|NCT02720016|80922419|FG001|Overall Study|Withdrawal by PI|2|||
27752690|NCT02720016|80922420|FG002|Overall Study|Withdrawal by PI|0|||
27752691|NCT02720016|80922418|FG000|Overall Study|Moved away|2|||
27752692|NCT02720016|80922419|FG001|Overall Study|Moved away|0|||
27752693|NCT02720016|80922420|FG002|Overall Study|Moved away|0|||
27752694|NCT02720016|80922418|FG000|Overall Study|Not Primary Health Concern|0|||
27752695|NCT02720016|80922419|FG001|Overall Study|Not Primary Health Concern|0|||
27752696|NCT02720016|80922420|FG002|Overall Study|Not Primary Health Concern|2|||
27752697|NCT02720016|80922418|FG000|Overall Study|Transportation issues|0|||
27752698|NCT02720016|80922419|FG001|Overall Study|Transportation issues|0|||
27752699|NCT02720016|80922420|FG002|Overall Study|Transportation issues|1|||
27752700|NCT02720016|80922418|FG000|Overall Study|Other|0|||
27752701|NCT02720016|80922419|FG001|Overall Study|Other|0|||
27752702|NCT02720016|80922420|FG002|Overall Study|Other|2|||
27752703|NCT01251276|80922423|FG000|Overall Study|Protocol Violation|1|||
27752704|NCT01251276|80922424|FG001|Overall Study|Protocol Violation|0|||
27752705|NCT01251276|80922423|FG000|Overall Study|Lost to Follow-up|0|||
27752706|NCT01251276|80922424|FG001|Overall Study|Lost to Follow-up|1|||
27752707|NCT02273752|80922427|FG000|Overall Study|Trial was terminated early|2|||
27752708|NCT00916370|80922429|FG000|Overall Study|Death|3|||
27752709|NCT00916370|80922430|FG001|Overall Study|Death|1|||
27955693|NCT00421148|81672248|FG011|Overall Study|Withdrawal by Subject|0|||
27752710|NCT00916370|80922429|FG000|Overall Study|Withdrawal by Subject|2|||
27752711|NCT00916370|80922430|FG001|Overall Study|Withdrawal by Subject|0|||
27752712|NCT00916370|80922429|FG000|Overall Study|Physician Decision|0|||
27752713|NCT00916370|80922430|FG001|Overall Study|Physician Decision|1|||
27752714|NCT00986258|80922431|FG000|Observation Period|Not eligible to be dosed|11|||
27752715|NCT00986258|80922431|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
27752716|NCT00986258|80922431|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
27752717|NCT00986258|80922431|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
27752718|NCT00986258|80922431|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
27752719|NCT00986258|80922431|FG000|Titration and Optimal Dose Period|Other|1|||
27752720|NCT00986258|80922431|FG000|Maintenance Period|Adverse Event|5|||
27752721|NCT00986258|80922431|FG000|Maintenance Period|Lack of Efficacy|2|||
27752722|NCT00986258|80922431|FG000|Maintenance Period|Withdrawal by Subject|2|||
27752723|NCT00547378|80922435|FG000|Randomized Cohort|Withdrawal by Subject|7|||
27752724|NCT00547378|80922436|FG001|Randomized Cohort|Withdrawal by Subject|5|||
27752725|NCT00547378|80922437|FG002|Randomized Cohort|Withdrawal by Subject|0|||
27752726|NCT00547378|80922435|FG000|Randomized Cohort|Death|0|||
27752727|NCT00547378|80922436|FG001|Randomized Cohort|Death|1|||
27752728|NCT00547378|80922437|FG002|Randomized Cohort|Death|0|||
27752729|NCT00547378|80922435|FG000|Randomized Cohort|Lost to Follow-up|1|||
27752730|NCT00547378|80922436|FG001|Randomized Cohort|Lost to Follow-up|0|||
27752731|NCT00547378|80922437|FG002|Randomized Cohort|Lost to Follow-up|0|||
27752732|NCT00547378|80922435|FG000|Randomized Cohort|Adverse Event|1|||
27752733|NCT00547378|80922436|FG001|Randomized Cohort|Adverse Event|0|||
27752734|NCT00547378|80922437|FG002|Randomized Cohort|Adverse Event|0|||
27752735|NCT00547378|80922435|FG000|Randomized Cohort|Other reasons|2|||
27752736|NCT00547378|80922436|FG001|Randomized Cohort|Other reasons|0|||
27752737|NCT00547378|80922437|FG002|Randomized Cohort|Other reasons|0|||
27752738|NCT00547378|80922435|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
27752739|NCT00547378|80922436|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
27752740|NCT00547378|80922437|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
27752741|NCT00547378|80922435|FG000|All Implanted Cohort|Adverse Event|4|||
27752742|NCT00547378|80922436|FG001|All Implanted Cohort|Adverse Event|10|||
27752743|NCT00547378|80922437|FG002|All Implanted Cohort|Adverse Event|17|||
27752744|NCT00547378|80922435|FG000|All Implanted Cohort|Lost to Follow-up|0|||
27752745|NCT00547378|80922436|FG001|All Implanted Cohort|Lost to Follow-up|1|||
27752746|NCT00547378|80922437|FG002|All Implanted Cohort|Lost to Follow-up|14|||
27752747|NCT00547378|80922435|FG000|All Implanted Cohort|Death|3|||
27752748|NCT00547378|80922436|FG001|All Implanted Cohort|Death|1|||
27752749|NCT00547378|80922437|FG002|All Implanted Cohort|Death|4|||
27752750|NCT00547378|80922435|FG000|All Implanted Cohort|Physician Decision|0|||
27752751|NCT00547378|80922436|FG001|All Implanted Cohort|Physician Decision|2|||
27752752|NCT00547378|80922437|FG002|All Implanted Cohort|Physician Decision|6|||
27752753|NCT00547378|80922435|FG000|All Implanted Cohort|Site closure|2|||
27752754|NCT00547378|80922436|FG001|All Implanted Cohort|Site closure|0|||
27752755|NCT00547378|80922437|FG002|All Implanted Cohort|Site closure|1|||
27752756|NCT00547378|80922435|FG000|All Implanted Cohort|Other reasons|1|||
27752757|NCT00547378|80922436|FG001|All Implanted Cohort|Other reasons|0|||
27752758|NCT00547378|80922437|FG002|All Implanted Cohort|Other reasons|1|||
27752759|NCT02531373|80922441|FG000|Overall Study|Lack of Efficacy|0|||
27752760|NCT02531373|80922442|FG001|Overall Study|Lack of Efficacy|0|||
27752761|NCT02531373|80922443|FG002|Overall Study|Lack of Efficacy|0|||
27752762|NCT02531373|80922444|FG003|Overall Study|Lack of Efficacy|0|||
27752763|NCT02531373|80922445|FG004|Overall Study|Lack of Efficacy|3|||
27752764|NCT02531373|80922446|FG005|Overall Study|Lack of Efficacy|2|||
27752765|NCT02531373|80922447|FG006|Overall Study|Lack of Efficacy|4|||
27752766|NCT02531373|80922448|FG007|Overall Study|Lack of Efficacy|8|||
27752767|NCT02531373|80922449|FG008|Overall Study|Lack of Efficacy|5|||
27752768|NCT02531373|80922441|FG000|Overall Study|Lost to Follow-up|0|||
27752769|NCT02531373|80922442|FG001|Overall Study|Lost to Follow-up|0|||
27752770|NCT02531373|80922443|FG002|Overall Study|Lost to Follow-up|0|||
27752771|NCT02531373|80922444|FG003|Overall Study|Lost to Follow-up|0|||
27752772|NCT02531373|80922445|FG004|Overall Study|Lost to Follow-up|0|||
27752773|NCT02531373|80922446|FG005|Overall Study|Lost to Follow-up|2|||
27752774|NCT02531373|80922447|FG006|Overall Study|Lost to Follow-up|2|||
27752775|NCT02531373|80922448|FG007|Overall Study|Lost to Follow-up|0|||
27752776|NCT02531373|80922449|FG008|Overall Study|Lost to Follow-up|0|||
27752777|NCT02531373|80922441|FG000|Overall Study|Physician Decision|0|||
27752778|NCT02531373|80922442|FG001|Overall Study|Physician Decision|0|||
27752779|NCT02531373|80922443|FG002|Overall Study|Physician Decision|0|||
27752780|NCT02531373|80922444|FG003|Overall Study|Physician Decision|0|||
27752781|NCT02531373|80922445|FG004|Overall Study|Physician Decision|2|||
27752782|NCT02531373|80922446|FG005|Overall Study|Physician Decision|1|||
27752783|NCT02531373|80922447|FG006|Overall Study|Physician Decision|0|||
27752784|NCT02531373|80922448|FG007|Overall Study|Physician Decision|0|||
27752785|NCT02531373|80922449|FG008|Overall Study|Physician Decision|0|||
27752786|NCT02531373|80922441|FG000|Overall Study|Protocol Violation|0|||
27752787|NCT02531373|80922442|FG001|Overall Study|Protocol Violation|0|||
27752788|NCT02531373|80922443|FG002|Overall Study|Protocol Violation|0|||
27752789|NCT02531373|80922444|FG003|Overall Study|Protocol Violation|0|||
27752790|NCT02531373|80922445|FG004|Overall Study|Protocol Violation|0|||
27752791|NCT02531373|80922446|FG005|Overall Study|Protocol Violation|1|||
27752792|NCT02531373|80922447|FG006|Overall Study|Protocol Violation|1|||
27752793|NCT02531373|80922448|FG007|Overall Study|Protocol Violation|0|||
27752794|NCT02531373|80922449|FG008|Overall Study|Protocol Violation|1|||
27752795|NCT02531373|80922441|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
27752796|NCT02531373|80922442|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
27752797|NCT02531373|80922443|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
27752798|NCT02531373|80922444|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
27752799|NCT02531373|80922445|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
27752800|NCT02531373|80922446|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
27752801|NCT02531373|80922447|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
27752802|NCT02531373|80922448|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
27752803|NCT02531373|80922449|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
27752804|NCT02531373|80922441|FG000|Overall Study|Withdrawal by Subject|0|||
27752805|NCT02531373|80922442|FG001|Overall Study|Withdrawal by Subject|0|||
27752806|NCT02531373|80922443|FG002|Overall Study|Withdrawal by Subject|0|||
27752807|NCT02531373|80922444|FG003|Overall Study|Withdrawal by Subject|0|||
27752808|NCT02531373|80922445|FG004|Overall Study|Withdrawal by Subject|3|||
27752809|NCT02531373|80922446|FG005|Overall Study|Withdrawal by Subject|0|||
27752810|NCT02531373|80922447|FG006|Overall Study|Withdrawal by Subject|0|||
27752811|NCT02531373|80922448|FG007|Overall Study|Withdrawal by Subject|0|||
27752812|NCT02531373|80922449|FG008|Overall Study|Withdrawal by Subject|0|||
27752813|NCT00745368|80922452|FG000|Overall Study|Unable to provide sample|3|||
27752814|NCT00403559|80922453|FG000|Overall Study|Adverse Event|0|||
27752815|NCT00403559|80922454|FG001|Overall Study|Adverse Event|1|||
27752816|NCT00403559|80922453|FG000|Overall Study|Lost to Follow-up|3|||
27752817|NCT00403559|80922454|FG001|Overall Study|Lost to Follow-up|3|||
27752818|NCT00403559|80922453|FG000|Overall Study|Withdrawal by Subject|1|||
27752819|NCT00403559|80922454|FG001|Overall Study|Withdrawal by Subject|0|||
27752820|NCT01276457|80922455|FG000|Core Study|Adverse Event|6|||
27752821|NCT01276457|80922456|FG001|Core Study|Adverse Event|3|||
27752822|NCT01276457|80922455|FG000|Core Study|Lost to Follow-up|1|||
27752823|NCT01276457|80922456|FG001|Core Study|Lost to Follow-up|2|||
27752824|NCT01276457|80922455|FG000|Core Study|Administrative problems|1|||
27752825|NCT01276457|80922456|FG001|Core Study|Administrative problems|1|||
27752826|NCT01276457|80922455|FG000|Core Study|Death|2|||
27752827|NCT01276457|80922456|FG001|Core Study|Death|2|||
27752828|NCT01276457|80922455|FG000|Core Study|Lack of Efficacy|3|||
27752829|NCT01276457|80922456|FG001|Core Study|Lack of Efficacy|12|||
27752830|NCT01276457|80922455|FG000|Extension Study|Lost to Follow-up|3|||
27752831|NCT01276457|80922456|FG001|Extension Study|Lost to Follow-up|0|||
27752832|NCT01276457|80922455|FG000|Extension Study|Death|0|||
27752833|NCT01276457|80922456|FG001|Extension Study|Death|1|||
27752834|NCT01276457|80922455|FG000|Extension Study|Lack of Efficacy|3|||
27752835|NCT01276457|80922456|FG001|Extension Study|Lack of Efficacy|1|||
27752836|NCT01975272|80922459|FG000|Overall Study|Excluded after protocol amendment|1|||
27752837|NCT01975272|80922460|FG001|Overall Study|Excluded after protocol amendment|1|||
27752838|NCT01975272|80922461|FG002|Overall Study|Excluded after protocol amendment|2|||
27752839|NCT01627067|80922463|FG000|Overall Study|Screen Failure|1|||
27752840|NCT01204658|80922464|FG000|Primary Phase|Adverse Event|0|||
27752841|NCT01204658|80922465|FG001|Primary Phase|Adverse Event|0|||
27752842|NCT01204658|80922466|FG002|Primary Phase|Adverse Event|1|||
27752843|NCT01204658|80922467|FG003|Primary Phase|Adverse Event|0|||
27752844|NCT02756650|80922470|FG000|Overall Study|Physician Decision|1|||
27752845|NCT02756650|80922470|FG000|Overall Study|Adverse Event|1|||
27752846|NCT02357849|80922471|FG000|Overall Study|Withdrawal by Subject|2|||
27752847|NCT02357849|80922472|FG001|Overall Study|Withdrawal by Subject|3|||
27752848|NCT03007953|80922473|FG000|Overall Study|Withdrawal by Subject|5|||
27752849|NCT03007953|80922474|FG001|Overall Study|Withdrawal by Subject|2|||
27752850|NCT03007953|80922473|FG000|Overall Study|Death|5|||
27752851|NCT03007953|80922474|FG001|Overall Study|Death|7|||
27752852|NCT03007953|80922473|FG000|Overall Study|Lost to Follow-up|3|||
27752853|NCT03007953|80922474|FG001|Overall Study|Lost to Follow-up|2|||
27752854|NCT03007953|80922473|FG000|Overall Study|Enrolled in Hospice|3|||
27752855|NCT03007953|80922474|FG001|Overall Study|Enrolled in Hospice|2|||
27752856|NCT00408421|80922475|FG000|Treatment Initial Randomization|Adverse Event|5|||
27752857|NCT00408421|80922476|FG001|Treatment Initial Randomization|Adverse Event|9|||
27752858|NCT00408421|80922477|FG002|Treatment Initial Randomization|Adverse Event|0|||
27752859|NCT00408421|80922475|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
27752860|NCT00408421|80922476|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
27752861|NCT00408421|80922477|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
27752862|NCT00408421|80922475|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
27752863|NCT00408421|80922476|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
27752864|NCT00408421|80922477|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
27752865|NCT00408421|80922475|FG000|Treatment Initial Randomization|Physician Decision|1|||
27752866|NCT00408421|80922476|FG001|Treatment Initial Randomization|Physician Decision|0|||
27752867|NCT00408421|80922477|FG002|Treatment Initial Randomization|Physician Decision|0|||
27752868|NCT00408421|80922475|FG000|Treatment Initial Randomization|Protocol Violation|0|||
27752869|NCT00408421|80922476|FG001|Treatment Initial Randomization|Protocol Violation|1|||
27752870|NCT00408421|80922477|FG002|Treatment Initial Randomization|Protocol Violation|0|||
27752871|NCT00408421|80922475|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
27752872|NCT00408421|80922476|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
27752873|NCT00408421|80922477|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
27752874|NCT00408421|80922475|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
27752875|NCT00408421|80922476|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
27752876|NCT00408421|80922477|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
27752877|NCT00408421|80922475|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
27752878|NCT00408421|80922476|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
27752879|NCT00408421|80922477|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
27752880|NCT00408421|80922475|FG000|Treatment Re-Randomization|Adverse Event|2|||
27752881|NCT00408421|80922476|FG001|Treatment Re-Randomization|Adverse Event|2|||
27752882|NCT00408421|80922477|FG002|Treatment Re-Randomization|Adverse Event|4|||
27752883|NCT00408421|80922475|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
27752884|NCT00408421|80922476|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
27752885|NCT00408421|80922477|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
27752886|NCT00408421|80922475|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
27752887|NCT00408421|80922476|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
27752888|NCT00408421|80922477|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
27752889|NCT00408421|80922475|FG000|Treatment Re-Randomization|Physician Decision|1|||
27752890|NCT00408421|80922476|FG001|Treatment Re-Randomization|Physician Decision|3|||
27752891|NCT00408421|80922477|FG002|Treatment Re-Randomization|Physician Decision|0|||
27752892|NCT00408421|80922475|FG000|Treatment Re-Randomization|Protocol Violation|1|||
27752893|NCT00408421|80922476|FG001|Treatment Re-Randomization|Protocol Violation|1|||
27752894|NCT00408421|80922477|FG002|Treatment Re-Randomization|Protocol Violation|0|||
27752895|NCT00408421|80922475|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
27752896|NCT00408421|80922476|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
27752897|NCT00408421|80922477|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
27752898|NCT04056455|80922480|FG000|Overall Study|Adverse Event|1|||
27752899|NCT04056455|80922481|FG001|Overall Study|Adverse Event|0|||
27752900|NCT02104804|80922485|FG000|Overall Study|Did not take study medication|0|||
27955694|NCT00421148|81672249|FG012|Overall Study|Withdrawal by Subject|0|||
27955695|NCT00421148|81672250|FG013|Overall Study|Withdrawal by Subject|0|||
27955696|NCT00421148|81672251|FG014|Overall Study|Withdrawal by Subject|0|||
27955697|NCT00421148|81672252|FG015|Overall Study|Withdrawal by Subject|0|||
27955698|NCT00421148|81672253|FG016|Overall Study|Withdrawal by Subject|0|||
27955699|NCT00421148|81672254|FG017|Overall Study|Withdrawal by Subject|1|||
27955700|NCT00421148|81672255|FG018|Overall Study|Withdrawal by Subject|0|||
27955701|NCT00421148|81672256|FG019|Overall Study|Withdrawal by Subject|0|||
27955702|NCT00421148|81672237|FG000|Overall Study|Protocol Violation|0|||
27955703|NCT00421148|81672238|FG001|Overall Study|Protocol Violation|0|||
27955704|NCT00421148|81672239|FG002|Overall Study|Protocol Violation|0|||
27955705|NCT00421148|81672240|FG003|Overall Study|Protocol Violation|0|||
27955706|NCT00421148|81672241|FG004|Overall Study|Protocol Violation|0|||
27955707|NCT00421148|81672242|FG005|Overall Study|Protocol Violation|1|||
27752901|NCT02104804|80922486|FG001|Overall Study|Did not take study medication|1|||
27752902|NCT02104804|80922485|FG000|Overall Study|Study specific discontinuation criteria|6|||
27752903|NCT02104804|80922486|FG001|Overall Study|Study specific discontinuation criteria|1|||
27752904|NCT02104804|80922485|FG000|Overall Study|Other listed|2|||
27752905|NCT02104804|80922486|FG001|Overall Study|Other listed|1|||
27752906|NCT02104804|80922485|FG000|Overall Study|Protocol Violation|0|||
27752907|NCT02104804|80922486|FG001|Overall Study|Protocol Violation|1|||
27752908|NCT02104804|80922485|FG000|Overall Study|Adverse Event|4|||
27752909|NCT02104804|80922486|FG001|Overall Study|Adverse Event|3|||
27752910|NCT02104804|80922485|FG000|Overall Study|Withdrawal by Subject|4|||
27752911|NCT02104804|80922486|FG001|Overall Study|Withdrawal by Subject|12|||
27752912|NCT02112994|80922487|FG000|Overall Study|Progressive Disease|0|||
27752913|NCT02112994|80922488|FG001|Overall Study|Progressive Disease|0|||
27752914|NCT02112994|80922489|FG002|Overall Study|Progressive Disease|1|||
27752915|NCT02112994|80922487|FG000|Overall Study|Pregnancy|0|||
27752916|NCT02112994|80922488|FG001|Overall Study|Pregnancy|1|||
27752917|NCT02112994|80922489|FG002|Overall Study|Pregnancy|1|||
27752918|NCT02112994|80922487|FG000|Overall Study|Liver Transplant|0|||
27752919|NCT02112994|80922488|FG001|Overall Study|Liver Transplant|1|||
27752920|NCT02112994|80922489|FG002|Overall Study|Liver Transplant|0|||
27752921|NCT02112994|80922487|FG000|Overall Study|Withdrawal by Subject|0|||
27752922|NCT02112994|80922488|FG001|Overall Study|Withdrawal by Subject|0|||
27752923|NCT02112994|80922489|FG002|Overall Study|Withdrawal by Subject|1|||
27752924|NCT01871896|80922490|FG000|Overall Study|Lost to Follow-up|1|||
27752925|NCT04146467|80922491|FG000|Overall Study|Adverse Event|0|||
27752926|NCT04146467|80922492|FG001|Overall Study|Adverse Event|1|||
27752927|NCT04146467|80922491|FG000|Overall Study|Lost to Follow-up|0|||
27752928|NCT04146467|80922492|FG001|Overall Study|Lost to Follow-up|2|||
27752929|NCT03011034|80922493|FG000|Overall Study|Adverse Event|1|||
27752930|NCT03011034|80922494|FG001|Overall Study|Adverse Event|0|||
27752931|NCT02128763|80922497|FG000|Overall Study|Death|1|||
27752932|NCT02128763|80922498|FG001|Overall Study|Death|0|||
27752933|NCT02128763|80922497|FG000|Overall Study|Lost to Follow-up|19|||
27752934|NCT02128763|80922498|FG001|Overall Study|Lost to Follow-up|16|||
27752935|NCT01201798|80922499|FG000|Overall Study|Adverse Event|2|||
27752936|NCT01201798|80922500|FG001|Overall Study|Adverse Event|0|||
27752937|NCT01201798|80922499|FG000|Overall Study|Lost to Follow-up|3|||
27752938|NCT01201798|80922500|FG001|Overall Study|Lost to Follow-up|5|||
27752939|NCT01201798|80922499|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
27752940|NCT01201798|80922500|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
27752941|NCT01201798|80922499|FG000|Overall Study|Noncompliance|1|||
27752942|NCT01201798|80922500|FG001|Overall Study|Noncompliance|0|||
27752943|NCT01201798|80922499|FG000|Overall Study|Protocol Violation|1|||
27752944|NCT01201798|80922500|FG001|Overall Study|Protocol Violation|1|||
27752945|NCT01201798|80922499|FG000|Overall Study|Treatment Failure|1|||
27752946|NCT01201798|80922500|FG001|Overall Study|Treatment Failure|8|||
27752947|NCT01842308|80922503|FG000|Overall Study|Withdrawal by Subject|0|||
27752948|NCT01842308|80922504|FG001|Overall Study|Withdrawal by Subject|0|||
27752949|NCT01842308|80922505|FG002|Overall Study|Withdrawal by Subject|0|||
27752950|NCT01842308|80922506|FG003|Overall Study|Withdrawal by Subject|0|||
27752951|NCT01842308|80922507|FG004|Overall Study|Withdrawal by Subject|1|||
27752952|NCT01725152|80922508|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
27752953|NCT01725152|80922509|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
27752954|NCT01725152|80922508|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
27752955|NCT01725152|80922509|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
27752956|NCT01725152|80922508|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
27752957|NCT01725152|80922509|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
27752958|NCT01725152|80922508|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
27752959|NCT01725152|80922509|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
27752960|NCT01952834|80922510|FG000|Overall Study|Adverse Event|1|||
27752961|NCT01005719|80922511|FG000|Period 1|Adverse Event|0|||
27752962|NCT01005719|80922512|FG001|Period 1|Adverse Event|0|||
27752963|NCT01005719|80922513|FG002|Period 1|Adverse Event|0|||
27752964|NCT01005719|80922514|FG003|Period 1|Adverse Event|1|||
27752965|NCT01005719|80922515|FG004|Period 1|Adverse Event|0|||
27752966|NCT01005719|80922516|FG005|Period 1|Adverse Event|0|||
27752967|NCT01005719|80922511|FG000|Period 1|Delay in completing study procedures|0|||
27752968|NCT01005719|80922512|FG001|Period 1|Delay in completing study procedures|0|||
27752969|NCT01005719|80922513|FG002|Period 1|Delay in completing study procedures|0|||
27752970|NCT01005719|80922514|FG003|Period 1|Delay in completing study procedures|0|||
27752971|NCT01005719|80922515|FG004|Period 1|Delay in completing study procedures|0|||
27752972|NCT01005719|80922516|FG005|Period 1|Delay in completing study procedures|1|||
27955708|NCT00421148|81672243|FG006|Overall Study|Protocol Violation|0|||
27955709|NCT00421148|81672244|FG007|Overall Study|Protocol Violation|0|||
27752973|NCT01005719|80922511|FG000|Period 2|Adverse Event|0|||
27752974|NCT01005719|80922512|FG001|Period 2|Adverse Event|0|||
27752975|NCT01005719|80922513|FG002|Period 2|Adverse Event|0|||
27752976|NCT01005719|80922514|FG003|Period 2|Adverse Event|0|||
27752977|NCT01005719|80922515|FG004|Period 2|Adverse Event|1|||
27752978|NCT01005719|80922516|FG005|Period 2|Adverse Event|1|||
27752979|NCT04191577|80922517|FG000|Overall Study|Withdrawal by Subject|2|||
27752980|NCT04191577|80922518|FG001|Overall Study|Withdrawal by Subject|2|||
27752981|NCT04191577|80922519|FG002|Overall Study|Withdrawal by Subject|1|||
27752982|NCT04191577|80922517|FG000|Overall Study|Physician Decision|1|||
27752983|NCT04191577|80922518|FG001|Overall Study|Physician Decision|1|||
27752984|NCT04191577|80922519|FG002|Overall Study|Physician Decision|0|||
27752985|NCT04191577|80922517|FG000|Overall Study|Adverse Event|0|||
27752986|NCT04191577|80922518|FG001|Overall Study|Adverse Event|0|||
27752987|NCT04191577|80922519|FG002|Overall Study|Adverse Event|1|||
27752988|NCT04191577|80922517|FG000|Overall Study|Death|0|||
27752989|NCT04191577|80922518|FG001|Overall Study|Death|0|||
27752990|NCT04191577|80922519|FG002|Overall Study|Death|1|||
27752991|NCT02618928|80922527|FG000|Overall Study|Failure to Return|28|||
27752992|NCT02618928|80922527|FG000|Overall Study|Insufficient Virological Response|1|||
27752993|NCT02618928|80922527|FG000|Overall Study|Withdrawal by Subject|2|||
27752994|NCT02618928|80922527|FG000|Overall Study|Death|3|||
27752995|NCT02618928|80922527|FG000|Overall Study|Other|11|||
27752996|NCT02618928|80922527|FG000|Overall Study|Missing|6|||
27752997|NCT02618928|80922527|FG000|Overall Study|Treatment Never Started|7|||
27752998|NCT03350750|80922529|FG000|Overall Study|Death|1|||
27752999|NCT03350750|80922530|FG001|Overall Study|Death|1|||
27753000|NCT03298412|80922531|FG000|Run-in Period|Other, Not Specified|1|||
27753001|NCT03298412|80922531|FG000|Run-in Period|Disease Progression|1|||
27753002|NCT03298412|80922531|FG000|Run-in Period|Ineligibility Determined|1|||
27955710|NCT00421148|81672245|FG008|Overall Study|Protocol Violation|0|||
27955711|NCT00421148|81672246|FG009|Overall Study|Protocol Violation|0|||
27753003|NCT03298412|80922531|FG000|Run-in Period|Decision by Sponsor|6|||
27955712|NCT00421148|81672247|FG010|Overall Study|Protocol Violation|0|||
27955713|NCT00421148|81672248|FG011|Overall Study|Protocol Violation|0|||
27955714|NCT00421148|81672249|FG012|Overall Study|Protocol Violation|0|||
27753004|NCT03314519|80922532|FG000|Overall Study|Protocol Violation|3|||
27753005|NCT03314519|80922533|FG001|Overall Study|Protocol Violation|2|||
27753006|NCT01763905|80922534|FG000|Overall Study|Withdrawal by Subject|1|||
27753007|NCT01763905|80922535|FG001|Overall Study|Withdrawal by Subject|1|||
27753008|NCT01763905|80922536|FG002|Overall Study|Withdrawal by Subject|0|||
27753009|NCT01763905|80922537|FG003|Overall Study|Withdrawal by Subject|1|||
27753010|NCT01763905|80922534|FG000|Overall Study|Decision by sponsor|5|||
27753011|NCT01763905|80922535|FG001|Overall Study|Decision by sponsor|0|||
27753012|NCT01763905|80922536|FG002|Overall Study|Decision by sponsor|8|||
27753013|NCT01763905|80922537|FG003|Overall Study|Decision by sponsor|0|||
27753014|NCT01763905|80922534|FG000|Overall Study|Lost to Follow-up|0|||
27753015|NCT01763905|80922535|FG001|Overall Study|Lost to Follow-up|0|||
27753016|NCT01763905|80922536|FG002|Overall Study|Lost to Follow-up|1|||
27753017|NCT01763905|80922537|FG003|Overall Study|Lost to Follow-up|0|||
27753018|NCT03855137|80922548|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
27753019|NCT03855137|80922549|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
27753020|NCT03855137|80922550|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
27753021|NCT03855137|80922548|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
27753022|NCT03855137|80922549|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
27753023|NCT03855137|80922550|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
27753024|NCT03855137|80922548|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
27753025|NCT03855137|80922549|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
27753026|NCT03855137|80922550|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
27753027|NCT03855137|80922548|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
27753028|NCT03855137|80922549|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
27753029|NCT03855137|80922550|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
27753030|NCT03855137|80922548|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
27753031|NCT03855137|80922549|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
27753032|NCT03855137|80922550|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
27753033|NCT03855137|80922548|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
27753034|NCT03855137|80922549|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
27753035|NCT03855137|80922550|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
27753036|NCT03855137|80922548|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
27753037|NCT03855137|80922549|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
27753038|NCT03855137|80922550|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
27753039|NCT03855137|80922548|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
27753040|NCT03855137|80922549|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
27753041|NCT03855137|80922550|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
27753042|NCT03855137|80922548|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
27753043|NCT03855137|80922549|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
27753044|NCT03855137|80922550|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
27753045|NCT03855137|80922548|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
27753046|NCT03855137|80922549|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
27753047|NCT03855137|80922550|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
27753048|NCT02491073|80922551|FG000|Overall Study|screen failure|1|||
27753049|NCT02491073|80922552|FG001|Overall Study|screen failure|0|||
27753050|NCT01603641|80922553|FG000|Overall Study|Did not Receive Treatment|3|||
27753051|NCT01603641|80922553|FG000|Overall Study|Adverse Event|1|||
27753052|NCT01603641|80922553|FG000|Overall Study|Lack of Efficacy|1|||
27753053|NCT01603641|80922553|FG000|Overall Study|Lost to Follow-up|6|||
27753054|NCT01603641|80922553|FG000|Overall Study|Personal Reasons|18|||
27753055|NCT01603641|80922553|FG000|Overall Study|Other Miscellaneous Reasons|6|||
27753056|NCT00617409|80922556|FG000|Overall Study|Withdrawal by Subject|4|||
27753057|NCT00617409|80922557|FG001|Overall Study|Withdrawal by Subject|1|||
27753058|NCT00617409|80922558|FG002|Overall Study|Withdrawal by Subject|2|||
27753059|NCT00617409|80922556|FG000|Overall Study|Adverse Event|0|||
27753060|NCT00617409|80922557|FG001|Overall Study|Adverse Event|2|||
27753061|NCT00617409|80922558|FG002|Overall Study|Adverse Event|3|||
27753062|NCT00617409|80922556|FG000|Overall Study|Disease Progression|8|||
27753063|NCT00617409|80922557|FG001|Overall Study|Disease Progression|8|||
27753064|NCT00617409|80922558|FG002|Overall Study|Disease Progression|18|||
27753065|NCT00617409|80922556|FG000|Overall Study|Death|3|||
27753066|NCT00617409|80922557|FG001|Overall Study|Death|5|||
27753067|NCT00617409|80922558|FG002|Overall Study|Death|4|||
27753068|NCT00617409|80922556|FG000|Overall Study|Alternative Therapy|1|||
27753069|NCT00617409|80922557|FG001|Overall Study|Alternative Therapy|2|||
27753070|NCT00617409|80922558|FG002|Overall Study|Alternative Therapy|0|||
27753071|NCT01361009|80922561|FG000|Overall Study|Protocol Violation|116|||
27753072|NCT02108600|80922562|FG000|Overall Study|Withdrawal by Subject|2|||
27753073|NCT02108600|80922563|FG001|Overall Study|Withdrawal by Subject|0|||
27753074|NCT02108600|80922562|FG000|Overall Study|Lost to Follow-up|1|||
27753075|NCT02108600|80922563|FG001|Overall Study|Lost to Follow-up|1|||
27753076|NCT04263142|80922564|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
27753077|NCT04263142|80922565|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
27753078|NCT04263142|80922566|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
27753079|NCT04263142|80922567|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
27753080|NCT04263142|80922568|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
27753081|NCT04263142|80922564|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
27753082|NCT04263142|80922565|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
27753083|NCT04263142|80922566|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
27753084|NCT04263142|80922567|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
27753085|NCT04263142|80922568|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
27753086|NCT00366548|80922569|FG000|Infant Series|Adverse Event|1|||
27753087|NCT00366548|80922570|FG001|Infant Series|Adverse Event|3|||
27753088|NCT00366548|80922569|FG000|Infant Series|Protocol Violation|0|||
27753089|NCT00366548|80922570|FG001|Infant Series|Protocol Violation|1|||
27753090|NCT00366548|80922569|FG000|Infant Series|Withdrawal by Subject|3|||
27753091|NCT00366548|80922570|FG001|Infant Series|Withdrawal by Subject|1|||
27753092|NCT00366548|80922569|FG000|After Infant Series|Withdrawal by Subject|3|||
27753093|NCT00366548|80922570|FG001|After Infant Series|Withdrawal by Subject|1|||
27753094|NCT00366548|80922569|FG000|After Infant Series|Adverse Event|2|||
27753095|NCT00366548|80922570|FG001|After Infant Series|Adverse Event|0|||
27753096|NCT00366548|80922569|FG000|After Infant Series|Lost to Follow-up|1|||
27753097|NCT00366548|80922570|FG001|After Infant Series|Lost to Follow-up|0|||
27753098|NCT02273050|80922571|FG000|Overall Study|Adverse Event|4|||
27753099|NCT02273050|80922572|FG001|Overall Study|Adverse Event|3|||
27753100|NCT02273050|80922573|FG002|Overall Study|Adverse Event|3|||
27753101|NCT02273050|80922571|FG000|Overall Study|Death|0|||
27753102|NCT02273050|80922572|FG001|Overall Study|Death|0|||
27753103|NCT02273050|80922573|FG002|Overall Study|Death|1|||
27753104|NCT02273050|80922571|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
27753105|NCT02273050|80922572|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
27753106|NCT02273050|80922573|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
27753107|NCT02273050|80922571|FG000|Overall Study|Lack of Efficacy|0|||
27753108|NCT02273050|80922572|FG001|Overall Study|Lack of Efficacy|1|||
27753109|NCT02273050|80922573|FG002|Overall Study|Lack of Efficacy|1|||
27753110|NCT02273050|80922571|FG000|Overall Study|Withdrawal by Subject|17|||
27753111|NCT02273050|80922572|FG001|Overall Study|Withdrawal by Subject|14|||
27753112|NCT02273050|80922573|FG002|Overall Study|Withdrawal by Subject|16|||
27753113|NCT02273050|80922571|FG000|Overall Study|Lost to Follow-up|0|||
27753114|NCT02273050|80922572|FG001|Overall Study|Lost to Follow-up|2|||
27753115|NCT02273050|80922573|FG002|Overall Study|Lost to Follow-up|3|||
27753116|NCT02273050|80922571|FG000|Overall Study|Protocol Violation|3|||
27753117|NCT02273050|80922572|FG001|Overall Study|Protocol Violation|1|||
27753118|NCT02273050|80922573|FG002|Overall Study|Protocol Violation|4|||
27753119|NCT00195260|80922577|FG000|Part 1: Dose Escalation|Adverse Event|0|||
27753120|NCT00195260|80922578|FG001|Part 1: Dose Escalation|Adverse Event|1|||
27753121|NCT00195260|80922579|FG002|Part 1: Dose Escalation|Adverse Event|0|||
27753122|NCT00195260|80922580|FG003|Part 1: Dose Escalation|Adverse Event|1|||
27753123|NCT00195260|80922581|FG004|Part 1: Dose Escalation|Adverse Event|1|||
27753124|NCT00195260|80922582|FG005|Part 1: Dose Escalation|Adverse Event|0|||
27753125|NCT00195260|80922583|FG006|Part 1: Dose Escalation|Adverse Event|3|||
27753126|NCT00195260|80922584|FG007|Part 1: Dose Escalation|Adverse Event|0|||
27753127|NCT00195260|80922585|FG008|Part 1: Dose Escalation|Adverse Event|0|||
27753128|NCT00195260|80922586|FG009|Part 1: Dose Escalation|Adverse Event|0|||
27753129|NCT00195260|80922587|FG010|Part 1: Dose Escalation|Adverse Event|0|||
27753130|NCT00195260|80922577|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753131|NCT00195260|80922578|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753132|NCT00195260|80922579|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753133|NCT00195260|80922580|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753134|NCT00195260|80922581|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
27753135|NCT00195260|80922582|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753136|NCT00195260|80922583|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753137|NCT00195260|80922584|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
27753138|NCT00195260|80922585|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27955715|NCT00421148|81672250|FG013|Overall Study|Protocol Violation|0|||
27753139|NCT00195260|80922586|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753140|NCT00195260|80922587|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27753141|NCT00195260|80922577|FG000|Part 1: Dose Escalation|Death|0|||
27753142|NCT00195260|80922578|FG001|Part 1: Dose Escalation|Death|0|||
27753143|NCT00195260|80922579|FG002|Part 1: Dose Escalation|Death|0|||
27955716|NCT00421148|81672251|FG014|Overall Study|Protocol Violation|0|||
27753144|NCT00195260|80922580|FG003|Part 1: Dose Escalation|Death|0|||
27753145|NCT00195260|80922581|FG004|Part 1: Dose Escalation|Death|0|||
27753146|NCT00195260|80922582|FG005|Part 1: Dose Escalation|Death|0|||
27753147|NCT00195260|80922583|FG006|Part 1: Dose Escalation|Death|0|||
27753148|NCT00195260|80922584|FG007|Part 1: Dose Escalation|Death|1|||
27753149|NCT00195260|80922585|FG008|Part 1: Dose Escalation|Death|0|||
27753150|NCT00195260|80922586|FG009|Part 1: Dose Escalation|Death|0|||
27753151|NCT00195260|80922587|FG010|Part 1: Dose Escalation|Death|0|||
27753152|NCT00195260|80922577|FG000|Part 1: Dose Escalation|Disease Progression|3|||
27753153|NCT00195260|80922578|FG001|Part 1: Dose Escalation|Disease Progression|2|||
27753154|NCT00195260|80922579|FG002|Part 1: Dose Escalation|Disease Progression|5|||
27753155|NCT00195260|80922580|FG003|Part 1: Dose Escalation|Disease Progression|6|||
27753156|NCT00195260|80922581|FG004|Part 1: Dose Escalation|Disease Progression|4|||
27753157|NCT00195260|80922582|FG005|Part 1: Dose Escalation|Disease Progression|6|||
27753158|NCT00195260|80922583|FG006|Part 1: Dose Escalation|Disease Progression|7|||
27753159|NCT00195260|80922584|FG007|Part 1: Dose Escalation|Disease Progression|4|||
27753160|NCT00195260|80922585|FG008|Part 1: Dose Escalation|Disease Progression|0|||
27753161|NCT00195260|80922586|FG009|Part 1: Dose Escalation|Disease Progression|0|||
27753162|NCT00195260|80922587|FG010|Part 1: Dose Escalation|Disease Progression|0|||
27753163|NCT00195260|80922577|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
27753164|NCT00195260|80922578|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
27753165|NCT00195260|80922579|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
27753166|NCT00195260|80922580|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753167|NCT00195260|80922581|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753168|NCT00195260|80922582|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
27753169|NCT00195260|80922583|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753170|NCT00195260|80922584|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753171|NCT00195260|80922585|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753172|NCT00195260|80922586|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753173|NCT00195260|80922587|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
27753174|NCT00195260|80922577|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753175|NCT00195260|80922578|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753176|NCT00195260|80922579|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753177|NCT00195260|80922580|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753178|NCT00195260|80922581|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753179|NCT00195260|80922582|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753180|NCT00195260|80922583|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753181|NCT00195260|80922584|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
27753182|NCT00195260|80922585|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
27753183|NCT00195260|80922586|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
27753184|NCT00195260|80922587|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
27753185|NCT00195260|80922577|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753186|NCT00195260|80922578|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753187|NCT00195260|80922579|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753188|NCT00195260|80922580|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753189|NCT00195260|80922581|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753190|NCT00195260|80922582|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753191|NCT00195260|80922583|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753192|NCT00195260|80922584|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
27753193|NCT00195260|80922585|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
27753194|NCT00195260|80922586|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
27753195|NCT00195260|80922587|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
27753196|NCT00195260|80922577|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753197|NCT00195260|80922578|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753198|NCT00195260|80922579|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753199|NCT00195260|80922580|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753200|NCT00195260|80922581|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753201|NCT00195260|80922582|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753202|NCT00195260|80922583|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753203|NCT00195260|80922584|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
27753204|NCT00195260|80922585|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
27753205|NCT00195260|80922586|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
27753206|NCT00195260|80922587|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
27753207|NCT00195260|80922577|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753208|NCT00195260|80922578|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753209|NCT00195260|80922579|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753210|NCT00195260|80922580|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753211|NCT00195260|80922581|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753212|NCT00195260|80922582|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753213|NCT00195260|80922583|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753214|NCT00195260|80922584|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
27753215|NCT00195260|80922585|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
27753216|NCT00195260|80922586|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
27753217|NCT00195260|80922587|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
27753218|NCT01346371|80922588|FG000|Overall Study|Lost to Follow-up|2|||
27753219|NCT01346371|80922589|FG001|Overall Study|Lost to Follow-up|0|||
27753220|NCT03799718|80922590|FG000|Overall Study|Adverse Event|2|||
27753221|NCT01687413|80922594|FG000|Overall Study|Withdrawal by Subject|0|||
27753222|NCT01687413|80922595|FG001|Overall Study|Withdrawal by Subject|2|||
27753223|NCT01687413|80922594|FG000|Overall Study|Not eligible|0|||
27753224|NCT01687413|80922595|FG001|Overall Study|Not eligible|2|||
27753225|NCT01687413|80922594|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
27753226|NCT01687413|80922595|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
27753227|NCT02322892|80922598|FG000|Overall Study|Surgery cancelled|1|||
27753228|NCT02322892|80922599|FG001|Overall Study|Surgery cancelled|2|||
27753229|NCT02322892|80922598|FG000|Overall Study|Met exclusion criteria|0|||
27753230|NCT02322892|80922599|FG001|Overall Study|Met exclusion criteria|1|||
27753231|NCT02322892|80922598|FG000|Overall Study|Protocol Violation|1|||
27753232|NCT02322892|80922599|FG001|Overall Study|Protocol Violation|0|||
27753233|NCT02078713|80922600|FG000|Overall Study|Lost to Follow-up|49|||
27753234|NCT02078713|80922601|FG001|Overall Study|Lost to Follow-up|55|||
27753235|NCT02078713|80922602|FG002|Overall Study|Lost to Follow-up|0|||
27753236|NCT02078713|80922603|FG003|Overall Study|Lost to Follow-up|0|||
27753237|NCT02078713|80922600|FG000|Overall Study|Pregnant at baseline|3|||
27753238|NCT02078713|80922601|FG001|Overall Study|Pregnant at baseline|5|||
27753239|NCT02078713|80922602|FG002|Overall Study|Pregnant at baseline|0|||
27753240|NCT02078713|80922603|FG003|Overall Study|Pregnant at baseline|0|||
27753241|NCT02078713|80922600|FG000|Overall Study|Enrolled twice|0|||
27753242|NCT02078713|80922601|FG001|Overall Study|Enrolled twice|1|||
27753243|NCT02078713|80922602|FG002|Overall Study|Enrolled twice|0|||
27753244|NCT02078713|80922603|FG003|Overall Study|Enrolled twice|0|||
27753245|NCT01079962|80922611|FG000|Overall Study|Adverse Event|2|||
27753246|NCT01079962|80922612|FG001|Overall Study|Adverse Event|2|||
27753247|NCT01079962|80922611|FG000|Overall Study|Withdrawal by Subject|5|||
27753248|NCT01079962|80922612|FG001|Overall Study|Withdrawal by Subject|7|||
27753249|NCT01079962|80922611|FG000|Overall Study|Protocol Violation|2|||
27753250|NCT01079962|80922612|FG001|Overall Study|Protocol Violation|2|||
27753251|NCT01079962|80922611|FG000|Overall Study|No blood pressure (BP) control|3|||
27753252|NCT01079962|80922612|FG001|Overall Study|No blood pressure (BP) control|0|||
27753253|NCT01079962|80922611|FG000|Overall Study|Inclusion/exclusion criteria|1|||
27753254|NCT01079962|80922612|FG001|Overall Study|Inclusion/exclusion criteria|3|||
27753255|NCT01079962|80922611|FG000|Overall Study|Participant not returning for next visit|1|||
27753256|NCT01079962|80922612|FG001|Overall Study|Participant not returning for next visit|0|||
27753257|NCT01079962|80922611|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
27753258|NCT01079962|80922612|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
27753259|NCT02683525|80925803|FG000|Overall Study|Lost to Follow-up|1|||
27753260|NCT02683525|80925803|FG000|Overall Study|Physician Decision|1|||
27753261|NCT02683525|80925803|FG000|Overall Study|Disease Progression|6|||
27753262|NCT02653976|80925804|FG000|Overall Study|Withdrawal by Subject|5|||
27753263|NCT02653976|80925804|FG000|Overall Study|Death|4|||
27753264|NCT01822691|80925816|FG000|Overall Study|Withdrawal by Subject|2|||
27753265|NCT00798694|80925817|FG000|Overall Study|Lost to Follow-up|1|||
27753266|NCT00798694|80925818|FG001|Overall Study|Lost to Follow-up|1|||
27753267|NCT00798694|80925817|FG000|Overall Study|Physician Decision|1|||
27753268|NCT00798694|80925818|FG001|Overall Study|Physician Decision|0|||
27753269|NCT02509598|80925821|FG000|Overall Study|Withdrawal by Subject|1|||
27753270|NCT05674344|80925822|FG000|Overall Study|Screen Fail|21|||
27753271|NCT05674344|80925822|FG000|Overall Study|Incomplete study procedures|3|||
27753272|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
27753273|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
27753274|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
27753275|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
27753276|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
27753277|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
27753278|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
27753279|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
27753280|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
27753281|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
27753282|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
27753283|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
27753284|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
27753285|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
27753286|NCT00848549|80925823|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
27753287|NCT00848549|80925824|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
27753288|NCT00848549|80925823|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
27753289|NCT00848549|80925824|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
27753290|NCT00848549|80925823|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
27753291|NCT00848549|80925824|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
27753292|NCT00848549|80925823|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
27753293|NCT00848549|80925824|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
27753294|NCT00848549|80925823|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
27753295|NCT00848549|80925824|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
27753296|NCT00848549|80925823|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
27753297|NCT00848549|80925824|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
27753298|NCT00848549|80925823|FG000|E2090-E044-314 (Extension Study)|Other|5|||
27753299|NCT00848549|80925824|FG001|E2090-E044-314 (Extension Study)|Other|6|||
27753300|NCT00028002|80925830|FG000|Overall Study|Withdrawal by Subject|3|||
27753301|NCT00028002|80925830|FG000|Overall Study|Ineligible|8|||
27753302|NCT03176277|80925831|FG000|Part A Dose Escalation Study|Adverse Event|1|||
27753303|NCT03176277|80925832|FG001|Part A Dose Escalation Study|Adverse Event|0|||
27753304|NCT03176277|80925833|FG002|Part A Dose Escalation Study|Adverse Event|1|||
27753305|NCT03176277|80925834|FG003|Part A Dose Escalation Study|Adverse Event|0|||
27753306|NCT03176277|80925831|FG000|Part A Dose Escalation Study|Physician Decision|1|||
27753307|NCT03176277|80925832|FG001|Part A Dose Escalation Study|Physician Decision|1|||
27753308|NCT03176277|80925833|FG002|Part A Dose Escalation Study|Physician Decision|2|||
27753309|NCT03176277|80925834|FG003|Part A Dose Escalation Study|Physician Decision|0|||
27753310|NCT03176277|80925831|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
27753311|NCT03176277|80925832|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
27753312|NCT03176277|80925833|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
27753313|NCT03176277|80925834|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
27753314|NCT03176277|80925831|FG000|Part A Dose Escalation Study|Progressive disease|3|||
27753315|NCT03176277|80925832|FG001|Part A Dose Escalation Study|Progressive disease|1|||
27753316|NCT03176277|80925833|FG002|Part A Dose Escalation Study|Progressive disease|3|||
27753317|NCT03176277|80925834|FG003|Part A Dose Escalation Study|Progressive disease|0|||
27753318|NCT00903032|80925837|FG000|Overall Study|Withdrawal by Subject|5|||
27753319|NCT00903032|80925838|FG001|Overall Study|Withdrawal by Subject|3|||
27753320|NCT00903032|80925837|FG000|Overall Study|Lost to Follow-up|2|||
27753321|NCT00903032|80925838|FG001|Overall Study|Lost to Follow-up|2|||
27753322|NCT00364845|80925839|FG000|Overall Study|Adverse Event|1|||
27753323|NCT00364845|80925840|FG001|Overall Study|Adverse Event|0|||
27753324|NCT00364845|80925839|FG000|Overall Study|Withdrawal by Subject|2|||
27753325|NCT00364845|80925840|FG001|Overall Study|Withdrawal by Subject|1|||
27753326|NCT00364845|80925839|FG000|Overall Study|Physician Decision|8|||
27753327|NCT00364845|80925840|FG001|Overall Study|Physician Decision|8|||
27753328|NCT00364845|80925839|FG000|Overall Study|Lost to Follow-up|0|||
27753329|NCT00364845|80925840|FG001|Overall Study|Lost to Follow-up|1|||
27753330|NCT00364845|80925839|FG000|Overall Study|Death|0|||
27753331|NCT00364845|80925840|FG001|Overall Study|Death|1|||
27753332|NCT03009539|80925841|FG000|Overall Study|Lost to Follow-up|132|||
27753333|NCT03009539|80925842|FG001|Overall Study|Lost to Follow-up|113|||
27753334|NCT03009539|80925843|FG002|Overall Study|Lost to Follow-up|132|||
27753335|NCT03009539|80925844|FG003|Overall Study|Lost to Follow-up|113|||
27753336|NCT02330549|80925845|FG000|Overall Study|Adverse Event|1|||
27753337|NCT02330549|80925846|FG001|Overall Study|Adverse Event|0|||
27753338|NCT02330549|80925845|FG000|Overall Study|Subject withdrew consent|2|||
27753339|NCT02330549|80925846|FG001|Overall Study|Subject withdrew consent|1|||
27753340|NCT02330549|80925845|FG000|Overall Study|Failure to meet randomization criteria|1|||
27753341|NCT02330549|80925846|FG001|Overall Study|Failure to meet randomization criteria|0|||
27753342|NCT03509207|80925854|FG000|Overall Study|Death|2|||
27753343|NCT02149836|80925855|FG000|Overall Study|Withdrawal by Subject|1|||
27753344|NCT01718509|80925859|FG000|Overall Study|Lost to Follow-up|18|||
27753345|NCT01718509|80925860|FG001|Overall Study|Lost to Follow-up|15|||
27753346|NCT01718509|80925859|FG000|Overall Study|Withdrawal by Subject|7|||
27753347|NCT01718509|80925860|FG001|Overall Study|Withdrawal by Subject|13|||
27753348|NCT01718509|80925859|FG000|Overall Study|Adverse Event|5|||
27753349|NCT01718509|80925860|FG001|Overall Study|Adverse Event|7|||
27753350|NCT01718509|80925859|FG000|Overall Study|Other|13|||
27753351|NCT01718509|80925860|FG001|Overall Study|Other|11|||
27753352|NCT01718509|80925859|FG000|Overall Study|Protocol Violation|4|||
27955717|NCT00421148|81672252|FG015|Overall Study|Protocol Violation|0|||
27955718|NCT00421148|81672253|FG016|Overall Study|Protocol Violation|0|||
27955719|NCT00421148|81672254|FG017|Overall Study|Protocol Violation|0|||
27955720|NCT00421148|81672255|FG018|Overall Study|Protocol Violation|1|||
27955721|NCT00421148|81672256|FG019|Overall Study|Protocol Violation|0|||
27955722|NCT00533429|81672257|FG000|Overall Study|Adverse Event|3|||
27955723|NCT00533429|81672258|FG001|Overall Study|Adverse Event|1|||
27955724|NCT00533429|81672257|FG000|Overall Study|Death|1|||
27955725|NCT00533429|81672258|FG001|Overall Study|Death|0|||
27955726|NCT00533429|81672257|FG000|Overall Study|Withdrawal by Subject|2|||
27955727|NCT00533429|81672258|FG001|Overall Study|Withdrawal by Subject|0|||
27955728|NCT00533429|81672257|FG000|Overall Study|Progressive Disease|12|||
27955729|NCT00533429|81672258|FG001|Overall Study|Progressive Disease|13|||
27955730|NCT00533429|81672257|FG000|Overall Study|Symptomatic deterioration|1|||
27955731|NCT00533429|81672258|FG001|Overall Study|Symptomatic deterioration|2|||
27955732|NCT04422431|81672259|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
27955733|NCT04422431|81672259|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
27955734|NCT04422431|81672259|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
27955735|NCT04422431|81672259|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
27955736|NCT04422431|81672259|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
27955737|NCT04422431|81672259|FG000|Extension Period (48 Weeks)|Other than specified|2|||
27955738|NCT01757665|81672262|FG000|Overall Study|Still on Study - Visit Completed|240|||
27955739|NCT01757665|81672263|FG001|Overall Study|Still on Study - Visit Completed|30|||
27955740|NCT01757665|81672262|FG000|Overall Study|Still on Study - Visit Pending|398|||
27955741|NCT01757665|81672263|FG001|Overall Study|Still on Study - Visit Pending|40|||
27955742|NCT01757665|81672262|FG000|Overall Study|Still on Study - Missed Visit|14|||
27955743|NCT01757665|81672263|FG001|Overall Study|Still on Study - Missed Visit|1|||
27955744|NCT01757665|81672262|FG000|Overall Study|Death|25|||
27955745|NCT01757665|81672263|FG001|Overall Study|Death|8|||
27955746|NCT01757665|81672262|FG000|Overall Study|Explant|1|||
27955747|NCT01757665|81672263|FG001|Overall Study|Explant|2|||
27955748|NCT01757665|81672262|FG000|Overall Study|Withdrawal by Subject|10|||
27955749|NCT01757665|81672263|FG001|Overall Study|Withdrawal by Subject|0|||
27955750|NCT01757665|81672262|FG000|Overall Study|Lost to Follow-up|1|||
27955751|NCT01757665|81672263|FG001|Overall Study|Lost to Follow-up|1|||
27955752|NCT01757665|81672262|FG000|Overall Study|Not Implanted with Device|5|||
27753353|NCT01718509|80925860|FG001|Overall Study|Protocol Violation|2|||
27753354|NCT01718509|80925859|FG000|Overall Study|Lack of Efficacy|1|||
27753355|NCT01718509|80925860|FG001|Overall Study|Lack of Efficacy|0|||
27753356|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
27753357|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753358|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753359|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753360|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753361|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753362|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753363|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753364|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
27753365|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
27753366|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753367|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753368|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753369|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753370|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753371|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753372|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753373|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
27753374|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
27753375|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753376|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753377|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753378|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753379|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753380|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753381|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753382|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
27753383|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
27753384|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753385|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753386|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753387|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753388|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753389|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753390|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753391|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
27753392|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
27753393|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753394|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753395|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753396|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27955753|NCT01757665|81672263|FG001|Overall Study|Not Implanted with Device|1|||
27955754|NCT03012334|81672264|FG000|Period 1|Withdrawal by Subject|0|||
27753397|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753398|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753399|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753400|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
27753401|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
27753402|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753403|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753404|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753405|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753406|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753407|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753408|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753409|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
27753410|NCT02175771|80925861|FG000|Run-In Period (Pre-assignment)|Other|8|||
27753411|NCT02175771|80925862|FG001|Run-In Period (Pre-assignment)|Other|0|||
27753412|NCT02175771|80925863|FG002|Run-In Period (Pre-assignment)|Other|0|||
27753413|NCT02175771|80925864|FG003|Run-In Period (Pre-assignment)|Other|0|||
27753414|NCT02175771|80925865|FG004|Run-In Period (Pre-assignment)|Other|0|||
27753415|NCT02175771|80925866|FG005|Run-In Period (Pre-assignment)|Other|0|||
27753416|NCT02175771|80925867|FG006|Run-In Period (Pre-assignment)|Other|0|||
27753417|NCT02175771|80925868|FG007|Run-In Period (Pre-assignment)|Other|0|||
27753418|NCT02175771|80925869|FG008|Run-In Period (Pre-assignment)|Other|0|||
27753419|NCT02175771|80925861|FG000|Treatment Period|Adverse Event|0|||
27753420|NCT02175771|80925862|FG001|Treatment Period|Adverse Event|2|||
27753421|NCT02175771|80925863|FG002|Treatment Period|Adverse Event|1|||
27753422|NCT02175771|80925864|FG003|Treatment Period|Adverse Event|1|||
27753423|NCT02175771|80925865|FG004|Treatment Period|Adverse Event|1|||
27753424|NCT02175771|80925866|FG005|Treatment Period|Adverse Event|3|||
27753425|NCT02175771|80925867|FG006|Treatment Period|Adverse Event|2|||
27753426|NCT02175771|80925868|FG007|Treatment Period|Adverse Event|0|||
27753427|NCT02175771|80925869|FG008|Treatment Period|Adverse Event|1|||
27753428|NCT02175771|80925861|FG000|Treatment Period|Withdrawal by Subject|0|||
27753429|NCT02175771|80925862|FG001|Treatment Period|Withdrawal by Subject|9|||
27753430|NCT02175771|80925863|FG002|Treatment Period|Withdrawal by Subject|3|||
27753431|NCT02175771|80925864|FG003|Treatment Period|Withdrawal by Subject|6|||
27753432|NCT02175771|80925865|FG004|Treatment Period|Withdrawal by Subject|2|||
27753433|NCT02175771|80925866|FG005|Treatment Period|Withdrawal by Subject|4|||
27753434|NCT02175771|80925867|FG006|Treatment Period|Withdrawal by Subject|2|||
27753435|NCT02175771|80925868|FG007|Treatment Period|Withdrawal by Subject|9|||
27753436|NCT02175771|80925869|FG008|Treatment Period|Withdrawal by Subject|2|||
27753437|NCT02175771|80925861|FG000|Treatment Period|Noncompliance|0|||
27753438|NCT02175771|80925862|FG001|Treatment Period|Noncompliance|1|||
27753439|NCT02175771|80925863|FG002|Treatment Period|Noncompliance|2|||
27753440|NCT02175771|80925864|FG003|Treatment Period|Noncompliance|0|||
27753441|NCT02175771|80925865|FG004|Treatment Period|Noncompliance|0|||
27753442|NCT02175771|80925866|FG005|Treatment Period|Noncompliance|0|||
27753443|NCT02175771|80925867|FG006|Treatment Period|Noncompliance|0|||
27753444|NCT02175771|80925868|FG007|Treatment Period|Noncompliance|0|||
27753445|NCT02175771|80925869|FG008|Treatment Period|Noncompliance|1|||
27753446|NCT02175771|80925861|FG000|Treatment Period|Protocol Violation|0|||
27753447|NCT02175771|80925862|FG001|Treatment Period|Protocol Violation|0|||
27753448|NCT02175771|80925863|FG002|Treatment Period|Protocol Violation|0|||
27753449|NCT02175771|80925864|FG003|Treatment Period|Protocol Violation|0|||
27753450|NCT02175771|80925865|FG004|Treatment Period|Protocol Violation|0|||
27753451|NCT02175771|80925866|FG005|Treatment Period|Protocol Violation|0|||
27955755|NCT03012334|81672265|FG001|Period 1|Withdrawal by Subject|0|||
27955756|NCT03012334|81672266|FG002|Period 1|Withdrawal by Subject|0|||
27955757|NCT03012334|81672267|FG003|Period 1|Withdrawal by Subject|0|||
27955758|NCT03012334|81672268|FG004|Period 1|Withdrawal by Subject|0|||
27955759|NCT03012334|81672269|FG005|Period 1|Withdrawal by Subject|0|||
27955760|NCT03012334|81672270|FG006|Period 1|Withdrawal by Subject|0|||
27955761|NCT03012334|81672271|FG007|Period 1|Withdrawal by Subject|0|||
27955762|NCT03012334|81672272|FG008|Period 1|Withdrawal by Subject|0|||
27955763|NCT03012334|81672273|FG009|Period 1|Withdrawal by Subject|1|||
27955764|NCT03012334|81672264|FG000|Period 2|Withdrawal by Subject|0|||
27955765|NCT03012334|81672265|FG001|Period 2|Withdrawal by Subject|1|||
27955766|NCT03012334|81672266|FG002|Period 2|Withdrawal by Subject|0|||
27955767|NCT03012334|81672267|FG003|Period 2|Withdrawal by Subject|0|||
27955768|NCT03012334|81672268|FG004|Period 2|Withdrawal by Subject|0|||
27955769|NCT03012334|81672269|FG005|Period 2|Withdrawal by Subject|0|||
27955770|NCT03012334|81672270|FG006|Period 2|Withdrawal by Subject|0|||
27955771|NCT03012334|81672271|FG007|Period 2|Withdrawal by Subject|0|||
27955772|NCT03012334|81672272|FG008|Period 2|Withdrawal by Subject|0|||
27955773|NCT03012334|81672273|FG009|Period 2|Withdrawal by Subject|0|||
27955774|NCT03012334|81672264|FG000|Period 2|Protocol Violation|0|||
27955775|NCT03012334|81672265|FG001|Period 2|Protocol Violation|0|||
27955776|NCT03012334|81672266|FG002|Period 2|Protocol Violation|1|||
27955777|NCT03012334|81672267|FG003|Period 2|Protocol Violation|0|||
27955778|NCT03012334|81672268|FG004|Period 2|Protocol Violation|0|||
27955779|NCT03012334|81672269|FG005|Period 2|Protocol Violation|0|||
27955780|NCT03012334|81672270|FG006|Period 2|Protocol Violation|0|||
27955781|NCT03012334|81672271|FG007|Period 2|Protocol Violation|1|||
27955782|NCT03012334|81672272|FG008|Period 2|Protocol Violation|0|||
27955783|NCT03012334|81672273|FG009|Period 2|Protocol Violation|0|||
27955784|NCT03012334|81672264|FG000|Period 4|Non-Compliance|0|||
27955785|NCT03012334|81672265|FG001|Period 4|Non-Compliance|0|||
27955786|NCT03012334|81672266|FG002|Period 4|Non-Compliance|0|||
27955787|NCT03012334|81672267|FG003|Period 4|Non-Compliance|0|||
27955788|NCT03012334|81672268|FG004|Period 4|Non-Compliance|0|||
27955789|NCT03012334|81672269|FG005|Period 4|Non-Compliance|0|||
27955790|NCT03012334|81672270|FG006|Period 4|Non-Compliance|1|||
27955791|NCT03012334|81672271|FG007|Period 4|Non-Compliance|0|||
27955792|NCT03012334|81672272|FG008|Period 4|Non-Compliance|0|||
27955793|NCT03012334|81672273|FG009|Period 4|Non-Compliance|0|||
27955794|NCT03012334|81672264|FG000|Period 4|Adverse Event|0|||
27955795|NCT03012334|81672265|FG001|Period 4|Adverse Event|0|||
27955796|NCT03012334|81672266|FG002|Period 4|Adverse Event|0|||
27955797|NCT03012334|81672267|FG003|Period 4|Adverse Event|0|||
27955798|NCT03012334|81672268|FG004|Period 4|Adverse Event|0|||
27955799|NCT03012334|81672269|FG005|Period 4|Adverse Event|0|||
27955800|NCT03012334|81672270|FG006|Period 4|Adverse Event|0|||
27955801|NCT03012334|81672271|FG007|Period 4|Adverse Event|0|||
27955802|NCT03012334|81672272|FG008|Period 4|Adverse Event|1|||
27955803|NCT03012334|81672273|FG009|Period 4|Adverse Event|0|||
27955804|NCT02071771|81672275|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
27955805|NCT02071771|81672276|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
27955806|NCT02071771|81672275|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
27955807|NCT02071771|81672276|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
27955808|NCT00806260|81672277|FG000|Period 1 (1 Day)|Adverse Event|0|||
27955809|NCT00806260|81672278|FG001|Period 1 (1 Day)|Adverse Event|0|||
27955810|NCT00806260|81672279|FG002|Period 1 (1 Day)|Adverse Event|0|||
27955811|NCT00806260|81672280|FG003|Period 1 (1 Day)|Adverse Event|0|||
27955812|NCT00806260|81672281|FG004|Period 1 (1 Day)|Adverse Event|3|||
27955813|NCT00806260|81672282|FG005|Period 1 (1 Day)|Adverse Event|0|||
27955814|NCT00806260|81672277|FG000|Period 2|Adverse Event|0|||
27955815|NCT00806260|81672278|FG001|Period 2|Adverse Event|0|||
27955816|NCT00806260|81672279|FG002|Period 2|Adverse Event|0|||
27955817|NCT00806260|81672280|FG003|Period 2|Adverse Event|1|||
27955818|NCT00806260|81672281|FG004|Period 2|Adverse Event|0|||
27955819|NCT00806260|81672282|FG005|Period 2|Adverse Event|0|||
27955820|NCT00806260|81672277|FG000|Period 2|Protocol Violation|1|||
27955821|NCT00806260|81672278|FG001|Period 2|Protocol Violation|0|||
27955822|NCT00806260|81672279|FG002|Period 2|Protocol Violation|1|||
27955823|NCT00806260|81672280|FG003|Period 2|Protocol Violation|0|||
27955824|NCT00806260|81672281|FG004|Period 2|Protocol Violation|0|||
27955825|NCT00806260|81672282|FG005|Period 2|Protocol Violation|0|||
27955826|NCT00806260|81672277|FG000|Period 2|Need to take concomitant medication|1|||
27955827|NCT00806260|81672278|FG001|Period 2|Need to take concomitant medication|0|||
27955828|NCT00806260|81672279|FG002|Period 2|Need to take concomitant medication|0|||
27955829|NCT00806260|81672280|FG003|Period 2|Need to take concomitant medication|0|||
27955830|NCT00806260|81672281|FG004|Period 2|Need to take concomitant medication|0|||
27955831|NCT00806260|81672282|FG005|Period 2|Need to take concomitant medication|0|||
27955832|NCT00806260|81672277|FG000|Period 2|sponsor request|0|||
27955833|NCT00806260|81672278|FG001|Period 2|sponsor request|0|||
27955834|NCT00806260|81672279|FG002|Period 2|sponsor request|1|||
27955835|NCT00806260|81672280|FG003|Period 2|sponsor request|1|||
27955836|NCT00806260|81672281|FG004|Period 2|sponsor request|0|||
27955837|NCT00806260|81672282|FG005|Period 2|sponsor request|0|||
27955838|NCT00806260|81672277|FG000|Period 3|Protocol Violation|0|||
27955839|NCT00806260|81672278|FG001|Period 3|Protocol Violation|1|||
27955840|NCT00806260|81672279|FG002|Period 3|Protocol Violation|1|||
27955841|NCT00806260|81672280|FG003|Period 3|Protocol Violation|0|||
27955842|NCT00806260|81672281|FG004|Period 3|Protocol Violation|0|||
27955843|NCT00806260|81672282|FG005|Period 3|Protocol Violation|0|||
27955844|NCT00806260|81672277|FG000|Period 3|Pregnancy|1|||
27955845|NCT00806260|81672278|FG001|Period 3|Pregnancy|0|||
27955846|NCT00806260|81672279|FG002|Period 3|Pregnancy|0|||
27955847|NCT00806260|81672280|FG003|Period 3|Pregnancy|0|||
27955848|NCT00806260|81672281|FG004|Period 3|Pregnancy|0|||
27955849|NCT00806260|81672282|FG005|Period 3|Pregnancy|0|||
27955850|NCT02015039|81672283|FG000|Overall Study|Not eligible|0|||
27955851|NCT02015039|81672284|FG001|Overall Study|Not eligible|1|||
27955852|NCT01904721|81672286|FG000|Overall Study|Other Reasons|0|||
27955853|NCT01904721|81672287|FG001|Overall Study|Other Reasons|0|||
27955854|NCT01904721|81672288|FG002|Overall Study|Other Reasons|1|||
27955855|NCT01904721|81672289|FG003|Overall Study|Other Reasons|1|||
27955856|NCT01904721|81672290|FG004|Overall Study|Other Reasons|2|||
27955857|NCT01904721|81672291|FG005|Overall Study|Other Reasons|2|||
27955858|NCT01904721|81672292|FG006|Overall Study|Other Reasons|2|||
27955859|NCT01904721|81672286|FG000|Overall Study|Personal Reasons|0|||
27955860|NCT01904721|81672287|FG001|Overall Study|Personal Reasons|0|||
27955861|NCT01904721|81672288|FG002|Overall Study|Personal Reasons|0|||
27955862|NCT01904721|81672289|FG003|Overall Study|Personal Reasons|0|||
27955863|NCT01904721|81672290|FG004|Overall Study|Personal Reasons|2|||
27955864|NCT01904721|81672291|FG005|Overall Study|Personal Reasons|3|||
27955865|NCT01904721|81672292|FG006|Overall Study|Personal Reasons|3|||
27955866|NCT01904721|81672286|FG000|Overall Study|Lost to Follow-up|0|||
27955867|NCT01904721|81672287|FG001|Overall Study|Lost to Follow-up|0|||
27955868|NCT01904721|81672288|FG002|Overall Study|Lost to Follow-up|0|||
27955869|NCT01904721|81672289|FG003|Overall Study|Lost to Follow-up|0|||
27955870|NCT01904721|81672290|FG004|Overall Study|Lost to Follow-up|1|||
27955871|NCT01904721|81672291|FG005|Overall Study|Lost to Follow-up|3|||
27955872|NCT01904721|81672292|FG006|Overall Study|Lost to Follow-up|1|||
27955873|NCT01904721|81672286|FG000|Overall Study|Lack of Efficacy|0|||
27955874|NCT01904721|81672287|FG001|Overall Study|Lack of Efficacy|0|||
27955875|NCT01904721|81672288|FG002|Overall Study|Lack of Efficacy|0|||
27955876|NCT01904721|81672289|FG003|Overall Study|Lack of Efficacy|0|||
27955877|NCT01904721|81672290|FG004|Overall Study|Lack of Efficacy|0|||
27955878|NCT01904721|81672291|FG005|Overall Study|Lack of Efficacy|0|||
27955879|NCT01904721|81672292|FG006|Overall Study|Lack of Efficacy|1|||
27955880|NCT01904721|81672286|FG000|Overall Study|Adverse Event|0|||
27955881|NCT01904721|81672287|FG001|Overall Study|Adverse Event|0|||
27955882|NCT01904721|81672288|FG002|Overall Study|Adverse Event|0|||
27955883|NCT01904721|81672289|FG003|Overall Study|Adverse Event|0|||
27955884|NCT01904721|81672290|FG004|Overall Study|Adverse Event|3|||
27955885|NCT01904721|81672291|FG005|Overall Study|Adverse Event|1|||
27955886|NCT01904721|81672292|FG006|Overall Study|Adverse Event|0|||
27955887|NCT03289143|81672293|FG000|Overall Study|Caregiver Unavailability|1|||
27955888|NCT03289143|81672294|FG001|Overall Study|Caregiver Unavailability|1|||
27955889|NCT03289143|81672295|FG002|Overall Study|Caregiver Unavailability|0|||
27955890|NCT03289143|81672296|FG003|Overall Study|Caregiver Unavailability|0|||
27955891|NCT03289143|81672293|FG000|Overall Study|Research Department Closure|0|||
27955892|NCT03289143|81672294|FG001|Overall Study|Research Department Closure|0|||
27955893|NCT03289143|81672295|FG002|Overall Study|Research Department Closure|1|||
27955894|NCT03289143|81672296|FG003|Overall Study|Research Department Closure|0|||
27955895|NCT03289143|81672293|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
27955896|NCT03289143|81672294|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
27955897|NCT03289143|81672295|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
27955898|NCT03289143|81672296|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
27955899|NCT03289143|81672293|FG000|Overall Study|Medical Monitor Decision|1|||
27955900|NCT03289143|81672294|FG001|Overall Study|Medical Monitor Decision|0|||
27955901|NCT03289143|81672295|FG002|Overall Study|Medical Monitor Decision|0|||
27955902|NCT03289143|81672296|FG003|Overall Study|Medical Monitor Decision|0|||
27955903|NCT03289143|81672293|FG000|Overall Study|Participant Non-Compliance|0|||
27955904|NCT03289143|81672294|FG001|Overall Study|Participant Non-Compliance|0|||
27955905|NCT03289143|81672295|FG002|Overall Study|Participant Non-Compliance|1|||
27955906|NCT03289143|81672296|FG003|Overall Study|Participant Non-Compliance|0|||
27955907|NCT03289143|81672293|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
27955908|NCT03289143|81672294|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
27955909|NCT03289143|81672295|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
27955910|NCT03289143|81672296|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
27955911|NCT03289143|81672293|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
27955912|NCT03289143|81672294|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
27955913|NCT03289143|81672295|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
27955914|NCT03289143|81672296|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
27955915|NCT03289143|81672293|FG000|Overall Study|Caregiver Passed Away|1|||
27955916|NCT03289143|81672294|FG001|Overall Study|Caregiver Passed Away|0|||
27955917|NCT03289143|81672295|FG002|Overall Study|Caregiver Passed Away|0|||
27955918|NCT03289143|81672296|FG003|Overall Study|Caregiver Passed Away|0|||
27955919|NCT03289143|81672293|FG000|Overall Study|Physician Decision|0|||
27955920|NCT03289143|81672294|FG001|Overall Study|Physician Decision|2|||
27955921|NCT03289143|81672295|FG002|Overall Study|Physician Decision|2|||
27955922|NCT03289143|81672296|FG003|Overall Study|Physician Decision|2|||
27955923|NCT03289143|81672293|FG000|Overall Study|Protocol Deviation|2|||
27955924|NCT03289143|81672294|FG001|Overall Study|Protocol Deviation|1|||
27955925|NCT03289143|81672295|FG002|Overall Study|Protocol Deviation|3|||
27551533|NCT01482884|80207482|FG000|Overall Study|Withdrawal by Subject|8|||
27551534|NCT01482884|80207483|FG001|Overall Study|Withdrawal by Subject|13|||
27551535|NCT00331682|80207484|FG000|Overall Study|Adverse Event|1|||
27551536|NCT01867424|80207485|FG000|Overall Study|Patient noncompliance|2|||
27551537|NCT01867424|80207486|FG001|Overall Study|Patient noncompliance|1|||
27551538|NCT04342897|80207487|FG000|Overall Study|Death|7|||
27551539|NCT04342897|80207488|FG001|Overall Study|Death|4|||
27551540|NCT04342897|80207487|FG000|Overall Study|Lost to Follow-up|6|||
27551541|NCT04342897|80207488|FG001|Overall Study|Lost to Follow-up|6|||
27955926|NCT03289143|81672296|FG003|Overall Study|Protocol Deviation|1|||
27955927|NCT03289143|81672293|FG000|Overall Study|Study Terminated By Sponsor|101|||
27955928|NCT03289143|81672294|FG001|Overall Study|Study Terminated By Sponsor|75|||
27955929|NCT03289143|81672295|FG002|Overall Study|Study Terminated By Sponsor|100|||
27955930|NCT03289143|81672296|FG003|Overall Study|Study Terminated By Sponsor|69|||
27955931|NCT03289143|81672293|FG000|Overall Study|Withdrawal by Subject|14|||
27955932|NCT03289143|81672294|FG001|Overall Study|Withdrawal by Subject|6|||
27955933|NCT03289143|81672295|FG002|Overall Study|Withdrawal by Subject|14|||
27955934|NCT03289143|81672296|FG003|Overall Study|Withdrawal by Subject|12|||
27955935|NCT03289143|81672293|FG000|Overall Study|Adverse Event|10|||
27955936|NCT03289143|81672294|FG001|Overall Study|Adverse Event|7|||
27955937|NCT03289143|81672295|FG002|Overall Study|Adverse Event|6|||
27955938|NCT03289143|81672296|FG003|Overall Study|Adverse Event|5|||
27955939|NCT03289143|81672293|FG000|Overall Study|Death|2|||
27955940|NCT03289143|81672294|FG001|Overall Study|Death|0|||
27955941|NCT03289143|81672295|FG002|Overall Study|Death|2|||
27955942|NCT03289143|81672296|FG003|Overall Study|Death|1|||
27955943|NCT03289143|81672293|FG000|Overall Study|Lost to Follow-up|2|||
27955944|NCT03289143|81672294|FG001|Overall Study|Lost to Follow-up|1|||
27955945|NCT03289143|81672295|FG002|Overall Study|Lost to Follow-up|1|||
27955946|NCT03289143|81672296|FG003|Overall Study|Lost to Follow-up|0|||
27955947|NCT03289143|81672293|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
27955948|NCT03289143|81672294|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
27955949|NCT03289143|81672295|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
27955950|NCT03289143|81672296|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
27955951|NCT03289143|81672293|FG000|Overall Study|Withdrawal by Caregiver|0|||
27955952|NCT03289143|81672294|FG001|Overall Study|Withdrawal by Caregiver|1|||
27955953|NCT03289143|81672295|FG002|Overall Study|Withdrawal by Caregiver|0|||
27955954|NCT03289143|81672296|FG003|Overall Study|Withdrawal by Caregiver|0|||
27955955|NCT03289143|81672293|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
27955956|NCT03289143|81672294|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
27955957|NCT03289143|81672295|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
27955958|NCT03289143|81672296|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
27955959|NCT03289143|81672293|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
27955960|NCT03289143|81672294|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
27955961|NCT03289143|81672295|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
27955962|NCT03289143|81672296|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
27955963|NCT00200967|81672300|FG000|First Treatment Period|Withdrawal by Subject|5|||
27955964|NCT00200967|81672301|FG001|First Treatment Period|Withdrawal by Subject|1|||
27955965|NCT00200967|81672300|FG000|First Treatment Period|Pregnancy|1|||
27955966|NCT00200967|81672301|FG001|First Treatment Period|Pregnancy|0|||
27955967|NCT00200967|81672300|FG000|Wash-out Period|Lost to Follow-up|0|||
27955968|NCT00200967|81672301|FG001|Wash-out Period|Lost to Follow-up|1|||
27955969|NCT00200967|81672300|FG000|Second Treatment Period|Withdrawal by Subject|1|||
27955970|NCT00200967|81672301|FG001|Second Treatment Period|Withdrawal by Subject|2|||
27955971|NCT00200967|81672300|FG000|Run-out Period|Lost to Follow-up|1|||
27955972|NCT00200967|81672301|FG001|Run-out Period|Lost to Follow-up|0|||
27955973|NCT02639247|81672302|FG000|Overall Study|Lost to Follow-up|2|||
27955974|NCT02639247|81672303|FG001|Overall Study|Lost to Follow-up|1|||
27955975|NCT02639247|81672302|FG000|Overall Study|Death|2|||
27955976|NCT02639247|81672303|FG001|Overall Study|Death|0|||
27955977|NCT02639247|81672302|FG000|Overall Study|Withdrew Consent|0|||
27955978|NCT02639247|81672303|FG001|Overall Study|Withdrew Consent|1|||
27955979|NCT02639247|81672302|FG000|Overall Study|Protocol Violation|1|||
27955980|NCT02639247|81672303|FG001|Overall Study|Protocol Violation|0|||
27955981|NCT04865289|81672306|FG000|Overall Study|Participant ongoing in study|47|||
27955982|NCT04865289|81672307|FG001|Overall Study|Participant ongoing in study|35|||
27955983|NCT04865289|81672306|FG000|Overall Study|Death|27|||
27955984|NCT04865289|81672307|FG001|Overall Study|Death|21|||
27955985|NCT00295646|81672308|FG000|Overall Study|Protocol Violation|18|||
27955986|NCT00295646|81672309|FG001|Overall Study|Protocol Violation|20|||
27955987|NCT00295646|81672310|FG002|Overall Study|Protocol Violation|20|||
27955988|NCT00295646|81672311|FG003|Overall Study|Protocol Violation|18|||
27551542|NCT04342897|80207487|FG000|Overall Study|Withdrawal by Subject|1|||
27955989|NCT00295646|81672308|FG000|Overall Study|Withdrawal by Subject|8|||
27955990|NCT00295646|81672309|FG001|Overall Study|Withdrawal by Subject|9|||
27955991|NCT00295646|81672310|FG002|Overall Study|Withdrawal by Subject|11|||
27955992|NCT00295646|81672311|FG003|Overall Study|Withdrawal by Subject|14|||
27955993|NCT00295646|81672308|FG000|Overall Study|Lost to Follow-up|0|||
27955994|NCT00295646|81672309|FG001|Overall Study|Lost to Follow-up|5|||
27955995|NCT00295646|81672310|FG002|Overall Study|Lost to Follow-up|1|||
27955996|NCT00295646|81672311|FG003|Overall Study|Lost to Follow-up|5|||
27955997|NCT00295646|81672308|FG000|Overall Study|Death|9|||
27955998|NCT00295646|81672309|FG001|Overall Study|Death|7|||
27955999|NCT00295646|81672310|FG002|Overall Study|Death|18|||
27956000|NCT00295646|81672311|FG003|Overall Study|Death|8|||
27956001|NCT00186628|81672312|FG000|Overall Study|Death|2|||
27956002|NCT00186628|81672312|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
27956003|NCT01824290|81672313|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
27956004|NCT01824290|81672314|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
27956005|NCT01824290|81672315|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
27956006|NCT01824290|81672316|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
27956007|NCT01824290|81672313|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
27956008|NCT01824290|81672314|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
27956009|NCT01824290|81672315|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
27956010|NCT01824290|81672316|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
27956011|NCT01824290|81672313|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
27956012|NCT01824290|81672314|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
27956013|NCT01824290|81672315|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
27956014|NCT01824290|81672316|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
27956015|NCT01824290|81672313|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
27956016|NCT01824290|81672314|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
27956017|NCT01824290|81672315|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
27956018|NCT01824290|81672316|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
27956019|NCT01824290|81672313|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
27956020|NCT01824290|81672314|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
27956021|NCT01824290|81672315|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
27956022|NCT01824290|81672316|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
27956023|NCT01824290|81672313|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
27956024|NCT01824290|81672314|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
27956025|NCT01824290|81672315|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
27956026|NCT01824290|81672316|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
27956027|NCT00670930|81672318|FG000|Overall Study|Adminstrative Problem|0|||
27956028|NCT00670930|81672319|FG001|Overall Study|Adminstrative Problem|1|||
27956029|NCT00670930|81672318|FG000|Overall Study|Lost to Follow-up|1|||
27956030|NCT00670930|81672319|FG001|Overall Study|Lost to Follow-up|0|||
27956031|NCT00107276|81672320|FG000|Overall Study|Progression|46|||
27956032|NCT00107276|81672320|FG000|Overall Study|Adverse Event|6|||
27956033|NCT00107276|81672320|FG000|Overall Study|M.D. decision|2|||
27956034|NCT00107276|81672320|FG000|Overall Study|Patient refusal|1|||
27956035|NCT00107276|81672320|FG000|Overall Study|Death|1|||
27956036|NCT00107276|81672320|FG000|Overall Study|Ineligible|16|||
27956037|NCT04245709|81672321|FG000|Overall Study|Adverse Event|13|||
27956038|NCT04245709|81672321|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
27956039|NCT02078752|81672327|FG000|Overall Study|Death|0|||
27956040|NCT02078752|81672328|FG001|Overall Study|Death|3|||
27956041|NCT02078752|81672329|FG002|Overall Study|Death|0|||
27956042|NCT02078752|81672330|FG003|Overall Study|Death|0|||
27956043|NCT02078752|81672331|FG004|Overall Study|Death|0|||
27956044|NCT02078752|81672332|FG005|Overall Study|Death|1|||
27956045|NCT02078752|81672333|FG006|Overall Study|Death|0|||
27956046|NCT02078752|81672334|FG007|Overall Study|Death|1|||
27956047|NCT02078752|81672335|FG008|Overall Study|Death|0|||
27956048|NCT02078752|81672336|FG009|Overall Study|Death|4|||
27956049|NCT02078752|81672327|FG000|Overall Study|Lost to Follow-up|1|||
27956050|NCT02078752|81672328|FG001|Overall Study|Lost to Follow-up|0|||
27956051|NCT02078752|81672329|FG002|Overall Study|Lost to Follow-up|0|||
27956052|NCT02078752|81672330|FG003|Overall Study|Lost to Follow-up|1|||
27956053|NCT02078752|81672331|FG004|Overall Study|Lost to Follow-up|0|||
27956054|NCT02078752|81672332|FG005|Overall Study|Lost to Follow-up|0|||
27956055|NCT02078752|81672333|FG006|Overall Study|Lost to Follow-up|0|||
27956056|NCT02078752|81672334|FG007|Overall Study|Lost to Follow-up|0|||
27956057|NCT02078752|81672335|FG008|Overall Study|Lost to Follow-up|0|||
27956058|NCT02078752|81672336|FG009|Overall Study|Lost to Follow-up|0|||
27956059|NCT02078752|81672327|FG000|Overall Study|Withdrawal by Subject|1|||
27956060|NCT02078752|81672328|FG001|Overall Study|Withdrawal by Subject|1|||
27956061|NCT02078752|81672329|FG002|Overall Study|Withdrawal by Subject|1|||
27956062|NCT02078752|81672330|FG003|Overall Study|Withdrawal by Subject|1|||
27956063|NCT02078752|81672331|FG004|Overall Study|Withdrawal by Subject|0|||
27956064|NCT02078752|81672332|FG005|Overall Study|Withdrawal by Subject|3|||
27956065|NCT02078752|81672333|FG006|Overall Study|Withdrawal by Subject|2|||
27956066|NCT02078752|81672334|FG007|Overall Study|Withdrawal by Subject|1|||
27956067|NCT02078752|81672335|FG008|Overall Study|Withdrawal by Subject|0|||
27956068|NCT02078752|81672336|FG009|Overall Study|Withdrawal by Subject|1|||
27956069|NCT02078752|81672327|FG000|Overall Study|Other|0|||
27956070|NCT02078752|81672328|FG001|Overall Study|Other|3|||
27956071|NCT02078752|81672329|FG002|Overall Study|Other|0|||
27956072|NCT02078752|81672330|FG003|Overall Study|Other|0|||
27956073|NCT02078752|81672331|FG004|Overall Study|Other|1|||
27956074|NCT02078752|81672332|FG005|Overall Study|Other|0|||
27956075|NCT02078752|81672333|FG006|Overall Study|Other|0|||
27956076|NCT02078752|81672334|FG007|Overall Study|Other|1|||
27956077|NCT02078752|81672335|FG008|Overall Study|Other|0|||
27956078|NCT02078752|81672336|FG009|Overall Study|Other|0|||
27956079|NCT02078752|81672327|FG000|Overall Study|Study terminated by sponsor|0|||
27956080|NCT02078752|81672328|FG001|Overall Study|Study terminated by sponsor|0|||
27956081|NCT02078752|81672329|FG002|Overall Study|Study terminated by sponsor|0|||
27956082|NCT02078752|81672330|FG003|Overall Study|Study terminated by sponsor|0|||
27956083|NCT02078752|81672331|FG004|Overall Study|Study terminated by sponsor|0|||
27956084|NCT02078752|81672332|FG005|Overall Study|Study terminated by sponsor|0|||
27956085|NCT02078752|81672333|FG006|Overall Study|Study terminated by sponsor|0|||
27956086|NCT02078752|81672334|FG007|Overall Study|Study terminated by sponsor|0|||
27956087|NCT02078752|81672335|FG008|Overall Study|Study terminated by sponsor|0|||
27956088|NCT02078752|81672336|FG009|Overall Study|Study terminated by sponsor|5|||
27956089|NCT03894891|81672337|FG000|Overall Study|Withdrawal by Subject|1|||
27956090|NCT03894891|81672337|FG000|Overall Study|Completed protocol treatment per protocol|5|||
27956091|NCT00181844|81672338|FG000|Signed Consent|Withdrawal by Subject|5|||
27956092|NCT00181844|81672338|FG000|Signed Consent|Did not meet entrance criteria|7|||
27956093|NCT00181844|81672338|FG000|Exposed to Study Medication|Adverse Event|10|||
27956094|NCT00181844|81672338|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
27956095|NCT00181844|81672338|FG000|Exposed to Study Medication|Non-compliance|2|||
27956096|NCT00181844|81672338|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
27956097|NCT00181844|81672338|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
27956098|NCT02473471|81672339|FG000|Overall Study|poor oral hygiene|2|||
27956099|NCT02473471|81672339|FG000|Overall Study|Lost to Follow-up|1|||
27956100|NCT00003645|81672340|FG000|Overall Study|Death|4|||
27956101|NCT00003645|81672341|FG001|Overall Study|Death|1|||
27956102|NCT00003645|81672340|FG000|Overall Study|Lost to Follow-up|7|||
27956103|NCT00003645|81672341|FG001|Overall Study|Lost to Follow-up|8|||
27956104|NCT00003645|81672340|FG000|Overall Study|Withdrawal by Subject|1|||
27956105|NCT00003645|81672341|FG001|Overall Study|Withdrawal by Subject|3|||
27956106|NCT02954458|81672343|FG000|Overall Study|Adverse Event|0|||
27956107|NCT02954458|81672344|FG001|Overall Study|Adverse Event|0|||
27956108|NCT02954458|81672345|FG002|Overall Study|Adverse Event|0|||
27956109|NCT02954458|81672346|FG003|Overall Study|Adverse Event|1|||
27956110|NCT02954458|81672343|FG000|Overall Study|Withdrawal by Subject|0|||
27956111|NCT02954458|81672344|FG001|Overall Study|Withdrawal by Subject|0|||
27956112|NCT02954458|81672345|FG002|Overall Study|Withdrawal by Subject|0|||
27956113|NCT02954458|81672346|FG003|Overall Study|Withdrawal by Subject|1|||
27956114|NCT02954458|81672343|FG000|Overall Study|Physician Decision|0|||
27956115|NCT02954458|81672344|FG001|Overall Study|Physician Decision|0|||
27956116|NCT02954458|81672345|FG002|Overall Study|Physician Decision|1|||
27956117|NCT02954458|81672346|FG003|Overall Study|Physician Decision|1|||
27956118|NCT02954458|81672343|FG000|Overall Study|Lost to Follow-up|1|||
27956119|NCT02954458|81672344|FG001|Overall Study|Lost to Follow-up|0|||
27956120|NCT02954458|81672345|FG002|Overall Study|Lost to Follow-up|0|||
27956121|NCT02954458|81672346|FG003|Overall Study|Lost to Follow-up|1|||
27956122|NCT02954458|81672343|FG000|Overall Study|Death|0|||
27956123|NCT02954458|81672344|FG001|Overall Study|Death|0|||
27956124|NCT02954458|81672345|FG002|Overall Study|Death|0|||
27956125|NCT02954458|81672346|FG003|Overall Study|Death|1|||
27956126|NCT02954458|81672343|FG000|Overall Study|Other|0|||
27956127|NCT02954458|81672344|FG001|Overall Study|Other|0|||
27956128|NCT02954458|81672345|FG002|Overall Study|Other|0|||
27956129|NCT02954458|81672346|FG003|Overall Study|Other|7|||
27956130|NCT03606486|81672348|FG000|Overall Study|Unable to collect sample|5|||
27956131|NCT03594110|81672351|FG000|Overall Study|Participant concerned about study treatment|23|||
27956132|NCT03594110|81672352|FG001|Overall Study|Participant concerned about study treatment|28|||
27956133|NCT03594110|81672351|FG000|Overall Study|Doctor advice|38|||
27956134|NCT03594110|81672352|FG001|Overall Study|Doctor advice|40|||
27956135|NCT03594110|81672351|FG000|Overall Study|Participants' wish|89|||
27956136|NCT03594110|81672352|FG001|Overall Study|Participants' wish|68|||
27956137|NCT03594110|81672351|FG000|Overall Study|Adverse Event|119|||
27956138|NCT03594110|81672352|FG001|Overall Study|Adverse Event|116|||
27956139|NCT03594110|81672351|FG000|Overall Study|Study drug stopped, reason missing|337|||
27956140|NCT03594110|81672352|FG001|Overall Study|Study drug stopped, reason missing|295|||
27956141|NCT03594110|81672351|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
27956142|NCT03594110|81672352|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
27956143|NCT03594110|81672351|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
27956144|NCT03594110|81672352|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
27956145|NCT03594110|81672351|FG000|Overall Study|Contraindicated drug started|32|||
27956146|NCT03594110|81672352|FG001|Overall Study|Contraindicated drug started|18|||
27956147|NCT03594110|81672351|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
27956148|NCT03594110|81672352|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
27956149|NCT03594110|81672351|FG000|Overall Study|Death|129|||
27956150|NCT03594110|81672352|FG001|Overall Study|Death|120|||
27956151|NCT01541865|81672353|FG000|Overall Study|Lost to Follow-up|11|||
27956152|NCT01541865|81672353|FG000|Overall Study|Withdrawal by Subject|9|||
27956153|NCT01541865|81672353|FG000|Overall Study|Adverse Event|1|||
27956154|NCT01541865|81672353|FG000|Overall Study|Protocol Violation|1|||
27956155|NCT01639469|81672354|FG000|Overall Study|Death|4|||
27956156|NCT01639469|81672355|FG001|Overall Study|Death|2|||
27956157|NCT01639469|81672354|FG000|Overall Study|Lost to Follow-up|1|||
27956158|NCT01639469|81672355|FG001|Overall Study|Lost to Follow-up|1|||
27956159|NCT00444925|81672356|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
27956160|NCT00444925|81672357|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
27956161|NCT00444925|81672358|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
27956162|NCT00444925|81672356|FG000|Double-blind Treatment Period|Death|2|||
27956163|NCT00444925|81672357|FG001|Double-blind Treatment Period|Death|0|||
27956164|NCT00444925|81672358|FG002|Double-blind Treatment Period|Death|0|||
27956165|NCT00444925|81672356|FG000|Double-blind Treatment Period|Adverse Event|6|||
27956166|NCT00444925|81672357|FG001|Double-blind Treatment Period|Adverse Event|28|||
27956167|NCT00444925|81672358|FG002|Double-blind Treatment Period|Adverse Event|44|||
27956168|NCT00444925|81672356|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
27956169|NCT00444925|81672357|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
27956170|NCT00444925|81672358|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
27956171|NCT00444925|81672356|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
27956172|NCT00444925|81672357|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
27956173|NCT00444925|81672358|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
27956174|NCT00444925|81672356|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
27956175|NCT00444925|81672357|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
27956176|NCT00444925|81672358|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
27956177|NCT00444925|81672356|FG000|Double-blind Treatment Period|Other|7|||
27956178|NCT00444925|81672357|FG001|Double-blind Treatment Period|Other|7|||
27956179|NCT00444925|81672358|FG002|Double-blind Treatment Period|Other|12|||
27956180|NCT00517699|81672359|FG000|Overall Study|Withdrawal by Subject|1|||
27956181|NCT00517699|81672359|FG000|Overall Study|Lack of Efficacy|1|||
27956182|NCT00517699|81672359|FG000|Overall Study|Administrative error|1|||
27956183|NCT00517699|81672359|FG000|Overall Study|Study terminated by Sponsor|2|||
27956184|NCT00524121|81672360|FG000|Overall Study|Disease progression|6|||
27956185|NCT00524121|81672360|FG000|Overall Study|Adverse Event|4|||
27956186|NCT00524121|81672360|FG000|Overall Study|Patient refused|2|||
27956187|NCT00524121|81672360|FG000|Overall Study|Other|1|||
27956188|NCT00524121|81672360|FG000|Overall Study|Death|1|||
27956189|NCT00524121|81672360|FG000|Overall Study|Not treated (became ineligible)|4|||
27956190|NCT00524121|81672360|FG000|Overall Study|Not treated (changed mind)|1|||
27956191|NCT00142792|81672361|FG000|Overall Study|Death|0|||
27956192|NCT00142792|81672362|FG001|Overall Study|Death|0|||
27956193|NCT00142792|81672363|FG002|Overall Study|Death|1|||
27956194|NCT00142792|81672361|FG000|Overall Study|Withdrawal by Subject|3|||
27956195|NCT00142792|81672362|FG001|Overall Study|Withdrawal by Subject|2|||
27956196|NCT00142792|81672363|FG002|Overall Study|Withdrawal by Subject|3|||
27956197|NCT00142792|81672361|FG000|Overall Study|Lost to Follow-up|8|||
27956198|NCT00142792|81672362|FG001|Overall Study|Lost to Follow-up|11|||
27956199|NCT00142792|81672363|FG002|Overall Study|Lost to Follow-up|7|||
27956200|NCT00142792|81672361|FG000|Overall Study|No category|1|||
27956201|NCT00142792|81672362|FG001|Overall Study|No category|2|||
27956202|NCT00142792|81672363|FG002|Overall Study|No category|1|||
27956203|NCT01490918|81672364|FG000|Overall Study|Lost to Follow-up|2|||
27956204|NCT01490918|81672365|FG001|Overall Study|Lost to Follow-up|1|||
27956205|NCT01490918|81672366|FG002|Overall Study|Lost to Follow-up|0|||
27956206|NCT01490918|81672364|FG000|Overall Study|Withdrawal by Subject|7|||
27956207|NCT01490918|81672365|FG001|Overall Study|Withdrawal by Subject|8|||
27956208|NCT01490918|81672366|FG002|Overall Study|Withdrawal by Subject|3|||
27956209|NCT01490918|81672364|FG000|Overall Study|Adverse Event|0|||
27956210|NCT01490918|81672365|FG001|Overall Study|Adverse Event|0|||
27956211|NCT01490918|81672366|FG002|Overall Study|Adverse Event|1|||
27956212|NCT01490918|81672364|FG000|Overall Study|other cause|4|||
27956213|NCT01490918|81672365|FG001|Overall Study|other cause|5|||
27956214|NCT01490918|81672366|FG002|Overall Study|other cause|8|||
27956215|NCT00800982|81672368|FG000|Overall Study|Lost to Follow-up|1|||
27956216|NCT00800982|81672369|FG001|Overall Study|Lost to Follow-up|2|||
27956217|NCT00800982|81672368|FG000|Overall Study|Withdrawal by Subject|0|||
27956218|NCT00800982|81672369|FG001|Overall Study|Withdrawal by Subject|1|||
27956219|NCT00800982|81672368|FG000|Overall Study|Patient moved out of state|1|||
27956220|NCT00800982|81672369|FG001|Overall Study|Patient moved out of state|0|||
27956221|NCT00087698|81672373|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
27956222|NCT00087698|81672373|FG000|Overall Study|Death from Other Causes|3|||
27956223|NCT00087698|81672373|FG000|Overall Study|Adverse Event|4|||
27956224|NCT00087698|81672373|FG000|Overall Study|Withdrawal by Subject|4|||
27956225|NCT00087698|81672373|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
27956226|NCT00087698|81672373|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
27956227|NCT00087698|81672373|FG000|Overall Study|Clinical Relapse|1|||
27956228|NCT00087698|81672373|FG000|Overall Study|Death from Study Disease|2|||
27956229|NCT00087698|81672373|FG000|Overall Study|Death from Study Drug Toxicity|2|||
27956230|NCT00087698|81672373|FG000|Overall Study|Protocol Violation|1|||
27956231|NCT00374595|81672374|FG000|Overall Study|Death|23|||
27956232|NCT00374595|81672374|FG000|Overall Study|Withdrawal by Subject|39|||
27956233|NCT00374595|81672374|FG000|Overall Study|Lost to Follow-up|3|||
27956234|NCT00374595|81672374|FG000|Overall Study|too much time commitment|1|||
27956235|NCT00374595|81672374|FG000|Overall Study|transfer care to other clinical site|1|||
27956236|NCT00374595|81672374|FG000|Overall Study|relocation|3|||
27956237|NCT02271529|81672375|FG000|Overall Study|Withdrawal by Subject|1|||
27956238|NCT01334554|81672376|FG000|Overall Study|Adverse Event|4|||
27956239|NCT01334554|81672377|FG001|Overall Study|Adverse Event|2|||
27956240|NCT03089047|81672378|FG000|Overall Study|Lost to Follow-up|1|||
27956241|NCT03089047|81672379|FG001|Overall Study|Lost to Follow-up|0|||
27956242|NCT02146131|81672382|FG000|Overall Study|Physician Decision|61|||
27956243|NCT02146131|81672383|FG001|Overall Study|Physician Decision|56|||
27956244|NCT03273907|81672384|FG000|Overall Study|Death|1|||
27956245|NCT03273907|81672384|FG000|Overall Study|Lost to Follow-up|4|||
27956246|NCT03273907|81672384|FG000|Overall Study|Withdrawal by Subject|2|||
27956247|NCT03273907|81672384|FG000|Overall Study|COVID 19|2|||
27956248|NCT00443118|81672385|FG000|Overall Study|unknown primary outcome|3|||
27956249|NCT00443118|81672386|FG001|Overall Study|unknown primary outcome|1|||
27956250|NCT00443118|81672387|FG002|Overall Study|unknown primary outcome|0|||
27956251|NCT00443118|81672385|FG000|Overall Study|Withdrawal by Subject|1|||
27956252|NCT00443118|81672386|FG001|Overall Study|Withdrawal by Subject|0|||
27956253|NCT00443118|81672387|FG002|Overall Study|Withdrawal by Subject|0|||
27956254|NCT04419467|81672388|FG000|Overall Study|Not treated with IP|0|||
27956255|NCT04419467|81672389|FG001|Overall Study|Not treated with IP|0|||
27956256|NCT04419467|81672390|FG002|Overall Study|Not treated with IP|2|||
27956257|NCT04419467|81672388|FG000|Overall Study|Adverse Event|0|||
27956258|NCT04419467|81672389|FG001|Overall Study|Adverse Event|2|||
27956259|NCT04419467|81672390|FG002|Overall Study|Adverse Event|0|||
27956260|NCT04419467|81672388|FG000|Overall Study|Death|1|||
27956261|NCT04419467|81672389|FG001|Overall Study|Death|0|||
27956262|NCT04419467|81672390|FG002|Overall Study|Death|0|||
27956263|NCT04419467|81672388|FG000|Overall Study|Lost to Follow-up|0|||
27956264|NCT04419467|81672389|FG001|Overall Study|Lost to Follow-up|1|||
27956265|NCT04419467|81672390|FG002|Overall Study|Lost to Follow-up|2|||
27956266|NCT04419467|81672388|FG000|Overall Study|Withdrawal by Subject|0|||
27956267|NCT04419467|81672389|FG001|Overall Study|Withdrawal by Subject|0|||
27956268|NCT04419467|81672390|FG002|Overall Study|Withdrawal by Subject|4|||
27956269|NCT04419467|81672388|FG000|Overall Study|Pandemic related|0|||
27956270|NCT04419467|81672389|FG001|Overall Study|Pandemic related|0|||
27956271|NCT04419467|81672390|FG002|Overall Study|Pandemic related|1|||
27956272|NCT04419467|81672388|FG000|Overall Study|Reason not known|1|||
27956273|NCT04419467|81672389|FG001|Overall Study|Reason not known|0|||
27956274|NCT04419467|81672390|FG002|Overall Study|Reason not known|0|||
27956275|NCT03465722|81672391|FG000|Overall Study|Withdrawal by Subject|21|||
27956276|NCT03465722|81672392|FG001|Overall Study|Withdrawal by Subject|14|||
27956277|NCT03465722|81672391|FG000|Overall Study|Death|89|||
27956278|NCT03465722|81672392|FG001|Overall Study|Death|87|||
27956279|NCT03465722|81672391|FG000|Overall Study|Lost to Follow-up|5|||
27956280|NCT03465722|81672392|FG001|Overall Study|Lost to Follow-up|3|||
27956281|NCT03465722|81672391|FG000|Overall Study|Administrative/Other|33|||
27956282|NCT03465722|81672392|FG001|Overall Study|Administrative/Other|32|||
27956283|NCT03465722|81672391|FG000|Overall Study|Not treated|1|||
27956284|NCT03465722|81672392|FG001|Overall Study|Not treated|2|||
27956285|NCT03465722|81672391|FG000|Overall Study|Sponsor decision|91|||
27956286|NCT03465722|81672392|FG001|Overall Study|Sponsor decision|98|||
27956287|NCT01070979|81672393|FG000|Overall Study|Adverse Event|2|||
27956288|NCT01070979|81672394|FG001|Overall Study|Adverse Event|3|||
27956289|NCT01070979|81672395|FG002|Overall Study|Adverse Event|3|||
27956290|NCT01070979|81672393|FG000|Overall Study|Lost to Follow-up|2|||
27956291|NCT01070979|81672394|FG001|Overall Study|Lost to Follow-up|1|||
27956292|NCT01070979|81672395|FG002|Overall Study|Lost to Follow-up|1|||
27956293|NCT01070979|81672393|FG000|Overall Study|Protocol Violation|0|||
27956294|NCT01070979|81672394|FG001|Overall Study|Protocol Violation|2|||
27956295|NCT01070979|81672395|FG002|Overall Study|Protocol Violation|6|||
27956296|NCT01070979|81672393|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
27956297|NCT01070979|81672394|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
27956298|NCT01070979|81672395|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
27956299|NCT01070979|81672393|FG000|Overall Study|Withdrawal by Subject|3|||
27956300|NCT01070979|81672394|FG001|Overall Study|Withdrawal by Subject|1|||
27956301|NCT01070979|81672395|FG002|Overall Study|Withdrawal by Subject|1|||
27956302|NCT01070979|81672393|FG000|Overall Study|No study drug taken|0|||
27956303|NCT01070979|81672394|FG001|Overall Study|No study drug taken|1|||
27956304|NCT01070979|81672395|FG002|Overall Study|No study drug taken|0|||
27956305|NCT02311881|81672396|FG000|Overall Study|Did not meet the study criteria|2|||
27956306|NCT02311881|81672397|FG001|Overall Study|Did not meet the study criteria|2|||
27956307|NCT02311881|81672398|FG002|Overall Study|Did not meet the study criteria|0|||
27956308|NCT02311881|81672396|FG000|Overall Study|Adverse Event|7|||
27956309|NCT02311881|81672397|FG001|Overall Study|Adverse Event|15|||
27956310|NCT02311881|81672398|FG002|Overall Study|Adverse Event|8|||
27956311|NCT02311881|81672396|FG000|Overall Study|Lost to Follow-up|3|||
27956312|NCT02311881|81672397|FG001|Overall Study|Lost to Follow-up|3|||
27956313|NCT02311881|81672398|FG002|Overall Study|Lost to Follow-up|2|||
27956314|NCT02311881|81672396|FG000|Overall Study|Protocol Violation|1|||
27956315|NCT02311881|81672397|FG001|Overall Study|Protocol Violation|2|||
27956316|NCT02311881|81672398|FG002|Overall Study|Protocol Violation|3|||
27956317|NCT02311881|81672396|FG000|Overall Study|Withdrawal of consent|14|||
27956318|NCT02311881|81672397|FG001|Overall Study|Withdrawal of consent|16|||
27956319|NCT02311881|81672398|FG002|Overall Study|Withdrawal of consent|17|||
27956320|NCT02311881|81672396|FG000|Overall Study|Other|0|||
27956321|NCT02311881|81672397|FG001|Overall Study|Other|0|||
27956322|NCT02311881|81672398|FG002|Overall Study|Other|1|||
27956323|NCT02311881|81672396|FG000|Overall Study|Lack of Efficacy|1|||
27956324|NCT02311881|81672397|FG001|Overall Study|Lack of Efficacy|2|||
27956325|NCT02311881|81672398|FG002|Overall Study|Lack of Efficacy|0|||
27956326|NCT02311881|81672396|FG000|Overall Study|Subject has border line pregnancy test|1|||
27956327|NCT02311881|81672397|FG001|Overall Study|Subject has border line pregnancy test|0|||
27956328|NCT02311881|81672398|FG002|Overall Study|Subject has border line pregnancy test|0|||
27956329|NCT02311881|81672396|FG000|Overall Study|Withdrawal by Subject|3|||
27956330|NCT02311881|81672397|FG001|Overall Study|Withdrawal by Subject|1|||
27956331|NCT02311881|81672398|FG002|Overall Study|Withdrawal by Subject|4|||
27956332|NCT02311881|81672396|FG000|Overall Study|Sponsor Decision|1|||
27956333|NCT02311881|81672397|FG001|Overall Study|Sponsor Decision|1|||
27956334|NCT02311881|81672398|FG002|Overall Study|Sponsor Decision|1|||
27956335|NCT02311881|81672396|FG000|Overall Study|Protocol Deviation|1|||
27956336|NCT02311881|81672397|FG001|Overall Study|Protocol Deviation|0|||
27956337|NCT02311881|81672398|FG002|Overall Study|Protocol Deviation|0|||
27956338|NCT02311881|81672396|FG000|Overall Study|Non-Compliance|1|||
27956339|NCT02311881|81672397|FG001|Overall Study|Non-Compliance|0|||
27956340|NCT02311881|81672398|FG002|Overall Study|Non-Compliance|2|||
27956341|NCT02311881|81672396|FG000|Overall Study|Physician Decision|0|||
27956342|NCT02311881|81672397|FG001|Overall Study|Physician Decision|0|||
27956343|NCT02311881|81672398|FG002|Overall Study|Physician Decision|1|||
27956344|NCT02311881|81672396|FG000|Overall Study|Medical Monitor Discretion|0|||
27956345|NCT02311881|81672397|FG001|Overall Study|Medical Monitor Discretion|0|||
27956346|NCT02311881|81672398|FG002|Overall Study|Medical Monitor Discretion|1|||
27956347|NCT02311881|81672396|FG000|Overall Study|Participant taking another medication|0|||
27956348|NCT02311881|81672397|FG001|Overall Study|Participant taking another medication|0|||
27956349|NCT02311881|81672398|FG002|Overall Study|Participant taking another medication|1|||
27956350|NCT02311881|81672396|FG000|Overall Study|Serious Adverse Event|0|||
27956351|NCT02311881|81672397|FG001|Overall Study|Serious Adverse Event|1|||
27956352|NCT02311881|81672398|FG002|Overall Study|Serious Adverse Event|0|||
27956353|NCT04872569|81672399|FG000|Overall Study|Withdrawal by Subject|2|||
27956354|NCT00700622|81672400|FG000|Overall Study|Adverse Event|4|||
27956355|NCT00700622|81672401|FG001|Overall Study|Adverse Event|0|||
27956356|NCT00700622|81672400|FG000|Overall Study|Lost to Follow-up|0|||
27956357|NCT00700622|81672401|FG001|Overall Study|Lost to Follow-up|1|||
27956358|NCT00700622|81672400|FG000|Overall Study|Physician Decision|2|||
27956359|NCT00700622|81672401|FG001|Overall Study|Physician Decision|1|||
27956360|NCT00700622|81672400|FG000|Overall Study|Protocol Violation|0|||
27956361|NCT00700622|81672401|FG001|Overall Study|Protocol Violation|1|||
27956362|NCT00700622|81672400|FG000|Overall Study|Withdrawal by Subject|4|||
27956363|NCT00700622|81672401|FG001|Overall Study|Withdrawal by Subject|1|||
27956364|NCT00700622|81672400|FG000|Overall Study|Other|3|||
27956365|NCT00700622|81672401|FG001|Overall Study|Other|1|||
27956366|NCT00503425|81672407|FG000|Overall Study|Participant files lost|6|||
27956367|NCT00503425|81672407|FG000|Overall Study|Adverse Event|5|||
27956368|NCT00503425|81672407|FG000|Overall Study|Lack of Efficacy|25|||
27956369|NCT00503425|81672407|FG000|Overall Study|Withdrawal by Subject|8|||
27956370|NCT00503425|81672407|FG000|Overall Study|Lost to Follow-up|3|||
27956371|NCT00503425|81672407|FG000|Overall Study|Death|3|||
27956372|NCT00503425|81672407|FG000|Overall Study|Missing Data/Unknown|4|||
27956373|NCT02240121|81672408|FG000|Overall Study|Protocol Violation|1|||
27956374|NCT02240121|81672409|FG001|Overall Study|Protocol Violation|2|||
27956375|NCT02240121|81672408|FG000|Overall Study|Physician Decision|0|||
27956376|NCT02240121|81672409|FG001|Overall Study|Physician Decision|1|||
27956377|NCT02240121|81672408|FG000|Overall Study|Change in protocol interpretation|1|||
27753452|NCT02175771|80925867|FG006|Treatment Period|Protocol Violation|0|||
27956378|NCT02240121|81672409|FG001|Overall Study|Change in protocol interpretation|0|||
27956379|NCT02240121|81672408|FG000|Overall Study|Lack of Efficacy|2|||
27956380|NCT02240121|81672409|FG001|Overall Study|Lack of Efficacy|3|||
27956381|NCT02240121|81672408|FG000|Overall Study|Site closed|1|||
27956382|NCT02240121|81672409|FG001|Overall Study|Site closed|1|||
27956383|NCT02240121|81672408|FG000|Overall Study|Pregnancy|1|||
27956384|NCT02240121|81672409|FG001|Overall Study|Pregnancy|0|||
27956385|NCT02240121|81672408|FG000|Overall Study|Adverse Event|2|||
27956386|NCT02240121|81672409|FG001|Overall Study|Adverse Event|4|||
27956387|NCT02240121|81672408|FG000|Overall Study|Withdrawal by Subject|6|||
27956388|NCT02240121|81672409|FG001|Overall Study|Withdrawal by Subject|2|||
27956389|NCT02240121|81672408|FG000|Overall Study|Lost to Follow-up|3|||
27956390|NCT02240121|81672409|FG001|Overall Study|Lost to Follow-up|4|||
27956391|NCT02240121|81672408|FG000|Overall Study|Other than specified|1|||
27956392|NCT02240121|81672409|FG001|Overall Study|Other than specified|3|||
27956393|NCT00952705|81672412|FG000|Overall Study|Lost to Follow-up|24|||
27956394|NCT00952705|81672413|FG001|Overall Study|Lost to Follow-up|8|||
27956395|NCT00952705|81672414|FG002|Overall Study|Lost to Follow-up|9|||
27956396|NCT00952705|81672412|FG000|Overall Study|Withdrawal by Subject|2|||
27956397|NCT00952705|81672413|FG001|Overall Study|Withdrawal by Subject|1|||
27956398|NCT00952705|81672414|FG002|Overall Study|Withdrawal by Subject|1|||
27956399|NCT00952705|81672412|FG000|Overall Study|Death|2|||
27956400|NCT00952705|81672413|FG001|Overall Study|Death|0|||
27956401|NCT00952705|81672414|FG002|Overall Study|Death|0|||
27956402|NCT00952705|81672412|FG000|Overall Study|Incarcerated post dose|5|||
27956403|NCT00952705|81672413|FG001|Overall Study|Incarcerated post dose|0|||
27956404|NCT00952705|81672414|FG002|Overall Study|Incarcerated post dose|0|||
27956405|NCT00952705|81672412|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
27956406|NCT00952705|81672413|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
27956407|NCT00952705|81672414|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
27956408|NCT01724216|81672426|FG000|Overall Study|Scan was not completed|1|||
27956409|NCT00600067|81672428|FG000|Overall Study|Adverse Event|0|||
27956410|NCT00600067|81672429|FG001|Overall Study|Adverse Event|1|||
27956411|NCT00600067|81672428|FG000|Overall Study|Lost to Follow-up|2|||
27956412|NCT00600067|81672429|FG001|Overall Study|Lost to Follow-up|3|||
27956413|NCT00600067|81672428|FG000|Overall Study|protocol non-compliance|0|||
27956414|NCT00600067|81672429|FG001|Overall Study|protocol non-compliance|3|||
27956415|NCT00600067|81672428|FG000|Overall Study|Lack of Efficacy|1|||
27956416|NCT00600067|81672429|FG001|Overall Study|Lack of Efficacy|0|||
27956417|NCT04460183|81672430|FG000|Overall Study|Lost to Follow-up|3|||
27956418|NCT04460183|81672431|FG001|Overall Study|Lost to Follow-up|1|||
27956419|NCT04460183|81672430|FG000|Overall Study|Withdrawal by Subject|1|||
27956420|NCT04460183|81672431|FG001|Overall Study|Withdrawal by Subject|0|||
27956421|NCT03381287|81672432|FG000|Overall Study|Withdrawal by Subject|0|||
27956422|NCT03381287|81672433|FG001|Overall Study|Withdrawal by Subject|1|||
27956423|NCT03381287|81672434|FG002|Overall Study|Withdrawal by Subject|0|||
27956424|NCT03381287|81672435|FG003|Overall Study|Withdrawal by Subject|0|||
27956425|NCT03381287|81672432|FG000|Overall Study|Adverse Event|0|||
27956426|NCT03381287|81672433|FG001|Overall Study|Adverse Event|0|||
27956427|NCT03381287|81672434|FG002|Overall Study|Adverse Event|0|||
27956428|NCT03381287|81672435|FG003|Overall Study|Adverse Event|1|||
27956429|NCT03381287|81672432|FG000|Overall Study|Physician Decision|0|||
27956430|NCT03381287|81672433|FG001|Overall Study|Physician Decision|0|||
27956431|NCT03381287|81672434|FG002|Overall Study|Physician Decision|0|||
27956432|NCT03381287|81672435|FG003|Overall Study|Physician Decision|1|||
27956433|NCT02850978|81672438|FG000|Overall Study|Uncollectable CRF|27|||
27956434|NCT02850978|81672438|FG000|Overall Study|No visit since the first visit|35|||
27956435|NCT02850978|81672438|FG000|Overall Study|Adverse Event|81|||
27956436|NCT02850978|81672438|FG000|Overall Study|Lack of Efficacy|40|||
27956437|NCT02850978|81672438|FG000|Overall Study|Improvement in condition|34|||
27956438|NCT02850978|81672438|FG000|Overall Study|Lost to Follow-up|121|||
27956439|NCT02850978|81672438|FG000|Overall Study|Reason not listed|88|||
27956440|NCT00783432|81672441|FG000|Overall Study|Adverse Event|22|||
27956441|NCT00783432|81672442|FG001|Overall Study|Adverse Event|17|||
27956442|NCT00783432|81672441|FG000|Overall Study|Lack of Efficacy|20|||
27956443|NCT00783432|81672442|FG001|Overall Study|Lack of Efficacy|21|||
27956444|NCT00783432|81672441|FG000|Overall Study|Lost to Follow-up|11|||
27956445|NCT00783432|81672442|FG001|Overall Study|Lost to Follow-up|6|||
27956446|NCT00783432|81672441|FG000|Overall Study|Withdrawal by Subject|23|||
27956447|NCT00783432|81672442|FG001|Overall Study|Withdrawal by Subject|20|||
27956448|NCT00783432|81672441|FG000|Overall Study|subject moved|3|||
27956449|NCT00783432|81672442|FG001|Overall Study|subject moved|5|||
27956450|NCT00783432|81672441|FG000|Overall Study|Protocol Violation|6|||
27956451|NCT00783432|81672442|FG001|Overall Study|Protocol Violation|9|||
27956452|NCT00272792|81672443|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
27956453|NCT00272792|81672444|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
27956454|NCT00272792|81672443|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
27956455|NCT00272792|81672444|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
27956456|NCT00272792|81672443|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
27956457|NCT00272792|81672444|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
27956458|NCT00272792|81672443|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
27956459|NCT00272792|81672444|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
27956460|NCT01192126|81672445|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
27956461|NCT01192126|81672446|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
27956462|NCT01192126|81672445|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
27956463|NCT01192126|81672446|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
27956464|NCT03637491|81672447|FG000|Overall Study|Death|9|||
27956465|NCT03637491|81672448|FG001|Overall Study|Death|9|||
27956466|NCT03637491|81672449|FG002|Overall Study|Death|5|||
27956467|NCT03637491|81672450|FG003|Overall Study|Death|3|||
27956468|NCT03637491|81672447|FG000|Overall Study|Lost to Follow-up|0|||
27956469|NCT03637491|81672448|FG001|Overall Study|Lost to Follow-up|1|||
27956470|NCT03637491|81672449|FG002|Overall Study|Lost to Follow-up|0|||
27956471|NCT03637491|81672450|FG003|Overall Study|Lost to Follow-up|1|||
27956472|NCT03637491|81672447|FG000|Overall Study|Study Terminated By Sponsor|0|||
27956473|NCT03637491|81672448|FG001|Overall Study|Study Terminated By Sponsor|2|||
27956474|NCT03637491|81672449|FG002|Overall Study|Study Terminated By Sponsor|1|||
27956475|NCT03637491|81672450|FG003|Overall Study|Study Terminated By Sponsor|0|||
27956476|NCT03637491|81672447|FG000|Overall Study|Withdrawal by Subject|1|||
27956477|NCT03637491|81672448|FG001|Overall Study|Withdrawal by Subject|0|||
27956478|NCT03637491|81672449|FG002|Overall Study|Withdrawal by Subject|1|||
27956479|NCT03637491|81672450|FG003|Overall Study|Withdrawal by Subject|2|||
27956480|NCT01856322|81676185|FG000|Overall Study|off study due to lack of accrual|0|||
27956481|NCT01856322|81676186|FG001|Overall Study|off study due to lack of accrual|0|||
27956482|NCT01856322|81676187|FG002|Overall Study|off study due to lack of accrual|3|||
27956483|NCT02131311|81676188|FG000|Overall Study|Adverse Event|2|||
27956484|NCT02131311|81676188|FG000|Overall Study|Protocol Violation|1|||
27956485|NCT02131311|81676188|FG000|Overall Study|Lost to Follow-up|1|||
27956486|NCT02829996|81676189|FG000|Overall Study|Withdrawal by Subject|1|||
27956487|NCT02829996|81676190|FG001|Overall Study|Withdrawal by Subject|0|||
27956488|NCT02829996|81676191|FG002|Overall Study|Withdrawal by Subject|0|||
27956489|NCT02829996|81676192|FG003|Overall Study|Withdrawal by Subject|0|||
27956490|NCT02829996|81676193|FG004|Overall Study|Withdrawal by Subject|0|||
27956491|NCT02712996|81676202|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
27956492|NCT02712996|81676203|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
27956493|NCT01082614|81676204|FG000|Overall Study|Adverse Event|1|||
27956494|NCT01082614|81676205|FG001|Overall Study|Adverse Event|4|||
27956495|NCT01082614|81676204|FG000|Overall Study|Equipment Malfunction|0|||
27956496|NCT01082614|81676205|FG001|Overall Study|Equipment Malfunction|1|||
27956497|NCT01082614|81676204|FG000|Overall Study|Physician Decision|2|||
27956498|NCT01082614|81676205|FG001|Overall Study|Physician Decision|0|||
27956499|NCT00856323|81676214|FG000|Overall Study|Withdrawal by Subject|2|||
27956500|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
27956501|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
27956502|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
27956503|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27956504|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27956505|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27956506|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
27956507|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
27956508|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27956509|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27956510|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27956511|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27956512|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27956513|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
27956514|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
27956515|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
27956516|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
27956517|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27956518|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27956519|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27956520|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
27956521|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
27956522|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
27551543|NCT04342897|80207488|FG001|Overall Study|Withdrawal by Subject|2|||
27551544|NCT03292588|80207489|FG000|Overall Study|Death|1|||
27956523|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27956524|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27956525|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27956526|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27956527|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
27956528|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
27959316|NCT02131662|81683272|FG003|Overall Study|Wish for pregnancy|0|||
27551545|NCT03292588|80207490|FG001|Overall Study|Death|0|||
27956529|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27956530|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27956531|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27956532|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27956533|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27956534|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
27956535|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27956536|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
27551546|NCT03292588|80207489|FG000|Overall Study|Lost to Follow-up|12|||
27551547|NCT03292588|80207490|FG001|Overall Study|Lost to Follow-up|16|||
27551548|NCT03292588|80207489|FG000|Overall Study|Physician Decision|0|||
27551549|NCT03292588|80207490|FG001|Overall Study|Physician Decision|1|||
27551550|NCT03292588|80207489|FG000|Overall Study|Withdrawal by Subject|4|||
27551551|NCT03292588|80207490|FG001|Overall Study|Withdrawal by Subject|4|||
27551552|NCT03292588|80207489|FG000|Overall Study|Move out of town|1|||
27551553|NCT03292588|80207490|FG001|Overall Study|Move out of town|0|||
27551554|NCT03292588|80207489|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
27551555|NCT03292588|80207490|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
27551556|NCT02954237|80207491|FG000|Overall Study|Withdrawal by Subject|25|||
27551557|NCT02954237|80207491|FG000|Overall Study|Missed visit|16|||
27551558|NCT02954237|80207491|FG000|Overall Study|Death|2|||
27551559|NCT00752232|80207492|FG000|Overall Study|Protocol Violation|0|||
27551560|NCT00752232|80207493|FG001|Overall Study|Protocol Violation|0|||
27551561|NCT00752232|80207494|FG002|Overall Study|Protocol Violation|0|||
27551562|NCT00752232|80207495|FG003|Overall Study|Protocol Violation|0|||
27551563|NCT00752232|80207496|FG004|Overall Study|Protocol Violation|0|||
27551564|NCT00752232|80207497|FG005|Overall Study|Protocol Violation|1|||
27551565|NCT00752232|80207498|FG006|Overall Study|Protocol Violation|0|||
27551566|NCT00752232|80207492|FG000|Overall Study|Caregiver request|2|||
27551567|NCT00752232|80207493|FG001|Overall Study|Caregiver request|0|||
27551568|NCT00752232|80207494|FG002|Overall Study|Caregiver request|0|||
27956537|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27956538|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27551569|NCT00752232|80207495|FG003|Overall Study|Caregiver request|0|||
27551570|NCT00752232|80207496|FG004|Overall Study|Caregiver request|1|||
27551571|NCT00752232|80207497|FG005|Overall Study|Caregiver request|0|||
27551572|NCT00752232|80207498|FG006|Overall Study|Caregiver request|0|||
27551573|NCT00752232|80207492|FG000|Overall Study|Investigator request|0|||
27551574|NCT00752232|80207493|FG001|Overall Study|Investigator request|0|||
27551575|NCT00752232|80207494|FG002|Overall Study|Investigator request|0|||
27551576|NCT00752232|80207495|FG003|Overall Study|Investigator request|0|||
27551577|NCT00752232|80207496|FG004|Overall Study|Investigator request|1|||
27551578|NCT00752232|80207497|FG005|Overall Study|Investigator request|0|||
27551579|NCT00752232|80207498|FG006|Overall Study|Investigator request|0|||
27551580|NCT00752232|80207492|FG000|Overall Study|Subject request|0|||
27551581|NCT00752232|80207493|FG001|Overall Study|Subject request|0|||
27551582|NCT00752232|80207494|FG002|Overall Study|Subject request|1|||
27551583|NCT00752232|80207495|FG003|Overall Study|Subject request|0|||
27551584|NCT00752232|80207496|FG004|Overall Study|Subject request|0|||
27551585|NCT00752232|80207497|FG005|Overall Study|Subject request|0|||
27551586|NCT00752232|80207498|FG006|Overall Study|Subject request|0|||
27551587|NCT00752232|80207492|FG000|Overall Study|Group home admission|0|||
27551588|NCT00752232|80207493|FG001|Overall Study|Group home admission|0|||
27551589|NCT00752232|80207494|FG002|Overall Study|Group home admission|0|||
27551590|NCT00752232|80207495|FG003|Overall Study|Group home admission|1|||
27551591|NCT00752232|80207496|FG004|Overall Study|Group home admission|0|||
27551592|NCT00752232|80207497|FG005|Overall Study|Group home admission|0|||
27551593|NCT00752232|80207498|FG006|Overall Study|Group home admission|0|||
27551594|NCT00752232|80207492|FG000|Overall Study|Caregiver could not attend the subject|0|||
27551595|NCT00752232|80207493|FG001|Overall Study|Caregiver could not attend the subject|0|||
27551596|NCT00752232|80207494|FG002|Overall Study|Caregiver could not attend the subject|0|||
27551597|NCT00752232|80207495|FG003|Overall Study|Caregiver could not attend the subject|0|||
27551598|NCT00752232|80207496|FG004|Overall Study|Caregiver could not attend the subject|1|||
27551599|NCT00752232|80207497|FG005|Overall Study|Caregiver could not attend the subject|0|||
27551600|NCT00752232|80207498|FG006|Overall Study|Caregiver could not attend the subject|0|||
27551601|NCT01652703|80207499|FG000|Overall Study|Withdrawal by Subject|0|||
27551602|NCT01652703|80207500|FG001|Overall Study|Withdrawal by Subject|1|||
27551603|NCT01652703|80207501|FG002|Overall Study|Withdrawal by Subject|3|||
27551604|NCT01652703|80207502|FG003|Overall Study|Withdrawal by Subject|1|||
27551605|NCT01652703|80207503|FG004|Overall Study|Withdrawal by Subject|0|||
27551606|NCT01652703|80207504|FG005|Overall Study|Withdrawal by Subject|1|||
27551607|NCT01652703|80207499|FG000|Overall Study|Other|0|||
27551608|NCT01652703|80207500|FG001|Overall Study|Other|0|||
27551609|NCT01652703|80207501|FG002|Overall Study|Other|0|||
27753453|NCT02175771|80925868|FG007|Treatment Period|Protocol Violation|1|||
27753454|NCT02175771|80925869|FG008|Treatment Period|Protocol Violation|0|||
27956539|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27956540|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27956541|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
27956542|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
27956543|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
27956544|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
27956545|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27956546|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27956547|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27956548|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
27956549|NCT03745638|81676217|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
27956550|NCT03745638|81676218|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
27956551|NCT03745638|81676219|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
27956552|NCT03745638|81676220|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
27956553|NCT03745638|81676221|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
27956554|NCT03745638|81676222|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
27956555|NCT03745638|81676223|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
27956556|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27956557|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27956558|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27956559|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27956560|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
27956561|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
27956562|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
27956563|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27956564|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27956565|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27956566|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
27956567|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
27956568|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
27956569|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
27956570|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27956571|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27956572|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
27956573|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
27956574|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
27956575|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
27956576|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
27956577|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27956578|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27956579|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27956580|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27956581|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
27956582|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
27956583|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
27956584|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27956585|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27956586|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27956587|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27956588|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27956589|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
27956590|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
27956591|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27956592|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27956593|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
27956594|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
27956595|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
27956596|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
27956597|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
27956598|NCT03745638|81676217|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
27956599|NCT03745638|81676218|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
27551610|NCT01652703|80207502|FG003|Overall Study|Other|1|||
27551611|NCT01652703|80207503|FG004|Overall Study|Other|1|||
27551612|NCT01652703|80207504|FG005|Overall Study|Other|1|||
27551613|NCT00371137|80207505|FG000|Overall Study|Adverse Event|20|||
27551614|NCT00371137|80207506|FG001|Overall Study|Adverse Event|35|||
27551615|NCT00371137|80207507|FG002|Overall Study|Adverse Event|42|||
27551616|NCT00371137|80207505|FG000|Overall Study|Withdrawal by Subject|11|||
27551617|NCT00371137|80207506|FG001|Overall Study|Withdrawal by Subject|10|||
27551618|NCT00371137|80207507|FG002|Overall Study|Withdrawal by Subject|15|||
27551619|NCT00371137|80207505|FG000|Overall Study|Lost to Follow-up|6|||
27551620|NCT00371137|80207506|FG001|Overall Study|Lost to Follow-up|3|||
27551621|NCT00371137|80207507|FG002|Overall Study|Lost to Follow-up|5|||
27551622|NCT00371137|80207505|FG000|Overall Study|Lack of Efficacy|30|||
27551623|NCT00371137|80207506|FG001|Overall Study|Lack of Efficacy|12|||
27551624|NCT00371137|80207507|FG002|Overall Study|Lack of Efficacy|13|||
27551625|NCT00371137|80207505|FG000|Overall Study|Sponsor Decision|2|||
27551626|NCT00371137|80207506|FG001|Overall Study|Sponsor Decision|1|||
27551627|NCT00371137|80207507|FG002|Overall Study|Sponsor Decision|2|||
27551628|NCT00371137|80207505|FG000|Overall Study|Physician Decision|1|||
27551629|NCT00371137|80207506|FG001|Overall Study|Physician Decision|1|||
27551630|NCT00371137|80207507|FG002|Overall Study|Physician Decision|1|||
27551631|NCT00371137|80207505|FG000|Overall Study|Protocol Violation|2|||
27551632|NCT00371137|80207506|FG001|Overall Study|Protocol Violation|1|||
27551633|NCT00371137|80207507|FG002|Overall Study|Protocol Violation|1|||
27551634|NCT02743871|80207508|FG000|Overall Study|Lost to Follow-up|0|||
27551635|NCT02743871|80207509|FG001|Overall Study|Lost to Follow-up|0|||
27551636|NCT02743871|80207510|FG002|Overall Study|Lost to Follow-up|0|||
27551637|NCT02743871|80207511|FG003|Overall Study|Lost to Follow-up|1|||
27551638|NCT02743871|80207512|FG004|Overall Study|Lost to Follow-up|0|||
27551639|NCT02743871|80207513|FG005|Overall Study|Lost to Follow-up|0|||
27551640|NCT02743871|80207514|FG006|Overall Study|Lost to Follow-up|1|||
27551641|NCT02743871|80207515|FG007|Overall Study|Lost to Follow-up|0|||
27551642|NCT02743871|80207516|FG008|Overall Study|Lost to Follow-up|0|||
27551643|NCT02743871|80207517|FG009|Overall Study|Lost to Follow-up|0|||
27551644|NCT02743871|80207518|FG010|Overall Study|Lost to Follow-up|0|||
27551645|NCT02743871|80207519|FG011|Overall Study|Lost to Follow-up|2|||
27551646|NCT02743871|80207520|FG012|Overall Study|Lost to Follow-up|0|||
27551647|NCT02743871|80207521|FG013|Overall Study|Lost to Follow-up|0|||
27551648|NCT02743871|80207508|FG000|Overall Study|Withdrawal by Subject|0|||
27551649|NCT02743871|80207509|FG001|Overall Study|Withdrawal by Subject|0|||
27551650|NCT02743871|80207510|FG002|Overall Study|Withdrawal by Subject|0|||
27551651|NCT02743871|80207511|FG003|Overall Study|Withdrawal by Subject|0|||
27551652|NCT02743871|80207512|FG004|Overall Study|Withdrawal by Subject|0|||
27551653|NCT02743871|80207513|FG005|Overall Study|Withdrawal by Subject|0|||
27551654|NCT02743871|80207514|FG006|Overall Study|Withdrawal by Subject|0|||
27551655|NCT02743871|80207515|FG007|Overall Study|Withdrawal by Subject|0|||
27551656|NCT02743871|80207516|FG008|Overall Study|Withdrawal by Subject|0|||
27551657|NCT02743871|80207517|FG009|Overall Study|Withdrawal by Subject|0|||
27551658|NCT02743871|80207518|FG010|Overall Study|Withdrawal by Subject|1|||
27551659|NCT02743871|80207519|FG011|Overall Study|Withdrawal by Subject|0|||
27551660|NCT02743871|80207520|FG012|Overall Study|Withdrawal by Subject|12|||
27551661|NCT02743871|80207521|FG013|Overall Study|Withdrawal by Subject|6|||
27551662|NCT02743871|80207508|FG000|Overall Study|Adverse Event|1|||
27551663|NCT02743871|80207509|FG001|Overall Study|Adverse Event|0|||
27551664|NCT02743871|80207510|FG002|Overall Study|Adverse Event|0|||
27551665|NCT02743871|80207511|FG003|Overall Study|Adverse Event|0|||
27551666|NCT02743871|80207512|FG004|Overall Study|Adverse Event|0|||
27551667|NCT02743871|80207513|FG005|Overall Study|Adverse Event|0|||
27551668|NCT02743871|80207514|FG006|Overall Study|Adverse Event|0|||
27551669|NCT02743871|80207515|FG007|Overall Study|Adverse Event|0|||
27551670|NCT02743871|80207516|FG008|Overall Study|Adverse Event|0|||
27551671|NCT02743871|80207517|FG009|Overall Study|Adverse Event|0|||
27551672|NCT02743871|80207518|FG010|Overall Study|Adverse Event|0|||
27551673|NCT02743871|80207519|FG011|Overall Study|Adverse Event|0|||
27551674|NCT02743871|80207520|FG012|Overall Study|Adverse Event|0|||
27551675|NCT02743871|80207521|FG013|Overall Study|Adverse Event|0|||
27551676|NCT02743871|80207508|FG000|Overall Study|Other|0|||
27551677|NCT02743871|80207509|FG001|Overall Study|Other|0|||
27551678|NCT02743871|80207510|FG002|Overall Study|Other|0|||
27551679|NCT02743871|80207511|FG003|Overall Study|Other|0|||
27551680|NCT02743871|80207512|FG004|Overall Study|Other|0|||
27551681|NCT02743871|80207513|FG005|Overall Study|Other|0|||
27551682|NCT02743871|80207514|FG006|Overall Study|Other|0|||
27551683|NCT02743871|80207515|FG007|Overall Study|Other|0|||
27551684|NCT02743871|80207516|FG008|Overall Study|Other|0|||
27551685|NCT02743871|80207517|FG009|Overall Study|Other|0|||
27551686|NCT02743871|80207518|FG010|Overall Study|Other|0|||
27551687|NCT02743871|80207519|FG011|Overall Study|Other|1|||
27551688|NCT02743871|80207520|FG012|Overall Study|Other|1|||
27551689|NCT02743871|80207521|FG013|Overall Study|Other|1|||
27551690|NCT02743871|80207508|FG000|Overall Study|Protocol Violation|0|||
27551691|NCT02743871|80207509|FG001|Overall Study|Protocol Violation|0|||
27551692|NCT02743871|80207510|FG002|Overall Study|Protocol Violation|0|||
27551693|NCT02743871|80207511|FG003|Overall Study|Protocol Violation|0|||
27551694|NCT02743871|80207512|FG004|Overall Study|Protocol Violation|0|||
27551695|NCT02743871|80207513|FG005|Overall Study|Protocol Violation|0|||
27551696|NCT02743871|80207514|FG006|Overall Study|Protocol Violation|0|||
27551697|NCT02743871|80207515|FG007|Overall Study|Protocol Violation|0|||
27551698|NCT02743871|80207516|FG008|Overall Study|Protocol Violation|0|||
27551699|NCT02743871|80207517|FG009|Overall Study|Protocol Violation|0|||
27551700|NCT02743871|80207518|FG010|Overall Study|Protocol Violation|0|||
27551701|NCT02743871|80207519|FG011|Overall Study|Protocol Violation|0|||
27551702|NCT02743871|80207520|FG012|Overall Study|Protocol Violation|2|||
27551703|NCT02743871|80207521|FG013|Overall Study|Protocol Violation|0|||
27551704|NCT01426373|80207522|FG000|Overall Study|Adverse Event|6|||
27551705|NCT01426373|80207522|FG000|Overall Study|Lost to Follow-up|14|||
27551706|NCT01426373|80207522|FG000|Overall Study|Participant Convenience|10|||
27551707|NCT01426373|80207522|FG000|Overall Study|Miscellaneous Reasons|4|||
27551708|NCT01442675|80207525|FG000|Overall Study|Protocol Violation|6|||
27551709|NCT01442675|80207525|FG000|Overall Study|Lost to Follow-up|2|||
27551710|NCT01442675|80207525|FG000|Overall Study|Withdrawal by Subject|4|||
27551711|NCT00673465|80207526|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551712|NCT00673465|80207527|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551713|NCT00673465|80207528|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551714|NCT00673465|80207529|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551715|NCT00673465|80207530|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
27551716|NCT00673465|80207531|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
27551717|NCT00673465|80207532|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551718|NCT00673465|80207533|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551719|NCT00673465|80207534|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551720|NCT00673465|80207535|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551721|NCT00673465|80207536|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551722|NCT00673465|80207537|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
27551723|NCT00673465|80207526|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551724|NCT00673465|80207527|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551725|NCT00673465|80207528|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551726|NCT00673465|80207529|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551727|NCT00673465|80207530|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
27551728|NCT00673465|80207531|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551729|NCT00673465|80207532|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551730|NCT00673465|80207533|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551731|NCT00673465|80207534|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551732|NCT00673465|80207535|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551733|NCT00673465|80207536|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551734|NCT00673465|80207537|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
27551735|NCT05227027|80207542|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
27551736|NCT05227027|80207543|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
27551737|NCT01340898|80207544|FG000|Primary Phase|Serious Adverse Events|0|||
27551738|NCT01340898|80207545|FG001|Primary Phase|Serious Adverse Events|0|||
27551739|NCT01340898|80207546|FG002|Primary Phase|Serious Adverse Events|1|||
27551740|NCT01340898|80207544|FG000|Primary Phase|Withdrawal by Subject|8|||
27551741|NCT01340898|80207545|FG001|Primary Phase|Withdrawal by Subject|7|||
27551742|NCT01340898|80207546|FG002|Primary Phase|Withdrawal by Subject|5|||
27551743|NCT01340898|80207544|FG000|Primary Phase|Migrated/moved from study area|4|||
27551744|NCT01340898|80207545|FG001|Primary Phase|Migrated/moved from study area|1|||
27551745|NCT01340898|80207546|FG002|Primary Phase|Migrated/moved from study area|0|||
27551746|NCT01340898|80207544|FG000|Primary Phase|Lost to Follow-up|4|||
27551747|NCT01340898|80207545|FG001|Primary Phase|Lost to Follow-up|1|||
27551748|NCT01340898|80207546|FG002|Primary Phase|Lost to Follow-up|0|||
27551749|NCT01340898|80207544|FG000|Booster Phase|Withdrawal by Subject|3|||
27551750|NCT01340898|80207545|FG001|Booster Phase|Withdrawal by Subject|0|||
27551751|NCT01340898|80207546|FG002|Booster Phase|Withdrawal by Subject|4|||
27551752|NCT01340898|80207544|FG000|Booster Phase|Migrated/moved from study area|3|||
27551753|NCT01340898|80207545|FG001|Booster Phase|Migrated/moved from study area|0|||
27551754|NCT01340898|80207546|FG002|Booster Phase|Migrated/moved from study area|0|||
27551755|NCT01340898|80207544|FG000|Booster Phase|Lost to Follow-up|4|||
27551756|NCT01340898|80207545|FG001|Booster Phase|Lost to Follow-up|2|||
27551757|NCT01340898|80207546|FG002|Booster Phase|Lost to Follow-up|3|||
27551758|NCT00165776|80207547|FG000|Overall Study|Lack of Efficacy|0|||
27551759|NCT00165776|80207548|FG001|Overall Study|Lack of Efficacy|0|||
27551760|NCT00165776|80207549|FG002|Overall Study|Lack of Efficacy|0|||
27551761|NCT00165776|80207550|FG003|Overall Study|Lack of Efficacy|1|||
27551762|NCT00165776|80207547|FG000|Overall Study|Withdrawal by Subject|4|||
27551763|NCT00165776|80207548|FG001|Overall Study|Withdrawal by Subject|1|||
27551764|NCT00165776|80207549|FG002|Overall Study|Withdrawal by Subject|2|||
27551765|NCT00165776|80207550|FG003|Overall Study|Withdrawal by Subject|0|||
27551766|NCT00165776|80207547|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
27551767|NCT00165776|80207548|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
27956600|NCT03745638|81676219|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
27956601|NCT03745638|81676220|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
27956602|NCT03745638|81676221|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
27956603|NCT03745638|81676222|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
27551768|NCT00165776|80207549|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
27551769|NCT00165776|80207550|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
27551770|NCT00646776|80207560|FG000|Overall Study|Adverse Event|1|||
27551771|NCT00646776|80207561|FG001|Overall Study|Adverse Event|9|||
27551772|NCT00646776|80207560|FG000|Overall Study|Investigator discretion|0|||
27551773|NCT00646776|80207561|FG001|Overall Study|Investigator discretion|4|||
27956604|NCT03745638|81676223|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
27551774|NCT01874054|80207562|FG000|Overall Study|Withdrawal by Subject|3|||
27551775|NCT01874054|80207562|FG000|Overall Study|Study Termination by Sponsor|42|||
27551776|NCT01874054|80207562|FG000|Overall Study|Lost to Follow-up|5|||
27551777|NCT01874054|80207562|FG000|Overall Study|Death|5|||
27551778|NCT00587054|80207563|FG000|Overall Study|Patient not treated|9|||
27551779|NCT04980040|80207571|FG000|Overall Study|Violated the Inclusion Criteria|260|||
27551780|NCT04980040|80207571|FG000|Overall Study|Violated the Administration & Dosage|225|||
27551781|NCT04980040|80207571|FG000|Overall Study|Lost to Safety-Follow-up|4|||
27551782|NCT04980040|80207571|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
27551783|NCT00276744|80207574|FG000|PART A|Reason unknown|98|||
27551784|NCT00793598|80207577|FG000|Overall Study|Patient Request|0|||
27551785|NCT00793598|80207578|FG001|Overall Study|Patient Request|1|||
27551786|NCT00793598|80207579|FG002|Overall Study|Patient Request|0|||
27551787|NCT00793598|80207580|FG003|Overall Study|Patient Request|0|||
27551788|NCT00793598|80207581|FG004|Overall Study|Patient Request|0|||
27551789|NCT00793598|80207582|FG005|Overall Study|Patient Request|0|||
27551790|NCT00793598|80207583|FG006|Overall Study|Patient Request|0|||
27551791|NCT00793598|80207584|FG007|Overall Study|Patient Request|0|||
27551792|NCT00793598|80207577|FG000|Overall Study|Protocol Violation|0|||
27551793|NCT00793598|80207578|FG001|Overall Study|Protocol Violation|0|||
27551794|NCT00793598|80207579|FG002|Overall Study|Protocol Violation|0|||
27551795|NCT00793598|80207580|FG003|Overall Study|Protocol Violation|0|||
27551796|NCT00793598|80207581|FG004|Overall Study|Protocol Violation|0|||
27551797|NCT00793598|80207582|FG005|Overall Study|Protocol Violation|0|||
27551798|NCT00793598|80207583|FG006|Overall Study|Protocol Violation|0|||
27551799|NCT00793598|80207584|FG007|Overall Study|Protocol Violation|1|||
27551800|NCT00793598|80207577|FG000|Overall Study|Subject not dosed|0|||
27956605|NCT03082677|81676252|FG000|Overall Study|Not Treated|2|||
27956606|NCT02534883|81676253|FG000|Overall Study|Early Termination|8|||
27956607|NCT02534883|81676254|FG001|Overall Study|Early Termination|3|||
27956608|NCT00678288|81676255|FG000|Overall Study|Adverse Event|0|||
27956609|NCT00678288|81676256|FG001|Overall Study|Adverse Event|2|||
27956610|NCT00678288|81676255|FG000|Overall Study|Withdrawal by Subject|1|||
27956611|NCT00678288|81676256|FG001|Overall Study|Withdrawal by Subject|1|||
27956612|NCT00678288|81676255|FG000|Overall Study|Study terminated by the sponsor|2|||
27956613|NCT00678288|81676256|FG001|Overall Study|Study terminated by the sponsor|0|||
27956614|NCT00678288|81676255|FG000|Overall Study|Not compliant with study medication|0|||
27956615|NCT00678288|81676256|FG001|Overall Study|Not compliant with study medication|1|||
27956616|NCT00678288|81676255|FG000|Overall Study|Switch to commercial drug|0|||
27956617|NCT00678288|81676256|FG001|Overall Study|Switch to commercial drug|1|||
27551801|NCT00793598|80207578|FG001|Overall Study|Subject not dosed|0|||
27551802|NCT00793598|80207579|FG002|Overall Study|Subject not dosed|0|||
27551803|NCT00793598|80207580|FG003|Overall Study|Subject not dosed|0|||
27551804|NCT00793598|80207581|FG004|Overall Study|Subject not dosed|0|||
27551805|NCT00793598|80207582|FG005|Overall Study|Subject not dosed|1|||
27551806|NCT00793598|80207583|FG006|Overall Study|Subject not dosed|0|||
27551807|NCT00793598|80207584|FG007|Overall Study|Subject not dosed|0|||
27551808|NCT00230607|80207585|FG000|Overall Study|Other|3|||
27551809|NCT01402492|80207586|FG000|Overall Study|Withdrawal by Subject|17|||
27551810|NCT01402492|80207587|FG001|Overall Study|Withdrawal by Subject|11|||
27551811|NCT01402492|80207588|FG002|Overall Study|Withdrawal by Subject|11|||
27551812|NCT01402492|80207586|FG000|Overall Study|Adverse Event|2|||
27551813|NCT01402492|80207587|FG001|Overall Study|Adverse Event|3|||
27551814|NCT01402492|80207588|FG002|Overall Study|Adverse Event|4|||
27551815|NCT01402492|80207586|FG000|Overall Study|Physician Decision|0|||
27551816|NCT01402492|80207587|FG001|Overall Study|Physician Decision|3|||
27551817|NCT01402492|80207588|FG002|Overall Study|Physician Decision|0|||
27551818|NCT01402492|80207586|FG000|Overall Study|Incarcerated (N=3)|2|||
27551819|NCT01402492|80207587|FG001|Overall Study|Incarcerated (N=3)|0|||
27551820|NCT01402492|80207588|FG002|Overall Study|Incarcerated (N=3)|1|||
27551821|NCT03700671|80207589|FG000|Overall Study|Lack of Efficacy|1|||
27551822|NCT03700671|80207590|FG001|Overall Study|Lack of Efficacy|2|||
27551823|NCT00867009|80207592|FG000|Induction Period|Nonserious Adverse Event|5|||
27551824|NCT00867009|80207592|FG000|Induction Period|Serious Adverse Event|10|||
27551825|NCT00867009|80207592|FG000|Induction Period|Death due to serious adverse event|6|||
27551826|NCT00867009|80207592|FG000|Induction Period|Death due to Study Disease|4|||
27551827|NCT00867009|80207592|FG000|Induction Period|Protocol Violation|1|||
27551828|NCT00867009|80207592|FG000|Induction Period|Withdrawal by Subject|8|||
27551829|NCT00867009|80207592|FG000|Induction Period|Physician Decision|3|||
27551830|NCT00867009|80207592|FG000|Induction Period|Progressive Disease (PD)|25|||
27551831|NCT00867009|80207592|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
27551832|NCT03462082|80207593|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
27551833|NCT03462082|80207594|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
27551834|NCT03462082|80207595|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
27551835|NCT03462082|80207596|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
27551836|NCT03462082|80207597|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
27551837|NCT03462082|80207598|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
27551838|NCT03462082|80207599|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
27551839|NCT03462082|80207600|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
27551840|NCT02132130|80207601|FG000|Overall Study|Lost to Follow-up|0|||
27551841|NCT02132130|80207602|FG001|Overall Study|Lost to Follow-up|2|||
27551842|NCT02132130|80207603|FG002|Overall Study|Lost to Follow-up|0|||
27551843|NCT02132130|80207604|FG003|Overall Study|Lost to Follow-up|0|||
27551844|NCT02132130|80207601|FG000|Overall Study|Withdrawal by Subject|0|||
27551845|NCT02132130|80207602|FG001|Overall Study|Withdrawal by Subject|0|||
27551846|NCT02132130|80207603|FG002|Overall Study|Withdrawal by Subject|0|||
27551847|NCT02132130|80207604|FG003|Overall Study|Withdrawal by Subject|1|||
27753455|NCT02175771|80925861|FG000|Treatment Period|Disease progression|0|||
27753456|NCT02175771|80925862|FG001|Treatment Period|Disease progression|0|||
27753457|NCT02175771|80925863|FG002|Treatment Period|Disease progression|0|||
27753458|NCT02175771|80925864|FG003|Treatment Period|Disease progression|0|||
27753459|NCT02175771|80925865|FG004|Treatment Period|Disease progression|0|||
27753460|NCT02175771|80925866|FG005|Treatment Period|Disease progression|0|||
27753461|NCT02175771|80925867|FG006|Treatment Period|Disease progression|0|||
27753462|NCT02175771|80925868|FG007|Treatment Period|Disease progression|2|||
27753463|NCT02175771|80925869|FG008|Treatment Period|Disease progression|0|||
27753464|NCT02175771|80925861|FG000|Treatment Period|Lost to Follow-up|0|||
27753465|NCT02175771|80925862|FG001|Treatment Period|Lost to Follow-up|3|||
27753466|NCT02175771|80925863|FG002|Treatment Period|Lost to Follow-up|1|||
27753467|NCT02175771|80925864|FG003|Treatment Period|Lost to Follow-up|3|||
27753468|NCT02175771|80925865|FG004|Treatment Period|Lost to Follow-up|1|||
27753469|NCT02175771|80925866|FG005|Treatment Period|Lost to Follow-up|2|||
27753470|NCT02175771|80925867|FG006|Treatment Period|Lost to Follow-up|1|||
27753471|NCT02175771|80925868|FG007|Treatment Period|Lost to Follow-up|2|||
27753472|NCT02175771|80925869|FG008|Treatment Period|Lost to Follow-up|2|||
27753473|NCT02175771|80925861|FG000|Treatment Period|Lack of Efficacy|0|||
27753474|NCT02175771|80925862|FG001|Treatment Period|Lack of Efficacy|0|||
27753475|NCT02175771|80925863|FG002|Treatment Period|Lack of Efficacy|0|||
27753476|NCT02175771|80925864|FG003|Treatment Period|Lack of Efficacy|0|||
27753477|NCT02175771|80925865|FG004|Treatment Period|Lack of Efficacy|0|||
27753478|NCT02175771|80925866|FG005|Treatment Period|Lack of Efficacy|1|||
27753479|NCT02175771|80925867|FG006|Treatment Period|Lack of Efficacy|0|||
27753480|NCT02175771|80925868|FG007|Treatment Period|Lack of Efficacy|1|||
27753481|NCT02175771|80925869|FG008|Treatment Period|Lack of Efficacy|0|||
27753482|NCT02175771|80925861|FG000|Treatment Period|Other|0|||
27753483|NCT02175771|80925862|FG001|Treatment Period|Other|1|||
27753484|NCT02175771|80925863|FG002|Treatment Period|Other|0|||
27753485|NCT02175771|80925864|FG003|Treatment Period|Other|3|||
27753486|NCT02175771|80925865|FG004|Treatment Period|Other|1|||
27753487|NCT02175771|80925866|FG005|Treatment Period|Other|0|||
27753488|NCT02175771|80925867|FG006|Treatment Period|Other|0|||
27753489|NCT02175771|80925868|FG007|Treatment Period|Other|2|||
27753490|NCT02175771|80925869|FG008|Treatment Period|Other|0|||
27753491|NCT00568958|80925870|FG000|Allocation|Withdrawal by Subject|7|||
27753492|NCT00568958|80925871|FG001|Allocation|Withdrawal by Subject|3|||
27753493|NCT00568958|80925870|FG000|Allocation|Physician Decision|2|||
27753494|NCT00568958|80925871|FG001|Allocation|Physician Decision|0|||
27753495|NCT00568958|80925870|FG000|Follow-Up|Withdrawal by Subject|6|||
27753496|NCT00568958|80925871|FG001|Follow-Up|Withdrawal by Subject|6|||
27753497|NCT00568958|80925870|FG000|Follow-Up|Physician Decision|1|||
27753498|NCT00568958|80925871|FG001|Follow-Up|Physician Decision|1|||
27753499|NCT00568958|80925870|FG000|Follow-Up|Family Emergency|1|||
27753500|NCT00568958|80925871|FG001|Follow-Up|Family Emergency|0|||
27753501|NCT00568958|80925870|FG000|Follow-Up|Adverse Event|1|||
27753502|NCT00568958|80925871|FG001|Follow-Up|Adverse Event|0|||
27753503|NCT04501679|80925872|FG000|Overall Study|Pregnancy|0|||
27753504|NCT04501679|80925873|FG001|Overall Study|Pregnancy|1|||
27753505|NCT04501679|80925872|FG000|Overall Study|Adverse Event|4|||
27753506|NCT04501679|80925873|FG001|Overall Study|Adverse Event|2|||
27753507|NCT04501679|80925872|FG000|Overall Study|Withdrawal by Subject|2|||
27753508|NCT04501679|80925873|FG001|Overall Study|Withdrawal by Subject|0|||
27753509|NCT04501679|80925872|FG000|Overall Study|Physician Decision|1|||
27753510|NCT04501679|80925873|FG001|Overall Study|Physician Decision|0|||
27753511|NCT04501679|80925872|FG000|Overall Study|Lost to Follow-up|2|||
27753512|NCT04501679|80925873|FG001|Overall Study|Lost to Follow-up|0|||
27753513|NCT02918266|80925878|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
27753514|NCT02918266|80925879|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753515|NCT02918266|80925880|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753516|NCT02918266|80925881|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753517|NCT02918266|80925882|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753518|NCT02918266|80925883|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753519|NCT02918266|80925884|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
27753520|NCT02918266|80925885|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753521|NCT02918266|80925886|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
27753522|NCT02918266|80925887|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753523|NCT02918266|80925888|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
27753524|NCT05127421|80925889|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
27753525|NCT05127421|80925890|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
27753526|NCT05127421|80925891|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
27753527|NCT05127421|80925892|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
27753528|NCT05127421|80925889|FG000|4-Week Double-Blind Period|Physician Decision|1|||
27753529|NCT05127421|80925890|FG001|4-Week Double-Blind Period|Physician Decision|0|||
27753530|NCT05127421|80925891|FG002|4-Week Double-Blind Period|Physician Decision|0|||
27753531|NCT05127421|80925892|FG003|4-Week Double-Blind Period|Physician Decision|0|||
27753532|NCT05127421|80925889|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
27753533|NCT05127421|80925890|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
27753534|NCT05127421|80925891|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
27753535|NCT05127421|80925892|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
27753536|NCT05127421|80925889|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
27753537|NCT05127421|80925890|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
27753538|NCT05127421|80925891|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
27753539|NCT05127421|80925892|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
27753540|NCT05127421|80925889|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
27753541|NCT05127421|80925890|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
27753542|NCT05127421|80925891|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
27753543|NCT05127421|80925892|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
27753544|NCT05127421|80925889|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
27753545|NCT05127421|80925890|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
27753546|NCT05127421|80925891|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
27753547|NCT05127421|80925892|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
27753548|NCT05127421|80925889|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
27753549|NCT05127421|80925890|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
27753550|NCT05127421|80925891|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
27753551|NCT05127421|80925892|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
27753552|NCT05127421|80925889|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
27753553|NCT05127421|80925890|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
27753554|NCT05127421|80925891|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
27753555|NCT05127421|80925892|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
27753556|NCT00436566|80925895|FG000|Overall Study|Withdrawal by Subject|2|||
27753557|NCT00436566|80925895|FG000|Overall Study|Protocol Violation|1|||
27753558|NCT02868216|80925897|FG000|Overall Study|Death|0|||
27753559|NCT02868216|80925898|FG001|Overall Study|Death|1|||
27753560|NCT02868216|80925897|FG000|Overall Study|coronary artery bypass|1|||
27753561|NCT02868216|80925898|FG001|Overall Study|coronary artery bypass|0|||
27753562|NCT02868216|80925897|FG000|Overall Study|Withdrawal by Subject|7|||
27753563|NCT02868216|80925898|FG001|Overall Study|Withdrawal by Subject|5|||
27753564|NCT02324842|80925903|FG000|Overall Study|Lost to Follow-up|1|||
27753565|NCT02324842|80925904|FG001|Overall Study|Lost to Follow-up|1|||
27753566|NCT02324842|80925905|FG002|Overall Study|Lost to Follow-up|2|||
27753567|NCT04426825|80925906|FG000|Overall Study|Death|17|||
27753568|NCT04426825|80925906|FG000|Overall Study|Lost to Follow-up|1|||
27753569|NCT04426825|80925906|FG000|Overall Study|Study terminated by sponsor|5|||
27753570|NCT03364608|80925907|FG000|Overall Study|Withdrawal by Subject|4|||
27753571|NCT03364608|80925907|FG000|Overall Study|Protocol Violation|2|||
27753572|NCT03364608|80925907|FG000|Overall Study|Lost to Follow-up|2|||
27753573|NCT02340819|80925911|FG000|Overall Study|Adverse Event|1|||
27753574|NCT02340819|80925911|FG000|Overall Study|Withdrawal by Subject|2|||
27753575|NCT02340819|80925911|FG000|Overall Study|Discontinued with other reason|1|||
27753576|NCT00986427|80925912|FG000|Overall Study|Lost to Follow-up|2|||
27753577|NCT00986427|80925913|FG001|Overall Study|Lost to Follow-up|0|||
27753578|NCT00986427|80925912|FG000|Overall Study|Lack of Efficacy|1|||
27753579|NCT00986427|80925913|FG001|Overall Study|Lack of Efficacy|0|||
27753580|NCT00986427|80925912|FG000|Overall Study|Withdrawal by Subject|1|||
27753581|NCT00986427|80925913|FG001|Overall Study|Withdrawal by Subject|0|||
27753582|NCT01525849|80925918|FG000|Overall Study|Lost to Follow-up|3|||
27753583|NCT01525849|80925919|FG001|Overall Study|Lost to Follow-up|2|||
27753584|NCT01525849|80925918|FG000|Overall Study|Withdrawal by Subject|1|||
27753585|NCT01525849|80925919|FG001|Overall Study|Withdrawal by Subject|9|||
27753586|NCT01525849|80925918|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
27753587|NCT01525849|80925919|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
27753588|NCT01525849|80925918|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
27753589|NCT01525849|80925919|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
27753590|NCT01996904|80925920|FG000|Overall Study|Lost to Follow-up|38|||
27753591|NCT01996904|80925921|FG001|Overall Study|Lost to Follow-up|27|||
27753592|NCT00632541|80925922|FG000|Overall Study|Adverse Event|7|||
27753593|NCT03628508|80925926|FG000|Overall Study|Lost to Follow-up|1|||
27753594|NCT00625365|80925927|FG000|Overall Study|Withdrawal by Subject|1|||
27753595|NCT00625365|80925927|FG000|Overall Study|No IV access|5|||
27753596|NCT00625365|80925927|FG000|Overall Study|VSD|1|||
27753597|NCT02436577|80925928|FG000|Overall Study|Protocol Deviation|0|||
27753598|NCT02436577|80925929|FG001|Overall Study|Protocol Deviation|1|||
27753599|NCT02436577|80925930|FG002|Overall Study|Protocol Deviation|0|||
27753600|NCT02436577|80925931|FG003|Overall Study|Protocol Deviation|0|||
27753601|NCT02436577|80925932|FG004|Overall Study|Protocol Deviation|0|||
27753602|NCT02436577|80925933|FG005|Overall Study|Protocol Deviation|0|||
27753603|NCT04737031|80925935|FG000|Overall Study|Patients who did not have a treatment visit|0|||
27753604|NCT04737031|80925936|FG001|Overall Study|Patients who did not have a treatment visit|31|||
27753605|NCT04737031|80925937|FG002|Overall Study|Patients who did not have a treatment visit|93|||
27753606|NCT04737031|80925938|FG003|Overall Study|Patients who did not have a treatment visit|227|||
27753607|NCT01830543|80925941|FG000|Overall Study|Subject Decision|19|||
27753608|NCT01830543|80925942|FG001|Overall Study|Subject Decision|21|||
27753609|NCT01830543|80925943|FG002|Overall Study|Subject Decision|57|||
27753610|NCT01830543|80925941|FG000|Overall Study|Adverse Event|91|||
27753611|NCT01830543|80925942|FG001|Overall Study|Adverse Event|77|||
27753612|NCT01830543|80925943|FG002|Overall Study|Adverse Event|76|||
27753613|NCT01830543|80925941|FG000|Overall Study|Death|20|||
27753614|NCT01830543|80925942|FG001|Overall Study|Death|22|||
27753615|NCT01830543|80925943|FG002|Overall Study|Death|22|||
27753616|NCT01830543|80925941|FG000|Overall Study|Protocol Violation|3|||
27753617|NCT01830543|80925942|FG001|Overall Study|Protocol Violation|7|||
27753618|NCT01830543|80925943|FG002|Overall Study|Protocol Violation|7|||
27753619|NCT01830543|80925941|FG000|Overall Study|Physician Decision|11|||
27753620|NCT01830543|80925942|FG001|Overall Study|Physician Decision|5|||
27753621|NCT01830543|80925943|FG002|Overall Study|Physician Decision|12|||
27753622|NCT01830543|80925941|FG000|Overall Study|Withdrawal by consent|3|||
27753623|NCT01830543|80925942|FG001|Overall Study|Withdrawal by consent|3|||
27753624|NCT01830543|80925943|FG002|Overall Study|Withdrawal by consent|3|||
27753625|NCT01830543|80925941|FG000|Overall Study|Other|12|||
27753626|NCT01830543|80925942|FG001|Overall Study|Other|17|||
27753627|NCT01830543|80925943|FG002|Overall Study|Other|37|||
27753628|NCT01774344|80925944|FG000|Overall Study|Withdrawal by Subject|3|||
27753629|NCT01774344|80925945|FG001|Overall Study|Withdrawal by Subject|10|||
27753630|NCT01774344|80925944|FG000|Overall Study|Protocol Violation|0|||
27753631|NCT01774344|80925945|FG001|Overall Study|Protocol Violation|1|||
27753632|NCT01774344|80925944|FG000|Overall Study|Lost to Follow-up|4|||
27753633|NCT01774344|80925945|FG001|Overall Study|Lost to Follow-up|10|||
27753634|NCT01774344|80925944|FG000|Overall Study|End of survival follow-up not available|2|||
27753635|NCT01774344|80925945|FG001|Overall Study|End of survival follow-up not available|2|||
27753636|NCT01774344|80925944|FG000|Overall Study|Data collection finished|4|||
27753637|NCT01774344|80925945|FG001|Overall Study|Data collection finished|14|||
27753638|NCT01774344|80925944|FG000|Overall Study|Other|0|||
27753639|NCT01774344|80925945|FG001|Overall Study|Other|1|||
27753640|NCT01774344|80925944|FG000|Overall Study|Did not enter Survival Follow up|49|||
27753641|NCT01774344|80925945|FG001|Overall Study|Did not enter Survival Follow up|83|||
27753642|NCT01163253|80925946|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
27753643|NCT01163253|80925947|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
27753644|NCT01163253|80925946|FG000|Overall Study|Study Terminated by Sponsor|978|||
27753645|NCT01163253|80925947|FG001|Overall Study|Study Terminated by Sponsor|349|||
27753646|NCT01163253|80925946|FG000|Overall Study|Protocol Violation|43|||
27753647|NCT01163253|80925947|FG001|Overall Study|Protocol Violation|12|||
27753648|NCT01163253|80925946|FG000|Overall Study|Withdrawal by Subject|199|||
27753649|NCT01163253|80925947|FG001|Overall Study|Withdrawal by Subject|50|||
27753650|NCT01163253|80925946|FG000|Overall Study|Medication Error|1|||
27753651|NCT01163253|80925947|FG001|Overall Study|Medication Error|0|||
27753652|NCT01163253|80925946|FG000|Overall Study|Lost to Follow-up|125|||
27753653|NCT01163253|80925947|FG001|Overall Study|Lost to Follow-up|23|||
27753654|NCT01163253|80925946|FG000|Overall Study|Insufficient Clinical Response|423|||
27753655|NCT01163253|80925947|FG001|Overall Study|Insufficient Clinical Response|29|||
27753656|NCT01163253|80925946|FG000|Overall Study|Adverse Event|300|||
27753657|NCT01163253|80925947|FG001|Overall Study|Adverse Event|78|||
27753658|NCT01163253|80925946|FG000|Overall Study|Death|17|||
27753659|NCT01163253|80925947|FG001|Overall Study|Death|5|||
27753660|NCT01163253|80925946|FG000|Overall Study|Ongoing|13|||
27753661|NCT01163253|80925947|FG001|Overall Study|Ongoing|4|||
27753662|NCT01163253|80925946|FG000|Overall Study|Other Unspecified|170|||
27753663|NCT01163253|80925947|FG001|Overall Study|Other Unspecified|34|||
27753664|NCT00578864|80925948|FG000|Overall Study|Death|1|||
27753665|NCT00578864|80925949|FG001|Overall Study|Death|0|||
27753666|NCT02364947|80925952|FG000|Overall Study|Withdrawal by Subject|10|||
27753667|NCT02364947|80925953|FG001|Overall Study|Withdrawal by Subject|8|||
27753668|NCT02364947|80925954|FG002|Overall Study|Withdrawal by Subject|9|||
27753669|NCT02364947|80925952|FG000|Overall Study|Adverse Event|45|||
27753670|NCT02364947|80925953|FG001|Overall Study|Adverse Event|33|||
27753671|NCT02364947|80925954|FG002|Overall Study|Adverse Event|11|||
27753672|NCT02364947|80925952|FG000|Overall Study|Protocol Violation|1|||
27753673|NCT02364947|80925953|FG001|Overall Study|Protocol Violation|1|||
27753674|NCT02364947|80925954|FG002|Overall Study|Protocol Violation|1|||
27753675|NCT02364947|80925952|FG000|Overall Study|Physician Decision|3|||
27753676|NCT02364947|80925953|FG001|Overall Study|Physician Decision|2|||
27753677|NCT02364947|80925954|FG002|Overall Study|Physician Decision|5|||
27753678|NCT02364947|80925952|FG000|Overall Study|Death|0|||
27753679|NCT02364947|80925953|FG001|Overall Study|Death|1|||
27753680|NCT02364947|80925954|FG002|Overall Study|Death|0|||
27753681|NCT00752609|80925955|FG000|Overall Study|Adverse Event|2|||
27753682|NCT00752609|80925956|FG001|Overall Study|Adverse Event|2|||
27753683|NCT00752609|80925955|FG000|Overall Study|Withdrawal by Subject|3|||
27753684|NCT00752609|80925956|FG001|Overall Study|Withdrawal by Subject|0|||
27753685|NCT00752609|80925955|FG000|Overall Study|Physician Decision|1|||
27753686|NCT00752609|80925956|FG001|Overall Study|Physician Decision|0|||
27753687|NCT00752609|80925955|FG000|Overall Study|Death|1|||
27753688|NCT00752609|80925956|FG001|Overall Study|Death|0|||
27753689|NCT00752609|80925955|FG000|Overall Study|Met exclusion criteria|1|||
27753690|NCT00752609|80925956|FG001|Overall Study|Met exclusion criteria|0|||
27753691|NCT00752609|80925955|FG000|Overall Study|Received Aranesp in error|1|||
27753692|NCT00752609|80925956|FG001|Overall Study|Received Aranesp in error|0|||
27753693|NCT03888391|80925959|FG000|Overall Study|Lost to Follow-up|15|||
27753694|NCT01096849|80925960|FG000|Overall Study|Consent Withdrawn|1|||
27753695|NCT01096849|80925961|FG001|Overall Study|Consent Withdrawn|4|||
27753696|NCT01096849|80925962|FG002|Overall Study|Consent Withdrawn|2|||
27753697|NCT01096849|80925960|FG000|Overall Study|Lack of Efficacy|0|||
27753698|NCT01096849|80925961|FG001|Overall Study|Lack of Efficacy|2|||
27753699|NCT01096849|80925962|FG002|Overall Study|Lack of Efficacy|0|||
27753700|NCT01096849|80925960|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
27753701|NCT01096849|80925961|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
27753702|NCT01096849|80925962|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
27753703|NCT01096849|80925960|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
27753704|NCT01096849|80925961|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
27753705|NCT01096849|80925962|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
27753706|NCT01096849|80925960|FG000|Overall Study|Administrative Reasons|0|||
27753707|NCT01096849|80925961|FG001|Overall Study|Administrative Reasons|1|||
27753708|NCT01096849|80925962|FG002|Overall Study|Administrative Reasons|2|||
27753709|NCT01096849|80925960|FG000|Overall Study|Lost to Follow-up|1|||
27753710|NCT01096849|80925961|FG001|Overall Study|Lost to Follow-up|3|||
27753711|NCT01096849|80925962|FG002|Overall Study|Lost to Follow-up|1|||
27753712|NCT01072539|80925963|FG000|Overall Study|Treated prior to the Site Initiation|1|||
27753713|NCT01072539|80925963|FG000|Overall Study|Protocol Violation|2|||
27753714|NCT02006667|80925964|FG000|Overall Study|Adverse Event|3|||
27753715|NCT02006667|80925964|FG000|Overall Study|Death|2|||
27753716|NCT02006667|80925964|FG000|Overall Study|Withdrawal by Subject|1|||
27753717|NCT04715230|80925965|FG000|Overall Study|Withdrawal by Subject|1|||
27753718|NCT04715230|80925966|FG001|Overall Study|Withdrawal by Subject|0|||
27753719|NCT04715230|80925967|FG002|Overall Study|Withdrawal by Subject|0|||
27753720|NCT04715230|80925965|FG000|Overall Study|Lost to Follow-up|0|||
27753721|NCT04715230|80925966|FG001|Overall Study|Lost to Follow-up|5|||
27753722|NCT04715230|80925967|FG002|Overall Study|Lost to Follow-up|1|||
27753723|NCT02410902|80925968|FG000|Overall Study|Adverse Event|2|||
27753724|NCT02410902|80925969|FG001|Overall Study|Adverse Event|3|||
27753725|NCT02410902|80925968|FG000|Overall Study|Lost to Follow-up|4|||
27753726|NCT02410902|80925969|FG001|Overall Study|Lost to Follow-up|1|||
27753727|NCT02410902|80925968|FG000|Overall Study|Protocol Violation|1|||
27753728|NCT02410902|80925969|FG001|Overall Study|Protocol Violation|4|||
27753729|NCT02410902|80925968|FG000|Overall Study|Withdrawal by Subject|6|||
27753730|NCT02410902|80925969|FG001|Overall Study|Withdrawal by Subject|8|||
27753731|NCT02410902|80925968|FG000|Overall Study|Non-Compliance|8|||
27753732|NCT02410902|80925969|FG001|Overall Study|Non-Compliance|2|||
27753733|NCT01826422|80925970|FG000|Overall Study|Withdrawal by Subject|1|||
27753734|NCT01826422|80925971|FG001|Overall Study|Withdrawal by Subject|3|||
27753735|NCT00115804|80925972|FG000|Overall Study|Adverse Event|2|||
27753736|NCT00074412|80925973|FG000|Overall Study|Death|30|||
27753737|NCT00074412|80925974|FG001|Overall Study|Death|26|||
27753738|NCT00074412|80925973|FG000|Overall Study|Lost to Follow-up|52|||
27753739|NCT00074412|80925974|FG001|Overall Study|Lost to Follow-up|58|||
27753740|NCT00995345|80925975|FG000|Overall Study|Withdrawal by Subject|4|||
27753741|NCT00995345|80925976|FG001|Overall Study|Withdrawal by Subject|2|||
27753742|NCT00995345|80925977|FG002|Overall Study|Withdrawal by Subject|1|||
27753743|NCT00995345|80925978|FG003|Overall Study|Withdrawal by Subject|3|||
27753744|NCT00995345|80925979|FG004|Overall Study|Withdrawal by Subject|1|||
27753745|NCT00995345|80925975|FG000|Overall Study|Adverse Event|3|||
27753746|NCT00995345|80925976|FG001|Overall Study|Adverse Event|1|||
27753747|NCT00995345|80925977|FG002|Overall Study|Adverse Event|2|||
27753748|NCT00995345|80925978|FG003|Overall Study|Adverse Event|0|||
27753749|NCT00995345|80925979|FG004|Overall Study|Adverse Event|1|||
27753750|NCT00995345|80925975|FG000|Overall Study|Lost to Follow-up|2|||
27753751|NCT00995345|80925976|FG001|Overall Study|Lost to Follow-up|2|||
27753752|NCT00995345|80925977|FG002|Overall Study|Lost to Follow-up|2|||
27753753|NCT00995345|80925978|FG003|Overall Study|Lost to Follow-up|1|||
27753754|NCT00995345|80925979|FG004|Overall Study|Lost to Follow-up|0|||
27753755|NCT00995345|80925975|FG000|Overall Study|all other reasons combined|2|||
27753756|NCT00995345|80925976|FG001|Overall Study|all other reasons combined|2|||
27753757|NCT00995345|80925977|FG002|Overall Study|all other reasons combined|2|||
27753758|NCT00995345|80925978|FG003|Overall Study|all other reasons combined|1|||
27753759|NCT00995345|80925979|FG004|Overall Study|all other reasons combined|3|||
27753760|NCT00782418|80925983|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
27753761|NCT00782418|80925984|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27753762|NCT00782418|80925985|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27753763|NCT00782418|80925986|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27753764|NCT00782418|80925987|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27753765|NCT00782418|80925988|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27753766|NCT00782418|80925989|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
27753767|NCT00782418|80925983|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
27753768|NCT00782418|80925984|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27753769|NCT00782418|80925985|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27753770|NCT00782418|80925986|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27753771|NCT00782418|80925987|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
27753772|NCT00782418|80925988|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
27753773|NCT00782418|80925989|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
27753774|NCT00937560|80925990|FG000|Initial Treatment|Death|6|||
27753775|NCT00937560|80925990|FG000|Initial Treatment|Withdraw consent|3|||
27753776|NCT00937560|80925990|FG000|Initial Treatment|Adverse Event|1|||
27753777|NCT00937560|80925990|FG000|Initial Treatment|Lost to Follow-up|1|||
27753778|NCT00937560|80925990|FG000|Initial Treatment|No end of study page|10|||
27753779|NCT00937560|80925990|FG000|Maintenance Treatment|Death|12|||
27753780|NCT00937560|80925990|FG000|Maintenance Treatment|Withdraw consent|5|||
27753781|NCT00937560|80925990|FG000|Maintenance Treatment|According to protocol|1|||
27753782|NCT01008995|80925991|FG000|Controlled Period|Adverse Event|1|||
27753783|NCT01008995|80925992|FG001|Controlled Period|Adverse Event|2|||
27753784|NCT01008995|80925993|FG002|Controlled Period|Adverse Event|0|||
27753785|NCT01008995|80925994|FG003|Controlled Period|Adverse Event|0|||
27753786|NCT01008995|80925991|FG000|Controlled Period|Other|2|||
27753787|NCT01008995|80925992|FG001|Controlled Period|Other|1|||
27753788|NCT01008995|80925993|FG002|Controlled Period|Other|0|||
27753789|NCT01008995|80925994|FG003|Controlled Period|Other|0|||
27753790|NCT01008995|80925991|FG000|After Controlled Period|Adverse Event|0|||
27753791|NCT01008995|80925992|FG001|After Controlled Period|Adverse Event|0|||
27753792|NCT01008995|80925993|FG002|After Controlled Period|Adverse Event|1|||
27753793|NCT01008995|80925994|FG003|After Controlled Period|Adverse Event|1|||
27753794|NCT01008995|80925991|FG000|After Controlled Period|Other|0|||
27753795|NCT01008995|80925992|FG001|After Controlled Period|Other|0|||
27753796|NCT01008995|80925993|FG002|After Controlled Period|Other|1|||
27753797|NCT01008995|80925994|FG003|After Controlled Period|Other|0|||
27753798|NCT02768194|80925997|FG000|Period 1|Adverse Event|0|||
27753799|NCT02768194|80925998|FG001|Period 1|Adverse Event|0|||
27753800|NCT02768194|80925999|FG002|Period 1|Adverse Event|0|||
27753801|NCT02768194|80926000|FG003|Period 1|Adverse Event|1|||
27753802|NCT02768194|80926001|FG004|Period 1|Adverse Event|0|||
27753803|NCT02768194|80926002|FG005|Period 1|Adverse Event|0|||
27753804|NCT02768194|80925997|FG000|Period 2|Other (Reason not specified)|1|||
27753805|NCT02768194|80925998|FG001|Period 2|Other (Reason not specified)|0|||
27753806|NCT02768194|80925999|FG002|Period 2|Other (Reason not specified)|0|||
27753807|NCT02768194|80926000|FG003|Period 2|Other (Reason not specified)|0|||
27753808|NCT02768194|80926001|FG004|Period 2|Other (Reason not specified)|0|||
27753809|NCT02768194|80926002|FG005|Period 2|Other (Reason not specified)|0|||
27753810|NCT02768194|80925997|FG000|Period 3|Other (Reason not specified)|0|||
27753811|NCT02768194|80925998|FG001|Period 3|Other (Reason not specified)|1|||
27753812|NCT02768194|80925999|FG002|Period 3|Other (Reason not specified)|0|||
27753813|NCT02768194|80926000|FG003|Period 3|Other (Reason not specified)|0|||
27753814|NCT02768194|80926001|FG004|Period 3|Other (Reason not specified)|0|||
27753815|NCT02768194|80926002|FG005|Period 3|Other (Reason not specified)|0|||
27753816|NCT03150095|80926010|FG000|Overall Study|Death|0|||
27753817|NCT03150095|80926011|FG001|Overall Study|Death|1|||
27753818|NCT03150095|80926010|FG000|Overall Study|Lost to Follow-up|1|||
27753819|NCT03150095|80926011|FG001|Overall Study|Lost to Follow-up|1|||
27753820|NCT03150095|80926010|FG000|Overall Study|Withdrawal by Subject|4|||
27753821|NCT03150095|80926011|FG001|Overall Study|Withdrawal by Subject|0|||
27753822|NCT03150095|80926010|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
27753823|NCT03150095|80926011|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
27753824|NCT00121992|80926012|FG000|Overall Study|Treatment not received|2|||
27753825|NCT00121992|80926013|FG001|Overall Study|Treatment not received|11|||
27753826|NCT00937768|80926014|FG000|Overall Study|Refused Further Treatment|3|||
27753827|NCT00937768|80926015|FG001|Overall Study|Refused Further Treatment|2|||
27753828|NCT00937768|80926014|FG000|Overall Study|Disease Progression|1|||
27753829|NCT00937768|80926015|FG001|Overall Study|Disease Progression|1|||
27753830|NCT00937768|80926014|FG000|Overall Study|Alternate Treatment|0|||
27753831|NCT00937768|80926015|FG001|Overall Study|Alternate Treatment|1|||
27753832|NCT00937768|80926014|FG000|Overall Study|No Further Funding|4|||
27753833|NCT00937768|80926015|FG001|Overall Study|No Further Funding|4|||
27753834|NCT01683071|80926016|FG000|Part 1|Lack of Efficacy|1|||
27753835|NCT01683071|80926017|FG001|Part 1|Lack of Efficacy|0|||
27753836|NCT01683071|80926018|FG002|Part 1|Lack of Efficacy|0|||
27753837|NCT01683071|80926019|FG003|Part 1|Lack of Efficacy|3|||
27753838|NCT01683071|80926020|FG004|Part 1|Lack of Efficacy|0|||
27753839|NCT01683071|80926021|FG005|Part 1|Lack of Efficacy|0|||
27753840|NCT01683071|80926016|FG000|Part 1|Withdrawal by Subject|1|||
27753841|NCT01683071|80926017|FG001|Part 1|Withdrawal by Subject|2|||
27753842|NCT01683071|80926018|FG002|Part 1|Withdrawal by Subject|2|||
27753843|NCT01683071|80926019|FG003|Part 1|Withdrawal by Subject|1|||
27753844|NCT01683071|80926020|FG004|Part 1|Withdrawal by Subject|0|||
27753845|NCT01683071|80926021|FG005|Part 1|Withdrawal by Subject|0|||
27753846|NCT01683071|80926016|FG000|Part 1|Surgery Cancelled|1|||
27753847|NCT01683071|80926017|FG001|Part 1|Surgery Cancelled|0|||
27753848|NCT01683071|80926018|FG002|Part 1|Surgery Cancelled|0|||
27753849|NCT01683071|80926019|FG003|Part 1|Surgery Cancelled|0|||
27753850|NCT01683071|80926020|FG004|Part 1|Surgery Cancelled|0|||
27753851|NCT01683071|80926021|FG005|Part 1|Surgery Cancelled|0|||
27753852|NCT01683071|80926016|FG000|Part 1|Did not receive study drug|1|||
27753853|NCT01683071|80926017|FG001|Part 1|Did not receive study drug|0|||
27753854|NCT01683071|80926018|FG002|Part 1|Did not receive study drug|0|||
27753855|NCT01683071|80926019|FG003|Part 1|Did not receive study drug|1|||
27753856|NCT01683071|80926020|FG004|Part 1|Did not receive study drug|0|||
27753857|NCT01683071|80926021|FG005|Part 1|Did not receive study drug|0|||
27753858|NCT01683071|80926016|FG000|Part 1|Early termination; met exclusion criteria|0|||
27753859|NCT01683071|80926017|FG001|Part 1|Early termination; met exclusion criteria|2|||
27753860|NCT01683071|80926018|FG002|Part 1|Early termination; met exclusion criteria|1|||
27753861|NCT01683071|80926019|FG003|Part 1|Early termination; met exclusion criteria|0|||
27753862|NCT01683071|80926020|FG004|Part 1|Early termination; met exclusion criteria|0|||
27753863|NCT01683071|80926021|FG005|Part 1|Early termination; met exclusion criteria|0|||
27753864|NCT01683071|80926016|FG000|Part 2|Lack of Efficacy|0|||
27753865|NCT01683071|80926017|FG001|Part 2|Lack of Efficacy|0|||
27753866|NCT01683071|80926018|FG002|Part 2|Lack of Efficacy|0|||
27753867|NCT01683071|80926019|FG003|Part 2|Lack of Efficacy|0|||
27753868|NCT01683071|80926020|FG004|Part 2|Lack of Efficacy|3|||
27753869|NCT01683071|80926021|FG005|Part 2|Lack of Efficacy|4|||
27753870|NCT01683071|80926016|FG000|Part 2|Lost to Follow-up|0|||
27753871|NCT01683071|80926017|FG001|Part 2|Lost to Follow-up|0|||
27753872|NCT01683071|80926018|FG002|Part 2|Lost to Follow-up|0|||
27753873|NCT01683071|80926019|FG003|Part 2|Lost to Follow-up|0|||
27753874|NCT01683071|80926020|FG004|Part 2|Lost to Follow-up|2|||
27753875|NCT01683071|80926021|FG005|Part 2|Lost to Follow-up|0|||
27753876|NCT01683071|80926016|FG000|Part 2|Withdrawal by Subject|0|||
27753877|NCT01683071|80926017|FG001|Part 2|Withdrawal by Subject|0|||
27753878|NCT01683071|80926018|FG002|Part 2|Withdrawal by Subject|0|||
27753879|NCT01683071|80926019|FG003|Part 2|Withdrawal by Subject|0|||
27753880|NCT01683071|80926020|FG004|Part 2|Withdrawal by Subject|3|||
27753881|NCT01683071|80926021|FG005|Part 2|Withdrawal by Subject|3|||
27753882|NCT01683071|80926016|FG000|Part 2|Surgery cancelled|0|||
27753883|NCT01683071|80926017|FG001|Part 2|Surgery cancelled|0|||
27753884|NCT01683071|80926018|FG002|Part 2|Surgery cancelled|0|||
27753885|NCT01683071|80926019|FG003|Part 2|Surgery cancelled|0|||
27753886|NCT01683071|80926020|FG004|Part 2|Surgery cancelled|4|||
27753887|NCT01683071|80926021|FG005|Part 2|Surgery cancelled|2|||
27753888|NCT01683071|80926016|FG000|Part 2|Did not receive study drug|0|||
27753889|NCT01683071|80926017|FG001|Part 2|Did not receive study drug|0|||
27753890|NCT01683071|80926018|FG002|Part 2|Did not receive study drug|0|||
27753891|NCT01683071|80926019|FG003|Part 2|Did not receive study drug|0|||
27753892|NCT01683071|80926020|FG004|Part 2|Did not receive study drug|2|||
27753893|NCT01683071|80926021|FG005|Part 2|Did not receive study drug|1|||
27753894|NCT01683071|80926016|FG000|Part 2|Met exclusion criterion|0|||
27753895|NCT01683071|80926017|FG001|Part 2|Met exclusion criterion|0|||
27753896|NCT01683071|80926018|FG002|Part 2|Met exclusion criterion|0|||
27753897|NCT01683071|80926019|FG003|Part 2|Met exclusion criterion|0|||
27753898|NCT01683071|80926020|FG004|Part 2|Met exclusion criterion|1|||
27753899|NCT01683071|80926021|FG005|Part 2|Met exclusion criterion|1|||
27753900|NCT01683071|80926016|FG000|Part 2|Protocol deviation|0|||
27753901|NCT01683071|80926017|FG001|Part 2|Protocol deviation|0|||
27753902|NCT01683071|80926018|FG002|Part 2|Protocol deviation|0|||
27753903|NCT01683071|80926019|FG003|Part 2|Protocol deviation|0|||
27753904|NCT01683071|80926020|FG004|Part 2|Protocol deviation|1|||
27753905|NCT01683071|80926021|FG005|Part 2|Protocol deviation|2|||
27753906|NCT01683071|80926016|FG000|Part 2|Withdrawal by investigator decision|0|||
27753907|NCT01683071|80926017|FG001|Part 2|Withdrawal by investigator decision|0|||
27753908|NCT01683071|80926018|FG002|Part 2|Withdrawal by investigator decision|0|||
27753909|NCT01683071|80926019|FG003|Part 2|Withdrawal by investigator decision|0|||
27753910|NCT01683071|80926020|FG004|Part 2|Withdrawal by investigator decision|1|||
27753911|NCT01683071|80926021|FG005|Part 2|Withdrawal by investigator decision|2|||
27753912|NCT02389816|80926022|FG000|Overall Study|Randomized but Not Treated|1|||
27753913|NCT02389816|80926023|FG001|Overall Study|Randomized but Not Treated|0|||
27753914|NCT02389816|80926024|FG002|Overall Study|Randomized but Not Treated|0|||
27753915|NCT02389816|80926022|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
27753916|NCT02389816|80926023|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
27753917|NCT02389816|80926024|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
27753918|NCT02389816|80926022|FG000|Overall Study|Major Protocol Deviation|1|||
27753919|NCT02389816|80926023|FG001|Overall Study|Major Protocol Deviation|0|||
27753920|NCT02389816|80926024|FG002|Overall Study|Major Protocol Deviation|0|||
27753921|NCT02389816|80926022|FG000|Overall Study|Lost to Follow-up|1|||
27753922|NCT02389816|80926023|FG001|Overall Study|Lost to Follow-up|0|||
27753923|NCT02389816|80926024|FG002|Overall Study|Lost to Follow-up|0|||
27753924|NCT02389816|80926022|FG000|Overall Study|Withdrawal of Consent|6|||
27753925|NCT02389816|80926023|FG001|Overall Study|Withdrawal of Consent|4|||
27753926|NCT02389816|80926024|FG002|Overall Study|Withdrawal of Consent|4|||
27753927|NCT02389816|80926022|FG000|Overall Study|Lack of Efficacy|1|||
27753928|NCT02389816|80926023|FG001|Overall Study|Lack of Efficacy|0|||
27753929|NCT02389816|80926024|FG002|Overall Study|Lack of Efficacy|0|||
27753930|NCT02389816|80926022|FG000|Overall Study|Non Compliance with Study Drug|1|||
27753931|NCT02389816|80926023|FG001|Overall Study|Non Compliance with Study Drug|1|||
27753932|NCT02389816|80926024|FG002|Overall Study|Non Compliance with Study Drug|1|||
27753933|NCT02389816|80926022|FG000|Overall Study|Reason not Specified|0|||
27753934|NCT02389816|80926023|FG001|Overall Study|Reason not Specified|2|||
27753935|NCT02389816|80926024|FG002|Overall Study|Reason not Specified|0|||
27753936|NCT01952730|80926025|FG000|Overall Study|FDA shut down core lab used by study|1|||
27753937|NCT00414310|80926026|FG000|Overall Study|Not treated|1|||
27753938|NCT00414310|80926027|FG001|Overall Study|Not treated|0|||
27753939|NCT00471445|80926028|FG000|Overall Study|Withdrawal by Subject|1|||
27753940|NCT00471445|80926029|FG001|Overall Study|Withdrawal by Subject|1|||
27753941|NCT00471445|80926028|FG000|Overall Study|Ineligible|1|||
27753942|NCT00471445|80926029|FG001|Overall Study|Ineligible|0|||
27753943|NCT00471445|80926028|FG000|Overall Study|Protocol Violation|0|||
27753944|NCT00471445|80926029|FG001|Overall Study|Protocol Violation|1|||
27753945|NCT01651052|80926030|FG000|Overall Study|Death|21|||
27753946|NCT01651052|80926030|FG000|Overall Study|Explant|1|||
27753947|NCT01651052|80926030|FG000|Overall Study|Withdrawal by Subject|1|||
27753948|NCT01651052|80926030|FG000|Overall Study|Lost to Follow-up|3|||
27753949|NCT00645567|80926031|FG000|Overall Study|Adverse Event|1|||
27753950|NCT03591146|80926035|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
27753951|NCT03591146|80926036|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
27753952|NCT03591146|80926037|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
27753953|NCT03591146|80926038|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
27753954|NCT03591146|80926039|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
27753955|NCT03591146|80926035|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
27753956|NCT03591146|80926036|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
27753957|NCT03591146|80926037|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
27753958|NCT03591146|80926038|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
27753959|NCT03591146|80926039|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
27753960|NCT03591146|80926035|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
27753961|NCT03591146|80926036|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
27753962|NCT03591146|80926037|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
27753963|NCT03591146|80926038|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
27753964|NCT03591146|80926039|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
27753965|NCT03591146|80926035|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
27956618|NCT00678288|81676255|FG000|Overall Study|Reason not reported|1|||
27753966|NCT03591146|80926036|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
27753967|NCT03591146|80926037|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
27753968|NCT03591146|80926038|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
27753969|NCT03591146|80926039|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
27753970|NCT01511419|80926040|FG000|Dose 2|Physician Decision|1|||
27753971|NCT01511419|80926041|FG001|Dose 2|Physician Decision|0|||
27753972|NCT04664855|80926042|FG000|Overall Study|Withdrawal by Subject|0|||
27753973|NCT04664855|80926043|FG001|Overall Study|Withdrawal by Subject|2|||
27753974|NCT02457182|80926044|FG000|Overall Study|Lost to Follow-up|1|||
27753975|NCT02457182|80926045|FG001|Overall Study|Lost to Follow-up|0|||
27753976|NCT04580394|80926051|FG000|First Intervention|Incorrectly Randomized|1|||
27753977|NCT04580394|80926051|FG000|First Intervention|Physician Decision|1|||
27753978|NCT04580394|80926051|FG000|First Intervention|Lost to Follow-up|1|||
27753979|NCT04580394|80926051|FG000|Washout (One Week)|Withdrawal by Subject|1|||
27753980|NCT04580394|80926051|FG000|Washout (One Week)|Adverse Event|1|||
27753981|NCT04580394|80926051|FG000|Washout (One Week)|Withdrawal by Subject|2|||
27753982|NCT04580394|80926051|FG000|Third Intervention|Adverse Event|1|||
27753983|NCT04580394|80926051|FG000|Third Intervention|Withdrawal by Subject|1|||
27753984|NCT04580394|80926051|FG000|Washout (One Week)|Withdrawal by Subject|2|||
27753985|NCT04387136|80926054|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
27753986|NCT04387136|80926055|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
27753987|NCT02142894|80926056|FG000|Overall Study|Protocol Violation|8|||
27753988|NCT01944969|80926057|FG000|Overall Study|Adverse Event|1|||
27753989|NCT01944969|80926057|FG000|Overall Study|Lack of Efficacy|1|||
27753990|NCT01944969|80926057|FG000|Overall Study|Non-compliance with IMP|1|||
27753991|NCT01944969|80926057|FG000|Overall Study|Administrative or other reasons|23|||
27753992|NCT00502307|80926058|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
27753993|NCT00502307|80926059|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
27753994|NCT00502307|80926060|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
27753995|NCT00502307|80926058|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
27753996|NCT00502307|80926059|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
27753997|NCT00502307|80926060|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
27753998|NCT00502307|80926058|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
27753999|NCT00502307|80926059|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
27754000|NCT00502307|80926060|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
27754001|NCT00502307|80926058|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
27754002|NCT00502307|80926059|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
27754003|NCT00502307|80926060|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
27754004|NCT00502307|80926058|FG000|Maintenance Period|Progressive disease|80|||
27754005|NCT00502307|80926059|FG001|Maintenance Period|Progressive disease|0|||
27754006|NCT00502307|80926060|FG002|Maintenance Period|Progressive disease|0|||
27754007|NCT00502307|80926058|FG000|Maintenance Period|Discontinued due to other reasons|68|||
27754008|NCT00502307|80926059|FG001|Maintenance Period|Discontinued due to other reasons|0|||
27754009|NCT00502307|80926060|FG002|Maintenance Period|Discontinued due to other reasons|0|||
27754010|NCT00882999|80926063|FG000|Overall Study|Adverse Event|0|||
27754011|NCT00882999|80926064|FG001|Overall Study|Adverse Event|0|||
27754012|NCT00882999|80926065|FG002|Overall Study|Adverse Event|0|||
27754013|NCT00882999|80926066|FG003|Overall Study|Adverse Event|0|||
27754014|NCT00882999|80926067|FG004|Overall Study|Adverse Event|1|||
27754015|NCT00882999|80926068|FG005|Overall Study|Adverse Event|0|||
27754016|NCT00882999|80926069|FG006|Overall Study|Adverse Event|0|||
27754017|NCT00882999|80926063|FG000|Overall Study|Death|0|||
27754018|NCT00882999|80926064|FG001|Overall Study|Death|1|||
27754019|NCT00882999|80926065|FG002|Overall Study|Death|0|||
27754020|NCT00882999|80926066|FG003|Overall Study|Death|0|||
27754021|NCT00882999|80926067|FG004|Overall Study|Death|0|||
27754022|NCT00882999|80926068|FG005|Overall Study|Death|0|||
27754023|NCT00882999|80926069|FG006|Overall Study|Death|0|||
27754024|NCT00882999|80926063|FG000|Overall Study|Withdrawal by Subject|7|||
27754025|NCT00882999|80926064|FG001|Overall Study|Withdrawal by Subject|6|||
27754026|NCT00882999|80926065|FG002|Overall Study|Withdrawal by Subject|3|||
27754027|NCT00882999|80926066|FG003|Overall Study|Withdrawal by Subject|3|||
27754028|NCT00882999|80926067|FG004|Overall Study|Withdrawal by Subject|6|||
27754029|NCT00882999|80926068|FG005|Overall Study|Withdrawal by Subject|5|||
27754030|NCT00882999|80926069|FG006|Overall Study|Withdrawal by Subject|5|||
27754031|NCT00882999|80926063|FG000|Overall Study|Lost to Follow-up|0|||
27754032|NCT00882999|80926064|FG001|Overall Study|Lost to Follow-up|1|||
27754033|NCT00882999|80926065|FG002|Overall Study|Lost to Follow-up|1|||
27754034|NCT00882999|80926066|FG003|Overall Study|Lost to Follow-up|2|||
27754035|NCT00882999|80926067|FG004|Overall Study|Lost to Follow-up|1|||
27754036|NCT00882999|80926068|FG005|Overall Study|Lost to Follow-up|1|||
27754037|NCT00882999|80926069|FG006|Overall Study|Lost to Follow-up|2|||
27754038|NCT00882999|80926063|FG000|Overall Study|Physician Decision|1|||
27754039|NCT00882999|80926064|FG001|Overall Study|Physician Decision|0|||
27754040|NCT00882999|80926065|FG002|Overall Study|Physician Decision|0|||
27754041|NCT00882999|80926066|FG003|Overall Study|Physician Decision|0|||
27754042|NCT00882999|80926067|FG004|Overall Study|Physician Decision|0|||
27754043|NCT00882999|80926068|FG005|Overall Study|Physician Decision|1|||
27754044|NCT00882999|80926069|FG006|Overall Study|Physician Decision|1|||
27754045|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
27754046|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27754047|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27754048|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27754049|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
27754050|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
27754051|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27754052|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27754053|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27754054|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
27754055|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
27754056|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27754057|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27754058|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27754059|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
27754060|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
27754061|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27754062|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27754063|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27754064|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
27754065|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
27754066|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27754067|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27754068|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27754069|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
27754070|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
27754071|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27754072|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27754073|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27754074|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
27754075|NCT01111539|80926070|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
27754076|NCT01111539|80926071|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27754077|NCT01111539|80926072|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27754078|NCT01111539|80926073|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27754079|NCT01111539|80926074|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
27754080|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27754081|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27754082|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
27754083|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
27754084|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
27754085|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27754086|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27754087|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
27754088|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
27754089|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
27754090|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
27754091|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
27754092|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
27754093|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27754094|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
27754095|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27754096|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27754097|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27754098|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
27754099|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
27754100|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27754101|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27754102|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27754103|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
27754104|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
27754105|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27754106|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27754107|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27754108|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
27754109|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
27754110|NCT01111539|80926070|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27754111|NCT01111539|80926071|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27754112|NCT01111539|80926072|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27754113|NCT01111539|80926073|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
27754114|NCT01111539|80926074|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
27754115|NCT00712322|80926075|FG000|Overall Study|Protocol deviation|0|||
27754116|NCT00712322|80926076|FG001|Overall Study|Protocol deviation|1|||
27754117|NCT00712322|80926077|FG002|Overall Study|Protocol deviation|0|||
27754118|NCT01151579|80926080|FG000|Overall Study|Physician Decision|3|||
27754119|NCT01151579|80926081|FG001|Overall Study|Physician Decision|1|||
27754120|NCT01151579|80926080|FG000|Overall Study|Withdrawal by Subject|3|||
27754121|NCT01151579|80926081|FG001|Overall Study|Withdrawal by Subject|2|||
27754122|NCT01151579|80926080|FG000|Overall Study|Not meet inclusion criteria|6|||
27754123|NCT01151579|80926081|FG001|Overall Study|Not meet inclusion criteria|4|||
27754124|NCT00008138|80926082|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
27754125|NCT00008138|80926082|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
27754126|NCT00008138|80926082|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
27754127|NCT00008138|80926082|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
27754128|NCT00008138|80926082|FG000|Interval Debulking|Withdrawal by Subject|2|||
27754129|NCT00008138|80926082|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
27754130|NCT00008138|80926082|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
27754131|NCT00008138|80926082|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
27754132|NCT00910429|80926083|FG000|Overall Study|Death|18|||
27754133|NCT00910429|80926084|FG001|Overall Study|Death|12|||
27754134|NCT00910429|80926083|FG000|Overall Study|Withdrawal by Subject|3|||
27754135|NCT00910429|80926084|FG001|Overall Study|Withdrawal by Subject|2|||
27754136|NCT00910429|80926083|FG000|Overall Study|Protocol Violation|1|||
27754137|NCT00910429|80926084|FG001|Overall Study|Protocol Violation|0|||
27754138|NCT00910429|80926083|FG000|Overall Study|Lost to Follow-up|2|||
27754139|NCT00910429|80926084|FG001|Overall Study|Lost to Follow-up|1|||
27754140|NCT00910429|80926083|FG000|Overall Study|Adverse Event|10|||
27754141|NCT00910429|80926084|FG001|Overall Study|Adverse Event|5|||
27754142|NCT00910429|80926083|FG000|Overall Study|Drug non-compliance|1|||
27754143|NCT00910429|80926084|FG001|Overall Study|Drug non-compliance|0|||
27754144|NCT00910429|80926083|FG000|Overall Study|Lack of Efficacy|4|||
27754145|NCT00910429|80926084|FG001|Overall Study|Lack of Efficacy|1|||
27754146|NCT02586233|80926085|FG000|Overall Study|Randomized but did not receive treatment|0|||
27754147|NCT02586233|80926086|FG001|Overall Study|Randomized but did not receive treatment|1|||
27754148|NCT02586233|80926087|FG002|Overall Study|Randomized but did not receive treatment|0|||
27754149|NCT02586233|80926088|FG003|Overall Study|Randomized but did not receive treatment|0|||
27754150|NCT02586233|80926089|FG004|Overall Study|Randomized but did not receive treatment|0|||
27754151|NCT02586233|80926090|FG005|Overall Study|Randomized but did not receive treatment|2|||
27754152|NCT02586233|80926091|FG006|Overall Study|Randomized but did not receive treatment|2|||
27754153|NCT02586233|80926085|FG000|Overall Study|Death|0|||
27754154|NCT02586233|80926086|FG001|Overall Study|Death|1|||
27754155|NCT02586233|80926087|FG002|Overall Study|Death|0|||
27754156|NCT02586233|80926088|FG003|Overall Study|Death|0|||
27754157|NCT02586233|80926089|FG004|Overall Study|Death|2|||
27754158|NCT02586233|80926090|FG005|Overall Study|Death|0|||
27754159|NCT02586233|80926091|FG006|Overall Study|Death|0|||
27754160|NCT03666858|80926093|FG000|Cohort 1|Adverse Event|1|||
27754161|NCT03666858|80926094|FG001|Cohort 1|Adverse Event|0|||
27754162|NCT03666858|80926093|FG000|Cohort 2|Adverse Event|0|||
27754163|NCT03666858|80926094|FG001|Cohort 2|Adverse Event|1|||
27754164|NCT00099359|80926095|FG000|Overall Study|Death|11|||
27754165|NCT00099359|80926096|FG001|Overall Study|Death|15|||
27754166|NCT00099359|80926097|FG002|Overall Study|Death|17|||
27754167|NCT00099359|80926095|FG000|Overall Study|Withdrawal by Subject|19|||
27754168|NCT00099359|80926096|FG001|Overall Study|Withdrawal by Subject|19|||
27754169|NCT00099359|80926097|FG002|Overall Study|Withdrawal by Subject|23|||
27754170|NCT00099359|80926095|FG000|Overall Study|Lost to Follow-up|15|||
27754171|NCT00099359|80926096|FG001|Overall Study|Lost to Follow-up|24|||
27754172|NCT00099359|80926097|FG002|Overall Study|Lost to Follow-up|24|||
27754173|NCT00099359|80926095|FG000|Overall Study|moved out of area|9|||
27754174|NCT00099359|80926096|FG001|Overall Study|moved out of area|7|||
27754175|NCT00099359|80926097|FG002|Overall Study|moved out of area|4|||
27754176|NCT05216406|80929377|FG000|Overall Study|Lost to Follow-up|8|||
27754177|NCT05216406|80929378|FG001|Overall Study|Lost to Follow-up|9|||
27754178|NCT01253044|80929381|FG000|Overall Study|Lost to Follow-up|38|||
27754179|NCT01253044|80929382|FG001|Overall Study|Lost to Follow-up|29|||
27754180|NCT02023164|80929385|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
27754181|NCT02023164|80929386|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
27754182|NCT02940626|80929387|FG000|Overall Study|Death|40|||
27754183|NCT02940626|80929388|FG001|Overall Study|Death|32|||
27754184|NCT02940626|80929387|FG000|Overall Study|Lost to Follow-up|5|||
27754185|NCT02940626|80929388|FG001|Overall Study|Lost to Follow-up|2|||
27754186|NCT02940626|80929387|FG000|Overall Study|Withdrawal by Subject|1|||
27754187|NCT02940626|80929388|FG001|Overall Study|Withdrawal by Subject|0|||
27754188|NCT02940626|80929387|FG000|Overall Study|Transfer to Hospice Care|1|||
27754189|NCT02940626|80929388|FG001|Overall Study|Transfer to Hospice Care|0|||
27754190|NCT02940626|80929387|FG000|Overall Study|Prohibited Concomitant Medication|0|||
27754191|NCT02940626|80929388|FG001|Overall Study|Prohibited Concomitant Medication|1|||
27754192|NCT02345252|80929393|FG000|Double-Blind Phase|Adverse Event|2|||
27754193|NCT02345252|80929394|FG001|Double-Blind Phase|Adverse Event|3|||
27754194|NCT02345252|80929393|FG000|Double-Blind Phase|Death|1|||
27754195|NCT02345252|80929394|FG001|Double-Blind Phase|Death|2|||
27754196|NCT02345252|80929393|FG000|Double-Blind Phase|Lack of Efficacy|1|||
27754197|NCT02345252|80929394|FG001|Double-Blind Phase|Lack of Efficacy|0|||
27754198|NCT02345252|80929393|FG000|Double-Blind Phase|Investigator's Discretion|4|||
27754199|NCT02345252|80929394|FG001|Double-Blind Phase|Investigator's Discretion|6|||
27754200|NCT02345252|80929393|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
27754201|NCT02345252|80929394|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
27754202|NCT02345252|80929393|FG000|Double-Blind Phase|Protocol Violation|2|||
27754203|NCT02345252|80929394|FG001|Double-Blind Phase|Protocol Violation|1|||
27754204|NCT02345252|80929393|FG000|Double-Blind Phase|Withdrew Consent|21|||
27754205|NCT02345252|80929394|FG001|Double-Blind Phase|Withdrew Consent|23|||
27754206|NCT02345252|80929393|FG000|Double-Blind Phase|Lost to Follow-up|8|||
27754207|NCT02345252|80929394|FG001|Double-Blind Phase|Lost to Follow-up|10|||
27754208|NCT02345252|80929393|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
27754209|NCT02345252|80929394|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
27754210|NCT02125331|80929395|FG000|Overall Study|Protocol Violation|1|||
27754211|NCT02125331|80929396|FG001|Overall Study|Protocol Violation|0|||
27754212|NCT02125331|80929395|FG000|Overall Study|technical problem|2|||
27754213|NCT02125331|80929396|FG001|Overall Study|technical problem|0|||
27754214|NCT02125331|80929395|FG000|Overall Study|screen failure|2|||
27754215|NCT02125331|80929396|FG001|Overall Study|screen failure|0|||
27754216|NCT00879814|80929397|FG000|Overall Study|Adverse Event|0|||
27754217|NCT00879814|80929398|FG001|Overall Study|Adverse Event|1|||
27754218|NCT00879814|80929399|FG002|Overall Study|Adverse Event|0|||
27754219|NCT00879814|80929400|FG003|Overall Study|Adverse Event|0|||
27754220|NCT00879814|80929397|FG000|Overall Study|Lost to Follow-up|1|||
27754221|NCT00879814|80929398|FG001|Overall Study|Lost to Follow-up|0|||
27754222|NCT00879814|80929399|FG002|Overall Study|Lost to Follow-up|0|||
27754223|NCT00879814|80929400|FG003|Overall Study|Lost to Follow-up|2|||
27754224|NCT00879814|80929397|FG000|Overall Study|Participant Failed to Return|0|||
27754225|NCT00879814|80929398|FG001|Overall Study|Participant Failed to Return|0|||
27754226|NCT00879814|80929399|FG002|Overall Study|Participant Failed to Return|0|||
27754227|NCT00879814|80929400|FG003|Overall Study|Participant Failed to Return|1|||
27754228|NCT00879814|80929397|FG000|Overall Study|Withdrawal by Subject|3|||
27754229|NCT00879814|80929398|FG001|Overall Study|Withdrawal by Subject|1|||
27754230|NCT00879814|80929399|FG002|Overall Study|Withdrawal by Subject|1|||
27754231|NCT00879814|80929400|FG003|Overall Study|Withdrawal by Subject|2|||
27754232|NCT00879814|80929397|FG000|Overall Study|Physician Decision|0|||
27754233|NCT00879814|80929398|FG001|Overall Study|Physician Decision|0|||
27754234|NCT00879814|80929399|FG002|Overall Study|Physician Decision|1|||
27754235|NCT00879814|80929400|FG003|Overall Study|Physician Decision|0|||
27754236|NCT00879814|80929397|FG000|Overall Study|Other|0|||
27754237|NCT00879814|80929398|FG001|Overall Study|Other|0|||
27754238|NCT00879814|80929399|FG002|Overall Study|Other|1|||
27754239|NCT00879814|80929400|FG003|Overall Study|Other|0|||
27754240|NCT02921919|80929407|FG000|Overall Study|Other|5|||
27754241|NCT02921919|80929408|FG001|Overall Study|Other|6|||
27754242|NCT02921919|80929407|FG000|Overall Study|Lost to Follow-up|0|||
27754243|NCT02921919|80929408|FG001|Overall Study|Lost to Follow-up|1|||
27754244|NCT02921919|80929407|FG000|Overall Study|Withdrawal by Subject|5|||
27754245|NCT02921919|80929408|FG001|Overall Study|Withdrawal by Subject|1|||
27754246|NCT02921919|80929407|FG000|Overall Study|Disease Progression|47|||
27754247|NCT02921919|80929408|FG001|Overall Study|Disease Progression|38|||
27754248|NCT02921919|80929407|FG000|Overall Study|Physician Decision|3|||
27754249|NCT02921919|80929408|FG001|Overall Study|Physician Decision|2|||
27754250|NCT02921919|80929407|FG000|Overall Study|Adverse Event|6|||
27754251|NCT02921919|80929408|FG001|Overall Study|Adverse Event|4|||
27754252|NCT00786032|80929409|FG000|Overall Study|Death|4|||
27754253|NCT00786032|80929409|FG000|Overall Study|Withdrawal by Subject|14|||
27754254|NCT00786032|80929409|FG000|Overall Study|Did not complete in the timeframe|6|||
27754255|NCT02121756|80929410|FG000|Overall Study|Adverse Event|3|||
27754256|NCT02121756|80929411|FG001|Overall Study|Adverse Event|0|||
27754257|NCT02121756|80929410|FG000|Overall Study|Protocol Violation|1|||
27754258|NCT02121756|80929411|FG001|Overall Study|Protocol Violation|1|||
27754259|NCT02121756|80929410|FG000|Overall Study|Physician Decision|2|||
27754260|NCT02121756|80929411|FG001|Overall Study|Physician Decision|1|||
27754261|NCT01727713|80929413|FG000|Overall Study|Lost to Follow-up|5|||
27754262|NCT01727713|80929413|FG000|Overall Study|Adverse Event|10|||
27754263|NCT01727713|80929413|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
27754264|NCT01727713|80929413|FG000|Overall Study|Withdrawal by Subject|13|||
27754265|NCT01727713|80929413|FG000|Overall Study|Protocol Deviation|2|||
27754266|NCT03050359|80929415|FG000|Overall Study|Randomized But Not Treated|2|||
27754267|NCT03050359|80929416|FG001|Overall Study|Randomized But Not Treated|0|||
27754268|NCT03050359|80929415|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
27754269|NCT03050359|80929416|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
27754270|NCT03050359|80929415|FG000|Overall Study|Significant Protocol Deviation|2|||
27754271|NCT03050359|80929416|FG001|Overall Study|Significant Protocol Deviation|3|||
27754272|NCT03050359|80929415|FG000|Overall Study|Lost to Follow-up|2|||
27754273|NCT03050359|80929416|FG001|Overall Study|Lost to Follow-up|1|||
27754274|NCT03050359|80929415|FG000|Overall Study|Voluntary Withdrawal|4|||
27754275|NCT03050359|80929416|FG001|Overall Study|Voluntary Withdrawal|6|||
27754276|NCT03050359|80929415|FG000|Overall Study|Pregnancy|1|||
27754277|NCT03050359|80929416|FG001|Overall Study|Pregnancy|0|||
27754278|NCT03050359|80929415|FG000|Overall Study|Reason Not Specified|1|||
27754279|NCT03050359|80929416|FG001|Overall Study|Reason Not Specified|0|||
27754280|NCT01432262|80929418|FG000|Overall Study|Withdrawal by Subject|2|||
27754281|NCT01432262|80929419|FG001|Overall Study|Withdrawal by Subject|1|||
27754282|NCT04032171|80929422|FG000|Overall Study|Study Termination|1|||
27754283|NCT04032171|80929423|FG001|Overall Study|Study Termination|0|||
27754284|NCT00948818|80929424|FG000|Overall Study|Adverse Event|10|||
27754285|NCT00948818|80929425|FG001|Overall Study|Adverse Event|32|||
27754286|NCT00948818|80929424|FG000|Overall Study|Protocol Violation|9|||
27754287|NCT00948818|80929425|FG001|Overall Study|Protocol Violation|10|||
27754288|NCT00948818|80929424|FG000|Overall Study|Withdrawal by Subject|25|||
27754289|NCT00948818|80929425|FG001|Overall Study|Withdrawal by Subject|25|||
27754290|NCT00948818|80929424|FG000|Overall Study|Lost to Follow-up|10|||
27754291|NCT00948818|80929425|FG001|Overall Study|Lost to Follow-up|17|||
27754292|NCT00948818|80929424|FG000|Overall Study|Lack of Efficacy|4|||
27754293|NCT00948818|80929425|FG001|Overall Study|Lack of Efficacy|5|||
27754294|NCT00948818|80929424|FG000|Overall Study|Other Reason|4|||
27754295|NCT00948818|80929425|FG001|Overall Study|Other Reason|5|||
27754296|NCT01259856|80929426|FG000|Overall Study|Adverse Event|12|||
27754297|NCT01259856|80929427|FG001|Overall Study|Adverse Event|9|||
27754298|NCT01259856|80929426|FG000|Overall Study|Death|0|||
27754299|NCT01259856|80929427|FG001|Overall Study|Death|1|||
27754300|NCT01259856|80929426|FG000|Overall Study|Lack of Efficacy|3|||
27754301|NCT01259856|80929427|FG001|Overall Study|Lack of Efficacy|1|||
27754302|NCT01259856|80929426|FG000|Overall Study|Lost to Follow-up|1|||
27754303|NCT01259856|80929427|FG001|Overall Study|Lost to Follow-up|1|||
27754304|NCT01259856|80929426|FG000|Overall Study|Physician Decision|2|||
27754305|NCT01259856|80929427|FG001|Overall Study|Physician Decision|1|||
27754306|NCT01259856|80929426|FG000|Overall Study|Withdrawal by Subject|9|||
27754307|NCT01259856|80929427|FG001|Overall Study|Withdrawal by Subject|10|||
27754308|NCT01259856|80929426|FG000|Overall Study|Treatment never started|0|||
27754309|NCT01259856|80929427|FG001|Overall Study|Treatment never started|6|||
27754310|NCT01259856|80929426|FG000|Overall Study|Study closure by sponsor|40|||
27754311|NCT01259856|80929427|FG001|Overall Study|Study closure by sponsor|41|||
27754312|NCT01259856|80929426|FG000|Overall Study|Patient developed other disease|0|||
27754313|NCT01259856|80929427|FG001|Overall Study|Patient developed other disease|1|||
27754314|NCT01259856|80929426|FG000|Overall Study|Transfer to another study|0|||
27754315|NCT01259856|80929427|FG001|Overall Study|Transfer to another study|1|||
27754316|NCT01259856|80929426|FG000|Overall Study|Unknown/missing|2|||
27754317|NCT01259856|80929427|FG001|Overall Study|Unknown/missing|2|||
27754318|NCT02512068|80929432|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
27754319|NCT02512068|80929433|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
27754320|NCT02512068|80929432|FG000|Overall Study|Major Protocol Deviation|1|||
27754321|NCT02512068|80929433|FG001|Overall Study|Major Protocol Deviation|0|||
27754322|NCT02512068|80929432|FG000|Overall Study|Voluntary Withdrawal|0|||
27754323|NCT02512068|80929433|FG001|Overall Study|Voluntary Withdrawal|1|||
27754324|NCT02512068|80929432|FG000|Overall Study|Lack of Efficacy|0|||
27754325|NCT02512068|80929433|FG001|Overall Study|Lack of Efficacy|1|||
27754326|NCT02512068|80929432|FG000|Overall Study|Reason Not Specified|3|||
27754327|NCT02512068|80929433|FG001|Overall Study|Reason Not Specified|5|||
27754328|NCT02504268|80929434|FG000|Overall Study|Adverse Event|18|||
27956619|NCT00678288|81676256|FG001|Overall Study|Reason not reported|0|||
27956620|NCT00678288|81676255|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
27754329|NCT02504268|80929435|FG001|Overall Study|Adverse Event|8|||
27754330|NCT02504268|80929436|FG002|Overall Study|Adverse Event|14|||
27754331|NCT02504268|80929437|FG003|Overall Study|Adverse Event|0|||
27754332|NCT02504268|80929438|FG004|Overall Study|Adverse Event|0|||
27754333|NCT02504268|80929439|FG005|Overall Study|Adverse Event|0|||
27754334|NCT02504268|80929440|FG006|Overall Study|Adverse Event|0|||
27754335|NCT02504268|80929441|FG007|Overall Study|Adverse Event|0|||
27956621|NCT00678288|81676256|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
27956622|NCT02765399|81676257|FG000|Overall Study|Nausea|1|||
27956623|NCT02765399|81676258|FG001|Overall Study|Nausea|0|||
27956624|NCT04179305|81676261|FG000|Overall Study|Death|1|||
27956625|NCT04179305|81676262|FG001|Overall Study|Death|1|||
27956626|NCT04179305|81676263|FG002|Overall Study|Death|0|||
27956627|NCT04179305|81676264|FG003|Overall Study|Death|0|||
27956628|NCT04179305|81676261|FG000|Overall Study|Lost to Follow-up|1|||
27956629|NCT04179305|81676262|FG001|Overall Study|Lost to Follow-up|1|||
27956630|NCT04179305|81676263|FG002|Overall Study|Lost to Follow-up|0|||
27956631|NCT04179305|81676264|FG003|Overall Study|Lost to Follow-up|0|||
27956632|NCT04179305|81676261|FG000|Overall Study|Withdrawal by Subject|0|||
27956633|NCT04179305|81676262|FG001|Overall Study|Withdrawal by Subject|1|||
27956634|NCT04179305|81676263|FG002|Overall Study|Withdrawal by Subject|0|||
27956635|NCT04179305|81676264|FG003|Overall Study|Withdrawal by Subject|0|||
27956636|NCT04179305|81676261|FG000|Overall Study|Did not have scan|1|||
27956637|NCT04179305|81676262|FG001|Overall Study|Did not have scan|0|||
27956638|NCT04179305|81676263|FG002|Overall Study|Did not have scan|0|||
27956639|NCT04179305|81676264|FG003|Overall Study|Did not have scan|0|||
27956640|NCT04179305|81676261|FG000|Overall Study|In hospice care|3|||
27956641|NCT04179305|81676262|FG001|Overall Study|In hospice care|0|||
27956642|NCT04179305|81676263|FG002|Overall Study|In hospice care|0|||
27956643|NCT04179305|81676264|FG003|Overall Study|In hospice care|0|||
27956644|NCT00473889|81676271|FG000|Overall Study|Did not receive study medication|1|||
27956645|NCT00473889|81676272|FG001|Overall Study|Did not receive study medication|4|||
27956646|NCT00473889|81676271|FG000|Overall Study|Adverse Event|30|||
27956647|NCT00473889|81676272|FG001|Overall Study|Adverse Event|17|||
27956648|NCT00473889|81676271|FG000|Overall Study|Protocol Violation|4|||
27956649|NCT00473889|81676272|FG001|Overall Study|Protocol Violation|2|||
27956650|NCT00473889|81676271|FG000|Overall Study|Lack of Efficacy|28|||
27956651|NCT00473889|81676272|FG001|Overall Study|Lack of Efficacy|29|||
27956652|NCT00473889|81676271|FG000|Overall Study|Lost to Follow-up|2|||
27956653|NCT00473889|81676272|FG001|Overall Study|Lost to Follow-up|1|||
27956654|NCT00473889|81676271|FG000|Overall Study|Physician Decision|10|||
27956655|NCT00473889|81676272|FG001|Overall Study|Physician Decision|5|||
27956656|NCT00473889|81676271|FG000|Overall Study|Trial Terminated|3|||
27956657|NCT00473889|81676272|FG001|Overall Study|Trial Terminated|6|||
27956658|NCT00473889|81676271|FG000|Overall Study|Withdrawal by Subject|5|||
27956659|NCT00473889|81676272|FG001|Overall Study|Withdrawal by Subject|0|||
27956660|NCT00165789|81676275|FG000|Overall Study|Adverse Event|0|||
27956661|NCT00165789|81676276|FG001|Overall Study|Adverse Event|3|||
27956662|NCT00165789|81676277|FG002|Overall Study|Adverse Event|0|||
27956663|NCT00165789|81676278|FG003|Overall Study|Adverse Event|12|||
27956664|NCT00165789|81676275|FG000|Overall Study|Withdrawal by Subject|0|||
27956665|NCT00165789|81676276|FG001|Overall Study|Withdrawal by Subject|1|||
27956666|NCT00165789|81676277|FG002|Overall Study|Withdrawal by Subject|1|||
27956667|NCT00165789|81676278|FG003|Overall Study|Withdrawal by Subject|2|||
27956668|NCT01206517|81676279|FG000|Overall Study|Withdrawal by Subject|0|||
27956669|NCT01206517|81676280|FG001|Overall Study|Withdrawal by Subject|0|||
27956670|NCT01206517|81676281|FG002|Overall Study|Withdrawal by Subject|2|||
27956671|NCT01206517|81676282|FG003|Overall Study|Withdrawal by Subject|0|||
27956672|NCT01206517|81676283|FG004|Overall Study|Withdrawal by Subject|1|||
27956673|NCT01206517|81676284|FG005|Overall Study|Withdrawal by Subject|0|||
27956674|NCT00955474|81676285|FG000|Overall Study|Physician Decision|7|||
27956675|NCT00955474|81676286|FG001|Overall Study|Physician Decision|5|||
27956676|NCT00570713|81676287|FG000|Overall Study|Adverse Event|16|||
27956677|NCT00570713|81676288|FG001|Overall Study|Adverse Event|9|||
27956678|NCT00570713|81676287|FG000|Overall Study|Death|7|||
27956679|NCT00570713|81676288|FG001|Overall Study|Death|7|||
27956680|NCT00570713|81676287|FG000|Overall Study|Lack of Efficacy|40|||
27956681|NCT00570713|81676288|FG001|Overall Study|Lack of Efficacy|49|||
27956682|NCT00570713|81676287|FG000|Overall Study|Physician Decision|2|||
27956683|NCT00570713|81676288|FG001|Overall Study|Physician Decision|2|||
27956684|NCT00570713|81676287|FG000|Overall Study|Withdrawal by Subject|3|||
27956685|NCT00570713|81676288|FG001|Overall Study|Withdrawal by Subject|3|||
27956686|NCT00570713|81676287|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
27956687|NCT00570713|81676288|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
27956688|NCT01558596|81676293|FG000|Overall Study|Withdrawal by Subject|1|||
27956689|NCT01558596|81676294|FG001|Overall Study|Withdrawal by Subject|0|||
27956690|NCT01558596|81676293|FG000|Overall Study|surgery elsewhere or cancelled|1|||
27956691|NCT01558596|81676294|FG001|Overall Study|surgery elsewhere or cancelled|1|||
27956692|NCT01558596|81676293|FG000|Overall Study|Protocol Violation|1|||
27956693|NCT01558596|81676294|FG001|Overall Study|Protocol Violation|0|||
27956694|NCT00784368|81676301|FG000|Overall Study|Physician Decision|0|||
27956695|NCT00784368|81676302|FG001|Overall Study|Physician Decision|0|||
27956696|NCT00784368|81676303|FG002|Overall Study|Physician Decision|6|||
27956697|NCT00784368|81676301|FG000|Overall Study|Lack of Efficacy|2|||
27956698|NCT00784368|81676302|FG001|Overall Study|Lack of Efficacy|0|||
27956699|NCT00784368|81676303|FG002|Overall Study|Lack of Efficacy|1|||
27956700|NCT00784368|81676301|FG000|Overall Study|Adverse Event|6|||
27956701|NCT00784368|81676302|FG001|Overall Study|Adverse Event|9|||
27956702|NCT00784368|81676303|FG002|Overall Study|Adverse Event|2|||
27956703|NCT00784368|81676301|FG000|Overall Study|Diagnosis of fever|0|||
27956704|NCT00784368|81676302|FG001|Overall Study|Diagnosis of fever|0|||
27956705|NCT00784368|81676303|FG002|Overall Study|Diagnosis of fever|1|||
27956706|NCT00784368|81676301|FG000|Overall Study|Worsening of complications|0|||
27956707|NCT00784368|81676302|FG001|Overall Study|Worsening of complications|0|||
27956708|NCT00784368|81676303|FG002|Overall Study|Worsening of complications|1|||
27956709|NCT00784368|81676301|FG000|Overall Study|Worsening of symptoms|0|||
27956710|NCT00784368|81676302|FG001|Overall Study|Worsening of symptoms|1|||
27956711|NCT00784368|81676303|FG002|Overall Study|Worsening of symptoms|0|||
27956712|NCT00784368|81676301|FG000|Overall Study|Withdrawal of informed consent|0|||
27956713|NCT00784368|81676302|FG001|Overall Study|Withdrawal of informed consent|1|||
27956714|NCT00784368|81676303|FG002|Overall Study|Withdrawal of informed consent|0|||
27956715|NCT02651116|81676306|FG000|Overall Study|Adverse Event|0|||
27956716|NCT02651116|81676307|FG001|Overall Study|Adverse Event|1|||
27956717|NCT02651116|81676306|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
27956718|NCT02651116|81676307|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
27956719|NCT03519997|81676312|FG000|Overall Study|Adverse Event|4|||
27956720|NCT03519997|81676312|FG000|Overall Study|Withdrawal by Subject|2|||
27956721|NCT03519997|81676312|FG000|Overall Study|Protocol Violation|1|||
27956722|NCT02230189|81676313|FG000|Overall Study|Withdrawal by Subject|3|||
27956723|NCT02230189|81676314|FG001|Overall Study|Withdrawal by Subject|0|||
27956724|NCT02230189|81676315|FG002|Overall Study|Withdrawal by Subject|1|||
27956725|NCT02230189|81676313|FG000|Overall Study|Lost to Follow-up|1|||
27956726|NCT02230189|81676314|FG001|Overall Study|Lost to Follow-up|0|||
27956727|NCT02230189|81676315|FG002|Overall Study|Lost to Follow-up|0|||
27956728|NCT02230189|81676313|FG000|Overall Study|Physician Decision|1|||
27956729|NCT02230189|81676314|FG001|Overall Study|Physician Decision|0|||
27956730|NCT02230189|81676315|FG002|Overall Study|Physician Decision|0|||
27956731|NCT00553631|81676316|FG000|Overall Study|Withdrawal by Subject|0|||
27956732|NCT00553631|81676317|FG001|Overall Study|Withdrawal by Subject|1|||
27956733|NCT00553631|81676316|FG000|Overall Study|Lost to Follow-up|1|||
27956734|NCT00553631|81676317|FG001|Overall Study|Lost to Follow-up|0|||
27956735|NCT01119287|81676319|FG000|Overall Study|Patient Decision, not related to AE|0|||
27956736|NCT01119287|81676320|FG001|Overall Study|Patient Decision, not related to AE|0|||
27956737|NCT01119287|81676321|FG002|Overall Study|Patient Decision, not related to AE|2|||
27956738|NCT01119287|81676322|FG003|Overall Study|Patient Decision, not related to AE|2|||
27956739|NCT01119287|81676323|FG004|Overall Study|Patient Decision, not related to AE|1|||
27956740|NCT01119287|81676324|FG005|Overall Study|Patient Decision, not related to AE|0|||
27956741|NCT04154605|81676330|FG000|Overall Study|Procedure Canceled|1|||
27956742|NCT04154605|81676331|FG001|Overall Study|Procedure Canceled|1|||
27956743|NCT04154605|81676330|FG000|Overall Study|Missed follow up|1|||
27956744|NCT04154605|81676331|FG001|Overall Study|Missed follow up|1|||
27956745|NCT04154605|81676330|FG000|Overall Study|Withdrawal by Subject|1|||
27956746|NCT04154605|81676331|FG001|Overall Study|Withdrawal by Subject|0|||
27956747|NCT00645840|81676333|FG000|Overall Study|Protocol Violation|3|||
27956748|NCT04819113|81676338|FG000|Overall Study|Withdrawal by parent/guardian|3|||
27956749|NCT04819113|81676338|FG000|Overall Study|Lost to Follow-up|1|||
27956750|NCT04819113|81676338|FG000|Overall Study|Withdrawn before vaccination|2|||
27956751|NCT00038948|81676339|FG000|Overall Study|Adverse Event|131|||
27956752|NCT00038948|81676340|FG001|Overall Study|Adverse Event|43|||
27956753|NCT00038948|81676339|FG000|Overall Study|Lost to Follow-up|4|||
27956754|NCT00038948|81676340|FG001|Overall Study|Lost to Follow-up|4|||
27956755|NCT00038948|81676339|FG000|Overall Study|Nonmedical event|5|||
27956756|NCT00038948|81676340|FG001|Overall Study|Nonmedical event|7|||
27956757|NCT00038948|81676339|FG000|Overall Study|Withdrawal by Subject|23|||
27956758|NCT00038948|81676340|FG001|Overall Study|Withdrawal by Subject|10|||
27956759|NCT00038948|81676339|FG000|Overall Study|Protocol Violation|3|||
27956760|NCT00038948|81676340|FG001|Overall Study|Protocol Violation|7|||
27956761|NCT00038948|81676339|FG000|Overall Study|Lack of Efficacy|3|||
27956762|NCT00038948|81676340|FG001|Overall Study|Lack of Efficacy|6|||
27754336|NCT02504268|80929442|FG008|Overall Study|Adverse Event|0|||
27754337|NCT02504268|80929434|FG000|Overall Study|Withdrawal of Consent|11|||
27754338|NCT02504268|80929435|FG001|Overall Study|Withdrawal of Consent|10|||
27754339|NCT02504268|80929436|FG002|Overall Study|Withdrawal of Consent|3|||
27754340|NCT02504268|80929437|FG003|Overall Study|Withdrawal of Consent|0|||
27754341|NCT02504268|80929438|FG004|Overall Study|Withdrawal of Consent|0|||
27754342|NCT02504268|80929439|FG005|Overall Study|Withdrawal of Consent|0|||
27754343|NCT02504268|80929440|FG006|Overall Study|Withdrawal of Consent|0|||
27754344|NCT02504268|80929441|FG007|Overall Study|Withdrawal of Consent|0|||
27754345|NCT02504268|80929442|FG008|Overall Study|Withdrawal of Consent|0|||
27754346|NCT02504268|80929434|FG000|Overall Study|Pregnancy|2|||
27754347|NCT02504268|80929435|FG001|Overall Study|Pregnancy|0|||
27754348|NCT02504268|80929436|FG002|Overall Study|Pregnancy|0|||
27754349|NCT02504268|80929437|FG003|Overall Study|Pregnancy|0|||
27956763|NCT00628446|81676341|FG000|Overall Study|Lost to Follow-up|3|||
27956764|NCT00628446|81676341|FG000|Overall Study|Withdrawal by Subject|1|||
27956765|NCT00628446|81676341|FG000|Overall Study|Protocol Violation|3|||
27956766|NCT00945659|81676357|FG000|Overall Study|Lost to Follow-up|7|||
27956767|NCT00945659|81676358|FG001|Overall Study|Lost to Follow-up|20|||
27956768|NCT00945659|81676359|FG002|Overall Study|Lost to Follow-up|17|||
27956769|NCT01055613|81676368|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
27956770|NCT01055613|81676369|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
27956771|NCT01055613|81676368|FG000|Overall Study|Unacceptable lens fit|1|||
27956772|NCT01055613|81676369|FG001|Overall Study|Unacceptable lens fit|0|||
27956773|NCT01055613|81676368|FG000|Overall Study|Discomfort|2|||
27956774|NCT01055613|81676369|FG001|Overall Study|Discomfort|1|||
27956775|NCT01055613|81676368|FG000|Overall Study|Lost to Follow-up|1|||
27956776|NCT01055613|81676369|FG001|Overall Study|Lost to Follow-up|1|||
27956777|NCT01055613|81676368|FG000|Overall Study|Protocol Violation|1|||
27956778|NCT01055613|81676369|FG001|Overall Study|Protocol Violation|1|||
27956779|NCT01055613|81676368|FG000|Overall Study|Subject Disinterest|1|||
27956780|NCT01055613|81676369|FG001|Overall Study|Subject Disinterest|1|||
27956781|NCT04339413|81676370|FG000|Overall Study|Reason Not Specified|2|||
27956782|NCT04339413|81676371|FG001|Overall Study|Reason Not Specified|7|||
27956783|NCT04339413|81676370|FG000|Overall Study|Study Terminated by Sponsor|30|||
27956784|NCT04339413|81676371|FG001|Overall Study|Study Terminated by Sponsor|33|||
27956785|NCT04339413|81676370|FG000|Overall Study|Progressive Disease|9|||
27956786|NCT04339413|81676371|FG001|Overall Study|Progressive Disease|6|||
27956787|NCT04339413|81676370|FG000|Overall Study|Withdrawal by Subject|9|||
27956788|NCT04339413|81676371|FG001|Overall Study|Withdrawal by Subject|10|||
27956789|NCT04339413|81676370|FG000|Overall Study|Physician Decision|3|||
27956790|NCT04339413|81676371|FG001|Overall Study|Physician Decision|1|||
27956791|NCT04339413|81676370|FG000|Overall Study|Death|2|||
27956792|NCT04339413|81676371|FG001|Overall Study|Death|0|||
27956793|NCT04339413|81676370|FG000|Overall Study|Adverse Event|3|||
27956794|NCT04339413|81676371|FG001|Overall Study|Adverse Event|0|||
27956795|NCT00539240|81676375|FG000|Overall Study|Withdrawal by Subject|0|||
27956796|NCT00539240|81676376|FG001|Overall Study|Withdrawal by Subject|2|||
27956797|NCT00539240|81676377|FG002|Overall Study|Withdrawal by Subject|0|||
27956798|NCT00539240|81676375|FG000|Overall Study|Protocol Violation|1|||
27956799|NCT00539240|81676376|FG001|Overall Study|Protocol Violation|1|||
27956800|NCT00539240|81676377|FG002|Overall Study|Protocol Violation|4|||
27956801|NCT00539240|81676375|FG000|Overall Study|Lost to Follow-up|2|||
27956802|NCT00539240|81676376|FG001|Overall Study|Lost to Follow-up|3|||
27956803|NCT00539240|81676377|FG002|Overall Study|Lost to Follow-up|1|||
27956804|NCT00539240|81676375|FG000|Overall Study|Adverse Event|3|||
27956805|NCT00539240|81676376|FG001|Overall Study|Adverse Event|1|||
27956806|NCT00539240|81676377|FG002|Overall Study|Adverse Event|10|||
27956807|NCT03801928|81676384|FG000|Overall Study|Adverse Event|1|||
27956808|NCT03801928|81676385|FG001|Overall Study|Adverse Event|0|||
27956809|NCT03801928|81676386|FG002|Overall Study|Adverse Event|1|||
27956810|NCT03801928|81676387|FG003|Overall Study|Adverse Event|2|||
27956811|NCT03801928|81676388|FG004|Overall Study|Adverse Event|0|||
27956812|NCT03801928|81676389|FG005|Overall Study|Adverse Event|2|||
27956813|NCT03801928|81676384|FG000|Overall Study|Lack of Efficacy|0|||
27956814|NCT03801928|81676385|FG001|Overall Study|Lack of Efficacy|0|||
27956815|NCT03801928|81676386|FG002|Overall Study|Lack of Efficacy|1|||
27956816|NCT03801928|81676387|FG003|Overall Study|Lack of Efficacy|0|||
27956817|NCT03801928|81676388|FG004|Overall Study|Lack of Efficacy|0|||
27956818|NCT03801928|81676389|FG005|Overall Study|Lack of Efficacy|0|||
27956819|NCT03801928|81676384|FG000|Overall Study|Lost to Follow-up|5|||
27956820|NCT03801928|81676385|FG001|Overall Study|Lost to Follow-up|1|||
27956821|NCT03801928|81676386|FG002|Overall Study|Lost to Follow-up|1|||
27956822|NCT03801928|81676387|FG003|Overall Study|Lost to Follow-up|4|||
27956823|NCT03801928|81676388|FG004|Overall Study|Lost to Follow-up|4|||
27956824|NCT03801928|81676389|FG005|Overall Study|Lost to Follow-up|2|||
27956825|NCT03801928|81676384|FG000|Overall Study|Withdrawal by Subject|0|||
27956826|NCT03801928|81676385|FG001|Overall Study|Withdrawal by Subject|0|||
27956827|NCT03801928|81676386|FG002|Overall Study|Withdrawal by Subject|2|||
27956828|NCT03801928|81676387|FG003|Overall Study|Withdrawal by Subject|1|||
27956829|NCT03801928|81676388|FG004|Overall Study|Withdrawal by Subject|0|||
27956830|NCT03801928|81676389|FG005|Overall Study|Withdrawal by Subject|0|||
27956831|NCT03801928|81676384|FG000|Overall Study|Other|0|||
27956832|NCT03801928|81676385|FG001|Overall Study|Other|2|||
27956833|NCT03801928|81676386|FG002|Overall Study|Other|0|||
27956834|NCT03801928|81676387|FG003|Overall Study|Other|1|||
27956835|NCT03801928|81676388|FG004|Overall Study|Other|0|||
27956836|NCT03801928|81676389|FG005|Overall Study|Other|1|||
27956837|NCT02041299|81676390|FG000|Overall Study|Adverse Event|9|||
27956838|NCT02041299|81676391|FG001|Overall Study|Adverse Event|3|||
27956839|NCT02041299|81676390|FG000|Overall Study|Lost to Follow-up|4|||
27956840|NCT02041299|81676391|FG001|Overall Study|Lost to Follow-up|1|||
27956841|NCT02041299|81676390|FG000|Overall Study|Physician Decision|1|||
27956842|NCT02041299|81676391|FG001|Overall Study|Physician Decision|1|||
27956843|NCT02041299|81676390|FG000|Overall Study|Withdrawal by Subject|13|||
27956844|NCT02041299|81676391|FG001|Overall Study|Withdrawal by Subject|7|||
27956845|NCT02041299|81676390|FG000|Overall Study|Protocol Violation|11|||
27956846|NCT02041299|81676391|FG001|Overall Study|Protocol Violation|4|||
27956847|NCT02041299|81676390|FG000|Overall Study|Termination of the study|7|||
27956848|NCT02041299|81676391|FG001|Overall Study|Termination of the study|3|||
27956849|NCT02041299|81676390|FG000|Overall Study|Required bone marrow transplant|0|||
27956850|NCT02041299|81676391|FG001|Overall Study|Required bone marrow transplant|1|||
27956851|NCT02041299|81676390|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
27956852|NCT02041299|81676391|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
27956853|NCT00811954|81676392|FG000|Overall Study|Death|10|||
27956854|NCT00811954|81676393|FG001|Overall Study|Death|6|||
27956855|NCT00811954|81676394|FG002|Overall Study|Death|13|||
27956856|NCT00811954|81676392|FG000|Overall Study|Lost to Follow-up|29|||
27956857|NCT00811954|81676393|FG001|Overall Study|Lost to Follow-up|23|||
27956858|NCT00811954|81676394|FG002|Overall Study|Lost to Follow-up|34|||
27956859|NCT00811954|81676392|FG000|Overall Study|Not able to get to clinic|28|||
27956860|NCT00811954|81676393|FG001|Overall Study|Not able to get to clinic|35|||
27956861|NCT00811954|81676394|FG002|Overall Study|Not able to get to clinic|30|||
27956862|NCT00811954|81676392|FG000|Overall Study|Not willing to adhere to requirements|12|||
27956863|NCT00811954|81676393|FG001|Overall Study|Not willing to adhere to requirements|2|||
27956864|NCT00811954|81676394|FG002|Overall Study|Not willing to adhere to requirements|16|||
27956865|NCT00811954|81676392|FG000|Overall Study|Withdraw consent prior study completion|4|||
27956866|NCT00811954|81676393|FG001|Overall Study|Withdraw consent prior study completion|6|||
27956867|NCT00811954|81676394|FG002|Overall Study|Withdraw consent prior study completion|5|||
27956868|NCT00811954|81676392|FG000|Overall Study|Site Closure|4|||
27956869|NCT00811954|81676393|FG001|Overall Study|Site Closure|0|||
27956870|NCT00811954|81676394|FG002|Overall Study|Site Closure|1|||
27956871|NCT00811954|81676392|FG000|Overall Study|Severe Debilitation|2|||
27956872|NCT00811954|81676393|FG001|Overall Study|Severe Debilitation|0|||
27956873|NCT00811954|81676394|FG002|Overall Study|Severe Debilitation|1|||
27956874|NCT00811954|81676392|FG000|Overall Study|Complete Protocol: No follow-up|0|||
27956875|NCT00811954|81676393|FG001|Overall Study|Complete Protocol: No follow-up|0|||
27956876|NCT00811954|81676394|FG002|Overall Study|Complete Protocol: No follow-up|1|||
27956877|NCT02628444|81676397|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
27956878|NCT02628444|81676398|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956879|NCT02628444|81676399|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956880|NCT02628444|81676400|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956881|NCT02628444|81676401|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956882|NCT02628444|81676402|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956883|NCT02628444|81676403|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956884|NCT02628444|81676404|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956885|NCT02628444|81676405|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
27956886|NCT02628444|81676397|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956887|NCT02628444|81676398|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
27956888|NCT02628444|81676399|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
27956889|NCT02628444|81676400|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956890|NCT02628444|81676401|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956891|NCT02628444|81676402|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956892|NCT02628444|81676403|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956893|NCT02628444|81676404|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956894|NCT02628444|81676405|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
27956895|NCT02628444|81676397|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
27956896|NCT02628444|81676398|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
27956897|NCT02628444|81676399|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
27956898|NCT02628444|81676400|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956899|NCT02628444|81676401|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956900|NCT02628444|81676402|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956901|NCT02628444|81676403|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956902|NCT02628444|81676404|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956903|NCT02628444|81676405|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956904|NCT02628444|81676397|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
27956905|NCT02628444|81676398|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
27959317|NCT02131662|81683273|FG004|Overall Study|Wish for pregnancy|1|||
27754350|NCT02504268|80929438|FG004|Overall Study|Pregnancy|0|||
27956906|NCT02628444|81676399|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
27956907|NCT02628444|81676400|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27956908|NCT02628444|81676401|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27956909|NCT02628444|81676402|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27956910|NCT02628444|81676403|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27956911|NCT02628444|81676404|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27956912|NCT02628444|81676405|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
27956913|NCT02628444|81676397|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
27956914|NCT02628444|81676398|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
27956915|NCT02628444|81676399|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
27956916|NCT02628444|81676400|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27956917|NCT02628444|81676401|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27956918|NCT02628444|81676402|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27956919|NCT02628444|81676403|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27956920|NCT02628444|81676404|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27956921|NCT02628444|81676405|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
27956922|NCT02628444|81676397|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956923|NCT02628444|81676398|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956924|NCT02628444|81676399|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956925|NCT02628444|81676400|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
27956926|NCT02628444|81676401|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956927|NCT02628444|81676402|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956928|NCT02628444|81676403|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956929|NCT02628444|81676404|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956930|NCT02628444|81676405|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
27956931|NCT02628444|81676397|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
27956932|NCT02628444|81676398|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
27956933|NCT02628444|81676399|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
27956934|NCT02628444|81676400|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
27956935|NCT02628444|81676401|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
27956936|NCT02628444|81676402|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
27956937|NCT02628444|81676403|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
27956938|NCT02628444|81676404|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
27956939|NCT02628444|81676405|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
27956940|NCT02628444|81676397|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956941|NCT02628444|81676398|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956942|NCT02628444|81676399|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
27956943|NCT02628444|81676400|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
27956944|NCT02628444|81676401|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
27956945|NCT02628444|81676402|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
27956946|NCT02628444|81676403|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
27956947|NCT02628444|81676404|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
27956948|NCT02628444|81676405|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
27956949|NCT02628444|81676397|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27956950|NCT02628444|81676398|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27956951|NCT02628444|81676399|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27956952|NCT02628444|81676400|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27956953|NCT02628444|81676401|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
27956954|NCT02628444|81676402|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27956955|NCT02628444|81676403|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
27956956|NCT02628444|81676404|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
27956957|NCT02628444|81676405|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
27956958|NCT02628444|81676397|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
27956959|NCT02628444|81676398|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
27956960|NCT02628444|81676399|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
27956961|NCT02628444|81676400|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
27956962|NCT02628444|81676401|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
27956963|NCT02628444|81676402|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
27956964|NCT02628444|81676403|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
27956965|NCT02628444|81676404|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
27956966|NCT02628444|81676405|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
27956967|NCT01964378|81676410|FG000|Overall Study|Disc. due to death before first dosing|0|||
27956968|NCT01964378|81676411|FG001|Overall Study|Disc. due to death before first dosing|1|||
27956969|NCT01964378|81676410|FG000|Overall Study|Disc. due to AE before first dosing|1|||
27956970|NCT01964378|81676411|FG001|Overall Study|Disc. due to AE before first dosing|0|||
27956971|NCT01964378|81676410|FG000|Overall Study|Death|3|||
27956972|NCT01964378|81676411|FG001|Overall Study|Death|2|||
27956973|NCT01964378|81676410|FG000|Overall Study|Adverse Event|12|||
27956974|NCT01964378|81676411|FG001|Overall Study|Adverse Event|5|||
27956975|NCT01964378|81676410|FG000|Overall Study|Lack of Efficacy|0|||
27956976|NCT01964378|81676411|FG001|Overall Study|Lack of Efficacy|1|||
27956977|NCT01964378|81676410|FG000|Overall Study|Protocol Violation|0|||
27956978|NCT01964378|81676411|FG001|Overall Study|Protocol Violation|1|||
27956979|NCT01964378|81676410|FG000|Overall Study|Lost to Follow-up|0|||
27956980|NCT01964378|81676411|FG001|Overall Study|Lost to Follow-up|1|||
27956981|NCT01964378|81676410|FG000|Overall Study|Withdrawal by Subject|7|||
27956982|NCT01964378|81676411|FG001|Overall Study|Withdrawal by Subject|5|||
27956983|NCT01964378|81676410|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
27956984|NCT01964378|81676411|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
27956985|NCT01964378|81676410|FG000|Overall Study|Other|1|||
27956986|NCT01964378|81676411|FG001|Overall Study|Other|2|||
27956987|NCT01082081|81676413|FG000|Overall Study|Lost to Follow-up|0|||
27956988|NCT01082081|81676414|FG001|Overall Study|Lost to Follow-up|0|||
27956989|NCT01082081|81676415|FG002|Overall Study|Lost to Follow-up|1|||
27956990|NCT01082081|81676413|FG000|Overall Study|Withdrawal by Subject|0|||
27956991|NCT01082081|81676414|FG001|Overall Study|Withdrawal by Subject|0|||
27956992|NCT01082081|81676415|FG002|Overall Study|Withdrawal by Subject|1|||
27956993|NCT01082081|81676413|FG000|Overall Study|Other Reason|0|||
27956994|NCT01082081|81676414|FG001|Overall Study|Other Reason|1|||
27956995|NCT01082081|81676415|FG002|Overall Study|Other Reason|0|||
27956996|NCT03364231|81676418|FG000|Overall Study|Adverse Event|1|||
27956997|NCT03364231|81676419|FG001|Overall Study|Adverse Event|4|||
27956998|NCT03364231|81676418|FG000|Overall Study|Death|1|||
27956999|NCT03364231|81676419|FG001|Overall Study|Death|0|||
27957000|NCT03364231|81676418|FG000|Overall Study|Investigator Decision|2|||
27957001|NCT03364231|81676419|FG001|Overall Study|Investigator Decision|2|||
27957002|NCT03364231|81676418|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
27957003|NCT03364231|81676419|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
27957004|NCT03364231|81676418|FG000|Overall Study|Withdrawal of Subject Consent|1|||
27957005|NCT03364231|81676419|FG001|Overall Study|Withdrawal of Subject Consent|0|||
27957006|NCT03364231|81676418|FG000|Overall Study|Reason Not Specified|1|||
27957007|NCT03364231|81676419|FG001|Overall Study|Reason Not Specified|0|||
27957008|NCT03364231|81676418|FG000|Overall Study|Disease Progression|0|||
27957009|NCT03364231|81676419|FG001|Overall Study|Disease Progression|6|||
27957010|NCT00355030|81676420|FG000|Study Period 1 Treatment|Adverse Event|1|||
27957011|NCT00355030|81676421|FG001|Study Period 1 Treatment|Adverse Event|1|||
27957012|NCT00355030|81676420|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
27957013|NCT00355030|81676421|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
27957014|NCT00355030|81676420|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
27957015|NCT00355030|81676421|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
27957016|NCT00355030|81676420|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
27957017|NCT00355030|81676421|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
27957018|NCT00355030|81676420|FG000|Study Period 1 Treatment|Physician Decision|0|||
27957019|NCT00355030|81676421|FG001|Study Period 1 Treatment|Physician Decision|1|||
27957020|NCT00355030|81676420|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
27957021|NCT00355030|81676421|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
27957022|NCT00355030|81676420|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
27957023|NCT00355030|81676421|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
27957024|NCT00355030|81676420|FG000|Study Period 1 Treatment|Other|2|||
27957025|NCT00355030|81676421|FG001|Study Period 1 Treatment|Other|6|||
27957026|NCT00355030|81676420|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
27957027|NCT00355030|81676421|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
27957028|NCT00355030|81676420|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
27957029|NCT00355030|81676421|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
27957030|NCT00132301|81676426|FG000|Overall Study|Death|7|||
27957031|NCT00132301|81676427|FG001|Overall Study|Death|6|||
27957032|NCT00132301|81676426|FG000|Overall Study|Withdrawal by Subject|5|||
27957033|NCT00132301|81676427|FG001|Overall Study|Withdrawal by Subject|2|||
27957034|NCT00132301|81676426|FG000|Overall Study|Physician Decision|1|||
27957035|NCT00132301|81676427|FG001|Overall Study|Physician Decision|1|||
27957036|NCT00132301|81676426|FG000|Overall Study|Lost to Follow-up|5|||
27957037|NCT00132301|81676427|FG001|Overall Study|Lost to Follow-up|3|||
27957038|NCT00132301|81676426|FG000|Overall Study|Other|1|||
27957039|NCT00132301|81676427|FG001|Overall Study|Other|1|||
27957040|NCT00132301|81676426|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
27957041|NCT00132301|81676427|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
27957042|NCT01581684|81676428|FG000|Overall Study|Other reason not defined|0|||
27959318|NCT02131662|81683269|FG000|Overall Study|Lack of Efficacy|1|||
27957043|NCT01581684|81676429|FG001|Overall Study|Other reason not defined|0|||
27957044|NCT01581684|81676430|FG002|Overall Study|Other reason not defined|0|||
27957045|NCT01581684|81676431|FG003|Overall Study|Other reason not defined|0|||
27957046|NCT01581684|81676432|FG004|Overall Study|Other reason not defined|0|||
27957047|NCT01581684|81676433|FG005|Overall Study|Other reason not defined|0|||
27957048|NCT01581684|81676434|FG006|Overall Study|Other reason not defined|0|||
27957049|NCT01581684|81676435|FG007|Overall Study|Other reason not defined|0|||
27957050|NCT01581684|81676436|FG008|Overall Study|Other reason not defined|1|||
27957051|NCT01581684|81676437|FG009|Overall Study|Other reason not defined|0|||
27957052|NCT02949024|81676438|FG000|Overall Study|Withdrawal by Subject|0|||
27957053|NCT02949024|81676439|FG001|Overall Study|Withdrawal by Subject|1|||
27957054|NCT02777086|81676440|FG000|Overall Study|Lost to Follow-up|96|||
27957055|NCT02777086|81676441|FG001|Overall Study|Lost to Follow-up|99|||
27957056|NCT00326599|81676456|FG000|Overall Study|Withdrawal by Subject|1|||
27957057|NCT00326599|81676457|FG001|Overall Study|Withdrawal by Subject|0|||
27957058|NCT00326599|81676458|FG002|Overall Study|Withdrawal by Subject|5|||
27957059|NCT00326599|81676459|FG003|Overall Study|Withdrawal by Subject|2|||
27957060|NCT00326599|81676456|FG000|Overall Study|Adverse Event|1|||
27957061|NCT00326599|81676457|FG001|Overall Study|Adverse Event|0|||
27957062|NCT00326599|81676458|FG002|Overall Study|Adverse Event|32|||
27957063|NCT00326599|81676459|FG003|Overall Study|Adverse Event|3|||
27957064|NCT00326599|81676456|FG000|Overall Study|Disease Progression|3|||
27957065|NCT00326599|81676457|FG001|Overall Study|Disease Progression|1|||
27957066|NCT00326599|81676458|FG002|Overall Study|Disease Progression|13|||
27957067|NCT00326599|81676459|FG003|Overall Study|Disease Progression|11|||
27957068|NCT00326599|81676456|FG000|Overall Study|Alternate Treatment|1|||
27957069|NCT00326599|81676457|FG001|Overall Study|Alternate Treatment|0|||
27957070|NCT00326599|81676458|FG002|Overall Study|Alternate Treatment|0|||
27957071|NCT00326599|81676459|FG003|Overall Study|Alternate Treatment|0|||
27957072|NCT00326599|81676456|FG000|Overall Study|Death|0|||
27957073|NCT00326599|81676457|FG001|Overall Study|Death|0|||
27957074|NCT00326599|81676458|FG002|Overall Study|Death|1|||
27957075|NCT00326599|81676459|FG003|Overall Study|Death|2|||
27957076|NCT00326599|81676456|FG000|Overall Study|Other Unspecified Reason|0|||
27957077|NCT00326599|81676457|FG001|Overall Study|Other Unspecified Reason|0|||
27957078|NCT00326599|81676458|FG002|Overall Study|Other Unspecified Reason|2|||
27957079|NCT00326599|81676459|FG003|Overall Study|Other Unspecified Reason|1|||
27957080|NCT01837680|81676462|FG000|Overall Study|Lost to Follow-up|2|||
27957081|NCT01837680|81676463|FG001|Overall Study|Lost to Follow-up|2|||
27957082|NCT01837680|81676462|FG000|Overall Study|lack of insurance|0|||
27957083|NCT01837680|81676463|FG001|Overall Study|lack of insurance|2|||
27957084|NCT01837680|81676462|FG000|Overall Study|allergic reaction|6|||
27957085|NCT01837680|81676463|FG001|Overall Study|allergic reaction|0|||
27957086|NCT01837680|81676462|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
27957087|NCT01837680|81676463|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
27957088|NCT00997984|81676464|FG000|Overall Study|Adverse Event|1|||
27957089|NCT00997984|81676465|FG001|Overall Study|Adverse Event|8|||
27957090|NCT00997984|81676466|FG002|Overall Study|Adverse Event|8|||
27957091|NCT00997984|81676464|FG000|Overall Study|Protocol Violation|1|||
27957092|NCT00997984|81676465|FG001|Overall Study|Protocol Violation|3|||
27957093|NCT00997984|81676466|FG002|Overall Study|Protocol Violation|0|||
27957094|NCT00997984|81676464|FG000|Overall Study|Withdrawal by Subject|6|||
27957095|NCT00997984|81676465|FG001|Overall Study|Withdrawal by Subject|9|||
27957096|NCT00997984|81676466|FG002|Overall Study|Withdrawal by Subject|5|||
27957097|NCT00997984|81676464|FG000|Overall Study|Lost to Follow-up|8|||
27957098|NCT00997984|81676465|FG001|Overall Study|Lost to Follow-up|5|||
27957099|NCT00997984|81676466|FG002|Overall Study|Lost to Follow-up|4|||
27957100|NCT00997984|81676464|FG000|Overall Study|Lack of Efficacy|20|||
27957101|NCT00997984|81676465|FG001|Overall Study|Lack of Efficacy|6|||
27957102|NCT00997984|81676466|FG002|Overall Study|Lack of Efficacy|3|||
27957103|NCT00997984|81676464|FG000|Overall Study|Met exclusion criteria|1|||
27957104|NCT00997984|81676465|FG001|Overall Study|Met exclusion criteria|0|||
27957105|NCT00997984|81676466|FG002|Overall Study|Met exclusion criteria|0|||
27957106|NCT00997984|81676464|FG000|Overall Study|non-compliance|0|||
27957107|NCT00997984|81676465|FG001|Overall Study|non-compliance|2|||
27957108|NCT00997984|81676466|FG002|Overall Study|non-compliance|3|||
27957109|NCT00997984|81676464|FG000|Overall Study|Wrong medication dispensed|0|||
27957110|NCT00997984|81676465|FG001|Overall Study|Wrong medication dispensed|1|||
27957111|NCT00997984|81676466|FG002|Overall Study|Wrong medication dispensed|0|||
27957112|NCT00997984|81676464|FG000|Overall Study|Suicidal ideation|0|||
27957113|NCT00997984|81676465|FG001|Overall Study|Suicidal ideation|0|||
27957114|NCT00997984|81676466|FG002|Overall Study|Suicidal ideation|1|||
27957115|NCT00997984|81676464|FG000|Overall Study|Work schedule|0|||
27957116|NCT00997984|81676465|FG001|Overall Study|Work schedule|0|||
27957117|NCT00997984|81676466|FG002|Overall Study|Work schedule|2|||
27957118|NCT02504372|81676467|FG000|Overall Study|Death|136|||
27957119|NCT02504372|81676468|FG001|Overall Study|Death|154|||
27957120|NCT02504372|81676467|FG000|Overall Study|Lost to Follow-up|0|||
27957121|NCT02504372|81676468|FG001|Overall Study|Lost to Follow-up|2|||
27957122|NCT02504372|81676467|FG000|Overall Study|Withdrawal of consent|25|||
27957123|NCT02504372|81676468|FG001|Overall Study|Withdrawal of consent|16|||
27957124|NCT02504372|81676467|FG000|Overall Study|Participants ongoing|429|||
27957125|NCT02504372|81676468|FG001|Overall Study|Participants ongoing|415|||
27957126|NCT00310375|81676469|FG000|Primary Reporting Phase|Adverse Event|28|||
27957127|NCT00310375|81676470|FG001|Primary Reporting Phase|Adverse Event|22|||
27957128|NCT00310375|81676471|FG002|Primary Reporting Phase|Adverse Event|0|||
27957129|NCT00310375|81676469|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
27957130|NCT00310375|81676470|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
27957131|NCT00310375|81676471|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
27957132|NCT00310375|81676469|FG000|Primary Reporting Phase|Pregnancy|2|||
27957133|NCT00310375|81676470|FG001|Primary Reporting Phase|Pregnancy|2|||
27957134|NCT00310375|81676471|FG002|Primary Reporting Phase|Pregnancy|0|||
27957135|NCT00310375|81676469|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
27957136|NCT00310375|81676470|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
27957137|NCT00310375|81676471|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
27957138|NCT00310375|81676469|FG000|Primary Reporting Phase|Protocol Violation|8|||
27957139|NCT00310375|81676470|FG001|Primary Reporting Phase|Protocol Violation|5|||
27957140|NCT00310375|81676471|FG002|Primary Reporting Phase|Protocol Violation|0|||
27957141|NCT00310375|81676469|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
27957142|NCT00310375|81676470|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
27957143|NCT00310375|81676471|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
27957144|NCT00310375|81676469|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
27957145|NCT00310375|81676470|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
27957146|NCT00310375|81676471|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
27957147|NCT00310375|81676469|FG000|Primary Reporting Phase|Physician Decision|5|||
27957148|NCT00310375|81676470|FG001|Primary Reporting Phase|Physician Decision|3|||
27957149|NCT00310375|81676471|FG002|Primary Reporting Phase|Physician Decision|0|||
27957150|NCT00310375|81676469|FG000|Primary Reporting Phase|Request of the sponsor|2|||
27957151|NCT00310375|81676470|FG001|Primary Reporting Phase|Request of the sponsor|2|||
27957152|NCT00310375|81676471|FG002|Primary Reporting Phase|Request of the sponsor|0|||
27957153|NCT00310375|81676469|FG000|Primary Reporting Phase|Failed to return|1|||
27957154|NCT00310375|81676470|FG001|Primary Reporting Phase|Failed to return|3|||
27957155|NCT00310375|81676471|FG002|Primary Reporting Phase|Failed to return|0|||
27957156|NCT00310375|81676469|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
27957157|NCT00310375|81676470|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
27957158|NCT00310375|81676471|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
27957159|NCT00310375|81676469|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
27957160|NCT00310375|81676470|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
27957161|NCT00310375|81676471|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
27957162|NCT00310375|81676469|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
27957163|NCT00310375|81676470|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
27957164|NCT00310375|81676471|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
27957165|NCT00310375|81676469|FG000|Primary Reporting Phase|Site closure|3|||
27957166|NCT00310375|81676470|FG001|Primary Reporting Phase|Site closure|0|||
27957167|NCT00310375|81676471|FG002|Primary Reporting Phase|Site closure|0|||
27957168|NCT00310375|81676469|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
27957169|NCT00310375|81676470|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
27957170|NCT00310375|81676471|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
27957171|NCT00310375|81676469|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
27957172|NCT00310375|81676470|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
27957173|NCT00310375|81676471|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
27957174|NCT00310375|81676469|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
27957175|NCT00310375|81676470|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
27957176|NCT00310375|81676471|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
27957177|NCT00310375|81676469|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
27957178|NCT00310375|81676470|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
27957179|NCT00310375|81676471|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
27957180|NCT03484429|81676472|FG000|Overall Study|Withdrawal by Subject|1|||
27957181|NCT03484429|81676473|FG001|Overall Study|Withdrawal by Subject|0|||
27957182|NCT03484429|81676472|FG000|Overall Study|Adverse Event|2|||
27957183|NCT03484429|81676473|FG001|Overall Study|Adverse Event|0|||
27957184|NCT01456130|81676474|FG000|Overall Study|Adverse Event|4|||
27957185|NCT01456130|81676474|FG000|Overall Study|Voluntary Withdrawal|1|||
27957186|NCT01456130|81676474|FG000|Overall Study|Lack of Efficacy|4|||
27957187|NCT01456130|81676474|FG000|Overall Study|Other|1|||
27957188|NCT00003869|81676475|FG000|Overall Study|Adverse Event|14|||
27957189|NCT00003869|81676476|FG001|Overall Study|Adverse Event|3|||
27957190|NCT00003869|81676475|FG000|Overall Study|Withdrawal by Subject|21|||
27957191|NCT00003869|81676476|FG001|Overall Study|Withdrawal by Subject|3|||
27957192|NCT00003869|81676475|FG000|Overall Study|Death|1|||
27957193|NCT00003869|81676476|FG001|Overall Study|Death|2|||
27957194|NCT00003869|81676475|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
27957195|NCT00003869|81676476|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
27957196|NCT01331681|81676477|FG000|Overall Study|Adverse Event|10|||
27957197|NCT01331681|81676478|FG001|Overall Study|Adverse Event|13|||
27957198|NCT01331681|81676479|FG002|Overall Study|Adverse Event|10|||
27957199|NCT01331681|81676477|FG000|Overall Study|Death|6|||
27957200|NCT01331681|81676478|FG001|Overall Study|Death|6|||
27957201|NCT01331681|81676479|FG002|Overall Study|Death|2|||
27957202|NCT01331681|81676477|FG000|Overall Study|Lack of Efficacy|0|||
27957203|NCT01331681|81676478|FG001|Overall Study|Lack of Efficacy|1|||
27957204|NCT01331681|81676479|FG002|Overall Study|Lack of Efficacy|0|||
27957205|NCT01331681|81676477|FG000|Overall Study|Withdrawal by Subject|12|||
27957206|NCT01331681|81676478|FG001|Overall Study|Withdrawal by Subject|8|||
27957207|NCT01331681|81676479|FG002|Overall Study|Withdrawal by Subject|15|||
27957208|NCT01331681|81676477|FG000|Overall Study|Protocol Violation|1|||
27957209|NCT01331681|81676478|FG001|Overall Study|Protocol Violation|1|||
27957210|NCT01331681|81676479|FG002|Overall Study|Protocol Violation|0|||
27957211|NCT01331681|81676477|FG000|Overall Study|Lost to Follow-up|2|||
27957212|NCT01331681|81676478|FG001|Overall Study|Lost to Follow-up|4|||
27957213|NCT01331681|81676479|FG002|Overall Study|Lost to Follow-up|1|||
27957214|NCT01331681|81676477|FG000|Overall Study|Physician Decision|2|||
27957215|NCT01331681|81676478|FG001|Overall Study|Physician Decision|0|||
27957216|NCT01331681|81676479|FG002|Overall Study|Physician Decision|4|||
27957217|NCT01331681|81676477|FG000|Overall Study|Therapeutic procedure required|1|||
27957218|NCT01331681|81676478|FG001|Overall Study|Therapeutic procedure required|0|||
27957219|NCT01331681|81676479|FG002|Overall Study|Therapeutic procedure required|0|||
27957220|NCT01331681|81676477|FG000|Overall Study|Sponsor decision|1|||
27957221|NCT01331681|81676478|FG001|Overall Study|Sponsor decision|1|||
27957222|NCT01331681|81676479|FG002|Overall Study|Sponsor decision|0|||
27957223|NCT01331681|81676477|FG000|Overall Study|Switching to other therapy|0|||
27957224|NCT01331681|81676478|FG001|Overall Study|Switching to other therapy|0|||
27957225|NCT01331681|81676479|FG002|Overall Study|Switching to other therapy|1|||
27957226|NCT01331681|81676477|FG000|Overall Study|Not Received Study Treatment|0|||
27957227|NCT01331681|81676478|FG001|Overall Study|Not Received Study Treatment|0|||
27957228|NCT01331681|81676479|FG002|Overall Study|Not Received Study Treatment|2|||
27957229|NCT03688919|81676480|FG000|Overall Study|Lost to Follow-up|2|||
27957230|NCT03688919|81676481|FG001|Overall Study|Lost to Follow-up|1|||
27957231|NCT03688919|81676480|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
27957232|NCT03688919|81676481|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
27957233|NCT01770743|81676482|FG000|Overall Study|Adverse Event|1|||
27957234|NCT01770743|81676483|FG001|Overall Study|Adverse Event|0|||
27957235|NCT01770743|81676484|FG002|Overall Study|Adverse Event|0|||
27957236|NCT01770743|81676485|FG003|Overall Study|Adverse Event|0|||
27957237|NCT01770743|81676486|FG004|Overall Study|Adverse Event|0|||
27957238|NCT01770743|81676482|FG000|Overall Study|Withdrawal by Subject|0|||
27957239|NCT01770743|81676483|FG001|Overall Study|Withdrawal by Subject|0|||
27957240|NCT01770743|81676484|FG002|Overall Study|Withdrawal by Subject|1|||
27957241|NCT01770743|81676485|FG003|Overall Study|Withdrawal by Subject|1|||
27957242|NCT01770743|81676486|FG004|Overall Study|Withdrawal by Subject|1|||
27957243|NCT01770743|81676482|FG000|Overall Study|Lost to Follow-up|0|||
27957244|NCT01770743|81676483|FG001|Overall Study|Lost to Follow-up|2|||
27957245|NCT01770743|81676484|FG002|Overall Study|Lost to Follow-up|0|||
27957246|NCT01770743|81676485|FG003|Overall Study|Lost to Follow-up|0|||
27957247|NCT01770743|81676486|FG004|Overall Study|Lost to Follow-up|1|||
27957248|NCT01770743|81676482|FG000|Overall Study|Sponsor Terminated Subject|1|||
27957249|NCT01770743|81676483|FG001|Overall Study|Sponsor Terminated Subject|0|||
27957250|NCT01770743|81676484|FG002|Overall Study|Sponsor Terminated Subject|0|||
27957251|NCT01770743|81676485|FG003|Overall Study|Sponsor Terminated Subject|1|||
27957252|NCT01770743|81676486|FG004|Overall Study|Sponsor Terminated Subject|0|||
27957253|NCT01770743|81676482|FG000|Overall Study|Moving Out of State|0|||
27957254|NCT01770743|81676483|FG001|Overall Study|Moving Out of State|1|||
27957255|NCT01770743|81676484|FG002|Overall Study|Moving Out of State|0|||
27957256|NCT01770743|81676485|FG003|Overall Study|Moving Out of State|0|||
27957257|NCT01770743|81676486|FG004|Overall Study|Moving Out of State|0|||
27957258|NCT00833027|81676487|FG000|Overall Study|Adverse Event|33|||
27957259|NCT00833027|81676487|FG000|Overall Study|Death|1|||
27957260|NCT00833027|81676487|FG000|Overall Study|Lack of Efficacy|12|||
27957261|NCT00833027|81676487|FG000|Overall Study|Lost to Follow-up|24|||
27957262|NCT00833027|81676487|FG000|Overall Study|Protocol Violation|115|||
27957263|NCT00833027|81676487|FG000|Overall Study|Withdrawal by Subject|16|||
27957264|NCT00833027|81676487|FG000|Overall Study|Missing|10|||
27957265|NCT01444430|81676488|FG000|Overall Study|Withdrawal by Subject|53|||
27957266|NCT01444430|81676489|FG001|Overall Study|Withdrawal by Subject|72|||
27957267|NCT01444430|81676488|FG000|Overall Study|Death|6|||
27957268|NCT01444430|81676489|FG001|Overall Study|Death|8|||
27957269|NCT01444430|81676488|FG000|Overall Study|Lost to Follow-up|2|||
27957270|NCT01444430|81676489|FG001|Overall Study|Lost to Follow-up|0|||
27957271|NCT01444430|81676488|FG000|Overall Study|CRF termination module not completed.|0|||
27957272|NCT01444430|81676489|FG001|Overall Study|CRF termination module not completed.|1|||
27957273|NCT00803361|81676490|FG000|Overall Study|Adverse Event|13|||
27957274|NCT00803361|81676491|FG001|Overall Study|Adverse Event|3|||
27957275|NCT00803361|81676490|FG000|Overall Study|Lack of Efficacy|4|||
27957276|NCT00803361|81676491|FG001|Overall Study|Lack of Efficacy|13|||
27957277|NCT00803361|81676490|FG000|Overall Study|Lost to Follow-up|1|||
27957278|NCT00803361|81676491|FG001|Overall Study|Lost to Follow-up|2|||
27957279|NCT00803361|81676490|FG000|Overall Study|Physician Decision|1|||
27957280|NCT00803361|81676491|FG001|Overall Study|Physician Decision|0|||
27957281|NCT00803361|81676490|FG000|Overall Study|Protocol Violation|2|||
27957282|NCT00803361|81676491|FG001|Overall Study|Protocol Violation|4|||
27957283|NCT00803361|81676490|FG000|Overall Study|Withdrawal by Subject|5|||
27957284|NCT00803361|81676491|FG001|Overall Study|Withdrawal by Subject|6|||
27957285|NCT03328832|81676492|FG000|Overall Study|Lost to Follow-up|0|||
27957286|NCT03328832|81676493|FG001|Overall Study|Lost to Follow-up|1|||
27957287|NCT04749745|81676494|FG000|Overall Study|Withdrawal by Subject|1|||
27957288|NCT04749745|81676495|FG001|Overall Study|Withdrawal by Subject|0|||
27957289|NCT00339040|81676496|FG000|Stage I|Not able to attend clinic|1|||
27957290|NCT00339040|81676497|FG001|Stage I|Not able to attend clinic|0|||
27957291|NCT00339040|81676496|FG000|Stage I|Protocol Violation|1|||
27957292|NCT00339040|81676497|FG001|Stage I|Protocol Violation|1|||
27957293|NCT00339040|81676496|FG000|Stage II|Lost to Follow-up|3|||
27957294|NCT00339040|81676497|FG001|Stage II|Lost to Follow-up|0|||
27957295|NCT00339040|81676496|FG000|Stage II|Withdrawal by Subject|1|||
27957296|NCT00339040|81676497|FG001|Stage II|Withdrawal by Subject|2|||
27957297|NCT00339040|81676496|FG000|Stage II|Protocol Violation|3|||
27957298|NCT00339040|81676497|FG001|Stage II|Protocol Violation|0|||
27957299|NCT00339040|81676496|FG000|Stage II|Not able to attend clinic|1|||
27957300|NCT00339040|81676497|FG001|Stage II|Not able to attend clinic|0|||
27957301|NCT00339040|81676496|FG000|Stage II|Site closing|2|||
27957302|NCT00339040|81676497|FG001|Stage II|Site closing|0|||
27957303|NCT02315703|81676498|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27957304|NCT02315703|81676499|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27957305|NCT02315703|81676500|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27957306|NCT02315703|81676501|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
27957307|NCT02315703|81676502|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
27957308|NCT02315703|81676503|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27957309|NCT02315703|81676504|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
27957310|NCT02315703|81676505|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
27957311|NCT02315703|81676498|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
27957312|NCT02315703|81676499|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
27957313|NCT02315703|81676500|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
27957314|NCT02315703|81676501|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
27957315|NCT02315703|81676502|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
27957316|NCT02315703|81676503|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
27957317|NCT02315703|81676504|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
27957318|NCT02315703|81676505|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
27957319|NCT02315703|81676498|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27957320|NCT02315703|81676499|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27957321|NCT02315703|81676500|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27957322|NCT02315703|81676501|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27957323|NCT02315703|81676502|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27957324|NCT02315703|81676503|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
27957325|NCT02315703|81676504|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
27957326|NCT02315703|81676505|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
27957327|NCT02315703|81676498|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957328|NCT02315703|81676499|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957329|NCT02315703|81676500|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957330|NCT02315703|81676501|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957331|NCT02315703|81676502|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957332|NCT02315703|81676503|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957333|NCT02315703|81676504|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
27957334|NCT02315703|81676505|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
27957335|NCT02315703|81676498|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
27957336|NCT02315703|81676499|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
27957337|NCT02315703|81676500|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
27957338|NCT02315703|81676501|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
27957339|NCT02315703|81676502|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
27957340|NCT02315703|81676503|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
27957341|NCT02315703|81676504|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
27957342|NCT02315703|81676505|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
27957343|NCT02315703|81676498|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
27957344|NCT02315703|81676499|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
27957345|NCT02315703|81676500|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
27957346|NCT02315703|81676501|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
27957347|NCT02315703|81676502|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
27957348|NCT02315703|81676503|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
27957349|NCT02315703|81676504|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
27957350|NCT02315703|81676505|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
27957351|NCT02315703|81676498|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
27957352|NCT02315703|81676499|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
27957353|NCT02315703|81676500|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27957354|NCT02315703|81676501|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27957355|NCT02315703|81676502|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27957356|NCT02315703|81676503|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27957357|NCT02315703|81676504|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27957358|NCT02315703|81676505|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
27957359|NCT02315703|81676498|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957360|NCT02315703|81676499|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
27957361|NCT02315703|81676500|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957362|NCT02315703|81676501|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957363|NCT02315703|81676502|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957364|NCT02315703|81676503|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957365|NCT02315703|81676504|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957366|NCT02315703|81676505|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
27957367|NCT02315703|81676498|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
27957368|NCT02315703|81676499|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
27957369|NCT02315703|81676500|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
27957370|NCT02315703|81676501|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
27957371|NCT02315703|81676502|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
27957372|NCT02315703|81676503|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
27957373|NCT02315703|81676504|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
27957374|NCT02315703|81676505|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
27957375|NCT01603043|81676513|FG000|Overall Study|Study Futility|7|||
27957376|NCT01603043|81676514|FG001|Overall Study|Study Futility|3|||
27957377|NCT01479764|81676515|FG000|Randomized|Adverse Event|1|||
27957378|NCT01479764|81676516|FG001|Randomized|Adverse Event|1|||
27957379|NCT01479764|81676515|FG000|Randomized|Withdrawal by Subject|1|||
27957380|NCT01479764|81676516|FG001|Randomized|Withdrawal by Subject|0|||
27957381|NCT01479764|81676515|FG000|Treated|Lost to Follow-up|0|||
27957382|NCT01479764|81676516|FG001|Treated|Lost to Follow-up|2|||
27957383|NCT01484496|81676517|FG000|Period 1|Protocol Violation|3|||
27957384|NCT01484496|81676518|FG001|Period 1|Protocol Violation|4|||
27957385|NCT01484496|81676519|FG002|Period 1|Protocol Violation|0|||
27957386|NCT01484496|81676520|FG003|Period 1|Protocol Violation|0|||
27957387|NCT01484496|81676517|FG000|Period 1|Physician Decision|5|||
27957388|NCT01484496|81676518|FG001|Period 1|Physician Decision|1|||
27957389|NCT01484496|81676519|FG002|Period 1|Physician Decision|0|||
27957390|NCT01484496|81676520|FG003|Period 1|Physician Decision|0|||
27957391|NCT01484496|81676517|FG000|Period 1|Lack of Efficacy|10|||
27957392|NCT01484496|81676518|FG001|Period 1|Lack of Efficacy|15|||
27957393|NCT01484496|81676519|FG002|Period 1|Lack of Efficacy|0|||
27957394|NCT01484496|81676520|FG003|Period 1|Lack of Efficacy|0|||
27957395|NCT01484496|81676517|FG000|Period 1|Adverse Event|25|||
27957396|NCT01484496|81676518|FG001|Period 1|Adverse Event|40|||
27957397|NCT01484496|81676519|FG002|Period 1|Adverse Event|0|||
27957398|NCT01484496|81676520|FG003|Period 1|Adverse Event|0|||
27957399|NCT01484496|81676517|FG000|Period 1|Withdrawal by Subject|15|||
27957400|NCT01484496|81676518|FG001|Period 1|Withdrawal by Subject|12|||
27957401|NCT01484496|81676519|FG002|Period 1|Withdrawal by Subject|0|||
27957402|NCT01484496|81676520|FG003|Period 1|Withdrawal by Subject|0|||
27957403|NCT01484496|81676517|FG000|Period 1|Lost to Follow-up|2|||
27957404|NCT01484496|81676518|FG001|Period 1|Lost to Follow-up|6|||
27957405|NCT01484496|81676519|FG002|Period 1|Lost to Follow-up|0|||
27957406|NCT01484496|81676520|FG003|Period 1|Lost to Follow-up|0|||
27957407|NCT01484496|81676517|FG000|Period 1|Positive Pregnancy|1|||
27957408|NCT01484496|81676518|FG001|Period 1|Positive Pregnancy|6|||
27957409|NCT01484496|81676519|FG002|Period 1|Positive Pregnancy|0|||
27957410|NCT01484496|81676520|FG003|Period 1|Positive Pregnancy|0|||
27957411|NCT01484496|81676517|FG000|Period 1|Treatment Failure|3|||
27957412|NCT01484496|81676518|FG001|Period 1|Treatment Failure|6|||
27957413|NCT01484496|81676519|FG002|Period 1|Treatment Failure|0|||
27754351|NCT02504268|80929439|FG005|Overall Study|Pregnancy|0|||
27957414|NCT01484496|81676520|FG003|Period 1|Treatment Failure|0|||
27957415|NCT01484496|81676517|FG000|Period 1|Lack of Compliance|2|||
27957416|NCT01484496|81676518|FG001|Period 1|Lack of Compliance|1|||
27957417|NCT01484496|81676519|FG002|Period 1|Lack of Compliance|0|||
27957418|NCT01484496|81676520|FG003|Period 1|Lack of Compliance|0|||
27957419|NCT01484496|81676517|FG000|Period 1|Unable to Visit Site|0|||
27957420|NCT01484496|81676518|FG001|Period 1|Unable to Visit Site|2|||
27957421|NCT01484496|81676519|FG002|Period 1|Unable to Visit Site|0|||
27957422|NCT01484496|81676520|FG003|Period 1|Unable to Visit Site|0|||
27957423|NCT01484496|81676517|FG000|Period 2|Lack of Efficacy|0|||
27957424|NCT01484496|81676518|FG001|Period 2|Lack of Efficacy|0|||
27957425|NCT01484496|81676519|FG002|Period 2|Lack of Efficacy|1|||
27957426|NCT01484496|81676520|FG003|Period 2|Lack of Efficacy|3|||
27957427|NCT01484496|81676517|FG000|Period 2|Adverse Event|0|||
27957428|NCT01484496|81676518|FG001|Period 2|Adverse Event|0|||
27957429|NCT01484496|81676519|FG002|Period 2|Adverse Event|5|||
27957430|NCT01484496|81676520|FG003|Period 2|Adverse Event|13|||
27957431|NCT01484496|81676517|FG000|Period 2|Other|0|||
27957432|NCT01484496|81676518|FG001|Period 2|Other|0|||
27957433|NCT01484496|81676519|FG002|Period 2|Other|9|||
27957434|NCT01484496|81676520|FG003|Period 2|Other|6|||
27957435|NCT00803595|81676522|FG000|Overall Study|Adverse Event|3|||
27957436|NCT00803595|81676523|FG001|Overall Study|Adverse Event|4|||
27957437|NCT00803595|81676524|FG002|Overall Study|Adverse Event|1|||
27957438|NCT00803595|81676522|FG000|Overall Study|Protocol Violation|7|||
27957439|NCT00803595|81676523|FG001|Overall Study|Protocol Violation|2|||
27957440|NCT00803595|81676524|FG002|Overall Study|Protocol Violation|12|||
27957441|NCT00803595|81676522|FG000|Overall Study|Withdrawal by Subject|5|||
27957442|NCT00803595|81676523|FG001|Overall Study|Withdrawal by Subject|2|||
27957443|NCT00803595|81676524|FG002|Overall Study|Withdrawal by Subject|3|||
27957444|NCT02820844|81676525|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
27957445|NCT02820844|81676526|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
27957446|NCT02820844|81676527|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
27957447|NCT02820844|81676528|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
27957448|NCT02820844|81676529|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
27957449|NCT02820844|81676530|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
27957450|NCT02820844|81676525|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
27957451|NCT02820844|81676526|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
27957452|NCT02820844|81676527|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
27957453|NCT02820844|81676528|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
27957454|NCT02820844|81676529|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
27957455|NCT02820844|81676530|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
27957456|NCT02820844|81676525|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
27957457|NCT02820844|81676526|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
27957458|NCT02820844|81676527|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
27957459|NCT02820844|81676528|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
27957460|NCT02820844|81676529|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
27957461|NCT02820844|81676530|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
27957462|NCT02820844|81676525|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
27957463|NCT02820844|81676526|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
27957464|NCT02820844|81676527|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
27957465|NCT02820844|81676528|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
27957466|NCT02820844|81676529|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
27957467|NCT02820844|81676530|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
27957468|NCT02820844|81676525|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
27957469|NCT02820844|81676526|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
27957470|NCT02820844|81676527|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
27957471|NCT02820844|81676528|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
27957472|NCT02820844|81676529|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
27957473|NCT02820844|81676530|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
27957474|NCT02820844|81676525|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
27957475|NCT02820844|81676526|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
27957476|NCT02820844|81676527|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
27957477|NCT02820844|81676528|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
27957478|NCT02820844|81676529|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
27957479|NCT02820844|81676530|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
27957480|NCT02820844|81676525|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
27957481|NCT02820844|81676526|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
27957482|NCT02820844|81676527|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
27957483|NCT02820844|81676528|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
27957484|NCT02820844|81676529|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
27957485|NCT02820844|81676530|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
27957486|NCT02820844|81676525|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957487|NCT02820844|81676526|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27959319|NCT02131662|81683270|FG001|Overall Study|Lack of Efficacy|0|||
27957488|NCT02820844|81676527|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
27957489|NCT02820844|81676528|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
27957490|NCT02820844|81676529|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957491|NCT02820844|81676530|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957492|NCT02820844|81676525|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
27957493|NCT02820844|81676526|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
27957494|NCT02820844|81676527|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
27957495|NCT02820844|81676528|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
27957496|NCT02820844|81676529|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
27957497|NCT02820844|81676530|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
27957498|NCT02820844|81676525|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957499|NCT02820844|81676526|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957500|NCT02820844|81676527|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957501|NCT02820844|81676528|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957502|NCT02820844|81676529|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
27957503|NCT02820844|81676530|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
27957504|NCT02336815|81676533|FG000|Overall Study|Disease Progression|45|||
27957505|NCT02336815|81676534|FG001|Overall Study|Disease Progression|70|||
27957506|NCT02336815|81676533|FG000|Overall Study|Adverse Event|18|||
27957507|NCT02336815|81676534|FG001|Overall Study|Adverse Event|39|||
27957508|NCT02336815|81676533|FG000|Overall Study|Physician Decision|11|||
27957509|NCT02336815|81676534|FG001|Overall Study|Physician Decision|4|||
27957510|NCT02336815|81676533|FG000|Overall Study|Withdrawal by Subject|3|||
27957511|NCT02336815|81676534|FG001|Overall Study|Withdrawal by Subject|2|||
27957512|NCT02336815|81676533|FG000|Overall Study|Lost to Follow-up|1|||
27957513|NCT02336815|81676534|FG001|Overall Study|Lost to Follow-up|3|||
27957514|NCT02336815|81676533|FG000|Overall Study|Other|1|||
27957515|NCT02336815|81676534|FG001|Overall Study|Other|5|||
27957516|NCT00756275|81676537|FG000|Overall Study|Lost to Follow-up|25|||
27957517|NCT00756275|81676538|FG001|Overall Study|Lost to Follow-up|21|||
27957518|NCT00756275|81676537|FG000|Overall Study|Withdrawal by Subject|4|||
27957519|NCT00756275|81676538|FG001|Overall Study|Withdrawal by Subject|7|||
27957520|NCT04403919|81676539|FG000|Overall Study|Lost to Follow-up|0|||
27957521|NCT04403919|81676540|FG001|Overall Study|Lost to Follow-up|0|||
27957522|NCT04403919|81676541|FG002|Overall Study|Lost to Follow-up|0|||
27957523|NCT04403919|81676542|FG003|Overall Study|Lost to Follow-up|1|||
27957524|NCT00442416|81676543|FG000|Overall Study|Adverse Event|4|||
27957525|NCT00442416|81676544|FG001|Overall Study|Adverse Event|1|||
27957526|NCT00442416|81676543|FG000|Overall Study|Death|1|||
27957527|NCT00442416|81676544|FG001|Overall Study|Death|0|||
27957528|NCT00442416|81676543|FG000|Overall Study|Lack of Efficacy|2|||
27957529|NCT00442416|81676544|FG001|Overall Study|Lack of Efficacy|0|||
27957530|NCT00442416|81676543|FG000|Overall Study|Protocol Violation|2|||
27957531|NCT00442416|81676544|FG001|Overall Study|Protocol Violation|3|||
27957532|NCT00442416|81676543|FG000|Overall Study|Withdrew consent|1|||
27957533|NCT00442416|81676544|FG001|Overall Study|Withdrew consent|2|||
27957534|NCT00442416|81676543|FG000|Overall Study|Administrative/Other|27|||
27957535|NCT00442416|81676544|FG001|Overall Study|Administrative/Other|33|||
27957536|NCT01008618|81676545|FG000|Period 1 (Titration Period)|Physician Decision|2|||
27957537|NCT01008618|81676546|FG001|Period 1 (Titration Period)|Physician Decision|0|||
27957538|NCT01008618|81676547|FG002|Period 1 (Titration Period)|Physician Decision|0|||
27957539|NCT01008618|81676545|FG000|Period 1 (Titration Period)|Adverse Event|33|||
27957540|NCT01008618|81676546|FG001|Period 1 (Titration Period)|Adverse Event|0|||
27957541|NCT01008618|81676547|FG002|Period 1 (Titration Period)|Adverse Event|0|||
27957542|NCT01008618|81676545|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
27957543|NCT01008618|81676546|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27957544|NCT01008618|81676547|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
27957545|NCT01008618|81676545|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
27957546|NCT01008618|81676546|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27957547|NCT01008618|81676547|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
27957548|NCT01008618|81676545|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
27957549|NCT01008618|81676546|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
27957550|NCT01008618|81676547|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
27957551|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
27957552|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
27957553|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
27957554|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
27957555|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
27957556|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
27957557|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
27957558|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
27957559|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
27957560|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
27957561|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
27957562|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
27957563|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27957564|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
27957565|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
27957566|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
27957567|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
27957568|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
27957569|NCT01008618|81676545|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
27957570|NCT01008618|81676546|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
27957571|NCT01008618|81676547|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
27957572|NCT01451749|81676550|FG000|Overall Study|Protocol Violation|14|||
27957573|NCT01451749|81676551|FG001|Overall Study|Protocol Violation|7|||
27957574|NCT01451749|81676550|FG000|Overall Study|Lost to Follow-up|15|||
27957575|NCT01451749|81676551|FG001|Overall Study|Lost to Follow-up|5|||
27957576|NCT01451749|81676550|FG000|Overall Study|Meet the exclusion criteria,and|1|||
27957577|NCT01451749|81676551|FG001|Overall Study|Meet the exclusion criteria,and|1|||
27957578|NCT01451749|81676550|FG000|Overall Study|Adverse Event|2|||
27957579|NCT01451749|81676551|FG001|Overall Study|Adverse Event|0|||
27957580|NCT01451749|81676550|FG000|Overall Study|Withdrawal by Subject|0|||
27957581|NCT01451749|81676551|FG001|Overall Study|Withdrawal by Subject|1|||
27957582|NCT04389866|81676552|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
27957583|NCT04389866|81676553|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
27957584|NCT00363311|81676554|FG000|Overall Study|Adverse Event|6|||
27957585|NCT00363311|81676555|FG001|Overall Study|Adverse Event|4|||
27957586|NCT00363311|81676554|FG000|Overall Study|Lost to Follow-up|3|||
27957587|NCT00363311|81676555|FG001|Overall Study|Lost to Follow-up|0|||
27957588|NCT00363311|81676554|FG000|Overall Study|Protocol Violation|1|||
27957589|NCT00363311|81676555|FG001|Overall Study|Protocol Violation|2|||
27957590|NCT00363311|81676554|FG000|Overall Study|Withdrawal by Subject|12|||
27957591|NCT00363311|81676555|FG001|Overall Study|Withdrawal by Subject|6|||
27957592|NCT00363311|81676554|FG000|Overall Study|Physician Decision|1|||
27957593|NCT00363311|81676555|FG001|Overall Study|Physician Decision|1|||
27957594|NCT00363311|81676554|FG000|Overall Study|Sponsor Terminated Study|2|||
27957595|NCT00363311|81676555|FG001|Overall Study|Sponsor Terminated Study|2|||
27957596|NCT00363311|81676554|FG000|Overall Study|Disease Progression|46|||
27957597|NCT00363311|81676555|FG001|Overall Study|Disease Progression|26|||
27957598|NCT00363311|81676554|FG000|Overall Study|Non-Compliance|1|||
27957599|NCT00363311|81676555|FG001|Overall Study|Non-Compliance|1|||
27957600|NCT00363311|81676554|FG000|Overall Study|Participant Refused Biopsy|1|||
27957601|NCT00363311|81676555|FG001|Overall Study|Participant Refused Biopsy|0|||
27957602|NCT00363311|81676554|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
27957603|NCT00363311|81676555|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
27957604|NCT00363311|81676554|FG000|Overall Study|Participant Opted for Treatment|1|||
27957605|NCT00363311|81676555|FG001|Overall Study|Participant Opted for Treatment|0|||
27957606|NCT00363311|81676554|FG000|Overall Study|Participant Moved to Another Country|1|||
27957607|NCT00363311|81676555|FG001|Overall Study|Participant Moved to Another Country|0|||
27957608|NCT00363311|81676554|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
27957609|NCT00363311|81676555|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
27957610|NCT00363311|81676554|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
27957611|NCT00363311|81676555|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
27957612|NCT00363311|81676554|FG000|Overall Study|Participant Moved to Louisiana|0|||
27957613|NCT00363311|81676555|FG001|Overall Study|Participant Moved to Louisiana|1|||
27957614|NCT00976716|81676556|FG000|Overall Study|Adverse Event|1|||
27957615|NCT01531998|81676557|FG000|Overall Study|Withdrawal by Subject|3|||
27957616|NCT01534481|81676559|FG000|Overall Study|Lost to Follow-up|29|||
27957617|NCT01534481|81676560|FG001|Overall Study|Lost to Follow-up|24|||
27957618|NCT01534481|81676559|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
27957619|NCT01534481|81676560|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
27957620|NCT00856609|81676561|FG000|Overall Study|Adverse Event|1|||
27957621|NCT00856609|81676562|FG001|Overall Study|Adverse Event|0|||
27957622|NCT01369199|81679753|FG000|Overall Study|Withdrawal by Subject|1|||
27957623|NCT01369199|81679753|FG000|Overall Study|Lost to Follow-up|2|||
27957624|NCT00658541|81679758|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
27957625|NCT00658541|81679759|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27957626|NCT00658541|81679758|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
27957627|NCT00658541|81679759|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
27957628|NCT00980148|81679760|FG000|Overall Study|Discharged from facility|89|||
27957629|NCT00980148|81679761|FG001|Overall Study|Discharged from facility|96|||
27957630|NCT00980148|81679760|FG000|Overall Study|Received other antichlamydia treatment|20|||
27957631|NCT00980148|81679761|FG001|Overall Study|Received other antichlamydia treatment|14|||
27957632|NCT00980148|81679760|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
27957633|NCT00980148|81679761|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
27957634|NCT00980148|81679760|FG000|Overall Study|Various other reasons|8|||
27957635|NCT00980148|81679761|FG001|Overall Study|Various other reasons|9|||
27957636|NCT01027650|81679764|FG000|Overall Study|Personal Reasons|0|||
27957637|NCT01027650|81679765|FG001|Overall Study|Personal Reasons|0|||
27957638|NCT01027650|81679766|FG002|Overall Study|Personal Reasons|0|||
27957639|NCT01027650|81679767|FG003|Overall Study|Personal Reasons|0|||
27957640|NCT01027650|81679768|FG004|Overall Study|Personal Reasons|2|||
27957641|NCT01027650|81679769|FG005|Overall Study|Personal Reasons|1|||
27957642|NCT01027650|81679770|FG006|Overall Study|Personal Reasons|0|||
27957643|NCT01027650|81679771|FG007|Overall Study|Personal Reasons|0|||
27957644|NCT01027650|81679764|FG000|Overall Study|Lost to Follow-up|0|||
27957645|NCT01027650|81679765|FG001|Overall Study|Lost to Follow-up|0|||
27957646|NCT01027650|81679766|FG002|Overall Study|Lost to Follow-up|0|||
27957647|NCT01027650|81679767|FG003|Overall Study|Lost to Follow-up|0|||
27957648|NCT01027650|81679768|FG004|Overall Study|Lost to Follow-up|0|||
27957649|NCT01027650|81679769|FG005|Overall Study|Lost to Follow-up|0|||
27957650|NCT01027650|81679770|FG006|Overall Study|Lost to Follow-up|1|||
27957651|NCT01027650|81679771|FG007|Overall Study|Lost to Follow-up|0|||
27957652|NCT01027650|81679764|FG000|Overall Study|Lack of Efficacy|0|||
27957653|NCT01027650|81679765|FG001|Overall Study|Lack of Efficacy|0|||
27957654|NCT01027650|81679766|FG002|Overall Study|Lack of Efficacy|0|||
27957655|NCT01027650|81679767|FG003|Overall Study|Lack of Efficacy|0|||
27957656|NCT01027650|81679768|FG004|Overall Study|Lack of Efficacy|0|||
27957657|NCT01027650|81679769|FG005|Overall Study|Lack of Efficacy|1|||
27957658|NCT01027650|81679770|FG006|Overall Study|Lack of Efficacy|0|||
27957659|NCT01027650|81679771|FG007|Overall Study|Lack of Efficacy|0|||
27957660|NCT02931838|81679774|FG000|Overall Study|Reason not provided by investigator|1|||
27957661|NCT02931838|81679775|FG001|Overall Study|Reason not provided by investigator|0|||
27957662|NCT02931838|81679776|FG002|Overall Study|Reason not provided by investigator|1|||
27957663|NCT02931838|81679777|FG003|Overall Study|Reason not provided by investigator|0|||
27957664|NCT02931838|81679778|FG004|Overall Study|Reason not provided by investigator|0|||
27957665|NCT02931838|81679779|FG005|Overall Study|Reason not provided by investigator|0|||
27957666|NCT02931838|81679774|FG000|Overall Study|Poor/non-compliance|0|||
27957667|NCT02931838|81679775|FG001|Overall Study|Poor/non-compliance|0|||
27957668|NCT02931838|81679776|FG002|Overall Study|Poor/non-compliance|1|||
27957669|NCT02931838|81679777|FG003|Overall Study|Poor/non-compliance|0|||
27957670|NCT02931838|81679778|FG004|Overall Study|Poor/non-compliance|0|||
27957671|NCT02931838|81679779|FG005|Overall Study|Poor/non-compliance|0|||
27957672|NCT02931838|81679774|FG000|Overall Study|Lack of Efficacy|5|||
27957673|NCT02931838|81679775|FG001|Overall Study|Lack of Efficacy|4|||
27957674|NCT02931838|81679776|FG002|Overall Study|Lack of Efficacy|0|||
27957675|NCT02931838|81679777|FG003|Overall Study|Lack of Efficacy|0|||
27957676|NCT02931838|81679778|FG004|Overall Study|Lack of Efficacy|0|||
27957677|NCT02931838|81679779|FG005|Overall Study|Lack of Efficacy|1|||
27957678|NCT02931838|81679774|FG000|Overall Study|Lost to Follow-up|1|||
27957679|NCT02931838|81679775|FG001|Overall Study|Lost to Follow-up|0|||
27957680|NCT02931838|81679776|FG002|Overall Study|Lost to Follow-up|1|||
27957681|NCT02931838|81679777|FG003|Overall Study|Lost to Follow-up|1|||
27957682|NCT02931838|81679778|FG004|Overall Study|Lost to Follow-up|2|||
27957683|NCT02931838|81679779|FG005|Overall Study|Lost to Follow-up|0|||
27957684|NCT02931838|81679774|FG000|Overall Study|Subject request to discontinue treatment|4|||
27957685|NCT02931838|81679775|FG001|Overall Study|Subject request to discontinue treatment|3|||
27957686|NCT02931838|81679776|FG002|Overall Study|Subject request to discontinue treatment|3|||
27957687|NCT02931838|81679777|FG003|Overall Study|Subject request to discontinue treatment|0|||
27957688|NCT02931838|81679778|FG004|Overall Study|Subject request to discontinue treatment|1|||
27957689|NCT02931838|81679779|FG005|Overall Study|Subject request to discontinue treatment|0|||
27957690|NCT02931838|81679774|FG000|Overall Study|Withdrawal by Subject|1|||
27957691|NCT02931838|81679775|FG001|Overall Study|Withdrawal by Subject|2|||
27957692|NCT02931838|81679776|FG002|Overall Study|Withdrawal by Subject|0|||
27957693|NCT02931838|81679777|FG003|Overall Study|Withdrawal by Subject|1|||
27957694|NCT02931838|81679778|FG004|Overall Study|Withdrawal by Subject|0|||
27957695|NCT02931838|81679779|FG005|Overall Study|Withdrawal by Subject|0|||
27957696|NCT02931838|81679774|FG000|Overall Study|Adverse Event|2|||
27957697|NCT02931838|81679775|FG001|Overall Study|Adverse Event|1|||
27957698|NCT02931838|81679776|FG002|Overall Study|Adverse Event|2|||
27957699|NCT02931838|81679777|FG003|Overall Study|Adverse Event|1|||
27957700|NCT02931838|81679778|FG004|Overall Study|Adverse Event|3|||
27957701|NCT02931838|81679779|FG005|Overall Study|Adverse Event|1|||
27957702|NCT05384834|81679780|FG000|Overall Study|Lost to Follow-up|43|||
27957703|NCT05384834|81679780|FG000|Overall Study|Withdrawal by Subject|5|||
27957704|NCT00375674|81679781|FG000|Overall Study|Other|26|||
27957705|NCT00375674|81679782|FG001|Overall Study|Other|18|||
27957706|NCT00375674|81679781|FG000|Overall Study|Death|67|||
27957707|NCT00375674|81679782|FG001|Overall Study|Death|76|||
27957708|NCT00375674|81679781|FG000|Overall Study|Participants refused further follow-up|31|||
27957709|NCT00375674|81679782|FG001|Overall Study|Participants refused further follow-up|30|||
27957710|NCT00375674|81679781|FG000|Overall Study|Lost to Follow-up|17|||
27957711|NCT00375674|81679782|FG001|Overall Study|Lost to Follow-up|15|||
27957712|NCT00375674|81679781|FG000|Overall Study|Enrolled but not treated|3|||
27957713|NCT00375674|81679782|FG001|Overall Study|Enrolled but not treated|2|||
27957714|NCT05219253|81679787|FG000|Overall Study|Withdrawal by Subject|1|||
27957715|NCT05219253|81679788|FG001|Overall Study|Withdrawal by Subject|2|||
27957716|NCT03341637|81679789|FG000|Overall Study|Lost to Follow-up|1|||
27957717|NCT03341637|81679790|FG001|Overall Study|Lost to Follow-up|0|||
27957718|NCT03341637|81679789|FG000|Overall Study|Withdrawal by Subject|3|||
27957719|NCT03341637|81679790|FG001|Overall Study|Withdrawal by Subject|3|||
27957720|NCT03341637|81679789|FG000|Overall Study|Reason not Specified|1|||
27957721|NCT03341637|81679790|FG001|Overall Study|Reason not Specified|1|||
27957722|NCT01847092|81679793|FG000|Overall Study|Adverse Event|12|||
27957723|NCT01847092|81679794|FG001|Overall Study|Adverse Event|3|||
27957724|NCT01847092|81679793|FG000|Overall Study|Withdrawal by Subject|5|||
27957725|NCT01847092|81679794|FG001|Overall Study|Withdrawal by Subject|5|||
27957726|NCT01847092|81679793|FG000|Overall Study|Protocol Specified|8|||
27957727|NCT01847092|81679794|FG001|Overall Study|Protocol Specified|0|||
27957728|NCT01847092|81679793|FG000|Overall Study|Physician Decision|1|||
27957729|NCT01847092|81679794|FG001|Overall Study|Physician Decision|1|||
27957730|NCT01847092|81679793|FG000|Overall Study|Protocol Violation|0|||
27957731|NCT01847092|81679794|FG001|Overall Study|Protocol Violation|2|||
27957732|NCT01408277|81679795|FG000|Overall Study|Adverse Event|3|||
27957733|NCT01408277|81679796|FG001|Overall Study|Adverse Event|4|||
27957734|NCT01408277|81679795|FG000|Overall Study|Lost to Follow-up|1|||
27957735|NCT01408277|81679796|FG001|Overall Study|Lost to Follow-up|0|||
27957736|NCT01408277|81679795|FG000|Overall Study|Withdrawal by Subject|2|||
27957737|NCT01408277|81679796|FG001|Overall Study|Withdrawal by Subject|0|||
27957738|NCT01408277|81679795|FG000|Overall Study|Protocol Violation|2|||
27957739|NCT01408277|81679796|FG001|Overall Study|Protocol Violation|0|||
27957740|NCT02175277|81679797|FG000|Overall Study|Protocol-specified Criteria|1|||
27957741|NCT00551031|81679798|FG000|Overall Study|Adverse Event|0|||
27957742|NCT00551031|81679799|FG001|Overall Study|Adverse Event|1|||
27957743|NCT00551031|81679800|FG002|Overall Study|Adverse Event|0|||
27957744|NCT00551031|81679801|FG003|Overall Study|Adverse Event|0|||
27957745|NCT00551031|81679802|FG004|Overall Study|Adverse Event|0|||
27957746|NCT00551031|81679798|FG000|Overall Study|Protocol Violation|1|||
27957747|NCT00551031|81679799|FG001|Overall Study|Protocol Violation|1|||
27957748|NCT00551031|81679800|FG002|Overall Study|Protocol Violation|0|||
27957749|NCT00551031|81679801|FG003|Overall Study|Protocol Violation|0|||
27957750|NCT00551031|81679802|FG004|Overall Study|Protocol Violation|0|||
27957751|NCT00551031|81679798|FG000|Overall Study|Lost to Follow-up|0|||
27957752|NCT00551031|81679799|FG001|Overall Study|Lost to Follow-up|1|||
27957753|NCT00551031|81679800|FG002|Overall Study|Lost to Follow-up|0|||
27957754|NCT00551031|81679801|FG003|Overall Study|Lost to Follow-up|1|||
27957755|NCT00551031|81679802|FG004|Overall Study|Lost to Follow-up|1|||
27957756|NCT00551031|81679798|FG000|Overall Study|Withdrawal by Subject|0|||
27957757|NCT00551031|81679799|FG001|Overall Study|Withdrawal by Subject|4|||
27957758|NCT00551031|81679800|FG002|Overall Study|Withdrawal by Subject|1|||
27957759|NCT00551031|81679801|FG003|Overall Study|Withdrawal by Subject|2|||
27957760|NCT00551031|81679802|FG004|Overall Study|Withdrawal by Subject|0|||
27957761|NCT00551031|81679798|FG000|Overall Study|Serious Adverse Event|0|||
27551848|NCT01906008|80207607|FG000|Overall Study|Lost to Follow-up|2|||
27551849|NCT01906008|80207608|FG001|Overall Study|Lost to Follow-up|0|||
27551850|NCT01906008|80207607|FG000|Overall Study|Oxaliplatin toxicity|2|||
27551851|NCT01906008|80207608|FG001|Overall Study|Oxaliplatin toxicity|0|||
27551852|NCT01906008|80207607|FG000|Overall Study|Protocol Violation|0|||
27551853|NCT01906008|80207608|FG001|Overall Study|Protocol Violation|1|||
27551854|NCT01906008|80207607|FG000|Overall Study|Withdrawal by Subject|1|||
27551855|NCT01906008|80207608|FG001|Overall Study|Withdrawal by Subject|5|||
27551856|NCT01906008|80207607|FG000|Overall Study|Did not start study med|3|||
27957762|NCT00551031|81679799|FG001|Overall Study|Serious Adverse Event|2|||
27957763|NCT00551031|81679800|FG002|Overall Study|Serious Adverse Event|1|||
27957764|NCT00551031|81679801|FG003|Overall Study|Serious Adverse Event|0|||
27957765|NCT00551031|81679802|FG004|Overall Study|Serious Adverse Event|0|||
27957766|NCT00551031|81679798|FG000|Overall Study|Did not receive vaccine|1|||
27957767|NCT00551031|81679799|FG001|Overall Study|Did not receive vaccine|2|||
27957768|NCT00551031|81679800|FG002|Overall Study|Did not receive vaccine|0|||
27957769|NCT00551031|81679801|FG003|Overall Study|Did not receive vaccine|0|||
27957770|NCT00551031|81679802|FG004|Overall Study|Did not receive vaccine|0|||
27957771|NCT03810014|81679807|FG000|Overall Study|Pregnancy|2|||
27957772|NCT03810014|81679808|FG001|Overall Study|Pregnancy|2|||
27957773|NCT03810014|81679809|FG002|Overall Study|Pregnancy|0|||
27957774|NCT03810014|81679810|FG003|Overall Study|Pregnancy|2|||
27957775|NCT00616642|81679816|FG000|Overall Study|Withdrawal by Subject|0|||
27551857|NCT01906008|80207608|FG001|Overall Study|Did not start study med|4|||
27551858|NCT01906008|80207607|FG000|Overall Study|Oxaliplatin stops|10|||
27551859|NCT01906008|80207608|FG001|Overall Study|Oxaliplatin stops|8|||
27551860|NCT01906008|80207607|FG000|Overall Study|Hospice|1|||
27551861|NCT01906008|80207608|FG001|Overall Study|Hospice|0|||
27551862|NCT01906008|80207607|FG000|Overall Study|Physician Decision|3|||
27551863|NCT01906008|80207608|FG001|Overall Study|Physician Decision|3|||
27551864|NCT01906008|80207607|FG000|Overall Study|Lack of compliance of study med|5|||
27551865|NCT01906008|80207608|FG001|Overall Study|Lack of compliance of study med|3|||
27551866|NCT01906008|80207607|FG000|Overall Study|Adverse Event|0|||
27551867|NCT01906008|80207608|FG001|Overall Study|Adverse Event|3|||
27551868|NCT04532164|80207609|FG000|Overall Study|Adverse Event|1|||
27551869|NCT04532164|80207609|FG000|Overall Study|Protocol Violation|5|||
27551870|NCT04532164|80207609|FG000|Overall Study|Lost to Follow-up|1|||
27551871|NCT04532164|80207609|FG000|Overall Study|Found to be Ineligible|3|||
27551872|NCT04532164|80207609|FG000|Overall Study|Withdrawal by Subject|14|||
27551873|NCT01648101|80207610|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
27551874|NCT01648101|80207611|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
27551875|NCT01648101|80207612|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
27551876|NCT01648101|80207610|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
27551877|NCT01648101|80207611|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
27551878|NCT01648101|80207612|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
27551879|NCT01648101|80207610|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
27551880|NCT01648101|80207611|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
27551881|NCT01648101|80207612|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
27551882|NCT01648101|80207610|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
27551883|NCT01648101|80207611|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
27551884|NCT01648101|80207612|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
27551885|NCT01648101|80207610|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
27551886|NCT01648101|80207611|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
27551887|NCT01648101|80207612|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
27551888|NCT01648101|80207610|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
27551889|NCT01648101|80207611|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
27551890|NCT01648101|80207612|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
27551891|NCT01648101|80207610|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
27551892|NCT01648101|80207611|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
27551893|NCT01648101|80207612|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
27551894|NCT01648101|80207610|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
27551895|NCT01648101|80207611|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
27551896|NCT01648101|80207612|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
27551897|NCT01648101|80207610|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
27551898|NCT01648101|80207611|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
27551899|NCT01648101|80207612|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
27551900|NCT01648101|80207610|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
27551901|NCT01648101|80207611|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
27551902|NCT01648101|80207612|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
27551903|NCT01648101|80207610|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
27551904|NCT01648101|80207611|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
27551905|NCT01648101|80207612|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
27551906|NCT02547454|80207613|FG000|Overall Study|Due to hemodialysis|53|||
27551907|NCT02547454|80207613|FG000|Overall Study|Due to transplantation|1|||
27551908|NCT02547454|80207613|FG000|Overall Study|Due to no further need to treat|4|||
27551909|NCT02547454|80207613|FG000|Overall Study|Death|38|||
27551910|NCT02547454|80207613|FG000|Overall Study|Lost to Follow-up|26|||
27551911|NCT02547454|80207613|FG000|Overall Study|Other|39|||
27551912|NCT02547454|80207613|FG000|Overall Study|No data|11|||
27551913|NCT04868890|80207614|FG000|Overall Study|Death|2|||
27551914|NCT04868890|80207615|FG001|Overall Study|Death|1|||
27551915|NCT04868890|80207614|FG000|Overall Study|Withdrawal by Subject|1|||
27551916|NCT04868890|80207615|FG001|Overall Study|Withdrawal by Subject|5|||
27551917|NCT03198234|80207616|FG000|Overall Study|Relapse of primary disease|0|||
27551918|NCT03198234|80207617|FG001|Overall Study|Relapse of primary disease|1|||
27551919|NCT03198234|80207618|FG002|Overall Study|Relapse of primary disease|0|||
27551920|NCT01411774|80207622|FG000|Overall Study|Withdrawal by Subject|0|||
27551921|NCT01411774|80207623|FG001|Overall Study|Withdrawal by Subject|3|||
27551922|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27551923|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
27551924|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27551925|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27551926|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27551927|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
27551928|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
27551929|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
27754352|NCT02504268|80929440|FG006|Overall Study|Pregnancy|0|||
27551930|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
27551931|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
27551932|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
27551933|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
27551934|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
27551935|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
27551936|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
27551937|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
27551938|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
27551939|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
27551940|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27551941|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27551942|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27551943|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27551944|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
27551945|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
27551946|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27551947|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
27551948|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27551949|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27551950|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27551951|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
27551952|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
27551953|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
27551954|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
27551955|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
27551956|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
27551957|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
27551958|NCT02603419|80207624|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27551959|NCT02603419|80207625|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27551960|NCT02603419|80207626|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27551961|NCT02603419|80207627|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
27551962|NCT02603419|80207628|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27551963|NCT02603419|80207629|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
27551964|NCT02603419|80207624|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27551965|NCT02603419|80207625|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27551966|NCT02603419|80207626|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27551967|NCT02603419|80207627|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27551968|NCT02603419|80207628|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
27551969|NCT02603419|80207629|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
27551970|NCT02603419|80207624|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27551971|NCT02603419|80207625|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27551972|NCT02603419|80207626|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27551973|NCT02603419|80207627|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27551974|NCT02603419|80207628|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
27551975|NCT02603419|80207629|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
27551976|NCT02603419|80207624|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27551977|NCT02603419|80207625|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27551978|NCT02603419|80207626|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27551979|NCT02603419|80207627|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27551980|NCT02603419|80207628|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
27551981|NCT02603419|80207629|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
27551982|NCT01575769|80207630|FG000|Overall Study|Adverse Event|1|||
27551983|NCT01575769|80207630|FG000|Overall Study|Study terminated by sponsor|40|||
27551984|NCT00964860|80207631|FG000|Overall Study|Withdrawal by Subject|0|||
27551985|NCT00964860|80207632|FG001|Overall Study|Withdrawal by Subject|1|||
27551986|NCT00543140|80207640|FG000|Overall Study|Lost to Follow-up|33|||
27551987|NCT00543140|80207640|FG000|Overall Study|Withdrawal by Subject|13|||
27551988|NCT00543140|80207640|FG000|Overall Study|Protocol Violation|10|||
27551989|NCT00543140|80207640|FG000|Overall Study|Insufficient weight loss|10|||
27551990|NCT00543140|80207640|FG000|Overall Study|SAE leading to explant of SAGB|3|||
27551991|NCT00543140|80207640|FG000|Overall Study|Death|1|||
27551992|NCT00543140|80207640|FG000|Overall Study|Subject moved|1|||
27551993|NCT00543140|80207640|FG000|Overall Study|Conversion to different procedure|1|||
27551994|NCT02370160|80207646|FG000|Overall Study|Death|3|||
27551995|NCT02370160|80207647|FG001|Overall Study|Death|4|||
27551996|NCT02370160|80207648|FG002|Overall Study|Death|1|||
27551997|NCT03519932|80207649|FG000|First Intervention|Adverse Event|1|||
27551998|NCT03519932|80207650|FG001|First Intervention|Adverse Event|3|||
27551999|NCT00965718|80207651|FG000|Overall Study|Withdrawal by Subject|4|||
27552000|NCT01513473|80207658|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
27552001|NCT01513473|80207659|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
27552002|NCT01513473|80207658|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
27552003|NCT01513473|80207659|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
27552004|NCT01513473|80207658|FG000|Main Trial (26 Weeks)|Unclassified|0|||
27552005|NCT01513473|80207659|FG001|Main Trial (26 Weeks)|Unclassified|2|||
27552006|NCT01513473|80207658|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
27552007|NCT01513473|80207659|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
27552008|NCT01513473|80207658|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
27552009|NCT01513473|80207659|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
27552010|NCT02674529|80207660|FG000|Overall Study|Lost to Follow-up|1|||
27552011|NCT02674529|80207661|FG001|Overall Study|Lost to Follow-up|2|||
27552012|NCT02674529|80207660|FG000|Overall Study|Withdrawal by Subject|2|||
27552013|NCT02674529|80207661|FG001|Overall Study|Withdrawal by Subject|1|||
27552014|NCT02674529|80207660|FG000|Overall Study|Physician Decision|0|||
27552015|NCT02674529|80207661|FG001|Overall Study|Physician Decision|1|||
27552016|NCT02674529|80207660|FG000|Overall Study|Protocol Violation|0|||
27552017|NCT02674529|80207661|FG001|Overall Study|Protocol Violation|1|||
27552018|NCT04983264|80207665|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
27552019|NCT04983264|80207666|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
27552020|NCT04983264|80207667|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
27552021|NCT04983264|80207665|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
27552022|NCT04983264|80207666|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
27552023|NCT04983264|80207667|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
27552024|NCT02617628|80207669|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
27552025|NCT02617628|80207670|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
27552026|NCT00062374|80207671|FG000|Overall Study|Not treated|12|||
27552027|NCT00801632|80207676|FG000|Overall Study|Re-transplant|1|||
27552028|NCT01928394|80207677|FG000|Treatment Period|Disease progression|17|||
27552029|NCT01928394|80207678|FG001|Treatment Period|Disease progression|2|||
27552030|NCT01928394|80207679|FG002|Treatment Period|Disease progression|12|||
27552031|NCT01928394|80207680|FG003|Treatment Period|Disease progression|48|||
27552032|NCT01928394|80207681|FG004|Treatment Period|Disease progression|3|||
27552033|NCT01928394|80207682|FG005|Treatment Period|Disease progression|25|||
27552034|NCT01928394|80207683|FG006|Treatment Period|Disease progression|38|||
27552035|NCT01928394|80207684|FG007|Treatment Period|Disease progression|16|||
27552036|NCT01928394|80207685|FG008|Treatment Period|Disease progression|3|||
27552037|NCT01928394|80207686|FG009|Treatment Period|Disease progression|11|||
27552038|NCT01928394|80207687|FG010|Treatment Period|Disease progression|22|||
27552039|NCT01928394|80207688|FG011|Treatment Period|Disease progression|73|||
27552040|NCT01928394|80207689|FG012|Treatment Period|Disease progression|38|||
27552041|NCT01928394|80207690|FG013|Treatment Period|Disease progression|118|||
27552042|NCT01928394|80207691|FG014|Treatment Period|Disease progression|59|||
27552043|NCT01928394|80207692|FG015|Treatment Period|Disease progression|1|||
27552044|NCT01928394|80207693|FG016|Treatment Period|Disease progression|43|||
27552045|NCT01928394|80207694|FG017|Treatment Period|Disease progression|56|||
27552046|NCT01928394|80207695|FG018|Treatment Period|Disease progression|50|||
27552047|NCT01928394|80207696|FG019|Treatment Period|Disease progression|71|||
27552048|NCT01928394|80207697|FG020|Treatment Period|Disease progression|30|||
27552049|NCT01928394|80207698|FG021|Treatment Period|Disease progression|31|||
27552050|NCT01928394|80207699|FG022|Treatment Period|Disease progression|31|||
27552051|NCT01928394|80207677|FG000|Treatment Period|Study drug toxicity|1|||
27552052|NCT01928394|80207678|FG001|Treatment Period|Study drug toxicity|1|||
27552053|NCT01928394|80207679|FG002|Treatment Period|Study drug toxicity|3|||
27552054|NCT01928394|80207680|FG003|Treatment Period|Study drug toxicity|3|||
27552055|NCT01928394|80207681|FG004|Treatment Period|Study drug toxicity|0|||
27552056|NCT01928394|80207682|FG005|Treatment Period|Study drug toxicity|9|||
27552057|NCT01928394|80207683|FG006|Treatment Period|Study drug toxicity|7|||
27552058|NCT01928394|80207684|FG007|Treatment Period|Study drug toxicity|1|||
27552059|NCT01928394|80207685|FG008|Treatment Period|Study drug toxicity|0|||
27552060|NCT01928394|80207686|FG009|Treatment Period|Study drug toxicity|5|||
27552061|NCT01928394|80207687|FG010|Treatment Period|Study drug toxicity|2|||
27552062|NCT01928394|80207688|FG011|Treatment Period|Study drug toxicity|3|||
27552063|NCT01928394|80207689|FG012|Treatment Period|Study drug toxicity|7|||
27552064|NCT01928394|80207690|FG013|Treatment Period|Study drug toxicity|5|||
27552065|NCT01928394|80207691|FG014|Treatment Period|Study drug toxicity|12|||
27552066|NCT01928394|80207692|FG015|Treatment Period|Study drug toxicity|0|||
27552067|NCT01928394|80207693|FG016|Treatment Period|Study drug toxicity|3|||
27552068|NCT01928394|80207694|FG017|Treatment Period|Study drug toxicity|3|||
27552069|NCT01928394|80207695|FG018|Treatment Period|Study drug toxicity|12|||
27552070|NCT01928394|80207696|FG019|Treatment Period|Study drug toxicity|15|||
27552071|NCT01928394|80207697|FG020|Treatment Period|Study drug toxicity|4|||
27552072|NCT01928394|80207698|FG021|Treatment Period|Study drug toxicity|7|||
27552073|NCT01928394|80207699|FG022|Treatment Period|Study drug toxicity|4|||
27552074|NCT01928394|80207677|FG000|Treatment Period|AE unrelated to study drug|0|||
27552075|NCT01928394|80207678|FG001|Treatment Period|AE unrelated to study drug|0|||
27552076|NCT01928394|80207679|FG002|Treatment Period|AE unrelated to study drug|2|||
27552077|NCT01928394|80207680|FG003|Treatment Period|AE unrelated to study drug|3|||
27552078|NCT01928394|80207681|FG004|Treatment Period|AE unrelated to study drug|0|||
27552079|NCT01928394|80207682|FG005|Treatment Period|AE unrelated to study drug|5|||
27552080|NCT01928394|80207683|FG006|Treatment Period|AE unrelated to study drug|1|||
27552081|NCT01928394|80207684|FG007|Treatment Period|AE unrelated to study drug|0|||
27552082|NCT01928394|80207685|FG008|Treatment Period|AE unrelated to study drug|0|||
27552083|NCT01928394|80207686|FG009|Treatment Period|AE unrelated to study drug|2|||
27552084|NCT01928394|80207687|FG010|Treatment Period|AE unrelated to study drug|0|||
27552085|NCT01928394|80207688|FG011|Treatment Period|AE unrelated to study drug|12|||
27552086|NCT01928394|80207689|FG012|Treatment Period|AE unrelated to study drug|6|||
27552087|NCT01928394|80207690|FG013|Treatment Period|AE unrelated to study drug|13|||
27552088|NCT01928394|80207691|FG014|Treatment Period|AE unrelated to study drug|6|||
27552089|NCT01928394|80207692|FG015|Treatment Period|AE unrelated to study drug|1|||
27552090|NCT01928394|80207693|FG016|Treatment Period|AE unrelated to study drug|1|||
27552091|NCT01928394|80207694|FG017|Treatment Period|AE unrelated to study drug|6|||
27552092|NCT01928394|80207695|FG018|Treatment Period|AE unrelated to study drug|3|||
27552093|NCT01928394|80207696|FG019|Treatment Period|AE unrelated to study drug|5|||
27552094|NCT01928394|80207697|FG020|Treatment Period|AE unrelated to study drug|1|||
27552095|NCT01928394|80207698|FG021|Treatment Period|AE unrelated to study drug|1|||
27552096|NCT01928394|80207699|FG022|Treatment Period|AE unrelated to study drug|0|||
27552097|NCT01928394|80207677|FG000|Treatment Period|Participant request to stop therapy|0|||
27552098|NCT01928394|80207678|FG001|Treatment Period|Participant request to stop therapy|0|||
27552099|NCT01928394|80207679|FG002|Treatment Period|Participant request to stop therapy|0|||
27552100|NCT01928394|80207680|FG003|Treatment Period|Participant request to stop therapy|0|||
27552101|NCT01928394|80207681|FG004|Treatment Period|Participant request to stop therapy|0|||
27552102|NCT01928394|80207682|FG005|Treatment Period|Participant request to stop therapy|3|||
27552103|NCT01928394|80207683|FG006|Treatment Period|Participant request to stop therapy|3|||
27552104|NCT01928394|80207684|FG007|Treatment Period|Participant request to stop therapy|0|||
27552105|NCT01928394|80207685|FG008|Treatment Period|Participant request to stop therapy|0|||
27552106|NCT01928394|80207686|FG009|Treatment Period|Participant request to stop therapy|0|||
27552107|NCT01928394|80207687|FG010|Treatment Period|Participant request to stop therapy|3|||
27552108|NCT01928394|80207688|FG011|Treatment Period|Participant request to stop therapy|2|||
27552109|NCT01928394|80207689|FG012|Treatment Period|Participant request to stop therapy|1|||
27552110|NCT01928394|80207690|FG013|Treatment Period|Participant request to stop therapy|2|||
27552111|NCT01928394|80207691|FG014|Treatment Period|Participant request to stop therapy|4|||
27552112|NCT01928394|80207692|FG015|Treatment Period|Participant request to stop therapy|0|||
27552113|NCT01928394|80207693|FG016|Treatment Period|Participant request to stop therapy|1|||
27552114|NCT01928394|80207694|FG017|Treatment Period|Participant request to stop therapy|3|||
27552115|NCT01928394|80207695|FG018|Treatment Period|Participant request to stop therapy|1|||
27552116|NCT01928394|80207696|FG019|Treatment Period|Participant request to stop therapy|1|||
27552117|NCT01928394|80207697|FG020|Treatment Period|Participant request to stop therapy|3|||
27552118|NCT01928394|80207698|FG021|Treatment Period|Participant request to stop therapy|1|||
27552119|NCT01928394|80207699|FG022|Treatment Period|Participant request to stop therapy|3|||
27552120|NCT01928394|80207677|FG000|Treatment Period|Participant withdrew consent|0|||
27552121|NCT01928394|80207678|FG001|Treatment Period|Participant withdrew consent|0|||
27552122|NCT01928394|80207679|FG002|Treatment Period|Participant withdrew consent|1|||
27552123|NCT01928394|80207680|FG003|Treatment Period|Participant withdrew consent|1|||
27552124|NCT01928394|80207681|FG004|Treatment Period|Participant withdrew consent|0|||
27552125|NCT01928394|80207682|FG005|Treatment Period|Participant withdrew consent|1|||
27552126|NCT01928394|80207683|FG006|Treatment Period|Participant withdrew consent|0|||
27552127|NCT01928394|80207684|FG007|Treatment Period|Participant withdrew consent|1|||
27552128|NCT01928394|80207685|FG008|Treatment Period|Participant withdrew consent|0|||
27552129|NCT01928394|80207686|FG009|Treatment Period|Participant withdrew consent|0|||
27552130|NCT01928394|80207687|FG010|Treatment Period|Participant withdrew consent|1|||
27552131|NCT01928394|80207688|FG011|Treatment Period|Participant withdrew consent|1|||
27552132|NCT01928394|80207689|FG012|Treatment Period|Participant withdrew consent|1|||
27552133|NCT01928394|80207690|FG013|Treatment Period|Participant withdrew consent|0|||
27552134|NCT01928394|80207691|FG014|Treatment Period|Participant withdrew consent|2|||
27552135|NCT01928394|80207692|FG015|Treatment Period|Participant withdrew consent|0|||
27552136|NCT01928394|80207693|FG016|Treatment Period|Participant withdrew consent|2|||
27552137|NCT01928394|80207694|FG017|Treatment Period|Participant withdrew consent|1|||
27754353|NCT02504268|80929441|FG007|Overall Study|Pregnancy|0|||
27754354|NCT02504268|80929442|FG008|Overall Study|Pregnancy|0|||
27552138|NCT01928394|80207695|FG018|Treatment Period|Participant withdrew consent|1|||
27552139|NCT01928394|80207696|FG019|Treatment Period|Participant withdrew consent|1|||
27552140|NCT01928394|80207697|FG020|Treatment Period|Participant withdrew consent|0|||
27552141|NCT01928394|80207698|FG021|Treatment Period|Participant withdrew consent|2|||
27552142|NCT01928394|80207699|FG022|Treatment Period|Participant withdrew consent|0|||
27552143|NCT01928394|80207677|FG000|Treatment Period|Poor/non-compliance|0|||
27552144|NCT01928394|80207678|FG001|Treatment Period|Poor/non-compliance|0|||
27552145|NCT01928394|80207679|FG002|Treatment Period|Poor/non-compliance|0|||
27552146|NCT01928394|80207680|FG003|Treatment Period|Poor/non-compliance|1|||
27552147|NCT01928394|80207681|FG004|Treatment Period|Poor/non-compliance|0|||
27552148|NCT01928394|80207682|FG005|Treatment Period|Poor/non-compliance|0|||
27552149|NCT01928394|80207683|FG006|Treatment Period|Poor/non-compliance|0|||
27552150|NCT01928394|80207684|FG007|Treatment Period|Poor/non-compliance|0|||
27552151|NCT01928394|80207685|FG008|Treatment Period|Poor/non-compliance|0|||
27552152|NCT01928394|80207686|FG009|Treatment Period|Poor/non-compliance|0|||
27552153|NCT01928394|80207687|FG010|Treatment Period|Poor/non-compliance|0|||
27552154|NCT01928394|80207688|FG011|Treatment Period|Poor/non-compliance|0|||
27552155|NCT01928394|80207689|FG012|Treatment Period|Poor/non-compliance|1|||
27552156|NCT01928394|80207690|FG013|Treatment Period|Poor/non-compliance|0|||
27552157|NCT01928394|80207691|FG014|Treatment Period|Poor/non-compliance|1|||
27552158|NCT01928394|80207692|FG015|Treatment Period|Poor/non-compliance|0|||
27552159|NCT01928394|80207693|FG016|Treatment Period|Poor/non-compliance|0|||
27552160|NCT01928394|80207694|FG017|Treatment Period|Poor/non-compliance|1|||
27552161|NCT01928394|80207695|FG018|Treatment Period|Poor/non-compliance|0|||
27552162|NCT01928394|80207696|FG019|Treatment Period|Poor/non-compliance|1|||
27552163|NCT01928394|80207697|FG020|Treatment Period|Poor/non-compliance|0|||
27552164|NCT01928394|80207698|FG021|Treatment Period|Poor/non-compliance|0|||
27552165|NCT01928394|80207699|FG022|Treatment Period|Poor/non-compliance|0|||
27552166|NCT01928394|80207677|FG000|Treatment Period|other reason|0|||
27552167|NCT01928394|80207678|FG001|Treatment Period|other reason|0|||
27552168|NCT01928394|80207679|FG002|Treatment Period|other reason|0|||
27552169|NCT01928394|80207680|FG003|Treatment Period|other reason|0|||
27552170|NCT01928394|80207681|FG004|Treatment Period|other reason|0|||
27552171|NCT01928394|80207682|FG005|Treatment Period|other reason|0|||
27552172|NCT01928394|80207683|FG006|Treatment Period|other reason|0|||
27552173|NCT01928394|80207684|FG007|Treatment Period|other reason|0|||
27552174|NCT01928394|80207685|FG008|Treatment Period|other reason|0|||
27552175|NCT01928394|80207686|FG009|Treatment Period|other reason|0|||
27552176|NCT01928394|80207687|FG010|Treatment Period|other reason|1|||
27552177|NCT01928394|80207688|FG011|Treatment Period|other reason|1|||
27552178|NCT01928394|80207689|FG012|Treatment Period|other reason|1|||
27552179|NCT01928394|80207690|FG013|Treatment Period|other reason|0|||
27552180|NCT01928394|80207691|FG014|Treatment Period|other reason|1|||
27552181|NCT01928394|80207692|FG015|Treatment Period|other reason|0|||
27552182|NCT01928394|80207693|FG016|Treatment Period|other reason|0|||
27552183|NCT01928394|80207694|FG017|Treatment Period|other reason|0|||
27552184|NCT01928394|80207695|FG018|Treatment Period|other reason|2|||
27552185|NCT01928394|80207696|FG019|Treatment Period|other reason|2|||
27552186|NCT01928394|80207697|FG020|Treatment Period|other reason|0|||
27552187|NCT01928394|80207698|FG021|Treatment Period|other reason|0|||
27552188|NCT01928394|80207699|FG022|Treatment Period|other reason|0|||
27552189|NCT01928394|80207677|FG000|Treatment Period|Maximum clinical benefit|0|||
27552190|NCT01928394|80207678|FG001|Treatment Period|Maximum clinical benefit|0|||
27552191|NCT01928394|80207679|FG002|Treatment Period|Maximum clinical benefit|0|||
27552192|NCT01928394|80207680|FG003|Treatment Period|Maximum clinical benefit|0|||
27552193|NCT01928394|80207681|FG004|Treatment Period|Maximum clinical benefit|0|||
27552194|NCT01928394|80207682|FG005|Treatment Period|Maximum clinical benefit|0|||
27552195|NCT01928394|80207683|FG006|Treatment Period|Maximum clinical benefit|0|||
27552196|NCT01928394|80207684|FG007|Treatment Period|Maximum clinical benefit|0|||
27552197|NCT01928394|80207685|FG008|Treatment Period|Maximum clinical benefit|0|||
27552198|NCT01928394|80207686|FG009|Treatment Period|Maximum clinical benefit|0|||
27552199|NCT01928394|80207687|FG010|Treatment Period|Maximum clinical benefit|1|||
27552200|NCT01928394|80207688|FG011|Treatment Period|Maximum clinical benefit|1|||
27552201|NCT01928394|80207689|FG012|Treatment Period|Maximum clinical benefit|0|||
27552202|NCT01928394|80207690|FG013|Treatment Period|Maximum clinical benefit|0|||
27552203|NCT01928394|80207691|FG014|Treatment Period|Maximum clinical benefit|1|||
27552204|NCT01928394|80207692|FG015|Treatment Period|Maximum clinical benefit|0|||
27552205|NCT01928394|80207693|FG016|Treatment Period|Maximum clinical benefit|0|||
27552206|NCT01928394|80207694|FG017|Treatment Period|Maximum clinical benefit|1|||
27552207|NCT01928394|80207695|FG018|Treatment Period|Maximum clinical benefit|1|||
27552208|NCT01928394|80207696|FG019|Treatment Period|Maximum clinical benefit|0|||
27552209|NCT01928394|80207697|FG020|Treatment Period|Maximum clinical benefit|2|||
27552210|NCT01928394|80207698|FG021|Treatment Period|Maximum clinical benefit|0|||
27552211|NCT01928394|80207699|FG022|Treatment Period|Maximum clinical benefit|0|||
27552212|NCT01928394|80207677|FG000|Treatment Period|Lost to Follow-up|0|||
27552213|NCT01928394|80207678|FG001|Treatment Period|Lost to Follow-up|0|||
27754355|NCT02504268|80929434|FG000|Overall Study|Lost to Follow-up|3|||
27552214|NCT01928394|80207679|FG002|Treatment Period|Lost to Follow-up|0|||
27552215|NCT01928394|80207680|FG003|Treatment Period|Lost to Follow-up|0|||
27552216|NCT01928394|80207681|FG004|Treatment Period|Lost to Follow-up|0|||
27552217|NCT01928394|80207682|FG005|Treatment Period|Lost to Follow-up|0|||
27552218|NCT01928394|80207683|FG006|Treatment Period|Lost to Follow-up|0|||
27552219|NCT01928394|80207684|FG007|Treatment Period|Lost to Follow-up|0|||
27552220|NCT01928394|80207685|FG008|Treatment Period|Lost to Follow-up|0|||
27552221|NCT01928394|80207686|FG009|Treatment Period|Lost to Follow-up|0|||
27552222|NCT01928394|80207687|FG010|Treatment Period|Lost to Follow-up|0|||
27552223|NCT01928394|80207688|FG011|Treatment Period|Lost to Follow-up|0|||
27552224|NCT01928394|80207689|FG012|Treatment Period|Lost to Follow-up|0|||
27552225|NCT01928394|80207690|FG013|Treatment Period|Lost to Follow-up|0|||
27552226|NCT01928394|80207691|FG014|Treatment Period|Lost to Follow-up|0|||
27552227|NCT01928394|80207692|FG015|Treatment Period|Lost to Follow-up|0|||
27552228|NCT01928394|80207693|FG016|Treatment Period|Lost to Follow-up|0|||
27552229|NCT01928394|80207694|FG017|Treatment Period|Lost to Follow-up|0|||
27552230|NCT01928394|80207695|FG018|Treatment Period|Lost to Follow-up|0|||
27552231|NCT01928394|80207696|FG019|Treatment Period|Lost to Follow-up|0|||
27552232|NCT01928394|80207697|FG020|Treatment Period|Lost to Follow-up|0|||
27552233|NCT01928394|80207698|FG021|Treatment Period|Lost to Follow-up|0|||
27552234|NCT01928394|80207699|FG022|Treatment Period|Lost to Follow-up|1|||
27552235|NCT01928394|80207677|FG000|Treatment Period|Death|0|||
27552236|NCT01928394|80207678|FG001|Treatment Period|Death|0|||
27552237|NCT01928394|80207679|FG002|Treatment Period|Death|0|||
27552238|NCT01928394|80207680|FG003|Treatment Period|Death|0|||
27552239|NCT01928394|80207681|FG004|Treatment Period|Death|0|||
27552240|NCT01928394|80207682|FG005|Treatment Period|Death|0|||
27552241|NCT01928394|80207683|FG006|Treatment Period|Death|0|||
27552242|NCT01928394|80207684|FG007|Treatment Period|Death|0|||
27552243|NCT01928394|80207685|FG008|Treatment Period|Death|0|||
27552244|NCT01928394|80207686|FG009|Treatment Period|Death|0|||
27552245|NCT01928394|80207687|FG010|Treatment Period|Death|0|||
27552246|NCT01928394|80207688|FG011|Treatment Period|Death|0|||
27552247|NCT01928394|80207689|FG012|Treatment Period|Death|0|||
27552248|NCT01928394|80207690|FG013|Treatment Period|Death|1|||
27552249|NCT01928394|80207691|FG014|Treatment Period|Death|2|||
27552250|NCT01928394|80207692|FG015|Treatment Period|Death|0|||
27552251|NCT01928394|80207693|FG016|Treatment Period|Death|0|||
27552252|NCT01928394|80207694|FG017|Treatment Period|Death|0|||
27552253|NCT01928394|80207695|FG018|Treatment Period|Death|0|||
27552254|NCT01928394|80207696|FG019|Treatment Period|Death|0|||
27552255|NCT01928394|80207697|FG020|Treatment Period|Death|0|||
27552256|NCT01928394|80207698|FG021|Treatment Period|Death|0|||
27552257|NCT01928394|80207699|FG022|Treatment Period|Death|0|||
27552258|NCT01928394|80207677|FG000|Follow-up Period|Participant withdrew consent|3|||
27552259|NCT01928394|80207678|FG001|Follow-up Period|Participant withdrew consent|0|||
27552260|NCT01928394|80207679|FG002|Follow-up Period|Participant withdrew consent|1|||
27552261|NCT01928394|80207680|FG003|Follow-up Period|Participant withdrew consent|4|||
27552262|NCT01928394|80207681|FG004|Follow-up Period|Participant withdrew consent|0|||
27552263|NCT01928394|80207682|FG005|Follow-up Period|Participant withdrew consent|2|||
27552264|NCT01928394|80207683|FG006|Follow-up Period|Participant withdrew consent|5|||
27552265|NCT01928394|80207684|FG007|Follow-up Period|Participant withdrew consent|1|||
27552266|NCT01928394|80207685|FG008|Follow-up Period|Participant withdrew consent|0|||
27552267|NCT01928394|80207686|FG009|Follow-up Period|Participant withdrew consent|0|||
27552268|NCT01928394|80207687|FG010|Follow-up Period|Participant withdrew consent|5|||
27552269|NCT01928394|80207688|FG011|Follow-up Period|Participant withdrew consent|8|||
27552270|NCT01928394|80207689|FG012|Follow-up Period|Participant withdrew consent|2|||
27552271|NCT01928394|80207690|FG013|Follow-up Period|Participant withdrew consent|12|||
27552272|NCT01928394|80207691|FG014|Follow-up Period|Participant withdrew consent|7|||
27552273|NCT01928394|80207692|FG015|Follow-up Period|Participant withdrew consent|0|||
27552274|NCT01928394|80207693|FG016|Follow-up Period|Participant withdrew consent|5|||
27552275|NCT01928394|80207694|FG017|Follow-up Period|Participant withdrew consent|3|||
27552276|NCT01928394|80207695|FG018|Follow-up Period|Participant withdrew consent|2|||
27552277|NCT01928394|80207696|FG019|Follow-up Period|Participant withdrew consent|7|||
27552278|NCT01928394|80207697|FG020|Follow-up Period|Participant withdrew consent|4|||
27552279|NCT01928394|80207698|FG021|Follow-up Period|Participant withdrew consent|6|||
27552280|NCT01928394|80207699|FG022|Follow-up Period|Participant withdrew consent|2|||
27552281|NCT01928394|80207677|FG000|Follow-up Period|Death|0|||
27552282|NCT01928394|80207678|FG001|Follow-up Period|Death|0|||
27552283|NCT01928394|80207679|FG002|Follow-up Period|Death|2|||
27552284|NCT01928394|80207680|FG003|Follow-up Period|Death|6|||
27552285|NCT01928394|80207681|FG004|Follow-up Period|Death|0|||
27552286|NCT01928394|80207682|FG005|Follow-up Period|Death|6|||
27552287|NCT01928394|80207683|FG006|Follow-up Period|Death|6|||
27552288|NCT01928394|80207684|FG007|Follow-up Period|Death|2|||
27552289|NCT01928394|80207685|FG008|Follow-up Period|Death|1|||
27552290|NCT01928394|80207686|FG009|Follow-up Period|Death|2|||
27552291|NCT01928394|80207687|FG010|Follow-up Period|Death|4|||
27552292|NCT01928394|80207688|FG011|Follow-up Period|Death|12|||
27552293|NCT01928394|80207689|FG012|Follow-up Period|Death|11|||
27552294|NCT01928394|80207690|FG013|Follow-up Period|Death|25|||
27552295|NCT01928394|80207691|FG014|Follow-up Period|Death|18|||
27552296|NCT01928394|80207692|FG015|Follow-up Period|Death|0|||
27552297|NCT01928394|80207693|FG016|Follow-up Period|Death|6|||
27552298|NCT01928394|80207694|FG017|Follow-up Period|Death|5|||
27552299|NCT01928394|80207695|FG018|Follow-up Period|Death|13|||
27552300|NCT01928394|80207696|FG019|Follow-up Period|Death|13|||
27552301|NCT01928394|80207697|FG020|Follow-up Period|Death|5|||
27552302|NCT01928394|80207698|FG021|Follow-up Period|Death|3|||
27552303|NCT01928394|80207699|FG022|Follow-up Period|Death|2|||
27552304|NCT01928394|80207677|FG000|Follow-up Period|other reason|0|||
27552305|NCT01928394|80207678|FG001|Follow-up Period|other reason|0|||
27552306|NCT01928394|80207679|FG002|Follow-up Period|other reason|0|||
27552307|NCT01928394|80207680|FG003|Follow-up Period|other reason|0|||
27552308|NCT01928394|80207681|FG004|Follow-up Period|other reason|0|||
27552309|NCT01928394|80207682|FG005|Follow-up Period|other reason|0|||
27552310|NCT01928394|80207683|FG006|Follow-up Period|other reason|1|||
27552311|NCT01928394|80207684|FG007|Follow-up Period|other reason|3|||
27552312|NCT01928394|80207685|FG008|Follow-up Period|other reason|0|||
27552313|NCT01928394|80207686|FG009|Follow-up Period|other reason|0|||
27552314|NCT01928394|80207687|FG010|Follow-up Period|other reason|2|||
27552315|NCT01928394|80207688|FG011|Follow-up Period|other reason|1|||
27552316|NCT01928394|80207689|FG012|Follow-up Period|other reason|0|||
27552317|NCT01928394|80207690|FG013|Follow-up Period|other reason|1|||
27552318|NCT01928394|80207691|FG014|Follow-up Period|other reason|4|||
27552319|NCT01928394|80207692|FG015|Follow-up Period|other reason|0|||
27552320|NCT01928394|80207693|FG016|Follow-up Period|other reason|2|||
27552321|NCT01928394|80207694|FG017|Follow-up Period|other reason|0|||
27552322|NCT01928394|80207695|FG018|Follow-up Period|other reason|1|||
27552323|NCT01928394|80207696|FG019|Follow-up Period|other reason|1|||
27552324|NCT01928394|80207697|FG020|Follow-up Period|other reason|0|||
27552325|NCT01928394|80207698|FG021|Follow-up Period|other reason|0|||
27552326|NCT01928394|80207699|FG022|Follow-up Period|other reason|1|||
27552327|NCT01928394|80207677|FG000|Follow-up Period|Lost to Follow-up|0|||
27552328|NCT01928394|80207678|FG001|Follow-up Period|Lost to Follow-up|0|||
27552329|NCT01928394|80207679|FG002|Follow-up Period|Lost to Follow-up|0|||
27552330|NCT01928394|80207680|FG003|Follow-up Period|Lost to Follow-up|0|||
27552331|NCT01928394|80207681|FG004|Follow-up Period|Lost to Follow-up|0|||
27552332|NCT01928394|80207682|FG005|Follow-up Period|Lost to Follow-up|0|||
27552333|NCT01928394|80207683|FG006|Follow-up Period|Lost to Follow-up|0|||
27552334|NCT01928394|80207684|FG007|Follow-up Period|Lost to Follow-up|0|||
27552335|NCT01928394|80207685|FG008|Follow-up Period|Lost to Follow-up|0|||
27552336|NCT01928394|80207686|FG009|Follow-up Period|Lost to Follow-up|0|||
27552337|NCT01928394|80207687|FG010|Follow-up Period|Lost to Follow-up|0|||
27552338|NCT01928394|80207688|FG011|Follow-up Period|Lost to Follow-up|1|||
27552339|NCT01928394|80207689|FG012|Follow-up Period|Lost to Follow-up|1|||
27552340|NCT01928394|80207690|FG013|Follow-up Period|Lost to Follow-up|0|||
27552341|NCT01928394|80207691|FG014|Follow-up Period|Lost to Follow-up|1|||
27552342|NCT01928394|80207692|FG015|Follow-up Period|Lost to Follow-up|0|||
27552343|NCT01928394|80207693|FG016|Follow-up Period|Lost to Follow-up|1|||
27552344|NCT01928394|80207694|FG017|Follow-up Period|Lost to Follow-up|0|||
27552345|NCT01928394|80207695|FG018|Follow-up Period|Lost to Follow-up|0|||
27552346|NCT01928394|80207696|FG019|Follow-up Period|Lost to Follow-up|0|||
27552347|NCT01928394|80207697|FG020|Follow-up Period|Lost to Follow-up|0|||
27552348|NCT01928394|80207698|FG021|Follow-up Period|Lost to Follow-up|0|||
27552349|NCT01928394|80207699|FG022|Follow-up Period|Lost to Follow-up|1|||
27552350|NCT00590720|80207703|FG000|Overall Study|Lost to Follow-up|1|||
27552351|NCT00590720|80207704|FG001|Overall Study|Lost to Follow-up|0|||
27552352|NCT00590720|80207703|FG000|Overall Study|Withdrawal by Subject|0|||
27552353|NCT00590720|80207704|FG001|Overall Study|Withdrawal by Subject|1|||
27552354|NCT02860169|80207706|FG000|Part A|Withdrawal by Subject|1|||
27552355|NCT02860169|80207706|FG000|Part A|Other (Screening failure)|6|||
27552356|NCT02860169|80207706|FG000|Part A|Other (Survey not completed)|3|||
27552357|NCT02860169|80207706|FG000|Part A|Other (did not completed consent)|1|||
27552358|NCT02860169|80207706|FG000|Part B|Other (Screening failure)|10|||
27552359|NCT02860169|80207706|FG000|Part B|Withdrawal by Subject|1|||
27552360|NCT02860169|80207706|FG000|Part C|Other (Screening failure)|1|||
27552361|NCT02279420|80207707|FG000|Overall Study|Lost to Follow-up|23|||
27552362|NCT01053221|80207708|FG000|Overall Study|The study was closed prematurely|5|||
27552363|NCT01053221|80207709|FG001|Overall Study|The study was closed prematurely|9|||
27552364|NCT02375113|80207717|FG000|Overall Study|Undisclosed Reason(s).|1|||
27552365|NCT02375113|80207718|FG001|Overall Study|Undisclosed Reason(s).|1|||
27552366|NCT02375113|80207717|FG000|Overall Study|Poor adherence (<70%).|1|||
27552367|NCT02375113|80207718|FG001|Overall Study|Poor adherence (<70%).|0|||
27552368|NCT02375113|80207717|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
27552369|NCT02375113|80207718|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
27552370|NCT00737282|80207719|FG000|Overall Study|Study prematurely terminated|175|||
27552371|NCT01871532|80207720|FG000|Overall Study|Withdrawal by Subject|1|||
27552372|NCT01871532|80207721|FG001|Overall Study|Withdrawal by Subject|2|||
27552373|NCT03274440|80207722|FG000|Overall Study|Time commitment too great|1|||
27552374|NCT03274440|80207723|FG001|Overall Study|Time commitment too great|0|||
27552375|NCT03274440|80207724|FG002|Overall Study|Time commitment too great|0|||
27552376|NCT03274440|80207725|FG003|Overall Study|Time commitment too great|1|||
27552377|NCT03274440|80207726|FG004|Overall Study|Time commitment too great|0|||
27552378|NCT03274440|80207727|FG005|Overall Study|Time commitment too great|0|||
27552379|NCT01535053|80207728|FG000|Overall Study|Ineligible|1|||
27552380|NCT01535053|80207729|FG001|Overall Study|Ineligible|2|||
27552381|NCT00642460|80207730|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
27552382|NCT00642460|80207731|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
27552383|NCT00642460|80207732|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
27552384|NCT00642460|80207733|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
27552385|NCT00642460|80207734|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
27552386|NCT00642460|80207735|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
27552387|NCT00642460|80207730|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
27552388|NCT00642460|80207731|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27552389|NCT00642460|80207732|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27552390|NCT00642460|80207733|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27552391|NCT00642460|80207734|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27552392|NCT00642460|80207735|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
27552393|NCT00642460|80207730|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
27552394|NCT00642460|80207731|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
27552395|NCT00642460|80207732|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27552396|NCT00642460|80207733|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27552397|NCT00642460|80207734|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27552398|NCT00642460|80207735|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
27552399|NCT00642460|80207730|FG000|Part II: Open-Label Up to Week 92|Death|0|||
27552400|NCT00642460|80207731|FG001|Part II: Open-Label Up to Week 92|Death|1|||
27552401|NCT00642460|80207732|FG002|Part II: Open-Label Up to Week 92|Death|0|||
27552402|NCT00642460|80207733|FG003|Part II: Open-Label Up to Week 92|Death|2|||
27552403|NCT00642460|80207734|FG004|Part II: Open-Label Up to Week 92|Death|0|||
27552404|NCT00642460|80207735|FG005|Part II: Open-Label Up to Week 92|Death|0|||
27552405|NCT00642460|80207730|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
27552406|NCT00642460|80207731|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
27552407|NCT00642460|80207732|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27552408|NCT00642460|80207733|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27552409|NCT00642460|80207734|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27552410|NCT00642460|80207735|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
27552411|NCT00642460|80207730|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
27552412|NCT00642460|80207731|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
27552413|NCT00642460|80207732|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27552414|NCT00642460|80207733|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27552415|NCT00642460|80207734|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27552416|NCT00642460|80207735|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
27552417|NCT00642460|80207730|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
27552418|NCT00642460|80207731|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
27552419|NCT00642460|80207732|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
27552420|NCT00642460|80207733|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
27552421|NCT00642460|80207734|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
27552422|NCT00642460|80207735|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
27552423|NCT00642460|80207730|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27552424|NCT00642460|80207731|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27552425|NCT00642460|80207732|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27552426|NCT00642460|80207733|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
27552427|NCT00642460|80207734|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27552428|NCT00642460|80207735|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
27552429|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27552430|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27552431|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27552432|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
27552433|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
27552434|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
27552435|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27552436|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27552437|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27552438|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
27552439|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
27552440|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
27552441|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27552442|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27552443|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27552444|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
27552445|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
27552446|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
27552447|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27552448|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27552449|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27552450|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
27552451|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
27552452|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
27552453|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Other|0|||
27552454|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Other|0|||
27552455|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Other|0|||
27552456|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Other|0|||
27552457|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Other|2|||
27552458|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Other|2|||
27552459|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Death|0|||
27552460|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Death|0|||
27552461|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Death|0|||
27552462|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Death|0|||
27552463|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Death|0|||
27552464|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Death|3|||
27552465|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27552466|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27552467|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27552468|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27552469|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
27552470|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
27552471|NCT00642460|80207730|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27552472|NCT00642460|80207731|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27552473|NCT00642460|80207732|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27552474|NCT00642460|80207733|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
27552475|NCT00642460|80207734|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
27552476|NCT00642460|80207735|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
27552477|NCT00573469|80207736|FG000|Overall Study|Adverse Event|1|||
27552478|NCT00573469|80207737|FG001|Overall Study|Adverse Event|1|||
27552479|NCT00573469|80207738|FG002|Overall Study|Adverse Event|1|||
27552480|NCT00573469|80207736|FG000|Overall Study|Withdrawal by Subject|0|||
27552481|NCT00573469|80207737|FG001|Overall Study|Withdrawal by Subject|2|||
27552482|NCT00573469|80207738|FG002|Overall Study|Withdrawal by Subject|0|||
27552483|NCT00573469|80207736|FG000|Overall Study|Other|5|||
27552484|NCT00573469|80207737|FG001|Overall Study|Other|1|||
27552485|NCT00573469|80207738|FG002|Overall Study|Other|3|||
27552486|NCT00546637|80207739|FG000|Overall Study|Adverse Event|46|||
27552487|NCT00546637|80207740|FG001|Overall Study|Adverse Event|20|||
27552488|NCT00546637|80207739|FG000|Overall Study|Lack of Efficacy|5|||
27552489|NCT00546637|80207740|FG001|Overall Study|Lack of Efficacy|5|||
27552490|NCT00546637|80207739|FG000|Overall Study|Lost to Follow-up|2|||
27552491|NCT00546637|80207740|FG001|Overall Study|Lost to Follow-up|2|||
27552492|NCT00546637|80207739|FG000|Overall Study|Other|10|||
27552493|NCT00546637|80207740|FG001|Overall Study|Other|12|||
27552494|NCT00546637|80207739|FG000|Overall Study|Withdrawal by Subject|7|||
27552495|NCT00546637|80207740|FG001|Overall Study|Withdrawal by Subject|9|||
27552496|NCT00546637|80207739|FG000|Overall Study|Randomized, but not treated|3|||
27552497|NCT00546637|80207740|FG001|Overall Study|Randomized, but not treated|1|||
27552498|NCT00023764|80207741|FG000|Overall Study|Other|1|||
27552499|NCT00023764|80207741|FG000|Overall Study|Adverse Event|4|||
27552500|NCT00023764|80207741|FG000|Overall Study|Withdrawal by Subject|1|||
27552501|NCT00023764|80207741|FG000|Overall Study|Progression of disease|6|||
27552502|NCT00023764|80207741|FG000|Overall Study|patient received other treatment|1|||
27552503|NCT00023764|80207741|FG000|Overall Study|delay in obtaining staging images|1|||
27552504|NCT04232124|80207742|FG000|Overall Study|Lost to Follow-up|3|||
27552505|NCT01958008|80207743|FG000|Overall Study|Worsening of disease under study|0|||
27552506|NCT01958008|80207744|FG001|Overall Study|Worsening of disease under study|0|||
27552507|NCT01958008|80207745|FG002|Overall Study|Worsening of disease under study|1|||
27552508|NCT01958008|80207746|FG003|Overall Study|Worsening of disease under study|0|||
27552509|NCT01958008|80207743|FG000|Overall Study|Other adverse event|1|||
27552510|NCT01958008|80207744|FG001|Overall Study|Other adverse event|0|||
27552511|NCT01958008|80207745|FG002|Overall Study|Other adverse event|0|||
27552512|NCT01958008|80207746|FG003|Overall Study|Other adverse event|0|||
27552513|NCT00320411|80207747|FG000|Overall Study|No investigational product admin.|4|||
27754356|NCT02504268|80929435|FG001|Overall Study|Lost to Follow-up|6|||
27754357|NCT02504268|80929436|FG002|Overall Study|Lost to Follow-up|4|||
27754358|NCT02504268|80929437|FG003|Overall Study|Lost to Follow-up|0|||
27754359|NCT02504268|80929438|FG004|Overall Study|Lost to Follow-up|0|||
27754360|NCT02504268|80929439|FG005|Overall Study|Lost to Follow-up|0|||
27754361|NCT02504268|80929440|FG006|Overall Study|Lost to Follow-up|0|||
27754362|NCT02504268|80929441|FG007|Overall Study|Lost to Follow-up|0|||
27754363|NCT02504268|80929442|FG008|Overall Study|Lost to Follow-up|0|||
27754364|NCT02504268|80929434|FG000|Overall Study|Death|1|||
27754365|NCT02504268|80929435|FG001|Overall Study|Death|1|||
27754366|NCT02504268|80929436|FG002|Overall Study|Death|0|||
27754367|NCT02504268|80929437|FG003|Overall Study|Death|0|||
27754368|NCT02504268|80929438|FG004|Overall Study|Death|0|||
27754369|NCT02504268|80929439|FG005|Overall Study|Death|0|||
27754370|NCT02504268|80929440|FG006|Overall Study|Death|0|||
27754371|NCT02504268|80929441|FG007|Overall Study|Death|0|||
27754372|NCT02504268|80929442|FG008|Overall Study|Death|0|||
27754373|NCT02504268|80929434|FG000|Overall Study|Subject Request to Discontinue|11|||
27754374|NCT02504268|80929435|FG001|Overall Study|Subject Request to Discontinue|3|||
27754375|NCT02504268|80929436|FG002|Overall Study|Subject Request to Discontinue|6|||
27754376|NCT02504268|80929437|FG003|Overall Study|Subject Request to Discontinue|0|||
27754377|NCT02504268|80929438|FG004|Overall Study|Subject Request to Discontinue|0|||
27754378|NCT02504268|80929439|FG005|Overall Study|Subject Request to Discontinue|0|||
27754379|NCT02504268|80929440|FG006|Overall Study|Subject Request to Discontinue|0|||
27754380|NCT02504268|80929441|FG007|Overall Study|Subject Request to Discontinue|0|||
27754381|NCT02504268|80929442|FG008|Overall Study|Subject Request to Discontinue|0|||
27754382|NCT02504268|80929434|FG000|Overall Study|No Longer Meets Study Criteria|2|||
27754383|NCT02504268|80929435|FG001|Overall Study|No Longer Meets Study Criteria|3|||
27754384|NCT02504268|80929436|FG002|Overall Study|No Longer Meets Study Criteria|0|||
27754385|NCT02504268|80929437|FG003|Overall Study|No Longer Meets Study Criteria|0|||
27754386|NCT02504268|80929438|FG004|Overall Study|No Longer Meets Study Criteria|0|||
27754387|NCT02504268|80929439|FG005|Overall Study|No Longer Meets Study Criteria|0|||
27754388|NCT02504268|80929440|FG006|Overall Study|No Longer Meets Study Criteria|0|||
27754389|NCT02504268|80929441|FG007|Overall Study|No Longer Meets Study Criteria|0|||
27754390|NCT02504268|80929442|FG008|Overall Study|No Longer Meets Study Criteria|0|||
27754391|NCT02504268|80929434|FG000|Overall Study|Lack of Efficacy|11|||
27754392|NCT02504268|80929435|FG001|Overall Study|Lack of Efficacy|35|||
27754393|NCT02504268|80929436|FG002|Overall Study|Lack of Efficacy|9|||
27754394|NCT02504268|80929437|FG003|Overall Study|Lack of Efficacy|0|||
27754395|NCT02504268|80929438|FG004|Overall Study|Lack of Efficacy|0|||
27754396|NCT02504268|80929439|FG005|Overall Study|Lack of Efficacy|0|||
27754397|NCT02504268|80929440|FG006|Overall Study|Lack of Efficacy|0|||
27754398|NCT02504268|80929441|FG007|Overall Study|Lack of Efficacy|0|||
27754399|NCT02504268|80929442|FG008|Overall Study|Lack of Efficacy|0|||
27754400|NCT02504268|80929434|FG000|Overall Study|Poor/Non-Compliance|3|||
27754401|NCT02504268|80929435|FG001|Overall Study|Poor/Non-Compliance|2|||
27754402|NCT02504268|80929436|FG002|Overall Study|Poor/Non-Compliance|3|||
27754403|NCT02504268|80929437|FG003|Overall Study|Poor/Non-Compliance|0|||
27754404|NCT02504268|80929438|FG004|Overall Study|Poor/Non-Compliance|0|||
27754405|NCT02504268|80929439|FG005|Overall Study|Poor/Non-Compliance|0|||
27754406|NCT02504268|80929440|FG006|Overall Study|Poor/Non-Compliance|0|||
27754407|NCT02504268|80929441|FG007|Overall Study|Poor/Non-Compliance|0|||
27754408|NCT02504268|80929442|FG008|Overall Study|Poor/Non-Compliance|0|||
27754409|NCT02504268|80929434|FG000|Overall Study|Not Disclosed|1|||
27754410|NCT02504268|80929435|FG001|Overall Study|Not Disclosed|0|||
27754411|NCT02504268|80929436|FG002|Overall Study|Not Disclosed|2|||
27754412|NCT02504268|80929437|FG003|Overall Study|Not Disclosed|0|||
27754413|NCT02504268|80929438|FG004|Overall Study|Not Disclosed|0|||
27754414|NCT02504268|80929439|FG005|Overall Study|Not Disclosed|0|||
27754415|NCT02504268|80929440|FG006|Overall Study|Not Disclosed|0|||
27754416|NCT02504268|80929441|FG007|Overall Study|Not Disclosed|0|||
27754417|NCT02504268|80929442|FG008|Overall Study|Not Disclosed|0|||
27754418|NCT00414960|80929446|FG000|Overall Study|Adverse Event|4|||
27754419|NCT00414960|80929447|FG001|Overall Study|Adverse Event|0|||
27754420|NCT00414960|80929446|FG000|Overall Study|Withdrawal by Subject|3|||
27754421|NCT00414960|80929447|FG001|Overall Study|Withdrawal by Subject|0|||
27754422|NCT00414960|80929446|FG000|Overall Study|Physician Decision|0|||
27754423|NCT00414960|80929447|FG001|Overall Study|Physician Decision|1|||
27754424|NCT02410772|80929449|FG000|Overall Study|Death|3|||
27754425|NCT02410772|80929450|FG001|Overall Study|Death|4|||
27754426|NCT02410772|80929451|FG002|Overall Study|Death|8|||
27754427|NCT02410772|80929449|FG000|Overall Study|Lost to Follow-up|31|||
27754428|NCT02410772|80929450|FG001|Overall Study|Lost to Follow-up|23|||
27754429|NCT02410772|80929451|FG002|Overall Study|Lost to Follow-up|22|||
27754430|NCT02410772|80929449|FG000|Overall Study|Pregnancy|8|||
27754431|NCT02410772|80929450|FG001|Overall Study|Pregnancy|4|||
27754432|NCT02410772|80929451|FG002|Overall Study|Pregnancy|5|||
27754433|NCT02410772|80929449|FG000|Overall Study|Protocol Violation|8|||
27754434|NCT02410772|80929450|FG001|Overall Study|Protocol Violation|8|||
27754435|NCT02410772|80929451|FG002|Overall Study|Protocol Violation|4|||
27754436|NCT02410772|80929449|FG000|Overall Study|Baseline Drug Resistance|49|||
27754437|NCT02410772|80929450|FG001|Overall Study|Baseline Drug Resistance|40|||
27754438|NCT02410772|80929451|FG002|Overall Study|Baseline Drug Resistance|51|||
27754439|NCT02410772|80929449|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
27754440|NCT02410772|80929450|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
27754441|NCT02410772|80929451|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
27754442|NCT02410772|80929449|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
27754443|NCT02410772|80929450|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
27754444|NCT02410772|80929451|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
27754445|NCT03076190|80929456|FG000|Overall Study|Lost to Follow-up|9|||
27754446|NCT03076190|80929457|FG001|Overall Study|Lost to Follow-up|34|||
27754447|NCT03076190|80929456|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
27754448|NCT03076190|80929457|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
27754449|NCT03282357|80929460|FG000|Overall Study|Lost to Follow-up|3|||
27754450|NCT03282357|80929460|FG000|Overall Study|Withdrawal by Subject|4|||
27754451|NCT03282357|80929460|FG000|Overall Study|Adverse Event|1|||
27754452|NCT03282357|80929460|FG000|Overall Study|Other|9|||
27754453|NCT02279524|80929461|FG000|Overall Study|Withdrawal by Subject|3|||
27754454|NCT02279524|80929462|FG001|Overall Study|Withdrawal by Subject|6|||
27754455|NCT02279524|80929463|FG002|Overall Study|Withdrawal by Subject|3|||
27754456|NCT02279524|80929461|FG000|Overall Study|Adverse Event|4|||
27754457|NCT02279524|80929462|FG001|Overall Study|Adverse Event|3|||
27754458|NCT02279524|80929463|FG002|Overall Study|Adverse Event|2|||
27754459|NCT02279524|80929461|FG000|Overall Study|Lost to Follow-up|1|||
27754460|NCT02279524|80929462|FG001|Overall Study|Lost to Follow-up|1|||
27754461|NCT02279524|80929463|FG002|Overall Study|Lost to Follow-up|0|||
27754462|NCT02279524|80929461|FG000|Overall Study|Disallowed medication|1|||
27754463|NCT02279524|80929462|FG001|Overall Study|Disallowed medication|1|||
27754464|NCT02279524|80929463|FG002|Overall Study|Disallowed medication|2|||
27754465|NCT02279524|80929461|FG000|Overall Study|Bariatric surgery|1|||
27754466|NCT02279524|80929462|FG001|Overall Study|Bariatric surgery|0|||
27754467|NCT02279524|80929463|FG002|Overall Study|Bariatric surgery|0|||
27754468|NCT03456713|80929468|FG000|Overall Study|Lost to Follow-up|1|||
27754469|NCT03456713|80929469|FG001|Overall Study|Lost to Follow-up|0|||
27754470|NCT03456713|80929470|FG002|Overall Study|Lost to Follow-up|0|||
27754471|NCT03456713|80929471|FG003|Overall Study|Lost to Follow-up|0|||
27754472|NCT01778127|80929473|FG000|Overall Study|Lost to Follow-up|5|||
27754473|NCT01778127|80929474|FG001|Overall Study|Lost to Follow-up|1|||
27754474|NCT01778127|80929475|FG002|Overall Study|Lost to Follow-up|2|||
27754475|NCT01778127|80929473|FG000|Overall Study|Withdrawal by Subject|3|||
27754476|NCT01778127|80929474|FG001|Overall Study|Withdrawal by Subject|1|||
27754477|NCT01778127|80929475|FG002|Overall Study|Withdrawal by Subject|4|||
27754478|NCT00862849|80929476|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27754479|NCT00862849|80929477|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
27754480|NCT00862849|80929478|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27754481|NCT00862849|80929479|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27754482|NCT00862849|80929480|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27754483|NCT00862849|80929481|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
27754484|NCT00862849|80929476|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27754485|NCT00862849|80929477|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
27754486|NCT00862849|80929478|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27754487|NCT00862849|80929479|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27754488|NCT00862849|80929480|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27754489|NCT00862849|80929481|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
27754490|NCT00418834|80929482|FG000|Overall Study|Adverse Event|16|||
27754491|NCT00418834|80929483|FG001|Overall Study|Adverse Event|9|||
27754492|NCT00418834|80929482|FG000|Overall Study|Lost to Follow-up|0|||
27754493|NCT00418834|80929483|FG001|Overall Study|Lost to Follow-up|1|||
27754494|NCT00418834|80929482|FG000|Overall Study|Protocol Violation|4|||
27754495|NCT00418834|80929483|FG001|Overall Study|Protocol Violation|3|||
27754496|NCT00418834|80929482|FG000|Overall Study|Withdrawal by Subject|3|||
27754497|NCT00418834|80929483|FG001|Overall Study|Withdrawal by Subject|7|||
27754498|NCT03331666|80929484|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
27754499|NCT03331666|80929485|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
27754500|NCT00788775|80929486|FG000|Overall Study|Progressive Disease|8|||
27754501|NCT00788775|80929487|FG001|Overall Study|Progressive Disease|6|||
27754502|NCT00788775|80929486|FG000|Overall Study|Withdrawal by Subject|0|||
27754503|NCT00788775|80929487|FG001|Overall Study|Withdrawal by Subject|2|||
27754504|NCT00788775|80929486|FG000|Overall Study|Patient Non-Compliance|1|||
27754505|NCT00788775|80929487|FG001|Overall Study|Patient Non-Compliance|0|||
27754506|NCT00788775|80929486|FG000|Overall Study|Patient's measurable disease resected.|1|||
27754507|NCT00788775|80929487|FG001|Overall Study|Patient's measurable disease resected.|0|||
27754508|NCT02855411|80929488|FG000|Overall Study|Study terminated by sponsor|21|||
27754509|NCT02855411|80929488|FG000|Overall Study|Does not meet entrance criteria|14|||
27754510|NCT04017442|80929492|FG000|Overall Study|Withdrawal by Subject|0|||
27754511|NCT04017442|80929493|FG001|Overall Study|Withdrawal by Subject|3|||
27754512|NCT04017442|80929492|FG000|Overall Study|Lost to Follow-up|21|||
27754513|NCT04017442|80929493|FG001|Overall Study|Lost to Follow-up|19|||
27754514|NCT02922634|80929494|FG000|Overall Study|Withdrawal by Subject|5|||
27754515|NCT02922634|80929494|FG000|Overall Study|Did not have their surgery|5|||
27754516|NCT00358917|80929495|FG000|Overall Study|Adverse Event|14|||
27754517|NCT00358917|80929496|FG001|Overall Study|Adverse Event|21|||
27754518|NCT00358917|80929495|FG000|Overall Study|Withdrawal by Subject|5|||
27754519|NCT00358917|80929496|FG001|Overall Study|Withdrawal by Subject|7|||
27754520|NCT00358917|80929495|FG000|Overall Study|Lost to Follow-up|20|||
27754521|NCT00358917|80929496|FG001|Overall Study|Lost to Follow-up|17|||
27754522|NCT00358917|80929495|FG000|Overall Study|Noncompliance|12|||
27754523|NCT00358917|80929496|FG001|Overall Study|Noncompliance|11|||
27754524|NCT00358917|80929495|FG000|Overall Study|Death|2|||
27754525|NCT00358917|80929496|FG001|Overall Study|Death|3|||
27754526|NCT00358917|80929495|FG000|Overall Study|Virologic failure|11|||
27754527|NCT00358917|80929496|FG001|Overall Study|Virologic failure|8|||
27754528|NCT00358917|80929495|FG000|Overall Study|Unable to Continue Participation|2|||
27754529|NCT00358917|80929496|FG001|Overall Study|Unable to Continue Participation|2|||
27754530|NCT03025217|80929497|FG000|Overall Study|Pregnancy|1|||
27754531|NCT03025217|80929497|FG000|Overall Study|Lost to Follow-up|1|||
27754532|NCT03025217|80929497|FG000|Overall Study|Not eligible, poor English|2|||
27754533|NCT01553916|80929508|FG000|Overall Study|Withdrawal by Subject|2|||
27754534|NCT01553916|80929508|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
27754535|NCT00288860|80929511|FG000|Overall Study|Did not complete intake|4|||
27754536|NCT00288860|80929512|FG001|Overall Study|Did not complete intake|8|||
27754537|NCT00288860|80929511|FG000|Overall Study|Death|4|||
27754538|NCT00288860|80929512|FG001|Overall Study|Death|3|||
27754539|NCT00288860|80929511|FG000|Overall Study|Withdrawal by Subject|20|||
27754540|NCT00288860|80929512|FG001|Overall Study|Withdrawal by Subject|15|||
27754541|NCT00288860|80929511|FG000|Overall Study|Lost to Follow-up|74|||
27754542|NCT00288860|80929512|FG001|Overall Study|Lost to Follow-up|71|||
27754543|NCT00683475|80929513|FG000|Overall Study|Withdrawal by Subject|1|||
27754544|NCT00683475|80929514|FG001|Overall Study|Withdrawal by Subject|0|||
27754545|NCT00683475|80929513|FG000|Overall Study|Never Treated: Adverse Event|2|||
27754546|NCT00683475|80929514|FG001|Overall Study|Never Treated: Adverse Event|3|||
27754547|NCT00683475|80929513|FG000|Overall Study|Never Treated: Progressive Disease|1|||
27754548|NCT00683475|80929514|FG001|Overall Study|Never Treated: Progressive Disease|0|||
27754549|NCT00621855|80929518|FG000|Overall Study|Adverse Event|32|||
27754550|NCT00621855|80929519|FG001|Overall Study|Adverse Event|31|||
27754551|NCT00621855|80929520|FG002|Overall Study|Adverse Event|48|||
27754552|NCT00621855|80929521|FG003|Overall Study|Adverse Event|34|||
27754553|NCT00621855|80929522|FG004|Overall Study|Adverse Event|31|||
27754554|NCT00621855|80929518|FG000|Overall Study|Lost to Follow-up|0|||
27754555|NCT00621855|80929519|FG001|Overall Study|Lost to Follow-up|1|||
27754556|NCT00621855|80929520|FG002|Overall Study|Lost to Follow-up|3|||
27754557|NCT00621855|80929521|FG003|Overall Study|Lost to Follow-up|4|||
27754558|NCT00621855|80929522|FG004|Overall Study|Lost to Follow-up|1|||
27754559|NCT00621855|80929518|FG000|Overall Study|Protocol Violation|16|||
27754560|NCT00621855|80929519|FG001|Overall Study|Protocol Violation|8|||
27754561|NCT00621855|80929520|FG002|Overall Study|Protocol Violation|6|||
27754562|NCT00621855|80929521|FG003|Overall Study|Protocol Violation|7|||
27754563|NCT00621855|80929522|FG004|Overall Study|Protocol Violation|8|||
27754564|NCT00621855|80929518|FG000|Overall Study|Withdrawal by Subject|16|||
27754565|NCT00621855|80929519|FG001|Overall Study|Withdrawal by Subject|11|||
27754566|NCT00621855|80929520|FG002|Overall Study|Withdrawal by Subject|13|||
27754567|NCT00621855|80929521|FG003|Overall Study|Withdrawal by Subject|13|||
27754568|NCT00621855|80929522|FG004|Overall Study|Withdrawal by Subject|9|||
27754569|NCT00621855|80929518|FG000|Overall Study|Other|9|||
27754570|NCT00621855|80929519|FG001|Overall Study|Other|7|||
27754571|NCT00621855|80929520|FG002|Overall Study|Other|6|||
27754572|NCT00621855|80929521|FG003|Overall Study|Other|5|||
27754573|NCT00621855|80929522|FG004|Overall Study|Other|4|||
27754574|NCT00621855|80929518|FG000|Overall Study|Patients did not receive study drug|3|||
27754575|NCT00621855|80929519|FG001|Overall Study|Patients did not receive study drug|3|||
27754576|NCT00621855|80929520|FG002|Overall Study|Patients did not receive study drug|5|||
27754577|NCT00621855|80929521|FG003|Overall Study|Patients did not receive study drug|4|||
27754578|NCT00621855|80929522|FG004|Overall Study|Patients did not receive study drug|2|||
27754579|NCT04167306|80929524|FG000|Overall Study|Lost to Follow-up|2|||
27754580|NCT04167306|80929525|FG001|Overall Study|Lost to Follow-up|2|||
27754581|NCT04167306|80929526|FG002|Overall Study|Lost to Follow-up|5|||
27754582|NCT04167306|80929527|FG003|Overall Study|Lost to Follow-up|5|||
27754583|NCT04167306|80929524|FG000|Overall Study|Adverse Event|13|||
27754584|NCT04167306|80929525|FG001|Overall Study|Adverse Event|14|||
27754585|NCT04167306|80929526|FG002|Overall Study|Adverse Event|5|||
27754586|NCT04167306|80929527|FG003|Overall Study|Adverse Event|4|||
27754587|NCT04167306|80929524|FG000|Overall Study|Withdrawal by Subject|4|||
27754588|NCT04167306|80929525|FG001|Overall Study|Withdrawal by Subject|6|||
27754589|NCT04167306|80929526|FG002|Overall Study|Withdrawal by Subject|8|||
27754590|NCT04167306|80929527|FG003|Overall Study|Withdrawal by Subject|3|||
27754591|NCT04167306|80929524|FG000|Overall Study|covid|1|||
27754592|NCT04167306|80929525|FG001|Overall Study|covid|1|||
27754593|NCT04167306|80929526|FG002|Overall Study|covid|2|||
27754594|NCT04167306|80929527|FG003|Overall Study|covid|1|||
27754595|NCT04167306|80929524|FG000|Overall Study|concomitant medication|0|||
27754596|NCT04167306|80929525|FG001|Overall Study|concomitant medication|0|||
27754597|NCT04167306|80929526|FG002|Overall Study|concomitant medication|0|||
27754598|NCT04167306|80929527|FG003|Overall Study|concomitant medication|1|||
27754599|NCT04167306|80929524|FG000|Overall Study|Alcohol treatment|0|||
27754600|NCT04167306|80929525|FG001|Overall Study|Alcohol treatment|4|||
27754601|NCT04167306|80929526|FG002|Overall Study|Alcohol treatment|3|||
27754602|NCT04167306|80929527|FG003|Overall Study|Alcohol treatment|2|||
27754603|NCT04167306|80929524|FG000|Overall Study|non-compliance|0|||
27754604|NCT04167306|80929525|FG001|Overall Study|non-compliance|0|||
27754605|NCT04167306|80929526|FG002|Overall Study|non-compliance|1|||
27754606|NCT04167306|80929527|FG003|Overall Study|non-compliance|0|||
27754607|NCT04167306|80929524|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
27754608|NCT04167306|80929525|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
27754609|NCT04167306|80929526|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
27754610|NCT04167306|80929527|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
27754611|NCT02034474|80929529|FG000|Overall Study|Adverse Event|3|||
27754612|NCT02034474|80929530|FG001|Overall Study|Adverse Event|2|||
27754613|NCT02034474|80929529|FG000|Overall Study|Withdrawal by Subject|1|||
27754614|NCT02034474|80929530|FG001|Overall Study|Withdrawal by Subject|2|||
27754615|NCT05086289|80929531|FG000|Overall Study|Adverse Event|4|||
27754616|NCT05086289|80929532|FG001|Overall Study|Adverse Event|2|||
27754617|NCT05086289|80929531|FG000|Overall Study|Lost to Follow-up|2|||
27754618|NCT05086289|80929532|FG001|Overall Study|Lost to Follow-up|0|||
27754619|NCT05086289|80929531|FG000|Overall Study|Non-compliance with study drug|2|||
27754620|NCT05086289|80929532|FG001|Overall Study|Non-compliance with study drug|1|||
27754621|NCT05086289|80929531|FG000|Overall Study|Physician Decision|2|||
27754622|NCT05086289|80929532|FG001|Overall Study|Physician Decision|0|||
27754623|NCT05086289|80929531|FG000|Overall Study|Withdrawal by Subject|5|||
27754624|NCT05086289|80929532|FG001|Overall Study|Withdrawal by Subject|2|||
27754625|NCT02938585|80929534|FG000|Overall Study|Withdrawal by parent or guardian|0|||
27754626|NCT02938585|80929535|FG001|Overall Study|Withdrawal by parent or guardian|1|||
27754627|NCT02938585|80929536|FG002|Overall Study|Withdrawal by parent or guardian|0|||
27754628|NCT02938585|80929537|FG003|Overall Study|Withdrawal by parent or guardian|0|||
27754629|NCT02938585|80929534|FG000|Overall Study|Withdrawal by Subject|0|||
27754630|NCT02938585|80929535|FG001|Overall Study|Withdrawal by Subject|0|||
27754631|NCT02938585|80929536|FG002|Overall Study|Withdrawal by Subject|0|||
27754632|NCT02938585|80929537|FG003|Overall Study|Withdrawal by Subject|5|||
27754633|NCT00717366|80929541|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
27754634|NCT00717366|80929542|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
27754635|NCT00717366|80929541|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
27754636|NCT00717366|80929542|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
27754637|NCT00717366|80929541|FG000|Core Study Period (20 Weeks)|Death|0|||
27754638|NCT00717366|80929542|FG001|Core Study Period (20 Weeks)|Death|1|||
27754639|NCT00717366|80929541|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
27754640|NCT00717366|80929542|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
27754641|NCT00717366|80929541|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
27754642|NCT00717366|80929542|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
27754643|NCT00717366|80929541|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
27754644|NCT00717366|80929542|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
27754645|NCT00717366|80929541|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
27754646|NCT00717366|80929542|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
27754647|NCT03105700|80929543|FG000|Overall Study|screen fail|3|||
27754648|NCT03105700|80929543|FG000|Overall Study|Lost to Follow-up|4|||
27754649|NCT02605447|80929544|FG000|Overall Study|Death|66|||
27754650|NCT02605447|80929544|FG000|Overall Study|Physician Decision|1|||
27754651|NCT02605447|80929544|FG000|Overall Study|Lost to Follow-up|24|||
27754652|NCT02605447|80929544|FG000|Overall Study|Withdrawal by Subject|10|||
27754653|NCT02605447|80929544|FG000|Overall Study|Not disclosed|1|||
27754654|NCT00701727|80929545|FG000|First Treatment Period|Adverse Event|0|||
27754655|NCT00701727|80929546|FG001|First Treatment Period|Adverse Event|0|||
27754656|NCT00701727|80929545|FG000|First Treatment Period|Withdrawal by Subject|1|||
27754657|NCT00701727|80929546|FG001|First Treatment Period|Withdrawal by Subject|0|||
27754658|NCT00701727|80929545|FG000|First Treatment Period|sponsor decision|0|||
27754659|NCT00701727|80929546|FG001|First Treatment Period|sponsor decision|1|||
27754660|NCT00701727|80929545|FG000|First Treatment Period|Lost to Follow-up|0|||
27754661|NCT00701727|80929546|FG001|First Treatment Period|Lost to Follow-up|1|||
27754662|NCT00701727|80929545|FG000|Second Treatment Period|Withdrawal by Subject|2|||
27754663|NCT00701727|80929546|FG001|Second Treatment Period|Withdrawal by Subject|0|||
27754664|NCT03629041|80929547|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
27754665|NCT03629041|80929548|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
27754666|NCT03629041|80929549|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
27754667|NCT03629041|80929550|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
27754668|NCT01842607|80929551|FG000|Overall Study|Adverse Event|11|||
27754669|NCT01842607|80929551|FG000|Overall Study|Lack of Efficacy|19|||
27754670|NCT01842607|80929551|FG000|Overall Study|Protocol Violation|8|||
27754671|NCT01842607|80929551|FG000|Overall Study|Protocol defined stopping criteria|2|||
27754672|NCT01842607|80929551|FG000|Overall Study|Lost to Follow-up|3|||
27754673|NCT01842607|80929551|FG000|Overall Study|Physician Decision|9|||
27754674|NCT01842607|80929551|FG000|Overall Study|Withdrawal by Subject|14|||
27754675|NCT04633473|80929552|FG000|Overall Study|Withdrawal by Subject|6|||
27754676|NCT03151148|80929557|FG000|Overall Study|Lost to Follow-up|1|||
27754677|NCT03151148|80929558|FG001|Overall Study|Lost to Follow-up|0|||
27754678|NCT03151148|80929557|FG000|Overall Study|Withdrawal by Subject|1|||
27754679|NCT03151148|80929558|FG001|Overall Study|Withdrawal by Subject|0|||
27754680|NCT02492997|80929564|FG000|Overall Study|Withdrawal by Subject|1|||
27754681|NCT02492997|80929565|FG001|Overall Study|Withdrawal by Subject|0|||
27754682|NCT02492997|80929564|FG000|Overall Study|Gained Weight|1|||
27754683|NCT02492997|80929565|FG001|Overall Study|Gained Weight|0|||
27754684|NCT02492997|80929564|FG000|Overall Study|Lost to Follow-up|0|||
27754685|NCT02492997|80929565|FG001|Overall Study|Lost to Follow-up|1|||
27754686|NCT01640925|80929566|FG000|Overall Study|Withdrawal by Subject|1|||
27754687|NCT01640925|80929567|FG001|Overall Study|Withdrawal by Subject|0|||
27754688|NCT01640925|80929566|FG000|Overall Study|Previously enrolled in this trial|13|||
27754689|NCT01640925|80929567|FG001|Overall Study|Previously enrolled in this trial|11|||
27754690|NCT00242580|80929568|FG000|Overall Study|Adverse Event|3|||
27754691|NCT00242580|80929569|FG001|Overall Study|Adverse Event|0|||
27754692|NCT00242580|80929570|FG002|Overall Study|Adverse Event|2|||
27754693|NCT00242580|80929568|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27754694|NCT00242580|80929569|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
27754695|NCT00242580|80929570|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
27754696|NCT00242580|80929568|FG000|Overall Study|Protocol Violation|0|||
27754697|NCT00242580|80929569|FG001|Overall Study|Protocol Violation|0|||
27754698|NCT00242580|80929570|FG002|Overall Study|Protocol Violation|1|||
27754699|NCT00242580|80929568|FG000|Overall Study|Subject withdrew consent|2|||
27754700|NCT00242580|80929569|FG001|Overall Study|Subject withdrew consent|2|||
27754701|NCT00242580|80929570|FG002|Overall Study|Subject withdrew consent|5|||
27754702|NCT00242580|80929568|FG000|Overall Study|Lost to Follow-up|0|||
27754703|NCT00242580|80929569|FG001|Overall Study|Lost to Follow-up|3|||
27754704|NCT00242580|80929570|FG002|Overall Study|Lost to Follow-up|0|||
27754705|NCT00242580|80929568|FG000|Overall Study|Death|1|||
27754706|NCT00242580|80929569|FG001|Overall Study|Death|2|||
27754707|NCT00242580|80929570|FG002|Overall Study|Death|1|||
27754708|NCT02509494|80929573|FG000|Overall Study|Lost to Follow-up|8|||
27754709|NCT02509494|80929574|FG001|Overall Study|Lost to Follow-up|47|||
27754710|NCT02509494|80929575|FG002|Overall Study|Lost to Follow-up|19|||
27754711|NCT02509494|80929576|FG003|Overall Study|Lost to Follow-up|6|||
27754712|NCT02509494|80929577|FG004|Overall Study|Lost to Follow-up|3|||
27754713|NCT02509494|80929578|FG005|Overall Study|Lost to Follow-up|3|||
27754714|NCT02509494|80929579|FG006|Overall Study|Lost to Follow-up|1|||
27754715|NCT02509494|80929580|FG007|Overall Study|Lost to Follow-up|3|||
27754716|NCT02509494|80929581|FG008|Overall Study|Lost to Follow-up|1|||
27754717|NCT02509494|80929573|FG000|Overall Study|Physician Decision|2|||
27754718|NCT02509494|80929574|FG001|Overall Study|Physician Decision|1|||
27754719|NCT02509494|80929575|FG002|Overall Study|Physician Decision|0|||
27754720|NCT02509494|80929576|FG003|Overall Study|Physician Decision|0|||
27754721|NCT02509494|80929577|FG004|Overall Study|Physician Decision|0|||
27754722|NCT02509494|80929578|FG005|Overall Study|Physician Decision|0|||
27754723|NCT02509494|80929579|FG006|Overall Study|Physician Decision|0|||
27754724|NCT02509494|80929580|FG007|Overall Study|Physician Decision|0|||
27754725|NCT02509494|80929581|FG008|Overall Study|Physician Decision|0|||
27754726|NCT02509494|80929573|FG000|Overall Study|Withdrawal by Subject|4|||
27754727|NCT02509494|80929574|FG001|Overall Study|Withdrawal by Subject|17|||
27754728|NCT02509494|80929575|FG002|Overall Study|Withdrawal by Subject|7|||
27754729|NCT02509494|80929576|FG003|Overall Study|Withdrawal by Subject|5|||
27754730|NCT02509494|80929577|FG004|Overall Study|Withdrawal by Subject|0|||
27754731|NCT02509494|80929578|FG005|Overall Study|Withdrawal by Subject|6|||
27754732|NCT02509494|80929579|FG006|Overall Study|Withdrawal by Subject|1|||
27754733|NCT02509494|80929580|FG007|Overall Study|Withdrawal by Subject|2|||
27754734|NCT02509494|80929581|FG008|Overall Study|Withdrawal by Subject|1|||
27754735|NCT02509494|80929573|FG000|Overall Study|Death|0|||
27754736|NCT02509494|80929574|FG001|Overall Study|Death|1|||
27754737|NCT02509494|80929575|FG002|Overall Study|Death|0|||
27754738|NCT02509494|80929576|FG003|Overall Study|Death|0|||
27754739|NCT02509494|80929577|FG004|Overall Study|Death|1|||
27754740|NCT02509494|80929578|FG005|Overall Study|Death|0|||
27754741|NCT02509494|80929579|FG006|Overall Study|Death|0|||
27754742|NCT02509494|80929580|FG007|Overall Study|Death|1|||
27754743|NCT02509494|80929581|FG008|Overall Study|Death|0|||
27754744|NCT02509494|80929573|FG000|Overall Study|Other|0|||
27754745|NCT02509494|80929574|FG001|Overall Study|Other|4|||
27754746|NCT02509494|80929575|FG002|Overall Study|Other|5|||
27754747|NCT02509494|80929576|FG003|Overall Study|Other|0|||
27754748|NCT02509494|80929577|FG004|Overall Study|Other|0|||
27754749|NCT02509494|80929578|FG005|Overall Study|Other|0|||
27754750|NCT02509494|80929579|FG006|Overall Study|Other|0|||
27754751|NCT02509494|80929580|FG007|Overall Study|Other|0|||
27754752|NCT02509494|80929581|FG008|Overall Study|Other|0|||
27754753|NCT02509494|80929573|FG000|Overall Study|Non-Compliance With Study Drug|1|||
27754754|NCT02509494|80929574|FG001|Overall Study|Non-Compliance With Study Drug|11|||
27754755|NCT02509494|80929575|FG002|Overall Study|Non-Compliance With Study Drug|7|||
27754756|NCT02509494|80929576|FG003|Overall Study|Non-Compliance With Study Drug|0|||
27754757|NCT02509494|80929577|FG004|Overall Study|Non-Compliance With Study Drug|1|||
27754758|NCT02509494|80929578|FG005|Overall Study|Non-Compliance With Study Drug|2|||
27754759|NCT02509494|80929579|FG006|Overall Study|Non-Compliance With Study Drug|1|||
27754760|NCT02509494|80929580|FG007|Overall Study|Non-Compliance With Study Drug|1|||
27754761|NCT02509494|80929581|FG008|Overall Study|Non-Compliance With Study Drug|0|||
27754762|NCT01767194|80929582|FG000|Overall Study|Adverse Event|1|||
27754763|NCT01767194|80929583|FG001|Overall Study|Adverse Event|1|||
27754764|NCT01767194|80929582|FG000|Overall Study|Death|0|||
27754765|NCT01767194|80929583|FG001|Overall Study|Death|1|||
27754766|NCT01767194|80929582|FG000|Overall Study|Lack of Efficacy|12|||
27754767|NCT01767194|80929583|FG001|Overall Study|Lack of Efficacy|11|||
27754768|NCT01767194|80929582|FG000|Overall Study|Physician Decision|2|||
27754769|NCT01767194|80929583|FG001|Overall Study|Physician Decision|23|||
27754770|NCT01767194|80929582|FG000|Overall Study|Withdrawal by Subject|0|||
27754771|NCT01767194|80929583|FG001|Overall Study|Withdrawal by Subject|1|||
27754772|NCT01767194|80929582|FG000|Overall Study|Ineligible|1|||
27754773|NCT01767194|80929583|FG001|Overall Study|Ineligible|1|||
27754774|NCT01767194|80929582|FG000|Overall Study|Refusal by patient/parent|2|||
27754775|NCT01767194|80929583|FG001|Overall Study|Refusal by patient/parent|4|||
27754776|NCT01767194|80929582|FG000|Overall Study|Criteria not met on time for next cycle|0|||
27754777|NCT01767194|80929583|FG001|Overall Study|Criteria not met on time for next cycle|1|||
27754778|NCT00077376|80929584|FG000|Overall Study|Adverse Event|8|||
27754779|NCT00077376|80929584|FG000|Overall Study|Withdrawal by Subject|2|||
27754780|NCT00077376|80929584|FG000|Overall Study|Death|1|||
27957776|NCT00616642|81679817|FG001|Overall Study|Withdrawal by Subject|1|||
27957777|NCT04011735|81679821|FG000|Overall Study|Withdrawal by Subject|1|||
27957778|NCT04011735|81679822|FG001|Overall Study|Withdrawal by Subject|0|||
27957779|NCT04011735|81679823|FG002|Overall Study|Withdrawal by Subject|1|||
27957780|NCT04011735|81679821|FG000|Overall Study|Met exclusion criteria after study entry|0|||
27957781|NCT04011735|81679822|FG001|Overall Study|Met exclusion criteria after study entry|1|||
27957782|NCT04011735|81679823|FG002|Overall Study|Met exclusion criteria after study entry|0|||
27957783|NCT00131352|81679824|FG000|Initial Treatment Period|Adverse Event|1|||
27957784|NCT00131352|81679825|FG001|Initial Treatment Period|Adverse Event|3|||
27957785|NCT00131352|81679824|FG000|Initial Treatment Period|Non-compliant|1|||
27957786|NCT00131352|81679825|FG001|Initial Treatment Period|Non-compliant|2|||
27957787|NCT00131352|81679824|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
27957788|NCT00131352|81679825|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
27957789|NCT00131352|81679824|FG000|Initial Treatment Period|Lack of Efficacy|6|||
27957790|NCT00131352|81679825|FG001|Initial Treatment Period|Lack of Efficacy|4|||
27957791|NCT00131352|81679824|FG000|Initial Treatment Period|Other|0|||
27957792|NCT00131352|81679825|FG001|Initial Treatment Period|Other|2|||
27957793|NCT00131352|81679824|FG000|Repeat Treatment Period|Adverse Event|1|||
27957794|NCT00131352|81679825|FG001|Repeat Treatment Period|Adverse Event|0|||
27957795|NCT00131352|81679824|FG000|Repeat Treatment Period|Other|1|||
27957796|NCT00131352|81679825|FG001|Repeat Treatment Period|Other|0|||
27957797|NCT03073525|81679828|FG000|Overall Study|Withdrawal by Subject|0|||
27957798|NCT03073525|81679829|FG001|Overall Study|Withdrawal by Subject|0|||
27957799|NCT03073525|81679830|FG002|Overall Study|Withdrawal by Subject|3|||
27957800|NCT02503085|81679831|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
27957801|NCT02503085|81679832|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
27957802|NCT02503085|81679833|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
27957803|NCT02503085|81679834|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
27957804|NCT03666988|81679835|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
27957805|NCT03666988|81679836|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
27957806|NCT03666988|81679837|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
27957807|NCT03666988|81679838|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
27957808|NCT03666988|81679839|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
27957809|NCT03666988|81679840|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
27957810|NCT03666988|81679835|FG000|Part 1 (Up to 28 Months)|Other|0|||
27957811|NCT03666988|81679836|FG001|Part 1 (Up to 28 Months)|Other|1|||
27957812|NCT03666988|81679837|FG002|Part 1 (Up to 28 Months)|Other|1|||
27957813|NCT03666988|81679838|FG003|Part 1 (Up to 28 Months)|Other|0|||
27957814|NCT03666988|81679839|FG004|Part 1 (Up to 28 Months)|Other|0|||
27957815|NCT03666988|81679840|FG005|Part 1 (Up to 28 Months)|Other|0|||
27957816|NCT03666988|81679835|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
27957817|NCT03666988|81679836|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
27957818|NCT03666988|81679837|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
27957819|NCT03666988|81679838|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
27957820|NCT03666988|81679839|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
27957821|NCT03666988|81679840|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
27957822|NCT03666988|81679835|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
27957823|NCT03666988|81679836|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
27957824|NCT03666988|81679837|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
27957825|NCT03666988|81679838|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
27957826|NCT03666988|81679839|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
27957827|NCT03666988|81679840|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
27957828|NCT03666988|81679835|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
27957829|NCT03666988|81679836|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
27957830|NCT03666988|81679837|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
27957831|NCT03666988|81679838|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
27957832|NCT03666988|81679839|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
27957833|NCT03666988|81679840|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
27957834|NCT04828707|81679841|FG000|Overall Study|Lost to Follow-up|3|||
27957835|NCT04828707|81679842|FG001|Overall Study|Lost to Follow-up|2|||
27957836|NCT04828707|81679841|FG000|Overall Study|Withdrawal by Subject|2|||
27957837|NCT04828707|81679842|FG001|Overall Study|Withdrawal by Subject|1|||
27957838|NCT01133665|81679846|FG000|Overall Study|Physician Decision|2|||
27957839|NCT00730756|81679847|FG000|Overall Study|Adverse Event|2|||
27957840|NCT00730756|81679848|FG001|Overall Study|Adverse Event|0|||
27957841|NCT00730756|81679847|FG000|Overall Study|Lack of Efficacy|1|||
27957842|NCT00730756|81679848|FG001|Overall Study|Lack of Efficacy|1|||
27957843|NCT00730756|81679847|FG000|Overall Study|Protocol Deviation|1|||
27957844|NCT00730756|81679848|FG001|Overall Study|Protocol Deviation|2|||
27957845|NCT00730756|81679847|FG000|Overall Study|Lost to Follow-up|0|||
27957846|NCT00730756|81679848|FG001|Overall Study|Lost to Follow-up|1|||
27957847|NCT00730756|81679847|FG000|Overall Study|Withdrew Consent|0|||
27957848|NCT00730756|81679848|FG001|Overall Study|Withdrew Consent|1|||
27957849|NCT02903823|81679849|FG000|Overall Study|Physician Decision|5|||
27957850|NCT02903823|81679849|FG000|Overall Study|Could not advance catheter|1|||
27957851|NCT02903823|81679849|FG000|Overall Study|Catheter dislodgement|1|||
27957852|NCT00856635|81679850|FG000|Overall Study|Lost to Follow-up|2|||
27957853|NCT00856635|81679851|FG001|Overall Study|Lost to Follow-up|5|||
27957854|NCT00856635|81679850|FG000|Overall Study|Pregnancy|1|||
27957855|NCT00856635|81679851|FG001|Overall Study|Pregnancy|0|||
27957856|NCT00856635|81679850|FG000|Overall Study|Withdrawal by Subject|3|||
27957857|NCT00856635|81679851|FG001|Overall Study|Withdrawal by Subject|1|||
27957858|NCT00856635|81679850|FG000|Overall Study|Serious Adverse Event|1|||
27957859|NCT00856635|81679851|FG001|Overall Study|Serious Adverse Event|0|||
27957860|NCT00856635|81679850|FG000|Overall Study|Other|1|||
27957861|NCT00856635|81679851|FG001|Overall Study|Other|0|||
27957862|NCT00856635|81679850|FG000|Overall Study|Discontinued at Randomization|2|||
27957863|NCT00856635|81679851|FG001|Overall Study|Discontinued at Randomization|2|||
27957864|NCT01198574|81679852|FG000|Overall Study|Resigned from schools|4|||
27957865|NCT01198574|81679853|FG001|Overall Study|Resigned from schools|1|||
27957866|NCT01198574|81679854|FG002|Overall Study|Resigned from schools|1|||
27957867|NCT01198574|81679855|FG003|Overall Study|Resigned from schools|4|||
27957868|NCT01465386|81679859|FG000|Overall Study|Lack of Efficacy|3|||
27957869|NCT01465386|81679859|FG000|Overall Study|Adverse Event|1|||
27957870|NCT00363142|81679863|FG000|Overall Study|Adverse Event|2|||
27957871|NCT00363142|81679864|FG001|Overall Study|Adverse Event|0|||
27957872|NCT00363142|81679863|FG000|Overall Study|Lack of Efficacy|0|||
27957873|NCT00363142|81679864|FG001|Overall Study|Lack of Efficacy|1|||
27957874|NCT00363142|81679863|FG000|Overall Study|Lost to Follow-up|1|||
27957875|NCT00363142|81679864|FG001|Overall Study|Lost to Follow-up|0|||
27957876|NCT00363142|81679863|FG000|Overall Study|Non-compliance|1|||
27957877|NCT00363142|81679864|FG001|Overall Study|Non-compliance|1|||
27957878|NCT00363142|81679863|FG000|Overall Study|Withdrawal by Subject|3|||
27957879|NCT00363142|81679864|FG001|Overall Study|Withdrawal by Subject|1|||
27957880|NCT00661830|81679865|FG000|Overall Study|Death|37|||
27957881|NCT00661830|81679866|FG001|Overall Study|Death|33|||
27957882|NCT00661830|81679865|FG000|Overall Study|Lost to Follow-up|1|||
27957883|NCT00661830|81679866|FG001|Overall Study|Lost to Follow-up|3|||
27957884|NCT00661830|81679865|FG000|Overall Study|Withdrawal by Subject|1|||
27957885|NCT00661830|81679866|FG001|Overall Study|Withdrawal by Subject|1|||
27957886|NCT00661830|81679865|FG000|Overall Study|Other reason|1|||
27957887|NCT00661830|81679866|FG001|Overall Study|Other reason|5|||
27957888|NCT02140970|81679871|FG000|Overall Study|Lost to Follow-up|1|||
27957889|NCT02140970|81679872|FG001|Overall Study|Lost to Follow-up|2|||
27957890|NCT02140970|81679871|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
27957891|NCT02140970|81679872|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
27957892|NCT02140970|81679871|FG000|Overall Study|Did not meet inclusion criteria|0|||
27957893|NCT02140970|81679872|FG001|Overall Study|Did not meet inclusion criteria|1|||
27957894|NCT00506779|81679877|FG000|Overall Study|Withdrawal by Subject|1|||
27957895|NCT00506779|81679878|FG001|Overall Study|Withdrawal by Subject|0|||
27957896|NCT00506779|81679879|FG002|Overall Study|Withdrawal by Subject|1|||
27957897|NCT00506779|81679880|FG003|Overall Study|Withdrawal by Subject|0|||
27957898|NCT00506779|81679877|FG000|Overall Study|Adverse Event|0|||
27957899|NCT00506779|81679878|FG001|Overall Study|Adverse Event|1|||
27957900|NCT00506779|81679879|FG002|Overall Study|Adverse Event|1|||
27957901|NCT00506779|81679880|FG003|Overall Study|Adverse Event|1|||
27957902|NCT02897115|81679883|FG000|Overall Study|Early termination of study by sponsor|11|||
27957903|NCT02897115|81679884|FG001|Overall Study|Early termination of study by sponsor|8|||
27957904|NCT00413660|81679885|FG000|Up To Week 12|Adverse Event|1|||
27957905|NCT00413660|81679886|FG001|Up To Week 12|Adverse Event|3|||
27957906|NCT00413660|81679887|FG002|Up To Week 12|Adverse Event|1|||
27957907|NCT00413660|81679888|FG003|Up To Week 12|Adverse Event|4|||
27957908|NCT00413660|81679889|FG004|Up To Week 12|Adverse Event|6|||
27957909|NCT00413660|81679890|FG005|Up To Week 12|Adverse Event|4|||
27957910|NCT00413660|81679891|FG006|Up To Week 12|Adverse Event|1|||
27957911|NCT00413660|81679892|FG007|Up To Week 12|Adverse Event|0|||
27957912|NCT00413660|81679893|FG008|Up To Week 12|Adverse Event|0|||
27957913|NCT00413660|81679894|FG009|Up To Week 12|Adverse Event|0|||
27957914|NCT00413660|81679895|FG010|Up To Week 12|Adverse Event|0|||
27957915|NCT00413660|81679885|FG000|Up To Week 12|Lack of Efficacy|2|||
27957916|NCT00413660|81679886|FG001|Up To Week 12|Lack of Efficacy|0|||
27957917|NCT00413660|81679887|FG002|Up To Week 12|Lack of Efficacy|0|||
27957918|NCT00413660|81679888|FG003|Up To Week 12|Lack of Efficacy|0|||
27957919|NCT00413660|81679889|FG004|Up To Week 12|Lack of Efficacy|0|||
27957920|NCT00413660|81679890|FG005|Up To Week 12|Lack of Efficacy|0|||
27957921|NCT00413660|81679891|FG006|Up To Week 12|Lack of Efficacy|5|||
27957922|NCT00413660|81679892|FG007|Up To Week 12|Lack of Efficacy|0|||
27957923|NCT00413660|81679893|FG008|Up To Week 12|Lack of Efficacy|0|||
27957924|NCT00413660|81679894|FG009|Up To Week 12|Lack of Efficacy|0|||
27957925|NCT00413660|81679895|FG010|Up To Week 12|Lack of Efficacy|0|||
27957926|NCT00413660|81679885|FG000|Up To Week 12|Lost to Follow-up|0|||
27957927|NCT00413660|81679886|FG001|Up To Week 12|Lost to Follow-up|1|||
27957928|NCT00413660|81679887|FG002|Up To Week 12|Lost to Follow-up|0|||
27957929|NCT00413660|81679888|FG003|Up To Week 12|Lost to Follow-up|0|||
27957930|NCT00413660|81679889|FG004|Up To Week 12|Lost to Follow-up|1|||
27957931|NCT00413660|81679890|FG005|Up To Week 12|Lost to Follow-up|0|||
27957932|NCT00413660|81679891|FG006|Up To Week 12|Lost to Follow-up|0|||
27957933|NCT00413660|81679892|FG007|Up To Week 12|Lost to Follow-up|0|||
27957934|NCT00413660|81679893|FG008|Up To Week 12|Lost to Follow-up|0|||
27957935|NCT00413660|81679894|FG009|Up To Week 12|Lost to Follow-up|0|||
27957936|NCT00413660|81679895|FG010|Up To Week 12|Lost to Follow-up|0|||
27957937|NCT00413660|81679885|FG000|Up To Week 12|Withdrawal by Subject|0|||
27957938|NCT00413660|81679886|FG001|Up To Week 12|Withdrawal by Subject|2|||
27957939|NCT00413660|81679887|FG002|Up To Week 12|Withdrawal by Subject|0|||
27957940|NCT00413660|81679888|FG003|Up To Week 12|Withdrawal by Subject|2|||
27957941|NCT00413660|81679889|FG004|Up To Week 12|Withdrawal by Subject|0|||
27957942|NCT00413660|81679890|FG005|Up To Week 12|Withdrawal by Subject|2|||
27957943|NCT00413660|81679891|FG006|Up To Week 12|Withdrawal by Subject|2|||
27957944|NCT00413660|81679892|FG007|Up To Week 12|Withdrawal by Subject|0|||
27957945|NCT00413660|81679893|FG008|Up To Week 12|Withdrawal by Subject|0|||
27957946|NCT00413660|81679894|FG009|Up To Week 12|Withdrawal by Subject|0|||
27957947|NCT00413660|81679895|FG010|Up To Week 12|Withdrawal by Subject|0|||
27957948|NCT00413660|81679885|FG000|Up To Week 12|Randomized, Not Treated|1|||
27957949|NCT00413660|81679886|FG001|Up To Week 12|Randomized, Not Treated|0|||
27957950|NCT00413660|81679887|FG002|Up To Week 12|Randomized, Not Treated|0|||
27957951|NCT00413660|81679888|FG003|Up To Week 12|Randomized, Not Treated|1|||
27957952|NCT00413660|81679889|FG004|Up To Week 12|Randomized, Not Treated|0|||
27957953|NCT00413660|81679890|FG005|Up To Week 12|Randomized, Not Treated|0|||
27957954|NCT00413660|81679891|FG006|Up To Week 12|Randomized, Not Treated|0|||
27957955|NCT00413660|81679892|FG007|Up To Week 12|Randomized, Not Treated|0|||
27957956|NCT00413660|81679893|FG008|Up To Week 12|Randomized, Not Treated|0|||
27957957|NCT00413660|81679894|FG009|Up To Week 12|Randomized, Not Treated|0|||
27957958|NCT00413660|81679895|FG010|Up To Week 12|Randomized, Not Treated|0|||
27957959|NCT00413660|81679885|FG000|Up To Week 12|Other|3|||
27957960|NCT00413660|81679886|FG001|Up To Week 12|Other|1|||
27957961|NCT00413660|81679887|FG002|Up To Week 12|Other|6|||
27957962|NCT00413660|81679888|FG003|Up To Week 12|Other|1|||
27957963|NCT00413660|81679889|FG004|Up To Week 12|Other|2|||
27957964|NCT00413660|81679890|FG005|Up To Week 12|Other|4|||
27957965|NCT00413660|81679891|FG006|Up To Week 12|Other|3|||
27957966|NCT00413660|81679892|FG007|Up To Week 12|Other|0|||
27957967|NCT00413660|81679893|FG008|Up To Week 12|Other|0|||
27957968|NCT00413660|81679894|FG009|Up To Week 12|Other|0|||
27957969|NCT00413660|81679895|FG010|Up To Week 12|Other|0|||
27957970|NCT00413660|81679885|FG000|Post Week 12|Adverse Event|2|||
27957971|NCT00413660|81679886|FG001|Post Week 12|Adverse Event|0|||
27957972|NCT00413660|81679887|FG002|Post Week 12|Adverse Event|2|||
27957973|NCT00413660|81679888|FG003|Post Week 12|Adverse Event|1|||
27957974|NCT00413660|81679889|FG004|Post Week 12|Adverse Event|4|||
27957975|NCT00413660|81679890|FG005|Post Week 12|Adverse Event|2|||
27957976|NCT00413660|81679891|FG006|Post Week 12|Adverse Event|2|||
27957977|NCT00413660|81679892|FG007|Post Week 12|Adverse Event|0|||
27957978|NCT00413660|81679893|FG008|Post Week 12|Adverse Event|0|||
27957979|NCT00413660|81679894|FG009|Post Week 12|Adverse Event|0|||
27957980|NCT00413660|81679895|FG010|Post Week 12|Adverse Event|0|||
27957981|NCT00413660|81679885|FG000|Post Week 12|Lack of Efficacy|0|||
27957982|NCT00413660|81679886|FG001|Post Week 12|Lack of Efficacy|0|||
27957983|NCT00413660|81679887|FG002|Post Week 12|Lack of Efficacy|1|||
27957984|NCT00413660|81679888|FG003|Post Week 12|Lack of Efficacy|0|||
27957985|NCT00413660|81679889|FG004|Post Week 12|Lack of Efficacy|0|||
27957986|NCT00413660|81679890|FG005|Post Week 12|Lack of Efficacy|0|||
27957987|NCT00413660|81679891|FG006|Post Week 12|Lack of Efficacy|0|||
27957988|NCT00413660|81679892|FG007|Post Week 12|Lack of Efficacy|0|||
27957989|NCT00413660|81679893|FG008|Post Week 12|Lack of Efficacy|0|||
27957990|NCT00413660|81679894|FG009|Post Week 12|Lack of Efficacy|1|||
27957991|NCT00413660|81679895|FG010|Post Week 12|Lack of Efficacy|0|||
27957992|NCT00413660|81679885|FG000|Post Week 12|Lost to Follow-up|0|||
27957993|NCT00413660|81679886|FG001|Post Week 12|Lost to Follow-up|1|||
27957994|NCT00413660|81679887|FG002|Post Week 12|Lost to Follow-up|1|||
27957995|NCT00413660|81679888|FG003|Post Week 12|Lost to Follow-up|0|||
27957996|NCT00413660|81679889|FG004|Post Week 12|Lost to Follow-up|0|||
27957997|NCT00413660|81679890|FG005|Post Week 12|Lost to Follow-up|0|||
27957998|NCT00413660|81679891|FG006|Post Week 12|Lost to Follow-up|0|||
27957999|NCT00413660|81679892|FG007|Post Week 12|Lost to Follow-up|0|||
27958000|NCT00413660|81679893|FG008|Post Week 12|Lost to Follow-up|0|||
27958001|NCT00413660|81679894|FG009|Post Week 12|Lost to Follow-up|0|||
27958002|NCT00413660|81679895|FG010|Post Week 12|Lost to Follow-up|0|||
27958003|NCT00413660|81679885|FG000|Post Week 12|Withdrawal by Subject|0|||
27958004|NCT00413660|81679886|FG001|Post Week 12|Withdrawal by Subject|1|||
27958005|NCT00413660|81679887|FG002|Post Week 12|Withdrawal by Subject|1|||
27958006|NCT00413660|81679888|FG003|Post Week 12|Withdrawal by Subject|0|||
27958007|NCT00413660|81679889|FG004|Post Week 12|Withdrawal by Subject|1|||
27958008|NCT00413660|81679890|FG005|Post Week 12|Withdrawal by Subject|0|||
27958009|NCT00413660|81679891|FG006|Post Week 12|Withdrawal by Subject|0|||
27958010|NCT00413660|81679892|FG007|Post Week 12|Withdrawal by Subject|0|||
27958011|NCT00413660|81679893|FG008|Post Week 12|Withdrawal by Subject|0|||
27958012|NCT00413660|81679894|FG009|Post Week 12|Withdrawal by Subject|0|||
27958013|NCT00413660|81679895|FG010|Post Week 12|Withdrawal by Subject|1|||
27958014|NCT00413660|81679885|FG000|Post Week 12|Other|1|||
27958015|NCT00413660|81679886|FG001|Post Week 12|Other|2|||
27958016|NCT00413660|81679887|FG002|Post Week 12|Other|3|||
27958017|NCT00413660|81679888|FG003|Post Week 12|Other|0|||
27958018|NCT00413660|81679889|FG004|Post Week 12|Other|1|||
27958019|NCT00413660|81679890|FG005|Post Week 12|Other|1|||
27958020|NCT00413660|81679891|FG006|Post Week 12|Other|1|||
27958021|NCT00413660|81679892|FG007|Post Week 12|Other|0|||
27958022|NCT00413660|81679893|FG008|Post Week 12|Other|0|||
27958023|NCT00413660|81679894|FG009|Post Week 12|Other|0|||
27958024|NCT00413660|81679895|FG010|Post Week 12|Other|0|||
27958025|NCT01123148|81679902|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
27958026|NCT01123148|81679902|FG000|Overall Study|Didn't meet milestone criteria|1|||
27958027|NCT04774380|81679903|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
27958028|NCT04232943|81679904|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
27958029|NCT04232943|81679905|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
27958030|NCT04232943|81679906|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
27958031|NCT04232943|81679904|FG000|Overall Study|Withdrawal by Subject|1|||
27958032|NCT04232943|81679905|FG001|Overall Study|Withdrawal by Subject|1|||
27958033|NCT04232943|81679906|FG002|Overall Study|Withdrawal by Subject|0|||
27958034|NCT01345929|81679907|FG000|Overall Study|Withdrawal by Subject|9|||
27958035|NCT01345929|81679908|FG001|Overall Study|Withdrawal by Subject|8|||
27958036|NCT01345929|81679907|FG000|Overall Study|Lost to Follow-up|9|||
27958037|NCT01345929|81679908|FG001|Overall Study|Lost to Follow-up|9|||
27958038|NCT01345929|81679907|FG000|Overall Study|Adverse Event|0|||
27958039|NCT01345929|81679908|FG001|Overall Study|Adverse Event|1|||
27958040|NCT01345929|81679907|FG000|Overall Study|Didn't meet eligibility criteria|2|||
27958041|NCT01345929|81679908|FG001|Overall Study|Didn't meet eligibility criteria|0|||
27958042|NCT01345929|81679907|FG000|Overall Study|40,000 CFU/ML|1|||
27958043|NCT01345929|81679908|FG001|Overall Study|40,000 CFU/ML|0|||
27958044|NCT01345929|81679907|FG000|Overall Study|Patient withdrawal|0|||
27958045|NCT01345929|81679908|FG001|Overall Study|Patient withdrawal|1|||
27958046|NCT02477527|81679923|FG000|Overall Study|Lost to Follow-up|2|||
27958047|NCT02477527|81679923|FG000|Overall Study|Withdrawal by Subject|1|||
27958048|NCT02477527|81679923|FG000|Overall Study|Screen Failure|3|||
27958049|NCT00573391|81679929|FG000|Overall Study|study stopped|2|||
27958050|NCT00573391|81679930|FG001|Overall Study|study stopped|2|||
27958051|NCT00573391|81679929|FG000|Overall Study|Death|1|||
27958052|NCT00573391|81679930|FG001|Overall Study|Death|0|||
27958053|NCT01151020|81679931|FG000|Overall Study|Death|25|||
27958054|NCT01151020|81679931|FG000|Overall Study|Conversion to open repair|1|||
27958055|NCT01151020|81679931|FG000|Overall Study|Lost to Follow-up|4|||
27958056|NCT01151020|81679931|FG000|Overall Study|Withdrawal by Subject|22|||
27958057|NCT01151020|81679931|FG000|Overall Study|Patients did not receive the device|2|||
27958058|NCT02528942|81679933|FG000|Overall Study|Did not meet imaging criteria|9|||
27958059|NCT02528942|81679933|FG000|Overall Study|Lost to Follow-up|25|||
27958060|NCT03335150|81679934|FG000|Overall Study|Withdrawal by Subject|10|||
27958061|NCT03335150|81679935|FG001|Overall Study|Withdrawal by Subject|4|||
27958062|NCT03335150|81679934|FG000|Overall Study|Adverse Event|0|||
27958063|NCT03335150|81679935|FG001|Overall Study|Adverse Event|1|||
27958064|NCT00589797|81679936|FG000|Overall Study|Death|1|||
27958065|NCT00589797|81679937|FG001|Overall Study|Death|0|||
27958066|NCT00589797|81679936|FG000|Overall Study|Lost to Follow-up|12|||
27958067|NCT00589797|81679937|FG001|Overall Study|Lost to Follow-up|9|||
27958068|NCT00589797|81679936|FG000|Overall Study|Physician Decision|8|||
27958069|NCT00589797|81679937|FG001|Overall Study|Physician Decision|3|||
27958070|NCT00589797|81679936|FG000|Overall Study|Withdrawal by Subject|6|||
27958071|NCT00589797|81679937|FG001|Overall Study|Withdrawal by Subject|5|||
27958072|NCT00589797|81679936|FG000|Overall Study|Non-Randomized Training Subjects|46|||
27958073|NCT00589797|81679937|FG001|Overall Study|Non-Randomized Training Subjects|6|||
27958074|NCT00892008|81679946|FG000|Overall Study|Death|5|||
27958075|NCT00892008|81679946|FG000|Overall Study|Lack of Efficacy|3|||
27958076|NCT00892008|81679946|FG000|Overall Study|Lost to Follow-up|142|||
27958077|NCT00892008|81679946|FG000|Overall Study|Other|378|||
27958078|NCT00892008|81679946|FG000|Overall Study|Adverse Event|37|||
27958079|NCT00592631|81679948|FG000|Overall Study|Lost to Follow-up|0|||
27958080|NCT00592631|81679949|FG001|Overall Study|Lost to Follow-up|2|||
27958081|NCT00570323|81679954|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
27958082|NCT00570323|81679955|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
27958083|NCT00570323|81679954|FG000|Started Treatment After Randomization|Protocol Violation|1|||
27958084|NCT00570323|81679955|FG001|Started Treatment After Randomization|Protocol Violation|0|||
27958085|NCT00570323|81679954|FG000|Started Treatment After Randomization|Physician Decision|1|||
27958086|NCT00570323|81679955|FG001|Started Treatment After Randomization|Physician Decision|0|||
27958087|NCT00570323|81679954|FG000|Complete Study After Start|Lost to Follow-up|0|||
27958088|NCT00570323|81679955|FG001|Complete Study After Start|Lost to Follow-up|1|||
27958089|NCT00570323|81679954|FG000|Complete Study After Start|Withdrawal by Subject|2|||
27958090|NCT00570323|81679955|FG001|Complete Study After Start|Withdrawal by Subject|0|||
27958091|NCT00570323|81679954|FG000|Complete Study After Start|Physician Decision|1|||
27958092|NCT00570323|81679955|FG001|Complete Study After Start|Physician Decision|0|||
27958093|NCT01775553|81679959|FG000|Overall Study|Adverse Event|1|||
27958094|NCT01775553|81679959|FG000|Overall Study|Disease Progression|12|||
27958095|NCT01945996|81679962|FG000|Overall Study|Lost to Follow-up|3|||
27958096|NCT01945996|81679963|FG001|Overall Study|Lost to Follow-up|5|||
27958097|NCT03008070|81679965|FG000|Overall Study|Adverse Event|3|||
27958098|NCT03008070|81679966|FG001|Overall Study|Adverse Event|3|||
27958099|NCT03008070|81679967|FG002|Overall Study|Adverse Event|3|||
27958100|NCT03008070|81679965|FG000|Overall Study|Lost to Follow-up|1|||
27958101|NCT03008070|81679966|FG001|Overall Study|Lost to Follow-up|1|||
27958102|NCT03008070|81679967|FG002|Overall Study|Lost to Follow-up|0|||
27958103|NCT03008070|81679965|FG000|Overall Study|Non compliance|0|||
27958104|NCT03008070|81679966|FG001|Overall Study|Non compliance|1|||
27958105|NCT03008070|81679967|FG002|Overall Study|Non compliance|1|||
27958106|NCT03008070|81679965|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
27958107|NCT03008070|81679966|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
27958108|NCT03008070|81679967|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
27958109|NCT03008070|81679965|FG000|Overall Study|Withdrawal by Subject|2|||
27958110|NCT03008070|81679966|FG001|Overall Study|Withdrawal by Subject|0|||
27958111|NCT03008070|81679967|FG002|Overall Study|Withdrawal by Subject|1|||
27958112|NCT03008070|81679965|FG000|Overall Study|Use of prohibited drug|0|||
27958113|NCT03008070|81679966|FG001|Overall Study|Use of prohibited drug|0|||
27958114|NCT03008070|81679967|FG002|Overall Study|Use of prohibited drug|2|||
27958115|NCT02973997|81679970|FG000|Overall Study|Withdrawal by Subject|4|||
27958116|NCT02973997|81679971|FG001|Overall Study|Withdrawal by Subject|0|||
27958117|NCT02973997|81679970|FG000|Overall Study|Adverse Event|4|||
27958118|NCT02973997|81679971|FG001|Overall Study|Adverse Event|1|||
27958119|NCT02973997|81679970|FG000|Overall Study|Disease Progression|11|||
27958120|NCT02973997|81679971|FG001|Overall Study|Disease Progression|20|||
27958121|NCT02973997|81679970|FG000|Overall Study|Alternative Therapy|3|||
27958122|NCT02973997|81679971|FG001|Overall Study|Alternative Therapy|0|||
27958123|NCT02973997|81679970|FG000|Overall Study|Other complicating disease|0|||
27958124|NCT02973997|81679971|FG001|Overall Study|Other complicating disease|1|||
27958125|NCT02973997|81679970|FG000|Overall Study|Death|0|||
27958126|NCT02973997|81679971|FG001|Overall Study|Death|1|||
27958127|NCT01963767|81679976|FG000|Overall Study|Withdrawal by Subject|4|||
27958128|NCT01963767|81679977|FG001|Overall Study|Withdrawal by Subject|2|||
27958129|NCT01963767|81679976|FG000|Overall Study|Adverse Event|2|||
27958130|NCT01963767|81679977|FG001|Overall Study|Adverse Event|0|||
27958131|NCT01135992|81679978|FG000|Overall Study|Adverse Event|1|||
27958132|NCT01135992|81679978|FG000|Overall Study|Lack of Efficacy|1|||
27958133|NCT01135992|81679978|FG000|Overall Study|Protocol Violation|2|||
27958134|NCT01135992|81679978|FG000|Overall Study|Withdrawal criteria|10|||
27958135|NCT01135992|81679978|FG000|Overall Study|Unclassified|7|||
27958136|NCT00443703|81679979|FG000|Overall Study|Never Treated|3|||
27958137|NCT00443703|81679980|FG001|Overall Study|Never Treated|1|||
27958138|NCT00443703|81679979|FG000|Overall Study|Adverse Event|7|||
27958139|NCT00443703|81679980|FG001|Overall Study|Adverse Event|3|||
27958140|NCT00443703|81679979|FG000|Overall Study|Lack of Efficacy|3|||
27958141|NCT00443703|81679980|FG001|Overall Study|Lack of Efficacy|1|||
27958142|NCT00443703|81679979|FG000|Overall Study|Lost to Follow-up|0|||
27958143|NCT00443703|81679980|FG001|Overall Study|Lost to Follow-up|4|||
27958144|NCT00443703|81679979|FG000|Overall Study|Physician Decision|4|||
27958145|NCT00443703|81679980|FG001|Overall Study|Physician Decision|2|||
27958146|NCT00443703|81679979|FG000|Overall Study|Protocol Violation|1|||
27958147|NCT00443703|81679980|FG001|Overall Study|Protocol Violation|1|||
27958148|NCT00443703|81679979|FG000|Overall Study|Withdrawal by Subject|9|||
27958149|NCT00443703|81679980|FG001|Overall Study|Withdrawal by Subject|6|||
27958150|NCT00443703|81679979|FG000|Overall Study|Progressive Disease|1|||
27958151|NCT00443703|81679980|FG001|Overall Study|Progressive Disease|0|||
27958152|NCT01509846|81679983|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
27958153|NCT01509846|81679984|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
27958154|NCT01509846|81679985|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
27958155|NCT01509846|81679986|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
27958156|NCT01509846|81679987|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
27958157|NCT01509846|81679983|FG000|Received Vaccination 2|Illness|0|||
27958158|NCT01509846|81679984|FG001|Received Vaccination 2|Illness|0|||
27958159|NCT01509846|81679985|FG002|Received Vaccination 2|Illness|0|||
27958160|NCT01509846|81679986|FG003|Received Vaccination 2|Illness|0|||
27958161|NCT01509846|81679987|FG004|Received Vaccination 2|Illness|1|||
27958162|NCT01509846|81679983|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
27958163|NCT01509846|81679984|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
27958164|NCT01509846|81679985|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
27958165|NCT01509846|81679986|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
27958166|NCT01509846|81679987|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
27958167|NCT01509846|81679983|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
27958168|NCT01509846|81679984|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
27958169|NCT01509846|81679985|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
27958170|NCT01509846|81679986|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
27958171|NCT01509846|81679987|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
27958172|NCT01509846|81679983|FG000|Received Vaccination 3|Pregnancy|0|||
27958173|NCT01509846|81679984|FG001|Received Vaccination 3|Pregnancy|0|||
27958174|NCT01509846|81679985|FG002|Received Vaccination 3|Pregnancy|0|||
27958175|NCT01509846|81679986|FG003|Received Vaccination 3|Pregnancy|1|||
27958176|NCT01509846|81679987|FG004|Received Vaccination 3|Pregnancy|0|||
27958177|NCT01509846|81679983|FG000|Received Vaccination 3|Lost to Follow-up|0|||
27958178|NCT01509846|81679984|FG001|Received Vaccination 3|Lost to Follow-up|0|||
27958179|NCT01509846|81679985|FG002|Received Vaccination 3|Lost to Follow-up|1|||
27958180|NCT01509846|81679986|FG003|Received Vaccination 3|Lost to Follow-up|0|||
27958181|NCT01509846|81679987|FG004|Received Vaccination 3|Lost to Follow-up|0|||
27958182|NCT01898286|81679990|FG000|Overall Study|Withdrawal by Subject|1|||
27958183|NCT01898286|81679990|FG000|Overall Study|Protocol Violation|1|||
27958184|NCT01898286|81679990|FG000|Overall Study|Lost to Follow-up|1|||
27958185|NCT02389465|81679991|FG000|Overall Study|Lost to Follow-up|1|||
27958186|NCT02389465|81679992|FG001|Overall Study|Lost to Follow-up|3|||
27958187|NCT02389465|81679993|FG002|Overall Study|Lost to Follow-up|3|||
27958188|NCT02389465|81679994|FG003|Overall Study|Lost to Follow-up|0|||
27958189|NCT02389465|81679991|FG000|Overall Study|Physician Decision|0|||
27958190|NCT02389465|81679992|FG001|Overall Study|Physician Decision|0|||
27958191|NCT02389465|81679993|FG002|Overall Study|Physician Decision|0|||
27958192|NCT02389465|81679994|FG003|Overall Study|Physician Decision|1|||
27958193|NCT02389465|81679991|FG000|Overall Study|Withdrawal by Subject|0|||
27958194|NCT02389465|81679992|FG001|Overall Study|Withdrawal by Subject|1|||
27958195|NCT02389465|81679993|FG002|Overall Study|Withdrawal by Subject|2|||
27958196|NCT02389465|81679994|FG003|Overall Study|Withdrawal by Subject|2|||
27958197|NCT01628913|81679995|FG000|Overall Study|Adverse Event|12|||
27958198|NCT01628913|81679996|FG001|Overall Study|Adverse Event|5|||
27958199|NCT01628913|81679995|FG000|Overall Study|Disease Progression|11|||
27958200|NCT01628913|81679996|FG001|Overall Study|Disease Progression|14|||
27958201|NCT01628913|81679995|FG000|Overall Study|Protocol Violation|1|||
27958202|NCT01628913|81679996|FG001|Overall Study|Protocol Violation|0|||
27958203|NCT01628913|81679995|FG000|Overall Study|Death|1|||
27958204|NCT01628913|81679996|FG001|Overall Study|Death|0|||
27958205|NCT01628913|81679995|FG000|Overall Study|study terminated by Sponsor|4|||
27958206|NCT01628913|81679996|FG001|Overall Study|study terminated by Sponsor|9|||
27958207|NCT01628913|81679995|FG000|Overall Study|Withdrawal by Subject|1|||
27958208|NCT01628913|81679996|FG001|Overall Study|Withdrawal by Subject|0|||
27958209|NCT01628913|81679995|FG000|Overall Study|Physician Decision|1|||
27958210|NCT01628913|81679996|FG001|Overall Study|Physician Decision|3|||
27958211|NCT03382912|81679998|FG000|Overall Study|Physician Decision|0|||
27958212|NCT03382912|81679999|FG001|Overall Study|Physician Decision|1|||
27958213|NCT03382912|81679998|FG000|Overall Study|Sponsor Decision|6|||
27958214|NCT03382912|81679999|FG001|Overall Study|Sponsor Decision|6|||
27958215|NCT03382912|81679998|FG000|Overall Study|Withdrawal by Subject|0|||
27958216|NCT03382912|81679999|FG001|Overall Study|Withdrawal by Subject|5|||
27958217|NCT06164691|81680000|FG000|Overall Study|Withdrawal by Subject|2|||
27958218|NCT06164691|81680001|FG001|Overall Study|Withdrawal by Subject|0|||
27958219|NCT06164691|81680002|FG002|Overall Study|Withdrawal by Subject|0|||
27958220|NCT02441101|81680003|FG000|Overall Study|Withdrawal by Subject|1|||
27958221|NCT02441101|81680004|FG001|Overall Study|Withdrawal by Subject|0|||
27958222|NCT02441101|81680003|FG000|Overall Study|Lost to Follow-up|1|||
27958223|NCT02441101|81680004|FG001|Overall Study|Lost to Follow-up|0|||
27958224|NCT02441101|81680003|FG000|Overall Study|PI relocated and study terminated|1|||
27958225|NCT02441101|81680004|FG001|Overall Study|PI relocated and study terminated|0|||
27958226|NCT02840253|81680005|FG000|Overall Study|Unsuccessful block|4|||
27958227|NCT01306643|81680009|FG000|Overall Study|Adverse Event|5|||
27958228|NCT01306643|81680009|FG000|Overall Study|Disease Progression|7|||
27958229|NCT01306643|81680009|FG000|Overall Study|Other: Change in Eligibility Status|1|||
27958230|NCT03886493|81680011|FG000|Overall Study|Adverse Event|1|||
27958231|NCT01016067|81680012|FG000|Overall Study|Lost to Follow-up|1|||
27958232|NCT01016067|81680013|FG001|Overall Study|Lost to Follow-up|2|||
27958233|NCT01016067|81680012|FG000|Overall Study|Physician Decision|1|||
27958234|NCT01016067|81680013|FG001|Overall Study|Physician Decision|1|||
27958235|NCT01016067|81680012|FG000|Overall Study|Withdrew due to Relocation|0|||
27958236|NCT01016067|81680013|FG001|Overall Study|Withdrew due to Relocation|1|||
27958237|NCT00355368|81680014|FG000|Overall Study|Protocol Violation|8|||
27958238|NCT00355368|81680015|FG001|Overall Study|Protocol Violation|7|||
27958239|NCT00355368|81680014|FG000|Overall Study|cardiac arrest prior to intubation|2|||
27958240|NCT00355368|81680015|FG001|Overall Study|cardiac arrest prior to intubation|2|||
27958241|NCT01030822|81680018|FG000|Overall Study|Moved/migrated from study area|6|||
27958242|NCT01030822|81680019|FG001|Overall Study|Moved/migrated from study area|7|||
27958243|NCT01030822|81680020|FG002|Overall Study|Moved/migrated from study area|3|||
27958244|NCT01030822|81680018|FG000|Overall Study|Withdrawal by Subject|16|||
27958245|NCT01030822|81680019|FG001|Overall Study|Withdrawal by Subject|13|||
27958246|NCT01030822|81680020|FG002|Overall Study|Withdrawal by Subject|16|||
27958247|NCT01030822|81680018|FG000|Overall Study|Lost to Follow-up|9|||
27958248|NCT01030822|81680019|FG001|Overall Study|Lost to Follow-up|4|||
27958249|NCT01030822|81680020|FG002|Overall Study|Lost to Follow-up|7|||
27958250|NCT02457247|81680021|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
27958251|NCT02457247|81680022|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
27958252|NCT02457247|81680023|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
27958253|NCT02457247|81680024|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
27958254|NCT02457247|81680021|FG000|Period 1|Significant Protocol Deviation|1|||
27958255|NCT02457247|81680022|FG001|Period 1|Significant Protocol Deviation|1|||
27958256|NCT02457247|81680023|FG002|Period 1|Significant Protocol Deviation|0|||
27958257|NCT02457247|81680024|FG003|Period 1|Significant Protocol Deviation|0|||
27958258|NCT02457247|81680021|FG000|Period 1|Voluntary Withdrawal|1|||
27958259|NCT02457247|81680022|FG001|Period 1|Voluntary Withdrawal|0|||
27958260|NCT02457247|81680023|FG002|Period 1|Voluntary Withdrawal|0|||
27958261|NCT02457247|81680024|FG003|Period 1|Voluntary Withdrawal|0|||
27958262|NCT02457247|81680021|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
27958263|NCT02457247|81680022|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
27958264|NCT02457247|81680023|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
27958265|NCT02457247|81680024|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
27958266|NCT02457247|81680021|FG000|Period 2|Significant Protocol Deviation|1|||
27958267|NCT02457247|81680022|FG001|Period 2|Significant Protocol Deviation|0|||
27958268|NCT02457247|81680023|FG002|Period 2|Significant Protocol Deviation|0|||
27958269|NCT02457247|81680024|FG003|Period 2|Significant Protocol Deviation|0|||
27958270|NCT02457247|81680021|FG000|Period 2|Lost to Follow-up|0|||
27958271|NCT02457247|81680022|FG001|Period 2|Lost to Follow-up|1|||
27958272|NCT02457247|81680023|FG002|Period 2|Lost to Follow-up|0|||
27958273|NCT02457247|81680024|FG003|Period 2|Lost to Follow-up|0|||
27958274|NCT02457247|81680021|FG000|Period 2|Voluntary Withdrawal|1|||
27958275|NCT02457247|81680022|FG001|Period 2|Voluntary Withdrawal|1|||
27958276|NCT02457247|81680023|FG002|Period 2|Voluntary Withdrawal|0|||
27958277|NCT02457247|81680024|FG003|Period 2|Voluntary Withdrawal|0|||
27958278|NCT00937495|81680025|FG000|Overall Study|Protocol Violation|2|||
27958279|NCT00755807|81680030|FG000|Acute Phase|Adverse Event|16|||
27958280|NCT00755807|81680031|FG001|Acute Phase|Adverse Event|5|||
27958281|NCT00755807|81680030|FG000|Acute Phase|Protocol Violation|1|||
27958282|NCT00755807|81680031|FG001|Acute Phase|Protocol Violation|3|||
27958283|NCT00755807|81680030|FG000|Acute Phase|Withdrawal by Subject|1|||
27958284|NCT00755807|81680031|FG001|Acute Phase|Withdrawal by Subject|2|||
27958285|NCT00755807|81680030|FG000|Acute Phase|Lack of Efficacy|0|||
27958286|NCT00755807|81680031|FG001|Acute Phase|Lack of Efficacy|1|||
27958287|NCT00755807|81680030|FG000|Acute Phase|Physician Decision|0|||
27958288|NCT00755807|81680031|FG001|Acute Phase|Physician Decision|1|||
27958289|NCT00755807|81680030|FG000|Open-label Extension Phase|Adverse Event|7|||
27958290|NCT00755807|81680031|FG001|Open-label Extension Phase|Adverse Event|7|||
27958291|NCT00755807|81680030|FG000|Open-label Extension Phase|Protocol Violation|5|||
27958292|NCT00755807|81680031|FG001|Open-label Extension Phase|Protocol Violation|2|||
27958293|NCT00755807|81680030|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
27958294|NCT00755807|81680031|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
27958295|NCT00755807|81680030|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
27958296|NCT00755807|81680031|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
27958297|NCT00755807|81680030|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
27958298|NCT00755807|81680031|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
27958299|NCT00755807|81680030|FG000|Open-label Extension Phase|Sponsor Decision|0|||
27958300|NCT00755807|81680031|FG001|Open-label Extension Phase|Sponsor Decision|1|||
27958301|NCT00825994|81680032|FG000|Overall Study|Withdrawal by Subject|2|||
27958302|NCT00825994|81680032|FG000|Overall Study|Lost to Follow-up|1|||
27958303|NCT00825994|81680032|FG000|Overall Study|Protocol Violation|1|||
27958304|NCT00825994|81680032|FG000|Overall Study|Placebo Responder at V2|1|||
27958305|NCT04677543|81680037|FG000|Overall Study|Withdrawal by Subject|4|||
27958306|NCT04677543|81680038|FG001|Overall Study|Withdrawal by Subject|1|||
27958307|NCT04677543|81680037|FG000|Overall Study|Physician Decision|0|||
27958308|NCT04677543|81680038|FG001|Overall Study|Physician Decision|1|||
27958309|NCT04677543|81680037|FG000|Overall Study|Adverse Event|0|||
27958310|NCT04677543|81680038|FG001|Overall Study|Adverse Event|1|||
27958311|NCT02727322|81680041|FG000|Overall Study|Withdrawal by Subject|1|||
27958312|NCT02727322|81680042|FG001|Overall Study|Withdrawal by Subject|1|||
27958313|NCT02727322|81680041|FG000|Overall Study|Protocol Violation|1|||
27958314|NCT02727322|81680042|FG001|Overall Study|Protocol Violation|0|||
27958315|NCT03154476|81680043|FG000|Overall Study|Lost to Follow-up|4|||
27958316|NCT03154476|81680044|FG001|Overall Study|Lost to Follow-up|4|||
27958317|NCT03759600|81680045|FG000|Overall Study|Adverse Event|2|||
27958318|NCT03759600|81680045|FG000|Overall Study|Progressive Disease|15|||
27958319|NCT03759600|81680045|FG000|Overall Study|Site Terminated by Sponsor|3|||
27958320|NCT00992056|81680048|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
27958321|NCT00992056|81680049|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
27958322|NCT00992056|81680048|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
27958323|NCT00992056|81680049|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
27958324|NCT02852967|81680050|FG000|Overall Study|Adverse Event|3|||
27958325|NCT02852967|81680051|FG001|Overall Study|Adverse Event|1|||
27958326|NCT02852967|81680052|FG002|Overall Study|Adverse Event|0|||
27958327|NCT02852967|81680053|FG003|Overall Study|Adverse Event|1|||
27958328|NCT02852967|81680054|FG004|Overall Study|Adverse Event|0|||
27958329|NCT02852967|81680050|FG000|Overall Study|Death|1|||
27958330|NCT02852967|81680051|FG001|Overall Study|Death|0|||
27958331|NCT02852967|81680052|FG002|Overall Study|Death|0|||
27958332|NCT02852967|81680053|FG003|Overall Study|Death|0|||
27958333|NCT02852967|81680054|FG004|Overall Study|Death|0|||
27958334|NCT02852967|81680050|FG000|Overall Study|Lost to Follow-up|1|||
27958335|NCT02852967|81680051|FG001|Overall Study|Lost to Follow-up|2|||
27958336|NCT02852967|81680052|FG002|Overall Study|Lost to Follow-up|3|||
27958337|NCT02852967|81680053|FG003|Overall Study|Lost to Follow-up|4|||
27958338|NCT02852967|81680054|FG004|Overall Study|Lost to Follow-up|4|||
27958339|NCT02852967|81680050|FG000|Overall Study|Withdrawal by Subject|6|||
27958340|NCT02852967|81680051|FG001|Overall Study|Withdrawal by Subject|12|||
27958341|NCT02852967|81680052|FG002|Overall Study|Withdrawal by Subject|7|||
27958342|NCT02852967|81680053|FG003|Overall Study|Withdrawal by Subject|10|||
27958343|NCT02852967|81680054|FG004|Overall Study|Withdrawal by Subject|10|||
27958344|NCT02852967|81680050|FG000|Overall Study|SAE|0|||
27958345|NCT02852967|81680051|FG001|Overall Study|SAE|0|||
27958346|NCT02852967|81680052|FG002|Overall Study|SAE|0|||
27958347|NCT02852967|81680053|FG003|Overall Study|SAE|3|||
27958348|NCT02852967|81680054|FG004|Overall Study|SAE|0|||
27958349|NCT02852967|81680050|FG000|Overall Study|Elevated Liver Enzymes|2|||
27958350|NCT02852967|81680051|FG001|Overall Study|Elevated Liver Enzymes|0|||
27958351|NCT02852967|81680052|FG002|Overall Study|Elevated Liver Enzymes|0|||
27958352|NCT02852967|81680053|FG003|Overall Study|Elevated Liver Enzymes|2|||
27958353|NCT02852967|81680054|FG004|Overall Study|Elevated Liver Enzymes|2|||
27958354|NCT02852967|81680050|FG000|Overall Study|Physician Decision|0|||
27958355|NCT02852967|81680051|FG001|Overall Study|Physician Decision|0|||
27958356|NCT02852967|81680052|FG002|Overall Study|Physician Decision|0|||
27958357|NCT02852967|81680053|FG003|Overall Study|Physician Decision|1|||
27958358|NCT02852967|81680054|FG004|Overall Study|Physician Decision|0|||
27958359|NCT02852967|81680050|FG000|Overall Study|Lack of Efficacy|0|||
27958360|NCT02852967|81680051|FG001|Overall Study|Lack of Efficacy|1|||
27958361|NCT02852967|81680052|FG002|Overall Study|Lack of Efficacy|0|||
27958362|NCT02852967|81680053|FG003|Overall Study|Lack of Efficacy|0|||
27958363|NCT02852967|81680054|FG004|Overall Study|Lack of Efficacy|0|||
27958364|NCT02852967|81680050|FG000|Overall Study|Non-compliance|0|||
27958365|NCT02852967|81680051|FG001|Overall Study|Non-compliance|0|||
27958366|NCT02852967|81680052|FG002|Overall Study|Non-compliance|1|||
27958367|NCT02852967|81680053|FG003|Overall Study|Non-compliance|1|||
27958368|NCT02852967|81680054|FG004|Overall Study|Non-compliance|0|||
27958369|NCT02852967|81680050|FG000|Overall Study|Dispensing Drug Violation|0|||
27958370|NCT02852967|81680051|FG001|Overall Study|Dispensing Drug Violation|0|||
27958371|NCT02852967|81680052|FG002|Overall Study|Dispensing Drug Violation|1|||
27958372|NCT02852967|81680053|FG003|Overall Study|Dispensing Drug Violation|0|||
27958373|NCT02852967|81680054|FG004|Overall Study|Dispensing Drug Violation|0|||
27958374|NCT02852967|81680050|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
27958375|NCT02852967|81680051|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
27958376|NCT02852967|81680052|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
27958377|NCT02852967|81680053|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
27958378|NCT02852967|81680054|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
27958379|NCT00469833|81680055|FG000|Overall Study|No IV access|2|||
27958380|NCT01737762|81680056|FG000|Overall Study|Adverse Event|2|||
27958381|NCT01737762|81680057|FG001|Overall Study|Adverse Event|2|||
27958382|NCT01737762|81680056|FG000|Overall Study|Lost to Follow-up|1|||
27958383|NCT01737762|81680057|FG001|Overall Study|Lost to Follow-up|0|||
27958384|NCT01737762|81680056|FG000|Overall Study|Withdrawal by Subject|2|||
27958385|NCT01737762|81680057|FG001|Overall Study|Withdrawal by Subject|2|||
27958386|NCT01737762|81680056|FG000|Overall Study|Progressive disease|1|||
27958387|NCT01737762|81680057|FG001|Overall Study|Progressive disease|2|||
27958388|NCT01737762|81680056|FG000|Overall Study|Physician Decision|1|||
27958389|NCT01737762|81680057|FG001|Overall Study|Physician Decision|1|||
27958390|NCT01737762|81680056|FG000|Overall Study|Moved from area|2|||
27958391|NCT01737762|81680057|FG001|Overall Study|Moved from area|1|||
27958392|NCT01737762|81680056|FG000|Overall Study|Trial termination|11|||
27958393|NCT01737762|81680057|FG001|Overall Study|Trial termination|9|||
27958394|NCT01791517|81680058|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
27958395|NCT01791517|81680059|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
27958396|NCT01791517|81680060|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
27958397|NCT01791517|81680061|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
27958398|NCT01791517|81680062|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
27958399|NCT01791517|81680063|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
27958400|NCT01791517|81680064|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
27958401|NCT01791517|81680065|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
27958402|NCT01791517|81680066|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
27958403|NCT01791517|81680067|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
27958404|NCT01791517|81680068|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
27958405|NCT01791517|81680069|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
27958406|NCT01791517|81680058|FG000|Phase I: Period 1|Adverse Event|0|||
27958407|NCT01791517|81680059|FG001|Phase I: Period 1|Adverse Event|0|||
27958408|NCT01791517|81680060|FG002|Phase I: Period 1|Adverse Event|1|||
27958409|NCT01791517|81680061|FG003|Phase I: Period 1|Adverse Event|1|||
27958410|NCT01791517|81680062|FG004|Phase I: Period 1|Adverse Event|0|||
27958411|NCT01791517|81680063|FG005|Phase I: Period 1|Adverse Event|0|||
27958412|NCT01791517|81680064|FG006|Phase I: Period 1|Adverse Event|0|||
27958413|NCT01791517|81680065|FG007|Phase I: Period 1|Adverse Event|0|||
27958414|NCT01791517|81680066|FG008|Phase I: Period 1|Adverse Event|0|||
27958415|NCT01791517|81680067|FG009|Phase I: Period 1|Adverse Event|0|||
27958416|NCT01791517|81680068|FG010|Phase I: Period 1|Adverse Event|0|||
27958417|NCT01791517|81680069|FG011|Phase I: Period 1|Adverse Event|0|||
27958418|NCT01791517|81680058|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
27958419|NCT01791517|81680059|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958420|NCT01791517|81680060|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958421|NCT01791517|81680061|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958422|NCT01791517|81680062|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958423|NCT01791517|81680063|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958424|NCT01791517|81680064|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958425|NCT01791517|81680065|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958426|NCT01791517|81680066|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958427|NCT01791517|81680067|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958428|NCT01791517|81680068|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958429|NCT01791517|81680069|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
27958430|NCT01791517|81680058|FG000|Phase I: Period 1|Protocol Violation|0|||
27958431|NCT01791517|81680059|FG001|Phase I: Period 1|Protocol Violation|1|||
27958432|NCT01791517|81680060|FG002|Phase I: Period 1|Protocol Violation|0|||
27958433|NCT01791517|81680061|FG003|Phase I: Period 1|Protocol Violation|0|||
27958434|NCT01791517|81680062|FG004|Phase I: Period 1|Protocol Violation|0|||
27958435|NCT01791517|81680063|FG005|Phase I: Period 1|Protocol Violation|0|||
27958436|NCT01791517|81680064|FG006|Phase I: Period 1|Protocol Violation|0|||
27958437|NCT01791517|81680065|FG007|Phase I: Period 1|Protocol Violation|0|||
27958438|NCT01791517|81680066|FG008|Phase I: Period 1|Protocol Violation|0|||
27958439|NCT01791517|81680067|FG009|Phase I: Period 1|Protocol Violation|0|||
27958440|NCT01791517|81680068|FG010|Phase I: Period 1|Protocol Violation|0|||
27958441|NCT01791517|81680069|FG011|Phase I: Period 1|Protocol Violation|0|||
27958442|NCT01791517|81680058|FG000|Phase I: Period 1|Lost to Follow-up|0|||
27958443|NCT01791517|81680059|FG001|Phase I: Period 1|Lost to Follow-up|0|||
27958444|NCT01791517|81680060|FG002|Phase I: Period 1|Lost to Follow-up|0|||
27958445|NCT01791517|81680061|FG003|Phase I: Period 1|Lost to Follow-up|1|||
27958446|NCT01791517|81680062|FG004|Phase I: Period 1|Lost to Follow-up|0|||
27958447|NCT01791517|81680063|FG005|Phase I: Period 1|Lost to Follow-up|0|||
27958448|NCT01791517|81680064|FG006|Phase I: Period 1|Lost to Follow-up|1|||
27958449|NCT01791517|81680065|FG007|Phase I: Period 1|Lost to Follow-up|0|||
27958450|NCT01791517|81680066|FG008|Phase I: Period 1|Lost to Follow-up|1|||
27958451|NCT01791517|81680067|FG009|Phase I: Period 1|Lost to Follow-up|1|||
27958452|NCT01791517|81680068|FG010|Phase I: Period 1|Lost to Follow-up|0|||
27958453|NCT01791517|81680069|FG011|Phase I: Period 1|Lost to Follow-up|0|||
27958454|NCT01791517|81680058|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958455|NCT01791517|81680059|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958456|NCT01791517|81680060|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958457|NCT01791517|81680061|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958458|NCT01791517|81680062|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958459|NCT01791517|81680063|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958460|NCT01791517|81680064|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958461|NCT01791517|81680065|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958462|NCT01791517|81680066|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958463|NCT01791517|81680067|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958464|NCT01791517|81680068|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
27958465|NCT01791517|81680069|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
27958466|NCT01791517|81680058|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
27958467|NCT01791517|81680059|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958468|NCT01791517|81680060|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958469|NCT01791517|81680061|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958470|NCT01791517|81680062|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958471|NCT01791517|81680063|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958472|NCT01791517|81680064|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958473|NCT01791517|81680065|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958474|NCT01791517|81680066|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958475|NCT01791517|81680067|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958476|NCT01791517|81680068|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958477|NCT01791517|81680069|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
27958478|NCT01791517|81680058|FG000|Phase I: Period 2|Protocol Violation|0|||
27958479|NCT01791517|81680059|FG001|Phase I: Period 2|Protocol Violation|0|||
27958480|NCT01791517|81680060|FG002|Phase I: Period 2|Protocol Violation|0|||
27958481|NCT01791517|81680061|FG003|Phase I: Period 2|Protocol Violation|1|||
27958482|NCT01791517|81680062|FG004|Phase I: Period 2|Protocol Violation|0|||
27958483|NCT01791517|81680063|FG005|Phase I: Period 2|Protocol Violation|0|||
27958484|NCT01791517|81680064|FG006|Phase I: Period 2|Protocol Violation|0|||
27754781|NCT00077376|80929584|FG000|Overall Study|Physician Decision|1|||
27754782|NCT00077376|80929584|FG000|Overall Study|Alternative therapy|5|||
27754783|NCT00077376|80929584|FG000|Overall Study|Complicating disease|1|||
27754784|NCT00077376|80929584|FG000|Overall Study|Still on treatment|1|||
27754785|NCT00077376|80929584|FG000|Overall Study|Symptomatic deterioration|1|||
27754786|NCT00077376|80929584|FG000|Overall Study|Surgery|1|||
27754787|NCT00077376|80929584|FG000|Overall Study|Insurance ran out|1|||
27754788|NCT01753076|80929585|FG000|Overall Study|Adverse Event|17|||
27754789|NCT01753076|80929586|FG001|Overall Study|Adverse Event|18|||
27754790|NCT01753076|80929585|FG000|Overall Study|Lack of Efficacy|3|||
27754791|NCT01753076|80929586|FG001|Overall Study|Lack of Efficacy|1|||
27754792|NCT01753076|80929585|FG000|Overall Study|Lost to Follow-up|2|||
27754793|NCT01753076|80929586|FG001|Overall Study|Lost to Follow-up|1|||
27754794|NCT01753076|80929585|FG000|Overall Study|Physician Decision|4|||
27754795|NCT01753076|80929586|FG001|Overall Study|Physician Decision|2|||
27754796|NCT01753076|80929585|FG000|Overall Study|Withdrawal by Subject|14|||
27754797|NCT01753076|80929586|FG001|Overall Study|Withdrawal by Subject|24|||
27754798|NCT01753076|80929585|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
27754799|NCT01753076|80929586|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
27754800|NCT01104558|80929587|FG000|Overall Study|Protocol Violation|6|||
27754801|NCT01104558|80929587|FG000|Overall Study|Missing of primary efficacy assessment|10|||
27754926|NCT02065622|80929631|FG001|Maintenance Study|Other, Not Specified|0|||
27754927|NCT02065622|80929632|FG002|Maintenance Study|Other, Not Specified|6|||
27754928|NCT02065622|80929633|FG003|Maintenance Study|Other, Not Specified|14|||
27754929|NCT02065622|80929634|FG004|Maintenance Study|Other, Not Specified|2|||
27754930|NCT02065622|80929630|FG000|Maintenance Study|Unknown Reason|0|||
27754931|NCT02065622|80929631|FG001|Maintenance Study|Unknown Reason|0|||
27754932|NCT02065622|80929632|FG002|Maintenance Study|Unknown Reason|0|||
27754933|NCT02065622|80929633|FG003|Maintenance Study|Unknown Reason|1|||
27754934|NCT02065622|80929634|FG004|Maintenance Study|Unknown Reason|0|||
27754935|NCT02985450|80929635|FG000|Overall Study|Lost to Follow-up|7|||
27754936|NCT00444626|80929636|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
27754937|NCT00444626|80929636|FG000|Initial Treatment Period|Adverse Event|1|||
27754938|NCT00444626|80929636|FG000|Initial Treatment Period|Lost to Follow-up|9|||
27754939|NCT01232894|80929638|FG000|Overall Study|Lost to Follow-up|0|||
27754940|NCT01232894|80929639|FG001|Overall Study|Lost to Follow-up|1|||
27754941|NCT01232894|80929638|FG000|Overall Study|Death|1|||
27754942|NCT01232894|80929639|FG001|Overall Study|Death|0|||
27754943|NCT01232894|80929638|FG000|Overall Study|Protocol Violation|1|||
27754944|NCT01232894|80929639|FG001|Overall Study|Protocol Violation|1|||
27754945|NCT01232894|80929638|FG000|Overall Study|Withdrawal by Subject|8|||
27754946|NCT01232894|80929639|FG001|Overall Study|Withdrawal by Subject|5|||
27754947|NCT01232894|80929638|FG000|Overall Study|Physician Decision|2|||
27754948|NCT01232894|80929639|FG001|Overall Study|Physician Decision|1|||
27754949|NCT03245723|80929640|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
27754950|NCT03245723|80929641|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
27754951|NCT03245723|80929640|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
27754952|NCT03245723|80929641|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
27754953|NCT03245723|80929640|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
27754954|NCT03245723|80929641|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
27754955|NCT03245723|80929640|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
27754956|NCT03245723|80929641|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
27754957|NCT00125190|80929642|FG000|Overall Study|Subject/Parent Decision|7|||
27754958|NCT00125190|80929642|FG000|Overall Study|Non-compliance|2|||
27754959|NCT00125190|80929642|FG000|Overall Study|Adverse Event|1|||
27754960|NCT00125190|80929642|FG000|Overall Study|Other|1|||
27754961|NCT00125190|80929642|FG000|Overall Study|Lost to Follow-up|4|||
27754962|NCT03649321|80929645|FG000|Overall Study|Withdrawal by Subject|1|||
27754963|NCT03649321|80929646|FG001|Overall Study|Withdrawal by Subject|0|||
27754964|NCT03649321|80929645|FG000|Overall Study|Death|1|||
27754965|NCT03649321|80929646|FG001|Overall Study|Death|0|||
27754966|NCT04937816|80929649|FG000|Overall Study|Study drug stopped, reason missing|5|||
27754967|NCT04937816|80929650|FG001|Overall Study|Study drug stopped, reason missing|3|||
27754968|NCT04937816|80929651|FG002|Overall Study|Study drug stopped, reason missing|4|||
27754969|NCT04937816|80929652|FG003|Overall Study|Study drug stopped, reason missing|6|||
27754970|NCT04937816|80929653|FG004|Overall Study|Study drug stopped, reason missing|1|||
27754971|NCT04937816|80929654|FG005|Overall Study|Study drug stopped, reason missing|0|||
27754972|NCT04937816|80929655|FG006|Overall Study|Study drug stopped, reason missing|0|||
27754973|NCT04937816|80929649|FG000|Overall Study|Other than stated below|173|||
27754974|NCT04937816|80929650|FG001|Overall Study|Other than stated below|143|||
27754975|NCT04937816|80929651|FG002|Overall Study|Other than stated below|125|||
27754976|NCT04937816|80929652|FG003|Overall Study|Other than stated below|44|||
27754977|NCT04937816|80929653|FG004|Overall Study|Other than stated below|45|||
27754978|NCT04937816|80929654|FG005|Overall Study|Other than stated below|28|||
27754979|NCT04937816|80929655|FG006|Overall Study|Other than stated below|31|||
27754980|NCT04937816|80929649|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
27754981|NCT04937816|80929650|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
27754982|NCT04937816|80929651|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
27754983|NCT04937816|80929652|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
27754984|NCT04937816|80929653|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
27754985|NCT04937816|80929654|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
27754986|NCT04937816|80929655|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
27754987|NCT04937816|80929649|FG000|Overall Study|Lost to Follow-up|15|||
27754988|NCT04937816|80929650|FG001|Overall Study|Lost to Follow-up|9|||
27754989|NCT04937816|80929651|FG002|Overall Study|Lost to Follow-up|6|||
27754990|NCT04937816|80929652|FG003|Overall Study|Lost to Follow-up|6|||
27754991|NCT04937816|80929653|FG004|Overall Study|Lost to Follow-up|16|||
27754992|NCT04937816|80929654|FG005|Overall Study|Lost to Follow-up|11|||
27754993|NCT04937816|80929655|FG006|Overall Study|Lost to Follow-up|17|||
27754994|NCT04937816|80929649|FG000|Overall Study|Protocol Violation|15|||
27754995|NCT04937816|80929650|FG001|Overall Study|Protocol Violation|15|||
27754996|NCT04937816|80929651|FG002|Overall Study|Protocol Violation|12|||
27754997|NCT04937816|80929652|FG003|Overall Study|Protocol Violation|30|||
27754998|NCT04937816|80929653|FG004|Overall Study|Protocol Violation|24|||
27754999|NCT04937816|80929654|FG005|Overall Study|Protocol Violation|5|||
27755000|NCT04937816|80929655|FG006|Overall Study|Protocol Violation|5|||
27755018|NCT03571256|80929664|FG000|Overall Study|Withdrawal by Subject|3|||
27755019|NCT03571256|80929665|FG001|Overall Study|Withdrawal by Subject|1|||
27755020|NCT03571256|80929666|FG002|Overall Study|Withdrawal by Subject|1|||
27755021|NCT03571256|80929664|FG000|Overall Study|Other than specified|0|||
27755022|NCT03571256|80929665|FG001|Overall Study|Other than specified|1|||
27755023|NCT03571256|80929666|FG002|Overall Study|Other than specified|1|||
27755024|NCT03571256|80929664|FG000|Overall Study|Protocol Violation|0|||
27755025|NCT03571256|80929665|FG001|Overall Study|Protocol Violation|1|||
27755026|NCT03571256|80929666|FG002|Overall Study|Protocol Violation|1|||
27755027|NCT02669862|80929667|FG000|Overall Study|Lost to Follow-up|0|||
27755028|NCT02669862|80929668|FG001|Overall Study|Lost to Follow-up|2|||
27755029|NCT02669862|80929669|FG002|Overall Study|Lost to Follow-up|1|||
27755030|NCT02669862|80929667|FG000|Overall Study|Withdrawal by Subject|2|||
27755031|NCT02669862|80929668|FG001|Overall Study|Withdrawal by Subject|2|||
27755032|NCT02669862|80929669|FG002|Overall Study|Withdrawal by Subject|3|||
27755033|NCT02669862|80929667|FG000|Overall Study|moved|0|||
27755034|NCT02669862|80929668|FG001|Overall Study|moved|1|||
27755035|NCT02669862|80929669|FG002|Overall Study|moved|0|||
27755036|NCT02669862|80929667|FG000|Overall Study|Protocol Violation|0|||
27755037|NCT02669862|80929668|FG001|Overall Study|Protocol Violation|0|||
27755038|NCT02669862|80929669|FG002|Overall Study|Protocol Violation|1|||
27755039|NCT01000727|80929670|FG000|Overall Study|Lost to Follow-up|41|||
27755040|NCT01000727|80929671|FG001|Overall Study|Lost to Follow-up|43|||
27755041|NCT01000727|80929670|FG000|Overall Study|Withdrawal by Subject|111|||
27755042|NCT01000727|80929671|FG001|Overall Study|Withdrawal by Subject|109|||
27755043|NCT01000727|80929670|FG000|Overall Study|Study closed/terminated|23|||
27755044|NCT01000727|80929671|FG001|Overall Study|Study closed/terminated|24|||
27755045|NCT00710034|80929673|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
27755046|NCT00710034|80929674|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
27755047|NCT00710034|80929673|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
27755048|NCT00710034|80929674|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
27755049|NCT00710034|80929673|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
27755050|NCT00710034|80929674|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
27755051|NCT00710034|80929673|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
27755052|NCT00710034|80929674|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
27755053|NCT00710034|80929673|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
27755054|NCT00710034|80929674|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
27755055|NCT00710034|80929673|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
27755056|NCT00710034|80929674|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
27755057|NCT00710034|80929673|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
27755058|NCT00710034|80929674|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
27755059|NCT00710034|80929673|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
27755060|NCT00710034|80929674|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
27755061|NCT00710034|80929673|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
27755062|NCT00710034|80929674|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
27755063|NCT00710034|80929673|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
27755064|NCT00710034|80929674|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
27755065|NCT00710034|80929673|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
27755066|NCT00710034|80929674|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
27755067|NCT00448916|80929681|FG000|Overall Study|Adverse Event|2|||
27755068|NCT00448916|80929682|FG001|Overall Study|Adverse Event|2|||
27755069|NCT00448916|80929683|FG002|Overall Study|Adverse Event|3|||
27755070|NCT00448916|80929684|FG003|Overall Study|Adverse Event|2|||
27755071|NCT00448916|80929681|FG000|Overall Study|Lack of Efficacy|1|||
27755072|NCT00448916|80929682|FG001|Overall Study|Lack of Efficacy|0|||
27755073|NCT00448916|80929683|FG002|Overall Study|Lack of Efficacy|2|||
27755074|NCT00448916|80929684|FG003|Overall Study|Lack of Efficacy|1|||
27755075|NCT00448916|80929681|FG000|Overall Study|Withdrawal by Subject|3|||
27755076|NCT00448916|80929682|FG001|Overall Study|Withdrawal by Subject|3|||
27755077|NCT00448916|80929683|FG002|Overall Study|Withdrawal by Subject|1|||
27755078|NCT00448916|80929684|FG003|Overall Study|Withdrawal by Subject|1|||
27755079|NCT00448916|80929681|FG000|Overall Study|Other|1|||
27755080|NCT00448916|80929682|FG001|Overall Study|Other|0|||
27755081|NCT00448916|80929683|FG002|Overall Study|Other|0|||
27755082|NCT00448916|80929684|FG003|Overall Study|Other|0|||
27755083|NCT00448916|80929681|FG000|Overall Study|Lost to Follow-up|0|||
27755084|NCT00448916|80929682|FG001|Overall Study|Lost to Follow-up|1|||
27755085|NCT00448916|80929683|FG002|Overall Study|Lost to Follow-up|0|||
27755086|NCT00448916|80929684|FG003|Overall Study|Lost to Follow-up|1|||
27755087|NCT00448916|80929681|FG000|Overall Study|Protocol Violation|0|||
27755088|NCT00448916|80929682|FG001|Overall Study|Protocol Violation|0|||
27755089|NCT00448916|80929683|FG002|Overall Study|Protocol Violation|0|||
27755090|NCT00448916|80929684|FG003|Overall Study|Protocol Violation|1|||
27755091|NCT01025817|80929685|FG000|Completed Study Medication|Adverse Event|66|||
27755092|NCT01025817|80929686|FG001|Completed Study Medication|Adverse Event|39|||
27755093|NCT01025817|80929685|FG000|Completed Study Medication|Protocol Deviation|9|||
27755094|NCT01025817|80929686|FG001|Completed Study Medication|Protocol Deviation|8|||
27755095|NCT01025817|80929685|FG000|Completed Study Medication|Withdrawal by Subject|8|||
27755096|NCT01025817|80929686|FG001|Completed Study Medication|Withdrawal by Subject|9|||
27755097|NCT01025817|80929685|FG000|Completed Study Medication|Administrative problems|7|||
27755098|NCT01025817|80929686|FG001|Completed Study Medication|Administrative problems|5|||
27755099|NCT01025817|80929685|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
27755100|NCT01025817|80929686|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
27755101|NCT01025817|80929685|FG000|Completed Study Medication|Abnormal test procedure|4|||
27755102|NCT01025817|80929686|FG001|Completed Study Medication|Abnormal test procedure|0|||
27755103|NCT01025817|80929685|FG000|Completed Study Medication|Graft loss|2|||
27755104|NCT01025817|80929686|FG001|Completed Study Medication|Graft loss|5|||
27755105|NCT01025817|80929685|FG000|Completed Study Medication|Death|2|||
27755106|NCT01025817|80929686|FG001|Completed Study Medication|Death|2|||
27755107|NCT01025817|80929685|FG000|Completed Study Medication|Abnormal lab values|0|||
27755108|NCT01025817|80929686|FG001|Completed Study Medication|Abnormal lab values|2|||
27755109|NCT01025817|80929685|FG000|Completed Study Medication|Subject no longer required study drug|0|||
27755110|NCT01025817|80929686|FG001|Completed Study Medication|Subject no longer required study drug|1|||
27755111|NCT01025817|80929685|FG000|Completed Study Medication|Lost to Follow-up|0|||
27755112|NCT01025817|80929686|FG001|Completed Study Medication|Lost to Follow-up|1|||
27755113|NCT01025817|80929685|FG000|Completed Study|Withdrawal by Subject|8|||
27755114|NCT01025817|80929686|FG001|Completed Study|Withdrawal by Subject|16|||
27755115|NCT01025817|80929685|FG000|Completed Study|Death|6|||
27755116|NCT01025817|80929686|FG001|Completed Study|Death|5|||
27755117|NCT01025817|80929685|FG000|Completed Study|Missing|2|||
27755118|NCT01025817|80929686|FG001|Completed Study|Missing|0|||
27755119|NCT01025817|80929685|FG000|Completed Study|Lost to Follow-up|0|||
27755120|NCT01025817|80929686|FG001|Completed Study|Lost to Follow-up|1|||
27755121|NCT00912015|80929687|FG000|Overall Study|Lack of Efficacy|1|||
27755122|NCT00912015|80929688|FG001|Overall Study|Lack of Efficacy|0|||
27755123|NCT00912015|80929689|FG002|Overall Study|Lack of Efficacy|0|||
27755124|NCT00912015|80929690|FG003|Overall Study|Lack of Efficacy|0|||
27755125|NCT00912015|80929687|FG000|Overall Study|Withdrawal by Subject|8|||
27755126|NCT00912015|80929688|FG001|Overall Study|Withdrawal by Subject|8|||
27755127|NCT00912015|80929689|FG002|Overall Study|Withdrawal by Subject|3|||
27755128|NCT00912015|80929690|FG003|Overall Study|Withdrawal by Subject|0|||
27755129|NCT00912015|80929687|FG000|Overall Study|Protocol Violation|1|||
27755130|NCT00912015|80929688|FG001|Overall Study|Protocol Violation|0|||
27755131|NCT00912015|80929689|FG002|Overall Study|Protocol Violation|0|||
27755132|NCT00912015|80929690|FG003|Overall Study|Protocol Violation|1|||
27755133|NCT00912015|80929687|FG000|Overall Study|Adverse Event|6|||
27755134|NCT00912015|80929688|FG001|Overall Study|Adverse Event|0|||
27755135|NCT00912015|80929689|FG002|Overall Study|Adverse Event|0|||
27755136|NCT00912015|80929690|FG003|Overall Study|Adverse Event|1|||
27755137|NCT01592409|80929691|FG000|Overall Study|Withdrawal by Subject|0|||
27755138|NCT01592409|80929692|FG001|Overall Study|Withdrawal by Subject|1|||
27755139|NCT02841787|80929693|FG000|Overall Study|Lost to Follow-up|1|||
27755140|NCT02841787|80929694|FG001|Overall Study|Lost to Follow-up|0|||
27755141|NCT02841787|80929695|FG002|Overall Study|Lost to Follow-up|0|||
27755142|NCT02841787|80929693|FG000|Overall Study|Symptoms dropped below threshold|1|||
27755143|NCT02841787|80929694|FG001|Overall Study|Symptoms dropped below threshold|0|||
27755144|NCT02841787|80929695|FG002|Overall Study|Symptoms dropped below threshold|0|||
27755145|NCT02841787|80929693|FG000|Overall Study|Withdrawal by Subject|1|||
27755146|NCT02841787|80929694|FG001|Overall Study|Withdrawal by Subject|4|||
27755147|NCT02841787|80929695|FG002|Overall Study|Withdrawal by Subject|0|||
27755148|NCT02622724|80929696|FG000|Overall Study|Death|51|||
27755149|NCT02622724|80929697|FG001|Overall Study|Death|53|||
27755150|NCT02622724|80929696|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
27755151|NCT02622724|80929697|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
27755152|NCT02622724|80929696|FG000|Overall Study|Early termination of study|38|||
27755153|NCT02622724|80929697|FG001|Overall Study|Early termination of study|43|||
27755154|NCT01093755|80929698|FG000|Overall Study|Withdrawal by Subject|3|||
27755155|NCT01093755|80929699|FG001|Overall Study|Withdrawal by Subject|4|||
27755156|NCT01449682|80929702|FG000|Overall Study|Death|0|||
27755157|NCT01449682|80929703|FG001|Overall Study|Death|1|||
27755158|NCT01449682|80929702|FG000|Overall Study|Adverse Event|1|||
27755159|NCT01449682|80929703|FG001|Overall Study|Adverse Event|0|||
27755160|NCT00793819|80929704|FG000|Overall Study|Adverse Event|8|||
27755161|NCT00793819|80929705|FG001|Overall Study|Adverse Event|4|||
27755162|NCT00793819|80929704|FG000|Overall Study|Lack of Efficacy|1|||
27755163|NCT00793819|80929705|FG001|Overall Study|Lack of Efficacy|1|||
27755164|NCT00793819|80929704|FG000|Overall Study|Withdrawal by Subject|4|||
27755165|NCT00793819|80929705|FG001|Overall Study|Withdrawal by Subject|3|||
27755166|NCT00793819|80929704|FG000|Overall Study|Lost to Follow-up|1|||
27755167|NCT00793819|80929705|FG001|Overall Study|Lost to Follow-up|1|||
27755168|NCT01795898|80929706|FG000|Overall Study|Adverse Event|27|||
27755169|NCT01795898|80929706|FG000|Overall Study|Lost to Follow-up|20|||
27755170|NCT01795898|80929706|FG000|Overall Study|Withdrawal of consent|6|||
27755171|NCT01795898|80929706|FG000|Overall Study|Diagnosed with metastasis|1|||
27755172|NCT01795898|80929706|FG000|Overall Study|No pain|1|||
27755173|NCT01795898|80929706|FG000|Overall Study|Death|1|||
27755174|NCT01795898|80929706|FG000|Overall Study|Withdrew consent & had adverse events|3|||
27755175|NCT01795898|80929706|FG000|Overall Study|Physician Decision|1|||
27755176|NCT02953782|80929707|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
27755177|NCT02953782|80929708|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
27755178|NCT02953782|80929709|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
27755179|NCT02953782|80929710|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
27755180|NCT02953782|80929711|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
27755181|NCT02953782|80929712|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
27755182|NCT02953782|80929713|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
27755183|NCT02953782|80929714|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
27755184|NCT02953782|80929707|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
27755185|NCT02953782|80929708|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
27755186|NCT02953782|80929709|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
27755187|NCT02953782|80929710|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
27755188|NCT02953782|80929711|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
27755189|NCT02953782|80929712|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
27755190|NCT02953782|80929713|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
27755191|NCT02953782|80929714|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
27755192|NCT02953782|80929707|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
27755193|NCT02953782|80929708|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
27755194|NCT02953782|80929709|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
27755195|NCT02953782|80929710|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
27755196|NCT02953782|80929711|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
27755197|NCT02953782|80929712|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
27755198|NCT02953782|80929713|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
27755199|NCT02953782|80929714|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
27755200|NCT02953782|80929707|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
27755201|NCT02953782|80929708|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
27755202|NCT02953782|80929709|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
27755203|NCT02953782|80929710|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
27755204|NCT02953782|80929711|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
27755205|NCT02953782|80929712|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
27755206|NCT02953782|80929713|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
27755207|NCT02953782|80929714|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
27755208|NCT02953782|80929707|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
27755209|NCT02953782|80929708|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
27755210|NCT02953782|80929709|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
27755211|NCT02953782|80929710|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
27755212|NCT02953782|80929711|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
27755213|NCT02953782|80929712|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
27755214|NCT02953782|80929713|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
27755215|NCT02953782|80929714|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
27755216|NCT02953782|80929707|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
27755217|NCT02953782|80929708|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
27755218|NCT02953782|80929709|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
27755219|NCT02953782|80929710|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
27755220|NCT02953782|80929711|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
27755221|NCT02953782|80929712|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
27755222|NCT02953782|80929713|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
27755223|NCT02953782|80929714|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
27755224|NCT02953782|80929707|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
27755225|NCT02953782|80929708|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
27755226|NCT02953782|80929709|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
27755227|NCT02953782|80929710|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
27755228|NCT02953782|80929711|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
27755229|NCT02953782|80929712|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
27755230|NCT02953782|80929713|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
27755231|NCT02953782|80929714|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
27755232|NCT02953782|80929707|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755233|NCT02953782|80929708|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755234|NCT02953782|80929709|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755235|NCT02953782|80929710|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755236|NCT02953782|80929711|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755237|NCT02953782|80929712|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755238|NCT02953782|80929713|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
27755239|NCT02953782|80929714|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
27755240|NCT01051986|80929715|FG000|Overall Study|Death|1|||
27755241|NCT01051986|80929716|FG001|Overall Study|Death|0|||
27755242|NCT01051986|80929715|FG000|Overall Study|Withdrawal by Subject|2|||
27755243|NCT01051986|80929716|FG001|Overall Study|Withdrawal by Subject|1|||
27755244|NCT01051986|80929715|FG000|Overall Study|Protocol Violation|2|||
27755245|NCT01051986|80929716|FG001|Overall Study|Protocol Violation|3|||
27755246|NCT02796391|80929717|FG000|Overall Study|Lost to Follow-up|2|||
27755247|NCT02796391|80929718|FG001|Overall Study|Lost to Follow-up|2|||
27755248|NCT02796391|80929719|FG002|Overall Study|Lost to Follow-up|13|||
27755249|NCT02796391|80929720|FG003|Overall Study|Lost to Follow-up|8|||
27755250|NCT02796391|80929721|FG004|Overall Study|Lost to Follow-up|14|||
27755251|NCT02796391|80929722|FG005|Overall Study|Lost to Follow-up|13|||
27755252|NCT02796391|80929717|FG000|Overall Study|COVID|0|||
27755253|NCT02796391|80929718|FG001|Overall Study|COVID|0|||
27755254|NCT02796391|80929719|FG002|Overall Study|COVID|5|||
27755255|NCT02796391|80929720|FG003|Overall Study|COVID|5|||
27755256|NCT02796391|80929721|FG004|Overall Study|COVID|2|||
27755257|NCT02796391|80929722|FG005|Overall Study|COVID|4|||
27755258|NCT02796391|80929717|FG000|Overall Study|Participant did not like study cigarettes|0|||
27755259|NCT02796391|80929718|FG001|Overall Study|Participant did not like study cigarettes|0|||
27755260|NCT02796391|80929719|FG002|Overall Study|Participant did not like study cigarettes|3|||
27755261|NCT02796391|80929720|FG003|Overall Study|Participant did not like study cigarettes|0|||
27755262|NCT02796391|80929721|FG004|Overall Study|Participant did not like study cigarettes|0|||
27755263|NCT02796391|80929722|FG005|Overall Study|Participant did not like study cigarettes|0|||
27755264|NCT02796391|80929717|FG000|Overall Study|Withdrawal by Subject|1|||
27755265|NCT02796391|80929718|FG001|Overall Study|Withdrawal by Subject|1|||
27755266|NCT02796391|80929719|FG002|Overall Study|Withdrawal by Subject|4|||
27755267|NCT02796391|80929720|FG003|Overall Study|Withdrawal by Subject|3|||
27755268|NCT02796391|80929721|FG004|Overall Study|Withdrawal by Subject|4|||
27755269|NCT02796391|80929722|FG005|Overall Study|Withdrawal by Subject|3|||
27755270|NCT02796391|80929717|FG000|Overall Study|Adverse Event|0|||
27755271|NCT02796391|80929718|FG001|Overall Study|Adverse Event|0|||
27755272|NCT02796391|80929719|FG002|Overall Study|Adverse Event|0|||
27755273|NCT02796391|80929720|FG003|Overall Study|Adverse Event|1|||
27755274|NCT02796391|80929721|FG004|Overall Study|Adverse Event|0|||
27755275|NCT02796391|80929722|FG005|Overall Study|Adverse Event|0|||
27755276|NCT02796391|80929717|FG000|Overall Study|Protocol Violation|0|||
27755277|NCT02796391|80929718|FG001|Overall Study|Protocol Violation|0|||
27755278|NCT02796391|80929719|FG002|Overall Study|Protocol Violation|0|||
27755279|NCT02796391|80929720|FG003|Overall Study|Protocol Violation|1|||
27755280|NCT02796391|80929721|FG004|Overall Study|Protocol Violation|0|||
27755281|NCT02796391|80929722|FG005|Overall Study|Protocol Violation|0|||
27755282|NCT02939937|80929726|FG000|Overall Study|Adverse Event|5|||
27755283|NCT02939937|80929727|FG001|Overall Study|Adverse Event|0|||
27755284|NCT02939937|80929726|FG000|Overall Study|Lost to Follow-up|1|||
27755285|NCT02939937|80929727|FG001|Overall Study|Lost to Follow-up|3|||
27755286|NCT03288493|80929732|FG000|Overall Study|Withdrawal by Subject|4|||
27755287|NCT03288493|80929733|FG001|Overall Study|Withdrawal by Subject|0|||
27755288|NCT03288493|80929734|FG002|Overall Study|Withdrawal by Subject|0|||
27755289|NCT03288493|80929735|FG003|Overall Study|Withdrawal by Subject|0|||
27755290|NCT03288493|80929736|FG004|Overall Study|Withdrawal by Subject|0|||
27755291|NCT03288493|80929737|FG005|Overall Study|Withdrawal by Subject|2|||
27755292|NCT03288493|80929738|FG006|Overall Study|Withdrawal by Subject|0|||
27755293|NCT03288493|80929732|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
27755294|NCT03288493|80929733|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
27755295|NCT03288493|80929734|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
27755296|NCT03288493|80929735|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
27755297|NCT03288493|80929736|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
27755298|NCT03288493|80929737|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
27755299|NCT03288493|80929738|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
27755300|NCT03288493|80929732|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
27755301|NCT03288493|80929733|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755302|NCT03288493|80929734|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755303|NCT03288493|80929735|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
27755304|NCT03288493|80929736|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755305|NCT03288493|80929737|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
27755306|NCT03288493|80929738|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
27755307|NCT03288493|80929732|FG000|Overall Study|Death|2|||
27755308|NCT03288493|80929733|FG001|Overall Study|Death|0|||
27755309|NCT03288493|80929734|FG002|Overall Study|Death|0|||
27755310|NCT03288493|80929735|FG003|Overall Study|Death|0|||
27755311|NCT03288493|80929736|FG004|Overall Study|Death|0|||
27755312|NCT03288493|80929737|FG005|Overall Study|Death|0|||
27755313|NCT03288493|80929738|FG006|Overall Study|Death|0|||
27755314|NCT03288493|80929732|FG000|Overall Study|other reason not listed above|2|||
27755315|NCT03288493|80929733|FG001|Overall Study|other reason not listed above|0|||
27755316|NCT03288493|80929734|FG002|Overall Study|other reason not listed above|0|||
27755317|NCT03288493|80929735|FG003|Overall Study|other reason not listed above|0|||
27755318|NCT03288493|80929736|FG004|Overall Study|other reason not listed above|0|||
27755319|NCT03288493|80929737|FG005|Overall Study|other reason not listed above|0|||
27755320|NCT03288493|80929738|FG006|Overall Study|other reason not listed above|0|||
27755321|NCT02045212|80929742|FG000|Overall Study|Adverse Event|0|||
27755322|NCT02045212|80929743|FG001|Overall Study|Adverse Event|1|||
27755323|NCT02045212|80929742|FG000|Overall Study|Withdrawal by Subject|1|||
27755324|NCT02045212|80929743|FG001|Overall Study|Withdrawal by Subject|0|||
27755325|NCT02045212|80929742|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
27755326|NCT02045212|80929743|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
27755327|NCT01324622|80929744|FG000|Overall Study|Lost to Follow-up|7|||
27755328|NCT01324622|80929745|FG001|Overall Study|Lost to Follow-up|7|||
27755329|NCT01324622|80929744|FG000|Overall Study|Death|1|||
27755330|NCT01324622|80929745|FG001|Overall Study|Death|0|||
27755331|NCT01324622|80929744|FG000|Overall Study|Lack of Efficacy|1|||
27755332|NCT01324622|80929745|FG001|Overall Study|Lack of Efficacy|0|||
27958485|NCT01791517|81680065|FG007|Phase I: Period 2|Protocol Violation|0|||
27958486|NCT01791517|81680066|FG008|Phase I: Period 2|Protocol Violation|0|||
27958487|NCT01791517|81680067|FG009|Phase I: Period 2|Protocol Violation|0|||
27958488|NCT01791517|81680068|FG010|Phase I: Period 2|Protocol Violation|0|||
27958489|NCT01791517|81680069|FG011|Phase I: Period 2|Protocol Violation|0|||
27958490|NCT01791517|81680058|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
27958491|NCT01791517|81680059|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
27958492|NCT01791517|81680060|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
27958493|NCT01791517|81680061|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
27958494|NCT01791517|81680062|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
27958495|NCT01791517|81680063|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
27958496|NCT01791517|81680064|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
27958497|NCT01791517|81680065|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
27958498|NCT01791517|81680066|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
27958499|NCT01791517|81680067|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
27958500|NCT01791517|81680068|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
27958501|NCT01791517|81680069|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
27958502|NCT01791517|81680058|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958503|NCT01791517|81680059|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958504|NCT01791517|81680060|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958505|NCT01791517|81680061|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958506|NCT01791517|81680062|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958507|NCT01791517|81680063|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958508|NCT01791517|81680064|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958509|NCT01791517|81680065|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958510|NCT01791517|81680066|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958511|NCT01791517|81680067|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958512|NCT01791517|81680068|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
27958513|NCT01791517|81680069|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
27958514|NCT01791517|81680058|FG000|Phase I: Period 2|Lens Discomfort|0|||
27958515|NCT01791517|81680059|FG001|Phase I: Period 2|Lens Discomfort|0|||
27958516|NCT01791517|81680060|FG002|Phase I: Period 2|Lens Discomfort|0|||
27958517|NCT01791517|81680061|FG003|Phase I: Period 2|Lens Discomfort|0|||
27958518|NCT01791517|81680062|FG004|Phase I: Period 2|Lens Discomfort|0|||
27958519|NCT01791517|81680063|FG005|Phase I: Period 2|Lens Discomfort|1|||
27958520|NCT01791517|81680064|FG006|Phase I: Period 2|Lens Discomfort|0|||
27958521|NCT01791517|81680065|FG007|Phase I: Period 2|Lens Discomfort|0|||
27958522|NCT01791517|81680066|FG008|Phase I: Period 2|Lens Discomfort|0|||
27958523|NCT01791517|81680067|FG009|Phase I: Period 2|Lens Discomfort|0|||
27958524|NCT01791517|81680068|FG010|Phase I: Period 2|Lens Discomfort|0|||
27958525|NCT01791517|81680069|FG011|Phase I: Period 2|Lens Discomfort|0|||
27958526|NCT01791517|81680058|FG000|Phase I: Period 2|Lost to Follow-up|0|||
27958527|NCT01791517|81680059|FG001|Phase I: Period 2|Lost to Follow-up|3|||
27958528|NCT01791517|81680060|FG002|Phase I: Period 2|Lost to Follow-up|2|||
27958692|NCT01023217|81683046|FG000|Overall Study|Withdrawal by Subject|1|||
27958693|NCT01023217|81683047|FG001|Overall Study|Withdrawal by Subject|0|||
27958694|NCT03306433|81683048|FG000|Overall Study|Lost to Follow-up|3|||
27958695|NCT03306433|81683048|FG000|Overall Study|Patient did not have teeth extracted|1|||
27958696|NCT03306433|81683048|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
27958697|NCT02382991|81683054|FG000|Overall Study|Adverse Event|1|||
27958698|NCT02382991|81683055|FG001|Overall Study|Adverse Event|2|||
27958699|NCT02382991|81683054|FG000|Overall Study|Lost to Follow-up|1|||
27958700|NCT02382991|81683055|FG001|Overall Study|Lost to Follow-up|0|||
27958701|NCT02382991|81683054|FG000|Overall Study|Withdrawal by Subject|0|||
27958702|NCT02382991|81683055|FG001|Overall Study|Withdrawal by Subject|1|||
27958703|NCT01694433|81683056|FG000|Overall Study|Adverse Event|7|||
27958704|NCT01694433|81683057|FG001|Overall Study|Adverse Event|0|||
27958705|NCT01694433|81683056|FG000|Overall Study|Physician Decision|1|||
27958706|NCT01694433|81683057|FG001|Overall Study|Physician Decision|0|||
27958707|NCT01694433|81683056|FG000|Overall Study|Withdrawal by Subject|3|||
27958708|NCT01694433|81683057|FG001|Overall Study|Withdrawal by Subject|4|||
27958709|NCT00912782|81683058|FG000|Overall Study|Death|2|||
27958710|NCT00912782|81683059|FG001|Overall Study|Death|1|||
27958711|NCT00912782|81683058|FG000|Overall Study|Lost to Follow-up|0|||
27958712|NCT00912782|81683059|FG001|Overall Study|Lost to Follow-up|1|||
27958713|NCT00912782|81683058|FG000|Overall Study|Did not receive vascular access type|1|||
27958714|NCT00912782|81683059|FG001|Overall Study|Did not receive vascular access type|2|||
27958715|NCT00912782|81683058|FG000|Overall Study|Relocated before study completion|0|||
27958716|NCT00912782|81683059|FG001|Overall Study|Relocated before study completion|1|||
27958717|NCT01977898|81683060|FG000|Overall Study|Non functioning catheter|1|||
27958718|NCT01977898|81683061|FG001|Overall Study|Non functioning catheter|1|||
27958719|NCT02776683|81683062|FG000|Pre-switch Period|Protocol Violation|1|||
27958720|NCT02776683|81683063|FG001|Pre-switch Period|Protocol Violation|0|||
27958721|NCT02776683|81683062|FG000|Pre-switch Period|Adverse Event|21|||
27958722|NCT02776683|81683063|FG001|Pre-switch Period|Adverse Event|0|||
27958723|NCT02776683|81683062|FG000|Pre-switch Period|Withdrawal by Subject|9|||
27958724|NCT02776683|81683063|FG001|Pre-switch Period|Withdrawal by Subject|0|||
27958725|NCT02776683|81683062|FG000|Pre-switch Period|Physician Decision|7|||
27958726|NCT02776683|81683063|FG001|Pre-switch Period|Physician Decision|0|||
27958727|NCT02776683|81683062|FG000|Pre-switch Period|Progressive disease|39|||
27958728|NCT02776683|81683063|FG001|Pre-switch Period|Progressive disease|0|||
27958729|NCT02776683|81683062|FG000|Pre-switch Period|Other than listed|3|||
27958730|NCT02776683|81683063|FG001|Pre-switch Period|Other than listed|0|||
27958731|NCT02776683|81683062|FG000|Post-switch Period|Adverse Event|0|||
27958732|NCT02776683|81683063|FG001|Post-switch Period|Adverse Event|3|||
27958733|NCT02776683|81683062|FG000|Post-switch Period|Withdrawal by Subject|0|||
27958734|NCT02776683|81683063|FG001|Post-switch Period|Withdrawal by Subject|2|||
27958735|NCT02776683|81683062|FG000|Post-switch Period|Physician Decision|0|||
27958736|NCT02776683|81683063|FG001|Post-switch Period|Physician Decision|3|||
27958737|NCT02776683|81683062|FG000|Post-switch Period|Progressive disease|0|||
27958738|NCT02776683|81683063|FG001|Post-switch Period|Progressive disease|20|||
27958739|NCT02776683|81683062|FG000|Post-switch Period|Other than listed|0|||
27958740|NCT02776683|81683063|FG001|Post-switch Period|Other than listed|15|||
27958741|NCT01595529|81683069|FG000|Overall Study|Adverse Event|2|||
27958742|NCT01595529|81683070|FG001|Overall Study|Adverse Event|0|||
27958743|NCT01595529|81683069|FG000|Overall Study|Subject Non-Compliant|2|||
27958744|NCT01595529|81683070|FG001|Overall Study|Subject Non-Compliant|0|||
27958745|NCT01595529|81683069|FG000|Overall Study|Lost to Follow-up|8|||
27958746|NCT01595529|81683070|FG001|Overall Study|Lost to Follow-up|14|||
27958747|NCT01595529|81683069|FG000|Overall Study|Protocol Violation|1|||
27958748|NCT01595529|81683070|FG001|Overall Study|Protocol Violation|2|||
27958749|NCT01595529|81683069|FG000|Overall Study|Physician Decision|1|||
27958750|NCT01595529|81683070|FG001|Overall Study|Physician Decision|0|||
27958751|NCT01595529|81683069|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
27958752|NCT01595529|81683070|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
27958753|NCT01595529|81683069|FG000|Overall Study|Administrative Decision|1|||
27958754|NCT01595529|81683070|FG001|Overall Study|Administrative Decision|0|||
27958755|NCT01595529|81683069|FG000|Overall Study|Entry Failure/Screening Failure|6|||
27958756|NCT01595529|81683070|FG001|Overall Study|Entry Failure/Screening Failure|1|||
27958757|NCT02549989|81683075|FG000|Overall Study|Adverse Event|4|||
27958758|NCT02549989|81683075|FG000|Overall Study|Death|1|||
27958759|NCT02549989|81683075|FG000|Overall Study|Lack of Efficacy|19|||
27958760|NCT02549989|81683075|FG000|Overall Study|Withdrawal by Subject|3|||
27958761|NCT00466947|81683076|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
27958762|NCT00466947|81683077|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
27958763|NCT00466947|81683076|FG000|Study End Analysis Period|Adverse Event|35|||
27958764|NCT00466947|81683077|FG001|Study End Analysis Period|Adverse Event|43|||
27958765|NCT00466947|81683076|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
27958766|NCT00466947|81683077|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
27958767|NCT00466947|81683076|FG000|Study End Analysis Period|Physician Decision|29|||
27958768|NCT00466947|81683077|FG001|Study End Analysis Period|Physician Decision|29|||
27958769|NCT00466947|81683076|FG000|Study End Analysis Period|Protocol Violation|9|||
27958770|NCT00466947|81683077|FG001|Study End Analysis Period|Protocol Violation|17|||
27958771|NCT00466947|81683076|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
27958772|NCT00466947|81683077|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
27958773|NCT00466947|81683076|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
27958774|NCT00466947|81683077|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
27958775|NCT00466947|81683076|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
27958776|NCT00466947|81683077|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
27958777|NCT00466947|81683076|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
27958778|NCT00466947|81683077|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
27958779|NCT01119443|81683078|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
27958780|NCT01119443|81683079|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
27958781|NCT03135431|81683080|FG000|Overall Study|Study Surgeon not available|2|||
27958782|NCT03135431|81683081|FG001|Overall Study|Study Surgeon not available|0|||
27958783|NCT00790582|81683084|FG000|Overall Study|Death|14|||
27958784|NCT00790582|81683085|FG001|Overall Study|Death|32|||
27958785|NCT00790582|81683084|FG000|Overall Study|Physician Decision|7|||
27958786|NCT00790582|81683085|FG001|Overall Study|Physician Decision|1|||
27958787|NCT00790582|81683084|FG000|Overall Study|Lost to Follow-up|3|||
27958788|NCT00790582|81683085|FG001|Overall Study|Lost to Follow-up|3|||
27958789|NCT00790582|81683084|FG000|Overall Study|Withdrawal by Subject|7|||
27958790|NCT00790582|81683085|FG001|Overall Study|Withdrawal by Subject|51|||
27958791|NCT01042158|81683087|FG000|Overall Study|Physician Decision|1|||
27958792|NCT02948582|81683097|FG000|Washout Period 1|Adverse Event|0|||
27958793|NCT02948582|81683098|FG001|Washout Period 1|Adverse Event|2|||
27958794|NCT02948582|81683099|FG002|Washout Period 1|Adverse Event|0|||
27958795|NCT02948582|81683100|FG003|Washout Period 1|Adverse Event|0|||
27958796|NCT02948582|81683101|FG004|Washout Period 1|Adverse Event|0|||
27958797|NCT02948582|81683102|FG005|Washout Period 1|Adverse Event|0|||
27958798|NCT02948582|81683097|FG000|Washout Period 1|Protocol Violation|0|||
27958799|NCT02948582|81683098|FG001|Washout Period 1|Protocol Violation|0|||
27958800|NCT02948582|81683099|FG002|Washout Period 1|Protocol Violation|0|||
27958801|NCT02948582|81683100|FG003|Washout Period 1|Protocol Violation|0|||
27958802|NCT02948582|81683101|FG004|Washout Period 1|Protocol Violation|0|||
27958803|NCT02948582|81683102|FG005|Washout Period 1|Protocol Violation|1|||
27958804|NCT02948582|81683097|FG000|Washout Period 2|Adverse Event|0|||
27958805|NCT02948582|81683098|FG001|Washout Period 2|Adverse Event|1|||
27958806|NCT02948582|81683099|FG002|Washout Period 2|Adverse Event|0|||
27958807|NCT02948582|81683100|FG003|Washout Period 2|Adverse Event|0|||
27958808|NCT02948582|81683101|FG004|Washout Period 2|Adverse Event|0|||
27958809|NCT02948582|81683102|FG005|Washout Period 2|Adverse Event|0|||
27958810|NCT02948582|81683097|FG000|Washout Period 2|personal reasons|0|||
27958811|NCT02948582|81683098|FG001|Washout Period 2|personal reasons|0|||
27958812|NCT02948582|81683099|FG002|Washout Period 2|personal reasons|0|||
27958813|NCT02948582|81683100|FG003|Washout Period 2|personal reasons|1|||
27958814|NCT02948582|81683101|FG004|Washout Period 2|personal reasons|0|||
27958815|NCT02948582|81683102|FG005|Washout Period 2|personal reasons|0|||
27958816|NCT02948582|81683097|FG000|Washout Period 4|Adverse Event|1|||
27958817|NCT02948582|81683098|FG001|Washout Period 4|Adverse Event|0|||
27958818|NCT02948582|81683099|FG002|Washout Period 4|Adverse Event|1|||
27958819|NCT02948582|81683100|FG003|Washout Period 4|Adverse Event|0|||
27958820|NCT02948582|81683101|FG004|Washout Period 4|Adverse Event|0|||
27958821|NCT02948582|81683102|FG005|Washout Period 4|Adverse Event|0|||
27958822|NCT00540592|81683103|FG000|Overall Study|Adverse Event|0|||
27958823|NCT00540592|81683104|FG001|Overall Study|Adverse Event|1|||
27958824|NCT00540592|81683105|FG002|Overall Study|Adverse Event|0|||
27958825|NCT00540592|81683106|FG003|Overall Study|Adverse Event|0|||
27958826|NCT00540592|81683107|FG004|Overall Study|Adverse Event|1|||
27958827|NCT00540592|81683108|FG005|Overall Study|Adverse Event|0|||
27958828|NCT00540592|81683109|FG006|Overall Study|Adverse Event|0|||
27958829|NCT00540592|81683110|FG007|Overall Study|Adverse Event|1|||
27958830|NCT00540592|81683111|FG008|Overall Study|Adverse Event|1|||
27958831|NCT00540592|81683112|FG009|Overall Study|Adverse Event|2|||
27958832|NCT00540592|81683103|FG000|Overall Study|Lost to Follow-up|2|||
27958833|NCT00540592|81683104|FG001|Overall Study|Lost to Follow-up|0|||
27958834|NCT00540592|81683105|FG002|Overall Study|Lost to Follow-up|0|||
27958835|NCT00540592|81683106|FG003|Overall Study|Lost to Follow-up|0|||
27958836|NCT00540592|81683107|FG004|Overall Study|Lost to Follow-up|0|||
27958837|NCT00540592|81683108|FG005|Overall Study|Lost to Follow-up|0|||
27958838|NCT00540592|81683109|FG006|Overall Study|Lost to Follow-up|0|||
27958839|NCT00540592|81683110|FG007|Overall Study|Lost to Follow-up|0|||
27958840|NCT00540592|81683111|FG008|Overall Study|Lost to Follow-up|0|||
27958841|NCT00540592|81683112|FG009|Overall Study|Lost to Follow-up|0|||
27958842|NCT00540592|81683103|FG000|Overall Study|Withdrawal by Subject|0|||
27958843|NCT00540592|81683104|FG001|Overall Study|Withdrawal by Subject|0|||
27958844|NCT00540592|81683105|FG002|Overall Study|Withdrawal by Subject|1|||
27958845|NCT00540592|81683106|FG003|Overall Study|Withdrawal by Subject|1|||
27958846|NCT00540592|81683107|FG004|Overall Study|Withdrawal by Subject|0|||
27958847|NCT00540592|81683108|FG005|Overall Study|Withdrawal by Subject|0|||
27958848|NCT00540592|81683109|FG006|Overall Study|Withdrawal by Subject|0|||
27958849|NCT00540592|81683110|FG007|Overall Study|Withdrawal by Subject|0|||
27958850|NCT00540592|81683111|FG008|Overall Study|Withdrawal by Subject|0|||
27958851|NCT00540592|81683112|FG009|Overall Study|Withdrawal by Subject|0|||
27958852|NCT01354223|81683113|FG000|Overall Study|Withdrawal by Subject|3|||
27958853|NCT01354223|81683114|FG001|Overall Study|Withdrawal by Subject|1|||
27958854|NCT03599518|81683115|FG000|Overall Study|Clinical progression|0|||
27958855|NCT03599518|81683116|FG001|Overall Study|Clinical progression|0|||
27958856|NCT03599518|81683117|FG002|Overall Study|Clinical progression|0|||
27958857|NCT03599518|81683118|FG003|Overall Study|Clinical progression|0|||
27958858|NCT03599518|81683119|FG004|Overall Study|Clinical progression|1|||
27958859|NCT03599518|81683115|FG000|Overall Study|Adverse Event|0|||
27958860|NCT03599518|81683116|FG001|Overall Study|Adverse Event|0|||
27958861|NCT03599518|81683117|FG002|Overall Study|Adverse Event|0|||
27958862|NCT03599518|81683118|FG003|Overall Study|Adverse Event|0|||
27958863|NCT03599518|81683119|FG004|Overall Study|Adverse Event|1|||
27958864|NCT03599518|81683115|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
27958865|NCT03599518|81683116|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
27958866|NCT03599518|81683117|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
27958867|NCT03599518|81683118|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
27958868|NCT03599518|81683119|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
27958869|NCT03599518|81683115|FG000|Overall Study|Participant withdrawal from study treatment|0|||
27958870|NCT03599518|81683116|FG001|Overall Study|Participant withdrawal from study treatment|0|||
27958871|NCT03599518|81683117|FG002|Overall Study|Participant withdrawal from study treatment|1|||
27958872|NCT03599518|81683118|FG003|Overall Study|Participant withdrawal from study treatment|0|||
27958873|NCT03599518|81683119|FG004|Overall Study|Participant withdrawal from study treatment|0|||
27958874|NCT00925002|81683123|FG000|Overall Study|Other|1|||
27958875|NCT00925002|81683124|FG001|Overall Study|Other|4|||
27958876|NCT00925002|81683125|FG002|Overall Study|Other|0|||
27958877|NCT00925002|81683123|FG000|Overall Study|Death|1|||
27958878|NCT00925002|81683124|FG001|Overall Study|Death|1|||
27958879|NCT00925002|81683125|FG002|Overall Study|Death|5|||
27958880|NCT00925002|81683123|FG000|Overall Study|Adverse Event|3|||
27958881|NCT00925002|81683124|FG001|Overall Study|Adverse Event|1|||
27958882|NCT00925002|81683125|FG002|Overall Study|Adverse Event|2|||
27958883|NCT00925002|81683123|FG000|Overall Study|Participant withdrew consent|1|||
27958884|NCT00925002|81683124|FG001|Overall Study|Participant withdrew consent|3|||
27958885|NCT00925002|81683125|FG002|Overall Study|Participant withdrew consent|3|||
27958886|NCT03768089|81683126|FG000|Part A|Lost to Follow-up|0|||
27958887|NCT03768089|81683127|FG001|Part A|Lost to Follow-up|0|||
27958888|NCT03768089|81683128|FG002|Part A|Lost to Follow-up|0|||
27958889|NCT03768089|81683129|FG003|Part A|Lost to Follow-up|0|||
27958890|NCT03768089|81683130|FG004|Part A|Lost to Follow-up|1|||
27958891|NCT03768089|81683131|FG005|Part A|Lost to Follow-up|0|||
27958892|NCT03768089|81683132|FG006|Part A|Lost to Follow-up|0|||
27958893|NCT03768089|81683133|FG007|Part A|Lost to Follow-up|0|||
27958894|NCT03768089|81683134|FG008|Part A|Lost to Follow-up|0|||
27958895|NCT03768089|81683135|FG009|Part A|Lost to Follow-up|0|||
27958896|NCT03768089|81683136|FG010|Part A|Lost to Follow-up|0|||
27958897|NCT03768089|81683137|FG011|Part A|Lost to Follow-up|0|||
27958898|NCT03768089|81683138|FG012|Part A|Lost to Follow-up|0|||
27958899|NCT03768089|81683139|FG013|Part A|Lost to Follow-up|0|||
27958900|NCT03768089|81683140|FG014|Part A|Lost to Follow-up|0|||
27958901|NCT03768089|81683141|FG015|Part A|Lost to Follow-up|0|||
27958902|NCT03768089|81683142|FG016|Part A|Lost to Follow-up|0|||
27958903|NCT03768089|81683143|FG017|Part A|Lost to Follow-up|0|||
27958904|NCT03768089|81683126|FG000|Part C|Randomized, Never Dosed|0|||
27958905|NCT03768089|81683127|FG001|Part C|Randomized, Never Dosed|0|||
27958906|NCT03768089|81683128|FG002|Part C|Randomized, Never Dosed|0|||
27958907|NCT03768089|81683129|FG003|Part C|Randomized, Never Dosed|0|||
27958908|NCT03768089|81683130|FG004|Part C|Randomized, Never Dosed|0|||
27958909|NCT03768089|81683131|FG005|Part C|Randomized, Never Dosed|0|||
27958910|NCT03768089|81683132|FG006|Part C|Randomized, Never Dosed|0|||
27958911|NCT03768089|81683133|FG007|Part C|Randomized, Never Dosed|0|||
27958912|NCT03768089|81683134|FG008|Part C|Randomized, Never Dosed|0|||
27958913|NCT03768089|81683135|FG009|Part C|Randomized, Never Dosed|0|||
27958914|NCT03768089|81683136|FG010|Part C|Randomized, Never Dosed|0|||
27958915|NCT03768089|81683137|FG011|Part C|Randomized, Never Dosed|0|||
27958916|NCT03768089|81683138|FG012|Part C|Randomized, Never Dosed|0|||
27958917|NCT03768089|81683139|FG013|Part C|Randomized, Never Dosed|0|||
27958918|NCT03768089|81683140|FG014|Part C|Randomized, Never Dosed|1|||
27958919|NCT03768089|81683141|FG015|Part C|Randomized, Never Dosed|0|||
27958920|NCT03768089|81683142|FG016|Part C|Randomized, Never Dosed|0|||
27958921|NCT03768089|81683143|FG017|Part C|Randomized, Never Dosed|0|||
27958922|NCT00886769|81683145|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
27958923|NCT00886769|81683146|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
27958924|NCT00375427|81683147|FG000|Overall Study|Adverse Event|21|||
27958925|NCT00375427|81683148|FG001|Overall Study|Adverse Event|27|||
27958926|NCT00375427|81683147|FG000|Overall Study|Abnormal test procedure result(s)|0|||
27958927|NCT00375427|81683148|FG001|Overall Study|Abnormal test procedure result(s)|1|||
27958928|NCT00375427|81683147|FG000|Overall Study|Abnormal laboratory value(s)|1|||
27958929|NCT00375427|81683148|FG001|Overall Study|Abnormal laboratory value(s)|2|||
27958930|NCT00375427|81683147|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
27958931|NCT00375427|81683148|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
27958932|NCT00375427|81683147|FG000|Overall Study|Patient no longer requires study drug|3|||
27958933|NCT00375427|81683148|FG001|Overall Study|Patient no longer requires study drug|7|||
27958934|NCT00375427|81683147|FG000|Overall Study|Protocol Violation|10|||
27958935|NCT00375427|81683148|FG001|Overall Study|Protocol Violation|8|||
27958936|NCT00375427|81683147|FG000|Overall Study|Withdrawal by Subject|9|||
27958937|NCT00375427|81683148|FG001|Overall Study|Withdrawal by Subject|13|||
27958938|NCT00375427|81683147|FG000|Overall Study|Lost to Follow-up|1|||
27958939|NCT00375427|81683148|FG001|Overall Study|Lost to Follow-up|1|||
27958940|NCT00375427|81683147|FG000|Overall Study|Administrative reasons|0|||
27958941|NCT00375427|81683148|FG001|Overall Study|Administrative reasons|1|||
27958942|NCT00375427|81683147|FG000|Overall Study|Death|11|||
27958943|NCT00375427|81683148|FG001|Overall Study|Death|10|||
27958944|NCT02122146|81683149|FG000|Part 1: Dose Escalation|Death|0|||
27958945|NCT02122146|81683150|FG001|Part 1: Dose Escalation|Death|1|||
27958946|NCT02122146|81683151|FG002|Part 1: Dose Escalation|Death|1|||
27958947|NCT02122146|81683152|FG003|Part 1: Dose Escalation|Death|0|||
27958948|NCT02122146|81683153|FG004|Part 1: Dose Escalation|Death|0|||
27958949|NCT02122146|81683154|FG005|Part 1: Dose Escalation|Death|0|||
27958950|NCT02122146|81683155|FG006|Part 1: Dose Escalation|Death|0|||
27958951|NCT02122146|81683156|FG007|Part 1: Dose Escalation|Death|0|||
27958952|NCT02122146|81683149|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
27958953|NCT02122146|81683150|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
27958954|NCT02122146|81683151|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
27958955|NCT02122146|81683152|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
27958956|NCT02122146|81683153|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
27958957|NCT02122146|81683154|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
27958958|NCT02122146|81683155|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
27958959|NCT02122146|81683156|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
27958960|NCT02122146|81683149|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958961|NCT02122146|81683150|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958962|NCT02122146|81683151|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958963|NCT02122146|81683152|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
27958964|NCT02122146|81683153|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958965|NCT02122146|81683154|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958966|NCT02122146|81683155|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958967|NCT02122146|81683156|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
27958968|NCT02122146|81683149|FG000|Part 1: Dose Escalation|Other|1|||
27958969|NCT02122146|81683150|FG001|Part 1: Dose Escalation|Other|0|||
27958970|NCT02122146|81683151|FG002|Part 1: Dose Escalation|Other|0|||
27958971|NCT02122146|81683152|FG003|Part 1: Dose Escalation|Other|0|||
27958972|NCT02122146|81683153|FG004|Part 1: Dose Escalation|Other|0|||
27958973|NCT02122146|81683154|FG005|Part 1: Dose Escalation|Other|1|||
27958974|NCT02122146|81683155|FG006|Part 1: Dose Escalation|Other|1|||
27958975|NCT02122146|81683156|FG007|Part 1: Dose Escalation|Other|2|||
27958976|NCT03554018|81683157|FG000|Overall Study|Lost to Follow-up|3|||
27958977|NCT03554018|81683158|FG001|Overall Study|Lost to Follow-up|7|||
27958978|NCT02625220|81683159|FG000|Overall Study|Adverse Event|2|||
27958979|NCT02625220|81683159|FG000|Overall Study|Lost to Follow-up|2|||
27958980|NCT02625220|81683159|FG000|Overall Study|Protocol Violation|1|||
27958981|NCT02625220|81683159|FG000|Overall Study|Study discontinued at site|2|||
27958982|NCT00003631|81683160|FG000|Overall Study|Patient not treated|1|||
27958983|NCT00003631|81683161|FG001|Overall Study|Patient not treated|0|||
27958984|NCT00003631|81683162|FG002|Overall Study|Patient not treated|1|||
27958985|NCT00003631|81683160|FG000|Overall Study|Protocol Violation|1|||
27958986|NCT00003631|81683161|FG001|Overall Study|Protocol Violation|0|||
27958987|NCT00003631|81683162|FG002|Overall Study|Protocol Violation|0|||
27958988|NCT00003631|81683160|FG000|Overall Study|Adverse Event|1|||
27958989|NCT00003631|81683161|FG001|Overall Study|Adverse Event|1|||
27958990|NCT00003631|81683162|FG002|Overall Study|Adverse Event|5|||
27958991|NCT00003631|81683160|FG000|Overall Study|Death|0|||
27958992|NCT00003631|81683161|FG001|Overall Study|Death|0|||
27958993|NCT00003631|81683162|FG002|Overall Study|Death|1|||
27958994|NCT00003631|81683160|FG000|Overall Study|Evaluable for toxicity only|0|||
27958995|NCT00003631|81683161|FG001|Overall Study|Evaluable for toxicity only|0|||
27958996|NCT00003631|81683162|FG002|Overall Study|Evaluable for toxicity only|2|||
27958997|NCT00972023|81683163|FG000|Overall Study|Withdrawal by Subject|1|||
27958998|NCT01485796|81683169|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
27958999|NCT01485796|81683169|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
27959001|NCT01485796|81683169|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
27959002|NCT01485796|81683169|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
27959003|NCT01485796|81683169|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
27959004|NCT01485796|81683169|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
27959005|NCT01485796|81683169|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
27959006|NCT00763256|81683170|FG000|Overall Study|Didn't return for appointments|7|||
27959007|NCT00763256|81683171|FG001|Overall Study|Didn't return for appointments|10|||
27959008|NCT00049322|81683172|FG000|Overall Study|disease burden|0|||
27959009|NCT00049322|81683173|FG001|Overall Study|disease burden|3|||
27959010|NCT00049322|81683172|FG000|Overall Study|Adverse Event|1|||
27959011|NCT00049322|81683173|FG001|Overall Study|Adverse Event|0|||
27959012|NCT00049322|81683172|FG000|Overall Study|refused angio|0|||
27959013|NCT00049322|81683173|FG001|Overall Study|refused angio|3|||
27959014|NCT03462758|81683175|FG000|Overall Study|Chose no or other method of contraception|20|||
27959015|NCT03462758|81683176|FG001|Overall Study|Chose no or other method of contraception|23|||
27959016|NCT03462758|81683175|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
27959017|NCT03462758|81683176|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
27959018|NCT03462758|81683175|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
27959019|NCT03462758|81683176|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
27959020|NCT03462758|81683175|FG000|Overall Study|Medical contraindication|2|||
27959021|NCT03462758|81683176|FG001|Overall Study|Medical contraindication|2|||
27959022|NCT03462758|81683175|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
27959023|NCT03462758|81683176|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
27959024|NCT00470262|81683178|FG000|Overall Study|Withdrawal by Subject|2|||
27959025|NCT00470262|81683179|FG001|Overall Study|Withdrawal by Subject|0|||
27959026|NCT02015481|81683180|FG000|Overall Study|Death|1|||
27959027|NCT02707965|81683181|FG000|Overall Study|Withdrawal by Subject|0|||
27959028|NCT02707965|81683182|FG001|Overall Study|Withdrawal by Subject|0|||
27959029|NCT02707965|81683183|FG002|Overall Study|Withdrawal by Subject|1|||
27959030|NCT02707965|81683184|FG003|Overall Study|Withdrawal by Subject|0|||
27959031|NCT02707965|81683185|FG004|Overall Study|Withdrawal by Subject|0|||
27959032|NCT02707965|81683186|FG005|Overall Study|Withdrawal by Subject|0|||
27959033|NCT02707965|81683187|FG006|Overall Study|Withdrawal by Subject|0|||
27959034|NCT02707965|81683188|FG007|Overall Study|Withdrawal by Subject|2|||
27959035|NCT02707965|81683189|FG008|Overall Study|Withdrawal by Subject|0|||
27959036|NCT02707965|81683190|FG009|Overall Study|Withdrawal by Subject|0|||
27959037|NCT02707965|81683191|FG010|Overall Study|Withdrawal by Subject|0|||
27959038|NCT02707965|81683192|FG011|Overall Study|Withdrawal by Subject|0|||
27959039|NCT02707965|81683193|FG012|Overall Study|Withdrawal by Subject|0|||
27959040|NCT02707965|81683194|FG013|Overall Study|Withdrawal by Subject|0|||
27959041|NCT02707965|81683195|FG014|Overall Study|Withdrawal by Subject|0|||
27959042|NCT02707965|81683196|FG015|Overall Study|Withdrawal by Subject|0|||
27959043|NCT02707965|81683181|FG000|Overall Study|PI decisions|0|||
27959044|NCT02707965|81683182|FG001|Overall Study|PI decisions|0|||
27959045|NCT02707965|81683183|FG002|Overall Study|PI decisions|0|||
27959046|NCT02707965|81683184|FG003|Overall Study|PI decisions|0|||
27959047|NCT02707965|81683185|FG004|Overall Study|PI decisions|0|||
27959048|NCT02707965|81683186|FG005|Overall Study|PI decisions|0|||
27959049|NCT02707965|81683187|FG006|Overall Study|PI decisions|0|||
27959050|NCT02707965|81683188|FG007|Overall Study|PI decisions|0|||
27959051|NCT02707965|81683189|FG008|Overall Study|PI decisions|0|||
27959052|NCT02707965|81683190|FG009|Overall Study|PI decisions|0|||
27959053|NCT02707965|81683191|FG010|Overall Study|PI decisions|0|||
27959054|NCT02707965|81683192|FG011|Overall Study|PI decisions|0|||
27959055|NCT02707965|81683193|FG012|Overall Study|PI decisions|0|||
27959056|NCT02707965|81683194|FG013|Overall Study|PI decisions|0|||
27959057|NCT02707965|81683195|FG014|Overall Study|PI decisions|2|||
27959058|NCT02707965|81683196|FG015|Overall Study|PI decisions|0|||
27959059|NCT02707965|81683181|FG000|Overall Study|Protocol deviation|1|||
27959060|NCT02707965|81683182|FG001|Overall Study|Protocol deviation|1|||
27959061|NCT02707965|81683183|FG002|Overall Study|Protocol deviation|0|||
27959062|NCT02707965|81683184|FG003|Overall Study|Protocol deviation|0|||
27959063|NCT02707965|81683185|FG004|Overall Study|Protocol deviation|0|||
27959064|NCT02707965|81683186|FG005|Overall Study|Protocol deviation|0|||
27959065|NCT02707965|81683187|FG006|Overall Study|Protocol deviation|0|||
27959066|NCT02707965|81683188|FG007|Overall Study|Protocol deviation|1|||
27959067|NCT02707965|81683189|FG008|Overall Study|Protocol deviation|0|||
27959068|NCT02707965|81683190|FG009|Overall Study|Protocol deviation|0|||
27959069|NCT02707965|81683191|FG010|Overall Study|Protocol deviation|0|||
27959070|NCT02707965|81683192|FG011|Overall Study|Protocol deviation|0|||
27959071|NCT02707965|81683193|FG012|Overall Study|Protocol deviation|0|||
27959072|NCT02707965|81683194|FG013|Overall Study|Protocol deviation|0|||
27959073|NCT02707965|81683195|FG014|Overall Study|Protocol deviation|0|||
27959074|NCT02707965|81683196|FG015|Overall Study|Protocol deviation|0|||
27959075|NCT01277822|81683199|FG000|Overall Study|Adverse Event|2|||
27959076|NCT01277822|81683200|FG001|Overall Study|Adverse Event|1|||
27959077|NCT01277822|81683199|FG000|Overall Study|Withdrawal by Subject|6|||
27959078|NCT01277822|81683200|FG001|Overall Study|Withdrawal by Subject|7|||
27959079|NCT01277822|81683199|FG000|Overall Study|Physician Decision|1|||
27959080|NCT01277822|81683200|FG001|Overall Study|Physician Decision|1|||
27959081|NCT01277822|81683199|FG000|Overall Study|Protocol Violation|1|||
27959082|NCT01277822|81683200|FG001|Overall Study|Protocol Violation|0|||
27959083|NCT01277822|81683199|FG000|Overall Study|Lost to Follow-up|2|||
27959084|NCT01277822|81683200|FG001|Overall Study|Lost to Follow-up|1|||
27959085|NCT01277822|81683199|FG000|Overall Study|Contraindicated medication used|2|||
27959086|NCT01277822|81683200|FG001|Overall Study|Contraindicated medication used|1|||
27959087|NCT01277822|81683199|FG000|Overall Study|Participant moved|1|||
27959088|NCT01277822|81683200|FG001|Overall Study|Participant moved|0|||
27959089|NCT00400517|81683203|FG000|Overall Study|Withdrawal by Subject|1|||
27959090|NCT00400517|81683203|FG000|Overall Study|Physician Decision|1|||
27959091|NCT01673646|81683206|FG000|Overall Study|Adverse Event|2|||
27959092|NCT01673646|81683207|FG001|Overall Study|Adverse Event|1|||
27959093|NCT01673646|81683208|FG002|Overall Study|Adverse Event|1|||
27959094|NCT01673646|81683206|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
27959095|NCT01673646|81683207|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
27959096|NCT01673646|81683208|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
27959097|NCT01673646|81683206|FG000|Overall Study|Condition no longer requires study drug|0|||
27959098|NCT01673646|81683207|FG001|Overall Study|Condition no longer requires study drug|1|||
27959099|NCT01673646|81683208|FG002|Overall Study|Condition no longer requires study drug|0|||
27959100|NCT01673646|81683206|FG000|Overall Study|Withdrawal by Subject|0|||
27959101|NCT01673646|81683207|FG001|Overall Study|Withdrawal by Subject|2|||
27959102|NCT01673646|81683208|FG002|Overall Study|Withdrawal by Subject|2|||
27959103|NCT01673646|81683206|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
27959104|NCT01673646|81683207|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
27959105|NCT01673646|81683208|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
27959106|NCT02969915|81683210|FG000|Overall Study|Death|104|||
27959107|NCT02969915|81683211|FG001|Overall Study|Death|125|||
27959108|NCT02969915|81683210|FG000|Overall Study|Lost to Follow-up|108|||
27959109|NCT02969915|81683211|FG001|Overall Study|Lost to Follow-up|112|||
27959110|NCT02969915|81683210|FG000|Overall Study|Censored due to COVID-19|481|||
27959111|NCT02969915|81683211|FG001|Overall Study|Censored due to COVID-19|471|||
27959112|NCT03386435|81683212|FG000|Overall Study|Protocol Violation|5|||
27959113|NCT03386435|81683213|FG001|Overall Study|Protocol Violation|7|||
27959114|NCT00506454|81683224|FG000|Overall Study|Withdrawal by Subject|1|||
27959115|NCT00506454|81683225|FG001|Overall Study|Withdrawal by Subject|1|||
27959116|NCT00984594|81683226|FG000|Overall Study|Lost to Follow-up|1|||
27959117|NCT00984594|81683227|FG001|Overall Study|Lost to Follow-up|0|||
27959118|NCT00984594|81683226|FG000|Overall Study|Withdrawal by Subject|0|||
27959119|NCT00984594|81683227|FG001|Overall Study|Withdrawal by Subject|1|||
27959120|NCT01170273|81683228|FG000|Overall Study|Lost to Follow-up|6|||
27959121|NCT01170273|81683229|FG001|Overall Study|Lost to Follow-up|8|||
27959122|NCT01170273|81683228|FG000|Overall Study|Protocol Violation|1|||
27959123|NCT01170273|81683229|FG001|Overall Study|Protocol Violation|0|||
27959124|NCT01170273|81683228|FG000|Overall Study|Death|1|||
27959125|NCT01170273|81683229|FG001|Overall Study|Death|0|||
27959126|NCT01170273|81683228|FG000|Overall Study|Adverse Event|0|||
27959127|NCT01170273|81683229|FG001|Overall Study|Adverse Event|1|||
27959128|NCT01853462|81683230|FG000|Overall Study|Withdrawal by Subject|1|||
27959129|NCT01853462|81683231|FG001|Overall Study|Withdrawal by Subject|1|||
27959130|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
27959131|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
27959132|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
27959133|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
27959134|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Death|58|||
27959135|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Death|65|||
27959136|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Adverse Event|28|||
27959137|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Adverse Event|40|||
27959138|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Disease Progression|22|||
27959139|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Disease Progression|35|||
27959140|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Other|25|||
27959141|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Other|33|||
27959142|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
27959143|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
27959144|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Noncompliance|8|||
27959145|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Noncompliance|8|||
27959146|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
27959147|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
27959148|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
27959149|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
27959150|NCT00286091|81683235|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
27959151|NCT00286091|81683236|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
27959152|NCT00286091|81683235|FG000|Open-label Treatment Phase|Physician Decision|24|||
27959153|NCT00286091|81683236|FG001|Open-label Treatment Phase|Physician Decision|21|||
27959154|NCT00286091|81683235|FG000|Open-label Treatment Phase|Adverse Event|5|||
27959155|NCT00286091|81683236|FG001|Open-label Treatment Phase|Adverse Event|16|||
27959156|NCT00286091|81683235|FG000|Open-label Treatment Phase|Other|11|||
27959157|NCT00286091|81683236|FG001|Open-label Treatment Phase|Other|11|||
27959158|NCT00286091|81683235|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
27959159|NCT00286091|81683236|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
27959160|NCT00286091|81683235|FG000|Open-label Treatment Phase|Death|10|||
27959161|NCT00286091|81683236|FG001|Open-label Treatment Phase|Death|7|||
27959162|NCT00286091|81683235|FG000|Open-label Treatment Phase|Disease Progression|9|||
27959163|NCT00286091|81683236|FG001|Open-label Treatment Phase|Disease Progression|3|||
27959164|NCT00286091|81683235|FG000|Open-label Treatment Phase|Noncompliance|3|||
27959165|NCT00286091|81683236|FG001|Open-label Treatment Phase|Noncompliance|1|||
27959166|NCT00286091|81683235|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
27959167|NCT00286091|81683236|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
27959168|NCT00286091|81683235|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
27959169|NCT00286091|81683236|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
27959170|NCT00286091|81683235|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
27959171|NCT00286091|81683236|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
27959172|NCT01722994|81683239|FG000|Overall Study|Missing data|25|||
27959173|NCT01722994|81683240|FG001|Overall Study|Missing data|17|||
27959174|NCT03230318|81683241|FG000|Overall Study|Radiographic disease progression|72|||
27959175|NCT03230318|81683242|FG001|Overall Study|Radiographic disease progression|19|||
27959176|NCT03230318|81683241|FG000|Overall Study|Clinical progression|17|||
27959177|NCT03230318|81683242|FG001|Overall Study|Clinical progression|7|||
27959178|NCT03230318|81683241|FG000|Overall Study|Adverse Event|5|||
27959179|NCT03230318|81683242|FG001|Overall Study|Adverse Event|3|||
27959180|NCT03230318|81683241|FG000|Overall Study|Physician Decision|2|||
27959181|NCT03230318|81683242|FG001|Overall Study|Physician Decision|3|||
27959182|NCT03230318|81683241|FG000|Overall Study|Death|3|||
27959183|NCT03230318|81683242|FG001|Overall Study|Death|2|||
27959184|NCT03230318|81683241|FG000|Overall Study|Lost to Follow-up|1|||
27959185|NCT03230318|81683242|FG001|Overall Study|Lost to Follow-up|0|||
27959186|NCT03230318|81683241|FG000|Overall Study|Withdrawal by Subject|1|||
27959187|NCT03230318|81683242|FG001|Overall Study|Withdrawal by Subject|3|||
27959188|NCT03230318|81683241|FG000|Overall Study|Other|3|||
27959189|NCT03230318|81683242|FG001|Overall Study|Other|7|||
27959190|NCT01393899|81683243|FG000|Overall Study|Study terminated by sponsor|1|||
27959191|NCT01393899|81683244|FG001|Overall Study|Study terminated by sponsor|0|||
27959192|NCT01393899|81683245|FG002|Overall Study|Study terminated by sponsor|1|||
27959193|NCT01393899|81683243|FG000|Overall Study|Other|1|||
27959194|NCT01393899|81683244|FG001|Overall Study|Other|0|||
27959195|NCT01393899|81683245|FG002|Overall Study|Other|0|||
27959196|NCT01393899|81683243|FG000|Overall Study|Withdrawal by Subject|2|||
27959197|NCT01393899|81683244|FG001|Overall Study|Withdrawal by Subject|2|||
27959198|NCT01393899|81683245|FG002|Overall Study|Withdrawal by Subject|1|||
27959199|NCT01393899|81683243|FG000|Overall Study|Lost to Follow-up|0|||
27959200|NCT01393899|81683244|FG001|Overall Study|Lost to Follow-up|0|||
27959201|NCT01393899|81683245|FG002|Overall Study|Lost to Follow-up|1|||
27959202|NCT01393899|81683243|FG000|Overall Study|Does not meet entrance criteria|1|||
27959203|NCT01393899|81683244|FG001|Overall Study|Does not meet entrance criteria|0|||
27959204|NCT01393899|81683245|FG002|Overall Study|Does not meet entrance criteria|1|||
27959205|NCT01393899|81683243|FG000|Overall Study|Lack of Efficacy|26|||
27959206|NCT01393899|81683244|FG001|Overall Study|Lack of Efficacy|21|||
27959207|NCT01393899|81683245|FG002|Overall Study|Lack of Efficacy|16|||
27959208|NCT01393899|81683243|FG000|Overall Study|Adverse Event|1|||
27959209|NCT01393899|81683244|FG001|Overall Study|Adverse Event|5|||
27959210|NCT01393899|81683245|FG002|Overall Study|Adverse Event|3|||
27959211|NCT00699413|81683246|FG000|Overall Study|Withdrawal by Subject|0|||
27959212|NCT00699413|81683247|FG001|Overall Study|Withdrawal by Subject|2|||
27959213|NCT00699413|81683246|FG000|Overall Study|Study terminated by sponsor|4|||
27959214|NCT00699413|81683247|FG001|Overall Study|Study terminated by sponsor|2|||
27959215|NCT04263766|81683254|FG000|Overall Study|Withdrawal by Subject|6|||
27959216|NCT04263766|81683255|FG001|Overall Study|Withdrawal by Subject|4|||
27959217|NCT04263766|81683254|FG000|Overall Study|Lack of Efficacy|1|||
27959218|NCT04263766|81683255|FG001|Overall Study|Lack of Efficacy|3|||
27959219|NCT01978145|81683256|FG000|Treatment Period 1|Adverse Event|1|||
27959220|NCT01978145|81683257|FG001|Treatment Period 1|Adverse Event|9|||
27959221|NCT01978145|81683256|FG000|Treatment Period 1|Physician Decision|1|||
27959222|NCT01978145|81683257|FG001|Treatment Period 1|Physician Decision|0|||
27959223|NCT01978145|81683256|FG000|Treatment Period 1|Withdrawal by Subject|5|||
27959224|NCT01978145|81683257|FG001|Treatment Period 1|Withdrawal by Subject|4|||
27959225|NCT01978145|81683256|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
27959226|NCT01978145|81683257|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
27959227|NCT01978145|81683256|FG000|Washout Period 1|Adverse Event|0|||
27959229|NCT01978145|81683256|FG000|Washout Period 1|Withdrawal by Subject|1|||
27959230|NCT01978145|81683257|FG001|Washout Period 1|Withdrawal by Subject|1|||
27959231|NCT01978145|81683256|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
27959232|NCT01978145|81683257|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
27959233|NCT01978145|81683256|FG000|Treatment Period 2|Adverse Event|3|||
27959234|NCT01978145|81683257|FG001|Treatment Period 2|Adverse Event|3|||
27959235|NCT01978145|81683256|FG000|Treatment Period 2|Protocol Violation|0|||
27959236|NCT01978145|81683257|FG001|Treatment Period 2|Protocol Violation|1|||
27959237|NCT01978145|81683256|FG000|Treatment Period 2|Lost to Follow-up|1|||
27959238|NCT01978145|81683257|FG001|Treatment Period 2|Lost to Follow-up|1|||
27959239|NCT01978145|81683256|FG000|Treatment Period 2|Withdrawal by Subject|7|||
27959240|NCT01978145|81683257|FG001|Treatment Period 2|Withdrawal by Subject|4|||
27959241|NCT01978145|81683256|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
27959242|NCT01978145|81683257|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
27959243|NCT01462929|81683258|FG000|Overall Study|Adverse Event|3|||
27959244|NCT01462929|81683259|FG001|Overall Study|Adverse Event|3|||
27959245|NCT01462929|81683260|FG002|Overall Study|Adverse Event|4|||
27959246|NCT01462929|81683258|FG000|Overall Study|Withdrawal by Subject|2|||
27959247|NCT01462929|81683259|FG001|Overall Study|Withdrawal by Subject|1|||
27959248|NCT01462929|81683260|FG002|Overall Study|Withdrawal by Subject|0|||
27959249|NCT01462929|81683258|FG000|Overall Study|Lack of Efficacy|0|||
27959250|NCT01462929|81683259|FG001|Overall Study|Lack of Efficacy|0|||
27959251|NCT01462929|81683260|FG002|Overall Study|Lack of Efficacy|1|||
27959252|NCT02375373|81683261|FG000|Overall Study|Withdrawal by Subject|11|||
27959253|NCT03432494|81683262|FG000|Overall Study|Death|1|||
27959254|NCT03432494|81683262|FG000|Overall Study|Noncompliance|1|||
27959255|NCT02581891|81683263|FG000|Overall Study|Adverse Event|4|||
27959256|NCT02581891|81683264|FG001|Overall Study|Adverse Event|6|||
27959257|NCT02581891|81683263|FG000|Overall Study|Death|3|||
27959258|NCT02581891|81683264|FG001|Overall Study|Death|4|||
27959259|NCT02581891|81683263|FG000|Overall Study|Lost to Follow-up|1|||
27959260|NCT02581891|81683264|FG001|Overall Study|Lost to Follow-up|2|||
27959261|NCT02581891|81683263|FG000|Overall Study|Physician Decision|0|||
27959262|NCT02581891|81683264|FG001|Overall Study|Physician Decision|1|||
27959263|NCT02581891|81683263|FG000|Overall Study|Withdrawal by Subject|4|||
27959264|NCT02581891|81683264|FG001|Overall Study|Withdrawal by Subject|5|||
27959265|NCT02581891|81683263|FG000|Overall Study|Other Reasons|3|||
27959266|NCT02581891|81683264|FG001|Overall Study|Other Reasons|1|||
27959267|NCT02581891|81683263|FG000|Overall Study|Discontinued during followup|1|||
27959268|NCT02581891|81683264|FG001|Overall Study|Discontinued during followup|0|||
27959269|NCT01000506|81683265|FG000|Overall Study|Adverse Event|6|||
27959270|NCT01000506|81683266|FG001|Overall Study|Adverse Event|5|||
27959271|NCT01000506|81683267|FG002|Overall Study|Adverse Event|8|||
27959272|NCT01000506|81683268|FG003|Overall Study|Adverse Event|9|||
27959273|NCT01000506|81683265|FG000|Overall Study|Lack of Efficacy|8|||
27959274|NCT01000506|81683266|FG001|Overall Study|Lack of Efficacy|6|||
27959275|NCT01000506|81683267|FG002|Overall Study|Lack of Efficacy|4|||
27959276|NCT01000506|81683268|FG003|Overall Study|Lack of Efficacy|4|||
27959277|NCT01000506|81683265|FG000|Overall Study|Protocol Violation|1|||
27959278|NCT01000506|81683266|FG001|Overall Study|Protocol Violation|1|||
27959279|NCT01000506|81683267|FG002|Overall Study|Protocol Violation|0|||
27959280|NCT01000506|81683268|FG003|Overall Study|Protocol Violation|0|||
27959281|NCT01000506|81683265|FG000|Overall Study|Lost to Follow-up|1|||
27959282|NCT01000506|81683266|FG001|Overall Study|Lost to Follow-up|1|||
27959283|NCT01000506|81683267|FG002|Overall Study|Lost to Follow-up|4|||
27959284|NCT01000506|81683268|FG003|Overall Study|Lost to Follow-up|0|||
27959285|NCT01000506|81683265|FG000|Overall Study|Physician Decision|1|||
27959286|NCT01000506|81683266|FG001|Overall Study|Physician Decision|3|||
27959287|NCT01000506|81683267|FG002|Overall Study|Physician Decision|3|||
27959288|NCT01000506|81683268|FG003|Overall Study|Physician Decision|3|||
27959289|NCT01000506|81683265|FG000|Overall Study|Withdrawal by Subject|11|||
27959290|NCT01000506|81683266|FG001|Overall Study|Withdrawal by Subject|8|||
27959291|NCT01000506|81683267|FG002|Overall Study|Withdrawal by Subject|2|||
27959292|NCT01000506|81683268|FG003|Overall Study|Withdrawal by Subject|7|||
27959293|NCT02131662|81683269|FG000|Overall Study|Protocol Violation|1|||
27959294|NCT02131662|81683270|FG001|Overall Study|Protocol Violation|0|||
27959295|NCT02131662|81683271|FG002|Overall Study|Protocol Violation|0|||
27959296|NCT02131662|81683272|FG003|Overall Study|Protocol Violation|0|||
27959297|NCT02131662|81683273|FG004|Overall Study|Protocol Violation|0|||
27959298|NCT02131662|81683269|FG000|Overall Study|Other|2|||
27959299|NCT02131662|81683270|FG001|Overall Study|Other|4|||
27959300|NCT02131662|81683271|FG002|Overall Study|Other|3|||
27959301|NCT02131662|81683272|FG003|Overall Study|Other|3|||
27959302|NCT02131662|81683273|FG004|Overall Study|Other|4|||
27959303|NCT02131662|81683269|FG000|Overall Study|Adverse Event|0|||
27959304|NCT02131662|81683270|FG001|Overall Study|Adverse Event|1|||
27959305|NCT02131662|81683271|FG002|Overall Study|Adverse Event|1|||
27959306|NCT02131662|81683272|FG003|Overall Study|Adverse Event|1|||
27959307|NCT02131662|81683273|FG004|Overall Study|Adverse Event|3|||
27959323|NCT02131662|81683269|FG000|Overall Study|Withdrawal by Subject|1|||
27959324|NCT02131662|81683270|FG001|Overall Study|Withdrawal by Subject|5|||
27959325|NCT02131662|81683271|FG002|Overall Study|Withdrawal by Subject|1|||
27959326|NCT02131662|81683272|FG003|Overall Study|Withdrawal by Subject|5|||
27959327|NCT02131662|81683273|FG004|Overall Study|Withdrawal by Subject|6|||
27959328|NCT02131662|81683269|FG000|Overall Study|Lost to Follow-up|1|||
27959329|NCT02131662|81683270|FG001|Overall Study|Lost to Follow-up|3|||
27959330|NCT02131662|81683271|FG002|Overall Study|Lost to Follow-up|0|||
27959331|NCT02131662|81683272|FG003|Overall Study|Lost to Follow-up|9|||
27959332|NCT02131662|81683273|FG004|Overall Study|Lost to Follow-up|0|||
27959333|NCT02131662|81683269|FG000|Overall Study|Not treated|2|||
27959334|NCT02131662|81683270|FG001|Overall Study|Not treated|0|||
27959335|NCT02131662|81683271|FG002|Overall Study|Not treated|2|||
27959336|NCT02131662|81683272|FG003|Overall Study|Not treated|2|||
27959337|NCT02131662|81683273|FG004|Overall Study|Not treated|3|||
27959338|NCT01558115|81683277|FG000|Overall Study|Withdrawal by Subject|3|||
27959339|NCT01558115|81683277|FG000|Overall Study|Study closed due to poor enrollment|4|||
27959340|NCT00401843|81683278|FG000|Overall Study|Achieved Complete Response|1|||
27959341|NCT00401843|81683279|FG001|Overall Study|Achieved Complete Response|5|||
27959342|NCT00401843|81683280|FG002|Overall Study|Achieved Complete Response|11|||
27959343|NCT00401843|81683278|FG000|Overall Study|Adverse Event|7|||
27959344|NCT00401843|81683279|FG001|Overall Study|Adverse Event|26|||
27959345|NCT00401843|81683280|FG002|Overall Study|Adverse Event|27|||
27959346|NCT00401843|81683278|FG000|Overall Study|Death|0|||
27959347|NCT00401843|81683279|FG001|Overall Study|Death|8|||
27959348|NCT00401843|81683280|FG002|Overall Study|Death|10|||
27959349|NCT00401843|81683278|FG000|Overall Study|Disease progression|10|||
27959350|NCT00401843|81683279|FG001|Overall Study|Disease progression|60|||
27959351|NCT00401843|81683280|FG002|Overall Study|Disease progression|49|||
27959352|NCT00401843|81683278|FG000|Overall Study|End of Study|1|||
27959353|NCT00401843|81683279|FG001|Overall Study|End of Study|1|||
27959354|NCT00401843|81683280|FG002|Overall Study|End of Study|2|||
27959355|NCT00401843|81683278|FG000|Overall Study|Lost to Follow-up|0|||
27959356|NCT00401843|81683279|FG001|Overall Study|Lost to Follow-up|0|||
27959357|NCT00401843|81683280|FG002|Overall Study|Lost to Follow-up|2|||
27959358|NCT00401843|81683278|FG000|Overall Study|Other Unspecified|0|||
27959359|NCT00401843|81683279|FG001|Overall Study|Other Unspecified|3|||
27959360|NCT00401843|81683280|FG002|Overall Study|Other Unspecified|5|||
27959361|NCT00401843|81683278|FG000|Overall Study|Physician Decision|0|||
27959362|NCT00401843|81683279|FG001|Overall Study|Physician Decision|16|||
27959363|NCT00401843|81683280|FG002|Overall Study|Physician Decision|10|||
27959364|NCT00401843|81683278|FG000|Overall Study|Protocol Violation|0|||
27959365|NCT00401843|81683279|FG001|Overall Study|Protocol Violation|0|||
27959366|NCT00401843|81683280|FG002|Overall Study|Protocol Violation|1|||
27959367|NCT00401843|81683278|FG000|Overall Study|Withdrawal by Subject|1|||
27959368|NCT00401843|81683279|FG001|Overall Study|Withdrawal by Subject|5|||
27959369|NCT00401843|81683280|FG002|Overall Study|Withdrawal by Subject|5|||
27959370|NCT00401843|81683278|FG000|Overall Study|Withdrawal of consent to study agent|1|||
27959371|NCT00401843|81683279|FG001|Overall Study|Withdrawal of consent to study agent|15|||
27959372|NCT00401843|81683280|FG002|Overall Study|Withdrawal of consent to study agent|17|||
27959373|NCT00401843|81683278|FG000|Overall Study|Randomized but not Treated|0|||
27959374|NCT00401843|81683279|FG001|Overall Study|Randomized but not Treated|2|||
27959375|NCT00401843|81683280|FG002|Overall Study|Randomized but not Treated|3|||
27959376|NCT00401843|81683278|FG000|Overall Study|Received incorrect treatment|0|||
27959377|NCT00401843|81683279|FG001|Overall Study|Received incorrect treatment|3|||
27959378|NCT00401843|81683280|FG002|Overall Study|Received incorrect treatment|0|||
27959379|NCT04971967|81683282|FG000|Overall Study|Lost to Follow-up|6|||
27959380|NCT04971967|81683283|FG001|Overall Study|Lost to Follow-up|7|||
27959381|NCT01194245|81683284|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
27959382|NCT01194245|81683285|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27959383|NCT01194245|81683286|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27959384|NCT01194245|81683287|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27959385|NCT01194245|81683288|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
27959386|NCT01194245|81683284|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
27959387|NCT01194245|81683285|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27959388|NCT01194245|81683286|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27959389|NCT01194245|81683287|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27959390|NCT01194245|81683288|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
27959391|NCT01194245|81683284|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
27959392|NCT01194245|81683285|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27959393|NCT01194245|81683286|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27959394|NCT01194245|81683287|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27959395|NCT01194245|81683288|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
27959396|NCT01194245|81683284|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
27959397|NCT01194245|81683285|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27959398|NCT01194245|81683286|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27959399|NCT01194245|81683287|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27959400|NCT01194245|81683288|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
27959401|NCT01194245|81683284|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27959402|NCT01194245|81683285|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27959403|NCT01194245|81683286|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27959404|NCT01194245|81683287|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
27959405|NCT01194245|81683288|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
27959406|NCT01194245|81683284|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27959407|NCT01194245|81683285|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
27959408|NCT01194245|81683286|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
27959409|NCT01194245|81683287|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
27959410|NCT01194245|81683288|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
27959411|NCT01508910|81683289|FG000|Treatment|Death|2|||
27959412|NCT01508910|81683290|FG001|Treatment|Death|3|||
27959413|NCT01508910|81683291|FG002|Treatment|Death|2|||
27959414|NCT01508910|81683292|FG003|Treatment|Death|0|||
27959415|NCT01508910|81683289|FG000|Treatment|Lost to Follow-up|0|||
27959416|NCT01508910|81683290|FG001|Treatment|Lost to Follow-up|0|||
27959417|NCT01508910|81683291|FG002|Treatment|Lost to Follow-up|2|||
27959418|NCT01508910|81683292|FG003|Treatment|Lost to Follow-up|1|||
27959419|NCT01508910|81683289|FG000|Treatment|Withdrawal by Subject|0|||
27959420|NCT01508910|81683290|FG001|Treatment|Withdrawal by Subject|1|||
27959421|NCT01508910|81683291|FG002|Treatment|Withdrawal by Subject|6|||
27959422|NCT01508910|81683292|FG003|Treatment|Withdrawal by Subject|1|||
27959423|NCT01508910|81683289|FG000|Treatment|Sponsor Decision|0|||
27959424|NCT01508910|81683290|FG001|Treatment|Sponsor Decision|0|||
27959425|NCT01508910|81683291|FG002|Treatment|Sponsor Decision|0|||
27959426|NCT01508910|81683292|FG003|Treatment|Sponsor Decision|1|||
27959427|NCT03547908|81683293|FG000|Overall Study|Still On Study|115|||
27959428|NCT03547908|81683294|FG001|Overall Study|Still On Study|118|||
27959429|NCT03547908|81683293|FG000|Overall Study|Lost to Follow-up|2|||
27959430|NCT03547908|81683294|FG001|Overall Study|Lost to Follow-up|2|||
27959431|NCT03547908|81683293|FG000|Overall Study|Withdrew Consent|2|||
27959432|NCT03547908|81683294|FG001|Overall Study|Withdrew Consent|1|||
27959433|NCT03547908|81683293|FG000|Overall Study|Adverse Event|1|||
27959434|NCT03547908|81683294|FG001|Overall Study|Adverse Event|0|||
27959435|NCT03547908|81683293|FG000|Overall Study|Death|1|||
27959436|NCT03547908|81683294|FG001|Overall Study|Death|0|||
27959437|NCT03547908|81683293|FG000|Overall Study|Investigator's Discretion|0|||
27959438|NCT03547908|81683294|FG001|Overall Study|Investigator's Discretion|1|||
27959439|NCT03547908|81683293|FG000|Overall Study|Randomized But Never Treated|1|||
27959440|NCT03547908|81683294|FG001|Overall Study|Randomized But Never Treated|0|||
27959441|NCT00120627|81683295|FG000|Overall Study|Withdrawal by Subject|5|||
27959442|NCT00120627|81683296|FG001|Overall Study|Withdrawal by Subject|5|||
27959443|NCT00625586|81683297|FG000|Overall Study|Adverse Event|1|||
27959444|NCT00625586|81683297|FG000|Overall Study|Progressive disease|1|||
27959445|NCT01284959|81683298|FG000|Overall Study|Withdrawal by Subject|1|||
27959446|NCT01284959|81683299|FG001|Overall Study|Withdrawal by Subject|0|||
27959447|NCT01284959|81683300|FG002|Overall Study|Withdrawal by Subject|0|||
27959448|NCT01284959|81683298|FG000|Overall Study|Adverse Event|0|||
27959449|NCT01284959|81683299|FG001|Overall Study|Adverse Event|0|||
27959450|NCT01284959|81683300|FG002|Overall Study|Adverse Event|1|||
27959451|NCT02484443|81683301|FG000|Overall Study|Lack of Efficacy|28|||
27959452|NCT02484443|81683301|FG000|Overall Study|Physician Decision|2|||
27959453|NCT02484443|81683301|FG000|Overall Study|Ineligible|2|||
